PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Cionni, M; Menke, C; Stottmann, RW				Cionni, Megan; Menke, Chelsea; Stottmann, Rolf W.			The Mouse MC13 Mutant Is a Novel ENU Mutation in Collagen Type II, Alpha 1	PLOS ONE			English	Article							STICKLER SYNDROME ARTHROOPHTHALMOPATHY; COL2A1 GENE; PROCOLLAGEN COL2A1; TRANSGENIC MICE; PHENOTYPE; SCREEN; INACTIVATION; MUTAGENESIS; CODON	Phenotype-driven mutagenesis experiments are a powerful approach to identifying novel alleles in a variety of contexts. The traditional disadvantage of this approach has been the subsequent task of identifying the affected locus in the mutants of interest. Recent advances in bioinformatics and sequencing have reduced the burden of cloning these ENU mutants. Here we report our experience with an ENU mutagenesis experiment and the rapid identification of a mutation in a previously known gene. A combination of mapping the mutation with a high-density SNP panel and a candidate gene approach has identified a mutation in collagen type II, alpha I (Col2a1). Col2a1 has previously been studied in the mouse and our mutant phenotype closely resembles mutations made in the Col2a1 locus.	[Cionni, Megan; Menke, Chelsea; Stottmann, Rolf W.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Human Genet, Cincinnati, OH 45229 USA; [Stottmann, Rolf W.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Dev Biol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Stottmann, RW (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Human Genet, Cincinnati, OH 45229 USA.	rolf.stottmann@cchmc.org	Stottmann, Rolf/U-6589-2019; Stottmann, Rolf/GRO-3453-2022	Stottmann, Rolf/0000-0003-4512-6806	Cincinnati Children's Research Foundation; National Institutes of Health [R01NS085023]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085023] Funding Source: NIH RePORTER	Cincinnati Children's Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the Cincinnati Children's Research Foundation (Change the Outcome Fund and Trustee Grant Program) and the National Institutes of Health (R01NS085023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD NN, 1991, P NATL ACAD SCI USA, V88, P6624, DOI 10.1073/pnas.88.15.6624; AHMAD NN, 1993, AM J HUM GENET, V52, P39; Bateman JF, 2009, NAT REV GENET, V10, P173, DOI 10.1038/nrg2520; BROWN DM, 1992, ARCH OPHTHALMOL-CHIC, V110, P1589, DOI 10.1001/archopht.1992.01080230089027; Buchovecky CM, 2013, NAT GENET, V45, P1013, DOI 10.1038/ng.2714; Dwyer ND, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-3; FRANCOMANO C A, 1987, Genomics, V1, P293, DOI 10.1016/0888-7543(87)90027-9; Ha S., 2013, CEREB CORTEX; Herron BJ, 2002, NAT GENET, V30, P185, DOI 10.1038/ng812; Hoornaert KP, 2006, J MED GENET, V43, P406, DOI 10.1136/jmg.2005.035717; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Kaarniranta K, 2006, EXP EYE RES, V83, P297, DOI 10.1016/j.exer.2005.11.027; Kamp A, 2010, HUM MOL GENET, V19, P3105, DOI 10.1093/hmg/ddq211; Kannu P, 2012, J PAEDIATR CHILD H, V48, pE38, DOI 10.1111/j.1440-1754.2010.01979.x; KORKKO J, 1993, AM J HUM GENET, V53, P55; LI SW, 1995, GENE DEV, V9, P2821, DOI 10.1101/gad.9.22.2821; Nagy A., 2003, MANIPULATING MOUSE E; RITVANIEMI P, 1993, GENOMICS, V17, P218, DOI 10.1006/geno.1993.1306; Stottmann RW, 2011, GENETICS, V188, P615, DOI 10.1534/genetics.111.126862; Stottmann RW, 2010, METHOD ENZYMOL, V477, P329, DOI 10.1016/S0076-6879(10)77017-8; VANDENBERG P, 1991, P NATL ACAD SCI USA, V88, P7640, DOI 10.1073/pnas.88.17.7640; Williams CJ, 1996, AM J MED GENET, V63, P461, DOI 10.1002/(SICI)1096-8628(19960614)63:3<461::AID-AJMG9>3.0.CO;2-U	22	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e116104	10.1371/journal.pone.0116104	http://dx.doi.org/10.1371/journal.pone.0116104			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541700	Green Submitted, Green Published, gold			2022-12-27	WOS:000347239900142
J	Ditekemena, J; Luhata, C; Bonane, W; Kiumbu, M; Tshefu, A; Colebunders, R; Koole, O				Ditekemena, John; Luhata, Christophe; Bonane, William; Kiumbu, Modeste; Tshefu, Antoinette; Colebunders, Robert; Koole, Olivier			Antiretroviral Treatment Program Retention among HIV-Infected Children in the Democratic Republic of Congo	PLOS ONE			English	Article							RESOURCE-LIMITED SETTINGS; FOLLOW-UP; MORTALITY; THERAPY; OUTCOMES; EXPERIENCE	Background: Retaining patients with HIV infection in care is still a major challenge in sub-Saharan Africa, particularly in the Democratic Republic of Congo (DRC) where the antiretroviral treatment (ART) coverage is low. Monitoring retention is an important tool for evaluating the quality of care. Methods and Findings: A review of medical records of HIV -infected children was performed in three health facilities in the DRC: the Amo-Congo Health center, the Monkole Clinic in Kinshasa, and the HEAL Africa Clinic in Goma. Medical records of 720 children were included. Kaplan Meier curves were constructed with the probability of retention at 6 months, 1 year, 2 years and 3 years. Retention rates were: 88.2% (95% CI: 85.1%-90.8%) at 6 months; 85% (95% CI: 81.5%-87.6%) at one year; 79.4% (95% CI: 75.5%-82.8%) at two years and 74.7% (95% CI: 70.5%-78.5%) at 3 years. The retention varied across study sites: 88.2%, 66.6% and 92.5% at 6 months; 84%, 59% and 90% at 12 months and 75.7%, 56.3% and 85.8% at 24 months respectively for Amo-Congo/Kasavubu, Monkole facility and HEAL Africa. After multivariable Cox regression four variables remained independently associated with attrition: study site, CD4 cell count,350 cells/mu L, children younger than 2 years and children whose caregivers were member of an independent church. Conclusions: Attrition remains a challenge for pediatric HIV positive patients in ART programs in DRC. In addition, the low coverage of pediatric treatment exacerbates the situation of pediatric HIV/AIDS.	[Ditekemena, John] Elizabeth Glaser Paediat AIDS Fdn, Kinshasa, DEM REP CONGO; [Luhata, Christophe; Kiumbu, Modeste; Tshefu, Antoinette] Sch Publ Hlth, Kinshasa, DEM REP CONGO; [Bonane, William] Heal Africa, Goma, DEM REP CONGO; [Colebunders, Robert] Univ Antwerp, B-2020 Antwerp, Belgium; [Koole, Olivier] London Sch Hyg & Trop Med, London WC1, England	University of Antwerp; University of London; London School of Hygiene & Tropical Medicine	Ditekemena, J (corresponding author), Elizabeth Glaser Paediat AIDS Fdn, Kinshasa, DEM REP CONGO.	Jditekemena@pedaids.org		Koole, Olivier/0000-0002-1122-5382; Colebunders, Robert/0000-0002-1919-1340	General Direction of Cooperation and Development (GDCD) from the Belgium Technical Cooperation	General Direction of Cooperation and Development (GDCD) from the Belgium Technical Cooperation	This study was carried out with funding provided by the General Direction of Cooperation and Development (GDCD) from the Belgium Technical Cooperation. GDCD didn't have any role in study design, data collection and analysis, manuscript development or decision to publish.	[Anonymous], 2013, UNAIDS REP GLOB AIDS; Arrive E, 2008, JAIDS-J ACQ IMM DEF, V49, P523, DOI 10.1097/QAI.0b013e31818aadce; Baveewo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019089; Cowburn C, 2007, ARCH DIS CHILD, V92, P234, DOI 10.1136/adc.2005.074856; Davies MA, 2009, SAMJ S AFR MED J, V99, P730; Decroo T, 2011, JAIDS-J ACQ IMM DEF, V56, pE39, DOI 10.1097/QAI.0b013e3182055138; Ditekemena J, 2011, INT J STD AIDS, V22, P165, DOI 10.1258/ijsa.2010.010379; Ekouevi DK, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-519; Eley B, 2004, SAMJ S AFR MED J, V94, P643; Ellis J, 2007, ANN TROP PAEDIATR, V27, P261, DOI 10.1179/146532807X245643; Fassinou P, 2004, AIDS, V18, P1905, DOI 10.1097/00002030-200409240-00006; Fatti G, 2012, J INT AIDS SOC, V15, P265, DOI 10.7448/IAS.15.2.17381; Fenner L, 2010, JAIDS-J ACQ IMM DEF, V54, P524, DOI 10.1097/QAI.0b013e3181e0c4cf; Forster M, 2008, B WORLD HEALTH ORGAN, V86, P939, DOI 10.2471/BLT.07.049908; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Koole O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040971; Mbaye AD, 2005, ARCH PEDIATRIE, V12, P404, DOI 10.1016/j.arcped.2005.01.011; McNairy ML, 2013, JAIDS-J ACQ IMM DEF, V62, pE70, DOI 10.1097/QAI.0b013e318278bcb0; Ministeres du plan et de la Sante, 2007, ENQ DEM SANT 2007; Musheke M, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.3.17366; Niekerk NKMV, 2006, J TROP PEDIATRICS, V52, P3, DOI 10.1093/tropej/fmi047; O'Brien DP, 2006, AIDS, V20, P1955, DOI 10.1097/01.aids.0000247117.66585.ce; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Sauvageot D, 2010, PEDIATRICS, V125, pE1039, DOI 10.1542/peds.2009-1062; Shroufi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064717; Sutcliffe CG, 2008, LANCET INFECT DIS, V8, P477, DOI 10.1016/S1473-3099(08)70180-4; UNAIDS, 2013, PROGR REP GLOB PLAN; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; World Health Organization, 2021, ANT DRUGS TREAT PREG	29	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e113877	10.1371/journal.pone.0113877	http://dx.doi.org/10.1371/journal.pone.0113877			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541707	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000347239900007
J	Fichna, JP; Karolczak, J; Potulska-Chromik, A; Miszta, P; Berdynski, M; Sikorska, A; Filipek, S; Redowicz, MJ; Kaminska, A; Zekanowski, C				Fichna, Jakub Piotr; Karolczak, Justyna; Potulska-Chromik, Anna; Miszta, Przemyslaw; Berdynski, Mariusz; Sikorska, Agata; Filipek, Slawomir; Redowicz, Maria Jolanta; Kaminska, Anna; Zekanowski, Cezary			Two Desmin Gene Mutations Associated with Myofibrillar Myopathies in Polish Families	PLOS ONE			English	Article							INTERMEDIATE-FILAMENTS; MISSENSE MUTATION; SKELETAL; ARCHITECTURE; DYNAMICS; DELETION; PATIENT; DOMAIN; BLOCK	Desmin is a muscle-specific intermediate filament protein which forms a network connecting the sarcomere, T tubules, sarcolemma, nuclear membrane, mitochondria and other organelles. Mutations in the gene coding for desmin (DES) cause skeletal myopathies often combined with cardiomyopathy, or isolated cardiomyopathies. The molecular pathomechanisms of the disease remain ambiguous. Here, we describe and comprehensively characterize two DES mutations found in Polish patients with a clinical diagnosis of desminopathy. The study group comprised 16 individuals representing three families. Two mutations were identified: a novel missense mutation (Q348P) and a small deletion of nine nucleotides (A357_E359del), previously described by us in the Polish population. A common ancestry of all the families bearing the A357_E359del mutation was confirmed. Both mutations were predicted to be pathogenic using a bioinformatics approach, including molecular dynamics simulations which helped to rationalize abnormal behavior at molecular level. To test the impact of the mutations on DES expression and the intracellular distribution of desmin muscle biopsies were investigated. Elevated desmin levels as well as its atypical localization in muscle fibers were observed. Additional staining for M-cadherin, a-actinin, and myosin heavy chains confirmed severe disruption of myofibrill organization. The abnormalities were more prominent in the Q348P muscle, where both small atrophic fibers as well large fibers with centrally localized nuclei were observed. We propose that the mutations affect desmin structure and cause its aberrant folding and subsequent aggregation, triggering disruption of myofibrils organization.	[Fichna, Jakub Piotr; Berdynski, Mariusz; Zekanowski, Cezary] Polish Acad Sci, Mossakowski Med Res Ctr, Dept Neurodegenerat Disorders, Warsaw, Poland; [Karolczak, Justyna; Sikorska, Agata; Redowicz, Maria Jolanta] Polish Acad Sci, Nencki Inst Expt Biol, Dept Biochem, Warsaw, Poland; [Potulska-Chromik, Anna; Kaminska, Anna] Med Univ Warsaw, Dept Neurol, Warsaw, Poland; [Miszta, Przemyslaw; Filipek, Slawomir] Univ Warsaw, Fac Chem, Warsaw, Poland; [Miszta, Przemyslaw; Filipek, Slawomir] Univ Warsaw, Biol & Chem Res Ctr, Warsaw, Poland; [Kaminska, Anna] Polish Acad Sci, Mossakowski Med Res Ctr, Neuromuscular Unit, Warsaw, Poland	Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Medical University of Warsaw; University of Warsaw; University of Warsaw; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences	Zekanowski, C (corresponding author), Polish Acad Sci, Mossakowski Med Res Ctr, Dept Neurodegenerat Disorders, Warsaw, Poland.	c.zekanowski@imdik.pan.pl	Berdyński, Mariusz/W-2382-2018; Sikorska, Agata/AAU-2962-2021; Fichna, Jakub P/X-7524-2018; Redowicz, Maria Jolanta/R-4083-2016; Redowicz, Maria Jolanta/AAM-8020-2020; Filipek, Slawomir/A-2985-2008	Berdyński, Mariusz/0000-0003-2076-4318; Fichna, Jakub P/0000-0002-4077-4807; Redowicz, Maria Jolanta/0000-0001-5834-471X; Potulska-Chromik, Anna/0000-0002-8332-1090; Zekanowski, Cezary/0000-0001-7332-8494; Sikorska, Agata/0000-0001-7737-9918; Filipek, Slawomir/0000-0003-3147-3858	National Science Centre (Poland) [2012/05/D/NZ4/02978, 2013/09/B/NZ4/03258]; National Scientific Leading Centre (KNOW-MMRC); Ministry of Science and Higher Education	National Science Centre (Poland)(National Science Centre, Poland); National Scientific Leading Centre (KNOW-MMRC); Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	Funding: This work was supported by the National Science Centre (Poland) grants 2012/05/D/NZ4/02978 and 2013/09/B/NZ4/03258 (CZ, MJR, AS, JK), as well as by the National Scientific Leading Centre (KNOW-MMRC) project (JPF). This work was also supported by a statutory grant to the Department of Neurology, Medical University of Warsaw from the Ministry of Science and Higher Education (APC, AK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen M., 2017, COMPUTER SIMULATIONS, V2nd; Antonarakis SE, 2010, VOGEL AND MOTULSKY'S HUMAN GENETICS, FOURTH EDITION, P319, DOI 10.1007/978-3-540-37654-5_10; Arslan M, 2011, COMPUT METHOD BIOMEC, V14, P483, DOI 10.1080/10255842.2011.560147; Bar H, 2005, HUM MOL GENET, V14, P1251, DOI 10.1093/hmg/ddi136; Bar H, 2004, J STRUCT BIOL, V148, P137, DOI 10.1016/j.jsb.2004.04.003; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Cao LL, 2013, CLIN NEUROPATHOL, V32, P9, DOI 10.5414/NP300514; Chernyatina AA, 2012, P NATL ACAD SCI USA, V109, P13620, DOI 10.1073/pnas.1206836109; Clemen CS, 2013, ACTA NEUROPATHOL, V125, P47, DOI 10.1007/s00401-012-1057-6; Cotton RGH, 1998, HUM MUTAT, V12, P1, DOI 10.1002/(SICI)1098-1004(1998)12:1<1::AID-HUMU1>3.0.CO;2-M; Dagvadorj A, 2003, MUSCLE NERVE, V27, P669, DOI 10.1002/mus.10370; Dalakas MC, 2003, NEUROMUSCULAR DISORD, V13, P252, DOI 10.1016/S0960-8966(02)00271-7; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Fidzianska A, 2005, NEUROMUSCULAR DISORD, V15, P525, DOI 10.1016/j.nmd.2005.05.006; Fuchs E, 1996, ANNU REV GENET, V30, P197, DOI 10.1146/annurev.genet.30.1.197; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; Goldfarb LG, 1998, NAT GENET, V19, P402, DOI 10.1038/1300; Herrmann H, 2009, J CLIN INVEST, V119, P1772, DOI 10.1172/JCI38214; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Kaminska A, 2004, HUM GENET, V114, P306, DOI 10.1007/s00439-003-1057-7; Klaavuniemi T, 2006, EXP CELL RES, V312, P1299, DOI 10.1016/j.yexcr.2005.12.036; LETAI A, 1993, P NATL ACAD SCI USA, V90, P3197, DOI 10.1073/pnas.90.8.3197; LI ZL, 1989, GENE, V78, P243; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; Munoz-Marmol AM, 1998, P NATL ACAD SCI USA, V95, P11312, DOI 10.1073/pnas.95.19.11312; Olive M, 2013, CURR OPIN NEUROL, V26, P527, DOI 10.1097/WCO.0b013e328364d6b1; Otten E, 2010, HEART RHYTHM, V7, P1058, DOI 10.1016/j.hrthm.2010.04.023; Pawelzyk P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093194; Pruszczyk P, 2007, INT J CARDIOL, V117, P244, DOI 10.1016/j.ijcard.2006.05.019; Purevjav E, 2012, HUM MOL GENET, V21, P2039, DOI 10.1093/hmg/dds022; Raguz S, 1998, DEV BIOL, V201, P26, DOI 10.1006/dbio.1998.8964; Schroder R, 2009, BRAIN PATHOL, V19, P483, DOI 10.1111/j.1750-3639.2009.00289.x; Segard BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076361; Selcen D, 2004, NEUROLOGY, V62, P1363, DOI 10.1212/01.WNL.0000123576.74801.75; Selcen D, 2009, ANN NEUROL, V65, P83, DOI 10.1002/ana.21553; Shatunov A, 2009, EUR J HUM GENET, V17, P656, DOI 10.1038/ejhg.2008.226; Sjoberg G, 1999, HUM MOL GENET, V8, P2191, DOI 10.1093/hmg/8.12.2191; Strelkov SV, 2002, EMBO J, V21, P1255, DOI 10.1093/emboj/21.6.1255; Taylor MRG, 2007, CIRCULATION, V115, P1244, DOI 10.1161/CIRCULATIONAHA.106.646778; van Spaendonck-Zwarts KY, 2011, CLIN GENET, V80, P354, DOI 10.1111/j.1399-0004.2010.01512.x; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; VIEGASPEQUIGNOT E, 1989, HUM GENET, V83, P33, DOI 10.1007/BF00274143	43	13	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115470	10.1371/journal.pone.0115470	http://dx.doi.org/10.1371/journal.pone.0115470			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541946	Green Published, gold, Green Submitted			2022-12-27	WOS:000347239900047
J	Militao, T; Gomez-Diaz, E; Kaliontzopoulou, A; Gonzalez-Soli, J				Militao, Teresa; Gomez-Diaz, Elena; Kaliontzopoulou, Antigoni; Gonzalez-Soli, Jacob			Comparing Multiple Criteria for Species Identification in Two Recently Diverged Seabirds	PLOS ONE			English	Article							STABLE-ISOTOPE; GEOMETRIC MORPHOMETRICS; YELKOUAN SHEARWATERS; GENE TREES; DNA; CONSERVATION; DIFFERENTIATION; DELIMITATION; INCONGRUENCE; GEOLOCATION	Correct species identification is a crucial issue in systematics with key implications for prioritising conservation effort. However, it can be particularly challenging in recently diverged species due to their strong similarity and relatedness. In such cases, species identification requires multiple and integrative approaches. In this study we used multiple criteria, namely plumage colouration, biometric measurements, geometric morphometrics, stable isotopes analysis (SIA) and genetics (mtDNA), to identify the species of 107 bycatch birds from two closely related seabird species, the Balearic (Puffinus mauretanicus) and Yelkouan (P. yelkouan) shearwaters. Biometric measurements, stable isotopes and genetic data produced two stable clusters of bycatch birds matching the two study species, as indicated by reference birds of known origin. Geometric morphometrics was excluded as a species identification criterion since the two clusters were not stable. The combination of plumage colouration, linear biometrics, stable isotope and genetic criteria was crucial to infer the species of 103 of the bycatch specimens. In the present study, particularly SIA emerged as a powerful criterion for species identification, but temporal stability of the isotopic values is critical for this purpose. Indeed, we found some variability in stable isotope values over the years within each species, but species differences explained most of the variance in the isotopic data. Yet this result pinpoints the importance of examining sources of variability in the isotopic data in a case-by-case basis prior to the cross-application of the SIA approach to other species. Our findings illustrate how the integration of several methodological approaches can help to correctly identify individuals from recently diverged species, as each criterion measures different biological phenomena and species divergence is not expressed simultaneously in all biological traits.	[Militao, Teresa; Gonzalez-Soli, Jacob] Univ Barcelona, Inst Recerca Biodiversitat IRBio, Barcelona, Spain; [Militao, Teresa; Gonzalez-Soli, Jacob] Univ Barcelona, Dept Biol Anim, Barcelona, Spain; [Gomez-Diaz, Elena] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Kaliontzopoulou, Antigoni] Univ Porto, InBIO, CIBIO Res Ctr Biodivers & Genet Resources, Vairao, Vila Do Conde, Portugal; [Kaliontzopoulou, Antigoni] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA USA	University of Barcelona; University of Barcelona; Emory University; Universidade do Porto; Iowa State University	Militao, T (corresponding author), Univ Barcelona, Inst Recerca Biodiversitat IRBio, Barcelona, Spain.	tnetomilitao@ub.edu	Kaliontzopoulou, Antigoni/AFJ-9860-2022; Gonzalez-Solis, Jacob/C-3942-2008; Gómez-Díaz, Elena/AAA-9141-2019; Gómez-Díaz, Elena/G-2503-2011; Kaliontzopoulou, Antigoni/L-8345-2013; Kaliontzopoulou, Antigoni/AAF-6921-2022; Militao, Teresa/AAA-6151-2019	Kaliontzopoulou, Antigoni/0000-0002-7897-7204; Gonzalez-Solis, Jacob/0000-0002-8691-9397; Gómez-Díaz, Elena/0000-0002-4146-9003; Gómez-Díaz, Elena/0000-0002-4146-9003; Kaliontzopoulou, Antigoni/0000-0002-7897-7204; Kaliontzopoulou, Antigoni/0000-0002-7897-7204; Militao, Teresa/0000-0002-2862-1592	FCT (Portugal) [SFRH/BD/47467/2008, SFRH/BPD/68493/2010]; JdC contract (MICIN, Spain); ERG grant (European Commission) [PERG08-GA-ERG-2010- 276838]; MICIN, Spain [CGL2009-11278/BOS]; Fondos FEDER	FCT (Portugal)(Portuguese Foundation for Science and TechnologyEuropean Commission); JdC contract (MICIN, Spain); ERG grant (European Commission)(European Commission); MICIN, Spain(Spanish Government); Fondos FEDER(European Commission)	T. Militao was supported by a Ph.D. grant (SFRH/BD/47467/2008) and A. Kaliontzopoulou by a post-doctoral grant (SFRH/BPD/68493/2010), both from FCT (Portugal). E. Gomez-Diaz was supported by a JdC contract (MICIN, Spain) and ERG grant (PERG08-GA-ERG-2010- 276838, European Commission). This study was funded by the MICIN, Spain (CGL2009-11278/BOS) and Fondos FEDER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2011, J HUM EVOL, V60, P240, DOI 10.1016/j.jhevol.2010.02.003; Adams DC, 2009, P ROY SOC B-BIOL SCI, V276, P2729, DOI 10.1098/rspb.2009.0543; Agapow PM, 2004, Q REV BIOL, V79, P161, DOI 10.1086/383542; Alstrom P, 2008, ZOOL J LINN SOC-LOND, V154, P291, DOI 10.1111/j.1096-3642.2008.00418.x; Altaba CR, 1993, ANU ORNITOL BALEARS, V8, P3; Arcos JM, 2001, ANUARI DORNITOLOGIA, V1998, P286; Becker BH, 2006, CONSERV BIOL, V20, P470, DOI 10.1111/j.1523-1739.2006.00379.x; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Blaxter ML, 2004, PHILOS T R SOC B, V359, P669, DOI 10.1098/rstb.2003.1447; Bond AL, 2012, WATERBIRDS, V35, P324, DOI 10.1675/063.035.0213; Bookstein FL, 1997, MED IMAGE ANAL, V1, P225, DOI DOI 10.1016/S1361-8415(97)85012-8; Bookstein FL, 2007, MORPHOMETRIC TOOLS L; Bourgeois K, 2007, J ORNITHOL, V148, P261, DOI 10.1007/s10336-007-0127-3; BOURNE WRP, 1988, BRIT BIRDS, V81, P306; BROUGHTON JM, 1994, CONDOR, V96, P203, DOI 10.2307/1369079; Brower AVZ, 1996, ANNU REV ECOL SYST, V27, P423, DOI 10.1146/annurev.ecolsys.27.1.423; Bull LS, 2004, IBIS, V146, P38, DOI 10.1111/j.1474-919X.2004.00209.x; CAILLIEZ F, 1983, PSYCHOMETRIKA, V48, P305, DOI 10.1007/BF02294026; Calix M., 2018, EUROPEAN RED LIST SA; Cardona L, 2007, MAR ECOL PROG SER, V335, P123, DOI 10.3354/meps335123; Cardona L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031329; Carstens BC, 2007, SYST BIOL, V56, P400, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; Charif D, 2012, SEQINR BIOL SEQUENCE; Collar NJ, 1992, THREATENED BIRDS AM; Committee on the Status of Endangered Wildlife in Canada, 2011, GUID REC DES UN; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Draper I, 2007, MOL PHYLOGENET EVOL, V42, P700, DOI 10.1016/j.ympev.2006.09.021; Dryden IL, 1998, STAT SHAPE ANAL, DOI DOI 10.5555/1046920.1088707; Fernandez R, 2011, MAR BIOL, V158, P1043, DOI 10.1007/s00227-011-1629-3; Foster DJ, 2008, J EVOLUTION BIOL, V21, P263, DOI 10.1111/j.1420-9101.2007.01449.x; Friesen VL, 2007, MOL ECOL, V16, P1765, DOI 10.1111/j.1365-294X.2006.03197.x; Genovart M, 2005, CONSERV GENET, V6, P601, DOI 10.1007/s10592-005-9010-z; Genovart M, 2003, WATERBIRDS, V26, P72, DOI 10.1675/1524-4695(2003)026[0072:ADFFPS]2.0.CO;2; Genovart M, 2007, BIOL CONSERV, V137, P283, DOI 10.1016/j.biocon.2007.02.016; Genovart M, 2012, J HERED, V103, P330, DOI 10.1093/jhered/ess010; Genovart M, 2009, BIODIVERS CONSERV, V18, P1435, DOI 10.1007/s10531-008-9550-x; Gillespie M, 2013, SYST ENTOMOL, V38, P151, DOI 10.1111/j.1365-3113.2012.00659.x; Gomez-Diaz E, 2006, MOL PHYLOGENET EVOL, V41, P322, DOI 10.1016/j.ympev.2006.05.006; Gonzalez-Solis J, 2011, MAR ECOL PROG SER, V435, P251, DOI 10.3354/meps09233; Guilford T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033753; Gunz P, 2013, HYSTRIX, V24, P103, DOI 10.4404/hystrix-24.1-6292; Gutierrez Ricard, 2004, Birding World, V17, P111; Hamer Keith C., 2003, BWP Update, V5, P203; Heidrich P, 1998, BIOCHEM SYST ECOL, V26, P145, DOI 10.1016/S0305-1978(97)00085-9; Hennig C., 2014, FPC FLEXIBLE PROCEDU; Krishnamurthy PK, 2012, BIODIVERS CONSERV, V21, P1901, DOI 10.1007/s10531-012-0306-2; Legendre P., 2012, NUMERICAL ECOLOGY; Lello, 2013, DATA ANAL R STAT SOF; Loss SR, 2012, FRONT ECOL ENVIRON, V10, P357, DOI 10.1890/110251; Louzao M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035728; Arcos JM, 2012, BIOL CONSERV, V156, P30, DOI 10.1016/j.biocon.2011.12.011; Mayaud N., 1932, Alauda Paris, V4, P41; McMahon KW, 2013, LIMNOL OCEANOGR, V58, P697, DOI 10.4319/lo.2013.58.2.0697; Militao T, 2013, DIVERS DISTRIB, V19, P317, DOI 10.1111/j.1472-4642.2012.00916.x; MOORE WS, 1995, EVOLUTION, V49, P718, DOI 10.1111/j.1558-5646.1995.tb02308.x; Navarro J, 2008, ZOOL, V112, P128; Navarro J, 2009, MAR BIOL, V156, P2571, DOI 10.1007/s00227-009-1281-3; Oppel S, 2011, BIOL CONSERV, V144, P2255, DOI 10.1016/j.biocon.2011.05.017; Oro D, 2004, BIOL CONSERV, V116, P93, DOI 10.1016/S0006-3207(03)00180-0; Owen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016457; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Padial JM, 2009, ZOOL J LINN SOC-LOND, V155, P97, DOI 10.1111/j.1096-3642.2008.00424.x; Perez SI, 2006, J ANAT, V208, P769, DOI 10.1111/j.1469-7580.2006.00576.x; Peron C, 2013, BIOL CONSERV, V168, P210, DOI 10.1016/j.biocon.2013.09.006; R Core Team, 2021, R LANGUAGE ENV STAT; Raine AF, 2013, J ORNITHOL, V154, P411, DOI 10.1007/s10336-012-0905-4; Ramos R, 2012, FRONT ECOL ENVIRON, V10, P258, DOI 10.1890/110140; Rohlf F. J., 2005, TPSDIG DIGITIZE LAND; ROHLF FJ, 1993, TRENDS ECOL EVOL, V8, P129, DOI 10.1016/0169-5347(93)90024-J; Rohlf FJ, 1998, SYST BIOL, V47, P147, DOI 10.1080/106351598261094; Rohlf FJ, 1999, J CLASSIF, V16, P197, DOI 10.1007/s003579900054; Rohlf FJ, 2005, TPSRELW RELATIVE WRA; Sibley CG, 1990, DISTRIBUTION TAXONOM; Siemers BM, 2011, OECOLOGIA, V166, P69, DOI 10.1007/s00442-011-1940-1; Sites JW, 2004, ANNU REV ECOL EVOL S, V35, P199, DOI 10.1146/annurev.ecolsys.35.112202.130128; Solomon CT, 2008, CAN J FISH AQUAT SCI, V65, P2191, DOI 10.1139/F08-125; SPSS, 2009, PASW STAT WIND VERS; Svensson L, 2009, BIRD GUIDE MOST COMP; Svensson L., 1992, IDENTIFICATION GUIDE; Vasconcelos R, 2012, ZOOL J LINN SOC-LOND, V164, P328, DOI 10.1111/j.1096-3642.2011.00768.x; Oliveira EJVM, 2011, EUR FOOD RES TECHNOL, V232, P97, DOI 10.1007/s00217-010-1367-7; WARHAM J, 1990, PETRELS THEIR ECOLOG; Wiens JJ, 2000, P ROY SOC B-BIOL SCI, V267, P631, DOI 10.1098/rspb.2000.1049; Wiens JJ, 2007, SYST BIOL, V56, P875, DOI 10.1080/10635150701748506; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878; YESOU P, 1990, British Birds, V83, P299; Yesou P., 1985, Oiseau et la Revue Francaise d'Ornithologie, V55, P177; Zenatello M, 2012, P 13 MEDM PAN MED S; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x	89	10	11	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115650	10.1371/journal.pone.0115650	http://dx.doi.org/10.1371/journal.pone.0115650			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541978	Green Published, Green Submitted, gold			2022-12-27	WOS:000347239900062
J	Posevitz-Fejfar, A; Posevitz, V; Gross, CC; Bhatia, U; Kurth, F; Schutte, V; Bar-Or, A; Meuth, SG; Wiendl, H				Posevitz-Fejfar, Anita; Posevitz, Vilmos; Gross, Catharina C.; Bhatia, Urvashi; Kurth, Frank; Schuette, Verena; Bar-Or, Amit; Meuth, Sven G.; Wiendl, Heinz			Effects of Blood Transportation on Human Peripheral Mononuclear Cell Yield, Phenotype and Function: Implications for Immune Cell Biobanking	PLOS ONE			English	Article							MULTICENTER CLINICAL-TRIALS; LYMPHOCYTE IMMUNOPHENOTYPE; PROLIFERATIVE RESPONSES; VIABILITY; CRYOPRESERVATION; EXPRESSION; CD4(+); MECHANISM; FREQUENCY; RECOVERY	Human biospecimen collection, processing and preservation are rapidly emerging subjects providing essential support to clinical as well as basic researchers. Unlike collection of other biospecimens (e.g. DNA and serum), biobanking of viable immune cells, such as peripheral blood mononuclear cells (PBMC) and/or isolated immune cell subsets is still in its infancy. While certain aspects of processing and freezing conditions have been studied in the past years, little is known about the effect of blood transportation on immune cell survival, phenotype and specific functions. However, especially for multicentric and cooperative projects it is vital to precisely know those effects. In this study we investigated the effect of blood shipping and pre-processing delay on immune cell phenotype and function both on cellular and subcellular levels. Peripheral blood was collected from healthy volunteers (n=9): at a distal location (shipped overnight) and in the central laboratory (processed immediately). PBMC were processed in the central laboratory and analyzed post-cryopreservation. We analyzed yield, major immune subset distribution, proliferative capacity of T cells, cytokine pattern and T-cell receptor signal transduction. Results show that overnight transportation of blood samples does not globally compromise T-cell subsets as they largely retain their phenotype and proliferative capacity. However, NK and B cell frequencies, the production of certain PBMC-derived cytokines and IL-6 mediated cytokine signaling pathway are altered due to transportation. Various control experiments have been carried out to compare issues related to shipping versus pre-processing delay on site. Our results suggest the implementation of appropriate controls when using multicenter logistics for blood transportation aiming at subsequent isolation of viable immune cells, e.g. in multicenter clinical trials or studies analyzing immune cells/subsets. One important conclusion might be that despite changes due to overnight shipment, highly standardized central processing (and analysis) could be superior to multicentric de-central processing with more difficult standardization.	[Posevitz-Fejfar, Anita; Posevitz, Vilmos; Gross, Catharina C.; Bhatia, Urvashi; Kurth, Frank; Schuette, Verena; Meuth, Sven G.; Wiendl, Heinz] Univ Hosp Muenster, Dept Neurol, Munster, Germany; [Bar-Or, Amit] McGill Univ, Dept Neurol & Neurosurg, Montreal Neurol Inst & Hosp, Montreal, PQ, Canada	University of Munster; McGill University	Posevitz-Fejfar, A (corresponding author), Univ Hosp Muenster, Dept Neurol, Albert Schweitzer Campus 1, Munster, Germany.	anita.posevitz-fejfar@ukmuenster.de; heinz.wiendl@ukmuenster.de	Wiendl, Heinz/AAX-6041-2021; Bar-Or, Amit/AIC-1416-2022; Meuth, Sven G/HHM-8941-2022	Meuth, Sven G/0000-0003-2571-3501; Wiendl, Heinz/0000-0003-4310-3432; Gross, Catharina/0000-0002-4872-9189	Kompetenznetz Multiple Sklerose (Competence Network for Multiple Sclerosis) - Federal Ministry of Education and Research [FKZ01GI1308B]; CRC128 Transregional Collaborative Research Center Program of the Deutsche Forschungsgemeinschaft [Z02]	Kompetenznetz Multiple Sklerose (Competence Network for Multiple Sclerosis) - Federal Ministry of Education and Research; CRC128 Transregional Collaborative Research Center Program of the Deutsche Forschungsgemeinschaft	This work was supported by the Kompetenznetz Multiple Sklerose (Competence Network for Multiple Sclerosis) funded by the Federal Ministry of Education and Research (FKZ01GI1308B to HW), and by the CRC128 Transregional Collaborative Research Center Program of the Deutsche Forschungsgemeinschaft (Project Z02 to HW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betensky RA, 2000, CLIN DIAGN LAB IMMUN, V7, P759, DOI 10.1128/CDLI.7.5.759-763.2000; Bull M, 2007, J IMMUNOL METHODS, V322, P57, DOI 10.1016/j.jim.2007.02.003; Costantini A, 2003, J IMMUNOL METHODS, V278, P145, DOI 10.1016/S0022-1759(03)00202-3; Duggleby RC, 2007, IMMUNOLOGY, V121, P129, DOI 10.1111/j.1365-2567.2006.02550.x; Germann A, 2011, BIOPRESERV BIOBANK, V9, P229, DOI 10.1089/bio.2010.0033; Jeurink PV, 2008, CRYOBIOLOGY, V57, P91, DOI 10.1016/j.cryobiol.2008.06.002; Kimura A, 2010, EUR J IMMUNOL, V40, P1830, DOI 10.1002/eji.201040391; Kleeberger CA, 1999, CLIN DIAGN LAB IMMUN, V6, P14, DOI 10.1128/CDLI.6.1.14-19.1999; Kreher CR, 2003, J IMMUNOL METHODS, V278, P79, DOI 10.1016/S0022-1759(03)00226-6; Kutscher S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076215; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Maecker HT, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-17; McKenna KC, 2009, J IMMUNOL METHODS, V341, P68, DOI 10.1016/j.jim.2008.10.019; Naranbhai V, 2011, J IMMUNOL METHODS, V366, P28, DOI 10.1016/j.jim.2011.01.001; Neurath MF, 2011, CYTOKINE GROWTH F R, V22, P83, DOI 10.1016/j.cytogfr.2011.02.003; Olemukan RE, 2010, CLIN VACCINE IMMUNOL, V17, P910, DOI 10.1128/CVI.00492-09; Olson WC, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-26; Owen RE, 2007, J IMMUNOL METHODS, V326, P93, DOI 10.1016/j.jim.2007.07.012; Pantaleo G, 2006, NAT REV IMMUNOL, V6, P417, DOI 10.1038/nri1840; Posevitz V, 2008, J IMMUNOL, V180, P1634, DOI 10.4049/jimmunol.180.3.1634; Posevitz-Fejfar A, 2008, EUR J IMMUNOL, V38, P250, DOI 10.1002/eji.200636664; Reimann KA, 2000, CLIN DIAGN LAB IMMUN, V7, P352, DOI 10.1128/CDLI.7.3.352-359.2000; Ruprecht CR, 2005, J EXP MED, V201, P1793, DOI 10.1084/jem.20050085; Schmielau J, 2001, CANCER RES, V61, P4756; Weinberg A, 2000, CLIN DIAGN LAB IMMUN, V7, P714, DOI 10.1128/CDLI.7.4.714-716.2000; Weinberg A, 2009, CLIN VACCINE IMMUNOL, V16, P1176, DOI 10.1128/CVI.00342-08; Zea AH, 2005, CANCER RES, V65, P3044, DOI 10.1158/0008-5472.CAN-04-4505	27	33	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115920	10.1371/journal.pone.0115920	http://dx.doi.org/10.1371/journal.pone.0115920			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541968	Green Published, gold, Green Submitted			2022-12-27	WOS:000347239900110
J	Villanueva, AA; Priya, S				Villanueva, Alex A.; Priya, Shashank			Cyanea capillata Bell Kinematics Analysis through Corrected In Situ Imaging and Modeling Using Strategic Discretization Techniques	PLOS ONE			English	Article							SWIMMING PERFORMANCE; JET PROPULSION; FLOW PATTERNS; JELLYFISH; MORPHOLOGY; FLIGHT; AERODYNAMICS; ORGANIZATION; LOCOMOTION; ENERGETICS	Obtaining accurate kinematic data of animals is essential for many biological studies and bio-inspired engineering. Many animals, however, are either too large or too delicate to transport to controlled environments where accurate kinematic data can be easily obtained. Often, in situ recordings are the only means available but are often subject to multi-axis motion and relative magnification changes with time leading to large discrepancies in the animal kinematics. Techniques to compensate for these artifacts were applied to a large jellyfish, Cyanea capillata, freely swimming in ocean waters. The bell kinematics were captured by digitizing exumbrella profiles for two full swimming cycles. Magnification was accounted for by tracking a reference point on the ocean floor and by observing the C. capillata exumbrella arclength in order to have a constant scale through the swimming cycles. A linear fit of the top bell section was used to find the body angle with respect to the camera coordinate system. Bell margin trajectories over two swimming cycles confirmed the accuracy of the correction techniques. The corrected profiles were filtered and interpolated to provide a set of time-dependent points along the bell. Discrete models of the exumbrella were used to analyze the bell kinematics. Exumbrella discretization was conducted using three different methods. Fourier series were fitted to the discretized models and subsequently used to analyze the bell kinematics of the C. capillata. The analysis showed that the bell did not deform uniformly over time with different segments lagging behind each other. Looping of the bell trajectory between contraction and relaxation was also present through most of the exumbrella. The bell margin had the largest looping with an outer path during contraction and inner path during relaxation. The subumbrella volume was approximated based on the exumbrella kinematics and was found to increase during contraction.	[Villanueva, Alex A.; Priya, Shashank] Virginia Tech, CEHMS, BMDL, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Priya, S (corresponding author), Virginia Tech, CEHMS, BMDL, Blacksburg, VA 24061 USA.	spriya@vt.edu	Priya, S/GQH-7176-2022	Priya, Shashank/0000-0003-1367-3434	Office of Naval Research [N00014-08-1-0654]	Office of Naval Research(Office of Naval Research)	Funding: Financial support came from the Office of Naval Research through grant #N00014-08-1-0654. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajcar T, 2009, HYDROBIOLOGIA, V616, P279, DOI 10.1007/s10750-008-9589-4; Blough T, 2011, BIOL BULL-US, V220, P6, DOI 10.1086/BBLv220n1p6; Chapra SC, 2005, APPL NUMERICAL METHO; Colin SP, 2002, J EXP BIOL, V205, P427; COSTELLO JH, 1994, MAR BIOL, V121, P327, DOI 10.1007/BF00346741; Costello JH, 1995, MAR BIOL, V124, P399, DOI 10.1007/BF00363913; Dabiri JO, 2005, J EXP BIOL, V208, P1257, DOI 10.1242/jeb.01519; Dabiri JO, 2003, J EXP BIOL, V206, P3675, DOI 10.1242/jeb.00597; Dabiri JO, 2007, J EXP BIOL, V210, P1868, DOI 10.1242/jeb.003772; DANIEL TL, 1983, CAN J ZOOL, V61, P1406, DOI 10.1139/z83-190; DEMONT ME, 1988, J EXP BIOL, V134, P313; Ford MD, 2000, SCI MAR, V64, P47; Fry SN, 2005, J EXP BIOL, V208, P2303, DOI 10.1242/jeb.01612; Fu YQ, 2007, ADV INTEL SYS RES, DOI 10.2991/iske.2007.210; GLADFELTER WB, 1972, HELGOLAND WISS MEER, V23, P38, DOI 10.1007/BF01616310; GLADFELTER WB, 1972, MAR BIOL, V14, P150, DOI 10.1007/BF00373214; Guo SX, 2003, IEEE-ASME T MECH, V8, P136, DOI 10.1109/TMECH.2003.809134; Herschlag G, 2011, J THEOR BIOL, V285, P84, DOI 10.1016/j.jtbi.2011.05.035; Ijspeert AJ, 2007, SCIENCE, V315, P1416, DOI 10.1126/science.1138353; Katija K, 2009, NATURE, V460, P624, DOI 10.1038/nature08207; KRAMP PL, 1961, J MAR BIOL ASSOC UK, V40, P7, DOI 10.1017/S0025315400007347; Luhmann T., 2006, CLOSE RANGE PHOTOGRA; Acuna JL, 2011, SCIENCE, V333, P1627, DOI 10.1126/science.1205134; Marut K, 2013, SMART MATER STRUCT, V22, DOI 10.1088/0964-1726/22/9/094021; Mayor AG, 1910, MEDUSAE WORLD; McHenry MJ, 2003, J EXP BIOL, V206, P4125, DOI 10.1242/jeb.00649; Mittal R, 2006, BIOINSPIR BIOMIM, V1, pS35, DOI 10.1088/1748-3182/1/4/S05; Nauen JC, 2002, J EXP BIOL, V205, P3271; NORBERG UM, 1976, J EXP BIOL, V65, P179; Pivkin IV, 2005, LECT NOTES COMPUT SC, V3515, P689; Poelma C, 2006, EXP FLUIDS, V41, P213, DOI 10.1007/s00348-006-0172-3; Rosenberger LJ, 2001, J EXP BIOL, V204, P379; Russell F. S., 1970, MEDUSAE BRIT ISLES, V2; Sahin M, 2009, J EXP BIOL, V212, P2656, DOI 10.1242/jeb.025536; Sathirapongsasuti J, 2004, MATH EXPLANATION MIL; Satterlie RA, 2005, BIOL BULL-US, V209, P154, DOI 10.2307/3593133; Satterlie RA, 2008, J EXP BIOL, V211, P3467, DOI 10.1242/jeb.018952; Sfakiotakis M, 1999, IEEE J OCEANIC ENG, V24, P237, DOI 10.1109/48.757275; Tian XD, 2006, BIOINSPIR BIOMIM, V1, pS10, DOI 10.1088/1748-3182/1/4/S02; Tobalske BW, 2003, J AVIAN BIOL, V34, P177, DOI 10.1034/j.1600-048X.2003.03006.x; Villanueva A., 2010, 2010 IEEE International Conference on Robotics and Biomimetics (ROBIO), P1124, DOI 10.1109/ROBIO.2010.5723486; Villanueva AA, 2014, PLOS ONE, V9; Villanueva A, 2011, BIOINSPIR BIOMIM, V6, DOI 10.1088/1748-3182/6/3/036004; Villanueva AA, 2013, BIOINSPIR BIOMIM, V8, DOI 10.1088/1748-3182/8/4/046005; WEBB PW, 1993, J EXP BIOL, V178, P97; Wilson MM, 2011, INT J NONLIN MECH, V46, P557, DOI 10.1016/j.ijnonlinmec.2010.12.005	46	1	1	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115220	10.1371/journal.pone.0115220	http://dx.doi.org/10.1371/journal.pone.0115220			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541980	Green Submitted, Green Published, gold			2022-12-27	WOS:000347239900026
J	Zou, Y; Zhang, L; Rao, S; Zhu, XY; Ye, LL; Chen, WX; Li, XP				Zou, Yuan; Zhang, Lin; Rao, Shen; Zhu, Xiaoyang; Ye, Lanlan; Chen, Weixin; Li, Xueping			The Relationship between the Expression of Ethylene-Related Genes and Papaya Fruit Ripening Disorder Caused by Chilling Injury	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; SIGNAL-TRANSDUCTION; MOLECULAR CHARACTERIZATION; FREEZING TOLERANCE; STRESS TREATMENTS; COLD-ACCLIMATION; FAMILY GENES; ARABIDOPSIS; TOMATO; BIOSYNTHESIS	Papaya (Carica papaya L.) is sensitive to low temperature and easy to be subjected to chilling injury, which causes fruit ripening disorder. This study aimed to investigate the relationship between the expression of genes related to ethylene and fruit ripening disorder caused by chilling injury. Papaya fruits were firstly stored at 7 degrees C and 12 degrees C for 25 and 30 days, respectively, then treated with exogenous ethylene and followed by ripening at 25 degrees C for 5 days. Chilling injury symptoms such as pulp water soaking were observed in fruit stored at 7 degrees C on 20 days, whereas the coloration and softening were completely blocked after 25 days, Large differences in the changes in the expression levels of twenty two genes involved in ethylene were seen during 7 degrees C-storage with chilling injury. Those genes with altered expression could be divided into three groups: the group of genes that were up-regulated, including ACS1/2/3, EIN2, EIN3s/EIL1, CTR1/2/ 3, and ERF1/3/4; the group of genes that were down-regulated, including ACO3, ETR1, CTR4, EBF2, and ERF2; and the group of genes that were un-regulated, including ACO1/2, ERS, and EBF1. The results also showed that pulp firmness had a significantly positive correlation with the expression of ACS2, ACO1, CTR1/ 4, EIN3a/b, and EBF1/2 in fruit without chilling injury. This positive correlation was changed to negative one in fruit after storage at 7 degrees C for 25 days with chilling injury. The coloring index displayed significantly negative correlations with the expression levels of ACS2, ACO1/2, CTR4, EIN3a/b, ERF3 in fruit without chilling injury, but these correlations were changed into the positive ones in fruit after storage at 7 degrees C for 25 days with chilling injury. All together, these results indicate that these genes may play important roles in the abnormal softening and coloration with chilling injury in papaya.	[Zou, Yuan; Zhang, Lin; Rao, Shen; Zhu, Xiaoyang; Ye, Lanlan; Chen, Weixin; Li, Xueping] South China Agr Univ, Coll Hort, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangdong Prov Key Lab Postharvest Sci & Technol, Guangzhou 510642, Guangdong, Peoples R China	South China Agricultural University	Li, XP (corresponding author), South China Agr Univ, Coll Hort, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangdong Prov Key Lab Postharvest Sci & Technol, Guangzhou 510642, Guangdong, Peoples R China.	lxp88@scau.edu.cn	Rao, Shen/GWV-1445-2022	Rao, Shen/0000-0001-5144-2878	National Natural Science Foundation of China [31372112]; National Key Technology R & D Program of China [2011BAD24B02-4]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology R & D Program of China(National Key Technology R&D Program)	The research work was supported by National Natural Science Foundation of China (31372112), the National Key Technology R & D Program of China (2011BAD24B02-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida RFd, 2005, REV BRAS FRUTIC, V27, P17; Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; Asensi-Fabado MA, 2012, J PLANT PHYSIOL, V169, P360, DOI 10.1016/j.jplph.2011.11.007; Antunes MDC, 2002, SCI HORTIC-AMSTERDAM, V92, P29, DOI 10.1016/S0304-4238(01)00278-3; Begheldo M, 2008, POSTHARVEST BIOL TEC, V48, P84, DOI 10.1016/j.postharvbio.2007.09.023; Binder BM, 2007, PLANT CELL, V19, P509, DOI 10.1105/tpc.106.048140; Blas AL, 2010, PLANT PHYSIOL, V152, P2013, DOI 10.1104/pp.109.152298; Chao QM, 1997, CELL, V89, P1133, DOI 10.1016/S0092-8674(00)80300-1; Chen YF, 2005, ANN BOT-LONDON, V95, P901, DOI 10.1093/aob/mci100; Chervin C, 2010, VITIS, V49, P129; Choudhury SR, 2008, J PLANT PHYSIOL, V165, P1865, DOI 10.1016/j.jplph.2008.04.012; Concellon A, 2005, FOOD CHEM, V92, P63, DOI 10.1016/j.foodchem.2004.04.048; El-Sharkawy I, 2003, J EXP BOT, V54, P1615, DOI 10.1093/jxb/erg158; El-Sharkawy I, 2009, J EXP BOT, V60, P907, DOI 10.1093/jxb/ern354; Fernandes FAN, 2006, FOOD RES INT, V39, P492, DOI 10.1016/j.foodres.2005.10.004; Ghasernnezhad M, 2008, POSTHARVEST BIOL TEC, V48, P364, DOI 10.1016/j.postharvbio.2007.09.014; Guo HW, 2003, CELL, V115, P667, DOI 10.1016/S0092-8674(03)00969-3; Hamilton AJ, 1990, ANTISENSE GENE INHIB; Hershkovitz V, 2009, J PLANT PHYSIOL, V166, P1855, DOI 10.1016/j.jplph.2009.05.012; Hiraga S, 2009, MOL GENET GENOMICS, V282, P517, DOI 10.1007/s00438-009-0483-1; Hu H- L, 2012, PLANT PHYSL BIOCH; Huang SZ, 2010, PLANT SCI, V178, P251, DOI 10.1016/j.plantsci.2010.01.005; Ireland HS, 2012, POSTHARVEST BIOL TEC, V72, P42, DOI 10.1016/j.postharvbio.2012.05.003; Katz E, 2004, PLANTA, V219, P243, DOI 10.1007/s00425-004-1228-3; Klee HJ, 2002, J EXP BOT, V53, P2057, DOI 10.1093/jxb/erf062; Kondo S, 2005, POSTHARVEST BIOL TEC, V36, P309, DOI 10.1016/j.postharvbio.2005.02.003; Konishi M, 2008, PLANT J, V55, P821, DOI 10.1111/j.1365-313X.2008.03551.x; Li M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058745, 10.1371/journal.pone.0078500, 10.1371/journal.pone.0059582, 10.1371/journal.pone.0079955]; Li X, 2013, PLANT PHYSL BIOCH; Li XP, 2013, PLANT PHYSIOL BIOCH, V70, P81, DOI 10.1016/j.plaphy.2013.05.020; Lin ZF, 2008, PLANT J, V54, P1083, DOI 10.1111/j.1365-313X.2008.03481.x; Lin ZF, 2009, J EXP BOT, V60, P3311, DOI 10.1093/jxb/erp204; Lopez-Gomez R, 2009, TRANSGENIC RES, V18, P89, DOI 10.1007/s11248-008-9197-0; Miller WR, 1999, HORTSCIENCE, V34, P1112, DOI 10.21273/HORTSCI.34.6.1112; Moussatche P, 2004, J BIOL CHEM, V279, P48734, DOI 10.1074/jbc.M403100200; Muller R, 2003, J HORTIC SCI BIOTECH, V78, P10; Nair S, 2003, J FOOD AGRIC ENVIRON, V1, P93; Novillo F, 2007, P NATL ACAD SCI USA, V104, P21002, DOI 10.1073/pnas.0705639105; Pang JH, 2007, POSTHARVEST BIOL TEC, V44, P195, DOI 10.1016/j.postharvbio.2006.12.017; Sakuma Y, 2006, P NATL ACAD SCI USA, V103, P18822, DOI 10.1073/pnas.0605639103; Savitch LV, 2005, PLANT CELL PHYSIOL, V46, P1525, DOI 10.1093/pcp/pci165; Sharma MK, 2010, MOL GENET GENOMICS, V284, P455, DOI 10.1007/s00438-010-0580-1; Shi YT, 2012, PLANT CELL, V24, P2578, DOI 10.1105/tpc.112.098640; Shibuya K, 2004, PLANT PHYSIOL, V136, P2900, DOI 10.1104/pp.104.046979; Szalai G, 2000, BIOL PLANTARUM, V43, P637, DOI 10.1023/A:1002824721597; Tian MS, 2002, PLANT GROWTH REGUL, V38, P249, DOI 10.1023/A:1021552002676; Tournier B, 2003, FEBS LETT, V550, P149, DOI 10.1016/S0014-5793(03)00757-9; Wang P, 2010, J EXP BOT, V61, P179, DOI 10.1093/jxb/erp302; Wong WS, 2001, PLANT SCI, V161, P969, DOI 10.1016/S0168-9452(01)00505-2; Wu LJ, 2007, PLANTA, V226, P815, DOI 10.1007/s00425-007-0528-9; Xu ZS, 2007, PLANT MOL BIOL, V65, P719, DOI 10.1007/s11103-007-9237-9; Yang XT, 2013, POSTHARVEST BIOL TEC, V78, P55, DOI 10.1016/j.postharvbio.2012.11.012; Yang YW, 2010, J EXP BOT, V61, P697, DOI 10.1093/jxb/erp332; Yin XR, 2010, PLANT PHYSIOL, V153, P1280, DOI 10.1104/pp.110.157081; Yin XR, 2009, POSTHARVEST BIOL TEC, V52, P9, DOI 10.1016/j.postharvbio.2008.09.016; Zhang ZJ, 2010, PLANT MOL BIOL, V73, P241, DOI 10.1007/s11103-010-9609-4; Zhong SL, 2008, J EXP BOT, V59, P965, DOI 10.1093/jxb/ern021; Zhou HW, 2001, J PLANT PHYSIOL, V158, P55, DOI 10.1078/0176-1617-00126; Zhou L, 2010, PLANT GROWTH REGUL, V62, P171, DOI 10.1007/s10725-010-9503-8; Zhu H, 2010, J HORTIC SCI BIOTECH, V85, P283, DOI 10.1080/14620316.2010.11512669; Zhu HL, 2006, J INTEGR PLANT BIOL, V48, P1478, DOI 10.1111/j.1744-7909.2006.00366.x; Zhu X, 2013, EUROPEAN FOOD RES TE, P1; Zhu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044405	63	18	19	7	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e116002	10.1371/journal.pone.0116002	http://dx.doi.org/10.1371/journal.pone.0116002			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542021	Green Published, gold, Green Submitted			2022-12-27	WOS:000347239900126
J	Capdevila, X; Jung, B; Bernard, N; Dadure, C; Biboulet, P; Jaber, S				Capdevila, Xavier; Jung, Boris; Bernard, Nathalie; Dadure, Christophe; Biboulet, Philippe; Jaber, Samir			Effects of Pressure Support Ventilation Mode on Emergence Time and Intra-Operative Ventilatory Function: A Randomized Controlled Trial	PLOS ONE			English	Article							LARYNGEAL MASK AIRWAY; INTENSIVE-CARE-UNIT; MECHANICAL VENTILATION; ASSISTED VENTILATION; GENERAL-ANESTHESIA; COMPARATIVE BENCH; WORK; CROSSOVER; PROPOFOL; CRITERIA	We tested the hypothesis that pressure-support ventilation (PSV) allows a reduction in emergence time and laryngeal mask airway (LMA) removal time after general anesthesia compared to volume-controlled mechanical ventilation (CMV). Because spontaneous breathing (SB) is often used with LMA under general anesthesia, patients were allocated randomly to three groups (CMV, SB and PSV). Thirty-six consecutive ASA I-II patients scheduled for knee arthroscopic surgery under general anesthesia with a LMA and breathing throughout the ventilator circuit were included. Hemodynamic and ventilatory variables were recorded before and 10-min after general anesthesia-induction, at the surgical incision, at the end of anaesthetic drugs infusion and when the patient was totally awake (which defines emergence time). LMA removal time, drug consumption were recorded at the end of the surgical procedure. Leak fraction around the LMA was also evaluated. LMA removal time was significantly higher in the CMV-group (18 +/- 6 min) compared to both SB (8 +/- 4 min) and PSV (7 +/- 4 min, P<0.05) groups as well as for emergence time: CMV-group (32 +/- 12 min), SB (17 +/- 7 min) and PSV (13 +/- 6 min, P<0.05) groups. Total propofol consumption was significantly lower in the PSV-group (610 +/- 180 mg) than in both CMV (852 +/- 330 mg) and SB (734 +/- 246 mg, P<0.05) groups. Air leaks around the LMA was significantly higher in the CMV-group than in the SB and PSV groups (16% vs 3% and 7%, all P<0.05). In conclusion, in knee arthroscopic surgery, in comparison to CMV, PSV use during general anesthesia in unparalyzed patients decreases LMA removal time, propofol consumption and leaks around LMA while improving ventilatory variables without adverse effects.	[Capdevila, Xavier; Bernard, Nathalie; Dadure, Christophe; Biboulet, Philippe] CHU Montpellier, Lapeyronie Teaching Hosp, Unite INSERM U1046, Anaesthesia & Crit Care Dept A, F-34295 Montpellier, France; [Jung, Boris; Jaber, Samir] Univ Montpellier I, CHU Montpellier, St Eloi Teaching Hosp, Unite INSERM U1046,Anaesthesiol & Intens Care Ana, F-34295 Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier	Jaber, S (corresponding author), Univ Montpellier I, CHU Montpellier, St Eloi Teaching Hosp, Unite INSERM U1046,Anaesthesiol & Intens Care Ana, F-34295 Montpellier, France.	s-jaber@chu-montpellier.fr	Jung, Boris/AAK-5066-2021	Jung, Boris/0000-0003-2522-1531; capdevila, xavier/0000-0002-9791-8779; DADURE, Christophe/0000-0001-7846-4022	Centre Hospitalier Universitaire Montpellier & Centre Hospitalier Universitaire Montpellier	Centre Hospitalier Universitaire Montpellier & Centre Hospitalier Universitaire Montpellier	Support was only provided solely from institutional sources; Centre Hospitalier Universitaire Montpellier & Centre Hospitalier Universitaire Montpellier. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKHTAR TM, 1994, BRIT J ANAESTH, V72, P447, DOI 10.1093/bja/72.4.447; Bijker JB, 2007, ANESTHESIOLOGY, V107, P213, DOI 10.1097/01.anes.0000270724.40897.8e; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Brimacombe J, 2000, ANESTHESIOLOGY, V92, P1621, DOI 10.1097/00000542-200006000-00019; BROCHARD L, 1989, AM REV RESPIR DIS, V139, P513, DOI 10.1164/ajrccm/139.2.513; BROCHARD L, 1991, ANESTHESIOLOGY, V75, P739, DOI 10.1097/00000542-199111000-00004; Brochard L, 2002, AM J RESP CRIT CARE, V166, P2, DOI 10.1164/rccm.2205008; Chanques G, 2013, CRIT CARE MED; Chiumello D, 2005, CRIT CARE MED, V33, P1170, DOI 10.1097/01.CCM.0000163227.70097.05; Chiumello D, 2003, CRIT CARE MED, V31, P2604, DOI 10.1097/01.CCM.0000089939.11032.36; Chiumello D, 2002, EUR RESPIR J, V20, P925, DOI 10.1183/09031936.02.01552001; Chiumello D, 2007, CRIT CARE MED, V35, P2547, DOI 10.1097/01.CCM.0000287594.80110.34; CHRISTIE JM, 1992, ANESTH ANALG, V75, P167; Cinnella G, 1996, AM J RESP CRIT CARE, V153, P1025, DOI 10.1164/ajrccm.153.3.8630541; DEVITT JH, 1994, ANESTHESIOLOGY, V80, P550, DOI 10.1097/00000542-199403000-00011; Jaber S, 2012, ANAESTHESIA, V67, P999, DOI 10.1111/j.1365-2044.2012.07218.x; Jaber S, 2007, ANESTHESIOLOGY, V107, P671, DOI 10.1097/01.anes.0000282837.36748.b1; Jaber S, 2006, ANESTHESIOLOGY, V105, P944, DOI 10.1097/00000542-200611000-00015; Jaber S, 2009, ANESTHESIOLOGY, V110, P620, DOI 10.1097/ALN.0b013e31819793fb; Keller C, 2005, EUR J ANAESTH, V22, P630, DOI 10.1017/S0265021505001055; Leykin Y, 2001, Minerva Anestesiol, V67, P563; Mirenda J V, 1990, Anesthesiol Rev, V17, P41; Napoli V, 2002, Minerva Anestesiol, V68, P669; Nouraei SAR, 2008, BRIT J ANAESTH, V101, P419, DOI 10.1093/bja/aen171; PEARL RG, 1992, ANESTH ANALG, V75, P161; Perrigault PFO, 1999, THORAX, V54, P119, DOI 10.1136/thx.54.2.119; Pouzeratte Y, 2008, EUR J ANAESTH, V25, P634, DOI 10.1017/S0265021508004043; Sukhani R, 1996, ANESTH ANALG, V83, P975, DOI 10.1097/00000539-199611000-00013; Tantawy H, 2007, ANESTHESIOLOGY, V107, P670, DOI 10.1097/01.anes.0000282821.25984.4a; Tassaux D, 2002, INTENS CARE MED, V28, P1254, DOI 10.1007/s00134-002-1421-4; Uppal V, 2009, BRIT J ANAESTH, V102, P264, DOI 10.1093/bja/aen366; VALENTINE J, 1994, BRIT J ANAESTH, V73, P543, DOI 10.1093/bja/73.4.543; Vivien B, 2003, ANESTHESIOLOGY, V99, P9, DOI 10.1097/00000542-200307000-00006; von Goedecke A, 2005, ANESTH ANALG, V100, P357, DOI 10.1213/01.ANE.0000143563.39519.FD; Zoremba M, 2010, ANAESTHESIA, V65, P124, DOI 10.1111/j.1365-2044.2009.06187.x	35	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115139	10.1371/journal.pone.0115139	http://dx.doi.org/10.1371/journal.pone.0115139			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536515	Green Published, gold			2022-12-27	WOS:000348563300031
J	Chidlow, G; Wood, JPM; Casson, RJ				Chidlow, Glyn; Wood, John P. M.; Casson, Robert J.			Expression of Inducible Heat Shock Proteins Hsp27 and Hsp70 in the Visual Pathway of Rats Subjected to Various Models of Retinal Ganglion Cell Injury	PLOS ONE			English	Article							LATERAL GENICULATE-NUCLEUS; METHYL-D-ASPARTATE; OPTIC-NERVE; GLAUCOMA MODEL; SPATIOTEMPORAL CHARACTERIZATION; NEURONAL DEGENERATION; TRANSIENT ISCHEMIA; MESSENGER-RNA; PROTECTS; HEAT-SHOCK-PROTEIN-27	Inducible heat shock proteins (Hsps) are upregulated in the central nervous system in response to a wide variety of injuries. Surprisingly, however, no coherent picture has emerged regarding the magnitude, duration and cellular distribution of inducible Hsps in the visual system following injury to retinal ganglion cells (RGCs). The current study sought, therefore, to achieve the following two objectives. The first aim of this study was to systematically characterise the patterns of Hsp27 and -70 expression in the retina and optic nerve in four discrete models of retinal ganglion cell (RGC) degeneration: axonal injury (ON crush), somato-dendritic injury (NMDA-induced excitotoxicity), chronic hypoperfusion (bilateral occlusion of the carotid arteris) and experimental glaucoma. The second aim was to document Hsp27 and -70 expression in the optic tract, the subcortical retinorecipient areas of the brain, and the visual cortex during Wallerian degeneration of RGC axons. Hsp27 was robustly upregulated in the retina in each injury paradigm, with the chronic models, 2VO and experimental glaucoma, displaying a more persistent Hsp27 transcriptional response than the acute models. Hsp27 expression was always associated with astrocytes and with a subset of RGCs in each of the models excluding NMDA. Hsp27 was present within astrocytes of the optic nerve/optic tract in control rats. During Wallerian degeneration, Hsp27 was upregulated in the optic nerve/optic tract and expressed de novo by astrocytes in the lateral geniculate nucleus and the stratum opticum of the superior colliculus. Conversely, the results of our study indicate Hsp70 was minimally induced in any of the models of injury, either in the retina, or in the optic nerve/optic tract, or in the subcortical, retinorecipient areas of the brain. The findings of the present study augment our understanding of the involvement of Hsp27 and Hsp70 in the response of the visual system to RGC degeneration.	[Chidlow, Glyn; Wood, John P. M.; Casson, Robert J.] South Australian Inst Ophthalmol, Hanson Inst, Ctr Neurol Dis, Ophthalm Res Labs, Adelaide, SA 5000, Australia; [Chidlow, Glyn; Wood, John P. M.; Casson, Robert J.] Univ Adelaide, Dept Ophthalmol & Visual Sci, Adelaide, SA 5000, Australia	Hanson Institute; University of Adelaide	Chidlow, G (corresponding author), South Australian Inst Ophthalmol, Hanson Inst, Ctr Neurol Dis, Ophthalm Res Labs, Frome Rd, Adelaide, SA 5000, Australia.	glyn.chidlow@health.sa.gov.au			National Health and Medical Research Council [APP1050982]; Ophthalmic Research Institute of Ophthalmology	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Ophthalmic Research Institute of Ophthalmology	Support from the National Health and Medical Research Council (project grant: APP1050982) and the Ophthalmic Research Institute of Ophthalmology is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2008, NEUROSCI LETT, V433, P11, DOI 10.1016/j.neulet.2007.12.045; Aviles-Trigueros M, 2003, EXP NEUROL, V184, P767, DOI 10.1016/S0014-4886(03)00298-X; Bernstein SL, 2003, INVEST OPHTH VIS SCI, V44, P4153, DOI 10.1167/iovs.03-0274; Biermann J, 2010, INVEST OPHTH VIS SCI, V51, P3784, DOI 10.1167/iovs.09-4894; Caprioli J, 1996, INVEST OPHTH VIS SCI, V37, P2376; Chidlow G, 2003, BRAIN RES, V963, P298, DOI 10.1016/S0006-8993(02)04052-0; Chidlow G, 2008, INVEST OPHTH VIS SCI, V49, P762, DOI 10.1167/iovs.07-0726; Chidlow G, 2011, J HISTOCHEM CYTOCHEM, V59, P884, DOI 10.1369/0022155411418115; Chidlow G, 2011, ACTA NEUROPATHOL, V121, P737, DOI 10.1007/s00401-011-0807-1; Chidlow G, 2010, INVEST OPHTH VIS SCI, V51, P1483, DOI 10.1167/iovs.09-4603; Costigan M, 1998, J NEUROSCI, V18, P5891; Crish SD, 2010, P NATL ACAD SCI USA, V107, P5196, DOI 10.1073/pnas.0913141107; Currie RW, 2000, BRAIN RES, V863, P169, DOI 10.1016/S0006-8993(00)02133-8; Dean DO, 1999, INVEST OPHTH VIS SCI, V40, P2952; Ebneter A, 2010, INVEST OPHTH VIS SCI, V51, P6448, DOI 10.1167/iovs.10-5284; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Fei Z, 2001, J CLIN NEUROSCI, V8, P250, DOI 10.1054/jocn.2000.0760; Franklin TB, 2005, INT J HYPERTHER, V21, P379, DOI 10.1080/02656730500069955; Hecker JG, 2011, CELL STRESS CHAPERON, V16, P119, DOI 10.1007/s12192-010-0224-8; Holman MC, 2010, INVEST OPHTH VIS SCI, V51, P2197, DOI 10.1167/iovs.09-4191; Hopkins DA, 1998, EXP NEUROL, V153, P173, DOI 10.1006/exnr.1998.6870; Huang W, 2007, INVEST OPHTH VIS SCI, V48, P4129, DOI 10.1167/iovs.06-0606; Ishii Y, 2003, INVEST OPHTH VIS SCI, V44, P1982, DOI 10.1167/iovs.02-0912; Ito Y, 2008, CNS NEUROSCI THER, V14, P192, DOI 10.1111/j.1755-5949.2008.00050.x; Ito Y, 2010, CNS NEUROSCI THER, V16, P103, DOI 10.1111/j.1755-5949.2009.00081.x; Kalesnykas G, 2008, NEUROSCIENCE, V155, P937, DOI 10.1016/j.neuroscience.2008.06.038; Kalesnykas G, 2007, NEUROSCIENCE, V150, P692, DOI 10.1016/j.neuroscience.2007.09.078; Kretz A, 2005, NEUROBIOL DIS; Krueger AMR, 1999, MOL BRAIN RES, V71, P265, DOI 10.1016/S0169-328X(99)00198-9; Krueger-Naug AMR, 2002, NEUROSCIENCE, V110, P653, DOI 10.1016/S0306-4522(01)00453-5; Krueger-Naug AMR, 2003, NEUROSCIENCE, V116, P49, DOI 10.1016/S0306-4522(02)00582-1; Kwong JMK, 2003, BRAIN RES, V970, P119, DOI 10.1016/S0006-8993(03)02298-4; LAWSON LJ, 1994, J NEUROCYTOL, V23, P729, DOI 10.1007/BF01268086; Levkovitch-Verbin H, 2002, INVEST OPHTH VIS SCI, V43, P402; Lewden O, 1998, OPHTHALMIC RES, V30, P291, DOI 10.1159/000055487; Li Y, 2003, INVEST OPHTH VIS SCI, V44, P1299, DOI 10.1167/iovs.02-0235; Liu M, 2014, CURR EYE RES; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Herrera MPL, 2002, EXP NEUROL, V178, P243, DOI 10.1006/exnr.2002.8043; MOORE RY, 1994, J COMP NEUROL, V344, P403, DOI 10.1002/cne.903440306; O'Reilly AM, 2010, MOL NEUROBIOL, V42, P124, DOI 10.1007/s12035-010-8143-3; Park KH, 2001, INVEST OPHTH VIS SCI, V42, P1522; Plumier JCL, 1996, NEUROSCIENCE, V75, P849, DOI 10.1016/0306-4522(96)00317-X; Popp A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004764; Schlamp CL, 2001, MOL VIS, V7, P192; Schmeer C, 2008, INVEST OPHTH VIS SCI, V49, P4971, DOI 10.1167/iovs.07-1597; SCHMIDTKASTNER R, 1993, INT J DEV NEUROSCI, V11, P157, DOI 10.1016/0736-5748(93)90076-P; Shimazawa M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030526; Swanson LW., 2004, BRAIN MAPS STRUCTURE, V3rd edition; Wang X, 2000, BRAIN RES, V878, P136, DOI 10.1016/S0006-8993(00)02727-X; Whitlock NA, 2005, INVEST OPHTH VIS SCI, V46, P1092, DOI 10.1167/iovs.04-0043; Yamamoto H, 2006, EXP EYE RES, V82, P767, DOI 10.1016/j.exer.2005.09.019; Zhang SD, 2009, BRAIN RES, V1303, P131, DOI 10.1016/j.brainres.2009.09.029; Zhao L, 2006, NEUROSCI LETT, V404, P44, DOI 10.1016/j.neulet.2006.05.044	54	36	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e114838	10.1371/journal.pone.0114838	http://dx.doi.org/10.1371/journal.pone.0114838			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25535743	gold, Green Published, Green Submitted			2022-12-27	WOS:000348563300023
J	D'Souza, JL; Smalheiser, NR				D'Souza, Jennifer L.; Smalheiser, Neil R.			Three Journal Similarity Metrics and Their Application to Biomedical Journals	PLOS ONE			English	Article								In the present paper, we have created several novel journal similarity metrics. The MeSH odds ratio measures the topical similarity of any pair of journals, based on the major MeSH headings assigned to articles in MEDLINE. The second metric employed the 2009 Author-ity author name disambiguation dataset as a gold standard for estimating the author odds ratio. This gives a straightforward, intuitive answer to the question: Given two articles in PubMed that share the same author name (lastname, first initial), how does knowing only the identity of the journals (in which the articles were published) predict the relative likelihood that they are written by the same person vs. different persons? The article pair odds ratio detects the tendency of authors to publish repeatedly in the same journal, as well as in specific pairs of journals. The metrics can be applied not only to estimate the similarity of a pair of journals, but to provide novel profiles of individual journals as well. For example, for each journal, one can define the MeSH cloud as the number of other journals that are topically more similar to it than expected by chance, and the author cloud as the number of other journals that share more authors than expected by chance. These metrics for journal pairs and individual journals have been provided in the form of public datasets that can be readily studied and utilized by others.	[D'Souza, Jennifer L.] Univ Texas Dallas, Dept Comp Sci, Richardson, TX 75230 USA; [Smalheiser, Neil R.] Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA	University of Texas System; University of Texas Dallas; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Smalheiser, NR (corresponding author), Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA.	neils@uic.edu			National Institutes of Health [R01LM010817, P01AG039347]; NATIONAL INSTITUTE ON AGING [P01AG039347] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010817] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	National Institutes of Health grants R01LM010817 and P01AG039347. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astrom F, 2002, COLIS4: EMERGING FRAMEWORKS AND METHODS, P185; Boyack KW, 2005, SCIENTOMETRICS, V64, P351, DOI 10.1007/s11192-005-0255-6; Cordier S, 2012, MEASURE SIMILARITY S; Humphrey Susanne M, 2006, AMIA Annu Symp Proc, P960; Leydesdorff L, 2014, OPERATIONALIZATION F; Leydesdorff L, 2014, J ASSOC INF SCI TECH, V65, P164, DOI 10.1002/asi.22953; Lu ZY, 2009, BIOINFORMATICS, V25, P3038, DOI 10.1093/bioinformatics/btp529; Ni C., 2010, P AM SOC INFORM SCI, V47, P1, DOI [10.1002/meet.14504701202, DOI 10.1002/MEET.14504701202]; Torvik VI, 2009, ACM T KNOWL DISCOV D, V3, DOI 10.1145/1552303.1552304; Torvik VI, 2005, J AM SOC INF SCI TEC, V56, P140, DOI 10.1002/asi.20105	10	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115681	10.1371/journal.pone.0115681	http://dx.doi.org/10.1371/journal.pone.0115681			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536326	Green Submitted, Green Published, gold			2022-12-27	WOS:000348563300065
J	Mezaal, YS; Eyyuboglu, HT; Ali, JK				Mezaal, Yaqeen S.; Eyyuboglu, Halil T.; Ali, Jawad K.			Wide Bandpass and Narrow Bandstop Microstrip Filters Based on Hilbert Fractal Geometry: Design and Simulation Results	PLOS ONE			English	Article								This paper presents new Wide Bandpass Filter (WBPF) and Narrow Bandstop Filter (NBSF) incorporating two microstrip resonators, each resonator is based on 2nd iteration of Hilbert fractal geometry. The type of filter as pass or reject band has been adjusted by coupling gap parameter (d) between Hilbert resonators using a substrate with a dielectric constant of 10.8 and a thickness of 1.27 mm. Numerical simulation results as well as a parametric study of d parameter on filter type and frequency responses are presented and studied. WBPF has designed at resonant frequencies of 2 and 2.2 GHz with a bandwidth of 0.52 GHz, -28 dB return loss and -0.125 dB insertion loss while NBSF has designed for electrical specifications of 2.37 GHz center frequency, 20 MHz rejection bandwidth, -0.1873 dB return loss and 13.746 dB insertion loss. The proposed technique offers a new alternative to construct low-cost high-performance filter devices, suitable for a wide range of wireless communication systems.	[Mezaal, Yaqeen S.; Eyyuboglu, Halil T.] Cankaya Univ, Elect & Commun Engn Dept, Ankara, Turkey; [Mezaal, Yaqeen S.; Ali, Jawad K.] Univ Technol Baghdad, Dept Elect Engn, Microwave Res Grp, Baghdad, Iraq	Cankaya University; University of Technology- Iraq	Mezaal, YS (corresponding author), Cankaya Univ, Elect & Commun Engn Dept, Ankara, Turkey.	yakeen_sbah@yahoo.com	Mezaal, Yaqeen Sabah/O-5095-2019; Ali, Jawad K./C-6710-2009	Mezaal, Yaqeen Sabah/0000-0002-9953-9975; Ali, Jawad K./0000-0002-6900-6844	Scientific and Technological Research Council of Turkey (TUBITAK) [B.14.2. TBT.0.06.01.03-215.01-24962]	Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This work is supported by the Scientific and Technological Research Council of Turkey (TUBITAK) for PhD Research Fellowship for Foreign Citizens Program under Fund Reference (B.14.2. TBT.0.06.01.03-215.01-24962). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali Jawad K., 2009, 2009 3rd IEEE International Symposium on Microwave, Antenna, Propagation and EMC Technologies for Wireless Communications (MAPE 2009), P1019, DOI 10.1109/MAPE.2009.5355854; Ali J. K., 2008, 5TH INT MULTI C SYST, P1; Ali JK, 2012, PR ELECTROMAGN RES S, P888; Barra M., 2004, THESIS U NAPOLI; Chang K., 2004, MICROWAVE RING CIRCU; Chen J, 2007, PROG ELECTROMAGN RES, V70, P269, DOI 10.2528/PIER07012603; Dong Yan, 2010, Proceedings 2010 IEEE Youth Conference on Information, Computing and Telecommunications (YC-ICT 2010), P5, DOI 10.1109/YCICT.2010.5713138; Eryilmaz GM, 2009, MICROW OPT TECHN LET, V51, P1470; Ghosh B., 2011, 2011 IEEE International Workshop on Electromagnetics; Applications and Student Innovation (iWEM 2011), P89, DOI 10.1109/iWEM.2011.6021445; Haiwen L., 2010, PROCEEDINGS OF INTER, P184; Hong J.-S., 2001, WILEY MICRO; Jarry P., 2009, DESIGN REALIZATIONS; Kwon .K, 2006, J KOREAN ELECTROMAGN, V6; Liu JC, 2007, MICROW OPT TECHN LET, V49, P1890, DOI 10.1002/mop.22630; Mandelbrot B, 1983, FRACTAL GEOMETRY NAT; Mezaal Y. S., 2009, INT J ADV COMPUT TEC, V1, P35; Mezaal YS, 2014, IETE J RES, V60, P257, DOI 10.1080/03772063.2014.922018; Mezaal YS, 2013, INT C ADV COMPUT COM, P343, DOI 10.1109/ACCT.2013.54; Waterhouse R. B., 2003, MICROSTRIP PATCH ANT	19	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115412	10.1371/journal.pone.0115412	http://dx.doi.org/10.1371/journal.pone.0115412			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536436	Green Published, gold			2022-12-27	WOS:000348563300039
J	Xu, Y; Fu, LR; Jia, MH; Dai, GY; Wang, Q; Huang, P; Zheng, H; Peng, ZH; Wang, L; Yu, RB; Wang, N				Xu, Yin; Fu, Li Ru; Jia, Manhong; Dai, Genyin; Wang, Qing; Huang, Peng; Zheng, Hui; Peng, Zhihang; Wang, Lu; Yu, Rongbin; Wang, Ning			HIV Prevalence and Associated Factors among Foreign Brides from Burma in Yunnan Province, China	PLOS ONE			English	Article							RISK BEHAVIORS; INFECTION; SYPHILIS; HIV/AIDS; SEX; EPIDEMIC; COUPLES; DEHONG; MEN	Background: Many Burmese women have migrated to Yunnan Province and married local residents over the past few decades; however, limited information is available on their HIV prevalence and ability to cope with HIV. This study aims to assess the prevalence of HIV and knowledge related to AIDS, as well as to discover possible risk factors of HIV infection among foreign brides from Burma in Yunnan Province. Methods: A cross-sectional study was taken of all Burmese cross-border wives residing in Tengchong County using standardized questionnaires. HIV and syphilis testing was conducted at the same time. Results: Among 600 Burmese brides, the HIV prevalence was 2.17%. Those aged 21-30, those with higher education levels and those who had resided in China less than one year had higher infection rates. The AIDS awareness rate of 39.50% was very low in this population. Only 28.67% of participants had ever been involved in prevention services. The rate of condom use was low. Classification by age, education, occupation, prior HIV testing and prior use of HIV prevention services showed a statistically significant association with mean knowledge score (p<0.05). Residing in China less than one year (OR=3.86, 95% CI=1.09-13.70) and having casual sex in the last year (OR=10.49, 95% CI=1.20-91.59) were risk factors for HIV infection. Conclusions: Burmese brides in China are not only exposed to a high risk of HIV infection, but also seriously lack response capabilities. Educational interventions and control efforts are practical approaches that need to be strengthened among this population.	[Xu, Yin; Dai, Genyin; Wang, Qing; Huang, Peng; Zheng, Hui; Peng, Zhihang; Yu, Rongbin] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Fu, Li Ru; Jia, Manhong] Yunnan Prov Ctr Dis Control & Prevent, Kunming, Peoples R China; [Wang, Lu; Wang, Ning] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China	Nanjing Medical University; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention	Peng, ZH (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China.	zhihangpeng@njmu.edn.cn; wangning_12@126.com			Natural Science Foundation of China [81001288]; National S&T Major Project Foundation of China [2012ZX10001-001, 2011ZX10004-902]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Jiangsu Province Health Development Project with Science and Education [ZX201109]; National Science and Technology Support Program [2011BAI09B02]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National S&T Major Project Foundation of China; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Jiangsu Province Health Development Project with Science and Education; National Science and Technology Support Program	This work was supported in part by Natural Science Foundation of China (81001288), National S&T Major Project Foundation of China (No. 2012ZX10001-001 and No. 2011ZX10004-902), Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), Jiangsu Province Health Development Project with Science and Education (NO. ZX201109), and National Science and Technology Support Program (2011BAI09B02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, UNAIDS REP GLOB AIDS; Bai ZH, 2011, J KUNMING U SCI TECH, V11, P12; Beyrer C, 2003, JAIDS-J ACQ IMM DEF, V32, P311, DOI 10.1097/00126334-200303010-00011; China A.I.D.S, 2012, RESP PROGR REP MIN H; Dean K, 2005, POLIT GEOGR, V24, P808, DOI 10.1016/j.polgeo.2005.06.004; Duan S, 2012, SEX HEALTH, V9, P481, DOI 10.1071/SH12065; Duan S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-180; Feng L, 2011, THESIS CHINESE CDCP; Ford K, 2012, INT J MIGR HEALTH SO, V8, P127, DOI 10.1108/17479891211267311; Fu LR, 2011, CHINESE J AIDS STD, V17, P316; Fu ZH, 2011, AIDS BEHAV, V15, P1017, DOI 10.1007/s10461-010-9797-6; He N., 2012, CHINESE J AIDS STD, V18, P156; Jia MH, 2010, JAIDS-J ACQ IMM DEF, V53, pS34, DOI 10.1097/QAI.0b013e3181c7d6ff; Jin X, 2010, JAIDS-J ACQ IMM DEF, V53, P131, DOI 10.1097/QAI.0b013e3181b3552a; Jun P, 2010, MED SOC, V7; Lao YF, 2012, INFECT DIS INFORM, V25, P360; Lin F, 2010, CHINESE J AIDS STD, V5, P515; Liu SY, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-250; Lu L, 2008, NATURE, V455, P609, DOI 10.1038/455609a; Lynn WA, 2004, LANCET INFECT DIS, V4, P456, DOI 10.1016/S1473-3099(04)01061-8; Schofer H, 1996, GENITOURIN MED, V72, P176; Tan S, 2010, THESIS KUNMING MED U; Tucker JD, 2005, AIDS, V19, P539, DOI 10.1097/01.aids.0000163929.84154.87; Wang L, 2012, AIDS CARE, V24, P1059, DOI 10.1080/09540121.2012.661837; Wang LL, 2009, CHIN J PHM, V25, P170; *WHO, EP FACT SHEET HIV AI; Xiao Y, 2007, SOC SCI MED, V64, P665, DOI 10.1016/j.socscimed.2006.09.019; Zetola NM, 2007, CLIN INFECT DIS, V44, P1222, DOI 10.1086/513427; Zhou H, 2007, SEX TRANSM INFECT, V83, P476, DOI 10.1136/sti.2007.026187	29	8	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115599	10.1371/journal.pone.0115599	http://dx.doi.org/10.1371/journal.pone.0115599			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ9UY	25536087	Green Published, Green Submitted, gold			2022-12-27	WOS:000348563300054
J	Kramer, C; Jordan, D; Kretschmer, A; Lehmeyer, V; Kellermann, K; Schaller, SJ; Blobner, M; Kochs, EF; Fink, H				Kramer, Christopher; Jordan, Denis; Kretschmer, Alexander; Lehmeyer, Veronika; Kellermann, Kristine; Schaller, Stephan J.; Blobner, Manfred; Kochs, Eberhard F.; Fink, Heidrun			Electromyographic Permutation Entropy Quantifies Diaphragmatic Denervation and Reinnervation	PLOS ONE			English	Article							ACCESSORY PHRENIC-NERVE; APPROXIMATE ENTROPY; POWER SPECTRUM; MUSCLE-FIBERS; RAT; ELECTROENCEPHALOGRAM; UNCONSCIOUSNESS; PARALYSIS	Spontaneous reinnervation after diaphragmatic paralysis due to trauma, surgery, tumors and spinal cord injuries is frequently observed. A possible explanation could be collateral reinnervation, since the diaphragm is commonly double-innervated by the (accessory) phrenic nerve. Permutation entropy (PeEn), a complexity measure for time series, may reflect a functional state of neuromuscular transmission by quantifying the complexity of interactions across neural and muscular networks. In an established rat model, electromyographic signals of the diaphragm after phrenicotomy were analyzed using PeEn quantifying denervation and reinnervation. Thirty-three anesthetized rats were unilaterally phrenicotomized. After 1, 3, 9, 27 and 81 days, diaphragmatic electromyographic PeEn was analyzed in vivo from sternal, mid-costal and crural areas of both hemidiaphragms. After euthanasia of the animals, both hemidiaphragms were dissected for fiber type evaluation. The electromyographic incidence of an accessory phrenic nerve was 76%. At day 1 after phrenicotomy, PeEn (normalized values) was significantly diminished in the sternal (median: 0.69; interquartile range: 0.66-0.75) and mid-costal area (0.68; 0.66-0.72) compared to the non-denervated side (0.84; 0.78-0.90) at threshold p<0.05. In the crural area, innervated by the accessory phrenic nerve, PeEn remained unchanged (0.79; 0.72-0.86). During reinnervation over 81 days, PeEn normalized in the mid-costal area (0.84; 0.77-0.86), whereas it remained reduced in the sternal area (0.77; 0.70-0.81). Fiber type grouping, a histological sign for reinnervation, was found in the mid-costal area in 20% after 27 days and in 80% after 81 days. Collateral reinnervation can restore diaphragm activity after phrenicotomy. Electromyographic PeEn represents a new, distinctive assessment characterizing intramuscular function following denervation and reinnervation.	[Kramer, Christopher; Jordan, Denis; Kretschmer, Alexander; Lehmeyer, Veronika; Kellermann, Kristine; Schaller, Stephan J.; Blobner, Manfred; Kochs, Eberhard F.; Fink, Heidrun] Tech Univ Munich, Klinikum Rechts Isar, Klin Anaesthesiol, D-81675 Munich, Germany	Technical University of Munich; University of Munich	Jordan, D (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Klin Anaesthesiol, Ismaninger Str 22, D-81675 Munich, Germany.	d.jordan@lrz.tu-muenchen.de	Blobner, Manfred/R-4411-2017; Kretschmer, Alexander/AAU-5922-2021; Schaller, Stefan J/L-8054-2019	Blobner, Manfred/0000-0002-0370-5247; Schaller, Stefan J/0000-0002-6683-9584; Lewald, Heidrun/0000-0002-5192-425X				BALLANTYNE JP, 1982, MUSCLE NERVE, V5, pS127; Bandt C, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.174102; BROOKE MH, 1970, ARCH NEUROL-CHICAGO, V23, P369, DOI 10.1001/archneur.1970.00480280083010; Cao YH, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.046217; Chen R, 1996, MUSCLE NERVE, V19, P324, DOI 10.1002/(SICI)1097-4598(199603)19:3<324::AID-MUS7>3.0.CO;2-F; De Bie G, 2007, AM J OTOLARYNG, V28, P357, DOI 10.1016/j.amjoto.2006.10.007; DOUGLASS BE, 1960, DIS CHEST, V37, P295; Elefteriades J, 2008, J CARDIOVASC SURG, V49, P289; FUGLSANGFREDERIKSEN A, 1990, J NEUROL SCI, V97, P81, DOI 10.1016/0022-510X(90)90100-2; GIBSON GJ, 1989, THORAX, V44, P960, DOI 10.1136/thx.44.11.960; Goebel HH, 2013, MUSCLE DISEASE: PATHOLOGY AND GENETICS, 2ND EDITION, P1, DOI 10.1002/9781118635469; GOTTSCHALL J, 1977, ANAT EMBRYOL, V151, P63, DOI 10.1007/BF00315298; HAGG GM, 1992, J APPL PHYSIOL, V73, P1211, DOI 10.1152/jappl.1992.73.4.1211; HARPER NJN, 1987, BRIT J ANAESTH, V59, P200, DOI 10.1093/bja/59.2.200; IWASAKI Y, 1991, INT J NEUROSCI, V58, P165, DOI 10.3109/00207459108985432; Jordan D, 2013, BIOMED TECH BERL; Jordan D, 2013, ANESTHESIOLOGY, V119, P1031, DOI 10.1097/ALN.0b013e3182a7ca92; Jordan D, 2008, ANESTHESIOLOGY, V109, P1014, DOI 10.1097/ALN.0b013e31818d6c55; Kaufman MR, 2011, CHEST, V140, P191, DOI 10.1378/chest.10-2765; Kreuzer M, 2014, J CLIN MONIT COMPUT; KUGELBERG E, 1970, J NEUROL NEUROSUR PS, V33, P319, DOI 10.1136/jnnp.33.3.319; Li D, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/4/046010; Loukas M, 2006, ANN THORAC SURG, V82, P1870, DOI 10.1016/j.athoracsur.2006.05.098; LULLMANNRAUCH R, 1971, Z ZELLFORSCH MIK ANA, V121, P593, DOI 10.1007/BF00560162; Marie JP, 1997, RESP PHYSIOL, V109, P139, DOI 10.1016/S0034-5687(97)00048-0; Merino-Ramirez MA, 2007, MUSCLE NERVE, V36, P267, DOI 10.1002/mus.20754; Nayak Soubhagya R, 2008, Acta Medica (Hradec Kralove), V51, P181; Olofsen E, 2008, BRIT J ANAESTH, V101, P810, DOI 10.1093/bja/aen290; Polla B, 2004, THORAX, V59, P808, DOI 10.1136/thx.2003.009894; Reilingh TSD, 1998, J PEDIATR SURG, V33, P602, DOI 10.1016/S0022-3468(98)90325-6; Stevens Robert D, 2009, Crit Care Med, V37, pS299, DOI 10.1097/CCM.0b013e3181b6ef67; Thakor NV, 2004, ANNU REV BIOMED ENG, V6, P453, DOI 10.1146/annurev.bioeng.5.040202.121601; Xie HB, 2010, ANN BIOMED ENG, V38, P1483, DOI 10.1007/s10439-010-9933-5; Zhan WZ, 1997, J APPL PHYSIOL, V82, P1145, DOI 10.1152/jappl.1997.82.4.1145; Zhou P, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/066010	35	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115754	10.1371/journal.pone.0115754	http://dx.doi.org/10.1371/journal.pone.0115754			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25532023	Green Published, gold, Green Submitted			2022-12-27	WOS:000348845100104
J	Pan, J; Bhardwaj, M; Nagabhyru, P; Grossman, RB; Schardl, CL				Pan, Juan; Bhardwaj, Minakshi; Nagabhyru, Padmaja; Grossman, Robert B.; Schardl, Christopher L.			Enzymes from Fungal and Plant Origin Required for Chemical Diversification of Insecticidal Loline Alkaloids in Grass-Epichloe Symbiota	PLOS ONE			English	Article							NEOTYPHODIUM-UNCINATUM; MEADOW FESCUE; IN-VITRO; ENDOPHYTE; BIOSYNTHESIS; ARUNDINACEA; PREVALENCE; CURRENCIES; SEQUENCE; HYBRID	The lolines are a class of bioprotective alkaloids that are produced by Epichloe species, fungal endophytes of grasses. These alkaloids are saturated 1-aminopyrrolizidines with a C2 to C7 ether bridge, and are structurally differentiated by the various modifications of the 1-amino group: -NH2 (norloline), -NHCH3 (loline), -N(CH3)(2) (N-methylloline), -N(CH3)Ac (N-acetylloline), -NHAc (N-acetylnorloline), and -N(CH3)CHO (N-formylloline). Other than the LoIP cytochrome P450, which is required for conversion of N-methylloline to N-formylloline, the enzymatic steps for loline diversification have not yet been established. Through isotopic labeling, we determined that N-acetylnorloline is the first fully cyclized loline alkaloid, implying that deacetylation, methylation, and acetylation steps are all involved in loline alkaloid diversification. Two genes of the loline alkaloid biosynthesis (LOL) gene cluster, lolN and lolM, were predicted to encode an N-acetamidase (deacetylase) and a methyltransferase, respectively. A knockout strain lacking both lolN and lolM stopped the biosynthesis at N-acetylnorloline, and complementation with the two wild-type genes restored production of N-formylloline and N-acetylloline. These results indicated that lolN and lolM are required in the steps from N-acetylnorloline to other lolines. The function of LolM as an N-methyltransferase was confirmed by its heterologous expression in yeast resulting in conversion of norloline to loline, and of loline to N-methylloline. One of the more abundant lolines, N-acetylloline, was observed in some but not all plants with symbiotic Epichloe siegelii, and when provided with exogenous loline, asymbiotic meadow fescue (Lolium pratense) plants produced N-acetylloline, suggesting that a plant acetyltransferase catalyzes	[Pan, Juan; Nagabhyru, Padmaja] Univ Kentucky, Dept Plant Pathol, Lexington, KY 40506 USA; [Bhardwaj, Minakshi; Grossman, Robert B.; Schardl, Christopher L.] Univ Kentucky, Dept Chem, Lexington, KY 40506 USA	University of Kentucky; University of Kentucky	Schardl, CL (corresponding author), Univ Kentucky, Dept Chem, Lexington, KY 40506 USA.	schardl@uky.edu	Pan, Juan/GSN-8862-2022; Schardl, Christopher L/P-5655-2014	Schardl, Christopher L/0000-0003-2197-0842; Bhardwaj, Minakshi/0000-0001-6544-7370	Kentucky's National Science Foundation Experimental Program [0814194]; National Institute of General Medical Sciences [R01GM086888]; United States Department of Agriculture [2012-6701319384]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086888] Funding Source: NIH RePORTER	Kentucky's National Science Foundation Experimental Program; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); United States Department of Agriculture(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by Kentucky's National Science Foundation Experimental Program to Stimulate Competitive Research grant 0814194 (http://www.kynsfepscor.org/), and National Institute of General Medical Sciences grant R01GM086888, and United States Department of Agriculture grant 2012-6701319384. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AN ZQ, 1993, APPL ENVIRON MICROB, V59, P1540, DOI 10.1128/AEM.59.5.1540-1548.1993; Ball O. J. P., 1999, Proceedings of the Fifty Second New Zealand Plant Protection Conference, Auckland Airport Centra, Auckland, New Zealand, 10-12 August, 1999, P264; Blankenship JD, 2005, CHEMBIOCHEM, V6, P1016, DOI 10.1002/cbic.200400327; Blankenship JD, 2001, PHYTOCHEMISTRY, V58, P395, DOI 10.1016/S0031-9422(01)00272-2; Bultman TL, 2009, ENTOMOL EXP APPL, V130, P173, DOI 10.1111/j.1570-7458.2008.00802.x; Bultman TL, 1997, OIKOS, V78, P170, DOI 10.2307/3545812; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Faulkner JR, 2006, CHEMBIOCHEM, V7, P1078, DOI 10.1002/cbic.200600066; Georghiou GP., 1972, ANNU REV ECOL EVOL S, V3, P133, DOI DOI 10.1146/ANNUREV.ES.03.110172.001025; Ghimire SR, 2011, MYCOLOGIA, V103, P75, DOI 10.3852/10-154; Hopp T. P., 1988, NAT BIOTECHNOL, V6, P1204, DOI DOI 10.1038/NBT1088-1204; Inoue I, 2002, PLANT CELL, V14, P1869, DOI 10.1105/tpc.002576; Jensen J. G., 2009, New Zealand Plant Protection, V62, P12; Kang Y, 2011, MYCOLOGIA, V103, P1341, DOI 10.3852/10-352; LATCH GCM, 1985, ANN APPL BIOL, V107, P17, DOI 10.1111/j.1744-7348.1985.tb01543.x; Moon CD, 2004, MOL ECOL, V13, P1455, DOI 10.1111/j.1365-294X.2004.02138.x; Pan J, 2014, PHYTOCHEMISTRY, V98, P60, DOI 10.1016/j.phytochem.2013.11.015; Panaccione DG, 2001, P NATL ACAD SCI USA, V98, P12820, DOI 10.1073/pnas.221198698; Pogany J, 2008, P NATL ACAD SCI USA, V105, P19956, DOI 10.1073/pnas.0810851105; Popay A. J., 2009, New Zealand Plant Protection, V62, P19; Rajendran KS, 2004, VIROLOGY, V326, P250, DOI 10.1016/j.virol.2004.06.018; RIBAS I., 1953, FARMACOGNOSIA [MADRID], V13, P367; RIEDELL WE, 1991, J ENTOMOL SCI, V26, P122, DOI 10.18474/0749-8004-26.1.122; Schardl CL, 2007, PHYTOCHEMISTRY, V68, P980, DOI 10.1016/j.phytochem.2007.01.010; Schardl CL, 2013, TOXINS, V5, P1064, DOI 10.3390/toxins5061064; Schardl CL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003323; Schardl CL, 2010, ENCY LIFE SCI, DOI [10.1002/9780470015902.a0001324.pub2, DOI 10.1002/9780470015902.A0001324.PUB2]; SIKORSKI RS, 1989, GENETICS, V122, P19; Spiering MJ, 2008, FUNGAL GENET BIOL, V45, P1307, DOI 10.1016/j.fgb.2008.07.001; Spiering MJ, 2005, GENETICS, V169, P1403, DOI 10.1534/genetics.104.035972; Spiering MJ, 2002, FUNGAL GENET BIOL, V36, P242, DOI 10.1016/S1087-1845(02)00023-3; Starnes JH, 2012, GENETICS, V191, P389, DOI 10.1534/genetics.111.137950; TSAI HF, 1992, CURR GENET, V22, P399, DOI 10.1007/BF00352441; VEEN G, 1992, Z NATURFORSCH C, V47, P341; Zientz E, 2004, MICROBIOL MOL BIOL R, V68, P745, DOI 10.1128/MMBR.68.4.745-770.2004	35	16	33	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115590	10.1371/journal.pone.0115590	http://dx.doi.org/10.1371/journal.pone.0115590			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531527	Green Submitted, gold, Green Published			2022-12-27	WOS:000348845100080
J	Zhang, X; Song, F; Taxipalati, M; Wei, W; Feng, FQ				Zhang, Xi; Song, Fei; Taxipalati, Maierhaba; Wei, Wei; Feng, Fengqin			Comparative Study of Surface-Active Properties and Antimicrobial Activities of Disaccharide Monoesters	PLOS ONE			English	Article							FATTY-ACID ESTERS; ETHYLENEDIAMINETETRAACETIC ACID; REGIOSELECTIVE ACYLATION; ESSENTIAL OILS; SUCROSE; CARBOHYDRATE; DERIVATIVES; MONOLAURIN; SOLVENT; MALTOSE	The objective of this research was to determine the effect of sugar or fatty acid in sugar ester compounds on the surface-active properties and antimicrobial activities of these compounds. Disaccharides of medium-chain fatty acid monoesters were synthesized through transesterifications by immobilized lipase (Lipozyme TLIM) to yield nine monoesters for subsequent study. Their antimicrobial activities were investigated using three pathogenic microorganisms: Staphylococcus aureus, Escherichia coli O157:H7 and Candida albicans. Their surface-active properties including air-water surface tension, critical micelle concentration, and foaming and emulsion power and stability were also studied. The results showed that all of the tested monoesters were more effective against Staphylococcus aureus (Gram-positive bacterium) than against Escherichia coli O157:H7 (Gram-negative bacterium). The results demonstrated that the carbon chain length was the most important factor influencing the surface properties, whereas degree of esterification and hydrophilic groups showed little effect.	[Zhang, Xi; Song, Fei; Taxipalati, Maierhaba; Wei, Wei; Feng, Fengqin] Zhejiang Univ, Coll Biosyst Engn & Food Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Xi] Yunnan Coll Tradit Chinese Med, Kunming, Yunnan, Peoples R China; [Zhang, Xi; Taxipalati, Maierhaba; Wei, Wei; Feng, Fengqin] Zhejiang Univ, Zhejiang Key Lab Agrofood Proc, Hangzhou 310003, Zhejiang, Peoples R China; [Song, Fei] Synutra Int Inc, Beijing Inst Nutr, Beijing, Peoples R China; [Feng, Fengqin] Zhejiang Univ, Fuli Inst Food Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Yunnan University of Chinese Medicine; Zhejiang University; Zhejiang University	Feng, FQ (corresponding author), Zhejiang Univ, Coll Biosyst Engn & Food Sci, Hangzhou 310003, Zhejiang, Peoples R China.	fengfq@zju.edu.cn			program of National Natural Science Foundation of China [31071501]; Key Innovation Team of Science and Technology in Zhejiang Province [2010R50032]; Zhejiang Key Laboratory for Agro-Food Processing [2010R50032]	program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Innovation Team of Science and Technology in Zhejiang Province; Zhejiang Key Laboratory for Agro-Food Processing	This work was supported by the program of National Natural Science Foundation of China (Project No. 31071501), Key Innovation Team of Science and Technology in Zhejiang Province (No. 2010R50032), and Zhejiang Key Laboratory for Agro-Food Processing (No. 2010R50032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becerra N, 2008, COLLOID SURFACE A, V327, P134, DOI 10.1016/j.colsurfa.2008.06.012; Branen AL, 1980, FOOD TECHNOL, P51; Branen JK, 2004, INT J FOOD MICROBIOL, V90, P63, DOI 10.1016/S0168-1605(03)00172-7; CONLEY AJ, 1973, ANTIMICROB AGENTS CH, V4, P501, DOI 10.1128/AAC.4.5.501; Devulapalle KS, 2004, CARBOHYD RES, V339, P1029, DOI 10.1016/j.carres.2004.01.007; Ducret A, 1996, J AM OIL CHEM SOC, V73, P109, DOI 10.1007/BF02523456; Ferrer M, 2005, ENZYME MICROB TECH, V36, P391, DOI 10.1016/j.enzmictec.2004.02.009; Ferrer M, 1999, BIOTECHNOL BIOENG, V65, P10, DOI 10.1002/(SICI)1097-0290(19991005)65:1&lt;10::AID-BIT2&gt;3.0.CO;2-L; Ferrer M, 2000, TETRAHEDRON, V56, P4053, DOI 10.1016/S0040-4020(00)00319-7; Garofalakis G, 2000, J COLLOID INTERF SCI, V229, P391, DOI 10.1006/jcis.2000.7035; Griffin W.C., 1949, J SOC COSMET CHEM, V1, P311; Habulin M, 2008, J SUPERCRIT FLUID, V45, P338, DOI 10.1016/j.supflu.2008.01.002; Hathcox AK, 1996, FOOD MICROBIOL, V13, P213, DOI 10.1006/fmic.1996.0027; Herrington TM, 1991, MICROEMULSIONS EMULS, P82; Huband FA, 1998, FOOD HYDROCOLLOIDS, V12, P237; KANAZAWA A, 1995, J APPL BACTERIOL, V78, P55, DOI 10.1111/j.1365-2672.1995.tb01673.x; KATO N, 1975, J FERMENT TECHNOL, V53, P793; Kempen SEHJ, 2013, J AGR FOOD CHEM, V61, P7829; Kempen SEHJ, 2013, FOOD BIOPHYSICS; Kim JE, 1998, BIOTECHNOL BIOENG, V57, P121, DOI 10.1002/(SICI)1097-0290(19980105)57:1&lt;121::AID-BIT15&gt;3.0.CO;2-N; Kjellin URM, 2001, LANGMUIR, V17, P1941, DOI 10.1021/la001309z; Li YK, 2004, TENSIDE SURFACT DET, V41, P26; [刘巧瑜 Liu Qiaoyu], 2010, [食品工业科技, Science & Technology of Food Industry], V31, P313; McNaught AD, 1997, COMPENDIUM CHEM TERM, DOI DOI 10.1351/GOLDBOOK; Nobmann P, 2009, INT J FOOD MICROBIOL, V128, P440, DOI 10.1016/j.ijfoodmicro.2008.10.008; Ouattara B, 1997, INT J FOOD MICROBIOL, V37, P155, DOI 10.1016/S0168-1605(97)00070-6; Plou FJ, 2002, J BIOTECHNOL, V96, P55, DOI 10.1016/S0168-1656(02)00037-8; Preuss HG, 2005, MOL CELL BIOCHEM, V272, P29, DOI 10.1007/s11010-005-6604-1; RICH JO, 1995, BIOTECHNOL BIOENG, V45, P426, DOI 10.1002/bit.260450507; Rodriguez E, 2004, J APPL MICROBIOL, V96, P903, DOI 10.1111/j.1365-2672.2004.02207.x; RUSSELL AD, 1991, J APPL BACTERIOL, V71, P191, DOI 10.1111/j.1365-2672.1991.tb04447.x; Neta NDS, 2012, FOOD HYDROCOLLOID, V27, P324, DOI 10.1016/j.foodhyd.2011.10.009; Seino H, 1984, J AM OIL CHEM SOC, V73, P1481; Smith A, 2008, CARBOHYD RES, V343, P2557, DOI 10.1016/j.carres.2008.07.012; Soultani S, 2003, COLLOID SURFACE A, V227, P35, DOI 10.1016/S0927-7757(03)00360-1; WANG YF, 1988, J AM CHEM SOC, V110, P7200, DOI 10.1021/ja00229a041; Watanabe T, 1999, FOODS FOOD INGREDIEN, V180, P18; WoudenbergvanOosterom M, 1996, BIOTECHNOL BIOENG, V49, P328, DOI 10.1002/(SICI)1097-0290(19960205)49:3&lt;328::AID-BIT11&gt;3.0.CO;2-A; Zhang H, 2012, J ZHEJIANG UNIV-SC B, V13, P83, DOI 10.1631/jzus.B1100049	39	35	37	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e114845	10.1371/journal.pone.0114845	http://dx.doi.org/10.1371/journal.pone.0114845			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531369	gold, Green Published, Green Submitted			2022-12-27	WOS:000348845100028
J	Aschenbrenner, D; Pippig, DA; Klamecka, K; Limmer, K; Leonhardt, H; Gaub, HE				Aschenbrenner, Daniela; Pippig, Diana A.; Klamecka, Kamila; Limmer, Katja; Leonhardt, Heinrich; Gaub, Hermann E.			Parallel Force Assay for Protein-Protein Interactions	PLOS ONE			English	Article							DNA; SFP; OLIGODEOXYNUCLEOTIDES; ARRAYS; BONDS; RNA	Quantitative proteome research is greatly promoted by high-resolution parallel format assays. A characterization of protein complexes based on binding forces offers an unparalleled dynamic range and allows for the effective discrimination of non-specific interactions. Here we present a DNA-based Molecular Force Assay to quantify protein-protein interactions, namely the bond between different variants of GFP and GFP-binding nanobodies. We present different strategies to adjust the maximum sensitivity window of the assay by influencing the binding strength of the DNA reference duplexes. The binding of the nanobody Enhancer to the different GFP constructs is compared at high sensitivity of the assay. Whereas the binding strength to wild type and enhanced GFP are equal within experimental error, stronger binding to superfolder GFP is observed. This difference in binding strength is attributed to alterations in the amino acids that form contacts according to the crystal structure of the initial wild type GFP-Enhancer complex. Moreover, we outline the potential for large-scale parallelization of the assay.	[Aschenbrenner, Daniela; Pippig, Diana A.; Klamecka, Kamila; Limmer, Katja; Gaub, Hermann E.] Univ Munich, Lehrstuhl Angew Phys, D-80799 Munich, Germany; [Aschenbrenner, Daniela; Pippig, Diana A.; Klamecka, Kamila; Limmer, Katja; Gaub, Hermann E.] Univ Munich, Ctr Nanosci CeNS, D-80799 Munich, Germany; [Klamecka, Kamila; Leonhardt, Heinrich] Univ Munich, Dept Biol 2, D-82152 Planegg Martinsried, Germany; [Klamecka, Kamila; Leonhardt, Heinrich] Univ Munich, Ctr Nanosci CeNS, D-82152 Planegg Martinsried, Germany; [Aschenbrenner, Daniela; Leonhardt, Heinrich] Munich Ctr Integrated Prot Sci CIPSM, D-81377 Munich, Germany	University of Munich; University of Munich; University of Munich; University of Munich; University of Munich	Pippig, DA (corresponding author), Univ Munich, Lehrstuhl Angew Phys, Amalienstr 54, D-80799 Munich, Germany.	diana.pippig@physik.uni-muenchen.de	Leonhardt, Heinrich/B-2791-2014		Deutsche Forschungsgemeinschaft [SFB 1032-A01, SPP 1623, LE 721/13-1]; European Research Council Advanced Grant; Elite Network of Bavaria (International Doctorate Program NanoBioTechnology); Nanosystems Initiative Munich	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council Advanced Grant(European Research Council (ERC)); Elite Network of Bavaria (International Doctorate Program NanoBioTechnology); Nanosystems Initiative Munich	Funding was provided by the Deutsche Forschungsgemeinschaft SFB 1032-A01 (HEG) and SPP 1623, LE 721/13-1 (HL) as well as a European Research Council Advanced Grant (HEG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. KK and KL are grateful to the Elite Network of Bavaria (International Doctorate Program NanoBioTechnology) for doctoral fellowships. DA, KK and KL thank Nanosystems Initiative Munich for support.	Albrecht C, 2003, SCIENCE, V301, P367, DOI 10.1126/science.1084713; Albrecht CH, 2008, BIOPHYS J, V94, P4766, DOI 10.1529/biophysj.107.125427; Barnes TW, 2001, J AM CHEM SOC, V123, P4107, DOI 10.1021/ja003208t; Binnig G., 1986, PHYS REV LETT; Blank K, 2004, ANAL BIOANAL CHEM, V379, P974, DOI 10.1007/s00216-004-2607-0; Dervan P, 2003, CURR OPIN STRUCT BIO; Dervan P, 2005, TOP CURR CHEM; Dietz H, 2006, P NATL ACAD SCI USA, V103, P1244, DOI 10.1073/pnas.0509217103; Dose C, 2007, RECOGNITION MIRROR I; FROEHLER BC, 1992, TETRAHEDRON LETT, V33, P5307, DOI 10.1016/S0040-4039(00)79079-4; Gerber D, 2009, NAT METHODS, V6, P71, DOI [10.1038/NMETH.1289, 10.1038/nmeth.1289]; Heim R, 1995, NATURE; Hinterdorfer P, 2006, NATURE METHODS; Ho D, 2009, ANAL CHEM, V81, P3159, DOI 10.1021/ac802766j; Ho D, 2009, BIOPHYS J, V96, P4661, DOI 10.1016/j.bpj.2009.02.059; Jongsma MA, 2006, PROTEOMICS, V6, P2650, DOI 10.1002/pmic.200500654; Karlsson R, 2004, J MOL RECOGNITION; Kirchhofer A, 2010, NAT STRUCT MOL BIOL, V17, P133, DOI 10.1038/nsmb.1727; Koch S, 2002, BIOPHYS J; Kong F, 2009, J CELL BIOL, V185, P1275, DOI 10.1083/jcb.200810002; Kornreich M, 2013, CURRENT OPINION BIOT; Krautbauer R, 2003, NANO LETT, V3, P493, DOI 10.1021/nl034049p; Krautbauer R, 2002, SINGLE MOL; Langenhan T, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003825; Leckband D, 2000, ANNU REV BIOPH BIOM, V29, P1, DOI 10.1146/annurev.biophys.29.1.1; Lefebvre A, 1995, EUR J BIOCH; Limmer K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089626; Limmer K, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1455; Lin S, 2005, CURRENT PROTEOMICS; Maillard RA, 2011, CELL, V145, P459, DOI 10.1016/j.cell.2011.04.010; Manibog K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4941; Moffitt J, 2008, BIOCHEMISTRY; Morfill J, 2007, BIOPHYS J, V93, P2400, DOI 10.1529/biophysj.107.106112; MOY VT, 1994, SCIENCE, V266, P257, DOI 10.1126/science.7939660; Otten M, 2014, NATURE METHODS; Otten M, 2013, LAB CHIP, V13, P4198, DOI 10.1039/c3lc50830g; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Pippig DA, 2014, ACS NANO; Quadri LEN, 1998, BIOCHEMISTRY-US, V37, P1585, DOI 10.1021/bi9719861; Rakshit S, 2014, PHYS CHEM CHEM PHYS, V16, P2211, DOI 10.1039/c3cp53963f; Rief M, 1999, NAT STRUCT BIOL, V6, P346; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Severin P, 2011, NUCL ACIDS RES; Severin PMD, 2011, LAB CHIP, V11, P856, DOI [10.1039/c0lc00302f, 10.1039/c01c00302f]; Severin PMD, 2012, SMALL; Shen L, 2003, EVALUATION C 5 PROPY; Shoemaker BA, 2007, PLOS COMPUT BIOL, V3, P337, DOI 10.1371/journal.pcbi.0030042; Stephanopoulos N, 2011, NAT CHEM BIOL, V7, P876, DOI [10.1038/NCHEMBIO.720, 10.1038/nchembio.720]; Strunz T, 1999, P NATL ACAD SCI US; Stumpf MPH, 2008, P NATL ACAD SCI USA, V105, P6959, DOI 10.1073/pnas.0708078105; Terrazas M, 2009, NUCLEIC ACIDS RES, V37, P346, DOI 10.1093/nar/gkn958; Thomas W, 2002, CELL; Truong K, 2001, CURR OPIN STRUCT BIO; Tsien R, 1998, ANN REV BIOCH; Uetz P, 2000, NATURE; WAGNER RW, 1993, SCIENCE, V260, P1510, DOI 10.1126/science.7684856; Werther M, 2008, PROTEIN PROTEIN INTE; Wiegand G, 1998, APPL OPTICS, V37, P6892, DOI 10.1364/AO.37.006892; Wienken U, 2013, BIOPHYS J; Yin J, 2005, P NATL ACAD SCI USA, V102, P15815, DOI 10.1073/pnas.0507705102; Yin J, 2006, NAT PROTOC, V1, P280, DOI 10.1038/nprot.2006.43; Zhu H, 2003, ANNU REV BIOCHEM, V72, P783, DOI 10.1146/annurev.biochem.72.121801.161511	63	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115049	10.1371/journal.pone.0115049	http://dx.doi.org/10.1371/journal.pone.0115049			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546146	Green Published, gold, Green Submitted			2022-12-27	WOS:000347120200020
J	Tadimalla, S; Momot, KI				Tadimalla, Sirisha; Momot, Konstantin I.			Effect of Partial H2O-D2O Replacement on the Anisotropy of Transverse Proton Spin Relaxation in Bovine Articular Cartilage	PLOS ONE			English	Article							MAGNETIC-RESONANCE; MULTICOMPONENT T-2; PROTEIN SOLUTIONS; LONGITUDINAL RELAXATION; STRUCTURAL ADAPTATIONS; DYNAMIC PROCESSES; NMR-SPECTROSCOPY; BASIC SCIENCE; MU-MRI; COLLAGEN	Anisotropy of transverse proton spin relaxation in collagen-rich tissues like cartilage and tendon is a well-known phenomenon that manifests itself as the "magic-angle" effect in magnetic resonance images of these tissues. It is usually attributed to the non-zero averaging of intra-molecular dipolar interactions in water molecules bound to oriented collagen fibers. One way to manipulate the contributions of these interactions to spin relaxation is by partially replacing the water in the cartilage sample with deuterium oxide. It is known that dipolar interactions in deuterated solutions are weaker, resulting in a decrease in proton relaxation rates. In this work, we investigate the effects of deuteration on the longitudinal and the isotropic and anisotropic contributions to transverse relaxation of water protons in bovine articular cartilage. We demonstrate that the anisotropy of transverse proton spin relaxation in articular cartilage is independent of the degree of deuteration, bringing into question some of the assumptions currently held over the origins of relaxation anisotropy in oriented tissues.	[Tadimalla, Sirisha; Momot, Konstantin I.] Queensland Univ Technol, Sch Chem Phys & Mech Engn, Brisbane, Qld 4001, Australia; [Tadimalla, Sirisha; Momot, Konstantin I.] Inst Hlth & Biomed Innovat, Kelvin Grove, Qld, Australia	Queensland University of Technology (QUT)	Momot, KI (corresponding author), Queensland Univ Technol, Sch Chem Phys & Mech Engn, Brisbane, Qld 4001, Australia.	k.momot@qut.edu.au	Momot, Konstantin/A-5631-2008; Tadimalla, Sirisha/AAE-2576-2021	Momot, Konstantin/0000-0002-5695-153X; Tadimalla, Sirisha/0000-0003-2054-055X	Institute of Health and Biomedical Innovation (IHBI)	Institute of Health and Biomedical Innovation (IHBI)	Financial support for this study was provided by the Institute of Health and Biomedical Innovation (IHBI). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abragam A., 1961, PRINCIPLES NUCL MAGN; AKITT JW, 1989, J CHEM SOC FARAD T 1, V85, P2035, DOI 10.1039/f19898502035; Alhadlaq HA, 2004, OSTEOARTHR CARTILAGE, V12, P887, DOI 10.1016/j.joca.2004.07.006; BERENDSEN HJC, 1962, J CHEM PHYS, V36, P3297, DOI 10.1063/1.1732460; Bryant RG, 1996, ANNU REV BIOPH BIOM, V25, P29, DOI 10.1146/annurev.bb.25.060196.000333; BURSTEIN D, 1993, J ORTHOPAED RES, V11, P465, DOI 10.1002/jor.1100110402; Chen EL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008565; Damion RA, 2012, OSTEOARTHR CARTILAGE, V20, P184, DOI 10.1016/j.joca.2011.12.005; de Visser SK, 2008, OSTEOARTHR CARTILAGE, V16, P689, DOI 10.1016/j.joca.2007.09.015; de Visser SK, 2008, OSTEOARTHR CARTILAGE, V16, P83, DOI 10.1016/j.joca.2007.05.013; Eliav U, 2002, J AM CHEM SOC, V124, P3125, DOI 10.1021/ja011791n; Eliav U, 1999, J MAGN RESON, V137, P295, DOI 10.1006/jmre.1998.1681; Fox AJS, 2009, SPORTS HEALTH, V1, P461, DOI 10.1177/1941738109350438; FULLERTON G D, 1982, Magnetic Resonance Imaging, V1, P209, DOI 10.1016/0730-725X(82)90172-2; Fullerton GD, 2007, J MAGN RESON IMAGING, V25, P345, DOI 10.1002/jmri.20808; FUNG BM, 1977, BIOPHYS J, V18, P235, DOI 10.1016/S0006-3495(77)85610-5; Galvis L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063518; Ghiassi-Nejad M, 2000, BIOMATERIALS, V21, P2089, DOI 10.1016/S0142-9612(00)00140-X; HENKELMAN RM, 1994, MAGNET RESON MED, V32, P592, DOI 10.1002/mrm.1910320508; HENKELMAN RM, 1993, MAGNET RESON MED, V29, P759, DOI 10.1002/mrm.1910290607; Jones CE, 2004, MAGN RESON IMAGING, V22, P211, DOI 10.1016/j.mri.2003.07.005; Keinan-Adamsky K, 2006, MAGN RESON MED, V55, P532, DOI 10.1002/mrm.20775; MIGCHELS.C, 1973, J CHEM PHYS, V59, P296, DOI 10.1063/1.1679805; Momot KI, 2012, BIOMED SPECTROSC IMA, V1, P27, DOI 10.3233/BSI-2012-0003; Momot KI, 2010, NMR BIOMED, V23, P313, DOI 10.1002/nbm.1466; Navon G, 2007, J MAGN RESON IMAGING, V25, P362, DOI 10.1002/jmri.20856; Navon G, 2001, NMR BIOMED, V14, P112, DOI 10.1002/nbm.687; Pearle AD, 2005, CLIN SPORT MED, V24, P1, DOI 10.1016/j.csm.2004.08.007; Pierce DM, 2010, ANN BIOMED ENG, V38, P2447, DOI 10.1007/s10439-010-9990-9; Raya JG, 2012, RADIOLOGY, V262, P550, DOI 10.1148/radiol.11110821; Reiter DA, 2009, MAGN RESON MED, V61, P803, DOI 10.1002/mrm.21926; Richter W, 2000, CONCEPT MAGNETIC RES, V12, P396, DOI 10.1002/1099-0534(2000)12:6<396::AID-CMR3>3.3.CO;2-P; SHERRY AD, 1973, ANAL BIOCHEM, V52, P415, DOI 10.1016/0003-2697(73)90044-4; Tsai PH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076658; Wang N, 2013, J MAGN RESON IMAGING, V38, P625, DOI 10.1002/jmri.24012; Wang NA, 2011, J MAGN RESON, V212, P124, DOI 10.1016/j.jmr.2011.06.031; Wellard RM, 2014, SENSORS-BASEL, V14, P7940, DOI 10.3390/s140507940; Xia Y, 2000, INVEST RADIOL, V35, P602, DOI 10.1097/00004424-200010000-00007; Xia Y, 1998, MAGN RESON MED, V39, P941, DOI 10.1002/mrm.1910390612; Yusuf KQ, 2013, J MATER SCI-MATER M, V24, P1005, DOI 10.1007/s10856-013-4858-9; Zheng SK, 2010, CARTILAGE, V1, P55, DOI 10.1177/1947603509359784; Zheng SK, 2011, MAGN RESON MED, V65, P656, DOI 10.1002/mrm.22648; Zheng SK, 2009, J MAGN RESON, V198, P188, DOI 10.1016/j.jmr.2009.02.005; ZHONG JH, 1990, MAGNET RESON MED, V13, P192, DOI 10.1002/mrm.1910130203; ZHONG JH, 1989, MAGNET RESON MED, V11, P295, DOI 10.1002/mrm.1910110304; [No title captured], DOI DOI 10.1002/9780470034590; [No title captured], DOI DOI 10.1016/S0076-6879(01)39315-1.; [No title captured]	48	25	25	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115288	10.1371/journal.pone.0115288	http://dx.doi.org/10.1371/journal.pone.0115288			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545955	Green Published, gold, Green Submitted			2022-12-27	WOS:000347120200035
J	Albrechtova, J; Albrecht, T; Dureje, L; Pallazola, VA; Pialek, J				Albrechtova, Jana; Albrecht, Tomas; Dureje, Ludovit; Pallazola, Vincent A.; Pialek, Jaroslav			Sperm Morphology in Two House Mouse Subspecies: Do Wild-Derived Strains and Wild Mice Tell the Same Story?	PLOS ONE			English	Article							MUS-MUSCULUS-MUSCULUS; MULTIPLE PATERNITY; SWIMMING VELOCITY; HYBRID ZONE; COMPETITION; COMMON; SIZE; EVOLUTIONARY; PHENOTYPES; FERTILITY	Being subject to intense post-copulatory selection, sperm size is a principal determining component of male fitness. Although previous studies have presented comparative sperm size data at higher taxonomic levels, information on the evolution of sperm size within species is generally lacking. Here, we studied two house mouse subspecies, Mus musculus musculus and Mus musculus domesticus, which undergo incipient speciation. We measured four sperm dimensions from cauda epididymis smears of 28 wild-caught mice of both subspecies. As inbred mouse strains are frequently used as proxies for exploring evolutionary processes, we further studied four wild-derived inbred strains from each subspecies. The subspecies differed significantly in terms of sperm head length and midpiece length, and these differences were consistent for wild mice and wild-derived strains pooled over genomes. When the inbred strains were analyzed individually, however, their strain-specific values were in some cases significantly shifted from subspecies-specific values derived from wild mice. We conclude that: (1) the size of sperm components differ in the two house mouse subspecies studied, and that (2) wild-derived strains reflect this natural polymorphism, serving as a potential tool to identify the genetic variation driving these evolutionary processes. Nevertheless, we suggest that more strains should be used in future experiments to account for natural variation and to avoid confounding results due to reduced variability and/or founder effect in the individual strains.	[Albrechtova, Jana; Albrecht, Tomas; Dureje, Ludovit; Pialek, Jaroslav] Acad Sci Czech Republ, Inst Vertebrate Biol, Res Facil Studenec, Brno, Czech Republic; [Albrechtova, Jana; Albrecht, Tomas] Charles Univ Prague, Fac Sci, Dept Zool, Prague, Czech Republic; [Pallazola, Vincent A.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Pallazola, Vincent A.] Univ Michigan, Museum Zool, Ann Arbor, MI 48109 USA	Czech Academy of Sciences; Institute of Vertebrate Biology of the Czech Academy of Sciences; Charles University Prague; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Albrechtova, J (corresponding author), Acad Sci Czech Republ, Inst Vertebrate Biol, Res Facil Studenec, Brno, Czech Republic.	jana.brehova@seznam.cz	Piálek, Jaroslav/AAP-8636-2020; Albrecht, Tomas/A-1130-2011; Pialek, Jaroslav/B-1237-2008; Dureje, Ludovit/F-9726-2014	Pialek, Jaroslav/0000-0002-0829-7481; Albrecht, Tomas/0000-0002-9213-0034	Czech Science Foundation [206-08-0640]; National Science Foundation [DEB0746560]	Czech Science Foundation(Grant Agency of the Czech Republic); National Science Foundation(National Science Foundation (NSF))	Research was supported by the Czech Science Foundation (206-08-0640) (JP), and the National Science Foundation (DEB0746560) (VAP). The funders had no role in study design, data collection, data analysis, decision to publish, or preparation of the manuscript.	Albrechtova J, 2012, P ROY SOC B-BIOL SCI, V279, P4803, DOI 10.1098/rspb.2012.1802; Anderson MJ, 2002, NATURE, V416, P496, DOI 10.1038/416496a; Baird SJE, 2012, EVOLUTION HOUSE MOUS, P334; BEATTY RA, 1963, J REPROD FERTIL, V6, P261, DOI 10.1530/jrf.0.0060261; BEATTY RA, 1970, BIOL REV, V45, P73, DOI 10.1111/j.1469-185X.1970.tb01076.x; Birkhead TR, 2010, J ZOOL, V281, P78, DOI 10.1111/j.1469-7998.2010.00701.x; Birkhead TR, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P1; Birkhead TR, 1998, SPERM COMPETITION SE; Bozikova E, 2005, BIOL J LINN SOC, V84, P363, DOI 10.1111/j.1095-8312.2005.00440.x; BRADEN A. W. H., 1959, AUSTRALIAN JOUR BIOL SCI, V12, P65; Burgstaller JP, 2014, CELL REP, V7, P2031, DOI 10.1016/j.celrep.2014.05.020; Cucchi T., 2012, EVOLUTION HOUSE MOUS, P65, DOI DOI 10.1017/CBO9781139044547.005; CUMMINS JM, 1985, J REPROD FERTIL, V75, P153, DOI 10.1530/jrf.0.0750153; Dean MD, 2006, MOL ECOL, V15, P4141, DOI 10.1111/j.1365-294X.2006.03068.x; Dean MD, 2009, EVOLUTION, V63, P20, DOI 10.1111/j.1558-5646.2008.00499.x; Dureje L, 2012, FOLIA ZOOL, V61, P308; Duvaux L, 2011, MOL ECOL, V20, P5248, DOI 10.1111/j.1365-294X.2011.05343.x; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; Festing MFV, 1996, GENETIC VARIANTS STR, P1577; Firman RC, 2008, J EVOLUTION BIOL, V21, P1524, DOI 10.1111/j.1420-9101.2008.01612.x; Firman RC, 2010, BIOL LETTERS, V6, P513, DOI 10.1098/rsbl.2009.1027; Gage MJG, 1998, P ROY SOC B-BIOL SCI, V265, P97, DOI 10.1098/rspb.1998.0269; Geraldes A, 2011, MOL ECOL, V20, P4722, DOI 10.1111/j.1365-294X.2011.05285.x; Geraldes A, 2008, MOL ECOL, V17, P5349, DOI 10.1111/j.1365-294X.2008.04005.x; Montoto LG, 2011, REPRODUCTION, V142, P819, DOI 10.1530/REP-11-0232; Montoto LG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018173; Gregorova S, 2000, FOLIA BIOL-PRAGUE, V46, P31; Higginson DM, 2012, P NATL ACAD SCI USA, V109, P4538, DOI 10.1073/pnas.1111474109; ILLISSON L, 1969, AUST J BIOL SCI, V22, P947, DOI 10.1071/BI9690947; Immler S, 2012, P ROY SOC B-BIOL SCI, V279, P4174, DOI 10.1098/rspb.2012.1398; Immler S, 2011, P NATL ACAD SCI USA, V108, P5325, DOI 10.1073/pnas.1009059108; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kleven O, 2008, EVOLUTION, V62, P494, DOI 10.1111/j.1558-5646.2007.00287.x; Laskemoen T, 2013, BEHAV ECOL SOCIOBIOL, V67, P301, DOI 10.1007/s00265-012-1450-0; Laskemoen T, 2010, BEHAV ECOL SOCIOBIOL, V64, P1473, DOI 10.1007/s00265-010-0962-8; Lupold S, 2009, P R SOC B, V276, P1175, DOI 10.1098/rspb.2008.1645; Lundrigan BL, 2002, SYST BIOL, V51, P410, DOI 10.1080/10635150290069878; Macholan M, 2007, EVOLUTION, V61, P746, DOI 10.1111/j.1558-5646.2007.00065.x; Macholan M, 2011, EVOLUTION, V65, P1428, DOI 10.1111/j.1558-5646.2011.01228.x; Malo AF, 2006, BIOL LETTERS, V2, P246, DOI 10.1098/rsbl.2006.0449; Manser A, 2011, EVOLUTION, V65, P2435, DOI 10.1111/j.1558-5646.2011.01336.x; Mossman J, 2009, EVOLUTION, V63, P2730, DOI 10.1111/j.1558-5646.2009.00753.x; Munclinger P, 2003, MAMM GENOME, V14, P359, DOI 10.1007/s00335-002-3065-7; Munclinger P, 2002, FOLIA ZOOL, V51, P81; NAPIER RA, 1961, J REPROD FERTIL, V2, P273, DOI 10.1530/jrf.0.0020273; Osadchuk LV, 2010, B EXP BIOL MED+, V149, P739, DOI 10.1007/s10517-010-1040-y; Pialek J, 2008, J HERED, V99, P34, DOI 10.1093/jhered/esm083; Pitnick S, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P69, DOI 10.1016/B978-0-12-372568-4.00003-3; Rolland C, 2003, BEHAVIOUR, V140, P1371, DOI 10.1163/156853903771980639; Suzuki H., 2012, EVOLUTION HOUSE MOUS, P35, DOI DOI 10.1017/CBO9781139044547.004; Thonhauser KE, 2014, ECOL EVOL, V4, P200, DOI 10.1002/ece3.920; Turner LM, 2012, EVOLUTION, V66, P443, DOI 10.1111/j.1558-5646.2011.01445.x; Ward PI, 1998, HEREDITY, V80, P655, DOI 10.1046/j.1365-2540.1998.00401.x; White MA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000729; Yang HN, 2011, NAT GENET, V43, P648, DOI 10.1038/ng.847	55	6	6	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115669	10.1371/journal.pone.0115669	http://dx.doi.org/10.1371/journal.pone.0115669			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541964	Green Submitted, Green Published, gold			2022-12-27	WOS:000347239900068
J	Awor, P; Wamani, H; Tylleskar, T; Jagoe, G; Peterson, S				Awor, Phyllis; Wamani, Henry; Tylleskar, Thorkild; Jagoe, George; Peterson, Stefan			Increased Access to Care and Appropriateness of Treatment at Private Sector Drug Shops with Integrated Management of Malaria, Pneumonia and Diarrhoea: A Quasi-Experimental Study in Uganda	PLOS ONE			English	Article							COMMUNITY CASE-MANAGEMENT; CHILDREN; STRATEGY; IMPACT; FEVER	Introduction: Drug shops are a major source of care for children in low income countries but they provide sub-standard care. We assessed the feasibility and effect on quality of care of introducing diagnostics and pre-packaged paediatric-dosage drugs for malaria, pneumonia and diarrhoea at drug shops in Uganda. Methods: We adopted and implemented the integrated community case management (iCCM) intervention within registered drug shops. Attendants were trained to perform malaria rapid diagnostic tests (RDTs) in each fever case and count respiratory rate in each case of cough with fast/difficult breathing, before dispensing recommended treatment. Using a quasi-experimental design in one intervention and one non-intervention district, we conducted before and after exit interviews for drug seller practices and household surveys for treatment-seeking practices in May-June 2011 and May-June 2012. Survey adjusted generalized linear models and difference-in-difference analysis was used. Results: 3759 (1604 before/2155 after) household interviews and 943 (163 before/780 after) exit interviews were conducted with caretakers of children under-5. At baseline, no child at a drug shop received any diagnostic testing before treatment in both districts. After the intervention, while no child in the non-intervention district received a diagnostic test, 87.7% (95% CI 79.0-96.4) of children with fever at the intervention district drug shops had a parasitological diagnosis of malaria, prior to treatment. The prevalence ratios of the effect of the intervention on treatment of cough and fast breathing with amoxicillin and diarrhoea with ORS/zinc at the drug shop were 2.8 (2.0-3.9), and 12.8 (4.2-38.6) respectively. From the household survey, the prevalence ratio of the intervention effect on use of RDTs was 3.2 (1.9-5.4); Artemisinin Combination Therapy for malaria was 0.74 (0.65-0.84), and ORS/zinc for diarrhoea was 2.3 (1.2-4.7). Conclusion: iCCM can be utilized to improve access and appropriateness of care for children at drug shops.	[Awor, Phyllis; Tylleskar, Thorkild] Univ Bergen, Ctr Int Hlth, Dept Global Publ Hlth & Primary Hlth Care, Bergen, Norway; [Awor, Phyllis; Wamani, Henry; Peterson, Stefan] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Kampala, Uganda; [Jagoe, George] Med Malaria Venture, Geneva, Switzerland; [Peterson, Stefan] Global Hlth, Karolinska Inst, Stockholm, Sweden; [Peterson, Stefan] Uppsala Univ, Int Maternal & Child Hlth Unit, Uppsala, Sweden	University of Bergen; Makerere University; Karolinska Institutet; Uppsala University	Awor, P (corresponding author), Univ Bergen, Ctr Int Hlth, Dept Global Publ Hlth & Primary Hlth Care, Bergen, Norway.	aworphyllis@yahoo.co.uk	Tylleskär, Thorkild/S-5529-2017	Tylleskär, Thorkild/0000-0003-4801-4324; Peterson, Stefan/0000-0001-7203-3096	Einhorn Family Foundation - Sweden; Norwegian Quota Scheme	Einhorn Family Foundation - Sweden; Norwegian Quota Scheme	Funding: The authors are grateful to the Einhorn Family Foundation - Sweden for funding this study, to Medicines for Malaria Venture - Switzerland for extensive field support, and to the Norwegian Quota Scheme for PhD scholarship for PA. The Einhorn Family Foundation had no role in study design, data collection, data analysis, interpretation or writing the report. Medicines for Malaria Venture participated in all the above stages. The corresponding author had full access to all the data in the study and had the final responsibility for the decision to submit for publication.	Arrow KJ, 2012, LANCET, V380, P1889, DOI 10.1016/S0140-6736(12)61843-1; Awor P, 2012, AM J TROP MED HYG, V87, P92, DOI 10.4269/ajtmh.2012.11-0791; Bennett S, 2014, TROP MED INT HLTH; Bloom G, 2011, HEALTH POLICY PLANN, V26, pi45, DOI 10.1093/heapol/czr025; CAPSS, 2011, CLOS AFF GAP ENS AFF; Chinbuah MA, 2012, AM J TROP MED HYG, V87, P11, DOI 10.4269/ajtmh.2012.12-0078; DeSavigny D, 2009, SYSTEMS THINKING FOR HEALTH SYSTEMS STRENGTHENING, P1; Fink G, 2013, HLTH POLICY PLAN; Forsberg BC, 2011, HEALTH POLICY PLANN, V26, pi1, DOI 10.1093/heapol/czr050; Global-Fund, 2012, BOARD APPR INT AMFM; Global-Fund, 2011, AFF MED FAC MAL; I.O.M IoMotNA, 2004, SAV LIV BUYING TIM E; Kamal-Yanni MM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-414; Kangwana BP, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000437; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Marsh DR, 2012, AM J TROP MED HYG, V87, P2, DOI 10.4269/ajtmh.2012.12-0504; Meessen B, 2011, HEALTH POLICY PLANN, V26, pi30, DOI 10.1093/heapol/czr026; MoH, 2010, INT COMM CAS MAN CHI; Mukanga David, 2012, Am J Trop Med Hyg, V87, P21, DOI 10.4269/ajtmh.2012.11-0816; Oxfam, 2012, SALT SUG MAL PILLS A; Rutebemberwa E, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-45; Schellenberg JRMA, 2004, LANCET, V364, P1583, DOI 10.1016/S0140-6736(04)17311-X; Smith F, 2009, PHARM WORLD SCI, V31, P351, DOI 10.1007/s11096-009-9294-z; Talisuna AO, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-356; Tougher S, 2012, LANCET, V380, P1916, DOI 10.1016/S0140-6736(12)61732-2; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; WHO, 2005, INT MAN CHILDH ILLN; WHO, 2010, GUID TREATM MAL, V2nd; World Health Organization, 2013, WHO INFORMAL CONSULT; Young M, 2012, AM J TROP MED HYG, V87, P6, DOI 10.4269/ajtmh.2012.12-0221	30	41	41	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115440	10.1371/journal.pone.0115440	http://dx.doi.org/10.1371/journal.pone.0115440			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541703	gold, Green Published, Green Submitted			2022-12-27	WOS:000347239900043
J	Coffeng, JK; Boot, CRL; Duijts, SFA; Twisk, JWR; van Mechelen, W; Hendriksen, IJM				Coffeng, Jennifer K.; Boot, Cecile R. L.; Duijts, Saskia F. A.; Twisk, Jos W. R.; van Mechelen, Willem; Hendriksen, Ingrid J. M.			Effectiveness of a Worksite Social & Physical Environment Intervention on Need for Recovery, Physical Activity and Relaxation; Results of a Randomized Controlled Trial	PLOS ONE			English	Article							HEALTH-PROMOTION; INTRACLASS CORRELATION; JOB-PERFORMANCE; LIFE-STYLE; STRESS; QUESTIONNAIRE; VALIDITY; WEEKEND; PERSPECTIVE; EXPERIENCES	Objective: To investigate the effectiveness of a worksite social and physical environment intervention on need for recovery (i.e., early symptoms of work-related mental and physical fatigue), physical activity and relaxation. Also, the effectiveness of the separate interventions was investigated. Methods: In this 2x2 factorial design study, 412 office employees from a financial service provider participated. Participants were allocated to the combined social and physical intervention, to the social intervention only, to the physical intervention only or to the control group. The primary outcome measure was need for recovery. Secondary outcomes were work-related stress (i.e., exhaustion, detachment and relaxation), small breaks, physical activity (i.e., stair climbing, active commuting, sport activities, light/moderate/vigorous physical activity) and sedentary behavior. Outcomes were measured by questionnaires at baseline, 6 and 12 months follow-up. Multilevel analyses were performed to investigate the effects of the three interventions. Results: In all intervention groups, a non-significant reduction was found in need for recovery. In the combined intervention (n=92), exhaustion and vigorous physical activities decreased significantly, and small breaks at work and active commuting increased significantly compared to the control group. The social intervention (n=118) showed a significant reduction in exhaustion, sedentary	[Coffeng, Jennifer K.; Boot, Cecile R. L.; Duijts, Saskia F. A.; van Mechelen, Willem] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Publ & Occupat Hlth, Amsterdam, Netherlands; [Coffeng, Jennifer K.; Boot, Cecile R. L.; van Mechelen, Willem; Hendriksen, Ingrid J. M.] Vrije Univ Amsterdam, Med Ctr, Body Work TNO, Amsterdam, Netherlands; [Twisk, Jos W. R.] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Twisk, Jos W. R.] Vrije Univ Amsterdam, Med Ctr, Dept Hlth Sci, Amsterdam, Netherlands; [Hendriksen, Ingrid J. M.] TNO, Expert Ctr Life Style, Leiden, Netherlands	Vrije Universiteit Amsterdam; Netherlands Organization Applied Science Research; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Netherlands Organization Applied Science Research	Coffeng, JK (corresponding author), Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Publ & Occupat Hlth, Amsterdam, Netherlands.	j.coffeng@vumc.nl		van Mechelen, Willem/0000-0001-7136-6382	Ohra Nuts fonds	Ohra Nuts fonds	The project was funded by Ohra Nuts fonds. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; [Anonymous], 2005, NETH WORK COND SURV; Bailey KA, 2004, DRUG ALCOHOL REV, V23, P157, DOI 10.1080/09595230410001704136; Barnes J, 2012, APPL PHYSIOL NUTR ME, V37, P540, DOI [10.1139/H2012-024, 10.1139/h2012-024]; Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Berlin JA, 1999, BIOMETRICS, V55, P470, DOI 10.1111/j.0006-341X.1999.00470.x; Bernaards CM, 2007, PAIN, V132, P142, DOI 10.1016/j.pain.2007.06.007; BERWICK DM, 1989, NEW ENGL J MED, V320, P53, DOI 10.1056/NEJM198901053200110; Binnewies C, 2010, J OCCUP ORGAN PSYCH, V83, P419, DOI 10.1348/096317909X418049; Coffeng JK, 2013, J OCCUP ENVIRON MED, V55, P1409, DOI 10.1097/JOM.0b013e3182a50053; Coffeng JK, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-592; Coffeng JK, 2014, ASSESSMENT REL UNPUB; de Croon EM, 2006, OCCUP ENVIRON MED, V63, P202, DOI 10.1136/oem.2004.018275; de Croon EM, 2003, J PSYCHOSOM RES, V55, P331, DOI 10.1016/S0022-3999(02)00630-X; DeJoy DM, 2003, AM J HEALTH PROMOT, V17, P337, DOI 10.4278/0890-1171-17.5.337; Demerouti E, 2003, EUR J PSYCHOL ASSESS, V19, P12, DOI 10.1027//1015-5759.19.1.12; Demerouti E., 2008, HDB STRESS BURNOUT H, P66; DiClemente C.C., 2002, MOTIVATIONAL INTERVI, V2nd ed., P201; Engbers LH, 2007, SCAND J MED SCI SPOR, V17, P165, DOI 10.1111/j.1600-0838.2006.00533.x; EU-OSHA, EUR SURV NEW EM RISK; Feuerstein M, 2004, APPL ERGON, V35, P565, DOI 10.1016/j.apergo.2004.05.003; Foote J, 1999, J SUBST ABUSE TREAT, V17, P181, DOI 10.1016/S0740-5472(99)00003-3; Fritz C, 2005, J OCCUP HEALTH PSYCH, V10, P187, DOI 10.1037/1076-8998.10.3.187; Galea S, 2007, ANN EPIDEMIOL, V17, P643, DOI 10.1016/j.annepidem.2007.03.013; Geurts SAE, 2006, SCAND J WORK ENV HEA, V32, P482, DOI 10.5271/sjweh.1053; Goetzel RZ, 2008, ANNU REV PUBL HEALTH, V29, P303, DOI 10.1146/annurev.publhealth.29.020907.090930; Goetzel RZ, 2007, J OCCUP ENVIRON MED, V49, P111, DOI 10.1097/JOM.0b013e31802ec6a3; Goetzel RZ, 1998, J OCCUP ENVIRON MED, V40, P341, DOI 10.1097/00043764-199804000-00008; Goetzel RZ, 2001, AM J HEALTH PROMOT, V15, P357, DOI 10.4278/0890-1171-15.5.357; Goldstein H, 1995, MULTILEVEL STAT MODE, DOI 10.1002/9780470973394; Green LW, 1996, AM J HEALTH PROMOT, V10, P270, DOI 10.4278/0890-1171-10.4.270; Hahn VC, 2011, J OCCUP HEALTH PSYCH, V16, P202, DOI 10.1037/a0022169; Hengel KMO, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1008; Ingersoll KS, 2000, MOTIVATIONAL GROUPS; JACOBS DR, 1993, MED SCI SPORT EXER, V25, P81, DOI 10.1249/00005768-199301000-00012; Jansen NWH, 2002, INT J BEHAV MED, V9, P322, DOI 10.1207/S15327558IJBM0904_03; Karasek R, 1998, J Occup Health Psychol, V3, P322, DOI 10.1037/1076-8998.3.4.322; Katzmarzyk PT, 2009, MED SCI SPORT EXER, V41, P998, DOI 10.1249/MSS.0b013e3181930355; KELDER SH, 1993, HEALTH EDUC RES, V8, P555, DOI 10.1093/her/8.4.555; Kuijer PPFM, 2005, AM J IND MED, V47, P394, DOI 10.1002/ajim.20159; Kwak L, 2007, EUR J SPORT SCI, V7, P193, DOI 10.1080/17461390701674088; LEWIS G, 1992, J EPIDEMIOL COMMUN H, V46, P92, DOI 10.1136/jech.46.2.92; Lincourt P, 2002, ADDICT BEHAV, V27, P381, DOI 10.1016/S0306-4603(01)00179-4; Martinson BC, 1999, AM J HEALTH PROMOT, V13, P347, DOI 10.4278/0890-1171-13.6.347; McLaren L, 2005, J EPIDEMIOL COMMUN H, V59, P6, DOI 10.1136/jech.2003.018044; MCLEROY KR, 1988, HEALTH EDUC QUART, V15, P351, DOI 10.1177/109019818801500401; Meijer EM, 2009, ERGONOMICS, V52, P1027, DOI 10.1080/00140130902842752; Meijman T, 2012, HDB WORK ORG PSYCHOL, P5; Murray DM, 2003, EVALUATION REV, V27, P79, DOI 10.1177/0193841X02239019; NORRIS R, 1990, J PSYCHOSOM RES, V34, P367, DOI 10.1016/0022-3999(90)90060-H; Peterson U, 2008, J ADV NURS, V63, P506, DOI 10.1111/j.1365-2648.2008.04743.x; Richard L, 2011, ANNU REV PUBL HEALTH, V32, P307, DOI 10.1146/annurev-publhealth-031210-101141; Robinson T, 2003, J COMMUNITY HLTH, V33, P395; Rook JW, 2006, EUR J WORK ORGAN PSY, V15, P218, DOI 10.1080/13594320500513962; Rose G, 2001, INT J EPIDEMIOL, V30, P427, DOI 10.1093/ije/30.3.427; Siltaloppi M, 2012, ANXIETY STRESS COPIN, V25, P23, DOI 10.1080/10615806.2010.540649; Sluiter JK, 2001, J PSYCHOSOM RES, V50, P29, DOI 10.1016/S0022-3999(00)00213-0; Sluiter JK, 1999, ERGONOMICS, V42, P573, DOI 10.1080/001401399185487; Sonnentag S, 2006, J APPL PSYCHOL, V91, P330, DOI 10.1037/0021-9010.91.2.330; Sonnentag S, 2001, J Occup Health Psychol, V6, P196, DOI 10.1037/1076-8998.6.3.196; Sonnentag S., 2004, INT J STRESS MANAGE, V11, P366, DOI [10.1037/1072-5245.11.4.366, DOI 10.1037/1072-5245.11.4.366]; Sonnentag S, 2008, J APPL PSYCHOL, V93, P674, DOI 10.1037/0021-9010.93.3.674; Sonnentag S, 2007, J OCCUP HEALTH PSYCH, V12, P204, DOI 10.1037/1076-8998.12.3.204; Stokols D, 1996, AM J HEALTH PROMOT, V10, P282, DOI 10.4278/0890-1171-10.4.282; Strijk JE, 2012, J EPIDEMIOL COMMUN H, V66, P1071, DOI 10.1136/jech-2011-200626; Taylor WC, 2005, AM J PREV MED, V29, P461, DOI 10.1016/j.amepre.2005.08.040; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004; Townsend N, 2013, PUBLIC HEALTH NUTR, V16, P1101, DOI 10.1017/S1368980011002655; Trougakos JP, 2008, ACAD MANAGE J, V51, P131, DOI 10.5465/AMJ.2008.30764063; Twisk J, 2002, J CLIN EPIDEMIOL, V55, P329, DOI 10.1016/S0895-4356(01)00476-0; Twisk JWR., 2006, APPL MULTILEVEL ANAL, DOI [10.1017/CBO9780511610806, DOI 10.1017/CBO9780511610806]; van Berkel J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084118; van der Starre RE, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1207; Van der Zee K. I, 1993, METEN GEZONDHEIDSTOE; van Dongen Johanna M, 2012, BMC Res Notes, V5, P514, DOI 10.1186/1756-0500-5-514; van Hooff MLM, 2007, INT ARCH OCC ENV HEA, V80, P599, DOI 10.1007/s00420-007-0172-5; van Hooff MLM, 2013, STRESS HLTH; Van Horn DHA, 2001, J SUBST ABUSE TREAT, V20, P191, DOI 10.1016/S0740-5472(00)00157-4; van Poppel MNM, 2010, SPORTS MED, V40, P565, DOI 10.2165/11531930-000000000-00000; van Veldhoven M, 2003, OCCUP ENVIRON MED, V60, P3; Velasquez MM, 2006, J GROUPS ADDICT RECO, V1, P27, DOI 10.1300/J384v01n01_03; von Hippel PT, 2007, SOCIOL METHODOL, V37, P83, DOI 10.1111/j.1467-9531.2007.00180.x; Wendel-Vos GCW, 2003, J CLIN EPIDEMIOL, V56, P1163, DOI 10.1016/S0895-4356(03)00220-8	83	40	41	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e114860	10.1371/journal.pone.0114860	http://dx.doi.org/10.1371/journal.pone.0114860			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX9RO	25542039	gold, Green Published, Green Submitted			2022-12-27	WOS:000347239900015
J	Li, XF; Guan, LL; Chang, H; Zhang, B				Li, Xiaofei; Guan, Lili; Chang, Hui; Zhang, Bo			Core Self-Evaluation and Burnout among Nurses: The Mediating Role of Coping Styles	PLOS ONE			English	Article							OCCUPATIONAL STRESS; JOB-SATISFACTION; PERSONALITY; STRATEGIES; PERFORMANCE; TURNOVER; CHINA	Objectives: This study aimed to determine the potential association between core self-evaluation and the burnout syndrome among Chinese nurses, and the mediating role of coping styles in this relationship. Methods: A cross-sectional survey was conducted in Shenyang, China, from May to July, 2013. A questionnaire which consisted of the Maslach Burnout Inventory-General Survey (MBI-GS), the Core Self-Evaluation Scale (CSE), and the Simplified Coping Style Questionnaire (CSQ), was completed by a total of 1,559 nurses. Hierarchical linear regression analyses and the Sobel test were performed to determine the mediating role of coping styles on the relationship between CSE and burnout. Results: Nurses who had higher self-evaluation characteristics, reported less emotional exhaustion and cynicism, and higher professional efficacy. Coping style had a partial mediating effect on the relationship between CSE and the burnout syndrome among nurses. Conclusions: Core self-evaluation had effects on burnout and coping style was a mediating factor in this relationship among Chinese nurses. Therefore, the improvement of coping strategies may be helpful in the prevention of burnout among nurses, thus enhancing professional performance.	[Li, Xiaofei] China Med Univ, Affiliated Hosp 1, Emergency Dept, Shenyang, Peoples R China; [Guan, Lili] Huaiyin Adv Vocat & Tech Sch Hlth, Fac Nursing, Huaian, Peoples R China; [Chang, Hui] Ctr Hlth Educ Liaoning Prov, Social Educ Dept, Shenyang, Peoples R China; [Zhang, Bo] China Med Univ, Affiliated Hosp 1, Dept Nursing, Shenyang, Peoples R China	China Medical University; China Medical University	Zhang, B (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Nursing, Shenyang, Peoples R China.	1345596429@qq.com	Li, xiaofei/GXF-7187-2022					Bakker AB, 2006, J SOC PSYCHOL, V146, P31, DOI 10.3200/SOCP.146.1.31-50; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Best RG, 2005, J OCCUP HEALTH PSYCH, V10, P441, DOI 10.1037/1076-8998.10.4.441; Cohen J., 2003, APPL MULTIPLE REGRES; Du J., 2012, PSYCHOL RES CHINESE, V5, P54; Erez A, 2001, J APPL PSYCHOL, V86, P1270, DOI 10.1037/0021-9010.86.6.1270; FOLKMAN S, 1988, J PERS SOC PSYCHOL, V54, P466, DOI 10.1037/0022-3514.54.3.466; Garrosa E, 2010, INT J NURS STUD, V47, P205, DOI 10.1016/j.ijnurstu.2009.05.014; Gibbons C, 2010, INT J NURS STUD, V47, P1299, DOI 10.1016/j.ijnurstu.2010.02.015; Hurtz GM, 2000, J APPL PSYCHOL, V85, P869, DOI 10.1037/0021-9010.85.6.869; Judge TA, 2003, PERS PSYCHOL, V56, P303, DOI 10.1111/j.1744-6570.2003.tb00152.x; Judge TA, 2000, J APPL PSYCHOL, V85, P237, DOI 10.1037//0021-9010.85.2.237; Judge TA, 2009, J APPL PSYCHOL, V94, P742, DOI 10.1037/a0015497; Kacmar KM, 2009, J APPL PSYCHOL, V94, P1572, DOI 10.1037/a0017498; Kammeyer-Mueller JD, 2009, J APPL PSYCHOL, V94, P177, DOI 10.1037/a0013214; Kulbe J, 2001, Home Healthc Nurse, V19, P707, DOI 10.1097/00004045-200111000-00016; Laschinger HKS, 2007, J NURS ADMIN, V37, P221, DOI 10.1097/01.NNA.0000269746.63007.08; Laschinger HKS, 2008, J NURS MANAGE, V16, P601, DOI 10.1111/j.1365-2834.2008.00904.x; Leiter MP, 2009, J NURS MANAGE, V17, P331, DOI 10.1111/j.1365-2834.2009.01004.x; Lian PH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087152; Lin QH, 2013, J OCCUP HEALTH, V55, P458, DOI 10.1539/joh.12-0287-OA; MASLACH C, 1981, J OCCUP BEHAV, V2, P99, DOI 10.1002/job.4030020205; Payne N, 2001, J ADV NURS, V33, P396, DOI 10.1046/j.1365-2648.2001.01677.x; Pejuskovic B, 2011, PSYCHIAT DANUB, V23, P389; Peng J., 2014, J HLTH PSYCHOL; Schaufeli W.B., 1996, MASLACH BURNOUT INVE, V3rd Edn.; Gomes SDS, 2013, REV LAT-AM ENFERM, V21, P1282, DOI 10.1590/0104-1169.2742.2365; Thiruchelvi A, 2012, SPAN J PSYCHOL, V15, P156, DOI 10.5209/rev_SJOP.2012.v15.n1.37302; Wang S., 2013, INT J NURS PRACT; Wang WR, 2011, APPL NURS RES, V24, P238, DOI 10.1016/j.apnr.2009.09.003; Wang Y, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-915; Wong D F, 2001, Int J Nurs Pract, V7, P188, DOI 10.1046/j.1440-172X.2001.00298.x; Wu SY, 2007, J ADV NURS, V59, P233, DOI 10.1111/j.1365-2648.2007.04301.x; [谢文 Xie Wen], 2005, [中国行为医学科学, Chinese Journal of Behavioral Medical Science], V14, P462; Xie Y., 1998, CHINESE J CLIN PSYCH, V6, P114, DOI DOI 10.16128/J.CNKI.1005-3611.1998.02.018; Xie ZY, 2011, J ADV NURS, V67, P1537, DOI 10.1111/j.1365-2648.2010.05576.x; Zhao XF, 2013, PSYCHIAT GENET, V23, P214, DOI 10.1097/YPG.0b013e328364365d	37	43	45	5	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115799	10.1371/journal.pone.0115799	http://dx.doi.org/10.1371/journal.pone.0115799			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX9RO	25541990	gold, Green Published, Green Submitted			2022-12-27	WOS:000347239900090
J	McFadden, JW; Aja, S; Li, Q; Bandaru, VVR; Kim, EK; Haughey, NJ; Kuhajda, FP; Ronnett, GV				McFadden, Joseph W.; Aja, Susan; Li, Qun; Bandaru, Veera V. R.; Kim, Eun-Kyoung; Haughey, Norman J.; Kuhajda, Francis P.; Ronnett, Gabriele V.			Increasing Fatty Acid Oxidation Remodels the Hypothalamic Neurometabolome to Mitigate Stress and Inflammation	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; ACTIVATED PROTEIN-KINASE; DIET-INDUCED OBESITY; CARNITINE PALMITOYLTRANSFERASE-I; REGULATES FOOD-INTAKE; INSULIN-RESISTANCE; LIVER-DISEASE; MITOCHONDRIAL DYSFUNCTION; SYNTHASE INHIBITOR; LIPID-ACCUMULATION	Modification of hypothalamic fatty acid (FA) metabolism can improve energy homeostasis and prevent hyperphagia and excessive weight gain in diet-induced obesity (DIO) from a diet high in saturated fatty acids. We have shown previously that C75, a stimulator of carnitine palmitoyl transferase-1 (CPT-1) and fatty acid oxidation (FAOx), exerts at least some of its hypophagic effects via neuronal mechanisms in the hypothalamus. In the present work, we characterized the effects of C75 and another anorexigenic compound, the glycerol-3-phosphate acyltransferase (GPAT) inhibitor FSG67, on FA metabolism, metabolomics profiles, and metabolic stress responses in cultured hypothalamic neurons and hypothalamic neuronal cell lines during lipid excess with palmitate. Both compounds enhanced palmitate oxidation, increased ATP, and inactivated AMP-activated protein kinase (AMPK) in hypothalamic neurons in vitro. Lipidomics and untargeted metabolomics revealed that enhanced catabolism of FA decreased palmitate availability and prevented the production of fatty acylglycerols, ceramides, and cholesterol esters, lipids that are associated with lipotoxicity-provoked metabolic stress. This improved metabolic signature was accompanied by increased levels of reactive oxygen species (ROS), and yet favorable changes in oxidative stress, overt ER stress, and inflammation. We propose that enhancing FAOx in hypothalamic neurons exposed to excess lipids promotes metabolic remodeling that reduces local inflammatory and cell stress responses. This shift would restore mitochondrial function such that increased FAOx can produce hypothalamic neuronal ATP and lead to decreased food intake and body weight to improve systemic metabolism.	[McFadden, Joseph W.; Aja, Susan; Li, Qun; Ronnett, Gabriele V.] Johns Hopkins Univ, Sch Med, Ctr Metab & Obes Res, Baltimore, MD 21205 USA; [McFadden, Joseph W.; Aja, Susan; Li, Qun; Ronnett, Gabriele V.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Bandaru, Veera V. R.; Haughey, Norman J.; Ronnett, Gabriele V.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Kuhajda, Francis P.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Kuhajda, Francis P.; Ronnett, Gabriele V.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Kim, Eun-Kyoung; Ronnett, Gabriele V.] Daegu Gyeongbuk Inst Sci & Technol, Dept Brain Sci, Taegu, South Korea	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Daegu Gyeongbuk Institute of Science & Technology (DGIST)	Aja, S (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Metab & Obes Res, Baltimore, MD 21205 USA.	saja1@jhmi.edu			National Institutes of Health National Institute of Neurological Disorders and Stroke [R01 NS041079]; FASgen, Inc.; Korean Ministry of Education, Science, and Technology [10-BD-04]; Agilent Technologies; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041079] Funding Source: NIH RePORTER	National Institutes of Health National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); FASgen, Inc.; Korean Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Agilent Technologies; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding: This work was supported by National Institutes of Health National Institute of Neurological Disorders and Stroke Grant R01 NS041079 to GVR; Sponsored Research Agreement between FASgen, Inc. to GVR; and a Research Collaboration funded by grant #10-BD-04 from Korean Ministry of Education, Science, and Technology, between SA and the Daegu-Gyeongbuk Institute of Science and Technology (DGIST) Convergence Science Center. Agilent Technologies provided support through a University Relations Grant to GVR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi Y, 2008, CELL STRUCT FUNCT, V33, P75, DOI 10.1247/csf.07044; Aja S, 2008, AM J PHYSIOL-REG I, V294, pR352, DOI 10.1152/ajpregu.00862.2006; Aja S, 2006, AM J PHYSIOL-REG I, V291, pR148, DOI 10.1152/ajpregu.00041.2006; Alkhouri N, 2013, LIVER INT, V33, P79, DOI 10.1111/liv.12024; Bandaru VVR, 2011, J NEUROIMMUNE PHARM, V6, P640, DOI 10.1007/s11481-011-9289-0; BELL RM, 1980, ANNU REV BIOCHEM, V49, P459, DOI 10.1146/annurev.bi.49.070180.002331; Bentebibel A, 2006, BIOCHEMISTRY-US, V45, P4339, DOI 10.1021/bi052186q; Blazquez C, 1998, J NEUROCHEM, V71, P1597; Chakravarthy MV, 2009, J LIPID RES, V50, P630, DOI 10.1194/jlr.M800379-JLR200; Choi SS, 2008, CURR OPIN LIPIDOL, V19, P295, DOI 10.1097/MOL.0b013e3282ff5e55; Choi SJ, 2010, AM J PHYSIOL-ENDOC M, V298, pE1122, DOI 10.1152/ajpendo.00006.2010; Cintra DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030571; de Luca C, 2008, FEBS LETT, V582, P97, DOI 10.1016/j.febslet.2007.11.057; Diano S, 2011, NAT MED, V17, P1121, DOI 10.1038/nm.2421; Downs SM, 2009, MOL REPROD DEV, V76, P844, DOI 10.1002/mrd.21047; Ebert D, 2003, J NEUROSCI, V23, P5928; Gao S, 2011, P NATL ACAD SCI USA, V108, P9691, DOI 10.1073/pnas.1103267108; Hamamura K, 2007, FEBS LETT, V581, P1769, DOI 10.1016/j.febslet.2007.03.063; Hammond LE, 2005, J BIOL CHEM, V280, P25629, DOI 10.1074/jbc.M503181200; Hardie DG, 2008, INT J OBESITY, V32, pS7, DOI 10.1038/ijo.2008.116; Haughey NJ, 2004, ANN NEUROL, V55, P257, DOI 10.1002/ana.10828; Hayashi T, 2003, J CEREBR BLOOD F MET, V23, P1117, DOI 10.1097/01.WCB.0000089600.87125.AD; Idrovo JP, 2012, J SURG RES, V177, P157, DOI 10.1016/j.jss.2012.05.053; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Kim EK, 2004, J BIOL CHEM, V279, P19970, DOI 10.1074/jbc.M402165200; Kim EK, 2002, AM J PHYSIOL-ENDOC M, V283, pE867, DOI 10.1152/ajpendo.00178.2002; Kim JA, 2008, CIRC RES, V102, P401, DOI 10.1161/CIRCRESAHA.107.165472; Kleman AM, 2008, J NEUROSCI METH, V167, P292, DOI 10.1016/j.jneumeth.2007.08.028; Kuhajda FP, 2011, AM J PHYSIOL-REG I, V301, pR116, DOI 10.1152/ajpregu.00147.2011; Kumashiro N, 2011, P NATL ACAD SCI USA, V108, P16381, DOI 10.1073/pnas.1113359108; Lam TKT, 2005, NAT NEUROSCI, V8, P579, DOI 10.1038/nn1456; Landree LE, 2004, J BIOL CHEM, V279, P3817, DOI 10.1074/jbc.M310991200; Le Foll C, 2009, AM J PHYSIOL-REG I, V297, pR655, DOI 10.1152/ajpregu.00223.2009; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Linden D, 2006, FASEB J, V20, P434, DOI 10.1096/fj.05-4568com; Lopez M, 2007, BIOESSAYS, V29, P248, DOI 10.1002/bies.20539; MacLean DB, 2004, BRAIN RES, V1020, P1, DOI 10.1016/j.brainres.2004.04.041; Makowski K, 2013, CHIRALITY, V25, P281, DOI 10.1002/chir.22139; Mayer CM, 2010, ENDOCRINOLOGY, V151, P576, DOI 10.1210/en.2009-1122; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; Mera P, 2009, BIOCHEM PHARMACOL, V77, P1084, DOI 10.1016/j.bcp.2008.11.020; Milanski M, 2009, J NEUROSCI, V29, P359, DOI 10.1523/JNEUROSCI.2760-08.2009; Miller I, 2004, NEUROREPORT, V15, P925, DOI 10.1097/00001756-200404090-00038; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Nicot C, 2004, BIOCHEM BIOPH RES CO, V325, P660, DOI 10.1016/j.bbrc.2004.10.085; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Posey KA, 2009, AM J PHYSIOL-ENDOC M, V296, pE1003, DOI 10.1152/ajpendo.90377.2008; Puig T, 2008, BREAST CANCER RES TR, V109, P471, DOI 10.1007/s10549-007-9678-5; Ramirez S, 2013, DIABETES, V62, P2329, DOI 10.2337/db12-1451; Ronnett GV, 2005, PHYSIOL BEHAV, V85, P25, DOI 10.1016/j.physbeh.2005.04.014; Ropelle ER, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000465; Rutkowski DT, 2007, TRENDS BIOCHEM SCI, V32, P469, DOI 10.1016/j.tibs.2007.09.003; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Sierra AY, 2008, J BIOL CHEM, V283, P6878, DOI 10.1074/jbc.M707965200; Sies H, 2005, J NUTR, V135, P969, DOI 10.1093/jn/135.5.969; Summers SA, 2006, PROG LIPID RES, V45, P42, DOI 10.1016/j.plipres.2005.11.002; Thaler JP, 2012, J CLIN INVEST, V122, P153, DOI 10.1172/JCI59660; Thupari JN, 2004, AM J PHYSIOL-ENDOC M, V287, pE97, DOI 10.1152/ajpendo.00261.2003; Thupari JN, 2002, P NATL ACAD SCI USA, V99, P9498, DOI 10.1073/pnas.132128899; Tu YJ, 2005, ENDOCRINOLOGY, V146, P486, DOI 10.1210/en.2004-0976; Usuki F, 2013, SCI REP-UK, V3, DOI 10.1038/srep02346; van Herpen NA, 2008, PHYSIOL BEHAV, V94, P231, DOI 10.1016/j.physbeh.2007.11.049; WAKIL SJ, 1989, BIOCHEMISTRY-US, V28, P4523, DOI 10.1021/bi00437a001; Wendel AA, 2009, BBA-MOL CELL BIOL L, V1791, P501, DOI 10.1016/j.bbalip.2008.10.010; Wolfgang MJ, 2006, P NATL ACAD SCI USA, V103, P7282, DOI 10.1073/pnas.0602205103; Won JC, 2009, OBESITY, V17, P1861, DOI 10.1038/oby.2009.194; Wydysh EA, 2009, J MED CHEM, V52, P3317, DOI 10.1021/jm900251a; Yang NY, 2005, J PHARMACOL EXP THER, V312, P127, DOI 10.1124/jpet.104.074104; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043; Zhu J, 2012, J NEUROSCI RES, V90, P422, DOI 10.1002/jnr.22765	72	41	42	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115642	10.1371/journal.pone.0115642	http://dx.doi.org/10.1371/journal.pone.0115642			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541737	Green Submitted, Green Published, gold			2022-12-27	WOS:000347239900061
J	Pahlevaninezhad, H; Lee, AMD; Rosin, M; Sun, I; Zhang, LW; Hakimi, M; MacAulay, C; Lane, PM				Pahlevaninezhad, Hamid; Lee, Anthony M. D.; Rosin, Miriam; Sun, Ivan; Zhang, Lewei; Hakimi, Mehrnoush; MacAulay, Calum; Lane, Pierre M.			Optical Coherence Tomography and Autofluorescence Imaging of Human Tonsil	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; SQUAMOUS-CELL CARCINOMA; LYMPH-NODE METASTASES; UNKNOWN PRIMARY HEAD; PERITONSILLAR ABSCESS; PALATINE TONSILS; FDG-PET/CT; HPV; ULTRASOUND; INTEGRATION	For the first time, we present co-registered autofluorescence imaging and optical coherence tomography (AF/OCT) of excised human palatine tonsils to evaluate the capabilities of OCT to visualize tonsil tissue components. Despite limited penetration depth, OCT can provide detailed structural information about tonsil tissue with much higher resolution than that of computed tomography, magnetic resonance imaging, and Ultrasound. Different tonsil tissue components such as epithelium, dense connective tissue, lymphoid nodules, and crypts can be visualized by OCT. The co-registered AF imaging can provide matching biochemical information. AF/OCT scans may provide a non-invasive tool for detecting tonsillar cancers and for studying the natural history of their development.	[Pahlevaninezhad, Hamid; Lee, Anthony M. D.; Rosin, Miriam; Sun, Ivan; Hakimi, Mehrnoush; MacAulay, Calum; Lane, Pierre M.] British Columbia Canc Res Ctr, Dept Integrat Oncol, Vancouver, BC V5Z 1L3, Canada; [Zhang, Lewei] Univ British Columbia, Dept Dent, Vancouver, BC V5Z 1M9, Canada	British Columbia Cancer Agency; University of British Columbia	Pahlevaninezhad, H (corresponding author), British Columbia Canc Res Ctr, Dept Integrat Oncol, Vancouver, BC V5Z 1L3, Canada.	hpahleva@bccrc.ca	MacAulay, Calum/K-1795-2016; Zhang, Lewei/AAP-4757-2021	Zhang, Lewei/0000-0003-3594-598X; Lane, Pierre/0000-0002-6370-4182; Lee, Anthony/0000-0001-6327-2351; MacAulay, Calum/0000-0003-4440-2792	Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Institutes of Health and Research (CIHR); Canadian Cancer Society Institute [2012-701143]; NSERC; Michael Smith Foundation for Health and Research (MSFHR); Lotte & John Hecht Memorial Foundation	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health and Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Institute; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Michael Smith Foundation for Health and Research (MSFHR); Lotte & John Hecht Memorial Foundation	This work was supported through grants from the Natural Sciences and Engineering Research Council of Canada (NSERC) and Canadian Institutes of Health and Research (CIHR). The collection of tonsil samples was supported by funding from Canadian Cancer Society Institute (Award #: 2012-701143). NSERC, the Michael Smith Foundation for Health and Research (MSFHR), and Lotte & John Hecht Memorial Foundation provided Postdoctoral fellowship for HP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ibraheem A, 2009, J ONCOL, V2009, DOI 10.1155/2009/208725; ASPESTRAND F, 1988, J COMPUT ASSIST TOMO, V12, P434, DOI 10.1097/00004728-198805010-00015; Begum S, 2005, CLIN CANCER RES, V11, P5694, DOI 10.1158/1078-0432.CCR-05-0587; Bhatia KSS, 2010, BRIT J RADIOL, V83, P753, DOI 10.1259/bjr/58331222; Blaivas M, 2003, AM J EMERG MED, V21, P155, DOI 10.1053/ajem.2003.50029; Chen XH, 2013, IRAN J RADIOL, V10, P148, DOI 10.5812/iranjradiol.9281; Donnelly LF, 2002, AM J ROENTGENOL, V179, DOI 10.2214/ajr.179.2.1790503; Fakhry C, 2014, ORAL ONCOL, V50, P640, DOI 10.1016/j.oraloncology.2014.03.015; Frisch M, 2000, CANCER CAUSE CONTROL, V11, P489, DOI 10.1023/A:1008918223334; Frisch M, 2000, CANCER-AM CANCER SOC, V88, P1464, DOI 10.1002/(SICI)1097-0142(20000315)88:6<1464::AID-CNCR26>3.0.CO;2-O; FUJIMOTO JG, 1995, NAT MED, V1, P970, DOI 10.1038/nm0995-970; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Jumper JR, 2005, AM J NEURORADIOL, V26, P411; Kim SH, 2007, INT J CANCER, V120, P1418, DOI 10.1002/ijc.22464; King AD, 2001, BRIT J RADIOL, V74, P226, DOI 10.1259/bjr.74.879.740226; Koch WM, 2012, OTOLARYNG CLIN N AM, V45, P779, DOI 10.1016/j.otc.2012.04.004; Kreimer AR, 2011, CANCER PREV RES, V4, P1346, DOI 10.1158/1940-6207.CAPR-11-0379; Kwee TC, 2009, EUR RADIOL, V19, P731, DOI 10.1007/s00330-008-1194-4; Lingen MW, 2011, CANCER PREV RES, V4, P1350, DOI 10.1158/1940-6207.CAPR-11-0373; Lyon M, 2003, J ULTRAS MED, V22, P993, DOI 10.7863/jum.2003.22.9.993; Mannina Edward M, 2011, Int J Otolaryngol, V2011, P928240, DOI 10.1155/2011/928240; Miller FR, 2005, ARCH OTOLARYNGOL, V131, P626, DOI 10.1001/archotol.131.7.626; Monici M, 2005, BIOTECHNOL ANN REV, V11, P227, DOI 10.1016/S1387-2656(05)11007-2; Nabili V, 2007, AM J OTOLARYNG, V28, P153, DOI 10.1016/j.amjoto.2006.08.001; Pahlevaninezhad H, 2014, BIOMED OPT EXPRESS, V5, P2978, DOI 10.1364/BOE.5.002978; Pahlevaninezhad H, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.3.036022; Pai SI, 2009, ANNU REV PATHOL-MECH, V4, P49, DOI 10.1146/annurev.pathol.4.110807.092158; Park JJH, 2012, ACTA OTO-LARYNGOL, V132, P218, DOI 10.3109/00016489.2011.636377; Ruan LX, 2008, J INT MED RES, V36, P1140, DOI 10.1177/147323000803600536; Rusthoven KE, 2004, CANCER-AM CANCER SOC, V101, P2641, DOI 10.1002/cncr.20687; Shott SR, 2004, LARYNGOSCOPE, V114, P1724, DOI 10.1097/00005537-200410000-00009; Strojan P, 2013, HEAD NECK-J SCI SPEC, V35, P286, DOI 10.1002/hed.21899; Suzumoto M, 2006, ACTA OTO-LARYNGOL, V126, P1164, DOI 10.1080/00016480600681593; Tearney GJ, 1997, SCIENCE, V276, P2037, DOI 10.1126/science.276.5321.2037; Tsuboi M, 2005, LUNG CANCER, V49, P387, DOI 10.1016/j.lungcan.2005.04.007; Wang Xiao-Yi, 2010, Chin J Cancer, V29, P556; Westra WH, 2014, ORAL ONCOL, V50, P771, DOI 10.1016/j.oraloncology.2014.05.004	37	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115889	10.1371/journal.pone.0115889	http://dx.doi.org/10.1371/journal.pone.0115889			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542010	Green Submitted, Green Published, gold			2022-12-27	WOS:000347239900105
J	Sui, YJ; Sun, MY; Wu, F; Yang, LF; Di, WH; Zhang, GZ; Zhong, LL; Ma, ZM; Zheng, JH; Fang, XD; Ma, TH				Sui, Yujie; Sun, Meiyan; Wu, Fei; Yang, Longfei; Di, Weihua; Zhang, Guizhen; Zhong, Lili; Ma, Zhiming; Zheng, Jinhao; Fang, Xuedong; Ma, Tonghui			Inhibition of TMEM16A Expression Suppresses Growth and Invasion in Human Colorectal Cancer Cells	PLOS ONE			English	Article							CA2+-ACTIVATED CL-CHANNEL; TRANSCRIPTOME ANALYSIS; CHLORIDE CHANNELS; CONTRIBUTES; CARCINOMA; MARKER; IDENTIFICATION; PATTERNS; ACINAR; 11Q13	Metastasis leads to poor prognosis in colorectal cancer patients, and there is a growing need for new therapeutic targets. TMEM16A (ANO1, DOG1 or TAOS2) has recently been identified as a calcium-activated chloride channel (CaCC) and is reported to be overexpressed in several malignancies; however, its expression and function in colorectal cancer (CRC) remains unclear. In this study, we found expression of TMEM16A mRNA and protein in high-metastatic-potential SW620, HCT116 and LS174T cells, but not in primary HCT8 and SW480 cells, using RT-PCR, western blotting and immunofluorescence labeling. Patch-clamp recordings detected CaCC currents regulated by intracellular Ca2+ and voltage in SW620 cells. Knockdown of TMEM16A by short hairpin RNAs (shRNA) resulted in the suppression of growth, migration and invasion of SW620 cells as detected by MTT, wound-healing and transwell assays. Mechanistically, TMEM16A depletion was accompanied by the dysregulation of phospho-MEK, phospho-ERK1/2 and cyclin D1 expression. Flow cytometry analysis showed that SW620 cells were inhibited from the G1 to S phase of the cell cycle in the TMEM16A shRNA group compared with the control group. In conclusion, our results indicate that TMEM16A CaCC is involved in growth, migration and invasion of metastatic CRC cells and provide evidence for TMEM16A as a potential drug target for treating metastatic colorectal carcinoma.	[Sui, Yujie; Sun, Meiyan; Yang, Longfei; Di, Weihua; Zhang, Guizhen; Zhong, Lili; Ma, Tonghui] Jilin Univ, Bethune Hosp 2, Key Lab Mol & Chem Genet Crit Human Dis Jilin Pro, Changchun 130023, Peoples R China; [Wu, Fei] Jilin Univ, Bethune Hosp 2, Dept Gynecol & Obstet, Changchun 130023, Peoples R China; [Ma, Zhiming; Zheng, Jinhao; Fang, Xuedong] Jilin Univ, Bethune Hosp 2, Dept Gen Surg, Changchun 130023, Peoples R China; [Fang, Xuedong] Jilin Univ, China Japan Friendship Hosp, Dept Gen Surg, Changchun 130023, Peoples R China; [Ma, Tonghui] Dalian Med Univ, Coll Basic Med Sci, Dalian, Peoples R China	Jilin University; Jilin University; Jilin University; China-Japan Friendship Hospital; Jilin University; Dalian Medical University	Fang, XD (corresponding author), Jilin Univ, Bethune Hosp 2, Dept Gen Surg, Changchun 130023, Peoples R China.	fangxuedong@medmail.com.cn; tonghuima@dlmedu.edu.cn	Yang, Longfei/B-4223-2018	Yang, Longfei/0000-0003-4153-9670; Ma, Tonghui/0000-0001-9338-1030	National Natural Science Foundation of China [81173109, 31471099, 31301179]; China Postdoctoral Science Foundation [2014M551198]; Jilin Province health and Family Planning Commission Project [2014Q024]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Jilin Province health and Family Planning Commission Project	Funding: This study was supported by National Natural Science Foundation of China (No. 81173109, 31471099, and 31301179), China Postdoctoral Science Foundation (No. 2014M551198), and Jilin Province health and Family Planning Commission Project (No. 2014Q024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERVALL JA, 1995, CANCER, V76, P853, DOI 10.1002/1097-0142(19950901)76:5<853::AID-CNCR2820760520>3.0.CO;2-6; Britschgi A, 2013, P NATL ACAD SCI USA, V110, pE1026, DOI 10.1073/pnas.1217072110; Bulley S, 2012, CIRC RES, V111, P1027, DOI 10.1161/CIRCRESAHA.112.277145; Cai K, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-208; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Carles A, 2006, ONCOGENE, V25, P1821, DOI 10.1038/sj.onc.1209203; Carneiro A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-98; Center MM, 2009, CA-CANCER J CLIN, V59, P366, DOI 10.3322/caac.20038; Chen HM, 2009, CANCER RES, V69, P9228, DOI 10.1158/0008-5472.CAN-09-1950; Chenevert J, 2012, MODERN PATHOL, V25, P919, DOI 10.1038/modpathol.2012.57; Chiang PC, 2013, LASER SURG MED, V45, P38, DOI 10.1002/lsm.22112; Dauner K, 2012, CELL TISSUE RES, V347, P327, DOI 10.1007/s00441-012-1324-9; Davis AJ, 2013, BRIT J PHARMACOL, V168, P773, DOI 10.1111/j.1476-5381.2012.02199.x; Dutta AK, 2011, J BIOL CHEM, V286, P766, DOI 10.1074/jbc.M110.164970; Duvvuri U, 2012, CANCER RES, V72, P3270, DOI 10.1158/0008-5472.CAN-12-0475-T; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Ferrera L, 2010, PHYSIOLOGY, V25, P357, DOI 10.1152/physiol.00030.2010; Fiorelli G, 1999, J STEROID BIOCHEM, V71, P223, DOI 10.1016/S0960-0760(99)00144-2; Forrest AS, 2012, AM J PHYSIOL-CELL PH, V303, pC1229, DOI 10.1152/ajpcell.00044.2012; Gaur S, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-21; Gomez-Pinilla PJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1370, DOI 10.1152/ajpgi.00074.2009; Guang RJ, 2000, CANCER RES, V60, P749; Hewitt RE, 2000, J PATHOL, V192, P446; Huang F, 2009, P NATL ACAD SCI USA, V106, P21413, DOI 10.1073/pnas.0911935106; Huang X, 2006, GENE CHROMOSOME CANC, V45, P1058, DOI 10.1002/gcc.20371; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jin QY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066439; Karpinski P, 2008, J APPL GENET, V49, P1, DOI 10.1007/BF03195243; Katoh M, 2004, INT J ONCOL, V24, P1345; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Knowles LM, 2013, MOL CANCER RES, V11, P194, DOI 10.1158/1541-7786.MCR-12-0300; Kumar S, 2012, BIOORGAN MED CHEM, V20, P4237, DOI 10.1016/j.bmc.2012.05.074; Leanza L, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00227; Li M, 2013, EUR J GYNAECOL ONCOL, V34, P60; Liu W, 2012, INHIBITION CA 2 ACTI; Namkung W, 2010, FASEB J, V24, P4178, DOI 10.1096/fj.10-160648; Ousingsawat J, 2011, CELL PHYSIOL BIOCHEM, V28, P715, DOI 10.1159/000335765; Ousingsawat J, 2009, J BIOL CHEM, V284, P28698, DOI 10.1074/jbc.M109.012120; Peng C, 2007, MOL CELL BIOCHEM, V303, P141, DOI 10.1007/s11010-007-9466-x; Rajput A, 2008, J SURG RES, V147, P276, DOI 10.1016/j.jss.2007.04.021; Rock JR, 2008, DEV BIOL, V321, P141, DOI 10.1016/j.ydbio.2008.06.009; Rock JR, 2009, J BIOL CHEM, V284, P14875, DOI 10.1074/jbc.C109.000869; Romanenko VG, 2010, J BIOL CHEM, V285, P12990, DOI 10.1074/jbc.M109.068544; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Sheridan JT, 2011, J BIOL CHEM, V286, P1381, DOI 10.1074/jbc.M110.174847; Stein U, 2009, NAT MED, V15, P59, DOI 10.1038/nm.1889; Terashima H, 2013, P NATL ACAD SCI US; Thomas-Gatewood C, 2011, AM J PHYSIOL-HEART C, V301, pH1819, DOI 10.1152/ajpheart.00404.2011; Tian YM, 2012, J CELL SCI, V125, P4991, DOI 10.1242/jcs.109553; Wan NK, 2011, FASEB J, V25, P4048, DOI 10.1096/fj.11-191627; Wang M, 2012, CIRCULATION, V125, P697, DOI 10.1161/CIRCULATIONAHA.111.041806; West RB, 2004, AM J PATHOL, V165, P107, DOI 10.1016/S0002-9440(10)63279-8; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313	54	86	88	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115443	10.1371/journal.pone.0115443	http://dx.doi.org/10.1371/journal.pone.0115443			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541940	Green Submitted, Green Published, gold			2022-12-27	WOS:000347239900044
J	Thomas, SF; Rooks, P; Rudin, F; Atkinson, S; Goddard, P; Bransgrove, RM; Mason, PT; Allen, MJ				Thomas, Simon F.; Rooks, Paul; Rudin, Fabian; Atkinson, Sov; Goddard, Paul; Bransgrove, Rachel M.; Mason, Paul T.; Allen, Michael J.			A Comparison between Ultraviolet Disinfection and Copper Alginate Beads within a Vortex Bioreactor for the Deactivation of Bacteria in Simulated Waste Streams with High Levels of Colour, Humic Acid and Suspended Solids	PLOS ONE			English	Article							ASCARIS-SUUM EGGS; DEINOCOCCUS-RADIODURANS; ESCHERICHIA-COLI; UV-IRRADIATION; WATER DISINFECTION; PYRIMIDINE DIMERS; LOW-PRESSURE; RADIATION; LIGHT; DAMAGE	We show in this study that the combination of a swirl flow reactor and an antimicrobial agent (in this case copper alginate beads) is a promising technique for the remediation of contaminated water in waste streams recalcitrant to UV-C treatment. This is demonstrated by comparing the viability of both common and UV-C resistant organisms in operating conditions where UV-C proves ineffective notably high levels of solids and compounds which deflect UV-C. The swirl flow reactor is easy to construct from commonly available plumbing parts and may prove a versatile and powerful tool in waste water treatment in developing countries.	[Thomas, Simon F.; Rudin, Fabian; Mason, Paul T.] PML Applicat, Plymouth, Devon, England; [Rooks, Paul; Atkinson, Sov; Bransgrove, Rachel M.; Allen, Michael J.] Plymouth Marine Lab, Plymouth, Devon, England; [Goddard, Paul] Prot Technol Ltd, Manchester, Lancs, England	Plymouth Marine Laboratory	Allen, MJ (corresponding author), Plymouth Marine Lab, Prospect Pl, Plymouth, Devon, England.	mija@pml.ac.uk	Allen, Michael J/C-1248-2011; Rudin, Fabian S/B-5877-2015	Allen, Michael J/0000-0001-8504-7171; Rudin, Fabian S/0000-0003-4539-3074; Thomas, Simon/0000-0002-8474-1230	Bill & Melinda Gates Foundation [OPP1044451, OPP1095464]; Protein Technologies Ltd; PML Applications	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Protein Technologies Ltd; PML Applications	This work was supported by grants awarded to MJA from the Bill & Melinda Gates Foundation (OPP1044451, OPP1095464). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Protein Technologies Ltd and PML Applications provided support in the form of salaries for authors PG, ST, FR, PM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Baik MH, 2010, J IND ENG CHEM, V16, P837, DOI 10.1016/j.jiec.2010.05.002; Basu S., 2007, ENV ENG APPL RES PRA, V4, P1; Ben Said M, 2010, ANN MICROBIOL, V60, P121, DOI 10.1007/s13213-010-0017-4; Bentchikou E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000774; Blatchley ER, 2007, WATER ENVIRON RES, V79, P81, DOI 10.2175/106143006X102024; Bolton JR, 2003, J ENVIRON ENG-ASCE, V129, P209, DOI 10.1061/(ASCE)0733-9372(2003)129:3(209); Boschi-Pinto C., 2006, DIS MORTALITY SUBSAH; Brahmi M, 2010, J ENVIRON SCI-CHINA, V22, P1218, DOI 10.1016/S1001-0742(09)60241-2; Brownell SA, 2006, APPL ENVIRON MICROB, V72, P2178, DOI 10.1128/AEM.72.3.2178-2184.2006; Buonanno M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076968; Cantwell RE, 2008, J APPL MICROBIOL, V105, P25, DOI 10.1111/j.1365-2672.2007.03714.x; Cantwell RE, 2011, WATER RES, V45, P1322, DOI 10.1016/j.watres.2010.10.020; Conroy RM, 1996, LANCET, V348, P1695, DOI 10.1016/S0140-6736(96)02309-4; Cox MM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000815; DALY MJ, 1995, J BACTERIOL, V177, P5495, DOI 10.1128/jb.177.19.5495-5505.1995; DALY MJ, 1994, J BACTERIOL, V176, P3508, DOI 10.1128/JB.176.12.3508-3517.1994; Eren E, 2008, J HAZARD MATER, V159, P235, DOI 10.1016/j.jhazmat.2008.02.035; FREEMAN SE, 1986, ANAL BIOCHEM, V158, P119, DOI 10.1016/0003-2697(86)90599-3; Goodsell DS, 2001, ONCOLOGIST, V6, P298, DOI 10.1634/theoncologist.6-3-298; Hijnen WAM, 2006, WATER RES, V40, P3, DOI 10.1016/j.watres.2005.10.030; Horikawa DD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064793; JAGGER J, 1981, PHOTOCHEM PHOTOBIOL, V34, P761, DOI 10.1111/j.1751-1097.1981.tb09437.x; Johnson PW, 1998, INT J PARASITOL, V28, P627, DOI 10.1016/S0020-7519(97)00210-5; Krisko A, 2010, P NATL ACAD SCI USA, V107, P14373, DOI 10.1073/pnas.1009312107; Lange CC, 1998, NAT BIOTECHNOL, V16, P929, DOI 10.1038/nbt1098-929; Lee E, 2009, KOREAN J CHEM ENG, V26, P1301, DOI 10.1007/s11814-009-0208-5; Liang YM, 2013, J ENVIRON ENG, V139, P1482, DOI 10.1061/(ASCE)EE.1943-7870.0000767; Makarova KS, 2001, MICROBIOL MOL BIOL R, V65, P44, DOI 10.1128/MMBR.65.1.44-79.2001; Oguma K, 2002, APPL ENVIRON MICROB, V68, P6029, DOI 10.1128/AEM.68.12.6029-6035.2002; Palmore TN, 2009, INFECT CONT HOSP EP, V30, P764, DOI 10.1086/598855; Pasternak C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000799; Patel BA, 2009, P NATL ACAD SCI USA, V106, P18183, DOI 10.1073/pnas.0907262106; Peng W, 2003, PARASITOLOGY, V127, P283, DOI 10.1017/S0031182003003615; SETLOW RB, 1962, P NATL ACAD SCI USA, V48, P1250, DOI 10.1073/pnas.48.7.1250; Thomas SF, 2015, J WATER PRO IN PRESS; Thomas SF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096225; VINTEN AJA, 1983, SOIL SCI SOC AM J, V47, P408, DOI 10.2136/sssaj1983.03615995004700030003x; Vollertsen J, 1999, WATER RES, V33, P3127, DOI 10.1016/S0043-1354(99)00033-0; Wang JL, 2006, J ENVIRON SCI, V18, P634; Zhao ZC, 2014, MOL BIOSYST, V10, P2607, DOI 10.1039/c4mb00320a	40	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115688	10.1371/journal.pone.0115688	http://dx.doi.org/10.1371/journal.pone.0115688			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541706	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000347239900070
J	Corsiero, E; Sutcliffe, N; Pitzalis, C; Bombardieri, M				Corsiero, Elisa; Sutcliffe, Nurhan; Pitzalis, Costantino; Bombardieri, Michele			Accumulation of Self-Reactive Naive and Memory B Cell Reveals Sequential Defects in B Cell Tolerance Checkpoints in Sjogren's Syndrome	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; SALIVARY-GLANDS; AUTOANTIBODY PRODUCTION; MONOCLONAL-ANTIBODIES; RHEUMATOID-ARTHRITIS; EXPRESSION; AUTOREACTIVITY; PROLIFERATION; ORGANIZATION; PRECURSORS	Sjogren's syndrome (SS) is an autoimmune disease characterised by breach of self-tolerance towards nuclear antigens resulting in high affinity circulating autoantibodies. Although peripheral B cell disturbances have been described in SS, with predominance of naive and reduction of memory B cells, the stage at which errors in B cell tolerance checkpoints accumulate in SS is unknown. Here we determined the frequency of self-and poly-reactive B cells in the circulating naive and memory compartment of SS patients. Single CD27 - IgD+ naive, CD27+IgD+ memory unswitched and CD27+IgD- memory switched B cells were sorted by FACS from the peripheral blood of 7 SS patients. To detect the frequency of polyreactive and autoreactive clones, paired Ig V-H and V-L genes were amplified, cloned and expressed as recombinant monoclonal antibodies (rmAbs) displaying identical specificity of the original B cells. IgV(H) and V-L gene usage and immunoreactivity of SS rmAbs were compared with those obtained from healthy donors (HD). From a total of 353 V-H and 293 V-L individual sequences, we obtained 114 rmAbs from circulating naive (n=66) and memory (n=48) B cells of SS patients. Analysis of the Ig V gene repertoire did not show significant differences in SS vs. HD B cells. In SS patients, circulating naive B cells (with germline V-H and V-L genes) displayed a significant accumulation of clones autoreactive against Hep-2 cells compared to HD (43.1% vs. 25%). Moreover, we demonstrated a progressive increase in the frequency of circulating anti-nuclear naive (9.3%), memory unswitched (22.2%) and memory switched (27.3%) B cells in SS patients. Overall, these data provide novel evidence supporting the existence of both early and late defects in B cell tolerance checkpoints in patients with SS resulting in the accumulation of autoreactive naive and memory B cells.	[Corsiero, Elisa; Sutcliffe, Nurhan; Pitzalis, Costantino; Bombardieri, Michele] Queen Mary Univ London, John Vane Sci Ctr, Barts & London Sch Med & Dent, Ctr Expt Med & Rheumatol,William Harvey Res Inst, London EC1M 6BQ, England	University of London; Queen Mary University London	Corsiero, E (corresponding author), Queen Mary Univ London, John Vane Sci Ctr, Barts & London Sch Med & Dent, Ctr Expt Med & Rheumatol,William Harvey Res Inst, Charterhouse Sq, London EC1M 6BQ, England.	e.corsiero@qmul.ac.uk; m.bombardieri@qmul.ac.uk	Corsiero, Elisa/ACG-1815-2022	Corsiero, Elisa/0000-0003-2092-6778; Pitzalis, Costantino/0000-0003-1326-5051	Arthritis Research UK [18237, 20089]; William Harvey Research Foundation; EMBO [ASTF 318-2010]; EFIS-IL	Arthritis Research UK(Versus Arthritis); William Harvey Research Foundation; EMBO(European Molecular Biology Organization (EMBO)); EFIS-IL	This work was funded by grants number 18237 and 20089 from Arthritis Research UK (http://www.arthritisresearchuk.org) to MB and the William Harvey Research Foundation. EC was recipient of short-term travel fellowships from EMBO (ASTF 318-2010) and EFIS-IL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barone F, 2005, ARTHRITIS RHEUM-US, V52, P1773, DOI 10.1002/art.21062; Bombardieri M, 2007, J IMMUNOL, V179, P4929, DOI 10.4049/jimmunol.179.7.4929; Cappione A, 2005, J CLIN INVEST, V115, P3205, DOI 10.1172/JCI24179; CHANG B, 1994, IMMUNOL TODAY, V15, P367, DOI 10.1016/0167-5699(94)90175-9; Dawson L, 2005, ARTHRITIS RHEUM-US, V52, P2984, DOI 10.1002/art.21347; Edwards JCW, 2006, NAT REV IMMUNOL, V6, P394, DOI 10.1038/nri1838; Haneji N, 1997, SCIENCE, V276, P604, DOI 10.1126/science.276.5312.604; Hansen A, 2003, SCAND J IMMUNOL, V57, P470, DOI 10.1046/j.1365-3083.2003.01226.x; Hansen A, 2002, ARTHRITIS RHEUM-US, V46, P2160, DOI 10.1002/art.10445; Hansen A, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2210; Hansen A, 2010, AUTOIMMUN REV, V9, P600, DOI 10.1016/j.autrev.2010.05.005; Kessel A, 2012, AUTOIMMUN REV, V11, P670, DOI 10.1016/j.autrev.2011.11.018; Le Pottier L, 2009, J IMMUNOL, V182, P3540, DOI 10.4049/jimmunol.0803588; Lossos IS, 2000, J IMMUNOL, V165, P5122, DOI 10.4049/jimmunol.165.9.5122; Meffre E, 2008, CURR OPIN IMMUNOL, V20, P632, DOI 10.1016/j.coi.2008.09.001; Mietzner B, 2008, P NATL ACAD SCI USA, V105, P9727, DOI 10.1073/pnas.0803644105; Mouquet H, 2011, CELL MOL LIFE SCI; Mouquet H, 2012, CELL MOL LIFE SCI, V69, P1435, DOI 10.1007/s00018-011-0872-6; Pijpe J, 2005, ARTHRITIS RHEUM-US, V52, P2740, DOI 10.1002/art.21260; Rogosch T, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00176; Routsias JG, 2010, EUR J CLIN INVEST, V40, P1026, DOI 10.1111/j.1365-2362.2010.02342.x; Salomonsson S, 2003, ARTHRITIS RHEUM-US, V48, P3187, DOI 10.1002/art.11311; Samuels J, 2005, J EXP MED, V201, P1659, DOI 10.1084/jem.20042321; Scheid JF, 2011, P NATL ACAD SCI USA, V108, P18044, DOI 10.1073/pnas.1113395108; Stott DI, 1998, J CLIN INVEST, V102, P938, DOI 10.1172/JCI3234; Takemoto F, 2007, NEPHRON PHYSIOL, V106, P63, DOI 10.1159/000104873; Theander E, 2011, ANN RHEUM DIS, V70, P1363, DOI 10.1136/ard.2010.144782; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Tiller T, 2007, IMMUNITY, V26, P205, DOI 10.1016/j.immuni.2007.01.009; Tsuboi H, 2012, MOD RHEUMATOL, V22, P264, DOI 10.1007/s10165-011-0514-8; Tsuiji M, 2006, J EXP MED, V203, P393, DOI 10.1084/jem.20052033; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Youinou P, 2010, ARTHRITIS RHEUM-US, V62, P2605, DOI 10.1002/art.27564; Yurasov S, 2005, J EXP MED, V201, P703, DOI 10.1084/jem.20042251	35	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e114575	10.1371/journal.pone.0114575	http://dx.doi.org/10.1371/journal.pone.0114575			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25535746	Green Submitted, Green Published, gold			2022-12-27	WOS:000348563300014
J	Domenici, L; Origlia, N; Falsini, B; Cerri, E; Barloscio, D; Fabiani, C; Sanso, M; Giovannini, L				Domenici, Luciano; Origlia, Nicola; Falsini, Benedetto; Cerri, Elisa; Barloscio, Davide; Fabiani, Carlotta; Sanso, Marco; Giovannini, Luca			Rescue of Retinal Function by BDNF in a Mouse Model of Glaucoma	PLOS ONE			English	Article							GANGLION-CELL SURVIVAL; OPTIC-NERVE INJURY; NEUROTROPHIC FACTOR; PATTERN ELECTRORETINOGRAM; DBA/2J MOUSE; AXONAL-TRANSPORT; VISUAL-ACUITY; RECEPTOR TRKB; GROWTH-FACTOR; MICE	Vision loss in glaucoma is caused by progressive dysfunction of retinal ganglion cells (RGCs) and optic nerve atrophy. Here, we investigated the effectiveness of BDNF treatment to preserve vision in a glaucoma experimental model. As an established experimental model, we used the DBA/2J mouse, which develops chronic intraocular pressure (IOP) elevation that mimics primary open-angle glaucoma (POAG). IOP was measured at different ages in DBA/2J mice. Visual function was monitored using the steady-state Pattern Electroretinogram (P-ERG) and visual cortical evoked potentials (VEP). RGC alterations were assessed using Brn3 immunolabeling, and confocal microscope analysis. Human recombinant BDNF was dissolved in physiological solution (0.9% NaCl); the effects of repeated intravitreal injections and topical eye BDNF applications were independently evaluated in DBA/2J mice with ocular hypertension. BDNF level was measured in retinal homogenate by ELISA and western blot. We found a progressive decline of P-ERG and VEP responses in DBA/2J mice between 4 and 7 months of age, in relationship with the development of ocular hypertension and the reduction of Brn3 immunopositive RGCs. Conversely, repeated intravitreal injections (BDNF concentration=2 mu g/mu l, volume=1 mu l, for each injection; 1 injection every four days, three injections over two weeks) and topical eye application of BDNF eye-drops (12 mu g/mu l, 5 ml eye-drop every 48 h for two weeks) were able to rescue visual responses in 7 month DBA/2J mice. In particular, BDNF topical eye treatment recovered P-ERG and VEP impairment increasing the number of Brn3 immunopositive RGCs. We showed that BDNF effects were independent of IOP reduction. Thus, topical eye treatment with BDNF represents a promisingly safe and feasible strategy to preserve visual function and diminish RGC vulnerability to ocular hypertension.	[Domenici, Luciano; Origlia, Nicola; Cerri, Elisa; Barloscio, Davide; Fabiani, Carlotta] CNR, Inst Neurosci, I-56100 Pisa, Italy; [Domenici, Luciano] Univ Aquila, Dept Appl Clin Sci & Biotechnol DISCAB, I-67100 Laquila, Italy; [Falsini, Benedetto] Catholic Univ, Policlin Gemelli, Inst Ophthalmol, Rome, Italy; [Sanso, Marco; Giovannini, Luca] Univ Pisa, Dept Translat Res New Technol Med & Surg, Pisa, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); University of L'Aquila; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Pisa	Domenici, L (corresponding author), CNR, Inst Neurosci, I-56100 Pisa, Italy.	domenici@in.cnr.it	Falsini, Benedetto/V-1070-2019; Falsini, Benedetto/AAC-5907-2022	Falsini, Benedetto/0000-0002-1694-1062; Falsini, Benedetto/0000-0002-3569-4968; Domenici, Luciano/0000-0003-2923-9421	Italian Ministry of Research (grant PRIN); intramural grant (CNR, Neuroscience Institute)	Italian Ministry of Research (grant PRIN); intramural grant (CNR, Neuroscience Institute)	This work was supported by the Italian Ministry of Research (grant PRIN, 2010) to Luciano Domenici (Title: Physiology and physiopathology of BDNF: towards the development of new therapeutic strategies) and intramural grant (CNR, Neuroscience Institute) to Nicola Origlia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasieh M, 2012, PROG RETIN EYE RES, V31, P152, DOI 10.1016/j.preteyeres.2011.11.002; Anderson MG, 2002, NAT GENET, V30, P81, DOI 10.1038/ng794; Atorf J, 2013, DOC OPHTHALMOL, V126, P221, DOI 10.1007/s10633-013-9380-3; Badea TC, 2009, NEURON, V61, P852, DOI 10.1016/j.neuron.2009.01.020; BAKER CL, 1988, J PHYSIOL-LONDON, V407, P155, DOI 10.1113/jphysiol.1988.sp017408; Buckingham BP, 2008, J NEUROSCI, V28, P2735, DOI 10.1523/JNEUROSCI.4443-07.2008; Butowt R, 2005, MOL CELL NEUROSCI, V29, P11, DOI 10.1016/j.mcn.2005.02.004; Caleo M, 2000, CURR BIOL, V10, P1155, DOI 10.1016/S0960-9822(00)00713-2; Cellerino A, 1998, J NEUROSCI, V18, P3351; Cellerino A, 1997, J COMP NEUROL, V386, P149; Chou TH, 2013, INVEST OPHTH VIS SCI, V54, P1236, DOI 10.1167/iovs.12-11188; Coleman JE, 2009, NEUROSCIENCE, V161, P561, DOI 10.1016/j.neuroscience.2009.03.045; Damiani D, 2012, J COMP NEUROL, V520, P1406, DOI 10.1002/cne.22802; DOMENICI L, 1991, EXP BRAIN RES, V86, P579; Falsini B, 1999, EUR J NEUROL, V6, P151, DOI 10.1111/j.1468-1331.1999.tb00008.x; Frankfort BJ, 2013, INVEST OPHTH VIS SCI, V54, P762, DOI 10.1167/iovs.12-10581; Guo Y, 2009, EXP EYE RES, V89, P921, DOI 10.1016/j.exer.2009.08.003; Kezic JM, 2013, INVEST OPHTH VIS SCI, V54, P3028, DOI 10.1167/iovs.13-11865; Kim H, 2004, J BIOL CHEM, V279, P33538, DOI 10.1074/jbc.M404115200; Ko ML, 2001, NEUROSCI LETT, V305, P139, DOI 10.1016/S0304-3940(01)01830-4; Lambiase A, 2005, INVEST OPHTH VIS SCI, V46, P3800, DOI 10.1167/iovs.05-0301; LAVAIL MM, 1992, P NATL ACAD SCI USA, V89, P11249, DOI 10.1073/pnas.89.23.11249; LaVail MM, 1998, INVEST OPHTH VIS SCI, V39, P592; Libby RT, 2005, VISUAL NEUROSCI, V22, P637, DOI 10.1017/S0952523805225130; MAFFEI L, 1982, EXP BRAIN RES, V48, P327; MANSOURROBAEY S, 1994, P NATL ACAD SCI USA, V91, P1632, DOI 10.1073/pnas.91.5.1632; Nadal-Nicolas FM, 2009, INVEST OPHTH VIS SCI, V50, P3860, DOI 10.1167/iovs.08-3267; Origlia N, 2012, INVEST OPHTH VIS SCI, V53, P1211, DOI 10.1167/iovs.11-8007; Pan WH, 1998, NEUROPHARMACOLOGY, V37, P1553, DOI 10.1016/S0028-3908(98)00141-5; Parrilla-Reverter G, 2009, EXP EYE RES, V89, P32, DOI 10.1016/j.exer.2009.02.015; Pease ME, 2000, INVEST OPHTH VIS SCI, V41, P764; PeinadoRamon P, 1996, INVEST OPHTH VIS SCI, V37, P489; PEREZ MTR, 1995, NEUROSCI LETT, V183, P96, DOI 10.1016/0304-3940(94)11123-Z; Porciatti V, 1996, P NATL ACAD SCI USA, V93, P14955, DOI 10.1073/pnas.93.25.14955; Porciatti V, 1999, VISION RES, V39, P3071, DOI 10.1016/S0042-6989(99)00022-X; Porciatti V, 2007, INVEST OPHTH VIS SCI, V48, P745, DOI 10.1167/iovs.06-0733; Prusky GT, 2000, VISION RES, V40, P2201, DOI 10.1016/S0042-6989(00)00081-X; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Rudzinski M, 2004, J NEUROBIOL, V58, P341, DOI 10.1002/neu.10293; Saleh M, 2007, INVEST OPHTH VIS SCI, V48, P4564, DOI 10.1167/iovs.07-0483; Sanchez-Migallon MC, 2011, EXP EYE RES, V92, P260, DOI 10.1016/j.exer.2011.02.001; Schlamp CL, 2006, BMC NEUROSCI, P7; Scholz M, 2008, INVEST OPHTH VIS SCI, V49, P255; SIEVING PA, 1987, J NEUROPHYSIOL, V57, P104, DOI 10.1152/jn.1987.57.1.104; Surgucheva I, 2008, MOL VIS, V14, P1540; Ventura LM, 2013, J GLAUCOMA, V22, P219, DOI 10.1097/IJG.0b013e318237c89f; Wahlin KJ, 2001, EXP EYE RES, V73, P693, DOI 10.1006/exer.2001.1078; Weber AJ, 2008, J PHYSIOL-LONDON, V586, P4393, DOI 10.1113/jphysiol.2008.156729; Weber AJ, 2010, INVEST OPHTH VIS SCI, V51, P327, DOI 10.1167/iovs.09-3740; XIANG MQ, 1995, J NEUROSCI, V15, P4762; Zhang CW, 2005, INVEST OPHTH VIS SCI, V46, P1497, DOI 10.1167/iovs.04-0664	51	81	83	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115579	10.1371/journal.pone.0115579	http://dx.doi.org/10.1371/journal.pone.0115579			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536045	Green Submitted, gold, Green Published			2022-12-27	WOS:000348563300052
J	Holm, G; Andersson, M; Ekberg, M; Fagrell, B; Sjoberg, J; Bottai, M; Bjorkholm, M				Holm, Goran; Andersson, Margareta; Ekberg, Monica; Fagrell, Bengt; Sjoberg, Jan; Bottai, Matteo; Bjorkholm, Magnus			Setae from Larvae of the Northern Processionary Moth (Thaumetopoea pinivora, TP) Stimulate Proliferation of Human Blood Lymphocytes In Vitro	PLOS ONE			English	Article							CATERPILLAR	Larvae of the Northern pine processionary moth (Thaumetopoea pinivora, TP) carry microscopic needles (setae), which by penetrating skin and mucous membranes, may cause inflammatory/immune derived symptoms in man. In the present study the stimulatory effects of setae on human blood lymphocytes in vitro was investigated. Blood mononuclear cells were separated from venous blood or buffy coat of ten healthy individuals, six previously exposed to setae and four with no known exposure. Lymphoproliferation was measured as uptake of H-3-thymidine. Setae were prepared from TP larvae. Setae and saline setae extracts stimulated proliferation of T-lymphocytes in the presence of monocytic cells. Stimulation was pronounced in cells from persons who had been exposed to setae, and weak in cells from non-exposed donors. Chitin also induced lymphocyte proliferation in most donors, but to a lesser extent and independently of donor's previous exposure to setae. In conclusion, setae contain molecules that in the presence of monocytes activate human T-lymphocytes to proliferation. The antigenic nature of stimulatory molecules was supported by the significantly stronger lymphocyte response in persons previously exposed to setae than in non-exposed donors. The nature of such molecules remains to be defined.	[Holm, Goran; Andersson, Margareta; Ekberg, Monica; Fagrell, Bengt; Sjoberg, Jan; Bjorkholm, Magnus] Karolinska Univ, Hosp Solna, Ctr Mol Med, Dept Med,Div Hematol, Stockholm, Sweden; [Holm, Goran; Andersson, Margareta; Ekberg, Monica; Fagrell, Bengt; Sjoberg, Jan; Bjorkholm, Magnus] Karolinska Inst, Stockholm, Sweden; [Bottai, Matteo] Karolinska Inst, Inst Enviromental Med, Div Biostat, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet	Holm, G (corresponding author), Karolinska Univ, Hosp Solna, Ctr Mol Med, Dept Med,Div Hematol, Stockholm, Sweden.	goran.holm@ki.se			Torsten and Ragnar Soderberg Foundations, Stockholm, Sweden	Torsten and Ragnar Soderberg Foundations, Stockholm, Sweden	This work was supported by the Torsten and Ragnar Soderberg Foundations, Stockholm, Sweden.	Battisti A, 2011, ANNU REV ENTOMOL, V56, P203, DOI 10.1146/annurev-ento-120709-144844; Fagrell B, 2008, CONTACT DERMATITIS, V59, P290, DOI 10.1111/j.1600-0536.2008.01423.x; Holm Goran, 2009, Lakartidningen, V106, P1891; Rodriguez-Mahillo AI, 2012, CONTACT DERMATITIS, V67, P367, DOI 10.1111/j.1600-0536.2012.02107.x; Larsson Stig, 2006, Entomologisk Tidskrift, V127, P1; Lee CG, 2008, CURR OPIN IMMUNOL, V20, P684, DOI 10.1016/j.coi.2008.10.002; Maier H, 2003, BRIT J DERMATOL, V149, P990, DOI 10.1111/j.1365-2133.2003.05673.x; Natsuaki M, 2002, J DERMATOL, V29, P471, DOI 10.1111/j.1346-8138.2002.tb00311.x; Vega JM, 1997, ALLERGY, V52, P1244, DOI 10.1111/j.1398-9995.1997.tb02532.x	9	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e113977	10.1371/journal.pone.0113977	http://dx.doi.org/10.1371/journal.pone.0113977			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531291	Green Published, Green Submitted, gold			2022-12-27	WOS:000348845100007
J	Karpel-Massler, G; Pareja, F; Aime, P; Shu, C; Chau, L; Westhoff, MA; Halatsch, ME; Crary, JF; Canoll, P; Siegelin, MD				Karpel-Massler, Georg; Pareja, Fresia; Aime, Pascaline; Shu, Chang; Chau, Lily; Westhoff, Mike-Andrew; Halatsch, Marc-Eric; Crary, John F.; Canoll, Peter; Siegelin, Markus D.			PARP Inhibition Restores Extrinsic Apoptotic Sensitivity in Glioblastoma	PLOS ONE			English	Article							DIPHOSPHATE-RIBOSE) POLYMERASE EXPRESSION; DEATH RECEPTOR 5; PHASE-II TRIAL; MONOCLONAL-ANTIBODY; CANCER-CELLS; MALIGNANT GLIOMA; DOWN-REGULATION; LIGAND; TRAIL; TEMOZOLOMIDE	Background: Resistance to apoptosis is a paramount issue in the treatment of Glioblastoma (GBM). We show that targeting PARP by the small molecule inhibitors, Olaparib (AZD-2281) or PJ34, reduces proliferation and lowers the apoptotic threshold of GBM cells in vitro and in vivo. Methods: The sensitizing effects of PARP inhibition on TRAIL-mediated apoptosis and potential toxicity were analyzed using viability assays and flow cytometry in established GBM cell lines, low-passage neurospheres and astrocytes in vitro. Molecular analyses included western blots and gene silencing. In vivo, effects on tumor growth were examined in a murine subcutaneous xenograft model. Results: The combination treatment of PARP inhibitors and TRAIL led to an increased cell death with activation of caspases and inhibition of formation of neurospheres when compared to single-agent treatment. Mechanistically, pharmacological PARP inhibition elicited a nuclear stress response with upregulation of down-stream DNA-stress response proteins, e.g., CCAAT enhancer binding protein (C/EBP) homology protein (CHOP). Furthermore, Olaparib and PJ34 increased protein levels of DR5 in a concentration and time-dependent manner. In turn, siRNA-mediated suppression of DR5 mitigated the effects of TRAIL/PARP inhibitor-mediated apoptosis. In addition, suppression of PARP-1 levels enhanced TRAIL-mediated apoptosis in malignant glioma cells. Treatment of human astrocytes with the combination of TRAIL/PARP inhibitors did not cause toxicity. Finally, the combination treatment of TRAIL and PJ34 significantly reduced tumor growth in vivo when compared to treatment with each agent alone. Conclusions: PARP inhibition represents a promising avenue to overcome apoptotic resistance in GBM.	[Karpel-Massler, Georg; Pareja, Fresia; Aime, Pascaline; Shu, Chang; Chau, Lily; Crary, John F.; Canoll, Peter; Siegelin, Markus D.] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10027 USA; [Westhoff, Mike-Andrew] Univ Ulm, Dept Pediat & Adolescent Med, Med Ctr, D-89069 Ulm, Germany; [Halatsch, Marc-Eric] Univ Ulm, Dept Neurosurg, Med Ctr, D-89069 Ulm, Germany	Columbia University; Ulm University; Ulm University	Siegelin, MD (corresponding author), Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10027 USA.	ms4169@cumc.columbia.edu	Westhoff, Mike-Andrew/ABA-9272-2021; Halatsch, Marc-Eric/B-7807-2008	Westhoff, Mike-Andrew/0000-0003-3256-7100; 	American Association for Cancer Research [13-20-23-SIEG]; American Brain Tumor Association (American Brain Tumor Translational Grant) [ABTA CU13-0098]; Irving Cancer Institute (CTO Pilot Award); National Institutes of Health [NINDS K08NS083732]; Mildred-Scheel-Postdoktorandenprogramm, Deutsche Krebshilfe (GK-M); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS083732] Funding Source: NIH RePORTER	American Association for Cancer Research; American Brain Tumor Association (American Brain Tumor Translational Grant); Irving Cancer Institute (CTO Pilot Award); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mildred-Scheel-Postdoktorandenprogramm, Deutsche Krebshilfe (GK-M); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by American Association for Cancer Research (13-20-23-SIEG) (MDS), American Brain Tumor Association (American Brain Tumor Translational Grant ABTA CU13-0098) (MDS), Irving Cancer Institute (2013 CTO Pilot Award) (MDS), National Institutes of Health NINDS K08NS083732 (MDS) and Fellowship award from Mildred-Scheel-Postdoktorandenprogramm, Deutsche Krebshilfe (GK-M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004828; Bangert A, 2012, ONCOGENE, V31, P4677, DOI 10.1038/onc.2011.614; Campos B, 2010, CLIN CANCER RES, V16, P2715, DOI 10.1158/1078-0432.CCR-09-1800; Capper D, 2009, ACTA NEUROPATHOL, V117, P445, DOI 10.1007/s00401-009-0494-3; Eckhardt I, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.457; Edagawa M, 2014, J BIOL CHEM, V289, P21544, DOI 10.1074/jbc.M114.558890; El-Zawahry A, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-2; Elias A, 2009, CLIN CANCER RES, V15, P5457, DOI 10.1158/1078-0432.CCR-09-1125; Fulda S, 2002, NAT MED, V8, P808, DOI 10.1038/nm735; Gan A, 2013, HUM PATHOL, V44, P1638, DOI 10.1016/j.humpath.2013.01.015; Gilbert CA, 2010, CANCER RES, V70, P6870, DOI 10.1158/0008-5472.CAN-10-1378; Happold C, 2014, MOL CANCER THER, V13, P948, DOI 10.1158/1535-7163.MCT-13-0772; Hastak K, 2010, CANCER RES, V70, P7970, DOI 10.1158/0008-5472.CAN-09-4521; Jensen SA, 2014, P NATL ACAD SCI USA, V111, P5682, DOI 10.1073/pnas.1316700111; Koschny R, 2007, CLIN CANCER RES, V13, P3403, DOI 10.1158/1078-0432.CCR-07-0251; Lavrik IN, 2008, J BIOL CHEM, V283, P26401, DOI 10.1074/jbc.M800823200; Lin TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063966; MacFarlane M, 2002, J BIOL CHEM, V277, P36611, DOI 10.1074/jbc.M200317200; Merchant MS, 2012, J CLIN ONCOL, V30, P4141, DOI 10.1200/JCO.2012.44.1055; Mihaliak AM, 2010, CANCER LETT, V296, P168, DOI 10.1016/j.canlet.2010.04.005; Murai J, 2014, J PHARMACOL EXP THER, V349, P408, DOI 10.1124/jpet.113.210146; Newsom-Davis T, 2009, APOPTOSIS, V14, P607, DOI 10.1007/s10495-009-0321-2; Palacios C, 2006, CANCER RES, V66, P8858, DOI 10.1158/0008-5472.CAN-06-0808; Pareja F, 2014, MOL CANCER RES, V12, P987, DOI 10.1158/1541-7786.MCR-13-0650; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Qi L, 2011, APOPTOSIS, V16, P1150, DOI 10.1007/s10495-011-0645-6; Russo AL, 2009, CLIN CANCER RES, V15, P607, DOI 10.1158/1078-0432.CCR-08-2079; Saito R, 2004, CANCER RES, V64, P6858, DOI 10.1158/0008-5472.CAN-04-1683; Sheng Z, 2010, NAT MED, V16, P671, DOI 10.1038/nm.2158; Siegelin MD, 2011, J CLIN INVEST, V121, P1349, DOI 10.1172/JCI44855; Siegelin MD, 2009, NEURO-ONCOLOGY, V11, P122, DOI 10.1215/15228517-2008-085; Siegelin MD, 2012, EXPERT OPIN THER TAR, V16, P801, DOI 10.1517/14728222.2012.703655; Song JH, 2008, J BIOL CHEM, V283, P25003, DOI 10.1074/jbc.M802511200; Stuckey DW, 2013, TRENDS MOL MED, V19, P685, DOI 10.1016/j.molmed.2013.08.007; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tagscherer KE, 2008, ONCOGENE, V27, P6646, DOI 10.1038/onc.2008.259; Tolcher AW, 2007, J CLIN ONCOL, V25, P1390, DOI 10.1200/JCO.2006.08.8898; Trarbach T, 2010, BRIT J CANCER, V102, P506, DOI 10.1038/sj.bjc.6605507; von Minckwitz G, 2011, J CLIN ONCOL, V29, P2150, DOI 10.1200/JCO.2010.31.9079; von Pawel J, 2014, CLIN LUNG CANCER, V15, P188, DOI 10.1016/j.cllc.2013.12.005; Walczak H, 1997, EMBO J, V16, P5386, DOI 10.1093/emboj/16.17.5386; Xu S, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju162; Yuan KY, 2013, CLIN CANCER RES, V19, P4750, DOI 10.1158/1078-0432.CCR-13-0516	43	35	35	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e114583	10.1371/journal.pone.0114583	http://dx.doi.org/10.1371/journal.pone.0114583			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531448	Green Published, Green Submitted, gold			2022-12-27	WOS:000348845100019
J	Andersson, S; Nilsson, K; Fagerberg, L; Hallstrom, BM; Sundstrom, C; Danielsson, A; Edlund, K; Uhlen, M; Asplund, A				Andersson, Sandra; Nilsson, Kenneth; Fagerberg, Linn; Hallstrom, Bjorn M.; Sundstrom, Christer; Danielsson, Angelika; Edlund, Karolina; Uhlen, Mathias; Asplund, Anna			The Transcriptomic and Proteomic Landscapes of Bone Marrow and Secondary Lymphoid Tissues	PLOS ONE			English	Article							HUMAN PROTEIN ATLAS; CALDAG-GEFI; EXPRESSION; GENE; MOUSE; RECEPTOR; IDENTIFICATION; LEUKEMIA; HEMOGEN; ANTIGEN	Background: The sequencing of the human genome has opened doors for global gene expression profiling, and the immense amount of data will lay an important ground for future studies of normal and diseased tissues. The Human Protein Atlas project aims to systematically map the human gene and protein expression landscape in a multitude of normal healthy tissues as well as cancers, enabling the characterization of both housekeeping genes and genes that display a tissue-specific expression pattern. This article focuses on identifying and describing genes with an elevated expression in four lymphohematopoietic tissue types (bone marrow, lymph node, spleen and appendix), based on the Human Protein Atlas-strategy that combines high throughput transcriptomics with affinity-based proteomics. Results: An enriched or enhanced expression in one or more of the lymphohematopoietic tissues, compared to other tissue-types, was seen for 693 out of 20,050 genes, and the highest levels of expression were found in bone marrow for neutrophilic and erythrocytic genes. A majority of these genes were found to constitute well-characterized genes with known functions in lymphatic or hematopoietic cells, while others are not previously studied, as exemplified by C19ORF59. Conclusions: In this paper we present a strategy of combining next generation RNA-sequencing with in situ affinity-based proteomics in order to identify and describe new gene targets for further research on lymphatic or hematopoietic cells and tissues. The results constitute lists of genes with enriched or enhanced expression in the four lymphohematopoietic tissues, exemplified also on protein level with immunohistochemical images.	[Andersson, Sandra; Nilsson, Kenneth; Sundstrom, Christer; Danielsson, Angelika; Edlund, Karolina; Asplund, Anna] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Andersson, Sandra; Danielsson, Angelika; Asplund, Anna] Uppsala Univ, Sci Life Lab, Uppsala, Sweden; [Edlund, Karolina] Dortmund TU, Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany; [Fagerberg, Linn; Hallstrom, Bjorn M.; Uhlen, Mathias] Royal Inst Technol, Sci Life Lab, Stockholm, Sweden	Uppsala University; Uppsala University; Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO); Royal Institute of Technology	Asplund, A (corresponding author), Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden.	anna.asplund@igp.uu.se	Uhlen, Mathias/B-3262-2016; Uhlen, Mathias/AAV-8746-2021	Uhlen, Mathias/0000-0002-4858-8056; Fagerberg, Linn/0000-0003-0198-7137	Knut and Alice Wallenberg Foundation [KAW2008.0143]	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was supported by the Knut and Alice Wallenberg Foundation (KAW2008.0143). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal M, 2009, MODERN PATHOL, V22, P206, DOI 10.1038/modpathol.2008.148; [Anonymous], 2012, SICKLE WINDOWED ADAP; [Anonymous], 2014, ARRAYEXPRESS DATABAS; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bain BJ, 1996, BONE MARROW PATHOLOG, Vviii; Bichi R, 2002, P NATL ACAD SCI USA, V99, P6955, DOI 10.1073/pnas.102181599; Carbo C, 2010, J LEUKOCYTE BIOL, V88, P313, DOI 10.1189/jlb.0110049; COLLINS SJ, 1977, NATURE, V270, P347, DOI 10.1038/270347a0; Crittenden JR, 2004, NAT MED, V10, P982, DOI 10.1038/nm1098; Csepanyi-Komi R, 2012, BLOOD, V119, P573, DOI 10.1182/blood-2010-12-324053; De Braekeleer E, 2007, LEUKEMIA, V21, P2220, DOI 10.1038/sj.leu.2404773; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Ericksen B, 2005, ANTIMICROB AGENTS CH, V49, P269, DOI 10.1128/AAC.49.1.269-275.2005; Facchetti F, 2002, P NATL ACAD SCI USA, V99, P3776, DOI 10.1073/pnas.022042699; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; GALLAGHER R, 1979, BLOOD, V54, P713; GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120; Goto M, 2010, HUM REPROD, V25, P1884, DOI 10.1093/humrep/deq138; Gregory RW, 2012, GPLOTS VARIOUS R PRO; Gunn MD, 1998, P NATL ACAD SCI USA, V95, P258, DOI 10.1073/pnas.95.1.258; HAMMOND MEW, 1995, J IMMUNOL, V155, P1428; Kampf C., 2004, CLIN PROTEOM, V1, P285, DOI DOI 10.1385/CP:1:3-4:285; Katoh M, 2004, INT J MOL MED, V14, P333; Kircher M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr771; Krupp M, 2012, BIOINFORMATICS, V28, P1184, DOI 10.1093/bioinformatics/bts084; LEE YTN, 1978, WESTERN J MED, V129, P374; Li K, 2005, GENOMICS, V86, P68, DOI 10.1016/j.ygeno.2005.03.006; Mechenthaler I, 2008, CELL MOL LIFE SCI, V65, P1826, DOI 10.1007/s00018-008-8157-4; Mechetina LV, 2002, EUR J IMMUNOL, V32, P87, DOI 10.1002/1521-4141(200201)32:1<87::AID-IMMU87>3.0.CO;2-#; Meijer B, 2012, INT J INFLAMM, V2012, DOI 10.1155/2012/907078; Nakata T, 2013, P NATL ACAD SCI USA, V110, P3417, DOI 10.1073/pnas.1218714110; Parkinson H, 2005, NUCLEIC ACIDS RES, V33, pD553; Petryszak R, 2014, NUCLEIC ACIDS RES, V42, pD926, DOI 10.1093/nar/gkt1270; Ponten F, 2011, J INTERN MED, V270, P428, DOI 10.1111/j.1365-2796.2011.02427.x; Ponten F, 2008, J PATHOL, V216, P387, DOI 10.1002/path.2440; R Core Team, 2021, R LANGUAGE ENV STAT; Saeki H, 1999, J IMMUNOL, V162, P2472; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Schneider P, 1999, J EXP MED, V189, P1747, DOI 10.1084/jem.189.11.1747; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Steininger H, 2004, PATHOL RES PRACT, V200, P479, DOI 10.1016/j.prp.2004.04.004; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Takase H, 2012, BLOOD, V120, P914, DOI 10.1182/blood-2011-12-398156; TEDDER TF, 1988, P NATL ACAD SCI USA, V85, P208, DOI 10.1073/pnas.85.1.208; TEDDER TF, 1989, J IMMUNOL, V143, P712; Thompson JS, 2001, SCIENCE, V293, P2108, DOI 10.1126/science.1061965; THORNE KJI, 1976, INFECT IMMUN, V14, P555, DOI 10.1128/IAI.14.2.555-563.1976; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Virgilio L, 1998, P NATL ACAD SCI USA, V95, P3885, DOI 10.1073/pnas.95.7.3885; WILDE CG, 1989, J BIOL CHEM, V264, P11200; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Xiao L, 2013, ANGIOGENESIS; Yang LV, 2003, DEV DYNAM, V228, P606, DOI 10.1002/dvdy.10399; Yang LV, 2001, MECH DEVELOP, V104, P105, DOI 10.1016/S0925-4773(01)00376-8; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578	62	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115911	10.1371/journal.pone.0115911	http://dx.doi.org/10.1371/journal.pone.0115911			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541736	Green Published, Green Submitted, gold			2022-12-27	WOS:000347239900109
J	Beane, OS; Fonseca, VC; Cooper, LL; Koren, G; Darling, EM				Beane, Olivia S.; Fonseca, Vera C.; Cooper, Leroy L.; Koren, Gideon; Darling, Eric M.			Impact of Aging on the Regenerative Properties of Bone Marrow-, Muscle-, and Adipose-Derived Mesenchymal Stem/Stromal Cells	PLOS ONE			English	Article							STEM-CELLS; STROMAL CELLS; IN-VITRO; CHONDROGENIC DIFFERENTIATION; PROLIFERATION RATE; CARTILAGE REPAIR; TISSUE; AGE; TRANSCRIPTION; ENRICHMENT	Mesenchymal stem/stromal cells (MSCs) are promising cell sources for regenerative therapies due to their multipotency and ready availability, but their application can be complicated by patient-specific factors like age or illness. MSCs have been investigated for the treatment of many musculoskeletal disorders, including osteoarthritis and osteoporosis. Due to the prevalence of these diseases in older populations, researchers have studied how aging affects MSC properties and have found that proliferation and differentiation potential are impaired. However, these effects have never been compared among MSCs isolated from multiple tissue sources in the same, healthy donor. Revealing differences in how MSCs are affected by age could help identify an optimal cell source for musculoskeletal therapies targeting older patients. MSCs were isolated from young and old rabbit bone marrow, muscle, and adipose tissue. Cell yield and viability were quantified after isolation procedures, and expansion properties were assessed using assays for proliferation, senescence, and colony formation. Multipotency was also examined using lineage-specific stains and spectrophotometry of metabolites. Results were compared between age groups and among MSC sources. Results showed that MSCs are differentially influenced by aging, with bone marrow-derived stem cells having impaired proliferation, senescence, and chondrogenic response, whereas muscle-derived stem cells and adipose-derived stem cells exhibited no negative effects. While age reduced overall cell yield and adipogenic potential of all MSC populations, osteogenesis and clonogenicity remained unchanged. These findings indicate the importance of age as a factor when designing cell-based therapies for older patients.	[Beane, Olivia S.; Darling, Eric M.] Brown Univ, Ctr Biomed Engn, Providence, RI 02912 USA; [Fonseca, Vera C.; Darling, Eric M.] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA; [Cooper, Leroy L.; Koren, Gideon] Brown Univ, Rhode Isl Hosp, Cardiovasc Res Ctr, Alpert Med Sch, Providence, RI 02903 USA; [Darling, Eric M.] Brown Univ, Dept Orthopaed, Providence, RI 02912 USA; [Darling, Eric M.] Brown Univ, Sch Engn, Providence, RI 02912 USA	Brown University; Brown University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Brown University	Darling, EM (corresponding author), Brown Univ, Ctr Biomed Engn, Providence, RI 02912 USA.	Eric_Darling@brown.edu	Koren, Gideon/AAG-7726-2019	Koren, Gideon/0000-0002-9234-0875; Darling, Eric/0000-0002-3932-8623	National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01 AR063642]; National Institute of General Medical Sciences [P20 GM104937]; National Science Foundation (CAREER Award) [CBET1253189]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104937] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation (CAREER Award)(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by awards from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01 AR063642 for EMD), National Institute of General Medical Sciences (P20 GM104937 for EMD), and National Science Foundation (CAREER Award, CBET1253189 for EMD). The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or National Science Foundation. The funders had no role in study design, data collection and analysis, decision publish, or preparation of the manuscript.	Al Faqeh H, 2012, EXP GERONTOL, V47, P458, DOI 10.1016/j.exger.2012.03.018; Antebi B, 2014, CURR OSTEOPOROS REP, V12, P41, DOI 10.1007/s11914-013-0184-x; Aronowitz JA, 2013, PLAST RECONSTR SURG, V132, p932E, DOI 10.1097/PRS.0b013e3182a80652; Asumda FZ, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-44; Awad HA, 2003, TISSUE ENG, V9, P1301, DOI 10.1089/10763270360728215; Baer PC, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/812693; Bourzac C, 2010, EQUINE VET J, V42, P519, DOI 10.1111/j.2042-3306.2010.00098.x; Buschmann J, 2013, CYTOTHERAPY, V15, P1098, DOI 10.1016/j.jcyt.2013.04.009; Chen HT, 2012, J CELL MOL MED, V16, DOI 10.1111/j.1582-4934.2011.01335.x; Choudhery MS, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-8; de Girolamo L, 2009, CYTOTHERAPY, V11, P793, DOI 10.3109/14653240903079393; Dexheimer V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022980; Doi K, 2014, CYTOTHERAPY, V16, P381, DOI 10.1016/j.jcyt.2013.09.002; Estes BT, 2010, NAT PROTOC, V5, P1294, DOI 10.1038/nprot.2010.81; Gao XQ, 2013, CELL TRANSPLANT, V22, P2393, DOI 10.3727/096368912X658854; Gharaibeh B, 2008, NAT PROTOC, V3, P1501, DOI 10.1038/nprot.2008.142; Gonzalez-Cruz RD, 2012, P NATL ACAD SCI USA, V109, pE1523, DOI 10.1073/pnas.1120349109; Guilak F, 2006, J CELL PHYSIOL, V206, P229, DOI 10.1002/jcp.20463; Gupta PK, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt116; Higashimoto T, 2007, GENE THER, V14, P1298, DOI 10.1038/sj.gt.3302979; Huang CYC, 2004, STEM CELLS, V22, P313, DOI 10.1634/stemcells.22-3-313; Huang SC, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-18; Huang WB, 2004, EXP CELL RES, V299, P325, DOI 10.1016/j.yexcr.2004.04.051; Izadpanah R, 2008, CANCER RES, V68, P4229, DOI 10.1158/0008-5472.CAN-07-5272; Jackson WM, 2010, EXPERT OPIN BIOL TH, V10, P505, DOI 10.1517/14712591003610606; Kanthilal M, 2014, CELL MOL BIOENG, V7, P585, DOI 10.1007/s12195-014-0350-y; Kim HP, 2012, CURR STEM CELL RES T, V7, P165; Kretlow JD, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-60; Lavasani M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1611; Lee Tsung-Han, 2013, BMC Res Notes, V6, P528, DOI 10.1186/1756-0500-6-528; Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005; Lim YW, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.128; Markarian CF, 2014, BIOTECHNOL LETT, V36, P693, DOI 10.1007/s10529-013-1425-x; Mendes SC, 2002, TISSUE ENG, V8, P911, DOI 10.1089/107632702320934010; Moerman EJ, 2004, AGING CELL, V3, P379, DOI 10.1111/j.1474-9728.2004.00127.x; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; Murphy JM, 2002, ARTHRITIS RHEUM-US, V46, P704, DOI 10.1002/art.10118; Ng LWC, 2009, HUM REPROD, V24, P1164, DOI 10.1093/humrep/dep001; Nilsson SK, 1997, BLOOD, V89, P4013, DOI 10.1182/blood.V89.11.4013; PATE DW, 1993, CLIN RES, V41, pA347; Patrascu JM, 2013, J BIOMED MATER RES B, V101, P1310, DOI 10.1002/jbm.b.32944; Pei ZJ, 2012, NUCL MED BIOL, V39, P813, DOI 10.1016/j.nucmedbio.2011.12.014; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Peng LY, 2008, STEM CELLS DEV, V17, P761, DOI 10.1089/scd.2007.0217; Pierini M, 2012, CYTOTHERAPY, V14, P686, DOI 10.3109/14653249.2012.677821; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rouger K, 2007, J HISTOCHEM CYTOCHEM, V55, P607, DOI 10.1369/jhc.6A6954.2007; Sakaguchi Y, 2005, ARTHRITIS RHEUM-US, V52, P2521, DOI 10.1002/art.21212; Savarino L, 2007, BIOMATERIALS, V28, P3101, DOI 10.1016/j.biomaterials.2007.03.011; Shi YY, 2005, PLAST RECONSTR SURG, V116, P1686, DOI 10.1097/01.prs.0000185606.03222.a9; Siegel G, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-146; Trivisonno A, 2014, AESTHET SURG J, V34, P601, DOI 10.1177/1090820X14528000; Tuan RS, 2003, ARTHRITIS RES THER, V5, P32, DOI 10.1186/ar614; Valorani MG, 2012, CELL PROLIFERAT, V45, P225, DOI 10.1111/j.1365-2184.2012.00817.x; van Harmelen V, 2004, METABOLISM, V53, P632, DOI 10.1016/j.metabol.2003.11.012; Vidal MA, 2012, STEM CELLS DEV, V21, P273, DOI 10.1089/scd.2010.0589; Winter A, 2003, ARTHRITIS RHEUM-US, V48, P418, DOI 10.1002/art.10767; Wu W, 2013, PLAST RECONSTR SURG, V131, P27, DOI 10.1097/PRS.0b013e3182729cfc; Yu JM, 2011, AGING CELL, V10, P66, DOI 10.1111/j.1474-9726.2010.00646.x; Yukata K, 2014, BONE, V62, P79, DOI 10.1016/j.bone.2014.02.002; Zhang WD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088794; Zheng HJ, 2007, J GERONTOL A-BIOL, V62, P136, DOI 10.1093/gerona/62.2.136; Zhou S, 2008, AGING CELL, V7, P335, DOI 10.1111/j.1474-9726.2008.00377.x; Zhu M, 2009, J TISSUE ENG REGEN M, V3, P290, DOI 10.1002/term.165; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	65	204	211	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115963	10.1371/journal.pone.0115963	http://dx.doi.org/10.1371/journal.pone.0115963			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541697	Green Submitted, Green Published, gold			2022-12-27	WOS:000347239900118
J	Chen, YX; Xu, FQ				Chen, Yi-Xiang; Xu, Fang-Qian			Higher Dimensional Gaussian-Type Solitons of Nonlinear Schrodinger Equation with Cubic and Power-Law Nonlinearities in PT-Symmetric Potentials	PLOS ONE			English	Article							WAVES	Two families of Gaussian-type soliton solutions of the (n+1)-dimensional Schrodinger equation with cubic and power-law nonlinearities in PT-symmetric potentials are analytically derived. As an example, we discuss some dynamical behaviors of two dimensional soliton solutions. Their phase switches, powers and transverse power-flow densities are discussed. Results imply that the powers flow and exchange from the gain toward the loss regions in the PT cell. Moreover, the linear stability analysis and the direct numerical simulation are carried out, which indicates that spatial Gaussian-type soliton solutions are stable below some thresholds for the imaginary part of PT-symmetric potentials in the defocusing cubic and focusing power-law nonlinear medium, while they are always unstable for all parameters in other media.	[Chen, Yi-Xiang; Xu, Fang-Qian] Zhejiang Univ Media & Commun, Sch Elect Informat, Hangzhou 310018, Zhejiang, Peoples R China	Communication University of Zhejiang	Chen, YX (corresponding author), Zhejiang Univ Media & Commun, Sch Elect Informat, Hangzhou 310018, Zhejiang, Peoples R China.	chenyix1979@126.com			Zhejiang Province welfare project [2014C32006]; Special Foundation for theoretical physics Research Program of China [11447124]	Zhejiang Province welfare project; Special Foundation for theoretical physics Research Program of China	This work was supported by Zhejiang Province welfare project (Grant No. 2014C32006) and the Special Foundation for theoretical physics Research Program of China (Grant No. 11447124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bender CM, 1998, PHYS REV LETT, V80, P5243, DOI 10.1103/PhysRevLett.80.5243; Biswas A, 2013, NONLINEAR DYNAM, V73, P2191, DOI 10.1007/s11071-013-0933-5; Bronski JC, 2001, PHYS REV LETT, V86, P1402, DOI 10.1103/PhysRevLett.86.1402; Dai CQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100484; Dai CQ, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.013834; Dai CQ, 2014, OPT COMMUN, V315, P303, DOI 10.1016/j.optcom.2013.11.030; Dai CQ, 2014, ANN PHYS-NEW YORK, V341, P142, DOI 10.1016/j.aop.2013.11.015; Dai CQ, 2013, J OPT SOC AM B, V30, P3291, DOI 10.1364/JOSAB.30.003291; Dai CQ, 2012, NONLINEAR DYNAM, V70, P189, DOI 10.1007/s11071-012-0441-z; Dai CQ, 2010, OPT LETT, V35, P1437, DOI 10.1364/OL.35.001437; El-Ganainy R, 2007, OPT LETT, V32, P2632, DOI 10.1364/OL.32.002632; Guo A, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.093902; Lederer F, 2008, PHYS REP, V463, P1, DOI 10.1016/j.physrep.2008.04.004; Liu WJ, 2013, LASER PHYS, V23, DOI 10.1088/1054-660X/23/9/095401; Makris KG, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.103904; Midya B, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.045803; Musslimani ZH, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.030402; Naher H., 2012, APPL MATH, V3, P1144, DOI [10.4236/am.2012.310168, DOI 10.4236/AM.2012.310168]; Naher H., 2012, APPL MATH SCI, V6, P5495; Naher H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064618; Naher H, 2013, AIP ADV, V3, DOI 10.1063/1.4794947; Serkin VN, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.074102; Wang YY, 2013, NONLINEAR DYNAM, V74, P429, DOI 10.1007/s11071-013-0980-y; Weise LD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021934; Yang J, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021128, 10.1371/journal.pone.0024111]; Zhong WP, 2012, NONLINEAR DYNAM, V70, P2027, DOI 10.1007/s11071-012-0594-9; Zhu HP, 2013, NONLINEAR DYNAM, V72, P873, DOI 10.1007/s11071-013-0759-1	27	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115935	10.1371/journal.pone.0115935	http://dx.doi.org/10.1371/journal.pone.0115935			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542020	Green Published, Green Submitted, gold			2022-12-27	WOS:000347239900111
J	da Costa, PB; Granada, CE; Ambrosini, A; Moreira, F; de Souza, R; dos Passos, JFM; Arruda, L; Passaglia, LMP				da Costa, Pedro Beschoren; Granada, Camille E.; Ambrosini, Adriana; Moreira, Fernanda; de Souza, Rocheli; dos Passos, Joao Frederico M.; Arruda, Leticia; Passaglia, Luciane M. P.			A Model to Explain Plant Growth Promotion Traits: A Multivariate Analysis of 2,211 Bacterial Isolates	PLOS ONE			English	Article							PHOSPHATE SOLUBILIZATION; SOIL; NITROGEN; RHIZOBACTERIA; RHIZOSPHERE; DIVERSITY; SIDEROPHORES; PHOSPHORUS; ACID; BIOSYNTHESIS	Plant growth-promoting bacteria can greatly assist sustainable farming by improving plant health and biomass while reducing fertilizer use. The plantmicroorganism- environment interaction is an open and complex system, and despite the active research in the area, patterns in root ecology are elusive. Here, we simultaneously analyzed the plant growth-promoting bacteria datasets from seven independent studies that shared a methodology for bioprospection and phenotype screening. The soil richness of the isolate's origin was classified by a Principal Component Analysis. A Categorical Principal Component Analysis was used to classify the soil richness according to isolate's indolic compound production, siderophores production and phosphate solubilization abilities, and bacterial genera composition. Multiple patterns and relationships were found and verified with nonparametric hypothesis testing. Including niche colonization in the analysis, we proposed a model to explain the expression of bacterial plant growthpromoting traits according to the soil nutritional status. Our model shows that plants favor interaction with growth hormone producers under rich nutrient conditions but favor nutrient solubilizers under poor conditions. We also performed several comparisons among the different genera, highlighting interesting ecological interactions and limitations. Our model could be used to direct plant growthpromoting bacteria bioprospection and metagenomic sampling.	[da Costa, Pedro Beschoren; Ambrosini, Adriana; Moreira, Fernanda; de Souza, Rocheli; dos Passos, Joao Frederico M.; Arruda, Leticia; Passaglia, Luciane M. P.] Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Genet, BR-90049 Porto Alegre, RS, Brazil; [Granada, Camille E.] UNIVATES, Lajeado, RS, Brazil; [dos Passos, Joao Frederico M.] Empresa Pesquisa & Extensao Agr Santa Catarina EP, Lages, SC, Brazil	Universidade Federal do Rio Grande do Sul; Universidade do Vale do Taquari	Passaglia, LMP (corresponding author), Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Genet, BR-90049 Porto Alegre, RS, Brazil.	luciane.passaglia@ufrgs.br	Ambrosini, Adriana/I-9140-2016; Granada, Camille E./N-6088-2018; Passaglia, Luciane M. P./L-1542-2015	Ambrosini, Adriana/0000-0003-2545-3332; 	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq/ Brazil); Coordenacao de Aperfeic, oamento de Pessoal de Nivel Superior (CAPES/Brazil); Instituto Nacional de Ciencia e Tecnologia (INCT) da Fixacao Biologica do Nitrogenio (Brazil)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq/ Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeic, oamento de Pessoal de Nivel Superior (CAPES/Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Instituto Nacional de Ciencia e Tecnologia (INCT) da Fixacao Biologica do Nitrogenio (Brazil)	This work was financed by a grant and fellowships from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq/ Brazil), Coordenacao de Aperfeic, oamento de Pessoal de Nivel Superior (CAPES/Brazil) and Instituto Nacional de Ciencia e Tecnologia (INCT) da Fixacao Biologica do Nitrogenio (Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesemoye AO, 2009, APPL MICROBIOL BIOT, V85, P1, DOI 10.1007/s00253-009-2196-0; Ahemad Munees, 2014, Journal of King Saud University Science, V26, P1, DOI 10.1016/j.jksus.2013.05.001; Ambrosini A, 2012, PLANT SOIL, V356, P245, DOI 10.1007/s11104-011-1079-1; Anandham R, 2008, RES MICROBIOL, V159, P579, DOI 10.1016/j.resmic.2008.08.007; Arruda L, 2013, APPL SOIL ECOL, V63, P15, DOI 10.1016/j.apsoil.2012.09.001; BAATH E, 1989, WATER AIR SOIL POLL, V47, P335, DOI 10.1007/BF00279331; Babalola OO, 2010, BIOTECHNOL LETT, V32, P1559, DOI 10.1007/s10529-010-0347-0; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Baptista IIR, 2008, BIOTECHNOL BIOENG, V99, P68, DOI 10.1002/bit.21576; Barraquio WL, 2000, QUEST NITROGEN FIXAT, P93; Bashan Y, 2013, BIOL FERT SOILS, V49, P465, DOI 10.1007/s00374-012-0737-7; Bellenger JP, 2008, NAT GEOSCI, V1, P243, DOI 10.1038/ngeo161; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bianco C, 2010, APPL ENVIRON MICROB, V76, P4626, DOI 10.1128/AEM.02756-09; Boddey RM, 2003, PLANT SOIL, V252, P139, DOI 10.1023/A:1024152126541; Chaiharn M, 2011, CURR MICROBIOL, V62, P173, DOI 10.1007/s00284-010-9674-6; Chen CY, 2009, J HAZARD MATER, V172, P1439, DOI 10.1016/j.jhazmat.2009.08.009; Coenye T, 2003, ENVIRON MICROBIOL, V5, P719, DOI 10.1046/j.1462-2920.2003.00471.x; da Costa PB, 2013, PLANT SOIL, V368, P267, DOI 10.1007/s11104-012-1513-z; de Souza R, 2013, PLANT SOIL, V366, P585, DOI 10.1007/s11104-012-1430-1; Dixon R, 2004, NAT REV MICROBIOL, V2, P621, DOI 10.1038/nrmicro954; DOBEREINER J, 1988, PLANT SOIL, V110, P207, DOI 10.1007/BF02226800; dos Passos JFM, 2014, GENET MOL BIOL, V37, P560, DOI 10.1590/S1415-47572014000400013; Emmerling C, 2002, J PLANT NUTR SOIL SC, V165, P408, DOI 10.1002/1522-2624(200208)165:4<408::AID-JPLN408>3.0.CO;2-3; Estrada GA, 2013, PLANT SOIL, V369, P115, DOI 10.1007/s11104-012-1550-7; GLICKMANN E, 1995, APPL ENVIRON MICROB, V61, P793, DOI 10.1128/AEM.61.2.793-796.1995; Good AG, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001124; Granada C, 2013, PLANT SOIL, V373, P339, DOI 10.1007/s11104-013-1796-8; Gray EJ, 2005, SOIL BIOL BIOCHEM, V37, P395, DOI 10.1016/j.soilbio.2004.08.030; GUERINOT ML, 1994, ANNU REV MICROBIOL, V48, P743, DOI 10.1146/annurev.micro.48.1.743; Han-Jen RE, 2013, SENSORS-BASEL, V13, P14121, DOI 10.3390/s131014121; Hartmann A, 2009, PLANT SOIL, V321, P235, DOI 10.1007/s11104-008-9814-y; Hayat R, 2010, ANN MICROBIOL, V60, P579, DOI 10.1007/s13213-010-0117-1; He ZL, 2010, ECOL LETT, V13, P564, DOI 10.1111/j.1461-0248.2010.01453.x; Hernlem BJ, 1999, WATER RES, V33, P951, DOI 10.1016/S0043-1354(98)00293-0; Hu JL, 2009, PEDOBIOLOGIA, V53, P49, DOI 10.1016/j.pedobi.2009.02.002; Jakobsen I., 2005, Phosphorus: agriculture and the environment, P437; JAYACHANDRAN K, 1989, SOIL SCI SOC AM J, V53, P1701, DOI 10.2136/sssaj1989.03615995005300060015x; Khalid A, 2004, AUST J SOIL RES, V42, P921, DOI 10.1071/SR04019; Kidd PS, 2008, PLANT SOIL, V302, P233, DOI 10.1007/s11104-007-9475-2; Kraepiel AML, 2009, BIOMETALS, V22, P573, DOI 10.1007/s10534-009-9222-7; Kuklinsky-Sobral J, 2004, ENVIRON MICROBIOL, V6, P1244, DOI 10.1111/j.1462-2920.2004.00658.x; Kunito T, 2012, ANN MICROBIOL, V62, P1339, DOI 10.1007/s13213-011-0393-4; Kuo S., 1996, Methods of soil analysis. Part 3 - chemical methods., P869; Lin TF, 2006, BIORESOURCE TECHNOL, V97, P957, DOI 10.1016/j.biortech.2005.02.017; Marasco R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048479; Marinari S, 2006, ECOL INDIC, V6, P701, DOI 10.1016/j.ecolind.2005.08.029; Mark GL, 2005, P NATL ACAD SCI USA, V102, P17454, DOI 10.1073/pnas.0506407102; Martinez-Viveros O, 2010, J SOIL SCI PLANT NUT, V10, P293, DOI 10.4067/S0718-95162010000100006; Matsuoka H, 2013, CURR MICROBIOL, V66, P314, DOI 10.1007/s00284-012-0276-3; Miransari M, 2011, APPL MICROBIOL BIOT, V92, P875, DOI 10.1007/s00253-011-3521-y; Neubauer U, 2000, ENVIRON SCI TECHNOL, V34, P2749, DOI 10.1021/es990495w; Nusslein K, 1999, APPL ENVIRON MICROB, V65, P3622; Ona O, 2005, FEMS MICROBIOL LETT, V246, P125, DOI 10.1016/j.femsle.2005.03.048; Parke JL, 2001, ANNU REV PHYTOPATHOL, V39, P225, DOI 10.1146/annurev.phyto.39.1.225; Rajkumar M, 2010, TRENDS BIOTECHNOL, V28, P142, DOI 10.1016/j.tibtech.2009.12.002; Rajkumar M, 2009, CHEMOSPHERE, V77, P153, DOI 10.1016/j.chemosphere.2009.06.047; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; Ramette A, 2009, ENV MICROBIOL REP, V1, P3, DOI 10.1111/j.1758-2229.2008.00010.x; Richardson AE, 2009, PLANT SOIL, V321, P305, DOI 10.1007/s11104-009-9895-2; Schalk IJ, 2011, ENVIRON MICROBIOL, V13, P2844, DOI 10.1111/j.1462-2920.2011.02556.x; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Sergeeva E, 2007, PLANT SOIL, V297, P1, DOI 10.1007/s11104-007-9314-5; Simpson RJ, 2011, PLANT SOIL, V349, P89, DOI 10.1007/s11104-011-0880-1; Singh JS, 2011, AGR ECOSYST ENVIRON, V140, P339, DOI 10.1016/j.agee.2011.01.017; Spaepen S, 2007, FEMS MICROBIOL REV, V31, P425, DOI 10.1111/j.1574-6976.2007.00072.x; Spaepen Stijn, 2011, Cold Spring Harb Perspect Biol, V3, DOI 10.1101/cshperspect.a001438; SYLVESTER-BRADLEY R, 1982, Acta Amazonica, V12, P15; Wakelin SA, 2004, BIOL FERT SOILS, V40, P36, DOI 10.1007/s00374-004-0750-6; Wakelin SA, 2009, PEDOBIOLOGIA, V52, P237, DOI 10.1016/j.pedobi.2008.10.001; Weyens N, 2009, TRENDS BIOTECHNOL, V27, P591, DOI 10.1016/j.tibtech.2009.07.006; Young LS, 2013, APPL SOIL ECOL, V66, P40, DOI 10.1016/j.apsoil.2013.02.001; Zar J.H., 1996, BIOSTAT ANAL	73	34	36	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e0116020	10.1371/journal.pone.0116020	http://dx.doi.org/10.1371/journal.pone.0116020			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542031	Green Published, gold, Green Submitted			2022-12-27	WOS:000347239900129
J	Huang, HS; Chu, CL; Tsai, CT; Wu, CK; Lai, LP; Yeh, HM				Huang, Ho-Shiang; Chu, Chun-Lin; Tsai, Chia-Ti; Wu, Cho-Kai; Lai, Ling-Ping; Yeh, Huei-Ming			Perfusion Index Derived from a Pulse Oximeter Can Detect Changes in Peripheral Microcirculation during Uretero-Renal-Scopy Stone Manipulation (URS-SM)	PLOS ONE			English	Article							PLETH VARIABILITY INDEX; PREDICT FLUID RESPONSIVENESS; GLOMERULAR-FILTRATION-RATE; OBSTRUCTION; ANESTHESIA; HYPOTENSION; INDICATOR; MORTALITY; PRESSURE; EQUATION	Background: The objective of this study was to test the effect of removal of a ureteral obstruction (renal calculus) from anesthetized patients on the perfusion index (PI), as measured by a pulse oximeter, and on the estimated glomerular filtration rate (eGFR). Patients and Methods: This prospective study enrolled 113 patients with unilateral ureteral obstructions (kidney stones) who were scheduled for ureteroscopy (URS) laser lithotripsy. One urologist graded patient hydronephrosis before surgery. A pulse oximeter was affixed to each patient's index finger ipsilateral to the intravenous catheter, and a non-invasive blood pressure cuff was placed on the contralateral side. Ipsilateral double J stents and Foley catheters were inserted and left indwelling for 24 h. PI and mean arterial pressure (MAP) were determined at baseline, 5 min after anesthesia, and 10 min after surgery; eGFR was determined at admission, 1 day after surgery, and 14 days after surgery. Results: Patients with different grades of hydronephrosis had similar age, eGFR, PI, mean arterial pressure (MAP), and heart rate (HR). PI increased significantly in each hydronephrosis group after ureteral stone disintegration. None of the groups had significant post-URS changes in eGFR, although eGFR increased in the grade I hydronephrosis group after 14 days. The percent change of PI correlates significantly with the percent change of MAP, but not with that of eGFR. Conclusion: Our results demonstrate that release of a ureteral obstruction leads to a concurrent increase of PI during anesthesia. Measurement of PI may be a valuable tool to monitor the successful release of ureteral obstructions and changes of microcirculation during surgery. There were also increases in eGFR after 14 days, but not immediately after surgery.	[Huang, Ho-Shiang] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Urol, Tainan 70101, Taiwan; [Chu, Chun-Lin] Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan; [Chu, Chun-Lin] Natl Taiwan Univ Hosp, Dept Anesthesiol, Yun Lin Branch, Yunlin, Taiwan; [Tsai, Chia-Ti; Wu, Cho-Kai; Lai, Ling-Ping] Natl Taiwan Univ Hosp, Dept Cardiol, Div Cardiol, Taipei, Taiwan; [Tsai, Chia-Ti; Wu, Cho-Kai; Lai, Ling-Ping] Natl Taiwan Univ Hosp, Dept Cardiol, Div Cardiol, Yunlin, Taiwan; [Yeh, Huei-Ming] Natl Taiwan Univ Hosp, Dept Anesthesiol, Taipei, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Tsai, CT (corresponding author), Natl Taiwan Univ Hosp, Dept Cardiol, Div Cardiol, Taipei, Taiwan.	cttsai@ntuh.gov.tw; y.y.hhmm@hotmail.com		Chu, Chun-Lin/0000-0001-9122-4437; LAI, LING-PING/0000-0002-9651-7420; TSAI, CHIA-TI/0000-0002-4853-8665; Yeh, Huei-Ming/0000-0003-0077-3284; WU, CHO-KAI/0000-0002-3867-150X				Atef HM, 2013, INDIAN J ANAESTH, V57, P156, DOI 10.4103/0019-5049.111843; Auer J, 2001, CIRCULATION, V104, pE100; Broch O, 2011, ACTA ANAESTH SCAND, V55, P686, DOI 10.1111/j.1399-6576.2011.02435.x; Chalisey A, 2013, J GEN INTERN MED, V28, P478, DOI 10.1007/s11606-012-2183-5; Devarajan P, 2008, SCAND J CLIN LAB INV, V68, P89, DOI 10.1080/00365510802150158; Ginosar Y, 2009, ACTA ANAESTH SCAND, V53, P1018, DOI 10.1111/j.1399-6576.2009.01968.x; Goertz JK, 2010, AM J EMERG MED, V28, P813, DOI 10.1016/j.ajem.2009.06.028; HARRIS KPG, 1991, EUR J CLIN INVEST, V21, P339, DOI 10.1111/j.1365-2362.1991.tb01379.x; HARRIS RH, 1974, AM J PHYSIOL, V227, P806, DOI 10.1152/ajplegacy.1974.227.4.806; He HW, 2013, CRIT CARE, V17, DOI 10.1186/cc12788; Hood JA, 2011, ANESTH ANALG, V113, P1058, DOI 10.1213/ANE.0b013e31822c10cd; Huang HS, 2006, KIDNEY INT, V70, P699, DOI 10.1038/sj.ki.5001651; Huang S, 2009, AM J PHYSIOL-RENAL, V296, pF34, DOI 10.1152/ajprenal.90309.2008; Kuroki C, 2013, J ANESTH; Kus A, 2013, J CLIN MONIT COMPUT, V27, P325, DOI 10.1007/s10877-013-9439-4; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lima A, 2012, INTENS CARE MED, V38, P606, DOI 10.1007/s00134-012-2486-3; Ma MC, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341008; Monnet X, 2013, BRIT J ANAESTH, V110, P207, DOI 10.1093/bja/aes373; Mousa Wesam Farid, 2013, Saudi J Anaesth, V7, P234, DOI 10.4103/1658-354X.115317; Mowafi HA, 2009, ANESTH ANALG, V108, P549, DOI 10.1213/ane.0b013e31818fc35b; Otani Y, 2013, INTERNAL MED, V52, P2417, DOI 10.2169/internalmedicine.52.0410; Takeyama M, 2011, J CLIN MONIT COMPUT, V25, P215, DOI 10.1007/s10877-011-9298-9; Toyama S, 2013, BRIT J ANAESTH, V111, P235, DOI 10.1093/bja/aet058; Tsuchiya M, 2010, ACTA ANAESTH SCAND, V54, P596, DOI 10.1111/j.1399-6576.2010.02225.x; Turek Z, 2009, SEMIN CARDIOTHORAC V, V13, P249, DOI 10.1177/1089253209353134; van Genderen Michel E, 2013, Ned Tijdschr Geneeskd, V157, pA5338; van Genderen ME, 2012, CURR OPIN CRIT CARE, V18, P273, DOI 10.1097/MCC.0b013e3283533924; Yamazaki H, 2012, LOCAL REG ANESTH, V5, P9, DOI 10.2147/LRA.S30257	30	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115743	10.1371/journal.pone.0115743	http://dx.doi.org/10.1371/journal.pone.0115743			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542000	gold, Green Submitted, Green Published			2022-12-27	WOS:000347239900075
J	Li, ZL; Cai, L; Liang, XL; Du, ZM; Chen, YH; An, SL; Tan, N; Xu, LX; Li, RZ; Li, LW; Shi, W				Li, Zhilian; Cai, Lu; Liang, Xinling; Du, Zhiming; Chen, Yuanhan; An, Shengli; Tan, Ning; Xu, Lixia; Li, Ruizhao; Li, Liwen; Shi, Wei			Identification and Predicting Short-Term Prognosis of Early Cardiorenal Syndrome Type 1: KDIGO Is Superior to RIFLE or AKIN	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; DECOMPENSATED HEART-FAILURE; WORSENING RENAL-FUNCTION; SERUM CREATININE; CONSENSUS CONFERENCE; OUTCOMES; CLASSIFICATION; IMPACT; DEFINITIONS; MORTALITY	Objective: Acute kidney injury (AKI) in patients hospitalized for acute heart failure (AHF) is usually type 1 of the cardiorenal syndrome (CRS) and has been associated with increased morbidity and mortality. Early recognition of AKI is critical. This study was to determine if the new KDIGO criteria (Kidney Disease: Improving Global Outcomes) for identification and short-term prognosis of early CRS type 1 was superior to the previous RIFLE and AKIN criteria. Methods: The association between AKI diagnosed by KDIGO but not by RIFLE or AKIN and in-hospital mortality was retrospectively evaluated in 1005 Chinese adult patients with AHF between July 2008 and May 2012. AKI was defined as RIFLE, AKIN and KDIGO criteria, respectively. Cox regression was used for multivariate analysis of in-hospital mortality. Results: Within 7 days on admission, the incidence of CRS type 1 was 38.9% by KDIGO criteria, 34.7% by AKIN, and 32.1% by RIFLE. A total of 110 (10.9%) cases were additional diagnosed by KDIGO criteria but not by RIFLE or AKIN. 89.1% of them were in Stage 1 (AKIN) or Stage Risk (RIFLE). They accounted for 18.4% (25 cases) of the overall death. After adjustment, this proportion remained an independent risk factor for in-hospital mortality [odds ratios (OR) 3.24, 95% confidence interval(95% CI) 1.97-5.35]. Kaplan-Meier curve showed AKI patients by RIFLE, AKIN, KDIGO and [K(+) R(-)+K(+)A(-)] had lower hospital survival than non-AKI patients (Log Rank P<0.001). Conclusion: KDIGO criteria identified significantly more CRS type 1 episodes than RIFLE or AKIN. AKI missed diagnosed by RIFLE or AKIN criteria was an independent risk factor for in-hospital mortality, indicating the new KDIGO criteria was superior to RIFLE and AKIN in predicting short-term outcomes in early CRS type 1.	[Li, Zhilian; Liang, Xinling; Chen, Yuanhan; Xu, Lixia; Li, Ruizhao; Shi, Wei] Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Nephrol, Guangzhou, Guangdong, Peoples R China; [Cai, Lu] Huzhou Cent Hosp, Dept Nephrol, Huzhou, Peoples R China; [Liang, Xinling; An, Shengli] Southern Med Univ, Dept Biostat, Guangzhou, Guangdong, Peoples R China; [Du, Zhiming] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Cardiol, Guangzhou 510275, Guangdong, Peoples R China; [Tan, Ning; Li, Liwen] Guangdong Cardiovasc Inst, Guangdong Gen Hosp, Dept Cardiol, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Medical Sciences & Guangdong General Hospital; Huzhou University; Southern Medical University - China; Sun Yat Sen University; Guangdong Academy of Medical Sciences & Guangdong General Hospital	Liang, XL (corresponding author), Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Nephrol, Guangzhou, Guangdong, Peoples R China.	xinlingliang_ggh@163.com		liang, Xinling/0000-0002-6764-9571	National Natural Science Foundation [81170683, 81200544]; Science and Technique Project of Guangzhou City [2013J4100064]; National Key Technology RD Program [2011BAI10B08]; National Clinical Key Specialty Construction Preparatory Projects, China	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Science and Technique Project of Guangzhou City; National Key Technology RD Program(National Key Technology R&D Program); National Clinical Key Specialty Construction Preparatory Projects, China	This study was supported by grants from the National Natural Science Foundation (81170683 and 81200544), the Science and Technique Project of Guangzhou City (2013J4100064), the National Key Technology R&D Program (2011BAI10B08), and the National Clinical Key Specialty Construction Preparatory Projects, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagshaw SM, 2009, NEPHROL DIAL TRANSPL, V24, P2739, DOI 10.1093/ndt/gfp159; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Belziti CA, 2010, REV ESP CARDIOL, V63, P294, DOI 10.1016/S0300-8932(10)70088-9; Chen YC, 2009, SHOCK, V31, P139, DOI 10.1097/SHK.0b013e31817d419e; Cowie MR, 2006, EUR HEART J, V27, P1216, DOI 10.1093/eurheartj/ehi859; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Goldberg A, 2005, AM HEART J, V150, P330, DOI 10.1016/j.ahj.2004.09.055; Haase M, 2013, CONTRIB NEPHROL, V182, P99, DOI 10.1159/000349969; Haase M, 2009, J THORAC CARDIOV SUR, V138, P1370, DOI 10.1016/j.jtcvs.2009.07.007; Hata N, 2010, EUR J HEART FAIL, V12, P32, DOI 10.1093/eurjhf/hfp169; Hsu CY, 2007, KIDNEY INT, V72, P208, DOI 10.1038/sj.ki.5002297; Ismail Y, 2012, SEMIN NEPHROL, V32, P18, DOI 10.1016/j.semnephrol.2011.11.003; Joannidis M, 2009, INTENS CARE MED, V35, P1692, DOI 10.1007/s00134-009-1530-4; Lafrance JP, 2010, AM J KIDNEY DIS, V56, P651, DOI 10.1053/j.ajkd.2010.05.011; Lameire Norbert, 2013, Arab J Nephrol Transplant, V6, P145; Lassnigg A, 2004, J AM SOC NEPHROL, V15, P1597, DOI 10.1097/01.ASN.0000130340.93930.DD; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lopes JA, 2008, CRIT CARE, V12, DOI 10.1186/cc6997; McAlister FA, 2004, CIRCULATION, V109, P1004, DOI 10.1161/01.CIR.0000116764.53225.A9; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Metra M, 2008, EUR J HEART FAIL, V10, P188, DOI 10.1016/j.ejheart.2008.01.011; Nohria A, 2008, J AM COLL CARDIOL, V51, P1268, DOI 10.1016/j.jacc.2007.08.072; Ostermann M, 2011, QJM-INT J MED, V104, P237, DOI 10.1093/qjmed/hcq185; Parikh CR, 2008, ARCH INTERN MED, V168, P987, DOI 10.1001/archinte.168.9.987; Praught ML, 2005, CURR OPIN NEPHROL HY, V14, P265, DOI 10.1097/01.mnh.0000165894.90748.72; Rodrigues FB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069998; Ronco C, 2013, LANCET, V382, P939, DOI 10.1016/S0140-6736(13)61932-7; Ronco C, 2012, J AM COLL CARDIOL, V60, P1031, DOI 10.1016/j.jacc.2012.01.077; Roy AK, 2013, CARDIORENAL MED, V3, P26, DOI 10.1159/000347037; Sampaio MC, 2013, ARQ BRAS CARDIOL, V101, P18, DOI 10.5935/abc.20130115; Shirakabe A, 2012, INT HEART J, V53, P313, DOI 10.1536/ihj.53.313; Siew ED, 2012, CLIN J AM SOC NEPHRO, V7, P712, DOI 10.2215/CJN.10821011; Siew ED, 2010, KIDNEY INT, V77, P536, DOI 10.1038/ki.2009.479; Zeng XX, 2014, CLIN J AM SOC NEPHRO, V9, P12, DOI 10.2215/CJN.02730313; Zhou QG, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-51	36	25	25	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e114369	10.1371/journal.pone.0114369	http://dx.doi.org/10.1371/journal.pone.0114369			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542014	Green Published, gold, Green Submitted			2022-12-27	WOS:000347239900009
J	Liao, LS; Cheng, YY; Liu, SY; Zhou, JN; An, SW; Lv, MF; Chen, YF; Gu, YF; Chen, SH; Zhang, LH				Liao, Lisheng; Cheng, Yingying; Liu, Shiyin; Zhou, Jianuan; An, Shuwen; Lv, Mingfa; Chen, Yufan; Gu, Yanfang; Chen, Shaohua; Zhang, Lian-Hui			Production of Novel Antibiotics Zeamines through Optimizing Dickeya zeae Fermentation Conditions	PLOS ONE			English	Article							RESPONSE-SURFACE METHODOLOGY; ERWINIA-CHRYSANTHEMI; SIGNAL MOLECULE; SUCROSE; OPTIMIZATION; ORGANIZATION; VIRULENCE; BACTERIA; SYNTHASE; STRAIN	Dickeya zeae strain EC1 was recently shown to produce a new type of phytotoxins designated as zeamine and zeamine II, which are potent wide-spectrum antibiotics against Gram-positive and Gram-negative bacterial pathogens, suggesting their promising potential as clinical medicines. In this study, the optimized medium composition and culture conditions for biosynthesis of novel antibiotics zeamines have been established by using response surface methodology, largely increasing the yield of zeamines from original about 7.35 mu g.mL(-1) in minimal medium to about 150 mu g.mL(-1) in LS5 medium. The study identified the major factors contributing to zeamines production, which include nitrate, sucrose, asparaginate, mineral elements Mg2+ and K+, and optimized amount of phosphate. In addition, the results showed that overexpression of zmsK in D. zeae strain EC1 could further increase zeamines yield to about 180 mu g.mL(-1) in LS5 medium. The findings from this study could facilitate further characterization and utilization of these two novel antibiotics, and also provide useful clues for understanding the regulatory mechanisms that govern D. zeae virulence.	[Liao, Lisheng; Cheng, Yingying; Liu, Shiyin; Zhou, Jianuan; Lv, Mingfa; Chen, Yufan; Gu, Yanfang; Chen, Shaohua; Zhang, Lian-Hui] South China Agr Univ, Coll Nat Resources & Environm, Guangdong Prov Key Lab Microbial Signals & Dis Co, Guangzhou, Guangdong, Peoples R China; [An, Shuwen; Zhang, Lian-Hui] ASTAR, Inst Mol & Cell Biol, Singapore, Singapore; [Zhang, Lian-Hui] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	South China Agricultural University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Chen, SH (corresponding author), South China Agr Univ, Coll Nat Resources & Environm, Guangdong Prov Key Lab Microbial Signals & Dis Co, Guangzhou, Guangdong, Peoples R China.	shchen@scau.edu.cn; lianhui@imcb.a-star.edu.sg	Liu, Shiyin/AAT-4278-2020; Chen, Shaohua/AAQ-9860-2021	Chen, Shaohua/0000-0001-8306-2626; CHEN, YUFAN/0000-0001-9669-7380	National Natural Science Foundation of China [31270170, 31201479]; Joint Research Council, Agency of Science, Technology and Research (A*Star), Singapore [10/03/FG/06/03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Joint Research Council, Agency of Science, Technology and Research (A*Star), Singapore	This work is funded by the National Natural Science Foundation of China (grant number 31270170, 31201479) and the Joint Research Council, Agency of Science, Technology and Research (A*Star), Singapore (grant number 10/03/FG/06/03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bezerra MA, 2008, TALANTA, V76, P965, DOI 10.1016/j.talanta.2008.05.019; Chen SH, 2013, BIORESOURCE TECHNOL, V132, P16, DOI 10.1016/j.biortech.2013.01.002; Chen SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050456; Chen SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030862; Chen SH, 2011, BIORESOURCE TECHNOL, V102, P8110, DOI 10.1016/j.biortech.2011.06.055; Chen SH, 2011, APPL MICROBIOL BIOT, V90, P1471, DOI 10.1007/s00253-011-3136-3; Cheng YY, 2013, MOL PLANT MICROBE IN, V26, P1294, DOI 10.1094/MPMI-04-13-0098-R; Chiou TJ, 1998, P NATL ACAD SCI USA, V95, P4784, DOI 10.1073/pnas.95.8.4784; Dragisic MJ, 2014, PLANT SCI, V223, P49; Gao H, 2009, BIORESOURCE TECHNOL, V100, P4012, DOI 10.1016/j.biortech.2009.03.013; GOTO M, 1979, PHYTOPATHOLOGY, V69, P213, DOI 10.1094/Phyto-69-213; Hussain MBBM, 2008, J BACTERIOL, V190, P1045, DOI 10.1128/JB.01472-07; Kocal N, 2008, PLANT PHYSIOL, V148, P1523, DOI 10.1104/pp.108.127977; Lalonde S, 1999, PLANT CELL, V11, P707, DOI 10.1105/tpc.11.4.707; Liu GQ, 2007, APPL MICROBIOL BIOT, V74, P78, DOI 10.1007/s00253-006-0661-6; Liu SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026825; Livermore D, 2004, NAT REV MICROBIOL, V2, P73, DOI 10.1038/nrmicro798; Masschelein J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054143; Powers JH, 2004, CLIN MICROBIOL INFEC, V10, P23, DOI 10.1111/j.1465-0691.2004.1007.x; RAHME LG, 1992, J BACTERIOL, V174, P3499, DOI 10.1128/JB.174.11.3499-3507.1992; Reid SJ, 2005, APPL MICROBIOL BIOT, V67, P312, DOI 10.1007/s00253-004-1885-y; Taubes G, 2008, SCIENCE, V321, P356, DOI 10.1126/science.321.5887.356; Tognetti JA, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.23316; Wind J, 2010, PHYTOCHEMISTRY, V71, P1610, DOI 10.1016/j.phytochem.2010.07.007; Wu J, 2010, CHEM COMMUN, V46, P333, DOI 10.1039/b916307g; XIAO YX, 1992, J BACTERIOL, V174, P1734, DOI 10.1128/jb.174.6.1734-1741.1992; Yang ZP, 2004, PLANT MOL BIOL, V54, P441, DOI 10.1023/B:PLAN.0000036375.40006.d3; Zhou JU, 2011, MOL PLANT MICROBE IN, V24, P1156, DOI 10.1094/MPMI-04-11-0087	28	21	21	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e116047	10.1371/journal.pone.0116047	http://dx.doi.org/10.1371/journal.pone.0116047			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541733	Green Submitted, gold, Green Published			2022-12-27	WOS:000347239900133
J	Lu, JL; Yan, ZZ; Peng, XY				Lu, Jingli; Yan, Zaizai; Peng, Xiuyun			A New Exponential Ratio-Type Estimator with Linear Combination of Two Auxiliary Variables	PLOS ONE			English	Article								In sample surveys, it is usual to make use of auxiliary information to increase the precision of estimators. We propose a new exponential ratio-type estimator of a finite population mean using linear combination of two auxiliary variables and obtain mean square error (MSE) equation for proposed estimator. We find theoretical conditions that make proposed estimator more efficient than traditional multivariate ratio estimator using information of two auxiliary variables, the estimator of Bahl and Tuteja and the estimator proposed by Abu-Dayeh et al. In addition, we support these theoretical results with the aid of two numerical examples.	[Lu, Jingli; Yan, Zaizai; Peng, Xiuyun] Inner Mongolia Univ Technol, Coll Sci, Hohhot, Inner Mongolia, Peoples R China	Inner Mongolia University of Technology	Lu, JL (corresponding author), Inner Mongolia Univ Technol, Coll Sci, Hohhot, Inner Mongolia, Peoples R China.	lujingli2004@163.com			National Natural Science Foundation of China [11361036, 11461051]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 11361036 and No. 11461051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Dayyeh WA, 2003, APPL MATH COMPUT, V139, P287, DOI 10.1016/S0096-3003(02)00180-7; Al-Omari A.I., 2009, REV INVESTIG OPER, V30, P97; Choudhury S, 2012, ASIAN J MATH STAT, V6; Feng SY, 1998, THEORY METHODS SAMPL; Kadilar C, 2007, HACET J MATH STAT, V36, P181; Lu JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089538; Lu JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081085; Ozgul N, 2014, HACET J MATH STAT, V43, P131; Singh HP, 2007, AUST J STAT, V36, P217; Tuteja R.K., 1991, J INFORM OPTIM SCI, V12, P159, DOI DOI 10.1080/02522667.1991.10699058	10	3	3	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e116124	10.1371/journal.pone.0116124	http://dx.doi.org/10.1371/journal.pone.0116124			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542037	Green Published, gold, Green Submitted			2022-12-27	WOS:000347239900147
J	Perez-Gonzalez, J; Costa, V; Santos, P; Slate, J; Carranza, J; Fernandez-Llario, P; Zsolnai, A; Monteiro, NM; Anton, I; Buzgo, J; Varga, G; Beja-Pereira, A				Perez-Gonzalez, Javier; Costa, Vania; Santos, Pedro; Slate, Jon; Carranza, Juan; Fernandez-Llario, Pedro; Zsolnai, Attila; Monteiro, Nuno M.; Anton, Istvan; Buzgo, Jozsef; Varga, Gyula; Beja-Pereira, Albano			Males and Females Contribute Unequally to Offspring Genetic Diversity in the Polygynandrous Mating System of Wild Boar	PLOS ONE			English	Article							MULTIPLE PATERNITY; PARENTAGE ANALYSIS; SEXUAL SELECTION; REPRODUCTIVE SUCCESS; POPULATION; EVOLUTION; HETEROZYGOSITY; CONSEQUENCES; VARIABILITY; INFERENCE	The maintenance of genetic diversity across generations depends on both the number of reproducing males and females. Variance in reproductive success, multiple paternity and litter size can all affect the relative contributions of male and female parents to genetic variation of progeny. The mating system of the wild boar (Sus scrofa) has been described as polygynous, although evidence of multiple paternity in litters has been found. Using 14 microsatellite markers, we evaluated the contribution of males and females to genetic variation in the next generation in independent wild boar populations from the Iberian Peninsula and Hungary. Genetic contributions of males and females were obtained by distinguishing the paternal and maternal genetic component inherited by the progeny. We found that the paternally inherited genetic component of progeny was more diverse than the maternally inherited component. Simulations showed that this finding might be due to a sampling bias. However, after controlling for the bias by fitting both the genetic diversity in the adult population and the number of reproductive individuals in the models, paternally inherited genotypes remained more diverse than those inherited maternally. Our results suggest new insights into how promiscuous mating systems can help maintain genetic variation.	[Perez-Gonzalez, Javier; Carranza, Juan] Univ Cordoba, CRCP, Ungulate Res Unit, Cordoba, Spain; [Perez-Gonzalez, Javier; Slate, Jon] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Perez-Gonzalez, Javier; Carranza, Juan; Fernandez-Llario, Pedro] Univ Extremadura, Biol & Ethol Unit, Caceres, Spain; [Perez-Gonzalez, Javier] MIMC, Guarderia Rural Mancomunidad Integral Municipios, Calamonte, Spain; [Costa, Vania; Monteiro, Nuno M.; Beja-Pereira, Albano] Univ Porto, CIBIO, Ctr Invest Biodiversidade & Recursos Genet, Vairao, Portugal; [Santos, Pedro] Univ Evora, ICAAM, Evora, Portugal; [Fernandez-Llario, Pedro] Innovac Gest & Conservac Ungulados SL, Caceres, Spain; [Zsolnai, Attila; Anton, Istvan] Res Inst Anim Breeding & Nutr, Herceghalom, Hungary; [Zsolnai, Attila] Univ Kaposvar, Kaposvar, Hungary; [Monteiro, Nuno M.] Univ Fernando Pessoa, Fac Hlth Sci, Ctr Invest Biomed CEBIMED, Oporto, Portugal; [Buzgo, Jozsef; Varga, Gyula] Forest Management & Wood Ind Share Co, SEFAG, Somogyi Erdo Fafeldolgozo Gazdasag, Kaposvar, Hungary	Universidad de Cordoba; University of Sheffield; Universidad de Extremadura; Universidade do Porto; University of Evora; Kaposvar University; Universidade Fernando Pessoa	Perez-Gonzalez, J (corresponding author), Univ Cordoba, CRCP, Ungulate Res Unit, Cordoba, Spain.	jpergon@gmail.com	Zsolnai, Attila/F-6441-2011; Slate, Jon/D-2925-2012; Monteiro, Nuno/A-2900-2009; Carranza, Juan/E-4472-2010; Beja-Pereira, Albano/B-3681-2008; Pérez-González, Javier/AAF-6106-2020; Costa, Vania/L-8074-2013	Zsolnai, Attila/0000-0002-8382-1503; Slate, Jon/0000-0003-3356-5123; Monteiro, Nuno/0000-0001-6994-4673; Beja-Pereira, Albano/0000-0002-1607-7382; Santos, Pedro/0000-0001-7907-5133; Carranza, Juan/0000-0002-0368-7173; Costa, Vania/0000-0001-6032-8321; Perez-Gonzalez, Javier/0000-0003-0624-835X	Innovacion en Gestion y Conservacion de Ungulados S.L.; SEFAG Forest Management and Wood Industry Share Company	Innovacion en Gestion y Conservacion de Ungulados S.L.; SEFAG Forest Management and Wood Industry Share Company	Funding: Co-author Pedro Fernandez-Llario is employed by Innovacion en Gestion y Conservacion de Ungulados S.L. Co-authors Jozsef Buzgo and Gyula Varga are employed by SEFAG Forest Management and Wood Industry Share Company. Innovacion en Gestion y Conservacion de Ungulados S.L. and SEFAG Forest Management and Wood Industry Share Company provided support in the form of salaries for authors PF-L, JB and GV, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Acevedo-Whitehouse K, 2005, MOL ECOL, V14, P3209, DOI 10.1111/j.1365-294X.2005.02656.x; Allendorf F., 2007, CONSERVATION GENETIC; Balloux F, 2003, GENETICS, V165, P2313; Barrete C, 1986, J MAMMAL, V67, P512; BIRKHEAD TR, 1993, J THEOR BIOL, V161, P51, DOI 10.1006/jtbi.1993.1039; Braga C, 2010, EUR J WILDLIFE RES, V56, P465, DOI 10.1007/s10344-010-0373-1; BRITON J, 1994, BIOL CONSERV, V69, P267, DOI 10.1016/0006-3207(94)90426-X; CABALLERO A, 1994, HEREDITY, V73, P657, DOI 10.1038/hdy.1994.174; Carranza J, 1996, AM NAT, V148, P81, DOI 10.1086/285912; Charpentier M, 2005, P NATL ACAD SCI USA, V102, P16723, DOI 10.1073/pnas.0507205102; CHESSER RK, 1991, GENETICS, V127, P437; CLUTTONBROCK TH, 1989, PROC R SOC SER B-BIO, V236, P339, DOI 10.1098/rspb.1989.0027; Costa Vania, 2012, BMC Res Notes, V5, P479, DOI 10.1186/1756-0500-5-479; DARDAILLON M, 1988, Z SAUGETIERKD, V53, P22; DELCROIX I, 1990, J REPROD FERTIL, V89, P613, DOI 10.1530/jrf.0.0890613; Delgado R, 2008, MAMM BIOL, V73, P169, DOI 10.1016/j.mambio.2007.07.008; Delgado-Acevedo J, 2010, WILDLIFE RES, V37, P539, DOI 10.1071/WR10052; DOBSON FS, 1982, ANIM BEHAV, V30, P1183; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Fernandez J, 2006, MOL ECOL, V15, P1657, DOI 10.1111/j.1365-294X.2006.02873.x; Fernandez-Llario P, 2005, J ETHOL, V23, P9, DOI 10.1007/s10164-004-0121-7; Fernandez-Llario P, 1990, MISC ZOOL, V19, P9; Fitzpatrick JL, 2009, BIOL LETTERS, V5, P320, DOI 10.1098/rsbl.2008.0734; Fiumera AC, 2001, GENET RES, V78, P163, DOI 10.1017/S0016672301005237; Griffiths SW, 2001, P ROY SOC B-BIOL SCI, V268, P1293, DOI 10.1098/rspb.2001.1660; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Hampton J, 2004, WILDLIFE RES, V31, P375, DOI 10.1071/WR03099; Hansson B, 2002, MOL ECOL, V11, P2467, DOI 10.1046/j.1365-294X.2002.01644.x; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Jones AG, 2001, P NATL ACAD SCI USA, V98, P9151, DOI 10.1073/pnas.171310198; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Karl SA, 2008, MOL ECOL, V17, P3973, DOI 10.1111/j.1365-294X.2008.03902.x; Lotterhos KE, 2011, EVOLUTION, V65, P1693, DOI 10.1111/j.1558-5646.2011.01249.x; Lowe A., 2004, ECOLOGICAL GENETICS; Martinez M, 2005, BIOL LETTERS, V1, P353, DOI 10.1098/rsbl.2005.0330; McLeod L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006347; Moore JA, 2008, CONSERV GENET, V9, P1243, DOI 10.1007/s10592-007-9452-6; NUNNEY L, 1993, EVOLUTION, V47, P1329, DOI 10.1111/j.1558-5646.1993.tb02158.x; Pearse DE, 2006, CHELONIAN CONSERV BI, V5, P232, DOI 10.2744/1071-8443(2006)5[232:PIAOPO]2.0.CO;2; Pearse DE, 2009, MOL ECOL, V18, P3124, DOI 10.1111/j.1365-294X.2009.04268.x; Perez-Gonzalez J, 2009, MOL ECOL, V18, P1591, DOI 10.1111/j.1365-294X.2009.04150.x; Poteaux C, 2009, J ZOOL, V278, P116, DOI 10.1111/j.1469-7998.2009.00553.x; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2012, R LANG ENV STAT COMP; Sauermann U, 2001, HUM GENET, V108, P249, DOI 10.1007/s004390100485; SCHMIDHEMPEL P, 1994, PHILOS T R SOC B, V346, P313, DOI 10.1098/rstb.1994.0148; Storz JF, 2001, EVOLUTION, V55, P1224; SUGG DW, 1994, GENETICS, V137, P1147; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; WAPLES RS, 1987, COPEIA, P1068, DOI 10.2307/1445580; Wright S, 1931, GENETICS, V16, P0097	52	9	9	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115394	10.1371/journal.pone.0115394	http://dx.doi.org/10.1371/journal.pone.0115394			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541986	Green Published, gold, Green Accepted			2022-12-27	WOS:000347239900038
J	Song, YW; Jiang, J; Vermeren, S; Tong, W				Song, Yiwen; Jiang, Jing; Vermeren, Sonja; Tong, Wei			ARAP3 Functions in Hematopoietic Stem Cells	PLOS ONE			English	Article							ACTIVATING PROTEIN ARAP3; RHO-GTPASES; BONE-MARROW; ARF GAPS; DEPENDENT PROCESSES; ACTIN CYTOSKELETON; PHOSPHATASE SHIP2; LINEAGE ANALYSIS; RAC GTPASES; SAM DOMAIN	ARAP3 is a GTPase-activating protein (GAP) that inactivates Arf6 and RhoA small GTPases. ARAP3 deficiency in mice causes a sprouting angiogenic defect resulting in embryonic lethality by E11. Mice with an ARAP3 R302,303A mutation (Arap3(KI/KI)) that prevents activation by phosphoinositide-3-kinase (PI3K) have a similar angiogenic phenotype, although some animals survive to adulthood. Here, we report that hematopoietic stem cells (HSCs) from rare adult Arap3(KI/KI) bone marrow are compromised in their ability to reconstitute recipient mice and to selfrenew. To elucidate the potential cell-autonomous and non-cell-autonomous roles of ARAP3 in hematopoiesis, we conditionally deleted Arap3 in hematopoietic cells and in several cell types within the HSC niche. Excision of Arap3 in hematopoietic cells using Vav1-Cre does not alter the ability of ARAP3-deficient progenitor cells to proliferate and differentiate in vitro or ARAP3-deficient HSCs to provide multilineage reconstitution and to undergo self-renewal in vivo. Thus, our data suggest that ARAP3 does not play a cell-autonomous role in HSPCs. Deletion of Arap3 in osteoblasts and mesenchymal stromal cells using Prx1-Cre resulted in no discernable phenotypes in hematopoietic development or HSC homeostasis in adult mice. In contrast, deletion of Arap3 using vascular endothelial cadherin (VEC or Cdh5)-driven Cre resulted in embryonic lethality, however HSCs from surviving adult mice were largely normal. Reverse transplantations into VEC-driven Arap3 conditional knockout mice revealed no discernable difference in HSC frequencies or function in comparison to control mice. Taken together, our investigation suggests that despite a critical role for ARAP3 in embryonic vascular development, its loss in endothelial cells minimally impacts HSCs in adult bone marrow.	[Song, Yiwen; Tong, Wei] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Song, Yiwen; Jiang, Jing; Tong, Wei] Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA; [Vermeren, Sonja] Univ Edinburgh, MRC Ctr Inflammat Res, Queens Med Res Inst, Edinburgh EH8 9YL, Midlothian, Scotland	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Edinburgh	Tong, W (corresponding author), Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA.	tongw@email.chop.edu	Vermeren, Sonja/AAK-7442-2020	Vermeren, Sonja/0000-0002-8460-0884; Tong, Wei/0000-0001-9951-2273	National Institutes of Health (NIH) [R01HL095675, R01HL110806, T32-DK007780-09]; Myeloproliferative Neoplasm Research Foundation; Gabrielle's Angel Foundation; Leukemia Lymphoma Society (LLS) Scholar; Biotechnology and Biological Sciences Research Council [BB/C520712]; BBSRC [BBS/E/B/0000M221, BB/C520712/1] Funding Source: UKRI; MRC [G0700740] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C520712/1, BBS/E/B/0000M221] Funding Source: researchfish; Medical Research Council [G0700740] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095675, R01HL110806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007780] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Myeloproliferative Neoplasm Research Foundation; Gabrielle's Angel Foundation; Leukemia Lymphoma Society (LLS) Scholar; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	WT is supported by National Institutes of Health (NIH) grants R01HL095675 and R01HL110806. WT received a New Investigator Award from the Myeloproliferative Neoplasm Research Foundation and Gabrielle's Angel Foundation for Cancer Research, and is a Leukemia Lymphoma Society (LLS) Scholar. YS is supported by NIH training grant T32-DK007780-09. SV is supported by the Biotechnology and Biological Sciences Research Council (BB/C520712). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alva JA, 2006, DEV DYNAM, V235, P759, DOI 10.1002/dvdy.20643; Bersenev A, 2008, J CLIN INVEST, V118, P2832, DOI 10.1172/JCI35808; Bersenev A, 2012, AGING CELL, V11, P949, DOI 10.1111/j.1474-9726.2012.00862.x; Cancelas JA, 2005, NAT MED, V11, P886, DOI 10.1038/nm1274; Cancelas JA, 2006, EXP HEMATOL, V34, P976, DOI 10.1016/j.exphem.2006.03.016; Chae HD, 2008, BLOOD, V111, P2597, DOI 10.1182/blood-2007-06-093237; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Choi W, 2006, BLOOD, V107, P3145, DOI 10.1182/blood-2005-09-3563; Craig HE, 2010, CELL SIGNAL, V22, P257, DOI 10.1016/j.cellsig.2009.09.025; Cuthbert EJ, 2008, AM J PHYSIOL-CELL PH, V294, pC263, DOI 10.1152/ajpcell.00292.2007; del Pozo MA, 1999, EUR J IMMUNOL, V29, P3609; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Dzierzak E, 2008, NAT IMMUNOL, V9, P129, DOI 10.1038/ni1560; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Florian MC, 2012, CELL STEM CELL, V10, P520, DOI 10.1016/j.stem.2012.04.007; Gambardella L, 2013, J IMMUNOL, V190, P381, DOI 10.4049/jimmunol.1201330; Gambardella L, 2011, BLOOD, V118, P1087, DOI 10.1182/blood-2010-10-312959; Gambardella L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001026; Ghiaur G, 2006, BLOOD, V108, P2087, DOI 10.1182/blood-2006-02-001560; Gottig S, 2006, EUR J IMMUNOL, V36, P180, DOI 10.1002/eji.200525607; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Gu Y, 2003, SCIENCE, V302, P445, DOI 10.1126/science.1088485; Guo FK, 2009, BLOOD, V114, P2909, DOI 10.1182/blood-2009-04-214676; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hall A, 2009, CANCER METAST REV, V28, P5, DOI 10.1007/s10555-008-9166-3; Iurlaro M, 2003, J CELL SCI, V116, P3635, DOI 10.1242/jcs.00629; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Jeon CY, 2010, J CELL PHYSIOL, V224, P786, DOI 10.1002/jcp.22184; Kalfa TA, 2010, HAEMATOL-HEMATOL J, V95, P27, DOI 10.3324/haematol.2009.006239; Karlsson R, 2009, BBA-REV CANCER, V1796, P91, DOI 10.1016/j.bbcan.2009.03.003; Kartopawiro J, 2014, HUM MOL GENET, V23, P1286, DOI 10.1093/hmg/ddt518; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Knizhnik AV, 2012, J CELL BIOCHEM, V113, P360, DOI 10.1002/jcb.23362; Kowanetz K, 2004, MOL BIOL CELL, V15, P3155, DOI 10.1091/mbc.E03-09-0683; Krugmann S, 2006, METHOD ENZYMOL, V406, P91, DOI 10.1016/S0076-6879(06)06008-3; Krugmann S, 2006, J CELL SCI, V119, P425, DOI 10.1242/jcs.02755; Krugmann S, 2004, CURR BIOL, V14, P1380, DOI 10.1016/j.cub.2004.07.058; Krugmann S, 2002, MOL CELL, V9, P95, DOI 10.1016/S1097-2765(02)00434-3; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lazer G, 2011, CELL SIGNAL, V23, P969, DOI 10.1016/j.cellsig.2010.10.022; Leko V, 2012, BLOOD, V119, P1856, DOI 10.1182/blood-2011-09-377077; Leone M, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-59; Lu Q, 2004, P NATL ACAD SCI USA, V101, P17246, DOI 10.1073/pnas.0407794101; Mercurio FA, 2013, CHEMBIOCHEM, V14, P100, DOI 10.1002/cbic.201200592; Miura K, 2002, MOL CELL, V9, P109, DOI 10.1016/S1097-2765(02)00428-8; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Mulloy JC, 2010, BLOOD, V115, P936, DOI 10.1182/blood-2009-09-198127; Nandy D, 2010, J CELL MOL MED, V14, P1396, DOI 10.1111/j.1582-4934.2009.00900.x; Nie ZZ, 2006, J CELL SCI, V119, P1203, DOI 10.1242/jcs.02924; Pesesse X, 1998, FEBS LETT, V437, P301, DOI 10.1016/S0014-5793(98)01255-1; Raaijmakers JH, 2007, CELL SIGNAL, V19, P1249, DOI 10.1016/j.cellsig.2006.12.015; Raman R, 2013, LEUKEMIA, V27, P2209, DOI 10.1038/leu.2013.103; Randazzo P A, 2000, Sci STKE, V2000, pre1, DOI 10.1126/stke.2000.59.re1; Randazzo PA, 2004, CELL SIGNAL, V16, P401, DOI 10.1016/j.cellsig.2003.09.012; Randazzo PA, 2007, BIOL CELL, V99, P583, DOI 10.1042/BC20070034; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Schweitzer JK, 2005, EXP CELL RES, V311, P74, DOI 10.1016/j.yexcr.2005.07.033; Singh SK, 2013, J EXP MED, V210, P987, DOI 10.1084/jem.20121608; Stacey TTI, 2004, J CELL SCI, V117, P6071, DOI 10.1242/jcs.01526; Stadtfeld M, 2005, DEVELOPMENT, V132, P203, DOI 10.1242/dev.01558; Tong JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064817; Tossidou I, 2012, MOL CELL BIOL, V32, P1068, DOI 10.1128/MCB.06106-11; Troeger A, 2013, EXP CELL RES, V319, P2375, DOI 10.1016/j.yexcr.2013.07.002; Wang L, 2006, BLOOD, V107, P98, DOI 10.1182/blood-2005-05-2171; Wu B, 2012, J STRUCT BIOL, V180, P84, DOI 10.1016/j.jsb.2012.06.011; Xu HM, 2009, BLOOD, V114, P3557, DOI 10.1182/blood-2009-02-205815; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; Yagi R, 2011, ONCOGENE, V30, P1413, DOI 10.1038/onc.2010.522; Yang L, 2007, BLOOD, V110, P3853, DOI 10.1182/blood-2007-03-079582; Yoon HY, 2006, J CELL SCI, V119, P4650, DOI 10.1242/jcs.03237; Zhang SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033773; Zheng XD, 2014, BMC BIOCHEM, V15, DOI 10.1186/1471-2091-15-13; Zhou X, 2013, J EXP MED, V210, P2371, DOI 10.1084/jem.20122348	76	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e116107	10.1371/journal.pone.0116107	http://dx.doi.org/10.1371/journal.pone.0116107			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542002	Green Published, Green Submitted, gold			2022-12-27	WOS:000347239900144
J	Olsen, PA; Solberg, NT; Lund, K; Vehus, T; Gelazauskaite, M; Wilson, SR; Krauss, S				Olsen, Petter Angell; Solberg, Nina Therese; Lund, Kaja; Vehus, Tore; Gelazauskaite, Monika; Wilson, Steven Ray; Krauss, Stefan			Implications of Targeted Genomic Disruption of beta-Catenin in BxPC-3 Pancreatic Adenocarcinoma Cells	PLOS ONE			English	Article							WNT SIGNALING PATHWAYS; ZINC-FINGER NUCLEASES; GAMMA-CATENIN; PROTEIN INTERACTIONS; ADHERENS JUNCTIONS; P120 CATENIN; CANCER; GENE; EXPRESSION; PLAKOGLOBIN	Pancreatic adenocarcinoma (PA) is among the most aggressive human tumors with an overall 5-year survival rate of <5% and available treatments are only minimal effective. WNT/beta-catenin signaling has been identified as one of 12 core signaling pathways that are commonly mutated in PA. To obtain more insight into the role of WNT/beta-catenin signaling in PA we established human PA cell lines that are deficient of the central canonical WNT signaling protein beta-catenin by using zinc-finger nuclease (ZFN) mediated targeted genomic disruption in the beta-catenin gene (CTNNB1). Five individual CTNNB1 gene disrupted clones (BxPC3 Delta CTNNB1) were established from a BxPC-3 founder cell line. Despite the complete absence of beta-catenin, all clones displayed normal cell cycle distribution profiles, overall normal morphology and no elevated levels of apoptosis although increased doubling times were observed in three of the five BxPC3 Delta CTNNB1 clones. This confirms that WNT/ beta-catenin signaling is not mandatory for long term cell growth and survival in BxPC-3 cells. Despite a normal morphology of the beta-catenin deficient cell lines, quantitative proteomic analysis combined with pathway analysis showed a significant down regulation of proteins implied in cell adhesion combined with an up-regulation of plakoglobin. Treatment of BxPC3 Delta CTNNB1 cell lines with siRNA for plakoglobin induced morphological changes compatible with a deficiency in the formation of functional cell to cell contacts. In addition, a re-localization of E-cadherin from membranous in untreated to accumulation in cytoplasmatic puncta in plakoglobin siRNA treated BxPC3 Delta CTNNB1 cells was observed. In conclusion we describe in beta-catenin deficient BxPC-3 cells a rescue function for plakoglobin on cell to cell contacts and maintaining the localization of E-cadherin at the cellular surface, but not on canonical WNT signaling as measured by TFC/LEF mediated transcription.	[Olsen, Petter Angell; Solberg, Nina Therese; Lund, Kaja; Gelazauskaite, Monika; Krauss, Stefan] Oslo Univ Hosp, Rigshosp, Unit Cell Signaling, Canc Stem Cell Innovat Ctr SFI CAST, Oslo, Norway; [Vehus, Tore; Wilson, Steven Ray] Univ Oslo, Dept Chem, Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo	Olsen, PA (corresponding author), Oslo Univ Hosp, Rigshosp, Unit Cell Signaling, Canc Stem Cell Innovat Ctr SFI CAST, Oslo, Norway.	petter.angell.olsen@rr-research.no	wilson, steven/D-6614-2012; Olsen, Petter Angell/AAO-1378-2020	wilson, steven/0000-0002-9755-1188; Olsen, Petter Angell/0000-0001-6976-5472; Krauss, Stefan/0000-0001-6992-8091	Research Council of Norway [174938/O30, 226290/O30]; Norwegian Cancer Society [2327614]	Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society)	Support was provided by The Research Council of Norway, grant nos. 174938/O30 and 226290/O30 [http://www.forskningsradet.no/en/Home_page/1177315753906] and The Norwegian Cancer Society, grant no. 2327614 [https://kreftforeningen.no/en/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin N, 2012, FRONT BIOSCI-LANDMRK, V17, P784, DOI 10.2741/3957; Arensman MD, 2014, ONCOGENE, V33, P899, DOI 10.1038/onc.2013.23; Boon EMJ, 2002, CANCER RES, V62, P5126; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Choi HJ, 2009, J BIOL CHEM, V284, P31776, DOI 10.1074/jbc.M109.047928; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Deer EL, 2010, PANCREAS, V39, P425, DOI 10.1097/MPA.0b013e3181c15963; di Magliano MP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001155; Doyon Y, 2010, NAT METHODS, V7, P459, DOI [10.1038/NMETH.1456, 10.1038/nmeth.1456]; Dysvik B, 2001, BIOINFORMATICS, V17, P369, DOI 10.1093/bioinformatics/17.4.369; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Fukunaga Y, 2005, CELL STRUCT FUNCT, V30, P25, DOI 10.1247/csf.30.25; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Ghadimi BM, 1999, AM J PATHOL, V154, P525, DOI 10.1016/S0002-9440(10)65298-4; Griffin CA, 2007, CYTOGENET GENOME RES, V118, P148, DOI 10.1159/000108295; HAEGEL H, 1995, DEVELOPMENT, V121, P3529; Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927; HINCK L, 1994, J CELL BIOL, V125, P1327, DOI 10.1083/jcb.125.6.1327; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Keirsebilck A, 1998, GENOMICS, V50, P129, DOI 10.1006/geno.1998.5325; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Kodama S, 1999, J BIOL CHEM, V274, P27682, DOI 10.1074/jbc.274.39.27682; Kruger U, 2007, OLIGONUCLEOTIDES, V17, P237, DOI 10.1089/oli.2006.0065; Li CW, 2011, GASTROENTEROLOGY, V141, P2218, DOI 10.1053/j.gastro.2011.08.009; Li Y, 2011, ONCOGENE, V30, P2633, DOI 10.1038/onc.2010.632; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lyashenko N, 2011, NAT CELL BIOL, V13, P753, DOI 10.1038/ncb2260; Mahendram S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065320; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; McManus MT, 2002, NAT REV GENET, V3, P737, DOI 10.1038/nrg908; Morris JP, 2010, NAT REV CANCER, V10, P683, DOI 10.1038/nrc2899; Olsen PA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-35; Pattanayak V, 2011, NAT METHODS, V8, P765, DOI 10.1038/nmeth.1670; Pieters T, 2012, FRONT BIOSCI-LANDMRK, V17, P1669, DOI 10.2741/4012; Raimondi S, 2009, NAT REV GASTRO HEPAT, V6, P699, DOI 10.1038/nrgastro.2009.177; Rao TP, 2010, CIRC RES, V106, P1798, DOI 10.1161/CIRCRESAHA.110.219840; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; STADDON JM, 1995, J CELL BIOL, V130, P369, DOI 10.1083/jcb.130.2.369; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Wickline ED, 2013, NEOPLASIA, V15, P421, DOI 10.1593/neo.122098; Wickline ED, 2011, J HEPATOL, V55, P1256, DOI 10.1016/j.jhep.2011.03.014; Williams BO, 2000, ONCOGENE, V19, P5720, DOI 10.1038/sj.onc.1203921; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001; Xue YZ, 2013, TUMOR BIOL, V34, P895, DOI 10.1007/s13277-012-0624-8; Zasadil LM, 2013, SEMIN CELL DEV BIOL, V24, P370, DOI 10.1016/j.semcdb.2013.02.001; Zhou JB, 2007, AM J PHYSIOL-HEART C, V292, pH270, DOI 10.1152/ajpheart.00576.2006; Zhurinsky J, 2000, J CELL SCI, V113, P3127	53	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115496	10.1371/journal.pone.0115496	http://dx.doi.org/10.1371/journal.pone.0115496			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536063	Green Published, Green Submitted, gold			2022-12-27	WOS:000348563300045
J	Zhao, YY; Chen, H; Tian, T; Chen, DQ; Bai, X; Wei, F				Zhao, Ying-Yong; Chen, Hua; Tian, Ting; Chen, Dan-Qian; Bai, Xu; Wei, Feng			A Pharmaco-Metabonomic Study on Chronic Kidney Disease and Therapeutic Effect of Ergone by UPLC-QTOF/HDMS	PLOS ONE			English	Article							CHRONIC-RENAL-FAILURE; POLYUNSATURATED FATTY-ACIDS; OXIDATIVE STRESS; MASS-SPECTROMETRY; URINARY METABONOMICS; POLYPORUS-UMBELLATUS; SERUM METABONOMICS; EXPERIMENTAL-MODEL; METABOLIC-CHANGES; PORIA-COCOS	Chronic kidney disease (CKD) is an important public health problem. Ergone has been proved to prevent the progression of CKD. UPLC-QTOF/HDMS was employed for metabolic profiling of adenine-induced CKD and to investigate the nephroprotective effects of ergone. Pharmacology parameters including blood biochemistry, histopathological evaluation and Western blot analysis were performed concurrently. The UPLC-MS data were analyzed by partial least squares-discriminate analysis, correlation analysis, heatmap analysis and mapped to KEGG pathways. Blood and serum biochemistry were observed to be significantly different in the CKD group than in the control group. In conjunction with biochemistry, histopathology and protein expression results, identified metabolites indicated perturbations in fatty acid metabolism, purine metabolism and amino acid metabolism as changes associated with adenine-induced CKD and the interventions of ergone. Upregulated expression of TGF-beta 1, ED-1, CTGF, bFGF and collagen I was observed in the CKD group. However, downregulated expression of these proteins was observed after oral administration of ergone. These results suggest that expression changes in these proteins had implications for fatty acid metabolism, purine metabolism and amino acid metabolism in the development of CKD and that ergone treatment could delay the development of CKD by normalizing or blocking abnormal changes in biomarker metabolites and protein expression in the CKD group.	[Zhao, Ying-Yong; Chen, Hua; Tian, Ting; Chen, Dan-Qian] Northwest Univ, Coll Life Sci, Minist Educ, Key Lab Resource Biol & Biotechnol Western China, Xian, Peoples R China; [Wei, Feng] State Food & Drug Adm, Natl Inst Food & Drug Control, Beijing, Peoples R China; [Bai, Xu] Waters Technol Shanghai Ltd, Solut Ctr, Shanghai, Peoples R China	Northwest University Xi'an; National Institute of Food & Drug Control - China	Zhao, YY (corresponding author), Northwest Univ, Coll Life Sci, Minist Educ, Key Lab Resource Biol & Biotechnol Western China, Xian, Peoples R China.	zyy@nwu.edu.cn	Zhao, Ying-Yong/I-3590-2019; Chen, Hua/Q-6933-2018; Zhao, Ying-Yong/I-9326-2014; Chen, Dan-Qian/HCH-6571-2022	Zhao, Ying-Yong/0000-0002-0239-7342; Chen, Hua/0000-0001-5564-4610; Zhao, Ying-Yong/0000-0002-0239-7342; 	New Century Excellent Talents in University [NCET-13-0954]; Changjiang Scholars and Innovative Research Team in University [IRT1174]; Ministry of Education of China; National Natural Science Foundation of China [J1210063, 81202909, 81274025, 81001622]; "As a Major New Drug to Create a Major National Science and Technology Special'' [2014ZX09304-307-02]; China Postdoctoral Science Foundation [2012M521831]; Key Program for the International S&T Cooperation Projects of Shaanxi Province [2013KW31-01]; Natural Science Foundation of Shaanxi Provincial Education Department [2013JK0811]; Administration of Traditional Chinese Medicine of Shaanxi [13-ZY006]	New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Ministry of Education of China(Ministry of Education, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "As a Major New Drug to Create a Major National Science and Technology Special''; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Key Program for the International S&T Cooperation Projects of Shaanxi Province; Natural Science Foundation of Shaanxi Provincial Education Department; Administration of Traditional Chinese Medicine of Shaanxi	This study was supported by the Program for the New Century Excellent Talents in University (NCET-13-0954) and the Changjiang Scholars and Innovative Research Team in University (IRT1174) from Ministry of Education of China, the National Natural Science Foundation of China (J1210063, 81202909, 81274025, 81001622), the project "As a Major New Drug to Create a Major National Science and Technology Special'' (2014ZX09304-307-02), the China Postdoctoral Science Foundation (2012M521831), the Key Program for the International S&T Cooperation Projects of Shaanxi Province (2013KW31-01), the Natural Science Foundation of Shaanxi Provincial Education Department (2013JK0811) and the Administration of Traditional Chinese Medicine of Shaanxi (13-ZY006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminzadeh MA, 2014, XENOBIOTICA, V44, P570, DOI 10.3109/00498254.2013.852705; Bok JW, 1999, PHYTOCHEMISTRY, V51, P891, DOI 10.1016/S0031-9422(99)00128-4; Calder PC, 2003, LIPIDS, V38, P343, DOI 10.1007/s11745-003-1068-y; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Chen H, 2014, ADV CLIN CHEM, V66, P101, DOI 10.1016/B978-0-12-801401-1.00004-9; DYERBERG J, 1986, NUTR REV, V44, P125, DOI 10.1111/j.1753-4887.1986.tb07603.x; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Iida Shuji, 2006, Clin Exp Nephrol, V10, P262, DOI 10.1007/s10157-006-0441-8; James MJ, 2000, AM J CLIN NUTR, V71, p343S, DOI 10.1093/ajcn/71.1.343s; Jia LW, 2008, METABOLOMICS, V4, P183, DOI 10.1007/s11306-008-0110-x; Kielstein JT, 2008, CURR OPIN NEPHROL HY, V17, P609, DOI 10.1097/MNH.0b013e328314b6ca; Kikuchi K, 2010, J CHROMATOGR B, V878, P2997, DOI 10.1016/j.jchromb.2010.09.006; Kim TH, 2012, ARCH TOXICOL, V86, P1885, DOI 10.1007/s00204-012-0910-7; Lenz EM, 2005, BIOMARKERS, V10, P173, DOI 10.1080/13547500500094034; Ma C, 2010, FOOD CHEM TOXICOL, V48, P2988, DOI 10.1016/j.fct.2010.07.038; Marescau B, 1997, METABOLISM, V46, P1024, DOI 10.1016/S0026-0495(97)90273-0; Maritim AC, 2003, J BIOCHEM MOL TOXIC, V17, P24, DOI 10.1002/jbt.10058; Miyazaki T, 1997, KIDNEY INT, V52, pS15; Nakamura N, 2008, IN VIVO, V22, P609; Nenseter MS, 1996, CURR OPIN LIPIDOL, V7, P8, DOI 10.1097/00041433-199602000-00003; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a; Priante G, 2009, J NEPHROL, V22, P137; Quang DN, 2008, NAT PROD RES, V22, P901, DOI 10.1080/14786410701642706; Rhee EP, 2010, J AM SOC NEPHROL, V21, P1041, DOI 10.1681/ASN.2009111132; Romieu I, 2008, ENVIRON HEALTH PERSP, V116, P1237, DOI 10.1289/ehp.10578; Shidfar F, 2008, East Mediterr Health J, V14, P305; Sui WG, 2012, CLINICS, V67, P363, DOI 10.6061/clinics/2012(04)10; Tumur Z, 2010, AM J NEPHROL, V31, P435, DOI 10.1159/000299798; Vanholder R, 2001, KIDNEY INT, V59, pS266, DOI 10.1046/j.1523-1755.2001.59780266.x; Wu IW, 2011, NEPHROL DIAL TRANSPL, V26, P938, DOI 10.1093/ndt/gfq580; WYNGAARDEN JB, 1957, ARCH BIOCHEM BIOPHYS, V70, P150, DOI 10.1016/0003-9861(57)90088-7; YOKOZAWA T, 1986, NEPHRON, V44, P230, DOI 10.1159/000183992; Zhao T, 2012, J PHARMACEUT BIOMED, V60, P32, DOI 10.1016/j.jpba.2011.11.010; Zhao YY, 2014, CLIN BIOCHEM, V47, P16, DOI 10.1016/j.clinbiochem.2014.07.019; Zhao YY, 2014, ADV CLIN CHEM, V65, P69, DOI 10.1016/B978-0-12-800141-7.00003-6; Zhao YY, 2014, CHEM-BIOL INTERACT, V215, P7, DOI 10.1016/j.cbi.2014.02.014; Zhao YY, 2013, J ETHNOPHARMACOL, V149, P35, DOI 10.1016/j.jep.2013.06.031; Zhao YY, 2013, J ETHNOPHARMACOL, V148, P403, DOI 10.1016/j.jep.2013.04.018; Zhao YY, 2013, CLIN CHIM ACTA, V422, P59, DOI 10.1016/j.cca.2013.03.033; Zhao YY, 2013, J PHARMACEUT BIOMED, V81-82, P202, DOI 10.1016/j.jpba.2013.03.028; Zhao YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059617; Zhao YY, 2013, J PROTEOME RES, V12, P692, DOI 10.1021/pr3007792; Zhao YY, 2012, PROCESS BIOCHEM, V47, P1980, DOI 10.1016/j.procbio.2012.07.008; Zhao YY, 2012, CLIN CHIM ACTA, V413, P1438, DOI 10.1016/j.cca.2012.06.005; Zhao YY, 2012, J SEP SCI, V35, P1619, DOI 10.1002/jssc.201200131; Zhao YY, 2012, BIOMARKERS, V17, P48, DOI 10.3109/1354750X.2011.637180; Zhao YY, 2012, CLIN CHIM ACTA, V413, P642, DOI 10.1016/j.cca.2011.12.014; Zhao YY, 2011, J PHARM PHARMACOL, V63, P1581, DOI 10.1111/j.2042-7158.2011.01361.x; Zhao YY, 2011, BBA-GEN SUBJECTS, V1810, P384, DOI 10.1016/j.bbagen.2010.12.005; Zhao YY, 2010, PLANTA MED, V76, P1755, DOI 10.1055/s-0030-1249926; Zhao YY, 2010, BIOMED CHROMATOGR, V24, P1120, DOI 10.1002/bmc.1414; Zhao YY, 2010, ANAL CHIM ACTA, V675, P199, DOI 10.1016/j.aca.2010.07.029; Zhao YY, 2010, J CHROMATOGR B, V878, P29, DOI 10.1016/j.jchromb.2009.11.013; Zhao YY, 2009, J ETHNOPHARMACOL, V126, P184, DOI 10.1016/j.jep.2009.07.033; Zhao YY, 2009, PHARMAZIE, V64, P366, DOI 10.1691/ph.2009.8364	55	51	52	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115467	10.1371/journal.pone.0115467	http://dx.doi.org/10.1371/journal.pone.0115467			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25535749	gold, Green Submitted, Green Published			2022-12-27	WOS:000348563300041
J	Calvino-Nunez, C; Dominguez-del-Toro, E				Calvino-Nunez, Cristina; Dominguez-del-Toro, Eduardo			Clonidine Treatment Delays Postnatal Motor Development and Blocks Short-Term Memory in Young Mice	PLOS ONE			English	Article							OBJECT RECOGNITION MEMORY; PREPULSE INHIBITION; LOCUS-COERULEUS; DEVELOPING RAT; KNOCKOUT MICE; 4-PLATE TEST; BRAIN-STEM; RECEPTOR; ANXIETY; BEHAVIOR	During the development of the nervous system, the perinatal period is particularly sensitive as neuronal connections are still forming in the brain of the neonate. Alpha2-adrenergic receptors are overexpressed temporarily in proliferative zones in the developing brain, reaching a peak during the first postnatal week of life. Both stimulation and blocking of these receptors during this period alter the development of neural circuits, affecting synaptic connectivity and neuronal responses. They even affect motor and cognitive skills later on in the adult. It's especially important to look for the early neurological consequences resulting from such modifications, because they may go unnoticed. The main objective of the present study has been to reaffirm the importance of the maturation of alpha-adrenergic system in mice, by carrying out a comprehensive examination of motor, behavioral and cognitive effects in neonates, during early postnatal development, following chronic administration of the drug Clonidine, an alpha2 adrenergic system agonist. Our study shows that mice treated postnatally with clonidine present a temporal delay in the appearance of developmental markers, a slow execution of vestibular reflexes during first postnatal week of life and a blockade of the short term memory in the novel object recognition task. Shortly after the treatment the startle response is hyperreactive.	[Calvino-Nunez, Cristina; Dominguez-del-Toro, Eduardo] Univ Pablo Olavide, Div Neurociencias, Seville, Spain	Universidad Pablo de Olavide	Dominguez-del-Toro, E (corresponding author), Univ Pablo Olavide, Div Neurociencias, Seville, Spain.	edomtor@upo.es			Fundacion Conocimiento y Cultura;  [BFU2007-67173]	Fundacion Conocimiento y Cultura; 	This work was supported by Spanish BFU2007-67173 grant and the Fundacion Conocimiento y Cultura. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida RG, 1996, COMP BIOCHEM PHYS C, V114, P123, DOI 10.1016/0742-8413(96)00013-8; Ansermino M, 2003, PAEDIATR ANAESTH, V13, P561, DOI 10.1046/j.1460-9592.2003.01048.x; Balemans MCM, 2010, BEHAV BRAIN RES, V208, P47, DOI 10.1016/j.bbr.2009.11.008; Bourin M, 2005, PHARMACOL BIOCHEM BE, V81, P645, DOI 10.1016/j.pbb.2005.04.015; Dornelles A, 2007, NEUROBIOL LEARN MEM, V88, P137, DOI 10.1016/j.nlm.2007.01.005; Dygalo N. N., 2000, Ontogenez, V31, P53; Dygalo NN, 2004, DEV BRAIN RES, V152, P225, DOI 10.1016/j.devbrainres.2004.06.018; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; FOX M. W., 1965, ANIM BEHAV, V13, P234; Fuentes S, 2007, TOXICOL SCI, V98, P589, DOI 10.1093/toxsci/kfm121; Gilsbach R, 2009, MOL PHARMACOL, V75, P1160, DOI 10.1124/mol.109.054544; Gleason G, 2010, P NATL ACAD SCI USA, V107, P7592, DOI 10.1073/pnas.0914805107; GORTER JA, 1990, BRAIN RES, V535, P62, DOI 10.1016/0006-8993(90)91824-Z; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; Happe HK, 1999, J PHARMACOL EXP THER, V288, P1134; Happe HK, 2004, NEUROSCIENCE, V123, P167, DOI 10.1016/j.neuroscience.2003.09.004; Harris AC, 2004, PSYCHOPHARMACOLOGY, V171, P140, DOI 10.1007/s00213-003-1573-0; Head GA, 1999, ANN NY ACAD SCI, V881, P279, DOI 10.1111/j.1749-6632.1999.tb09370.x; Iushkova A A, 1995, Fiziol Zh Im I M Sechenova, V81, P7; Jacquin TD, 1996, NEURON, V17, P747, DOI 10.1016/S0896-6273(00)80206-8; Jentsch JD, 2004, PSYCHOPHARMACOLOGY, V175, P76, DOI 10.1007/s00213-004-1772-3; Kang EH, 2005, PROG NEURO-PSYCHOPH, V29, P733, DOI 10.1016/j.pnpbp.2005.04.027; Kleefstra T, 2006, AM J HUM GENET, V79, P370, DOI 10.1086/505693; Lakhlani PP, 1997, P NATL ACAD SCI USA, V94, P9950, DOI 10.1073/pnas.94.18.9950; Lee SB, 2009, J COMP NEUROL, V514, P387, DOI 10.1002/cne.22012; Mas-Nieto M, 2005, NEUROSCIENCE, V135, P305; Masse F, 2006, PSYCHOPHARMACOLOGY, V183, P471, DOI 10.1007/s00213-005-0220-3; Maze M, 2001, CRIT CARE CLIN, V17, P881, DOI 10.1016/S0749-0704(05)70185-8; Menshanov PN, 2007, J NEUROSCI METH, V164, P299, DOI 10.1016/j.jneumeth.2007.04.014; MIRMIRAN M, 1987, DEV PHARMACOL THERAP, V10, P377, DOI 10.1159/000457767; MIRMIRAN M, 1985, NEUROBEH TOXICOL TER, V7, P677; Morrissey MJ, 2004, MED HYPOTHESES, V62, P876, DOI 10.1016/j.mehy.2004.01.014; Muigg P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005346; NOMURA Y, 1980, N-S ARCH PHARMACOL, V313, P33, DOI 10.1007/BF00505802; Porras-Garcia E, 2005, EUR J NEUROSCI, V21, P979, DOI 10.1111/j.1460-9568.2005.03940.x; Roozendaal B, 2008, NEUROBIOL LEARN MEM, V90, P576, DOI 10.1016/j.nlm.2008.06.010; Shishkina GT, 2004, BEHAV NEUROSCI, V118, P1285, DOI 10.1037/0735-7044.118.6.1285; Shishkina GT, 2001, J NEUROSCI, V21, P726, DOI 10.1523/JNEUROSCI.21-02-00726.2001; SOTOMOYANO R, 1991, BRAIN RES BULL, V26, P259, DOI 10.1016/0361-9230(91)90236-D; Steckler T, 1998, PROG NEUROBIOL, V54, P289, DOI 10.1016/S0301-0082(97)00060-9; Tamashiro KLK, 2000, BIOL REPROD, V63, P328, DOI 10.1095/biolreprod63.1.328; Tanaka M, 2000, EUR J PHARMACOL, V405, P397, DOI 10.1016/S0014-2999(00)00569-0; Thomas AJ, 2000, DEV BRAIN RES, V120, P181, DOI 10.1016/S0165-3806(00)00008-0; UHDE TW, 1989, ARCH GEN PSYCHIAT, V46, P170; VELLEY L, 1991, PROG BRAIN RES, V88, P555; Zelena D, 2009, INT J DEV NEUROSCI, V27, P175, DOI 10.1016/j.ijdevneu.2008.11.003	46	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e114869	10.1371/journal.pone.0114869	http://dx.doi.org/10.1371/journal.pone.0114869			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531525	gold, Green Submitted, Green Published			2022-12-27	WOS:000348845100030
J	Jain, V; Basak, S; Bhandari, S; Bharti, PK; Thomas, T; Singh, MP; Singh, N				Jain, Vidhan; Basak, Sanjay; Bhandari, Sneha; Bharti, Praveen K.; Thomas, Trilok; Singh, Mrigendra P.; Singh, Neeru			Burden of Complicated Malaria in a Densely Forested Bastar Region of Chhattisgarh State (Central India)	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; CEREBRAL MALARIA; CHILDREN; ADULTS; AREA; ROURKELA; PATTERNS; VIVAX; AGE	Background: A prospective study on severe and complicated malaria was undertaken in the tribal dominated area of Bastar division, Chhattisgarh (CG), Central India, with an objective to understand the clinical epidemiology of complicated malaria in patients attending at a referral hospital. Methods: Blood smears, collected from the general medicine and pediatric wards of a government tertiary health care facility located in Jagdalpur, CG, were microscopically examined for malaria parasite from July 2010 to December 2013. The Plasmodium falciparum positive malaria cases who met enrollment criteria and provided written informed consent were enrolled under different malaria categories following WHO guidelines. PCR was performed to reconfirm the presence of P. falciparum mono infection among enrolled cases. Univariate and multivariate logistic regression analysis was done to identify different risk factors using STATA 11.0. Results: A total of 40,924 cases were screened for malaria. The prevalence of malaria and P. falciparum associated complicated malaria (severe and cerebral both) in the hospital was 6% and 0.81%, respectively. P. falciparum malaria prevalence, severity and associated mortality in this region peaked at the age of>4-5 years and declined with increasing age. P. falciparum malaria was significantly more prevalent in children than adults (P<0.00001). Among adults, males had significantly more P. falciparum malaria than females (P<0.00001). Case fatality rate due to cerebral malaria and severe malaria was, respectively, 32% and 9% among PCR confirmed mono P. falciparum cases. Coma was the only independent predictor of mortality in multivariate regression analysis. Mortality was significantly associated with multi-organ complication score (P=0.0003). Conclusion: This study has revealed that the pattern of morbidity and mortality in this part of India is very different from earlier reported studies from India. We find that the peak morbidity and mortality in younger children regardless of seasonality. This suggests that this age group needs special care for control and clinical management.	[Jain, Vidhan; Bhandari, Sneha; Bharti, Praveen K.; Thomas, Trilok; Singh, Neeru] ICMR, RMRCT, Jabalpur, Madhya Pradesh, India; [Basak, Sanjay] Maharani Hosp, Dist Malaria Off, Chhattisgarh, India; [Basak, Sanjay] Associated Med Coll Jagdalpur, Chhattisgarh, India; [Singh, Mrigendra P.] Natl Inst Malaria Res, Field Unit, Jabalpur, Madhya Pradesh, India	Indian Council of Medical Research (ICMR); Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR)	Singh, N (corresponding author), ICMR, RMRCT, Jabalpur, Madhya Pradesh, India.	oicmrc@yahoo.co.in		Singh, Mrigendra/0000-0003-4336-4413	Indian council of Medical research (ICMR), India	Indian council of Medical research (ICMR), India(Indian Council of Medical Research (ICMR))	This work was funded under "Tribal Sub plan'' by Indian council of Medical research (ICMR), India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla SH, 2004, MALARIA HEMATOLOGICA, P17; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Carneiro I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008988; D'Alessandro U, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-400; Hanson J, 2010, CLIN INFECT DIS, V50, P679, DOI 10.1086/649928; Hay SI, 2010, LANCET, V376, P1716, DOI 10.1016/S0140-6736(10)61084-7; Imbert P, 1997, T ROY SOC TROP MED H, V91, P22, DOI 10.1016/S0035-9203(97)90380-1; Jain V, 2008, AM J TROP MED HYG, V79, P636; Kendjo E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058686; Kochar DK, 2014, J VECTOR DIS, V51, P200; Kochar Dhanpat, 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P259; KULKARNI S M, 1987, Indian Journal of Malariology, V24, P163; Lucchi NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031848; Manning L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029203; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Medana IM, 2010, HISTOPATHOLOGY, V57, P282, DOI 10.1111/j.1365-2559.2010.03619.x; Mishra SK, 2007, ANN TROP MED PARASIT, V101, P187, DOI 10.1179/136485907X157004; Mohanty S, 2003, T ROY SOC TROP MED H, V97, P69, DOI 10.1016/S0035-9203(03)90027-7; Mohapatra PK, 2001, NATL MED J INDIA, V14, P139; Nanda N, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-215; Newton CRJC, 1998, PHARMACOL THERAPEUT, V79, P1, DOI 10.1016/S0163-7258(98)00008-4; NVBDCP, 2013, DIAGN TREATM MAL 201; NVBDCP, 2012, MAL SIT; Pathak S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035592; Singh J., 1944, Indian Medical Gazette, V79, P102; Singh N, 2004, VECTOR-BORNE ZOONOT, V4, P239, DOI 10.1089/1530366042162506; Singh N, 2004, ICMR B, V34, P1; Singh N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073730; Singh R, 2013, TROP MED INT HEALTH, V18, P1416, DOI 10.1111/tmi.12184; Singh V, 2009, TRENDS PARASITOL, V25, P452, DOI 10.1016/j.pt.2009.06.004; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; Tripathy R, 2007, PEDIATRICS, V120, pE454, DOI 10.1542/peds.2006-3171; WHO, 2012, MAN SEV MAL PRACT HD, P5	34	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115266	10.1371/journal.pone.0115266	http://dx.doi.org/10.1371/journal.pone.0115266			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531373	gold, Green Published, Green Submitted			2022-12-27	WOS:000348845100048
J	Jimenez-Maldonado, A; de Alvarez-Buylla, ER; Montero, S; Melnikov, V; Castro-Rodriguez, E; Gamboa-Dominguez, A; Rodriguez-Hernandez, A; Lemus, M; Murguia, JM				Jimenez-Maldonado, Alberto; Roces de Alvarez-Buylla, Elena; Montero, Sergio; Melnikov, Valery; Castro-Rodriguez, Elena; Gamboa-Dominguez, Armando; Rodriguez-Hernandez, Alejandrina; Lemus, Monica; Muniz Murguia, Jesus			Chronic Exercise Increases Plasma Brain-Derived Neurotrophic Factor Levels, Pancreatic Islet Size, and Insulin Tolerance in a TrkB-Dependent Manner	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; BETA-CELL FUNCTION; SKELETAL-MUSCLE; SIGNAL-TRANSDUCTION; BDNF; EXPRESSION; LIVER; RESISTANCE; SECRETION; PHOSPHORYLATION	Background: Physical exercise improves glucose metabolism and insulin sensitivity. Brain-derived neurotrophic factor (BDNF) enhances insulin activity in diabetic rodents. Because physical exercise modifies BDNF production, this study aimed to investigate the effects of chronic exercise on plasma BDNF levels and the possible effects on insulin tolerance modification in healthy rats. Methods: Wistar rats were divided into five groups: control (sedentary, C); moderate-intensity training (MIT); MIT plus K252A TrkB blocker (MITK); highintensity training (HIT); and HIT plus K252a (HITK). Training comprised 8 weeks of treadmill running. Plasma BDNF levels (ELISA assay), glucose tolerance, insulin tolerance, and immunohistochemistry for insulin and the pancreatic islet area were evaluated in all groups. In addition, Bdnf mRNA expression in the skeletal muscle was measured. Principal Findings: Chronic treadmill exercise significantly increased plasma BDNF levels and insulin tolerance, and both effects were attenuated by TrkB blocking. In the MIT and HIT groups, a significant TrkB-dependent pancreatic islet enlargement was observed. MIT rats exhibited increased liver glycogen levels following insulin administration in a TrkB-independent manner. Conclusions/Significance: Chronic physical exercise exerted remarkable effects on insulin regulation by inducing significant increases in the pancreatic islet size and insulin sensitivity in a TrkB-dependent manner. A threshold for the induction of BNDF in response to physical exercise exists in certain muscle groups. To the best of our knowledge, these are the first results to reveal a role for TrkB in the chronic exercise-mediated insulin regulation in healthy rats.	[Jimenez-Maldonado, Alberto; Roces de Alvarez-Buylla, Elena; Montero, Sergio; Castro-Rodriguez, Elena; Lemus, Monica; Muniz Murguia, Jesus] Univ Colima, Ctr Univ Invest Biomed, Colima, Mexico; [Melnikov, Valery; Rodriguez-Hernandez, Alejandrina] Univ Colima, Fac Med, Colima, Mexico; [Gamboa-Dominguez, Armando] Inst Nacl Nutr & Ciencias Med Salvador Zubiran, Dept Patol, Mexico City, DF, Mexico	Universidad de Colima; Universidad de Colima; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico	Murguia, JM (corresponding author), Univ Colima, Ctr Univ Invest Biomed, Colima, Mexico.	jesusmuniz@hotmail.com		Lemus, Monica/0000-0001-9536-3020; Montero, Sergio/0000-0002-4776-6236; Alvarez-Buylla Roces, Maria Elena/0000-0002-7938-6473; Melnikov, Valery/0000-0002-0869-6394	CONACYT [49936-Q]; FRABA [798/12]	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); FRABA	This work was partly supported by CONACYT 49936-Q, and FRABA 798/12 grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aid T, 2007, J NEUROSCI RES, V85, P525, DOI 10.1002/jnr.21139; BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; Beaudry JL, 2012, DIABETES-METAB RES, V28, P560, DOI 10.1002/dmrr.2310; Blum R, 2005, PHYSIOLOGY, V20, P70, DOI 10.1152/physiol.00042.2004; Calegari VC, 2011, J ENDOCRINOL, V208, P257, DOI 10.1530/JOE-10-0450; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Chibalin AV, 2000, P NATL ACAD SCI USA, V97, P38, DOI 10.1073/pnas.97.1.38; Choi YH, 2006, J CLIN INVEST, V116, P3240, DOI 10.1172/JCI24867; Correia PR, 2011, NEUROSCI BULL, V27, P325, DOI 10.1007/s12264-011-1531-5; Coskun O, 2004, TOHOKU J EXP MED, V203, P145, DOI 10.1620/tjem.203.145; Cuppini R, 2007, ARCH ITAL BIOL, V145, P99; da Silva Xavier Gabriela, 2003, Biochem J, V371, P761, DOI 10.1042/BJ20021812; De Souza CT, 2010, J PHYSIOL-LONDON, V588, P2239, DOI 10.1113/jphysiol.2009.183996; Farese RV, 2001, EXP BIOL MED, V226, P283, DOI 10.1177/153537020122600404; Fujii N, 2006, AM J PHYSIOL-ENDOC M, V291, pE867, DOI 10.1152/ajpendo.00207.2006; Galvao RP, 2008, J NEUROSCI, V28, P13368, DOI 10.1523/JNEUROSCI.2918-08.2008; Gomez-Pinilla F, 2002, J NEUROPHYSIOL, V88, P2187, DOI 10.1152/jn.00152.2002; Gomez-Pinilla F, 2001, EUR J NEUROSCI, V13, P1078, DOI 10.1046/j.0953-816x.2001.01484.x; Gomez-Pinilla F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032298; Hanyu O, 2003, DIABETES OBES METAB, V5, P27, DOI 10.1046/j.1463-1326.2003.00238.x; Hawley JA, 2008, ACTA PHYSIOL, V192, P127, DOI 10.1111/j.1748-1716.2007.01783.x; Cardenas CMH, 2009, J PANCREAS, V10, P321; Hoene M, 2009, J PHYSIOL-LONDON, V587, P241, DOI 10.1113/jphysiol.2008.160275; Howarth FC, 2009, J PANCREAS, V10, P485; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; Jorgensen SB, 2006, J PHYSIOL-LONDON, V574, P17, DOI 10.1113/jphysiol.2006.109942; Kim H, 2004, DIABETES, V53, pS60, DOI 10.2337/diabetes.53.2007.S60; Kiraly MA, 2010, AM J PHYSIOL-ENDOC M, V298, pE671, DOI 10.1152/ajpendo.90575.2008; KORANYI LI, 1991, DIABETES, V40, P401, DOI 10.2337/diabetes.40.3.401; Krisan AD, 2004, J APPL PHYSIOL, V96, P1691, DOI 10.1152/japplphysiol.01054.2003; Kump DS, 2004, J PHYSL, V562, P829; Leibiger B, 2002, BIOCHEM SOC T, V30, P312, DOI 10.1042/bst0300312; Leite ND, 2013, CELL PHYSIOL BIOCHEM, V31, P242, DOI 10.1159/000343365; Luciano E, 2002, EUR J ENDOCRINOL, V147, P149, DOI 10.1530/eje.0.1470149; Lucini C, 2003, ANAT EMBRYOL, V206, P311, DOI 10.1007/s00429-002-0304-3; Luo J, 2006, CELL METAB, V3, P355, DOI 10.1016/j.cmet.2006.04.003; Marini M, 2010, EUR J TRANSL MYOL, V20, P105, DOI 10.4081/bam.2010.3.105; Matthews VB, 2009, DIABETOLOGIA, V52, P1409, DOI 10.1007/s00125-009-1364-1; Melloul D, 2004, ANN NY ACAD SCI, V1014, P28, DOI 10.1196/annals.1294.003; Mousavi K, 2004, AM J PHYSIOL-CELL PH, V287, pC22, DOI 10.1152/ajpcell.00583.2003; Mowla SJ, 2001, J BIOL CHEM, V276, P12660, DOI 10.1074/jbc.M008104200; Nakagawa T, 2000, DIABETES, V49, P436, DOI 10.2337/diabetes.49.3.436; Ogborn DI, 2010, MUSCLE NERVE, V41, P385, DOI 10.1002/mus.21503; Park SM, 2007, J APPL PHYSIOL, V103, P1764, DOI 10.1152/japplphysiol.00434.2007; Peeters A, 2010, PPAR RES, V2010, DOI 10.1155/2010/572405; Peres SB, 2005, J APPL PHYSIOL, V98, P1037, DOI 10.1152/japplphysiol.00536.2004; Pierucci D, 2001, DIABETOLOGIA, V44, P1281, DOI 10.1007/s001250100650; Podolin DA, 2001, AM J PHYSIOL-ENDOC M, V281, pE516, DOI 10.1152/ajpendo.2001.281.3.E516; Qin B, 2007, EXP BIOL MED, V232, P1330, DOI 10.3181/0704-RM-107; Rasmussen P, 2009, EXP PHYSIOL, V94, P1062, DOI 10.1113/expphysiol.2009.048512; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Rolland JF, 2002, J BIOL CHEM, V277, P38373, DOI 10.1074/jbc.M203888200; Sakuma K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/201696; Seifert T, 2010, AM J PHYSIOL-REG I, V298, pR372, DOI 10.1152/ajpregu.00525.2009; Skurat AV, 2000, DIABETES, V49, P1096, DOI 10.2337/diabetes.49.7.1096; Suefuji M, 2012, BIOCHEM BIOPH RES CO, V421, P801, DOI 10.1016/j.bbrc.2012.04.091; Thomson DM, 2009, J PHYSIOL-LONDON, V587, P2077, DOI 10.1113/jphysiol.2008.166512; Tsuchida A, 2001, DIABETOLOGIA, V44, P555, DOI 10.1007/s001250051661; Wei YZ, 2008, AM J PHYSIOL-REG I, V294, pR673, DOI 10.1152/ajpregu.00561.2007; Wisloff U, 2001, AM J PHYSIOL-HEART C, V280, pH1301, DOI 10.1152/ajpheart.2001.280.3.H1301; Zoladz JA, 2008, J PHYSIOL PHARMACOL, V59, P119; Zweifel LS, 2005, NAT REV NEUROSCI, V6, P615, DOI 10.1038/nrn1727; Zywert A, 2011, PHYSIOL RES, V60, P905, DOI 10.33549/physiolres.932165	63	22	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115177	10.1371/journal.pone.0115177	http://dx.doi.org/10.1371/journal.pone.0115177			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531651	gold, Green Published			2022-12-27	WOS:000348845100041
J	Gonzalez-Rosa, JM; Guzman-Martinez, G; Marques, IJ; Sanchez-Iranzo, H; Jimenez-Borreguero, LJ; Mercader, N				Manuel Gonzalez-Rosa, Juan; Guzman-Martinez, Gabriela; Joao Marques, Ines; Sanchez-Iranzo, Hector; Jesus Jimenez-Borreguero, Luis; Mercader, Nadia			Use of Echocardiography Reveals Reestablishment of Ventricular Pumping Efficiency and Partial Ventricular Wall Motion Recovery upon Ventricular Cryoinjury in the Zebrafish	PLOS ONE			English	Article							HEART REGENERATION; ADULT ZEBRAFISH; MYOCARDIAL-INFARCTION; CARDIAC REGENERATION; GENE; REPRODUCIBILITY; EXPRESSION; DISEASE	Aims: While zebrafish embryos are amenable to in vivo imaging, allowing the study of morphogenetic processes during development, intravital imaging of adults is hampered by their small size and loss of transparency. The use of adult zebrafish as a vertebrate model of cardiac disease and regeneration is increasing at high speed. It is therefore of great importance to establish appropriate and robust methods to measure cardiac function parameters. Methods and Results: Here we describe the use of 2D-echocardiography to study the fractional volume shortening and segmental wall motion of the ventricle. Our data show that 2D-echocardiography can be used to evaluate cardiac injury and also to study recovery of cardiac function. Interestingly, our results show that while global systolic function recovered following cardiac cryoinjury, ventricular wall motion was only partially restored. Conclusion: Cryoinjury leads to long-lasting impairment of cardiac contraction, partially mimicking the consequences of myocardial infarction in humans. Functional assessment of heart regeneration by echocardiography allows a deeper understanding of the mechanisms of cardiac regeneration and has the advantage of being easily transferable to other cardiovascular zebrafish disease models.	[Manuel Gonzalez-Rosa, Juan; Joao Marques, Ines; Sanchez-Iranzo, Hector; Mercader, Nadia] Ctr Nacl Invest Cardiovasc, Dept Cardiovasc Dev & Repair Atherothrombosis & I, Madrid, Spain; [Guzman-Martinez, Gabriela; Jesus Jimenez-Borreguero, Luis] Ctr Nacl Invest Cardiovasc, Dept Epidemiol Atherothrombosis & Imaging, Madrid, Spain; [Guzman-Martinez, Gabriela] Univ Hosp La Paz, Dept Cardiol, Madrid, Spain; [Jesus Jimenez-Borreguero, Luis] Hosp La Princesa, Madrid, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC); Centro Nacional de Investigaciones Cardiovasculares (CNIC); Hospital Universitario La Paz; Hospital de La Princesa	Jimenez-Borreguero, LJ (corresponding author), Ctr Nacl Invest Cardiovasc, Dept Epidemiol Atherothrombosis & Imaging, Madrid, Spain.	ljborreguero@cnic.es; nmercader@cnic.es	Guzman, Gabriela/AAC-9084-2022; Gonzalez-Rosa, Juan Manuel/F-5332-2018; Sánchez-Iranzo, Héctor/L-8429-2014; Marques, Ines J./X-6325-2019; Marques, Ines Joao/L-8392-2014; Jimenez-Borreguero, Luis Jesus/L-8107-2014; Mercader, Nadia/L-2728-2014	Gonzalez-Rosa, Juan Manuel/0000-0002-2453-5670; Sánchez-Iranzo, Héctor/0000-0003-2032-0231; Marques, Ines J./0000-0003-1254-9394; Marques, Ines Joao/0000-0003-1254-9394; Guzman-Martinez, Gabriela/0000-0003-1077-7959; Jimenez-Borreguero, Luis Jesus/0000-0001-5870-237X; Mercader, Nadia/0000-0002-0905-6399	Fundacion CNIC Carlos III; Fundacion ProCNIC; Spanish Ministry of Economy and Competitiveness (Tercel) [BFU2011-25297, FPU AP2008-00546, FPU12/03007]; Community of Madrid [FIBROTEAM S2010/BMD-2321, PIEF-GA-2012-330728]; ERC [337703 - zebraHeart]	Fundacion CNIC Carlos III; Fundacion ProCNIC; Spanish Ministry of Economy and Competitiveness (Tercel); Community of Madrid(Comunidad de Madrid); ERC(European Research Council (ERC)European Commission)	Funding was from the Fundacion CNIC Carlos III, the Fundacion ProCNIC, the Spanish Ministry of Economy and Competitiveness (Tercel and BFU2011-25297 to N.M., FPU AP2008-00546 to J.M.G.-R. and FPU12/03007 to H.S-I.), the Community of Madrid (FIBROTEAM S2010/BMD-2321 to N.M), PIEF-GA-2012-330728 to I.J.M. and an ERC Starting grant 337703 - zebraHeart to N.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakawa K, 2008, P NATL ACAD SCI USA, V105, P1255, DOI 10.1073/pnas.0704963105; Berdougo E, 2003, DEVELOPMENT, V130, P6121, DOI 10.1242/dev.00838; Cao H, 2014, INTEGR BIOL CAMB; Chablais F, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-21; Choi WY, 2012, CURR TOP DEV BIOL, V100, P319, DOI 10.1016/B978-0-12-387786-4.00010-5; De Sutter J, 1999, HEART, V81, P533, DOI 10.1136/hrt.81.5.533; Ellett F, 2011, BLOOD, V117, pE49, DOI 10.1182/blood-2010-10-314120; GORDON EP, 1983, J AM COLL CARDIOL, V2, P506, DOI 10.1016/S0735-1097(83)80278-2; Gupta V, 2013, CURR BIOL, V23, P1221, DOI 10.1016/j.cub.2013.05.028; Hoage T, 2012, METHODS MOL BIOL, V843, P11, DOI 10.1007/978-1-61779-523-7_2; Houweling AC, 2005, CARDIOVASC RES, V67, P583, DOI 10.1016/j.cardiores.2005.06.013; Hu N, 2001, ANAT REC, V264, P1, DOI 10.1002/ar.1111; Huang WC, 2010, ZEBRAFISH, V7, P297, DOI 10.1089/zeb.2010.0653; Jennings RB, 1990, CIRCULATION, V82, P112; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147; Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Lindekleiv H, 2012, J CARDIOVASC ELECTR, V23, P846, DOI 10.1111/j.1540-8167.2012.02308.x; Liu TY, 2013, IEEE T ULTRASON FERR, V60, P1827, DOI 10.1109/TUFFC.2013.2769; Mably JD, 2003, CURR BIOL, V13, P2138, DOI 10.1016/j.cub.2003.11.055; Mallo M, 2000, DEVELOPMENT, V127, P4127; Gonzalez-Rosa JM, 2012, NAT PROTOC, V7, P782, DOI 10.1038/nprot.2012.025; Gonzalez-Rosa JM, 2011, DEVELOPMENT, V138, P1663, DOI 10.1242/dev.060897; Parente V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053748; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Raya A, 2003, P NATL ACAD SCI USA, V100, P11889, DOI 10.1073/pnas.1834204100; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Schnabel K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018503; Sedmera D, 2011, DEV DYNAM, V240, P1322, DOI 10.1002/dvdy.22650; Steeds RP, 2011, BRIT J RADIOL, V84, P237; Sun L, 2008, ULTRASOUND MED BIOL, V34, P31, DOI 10.1016/j.ultrasmedbio.2007.07.002; Wang JH, 2011, DEVELOPMENT, V138, P3421, DOI 10.1242/dev.068601; Wasmeier GH, 2007, CORONARY ARTERY DIS, V18, P283, DOI 10.1097/MCA.0b013e3280d5a7e3; Yu F, 2010, ANN BIOMED ENG, V38, P2346, DOI 10.1007/s10439-010-9993-6; ZELLER R, 1987, GENE DEV, V1, P693, DOI 10.1101/gad.1.7.693	36	33	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115604	10.1371/journal.pone.0115604	http://dx.doi.org/10.1371/journal.pone.0115604			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25532015	gold, Green Published			2022-12-27	WOS:000348845100084
J	Nehdi, A; Sean, P; Linares, I; Colina, R; Jaramillo, M; Alain, T				Nehdi, Atef; Sean, Polen; Linares, Izzar; Colina, Rodney; Jaramillo, Maritza; Alain, Tommy			Deficiency in Either 4E-BP1 or 4E-BP2 Augments Innate Antiviral Immune Responses	PLOS ONE			English	Article							MESSENGER-RNA TRANSLATION; CAP-DEPENDENT TRANSLATION; P70 S6 KINASE; I-INTERFERON; INITIATION-FACTORS; MAMMALIAN TARGET; PHAS-I; PHOSPHORYLATION; PROTEIN; CELLS	Genetic deletion of both 4E-BP1 and 4E-BP2 was found to protect cells against viral infections. Here we demonstrate that the individual loss of either 4E-BP1 or 4E-BP2 in mouse embryonic fibroblasts (MEFs) is sufficient to confer viral resistance. shRNA-mediated silencing of 4E-BP1 or 4E-BP2 renders MEFs resistant to viruses, and compared to wild type cells, MEFs knockout for either 4E-BP1 or 4E-BP2 exhibit enhanced translation of Irf-7 and consequently increased innate immune response to viruses. Accordingly, the replication of vesicular stomatitis virus, encephalomyocarditis virus, influenza virus and Sindbis virus is markedly suppressed in these cells. Importantly, expression of either 4E-BP1 or 4E-BP2 in double knockout or respective single knockout cells diminishes their resistance to viral infection. Our data show that loss of 4E-BP1 or 4E-BP2 potentiates innate antiviral immunity. These results provide further evidence for translational control of innate immunity and support targeting translational effectors as an antiviral strategy.	[Nehdi, Atef; Sean, Polen] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada; [Nehdi, Atef; Sean, Polen] McGill Univ, Goodman Canc Ctr, Montreal, PQ H3A 1A3, Canada; [Nehdi, Atef] King Saud Bin Abdulaziz Univ Hlth Sci, King Abdullah Int Med Res Ctr, Coll Med, Riyadh 11426, Saudi Arabia; [Linares, Izzar; Alain, Tommy] Univ Ottawa, Childrens Hosp, Eastern Ontario Res Inst, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Colina, Rodney] Univ Republ, Lab Virol Mol PDU, Salto 50000, Uruguay; [Jaramillo, Maritza] INRS, Frappier Res Ctr, Inst Armand, Laval, PQ, Canada	McGill University; McGill University; King Saud Bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center (KAIMRC); University of Ottawa; Children's Hospital of Eastern Ontario; Universidad de la Republica, Uruguay; University of Quebec; Institut national de la recherche scientifique (INRS)	Nehdi, A (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada.	atef0002@gmail.com; tommy@arc.cheo.ca	Nehdi, Atef/GWZ-1906-2022; Jaramillo, Maritza/T-7467-2019	Jaramillo, Maritza/0000-0002-1910-5684; Colina, Rodney/0000-0003-3731-5383	CIHR Fellowship; ANII [FCE_543]; Agencia Nacional de Investigacion e Innovacion Uruguay; NSERC; CHEO Foundation; Cancer Research Society	CIHR Fellowship(Canadian Institutes of Health Research (CIHR)); ANII; Agencia Nacional de Investigacion e Innovacion Uruguay; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CHEO Foundation; Cancer Research Society	A. Nehdi was a recipient of a CIHR Fellowship. This research was funded by grants from ANII FCE_543, Agencia Nacional de Investigacion e Innovacion Uruguay to R. Colina, from the NSERC to M. Jaramillo, and from the CHEO Foundation and the Cancer Research Society to T. Alain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Alain T, 2012, CANCER RES, V72, P6468, DOI 10.1158/0008-5472.CAN-12-2395; Alain T, 2010, P NATL ACAD SCI USA, V107, P1576, DOI 10.1073/pnas.0912344107; Cao WP, 2008, NAT IMMUNOL, V9, P1157, DOI 10.1038/ni.1645; Colina R, 2008, NATURE, V452, P323, DOI 10.1038/nature06730; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gingras AC, 2001, GENE DEV, V15, P2852; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Grolleau A, 1999, J IMMUNOL, V162, P3491; Guiducci C, 2008, J EXP MED, V205, P315, DOI 10.1084/jem.20070763; HAGHIGHAT A, 1995, EMBO J, V14, P5701, DOI 10.1002/j.1460-2075.1995.tb00257.x; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.bi.60.070191.003441; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Ioannou Y, 2000, ARTHRITIS RHEUM-US, V43, P1431, DOI 10.1002/1529-0131(200007)43:7<1431::AID-ANR3>3.0.CO;2-E; Judge A, 2008, HUM GENE THER, V19, P111, DOI 10.1089/hum.2007.179; Katze MG, 2002, J INTERF CYTOK RES, V22, P283, DOI 10.1089/107999002753675695; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Kaur S, 2008, J IMMUNOL, V181, P7316, DOI 10.4049/jimmunol.181.10.7316; Kaur S, 2008, P NATL ACAD SCI USA, V105, P4808, DOI 10.1073/pnas.0710907105; Kaur S, 2007, J BIOL CHEM, V282, P1757, DOI 10.1074/jbc.M607365200; Kaur S, 2012, P NATL ACAD SCI USA, V109, P7723, DOI 10.1073/pnas.1118122109; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Konno H, 2013, CELL, V155, P688, DOI 10.1016/j.cell.2013.09.049; KOROMILAS AE, 1992, EMBO J, V11, P4153, DOI 10.1002/j.1460-2075.1992.tb05508.x; Kroczynska B, 2009, MOL CELL BIOL; Kusaba H, 2005, J BIOL CHEM, V280, P1037, DOI 10.1074/jbc.M405204200; Lekmine F, 2004, EXP CELL RES, V295, P173, DOI 10.1016/j.yexcr.2003.12.021; Lekmine F, 2003, J BIOL CHEM, V278, P27772, DOI 10.1074/jbc.M301364200; Lin TA, 1996, J BIOL CHEM, V271, P30199, DOI 10.1074/jbc.271.47.30199; MADER S, 1995, MOL CELL BIOL, V15, P4990; Magagnin MG, 2008, PROTEOMICS, V8, P1019, DOI 10.1002/pmic.200700551; Marcotrigiano J, 1999, MOL CELL, V3, P707, DOI 10.1016/S1097-2765(01)80003-4; Matsumoto A, 2009, J GASTROENTEROL, V44, P856, DOI 10.1007/s00535-009-0075-1; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Mothe-Satney I, 2000, MOL CELL BIOL, V20, P3558, DOI 10.1128/MCB.20.10.3558-3567.2000; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; PESTKA S, 1987, ANNU REV BIOCHEM, V56, P727, DOI 10.1146/annurev.biochem.56.1.727; Pestova TV, 2000, CELL MOL LIFE SCI, V57, P651, DOI 10.1007/PL00000726; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Poulin F, 1998, J BIOL CHEM, V273, P14002, DOI 10.1074/jbc.273.22.14002; Proud CG, 2009, BIOCHEM SOC T, V37, P227, DOI 10.1042/BST0370227; ROZEN F, 1990, MOL CELL BIOL, V10, P1134, DOI 10.1128/MCB.10.3.1134; Schaefer Martin, 2008, Curr Drug Abuse Rev, V1, P177; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; SHATKIN AJ, 1985, CELL, V40, P223, DOI 10.1016/0092-8674(85)90132-1; SONENBERG N, 1979, P NATL ACAD SCI USA, V76, P4345, DOI 10.1073/pnas.76.9.4345; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Tamiya T, 2011, ARTERIOSCL THROM VAS, V31, P980, DOI 10.1161/ATVBAHA.110.207464; Tsukiyama-Kohara K, 2001, NAT MED, V7, P1128, DOI 10.1038/nm1001-1128; Yonezawa K, 2003, CURR TOP MICROBIOL, V279, P271	55	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e114854	10.1371/journal.pone.0114854	http://dx.doi.org/10.1371/journal.pone.0114854			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531441	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000348845100029
J	Xu, X; Kang, CY; Guo, TM				Xu, Xu; Kang, Chunyan; Guo, Taomei			The Effects of Gender and Self-Insight on Early Semantic Processing	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; EMOTIONAL WORDS; SEX-DIFFERENCES; ERP EVIDENCE; CONCRETE; CONTEXT; COMPREHENSION; NETWORKS	This event-related potential (ERP) study explored individual differences associated with gender and level of self-insight in early semantic processing. Forty-eight Chinese native speakers completed a semantic judgment task with three different categories of words: abstract neutral words (e.g., logic, effect), concrete neutral words (e.g., teapot, table), and emotion words (e.g., despair, guilt). They then assessed their levels of self-insight. Results showed that women engaged in greater processing than did men. Gender differences also manifested in the relationship between level of self-insight and word processing. For women, level of self-insight was associated with level of semantic activation for emotion words and abstract neutral words, but not for concrete neutral words. For men, level of self-insight was related to processing speed, particularly in response to abstract and concrete neutral words. These findings provide electrophysiological evidence for the effects of gender and self-insight on semantic processing and highlight the need to take into consideration subject variables in related research.	[Xu, Xu] Penn State Univ Harrisburg, Sch Behav Sci & Educ, Middletown, PA USA; [Kang, Chunyan; Guo, Taomei] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Kang, Chunyan; Guo, Taomei] Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing 100875, Peoples R China; [Guo, Taomei] Beijing Normal Univ, Ctr Collaborat & Innovat Brain & Learning Sci, Beijing 100875, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Beijing Normal University; Beijing Normal University; Beijing Normal University	Guo, TM (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	guotm@bnu.edu.cn	Kang, Chunyan/AAF-5698-2019		National Natural Science Foundation of China [31170970]; National Key Basic Research Program of China [2014CB846102]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China)	The study was supported by the National Natural Science Foundation of China (31170970) and the National Key Basic Research Program of China (2014CB846102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altarriba J, 2004, AM J PSYCHOL, V117, P389, DOI 10.2307/4149007; Altarriba J, 1999, BEHAV RES METH INS C, V31, P578, DOI 10.3758/BF03200738; Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Cahill L, 2006, NAT REV NEUROSCI, V7, P477, DOI 10.1038/nrn1909; Citron FMM, 2012, BRAIN LANG, V122, P211, DOI 10.1016/j.bandl.2011.12.007; Daltrozzo J, 2007, ARCH SEX BEHAV, V36, P555, DOI 10.1007/s10508-006-9161-0; Else-Quest NM, 2012, PSYCHOL BULL, V138, P947, DOI 10.1037/a0027930; Grant AM, 2002, SOC BEHAV PERSONAL, V30, P821, DOI 10.2224/sbp.2002.30.8.821; Hinojosa JA, 2001, BRAIN LANG, V78, P128, DOI 10.1006/brln.2001.2455; Hinojosa JA, 2010, PSYCHOPHYSIOLOGY, V47, P748, DOI 10.1111/j.1469-8986.2010.00982.x; Iglesias A, 2004, INT J PSYCHOPHYSIOL, V52, P169, DOI 10.1016/j.ijpsycho.2003.06.003; Kaltwasser L, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00168; Kanske P, 2007, BRAIN RES, V1148, P138, DOI 10.1016/j.brainres.2007.02.044; Kissler J, 2007, PSYCHOL SCI, V18, P475, DOI 10.1111/j.1467-9280.2007.01924.x; Kissler J, 2006, PROG BRAIN RES, V156, P147, DOI 10.1016/S0079-6123(06)56008-X; KOUNIOS J, 1994, J EXP PSYCHOL LEARN, V20, P804, DOI 10.1037/0278-7393.20.4.804; Kousta ST, 2011, J EXP PSYCHOL GEN, V140, P14, DOI 10.1037/a0021446; Martin-Loeches M, 2004, SCHIZOPHR RES, V71, P393, DOI 10.1016/j.schres.2004.02.009; Martin-Loeches M, 2001, NEUROPSYCHOLOGIA, V39, P1086, DOI 10.1016/S0028-3932(01)00033-1; Martin-Loeches M, 2007, BRAIN RES REV, V53, P89, DOI 10.1016/j.brainresrev.2006.07.001; MEYERSLEVY J, 1991, J CONSUM RES, V18, P63, DOI 10.1086/209241; PAIVIO A, 1971, PERCEPT PSYCHOPHYS, V10, P408, DOI 10.3758/BF03210323; Palazova M, 2013, BRAIN LANG, V125, P264, DOI 10.1016/j.bandl.2013.02.008; Potts GF, 2001, COGNITIVE BRAIN RES, V11, P147, DOI 10.1016/S0926-6410(00)00075-6; Pu J, 2005, COGNITIVE BRAIN RES, V25, P273, DOI 10.1016/j.cogbrainres.2005.06.001; RUDELL AP, 1991, INT J NEUROSCI, V60, P85, DOI 10.3109/00207459109082040; Rudell AP, 1997, J EXP PSYCHOL HUMAN, V23, P1170; RUDELL AP, 1992, ELECTROEN CLIN NEURO, V83, P77, DOI 10.1016/0013-4694(92)90135-5; Sass SM, 2010, PSYCHOPHYSIOLOGY, V47, P247, DOI 10.1111/j.1469-8986.2009.00926.x; Schacht A, 2009, BRAIN COGNITION, V69, P538, DOI 10.1016/j.bandc.2008.11.005; SCHWANENFLUGEL PJ, 1983, J EXP PSYCHOL LEARN, V9, P82, DOI 10.1037/0278-7393.9.1.82; Van Hell J.G., 1998, BILING LANG CONGN, V1, P193, DOI [10.1017/S1366728998000352, DOI 10.1017/S1366728998000352]; Vigliocco G, 2014, CEREB CORTEX, V24, P1767, DOI 10.1093/cercor/bht025; WATTENMAKER WD, 1987, J EXP PSYCHOL LEARN, V13, P140, DOI 10.1037/0278-7393.13.1.140; West WC, 2000, J COGNITIVE NEUROSCI, V12, P1024, DOI 10.1162/08989290051137558; Wiemer-Hastings K, 2005, COGNITIVE SCI, V29, P719, DOI 10.1207/s15516709cog0000_33; Wirth M, 2007, CEREB CORTEX, V17, P1987, DOI 10.1093/cercor/bhl121; Zhang Y, 2009, NEUROSCI LETT, V454, P86, DOI 10.1016/j.neulet.2009.02.047	39	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e114421	10.1371/journal.pone.0114421	http://dx.doi.org/10.1371/journal.pone.0114421			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7UN	25545394	Green Published, gold			2022-12-27	WOS:000347120200013
J	Bjursell, M; Xu, XF; Admyre, T; Bottcher, G; Lundin, S; Nilsson, R; Stone, VM; Morgan, NG; Lam, YY; Storlien, LH; Linden, D; Smith, DM; Bohlooly-Y, M; Oscarsson, J				Bjursell, Mikael; Xu, Xiufeng; Admyre, Therese; Bottcher, Gerhard; Lundin, Sofia; Nilsson, Ralf; Stone, Virginia M.; Morgan, Noel G.; Lam, Yan Y.; Storlien, Leonard H.; Linden, Daniel; Smith, David M.; Bohlooly-Y, Mohammad; Oscarsson, Jan			The Beneficial Effects of n-3 Polyunsaturated Fatty Acids on Diet Induced Obesity and Impaired Glucose Control Do Not Require Gpr120	PLOS ONE			English	Article							INSULIN-RESISTANCE; FISH-OIL; MICE; RECEPTOR; OMEGA-3-FATTY-ACIDS; SECRETION; DISEASE; MOUSE; INFLAMMATION; DYSFUNCTION	GPR120 (Ffar4) has been postulated to represent an important receptor mediating the improved metabolic profile seen upon ingestion of a diet enriched in polyunsaturated fatty acids (PUFAs). GPR120 is highly expressed in the digestive system, adipose tissue, lung and macrophages and also present in the endocrine pancreas. A new Gpr120 deficient mouse model on pure C57bl/6N background was developed to investigate the importance of the receptor for long-term feeding with a diet enriched with fish oil. Male Gpr120 deficient mice were fed two different high fat diets (HFDs) for 18 weeks. The diets contained lipids that were mainly saturated (SAT) or mainly n-3 polyunsaturated fatty acids (PUFA). Body composition, as well as glucose, lipid and energy metabolism, was studied. As expected, wild type mice fed the PUFA HFD gained less body weight and had lower body fat mass, hepatic lipid levels, plasma cholesterol and insulin levels and better glucose tolerance as compared to those fed the SAT HFD. Gpr120 deficient mice showed a similar improvement on the PUFA HFD as was observed for wild type mice. If anything, the Gpr120 deficient mice responded better to the PUFA HFD as compared to wild type mice with respect to liver fat content, plasma glucose levels and islet morphology. Gpr120 deficient animals were found to have similar energy, glucose and lipid metabolism when fed HFD PUFA compared to wild type mice. Therefore, GPR120 appears to be dispensable for the improved metabolic profile associated with intake of a diet enriched in n-3 PUFA fatty acids.	[Bjursell, Mikael; Xu, Xiufeng; Admyre, Therese; Bottcher, Gerhard; Lundin, Sofia; Nilsson, Ralf; Linden, Daniel; Smith, David M.; Bohlooly-Y, Mohammad; Oscarsson, Jan] AstraZeneca R&D, Molndal, Sweden; [Stone, Virginia M.; Morgan, Noel G.] Univ Exeter, Sch Med, Exeter EX2 5DW, Devon, England; [Storlien, Leonard H.] Univ Sydney, Sydney, NSW 2006, Australia; [Lam, Yan Y.] Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA	AstraZeneca; University of Exeter; University of Sydney; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Bjursell, M (corresponding author), AstraZeneca R&D, Molndal, Sweden.	mikael.bjursell@astrazeneca.com		Smith, David/0000-0001-6831-280X; Morgan, Noel/0000-0003-1537-8113; Stone, Virginia M/0000-0003-3091-2142				Bellenger J, 2011, DIABETES, V60, P1090, DOI 10.2337/db10-0901; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Bjursell M, 2006, DIABETES, V55, P725, DOI 10.2337/diabetes.55.03.06.db05-1302; Bjursell M, 2007, DIABETES, V56, P583, DOI 10.2337/db06-1432; Bjursell M, 2006, BIOCHEM BIOPH RES CO, V348, P359, DOI 10.1016/j.bbrc.2006.07.090; Bjursell M, 2011, AM J PHYSIOL-ENDOC M, V300, pE211, DOI 10.1152/ajpendo.00229.2010; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Buettner R, 2006, J MOL ENDOCRINOL, V36, P485, DOI 10.1677/jme.1.01909; Burns RN, 2010, BIOCHEM BIOPH RES CO, V396, P1030, DOI 10.1016/j.bbrc.2010.05.057; Butler AA, 2010, DIABETES, V59, P323, DOI 10.2337/db09-1471; Carpentier YA, 2006, AM J CLIN NUTR, V83, p1499S, DOI 10.1093/ajcn/83.6.1499S; Couet C, 1997, INT J OBESITY, V21, P637, DOI 10.1038/sj.ijo.0800451; Doetschman Thomas, 2009, V530, P423, DOI 10.1007/978-1-59745-471-1_23; Duca FA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039748; Flachs P, 2013, BBA-MOL CELL BIOL L, V1831, P986, DOI 10.1016/j.bbalip.2013.02.003; Gerdin AK, 2006, BIOCHEM BIOPH RES CO, V349, P825, DOI 10.1016/j.bbrc.2006.08.103; Gonzalez-Periz A, 2009, FASEB J, V23, P1946, DOI 10.1096/fj.08-125674; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Huang XF, 2004, DIABETES OBES METAB, V6, P35, DOI 10.1111/j.1463-1326.2004.00312.x; Hulbert AJ, 2005, BIOL REV, V80, P155, DOI 10.1017/S1464793104006578; Ichimura A, 2012, NATURE, V483, P350, DOI 10.1038/nature10798; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Janovska P, 2013, PHYSIOL RES, V62, P153, DOI 10.33549/physiolres.932464; Kato T, 2008, DIABETES, V57, P2382, DOI 10.2337/db06-1806; Kim EH, 2012, BIOCHEM PHARMACOL, V84, P1359, DOI 10.1016/j.bcp.2012.08.029; Lamping KG, 2013, DIABETES OBES METAB, V15, P144, DOI 10.1111/dom.12004; Lofgren L, 2012, J LIPID RES, V53, P1690, DOI 10.1194/jlr.D023036; Miyauchi S, 2009, N-S ARCH PHARMACOL, V379, P427, DOI 10.1007/s00210-008-0390-8; Mozaffarian D, 2011, J AM COLL CARDIOL, V58, P2047, DOI 10.1016/j.jacc.2011.06.063; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; PAN DA, 1994, J NUTR, V124, P1555, DOI 10.1093/jn/124.9.1555; Perez-Martinez P, 2010, BBA-MOL CELL BIOL L, V1801, P362, DOI 10.1016/j.bbalip.2009.09.010; Rossmeisl M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038834; Scacheri PC, 2001, GENESIS, V30, P259, DOI 10.1002/gene.1072; Stone VM, 2014, DIABETOLOGIA; STORLIEN LH, 1987, SCIENCE, V237, P885, DOI 10.1126/science.3303333; Suckow AT, 2014, J BIOL CHEM; Superko HR, 2013, CIRCULATION, V128, P2154, DOI 10.1161/CIRCULATIONAHA.113.002731; Sykaras AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042373; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Todoric J, 2006, DIABETOLOGIA, V49, P2109, DOI 10.1007/s00125-006-0300-x; White PJ, 2010, DIABETES, V59, P3066, DOI 10.2337/db10-0054; Xu AM, 2003, J CLIN INVEST, V112, P91, DOI 10.1172/JCI200317797	43	49	49	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e114942	10.1371/journal.pone.0114942	http://dx.doi.org/10.1371/journal.pone.0114942			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541716	gold, Green Published, Green Submitted			2022-12-27	WOS:000347239900016
J	Roca-Feltrer, A; Khim, N; Kim, S; Chy, S; Canier, L; Kerleguer, A; Tor, P; Chuor, CM; Kheng, S; Siv, S; Kachur, PS; Taylor, WRJ; Hwang, J; Menard, D				Roca-Feltrer, Arantxa; Khim, Nimol; Kim, Saorin; Chy, Sophy; Canier, Lydie; Kerleguer, Alexandra; Tor, Pety; Chuor, Char Meng; Kheng, Sim; Siv, Sovannaroth; Kachur, Patrick S.; Taylor, Walter R. J.; Hwang, Jimee; Menard, Didier			Field Trial Evaluation of the Performances of Point-of-Care Tests for Screening G6PD Deficiency in Cambodia	PLOS ONE			English	Article							GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENCY; PLASMODIUM-FALCIPARUM; X-CHROMOSOME; PRIMAQUINE; 871G-GREATER-THAN-A; SENSITIVITY; HEMOLYSIS; VARIANT; GENE	Background: User-friendly, accurate, point-of-care rapid tests to detect glucose-6-phosphate dehydrogenase deficiency (G6PDd) are urgently needed at peripheral level to safely recommend primaquine for malaria elimination. Methods: The CareStart G6PD RDT (AccessBio, New Jersey, USA), a novel rapid diagnostic test and the most commonly used test, the fluorescent spot test (FST) were assessed against the quantitatively measured G6PD enzyme activity for detecting G6PDd. Subjects were healthy males and non-pregnant females aged 18 years or older residing in six villages in Pailin Province, western Cambodia. Findings: Of the 938 subjects recruited, 74 (7.9%) were severe and moderately severe G6PD deficient (enzyme activity <30%), mostly in male population; population median G6PD activity was 12.0 UI/g Hb. The performances of the CareStart G6PD RDT and the FST, according to different cut-off values used to define G6PDd were very similar. For the detection of severe and moderately severe G6PDd (enzyme activity <30%, <3.6 UI/g Hb) in males and females, sensitivity and negative (normal status) predictive value were 100% for both point-of-care tools. When the G6PDd cut-off value increased (from <40% to <60%), the sensitivity for both PoCs decreased: 93.3% to 71.7% (CareStart G6PD RDT, p=10(-6)) and 95.5% to 73.2% (FST, p=10(-6)) while the specificity for both PoCs remained similar: 97.4% to 98.3% (CareStart G6PD RDT, p=0.23) and 98.7% to 99.6% (FST, p=0.06). The cut-off values for classifying individuals as normal were 4.0 UI/g Hb and 4.3 UI/g Hb for the CareStart G6PD RDTand the FST, respectively. Conclusions: The CareStart G6PD RDT reliably detected moderate and severe G6PD deficient individuals (enzyme activity <30%), suggesting that this novel point-of-care is a promising tool for tailoring appropriate primaquine treatment for malaria elimination by excluding individuals with severe G6PDd for primaquine treatment.	[Roca-Feltrer, Arantxa] Malaria Consortium, Phnom Penh, Cambodia; [Khim, Nimol; Kim, Saorin; Chy, Sophy; Canier, Lydie; Menard, Didier] Inst Pasteur Cambodia, Malaria Mol Epidemiol Unit, Phnom Penh, Cambodia; [Kerleguer, Alexandra; Tor, Pety] Inst Pasteur Cambodia, Med Lab, Phnom Penh, Cambodia; [Chuor, Char Meng; Kheng, Sim; Siv, Sovannaroth; Taylor, Walter R. J.] Entomol & Malaria Control CNM, Natl Ctr Parasitol, Phnom Penh, Cambodia; [Kachur, Patrick S.] US Ctr Dis Control & Prevent, Atlanta, GA USA; [Taylor, Walter R. J.] Hop Univ Geneve, Ctr Med Humanitaire, Geneva, Switzerland; [Hwang, Jimee] Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94143 USA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; National Center Parasitology, Entomology & Malaria Control; Centers for Disease Control & Prevention - USA; University of Geneva; University of California System; University of California San Francisco	Menard, D (corresponding author), Inst Pasteur Cambodia, Malaria Mol Epidemiol Unit, Phnom Penh, Cambodia.	dmenard@pasteur-kh.org	Menard, Didier/O-3294-2013; Roca-Feltrer, Arantxa/AAW-6986-2020	Menard, Didier/0000-0003-1357-4495; 	Presidents Malaria Initiative via the Office of Health, Infectious Diseases, and Nutrition; Bureau for Global Health, U.S. Agency for International Development; French Ministry of Foreign Affairs	Presidents Malaria Initiative via the Office of Health, Infectious Diseases, and Nutrition(United States Agency for International Development (USAID)President's Malaria Initiative (PMI)); Bureau for Global Health, U.S. Agency for International Development(United States Agency for International Development (USAID)); French Ministry of Foreign Affairs	This research was made possible through support provided by the Presidents Malaria Initiative via the Office of Health, Infectious Diseases, and Nutrition, Bureau for Global Health, U.S. Agency for International Development, under the terms of an Inter-agency Agreement with CDC and by the Institut Pasteur in Cambodia. DM was supported by the French Ministry of Foreign Affairs. WRJT was supported by the 5% initiative of the French Government from October 2013 for one year as a consultant in operational research to the National Center for Parasitology, Entomology and Malaria Control (CNM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG., 1999, PRACTICAL STAT MED R; ALVING A S, 1960, Bull World Health Organ, V22, P621; Baird JK, 2004, CLIN INFECT DIS, V39, P1336, DOI 10.1086/424663; Baird JK, 2012, EXPERT OPIN EMERG DR, V17, P439, DOI 10.1517/14728214.2012.720252; Banoo S, 2010, NAT REV MICROBIOL, pS17, DOI [10.1038/nrmico1523, 10.1038/nrmicro1523]; BERNSTEIN RE, 1962, NATURE, V194, P192, DOI 10.1038/194192a0; BEUTLER E, 1968, BLOOD, V32, P816, DOI 10.1182/blood.V32.5.816.816; BEUTLER E, 1994, BLOOD, V84, P3613, DOI 10.1182/blood.V84.11.3613.bloodjournal84113613; BEUTLER E, 1979, BRIT J HAEMATOL, V43, P465, DOI 10.1111/j.1365-2141.1979.tb03774.x; BEUTLER E, 1962, P NATL ACAD SCI USA, V48, P9, DOI 10.1073/pnas.48.1.9; Beutler E, 2008, BLOOD, V111, P16, DOI 10.1182/blood-2007-04-077412; BREWER GJ, 1962, JAMA-J AM MED ASSOC, V180, P386, DOI 10.1001/jama.1962.03050180032008; Canier L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-405; Cappellini MD, 2008, LANCET, V371, P64, DOI 10.1016/S0140-6736(08)60073-2; CARSON PE, 1956, SCIENCE, V124, P484, DOI 10.1126/science.124.3220.484-a; Chan ER, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001811; CHAN TK, 1976, BRIT MED J, V2, P1227, DOI 10.1136/bmj.2.6046.1227; DERN RJ, 1955, J LAB CLIN MED, V45, P30; Domingo GJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-391; ECHLER G, 1983, AM J MED TECHNOL, V49, P259; EVERETT WD, 1977, AM J TROP MED HYG, V26, P597, DOI 10.4269/ajtmh.1977.26.597; Hill DR, 2006, AM J TROP MED HYG, V75, P402, DOI 10.4269/ajtmh.2006.75.402; Howes RE, 2013, ADV PARASIT, V81, P133, DOI 10.1016/B978-0-12-407826-0.00004-7; Khim N, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-171; Kim S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028357; Louicharoen C, 2005, J HUM GENET, V50, P448, DOI 10.1007/s10038-005-0276-2; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Matsuoka H, 2005, J HUM GENET, V50, P468, DOI 10.1007/s10038-005-0279-z; Shekalaghe SA, 2010, ANTIMICROB AGENTS CH, V54, P1762, DOI 10.1128/AAC.01135-09; Tantular IS, 2003, TROP MED INT HEALTH, V8, P569, DOI 10.1046/j.1365-3156.2003.01055.x; von Seidlein L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-112; White NJ, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-418; WHO, 2013, WORLD MALARIA REPORT 2013, P1	33	41	41	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e116143	10.1371/journal.pone.0116143	http://dx.doi.org/10.1371/journal.pone.0116143			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541721	gold, Green Published, Green Submitted			2022-12-27	WOS:000347239900148
J	Lu, J; Wei, HM; Wu, JJ; Jamil, MFA; Tan, ML; Adenan, MI; Wong, P; Shim, W				Lu, Jun; Wei, Heming; Wu, Jianjun; Jamil, Mohd Fadzly Amar; Tan, Mei Lan; Adenan, Mohd Ilham; Wong, Philip; Shim, Winston			Evaluation of the Cardiotoxicity of Mitragynine and Its Analogues Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes	PLOS ONE			English	Article							CARDIAC POTASSIUM CHANNEL; LONG-QT SYNDROME; SPECIOSA-KORTH; HERG; KRATOM; TRAFFICKING; MECHANISMS; EXTRACTS; LEAVES; MICE	Introduction: Mitragynine is a major bioactive compound of Kratom, which is derived from the leave extracts of Mitragyna speciosa Korth or Mitragyna speciosa (M. speciosa), a medicinal plant from South East Asia used legally in many countries as stimulant with opioid-like effects for the treatment of chronic pain and opioid-withdrawal symptoms. Fatal incidents with Mitragynine have been associated with cardiac arrest. In this study, we determined the cardiotoxicity of Mitragynine and other chemical constituents isolated using human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs). Methods and Results: The rapid delayed rectifier potassium current (l(Kr)), L-type Ca2+ current (I-Ca,(L)) and action potential duration (APD) were measured by whole cell patch-clamp. The expression of KCNH2 and cytotoxicity was determined by real-time PCR and Caspase activity measurements. After significant I-Kr suppression by Mitragynine (10 mu M) was confirmed in hERG-HEK cells, we systematically examined the effects of Mitragynine and other chemical constituents in hiPSC-CMs. Mitragynine, Paynantheine, Speciogynine and Speciociliatine, dosage-dependently (0.1 similar to 100 mu M) suppressed I-Kr in hiPSC-CMs by 67%,84% with IC50 ranged from 0.91 to 2.47 mu M. Moreover, Mitragynine (10 mu M) significantly prolonged APD at 50 and 90% repolarization (APD50 and APD90) (439.0 +/- 11.6 vs. 585.2 +/- 45.5 ms and 536.0 +/- 22.6 vs. 705.9 +/- 46.1 ms, respectively) and induced arrhythmia, without altering the L-type Ca2+ current. Neither the expression, and intracellular distribution of KCNH2/Kv11.1, nor the Caspase 3 activity were significantly affected by Mitragynine. Conclusions: Our study indicates that Mitragynine and its analogues may potentiate Torsade de Pointes through inhibition of IKr in human cardiomyocytes.	[Lu, Jun; Wei, Heming; Wu, Jianjun; Wong, Philip; Shim, Winston] Natl Heart Ctr Singapore, Natl Heart Res Inst Singapore, Singapore, Singapore; [Wei, Heming; Wong, Philip; Shim, Winston] DUKE NUS Grad Med Sch Singapore, Cardiovasc & Metab Disorders Program, Singapore, Singapore; [Tan, Mei Lan; Adenan, Mohd Ilham] Minist Sci Technol & Innovat MOSTI, Malaysian Inst Pharmaceut & Nutraceut, George Town, Malaysia; [Jamil, Mohd Fadzly Amar; Tan, Mei Lan] Univ Sains Malaysia, Adv Med & Dent Inst, George Town, Malaysia	National Heart Centre Singapore; National University of Singapore; Universiti Sains Malaysia	Tan, ML (corresponding author), Minist Sci Technol & Innovat MOSTI, Malaysian Inst Pharmaceut & Nutraceut, George Town, Malaysia.	tanml@usm.my; winston.shim.s.n@nhcs.com.sg	Wu, Jian/AAU-5221-2020; Lan, Tan Mei/E-3500-2012; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Lan, Tan Mei/0000-0001-6565-699X; Wu, Jian/0000-0002-3394-1507	National Research Foundation [NRF2008-CRP003-02]; National Medical Research Council [NMRC EDG10may050]; Ministry of Science, Technology and Innovation Malaysia	National Research Foundation; National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ministry of Science, Technology and Innovation Malaysia(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia)	This work was supported by the National Research Foundation (Grant number NRF2008-CRP003-02) and National Medical Research Council (Grant number NMRC EDG10may050) of Singapore; and the Ministry of Science, Technology and Innovation Malaysia (Sciencefund Grant to Tan Mei Lan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad K, 2012, J ETHNOPHARMACOL, V141, P446, DOI 10.1016/j.jep.2012.03.009; Arndt T, 2011, FORENSIC SCI INT, V208, P47, DOI 10.1016/j.forsciint.2010.10.025; Azizi J, 2010, MOLECULES, V15, P432, DOI 10.3390/molecules15010432; Bellin M, 2013, EMBO J, V32, P3161, DOI 10.1038/emboj.2013.240; Boyer EW, 2008, ADDICTION, V103, P1048, DOI 10.1111/j.1360-0443.2008.02209.x; Caspi O, 2009, STEM CELLS DEV, V18, P161, DOI 10.1089/scd.2007.0280; Chan K B, 2005, Bull Narc, V57, P249; Charbit B, 2008, ANESTHESIOLOGY, V109, P206, DOI 10.1097/ALN.0b013e31817fd8c8; Cubeddu Luigi X, 2003, Am J Ther, V10, P452, DOI 10.1097/00045391-200311000-00013; de Moraes NV, 2009, J CHROMATOGR B, V877, P2593, DOI 10.1016/j.jchromb.2009.06.023; Dykens JA, 2007, DRUG DISCOV TODAY, V12, P777, DOI 10.1016/j.drudis.2007.07.013; Harizal SN, 2010, J ETHNOPHARMACOL, V131, P404, DOI 10.1016/j.jep.2010.07.013; Holler JM, 2011, J ANAL TOXICOL, V35, P54, DOI 10.1093/anatox/35.1.54; Idayu NF, 2011, PHYTOMEDICINE, V18, P402, DOI 10.1016/j.phymed.2010.08.011; Itzhaki I, 2011, NATURE, V471, P225, DOI 10.1038/nature09747; Jamil MF, 2013, J ETHNOPHARMACOL; Kong WM, 2011, MOLECULES, V16, P7344, DOI 10.3390/molecules16097344; Kronstrand R, 2011, J ANAL TOXICOL, V35, P242, DOI 10.1093/anatox/35.4.242; Kumarnsit E, 2007, FITOTERAPIA, V78, P182, DOI 10.1016/j.fitote.2006.11.012; Leon F, 2009, NAT PROD COMMUN, V4, P907; Liang P, 2013, CIRCULATION, V127, P1677, DOI 10.1161/CIRCULATIONAHA.113.001883; Mehta A, 2011, CARDIOVASC RES, V91, P577, DOI 10.1093/cvr/cvr132; Mercola M, 2013, CIRC RES, V112, P534, DOI 10.1161/CIRCRESAHA.111.250266; Neerman MF, 2013, J FORENSIC SCI, V58, pS278, DOI 10.1111/1556-4029.12009; Nelsen JL, 2010, J MED TOXICOL, V6, P424, DOI 10.1007/s13181-010-0079-5; Parthasarathy S, 2009, MOLECULES, V14, P3964, DOI 10.3390/molecules14103964; Perry M, 2010, J PHYSIOL-LONDON, V588, P3157, DOI 10.1113/jphysiol.2010.194670; Philipp AA, 2011, ANAL BIOANAL CHEM, V400, P127, DOI 10.1007/s00216-010-4464-3; Philipp AA, 2010, J MASS SPECTROM, V45, P1344, DOI 10.1002/jms.1848; Rosenbaum CD, 2012, J MED TOXICOL, V8, P15, DOI 10.1007/s13181-011-0202-2; Roy ML, 1996, CIRCULATION, V94, P817, DOI 10.1161/01.CIR.94.4.817; Smith PL, 1996, NATURE, V379, P833, DOI 10.1038/379833a0; Steele DF, 2007, J PHYSIOL-LONDON, V582, P17, DOI 10.1113/jphysiol.2007.130245; SUWANLERT S, 1975, B NARCOTICS, V27, P21; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takayama H, 2004, CHEM PHARM BULL, V52, P916, DOI 10.1248/cpb.52.916; Thomas D, 2003, CARDIOVASC RES, V60, P235, DOI 10.1016/j.cardiores.2003.08.002; Tie H, 2000, BRIT J PHARMACOL, V130, P1967, DOI 10.1038/sj.bjp.0703470; Utar Z, 2011, J ETHNOPHARMACOL, V136, P75, DOI 10.1016/j.jep.2011.04.011; Wei HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050641	40	41	42	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115648	10.1371/journal.pone.0115648	http://dx.doi.org/10.1371/journal.pone.0115648			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25535742	Green Published, Green Submitted, gold			2022-12-27	WOS:000348563300059
J	Aziz, A; Siddique, JI; Aziz, T				Aziz, Asim; Siddique, J. I.; Aziz, Taha			Steady Boundary Layer Slip Flow along with Heat and Mass Transfer over a Flat Porous Plate Embedded in a Porous Medium	PLOS ONE			English	Article							NATURAL-CONVECTION; FORCED-CONVECTION; NON-DARCIAN; VERTICAL-PLATE; POROSITY	In this paper, a simplified model of an incompressible fluid flow along with heat and mass transfer past a porous flat plate embedded in a Darcy type porous medium is investigated. The velocity, thermal and mass slip conditions are utilized that has not been discussed in the literature before. The similarity transformations are used to transform the governing partial differential equations (PDEs) into a nonlinear ordinary differential equations (ODEs). The resulting system of ODEs is then reduced to a system of first order differential equations which was solved numerically by using Matlab bvp4c code. The effects of permeability, suction/injection parameter, velocity parameter and slip parameter on the structure of velocity, temperature and mass transfer rates are examined with the aid of several graphs. Moreover, observations based on Schmidt number and Soret number are also presented. The result shows, the increase in permeability of the porous medium increase the velocity and decrease the temperature profile. This happens due to a decrease in drag of the fluid flow. In the case of heat transfer, the increase in permeability and slip parameter causes an increase in heat transfer. However for the case of increase in thermal slip parameter there is a decrease in heat transfer. An increase in the mass slip parameter causes a decrease in the concentration field. The suction and injection parameter has similar effect on concentration profile as for the case of velocity profile.	[Aziz, Asim] Natl Univ Sci & Technol, Coll Elect & Mech Engn, Rawalpindi 46000, Pakistan; [Siddique, J. I.] Penn State Univ, Dept Math, York, PA 17403 USA; [Aziz, Taha] Univ Witwatersrand, Sch Computat & Appl Math, DST NRF Ctr Excellence Math & Stat Sci, ZA-2050 Johannesburg, South Africa; [Aziz, Taha] Natl Univ Sci & Technol, Sch Nat Sci, Islamabad, Pakistan	National University of Sciences & Technology - Pakistan; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; University of Witwatersrand; National University of Sciences & Technology - Pakistan	Aziz, A (corresponding author), Natl Univ Sci & Technol, Coll Elect & Mech Engn, Rawalpindi 46000, Pakistan.	aaziz@ceme.nust.edu.pk	Aziz, Taha/AAD-5198-2020	Aziz, Asim/0000-0002-2798-5191; Aziz, Taha/0000-0003-0519-1320				ABUSITTA AMM, 1994, APPL MATH COMPUT, V64, P73, DOI 10.1016/0096-3003(94)90140-6; Alazmi B, 2004, J HEAT TRANS-T ASME, V126, P389, DOI 10.1115/1.1723470; Ali F., 2013, PLOS ONE, P8; Andersson HI, 2002, ACTA MECH, V158, P121, DOI 10.1007/BF01463174; Aziz A, 2009, COMMUN NONLINEAR SCI, V14, P1064, DOI 10.1016/j.cnsns.2008.05.003; BEAVERS GS, 1967, J FLUID MECH, V30, P197, DOI 10.1017/S0022112067001375; Bhattacharyya K, 2011, J PETROL SCI ENG, V78, P304, DOI 10.1016/j.petrol.2011.06.009; Blasius H., 1908, GRENZSCHICHTEN FLUSS, V1256; Cortell R, 2005, APPL MATH COMPUT, V170, P706, DOI 10.1016/j.amc.2004.12.037; Cortell R, 2008, CHINESE PHYS LETT, V25, P1340, DOI 10.1088/0256-307X/25/4/048; CRANE LJ, 1970, Z ANGEW MATH PHYS, V21, P645, DOI 10.1007/BF01587695; Falkner VM, 1931, PHILOS MAG, V12, P865; GEBHART B, 1971, INT J HEAT MASS TRAN, V14, P2025, DOI 10.1016/0017-9310(71)90026-3; GEORGANTOPOULOS GA, 1981, ASTROPHYS SPACE SCI, V74, P357, DOI 10.1007/BF00656444; GUPTA PS, 1977, CAN J CHEM ENG, V55, P744, DOI 10.1002/cjce.5450550619; Hajmohammadi MR, 2014, INT J HEAT MASS TRAN, V75, P97, DOI 10.1016/j.ijheatmasstransfer.2014.03.065; Hajmohammadi MR, 2014, APPL MATH COMPUT, V239, P126, DOI 10.1016/j.amc.2014.04.060; Hajmohammadi MR, 2014, HEAT TRANSFER ENG, V35, P863, DOI 10.1080/01457632.2014.852896; Hajmohammadi MR, 2014, J MECH SCI TECHNOL, V28, P1849, DOI 10.1007/s12206-014-0332-y; Hajmohammadi MR, 2013, P I MECH ENG C-J MEC, V227, P492, DOI 10.1177/0954406212463514; HONG JT, 1987, J HEAT TRANS-T ASME, V109, P356, DOI 10.1115/1.3248088; Howarth L, 1938, PROC R SOC LON SER-A, V164, P0547, DOI 10.1098/rspa.1938.0037; Ingham D. B., 1998, TRANSPORT PHENOMENA; Ishak A, 2010, APPL MATH COMPUT, V217, P837, DOI 10.1016/j.amc.2010.06.026; KAVIANY M, 1987, J HEAT TRANS-T ASME, V109, P345, DOI 10.1115/1.3248086; KAVIANY M, 1987, INT J HEAT MASS TRAN, V30, P967, DOI 10.1016/0017-9310(87)90015-9; Khaled ARA, 2003, INT J HEAT MASS TRAN, V46, P4989, DOI 10.1016/S0017-9310(03)00301-6; Khan AE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108715; Khan WA, 2014, APPL NANOSCI, V4, P633, DOI 10.1007/s13204-013-0242-9; Khan ZH, 2009, HT2008: PROCEEDINGS OF THE ASME SUMMER HEAT TRANSFER CONFERENCE, VOL 1, P301, DOI 10.1115/HT2008-56448; KUMARI M, 1990, ACTA MECH, V84, P201, DOI 10.1007/BF01176098; Luna N, 2005, INT J THERM SCI, V44, P656, DOI 10.1016/j.ijthermalsci.2004.12.008; Magyari E, 2011, COMMUN NONLINEAR SCI, V16, P599, DOI 10.1016/j.cnsns.2010.03.020; Martin MJ, 2006, J THERMOPHYS HEAT TR, V20, P710, DOI 10.2514/1.22968; Nadeem S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069811; Nield D.A., 1998, CONVECTION POROUS ME; Pal D, 2010, COMMUN NONLINEAR SCI, V15, P1813, DOI 10.1016/j.cnsns.2009.07.011; Prandtl L., 1905, VERH 3 INT MATH K HE, P484; Qasim M., 2014, PLOS ONE, V9; Qasim M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059393; SAKIADIS BC, 1961, AICHE J, V7, P26, DOI 10.1002/aic.690070108; Vafai K., 2000, HDB POROUS MEDIA, V1st; Wang CY, 2002, CHEM ENG SCI, V57, P3745, DOI 10.1016/S0009-2509(02)00267-1; Yao SS, 2011, COMMUN NONLINEAR SCI, V16, P752, DOI 10.1016/j.cnsns.2010.05.028	44	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e114544	10.1371/journal.pone.0114544	http://dx.doi.org/10.1371/journal.pone.0114544			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531301	Green Published, gold, Green Submitted			2022-12-27	WOS:000348845100017
J	Jensik, PJ; Vargas, JD; Reardon, SN; Rajamanickam, S; Huggenvik, JI; Collard, MW				Jensik, Philip J.; Vargas, Jesse D.; Reardon, Sara N.; Rajamanickam, Shivakumar; Huggenvik, Jodi I.; Collard, Michael W.			DEAF1 Binds Unmethylated and Variably Spaced CpG Dinucleotide Motifs	PLOS ONE			English	Article							MAJOR DEPRESSIVE DISORDER; FACTOR-I DEAF-1; TRANSCRIPTIONAL REGULATION; CYTOSINE METHYLATION; SAND DOMAIN; PROTEIN; GENES; EXPRESSION; SITES; NUDR	DEAF1 is a transcriptional regulator associated with autoimmune and neurological disorders and is known to bind TTCG motifs. To further ascertain preferred DEAF1 DNA ligands, we screened a random oligonucleotide library containing an "anchored'' CpG motif. We identified a binding consensus that generally conformed to a repeated TTCGGG motif, with the two invariant CpG dinucleotides separated by 6-11 nucleotides. Alteration of the consensus surrounding the dual CpG dinucleotides, or cytosine methylation of a single CpG half-site, eliminated DEAF1 binding. A sequence within the Htr1a promoter that resembles the binding consensus but contains a single CpG motif was confirmed to have low affinity binding with DEAF1. A DEAF1 binding consensus was identified in the EIF4G3 promoter and ChIP assay showed endogenous DEAF1 was bound to the region. We conclude that DEAF1 preferentially binds variably spaced and unmethylated CpG-containing half-sites when they occur within an appropriate consensus.	[Jensik, Philip J.; Vargas, Jesse D.; Reardon, Sara N.; Rajamanickam, Shivakumar; Huggenvik, Jodi I.; Collard, Michael W.] So Illinois Univ, Sch Med, Dept Physiol, Carbondale, IL 62901 USA	Southern Illinois University System; Southern Illinois University	Jensik, PJ (corresponding author), So Illinois Univ, Sch Med, Dept Physiol, Carbondale, IL 62901 USA.	pjensik@siumed.edu		Vargas, Jesse/0000-0002-3671-6778	National Institutes of Health [CA89438, CA137556, HD060122]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R15HD060122] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R15CA137556, R01CA089438] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grants CA89438, CA137556, and HD060122 to JH and MC (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert PR, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00199; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Barker HE, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-94; Bottomley MJ, 2001, NAT STRUCT BIOL, V8, P626, DOI 10.1038/89675; Burnett E, 2001, J MOL BIOL, V314, P1029, DOI 10.1006/jmbi.2000.5198; CROSS SH, 1995, CURR OPIN GENET DEV, V5, P309, DOI 10.1016/0959-437X(95)80044-1; Cubeddu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039218; Czesak M, 2012, J BIOL CHEM, V287, P6615, DOI 10.1074/jbc.M111.293027; Goswami DB, 2010, J NEUROCHEM, V112, P397, DOI 10.1111/j.1471-4159.2009.06462.x; Gross CT, 1996, EMBO J, V15, P1961, DOI 10.1002/j.1460-2075.1996.tb00547.x; Hahm KM, 2004, MOL CELL BIOL, V24, P2074, DOI 10.1128/MCB.24.5.2074-2082.2004; Huggenvik JI, 1998, MOL ENDOCRINOL, V12, P1619, DOI 10.1210/me.12.10.1619; Jensik PJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033404; Jensik PJ, 2004, J BIOL CHEM, V279, P32692, DOI 10.1074/jbc.M400946200; Joseph S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109108; Joseph S, 2014, BIOMOL NMR ASSIGN, V8, P141, DOI 10.1007/s12104-013-9470-x; Kateb F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054715; Lemonde S, 2003, J NEUROSCI, V23, P8788; Lo Surdo P, 2003, MOL ENDOCRINOL, V17, P1283, DOI 10.1210/me.2002-0409; Manne U, 2001, CLIN CANCER RES, V7, P3495; Medvedeva YA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-119; Michelson RJ, 1999, J BIOL CHEM, V274, P30510, DOI 10.1074/jbc.274.43.30510; Ordureau A, 2013, J BIOL CHEM, V288, P24569, DOI 10.1074/jbc.M113.479550; Perini G, 2005, P NATL ACAD SCI USA, V102, P12117, DOI 10.1073/pnas.0409097102; Rishi V, 2010, P NATL ACAD SCI USA, V107, P20311, DOI 10.1073/pnas.1008688107; Sen N, 2009, BIOINFORMATION, V3, P415, DOI 10.6026/97320630003415; Szewczyk B, 2009, INT J NEUROPSYCHOPH, V12, P155, DOI 10.1017/S1461145708009012; Thomas-Chollier M, 2011, NUCLEIC ACIDS RES, V39, pW86, DOI 10.1093/nar/gkr377; Veraksa A, 2002, GENESIS, V33, P67, DOI 10.1002/gene.10090; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Vulto-van Silfhout AT, 2014, AM J HUM GENET, V94, P649, DOI 10.1016/j.ajhg.2014.03.013; Walsh CP, 1999, GENE DEV, V13, P26, DOI 10.1101/gad.13.1.26; Yip L, 2013, J MOL CELL BIOL, V5, P99, DOI 10.1093/jmcb/mjs052; Yip LD, 2009, NAT IMMUNOL, V10, P1026, DOI 10.1038/ni.1773	34	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115908	10.1371/journal.pone.0115908	http://dx.doi.org/10.1371/journal.pone.0115908			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531106	Green Published, Green Submitted, gold			2022-12-27	WOS:000348845100116
J	Liu, XJ; Zheng, YB; Li, Y; Wu, SY; Zhen, YS				Liu, Xiu-Jun; Zheng, Yan-Bo; Li, Yi; Wu, Shu-Ying; Zhen, Yong-Su			A Multifunctional Drug Combination Shows Highly Potent Therapeutic Efficacy against Human Cancer Xenografts in Athymic Mice	PLOS ONE			English	Article							TUMOR MICROENVIRONMENT; BESTATIN; TARGET; DIPYRIDAMOLE; ANGIOGENESIS; INHIBITOR	The tumor microenvironment plays a crucial role during tumor development. Integrated combination of drugs that target tumor microenvironment is a promising approach to anticancer therapy. Here, we report a multifunctional combination of low-cytotoxic drugs composed of dipyridamole, bestatin and dexamethasone (DBDx) which mainly acts on the tumor microenvironment shows highly potent antitumor efficacy in vivo. In mouse hepatoma H22 model, the triple drug combination showed synergistic and highly potent antitumor efficacy. The combination indices of various combinations of the triple drugs were between 0.2 and 0.5. DBDx inhibited the growth of a panel of human tumor xenografts and showed no obvious systemic toxicity. At tolerated doses, DBDx suppressed the growth of human hepatocellular carcinoma BEL-7402, HepG2, and lung adenocarcinoma A549 xenografts by 94.5%, 93.7% and 96.9%, respectively. Clonogenic assay demonstrated that DBDx showed weak cytotoxicity. Western blot showed that Flk1 and Nos3 were down-regulated in the DBDx-treated group. Proteomic analysis showed that DBDx mainly affected the metabolic process and immune system process; in addition, the angiogenesis and VEGF signaling pathway were also affected. Conclusively, DBDx, a multifunctional drug combination of three low-cytotoxic drugs, shows synergistic and highly potent antitumor efficacy evidently mediated by the modulation of tumor microenvironment. Based on its low-cytotoxic attributes and its broad-spectrum antitumor therapeutic efficacy, this multifunctional combination might be useful in the treatment of cancers, especially those refractory to conventional chemotherapeutics.	[Zhen, Yong-Su] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Zhen, YS (corresponding author), Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100730, Peoples R China.	zhenysm@126.com		Zheng, Yan-Bo/0000-0001-9552-8411	"Significant new drugs development'' Major Science and Technology Projects of China [2012ZX09301002]; National Natural Science Foundation of China [81201665]	"Significant new drugs development'' Major Science and Technology Projects of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the "Significant new drugs development'' Major Science and Technology Projects of China (No. 2012ZX09301002, http://www.nmp.gov.cn) and the National Natural Science Foundation of China (No. 81201665, http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aapro MS, 2013, CANCER TREAT REV, V39, P113, DOI 10.1016/j.ctrv.2012.09.002; Albini A, 2007, NAT REV CANCER, V7, P139, DOI 10.1038/nrc2067; Aozuka Y, 2004, CANCER LETT, V216, P35, DOI 10.1016/j.canlet.2004.06.050; Blansfield JA, 2008, CLIN CANCER RES, V14, P270, DOI 10.1158/1078-0432.CCR-07-1562; CAO SS, 1989, CANCER CHEMOTH PHARM, V24, P181, DOI 10.1007/BF00300240; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Fan Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093264; Fukumura D, 2006, NAT REV CANCER, V6, P521, DOI 10.1038/nrc1910; Furuse K, 1993, Gan To Kagaku Ryoho, V20, P1187; Gus-Brautbar Y, 2012, MOL CELL, V45, P610, DOI 10.1016/j.molcel.2012.01.006; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Lu HT, 2006, MOL CANCER RES, V4, P221, DOI 10.1158/1541-7786.MCR-05-0261; Mangiameli DP, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-38; Mayer LD, 2006, MOL CANCER THER, V5, P1854, DOI 10.1158/1535-7163.MCT-06-0118; OZONO S, 1990, ACTA ONCOL, V29, P813, DOI 10.3109/02841869009093006; Reisfeld Ralph A., 2013, Critical Reviews in Oncogenesis, V18, P115; Spano D, 2013, CLIN EXP METASTAS, V30, P47, DOI 10.1007/s10585-012-9506-0; Swartz MA, 2012, CANCER RES, V72, P2473, DOI 10.1158/0008-5472.CAN-12-0122; TALMADGE JE, 1986, CANCER RES, V46, P4505; Whiteside TL, 2008, ONCOGENE, V27, P5904, DOI 10.1038/onc.2008.271; Yano A, 2006, CLIN CANCER RES, V12, P3003, DOI 10.1158/1078-0432.CCR-05-2085; Zheng Yan-Bo, 2012, Yao Xue Xue Bao, V47, P1593	24	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115790	10.1371/journal.pone.0115790	http://dx.doi.org/10.1371/journal.pone.0115790			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531414	gold, Green Published, Green Submitted			2022-12-27	WOS:000348845100108
J	Wehner, T; Steiner, M; Ignatius, A; Claes, L				Wehner, Tim; Steiner, Malte; Ignatius, Anita; Claes, Lutz			Prediction of the Time Course of Callus Stiffness as a Function of Mechanical Parameters in Experimental Rat Fracture Healing Studies - A Numerical Study	PLOS ONE			English	Article							TISSUE DIFFERENTIATION; GAP SIZE; BONE; MODEL; SIMULATION; STABILITY; FIXATION; STIMULI; TRAUMA; CELL	Numerous experimental fracture healing studies are performed on rats, in which different experimental, mechanical parameters are applied, thereby prohibiting direct comparison between each other. Numerical fracture healing simulation models are able to predict courses of fracture healing and offer support for pre-planning animal experiments and for post-hoc comparison between outcomes of different in vivo studies. The aims of this study are to adapt a pre-existing fracture healing simulation algorithm for sheep and humans to the rat, to corroborate it using the data of numerous different rat experiments, and to provide healing predictions for future rat experiments. First, material properties of different tissue types involved were adjusted by comparing experimentally measured callus stiffness to respective simulated values obtained in three finite element (FE) models. This yielded values for Young's moduli of cortical bone, woven bone, cartilage, and connective tissue of 15,750 MPa, 1,000 MPa, 5 MPa, and 1 MPa, respectively. Next, thresholds in the underlying mechanoregulatory tissue differentiation rules were calibrated by modifying model parameters so that predicted fracture callus stiffness matched experimental data from a study that used rigid and flexible fixators. This resulted in strain thresholds at higher magnitudes than in models for sheep and humans. The resulting numerical model was then used to simulate numerous fracture healing scenarios from literature, showing a considerable mismatch in only 6 of 21 cases. Based on this corroborated model, a fit curve function was derived which predicts the increase of callus stiffness dependent on bodyweight, fixation stiffness, and fracture gap size. By mathematically predicting the time course of the healing process prior to the animal studies, the data presented in this work provides support for planning new fracture healing experiments in rats. Furthermore, it allows one to transfer and compare new in vivo findings to previously performed studies with differing mechanical parameters.	[Wehner, Tim; Steiner, Malte; Ignatius, Anita; Claes, Lutz] Univ Hosp Ulm, Ctr Musculoskeletal Res Ulm, Inst Orthoped Res & Biomechan, Ulm, Germany	Ulm University	Steiner, M (corresponding author), Univ Hosp Ulm, Ctr Musculoskeletal Res Ulm, Inst Orthoped Res & Biomechan, Ulm, Germany.	malte.steiner@uni-ulm.de	Claes, Lutz/O-4697-2014; Ignatius, Anita/M-6012-2013	Ignatius, Anita/0000-0002-4782-1979; Aegerter, Christof/0000-0002-7200-7987	German Research Foundation [WE 4859/1-1]	German Research Foundation(German Research Foundation (DFG))	This work was funded by the German Research Foundation (WE 4859/1-1), www.dfg.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailon-Plaza A, 2001, J THEOR BIOL, V212, P191, DOI 10.1006/jtbi.2001.2372; Checa S, 2011, J BIOMECH, V44, P1237, DOI 10.1016/j.jbiomech.2011.02.074; Checa S, 2009, ANN BIOMED ENG, V37, P129, DOI 10.1007/s10439-008-9594-9; Claes L, 1997, J ORTHOP RES, V15, P577, DOI 10.1002/jor.1100150414; Claes LE, 1999, J BIOMECH, V32, P255, DOI 10.1016/S0021-9290(98)00153-5; Claes L, 2009, J ORTHOP RES, V27, P22, DOI 10.1002/jor.20712; Einhorn TA, 1998, CLIN ORTHOP RELAT R, pS7; Geris L, 2010, BIOMECH MODEL MECHAN, V9, P713, DOI 10.1007/s10237-010-0208-8; Gomez-Benito MJ, 2005, J THEOR BIOL, V235, P105, DOI 10.1016/j.jtbi.2004.12.023; GOODSHIP AE, 1985, J BONE JOINT SURG BR, V67, P650, DOI 10.1302/0301-620X.67B4.4030869; Harrison LJ, 2003, J ORTHOP TRAUMA, V17, P11, DOI 10.1097/00005131-200301000-00003; Isaksson H, 2008, J THEOR BIOL, V252, P230, DOI 10.1016/j.jtbi.2008.01.030; Kaspar K, 2007, BIOMED TECH, V52, P383, DOI 10.1515/BMT.2007.063; Lacroix D, 2002, J BIOMECH, V35, P1163, DOI 10.1016/S0021-9290(02)00086-6; Leong PL, 2008, ACTA BIOMATER, V4, P1569, DOI 10.1016/j.actbio.2008.02.030; Mark H, 2005, ACTA ORTHOP, V76, P428, DOI 10.1080/17453670510041349; Mehta M, 2011, CLIN ORTHOP RELAT R, V469, P3102, DOI 10.1007/s11999-011-1914-y; Mehta M, 2011, ARCH ORTHOP TRAUM SU, V131, P121, DOI 10.1007/s00402-010-1155-7; ONI OOA, 1991, CLIN ORTHOP RELAT R, P278; Prendergast PJ, 1997, J BIOMECH, V30, P539, DOI 10.1016/S0021-9290(96)00140-6; Recknagel S, 2013, J ORTHOP RES, V31, P465, DOI 10.1002/jor.22242; Recknagel S, 2012, J ORTHOP RES, V30, P581, DOI 10.1002/jor.21561; Recknagel S, 2011, J ORTHOP RES, V29, P734, DOI 10.1002/jor.21299; RUBIN CT, 1987, J ORTHOPAED RES, V5, P300, DOI 10.1002/jor.1100050217; Shefelbine SJ, 2005, J BIOMECH, V38, P2440, DOI 10.1016/j.jbiomech.2004.10.019; Simon U, 2011, COMPUT METHOD BIOMEC, V14, P79, DOI 10.1080/10255842.2010.499865; Smit TH, 2002, J BIOMECH, V35, P829, DOI 10.1016/S0021-9290(02)00021-0; Steiner M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101370; Steiner M, 2014, J ORTHOP RES, V32, P865, DOI 10.1002/jor.22617; Steiner M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0389; Strube P, 2008, BONE, V42, P758, DOI 10.1016/S0021-9290(08)70350-6; Strube P, 2009, BONE, V45, P1065, DOI 10.1016/j.bone.2009.08.005; Wehner T, 2014, J ORTHOP RE IN PRESS; Wehner T, 2014, J ORTHOP RES, V32, P1589, DOI 10.1002/jor.22721; Wehner T, 2012, J ORTHOP RES, V30, P569, DOI 10.1002/jor.21568; Wehner T, 2010, J BIOMECH, V43, P2473, DOI 10.1016/j.jbiomech.2010.05.028; Wehner T, 2010, CLIN BIOMECH, V25, P606, DOI 10.1016/j.clinbiomech.2010.03.003	37	23	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115695	10.1371/journal.pone.0115695	http://dx.doi.org/10.1371/journal.pone.0115695			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25532060	Green Published, Green Submitted, gold			2022-12-27	WOS:000348845100095
J	Zhang, XW; Wang, DF; Zhao, SN; Shen, ZC				Zhang, Xianwen; Wang, Dongfang; Zhao, Sinan; Shen, Zhicheng			A Double Built-In Containment Strategy for Production of Recombinant Proteins in Transgenic Rice	PLOS ONE			English	Article							RED FLUORESCENT PROTEIN; USE RESTRICTION TECHNOLOGIES; HUMAN SERUM-ALBUMIN; GENE FLOW; ORYZA-SATIVA; LARGE-SCALE; EXPRESSION; MAIZE; TRANSFORMATION; PURIFICATION	Using transgenic rice as a bioreactor for mass production of pharmaceutical proteins could potentially reduce the cost of production significantly. However, a major concern over the bioreactor transgenic rice is the risk of its unintended spreading into environment and into food or feed supplies. Here we report a mitigating method to prevent unwanted transgenic rice spreading by a double built-in containment strategy, which sets a selectively termination method and a visual tag technology in the T-DNA for transformation. We created transgenic rice with an inserted T-DNA that harbors a human proinsulin gene fused with the far-red fluorescent protein gene mKate_S158A, an RNAi cassette suppressing the expression of the rice bentazon detoxification enzyme CYP81A6, and an EPSPS gene as the selection marker for transformation. Herbicide spray tests indicated that such transgenic rice plants can be killed selectively by a spray of bentazon at regular field application dosage for rice weed control. Moreover, the transgenic rice seeds were bright red in color due to the fused far-red fluorescent protein, and could be easily visualized under daylight by naked eyes. Thus, the transgenic rice plants reported in this study could be selectively killed by a commonly used herbicide during their growth stage, and their seeds may be detected visually during processing and consumption after harvest. This double built-in containment strategy may greatly enhance the confinement of the transgenic rice.	[Zhang, Xianwen; Wang, Dongfang; Zhao, Sinan; Shen, Zhicheng] Zhejiang Univ, Coll Agr & Biotechnol, Inst Insect Sci, State Key Lab Rice Biol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Shen, ZC (corresponding author), Zhejiang Univ, Coll Agr & Biotechnol, Inst Insect Sci, State Key Lab Rice Biol, Hangzhou 310003, Zhejiang, Peoples R China.	zcshen@zju.edu.cn	zhang, xian/GYA-0290-2022		Department of Agriculture of China [2014ZX08011-006]	Department of Agriculture of China	This work was supported by the Grant from the Department of Agriculture of China (2014ZX08011-006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boothe J, 2010, PLANT BIOTECHNOL J, V8, P588, DOI 10.1111/j.1467-7652.2010.00511.x; Breyer D, 2009, J MED PLANTS RES, V3, P825; Chase CD, 2006, TRENDS PLANT SCI, V11, P7, DOI 10.1016/j.tplants.2005.11.003; Chebolu S, 2009, CURR TOP MICROBIOL, V332, P33, DOI 10.1007/978-3-540-70868-1_3; Chen LJ, 2004, ANN BOT-LONDON, V93, P67, DOI 10.1093/aob/mch006; Chong SR, 1998, NUCLEIC ACIDS RES, V26, P5109, DOI 10.1093/nar/26.22.5109; Chong SR, 1996, J BIOL CHEM, V271, P22159, DOI 10.1074/jbc.271.36.22159; Chong SR, 1997, GENE, V192, P271, DOI 10.1016/S0378-1119(97)00105-4; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; DEZOETEN GA, 1989, VIROLOGY, V172, P213, DOI 10.1016/0042-6822(89)90123-2; Feil B, 2003, EUPHYTICA, V130, P163, DOI 10.1023/A:1022843504598; Franz N, 2001, CHEM WEEK, V163, P33; Gressel J, 2010, PLANT SCI, V179, P630, DOI 10.1016/j.plantsci.2010.02.012; Grevich JJ, 2005, CRIT REV PLANT SCI, V24, P83, DOI 10.1080/07352680590935387; Ha SH, 2010, PLANT BIOTECHNOL J, V8, P928, DOI 10.1111/j.1467-7652.2010.00543.x; Haider N, 2009, CURR GENET, V55, P139, DOI 10.1007/s00294-009-0230-5; He Y, 2011, P NATL ACAD SCI USA, V108, P19078, DOI 10.1073/pnas.1109736108; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Hileman B, 2003, CHEM ENG NEWS, V81, P30; Hills MJ, 2007, TRENDS PLANT SCI, V12, P177, DOI 10.1016/j.tplants.2007.02.002; Hood EE, 1997, MOL BREEDING, V3, P291, DOI 10.1023/A:1009676322162; Jach G, 2001, PLANT J, V28, P483, DOI 10.1046/j.1365-313X.2001.01153.x; Kamle S, 2013, GENE, V522, P123, DOI 10.1016/j.gene.2013.03.107; Kuo YC, 2013, INT J MOL SCI, V14, P8719, DOI 10.3390/ijms14058719; Lau OS, 2009, BIOTECHNOL ADV, V27, P1015, DOI 10.1016/j.biotechadv.2009.05.005; Lin CY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001818; Lin CY, 2010, PROTEIN EXPRES PURIF, V74, P60, DOI 10.1016/j.pep.2010.04.015; Liu CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031625; Luo H, 2005, MOL BREEDING, V16, P185, DOI 10.1007/s11032-005-4784-8; Ma JKC, 2005, EMBO REP, V6, P593, DOI 10.1038/sj.embor.7400470; Mallory-Smith C, 2008, PEST MANAG SCI, V64, P428, DOI 10.1002/ps.1517; Mann DGJ, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-17; Murphy DJ, 2007, PLANT BIOTECHNOL J, V5, P555, DOI 10.1111/j.1467-7652.2007.00278.x; Nishizawa K, 2006, PLANT CELL REP, V25, P1355, DOI 10.1007/s00299-006-0210-x; Ou JQ, 2014, PLANT CELL REP, V33, P585, DOI 10.1007/s00299-013-1559-2; Pan G, 2006, PLANT MOL BIOL, V61, P933, DOI 10.1007/s11103-006-0058-z; Pletnev S, 2008, J BIOL CHEM, V283, P28980, DOI 10.1074/jbc.M800599200; Qian BJ, 2008, TRANSGENIC RES, V17, P621, DOI 10.1007/s11248-007-9135-6; Ramessar Koreen, 2008, Phytochemistry Reviews, V7, P579, DOI 10.1007/s11101-008-9087-3; Rizzon C, 2006, PLOS COMPUT BIOL, V2, P989, DOI 10.1371/journal.pcbi.0020115; Sang Y, 2013, PLANT BIOTECHNOL J, V11, P649, DOI 10.1111/pbi.12084; Stewart CN, 2001, PLANT CELL REP, V20, P376, DOI 10.1007/s002990100346; Stoger E, 2005, CURR OPIN BIOTECH, V16, P167, DOI 10.1016/j.copbio.2005.01.005; Szymczak- Workman AL, 2012, COLD SPRING HARBOR P, V2012; von der Lippe M, 2007, ECOGRAPHY, V30, P483, DOI 10.1111/j.2007.0906-7590.05072.x; Woodard SL, 2003, BIOTECHNOL APPL BIOC, V38, P123, DOI 10.1042/BA20030026; Xu MQ, 1996, EMBO J, V15, P5146, DOI 10.1002/j.1460-2075.1996.tb00898.x; Yang Y, 2014, PLANT BIOTECHNOL J, V12, P963, DOI 10.1111/pbi.12204; Yoshida S., 1976, LAB MANUAL PHYSL STU, P61; ZENG ZB, 1993, P NATL ACAD SCI USA, V90, P10972, DOI 10.1073/pnas.90.23.10972; Zhang NY, 2003, EUPHYTICA, V130, P35, DOI 10.1023/A:1022371104679; Zhang Q, 2013, J ZHEJIANG UNIV-SC B, V14, P867, DOI 10.1631/jzus.B1300090; Zhang Q, 2012, PROTEIN EXPRES PURIF, V82, P279, DOI 10.1016/j.pep.2012.01.011	53	3	3	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115459	10.1371/journal.pone.0115459	http://dx.doi.org/10.1371/journal.pone.0115459			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531447	Green Submitted, Green Published, gold			2022-12-27	WOS:000348845100069
J	Cheng, FHC; Aguda, BD; Tsai, JC; Kochanczyk, M; Lin, JMJ; Chen, GCW; Lai, HC; Nephew, KP; Hwang, TW; Chan, MWY				Cheng, Frank H. C.; Aguda, Baltazar D.; Tsai, Je-Chiang; Kochanczyk, Marek; Lin, Jora M. J.; Chen, Gary C. W.; Lai, Hung-Cheng; Nephew, Kenneth P.; Hwang, Tzy-Wei; Chan, Michael W. Y.			A Mathematical Model of Bimodal Epigenetic Control of miR-193a in Ovarian Cancer Stem Cells	PLOS ONE			English	Article							HORMONE-THERAPY; DNA METHYLATION; MICRORNAS; PROLIFERATION; EXPRESSION; RISK; GENE	Accumulating data indicate that cancer stem cells contribute to tumor chemoresistance and their persistence alters clinical outcome. Our previous study has shown that ovarian cancer may be initiated by ovarian cancer initiating cells (OCIC) characterized by surface antigen CD44 and c-KIT (CD117). It has been experimentally demonstrated that a microRNA, namely miR-193a, targets c-KIT mRNA for degradation and could play a crucial role in ovarian cancer development. How miR-193a is regulated is poorly understood and the emerging picture is complex. To unravel this complexity, we propose a mathematical model to explore how estrogen-mediated up-regulation of another target of miR-193a, namely E2F6, can attenuate the function of miR-193a in two ways, one through a competition of E2F6 and c-KIT transcripts for miR-193a, and second by binding of E2F6 protein, in association with a polycomb complex, to the promoter of miR-193a to downregulate its transcription. Our model predicts that this bimodal control increases the expression of c-KITand that the second mode of epigenetic regulation is required to generate a switching behavior in c-KIT and E2F6 expressions. Additional analysis of the TCGA ovarian cancer dataset demonstrates that ovarian cancer patients with low expression of EZH2, a polycomb-group family protein, show positive correlation between E2F6 and c-KIT. We conjecture that a simultaneous EZH2 inhibition and anti-estrogen therapy can constitute an effective combined therapeutic strategy against ovarian cancer.	[Cheng, Frank H. C.; Lin, Jora M. J.; Chen, Gary C. W.; Chan, Michael W. Y.] Natl Chung Cheng Univ, Dept Life Sci, Chiayi, Taiwan; [Cheng, Frank H. C.; Lin, Jora M. J.; Chen, Gary C. W.; Chan, Michael W. Y.] Natl Chung Cheng Univ, Inst Mol Biol, Chiayi, Taiwan; [Tsai, Je-Chiang; Hwang, Tzy-Wei] Natl Chung Cheng Univ, Dept Math, Chiayi, Taiwan; [Aguda, Baltazar D.] DiseasePathways LLC, Bethesda, MD USA; [Kochanczyk, Marek] Polish Acad Sci, Inst Fundamental Technol Res, Warsaw, Poland; [Lai, Hung-Cheng] Taipei Med Univ, Coll Med, Sch Med, Dept Obstet & Gynecol, Taipei, Taiwan; [Lai, Hung-Cheng] Taipei Med Univ, Shuang Ho Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Lai, Hung-Cheng] Cent South Univ, Xiangya Hosp, Dept Clin Pharmacol, Changsha, Hunan, Peoples R China; [Lai, Hung-Cheng] Cent South Univ, Inst Clin Pharmacol, Changsha, Hunan, Peoples R China; [Lai, Hung-Cheng] Hunan Key Lab Pharmacogenet, Changsha, Hunan, Peoples R China; [Nephew, Kenneth P.] Indiana Univ, Sch Med, Dept Cellular & Integrat Physiol, Bloomington, IN USA	National Chung Cheng University; National Chung Cheng University; National Chung Cheng University; Polish Academy of Sciences; Institute of Fundamental Technological Research of the Polish Academy of Sciences; Taipei Medical University; Taipei Medical University; Shuang Ho Hospital; Central South University; Central South University; Indiana University System; Indiana University Bloomington	Hwang, TW (corresponding author), Natl Chung Cheng Univ, Dept Math, Chiayi, Taiwan.	twhwang@math.ccu.edu.tw; biowyc@ccu.edu.tw	Kochanczyk, Marek/D-7825-2011; Chan, Michael/F-9615-2018	Kochanczyk, Marek/0000-0003-1215-3920; Chan, Michael/0000-0003-1431-322X; Chan, Michael/0000-0003-0314-2437	Ministry of Science and Technology, Taiwan [NSC102-2320-B-194-006, NSC102-2115-M-194-007-MY2, MOST103-2911-I-194- 504, MOST103-2320-B-194-002]; National Center for Theoretical Sciences (NCTS); National Chung Cheng University (NCCU Interdisciplinary Science), Taiwan [103-03]; DiseasePathways LLC	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Center for Theoretical Sciences (NCTS); National Chung Cheng University (NCCU Interdisciplinary Science), Taiwan; DiseasePathways LLC	This study was supported by the research grants from the Ministry of Science and Technology, Taiwan (NSC102-2320-B-194-006, NSC102-2115-M-194-007-MY2, MOST103-2911-I-194- 504 and MOST103-2320-B-194-002), National Center for Theoretical Sciences (NCTS), and National Chung Cheng University (NCCU Interdisciplinary Science grant 103-03), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-author Baltazar D. Aguda is employed by DiseasePathways LLC. DiseasePathways LLC provided support in the form of salary for author BDA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the "author contributions'' section.	Attwooll C, 2005, J BIOL CHEM, V280, P1199, DOI 10.1074/jbc.M412509200; Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Beral V, 2007, LANCET, V369, P1703, DOI 10.1016/S0140-6736(07)60534-0; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Chau WK, 2013, ONCOGENE, V32, P2767, DOI 10.1038/onc.2012.290; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Cunat S, 2004, GYNECOL ONCOL, V94, P25, DOI 10.1016/j.ygyno.2004.03.026; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Fung-Kee-Fung M, 2007, Curr Oncol, V14, P195; Gao XN, 2011, ONCOGENE, V30, P3416, DOI 10.1038/onc.2011.62; Garzon R, 2010, NAT REV DRUG DISCOV, V9, P775, DOI 10.1038/nrd3179; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Glud E, 2004, ARCH INTERN MED, V164, P2253, DOI 10.1001/archinte.164.20.2253; Heller G, 2012, CLIN CANCER RES, V18, P1619, DOI 10.1158/1078-0432.CCR-11-2450; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kozaki KI, 2008, CANCER RES, V68, P2094, DOI 10.1158/0008-5472.CAN-07-5194; Lacey JV, 2006, JNCI-J NATL CANCER I, V98, P1397, DOI 10.1093/jnci/djj375; Li H, 2010, MOL CANCER RES, V8, P1610, DOI 10.1158/1541-7786.MCR-10-0398; Li YH, 2013, BLOOD, V121, P499, DOI 10.1182/blood-2012-07-444729; Lu CH, 2010, CANCER CELL, V18, P185, DOI 10.1016/j.ccr.2010.06.016; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Makar AP, 2000, ENDOCR-RELAT CANCER, V7, P85, DOI 10.1677/erc.0.0070085; Nossov V, 2008, AM J OBSTET GYNECOL, V199, P215, DOI 10.1016/j.ajog.2008.04.009; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Smyth JF, 2007, CLIN CANCER RES, V13, P3617, DOI 10.1158/1078-0432.CCR-06-2878; Trimarchi JM, 2001, P NATL ACAD SCI USA, V98, P1519, DOI 10.1073/pnas.041597698; Velasco G, 2010, P NATL ACAD SCI USA, V107, P9281, DOI 10.1073/pnas.1000473107; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; WEISS NS, 1982, J NATL CANCER I, V68, P95; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364	35	13	13	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e116050	10.1371/journal.pone.0116050	http://dx.doi.org/10.1371/journal.pone.0116050			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545504	Green Published, gold			2022-12-27	WOS:000347120200093
J	Kuhn, M; Hoger, N; Feige, B; Blechert, J; Normann, C; Nissen, C				Kuhn, Marion; Hoeger, Nora; Feige, Bernd; Blechert, Jens; Normann, Claus; Nissen, Christoph			Fear Extinction as a Model for Synaptic Plasticity in Major Depressive Disorder	PLOS ONE			English	Article							MEDIAL TEMPORAL-LOBE; CONDITIONED FEAR; POTENTIATED STARTLE; HIPPOCAMPAL VOLUME; SPONTANEOUS-RECOVERY; UNIPOLAR DEPRESSION; DELAYED EXTINCTION; EMOTION PERCEPTION; CONTEXTUAL CONTROL; ANXIETY DISORDERS	Background: The neuroplasticity hypothesis of major depressive disorder proposes that a dysfunction of synaptic plasticity represents a basic pathomechanism of the disorder. Animal models of depression indicate enhanced plasticity in a ventral emotional network, comprising the amygdala. Here, we investigated fear extinction learning as a non-invasive probe for amygdala-dependent synaptic plasticity in patients with major depressive disorder and healthy controls. Methods: Differential fear conditioning was measured in 37 inpatients with severe unipolar depression (International Classification of Diseases, 10th revision, criteria) and 40 healthy controls. The eye-blink startle response, a subcortical output signal that is modulated by local synaptic plasticity in the amygdala in fear acquisition and extinction learning, was recorded as the primary outcome parameter. Results: After robust and similar fear acquisition in both groups, patients with major depressive disorder showed significantly enhanced fear extinction learning in comparison to healthy controls, as indicated by startle responses to conditioned stimuli. The strength of extinction learning was positively correlated with the total illness duration. Conclusions: The finding of enhanced fear extinction learning in major depressive disorder is consistent with the concept that the disorder is characterized by enhanced synaptic plasticity in the amygdala and the ventral emotional network. Clinically, the observation emphasizes the potential of successful extinction learning, the basis of exposure therapy, in anxiety-related disorders despite the frequent comorbidity of major depressive disorder.	[Kuhn, Marion; Hoeger, Nora; Feige, Bernd; Normann, Claus; Nissen, Christoph] Univ Med Ctr Freiburg, Dept Psychiat & Psychotherapy, Freiburg, Germany; [Blechert, Jens] Salzburg Univ, Div Clin Psychol Psychotherapy & Hlth Psychol, Dept Psychol, A-5020 Salzburg, Austria	University of Freiburg; Salzburg University	Nissen, C (corresponding author), Univ Med Ctr Freiburg, Dept Psychiat & Psychotherapy, Freiburg, Germany.	christoph.nissen@uniklinik-freiburg.de	Blechert, Jens/X-4040-2019; Nissen, Christoph/C-7642-2015; Feige, Bernd/C-6690-2012	Blechert, Jens/0000-0002-3820-109X; Nissen, Christoph/0000-0001-9809-0275; Feige, Bernd/0000-0002-9436-1258	FAZIT Stiftung; Albert Ludwigs University Freiburg	FAZIT Stiftung; Albert Ludwigs University Freiburg	The work was supported by the FAZIT Stiftung (PhD grant to MK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The article processing charge was funded by the open access publication fund of the Albert Ludwigs University Freiburg.	Angrilli A, 1996, BRAIN, V119, P1991, DOI 10.1093/brain/119.6.1991; Arce E, 2008, PSYCHOPHARMACOLOGY, V196, P661, DOI 10.1007/s00213-007-1004-8; BECHARA A, 2002, SO NEUROSCI SER, P149; Blair HT, 2001, LEARN MEMORY, V8, P229, DOI 10.1101/lm.30901; Blechert J, 2007, BEHAV RES THER, V45, P2019, DOI 10.1016/j.brat.2007.02.012; Bontempi B, 1999, NATURE, V400, P671, DOI 10.1038/23270; BOUTON ME, 1979, J EXP PSYCHOL ANIM B, V5, P368, DOI 10.1037/0097-7403.5.4.368; BOUTON ME, 1979, LEARN MOTIV, V10, P445, DOI 10.1016/0023-9690(79)90057-2; BOUTON ME, 1983, J EXP PSYCHOL ANIM B, V9, P248, DOI 10.1037/0097-7403.9.3.248; Bremner JD, 2000, AM J PSYCHIAT, V157, P115, DOI 10.1176/ajp.157.1.115; BROOKS DC, 1993, J EXP PSYCHOL ANIM B, V19, P77, DOI 10.1037/0097-7403.19.1.77; Burghardt NS, 2013, NEUROSCIENCE, V247, P253, DOI 10.1016/j.neuroscience.2013.05.050; Burghardt NS, 2013, BIOL PSYCHIAT, V73, P1078, DOI 10.1016/j.biopsych.2012.10.012; Burghardt NS, 2004, BIOL PSYCHIAT, V55, P1171, DOI 10.1016/j.biopsych.2004.02.029; Calder AJ, 2001, NAT REV NEUROSCI, V2, P352, DOI 10.1038/35072584; Camp MC, 2012, NEUROPSYCHOPHARMACOL, V37, P1534, DOI 10.1038/npp.2011.340; Campbell S, 2004, AM J PSYCHIAT, V161, P598, DOI 10.1176/appi.ajp.161.4.598; Castren E, 2005, NAT REV NEUROSCI, V6, P241, DOI 10.1038/nrn1629; Castren E, 2013, JAMA PSYCHIAT, V70, P983, DOI 10.1001/jamapsychiatry.2013.1; Citri A, 2008, NEUROPSYCHOPHARMACOL, V33, P18, DOI 10.1038/sj.npp.1301559; DREVETS WC, 1992, J NEUROSCI, V12, P3628; FALLS WA, 1992, J NEUROSCI, V12, P854; Feige B., 1996, OSCILLATORY BRAIN AC; Fitzgerald PJ, 2013, BRAIN RES B; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Frodl T, 2002, BIOL PSYCHIAT, V51, P708, DOI 10.1016/S0006-3223(01)01359-2; Gale GD, 2004, J NEUROSCI, V24, P3810, DOI 10.1523/JNEUROSCI.4100-03.2004; Garcia R, 2002, REV NEUROSCIENCE, V13, P195; Grillon C, 2003, CLIN NEUROPHYSIOL, V114, P1557, DOI 10.1016/S1388-2457(03)00202-5; Grillon C, 2002, BIOL PSYCHIAT, V52, P958, DOI 10.1016/S0006-3223(02)01665-7; Hartley CA, 2010, NEUROPSYCHOPHARMACOL, V35, P136, DOI 10.1038/npp.2009.121; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; HITCHCOCK J, 1986, BEHAV NEUROSCI, V100, P11, DOI 10.1037/0735-7044.100.1.11; Holderbach R, 2007, BIOL PSYCHIAT, V62, P92, DOI 10.1016/j.biopsych.2006.07.007; Huff NC, 2009, BEHAV NEUROSCI, V123, P834, DOI 10.1037/a0016511; Karpova NN, 2011, SCIENCE, V334, P1731, DOI 10.1126/science.1214592; Keller SM, 2014, J CONSULT CLIN PSYCH, V82, P102, DOI 10.1037/a0035286; Kim JJ, 1996, P NATL ACAD SCI USA, V93, P4750, DOI 10.1073/pnas.93.10.4750; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; LABAR KS, 1995, J NEUROSCI, V15, P6846; LaBar KS, 1998, PSYCHOL SCI, V9, P490, DOI 10.1111/1467-9280.00090; Lange C, 2004, PSYCHOL MED, V34, P1059, DOI 10.1017/S0033291703001806; Ledgerwood L, 2003, BEHAV NEUROSCI, V117, P341, DOI 10.1037/0735-7044.117.2.341; Li XB, 2001, EUR J PHARMACOL, V425, P43, DOI 10.1016/S0014-2999(01)01159-1; Lissek S, 2005, BEHAV RES THER, V43, P1391, DOI 10.1016/j.brat.2004.10.007; MacQueen G, 2011, MOL PSYCHIATR, V16, P252, DOI 10.1038/mp.2010.80; Maier S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050120; Mann JJ, 2005, NEW ENGL J MED, V353, P1819, DOI 10.1056/NEJMra050730; Maren S, 2003, ANN NY ACAD SCI, V985, P106; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; Maren S., 2013, NEUROBIOLOGY LEARNIN; Maren S, 2011, NEURON, V70, P830, DOI 10.1016/j.neuron.2011.04.023; MAYBERG HS, 1994, J NUCL MED, V35, P929; McEwen BS, 2005, METABOLISM, V54, P20, DOI 10.1016/j.metabol.2005.01.008; Michael T, 2007, J ABNORM PSYCHOL, V116, P612, DOI 10.1037/0021-843X.116.3.612; Myers KM, 2006, LEARN MEMORY, V13, P216, DOI 10.1101/lm.119806; Nissen C, 2010, BIOL PSYCHIAT, V68, P544, DOI 10.1016/j.biopsych.2010.05.026; Normann C, 2007, BIOL PSYCHIAT, V62, P373, DOI 10.1016/j.biopsych.2006.10.006; Norrholm SD, 2008, BEHAV NEUROSCI, V122, P1016, DOI 10.1037/a0012604; Pavlides C, 2002, HIPPOCAMPUS, V12, P245, DOI 10.1002/hipo.1116; Pavlov I.P., 1927, CONDITIONED REFLEXES; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Phillips ML, 2003, BIOL PSYCHIAT, V54, P515, DOI 10.1016/S0006-3223(03)00171-9; Pittenger C, 2008, NEUROPSYCHOPHARMACOL, V33, P88, DOI 10.1038/sj.npp.1301574; Rajkowska G, 1999, BIOL PSYCHIAT, V45, P1085, DOI 10.1016/S0006-3223(99)00041-4; Rescorla RA, 2004, LEARN MEMORY, V11, P501, DOI 10.1101/lm.77504; Rescorla RA, 1975, J EXPT PSYCHOL ANIMA, V1, P88, DOI DOI 10.1037/0097-7403.1.1.88; Schiller D, 2010, NATURE, V463, P49, DOI 10.1038/nature08637; Schwab M, 2012, NATURE, V483, P267, DOI 10.1038/483267a; Senn V, 2014, NEURON, V81, P428, DOI 10.1016/j.neuron.2013.11.006; Sheline YI, 1996, P NATL ACAD SCI USA, V93, P3908, DOI 10.1073/pnas.93.9.3908; Sheline YI, 1999, J NEUROSCI, V19, P5034; SMITH MA, 1995, J NEUROSCI, V15, P1768, DOI 10.1523/JNEUROSCI.15-03-01768.1995; Sotres-Bayon F, 2007, NEUROPSYCHOPHARMACOL, V32, P1929, DOI 10.1038/sj.npp.1301316; Spedding M, 2003, CURR OPIN PHARMACOL, V3, P33, DOI 10.1016/S1471-4892(02)00008-5; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Stockmeier CA, 2004, BIOL PSYCHIAT, V56, P640, DOI 10.1016/j.biopsych.2004.08.022; Suvrathan A, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0151; The National Institute for Health and Care Excellence (NICE), 2005, POSTTRAUM STRESS DIS; Vriends N, 2011, J BEHAV THER EXP PSY, V42, P46, DOI 10.1016/j.jbtep.2010.09.001; Vyas A, 2002, J NEUROSCI, V22, P6810; Walker DL, 2002, PSYCHOPHARMACOLOGY, V164, P318, DOI 10.1007/s00213-002-1213-0; Walker DL, 2002, J NEUROSCI, V22, P2343, DOI 10.1523/JNEUROSCI.22-06-02343.2002; Walker DL, 2002, PHARMACOL BIOCHEM BE, V71, P379, DOI 10.1016/S0091-3057(01)00698-0; Welberg L, 2014, NAT REV NEUROSCI, V15, DOI 10.1038/nrn3698	86	21	29	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115280	10.1371/journal.pone.0115280	http://dx.doi.org/10.1371/journal.pone.0115280			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545818	Green Published, gold, Green Submitted			2022-12-27	WOS:000347120200034
J	Lieven, O; Dronka, J; Burmuhl, S; Ruther, U				Lieven, Oliver; Dronka, Julia; Burmuehl, Stephan; Ruether, Ulrich			Differential Binding of Lef1 and Msx1/2 Transcription Factors to Dkk1 CNEs Correlates with Reporter Gene Expression In Vivo	PLOS ONE			English	Article							WNT ANTAGONIST DICKKOPF-1; BETA-CATENIN; EYE; TARGET; MOUSE; INTERACT; PROTEINS; MORPHOGENESIS; ORGANIZATION; MAINTENANCE	Besides the active Wnt signalling itself, the extracellular inhibition by Dkk1 is important for various embryonic developmental processes, such as optic vesicle differentiation and facial outgrowth. Although a feedback crosstalk of the active Wnt/beta-catenin signaling and Dkk1 regulation has been suggested, the control of Dkk1 transcription by the Tcf/Lef1 mediated Wnt signalling and its connection to additional signalling factors has not been elucidated in vivo. Here, we used a combination of transgenic mouse approaches and biochemical analyses to unravel the direct Dkk1 transcriptional regulation via Tcf/Lefs. By using site directed mutagenesis, we tested several conserved Tcf/Lef1 binding sites within Dkk1 conserved non-coding elements (CNEs) and found that these are required for tissue specific reporter expression. In addition a conserved Msx1/2 binding site is required for retinal reporter expression and Msx2 but not Msx1 binds its conserved binding site within CNE195 in the optic cups. Within craniofacial expression domains, Lef1 interferes with Dkk1 directly via two conserved Tcf/Lef1 binding sites in the craniofacial enhancer CNE114, both of which are required for the general craniofacial Dkk1 reporter activation. Furthermore, these Tcf/Lef1 sites are commonly bound in the whisker hair bud mesenchyme but specifically Tcf/Lef1 (no. 2) is required for mandibular activation and repression of maxillar Dkk1 activation. Lastly, we tested the Tcf/Lef1 binding capacities of the Dkk1 promoter and found that although Lef1 binds the Dkk1 promoter, these sites are not sufficient for tissue specific Dkk1 activation. Together, we here present the importance of conserved Tcf/Lef1 and Msx1/2 sites that are required for differential Dkk1 transcriptional reporter activation in vivo. This requirement directly correlates with Lef1 and Msx1/2 interaction with these genomic loci.	[Lieven, Oliver] Univ Copenhagen, Danish Stem Cell Ctr, DK-2200 Copenhagen N, Denmark; [Dronka, Julia; Burmuehl, Stephan; Ruether, Ulrich] Univ Dusseldorf, Inst Anim Dev & Mol Biol, D-40225 Dusseldorf, Germany	University of Copenhagen; Heinrich Heine University Dusseldorf	Lieven, O (corresponding author), Univ Copenhagen, Danish Stem Cell Ctr, Blegdamsvej 3B,Bldg 6,4th Floor, DK-2200 Copenhagen N, Denmark.	oliver.lieven@sund.ku.dk			strategic research fonds (SFF) of the Heinrich-Heine University Dusseldorf	strategic research fonds (SFF) of the Heinrich-Heine University Dusseldorf	This work was supported by the strategic research fonds (SFF) of the Heinrich-Heine University Dusseldorf. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamska M, 2004, DEV BIOL, V272, P134, DOI 10.1016/j.ydbio.2004.04.026; Ang SJ, 2004, GENE EXPR PATTERNS, V4, P289, DOI 10.1016/j.modgep.2003.11.002; Arnold SJ, 2000, MECH DEVELOP, V91, P249, DOI 10.1016/S0925-4773(99)00309-3; Baeg GH, 2001, DEVELOPMENT, V128, P87; Brugmann SA, 2007, DEVELOPMENT, V134, P3283, DOI 10.1242/dev.005132; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Cain S, 2008, DEV BIOL, V321, P420, DOI 10.1016/j.ydbio.2008.07.002; Catron KM, 1996, MECH DEVELOP, V55, P185, DOI 10.1016/0925-4773(96)00503-5; Chamorro MN, 2005, EMBO J, V24, P73, DOI 10.1038/sj.emboj.7600460; Chen YJ, 2004, INT J DEV BIOL, V48, P867, DOI 10.1387/ijdb.041882yc; Chen YJ, 2008, DEV BIOL, V324, P161, DOI 10.1016/j.ydbio.2008.09.002; de Iongh RU, 2006, FRONT BIOSCI-LANDMRK, V11, P2442, DOI 10.2741/1982; Diep DB, 2004, DEV BRAIN RES, V153, P261, DOI 10.1016/j.devbrainres.2004.09.008; Fjeld K, 2005, DEV DYNAM, V233, P161, DOI 10.1002/dvdy.20285; FoerstPotts L, 1997, DEV DYNAM, V209, P70, DOI 10.1002/(SICI)1097-0177(199705)209:1<70::AID-AJA7>3.0.CO;2-U; Fokina VM, 2006, DEV DYNAM, V235, P496, DOI 10.1002/dvdy.20621; Fuhrmann S, 2003, GENE EXPR PATTERNS, V3, P659, DOI 10.1016/S1567-133X(03)00107-8; Galceran J, 2001, P NATL ACAD SCI USA, V98, P8668, DOI 10.1073/pnas.151258098; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Gonzalex-Sancho JM, 2005, ONCOGENE, V24, P1098, DOI 10.1038/sj.onc.1208303; GORDON JW, 1981, SCIENCE, V214, P1244, DOI 10.1126/science.6272397; Grotewold L, 2002, EMBO J, V21, P966, DOI 10.1093/emboj/21.5.966; Hussein SM, 2003, J BIOL CHEM, V278, P48805, DOI 10.1074/jbc.M305472200; Jasoni C, 1999, DEV DYNAM, V215, P215, DOI 10.1002/(SICI)1097-0177(199907)215:3<215::AID-AJA4>3.0.CO;2-W; Jin EJ, 2002, MECH DEVELOP, V116, P173, DOI 10.1016/S0925-4773(02)00128-4; Lewis SL, 2008, DEVELOPMENT, V135, P1791, DOI 10.1242/dev.018853; Lieven O, 2011, DEV BIOL, V355, P124, DOI 10.1016/j.ydbio.2011.04.023; Lieven O, 2010, DEV BIOL, V340, P256, DOI 10.1016/j.ydbio.2010.01.037; Liu CQ, 2008, DEVELOPMENT, V135, P3567, DOI 10.1242/dev.028076; Liu H, 2003, DEV DYNAM, V227, P323, DOI 10.1002/dvdy.10315; Liu H, 2006, INVEST OPHTH VIS SCI, V47, P5088, DOI 10.1167/iovs.06-0403; Liu ZT, 2011, J BIOL CHEM, V286, P28520, DOI 10.1074/jbc.M111.236307; LOVE JJ, 1995, NATURE, V376, P791, DOI 10.1038/376791a0; MacDonald BT, 2004, DEVELOPMENT, V131, P2543, DOI 10.1242/dev.01126; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Merrill BJ, 2001, GENE DEV, V15, P1688, DOI 10.1101/gad.891401; Monaghan AP, 1999, MECH DEVELOP, V87, P45, DOI 10.1016/S0925-4773(99)00138-0; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Mukhopadhyay M, 2001, DEV CELL, V1, P423, DOI 10.1016/S1534-5807(01)00041-7; Nie XG, 2005, J MOL HISTOL, V36, P367, DOI 10.1007/s10735-005-9008-3; Nie XG, 2005, J MOL HISTOL, V36, P419, DOI 10.1007/s10735-005-9014-5; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; OOSTERWEGEL M, 1993, DEVELOPMENT, V118, P439; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Sick S, 2006, SCIENCE, V314, P1447, DOI 10.1126/science.1130088; Song LY, 2009, DEVELOPMENT, V136, P3161, DOI 10.1242/dev.037440; Stump RJW, 2003, DEV BIOL, V259, P48, DOI 10.1016/S0012-1606(03)00179-9; Theil T, 1999, DEVELOPMENT, V126, P3561; Van Raay TJ, 2004, DEV NEUROSCI-BASEL, V26, P352, DOI 10.1159/000082277; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; Veien ES, 2008, DEVELOPMENT, V135, P4101, DOI 10.1242/dev.027367; Wehrli M, 2001, NATURE, V410, P847, DOI 10.1038/35071131; Wu LY, 2003, INVEST OPHTH VIS SCI, V44, P2404, DOI 10.1167/iovs.02-0317; Zhao JY, 2012, AM J PATHOL, V180, P2230, DOI 10.1016/j.ajpath.2012.02.017; ZHOU PB, 1995, GENE DEV, V9, P700, DOI 10.1101/gad.9.6.700	57	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115442	10.1371/journal.pone.0115442	http://dx.doi.org/10.1371/journal.pone.0115442			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545010	Green Published, gold, Green Submitted			2022-12-27	WOS:000347120200042
J	Reemann, P; Reimann, E; Ilmjarv, S; Porosaar, O; Silm, H; Jaks, V; Vasar, E; Kingo, K; Koks, S				Reemann, Paula; Reimann, Ene; Ilmjaerv, Sten; Porosaar, Orm; Silm, Helgi; Jaks, Viljar; Vasar, Eero; Kingo, Kuelli; Koks, Sulev			Melanocytes in the Skin - Comparative Whole Transcriptome Analysis of Main Skin Cell Types	PLOS ONE			English	Article							GENE-EXPRESSION; STEM-CELLS; OXIDATIVE STRESS; ULTRAVIOLET-B; CANCER; MELANOMA; PROTEIN; DIFFERENTIATION; KERATINOCYTES; MELANOGENESIS	Melanocytes possess several functions besides a role in pigment synthesis, but detailed characteristics of the cells are still unclear. We used whole transcriptome sequencing (RNA- Seq) to assess differential gene expression of cultivated normal human melanocytes with respect to keratinocytes, fibroblasts and whole skin. The present results reveal cultivated melanocytes as highly proliferative cells with possible stem cell-like properties. The enhanced readiness to regenerate makes melanocytes the most vulnerable cells in the skin and explains their high risk of developing into malignant melanoma.	[Reemann, Paula; Ilmjaerv, Sten; Vasar, Eero] Univ Tartu, Dept Physiol, Inst Biomed & Translat Med, EE-50090 Tartu, Estonia; [Reimann, Ene] Univ Tartu, Core Facil Clin Genom, Dept Pathophysiol, Dept Biomed,Inst Biomed & Translat Med, EE-50090 Tartu, Estonia; [Reimann, Ene; Koks, Sulev] Estonian Univ Life Sci, Inst Vet Med & Anim Sci, Competence Ctr Reprod Med & Biol, Tartu, Estonia; [Ilmjaerv, Sten] Quretec Ltd, Tartu, Estonia; [Porosaar, Orm] Tallinn Childrens Hosp, Dept Pediat Surg, Tallinn, Estonia; [Silm, Helgi; Kingo, Kuelli] Univ Tartu, Dermatol Clin, Tartu Univ Hosp, Dept Dermatol, EE-50090 Tartu, Estonia; [Jaks, Viljar] Univ Tartu, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia; [Vasar, Eero; Koks, Sulev] Univ Tartu, Ctr Translat Med, EE-50090 Tartu, Estonia; [Koks, Sulev] Univ Tartu, Dept Pathophysiol, Inst Biomed & Translat Med, EE-50090 Tartu, Estonia	University of Tartu; University of Tartu; Estonian University of Life Sciences; University of Tartu; University of Tartu; University of Tartu; University of Tartu	Reemann, P (corresponding author), Univ Tartu, Dept Physiol, Inst Biomed & Translat Med, Ulikooli 18, EE-50090 Tartu, Estonia.	paula.reemann@ut.ee	Jaks, Viljar/H-2467-2012; Kingo, Külli/H-3603-2012; Vasar, Eero/H-4490-2015; Koks, Sulev/H-3655-2015; Reimann, Ene/M-9912-2017	Jaks, Viljar/0000-0002-2221-6262; Koks, Sulev/0000-0001-6087-6643; Kingo, Kulli/0000-0001-6301-9612; Vasar, Eero/0000-0001-5226-345X; Reimann, Ene/0000-0002-5410-4433	European Union through the European Regional Development Fund via project of Centre of Excellence for Translational Medicine; Estonian Ministry of Education and Research [PUT177, PUT4, ETF8139]; Centre of Translational Genomics of University of Tartu; European Molecular Biology Organization Integration Grant; European Social Fund's Doctoral Studies Internationalization Programme DoRa;  [IUT20-46]	European Union through the European Regional Development Fund via project of Centre of Excellence for Translational Medicine; Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); Centre of Translational Genomics of University of Tartu; European Molecular Biology Organization Integration Grant; European Social Fund's Doctoral Studies Internationalization Programme DoRa; 	This study was financially supported by the European Union through the European Regional Development Fund via project of Centre of Excellence for Translational Medicine (http:// biomedicum.ut.ee/cetm/) (EV, PR); by the institutional research funding grant (IUT20-46) and by personal research funding grants (PUT177 (KK, HS, PR), PUT4, ETF8139 (VJ)) of the Estonian Ministry of Education and Research (http://www.etag.ee/en/); by the Centre of Translational Genomics of University of Tartu (http://www.ctg.ut. ee) (SP1GVARENG) (SK, ER); by the European Molecular Biology Organization Integration Grant (http://www.embo.org) (VJ) and by the European Social Fund's Doctoral Studies Internationalization Programme DoRa carried out by Archimedes Foundation (http://adm.archimedes.ee/ stipendiumid/en/programm-dora/t3/) (SI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed IA, 2010, CANCER GENET CYTOGEN, V199, P96, DOI 10.1016/j.cancergencyto.2010.02.007; Akaneya Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012486; Auge JM, 2005, ANTICANCER RES, V25, P1779; Bair EL, 2005, NEOPLASIA, V7, P380, DOI 10.1593/neo.04619; Cantaert T, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3150; Cao SJ, 2006, J BIOL CHEM, V281, P26041, DOI 10.1074/jbc.M602222200; Chakrabarty K, 2012, BIOL OPEN, V1, P693, DOI 10.1242/bio.20121230; Chakraborty AK, 1996, BBA-MOL CELL RES, V1313, P130, DOI 10.1016/0167-4889(96)00063-8; Chen JD, 2003, CANCER CELL, V4, P405, DOI 10.1016/S1535-6108(03)00269-1; Chen YK, 2012, J NEUROSCI, V32, P1043, DOI 10.1523/JNEUROSCI.4405-11.2012; Chen ZX, 2014, CANCER DISCOV, V4, P434, DOI 10.1158/2159-8290.CD-13-0362; Cichorek M, 2013, POSTEP DERM ALERGOL, V30, P30, DOI 10.5114/pdia.2013.33376; Costin GE, 2007, FASEB J, V21, P976, DOI 10.1096/fj.06-6649rev; de Souza CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044800; Du JY, 2003, AM J PATHOL, V163, P333, DOI 10.1016/S0002-9440(10)63657-7; Ekblom P, 2003, MATRIX BIOL, V22, P35, DOI 10.1016/S0945-053X(03)00015-5; Elinav E, 2013, NAT REV CANCER, V13, P759, DOI 10.1038/nrc3611; Fang CC, 2013, CARDIOVASC RES, V99, P146, DOI 10.1093/cvr/cvt060; Foltz G, 2006, CANCER RES, V66, P6665, DOI 10.1158/0008-5472.CAN-05-4453; Freinkel, 2001, BIOL SKIN; Funasaka Y, 1998, BRIT J DERMATOL, V139, P216; Garcia-Areas R, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00017; Gillis JS, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-27; Goldsmith LA, 2012, FITZPATRICKS DERMATO; HILL KK, 1995, GENETICS, V141, P595; Hoath SB, 2003, J INVEST DERMATOL, V121, P1440, DOI 10.1046/j.1523-1747.2003.12606.x; Hoek K, 2004, CANCER RES, V64, P5270, DOI 10.1158/0008-5472.CAN-04-0731; Hotta K, 2009, J ENDOCRINOL, V202, P111, DOI 10.1677/JOE-08-0531; Hou L, 2008, CELL RES, V18, P1163, DOI 10.1038/cr.2008.303; Itsui Y, 2006, J VIRAL HEPATITIS, V13, P690, DOI 10.1111/j.1365-2893.2006.00732.x; Jiao Y, 2005, GENETICS, V171, P1239, DOI 10.1534/genetics.105.044487; Jimenez-Cervantes C, 2001, J CELL SCI, V114, P2335; Kawakami Akinori, 2011, J Invest Dermatol, V131, pE2, DOI 10.1038/skinbio.2011.2; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Koga Y, 2009, GENOME RES, V19, P1462, DOI 10.1101/gr.091447.109; Kos R, 2001, DEVELOPMENT, V128, P1467; Kumari K, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-42; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee JS, 2013, ANN DERMATOL, V25, P36, DOI 10.5021/ad.2013.25.1.36; LEE ST, 1995, GENOMICS, V26, P354, DOI 10.1016/0888-7543(95)80220-G; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Liu WT, 2013, PEERJ, V1, DOI 10.7717/peerj.49; Louro R, 2004, BIOCHEM BIOPH RES CO, V316, P618, DOI 10.1016/j.bbrc.2004.02.091; Marzook H, 2012, J BIOL CHEM, V287, P5615, DOI 10.1074/jbc.M111.314088; Miller CC, 2003, EXP DERMATOL, V12, P403, DOI 10.1034/j.1600-0625.2003.00023.x; Neufeld G, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006718; Padmanabhan R, 2012, STEM CELLS, V30, P2175, DOI 10.1002/stem.1195; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Randolph RK, 1998, J INVEST DERMATOL, V111, P478, DOI 10.1046/j.1523-1747.1998.00307.x; Reemann P, 2013, ACTA DERM VENEREOL; Reimand J, 2011, NUCLEIC ACIDS RES, V39, pW307, DOI 10.1093/nar/gkr378; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Roberts DW, 2006, PIGM CELL RES, V19, P76, DOI 10.1111/j.1600-0749.2005.00286.x; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosenblum MD, 2004, BLOOD, V103, P2691, DOI 10.1182/blood-2003-09-3184; Slominski A, 2009, EXP DERMATOL, V18, P760, DOI 10.1111/j.1600-0625.2009.00892.x; Stark JL, 2014, BIOCHEMISTRY-US, V53, P1360, DOI 10.1021/bi401329a; Szatanik M, 2008, NEUROGENETICS, V9, P237, DOI 10.1007/s10048-008-0136-2; Thingnes J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040377; Utikal J, 2009, J CELL SCI, V122, P3502, DOI 10.1242/jcs.054783; Verhey KJ, 2011, ANNU REV BIOPHYS, V40, P267, DOI 10.1146/annurev-biophys-042910-155310; Videira PA, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-357; Wajant H, 2009, RESULTS PROBL CELL D, V49, P1, DOI 10.1007/400_2008_26; Wang K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.50; White RM, 2008, CELL STEM CELL, V3, P242, DOI 10.1016/j.stem.2008.08.005; Wu S, 2012, CANCER MED-US, V1, P306, DOI 10.1002/cam4.28; Wu Z, J IMMUNOL, V191, P5885; Yeo H, 2013, EMBO J, V32, P2589, DOI 10.1038/emboj.2013.186; Yim YS, 2013, P NATL ACAD SCI USA, V110, P4057, DOI 10.1073/pnas.1209881110; Zentner GE, 2013, NAT STRUCT MOL BIOL, V20, P259, DOI 10.1038/nsmb.2470; Zhang XF, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-244	73	29	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115717	10.1371/journal.pone.0115717	http://dx.doi.org/10.1371/journal.pone.0115717			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545474	Green Published, Green Submitted, gold			2022-12-27	WOS:000347120200061
J	Sinues, PML; Tarokh, L; Li, X; Kohler, M; Brown, SA; Zenobi, R; Dallmann, R				Sinues, Pablo Martinez-Lozano; Tarokh, Leila; Li, Xue; Kohler, Malcolm; Brown, Steven A.; Zenobi, Renato; Dallmann, Robert			Circadian Variation of the Human Metabolome Captured by Real-Time Breath Analysis	PLOS ONE			English	Article							IONIZATION MASS-SPECTROMETRY; ELECTROSPRAY-IONIZATION; BODY TIME; DISRUPTION; EXPRESSION; VOLATILES; RESPONSES; INSIGHTS; VAPORS; MOUSE	Circadian clocks play a significant role in the correct timing of physiological metabolism, and clock disruption might lead to pathological changes of metabolism. One interesting method to assess the current state of metabolism is metabolomics. Metabolomics tries to capture the entirety of small molecules, i.e. the building blocks of metabolism, in a given matrix, such as blood, saliva or urine. Using mass spectrometric approaches we and others have shown that a significant portion of the human metabolome in saliva and blood exhibits circadian modulation; independent of food intake or sleep/wake rhythms. Recent advances in mass spectrometry techniques have introduced completely non-invasive breathprinting; a method to instantaneously assess small metabolites in human breath. In this proof-of-principle study, we extend these findings about the impact of circadian clocks on metabolomics to exhaled breath. As previously established, our method allows for real-time analysis of a rich matrix during frequent non-invasive sampling. We sampled the breath of three healthy, non-smoking human volunteers in hourly intervals for 24 hours during total sleep deprivation, and found 111 features in the breath of all individuals, 36-49% of which showed significant circadian variation in at least one individual. Our data suggest that real-time mass spectrometric "breathprinting" has high potential to become a useful tool to understand circadian metabolism, and develop new biomarkers to easily and in real-time assess circadian clock phase and function in experimental and clinical settings.	[Sinues, Pablo Martinez-Lozano; Li, Xue; Zenobi, Renato] Swiss Fed Inst Technol, Dept Chem & Appl Biosci, Zurich, Switzerland; [Tarokh, Leila; Brown, Steven A.; Dallmann, Robert] Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland; [Tarokh, Leila] Univ Bern, Univ Hosp Child & Adolescent Psychiat & Psychothe, Bern, Switzerland; [Kohler, Malcolm] Univ Zurich Hosp, Div Pulm, Zurich, Switzerland; [Kohler, Malcolm] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Bern; University Hospital of Bern; University of Zurich; University Zurich Hospital; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Zenobi, R (corresponding author), Swiss Fed Inst Technol, Dept Chem & Appl Biosci, Zurich, Switzerland.	zenobi@org.chem.ethz.ch; dallmann@pharma.uzh.ch	Sinues, Pablo/A-9576-2014; Dallmann, Bob/AAA-4929-2022; Sinues, Pablo/X-2311-2019	Sinues, Pablo/0000-0001-5602-2880; Sinues, Pablo/0000-0001-5602-2880; Dallmann, Robert/0000-0002-7490-0218; Tarokh, Leila/0000-0003-4014-428X	Marie Curie European Reintegration Grant within the 7th European Community Framework Programme [276860]	Marie Curie European Reintegration Grant within the 7th European Community Framework Programme	Marie Curie European Reintegration Grant within the 7th European Community Framework Programme No. 276860 to PMLS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann A, 2014, J BREATH RES, V8, DOI 10.1088/1752-7155/8/3/034001; Ang JE, 2012, CHRONOBIOL INT, V29, P868, DOI 10.3109/07420528.2012.699122; Archer SN, 2014, P NATL ACAD SCI US; Bean HD, 2011, JOVE-J VIS EXP, DOI 10.3791/2664; BENOIT FM, 1985, INT ARCH OCC ENV HEA, V55, P113, DOI 10.1007/BF00378373; BENOIT FM, 1983, ANAL CHEM, V55, P805, DOI 10.1021/ac00255a053; Berchtold C, 2013, METABOLOMICS, P1; Bhatti P, 2014, OCCUP ENV MED; Brown SA, 2008, P NATL ACAD SCI USA, V105, P1602, DOI 10.1073/pnas.0707772105; Castanon-Cervantes O, 2010, J IMMUNOL, V185, P5796, DOI 10.4049/jimmunol.1001026; Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377; Chua ECP, 2013, P NATL ACAD SCI USA, V110, P14468, DOI 10.1073/pnas.1222647110; Costello BD, 2014, J BREATH RES, V8, DOI 10.1088/1752-7155/8/1/014001; Dallmann R, 2014, ANNU REV PHARMACOL, V54, P339, DOI 10.1146/annurev-pharmtox-011613-135923; Dallmann R, 2012, P NATL ACAD SCI USA, V109, P2625, DOI 10.1073/pnas.1114410109; Davies SK, 2014, P NATL ACAD SCI US; Dillon LA, 2010, ANALYST, V135, P306, DOI 10.1039/b918899a; Diskin AM, 2003, PHYSIOL MEAS, V24, P107, DOI 10.1088/0967-3334/24/1/308; Filipski E, 2004, CANCER RES, V64, P7879, DOI 10.1158/0008-5472.CAN-04-0674; Filipski E, 2009, MUTAT RES; Foster RG, 2008, CURR BIOL, V18, pR784, DOI 10.1016/j.cub.2008.07.003; Fuerstenau S, 1994, AGGREGATION FRAGMENT; Fuerstenau S, 1999, ESIMS ANAL TRACE SPE; Hidalgo MP, 2009, PSYCHIAT CLIN NEUROS, V63, P283, DOI 10.1111/j.1440-1819.2009.01965.x; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Innominato PF, 2010, ADV DRUG DELIVER REV, V62, P979, DOI 10.1016/j.addr.2010.06.002; Jiangjiang Z., 2013, J BREATH RES, V7; Jiangjiang Z., 2013, J BREATH RES, V7; Kasukawa T, 2012, P NATL ACAD SCI USA, V109, P15036, DOI 10.1073/pnas.1207768109; Keller BO, 2008, ANAL CHIM ACTA, V627, P71, DOI 10.1016/j.aca.2008.04.043; King J, 2012, PHYSIOL MEAS, V33, P413, DOI 10.1088/0967-3334/33/3/413; Kiselev P, 2001, ESIMS ANAL VAPORS TR; Krug S, 2012, FASEB J, V26, P2607, DOI 10.1096/fj.11-198093; Lee CY, 1998, ANAL CHEM, V70, P2757, DOI 10.1021/ac971325+; LOVETT AM, 1979, BIOMED MASS SPECTROM, V6, P91, DOI 10.1002/bms.1200060302; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Martinez-Lozano P, 2011, J BREATH RES, V5, DOI 10.1088/1752-7155/5/1/016002; Martinez-Lozano P, 2008, ANAL CHEM, V80, P8210, DOI 10.1021/ac801185e; Martinez-Lozano P, 2009, J AM SOC MASS SPECTR, V20, P287, DOI 10.1016/j.jasms.2008.10.006; Minami Y, 2009, P NATL ACAD SCI USA, V106, P9890, DOI 10.1073/pnas.0900617106; Moller-Levet CS, 2013, P NATL ACAD SCI; Oliver PL, 2012, CURR BIOL, V22, P314, DOI 10.1016/j.cub.2011.12.051; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Reddy AB, 2006, CURR BIOL, V16, P1107, DOI 10.1016/j.cub.2006.04.026; Roenneberg T, 2007, COLD SPRING HARB SYM, V72, P293, DOI 10.1101/sqb.2007.72.043; Roenneberg T, 2012, CURR BIOL, V22, P939, DOI 10.1016/j.cub.2012.03.038; Roybal K, 2007, P NATL ACAD SCI USA, V104, P6406, DOI 10.1073/pnas.0609625104; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Shin SY, 2014, NAT GENET, V46, P543, DOI 10.1038/ng.2982; Sinues PML, 2014, RESPIRATION, V87, P301, DOI 10.1159/000357785; Sinues PML, 2013, CHEST, V144, P746, DOI 10.1378/chest.13-1106; Sinues PML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059909; Sinues PML, 2013, ANAL CHEM, V85, P369, DOI 10.1021/ac3029097; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Smith D, 1999, J APPL PHYSIOL, V87, P1584, DOI 10.1152/jappl.1999.87.5.1584; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Suhre K, 2011, NATURE, V477, P54, DOI 10.1038/nature10354; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Ueda HR, 2004, P NATL ACAD SCI USA, V101, P11227, DOI 10.1073/pnas.0401882101; Weaver D. R., 2013, FUNDAMENTAL NEUROSCI, P819; Whitehouse CM, 1986, FURTHER ADVENTURES E; Wu C, 2000, ANAL CHEM, V72, P396, DOI 10.1021/ac9907235; Wulff K, 2012, BRIT J PSYCHIAT, V200, P308, DOI 10.1192/bjp.bp.111.096321; Yong M, 2012, ARH HIG RADA TOKSIKO, V63, P153, DOI 10.2478/10004-1254-63-2012-2209; Zhu J, 2013, J APPL PHYSL; Zhu JJ, 2013, J BREATH RES, V7, DOI 10.1088/1752-7155/7/1/016003; Zhu JJ, 2010, J CLIN MICROBIOL, V48, P4426, DOI 10.1128/JCM.00392-10	67	53	53	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e114422	10.1371/journal.pone.0114422	http://dx.doi.org/10.1371/journal.pone.0114422			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545545	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000347120200014
J	Basson, M; Farley, JH				Basson, Marinelle; Farley, Jessica H.			A Standardised Abundance Index from Commercial Spotting Data of Southern Bluefin Tuna (Thunnus maccoyii): Random Effects to the Rescue	PLOS ONE			English	Article							THYNNUS; CATCH	Commercial aerial spotting of surface schools of juvenile southern bluefin tuna (SBT), Thunnus maccoyii, is conducted as part of fishing operations in the Great Australian Bight in summer. This provides the opportunity to efficiently collect large amounts of data on sightings of SBT. The data can potentially be used to construct a time-series index of relative abundance by standardising the data for issues such as weather, spotter ability and ocean conditions. Unlike a statistically designed survey, the commercial spotting is governed by business considerations and fishing operations. The SBT dataset is therefore highly unbalanced with regard to spotters operating in each season. This complicates the standardisation of the data, particularly with regard to interactions between covariates. We show how a generalized additive model with random effects can simplify both the fitting of the model and the construction of an index, while also avoiding the need to leave out strata or interaction terms that are important. The approach is applicable to standardisation of more traditional catch and effort data.	[Basson, Marinelle; Farley, Jessica H.] CSIRO, Oceans & Atmosphere Flagship, Hobart, Tas, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Farley, JH (corresponding author), CSIRO, Oceans & Atmosphere Flagship, Hobart, Tas, Australia.	jessica.farley@csiro.au	Farley, Jessica/E-4957-2014	Farley, Jessica/0000-0002-5047-746X	Australian Fisheries Management Authority; Australian Government Department of Agriculture; CSIRO's Wealth from Ocean Flagship	Australian Fisheries Management Authority; Australian Government Department of Agriculture(Australian Government); CSIRO's Wealth from Ocean Flagship	This work was supported by funding from the Australian Fisheries Management Authority, the Australian Government Department of Agriculture and CSIRO's Wealth from Ocean Flagship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, 18 ANN M COMM COMM C; [Anonymous], 2001, 2 M STOCK ASS GROUP; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 2008, 9 M STOCK ASS GROUP; Basson M., 2012, SPATIAL INTERACTIONS; Bravington M, 2002, 3 CCSBT STOCK ASS GR; Candy SG, 2004, CCAMLR SCI, V11, P59; Caton A.E., 1991, WORLD M STOCK ASSESS, V7, P181; Eveson JP, 2013, 18 M CCSBT SCI COMM; Glencross BD, 2002, J WORLD AQUACULT SOC, V33, P138, DOI 10.1111/j.1749-7345.2002.tb00488.x; Gunn J, 2001, TUNA PHYSL ECOLOGY E, P167, DOI DOI 10.1016/S1546-5098(01)19006-0; Hartog J.R., 2011, SDODE SPATIAL DYNAMI; Hobday A, 2004, 9 M CCSBT SCI COMM 1; Jorgensen B., 1997, THEORY DISPERSION MO; Klaer N, 2002, R991498 CSIRO; LO NCH, 1992, CAN J FISH AQUAT SCI, V49, P2515, DOI 10.1139/f92-278; LUTCAVAGE M, 1995, FISH B-NOAA, V93, P495; Lutcavage M, 1997, COLL SCI PAP INT COM, V46, P332; Maunder MN, 2004, FISH RES, V70, P141, DOI 10.1016/j.fishres.2004.08.002; Royer F, 2004, MAR ECOL PROG SER, V269, P249, DOI 10.3354/meps269249; Schick RS, 2004, FISH OCEANOGR, V13, P225, DOI 10.1111/j.1365-2419.2004.00290.x; SQUIRE JL, 1993, FISH B-NOAA, V91, P348; Venables WN, 2004, FISH RES, V70, P319, DOI 10.1016/j.fishres.2004.08.011; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x	25	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e116245	10.1371/journal.pone.0116245	http://dx.doi.org/10.1371/journal.pone.0116245			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541730	Green Submitted, Green Published, gold			2022-12-27	WOS:000347239900157
J	Mbah, H; Ojo, E; Ameh, J; Musuluma, H; Negedu-Momoh, OR; Jegede, F; Ojo, O; Uwakwe, N; Ochei, K; Dada, M; Udah, D; Chiegil, R; Torpey, K				Mbah, Henry; Ojo, Emmanuel; Ameh, James; Musuluma, Humphrey; Negedu-Momoh, Olubunmi Ruth; Jegede, Feyisayo; Ojo, Olufunmilayo; Uwakwe, Nkem; Ochei, Kingsley; Dada, Michael; Udah, Donald; Chiegil, Robert; Torpey, Kwasi			Piloting Laboratory Quality System Management in Six Health Facilities in Nigeria	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; ACCREDITATION; CARE	Background: Achieving accreditation in laboratories is a challenge in Nigeria like in most African countries. Nigeria adopted the World Health Organization Regional Office for Africa Stepwise Laboratory (Quality) Improvement Process Towards Accreditation (WHO/AFRO-SLIPTA) in 2010. We report on FHI360 effort and progress in piloting WHO-AFRO recognition and accreditation preparedness in six health facility laboratories in five different states of Nigeria. Method: Laboratory assessments were conducted at baseline, follow up and exit using the WHO/AFRO-SLIPTA checklist. From the total percentage score obtained, the quality status of laboratories were classified using a zero to five star rating, based on the WHO/AFRO quality improvement stepwise approach. Major interventions include advocacy, capacity building, mentorship and quality improvement projects. Results: At baseline audit, two of the laboratories attained 1-star while the remaining four were at 0-star. At follow up audit one lab was at 1-star, two at 3-star and three at 4-star. At exit audit, four labs were at 4-star, one at 3-star and one at 2-star rating. One laboratory dropped a 'star' at exit audit, while others consistently improved. The two weakest elements at baseline; internal audit (4%) and occurrence/incidence management (15%) improved significantly, with an exit score of 76% and 81% respectively. The elements facility and safety was the major strength across board throughout the audit exercise. Conclusion: This effort resulted in measurable and positive impact on the laboratories. We recommend further improvement towards a formal international accreditation status and scale up of WHO/AFRO-SLIPTA implementation in Nigeria.	[Mbah, Henry; Ojo, Emmanuel; Ameh, James; Musuluma, Humphrey; Negedu-Momoh, Olubunmi Ruth; Jegede, Feyisayo; Ojo, Olufunmilayo; Uwakwe, Nkem; Ochei, Kingsley; Dada, Michael; Udah, Donald; Chiegil, Robert; Torpey, Kwasi] Family Hlth Int FHI360, Garki Abuja, Nigeria		Mbah, H (corresponding author), Family Hlth Int FHI360, Plot 1073-A1,GODAB Plaza,Area 3, Garki Abuja, Nigeria.	hmbah@ng.fhi360.org	Dada, Michael/AIA-1258-2022	Dada, Michael/0000-0002-0278-0579; James, Ameh/0000-0001-7954-5254; Torpey, Kwasi/0000-0003-1628-2922	U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through U.S. Agency for International Development (USAID);  [FHI360]	U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); 	Support for this paper was provided by FHI360 Nigeria with funds from the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through U.S. Agency for International Development (USAID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abimiku AG, 2009, AM J CLIN PATHOL, V131, P875, DOI 10.1309/AJCPELMG6GX6RQSM; African Society for Laboratory Medicine, DEC 2012 1 INT C; Alemnji GA, 2014, TROP MED INT HEALTH, V19, P450, DOI 10.1111/tmi.12269; Audu RA, 2012, AFR J LAB MED, V1, DOI 10.4102/ajlm.v1i1.18; Elbireer AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064661; Gershy-Damet GM, 2010, AM J CLIN PATHOL, V134, P393, DOI 10.1309/AJCPTUUC2V1WJQBM; International Organization for Standardization, 2012, 15189 ISO; Maruta T, 2011, AFRICAN J LAB MED, V1, P1; Maruta T, 2013, AFR J LAB MED, V2, DOI 10.4102/ajlm.v2i1.77; Mbah H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107277; Mothabeng D, 2012, AFR J LAB MED, V1, DOI 10.4102/ajlm.v1i1.9; Nordling L, 2009, NAT NEWS, P1; Peter TF, 2010, AM J CLIN PATHOL, V134, P550, DOI 10.1309/AJCPH1SKQ1HNWGHF; Rabinovitch A, 2002, ACCREDIT QUAL ASSUR, V7, P473, DOI 10.1007/s00769-002-0537-0; Schroeder LF, 2014, AM J CLIN PATHOL, V141, P791, DOI 10.1309/AJCPQ5KTKAGSSCFN; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; Yao K, 2010, AM J CLIN PATHOL, V134, P401, DOI 10.1309/AJCPNBBL53FWUIQJ	17	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e116185	10.1371/journal.pone.0116185	http://dx.doi.org/10.1371/journal.pone.0116185			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542022	Green Submitted, Green Published, gold			2022-12-27	WOS:000347239900156
J	Romero-Aguirregomezcorta, J; Santa, AP; Garcia-Vazquez, FA; Coy, P; Matas, C				Romero-Aguirregomezcorta, Jon; Patricia Santa, Angela; Alberto Garcia-Vazquez, Francisco; Coy, Pilar; Matas, Carmen			Nitric Oxide Synthase (NOS) Inhibition during Porcine In Vitro Maturation Modifies Oocyte Protein S-Nitrosylation and In Vitro Fertilization	PLOS ONE			English	Article							MEIOTIC MATURATION; SIGNALING PATHWAYS; EMBRYO DEVELOPMENT; REACTIVE OXYGEN; MOUSE OOCYTES; EXPRESSION; COMPLEXES; CELLS; RESUMPTION; SPERM	Nitric oxide (NO) is a molecule involved in many reproductive processes. Its importance during oocyte in vitro maturation (IVM) has been demonstrated in various species although sometimes with contradictory results. The objective of this study was to determine the effect of NO during IVM of cumulus oocyte complexes and its subsequent impact on gamete interaction in porcine species. For this purpose, IVM media were supplemented with three NOS inhibitors: NG-nitro-L-arginine methyl ester (L-NAME), NG-monomethyl-L-arginine (L-NMMA) and aminoguanidine (AG). A NO donor, S-nitrosoglutathione (GSNO), was also used. The effects on the cumulus cell expansion, meiotic resumption, zona pellucida digestion time (ZPdt) and, finally, on in vitro fertilization (IVF) parameters were evaluated. The oocyte S-nitrosoproteins were also studied by in situ nitrosylation. The results showed that after 42 h of IVM, AG, L-NAME and L-NMMA had an inhibitory effect on cumulus cell expansion. Meiotic resumption was suppressed only when AG was added, with 78.7% of the oocytes arrested at the germinal vesicle state (P<0.05). Supplementation of the IVM medium with NOS inhibitors or NO donor did not enhance the efficiency of IVF, but revealed the importance of NO in maturation and subsequent fertilization. Furthermore, protein S-nitrosylation is reported for the first time as a pathway through which NO exerts its effect on porcine IVM; therefore, it would be important to determine which proteins are nitrosylated in the oocyte and their functions, in order to throw light on the mechanism of action of NO in oocyte maturation and subsequent fertilization.	[Romero-Aguirregomezcorta, Jon; Patricia Santa, Angela; Alberto Garcia-Vazquez, Francisco; Coy, Pilar; Matas, Carmen] Univ Murcia, Fac Vet, Dept Physiol, Int Excellence Campus Higher Educ & Res, Murcia, Spain; [Romero-Aguirregomezcorta, Jon; Alberto Garcia-Vazquez, Francisco; Coy, Pilar; Matas, Carmen] Inst Biomed Res Murcia IMIB, Murcia, Spain	University of Murcia	Matas, C (corresponding author), Univ Murcia, Fac Vet, Dept Physiol, Int Excellence Campus Higher Educ & Res, Murcia, Spain.	cmatas@um.es	Romero-Aguirregomezcorta, Jon/H-9277-2015; VAZQUEZ, FRANCISCO A GARCIA/H-1524-2015; Coy, Pilar/G-6811-2015	Romero-Aguirregomezcorta, Jon/0000-0001-7779-6869; VAZQUEZ, FRANCISCO A GARCIA/0000-0001-7665-3858; Coy, Pilar/0000-0002-3943-1890; Matas, Carmen/0000-0002-8252-120X	Spanish Ministry of Economy and Competitiveness; European Regional Development Fund [AGL2012-40180-C03-01];  [BES-2010-029858]	Spanish Ministry of Economy and Competitiveness(Spanish Government); European Regional Development Fund(European Commission); 	Funding: This study was supported by the Spanish Ministry of Economy and Competitiveness and the European Regional Development Fund, Grant AGL2012-40180-C03-01. JR-A received scholarship Formacion Personal Investigador (FPI), BES-2010-029858. JR-A, FAG-V, PC, and CM are members of the European Cooperation in Science and Technology (COST) Action FA1201 (EPICONCEPT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amale MH, 2011, CZECH J ANIM SCI, V56, P284, DOI 10.17221/1284-CJAS; Barroso RP, 1998, MOL HUM REPROD, V4, P503, DOI 10.1093/molehr/4.5.503; Bilodeaul-Goeseels S, 2007, THERIOGENOLOGY, V68, P693, DOI 10.1016/j.theriogenology.2007.05.063; Bu SM, 2003, MOL CELL ENDOCRINOL, V207, P21, DOI 10.1016/S0303-7207(03)00213-2; CAMPBELL G, 1985, J AM STAT ASSOC, V80, P998, DOI 10.2307/2288566; Chmelikova E, 2009, CZECH J ANIM SCI, V54, P137, DOI 10.17221/1742-CJAS; Chmelikova E, 2010, ZYGOTE, V18, P235, DOI 10.1017/S0967199409990268; Coy P, 2008, BIOL REPROD, V667; Coy P, 2008, P NATL ACAD SCI USA, V105, P15809, DOI 10.1073/pnas.0804422105; Coy P, 2010, BIOL REV, V85, P593, DOI 10.1111/j.1469-185X.2009.00117.x; Forrester MT, 2009, FREE RADICAL BIO MED, V46, P119, DOI 10.1016/j.freeradbiomed.2008.09.034; Francis SH, 2010, PHARMACOL REV, V62, P525, DOI 10.1124/pr.110.002907; Friebe A, 2003, CIRC RES, V93, P96, DOI 10.1161/01.RES.0000082524.34487.31; Goud PT, 2008, FREE RADICAL BIO MED, V45, P453, DOI 10.1016/j.freeradbiomed.2008.04.035; Goud PT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098720; GRIFFITH OW, 1995, ANNU REV PHYSIOL, V57, P707, DOI 10.1146/annurev.ph.57.030195.003423; GROSS SS, 1991, BIOCHEM BIOPH RES CO, V178, P823, DOI 10.1016/0006-291X(91)90965-A; Grupen CG, 2014, THERIOGENOLOGY, V81, P24, DOI 10.1016/j.theriogenology.2013.09.022; Hartig SM, 2013, CURR PROTOC MOL BIOL, V14; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Jablonka-Shariff A, 1999, J SOC GYNECOL INVEST, V6, P95, DOI 10.1177/107155769900600208; Jablonka-Shariff A, 1998, ENDOCRINOLOGY, V139, P2944, DOI 10.1210/en.139.6.2944; Jablonka-Shariff A, 2000, MOL REPROD DEV, V55, P412, DOI 10.1002/(SICI)1098-2795(200004)55:4&lt;412::AID-MRD9&gt;3.0.CO;2-W; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Ji YB, 1999, ARCH BIOCHEM BIOPHYS, V362, P67, DOI 10.1006/abbi.1998.1013; Kimura N, 2002, BIOL REPROD, V66, P707, DOI 10.1095/biolreprod66.3.707; Kuo RK, 2000, NATURE, V406, P633, DOI 10.1038/35020577; KWON NS, 1990, J BIOL CHEM, V265, P13442; LAMAS S, 1992, P NATL ACAD SCI USA, V89, P6348, DOI 10.1073/pnas.89.14.6348; LAMBERT LE, 1992, EUR J PHARMACOL, V216, P131, DOI 10.1016/0014-2999(92)90221-O; Lee TH, 2013, J ASSIST REPROD GEN, V30, P1063, DOI 10.1007/s10815-013-0045-7; Lefievre L, 2007, PROTEOMICS, V7, P3066, DOI 10.1002/pmic.200700254; Abbasi M, 2009, DARU, V17, P48; Matta SGC, 2009, ANIM REPROD SCI, V111, P189, DOI 10.1016/j.anireprosci.2008.03.002; MCCALL TB, 1991, BRIT J PHARMACOL, V102, P234, DOI 10.1111/j.1476-5381.1991.tb12159.x; Miao YL, 2009, HUM REPROD UPDATE, V15, P573, DOI 10.1093/humupd/dmp014; MONCADA S, 1991, PHARMACOL REV, V43, P109; MORRIS SM, 1994, AM J PHYSIOL, V266, pE829, DOI 10.1152/ajpendo.1994.266.6.E829; Oliveira-Paula GH, 2014, CURR DRUG TARGETS, V15, P164, DOI 10.2174/13894501113146660227; Oropeza A, 2004, BIOL REPROD, V70, P1634, DOI 10.1095/biolreprod.103.025494; Pandey AN, 2010, J CELL BIOCHEM, V111, P521, DOI 10.1002/jcb.22736; PETTERS RM, 1993, J REPROD FERTIL, P61; PURSEL VG, 1975, J ANIM SCI, V40, P99, DOI 10.2527/jas1975.40199x; Rath D, 1999, J ANIM SCI, V77, P3346; Schwarz KRL, 2008, REPROD FERT DEVELOP, V20, P529, DOI 10.1071/RD07209; Stricker SA, 2012, REPRODUCTION, V143, P261, DOI 10.1530/REP-11-0358; Takesue K, 2003, J REPROD DEVELOP, V49, P135, DOI 10.1262/jrd.49.135; Takesue K, 2001, J MOL ENDOCRINOL, V26, P259, DOI 10.1677/jme.0.0260259; Tang DW, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.111302; Tao Y, 2005, ZYGOTE, V13, P1, DOI 10.1017/S0967199404002953; Tao Y, 2004, MOL CELL ENDOCRINOL, V222, P93, DOI 10.1016/j.mce.2004.04.014; Tatemoto H, 2004, BIOL REPROD, V71, P1150, DOI 10.1095/biolreprod.104.029264; Tichovska H, 2011, ANIMAL, V5, P1398, DOI 10.1017/S1751731111000565; VANVOORHIS BJ, 1994, ENDOCRINOLOGY, V135, P1799, DOI 10.1210/en.135.5.1799; Yamashita Y, 2011, BIOL REPROD, V85, P1073, DOI 10.1095/biolreprod.110.090092; Yamauchi J, 1997, ENDOCRINOLOGY, V138, P3630, DOI 10.1210/en.138.9.3630; Zhang YH, 2005, FREE RADICAL BIO MED, V38, P831, DOI 10.1016/j.freeradbiomed.2004.12.016	57	11	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115044	10.1371/journal.pone.0115044	http://dx.doi.org/10.1371/journal.pone.0115044			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542028	Green Submitted, Green Published, gold			2022-12-27	WOS:000347239900021
J	Wegener, E; Brendel, C; Fischer, A; Hulsmann, S; Gartner, J; Huppke, P				Wegener, Eike; Brendel, Cornelia; Fischer, Andre; Huelsmann, Swen; Gaertner, Jutta; Huppke, Peter			Characterization of the MeCP2(R168X) Knockin Mouse Model for Rett Syndrome	PLOS ONE			English	Article							CPG-BINDING PROTEIN-2; MUTANT MICE; RESPIRATORY PHENOTYPES; SUBSTANCE-P; MECP2; MUTATIONS; ABNORMALITIES; DEFICIENCY; EXPRESSION; REVERSAL	Rett syndrome, one of the most common causes of mental retardation in females, is caused by mutations in the X chromosomal gene MECP2. Mice deficient for MeCP2 recapitulate some of the symptoms seen in patients with Rett syndrome. It has been shown that reactivation of silent MECP2 alleles can reverse some of the symptoms in these mice. We have generated a knockin mouse model for translational research that carries the most common nonsense mutation in Rett syndrome, R168X. In this article we describe the phenotype of this mouse model. In male MeCP2(R168X) mice life span was reduced to 12-14 weeks and bodyweight was significantly lower than in wild type littermates. First symptoms including tremor, hind limb clasping and inactivity occurred at age 27 days. At age 6 weeks nest building, rotarod, open-field and elevated plus maze experiments showed impaired motor performance, reduced activity and decreased anxiety-like behavior. Plethysmography at the same time showed apneas and irregular breathing with reduced frequency. Female MeCP2R168X mice showed no significant abnormalities except decreased performance on the rotarod at age 9 months. In conclusion we show that the male MeCP2R168X mice have a phenotype similar to that seen in MECP2 knockout mouse models and are therefore well suited for translational research. The female mice, however, have a much milder and less constant phenotype making such research with this mouse model more challenging.	[Wegener, Eike; Brendel, Cornelia; Gaertner, Jutta; Huppke, Peter] Univ Med Ctr Gottingen, Dept Child & Adolescent Hlth, Div Neuropediat, Gottingen, Germany; [Fischer, Andre] German Ctr Neurodegenerat Dis, Gottingen, Germany; [Fischer, Andre] Univ Med Ctr Gottingen, Dept Psychiat & Psychotherapy, Gottingen, Germany; [Huelsmann, Swen] Ctr Nanoscale Microscopy & Mol Physiol Brain CNMP, Gottingen, Germany	University of Gottingen; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Gottingen	Huppke, P (corresponding author), Univ Med Ctr Gottingen, Dept Child & Adolescent Hlth, Div Neuropediat, Gottingen, Germany.	phuppke@med.uni-goettingen.de	Hülsmann, Swen/F-7169-2010; Fischer, Andre/AAU-7487-2021	Hülsmann, Swen/0000-0001-5042-8724; Wegener, Jan Eike/0000-0003-3712-8748; Fischer, Andre/0000-0001-8546-1161	German Research Foundation [HU 941/2-1]; German-Israel Foundation (GIF) [1048/2009]; Open Access Publication Funds of the Gottingen University	German Research Foundation(German Research Foundation (DFG)); German-Israel Foundation (GIF)(German-Israeli Foundation for Scientific Research and Development); Open Access Publication Funds of the Gottingen University	Funding: The authors acknowledge support by the German Research Foundation grant HU 941/2-1 to P.H., the German-Israel Foundation (GIF) grant 1048/2009 to P.H. and the Open Access Publication Funds of the Gottingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdala AP, 2013, AM J RESP CELL MOL B; Alvarez-Saavedra M, HUM MOL GENET, V19, P2177; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Barthe JY, 1997, EXP BRAIN RES, V115, P485, DOI 10.1007/PL00005718; Bissonnete JM, 2006, PEDIATR RES, V59, P513, DOI 10.1203/01.pdr.0000203157.31924.4a; Bissonnette JM, 2014, NEUROSCIENCE, V267, P166, DOI 10.1016/j.neuroscience.2014.02.043; Brendel C, 2011, J MOL MED, V89, P389, DOI 10.1007/s00109-010-0704-4; Brendel C, 2009, PEDIATR RES, V65, P520, DOI 10.1203/PDR.0b013e31819d9ebc; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chang QA, 2006, NEURON, V49, P341, DOI 10.1016/j.neuron.2005.12.027; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; De Filippis B, GENES BRAIN BEHAV, V9, P213; Deacon RMJ, 2006, NAT PROTOC, V1, P1117, DOI 10.1038/nprot.2006.170; DRORBAUGH JE, 1955, PEDIATRICS, V16, P81; Goffin D, 2012, NAT NEUROSCI, V15, P274, DOI 10.1038/nn.2997; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; HAGBERG B, 1995, ACTA PAEDIATR, V84, P971, DOI 10.1111/j.1651-2227.1995.tb13809.x; Katz DM, 2012, DIS MODEL MECH, V5, P733, DOI 10.1242/dmm.011007; Kerr AM, 1999, ARCH DIS CHILD, V80, P384, DOI 10.1136/adc.80.4.384; Lawson-Yuen A, 2007, BRAIN RES, V1180, P1, DOI 10.1016/j.brainres.2007.08.039; Levitt ES, 2013, J APPL PHYSIOL, V115, P1626, DOI 10.1152/japplphysiol.00889.2013; Lonetti G, BIOL PSYCHIAT, V67, P657; LUGARESI E, 1985, BRAIN DEV-JPN, V7, P329, DOI 10.1016/S0387-7604(85)80039-5; McGraw CM, 2011, SCIENCE, V333, P186, DOI 10.1126/science.1206593; Moretti P, 2005, HUM MOL GENET, V14, P205, DOI 10.1093/hmg/ddi016; Mount RH, 2002, J CHILD PSYCHOL PSYC, V43, P1099, DOI 10.1111/1469-7610.00236; Pelka GJ, 2006, BRAIN, V129, P887, DOI 10.1093/brain/awl022; Ramirez JM, 2013, RESP PHYSIOL NEUROBI, V189, P280, DOI 10.1016/j.resp.2013.06.022; Rett A, 1966, Wien Med Wochenschr, V116, P723; Ricceri L, 2013, NEUROPHARMACOLOGY, V68, P106, DOI 10.1016/j.neuropharm.2012.08.010; Robinson L, 2012, BRAIN, V135, P2699, DOI 10.1093/brain/aws096; Samaco RC, 2008, HUM MOL GENET, V17, P1718, DOI 10.1093/hmg/ddn062; Schaevitz LR, 2013, GENES BRAIN BEHAV, V12, P732, DOI 10.1111/gbb.12070; Shahbazian MD, 2002, AM J HUM GENET, V71, P1259, DOI 10.1086/345360; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Stearns NA, 2007, NEUROSCIENCE, V146, P907, DOI 10.1016/j.neuroscience.2007.02.009; Stettner GM, 2007, J PHYSIOL-LONDON, V579, P863, DOI 10.1113/jphysiol.2006.119966; Telgkamp P, 2002, J NEUROPHYSIOL, V88, P206, DOI 10.1152/jn.2002.88.1.206; VandeWeerd HA, 1997, LAB ANIM, V31, P133, DOI 10.1258/002367797780600152; Voituron N, 2009, RESP PHYSIOL NEUROBI, V168, P109, DOI 10.1016/j.resp.2009.05.013	41	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115444	10.1371/journal.pone.0115444	http://dx.doi.org/10.1371/journal.pone.0115444			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541993	Green Published, Green Submitted, gold			2022-12-27	WOS:000347239900045
J	Zhang, N; Wang, L; Chai, ZT; Zhu, ZM; Zhu, XD; Ma, DN; Zhang, QB; Zhao, YM; Wang, M; Ao, JY; Ren, ZG; Gao, DM; Sun, HC; Tang, ZY				Zhang, Ning; Wang, Lu; Chai, Zong-Tao; Zhu, Zi-Man; Zhu, Xiao-Dong; Ma, De-Ning; Zhang, Qiang-Bo; Zhao, Yi-Ming; Wang, Miao; Ao, Jian-Yang; Ren, Zheng-Gang; Gao, Dong-Mei; Sun, Hui-Chuan; Tang, Zhao-You			Incomplete Radiofrequency Ablation Enhances Invasiveness and Metastasis of Residual Cancer of Hepatocellular Carcinoma Cell HCCLM3 via Activating beta-Catenin Signaling	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; NUDE-MICE; NONSURGICAL TREATMENT; RAPID PROGRESSION; THERMAL ABLATION; TUMOR-GROWTH; IN-VIVO; MODEL; THERAPY; MANAGEMENT	Background: Radiofrequency ablation (RFA) is one of the curative therapies for hepatocellular carcinoma (HCC), however, accelerated progression of residual HCC after incomplete RFA has been reported more frequently. The underlying molecular mechanism of this phenomenon remains to be elucidated. In this study, we used an incomplete RFA orthotopic HCC nude mouse model to study the invasive and metastatic potential of residual cancer as well as the correlated mechanism. Methods: The incomplete RFA orthotopic nude mouse models were established using high metastatic potential HCC cell line HCCLM3 and low metastatic potential HCC cell line HepG2, respectively. The changes in cellular morphology, motility, metastasis and epithelial-mesenchymal transition (EMT), and HCC cell molecular markers after in vitro and in vivo incomplete RFA intervention were observed. Results: Pulmonary and intraperitoneal metastasis were observed in an in vivo study. The underlying pro-invasive mechanism of incomplete RFA appeared to be associated with promoting EMT, including down-regulation of E-cadherin and up-regulation of N-cadherin and vimentin. These results were in accordance with the in vitro response of HCC cells to heat intervention. Further studies demonstrated that beta-catenin was a pivotal factor during this course and blocking beta-catenin reduced metastasis and EMT phenotype changes in heat-treated HCCLM3 cells in vitro. Conclusion: Incomplete RFA enhanced the invasive and metastatic potential of residual cancer, accompanying with EMT-like phenotype changes by activating beta-catenin signaling in HCCLM3 cells.	[Zhang, Ning; Wang, Lu; Chai, Zong-Tao; Zhu, Xiao-Dong; Ma, De-Ning; Zhao, Yi-Ming; Wang, Miao; Ao, Jian-Yang; Ren, Zheng-Gang; Gao, Dong-Mei; Sun, Hui-Chuan; Tang, Zhao-You] Fudan Univ, Liver Canc Inst, Shanghai 200032, Peoples R China; [Zhang, Ning; Wang, Lu; Chai, Zong-Tao; Zhu, Xiao-Dong; Ma, De-Ning; Zhao, Yi-Ming; Wang, Miao; Ao, Jian-Yang; Ren, Zheng-Gang; Gao, Dong-Mei; Sun, Hui-Chuan; Tang, Zhao-You] Fudan Univ, Zhongshan Hosp, Key Lab Carcinogenesis & Canc Invas, Chinese Minist Educ, Shanghai 200032, Peoples R China; [Zhu, Zi-Man] Chinese Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Hepatobiliary Surg, Beijing, Peoples R China; [Zhang, Qiang-Bo] Shandong Univ, Qilu Hosp, Dept Gen Surg, Jinan 250100, Peoples R China	Fudan University; Fudan University; Chinese People's Liberation Army General Hospital; Shandong University	Tang, ZY (corresponding author), Fudan Univ, Liver Canc Inst, Shanghai 200032, Peoples R China.	zytang88@163.com	Zhu, Xiao-Dong/A-8197-2010	Zhu, Xiao-Dong/0000-0001-9864-6763; Sun, Hui-Chuan/0000-0003-3761-7058	National Natural Science Foundation of China [81372314]; Shanghai Natural Science Fund for Youth Scholars [12ZR1442300]; National Key Project for Infectious Diseases [2012ZX10002012-004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Natural Science Fund for Youth Scholars; National Key Project for Infectious Diseases	This work was supported by National Natural Science Foundation of China (grant number: 81372314); Shanghai Natural Science Fund for Youth Scholars (12ZR1442300); the National Key Project for Infectious Diseases (2012ZX10002012-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arii S, 2000, HEPATOLOGY, V32, P1224, DOI 10.1053/jhep.2000.20456; Bu W, 1998, HEPATO-GASTROENTEROL, V45, P1056; Curley SA, 2000, ANN SURG, V232, P381, DOI 10.1097/00000658-200009000-00010; Dahmani R, 2011, CLIN RES HEPATOL GAS, V35, P709, DOI 10.1016/j.clinre.2011.05.010; Devereux TR, 1999, ONCOGENE, V18, P4726, DOI 10.1038/sj.onc.1202858; Firrincieli D, 2010, GASTROEN CLIN BIOL, V34, P523, DOI 10.1016/j.gcb.2010.04.017; Hu TH, 2014, CANC LETT, V20; Hur K, 2013, GUT, V62, P1315, DOI 10.1136/gutjnl-2011-301846; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kasugai H, 2007, ONCOLOGY-BASEL, V72, P72, DOI 10.1159/000111710; Ke S, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-73; Komorizono Y, 2003, CANCER-AM CANCER SOC, V97, P1253, DOI 10.1002/cncr.11168; Kong J, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-230; Kong J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037266; Kroeze SGC, 2012, BJU INT, V110, pE281, DOI 10.1111/j.1464-410X.2012.11261.x; Lau WY, 2009, ANN SURG, V249, P20, DOI 10.1097/SLA.0b013e31818eec29; Laurent-Puig P, 2006, ONCOGENE, V25, P3778, DOI 10.1038/sj.onc.1209547; Liang XH, 2014, CANCER SCI, V105, P660, DOI 10.1111/cas.12404; Liu LA, 2010, CLIN CANCER RES, V16, P2740, DOI 10.1158/1078-0432.CCR-09-2610; Liu L, 2010, CANCER SCI, V101, P120, DOI 10.1111/j.1349-7006.2009.01363.x; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Llovet JM, 2008, HEPATOLOGY, V48, P1312, DOI 10.1002/hep.22506; Medici D, 2008, MOL BIOL CELL, V19, P4875, DOI 10.1091/mbc.E08-05-0506; Miao LF, 2014, CANCER GENET-NY, V207, P75, DOI 10.1016/j.cancergen.2014.02.008; Miyoshi H, 2009, CANCER SCI, V100, P2046, DOI 10.1111/j.1349-7006.2009.01284.x; Nakagawa H, 2014, CANCER IMMUNOL IMMUN, V63, P347, DOI 10.1007/s00262-013-1514-7; Oh SJ, 2013, J PATHOL, V231, P210, DOI 10.1002/path.4224; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Ruzzenente A, 2004, WORLD J GASTROENTERO, V10, P1137; Schmalhofer O, 2009, CANCER METAST REV, V28, P151, DOI 10.1007/s10555-008-9179-y; Shiina S, 2002, ONCOLOGY-BASEL, V62, P64, DOI 10.1159/000048278; Shiina S, 2012, AM J GASTROENTEROL, V107, P569, DOI 10.1038/ajg.2011.425; Song TJ, 2004, GASTROENTEROLOGY, V127, pS248, DOI 10.1053/j.gastro.2004.09.039; Sun FX, 1996, INT J CANCER, V66, P239, DOI 10.1002/(SICI)1097-0215(19960410)66:2<239::AID-IJC17>3.3.CO;2-G; Tajima H, 2010, ONCOL LETT, V1, P91, DOI 10.3892/ol_00000016; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tian J, 1999, BRIT J CANCER, V81, P814, DOI 10.1038/sj.bjc.6690769; van Zijl F, 2009, FUTURE ONCOL, V5, P1169, DOI [10.2217/fon.09.91, 10.2217/FON.09.91]; Villanueva A, 2007, SEMIN LIVER DIS, V27, P55, DOI 10.1055/s-2006-960171; Wang L, 2000, HEPATOLOGY, V32, P43, DOI 10.1053/jhep.2000.8525; Wang YY, 2005, P NATL ACAD SCI USA, V102, P1104, DOI 10.1073/pnas.0408831102; Wong CCL, 2009, HEPATOLOGY, V49, P1583, DOI 10.1002/hep.22836; Xu M, 2013, ACTA RADIOL, V54, P199, DOI 10.1258/ar.2012.120249; Yang BW, 2008, EUR J GASTROEN HEPAT, V20, P1077, DOI 10.1097/MEG.0b013e3283050a67; Yang JD, 2010, INFECT DIS CLIN N AM, V24, P899, DOI 10.1016/j.idc.2010.07.004; Yang N, 2014, TUMOR BIOL, V35, P7965, DOI 10.1007/s13277-014-2045-3; Yoshida S, 2013, HEPATOLOGY, V58, P1667, DOI 10.1002/hep.26526; Zavaglia C, 2008, EUR J GASTROEN HEPAT, V20, P196, DOI 10.1097/MEG.0b013e3282f1cc4a; Zhang W, 2010, CLIN CANCER RES, V16, P3420, DOI 10.1158/1078-0432.CCR-09-2904; Zhao JH, 2011, CANCER INVEST, V29, P377, DOI 10.3109/07357907.2010.512595	50	37	43	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115949	10.1371/journal.pone.0115949	http://dx.doi.org/10.1371/journal.pone.0115949			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542041	Green Published, Green Submitted, gold			2022-12-27	WOS:000347239900114
J	Zmyslowska, A; Malkowski, B; Fendler, W; Borowiec, M; Antosik, K; Gnys, P; Baranska, D; Mlynarski, W				Zmyslowska, Agnieszka; Malkowski, Bogdan; Fendler, Wojciech; Borowiec, Maciej; Antosik, Karolina; Gnys, Piotr; Baranska, Dobromila; Mlynarski, Wojciech			Central Nervous System PET-CT Imaging Reveals Regional Impairments in Pediatric Patients with Wolfram Syndrome	PLOS ONE			English	Article							GENOTYPE-PHENOTYPE CORRELATION; HYPOGLYCEMIA UNAWARENESS; GLUCOSE-METABOLISM; DIDMOAD SYNDROME; DISEASE; MRI; MEN	Wolfram syndrome (WFS) is inherited as an autosomal recessive disease with main clinical features of diabetes mellitus, optic atrophy, diabetes insipidus and deafness. However, various neurological defects may also be detected. The aim of this study was to evaluate aspects of brain structure and function using PET-CT (positron emission tomography and computed tomography) and MRI (magnetic resonance imaging) in pediatric patients with WFS. Regional changes in brain glucose metabolism were measured using standardized uptake values (SUVs) based on images of (F-18) fluorodeoxyglucose (FDG) uptake in 7 WFS patients aged 10.1-16.0 years (mean 12.9 +/- 2.4) and in 20 healthy children aged 3-17.9 years (mean 12.8 +/- 4.1). In all patients the diagnosis of WFS was confirmed by DNA sequencing of the WFS1 gene. Hierarchical clustering showed remarkable similarities of glucose uptake patterns among WFS patients and their differences from the control group. SUV data were subsequently standardized for age groups, <13 years old and >13 years old to account for developmental differences. Reduced SUVs in WFS patients as compared to the control group for the bilateral brain regions such as occipital lobe (-1.24 +/- 1.20 vs. -0.13 +/- 1.05; p=0.028) and cerebellum (-1.11 +/- 0.69 vs. -0.204 +/- 1.00; p=0.036) were observed and the same tendency for cingulate (-1.13 +/- 1.05 vs. -0.15 +/- 1.12; p=0.056), temporal lobe (-1.10 +/- 0.98 vs. -0.15 +/- 1.10; p=0.057), parietal lobe (-1.06 +/- 1.20 vs. -0.08 +/- 1.08; p=0.058), central region (-1.01 +/- 1.04 vs. -0.09 +/- 1.06; p=0.060), basal ganglia (-1.05 +/- 0.74 vs. -0.20 +/- 1.07; p=0.066) and mesial temporal lobe (-1.06 +/- 0.82 vs. -0.26 +/- 1.08; p=0.087) was also noticed. After adjusting for multiple hypothesis testing, the differences in glucose uptake were non-significant. For the first time, regional differences in brain glucose metabolism among patients with WFS were shown using PET-CT imaging.	[Zmyslowska, Agnieszka; Fendler, Wojciech; Gnys, Piotr; Mlynarski, Wojciech] Med Univ Lodz, Dept Pediat Oncol Hematol & Diabetol, Lodz, Poland; [Malkowski, Bogdan] Ctr Oncol, Dept Nucl Med, Bydgoszcz, Poland; [Borowiec, Maciej; Antosik, Karolina] Med Univ Lodz, Dept Clin Genet, Lodz, Poland; [Baranska, Dobromila] Clin Hosp 4, Dept Radiol, Lodz, Poland	Medical University Lodz; Medical University Lodz	Mlynarski, W (corresponding author), Med Univ Lodz, Dept Pediat Oncol Hematol & Diabetol, Lodz, Poland.	wojciech.mlynarski@umed.lodz.pl	Fendler, Wojciech Maksymilian/S-9592-2016; Fendler, Wojciech/AAG-7020-2019; Borowiec, Maciej/S-9220-2016	Fendler, Wojciech Maksymilian/0000-0002-5083-9168; Fendler, Wojciech/0000-0002-5083-9168; Malkowski, Bogdan/0000-0003-1421-4694; Borowiec, Maciej/0000-0003-2812-5676; Antosik, Karolina/0000-0002-0471-5826; Zmyslowska, Agnieszka/0000-0001-8781-4469; Mlynarski, Wojciech/0000-0003-2714-5851	Polish Ministry of Science and Higher Education [N 407 100040]; EURO-WABB Project; National Science Center [2012/05/E/NZ5/02130]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); EURO-WABB Project; National Science Center(National Science Centre, Poland)	Funding: This study was supported by the Polish Ministry of Science and Higher Education (grant no. N 407 100040) and EURO-WABB Project. Wojciech Fendler received financial support from the National Science Center (grant no. 2012/05/E/NZ5/02130). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett TG, 1997, J MED GENET, V34, P838, DOI 10.1136/jmg.34.10.838; BARRETT TG, 1995, LANCET, V346, P1458, DOI 10.1016/S0140-6736(95)92473-6; Bingham EM, 2005, DIABETOLOGIA, V48, P2080, DOI 10.1007/s00125-005-1900-6; Chaussenot A, 2011, ANN NEUROL, V69, P501, DOI 10.1002/ana.22160; Cranston I, 2001, DIABETES, V50, P2329, DOI 10.2337/diabetes.50.10.2329; D'Annunzio G, 2008, DIABETES CARE, V31, P1743, DOI 10.2337/dc08-0178; Dunn JT, 2007, DIABETES, V56, P2766, DOI 10.2337/db07-0666; Fonseca SG, 2010, J CLIN INVEST, V120, P744, DOI 10.1172/JCI39678; Galluzzi P, 1999, NEURORADIOLOGY, V41, P729, DOI 10.1007/s002340050832; Genis D, 1997, ACTA NEUROPATHOL, V93, P426, DOI 10.1007/s004010050635; Hadidy AM, 2004, SAUDI MED J, V25, P638; Hershey T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040604; Hilson JB, 2009, ACTA NEUROPATHOL, V118, P415, DOI 10.1007/s00401-009-0546-8; Imabayashi E, 2013, BRAIN BEHAV, V3, P487, DOI 10.1002/brb3.146; Ito S, 2007, AM J NEURORADIOL, V28, P305; KINSLEY BT, 1995, DIABETES CARE, V18, P1566, DOI 10.2337/diacare.18.12.1566; LEIVASANTANA C, 1993, REV NEUROL, V149, P26; London K, 2014, EUR J NUCL MED MOL I, V41, P723, DOI 10.1007/s00259-013-2639-9; Marshall BA, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-64; Mathis S, 2007, REV NEUROL-FRANCE, V163, P197, DOI 10.1016/S0035-3787(07)90391-4; Pakdemirli E, 2005, Australas Radiol, V49, P189, DOI 10.1111/j.1440-1673.2005.01420.x; RANDO TA, 1992, NEUROLOGY, V42, P1220, DOI 10.1212/WNL.42.6.1220; Shan ZYY, 2014, HUM BRAIN MAPP, V35, P2297, DOI 10.1002/hbm.22328; Shannon P, 1999, ACTA NEUROPATHOL, V98, P304, DOI 10.1007/s004010051084; Waschbisch A, 2011, J NEUROL SCI, V300, P191, DOI 10.1016/j.jns.2010.08.044; Yamada T, 2006, HUM MOL GENET, V15, P1600, DOI 10.1093/hmg/ddl081; Yamane T., 2013, AJNR AM J NEURORADIO; Yang MS, 2005, J FORMOS MED ASSOC, V104, P129; Zmyslowska A, 2014, EXP CLIN ENDOCR DIAB, V122, P35, DOI 10.1055/s-0033-1357160; Zmyslowska A, 2011, CLIN ENDOCRINOL, V75, P636, DOI 10.1111/j.1365-2265.2011.04102.x	30	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115605	10.1371/journal.pone.0115605	http://dx.doi.org/10.1371/journal.pone.0115605			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542043	Green Published, Green Submitted, gold			2022-12-27	WOS:000347239900057
J	Bancone, G; Chu, CS; Somsakchaicharoen, R; Chowwiwat, N; Parker, DM; Charunwatthana, P; White, NJ; Nosten, FH				Bancone, Germana; Chu, Cindy S.; Somsakchaicharoen, Raweewan; Chowwiwat, Nongnud; Parker, Daniel M.; Charunwatthana, Prakaykaew; White, Nicholas J.; Nosten, Francois H.			Characterization of G6PD Genotypes and Phenotypes on the Northwestern Thailand-Myanmar Border	PLOS ONE			English	Article							MOLECULAR HETEROGENEITY; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENCY; COMMON VARIANT; MUTATIONS; POLYMORPHISM; BURMESE; MAHIDOL	Mutations in the glucose-6-phosphate dehydrogenase (G6PD) gene result in red blood cells with increased susceptibility to oxidative damage. Significant haemolysis can be caused by primaquine and other 8-aminoquinoline antimalarials used for the radical treatment of Plasmodium vivax malaria. The distribution and phenotypes of mutations causing G6PD deficiency in the male population of migrants and refugees in a malaria endemic region on the Thailand-Myanmar border were characterized. Blood samples for G6PD fluorescent spot test (FST), G6PD genotyping, and malaria testing were taken from 504 unrelated males of Karen and Burman ethnicities presenting to the outpatient clinics. The overall frequency of G6PD deficiency by the FST was 13.7%. Among the deficient subjects, almost 90% had the Mahidol variant (487G>A) genotype. The remaining subjects had Chinese-4 (392G>T), Viangchan (871G>A), Acores (595A>G), Seattle (844G>C) and Mediterranean (563C>T) variants. Quantification of G6PD activity was performed using a modification of the standard spectrophotometric assay on a subset of 24 samples with Mahidol, Viangchan, Seattle and Chinese-4 mutations; all samples showed a residual enzymatic activity below 10% of normal and were diagnosed correctly by the FST. Further studies are needed to characterise the haemolytic risk of using 8-aminoquinolines in patients with these genotypes.	[Bancone, Germana; Chu, Cindy S.; Somsakchaicharoen, Raweewan; Chowwiwat, Nongnud; Parker, Daniel M.; Nosten, Francois H.] Mahidol Univ, Fac Trop Med, Shoklo Malaria Res Unit, Mahidol Oxford Trop Med Res Unit, Mae Sot, Thailand; [Charunwatthana, Prakaykaew; White, Nicholas J.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [White, Nicholas J.; Nosten, Francois H.] Univ Oxford, Nuffield Dept Med, Ctr Trop Med, Oxford, England	Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford	Bancone, G (corresponding author), Mahidol Univ, Fac Trop Med, Shoklo Malaria Res Unit, Mahidol Oxford Trop Med Res Unit, Mae Sot, Thailand.	germana@tropmedres.ac	Parker, Daniel M./B-5471-2013; Chu, Cindy S/E-3135-2014; Nosten, Francois/AAC-5509-2019; White, Nick/AAC-6527-2019	Parker, Daniel M./0000-0002-5352-7338; Chu, Cindy S/0000-0001-9465-8214; Nosten, Francois/0000-0002-7951-0745; White, Nick/0000-0002-1897-1978; Bancone, Germana/0000-0003-4550-0431	Wellcome Trust [089179]	Wellcome Trust(Wellcome TrustEuropean Commission)	This study was supported by the Wellcome Trust (Programme Grant 089179) and was part of the Wellcome Trust Mahidol University Oxford Tropical Medicine Research Programme funded by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algur N, 2012, J PEDIATR-US, V161, P197, DOI 10.1016/j.jpeds.2012.02.045; BEUTLER E, 1968, BLOOD, V32, P816, DOI 10.1182/blood.V32.5.816.816; BEUTLER E, 1977, BRIT J HAEMATOL, V35, P331, DOI 10.1111/j.1365-2141.1977.tb00589.x; BEUTLER E, 1990, AM J HUM GENET, V47, P1008; Cabrera VM, 1996, HUM HERED, V46, P197, DOI 10.1159/000154353; Cappellini MD, 2008, LANCET, V371, P64, DOI 10.1016/S0140-6736(08)60073-2; CAPPELLINI MD, 1995, HUM GENET, V95, P440, DOI 10.1007/BF00208972; Carrara VI, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001398; Chesher Douglas, 2008, Clin Biochem Rev, V29 Suppl 1, pS23; Clark TG, 2009, EUR J HUM GENET, V17, P1080, DOI 10.1038/ejhg.2009.8; De Araujo C, 2006, HAEMATOL-HEMATOL J, V91, P262; Howes RE, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-418; Howes RE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001339; Huang CS, 1996, AM J HEMATOL, V51, P19, DOI 10.1002/(SICI)1096-8652(199601)51:1<19::AID-AJH4>3.0.CO;2-A; Huang YX, 2008, MOL GENET METAB, V93, P44, DOI 10.1016/j.ymgme.2007.08.122; Iwai K, 2001, HUM GENET, V108, P445, DOI 10.1007/s004390100527; Jalloh A, 2008, J HUM GENET, V53, P675, DOI 10.1007/s10038-008-0294-y; Jamornthanyawat N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088605; Kim S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028357; Laosombat V, 2005, BLOOD CELL MOL DIS, V34, P191, DOI 10.1016/j.bcmd.2004.11.001; Luzzatto L, 2009, GLUCOSE 6 PHOSPHATE; Manco L, 2007, HAEMATOLOGICA, V92, P1713, DOI 10.3324/haematol.11670; Matsuoka H, 2005, J HUM GENET, V50, P468, DOI 10.1007/s10038-005-0279-z; Matsuoka H, 2004, J HUM GENET, V49, P544, DOI 10.1007/s10038-004-0187-7; Matsuoka H, 2007, ACTA MED OKAYAMA, V61, P213; Menounos P, 2000, HUM HERED, V50, P237, DOI 10.1159/000022922; Nguyen TH, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-152; Nuchprayoon I, 2002, Hum Mutat, V19, P185, DOI 10.1002/humu.9010; Nuchprayoon I, 2008, J HUM GENET, V53, P48, DOI 10.1007/s10038-007-0217-3; PANICH V, 1972, Journal of the Medical Association of Thailand, V55, P576; Phompradit P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-368; SALVIDIO E, 1969, ACTA HAEMATOL-BASEL, V41, P331, DOI 10.1159/000208870; Sanders S, 1997, MUTAT RES-FUND MOL M, V374, P79, DOI 10.1016/S0027-5107(96)00222-9; Sriprawat K, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-115; VULLIAMY TJ, 1989, NUCLEIC ACIDS RES, V17, P5868, DOI 10.1093/nar/17.14.5868; Yan TZ, 2006, HAEMATOLOGICA, V91, P1321	36	56	57	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e0116063	10.1371/journal.pone.0116063	http://dx.doi.org/10.1371/journal.pone.0116063			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536053	Green Published, gold			2022-12-27	WOS:000348563300098
J	Chen, J; Li, W; Zhang, T; Wang, YJ; Jiang, XJ; Xu, ZQ				Chen, Jia; Li, Wei; Zhang, Tao; Wang, Yan-jiang; Jiang, Xiao-jiang; Xu, Zhi-qiang			Glucocerebrosidase Gene Mutations Associated with Parkinson's Disease: A Meta-Analysis in a Chinese population	PLOS ONE			English	Article							GAUCHER-DISEASE; ASHKENAZI-JEWS; RISK-FACTOR; LEWY BODY	Mutations of glucocerebrosidase (GBA) confer susceptibility to Parkinson's disease in several ethnical populations, with a high incidence especially in the Ashkenazi Jewish population. Although there are several studies that have investigated a similar association in a Chinese population, small sample sizes and few positive outcomes have made it difficult to obtain conclusive results from these individual studies. Therefore, the present study used a meta-analysis approach, pooling the appropriate data from published studies to investigate the association of GBA mutations and Parkinson's disease in a Chinese population. Nine studies containing 6536 Chinese subjects (3438 cases and 3098 healthy controls) and examining the GBA mutations of L444P, N370S and several other mutations were included. Review Manager 5.2 software was applied to analyze the pooled odds ratios (ORs) and 95% confidence intervals (CIs). The results showed a significant association of Parkinson's disease risk with overall GBA mutations (OR = 6.34, 95% CI = 3.77-10.68, p < 0.00001), and with the subgroup of L444P mutation (OR = 11.68, 95% CI = 5.23-26.06, p < 0.00001). No such association was observed for the subgroup with N370S mutation or other mutations, in part because of the small sample size or rare events. Thus, for the rare occurrence of GBA mutations, studies with larger sample size are necessary to minimize the sampling error and to obtain convincing results.	[Chen, Jia; Li, Wei; Zhang, Tao; Wang, Yan-jiang; Jiang, Xiao-jiang; Xu, Zhi-qiang] Third Mil Med Univ, Daping Hosp, Dept Neurol, Chongqing 400042, Peoples R China; [Chen, Jia] PLA 123 Hosp, Dept Neurol, Bengbu 233000, Peoples R China	Army Medical University	Xu, ZQ (corresponding author), Third Mil Med Univ, Daping Hosp, Dept Neurol, 10 Changjiang Branch Rd, Chongqing 400042, Peoples R China.	xzq881@163.com	Wang, Yanjiang/F-3703-2012	Wang, Yanjiang/0000-0002-6227-6112	National Natural Science Foundation of China [81271411]; Natural Science Foundation Project of CQ CSTC [cstc2012jjA10098]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Project of CQ CSTC(Natural Science Foundation Project of CQ CSTC)	This study was supported by Grants from the National Natural Science Foundation of China (81271411) and Natural Science Foundation Project of CQ CSTC (cstc2012jjA10098). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon-Peretz J, 2004, NEW ENGL J MED, V351, P1972, DOI 10.1056/NEJMoa033277; BARNEVELD RA, 1983, HUM GENET, V64, P227, DOI 10.1007/BF00279398; BEUTLER E, 1993, AM J HUM GENET, V52, P85; Bras J, 2009, NEUROBIOL AGING, V30, P1515, DOI 10.1016/j.neurobiolaging.2007.11.016; Choi JM, 2012, NEUROSCI LETT, V514, P12, DOI 10.1016/j.neulet.2012.02.035; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Eblan MJ, 2005, NEW ENGL J MED, V352, P728; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hruska KS, 2008, HUM MUTAT, V29, P567, DOI 10.1002/humu.20676; Hu FY, 2010, EUR J NEUROL, V17, P1476, DOI 10.1111/j.1468-1331.2010.03097.x; Huang CL, 2011, EUR J NEUROL, V18, P1227, DOI 10.1111/j.1468-1331.2011.03362.x; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Lwin A, 2004, MOL GENET METAB, V81, P70, DOI 10.1016/j.ymgme.2003.11.004; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mao XY, 2010, NEUROSCI LETT, V469, P256, DOI 10.1016/j.neulet.2009.12.007; Nishioka K, 2010, NEUROSCI LETT, V477, P57, DOI 10.1016/j.neulet.2009.11.066; Noreau A, 2011, CAN J NEUROL SCI, V38, P772, DOI 10.1017/S0317167100012300; Rogaeva E, 2008, NEUROLOGY, V70, P2272, DOI 10.1212/01.wnl.0000314657.92762.0f; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; Socal MP, 2009, PARKINSONISM RELAT D, V15, P76, DOI 10.1016/j.parkreldis.2008.01.019; Tan EK, 2007, ARCH NEUROL-CHICAGO, V64, P1056, DOI 10.1001/archneur.64.7.1056; Toft M, 2006, NEUROLOGY, V66, P415, DOI 10.1212/01.wnl.0000196492.80676.7c; Trinh J, 2013, NAT REV NEUROL, V9, P445, DOI 10.1038/nrneurol.2013.132; Velayati A, 2010, CURR NEUROL NEUROSCI, V10, P190, DOI 10.1007/s11910-010-0102-x; Wang YP, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-57; Wu YR, 2007, J NEUROL NEUROSUR PS, V78, P977, DOI 10.1136/jnnp.2006.105940; Zhang X, 2012, CHINESE J PHYSIOL, V55, P398, DOI [10.4077/CJP.2011.AMM076, 10.4077/CJP.2012.BAA076]; Ziegler SG, 2007, MOL GENET METAB, V91, P195, DOI 10.1016/j.ymgme.2007.03.004	30	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115747	10.1371/journal.pone.0115747	http://dx.doi.org/10.1371/journal.pone.0115747			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25535748	Green Published, gold, Green Submitted			2022-12-27	WOS:000348563300068
J	Du, JH; Forster, B; Rourke, L; Howitt, SM; Price, GD				Du, Jiahui; Foerster, Britta; Rourke, Loraine; Howitt, Susan M.; Price, G. Dean			Characterisation of Cyanobacterial Bicarbonate Transporters in E. coli Shows that SbtA Homologs Are Functional in This Heterologous Expression System	PLOS ONE			English	Article							STRAIN PCC 7942; GLNK COMPLEX REVEALS; ESCHERICHIA-COLI; CO2 FIXATION; IDENTIFICATION; GENES; PHOTOSYNTHESIS; CARBOXYSOMES; COMPONENTS; DIVERSITY	Cyanobacterial HCO3- transporters BCT1, SbtA and BicA are important components of cyanobacterial CO2-concentration mechanisms. They also show potential in applications aimed at improving photosynthetic rates and yield when expressed in the chloroplasts of C3 crop species. The present study investigated the feasibility of using Escherichia coli to assess function of a range of SbtA and BicA transporters in a heterologous expression system, ultimately for selection of transporters suitable for chloroplast expression. Here, we demonstrate that six beta-forms of SbtA are active in E. coli, although other tested bicarbonate transporters were inactive. The sbtA clones were derived from Synechococcus sp. WH5701, Cyanobium sp. PCC7001, Cyanobium sp. PCC6307, Synechococcus elongatus PCC7942, Synechocystis sp. PCC6803, and Synechococcus sp. PCC7002. The six SbtA homologs varied in bicarbonate uptake kinetics and sodium requirements in E. coli. In particular, SbtA from PCC7001 showed the lowest uptake affinity and highest flux rate and was capable of increasing the internal inorganic carbon pool by more than 8 mM relative to controls lacking transporters. Importantly, we were able to show that the SbtB protein (encoded by a companion gene near sbtA) binds to SbtA and suppresses bicarbonate uptake function of SbtA in E. coli, suggesting a role in post-translational regulation of SbtA, possibly as an inhibitor in the dark. This study established E. coli as a heterologous expression and analysis system for HCO3- transporters from cyanobacteria, and identified several SbtA transporters as useful for expression in the chloroplast inner envelope membranes of higher plants.	[Du, Jiahui; Foerster, Britta; Rourke, Loraine; Howitt, Susan M.; Price, G. Dean] Australian Natl Univ, Plant Sci Div, Realizing Increased Photosynthet Efficiency RIPE, Res Sch Biol, Canberra, ACT 2601, Australia	Australian National University	Price, GD (corresponding author), Australian Natl Univ, Plant Sci Div, Realizing Increased Photosynthet Efficiency RIPE, Res Sch Biol, Linnaeus Bldg 134, Canberra, ACT 2601, Australia.	dean.price@anu.edu.au	Price, G Dean/C-9505-2009; Förster, Britta/O-7908-2015	Price, G Dean/0000-0001-5906-4912; 	Australian Research Council	Australian Research Council(Australian Research Council)	Funding provided by an Australian Research Council to GDP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badger MR, 2002, FUNCT PLANT BIOL, V29, P161, DOI 10.1071/PP01213; Conroy MJ, 2007, P NATL ACAD SCI USA, V104, P1213, DOI 10.1073/pnas.0610348104; Durand A, 2006, J BIOL CHEM, V281, P29558, DOI 10.1074/jbc.M602477200; Evans JR, 1996, PLANT PHYSIOL, V110, P339, DOI 10.1104/pp.110.2.339; Herrera-Estrella LR, 2000, PLANT PHYSIOL, V124, P923, DOI 10.1104/pp.124.3.923; Imamura T, 2006, ENCY SURFACE COLLOID; Joyce AR, 2006, J BACTERIOL, V188, P8259, DOI 10.1128/JB.00740-06; Karley AJ, 2000, TRENDS PLANT SCI, V5, P465, DOI 10.1016/S1360-1385(00)01758-1; Kimball BA, 2002, ADV AGRON, V77, P293, DOI 10.1016/S0065-2113(02)77017-X; Long SP, 2006, PLANT CELL ENVIRON, V29, P315, DOI 10.1111/j.1365-3040.2005.01493.x; Maeda S, 1998, J BACTERIOL, V180, P4080, DOI 10.1128/JB.180.16.4080-4088.1998; Maeda S, 2000, J BIOL CHEM, V275, P20551, DOI 10.1074/jbc.M003034200; Merlin C, 2003, J BACTERIOL, V185, P6415, DOI 10.1128/JB.185.21.6415-6424.2003; Narayanan M, 2013, J BIOL CHEM, V288, P14310, DOI 10.1074/jbc.M113.467803; Omata T, 1999, P NATL ACAD SCI USA, V96, P13571, DOI 10.1073/pnas.96.23.13571; Pengelly JJL, 2014, J EXP BOT, V65, P3071, DOI 10.1093/jxb/eru156; Price GD, 2008, J EXP BOT, V59, P1441, DOI 10.1093/jxb/erm112; Price GD, 2014, MOL MEMBR BIOL, V31, P177, DOI 10.3109/09687688.2014.953222; Price GD, 2013, J EXP BOT, V64, P753, DOI 10.1093/jxb/ers257; Price GD, 2011, MOL MEMBR BIOL, V28, P265, DOI 10.3109/09687688.2011.593049; Price GD, 2011, PLANT PHYSIOL, V155, P20, DOI 10.1104/pp.110.164681; Price GD, 2004, P NATL ACAD SCI USA, V101, P18228, DOI 10.1073/pnas.0405211101; PRICE GD, 1989, PLANT PHYSIOL, V89, P37, DOI 10.1104/pp.89.1.37; Radchenko M, 2011, BIOCHEM SOC T, V39, P189, DOI 10.1042/BST0390189; Rae BD, 2013, J MOL MICROB BIOTECH, V23, P300, DOI 10.1159/000351342; Rae BD, 2011, PHOTOSYNTH RES, V109, P59, DOI 10.1007/s11120-011-9641-5; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Rolland N, 2003, PHOTOSYNTH RES, V78, P205, DOI 10.1023/B:PRES.0000006891.12416.6c; Schwarz D, 2011, PLANT PHYSIOL, V155, P1640, DOI 10.1104/pp.110.170225; Shelden MC, 2010, MOL MEMBR BIOL, V27, P11, DOI 10.3109/09687680903400120; Shibata M, 2002, J BIOL CHEM, V277, P18658, DOI 10.1074/jbc.M112468200; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Whitehead L, 2014, PLANT PHYSIOL, V165, P398, DOI 10.1104/pp.114.237941; YOKOTA A, 1985, BIOCHEM BIOPH RES CO, V131, P1075, DOI 10.1016/0006-291X(85)90200-1; Zhang PP, 2004, PLANT CELL, V16, P3326, DOI 10.1105/tpc.104.026526; Zhu XG, 2010, ANNU REV PLANT BIOL, V61, P235, DOI 10.1146/annurev-arplant-042809-112206; ZWAIG N, 1970, J BACTERIOL, V102, P753, DOI 10.1128/JB.102.3.753-759.1970	37	47	50	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115905	10.1371/journal.pone.0115905	http://dx.doi.org/10.1371/journal.pone.0115905			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536191	Green Published, Green Submitted, gold			2022-12-27	WOS:000348563300083
J	de la Cruz, ML; Perez, A; Bezos, J; Pages, E; Casal, C; Carpintero, J; Romero, B; Dominguez, L; Barker, CM; Diaz, R; Alvarez, J				Luisa de la Cruz, Maria; Perez, Andres; Bezos, Javier; Pages, Enrique; Casal, Carmen; Carpintero, Jesus; Romero, Beatriz; Dominguez, Lucas; Barker, Christopher M.; Diaz, Rosa; Alvarez, Julio			Spatial Dynamics of Bovine Tuberculosis in the Autonomous Community of Madrid, Spain (2010-2012)	PLOS ONE			English	Article							WITHIN-HERD TRANSMISSION; TO-CATTLE TRANSMISSION; MYCOBACTERIUM-BOVIS; SIMULATION-MODEL; WILD BOAR; 4 AREAS; EPIDEMIOLOGY; SPOLIGOTYPE; ERADICATION; POPULATION	Progress in control of bovine tuberculosis (bTB) is often not uniform, usually due to the effect of one or more sometimes unknown epidemiological factors impairing the success of eradication programs. Use of spatial analysis can help to identify clusters of persistence of disease, leading to the identification of these factors thus allowing the implementation of targeted control measures, and may provide some insights of disease transmission, particularly when combined with molecular typing techniques. Here, the spatial dynamics of bTB in a high prevalence region of Spain were assessed during a three year period (2010-2012) using data from the eradication campaigns to detect clusters of positive bTB herds and of those infected with certain Mycobacterium bovis strains (characterized using spoligotyping and VNTR typing). In addition, the within-herd transmission coefficient (b) was estimated in infected herds and its spatial distribution and association with other potential outbreak and herd variables was evaluated. Significant clustering of positive herds was identified in the three years of the study in the same location ("high risk area''). Three spoligotypes (SB0339, SB0121 and SB1142) accounted for >70% of the outbreaks detected in the three years. VNTR subtyping revealed the presence of few but highly prevalent strains within the high risk area, suggesting maintained transmission in the area. The spatial autocorrelation found in the distribution of the estimated within-herd transmission coefficients in herds located within distances,14 km and the results of the spatial regression analysis, support the hypothesis of shared local factors affecting disease transmission in farms located at a close proximity.	[Luisa de la Cruz, Maria; Bezos, Javier; Casal, Carmen; Romero, Beatriz] Univ Complutense, Ctr Vigilancia Sanitaria Vet VISAVET, E-28040 Madrid, Spain; [Perez, Andres; Alvarez, Julio] Univ Minnesota, Dept Vet Populat Med, St Paul, MN 55108 USA; [Bezos, Javier] MAEVA SERVET SL, Madrid, Spain; [Pages, Enrique; Carpintero, Jesus; Dominguez, Lucas; Diaz, Rosa] Consejeria Medio Ambiente Vivienda & Ordenac Terr, Direcc Gen Medio Ambiente, Area Ganaderia, Madrid, Spain; [Dominguez, Lucas] Univ Complutense, Fac Vet, Dept Sanidad Anim, E-28040 Madrid, Spain; [Barker, Christopher M.] Univ Calif Davis, Sch Vet Med, Ctr Vectorborne Dis, Davis, CA 95616 USA; [Barker, Christopher M.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA	Complutense University of Madrid; University of Minnesota System; University of Minnesota Twin Cities; Complutense University of Madrid; University of California System; University of California Davis; University of California System; University of California Davis	Alvarez, J (corresponding author), Univ Minnesota, Dept Vet Populat Med, St Paul, MN 55108 USA.	jalvarez@umn.edu	Perez, Andres/HGD-8377-2022; Garrido, Javier Bezos/Q-2536-2019; Casal Comendador, Carmen/E-8998-2016; de la Cruz, María Luisa/Q-5725-2016; Romero, Beatriz/J-5942-2015; studies, IT VISAVET Account for bibliometric/C-3115-2014; Alvarez, Julio/H-8292-2013; de la Cruz, María Luisa/AAH-6542-2020; Bezos, Javier/K-1335-2014; Dominguez Rodriguez, Lucas/B-9668-2014	Casal Comendador, Carmen/0000-0003-2433-2870; de la Cruz, María Luisa/0000-0002-0206-1750; Romero, Beatriz/0000-0001-5263-1806; studies, IT VISAVET Account for bibliometric/0000-0003-3319-0050; Alvarez, Julio/0000-0002-8999-9417; de la Cruz, María Luisa/0000-0002-0206-1750; Bezos, Javier/0000-0003-1913-0545; Dominguez Rodriguez, Lucas/0000-0001-8843-0010	USDA National Institute of Food and Agriculture [2013-67015-21244]; Research and Policy for Infectious Disease Dynamics program of the Science and Technology Directorate, Department of Homeland Security; Fogarty International Center; National Institutes of Health	USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Research and Policy for Infectious Disease Dynamics program of the Science and Technology Directorate, Department of Homeland Security(United States Department of Homeland Security (DHS)); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project was partly supported by Agriculture and Food Research Initiative Competitive Grant no. 2013-67015-21244 from the USDA National Institute of Food and Agriculture. CMB also acknowledges support from the Research and Policy for Infectious Disease Dynamics program of the Science and Technology Directorate, Department of Homeland Security and the Fogarty International Center, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo P, 2014, ECOL INDIC, V36, P594, DOI 10.1016/j.ecolind.2013.09.019; Allepuz A, 2011, PREV VET MED, V100, P44, DOI 10.1016/j.prevetmed.2011.02.012; Alvarez J, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-100; Alvarez J, 2012, VET MICROBIOL, V155, P38, DOI 10.1016/j.vetmic.2011.07.034; [Anonymous], 2006, SANCO102002006; Barlow ND, 1997, PREV VET MED, V32, P57, DOI 10.1016/S0167-5877(97)00002-0; Begon M, 2002, EPIDEMIOL INFECT, V129, P147, DOI 10.1017/S0950268802007148; Bivand R., 2020, SPDEP SPATIAL DEPEND; Bivand RS, 2008, USE R, P1; Bosch J, 2012, FOLIA ZOOL, V61, P138, DOI 10.25225/fozo.v61.i2.a7.2012; COCHRANE D, 1949, J AM STAT ASSOC, V44, P32, DOI 10.2307/2280349; Collins JD, 2006, VET MICROBIOL, V112, P369, DOI 10.1016/j.vetmic.2005.11.041; Consejeria de Medio Ambiente y Ordenacion del Territorio C, 2013, BOCM, V73, P77; CORNER LA, 1988, VET MICROBIOL, V18, P127, DOI 10.1016/0378-1135(88)90058-2; Cousins DV, 2001, TUBERCULOSIS, V81, P5, DOI 10.1054/tube.2000.0261; deJong MCM, 1995, PREV VET MED, V25, P183, DOI 10.1016/0167-5877(95)00538-2; Dommergues L, 2012, TRANSBOUND EMERG DIS, V59, P292, DOI 10.1111/j.1865-1682.2011.01269.x; Duarte EL, 2008, VET MICROBIOL, V130, P415, DOI 10.1016/j.vetmic.2008.02.012; Duarte EL, 2010, VET MICROBIOL, V143, P299, DOI 10.1016/j.vetmic.2009.11.027; European Food Safety Authority European Centre for Disease Prevention and Control, 2013, EFSA J, V11, P1, DOI DOI 10.2903/J.EFSA.2013.3158; Fischer EAJ, 2005, PREV VET MED, V67, P283, DOI 10.1016/j.prevetmed.2004.12.002; Frothingham R, 1998, MICROBIOL-UK, V144, P1189, DOI 10.1099/00221287-144-5-1189; Goodchild AV, 2001, TUBERCULOSIS, V81, P23, DOI 10.1054/tube.2000.0256; Hewinson RG, 2006, VET MICROBIOL, V112, P127, DOI 10.1016/j.vetmic.2005.11.050; Humblet MF, 2009, VET RES, V40, DOI 10.1051/vetres/2009033; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809; Kulldorff M, 2009, SATSCAN TM V8 0 SOFT; MALLOWS CL, 1973, TECHNOMETRICS, V15, P661, DOI 10.2307/1267380; MASLOW JN, 1993, CLIN INFECT DIS, V17, P153, DOI 10.1093/clinids/17.2.153; Menzies FD, 2000, VET J, V160, P92, DOI 10.1053/tvjl.2000.0482; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Olea-Popelka FJ, 2005, PREV VET MED, V71, P57, DOI 10.1016/j.prevetmed.2005.05.008; Olea-Popelka FJ, 2004, PREV VET MED, V63, P163, DOI 10.1016/j.prevetmed.2004.03.001; Olea-Popelka FJ, 2003, PREV VET MED, V59, P103, DOI 10.1016/S0167-5877(03)00055-2; ORD JK, 1995, GEOGR ANAL, V27, P286, DOI 10.1111/j.1538-4632.1995.tb00912.x; Perez AM, 2002, PREV VET MED, V56, P63, DOI 10.1016/S0167-5877(02)00124-1; Perez AM, 2002, PREV VET MED, V54, P361, DOI 10.1016/S0167-5877(02)00043-0; Pfeiffer DU, 2013, TRANSBOUND EMERG DIS, V60, P104, DOI 10.1111/tbed.12105; Phillips CJC, 2003, RES VET SCI, V74, P1, DOI 10.1016/S0034-5288(02)00145-5; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ramirez-Villaescusa AM, 2009, PREV VET MED, V92, P188, DOI 10.1016/j.prevetmed.2009.08.011; Rodriguez S, 2011, EMERG INFECT DIS, V17, P532, DOI 10.3201/eid1703.100618; Rodriguez S, 2010, VET MICROBIOL, V141, P89, DOI 10.1016/j.vetmic.2009.08.007; Rodriguez-Campos S, 2013, J CLIN MICROBIOL, V51, P3658, DOI 10.1128/JCM.01271-13; Rodriguez-Campos S, 2012, INFECT GENET EVOL, V12, P877, DOI 10.1016/j.meegid.2011.10.008; Romero B, 2008, VET MICROBIOL, V132, P87, DOI 10.1016/j.vetmic.2008.04.032; Schabenberger O., 2005, STAT METHODS SPATIAL; Smith NH, 2012, INFECT GENET EVOL, V12, P857, DOI 10.1016/j.meegid.2011.09.007; Smith NH, 2011, INFECT GENET EVOL, V11, P1340, DOI 10.1016/j.meegid.2011.04.027; Srinivasan S., 2008, ENCY GIS, DOI [10.1007/978-0-387-35973-1_1294, DOI 10.1007/978-0-387-35973-1_1294]; Ward MP, 2000, PREV VET MED, V43, P225, DOI 10.1016/S0167-5877(99)00111-7; Wright DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074503	54	28	29	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115632	10.1371/journal.pone.0115632	http://dx.doi.org/10.1371/journal.pone.0115632			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536514	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000348563300058
J	Sayler, KA; Barbet, AF; Chamberlain, C; Clapp, WL; Alleman, R; Loeb, JC; Lednicky, JA				Sayler, Katherine A.; Barbet, Anthony F.; Chamberlain, Casey; Clapp, William L.; Alleman, Rick; Loeb, Julia C.; Lednicky, John A.			Isolation of Tacaribe Virus, a Caribbean Arenavirus, from Host-Seeking Amblyomma americanum Ticks in Florida	PLOS ONE			English	Article							ARGENTINE HEMORRHAGIC-FEVER; JUNIN VIRUS; GUINEA-PIGS; INFECTION; REPLICATION; PROTECTION; RESERVOIR; EVOLUTION	Arenaviridae are a family of single stranded RNA viruses of mammals and boid snakes. Twenty-nine distinct mammalian arenaviruses have been identified, many of which cause severe hemorrhagic disease in humans, particularly in parts of sub-Saharan Africa, and in Central and South America. Humans typically become infected with an arenavirus through contact with excreta from infected rodents. Tacaribe virus (TCRV) is an arenavirus that was first isolated from bats and mosquitoes during a rabies surveillance survey conducted in Trinidad from 1956 to 1958. Tacaribe virus is unusual because it has never been associated with a rodent host and since that one time isolation, the virus has not been isolated from any vertebrate or invertebrate hosts. We report the re-isolation of the virus from a pool of 100 host-seeking Amblyomma americanum (lone star ticks) collected in a Florida state park in 2012. TCRV was isolated in two cell lines and its complete genome was sequenced. The tick-derived isolate is nearly identical to the only remaining isolate from Trinidad (TRVL-11573), with 99.6% nucleotide identity across the genome. A quantitative RT-PCR assay was developed to test for viral RNA in hostseeking ticks collected from 3 Florida state parks. Virus RNA was detected in 56/500 (11.2%) of surveyed ticks. As this virus was isolated from ticks that parasitize humans, the ability of the tick to transmit the virus to people should be evaluated. Furthermore, reservoir hosts for the virus need to be identified in order to develop risk assessment models of human infection.	[Sayler, Katherine A.; Alleman, Rick] Univ Florida, Coll Vet Med, Dept Physiol Sci, Gainesville, FL 32610 USA; [Sayler, Katherine A.; Barbet, Anthony F.; Chamberlain, Casey] Univ Florida, Coll Vet Med, Dept Infect Dis & Pathol, Gainesville, FL USA; [Clapp, William L.] Univ Florida, Coll Med, Dept Pathol, Gainesville, FL USA; [Sayler, Katherine A.; Loeb, Julia C.; Lednicky, John A.] Univ Florida, Dept Environm & Global Hlth, Coll Publ Hlth & Hlth Profess, Gainesville, FL USA; [Sayler, Katherine A.; Barbet, Anthony F.; Lednicky, John A.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Sayler, KA (corresponding author), Univ Florida, Coll Vet Med, Dept Physiol Sci, Gainesville, FL 32610 USA.	saylerk@ufl.edu	Lednicky, John A/C-5678-2012; Chamberlain, Casey/ABD-2813-2020	Chamberlain, Casey/0000-0002-3633-8594	University of Florida College of Veterinary Medicine	University of Florida College of Veterinary Medicine(University of Florida)	The University of Florida College of Veterinary Medicine internal "bridge grant'' awarded to Dr. Anthony Barbet was used to fund this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON LMC, 1991, J GEN VIROL, V72, P2025, DOI 10.1099/0022-1317-72-8-2025; Bowen MD, 1996, VIROLOGY, V219, P285, DOI 10.1006/viro.1996.0248; Bowen MD, 1997, MOL PHYLOGENET EVOL, V8, P301, DOI 10.1006/mpev.1997.0436; CARBALLAL G, 1987, J MED VIROL, V23, P257, DOI 10.1002/jmv.1890230308; Charrel RN, 2010, VET MICROBIOL, V140, P213, DOI 10.1016/j.vetmic.2009.08.027; Cogswell-Hawkinson A, 2012, J VIROL, V86, P5791, DOI 10.1128/JVI.00201-12; COTO CE, 1980, J INFECT DIS, V141, P389, DOI 10.1093/infdis/141.3.389; DOWNS WG, 1963, AM J TROP MED HYG, V12, P640, DOI 10.4269/ajtmh.1963.12.640; Enria DA, 2008, ANTIVIR RES, V78, P132, DOI 10.1016/j.antiviral.2007.10.010; FRANZEFERNANDEZ MT, 1987, VIRUS RES, V7, P309, DOI 10.1016/0168-1702(87)90045-1; GINSBERG HS, 1989, EXP APPL ACAROL, V7, P313, DOI 10.1007/BF01197925; Grant A, 2012, VIRUSES-BASEL, V4, P2317, DOI 10.3390/v4102317; Harmon B, 2013, J BIOL CHEM, V288, P8702, DOI 10.1074/jbc.M112.444760; Holland J, 1998, VIRUS GENES, V16, P13, DOI 10.1023/A:1007989407305; HOTCHIN J, 1973, INFECT IMMUN, V7, P825, DOI 10.1128/IAI.7.5.825-826.1973; Liang YY, 2009, ANN NY ACAD SCI, V1171, pE65, DOI 10.1111/j.1749-6632.2009.05051.x; Lopez N, 2000, J GEN VIROL, V81, P1273, DOI 10.1099/0022-1317-81-5-1273; Martinez-Sobrido L, 2009, J VIROL, V83, P11330, DOI 10.1128/JVI.00763-09; McMullan LK, 2012, NEW ENGL J MED, V367, P834, DOI 10.1056/NEJMoa1203378; Milazzo ML, 2011, EMERG INFECT DIS, V17, P1417, DOI 10.3201/eid1708.110285; MILLS JN, 1994, AM J TROP MED HYG, V51, P554, DOI 10.4269/ajtmh.1994.51.554; MILLS JN, 1992, AM J TROP MED HYG, V47, P749, DOI 10.4269/ajtmh.1992.47.749; Sang R, 2006, EMERG INFECT DIS, V12, P1074, DOI 10.3201/eid1207.060253; Swei A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062083; Xu BL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002369; Zapata JC, 2013, VIRUSES-BASEL, V5, P241, DOI 10.3390/v5010241	26	32	32	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115769	10.1371/journal.pone.0115769	http://dx.doi.org/10.1371/journal.pone.0115769			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536075	Green Published, Green Submitted, gold			2022-12-27	WOS:000348563300073
J	Xu, YN; Liu, SR; Yi, HL; Wang, JD; Dong, P; Li, XY; Yin, SK				Xu, Yanan; Liu, Suru; Yi, Hongliang; Wang, Jiadong; Dong, Pin; Li, Xiaoyan; Yin, Shankai			Human Papillomavirus Infection in 674 Chinese Patients with Laryngeal Squamous Cell Carcinoma	PLOS ONE			English	Article							NECK-CANCER; HEAD; PREVALENCE; SURVIVAL; RISK; SENSITIVITY	Objectives: Previous reports suggest a strong association between human papillomavirus (HPV) and the etiology of laryngeal squamous cell carcinoma (LSCC). However, clinical data regarding the HPV infection rate among LSCC patients remain largely inconsistent. Methods: In total, 674 LSCC patients from three major hospitals in Shanghai were enrolled in this study. We determined the patients' HPV infection status using immunohistochemistry and the GenoArray HPV genotyping assay and calculated their long-term survival rate using the Kaplan-Meier method. Results: The total P16-positive rate according to immunostaining results was 7.57% (51/674). None of the P16-negative patients were HPV-positive according to the HPV genotyping test. The rate of HPV infection among patients with LSCC was 4.9% (33/674). HPV infection was more common among nonsmokers (P<0.05), nondrinkers (P<0.05), and patients with supraglottic LSCC (P<0.05). Of the 33 HPV-positive patients, 28 (84.8%) were infected with HPV-16, 2 with HPV-18, 1 with HPV-31, 1 with HPV-33 and 1 with HPV-45. The 3-year overall survival rate and progression-free survival rate were higher in HPV-positive than HPV-negative patients, but the difference was not statistically significant (76.3% vs. 70.7%, P=0.30 and 65.1% vs. 58.3%, P=0.37, respectively). Conclusion: HPV was not a main causal factor in LSCC carcinogenesis in this Chinese population. HPV infection did not alter patients' overall survival or progression-free survival rates in this study.	[Xu, Yanan; Liu, Suru; Yi, Hongliang; Yin, Shankai] Shanghai Jiao Tong Univ, Dept Otolaryngol, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China; [Xu, Yanan; Wang, Jiadong] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Head & Neck Surg, Shanghai 200030, Peoples R China; [Dong, Pin] Shanghai Jiao Tong Univ, Dept Otolaryngol Head & Neck Surg, Affiliated Peoples Hosp 1, Shanghai 200030, Peoples R China; [Xu, Yanan; Liu, Suru; Yi, Hongliang; Wang, Jiadong; Dong, Pin; Yin, Shankai] Shanghai Jiao Tong Univ, Otolaryngol Inst, Shanghai 200030, Peoples R China; [Li, Xiaoyan] Shanghai Jiao Tong Univ, Childrens Hosp, Dept Otolaryngol Head & Neck Surg, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Wang, JD (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Head & Neck Surg, Shanghai 200030, Peoples R China.	drjiadongw@aliyun.com; dongpin64@aliyun.com; yinshankai@china.com						Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Azvolinsky A, 2013, JNCI-J NATL CANCER I, V105, P1335, DOI 10.1093/jnci/djt260; Barrera R, 2014, INT J CHEM ENG, V2014, DOI 10.1155/2014/192057; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Chang YL, 2009, VACCINE, V27, P4355, DOI 10.1016/j.vaccine.2009.03.008; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; Dayyani F, 2010, HEAD NECK ONCOL, V2, DOI 10.1186/1758-3284-2-15; Fakhry C, 2008, JNCI-J NATL CANCER I, V100, P261, DOI 10.1093/jnci/djn011; Gillison ML, 2008, JNCI-J NATL CANCER I, V100, P407, DOI 10.1093/jnci/djn025; Guihard S, 2012, INT J ONCOL, V41, P1531, DOI 10.3892/ijo.2012.1584; Halec G, 2013, BRIT J CANCER, V109, P172, DOI 10.1038/bjc.2013.296; Hobbs CGL, 2006, CLIN OTOLARYNGOL, V31, P259, DOI 10.1111/j.1749-4486.2006.01246.x; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2012, IARC Monogr Eval Carcinog Risks Hum, V100, P9; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Li W, 2003, AM J PATHOL, V163, P2185, DOI 10.1016/S0002-9440(10)63576-6; Li XW, 2013, J INFECT DIS, V207, P479, DOI 10.1093/infdis/jis698; Liu SS, 2010, J CLIN MICROBIOL, V48, P758, DOI 10.1128/JCM.00989-09; Marklund L, 2012, CANCER MED-US, V1, P82, DOI 10.1002/cam4.2; Marur S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6; Maxwell JH, 2010, CLIN CANCER RES, V16, P1226, DOI 10.1158/1078-0432.CCR-09-2350; Ribeiro KB, 2011, INT J EPIDEMIOL, V40, P489, DOI 10.1093/ije/dyq249; Rischin D, 2009, 2009 ASCO ANN M ORL; Schache AG, 2011, CLIN CANCER RES, V17, P6262, DOI 10.1158/1078-0432.CCR-11-0388; Sethi S, 2012, INT J CANCER, V131, P1179, DOI 10.1002/ijc.26500; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Smeets SJ, 2007, INT J CANCER, V121, P2465, DOI 10.1002/ijc.22980; Snow AN, 2010, ADV ANAT PATHOL, V17, P394, DOI 10.1097/PAP.0b013e3181f895c1; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Wei W, 2012, ONCOL REP, V28, P1750, DOI 10.3892/or.2012.1990; Wilson DD, 2012, ARCH OTOLARYNGOL, V138, P556, DOI 10.1001/archoto.2012.950	30	18	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115914	10.1371/journal.pone.0115914	http://dx.doi.org/10.1371/journal.pone.0115914			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536405	gold, Green Submitted, Green Published			2022-12-27	WOS:000348563300085
J	Amornwichet, N; Oike, T; Shibata, A; Ogiwara, H; Tsuchiya, N; Yamauchi, M; Saitoh, Y; Sekine, R; Isono, M; Yoshida, Y; Ohno, T; Kohno, T; Nakano, T				Amornwichet, Napapat; Oike, Takahiro; Shibata, Atsushi; Ogiwara, Hideaki; Tsuchiya, Naoto; Yamauchi, Motohiro; Saitoh, Yuka; Sekine, Ryota; Isono, Mayu; Yoshida, Yukari; Ohno, Tatsuya; Kohno, Takashi; Nakano, Takashi			Carbon-Ion Beam Irradiation Kills X-Ray-Resistant p53-Null Cancer Cells by Inducing Mitotic Catastrophe	PLOS ONE			English	Article							RADIATION-THERAPY; DNA-DAMAGE; P53 STATUS; REPLICATION STRESS; GLIOBLASTOMA CELLS; CYCLE CHECKPOINTS; IN-VITRO; CARCINOMA; OPTIMIZATION; SENSITIVITY	Background and Purpose: To understand the mechanisms involved in the strong killing effect of carbon-ion beam irradiation on cancer cells with TP53 tumor suppressor gene deficiencies. Materials and Methods: DNA damage responses after carbon-ion beam or X-ray irradiation in isogenic HCT116 colorectal cancer cell lines with and without TP53 (p53(+/+) and p53(-/-), respectively) were analyzed as follows: cell survival by clonogenic assay, cell death modes by morphologic observation of DAPI-stained nuclei, DNA double-strand breaks (DSBs) by immunostaining of phosphorylated H2AX (gamma H2AX), and cell cycle by flow cytometry and immunostaining of Ser10-phosphorylated histone H3. Results: The p53(-/-) cells were more resistant than the p53(+/+) cells to X-ray irradiation, while the sensitivities of the p53(+/+) and p53(-/-) cells to carbon-ion beam irradiation were comparable. X-ray and carbon-ion beam irradiations predominantly induced apoptosis of the p53(+/+) cells but not the p53(-/-) cells. In the p53(-/-) cells, carbon-ion beam irradiation, but not X-ray irradiation, markedly induced mitotic catastrophe that was associated with premature mitotic entry with harboring long-retained DSBs at 24 h post-irradiation. Conclusions: Efficient induction of mitotic catastrophe in apoptosis-resistant p53-deficient cells implies a strong cancer cell-killing effect of carbon-ion beam irradiation that is independent of the p53 status, suggesting its biological advantage over X-ray treatment.	[Amornwichet, Napapat; Oike, Takahiro; Saitoh, Yuka; Nakano, Takashi] Gunma Univ, Grad Sch Med, Dept Radiat Oncol, Maebashi, Gunma, Japan; [Amornwichet, Napapat] Chulalongkorn Univ, Dept Radiol, Bangkok, Thailand; [Oike, Takahiro; Ogiwara, Hideaki; Tsuchiya, Naoto; Kohno, Takashi] Natl Canc Ctr, Res Inst, Div Genome Biol, Chuo Ku, Tokyo 104, Japan; [Shibata, Atsushi; Sekine, Ryota] Gunma Univ, Adv Sci Res Leaders Dev Unit, Maebashi, Gunma, Japan; [Yamauchi, Motohiro] Nagasaki Univ, Atom Bomb Dis Inst, Div Radiat Biol & Protect, Nagasaki 852, Japan; [Isono, Mayu; Yoshida, Yukari; Ohno, Tatsuya] Gunma Univ, Heavy Ion Med Ctr, Maebashi, Gunma, Japan	Gunma University; Chulalongkorn University; National Cancer Center - Japan; Gunma University; Nagasaki University; Gunma University	Oike, T (corresponding author), Gunma Univ, Grad Sch Med, Dept Radiat Oncol, Maebashi, Gunma, Japan.	oiketakahiro@gmail.com	真由, 磯野/GPG-2740-2022; Shibata, Atsushi/AAX-1283-2021	Shibata, Atsushi/0000-0001-8912-6977; Amornwichet, Napapat/0000-0002-4285-4886; Ogiwara, Hideaki/0000-0003-0860-1807	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation, and Scientific Research on Innovative Areas [22131006]; Japan Society for the Promotion of Science [10643471]; Grants-in-Aid for Scientific Research [26670549] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation, and Scientific Research on Innovative Areas; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan for programs for Leading Graduate Schools, Cultivating Global Leaders in Heavy Ion Therapeutics and Engineering, and for Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation, and Scientific Research on Innovative Areas (22131006). This work was also supported by Grants-in-Aid from the Japan Society for the Promotion of Science for Young Scientists (B) KAKENHI [10643471]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bucher N, 2008, BRIT J CANCER, V98, P523, DOI 10.1038/sj.bjc.6604208; Bullock AN, 2001, NAT REV CANCER, V1, P68, DOI 10.1038/35094077; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; CIATTO S, 1982, ACTA RADIOL ONCOL, V21, P105, DOI 10.3109/02841868209133991; Deckbar D, 2011, CRIT REV BIOCHEM MOL, V46, P271, DOI 10.3109/10409238.2011.575764; Di Micco R, 2011, NAT CELL BIOL, V13, P292, DOI 10.1038/ncb2170; Giono LE, 2006, J CELL PHYSIOL, V209, P13, DOI 10.1002/jcp.20689; Giunta S, 2010, J CELL BIOL, V190, P197, DOI 10.1083/jcb.200911156; Hall EJ, 2006, RADIOBIOLOGY RADIOLO, P16; Harrigan JA, 2011, J CELL BIOL, V193, P97, DOI 10.1083/jcb.201011083; Huerta S, 2013, SURGERY, V154, P143, DOI 10.1016/j.surg.2013.03.012; Huerta S, 2010, DIGEST LIVER DIS, V42, P679, DOI 10.1016/j.dld.2010.02.003; Ishikawa H, 2001, CANCER-AM CANCER SOC, V91, P80, DOI 10.1002/1097-0142(20010101)91:1<80::AID-CNCR11>3.0.CO;2-E; Kurioka D, 2014, SCI REP-UK, V4, DOI 10.1038/srep06111; Lobrich M, 2010, CELL CYCLE, V9, P662, DOI 10.4161/cc.9.4.10764; Loeffler JS, 2013, NAT REV CLIN ONCOL, V10, P411, DOI 10.1038/nrclinonc.2013.79; Lukas C, 2011, NAT CELL BIOL, V13, P243, DOI 10.1038/ncb2201; Maalouf M, 2009, INT J RADIAT ONCOL, V74, P200, DOI 10.1016/j.ijrobp.2009.01.012; Mak RH, 2011, ONCOLOGIST, V16, P886, DOI 10.1634/theoncologist.2011-0040; Nakajima NI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070107; Oike T, 2013, CANCER RES, V73, P5508, DOI 10.1158/0008-5472.CAN-12-4593; Oike T, 2012, INT J RADIAT ONCOL, V84, P815, DOI 10.1016/j.ijrobp.2012.01.017; Oishi T, 2008, NEUROPATHOLOGY, V28, P408, DOI 10.1111/j.1440-1789.2008.00899.x; Russo AL, 2009, CLIN CANCER RES, V15, P607, DOI 10.1158/1078-0432.CCR-08-2079; Sawai Y, 2013, ONCOL REP, V29, P941, DOI 10.3892/or.2012.2195; Schulz-Ertner D, 2007, J CLIN ONCOL, V25, P953, DOI 10.1200/JCO.2006.09.7816; Shibata A, 2011, EMBO J, V30, P1079, DOI 10.1038/emboj.2011.27; Takahashi A, 2004, INT J RADIAT ONCOL, V60, P591, DOI 10.1016/j.ijrobp.2004.05.062; Takahashi A, 2001, INT J RADIAT BIOL, V77, P1043, DOI 10.1080/09553000110066095; Takahashi T, 2010, ANTICANCER RES, V30, P1961; Terato Hiroaki, 2004, Biol Sci Space, V18, P206, DOI 10.2187/bss.18.206; Torres-Roca JF, 2012, PERS MED, V9, P547, DOI 10.2217/PME.12.55; Wouters B.G., 2009, BASIC CLIN RADIOBIOL, Vfourth, P27; Yamada S, 2014, CARBON ION RADIOTHER, P203; Yamakawa N, 2008, CANCER SCI, V99, P1455, DOI 10.1111/j.1349-7006.2008.00818.x; Yamauchi M, 2011, BIOCHEM BIOPH RES CO, V416, P111, DOI 10.1016/j.bbrc.2011.11.006	36	32	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115121	10.1371/journal.pone.0115121	http://dx.doi.org/10.1371/journal.pone.0115121			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531293	Green Submitted, Green Published, gold			2022-12-27	WOS:000348845100037
J	Chen, JJ; Huang, H; Zhao, LB; Zhou, DZ; Yang, YT; Zheng, P; Yang, DY; He, P; Zhou, JJ; Fang, L; Xie, P				Chen, Jian-jun; Huang, Hua; Zhao, Li-bo; Zhou, De-zhi; Yang, Yong-tao; Zheng, Peng; Yang, De-yu; He, Peng; Zhou, Jing-jing; Fang, Liang; Xie, Peng			Sex-Specific Urinary Biomarkers for Diagnosing Bipolar Disorder	PLOS ONE			English	Article							METABONOMICS; BRAIN	Sex-based differences are prominent in affective disorders, but there are no biomarkers available to support sex-specific, laboratory-based diagnostics for male and female bipolar disorder (BD) patients. Here, a NMR-based metabonomic approach was used to preliminarily identify sex-specific urinary metabolite biomarkers for diagnosing male and female BD patients. A male-specific biomarker panel consisting of four metabolites (alpha-hydroxybutyrate, choline, formate, and N-methylnicotinamide) effectively discriminated between male BD and healthy controls (HC) subjects, achieving an area under the receiver operating characteristic curve (AUC) of 0.942. A female-specific biomarkers panel consisting of four metabolites (alpha-hydroxybutyrate, oxalacetate, acetone, and N-methylnicotinamide) effectively discriminated between female BD and HC subjects, achieving an AUC of 0.909. The male-specific biomarker panel displayed low discriminatory power in the female group, and the female-specific biomarker panel displayed low discriminatory power in the male group. Moreover, several other metabolites showed different trends between male and female BD subjects. These findings suggest that male and female BD patients have distinct biomarker fingerprints and that these two sex-specific biomarker panels may serve as effective diagnostic tools in distinguishing male and female BD patients from their healthy counterparts. Our work may provide a window into the mechanisms underlying the pathoetiology of BD in both men and women.	[Chen, Jian-jun; Yang, De-yu; He, Peng; Zhou, Jing-jing; Fang, Liang; Xie, Peng] Chongqing Med Univ, Yongchuan Hosp, Dept Neurol, Chongqing, Peoples R China; [Huang, Hua; Zhao, Li-bo; Zhou, De-zhi; Yang, Yong-tao; Zheng, Peng; Xie, Peng] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China; [Chen, Jian-jun; Huang, Hua; Zhao, Li-bo; Zhou, De-zhi; Yang, Yong-tao; Zheng, Peng; Yang, De-yu; He, Peng; Zhou, Jing-jing; Fang, Liang; Xie, Peng] Chongqing Key Lab Neurobiol, Chongqing, Peoples R China; [Chen, Jian-jun; Huang, Hua; Zhao, Li-bo; Zhou, De-zhi; Yang, Yong-tao; Zheng, Peng; Yang, De-yu; He, Peng; Zhou, Jing-jing; Fang, Liang; Xie, Peng] Chongqing Med Univ, Inst Neurosci, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Xie, P (corresponding author), Chongqing Med Univ, Yongchuan Hosp, Dept Neurol, Chongqing, Peoples R China.	xiepeng@cqmu.edu.cn	chen, jian-jun/J-9118-2019	chen, jian-jun/0000-0002-6439-5123	Chongqing Science & Technology Commission [cstc2014jcyjA10102]; National Youth Division [31300881]; Postdoctoral Fund [XM201101003]; National Basic Research Program of China (973 Program) [2009CB918300]	Chongqing Science & Technology Commission(Natural Science Foundation Project of CQ CSTC); National Youth Division; Postdoctoral Fund; National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the Chongqing Science & Technology Commission (cstc2014jcyjA10102), the National Youth Division (31300881), the Postdoctoral Fund (XM201101003), and the National Basic Research Program of China (973 Program, grant no. 2009CB918300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouatra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073076; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Bylesjo M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006; Chen JJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep05855; Cloarec O, 2005, ANAL CHEM, V77, P517, DOI 10.1021/ac048803i; Cloarec O, 2012, MOL CELL PROTEOMICS, V11; Farooqui AA, 2000, CHEM PHYS LIPIDS, V106, P1, DOI 10.1016/S0009-3084(00)00128-6; Ge YC, 2008, STAT SINICA, V18, P881; Grigoroiu-Serbanescu M, 2005, AM J MED GENET B, V133B, P6, DOI 10.1002/ajmg.b.30133; Hilty, 2000, Prim Care Update Ob Gyns, V7, P105, DOI 10.1016/S1068-607X(00)00030-5; Hirschfeld RMA, 2003, J CLIN PSYCHIAT, V64, P161, DOI 10.4088/JCP.v64n0209; Jia HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063624; Kaddurah-Daouk R, 2008, ANNU REV PHARMACOL, V48, P653, DOI 10.1146/annurev.pharmtox.48.113006.094715; Lan MJ, 2009, MOL PSYCHIATR, V14, P269, DOI 10.1038/sj.mp.4002130; Mackay CE, 2010, BIPOLAR DISORD, V12, P306, DOI 10.1111/j.1399-5618.2010.00804.x; Maes M, 1998, ACTA PSYCHIAT SCAND, V97, P302, DOI 10.1111/j.1600-0447.1998.tb10004.x; Merikangas KR, 2011, ARCH GEN PSYCHIAT, V68, P241, DOI 10.1001/archgenpsychiatry.2011.12; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a; Nierenberg AA, 2013, AUST NZ J PSYCHIAT, V47, P26, DOI 10.1177/0004867412449303; Oquendo MA, 2006, ACTA PSYCHIAT SCAND, V114, P151, DOI 10.1111/j.1600-0447.2006.00829.x; Roiser JP, 2005, NEUROPSYCHOPHARMACOL, V30, P775, DOI 10.1038/sj.npp.1300659; Sharma V, 2012, J CLIN PSYCHIAT, V73, P1447, DOI 10.4088/JCP.11r07499; Sharma Verinder, 2009, Can J Clin Pharmacol, V16, pe33; Sussulini A, 2009, ANAL CHEM, V81, P9755, DOI 10.1021/ac901502j; Teatero ML, 2014, BIPOLAR DISORD, V16, P22, DOI 10.1111/bdi.12138; Yang J, 2013, MOL PSYCHIATR, V18, P67, DOI 10.1038/mp.2011.131; Yap IKS, 2010, J PROTEOME RES, V9, P2996, DOI 10.1021/pr901188e; Zheng P, 2013, METABOLOMICS, V9, P800, DOI 10.1007/s11306-013-0508-y; Zheng P, 2013, MOL CELL PROTEOMICS, V12, P207, DOI 10.1074/mcp.M112.021816; Zheng P, 2012, J PROTEOME RES, V11, P1741, DOI 10.1021/pr2010082	30	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115221	10.1371/journal.pone.0115221	http://dx.doi.org/10.1371/journal.pone.0115221			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531985	Green Published, gold, Green Submitted			2022-12-27	WOS:000348845100044
J	Cuccio, V; Ambrosecchia, M; Ferri, F; Carapezza, M; Lo Piparo, F; Fogassi, L; Gallese, V				Cuccio, Valentina; Ambrosecchia, Marianna; Ferri, Francesca; Carapezza, Marco; Lo Piparo, Franco; Fogassi, Leonardo; Gallese, Vittorio			How the Context Matters. Literal and Figurative Meaning in the Embodied Language Paradigm	PLOS ONE			English	Article							ACTION-RELATED SENTENCES; MOTOR SYSTEM; PREMOTOR CORTICES; MIRROR NEURONS; ACTION WORDS; CROSS-TALK; COMPREHENSION; VERB; MODULATION; IDIOMS	The involvement of the sensorimotor system in language understanding has been widely demonstrated. However, the role of context in these studies has only recently started to be addressed. Though words are bearers of a semantic potential, meaning is the product of a pragmatic process. It needs to be situated in a context to be disambiguated. The aim of this study was to test the hypothesis that embodied simulation occurring during linguistic processing is contextually modulated to the extent that the same sentence, depending on the context of utterance, leads to the activation of different effector-specific brain motor areas. In order to test this hypothesis, we asked subjects to give a motor response with the hand or the foot to the presentation of ambiguous idioms containing action-related words when these are preceded by context sentences. The results directly support our hypothesis only in relation to the comprehension of hand-related action sentences.	[Cuccio, Valentina; Ambrosecchia, Marianna; Ferri, Francesca; Fogassi, Leonardo; Gallese, Vittorio] Univ Parma, Dept Neurosci, I-43100 Parma, Italy; [Cuccio, Valentina; Carapezza, Marco; Lo Piparo, Franco] Univ Palermo, Dept Humanities, Palermo, Italy; [Ferri, Francesca] Univ Ottawa, Mental Hlth Res Inst, Ottawa, ON, Canada	University of Parma; University of Palermo; University of Ottawa	Cuccio, V (corresponding author), Univ Parma, Dept Neurosci, I-43100 Parma, Italy.	vale.cuccio@libero.it	Gallese, Vittorio/ABD-5097-2021; Cuccio, Valentina/AAT-8722-2020; Ferri, Francesca/AAC-2527-2022; FOGASSI, Leonardo/K-3541-2018	Gallese, Vittorio/0000-0003-4815-3607; Cuccio, Valentina/0000-0001-7908-4216; Ferri, Francesca/0000-0003-1821-5870; FOGASSI, Leonardo/0000-0003-3348-039X	European Union	European Union(European Commission)	This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. The research was supported by the European Union grant TESIS to VG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin John, 1960, DO THINGS WORDS; Aziz-Zadeh L, 2006, CURR BIOL, V16, P1818, DOI 10.1016/j.cub.2006.07.060; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Barsalou LW, 2010, TOP COGN SCI, V2, P716, DOI 10.1111/j.1756-8765.2010.01115.x; Bonini L, 2011, J NEUROSCI, V31, P5876, DOI 10.1523/JNEUROSCI.5186-10.2011; Bonini L, 2010, CEREB CORTEX, V20, P1372, DOI 10.1093/cercor/bhp200; Borreggine KL, 2006, COGNITIVE SCI, V30, P1097, DOI 10.1207/s15516709cog0000_91; Boulenger V, 2006, J COGNITIVE NEUROSCI, V18, P1607, DOI 10.1162/jocn.2006.18.10.1607; Boulenger V, 2012, NEUROIMAGE, V59, P3502, DOI 10.1016/j.neuroimage.2011.11.011; Boulenger V, 2009, CEREB CORTEX, V19, P1905, DOI 10.1093/cercor/bhn217; Buccino G, 2005, COGNITIVE BRAIN RES, V24, P355, DOI 10.1016/j.cogbrainres.2005.02.020; Cacciari C, 2011, BRAIN LANG, V119, P149, DOI 10.1016/j.bandl.2011.05.004; Cain K, 2009, J EXP CHILD PSYCHOL, V102, P280, DOI 10.1016/j.jecp.2008.08.001; Chersi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027652; Cuccio V, 2012, BIOLINGUISTICS, V6, P259; Cunnings I, 2012, SECOND LANG RES, V28, P369, DOI 10.1177/0267658312443651; Dalla Volta R, 2009, EXP BRAIN RES, V196, P403, DOI 10.1007/s00221-009-1864-8; de Vega M, 2013, PSYCHOL RES-PSYCH FO, V77, P20, DOI 10.1007/s00426-011-0356-1; Desai RH, 2013, NEUROIMAGE, V83, P862, DOI 10.1016/j.neuroimage.2013.07.044; Desai RH, 2011, J COGNITIVE NEUROSCI, V23, P2376, DOI 10.1162/jocn.2010.21596; Egorova N, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00086; Fodor J, 1983, MODULARITY MIND; Fogassi L, 2007, CURR DIR PSYCHOL SCI, V16, P136, DOI 10.1111/j.1467-8721.2007.00491.x; Frege G, 1892, SENSE REFERENCE, V1997, P25; Frege J.L., 1959, FDN ARITHMETIC; Gallese V, 2011, TRENDS COGN SCI, V15, P512, DOI 10.1016/j.tics.2011.09.003; Gallese V, 2008, SOC NEUROSCI-UK, V3, P317, DOI 10.1080/17470910701563608; Gentilucci M, 2006, NEUROSCI BIOBEHAV R, V30, P949, DOI 10.1016/j.neubiorev.2006.02.004; Gibbs Jr RW, 2002, J MENT IMAGERY, V26, P82; Gibbs Jr RW, 2002, J MENTAL IMAGERY, V26, P1; Gibbs R., 2006, EMBODIMENT COGNITIVE; Gibbs R.W., 2012, INTERPRETING FIGURAT, DOI 10.1017/CBO9781139168779; Gibbs RW, 2010, STUD HIST PHILOS SCI, V41, P305, DOI 10.1016/j.shpsa.2010.07.004; GIBBS RW, 1992, J MEM LANG, V31, P485, DOI 10.1016/0749-596X(92)90025-S; GIBBS RW, 1990, COGNITION, V36, P35, DOI 10.1016/0010-0277(90)90053-M; Gibbs RW, 2003, BRAIN LANG, V84, P1, DOI 10.1016/S0093-934X(02)00517-5; GIBBS RW, 1985, J PSYCHOLINGUIST RES, V14, P465, DOI 10.1007/BF01666721; Glenberg AM, 2002, PSYCHON B REV, V9, P558, DOI 10.3758/BF03196313; Glenberg AM, 2013, PERSPECT PSYCHOL SCI, V8, P573, DOI 10.1177/1745691613498098; Glenberg AM, 2012, CORTEX, V48, P905, DOI 10.1016/j.cortex.2011.04.010; Grodzinsky Y, 2006, CURR OPIN NEUROBIOL, V16, P240, DOI 10.1016/j.conb.2006.03.007; Guan CQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075183; Hauk O, 2004, NEURON, V41, P301, DOI 10.1016/S0896-6273(03)00838-9; Iacoboni M, 2005, PLOS BIOL, V3, P529, DOI 10.1371/journal.pbio.0030079; Kaschak MP, 2008, J MEM LANG, V58, P862, DOI 10.1016/j.jml.2006.12.002; Kemmerer D, 2008, BRAIN LANG, V107, P16, DOI 10.1016/j.bandl.2007.09.003; Kiefer M, 2012, CORTEX, V48, P805, DOI 10.1016/j.cortex.2011.04.006; Kuperberg GR, 2008, BIOL PSYCHIAT, V64, P407, DOI 10.1016/j.biopsych.2008.03.018; Lepore Ernest, 2005, INSENSITIVE SEMANTIC; Meteyard L, 2009, BRAIN LANG, V110, P121, DOI 10.1016/j.bandl.2009.03.007; Mirabella G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035403; Nazir TA, 2008, Q J EXP PSYCHOL, V61, P933, DOI 10.1080/17470210701625667; NUNBERG G, 1994, LANGUAGE, V70, P491, DOI 10.2307/416483; Papeo L, 2012, J COGNITIVE NEUROSCI, V24, P2348, DOI 10.1162/jocn_a_00291; Papeo L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004508; Pulvermuller F, 2001, BRAIN LANG, V78, P143, DOI 10.1006/brln.2000.2390; Pylyshyn Z., 1984, COMPUTATION COGNITIO; Raposo A, 2009, NEUROPSYCHOLOGIA, V47, P388, DOI 10.1016/j.neuropsychologia.2008.09.017; RASTIER Francois, 2001, ARTS SCI TEXTE; Rizzo S, 2007, BRAIN RES BULL, V71, P523, DOI 10.1016/j.brainresbull.2006.11.006; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; Sato M, 2008, BRAIN LANG, V105, P83, DOI 10.1016/j.bandl.2007.10.001; Temple JG, 1999, J PSYCHOLINGUIST RES, V28, P41, DOI 10.1023/A:1023287420088; Tettamanti M, 2005, J COGNITIVE NEUROSCI, V17, P273, DOI 10.1162/0898929053124965; Vachon F, 2012, J COGNITIVE NEUROSCI, V24, P611, DOI 10.1162/jocn_a_00149; van Ackeren MJ, 2012, J COGNITIVE NEUROSCI, V24, P2237, DOI 10.1162/jocn_a_00274; Van Dam WO, 2010, EMBODIED GROUNDED CO, V57; Vogt S, 2007, NEUROIMAGE, V37, P1371, DOI 10.1016/j.neuroimage.2007.07.005; Wittgenstein L, 1953, PHILOS UNTERSUCHUNGE; Wurm MF, 2012, J COGNITIVE NEUROSCI, V24, P1548, DOI 10.1162/jocn_a_00232	71	16	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115381	10.1371/journal.pone.0115381	http://dx.doi.org/10.1371/journal.pone.0115381			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA3ZY	25531530	Green Accepted, Green Published, gold			2022-12-27	WOS:000348845100060
J	Perez-Ramos, IM; Aponte, C; Garcia, LV; Padilla-Diaz, CM; Maranon, T				Perez-Ramos, Ignacio M.; Aponte, Cristina; Garcia, Luis V.; Padilla-Diaz, Carmen M.; Maranon, Teodoro			Why Is Seed Production So Variable among Individuals? A Ten-Year Study with Oaks Reveals the Importance of Soil Environment	PLOS ONE			English	Article							ACORN PRODUCTION; EVOLUTIONARY ECOLOGY; WIND POLLINATION; PREDATION; PATTERNS; REPRODUCTION; PHENOLOGY; REMOVAL; GROWTH; MODEL	Mast-seeding species exhibit not only a large inter-annual variability in seed production but also considerable variability among individuals within the same year. However, very little is known about the causes and consequences for population dynamics of this potentially large between-individual variability. Here, we quantified seed production over ten consecutive years in two Mediterranean oak species - the deciduous Quercus canariensis and the evergreen Q. suber - that coexist in forests of southern Spain. First, we calibrated likelihood models to identify which abiotic and biotic variables best explain the magnitude (hereafter seed productivity) and temporal variation of seed production at the individual level (hereafter CVi), and infer whether reproductive effort results from the available soil resources for the plant or is primarily determined by selectively favoured strategies. Second, we explored the contribution of between-individual variability in seed production as a potential mechanism of satiation for predispersal seed predators. We found that Q. canariensis trees inhabiting moister and more fertile soils were more productive than those growing in more resource-limited sites. Regarding temporal variation, individuals of the two studied oak species inhabiting these resource-rich environments also exhibited larger values of CVi. Interestingly, we detected a satiating effect on granivorous insects at the tree level in Q. suber, which was evident in those years where between-individual variability in acorn production was higher. These findings suggest that individual seed production (both in terms of seed productivity and inter-annual variability) is strongly dependent on soil resource heterogeneity (at least for one of the two studied oak species) with potential repercussions for recruitment and population dynamics. However, other external factors (such as soil heterogeneity in pathogen abundance) or certain inherent characteristics of the tree might be also involved in this process.	[Perez-Ramos, Ignacio M.; Garcia, Luis V.; Padilla-Diaz, Carmen M.; Maranon, Teodoro] CSIC, IRNAS, E-41080 Seville, Spain; [Aponte, Cristina] Univ Melbourne, Dept Forest & Ecosyst Sci, Melbourne, Vic, Australia	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Recursos Naturales y Agrobiologia de Sevilla (IRNAS); University of Melbourne	Perez-Ramos, IM (corresponding author), CSIC, IRNAS, E-41080 Seville, Spain.	imperez@irnase.csic.es	Garcia, Luis V/A-4252-2008; Aponte, Cristina/AAV-5567-2020; PADILLA-DIAZ, CARMEN M./C-6762-2019; Perez-Ramos, Ignacio M/H-6048-2015; Aponte, Cristina/I-1586-2014; García, Luis V/GQA-9712-2022; Maranon, Teodoro/K-6648-2014	Garcia, Luis V/0000-0002-5514-2941; Aponte, Cristina/0000-0002-8457-7573; PADILLA-DIAZ, CARMEN M./0000-0002-7220-8041; Perez-Ramos, Ignacio M/0000-0003-2332-7818; Aponte, Cristina/0000-0002-8457-7573; Maranon, Teodoro/0000-0002-7751-9316	Andalusian Government; Spanish MEC project Heteromed [REN2002-4041-C02-02]; Spanish MEC project Dinamed [CGL2005-5830-C03-01]; Spanish MEC project Interbos [CGL2008-04503-C03-01]; Spanish MEC project Diverbos [CGL2011-30285-C02]; Andalusian project [Anasinque-PE2010-RNM-5782]; European FEDER	Andalusian Government; Spanish MEC project Heteromed; Spanish MEC project Dinamed; Spanish MEC project Interbos; Spanish MEC project Diverbos; Andalusian project; European FEDER(European Commission)	This study was supported by a postdoctoral contract of the Andalusian Government to IMPR, by the Spanish MEC projects Heteromed (REN2002-4041-C02-02), Dinamed (CGL2005-5830-C03-01), Interbos (CGL2008-04503-C03-01) and Diverbos (CGL2011-30285-C02), by the Andalusian Anasinque-PE2010-RNM-5782 project and the European FEDER funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson WG, 2003, ECOLOGY, V84, P2476, DOI 10.1890/01-0707; Aponte C, 2010, BIOGEOCHEMISTRY, V101, P77, DOI 10.1007/s10533-010-9418-5; Buonaccorsi JP, 2003, J THEOR BIOL, V224, P107, DOI 10.1016/S0022-5193(03)00148-6; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carevic FS, 2010, AGROFOREST SYST, V78, P299, DOI 10.1007/s10457-009-9245-7; Edwards AWF, 1992, LIKELIHOOD; Espelta JM, 2009, J ECOL, V97, P1416, DOI 10.1111/j.1365-2745.2009.01564.x; Espelta JM, 2008, ECOLOGY, V89, P805, DOI 10.1890/07-0217.1; Fernandez-Martinez M, 2012, ACTA OECOL, V43, P51, DOI 10.1016/j.actao.2012.05.006; Garcia-Mozo H, 2012, ANN AGR ENV MED, V19, P403; Gomez-Aparicio L, 2012, NEW PHYTOL, V194, P1014, DOI 10.1111/j.1469-8137.2012.04108.x; GOODRUM PD, 1971, J WILDLIFE MANAGE, V35, P520, DOI 10.2307/3799707; Greenberg CH, 2000, FOREST ECOL MANAG, V132, P199, DOI 10.1016/S0378-1127(99)00226-1; Healy WM, 1999, FOREST ECOL MANAG, V116, P1, DOI 10.1016/S0378-1127(98)00460-5; HERRERA CM, 1994, ECOL MONOGR, V64, P315, DOI 10.2307/2937165; Isagi Y, 1997, J THEOR BIOL, V187, P231, DOI 10.1006/jtbi.1997.0442; Janzen D. H., 1971, A Rev Ecol Syst, V2, P465, DOI 10.1146/annurev.es.02.110171.002341; KELLY D, 1994, TRENDS ECOL EVOL, V9, P465, DOI 10.1016/0169-5347(94)90310-7; Kelly D, 2002, ANNU REV ECOL SYST, V33, P427, DOI 10.1146/annurev.ecolsys.33.020602.095433; Kelly D, 2001, ECOLOGY, V82, P117, DOI 10.1890/0012-9658(2001)082[0117:ETWPBO]2.0.CO;2; Knapp EE, 2001, OECOLOGIA, V128, P48, DOI 10.1007/s004420000623; Knops JMH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043492; Kobe RK, 2006, OECOLOGIA, V147, P119, DOI 10.1007/s00442-005-0252-8; Koenig WD, 2000, AM NAT, V155, P59, DOI 10.1086/303302; Koenig WD, 2003, OIKOS, V102, P581, DOI 10.1034/j.1600-0706.2003.12272.x; Koenig WD, 1996, CAN J FOREST RES, V26, P1677, DOI 10.1139/x26-189; MULDER J, 1994, SCOPE SER, V51, P107; Murphy L, 2012, LIKELIHOOD METHODS M; NILSSON SG, 1987, ECOLOGY, V68, P260, DOI 10.2307/1939256; Norton DA, 1988, FUNCT ECOL, V2, P399, DOI 10.2307/2389413; Pausas J., 2009, CORK OAK WOODLANDS E, P115; Perea R, 2011, FOREST ECOL MANAG, V262, P1251, DOI 10.1016/j.foreco.2011.06.022; Perez-Ramos IM, 2010, ECOLOGY, V91, P3057, DOI 10.1890/09-2313.1; Perez-Ramos IM, 2008, OIKOS, V117, P1386, DOI 10.1111/j.0030-1299.2008.16370.x; Perez-Ramos IM, 2008, FOREST ECOL MANAG, V255, P3506, DOI 10.1016/j.foreco.2008.02.032; Perez-Ramos IM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077197; Perez-Ramos IM, 2010, J VEG SCI, V21, P419, DOI 10.1111/j.1654-1103.2009.01165.x; Perez-Ramos IM, 2007, THESIS U SEVILLE SPA; Pons J, 2012, OECOLOGIA, V169, P723, DOI 10.1007/s00442-011-2244-1; Pulido FJ, 2005, REGENERATION MEDITER; Sala A, 1996, AGR FOREST METEOROL, V78, P203, DOI 10.1016/0168-1923(95)02250-3; Sala A, 2012, NEW PHYTOL, V196, P189, DOI 10.1111/j.1469-8137.2012.04257.x; Sanchez-Humanes B, 2011, FORESTRY, V84, P73, DOI 10.1093/forestry/cpq045; Satake A, 2000, J THEOR BIOL, V203, P63, DOI 10.1006/jtbi.1999.1066; Satake A, 2008, ECOL RES, V23, P3, DOI 10.1007/s11284-007-0397-5; SILVERTOWN JW, 1980, BIOL J LINN SOC, V14, P235, DOI 10.1111/j.1095-8312.1980.tb00107.x; Smaill SJ, 2011, J ECOL, V99, P870, DOI 10.1111/j.1365-2745.2011.01803.x; SORK VL, 1993, VEGETATIO, V108, P133; SORK VL, 1993, ECOLOGY, V74, P528, DOI 10.2307/1939313; Thomas GW, 1996, METHODS SOIL ANAL PA, P475; Urbieta IR, 2008, CAN J FOREST RES, V38, P2382, DOI 10.1139/X08-089; Urbieta IR, 2008, J BIOGEOGR, V35, P1688, DOI 10.1111/j.1365-2699.2008.01914.x	52	24	24	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115371	10.1371/journal.pone.0115371	http://dx.doi.org/10.1371/journal.pone.0115371			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25532130	Green Submitted, Green Published, gold			2022-12-27	WOS:000348845100055
J	Kon, S; Nakayama, Y; Matsumoto, N; Ito, K; Kanayama, M; Kimura, C; Kouro, H; Ashitomi, D; Matsuda, T; Uede, T				Kon, Shigeyuki; Nakayama, Yosuke; Matsumoto, Naoki; Ito, Koyu; Kanayama, Masashi; Kimura, Chiemi; Kouro, Hitomi; Ashitomi, Dai; Matsuda, Tadashi; Uede, Toshimitsu			A Novel Cryptic Binding Motif, LRSKSRSFQVSDEQY, in the C-Terminal Fragment of MMP-3/7-Cleaved Osteopontin as a Novel Ligand for alpha 9b1 Integrin Is Involved in the Anti-Type II Collagen Antibody-Induced Arthritis	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; THROMBIN-CLEAVAGE; ADHESIVE; DOMAIN; INFLAMMATION; ACTIVATION; EXPRESSION; RECEPTORS; MIGRATION; PEPTIDES	Osteopontin (OPN) is a multifunctional protein that has been linked to various intractable inflammatory diseases. One way by which OPN induces inflammation is the production of various functional fragments by enzyme cleavage. It has been well appreciated that OPN is cleaved by thrombin, and/or matrix metalloproteinase-3 and -7 (MMP-3/7). Although the function of thrombin-cleaved OPN is well characterized, little is known about the function of MMP-3/7-cleaved OPN. In this study, we found a novel motif, LRSKSRSFQVSDEQY, in the C-terminal fragment of MMP-3/7-cleaved mouse OPN binds to alpha 9b1 integrin. Importantly, this novel motif is involved in the development of anti-type II collagen antibody-induced arthritis (CAIA). This study provides the first in vitro and in vivo evidence that OPN cleavage by MMP-3/7 is an important regulatory mechanism for CAIA.	[Kon, Shigeyuki; Nakayama, Yosuke; Ito, Koyu; Kanayama, Masashi; Kimura, Chiemi; Uede, Toshimitsu] Hokkaido Univ, Inst Med Genet, Div Mol Immunol, Sapporo, Hokkaido, Japan; [Kon, Shigeyuki; Matsumoto, Naoki; Kouro, Hitomi; Ashitomi, Dai; Matsuda, Tadashi] Hokkaido Univ, Fac Pharmaceut Sci, Dept Immunol, Sapporo, Hokkaido 060, Japan	Hokkaido University; Hokkaido University	Kon, S (corresponding author), Hokkaido Univ, Inst Med Genet, Div Mol Immunol, Sapporo, Hokkaido, Japan.	kon@pharm.hokudai.ac.jp; uedetoshimitsu@icloud.com	Matsuda, Tadashi/A-3835-2012; Ito, Koyu/CAH-5669-2022	Matsuda, Tadashi/0000-0002-3089-3757; Kanayama, Masashi/0000-0001-8366-5275	JSPS KAKENHI [24590072]; Akiyama Life Science Foundation; Suzuken Memorial Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Akiyama Life Science Foundation; Suzuken Memorial Foundation	This work was supported in part by research grant from JSPS KAKENHI, Grant Number 24590072, the Akiyama Life Science Foundation, and Suzuken Memorial Foundation to SK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnihotri R, 2001, J BIOL CHEM, V276, P28261, DOI 10.1074/jbc.M103608200; Barry ST, 2000, EXP CELL RES, V258, P342, DOI 10.1006/excr.2000.4941; Barry ST, 2000, BIOCHEM BIOPH RES CO, V267, P764, DOI 10.1006/bbrc.1999.2032; Bayless KJ, 2001, J BIOL CHEM, V276, P13483, DOI 10.1074/jbc.M011392200; BUCK CA, 1987, J CELL SCI, P231; BUCK CA, 1987, ANNU REV CELL BIOL, V3, P179, DOI 10.1146/annurev.cb.03.110187.001143; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; Diao HY, 2004, IMMUNITY, V21, P539, DOI 10.1016/j.immuni.2004.08.012; GAILIT J, 1988, J BIOL CHEM, V263, P12927; Gao YA, 2004, MATRIX BIOL, V23, P457, DOI 10.1016/j.matbio.2004.09.003; GIACHELLI CM, 1995, ANN NY ACAD SCI, V760, P109, DOI 10.1111/j.1749-6632.1995.tb44624.x; Green PM, 2001, FEBS LETT, V503, P75, DOI 10.1016/S0014-5793(01)02690-4; Helluin O, 2000, J BIOL CHEM, V275, P18337, DOI 10.1074/jbc.M001529200; Ito K, 2009, MATRIX BIOL, V28, P11, DOI 10.1016/j.matbio.2008.10.002; Kaartinen MT, 2002, J BONE MINER RES, V17, P2161, DOI 10.1359/jbmr.2002.17.12.2161; Kanayama M, 2009, J IMMUNOL, V182, P8015, DOI 10.4049/jimmunol.0900725; Kim SY, 2006, FRONT BIOSCI-LANDMRK, V11, P3026, DOI 10.2741/2030; Kon S, 2000, J CELL BIOCHEM, V77, P487; Kon S, 2008, J EXP MED, V205, P25, DOI 10.1084/jem.20071324; Nishimichi N, 2011, J BIOL CHEM, V286, P11170, DOI 10.1074/jbc.M110.189258; Nishimichi N, 2009, J BIOL CHEM, V284, P14769, DOI 10.1074/jbc.M901515200; O'Regan AW, 1999, J IMMUNOL, V162, P1024; Senger DR, 1996, BBA-MOL CELL RES, V1314, P13, DOI 10.1016/S0167-4889(96)00067-5; SENGER DR, 1994, MOL BIOL CELL, V5, P565, DOI 10.1091/mbc.5.5.565; Sharif SA, 2009, ARTHRITIS RHEUM-US, V60, P2902, DOI 10.1002/art.24814; Smith LL, 1996, J BIOL CHEM, V271, P28485, DOI 10.1074/jbc.271.45.28485; Uede T, 1997, MICROBIOL IMMUNOL, V41, P641, DOI 10.1111/j.1348-0421.1997.tb01906.x; Weber Georg F., 1996, Cytokine and Growth Factor Reviews, V7, P241, DOI 10.1016/S1359-6101(96)00030-5; Weber GF, 2002, J LEUKOCYTE BIOL, V72, P752; Yamamoto N, 2003, J CLIN INVEST, V112, P181, DOI 10.1172/JCI200317778; Yokosaki Y, 1999, J BIOL CHEM, V274, P36328, DOI 10.1074/jbc.274.51.36328	31	26	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e0116210	10.1371/journal.pone.0116210	http://dx.doi.org/10.1371/journal.pone.0116210			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545242	Green Published, gold			2022-12-27	WOS:000347120200107
J	Luo, Q; Sun, LN; Hu, XM; Zhou, RR				Luo, Qing; Sun, Lina; Hu, Xiaomin; Zhou, Ruiren			The Variation of Root Exudates from the Hyperaccumulator Sedum alfredii under Cadmium Stress: Metabonomics Analysis	PLOS ONE			English	Article							WEIGHT ORGANIC-ACIDS; DISCOVERED CD-HYPERACCUMULATOR; QUANTITATIVE-ANALYSIS; METAL ACCUMULATION; CONTAMINATED SOILS; PLANT; PHYTOREMEDIATION; MAIZE; ZINC; L.	Hydroponic experiments were conducted to investigate the variation of root exudates from the hyperaccumulator Sedum alfredii under the stress of cadmium (Cd). S. alfredii was cultured for 4 days in the nutrient solution spiked with CdCl2 at concentrations of 0, 5, 10, 40, and 400 mu M Cd after the pre-culture. The root exudates were collected and analyzed by GC-MS, and 62 compounds were identified. Of these compounds, the orthogonal partial least-squares discrimination analysis (OPLS-DA) showed that there were a distinct difference among the root exudates with different Cd treatments and 20 compounds resulting in this difference were found out. Changing tendencies in the relative content of these 20 compounds under the different Cd treatments were analyzed. These results indicated that trehalose, erythritol, naphthalene, d-pinitol and n-octacosane might be closely related to the Cd stabilization, phosphoric acid, tetradecanoic acid, oxalic acid, threonic acid and glycine could be attributed to the Cd mobilization, and mannitol, oleic acid, 3-hydroxybutanoic acid, fructose, octacosanol and ribitol could copy well with the Cd stress.	[Luo, Qing; Hu, Xiaomin] Northeast Univ, Sch Resources & Civil Engn, Shenyang, Peoples R China; [Luo, Qing; Sun, Lina] Shenyang Agr Univ, Key Lab Reg Environm & Ecoremediat, Minist Educ, Shenyang 110161, Peoples R China; [Zhou, Ruiren] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China	Northeastern University - China; Shenyang Agricultural University; Nankai University	Sun, LN (corresponding author), Shenyang Agr Univ, Key Lab Reg Environm & Ecoremediat, Minist Educ, Shenyang 110161, Peoples R China.	sln629@163.com	Hu, Xiaomin/GRY-1539-2022; Luo, Qing/ABD-4148-2020	Luo, Qing/0000-0002-4306-6283	National Natural Science Foundation of China [21037002, 41071304, 21107075]; Program for the Innovative Research Team in Liaoning Province [LT2011017]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for the Innovative Research Team in Liaoning Province	The authors are thankful for the financial support from the National Natural Science Foundation of China (no. 21037002, 41071304, and 21107075) and Program for the Innovative Research Team in Liaoning Province (LT2011017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnon, 1950, WATER CULTURE METHOD, V347, DOI DOI 10.1073/PNAS.1211132109; Asemaneh T, 2006, PLANTA, V225, P193, DOI 10.1007/s00425-006-0340-y; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; Blaylock MJ, 2000, PHYTOREMEDIATION OF TOXIC METALS, P53; Chiang PN, 2011, SOIL SCI, V176, P33, DOI 10.1097/SS.0b013e318202fdc9; Cieslinski G, 1998, PLANT SOIL, V203, P109, DOI 10.1023/A:1004325817420; CUNNINGHAM SD, 1995, TRENDS BIOTECHNOL, V13, P393, DOI 10.1016/S0167-7799(00)88987-8; CURL EA, 1986, RHIZOSPHERE, P288, DOI DOI 10.1007/978-3-642-70722-3; Dakora FD, 2002, PLANT SOIL, V245, P35, DOI 10.1023/A:1020809400075; Dong J, 2007, PLANT SOIL ENVIRON, V53, P193, DOI 10.17221/2205-PSE; Fan TWM, 2001, PHYTOCHEMISTRY, V57, P209, DOI 10.1016/S0031-9422(01)00007-3; Gransee A, 2000, J PLANT NUTR SOIL SC, V163, P381, DOI 10.1002/1522-2624(200008)163:4<381::AID-JPLN381>3.0.CO;2-7; Groleau-Renaud V, 2000, J PLANT NUTR, V23, P1283, DOI 10.1080/01904160009382100; Guo GL, 2006, ENVIRON MONIT ASSESS, V116, P513, DOI 10.1007/s10661-006-7668-4; Han F, 2006, PLANT SOIL, V289, P355, DOI 10.1007/s11104-006-9145-9; Jiang CA, 2013, J ENVIRON SCI-CHINA, V25, P1890, DOI 10.1016/S1001-0742(12)60213-7; Johansson EM, 2008, PLANT SOIL, V313, P39, DOI 10.1007/s11104-008-9678-1; Jones DL, 2004, NEW PHYTOL, V163, P459, DOI 10.1111/j.1469-8137.2004.01130.x; Kim S, 2010, J BIOSCI BIOENG, V109, P47, DOI 10.1016/j.jbiosc.2009.06.018; Kramer U, 2000, PLANT PHYSIOL, V122, P1343, DOI 10.1104/pp.122.4.1343; Kupper H, 2001, J EXP BOT, V52, P2291, DOI 10.1093/jexbot/52.365.2291; Li TQ, 2011, J HAZARD MATER, V192, P1616, DOI 10.1016/j.jhazmat.2011.06.086; Li TQ, 2005, J ENVIRON SCI HEAL A, V40, P1081, DOI 10.1081/ESE-200056163; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Liu D, 2008, J HAZARD MATER, V153, P114, DOI 10.1016/j.jhazmat.2007.08.026; Liu WT, 2011, J AGR FOOD CHEM, V59, P8324, DOI 10.1021/jf201454w; [龙新宪 Long Xinxian], 2002, [植物营养与肥料学报, Plant nutrition and fertitizer science], V8, P467; Luo CL, 2008, WATER AIR SOIL POLL, V193, P147, DOI 10.1007/s11270-008-9678-z; Marschner H., 1995, MARSCHNERS MINERAL N, DOI DOI 10.1016/B978-0-12-473542-2.X5000-7; Nigam R, 2001, PLANT SOIL, V230, P107, DOI 10.1023/A:1004865811529; Prasad MNV, 2003, ELECTRON J BIOTECHN, V6, P285, DOI 10.2225/vol6-issue3-fulltext-6; Quartacci MF, 2009, ENVIRON POLLUT, V157, P2697, DOI 10.1016/j.envpol.2009.04.035; Selvakumar G., 2012, BACTERIAL MEDIATED A, P205; Sheng PH., 2001, POLLUTION ECOLOGY; Sun RL, 2007, ENVIRON EXP BOT, V60, P468, DOI 10.1016/j.envexpbot.2007.01.004; Sun RL, 2006, PLANT SOIL, V285, P125, DOI 10.1007/s11104-006-0064-6; Sun RuiLian, 2005, Acta Phytoecologica Sinica, V29, P497; Sun YB, 2009, GEODERMA, V150, P106, DOI 10.1016/j.geoderma.2009.01.016; Sun YB, 2009, J HAZARD MATER, V161, P808, DOI 10.1016/j.jhazmat.2008.04.030; Suzuki K, 2009, SOIL SCI PLANT NUTR, V55, P505, DOI 10.1111/j.1747-0765.2009.00390.x; Wei SH, 2005, CHINESE SCI BULL, V50, P33, DOI 10.1360/982004-292; Wei SH, 2004, PROG NAT SCI-MATER, V14, P495, DOI 10.1080/10020070412331343851; Wei SH, 2006, ENVIRON SCI POLLUT R, V13, P151, DOI 10.1065/espr2005.06.269; Wiltse CC, 1998, J ENVIRON QUAL, V27, P169, DOI 10.2134/jeq1998.00472425002700010024x; Yang X, 2002, CHINESE SCI BULL, V47, P1634, DOI 10.1360/02tb9359; Yang X, 1996, J PLANT NUTR, V19, P643, DOI 10.1080/01904169609365148; Yang X, 2014, J INTEGR AGR, V13, P105, DOI 10.1016/S2095-3119(13)60495-5; Zhao FJ, 2001, NEW PHYTOL, V151, P613, DOI 10.1046/j.0028-646x.2001.00213.x; Zhou Q., 1995, ECOLOGY COMBINED POL; Zhou Q.X., 2006, ECOLOGICAL REMEDIATI; Zhou QX., 2004, PRINCIPLES METHODS C	51	42	46	8	178	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115581	10.1371/journal.pone.0115581	http://dx.doi.org/10.1371/journal.pone.0115581			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545686	Green Published, Green Submitted, gold			2022-12-27	WOS:000347120200048
J	Ormos, M; Zibriczky, D				Ormos, Mihaly; Zibriczky, David			Entropy-Based Financial Asset Pricing	PLOS ONE			English	Article							SELECTION	We investigate entropy as a financial risk measure. Entropy explains the equity premium of securities and portfolios in a simpler way and, at the same time, with higher explanatory power than the beta parameter of the capital asset pricing model. For asset pricing we define the continuous entropy as an alternative measure of risk. Our results show that entropy decreases in the function of the number of securities involved in a portfolio in a similar way to the standard deviation, and that efficient portfolios are situated on a hyperbola in the expected return - entropy system. For empirical investigation we use daily returns of 150 randomly selected securities for a period of 27 years. Our regression results show that entropy has a higher explanatory power for the expected return than the capital asset pricing model beta. Furthermore we show the time varying behavior of the beta along with entropy.	[Ormos, Mihaly; Zibriczky, David] Budapest Univ Technol & Econ, Dept Finance, H-1117 Budapest, Hungary	Budapest University of Technology & Economics	Ormos, M (corresponding author), Budapest Univ Technol & Econ, Dept Finance, Magyar Tudosok Krt 2, H-1117 Budapest, Hungary.	ormos@finance.bme.hu	Ormos, Mihály/E-1051-2011	Ormos, Mihály/0000-0002-3224-7636				Andor G, 2013, ENG ECON, V58, P3, DOI 10.1080/0013791X.2012.742607; Boltzmann L., 2012, WEITERE STUDIEN WARM, P316, DOI [10.1017/CBO9781139381420.023, DOI 10.1017/CBO9781139381420.023]; Clausius R., 1870, LONDON EDINB DUBLIN, V40, P122, DOI DOI 10.1080/14786447008640370; Dionisio A, 2006, EUR PHYS J B, V50, P161, DOI 10.1140/epjb/e2006-00113-2; Erdos P, 2009, ACTA OECON, V59, P391, DOI 10.1556/AOecon.59.2009.4.2; Erdos P, 2011, ECON MODEL, V28, P1150, DOI 10.1016/j.econmod.2010.12.008; FREEDMAN D, 1981, Z WAHRSCHEINLICHKEIT, V57, P453, DOI 10.1007/BF01025868; Gyorfi L., 1997, INT J MATH STAT SCI, V6, P17; HARDLE W., 2012, NONPARAMETRIC SEMIPA, DOI [10.1007/978-3-642-17146-8, DOI 10.1007/978-3-642-17146-8]; JENSEN MC, 1968, J FINANC, V23, P389, DOI 10.2307/2325404; Maasoumi E, 2002, J ECONOMETRICS, V107, P291, DOI 10.1016/S0304-4076(01)00125-7; Markowitz H, 1952, J FINANC, V7, P77, DOI 10.1111/j.1540-6261.1952.tb01525.x; NAWROCKI DN, 1986, APPL ECON, V18, P411, DOI 10.1080/00036848600000038; PHILIPPATOS GC, 1972, APPL ECON, V4, P209, DOI 10.1080/00036847200000017; Renyi A, 1961, P 4 BERK S MATH STAT, V1; SCOTT DW, 1979, BIOMETRIKA, V66, P605, DOI 10.1093/biomet/66.3.605; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHARPE WF, 1964, J FINANC, V19, P425, DOI 10.2307/2977928; Silverman BW, 1986, MONOGRAPHS STAT APPL, DOI [DOI 10.1371/journal.pone.0064841, 10.1007/978-1-4899-3324-9, DOI 10.1007/978-1-4899-3324-9]; Turlach B.A., 1993, BANDWIDTH SELECTION; Wachowiak MP, 2005, PATTERN ANAL APPL, V8, P95, DOI 10.1007/s10044-005-0247-4; Zunckel C., 2011, ARXIV11024722	22	38	40	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115742	10.1371/journal.pone.0115742	http://dx.doi.org/10.1371/journal.pone.0115742			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7UN	25545668	Green Published, Green Submitted, gold			2022-12-27	WOS:000347120200063
J	Alvarez-Castaneda, ST; Murphy, RW				Alvarez-Castananeda, Sergio Ticul; Murphy, Robert W.			The Endemic Insular and Peninsular Species Chaetodipus spinatus (Mammalia, Heteromyidae) Breaks Patterns for Baja California	PLOS ONE			English	Article							DNA-SEQUENCE DATA; POPULATION-GROWTH; GENETIC-STRUCTURE; EVOLUTION; DIVERSIFICATION; PHYLOGEOGRAPHY; BIOGEOGRAPHY; OSCILLATIONS; SYSTEMATICS; PEROMYSCUS	The Baja California peninsula is the second longest, most geographically isolated peninsula on Earth. Its physiography and the presence of many surrounding islands has facilitated studies of the underlying patterns and drivers of genetic structuring for a wide spectrum of organisms. Chaetodipus spinatus is endemic to the region and occurs on 12 associated islands, including 10 in the Gulf of California and two in the Pacific Ocean. This distribution makes it a model species for evaluating natural historical barriers. We test hypotheses associated with the relationship between the range of the species, patterns in other species, and its relationship to Pleistocene-Holocene climatic changes. We analyzed sequence data from mtDNA genes encoding cytochrome b (Cytb) and cytochrome c oxidase subunits I (COI) and III (COIII) in 26 populations including all 12 islands. The matrilineal genealogy, statistical parsimony network and Bayesian skyline plot indicated an origin of C. spinatus in the southern part of the peninsula. Our analyses detected several differences from the common pattern of peninsular animals: no mid-peninsula break exists, Isla Carmen hosts the most divergent population, the population on an ancient southern Midriff island does not differ from peninsular populations, and a mtDNA peninsular discordance occurs near Loreto.	[Alvarez-Castananeda, Sergio Ticul] Inst Politecn Nacl 195, Ctr Invest Biol Noroeste, La Paz, Baja California, Mexico; [Murphy, Robert W.] Royal Ontario Museum, Ctr Biodivers & Conservat Biol, Toronto, ON M5S 2C6, Canada	CIBNOR - Centro de Investigaciones Biologicas del Noroeste; Telefonica SA; Royal Ontario Museum	Alvarez-Castaneda, ST (corresponding author), Inst Politecn Nacl 195, Ctr Invest Biol Noroeste, La Paz, Baja California, Mexico.	sticul@cibnor.mx			Consejo Nacional de Ciencia y Tecnologia (CONACYT) [39467Q, 151189, SEMARNAP-2002-COL-019]; University of California (UC-MEXUS-CONACYT)	Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); University of California (UC-MEXUS-CONACYT)	Financial support (grant 39467Q, 151189, SEMARNAP-2002-COL-019) was provided by the Consejo Nacional de Ciencia y Tecnologia (CONACYT) and University of California (UC-MEXUS-CONACYT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre G, 1999, HERPETOLOGICA, V55, P369; Alexander LF, 2005, J MAMMAL, V86, P366, DOI 10.1644/BER-120.1; ALVAREZ T, 1974, ESCENARIO GEOGRAFICO; Alvarez-Castaneda ST, 2004, MOL ECOL, V13, P2287, DOI 10.1111/j.1365-294X.2004.02243.x; Blair C, 2009, ZOOTAXA, P28, DOI 10.11646/zootaxa.2027.1.2; BRATTSTROM BAYARD H., 1956, CONDER, V58, P107, DOI 10.2307/1364977; BRATTSTROM BH, 1990, J BIOGEOGR, V17, P177, DOI 10.2307/2845325; Brattstrom BH, 1963, PACIFIC BASIN BIOGEO; Canon C, 2010, J MAMMAL, V91, P1449, DOI 10.1644/10-MAMM-A-027.1; Capra L, 1998, J VOLCANOL GEOTH RES, V80, P239, DOI 10.1016/S0377-0273(97)00049-8; Carreno AL, 2002, NEW ISLAND BIOGEOGRA; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Davy CM, 2011, J BIOGEOGR, V38, P272, DOI 10.1111/j.1365-2699.2010.02422.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; FAIRBANKS RG, 1989, NATURE, V342, P637, DOI 10.1038/342637a0; Fu YX, 1997, GENETICS, V147, P915; Gao Y, 2012, J BIOGEOGR, V39, P2264, DOI 10.1111/j.1365-2699.2012.02755.x; Gastil G, 1983, ISLAND BIOGEOGRAPHY; GRIsMER L. L., 2002, TUCSON HERPETOLOGICA; Hafner DJ, 2005, BIODIVERSITY ECOSYST; Hafner DJ, 2011, PALEOGEOGRAPHY PALEO; Hall E. R., 1981, MAMMALS N AM; Helenes J, 1999, J S AM EARTH SCI, V12, P589, DOI 10.1016/S0895-9811(99)00042-5; Herbert TD, 2001, SCIENCE, V293, P71, DOI 10.1126/science.1059209; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Holt JW, 2000, GEOL SOC AM BULL, V112, P540, DOI 10.1130/0016-7606(2000)112<540:AACOGO>2.0.CO;2; Huey L. M., 1960, Transactions of the San Diego Society for Natural History, V12, P409; HUEY LAURENCE M., 1964, TRANS SAN DIEGO SOC NAT HIST, V13, P85; HUEY LAURENCE M., 1930, TRANS SAN DIEGO SOC NAT HIST, V6, P231; Ivanova NV, 2007, MOL ECOL NOTES, V7, P544, DOI 10.1111/j.1471-8286.2007.01748.x; IVES RL, 1962, GEOL SOC AM BULL, V73, P647, DOI 10.1130/0016-7606(1962)73[647:DOTEOT]2.0.CO;2; Lackey J.A., 1991, Mammalian Species, P1; Lawlor TE, 2002, NEW ISLAND BIOGEOGRA; Leache AD, 2007, BIOL LETTERS, V3, P646, DOI 10.1098/rsbl.2007.0368; Ledesma-Vazquez J, 2002, REV MEXICANA CIENCIA, V19, P143; Lindell J, 2005, MOL PHYLOGENET EVOL, V36, P682, DOI 10.1016/j.ympev.2005.04.031; Lindell J, 2008, MOL ECOL RESOUR, V8, P66, DOI 10.1111/j.1471-8286.2007.01894.x; Lindell J, 2006, J BIOGEOGR, V33, P1327, DOI 10.1111/j.1365-2699.2006.01532.x; Lorenzo C, 2010, WEST N AM NATURALIST, V70, P249, DOI 10.3398/064.070.0214; MOORE DG, 1973, GEOL SOC AM BULL, V84, P1883, DOI 10.1130/0016-7606(1973)84<1883:PDACGG>2.0.CO;2; Murphy RW, 2010, CONSERVATION MESOAME; Murphy RW., 2002, NEW ISLAND BIOGEOGRA; MURPHY RW, 1983, OCCAS PAP CALIF ACAD, V137, P1; Nabhan G. P., 2003, SINGING TURTLES SEA; Nei M, 1987, MOL EVOLUTION GENETI; Nylander J.A.A., 2004, MRMODELTEST V2 2 PRO; Patton JL, 1999, MAMIFEROS NOROESTE M; Pichaud N, 2012, EVOLUTION, V66, P3189, DOI 10.1111/j.1558-5646.2012.01683.x; Posada D, 2004, COLLAPSE VERSION 1 1; Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; Radtkey RR, 1997, P NATL ACAD SCI USA, V94, P9740, DOI 10.1073/pnas.94.18.9740; Riddle BR, 2000, MOL PHYLOGENET EVOL, V17, P161, DOI 10.1006/mpev.2000.0842; RIDDLE BR, 1995, J MAMMAL, V76, P283, DOI 10.2307/1382342; Riddle BR, 2000, PNAS, V26, P14443; Rodriguez-Robles JA, 2000, MOL PHYLOGENET EVOL, V14, P35, DOI 10.1006/mpev.1999.0698; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SAVAGE JM, 1960, SYST ZOOL, V9, P184, DOI 10.2307/2411967; Schmidly JD, 1993, SPECIAL PUBLICATIONS, V10; Schmitt AK, 2010, QUAT GEOCHRONOL, V5, P503, DOI 10.1016/j.quageo.2010.02.004; Schneider S., 2000, ARLEQUIN VERSION 20; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Smith MF, 1998, MOL PHYLOGENET EVOL, V9, P1, DOI 10.1006/mpev.1997.0459; SMITH MF, 1993, BIOL J LINN SOC, V50, P149, DOI 10.1111/j.1095-8312.1993.tb00924.x; SOULE MICHAEL, 1966, TRANS SAN DIEGO SOC NATUR HIST, V14, P137; Swofford DL., 2001, PAUP PHYLOGENETIC AN; TAJIMA F, 1989, GENETICS, V123, P585; TEMPLETON AR, 1992, GENETICS, V132, P619; Alvarez-Castaneda ST, 2007, J MAMMAL, V88, P1160, DOI 10.1644/06-MAMM-A-065R3.1; Alvarez-Castaneda ST, 2009, J MAMMAL, V90, P992, DOI 10.1644/07-MAMM-A-398.1; Upton DE, 1997, MOL PHYLOGENET EVOL, V8, P104, DOI 10.1006/mpev.1996.0392; WEBB T, 1992, ANNU REV ECOL SYST, V23, P141, DOI 10.1146/annurev.es.23.110192.001041; Whorley JR, 2004, MOL ECOL, V13, P2709, DOI 10.1111/j.1365-294X.2004.02257.x; Williams DF, 1993, SPECIAL PUBLICATION, V10; Zhang FF, 2013, GENOME BIOL EVOL, V5, P1781, DOI 10.1093/gbe/evt129; Zheng XG, 2003, MOL ECOL, V12, P711, DOI 10.1046/j.1365-294X.2003.01770.x	77	11	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e116146	10.1371/journal.pone.0116146	http://dx.doi.org/10.1371/journal.pone.0116146			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542029	gold, Green Published, Green Submitted			2022-12-27	WOS:000347239900150
J	Grunert, T; Monahan, A; Lassnig, C; Vogl, C; Muller, M; Ehling-Schulz, M				Grunert, Tom; Monahan, Avril; Lassnig, Caroline; Vogl, Claus; Mueller, Mathias; Ehling-Schulz, Monika			Deciphering Host Genotype-Specific Impacts on the Metabolic Fingerprint of Listeria monocytogenes by FTIR Spectroscopy	PLOS ONE			English	Article							TRANSFORM INFRARED-SPECTROSCOPY; IR SPECTROSCOPY; IDENTIFICATION; BACTERIA; TYPHIMURIUM	Bacterial pathogens are known for their wide range of strategies to specifically adapt to host environments and infection sites. An in-depth understanding of these adaptation mechanisms is crucial for the development of effective therapeutics and new prevention measures. In this study, we assessed the suitability of Fourier Transform Infrared (FTIR) spectroscopy for monitoring metabolic adaptations of the bacterial pathogen Listeria monocytogenes to specific host genotypes and for exploring the potential of FTIR spectroscopy to gain novel insights into the host-pathogen interaction. Three different mouse genotypes, showing different susceptibility to L. monocytogenes infections, were challenged with L. monocytogenes and re-isolated bacteria were subjected to FTIR spectroscopy. The bacteria from mice with different survival characteristics showed distinct IR spectral patterns, reflecting specific changes in the backbone conformation and the hydrogen-bonding pattern of the protein secondary structure in the bacterial cell. Coupling FTIR spectroscopy with chemometrics allowed us to link bacterial metabolic fingerprints with host infection susceptibility and to decipher longtime memory effects of the host on the bacteria. After prolonged cultivation of host-passaged bacteria under standard laboratory conditions, the host's imprint on bacterial metabolism vanished, which suggests a revertible metabolic adaptation of bacteria to host environment and loss of host environment triggered memory effects over time. In summary, our work demonstrates the potential and power of FTIR spectroscopy to be used as a fast, simple and highly discriminatory tool to investigate the mechanism of bacterial host adaptation on a macromolar and metabolic level.	[Grunert, Tom; Ehling-Schulz, Monika] Univ Vet Med Vienna, Inst Microbiol, Dept Pathobiol, Vienna, Austria; [Monahan, Avril; Lassnig, Caroline; Vogl, Claus; Mueller, Mathias] Univ Vet Med Vienna, Inst Anim Breeding & Genet, Dept Biomed Sci, Vienna, Austria	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna	Ehling-Schulz, M (corresponding author), Univ Vet Med Vienna, Inst Microbiol, Dept Pathobiol, Vienna, Austria.	monika.ehling-schulz@vetmeduni.ac.at	Ehling-Schulz, Monika/J-3592-2014; Grunert, Tom/N-1452-2018; Grunert, Tom/AAS-4748-2020; Grunert, Tom/AFQ-4195-2022	Grunert, Tom/0000-0001-5722-6631; Grunert, Tom/0000-0001-5722-6631; Grunert, Tom/0000-0001-5722-6631; Ehling-Schulz, Monika/0000-0001-7384-0594; Muller, Mathias/0000-0002-7879-3552	University of Veterinary Medicine Vienna, Vienna, Austria; Austrian Science Fund (FWF) [SFB-F28]	University of Veterinary Medicine Vienna, Vienna, Austria; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	AM was supported by the postdoctoral program of the University of Veterinary Medicine Vienna, Vienna, Austria (www.vetmeduni.ac.at) and MM by a grant of the Austrian Science Fund (FWF) SFB-F28 (www.fwf.ac.at). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afroz T, 2014, MOL MICROBIOL, V93, P1093, DOI 10.1111/mmi.12695; Al-Qadiri HM, 2008, J FOOD SCI, V73, pM54, DOI 10.1111/j.1750-3841.2007.00640.x; Alvarez-Ordonez A, 2011, J MICROBIOL METH, V84, P369, DOI 10.1016/j.mimet.2011.01.009; Alvarez-Ordonez A, 2010, INT J FOOD MICROBIOL, V142, P97, DOI 10.1016/j.ijfoodmicro.2010.06.008; Beekes M, 2007, VET MICROBIOL, V123, P305, DOI 10.1016/j.vetmic.2007.04.010; Bosch A, 2010, J BIOPHOTONICS, V3, P522, DOI 10.1002/jbio.201000027; Camejo A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000449; Ehling-Schulz M, 2005, MICROBIOL-SGM, V151, P183, DOI 10.1099/mic.0.27607-0; Fricker M, 2011, INT J FOOD MICROBIOL, V145, pS24, DOI 10.1016/j.ijfoodmicro.2010.08.025; Grunert T, 2013, J CLIN MICROBIOL, V51, P2261, DOI 10.1128/JCM.00581-13; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; HELM D, 1991, J GEN MICROBIOL, V137, P69, DOI 10.1099/00221287-137-1-69; Karaghiosoff M, 2000, IMMUNITY, V13, P549, DOI 10.1016/S1074-7613(00)00054-6; KONGSHAVN PAL, 1985, IMMUNOL LETT, V11, P181, DOI 10.1016/0165-2478(85)90166-X; Kotula JW, 2014, P NATL ACAD SCI USA, V111, P4838, DOI 10.1073/pnas.1321321111; Lasch P., 2015, ENCY ANAL CHEM, P1, DOI DOI 10.1002/9780470027318.A0117.PUB2; Lu XN, 2011, FOOD MICROBIOL, V28, P537, DOI 10.1016/j.fm.2010.11.002; NAUMANN D, 1991, NATURE, V351, P81, DOI 10.1038/351081a0; Oberreuter H, 2002, INT J SYST EVOL MICR, V52, P91, DOI 10.1099/00207713-52-1-91; Semper C, 2014, MOL CELL BIOL, V34, P2235, DOI 10.1128/MCB.00295-14; Serra D, 2007, ANAL BIOANAL CHEM, V387, P1759, DOI 10.1007/s00216-006-1079-9; Serra DO, 2008, PROTEOMICS, V8, P4995, DOI 10.1002/pmic.200800218; Strobl B, 2011, FRONT BIOSCI-LANDMRK, V16, P3224, DOI 10.2741/3908; Wenning M., 2008, VIB SPECTROSC, P71; Wenning M, 2013, APPL MICROBIOL BIOT, V97, P7111, DOI 10.1007/s00253-013-5087-3	25	13	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115959	10.1371/journal.pone.0115959	http://dx.doi.org/10.1371/journal.pone.0115959			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541972	Green Published, gold, Green Submitted			2022-12-27	WOS:000347239900116
J	Lappas, M				Lappas, Martha			GSK3 beta Is Increased in Adipose Tissue and Skeletal Muscle from Women with Gestational Diabetes Where It Regulates the Inflammatory Response	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; PREEXISTING MATERNAL OBESITY; FACTOR-KAPPA-B; INSULIN-RESISTANCE; PROINFLAMMATORY CYTOKINES; PERIODONTAL-DISEASE; ADHESION MOLECULES; GLUCOSE-METABOLISM; HUMAN PLACENTA; TNF-ALPHA	Infection and inflammation, through their ability to increase pro-inflammatory cytokines and chemokines and adhesion molecules, are thought to play a central role in the pathophysiology of insulin resistance and type 2 diabetes. Recent studies have shown that glycogen synthase kinase 3 (GSK3) plays a central role in regulating this inflammation. There are, however, no studies on the role of GSK3 in pregnancies complicated by gestational diabetes mellitus (GDM). Thus, the aims of this study were (i) to determine whether GSK3 is increased in adipose tissue and skeletal muscle from women with GDM; and (ii) to investigate the effect of GSK3 inhibition on inflammation in the presence of inflammation induced by bacterial endotoxin lipopolysaccharide (LPS) or the pro-inflammatory cytokine IL-1 beta. Human omental adipose tissue and skeletal muscle were obtained from normal glucose tolerant (NGT) women and BMI-matched women with diet-control GDM at the time of Caesarean section. Western blotting was performed to determine GSK3 protein expression. Tissue explants were performed to determine the effect of the GSK3 inhibitor CHIR99021 on markers of inflammation. When compared to women with NGT, omental adipose tissue and skeletal muscle obtained from women with diet-controlled GDM had significantly higher GSK3 beta activity as evidenced by a decrease in the expression of GSK3 beta phosphorylated at serine 9. The GSK3 inhibitor CHIR99021 significantly reduced the gene expression and secretion of the pro-inflammatory cytokines TNF-alpha, IL-1 beta and IL-6; the pro-inflammatory chemokines IL-8 and MCP-1; and the adhesion molecules ICAM-1 and VCAM-1 in tissues stimulated with LPS or IL-1 beta. In conclusion, GSK3 activity is increased in GDM adipose tissue and skeletal muscle and regulates infection- and inflammation-induced pro-inflammatory mediators.	[Lappas, Martha] Univ Melbourne, Dept Obstet & Gynaecol, Obstet Nutr & Endocrinol Grp, Melbourne, Vic 3010, Australia; [Lappas, Martha] Mercy Hosp Women, Mercy Perinatal Res Ctr, Heidelberg, Vic, Australia	University of Melbourne	Lappas, M (corresponding author), Univ Melbourne, Dept Obstet & Gynaecol, Obstet Nutr & Endocrinol Grp, Melbourne, Vic 3010, Australia.	mlappas@unimelb.edu.au	Sánchez-Margalet, Victor/AAB-9986-2021	Sánchez-Margalet, Victor/0000-0001-8638-8680	National Health and Medical Research Council (NHMRC) [1047025]; Medical Research Foundation for Women and Babies	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Foundation for Women and Babies	Associate Professor Martha Lappas was a recipient of a Career Development Fellowship from National Health and Medical Research Council (NHMRC; grant no. 1047025). The work described in this manuscript was funded by the Medical Research Foundation for Women and Babies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agwunobi AO, 2000, J CLIN ENDOCR METAB, V85, P3770, DOI 10.1210/jc.85.10.3770; Ategbo JM, 2006, J CLIN ENDOCR METAB, V91, P4137, DOI 10.1210/jc.2006-0980; Aye ILMH, 2013, MOL CELL ENDOCRINOL, V381, P46, DOI 10.1016/j.mce.2013.07.013; Baarsma HA, 2011, AM J PHYSIOL-LUNG C, V300, pL910, DOI 10.1152/ajplung.00232.2010; Balamurugan K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2677; Bari MF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101327; Barker G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042943; Basu S, 2011, OBESITY, V19, P476, DOI 10.1038/oby.2010.215; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Catalano PM, 1999, AM J OBSTET GYNECOL, V180, P903, DOI 10.1016/S0002-9378(99)70662-9; Catalano PM, 2003, AM J OBSTET GYNECOL, V189, P1698, DOI 10.1016/S0002-9378(03)00828-7; Catalano PM, 2003, J NUTR, V133, p1674S, DOI 10.1093/jn/133.5.1674S; Catalano PM, 2002, AM J PHYSIOL-ENDOC M, V282, pE522, DOI 10.1152/ajpendo.00124.2001; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Cline GW, 2002, DIABETES, V51, P2903, DOI 10.2337/diabetes.51.10.2903; Colomiere M, 2010, J MOL ENDOCRINOL, V44, P213, DOI 10.1677/JME-09-0091; Cortes-Vieyra R, 2012, J INFLAMM-LOND, V9, DOI 10.1186/1476-9255-9-23; Creely SJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE740, DOI 10.1152/ajpendo.00302.2006; Dabelea D, 2000, DIABETES, V49, P2208, DOI 10.2337/diabetes.49.12.2208; Ding SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012191; Dugo L, 2006, SHOCK, V25, P485, DOI 10.1097/01.shk.0000209545.29671.31; Eldar-Finkelman H, 1999, DIABETES, V48, P1662, DOI 10.2337/diabetes.48.8.1662; Ferrara A, 2007, DIABETES CARE, V30, pS141, DOI 10.2337/dc07-s206; Green HF, 2012, NEUROCHEM INT, V61, P666, DOI 10.1016/j.neuint.2012.07.003; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Hu XY, 2006, IMMUNITY, V24, P563, DOI 10.1016/j.immuni.2006.02.014; Jones HN, 2009, AM J PHYSIOL-CELL PH, V297, pC1228, DOI 10.1152/ajpcell.00195.2009; Jope RS, 2007, NEUROCHEM RES, V32, P577, DOI 10.1007/s11064-006-9128-5; Kacimi R, 1998, CIRC RES, V82, P576, DOI 10.1161/01.RES.82.5.576; Kautzky-Willer A, 1997, J CLIN ENDOCR METAB, V82, P4117, DOI 10.1210/jc.82.12.4117; Kim SJ, 2014, TOXICOLOGY, V320, P74, DOI 10.1016/j.tox.2014.01.013; Kirwan JP, 2002, DIABETES, V51, P2207, DOI 10.2337/diabetes.51.7.2207; Klein K, 2008, PRENATAL DIAG, V28, P845, DOI 10.1002/pd.2064; Krauss T, 2002, CLIN CHEM, V48, P1418; Kuzmicki M, 2009, GYNECOL ENDOCRINOL, V25, P258, DOI 10.1080/09513590802653825; Lager S, 2011, PLACENTA, V32, P121, DOI 10.1016/j.placenta.2010.10.012; Lain KY, 2007, CLIN OBSTET GYNECOL, V50, P938, DOI 10.1097/GRF.0b013e31815a5494; Lappas M, 2005, J ENDOCRINOL, V186, P457, DOI 10.1677/joe.1.06227; Lappas M, 2005, ENDOCRINOLOGY, V146, P1491, DOI 10.1210/en.2004-0809; Lappas M, 2004, J CLIN ENDOCR METAB, V89, P5627, DOI 10.1210/jc.2003-032097; Lappas M, 2005, ENDOCRINOLOGY, V146, P3334, DOI 10.1210/en.2005-0406; Lappas M, 2014, J ENDOCRINOL, V222, P99, DOI 10.1530/JOE-14-0179; Lappas M, 2014, METABOLISM, V63, P860, DOI 10.1016/j.metabol.2014.03.007; Lappas M, 2014, METABOLISM, V63, P250, DOI 10.1016/j.metabol.2013.10.001; Lappas M, 2014, MOL CELL ENDOCRINOL, V382, P74, DOI 10.1016/j.mce.2013.09.011; Lassenius MI, 2011, DIABETES CARE, V34, P1809, DOI 10.2337/dc10-2197; Lee AJ, 2007, DIABETES CARE, V30, P878, DOI 10.2337/dc06-1816; Leinonen E, 2003, ATHEROSCLEROSIS, V166, P387, DOI 10.1016/S0021-9150(02)00371-4; Manco M, 2010, ENDOCR REV, V31, P817, DOI 10.1210/er.2009-0030; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Metzger BE, 2007, CLIN OBSTET GYNECOL, V50, P972, DOI 10.1097/GRF.0b013e31815a61d6; Mordwinkin NM, 2013, J MATERN-FETAL NEO M, V26, P507, DOI 10.3109/14767058.2012.736564; Nikoulina SE, 2000, DIABETES, V49, P263, DOI 10.2337/diabetes.49.2.263; Patel S, 2009, PHARMACOL REP, V61, P595, DOI 10.1016/S1734-1140(09)70111-2; Radaelli T, 2006, J SOC GYNECOL INVEST, V13, P53, DOI 10.1016/j.jsgi.2005.10.003; Radaelli T, 2003, DIABETES, V52, P2951, DOI 10.2337/diabetes.52.12.2951; Ramirez SH, 2010, AM J PATHOL, V176, P881, DOI 10.2353/ajpath.2010.090671; Rayasam GV, 2009, BRIT J PHARMACOL, V156, P885, DOI 10.1111/j.1476-5381.2008.00085.x; Retnakaran R, 2003, J CLIN ENDOCR METAB, V88, P3507, DOI 10.1210/jc.2003-030186; Reyna SM, 2008, DIABETES, V57, P2595, DOI 10.2337/db08-0038; Ring DB, 2003, DIABETES, V52, P588, DOI 10.2337/diabetes.52.3.588; Rodionova E, 2007, BLOOD, V109, P1584, DOI 10.1182/blood-2006-06-028951; Sell H, 2006, ENDOCRINOLOGY, V147, P2458, DOI 10.1210/en.2005-0969; Vitoratos N, 2008, HORM-INT J ENDOCRINO, V7, P230, DOI 10.14310/horm.2002.1202; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Xiong X, 2006, AM J OBSTET GYNECOL, V195, P1086, DOI 10.1016/j.ajog.2006.06.035; Xiong X, 2009, J PERIODONTOL, V80, P1742, DOI 10.1902/jop.2009.090250	68	40	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115854	10.1371/journal.pone.0115854	http://dx.doi.org/10.1371/journal.pone.0115854			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541965	Green Published, gold			2022-12-27	WOS:000347239900098
J	McGuyer, B				McGuyer, Bart			Paul Drude's Prediction of Nonreciprocal Mutual Inductance for Tesla Transformers	PLOS ONE			English	Article							DISTRIBUTED CAPACITY; SELF-INDUCTION; COILS; CIRCUIT; CONSTRUCTION; OSCILLATION; M12=M21; PERIOD; LINE	Inductors, transmission lines, and Tesla transformers have been modeled with lumped-element equivalent circuits for over a century. In a well-known paper from 1904, Paul Drude predicts that the mutual inductance for an unloaded Tesla transformer should be nonreciprocal. This historical curiosity is mostly forgotten today, perhaps because it appears incorrect. However, Drude's prediction is shown to be correct for the conditions treated, demonstrating the importance of constraints in deriving equivalent circuits for distributed systems. The predicted nonreciprocity is not fundamental, but instead is an artifact of the misrepresentation of energy by an equivalent circuit. The application to modern equivalent circuits is discussed.	Columbia Univ, Dept Phys, New York, NY 10027 USA	Columbia University	McGuyer, B (corresponding author), Columbia Univ, Dept Phys, 538 W 120th St, New York, NY 10027 USA.	bmcguyer@columbia.edu						Breit G, 1921, PHYS REV, V17, P649, DOI 10.1103/PhysRev.17.649; Carson JR, 1924, BELL SYST TECH J, V3, P393, DOI 10.1002/j.1538-7305.1924.tb00009.x; Christopoulos C., 1995, TRANSMISSION LINE MO; Collin R.E., 2001, FDN MICROWAVE ENG; COUFFIGNAL P, 1992, IEE PROC-H, V139, P221, DOI 10.1049/ip-h-2.1992.0041; CRAWFORD FS, 1992, AM J PHYS, V60, P186, DOI 10.1119/1.16941; Denicolai M, 2002, REV SCI INSTRUM, V73, P3332, DOI 10.1063/1.1498905; Drude P, 1904, ANN PHYS-BERLIN, V13, P512; Drude P, 1905, ANN PHYS-BERLIN, V16, P116; Drude P, 1902, ANN PHYS-BERLIN, V9, P590; Drude P, 1902, ANN PHYS-BERLIN, V9, P293; Fleming J.A., 1919, PRINCIPLES ELECT WAV, V4th; Gedney S.D., 2011, INTRO FDTD METHOD EL; HASKAL H, 1964, IEEE T MICROW THEORY, VMT12, P184, DOI 10.1109/TMTT.1964.1125782; Hoffmann D, 2006, ANN PHYS-BERLIN, V15, P449, DOI 10.1002/andp.200610210; Howe G. W. O., 1911, P PHYS SOC LOND, V24, P251, DOI 10.1088/1478-7814/24/1/339; Hubbard JC, 1917, PHYS REV, V9, P529, DOI 10.1103/PhysRev.9.529; Hund A, 1951, HIGH FREQUENCY MEASU; Jackson J.D., 1999, CLASSICAL ELECTRODYN; Lee T. H., 2004, PLANAR MICROWAVE ENG; LIN PM, 1989, IEEE T CIRCUITS SYST, V36, P1153, DOI 10.1109/31.34660; Mariantoni M, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.104508; MARKS RB, 1992, J RES NATL INST STAN, V97, P533, DOI 10.6028/jres.097.024; Medhurst R.G., 1947, WIRELESS ENG, V24, P80; Medhurst RGHF, 1947, WIRELESS ENG, V24, P35; Miller JM, 1919, P IRE, V7, P299, DOI 10.1109/JRPROC.1919.217442; Montgomery C. G., 1948, PRINCIPLES MICROWAVE; Nahin PJ, 2001, SCI RADIO; Naidu MS., 1995, HIGH VOLTAGE ENG; Paul Nicholson and the Tesla Secondary Simulation Project Collaboration, 2000, THEORY NOTES SECONDA; Potton RJ, 2004, REP PROG PHYS, V67, P717, DOI 10.1088/0034-4885/67/5/R03; Ramo S., 1994, FIELDS WAVES COMMUNI, Vthird; Reed JL, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4732811; Rhea R, 2000, APPL MICROW WIREL, V12, P30; Sederberg AJ, 2013, ARXIV13031588; SENSIPER S, 1955, P IRE, V43, P149, DOI 10.1109/JRPROC.1955.278072; Skeldon KD, 1997, AM J PHYS, V65, P744, DOI 10.1119/1.18645; Terman F, 1943, RADIO ENG HDB; Till BC, 2014, EUR J PHYS, V35, DOI 10.1088/0143-0807/35/1/015007; Wang D, 2012, AM J PHYS, V80, P840, DOI 10.1119/1.4736978; Welsby V G, 1960, THEORY DESIGN INDUCT	41	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115397	10.1371/journal.pone.0115397	http://dx.doi.org/10.1371/journal.pone.0115397			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542040	gold, Green Published, Green Submitted			2022-12-27	WOS:000347239900039
J	Schablon, A; Nienhaus, A; Ringshausen, FC; Preisser, AM; Peters, C				Schablon, Anja; Nienhaus, Albert; Ringshausen, Felix C.; Preisser, Alexandra M.; Peters, Claudia			Occupational Screening for Tuberculosis and the Use of a Borderline Zone for Interpretation of the IGRA in German Healthcare Workers	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; WITHIN-SUBJECT VARIABILITY; LATENT TUBERCULOSIS; SKIN-TEST; TB INFECTION; RISK-FACTORS; PREVALENCE; CONVERSIONS; CHALLENGES; STUDENTS	Introduction: Healthcare workers (HCWs) in low incidence countries with contact to patients with tuberculosis (TB) are considered a high-risk group for latent TB infection (LTBI) and therefore are routinely screened for LTBI. The German Occupational TB Network data is analyzed in order to estimate the prevalence and incidence of LTBI and to evaluate putative risk factors for a positive IGRA and the performance of IGRA in serial testing. Methods: 3,823 HCWs were screened with the Quantiferon Gold in Tube (QFT) at least once; a second QFT was performed on 817 HCWs either in the course of contact tracing or serial examination. Risk factors for a positive QFT were assessed by a questionnaire. Results: We observed a prevalence of LTBI of 8.3%. Putative risk factors for a positive QFT result were age >55 years (OR 6.89), foreign country of birth (OR 2.39), personal history of TB (OR 6.23) and workplace, e.g. internal medicine (OR 1.40), infection ward (OR 1.8) or geriatric care (OR 1.8). Of those repeatedly tested, 88.2% (721/817) tested consistently QFT-negative and 47 were consistently QFT-positive (5.8%). A conversion was observed in 2.8% (n=21 of 742 with a negative first QFT) and a reversion occurred in 37.3% (n=28 of 75 with a positive first QFT). Defining a conversion as an increase of the specific interferon concentration from <0.2 to >0.7 IU/ml, the conversion rate decreased to 1.2% (n=8). Analogous to this, the reversion rate decreased to 18.8% (n=9). Discussion: In countries with a low incidence of TB and high hygiene standards, the LTBI infection risk for HCWs seems low. Introducing a borderline zone from 0.2 to <= 0.7 IU/ml may help to avoid unnecessary X-rays and preventive chemotherapy. No case of active TB was detected. Therefore, it might be reasonable to further restrict TB screening to HCWs who had unprotected contact with infectious patients or materials.	[Schablon, Anja; Nienhaus, Albert; Peters, Claudia] Univ Med Ctr Hamburg Eppendorf UKE, Ctr Excellence Hlth Serv Res Nursing CVcare, Hamburg, Germany; [Nienhaus, Albert] Inst Statutory Accid Insurance & Prevent Hlth & W, Principles Prevent & Rehabil Dept GPR, Hamburg, Germany; [Ringshausen, Felix C.] Hannover Med Sch, Dept Resp Med, Hannover, NH, Germany; [Preisser, Alexandra M.] Univ Med Ctr Hamburg Eppendorf UKE, Inst Occupat & Maritime Med, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Hannover Medical School; University of Hamburg; University Medical Center Hamburg-Eppendorf	Nienhaus, A (corresponding author), Univ Med Ctr Hamburg Eppendorf UKE, Ctr Excellence Hlth Serv Res Nursing CVcare, Hamburg, Germany.	a.nienhaus@uke.de	Ringshausen, Felix C./AAA-9154-2021	Ringshausen, Felix C./0000-0001-9084-4968	Institution for Statutory Accident Insurance and Prevention in the Health and Welfare services (BGW) on an annual basis to maintain the working group at the UKE; social security system in Germany	Institution for Statutory Accident Insurance and Prevention in the Health and Welfare services (BGW) on an annual basis to maintain the working group at the UKE; social security system in Germany	Funding: No special funds were received for this study. However, the Institute for Health Services Research in Dermatology and Nursing of the University Medical Centre Hamburg-Eppendorf (UKE) receives an unrestricted fund from the Institution for Statutory Accident Insurance and Prevention in the Health and Welfare services (BGW) on an annual basis to maintain the working group at the UKE. The funds are provided by a non-profit organization that is part of the social security system in Germany. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baussano I, 2011, EMERG INFECT DIS, V17, P488, DOI 10.3201/eid1703.100947; Brodhun B, 2012, RKI BERICHT EPIDEMIO; Costa JT, 2009, EUR RESPIR J, V34, P1423, DOI 10.1183/09031936.00053809; Costa JT, 2011, J OCCUP MED TOXICOL, V6, DOI 10.1186/1745-6673-6-19; Diel R, 2002, J CLIN MICROBIOL, V40, P532, DOI 10.1128/JCM.40.2.532-539.2002; Diel R, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-35; Diel R, 2012, CHEST, V142, P63, DOI 10.1378/chest.11-3157; Dorman SE, 2014, AM J RESP CRIT CARE, V189, P77, DOI 10.1164/rccm.201302-0365OC; Durando P, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-443; Fong KS, 2012, CHEST, V142, P55, DOI 10.1378/chest.11-0992; Franchi A, 2007, INT ARCH OCC ENV HEA, V80, P533, DOI 10.1007/s00420-006-0160-1; Gran G, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-353; Jensen Paul A., 2005, Morbidity and Mortality Weekly Report, V54, P1; Joshi M, 2012, CAN RESPIR J, V19, P84, DOI 10.1155/2012/576324; Lamberti M, 2014, J OCCUP MED TOXICOL, V9, DOI 10.1186/s12995-014-0034-5; Menzies D, 2007, INT J TUBERC LUNG D, V11, P593; Moucaut A, 2013, J OCCUP MED TOXICOL, V8, DOI 10.1186/1745-6673-8-12; Nienhaus A, 2007, Pneumologie, V61, P219, DOI 10.1055/s-2007-959161; Nienhaus A, 2011, Pneumologie, V65, P726, DOI 10.1055/s-0031-1291392; Nienhaus A, 2013, J OCCUP MED TOXICOL, V8, DOI 10.1186/1745-6673-8-1; Nienhaus A, 2013, EXPERT REV ANTI-INFE, V11, P37, DOI [10.1586/ERI.12.150, 10.1586/eri.12.150]; Nienhaus A, 2012, J OCCUP MED TOXICOL, V7, DOI 10.1186/1745-6673-7-8; Pai M, 2009, INT J TUBERC LUNG D, V13, P84; Pai M, 2013, CAN J RESPIR CRIT CA, P1; Pai M, 2013, OCCUP MED-OXFORD, V63, P458, DOI 10.1093/occmed/kqt105; Rafiza S, 2012, INT J TUBERC LUNG D, V16, P163, DOI 10.5588/ijtld.11.0364; Ringshausen FC, 2012, J OCCUP MED TOXICOL, V7, DOI 10.1186/1745-6673-7-6; Ringshausen FC, 2011, CLIN VACCINE IMMUNOL, V18, P1176, DOI 10.1128/CVI.05058-11; Ringshausen Felix C, 2009, J Occup Med Toxicol, V4, P11, DOI 10.1186/1745-6673-4-11; Schablon A, 2010, GMS HYG INFECT CONTR, V5; Schablon A, 2013, GMS HYG INFECT CONTR, V8, DOI 10.3205/dgkh000217; Schablon A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-107; Seidler A, 2005, RESPIRATION, V72, P431, DOI 10.1159/000086261; Slater ML, 2013, AM J RESP CRIT CARE, V188, P1005, DOI 10.1164/rccm.201305-0831OC; Soborg B, 2007, SCAND J INFECT DIS, V39, P554, DOI 10.1080/00365540601148483; Tagmouti S, 2014, ANN AM THORAC SOC, V4; Thanassi W, 2012, PULM MED, V2012, DOI 10.1155/2012/291294; van Zyl-Smit RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008517; Zwerling A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054748; Zwerling A, 2012, THORAX, V67, P62, DOI 10.1136/thx.2010.143180	40	42	42	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115322	10.1371/journal.pone.0115322	http://dx.doi.org/10.1371/journal.pone.0115322			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541947	Green Published, gold, Green Submitted			2022-12-27	WOS:000347239900035
J	Wittmann, BM; Stirdivant, SM; Mitchell, MW; Wulff, JE; McDunn, JE; Li, Z; Dennis-Barrie, A; Neri, BP; Milburn, MV; Lotan, Y; Wolfert, RL				Wittmann, Bryan M.; Stirdivant, Steven M.; Mitchell, Matthew W.; Wulff, Jacob E.; McDunn, Jonathan E.; Li, Zhen; Dennis-Barrie, Aphrihl; Neri, Bruce P.; Milburn, Michael V.; Lotan, Yair; Wolfert, Robert L.			Bladder Cancer Biomarker Discovery Using Global Metabolomic Profiling of Urine	PLOS ONE			English	Article							ISOCITRATE DEHYDROGENASE MUTATIONS; INVASIVE UROTHELIAL CARCINOMA; EAU GUIDELINES; MANAGEMENT; IDENTIFICATION; DIAGNOSIS; SARCOSINE	Bladder cancer (BCa) is a common malignancy worldwide and has a high probability of recurrence after initial diagnosis and treatment. As a result, recurrent surveillance, primarily involving repeated cystoscopies, is a critical component of post diagnosis patient management. Since cystoscopy is invasive, expensive and a possible deterrent to patient compliance with regular follow-up screening, new non-invasive technologies to aid in the detection of recurrent and/or primary bladder cancer are strongly needed. In this study, mass spectrometry based metabolomics was employed to identify biochemical signatures in human urine that differentiate bladder cancer from non-cancer controls. Over 1000 distinct compounds were measured including 587 named compounds of known chemical identity. Initial biomarker identification was conducted using a 332 subject sample set of retrospective urine samples (cohort 1), which included 66 BCa positive samples. A set of 25 candidate biomarkers was selected based on statistical significance, fold difference and metabolic pathway coverage. The 25 candidate biomarkers were tested against an independent urine sample set (cohort 2) using random forest analysis, with palmitoyl sphingomyelin, lactate, adenosine and succinate providing the strongest predictive power for differentiating cohort 2 cancer from non-cancer urines. Cohort 2 metabolite profiling revealed additional metabolites, including arachidonate, that were higher in cohort 2 cancer vs. non-cancer controls, but were below quantitation limits in the cohort 1 profiling. Metabolites related to lipid metabolism may be especially interesting biomarkers. The results suggest that urine metabolites may provide a much needed non-invasive adjunct diagnostic to cystoscopy for detection of bladder cancer and recurrent disease management.	[Wittmann, Bryan M.; Stirdivant, Steven M.; Mitchell, Matthew W.; Wulff, Jacob E.; McDunn, Jonathan E.; Li, Zhen; Neri, Bruce P.; Milburn, Michael V.; Wolfert, Robert L.] Metabolon Inc, Durham, NC 27713 USA; [Dennis-Barrie, Aphrihl; Lotan, Yair] Univ Texas SW Med Ctr Dallas, Dept Urol, Dallas, TX 75390 USA	Metabolon; University of Texas System; University of Texas Southwestern Medical Center Dallas	Wittmann, BM (corresponding author), Metabolon Inc, Durham, NC 27713 USA.	bwittmann@metabolon.com		Mitchell, Matthew/0000-0002-2681-4091	 [NIH 1R01-CA151489-01];  [NIH/NCRR 5 UL1 RR24982-02]; NATIONAL CANCER INSTITUTE [R01CA151489] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024982] Funding Source: NIH RePORTER	; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding for sample collection and annotation was supported by grants NIH 1R01-CA151489-01 (Bogdan Czerniak PI), and NIH/NCRR 5 UL1 RR24982-02 (YL co-investigator). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Metabolon acquired samples on fee per sample basis.	Babjuk M, 2013, EUR UROL, V64, P639, DOI 10.1016/j.eururo.2013.06.003; Babjuk M, 2011, EUR UROL, V59, P997, DOI 10.1016/j.eururo.2011.03.017; Botteman MF, 2003, PHARMACOECONOMICS, V21, P1315, DOI 10.1007/BF03262330; Brausi M, 2011, J UROLOGY, V186, P2158, DOI 10.1016/j.juro.2011.07.076; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cairns RA, 2013, CANCER DISCOV, V3, P730, DOI 10.1158/2159-8290.CD-13-0083; Chamie K, 2011, CANCER-AM CANCER SOC, V117, P5392, DOI 10.1002/cncr.26198; Chatterjee S, 1999, J BIOL CHEM, V274, P37407, DOI 10.1074/jbc.274.52.37407; Chen TL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004945; DAVIES P, 1984, ANNU REV IMMUNOL, V2, P335, DOI 10.1146/annurev.immunol.2.1.335; DiNardo CD, 2013, BLOOD, V121, P4917, DOI 10.1182/blood-2013-03-493197; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Ganti S, 2012, CANCER RES, V72, P3471, DOI 10.1158/0008-5472.CAN-11-3105; Ganti S, 2011, UROL ONCOL-SEMIN ORI, V29, P551, DOI 10.1016/j.urolonc.2011.05.013; Gaston KE, 2004, UROLOGY, V63, P1009, DOI 10.1016/j.urology.2003.12.004; Gazzaniga P, 2012, ANN ONCOL, V23, P2352, DOI 10.1093/annonc/mdr619; Hall MC, 2007, J UROLOGY, V178, P2314, DOI 10.1016/j.juro.2007.09.003; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Holecek M, 2002, NUTRITION, V18, P130, DOI 10.1016/S0899-9007(01)00767-5; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Huang ZZ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.007922; Issaq HJ, 2008, J UROLOGY, V179, P2422, DOI 10.1016/j.juro.2008.01.084; Kaelin WG, 2010, NATURE, V465, P562, DOI 10.1038/465562a; Khan AP, 2013, NEOPLASIA, V15, P491, DOI 10.1593/neo.13314; Kim K, 2011, OMICS, V15, P293, DOI 10.1089/omi.2010.0094; LANDAAS S, 1975, SCAND J CLIN LAB INV, V35, P259, DOI 10.3109/00365517509095738; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; LINARDIC CM, 1994, J BIOL CHEM, V269, P23530; Mazurek S, 2011, INT J BIOCHEM CELL B, V43, P969, DOI 10.1016/j.biocel.2010.02.005; McDunn JE, 2013, PROSTATE, V73, P1547, DOI 10.1002/pros.22704; Milburn MV, 2012, GENETICS MEETS METAB, P177; MITCHELL GA, 1995, CLIN INVEST MED, V18, P193; Pasikanti KK, 2010, J PROTEOME RES, V9, P2988, DOI 10.1021/pr901173v; Putluri N, 2011, CANCER RES, V71, P7376, DOI 10.1158/0008-5472.CAN-11-1154; R Core Team, 2021, R LANGUAGE ENV STAT; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Scher H, 1998, ONCOLOGY-NY, V12, P225; Schroeder MA, 2012, CIRC-CARDIOVASC IMAG, V5, P201, DOI 10.1161/CIRCIMAGING.111.969451; Sengupta S, 2006, UROLOGY, V67, P48, DOI 10.1016/j.urology.2006.01.041; Shore ND, 2012, RES REP UROL, V4, P49, DOI 10.2147/RRU.S36006; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Srivastava S, 2010, CANCER BIOMARK, V6, P11, DOI 10.3233/CBM-2009-0115; Tonjes M, 2013, NAT MED, V19, P901, DOI 10.1038/nm.3217; van der Poel H G, 2001, Curr Opin Urol, V11, P503, DOI 10.1097/00042307-200109000-00009; van Rhijn BWG, 2009, EUR UROL, V56, P430, DOI 10.1016/j.eururo.2009.06.028; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365	47	73	74	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115870	10.1371/journal.pone.0115870	http://dx.doi.org/10.1371/journal.pone.0115870			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541698	Green Published, Green Submitted, gold			2022-12-27	WOS:000347239900100
J	Broekman, BFP; Wang, CQ; Li, Y; Rifkin-Graboi, A; Saw, SM; Chong, YS; Kwek, K; Gluckman, PD; Fortier, MV; Meaney, MJ; Qiu, AQ				Broekman, Birit F. P.; Wang, Changqing; Li, Yue; Rifkin-Graboi, Anne; Saw, Seang Mei; Chong, Yap-Seng; Kwek, Kenneth; Gluckman, Peter D.; Fortier, Marielle V.; Meaney, Michael J.; Qiu, Anqi		GUSTO Study Grp	Gestational Age and Neonatal Brain Microstructure in Term Born Infants: A Birth Cohort Study	PLOS ONE			English	Article							WHITE-MATTER DEVELOPMENT; HUMAN FETAL-BRAIN; DIFFUSION-TENSOR; CORPUS-CALLOSUM; PRETERM INFANTS; INTERNAL CAPSULE; EQUIVALENT AGE; MRI; ABNORMALITIES; TRACTOGRAPHY	Objective: Understanding healthy brain development in utero is crucial in order to detect abnormal developmental trajectories due to developmental disorders. However, in most studies neuroimaging was done after a significant postnatal period, and in those studies that performed neuroimaging on fetuses, the quality of data has been affected due to complications of scanning during pregnancy. To understand healthy brain development between 37-41 weeks of gestational age, our study assessed the in utero growth of the brain in healthy term born babies with DTI scanning soon after birth. Methods: A cohort of 93 infants recruited from maternity hospitals in Singapore underwent diffusion tensor imaging between 5 to 17 days after birth. We did a cross-sectional examination of white matter microstructure of the brain among healthy term infants as a function of gestational age via voxel-based analysis on fractional anisotropy. Results: Greater gestational age at birth in term infants was associated with larger fractional anisotropy values in early developing brain regions, when corrected for age at scan. Specifically, it was associated with a cluster located at the corpus callosum (corrected p<0.001), as well as another cluster spanning areas of the anterior corona radiata, anterior limb of internal capsule, and external capsule (corrected p<0.001). Conclusions: Our findings show variation in brain maturation associated with gestational age amongst 'term' infants, with increased brain maturation when born with a relatively higher gestational age in comparison to those infants born with a relatively younger gestational age. Future studies should explore if these differences in brain maturation between 37 and 41 weeks of gestational age will persist over time due to development outside the womb.	[Broekman, Birit F. P.] Natl Univ Hlth Syst, Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Psychol Med, Singapore, Singapore; [Wang, Changqing; Li, Yue; Qiu, Anqi] Natl Univ Singapore, Dept Biomed Engn, Singapore 117548, Singapore; [Broekman, Birit F. P.; Rifkin-Graboi, Anne; Gluckman, Peter D.; Meaney, Michael J.; Qiu, Anqi] Agcy Sci Technol & Res, Singapore Inst Clin Sci, Singapore, Singapore; [Saw, Seang Mei] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Chong, Yap-Seng] Natl Univ Hlth Syst, Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Obstet & Gynaecol, Singapore, Singapore; [Kwek, Kenneth] KK Womens & Childrens Hosp, Dept Maternal Fetal Med, Singapore, Singapore; [Gluckman, Peter D.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; [Fortier, Marielle V.] KK Womens & Childrens Hosp, Dept Diagnost & Intervent Imaging, Singapore, Singapore; [Meaney, Michael J.] McGill Univ, Dept Psychiat & Neurol, Montreal, PQ, Canada; [Meaney, Michael J.] McGill Univ, Dept Neurosurg, Montreal, PQ H3A 2T5, Canada; [Qiu, Anqi] Natl Univ Singapore, Clin Imaging Res Ctr, Singapore 117548, Singapore	National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); National University of Singapore; National University of Singapore; KK Women's & Children's Hospital; University of Auckland; KK Women's & Children's Hospital; McGill University; McGill University; National University of Singapore	Qiu, AQ (corresponding author), Natl Univ Singapore, Dept Biomed Engn, Singapore 117548, Singapore.	bieqa@nus.edu.sg	Lee, Yung Seng/F-2169-2014; Chew, Fook Tim/E-7259-2010; Rifkin-Graboi, Anne/AFM-0959-2022; Henry, Christiani Jeyakumar/AHB-2632-2022; Rifkin-Graboi, Anne/AAH-3658-2022; Qiu, Anqi/H-2267-2011; Meaney, Michael/N-5931-2019; Inskip, Hazel/L-5467-2018; Venkatesh, Sudhakar/T-9385-2019; Hsu, Chin-ying/E-7855-2016	Lee, Yung Seng/0000-0002-1253-0557; Chew, Fook Tim/0000-0003-1337-5146; Henry, Christiani Jeyakumar/0000-0002-1602-0140; Qiu, Anqi/0000-0002-0215-6338; Inskip, Hazel/0000-0001-8897-1749; TINT, Mya Thway/0000-0002-9548-7186; Godfrey, Keith/0000-0002-4643-0618; Richmond, Jenny/0000-0002-5808-4249; BISWAS, ARIJIT/0000-0002-3311-2135; Rifkin-Graboi, Anne/0000-0002-7641-4678; Ferguson-Smith, Anne/0000-0002-7608-5894; Venkatesh, Sudhakar/0000-0002-7514-1030; Morton, Susan/0000-0002-2231-7020; Tan, Kok Hian/0000-0003-1945-0266; Yap, Fabian/0000-0003-1083-7958; Amutha, Chinnaiah/0000-0003-1395-2089; Shek, Lynette/0000-0001-9064-8983; Kapur, Jeevesh/0000-0002-5696-0233; Hsu, Chin-ying/0000-0001-7367-3204; Chong, Yap Seng/0000-0002-7232-8473; SOH, SHU E/0000-0002-0790-4200	National Medical Research Council (NMRC) [NMRC/TCR/004-NUS/2008, NMRC/CBRG/0039/2013]; Young Investigator Award at the National University of Singapore [NUSYIA FY10 P07]; National University of Singapore MOE AcRF Tier 1; Singapore Ministry of Education Academic Research Fund Tier 2 [MOE2012-T2-2-130]; MRC [MC_UU_12011/4] Funding Source: UKRI; Medical Research Council [MC_UU_12011/4] Funding Source: researchfish	National Medical Research Council (NMRC)(National Medical Research Council, Singapore); Young Investigator Award at the National University of Singapore(National University of Singapore); National University of Singapore MOE AcRF Tier 1(Ministry of Education, SingaporeNational University of Singapore); Singapore Ministry of Education Academic Research Fund Tier 2(Ministry of Education, Singapore); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study is supported by National Medical Research Council (NMRC; NMRC/TCR/004-NUS/2008, NMRC/CBRG/0039/2013), the Young Investigator Award at the National University of Singapore (NUSYIA FY10 P07), the National University of Singapore MOE AcRF Tier 1, and Singapore Ministry of Education Academic Research Fund Tier 2 (MOE2012-T2-2-130). The funding agencies did not play any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeby A, 2009, AM J NEURORADIOL, V30, P1780, DOI 10.3174/ajnr.A1660; Alderson RM, 2007, J ABNORM CHILD PSYCH, V35, P745, DOI 10.1007/s10802-007-9131-6; Bai J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047816; Berman JI, 2005, NEUROIMAGE, V27, P862, DOI 10.1016/j.neuroimage.2005.05.018; Bonifacio SL, 2010, J PEDIATR-US, V157, P726, DOI 10.1016/j.jpeds.2010.05.026; Bulas D, 2013, SEMIN PERINATOL, V37, P301, DOI 10.1053/j.semperi.2013.06.005; Caldu X, 2006, J CHILD NEUROL, V21, P406, DOI 10.1177/08830738060210050801; de Bruine FT, 2011, EUR RADIOL, V21, P538, DOI 10.1007/s00330-010-1945-x; Du J, 2011, NEUROIMAGE, V56, P162, DOI 10.1016/j.neuroimage.2011.01.067; Dubois J, 2014, NEUROSCIENCE, V276, P48, DOI 10.1016/j.neuroscience.2013.12.044; Dubois J, 2008, HUM BRAIN MAPP, V29, P14, DOI 10.1002/hbm.20363; Dudink J, 2007, PEDIATR RADIOL, V37, P1216, DOI 10.1007/s00247-007-0626-7; Eikenes L, 2011, NEUROIMAGE, V54, P1774, DOI 10.1016/j.neuroimage.2010.10.037; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Floresco SB, 1999, J NEUROSCI, V19, P11061, DOI 10.1523/JNEUROSCI.19-24-11061.1999; Gilmore JH, 2007, J NEUROSCI, V27, P1255, DOI 10.1523/JNEUROSCI.3339-06.2007; Griffiths PD, 2013, BRIT J RADIOL, V86, DOI 10.1259/bjr.20130168; Hasegawa T, 2011, PEDIATR RES, V69, P249, DOI 10.1203/PDR.0b013e3182084e54; Holland D, 2014, JAMA NEUROL; Hoon AH, 2009, DEV MED CHILD NEUROL, V51, P697, DOI 10.1111/j.1469-8749.2009.03306.x; Horsch S, 2007, ACTA PAEDIATR, V96, P979, DOI 10.1111/j.1651-2227.2007.00294.x; Huang H, 2006, NEUROIMAGE, V33, P27, DOI 10.1016/j.neuroimage.2006.06.009; Huang H, 2009, J NEUROSCI, V29, P4263, DOI 10.1523/JNEUROSCI.2769-08.2009; Jo HM, 2012, NEURORADIOLOGY, V54, P997, DOI 10.1007/s00234-012-1042-8; Joshi S, 2004, NEUROIMAGE, V23, pS151, DOI 10.1016/j.neuroimage.2004.07.068; Kasprian G, 2008, NEUROIMAGE, V43, P213, DOI 10.1016/j.neuroimage.2008.07.026; Kato S, 2011, J NEUROSCI, V31, P17169, DOI 10.1523/JNEUROSCI.4005-11.2011; Kaur S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085807; Kierans William J, 2008, BMC Pregnancy Childbirth, V8, P1, DOI 10.1186/1471-2393-8-1; Kostovic I, 2010, ACTA PAEDIATR, V99, P1119, DOI 10.1111/j.1651-2227.2010.01811.x; Krebs RM, 2012, CEREB CORTEX, V22, P607, DOI 10.1093/cercor/bhr134; Lepomaki V, 2012, PEDIATR RADIOL, V42, P692, DOI 10.1007/s00247-012-2352-z; Matthew APG, 2011, PLOS ONE, V6; Ment LR, 2009, LANCET NEUROL, V8, P1042, DOI 10.1016/S1474-4422(09)70257-1; Miao XL, 2014, INT J DEV NEUROSCI, V34, P42, DOI 10.1016/j.ijdevneu.2014.01.004; Nagy Z, 2009, PEDIATRICS, V124, pE964, DOI 10.1542/peds.2008-3801; Narberhaus A, 2007, J CHILD NEUROL, V22, P761, DOI 10.1177/0883073807304006; Nossin-Manor R, 2013, NEUROIMAGE, V64, P505, DOI 10.1016/j.neuroimage.2012.08.086; Oishi K, 2011, NEUROIMAGE, V56, P8, DOI 10.1016/j.neuroimage.2011.01.051; Partridge SC, 2004, NEUROIMAGE, V22, P1302, DOI 10.1016/j.neuroimage.2004.02.038; Perenyi A, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002499; Phua DYL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036502; Qiu AQ, 2013, NEUROIMAGE, V65, P315, DOI 10.1016/j.neuroimage.2012.09.032; Raisanen S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060660; Rose J, 2014, NEUROIMAGE, V86, P244, DOI 10.1016/j.neuroimage.2013.09.053; Rose J, 2009, DEV MED CHILD NEUROL, V51, P526, DOI 10.1111/j.1469-8749.2008.03231.x; Rose O, 2013, PEDIATRICS, V131, pE1475, DOI 10.1542/peds.2012-3215; Shim SY, 2012, NEONATOLOGY, V102, P309, DOI 10.1159/000341867; SHINOHARA T, 1977, APPL NEUROPHYSIOL, V39, P251; Skiold B, 2010, ACTA PAEDIATR, V99, P842, DOI 10.1111/j.1651-2227.2009.01634.x; Soh SE, 2013, INT J EPIDEMIOL; Soria-Pastor S, 2008, INT J DEV NEUROSCI, V26, P647, DOI 10.1016/j.ijdevneu.2008.08.001; Tang YC, 2010, NEUROIMAGE, V51, P33, DOI 10.1016/j.neuroimage.2010.01.111; Thomason ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094423; van den Berg G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037002; van Pul C, 2012, AM J NEURORADIOL, V33, P678, DOI 10.3174/ajnr.A2859; VANDERKNAAP MS, 1990, NEURORADIOLOGY, V31, P459, DOI 10.1007/BF00340123	57	22	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115229	10.1371/journal.pone.0115229	http://dx.doi.org/10.1371/journal.pone.0115229			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25535959	Green Submitted, Green Published, gold			2022-12-27	WOS:000348563300033
J	Hu, J; Li, M; Han, TX; Chen, JW; Ye, LX; Wang, Q; Zhou, YK				Hu, Jia; Li, Mei; Han, Tian-xu; Chen, Jian-wei; Ye, Lin-xiang; Wang, Qi; Zhou, Yi-kai			Benchmark Dose Estimation for Cadmium-Induced Renal Tubular Damage among Environmental Cadmium-Exposed Women Aged 35-54 Years in Two Counties of China	PLOS ONE			English	Article							URINARY CADMIUM; RESPONSE RELATIONSHIP; GENDER-DIFFERENCES; FOLLOW-UP; DYSFUNCTION; BIOMARKERS; TOXICITY; RISK; BETA(2)-MICROGLOBULINURIA; GLUCOSAMINIDASE	Background: A number of factors, including gender, age, smoking habits, and occupational exposure, affect the levels of urinary cadmium. Few studies have considered these influences when calculating the benchmark dose (BMD) of cadmium. In the present study, we aimed to calculate BMDs and their 95% lower confidence bounds (BMDLs) for cadmium-induced renal tubular effects in an age-specific population in south-central China. Methods: In this study, urinary cadmium, beta 2-microglobulin, and N-acetyl-beta-D-glucosaminidase levels were measured in morning urine samples from 490 randomly selected non-smoking women aged 35-54 years. Participants were selected using stratified cluster sampling in two counties (counties A and B) in China. Multiple regression and logistic regression analyses were used to investigate the dose-response relationship between urinary cadmium levels and tubular effects. BMDs/BMDLs corresponding to an additional risk (benchmark response) of 5% and 10% were calculated with assumed cut-off values of the 84th and 90th percentile of urinary beta 2-microglobulin and N-acetyl-beta-D-glucosaminidase levels of the controls. Results: Urinary levels of beta 2-microglobulin and N-acetyl-beta-D-glucosaminidase increased significantly with increasing levels of urinary cadmium. Age was not associated with urinary cadmium levels, possibly because of the narrow age range included in this study. Based on urinary beta 2-microglobulin and N-acetyl-beta-D-glucosaminidase, BMDs and BMDLs of urinary cadmium ranged from 2.08 to 3.80 (1.41-2.18) mu g/g cr for subjects in county A and from 0.99 to 3.34 (0.74-1.91) mu g/g cr for those in county B. The predetermined benchmark response of 0.05 and the 90th percentiles of urinary beta 2-microglobulin and N-acetyl-beta-D-glucosaminidase levels of the subjects not exposed to cadmium (i.e., the control group) served as cut-off values. Conclusions: The obtained BMDs of urinary cadmium were similar to the reference point of 1 mu g/g cr, as suggested by the European Food Safety Authority, indicating that cadmium exposure must be reduced to protect human health.	[Hu, Jia; Li, Mei; Han, Tian-xu; Chen, Jian-wei; Zhou, Yi-kai] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, MOE Key Lab Environm & Hlth,Inst Environm Med, Wuhan 430074, Peoples R China; [Ye, Lin-xiang; Wang, Qi] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Wang, Q (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China.	lwq95@126.com; zhouyk@mails.tjmu.edu.cn	Burdmann, Emmanuel/AAY-1966-2020; Burdmann, Emmanuel/B-7023-2009	Burdmann, Emmanuel/0000-0002-7644-8579; Hu, Jia/0000-0001-5779-257X	Special Fund for the Environmental Protection Research in the Public Interest [201109058]; National Natural Science Foundation of China [81102185]; Fundamental Research Funds for the Central Universities [2011QN202]	Special Fund for the Environmental Protection Research in the Public Interest; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The study was supported by the Special Fund for the Environmental Protection Research in the Public Interest (Grant no. of 201109058), the National Natural Science Foundation of China (Grant no. of 81102185), and the Fundamental Research Funds for the Central Universities (Grant no. of 2011QN202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson AA, 2005, ENVIRON HEALTH PERSP, V113, P1627, DOI 10.1289/ehp.8033; Bernard A, 2004, BIOMETALS, V17, P519, DOI 10.1023/B:BIOM.0000045731.75602.b9; BERNARD A, 1995, OCCUP ENVIRON MED, V52, P177, DOI 10.1136/oem.52.3.177; Bernard A, 2008, INDIAN J MED RES, V128, P557; Bernard A, 2008, J TOXICOL ENV HEAL A, V71, P1259, DOI 10.1080/15287390802211885; BONSNES RW, 1945, J BIOL CHEM, V158, P581; Cho YA, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0075087, 10.1371/journal.pone.0081560]; CRUMP KS, 1984, FUND APPL TOXICOL, V4, P854, DOI 10.1016/0272-0590(84)90107-6; Crump KS, 1995, USE BENCHMARK DOSE A; Filipsson AF, 2003, CRIT REV TOXICOL, V33, P505, DOI 10.1080/10408440390242360; Galazyn-Sidorczuk M, 2008, ENVIRON MONIT ASSESS, V137, P481, DOI 10.1007/s10661-007-9783-2; Gallagher CM, 2011, ENVIRON RES, V111, P702, DOI 10.1016/j.envres.2011.03.007; Gamo M, 2006, ENVIRON RES, V101, P104, DOI 10.1016/j.envres.2005.09.004; Hayano M, 1996, ARCH ENVIRON HEALTH, V51, P162, DOI 10.1080/00039896.1996.9936011; Hellstrom L, 2007, SCI TOTAL ENVIRON, V373, P447, DOI 10.1016/j.scitotenv.2006.11.028; Hong F, 2004, BIOMETALS, V17, P573, DOI 10.1023/B:BIOM.0000045741.22924.d8; Hotz P, 1999, LANCET, V354, P1508, DOI 10.1016/S0140-6736(99)91145-5; ISHIZAKI M, 1989, TOXICOLOGY, V58, P121, DOI 10.1016/0300-483X(89)90002-4; IWATA K, 1993, ARCH ENVIRON HEALTH, V48, P157, DOI 10.1080/00039896.1993.9940814; Jarup L, 2009, TOXICOL APPL PHARM, V238, P201, DOI 10.1016/j.taap.2009.04.020; Jarup Lars, 1998, Scandinavian Journal of Work Environment and Health, V24, P1; Jin TY, 2002, BIOMETALS, V15, P397, DOI 10.1023/A:1020229923095; Ju YR, 2012, J HAZARD MATER, V227, P353, DOI 10.1016/j.jhazmat.2012.05.060; Julin B, 2011, ENV HLTH, V10; KIDO T, 1988, ARCH ENVIRON HEALTH, V43, P213, DOI 10.1080/00039896.1988.9934935; Kippler M, 2007, TOXICOL APPL PHARM, V222, P221, DOI 10.1016/j.taap.2007.04.009; Kobayashi E, 2008, BIOL TRACE ELEM RES, V124, P164, DOI 10.1007/s12011-008-8125-8; Kobayashi E, 2006, J APPL TOXICOL, V26, P351, DOI 10.1002/jat.1147; Kobayashi E, 2006, ENVIRON RES, V101, P401, DOI 10.1016/j.envres.2005.12.002; Liang YH, 2012, ENVIRON HEALTH PERSP, V120, P223, DOI 10.1289/ehp.1103699; Moriguchi J, 2009, TOXICOL LETT, V190, P1, DOI 10.1016/j.toxlet.2009.05.009; MUELLER PW, 1989, NEPHRON, V52, P45, DOI 10.1159/000185581; Nishijo M, 2004, MOL CELL BIOCHEM, V255, P87, DOI 10.1023/B:MCBI.0000007264.37170.39; Olsson IM, 2002, ENVIRON HEALTH PERSP, V110, P1185, DOI 10.1289/ehp.021101185; Prozialeck WC, 2010, BIOMETALS, V23, P793, DOI 10.1007/s10534-010-9288-2; Satarug S, 2003, TOXICOL LETT, V137, P65, DOI 10.1016/S0378-4274(02)00381-8; Satarug S, 2004, ENVIRON HEALTH PERSP, V112, P1099, DOI 10.1289/ehp.6751; Satarug Soisungwan, 2011, Ciênc. saúde coletiva, V16, P2587, DOI 10.1590/S1413-81232011000500029; Shimizu A, 2006, INT J ENVIRON HEAL R, V16, P329, DOI 10.1080/09603120600869174; Suwazono Y, 2000, ENVIRON RES, V84, P44, DOI 10.1006/enrs.2000.4086; Suwazono Y, 2006, ENVIRON HEALTH PERSP, V114, P1072, DOI 10.1289/ehp.9028; Suwazono Y, 2010, TOXICOL LETT, V198, P40, DOI 10.1016/j.toxlet.2010.04.015; Trzcinka-Ochocka M, 2004, ENVIRON RES, V95, P143, DOI 10.1016/j.envres.2003.10.003; TUCKER SM, 1975, CLIN CHIM ACTA, V62, P333, DOI 10.1016/0009-8981(75)90245-4; Vahter M, 2007, ENVIRON RES, V104, P85, DOI 10.1016/j.envres.2006.08.003; Wang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087817; Yamanaka O, 1998, ENVIRON RES, V77, P1, DOI 10.1006/enrs.1998.3839	47	5	5	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115794	10.1371/journal.pone.0115794	http://dx.doi.org/10.1371/journal.pone.0115794			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536107	Green Published, Green Submitted, gold			2022-12-27	WOS:000348563300074
J	Kim, JE; Kim, UJ; Kim, HK; Cho, SK; An, JH; Kang, SJ; Park, KH; Jung, SI; Jang, HC				Kim, Ji Eun; Kim, Uh Jin; Kim, Hee Kyung; Cho, Soo Kyung; An, Joon Hwan; Kang, Seung-Ji; Park, Kyung-Hwa; Jung, Sook-In; Jang, Hee-Chang			Predictors of Viral Pneumonia in Patients with Community-Acquired Pneumonia	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; ANTIVIRAL THERAPY; INFLUENZA; ADULTS; ETIOLOGY; BACTERIAL; OUTCOMES; VIRUSES; CT	Background: Viruses are increasingly recognized as major causes of community-acquired pneumonia (CAP). Few studies have investigated the clinical predictors of viral pneumonia, and the results have been inconsistent. In this study, the clinical predictors of viral pneumonia were investigated in terms of their utility as indicators for viral pneumonia in patients with CAP. Methods: Adult patients (>= 18 years old) with CAP, tested by polymerase chain reaction (PCR) for respiratory virus, at two teaching hospitals between October 2010 and May 2013, were identified retrospectively. Demographic and clinical data were collected by reviewing the hospital electronic medical records. Results: During the study period, 456 patients with CAP were identified who met the definition, and 327 (72%) patients were tested using the respiratory virus PCR detection test. Viral pneumonia (n=60) was associated with rhinorrhea, a higher lymphocyte fraction in the white blood cells, lower serum creatinine and ground-glass opacity (GGO) in radiology results, compared to non-viral pneumonia (n=250) (p < 0.05, each). In a multivariate analysis, rhinorrhea (Odd ratio (OR) 3.52; 95% Confidence interval (CI), 1.58-7.87) and GGO (OR 4.68; 95% CI, 2.48-8.89) were revealed as independent risk factors for viral pneumonia in patients with CAP. The sensitivity, specificity, positive-and negative-predictive values (PPV and NPV) of rhinorrhea were 22, 91, 36 and 83%: the sensitivity, specificity, PPV and NPV of GGO were and 43, 84, 40 and 86%, respectively. Conclusion: Symptom of rhinorrhea and GGO predicted viral pneumonia in patients with CAP. The high specificity of rhinorrhea and GGO suggested that these could be useful indicators for empirical antiviral therapy.	[Kim, Ji Eun; Kim, Uh Jin; Kim, Hee Kyung; Cho, Soo Kyung; An, Joon Hwan; Kang, Seung-Ji; Park, Kyung-Hwa; Jung, Sook-In; Jang, Hee-Chang] Chonnam Natl Univ, Sch Med, Dept Internal Med, Kwangju, South Korea	Chonnam National University	Jang, HC (corresponding author), Chonnam Natl Univ, Sch Med, Dept Internal Med, Kwangju, South Korea.	haroc153@naver.com		Kang, Seung ji/0000-0002-3298-0520; Jang, Hee-Chang/0000-0002-3407-8493				Albrich WC, 2012, ARCH INTERN MED, V172, P715, DOI 10.1001/archinternmed.2012.770; An Joon Hwan, 2013, Chonnam Med J, V49, P96, DOI 10.4068/cmj.2013.49.2.96; Cesario TC, 2012, CLIN INFECT DIS, V55, P107, DOI 10.1093/cid/cis297; Choi SH, 2012, AM J RESP CRIT CARE, V186, P325, DOI 10.1164/rccm.201112-2240OC; File TM, 2003, LANCET, V362, P1991, DOI 10.1016/S0140-6736(03)15021-0; Franquet T, 2011, RADIOLOGY, V260, P18, DOI 10.1148/radiol.11092149; Gueller S, 2013, TRANSPL INFECT DIS, V15, P435, DOI 10.1111/tid.12092; Guthrie R, 2001, CHEST, V120, P2021, DOI 10.1378/chest.120.6.2021; Iglesias ALH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021838; Hong HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095865; Hong Seung-Dok, 2011, Chonnam Med J, V47, P127, DOI 10.4068/cmj.2011.47.2.127; Huijskens EGW, 2014, J MED MICROBIOL, V63, P441, DOI 10.1099/jmm.0.067108-0; Ison MG, 2013, INFLUENZA OTHER RESP, V7, P7, DOI 10.1111/irv.12046; Jacobs SE, 2013, CLIN MICROBIOL REV, V26, P135, DOI 10.1128/CMR.00077-12; Jefferson T, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008965.pub3, 10.1002/14651858.CD008965.pub4]; Jennings LC, 2008, THORAX, V63, P42, DOI 10.1136/thx.2006.075077; Johansson N, 2010, CLIN INFECT DIS, V50, P202, DOI 10.1086/648678; Kang SJ, 2013, JPN J INFECT DIS, V66, P425, DOI 10.7883/yoken.66.425; Kim EA, 2002, RADIOGRAPHICS, V22, pS137, DOI 10.1148/radiographics.22.suppl_1.g02oc15s137; Kim HK, 2013, J CLIN MICROBIOL, V51, P1137, DOI 10.1128/JCM.02958-12; Laskowski M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089651; Lee N, 2010, THORAX, V65, P510, DOI 10.1136/thx.2009.130799; Leibovici L, 2014, CLIN MICROBIOL INFEC; McGeer A, 2007, CLIN INFECT DIS, V45, P1568, DOI 10.1086/523584; Miller WT, 2011, AM J ROENTGENOL, V197, P1088, DOI 10.2214/AJR.11.6501; Musher DM, 2013, J INFECTION, V67, P11, DOI 10.1016/j.jinf.2013.03.003; Muthuri SG, 2014, LANCET RESP MED, V2, P395, DOI 10.1016/S2213-2600(14)70041-4; Pavia AT, 2013, INFECT DIS CLIN N AM, V27, P157, DOI 10.1016/j.idc.2012.11.007; Ruuskanen O, 2011, LANCET, V377, P1264, DOI 10.1016/S0140-6736(10)61459-6; Sandrock C, 2008, CHEST, V133, P1221, DOI 10.1378/chest.07-0778; Sandrock CE, 2008, RESP CARE, V53, P40; Sangil A, 2012, EUR J CLIN MICROBIOL, V31, P2765, DOI 10.1007/s10096-012-1626-6; Shiley KT, 2010, J THORAC IMAG, V25, P68, DOI 10.1097/RTI.0b013e3181b0ba8b; Singanayagam A, 2013, LANCET RESP MED, V1, P653, DOI 10.1016/S2213-2600(13)70084-5; Templeton KE, 2005, CLIN INFECT DIS, V41, P345, DOI 10.1086/431588; You JHS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033123; Zhang Q, 2013, BIOMED REP, V1, P723, DOI 10.3892/br.2013.128; Zhou WM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079477	38	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e114710	10.1371/journal.pone.0114710	http://dx.doi.org/10.1371/journal.pone.0114710			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531901	Green Published, Green Submitted, gold			2022-12-27	WOS:000348845100023
J	Stock, MS; Thompson, BJ				Stock, Matt S.; Thompson, Brennan J.			Effects of Barbell Deadlift Training on Submaximal Motor Unit Firing Rates for the Vastus Lateralis and Rectus Femoris	PLOS ONE			English	Article							RECRUITMENT THRESHOLD; DISCHARGE RATE; STRENGTH; MUSCLE; ADAPTATIONS; STEADINESS; BEHAVIOR; YOUNG; SYNCHRONIZATION; DECOMPOSITION	Previous investigations that have studied motor unit firing rates following strength training have been limited to small muscles, isometric training, or interventions involving exercise machines. We examined the effects of ten weeks of supervised barbell deadlift training on motor unit firing rates for the vastus lateralis and rectus femoris during a 50% maximum voluntary contraction (MVC) assessment. Twenty-four previously untrained men (mean age 524 years) were randomly assigned to training (n = 15) or control (n = 9) groups. Before and following the intervention, the subjects performed isometric testing of the right knee extensors while bipolar surface electromyographic signals were detected from the two muscles. The signals were decomposed into their constituent motor unit action potential trains, and motor units that demonstrated accuracy levels less than 92.0% were not considered for analysis. One thousand eight hundred ninety-two and 2,013 motor units were examined for the vastus lateralis and rectus femoris, respectively. Regression analyses were used to determine the linear slope coefficients (pulses per second [pps]/% MVC) and y-intercepts (pps) of the mean firing rate and firing rate at recruitment versus recruitment threshold relationships. Deadlift training significantly improved knee extensor MVC force (Cohen's d = .70), but did not influence force steadiness. Training had no influence on the slopes and y-intercepts for the mean firing rate and firing rate at recruitment versus recruitment threshold relationships. In agreement with previous cross-sectional comparisons and randomized control trials, our findings do not support the notion that strength training affects the submaximal control of motor units.	[Stock, Matt S.; Thompson, Brennan J.] Texas Tech Univ, Muscular Assessment Lab, Lubbock, TX 79409 USA	Texas Tech University System; Texas Tech University	Stock, MS (corresponding author), Texas Tech Univ, Muscular Assessment Lab, Lubbock, TX 79409 USA.	matt.stock@ttu.edu	Stock, Matt S./G-8308-2018	Stock, Matt S./0000-0003-1156-1084; Thompson, Brennan/0000-0003-3534-8755				Aagaard P, 2002, J APPL PHYSIOL, V93, P1318, DOI 10.1152/japplphysiol.00283.2002; Adam A, 1998, J NEUROPHYSIOL, V80, P1373, DOI 10.1152/jn.1998.80.3.1373; Baechle T.R., 2008, ESSENTIALS STRENGTH; Beck TW, 2011, MUSCLE NERVE, V43, P245, DOI 10.1002/mus.21836; Beck TW., 2011, CLIN KINESIOL, V65, P1; Bilodeau M, 2000, MUSCLE NERVE, V23, P771, DOI 10.1002/(SICI)1097-4598(200005)23:5<771::AID-MUS15>3.0.CO;2-9; Cohen J.E., 1988, STAT POWER ANAL BEHA; De Luca CJ, 2006, J NEUROPHYSIOL, V96, P1646, DOI 10.1152/jn.00009.2006; De Luca CJ, 2012, J NEUROPHYSIOL, V107, P178, DOI 10.1152/jn.00961.2010; De Luca CJ, 2010, J NEUROPHYSIOL, V104, P1034, DOI 10.1152/jn.01018.2009; DE LUCA CJ, 1982, J PHYSIOL-LONDON, V329, P113, DOI 10.1113/jphysiol.1982.sp014293; DE LUCA CJ, 1982, J PHYSIOL-LONDON, V329, P129, DOI 10.1113/jphysiol.1982.sp014294; Defreitas JM, 2014, MUSCLE NERVE, V49, P575, DOI 10.1002/mus.23978; Dideriksen JL, 2012, J NEUROPHYSIOL, V107, P3357, DOI 10.1152/jn.00938.2011; Duchateau J, 2006, J APPL PHYSIOL, V101, P1766, DOI 10.1152/japplphysiol.00543.2006; Erim Z, 1996, MUSCLE NERVE, V19, P563, DOI 10.1002/(SICI)1097-4598(199605)19:5<563::AID-MUS3>3.0.CO;2-9; Escamilla RF, 2000, MED SCI SPORT EXER, V32, P1265, DOI 10.1097/00005768-200007000-00013; Escamilla RF, 2002, MED SCI SPORT EXER, V34, P682, DOI 10.1097/00005768-200204000-00019; Gabriel DA, 2006, SPORTS MED, V36, P133, DOI 10.2165/00007256-200636020-00004; Hu XG, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/2/026015; Hu XG, 2012, IEEE ENG MED BIO, P4116, DOI 10.1109/EMBC.2012.6346872; JOHNSON MA, 1973, J NEUROL SCI, V18, P111, DOI 10.1016/0022-510X(73)90023-3; Kamen G, 2004, J GERONTOL A-BIOL, V59, P1334, DOI 10.1093/gerona/59.12.1334; KEEN DA, 1994, J APPL PHYSIOL, V77, P2648, DOI 10.1152/jappl.1994.77.6.2648; Kidgell DJ, 2006, EXP BRAIN RES, V175, P745, DOI 10.1007/s00221-006-0724-z; KRAEMER WJ, 1995, J APPL PHYSIOL, V78, P976, DOI 10.1152/jappl.1995.78.3.976; Laidlaw DH, 1999, J APPL PHYSIOL, V87, P1786, DOI 10.1152/jappl.1999.87.5.1786; MORITANI T, 1979, AM J PHYS MED REHAB, V58, P115; Nawab SH, 2010, CLIN NEUROPHYSIOL, V121, P1602, DOI 10.1016/j.clinph.2009.11.092; Patten C, 2000, EUR J APPL PHYSIOL, V83, P128, DOI 10.1007/s004210000271; Patten C, 2001, MUSCLE NERVE, V24, P542, DOI 10.1002/mus.1038; Ratamess NA, 2009, MED SCI SPORT EXER, V41, P687, DOI 10.1249/MSS.0b013e3181915670; Rich C, 2000, MED SCI SPORT EXER, V32, P190; Rutherford OM, 1986, J SPORT SCI, V4, P101, DOI 10.1080/02640418608732105; STARON RS, 1994, J APPL PHYSIOL, V76, P1247, DOI 10.1152/jappl.1994.76.3.1247; Stevens J. P., 2007, INTERMEDIATE STAT MO; Stock MS, 2012, MUSCLE NERVE, V45, P100, DOI 10.1002/mus.22266; TANJI J, 1973, EXP NEUROL, V40, P771, DOI 10.1016/0014-4886(73)90111-8; Vila-Cha C, 2010, J APPL PHYSIOL, V109, P1455, DOI 10.1152/japplphysiol.01213.2009; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Zaheer F, 2012, PHYSIOL MEAS, V33, P195, DOI 10.1088/0967-3334/33/2/195	41	13	13	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115567	10.1371/journal.pone.0115567	http://dx.doi.org/10.1371/journal.pone.0115567			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531294	Green Published, gold, Green Submitted			2022-12-27	WOS:000348845100077
J	Barbi, F; Bragalini, C; Vallon, L; Prudent, E; Dubost, A; Fraissinet-Tachet, L; Marmeisse, R; Luis, P				Barbi, Florian; Bragalini, Claudia; Vallon, Laurent; Prudent, Elsa; Dubost, Audrey; Fraissinet-Tachet, Laurence; Marmeisse, Roland; Luis, Patricia			PCR Primers to Study the Diversity of Expressed Fungal Genes Encoding Lignocellulolytic Enzymes in Soils Using High-Throughput Sequencing	PLOS ONE			English	Article							ELEVATED ATMOSPHERIC CO2; LITTER DECOMPOSITION; LACCASE GENES; LEAF-LITTER; FOREST SOILS; COMMUNITIES; ECTOMYCORRHIZAL; EVOLUTION; PERFORMANCE; RESPONSES	Plant biomass degradation in soil is one of the key steps of carbon cycling in terrestrial ecosystems. Fungal saprotrophic communities play an essential role in this process by producing hydrolytic enzymes active on the main components of plant organic matter. Open questions in this field regard the diversity of the species involved, the major biochemical pathways implicated and how these are affected by external factors such as litter quality or climate changes. This can be tackled by environmental genomic approaches involving the systematic sequencing of key enzyme-coding gene families using soil-extracted RNA as material. Such an approach necessitates the design and evaluation of gene family-specific PCR primers producing sequence fragments compatible with high-throughput sequencing approaches. In the present study, we developed and evaluated PCR primers for the specific amplification of fungal CAZy Glycoside Hydrolase gene families GH5 (subfamily 5) and GH11 encoding endo-beta-1,4-glucanases and endo beta-1,4-xylanases respectively as well as Basidiomycota class II peroxidases, corresponding to the CAZy Auxiliary Activity family 2 (AA2), active on lignin. These primers were experimentally validated using DNA extracted from a wide range of Ascomycota and Basidiomycota species including 27 with sequenced genomes. Along with the published primers for Glycoside Hydrolase GH7 encoding enzymes active on cellulose, the newly design primers were shown to be compatible with the Illumina MiSeq sequencing technology. Sequences obtained from RNA extracted from beech or spruce forest soils showed a high diversity and were uniformly distributed in gene trees featuring the global diversity of these gene families. This high-throughput sequencing approach using several degenerate primers	[Barbi, Florian; Bragalini, Claudia; Vallon, Laurent; Prudent, Elsa; Dubost, Audrey; Fraissinet-Tachet, Laurence; Marmeisse, Roland; Luis, Patricia] Univ Lyon 1, USC INRA 1364, UMR CNRS 5557, F-69622 Villeurbanne, France; [Bragalini, Claudia] Univ Turin, Dept Life Sci & Syst Biol, Turin, Italy	INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); VetAgro Sup; University of Turin	Luis, P (corresponding author), Univ Lyon 1, USC INRA 1364, UMR CNRS 5557, F-69622 Villeurbanne, France.	patricia.luis@univ-lyon1.fr		Marmeisse, Roland/0000-0003-1653-3517; Barbi, Florian/0000-0002-5547-935X; DUBOST, Audrey/0000-0003-0572-7834; Luis, Patricia/0000-0001-7002-6212	French ''Ministere de l'Enseignement Superieur et de la Recherche''; University of Turin (Italy); CMIRA; French county Rhone-Alpes; French Research foundation CNRS-INSU	French ''Ministere de l'Enseignement Superieur et de la Recherche''; University of Turin (Italy); CMIRA(Region Auvergne-Rhone-Alpes); French county Rhone-Alpes(Region Auvergne-Rhone-Alpes); French Research foundation CNRS-INSU	Funding: Florian Barbi was supported by a PhD grant from the French ''Ministere de l'Enseignement Superieur et de la Recherche''. Claudia Bragalini was supported by a PhD grant from the University of Turin (Italy) and a CMIRA (Cooperation et Mobilite 'Internationales Rhone-Alpes) fellowship from the French county Rhone-Alpes. The work was financed by the French Research foundation CNRS-INSU (Centre National de la Recherche Scientifique -Institut National des Sciences de l'Univers) through an ''Ecosphere Continentale et Cotiere'' program (EC2CO MicrobiEn 2013) and an `` Agence Nationale de la Recherche'' project (ANR 09-GENM-033-001/ Eumetasol). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186; Austin AT, 2010, P NATL ACAD SCI USA, V107, P4618, DOI 10.1073/pnas.0909396107; Bailly J, 2007, ISME J, V1, P632, DOI 10.1038/ismej.2007.68; Baldrian P, 2006, FEMS MICROBIOL REV, V30, P215, DOI 10.1111/j.1574-4976.2005.00010.x; Baldrian P, 2012, ISME J, V6, P248, DOI 10.1038/ismej.2011.95; Baldrian P, 2011, PLANT SOIL, V338, P111, DOI 10.1007/s11104-010-0324-3; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bodeker ITM, 2014, NEW PHYTOL, V203, P245, DOI 10.1111/nph.12791; Bodeker ITM, 2009, ISME J, V3, P1387, DOI 10.1038/ismej.2009.77; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Buee M, 2011, FUNGAL ECOL, V4, P22, DOI 10.1016/j.funeco.2010.07.003; Damon C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028967; Damon C, 2010, FEMS MICROBIOL ECOL, V74, P693, DOI 10.1111/j.1574-6941.2010.00983.x; de Boer W, 2005, FEMS MICROBIOL REV, V29, P795, DOI 10.1016/j.femsre.2004.11.005; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edwards IP, 2008, APPL ENVIRON MICROB, V74, P3481, DOI 10.1128/AEM.02893-07; Edwards IP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020421; Fawal N, 2013, NUCLEIC ACIDS RES, V41, pD441, DOI 10.1093/nar/gks1083; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Gifford RM, 2003, FUNCT PLANT BIOL, V30, P171, DOI 10.1071/FP02083; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grigoriev IV, 2014, NUCLEIC ACIDS RES, V42, pD699, DOI 10.1093/nar/gkt1183; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hadziavdic K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087624; Hao JJ, 2006, J EUKARYOT MICROBIOL, V53, P193, DOI 10.1111/j.1550-7408.2006.00093.x; Hattenschwiler S, 2005, ANNU REV ECOL EVOL S, V36, P191, DOI 10.1146/annurev.ecolsys.36.112904.151932; Herculano PN, 2011, CURR MICROBIOL, V62, P1416, DOI 10.1007/s00284-011-9879-3; Kellner H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095557; Kellner H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010971; Kellner H, 2009, SOIL BIOL BIOCHEM, V41, P1380, DOI 10.1016/j.soilbio.2009.03.012; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Levasseur A, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-32; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Luis P, 2005, MICROB ECOL, V50, P570, DOI 10.1007/s00248-005-5047-2; Luis P, 2004, SOIL BIOL BIOCHEM, V36, P1025, DOI 10.1016/j.soilbio.2004.02.017; MacDonald J, 2011, APPL ENVIRON MICROB, V77, P3211, DOI 10.1128/AEM.02490-10; Manzoni S, 2012, ECOLOGY, V93, P930, DOI 10.1890/11-0026.1; Martinez D, 2009, P NATL ACAD SCI USA, V106, P1954, DOI 10.1073/pnas.0809575106; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; MOLLER EM, 1992, NUCLEIC ACIDS RES, V20, P6115, DOI 10.1093/nar/20.22.6115; Osono T, 2006, MYCOLOGIA, V98, P172, DOI 10.3852/mycologia.98.2.172; Palomares-Rius JE, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-69; RANGER J, 2004, EFFET SUBSTITUTIONS; Richard F, 2011, ANN FOREST SCI, V68, P57, DOI 10.1007/s13595-010-0007-5; Sarkar P, 2009, J EXP BOT, V60, P3615, DOI 10.1093/jxb/erp245; Schadel C, 2010, PLANT PHYSIOL BIOCH, V48, P1, DOI 10.1016/j.plaphy.2009.09.008; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmidt PA, 2013, SOIL BIOL BIOCHEM, V65, P128, DOI 10.1016/j.soilbio.2013.05.014; Schneider T, 2012, ISME J, V6, P1749, DOI 10.1038/ismej.2012.11; Sinsabaugh RL, 2002, BOOK SOIL P, P249; Sinsabaugh RL, 2010, SOIL BIOL BIOCHEM, V42, P391, DOI 10.1016/j.soilbio.2009.10.014; Snajdr J, 2008, SOIL BIOL BIOCHEM, V40, P2068, DOI 10.1016/j.soilbio.2008.01.015; Snajdr J, 2011, FEMS MICROBIOL ECOL, V75, P291, DOI 10.1111/j.1574-6941.2010.00999.x; Tedersoo L, 2008, NEW PHYTOL, V180, P479, DOI 10.1111/j.1469-8137.2008.02561.x; Trap J, 2011, SOIL BIOL BIOCHEM, V43, P1553, DOI 10.1016/j.soilbio.2011.04.005; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; Valaskova V, 2007, SOIL BIOL BIOCHEM, V39, P2651, DOI 10.1016/j.soilbio.2007.05.023; von Lutzow M, 2006, EUR J SOIL SCI, V57, P426, DOI 10.1111/j.1365-2389.2006.00809.x; Voriskova J, 2013, ISME J, V7, P477, DOI 10.1038/ismej.2012.116; Wall DP, 2005, P NATL ACAD SCI USA, V102, P5483, DOI 10.1073/pnas.0501761102; Weber CF, 2012, APPL ENVIRON MICROB, V78, P3950, DOI 10.1128/AEM.08018-11; Weber CF, 2011, ENVIRON MICROBIOL, V13, P2778, DOI 10.1111/j.1462-2920.2011.02548.x; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Wolfe BE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039597; Wubet T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047500; Yoon JJ, 2008, BIOTECHNOL LETT, V30, P1373, DOI 10.1007/s10529-008-9715-4; Zhang DQ, 2008, J PLANT ECOL, V1, P85, DOI 10.1093/jpe/rtn002; Zhou DQ, 2001, MYCOL RES, V105, P1449, DOI 10.1017/S0953756201004713	70	22	25	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e0116264	10.1371/journal.pone.0116264	http://dx.doi.org/10.1371/journal.pone.0116264			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545363	gold, Green Published, Green Submitted			2022-12-27	WOS:000347120200108
J	Hasegawa, H; Ishibashi, K; Kubota, S; Yamaguchi, C; Yuki, R; Nakajo, H; Eckner, R; Yamaguchi, N; Yokoyama, KK; Yamaguchi, N				Hasegawa, Hitomi; Ishibashi, Kenichi; Kubota, Shoichi; Yamaguchi, Chihiro; Yuki, Ryuzaburo; Nakajo, Haruna; Eckner, Richard; Yamaguchi, Noritaka; Yokoyama, Kazunari K.; Yamaguchi, Naoto			Cdk1-Mediated Phosphorylation of Human ATF7 at Thr-51 and Thr-53 Promotes Cell-Cycle Progression into M Phase	PLOS ONE			English	Article							JUN DIMERIZATION PROTEIN-2; ACTIVATING TRANSCRIPTION FACTOR-2; AURORA-A KINASE; HISTONE H3; MITOTIC PHOSPHORYLATION; TYROSINE KINASES; C-SRC; COMPLEX; ROLES; SPINDLE	Activating transcription factor 2 (ATF2) and its homolog ATF7 are phosphorylated at Thr-69/Thr-71 and at Thr-51/Thr-53, respectively, by stress-activated MAPKs regulating their transcriptional functions in G1 and S phases. However, little is known about the role of ATF2 and ATF7 in G2/M phase. Here, we show that Cdk1-cyclin B1 phosphorylates ATF2 at Thr-69/Thr-71 and ATF7 at Thr-51/Thr-53 from early prophase to anaphase in the absence of any stress stimulation. Knockdown of ATF2 or ATF7 decreases the rate of cell proliferation and the number of cells in M-phase. In particular, the knockdown of ATF7 severely inhibits cell proliferation and G2/M progression. The inducible expression of a mitotically nonphosphorylatable version of ATF7 inhibits G2/M progression despite the presence of endogenous ATF7. We also show that mitotic phosphorylation of ATF7 promotes the activation of Aurora kinases, which are key enzymes for early mitotic events. These results suggest that the Cdk1-mediated phosphorylation of ATF7 facilitates G2/M progression, at least in part, by enabling Aurora signaling.	[Hasegawa, Hitomi; Ishibashi, Kenichi; Kubota, Shoichi; Yamaguchi, Chihiro; Yuki, Ryuzaburo; Nakajo, Haruna; Yamaguchi, Noritaka; Yamaguchi, Naoto] Chiba Univ, Grad Sch Pharmaceut Sci, Dept Mol Cell Biol, Chiba, Japan; [Eckner, Richard] Rutgers State Univ, Rutgers New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07102 USA; [Yokoyama, Kazunari K.] Kaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan	Chiba University; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Kaohsiung Medical University	Yokoyama, KK (corresponding author), Kaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan.	kazu@kmu.edu.tw; nyama@faculty.chiba-u.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology; G-COE Research Assistants;  [NSC-101-2320-B-037-047-My3];  [NSC-101-2314-B-037-004-My2];  [NHRI-Ex102-10109BI];  [NHRI-102A1-PDCO-0310201];  [KMU-DT103001]	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); G-COE Research Assistants; ; ; ; ; 	This work was supported by Grants-in-aid for Scientific Research and the Global COE Program (G-COE, Global Center for Education and Research in Immune Regulation and Treatment) from the Japanese Ministry of Education, Culture, Sports, Science and Technology; Grants from Taiwan (NSC-101-2320-B-037-047-My3; NSC-101-2314-B-037-004-My2; NHRI-Ex102-10109BI; NHRI-102A1-PDCO-0310201; KMU-DT103001); G-COE Research Assistants (HH KI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquaviva C, 2006, J CELL SCI, V119, P2401, DOI 10.1242/jcs.02937; Aoyama K, 2013, EXP CELL RES, V319, P3251, DOI 10.1016/j.yexcr.2013.09.003; Barr AR, 2007, J CELL SCI, V120, P2987, DOI 10.1242/jcs.013136; Bassermann F, 2014, BBA-MOL CELL RES, V1843, P150, DOI 10.1016/j.bbamcr.2013.02.028; BENBROOK DM, 1990, ONCOGENE, V5, P295; Bhoumik A, 2005, MOL CELL, V18, P577, DOI 10.1016/j.molcel.2005.04.015; Bhoumik A, 2007, PIGM CELL RES, V20, P498, DOI 10.1111/j.1600-0749.2007.00414.x; Breitwieser W, 2007, GENE DEV, V21, P2069, DOI 10.1101/gad.430207; Camuzeaux B, 2008, J MOL BIOL, V384, P980, DOI 10.1016/j.jmb.2008.10.008; CHATTON B, 1993, MOL CELL BIOL, V13, P561, DOI 10.1128/MCB.13.1.561; Chow JPH, 2003, J BIOL CHEM, V278, P40815, DOI 10.1074/jbc.M306683200; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Crosio C, 2002, MOL CELL BIOL, V22, P874, DOI 10.1128/MCB.22.3.874-885.2002; De Graeve F, 1999, ONCOGENE, V18, P3491, DOI 10.1038/sj.onc.1202723; Diring J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023351; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Fuchs SY, 1999, MOL CELL BIOL, V19, P3289; Fuchs SY, 2000, J BIOL CHEM, V275, P12560, DOI 10.1074/jbc.275.17.12560; Fukumoto Y, 2010, CYTOTECHNOLOGY, V62, P73, DOI 10.1007/s10616-010-9259-z; Giet R, 2001, J CELL BIOL, V152, P669, DOI 10.1083/jcb.152.4.669; Goetz J, 1996, J BIOL CHEM, V271, P29589, DOI 10.1074/jbc.271.47.29589; Gozdecka M, 2012, BIOCHEM SOC T, V40, P230, DOI 10.1042/BST20110630; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Hamard PJ, 2005, ONCOGENE, V24, P3472, DOI 10.1038/sj.onc.1208565; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Ishibashi K, 2013, J CELL SCI, V126, P625, DOI 10.1242/jcs.116277; Jin CY, 2001, FEBS LETT, V489, P34, DOI 10.1016/S0014-5793(00)02387-5; Kasahara K, 2004, J CELL BIOL, V165, P641, DOI 10.1083/jcb.200403011; Kasahara K, 2007, J BIOL CHEM, V282, P5327, DOI 10.1074/jbc.M608396200; Kawasaki H, 1998, GENE DEV, V12, P233, DOI 10.1101/gad.12.2.233; KNEHR M, 1995, EXP CELL RES, V217, P546, DOI 10.1006/excr.1995.1121; Kubota S, 2013, J BIOL CHEM, V288, P17871, DOI 10.1074/jbc.M112.437756; Kubota S, 2014, J BIOL CHEM, V289, P5730, DOI 10.1074/jbc.M113.546655; Kuga T, 2007, ARCH BIOCHEM BIOPHYS, V466, P116, DOI 10.1016/j.abb.2007.07.002; Lau E, 2012, J CELL SCI, V125, P2815, DOI 10.1242/jcs.095000; Lau E, 2012, CELL, V148, P543, DOI 10.1016/j.cell.2012.01.016; Li XY, 1996, GENE DEV, V10, P517, DOI 10.1101/gad.10.5.517; LIVINGSTONE C, 1995, EMBO J, V14, P1785, DOI 10.1002/j.1460-2075.1995.tb07167.x; Lopez-Bergami P, 2010, NAT REV CANCER, V10, P65, DOI 10.1038/nrc2681; Maekawa T, 1999, J BIOL CHEM, V274, P17813, DOI 10.1074/jbc.274.25.17813; Maekawa T, 2010, EMBO J, V29, P184, DOI 10.1038/emboj.2009.318; Marumoto T, 2002, GENES CELLS, V7, P1173, DOI 10.1046/j.1365-2443.2002.00592.x; Marumoto T, 2003, J BIOL CHEM, V278, P51786, DOI 10.1074/jbc.M306275200; Matsui Y, 2012, EUR J CELL BIOL, V91, P413, DOI 10.1016/j.ejcb.2011.12.008; Morton S, 2004, FEBS LETT, V572, P177, DOI 10.1016/j.febslet.2004.07.031; Nakayama Y, 2012, J BIOL CHEM, V287, P24905, DOI 10.1074/jbc.M112.341578; Newman JRS, 2003, SCIENCE, V300, P2097, DOI 10.1126/science.1084648; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Ouwens DM, 2002, EMBO J, V21, P3782, DOI 10.1093/emboj/cdf361; Pan J, 2010, ONCOGENE, V29, P6245, DOI 10.1038/onc.2010.355; Perez de Castro I, 2008, CURR OPIN PHARMACOL, V8, P375, DOI 10.1016/j.coph.2008.06.013; Pines J, 2001, NAT CELL BIOL, V3, pE3, DOI 10.1038/35050676; Reimold AM, 1996, NATURE, V379, P262, DOI 10.1038/379262a0; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Sato I, 2009, J CELL SCI, V122, P965, DOI 10.1242/jcs.034843; Song B, 2011, NEUROSCI LETT, V505, P76, DOI 10.1016/j.neulet.2011.09.060; Takahashi A, 2009, EXP CELL RES, V315, P1117, DOI 10.1016/j.yexcr.2009.02.010; TAKEDA J, 1991, ONCOGENE, V6, P1009; Tanigawa S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.448; VANDAM H, 1995, EMBO J, V14, P1798, DOI 10.1002/j.1460-2075.1995.tb07168.x; Walczynski J, 2014, ONCOGENE, V33, P1027, DOI 10.1038/onc.2013.28; Yamasaki T, 2009, J BIOL CHEM, V284, P8567, DOI 10.1074/jbc.M808719200; Yuan ZM, 2009, MOL CELL BIOL, V29, P2431, DOI 10.1128/MCB.01344-08	64	14	14	0	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e116048	10.1371/journal.pone.0116048	http://dx.doi.org/10.1371/journal.pone.0116048			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545367	gold, Green Published, Green Submitted			2022-12-27	WOS:000347120200092
J	Matsuda, S; Matsumoto, H; Furubayashi, T; Fukuda, H; Emoto, M; Hanajima, R; Tsuji, S; Ugawa, Y; Terao, Y				Matsuda, Shunichi; Matsumoto, Hideyuki; Furubayashi, Toshiaki; Fukuda, Hideki; Emoto, Masaki; Hanajima, Ritsuko; Tsuji, Shoji; Ugawa, Yoshikazu; Terao, Yasuo			Top-Down but Not Bottom-Up Visual Scanning is Affected in Hereditary Pure Cerebellar Ataxia	PLOS ONE			English	Article							EYE-MOVEMENTS; SACCADIC DYSMETRIA; FASTIGIAL NUCLEUS; COVERT SHIFTS; ATTENTION; LESIONS; SEARCH; INTEGRATION; NYSTAGMUS; FEATURES	The aim of this study was to clarify the nature of visual processing deficits caused by cerebellar disorders. We studied the performance of two types of visual search (top-down visual scanning and bottom-up visual scanning) in 18 patients with pure cerebellar types of spinocerebellar degeneration (SCA6: 11; SCA31: 7). The gaze fixation position was recorded with an eye-tracking device while the subjects performed two visual search tasks in which they looked for a target Landolt figure among distractors. In the serial search task, the target was similar to the distractors and the subject had to search for the target by processing each item with top-down visual scanning. In the pop-out search task, the target and distractor were clearly discernible and the visual salience of the target allowed the subjects to detect it by bottom-up visual scanning. The saliency maps clearly showed that the serial search task required top-down visual attention and the pop-out search task required bottom-up visual attention. In the serial search task, the search time to detect the target was significantly longer in SCA patients than in normal subjects, whereas the search time in the pop-out search task was comparable between the two groups. These findings suggested that SCA patients cannot efficiently scan a target using a top-down attentional process, whereas scanning with a bottom-up attentional process is not affected. In the serial search task, the amplitude of saccades was significantly smaller in SCA patients than in normal subjects. The variability of saccade amplitude (saccadic dysmetria), number of re-fixations, and unstable fixation (nystagmus) were larger in SCA patients than in normal subjects, accounting for a substantial proportion of scattered fixations around the items. Saccadic dysmetria, re-fixation, and nystagmus may play important roles in the impaired top-down visual scanning in SCA, hampering precise visual processing of individual items.	[Matsuda, Shunichi; Matsumoto, Hideyuki; Hanajima, Ritsuko; Tsuji, Shoji; Terao, Yasuo] Univ Tokyo, Dept Neurol, Tokyo, Japan; [Furubayashi, Toshiaki; Ugawa, Yoshikazu] Fukushima Med Univ, Sch Med, Dept Neurol, Fukushima, Japan; [Fukuda, Hideki] Segawa Neurol Clin Children, Tokyo, Japan; [Emoto, Masaki] Univ Tokyo, Interfac Initiat Informat Studies, Tokyo, Japan	University of Tokyo; Fukushima Medical University; University of Tokyo	Matsumoto, H (corresponding author), Univ Tokyo, Dept Neurol, Tokyo, Japan.	hideyukimatsumoto.jp@gmail.com	Ugawa, Yoshikazu/AAM-2052-2020	Ugawa, Yoshikazu/0000-0002-8016-152X	Committee of the Study of Human Exposure; Ministry of Public Management, Home Affairs, Post and Telecommunications	Committee of the Study of Human Exposure; Ministry of Public Management, Home Affairs, Post and Telecommunications	Dr. Hanajima was supported by a Research Project Grant- in- Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and Research, and Dainippon Sumitomo Pharma. Co., Ltd; and has received a speaker's honorarium from Kyowa Hakko Kilin Co., Ltd. Dr. Ugawa was supported by a Research Project Grant- in- Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; by grants for the Research Committee on degenerative ataxia from the Ministry of Health and Welfare of Japan; by the Research Committee on insomnia in Parkinson's disease from the Ministry of Health and Welfare of Japan; by a grant from the Committee of the Study of Human Exposure to EMF from the Ministry of Public Management, Home Affairs, Post and Telecommunications; and by a grant from the Uehara Memorial Foundation. Dr. Terao was supported by a Research Project Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan Research, by grants from GlaxoSmithKline and Boehringer Ingelheim, and has received a speaker's honorarium from Boehringer Ingelheim. The other authors have no disclosures. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre MF, 2013, CEREBELLUM, V12, P396, DOI 10.1007/s12311-012-0433-z; Andreasen NC, 1996, P NATL ACAD SCI USA, V93, P9985, DOI 10.1073/pnas.93.18.9985; Barash S, 1999, J NEUROSCI, V19, P10931, DOI 10.1523/JNEUROSCI.19-24-10931.1999; BURR DC, 1982, VISION RES, V22, P479, DOI 10.1016/0042-6989(82)90196-1; BUTTNER U, 1995, J NEUROL, V242, P384, DOI 10.1007/BF00868394; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; Eckstein M. P., 2011, J VIS, V11; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Foulsham T, 2008, J VISION, V8, DOI 10.1167/8.2.6; Foulsham T, 2009, NEUROPSYCHOLOGIA, V47, P1994, DOI 10.1016/j.neuropsychologia.2009.03.013; Frings M, 2007, CEREBELLUM, V6, P328, DOI 10.1080/14734220701200063; Golla H, 2005, BRAIN, V128, P1525, DOI 10.1093/brain/awh523; Gomez CM, 1997, ANN NEUROL, V42, P933, DOI 10.1002/ana.410420616; Haarmeier T, 2007, CEREBELLUM, V6, P177, DOI 10.1080/14734220701286187; Harel J, 2006, P NEURAL INFORM P SY; Harel J., SALIENCY IMPLEMENTAT; Ignashchenkova A, 2009, J NEUROPHYSIOL, V102, P3156, DOI 10.1152/jn.00659.2009; Ishikawa K, 1999, J NEUROL NEUROSUR PS, V67, P86, DOI 10.1136/jnnp.67.1.86; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; JACOBS RJ, 1979, VISION RES, V19, P1187, DOI 10.1016/0042-6989(79)90183-4; Kawai Y, 2008, J NEUROL SCI, V271, P68, DOI 10.1016/j.jns.2008.03.018; Kelly RM, 2003, J NEUROSCI, V23, P8432; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Land MF, 2009, VISUAL NEUROSCI, V26, P51, DOI 10.1017/S0952523808080899; Ludwig CJH, 2002, J EXP PSYCHOL HUMAN, V28, P902, DOI 10.1037//0096-1523.28.4.902; Machner B, 2005, NEUROREPORT, V16, P1507, DOI 10.1097/01.wnr.0000177015.75096.b6; Matsuda S, 2014, CEREBELLUM; Matsumoto H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028928; Matsumoto H, 2011, MOVEMENT DISORD, V26, P1619, DOI 10.1002/mds.23683; NODA H, 1988, J NEUROPHYSIOL, V60, P1036, DOI 10.1152/jn.1988.60.3.1036; NOTHDURFT HC, 1993, VISION RES, V33, P1937, DOI 10.1016/0042-6989(93)90020-W; Owada K, 2005, NEUROLOGY, V65, P629, DOI 10.1212/01.wnl.0000173065.75680.e2; Ramnani N, 2006, NAT REV NEUROSCI, V7, P511, DOI 10.1038/nrn1953; ROBINSON FR, 1993, J NEUROPHYSIOL, V70, P1741, DOI 10.1152/jn.1993.70.5.1741; Sato N, 2009, AM J HUM GENET, V85, P544, DOI 10.1016/j.ajhg.2009.09.019; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; SCHMAHMANN JD, 1991, ARCH NEUROL-CHICAGO, V48, P1178, DOI 10.1001/archneur.1991.00530230086029; Suenaga M, 2008, J NEUROL NEUROSUR PS, V79, P496, DOI 10.1136/jnnp.2007.119883; Suzuki Y, 2003, JPN J OPHTHALMOL, V47, P535, DOI 10.1016/S0021-5155(03)00144-8; Takagi M, 1998, J NEUROPHYSIOL, V80, P1911, DOI 10.1152/jn.1998.80.4.1911; TREISMAN A, 1991, J EXP PSYCHOL HUMAN, V17, P652, DOI 10.1037/0096-1523.17.3.652; TREISMAN A, 1988, Q J EXP PSYCHOL-A, V40, P201, DOI 10.1080/02724988843000104; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Trouillas P, 1997, J NEUROL SCI, V145, P205, DOI 10.1016/S0022-510X(96)00231-6; van Zoest W, 2004, PERCEPTION, V33, P927, DOI 10.1068/p5158; VILIS T, 1981, J NEUROPHYSIOL, V46, P828, DOI 10.1152/jn.1981.46.4.828; WAESPE W, 1990, BRAIN, V113, P821, DOI 10.1093/brain/113.3.821; Yabe I, 2003, J NEUROL, V250, P440, DOI 10.1007/s00415-003-1020-5; ZEE DS, 1976, BRAIN, V99, P207, DOI 10.1093/brain/99.2.207	51	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e0116181	10.1371/journal.pone.0116181	http://dx.doi.org/10.1371/journal.pone.0116181			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545148	Green Published, Green Submitted, gold			2022-12-27	WOS:000347120200106
J	Muniz, JAPC; de Athaide, LM; Gomes, BD; Finlay, BL; Silveira, LCD				Pereira Carneiro Muniz, Jose Augusto; de Athaide, Luana Modesto; Gomes, Bruno Duarte; Finlay, Barbara L.; de Lima Silveira, Luiz Carlos			Ganglion Cell and Displaced Amacrine Cell Density Distribution in the Retina of the Howler Monkey (Alouatta caraya)	PLOS ONE			English	Article							NEW-WORLD MONKEY; CORTICAL MAGNIFICATION FACTOR; OPTIC-NERVE; COLOR-VISION; HORIZONTAL CELLS; RHESUS-MONKEY; OWL MONKEY; STEREOLOGIC ANALYSIS; CAPUCHIN MONKEY; PRIMATE RETINA	Unlike all other New World (platyrrine) monkeys, both male and female howler monkeys (Alouatta sp.) are obligatory trichromats. In all other platyrrines, only females can be trichromats, while males are always dichromats, as determined by multiple behavioral, electrophysiological, and genetic studies. In addition to obligatory trichromacy, Alouatta has an unusual fovea, with substantially higher peak cone density in the foveal pit than every other diurnal anthropoid monkey (both platyrrhines and catarrhines) and great ape yet examined, including humans. In addition to documenting the general organization of the retinal ganglion cell layer in Alouatta, the distribution of cones is compared to retinal ganglion cells, to explore possible relationships between their atypical trichromacy and foveal specialization. The number and distribution of retinal ganglion cells and displaced amacrine cells were determined in six flat-mounted retinas from five Alouatta caraya. Ganglion cell density peaked at 0.5 mm between the fovea and optic nerve head, reaching 40,700-45,200 cells/mm(2). Displaced amacrine cell density distribution peaked between 0.5-1.75 mm from the fovea, reaching mean values between 2,050-3,100 cells/mm2. The mean number of ganglion cells was 1,133,000 +/- 79,000 cells and the mean number of displaced amacrine cells was 537,000 +/- 61,800 cells, in retinas of mean area 641 +/- 62 mm(2). Ganglion cell and displaced amacrine cell density distribution in the Alouatta retina was consistent with that observed among several species of diurnal Anthropoidea, both platyrrhines and catarrhines. The principal alteration in the Alouatta retina appears not to be in the number of any retinal cell class, but rather a marked gradient in cone density within the fovea, which could potentially support high chromatic acuity in a restricted central region.	[Pereira Carneiro Muniz, Jose Augusto] Ctr Nacl Primatas, Ananindeua, Para, Brazil; [de Athaide, Luana Modesto] Fed Univ Para, Inst Tecnol, BR-66059 Belem, Para, Brazil; [Gomes, Bruno Duarte; de Lima Silveira, Luiz Carlos] Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil; [Finlay, Barbara L.] Cornell Univ, Dept Psychol, Ithaca, NY 14853 USA; [de Lima Silveira, Luiz Carlos] Fed Univ Para, Nucleo Med Trop, BR-66059 Belem, Para, Brazil	Universidade Federal do Para; Universidade Federal do Para; Cornell University; Universidade Federal do Para	Silveira, LCD (corresponding author), Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil.	luiz@ufpa.br	Gomes, Bruno Duarte/I-4499-2013		CNPq-PRONEX/FAPESPA/UFPA/FADESP [2268]; CNPq-PRONEX/FAPESPA [316799/2009]; CNPq [476744/2009-1, 479500/2011-8]; NSF [0130789]; FINEP/UFPA/FADESP [1723]	CNPq-PRONEX/FAPESPA/UFPA/FADESP; CNPq-PRONEX/FAPESPA(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NSF(National Science Foundation (NSF)); FINEP/UFPA/FADESP	This research was supported by the following grants: CNPq-PRONEX/FAPESPA/UFPA/FADESP #2268, CNPq-PRONEX/FAPESPA #316799/2009, CNPq #476744/2009-1 and #479500/2011-8, NSF #0130789, and FINEP/UFPA/FADESP #1723 (IBN Net). LCLS is a CNPq research fellow. The funders had no rule in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1977, VISUAL SYSTEM VERTEB, DOI [DOI 10.1007/978-3-642-66468-7, 10.1007/978-3-642-66468-7_11, DOI 10.1007/978-3-642-66468-7_11]; Araujo AC, 2008, VISUAL NEUROSCI, V25, P243, DOI 10.1017/S0952523808080292; Arey LB, 1935, ANAT REC S, V61, P3; AYRES M., 2007, BIOESTAT; BALAZSI AG, 1984, AM J OPHTHALMOL, V97, P760, DOI 10.1016/0002-9394(84)90509-9; BOYCOTT BB, 1991, EUR J NEUROSCI, V3, P1069, DOI 10.1111/j.1460-9568.1991.tb00043.x; Bruesch SR, 1942, J COMP NEUROL, V77, P631, DOI 10.1002/cne.900770310; Chan TL, 2001, J COMP NEUROL, V437, P219, DOI 10.1002/cne.1280; Coimbra JP, 2013, J COMP NEUROL, V521, P2042, DOI 10.1002/cne.23271; Collin SP, 2012, BRAIN BEHAV EVOLUT, V80, P80, DOI 10.1159/000339870; CONRADI N, 1993, GRAEF ARCH CLIN EXP, V231, P169, DOI 10.1007/BF00920942; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103; De Lima SMA, 2005, VISUAL NEUROSCI, V22, P707, DOI 10.1017/S0952523805226032; DEMONASTERIO FM, 1975, J PHYSIOL-LONDON, V251, P217, DOI 10.1113/jphysiol.1975.sp011088; DEMONASTERIO FM, 1975, J PHYSIOL-LONDON, V251, P197, DOI 10.1113/jphysiol.1975.sp011087; DEMONASTERIO FM, 1975, J PHYSIOL-LONDON, V251, P167, DOI 10.1113/jphysiol.1975.sp011086; Doi E, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003761; Dos Reis JWL, 2002, J COMP NEUROL, V443, P105, DOI 10.1002/cne.10105; Dyer MA, 2001, NAT REV NEUROSCI, V2, P333, DOI 10.1038/35072555; Dyer MA, 2009, P NATL ACAD SCI USA, V106, P8963, DOI 10.1073/pnas.0901484106; Finlay BL, 2008, VISUAL NEUROSCI, V25, P289, DOI 10.1017/S0952523808080371; Finlay BL, 2008, BRAIN RES, V1192, P5, DOI 10.1016/j.brainres.2007.07.005; Finlay BL, 2005, PRIMATE VISUAL SYSTEM: A COMPARATIVE APPROACH, P37; FINLAY BL, 1995, SCIENCE, V268, P1578, DOI 10.1126/science.7777856; FISCHER QS, 1991, BRAIN BEHAV EVOLUT, V37, P189, DOI 10.1159/000114358; Fleagle JG, 1988, PRIMATE ADAPTATION E; Franco ECS, 2000, BRAIN BEHAV EVOLUT, V56, P276, DOI 10.1159/000047211; Ghosh KK, 1996, J COMP NEUROL, V366, P76, DOI 10.1002/(SICI)1096-9861(19960226)366:1<76::AID-CNE6>3.0.CO;2-H; Ghosh KK, 1999, J COMP NEUROL, V413, P417, DOI 10.1002/(SICI)1096-9861(19991025)413:3<417::AID-CNE5>3.0.CO;2-H; Ghosh KK, 1997, J COMP NEUROL, V379, P211; Gomes FL, 2005, BRAZ J MED BIOL RES, V38, P915, DOI 10.1590/S0100-879X2005000600014; Harman A, 2000, ANAT REC, V260, P124; HENDRICKSON AE, 1994, INVEST OPHTH VIS SCI, V35, P3129; Herbin M, 1997, J COMP NEUROL, V383, P459, DOI 10.1002/(SICI)1096-9861(19970714)383:4<459::AID-CNE5>3.0.CO;2-1; Hess RF, 2003, J PHYSIOL-PARIS, V97, P105, DOI 10.1016/j.jphysparis.2003.09.013; HUGHES A, 1971, DOC OPHTHALMOL, V30, P33, DOI 10.1007/BF00142518; Hunt DM, 1998, VISION RES, V38, P3299, DOI 10.1016/S0042-6989(97)00443-4; IBBOTSON RE, 1992, P ROY SOC B-BIOL SCI, V247, P145, DOI 10.1098/rspb.1992.0021; Jacobs GH, 2007, INT J PRIMATOL, V28, P729, DOI 10.1007/s10764-007-9168-y; Jacobs GH, 1996, NATURE, V382, P156, DOI 10.1038/382156a0; Jacobs GH, 1996, P ROY SOC B-BIOL SCI, V263, P705, DOI 10.1098/rspb.1996.0105; JOHNSON BM, 1987, AGE, V10, P5, DOI 10.1007/BF02431765; JONAS JB, 1992, INVEST OPHTH VIS SCI, V33, P2012; Kremers Jan, 1999, P123; KUPFER C, 1967, J ANAT, V101, P393; LAVAIL MM, 1991, J COMP NEUROL, V309, P86, DOI 10.1002/cne.903090107; Lee Barry B., 1996, Revista Brasileira de Biologia, V56, P323; LEE BB, 1989, J PHYSIOL-LONDON, V414, P223, DOI 10.1113/jphysiol.1989.sp017685; LEE BB, 1989, J PHYSIOL-LONDON, V414, P245, DOI 10.1113/jphysiol.1989.sp017686; Lee BB, 2000, J PHYSIOL-LONDON, V528, P573, DOI 10.1111/j.1469-7793.2000.00573.x; LEE BB, 1988, J PHYSIOL-LONDON, V404, P323, DOI 10.1113/jphysiol.1988.sp017292; Lima SMA, 1996, J COMP NEUROL, V368, P538; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Moran RJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003422; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; OGDEN TE, 1966, VISION RES, V6, P485, DOI 10.1016/0042-6989(66)90108-8; Oppel O, 1967, Albrecht Von Graefes Arch Klin Exp Ophthalmol, V172, P1, DOI 10.1007/BF00577151; PERRY VH, 1985, VISION RES, V25, P1795, DOI 10.1016/0042-6989(85)90004-5; PERRY VH, 1988, NEUROSCIENCE, V25, P225, DOI 10.1016/0306-4522(88)90021-8; PICANCODINIZ CW, 1992, BRAZ J MED BIOL RES, V25, P57; Polyak S. L., 1941, RETINA-J RET VIT DIS; POTTS AM, 1972, INVEST OPHTH VISUAL, V11, P980; QUIGLEY HA, 1982, ARCH OPHTHALMOL-CHIC, V100, P135, DOI 10.1001/archopht.1982.01030030137016; RAKIC P, 1983, SCIENCE, V219, P1441, DOI 10.1126/science.6828871; REPKA MX, 1989, OPHTHALMOLOGY, V96, P26; SCHEIN SJ, 1988, J COMP NEUROL, V269, P479, DOI 10.1002/cne.902690403; Silveira LCD, 2004, METH NE FRO NEUROSCI, P29; SILVEIRA LCL, 1989, VISUAL NEUROSCI, V2, P221, DOI 10.1017/S0952523800001140; Silveira LCL, 1999, VISUAL NEUROSCI, V16, P333, DOI 10.1017/S0952523899162138; SILVEIRA LCL, 1993, VISUAL NEUROSCI, V10, P887, DOI 10.1017/S095252380000609X; SILVEIRA LCL, 1989, VISUAL NEUROSCI, V3, P483, DOI 10.1017/S0952523800005988; SILVEIRA LCL, 1994, NEUROREPORT, V5, P2077; SILVEIRA LCL, 1989, VISION RES, V29, P1471, DOI 10.1016/0042-6989(89)90131-4; Silveira LCL, 1998, VISION RES, V38, P3329, DOI 10.1016/S0042-6989(97)00335-0; SJOSTRAND J, 1994, GRAEF ARCH CLIN EXP, V232, P432, DOI 10.1007/BF00186586; Sjostrand J, 1999, VISION RES, V39, P2987, DOI 10.1016/S0042-6989(99)00030-9; Sjostrand J, 1999, GRAEF ARCH CLIN EXP, V237, P1014, DOI 10.1007/s004170050338; Springer AD, 2004, VISUAL NEUROSCI, V21, P53, DOI 10.1017/S0952523804041057; STONE J, 1981, J COMP NEUROL, V196, P205, DOI 10.1002/cne.901960204; Stone J., 1983, PARALLEL PROCESSING, DOI DOI 10.1007/978-1-4684-4433-9; TROILO D, 1993, VISION RES, V33, P1301, DOI 10.1016/0042-6989(93)90038-X; WASSLE H, 1989, NATURE, V341, P643, DOI 10.1038/341643a0; WASSLE H, 1990, VISION RES, V30, P1897, DOI 10.1016/0042-6989(90)90166-I; Wassle H, 2000, VISUAL NEUROSCI, V17, P591, DOI 10.1017/S0952523800174097; WEBB SV, 1976, VISION RES, V16, P1247, DOI 10.1016/0042-6989(76)90049-3; Wikler KC, 1996, PERSPECT DEV NEUROBI, V3, P161; WIKLER KC, 1990, J NEUROSCI, V10, P3390; Wilder HD, 1996, VISUAL NEUROSCI, V13, P335, DOI 10.1017/S0952523800007586; Williams AL, 2002, J COMP NEUROL, V445, P269, DOI 10.1002/cne.10171; Yamada Elizabeth S., 1996, Revista Brasileira de Biologia, V56, P381; Yamada ES, 1996, VISUAL NEUROSCI, V13, P1011, DOI 10.1017/S0952523800007677; Yamada ES, 2001, VISION RES, V41, P119, DOI 10.1016/S0042-6989(00)00244-3	93	18	18	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115291	10.1371/journal.pone.0115291	http://dx.doi.org/10.1371/journal.pone.0115291			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546077	Green Published, Green Submitted, gold			2022-12-27	WOS:000347120200036
J	Price, JS; Shear, P; Lisdahl, KM				Price, Jenessa S.; Shear, Paula; Lisdahl, Krista M.			Ecstasy Exposure & Gender: Examining Components of Verbal Memory Functioning	PLOS ONE			English	Article							SEROTONIN TRANSPORTER AVAILABILITY; MONOAMINE METABOLITE CONCENTRATIONS; LONG-TERM ABSTENTION; MDMA ECSTASY; WORKING-MEMORY; HIPPOCAMPAL DYSFUNCTION; MINIMAL EXPOSURE; SUBSTANCE USE; NEUROPSYCHOLOGICAL EVIDENCE; COGNITIVE PERFORMANCE	Objective: Studies have demonstrated verbal memory deficits associated with past year ecstasy use, although specific underlying components of these deficits are less understood. Further, prior research suggests potential gender differences in ecstasy-induced serotonergic changes. Therefore, the current study investigated whether gender moderated the relationship between ecstasy exposure and components of verbal memory after controlling for polydrug use and confounding variables. Method: Data were collected from 65 polydrug users with a wide range of ecstasy exposure (ages 18-35; 48 ecstasy and 17 marijuana users; 0-2310 ecstasy tablets). Participants completed a verbal learning and memory task, psychological questionnaires, and a drug use interview. Results: Increased past year ecstasy exposure predicted poorer short and long delayed free and cued recalls, retention, and recall discrimination. Male ecstasy users were more susceptible to dose-dependent deficits in retention than female users. Conclusion: Past year ecstasy consumption was associated with verbal memory retrieval, retention, and discrimination deficits in a dose-dependent manner in a sample of healthy young adult polydrug users. Male ecstasy users were at particular risk for deficits in retention following a long delay. Gender difference may be reflective of different patterns of polydrug use as well as increased hippocampal sensitivity. Future research examining neuronal correlates of verbal memory deficits in ecstasy users are needed.	[Price, Jenessa S.] Harvard Univ, McLean Hosp, Sch Med, Belmont, MA USA; [Shear, Paula] Univ Cincinnati, Dept Psychol, Cincinnati, OH 45221 USA; [Lisdahl, Krista M.] Univ Wisconsin, Dept Psychol, Milwaukee, WI 53201 USA	Harvard University; McLean Hospital; University of Cincinnati; University of Wisconsin System; University of Wisconsin Milwaukee	Lisdahl, KM (corresponding author), Univ Wisconsin, Dept Psychol, Milwaukee, WI 53201 USA.	krista.medina@gmail.com	Lisdahl, Krista/P-8470-2019	Lisdahl, Krista/0000-0001-9515-1335	University of Cincinnati University Research Council (URC) faculty grant; URC Summer Graduate Student Research Fellowship Program; NIDA [R03 DA027457-01, 2T32DA015036]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030354, R03DA027457, T32DA015036] Funding Source: NIH RePORTER	University of Cincinnati University Research Council (URC) faculty grant; URC Summer Graduate Student Research Fellowship Program; NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding for this research was provided by the University of Cincinnati University Research Council (URC) faculty grant (Co-PIs: Lisdahl, Shear) and URC Summer Graduate Student Research Fellowship Program (Price, Mentor: Lisdahl). Drs. Lisdahl and Price were supported by NIDA during manuscript preparation (R03 DA027457-01; PI: Lisdahl; 2T32DA015036, PI: Scott E. Lukas). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allott K, 2007, NEUROSCI BIOBEHAV R, V31, P327, DOI 10.1016/j.neubiorev.2006.09.009; Benningfield MM, 2013, NEUROPSYCHOPHARMACOL, V38, P253, DOI 10.1038/npp.2012.178; Biezonski DK, 2011, CURR NEUROPHARMACOL, V9, P84, DOI 10.2174/157015911795017146; Bolla KI, 1998, NEUROLOGY, V51, P1532, DOI 10.1212/WNL.51.6.1532; Bosch OG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061234; Brennan KA, 2006, PSYCHOPHARMACOLOGY, V184, P239, DOI 10.1007/s00213-005-0278-y; Brezun JM, 1999, NEUROSCIENCE, V89, P999, DOI 10.1016/S0306-4522(98)00693-9; Brezun JM, 2000, EUR J NEUROSCI, V12, P391, DOI 10.1046/j.1460-9568.2000.00932.x; Cohen J., 2003, APPL MULTIPLE REGRES; CONSROE P, 1979, PSYCHOPHARMACOLOGY, V66, P45, DOI 10.1007/BF00431988; Croft RJ, 2001, PSYCHOPHARMACOLOGY, V153, P373, DOI 10.1007/s002130000591; Curran HV, 2003, PSYCHOPHARMACOLOGY, V169, P91, DOI 10.1007/s00213-003-1463-5; Daumann J, 2005, PSYCHOPHARMACOLOGY, V180, P607, DOI 10.1007/s00213-004-2002-8; Daumann J, 2003, NEUROREPORT, V14, P1983, DOI 10.1097/00001756-200310270-00021; Daumann J, 2003, COGNITIVE BRAIN RES, V16, P479, DOI 10.1016/S0926-6410(03)00075-2; Debassio WA, 1996, BRAIN RES BULL, V41, P379, DOI 10.1016/S0361-9230(96)00214-6; Delis DC, 2001, CALIFORNIA VERBAL LE; Disney ER, 1999, AM J PSYCHIAT, V156, P1515, DOI 10.1176/ajp.156.10.1515; DOUDET D, 1995, AM J PSYCHIAT, V152, P1782; Fals-Stewart W, 2000, J CONSULT CLIN PSYCH, V68, P134, DOI 10.1037/0022-006X.68.1.134; Feise Ronald J, 2002, BMC Med Res Methodol, V2, P8, DOI 10.1186/1471-2288-2-8; First MB, 2002, STRUCTURED CLIN INTE; Fisk JE, 2011, HUM PSYCHOPHARM CLIN, V26, P313, DOI 10.1002/hup.1207; Foster TC, 1999, BRAIN RES REV, V30, P236, DOI 10.1016/S0165-0173(99)00017-X; Fox HC, 2002, PSYCHOPHARMACOLOGY, V162, P203, DOI 10.1007/s00213-002-1071-9; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gould E, 1999, NEUROPSYCHOPHARMACOL, V21, pS46, DOI 10.1016/S0893-133X(99)00045-7; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Gould E, 1999, P NATL ACAD SCI USA, V96, P5263, DOI 10.1073/pnas.96.9.5263; Gould RW, 2011, NEUROPHARMACOLOGY, V61, P245, DOI 10.1016/j.neuropharm.2011.04.007; Gouzoulis-Mayfrank E, 2000, J NEUROL NEUROSUR PS, V68, P719, DOI 10.1136/jnnp.68.6.719; Gouzoulis-Mayfrank E, 2003, PROG NEURO-PSYCHOPH, V27, P819, DOI 10.1016/S0278-5846(03)00114-3; Gudelsky GA, 2008, PHARMACOL BIOCHEM BE, V90, P198, DOI 10.1016/j.pbb.2007.10.003; Halpern JH, 2004, DRUG ALCOHOL DEPEN, V75, P135, DOI 10.1016/j.drugalcdep.2004.02.008; Halpern JH, 2011, ADDICTION, V106, P777, DOI 10.1111/j.1360-0443.2010.03252.x; Hanson KL, 2004, PSYCHOL MED, V34, P229, DOI 10.1017/S0033291703001132; Hillman CH, 2003, INT J PSYCHOPHYSIOL, V48, P307, DOI 10.1016/S0167-8760(03)00080-1; Hjorthoj CR, 2012, ADDICT BEHAV, V37, P225, DOI 10.1016/j.addbeh.2011.11.025; HUTTENLOCHER PR, 1990, NEUROPSYCHOLOGIA, V28, P517, DOI 10.1016/0028-3932(90)90031-I; Izco M, 2007, PSYCHOPHARMACOLOGY, V189, P459, DOI 10.1007/s00213-006-0602-1; Jacobsen LK, 2004, PSYCHOPHARMACOLOGY, V173, P383, DOI 10.1007/s00213-003-1679-4; Johnston L. D., 2014, MONITORING FUTURE NA; Jonsson EG, 1998, PSYCHIAT RES, V79, P1, DOI 10.1016/S0165-1781(98)00027-4; Jonsson EG, 2000, J PSYCHIAT RES, V34, P239, DOI 10.1016/S0022-3956(00)00013-3; Keyes KM, 2008, DRUG ALCOHOL DEPEN, V97, P139, DOI 10.1016/j.drugalcdep.2008.04.001; Klugman A, 1999, LANCET, V353, P1269, DOI 10.1016/S0140-6736(05)66942-5; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Laws KR, 2007, HUM PSYCHOPHARM CLIN, V22, P381, DOI 10.1002/hup.857; Liechti ME, 2000, J PSYCHOPHARMACOL, V14, P269, DOI 10.1177/026988110001400313; Manly JJ, 2002, J INT NEUROPSYCH SOC, V8, P341, DOI 10.1017/S1355617702813157; Martinowich K, 2008, NEUROPSYCHOPHARMACOL, V33, P73, DOI 10.1038/sj.npp.1301571; Mattson MP, 2004, TRENDS NEUROSCI, V27, P589, DOI 10.1016/j.tins.2004.08.001; McCann UD, 2005, NEUROPSYCHOPHARMACOL, V30, P1741, DOI 10.1038/sj.npp.1300736; McCann UD, 1998, LANCET, V352, P1433, DOI 10.1016/S0140-6736(98)04329-3; McCann UD, 2008, POSITRON EMISSION TO; McCardle K, 2004, PSYCHOPHARMACOLOGY, V173, P434, DOI 10.1007/s00213-004-1791-0; MEDINA KL, 2005, J INT NEUROPSYCH SOC, V11, P1; Medina KL, 2007, DRUG ALCOHOL DEPEN, V87, P303, DOI 10.1016/j.drugalcdep.2006.09.003; Morgan MJ, 1999, PSYCHOPHARMACOLOGY, V141, P30, DOI 10.1007/s002130050803; Morgan MJ, 2002, PSYCHOPHARMACOLOGY, V159, P294, DOI 10.1007/s002130100907; Munafo MR, 2008, BIOL PSYCHIAT, V63, P852, DOI 10.1016/j.biopsych.2007.08.016; O'Shea E, 1998, NEUROPHARMACOLOGY, V37, P919, DOI 10.1016/S0028-3908(98)00029-X; Parrott AC, 2001, HUM PSYCHOPHARM CLIN, V16, P557, DOI 10.1002/hup.351; Pezawas L, 2008, MOL PSYCHIATR, V13, P709, DOI 10.1038/mp.2008.32; Quednow BB, 2006, J PSYCHOPHARMACOL, V20, P373, DOI 10.1177/0269881106061200; Reneman L, 2001, LANCET, V358, P1864, DOI 10.1016/S0140-6736(01)06888-X; Rodgers J, 2000, PSYCHOPHARMACOLOGY, V151, P19, DOI 10.1007/s002130000467; Roiser JP, 2006, PSYCHOPHARMACOLOGY, V188, P213, DOI 10.1007/s00213-006-0495-z; SAVITZ DA, 1995, AM J EPIDEMIOL, V142, P904, DOI 10.1093/oxfordjournals.aje.a117737; SCHEFFEL U, 1992, NEUROPHARMACOLOGY, V31, P881, DOI 10.1016/0028-3908(92)90126-A; Schilt T, 2007, ARCH GEN PSYCHIAT, V64, P728, DOI 10.1001/archpsyc.64.6.728; SHARKEY J, 1991, PSYCHOPHARMACOLOGY, V105, P113, DOI 10.1007/BF02316872; SOBELL LC, 1979, BEHAV RES THER, V17, P157, DOI 10.1016/0005-7967(79)90025-1; Sowell ER, 2002, DEV MED CHILD NEUROL, V44, P4, DOI 10.1017/S0012162201001591; Sprague JE, 1993, PHYSIOL BEHAV, V79, P1281; STANLEY M, 1985, LIFE SCI, V37, P1279, DOI 10.1016/0024-3205(85)90242-5; Substance Abuse and Mental Health Services Administration, 2011, NSDUH SER H; Tapert SF, 2000, ADDICTION, V95, P1043, DOI 10.1046/j.1360-0443.2000.95710436.x; Tapert SF, 2002, J INT NEUROPSYCH SOC, V8, P873, DOI 10.1017/S1355617702870011; Thomasius R, 2006, J PSYCHOPHARMACOL, V20, P211, DOI 10.1177/0269881106059486; Thomasius R, 2003, PSYCHOPHARMACOLOGY, V167, P85, DOI 10.1007/s00213-002-1383-9; Urban NBL, 2012, NEUROPSYCHOPHARMACOL, V37, P1465, DOI 10.1038/npp.2011.332; Verbaten MN, 2003, HUM PSYCHOPHARM, V167, P85; Verrico CD, 2007, PSYCHOPHARMACOLOGY, V189, P489, DOI 10.1007/s00213-005-0174-5; Wang GJ, 2008, OBESITY, V16, pS88, DOI 10.1038/oby.2008.469; Wareing M, 2005, HUM PSYCHOPHARM CLIN, V20, P115, DOI 10.1002/hup.670; Wilkinson G.S, 1993, WIDE RANGE ACHIEVEME; Williams RB, 2003, NEUROPSYCHOPHARMACOL, V28, P533, DOI 10.1038/sj.npp.1300054; Wilson J J, 2001, Curr Psychiatry Rep, V3, P497, DOI 10.1007/s11920-001-0044-8; YOUNG SN, 1980, J NEUROL NEUROSUR PS, V43, P438, DOI 10.1136/jnnp.43.5.438; Zakzanis KK, 2001, NEUROLOGY, V56, P966, DOI 10.1212/WNL.56.7.966; Zakzanis KK, 2007, HUM PSYCHOPHARM CLIN, V22, P427, DOI 10.1002/hup.873	93	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115645	10.1371/journal.pone.0115645	http://dx.doi.org/10.1371/journal.pone.0115645			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545890	gold, Green Published, Green Submitted			2022-12-27	WOS:000347120200050
J	Williamson, DH; Ceccarelli, DM; Evans, RD; Hill, JK; Russ, GR				Williamson, David H.; Ceccarelli, Daniela M.; Evans, Richard D.; Hill, Jos K.; Russ, Garry R.			Derelict Fishing Line Provides a Useful Proxy for Estimating Levels of Non-Compliance with No-Take Marine Reserves	PLOS ONE			English	Article							GREAT-BARRIER-REEF; CORAL TROUT; IMPACTS; GEAR; BIOMASS; DEBRIS; SIZE; LOST; ENFORCEMENT; NETWORKS	No-take marine reserves (NTMRs) are increasingly being established to conserve or restore biodiversity and to enhance the sustainability of fisheries. Although effectively designed and protected NTMR networks can yield conservation and fishery benefits, reserve effects often fail to manifest in systems where there are high levels of non-compliance by fishers (poaching). Obtaining reliable estimates of NTMR non-compliance can be expensive and logistically challenging, particularly in areas with limited or non-existent resources for conducting surveillance and enforcement. Here we assess the utility of density estimates and re-accumulation rates of derelict (lost and abandoned) fishing line as a proxy for fishing effort and NTMR non-compliance on fringing coral reefs in three island groups of the Great Barrier Reef Marine Park (GBRMP), Australia. Densities of derelict fishing line were consistently lower on reefs within old (> 20 year) NTMRs than on non-NTMR reefs (significantly in the Palm and Whitsunday Islands), whereas line densities did not differ significantly between reefs in new NTMRs (5 years of protection) and non-NTMR reefs. A manipulative experiment in which derelict fishing lines were removed from a subset of the monitoring sites demonstrated that lines re-accumulated on NTMR reefs at approximately one third (32.4%) of the rate observed on non-NTMR reefs over a thirty-two month period. Although these inshore NTMRs have long been considered some of the best protected within the GBRMP, evidence presented here suggests that the level of non-compliance with NTMR regulations is higher than previously assumed.	[Williamson, David H.; Ceccarelli, Daniela M.; Russ, Garry R.] Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia; [Russ, Garry R.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Evans, Richard D.] Dept Pk & Wildlife, Perth, WA 6151, Australia; [Evans, Richard D.] Univ Western Australia, Oceans Inst, Sch Plant Biol, Crawley, WA 6009, Australia; [Hill, Jos K.] Olazul, San Francisco, CA 94108 USA	James Cook University; University of Western Australia	Williamson, DH (corresponding author), Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia.	david.williamson@jcu.edu.au	Ceccarelli, Daniela/AGO-7628-2022; Evans, Richard D./O-3559-2019; Ceccarelli, Daniela/AAN-3577-2020	Evans, Richard D./0000-0003-4364-4810; Williamson, David/0000-0001-8447-039X	Australian Department of Environment through the Marine and Tropical Sciences Research Facility (MTSRF); Landcare Australia; George Alexander Foundation; PADI Project Aware	Australian Department of Environment through the Marine and Tropical Sciences Research Facility (MTSRF)(Australian Government); Landcare Australia; George Alexander Foundation; PADI Project Aware	Funding for this work was provided by the Australian Department of Environment (previously; Department of Sustainability, Environment, Water, Population and Communities) through the Marine and Tropical Sciences Research Facility (MTSRF) (http://www.environment.gov.au/topics/science-and-research/cerf/marine-and-tropicalsciences-research-facility). Reef Check funding was provided by Landcare Australia (http://www.landcareonline.com.au/), The George Alexander Foundation (http://www.georgealexander.org.au/) and PADI Project Aware (http://www.projectaware.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abesamis RA, 2005, ECOL APPL, V15, P1798, DOI 10.1890/05-0174; Alder J, 1996, ENVIRON MANAGE, V20, P541, DOI 10.1007/BF01474654; Almany GR, 2009, CORAL REEFS, V28, P339, DOI 10.1007/s00338-009-0484-x; Almany GR, 2013, CURR BIOL, V23, P626, DOI 10.1016/j.cub.2013.03.006; Arias A, 2013, ECOL SOC, V18, DOI 10.5751/ES-05872-180418; Asoh K, 2004, CONSERV BIOL, V18, P1645, DOI 10.1111/j.1523-1739.2004.00122.x; Ayling A.M., 2008, ABUNDANCE PATTERNS R; Ban NC, 2011, CONSERV LETT, V4, P241, DOI 10.1111/j.1755-263X.2011.00171.x; Bauer LJ, 2008, MAR POLLUT BULL, V56, P402, DOI 10.1016/j.marpolbul.2007.11.001; Bergseth BJ, 2015, FISH FISH, V16, P240, DOI 10.1111/faf.12051; Brainard RE, 2000, ORIGINS TYPES MAGNIT; Byers JE, 2007, ECOL APPL, V17, P1851, DOI 10.1890/07-0067.1; Chiappone M, 2005, BIOL CONSERV, V121, P221, DOI 10.1016/j.biocon.2004.04.023; Chiappone M, 2004, CARIBB J SCI, V40, P312; Chiappone M, 2002, MAR POLLUT BULL, V44, P597, DOI 10.1016/S0025-326X(01)00290-9; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Claudet J, 2008, ECOL LETT, V11, P481, DOI 10.1111/j.1461-0248.2008.01166.x; Davis KLF, 2004, COAST MANAGE, V32, P373, DOI 10.1080/08920750490487223; Donohue MJ, 2001, MAR POLLUT BULL, V42, P1301, DOI 10.1016/S0025-326X(01)00139-4; Evans RD, 2004, AQUAT CONSERV, V14, P505, DOI 10.1002/aqc.631; GBRMPA, 2003, GREAT BARR REEF MAR, P220; Goni R, 2010, MAR ECOL PROG SER, V400, P233, DOI 10.3354/meps08419; Gorley C.K., 2006, GETTING STARTED PRIM; Graham NAJ, 2011, OCEANOGR MAR BIOL, V49, P105; Gribble NA, 1998, J ENVIRON MANAGE, V52, P53, DOI 10.1006/jema.1997.0160; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2003, ECOL APPL, V13, pS117; Halpern BS, 2002, ECOL LETT, V5, P361, DOI 10.1046/j.1461-0248.2002.00326.x; Harrison HB, 2012, CURR BIOL, V22, P1023, DOI 10.1016/j.cub.2012.04.008; Ishida T, 2001, ENV MONITORING BIODI, P79; Jennings S, 1996, AMBIO, V25, P44; Kerwath SE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3347; Laist David W., 1997, P99; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Little LR, 2005, FISHERIES MANAG ECOL, V12, P177, DOI 10.1111/j.1365-2400.2005.00440.x; Lubchenco J, 2003, ECOL APPL, V13, pS3; Mangi SC, 2006, MAR POLLUT BULL, V52, P1646, DOI 10.1016/j.marpolbul.2006.06.006; Mapstone BD, 2003, EFFECTS LINE FISHING, P205; McCook LJ, 2010, P NATL ACAD SCI USA, V107, P18278, DOI 10.1073/pnas.0909335107; McIntosh N, 2000, 2000 6 11 AUG 2000 H, P364; Miller I, 2012, MAR ENVIRON RES, V79, P167, DOI 10.1016/j.marenvres.2012.05.008; Mora C, 2006, SCIENCE, V312, P1750, DOI 10.1126/science.1125295; Pauly D, 2005, PHILOS T R SOC B, V360, P5, DOI 10.1098/rstb.2004.1574; Robbins WD, 2006, CURR BIOL, V16, P2314, DOI 10.1016/j.cub.2006.09.044; Roberts CM, 2005, PHILOS T R SOC B, V360, P123, DOI 10.1098/rstb.2004.1578; Roberts CM, 2000, B MAR SCI, V66, P581; Russ GR, 2008, CURR BIOL, V18, pR514, DOI 10.1016/j.cub.2008.04.016; Russ GR, 2011, ECOL APPL, V21, P241, DOI 10.1890/09-1197.1; Russ GR, 2010, OECOLOGIA, V163, P1103, DOI 10.1007/s00442-010-1692-3; Russ Garry R., 2002, P421, DOI 10.1016/B978-012615185-5/50024-4; Russ GR, 2003, ECOL APPL, V13, P1553, DOI 10.1890/01-5341; Spengler A, 2008, MAR POLLUT BULL, V56, P226, DOI 10.1016/j.marpolbul.2007.09.040; Taylor S, 2012, STATEWIDE RECREATION, P93; Thompson RC, 2004, SCIENCE, V304, P838, DOI 10.1126/science.1094559; Watson J, 2010, PALM ISLAND LONG LEN, P212; Williamson DH, 2014, ECOL EVOL, V4, P337, DOI 10.1002/ece3.934; Williamson DH, 2004, ENVIRON CONSERV, V31, P149, DOI 10.1017/S0376892904001262; Yoshikawa T, 2004, BIOL CONSERV, V117, P557, DOI 10.1016/j.biocon.2003.09.025	58	18	18	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e114395	10.1371/journal.pone.0114395	http://dx.doi.org/10.1371/journal.pone.0114395			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545154	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000347120200011
J	Yu, HL; Yin, L; Jiang, XS; Sun, XJ; Wu, J; Tian, H; Gao, XS; He, X				Yu, Hongliang; Yin, Li; Jiang, Xuesong; Sun, Xiujin; Wu, Jing; Tian, Hao; Gao, Xianshu; He, Xia			Effect of Metformin on Cancer Risk and Treatment Outcome of Prostate Cancer: A Meta-Analysis of Epidemiological Observational Studies	PLOS ONE			English	Article							DIABETIC-PATIENTS; INCIDENT CANCER; SULFONYLUREA; MORTALITY; COHORT; IMPACT; TRIAL; BIAS	Background: Laboratory studies have shown the anti-tumor effect of metformin on prostate cancer. However, recent epidemiological studies have yielded inconclusive results. Methods: We searched PubMed database from the inception to May 30 2014 for studies which assessed the effect of metformin use on cancer risk of prostate cancer, biochemical recurrence (BCR) and all-cause mortality of patients with prostate cancer. The pooled results and 95% confidence intervals (CIs) were estimated by random-effect model. Results: Twenty-one studies were eligible according to the inclusion criteria. Based on the pooled results of available observational studies, metformin use was significantly associated with a decreased cancer risk (14 datasets, 963991 male subjects, odds ratio: 0.91, 95% CI: 0.85-0.97) and BCR (6 datasets, 2953 patients, hazard ratio: 0.81, 95% CI: 0.68-0.98) of prostate cancer. However, the association of metformin use with all-cause mortality of patients with prostate cancer was not significant (5 datasets, 9241 patients, hazard ratio: 0.86, 95% CI: 0.64-1.14). Conclusion: Results suggest that metformin use appears to be associated with a significant reduction in the cancer risk and BCR of prostate cancer, but not in all-cause mortality of patients with prostate cancer.	[Yu, Hongliang; Yin, Li; Jiang, Xuesong; Sun, Xiujin; Wu, Jing; Tian, Hao; He, Xia] Nanjing Med Univ, Affiliated Canc Hosp, Jiangsu Canc Hosp, Dept Radiat Oncol, Nanjing, Jiangsu, Peoples R China; [Yu, Hongliang; Yin, Li; Jiang, Xuesong; Sun, Xiujin; Wu, Jing; Tian, Hao; He, Xia] Nanjing Med Univ, Affiliated Canc Hosp, Jiangsu Inst Canc Res, Nanjing, Jiangsu, Peoples R China; [Gao, Xianshu] Peking Univ, Hosp 1, Dept Radiat Oncol, Beijing 100871, Peoples R China	Nanjing Medical University; Nanjing Medical University; Peking University	He, X (corresponding author), Nanjing Med Univ, Affiliated Canc Hosp, Jiangsu Canc Hosp, Dept Radiat Oncol, Nanjing, Jiangsu, Peoples R China.	hexia200302@tom.com			Jiangsu Provincial Natural Science Fund [BK20141018]; "333" Project of Jiangsu Province [BRA2013292]; Six Major Talent Peak Project of Jiangsu Province [WS-047]; Natural Science Foundation of China [30670619, 81072017]	Jiangsu Provincial Natural Science Fund; "333" Project of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Six Major Talent Peak Project of Jiangsu Province; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Jiangsu Provincial Natural Science Fund (No. BK20141018), "333" Project of Jiangsu Province (No. BRA2013292), Six Major Talent Peak Project of Jiangsu Province (class B, No. WS-047), the Natural Science Foundation of China (Nos. 30670619, 81072017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allott EH, 2013, PROSTATE CANC PROSTA; Azoulay L, 2011, CANCER EPIDEM BIOMAR, V20, P337, DOI 10.1158/1055-9965.EPI-10-0940; Ben Sahra I, 2008, ONCOGENE, V27, P3576, DOI 10.1038/sj.onc.1211024; Currie CJ, 2009, DIABETOLOGIA, V52, P1766, DOI 10.1007/s00125-009-1440-6; Currie CJ, 2012, DIABETES CARE, V35, P299, DOI 10.2337/dc11-1313; DeCensi A, 2010, CANCER PREV RES, V3, P1451, DOI 10.1158/1940-6207.CAPR-10-0157; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dong JY, 2011, AM J CLIN NUTR, V94, P900, DOI 10.3945/ajcn.111.015578; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ferrara A, 2011, DIABETES CARE, V34, P923, DOI 10.2337/dc10-1067; Franciosi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071583; Grimes DA, 2002, LANCET, V359, P248, DOI 10.1016/S0140-6736(02)07451-2; He XX, 2011, ANN ONCOL, V22, P2640, DOI 10.1093/annonc/mdr020; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Home PD, 2010, DIABETOLOGIA, V53, P1838, DOI 10.1007/s00125-010-1804-y; Hsieh MC, 2012, EXP DIABETES RES, DOI 10.1155/2012/413782; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiralerspong S, 2009, J CLIN ONCOL, V27, P3297, DOI 10.1200/JCO.2009.19.6410; Kaushik D, 2014, UROL ONCOL-SEMIN ORI, V32, DOI 10.1016/j.urolonc.2013.05.005; Kourelis TV, 2012, MED ONCOL, V29, P1314, DOI 10.1007/s12032-011-9846-7; Margel D, 2013, J CLIN ONCOL, V31, P3069, DOI 10.1200/JCO.2012.46.7043; Margel D, 2013, JNCI-J NATL CANCER I, V105, P1123, DOI 10.1093/jnci/djt170; Morden NE, 2011, DIABETES CARE, V34, P1965, DOI 10.2337/dc11-0699; Murtola TJ, 2008, AM J EPIDEMIOL, V168, P925, DOI 10.1093/aje/kwn190; Noto H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033411; Onitilo AA, 2013, EUR J CANC PREV; Papanas N, 2009, EXPERT OPIN PHARMACO, V10, P2395, DOI 10.1517/14656560903176453; Patel T, 2010, UROLOGY, V76, P1240, DOI 10.1016/j.urology.2010.03.059; Penney KL, 2013, J CLIN ONCOL, V31, P3054, DOI 10.1200/JCO.2013.50.7715; Preston MA, 2014, EUR UROL; Qiu H, 2013, DIABETES OBES METAB, V15, P349, DOI 10.1111/dom.12036; Rieken M, 2013, WORLD J UROL; Rothermundt C, 2014, EUR UROL, V66, P468, DOI 10.1016/j.eururo.2013.12.057; Ruiter R, 2012, DIABETES CARE, V35, P119, DOI 10.2337/dc11-0857; Soranna D, 2012, ONCOLOGIST, V17, P813, DOI 10.1634/theoncologist.2011-0462; Spratt DE, 2013, EUR UROL, V63, P709, DOI 10.1016/j.eururo.2012.12.004; Tseng CH, 2011, DIABETES CARE, V34, P616, DOI 10.2337/dc10-1640; Uchio EM, 2010, ARCH INTERN MED, V170, P1390, DOI 10.1001/archinternmed.2010.262; van Staa TP, 2012, DIABETOLOGIA, V55, P654, DOI 10.1007/s00125-011-2390-3; Wells G.A., NEWCASTLE OTTAWA SCA; Wright JL, 2009, CANCER CAUSE CONTROL, V20, P1617, DOI 10.1007/s10552-009-9407-y; Zannella V, 2013, CLIN CANC RES OFFICI	42	57	60	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e116327	10.1371/journal.pone.0116327	http://dx.doi.org/10.1371/journal.pone.0116327			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545701	Green Published, Green Submitted, gold			2022-12-27	WOS:000347120200112
J	Zhang, YX; Zhang, S; Ma, KM; Fu, BJ; Anand, M				Zhang, Yuxin; Zhang, Shuang; Ma, Keming; Fu, Bojie; Anand, Madhur			Woody Species Diversity in Forest Plantations in a Mountainous Region of Beijing, China: Effects of Sampling Scale and Species Selection	PLOS ONE			English	Article							PLANT DIVERSITY; BETA-DIVERSITY; SPATIAL SCALES; ALPHA-DIVERSITY; BIODIVERSITY; CONSERVATION; PATTERN	The role of forest plantations in biodiversity conservation has gained more attention in recent years. However, most work on evaluating the diversity of forest plantations focuses only on one spatial scale; thus, we examined the effects of sampling scale on diversity in forest plantations. We designed a hierarchical sampling strategy to collect data on woody species diversity in planted pine (Pinus tabuliformis Carr.), planted larch (Larix principis-rupprechtii Mayr.), and natural secondary deciduous broadleaf forests in a mountainous region of Beijing, China. Additive diversity partition analysis showed that, compared to natural forests, the planted pine forests had a different woody species diversity partitioning pattern at multi-scales (except the Simpson diversity in the regeneration layer), while the larch plantations did not show multi-scale diversity partitioning patterns that were obviously different from those in the natural secondary broadleaf forest. Compare to the natural secondary broadleaf forests, the effects of planted pine forests on woody species diversity are dependent on the sampling scale and layers selected for analysis. Diversity in the planted larch forest, however, was not significantly different from that in the natural forest for all diversity components at all sampling levels. Our work demonstrated that the species selected for afforestation and the sampling scales selected for data analysis alter the conclusions on the levels of diversity supported by plantations. We suggest that a wide range of scales should be considered in the evaluation of the role of forest plantations on biodiversity conservation.	[Zhang, Yuxin; Zhang, Shuang; Ma, Keming; Fu, Bojie] Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State Key Lab Urban & Reg Ecol, Beijing 100085, Peoples R China; [Anand, Madhur] Univ Guelph, Sch Environm Sci, Global Ecol Change Lab, Guelph, ON N1G 2W1, Canada	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); University of Guelph	Ma, KM (corresponding author), Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State Key Lab Urban & Reg Ecol, Beijing 100085, Peoples R China.	mkm@rcees.ac.cn	Fu, Bojie/B-1493-2009		Innovation Project of the State Key Laboratory of Urban and Regional Ecology of China [SKLURE2013-1-02]; National Natural Science Foundation of China [31370451]	Innovation Project of the State Key Laboratory of Urban and Regional Ecology of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research is supported by the Innovation Project of the State Key Laboratory of Urban and Regional Ecology of China (SKLURE2013-1-02) and National Natural Science Foundation of China (31370451). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALATALO RV, 1981, OIKOS, V37, P199, DOI 10.2307/3544465; ALLAN JD, 1975, OECOLOGIA, V18, P359, DOI 10.1007/BF00345855; Bremer LL, 2010, BIODIVERS CONSERV, V19, P3893, DOI 10.1007/s10531-010-9936-4; Bretz F., 2010, MULTIPLE COMP USING; Brockerhoff EG, 2008, BIODIVERS CONSERV, V17, P925, DOI 10.1007/s10531-008-9380-x; Brockerhoff EG, 2013, FOREST ECOL MANAG, V301, P43, DOI 10.1016/j.foreco.2012.09.018; Chandy S, 2006, J APPL ECOL, V43, P792, DOI 10.1111/j.1365-2664.2006.01178.x; Chazdon R.L., 2008, INTROPICAL FORESTCOM, P384; Chen L.Z, 1997, STUDY STRUCTURE FUNC, P1; Concepcion ED, 2012, ECOL APPL, V22, P972, DOI 10.1890/11-1471.1; Crawley M.J., 2007, R BOOK; Crawley MJ, 2001, SCIENCE, V291, P864, DOI 10.1126/science.291.5505.864; Crist TO, 2006, ECOL LETT, V9, P923, DOI 10.1111/j.1461-0248.2006.00941.x; Crist TO, 2003, AM NAT, V162, P734, DOI 10.1086/378901; Ellison AM, 2010, ECOLOGY, V91, P1962, DOI 10.1890/09-1692.1; Eycott AE, 2006, J APPL ECOL, V43, P1160, DOI 10.1111/j.1365-2664.2006.01235.x; FAO, 2012, STAT WORLDS FOR 2012; FAO-UNESCO, 1988, 60 FAOUNESCO WORLD S; Finegan B, 1996, TRENDS ECOL EVOL, V11, P119, DOI 10.1016/0169-5347(96)81090-1; Fu BJ, 2004, PLANT SOIL, V261, P47, DOI 10.1023/B:PLSO.0000035567.97093.48; Gabriel D, 2006, ECOL APPL, V16, P2011, DOI 10.1890/1051-0761(2006)016[2011:BDADSS]2.0.CO;2; Gabriel D, 2010, ECOL LETT, V13, P858, DOI 10.1111/j.1461-0248.2010.01481.x; Gering JC, 2003, CONSERV BIOL, V17, P488, DOI 10.1046/j.1523-1739.2003.01465.x; Golodets C, 2011, J APPL ECOL, V48, P1260, DOI 10.1111/j.1365-2664.2011.02031.x; Hartmann H, 2010, FOREST CHRON, V86, P354, DOI 10.5558/tfc86354-3; Hassan R., 2005, ECOSYSTEMS HUMAN WEL; HORNBECK JW, 1992, ECOL APPL, V2, P238, DOI 10.2307/1941858; Irwin S, 2014, BIODIVERS CONSERV, V23, P697, DOI 10.1007/s10531-014-0627-4; Kuznetsova A., 2014, IMERTEST TESTS RANDO; Lamb D, 2005, SCIENCE, V310, P1628, DOI 10.1126/science.1111773; Lande R, 1996, OIKOS, V76, P5, DOI 10.2307/3545743; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Ma KP, 1997, STUDY STRUCTURE FUNC, P56; MACARTHUR R, 1966, AM NAT, V100, P319, DOI 10.1086/282425; Magurran A.E., 1988, ECOLOGICAL DIVERSITY; Oxbrough A, 2014, FOREST ECOL MANAG, V321, P1, DOI 10.1016/j.foreco.2013.09.038; Parrotta JA, 1997, FOREST ECOL MANAG, V99, P1, DOI 10.1016/S0378-1127(97)00190-4; Pawson SM, 2013, BIODIVERS CONSERV, V22, P1203, DOI 10.1007/s10531-013-0458-8; R Core Team, 2021, R LANGUAGE ENV STAT; Ricotta C, 2010, ECOLOGY, V91, P1981, DOI 10.1890/09-0126.1; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Smart SM, 2006, P ROY SOC B-BIOL SCI, V273, P2659, DOI 10.1098/rspb.2006.3630; UNEP, 2001, ASS STAT WORLDS REM; Veech JA, 2002, OIKOS, V99, P3, DOI 10.1034/j.1600-0706.2002.990101.x; Veech JA, 2010, ECOLOGY, V91, P1988, DOI 10.1890/09-1140.1; Verstraeten G, 2013, FOREST ECOL MANAG, V289, P363, DOI 10.1016/j.foreco.2012.10.049; Wagner HH, 2000, LANDSCAPE ECOL, V15, P219, DOI 10.1023/A:1008114117913; Zuur Alain F., 2009, P1	49	5	5	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115038	10.1371/journal.pone.0115038	http://dx.doi.org/10.1371/journal.pone.0115038			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545860	Green Published, gold, Green Submitted			2022-12-27	WOS:000347120200018
J	Zhao, H; Chen, D; Tang, JY; Jia, G; Long, DB; Liu, GM; Chen, XL; Shang, HY				Zhao, Hua; Chen, Dan; Tang, Jiayong; Jia, Gang; Long, Dingbiao; Liu, Guangmang; Chen, Xiaoling; Shang, Haiying			Partial Optimization of the 5-Terminal Codon Increased a Recombination Porcine Pancreatic Lipase (opPPL) Expression in Pichia pastoris	PLOS ONE			English	Article							HIGH-LEVEL EXPRESSION; COVALENT IMMOBILIZATION; TRIACYLGLYCEROL LIPASE; GENE-EXPRESSION; PURIFICATION; ENZYMES; PIGLETS; PIGS; STOMACH; CLONING	Pancreatic lipase plays a key role in intestinal digestion of feed fat, and is often deficient in young animals such as weaning piglets. The objective of this study was to express and characterize a partial codon optimized porcine pancreatic lipase (opPPL). A 537 bp cDNA fragment encoding N-terminus amino acid residue of the mature porcine pancreatic lipase was synthesized according to the codon bias of Pichia pastoris and ligated to the full-length porcine pancreatic lipase cDNA fragment. The codon optimized PPL was cloned into the pPICZ alpha A (Invitrogen, Beijing, China) vector. After the resultant opPPL/pPICZ alpha A plasmid was transformed into P. pastoris, the over-expressed extracellular opPPL containing a His-tag to the C terminus was purified using Ni Sepharose affinity column (GE Healthcare, Piscataway, NJ, USA), and was characterized against the native enzyme (commercial PPL from porcine pancreas, Sigma). The opPPL exhibited a molecular mass of approximately 52 kDa, and showed optimal temperature (40 degrees C), optimal pH (8.0), K-m (0.041 mM), and V-max (2.008 mu mol.mg protein(-1).min(-1)) similar to those of the commercial enzyme with p-NPP as the substrate. The recombinant enzyme was stable at 60 degrees C, but lost 80% (P<0.05) of its activity after exposure to heat >= 60 degrees C for 20 min. The codon optimization increased opPPL yield for ca 4 folds (146 mg.L-1 vs 36 mg.L-1) and total enzyme activity increased about 5 folds (1900 IU.L-1 vs 367 IU.L-1) compared with those native naPPL/pPICZ alpha A tranformant. Comparison of gene copies and mRNA profiles between the two strains indicated the increased rePPL yields may partly be ascribed to the increased protein translational efficiency after codon optimization. In conclusion, we successfully optimized 5-terminal of porcine pancreatic lipase encoding gene and over-expressed the gene in P. pastoris as an extracellular, functional enzyme. The recombination enzyme demonstrates a potential for future use as an animal feed additive for animal improvement.	[Zhao, Hua; Chen, Dan; Tang, Jiayong; Jia, Gang; Liu, Guangmang; Chen, Xiaoling; Shang, Haiying] Sichuan Agr Univ, Inst Anim Nutr, Chengdu 611130, Sichuan, Peoples R China; [Long, Dingbiao] Chongqing Acad Anim Sci, Chongqing 402460, Peoples R China	Sichuan Agricultural University	Zhao, H (corresponding author), Sichuan Agr Univ, Inst Anim Nutr, Chengdu 611130, Sichuan, Peoples R China.	zhua666@126.com			National Natural Science Foundation of China [31272468]; Special Research Funding for Discipline Construction in Sichuan Agricultural University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Research Funding for Discipline Construction in Sichuan Agricultural University	This work was supported in part by the National Natural Science Foundation of China (No. 31272468) and by the Special Research Funding for Discipline Construction in Sichuan Agricultural University (to H. Zhao). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MB, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-24; Bai YX, 2006, J BIOTECHNOL, V125, P574, DOI 10.1016/j.jbiotec.2006.04.003; Bai YX, 2006, PROCESS BIOCHEM, V41, P770, DOI 10.1016/j.procbio.2005.09.012; Boettner M, 2007, J BIOTECHNOL, V130, P1, DOI 10.1016/j.jbiotec.2007.02.019; Borgstrom Bengt, 1993, P475; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carvalho NB, 2008, APPL BIOCHEM BIOTECH, V150, P25, DOI 10.1007/s12010-008-8194-3; CHWALIBOG A, 1994, J ANIM PHYSIOL AN N, V72, P80, DOI 10.1111/j.1439-0396.1994.tb00374.x; CLARE JJ, 1991, BIO-TECHNOL, V9, P455, DOI 10.1038/nbt0591-455; De Caro J, 1981, BIOCHIM BIOPHYS ACTA, V671, P29; Dheeman DS, 2010, J IND MICROBIOL BIOT, V37, P1, DOI 10.1007/s10295-009-0643-7; DINTZIS FR, 1995, J ANIM SCI, V73, P1138; Freitas L, 2007, WORLD J MICROB BIOT, V23, P1725, DOI 10.1007/s11274-007-9421-8; Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006; Gvritishvili AG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015056; Hasan F, 2009, BIOTECHNOL ADV, V27, P782, DOI 10.1016/j.biotechadv.2009.06.001; Hedemann MS, 2004, ARCH ANIM NUTR, V58, P47, DOI 10.1080/00039420310001656677; Hopkins SA, 1992, PHARM ENG, V12, P48; Huang H, 2008, APPL MICROBIOL BIOT, V78, P95, DOI 10.1007/s00253-007-1290-4; Jacobsen EE, 2013, J MOL CATAL B-ENZYM, V85-86, P134, DOI 10.1016/j.molcatb.2012.09.007; Jensen MS, 1997, J ANIM SCI, V75, P437; Jia HY, 2012, J MOL CATAL B-ENZYM, V78, P72, DOI 10.1016/j.molcatb.2012.02.009; Kim T, 2006, APPL ENVIRON MICROB, V72, P4397, DOI 10.1128/AEM.02612-05; Lin L, 2001, CHINESE J BIOCH MOL, V18, P32; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; Liu FC, 2010, J AGR FOOD CHEM, V58, P3322, DOI 10.1021/jf903439q; Liu Y, 2011, BIORESOURCE TECHNOL, V102, P10414, DOI 10.1016/j.biortech.2011.08.056; Mendes AA, 2012, J MOL CATAL B-ENZYM, V78, P119, DOI 10.1016/j.molcatb.2012.03.004; Pierzynowski S, 2012, J ANIM SCI, V90, P439, DOI 10.2527/jas.53868; Pierzynowski S, 2012, J ANIM SCI, V90, P324, DOI 10.2527/jas.53872; Richter S, 2006, BIOTECHNOL BIOENG, V93, P1017, DOI 10.1002/bit.20705; ROMANOS M, 1995, CURR OPIN BIOTECH, V6, P527, DOI 10.1016/0958-1669(95)80087-5; Sebban-Kreuzer C, 2006, PROTEIN EXPRES PURIF, V49, P284, DOI 10.1016/j.pep.2006.06.001; Simons JWFA, 1998, EUR J BIOCHEM, V253, P675, DOI 10.1046/j.1432-1327.1998.2530675.x; Slupecka M, 2012, J ANIM SCI, V90, P311, DOI [10.2527/jas.53921, 10.2527/jas53921]; Svihus B, 2011, ANIM PROD SCI, V51, P590, DOI 10.1071/AN11004; Tang SJ, 2001, ARCH BIOCHEM BIOPHYS, V387, P93, DOI 10.1006/abbi.2000.2235; Vakhlu J, 2006, ELECTRON J BIOTECHN, V9, P69, DOI 10.2225/vol9-issue1-fulltext-9; VERGER R, 1969, BIOCHIM BIOPHYS ACTA, V188, P272, DOI 10.1016/0005-2795(69)90075-0; WINKLER UK, 1979, J BACTERIOL, V138, P663, DOI 10.1128/JB.138.3.663-670.1979; Xie XL, 2011, THESIS SICHUAN AGR U; Yu MR, 2007, PROTEIN EXPRES PURIF, V53, P255, DOI 10.1016/j.pep.2006.10.018; Zheng JH, 2012, J MOL MICROB BIOTECH, V22, P300, DOI 10.1159/000343819; Zhou JC, 2009, J NUTR, V139, P1061, DOI 10.3945/jn.109.104901	44	6	7	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e114385	10.1371/journal.pone.0114385	http://dx.doi.org/10.1371/journal.pone.0114385			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25544987	gold, Green Published, Green Submitted			2022-12-27	WOS:000347120200010
J	Lando, T; Bertoli-Barsotti, L				Lando, Tommaso; Bertoli-Barsotti, Lucio			A New Bibliometric Index Based on the Shape of the Citation Distribution	PLOS ONE			English	Article							H-INDEX; IMPACT	In order to improve the h-index in terms of its accuracy and sensitivity to the form of the citation distribution, we propose the new bibliometric index l. The basic idea is to define, for any author with a given number of citations, an "ideal'' citation distribution which represents a benchmark in terms of number of papers and number of citations per publication, and to obtain an index which increases its value when the real citation distribution approaches its ideal form. The method is very general because the ideal distribution can be defined differently according to the main objective of the index. In this paper we propose to define it by a "squared-form'' distribution: this is consistent with many popular bibliometric indices, which reach their maximum value when the distribution is basically a "square''. This approach generally rewards the more regular and reliable researchers, and it seems to be especially suitable for dealing with common situations such as applications for academic positions. To show the advantages of the l-index some mathematical properties are proved and an application to real data is proposed.	[Lando, Tommaso] VSB Tech Univ Ostrava, Dept Finance, Ostrava, Czech Republic; [Bertoli-Barsotti, Lucio] Univ Bergamo, Dipartimento Sci Aziendali Econ & Metodi Quantita, Bergamo, Italy	Technical University of Ostrava; University of Bergamo	Bertoli-Barsotti, L (corresponding author), Univ Bergamo, Dipartimento Sci Aziendali Econ & Metodi Quantita, Bergamo, Italy.	lucio.bertoli-barsotti@unibg.it	BERTOLI-BARSOTTI, LUCIO/Q-1118-2016	BERTOLI-BARSOTTI, LUCIO/0000-0003-4508-3172; LANDO, Tommaso/0000-0003-4288-0264	Operational Programme Education for Competitiveness [CZ.1.07/2.3.00/30.0016]; European Social Fund; state budget of the Czech Republic	Operational Programme Education for Competitiveness; European Social Fund(European Social Fund (ESF)); state budget of the Czech Republic	TL's research has been elaborated in the framework of the project Opportunity for young researchers, reg. no. CZ.1.07/2.3.00/30.0016, supported by Operational Programme Education for Competitiveness and co-financed by the European Social Fund and the state budget of the Czech Republic (www.msmt.cz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AM, 2014, PLOS ONE, V7; ALI SM, 1966, J ROY STAT SOC B, V28, P131; Anderson TR, 2008, SCIENTOMETRICS, V76, P577, DOI 10.1007/s11192-007-2071-2; Bertoli-Barsotti L, 2013, J AM SOC INF SCI TEC, V64, P1522, DOI 10.1002/asi.22893; Bornmann L, 2012, MEAS-INTERDISCIP RES, V10, P149, DOI 10.1080/15366367.2012.716255; Bornmann L, 2013, EMBO REP, V14, P226, DOI 10.1038/embor.2013.9; De Visscher A, 2011, J AM SOC INF SCI TEC, V62, P2290, DOI 10.1002/asi.21621; Egghe L., 2006, ISSI NEWSLETTER, V2, P8; Egghe L, 2010, ANNU REV INFORM SCI, V44, P65, DOI 10.1002/aris.2010.1440440109; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Jin B., 2006, SCI FOCUS, V1, P8; Jin BH, 2007, CHINESE SCI BULL, V52, P855, DOI 10.1007/s11434-007-0145-9; JOE H, 1990, J MATH ANAL APPL, V148, P287, DOI 10.1016/0022-247X(90)90002-W; Kongo T, 2014, J INFORMETR, V8, P252, DOI 10.1016/j.joi.2013.12.005; Marshall AW, 2011, SPRINGER SER STAT, P3, DOI 10.1007/978-0-387-68276-1; Prathap G, 2014, J ASSOC INF SCI TECH, V65, P426, DOI 10.1002/asi.23046; Prathap G, 2010, SCIENTOMETRICS, V84, P167, DOI 10.1007/s11192-009-0068-0; Rousseau R., 2006, SCI FOCUS, V1, P23; van Eck NJ, 2008, J INFORMETR, V2, P263, DOI 10.1016/j.joi.2008.09.004; Vinkler P, 2007, J INF SCI, V33, P481, DOI 10.1177/0165551506072165; Vinkler P, 2010, SCIENTOMETRICS, V82, P461, DOI 10.1007/s11192-010-0182-z; Vinkler P, 2009, J INF SCI, V35, P602, DOI 10.1177/0165551509103601; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Woeginger GJ, 2008, J INFORMETR, V2, P364, DOI 10.1016/j.joi.2008.05.002; Zhang CT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059912; Zhang CT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005429	26	12	12	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115962	10.1371/journal.pone.0115962	http://dx.doi.org/10.1371/journal.pone.0115962			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX9RO	25542026	Green Published, gold, Green Submitted			2022-12-27	WOS:000347239900117
J	Li, CJ; Dong, Y; Li, HG; Shen, JB; Zhang, FS				Li, Chunjie; Dong, Yan; Li, Haigang; Shen, Jianbo; Zhang, Fusuo			The Dynamic Process of Interspecific Interactions of Competitive Nitrogen Capture between Intercropped Wheat (Triticum aestivum L.) and Faba Bean (Vicia faba L.)	PLOS ONE			English	Article							GROWTH; PRODUCTIVITY; RHIZOSPHERE; DIVERSITY; FIXATION; BARLEY; YIELD	Wheat (Triticum aestivum L.)/faba bean (Vicia faba L.) intercropping shows significant overyielding and high nitrogen (N)-use efficiency, but the dynamics of plant interactions have rarely been estimated. The objective of the present study was to investigate the temporal dynamics of competitive N acquisition between intercropped wheat and faba bean with the logistic model. Wheat and faba bean were grown together or alone with limited N supply in pots. Data of shoot and root biomass and N content measured from 14 samplings were fitted to logistic models to determine instantaneous rates of growth and N uptake. The superiority of instantaneous biomass production and N uptake shifted from faba bean to wheat with their growth. Moreover, the shift of superiority on N uptake occurred 7-12 days earlier than that of biomass production. Interspecific competition stimulated intercropped wheat to have a much earlier and stronger superiority on instantaneous N uptake compared with isolated wheat. The modeling methodology characterized the temporal dynamics of biomass production and N uptake of intercropped wheat and faba bean in different planting systems, which helps to understand the underlying process of plant interaction for intercropping plants.	[Li, Chunjie; Li, Haigang; Shen, Jianbo; Zhang, Fusuo] China Agr Univ, CREFS, Beijing 100193, Peoples R China; [Dong, Yan] Yunnan Agr Univ, Coll Resources & Environm, Kunming 650201, Peoples R China	China Agricultural University; Yunnan Agricultural University	Li, HG (corresponding author), China Agr Univ, CREFS, Beijing 100193, Peoples R China.	haigangli@cau.edu.cn	Shen, Jianbo/Y-3591-2019; Zhang, Fusuo/AAV-4517-2021; Li, Chunjie/AAG-6790-2020	Shen, Jianbo/0000-0001-8943-948X; Li, Chunjie/0000-0002-2761-1085	Projects of International Cooperation and Exchanges NSFC [31210103906]; Innovative Group Grant of the National Natural Science Foundation of China [31121062]; National Natural Science Foundation of China [31201691, 30925024, 31330070]	Projects of International Cooperation and Exchanges NSFC; Innovative Group Grant of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by Projects of International Cooperation and Exchanges NSFC (31210103906), the Innovative Group Grant of the National Natural Science Foundation of China (31121062) and the National Natural Science Foundation of China (31201691, 30925024, 31330070). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anandacoomaraswamy A, 2002, PLANT SOIL, V238, P1, DOI 10.1023/A:1014251714435; Bedoussac L, 2010, PLANT SOIL, V330, P37, DOI 10.1007/s11104-010-0303-8; Bretagnolle F, 1996, J ECOL, V84, P343, DOI 10.2307/2261197; Brown AM, 2001, COMPUT METH PROG BIO, V65, P191, DOI 10.1016/S0169-2607(00)00124-3; Cahill JF, 2011, ANNU REV ECOL EVOL S, V42, P289, DOI 10.1146/annurev-ecolsys-102710-145006; Fan FL, 2006, PLANT SOIL, V283, P275, DOI 10.1007/s11104-006-0019-y; Hortensteiner S, 2002, J EXP BOT, V53, P927, DOI 10.1093/jexbot/53.370.927; Jensen ES, 1996, PLANT SOIL, V182, P25, DOI 10.1007/BF00010992; Li H, 2008, PLANT SOIL, V312, P139, DOI 10.1007/s11104-007-9512-1; Li HG, 2010, BIOL FERT SOILS, V46, P79, DOI 10.1007/s00374-009-0411-x; Li HG, 2013, CROP PASTURE SCI, V64, P976, DOI 10.1071/CP13268; Li L, 2007, P NATL ACAD SCI USA, V104, P11192, DOI 10.1073/pnas.0704591104; Li QZ, 2011, PLANT SOIL, V339, P147, DOI 10.1007/s11104-010-0561-5; Li SM, 2004, ANN BOT-LONDON, V94, P297, DOI 10.1093/aob/mch140; Lithourgidis A, 2007, AGRON SUSTAIN DEV, V27, P95, DOI 10.1051/agro:2006033; Mariotti M, 2012, GRASS FORAGE SCI, V67, P243, DOI 10.1111/j.1365-2494.2011.00839.x; Mariotti M, 2009, GRASS FORAGE SCI, V64, P401, DOI 10.1111/j.1365-2494.2009.00705.x; Novoplansky A, 2009, PLANT CELL ENVIRON, V32, P726, DOI 10.1111/j.1365-3040.2009.01979.x; Peng YF, 2013, PLANT SOIL, V372, P41, DOI 10.1007/s11104-013-1678-0; PUCKRIDG.DW, 1967, AUST J AGR RES, V18, P193, DOI 10.1071/AR9670193; Robinson D, 2010, ANN BOT-LONDON, V106, P921, DOI 10.1093/aob/mcq186; Sanginga N, 1996, PLANT SOIL, V179, P119, DOI 10.1007/BF00011649; Shi JC, 2013, PLANT SOIL, V363, P139, DOI 10.1007/s11104-012-1299-z; TRENBATH BR, 1993, FIELD CROP RES, V34, P381, DOI 10.1016/0378-4290(93)90123-5; Trinder C, 2012, NEW PHYTOL, V193, P948, DOI 10.1111/j.1469-8137.2011.04020.x; Trinder CJ, 2013, FUNCT ECOL, V27, P918, DOI 10.1111/1365-2435.12078; Vandermeer J.H., 1992, ECOLOGY INTERCROPPIN, DOI [10.1017/CBO9780511623523, DOI 10.1017/CBO9780511623523]; WILLEY RW, 1990, AGR WATER MANAGE, V17, P215, DOI 10.1016/0378-3774(90)90069-B; Xiao YB, 2004, PLANT SOIL, V262, P45, DOI 10.1023/B:PLSO.0000037019.34719.0d; Yin XY, 2003, ANN BOT-LONDON, V91, P361, DOI 10.1093/aob/mcg029; Zhang FS, 2003, PLANT SOIL, V248, P305, DOI 10.1023/A:1022352229863; Zhu YY, 2000, NATURE, V406, P718, DOI 10.1038/35021046	32	18	19	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115804	10.1371/journal.pone.0115804	http://dx.doi.org/10.1371/journal.pone.0115804			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541699	Green Published, Green Submitted, gold			2022-12-27	WOS:000347239900091
J	Liu, D; Hu, K; Stork, S; Herrmann, S; Kramer, B; Cikes, M; Gaudron, PD; Knop, S; Ertl, G; Bijnens, B; Weidemann, F				Liu, Dan; Hu, Kai; Stoerk, Stefan; Herrmann, Sebastian; Kramer, Bastian; Cikes, Maja; Gaudron, Philipp Daniel; Knop, Stefan; Ertl, Georg; Bijnens, Bart; Weidemann, Frank			Predictive Value of Assessing Diastolic Strain Rate on Survival in Cardiac Amyloidosis Patients with Preserved Ejection Fraction	PLOS ONE			English	Article							LIGHT-CHAIN AMYLOIDOSIS; SPECKLE-TRACKING ECHOCARDIOGRAPHY; LEFT-VENTRICULAR FUNCTION; SYSTEMIC AMYLOIDOSIS; DOPPLER-ECHOCARDIOGRAPHY; PROGNOSTIC-SIGNIFICANCE; AL AMYLOIDOSIS; INVOLVEMENT; FEATURES; RECOMMENDATIONS	Objectives: Since diastolic abnormalities are typical findings of cardiac amyloidosis (CA), we hypothesized that speckle-tracking-imaging (STI) derived longitudinal early diastolic strain rate (LSRdias) could predict outcome in CA patients with preserved left ventricular ejection fraction (LVEF >50%). Background: Diastolic abnormalities including altered early filling are typical findings and are related to outcome in CA patients. Reduced longitudinal systolic strain (LSsys) assessed by STI predicts increased mortality in CA patients. It remains unknown if LSRdias also related to outcome in these patients. Methods: Conventional echocardiography and STI were performed in 41 CA patients with preserved LVEF (25 male; mean age 65 +/- 9 years). Global and segmental LSsys and LSRdias were obtained in six LV segments from apical 4-chamber views. Results: Nineteen (46%) out of 41 CA patients died during a median of 16 months (quartiles 5-35 months) follow-up. Baseline mitral annular plane systolic excursion (MAPSE, 6 +/- 2 vs. 8 +/- 3 mm), global LSRdias and basal-septal LSRdias were significantly lower in non-survivors than in survivors (all p< 0.05). NYHA class, number of non-cardiac organs involved, MAPSE, mid-septal LSsys, global LSRdias, basal-septal LSRdias and E/LSRdias were the univariable predictors of all-cause death. Multivariable analysis showed that number of non-cardiac organs involved hazard ratio [HR] =1.96, 95% confidence interval [CI] 1.17-3.26, P=0.010), global LSRdias (HR=7.30, 95% CI 2.08-25.65, P=0.002), and E/LSRdias (HR=2.98, 95% CI 1.54-5.79, P=0.001) remained independently predictive of increased mortality risk. The prognostic performance of global LSRdias was optimal at a cutoff value of 0.85 S-1 (sensitivity 68%, specificity 67%). Global LSRdias,0.85 S21 predicted a 4-fold increased mortality in CA patients with preserved LVEF. Conclusions: STI-derived early diastolic strain rate is a powerful independent predictor of survival in CA patients with preserved LVEF.	[Liu, Dan; Hu, Kai; Stoerk, Stefan; Herrmann, Sebastian; Kramer, Bastian; Gaudron, Philipp Daniel; Ertl, Georg; Weidemann, Frank] Univ Hosp Wurzburg, Dept Internal Med 1, Wurzburg, Germany; [Liu, Dan; Hu, Kai; Stoerk, Stefan; Herrmann, Sebastian; Kramer, Bastian; Gaudron, Philipp Daniel; Ertl, Georg; Weidemann, Frank] Univ Hosp Wurzburg, Comprehens Heart Failure Ctr, Wurzburg, Germany; [Cikes, Maja] Univ Hosp Ctr Zagreb, Dept Cardiovasc Dis, Zagreb, Croatia; [Cikes, Maja] Univ Zagreb, Sch Med, Zagreb 41001, Croatia; [Knop, Stefan] Univ Hosp Wurzburg, Dept Internal Med 2, Wurzburg, Germany; [Bijnens, Bart] Univ Pompeu Fabra, ICREA, Barcelona, Spain; [Bijnens, Bart] Katholieke Univ Leuven, Dept Cardiovasc Dis, Leuven, Belgium	University of Wurzburg; University of Wurzburg; University of Zagreb; University of Zagreb; University of Wurzburg; ICREA; Pompeu Fabra University; KU Leuven	Weidemann, F (corresponding author), Univ Hosp Wurzburg, Dept Internal Med 1, Wurzburg, Germany.	Weidemann_F@ukw.de	Bijnens, Bart/AAE-7186-2021; Stork, Stefan/AAR-4182-2020; Bijnens, Bart H/C-2955-2008	Bijnens, Bart/0000-0003-3130-6937; Stork, Stefan/0000-0002-1771-7249; Bijnens, Bart H/0000-0003-3130-6937	Bundesministerium fur Bildung und Forschung, Germany [BMBF01 EO1004]; ICREA Funding Source: Custom	Bundesministerium fur Bildung und Forschung, Germany(Federal Ministry of Education & Research (BMBF)); ICREA(ICREA)	This work was supported by grants from the Bundesministerium fur Bildung und Forschung (BMBF01 EO1004), Germany (http://.bmbf.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Zahrani GB, 2009, J AM SOC ECHOCARDIOG, V22, P290, DOI 10.1016/j.echo.2008.11.013; APPLETON CP, 1988, J AM COLL CARDIOL, V12, P426, DOI 10.1016/0735-1097(88)90416-0; Baccouche H, 2012, ECHOCARDIOGR-J CARD, V29, P668, DOI 10.1111/j.1540-8175.2012.01680.x; Bellavia D, 2008, AM J CARDIOL, V101, P1039, DOI 10.1016/j.amjcard.2007.11.047; Bellavia D, 2010, J AM SOC ECHOCARDIOG, V23, P643, DOI 10.1016/j.echo.2010.03.027; Blessberger H, 2010, HEART, V96, P2032, DOI 10.1136/hrt.2010.199885; Buss SJ, 2012, J AM COLL CARDIOL, V60, P1067, DOI 10.1016/j.jacc.2012.04.043; CUETOGARCIA L, 1985, J AM COLL CARDIOL, V6, P737, DOI 10.1016/S0735-1097(85)80475-7; Dong SJ, 2001, AM J PHYSIOL-HEART C, V281, pH2002, DOI 10.1152/ajpheart.2001.281.5.H2002; Ersboll M, 2014, EUR HEART J, V35, P648, DOI 10.1093/eurheartj/eht179; Falk RH, 2005, CIRCULATION, V112, P2047, DOI 10.1161/CIRCULATIONAHA.104.489187; FALK RH, 1987, AM J CARDIOL, V59, P418, DOI 10.1016/0002-9149(87)90948-9; Gertz MA, 2005, AM J HEMATOL, V79, P319, DOI 10.1002/ajh.20381; Hu K, 2013, EUR HEART J-CARD IMG, V14, P205, DOI 10.1093/ehjci/jes240; Jasaityte R, 2013, J AM SOC ECHOCARDIOG, V26, P15, DOI 10.1016/j.echo.2012.10.005; Kadish AH, 2001, CIRCULATION, V104, P3169; Kasner M, 2010, EUR J ECHOCARDIOGR, V11, P743, DOI 10.1093/ejechocard/jeq060; Kim H, 2008, HEART VESSELS, V23, P271, DOI 10.1007/s00380-008-1042-0; KLEIN AL, 1991, CIRCULATION, V83, P808, DOI 10.1161/01.CIR.83.3.808; KLEIN AL, 1989, J AM COLL CARDIOL, V13, P1017, DOI 10.1016/0735-1097(89)90254-4; KLEIN AL, 1990, J AM COLL CARDIOL, V16, P1135, DOI 10.1016/0735-1097(90)90545-Z; Koyama J, 2010, JACC-CARDIOVASC IMAG, V3, P333, DOI 10.1016/j.jcmg.2009.11.013; Kristen AV, 2007, EUR J HEART FAIL, V9, P617, DOI 10.1016/j.ejheart.2007.01.012; Kristen AV, 2010, BLOOD, V116, P2455, DOI 10.1182/blood-2010-02-267708; KROEKER CAG, 1995, CIRCULATION, V92, P130, DOI 10.1161/01.CIR.92.1.130; KYLE RA, 1995, SEMIN HEMATOL, V32, P45; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Liu D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056923; Liu D, 2011, AM J CARDIOL, V108, P591, DOI 10.1016/j.amjcard.2011.03.092; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Palka P, 2002, J AM SOC ECHOCARDIOG, V15, P1353, DOI 10.1067/mje.2002.125285; Palladini G, 2003, CIRCULATION, V107, P2440, DOI 10.1161/01.CIR.0000068314.02595.B2; Perry R, 2008, EUR J ECHOCARDIOGR, V9, P791, DOI 10.1093/ejechocard/jen148; Phelan D, 2012, HEART, V98, P1442, DOI 10.1136/heartjnl-2012-302353; SUTTON MGS, 1982, CIRCULATION, V66, P790, DOI 10.1161/01.CIR.66.4.790; Wang JW, 2007, CIRCULATION, V115, P1376, DOI 10.1161/CIRCULATIONAHA.106.662882	36	39	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115910	10.1371/journal.pone.0115910	http://dx.doi.org/10.1371/journal.pone.0115910			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542015	Green Published, gold			2022-12-27	WOS:000347239900108
J	Liu, GM; Xiao, L; Fang, TT; Cai, YM; Jia, G; Zhao, H; Wang, J; Chen, XL; Wu, CM				Liu, Guangmang; Xiao, Liang; Fang, Tingting; Cai, Yimin; Jia, Gang; Zhao, Hua; Wang, Jing; Chen, Xiaoling; Wu, Caimei			Pea Fiber and Wheat Bran Fiber Show Distinct Metabolic Profiles in Rats as Investigated by a H-1 NMR-Based Metabolomic Approach	PLOS ONE			English	Article							DIETARY FIBER; INTESTINAL-TRACT; FATTY-ACIDS; BILE-ACID; PLASMA; FERMENTATION; URINE; CHOLESTEROL; EXCRETION; RESPONSES	This study aimed to examine the effect of pea fiber (PF) and wheat bran fiber (WF) supplementation in rat metabolism. Rats were assigned randomly to one of three dietary groups and were given a basal diet containing 15% PF, 15% WF, or no supplemental fiber. Urine and plasma samples were analyzed by NMR-based metabolomics. PF significantly increased the plasma levels of 3-hydroxybutyrate, and myo-inositol as well as the urine levels of alanine, hydroxyphenylacetate, phenylacetyglycine, and a-ketoglutarate. However, PF significantly decreased the plasma levels of isoleucine, leucine, lactate, and pyruvate as well as the urine levels of allantoin, bile acids, and trigonelline. WF significantly increased the plasma levels of acetone, isobutyrate, lactate, myo-inositol, and lipids as well as the urine levels of alanine, lactate, dimethylglycine, N-methylniconamide, and alpha-ketoglutarate. However, WF significantly decreased the plasma levels of amino acids, and glucose as well as the urine levels of acetate, allantoin, citrate, creatine, hippurate, hydroxyphenylacetate, and trigonelline. Results suggest that PF and WF exposure can promote antioxidant activity and can exhibit common systemic metabolic changes, including lipid metabolism, energy metabolism, glycogenolysis and glycolysis metabolism, protein biosynthesis, and gut microbiota metabolism. PF can also decrease bile acid metabolism. These findings indicate that different fiber diet may cause differences in the biofluid profile in rats.	[Liu, Guangmang; Xiao, Liang; Fang, Tingting; Jia, Gang; Zhao, Hua; Chen, Xiaoling; Wu, Caimei] Sichuan Agr Univ, Inst Anim Nutr, Chengdu 611130, Sichuan, Peoples R China; [Liu, Guangmang; Xiao, Liang; Fang, Tingting; Jia, Gang; Zhao, Hua; Chen, Xiaoling; Wu, Caimei] China Minist Educ, Key Lab Anim Dis Resistance Nutr, Chengdu 611130, Sichuan, Peoples R China; [Cai, Yimin] Japan Int Res Ctr Agr Sci, Ohwashi, Tibaragi 3058686, Japan; [Wang, Jing] Sichuan Agr Univ, Maize Res Inst, Chengdu 611130, Sichuan, Peoples R China	Sichuan Agricultural University; Japan International Research Center for Agricultural Sciences; Sichuan Agricultural University	Liu, GM (corresponding author), Sichuan Agr Univ, Inst Anim Nutr, Chengdu 611130, Sichuan, Peoples R China.	liugm@sicau.edu.cn			National Natural Science Foundation of China [31301986]; Research Foundation of Education Bureau of Sichuan Province [00924901]; Ministry of Education Chunhui Project of China [Z2010092]; Specific Research Supporting Program for Discipline Construction in Sichuan Agricultural University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Foundation of Education Bureau of Sichuan Province; Ministry of Education Chunhui Project of China; Specific Research Supporting Program for Discipline Construction in Sichuan Agricultural University	Funding: This work was supported by the National Natural Science Foundation of China (No: 31301986), Research Foundation of Education Bureau of Sichuan Province (No:00924901), Ministry of Education Chunhui Project of China (No:Z2010092) and Specific Research Supporting Program for Discipline Construction in Sichuan Agricultural University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts DS, 1996, JNCI-J NATL CANCER I, V88, P81, DOI 10.1093/jnci/88.2.81; Almar M, 2002, FREE RADICAL RES, V36, P247, DOI 10.1080/10715760290019255; Bohus E, 2008, J PROTEOME RES, V7, P4435, DOI 10.1021/pr800407j; CASSIDY MM, 1981, AM J CLIN NUTR, V34, P218, DOI 10.1093/ajcn/34.2.218; Chen H, 2013, BRIT J NUTR, V110, P1837, DOI 10.1017/S0007114513001293; Cloarec O, 2005, ANAL CHEM, V77, P517, DOI 10.1021/ac048803i; CUMMINGS JH, 1987, AM J CLIN NUTR, V45, P1243, DOI 10.1093/ajcn/45.5.1243; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Fardet A, 2007, J NUTR, V137, P923, DOI 10.1093/jn/137.4.923; HAMBERG O, 1989, AM J CLIN NUTR, V50, P324, DOI 10.1093/ajcn/50.2.324; Hill MJ, 1997, EUR J CANCER PREV, V6, pS43, DOI 10.1097/00008469-199703001-00009; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Huang CY, 2013, J PROTEOME RES, V12, P537, DOI 10.1021/pr301033a; Huang YL, 2008, J SCI FOOD AGR, V88, P435, DOI 10.1002/jsfa.3104; Jenkins DJA, 2002, DIABETES CARE, V25, P1522, DOI 10.2337/diacare.25.9.1522; Johansson-Persson A, 2013, ANAL BIOANAL CHEM, V405, P4799, DOI 10.1007/s00216-013-6874-5; Kasuya F, 1996, BIOCHEM PHARMACOL, V51, P805, DOI 10.1016/0006-2952(95)02399-2; Klein J, 2000, J NEURAL TRANSM, V107, P1027, DOI 10.1007/s007020070051; Lambo-Fodje AM, 2006, BRIT J NUTR, V96, P47, DOI 10.1079/BJN20061797; Lee JY, 1997, BIOCHEM ARCH, V13, P285; Li WD, 2005, J AGR FOOD CHEM, V53, P8533, DOI 10.1021/jf051634y; Lindgren F, 1996, J CHEMOMETR, V10, P521; Liu GM, 2014, RSC ADV, V4, P23749, DOI 10.1039/c4ra02421d; Liu GM, 2013, J AGR FOOD CHEM, V61, P11212, DOI 10.1021/jf403401v; Liu GM, 2011, J AGR FOOD CHEM, V59, P5572, DOI 10.1021/jf104129k; Maes C, 2002, J CEREAL SCI, V35, P315, DOI 10.1006/jcrs.2001.0439; Martins JM, 2004, J NUTR, V134, P3305, DOI 10.1093/jn/134.12.3305; MEIJER AJ, 1984, BIOCHEM J, V223, P559, DOI 10.1042/bj2230559; Monteith DK, 2006, EXPERT OPIN DRUG MET, V2, P687, DOI 10.1517/17425255.2.5.687; Norskov NP, 2013, J PROTEOME RES, V12, P2818, DOI 10.1021/pr400164b; NYMAN M, 1990, J NUTR, V120, P459, DOI 10.1093/jn/120.5.459; NYMAN M, 1986, BRIT J NUTR, V55, P487, DOI 10.1079/BJN19860056; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Pylkas AM, 2005, J MED FOOD, V8, P113, DOI 10.1089/jmf.2005.8.113; Rechner AR, 2002, FREE RADICAL RES, V36, P1229, DOI 10.1080/246-1071576021000016472; REDDY BS, 1980, J NUTR, V110, P1247, DOI 10.1093/jn/110.6.1247; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; SHAH N, 1982, J NUTR, V112, P658, DOI 10.1093/jn/112.4.658; Siddiqui RA, 2008, J NUTR BIOCHEM, V19, P417, DOI 10.1016/j.jnutbio.2007.07.001; Slavin JL, 1999, AM J CLIN NUTR, V70, p459S, DOI 10.1093/ajcn/70.3.459s; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; WU G, 1991, AM J PHYSIOL, V261, pE221, DOI 10.1152/ajpendo.1991.261.2.E221; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Yde CC, 2012, BRIT J NUTR, V107, P1603, DOI 10.1017/S0007114511004909; ZEISEL SH, 1994, ANNU REV NUTR, V14, P269, DOI 10.1146/annurev.nu.14.070194.001413	47	4	4	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115561	10.1371/journal.pone.0115561	http://dx.doi.org/10.1371/journal.pone.0115561			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541729	Green Submitted, Green Published, gold			2022-12-27	WOS:000347239900052
J	O'Connell, BC; O'Callaghan, K; Tillotson, B; Douglas, M; Hafeez, N; West, KA; Stern, H; Ali, JA; Changelian, P; Fritz, CC; Palombella, VJ; McGovern, K; Kutok, JL				O'Connell, Brenda C.; O'Callaghan, Katie; Tillotson, Bonnie; Douglas, Mark; Hafeez, Nafeeza; West, Kip A.; Stern, Howard; Ali, Janid A.; Changelian, Paul; Fritz, Christian C.; Palombella, Vito J.; McGovern, Karen; Kutok, Jeffery L.			HSP90 Inhibition Enhances Antimitotic Drug-Induced Mitotic Arrest and Cell Death in Preclinical Models of Non-Small Cell Lung Cancer	PLOS ONE			English	Article							PROTEIN 90 INHIBITOR; CHECKPOINT; IPI-504; DESTRUCTION; DEGRADATION; MITOSIS; PHOSPHORYLATION; COMBINATION; INDUCTION; APOPTOSIS	HSP90 inhibitors are currently undergoing clinical evaluation in combination with antimitotic drugs in non-small cell lung cancer (NSCLC), but little is known about the cellular effects of this novel drug combination. Therefore, we investigated the molecular mechanism of action of IPI-504 (retaspimycin HCl), a potent and selective inhibitor of HSP90, in combination with the microtubule targeting agent (MTA) docetaxel, in preclinical models of NSCLC. We identified a subset of NSCLC cell lines in which these drugs act in synergy to enhance cell death. Xenograft models of NSCLC demonstrated tumor growth inhibition, and in some cases, regression in response to combination treatment. Treatment with IPI-504 enhanced the antimitotic effects of docetaxel leading to the hypothesis that the mitotic checkpoint is required for the response to drug combination. Supporting this hypothesis, overriding the checkpoint with an Aurora kinase inhibitor diminished the cell death synergy of IPI-504 and docetaxel. To investigate the molecular basis of synergy, an unbiased stable isotope labeling by amino acids in cell culture (SILAC) proteomic approach was employed. Several mitotic regulators, including components of the ubiquitin ligase, anaphase promoting complex (APC/C), were specifically down-regulated in response to combination treatment. Loss of APC/C by RNAi sensitized cells to docetaxel and enhanced its antimitotic effects. Treatment with a PLK1 inhibitor (BI2536) also sensitized cells to IPI-504, indicating that combination effects may be broadly applicable to other classes of mitotic inhibitors. Our data provide a preclinical rationale for testing the combination of IPI-504 and docetaxel in NSCLC.	[O'Connell, Brenda C.; O'Callaghan, Katie; Tillotson, Bonnie; Douglas, Mark; Hafeez, Nafeeza; West, Kip A.; Stern, Howard; Ali, Janid A.; Changelian, Paul; Fritz, Christian C.; Palombella, Vito J.; McGovern, Karen; Kutok, Jeffery L.] Infin Pharmaceut Inc, Cambridge, MA 02139 USA		O'Connell, BC (corresponding author), Infin Pharmaceut Inc, Cambridge, MA 02139 USA.	brenda.oconnell@infi.com						Agarwal R, 2002, GENE DEV, V16, P1371, DOI 10.1101/gad.971402; Bagatell R, 2000, CLIN CANCER RES, V6, P3312; Beck Alain, 2012, MAbs, V4, P637, DOI 10.4161/mabs.21697; Blagg BSJ, 2006, MED RES REV, V26, P310, DOI 10.1002/med.20052; Brito DA, 2006, CURR BIOL, V16, P1194, DOI 10.1016/j.cub.2006.04.043; Chan KS, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.148; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; de Carcer G, 2004, CANCER RES, V64, P5106, DOI 10.1158/0008-5472.CAN-03-2214; de Carcer G, 2001, EMBO J, V20, P2878, DOI 10.1093/emboj/20.11.2878; Dewaele B, 2008, CLIN CANCER RES, V14, P5749, DOI 10.1158/1078-0432.CCR-08-0533; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Harley ME, 2010, EMBO J, V29, P2407, DOI 10.1038/emboj.2010.112; Hernandez-Vargas H, 2007, CELL CYCLE, V6, P780, DOI 10.4161/cc.6.7.4050; Huang HC, 2009, CANCER CELL, V16, P347, DOI 10.1016/j.ccr.2009.08.020; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; Leow CC, 2009, MOL CANCER THER, V8, P2131, DOI 10.1158/1535-7163.MCT-08-1038; Masuda A, 2003, AM J PATHOL, V163, P1109, DOI 10.1016/S0002-9440(10)63470-0; Min MW, 2012, SEMIN CELL DEV BIOL, V23, P482, DOI 10.1016/j.semcdb.2012.01.015; MURRAY AW, 1989, NATURE, V339, P280, DOI 10.1038/339280a0; Normant E, 2011, ONCOGENE, V30, P2581, DOI 10.1038/onc.2010.625; Orth JD, 2008, MOL CANCER THER, V7, P3480, DOI 10.1158/1535-7163.MCT-08-0684; Peng C, 2007, BLOOD, V110, P678, DOI 10.1182/blood-2006-10-054098; Pratt WB, 2006, HANDB EXP PHARM, V172, P111; Proia DA, 2012, INVEST NEW DRUG, V30, P2201, DOI 10.1007/s10637-011-9790-6; ROWINSKY EK, 1993, SEMIN ONCOL, V20, P1; Song D, 2008, MOL CANCER THER, V7, P3275, DOI 10.1158/1535-7163.MCT-08-0508; Stewart S, 2005, CANCER RES, V65, P8730, DOI 10.1158/0008-5472.CAN-05-1500; Topham CH, 2013, CURR OPIN CELL BIOL, V25, P780, DOI 10.1016/j.ceb.2013.07.003; Torres K, 1998, CANCER RES, V58, P3620; Wu JY, 2014, EXP THER MED, V8, P893, DOI 10.3892/etm.2014.1800; Yamada HY, 2006, MOL CANCER THER, V5, P2963, DOI 10.1158/1535-7163.MCT-06-0319	33	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115228	10.1371/journal.pone.0115228	http://dx.doi.org/10.1371/journal.pone.0115228			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542032	Green Submitted, gold, Green Published			2022-12-27	WOS:000347239900027
J	Rosenberg, C; Jahn, A; Pickartz, T; Wahnschaffe, U; Patrzyk, M; Hosten, N				Rosenberg, Christian; Jahn, Andrea; Pickartz, Tilman; Wahnschaffe, Ulrich; Patrzyk, Maciej; Hosten, Norbert			Gd-EOB-DTPA-Enhanced MR Guidance in Thermal Ablation of Liver Malignancies	PLOS ONE			English	Article							LASER-INDUCED THERMOTHERAPY; GADOXETIC ACID; RADIOFREQUENCY ABLATION; CLINICAL-EVALUATION; CONTRAST AGENTS; HEPATOCELLULAR-CARCINOMA; TUMOR ABLATION; THERMOMETRY; METASTASES; LESIONS	Objective: To evaluate the potency of Gd-EOB-DTPA to support hepatic catheter placement in laser ablation procedures by quantifying time-dependent delineation effects for instrumentation and target tumor within liver parenchyma. Monitoring potential influence on online MR thermometry during the ablation procedure is a secondary aim. Materials and Methods: 30 cases of MR-guided laser ablation were performed after i.v. bolus injection of gadoxetic acid (0.025 mmol/Kg Gd-EOB-DTPA; Bayer Healthcare, Berlin, Germany). T1-weighted GRE sequences were used for applicator guidance (FLASH 3D) in the catheter placement phase and for therapy monitoring (FLASH 2D) in the therapy phase. SNR and consecutive CNR values were measured for elements of interest plotted over time both for catheter placement and therapy phase and compared with a non-contrast control group of 19 earlier cases. Statistical analysis was realized using the paired Wilcoxon test. Results: Sustainable signal elevation of liver parenchyma in the contrast-enhanced group was sufficient to silhouette both target tumor and applicator against the liver. Differences in time dependent CNR alteration were highly significant between contrast-enhanced and non-contrast interventions for parenchyma and target on the one hand (p=0.020) and parenchyma and instrument on the other hand (p=0.002). Effects lasted for the whole procedure (monitoring up to 60 min) and were specific for the contrast-enhanced group. Contrasting maxima were seen after median 30 (applicator) and 38 (tumor) minutes, in the potential core time of a multineedle procedure. Contrast influence on T1 thermometry for real-time monitoring of thermal impact was not significant (p=0.068-0.715). Conclusion: Results strongly support anticipated promotive effects of Gd-EOB-DTPA for MR-guided percutaneous liver interventions by proving and quantifying the delineating effects for therapy-relevant elements in the procedure. Time benefit, cost effectiveness and oncologic outcome of the described beneficiary effects will have to be part of further investigations.	[Rosenberg, Christian; Jahn, Andrea; Hosten, Norbert] Univ Med Greifswald, Inst Diagnost Radiol & Neuroradiol, Greifswald, Mecklenburg Vor, Germany; [Pickartz, Tilman; Wahnschaffe, Ulrich] Univ Med Greifswald, Div Gastroenterol Endocrinol & Nutr Med, Clin Internal Med, Greifswald, Mecklenburg Vor, Germany; [Patrzyk, Maciej] Univ Med Greifswald, Clin Gen Surg Visceral Thorac & Vasc Surg, Greifswald, Mecklenburg Vor, Germany	Greifswald Medical School; Greifswald Medical School; Greifswald Medical School	Rosenberg, C (corresponding author), Univ Med Greifswald, Inst Diagnost Radiol & Neuroradiol, Greifswald, Mecklenburg Vor, Germany.	rosenberg@uni-greifswald.de						Ba-Ssalamah A, 2009, EUR RADIOL, V19, P342, DOI 10.1007/s00330-008-1172-x; Bathe OF, 2007, J SURG ONCOL, V95, P670, DOI 10.1002/jso.20768; Bluemke DA, 2005, RADIOLOGY, V237, P89, DOI 10.1148/radiol.2371031842; Bruderl J., 2010, HDB SOZIALWISSENSCHA, P963; Crocetti L, 2010, CARDIOVASC INTER RAD, V33, P11, DOI 10.1007/s00270-009-9736-y; de Senneville BD, 2007, EUR RADIOL, V17, P2401, DOI 10.1007/s00330-007-0646-6; Elst LV, 1997, MAGNET RESON MED, V38, P604, DOI 10.1002/mrm.1910380415; Fahrmeir  L., 1996, MULTIVARIATE STAT VE; Filippone A, 2010, J MAGN RESON IMAGING, V31, P356, DOI 10.1002/jmri.22054; Fischbach F, 2011, J MAGN RESON IMAGING, V34, P874, DOI 10.1002/jmri.22691; Frericks BB, 2009, AM J ROENTGENOL, V193, P1053, DOI 10.2214/AJR.08.1946; Gillams AR, 2005, ABDOM IMAGING, V30, P419, DOI 10.1007/s00261-004-0256-6; Goldberg SN, 2009, J VASC INTERV RADIOL, V20, pS377, DOI 10.1016/j.jvir.2009.04.011; Halavaara J, 2006, J COMPUT ASSIST TOMO, V30, P345, DOI 10.1097/00004728-200605000-00001; HAMM B, 1995, RADIOLOGY, V195, P785, DOI 10.1148/radiology.195.3.7754011; Hammerstingl R, 2008, EUR RADIOL, V18, P457, DOI 10.1007/s00330-007-0716-9; Kickhefel A, 2011, J MAGN RESON IMAGING, V33, P704, DOI 10.1002/jmri.22499; Kuhn FP, 2013, EUR J NUCL MED MOL I, V40, P44, DOI 10.1007/s00259-012-2236-3; Lencioni Riccardo, 2013, Recent Results Cancer Res, V190, P181, DOI 10.1007/978-3-642-16037-0_12; Lencioni Riccardo, 2008, Expert Rev Gastroenterol Hepatol, V2, P697, DOI 10.1586/17474124.2.5.697; Lepetit-Coiffe M, 2010, EUR RADIOL, V20, P193, DOI 10.1007/s00330-009-1532-1; Mahnken AH, 2013, RADIOLOGY, V266, P407, DOI 10.1148/radiol.12112544; McDermott S, 2013, SEMIN INTERVENT RAD, V30, P49, DOI 10.1055/s-0033-1333653; Meister D, 2007, ROFO-FORTSCHR RONTG, V179, P497, DOI 10.1055/s-2007-962979; Nour Sherif Gamal, 2005, Magn Reson Imaging Clin N Am, V13, P561, DOI 10.1016/j.mric.2005.04.007; PARKER DL, 1984, IEEE T BIO-MED ENG, V31, P161, DOI 10.1109/TBME.1984.325382; Puls R, 2007, J MAGN RESON IMAGING, V25, P1174, DOI 10.1002/jmri.20936; Puls R, 2009, J VASC INTERV RADIOL, V20, P225, DOI 10.1016/j.jvir.2008.10.018; Raman SS, 2010, J COMPUT ASSIST TOMO, V34, P163, DOI 10.1097/RCT.0b013e3181c89d87; Reimer P, 1997, EUR RADIOL, V7, P275, DOI 10.1007/s003300050150; Reimer P, 1996, RADIOLOGY, V199, P177, DOI 10.1148/radiology.199.1.8633143; Rempp H, 2009, J MAGN RESON IMAGING, V30, P631, DOI 10.1002/jmri.21863; Rieke V, 2008, J MAGN RESON IMAGING, V27, P376, DOI 10.1002/jmri.21265; Rosenberg C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078559; Schmiegel W, 2010, Z GASTROENTEROL, V48, P65, DOI 10.1055/s-0028-1109936; Seale MK, 2009, RADIOGRAPHICS, V29, P1725, DOI 10.1148/rg.296095515; Sieber MA, 2009, J MAGN RESON IMAGING, V30, P1268, DOI 10.1002/jmri.21971; Stafford R. Jason, 2010, Critical Reviews in Biomedical Engineering, V38, P79, DOI 10.1615/CritRevBiomedEng.v38.i1.70; Vogl TJ, 1998, ROFO-FORTSCHR RONTG, V169, P182, DOI 10.1055/s-2007-1015071; Vogl TJ, 2004, INT J HYPERTHER, V20, P713, DOI 10.1080/02656730400007212	40	10	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e109217	10.1371/journal.pone.0109217	http://dx.doi.org/10.1371/journal.pone.0109217			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541950	gold, Green Published, Green Submitted			2022-12-27	WOS:000347239900002
J	Marthandan, S; Priebe, S; Hemmerich, P; Klement, K; Diekmann, S				Marthandan, Shiva; Priebe, Steffen; Hemmerich, Peter; Klement, Karolin; Diekmann, Stephan			Long-Term Quiescent Fibroblast Cells Transit into Senescence	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; TELOMERE SHORTENING TRIGGERS; HUMAN-DIPLOID FIBROBLASTS; CYTOCHROME-C RELEASE; DNA-DAMAGE RESPONSE; CELLULAR SENESCENCE; REPLICATIVE SENESCENCE; PREMATURE SENESCENCE; LIFE-SPAN; MOLECULAR-MECHANISMS	Cellular senescence is described to be a consequence of telomere erosion during the replicative life span of primary human cells. Quiescence should therefore not contribute to cellular aging but rather extend lifespan. Here we tested this hypothesis and demonstrate that cultured long-term quiescent human fibroblasts transit into senescence due to similar cellular mechanisms with similar dynamics and with a similar maximum life span as proliferating controls, even under physiological oxygen conditions. Both, long-term quiescent and senescent fibroblasts almost completely fail to undergo apoptosis. The transition of long-term quiescent fibroblasts into senescence is also independent of HES1 which protects short-term quiescent cells from becoming senescent. Most significantly, DNA damage accumulates during senescence as well as during long-term quiescence at physiological oxygen levels. We suggest that telomere-independent, potentially maintenance driven gradual induction of cellular senescence during quiescence is a counterbalance to tumor development.	[Marthandan, Shiva; Hemmerich, Peter; Klement, Karolin; Diekmann, Stephan] JenAge Jena Ctr Syst Biol Aging, Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany; [Priebe, Steffen] Hans Knoll Inst eV HKI, Leibniz Inst Nat Prod Res & Infect Biol, Jena, Germany	Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Hans Knoll Institute (HKI)	Diekmann, S (corresponding author), JenAge Jena Ctr Syst Biol Aging, Fritz Lipmann Inst, Leibniz Inst Age Res, Beutenbergstr 11, Jena, Germany.	diekmann@fli-leibniz.de			Bundesministerium fur Bildung und Forschung (BMBF) [0315581]	Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by Bundesministerium fur Bildung und Forschung (BMBF), Grant code: 0315581.	Adams PD, 2009, MOL CELL, V36, P2, DOI 10.1016/j.molcel.2009.09.021; ALLSOPP RC, 1995, EXP CELL RES, V220, P194, DOI 10.1006/excr.1995.1306; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Asai T, 2011, J CELL PHYSIOL, V226, P2215, DOI 10.1002/jcp.22561; Ashrafi K, 1999, P NATL ACAD SCI USA, V96, P9100, DOI 10.1073/pnas.96.16.9100; ATADJA P, 1995, EXP CELL RES, V217, P205, DOI 10.1006/excr.1995.1080; Atamna H, 2000, J BIOL CHEM, V275, P6741, DOI 10.1074/jbc.275.10.6741; AUGENLICHT LH, 1974, EXP CELL RES, V89, P255, DOI 10.1016/0014-4827(74)90789-7; Bauer DE, 2004, FASEB J, V18, P1303, DOI 10.1096/fj.03-1001fje; BEAUSEJOUR CM, 2003, REVERSAL HUMAN CELLU, V22, P4212; Beerman I, 2014, CELL STEM CELL, V15, P37, DOI 10.1016/j.stem.2014.04.016; Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013; Ben-Porath I, 2004, J CLIN INVEST, V113, P8, DOI 10.1172/JCI200420663; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bladier C, 1997, CELL GROWTH DIFFER, V8, P589; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Campisi J, 2005, SCIENCE, V309, P886, DOI 10.1126/science.1116801; Campisi J, 2008, AGING CELL, V7, P281, DOI 10.1111/j.1474-9726.2008.00383.x; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chassot AA, 2008, CELL CYCLE, V7, P2038, DOI 10.4161/cc.7.13.6233; Chicas A, 2010, CANCER CELL, V17, P376, DOI 10.1016/j.ccr.2010.01.023; Cho S, 2012, MOL CELLS, V33, P597, DOI 10.1007/s10059-012-0042-1; Coller HA, 2006, PLOS BIOL, V4, P329, DOI 10.1371/journal.pbio.0040083; Crescenzi E, 2003, BIOCHEM J, V375, P263, DOI 10.1042/BJ20030868; Cristofalo VJ, 2004, MECH AGEING DEV, V125, P827, DOI 10.1016/j.mad.2004.07.010; CRISTOFALO VJ, 1993, PHYSIOL REV, V73, P617, DOI 10.1152/physrev.1993.73.3.617; Cristofalo VJ, 2005, EXP GERONTOL, V40, P836, DOI 10.1016/j.exger.2005.08.005; Dai CY, 2000, ONCOGENE, V19, P1613, DOI 10.1038/sj.onc.1203438; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; Debacq-Chainlaux F, 2005, J CELL SCI, V118, P743, DOI 10.1242/jcs.01651; DeJesus V, 2002, EXP CELL RES, V274, P92, DOI 10.1006/excr.2001.5425; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; Dimri GP, 2000, MOL CELL BIOL, V20, P273, DOI 10.1128/MCB.20.1.273-285.2000; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dulic V, 2011, AGING-US, V3, P3, DOI 10.18632/aging.100257; Durand B, 1997, EMBO J, V16, P306, DOI 10.1093/emboj/16.2.306; Ekholm SV, 2000, CURR OPIN CELL BIOL, V12, P676, DOI 10.1016/S0955-0674(00)00151-4; Evertts AG, 2013, MOL BIOL CELL, V24, P3025, DOI 10.1091/mbc.E12-07-0529; Finucane DM, 1999, J BIOL CHEM, V274, P2225, DOI 10.1074/jbc.274.4.2225; Forsyth NR, 2003, AGING CELL, V2, P235, DOI 10.1046/j.1474-9728.2003.00057.x; Forsyth NR, 2002, DIFFERENTIATION, V69, P188, DOI 10.1046/j.1432-0436.2002.690412.x; Gire V, 1998, MOL CELL BIOL, V18, P1611, DOI 10.1128/MCB.18.3.1611; Gray JV, 2004, MICROBIOL MOL BIOL R, V68, P187, DOI 10.1128/MMBR.68.2.187-206.2004; Grigoryev SA, 2004, J CELL SCI, V117, P6153, DOI 10.1242/cs.01537; Hara E, 1996, MOL CELL BIOL, V16, P859; Hardcastle TJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-422; HARLEY CB, 1991, MUTAT RES, V256, P271, DOI 10.1016/0921-8734(91)90018-7; HAYFLICK L, 1985, EXP GERONTOL, V20, P145, DOI 10.1016/0531-5565(85)90032-4; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Holliday R, 2014, INTERD T GERONT GERI, V39, P1, DOI 10.1159/000358896; Hornsby PJ, 2002, J GERONTOL A-BIOL, V57, pB251, DOI 10.1093/gerona/57.7.B251; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hwang ES, 2002, MECH AGEING DEV, V123, P1681, DOI 10.1016/S0047-6374(02)00102-1; Imai Y, 2014, CELL REP, V7, P194, DOI 10.1016/j.celrep.2014.03.006; JACOBS JP, 1970, NATURE, V227, P168, DOI 10.1038/227168a0; Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008; JIANG HP, 1994, ONCOGENE, V9, P3397; Johansson AC, 2003, CELL DEATH DIFFER, V10, P1253, DOI 10.1038/sj.cdd.4401290; Jones CJ, 2000, MOL CELL BIOL, V20, P5690, DOI 10.1128/MCB.20.15.5690-5699.2000; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim SY, 2011, APOPTOSIS, V16, P795, DOI 10.1007/s10495-011-0612-2; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krtolica A, 2002, INT J BIOCHEM CELL B, V34, P1401, DOI 10.1016/S1357-2725(02)00053-5; Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560; Lackner DH, 2014, AGING CELL, V13, P946, DOI 10.1111/acel.12234; Ladha MH, 1998, MOL CELL BIOL, V18, P6605, DOI 10.1128/MCB.18.11.6605; Lane AA, 2010, CELL, V142, P360, DOI 10.1016/j.cell.2010.07.030; Laporte D, 2013, J CELL BIOL, V203, P585, DOI 10.1083/jcb.201306075; Lemons JMS, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000514; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu Y, 2009, CELL STEM CELL, V4, P37, DOI 10.1016/j.stem.2008.11.006; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lorenzini A, 2009, MECH AGEING DEV, V130, P784, DOI 10.1016/j.mad.2009.10.004; Lowndes NF, 2005, CURR BIOL, V15, pR99, DOI 10.1016/j.cub.2005.01.029; LUCIBELLO FC, 1993, J CELL SCI, V105, P123; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; Mallette FA, 2007, GENE DEV, V21, P43, DOI 10.1101/gad.1487307; Manns J, 2011, FASEB J, V25, P3250, DOI 10.1096/fj.10-177527; Mazars GR, 1997, P NATL ACAD SCI USA, V94, P151, DOI 10.1073/pnas.94.1.151; Mazzini G, 2003, EUR J HISTOCHEM, V47, P289; Meyyappan M, 1998, MOL CELL BIOL, V18, P3163, DOI 10.1128/MCB.18.6.3163; Munro J, 2001, ONCOGENE, V20, P3541, DOI 10.1038/sj.onc.1204460; Naderi J, 2003, APOPTOSIS, V8, P91, DOI 10.1023/A:1021657220843; OKAMOTO A, 1994, P NATL ACAD SCI USA, V91, P11045, DOI 10.1073/pnas.91.23.11045; OLOVNIKO.AM, 1971, DOKL AKAD NAUK SSSR+, V201, P1496; Pajalunga D, 2007, J CELL BIOL, V176, P807, DOI 10.1083/jcb.200608109; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Passos JF, 2009, AGE, V31, P353, DOI 10.1007/s11357-009-9108-1; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Pawlowski J, 2000, P NATL ACAD SCI USA, V97, P529, DOI 10.1073/pnas.97.2.529; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; Perucca P, 2009, CELL CYCLE, V8, P105, DOI 10.4161/cc.8.1.7507; Pignolo RJ, 1998, EXP GERONTOL, V33, P67, DOI 10.1016/S0531-5565(97)00090-9; Pitiyage GN, 2011, J PATHOL, V223, P604, DOI 10.1002/path.2839; Rivard N, 1996, J BIOL CHEM, V271, P18337, DOI 10.1074/jbc.271.31.18337; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; SAGER R, 1991, ENVIRON HEALTH PERSP, V93, P59, DOI 10.2307/3431170; Sang LY, 2008, SCIENCE, V321, P1095, DOI 10.1126/science.1155998; Saretzki G, 1999, ONCOGENE, V18, P5148, DOI 10.1038/sj.onc.1202898; Schauble S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042150; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Seluanov A, 2001, MOL CELL BIOL, V21, P1552, DOI 10.1128/MCB.21.5.1552-1564.2001; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Severino J, 2000, EXP CELL RES, V257, P162, DOI 10.1006/excr.2000.4875; Sgambato A, 2000, J CELL PHYSIOL, V183, P18, DOI 10.1002/(SICI)1097-4652(200004)183:1<18::AID-JCP3>3.0.CO;2-S; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Sitte N, 1998, FREE RADICAL BIO MED, V24, P885, DOI 10.1016/S0891-5849(97)00363-8; SMITH JR, 1980, SCIENCE, V207, P82; Soldani C, 2001, EUR J HISTOCHEM, V45, P389; SOPRANO KJ, 1994, J CELL BIOCHEM, V54, P405, DOI 10.1002/jcb.240540407; Steinert S, 2000, BIOCHEM BIOPH RES CO, V273, P1095, DOI 10.1006/bbrc.2000.3080; Suram A, 2014, AGING CELL, V13, P780, DOI 10.1111/acel.12246; Thuret G, 2003, BRIT J OPHTHALMOL, V87, P346, DOI 10.1136/bjo.87.3.346; Toussaint O, 2000, EXP GERONTOL, V35, P927, DOI 10.1016/S0531-5565(00)00180-7; TRLIFAJO.J, 1968, J HYG EPID MICROB IM, V12, P212; Uhrbom L, 1997, ONCOGENE, V15, P505, DOI 10.1038/sj.onc.1201227; van Os R, 2009, CELL STEM CELL, V4, P7, DOI 10.1016/j.stem.2008.12.007; von Zglinicki T, 2005, MECH AGEING DEV, V126, P111, DOI 10.1016/j.mad.2004.09.034; WANG E, 1995, CANCER RES, V55, P2284; WATSON JD, 1972, NATURE-NEW BIOL, V239, P197, DOI 10.1038/newbio239197a0; Wolstein JM, 2010, AM J PHYSIOL-RENAL, V299, pF1486, DOI 10.1152/ajprenal.00378.2010; Wright WE, 2001, CURR OPIN GENET DEV, V11, P98, DOI 10.1016/S0959-437X(00)00163-5; Yang NC, 2005, EXP GERONTOL, V40, P813, DOI 10.1016/j.exger.2005.07.011; Yusuf I, 2003, TRENDS IMMUNOL, V24, P380, DOI 10.1016/S1471-4906(03)00141-8; Zezula J, 2001, EMBO REP, V2, P27, DOI 10.1093/embo-reports/kve008; Zhang JL, 2002, MECH AGEING DEV, V123, P613, DOI 10.1016/S0047-6374(01)00412-2; Zhang XF, 2012, INT J MOL SCI, V13, P5866, DOI 10.3390/ijms13055866	135	31	32	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115597	10.1371/journal.pone.0115597	http://dx.doi.org/10.1371/journal.pone.0115597			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531649	Green Submitted, Green Published, gold			2022-12-27	WOS:000348845100081
J	Lahesaare, A; Moor, H; Kivisaar, M; Teras, R				Lahesaare, Andrio; Moor, Hanna; Kivisaar, Maia; Teras, Riho			Pseudomonas putida Fis Binds to the lapF Promoter In Vitro and Represses the Expression of LapF	PLOS ONE			English	Article							ESCHERICHIA-COLI; BIOFILM FORMATION; TOL PLASMID; PROTEIN; DNA; SIGMA(S); IDENTIFICATION; TRANSCRIPTION; COLONIZATION; DERIVATIVES	The biofilm matrix of the rhizospheric bacterium Pseudomonas putida consists mainly of a proteinaceous component. The two largest P. putida proteins, adhesins LapA and LapF, are involved in biofilm development but prevail in different developmental stages of the biofilm matrix. LapA is abundant in the initial stage of biofilm formation whereas LapF is found in the mature biofilm. Although the transcriptional regulation of the adhesins is not exhaustively studied, some factors that can be involved in their regulation have been described. For example, RpoS, the major stress response sigma factor, activates, and Fis represses LapF expression. This study focused on the LapF expression control by Fis. Indeed, using DNase I footprint analysis a Fis binding site Fis-F2 was located 150 bp upstream of the lapF gene coding sequence. The mapped 59 end of the lapF mRNA localized the promoter to the same region, overlapping with the Fis binding site Fi-sF2. Monitoring the lapF promoter activity by a beta-galactosidase assay revealed that Fis overexpression causes a 4-fold decrease in the transcriptional activity. Furthermore, mutations that diminished Fis binding to the Fis-F2 site abolished the repression of the lapF promoter. Thus, these data suggest that Fis is involved in the biofilm regulation via repression of LapF expression.	[Lahesaare, Andrio; Moor, Hanna; Kivisaar, Maia; Teras, Riho] Univ Tartu, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia	University of Tartu	Teras, R (corresponding author), Univ Tartu, Inst Mol & Cell Biol, Ulikooli 18, EE-50090 Tartu, Estonia.	riho.teras@ut.ee	Teras, Riho/ABA-8761-2021	Ainelo, Hanna/0000-0003-3340-9120	Estonian Ministry of Education and Research [SF0180031s08, IUT20-19]	Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia)	This work was supported by funding of Targeted Financing Project SF0180031s08 and Institutional Research Funding IUT20-19 from Estonian Ministry of Education and Research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertani I, 2003, ARCH MICROBIOL, V180, P264, DOI 10.1007/s00203-003-0586-8; Browning DF, 2010, CURR OPIN MICROBIOL, V13, P773, DOI 10.1016/j.mib.2010.09.013; Canosa I, 1999, J BACTERIOL, V181, P1748, DOI 10.1128/JB.181.6.1748-1754.1999; Chaudhuri RR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008801; Czeczulin JR, 1997, INFECT IMMUN, V65, P4135, DOI 10.1128/IAI.65.10.4135-4145.1997; DELORENZO V, 1993, J BACTERIOL, V175, P6902, DOI 10.1128/jb.175.21.6902-6907.1993; DELORENZO V, 1990, J BACTERIOL, V172, P6568, DOI 10.1128/jb.172.11.6568-6572.1990; Dorman CJ, 2009, ADV APPL MICROBIOLOG; Espinosa-Urgel M, 2000, J BACTERIOL, V182, P2363, DOI 10.1128/JB.182.9.2363-2369.2000; FINKEL SE, 1992, MOL MICROBIOL, V6, P3257, DOI 10.1111/j.1365-2958.1992.tb02193.x; Friedman L, 2004, MOL MICROBIOL, V51, P675, DOI 10.1046/j.1365-2958.2003.03877.x; Fuqua C, 2010, MOL MICROBIOL, V77, P533, DOI 10.1111/j.1365-2958.2010.07250.x; Gama-Castro S., NUCL ACIDS RES, V39, pD98; Gjermansen M, 2010, MOL MICROBIOL, V75, P815, DOI 10.1111/j.1365-2958.2009.06793.x; Hinsa SM, 2003, MOL MICROBIOL, V49, P905, DOI 10.1046/j.1365-2958.2003.03615.x; Jahn A, 1999, BIOFOULING, V14, P49, DOI 10.1080/08927019909378396; Jakovleva J, 2012, MICROBIOL-SGM, V158, P708, DOI 10.1099/mic.0.053355-0; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; LANG HN, 1993, MOL MICROBIOL, V10, P891, DOI 10.1111/j.1365-2958.1993.tb00960.x; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Marques S, 1995, MOL MICROBIOL, V18, P851, DOI 10.1111/j.1365-2958.1995.18050851.x; Martinez-Gil M, 2014, J BACTERIOL, V196, P1484, DOI 10.1128/JB.01287-13; Martinez-Gil M, 2010, MOL MICROBIOL, V77, P549, DOI 10.1111/j.1365-2958.2010.07249.x; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Miura K, 1998, MOL GEN GENET, V259, P72, DOI 10.1007/s004380050790; Moor H, 2014, MICROBIOLOGY; Prigent-Combaret C, 2012, MOL MICROBIOL, V86, P172, DOI 10.1111/j.1365-2958.2012.08182.x; Ryder C, 2007, CURR OPIN MICROBIOL, V10, P644, DOI 10.1016/j.mib.2007.09.010; Saldana Z, 2009, ENVIRON MICROBIOL, V11, P992, DOI 10.1111/j.1462-2920.2008.01824.x; Sambrook J., 2001, MOL CLONING LAB MANU; Shao YP, 2008, J MOL BIOL, V376, P771, DOI 10.1016/j.jmb.2007.11.101; Sharma RC, 1996, BIOTECHNIQUES, V20, P42; Sheikh J, 2001, MOL MICROBIOL, V41, P983, DOI 10.1046/j.1365-2958.2001.02512.x; Sutherland IW, 2001, TRENDS MICROBIOL, V9, P222, DOI 10.1016/S0966-842X(01)02012-1; Tavita K, 2012, MUTAT RES-FUND MOL M, V737, P12, DOI 10.1016/j.mrfmmm.2012.07.004; Teras R, 2000, J BACTERIOL, V182, P589, DOI 10.1128/JB.182.3.589-598.2000; Teras R, 2009, MICROBIOL-SGM, V155, P1203, DOI 10.1099/mic.0.022830-0; Typas A, 2007, MOL MICROBIOL, V63, P1296, DOI 10.1111/j.1365-2958.2007.05601.x; Waite RD, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-162; Yousef-Coronado F, 2008, FEMS MICROBIOL LETT, V288, P118, DOI 10.1111/j.1574-6968.2008.01339.x; Yuste L, 2006, ENVIRON MICROBIOL, V8, P165, DOI 10.1111/j.1462-2920.2005.00890.x	41	10	10	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115901	10.1371/journal.pone.0115901	http://dx.doi.org/10.1371/journal.pone.0115901			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545773	gold, Green Published, Green Submitted			2022-12-27	WOS:000347120200080
J	O'Loughlin, J; Sylvestre, MP; Labbe, A; Low, NC; Roy-Gagnon, MH; Dugas, EN; Karp, I; Engert, JC				O'Loughlin, Jennifer; Sylvestre, Marie-Pierre; Labbe, Aurelie; Low, Nancy C.; Roy-Gagnon, Marie-Helene; Dugas, Erika N.; Karp, Igor; Engert, James C.			Genetic Variants and Early Cigarette Smoking and Nicotine Dependence Phenotypes in Adolescents	PLOS ONE			English	Article							DOPAMINE TRANSPORTER GENE; RECEPTOR DRD2 GENE; FUNCTIONAL POLYMORPHISM; GENOME-WIDE; RISK-FACTOR; ASSOCIATION; BEHAVIOR; SMOKERS; METAANALYSIS; HAPLOTYPE	Background: While the heritability of cigarette smoking and nicotine dependence (ND) is well-documented, the contribution of specific genetic variants to specific phenotypes has not been closely examined. The objectives of this study were to test the associations between 321 tagging single-nucleotide polymorphisms (SNPs) that capture common genetic variation in 24 genes, and early smoking and ND phenotypes in novice adolescent smokers, and to assess if genetic predictors differ across these phenotypes. Methods: In a prospective study of 1294 adolescents aged 12-13 years recruited from ten Montreal-area secondary schools, 544 participants who had smoked at least once during the 7-8 year follow-up provided DNA. 321 single-nucleotide polymorphisms (SNPs) in 24 candidate genes were tested for an association with number of cigarettes smoked in the past 3 months, and with five ND phenotypes (a modified version of the Fagerstrom Tolerance Questionnaire, the ICD-10 and three clusters of ND symptoms representing withdrawal symptoms, use of nicotine for self-medication, and a general ND/craving symptom indicator). Results: The pattern of SNP-gene associations differed across phenotypes. Sixteen SNPs in seven genes (ANKK1, CHRNA7, DDC, DRD2, COMT, OPRM1, SLC6A3 (also known as DAT1)) were associated with at least one phenotype with a p-value <0.01 using linear mixed models. After permutation and FDR adjustment, none of the associations remained statistically significant, although the p-values for the association between rs557748 in OPRM1 and the ND/craving and self-medication phenotypes were both 0.076. Conclusions: Because the genetic predictors differ, specific cigarette smoking and ND phenotypes should be distinguished in genetic studies in adolescents. Fifteen of the 16 top-ranked SNPs identified in this study were from loci involved in dopaminergic pathways (ANKK1/DRD2, DDC, COMT, OPRM1, and SLC6A3). Impact: Dopaminergic pathways may be salient during early smoking and the development of ND.	[O'Loughlin, Jennifer; Sylvestre, Marie-Pierre; Dugas, Erika N.; Karp, Igor] Ctr Rech CHUM, Montreal, PQ, Canada; [O'Loughlin, Jennifer; Sylvestre, Marie-Pierre; Karp, Igor] Univ Montreal, Dept Social & Prevent Med, Montreal, PQ, Canada; [O'Loughlin, Jennifer] Inst Natl Sante Publ Quebec, Montreal, PQ, Canada; [Labbe, Aurelie] McGill Univ, Dept Epidemiol, Montreal, PQ, Canada; [Low, Nancy C.] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Roy-Gagnon, Marie-Helene] Univ Ottawa, Fac Med, Dept Epidemiol & Community Med, Ottawa, ON, Canada; [Karp, Igor] Univ Western Ontario, Dept Epidemiol & Biostat, Schulich Sch Med & Dent, London, ON, Canada; [Engert, James C.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Engert, James C.] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Engert, James C.] McGill Univ, Res Inst, Ctr Hlth, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Institut national de sante publique du Quebec (INSPQ); McGill University; McGill University; University of Ottawa; Western University (University of Western Ontario); McGill University; McGill University; McGill University	O'Loughlin, J (corresponding author), Ctr Rech CHUM, Montreal, PQ, Canada.	jennifer.oloughlin@umontreal.ca	Sylvestre, Marie-Pierre/CAF-5219-2022; Dugas, Erika/AAH-7550-2020	Sylvestre, Marie-Pierre/0000-0001-5803-4615; Roy-Gagnon, Marie-Helene/0000-0001-8747-0846; Engert, James/0000-0001-8411-4790	Canadian Cancer Society [010271, 017435]	Canadian Cancer Society(Canadian Cancer Society (CCS))	J O'Loughlin holds a Canada Research Chair in the Early Determinants of Adult Chronic Disease. I Karp is a Fonds de la Recherche en Sante du Quebec Junior 1 Scholar and Canadian Institutes of Health Research New Investigator. This work was supported by Canadian Cancer Society grant numbers 010271 and 017435 awarded to J O'Loughlin (http://www.cancer.ca/en/?region=qc). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Audrain-McGovern J, 2004, AM J PSYCHIAT, V161, P1224, DOI 10.1176/appi.ajp.161.7.1224; Baker TB, 2009, NICOTINE TOB RES, V11, P785, DOI 10.1093/ntr/ntp064; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bates D, 2014, LME4 LINEAR MIXED EF; Batra A, 2000, ADDICT BIOL, V5, P429, DOI 10.1111/j.1369-1600.2000.tb00212.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BENOWITZ NL, 1988, NEW ENGL J MED, V319, P1318; Bergen AW, 2009, NEUROPSYCHOPHARMACOL, V34, P2252, DOI 10.1038/npp.2009.52; Breitling LP, 2009, PHARMACOGENET GENOM, V19, P657, DOI 10.1097/FPC.0b013e32832fabf3; Caporaso N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004653; Carpenter CM, 2007, ADDICTION, V102, P136, DOI 10.1111/j.1360-0443.2006.01649.x; Centers for Disease Control and Prevention (CDC), 1998, MMWR Morb Mortal Wkly Rep, V47, P386; Chen YT, 2013, J HUM GENET, V58, P84, DOI 10.1038/jhg.2012.139; Comings DE, 1996, PHARMACOGENETICS, V6, P73, DOI 10.1097/00008571-199602000-00006; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; DiFranza JR, 2007, ARCH PEDIAT ADOL MED, V161, P704, DOI 10.1001/archpedi.161.7.704; Doran N, 2013, SUBST USE MISUSE, V48, P106, DOI 10.3109/10826084.2012.733791; Ducci F, 2011, BIOL PSYCHIAT, V69, P650, DOI 10.1016/j.biopsych.2010.09.055; Eppel A, 2006, ADDICT BEHAV, V31, P1700, DOI 10.1016/j.addbeh.2005.11.006; Erblich J, 2004, PHARMACOGENOMICS J, V4, P102, DOI 10.1038/sj.tpj.6500227; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Gelernter J, 2006, HUM MOL GENET, V15, P3498, DOI 10.1093/hmg/ddl426; Goeman JJ, 2014, STAT MED, V33, P1946, DOI 10.1002/sim.6082; Han SZ, 2010, BIOL PSYCHIAT, V67, P12, DOI 10.1016/j.biopsych.2009.08.028; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Hiemstra M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086497; Hiemstra M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061673; Huang SW, 2005, PHARMACOGENET GENOM, V15, P839, DOI 10.1097/01213011-200512000-00002; Huang WH, 2009, NEUROPSYCHOPHARMACOL, V34, P319, DOI 10.1038/npp.2008.37; Jorm AF, 2000, AM J MED GENET, V96, P331, DOI 10.1002/1096-8628(20000612)96:3<331::AID-AJMG19>3.0.CO;2-0; Keskitalo-Vuokko K, 2011, NICOTINE TOB RES, V13, P686, DOI 10.1093/ntr/ntr059; Laucht M, 2008, J AM ACAD CHILD PSY, V47, P673, DOI 10.1097/CHI.0b013e31816bff77; Leonard S, 2001, Nicotine Tob Res, V3, P203; Lerman CE, 2007, AM J PREV MED, V33, pS398, DOI 10.1016/j.amepre.2007.09.006; Li DL, 2011, AM J EPIDEMIOL, V173, P1039, DOI 10.1093/aje/kwq471; Li MD, 2003, ADDICTION, V98, P23, DOI 10.1046/j.1360-0443.2003.00295.x; Li MD, 2004, CLIN GENET, V66, P382, DOI 10.1111/j.1399-0004.2004.00302.x; Ling DJ, 2004, J HUM GENET, V49, P35, DOI 10.1007/s10038-003-0104-5; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; Lobo DSS, 2012, WORLD J BIOL PSYCHIA, V13, P232, DOI 10.3109/15622975.2011.598560; Ma JZ, 2005, HUM MOL GENET, V14, P1691, DOI 10.1093/hmg/ddi177; Munafo MR, 2008, ADDICTION, V103, P893, DOI 10.1111/j.1360-0443.2007.02071.x; Munafo MR, 2004, TRENDS GENET, V20, P439, DOI 10.1016/j.tig.2004.06.014; Munafo MR, 2004, NICOTINE TOB RES, V6, P583, DOI 10.1080/14622200410001734030; National Cancer Institute, 2009, NIH PUBLICATION; Nestler EJ, 2002, NAT NEUROSCI, V5, P1076, DOI 10.1038/nn945; O'Loughlin J, 2002, TOB CONTROL, V11, P354, DOI 10.1136/tc.11.4.354; O'Loughlin J, 2002, NICTOB RES, V4, P20; O'Loughlin J., 2014, INT J EPIDE IN PRESS; O'Loughlin J, 2009, AM J PUBLIC HEALTH, V99, P499, DOI 10.2105/AJPH.2007.128629; Omidvar M, 2009, PHARMACOGENET GENOM, V19, P45, DOI 10.1097/FPC.0b013e328317f3f8; Pedneault M, 2014, ADDICT BEHAV, V39, P316, DOI 10.1016/j.addbeh.2013.08.033; Perkins KA, 2008, BEHAV PHARMACOL, V19, P641, DOI 10.1097/FBP.0b013e32830c367c; Radwan GN, 2007, NICOTINE TOB RES, V9, P1325, DOI 10.1080/14622200701704889; Ray R, 2011, P NATL ACAD SCI USA, V108, P9268, DOI 10.1073/pnas.1018699108; Rojas NL, 1998, ARCH PEDIAT ADOL MED, V152, P151, DOI 10.1001/archpedi.152.2.151; Saccone NL, 2010, GENES BRAIN BEHAV, V9, P741, DOI 10.1111/j.1601-183X.2010.00608.x; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Sherva R, 2008, ADDICTION, V103, P1544, DOI 10.1111/j.1360-0443.2008.02279.x; Shield AJ, 2004, MOL PSYCHIATR, V9, P151, DOI 10.1038/sj.mp.4001386; SHIPPENBERG TS, 1992, ANN NY ACAD SCI, V654, P347, DOI 10.1111/j.1749-6632.1992.tb25980.x; Singleton AB, 1998, PHARMACOGENETICS, V8, P125, DOI 10.1097/00008571-199804000-00005; Stapleton JA, 2007, ADDICT BIOL, V12, P221, DOI 10.1111/j.1369-1600.2007.00058.x; Stephens SH, 2013, GENET EPIDEMIOL, V37, P846, DOI 10.1002/gepi.21760; Sullivan P F, 1999, Nicotine Tob Res, V1 Suppl 2, pS51; Sullivan P.F., 1999, NICOTINE TOB RES S2, V1, pS69; Tammimaki AE, 2010, PHARMACOGENET GENOM, V20, P717, DOI 10.1097/FPC.0b013e328340bdf2; TENHUNEN J, 1994, EUR J BIOCHEM, V223, P1049, DOI 10.1111/j.1432-1033.1994.tb19083.x; Thorgeirsson TE, 2010, NAT GENET, V42, P448, DOI 10.1038/ng.573; Timberlake DS, 2006, HEALTH PSYCHOL, V25, P190, DOI 10.1037/0278-6133.25.2.190; *US DEP HHS, 1994, PREV TOB US YOUNG PE; Vandenbergh David J, 2002, Nicotine Tob Res, V4, P333, DOI 10.1080/14622200210142689; Voisey J, 2012, PSYCHIAT RES, V196, P285, DOI 10.1016/j.psychres.2011.09.024; Wernicke C, 2009, PHARMACOPSYCHIATRY, V42, P41, DOI 10.1055/s-0028-1085444; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; Wheeler KC, 2004, J ADOLESCENT HEALTH, V35, P225, DOI 10.1016/j.jadohealth.2003.10.004; Wong SL, 2012, HEALTH REP, V23, P47; World Health Organization, 1992, INT STAT CLASS DIS R; Yi Y, 2006, HUM MOL GENET, V15, P2192, DOI 10.1093/hmg/ddl144; Zhang Lan, 2006, Behav Brain Funct, V2, P28, DOI 10.1186/1744-9081-2-28	82	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115716	10.1371/journal.pone.0115716	http://dx.doi.org/10.1371/journal.pone.0115716			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545355	Green Published, Green Submitted, gold			2022-12-27	WOS:000347120200060
J	Dendumrongsup, T; Plumb, AA; Halligan, S; Fanshawe, TR; Altman, DG; Mallett, S				Dendumrongsup, Thaworn; Plumb, Andrew A.; Halligan, Steve; Fanshawe, Thomas R.; Altman, Douglas G.; Mallett, Susan			Multi-Reader Multi-Case Studies Using the Area under the Receiver Operator Characteristic Curve as a Measure of Diagnostic Accuracy: Systematic Review with a Focus on Quality of Data Reporting	PLOS ONE			English	Article							COMPUTER-AIDED DETECTION; DORFMAN-BERBAUM-METZ; DIGITAL BREAST TOMOSYNTHESIS; MONTE-CARLO VALIDATION; RADIOLOGIST PERFORMANCE; CHEST RADIOGRAPHS; CT COLONOGRAPHY; LUNG NODULES; MAMMOGRAPHY; MULTIREADER	Introduction: We examined the design, analysis and reporting in multi-reader multi-case (MRMC) research studies using the area under the receiver-operating curve (ROC AUC) as a measure of diagnostic performance. Methods: We performed a systematic literature review from 2005 to 2013 inclusive to identify a minimum 50 studies. Articles of diagnostic test accuracy in humans were identified via their citation of key methodological articles dealing with MRMC ROC AUC. Two researchers in consensus then extracted information from primary articles relating to study characteristics and design, methods for reporting study outcomes, model fitting, model assumptions, presentation of results, and interpretation of findings. Results were summarized and presented with a descriptive analysis. Results: Sixty-four full papers were retrieved from 475 identified citations and ultimately 49 articles describing 51 studies were reviewed and extracted. Radiological imaging was the index test in all. Most studies focused on lesion detection vs. characterization and used less than 10 readers. Only 6 (12%) studies trained readers in advance to use the confidence scale used to build the ROC curve. Overall, description of confidence scores, the ROC curve and its analysis was often incomplete. For example, 21 (41%) studies presented no ROC curve and only 3 (6%) described the distribution of confidence scores. Of 30 studies presenting curves, only 4 (13%) presented the data points underlying the curve,thereby allowing assessment of extrapolation. The mean change in AUC was 0.05 (-0.05 to 0.28). Non-significant change in AUC was attributed to underpowering rather than the diagnostic test failing to improve diagnostic accuracy. Conclusions: Data reporting in MRMC studies using ROC AUC as an outcome measure is frequently incomplete, hampering understanding of methods and the reliability of results and study conclusions. Authors using this analysis should be encouraged to provide a full description of their methods and results.	[Dendumrongsup, Thaworn] Prince Songkla Univ, Dept Radiol, Hat Yai, Thailand; [Plumb, Andrew A.; Halligan, Steve] UCL, Ctr Med Imaging, London, England; [Fanshawe, Thomas R.; Mallett, Susan] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Altman, Douglas G.] Univ Oxford, Wolfson Coll, Ctr Stat Med, Oxford, England	Prince of Songkla University; University of London; University College London; University of Oxford; University of Oxford	Halligan, S (corresponding author), UCL, Ctr Med Imaging, London, England.	s.halligan@ucl.ac.uk	Halligan, Steve/C-5875-2009; Mallett, Sue/GPS-9933-2022	Halligan, Steve/0000-0003-0632-5108; Mallett, Sue/0000-0002-0596-8200	UK National Institute for Health (NIHR) Research [RP-PG-0407-10338]; Cancer Research UK [16895] Funding Source: researchfish; National Institute for Health Research [RP-PG-0407-10338] Funding Source: researchfish	UK National Institute for Health (NIHR) Research; Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the UK National Institute for Health (NIHR) Research under its Programme Grants for Applied Research funding scheme (RP-PG-0407-10338). The funder had no role in the design, execution, analysis, reporting, or decision to submit for publication.	Aoki T, 2011, ACAD RADIOL, V18, P1000, DOI 10.1016/j.acra.2011.04.008; Aoki T, 2012, EUR J RADIOL, V81, P1062, DOI 10.1016/j.ejrad.2011.02.010; Baker ME, 2007, RADIOLOGY, V245, P140, DOI 10.1148/radiol.2451061116; Berbaum KS, 2012, J AM COLL RADIOL, V9, P344, DOI 10.1016/j.jacr.2011.12.040; Berg WA, 2012, AM J ROENTGENOL, V198, P219, DOI 10.2214/AJR.10.6342; Bilello M, 2010, ACAD RADIOL, V17, P686, DOI 10.1016/j.acra.2010.01.019; Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41; Choi HJ, 2012, J TELEMED TELECARE, V18, P26, DOI 10.1258/jtt.2011.110412; Cole EB, 2012, ACAD RADIOL, V19, P916, DOI 10.1016/j.acra.2012.03.005; Collettini F, 2012, EUR RADIOL, V22, P350, DOI 10.1007/s00330-011-2276-2; Dachman AH, 2010, RADIOLOGY, V256, P827, DOI 10.1148/radiol.10091890; Destounis S, 2011, J DIGIT IMAGING, V24, P66, DOI 10.1007/s10278-010-9277-6; Dorfman DD, 2000, ACAD RADIOL, V7, P420, DOI 10.1016/S1076-6332(00)80382-7; Dorfman DD, 1998, ACAD RADIOL, V5, P591, DOI 10.1016/S1076-6332(98)80294-8; DORFMAN DD, 1992, INVEST RADIOL, V27, P723, DOI 10.1097/00004424-199209000-00015; Dromain C, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3210; Gallas BD, 2012, ACAD RADIOL, V19, P463, DOI 10.1016/j.acra.2011.12.016; Gennaro G, 2010, EUR RADIOL, V20, P1545, DOI 10.1007/s00330-009-1699-5; Gur D, 2008, RADIOLOGY, V247, P12, DOI 10.1148/radiol.2471071321; Gur D, 2007, ACAD RADIOL, V14, P871, DOI 10.1016/j.acra.2007.03.014; Halligan S, 2006, GASTROENTEROLOGY, V131, P1690, DOI 10.1053/j.gastro.2006.09.051; HANLEY JA, 1988, MED DECIS MAKING, V8, P197, DOI 10.1177/0272989X8800800308; Harrington M B, 1990, J Digit Imaging, V3, P211; Hillis SL, 2005, ACAD RADIOL, V12, P1534, DOI 10.1016/j.acra.2005.07.012; Hillis SL, 2005, STAT MED, V24, P1579, DOI 10.1002/sim.2024; Hillis SL, 2004, ACAD RADIOL, V11, P1260, DOI 10.1016/j.acra.2004.08.009; Hillis SL, 2007, STAT MED, V26, P596, DOI 10.1002/sim.2532; Hupse R, 2013, RADIOLOGY, V266, P123, DOI 10.1148/radiol.12120218; Jinzaki M, 2011, AM J ROENTGENOL, V196, P1102, DOI [10.1590/S1677-55382011000300019, 10.2214/AJR.10.5249]; Kelly KM, 2010, EUR RADIOL, V20, P2557, DOI 10.1007/s00330-010-1844-1; Kim H, 2012, WORLD J GASTROENTERO, V18, P4905, DOI 10.3748/wjg.v18.i35.4905; Kim S, 2010, J TRAUMA, V69, P437, DOI 10.1097/TA.0b013e3181e491d8; Krupinski EA, 2012, J DIGIT IMAGING, V25, P738, DOI 10.1007/s10278-012-9479-1; Leong DL, 2012, J DIGIT IMAGING, V25, P662, DOI 10.1007/s10278-012-9478-2; Li F, 2012, EUR RADIOL, V22, P2729, DOI 10.1007/s00330-012-2550-y; Li F, 2011, RADIOLOGY, V261, P937, DOI 10.1148/radiol.11110192; Li F, 2011, AM J ROENTGENOL, V196, pW535, DOI 10.2214/AJR.10.4816; Mallett S, 2014, PLOS ONE IN PRESS; Mallett S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107633; Matsushima M, 2010, MAGN RESON MED SCI, V9, P49, DOI 10.2463/mrms.9.49; McNulty JP, 2012, ACAD RADIOL, V19, P1023, DOI 10.1016/j.acra.2012.02.021; Medved M, 2011, ACAD RADIOL, V18, P1467, DOI 10.1016/j.acra.2011.07.017; Mermuys K, 2010, AM J ROENTGENOL, V195, P161, DOI 10.2214/AJR.09.3075; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moin P, 2011, ACAD RADIOL, V18, P1420, DOI 10.1016/j.acra.2011.07.003; Muramatsu C, 2010, J DIGIT IMAGING, V23, P592, DOI 10.1007/s10278-009-9263-z; Nishida K, 2011, ACTA RADIOL, V52, P120, DOI 10.1258/ar.2010.100293; Noroozian M, 2012, RADIOLOGY, V262, P61, DOI 10.1148/radiol.11101763; OBUCHOWSKI NA, 1995, ACAD RADIOL, V2, P709, DOI 10.1016/S1076-6332(05)80441-6; Obuchowski NA, 2005, AM J ROENTGENOL, V184, P364, DOI 10.2214/ajr.184.2.01840364; Obuchowski NA, 2004, ACAD RADIOL, V11, P980, DOI 10.1016/j.arca.2004.04.014; Obuchowski NA, 2003, RADIOLOGY, V229, P3, DOI 10.1148/radiol.2291010898; Obuchowski NA, 1995, COMM STAT, V24, P934; Obuchowski NA, 2010, ACAD RADIOL, V17, P761, DOI 10.1016/j.acra.2010.01.018; Ohgiya Y, 2012, CLIN IMAG, V36, P526, DOI 10.1016/j.clinimag.2011.11.016; Okamoto S, 2011, ANN NUCL MED, V25, P213, DOI 10.1007/s12149-010-0450-2; Otani H, 2012, J THORAC IMAG, V27, P51, DOI 10.1097/RTI.0b013e31820321e2; Padilla F, 2013, J ULTRAS MED, V32, P93, DOI 10.7863/jum.2013.32.1.93; Petrick N, 2008, RADIOLOGY, V246, P148, DOI 10.1148/radiol.2453062161; Pollard BJ, 2012, J DIGIT IMAGING, V25, P520, DOI 10.1007/s10278-012-9459-5; Purysko AS, 2012, AM J ROENTGENOL, V198, P115, DOI 10.2214/AJR.11.6836; Rafferty EA, 2013, RADIOLOGY, V266, P104, DOI 10.1148/radiol.12120674; Reed WM, 2011, RADIOLOGY, V258, P938, DOI 10.1148/radiol.10101090; Saade C, 2013, EUR J RADIOL, V82, pE64, DOI 10.1016/j.ejrad.2012.09.016; Salazar AJ, 2011, TELEMED E-HEALTH, V17, P275, DOI 10.1089/tmj.2010.0189; Shimauchi A, 2011, RADIOLOGY, V258, P696, DOI 10.1148/radiol.10100409; Shiraishi J, 2010, J DIGIT IMAGING, V23, P161, DOI 10.1007/s10278-009-9192-x; Shiraishi J, 2009, RADIOLOGY, V253, P822, DOI 10.1148/radiol.2533081632; Subhas N, 2011, AM J ROENTGENOL, V197, P442, DOI 10.2214/AJR.10.5709; Sung YM, 2010, EUR J RADIOL, V74, P275, DOI 10.1016/j.ejrad.2009.02.009; Svahn TM, 2012, BRIT J RADIOL, V85, pE1074, DOI 10.1259/bjr/53282892; Svane G, 2011, ACTA RADIOL, V52, P134, DOI 10.1258/ar.2010.100262; Szucs-Farkas Z, 2010, AM J ROENTGENOL, V194, pW388, DOI 10.2214/AJR.09.3378; Takahashi N, 2010, J COMPUT ASSIST TOMO, V34, P751, DOI 10.1097/RCT.0b013e3181e66473; Tan T, 2012, IEEE T MED IMAGING, V31, P1034, DOI 10.1109/TMI.2012.2184549; Timp S, 2010, IEEE T INF TECHNOL B, V14, P803, DOI 10.1109/TITB.2010.2043296; Toomey RJ, 2010, AM J ROENTGENOL, V194, P469, DOI 10.2214/AJR.09.3418; Uchiyama Y, 2012, J DIGIT IMAGING, V25, P497, DOI 10.1007/s10278-011-9444-4; Visser R, 2012, EUR RADIOL, V22, P908, DOI 10.1007/s00330-011-2320-2; Wagner RF, 2007, ACAD RADIOL, V14, P723, DOI 10.1016/j.acra.2007.03.001; Wallis MG, 2012, RADIOLOGY, V262, P788, DOI 10.1148/radiol.11103514; Wardlaw JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015757; Warren LM, 2012, MED PHYS, V39, P3202, DOI 10.1118/1.4718571; Way T, 2010, ACAD RADIOL, V17, P323, DOI 10.1016/j.acra.2009.10.016; Webb LJ, 2011, MED PHYS, V38, P1972, DOI 10.1118/1.3562901; Yakabe M, 2010, J DIGIT IMAGING, V23, P520, DOI 10.1007/s10278-009-9203-y; Yamada Y, 2012, RADIOLOGY, V263, P419, DOI 10.1148/radiol.12111024; Yamada Y, 2011, INVEST RADIOL, V46, P471, DOI 10.1097/RLI.0b013e318217b838; Yoshida A, 2013, J COMPUT ASSIST TOMO, V37, P84, DOI 10.1097/RCT.0b013e318271f216; Zanca F, 2012, MED PHYS, V39, P5917, DOI 10.1118/1.4747262; Zhou X.H., 2002, STAT METHODS DIAGNOS, DOI 10.1002/9780470317082	91	18	19	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e116018	10.1371/journal.pone.0116018	http://dx.doi.org/10.1371/journal.pone.0116018			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541977	Green Published, gold			2022-12-27	WOS:000347239900128
J	Franceschini, N; Hu, YJ; Reiner, AP; Buyske, S; Nalls, M; Yanek, LR; Li, Y; Hindorff, LA; Cole, SA; Howard, BV; Stafford, JM; Carty, CL; Sethupathy, P; Martin, LW; Lin, DY; Johnson, KC; Becker, LC; North, KE; Dehghan, A; Bis, JC; Liu, YM; Greenland, P; Manson, JE; Maeda, N; Garcia, M; Harris, TB; Becker, DM; O'Donnell, C; Heiss, G; Kooperberg, C; Boerwinkle, E				Franceschini, Nora; Hu, Yijuan; Reiner, Alex P.; Buyske, Steven; Nalls, Mike; Yanek, Lisa R.; Li, Yun; Hindorff, Lucia A.; Cole, Shelley A.; Howard, Barbara V.; Stafford, Jeanette M.; Carty, Cara L.; Sethupathy, Praveen; Martin, Lisa W.; Lin, Dan-Yu; Johnson, Karen C.; Becker, Lewis C.; North, Kari E.; Dehghan, Abbas; Bis, Joshua C.; Liu, Yongmei; Greenland, Philip; Manson, JoAnn E.; Maeda, Nobuyo; Garcia, Melissa; Harris, Tamara B.; Becker, Diane M.; O'Donnell, Christopher; Heiss, Gerardo; Kooperberg, Charles; Boerwinkle, Eric			Prospective Associations of Coronary Heart Disease Loci in African Americans Using the MetaboChip: The PAGE Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ARTERY-DISEASE; MYOCARDIAL-INFARCTION; SUSCEPTIBILITY LOCUS; BLOOD-PRESSURE; CELL-CYCLE; HEALTH; RISK; METAANALYSIS; VARIANTS	Background: Coronary heart disease (CHD) is a leading cause of morbidity and mortality in African Americans. However, there is a paucity of studies assessing genetic determinants of CHD in African Americans. We examined the association of published variants in CHD loci with incident CHD, attempted to fine map these loci, and characterize novel variants influencing CHD risk in African Americans. Methods and Results: Up to 8,201 African Americans (including 546 first CHD events) were genotyped using the MetaboChip array in the Atherosclerosis Risk in Communities (ARIC) study and Women's Health Initiative (WHI). We tested associations using Cox proportional hazard models in sex-and study-stratified analyses and combined results using meta-analysis. Among 44 validated CHD loci available in the array, we replicated and fine-mapped the SORT1 locus, and showed same direction of effects as reported in studies of individuals of European ancestry for SNPs in 22 additional published loci. We also identified a SNP achieving array wide significance (MYC: rs2070583, allele frequency 0.02, P=8.1x10(-8)), but the association did not replicate in an additional 8,059 African Americans (577 events) from the WHI, HealthABC and GeneSTAR studies, and in a meta-analysis of 5 cohort studies of European ancestry (24,024 individuals including 1,570 cases of MI and 2,406 cases of CHD) from the CHARGE Consortium. Conclusions: Our findings suggest that some CHD loci previously identified in individuals of European ancestry may be relevant to incident CHD in African Americans.	[Franceschini, Nora; North, Kari E.; Heiss, Gerardo] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27514 USA; [Hu, Yijuan] Emory Univ, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA; [Reiner, Alex P.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Buyske, Steven] Rutgers State Univ, Dept Stat & Biostat, Piscataway, NJ USA; [Nalls, Mike] NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Yanek, Lisa R.; Becker, Lewis C.; Becker, Diane M.] Johns Hopkins Univ, Sch Med, Dept Med, Div Gen Internal Med, Baltimore, MD 21205 USA; [Li, Yun; Lin, Dan-Yu] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Hindorff, Lucia A.] NHGRI, Div Gen Med, NIH, Bethesda, MD USA; [Cole, Shelley A.] SW Fdn Biomed Res, Dept Genet, San Antonio, TX USA; [Howard, Barbara V.] MedStar Hlth Res Inst, Hyattsville, MD USA; [Reiner, Alex P.; Stafford, Jeanette M.] Wake Forest Univ, Bowman Gray Sch Med, Dept Biostat Sci, Winston Salem, NC USA; [Carty, Cara L.; Kooperberg, Charles] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Sethupathy, Praveen] Univ N Carolina, Lineberger Comprehens Canc Ctr, Sch Med, Dept Genet, Chapel Hill, NC 27599 USA; [Martin, Lisa W.] George Washington Univ, Cardiovasc Inst, Washington, DC USA; [Johnson, Karen C.] Univ Tennessee, Ctr Hlth Sci, Dept Prevent Med, Memphis, TN 38163 USA; [North, Kari E.] UNC, Ctr Genome Sci, Chapel Hill, NC USA; [Dehghan, Abbas] Erasmus Univ, Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [Bis, Joshua C.] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Bis, Joshua C.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Liu, Yongmei] Wake Forest Univ, Sch Med, Ctr Human Gen, Dept Epidemiol & Prevent, Winston Salem, NC 27109 USA; [Greenland, Philip] Northwestern Univ, Dept Prevent Med, Chicago, IL 60611 USA; [Greenland, Philip] Northwestern Univ, Dept Med, Chicago, IL 60611 USA; [Manson, JoAnn E.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA USA; [Maeda, Nobuyo] Univ N Carolina, Dept Pathol, Chapel Hill, NC USA; [Maeda, Nobuyo] Univ N Carolina, Lab Med, Chapel Hill, NC USA; [Garcia, Melissa; Harris, Tamara B.] NIA, Lab Epidemiol & Populat Sci, NIH, Bethesda, MD 20892 USA; [Becker, Diane M.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA; [O'Donnell, Christopher] Lung & Blood Inst, Framingham Heart Study, Framingham, MA USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA	University of North Carolina; University of North Carolina Chapel Hill; Emory University; University of Washington; University of Washington Seattle; Rutgers State University New Brunswick; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Johns Hopkins University; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Texas Biomedical Research Institute; MedStar Health Research Institute; Wake Forest University; Wake Forest Baptist Medical Center; Fred Hutchinson Cancer Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; George Washington University; University of Tennessee System; University of Tennessee Health Science Center; University of North Carolina; University of North Carolina Chapel Hill; Erasmus University Rotterdam; Erasmus MC; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Wake Forest University; Northwestern University; Northwestern University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Framingham Heart Study; University of Texas System; University of Texas Health Science Center Houston	Franceschini, N (corresponding author), Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27514 USA.	noraf@unc.edu	Greenland, Philip/ABD-5528-2021; Dehghan, Abbas/ABE-7377-2020; Dehghan, Abbas/B-9896-2008	Dehghan, Abbas/0000-0001-6403-016X; Buyske, Steven/0000-0001-8539-5416	National Human Genome Research Institute (NHGRI); CALiCo [U01HG004803]; EAGLE [U01HG004798]; MEC [U01HG004802]; WHI [U01HG004790]; Coordinating Center [U01HG004801]; National Heart, Lung, and Blood Institute contracts [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C, R01HL087641, R01HL59367, R01HL086694]; National Human Genome Research Institute [U01HG004402]; National Institutes of Health [HHSN268200625226C, HHSN268200782096C]; National Institutes of Health and NIH Roadmap for Medical Research [UL1RR025005]; National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services [N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, 44221]; NIA [N01AG62101, N01AG62103, N01AG62106, 1R01AG032098-01A1]; Intramural Research Program of the NIH, National Institute on Aging [Z01 AG000949-02, Z01 AG007390-07]; National Institutes of Health, Bethesda, Maryland [U01 HL72518, HL097698, HL59684, HL58625-01A1, HL071025-01A1, NR0224103, NR008153-01, M01 RR00052];  [R21HL123677-01]; NATIONAL CANCER INSTITUTE [R01CA082659] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000052, UL1RR025005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087641, ZIAHL006173, R01HL042630, R18HL058625, ZIAHL006175, R01HL071025, R01HL086694, R01HL058625, ZIAHL006002, R21HL123677, R01HL059684, R01HL109301, R01HL059367, U01HL072518] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004803, U01HG007376, U01HG004801, U01HG004802, U01HG004798, U01HG004790, U01HG004402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR008153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [N01AG062106, Z01AG007390, Z01AG000949, ZIAAG007390, R01AG032098, ZIAAG006000, N01AG062101, N01AG062103] Funding Source: NIH RePORTER; WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH [N01WH022110] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); CALiCo; EAGLE; MEC(European Commission); WHI; Coordinating Center; National Heart, Lung, and Blood Institute contracts; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health and NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural Research Program of the NIH, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health, Bethesda, Maryland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The Population Architecture Using Genomics and Epidemiology (PAGE) program is funded by the National Human Genome Research Institute (NHGRI), supported by U01HG004803 (CALiCo), U01HG004798 (EAGLE), U01HG004802 (MEC), U01HG004790 (WHI), and U01HG004801 (Coordinating Center), and their respective NHGRI ARRA supplements. The contents of this paper are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The complete list of PAGE members can be found at http://www.pagestudy.org. The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C), R01HL087641, R01HL59367 and R01HL086694; National Human Genome Research Institute contract U01HG004402; and National Institutes of Health contract HHSN268200625226C. NF is supported by R21HL123677-01. The authors thank the staff and participants of the ARIC study for their important contributions. Infrastructure was partly supported by Grant Number UL1RR025005, a component of the National Institutes of Health and NIH Roadmap for Medical Research. The WHI program is funded by the National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services through contracts N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, and 44221. This manuscript was prepared in collaboration with investigators of the WHI, and has been approved by the WHI. WHI investigators are listed at http://www.whiscience.org/publications/WHI_investigators_shortlist.pdf. HealthABC was supported by NIA contracts N01AG62101, N01AG62103, and N01AG62106 and was supported in part by the Intramural Research Program of the NIH, National Institute on Aging (Z01 AG000949-02 and Z01 AG007390-07, Human subjects protocol UCSF IRB is H5254-12688- 11). The genome-wide association study was funded by NIA grant 1R01AG032098-01A1 to Wake Forest University Health Sciences and genotyping services were provided by the Center for Inherited Disease Research (CIDR). CIDR is fully funded through a federal contract from the National Institutes of Health to The Johns Hopkins University, contract number HHSN268200782096C. This study utilized the high performance computational capabilities of the Biowulf Linux cluster at the National Institutes of Health, Bethesda, Md. (http://biowulf.nih.gov). GeneSTAR was supported in part by grants U01 HL72518, HL097698, HL59684, HL58625-01A1, HL071025-01A1, NR0224103, NR008153-01 from the National Institutes of Health, Bethesda, Maryland, and grant M01 RR00052 from the National Institutes of Health, Bethesda, Maryland, to the Johns Hopkins University School of Medicine General Clinical Research Center.	Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Barbalic M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002199; Boyden LM, 2012, NATURE, V482, P98, DOI 10.1038/nature10814; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Bulik-Sullivan B, 2013, HUM MUTAT, V34, P1049, DOI 10.1002/humu.22337; Buyske S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035651; Cesari M, 2003, AM J CARDIOL, V92, P522, DOI 10.1016/S0002-9149(03)00718-5; Coller HA, 2000, P NATL ACAD SCI USA, V97, P3260, DOI 10.1073/pnas.97.7.3260; Curb JD, 2003, ANN EPIDEMIOL, V13, pS122, DOI 10.1016/S1047-2797(03)00048-6; Deloukas P, 2012, NATURE GENETICS; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Erdmann J, 2009, NAT GENET, V41, P280, DOI 10.1038/ng.307; Franceschini Nora, 2011, Circ Cardiovasc Genet, V4, P661, DOI 10.1161/CIRCGENETICS.111.960096; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Ioannidis JPA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000841; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Kato N, 2011, NAT GENET, V43, P530, DOI 10.1038/ng.834; Katzmarzyk Peter T., 2000, Ethnicity and Disease, V10, P138; Kral BG, 2011, J HUM GENET, V56, P224, DOI 10.1038/jhg.2010.171; Lee HG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007172; Lettre G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001300; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Liu EY, 2012, GENET EPIDEMIOL, V36, P107, DOI 10.1002/gepi.21603; Lloyd-Jones DM, 1999, LANCET, V353, P89, DOI 10.1016/S0140-6736(98)10279-9; Matise TC, 2011, AM J EPIDEMIOL, V174, P849, DOI 10.1093/aje/kwr160; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Ozaki K, 2009, NAT GENET, V41, P329, DOI 10.1038/ng.326; Peterson LE, 2003, COMPUT METH PROG BIO, V70, P107, DOI 10.1016/S0169-2607(02)00009-3; Preuss M, 2010, CIRCULATION; Roger VL, 2012, CIRCULATION, V125, P188, DOI 10.1161/CIR.0b013e3182456d46; Roger VL, 2004, JAMA-J AM MED ASSOC, V292, P344, DOI 10.1001/jama.292.3.344; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Souders CA, 2012, ARTERIOSCLEROSIS THR; Wang F, 2011, NAT GENET, V43, P345, DOI 10.1038/ng.783; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wojczynski MK, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-75	40	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e113203	10.1371/journal.pone.0113203	http://dx.doi.org/10.1371/journal.pone.0113203			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542012	Green Published, gold, Green Submitted			2022-12-27	WOS:000347239900006
J	Higo, S; Shimizu, A; Masuda, Y; Nagasaka, S; Kajimoto, Y; Kanzaki, G; Fukui, M; Nagahama, K; Mii, A; Kaneko, T; Tsuruoka, S				Higo, Seiichiro; Shimizu, Akira; Masuda, Yukinari; Nagasaka, Shinya; Kajimoto, Yusuke; Kanzaki, Go; Fukui, Megumi; Nagahama, Kiyotaka; Mii, Akiko; Kaneko, Tomohiro; Tsuruoka, Shuichi			Acute Graft-Versus-Host Disease of the Kidney in Allogeneic Rat Bone Marrow Transplantation	PLOS ONE			English	Article							HEMATOPOIETIC-CELL TRANSPLANTATION; ACUTE-RENAL-FAILURE; NEPHROTIC SYNDROME; LETHAL GRAFT; ACUTE GVHD; T-CELLS; INJURY; RECIPIENTS; REJECTION; SURVIVAL	Allogeneic hematopoietic cell or bone marrow transplantation (BMT) causes graft-versus- host-disease (GVHD). However, the involvement of the kidney in acute GVHD is not well-understood. Acute GVHD was induced in Lewis rats (RT1(l)) by transplantation of Dark Agouti (DA) rat (RT1(a)) bone marrow cells (6.0x10(7) cells) without immunosuppression after lethal irradiation (10 Gy). We examined the impact of acute GVHD on the kidney in allogeneic BMT rats and compared them with those in Lewis-to-Lewis syngeneic BMT control and non-BMT control rats. In syngeneic BMT and non-BMT control rats, acute GVHD did not develop by day 28. In allogeneic BMT rats, severe acute GVHD developed at 21-28 days after BMT in the skin, intestine, and liver with decreased body weight (> 20%), skin rush, diarrhea, and liver dysfunction. In the kidney, infiltration of donor-type leukocytes was by day 28. Mild inflammation characterized by infiltration of CD3+ T-cells, including CD8+ T-cells and CD4+ T-cells, and CD68+ macrophages to the interstitium around the small arteries was noted. During moderate to severe inflammation, these infiltrating cells expanded into the peritubular interstitium with peritubular capillaritis, tubulitis, acute glomerulitis, and endarteritis. Renal dysfunction also developed, and the serum blood urea nitrogen (33.9 +/- 4.7 mg/dL) and urinary N-acetyl-beta-D-glucosaminidase (NAG: 31.5 +/- 15.5 U/L) levels increased. No immunoglobulin and complement deposition was detected in the kidney. In conclusion, the kidney was a primary target organ of acute GVHD after BMT. Acute GVHD of the kidney was characterized by increased levels of urinary NAG and cell-mediated injury to the renal microvasculature and renal tubules.	[Higo, Seiichiro; Fukui, Megumi; Mii, Akiko; Kaneko, Tomohiro; Tsuruoka, Shuichi] Nippon Med Sch, Dept Nephrol, Tokyo 113, Japan; [Higo, Seiichiro; Shimizu, Akira; Masuda, Yukinari; Nagasaka, Shinya; Kajimoto, Yusuke; Kanzaki, Go; Nagahama, Kiyotaka] Nippon Med Sch, Dept Analyt Human Pathol, Tokyo 113, Japan	Nippon Medical School; Nippon Medical School	Shimizu, A (corresponding author), Nippon Med Sch, Dept Analyt Human Pathol, 1-1-5 Sendagi, Tokyo 113, Japan.	ashimizu@nms.ac.jp	Tsuruoka, Shuichi/ABF-8453-2020; Kanzaki, Go/GLR-4254-2022; Kanzaki, Go/AAI-1150-2019; Tsuruoka, Shuichi/W-3322-2019	Kanzaki, Go/0000-0002-7795-369X; Mii, Akiko/0000-0003-0326-8267				ALMARAZ R, 1983, J SURG RES, V34, P133, DOI 10.1016/0022-4804(83)90052-5; Appelbaum FR, 2001, NATURE, V411, P385, DOI 10.1038/35077251; Biedermann BC, 2003, BONE MARROW TRANSPL, V32, P1077, DOI 10.1038/sj.bmt.1704258; Choi SW, 2008, BLOOD, V112, P1539, DOI 10.1182/blood-2008-02-138867; Coghill JM, 2011, BLOOD, V117, P3268, DOI 10.1182/blood-2010-12-290403; Copelan EA, 2006, NEW ENGL J MED, V354, P1813, DOI 10.1056/NEJMra052638; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; Heung M, 2012, CURR OPIN NEPHROL HY, V21, P628, DOI 10.1097/MNH.0b013e3283588f24; Ho VT, 2008, BEST PRACT RES CL HA, V21, P223, DOI 10.1016/j.beha.2008.02.009; HOLLER E, 1990, BLOOD, V75, P1011; Humphreys BD, 2005, J AM SOC NEPHROL, V16, P151, DOI 10.1681/ASN.2004100843; Ichiki Y, 2006, AUTOIMMUN REV, V5, P1, DOI 10.1016/j.autrev.2005.02.006; Kogon A, 2010, SEMIN NEPHROL, V30, P615, DOI 10.1016/j.semnephrol.2010.09.009; KORNGOLD R, 1985, J IMMUNOL, V135, P3004; Kusumi E, 2008, INT J HEMATOL, V87, P225, DOI 10.1007/s12185-008-0026-2; Lee SJ, 2005, BLOOD, V105, P4200, DOI 10.1182/blood-2004-10-4023; Liu AB, 2013, J CLIN VIROL, V58, P427, DOI 10.1016/j.jcv.2013.07.006; Lopes JA, 2011, BONE MARROW TRANSPL, V46, P1399, DOI 10.1038/bmt.2011.46; Mori J, 2012, INTERNAL MED, V51, P2105, DOI 10.2169/internalmedicine.51.7418; Paczesny S, 2010, BONE MARROW TRANSPL, V45, P1, DOI 10.1038/bmt.2009.328; Panoskaltsis-Mortari A, 2004, BLOOD, V103, P3590, DOI 10.1182/blood-2003-08-2827; Parikh CR, 2006, KIDNEY INT, V69, P430, DOI 10.1038/sj.ki.5000055; Parikh CR, 2005, AM J KIDNEY DIS, V45, P502, DOI 10.1053/j.ajkd.2004.11.013; Patzer L, 2003, PEDIATR NEPHROL, V18, P623, DOI 10.1007/s00467-003-1146-9; Reddy P, 2006, BONE MARROW TRANSPL, V38, P351, DOI 10.1038/sj.bmt.1705446; Reddy P, 2003, BLOOD REV, V17, P187, DOI 10.1016/S0268-960X(03)00009-2; ROOSNEK E, 1993, TRANSPLANTATION, V56, P691, DOI 10.1097/00007890-199309000-00036; Saba N, 2002, J HEMATOTH STEM CELL, V11, P377, DOI 10.1089/152581602753658565; Sale George E., 1995, P435; Shimabukuro-Vornhagen A, 2009, BLOOD, V114, P4919, DOI 10.1182/blood-2008-10-161638; Shimizu A, 2000, KIDNEY INT, V58, P2546, DOI 10.1046/j.1523-1755.2000.00440.x; Shimizu A, 2002, KIDNEY INT, V61, P1867, DOI 10.1046/j.1523-1755.2002.00309.x; Socie G, 2009, BLOOD, V114, P4327, DOI 10.1182/blood-2009-06-204669; Solez K, 2008, AM J TRANSPLANT, V8, P753, DOI 10.1111/j.1600-6143.2008.02159.x; Srinivasan R, 2005, BRIT J HAEMATOL, V131, P74, DOI 10.1111/j.1365-2141.2005.05728.x; Uchiyama M, 2013, MOL VIS, V19, P2135; VOGELSANG GB, 1986, TRANSPLANTATION, V41, P644, DOI 10.1097/00007890-198605000-00018; ZAGER RA, 1994, KIDNEY INT, V46, P1443, DOI 10.1038/ki.1994.417; Zinocker S, 2011, J LEUKOCYTE BIOL, V90, P177, DOI 10.1189/jlb.0211067	39	20	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115399	10.1371/journal.pone.0115399	http://dx.doi.org/10.1371/journal.pone.0115399			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541735	Green Published, Green Submitted, gold			2022-12-27	WOS:000347239900040
J	Malejko, K; Weydt, P; Sussmuth, SD; Gron, G; Landwehrmeyer, BG; Abler, B				Malejko, Kathrin; Weydt, Patrick; Suessmuth, Sigurd D.; Groen, Georg; Landwehrmeyer, Bernhard G.; Abler, Birgit			Prodromal Huntington Disease as a Model for Functional Compensation of Early Neurodegeneration	PLOS ONE			English	Article							REWARD SYSTEM ACTIVATION; ALZHEIMERS-DISEASE; BRAIN ACTIVATION; DYSFUNCTION; PREDICTION; FMRI; PREMANIFEST; OLANZAPINE; DIAGNOSIS; STRIATUM	Functional compensation demonstrated as mechanism to offset neuronal loss in early Alzheimer disease may also occur in other adult-onset neurodegenerative diseases, particularly Huntington disease (HD) with its genetic determination and gradual changes in structural integrity. In HD, neurodegeneration typically initiates in the dorsal striatum, successively affecting ventral striatal areas. Investigating carriers of the HD mutation with evident dorsal, but only minimal or no ventral striatal atrophy, we expected to find evidence for compensation of ventral striatal functioning. We investigated 14 pre-or early symptomatic carriers of the mutation leading to HD and 18 matched healthy controls. Participants underwent structural T1 magnetic resonance imaging (MRI) and functional MRI during a reward task that probes ventral striatal functioning. Motor functioning and attention were assessed with reaction time (RT) tasks. Structural images confirmed a specific decrease of dorsal striatal but only marginal ventral striatal volume in HD relative to control subjects, paralleling prolonged RT in the motor response tasks. While behavioral performance in the reward task during fMRI scanning was unimpaired, reward-related fMRI signaling in the HD group was differentially enhanced in the bilateral ventral striatum and in bilateral orbitofrontal cortex/anterior insula, as another region sensitive to reward processing. We provide evidence for the concept of functional compensation in premanifest HD which may suggest a defense mechanism in neurodegeneration. Given the so far inevitable course of HD with its genetically determined endpoint, this disease may provide another model to study the different aspects of the concept of functional compensation.	[Malejko, Kathrin; Groen, Georg; Abler, Birgit] Univ Ulm, Dept Psychiat, D-89522 Ulm, Germany; [Suessmuth, Sigurd D.; Landwehrmeyer, Bernhard G.] Univ Ulm, Dept Neurol, D-89081 Ulm, Germany	Ulm University; Ulm University	Abler, B (corresponding author), Univ Ulm, Dept Psychiat, Leimgrubenweg 12-14, D-89522 Ulm, Germany.	birgit.abler@uni-ulm.de	Landwehrmeyer, Georg Bernhard/AHB-4443-2022; Weydt, Patrick/F-5114-2015	Landwehrmeyer, Georg Bernhard/0000-0003-3375-790X; Weydt, Patrick/0000-0003-2344-5662; Gron, Georg/0000-0002-0282-3575	European Huntington's Disease Network (EHDN); PREDICT HD; Ulm University	European Huntington's Disease Network (EHDN); PREDICT HD; Ulm University	This study was supported by the European Huntington's Disease Network (EHDN) and by PREDICT HD. The study was sponsored by departmental funds from Ulm University. K.M., P.W., G.G. and B.A. report no disclosures. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abler B, 2008, NEUROPSYCHOPHARMACOL, V33, P2217, DOI 10.1038/sj.npp.1301620; Abler B, 2007, PSYCHOPHARMACOLOGY, V191, P823, DOI 10.1007/s00213-006-0690-y; Abler B, 2006, NEUROIMAGE, V31, P790, DOI 10.1016/j.neuroimage.2006.01.001; Abler B, 2009, BRAIN, V132, P2396, DOI 10.1093/brain/awp170; APA, 1994, DIAGN STAT MAN MENT; Beauducel A, 2003, DIAGNOSTICA, V49, P61, DOI 10.1026//0012-1924.49.2.61; Benjamini Y, 2001, ANN STAT, V29, P1165; Bookheimer SY, 2000, NEW ENGL J MED, V343, P450, DOI 10.1056/NEJM200008173430701; Dekosky ST, 2003, SCIENCE, V302, P830, DOI 10.1126/science.1090349; Douaud G, 2006, NEUROIMAGE, V32, P1562, DOI 10.1016/j.neuroimage.2006.05.057; Enzi B, 2012, EXP NEUROL, V235, P256, DOI 10.1016/j.expneurol.2012.02.003; Hautzinger M., 1993, ALLGEMEINE DEPRESSIO; Juckel G, 2006, NEUROIMAGE, V29, P409, DOI 10.1016/j.neuroimage.2005.07.051; Kalbe E, 2004, INT J GERIATR PSYCH, V19, P136, DOI 10.1002/gps.1042; Langbehn DR, 2004, CLIN GENET, V65, P267, DOI 10.1111/j.1399-0004.2004.00241.x; Lappin JM, 2009, J CEREBR BLOOD F MET, V29, P554, DOI 10.1038/jcbfm.2008.146; Palminteri S, 2012, NEURON, V76, P998, DOI 10.1016/j.neuron.2012.10.017; Paulsen JS, 2008, J NEUROL NEUROSUR PS, V79, P874, DOI 10.1136/jnnp.2007.128728; Paulsen JS, 2004, AM J NEURORADIOL, V25, P1715; Politis M, 2008, BRAIN, V131, P2860, DOI 10.1093/brain/awn244; Politis M, 2011, HUM BRAIN MAPP, V32, P258, DOI 10.1002/hbm.21008; Quiroz YT, 2010, ANN NEUROL, V68, P865, DOI 10.1002/ana.22105; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Schlagenhauf F, 2008, PSYCHOPHARMACOLOGY, V196, P673, DOI 10.1007/s00213-007-1016-4; Tabrizi SJ, 2012, LANCET NEUROL, V11, P42, DOI 10.1016/S1474-4422(11)70263-0; Tabrizi SJ, 2009, LANCET NEUROL, V8, P791, DOI 10.1016/S1474-4422(09)70170-X; Vonsattel JPG, 2011, HDB CLIN NEUROLOGY H; Wishart HA, 2006, AM J PSYCHIAT, V163, P1603, DOI 10.1176/appi.ajp.163.9.1603; Wolf RC, 2007, BRAIN, V130, P2845, DOI 10.1093/brain/awm210; Zuckerman M, 1996, PERS INDIV DIFFER, V21, P283, DOI 10.1016/0191-8869(96)00042-6; Zuckerman M., 1994, BEHAV EXPRESSIONS BI	31	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e114569	10.1371/journal.pone.0114569	http://dx.doi.org/10.1371/journal.pone.0114569			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541992	gold, Green Published, Green Submitted			2022-12-27	WOS:000347239900012
J	Pan, HS; Liu, B; Lu, YH; Desneux, N				Pan, Hongsheng; Liu, Bing; Lu, Yanhui; Desneux, Nicolas			Life Table Parameters of Three Mirid Bug (Adelphocoris) Species (Hemiptera: Miridae) under Contrasted Relative Humidity Regimes	PLOS ONE			English	Article							BT COTTON; SEASONAL ABUNDANCE; MULTIPLE CROPS; NORTHERN CHINA; ADOPTION; LUCORUM; HISTORY	The genus Adelphocoris (Hemiptera: Miridae) is a group of important insect pests of Bt cotton in China. The three dominant species are A. lineolatus, A. suturalis, and A. fasciaticollis, and these species have different population dynamics. The causal factors for the differences in population dynamics have not been determined; one hypothesis is that humidity may be important for the growth of Adelphocoris populations. In the laboratory, the demographic parameters of the three Adelphocoris species were compared when the mirid bugs were subjected to various levels of relative humidity (40, 50, 60, 70 and 80% RH). Middle to high levels of RH (60, 70 and 80%) were associated with higher egg and nymph survival rates and increased adult longevity and female fecundity. Lower humidity levels (40 and 50% RH) had negative effects on the survival of nymphs, adult longevity and fecundity. The intrinsic rate of increase (r(m)), the net reproductive rate (R-0) and the finite rate of increase (lambda) for each Adelphocoris species increased with increasing RH. Significant positive relationships were found between RH and the life table parameters, r(m), R-0 and lambda for the three Adelphocoris species. These results will help to better understand the phenology of the three Adelphocoris species, and the information can be used in population growth models to optimize pest forecasting and management strategies for these key pests.	[Pan, Hongsheng; Liu, Bing; Lu, Yanhui] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Desneux, Nicolas] INRA, French Natl Inst Agr Res, Sophia Antipolis, France	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; INRAE	Lu, YH (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	yhlu@ippcaas.cn	Desneux, Nicolas/J-6262-2013	Lu, Yanhui/0000-0002-6552-0248	National Natural Science Foundation [31321004]; Special Fund for Agro-scientific Research in the Public Interest [201103011]; CMS [2014ZL047]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; CMS	This study was financially supported by the National Natural Science Foundation (No. 31321004), the Special Fund for Agro-scientific Research in the Public Interest (No. 201103011), and funds from CMS (2014ZL047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Broufas GD, 2009, ANN ENTOMOL SOC AM, V102, P70, DOI 10.1603/008.102.0107; CHU H. F., 1958, ACTA ENT SINICA, V8, P97; Guarneri AA, 2002, PHYSIOL ENTOMOL, V27, P142, DOI 10.1046/j.1365-3032.2002.00279.x; Han RD, 2008, INSECT SCI, V15, P147, DOI 10.1111/j.1744-7917.2008.00195.x; Holmes LA, 2012, ENVIRON ENTOMOL, V41, P971, DOI 10.1603/EN12054; Li Qiaosi, 1994, Acta Ecologica Sinica, V14, P312; Liu HM, 1991, ACTA PHYTOPHYL SIN, V18, P147; Lu Y., 2008, BIOL CONTROL COTTON; Lu YH, 2008, CROP PROT, V27, P465, DOI 10.1016/j.cropro.2007.07.017; Lu YH, 2009, B ENTOMOL RES, V99, P543, DOI 10.1017/S000748530800655X; Lu Y H, 2008, ACTA PHYTOPHYLACICA, V35, P251, DOI [DOI 10.3866/PKU.WHXB201803163, DOI 10.1016/S1673-8527(08)60035-1]; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; Lu YanHui, 2011, Outlooks on Pest Management, V22, P248, DOI 10.1564/22dec02; Lu YH, 2011, CROP PROT, V30, P1455, DOI 10.1016/j.cropro.2011.07.010; Lu YH, 2011, APPL ENTOMOL ZOOL, V46, P421, DOI 10.1007/s13355-011-0058-6; Lu YH, 2010, SCIENCE, V328, P1151, DOI 10.1126/science.1187881; Lu YH, 2009, PHYSIOL ENTOMOL, V34, P318, DOI 10.1111/j.1365-3032.2009.00692.x; SAS Institute, 2005, SAS STAT US GUID; SMITH L, 1993, ENVIRON ENTOMOL, V22, P618, DOI 10.1093/ee/22.3.618; TING Yen-chin, 1963, Acta Phytophylacica Sinica, Peking, V2, P365; TING Yen-chin, 1963, Acta Phytophylacica Sinica, Peking, V2, P285; Ting YQ, 1964, ACTA ENTOMOL SINICA, V13, P298; WILLMER PG, 1982, ADV INSECT PHYSIOL, V16, P1, DOI 10.1016/S0065-2806(08)60151-4; Wu K, 2002, CROP PROT, V21, P997, DOI 10.1016/S0261-2194(02)00080-7; Wu KM, 2005, ANNU REV ENTOMOL, V50, P31, DOI 10.1146/annurev.ento.50.071803.130349; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Zhang SM., 1996, GEOGRAPHICAL DISTRIB	27	6	6	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115878	10.1371/journal.pone.0115878	http://dx.doi.org/10.1371/journal.pone.0115878			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541705	Green Published, gold, Green Submitted			2022-12-27	WOS:000347239900103
J	Rafei, R; Dabboussi, F; Hamze, M; Eveillard, M; Lemarie, C; Gaultier, MP; Mallat, H; Moghnieh, R; Husni-Samaha, R; Joly-Guillou, ML; Kempf, M				Rafei, Rayane; Dabboussi, Fouad; Hamze, Monzer; Eveillard, Matthieu; Lemarie, Carole; Gaultier, Marie-Pierre; Mallat, Hassan; Moghnieh, Rima; Husni-Samaha, Rola; Joly-Guillou, Marie-Laure; Kempf, Marie			Molecular Analysis of Acinetobacter baumannii Strains Isolated in Lebanon Using Four Different Typing Methods	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; METALLO-BETA-LACTAMASE; REP-PCR; INTERLABORATORY REPRODUCIBILITY; EPIDEMIOLOGY; IDENTIFICATION; OUTBREAK; GENES; STANDARDIZATION; PREVALENCE	This study analyzed 42 Acinetobacter baumannii strains collected between 2009-2012 from different hospitals in Beyrouth and North Lebanon to better understand the epidemiology and carbapenem resistance mechanisms in our collection and to compare the robustness of pulsed field gel electrophoresis (PFGE), multilocus sequence typing (MLST), repetitive sequence-based PCR (rep-PCR) and bla(OXA-51) sequence-based typing (SBT). Among 31 carbapenem resistant strains, we have detected three carbapenem resistance genes: 28 carried the bla(OXA-23) gene, 1 the bla(OXA-24) gene and 2 strains the bla(OXA-58) gene. This is the first detection of bla(OXA-23) and bla(OXA-24) in Lebanon. PFGE identified 11 types and was the most discriminating technique followed by rep-PCR (9 types), bla(OXA-51) SBT (8 types) and MLST (7 types). The PFGE type A'/ST2 was the dominant genotype in our collection present in Beyrouth and North Lebanon. The clustering agreement between all techniques was measured by adjust Wallace coefficient. An overall agreement has been demonstrated. High values of adjust Wallace coefficient were found with followed combinations: PFGE to predict MLST types =100%, PFGE to predict bla(OXA-51) SBT=100%, bla(OXA-51) SBT to predict MLST=100%, MLST to predict bla(OXA-51) SBT=84.7%, rep-PCR to predict MLST=81.5%, PFGE to predict rep-PCR=69% and rep-PCR to predict bla(OXA-51) SBT=67.2%. PFGE and MLST are gold standard methods for outbreaks investigation and population structure studies respectively. Otherwise, these two techniques are technically, time and cost demanding. We recommend the use of bla(OXA-51) SBT as first typing method to screen isolates and assign them to their corresponding clonal lineages. Repetitive sequence-based PCR is a rapid tool to access outbreaks but careful interpretation of results must be always performed.	[Rafei, Rayane; Eveillard, Matthieu; Joly-Guillou, Marie-Laure; Kempf, Marie] Univ Angers, LUNAM Univ, Grp Etud Interact Hote Pathogene, CHU,Inst Biol Sante IRIS,UPRES EA3142, Angers, France; [Rafei, Rayane; Dabboussi, Fouad; Hamze, Monzer; Mallat, Hassan] Univ Libanaise, Ctr AZM Rech Biotechnol & Ses Applicat, Lab Sante & Environm, Tripoli, Libya; [Eveillard, Matthieu; Lemarie, Carole; Gaultier, Marie-Pierre; Joly-Guillou, Marie-Laure; Kempf, Marie] CHU, Inst Biol Sante PBH, Bacteriol Lab, Angers, France; [Moghnieh, Rima] Ain Wa Zein Hosp, Shouf, Lebanon; [Husni-Samaha, Rola] Lebanese Amer Univ, Rizk Hosp, Med Ctr, Dept Internal Med,Div Infect Dis, Beirut, Lebanon	Universite d'Angers; Centre Hospitalier Universitaire d'Angers; University of Benghazi; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; American University of Beirut; Lebanese American University	Kempf, M (corresponding author), Univ Angers, LUNAM Univ, Grp Etud Interact Hote Pathogene, CHU,Inst Biol Sante IRIS,UPRES EA3142, Angers, France.	makempf@chu-angers.fr	Joly-Guillou, Marie-Laure/E-8206-2014; RAFEI, Rayane/AAI-3619-2020	Joly-Guillou, Marie-Laure/0000-0003-2593-6684; RAFEI, Rayane/0000-0001-9633-1290; Husni, Rola/0000-0002-6893-5027; KEMPF, Marie/0000-0002-2943-7500				Adams-Haduch JM, 2011, J CLIN MICROBIOL, V49, P3849, DOI 10.1128/JCM.00619-11; Bartual SG, 2005, J CLIN MICROBIOL, V43, P4382, DOI 10.1128/JCM.43.9.4382-4390.2005; Bonnin RA, 2012, J CLIN MICROBIOL, V50, P1419, DOI 10.1128/JCM.06276-11; Chang KM, 2013, J MICROBIOL IMMUNOL, V46, P195, DOI 10.1016/j.jmii.2012.05.011; Di Popolo A, 2011, CLIN MICROBIOL INFEC, V17, P197, DOI 10.1111/j.1469-0691.2010.03254.x; Diancourt L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010034; Dijkshoorn L, 1996, J CLIN MICROBIOL, V34, P1519, DOI 10.1128/JCM.34.6.1519-1525.1996; Evans BA, 2014, CLIN MICROBIOL REV, V27, P241, DOI 10.1128/CMR.00117-13; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Giannouli M, 2009, J ANTIMICROB CHEMOTH, V63, P828, DOI 10.1093/jac/dkp032; Grisold AJ, 2010, J INFECTION, V60, P44, DOI 10.1016/j.jinf.2009.10.045; Grosso F, 2011, CLIN MICROBIOL INFEC, V17, P1275, DOI 10.1111/j.1469-0691.2011.03469.x; Grosso F, 2011, J ANTIMICROB CHEMOTH, V66, P62, DOI 10.1093/jac/dkq406; Gundi VAKB, 2009, MICROBIOL-SGM, V155, P2333, DOI 10.1099/mic.0.026054-0; Hamouda A, 2010, J CLIN MICROBIOL, V48, P2476, DOI 10.1128/JCM.02431-09; Higgins PG, 2012, J CLIN MICROBIOL, V50, P3493, DOI 10.1128/JCM.01759-12; Higgins PG, 2012, J MED MICROBIOL, V61, P137, DOI 10.1099/jmm.0.036046-0; Higgins PG, 2010, J ANTIMICROB CHEMOTH, V65, P233, DOI 10.1093/jac/dkp428; Higgins PG, 2010, INT J ANTIMICROB AG, V35, P305, DOI 10.1016/j.ijantimicag.2009.10.014; Karah N, 2012, DRUG RESIST UPDATE, V15, P237, DOI 10.1016/j.drup.2012.06.001; Kempf M, 2013, APMIS, V121, P64, DOI 10.1111/j.1600-0463.2012.02935.x; Kempf M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039495; Kempf M, 2012, INT J ANTIMICROB AG, V39, P105, DOI 10.1016/j.ijantimicag.2011.10.004; Li WJ, 2009, FEMS MICROBIOL REV, V33, P892, DOI 10.1111/j.1574-6976.2009.00182.x; Maatallah M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082069; Mesli E, 2013, INT J INFECT DIS, V17, pE739, DOI 10.1016/j.ijid.2013.02.024; Minandri F, 2012, J CLIN MICROBIOL, V50, P590, DOI 10.1128/JCM.05555-11; Nemec A, 2004, J MED MICROBIOL, V53, P147, DOI 10.1099/jmm.0.05445-0; Pourcel C, 2011, J CLIN MICROBIOL, V49, P539, DOI 10.1128/JCM.02003-10; Pournaras S, 2014, J CLIN MICROBIOL, V52, P1653, DOI 10.1128/JCM.03565-13; Rafei R, 2014, INT J INFECT DIS, V21, P21, DOI 10.1016/j.ijid.2014.01.004; Ruiz M, 2007, CLIN MICROBIOL INFEC, V13, P1192, DOI 10.1111/j.1469-0691.2007.01825.x; Runnegar N, 2010, J CLIN MICROBIOL, V48, P4051, DOI 10.1128/JCM.01208-10; Schleicher X, 2013, CLIN MICROBIOL INFEC, V19, P737, DOI 10.1111/1469-0691.12026; Schuetz AN, 2012, DIAGN MICR INFEC DIS, V72, P14, DOI 10.1016/j.diagmicrobio.2011.09.012; Seifert H, 2005, J CLIN MICROBIOL, V43, P4328, DOI 10.1128/JCM.43.9.4328-4335.2005; Severiano A, 2011, J CLIN MICROBIOL, V49, P3997, DOI 10.1128/JCM.00624-11; Turton JF, 2007, CLIN MICROBIOL INFEC, V13, P807, DOI 10.1111/j.1469-0691.2007.01759.x; van Dessel H, 2004, RES MICROBIOL, V155, P105, DOI 10.1016/j.resmic.2003.10.003; Zander E, 2012, J CLIN MICROBIOL, V50, P1900, DOI 10.1128/JCM.06462-11; Zarrilli R, 2008, ANTIMICROB AGENTS CH, V52, P4115, DOI 10.1128/AAC.00366-08; Zarrilli R, 2013, INT J ANTIMICROB AG, V41, P11, DOI 10.1016/j.ijantimicag.2012.09.008	42	28	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115969	10.1371/journal.pone.0115969	http://dx.doi.org/10.1371/journal.pone.0115969			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541711	Green Published, gold			2022-12-27	WOS:000347239900121
J	Tange, S; Oktyabri, D; Terashima, M; Ishimura, A; Suzuki, T				Tange, Shoichiro; Oktyabri, Dulamsuren; Terashima, Minoru; Ishimura, Akihiko; Suzuki, Takeshi			JARID2 Is Involved in Transforming Growth Factor-Beta-Induced Epithelial-Mesenchymal Transition of Lung and Colon Cancer Cell Lines	PLOS ONE			English	Article							GROUP PROTEIN EZH2; GENE-EXPRESSION; MIR-200 FAMILY; STEM-CELLS; E-CADHERIN; HISTONE; PRC2; PROGRESSION; SNAIL; METHYLATION	Histone methylation plays a crucial role in various biological and pathological processes including cancer development. In this study, we discovered that JARID2, an interacting component of Polycomb repressive complex-2 (PRC2) that catalyzes methylation of lysine 27 of histone H3 (H3K27), was involved in Transforming Growth Factor-beta (TGF-beta)-induced epithelial-mesenchymal transition (EMT) of A549 lung cancer cell line and HT29 colon cancer cell line. The expression of JARID2 was increased during TGF-beta-induced EMT of these cell lines and knockdown of JARID2 inhibited TGF-beta-induced morphological conversion of the cells associated with EMT. JARID2 knockdown itself had no effect in the expression of EMT-related genes but antagonized TGF-beta-dependent expression changes of EMT-related genes such as CDH1, ZEB family and microRNA-200 family. Chromatin immunoprecipitation assays showed that JARID2 was implicated in TGF-beta-induced transcriptional repression of CDH1 and microRNA-200 family genes through the regulation of histone H3 methylation and EZH2 occupancies on their regulatory regions. Our study demonstrated a novel role of JARID2 protein, which may control PRC2 recruitment and histone methylation during TGF-beta-induced EMT of lung and colon cancer cell lines.	[Tange, Shoichiro; Oktyabri, Dulamsuren; Terashima, Minoru; Ishimura, Akihiko; Suzuki, Takeshi] Kanazawa Univ, Canc Res Inst, Div Funct Genom, Kanazawa, Ishikawa 920, Japan	Kanazawa University	Suzuki, T (corresponding author), Kanazawa Univ, Canc Res Inst, Div Funct Genom, Kanazawa, Ishikawa 920, Japan.	suzuki-t@staff.kanazawa-u.ac.jp	Tange, Shoichiro/AAJ-5265-2020; Terashima, Minoru/D-8462-2015	Tange, Shoichiro/0000-0002-2126-6938; Suzuki, Takeshi/0000-0002-1737-0900	Ministry of Education, Culture, Sports, Science and Technology of Japan [24590346, 22112010]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-Aid for Scientific Research C (grant number 24590346 to T.S.) and Scientific Research on Innovative Areas (grant number 22112010 to T.S.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao Q, 2008, ONCOGENE, V27, P7274, DOI 10.1038/onc.2008.333; Cao Q, 2011, CANCER CELL, V20, P187, DOI 10.1016/j.ccr.2011.06.016; Chase A, 2011, CLIN CANCER RES, V17, P2613, DOI 10.1158/1078-0432.CCR-10-2156; Cifuentes-Rojas C, 2014, MOL CELL; da Rocha ST, 2014, MOL CELL, V53, P301, DOI 10.1016/j.molcel.2014.01.002; Davalos V, 2012, ONCOGENE, V31, P2062, DOI 10.1038/onc.2011.383; Enkhbaatar Z, 2013, CELL CYCLE, V12, P2100, DOI 10.4161/cc.25142; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Herz HM, 2010, GENE DEV, V24, P857, DOI 10.1101/gad.1921610; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kaneko S, 2014, MOL CELL, V53, P290, DOI 10.1016/j.molcel.2013.11.012; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Ke XS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-669; Kimura H, 2008, CELL STRUCT FUNCT, V33, P61, DOI 10.1247/csf.07035; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Li G, 2010, GENE DEV, V24, P368, DOI 10.1101/gad.1886410; Lin T, 2010, ONCOGENE, V29, P4896, DOI 10.1038/onc.2010.234; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Miyazono K, 2012, UPSALA J MED SCI, V117, P143, DOI 10.3109/03009734.2011.638729; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Puda A, 2012, AM J HEMATOL, V87, P245, DOI 10.1002/ajh.22257; Scheel C, 2012, SEMIN CANCER BIOL, V22, P396, DOI 10.1016/j.semcancer.2012.04.001; Shen XH, 2009, CELL, V139, P1303, DOI 10.1016/j.cell.2009.12.003; Siemens H, 2011, CELL CYCLE, V10, P4256, DOI 10.4161/cc.10.24.18552; Suzuki T, 2002, NAT GENET, V32, P166, DOI 10.1038/ng949; Suzuki T, 2006, EMBO J, V25, P3422, DOI 10.1038/sj.emboj.7601215; Suzuki T, 2013, CANCER SCI, V104, P795, DOI 10.1111/cas.12169; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Walters ZS, 2014, ONCOGENE, V33, P1148, DOI 10.1038/onc.2013.46; Wu CY, 2012, TRENDS GENET; Yoshida M, 2011, BIOCHEM J, V437, P555, DOI 10.1042/BJ20110343	36	49	51	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115684	10.1371/journal.pone.0115684	http://dx.doi.org/10.1371/journal.pone.0115684			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542019	Green Published, gold, Green Submitted			2022-12-27	WOS:000347239900069
J	Allard, M; Husky, M; Catheline, G; Pelletier, A; Dilharreguy, B; Amieva, H; Peres, K; Foubert-Samier, A; Dartigues, JF; Swendsen, J				Allard, Michele; Husky, Mathilde; Catheline, Gwenaelle; Pelletier, Amandine; Dilharreguy, Bixente; Amieva, Helene; Peres, Karine; Foubert-Samier, Alexandra; Dartigues, Jean-Francois; Swendsen, Joel			Mobile Technologies in the Early Detection of Cognitive Decline	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; PRECLINICAL PHASE; DEMENTIA; MEMORY; STATE	The identification of biological and pathophysiological processes implicated in different forms of dementia is itself dependent on reliable descriptions of cognitive performance and capacities. However, traditional instruments are often unable to detect subtle declines in cognitive functions due to natural variation at the time of testing. Mobile technologies permit the repeated assessment of cognitive functions and may thereby provide more reliable descriptions of early cognitive difficulties that are inaccessible to clinic or hospital-based instruments. This assessment strategy is also able to characterize in real-time the dynamic associations between cognitive performance and specific daily life behaviors or activities. In a cohort of elderly rural residents, 60 individuals were administered neuropsychological and neuroimaging exams as well as a one-week period of electronic ambulatory monitoring of behavior, semantic memory performance, and daily life experiences. Whereas imaging markers were unrelated to traditional neuropsychological test scores, they were significantly associated with mobile assessments of semantic memory performance. Moreover, certain daily life activities such as reading or completing crossword puzzles were associated with increases in semantic memory performance over the subsequent hours of the same day. The revolution in mobile technologies provides unprecedented opportunities to overcome the barriers of time and context that characterize traditional hospital and clinical-based assessments. The combination of both novel and traditional methods should provide the best opportunity for identifying the earliest risk factors and biomarkers for Alzheimer's disease and other forms of dementia.	[Allard, Michele; Husky, Mathilde; Catheline, Gwenaelle; Pelletier, Amandine; Dilharreguy, Bixente; Swendsen, Joel] Univ Bordeaux, INCIA, UMR 5287, Bordeaux, France; [Allard, Michele; Husky, Mathilde; Catheline, Gwenaelle; Pelletier, Amandine; Dilharreguy, Bixente; Swendsen, Joel] INCIA, CNRS, UMR 5287, Bordeaux, France; [Allard, Michele; Catheline, Gwenaelle; Pelletier, Amandine; Swendsen, Joel] EPHE, Bordeaux, France; [Allard, Michele; Foubert-Samier, Alexandra; Dartigues, Jean-Francois] CHU Bordeaux, Bordeaux, France; [Amieva, Helene; Peres, Karine; Foubert-Samier, Alexandra; Dartigues, Jean-Francois] Univ Bordeaux, ISPED, Ctr INSERM U897, Bordeaux, France; [Amieva, Helene; Peres, Karine; Foubert-Samier, Alexandra; Dartigues, Jean-Francois] INSERM, ISPED, Ctr INSERM U897, Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm)	Swendsen, J (corresponding author), Univ Bordeaux, INCIA, UMR 5287, Bordeaux, France.	Joel.Swendsen@u-bordeaux2.fr	Swendsen, Joel/ABE-7212-2021; Foubert-Samier, Alexandra/T-4492-2019; catheline, gwenaelle/C-8532-2018; DARTIGUES, Jean François/T-4513-2019; PERES, Karine/T-4128-2019; Amieva, Helene/T-4170-2019	Swendsen, Joel/0000-0002-1886-3889; PERES, Karine/0000-0002-0720-0684; Amieva, Helene/0000-0002-0119-7242; dilharreguy, bixente/0000-0002-7771-1383; Husky, Mathilde/0000-0001-5314-1403; Catheline, Gwenaelle/0000-0003-1949-8913	French Ministry of Health (PHRC "Amimage"); French National Center for Scientific Research (ATIP)	French Ministry of Health (PHRC "Amimage"); French National Center for Scientific Research (ATIP)	This research was supported by grants from the French Ministry of Health (PHRC "Amimage") and from the French National Center for Scientific Research (ATIP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amieva H, 2008, ANN NEUROL, V64, P492, DOI 10.1002/ana.21509; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Cain AE, 2009, J PSYCHIATR RES, V43, P987, DOI 10.1016/j.jpsychires.2009.01.014; Elias MF, 2000, ARCH NEUROL-CHICAGO, V57, P808, DOI 10.1001/archneur.57.6.808; Fellgiebel A, 2011, J ALZHEIMERS DIS, V26, P257, DOI 10.3233/JAD-2011-0001; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Hess TM, 2012, AGING NEUROPSYCHOL C, V19, P13, DOI 10.1080/13825585.2011.622740; ISAACS B, 1973, BRIT J PSYCHIAT, V123, P467, DOI 10.1192/bjp.123.4.467; Johnson EI, 2009, NEUROLOGY, V73, P1579, DOI 10.1212/WNL.0b013e3181c0d466; Johnson EI, 2009, INT J METH PSYCH RES, V18, P48, DOI 10.1002/mpr.276; Metternich B, 2009, J PSYCHOSOM RES, V66, P435, DOI 10.1016/j.jpsychores.2008.07.005; Morrison JH, 2012, NAT REV NEUROSCI, V13, P240, DOI 10.1038/nrn3200; Palmer K, 2003, BRIT MED J, V326, P245, DOI 10.1136/bmj.326.7383.245; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Sagi Y, 2012, NEURON, V73, P1195, DOI 10.1016/j.neuron.2012.01.025; Schmidt C, 2007, COGN NEUROPSYCHOL, V24, P755, DOI 10.1080/02643290701754158; Sperling R, 2007, ANN NY ACAD SCI, V1097, P146, DOI 10.1196/annals.1379.009; Tollenaar MS, 2009, NEUROBIOL LEARN MEM, V91, P23, DOI 10.1016/j.nlm.2008.08.002; Tucker AM, 2011, CURR ALZHEIMER RES, V8, P354	22	50	52	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e112197	10.1371/journal.pone.0112197	http://dx.doi.org/10.1371/journal.pone.0112197			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ9UY	25536290	Green Published, gold, Green Submitted			2022-12-27	WOS:000348563300003
J	Andreas, NJ; Hyde, MJ; Gale, C; Parkinson, JRC; Jeffries, S; Holmes, E; Modi, N				Andreas, Nicholas J.; Hyde, Matthew J.; Gale, Chris; Parkinson, James R. C.; Jeffries, Suzan; Holmes, Elaine; Modi, Neena			Effect of Maternal Body Mass Index on Hormones in Breast Milk: A Systematic Review	PLOS ONE			English	Review							LACTATING MOTHERS; LEPTIN CONCENTRATIONS; ADIPONECTIN CONCENTRATION; GASTROINTESTINAL-TRACT; INSULIN SENSITIVITY; GHRELIN LEVELS; NORMAL-WEIGHT; CORD BLOOD; 1ST YEAR; SERUM	Background: Maternal Body Mass Index (BMI) is positively associated with infant obesity risk. Breast milk contains a number of hormones that may influence infant metabolism during the neonatal period; these may have additional downstream effects on infant appetite regulatory pathways, thereby influencing propensity towards obesity in later life. Objective: To conduct a systematic review of studies examining the association between maternal BMI and the concentration of appetite-regulating hormones in breast milk. Method: Pubmed was searched for studies reporting the association between maternal BMI and leptin, adiponectin, insulin, ghrelin, resistin, obestatin, Peptide YY and Glucagon-Like Peptide 1 in breast milk. Results: Twenty six studies were identified and included in the systematic review. There was a high degree of variability between studies with regard to collection, preparation and analysis of breast milk samples. Eleven of fifteen studies reporting breast milk leptin found a positive association between maternal BMI and milk leptin concentration. Two of nine studies investigating adiponectin found an association between maternal BMI and breast milk adiponectin concentration; however significance was lost in one study following adjustment for time post-partum. No association was seen between maternal BMI and milk adiponectin in the other seven studies identified. Evidence for an association between other appetite regulating hormones and maternal BMI was either inconclusive, or lacking. Conclusions: A positive association between maternal BMI and breast milk leptin concentration is consistently found in most studies, despite variable methodology. Evidence for such an association with breast milk adiponectin concentration, however, is lacking with additional research needed for other hormones including insulin, ghrelin, resistin, obestatin, peptide YY and glucagon-like peptide-1. As most current studies have been conducted with small sample sizes, future studies should ensure adequate sample sizes and standardized methodology.	[Andreas, Nicholas J.; Hyde, Matthew J.; Gale, Chris; Parkinson, James R. C.; Jeffries, Suzan; Modi, Neena] Univ London Imperial Coll Sci Technol & Med, Chelsea & Westminster Hosp, Dept Med, Sect Neonatal Med, London, England; [Holmes, Elaine] Univ London Imperial Coll Sci Technol & Med, Fac Med, Sect Computat & Syst Med, London, England	Imperial College London; Imperial College London	Modi, N (corresponding author), Univ London Imperial Coll Sci Technol & Med, Chelsea & Westminster Hosp, Dept Med, Sect Neonatal Med, London, England.	n.modi@imperial.ac.uk	Gale, Chris/F-1833-2010; Holmes, Elaine/A-2189-2015; Holmes, Elaine/ABE-6606-2020	Gale, Chris/0000-0003-0707-876X; Holmes, Elaine/0000-0002-0556-8389; Hyde, Matthew/0000-0002-4489-7003; Andreas, Nicholas/0000-0002-7224-0420	Westminster Medical School Research Trust; Chelsea and Westminster Hospital Charity	Westminster Medical School Research Trust; Chelsea and Westminster Hospital Charity	NJA is funded by Westminster Medical School Research Trust, CG is supported by the Chelsea and Westminster Hospital Charity.	Agostoni C, 2005, ACTA PAEDIATR, V94, P523, DOI 10.1080/08035320510031054; Ahuja S., 2011, Food and Nutrition Sciences, V2, P201, DOI 10.4236/fns.2011.23027; Arenz S, 2004, INT J OBESITY, V28, P1247, DOI 10.1038/sj.ijo.0802758; Aydin S, 2006, PEPTIDES, V27, P878, DOI 10.1016/j.peptides.2005.08.006; Aydin S, 2008, NUTRITION, V24, P689, DOI 10.1016/j.nut.2008.03.020; Aydin S, 2007, NUTRITION, V23, P807, DOI 10.1016/j.nut.2007.08.015; Aydin S, 2010, PEPTIDES, V31, P2236, DOI 10.1016/j.peptides.2010.08.021; Bartolome MA, 2002, OBES SURG, V12, P324, DOI 10.1381/096089202321088084; BERSETH CL, 1990, AM J CLIN NUTR, V51, P985, DOI 10.1093/ajcn/51.6.985; Bielicki J, 2004, EUR J ENDOCRINOL, V151, P271, DOI 10.1530/eje.0.1510271; Bronsky J, 2012, Cesk Patol, V48, P165; Bronsky J, 2006, CLIN CHEM, V52, P1763, DOI 10.1373/clinchem.2005.063032; Bronsky J, 2011, J PEDIATR GASTR NUTR, V52, P474, DOI 10.1097/MPG.0b013e3182062fcc; Brunner S, 2014, PEDIAT OBES; Casabiell X, 1997, J CLIN ENDOCR METAB, V82, P4270, DOI 10.1210/jc.82.12.4270; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Coppola A, 2009, INT J CARDIOL, V134, P414, DOI 10.1016/j.ijcard.2007.12.087; Cripps RL, 2007, BIOCHEM SOC T, V35, P1203, DOI 10.1042/BST0351203; Cummings DE, 2002, NEW ENGL J MED, V346, P1623, DOI 10.1056/NEJMoa012908; Degawa-Yamauchi M, 2003, J CLIN ENDOCR METAB, V88, P5452, DOI 10.1210/jc.2002-021808; Doneray H, 2009, ACTA PAEDIATR, V98, P643, DOI 10.1111/j.1651-2227.2008.01192.x; Dundar NO, 2010, PEDIATR INT, V52, P622, DOI 10.1111/j.1442-200X.2010.03100.x; Dundar NO, 2005, J PEDIATR ENDOCR MET, V18, P181; Eilers E, 2011, EARLY HUM DEV, V87, P415, DOI 10.1016/j.earlhumdev.2011.03.004; Fields DA, 2012, PEDIAT OBES; Gale C, 2012, AM J CLIN NUTR, V95, P656, DOI 10.3945/ajcn.111.027284; Hamosh M, 2001, PEDIATR CLIN N AM, V48, P69, DOI 10.1016/S0031-3955(05)70286-8; Harder T, 2005, AM J EPIDEMIOL, V162, P397, DOI 10.1093/aje/kwi222; HIRSOVA D, 1969, PHYSIOL BOHEMOSLOV, V18, P281; Houseknecht KL, 1997, BIOCHEM BIOPH RES CO, V240, P742, DOI 10.1006/bbrc.1997.7736; JOVANOVICPETERSON L, 1989, J AM COLL NUTR, V8, P125; Kierson JA, 2006, ACTA PAEDIATR, V95, P991, DOI 10.1080/08035250600669769; Ley SH, 2012, AM J CLIN NUTR, V95, P867, DOI 10.3945/ajcn.111.028431; Li RW, 2012, ARCH PEDIAT ADOL MED, V166, P431, DOI 10.1001/archpediatrics.2011.1665; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lippl F, 2008, HORM METAB RES, V40, P806, DOI 10.1055/s-2008-1081503; Lonnerdal B, 2000, AM J CLIN NUTR, V72, P484; LOVEJOY J, 1992, AM J CLIN NUTR, V55, P1174, DOI 10.1093/ajcn/55.6.1174; Lucas Alan, 2005, J Perinatol, V25 Suppl 2, pS2, DOI 10.1038/sj.jp.7211308; Luoto R, 2012, EARLY HUM DEV, V88, P339, DOI 10.1016/j.earlhumdev.2011.09.006; Luoto R, 2011, J PEDIATR GASTR NUTR, V52, P90, DOI 10.1097/MPG.0b013e3181f3457f; Madsbad S, 2014, DIABETES OBES METAB, V16, P9, DOI 10.1111/dom.12119; Martin LJ, 2006, AM J CLIN NUTR, V83, P1106, DOI 10.1093/ajcn/83.5.1106; Martin RM, 2013, JAMA-J AM MED ASSOC, V309, P1005, DOI 10.1001/jama.2013.167; Mayfield J, 1998, AM FAM PHYSICIAN, V58, P1355; Miralles O, 2006, OBESITY, V14, P1371, DOI 10.1038/oby.2006.155; Newburg DS, 2010, J PEDIATR-US, V156, pS41, DOI 10.1016/j.jpeds.2009.11.020; Nilsson L, 2005, BIOCHEM BIOPH RES CO, V331, P1120, DOI 10.1016/j.bbrc.2005.04.026; Oddy Wendy H, 2012, Breastfeed Rev, V20, P7; Owen CG, 2005, PEDIATRICS, V115, P1367, DOI 10.1542/peds.2004-1176; Parsons TJ, 2001, BRIT MED J, V323, P1331, DOI 10.1136/bmj.323.7325.1331; Pico C, 2007, GENES NUTR, V2, P139, DOI 10.1007/s12263-007-0038-1; Priego T, 2010, INT J OBESITY, V34, P809, DOI 10.1038/ijo.2010.18; Sanchez J, 2005, ENDOCRINOLOGY, V146, P2575, DOI 10.1210/en.2005-0112; Sanchez J, 2008, ENDOCRINOLOGY, V149, P733, DOI 10.1210/en.2007-0630; Savino F, 2006, ACTA PAEDIATR, V95, P414, DOI 10.1080/08035250500440428; Savino F, 2012, HORM RES PAEDIAT, V78, P297, DOI 10.1159/000345876; Savino F, 2012, ACTA PAEDIATR, V101, P1058, DOI 10.1111/j.1651-2227.2012.02744.x; Savino F, 2010, EUR J CLIN NUTR, V64, P972, DOI 10.1038/ejcn.2010.105; Savino F, 2012, EARLY HUM DEV, V88, P779, DOI 10.1016/j.earlhumdev.2012.05.004; Savino F, 2010, EARLY HUM DEV, V86, pS77, DOI 10.1016/j.earlhumdev.2010.01.011; Schueler J, 2013, OBESITY, V21, P1451, DOI 10.1002/oby.20345; Schuster S, 2011, PEDIATR RES, V70, P633, DOI 10.1203/PDR.0b013e31823214ea; Shehadeh N, 2003, ARCH DIS CHILD-FETAL, V88, P214, DOI 10.1136/fn.88.3.F214; Shehadeh N, 2006, J PEDIATR GASTR NUTR, V43, P276, DOI 10.1097/01.mpg.0000226377.03247.fb; Smith-Kirwin SM, 1998, J CLIN ENDOCR METAB, V83, P1810, DOI 10.1210/jc.83.5.1810; Stengel A, 2009, ENDOCRINOLOGY, V150, P5113, DOI 10.1210/en.2009-0697; Toshinai K, 2006, ENDOCRINOLOGY, V147, P2306, DOI 10.1210/en.2005-1357; Ucar B, 2000, J PEDIATR ENDOCR MET, V13, P149; Uysal FK, 2002, CLIN NUTR, V21, P157, DOI 10.1054/clnu.2001.0525; VUKAVIC T, 1984, J PEDIATR GASTR NUTR, V3, P700, DOI 10.1097/00005176-198411000-00011; Weyermann M, 2007, EPIDEMIOLOGY, V18, P722, DOI 10.1097/EDE.0b013e3181567ed4; Weyermann M, 2006, CLIN CHEM, V52, P2095, DOI 10.1373/clinchem.2006.071019; Whitmore TJ, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/296368; Woo JG, 2009, BREASTFEED MED, V4, P101, DOI 10.1089/bfm.2008.0137; Zhang N, 2011, AM J MED SCI, V341, P48, DOI 10.1097/MAJ.0b013e3181ec41ed	76	68	70	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115043	10.1371/journal.pone.0115043	http://dx.doi.org/10.1371/journal.pone.0115043			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536196	gold, Green Published, Green Submitted			2022-12-27	WOS:000348563300028
J	Wei, QY; Chen, YL; Zeng, Z; Shu, C; Long, L; Lu, JH; Huang, YX; Yin, P				Wei, Qinyu; Chen, Yuanli; Zeng, Zheng; Shu, Chang; Long, Lu; Lu, Jianhua; Huang, Yangxin; Yin, Ping			Transmission/Disequilibrium Tests Incorporating Unaffected Offspring	PLOS ONE			English	Article							TRANSMISSION DISEQUILIBRIUM TEST; FAMILY-BASED TESTS; LINKAGE; ASSOCIATION; TDT	We propose a new method for family-based tests of association and linkage called transmission/disequilibrium tests incorporating unaffected offspring (TDTU). This new approach, constructed based on transmission/disequilibrium tests for quantitative traits (QTDT), provides a natural extension of the transmission/disequilibrium test (TDT) to utilize transmission information from heterozygous parents to their unaffected offspring as well as the affected offspring from ascertained nuclear families. TDTU can be used in various study designs and can accommodate all types of independent nuclear families with at least one affected offspring. When the study sample contains only case-parent trios, the TDTU is equivalent to TDT. Informative-transmission disequilibrium test (i-TDT) and generalized disequilibrium test(GDT) are another two methods that can use information of both unaffected offspring and affected offspring. In contract to i-TDT and GDT, the test statistic of TDTU is simpler and more explicit, and can be implemented more easily. Through computer simulations, we demonstrate that power of the TDTU is slightly higher compared to i-TDT and GDT. All the three methods are more powerful than method that uses affected offspring only, suggesting that unaffected siblings also provide information about linkage and association.	[Wei, Qinyu; Chen, Yuanli; Zeng, Zheng; Shu, Chang; Long, Lu; Lu, Jianhua; Yin, Ping] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China; [Huang, Yangxin] Univ S Florida, Coll Publ Hlth, Dept Biostat & Epidemiol, Tampa, FL USA	Huazhong University of Science & Technology; State University System of Florida; University of South Florida	Yin, P (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China.	pingyin2000@126.com						Chen WM, 2009, AM J HUM GENET, V85, P364, DOI 10.1016/j.ajhg.2009.08.003; EWENS WJ, 1995, AM J HUM GENET, V57, P455; Guo CY, 2007, GENET EPIDEMIOL, V31, P115, DOI 10.1002/gepi.20195; Horvath S, 1998, AM J HUM GENET, V63, P1886, DOI 10.1086/302137; Lake SL, 2000, AM J HUM GENET, V67, P1515, DOI 10.1086/316895; Lunetta KL, 2000, AM J HUM GENET, V66, P605, DOI 10.1086/302782; Martin ER, 1997, AM J HUM GENET, V61, P439, DOI 10.1086/514860; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Sun FZ, 1999, AM J EPIDEMIOL, V150, P97; Sun FZ, 2000, ANN HUM GENET, V64, P555, DOI 10.1017/S000348000000840X	10	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e114892	10.1371/journal.pone.0114892	http://dx.doi.org/10.1371/journal.pone.0114892			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25535968	Green Submitted, Green Published, gold			2022-12-27	WOS:000348563300024
J	Kuranov, AB; Vavilov, MN; Abildinova, GZ; Akilzhanova, AR; Iskakova, AN; Zholdybayeva, EV; Boldyreva, MN; Muller, CA; Momynaliev, KT				Kuranov, Alexandr B.; Vavilov, Mikhail N.; Abildinova, Gulshara Zh.; Akilzhanova, Ainur R.; Iskakova, Aisha N.; Zholdybayeva, Elena V.; Boldyreva, Margarita N.; Mueller, Claudia A.; Momynaliev, Kuvat T.			Polymorphisms of HLA-DRB1,-DQA1 and-DQB1 in Inhabitants of Astana, the Capital City of Kazakhstan	PLOS ONE			English	Article							CLASS-II ALLELE; HLA CLASS-I; HAPLOTYPE FREQUENCIES; MOLECULAR ANALYSIS; ETHNIC-GROUPS; POPULATION; GENES; DIVERSITY; ORIGIN; RUSSIA	Background: Kazakhstan has been inhabited by different populations, such as the Kazakh, Kyrgyz, Uzbek and others. Here we investigate allelic and haplotypic polymorphisms of human leukocyte antigen (HLA) genes at DRB1, DQA1 and DQB1 loci in the Kazakh ethnic group, and their genetic relationship between world populations. Methodology/Principal Findings: A total of 157 unrelated Kazakh ethnic individuals from Astana were genotyped using sequence based typing (SBTMethod) for HLA-DRB1, -DQA1 and -DQB1 loci. Allele frequencies, neighborjoining method, and multidimensional scaling analysis have been obtained for comparison with other world populations. Statistical analyses were performed using Arlequin v3.11. Applying the software PAST v. 2.17 the resulting genetic distance matrix was used for a multidimensional scaling analysis (MDS). Respectively 37, 17 and 19 alleles were observed at HLA-DRB1, -DQA1 and -DQB1 loci. The most frequent alleles were HLA-DRB1*07: 01 (13.1%), HLA-DQA1*03:01 (13.1%) and HLA-DQB1*03:01 (17.6%). In the observed group of Kazakhs DRB1*07:01DQA1* 02: 01-DQB1*02: 01 (8.0%) was the most common three loci haplotype. DRB1*10:01-DQB1*05:01 showed the strongest linkage disequilibrium. The Kazakh population shows genetic kinship with the Kazakhs from China, Uyghurs, Mongolians, Todzhinians, Tuvinians and as well as with other Siberians and Asians. Conclusions/Significance: The HLA-DRB1, -DQA1and -DQB1 loci are highly polymorphic in the Kazakh population, and this population has the closest relationship with other Asian and Siberian populations.	[Kuranov, Alexandr B.; Mueller, Claudia A.] Med Univ Clin, Tubingen, Germany; [Vavilov, Mikhail N.] Chelyabinsk Reg Blood Ctr, Chelyabinsk, Russia; [Abildinova, Gulshara Zh.] Natl Res Ctr Maternal & Child Hlth, Astana, Kazakhstan; [Akilzhanova, Ainur R.; Iskakova, Aisha N.; Zholdybayeva, Elena V.; Momynaliev, Kuvat T.] Natl Biotechnol Ctr, Astana, Kazakhstan; [Boldyreva, Margarita N.] NRC Inst Immunol FMBA Russia, Moscow, Russia	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; National Center for Biotechnology (NCB); NRC Institute of Immunology FMBA of Russia	Kuranov, AB (corresponding author), Med Univ Clin, Tubingen, Germany.	iskander.kuranov@gmail.com	Momynaliev, Kuvat/ADR-6456-2022; Akilzhanova, Ainur R/N-6931-2015; Zholdybayeva, Elena/AAB-1509-2020; Iskakova, Aisha N/C-7136-2015	Akilzhanova, Ainur R/0000-0001-6161-8355; Zholdybayeva, Elena/0000-0002-9677-008X; Iskakova, Aisha N/0000-0002-0631-062X; Momynaliev, Kuvat/0000-0003-4656-1025	Ministry of Education and Science of the Republic of Kazakhstan [N01.04.01]; German Academic Exchange Service (DAAD); Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tubingen University	Ministry of Education and Science of the Republic of Kazakhstan(Government of the Republic of KazakhstanMinistry of Education and Science of the Republic of Kazakhstan); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tubingen University	This research was supported by funding from the Ministry of Education and Science of the Republic of Kazakhstan N01.04.01, German Academic Exchange Service (DAAD) for Alexandr B. Kuranov, Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tubingen University. This work was also supported in part by an intramural funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acland A, 2014, DATABASE NATL CTR BI; Alexeev LP, 1991, P 11 INT HIST WORKSH, V1, P666; Amar A, 1999, HUM IMMUNOL, V60, P723, DOI 10.1016/S0198-8859(99)00043-9; Arnaiz-Villena A, 1999, TISSUE ANTIGENS, V53, P213, DOI 10.1034/j.1399-0039.1999.530301.x; Arnaiz-Villena A, 2003, HUM BIOL, V75, P375, DOI 10.1353/hub.2003.0040; Arnaiz-Villena A, 2001, TISSUE ANTIGENS, V57, P308, DOI 10.1034/j.1399-0039.2001.057004308.x; Arnaiz-Villena A, 2001, TISSUE ANTIGENS, V57, P118, DOI 10.1034/j.1399-0039.2001.057002118.x; Arnaiz-Villena A, 2001, HUM IMMUNOL, V62, P869, DOI 10.1016/S0198-8859(01)00285-3; Arnaiz-Villena A, 2000, TISSUE ANTIGENS, V56, P405, DOI 10.1034/j.1399-0039.2000.560503.x; Bera O, 2001, TISSUE ANTIGENS, V57, P200, DOI 10.1034/j.1399-0039.2001.057003200.x; Boldyreva M. N., 2006, Immunologiya, V27, P198; Boldyreva MN, 2007, THESIS NRC I IMMUNOL; Brynedal B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000664; Cechova E, 1998, TISSUE ANTIGENS, V51, P574, DOI 10.1111/j.1399-0039.1998.tb02996.x; Chen RB, 1992, HLA 1991, V1, P676; Derenko MV, 2007, RUSS J GENET+, V43, P334, DOI 10.1134/S1022795407030179; Derenko M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015214; DOHERTY DG, 1992, HUM IMMUNOL, V34, P53, DOI 10.1016/0198-8859(92)90085-2; Dulik MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017548; Dunn PPJ, 2005, TISSUE ANTIGENS, V66, P99, DOI 10.1111/j.1399-0039.2005.00445.x; Dunn PPJ, 2003, METH MOLEC MED, V91, P233; Evseeva I, 2002, TISSUE ANTIGENS, V59, P38, DOI 10.1034/j.1399-0039.2002.590107.x; Farjadian S, 2007, INT J IMMUNOGENET, V34, P457, DOI 10.1111/j.1744-313X.2007.00723.x; Felsenstein J, 2005, DATABASE PHYLIP PHYL; Gonzalez-Galarza FF, 2011, DATABASE ALLELE FREQ; Grahovac B, 1998, HUM GENET, V102, P27, DOI 10.1007/s004390050650; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; Helmberg W, 2004, DATABASE DBMHC SBT I; Hoppe Berthold, 2007, Methods Mol Med, V134, P71; Ivanova M, 2002, TISSUE ANTIGENS, V60, P496, DOI 10.1034/j.1399-0039.2002.600605.x; Jinam TA, 2010, TISSUE ANTIGENS, V75, P151, DOI 10.1111/j.1399-0039.2009.01417.x; Johansson A, 2008, EUR J HUM GENET, V16, P1341, DOI 10.1038/ejhg.2008.88; Kapustin S, 1999, TISSUE ANTIGENS, V54, P517, DOI 10.1034/j.1399-0039.1999.540509.x; Khidiyatova I. M., 2004, Genetika, V40, P267; Kotsch K, 1999, TISSUE ANTIGENS, V53, P486, DOI 10.1034/j.1399-0039.1999.530505.x; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Kuranov AB, 2014, TISSUE ANTIGENS, V83, P106, DOI 10.1111/tan.12279; Kuranov AB, 2011, TISSUE ANTIGENS, V77, P263, DOI 10.1111/j.1399-0039.2010.01611.x; Leffell MS, 2002, HUM IMMUNOL, V63, P614, DOI 10.1016/S0198-8859(02)00415-9; Mack SJ, 2000, TISSUE ANTIGENS, V55, P383, DOI 10.1034/j.1399-0039.2000.550501.x; Marsh SGE, 2010, BONE MARROW TRANSPL, V45, P846, DOI 10.1038/bmt.2010.79; Marsh SGE, 2010, TISSUE ANTIGENS, V75, P291, DOI 10.1111/j.1399-0039.2010.01466.x; Martinez-Laso J, 2001, ANN HUM GENET, V65, P245, DOI 10.1017/S0003480001008624; MartinezLaso J, 1996, TISSUE ANTIGENS, V47, P63, DOI 10.1111/j.1399-0039.1996.tb02515.x; Mas A, 2005, HUM IMMUNOL, V66, P1062, DOI 10.1016/j.humimm.2005.10.001; Matevosyan L, 2011, TISSUE ANTIGENS, V78, P21, DOI 10.1111/j.1399-0039.2011.01668.x; Matsumura Y, 2008, TISSUE ANTIGENS, V71, P447, DOI 10.1111/j.1399-0039.2008.01031.x; Mizuki N, 1997, TISSUE ANTIGENS, V50, P527, DOI 10.1111/j.1399-0039.1997.tb02909.x; Mizuki N, 1998, TISSUE ANTIGENS, V51, P287; Moscoso J, 2008, MOL IMMUNOL, V45, P1018, DOI 10.1016/j.molimm.2007.07.024; Nowak J, 2008, TISSUE ANTIGENS, V71, P193, DOI 10.1111/j.1399-0039.2007.00991.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pascual M, 2001, ARTHRITIS RHEUM, V44, P307, DOI 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K; Rajalingam R, 2004, HUM IMMUNOL, V65, P373, DOI 10.1016/j.humimm.2004.01.012; Robinson J, 2003, DATABASE IMGT HLA; RONNINGEN KS, 1990, HUM IMMUNOL, V29, P275, DOI 10.1016/0198-8859(90)90041-M; Samaha H, 2003, MOL IMMUNOL, V39, P1079, DOI 10.1016/S0161-5890(03)00073-7; Sanchez-Velasco P, 2001, TISSUE ANTIGENS, V58, P223, DOI 10.1034/j.1399-0039.2001.580402.x; Sayer D, 2001, TISSUE ANTIGENS, V57, P46, DOI 10.1034/j.1399-0039.2001.057001046.x; Shen CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013458; Shen CM, 2010, HUM IMMUNOL, V71, P627, DOI 10.1016/j.humimm.2010.02.012; Song EY, 2002, TISSUE ANTIGENS, V59, P475, DOI 10.1034/j.1399-0039.2002.590604.x; Sulcebe G, 2009, INT J IMMUNOGENET, V36, P337, DOI 10.1111/j.1744-313X.2009.00868.x; Suslova TA, 2012, INT J IMMUNOGENET, V39, P394, DOI 10.1111/j.1744-313X.2012.01117.x; Tolstov SP, 1963, PEOPLES CENTRAL AS 2, P777; Tsuneto LT, 2003, TISSUE ANTIGENS, V62, P512, DOI 10.1046/j.1399-0039.2003.00139.x; Uinuk-ool TS, 2004, EUR J IMMUNOGENET, V31, P43, DOI 10.1111/j.1365-2370.2004.00443.x; Uinuk-ool TS, 2002, HUM GENET, V110, P209, DOI 10.1007/s00439-001-0668-0; Voorter CEM, 2006, HUM IMMUNOL, V67, P756, DOI 10.1016/j.humimm.2006.01.002; Vu-Trieu A, 1997, EUR J IMMUNOGENET, V24, P345, DOI 10.1046/j.1365-2370.1997.d01-107.x; Welinder L, 2000, EUR J IMMUNOGENET, V27, P93, DOI 10.1046/j.1365-2370.2000.00209.x; Zuniga J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074442	72	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115265	10.1371/journal.pone.0115265	http://dx.doi.org/10.1371/journal.pone.0115265			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531278	Green Published, Green Submitted, gold			2022-12-27	WOS:000348845100047
J	Magalhaes, GF; Santos, GBND; Rosa, MB; Noblat, LDCB				Magalhaes, Gabriella Fernandes; Noblat de Carvalho Santos, Glaucia Beisl; Rosa, Mario Borges; Costa Beisl Noblat, Lucia de Araujo			Medication Reconciliation in Patients Hospitalized in a Cardiology Unit	PLOS ONE			English	Article							ADMISSION; DISCREPANCIES; ERRORS; IMPACT; TRANSITIONS; ORDERS	Objectives: To compare drugs prescribed on hospital admission with the list of drugs taken prior to admission for adult patients admitted to a cardiology unit and to identify the role of a pharmacist in identifying and resolving medication discrepancies. Method: This study was conducted in a 300 bed university hospital in Brazil. Clinical pharmacists taking medication histories and reconciling medications prescribed on admission with a list of drugs used prior to admission. Discrepancies were classified as justified (e.g., based on the pharmacotherapeutic guidelines of the hospital studied) or unintentional. Treatments were reviewed within 48 hours following hospitalization. Unintentional discrepancies were further classified according to the categorization of medication error severity. Pharmacists verbally contacted the prescriber to recommend actions to resolve the discrepancies. Results: A total of 181 discrepancies were found in 50 patients (86%). Of these discrepancies, 149 (82.3%) were justified changes to the patient's home medication regimen; however, 32 (17.7%) discrepancies found in 24 patients were unintentional. Pharmacists made 31 interventions and 23 (74.2%) were accepted. Among unintentional discrepancies, the most common was a different medication dose on admission (42%). Of the unintentional discrepancies 13 (40.6%) were classified as error without harm, 11 (34.4%) were classified as error without harm but which could affect the patient and require monitoring, 3 (9.4%) as errors could have resulted in harm and 5 (15.6%) were classified as circumstances or events that have the capacity to cause harm. Conclusion: The results revealed a high number of unintentional discrepancies and the pharmacist can play an important role by intervening and correcting medication errors at a hospital cardiology unit.	[Magalhaes, Gabriella Fernandes] Fed Univ Bahia State UFBA, Prof Edgard Santos Univ Hosp, Salvador, BA, Brazil; [Noblat de Carvalho Santos, Glaucia Beisl; Costa Beisl Noblat, Lucia de Araujo] Fed Univ Bahia State UFBA, Prof Edgard Santos Univ Hosp, Salvador, BA, Brazil; [Rosa, Mario Borges] Hosp Fdn Minas Gerais State FHEMIG, Inst Safe Medicat Practices Brazil, Belo Horizonte, MG, Brazil; [Costa Beisl Noblat, Lucia de Araujo] Fed Univ Bahia UFBA, Fac Pharm, Salvador, BA, Brazil	Universidade Federal da Bahia	Magalhaes, GF (corresponding author), Fed Univ Bahia State UFBA, Prof Edgard Santos Univ Hosp, Salvador, BA, Brazil.	gabimagalhaes@yahoo.com.br	Rosa, Mario B/I-8640-2012					ALFAROLARA ER, 2013, ATEN PRIMARIA; Aljadhey H, 2013, INT J QUAL HEALTH C, V25, P648, DOI 10.1093/intqhc/mzt075; BARNSTEINER JH, 2008, PATIENT SAFETY AND Q; BRAGA JF, 2011, REVISTA BRASILEIRA D, V2, P12; Buckley MS, 2013, ANN PHARMACOTHER, V47, P1599, DOI 10.1177/1060028013507428; Coffey Maitreya, 2009, Healthc Q, V12 Spec No Patient, P102; Cornish PL, 2005, ARCH INTERN MED, V165, P424, DOI 10.1001/archinte.165.4.424; Delgado SO, 2007, MED CLIN, V129, P343, DOI DOI 10.1157/13109550; Galvin M, 2013, INT J CLIN PHARM-NET, V35, P14, DOI 10.1007/s11096-012-9696-1; Gleason KM, 2004, AM J HEALTH-SYST PH, V61, P1689, DOI 10.1093/ajhp/61.16.1689; Gleason KM, 2010, J GEN INTERN MED, V25, P441, DOI 10.1007/s11606-010-1256-6; Hellstrom Lina M, 2012, BMC Clin Pharmacol, V12, P9, DOI 10.1186/1472-6904-12-9; *JOINT COMM INT, 2006, USING MEDICATION REC; *JOINT COMM INT, 2013, NATIONAL PATIENT SAF; Ketchum K, 2005, AM J NURS, V105, P78, DOI 10.1097/00000446-200511000-00033; KLIETHERMES MA, 2008, MEDICATION RECONCILI; LEGUELINELBLACH.G, 2014, EUR J INTERN MED, V48, P1298; Lehnbom EC, 2014, ANN PHARMACOTHER, V48, P1298, DOI 10.1177/1060028014543485; Lessard S, 2006, AM J HEALTH-SYST PH, V63, P740, DOI 10.2146/ajhp050291; Messeder AM, 2007, CAD SAUDE PUBLICA, V23, P835, DOI 10.1590/S0102-311X2007000400011; Moriel M C, 2008, Farm Hosp, V32, P65; Morimoto T, 2011, J GEN INTERN MED, V26, P148, DOI 10.1007/s11606-010-1518-3; Mueller SK, 2012, ARCH INTERN MED, V172, P1057, DOI 10.1001/archinternmed.2012.2246; *NICE, 2007, TECHNICAL PATIENT SA; Paez VF., 2010, REV CALID ASIST, V25, P308, DOI DOI 10.1016/J.CALI.2010.03.002; QUAGLIA TP, 2011, REVISTA BRASILEIRA D, V2, P40; Quelennec B, 2013, EUR J INTERN MED, V24, P530, DOI 10.1016/j.ejim.2013.02.007; Reeder TA, 2008, AM J HEALTH-SYST PH, V65, P857, DOI 10.2146/ajhp070292; RIBEIRO AF, 2011, REVISTA BRASILEIRA D, V2, P34; Rogers G, 2006, JT COMM J QUAL PATIE, V32, P37, DOI 10.1016/S1553-7250(06)32006-5; Rozich J., 2001, J CLIN OUTCOMES MANA, V8, P27; Schnipper JL, 2006, ARCH INTERN MED, V166, P565, DOI 10.1001/archinte.166.5.565; Sinvani LD, 2013, J AM MED DIR ASSOC, V14, P668, DOI 10.1016/j.jamda.2013.02.021; *SOC CAT FARM CLIN, 2009, GUIA PARA LA IMPLANT; Tam VC, 2005, CAN MED ASSOC J, V173, P510, DOI 10.1503/cmaj.045311; UNROE KT, 2010, THE AMERICAN JOURNAL, V8, P115, DOI DOI 10.1016/J.AMJOPHARM.2010.04.002; Vira T, 2006, QUAL SAF HEALTH CARE, V15, P122, DOI 10.1136/qshc.2005.015347; *WHO, 2012, PATIENT SAFETY ACTIO	38	22	24	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115491	10.1371/journal.pone.0115491	http://dx.doi.org/10.1371/journal.pone.0115491			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA3ZY	25531902	Green Published, gold, Green Submitted			2022-12-27	WOS:000348845100073
J	Naue, J; Hansmann, T; Schmidt, U				Naue, Jana; Hansmann, Tobias; Schmidt, Ulrike			High-Resolution Melting of 12S rRNA and Cytochrome b DNA Sequences for Discrimination of Species within Distinct European Animal Families	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; IDENTIFICATION; GENE; HRM; ASSAY; FOOD	The cheap and easy identification of species is necessary within multiple fields of molecular biology. The use of high-resolution melting (HRM) of DNA provides a fast closed-tube method for analysis of the sequence composition of the mitochondrial genes 12S rRNA and cytochrome b. We investigated the potential use of HRM for species identification within eleven different animal groups commonly found in Europe by animal-group-specific DNA amplification followed by DNA melting. Influence factors as DNA amount, additional single base alterations, and the existence of mixed samples were taken into consideration. Visual inspection combined with mathematical evaluation of the curve shapes did resolve nearly all species within an animal group. The assay can therefore not only be used for identification of animal groups and mixture analysis but also for species identification within the respective groups. The use of a universal 12S rRNA system additionally revealed a possible approach for species discrimination, mostly by exclusion. The use of the HRM assay showed to be a reliable, fast, and cheap method for species discrimination within a broad range of different animal species and can be used in a flexible "modular" manner depending on the question to be solved.	[Naue, Jana; Hansmann, Tobias; Schmidt, Ulrike] Univ Freiburg, Med Ctr, Inst Legal Med, D-79104 Freiburg, Germany; [Naue, Jana] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg	Naue, J (corresponding author), Univ Freiburg, Med Ctr, Inst Legal Med, Albertstr 9, D-79104 Freiburg, Germany.	jana.naue@uniklinik-freiburg.de			German Research Foundation (DFG); Albert Ludwigs University Freiburg	German Research Foundation (DFG)(German Research Foundation (DFG)); Albert Ludwigs University Freiburg	The article processing charge was funded by the German Research Foundation (DFG) and the Albert Ludwigs University Freiburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alacs EA, 2010, FORENSIC SCI MED PAT, V6, P180, DOI 10.1007/s12024-009-9131-7; Alonso A, 2006, ELECTROPHORESIS, V27, P5101, DOI 10.1002/elps.200600331; Balitzki-Korte B, 2005, INT J LEGAL MED, V119, P291, DOI 10.1007/s00414-005-0537-9; Cousins MM, 2012, J CLIN MICROBIOL, V50, P3054, DOI 10.1128/JCM.01460-12; Dobrowolski SF, 2007, MOL GENET METAB, V91, P218, DOI 10.1016/j.ymgme.2007.03.010; Druml B, 2014, FOOD CHEM, V158, P245, DOI 10.1016/j.foodchem.2014.02.111; Er TK, 2012, CLIN CHIM ACTA, V414, P197, DOI 10.1016/j.cca.2012.09.012; Karlsson AO, 2007, FORENSIC SCI INT, V173, P16, DOI 10.1016/j.forsciint.2007.01.019; Liew M, 2004, CLIN CHEM, V50, P1156, DOI 10.1373/clinchem.2004.032136; Linacre Adrian, 2011, Investig Genet, V2, P2, DOI 10.1186/2041-2223-2-2; Martin-Nunez GM, 2012, CLIN CHIM ACTA, V413, P331, DOI 10.1016/j.cca.2011.09.014; Melton T, 2007, J FORENSIC SCI, V52, P1305, DOI 10.1111/j.1556-4029.2007.00553.x; Montgomery J, 2007, NAT PROTOC, V2, P59, DOI 10.1038/nprot.2007.10; Naue J, 2014, INT J LEGAL MED, V128, P11, DOI 10.1007/s00414-013-0857-0; Parson W, 2000, INT J LEGAL MED, V114, P23, DOI 10.1007/s004140000134; Pena VH, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001530; Ramon-Laca A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092043; Reed GH, 2004, CLIN CHEM, V50, P1748, DOI 10.1373/clinchem.2003.029751; Reed GH, 2007, PHARMACOGENOMICS, V8, P597, DOI 10.2217/14622416.8.6.597; Schutz E, 2009, ANAL BIOCHEM, V385, P143, DOI 10.1016/j.ab.2008.10.045; Teletchea F, 2005, TRENDS BIOTECHNOL, V23, P359, DOI 10.1016/j.tibtech.2005.05.006; Tobe SS, 2008, FORENSIC SCI INT-GEN, V2, P249, DOI 10.1016/j.fsigen.2008.03.002; Vietina M, 2013, FOOD CHEM, V141, P3820, DOI 10.1016/j.foodchem.2013.06.075; Yu L, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-92; Zhou LM, 2005, CLIN CHEM, V51, P1770, DOI 10.1373/clinchem.2005.054924	25	14	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115575	10.1371/journal.pone.0115575	http://dx.doi.org/10.1371/journal.pone.0115575			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531439	Green Published, gold, Green Submitted			2022-12-27	WOS:000348845100079
J	Petrie, MA; Suneja, M; Faidley, E; Shields, RK				Petrie, Michael A.; Suneja, Manish; Faidley, Elizabeth; Shields, Richard K.			A Minimal Dose of Electrically Induced Muscle Activity Regulates Distinct Gene Signaling Pathways in Humans with Spinal Cord Injury	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; TYPE-2 DIABETES-MELLITUS; PARALYZED SOLEUS MUSCLE; MESSENGER-RNA EXPRESSION; INSULIN-RESISTANCE; DEHYDROGENASE-DEFICIENCY; COMPRESSIVE LOADS; EXERCISE; STIMULATION; INDIVIDUALS	Paralysis after a spinal cord injury (SCI) induces physiological adaptations that compromise the musculoskeletal and metabolic systems. Unlike non-SCI individuals, people with spinal cord injury experience minimal muscle activity which compromises optimal glucose utilization and metabolic control. Acute or chronic muscle activity, induced through electrical stimulation, may regulate key genes that enhance oxidative metabolism in paralyzed muscle. We investigated the short and long term effects of electrically induced exercise on mRNA expression of human paralyzed muscle. We developed an exercise dose that activated the muscle for only 0.6% of the day. The short term effects were assessed 3 hours after a single dose of exercise, while the long term effects were assessed after training 5 days per week for at least one year (adherence 81%). We found a single dose of exercise regulated 117 biological pathways as compared to 35 pathways after one year of training. A single dose of electrical stimulation increased the mRNA expression of transcriptional, translational, and enzyme regulators of metabolism important to shift muscle toward an oxidative phenotype (PGC-1 alpha, NR4A3, IFRD1, ABRA, PDK4). However, chronic training increased the mRNA expression of specific metabolic pathway genes (BRP44, BRP44L, SDHB, ACADVL), mitochondrial fission and fusion genes (MFF, MFN1, MFN2), and slow muscle fiber genes (MYH6, MYH7, MYL3, MYL2). These findings support that a dose of electrical stimulation (similar to 10 minutes/day) regulates metabolic gene signaling pathways in human paralyzed muscle. Regulating these pathways early after SCI may contribute to reducing diabetes in people with longstanding paralysis from SCI.	[Petrie, Michael A.; Faidley, Elizabeth; Shields, Richard K.] Univ Iowa, Carver Coll Med, Dept Phys Therapy & Rehabil Sci, Iowa City, IA 52242 USA; [Suneja, Manish] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA USA; [Shields, Richard K.] VA Med Ctr, Dept Vet Affairs, Iowa City, IA USA	University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Shields, RK (corresponding author), Univ Iowa, Carver Coll Med, Dept Phys Therapy & Rehabil Sci, Iowa City, IA 52242 USA.	richard-shields@uiowa.edu		Petrie, Michael/0000-0002-5212-0907; Suneja, Manish/0000-0002-1613-8456; Shields, Richard/0000-0002-5838-9317	National Institute of Child Health and Human Development from National Institue of Health [R01HD062507]; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development [1I01RXOOO149-01]; Craig H. Neilsen Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD062507] Funding Source: NIH RePORTER; Veterans Affairs [I01RX000149] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development from National Institue of Health; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development(US Department of Veterans Affairs); Craig H. Neilsen Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Veterans Affairs(US Department of Veterans Affairs)	This study was supported in part by awards to RKS from the National Institute of Child Health and Human Development Grant R01HD062507 from National Institue of Health and Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development Grant 1I01RXOOO149-01, and the Craig H. Neilsen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CM, 2011, MUSCLE NERVE, V43, P65, DOI 10.1002/mus.21831; Andresen BS, 1996, HUM MOL GENET, V5, P461, DOI 10.1093/hmg/5.4.461; Arai A, 2002, J BIOL CHEM, V277, P24453, DOI 10.1074/jbc.M202216200; Babraj JA, 2009, BMC ENDOCR DISORD, V9, DOI 10.1186/1472-6823-9-3; Barbour Jayne Alexandra, 2014, Int J Cell Biol, V2014, P156020, DOI 10.1155/2014/156020; Bauman WA, 1999, SPINAL CORD, V37, P765, DOI 10.1038/sj.sc.3100893; BIGLANDRITCHIE B, 1983, J PHYSIOL-LONDON, V340, P335, DOI 10.1113/jphysiol.1983.sp014765; Bjornholm M, 2005, BIOCHEM SOC T, V33, P354; Bricker DK, 2012, SCIENCE, V337, P96, DOI 10.1126/science.1218099; Brown RM, 2004, HUM GENET, V115, P123, DOI 10.1007/s00439-004-1124-8; Chu V, 2006, SPIE; Cragg JJ, 2013, NEUROLOGY, V81, P1864, DOI 10.1212/01.wnl.0000436074.98534.6e; Crameri RM, 2002, SCAND J MED SCI SPOR, V12, P316, DOI 10.1034/j.1600-0838.2002.20106.x; DUCKWORTH WC, 1980, DIABETES, V29, P906, DOI 10.2337/diabetes.29.11.906; Dudley-Javoroski S, 2012, OSTEOPOROSIS INT, V23, P2335, DOI 10.1007/s00198-011-1879-4; Dudley-Javoroski S, 2011, ARCH PHYS MED REHAB, V92, P242, DOI 10.1016/j.apmr.2010.10.031; Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012; Egan B, 2010, J PHYSIOL-LONDON, V588, P1779, DOI 10.1113/jphysiol.2010.188011; Fritz T, 2011, DIABETIC MED, V28, P1362, DOI 10.1111/j.1464-5491.2011.03348.x; Gaignard P, 2013, AM J HUM GENET, V93, P384, DOI 10.1016/j.ajhg.2013.06.015; Giger JM, 2009, J APPL PHYSIOL, V107, P1204, DOI 10.1152/japplphysiol.00344.2009; GRIMBY G, 1976, SCAND J REHABIL MED, V8, P37; HENNEMAN E, 1985, J EXP BIOL, V115, P105; Holmstrom MH, 2012, AM J PHYSIOL-ENDOC M, V302, pE731, DOI 10.1152/ajpendo.00159.2011; Iqbal S, 2013, MUSCLE NERVE, V48, P963, DOI 10.1002/mus.23838; Jensen MP, 2012, SPINAL CORD, V50, P373, DOI 10.1038/sc.2011.150; Jin WZ, 2011, J CLIN INVEST, V121, P918, DOI 10.1172/JCI41940; Kawasaki E, 2009, J APPL PHYSIOL, V106, P1826, DOI 10.1152/japplphysiol.90923.2008; Kim JA, 2008, CIRC RES, V102, P401, DOI 10.1161/CIRCRESAHA.107.165472; Kulkarni SS, 2012, METABOLISM, V61, P175, DOI 10.1016/j.metabol.2011.06.014; Lamon S, 2009, J PHYSIOL-LONDON, V587, P1795, DOI 10.1113/jphysiol.2009.168674; LaVela SL, 2006, J SPINAL CORD MED, V29, P387, DOI 10.1080/10790268.2006.11753887; Le WP, 2000, BBA-MOL CELL BIOL L, V1485, P121, DOI 10.1016/S1388-1981(00)00034-2; Little JP, 2011, J APPL PHYSIOL, V111, P1554, DOI 10.1152/japplphysiol.00921.2011; Little JP, 2011, AM J PHYSIOL-REG I, V300, pR1303, DOI 10.1152/ajpregu.00538.2010; Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098; Micheli L, 2011, J BIOL CHEM, V286, P5691, DOI 10.1074/jbc.M110.162842; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Palikaras K., 2014, EXP GERONTOL; Pearen MA, 2012, MOL ENDOCRINOL, V26, P372, DOI 10.1210/me.2011-1274; Petrie MA, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.248; Pilegaard H, 2006, DIABETES, V55, P3020, DOI 10.2337/db06-0152; Pruitt K., 2002, NCBI HDB, P307; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shields RK, 2007, NEUROREHAB NEURAL RE, V21, P169, DOI 10.1177/1545968306293447; Shields RK, 2006, J APPL PHYSIOL, V101, P556, DOI 10.1152/japplphysiol.00099.2006; Shields RK, 2006, MUSCLE NERVE, V34, P84, DOI 10.1002/mus.20564; Shields RK, 2006, J NEUROPHYSIOL, V95, P2380, DOI 10.1152/jn.01181.2005; Shields RK, 2006, SPINE, V31, P548, DOI 10.1097/01.brs.0000201303.49308.a8; Shields RK, 1997, J APPL PHYSIOL, V82, P1499, DOI 10.1152/jappl.1997.82.5.1499; SHIELDS RK, 1995, J NEUROPHYSIOL, V73, P2195, DOI 10.1152/jn.1995.73.6.2195; Spriet LL, 2004, J APPL PHYSIOL, V96, P2082, DOI 10.1152/japplphysiol.01318.2003; Spriet LL, 2002, EXERC SPORT SCI REV, V30, P91, DOI 10.1097/00003677-200204000-00009; STRAUSS AW, 1995, P NATL ACAD SCI USA, V92, P10496, DOI 10.1073/pnas.92.23.10496; Stuart CA, 2013, J CLIN ENDOCR METAB, V98, P2027, DOI 10.1210/jc.2012-3876; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sugden MC, 2003, AM J PHYSIOL-ENDOC M, V284, pE855, DOI 10.1152/ajpendo.00526.2002; Wallace MA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00469; Wallace MA, 2011, J PHYSIOL-LONDON, V589, P2027, DOI 10.1113/jphysiol.2011.205468; Winnick JJ, 2008, J CLIN ENDOCR METAB, V93, P771, DOI 10.1210/jc.2007-1524; Zijdewind I, 2012, J PHYSIOL-LONDON, V590, P1683, DOI 10.1113/jphysiol.2011.220103	61	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115791	10.1371/journal.pone.0115791	http://dx.doi.org/10.1371/journal.pone.0115791			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531450	Green Submitted, Green Published, gold			2022-12-27	WOS:000348845100109
J	Geng, RX; Chen, ZY; Zhao, XY; Qiu, LX; Liu, X; Liu, RJ; Guo, WJ; He, G; Li, J; Zhu, XD				Geng, Ruixuan; Chen, Zhiyu; Zhao, Xiaoying; Qiu, Lixin; Liu, Xin; Liu, Rujiao; Guo, Weijian; He, Guang; Li, Jin; Zhu, Xiaodong			Oxidative Stress-Related Genetic Polymorphisms Are Associated with the Prognosis of Metastatic Gastric Cancer Patients Treated with Epirubicin, Oxaliplatin and 5-Fluorouracil Combination Chemotherapy	PLOS ONE			English	Article							DISEASE-FREE SURVIVAL; BREAST-CANCER; NITRIC-OXIDE; PARAOXONASE; SUSCEPTIBILITY; TOXICITY; RISK; NQO1	Background: Oxidative stress genes are related to cancer development and treatment response. In this study, we aimed to determine the predictive and prognostic roles of oxidative stress-related genetic polymorphisms in metastatic gastric cancer (MGC) patients treated with chemotherapy. Methods: In this retrospective study, we genotyped nine oxidative stress-related single nucleotide polymorphisms (SNPs) in NQO1, SOD2, SOD3, PON1, GSTP1, GSTT1, and NOS3 (rs1800566, rs10517, rs4880, rs1799895, rs662, rs854560, rs1695, rs2266637, rs1799983, respectively) in 108 consecutive MGC patients treated with epirubicin, oxaliplatin, and 5-fluorouracil (EOF) regimen as the first-line chemotherapy and analyzed the association between the genotypes and the disease control rate (DCR), progression-free survival (PFS), and overall survival (OS). Results: We found that, in addition to a lower pathological grade (p50.017), NQO1 rs1800566 CT/TT genotype was an independent predictive factor of poor PFS (hazard ratio [HR] = 1.97, 95% confidence interval [CI] = 1.23-3.16; p = 0.005). PON1 rs662 AA/AG genotype was significantly associated with poor OS HR=1.95, 95% CI=1.07-3.54; p=0.029). No associations were detected between the nine SNPs and DCR. Conclusions: NQO1 rs1800566 is an independent predictive factor of PFS for MGC patients treated with EOF chemotherapy, and PON1 rs662 is a noteworthy prognostic factor of OS. Information on oxidative stress-related genetic variants may facilitate optimization of individualized chemotherapy in clinical practice.	[Geng, Ruixuan; Chen, Zhiyu; Zhao, Xiaoying; Qiu, Lixin; Liu, Xin; Liu, Rujiao; Guo, Weijian; Li, Jin; Zhu, Xiaodong] Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai 200433, Peoples R China; [Geng, Ruixuan; Chen, Zhiyu; Zhao, Xiaoying; Qiu, Lixin; Liu, Xin; Liu, Rujiao; Guo, Weijian; Li, Jin; Zhu, Xiaodong] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [He, Guang] Shanghai Jiao Tong Univ, BioX Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Minist Educ, Shanghai 200030, Peoples R China	Fudan University; Fudan University; Shanghai Jiao Tong University	Li, J (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai 200433, Peoples R China.	fudanlijin@163.com; xddr@netease.com			Natural Science Foundation of Shanghai [13ZR1408200]	Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai)	The project is supported by the Natural Science Foundation of Shanghai (Grant No. 13ZR1408200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Atay A E, 2014, Clin Ter, V165, pe1, DOI 10.7471/CT.2014.1663; Bag A, 2008, CANCER EPIDEM BIOMAR, V17, P3298, DOI 10.1158/1055-9965.EPI-08-0235; Barragan E, 2007, LEUKEMIA RES, V31, P947, DOI 10.1016/j.leukres.2006.10.002; Chen S, 2000, FREE RADICAL BIO MED, V29, P276, DOI 10.1016/S0891-5849(00)00308-7; Choi JY, 2009, CLIN CANCER RES, V15, P5258, DOI 10.1158/1078-0432.CCR-09-0685; Conklin Kenneth A, 2004, Integr Cancer Ther, V3, P294, DOI 10.1177/1534735404270335; Fagerholm R, 2008, NAT GENET, V40, P844, DOI 10.1038/ng.155; Fukumura D, 2006, NAT REV CANCER, V6, P521, DOI 10.1038/nrc1910; Glimelius B, 1997, ANN ONCOL, V8, P163, DOI 10.1023/A:1008243606668; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Hayes JD, 1999, FREE RADICAL RES, V31, P273, DOI 10.1080/10715769900300851; HUMBERT R, 1993, NAT GENET, V3, P73, DOI 10.1038/ng0193-73; Hwang IT, 2007, BIOCHEM BIOPH RES CO, V359, P304, DOI 10.1016/j.bbrc.2007.05.088; Hwang PM, 2001, NAT MED, V7, P1111, DOI 10.1038/nm1001-1111; Jang MJ, 2013, GENE, V512, P275, DOI 10.1016/j.gene.2012.10.032; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jungwirth U, 2011, ANTIOXID REDOX SIGN, V15, P1085, DOI 10.1089/ars.2010.3663; Krzystek-Korpacka M, 2008, CLIN BIOCHEM, V41, P804, DOI 10.1016/j.clinbiochem.2008.03.012; Lajin B, 2013, BRIT J CANCER, V109, P1325, DOI 10.1038/bjc.2013.357; Leviev I, 2001, J LIPID RES, V42, P528; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Lurie G, 2008, CANCER EPIDEM BIOMAR, V17, P2070, DOI 10.1158/1055-9965.EPI-08-0145; Menzel HJ, 2004, BRIT J CANCER, V90, P1989, DOI 10.1038/sj.bjc.6601779; Ruzzo A, 2006, J CLIN ONCOL, V24, P1883, DOI 10.1200/JCO.2005.04.8322; Saadat M, 2012, CANCER EPIDEMIOL, V36, pE101, DOI 10.1016/j.canep.2011.10.015; SANDSTROM J, 1994, J BIOL CHEM, V269, P19163; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Simunek T, 2009, PHARMACOL REP, V61, P154; Tian G, 2014, CELL BIOCH BIOPHYS; Tulsyan S, 2013, MOL DIAGN THER, V17, P371, DOI 10.1007/s40291-013-0045-4; Verim L, 2013, ASIAN PAC J CANCER P, V14, P665, DOI 10.7314/APJCP.2013.14.2.665; Wagner AD, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004064.pub3; Yao S, 2010, BREAST CANCER RES TR, V124, P433, DOI 10.1007/s10549-010-0840-0	34	20	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e116027	10.1371/journal.pone.0116027	http://dx.doi.org/10.1371/journal.pone.0116027			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545243	Green Submitted, Green Published, gold			2022-12-27	WOS:000347120200091
J	Greferath, U; Vessey, KA; Jobling, AI; Mills, SA; Bui, BV; He, Z; Nag, N; Ohtsu, H; Fletcher, EL				Greferath, Ursula; Vessey, Kirstan A.; Jobling, Andrew I.; Mills, Samuel A.; Bui, Bang V.; He, Zheng; Nag, Nupur; Ohtsu, Hiroshi; Fletcher, Erica L.			The Role of Histamine in the Retina: Studies on the Hdc Knockout Mouse	PLOS ONE			English	Article							NERVOUS-SYSTEM; RAT RETINA; VERTEBRATE RETINA; MAMMALIAN RETINA; CONE RESPONSES; GANGLION-CELLS; RABBIT RETINA; MICE; MODEL; BRAIN	The role of histamine in the retina is not well understood, despite it regulating a number of functions within the brain, including sleep, feeding, energy balance, and anxiety. In this study we characterized the structure and function of the retina in mice that lacked expression of the rate limiting enzyme in the formation of histamine, histidine decarboxylase (Hdc(-/-) mouse). Using laser capture microdissection, Hdc mRNA expression was assessed in the inner and outer nuclear layers of adult C57BI6J wildtype (WT) and Hdc(-/-)-retinae. In adult WTand Hdc(-/-)-mice, retinal fundi were imaged, retinal structure was assessed using immunocytochemistry and function was probed by electroretinography. Blood flow velocity was assessed by quantifying temporal changes in the dynamic fluorescein angiography in arterioles and venules. In WT retinae, Hdc gene expression was detected in the outer nuclear layer, but not the inner nuclear layer, while the lack of Hdc expression was confirmed in the Hdc(-/-) retina. Preliminary examination of the fundus and retinal structure of the widely used Hdc(-/-) mouse strain revealed discrete lesions across the retina that corresponded to areas of photoreceptor abnormality reminiscent of the rd8 (Crb1) mutation. This was confirmed after genotyping and the strain designated Hd(crd8/rd8). In order to determine the effect of the lack of Hdc-alone on the retina, Hdc(-/-) mice free of the Crb1 mutation were bred. Retinal fundi appeared normal in these animals and there was no difference in retinal structure, macrogliosis, nor any change in microglial characteristics in Hdc(-/-) compared to wildtype retinae. In addition, retinal function and retinal blood flow dynamics showed no alterations in the Hdc(-/-) retina. Overall, these results suggest that histamine plays little role in modulating retinal structure and function.	[Greferath, Ursula; Vessey, Kirstan A.; Jobling, Andrew I.; Mills, Samuel A.; Nag, Nupur; Fletcher, Erica L.] Univ Melbourne, Dept Anat & Neurosci, Parkville, Vic 3052, Australia; [Bui, Bang V.; He, Zheng] Univ Melbourne, Dept Optometry & Vis Sci, Parkville, Vic 3052, Australia; [Ohtsu, Hiroshi] Tohoku Univ, Sch Med, Dept Engn, Sendai, Miyagi 980, Japan	University of Melbourne; University of Melbourne; Tohoku University	Fletcher, EL (corresponding author), Univ Melbourne, Dept Anat & Neurosci, Parkville, Vic 3052, Australia.	elf@unimelb.edu.au	Bui, Bang/AAD-2679-2021; Fletcher, Erica/E-6364-2012; Jobling, Andrew/C-8221-2015	Bui, Bang/0000-0001-7298-1352; Fletcher, Erica/0000-0001-9412-9523; Greferath, Ursula/0000-0003-1028-648X; Vessey, Kirstan/0000-0003-1031-1964; Nag, Nupur/0000-0002-0271-0781; Jobling, Andrew/0000-0002-7827-3135; He, Zheng/0000-0001-6496-3971	National Health and Medical Research Council (Australia) [APP1021918]; Retina Australia	National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Retina Australia	Funding provided by Grant #APP1021918 from the National Health and Medical Research Council (Australia) to ELF, UG and a grant from Retina Australia to ELF, UG. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	AIRAKSINEN MS, 1988, J COMP NEUROL, V273, P163, DOI 10.1002/cne.902730204; Akimov NP, 2010, INVEST OPHTH VIS SCI, V51, P3825, DOI 10.1167/iovs.09-4806; Aleman TS, 2011, INVEST OPHTH VIS SCI, V52, P6898, DOI 10.1167/iovs.11-7701; Baldan LC, 2014, NEURON, V81, P77, DOI 10.1016/j.neuron.2013.10.052; BENEDITO S, 1991, INVEST OPHTH VIS SCI, V32, P32; Casini G, 2002, NEUROSCIENCE, V115, P1309, DOI 10.1016/S0306-4522(02)00408-6; den Hollander AI, 2004, HUM MUTAT, V24, P355, DOI 10.1002/humu.20093; den Hollander AI, 2002, MECH DEVELOP, V110, P203, DOI 10.1016/S0925-4773(01)00568-8; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; Dmitrieva NA, 2001, VISUAL NEUROSCI, V18, P93, DOI 10.1017/S0952523801181083; Fletcher EL, 2000, J COMP NEUROL, V420, P98; Frazao R, 2011, INVEST OPHTH VIS SCI, V52, P3083, DOI 10.1167/iovs.10-6160; Gastinger MJ, 2006, J COMP NEUROL, V495, P658, DOI 10.1002/cne.20902; Gastinger MJ, 2004, VISUAL NEUROSCI, V21, P935, DOI 10.1017/S0952523804216133; Gastinger MJ, 1999, INVEST OPHTH VIS SCI, V40, P487; GREFERATH U, 1990, J COMP NEUROL, V301, P433, DOI 10.1002/cne.903010308; Greferath U, 2009, NEUROSCIENCE, V158, P932, DOI 10.1016/j.neuroscience.2008.10.034; Haas HL, 2008, PHYSIOL REV, V88, P1183, DOI 10.1152/physrev.00043.2007; Ho T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029892; Hui FR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111330; Jobling AI, 2013, INVEST OPHTH VIS SCI, V54, P3350, DOI 10.1167/iovs.13-11831; John J, 2013, ANN NEUROL, V74, P786, DOI 10.1002/ana.23968; Kalloniatis M, 1999, PROG RETIN EYE RES, V18, P811, DOI 10.1016/S1350-9462(98)00036-6; Kaneko H, 2014, BR J PHARM; KARTEN HJ, 1983, VISION RES, V23, P1197, DOI 10.1016/0042-6989(83)90033-0; Ly A, 2011, INVEST OPHTH VIS SCI, V52, P9316, DOI 10.1167/iovs.11-7879; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; Mehalow AK, 2003, HUM MOL GENET, V12, P2179, DOI 10.1093/hmg/ddg232; Melzig J, 1998, J NEUROSCI, V18, P7160; Melzig J, 1996, J COMP PHYSIOL A, V179, P763, DOI 10.1007/BF00207355; Nixon PJ, 2001, CLIN EXP OPHTHALMOL, V29, P193, DOI 10.1046/j.1442-9071.2001.00402.x; Oh SJ, 2002, J COMP NEUROL, V446, P219, DOI 10.1002/cne.10184; Ohtsu H, 2001, FEBS LETT, V502, P53, DOI 10.1016/S0014-5793(01)02663-1; Ohtsu H, 2002, EUR J IMMUNOL, V32, P1698, DOI 10.1002/1521-4141(200206)32:6<1698::AID-IMMU1698>3.0.CO;2-7; Opie NL, 2012, INVEST OPHTH VIS SCI, V53, P7802, DOI 10.1167/iovs.12-10600; PANULA P, 1989, NEUROSCIENCE, V28, P585, DOI 10.1016/0306-4522(89)90007-9; Panula P, 2013, NAT REV NEUROSCI, V14, P472, DOI 10.1038/nrn3526; Parmentier R, 2002, J NEUROSCI, V22, P7695; Plithussery T, 2007, NEUROSCIENCE, V146, P403, DOI 10.1016/j.neuroscience.2007.01.055; Schmetterer L, 1997, CEPHALALGIA, V17, P175, DOI 10.1046/j.1468-2982.1997.1703175.x; van de Pavert SA, 2004, J CELL SCI, V117, P4169, DOI 10.1242/jcs.01301; Vaney D.I., 1990, PROGR RETINAL RES, V9, P49, DOI [10.1016/0278-4327(90)90004-2, DOI 10.1016/0278-4327(90)90004-2]; VERSAUXBOTTERI C, 1986, J COMP NEUROL, V243, P422, DOI 10.1002/cne.902430311; Vessey KA, 2011, J COMP NEUROL, V519, P506, DOI 10.1002/cne.22530; Vessey KA, 2014, J COMP NEUROL; Vessey KA, 2012, INVEST OPHTH VIS SCI, V53, P7833, DOI 10.1167/iovs.12-10650; Vila A, 2012, J COMP NEUROL, V520, P528, DOI 10.1002/cne.22731; Weigert G, 2006, INVEST OPHTH VIS SCI, V47, P1096, DOI 10.1167/iovs.05-1174; Weymouth AE, 2008, PROG RETIN EYE RES, V27, P1, DOI 10.1016/j.preteyeres.2007.09.003; Zawinka C, 2004, INVEST OPHTH VIS SCI, V45, P2337, DOI 10.1167/iovs.03-1235	50	8	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e116025	10.1371/journal.pone.0116025	http://dx.doi.org/10.1371/journal.pone.0116025			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545149	Green Published, gold			2022-12-27	WOS:000347120200090
J	Li, K; Xue, YM; Chen, AJ; Jiang, YF; Xie, HF; Shi, QX; Zhang, SY; Ni, Y				Li, Kun; Xue, Yamei; Chen, Aijun; Jiang, Youfang; Xie, Haifeng; Shi, Qixian; Zhang, Songying; Ni, Ya			Heat Shock Protein 90 Has Roles in Intracellular Calcium Homeostasis, Protein Tyrosine Phosphorylation Regulation, and Progesterone-Responsive Sperm Function in Human Sperm	PLOS ONE			English	Article							MITOCHONDRIAL-TYPE RIBOSOMES; HUMAN SPERMATOZOA; MAMMALIAN SPERM; ACROSOME REACTION; FERTILIZING-CAPACITY; BOAR SPERMATOZOA; HSP90; GELDANAMYCIN; EXPRESSION; KINASE	Heat shock protein 90 plays critical roles in client protein maturation, signal transduction, protein folding and degradation, and morphological evolution; however, its function in human sperm is not fully understood. Therefore, our objective in this study was to elucidate the mechanism by which heat shock protein 90 exerts its effects on human sperm function. By performing indirect immunofluorescence staining, we found that heat shock protein 90 was localized primarily in the neck, midpiece, and tail regions of human sperm, and that its expression increased with increasing incubation time under capacitation conditions. Geldanamycin, a specific inhibitor of heat shock protein 90, was shown to inhibit this increase in heat shock protein 90 expression in western blotting analyses. Using a multifunctional microplate reader to examine Fluo-3 AM-loaded sperm, we observed for the first time that inhibition of heat shock protein 90 by using geldanamycin significantly decreased intracellular calcium concentrations during capacitation. Moreover, western blot analysis showed that geldanamycin enhanced tyrosine phosphorylation of several proteins, including heat shock protein 90, in a dose-dependent manner. The effects of geldanamycin on human sperm function in the absence or presence of progesterone was evaluated by performing chlortetracycline staining and by using a computer-assisted sperm analyzer. We found that geldanamycin alone did not affect sperm capacitation, hyperactivation, and motility, but did so in the presence of progesterone. Taken together, these data suggest that heat shock protein 90, which increases in expression in human sperm during capacitation, has roles in intracellular calcium homeostasis, protein tyrosine phosphorylation regulation, and progesterone-stimulated sperm function. In this study, we provide new insights into the roles of heat shock protein 90 in sperm function.	[Li, Kun; Chen, Aijun; Jiang, Youfang; Xie, Haifeng; Shi, Qixian; Ni, Ya] Zhejiang Acad Med Sci, Dept Reprod Physiol, Hangzhou 310013, Zhejiang, Peoples R China; [Xue, Yamei; Zhang, Songying] Zhejiang Univ, Sir Run Run Shaw Hosp, Coll Med, Reprod Med Ctr,Dept Obstet & Gynecol, Hangzhou 310016, Zhejiang, Peoples R China	Zhejiang Academy of Medical Sciences; Zhejiang University	Zhang, SY (corresponding author), Zhejiang Univ, Sir Run Run Shaw Hosp, Coll Med, Reprod Med Ctr,Dept Obstet & Gynecol, Hangzhou 310016, Zhejiang, Peoples R China.	zhangsongying@126.com; niya99@126.com	Li, Kun/I-1992-2014	Li, Kun/0000-0002-0678-1122; Xue, Yamei/0000-0001-5019-1587	Natural Science Foundation of China [81170554, 81000244]; Zhejiang Provincial Natural Science Foundation [Y2100058, LY14H040012]; Science and Technology Plan Project of Zhejiang Province [2013C31066, 2012F10004]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Science and Technology Plan Project of Zhejiang Province	This work was supported by the Natural Science Foundation of China (Nos. 81170554 and 81000244), Zhejiang Provincial Natural Science Foundation (Nos. Y2100058 and LY14H040012) and the Science and Technology Plan Project of Zhejiang Province (Nos. 2013C31066 and 2012F10004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	aE Calogero, 1996, MOL HUM REPROD, V2, P733; AITKEN J, 1994, BIOESSAYS, V16, P259, DOI 10.1002/bies.950160409; Alekseev OM, 2005, J BIOL CHEM, V280, P2904, DOI 10.1074/jbc.M410397200; Audouard C, 2011, FERTIL STERIL, V95, P1475, DOI 10.1016/j.fertnstert.2010.12.006; Baker MA, 2004, J CELL SCI, V117, P211, DOI 10.1242/jcs.00842; Baldi E, 2009, MOL CELL ENDOCRINOL, V308, P39, DOI 10.1016/j.mce.2009.02.006; Biggiogera M, 1996, EXP CELL RES, V229, P77, DOI 10.1006/excr.1996.0345; Cao WL, 2003, ASIAN J ANDROL, V5, P43; Casas I, 2010, THERIOGENOLOGY, V74, P940, DOI 10.1016/j.theriogenology.2010.04.021; Cole JA, 2011, J ANDROL, V32, P402, DOI 10.2164/jandrol.110.010702; Dai BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045109; De Amicis F, 2011, INT J ANDROL, V34, P430, DOI 10.1111/j.1365-2605.2010.01111.x; de Lamirande E, 1998, J ANDROL, V19, P215; Dun MD, 2012, HUM REPROD UPDATE, V18, P420, DOI 10.1093/humupd/dms009; Ecroyd H, 2003, BIOL REPROD, V69, P1801, DOI 10.1095/biolreprod.103.017350; Ferlin A, 2010, J UROLOGY, V183, P1248, DOI 10.1016/j.juro.2009.11.009; Gomendio M, 2006, P NATL ACAD SCI USA, V103, P15113, DOI 10.1073/pnas.0605795103; Grad I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015770; GRUPPI CM, 1993, DEV GENET, V14, P119, DOI 10.1002/dvg.1020140206; Gur Y, 2006, GENE DEV, V20, P411, DOI 10.1101/gad.367606; Gur Y, 2008, MOL CELL ENDOCRINOL, V282, P45, DOI 10.1016/j.mce.2007.11.015; Harper CV, 2005, HUM REPROD, V20, P2675, DOI 10.1093/humrep/dei158; Hou ML, 2008, ANIM REPROD SCI, V104, P56, DOI 10.1016/j.anireprosci.2007.01.006; Huang SY, 1999, THERIOGENOLOGY, V51, P1007, DOI 10.1016/S0093-691X(99)00046-1; Huang SY, 2000, THERIOGENOLOGY, V53, P1177, DOI 10.1016/S0093-691X(00)00262-4; ITOH H, 1991, FEBS LETT, V289, P110, DOI 10.1016/0014-5793(91)80920-X; Jaiswal BS, 1999, BIOL REPROD, V60, P1314, DOI 10.1095/biolreprod60.6.1314; Jarosz DF, 2010, ANNU REV GENET, V44, P189, DOI 10.1146/annurev.genet.40.110405.090412; Kiang JG, 2006, AM J PHYSIOL-GASTR L, V291, pG117, DOI 10.1152/ajpgi.00397.2005; Kirichok Y, 2006, NATURE, V439, P737, DOI 10.1038/nature04417; Koga F, 2006, P NATL ACAD SCI USA, V103, P11318, DOI 10.1073/pnas.0604705103; Leach MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032467; Li CY, 2010, HUM REPROD, V25, P317, DOI 10.1093/humrep/dep406; Li K, 2012, J ANDROL, P937; Li K, 2013, HUM REPROD, V28, P47, DOI 10.1093/humrep/des384; Meizel S, 1997, BIOL REPROD, V56, P569, DOI 10.1095/biolreprod56.3.569; Mitchell LA, 2007, MOL HUM REPROD, V13, P605, DOI 10.1093/molehr/gam043; Mortimer ST, 1998, HUM REPROD, V13, P2139, DOI 10.1093/humrep/13.8.2139; Ni Y, 2007, J ANDROL, V28, P381, DOI 10.2164/jandrol.106.001289; Olson SD, 2011, MOL HUM REPROD, V17, P500, DOI 10.1093/molehr/gar040; Primakoff P, 2002, SCIENCE, V296, P2183, DOI 10.1126/science.1072029; ROLDAN ERS, 1994, SCIENCE, V266, P1578, DOI 10.1126/science.7985030; Sagare-Patil V, 2013, MOL CELL ENDOCRINOL, V374, P82, DOI 10.1016/j.mce.2013.04.005; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; SMITH DF, 1995, MOL CELL BIOL, V15, P6804; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; UEHARA Y, 1988, VIROLOGY, V164, P294, DOI 10.1016/0042-6822(88)90649-6; Usachev YM, 2002, NEURON, V33, P113, DOI 10.1016/S0896-6273(01)00557-8; Visconti PE, 2011, ASIAN J ANDROL, V13, P395, DOI 10.1038/aja.2010.69; Volpe S, 2008, REPROD DOMEST ANIM, V43, P385, DOI 10.1111/j.1439-0531.2007.00918.x; Wertheimer EV, 2008, J BIOL CHEM, V283, P35539, DOI 10.1074/jbc.M804586200; World Health Organization (WHO), 1999, WHO LAB MANUAL EXAMI, V4th; Wu YJ, 2011, CELL TISSUE RES, V344, P355, DOI 10.1007/s00441-011-1151-4; Xie HF, 2014, J MED RES, V43, P59; Zhang J, 2010, HUM REPROD, V25, P29, DOI 10.1093/humrep/dep356; Zhao C, 2009, PROTEOMICS, V9, P1385, DOI 10.1002/pmic.200800353; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	57	39	42	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115841	10.1371/journal.pone.0115841	http://dx.doi.org/10.1371/journal.pone.0115841			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541943	Green Submitted, Green Published, gold			2022-12-27	WOS:000347239900095
J	Lliros, M; Inceoglu, O; Garcia-Armisen, T; Anzil, A; Leporcq, B; Pigneur, LM; Viroux, L; Darchambeau, F; Descy, JP; Servais, P				Lliros, Marc; Inceoglu, Ozgul; Garcia-Armisen, Tamara; Anzil, Adriana; Leporcq, Bruno; Pigneur, Lise-Marie; Viroux, Laurent; Darchambeau, Francois; Descy, Jean-Pierre; Servais, Pierre			Bacterial Community Composition in Three Freshwater Reservoirs of Different Alkalinity and Trophic Status	PLOS ONE			English	Article							BACTERIOPLANKTON PRODUCTION; MICROBIAL DIVERSITY; SEASONAL DYNAMICS; LONGITUDINAL AXIS; ABUNDANT GROUP; HUMIC LAKE; BOTTOM-UP; TOP-DOWN; ACTINOBACTERIA; RATES	In order to investigate the factors controlling the bacterial community composition (BCC) in reservoirs, we sampled three freshwater reservoirs with contrasted physical and chemical characteristics and trophic status. The BCC was analysed by 16S rRNA gene amplicon 454 pyrosequencing. In parallel, a complete dataset of environmental parameters and phytoplankton community composition was also collected. BCC in the analysed reservoirs resembled that of epilimnetic waters of natural freshwater lakes with presence of Actinobacteria, Alpha-and Betaproteobacteria, Cytophaga-Flavobacteria-Bacteroidetes (CFB) and Verrucomicrobia groups. Our results evidenced that the retrieved BCC in the analysed reservoirs was strongly influenced by pH, alkalinity and organic carbon content, whereas comparatively little change was observed among layers in stratified conditions.	[Lliros, Marc; Leporcq, Bruno; Pigneur, Lise-Marie; Viroux, Laurent; Descy, Jean-Pierre] Univ Namur, Lab Freshwater Ecol, Namur, Belgium; [Inceoglu, Ozgul; Garcia-Armisen, Tamara; Anzil, Adriana; Servais, Pierre] Univ Libre Bruxelles, Brussels, Belgium; [Darchambeau, Francois] Univ Liege, Chem Oceanog Unit, Liege, Belgium	University of Namur; Universite Libre de Bruxelles; University of Liege	Servais, P (corresponding author), Univ Libre Bruxelles, Brussels, Belgium.	pservais@ulb.ac.be	Darchambeau, Francois/AAX-1206-2021; Llirós, Marc/R-5241-2016	Llirós, Marc/0000-0001-8456-4230; Descy, Jean-Pierre/0000-0003-1649-7800	Fonds National de la Recherche Scientifique (FNRS, Belgium) [2.4.547.09]; postdoctoral CERUNA grant from the Universite de Namur (Belgium); FNRS	Fonds National de la Recherche Scientifique (FNRS, Belgium)(Fonds de la Recherche Scientifique - FNRS); postdoctoral CERUNA grant from the Universite de Namur (Belgium); FNRS(Fonds de la Recherche Scientifique - FNRS)	The Fonds National de la Recherche Scientifique (FNRS, Belgium; project 2.4.547.09) funded this work. MLI was recipient of a postdoctoral CERUNA grant from the Universite de Namur (Belgium). OI benefits from a FNRS postdoctoral grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgaier M, 2006, APPL ENVIRON MICROB, V72, P3489, DOI 10.1128/AEM.72.5.3489-3497.2006; Amado AM, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00167; American Public Health Association, 2005, STANDARD METHODS FOR; Andersson AF, 2010, ISME J, V4, P171, DOI 10.1038/ismej.2009.108; Berdjeb L, 2011, APPL ENVIRON MICROB, V77, P3591, DOI 10.1128/AEM.02739-10; Berdjeb L, 2011, MICROB ECOL, V61, P941, DOI 10.1007/s00248-010-9767-6; Berg KA, 2009, ISME J, V3, P314, DOI 10.1038/ismej.2008.110; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; CLARKE KR, 2001, CHANGES IN MARINE CO; COLE JJ, 1988, MAR ECOL PROG SER, V43, P1, DOI 10.3354/meps043001; Crump BC, 2007, ECOLOGY, V88, P1365, DOI 10.1890/06-0387; de Figueiredo DR, 2007, FEMS MICROBIOL ECOL, V59, P638, DOI 10.1111/j.1574-6941.2006.00241.x; Descy JP, 2000, J PHYCOL, V36, P274, DOI 10.1046/j.1529-8817.2000.99063.x; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Dumestre JF, 2002, AQUAT MICROB ECOL, V26, P209, DOI 10.3354/ame026209; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edwards RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-57; Eiler A, 2007, APPL ENVIRON MICROB, V73, P3511, DOI 10.1128/AEM.02534-06; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Fortunato CS, 2011, MICROB ECOL, V62, P374, DOI 10.1007/s00248-011-9805-z; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; FUHRMAN JA, 1982, MAR BIOL, V66, P109, DOI 10.1007/BF00397184; Garcia-Armisen T, 2010, APPL MICROBIOL BIOT, V87, P2281, DOI 10.1007/s00253-010-2698-9; Gasol JM, 2002, LIMNOL OCEANOGR, V47, P62, DOI 10.4319/lo.2002.47.1.0062; Glockner FO, 2000, APPL ENVIRON MICROB, V66, P5053, DOI 10.1128/AEM.66.11.5053-5065.2000; Gorley C.K., 2006, GETTING STARTED PRIM; Hahn MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032772; Hahn MW, 2003, APPL ENVIRON MICROB, V69, P1442, DOI 10.1128/AEM.69.3.1442-1451.2003; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Hutalle-Schmelzer KML, 2010, FEMS MICROBIOL ECOL, V72, P58, DOI 10.1111/j.1574-6941.2009.00831.x; Jezbera J, 2012, FEMS MICROBIOL ECOL, V81, P467, DOI 10.1111/j.1574-6941.2012.01372.x; Jones SE, 2009, ENVIRON MICROBIOL, V11, P2463, DOI 10.1111/j.1462-2920.2009.01977.x; Katsiapi M, 2011, ENVIRON MONIT ASSESS, V181, P563, DOI 10.1007/s10661-010-1851-3; Kent AD, 2007, ISME J, V1, P38, DOI 10.1038/ismej.2007.6; Kent AD, 2006, ENVIRON MICROBIOL, V8, P1448, DOI 10.1111/j.1462-2920.2006.01039.x; Kirchman DL, 2002, FEMS MICROBIOL ECOL, V39, P91, DOI 10.1111/j.1574-6941.2002.tb00910.x; Kritzberg ES, 2006, FEMS MICROBIOL ECOL, V56, P406, DOI 10.1111/j.1574-6941.2006.00084.x; Lemarchand C, 2006, FEMS MICROBIOL ECOL, V57, P442, DOI 10.1111/j.1574-6941.2006.00131.x; Lenchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066588; Lindstrom ES, 2000, MICROBIAL ECOL, V40, P104; Lindstrom ES, 2005, AQUAT SCI, V67, P210, DOI 10.1007/s00027-005-0769-2; Lindstrom ES, 2004, J PLANKTON RES, V26, P241, DOI 10.1093/plankt/fbh010; Lindstrom ES, 2001, MICROBIAL ECOL, V42, P598, DOI 10.1007/s00248-001-0031-y; Lindstrom ES, 2010, LIMNOL OCEANOGR, V55, P2052, DOI 10.4319/lo.2010.55.5.2052; Logue JB, 2012, ISME J, V6, P1127, DOI 10.1038/ismej.2011.184; Lymperopoulou DS, 2012, MICROBES ENVIRON, V27, P1, DOI 10.1264/jsme2.ME11253; Masin M, 2003, HYDROBIOLOGIA, V504, P99, DOI 10.1023/B:HYDR.0000008512.04563.0b; Naselli-Flores L, 2005, HYDROBIOLOGIA, V548, P85, DOI 10.1007/s10750-005-1149-6; Newton RJ, 2007, APPL ENVIRON MICROB, V73, P7169, DOI 10.1128/AEM.00794-07; Newton RJ, 2011, MICROBIOL MOL BIOL R, V75, P14, DOI 10.1128/MMBR.00028-10; Oksanen J., 2008, VEGAN COMMUNITY ECOL; Pedros-Alio C, 2007, SCIENCE, V315, P192, DOI 10.1126/science.1135933; Pedros-Alio C, 2006, TRENDS MICROBIOL, V14, P257, DOI 10.1016/j.tim.2006.04.007; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Pernthaler J, 2001, APPL ENVIRON MICROB, V67, P2145, DOI 10.1128/AEM.67.5.2145-2155.2001; Pernthaler J, 2005, NAT REV MICROBIOL, V3, P537, DOI 10.1038/nrmicro1180; Peura S, 2012, ISME J, V6, P1640, DOI 10.1038/ismej.2012.21; Poikane S., 2009, WATER FRAMEWORK DIRE, P1; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; Posch T, 2009, AQUAT MICROB ECOL, V54, P113, DOI 10.3354/ame01269; Ptacnik R, 2008, P NATL ACAD SCI USA, V105, P5134, DOI 10.1073/pnas.0708328105; Reiss J, 2009, TRENDS ECOL EVOL, V24, P505, DOI 10.1016/j.tree.2009.03.018; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Ruiz-Gonzalez C, 2013, FEMS MICROBIOL ECOL, V84, P316, DOI 10.1111/1574-6941.12063; Salcher MM, 2008, ENVIRON MICROBIOL, V10, P2074, DOI 10.1111/j.1462-2920.2008.01628.x; Sarmento H, 2008, J APPL PHYCOL, V20, P1001, DOI 10.1007/s10811-007-9294-0; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SERVAIS P, 1989, HYDROBIOLOGIA, V174, P99, DOI 10.1007/BF00014058; Shah V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026263; Simek K, 2005, APPL ENVIRON MICROB, V71, P2381, DOI 10.1128/AEM.71.5.2381-2390.2005; Simek K, 2001, MICROB ECOL, V42, P359, DOI 10.1007/s00248-001-0014-z; Simek K, 2001, APPL ENVIRON MICROB, V67, P2723, DOI 10.1128/AEM.67.6.2723-2733.2001; Simek K, 2008, AQUAT MICROB ECOL, V51, P249, DOI 10.3354/ame01193; Simek K, 2006, ENVIRON MICROBIOL, V8, P1613, DOI 10.1111/j.1462-2920.2006.01053.x; SIMON M, 1989, MAR ECOL PROG SER, V51, P201, DOI 10.3354/meps051201; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Taipale S, 2009, AQUAT MICROB ECOL, V55, P1, DOI 10.3354/ame01277; Tarao M, 2009, APPL ENVIRON MICROB, V75, P4720, DOI 10.1128/AEM.00251-09; Trusova MY, 2002, MICROBIAL ECOL, V44, P252, DOI 10.1007/s00248-002-2020-1; Van der Gucht K, 2005, FEMS MICROBIOL ECOL, V53, P205, DOI 10.1016/j.femsec.2004.12.006; Watanabe K, 2009, FEMS MICROBIOL ECOL, V67, P57, DOI 10.1111/j.1574-6941.2008.00606.x; Weiss P, 1996, APPL ENVIRON MICROB, V62, P1998, DOI 10.1128/AEM.62.6.1998-2005.1996; Weyhenmeyer GA, 2013, FRESHWATER BIOL, V58, P612, DOI 10.1111/j.1365-2427.2012.02779.x; Yannarell AC, 2005, APPL ENVIRON MICROB, V71, P227, DOI 10.1128/AEM.71.1.227-239.2005; Yannarell AC, 2004, APPL ENVIRON MICROB, V70, P214, DOI 10.1128/AEM.70.1.214-223.2004; Yannarell AC, 2003, MICROB ECOL, V46, P391, DOI 10.1007/s00248-003-1008-9; Youngblut ND, 2013, APPL ENVIRON MICROB, V79, P39, DOI 10.1128/AEM.02226-12; Yuan SQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033865; Zwart G, 2002, AQUAT MICROB ECOL, V28, P141, DOI 10.3354/ame028141	92	65	68	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e116145	10.1371/journal.pone.0116145	http://dx.doi.org/10.1371/journal.pone.0116145			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541975	Green Published, gold, Green Submitted			2022-12-27	WOS:000347239900149
J	Sparkes, J; Kortner, G; Ballard, G; Fleming, PJS; Brown, WY				Sparkes, Jessica; Koertner, Gerhard; Ballard, Guy; Fleming, Peter J. S.; Brown, Wendy Y.			Effects of Sex and Reproductive State on Interactions between Free-Roaming Domestic Dogs	PLOS ONE			English	Article							BEHAVIOR; DOMINANCE; TRANSMISSION; AGGRESSION; DINGOES; ECOLOGY	Free-roaming dogs (Canis familiaris) are common worldwide, often maintaining diseases of domestic pets and wildlife. Management of these dogs is difficult and often involves capture, treatment, neutering and release. Information on the effects of sex and reproductive state on intraspecific contacts and disease transmission is currently lacking, but is vital to improving strategic management of their populations. We assessed the effects of sex and reproductive state on short-term activity patterns and contact rates of free-roaming dogs living in an Australian Indigenous community. Population, social group sizes and rates of contact were estimated from structured observations along walked transects. Simultaneously, GPS telemetry collars were used to track dogs' movements and to quantify the frequency of contacts between individual animals. We estimated that the community's dog population was 326 +/- 52, with only 9.8 +/- 2.5% confined to a house yard. Short-term activity ranges of dogs varied from 9.2 to 133.7 ha, with males ranging over significantly larger areas than females. Contacts between two or more dogs occurred frequently, with entire females and neutered males accumulating significantly more contacts than spayed females or entire males. This indicates that sex and reproductive status are potentially important to epidemiology, but the effect of these differential contact rates on disease transmission requires further investigation. The observed combination of unrestrained dogs and high contact rates suggest that contagious disease would likely spread rapidly through the population. Pro-active management of dog populations and targeted education programs could help reduce the risks associated with disease spread.	[Sparkes, Jessica; Koertner, Gerhard; Ballard, Guy; Fleming, Peter J. S.; Brown, Wendy Y.] Univ New England, Sch Environm & Rural Sci, Armidale, NSW, Australia; [Sparkes, Jessica; Koertner, Gerhard; Ballard, Guy] Biosecur New South Wales, Vertebrate Pest Res Unit, Armidale, NSW, Australia; [Fleming, Peter J. S.] Biosecur New South Wales, Vertebrate Pest Res Unit, Orange, Australia; [Sparkes, Jessica; Koertner, Gerhard; Ballard, Guy; Fleming, Peter J. S.] Invas Anim Cooperat Res Ctr, Armidale, NSW, Australia	University of New England	Sparkes, J (corresponding author), Univ New England, Sch Environm & Rural Sci, Armidale, NSW, Australia.	jsparke4@une.edu.au		Ballard, Guy/0000-0002-0287-9720; Brown, Wendy/0000-0002-5309-3381; Sparkes, Jessica/0000-0001-9924-1143; Koertner, Gerhard/0000-0001-8230-0709; Fleming, Peter/0000-0002-3490-6148	Australian Postgraduate Award; UNE Apted scholar; Wildlife and Exotic Disease Preparedness Program	Australian Postgraduate Award(Australian Government); UNE Apted scholar; Wildlife and Exotic Disease Preparedness Program	Jessica Sparkes is an Australian Postgraduate Award and UNE Apted scholar recipient. The authors acknowledge the financial support of the Wildlife and Exotic Disease Preparedness Program (www.daff.gov.au/animalplant-health/emergency/wedpp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Bureau of Statistics, 2013, 2011 CENS QUICKSTATS; Australian Companion Animal Council, 2010, CONTR PET CAR IND AU; BERMAN M, 1983, APPL ANIM ETHOL, V10, P5, DOI 10.1016/0304-3762(83)90107-4; Boitani L, 2007, BEHAVIOURAL BIOLOGY OF DOGS, P147, DOI 10.1079/9781845931872.0147; Bourke S, 2009, DOGS REMOTE COMMUNIT; Bradbury L, 2006, AUST VET J, V84, P317, DOI 10.1111/j.1751-0813.2006.00028.x; Bradshaw JWS, 2009, J VET BEHAV, V4, P135, DOI 10.1016/j.jveb.2008.08.004; Bureau of Meteorology, 2014, CLIM STAT AUSTR LOC; Burt W. H., 1943, Journal of Mammalogy, V24, P346, DOI 10.2307/1374834; Cafazzo S, 2010, BEHAV ECOL, V21, P443, DOI 10.1093/beheco/arq001; Chapman DG, 1951, SOME PROPERTIES HYPE; Constable S, 2010, ANTHROZOOS, V23, P337, DOI 10.2752/175303710X12750451259336; Currie B., 1998, World Health, V51, P26; Durr S, 2014, PREV VET MED, V117, P340, DOI 10.1016/j.prevetmed.2014.07.008; Fox M. W., 1975, Applied Animal Ethology, V1, P119, DOI 10.1016/0304-3762(75)90082-6; Gompper ME, 2014, FREE-RANGING DOGS AND WILDLIFE CONSERVATION, P1; Gunata IK, 2011, THESIS UDAYANA U BAL; Hardaker J., 2012, P AUSTR I AN MAN ANN, P48; HARDEN RH, 1985, AUST WILDLIFE RES, V12, P25; Jackman J., 2007, STATE ANIMALS, P55; Kenward R., 1987, WILDLIFE RADIO TAGGI; Lisberg AE, 2011, ANIM BEHAV, V81, P757, DOI 10.1016/j.anbehav.2011.01.006; Majumder SS, 2014, ACTA ETHOL, V17, P1, DOI 10.1007/s10211-013-0158-0; Meek PD, 1999, WILDLIFE RES, V26, P847, DOI 10.1071/WR97101; Newsome TM, 2014, J MAMMAL, V95, P392, DOI 10.1644/13-MAMM-A-145.1; Newsome TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063931; Newsome TM, 2013, ECOGRAPHY, V36, P914, DOI 10.1111/j.1600-0587.2013.00056.x; Pal S.K., 2011, International Journal of Zoology, V2011, P1, DOI 10.1155/2011/314216; Perez-Guisado J, 2009, J ANIM VET ADV, V8, P336; Perez-Guisado J, 2009, J ANIM VET ADV, V8, P1412; R Core Team, 2021, R LANGUAGE ENV STAT; RUBIN HD, 1982, APPL ANIM ETHOL, V8, P161, DOI 10.1016/0304-3762(82)90141-9; SALMERI KR, 1991, J AM VET MED ASSOC, V198, P1193; Slater MR, 2001, PREV VET MED, V48, P273, DOI 10.1016/S0167-5877(00)00201-4; Sparkes J, 2014, CANINE RABIES AUSTR; Thomson P.C., 1992, Department of Primary Industries and Energy Bureau of Rural Resources Proceedings, V11, P125; THOMSON PC, 1992, WILDLIFE RES, V19, P543, DOI 10.1071/WR9920543; Totton SC, 2010, PREV VET MED, V97, P51, DOI 10.1016/j.prevetmed.2010.07.009; Van Kesteren F, 2013, PARASITOLOGY, V140, P1674, DOI 10.1017/S0031182013001182; Vaniscotte A, 2011, PARASITOLOGY, V138, P1316, DOI 10.1017/S0031182011000874; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510	41	37	38	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e116053	10.1371/journal.pone.0116053	http://dx.doi.org/10.1371/journal.pone.0116053			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541983	Green Published, Green Submitted, gold			2022-12-27	WOS:000347239900134
J	Taylor, JL; Zimet, GD; Donahue, KL; Alexander, AB; Shew, ML; Stupiansky, NW				Taylor, Jaime L.; Zimet, Greg D.; Donahue, Kelly L.; Alexander, Andreia B.; Shew, Marcia L.; Stupiansky, Nathan W.			Vaccinating Sons against HPV: Results from a US National Survey of Parents	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINE; INFLUENZA VACCINATION; ADOLESCENT GIRLS; ACCEPTABILITY; WOMEN; PREDICTORS; SAMPLE; MALES; BOYS; CARE	Purpose: The quadrivalent HPV vaccination was approved for use in males ages 9 to 26 in 2009 and recommended for routine administration in 2011. The purpose of this study was to uncover predictable commonalities amongst parents who chose to vaccinate their 11-17 year old sons against HPV. Methods: We compiled data from a U.S. national sample of 779 parents with sons 11-17 years old using a web-based survey to gather information about behavioral and sociodemographic factors which predicted receipt of 1 or more HPV vaccine doses based on parental report. Predictors were first modeled individually for univariable associations. Significant predictors (p<0.10) were combined in a multivariable model. Results: In the adjusted model, independent predictors included receipt of flu vaccination, health insurance coverage and sexual health topic discussions with sons. Sons who had received a flu shot in the last two years more frequently received at least one dose of the vaccine (OR 1.82; 95% CI 1.45-2.26). Sons covered by private health insurance had decreased odds of HPV vaccination (OR 0.56 95% CI 0.37-0.83). Lastly, parents who had discussed sexual health topics with their sons were more likely to vaccinate (OR 1.61; 95% CI 1.37-1.89). Conclusions: Male vaccination rates in the U.S. have increased, but males continue to be under-immunized. Utilization of health care is an important factor in HPV vaccine uptake; therefore, health care providers should use every contact as an opportunity to vaccinate. Communication about sexual health topics may provide a forum for parents and health care providers to have conversations about HPV vaccination as those more comfortable discussing these topics may also be more comfortable discussing HPV vaccination.	[Taylor, Jaime L.; Zimet, Greg D.; Donahue, Kelly L.; Alexander, Andreia B.; Shew, Marcia L.; Stupiansky, Nathan W.] Indiana Univ, Sch Med, Dept Pediat, Sect Adolescent Med, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Taylor, JL (corresponding author), Indiana Univ, Sch Med, Dept Pediat, Sect Adolescent Med, Indianapolis, IN 46202 USA.	jletaylo@iu.edu		Donahue, Kelly/0000-0002-2143-4612; Alexander, Andreia/0000-0001-8483-1124; Stupiansky, Nathan/0000-0003-1682-973X; Zimet, Gregory/0000-0003-3835-937X	Merck MISP [38094]	Merck MISP	Funding: Support was provided by Merck MISP #38094 (Zimet, PI) [http://engagezone.merck.com/misp.html]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AB, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-192; Barnack JL, 2010, WOMEN HEALTH ISS, V20, P28, DOI 10.1016/j.whi.2009.08.007; Centers for Disease Control and Prevention, 2014, HUM PAP; Centers for Disease Control and Prevention (CDC), 2011, MMWR-MORBID MORTAL W, V60, P1705; Centers for Disease Control and Prevetnion, 2013, FLU VACC COV; Chao C, 2010, AM J EPIDEMIOL, V171, P357, DOI 10.1093/aje/kwp365; Chaturvedi AK, 2010, J ADOLESCENT HEALTH, V46, pS20, DOI 10.1016/j.jadohealth.2010.01.016; Crawford M, 2003, J SEX RES, V40, P13, DOI 10.1080/00224490309552163; Curtis CR, 2013, MMWR-MORBID MORTAL W, V62, P685; Daley MF, 2007, CLIN PEDIATR, V46, P408, DOI 10.1177/0009922806298647; Dempsey A, 2010, VACCINE, V28, P989, DOI 10.1016/j.vaccine.2009.10.133; Donahue KL, 2014, VACCINE, V32, P3883, DOI 10.1016/j.vaccine.2014.05.035; Etter DJ, 2012, CURR OPIN OBSTET GYN, V24, P305, DOI 10.1097/GCO.0b013e3283567005; Gilkey MB, 2012, VACCINE, V30, P5928, DOI 10.1016/j.vaccine.2012.07.045; Hagan JF, 2008, BRIGHT FUTURES GUIDE; Hechter RC, 2013, AM J PUBLIC HEALTH, V103, pE63, DOI 10.2105/AJPH.2013.301495; Hendry M, 2013, VACCINE, V31, P5152, DOI 10.1016/j.vaccine.2013.08.091; Holman DM, 2014, JAMA PEDIATR, V168, P76, DOI 10.1001/jamapediatrics.2013.2752; Humiston SG, 2005, ARCH PEDIAT ADOL MED, V159, P108, DOI 10.1001/archpedi.159.2.108; IBM Corp, 2012, SPSS STAT WIND; Kester LM, 2013, MATERN CHILD HLTH J, V17, P879, DOI 10.1007/s10995-012-1066-z; Laz TH, 2013, HUM VACC IMMUNOTHER, V9, P874, DOI 10.4161/hv.23190; Middleman AB, 2006, J ADOLESCENT HEALTH, V38, P321, DOI 10.1016/j.jadohealth.2006.01.002; Reiter PL, 2013, AM J PUBLIC HEALTH, V103, P1419, DOI 10.2105/AJPH.2012.301189; Reiter PL, 2011, SEX TRANSM DIS, V38, P235, DOI 10.1097/OLQ.0b013e3181f422bb; Reiter PL, 2010, VACCINE, V28, P6292, DOI 10.1016/j.vaccine.2010.06.114; Reiter PL, 2009, SOC SCI MED, V69, P475, DOI 10.1016/j.socscimed.2009.05.024; Stupiansky NW, 2013, SEXUALLY TRANSMITTED DISEASES: VACCINES, PREVENTION, AND CONTROL, 2ND EDITION, P251, DOI 10.1016/B978-0-12-391059-2.00011-5; Stupiansky NW, 2012, J ADOLESCENT HEALTH, V50, P103, DOI 10.1016/j.jadohealth.2011.04.010; Stupiansky NW, 2010, SEX HEALTH, V7, P304, DOI 10.1071/SH09127; Vadaparampil ST, 2011, VACCINE, V29, P8634, DOI 10.1016/j.vaccine.2011.09.006	31	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115154	10.1371/journal.pone.0115154	http://dx.doi.org/10.1371/journal.pone.0115154			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX9RO	25541726	Green Published, gold			2022-12-27	WOS:000347239900025
J	Tian, YP; Hepojoki, J; Ranki, H; Lankinen, H; Valkonen, JPT				Tian, Yan-Ping; Hepojoki, Jussi; Ranki, Harri; Lankinen, Hilkka; Valkonen, Jari P. T.			Analysis of Potato virus Y Coat Protein Epitopes Recognized by Three Commercial Monoclonal Antibodies	PLOS ONE			English	Article							HELPER COMPONENT-PROTEINASE; MOLECULAR CHARACTERIZATION; STRAIN DIFFERENTIATION; APHID TRANSMISSION; GENOME SEQUENCE; TERMINAL REGION; PVY; POTYVIRUS; RESISTANCE; GENES	Background: Potato virus Y (PVY, genus Potyvirus) causes substantial economic losses in solanaceous plants. Routine screening for PVY is an essential part of seed potato certification, and serological assays are often used. The commercial, commonly used monoclonal antibodies, MAb1128, MAb1129, and MAb1130, recognize the viral coat protein (CP) of PVY and distinguish PVYN strains from PVYO and PVYC strains, or detect all PVY strains, respectively. However, the minimal epitopes recognized by these antibodies have not been identified. Methodology/Principal Findings: SPOT peptide array was used to map the epitopes in CP recognized by MAb1128, MAb1129, and MAb1130. Then alanine replacement as well as N-and C-terminal deletion analysis of the identified peptide epitopes was done to determine critical amino acids for antibody recognition and the respective minimal epitopes. The epitopes of all antibodies were located within the 30 N-terminal-most residues. The minimal epitope of MAb1128 was (NLNKEK30)-N-25. Replacement of N-25 or N-27 with alanine weakened the recognition by MAb1128, and replacement of L-26, E-29, or K-30 nearly precluded recognition. The minimal epitope for MAb1129 was (16)RPEQGSIQSNP(26) and the most critical residues for recognition were I-22 and (23)Q. The epitope of MAb1130 was defined by residues (5)IDAGGS(10). Mutation of residue D-6 abrogated and mutation of (9)G strongly reduced recognition of the peptide by MAb1130. Amino acid sequence alignment demonstrated that these epitopes are relatively conserved among PVY strains. Finally, recombinant CPs were produced to demonstrate that mutations in the variable positions of the epitope regions can affect detection with the MAbs. Conclusions/Significance: The epitope data acquired can be compared with data on PVY CP-encoding sequences produced by laboratories worldwide and utilized to monitor how widely the new variants of PVY can be detected with current seed potato certification schemes or during the inspection of imported seed potatoes as conducted with these MAbs.	[Tian, Yan-Ping; Valkonen, Jari P. T.] Univ Helsinki, Dept Agr Sci, Plant Pathol Lab, Helsinki, Finland; [Hepojoki, Jussi; Ranki, Harri; Lankinen, Hilkka] Univ Helsinki, Haartman Inst, Infect Biol Res Program, Dept Virol,Peptide & Prot Lab, Helsinki, Finland	University of Helsinki; University of Helsinki	Valkonen, JPT (corresponding author), Univ Helsinki, Dept Agr Sci, Plant Pathol Lab, Helsinki, Finland.	jari.valkonen@helsinki.fi	Hepojoki, Jussi/W-4667-2017; Tian, Yanping/F-3403-2010	Hepojoki, Jussi/0000-0001-5699-214X; Tian, Yanping/0000-0002-3452-2013; Valkonen, Jari/0000-0002-3704-9911	Academy of Finland [1253126]; Ministry of Agriculture and Forestry [2383/312]	Academy of Finland(Academy of Finland); Ministry of Agriculture and Forestry	Financial support from the Academy of Finland (grant 1253126) and the Ministry of Agriculture and Forestry (grant 2383/312) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams M.J., 2012, VIRUS TAXONOMY, P1069; Adams MJ, 2006, NUCLEIC ACIDS RES, V34, pD382, DOI 10.1093/nar/gkj023; Ali MC, 2008, J PHYTOPATHOL, V156, P413, DOI 10.1111/j.1439-0434.2007.01377.x; Ali MC, 2007, VIRUS GENES, V35, P359, DOI 10.1007/s11262-007-0115-y; ANDREEVA L, 1994, ANN APPL BIOL, V125, P337, DOI 10.1111/j.1744-7348.1994.tb04974.x; Andrejeva J, 1999, J GEN VIROL, V80, P1133, DOI 10.1099/0022-1317-80-5-1133; Bakker E, 2011, THEOR APPL GENET, V123, P493, DOI 10.1007/s00122-011-1602-z; Baratova LA, 2001, J VIROL, V75, P9696, DOI 10.1128/JVI.75.20.9696-9702.2001; Barker H, 2009, AM J POTATO RES, V86, P227, DOI 10.1007/s12230-009-9076-0; Blanc S, 1997, VIROLOGY, V231, P141, DOI 10.1006/viro.1997.8521; Bolotova YV, 2009, AM J POTATO RES, V86, P265, DOI 10.1007/s12230-009-9079-x; BOONEKAMP PM, 1991, ACTA BOT NEERL, V40, P41, DOI 10.1111/j.1438-8677.1991.tb01512.x; Boonham N, 1998, J VIROL METHODS, V74, P193, DOI 10.1016/S0166-0934(98)00097-4; Candresse T, 2011, PHYTOPATHOLOGY, V101, P611, DOI 10.1094/PHYTO-10-10-0274; CANTO T, 1995, PLANT DIS, V79, P234, DOI 10.1094/PD-79-0234; Chikh-Ali M, 2013, PLANT DIS, V97, P1370, DOI 10.1094/PDIS-02-13-0161-SR; Chung BYW, 2008, P NATL ACAD SCI USA, V105, P5897, DOI 10.1073/pnas.0800468105; CLARK MF, 1977, J GEN VIROL, V34, P475, DOI 10.1099/0022-1317-34-3-475; COCKERHAM G, 1970, HEREDITY, V25, P309, DOI 10.1038/hdy.1970.35; Dhar AK, 1997, CAN J MICROBIOL, V43, P677, DOI 10.1139/m97-096; Ellis P, 1996, CAN J PLANT PATHOL, V18, P64, DOI 10.1080/07060669609500657; Faurez F, 2012, MOL PLANT PATHOL, V13, P948, DOI 10.1111/j.1364-3703.2012.00803.x; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Gebhardt C, 2006, THEOR APPL GENET, V112, P1458, DOI 10.1007/s00122-006-0248-8; Glais L, 2002, ARCH VIROL, V147, P363, DOI 10.1007/s705-002-8325-0; GOVIER DA, 1977, VIROLOGY, V78, P306, DOI 10.1016/0042-6822(77)90101-5; GUGERLI P, 1983, J GEN VIROL, V64, P2471, DOI 10.1099/0022-1317-64-11-2471; Gutierrez-Aguirre I, 2014, ANAL BIOCHEM, V447, P74, DOI 10.1016/j.ab.2013.10.032; HIDAKA M, 1992, NUCLEIC ACIDS RES, V20, P3515, DOI 10.1093/nar/20.13.3515; Huhnlein A, 2013, J PLANT DIS PROTECT, V120, P57; Jakab G, 1997, J GEN VIROL, V78, P3141, DOI 10.1099/0022-1317-78-12-3141; Jayaram C, 1998, VIRUS RES, V58, P1, DOI 10.1016/S0168-1702(98)00091-4; JONES RAC, 1990, ANN APPL BIOL, V117, P93, DOI 10.1111/j.1744-7348.1990.tb04198.x; Kaikkonen L, 1999, J CLIN MICROBIOL, V37, P3952, DOI 10.1128/JCM.37.12.3952-3956.1999; Karasev AV, 2013, ANNU REV PHYTOPATHOL, V51, P571, DOI 10.1146/annurev-phyto-082712-102332; Karasev AV, 2010, AM J POTATO RES, V87, P1, DOI 10.1007/s12230-009-9110-2; Keller H, 2005, EUR J PLANT PATHOL, V111, P391, DOI 10.1007/s10658-004-6892-4; Kirchner SM, 2014, POTATO RES IN PRESS; Mallik I, 2012, AM J POTATO RES, V89, P184, DOI 10.1007/s12230-012-9241-8; MCDONALD JG, 1993, PLANT DIS, V77, P87, DOI 10.1094/PD-77-0087; Mink GI, 1999, ARCH VIROL, V144, P1173, DOI 10.1007/s007050050577; Moury B, 2011, MOL PLANT MICROBE IN, V24, P787, DOI 10.1094/MPMI-10-10-0246; Nikolaeva OV, 2012, AM J POTATO RES, V89, P121, DOI 10.1007/s12230-012-9233-8; OHSHIMA K, 1992, J VIROL METHODS, V40, P265, DOI 10.1016/0166-0934(92)90085-R; Oruetxebarria I, 2001, VIRUS GENES, V22, P335, DOI 10.1023/A:1011174509453; Ounouna H, 2002, PLANT PATHOL, V51, P487, DOI 10.1046/j.1365-3059.2002.00734.x; PAPPU HR, 1993, P NATL ACAD SCI USA, V90, P3641, DOI 10.1073/pnas.90.8.3641; PEREIRA LG, 1994, VIROLOGY, V203, P277, DOI 10.1006/viro.1994.1485; Rajamaki M, 1998, PHYTOPATHOLOGY, V88, P311, DOI 10.1094/PHYTO.1998.88.4.311; Regenmortel MHW, 1993, PLANT VIRUS DIS, P165; Romero A, 2001, VIRUS RES, V79, P71, DOI 10.1016/S0168-1702(01)00300-8; ROSE DG, 1986, ANN APPL BIOL, V109, P317, DOI 10.1111/j.1744-7348.1986.tb05323.x; Roudet-Tavert G, 2002, J GEN VIROL, V83, P1765, DOI 10.1099/0022-1317-83-7-1765; Rupar M, 2013, J VIROL METHODS, V189, P93, DOI 10.1016/j.jviromet.2013.01.013; Schubert J, 2007, J VIROL METHODS, V140, P66, DOI 10.1016/j.jviromet.2006.10.017; Seo JK, 2010, MOL PLANT PATHOL, V11, P265, DOI 10.1111/j.1364-3703.2009.00603.x; Singh RP, 2008, ARCH VIROL, V153, P1, DOI 10.1007/s00705-007-1059-1; Soto MJ, 1994, ANN APPL BIOL, V124, P31; Sudarsono, 1993, ARCH VIROL, V132, P161; Tian YP, 2011, PHYTOPATHOLOGY, V101, P377, DOI 10.1094/PHYTO-02-10-0055; Tian YP, 2013, MOL PLANT MICROBE IN, V26, P297, DOI 10.1094/MPMI-09-12-0219-R; Valkonen Jari P. T., 2007, P619; VALKONEN JPT, 1994, PLANT BREEDING, V112, P1, DOI 10.1111/j.1439-0523.1994.tb01270.x; VANDERVLUGT RAA, 1993, ARCH VIROL, V131, P361, DOI 10.1007/BF01378638; VUENTO M, 1993, BIOCHIM BIOPHYS ACTA, V1162, P155, DOI 10.1016/0167-4838(93)90142-E	65	5	7	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115766	10.1371/journal.pone.0115766	http://dx.doi.org/10.1371/journal.pone.0115766			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542005	Green Published, Green Submitted, gold			2022-12-27	WOS:000347239900081
J	Wong, DM; Shen, ZY; Owyang, KE; Martinez-Agosto, JA				Wong, Daniel M.; Shen, Zhouyang; Owyang, Kristin E.; Martinez-Agosto, Julian A.			Insulin- and Warts-Dependent Regulation of Tracheal Plasticity Modulates Systemic Larval Growth during Hypoxia in Drosophila melanogaster	PLOS ONE			English	Article							BODY-SIZE; TUMOR-SUPPRESSOR; SIGNAL-TRANSDUCTION; CRITICAL WEIGHT; FAT-CELLS; OXYGEN; METAMORPHOSIS; HOMEOSTASIS; METABOLISM; PATHWAY	Adaptation to dynamic environmental cues during organismal development requires coordination of tissue growth with available resources. More specifically, the effects of oxygen availability on body size have been well-documented, but the mechanisms through which hypoxia restricts systemic growth have not been fully elucidated. Here, we characterize the larval growth and metabolic defects in Drosophila that result from hypoxia. Hypoxic conditions reduced fat body opacity and increased lipid droplet accumulation in this tissue, without eliciting lipid aggregation in hepatocyte-like cells called oenocytes. Additionally, hypoxia increased the retention of Dilp2 in the insulin-producing cells of the larval brain, associated with a reduction of insulin signaling in peripheral tissues. Overexpression of the wildtype form of the insulin receptor ubiquitously and in the larval trachea rendered larvae resistant to hypoxia-induced growth restriction. Furthermore, Warts downregulation in the trachea was similar to increased insulin receptor signaling during oxygen deprivation, which both rescued hypoxia-induced growth restriction, inhibition of tracheal molting, and developmental delay. Insulin signaling and loss of Warts function increased tracheal growth and augmented tracheal plasticity under hypoxic conditions, enhancing oxygen delivery during periods of oxygen deprivation. Our findings demonstrate a mechanism that coordinates oxygen availability with systemic growth in which hypoxia-induced reduction of insulin receptor signaling decreases plasticity of the larval trachea that is required for the maintenance of systemic growth during times of limiting oxygen availability.	[Wong, Daniel M.; Shen, Zhouyang; Owyang, Kristin E.; Martinez-Agosto, Julian A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Martinez-Agosto, Julian A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Martinez-Agosto, Julian A.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Martinez-Agosto, Julian A.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Martinez-Agosto, JA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA.	julianmartinez@mednet.ucla.edu	Martinez-Agosto, Julian A/I-9435-2019	Martinez-Agosto, Julian A/0000-0001-6776-6949; Shen, Zhouyang/0000-0002-6524-8993	David Geffen School of Medicine at UCLA; Irving and Jean Stone Stipend Award; URC/CARE Undergraduate Research Scholars Program; UCLA from Amgen Foundation; Howard Hughes Medical Institute through Precollege and Undergraduate Science Education Program	David Geffen School of Medicine at UCLA(University of California System); Irving and Jean Stone Stipend Award; URC/CARE Undergraduate Research Scholars Program; UCLA from Amgen Foundation; Howard Hughes Medical Institute through Precollege and Undergraduate Science Education Program	Funding: This work was supported by the David Geffen School of Medicine at UCLA, the Irving and Jean Stone Stipend Award and URC/CARE Undergraduate Research Scholars Program to KEO, and UCLA grants from the Amgen Foundation and Howard Hughes Medical Institute through the Precollege and Undergraduate Science Education Program to DMW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhouayri I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002319; Alic N, 2011, AGING CELL, V10, P137, DOI 10.1111/j.1474-9726.2010.00653.x; Andersen DS, 2013, TRENDS CELL BIOL, V23, P336, DOI 10.1016/j.tcb.2013.03.005; Arquier N, 2008, CELL METAB, V7, P333, DOI 10.1016/j.cmet.2008.02.003; Azad P, 2012, G3-GENES GENOM GENET, V2, P1169, DOI 10.1534/g3.112.003681; Ballard SL, 2010, DEV BIOL, V337, P375, DOI 10.1016/j.ydbio.2009.11.011; Bauer R, 2009, EMBO J, V28, P3706, DOI 10.1038/emboj.2009.305; Billeter JC, 2009, NATURE, V461, P987, DOI 10.1038/nature08495; Boulan L, 2013, CURR BIOL, V23, P473, DOI 10.1016/j.cub.2013.01.072; Brahimi-Horn MC, 2007, CURR OPIN CELL BIOL, V19, P223, DOI 10.1016/j.ceb.2007.02.003; Britton JS, 1998, DEVELOPMENT, V125, P2149; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Callier V, 2013, J EXP BIOL, V216, P4334, DOI 10.1242/jeb.093120; Callier V, 2011, P NATL ACAD SCI USA, V108, P14664, DOI 10.1073/pnas.1106556108; Centanin L, 2005, EMBO REP, V6, P1070, DOI 10.1038/sj.embor.7400528; Centanin L, 2008, DEV CELL, V14, P547, DOI 10.1016/j.devcel.2008.01.020; Cheng ZY, 2010, TRENDS ENDOCRIN MET, V21, P589, DOI 10.1016/j.tem.2010.06.005; Colombani J, 2005, SCIENCE, V310, P667, DOI 10.1126/science.1119432; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; Davidowitz G, 2003, EVOL DEV, V5, P188, DOI 10.1046/j.1525-142X.2003.03026.x; Dekanty A, 2005, J CELL SCI, V118, P5431, DOI 10.1242/jcs.02648; Delanoue R, 2010, DEV CELL, V18, P1012, DOI 10.1016/j.devcel.2010.05.007; Demontis F, 2009, DEVELOPMENT, V136, P983, DOI 10.1242/dev.027466; Edgar BA, 2001, CELL, V105, P297, DOI 10.1016/S0092-8674(01)00334-8; Edgar BA, 2006, NAT REV GENET, V7, P907, DOI 10.1038/nrg1989; Evdokimova V, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003184; Frazier MR, 2001, PHYSIOL BIOCHEM ZOOL, V74, P641, DOI 10.1086/322172; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; Ghabrial AS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002087; Gleixner E, 2008, FEBS J, V275, P5108, DOI 10.1111/j.1742-4658.2008.06642.x; Gorr TA, 2004, J BIOL CHEM, V279, P36048, DOI 10.1074/jbc.M405077200; Gutierrez E, 2007, NATURE, V445, P275, DOI 10.1038/nature05382; Harrison JF, 2011, ANNU REV PHYSIOL, V73, P95, DOI 10.1146/annurev-physiol-012110-142155; Heinrich EC, 2011, J EXP BIOL, V214, P1419, DOI 10.1242/jeb.051904; Honegger Basil, 2008, J Biol, V7, P10, DOI 10.1186/jbiol72; Hyun S, 2013, CELL MOL LIFE SCI, V70, P2351, DOI 10.1007/s00018-013-1313-5; Jarecki J, 1999, CELL, V99, P211, DOI 10.1016/S0092-8674(00)81652-9; Jaspers MHJ, 2014, DEV BIOL, V385, P23, DOI 10.1016/j.ydbio.2013.10.022; Jiang CT, 2013, J BIOL CHEM, V288, P3844, DOI 10.1074/jbc.M112.426338; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kunte AS, 2006, CELL METAB, V3, P439, DOI 10.1016/j.cmet.2006.04.011; Lavista-Llanos S, 2002, MOL CELL BIOL, V22, P6842, DOI 10.1128/MCB.22.19.6842-6853.2002; Layalle S, 2008, DEV CELL, V15, P568, DOI 10.1016/j.devcel.2008.08.003; Li Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003230; Li ZH, 2013, DEV CELL, V24, P133, DOI 10.1016/j.devcel.2012.12.010; Linneweber GA, 2014, CELL, V156, P69, DOI 10.1016/j.cell.2013.12.008; Low P, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-29; Makki R, 2014, ANNU REV ENTOMOL, V59, P405, DOI 10.1146/annurev-ento-011613-162056; Manning Gerards, 1993, P609; Mazure NM, 2010, CURR OPIN CELL BIOL, V22, P177, DOI 10.1016/j.ceb.2009.11.015; Mirth C, 2005, CURR BIOL, V15, P1796, DOI 10.1016/j.cub.2005.09.017; Mirth Christen Kerry, 2012, Front Endocrinol (Lausanne), V3, P49, DOI 10.3389/fendo.2012.00049; Mirth CK, 2014, P NATL ACAD SCI US; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Okamoto N, 2013, GENE DEV, V27, P87, DOI 10.1101/gad.204479.112; Owusu-Ansah E, 2013, CELL, V155, P699, DOI 10.1016/j.cell.2013.09.021; Parvy JP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002925; Peck LS, 2005, J EXP ZOOL PART A, V303A, P968, DOI 10.1002/jez.a.211; Raftery LA, 1999, DEV BIOL, V210, P251, DOI 10.1006/dbio.1999.9282; Rajan A, 2012, CELL, V151, P123, DOI 10.1016/j.cell.2012.08.019; Regazzetti C, 2009, DIABETES, V58, P95, DOI 10.2337/db08-0457; Reiling JH, 2004, GENE DEV, V18, P2879, DOI 10.1101/gad.322704; Riddiford L, 1985, DEV DROSOPHILA MELAN, P899; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Sato-Miyata Y, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00147; Shin SC, 2011, SCIENCE, V334, P670, DOI 10.1126/science.1212782; Strassburger K, 2012, DEV BIOL, V367, P187, DOI 10.1016/j.ydbio.2012.05.008; Tennessen JM, 2011, CURR BIOL, V21, pR750, DOI 10.1016/j.cub.2011.06.033; Trayhurn P, 2013, PHYSIOL REV, V93, P1, DOI 10.1152/physrev.00017.2012; Walkiewicz MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005072; WIGGLESWORTH VB, 1988, TISSUE CELL, V20, P919, DOI 10.1016/0040-8166(88)90033-X; XU TA, 1995, DEVELOPMENT, V121, P1053; Ye J, 2009, INT J OBESITY, V33, P54, DOI 10.1038/ijo.2008.229; Yu JN, 2011, EUR J CELL BIOL, V90, P1000, DOI 10.1016/j.ejcb.2011.06.004; Zhou D, 2013, ANNU REV GENOM HUM G, V14, P25, DOI 10.1146/annurev-genom-091212-153439; Zhou D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000221	79	31	33	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115297	10.1371/journal.pone.0115297	http://dx.doi.org/10.1371/journal.pone.0115297			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541690	gold, Green Published			2022-12-27	WOS:000347239900034
J	Xiang, K; Cheng, L; Luo, ZL; Ren, JD; Tian, FZ; Tang, LJ; Chen, T; Dai, RW				Xiang, Ke; Cheng, Long; Luo, Zhulin; Ren, Jiandong; Tian, Fuzhou; Tang, Lijun; Chen, Tao; Dai, Ruiwu			Glycyrrhizin Suppresses the Expressions of HMGB1 and Relieves the Severity of Traumatic Pancreatitis in Rats	PLOS ONE			English	Article							MOBILITY GROUP BOX-1; IMPROVES SURVIVAL; ORGAN INJURY; CYTOKINE; PROTEIN; INFLAMMATION; RELEASE	Background: High mobility group box 1 (HMGB1) plays important roles in a large variety of diseases; glycyrrhizin (GL) is recognized as an HMGB1 inhibitor. However, few studies have focused on whether glycyrrhizin can potentially improve the outcome of traumatic pancreatitis (TP) by inhibiting HMGB1. Methods: A total of 60 male Wistar rats were randomly divided into three groups (n=20 in each): Control group, TP group and TP-GL group. Pancreatic trauma was established with a custom-made biological impact machine-III, and GL was administered at 15 minutes after the accomplishment of operation. To determine survival rates during the first 7 days after injury, another 60 rats (n=20 in each) were grouped and treated as mentioned above. At 24 hours of induction of TP, the histopathological changes in pancreas were evaluated and serum amylase levels were tested. Serum tumor necrosis factor alpha (TNF-alpha), interleukin 6 (IL-6), and HMGB1 were measured using enzyme linked immunosorbent assay. HMGB1 expressions in pancreas were measured using immunohistochemical staining, Western blot and Real-Time PCR analysis. Results: Serum levels of HMGB1, TNF-alpha and IL-6 were increased dramatically in TP group at 24 hours after induction of TP. However, these indicators were reduced significantly by GL administration in TP-GL group comparing with TP group (P<0.05). Meanwhile, survival analysis showed that the seven-day survival rate in TP-GL group was significantly higher than that in TP group (85% versus 65%, P<0.05). GL treatment significantly decreased the pancreatic protein and mRNA expressions of HMGB1 and ameliorated the pancreatic injury in rats with TP. Conclusions: Glycyrrhizin might play an important role in improving survival rates and ameliorating pancreatic injury of TP by suppression of the expressions of HMGB1 and other proinflammatory cytokine.	[Xiang, Ke] Third Mil Med Univ, Chongqing, Peoples R China; [Xiang, Ke; Cheng, Long; Luo, Zhulin; Tian, Fuzhou; Tang, Lijun; Chen, Tao; Dai, Ruiwu] Chengdu Mil Gen Hosp, Dept Gen Surg, Chengdu, Peoples R China; [Ren, Jiandong] Chengdu Mil Gen Hosp, Dept Pharm, Chengdu, Peoples R China	Army Medical University	Tian, FZ (corresponding author), Chengdu Mil Gen Hosp, Dept Gen Surg, Chengdu, Peoples R China.	tfz3006101@163.com			PLA Medicine Key Project [BWS12J020]	PLA Medicine Key Project	This work was supported by Grant from the PLA Medicine Key Project (to F. T. No. BWS12J020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrassy M, 2008, CIRCULATION, V117, P3216, DOI 10.1161/CIRCULATIONAHA.108.769331; Asl MN, 2008, PHYTOTHER RES, V22, P709, DOI 10.1002/ptr.2362; Bianchi ME, 2007, IMMUNOL REV, V220, P35, DOI 10.1111/j.1600-065X.2007.00574.x; Cheng BQ, 2007, PANCREAS, V35, P256, DOI 10.1097/MPA.0b013e318064678a; Dai RW, 2012, J TRAUMA ACUTE CARE, V73, P648, DOI 10.1097/TA.0b013e318250ad07; Delany HM, 1996, J SURG RES, V60, P41, DOI 10.1006/jsre.1996.0008; Felderbauer P, 2005, BASIC CLIN PHARMACOL, V97, P342, DOI 10.1111/j.1742-7843.2005.pto_274.x; Fiuza C, 2003, BLOOD, V101, P2652, DOI 10.1182/blood-2002-05-1300; Gwak GY, 2012, WORLD J GASTROENTERO, V18, P679, DOI 10.3748/wjg.v18.i7.679; Huang WC, 2010, CYTOKINE, V51, P119, DOI 10.1016/j.cyto.2010.02.021; Lantos J, 2010, SHOCK, V33, P562, DOI 10.1097/SHK.0b013e3181cd8c88; Laveda R, 2005, WORLD J GASTROENTERO, V11, P5309, DOI 10.3748/wjg.v11.i34.5309; Lesina M, 2014, SEMIN IMMUNOL, V26, P80, DOI 10.1016/j.smim.2014.01.002; Levine RA, 2011, J PANCREAS, V12, P47; Levy RM, 2007, AM J PHYSIOL-REG I, V293, pR1538, DOI 10.1152/ajpregu.00272.2007; MODLIN IM, 1989, ARCH SURG-CHICAGO, V124, P574; Mollica L, 2007, CHEM BIOL, V14, P431, DOI 10.1016/j.chembiol.2007.03.007; Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005; Ren JD, 2012, J TRAUMA ACUTE CARE, V72, P1555, DOI 10.1097/TA.0b013e31824a7913; Rongione AJ, 1997, GASTROENTEROLOGY, V112, P960, DOI 10.1053/gast.1997.v112.pm9041259; Sawa H, 2006, WORLD J GASTROENTERO, V12, P7666, DOI 10.3748/wjg.v12.i47.7666; Subramanian A, 2007, SURG CLIN N AM, V87, P1515, DOI 10.1016/j.suc.2007.08.007; Tang DL, 2011, ANTIOXID REDOX SIGN, V14, P1315, DOI 10.1089/ars.2010.3356; Ulloa L, 2003, ANN NY ACAD SCI, V987, P319, DOI 10.1111/j.1749-6632.2003.tb06075.x; van Rossum TGJ, 2001, AM J GASTROENTEROL, V96, P2432, DOI 10.1111/j.1572-0241.2001.04049.x; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wang W, 2013, CRIT CARE, V17, DOI 10.1186/cc12558; Yang RK, 2006, MOL MED, V12, P105, DOI 10.2119/2006-00010.Yang; Yasuda T, 2006, PANCREAS, V33, P359, DOI 10.1097/01.mpa.0000236741.15477.8b; Yu M, 2006, SHOCK, V26, P174, DOI 10.1097/01.shk.0000225404.51320.82; Yuan H, 2009, PANCREAS, V38, P143, DOI 10.1097/MPA.0b013e31818166b4; Zhang ZW, 2010, DIGEST DIS SCI, V55, P2529, DOI 10.1007/s10620-009-1073-0	33	14	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115982	10.1371/journal.pone.0115982	http://dx.doi.org/10.1371/journal.pone.0115982			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541713	Green Published, gold, Green Submitted			2022-12-27	WOS:000347239900124
J	Anbalagan, D; Yap, G; Yuan, Y; Pandey, VK; Lau, WH; Arora, S; Bist, P; Wong, JSB; Sethi, G; Nissom, PM; Lobie, PE; Lim, LHK				Anbalagan, Durkeshwari; Yap, Gracemary; Yuan, Yi; Pandey, Vijay K.; Lau, Wai Hoe; Arora, Suruchi; Bist, Pradeep; Wong, Justin S. B.; Sethi, Gautam; Nissom, Peter M.; Lobie, Peter E.; Lim, Lina H. K.			Annexin-A1 Regulates MicroRNA-26b*and MicroRNA-562 to Directly Target NF-kappa B and Angiogenesis in Breast Cancer Cells	PLOS ONE			English	Article							A1 EXPRESSION; PROGRESSION; METASTASIS; ACTIVATION; GROWTH; PHOSPHORYLATION; INHIBITION; ESOPHAGEAL; MECHANISM; LEUKEMIA	Annexin 1 (ANXA1) is an endogenous anti-inflammatory protein implicated in cancer. ANXA1 was previously shown to be regulated by hsa-miR-196a. However, whether ANXA1 itself regulates microRNA (miR) expression is unknown. Therefore, we investigated the regulation of miR by ANXA1 in MCF7 breast cancer cells. MCF7-EV (Empty vector) and MCF7-V5 (ANXA1-V5 expressing cells) were subjected to a miR microarray. Microarray analysis revealed a number of miRNAs which were dysregulated in MCF7-V5 cells. 2 novel miRNAs (miR562 and miR26b*) were validated, cloned and functionally characterized. As ANXA1 constitutively activates NF-kappa B activity to modulate breast cancer metastasis, we found that miR26b* and miR562 directly targeted the canonical NF-kappa B pathway by targeting the 3' UTR and inhibiting expression of Rel A (p65) and NF-kappa B1 (p105) respectively. MiR562 inhibited wound healing, which was reversed when ANXA1 was overexpressed. Overexpression of either miR562 or miR26b* in MCF-7 cells enhanced endothelial tube formation when cocultured with human umbilical cord endothelial cells while conversely, treatment of MCF7 cells with either anti-miR562 or anti-miR26b* inhibited endothelial tube formation after co-culture. Further analysis of miR562 revealed that miR562-transfected cell conditioned media enhances endothelial cell tube formation, indicating that miR562 increased angiogenic secreted factors from MCF-7 breast tumor cells. TNF alpha was increased upon overexpression of miR562, which was reversed when ANXA1 was co-transfected In conclusion, this data suggests that ANXA1-regulated miR26b* and miR562 may play a role in wound healing and tumor-induced endothelial cell tube formation by targeting NF-kappa B expression and point towards a potential therapeutic target for breast cancer.	[Anbalagan, Durkeshwari; Yap, Gracemary; Yuan, Yi; Arora, Suruchi; Bist, Pradeep; Lim, Lina H. K.] Natl Univ Singapore, Yong Loo Lin Sch Med, Ctr Life Sci, Dept Physiol, Singapore 117456, Singapore; [Pandey, Vijay K.; Lau, Wai Hoe; Lobie, Peter E.] Canc Sci Inst, Singapore 117599, Singapore; [Wong, Justin S. B.] Natl Univ Singapore, Yong Loo Lin Sch Med, Ctr Life Sci, Dept Microbiol, Singapore 117456, Singapore; [Sethi, Gautam] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117597, Singapore; [Nissom, Peter M.; Lim, Lina H. K.] Astar Bioproc Technol Inst, Singapore 138668, Singapore; [Anbalagan, Durkeshwari; Yap, Gracemary; Yuan, Yi; Arora, Suruchi; Bist, Pradeep; Wong, Justin S. B.] Ctr Life Sci, Inst Life Sci, NUS Immunol Program, Singapore 117456, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Bioprocessing Technology Institute (BTI); National University of Singapore	Lim, LHK (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Ctr Life Sci, Dept Physiol, 28 Med Dr, Singapore 117456, Singapore.	lina_lim@nuhs.edu.sg	Pandey, Vijay/P-2767-2016; Sethi, Gautam/F-2372-2011; BIST, PRADEEP/AAG-7986-2019; Nissom, Peter/F-6619-2017	Sethi, Gautam/0000-0002-8677-8475; Lim, Lina/0000-0002-2935-2275; Nissom, Peter/0000-0002-6514-3921	A-Star (SIGN) [07-11]; Biomedical Research Council [BMRC 07/1/21/19/507]; Singapore National Kidney Foundation [NKFRC-2011/01/05]	A-Star (SIGN)(Agency for Science Technology & Research (A*STAR)); Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Singapore National Kidney Foundation	This grant was funded by A-Star (SIGN grant 07-11), Biomedical Research Council (BMRC 07/1/21/19/507) and Singapore National Kidney Foundation (NKFRC-2011/01/05) to LL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SH, 1997, CLIN EXP METASTAS, V15, P151, DOI 10.1023/A:1018452810915; Akao Y, 2006, BIOL PHARM BULL, V29, P903, DOI 10.1248/bpb.29.903; Bai XF, 2004, WORLD J GASTROENTERO, V10, P1466; Bazzoni F, 2009, P NATL ACAD SCI USA, V106, P5282, DOI 10.1073/pnas.0810909106; Bhaumik D, 2008, ONCOGENE, V27, P5643, DOI 10.1038/onc.2008.171; Bist P, 2011, ONCOGENE, V30, P3174, DOI 10.1038/onc.2011.28; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Borralho PM, 2009, FEBS J, V276, P6689, DOI 10.1111/j.1742-4658.2009.07383.x; Cao Y, 2008, APPL IMMUNOHISTO M M, V16, P530, DOI 10.1097/PAI.0b013e31817432c3; de Graauw M, 2010, P NATL ACAD SCI USA, V107, P6340, DOI 10.1073/pnas.0913360107; Dolcet X, 2005, VIRCHOWS ARCH, V446, P475, DOI 10.1007/s00428-005-1264-9; Falini B, 2004, LANCET, V363, P1869, DOI 10.1016/S0140-6736(04)16356-3; Garzon R, 2008, BLOOD, V111, P3183, DOI 10.1182/blood-2007-07-098749; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Hammer DA, 2005, CURR BIOL, V15, pR96, DOI 10.1016/j.cub.2005.01.028; Hongsrichan N, 2013, WORLD J GASTROENTERO, V19, P2456, DOI 10.3748/wjg.v19.i16.2456; Hou SH, 2003, J BIOL CHEM, V278, P45994, DOI 10.1074/jbc.M307971200; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kisseleva T, 2006, J CLIN INVEST, V116, P2955, DOI 10.1172/JCI27392; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Lim LHK, 2007, FASEB J, V21, P968, DOI 10.1096/fj.06-7464rev; Lin L, 2000, EMBO J, V19, P4712, DOI 10.1093/emboj/19.17.4712; Luthra R, 2008, ONCOGENE, V27, P6667, DOI 10.1038/onc.2008.256; Nakshatri H, 1997, MOL CELL BIOL, V17, P3629, DOI 10.1128/MCB.17.7.3629; Tran N, 2013, ESSAYS BIOCHEM, V54, P17, DOI [10.1042/BSE0540017, 10.1042/bse0540017]; Patton KT, 2005, HISTOPATHOLOGY, V47, P597, DOI 10.1111/j.1365-2559.2005.02300.x; Paweletz CP, 2000, CANCER RES, V60, P6293; Pratt MAC, 2003, MOL CELL BIOL, V23, P6887, DOI 10.1128/MCB.23.19.6887-6900.2003; Sato Y, 2011, EXP THER MED, V2, P239, DOI 10.3892/etm.2011.210; Shen DJ, 2006, HUM PATHOL, V37, P1583, DOI 10.1016/j.humpath.2006.06.001; Shibata A, 2002, BREAST CANCER RES TR, V73, P237, DOI 10.1023/A:1015872531675; Sovak MA, 1997, J CLIN INVEST, V100, P2952, DOI 10.1172/JCI119848; Tabruyn SP, 2007, CELL DEATH DIFFER, V14, P1393, DOI 10.1038/sj.cdd.4402156; Wilczynska KM, 2006, J BIOL CHEM, V281, P34955, DOI 10.1074/jbc.M604616200; Xia SH, 2002, ONCOGENE, V21, P6641, DOI 10.1038/sj.onc.1205818; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Zhang XY, 2009, HEPATOLOGY, V50, P490, DOI 10.1002/hep.23008	38	33	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e114507	10.1371/journal.pone.0114507	http://dx.doi.org/10.1371/journal.pone.0114507			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536365	Green Published, gold, Green Submitted			2022-12-27	WOS:000348563300013
J	Ulbrich, F; Schallner, N; Coburn, M; Loop, T; Lagreze, WA; Biermann, J; Goebel, U				Ulbrich, Felix; Schallner, Nils; Coburn, Mark; Loop, Torsten; Lagreze, Wolf Alexander; Biermann, Julia; Goebel, Ulrich			Argon Inhalation Attenuates Retinal Apoptosis after Ischemia/Reperfusion Injury in a Time- and Dose-Dependent Manner in Rats	PLOS ONE			English	Article							GANGLION-CELL DEATH; NF-KAPPA-B; BCL-2 PROTEIN FAMILY; NOBLE-GASES; BRAIN-INJURY; IN-VITRO; GENE-EXPRESSION; ISCHEMIA; NEUROPROTECTION; TRANSCRIPTION	Purpose: Retinal ischemia and reperfusion injuries (IRI) permanently affect neuronal tissue and function by apoptosis and inflammation due to the limited regenerative potential of neurons. Recently, evidence emerged that the noble gas Argon exerts protective properties, while lacking any detrimental or adverse effects. We hypothesized that Argon inhalation after IRI would exert antiapoptotic effects in the retina, thereby protecting retinal ganglion cells (RGC) of the rat's eye. Methods: IRI was performed on the left eyes of rats (n=8) with or without inhaled Argon postconditioning (25, 50 and 75 Vol%) for 1 hour immediately or delayed after ischemia (i.e. 1.5 and 3 hours). Retinal tissue was harvested after 24 hours to analyze mRNA and protein expression of Bcl-2, Bax and Caspase-3, NF-kappa B. Densities of fluorogold-prelabeled RGCs were analyzed 7 days after injury in whole-mounts. Histological tissue samples were prepared for immunohistochemistry and blood was analyzed regarding systemic effects of Argon or IRI. Statistics were performed using One-Way ANOVA. Results: IRI induced RGC loss was reduced by Argon 75 Vol% inhalation and was dose-dependently attenuated by lower concentrations, or by delayed Argon inhalation (1504 +/- 300 vs. 2761 +/- 257; p<0.001). Moreover, Argon inhibited Bax and Bcl- 2 mRNA expression significantly ( Bax: 1.64 +/- 0.30 vs. 0.78 +/- 0.29 and Bcl2: 2.07 +/- 0.29 vs. 0.99 +/- 0.22; both p<0.01), as well as caspase-3 cleavage (1.91 +/- 0.46 vs. 1.05 +/- 0.36; p<0.001). Expression of NF-kappa B was attenuated significantly. Immunohistochemistry revealed an affection of Muller cells and astrocytes. In addition, IRI induced leukocytosis was reduced significantly after Argon inhalation at 75 Vol%. Conclusion: Immediate and delayed Argon postconditioning protects IRI induced apoptotic loss of RGC in a time- and dose-dependent manner, possibly mediated by the inhibition of NF-kappa B. Further studies need to evaluate Argon's possible role as a therapeutic option.	[Ulbrich, Felix; Schallner, Nils; Loop, Torsten; Goebel, Ulrich] Univ Med Ctr, Dept Anesthesiol & Intens Care Med, Freiburg, Germany; [Coburn, Mark] Univ Hosp RWTH Aachen, Dept Anesthesiol, Aachen, Germany; [Lagreze, Wolf Alexander; Biermann, Julia] Univ Med Ctr, Ctr Eye, Freiburg, Germany	University of Freiburg; RWTH Aachen University; RWTH Aachen University Hospital; University of Freiburg	Goebel, U (corresponding author), Univ Med Ctr, Dept Anesthesiol & Intens Care Med, Freiburg, Germany.	ulrich.goebel@uniklinik-freiburg.de	Goebel, Ulrich M./AGG-1495-2022; Göbel, Ulrich/Q-7613-2016	Göbel, Ulrich/0000-0002-9991-3226; Coburn, Mark/0000-0002-7930-0270	Department of Anesthesiology and Intensive Care Medicine; Eye Center, University Medical Center Freiburg, Germany; Albert Ludwigs University Freiburg	Department of Anesthesiology and Intensive Care Medicine; Eye Center, University Medical Center Freiburg, Germany; Albert Ludwigs University Freiburg	This work was funded by departmental funding of the Department of Anesthesiology and Intensive Care Medicine and the Eye Center, University Medical Center Freiburg, Germany. The article processing charge was funded by the open access publication fund of the Albert Ludwigs University Freiburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraini JH, 2003, ANESTH ANALG, V96, P746, DOI 10.1213/01.ANE.0000050282.14291.38; Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Agnihotri S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-160; Antonsson B, 2000, EXP CELL RES, V256, P50, DOI 10.1006/excr.2000.4839; ARCHER DB, 1976, DOC OPHTHALMOL, V40, P339, DOI 10.1007/BF00155046; Aronowski J, 2011, STROKE, V42, P1781, DOI 10.1161/STROKEAHA.110.596718; Bhakar AL, 2002, J NEUROSCI, V22, P8466; Biermann J, 2011, MOL VIS, V17, P1275; Biermann J, 2010, INVEST OPHTH VIS SCI, V51, P526, DOI 10.1167/iovs.09-3903; Burda J, 2006, CELL MOL NEUROBIOL, V26, P1141, DOI 10.1007/s10571-006-9036-x; Chiarugi A, 2002, MOL BRAIN RES, V109, P179, DOI 10.1016/S0169-328X(02)00558-2; Coburn M, 2012, CRIT CARE MED, V40, P1965, DOI 10.1097/CCM.0b013e3182474cf5; David HN, 2013, N-S ARCH PHARMACOL, V386, P91, DOI 10.1007/s00210-012-0809-0; David HN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030934; Dickinson R, 2010, CRIT CARE, V14, DOI 10.1186/cc9051; Fischer D, 2000, INVEST OPHTH VIS SCI, V41, P3943; Hayreh S S, 1978, Int Ophthalmol, V1, P9, DOI 10.1007/BF00133273; Hayreh SS, 2004, EXP EYE RES, V78, P723, DOI 10.1016/S0014-4835(03)00214-8; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Irani Y, 2011, NEPHRON EXTRA, V1, P272, DOI 10.1159/000335197; Jawad N, 2009, NEUROSCI LETT, V460, P232, DOI 10.1016/j.neulet.2009.05.069; Jehle T, 2008, GRAEF ARCH CLIN EXP, V246, P1255, DOI 10.1007/s00417-007-0746-7; Joo CK, 1999, INVEST OPHTH VIS SCI, V40, P713; KALTSCHMIDT C, 1993, MECH DEVELOP, V43, P135, DOI 10.1016/0925-4773(93)90031-R; Kamphuis W, 2007, MOL VIS, V13, P1020; Koblin DD, 1998, ANESTH ANALG, V87, P419, DOI 10.1097/00000539-199808000-00035; Lee JJ, 2008, ANESTHESIOLOGY, V108, P1055, DOI 10.1097/ALN.0b013e3181730257; Li SY, 2009, INVEST OPHTH VIS SCI, V50, P836, DOI 10.1167/iovs.08-2310; Loetscher PD, 2009, CRIT CARE, V13, DOI 10.1186/cc8214; Meberg PJ, 1996, MOL BRAIN RES, V38, P179, DOI 10.1016/0169-328X(95)00229-L; Mukaida Y, 2004, CURR EYE RES, V28, P381, DOI 10.1080/02713680490503679; Nickells RW, 1996, J GLAUCOMA, V5, P345; Pagel PS, 2007, ANESTH ANALG, V105, P562, DOI 10.1213/01.ane.0000278083.31991.36; Peng T, 2013, CNS NEUROSCI THER, V19, P773, DOI 10.1111/cns.12159; Preckel B, 2006, ANESTHESIOLOGY, V105, P187, DOI 10.1097/00000542-200607000-00029; Rizvi M, 2010, EXP BIOL MED, V235, P886, DOI 10.1258/ebm.2010.009366; Ryang YM, 2011, CRIT CARE MED, V39, P1448, DOI 10.1097/CCM.0b013e31821209be; Schallner N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060672; Schallner N, 2011, EUR J PHARMACOL, V670, P58, DOI 10.1016/j.ejphar.2011.08.028; Schmidt KG, 2004, OPHTHALMOLOGE, V101, P1071, DOI 10.1007/s00347-004-1131-0; Soldatov P E, 1998, Aviakosm Ekolog Med, V32, P33; VERMA D, 1993, MED HYPOTHESES, V41, P205, DOI 10.1016/0306-9877(93)90231-E; Wang LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023194; Yi JH, 2007, NEUROCHEM INT, V50, P1014, DOI 10.1016/j.neuint.2007.04.019; Zhang C, 2002, INVEST OPHTH VIS SCI, V43, P3059; Zhao H, 2006, J CEREBR BLOOD F MET, V26, P1114, DOI 10.1038/sj.jcbfm.9600348; Zhuang L, 2012, CRIT CARE MED, V40, P1724, DOI 10.1097/CCM.0b013e3182452164	47	32	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115984	10.1371/journal.pone.0115984	http://dx.doi.org/10.1371/journal.pone.0115984			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25535961	Green Published, gold, Green Submitted			2022-12-27	WOS:000348563300096
J	Berman, MG; Hout, MC; Kardan, O; Hunter, MR; Yourganov, G; Henderson, JM; Hanayik, T; Karimi, H; Jonides, J				Berman, Marc G.; Hout, Michael C.; Kardan, Omid; Hunter, MaryCarol R.; Yourganov, Grigori; Henderson, John M.; Hanayik, Taylor; Karimi, Hossein; Jonides, John			The Perception of Naturalness Correlates with Low-Level Visual Features of Environmental Scenes	PLOS ONE			English	Article							INNER-CITY; STATISTICS; ATTENTION; IMAGES; EFFICIENT; COGNITION; BENEFITS; EXPOSURE	Previous research has shown that interacting with natural environments vs. more urban or built environments can have salubrious psychological effects, such as improvements in attention and memory. Even viewing pictures of nature vs. pictures of built environments can produce similar effects. A major question is: What is it about natural environments that produces these benefits? Problematically, there are many differing qualities between natural and urban environments, making it difficult to narrow down the dimensions of nature that may lead to these benefits. In this study, we set out to uncover visual features that related to individuals' perceptions of naturalness in images. We quantified naturalness in two ways: first, implicitly using a multidimensional scaling analysis and second, explicitly with direct naturalness ratings. Features that seemed most related to perceptions of naturalness were related to the density of contrast changes in the scene, the density of straight lines in the scene, the average color saturation in the scene and the average hue diversity in the scene. We then trained a machine-learning algorithm to predict whether a scene was perceived as being natural or not based on these low-level visual features and we could do so with 81% accuracy. As such we were able to reliably predict subjective perceptions of naturalness with objective low-level visual features. Our results can be used in future studies to determine if these features, which are related to naturalness, may also lead to the benefits attained from interacting with nature.	[Berman, Marc G.; Kardan, Omid] Univ Chicago, Dept Psychol, Chicago, IL 60637 USA; [Hout, Michael C.] New Mexico State Univ, Dept Psychol, Las Cruces, NM 88003 USA; [Hunter, MaryCarol R.] Univ Michigan, Dept Nat Resources & Environm, Ann Arbor, MI 48109 USA; [Yourganov, Grigori; Henderson, John M.; Hanayik, Taylor; Karimi, Hossein] Univ S Carolina, Dept Psychol, Columbia, SC 29208 USA; [Jonides, John] Univ Michigan, Dept Psychol, Ann Arbor, MI USA	University of Chicago; New Mexico State University; University of Michigan System; University of Michigan; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of Michigan System; University of Michigan	Berman, MG (corresponding author), Univ Chicago, Dept Psychol, 5848 S Univ Ave, Chicago, IL 60637 USA.	bermanm@uchicago.edu	Karimi, Hossein/N-7151-2019	Hanayik, Taylor/0000-0003-0751-9844	Tom and Kitty Stoner Foundation (TKF); University of South Carolina; Division Of Behavioral and Cognitive Sci [1151358] Funding Source: National Science Foundation	Tom and Kitty Stoner Foundation (TKF); University of South Carolina; Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This work was partially funded by the The Tom and Kitty Stoner Foundation (TKF) and the University of South Carolina to MGB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BADDELEY RJ, 1991, P ROY SOC B-BIOL SCI, V246, P219, DOI 10.1098/rspb.1991.0147; Berman MG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2374; Berman MG, 2012, J AFFECT DISORDERS, V140, P300, DOI 10.1016/j.jad.2012.03.012; Berman MG, 2008, PSYCHOL SCI, V19, P1207, DOI 10.1111/j.1467-9280.2008.02225.x; Berto R, 2005, J ENVIRON PSYCHOL, V25, P249, DOI 10.1016/j.jenvp.2005.07.001; Busing F. M. T. A., 1997, SoftStat '97. Advances in Statistical Software 6. 9th Conference on the Scientific Use of Statistical Software, P67; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; Chandler DM, 2007, J OPT SOC AM A, V24, P922, DOI 10.1364/JOSAA.24.000922; Cimprich B, 2003, CANCER NURS, V26, P284, DOI 10.1097/00002820-200308000-00005; CRAIK KH, 1973, ANNU REV PSYCHOL, V24, P403, DOI 10.1146/annurev.ps.24.020173.002155; DOYEN J, 1978, MATH Z, V163, P251, DOI 10.1007/BF01174898; Fei-Fei L, 2005, PROC CVPR IEEE, P524; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Field DJ, 1999, PHILOS T R SOC A, V357, P2527, DOI 10.1098/rsta.1999.0446; GOLDSTONE R, 1994, BEHAV RES METH INS C, V26, P381, DOI 10.3758/BF03204653; HANCOCK PJB, 1992, NETWORK-COMP NEURAL, V3, P61, DOI 10.1088/0954-898X/3/1/008; Hout MC, 2013, J EXP PSYCHOL GEN, V142, P256, DOI 10.1037/a0028860; Hout MC, 2013, WIRES COGN SCI, V4, P93, DOI 10.1002/wcs.1203; Huang J, 1999, STAT NATURAL IMAGES; Jaworska N, 2009, TUTOR QUANT METHODS, V5, P1, DOI 10.20982/tqmp.05.1.p001; KAPLAN S, 1995, J ENVIRON PSYCHOL, V15, P169, DOI 10.1016/0272-4944(95)90001-2; Kaplan S, 2010, PERSPECT PSYCHOL SCI, V5, P43, DOI 10.1177/1745691609356784; Kellert S.R., 1993, BIOPHILIA HYPOTHESIS, P42; KERSTEN D, 1987, J OPT SOC AM A, V4, P2395, DOI 10.1364/JOSAA.4.002395; Klette R, 1996, HDB IMAGE PROCESSING, V1996, P1; Kriegeskorte N, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00245; Kuo FE, 2001, ENVIRON BEHAV, V33, P343, DOI 10.1177/00139160121973025; Kuo FE, 2001, ENVIRON BEHAV, V33, P543, DOI 10.1177/00139160121973124; Leykin A, 2003, DIFFERENCES EDGE PRO, V542; Mayer FS, 2009, ENVIRON BEHAV, V41, P607, DOI 10.1177/0013916508319745; Oliva A, 2001, INT J COMPUT VISION, V42, P145, DOI 10.1023/A:1011139631724; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; RUDERMAN DL, 1994, NETWORK-COMP NEURAL, V5, P517, DOI 10.1088/0954-898X/5/4/006; SHEPARD RN, 1980, SCIENCE, V210, P390, DOI 10.1126/science.210.4468.390; Taylor AF, 2009, J ATTEN DISORD, V12, P402, DOI 10.1177/1087054708323000; Torralba A, 2003, NETWORK-COMP NEURAL, V14, P391, DOI 10.1088/0954-898X/14/3/302; ULRICH RS, 1991, J ENVIRON PSYCHOL, V11, P201, DOI 10.1016/S0272-4944(05)80184-7; ULRICH RS, 1984, SCIENCE, V224, P420, DOI 10.1126/science.6143402; van Hateren JH, 1998, P ROY SOC B-BIOL SCI, V265, P359, DOI 10.1098/rspb.1998.0303; WARD LM, 1980, CAN J BEHAV SCI, V12, P329, DOI 10.1037/h0081077; WARD LM, 1977, MULTIVAR BEHAV RES, V12, P23, DOI 10.1207/s15327906mbr1201_2; WARD LM, 1981, ENVIRON BEHAV, V13, P610, DOI 10.1177/0013916581135005; Wilson E. O., 1984, HARV U PRESS, DOI DOI 10.2307/J.CTVK12S6H; Yourganov G, 2010, ARCH ITAL BIOL, V148, P259; Yourganov G, 2014, NEUROIMAGE, V96, P117, DOI 10.1016/j.neuroimage.2014.03.074	45	76	76	7	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e114572	10.1371/journal.pone.0114572	http://dx.doi.org/10.1371/journal.pone.0114572			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA3ZY	25531411	Green Published, Green Submitted, gold			2022-12-27	WOS:000348845100018
J	Kumar, S; Zheng, H; Deng, BB; Mahajan, B; Grabias, B; Kozakai, Y; Morin, MJ; Locke, E; Birkett, A; Miura, K; Long, C				Kumar, Sanjai; Zheng, Hong; Deng, Bingbing; Mahajan, Babita; Grabias, Bryan; Kozakai, Yukiko; Morin, Merribeth J.; Locke, Emily; Birkett, Ashley; Miura, Kazutoyo; Long, Carole			A Slot Blot Immunoassay for Quantitative Detection of Plasmodium falciparum Circumsporozoite Protein in Mosquito Midgut Oocyst	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; MALARIA TRANSMISSION; FALSE POSITIVITY; SPOROZOITES; VIVAX; ANTIBODIES; PFS48/45; ANTIGEN; VACCINE; VECTOR	There is still a need for sensitive and reproducible immunoassays for quantitative detection of malarial antigens in preclinical and clinical phases of vaccine development and in epidemiology and surveillance studies, particularly in the vector host. Here we report the results of sensitivity and reproducibility studies for a research-grade, quantitative enhanced chemiluminescent-based slot blot assay (ECL-SB) for detection of both recombinant Plasmodium falciparum circumsporozoite protein (rPfCSP) and native PfCSP from Oocysts (Pf Oocyst) developing in the midguts of Anopheles stephensi mosquitoes. The ECL-SB detects as little as 1.25 pg of rPfCSP (linear range of quantitation 2.5-20 pg; R-2 = 0.9505). We also find the earliest detectable expression of native PfCSP in Pf Oocyst by ECL-SB occurs on day 7 post feeding with infected blood meal. The ECL-SB was able to detect approximately as few as 0.5 day 8 Pf Oocysts (linear quantitation range 1-4, R-2 = 0.9795) and determined that one Pf Oocyst expressed approximately 2.0 pg (0.5-3 pg) of native PfCSP, suggesting a similar range of detection for recombinant and native forms of PfCSP. The ECL-SB is highly reproducible; the Coefficient of Variation (CV) for inter-assay variability for rPfCSP and native PfCSP were 1.74% and 1.32%, respectively. The CVs for intra-assay variability performed on three days for rPfCSP were 2.41%, 0.82% and 2% and for native PfCSP 1.52%, 0.57%, and 1.86%, respectively. In addition, the ECL-SB was comparable to microscopy in determining the P. falciparum prevalence in mosquito populations that distinctly contained either high and low midgut Pf Oocyst burden. In whole mosquito samples, estimations of positivity for P. falciparum in the high and low burden groups were 83.3% and 23.3% by ECL-SB and 85.7% and 27.6% by microscopy. Based on its performance characteristics, ECL-SB could be valuable in vaccine development and to measure the parasite prevalence in mosquitoes and transmission-blocking interventions in endemic areas.	[Kumar, Sanjai; Zheng, Hong; Mahajan, Babita; Grabias, Bryan; Kozakai, Yukiko] Ctr Biol Evaluat & Res Food & Drug Adm, Div Emerging & Transfus Transmitted Dis, Lab Emerging Pathogens, Silver Spring, MD 20993 USA; [Deng, Bingbing; Miura, Kazutoyo; Long, Carole] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA; [Morin, Merribeth J.; Locke, Emily; Birkett, Ashley] PATH Malaria Vaccine Initiat, Washington, DC 20001 USA	US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Kumar, S (corresponding author), Ctr Biol Evaluat & Res Food & Drug Adm, Div Emerging & Transfus Transmitted Dis, Lab Emerging Pathogens, Silver Spring, MD 20993 USA.	Sanjai.kumar@fda.hhs.gov	Miura, Kazutoyo/AAY-9751-2020	Miura, Kazutoyo/0000-0003-4455-2432	PATH Malaria Vaccine Initiative; US Food and Drug Administration [CRADA 145-08]; National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001020] Funding Source: NIH RePORTER	PATH Malaria Vaccine Initiative; US Food and Drug Administration; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded, in part, through financial support from the PATH Malaria Vaccine Initiative (http://www.malariavaccine.org, SK) and intramural funding from the US Food and Drug Administration (http://www.FDA.gov, SK, CRADA 145-08) and the National Institute of Allergy and Infectious Diseases (http://www.NIAID.NIH.gov, CL). The Path Malaria Vaccine initiative was extensively involved in the design of the study, data collection and analysis, decision to publish, and the preparation of the manuscript. All other funders had no such involvement.	Bashar K, 2013, ACTA TROP, V125, P220, DOI 10.1016/j.actatropica.2012.10.004; Bell AS, 2004, INT J PARASITOL, V34, P795, DOI 10.1016/j.ijpara.2004.03.008; Bowman NM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01990; Chowdhury DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006352; Churcher TS, 2012, INT J PARASITOL, V42, P1037, DOI 10.1016/j.ijpara.2012.09.002; Durnez L, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-195; Healer J, 1997, INFECT IMMUN, V65, P3017, DOI 10.1128/IAI.65.8.3017-3023.1997; KASLOW DC, 1994, INFECT IMMUN, V62, P5576, DOI 10.1128/IAI.62.12.5576-5580.1994; Kumar R, 2013, VACCINE, V31, P3140, DOI 10.1016/j.vaccine.2013.05.006; Kumar S, 2013, J IMMUNOL METHODS, V390, P99, DOI 10.1016/j.jim.2013.02.001; Michaelis L, 2013, FEBS LETT, V587, P2712, DOI 10.1016/j.febslet.2013.07.015; Miura K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057909; NAGASAWA H, 1988, EXP PARASITOL, V66, P27, DOI 10.1016/0014-4894(88)90047-1; NARDIN EH, 1982, J EXP MED, V156, P20, DOI 10.1084/jem.156.1.20; Ouedraogo AL, 2011, INFECT IMMUN, V79, P4957, DOI 10.1128/IAI.05288-11; Rathore D, 2003, J BIOL CHEM, V278, P40905, DOI 10.1074/jbc.M306250200; Roeffen W, 1996, PARASITE IMMUNOL, V18, P103, DOI 10.1046/j.1365-3024.1996.d01-54.x; Rosenberg R, 2008, TRENDS PARASITOL, V24, P487, DOI 10.1016/j.pt.2008.07.009; SOMBOON P, 1993, T ROY SOC TROP MED H, V87, P322, DOI 10.1016/0035-9203(93)90148-J; Stone WJ, 2014, J INFECT DI IN PRESS; WEBER JL, 1985, MOL BIOCHEM PARASIT, V15, P305, DOI 10.1016/0166-6851(85)90092-1; WIRTZ RA, 1992, J MED ENTOMOL, V29, P854, DOI 10.1093/jmedent/29.5.854; WIRTZ RA, 1985, AM J TROP MED HYG, V34, P1048, DOI 10.4269/ajtmh.1985.34.1048; YOSHIDA N, 1981, J EXP MED, V154, P1225, DOI 10.1084/jem.154.4.1225; Zeeshan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043430	25	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115807	10.1371/journal.pone.0115807	http://dx.doi.org/10.1371/journal.pone.0115807			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531543	Green Submitted, Green Published, gold			2022-12-27	WOS:000348845100110
J	Wolff-Hughes, DL; Bassett, DR; Fitzhugh, EC				Wolff-Hughes, Dana L.; Bassett, David R.; Fitzhugh, Eugene C.			Population-Referenced Percentiles for Waist-Worn Accelerometer-Derived Total Activity Counts in US Youth: 2003-2006 NHANES	PLOS ONE			English	Article							PHYSICAL-ACTIVITY ASSESSMENT; ACTIVITY MONITORS; EPOCH LENGTH; CALIBRATION; VALIDATION; CHILDREN; AGE	Background: The total activity volume performed is an overall measure that takes into account the frequency, intensity, and duration of activities performed. The importance of considering total activity volume is shown by recent studies indicating that light physical activity (LPA) and intermittent moderate-to-vigorous physical activity (MVPA) have health benefits. Accelerometer-derived total activity counts (TAC) per day from a waist-worn accelerometer can serve as a proxy for an individual's total activity volume. The purpose of this study was to develop age- and gender-specific percentiles for daily TAC, minutes of MVPA, and minutes of LPA in U.S. youth ages 6 - 19 y. Methods: Data from the 2003 - 2006 NHANES waist-worn accelerometer component were used in this analysis. The sample was composed of youth aged 6 - 19 years with at least 4 d of >= 10 hours of accelerometer wear time (N=3698). MVPA was defined using age specific cutpoints as the total number of minutes at >= 4 metabolic equivalents (METs) for youth 6 - 17 y or minutes with >= 2020 counts for youth 18 - 19 y. LPA was defined as the total number of minutes between 100 counts and the MVPA threshold. TAC/d, MVPA, and LPA were averaged across all valid days. Results: For males in the 50th percentile, the median activity level was 441,431 TAC/d, with 53 min/d of MVPA and 368 min/d of LPA. The median level of activity for females was 234,322 TAC/d, with 32 min/d of MVPA and 355 min/d of LPA. Conclusion: Population referenced TAC/d percentiles for U.S. youth ages 6- 19 y provide a novel means of characterizing the total activity volume performed by children and adolescents.	[Wolff-Hughes, Dana L.; Bassett, David R.; Fitzhugh, Eugene C.] Univ Tennessee, Dept Kinesiol Recreat & Sports Studies, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville	Wolff-Hughes, DL (corresponding author), Univ Tennessee, Dept Kinesiol Recreat & Sports Studies, Knoxville, TN 37996 USA.	dwolff@utk.edu	Fitzhugh, Eugene/AAI-2489-2019	Wolff-Hughes, Dana/0000-0003-3280-9771				Ayabe Makoto, 2013, BMC Res Notes, V6, P20, DOI 10.1186/1756-0500-6-20; BAILEY RC, 1995, MED SCI SPORT EXER, V27, P1033, DOI 10.1249/00005768-199507000-00012; Baquet G, 2007, PREV MED, V44, P143, DOI 10.1016/j.ypmed.2006.10.004; Bassett DR, 2014, MED SCI SPORTS EXERC; Bischoff AL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056700, 10.1371/journal.pone.0071417]; Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR; Chen KY, 2005, MED SCI SPORT EXER, V37, pS490, DOI 10.1249/01.mss.0000185571.49104.82; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; Edwardson CL, 2010, MED SCI SPORT EXER, V42, P928, DOI 10.1249/MSS.0b013e3181c301f5; Esliger DW, 2011, MED SCI SPORT EXER, V43, P1085, DOI 10.1249/MSS.0b013e31820513be; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Freedson P, 2005, MED SCI SPORT EXER, V37, pS523, DOI 10.1249/01.mss.0000185658.28284.ba; Freedson P, 2012, MED SCI SPORT EXER, V44, pS1, DOI 10.1249/MSS.0b013e3182399b7e; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Glazer NL, 2013, MED SCI SPORT EXER, V45, P109, DOI 10.1249/MSS.0b013e31826beae5; Holman RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025733; John D, 2010, MED SCI SPORT EXER, V42, P368, DOI 10.1249/MSS.0b013e3181b3af49; Kim J, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-30; Lee IM, 2014, BRIT J SPORT MED, V48, P197, DOI 10.1136/bjsports-2013-093154; Loprinzi PD, 2012, RES Q EXERCISE SPORT, V83, P422; Maher C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086403; Mark AE, 2009, AM J PREV MED, V36, P416, DOI 10.1016/j.amepre.2009.01.027; Mattocks C, 2007, INT J PEDIATR OBES, V2, P218, DOI 10.1080/17477160701408809; Mcclain JJ, 2008, MED SCI SPORT EXER, V40, P2080, DOI 10.1249/MSS.0b013e3181824d98; National Cancer Institute, SAS PROGR AN NHANES; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Puyau MR, 2002, OBES RES, V10, P150, DOI 10.1038/oby.2002.24; Rothney MP, 2008, J APPL PHYSIOL, V105, P1091, DOI 10.1152/japplphysiol.90641.2008; Sasaki JE, 2011, J SCI MED SPORT, V14, P411, DOI 10.1016/j.jsams.2011.04.003; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Swartz AM, 2000, MED SCI SPORT EXER, V32, pS450, DOI 10.1097/00005768-200009001-00003; Treuth MS, 2004, MED SCI SPORT EXER, V36, P198, DOI 10.1249/01.MSS.0000113666.98463.B0; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Troiano RP, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2014-093546; Trost SG, 2002, MED SCI SPORT EXER, V34, P350, DOI 10.1097/00005768-200202000-00025; Trost SG, 2011, MED SCI SPORT EXER, V43, P1360, DOI 10.1249/MSS.0b013e318206476e; Tudor-Locke C, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110332; US Department of Health and Human Services, 2008, PHYS ACT GUID AM; Welch WA, 2014, MED SCI SPORT EXER, V46, P1825, DOI 10.1249/MSS.0000000000000283; Welch WA, 2013, MED SCI SPORT EXER, V45, P2012, DOI 10.1249/MSS.0b013e3182965249; Welk GJ, 2004, MED SCI SPORT EXER, V36, P1637, DOI 10.1249/01.MSS.0000074670.03001.98; Westerterp KR, 1999, INT J OBESITY, V23, pS45, DOI 10.1038/sj.ijo.0800883	42	36	36	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115915	10.1371/journal.pone.0115915	http://dx.doi.org/10.1371/journal.pone.0115915			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531290	gold, Green Submitted, Green Published			2022-12-27	WOS:000348845100117
J	Guyochin, A; Maenner, S; Chu, ETJ; Hentati, A; Attia, M; Avner, P; Clerc, P				Guyochin, Aurelia; Maenner, Sylvain; Chu, Erin Tsi-Jia; Hentati, Asma; Attia, Mikael; Avner, Philip; Clerc, Philippe			Live Cell Imaging of the Nascent Inactive X Chromosome during the Early Differentiation Process of Naive ES Cells towards Epiblast Stem Cells	PLOS ONE			English	Article							COUNTING PROCESS; GROUND-STATE; XIST RNA; MOUSE; LINES; ESTABLISHMENT; PLURIPOTENCY; RECRUITMENT; METHYLATION; DERIVATION	Random X-chromosome inactivation ensures dosage compensation in mammals through the transcriptional silencing of one of the two X chromosomes present in each female cell. Silencing is initiated in the differentiating epiblast of the mouse female embryos through coating of the nascent inactive X chromosome by the noncoding RNA Xist, which subsequently recruits the Polycomb Complex PRC2 leading to histone H3-K27 methylation. Here we examined in mouse ES cells the early steps of the transition from naive ES cells towards epiblast stem cells as a model for inducing X chromosome inactivation in vitro. We show that these conditions efficiently induce random XCI. Importantly, in a transient phase of this differentiation pathway, both X chromosomes are coated with Xist RNA in up to 15% of the XX cells. In an attempt to determine the dynamics of this process, we designed a strategy aimed at visualizing the nascent inactive X-chromosome in live cells. We generated transgenic female XX ES cells expressing the PRC2 component Ezh2 fused to the fluorescent protein Venus. The fluorescent fusion protein was expressed at sub-physiological levels and located in nuclei of ES cells. Upon differentiation of ES cell towards epiblast stem cell fate, Venus-fluorescent territories appearing in interphase nuclei were identified as nascent inactive X chromosomes by their association with Xist RNA. Imaging of Ezh2-Venus for up to 24 hours during the differentiation process showed survival of some cells with two fluorescent domains and a surprising dynamics of the fluorescent territories across cell division and in the course of the differentiation process. Our data reveal a strategy for visualizing the nascent inactive X chromosome and suggests the possibility for a large plasticity of the nascent inactive X chromosome.	[Guyochin, Aurelia; Maenner, Sylvain; Chu, Erin Tsi-Jia; Hentati, Asma; Attia, Mikael; Avner, Philip; Clerc, Philippe] Inst Pasteur, CNRS, URA2578, Paris, France; [Avner, Philip] EMBL Monterotondo, Monterotondo, Italy; [Clerc, Philippe] Inst Pasteur, CNRS, Dept Dev Biol, URA2578, Paris, France; [Guyochin, Aurelia] Univ Technol Compiegne, Compiegne, France; [Hentati, Asma] Univ Blaise Pascal, Clermont Ferrand, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Picardie Universites; Universite de Technologie de Compiegne; Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA)	Clerc, P (corresponding author), Inst Pasteur, CNRS, URA2578, Paris, France.	pclerc@pasteur.fr			Institut Pasteur; Centre National pour la Recherche Scientifique; Agence Nationale pour la Recherche; Epigenome Network of Excellence, REVIVE Labex; Foundation Louis D. Institut de France	Institut Pasteur(European Commission); Centre National pour la Recherche Scientifique; Agence Nationale pour la Recherche(French National Research Agency (ANR)); Epigenome Network of Excellence, REVIVE Labex; Foundation Louis D. Institut de France	AG, SM, ETC, MA, PA, and PC were supported by Institut Pasteur (www.pasteur.fr), Centre National pour la Recherche Scientifique (www.cnrs.fr), Agence Nationale pour la Recherche (www.agence-nationale-recherche.fr), Epigenome Network of Excellence, REVIVE Labex, (www.pasteur.fr/easysite/pasteur/en/research/labex/revive), and Foundation Louis D. Institut de France (http://www.institut-de-france.fr/institutions/prix-amp-fondations/fondations/fondation-louis-d-florence-dec). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augui S, 2007, SCIENCE, V318, P1632, DOI 10.1126/science.1149420; Bao SQ, 2005, EMBO REP, V6, P748, DOI 10.1038/sj.embor.7400461; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; Brockdorff N, 2013, RNA, V19, P429, DOI 10.1261/rna.037598.112; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Burgoyne PS, 1995, PHILOS T R SOC B, V350, P253, DOI 10.1098/rstb.1995.0159; Chaumeil J, 2006, GENE DEV, V20, P2223, DOI 10.1101/gad.380906; Clerc P, 1998, NAT GENET, V19, P249, DOI 10.1038/924; Donohoe ME, 2009, NATURE, V460, P128, DOI 10.1038/nature08098; Escamilla-Del-Arenal M, 2011, HUM GENET, V130, P307, DOI 10.1007/s00439-011-1029-2; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Heard E, 1997, ANNU REV GENET, V31, P571, DOI 10.1146/annurev.genet.31.1.571; Hofemeister H, 2011, METHODS, V53, P437, DOI 10.1016/j.ymeth.2010.12.026; JOHNSTON PG, 1981, GENET RES, V37, P151, DOI 10.1017/S0016672300020127; Kress C, 1998, MAMM GENOME, V9, P998, DOI 10.1007/s003359900914; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Maenner S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000276; Mak W, 2002, CURR BIOL, V12, P1016, DOI 10.1016/S0960-9822(02)00892-8; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Minkovsky A, 2012, STEM CELLS, V30, P48, DOI 10.1002/stem.755; MITTWOCH U, 1993, HUM REPROD, V8, P1550, DOI 10.1093/oxfordjournals.humrep.a137889; Monkhorst K, 2008, CELL, V132, P410, DOI 10.1016/j.cell.2007.12.036; Ng K, 2011, MOL BIOL CELL, V22, P2634, DOI 10.1091/mbc.E11-02-0146; Nichols J, 2009, NAT MED, V15, P814, DOI 10.1038/nm.1996; Okamoto I, 2000, DEVELOPMENT, V127, P4137; Okamoto I, 2006, CYTOGENET GENOME RES, V113, P318, DOI 10.1159/000090848; Payer B, 2008, ANNU REV GENET, V42, P733, DOI 10.1146/annurev.genet.42.110807.091711; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Plath K, 2002, ANNU REV GENET, V36, P233, DOI 10.1146/annurev.genet.36.042902.092433; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Shin J., 2014, NATURE; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Soma A, 2013, GENESIS, V51, P259, DOI 10.1002/dvg.22369; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Vigneau S, 2006, P NATL ACAD SCI USA, V103, P7390, DOI 10.1073/pnas.0602381103; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, METHOD ENZYMOL, V365, P327	38	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e116109	10.1371/journal.pone.0116109	http://dx.doi.org/10.1371/journal.pone.0116109			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546018	Green Published, gold, Green Submitted			2022-12-27	WOS:000347120200098
J	Huichalaf, C; Micheloni, S; Ferri, G; Caccia, R; Gabellini, D				Huichalaf, Claudia; Micheloni, Stefano; Ferri, Giulia; Caccia, Roberta; Gabellini, Davide			DNA Methylation Analysis of the Macrosatellite Repeat Associated with FSHD Muscular Dystrophy at Single Nucleotide Level	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; CANDIDATE GENE; D4Z4; BINDING; LOCUS; HYPOMETHYLATION; EXPRESSION; PROTEIN; CPG; LOCALIZATION	Facioscapulohumeral muscular dystrophy ( FSHD) is one of the most common inherited diseases of the skeletal muscle. It is characterized by asymmetric muscle weakness and variable penetrance. FSHD is linked to a reduction in copy number of the D4Z4 3.3 kb macrosatellite repeat, located in 4q35. This causes the epigenetic de-repression of FSHD candidate genes leading to disease. Nevertheless, the molecular mechanism responsible for silencing of FSHD candidate genes in healthy subjects is not fully understood. While a role for DNA methylation has been suggested, so far there is limited information regarding the methylation status of the 325 CpGs contained in each D4Z4 unit. Using a human/rodent monochromosomal hybrid cell line containing a single human chromosome 4, we performed an in depth analysis of DNA methylation for the majority of the CpGs inside D4Z4 at single nucleotide level. We found that D4Z4 is not uniformly methylated and that the level of DNA methylation does not correlate with the density of CpG dinucleotides. Moreover, in several D4Z4 regions characterized by near complete methylation, we found specific unmethylated CpGs. These elements are enriched in transcription factor binding sites that could be involved in muscle-specific D4Z4 activity. Our approach also detected differential methylation among different D4Z4 units, suggesting that the D4Z4 array is a mosaic of euchromatic and heterochromatic domains. Finally, we found that DNA methylation and histone deacetylation are required to maintain FSHD candidate genes repressed. Taken together, our data underscore new players involved in the epigenetic regulation of the FSHD locus that could be targeted for therapeutic purposes.	[Huichalaf, Claudia; Micheloni, Stefano; Ferri, Giulia; Caccia, Roberta; Gabellini, Davide] Ist Sci San Raffaele, Dulbecco Telethon Inst, Div Regenerat Med, DIBIT2, I-20132 Milan, Italy; [Huichalaf, Claudia; Ferri, Giulia] Univ Vita Salute San Raffaele, Milan, Italy	Fondazione Telethon; Dulbecco Telethon Institute (DTI); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University	Gabellini, D (corresponding author), Ist Sci San Raffaele, Dulbecco Telethon Inst, Div Regenerat Med, DIBIT2, 5A3,Via Olgettina 58, I-20132 Milan, Italy.	gabellini.davide@hsr.it	Gabellini, Davide/I-4551-2018; Caccia, Roberta/AAN-1851-2020	Gabellini, Davide/0000-0002-3811-4121; Caccia, Roberta/0000-0003-3212-3104	Association Francaise contre les Myopathies; ERA-Net for Research on Rare Diseases; European Research Council; Italian Epigenomics Flagship Project; Italian Ministry of Health; FSHD Global Research Foundation; Fondazione Telethon Funding Source: Custom	Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); ERA-Net for Research on Rare Diseases; European Research Council(European Research Council (ERC)European Commission); Italian Epigenomics Flagship Project; Italian Ministry of Health(Ministry of Health, Italy); FSHD Global Research Foundation; Fondazione Telethon(Fondazione Telethon)	This work was supported by the Association Francaise contre les Myopathies (http://www.afm-telethon.com/); the ERA-Net for Research on Rare Diseases (http://www.erare.eu/); the European Research Council (http://erc.europa.eu/); the Italian Epigenomics Flagship Project (http://www.epigen.it/); the Italian Ministry of Health (http://www.salute.gov.it/) and the FSHD Global Research Foundation (http://fshdglobal.org/).	Ansseau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007482; Bartke T, 2010, CELL, V143, P470, DOI 10.1016/j.cell.2010.10.012; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bodega B, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-41; Bosnakovski D, 2008, EMBO J, V27, P2766, DOI 10.1038/emboj.2008.201; Broucqsault N, 2013, HUMAN MOL GENETICS; Cabianca DS, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.035; Cabianca DS, 2010, J CELL BIOL, V191, P1049, DOI 10.1083/jcb.201007028; Caruso N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003550; Cedar H, 2012, ANNU REV BIOCHEM, V81, P97, DOI 10.1146/annurev-biochem-052610-091920; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Clapp J, 2007, AM J HUM GENET, V81, P264, DOI 10.1086/519311; Clark LN, 1996, CHROMOSOMA, V105, P180, DOI 10.1007/BF02509499; de Greef JC, 2007, NEUROLOGY, V69, P1018, DOI 10.1212/01.wnl.0000271391.44352.fe; de Greef JC, 2010, NEUROLOGY, V75, P1548, DOI 10.1212/WNL.0b013e3181f96175; de Greef JC, 2009, HUM MUTAT, V30, P1449, DOI 10.1002/humu.21091; Dixit M, 2007, P NATL ACAD SCI USA, V104, P18157, DOI 10.1073/pnas.0708659104; Do Kim J, 2009, NUCLEIC ACIDS RES, V37, P5656, DOI 10.1093/nar/gkp613; Flanigan KM, 2001, NEUROMUSCULAR DISORD, V11, P525, DOI 10.1016/S0960-8966(01)00201-2; Fraga ME, 2002, BIOTECHNIQUES, V33, P632, DOI 10.2144/02333rv01; Gabellini D, 2006, NATURE, V439, P973, DOI 10.1038/nature04422; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hartweck LM, 2013, NEUROLOGY, V80, P392, DOI 10.1212/WNL.0b013e31827f075c; HEWITT JE, 1994, HUM MOL GENET, V3, P1287, DOI 10.1093/hmg/3.8.1287; Hu SH, 2013, ELIFE, V2, DOI 10.7554/eLife.00726; Jabbari K, 2004, GENE, V333, P143, DOI 10.1016/j.gene.2004.02.043; Jiang GC, 2003, HUM MOL GENET, V12, P2909, DOI 10.1093/hmg/ddg323; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kim J, 2003, HUM MOL GENET, V12, P233, DOI 10.1093/hmg/ddg028; Kowaljow V, 2007, NEUROMUSCULAR DISORD, V17, P611, DOI 10.1016/j.nmd.2007.04.002; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Laoudj-Chenivesse D, 2005, J MOL MED, V83, P216, DOI 10.1007/s00109-004-0583-7; Lemmers RJLF, 2012, NAT GENET, V44, P1370, DOI 10.1038/ng.2454; Lemmers RJLF, 2010, SCIENCE, V329, P1650, DOI 10.1126/science.1189044; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; LI LH, 1970, CANCER RES, V30, P2760; LUNT PW, 1989, J MED GENET, V26, P755, DOI 10.1136/jmg.26.12.755; LYLE R, 1995, GENOMICS, V28, P389, DOI 10.1006/geno.1995.1166; Marks PA, 2001, CURR OPIN ONCOL, V13, P477, DOI 10.1097/00001622-200111000-00010; Masny PS, 2004, HUM MOL GENET, V13, P1857, DOI 10.1093/hmg/ddh205; Meehan RR, 2005, EXP CELL RES, V309, P241, DOI 10.1016/j.yexcr.2005.06.023; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Neguembor MV, 2010, EPIGENOMICS-UK, V2, P271, DOI [10.2217/epi.10.8, 10.2217/EPI.10.8]; Ottaviani A, 2009, EMBO J, V28, P2428, DOI 10.1038/emboj.2009.201; Ottaviani A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000394; Rijkers T, 2004, J MED GENET, V41, P826, DOI 10.1136/jmg.2004.019364; Sekimata M, 2011, BIOCHEM BIOPH RES CO, V414, P767, DOI 10.1016/j.bbrc.2011.09.155; Snider L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001181; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Tam R, 2004, J CELL BIOL, V167, P269, DOI 10.1083/jcb.200403128; Tawil R, 2006, MUSCLE NERVE, V34, P1, DOI 10.1002/mus.20522; Tupler R, 2004, CELL MOL LIFE SCI, V61, P557, DOI 10.1007/s00018-003-3285-3; van Geel M, 2002, GENOMICS, V79, P210, DOI 10.1006/geno.2002.6690; van Overveld PGM, 2005, ANN NEUROL, V58, P569, DOI 10.1002/ana.20625; van Overveld PGM, 2003, NAT GENET, V35, P315, DOI 10.1038/ng1262; Vanhaecke T, 2004, CURR MED CHEM, V11, P1629, DOI 10.2174/0929867043365099; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Zeng WH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000559; Zhang Yingying, 2009, V507, P177, DOI 10.1007/978-1-59745-522-0_14	61	23	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115278	10.1371/journal.pone.0115278	http://dx.doi.org/10.1371/journal.pone.0115278			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545674	Green Submitted, gold, Green Published			2022-12-27	WOS:000347120200032
J	Langhans, SD; Tockner, K				Langhans, Simone D.; Tockner, Klement			Edge Effects Are Important in Supporting Beetle Biodiversity in a Gravel-Bed River Floodplain	PLOS ONE			English	Article							TAGLIAMENTO RIVER; GROUND BEETLE; BRAIDED-RIVER; COLEOPTERA; CARABIDAE; HABITAT; INVERTEBRATES; SEDIMENTS; ECOLOGY; FOREST	Understanding complex, dynamic, and diverse ecosystems is essential for developing sound management and conservation strategies. Gravel-bed river floodplains are composed of an interlinked mosaic of aquatic and terrestrial habitats hosting a diverse, specialized, and endangered fauna. Therefore, they serve as excellent models to investigate the biodiversity of multiple ecotones and related edge effects. In this study, we investigated the abundance, composition, richness, and conservation status of beetle assemblages at varying sediment depth (0, 0.1, 0.6 and 1.1 m), distance from the channel (1, 5, 20, and 60-100 m, and 5 m within the riparian forest), and time of the year (February-November) across a 200 m-wide gravel bar at the near-natural Tagliamento River (Italy), to detect edge effects in four floodplain ecotones: aquatic-terrestrial, forest-active floodplain, sediment-air, and sediment-groundwater. We used conventional pitfall traps and novel tube traps to sample beetles comparably on the sediment surface and within the unsaturated sediments. We found a total of 308 beetle species (including 87 of conservation concern) that showed multiple, significant positive edge effects across the floodplain ecotones, mainly driven by spatial heterogeneity: Total and red list beetle abundance and richness peaked on the sediment surface, at channel margins, and at the edge of the riparian forest. All ecotones possessed edge/habitat specialists. Most red list species occurred on the sediment surface, including five species previously considered extinct - yet two of these species occurred in higher densities in the unsaturated sediments. Conservation and management efforts along gravel-bed rivers must therefore promote a dynamic flow and sediment regime to create and maintain habitat heterogeneity and ecotone diversity, which support a unique and high biodiversity.	[Langhans, Simone D.] Swiss Fed Inst Aquat Sci & Technol, Eawag, CH-8600 Dubendorf, Switzerland; [Langhans, Simone D.] ETH Zrich, Inst Integrat Biol, CH-8092 Zurich, Switzerland; [Langhans, Simone D.; Tockner, Klement] Leibniz Inst Freshwater Ecol & Inland Fisheries, D-12587 Berlin, Germany; [Tockner, Klement] Free Univ Berlin, Inst Biol, Berlin, Germany	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Free University of Berlin	Langhans, SD (corresponding author), Swiss Fed Inst Aquat Sci & Technol, Eawag, Uberlandstr 133, CH-8600 Dubendorf, Switzerland.	langhans@igb-berlin.de	Tockner, Klement/G-9265-2011; Langhans, Simone D/A-5314-2019	Langhans, Simone Daniela/0000-0001-9581-3183; Tockner, Klement/0000-0002-0038-8151	European Commission; tempQsim-project [EVK1-CT-20020012]; Swiss State Secretariat for Education and Research (SBF) [02.0072]; Alexander von Humboldt-Foundation	European Commission(European CommissionEuropean Commission Joint Research Centre); tempQsim-project; Swiss State Secretariat for Education and Research (SBF); Alexander von Humboldt-Foundation(Alexander von Humboldt Foundation)	This research was funded by the European Commission and supported through the tempQsim-project (contract no. EVK1-CT-20020012) and the Swiss State Secretariat for Education and Research (SBF no. 02.0072). S. D. Langhans was additionally supported by the Alexander von Humboldt-Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoros C, 1996, FLUVIAL HYDROSYSTEMS, P184; ANDERSEN J, 1968, Norsk Entomologisk Tidsskrift, V15, P115; Andersen J, 2011, J INSECT CONSERV, V15, P799, DOI 10.1007/s10841-011-9378-7; BAARS MA, 1979, OECOLOGIA, V41, P25, DOI 10.1007/BF00344835; Bates AJ, 2006, OECOLOGIA, V150, P50, DOI 10.1007/s00442-006-0508-y; BAUER T, 1985, J INSECT PHYSIOL, V31, P593, DOI 10.1016/0022-1910(85)90057-5; Binot M., 1998, ROTE LISTE GEFAHRDET; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Cao Y, 1999, LIMNOL OCEANOGR, V44, P1841; Cao Y, 2001, J N AM BENTHOL SOC, V20, P144, DOI 10.2307/1468195; Cardenas AM, 2004, VIE MILIEU, V54, P47; Corti R, 2013, HYDROBIOLOGIA, V717, P13, DOI 10.1007/s10750-013-1563-0; Datry T, 2014, FRESHWATER BIOL, V59, P1308, DOI 10.1111/fwb.12350; Dieterich M, 1996, VERHANDLUNGEN DER GESELLSCHAFT FUR OKOLOGIE, VOL 26, P363; Ewers RM, 2008, P NATL ACAD SCI USA, V105, P5426, DOI 10.1073/pnas.0800460105; Ewers RM, 2006, J APPL ECOL, V43, P527, DOI 10.1111/j.1365-2664.2006.01151.x; Eyre MD, 2001, J INSECT CONSERV, V5, P173, DOI 10.1023/A:1017956927482; Hering D, 1997, OECOLOGIA, V111, P261, DOI 10.1007/s004420050234; Hering D, 1998, COLEOPTS BULL, V52, P161; Horvath R., 2002, Web Ecology, V3, P43; Imbeau L, 2003, ECOGRAPHY, V26, P514, DOI 10.1034/j.1600-0587.2003.03509.x; Johnson VE, 2013, P NATL ACAD SCI USA, V110, P19313, DOI 10.1073/pnas.1313476110; Kahlen M, 2003, GORTANIA, V24, P147; Kahlen Manfred, 2009, Gortania-Atti del Museo Friulano di Storia Naturale Botanica Zoologia, V31, P65; Karrenberg S, 2003, BASIC APPL ECOL, V4, P157, DOI 10.1078/1439-1791-00123; Langhans SD, 2014, GLOB ECOL CONSERV, V2, P129, DOI 10.1016/j.gecco.2014.08.009; Legendre P, 2005, ECOL MONOGR, V75, P435, DOI 10.1890/05-0549; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Lovei GL, 2006, GLOBAL ECOL BIOGEOGR, V15, P283, DOI 10.1111/j.1466-8238.2005.00221.x; LUFF ML, 1975, OECOLOGIA, V19, P345, DOI 10.1007/BF00348110; Magura T., 2001, Web Ecology, V2, P7; Magura T, 2001, BIODIVERS CONSERV, V10, P287, DOI 10.1023/A:1008967230493; Molnar T, 2001, EUR J SOIL BIOL, V37, P297, DOI 10.1016/S1164-5563(01)01103-7; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; Naiman R, 1990, ECOLOGY MANAGEMENT A; NAIMAN RJ, 1988, J N AM BENTHOL SOC, V7, P289, DOI 10.2307/1467295; Naiman RJ, 2005, RIPARIA ECOLOGY CONS; OKLAND RH, 1994, J VEG SCI, V5, P117, DOI 10.2307/3235645; Okland RH, 1999, J VEG SCI, V10, P131, DOI 10.2307/3237168; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Paetzold A, 2005, ECOSYSTEMS, V8, P748, DOI 10.1007/s10021-005-0004-y; Parris KM, 2004, ECOGRAPHY, V27, P392, DOI 10.1111/j.0906-7590.2004.03711.x; Pe'er G, 2008, ECOL MODEL, V213, P73, DOI 10.1016/j.ecolmodel.2007.11.020; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Petts GE, 2000, AQUAT CONSERV, V10, P249, DOI 10.1002/1099-0755(200007/08)10:4<249::AID-AQC410>3.0.CO;2-R; Poos MS, 2012, ECOL INDIC, V18, P82, DOI 10.1016/j.ecolind.2011.10.008; R Core Team, 2021, R LANGUAGE ENV STAT; Sadler JP, 2004, BIOL CONSERV, V118, P41, DOI 10.1016/j.biocon.2003.07.007; Sadler JP, 2000, W196 R D ENV AG; Smilauer, 1998, REFERENCE MANUAL USE; Stanley EH, 2010, J N AM BENTHOL SOC, V29, P67, DOI 10.1899/08-027.1; Steward AL, 2011, AQUAT SCI, V73, P551, DOI 10.1007/s00027-011-0217-4; Strayer DL, 2003, BIOSCIENCE, V53, P723, DOI 10.1641/0006-3568(2003)053[0723:ACOEB]2.0.CO;2; Thomas JA, 2001, P ROY SOC B-BIOL SCI, V268, P1791, DOI 10.1098/rspb.2001.1693; Tockner K, 2003, AQUAT SCI, V65, P239, DOI 10.1007/s00027-003-0699-9; Tockner K, 2002, ENVIRON CONSERV, V29, P308, DOI 10.1017/S037689290200022X; Tockner K., 2006, BRAIDED RIVERS PROCE, DOI [10.1002/9781444304374.ch17, DOI 10.1002/9781444304374.CH17]; Tockner K, 2010, FRESHWATER BIOL, V55, P135, DOI 10.1111/j.1365-2427.2009.02371.x; van der Nat D, 2002, ECOSYSTEMS, V5, P636, DOI 10.1007/s10021-002-0170-0; Ward JV, 2002, FRESHWATER BIOL, V47, P517, DOI 10.1046/j.1365-2427.2002.00893.x; Ward JV, 1999, REGUL RIVER, V15, P125, DOI 10.1002/(SICI)1099-1646(199901/06)15:1/3&lt;125::AID-RRR523&gt;3.0.CO;2-E; West B. T., 2007, LINEAR MIXED MODELS; Wiens JA, 2002, FRESHWATER BIOL, V47, P501, DOI 10.1046/j.1365-2427.2002.00887.x	63	10	11	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e114415	10.1371/journal.pone.0114415	http://dx.doi.org/10.1371/journal.pone.0114415			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545280	Green Submitted, Green Published, gold			2022-12-27	WOS:000347120200012
J	Schrobback, P; Pascoe, S; Coglan, L				Schrobback, Peggy; Pascoe, Sean; Coglan, Louisa			Shape Up or Ship Out: Can We Enhance Productivity in Coastal Aquaculture to Compete with Other Uses?	PLOS ONE			English	Article							TECHNICAL EFFICIENCY; CAPACITY UTILIZATION; PRODUCTION FRONTIER; 2ND-STAGE DEA; MORETON BAY; OYSTERS; MANAGEMENT; FISHERIES; IMPACTS; QUALITY	Coastal resources are coming under increasing pressure from competition between recreational, commercial and conservation uses. This is particularly so in coastal areas adjacent to major population centres. Given high recreational and conservation values in such areas, economic activities need to be highly efficient in order to persist. Management of these industries must therefore also encourage efficient production and full utilisation of the areas available. In order to achieve this, managers must first understand the level and drivers of productivity, and how these can be influenced. In this study, by way of illustration, the focus was on the Sydney rock oyster industry within Queensland's Moreton Bay, a multiple use marine park with high recreational and conservation value adjacent to Australia's third largest city. Productivity of the oyster industry in Moreton Bay is currently low compared to historic levels, and management has an objective of reversing this trend. It is unclear whether this difference is due to oyster farmers' business choices and personal characteristics or whether varying environmental conditions in the Moreton Bay limit the capacity of the oyster industry. These require different management responses in order to enhance productivity. The study examined different productivity measures of the oyster industry using data envelopment analysis (DEA) to determine where productivity gains can be made and by how much. The findings suggest that the industry is operating at a high level of capacity utilisation, but a low level of efficiency. The results also suggest that both demographic and environmental conditions affect technical efficiency in the Bay, with water characteristics improvements and appropriate training potentially providing the greatest benefits to the industry. Methods used in this study are transferable to other industries and provide a means by which coastal aquaculture may be managed to ensure it remains competitive with other uses of coastal resources.	[Schrobback, Peggy; Coglan, Louisa] Queensland Univ Technol, Sch Econ & Finance, Brisbane, Qld 4001, Australia; [Pascoe, Sean] CSIRO Oceans & Atmospher Flagship, EcoSci Precinct, Brisbane, Qld, Australia	Queensland University of Technology (QUT); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Schrobback, P (corresponding author), Queensland Univ Technol, Sch Econ & Finance, Brisbane, Qld 4001, Australia.	p.schrobback@gmail.com	Coglan, Louisa/J-1113-2012; Coglan, Louisa/AAF-2356-2019; Schrobback, Peggy/X-4697-2019; Pascoe, Sean/D-9710-2011	Coglan, Louisa/0000-0001-5730-7845; Coglan, Louisa/0000-0001-5730-7845; Schrobback, Peggy/0000-0003-0526-1659; Pascoe, Sean/0000-0001-6581-2649	Fisheries Research Development Cooperation (FRDC) [2008/306]; Commonwealth Scientific and Industrial Research Organisation (CSIRO)	Fisheries Research Development Cooperation (FRDC)(Fisheries R&D Corp); Commonwealth Scientific and Industrial Research Organisation (CSIRO)(Commonwealth Scientific & Industrial Research Organisation (CSIRO))	The authors would like to acknowledge the financial support of the Fisheries Research Development Cooperation (FRDC) (www.frdc.com.au) under the FRDC-funded project 2008/306: "Building economic capability to improve the management of marine resources in Australia,'' and in-kind support of the Commonwealth Scientific and Industrial Research Organisation (CSIRO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABARES (Australian Bureau of Agricultural and Resource Economics and Sciences), 2013, AUSTR FISH STAT 2012; Ahmed N, 2011, AUST J AGR RESOUR EC, V55, P199, DOI 10.1111/j.1467-8489.2011.00535.x; Alam MF, 2011, AQUAC RES, V42, P1487, DOI 10.1111/j.1365-2109.2010.02741.x; [Anonymous], 2000, AQUACULT ECON MANAG, V4, P33, DOI [10.1080/13657300009380259, DOI 10.1080/13657300009380259]; [Anonymous], 1981, J ROYAL HIST SOC QUE; Australian Government, 2014, AUSTR RAMS WETL; Australian Taxation Office, 2013, TAX WITHH CALC IND N; Azizi H, 2010, COMPUT IND ENG, V59, P411, DOI 10.1016/j.cie.2010.05.013; BANKER RD, 1984, MANAGE SCI, V30, P1078, DOI 10.1287/mnsc.30.9.1078; Bayne BL, 1999, BIOL BULL-US, V197, P377, DOI 10.2307/1542792; Byron C, 2011, MAR POLICY, V35, P363, DOI 10.1016/j.marpol.2010.10.016; Chambers RG, 2011, AUST J AGR RESOUR EC, V55, P90, DOI 10.1111/j.1467-8489.2010.00517.x; Chapelle A, 2000, ECOL MODEL, V127, P161, DOI 10.1016/S0304-3800(99)00206-9; CHARNES A, 1978, EUR J OPER RES, V2, P429, DOI 10.1016/0377-2217(78)90138-8; Chiang FS, 2004, AQUACULTURE, V230, P99, DOI 10.1016/j.aquaculture.2003.09.038; Coelli T, 2000, APPL ECON, V32, P1967, DOI 10.1080/00036840050155896; Coelli T. J., 2005, MEDICINE; de la Mare W, 2012, MAR POLLUT BULL, V64, P704, DOI 10.1016/j.marpolbul.2012.01.039; DOVE MC, 2003, THESIS U NEW S WALES; Dove MC, 2007, J SHELLFISH RES, V26, P939, DOI 10.2983/0730-8000(2007)26[939:SATTOS]2.0.CO;2; DPI NSW, 2013, AQUACULTURE PRODUCTI; Dupont DP, 2002, RESOUR ENERGY ECON, V24, P193, DOI 10.1016/S0928-7655(01)00050-1; FARE R, 1989, INT ECON REV, V30, P655, DOI 10.2307/2526781; FARE R, 1983, RESOUR ENERG, V5, P349, DOI 10.1016/0165-0572(83)90033-6; Fare R, 2000, J PROD ANAL, V13, P93, DOI 10.1023/A:1007844628920; Fare R, 2000, B EC RES, V52, P101, DOI DOI 10.1111/1467-8586.00097; Grant J, 1997, J MAR RES, V55, P965, DOI 10.1357/0022240973224193; GROSSKOPF S, 1995, EUR J OPER RES, V80, P575, DOI 10.1016/0377-2217(94)00138-3; Healthy Waterways Ltd, 2012, EST MAR DAT EC HLTH; Higgins CB, 2011, J ENVIRON QUAL, V40, P271, DOI 10.2134/jeq2010.0203; Hoff A, 2007, EUR J OPER RES, V181, P425, DOI 10.1016/j.ejor.2006.05.019; Holland DS, 2002, EUR J OPER RES, V137, P10, DOI 10.1016/S0377-2217(01)00087-X; Holliday JE, 1995, THESIS U TASMANIA; Humphreys J, 2014, AQUACULTURE, V428, P117, DOI 10.1016/j.aquaculture.2014.02.034; Iliyasu A, 2014, AQUACULT ECON MANAG, V18, P221, DOI 10.1080/13657305.2014.926464; Irz X., 2003, Aquaculture Economics & Management, V7, P195, DOI 10.1080/13657300309380340; Islam MS, 2004, MAR POLLUT BULL, V48, P624, DOI 10.1016/j.marpolbul.2003.12.004; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Kellogg ML, 2013, MAR ECOL PROG SER, V480, P1, DOI 10.3354/meps10331; Kieschnick R, 2003, STAT MODEL, V3, P193, DOI 10.1191/1471082X03st053oa; Klein CJ, 2010, FRONT ECOL ENVIRON, V8, P349, DOI 10.1890/090047; Lampe HW, 2014, EUROPEAN J OPERATION; Lergessner JG, 2006, OYSTERERS MORETON BA; Mazor T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104489; McDonald J, 2009, EUR J OPER RES, V197, P792, DOI 10.1016/j.ejor.2008.07.039; Mugera AW, 2013, AUST J AGR RESOUR EC, V57, P501, DOI 10.1111/1467-8489.12008; O'Donnell CJ, 2005, J ECONOMETRICS, V126, P493, DOI 10.1016/j.jeconom.2004.05.011; Ogburn DM, 2007, COAST MANAGE, V35, P271, DOI 10.1080/08920750601169618; Onumah EE, 2010, J WORLD AQUACULT SOC, V41, P506, DOI 10.1111/j.1749-7345.2010.00391.x; Pantus FJ, 2005, ENVIRON MANAGE, V36, P757, DOI 10.1007/s00267-003-0110-6; Parker LM, 2011, MAR BIOL, V158, P689, DOI 10.1007/s00227-010-1592-4; Pascoe S, 2000, MAR POLICY, V24, P301, DOI 10.1016/S0308-597X(00)00006-3; Pascoe S., 2002, Aquaculture Economics & Management, V6, P295, DOI 10.1080/13657300209380320; Pascoe S, 2014, TOURISM MANAGE, V41, P53, DOI 10.1016/j.tourman.2013.08.015; Pascoe S, 2010, EUR REV AGRIC ECON, V37, P313, DOI 10.1093/erae/jbq022; QLD DPI, 2008, OYST IND MAN PLAN MO; QLD DPI&F, 2007, POL MAX ROCK OYST PR; QLD DPI&F, 2008, OYST IND MAN PLAN MO; Reid C, 2003, MAR POLICY, V27, P449, DOI 10.1016/S0308-597X(03)00065-4; Rubio Zuazo AM, 2008, THESIS AUSTR NATL U; Schrobback P, 2014, AQUACULT ECON MANAG, V18, P248, DOI 10.1080/13657305.2014.926465; Sharma K.R., 1998, MAR RESOUR ECON, V13, P259, DOI 10.1086/mre.13.4.42629241.; Sharma KR, 2000, AQUAC RES, V31, P937, DOI 10.1046/j.1365-2109.2000.00521.x; Singh K., 2009, AG EC RE REV, V22, P185; Smith G., 1985, QUEENSLAND OYSTER FI; Stewart RR, 2005, ENVIRON MODEL ASSESS, V10, P203, DOI 10.1007/s10666-005-9001-y; Tingley D, 2005, J AGR ECON, V56, P287, DOI 10.1111/j.1477-9552.2005.00005.x; Tingley D, 2005, FISH RES, V73, P363, DOI 10.1016/j.fishres.2005.01.008; Vestergaard N, 2003, FISH RES, V60, P357, DOI 10.1016/S0165-7836(02)00141-8; Whitmore M, 2005, SUSTAINABLE DEV MANA; Wingfield M, 2013, ANN SYDNEY ROCK OYST	71	9	9	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115912	10.1371/journal.pone.0115912	http://dx.doi.org/10.1371/journal.pone.0115912			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7UN	25545861	Green Published, Green Submitted, gold			2022-12-27	WOS:000347120200081
J	Yu, HT; Tian, D; Wang, JY; Guo, CX; Li, Y; Wang, X; Li, D; Zhang, FM; Zhuang, M; Ling, H				Yu, Hao-Tong; Tian, Dan; Wang, Jia-Ye; Guo, Cai-Xia; Li, Yan; Wang, Xin; Li, Di; Zhang, Feng-Min; Zhuang, Min; Ling, Hong			An HIV-1 Envelope Immunogen with W427S Mutation in CD4 Binding Site Induced More T Follicular Helper Memory Cells and Reduced Non-Specific Antibody Responses	PLOS ONE			English	Article							VACCINE EFFICACY TRIAL; TEST-OF-CONCEPT; NEUTRALIZING ANTIBODIES; CD4-BINDING SITE; GERMINAL CENTER; DOUBLE-BLIND; B-CELLS; VIRUS; INFECTION; GLYCOPROTEIN	The CD4 binding site (CD4BS) of the HIV-1 envelope glycoprotein (Env) contains epitopes for broadly neutralizing antibody (nAb) and is the target for the vaccine development. However, the CD4BS core including residues 425-430 overlaps the B cell superantigen site and may be related to B cell exhaustion in HIV-1 infection. Furthermore, production of nAb and high-affinity plasma cells needs germinal center reaction and the help of T follicular helper (Tfh) cells. We believe that strengthening the ability of Env CD4BS in inducing Tfh response and decreasing the effects of the superantigen are the strategies for eliciting nAb and development of HIV-1 vaccine. We constructed a gp120 mutant W427S of an HIV-1 primary R5 strain and examined its ability in the elicitation of Ab and the production of Tfh by immunization of BALB/c mice. We found that the trimeric wild-type gp120 can induce more non-specific antibody-secreting plasma cells, higher serum IgG secretion, and more Tfh cells by splenocyte. The modified W427S gp120 elicits higher levels of specific binding antibodies as well as nAbs though it produces less Tfh cells. Furthermore, higher Tfh cell frequency does not correlate to the specific binding Abs or nAbs indicating that the wild-type gp120 induced some non-specific Tfh that did not contribute to the production of specific Abs. This gp120 mutant led to more memory Tfh production, especially, the effector memory Tfh cells. Taken together, W427S gp120 could induce higher level of specific binding and neutralizing Ab production that may be associated with the reduction of non-specific Tfh but strengthening of the memory Tfh.	[Yu, Hao-Tong; Tian, Dan; Wang, Jia-Ye; Guo, Cai-Xia; Li, Yan; Wang, Xin; Li, Di; Zhang, Feng-Min; Zhuang, Min; Ling, Hong] Harbin Med Univ, Dept Microbiol, Harbin, Peoples R China; [Wang, Jia-Ye; Li, Yan; Li, Di; Zhang, Feng-Min; Zhuang, Min; Ling, Hong] Key Lab Etiol Heilongjiang Prov Educ Bur, Heilongjiang Prov Key Lab Infect & Immun, Harbin, Peoples R China; [Ling, Hong] Harbin Med Univ, Dept Parasitol, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University	Zhuang, M (corresponding author), Harbin Med Univ, Dept Microbiol, Harbin, Peoples R China.	zhuangm@ems.hrbmu.edu.cn; lingh@ems.hrbmu.edu.cn	Tian, Dan/AAR-4019-2020	Tian, Dan/0000-0002-6894-2673; ling, hong/0000-0002-1886-1242	Key Projects in the National Science & Technology Pillar Program [2012ZX10001009-002-003]; National Natural Science Foundation of China [30771910, 81271824, 81202364]	Key Projects in the National Science & Technology Pillar Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Key Projects in the National Science & Technology Pillar Program during the twelfth Five-Year Plan Period (2012ZX10001009-002-003), and The National Natural Science Foundation of China (30771910; 81271824; 81202364). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameri M, 2008, J MED ENTOMOL, V45, P94, DOI 10.1603/0022-2585(2008)45[94:AIBPAO]2.0.CO;2; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; Bonsignori M, 2012, J VIROL, V86, P11521, DOI 10.1128/JVI.01023-12; Bouhdoud L, 2000, J VIROL, V74, P2121, DOI 10.1128/JVI.74.5.2121-2130.2000; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; BUERKI H, 1989, IMMUNOL LETT, V23, P87, DOI 10.1016/0165-2478(89)90118-1; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Carbonetti S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086905; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Deenick EK, 2011, IMMUNOLOGY, V134, P361, DOI 10.1111/j.1365-2567.2011.03487.x; Dosenovic P, 2009, J IMMUNOL, V183, P3373, DOI 10.4049/jimmunol.0900407; Euler Z, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00215; Feng Y, 2012, J BIOL CHEM, V287, P5673, DOI 10.1074/jbc.M111.317776; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Gaschen B, 2002, SCIENCE, V296, P2354, DOI 10.1126/science.1070441; Gray G, 2010, CURR OPIN HIV AIDS, V5, P357, DOI 10.1097/COH.0b013e32833d2d2b; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hioe CE, 2009, VACCINE, V28, P352, DOI 10.1016/j.vaccine.2009.10.040; Hollister K, 2014, HUM VACCIN IMMUNOTHE, V10; Hoot S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003106; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Karray S, 1997, P NATL ACAD SCI USA, V94, P1356, DOI 10.1073/pnas.94.4.1356; Klebanoff CA, 2005, P NATL ACAD SCI USA, V102, P9571, DOI 10.1073/pnas.0503726102; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; LANDAU NR, 1988, NATURE, V334, P159, DOI 10.1038/334159a0; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Lindqvist M, 2012, J CLIN INVEST, V122, P3271, DOI 10.1172/JCI64314; Locci M, 2013, IMMUNITY, V39, P758, DOI 10.1016/j.immuni.2013.08.031; Lynch RM, 2012, J VIROL, V86, P7588, DOI 10.1128/JVI.00734-12; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; Moir S, 2013, IMMUNOL REV, V254, P207, DOI 10.1111/imr.12067; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; Narayan KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052732; Nishiyama Y, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00383; OLSHEVSKY U, 1990, J VIROL, V64, P5701, DOI 10.1128/JVI.64.12.5701-5707.1990; Ozaki K, 2004, J IMMUNOL, V173, P5361, DOI 10.4049/jimmunol.173.9.5361; Perreau M, 2013, J EXP MED, V210, P143, DOI 10.1084/jem.20121932; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Planque SA, 2012, J IMMUNOL, V189, P5367, DOI 10.4049/jimmunol.1200981; Ramiscal RR, 2013, IMMUNOL REV, V252, P146, DOI 10.1111/imr.12031; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; ROBEY WG, 1986, P NATL ACAD SCI USA, V83, P7023, DOI 10.1073/pnas.83.18.7023; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Schief WR, 2009, CURR OPIN HIV AIDS, V4, P431, DOI 10.1097/COH.0b013e32832e6184; SCHNITTMAN SM, 1986, SCIENCE, V233, P1084, DOI 10.1126/science.3016902; Silverman GJ, 2006, NAT REV IMMUNOL, V6, P465, DOI 10.1038/nri1853; Stamatatos L, 2012, CURR OPIN IMMUNOL, V24, P316, DOI 10.1016/j.coi.2012.04.006; Stephenson KE, 2013, IMMUNOL REV, V254, P295, DOI 10.1111/imr.12073; Sundling C, 2013, J INFECT DIS, V207, P426, DOI 10.1093/infdis/jis696; THALI M, 1992, J VIROL, V66, P5635, DOI 10.1128/JVI.66.9.5635-5641.1992; Townsley-Fuchs J, 1997, Int Rev Immunol, V14, P325, DOI 10.3109/08830189709116523; Van Regenmortel MHV, 2011, J MOL RECOGNIT, V24, P741, DOI 10.1002/jmr.1116; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang JY, 2011, APPL MICROBIOL BIOT, V91, P731, DOI 10.1007/s00253-011-3297-0; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Willinger T, 2005, J IMMUNOL, V175, P5895, DOI 10.4049/jimmunol.175.9.5895; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	63	3	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115047	10.1371/journal.pone.0115047	http://dx.doi.org/10.1371/journal.pone.0115047			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546013	Green Submitted, Green Published, gold			2022-12-27	WOS:000347120200019
J	Yuki, K; Asaoka, R; Tsubota, K				Yuki, Kenya; Asaoka, Ryo; Tsubota, Kazuo			The Relationship between Central Visual Field Damage and Motor Vehicle Collisions in Primary Open-Angle Glaucoma Patients	PLOS ONE			English	Article							QUALITY-OF-LIFE; OLDER-ADULTS; EYE; RISK; QUESTIONNAIRE; ASSOCIATION; SENSITIVITY; INVOLVEMENT; STAGE	Purpose: To investigate the relationship between visual field (VF) damage and history of motor vehicle collisions (MVCs) in subjects with primary open-angle glaucoma (POAG). Methods: MVC history and driving habits were recorded using patient questionnaires in 247 POAG patients. Patients' driving attitudes (carefulness) were estimated using Rasch analysis. The relationship between MVC outcomes and 52 total deviation (TD) values of integrated binocular VF (IVF), better and worse visual acuities (VAs), age and gender was analyzed using principal component analysis and logistic regression. Results: 51 patients had the history of MVCs. Significant difference was observed between patients with and without history of MVCs only for: better VA, a single TD value in the superior-right VF, and the typical distance driven in a week (unpaired t-test, p=0.002, 0.015 and 0.006, respectively). There was not a significant relationship between MVCs and mean deviation (MD) of IVF (p=0.41, logistic regression). None of the principal components were significantly correlated with MVC outcome (p>0.05, polynomial logistic regression analysis). There was a significant relationship between IVF MD and Rasch derived Person parameter (R-2 = 0.023, p=0.0095). There was also a significant positive relationship between MVCs and the distance driven in a week (p=0.005, logistic regression). Conclusions: In this study of POAG patients, MVCs were not related to central binocular VF damage. These results suggest the relationship between visual function and driving is not straightforward, and careful consideration should be given when predicting patients' driving ability using their VF.	[Yuki, Kenya; Tsubota, Kazuo] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan; [Asaoka, Ryo] Univ Tokyo, Dept Ophthalmol, Grad Sch Med, Tokyo 113, Japan	Keio University; University of Tokyo	Asaoka, R (corresponding author), Univ Tokyo, Dept Ophthalmol, Grad Sch Med, Tokyo 113, Japan.	rasaoka-tky@umin.ac.jp			Japan Science and Technology Agency (JST) CREST; KAKENHI Grant [26462679]	Japan Science and Technology Agency (JST) CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	RA (Japan Science and Technology Agency (JST) CREST and KAKENHI Grant 26462679). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora KS, 2013, OPHTHALMOLOGY, V120, P2476, DOI 10.1016/j.ophtha.2013.07.020; Asaoka R, 2013, BRIT J OPHTHALMOL, V97, P1355, DOI 10.1136/bjophthalmol-2013-303431; Asaoka R, 2013, GRAEF ARCH CLIN EXP, V251, P1335, DOI 10.1007/s00417-012-2214-2; Asaoka R, 2011, INVEST OPHTH VIS SCI, V52, P7007, DOI 10.1167/iovs.11-7643; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Black AA, 2008, OPTOMETRY VISION SCI, V85, P489, DOI 10.1097/OPX.0b013e31817882db; Black AA, 2011, OPHTHAL PHYSL OPT, V31, P283, DOI 10.1111/j.1475-1313.2010.00811.x; Bond TG., 2020, APPL RASCH MODEL FUN; Bowers A, 2005, OPTOMETRY VISION SCI, V82, P657, DOI 10.1097/01.opx.0000175558.33268.b5; Bronstad PM, 2013, JAMA OPHTHALMOL, V131, P303, DOI 10.1001/jamaophthalmol.2013.1443; Burian MA, 1980, PHYSL SENSORIMOTOR C; Cochrane GM, 2011, INVEST OPHTH VIS SCI, V52, P1632, DOI 10.1167/iovs.10-6079; Coleman AL, 2009, J AM GERIATR SOC, V57, P1825, DOI 10.1111/j.1532-5415.2009.02432.x; Coleman AL, 2008, SURV OPHTHALMOL, V53, pS3, DOI 10.1016/j.survophthal.2008.08.006; Crabb DP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009710; Crabb DP, 2005, GRAEF ARCH CLIN EXP, V243, P210, DOI 10.1007/s00417-004-0984-x; Crabb DP, 2004, BRIT J OPHTHALMOL, V88, P1191, DOI 10.1136/bjo.2003.035949; Crabb DP, 1998, BRIT J OPHTHALMOL, V82, P1236, DOI 10.1136/bjo.82.11.1236; FARRAR DE, 1967, REV ECON STAT, V49, P92, DOI 10.2307/1937887; Gothwal VK, 2013, QUAL LIFE RES, V22, P839, DOI 10.1007/s11136-012-0195-6; Hamel J, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00339; Haymes SA, 2008, INVEST OPHTH VIS SCI, V49, P3035, DOI 10.1167/iovs.07-1609; Haymes SA, 2007, INVEST OPHTH VIS SCI, V48, P1149, DOI 10.1167/iovs.06-0886; JOHNSON CA, 1983, ARCH OPHTHALMOL-CHIC, V101, P371; Kasneci E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087470; Khadka J, 2011, INVEST OPHTH VIS SCI, V52, P6971, DOI 10.1167/iovs.11-7423; Khattree R., 2000, MULTIVARIATE DATA RE; Kotecha A, 2009, INVEST OPHTH VIS SCI, V50, P203, DOI 10.1167/iovs.08-2496; Labiris G, 2008, BMC OPHTHALMOL, V8, DOI 10.1186/1471-2415-8-4; Lachenmayr B J, 1995, Ger J Ophthalmol, V4, P175; Lappi O, 2013, J VISION, V13, DOI 10.1167/13.13.11; Linacre JM, 2000, RASCH MEAS T, V14, P743; Lisboa R, 2013, JAMA OPHTHALMOL, V131, P486, DOI 10.1001/jamaophthalmol.2013.2602; Mallinson T, 2007, OPTOMETRY VISION SCI, V84, P675, DOI 10.1097/OPX.0b013e3181339f44; Marottoli RA, 1997, J GERONTOL A-BIOL, V52, pM184, DOI 10.1093/gerona/52A.3.M184; McAlinden C, 2011, INVEST OPHTH VIS SCI, V52, P5685, DOI 10.1167/iovs.10-67951; McGwin G, 2005, INVEST OPHTH VIS SCI, V46, P4437, DOI 10.1167/iovs.05-0750; McGwin G, 2004, INVEST OPHTH VIS SCI, V45, P3934, DOI 10.1167/iovs.04-0524; McGwin G, 1998, ACCIDENT ANAL PREV, V30, P781, DOI 10.1016/S0001-4575(98)00031-1; Mills RP, 2006, AM J OPHTHALMOL, V141, P24, DOI 10.1016/j.ajo.2005.07.044; Murata H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058695; Nelson-Quigg JM, 2000, INVEST OPHTH VIS SCI, V41, P2212; Owsley C, 1999, J GERONTOL A-BIOL, V54, pM203, DOI 10.1093/gerona/54.4.M203; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Pesudovs K, 2007, OPTOMETRY VISION SCI, V84, P663, DOI 10.1097/OPX.0b013e318141fe75; Pesudovs K, 2010, J CATARACT REFR SURG, V36, P718, DOI 10.1016/j.jcrs.2009.11.019; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Ramulu P, 2009, CURR OPIN OPHTHALMOL, V20, P92, DOI 10.1097/ICU.0b013e32832401a9; Rasch G., 1980, PROBABILISTIC MODELS; Smith Everett V Jr, 2002, J Appl Meas, V3, P205; SUZUKI Y, 1993, OPHTHALMOLOGY, V100, P69; Szlyk JP, 2005, J GLAUCOMA, V14, P145, DOI 10.1097/01.ijg.0000151686.89162.28; Tanabe S, 2011, INVEST OPHTH VIS SCI, V52, P4177, DOI 10.1167/iovs.10-6264; Transporation: Motor Vehicle Accidents and Fatalities, TRANSP MOT VEH ACC F; Vianya-Estopa M, 2010, INVEST OPHTH VIS SCI, V51, P2496, DOI 10.1167/iovs.09-4381; Viswanathan AC, 1999, ARCH OPHTHALMOL-CHIC, V117, P450; Wright BD, 1982, RATING SCALE ANAL; Wright BD, 1979, BEST TEST DESIGN RAS; ZEYEN TG, 1993, OPHTHALMOLOGY, V100, P518	59	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115572	10.1371/journal.pone.0115572	http://dx.doi.org/10.1371/journal.pone.0115572			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545660	gold, Green Published, Green Submitted			2022-12-27	WOS:000347120200047
J	Bayin, NS; Modrek, AS; Dietrich, A; Lebowitz, J; Abel, T; Song, HR; Schober, M; Zagzag, D; Buchholz, CJ; Chao, MV; Placantonakis, DG				Bayin, N. Sumru; Modrek, Aram S.; Dietrich, August; Lebowitz, Jonathan; Abel, Tobias; Song, Hae-Ri; Schober, Markus; Zagzag, David; Buchholz, Christian J.; Chao, Moses V.; Placantonakis, Dimitris G.			Selective Lentiviral Gene Delivery to CD133-Expressing Human Glioblastoma Stem Cells	PLOS ONE			English	Article							TUMOR-INITIATING CELLS; HEMATOPOIETIC STEM; CANCER; CD133; IDENTIFICATION; VECTORS; GROWTH; VIRUS; AC133; MICROENVIRONMENT	Glioblastoma multiforme (GBM) is a deadly primary brain malignancy. Glioblastoma stem cells (GSC), which have the ability to self-renew and differentiate into tumor lineages, are believed to cause tumor recurrence due to their resistance to current therapies. A subset of GSCs is marked by cell surface expression of CD133, a glycosylated pentaspan transmembrane protein. The study of CD133-expressing GSCs has been limited by the relative paucity of genetic tools that specifically target them. Here, we present CD133-LV, a lentiviral vector presenting a single chain antibody against CD133 on its envelope, as a vehicle for the selective transduction of CD133-expressing GSCs. We show that CD133-LV selectively transduces CD133+ human GSCs in dose-dependent manner and that transduced cells maintain their stem-like properties. The transduction efficiency of CD133-LV is reduced by an antibody that recognizes the same epitope on CD133 as the viral envelope and by shRNA-mediated knockdown of CD133. Conversely, the rate of transduction by CD133-LV is augmented by overexpression of CD133 in primary human GBM cultures. CD133-LV selectively transduces CD133-expressing cells in intracranial human GBM xenografts in NOD. SCID mice, but spares normal mouse brain tissue, neurons derived from human embryonic stem cells and primary human astrocytes. Our findings indicate that CD133-LV represents a novel tool for the selective genetic manipulation of CD133-expressing GSCs, and can be used to answer important questions about how these cells contribute to tumor biology and therapy resistance.	[Bayin, N. Sumru; Modrek, Aram S.; Dietrich, August; Lebowitz, Jonathan; Song, Hae-Ri; Placantonakis, Dimitris G.] NYU, Dept Neurosurg, Sch Med, New York, NY 10016 USA; [Bayin, N. Sumru; Schober, Markus; Placantonakis, Dimitris G.] NYU, Helen L & Martin S Kimmel Ctr Stem Cell Biol, Sch Med, New York, NY 10016 USA; [Modrek, Aram S.] NYU, Sch Med, Med Scientist Training Program, New York, NY 10016 USA; [Abel, Tobias; Buchholz, Christian J.] Paul Ehrlich Inst, Langen, Germany; [Schober, Markus] NYU, Dept Cell Biol, Sch Med, New York, NY 10016 USA; [Schober, Markus] NYU, Sch Med, Ronald O Perelman Dept Dermatol, New York, NY 10016 USA; [Zagzag, David] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Buchholz, Christian J.] German Canc Consortium, Heidelberg, Germany; [Chao, Moses V.] NYU, Sch Med, Skirball Inst, New York, NY 10016 USA; [Placantonakis, Dimitris G.] NYU, Sch Med, Brain Tumor Ctr, New York, NY 10016 USA	New York University; New York University; New York University; Paul Ehrlich Institute; New York University; New York University; New York University; Helmholtz Association; German Cancer Research Center (DKFZ); New York University; New York University	Placantonakis, DG (corresponding author), NYU, Dept Neurosurg, Sch Med, 550 1St Ave, New York, NY 10016 USA.	dimitris.placantonakis@nyumc.org		Chao, Moses/0000-0002-6969-3744; Bayin, Nermin Sumru/0000-0003-4371-855X; Modrek, Aram/0000-0001-7586-9833; Placantonakis, Dimitris/0000-0003-1950-2978	NYSTEM Institutional training grant [CO26880]; Medical Scientist Training Program at NYU School of Medicine; American Brain Tumor Association Medical Student Summer Fellowship; NIH/NINDS [K08N5064297, 1R21N5087241- 01, 1R21NS088775-01]; LOEWE Center for Cell and Gene Therapy Frankfurt - Hessische Ministerium fur Wissenschaft und Kunst (HMWK) [Ill L 4-518/17.004]; Deutsche Forschungsgemeinschaft [BU 1301/3-1]; NIH/NCI [2P30CA016087-33]; NIH/NCATS [UL1 TR000038]; B*Cured Foundation; NYU Cancer Institute; NYU Clinical and Translational Science Institute; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS088775, K08NS064297, R21NS087241] Funding Source: NIH RePORTER	NYSTEM Institutional training grant; Medical Scientist Training Program at NYU School of Medicine; American Brain Tumor Association Medical Student Summer Fellowship; NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); LOEWE Center for Cell and Gene Therapy Frankfurt - Hessische Ministerium fur Wissenschaft und Kunst (HMWK); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); B*Cured Foundation; NYU Cancer Institute; NYU Clinical and Translational Science Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	N. Sumru Bayin received support from NYSTEM Institutional training grant #CO26880. Aram S. Modrek received support from the Medical Scientist Training Program at NYU School of Medicine. August Dietrich received support from American Brain Tumor Association Medical Student Summer Fellowship in Honor of Audley Ciamporcero, Jr. Hae-Ri Song received support from NIH/NINDS K08N5064297. Christian J. Buchholz receives support from the LOEWE Center for Cell and Gene Therapy Frankfurt funded by the Hessische Ministerium fur Wissenschaft und Kunst (HMWK; funding reference number: Ill L 4-518/17.004 (2010)) and the Deutsche Forschungsgemeinschaft (BU 1301/3-1). Dimitris Placantonakis received support from NIH/NINDS 1R21N5087241- 01, NIH/NINDS 1R21NS088775-01, NIH/NCI 2P30CA016087-33, NIH/NCATS UL1 TR000038, B*Cured Foundation, NYU Cancer Institute, and NYU Clinical and Translational Science Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anliker B, 2010, NAT METHODS, V7, P929, DOI 10.1038/nmeth.1514; Bach P, 2013, CANCER RES, V73, P865, DOI 10.1158/0008-5472.CAN-12-2221; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bauer N, 2011, EMBO MOL MED, V3, P398, DOI 10.1002/emmm.201100147; Brescia P, 2013, STEM CELLS, V31, P857, DOI 10.1002/stem.1317; Campos B, 2011, GLIA, V59, P1974, DOI 10.1002/glia.21239; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Cheng L, 2013, CELL, V153, P139, DOI 10.1016/j.cell.2013.02.021; Cockrell AS, 2007, MOL BIOTECHNOL, V36, P184, DOI 10.1007/s12033-007-0010-8; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Coskun V, 2008, P NATL ACAD SCI USA, V105, P1026, DOI 10.1073/pnas.0710000105; de Miera EVS, 2012, PIGM CELL MELANOMA R, V25, P395, DOI 10.1111/j.1755-148X.2012.00994.x; Dirks PB, 2008, J CLIN ONCOL, V26, P2916, DOI 10.1200/JCO.2008.17.6792; Eyler CE, 2008, J CLIN ONCOL, V26, P2839, DOI 10.1200/JCO.2007.15.1829; Fargeas CA, 2003, STEM CELLS, V21, P506, DOI 10.1634/stemcells.21-4-506; Finkelshtein D, 2013, P NATL ACAD SCI USA, V110, P7306, DOI 10.1073/pnas.1214441110; Funke S, 2008, MOL THER, V16, P1427, DOI 10.1038/mt.2008.128; Hardee ME, 2012, CANCER RES, V72, P4119, DOI 10.1158/0008-5472.CAN-12-0546; Jamal M, 2012, NEOPLASIA, V14, P150, DOI 10.1593/neo.111794; Kang MK, 2007, STEM CELLS DEV, V16, P837, DOI 10.1089/scd.2007.0006; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Levine BL, 2006, P NATL ACAD SCI USA, V103, P17372, DOI 10.1073/pnas.0608138103; Miraglia S, 1997, BLOOD, V90, P5013, DOI 10.1182/blood.V90.12.5013.5013_5013_5021; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Pfenninger CV, 2007, CANCER RES, V67, P5727, DOI 10.1158/0008-5472.CAN-07-0183; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Placantonakis DG, 2009, STEM CELLS, V27, P521, DOI 10.1634/stemcells.2008-0884; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Schnierle BS, 1997, P NATL ACAD SCI USA, V94, P8640, DOI 10.1073/pnas.94.16.8640; Shimozato O, 2014, ONCOGENE; Singh SK, 2004, ONCOGENE, V23, P7267, DOI 10.1038/sj.onc.1207946; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Taylor MD, 2005, CANCER CELL, V8, P323, DOI 10.1016/j.ccr.2005.09.001; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Zacchigna S, 2009, J NEUROSCI, V29, P2297, DOI 10.1523/JNEUROSCI.2034-08.2009	41	16	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e116114	10.1371/journal.pone.0116114	http://dx.doi.org/10.1371/journal.pone.0116114			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541984	Green Published, Green Submitted, gold			2022-12-27	WOS:000347239900146
J	Fallahi, M; Amelio, AL; Cleveland, JL; Rounbehler, RJ				Fallahi, Mohammad; Amelio, Antonio L.; Cleveland, John L.; Rounbehler, Robert J.			CREB Targets Define the Gene Expression Signature of Malignancies Having Reduced Levels of the Tumor Suppressor Tristetraprolin	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; AU-RICH ELEMENT; MESSENGER-RNA; STABILITY; SUBTYPES; CANCER; ALPHA; P38; INFLAMMATION; REGULATOR	The RNA-binding protein Tristetraprolin (TTP, ZFP36) functions as a tumor suppressor that impairs the development and disables the maintenance of MYC-driven lymphoma. In addition, other human cancers expressed reduced levels of TTP, suggesting that it may function as a tumor suppressor in several malignancies. To identify genes that may be associated with TTP tumor suppressor functions in human cancer, we analyzed The Cancer Genome Atlas (TCGA) breast cancer, lung adenocarcinoma, lung squamous cell carcinoma, and colon adenocarcinoma datasets. These analyses defined a signature of 50 genes differentially regulated between high and low TTP-expressing tumors. Notably, patients with low TTP-expressing breast cancer and lung adenocarcinoma had decreased survival rates and more aggressive tumors with increased necrosis. In addition, analysis across non-TCGA tumor gene expression databases identified a broad spectrum of human cancers having similarities with the TTP-low tumor gene signature, including pancreatic, bladder, and prostate cancer. TTP has documented roles in regulating mRNAs encoding inflammatory proteins, and pathway analysis identified several inflammatory pathways that are altered in tumors with low TTP expression. Surprisingly, the TTP-low tumor gene signature includes a core component of 20 under-expressed CREB target genes, suggesting that the regulation of CREB activity may be related to the tumor suppressor function of TTP. Thus, reduced levels of TTP are a potential biomarker for human cancers with poor outcome, and targeting the CREB pathway may be a therapeutic route for treating aggressive TTP-low tumors.	[Fallahi, Mohammad] Scripps Florida, Scripps Res Inst, Informat Core, Jupiter, FL USA; [Amelio, Antonio L.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Sch Dent, Chapel Hill, NC 27599 USA; [Cleveland, John L.; Rounbehler, Robert J.] H Lee Moffitt Canc Ctr & Res Inst, Dept Tumor Biol, Tampa, FL 33612 USA	Scripps Research Institute; State University System of Florida; University of Florida; University of North Carolina; University of North Carolina Chapel Hill; H Lee Moffitt Cancer Center & Research Institute	Rounbehler, RJ (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Tumor Biol, Tampa, FL 33612 USA.	Robert.Rounbehler@moffitt.org		Amelio, Antonio L./0000-0002-6295-2694	NIH [R01-CA167093, K99-CA157954]; ThinkPink Kids Foundation; State of Florida; UNC University Cancer Research Funds; NCI Comprehensive Cancer Center [P30-CA076292, P30-CA016086]; NATIONAL CANCER INSTITUTE [R00CA157954, R01CA167093, P30CA076292, K99CA157954, P30CA016086] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ThinkPink Kids Foundation; State of Florida; UNC University Cancer Research Funds; NCI Comprehensive Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding: This work is supported by NIH grants (R01-CA167093 to J.L.C. and K99-CA157954 to ALA.), by monies from the ThinkPink Kids Foundation (J.L.C.), by monies from the State of Florida to TSRI (J.L.C.), and UNC University Cancer Research Funds (A.L.A.). This work was also supported in part by NCI Comprehensive Cancer Center Grants P30-CA076292 awarded to the H. Lee Moffitt Cancer Center & Research Institute and P30-CA016086 awarded to the Lineberger Comprehensive Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Bourcier C, 2011, AM J PHYSIOL-CELL PH, V301, pC609, DOI 10.1152/ajpcell.00506.2010; Brennan SE, 2009, CANCER RES, V69, P5168, DOI 10.1158/0008-5472.CAN-08-4238; Brook M, 2006, MOL CELL BIOL, V26, P2408, DOI 10.1128/MCB.26.6.2408-2418.2006; Brooks SA, 2013, BBA-GENE REGUL MECH, V1829, P666, DOI 10.1016/j.bbagrm.2013.02.003; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; CHEN BPC, 1994, J BIOL CHEM, V269, P15819; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gruber AR, 2011, NUCLEIC ACIDS RES, V39, pD66, DOI 10.1093/nar/gkq990; Halees AS, 2008, NUCLEIC ACIDS RES, V36, pD137, DOI 10.1093/nar/gkm959; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hayes DN, 2006, J CLIN ONCOL, V24, P5079, DOI 10.1200/JCO.2005.05.1748; Hudson BP, 2004, NAT STRUCT MOL BIOL, V11, P257, DOI 10.1038/nsmb738; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lai WS, 2005, J BIOL CHEM, V280, P34365, DOI 10.1074/jbc.M506757200; Lee HH, 2010, INT J CANCER, V126, P1817, DOI 10.1002/ijc.24847; Lynn DJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.55; Mahtani KR, 2001, MOL CELL BIOL, V21, P6461, DOI 10.1128/MCB.21.9.6461-6469.2001; MOLINA CA, 1993, CELL, V75, P875, DOI 10.1016/0092-8674(93)90532-U; Mukherjee N, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r12; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Newton K., 2012, COLD SPRING HARB PER, V4; Perou CM, 2011, ONCOLOGIST, V16, P61, DOI 10.1634/theoncologist.2011-S1-61; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Prat A, 2011, MOL ONCOL, V5, P5, DOI 10.1016/j.molonc.2010.11.003; Rounbehler RJ, 2012, CELL, V150, P563, DOI 10.1016/j.cell.2012.06.033; Sanduja S, 2012, FRONT BIOSCI-LANDMRK, V17, P174, DOI 10.2741/3920; Sanduja S, 2009, AGING-US, V1, P803, DOI 10.18632/aging.100086; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Suswam E, 2008, CANCER RES, V68, P674, DOI 10.1158/0008-5472.CAN-07-2751; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Tchen CR, 2004, J BIOL CHEM, V279, P32393, DOI 10.1074/jbc.M402059200; Vakkila J, 2004, NAT REV IMMUNOL, V4, P641, DOI 10.1038/nri1415; Van Tubergen E, 2011, CANCER-AM CANCER SOC, V117, P2677, DOI 10.1002/cncr.25859; Whitmore MM, 2007, J IMMUNOL, V179, P3622, DOI 10.4049/jimmunol.179.6.3622; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; Wilkerson MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036530; Wilkerson MD, 2010, CLIN CANCER RES, V16, P4864, DOI 10.1158/1078-0432.CCR-10-0199; Young LE, 2009, GASTROENTEROLOGY, V136, P1669, DOI 10.1053/j.gastro.2009.01.010	46	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115517	10.1371/journal.pone.0115517	http://dx.doi.org/10.1371/journal.pone.0115517			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541715	Green Published, Green Submitted, gold			2022-12-27	WOS:000347239900049
J	TenNapel, MJ; Lynch, CF; Burns, TL; Wallace, R; Smith, BJ; Button, A; Domann, FE				TenNapel, Mindi J.; Lynch, Charles F.; Burns, Trudy L.; Wallace, Robert; Smith, Brian J.; Button, Anna; Domann, Frederick E.			SIRT6 Minor Allele Genotype Is Associated with > 5-Year Decrease in Lifespan in an Aged Cohort	PLOS ONE			English	Article							IOWA ESTABLISHED POPULATIONS; HUMAN LONGEVITY; OXIDATIVE STRESS; APOLIPOPROTEIN-E; ELDERLY COHORT; OLDER-ADULTS; BODY-MASS; GENE; SURVIVAL; RISK	Aging is a natural process involving complex interplay between environment, metabolism, and genes. Sirtuin genes and their downstream targets have been associated with lifespan in numerous organisms from nematodes to humans. Several target proteins of the sirtuin genes are key sensors and/or effectors of oxidative stress pathways including FOXO3, SOD3, and AKT1. To examine the relationship between single nucleotide polymorphisms (SNP) at candidate genes in these pathways and human lifespan, we performed a molecular epidemiologic study of an elderly cohort (>= 65 years old.). Using age at death as a continuous outcome variable and assuming a co-dominant genetic model within the framework of multi-variable linear regression analysis, the genotype-specific adjusted mean age at death was estimated for individual SNP genotypes while controlling for age-related risk factors including smoking, body mass index, alcohol consumption and co-morbidity. Significant associations were detected between human lifespan and SNPs in genes SIRT3, SIRT5, SIRT6, FOXO3 and SOD3. Individuals with either the CC or CT genotype at rs107251 within SIRT6 displayed >5-year mean survival advantages compared to the TT genotype (5.5 and 5.9 years, respectively; q-value =0.012). Other SNPs revealed genotype-specific mean survival advantages ranging from 0.5 to 1.6 years. Gender also modified the effect of SNPs in SIRT3, SIRT5 and AKT1 on lifespan. Our novel findings highlight the impact of sirtuins and sirtuin-related genotypes on lifespan, the importance of evaluating gender and the advantage of using age as a continuous variable in analyses to report mean age at death.	[TenNapel, Mindi J.; Lynch, Charles F.; Burns, Trudy L.; Wallace, Robert; Smith, Brian J.; Button, Anna] Univ Iowa, Coll Publ Hlth, Dept Epidemiol, Iowa City, IA 52242 USA; [Domann, Frederick E.] Univ Iowa, Dept Radiat Oncol, Free Radical & Radiat Biol Program, Iowa City, IA USA	University of Iowa; University of Iowa	TenNapel, MJ (corresponding author), Univ Iowa, Coll Publ Hlth, Dept Epidemiol, 01620 PFPW,200 Hawkins Dr, Iowa City, IA 52242 USA.	mindi-tennapel@uiowa.edu		Smith, Brian/0000-0003-1250-1710; Domann, Frederick/0000-0002-0489-2179	University of Iowa from the Environmental Health Sciences Research Center (NIH) [P30 ES005605]; Holden Comprehensive Cancer Center at the University of Iowa (NIH) [P30 CA086862]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER	University of Iowa from the Environmental Health Sciences Research Center (NIH); Holden Comprehensive Cancer Center at the University of Iowa (NIH); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding: This work was supported by pilot grants at the University of Iowa from the Environmental Health Sciences Research Center (NIH P30 ES005605) awarded to FED and the Holden Comprehensive Cancer Center at the University of Iowa (NIH P30 CA086862) awarded to BJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albani D, 2014, AGE, V36, P469, DOI 10.1007/s11357-013-9559-2; Austad Steven N, 2006, Gend Med, V3, P79, DOI 10.1016/S1550-8579(06)80198-1; Avendano M, 2006, STROKE, V37, P1368, DOI 10.1161/01.STR.0000221702.75002.66; Beydoun MA, 2013, J AM GERIATR SOC, V61, P525, DOI 10.1111/jgs.12156; Beydoun MA, 2012, AM J CLIN NUTR, V95, P163, DOI 10.3945/ajcn.111.017137; Brooks-Wilson AR, 2013, HUM GENET, V132, P1323, DOI 10.1007/s00439-013-1342-z; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Burnett C, 2011, NATURE, V477, P482, DOI 10.1038/nature10296; Cerhan JR, 1997, CANCER CAUSE CONTROL, V8, P229, DOI 10.1023/A:1018428531619; CORNONIHUNTLEY J, 1993, AGING-CLIN EXP RES, V5, P27; Crimmins EM, 2012, J GERONTOL A-BIOL, V67, P467, DOI 10.1093/gerona/gls101; Dresler CM, 2000, LUNG CANCER-J IASLC, V30, P153, DOI 10.1016/S0169-5002(00)00163-X; Dutta A, 2011, J AM GERIATR SOC, V59, P963, DOI 10.1111/j.1532-5415.2011.03451.x; Engelfriet PM, 2013, EPIDEMIOL REV, V35, P132, DOI 10.1093/epirev/mxs011; Eskes T, 2007, EUR J OBSTET GYN R B, V133, P126, DOI 10.1016/j.ejogrb.2007.01.006; Fallin MD, 2009, J GERONTOL A-BIOL, V64, P47, DOI 10.1093/gerona/gln021; Fillenbaum GG, 2000, J GERONTOL A-BIOL, V55, pM84; Glorioso C, 2011, NEUROBIOL DIS, V41, P279, DOI 10.1016/j.nbd.2010.09.016; Guarente L, 2011, NEW ENGL J MED, V364, P2235, DOI 10.1056/NEJMra1100831; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Lescai F, 2009, EUR J HUM GENET, V17, P1515, DOI 10.1038/ejhg.2009.54; Lettre G, 2007, GENET EPIDEMIOL, V31, P358, DOI 10.1002/gepi.20217; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Mahlknecht U, 2006, INT J ONCOL, V28, P447; Malovini A, 2011, REJUV RES, V14, P283, DOI 10.1089/rej.2010.1114; Merksamer PI, 2013, AGING-US, V5, P144, DOI 10.18632/aging.100544; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Murabito JM, 2012, J GERONTOL A-BIOL, V67, P470, DOI 10.1093/gerona/gls089; Napolioni V, 2010, BIOGERONTOLOGY, V11, P457, DOI 10.1007/s10522-010-9266-7; Newman AB, 2013, EPIDEMIOL REV, V35, P181, DOI 10.1093/epirev/mxs013; Orsted DD, 2007, J EXP MED, V204, P1295, DOI 10.1084/jem.20062476; Purser JL, 2005, J AM GERIATR SOC, V53, P1966, DOI 10.1111/j.1532-5415.2005.53566.x; Roerecke M, 2012, CURR ATHEROSCLER REP, V14, P556, DOI 10.1007/s11883-012-0277-5; Rose G, 2003, EXP GERONTOL, V38, P1065, DOI 10.1016/S0531-5565(03)00209-2; Seripa D, 2006, J GERONTOL A-BIOL, V61, P918, DOI 10.1093/gerona/61.9.918; Simeoni F, 2013, SCI REP-UK, V3, DOI 10.1038/srep03085; SIMONSICK EM, 1993, AM J PUBLIC HEALTH, V83, P1443, DOI 10.2105/AJPH.83.10.1443; Soerensen M, 2013, AGE, V35, P487, DOI 10.1007/s11357-011-9373-7; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Tremblay A, 2003, CHEST, V123, P1202, DOI 10.1378/chest.123.4.1202; Vina J, 2005, SCI AGING KNOWLEDGE, V2005, ppe17; Wang F, 2007, AGING CELL, V6, P505, DOI 10.1111/j.1474-9726.2007.00304.x; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; Yi NJ, 2010, GENET RES, V92, P443, DOI 10.1017/S0016672310000595; Zeng Y, 2010, J GERONTOL A-BIOL, V65, P1285, DOI 10.1093/gerona/glq156; Zhang B, 2013, AGE, V35, P2237, DOI 10.1007/s11357-013-9520-4; Zillikens MC, 2008, DIABETOLOGIA, V51, P2233, DOI 10.1007/s00125-008-1163-0	52	31	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115616	10.1371/journal.pone.0115616	http://dx.doi.org/10.1371/journal.pone.0115616			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541994	Green Submitted, Green Published, gold			2022-12-27	WOS:000347239900060
J	Filipiak, M; Weiner, J				Filipiak, Michal; Weiner, January			How to Make a Beetle Out of Wood: Multi-Elemental Stoichiometry of Wood Decay, Xylophagy and Fungivory	PLOS ONE			English	Article							NUTRITIONAL CONSTRAINTS; LITTER DECOMPOSITION; NITROGEN; FORESTS; DEBRIS; PHYTOPLANKTON; ACCUMULATION; TERRESTRIAL; ERGOSTEROL; NUTRIENTS	The majority of terrestrial biomass is wood, but the elemental composition of its potential consumers, xylophages, differs hugely from that of wood. This causes a severe nutritional imbalance. We studied the stoichiometric relationships of 11 elements (C, N, P, K, Ca, Mg, Fe, Zn, Mn, Cu, Na) in three species of pine-xylem-feeding insects, Stictoleptura rubra, Arhopalus rusticus (Coleoptera, Cerambycidae) and Chalcophora mariana (Coleoptera, Buprestidae), to elucidate their mechanisms of tissue growth and to match their life histories to their dietary constraints. These beetles do not differ from other Coleoptera in their absolute elemental compositions, which are approximately 1000 (N), 100 (P, Cu) and 50 (K, Na) times higher than in dead but undecayed pine wood. This discrepancy diminishes along the wood decay gradient, but the elemental concentrations remain higher by an order of magnitude in beetles than in highly decayed wood. Numerical simulation of the life history of S. rubra shows that feeding on nutrient-poor undecayed wood would extend its development time to implausible values, whereas feeding on highly decomposed wood (heavily infected with fungi) would barely balance its nutritional budget during the long development period of this species. The changes in stoichiometry indicate that the relative change in the nutrient levels in decaying wood cannot be attributed solely to carbon loss resulting from decomposer respiration: the action of fungi substantially enriches the decaying wood with nutritional elements imported from the outside of the system, making it a suitable food for wood-eating invertebrates.	[Filipiak, Michal; Weiner, January] Jagiellonian Univ, Inst Environm Sci, PL-30387 Krakow, Poland	Jagiellonian University	Filipiak, M (corresponding author), Jagiellonian Univ, Inst Environm Sci, Ul Gronostajowa 7, PL-30387 Krakow, Poland.	michal0filipiak@gmail.com	Filipiak, Michał/C-1907-2016	Filipiak, Michał/0000-0001-7438-4885	National Science Centre [2011/01/B/NZ8/00103]; Polish Ministry of Science and Higher Education [DS/WBiNoZ/INoS/DS 756, DS/MND/WBiNoZ/INoS/11/2013]	National Science Centre(National Science Centre, Poland); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	The study was supported by the National Science Centre (Grant No. 2011/01/B/NZ8/00103) and Polish Ministry of Science and Higher Education (Grant No. DS/WBiNoZ/INoS/DS 756 and DS/MND/WBiNoZ/INoS/11/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayres MP, 2000, ECOLOGY, V81, P2198, DOI 10.1890/0012-9658(2000)081[2198:NBOPFB]2.0.CO;2; BODDY L, 1995, CAN J BOT, V73, pS1377, DOI 10.1139/b95-400; Boddy L, 2009, MYCOSCIENCE, V50, P9, DOI 10.1007/s10267-008-0450-4; Cairney JWG, 2005, MYCOL RES, V109, P7, DOI 10.1017/S0953756204001753; Campos JA, 2011, BIOL TRACE ELEM RES, V144, P1370, DOI 10.1007/s12011-011-9134-6; Clinton PW, 2009, CAN J FOREST RES, V39, P2193, DOI 10.1139/X09-134; Cohen AC, 2005, INSECT DIETS SCI TEC; Denno RF, 2003, ECOLOGY, V84, P2522, DOI 10.1890/02-0370; Dighton J., 2007, P287; DOMINIK J., 2004, OWADY USZKADZAJACE D; Douglas A.E., 2009, FUNCT ECOL, V23, P38; Elser JJ, 2000, NATURE, V408, P578, DOI 10.1038/35046058; Esseen Per-Anders, 1997, Ecological Bulletins, V46, P16; Fagan WF, 2002, AM NAT, V160, P784, DOI 10.1086/343879; Fukasawa Y, 2014, ECOL RES, V29, P257, DOI 10.1007/s11284-013-1120-3; Garrett LG, 2008, FOREST ECOL MANAG, V255, P3839, DOI 10.1016/j.foreco.2008.03.031; Gonzalez AL, 2011, OIKOS, V120, P1247, DOI 10.1111/j.1600-0706.2010.19151.x; Haack R.A., 1987, P449; Hessen DO, 2013, LIMNOL OCEANOGR, V58, P2219, DOI 10.4319/lo.2013.58.6.2219; Joern A, 2012, ECOLOGY, V93, P1002, DOI 10.1890/11-1142.1; Karimi R, 2006, ECOL LETT, V9, P1273, DOI 10.1111/j.1461-0248.2006.00979.x; Klamer M, 2004, SOIL BIOL BIOCHEM, V36, P57, DOI 10.1016/j.soilbio.2003.08.019; Lindahl BD, 2007, NEW PHYTOL, V173, P611, DOI 10.1111/j.1469-8137.2006.01936.x; Lindahl BO, 2002, PLANT SOIL, V242, P123, DOI 10.1023/A:1019650226585; Meerts P, 2002, ANN FOR SCI, V59, P713, DOI 10.1051/forest:2002059; Mooshammer M, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00022; Niemenmaa O, 2008, INT BIODETER BIODEGR, V62, P125, DOI 10.1016/j.ibiod.2007.12.009; Palviainen M, 2010, FOREST ECOL MANAG, V260, P1478, DOI 10.1016/j.foreco.2010.07.046; Palviainen M, 2010, FOREST ECOL MANAG, V259, P390, DOI 10.1016/j.foreco.2009.10.034; Quigg A, 2011, P ROY SOC B-BIOL SCI, V278, P526, DOI 10.1098/rspb.2010.1356; ROSKOSKI JP, 1980, PLANT SOIL, V54, P33, DOI 10.1007/BF02181997; Rudawska M, 2005, FOOD CHEM, V92, P499, DOI 10.1016/j.foodchem.2004.08.017; Rumpold BA, 2013, MOL NUTR FOOD RES, V57, P802, DOI 10.1002/mnfr.201200735; Russell MB, 2014, ECOSYSTEMS, V17, P765, DOI 10.1007/s10021-014-9757-5; Schneider K, 2010, ECOL RES, V25, P565, DOI 10.1007/s11284-009-0686-2; Schneider T, 2012, ISME J, V6, P1749, DOI 10.1038/ismej.2012.11; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Sun X, 2013, J INSECT PHYSIOL, V59, P408, DOI 10.1016/j.jinsphys.2013.01.010; Tanahashi M, 2009, J INSECT PHYSIOL, V55, P983, DOI 10.1016/j.jinsphys.2009.07.002; Tobin B, 2007, FORESTRY, V80, P455, DOI 10.1093/forestry/cpm024; Twining BS, 2013, ANNU REV MAR SCI, V5, P191, DOI 10.1146/annurev-marine-121211-172322; Vetter J, 2005, MYCOL RES, V109, P746, DOI 10.1017/S0953756205002455; Walczynska A, 2012, B ENTOMOL RES, V102, P644, DOI 10.1017/S0007485312000296; Walczynska A, 2010, B ENTOMOL RES, V100, P461, DOI 10.1017/S0007485309990514; Walczynska A, 2007, EUR J ENTOMOL, V104, P181, DOI 10.14411/eje.2007.027; Watkinson S, 2006, FUNGI BIOGEOCHEMICAL, P151, DOI [10.1017/CBO9780511550522.008, DOI 10.1017/CBO9780511550522.008]	46	37	37	9	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115104	10.1371/journal.pone.0115104	http://dx.doi.org/10.1371/journal.pone.0115104			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536334	Green Published, gold, Green Submitted			2022-12-27	WOS:000348563300029
J	Jin, SJ; Sonobe, Y; Kawanokuchi, J; Horiuchi, H; Cheng, Y; Wang, Y; Mizuno, T; Takeuchi, H; Suzumura, A				Jin, Shijie; Sonobe, Yoshifumi; Kawanokuchi, Jun; Horiuchi, Hiroshi; Cheng, Yi; Wang, Yue; Mizuno, Tetsuya; Takeuchi, Hideyuki; Suzumura, Akio			Interleukin-34 Restores Blood-Brain Barrier Integrity by Upregulating Tight Junction Proteins in Endothelial Cells	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; AMYLOID-BETA NEUROTOXICITY; LANGERHANS CELLS; RAT-BRAIN; IN-VITRO; RECEPTOR; MICROGLIA; IL-34; LYMPHOCYTES; DISRUPTION	Interleukin-34 (IL-34) is a newly discovered cytokine as an additional ligand for colony stimulating factor-1 receptor (CSF1R), and its functions are expected to overlap with colony stimulating factor-1/macrophage-colony stimulating factor. We have previously shown that the IL-34 is primarily produced by neurons in the central nervous system (CNS) and induces proliferation and neuroprotective properties of microglia which express CSF1R. However, the functions of IL-34 in the CNS are still elucidative. Here we show that CNS capillary endothelial cells also express CSF1R. IL-34 protected blood-brain barrier integrity by restored expression levels of tight junction proteins, which were downregulated by pro-inflammatory cytokines. The novel function of IL-34 on the blood-brain barrier may give us a clue for new therapeutic strategies in neuroinflammatory and neurodegenerative diseases such as multiple sclerosis and Alzheimer's disease.	[Jin, Shijie; Sonobe, Yoshifumi; Kawanokuchi, Jun; Horiuchi, Hiroshi; Cheng, Yi; Wang, Yue; Mizuno, Tetsuya; Takeuchi, Hideyuki; Suzumura, Akio] Nagoya Univ, Environm Med Res Inst, Dept Neuroimmunol, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Nagoya University	Takeuchi, H (corresponding author), Nagoya Univ, Environm Med Res Inst, Dept Neuroimmunol, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	htake@riem.nagoya-u.ac.jp		Takeuchi, Hideyuki/0000-0001-5912-7581; jin, shijie/0000-0001-5689-841X; Horiuchi, Hiroshi/0000-0001-9008-2027	Ministry of Education, Culture, Sports, Science and Technology of Japan; Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO) of Japan; Ministry of Health, Labour and Welfare of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO) of Japan; Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by a Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan; a grant from the Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO) of Japan; and grants from the Ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 1996, MOL MED TODAY, V2, P106, DOI 10.1016/1357-4310(96)88720-X; Abbott NJ, 2002, J ANAT, V200, P629, DOI 10.1046/j.1469-7580.2002.00064.x; Afonso PV, 2007, J IMMUNOL, V179, P2576, DOI 10.4049/jimmunol.179.4.2576; Begley DJ, 2003, ACTA PAEDIATR, V92, P83, DOI 10.1080/08035320310020904; Blamire AM, 2000, J NEUROSCI, V20, P8153; Bostrom EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081665; Chihara T, 2010, CELL DEATH DIFFER, V17, P1917, DOI 10.1038/cdd.2010.60; Conejo-Garcia JR, 2005, BLOOD, V105, P679, DOI 10.1182/blood-2004-05-1906; FABRY Z, 1995, J IMMUNOL, V155, P325; Forster C, 2008, J PHYSIOL-LONDON, V586, P1937, DOI 10.1113/jphysiol.2007.146852; Greter M, 2012, IMMUNITY, V37, P1050, DOI 10.1016/j.immuni.2012.11.001; HAO C, 1990, J NEUROSCI RES, V27, P314, DOI 10.1002/jnr.490270310; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Kook SY, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.23993; Li ED, 2011, J NEUROIMMUNOL, V240, P58, DOI 10.1016/j.jneuroim.2011.09.012; Lin HS, 2008, SCIENCE, V320, P807, DOI 10.1126/science.1154370; Luo J, 2013, J EXP MED, V210, P157, DOI 10.1084/jem.20120412; Ma D, 2012, NEUROSCI LETT, V529, P86, DOI 10.1016/j.neulet.2012.08.071; Minagar A, 2003, ENDOTHELIUM-J ENDOTH, V10, P299, DOI 10.1080/10623320390272299; Minagar A, 2003, MULT SCLER J, V9, P540, DOI 10.1191/1352458503ms965oa; Mitrasinovic OM, 2005, J NEUROSCI, V25, P4442, DOI 10.1523/JNEUROSCI.0514-05.2005; Mizuno T, 2008, FASEB J, V22, P1797, DOI 10.1096/fj.07-099499; Mizuno T, 2011, AM J PATHOL, V179, P2016, DOI 10.1016/j.ajpath.2011.06.011; Nakamichi Y, 2012, P NATL ACAD SCI USA, V109, P10006, DOI 10.1073/pnas.1207361109; Nandi S, 2012, DEV BIOL, V367, P100, DOI 10.1016/j.ydbio.2012.03.026; Ransohoff RM, 2012, J CLIN INVEST, V122, P1164, DOI 10.1172/JCI58644; RISAU W, 1990, J CELL BIOL, V110, P1757, DOI 10.1083/jcb.110.5.1757; Sonobe Y, 2009, J BIOL CHEM, V284, P31834, DOI 10.1074/jbc.M109.025940; TATSUTA T, 1992, J BIOL CHEM, V267, P20383; Tureci O, 2011, GENE, V481, P83, DOI 10.1016/j.gene.2011.04.007; Wang Y, 2014, EUROPEAN J IMMUNOLOG; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; Zhong Y, 2012, J NEUROSCI, V32, P143, DOI 10.1523/JNEUROSCI.4266-11.2012; Zhong ZH, 2008, NAT NEUROSCI, V11, P420, DOI 10.1038/nn2073	35	28	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115981	10.1371/journal.pone.0115981	http://dx.doi.org/10.1371/journal.pone.0115981			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25535736	gold, Green Submitted, Green Published			2022-12-27	WOS:000348563300095
J	Teshome, W; Assefa, A				Teshome, Wondu; Assefa, Anteneh			Predictors of Immunological Failure of Antiretroviral Therapy among HIV Infected Patients in Ethiopia: A Matched Case-Control Study	PLOS ONE			English	Article							VIROLOGICAL RESPONSES; RECOVERY; ADHERENCE; NONADHERENCE; MORTALITY; AFRICA; ADULTS; SWITCH; HAART; CARE	Background: In resource constrained settings, immunological assessment through CD4 count is used to assess response to first line Highly Active Antiretroviral Therapy (HAART). In this study, we aim to investigate factors associated with immunological treatment failure. Methods: A matched case-control study design was used. Cases were subjects who already experienced immunological treatment failure and controls were those without immunological failure after an exactly or approximately equivalent duration of first line treatment with cases. Data were analyzed using SPSS v16.0. Conditional logistic regression was carried out. Results: A total of 134 cases and 134 controls were included in the study. At baseline, the mean age +/- 1 SD of cases was 37.5 +/- 9.7 years whereas it was 36.9 +/- 9.2 years among controls. The median baseline CD4 counts of cases and controls were 121.0 cells/ml (IQR: 47-183 cells/ml) and 122.0 cells/ml (IQR: 80.0189.8 cells/ml), respectively. The median rate of CD4 cells increase was comparable for the two groups in the first six months of commencing HAART (P50.442). However, the median rate of CD4 increase was significantly different for the two groups in the next 6 months period (M6 to M12). The rate of increment was 8.8 (IQR: 0.5, 14.6) and 1.8 (IQR: 8.8, 11.3) cells/ml/month for controls and cases, respectively (Mann-Whitney U test, P50.003). In conditional logistic regressions grouped baseline CD4 count (P50.028), old age group and higher educational status (P, 0.001) were significant predictors of immunological treatment failure. Conclusion: Subjects with immunological treatment failure have an optimal rate of immunological recovery in the first 6 months of treatment with first line HAART, but relative to the non-failing group the rate declines at a later period, notably between 6 and 12 months. Low baseline CD4 count, old age and higher educational status were associated with immunological treatment failure.	[Teshome, Wondu; Assefa, Anteneh] Hawassa Univ, Coll Med & Hlth Sci, Sch Publ & Environm Hlth, Hawassa, Ethiopia	Hawassa University	Teshome, W (corresponding author), Hawassa Univ, Coll Med & Hlth Sci, Sch Publ & Environm Hlth, Hawassa, Ethiopia.	wondu_teshome@yahoo.com	Asefa, Anteneh/AAG-6341-2020	Asefa, Anteneh/0000-0003-4470-1848; Teshome, Wondu/0000-0001-8292-7026	Hawassa University	Hawassa University	The study was funded by Hawassa University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrogoua DP, 2012, PATIENT PREFER ADHER, V6, P227, DOI 10.2147/PPA.S26507; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; Chandy S, 2011, AIDS CARE, V23, P569, DOI 10.1080/09540121.2010.525607; Charles M, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17375; Esposito A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-341; Federal Ministry of Health (FMoH) website, GUID MAN OPP INF ANT; FHAPCO website, MONTHL HIV CAR ART U; Grabar S, 2000, ANN INTERN MED, V133, P401, DOI 10.7326/0003-4819-133-6-200009190-00007; Gsponer T, 2012, AIDS, V26, P57, DOI 10.1097/QAD.0b013e32834e1b5f; Gutierrez F, 2008, CURR HIV RES, V6, P100, DOI 10.2174/157016208783885038; Hansana V, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-617; Herrmann S, 2008, INTERN MED J, V38, P8, DOI [10.1111/j.1445-5994.2008.01767.x, 10.1111/j.1445-5994.2007.01477.x]; Johnston V, 2012, JAIDS-J ACQ IMM DEF, V61, P370, DOI 10.1097/QAI.0b013e318266ee3f; Kanapathipillai R, 2011, TROP MED INT HEALTH, V16, P1495, DOI 10.1111/j.1365-3156.2011.02874.x; Kaufmann GR, 2003, ARCH INTERN MED, V163, P2187, DOI 10.1001/archinte.163.18.2187; Koethe JR, 2011, CLIN INFECT DIS, V53, P952, DOI 10.1093/cid/cir606; Landier J, 2011, AIDS CARE, V23, P75, DOI 10.1080/09540121.2010.498867; Langford Simone E, 2007, AIDS Res Ther, V4, P11, DOI 10.1186/1742-6405-4-11; Lawn SD, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-59; Mee P, 2008, AIDS, V22, P1971, DOI 10.1097/QAD.0b013e32830e4cd8; Moore DM, 2005, JAIDS-J ACQ IMM DEF, V40, P288, DOI 10.1097/01.qai.0000182847.38098.d1; Nicastri E, 2005, J MED VIROL, V76, P153, DOI 10.1002/jmv.20352; Palombi L, 2009, CLIN INFECT DIS, V48, P115, DOI 10.1086/593312; Peltzer K, 2013, J HEALTH POPUL NUTR, V31, P150; Rajasuriar R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020713; Tan RM, 2008, JAIDS-J ACQ IMM DEF, V47, P553, DOI 10.1097/QAI.0b013e31816856c5; UNAIDS, TOG WE WILL END AIDS; van Griensven J, 2011, T ROY SOC TROP MED H, V105, P694, DOI 10.1016/j.trstmh.2011.08.007; Viard JP, 2001, J INFECT DIS, V183, P1290, DOI 10.1086/319678; WHO, ANT THER HIV INF AD	30	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115125	10.1371/journal.pone.0115125	http://dx.doi.org/10.1371/journal.pone.0115125			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536416	Green Submitted, gold, Green Published			2022-12-27	WOS:000348563300030
J	Ribeiro, MRC; Alves, MTSSDE; Batista, RFL; Ribeiro, CCC; Schraiber, LB; Barbieri, MA; Bettiol, H; da Silva, AAM				Costa Ribeiro, Marizelia Rodrigues; Soares de Britto E Alves, Maria Teresa Seabra; Lucena Batista, Rosangela Fernandes; Costa Ribeiro, Cecilia Claudia; Schraiber, Lilia Blima; Barbieri, Marco Antonio; Bettiol, Heloisa; Moura da Silva, Antonio Augusto			Confirmatory Factor Analysis of the WHO Violence Against Women Instrument in Pregnant Women: Results from the BRISA Prenatal Cohort	PLOS ONE			English	Article								Background: Screening for violence during pregnancy is one of the strategies for the prevention of abuse against women. Since violence is difficult to measure, it is necessary to validate questionnaires that can provide a good measure of the phenomenon. The present study analyzed the psychometric properties of the World Health Organization Violence Against Women (WHO VAW) instrument for the measurement of violence against pregnant women. Methods: Data from the Brazilian Ribeirao Preto and Sao Luis birth cohort studies (BRISA) were used. The sample consisted of 1,446 pregnant women from Sao Luis and 1,378 from Ribeirao Preto, interviewed in 2010 and 2011. Thirteen variables were selected from a self-applied questionnaire. Confirmatory factor analysis was used to investigate whether violence is a uni-or-multidimensional construct consisting of psychological, physical and sexual dimensions. The mean-and-variance- adjusted weighted least squares estimator was used. Models were fitted separately for each city and a third model combining data from the two settings was also tested. Models suggested from modification indices were tested to determine whether changes in the WHO VAW model would produce a better fit. Results: The unidimensional model did not show good fit (Root mean square error of approximation [RMSEA] = 0.060, p<0.001 for the combined model). The multidimensional WHO VAW model showed good fit (RMSEA=0.036, p=0.999 for the combined model) and standardized factor loadings higher than 0.70, except for the sexual dimension for SL (0.65). The models suggested by the modification indices with cross loadings measuring simultaneously physical and psychological violence showed a significantly better fit compared to the original WHO model (p<0.001 for the difference between the model chi-squares). Conclusions: Violence is a multidimensional second-order construct consisting of psychological, physical and sexual dimensions. The WHO VAW model and the modified models are suitable for measuring violence against pregnant women.	[Costa Ribeiro, Marizelia Rodrigues] Univ Fed Maranhao, Dept Med 3, Sao Luis, Brazil; [Soares de Britto E Alves, Maria Teresa Seabra; Lucena Batista, Rosangela Fernandes; Moura da Silva, Antonio Augusto] Univ Fed Maranhao, Dept Publ Hlth, Sao Luis, Brazil; [Costa Ribeiro, Cecilia Claudia] Univ Fed Maranhao, Dept Odontol, Sao Luis, Brazil; [Schraiber, Lilia Blima] Univ Sao Paulo, Fac Med, Dept Prevent Med, Sao Paulo, Brazil; [Barbieri, Marco Antonio; Bettiol, Heloisa] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Pediat, BR-14049 Ribeirao Preto, Brazil	Universidade Federal do Maranhao; Universidade Federal do Maranhao; Universidade Federal do Maranhao; Universidade de Sao Paulo; Universidade de Sao Paulo	Ribeiro, MRC (corresponding author), Univ Fed Maranhao, Dept Med 3, Sao Luis, Brazil.	marizelia13@gmail.com	Silva, Antonio A M/B-5410-2009; Batista, Rosangela Fernandes Lucena/G-6808-2016; Ribeiro, Cecilia Claudia Costa/AAI-2855-2021; Bettiol, Heloisa/B-4190-2013; Ribeiro, Cecilia CC/H-2198-2016; de Britto e Alves, Maria Teresa Seabra Soares/M-4107-2016; Barbieri, Marco/J-2597-2014	Silva, Antonio A M/0000-0003-4968-5138; Batista, Rosangela Fernandes Lucena/0000-0002-1529-0165; Bettiol, Heloisa/0000-0001-8744-4373; Ribeiro, Cecilia CC/0000-0003-0041-7618; de Britto e Alves, Maria Teresa Seabra Soares/0000-0002-4806-7752; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Sao Paulo Research Foundation) [2008-53593-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazilian National Research Council) [471923/20117, 561058/2010-5]; Fundacao de Amparo a Pesquisa e ao Desenvolvimento Cientifico e Tecnologico do Maranhao (Maranhao State Research Foundation) [0035/2008, 00356/11, 01362-11]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Sao Paulo Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazilian National Research Council); Fundacao de Amparo a Pesquisa e ao Desenvolvimento Cientifico e Tecnologico do Maranhao (Maranhao State Research Foundation)	This research was supported by: 1) Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Sao Paulo Research Foundation; http:// www.fapesp.br/), grant 2008-53593-0 to MAB; 2) Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazilian National Research Council; http://www.cnpq.br/), grants 471923/20117 and 561058/2010-5 to MAB and AAMS; 3) Fundacao de Amparo a Pesquisa e ao Desenvolvimento Cientifico e Tecnologico do Maranhao (Maranhao State Research Foundation; http://www.fapema.br/site2012/), grants 0035/2008, 00356/11 and 01362-11 to AAMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhabib S, 2010, J FAM VIOLENCE, V25, P369, DOI 10.1007/s10896-009-9298-4; Brazil, 2011, POLITICA NACL ENFREN, P19; Campbell J, 2004, VIOLENCE AGAINST WOM, V10, P770, DOI 10.1177/1077801204265551; Cobertura de consultas de pre-natal: Ribeirao Preto, 2011, BAS DAD DATASUS; Ellsberg M., 2005, RES VIOLENCE WOMEN P; Garcia-Moreno C, 2005, WHO MULTICOUNTRY STU; Kline R.B., 2011, PRINCIPLES PRACTICE; Nybergh L, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002053; Programa das Nacoes Unidas para o Desenvolvimento Instituto de Pesquisa Economica Aplicada Fundacao Joao Pinheiro, 2013, PERF MUN RIB PRET SP; Schraiber LB, 2010, REV SAUDE PUBL, V44, P658, DOI 10.1590/S0034-89102010000400009; Shamu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017591; Taillieu TL, 2010, AGGRESS VIOLENT BEH, V15, P14, DOI 10.1016/j.avb.2009.07.013; United Nations, 1994, AR48104 UN; Wang J., 2020, STRUCTURAL EQUATION, DOI [DOI 10.1002/, DOI 10.1002/9781118356258]; WHO, 2005, MULT STUD WOM HLTH D; World Health Organization, 2000, EST MULT SAUD MULH V; World Health Organization, 2021, VIOL WOM PREV EST 20	17	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115382	10.1371/journal.pone.0115382	http://dx.doi.org/10.1371/journal.pone.0115382			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA3ZY	25531654	Green Published, gold, Green Submitted			2022-12-27	WOS:000348845100061
J	Patterson, VL; Zullo, AJ; Koenig, C; Stoessel, S; Jo, H; Liu, XR; Han, J; Choi, M; Dewan, AT; Thomas, JL; Kuan, CY; Hoh, J				Patterson, Victoria L.; Zullo, Alfred J.; Koenig, Claire; Stoessel, Sean; Jo, Hakryul; Liu, Xinran; Han, Jinah; Choi, Murim; Dewan, Andrew T.; Thomas, Jean-Leon; Kuan, Chia-Yi; Hoh, Josephine			Neural-Specific Deletion of Htra2 Causes Cerebellar Neurodegeneration and Defective Processing of Mitochondrial OPA1	PLOS ONE			English	Article							SERINE-PROTEASE HTRA2/OMI; CYTOCHROME-C RELEASE; M-AAA PROTEASE; AUTOPHAGY; FUSION; OMI/HTRA2; MOVEMENTS; BRAIN; MND2; DEGRADATION	HTRA2, a serine protease in the intermembrane space, has important functions in mitochondrial stress signaling while its abnormal activity may contribute to the development of Parkinson's disease. Mice with a missense or null mutation of Htra2 fail to thrive, suffer striatal neuronal loss, and a parkinsonian phenotype that leads to death at 30-40 days of age. While informative, these mouse models cannot separate neural contributions from systemic effects due to the complex phenotypes of HTRA2 deficiency. Hence, we developed mice carrying a Htra2-floxed allele to query the consequences of tissue-specific HTRA2 deficiency. We found that mice with neural-specific deletion of Htra2 exhibited atrophy of the thymus and spleen, cessation to gain weight past postnatal (P) day 18, neurological symptoms including ataxia and complete penetrance of premature death by P40. Histologically, increased apoptosis was detected in the cerebellum, and to a lesser degree in the striatum and the entorhinal cortex, from P25. Even earlier at P20, mitochondria in the cerebella already exhibited abnormal morphology, including swelling, vesiculation, and fragmentation of the cristae. Furthermore, the onset of these structural anomalies was accompanied by defective processing of OPA1, a key molecule for mitochondrial fusion and cristae remodeling, leading to depletion of the L-isoform. Together, these findings suggest that HTRA2 is essential for maintenance of the mitochondrial integrity in neurons. Without functional HTRA2, a lifespan as short as 40 days accumulates a large quantity of dysfunctional mitochondria that contributes to the demise of mutant mice.	[Patterson, Victoria L.; Zullo, Alfred J.; Koenig, Claire; Stoessel, Sean; Jo, Hakryul; Hoh, Josephine] Yale Univ, Sch Med, Dept Environm Hlth Sci, New Haven, CT 06520 USA; [Han, Jinah; Thomas, Jean-Leon] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Choi, Murim] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Dewan, Andrew T.] Yale Univ, Sch Med, Dept Chron Dis Epidemiol, New Haven, CT 06510 USA; [Liu, Xinran] Yale Univ, Sch Med, Ctr Cellular & Mol Imaging, New Haven, CT 06510 USA; [Kuan, Chia-Yi] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA; [Kuan, Chia-Yi] Childrens Healthcare Atlanta, Atlanta, GA USA	Yale University; Yale University; Yale University; Yale University; Yale University; Emory University; Children's Healthcare of Atlanta (CHOA)	Hoh, J (corresponding author), Yale Univ, Sch Med, Dept Environm Hlth Sci, New Haven, CT 06520 USA.	josephine.hoh@yale.edu	Choi, Murim/AAP-9120-2021; Han, Jinah/Q-5392-2019; Thomas, Jean-Leon/F-1151-2016	DeWan, Andrew/0000-0002-7679-8704; Koenig, Claire/0000-0003-2546-4031	Rosebay Medical Foundation; Yale Medical School Dean's Research Fund	Rosebay Medical Foundation; Yale Medical School Dean's Research Fund	This work was funded by Rosebay Medical Foundation and Yale Medical School Dean's Research Fund to JHoh. No URL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akepati VR, 2008, J NEUROCHEM, V106, P372, DOI 10.1111/j.1471-4159.2008.05401.x; Arnoult D, 2005, J BIOL CHEM, V280, P35742, DOI 10.1074/jbc.M505970200; Baker M.J., 2011, COLD SPRING HARB PER, V3; Benninger DH, 2009, J NEUROL, V256, P256, DOI 10.1007/s00415-009-0092-2; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Bogaerts V, 2008, HUM MUTAT, V29, P832, DOI 10.1002/humu.20713; Borghammer P, 2010, EUR J NEUROL, V17, P314, DOI 10.1111/j.1468-1331.2009.02807.x; Camicioli R, 2009, PARKINSONISM RELAT D, V15, P187, DOI 10.1016/j.parkreldis.2008.05.002; Catalan MJ, 1999, BRAIN, V122, P483, DOI 10.1093/brain/122.3.483; Cerasa A, 2006, BRAIN RES BULL, V71, P259, DOI 10.1016/j.brainresbull.2006.09.014; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021; Clausen T, 2011, NAT REV MOL CELL BIO, V12, P152, DOI 10.1038/nrm3065; Desideri Enrico, 2012, Int J Cell Biol, V2012, P607929, DOI 10.1155/2012/607929; Duvezin-Caubet S, 2007, MOL BIOL CELL, V18, P3582, DOI 10.1091/mbc.E07-02-0164; Ehses S, 2009, J CELL BIOL, V187, P1023, DOI 10.1083/jcb.200906084; El-Khodor BF, 2008, EXP NEUROL, V212, P29, DOI 10.1016/j.expneurol.2008.02.025; Faccio L, 2000, J BIOL CHEM, V275, P2581, DOI 10.1074/jbc.275.4.2581; Fitzgerald JC, 2012, CELL DEATH DIFFER, V19, P257, DOI 10.1038/cdd.2011.90; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Gerhardt E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028855; Golub MS, 2004, BEHAV BRAIN RES, V153, P159, DOI 10.1016/j.bbr.2003.11.010; Goo HG, 2013, BBA-MOL CELL RES, V1833, P1866, DOI 10.1016/j.bbamcr.2013.03.016; Gray CW, 2000, EUR J BIOCHEM, V267, P5699, DOI 10.1046/j.1432-1327.2000.01589.x; Griparic L, 2004, J BIOL CHEM, V279, P18792, DOI 10.1074/jbc.M400920200; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Ichimura Y, 2008, AUTOPHAGY, V4, P1063, DOI 10.4161/auto.6826; Ideguchi K, 2010, BIOCHEM BIOPH RES CO, V393, P264, DOI 10.1016/j.bbrc.2010.01.117; Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184; JONES JM, 1993, GENOMICS, V16, P669, DOI 10.1006/geno.1993.1246; Jones JM, 2003, NATURE, V425, P721, DOI 10.1038/nature02052; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kang S, 2013, CELL DEATH DIFFER, V20, P259, DOI 10.1038/cdd.2012.117; Kieper N, 2010, EXP CELL RES, V316, P1213, DOI 10.1016/j.yexcr.2010.01.005; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kruger R, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2009.11.021; Kuusisto E, 2001, NEUROREPORT, V12, P2085, DOI 10.1097/00001756-200107200-00009; Landes T, 2010, SEMIN CELL DEV BIOL, V21, P593, DOI 10.1016/j.semcdb.2009.12.012; Li B, 2010, CELL DEATH DIFFER, V17, P1773, DOI 10.1038/cdd.2010.55; Li WY, 2002, NAT STRUCT BIOL, V9, P436, DOI 10.1038/nsb795; Martins LM, 2004, MOL CELL BIOL, V24, P9848, DOI 10.1128/MCB.24.22.9848-9862.2004; Misaka T, 2002, J BIOL CHEM, V277, P15834, DOI 10.1074/jbc.M109260200; Moisoi N, 2009, CELL DEATH DIFFER, V16, P449, DOI 10.1038/cdd.2008.166; Niemann S, 2000, J NEUROSCI, V20, P4120; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pereira JB, 2009, NEUROREPORT, V20, P741, DOI 10.1097/WNR.0b013e328329370b; Plun-Favreau H, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.77; Plun-Favreau H, 2007, NAT CELL BIOL, V9, P1243, DOI 10.1038/ncb1644; Rascol O, 1997, BRAIN, V120, P103, DOI 10.1093/brain/120.1.103; Ross OA, 2008, PARKINSONISM RELAT D, V14, P539, DOI 10.1016/j.parkreldis.2008.08.003; Simon-Sanchez J, 2008, HUM MOL GENET, V17, P1988, DOI 10.1093/hmg/ddn096; Song ZY, 2007, J CELL BIOL, V178, P749, DOI 10.1083/jcb.200704110; Strauss KM, 2005, HUM MOL GENET, V14, P2099, DOI 10.1093/hmg/ddi215; Sun MG, 2007, NAT CELL BIOL, V9, P1057, DOI 10.1038/ncb1630; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; TAKADA M, 1993, NEUROSCI LETT, V150, P49, DOI 10.1016/0304-3940(93)90105-T; Tanida I, 2004, J BIOL CHEM, V279, P47704, DOI 10.1074/jbc.M407016200; Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Vande Walle L, 2008, CELL DEATH DIFFER, V15, P453, DOI 10.1038/sj.cdd.4402291; Wang CY, 2011, BRAIN RES, V1385, P293, DOI 10.1016/j.brainres.2011.02.037; Wu T, 2008, J NEUROL NEUROSUR PS, V79, P760, DOI 10.1136/jnnp.2007.126599; Wu T, 2005, BRAIN, V128, P2250, DOI 10.1093/brain/awh569; Wu T, 2013, BRAIN, V136, P696, DOI 10.1093/brain/aws360; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Yu H, 2007, NEUROIMAGE, V35, P222, DOI 10.1016/j.neuroimage.2006.11.047; Zhang KY, 2011, EUR J RADIOL, V77, P269, DOI 10.1016/j.ejrad.2009.07.032; Zullo AJ, 2012, J BIOL CHEM, V287, P12668, DOI 10.1074/jbc.M111.320135	73	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115789	10.1371/journal.pone.0115789	http://dx.doi.org/10.1371/journal.pone.0115789			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531304	Green Published, Green Submitted, gold			2022-12-27	WOS:000348845100107
J	Coffeng, LE; Stolk, WA; Hoerauf, A; Habbema, D; Bakker, R; Hopkins, AD; de Vlas, SJ				Coffeng, Luc E.; Stolk, Wilma A.; Hoerauf, Achim; Habbema, Dik; Bakker, Roel; Hopkins, Adrian D.; de Vlas, Sake J.			Elimination of African Onchocerciasis: Modeling the Impact of Increasing the Frequency of Ivermectin Mass Treatment	PLOS ONE			English	Article							CONTROL PROGRAM; ENDEMIC FOCI; MULTIPLE TREATMENTS; TREATED POPULATION; SKIN MICROFILARIAE; ADULT PARASITES; VECTOR CONTROL; 1ST EVIDENCE; WEST-AFRICA; VOLVULUS	The African Programme for Onchocerciasis Control (APOC) is currently shifting its focus from morbidity control to elimination of infection. To enhance the likelihood of elimination and speed up its achievement, programs may consider to increase the frequency of ivermectin mass treatment from annual to 6-monthly or even higher. In a computer simulation study, we examined the potential impact of increasing the mass treatment frequency for different settings. With the ONCHOSIM model, we simulated 92,610 scenarios pertaining to different assumptions about transmission conditions, history of mass treatment, the future mass treatment strategy, and ivermectin efficacy. Simulation results were used to determine the minimum remaining program duration and number of treatment rounds required to achieve 99% probability of elimination. Doubling the frequency of treatment from yearly to 6-monthly or 3-monthly was predicted to reduce remaining program duration by about 40% or 60%, respectively. These reductions come at a cost of additional treatment rounds, especially in case of 3-monthly mass treatment. Also, aforementioned reductions are highly dependent on maintained coverage, and could be completely nullified if coverage of mass treatment were to fall in the future. In low coverage settings, increasing treatment coverage is almost just as effective as increasing treatment frequency. We conclude that 6-monthly mass treatment may only be worth the effort in situations where annual treatment is expected to take a long time to achieve elimination in spite of good treatment coverage, e. g. because of unfavorable transmission conditions or because mass treatment started recently.	[Coffeng, Luc E.; Stolk, Wilma A.; Habbema, Dik; Bakker, Roel; de Vlas, Sake J.] Erasmus MC Univ Med Ctr Rotterdam, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands; [Hoerauf, Achim] Univ Hosp Bonn, Inst Med Microbiol Immunol & Parasitol, D-53105 Bonn, Germany; [Hopkins, Adrian D.] Mectizan Donat Program, Decatur, GA 30030 USA	Erasmus University Rotterdam; Erasmus MC; University of Bonn	Coffeng, LE (corresponding author), Erasmus MC Univ Med Ctr Rotterdam, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands.	l.coffeng@erasmusmc.nl	Coffeng, Luc/AAL-6631-2021	Coffeng, Luc/0000-0002-4425-2264; de Vlas, Sake J./0000-0002-1830-5668; Stolk, Wilma/0000-0001-9509-1328	Mectizan Donation Program	Mectizan Donation Program	The study was funded by the Mectizan Donation Program. ADH is the director of the Mectizan Donation Program. The funder provided support in the form of salary for author ADH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the "author contributions" section.	African Programme for Onchocerciasis Control and World Health Organization, 2010, CONC OP FRAM ONCH EL; ALLEY ES, 1994, T ROY SOC TROP MED H, V88, P581, DOI 10.1016/0035-9203(94)90172-4; Amazigo U, 2008, ANN TROP MED PARASIT, V102, P19, DOI 10.1179/136485908X337436; [Anonymous], 2013, Wkly Epidemiol Rec, V88, P533; Awadzi K, 2004, ANN TROP MED PARASIT, V98, P359, DOI 10.1179/000349804225003442; Basanez MG, 2008, LANCET INFECT DIS, V8, P310, DOI 10.1016/S1473-3099(08)70099-9; Basanez MG, 2009, ADV PARASIT, V68, P263, DOI 10.1016/S0065-308X(08)00611-8; BASANEZ MG, 1995, PARASITOLOGY, V110, P409, DOI 10.1017/S0031182000064751; Bottomley C, 2008, PARASITOLOGY, V135, P1571, DOI 10.1017/S0031182008000425; CHAVASSE DC, 1993, TROP MED PARASITOL, V44, P155; Churcher TS, 2005, PARASITOLOGY, V131, P121, DOI 10.1017/S0031182005007341; Coffeng LE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002168; Coffeng LE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002032; Coulibaly Y, 2008, TROP MED INT HEALTH, V13, P1430, DOI 10.1111/j.1365-3156.2008.02174.x; Cupp EW, 2011, ACTA TROP, V120, pS100, DOI 10.1016/j.actatropica.2010.08.009; Cupp EW, 2005, AM J TROP MED HYG, V73, P1159, DOI 10.4269/ajtmh.2005.73.1159; Cupp EW, 2004, AM J TROP MED HYG, V71, P602; Dembele M, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001574; Diawara L, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000497; Duerr HP, 2011, INT J PARASITOL, V41, P581, DOI 10.1016/j.ijpara.2010.12.009; Duerr HP, 2004, INT J PARASITOL, V34, P463, DOI 10.1016/j.ijpara.2003.11.008; DUKE BOL, 1992, AM J TROP MED HYG, V46, P189, DOI 10.4269/ajtmh.1992.46.189; DUKE BOL, 1990, AM J TROP MED HYG, V43, P657, DOI 10.4269/ajtmh.1990.43.657; Duke BOL, 2005, PARASITOLOGY, V130, P447, DOI 10.1017/S0031182004006766; DUKE BOL, 1991, AM J TROP MED HYG, V45, P132, DOI 10.4269/ajtmh.1991.45.132; DUKE BOL, 1991, B WORLD HEALTH ORGAN, V69, P163; Gardon J, 2002, LANCET, V360, P203, DOI 10.1016/S0140-6736(02)09456-4; Habbema JDF, 1996, MODELS INFECT HUMAN, P360; KLAGER S, 1993, TROP MED PARASITOL, V44, P305; Klager SL, 1996, TROP MED INT HEALTH, V1, P581; Mwinzi PNM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-182; Nana-Djeunga HC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002824; Osei-Atweneboana MY, 2012, INT J PARASITOL-DRUG, V2, P20, DOI 10.1016/j.ijpddr.2012.01.005; Osei-Atweneboana MY, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000998; Pion SDS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002084; PLAISIER AP, 1995, J INFECT DIS, V172, P204, DOI 10.1093/infdis/172.1.204; Plaisier AP, 1997, B WORLD HEALTH ORGAN, V75, P237; PLAISIER AP, 1991, ACTA TROP, V48, P271, DOI 10.1016/0001-706X(91)90015-C; PLAISIER AP, 1990, COMPUT METH PROG BIO, V31, P43, DOI 10.1016/0169-2607(90)90030-D; PLAISIER AP, 1991, B WORLD HEALTH ORGAN, V69, P169; Sauerbrey M, 2008, ANN TROP MED PARASIT, V102, P25, DOI 10.1179/136485908X337454; Soumbey-Alley E, 2004, J MED ENTOMOL, V41, P83, DOI 10.1603/0022-2585-41.1.83; Stolk WA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001984; Tekle AH, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-28; Traore MO, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001825; Turner HC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002452; Turner HC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002169; WHO, 2012, ACC WORK OV GLOB IMP, P13; Winnen M, 2002, B WORLD HEALTH ORGAN, V80, P384	49	50	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115886	10.1371/journal.pone.0115886	http://dx.doi.org/10.1371/journal.pone.0115886			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545677	Green Published, Green Submitted, gold			2022-12-27	WOS:000347120200079
J	Pearson-Dennett, V; Flavel, SC; Wilcox, RA; Thewlis, D; Vogel, AP; White, JM; Todd, G				Pearson-Dennett, Verity; Flavel, Stanley C.; Wilcox, Robert A.; Thewlis, Dominic; Vogel, Adam P.; White, Jason M.; Todd, Gabrielle			Hand Function is Altered in Individuals with a History of Illicit Stimulant Use	PLOS ONE			English	Article							GRIP FORCE CONTROL; PARKINSONS-DISEASE; CLINICAL-PHARMACOLOGY; COGNITIVE IMPAIRMENT; OBJECT MANIPULATION; ECSTASY; AGE; PERFORMANCE; DISORDERS	Use of illicit stimulant drugs such as methamphetamine, cocaine, and ecstasy are a significant worldwide problem. However, little is known about the effect of these drugs on movement. The aim of the current study was to investigate hand function in adults with a history of illicit stimulant use. We hypothesized that prior use of illicit stimulant drugs is associated with abnormal manipulation of objects. The study involved 22 subjects with a history of illicit stimulant use (aged 29 +/- 8 yrs; time since last use: 1.8 +/- 4.0 yrs) and two control groups comprising 27 non-drug users (aged 25 +/- 8 yrs) and 17 cannabis users with no history of stimulant use (aged 22 +/- 5 yrs). Each subject completed screening tests (neuropsychological assessment, medical history questionnaire, lifetime drug history questionnaire, and urine drug screen) prior to gripping and lifting a light-weight object with the dominant right hand. Horizontal grip force, vertical lift force, acceleration, and first dorsal interosseus electromyographic (EMG) activity were recorded during three trials. In trial one, peak grip force was significantly greater in the stimulant group (12.8 +/- 3.9 N) than in the control groups (non-drug: 10.3 +/- 4.6 N; cannabis: 9.4 +/- 2.9 N, P<0.022). However, peak grip force did not differ between groups in trials two and three. The results suggest that individuals with a history of stimulant use overestimate the grip force required to manipulate a novel object but, are able to adapt grip force in subsequent lifts. The results suggest that movement dysfunction may be an unrecognized consequence of illicit stimulant use.	[Pearson-Dennett, Verity; Flavel, Stanley C.; White, Jason M.; Todd, Gabrielle] Univ S Australia, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia; [Pearson-Dennett, Verity; Flavel, Stanley C.; Thewlis, Dominic; White, Jason M.; Todd, Gabrielle] Univ S Australia, Sansom Inst, Adelaide, SA 5001, Australia; [Wilcox, Robert A.] Flinders Med Ctr, Dept Neurol, Bedford Pk, SA, Australia; [Wilcox, Robert A.] Flinders Univ S Australia, Sch Med, Bedford Pk, SA, Australia; [Thewlis, Dominic] Univ S Australia, Sch Hlth Sci, Adelaide, SA 5001, Australia; [Vogel, Adam P.] Univ Melbourne, Speech Neurosci Unit, Melbourne, Vic 3010, Australia	University of South Australia; University of South Australia; Flinders Medical Centre; Flinders University South Australia; University of South Australia; University of Melbourne	Todd, G (corresponding author), Univ S Australia, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia.	gabrielle.todd@unisa.edu.au	Todd, Gabrielle/K-7122-2012; Thewlis, Dominic/X-1184-2019; White, Jason M/A-2795-2011; Thewlis, Dominic/C-5686-2009; Vogel, Adam/ABD-7685-2020	Todd, Gabrielle/0000-0002-2465-6026; Thewlis, Dominic/0000-0001-6614-8663; White, Jason M/0000-0001-6750-1078; Thewlis, Dominic/0000-0001-6614-8663; Vogel, Adam/0000-0002-3505-2631; Wilcox, Robert/0000-0001-9911-8743; Pearson-Dennett, Verity/0000-0003-0971-2007	Ramaciotti Foundation [ID2974/2010]; National Health and Medical Research Council of Australia [627003]; APV holds an Early Career Research Fellowship [ID 1012302]; Australian Government; University of South Australia	Ramaciotti Foundation; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); APV holds an Early Career Research Fellowship; Australian Government(Australian GovernmentCGIAR); University of South Australia	This work was supported by the Ramaciotti Foundation (GT holds an Establishment Grant; ID2974/2010), National Health and Medical Research Council of Australia (GT holds a Career Development Award: ID 627003; APV holds an Early Career Research Fellowship: ID 1012302), Australian Government (VPD holds an Australian Postgraduate Award), and the University of South Australia (GT holds a Research SA Fellowship and Division of Health Sciences Research Grant, SCF held an Australian Postgraduate Award, and VPD holds a Top-up Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMSON GT, 1965, ERGONOMICS, V8, P237, DOI 10.1080/00140136508930795; AIHW, 2011, AIHW DRUG STAT SER, V22, P1; [Anonymous], 2012, WORLD DRUG REP 2012; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; BENOWITZ NL, 1993, PHARMACOL TOXICOL, V72, P3, DOI 10.1111/j.1600-0773.1993.tb01331.x; Benton AL, 1983, MULTILINGUAL APHASIA; Bousman CA, 2010, J INT NEUROPSYCH SOC, V16, P1047, DOI 10.1017/S1355617710000846; Breen C, 2006, SUBST USE MISUSE, V41, P1095, DOI 10.1080/10826080500411528; Callaghan RC, 2010, MOVEMENT DISORD, V25, P2333, DOI 10.1002/mds.23263; CARDOSO F, 1993, NEUROL CLIN, V11, P625, DOI 10.1016/S0733-8619(18)30143-9; Claudino R, 2013, PERCEPT MOTOR SKILL, V116, P859, DOI 10.2466/10.06.PMS.116.3.859-871; Croft RJ, 2001, PSYCHOPHARMACOLOGY, V153, P373, DOI 10.1007/s002130000591; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Fellows SJ, 2004, MOVEMENT DISORD, V19, P560, DOI 10.1002/mds.10710; Flanagan JR, 2006, CURR OPIN NEUROBIOL, V16, P650, DOI 10.1016/j.conb.2006.10.005; Flanagan JR, 1997, J NEUROSCI, V17, P1519; Flavel SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052025; Flavel SC, 2012, J APPL PHYSIOL, V113, P1486, DOI 10.1152/japplphysiol.00718.2012; GORDON AM, 1993, J NEUROPHYSIOL, V69, P1789, DOI 10.1152/jn.1993.69.6.1789; Green AR, 2003, PHARMACOL REV, V55, P463, DOI 10.1124/pr.55.3.3; GRIGSBY J, 1995, PERCEPT MOTOR SKILL, V80, P732, DOI 10.2466/pms.1995.80.3.732; Hermsdorfer J, 2003, CLIN NEUROPHYSIOL, V114, P915, DOI 10.1016/S1388-2457(03)00042-7; Johansson RS, 1998, NOVART FDN SYMP, V218, P45; KEARCOLWELL JJ, 1978, J CLIN PSYCHOL, V34, P437, DOI 10.1002/1097-4679(197804)34:2<437::AID-JCLP2270340239>3.0.CO;2-K; King G, 2010, PSYCHOPHARMACOLOGY, V212, P243, DOI 10.1007/s00213-010-1949-x; Melega WP, 2007, NEUROREPORT, V18, P1741, DOI 10.1097/WNR.0b013e3282f0d4f4; Mrazik M, 2010, ARCH CLIN NEUROPSYCH, V25, P236, DOI 10.1093/arclin/acq006; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; STEADWARD RD, 1975, MED SCI SPORT EXER, V7, P309; Thompson G.B., 1992, PSYCHOL ASSESSMENT, V4, P363; Todd G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056438; Todd G, 2010, EUR J NEUROSCI, V32, P1686, DOI 10.1111/j.1460-9568.2010.07444.x; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Wechsler D, 1987, WMS R WECHSLER MEMOR; Wechsler D, 2008, WAIS 3 WECHSLER ADUL, VFourth; Yamamoto BK, 2010, ANN NY ACAD SCI, V1187, P101, DOI 10.1111/j.1749-6632.2009.05141.x	36	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115771	10.1371/journal.pone.0115771	http://dx.doi.org/10.1371/journal.pone.0115771			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545892	Green Published, Green Accepted, gold			2022-12-27	WOS:000347120200066
J	Fu, C; Zhang, GY; Bian, O; Lei, WM; Ma, HF				Fu, Chong; Zhang, Gao-yuan; Bian, Ou; Lei, Wei-min; Ma, Hong-feng			A Novel Medical Image Protection Scheme Using a 3-Dimensional Chaotic System	PLOS ONE			English	Article							ENCRYPTION SCHEME; ALGORITHM; STANDARD; BAKER	Recently, great concerns have been raised regarding the issue of medical image protection due to the increasing demand for telemedicine services, especially the teleradiology service. To meet this challenge, a novel chaos-based approach is suggested in this paper. To address the security and efficiency problems encountered by many existing permutation-diffusion type image ciphers, the new scheme utilizes a single 3D chaotic system, Chen's chaotic system, for both permutation and diffusion. In the permutation stage, we introduce a novel shuffling mechanism, which shuffles each pixel in the plain image by swapping it with another pixel chosen by two of the three state variables of Chen's chaotic system. The remaining variable is used for quantification of pseudorandom keystream for diffusion. Moreover, the selection of state variables is controlled by plain pixel, which enhances the security against known/chosen-plaintext attack. Thorough experimental tests are carried out and the results indicate that the proposed scheme provides an effective and efficient way for real-time secure medical image transmission over public networks.	[Fu, Chong; Zhang, Gao-yuan; Lei, Wei-min] Northeastern Univ, Sch Informat Sci & Engn, Shenyang, Peoples R China; [Bian, Ou] Shenyang Mil Command, Gen Hosp, Shenyang, Peoples R China; [Ma, Hong-feng] TeraRecon, Foster City, CA USA	Northeastern University - China	Fu, C (corresponding author), Northeastern Univ, Sch Informat Sci & Engn, Shenyang, Peoples R China.	fuchong@ise.neu.edu.cn			National Natural Science Foundation of China [61271350]; Fundamental Research Funds for the Central Universities [N120504005]; TeraRecon Inc.	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); TeraRecon Inc.	This work is supported by the National Natural Science Foundation of China (No. 61271350), and the Fundamental Research Funds for the Central Universities (No. N120504005). TeraRecon Inc., provided support in the form of a salary for author Hong-feng Ma, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin M, 2010, COMMUN NONLINEAR SCI, V15, P3484, DOI 10.1016/j.cnsns.2009.12.025; Behnia S, 2008, CHAOS SOLITON FRACT, V35, P408, DOI 10.1016/j.chaos.2006.05.011; Behnia S, 2007, PHYS LETT A, V366, P391, DOI 10.1016/j.physleta.2007.01.081; Cao F, 2003, COMPUT MED IMAG GRAP, V27, P185, DOI 10.1016/S0895-6111(02)00073-3; Chen GR, 2004, CHAOS SOLITON FRACT, V21, P749, DOI 10.1016/j.chaos.2003.12.022; Chen GR, 1999, INT J BIFURCAT CHAOS, V9, P1465, DOI 10.1142/S0218127499001024; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Fridrich J, 1998, INT J BIFURCAT CHAOS, V8, P1259, DOI 10.1142/S021812749800098X; Fu C, 2013, COMPUT BIOL MED, V43, P1000, DOI 10.1016/j.compbiomed.2013.05.005; Fu C, 2012, OPT EXPRESS, V20, P2363, DOI 10.1364/OE.20.002363; Fu C, 2011, OPT COMMUN, V284, P5415, DOI 10.1016/j.optcom.2011.08.013; Gao TG, 2008, CHAOS SOLITON FRACT, V38, P213, DOI 10.1016/j.chaos.2006.11.009; Gao TG, 2008, PHYS LETT A, V372, P394, DOI 10.1016/j.physleta.2007.07.040; Herman GT, 2009, ADV PATTERN RECOGNIT, P1, DOI 10.1007/978-1-84628-723-7; Hu JK, 2009, J NETW COMPUT APPL, V32, P788, DOI 10.1016/j.jnca.2009.02.009; IEEE, 1985, IEEE STAND BIN FLOAT; Li CQ, 2013, NONLINEAR DYNAM, V73, P2083, DOI 10.1007/s11071-013-0924-6; Li MY, 2005, COMPUT MED IMAG GRAP, V29, P367, DOI 10.1016/j.compmedimag.2005.02.003; Lian SG, 2005, CHAOS SOLITON FRACT, V26, P117, DOI 10.1016/j.chaos.2004.11.096; Lou DC, 2009, COMPUT STAND INTER, V31, P329, DOI 10.1016/j.csi.2008.05.009; Mao YB, 2004, INT J BIFURCAT CHAOS, V14, P3613, DOI 10.1142/S021812740401151X; Mazloom S, 2009, CHAOS SOLITON FRACT, V42, P1745, DOI 10.1016/j.chaos.2009.03.084; National Institute of Standards and Technology (NIST), 2010, NIST SPECIAL PUBLICA; Ozkaynak F, 2012, OPT COMMUN, V285, P4946, DOI 10.1016/j.optcom.2012.07.106; Pareek NK, 2006, IMAGE VISION COMPUT, V24, P926, DOI 10.1016/j.imavis.2006.02.021; Patidar V, 2011, OPT COMMUN, V284, P4331, DOI 10.1016/j.optcom.2011.05.028; Patidar V, 2009, COMMUN NONLINEAR SCI, V14, P3056, DOI 10.1016/j.cnsns.2008.11.005; Rhouma R, 2009, CHAOS SOLITON FRACT, V40, P309, DOI 10.1016/j.chaos.2007.07.083; Rhouma R, 2010, COMMUN NONLINEAR SCI, V15, P1887, DOI 10.1016/j.cnsns.2009.07.007; Scharinger J, 1998, J ELECTRON IMAGING, V7, P318, DOI 10.1117/1.482647; Seyedzadeh SM, 2012, SIGNAL PROCESS, V92, P1202, DOI 10.1016/j.sigpro.2011.11.004; Sun FY, 2008, CHAOS SOLITON FRACT, V38, P631, DOI 10.1016/j.chaos.2008.01.028; Tong XJ, 2009, SIGNAL PROCESS, V89, P480, DOI 10.1016/j.sigpro.2008.09.011; Ueta T, 2000, INT J BIFURCAT CHAOS, V10, P1917, DOI 10.1142/S0218127400001183; United States Department of Health and Human Services, 1996, HIPPA MED PRIV NAT S; Wang Y, 2011, APPL SOFT COMPUT, V11, P514, DOI 10.1016/j.asoc.2009.12.011; Wang Y, 2009, CHAOS SOLITON FRACT, V41, P1773, DOI 10.1016/j.chaos.2008.07.031; Wong KW, 2008, PHYS LETT A, V372, P2645, DOI 10.1016/j.physleta.2007.12.026; Wong KW, 2009, CHAOS SOLITON FRACT, V41, P2652, DOI 10.1016/j.chaos.2008.09.047; Xiang T, 2007, CHAOS, V17, DOI 10.1063/1.2728112; Zhang W, 2012, OPT COMMUN, V285, P2343, DOI 10.1016/j.optcom.2012.01.029; Zhu ZL, 2011, INFORM SCIENCES, V181, P1171, DOI 10.1016/j.ins.2010.11.009	42	24	24	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115773	10.1371/journal.pone.0115773	http://dx.doi.org/10.1371/journal.pone.0115773			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541941	Green Submitted, Green Published, gold			2022-12-27	WOS:000347239900083
J	Klein, M; Van de Sompel, H; Sanderson, R; Shankar, H; Balakireva, L; Zhou, K; Tobin, R				Klein, Martin; Van de Sompel, Herbert; Sanderson, Robert; Shankar, Harihar; Balakireva, Lyudmila; Zhou, Ke; Tobin, Richard			Scholarly Context Not Found: One in Five Articles Suffers from Reference Rot	PLOS ONE			English	Article							INTERNET REFERENCES; WEB; PERSISTENCE; DECAY; JOURNALS; GONE; TIME	The emergence of the web has fundamentally affected most aspects of information communication, including scholarly communication. The immediacy that characterizes publishing information to the web, as well as accessing it, allows for a dramatic increase in the speed of dissemination of scholarly knowledge. But, the transition from a paper-based to a web-based scholarly communication system also poses challenges. In this paper, we focus on reference rot, the combination of link rot and content drift to which references to web resources included in Science, Technology, and Medicine (STM) articles are subject. We investigate the extent to which reference rot impacts the ability to revisit the web context that surrounds STM articles some time after their publication. We do so on the basis of a vast collection of articles from three corpora that span publication years 1997 to 2012. For over one million references to web resources extracted from over 3.5 million articles, we determine whether the HTTP URI is still responsive on the live web and whether web archives contain an archived snapshot representative of the state the referenced resource had at the time it was referenced. We observe that the fraction of articles containing references to web resources is growing steadily over time. We find one out of five STM articles suffering from reference rot, meaning it is impossible to revisit the web context that surrounds them some time after their publication. When only considering STM articles that contain references to web resources, this fraction increases to seven out of ten. We suggest that, in order to safeguard the long-term integrity of the web-based scholarly record, robust solutions to combat the reference rot problem are required. In conclusion, we provide a brief insight into the directions that are explored with this regard in the context of the Hiberlink project.	[Klein, Martin; Van de Sompel, Herbert; Sanderson, Robert; Shankar, Harihar; Balakireva, Lyudmila] Los Alamos Natl Lab, Digital Lib Res & Prototyping Team, Res Lib, Los Alamos, NM 87545 USA; [Zhou, Ke; Tobin, Richard] Univ Edinburgh, Language Technol Grp, Edinburgh, Midlothian, Scotland	United States Department of Energy (DOE); Los Alamos National Laboratory; University of Edinburgh	Klein, M (corresponding author), Los Alamos Natl Lab, Digital Lib Res & Prototyping Team, Res Lib, Los Alamos, NM 87545 USA.	martinklein0815@gmail.com	Balakireva, Lyudmila/AAX-9674-2020	Balakireva, Lyudmila/0000-0002-3919-3634; Klein, Martin/0000-0003-0130-2097; Van de Sompel, Herbert/0000-0002-0715-6126; Shankar, Harihar/0000-0003-4949-0728	Andrew W. Mellon Foundation	Andrew W. Mellon Foundation	Funding: The Hiberlink project is funded by the Andrew W. Mellon Foundation under the name "Time Travel for the Scholarly Web." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adar E., 2009, WSDM; Adar E, 2008, UIST 2008: PROCEEDINGS OF THE 21ST ANNUAL ACM SYMPOSIUM ON USER INTERFACE SOFTWARE AND TECHNOLOGY, P239, DOI 10.1145/1449715.1449756; Alsum A, 2014, INT J DIGIT LIBRARIE, V14, P149, DOI 10.1007/s00799-014-0118-y; [Anonymous], 2014, MEMENTO TIME TRAVEL; [Anonymous], 2014, NIHMS STAT; [Anonymous], 2014, LINK ROT; [Anonymous], 2009, NIH OPEN ACCESS MAND; [Anonymous], 2014, BROKEN WORDPRESS LIN; [Anonymous], 2014, REVERSE DOMAIN LOOKU; [Anonymous], 2013, NY TIMES; [Anonymous], 2014, CROSSREF TEXT DATA M; [Anonymous], 2014, DOI DISPLAY GUIDELIN; Aronsky D, 2007, J AM MED INFORM ASSN, V14, P232, DOI 10.1197/jamia.M2243; Bechhofer S., 2010, FUTURE WEB COLLABORA; Berners-Lee T., 1998, COOL URIS DONT CHANG; Brewington BE, 2000, COMPUTER, V33, P52, DOI 10.1109/2.841784; Buckheit JB., 1995, WAVELETS STAT, P55, DOI [DOI 10.1007/978-1-4612-2544-7_5, 10.1007/978-1-4612-2544-7_5]; Cheshire S., 2013, 6761 RFC; Cho J., 2000, PROCEEDING VLDB 2000, P200; Dellavalle RP, 2003, SCIENCE, V302, P787, DOI 10.1126/science.1088234; Dimitrova DV, 2007, NEW MEDIA SOC, V9, P811, DOI 10.1177/1461444807081226; Dimitrova DV, 2007, AM COMMUNICATION J, V9; Douglis F, 1997, USENIX S INT TECHN S, V119; Duda JJ, 2008, FRONT ECOL ENVIRON, V6, P145, DOI 10.1890/070022; Fetterly D., 2003, PROCEEDING WWW 2003, P669, DOI DOI 10.1145/775152.775246; Hennessey J, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S14-S5; Klein M, 2008, LECT NOTES COMPUT SC, V5173, P371; Klein M, 2014, INT J DIGIT LIBRARIE, V14, P17, DOI 10.1007/s00799-014-0108-0; Koehler W, 2002, J AM SOC INF SCI TEC, V53, P162, DOI 10.1002/asi.10018; Lawrence S, 2001, COMPUTER, V34, P26, DOI 10.1109/2.901164; National Science Board, 2014, SCI ENG IND 2014; Ntoulas A., 2004, P WWW 2004, P1, DOI DOI 10.1145/988672.988674; Sadatmoosavi A, 2012, ASLIB PROC, V64, P178, DOI 10.1108/00012531211215196; SalahEldeen Hany M., 2012, Theory and Practice of Digital Libraries. Second International Conference, TPDL 2012. Proceedings: LNCS 7489, P125, DOI 10.1007/978-3-642-33290-6_14; Sanderson R., 2011, ARXIV11053459; Spinellis D, 2003, COMMUN ACM, V46, P71, DOI 10.1145/602421.602422; The Chesapeake Digital Preservation Group, 2013, LINK ROT LEG RES WEB; Tyler DC, 2003, PORTAL-LIBR ACAD, V3, P615, DOI 10.1353/pla.2003.0098; Ulrich's knowledgebase, 2014, ULRICHS KNOWLEDGEBAS; Van de Sompel H, 2014, THOUGHTS REFERENCING; Van de Sompel H., 2013, 7089 RFC; Van de Sompel H, 2014, LECT NOTES ARTIF INT, V8543, P12, DOI 10.1007/978-3-319-08434-3_2; Wagner C, 2009, J MED LIBR ASSOC, V97, P122, DOI 10.3163/1536-5050.97.2.009; Ware M, 2012, STM REPORT OVERVIEW; Wren JD, 2004, BIOINFORMATICS, V20, P668, DOI 10.1093/bioinformatics/btg465; Wren JD, 2008, BIOINFORMATICS, V24, P1381, DOI 10.1093/bioinformatics/btn127; Zhou K, 2014, P DL 14 IN PRESS; Zittrain J, 2014, HARWARD LAW REV FORU, V127	48	69	69	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115253	10.1371/journal.pone.0115253	http://dx.doi.org/10.1371/journal.pone.0115253			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541969	Green Submitted, Green Published, gold			2022-12-27	WOS:000347239900029
J	La Rocca, R; Tallerico, R; Hassan, AT; Das, G; Tadepally, L; Matteucci, M; Liberale, C; Mesuraca, M; Scumaci, D; Gentile, F; Cojoc, G; Perozziello, G; Ammendolia, A; Gallo, A; Karre, K; Cuda, G; Candeloro, P; Di Fabrizio, E; Carbone, E				La Rocca, Rosanna; Tallerico, Rossana; Hassan, Almosawy Talib; Das, Gobind; Tadepally, Lakshmikanth; Matteucci, Marco; Liberale, Carlo; Mesuraca, Maria; Scumaci, Domenica; Gentile, Francesco; Cojoc, Gheorghe; Perozziello, Gerardo; Ammendolia, Antonio; Gallo, Adriana; Karre, Klas; Cuda, Giovanni; Candeloro, Patrizio; Di Fabrizio, Enzo; Carbone, Ennio			Mechanical Stress Downregulates MHC Class I Expression on Human Cancer Cell Membrane	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; ENERGY SHOCK-WAVES; T-CELLS; OPTICAL DEFORMABILITY; RAMAN-SPECTROSCOPY; PHYSICAL-ACTIVITY; NK CELLS; NKG2D; RECOGNITION; IMMUNITY	In our body, cells are continuously exposed to physical forces that can regulate different cell functions such as cell proliferation, differentiation and death. In this work, we employed two different strategies to mechanically stress cancer cells. The cancer and healthy cell populations were treated either with mechanical stress delivered by a micropump (fabricated by deep X-ray nanolithography) or by ultrasound wave stimuli. A specific down-regulation of Major Histocompatibility Complex (MHC) class I molecules expression on cancer cell membrane compared to different kinds of healthy cells (fibroblasts, macrophages, dendritic and lymphocyte cells) was observed, stimulating the cells with forces in the range of nano-newton, and pressures between 1 and 10 bar (1 bar=100.000 Pascal), depending on the devices used. Moreover, Raman spectroscopy analysis, after mechanical treatment, in the range between 700-1800 cm(-1), indicated a relative concentration variation of MHC class I. PCA analysis was also performed to distinguish control and stressed cells within different cell lines. These mechanical induced phenotypic changes increase the tumor immunogenicity, as revealed by the related increased susceptibility to Natural Killer (NK) cells cytotoxic recognition.	[La Rocca, Rosanna; Tallerico, Rossana; Hassan, Almosawy Talib; Das, Gobind; Liberale, Carlo; Mesuraca, Maria; Scumaci, Domenica; Gentile, Francesco; Cojoc, Gheorghe; Perozziello, Gerardo; Cuda, Giovanni; Candeloro, Patrizio; Di Fabrizio, Enzo; Carbone, Ennio] Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Catanzaro, Italy; [La Rocca, Rosanna] IIT, Genoa, Italy; [Hassan, Almosawy Talib] Univ Thi Qar, Coll Med, Dept Microbiol, Nasseriah, Iraq; [Das, Gobind; Liberale, Carlo; Di Fabrizio, Enzo] King Abdullah Univ Sci & Technol, Thuwal, Saudi Arabia; [Tadepally, Lakshmikanth] Karolinska Inst, Dept Med, Sci Life Lab, Stockholm, Sweden; [Matteucci, Marco] Tech Univ Denmark, Nanotech Dept Micro & Nanotechnol, Lyngby, Denmark; [Ammendolia, Antonio] Magna Graecia Univ Catanzaro, Dept Surg & Med Sci, Catanzaro, Italy; [Gallo, Adriana] CNR, Endocrinol & Expt Oncol Inst, I-80125 Naples, Italy; [Karre, Klas; Carbone, Ennio] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden	Magna Graecia University of Catanzaro; Istituto Italiano di Tecnologia - IIT; University of Thi-Qar; King Abdullah University of Science & Technology; Karolinska Institutet; Technical University of Denmark; Magna Graecia University of Catanzaro; Consiglio Nazionale delle Ricerche (CNR); Karolinska Institutet	Di Fabrizio, E (corresponding author), Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Catanzaro, Italy.	enzo.difabrizio@kaust.edu.sa; ennio.carbone@ki.se	Cuda, Giovanni/F-5359-2012; Ammendolia, Antonio/K-2155-2016; Candeloro, Patrizio/K-8097-2016; Tadepally, Lakshmikanth/P-5154-2019; Das, Gobind/N-7405-2013; Scumaci, Domenica/AAH-1493-2019; Cuda, Giovanni/AAC-2821-2019; GENTILE, Francesco/K-8565-2016; Liberale, Carlo/F-8370-2011	Cuda, Giovanni/0000-0001-6313-1866; Ammendolia, Antonio/0000-0002-2828-2455; Candeloro, Patrizio/0000-0001-6156-887X; Tadepally, Lakshmikanth/0000-0001-7256-5770; Das, Gobind/0000-0003-0942-681X; Cuda, Giovanni/0000-0001-6313-1866; GENTILE, Francesco/0000-0002-1724-6301; Liberale, Carlo/0000-0002-5653-199X; carbone, ennio/0000-0002-2275-8803; MESURACA, Maria/0000-0002-5455-168X; Scumaci, Domenica/0000-0002-8117-834X	UICC International Cancer Technology Transfer Fellowship [AIRC-IG 10189, AIRC 15521]; Ministry of Education and Research [PON01_02834 Prometeo, PONa3_00435 Biomedpark@UMG]; triennial fellowships "Luciana Selce'' FIRC; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	UICC International Cancer Technology Transfer Fellowship; Ministry of Education and Research; triennial fellowships "Luciana Selce'' FIRC(Fondazione AIRC per la ricerca sul cancro); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	Ennio Carbone's work has been supported by a UICC International Cancer Technology Transfer Fellowship, grant AIRC-IG 10189, and grant AIRC 15521. Rossana Tallerico is a Post Doc awarded by triennial fellowships "Luciana Selce'' FIRC. Giovanni Cuda has been supported by PON01_02834 Prometeo (Ministry of Education and Research) and PONa3_00435 Biomedpark@UMG (Ministry of Education and Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; ASHKIN A, 1970, PHYS REV LETT, V24, P156, DOI 10.1103/PhysRevLett.24.156; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; BISCHOFF F, 1964, PROG EXP TUMOR RES, V5, P85; Bonnier F, 2010, ANALYST, V135, P3169, DOI 10.1039/c0an00539h; Bussani R, 2007, J CLIN PATHOL, V60, P27, DOI 10.1136/jcp.2005.035105; Candeloro P, 2013, ANALYST, V138, P7331, DOI 10.1039/c3an01665j; Carbone E, 1999, EUR J IMMUNOL, V29, P4022, DOI 10.1002/(SICI)1521-4141(199912)29:12<4022::AID-IMMU4022>3.3.CO;2-F; Carbone E, 2005, BLOOD, V105, P251, DOI 10.1182/blood-2004-04-1422; Chan JW, 2006, BIOPHYS J, V90, P648, DOI 10.1529/biophysj.105.066761; CLAYMAN RV, 1991, AM J KIDNEY DIS, V17, P436, DOI 10.1016/S0272-6386(12)80638-X; CONSTABLE A, 1993, OPT LETT, V18, P1867, DOI 10.1364/OL.18.001867; Das G, 2011, J MOL STRUCT, V993, P500, DOI 10.1016/j.molstruc.2010.12.044; Das G, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3368687; Das G, 2009, BIOSENS BIOELECTRON, V24, P1693, DOI 10.1016/j.bios.2008.08.050; De Gelder J, 2007, ANAL CHIM ACTA, V585, P234, DOI 10.1016/j.aca.2006.12.050; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Farag SS, 2006, BLOOD REV, V20, P123, DOI 10.1016/j.blre.2005.10.001; Ferlay J, 2007, ANN ONCOL, V18, P581, DOI 10.1093/annonc/mdl498; Fregni G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076928; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Guck J, 2000, PHYS REV LETT, V84, P5451, DOI 10.1103/PhysRevLett.84.5451; Guck J, 2001, BIOPHYS J, V81, P767, DOI 10.1016/S0006-3495(01)75740-2; Guck J, 2005, BIOPHYS J, V88, P3689, DOI 10.1529/biophysj.104.045476; Jewett A, 2013, J CANCER, V4, P12, DOI 10.7150/jca.5519; Khaled W, 2004, ST HEAL T, V98, P147; KLEIN D, 1995, BIOCHEM MOL BIOL INT, V36, P59; KOHRI K, 1990, UROL RES, V18, P101, DOI 10.1007/BF00302468; Lakshmikanth T, 2009, J CLIN INVEST, V119, P1251, DOI 10.1172/JCI36022; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Majzner K, 2013, ANALYST, V138, P603, DOI 10.1039/c2an36222h; Matteucci M, 2007, MICROELECTRON ENG, V84, P1729, DOI 10.1016/j.mee.2007.01.242; Matthaus C, 2007, BIOPHYS J, V93, P668, DOI 10.1529/biophysj.106.102061; MCGINNES K, 1986, J IMMUNOL METHODS, V86, P7, DOI 10.1016/0022-1759(86)90258-9; McTiernan A, 2008, NAT REV CANCER, V8, P205, DOI 10.1038/nrc2325; Nausch N, 2008, ONCOGENE, V27, P5944, DOI 10.1038/onc.2008.272; Paszek MJ, 2004, J MAMMARY GLAND BIOL, V9, P325, DOI 10.1007/s10911-004-1404-x; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Perozziello G, 2013, ELECTROPHORESIS, V34, P1845, DOI 10.1002/elps.201300106; Perozziello G, 2012, SMALL, V8, P2886, DOI 10.1002/smll.201200160; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Podo F, 1999, NMR BIOMED, V12, P413, DOI 10.1002/(SICI)1099-1492(199911)12:7<413::AID-NBM587>3.0.CO;2-U; Rathje LSZ, 2014, P NATL ACAD SCI USA, V111, P1515, DOI 10.1073/pnas.1300238111; Reynen K, 2004, ANN ONCOL, V15, P375, DOI 10.1093/annonc/mdh086; Ruggeri L, 2002, SCIENCE, V295, P2097, DOI 10.1126/science.1068440; Sun JC, 2011, NAT REV IMMUNOL, V11, P645, DOI 10.1038/nri3044; Szachowicz-Petelska B, 2013, J MEMBRANE BIOL, V246, P421, DOI 10.1007/s00232-013-9554-7; THOMAS GJ, 1983, J MOL BIOL, V165, P321, DOI 10.1016/S0022-2836(83)80260-5; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; Winzer BM, 2011, CANCER CAUSE CONTROL, V22, P811, DOI 10.1007/s10552-011-9761-4; Yang GG, 2004, J BIOMECH, V37, P1543, DOI 10.1016/j.jbiomech.2004.01.005	52	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e0111758	10.1371/journal.pone.0111758	http://dx.doi.org/10.1371/journal.pone.0111758			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541692	Green Published, gold			2022-12-27	WOS:000347239900004
J	Navarro, JY; Lahti, DC				Navarro, Johanna Y.; Lahti, David C.			Light Dulls and Darkens Bird Eggs	PLOS ONE			English	Article							FEMALE CONDITION; COLOR; POULTRY; INHERITANCE; MUSEUM; POPULATION; EVOLUTION; SPECIMENS	Although egg color is generally consistent within individual birds and robust to environmental variation, recent evidence suggests a degree of susceptibility to environmental perturbation or modulation of egg color. Most of this variation manifests via the physiology of the laying female, but some direct impacts of the environment on laid eggs have also been discovered. Here we test whether light changes bird egg color and we quantify its effect, by subjecting variable blue-green eggs of Ruppell's weaver (Ploceus galbula) to a broad-spectrum light source under laboratory conditions, and measuring egg reflectance every few hours. Eggshells gradually decreased in reflectance across the entire measured wavelength spectrum of 250-800 nm. Reflectance peaks were disproportionately affected, such that the height decreased of both the blue-green peak and the smaller UV peak typical of blue-green eggs. The reflectance of lighter eggs was affected slightly more than that of darker eggs. These changes are similar to previous results for changes over long periods of time in darkness, suggesting that light might hasten the same process of pigment degradation that proceeds even without light. Comparison between the experimental light source and both sunlight and typical artificial lighting situations raises the possibility that significant color change might occur during incubation in some birds, but indicates that eggshell illumination in museums for short periods of study is unlikely to affect their color to a detectable extent. Additional research should be performed on eggs of other species and in other light environments, with an eye to an eventual generalized model of the effect of light on eggshell color.	[Navarro, Johanna Y.; Lahti, David C.] CUNY, Queens Coll, Dept Biol, Flushing, NY 11367 USA	City University of New York (CUNY) System; Queens College NY (CUNY)	Lahti, DC (corresponding author), CUNY, Queens Coll, Dept Biol, Flushing, NY 11367 USA.	david.lahti@qc.cuny.edu						Arendt WJ, 2004, CARIBB J SCI, V40, P204; Aviles JM, 2007, BEHAV ECOL SOCIOBIOL, V61, P475, DOI 10.1007/s00265-006-0275-0; Brown BE, 1997, CORAL REEFS, V16, pS129, DOI 10.1007/s003380050249; Butcher GD, 1995, FACTORS CAUSING POOR; Butler MW, 2013, FUNCT ECOL, V27, P1176, DOI 10.1111/1365-2435.12123; Cassey P, 2012, METHODS ECOL EVOL, V3, P450, DOI 10.1111/j.2041-210X.2011.00152.x; Cassey P, 2011, AVIAN BIOL RES, V4, P185, DOI 10.3184/175815511X13207699868421; Cassey P, 2010, BEHAV ECOL SOCIOBIOL, V64, P1711, DOI 10.1007/s00265-010-1027-8; Cato PS, 1986, GUIDELINES MANAGING, V7; Collias E.C., 1984, P461; COLLIAS EC, 1993, AUK, V110, P683, DOI 10.2307/4088624; Craig A.J.F.K., 2010, P74; Dearborn DC, 2012, FUNCT ECOL, V26, P912, DOI 10.1111/j.1365-2435.2012.02001.x; Doucet SM, 2009, J AVIAN BIOL, V40, P146, DOI 10.1111/j.1600-048X.2009.03763.x; Duval C, 2013, J EXP BIOL, V216, P700, DOI 10.1242/jeb.077370; Francesch A, 1997, POULTRY SCI, V76, P1627, DOI 10.1093/ps/76.12.1627; Gomez D., 2006, AVICOL PROGRAM ANAL; Gosler AG, 2005, ECOL LETT, V8, P1105, DOI 10.1111/j.1461-0248.2005.00816.x; Gosler AG, 2000, P ROY SOC B-BIOL SCI, V267, P2469, DOI 10.1098/rspb.2000.1307; Hanley D, 2013, AVIAN BIOL RES, V6, P147, DOI 10.3184/175815513X13617279883973; Hanley D, 2012, J APPL ECOL, V49, P1055, DOI 10.1111/j.1365-2664.2012.02184.x; Heirwegh KPM, 1982, BILIRUBIN; Hill G. E., 2006, BIRD COLORATION, V1; Honza M, 2012, FOLIA ZOOL, V61, P219, DOI 10.25225/fozo.v61.i3.a5.2012; Hutt F.B., 1949, GENETICS OF THE FOWL; Jagannath A, 2008, J APPL ECOL, V45, P133, DOI 10.1111/j.1365-2664.2007.01386.x; JUDD DB, 1964, J OPT SOC AM, V54, P1031, DOI 10.1364/JOSA.54.001031; Lahti DC, 2013, OSTRICH, V84, P235, DOI 10.2989/00306525.2013.867548; Lahti DC, 2008, AUK, V125, P796, DOI 10.1525/auk.2008.07033; Lahti DC, 2005, P NATL ACAD SCI USA, V102, P18057, DOI 10.1073/pnas.0508930102; McCormack JE, 2010, AUK, V127, P35, DOI 10.1525/auk.2009.09043; MOAN J, 1991, PHOTOCHEM PHOTOBIOL, V53, P549, DOI 10.1111/j.1751-1097.1991.tb03669.x; Morales J, 2011, BEHAV ECOL SOCIOBIOL, V65, P197, DOI 10.1007/s00265-010-1025-x; Moreno J, 2006, BEHAV ECOL, V17, P651, DOI 10.1093/beheco/ark014; Moreno J, 2011, ORNIS FENNICA, V88, P51; Paterson D, 1897, NATURE, V56, P11; Pohland G, 2006, J ORNITHOL, V147, P464, DOI 10.1007/s10336-005-0038-0; Punnett RC, 1933, J GENET, V27, P465, DOI 10.1007/BF02981757; Punnett RC, 1920, J GENET, V10, P277, DOI 10.1007/BF02984299; Romanoff A. L., 1949, AVIAN EGG; Siefferman L, 2006, BEHAV ECOL SOCIOBIOL, V59, P651, DOI 10.1007/s00265-005-0092-x; Walters M., 1994, BIRDS EGGS; Wang ZP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003183; Wheelwright NT, 2012, CONDOR, V114, P412, DOI 10.1525/cond.2012.110149; Yoshizumi K, 2003, DYES PIGMENTS, V58, P197, DOI 10.1016/S0143-7208(03)00065-2	45	13	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e116112	10.1371/journal.pone.0116112	http://dx.doi.org/10.1371/journal.pone.0116112			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541724	Green Published, gold			2022-12-27	WOS:000347239900145
J	Rasmussen, NR; Debebe, Z; Wright, TM; Brooks, SA; Sendor, AB; Brannon, AR; Hakimi, AA; Hsieh, JJ; Choueiri, TK; Tamboli, P; Maranchie, JK; Hinds, P; Wallen, EM; Simpson, C; Norris, JL; Janzen, WP; Rathmell, WK				Rasmussen, Neal R.; Debebe, Zufan; Wright, Tricia M.; Brooks, Samira A.; Sendor, Adam B.; Brannon, A. Rose; Hakimi, A. Ari; Hsieh, James J.; Choueiri, Toni K.; Tamboli, Pheroze; Maranchie, Jodi K.; Hinds, Peter; Wallen, Eric M.; Simpson, Catherine; Norris, Jacqueline L.; Janzen, William P.; Rathmell, W. Kimryn			Expression of Ror2 Mediates Invasive Phenotypes in Renal Cell Carcinoma	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; RECEPTOR TYROSINE KINASE; BRACHYDACTYLY TYPE-B; TUMOR; METALLOPROTEINASE; OSTEOSARCOMA; PSEUDOKINASE; MELANOMA; DISEASE; CANCER	Ror2 is a Wnt ligand receptor that is overexpressed in a variety of tumors including clear cell renal cell carcinoma (ccRCC). Here we demonstrate that expression of wild type Ror2 results in increased tumorigenic properties in in vitro cell culture and in vivo xenograft models. In addition, Ror2 expression produced positive changes in both cell migration and invasion, which were dependent on matrix metalloprotease 2 (MMP2) activity. Mutations in key regions of the kinase domain of Ror2 resulted in the abrogation of increased tumor growth, cell migration, and cell invasion observed with expression of wild-type Ror2. Finally, we examined Ror2 expression as a prognostic biomarker for ccRCC utilizing the TCGA ccRCC dataset. High expression of Ror2 showed a significant correlation with higher clinical stage, nuclear grade, and tumor stage. Furthermore, high expression of Ror2 in ccRCC patients correlated with significant lower overall survival, cancer specific survival, and recurrence free survival. Together, these findings suggest that Ror2 plays a central role in influencing the ccRCC phenotype, and can be considered as a negative prognostic biomarker and potential therapeutic target in this cancer.	[Rasmussen, Neal R.; Wright, Tricia M.; Brannon, A. Rose] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Rasmussen, Neal R.; Debebe, Zufan; Wright, Tricia M.; Brooks, Samira A.; Sendor, Adam B.; Brannon, A. Rose; Rathmell, W. Kimryn] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Brooks, Samira A.] Univ N Carolina, Curriculum Toxicol, Chapel Hill, NC 27599 USA; [Brannon, A. Rose; Hakimi, A. Ari; Hsieh, James J.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Hakimi, A. Ari; Hsieh, James J.] Mem Sloan Kettering Canc Ctr, Dept Surg, Urol Serv, New York, NY 10065 USA; [Choueiri, Toni K.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Choueiri, Toni K.] Dana Farber Canc Inst, Kidney Canc Ctr, Boston, MA 02215 USA; [Tamboli, Pheroze] Univ Texas Houston, MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Maranchie, Jodi K.; Hinds, Peter] Univ Pittsburgh, Med Ctr, Dept Urol Oncol, Pittsburgh, PA 15219 USA; [Wallen, Eric M.] Univ N Carolina, Dept Urol, Chapel Hill, NC 27599 USA; [Wallen, Eric M.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Simpson, Catherine; Norris, Jacqueline L.; Janzen, William P.] Univ N Carolina, Ctr Integrat Chem Biol & Drug Discovery, Chapel Hill, NC 27599 USA; [Rathmell, W. Kimryn] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Rathmell, W. Kimryn] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Rathmell, WK (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	Rathmell@med.unc.edu	Choueiri, Toni/K-5238-2019; , Pathology Services Core/CEZ-2246-2022; Maranchie, Jodi/AAG-1035-2020	Choueiri, Toni/0000-0002-9201-3217; Rasmussen, Neal/0000-0002-5343-9119; Maranchie, Jodi/0000-0002-8534-9468; Sendor, Adam/0000-0003-4958-4660	American Cancer Society Research Scholar [RSG-10-192-01]; National Heart, Lung, and Blood Institute [T32 HL069768-09]; National Cancer Institute [5T32CA160001]; NATIONAL CANCER INSTITUTE [T32CA160001] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007126] Funding Source: NIH RePORTER	American Cancer Society Research Scholar(American Cancer Society); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding provided by (www.cancer.org) American Cancer Society Research Scholar Grant RSG-10-192-01 (WKR), (www.nhlbi.nih.gov) National Heart, Lung, and Blood Institute T32 HL069768-09 (NR) and (www.cancer.gov) National Cancer Institute 5T32CA160001 (ARB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal AR, 2000, NAT GENET, V25, P419, DOI 10.1038/78107; [Anonymous], 2013, NATURE, V499, P43; Brannon A Rose, 2010, Genes Cancer, V1, P152; Brooks SA, 2014, EUROPEAN UROLOGY; Choi H, 2010, CANCER RES, V70, P10101, DOI 10.1158/0008-5472.CAN-10-0505; Edris B, 2012, J PATHOL, V227, P223, DOI 10.1002/path.3986; Eggener SE, 2006, J CLIN ONCOL, V24, P3101, DOI 10.1200/JCO.2005.04.8280; Enomoto M, 2009, ONCOGENE, V28, P3197, DOI 10.1038/onc.2009.175; Gentile A, 2011, CANCER RES, V71, P3132, DOI 10.1158/0008-5472.CAN-10-2662; Gupta K, 2008, CANCER TREAT REV, V34, P193, DOI 10.1016/j.ctrv.2007.12.001; ILIOPOULOS O, 1995, NAT MED, V1, P822, DOI 10.1038/nm0895-822; Kobayashi M, 2009, ORAL SURG ORAL MED O, V107, P398, DOI 10.1016/j.tripleo.2008.08.018; Kubo T, 2009, CARCINOGENESIS, V30, P1857, DOI 10.1093/carcin/bgp206; Lai SS, 2012, CANCER GENET-NY, V205, P552, DOI 10.1016/j.cancergen.2012.09.002; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li X, 2013, GENES CELLS, V18, P608, DOI 10.1111/gtc.12064; Liotta L A, 1990, Semin Cancer Biol, V1, P99; Lu BJ, 2012, MOL MED REP, V5, P1033, DOI 10.3892/mmr.2012.772; Mei H, 2014, BIOCH BIOPHYSICAL RE; Mendrola JM, 2013, BIOCHEM SOC T, V41, P1029, DOI 10.1042/BST20130104; Morioka K, 2009, CANC SCI; O'Connell MP, 2010, ONCOGENE, V29, P34, DOI 10.1038/onc.2009.305; O'Connell MP, 2013, CANCER DISCOV, V3, P1378, DOI 10.1158/2159-8290.CD-13-0005; O'Connell MP, 2009, ONCOGENE; Ohta H, 2009, BRIT J CANCER, V100, P389, DOI 10.1038/sj.bjc.6604846; Oldridge M, 2000, NAT GENET, V24, P275, DOI 10.1038/73495; Rasmussen NR, 2013, J BIOL CHEM; Ren DY, 2011, GENES CELLS, V16, P304, DOI 10.1111/j.1365-2443.2011.01487.x; Takeuchi S, 2000, GENES CELLS, V5, P71, DOI 10.1046/j.1365-2443.2000.00300.x; Wright TM, 2009, ONCOGENE, V28, P2513, DOI 10.1038/onc.2009.116; Yamagata K, 2012, J BIOL CHEM, V287, P1588, DOI 10.1074/jbc.M111.315127; Yamamoto H, 2010, ONCOGENE, V29, P2036, DOI 10.1038/onc.2009.496	32	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e116101	10.1371/journal.pone.0116101	http://dx.doi.org/10.1371/journal.pone.0116101			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542006	Green Published, Green Submitted, gold			2022-12-27	WOS:000347239900141
J	Polavarapu, S; Mani, AM; Gundala, NKV; Hari, AD; Bathina, S; Das, UN				Polavarapu, Sailaja; Mani, Arul M.; Gundala, Naveen K. V.; Hari, Anasuya D.; Bathina, Siresha; Das, Undurti N.			Effect of Polyunsaturated Fatty Acids and Their Metabolites on Bleomycin-Induced Cytotoxic Action on Human Neuroblastoma Cells In Vitro	PLOS ONE			English	Article							GAMMA-LINOLENIC ACID; INDUCED DIABETES-MELLITUS; ARACHIDONIC-ACID; PROSTAGLANDIN E-2; EICOSAPENTAENOIC ACID; LIPID-PEROXIDATION; INVASIVE CAPACITY; ANALOG SUPPRESS; OXIDANT STRESS; CANCER GROWTH	In the present study, we noted that bleomycin induced growth inhibitory action was augmented by all the polyunsaturated fatty acids (PUFAs) tested on human neuroblastoma IMR-32 (0.5x10(4) cells/100 mu l of IMR) cells (EPA> DHA> ALA=GLA=AA> DGLA=LA: similar to 60, 40, 30, 10-20% respectively) at the maximum doses used. Of all the prostaglandins (PGE(1), PGE(2), PGF(2 alpha), and PGI2) and leukotrienes (LTD4 and LTE4) tested; PGE(1), PGE(2) and LTD4 inhibited the growth of IMR-32 cells to a significant degree at the highest doses used. Lipoxin A(4) (LXA(4)), 19,20-dihydroxydocosapentaenoate (19, 20 DiHDPA) and 10(S), 17(S)-dihydroxy-4Z, 7Z, 11E, 13Z, 15E, 19Z-docosahexaenoic acid (protectin: 10(S), 17(S) DiHDoHE), metabolites of DHA, significantly inhibited the growth of IMR-32 cells. Pre-treatment with AA, GLA, DGLA and EPA and simultaneous treatment with all PUFAs used in the study augmented growth inhibitory action of bleomycin. Surprisingly, both indomethacin and nordihydroguaiaretic acid (NDGA) at 60 and 20 mu g/ml respectively enhanced the growth of IMR-32 cells even in the presence of bleomycin. AA enhanced oxidant stress in IMR-32 cells as evidenced by an increase in lipid peroxides, superoxide dismutase levels and glutathione peroxidase activity. These results suggest that PUFAs suppress growth of human neuroblastoma cells, augment growth inhibitory action of bleomycin by enhancing formation of lipid peroxides and altering the status of anti-oxidants and, in all probability, increase the formation of lipoxins, resolvins and protectins from their respective precursors that possess growth inhibitory actions.	[Polavarapu, Sailaja; Mani, Arul M.; Gundala, Naveen K. V.; Hari, Anasuya D.; Bathina, Siresha] Biosci Res Ctr, Visakhapatnam 530048, Andhra Pradesh, India; [Das, Undurti N.] UND Life Sci, Federal Way, WA 98003 USA		Das, UN (corresponding author), UND Life Sci, 2020 S 360th St,K-202, Federal Way, WA 98003 USA.	Undurti@hotmail.com	Gundala, Venkata Naveen K/L-8395-2019; Bathina, Siresha/ABF-2315-2021	Bathina, Siresha/0000-0002-1092-5600; Mani, Arul Murugan/0000-0002-8943-7406; Polavarapu, Sailaja/0000-0001-8189-6969	Ramalingaswami Fellowship of the Department of Biotechnology; Department of Biotechnology (DBT) [BT/PR11627/MED/30/157/2010]; Department of Science and Technology under Intensification of Research in High Priority Areas (IRPHA) [IR/SO/LU/03/2008/1]; Defence Research and Development Organisation, New Delhi [TC/2519/INM 203/2011/CARS, INM-311]; Indian Council of Medical Research (ICMR), Government of India	Ramalingaswami Fellowship of the Department of Biotechnology; Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Department of Science and Technology under Intensification of Research in High Priority Areas (IRPHA); Defence Research and Development Organisation, New Delhi(Defence Research & Development Organisation (DRDO)); Indian Council of Medical Research (ICMR), Government of India(Indian Council of Medical Research (ICMR))	UND is in receipt of Ramalingaswami Fellowship of the Department of Biotechnology during the tenure of this study. This work was supported, in part, by grants from the Department of Biotechnology (DBT No. BT/PR11627/MED/30/157/2010), Department of Science and Technology (No. IR/SO/LU/03/2008/1) under Intensification of Research in High Priority Areas (IRPHA), and Defence Research and Development Organisation, New Delhi ([TC/2519/INM 203/2011/CARS] under R & D Project INM-311) to UND. SB was recipient of a fellowship from Indian Council of Medical Research (ICMR), Government of India. Author UND is the President and CEO of UND Life Sciences without any financial compensation. UND Life Sciences did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avis I, 2005, CANCER RES, V65, P4181, DOI 10.1158/0008-5472.CAN-04-3441; BECKMAN BS, 1992, P SOC EXP BIOL MED, V201, P169; BEGIN ME, 1986, JNCI-J NATL CANCER I, V77, P1053; BEGIN ME, 1986, PROG LIPID RES, V25, P573, DOI 10.1016/0163-7827(86)90116-5; BHAT KS, 1967, AM J CLIN NUTR, V20, P386, DOI 10.1093/ajcn/20.5.386; BOTHA JH, 1989, PROSTAG LEUKOTR ESS, V35, P119, DOI 10.1016/0952-3278(89)90175-0; BOTHA JH, 1985, PROSTA LEUKOTR MED, V19, P63, DOI 10.1016/0262-1746(85)90161-1; Brock TG, 2008, LIPIDS, V43, P161, DOI 10.1007/s11745-007-3136-3; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Chen Y, 2010, MOL CANCER THER, V9, P2164, DOI 10.1158/1535-7163.MCT-10-0173; Claria J, 1996, MOL MED, V2, P583, DOI 10.1007/BF03401642; Dajani OF, 2008, J CELL PHYSIOL, V214, P371, DOI 10.1002/jcp.21205; Das UN, 2004, PROSTAG LEUKOTR ESS, V70, P539, DOI 10.1016/j.plefa.2003.12.001; DAS UN, 1991, CANCER LETT, V56, P235, DOI 10.1016/0304-3835(91)90008-6; Das UN, 2006, CURR PHARM BIOTECHNO, V7, P467, DOI 10.2174/138920106779116856; Das Undurti N., 2006, Biotechnology Journal, V1, P420, DOI 10.1002/biot.200600012; Das UN, 2012, PROSTAG LEUKOTR ESS, V86, P3, DOI 10.1016/j.plefa.2011.09.008; Das UN, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-37; de Bittencourt PIH, 1998, BIOCHEM MOL BIOL INT, V45, P1255; De Carlo F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069760; DEBYDUPONT G, 1983, BIOMED PHARMACOTHER, V37, P386; Devi MMS, 2000, J PINEAL RES, V29, P108; Fahrmann JF, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-36; Ge HT, 2009, CELL BIOL INT, V33, P402, DOI 10.1016/j.cellbi.2009.01.014; Germain E, 1998, INT J CANCER, V75, P578, DOI 10.1002/(SICI)1097-0215(19980209)75:4<578::AID-IJC14>3.3.CO;2-I; Gillis RC, 2002, J SURG RES, V107, P145, DOI 10.1006/jsre.2002.6496; GIRI SN, 1983, TOXICOL APPL PHARM, V71, P132, DOI 10.1016/0041-008X(83)90052-2; Hao H, 2011, CANCER LETT, V309, P85, DOI 10.1016/j.canlet.2011.05.020; Jiang WG, 1998, INT J ONCOL, V13, P611; Kenny FS, 2001, INT J CANCER, V92, P342, DOI 10.1002/ijc.1213; KHAN MA, 1993, LEUKEMIA RES, V17, P241; KIRKOVA M, 1992, GEN PHARMACOL, V23, P503, DOI 10.1016/0306-3623(92)90119-5; KOBAYASHI H, 1985, PROSTAGLANDINS, V29, P255, DOI 10.1016/0090-6980(85)90206-0; Krenzel ES, 2013, BIOCHEMISTRY-US, V52, P1559, DOI 10.1021/bi301458b; KUMAR GS, 1995, CANCER LETT, V92, P27, DOI 10.1016/0304-3835(95)03753-J; Li CG, 2014, J EXP MED, V211, P15, DOI 10.1084/jem.20131080; Lu XF, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-106; Lu JM, 2010, MED SCI MONITOR, V16, pRA93; MADHAVI N, 1994, CANCER LETT, V84, P31, DOI 10.1016/0304-3835(94)90355-7; Maheo K, 2005, FREE RADICAL BIO MED, V39, P742, DOI 10.1016/j.freeradbiomed.2005.04.023; Manjari V, 2001, PROSTAG LEUKOTR ESS, V64, P53, DOI 10.1054/plef.2000.0237; Menendez JA, 2005, JNCI-J NATL CANCER I, V97, P1611, DOI 10.1093/jnci/dji343; MENGEAUD V, 1992, PROSTAG LEUKOTR ESS, V47, P313, DOI 10.1016/0952-3278(92)90204-V; Morita I, 1983, Gan To Kagaku Ryoho, V10, P1919; Mouradian M, 2014, PROSTAG LEUKOTR ESS, V90, P105, DOI 10.1016/j.plefa.2013.12.001; Mun GI, 2008, AM J PHYSIOL-HEART C, V295, pH1966, DOI 10.1152/ajpheart.00727.2008; PHILLIPS GB, 1967, J LIPID RES, V8, P676; Pompeia C, 2002, BIOL CELL, V94, P251, DOI 10.1016/S0248-4900(02)01200-5; RAMESH G, 1992, NUTRITION, V8, P343; Ramesh G, 1998, CANCER LETT, V123, P207, DOI 10.1016/S0304-3835(97)00426-6; Rizzo MT, 1999, CANCER RES, V59, P5047; ROBINSON KM, 1985, PROSTA LEUKOTR MED, V20, P209, DOI 10.1016/0262-1746(85)90011-3; ROSE DP, 1993, CANCER RES, V53, P4686; ROSE DP, 1994, CANCER RES, V54, P6557; ROSE DP, 1995, NUTR CANCER, V24, P33, DOI 10.1080/01635589509514391; RUSSO A, 1984, INT J RADIAT ONCOL, V10, P1675, DOI 10.1016/0360-3016(84)90526-1; SAGAR PS, 1993, MED SCI RES, V21, P457; SANTORO MG, 1986, CANCER RES, V46, P6073; Scioscia KA, 2000, HEAD NECK-J SCI SPEC, V22, P149, DOI 10.1002/(SICI)1097-0347(200003)22:2<149::AID-HED6>3.0.CO;2-T; Sheng HM, 1998, CANCER RES, V58, P362; Sheng HM, 2001, J BIOL CHEM, V276, P18075, DOI 10.1074/jbc.M009689200; SMITH DL, 1984, PROSTA LEUKOTR MED, V16, P1, DOI 10.1016/0262-1746(84)90080-5; SNYDER DS, 1989, EXP HEMATOL, V17, P6; Suresh Y, 2000, ENVIRON POLLUT, V109, P321, DOI 10.1016/S0269-7491(99)00254-7; Suresh Y, 2003, NUTRITION, V19, P213, DOI 10.1016/S0899-9007(02)00855-9; Suresh Y, 2003, NUTRITION, V19, P93, DOI 10.1016/S0899-9007(02)00856-0; Suresh Y, 2001, PROSTAG LEUKOTR ESS, V64, P37, DOI 10.1054/plef.2000.0236; Vang K, 2005, PROSTAG LEUKOTR ESS, V72, P363, DOI 10.1016/j.plefa.2005.02.002; Vartak S, 1998, BRIT J CANCER, V77, P1612, DOI 10.1038/bjc.1998.264; Wirtitsch M, 2009, ONCOL RES, V18, P83, DOI 10.3727/096504009789954654; Yu L, 2009, INT J CANCER, V125, P2540, DOI 10.1002/ijc.24607; ZEIDLER RB, 1987, INT J IMMUNOPHARMACO, V9, P691, DOI 10.1016/0192-0561(87)90040-3; Zweifel BS, 2002, CANCER RES, V62, P6706	73	27	27	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e114766	10.1371/journal.pone.0114766	http://dx.doi.org/10.1371/journal.pone.0114766			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536345	gold, Green Published, Green Submitted			2022-12-27	WOS:000348563300020
J	Wang, DY; Yu, YL; Li, YX; Wang, Y; Wang, DY				Wang, Daoyong; Yu, Yonglin; Li, Yinxia; Wang, Yang; Wang, Dayong			Dopamine Receptors Antagonistically Regulate Behavioral Choice between Conflicting Alternatives in C-elegans	PLOS ONE			English	Article							DECISION-MAKING; CAENORHABDITIS-ELEGANS; SENSORY INTEGRATION; PREFRONTAL CORTEX; MODULATION; SEROTONIN; INHIBIT; NEURONS; GENE; POLYMORPHISMS	Caenorhabditis elegans is a useful model to study the neuronal or molecular basis for behavioral choice, a specific form of decision-making. Although it has been implied that both D1-like and D2-like dopamine receptors may contribute to the control of decision-making in mammals, the genetic interactions between D1-like and D2-like dopamine receptors in regulating decision-making are still largely unclear. In the present study, we investigated the molecular control of behavioral choice between conflicting alternatives (diacetyl and Cu2+) by D1-like and D2-like dopamine receptors and their possible genetic interactions with C. elegans as the assay system. In the behavioral choice assay system, mutation of dop-1 gene encoding D1-like dopamine receptor resulted in the enhanced tendency to cross the Cu2+ barrier compared with wild-type. In contrast, mutations of dop-2 or dop-3 gene encoding D2-like dopamine receptor caused the weak tendency to cross the Cu2+ barrier compared with wild-type. During the control of behavioral choice, DOP-3 antagonistically regulated the function of DOP-1. The behavioral choice phenotype of dop-2; dop-1dop-3 triple mutant further confirmed the possible antagonistic function of D2-like dopamine receptor on D1-like dopamine receptor in regulating behavioral choice. The genetic assays further demonstrate that DOP-3 might act through G alpha(o) signaling pathway encoded by GOA-1 and EGL-10, and DOP-1 might act through G alpha(q) signaling pathway encoded by EGL-30 and EAT-16 to regulate the behavioral choice. DOP-1 might function in cholinergic neurons to regulate the behavioral choice, whereas DOP-3 might function in GABAergic neurons, RIC, and SIA neurons to regulate the behavioral choice. In this study, we provide the genetic evidence to indicate the antagonistic relationship between D1-like dopamine receptor and D2-like dopamine receptor in regulating the decision-making of animals. Our data will be useful for understanding the complex functions of dopamine receptors in regulating decision-making in animals.	[Wang, Daoyong; Yu, Yonglin; Li, Yinxia; Wang, Yang; Wang, Dayong] Southeast Univ, Sch Med, Minist Educ, Key Lab Dev Genes & Human Dis, Nanjing 210009, Jiangsu, Peoples R China	Southeast University - China	Wang, DY (corresponding author), Southeast Univ, Sch Med, Minist Educ, Key Lab Dev Genes & Human Dis, Nanjing 210009, Jiangsu, Peoples R China.	dayongw@seu.edu.cn	da, chen/AAA-2175-2020		National Natural Science Foundation of China [30870810]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grant from the National Natural Science Foundation of China (No. 30870810). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardgett ME, 2009, BEHAV NEUROSCI, V123, P242, DOI 10.1037/a0014625; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Bendesky A, 2011, NATURE, V472, P313, DOI 10.1038/nature09821; BRENNER S, 1974, GENETICS, V77, P71; Chase DL, 2004, NAT NEUROSCI, V7, P1096, DOI 10.1038/nn1316; COMINGS DE, 1991, JAMA-J AM MED ASSOC, V266, P1793, DOI 10.1001/jama.266.13.1793; Correa P, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003015; de Krom M, 2009, BIOL PSYCHIAT, V65, P625, DOI 10.1016/j.biopsych.2008.09.035; Esposito G, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-138; Etchberger JF, 2007, GENE DEV, V21, P1653, DOI 10.1101/gad.1560107; Ezak MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009487; Faumont S, 2012, CURR OPIN NEUROBIOL, V22, P580, DOI 10.1016/j.conb.2012.05.005; Flavell SW, 2013, CELL, V154, P1023, DOI 10.1016/j.cell.2013.08.001; Gong W, 1999, NEUROSCIENCE, V93, P1349, DOI 10.1016/S0306-4522(99)00235-3; Ha RY, 2009, PROG NEURO-PSYCHOPH, V33, P1217, DOI 10.1016/j.pnpbp.2009.07.009; Harris G, 2010, J NEUROSCI, V30, P7889, DOI 10.1523/JNEUROSCI.0497-10.2010; Ishihara T, 2002, CELL, V109, P639, DOI 10.1016/S0092-8674(02)00748-1; Jiu YM, 2010, PROTEIN CELL, V1, P75, DOI 10.1007/s13238-010-0003-4; Kimura KD, 2010, J NEUROSCI, V30, P16365, DOI 10.1523/JNEUROSCI.6023-09.2010; Kindt KS, 2007, NEURON, V55, P662, DOI 10.1016/j.neuron.2007.07.023; Knable MB, 1997, J PSYCHOPHARMACOL, V11, P123, DOI 10.1177/026988119701100205; Li YX, 2011, NEUROSCI BULL, V27, P69, DOI 10.1007/s12264-011-1152-z; Li ZY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1780; Mello C, 1995, METHOD CELL BIOL, V48, P451; Mills H, 2012, EMBO J, V31, P667, DOI 10.1038/emboj.2011.422; Omura DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038649; Paine TA, 2013, BEHAV BRAIN RES, V243, P247, DOI 10.1016/j.bbr.2013.01.018; Pardo M, 2012, NEUROPHARMACOLOGY, V62, P2068, DOI 10.1016/j.neuropharm.2011.12.033; Reuter M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00242; Sambongi Y, 1999, NEUROREPORT, V10, P753, DOI 10.1097/00001756-199903170-00017; Sanyal S, 2004, EMBO J, V23, P473, DOI 10.1038/sj.emboj.7600057; Shinkai Y, 2011, J NEUROSCI, V31, P3007, DOI 10.1523/JNEUROSCI.4691-10.2011; Simon NW, 2011, J NEUROSCI, V31, P17460, DOI 10.1523/JNEUROSCI.3772-11.2011; St Onge JR, 2011, J NEUROSCI, V31, P8625, DOI 10.1523/JNEUROSCI.1020-11.2011; St Onge JR, 2009, NEUROPSYCHOPHARMACOL, V34, P681, DOI 10.1038/npp.2008.121; Sugiura M, 2005, J NEUROCHEM, V94, P1146, DOI 10.1111/j.1471-4159.2005.03268.x; Suo S, 2009, EMBO J, V28, P2437, DOI 10.1038/emboj.2009.194; Tsalik EL, 2003, DEV BIOL, V263, P81, DOI 10.1016/S0012-1606(03)00447-0; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wragg RT, 2007, J NEUROSCI, V27, P13402, DOI 10.1523/JNEUROSCI.3495-07.2007; Ye Hua-Yue, 2006, Neurosci Bull, V22, P355	41	12	18	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115985	10.1371/journal.pone.0115985	http://dx.doi.org/10.1371/journal.pone.0115985			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536037	gold, Green Published, Green Submitted			2022-12-27	WOS:000348563300097
J	Kimura, Y; Akagi, T; Hangai, M; Takayama, K; Hasegawa, T; Suda, K; Yoshikawa, M; Yamada, H; Nakanishi, H; Unoki, N; Ikeda, HO; Yoshimura, N				Kimura, Yugo; Akagi, Tadamichi; Hangai, Masanori; Takayama, Kohei; Hasegawa, Tomoko; Suda, Kenji; Yoshikawa, Munemitsu; Yamada, Hiroshi; Nakanishi, Hideo; Unoki, Noriyuki; Ikeda, Hanako Ohashi; Yoshimura, Nagahisa			Lamina Cribrosa Defects and Optic Disc Morphology in Primary Open Angle Glaucoma with High Myopia	PLOS ONE			English	Article							PERIPAPILLARY INTRACHOROIDAL CAVITATION; ZONE PARAPAPILLARY ATROPHY; COHERENCE TOMOGRAPHY; SWEPT-SOURCE; NERVE; EYES; DAMAGE; PARAMETERS; LOCATION; PREDICTS	Purpose: To investigate whether lamina cribrosa (LC) defects are associated with optic disc morphology in primary open angle glaucoma (POAG) eyes with high myopia. Methods: A total of 129 POAG patients and 55 age-matched control subjects with high myopia were evaluated. Three-dimensional scan images obtained by swept source optical coherence tomography were used to detect LC defects. Radial B-scans and infrared images obtained by spectral domain optical coherence tomography were used to measure beta-peripapillary atrophy (PPA) lengths with and without Bruch's membrane (BM) (temporal, nasal, superior, and inferior), tilt angle (vertical and horizontal), and disc diameter (transverse and longitudinal). Peripapillary intrachoroidal cavitations (PICCs), disc area, ovality index, and cyclotorsion of the optic disc were analyzed as well. Results: LC defects were found in 70 of 129 (54.2%) POAG eyes and 1 of 55 (1.8%) control eyes (P < 0.001). Age, sex, spherical equivalent, axial length, intraocular pressure, and central corneal thickness were not significantly different among POAG eyes with LC defects, POAG eyes without LC defects, and control eyes. Temporal PPA lengths without BM in all three groups correlated significantly with vertical and horizontal tilt angles, although no PPA length with BM correlated significantly with any tilt angle. PICCs were detected more frequently in POAG eyes with LC defects than those without LC defects (P = 0.01) and control eyes (P = 0.02). POAG eyes with LC defects showed a smaller ovality index (P = 0.004), longer temporal PPA without BM (P < 0.001), and larger vertical/horizontal tilt angles (vertical, P < 0.001; horizontal, P = 0.01), and transverse diameter (P = 0.01). In multivariate analysis for the presence of LC defects, presence of POAG (P < 0.001) and vertical tilt angle (P < 0.001) were identified as significant. Conclusions: The presence of LC defects was associated with myopic optic disc morphology in POAG eyes with high myopia.	[Kimura, Yugo; Akagi, Tadamichi; Hangai, Masanori; Takayama, Kohei; Hasegawa, Tomoko; Suda, Kenji; Yoshikawa, Munemitsu; Yamada, Hiroshi; Nakanishi, Hideo; Unoki, Noriyuki; Ikeda, Hanako Ohashi; Yoshimura, Nagahisa] Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Sakyo Ku, Kyowa, Hokkaido 6068507, Japan	Kyoto University	Kimura, Y (corresponding author), Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Sakyo Ku, 54 Kawahara Cho, Kyowa, Hokkaido 6068507, Japan.	akagi@kuhp.kyoto-u.ac.jp	SUDA, Kenji/W-1979-2019	SUDA, Kenji/0000-0003-1636-0898; Ikeda, Hanako/0000-0001-9572-8659	Japan Society for the Promotion of Science (JSPS) [25462713]; Public Trust Suda Memorial fund for Glaucoma Research [203120700072]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Public Trust Suda Memorial fund for Glaucoma Research	This research was supported by a Grant-in-Aid for Scientific Research (25462713) from the Japan Society for the Promotion of Science (JSPS), and Public Trust Suda Memorial fund for Glaucoma Research (203120700072) (http://www.smtb.jp/personal/entrustment/management/public/example/list.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi T, 2013, AM J OPHTHALMOL, V155, P927, DOI 10.1016/j.ajo.2012.12.014; Bellezza AJ, 2000, INVEST OPHTH VIS SCI, V41, P2991; CASHWELL LF, 1995, OPHTHALMOLOGY, V102, P1270, DOI 10.1016/S0161-6420(95)30874-3; Chang L, 2013, AM J OPHTHALMOL, V155, P991, DOI 10.1016/j.ajo.2013.01.016; CHIHARA E, 1992, GRAEF ARCH CLIN EXP, V230, P511, DOI 10.1007/BF00181770; Cho BJ, 2013, OPHTHALMOLOGY, V120, P528, DOI 10.1016/j.ophtha.2012.09.004; Hosseini H, 2013, AM J OPHTHALMOL, V156, P737, DOI 10.1016/j.ajo.2013.05.036; Inoue R, 2009, OPHTHALMOLOGY, V116, P214, DOI 10.1016/j.ophtha.2008.09.008; JONAS JB, 1988, GRAEF ARCH CLIN EXP, V226, P587, DOI 10.1007/BF02169209; Jonas JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047237; Jonas JB, 2011, AM J OPHTHALMOL, V152, P1021, DOI 10.1016/j.ajo.2011.05.006; Kempen AH, 2004, ARCH OPHTHALMOL-CHIC, V122, P495; Kim M, 2013, OPHTHALMOLOGY, V120, P1790, DOI 10.1016/j.ophtha.2013.02.011; Kim TW, 2012, OPHTHALMOLOGY, V119, P21, DOI 10.1016/j.ophtha.2011.07.051; Kimura Y, 2012, INVEST OPHTH VIS SCI, V53, P6472, DOI 10.1167/iovs.12-10319; Kiumehr S, 2012, ARCH OPHTHALMOL-CHIC, V130, P552, DOI 10.1001/archopthalmol.2011.1309; Lee EJ, 2012, INVEST OPHTH VIS SCI, V53, P198, DOI 10.1167/iovs.11-7848; Lin LLK, 1999, OPTOMETRY VISION SCI, V76, P275, DOI 10.1097/00006324-199905000-00013; Marcus MW, 2011, OPHTHALMOLOGY, V118, P1989, DOI 10.1016/j.ophtha.2011.03.012; Mayama C, 2002, OPHTHALMOLOGY, V109, P2072, DOI 10.1016/S0161-6420(02)01175-2; Ohno-Matsui K, 2012, OPHTHALMOLOGY, V119, P1685, DOI 10.1016/j.ophtha.2012.01.047; Ohno-Matsui K, 2011, AM J OPHTHALMOL, V152, P256, DOI 10.1016/j.ajo.2011.01.052; Park HYL, 2012, OPHTHALMOLOGY, V119, P1844, DOI 10.1016/j.ophtha.2012.03.006; Park HYL, 2014, AM J OPHTHALMOL, V157, P550, DOI 10.1016/j.ajo.2013.11.008; Park KH, 1996, OPHTHALMOLOGY, V103, P1899, DOI 10.1016/S0161-6420(96)30409-0; Park SC, 2013, INVEST OPHTH VIS SCI, V54, P8401, DOI 10.1167/iovs.13-13014; QUIGLEY HA, 1983, AM J OPHTHALMOL, V95, P673, DOI 10.1016/0002-9394(83)90389-6; QUIGLEY HA, 1993, NEW ENGL J MED, V328, P1097, DOI 10.1056/NEJM199304153281507; Shimada N, 2007, OPHTHALMOLOGY, V114, P2070, DOI 10.1016/j.ophtha.2007.01.016; Spaide RF, 2012, RETINA-J RET VIT DIS, V32, P1037, DOI 10.1097/IAE.0b013e318242b9c0; Srinivasan VJ, 2008, INVEST OPHTH VIS SCI, V49, P5103, DOI 10.1167/iovs.08-2127; Takayama K, 2013, INVEST OPHTH VIS SCI, V54, P4798, DOI 10.1167/iovs.13-11677; Tatham AJ, 2014, OPHTHALMOLOGY, V121, P110, DOI 10.1016/j.ophtha.2013.08.018; Tay E, 2005, AM J OPHTHALMOL, V139, P247, DOI 10.1016/j.ajo.2004.08.076; Teng CC, 2011, OPHTHALMOLOGY, V118, P2409, DOI 10.1016/j.ophtha.2011.06.014; Teng CC, 2010, OPHTHALMOLOGY, V117, P909, DOI 10.1016/j.ophtha.2009.10.016; Tezel G, 2004, BRIT J OPHTHALMOL, V88, P251, DOI 10.1136/bjo.2003.019281; Toranzo J, 2005, AM J OPHTHALMOL, V140, P731, DOI 10.1016/j.ajo.2005.03.063; Wong TY, 2000, INVEST OPHTH VIS SCI, V41, P2486; Wu RY, 2011, AM J OPHTHALMOL, V152, P81, DOI 10.1016/j.ajo.2011.01.018; Xu LA, 2007, OPHTHALMOLOGY, V114, P216, DOI 10.1016/j.ophtha.2006.06.050; Yeh SI, 2013, OPHTHALMOLOGY, V120, P544, DOI 10.1016/j.ophtha.2012.08.028; You JY, 2013, JAMA OPHTHALMOL, V131, P314, DOI 10.1001/jamaophthalmol.2013.1926; You QS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078743	44	36	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115313	10.1371/journal.pone.0115313	http://dx.doi.org/10.1371/journal.pone.0115313			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531656	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000348845100051
J	Velazquez, J; Garrahan, JP; Eichhorn, MP				Velazquez, Jorge; Garrahan, Juan P.; Eichhorn, Markus P.			Spatial Complementarity and the Coexistence of Species	PLOS ONE			English	Article							INTRASPECIFIC AGGREGATION; COMPETITIVE INTERACTIONS; POPULATION-DYNAMICS; PLANT-COMMUNITIES; PATTERNS; MODEL	Coexistence of apparently similar species remains an enduring paradox in ecology. Spatial structure has been predicted to enable coexistence even when population-level models predict competitive exclusion if it causes each species to limit its own population more than that of its competitor. Nevertheless, existing hypotheses conflict with regard to whether clustering favours or precludes coexistence. The spatial segregation hypothesis predicts that in clustered populations the frequency of intra-specific interactions will be increased, causing each species to be self-limiting. Alternatively, individuals of the same species might compete over greater distances, known as heteromyopia, breaking down clusters and opening space for a second species to invade. In this study we create an individual-based model in homogeneous two-dimensional space for two putative sessile species differing only in their demographic rates and the range and strength of their competitive interactions. We fully characterise the parameter space within which coexistence occurs beyond population-level predictions, thereby revealing a region of coexistence generated by a previously-unrecognised process which we term the triadic mechanism. Here coexistence occurs due to the ability of a second generation of offspring of the rarer species to escape competition from their ancestors. We diagnose the conditions under which each of three spatial coexistence mechanisms operates and their characteristic spatial signatures. Deriving insights from a novel metric - ecological pressure - we demonstrate that coexistence is not solely determined by features of the numerically-dominant species. This results in a common framework for predicting, given any pair of species and knowledge of the relevant parameters, whether they will coexist, the mechanism by which they will do so, and the resultant spatial pattern of the community. Spatial coexistence arises from complementary combinations of traits in each species rather than solely through self-limitation.	[Velazquez, Jorge; Garrahan, Juan P.] Univ Nottingham, Sch Phys & Astron, Nottingham NG7 2RD, England; [Velazquez, Jorge] Univ Autonoma Puebla, Fac Ciencias Fis Matemat, Puebla 72001, Pue, Mexico; [Eichhorn, Markus P.] Univ Nottingham, Sch Life Sci, Nottingham NG7 2RD, England	University of Nottingham; Benemerita Universidad Autonoma de Puebla; University of Nottingham	Eichhorn, MP (corresponding author), Univ Nottingham, Sch Life Sci, Univ Pk, Nottingham NG7 2RD, England.	markus.eichhorn@nottingham.ac.uk	Velázquez-Castro, Jorge/A-9348-2016; Eichhorn, Markus/L-5027-2013	Velázquez-Castro, Jorge/0000-0002-7176-2008; Eichhorn, Markus/0000-0002-3381-0822	Consejo Nacional de Ciencia y Tecnologia; Engineering and Physical Sciences Research Council [EP/K50354X/1]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	JV was supported by a Consejo Nacional de Ciencia y Tecnologia post-doctoral fellowship (http://www.conacyt.mx) and by Engineering and Physical Sciences Research Council grant no. EP/K50354X/1 (http://www.epsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarasekare P, 2003, ECOL LETT, V6, P1109, DOI 10.1046/j.1461-0248.2003.00530.x; Berger U, 2008, PERSPECT PLANT ECOL, V9, P121, DOI 10.1016/j.ppees.2007.11.002; Bolker B, 1997, THEOR POPUL BIOL, V52, P179, DOI 10.1006/tpbi.1997.1331; Bolker BM, 2003, AM NAT, V162, P135, DOI 10.1086/376575; Chase J.M., 2009, ECOLOGICAL NICHES LI; Chesson P, 2002, TRENDS ECOL EVOL, V17, P210, DOI 10.1016/S0169-5347(02)02482-5; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; CHESSON PL, 1989, J MATH BIOL, V27, P117, DOI 10.1007/BF00276099; Dieckmann U, 1999, NATURE, V400, P354, DOI 10.1038/22521; Dislich C, 2010, ECOL MODEL, V221, P2227, DOI 10.1016/j.ecolmodel.2010.06.011; Filipe JAN, 2003, MATH BIOSCI, V183, P15, DOI 10.1016/S0025-5564(02)00224-9; Gabel A, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.010101; Gandhi A, 1998, J THEOR BIOL, V192, P363, DOI 10.1006/jtbi.1998.0660; Goreaud F, 2002, ECOL MODEL, V158, P1, DOI 10.1016/S0304-3800(02)00058-3; Hart SP, 2009, ECOLOGY, V90, P1485, DOI 10.1890/08-1813.1; Hubbell SP, 2005, FUNCT ECOL, V19, P166, DOI 10.1111/j.0269-8463.2005.00965.x; Law R., 2000, GEOMETRY ECOLOGICAL, P412, DOI DOI 10.1017/CBO9780511525537.025; Law R, 2009, J ECOL, V97, P616, DOI 10.1111/j.1365-2745.2009.01510.x; Monzeglio U, 2005, OECOLOGIA, V145, P619, DOI 10.1007/s00442-005-0168-3; Murrell DJ, 2010, ECOLOGY, V91, P1605, DOI 10.1890/09-0832.1; Murrell DJ, 2003, ECOL LETT, V6, P48, DOI 10.1046/j.1461-0248.2003.00397.x; Murrell DJ, 2004, J THEOR BIOL, V229, P421, DOI 10.1016/j.jtbi.2004.04.013; Neuhauser C, 1999, ANN APPL PROBAB, V9, P1226; Newman M., 1999, MONTE CARLO METHODS; Pacala Stephen W., 1997, P532; Perry GLW, 2006, PLANT ECOL, V187, P59, DOI 10.1007/s11258-006-9133-4; Purves DW, 2002, J ECOL, V90, P121, DOI 10.1046/j.0022-0477.2001.00652.x; Rejmanek M, 2002, TRENDS ECOL EVOL, V17, P209, DOI 10.1016/S0169-5347(02)02494-1; RIPLEY BD, 1977, J ROY STAT SOC B MET, V39, P172; Semchenko M, 2013, J ECOL, V101, P1313, DOI 10.1111/1365-2745.12127; Siepielski AM, 2010, ECOLOGY, V91, P3153, DOI 10.1890/10-0154.1; SKELLAM JG, 1952, BIOMETRIKA, V39, P346, DOI 10.2307/2334030; Snyder RE, 2004, AM NAT, V164, P633, DOI 10.1086/424969; Snyder RE, 2008, THEOR ECOL-NETH, V1, P129, DOI 10.1007/s12080-008-0015-3; Stoll P, 2001, ECOLOGY, V82, P319, DOI 10.1890/0012-9658(2001)082[0319:IAACII]2.0.CO;2; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; TURKINGTON R, 1979, J ECOL, V67, P201, DOI 10.2307/2259345; Turnbull LA, 2004, J ECOL, V92, P97, DOI 10.1111/j.1365-2745.2004.00856.x; Turnbull LA, 2007, J ECOL, V95, P79, DOI 10.1111/j.1365-2745.2006.01184.x; Vogt DR, 2010, AM NAT, V175, P73, DOI 10.1086/648556; Wassmuth BE, 2009, PERSPECT PLANT ECOL, V11, P127, DOI 10.1016/j.ppees.2009.02.001	41	10	10	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e114979	10.1371/journal.pone.0114979	http://dx.doi.org/10.1371/journal.pone.0114979			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25532018	gold, Green Published, Green Submitted			2022-12-27	WOS:000348845100034
J	Grane, VA; Endestad, T; Pinto, AF; Solbakk, AK				Grane, Venke Arntsberg; Endestad, Tor; Pinto, Arnfrid Farbu; Solbakk, Anne-Kristin			Attentional Control and Subjective Executive Function in Treatment-Naive Adults with Attention Deficit Hyperactivity Disorder	PLOS ONE			English	Article							AGE-DEPENDENT DECLINE; DEFICIT/HYPERACTIVITY-DISORDER; COGNITIVE COMPLAINTS; SUSTAINED ATTENTION; RESPONSE-INHIBITION; EF TESTS; ADHD; PERFORMANCE; CHILDREN; VARIABILITY	We investigated performance-derived measures of executive control, and their relationship with self- and informant reported executive functions in everyday life, in treatment-naive adults with newly diagnosed Attention Deficit Hyperactivity Disorder (ADHD; n=36) and in healthy controls (n=35). Sustained attentional control and response inhibition were examined with the Test of Variables of Attention (T.O.V.A.). Delayed responses, increased reaction time variability, and higher omission error rate to Go signals in ADHD patients relative to controls indicated fluctuating levels of attention in the patients. Furthermore, an increment in NoGo commission errors when Go stimuli increased relative to NoGo stimuli suggests reduced inhibition of task-irrelevant stimuli in conditions demanding frequent responding. The ADHD group reported significantly more cognitive and behavioral executive problems than the control group on the Behavior Rating Inventory of Executive Function-Adult Version (BRIEF-A). There were overall not strong associations between task performance and ratings of everyday executive function. However, for the ADHD group, T.O.V.A. omission errors predicted self-reported difficulties on the Organization of Materials scale, and commission errors predicted informant reported difficulties on the same scale. Although ADHD patients endorsed more symptoms of depression and anxiety on the Achenbach System of Empirically Based Assessment (ASEBA) than controls, ASEBA scores were not significantly associated with T.O.V.A. performance scores. Altogether, the results indicate multifaceted alteration of attentional control in adult ADHD, and accompanying subjective difficulties with several aspects of executive function in everyday living. The relationships between the two sets of data were modest, indicating that the measures represent non-redundant features of adult ADHD.	[Grane, Venke Arntsberg; Pinto, Arnfrid Farbu; Solbakk, Anne-Kristin] Helgeland Hosp, Dept Neuropsychol, Mosjoen, Norway; [Grane, Venke Arntsberg; Endestad, Tor] Univ Oslo, Dept Psychol, Oslo, Norway; [Solbakk, Anne-Kristin] Oslo Univ Hosp Rikshosp, Div Surg & Clin Neurosci, Dept Neurosurg, Oslo, Norway	University of Oslo; University of Oslo; National Hospital Norway	Grane, VA (corresponding author), Helgeland Hosp, Dept Neuropsychol, Mosjoen, Norway.	venke.arntsberg.grane@helgelandssykehuset.no		Endestad, Tor/0000-0002-4403-6887	Northern Norway Regional Health Authority [5154/PEP1012-11]; Helgeland Hospital, Norway	Northern Norway Regional Health Authority; Helgeland Hospital, Norway	AKS was supported by the Northern Norway Regional Health Authority under Grant number 5154/PEP1012-11; VAG was supported by the Helgeland Hospital, Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach TM, 2003, MANUAL ASEBA ADULT F; Adams ZW, 2011, PSYCHOL ASSESSMENT, V23, P427, DOI 10.1037/a0022112; Adler LA, 2008, J CLIN PSYCHIAT, V69, P1328, DOI 10.4088/JCP.1208e36; Adler LA, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-253; Advokat Claire, 2007, J Atten Disord, V10, P253, DOI 10.1177/1087054706292106; Aggarwal A, 2000, J PAEDIATR CHILD H, V36, P134, DOI 10.1046/j.1440-1754.2000.00464.x; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Antonini TN, 2013, NEUROPSYCHOLOGY, V27, P201, DOI 10.1037/a0032071; Association AP, 1994, DIAGN STAT MAN MENT, V4th; Balint Sara, 2008, Psychiatr Hung, V23, P324; Barkley R. A., 2008, ADHD ADULTS WHAT SCI; Barkley R.A, 2006, ATTENTION DEFICIT HY, V3rd; Barkley R.A., 2010, ADHD ADULTS WHAT SCI; Barkley RA, 2005, J SAFETY RES, V36, P121, DOI 10.1016/j.jsr.2005.01.001; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Barkley RA, 2002, J ABNORM PSYCHOL, V111, P279, DOI 10.1037//0021-843X.111.2.279; Barkley RA, 1997, J DEV BEHAV PEDIATR, V18, P271; Barkley RA, 2001, J ABNORM CHILD PSYCH, V29, P541, DOI 10.1023/A:1012233310098; Barkley RA, 1996, J ATTEN DISORD, V1, P41, DOI DOI 10.1177/108705479600100104; Barkley RA, 2012, J ABNORM PSYCHOL, V121, P978, DOI 10.1037/a0023961; Barkley RA, 2011, DEV NEUROPSYCHOL, V36, P137, DOI 10.1080/87565641.2010.549877; Barkley Russell A, 2010, J Clin Psychiatry, V71, pe17, DOI 10.4088/JCP.9066tx1c; Barkley RA, 2010, ARCH CLIN NEUROPSYCH, V25, P157, DOI 10.1093/arclin/acq014; Baron IS, 2007, NEUROPSYCHOL REV, V17, P1, DOI 10.1007/s11065-006-9016-4; Bashem JR, 2014, CLIN NEUROPSYCHOL, V28, P851, DOI 10.1080/13854046.2014.927927; Bekker EM, 2005, PSYCHOL MED, V35, P807, DOI 10.1017/S0033291704003459; Biederman J, 2000, AM J PSYCHIAT, V157, P816, DOI 10.1176/appi.ajp.157.5.816; Biederman J, 2005, BIOL PSYCHIAT, V57, P1215, DOI 10.1016/j.biopsych.2004.10.020; Biederman J, 2011, EUR NEUROPSYCHOPHARM, V21, P508, DOI 10.1016/j.euroneuro.2010.11.005; Boonstra AM, 2005, PSYCHOL MED, V35, P1097, DOI 10.1017/S003329170500499X; Brown TE, 2006, REV BRAS PSIQUIATR, V28, P261, DOI 10.1590/S1516-44462006000700002; Carmona S, 2012, HUM BRAIN MAPP, V33, P2350, DOI 10.1002/hbm.21368; Castellanos FX, 2006, TRENDS COGN SCI, V10, P117, DOI 10.1016/j.tics.2006.01.011; Castellanos FX, 2002, NAT REV NEUROSCI, V3, P617, DOI 10.1038/nrn896; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Crocker LD, 2013, FRONTIERS HUMAN NEUR, V7; Cubillo A, 2012, CORTEX, V48, P194, DOI 10.1016/j.cortex.2011.04.007; Das D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031500; Di Martino LD, 2008, FOOD DRUG LAW J, V63, P891; Epstein JN, 2001, J CLIN EXP NEUROPSYC, V23, P362, DOI 10.1076/jcen.23.3.362.1186; Erskine HE, 2013, J CHILD PSYCHOL PSYC, V54, P1263, DOI 10.1111/jcpp.12144; Faraone SV, 2006, PSYCHOL MED, V36, P159, DOI 10.1017/S003329170500471X; Fayyad J, 2007, BRIT J PSYCHIAT, V190, P402, DOI 10.1192/bjp.bp.106.034389; Forbes GB, 1998, J CLIN PSYCHOL, V54, P461, DOI 10.1002/(SICI)1097-4679(199806)54:4<461::AID-JCLP8>3.3.CO;2-S; Gansler DA, 1998, J NERV MENT DIS, V186, P776, DOI 10.1097/00005053-199812000-00006; Geurts HM, 2008, NEUROPSYCHOLOGIA, V46, P3030, DOI 10.1016/j.neuropsychologia.2008.06.013; Ghanizadeh A, 2013, COMPR PSYCHIAT, V54, P7, DOI 10.1016/j.comppsych.2012.06.001; Gioia GA, 2002, CHILD NEUROPSYCHOL, V8, P121, DOI 10.1076/chin.8.2.121.8727; Gray QH, 1996, BEHAV INHIBITION ADH; Greenberg L. M., 2000, TOVA CLIN GUIDE; GREENBERG LM, 1993, J CHILD PSYCHOL PSYC, V34, P1019, DOI 10.1111/j.1469-7610.1993.tb01105.x; Haavik J, 2010, EXPERT REV NEUROTHER, V10, P1569, DOI [10.1586/ern.10.149, 10.1586/ERN.10.149]; Hervey AS, 2004, NEUROPSYCHOLOGY, V18, P485, DOI 10.1037/0894-4105.18.3.485; Kaufmann L, 2010, DEV MED CHILD NEUROL, V52, P371, DOI 10.1111/j.1469-8749.2009.03560.x; Kent KM, 2011, J ABNORM CHILD PSYCH, V39, P451, DOI 10.1007/s10802-010-9472-4; Kessler RC, 2006, AM J PSYCHIAT, V163, P716, DOI 10.1176/appi.ajp.163.4.716; Kessler RC, 2010, ARCH GEN PSYCHIAT, V67, P1168, DOI 10.1001/archgenpsychiatry.2010.146; Klein C, 2006, BIOL PSYCHIAT, V60, P1088, DOI 10.1016/j.biopsych.2006.04.003; Lancaster J., 2012, J ATTEN DISORD; Leark R.A., 2007, TEST VARIABLES ATTEN; Leth-Steensen C, 2000, ACTA PSYCHOL, V104, P167, DOI 10.1016/S0001-6918(00)00019-6; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Lovstad M, 2012, BRAIN INJURY, V26, P1586, DOI 10.3109/02699052.2012.698787; Malloy-Diniz L, 2007, J INT NEUROPSYCH SOC, V13, P693, DOI 10.1017/S1355617707070889; Manor I, 2011, CLIN NEUROPHARMACOL, V34, P148, DOI 10.1097/WNF.0b013e3182206dc1; Marx I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067002; McGough JJ, 2005, AM J PSYCHIAT, V162, P1621, DOI 10.1176/appi.ajp.162.9.1621; Metin B, 2012, BIOL PSYCHIAT, V72, P990, DOI 10.1016/j.biopsych.2012.08.023; Nigg JT, 2005, J ABNORM PSYCHOL, V114, P706, DOI 10.1037/0021-843X.114.3.706; Nigg JT, 2005, BIOL PSYCHIAT, V57, P1424, DOI 10.1016/j.biopsych.2004.11.011; Nigg JT, 2002, J CONSULT CLIN PSYCH, V70, P153, DOI 10.1037/0022-006X.70.1.153; Ossmann JM, 2003, AM J PSYCHOL; Pollak Y, 2009, J DEV BEHAV PEDIATR, V30, P413, DOI 10.1097/DBP.0b013e3181ba0f89; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Posner MI, 2007, ANNU REV PSYCHOL, V58, P1, DOI 10.1146/annurev.psych.58.110405.085516; Qiu AQ, 2009, AM J PSYCHIAT, V166, P74, DOI 10.1176/appi.ajp.2008.08030426; Quintero J, 2013, ACTAS ESP PSIQUIATRI, V41, P185; Rabin LA, 2006, ARCH CLIN NEUROPSYCH, V21, P721, DOI 10.1016/j.acn.2006.08.004; Rapport LJ, 2001, CLIN NEUROPSYCHOL, V15, P479, DOI 10.1076/clin.15.4.479.1878; Rezazadeh SM, 2011, CHILD NEUROPSYCHOL, V17, P197, DOI 10.1080/09297049.2010.532203; Roth R, 2005, BRIEF A BEHAV RATING; Roth RM, 2013, ARCH CLIN NEUROPSYCH, V28, P425, DOI 10.1093/arclin/act031; Roth RS, 2005, ARCH PHYS MED REHAB, V86, P1147, DOI 10.1016/j.apmr.2004.10.041; Sarter M, 2001, BRAIN RES REV, V35, P146, DOI 10.1016/S0165-0173(01)00044-3; Schoechlin C, 2005, ARCH CLIN NEUROPSYCH, V20, P727, DOI 10.1016/j.acn.2005.04.005; Sergeant J, 2005, REV BRAS PSIQUIATR, V27, P262, DOI 10.1590/S1516-44462005000400001; Sergeant JA, 2003, NEUROSCI BIOBEHAV R, V27, P583, DOI 10.1016/j.neubiorev.2003.08.004; Sonuga-Barke EJS, 2005, BIOL PSYCHIAT, V57, P1231, DOI 10.1016/j.biopsych.2004.09.008; Sonuga-Barke EJS, 2003, NEUROSCI BIOBEHAV R, V27, P593, DOI 10.1016/j.neubiorev.2003.08.005; Spss I, 2012, IBM SPSS STAT VERS 2; Tabachnick B.G., 2007, EXPT DESIGNS USING A; Toplak ME, 2013, J CHILD PSYCHOL PSYC, V54, P131, DOI 10.1111/jcpp.12001; van Ewijk H, 2012, NEUROSCI BIOBEHAV R, V36, P1093, DOI 10.1016/j.neubiorev.2012.01.003; Vaurio RG, 2009, NEUROPSYCHOLOGIA, V47, P2389, DOI 10.1016/j.neuropsychologia.2009.01.022; Wechsler D, 1997, WAIS 3 WECHSLER ADUL; Weinberg W. A., 1993, NEUROLOGIC CLIN; Weyandt LL, 2002, J LEARN DISABIL-US, V35, P114, DOI 10.1177/002221940203500203; Willcutt EG, 2005, BIOL PSYCHIAT, V57, P1336, DOI 10.1016/j.biopsych.2005.02.006; Woods SP, 2002, ARCH CLIN NEUROPSYCH, V17, P351, DOI 10.1016/S0887-6177(01)00120-2	99	23	28	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115227	10.1371/journal.pone.0115227	http://dx.doi.org/10.1371/journal.pone.0115227			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7UN	25545156	Green Submitted, Green Published, gold			2022-12-27	WOS:000347120200027
J	Kamp, MA; Dibue, M; Sommer, C; Steiger, HJ; Schneider, T; Hanggi, D				Kamp, Marcel A.; Dibue, Maxine; Sommer, Clemens; Steiger, Hans-Jakob; Schneider, Toni; Haenggi, Daniel			Evaluation of a Murine Single-Blood-Injection SAH Model	PLOS ONE			English	Article							EXPERIMENTAL SUBARACHNOID HEMORRHAGE; DELAYED CEREBRAL-ISCHEMIA; SPREADING DEPOLARIZATION; PERFUSION-PRESSURE; CONTINUOUS EEG; MOUSE MODEL; IN-VIVO; FLOW; VASOSPASM; BRAIN	The molecular pathways underlying the pathogenesis after subarachnoid haemorrhage (SAH) are poorly understood and continue to be a matter of debate. A valid murine SAH injection model is not yet available but would be the prerequisite for further transgenic studies assessing the mechanisms following SAH. Using the murine single injection model, we examined the effects of SAH on regional cerebral blood flow (rCBF) in the somatosensory (S1) and cerebellar cortex, neuro-behavioural and morphological integrity and changes in quantitative electrocorticographic and electrocardiographic parameters. Micro CT imaging verified successful blood delivery into the cisterna magna. An acute impairment of rCBF was observed immediately after injection in the SAH and after 6, 12 and 24 hours in the S1 and 6 and 12 hours after SAH in the cerebellum. Injection of blood into the foramen magnum reduced telemetric recorded total ECoG power by an average of 65%. Spectral analysis of ECoGs revealed significantly increased absolute delta power, i.e., slowing, cortical depolarisations and changes in ripples and fast ripple oscillations 12 hours and 24 hours after SAH. Therefore, murine single-blood-injection SAH model is suitable for pathophysiological and further molecular analysis following SAH.	[Kamp, Marcel A.; Dibue, Maxine; Steiger, Hans-Jakob; Haenggi, Daniel] Univ Dusseldorf, Fac Med, Dept Neurosurg, D-40225 Dusseldorf, Germany; [Kamp, Marcel A.; Dibue, Maxine; Schneider, Toni] Univ Cologne, Fac Med, Inst Neurophysiol, D-50931 Cologne, Germany; [Dibue, Maxine; Schneider, Toni] CMMC, D-50931 Cologne, Germany; [Sommer, Clemens] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Neuropathol, D-55131 Mainz, Germany	Heinrich Heine University Dusseldorf; University of Cologne; University of Cologne; Johannes Gutenberg University of Mainz	Kamp, MA (corresponding author), Univ Dusseldorf, Fac Med, Dept Neurosurg, Moorenstr 5, D-40225 Dusseldorf, Germany.	marcelalexander.kamp@med.uni-duesseldorf.de	Steiger, Hans-Jakob/AAN-8307-2021	Steiger, Hans-Jakob/0000-0002-8249-2998; Kamp, Marcel/0000-0002-1252-2944				Badan I, 2003, J CEREBR BLOOD F MET, V23, P845, DOI 10.1097/01.WCB.0000071883.63724.A7; BEDERSON JB, 1995, STROKE, V26, P1086, DOI 10.1161/01.STR.26.6.1086; Bosche B, 2010, ANN NEUROL, V67, P607, DOI 10.1002/ana.21943; Chen S, 2014, PROG NEUROBIOL, V115, P64, DOI 10.1016/j.pneurobio.2013.09.002; Claassen J, 2004, CLIN NEUROPHYSIOL, V115, P2699, DOI 10.1016/j.clinph.2004.06.017; DAVIDSON RJ, 1990, PSYCHOPHYSIOLOGY, V27, P528, DOI 10.1111/j.1469-8986.1990.tb01970.x; Dibue M, 2013, EPILEPSIA, V54, P1542, DOI 10.1111/epi.12250; Dreier JP, 2006, BRAIN, V129, P3224, DOI 10.1093/brain/awl297; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Dreier JP, 2001, J PHYSIOL-LONDON, V531, P515, DOI 10.1111/j.1469-7793.2001.0515i.x; Drenckhahn C, 2012, BRAIN, V135, P853, DOI 10.1093/brain/aws010; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Feiler S, 2010, J NEUROSCI METH, V190, P164, DOI 10.1016/j.jneumeth.2010.05.005; Frauenknecht K, 2010, J NEUROIMMUNOL, V227, P1, DOI 10.1016/j.jneuroim.2010.05.043; Friedrich B, 2012, J CEREBR BLOOD F MET, V32, P447, DOI 10.1038/jcbfm.2011.154; GASSER T, 1982, PSYCHOPHYSIOLOGY, V19, P237, DOI 10.1111/j.1469-8986.1982.tb02553.x; GASSER T, 1982, ELECTROEN CLIN NEURO, V53, P119, DOI 10.1016/0013-4694(82)90112-2; Gelderblom M, 2009, STROKE, V40, P1849, DOI 10.1161/STROKEAHA.108.534503; Hertle DN, 2012, BRAIN, V135, P2390, DOI 10.1093/brain/aws152; Kamii H, 1999, STROKE, V30, P867, DOI 10.1161/01.STR.30.4.867; King JT, 1997, NEUROIMAG CLIN N AM, V7, P659; LABAR DR, 1991, ELECTROEN CLIN NEURO, V78, P325, DOI 10.1016/0013-4694(91)90094-K; LEWONTIN RC, 1966, GENETICS, V54, P595; Lin CL, 2003, J NEUROSCI METH, V123, P89, DOI 10.1016/S0165-0270(02)00344-8; Offenhauser N, 2011, ACTA NEUROCHIR SUPPL, V110, P119, DOI [10.1007/978-3-7091-0353-1_21, 10.1007/978-3-7091-0353-1_2l]; Parra A, 2002, NEUROL RES, V24, P510, DOI 10.1179/016164102101200276; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Prunell GF, 2005, J NEUROSURG, V102, P1046, DOI 10.3171/jns.2005.102.6.1046; Prunell GF, 2003, NEUROSURGERY, V52, P165, DOI 10.1097/00006123-200301000-00022; Prunell GF, 2004, NEUROSURGERY, V54, P426, DOI 10.1227/01.NEU.0000103670.09687.7A; Sabri M, 2012, NEUROSCIENCE, V224, P26, DOI 10.1016/j.neuroscience.2012.08.002; Sabri M, 2009, BRAIN RES, V1295, P179, DOI 10.1016/j.brainres.2009.08.021; Stuart RM, 2010, NEUROCRIT CARE, V13, P355, DOI 10.1007/s12028-010-9414-6; Vespa PM, 1997, ELECTROEN CLIN NEURO, V103, P607, DOI 10.1016/S0013-4694(97)00071-0; Weiergraber M, 2006, EPILEPSIA, V47, P839, DOI 10.1111/j.1528-1167.2006.00541.x; Weiergraber M, 2005, BRAIN RES PROTOC, V14, P154, DOI 10.1016/j.brainresprot.2004.12.006; Westermaier T, 2011, NEUROSURGERY, V68, P223, DOI 10.1227/NEU.0b013e3181fe23c1; Westermaier T, 2009, J NEUROSURG, V110, P996, DOI 10.3171/2008.8.JNS08591; Westermaier T, 2009, J CEREBR BLOOD F MET, V29, P771, DOI 10.1038/jcbfm.2008.169; Woitzik J, 2012, J CEREBR BLOOD F MET, V32, P203, DOI 10.1038/jcbfm.2011.169	40	15	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e114946	10.1371/journal.pone.0114946	http://dx.doi.org/10.1371/journal.pone.0114946			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545775	Green Published, Green Submitted, gold			2022-12-27	WOS:000347120200017
J	Le, QT; Lotfi-Emran, S; Min, HK; Schwartz, LB				Quang Trong Le; Lotfi-Emran, Sahar; Min, Hae-Ki; Schwartz, Lawrence B.			A Simple, Sensitive and Safe Method to Determine the Human alpha/beta-Tryptase Genotype	PLOS ONE			English	Article							GC-RICH DNA; PCR AMPLIFICATION; MESSENGER-RNA; BETA-TRYPTASE; CELL-LINE; GENES; ESTABLISHMENT; EXPRESSION; IMPROVES	The human tryptase locus on chromosome 16 contains one gene encoding only beta-tryptase and another encoding either b-tryptase or the homologous a-tryptase, providing alpha:beta gene ratios of 0:4, 1:3 or 2:2 in the diploid genome, these genotypes being of potential clinical relevance in severe atopy. Using an EcoRV restriction site in alpha-but not beta-tryptase, PCR products, spanning intron 1 to exon 5, were used to determine alpha/beta-tryptase gene ratios using non-radioactive labels, including ethidium bromide labeling of all PCR products, and either digoxigenin-primer or DY682-primer labeling of only the final PCR cycle products. Sensitivity increased similar to 60-fold with each final PCR cycle labeling technique. Ethidium bromide labeling underestimated amounts of alpha-tryptase, presumably because heteroduplexes of alpha/beta-tryptase amplimers, formed during annealing, were EcoRV resistant. In contrast, both final PCR cycle labeling techniques precisely quantified these gene ratios, because only homoduplexes were labeled. Using the DY682-primer was most efficient, because PCR/EcoRV products could be analyzed directly in the gel; while digoxigenin-labeled products required transfer to a nitrocellulose membrane followed by immunoblotting. This technique for determining the alpha/beta-tryptase genotype is sensitive, accurate, simple and safe, and should permit high-throughput screening to detect potential phenotype-genotype relations for alpha/beta-tryptases, and for other closely related alleles.	[Quang Trong Le; Lotfi-Emran, Sahar; Min, Hae-Ki; Schwartz, Lawrence B.] Virginia Commonwealth Univ, Dept Internal Med, Richmond, VA 23284 USA	Virginia Commonwealth University	Schwartz, LB (corresponding author), Virginia Commonwealth Univ, Dept Internal Med, Richmond, VA 23284 USA.	lbschwar@vcu.edu	Lotfi-Emran, Sahar/AGY-2353-2022	Lotfi-Emran, Sahar/0000-0002-8650-6779	National Institutes of Health [AI27517, AI77435]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI077435, R01AI027517] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (AI27517, AI77435 to L.B.S.).	Abdelmotelb AM, 2014, CLIN EXP ALLERGY, V44, P822, DOI 10.1111/cea.12259; BUTTERFIELD JH, 1988, LEUKEMIA RES, V12, P345, DOI 10.1016/0145-2126(88)90050-1; Caughey GH, 2000, J IMMUNOL, V164, P6566, DOI 10.4049/jimmunol.164.12.6566; Court M. H., 2008, SIMPLE HARDY WEINBER; Fukuoka Y, 2013, J IMMUNOL, V191, P1827, DOI 10.4049/jimmunol.1202889; Guida M, 2000, PHARMACOGENETICS, V10, P389, DOI 10.1097/00008571-200007000-00002; Henke W, 1997, NUCLEIC ACIDS RES, V25, P3957, DOI 10.1093/nar/25.19.3957; Huang CF, 1999, J BIOL CHEM, V274, P19670, DOI 10.1074/jbc.274.28.19670; Jensen MA, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011024, 10.1371/journal.pone.0012965]; Jogie-Brahim S, 2004, J ALLERGY CLIN IMMUN, V113, P1086, DOI 10.1016/j.jaci.2004.02.032; KOMMINOTH P, 1992, HISTOCHEMISTRY, V98, P217, DOI 10.1007/BF00271035; Le QT, 2011, J IMMUNOL, V186, P7136, DOI 10.4049/jimmunol.1001804; Marquardt U, 2002, J MOL BIOL, V321, P491, DOI 10.1016/S0022-2836(02)00625-3; Min HK, 2004, J ALLERGY CLIN IMMUN, V114, P48, DOI 10.1016/j.jaci.2004.04.008; Min HK, 2001, J ALLERGY CLIN IMMUN, V107, P315, DOI 10.1067/mai.2001.112130; MOXLEY G, 1990, NUCLEIC ACIDS RES, V18, P7197, DOI 10.1093/nar/18.23.7197-a; Onouchi Y, 2010, HUM MOL GENET, V19, P2898, DOI 10.1093/hmg/ddq176; Pallaoro M, 1999, J BIOL CHEM, V274, P3355, DOI 10.1074/jbc.274.6.3355; Pereira PJB, 1998, NATURE, V392, P306, DOI 10.1038/32703; Schwartz LB, 2006, IMMUNOL ALLERGY CLIN, V26, P451, DOI 10.1016/j.iac.2006.05.010; Simonovic A, 2012, ARCH BIOL SCI, V64, P865, DOI 10.2298/ABS1203865S; Soto D, 2002, CLIN EXP ALLERGY, V32, P1000, DOI 10.1046/j.1365-2222.2002.01416.x; Trivedi NN, 2008, J ALLERGY CLIN IMMUN, V121, P1262, DOI 10.1016/j.jaci.2008.01.019; Trivedi NN, 2009, J ALLERGY CLIN IMMUN, V124, P1099, DOI 10.1016/j.jaci.2009.07.026; Wang HW, 2002, J IMMUNOL, V169, P5145, DOI 10.4049/jimmunol.169.9.5145; Wong GW, 2002, J BIOL CHEM; Ying BW, 2007, RNA, V13, P2042, DOI 10.1261/rna.637907; Zhang ZZ, 2009, BIOTECHNIQUES, V47, P775, DOI 10.2144/000113203; Zhou Y, 2001, EXP MOL PATHOL, V70, P281, DOI 10.1006/exmp.2001.2365; ZIEGLERHEITBROCK HWL, 1988, INT J CANCER, V41, P456, DOI 10.1002/ijc.2910410324	30	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e114944	10.1371/journal.pone.0114944	http://dx.doi.org/10.1371/journal.pone.0114944			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545679	Green Published, Green Submitted, gold			2022-12-27	WOS:000347120200016
J	Politano, G; Benso, A; Savino, A; Di Carlo, S				Politano, Gianfranco; Benso, Alfredo; Savino, Alessandro; Di Carlo, Stefano			ReNE: A Cytoscape Plugin for Regulatory Network Enhancement	PLOS ONE			English	Article							MICRORNA; GENES; EXPRESSION; PREDICTION; BRAIN; RNAS	One of the biggest challenges in the study of biological regulatory mechanisms is the integration, americanmodeling, and analysis of the complex interactions which take place in biological networks. Despite post transcriptional regulatory elements (i.e., miRNAs) are widely investigated in current research, their usage and visualization in biological networks is very limited. Regulatory networks are commonly limited to gene entities. To integrate networks with post transcriptional regulatory data, researchers are therefore forced to manually resort to specific third party databases. In this context, we introduce ReNE, a Cytoscape 3.x plugin designed to automatically enrich a standard gene-based regulatory network with more detailed transcriptional, post transcriptional, and translational data, resulting in an enhanced network that more precisely models the actual biological regulatory mechanisms. ReNE can automatically import a network layout from the Reactome or KEGG repositories, or work with custom pathways described using a standard OWL/XML data format that the Cytoscape import procedure accepts. Moreover, ReNE allows researchers to merge multiple pathways coming from different sources. The merged network structure is normalized to guarantee a consistent and uniform description of the network nodes and edges and to enrich all integrated data with additional annotations retrieved from genome-wide databases like NCBI, thus producing a pathway fully manageable through the Cytoscape environment. The normalized network is then analyzed to include missing transcription factors, miRNAs, and proteins. The resulting enhanced network is still a fully functional Cytoscape network where each regulatory element (transcription factor, miRNA, gene, protein) and regulatory mechanism (up-regulation/down-regulation) is clearly visually identifiable, thus enabling a better visual understanding of its role and the effect in the network behavior. The enhanced network produced by ReNE is exportable in multiple formats for further analysis via third party applications. ReNE can be freely installed from the Cytoscape App Store (http://apps.cytoscape.org/apps/rene) and the full source code is freely available for download through a SVN repository accessible at http://www.sysbio.polito.it/tools_svn/BioInformatics/Rene/releases/. ReNE enhances a network by only integrating data from public repositories, without any inference or prediction. The reliability of the introduced interactions only depends on the reliability of the source data, which is out of control of ReNe developers.	[Politano, Gianfranco; Benso, Alfredo; Savino, Alessandro; Di Carlo, Stefano] Politecn Torino, Dept Control & Comp Engn, Turin, Italy; [Benso, Alfredo] Consorzio Interuniv Nazl Informat, Verres, AO, Italy	Polytechnic University of Turin	Politano, G (corresponding author), Politecn Torino, Dept Control & Comp Engn, Turin, Italy.	gianfranco.politano@polito.it	Benso, Alfredo/ABC-5311-2020; Di Carlo, Stefano/I-8872-2012; Benso, Alfredo/GRO-2198-2022; Savino, Alessandro/I-6132-2016	Benso, Alfredo/0000-0003-3433-7739; Di Carlo, Stefano/0000-0002-7512-5356; Savino, Alessandro/0000-0003-0529-7950	Regione Valle dAosta for the project: "Open Health Care Network Analysis" [CUP B15G13000010006]; Italian Ministry of Education, University & Research (MIUR)	Regione Valle dAosta for the project: "Open Health Care Network Analysis"; Italian Ministry of Education, University & Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	Funding: This work has been partially supported by Grant No. CUP B15G13000010006 awarded by the Regione Valle dAosta for the project: "Open Health Care Network Analysis" and by the Italian Ministry of Education, University & Research (MIUR) (Project PRIN 2010, MIND). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Bader G, 2013, PATHGUIDE; Benso A, 2014, THEOR BIOL MED MODEL, V11, DOI 10.1186/1742-4682-11-S1-S5; Benso A, 2013, PROCEEDINGS IWBBIO 2013: INTERNATIONAL WORK-CONFERENCE ON BIOINFORMATICS AND BIOMEDICAL ENGINEERING, P397; Bethesda (MD): National Center for Biotechnology Information (US), 2008, NCBI GEN FREQ ASK QU; Bindea G, 2013, BIOINFORMATICS, V29, P661, DOI 10.1093/bioinformatics/btt019; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Cerami Ethan G, 2011, Nucleic Acids Res, V39, pD685, DOI 10.1093/nar/gkq1039; Chen YT, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017876, 10.1371/journal.pone.0021428, 10.1371/journal.pone.0017844, 10.1371/journal.pone.0024144, 10.1371/journal.pone.0027163, 10.1371/journal.pone.0027333]; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; D'Amelio M, 2009, PARKINSONISM RELAT D, V15, P660, DOI 10.1016/j.parkreldis.2009.02.013; Demir E, 2010, NAT BIOTECHNOL, V28, P935, DOI 10.1038/nbt.1666; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Fazekas D, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-7; Fusco S, 2012, P NATL ACAD SCI USA, V109, P621, DOI 10.1073/pnas.1109237109; Hinske L. C., 2013, MIRIAD INTRAGENIC MI; Hinske LCG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-533; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; IPA QRC, 2013, ING; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kutmon M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082160; Lagana A, 2009, MIRO MIRNA KNOWLEDGE; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lepoivre C, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-19; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; LLC B, 2013, BIOC; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; Manyam G., 2013, BIOINFORMATICS; Maziere P, 2007, DRUG DISCOV TODAY, V12, P452, DOI 10.1016/j.drudis.2007.04.002; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Pearson ER, 2005, DIABETOLOGIA, V48, P878, DOI 10.1007/s00125-005-1738-y; Pesch R, 2012, OASICS OPENACCESS SE, V26, P69, DOI [10.4230/OASIcs.GCB.2012.69, DOI 10.4230/OASICS.GCB.2012.69]; Piao Y, 2012, BBA-GEN SUBJECTS, V1820, P577, DOI 10.1016/j.bbagen.2011.08.007; Pico AR, 2008, PLOS BIOL, V6, P1403, DOI 10.1371/journal.pbio.0060184; Potashkin JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043595; Punin J, 2001, XGMML REFERENCE; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/nmeth.2212, 10.1038/NMETH.2212]; Salomonis N, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-217; Sandyk R, 1993, Int J Neurosci, V69, P125; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Seitz H, 2009, CURR BIOL, V19, P870, DOI 10.1016/j.cub.2009.03.059; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; van Iersel MP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-399; Xu HC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-499; Yu N, 2012, NUCLEIC ACIDS RES, V40, pD797, DOI 10.1093/nar/gkr1127; Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100	52	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115585	10.1371/journal.pone.0115585	http://dx.doi.org/10.1371/journal.pone.0115585			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541727	Green Submitted, Green Published, gold			2022-12-27	WOS:000347239900055
J	Xing, JH; Liu, HT; Yang, HB; Chen, R; Chen, YG; Xu, J				Xing, Junhui; Liu, Hongtao; Yang, Huabing; Chen, Rui; Chen, Yuguo; Xu, Jian			Upregulation of Unc-51-Like Kinase 1 by Nitric Oxide Stabilizes SIRT1, Independent of Autophagy	PLOS ONE			English	Article							HEPATIC STEATOSIS; DEPENDENT DEGRADATION; PROTEIN MODIFICATION; CALORIE RESTRICTION; PROTEASOME ACTIVITY; DIABETES-MELLITUS; OXIDATIVE STRESS; DOWN-REGULATION; UBIQUITIN; MICE	SIRT1 is central to the lifespan and vascular health, but undergoes degradation that contributes to several medical conditions, including diabetes. How SIRT1 turnover is regulated remains unclear. However, emerging evidence suggests that endothelial nitric oxide synthase (eNOS) positively regulates SIRT1 protein expression. We recently identified NO as an endogenous inhibitor of 26S proteasome functionality with a cellular reporter system. Here we extended this finding to a novel pathway that regulates SIRT1 protein breakdown. In cycloheximide (CHX)-treated endothelial cells, NONOate, an NO donor, and A23187, an eNOS activator, significantly stabilized SIRT1 protein. Similarly, NO enhanced SIRT1 protein, but not mRNA expression, in CHX-free cells. NO also stabilized an autophagy-related protein unc-51 like kinase (ULK1), but did not restore SIRT1 protein levels in ULK1-siRNA-treated cells or in mouse embryonic fibroblasts (MEF) from Ulk(-/-) mice. This suggests that ULK1 mediated the NO regulation of SIRT1. Furthermore, adenoviral overexpression of ULK1 increased SIRT1 protein expression, while ULK1 siRNA treatment decreased it. Rapamycin-induced autophagy did not mimic these effects, suggesting that the effects of ULK1 were autophagy-independent. Treatment with MG132, a proteasome inhibitor, or siRNA of beta-TrCP1, an E3 ligase, prevented SIRT1 reduction induced by ULK1-siRNA. Mechanistically, ULK1 negatively regulated 26S proteasome functionality, which was at least partly mediated by O-linked-GlcNAc transferase (OGT), probably by increased O-GlcNAc modification of proteasomal subunit Rpt2. The NO-ULK1-SIRT1 axis was likely operative in the whole animal: both ULK1 and SIRT1 protein levels were significantly reduced in tissue homogenates in eNOS-knockout mice (lung) and in db/db mice where eNOS is downregulated (lung and heart). Taken together, the results show that NO stabilizes SIRT1 by regulating 26S proteasome functionality through ULK1 and OGT, but not autophagy, in endothelial cells.	[Xing, Junhui; Chen, Yuguo] Shandong Univ, Qilu Hosp, Dept Emergency, Jinan 250100, Peoples R China; [Xing, Junhui; Liu, Hongtao; Yang, Huabing; Xu, Jian] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK 73106 USA; [Xing, Junhui; Liu, Hongtao; Yang, Huabing; Xu, Jian] Univ Oklahoma, Hlth Sci Ctr, Harold Hamm Oklahoma Diabet Ctr, Oklahoma City, OK USA; [Chen, Rui] Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK USA	Shandong University; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Xu, J (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK 73106 USA.	jian-xu@ouhsc.edu		Xu, Jian/0000-0002-9557-2671	National Institutes of Health Grant from the COBRE Program of the National Institute of General Medical Sciences [5P20GM104934-08]; American Heart Association [14BGIA20030027]; American Diabetes Association [1-12-JF-58]; Oklahoma Center for Advancement of Science and Technology [HR14-062]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104934] Funding Source: NIH RePORTER	National Institutes of Health Grant from the COBRE Program of the National Institute of General Medical Sciences; American Heart Association(American Heart Association); American Diabetes Association(American Diabetes Association); Oklahoma Center for Advancement of Science and Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by an National Institutes of Health Grant from the COBRE Program of the National Institute of General Medical Sciences (5P20GM104934-08) (JX, Project 2). This work was also supported by a Beginning-Grant-in-Aid Award (14BGIA20030027) from the American Heart Association (JX), a Junior Faculty Award (1-12-JF-58) from the American Diabetes Association (JX), and a Research Award (HR14-062) from the Oklahoma Center for Advancement of Science and Technology (JX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Chalkiadaki A, 2012, CELL METAB, V16, P180, DOI 10.1016/j.cmet.2012.07.003; Chan EY, 2009, AUTOPHAGY, V5, P758, DOI 10.4161/auto.8709; Chan EYW, 2009, MOL CELL BIOL, V29, P157, DOI 10.1128/MCB.01082-08; Chung SW, 2010, ARCH BIOCHEM BIOPHYS, V501, P79, DOI 10.1016/j.abb.2010.05.003; de Kreutzenberg SV, 2010, DIABETES, V59, P1006, DOI 10.2337/db09-1187; Dodson M, 2013, FREE RADICAL BIO MED, V63, P207, DOI 10.1016/j.freeradbiomed.2013.05.014; Fekete MR, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-114; Gao ZG, 2011, J BIOL CHEM, V286, P22227, DOI 10.1074/jbc.M111.228874; Guarente L, 2011, NEW ENGL J MED, V364, P2235, DOI 10.1056/NEJMra1100831; Heessen S, 2003, FEBS LETT, V555, P397, DOI 10.1016/S0014-5793(03)01296-1; Herranz D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1001; HERSHKO A, 1984, P NATL ACAD SCI-BIOL, V81, P1619, DOI 10.1073/pnas.81.6.1619; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HERSHKO A, 1983, CELL, V34, P11, DOI 10.1016/0092-8674(83)90131-9; Hong EH, 2010, J BIOL CHEM, V285, P1283, DOI 10.1074/jbc.M109.058628; Jang SH, 2012, J CLIN PATHOL, V65, P735, DOI 10.1136/jclinpath-2012-200685; Jin JL, 2011, HEPATOLOGY, V54, P989, DOI 10.1002/hep.24471; Joo JH, 2011, MOL CELL, V43, P572, DOI 10.1016/j.molcel.2011.06.018; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Koka S, 2014, AM J PHYSIOL-HEART C, V306, pH1558, DOI 10.1152/ajpheart.00865.2013; Kornberg MD, 2010, NAT CELL BIOL, V12, P1094, DOI 10.1038/ncb2114; Kwon HS, 2008, TRENDS BIOCHEM SCI, V33, P517, DOI 10.1016/j.tibs.2008.08.001; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Li Y, 2014, GASTROENTEROLOGY, V146, P539, DOI 10.1053/j.gastro.2013.10.059; Liu HT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098486; Liu HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046720; Liu HT, 2012, ARTERIOSCL THROM VAS, V32, P2131, DOI 10.1161/ATVBAHA.112.253385; Liu XY, 2011, P NATL ACAD SCI USA, V108, P1925, DOI 10.1073/pnas.1019619108; Liu Y, 2014, DIABETES; Luu L, 2013, DIABETOLOGIA, V56, P2010, DOI 10.1007/s00125-013-2946-5; McAlpine F, 2013, AUTOPHAGY, V9, P361, DOI 10.4161/auto.23066; Nasrin N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008414; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Nogueiras R, 2012, PHYSIOL REV, V92, P1479, DOI 10.1152/physrev.00022.2011; Ooboshi H, 1997, AM J PHYSIOL-HEART C, V273, pH265, DOI 10.1152/ajpheart.1997.273.1.H265; Ota H, 2008, ARTERIOSCL THROM VAS, V28, P1634, DOI 10.1161/ATVBAHA.108.164368; Ota H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029598; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Potente M, 2008, ARTERIOSCL THROM VAS, V28, P1577, DOI 10.1161/ATVBAHA.108.173682; Purushotham A, 2012, MOL CELL BIOL, V32, P1226, DOI 10.1128/MCB.05988-11; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Revollo JR, 2013, TRENDS BIOCHEM SCI, V38, P160, DOI 10.1016/j.tibs.2012.12.004; Sarkar S, 2011, MOL CELL, V43, P19, DOI 10.1016/j.molcel.2011.04.029; Schmidt M, 2014, BBA-MOL CELL RES, V1843, P13, DOI 10.1016/j.bbamcr.2013.08.012; Schwartz AL, 1999, ANNU REV MED, V50, P57; Singh SK, 2013, J EXP MED, V210, P987, DOI 10.1084/jem.20121608; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Tomada I, 2013, AGE, V35, P35, DOI 10.1007/s11357-011-9328-z; Tripathi DN, 2013, P NATL ACAD SCI USA, V110, pE2950, DOI 10.1073/pnas.1307736110; Vasko R, 2014, J AM SOC NEPHROL, V25, P276, DOI 10.1681/ASN.2013010069; Woo SR, 2013, BIOCHEM BIOPH RES CO, V441, P831, DOI 10.1016/j.bbrc.2013.10.146; Xu J, 2007, CIRCULATION, V116, P944, DOI 10.1161/CIRCULATIONAHA.106.684795; Yang YH, 2007, NAT CELL BIOL, V9, P1253, DOI 10.1038/ncb1645; Zachara N. E., 2011, CURR PROTOC MOL BIOL; Zachara NE, 2004, TRENDS CELL BIOL, V14, P218, DOI 10.1016/j.tcb.2004.03.005; Zeidan Q, 2010, MOL BIOL CELL, V21, P1922, DOI 10.1091/mbc.E09-11-0941; Zhang FX, 2003, CELL, V115, P715, DOI 10.1016/S0092-8674(03)00974-7	62	12	12	5	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e116165	10.1371/journal.pone.0116165	http://dx.doi.org/10.1371/journal.pone.0116165			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541949	gold, Green Published, Green Submitted			2022-12-27	WOS:000347239900152
J	Zhu, SL; Ke, Y; Peng, YC; Ma, L; Li, H; Li, LQ; Zhong, JH				Zhu, Shao-Liang; Ke, Yang; Peng, Yu-Chong; Ma, Liang; Li, Hang; Li, Le-Qun; Zhong, Jian-Hong			Comparison of Long-Term Survival of Patients with Solitary Large Hepatocellular Carcinoma of BCLC Stage A after Liver Resection or Transarterial Chemoembolization: A Propensity Score Analysis	PLOS ONE			English	Article							GAMMA-CARBOXY PROTHROMBIN; ALPHA-FETOPROTEIN; CIRRHOTIC-PATIENTS; HEPATIC RESECTION; PORTAL-VEIN; TRANSPLANTATION; HEPATECTOMY; PROGNOSIS	Background: The aim of this study was to compare the long-term outcome of patients with a solitary large (>5 cm) hepatocellular carcinoma (HCC) in Barcelona Clinic Liver Cancer (BCLC) stage A who received liver resection (LR) or transarterial chemoembolization (TACE). Methods: Our study examined 128 patients treated by LR and 90 treated by TACE. To reduce bias in patient selection, we conducted propensity score analysis in the present study and 54 pairs of patients after propensity score matching were generated, their long-term survival was compared using the Kaplan-Meier method. Independent predictors of survival were identified by multivariate analysis. Results: Long-term survival was significantly better for the LR group by log-rank test (P<0.001). In multivariate analysis, tumor size, serum ALT level and TACE independently predicted survival. Despite similar baseline characteristics after propensity score matching, LR group still had significantly better survival (1 year, 68.5 vs. 55.0%; 3 years, 47.6 vs. 21.2%; 5 years, 41.3 vs. 18.5%; P=0.007) than TACE group. The LR and TACE groups had comparable 30- and 90-day post-treatment mortality. Multivariate analysis showed that serum ALT level, serum AFP level and TACE independently predicted survival by multivariate analysis after propensity score matching. Conclusion: Our propensity-score-matched study suggested that LR provided significantly better long-term survival than TACE for a solitary large HCC of the BCLC stage A, regardless of tumor size.	[Zhu, Shao-Liang; Ke, Yang; Peng, Yu-Chong; Ma, Liang; Li, Le-Qun; Zhong, Jian-Hong] Guangxi Med Univ, Affiliated Tumor Hosp, Dept Hepatobiliary Surg, Nanning 530021, Peoples R China; [Ke, Yang] Kunming Med Univ, Affiliated Hosp 2, Dept Hepatobiliary Surg, Kunming 650101, Peoples R China; [Li, Hang] Guangxi Med Univ, Affiliated Tumor Hosp, Dept Ultrasound, Nanning 530021, Peoples R China	Guangxi Medical University; Kunming Medical University; Guangxi Medical University	Li, LQ (corresponding author), Guangxi Med Univ, Affiliated Tumor Hosp, Dept Hepatobiliary Surg, Nanning 530021, Peoples R China.	xitongpingjia@163.com; zhongjianhong66@163.com	LI, LI QING/GRR-8855-2022; li, li/HII-4157-2022; Li, Li/AEM-3636-2022; Zhong, Jian-Hong/D-6641-2018; LI, LI/GVS-5344-2022	Zhong, Jian-Hong/0000-0002-1494-6396; 	National Natural Science Foundation of China [81160262]; HCC Bridge Study [CA182023]; Self-raised Scientific Research Fund of the Ministry of Health of Guangxi Province [Z2012345, Z2014241]; Youth Science Foundation of Guangxi Medical University [GXMUYSF201302]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); HCC Bridge Study; Self-raised Scientific Research Fund of the Ministry of Health of Guangxi Province; Youth Science Foundation of Guangxi Medical University	National Natural Science Foundation of China (no. 81160262), HCC Bridge Study (no. CA182023) to L.Q.L., and the Self-raised Scientific Research Fund of the Ministry of Health of Guangxi Province (no: Z2012345 and Z2014241) and Youth Science Foundation of Guangxi Medical University (no. GXMUYSF201302) to J.H.Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bargellini I, 2012, EUR J RADIOL, V81, P1173, DOI 10.1016/j.ejrad.2011.03.046; Bertino G, 2011, MINERVA MED, V102, P363; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Choi GH, 2009, AM J SURG, V198, P693, DOI 10.1016/j.amjsurg.2008.09.019; Chung GE, 2011, RADIOLOGY, V258, P627, DOI 10.1148/radiol.10101058; Cillo U, 2006, J HEPATOL, V44, P723, DOI 10.1016/j.jhep.2005.12.015; Cillo U, 2004, ANN SURG, V239, P150, DOI 10.1097/01.sla.0000109146.72827.76; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Debruyne EN, 2008, CLIN CHIM ACTA, V395, P19, DOI 10.1016/j.cca.2008.05.010; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Figueras J, 1997, HEPATOLOGY, V25, P1485, DOI 10.1002/hep.510250629; Guo Z, 2014, ANN SURG ONCOL, P1; Hsieh CB, 2006, EJSO-EUR J SURG ONC, V32, P72, DOI 10.1016/j.ejso.2005.09.003; Hsu CY, 2012, ANN SURG ONCOL, V19, P842, DOI 10.1245/s10434-011-2060-1; Hsu CY, 2011, LIVER TRANSPLANT, V17, P556, DOI 10.1002/lt.22273; Hsu KF, 2012, EUR J RADIOL, V81, P466, DOI 10.1016/j.ejrad.2010.12.058; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jin YJ, 2014, J GASTROINTEST SURG, V18, P555, DOI 10.1007/s11605-013-2440-x; Kao WY, 2012, CLIN RADIOL, V67, P429, DOI 10.1016/j.crad.2011.10.009; Ke Yang, 2014, Zhonghua Yi Xue Za Zhi, V94, P747; Kudo M, 2007, ONCOLOGY-BASEL, V72, P2, DOI 10.1159/000111702; Kuzuya T, 2011, ONCOLOGY-BASEL, V81, P251, DOI 10.1159/000334454; Llovet Josep M, 2004, Liver Transpl, V10, pS115, DOI 10.1002/lt.20034; Manghisi G, 1998, HEPATOLOGY, V28, P751; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Pawlik TM, 2005, ARCH SURG-CHICAGO, V140, P450, DOI 10.1001/archsurg.140.5.450; Santambrogio R, 2012, ANN SURG ONCOL, V19, P426, DOI 10.1245/s10434-011-1845-6; Sherman M, 2010, ONCOLOGY-BASEL, V78, P7, DOI 10.1159/000315223; Shrager B, 2013, J SURG ONCOL, V107, P111, DOI 10.1002/jso.23246; Sotiropoulos GC, 2009, DIGEST DIS SCI, V54, P2264, DOI 10.1007/s10620-008-0604-4; Taniai N, 2008, J HEPATO-BILIARY-PAN, V15, P410, DOI 10.1007/s00534-007-1317-3; TOBE T, 1994, CANCER-AM CANCER SOC, V74, P2772, DOI 10.1002/1097-0142(19941115)74:10<2772::AID-CNCR2820741006>3.0.CO;2-V; Vauthey JN, 2002, J CLIN ONCOL, V20, P1527, DOI 10.1200/JCO.20.6.1527; Yamamoto J, 2007, JPN J CLIN ONCOL, V37, P287, DOI 10.1093/jjco/hym025; Yang LY, 2009, ANN SURG, V249, P118, DOI 10.1097/SLA.0b013e3181904988; Yang LY, 2013, WORLD J SURG, V37, P2189, DOI 10.1007/s00268-013-2095-5; Yang XR, 2010, GUT, V59, P953, DOI 10.1136/gut.2008.176271; Zhong JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068193; Zhou L, 2011, EJSO-EUR J SURG ONC, V37, P521, DOI 10.1016/j.ejso.2011.03.137	40	27	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115834	10.1371/journal.pone.0115834	http://dx.doi.org/10.1371/journal.pone.0115834			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541684	Green Published, gold, Green Submitted			2022-12-27	WOS:000347239900094
J	Dasgupta, K; Jarvandi, S; De Civita, M; Pillay, S; Hajna, S; Gougeon, R; Bader, A; Da Costa, D				Dasgupta, Kaberi; Jarvandi, Soghra; De Civita, Mirella; Pillay, Sabrina; Hajna, Samantha; Gougeon, Rejeanne; Bader, Abeer; Da Costa, Deborah			Participants' Perceptions of a Group Based Program Incorporating Hands-On Meal Preparation and Pedometer-Based Self-Monitoring in Type 2 Diabetes	PLOS ONE			English	Article							AWAY-FROM-HOME; OUT-OF-HOME; WEIGHT-LOSS; PHYSICAL-ACTIVITY; DIETARY-INTAKE; RISK-FACTORS; BODY-WEIGHT; FOOD; PREVENTION; ADULTS	Background: Nutrition education (portion sizes, balanced meals) is a cornerstone of diabetes management; however, moving from information to behavior change is challenging. Through a single arm intervention study, we recently demonstrated that combining education with group-based meal preparation training has measureable effects on weight, eating behaviour, and glycemic control in adults with type 2 diabetes. In the present study, we conducted an in-depth examination of participants' perceptions of this strategy, through focus group discussion, to delineate effective elements of the strategy from participants' perspectives. Methods: Participants who had completed the nutrition education/meal preparation training program were invited to attend one of four focus group discussions. These were led by experienced facilitators and guided by questions addressing experiences during the intervention and their perceived impact. Audiotapes were transcribed and qualitative content analysis of transcripts was performed. We report herein themes that achieved saturation across the four discussions. Results: Twenty-nine (80.6%, 29/36) attended a focus group discussion. The program elements perceived as effective by participants included the hands-on interactive learning approach to meal preparation, the grocery store tour, pedometer-based self-monitoring, experiencing the link between food consumption/physical activity and glucose changes during the program, and peer support. Discussants reported changes in eating and walking behaviour, greater confidence in ability to self-manage diabetes, reductions in glucose levels and/or need for glucose-lowering medications, and, in some cases, weight loss. Family members and friends were facilitators for some and barriers for others in terms of achieving health behavior changes. Conclusions: Among adults with type 2 diabetes, a group based program that included hands-on meal preparation and pedometer-based self-monitoring was perceived as effective in conveying information, developing skills, building confidence, and changing health behaviors.	[Dasgupta, Kaberi; De Civita, Mirella; Pillay, Sabrina; Hajna, Samantha; Gougeon, Rejeanne; Da Costa, Deborah] McGill Univ, Dept Med, Ctr Hlth, Montreal, PQ, Canada; [Jarvandi, Soghra] Washington Univ, Sch Med, Div Hlth Behav Res, St Louis, MO USA; [Bader, Abeer] Community Diabet Educ Program Ottawa, Ottawa, ON, Canada	McGill University; Washington University (WUSTL)	Dasgupta, K (corresponding author), McGill Univ, Dept Med, Ctr Hlth, Montreal, PQ, Canada.	kaberi.dasgupta@mcgill.ca		Jepson, Ruth/0000-0002-9446-445X; Hajna, Samantha/0000-0002-0431-2787	McGill University Office of the Vice-Principal; Canadian Institutes of Health Research [CAI 117789]; Lawson Foundation; Fonds de recherche du Quebec - Sante (FRQS); FRQS; Canadian Institutes of Health Research	McGill University Office of the Vice-Principal; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Lawson Foundation; Fonds de recherche du Quebec - Sante (FRQS)(Fonds de la Recherche en Sante du Quebec); FRQS; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This research was supported by operating grants from the McGill University Office of the Vice-Principal (Research), the Canadian Institutes of Health Research (CAI 117789), and The Lawson Foundation awarded to KD. KD holds a senior clinician scientist career award from the Fonds de recherche du Quebec - Sante (FRQS). DD also holds a career award from the FRQS and SH holds a doctoral award from the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya SD, 2011, J AM DIET ASSOC, V111, P583, DOI 10.1016/j.jada.2011.01.009; Baker MK, 2011, DIABETES RES CLIN PR, V91, P1, DOI 10.1016/j.diabres.2010.06.030; Bandura A., 1986, SOCIAL FDN THOUGHT A; Beydoun MA, 2009, PUBLIC HEALTH NUTR, V12, P369, DOI 10.1017/S1368980008002140; Bezerra IN, 2012, NUTR REV, V70, P65, DOI 10.1111/j.1753-4887.2011.00459.x; Binkley JK, 2006, J CONSUM AFF, V40, P372, DOI 10.1111/j.1745-6606.2006.00062.x; Bravata DM, 2007, JAMA-J AM MED ASSOC, V298, P2296, DOI 10.1001/jama.298.19.2296; Burke LE, 2011, OBESITY, V19, P338, DOI 10.1038/oby.2010.208; Casey D, 2010, DIABETIC MED, V27, P79, DOI 10.1111/j.1464-5491.2009.02873.x; Dasgupta K, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-125; De Civita M, 2007, J PUBLIC HEALTH-UK, V29, P263, DOI 10.1093/pubmed/fdm033; Duffey KJ, 2007, AM J CLIN NUTR, V85, P201, DOI 10.1093/ajcn/85.1.201; Greaves CJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-119; Guthrie JF, 2002, J NUTR EDUC BEHAV, V34, P140, DOI 10.1016/S1499-4046(06)60083-3; Johnson F, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-83; Kant AK, 2004, PREV MED, V38, P243, DOI 10.1016/j.ypmed.2003.10.004; Krishnan S, 2010, AM J CLIN NUTR, V91, P465, DOI 10.3945/ajcn.2009.28682; Krueger R. A., 1988, FOCUS GROUPS PRACTIC; Krukowski RA, 2008, TELEMED J E-HEALTH, V14, P775, DOI 10.1089/tmj.2007.0132; Lee C, 2012, DIABETES METAB, V38, P420, DOI 10.1016/j.diabet.2012.04.002; Lindstrom J, 2010, HORM METAB RES, V42, pS37, DOI 10.1055/s-0029-1240975; Manrique J, 1998, J AGR ECON, V49, P321, DOI 10.1111/j.1477-9552.1998.tb01275.x; McAndrew LM, 2008, BRIT J HEALTH PSYCH, V13, P195, DOI 10.1348/135910708X295604; Orfanos P, 2007, PUBLIC HEALTH NUTR, V10, P1515, DOI 10.1017/S1368980007000171; Paulweber B, 2010, HORM METAB RES, V42, pS3, DOI 10.1055/s-0029-1240928; Prentice A M, 2003, Obes Rev, V4, P187, DOI 10.1046/j.1467-789X.2003.00117.x; Thornton LE, 2011, PUBLIC HEALTH NUTR, V14, P523, DOI 10.1017/S1368980010003022; Tudor-Locke C, 2008, MED SCI SPORT EXER, V40, pS537, DOI 10.1249/MSS.0b013e31817c7133; Wadden TA, 2009, OBESITY, V17, P713, DOI 10.1038/oby.2008.637; *WHO, 2003, WHO TECH REP SER, V916; Wing RR, 2011, DIABETES CARE, V34, P1481, DOI 10.2337/dc10-2415; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	32	4	4	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e114620	10.1371/journal.pone.0114620	http://dx.doi.org/10.1371/journal.pone.0114620			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536068	Green Published, Green Submitted, gold			2022-12-27	WOS:000348563300017
J	Grabenhenrich, LB; Reich, A; Fischer, F; Zepp, F; Forster, J; Schuster, A; Bauer, CP; Bergmann, RL; Bergmann, KE; Wahn, U; Keil, T; Lau, S				Grabenhenrich, Linus B.; Reich, Andreas; Fischer, Felix; Zepp, Fred; Forster, Johannes; Schuster, Antje; Bauer, Carl-Peter; Bergmann, Renate L.; Bergmann, Karl E.; Wahn, Ulrich; Keil, Thomas; Lau, Susanne			The Novel 10-Item Asthma Prediction Tool: External Validation in the German MAS Birth Cohort	PLOS ONE			English	Article							PRESCHOOL-CHILDREN; YOUNG-CHILDREN; RISK; SYMPTOMS; DISEASE; SAMPLE; WHEEZE; AGE	Background: A novel non-invasive asthma prediction tool from the Leicester Cohort, UK, forecasts asthma at age 8 years based on 10 predictors assessed in early childhood, including current respiratory symptoms, eczema, and parental history of asthma. Objective: We aimed to externally validate the proposed asthma prediction method in a German birth cohort. Methods: The MAS-90 study (Multicentre Allergy Study) recorded details on allergic diseases prospectively in about yearly follow-up assessments up to age 20 years in a cohort of 1,314 children born 1990. We replicated the scoring method from the Leicester cohort and assessed prediction, performance and discrimination. The primary outcome was defined as the combination of parent-reported wheeze and asthma drugs (both in last 12 months) at age 8. Sensitivity analyses assessed model performance for outcomes related to asthma up to age 20 years. Results: For 140 children parents reported current wheeze or cough at age 3 years. Score distribution and frequencies of later asthma resembled the Leicester cohort: 9% vs. 16% (MAS-90 vs. Leicester) of children at low risk at 3 years had asthma at 8 years, at medium risk 45% vs. 48%. Performance of the asthma prediction tool in the MAS-90 cohort was similar (Brier score 0.22 vs. 0.23) and discrimination slightly better than in the original cohort (area under the curve, AUC 0.83 vs. 0.78). Prediction and discrimination were robust against changes of inclusion criteria, scoring and outcome definitions. The secondary outcome 'physicians' diagnosed asthma at 20 years' showed the highest discrimination (AUC 0.89). Conclusion: The novel asthma prediction tool from the Leicester cohort, UK, performed well in another population, a German birth cohort, supporting its use and further development as a simple aid to predict asthma risk in clinical settings.	[Grabenhenrich, Linus B.; Reich, Andreas; Fischer, Felix; Keil, Thomas] Charite, Inst Social Med Epidemiol & Hlth Econ, D-13353 Berlin, Germany; [Fischer, Felix] Charite, Dept Psychosomat Med, Clin Internal Med, D-13353 Berlin, Germany; [Zepp, Fred] Univ Med Ctr Mainz, Ctr Paediat & Adolescent Med, Mainz, Germany; [Forster, Johannes] St Josefs Hosp, Dept Paediat, Freiburg, Germany; [Schuster, Antje] Univ Dusseldorf, Dept Paediat, Dusseldorf, Germany; [Bauer, Carl-Peter] Tech Univ Munich, Dept Paediat, D-80290 Munich, Germany; [Bergmann, Renate L.; Bergmann, Karl E.] Charite, Dept Obstet, D-13353 Berlin, Germany; [Wahn, Ulrich; Lau, Susanne] Charite, Dept Paediat Pneumol & Immunol, D-13353 Berlin, Germany; [Keil, Thomas] Univ Wurzburg, Inst Clin Epidemiol & Biometry, D-97070 Wurzburg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Johannes Gutenberg University of Mainz; Heinrich Heine University Dusseldorf; Technical University of Munich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Wurzburg	Grabenhenrich, LB (corresponding author), Charite, Inst Social Med Epidemiol & Hlth Econ, D-13353 Berlin, Germany.	linus.grabenhenrich@charite.de	Reich, Andreas/B-1204-2016; fischer, felix/AAW-6634-2021	Reich, Andreas/0000-0002-3729-0772; fischer, felix/0000-0002-9693-6676; Grabenhenrich, Linus/0000-0002-9300-6625; Lau, Susanne/0000-0002-5189-4265	German Federal Ministry of Education and Research [07015633, 07 ALE 27, 01EE9405/5, 01EE9406]; German Research Foundation [KE 1462/2-1]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Foundation(German Research Foundation (DFG))	The MAS study was funded by grants from the German Federal Ministry of Education and Research (07015633, 07 ALE 27, 01EE9405/5, 01EE9406) and the German Research Foundation (KE 1462/2-1). The funders had no role in the design, management, data collection, analysis or interpretation of the data or in the writing of the manuscript or the decision to submit for publication.	[Anonymous], 2012, BTS SIGN GUID MAN AS; Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; Bergmann R L, 1994, Pediatr Allergy Immunol, V5, P19, DOI 10.1111/j.1399-3038.1994.tb00343.x; Bergmann R L, 1993, Pediatr Allergy Immunol, V4, P130, DOI 10.1111/j.1399-3038.1993.tb00081.x; Bouwmeester W, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001221; Castro-Rodriguez JA, 2000, AM J RESP CRIT CARE, V162, P1403, DOI 10.1164/ajrccm.162.4.9912111; Caudri D, 2009, J ALLERGY CLIN IMMUN, V124, P903, DOI 10.1016/j.jaci.2009.06.045; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Grabenhenrich LB, 2014, J ALLERGY CLIN IMMUN, V133, P979, DOI 10.1016/j.jaci.2013.11.035; Guilbert TW, 2006, NEW ENGL J MED, V354, P1985, DOI 10.1056/NEJMoa051378; Hafkamp-de Groen E, 2013, J ALLERGY CLIN IMMUN, V132, P1303, DOI 10.1016/j.jaci.2013.07.007; Kuehni CE, 2007, INT J EPIDEMIOL, V36, P977, DOI 10.1093/ije/dym090; Kurukulaaratchy RJ, 2003, EUR RESPIR J, V22, P767, DOI 10.1183/09031936.03.00005903; Leonardi NA, 2011, J ALLERGY CLIN IMMUN, V127, P1466, DOI 10.1016/j.jaci.2011.03.001; Maguire JL, 2011, PEDIATRICS, V128, pE666, DOI 10.1542/peds.2011-0043; Martino D, 2011, CHEST, V139, P640, DOI 10.1378/chest.10-1800; Matricardi PM, 2010, EUR RESPIR J, V35, P701, DOI 10.1183/09031936.00163709; Moons KGM, 2012, HEART, V98, P691, DOI 10.1136/heartjnl-2011-301247; Pescatore AM, 2014, J ALLERGY CLIN IMMUN, V133, P111, DOI 10.1016/j.jaci.2013.06.002; Prescott SL, 2010, P NUTR SOC, V69, P366, DOI 10.1017/S0029665110001874; Rodriguez-Martinez CE, 2011, PEDIATR PULM, V46, P1175, DOI 10.1002/ppul.21493; Savenije OEM, 2012, J ALLERGY CLIN IMMUN, V130, P325, DOI 10.1016/j.jaci.2012.05.007; Simpson A, 2004, CURR OPIN ALLERGY CL, V4, P45, DOI [10.1097/00130832-200402000-00010, 10.1097/01.all.0000113678.18759.38]; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Turner S, 2014, J ALLERGY CLIN IMMUN, V133, P119, DOI 10.1016/j.jaci.2013.07.001; Turner S, 2011, THORAX, V66, P1104, DOI 10.1136/thoraxjnl-2011-200213; van Schayck OCP, 2007, J ALLERGY CLIN IMMUN, V119, P1323, DOI 10.1016/j.jaci.2007.02.024; Vergouwe Y, 2005, J CLIN EPIDEMIOL, V58, P475, DOI 10.1016/j.jclinepi.2004.06.017	29	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115852	10.1371/journal.pone.0115852	http://dx.doi.org/10.1371/journal.pone.0115852			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536057	gold, Green Published, Green Submitted			2022-12-27	WOS:000348563300080
J	Iotti, M; Leonardi, M; Lancellotti, E; Salerni, E; Oddis, M; Leonardi, P; Perini, C; Pacioni, G; Zambonelli, A				Iotti, Mirco; Leonardi, Marco; Lancellotti, Enrico; Salerni, Elena; Oddis, Marilena; Leonardi, Pamela; Perini, Claudia; Pacioni, Giovanni; Zambonelli, Alessandra			Spatio-Temporal Dynamic of Tuber magnatum Mycelium in Natural Truffle Grounds	PLOS ONE			English	Article							REAL-TIME PCR; EXTRARADICAL SOIL MYCELIUM; SPATIAL-DISTRIBUTION; LACTARIUS-DELICIOSUS; FUNGAL COMMUNITIES; SEASONAL DYNAMICS; BOLETUS-EDULIS; ECTOMYCORRHIZAL COMMUNITIES; FOREST; QUANTIFICATION	Tuber magnatum produces the world's most expensive truffle. This fungus produces very rare ectomycorrhizas which are difficult or even impossible to detect in the field. A "real-time'' PCR assay was recently developed to quantify and to track T. magnatum mycelium in soil. Here, this technique was used to investigate the spatial distribution of T. magnatum extra-radical mycelium in soil productive patches and its dynamic across seasons. This study was carried out in four different natural T. magnatum truffle grounds located in different Italian regions. During the fruiting seasons, the amount of T. magnatum mycelium was significantly higher around the fruiting points and decreased going farther away from them. Moreover, T. magnatum mycelium inside the productive patches underwent seasonal fluctuations. In early spring, the amount of T. magnatum mycelium was significantly higher than in summer. In summer, probably due to the hot and dry season, T. magnatum mycelium significantly decreased, whereas in autumn it increased again and was concentrated at the putative fruiting points. These results give new insights on T. magnatum ecology and are useful to plan the most appropriate sampling strategy for evaluating the management of a truffle ground.	[Iotti, Mirco; Leonardi, Pamela; Zambonelli, Alessandra] Univ Bologna, Dept Agr Sci, Bologna, Italy; [Leonardi, Marco; Oddis, Marilena; Pacioni, Giovanni] Univ Aquila, Dept Life Hlth & Environm Sci, I-67100 Laquila, Italy; [Lancellotti, Enrico] Univ Sassari, Dipartimento Agr, I-07100 Sassari, Italy; [Salerni, Elena; Perini, Claudia] Univ Siena, Dept Life Sci, I-53100 Siena, Italy	University of Bologna; University of L'Aquila; University of Sassari; University of Siena	Zambonelli, A (corresponding author), Univ Bologna, Dept Agr Sci, Bologna, Italy.	alessandr.zambonelli@unibo.it	Iotti, Mirco/M-1750-2015; Pacioni, Giovanni/O-7646-2015; Leonardi, Marco/AAA-5112-2020; Zambonelli, Alessandra/AAF-3581-2019	Iotti, Mirco/0000-0003-2705-0385; Pacioni, Giovanni/0000-0002-0201-5789; Leonardi, Marco/0000-0003-3502-4232; Lancellotti, Enrico/0000-0001-9966-0479	Interregional Project MAGNATUM - Emilia Romagna Region, Tuscany Region, Abruzzo Region [321 - 25.9.2007]	Interregional Project MAGNATUM - Emilia Romagna Region, Tuscany Region, Abruzzo Region	This work was supported by Interregional Project MAGNATUM (Decree n. 321 - 25.9.2007 of ARSIA Tuscany) funded by Emilia Romagna Region ( http://www.regione.emilia-romagna.it/), Tuscany Region (http://www.regione.toscana.it/), Abruzzo Region (http://www.regione.abruzzo.it/portale/index.asp), and Molise Region (http://www3.regione.molise.it/flex/cm/pages/ServeBLOB.php/L/IT/IDPagina/1) to AZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbieri E, 2010, FUNGAL BIOL-UK, V114, P936, DOI 10.1016/j.funbio.2010.09.001; Benucci GMN, 2014, MYCORRHIZA, V24, P281, DOI 10.1007/s00572-013-0538-3; Benucci GMN, 2011, FEMS MICROBIOL ECOL, V76, P170, DOI 10.1111/j.1574-6941.2010.01039.x; Benucci GMN, 2013, SOIL BIOLOGY, V34, P265, DOI [10.1007/978-3-642-33823-6_15, DOI 10.1007/978-3-642-33823-6_15]; Bertini L, 2006, MICROBIOL RES, V161, P59, DOI 10.1016/j.micres.2005.06.003; Bidartondo MI, 2005, FUNGAL COMMUNITY ITS, P215; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Buntgen U, 2012, NAT CLIM CHANGE, V2, P827, DOI 10.1038/nclimate1733; Coll L, 2012, ECOSCIENCE, V19, P238, DOI 10.2980/19-3-3488; De la Varga H, 2013, MYCORRHIZA, V23, P391, DOI 10.1007/s00572-013-0481-3; De la Varga H, 2012, MYCORRHIZA, V22, P59, DOI 10.1007/s00572-011-0382-2; Ekblad A, 2013, PLANT SOIL, V366, P1, DOI 10.1007/s11104-013-1630-3; Feinstein LM, 2009, APPL ENVIRON MICROB, V75, P5428, DOI 10.1128/AEM.00120-09; Garcia-Barreda S, 2012, MYCORRHIZA, V22, P361, DOI 10.1007/s00572-011-0410-2; Giomaro GM, 2005, SOIL BIOL, V4, P253; Gryndler M, 2013, MYCORRHIZA, V23, P341, DOI 10.1007/s00572-012-0475-6; Guidot A, 2002, FEMS MICROBIOL ECOL, V42, P477, DOI 10.1111/j.1574-6941.2002.tb01036.x; Guidot A, 2001, MOL ECOL, V10, P1121, DOI 10.1046/j.1365-294X.2001.01265.x; Hall I. R., 2012, EDIBLE ECTOMYCORRHIZ, P191; Hall IR, 1998, ECON BOT, V52, P192, DOI 10.1007/BF02861209; HALL IR, 2007, TAMING TRUFFLE HIST; Hortal S, 2008, MYCORRHIZA, V18, P69, DOI 10.1007/s00572-007-0160-3; Horton TR, 2001, MOL ECOL, V10, P1855, DOI 10.1046/j.0962-1083.2001.01333.x; Iotti M, 2012, SOIL BIOLOGY, V34, P145, DOI DOI 10.1007/978-3-642-33823-6_; Iotti M, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-93; Iotti M, 2010, FEMS MICROBIOL ECOL, V72, P250, DOI 10.1111/j.1574-6941.2010.00844.x; Kennedy PG, 2007, MOL ECOL, V16, P881, DOI 10.1111/j.1365-294X.2006.03191.x; Landeweert R, 2003, FEMS MICROBIOL ECOL, V45, P283, DOI 10.1016/S0168-6496(03)00163-6; Le Tacon F, 2014, MYCORRHIZA, V24, pS115, DOI 10.1007/s00572-014-0568-5; Lefevre C, 2012, SOIL BIOLOGY, V34, P209, DOI DOI 10.1007/978-3-642-33823-6_; Leonardi M, 2013, MYCORRHIZA, V23, P349, DOI 10.1007/s00572-012-0474-7; Lian CL, 2006, NEW PHYTOL, V171, P825, DOI 10.1111/j.1469-8137.2006.01801.x; Mello A, 2006, FEMS MICROBIOL LETT, V260, P1, DOI 10.1111/j.1574-6968.2006.00252.x; Morris J., 2005, FUNGAL COMMUNITY, P13; Morte A, 2012, SOIL BIOLOGY, V34, P241; Murat C, 2005, FEMS MICROBIOL LETT, V245, P307, DOI 10.1016/j.femsle.2005.03.019; Neumann J, 2013, PLANT SOIL, V371, P435, DOI 10.1007/s11104-013-1701-5; Orgiazzi A., 2013, Diversity, V5, P73; Parlade J, 2007, J BIOTECHNOL, V128, P14, DOI 10.1016/j.jbiotec.2006.09.010; Parlade J, 2013, MYCORRHIZA, V23, P99, DOI 10.1007/s00572-012-0454-y; Peintner U, 2007, ENVIRON MICROBIOL, V9, P880, DOI 10.1111/j.1462-2920.2006.01208.x; R Core Team, 2020, R LANG ENV STAT COMP; Raidl S, 2005, PLANT BIOLOGY, V7, P713, DOI 10.1055/s-2005-873003; Rellini I, 2011, J MAPS, V7, P353, DOI 10.4113/jom.2011.1180; Salerni E, 2014, MYCORRHIZA, V24, pS79, DOI 10.1007/s00572-013-0543-6; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Smith CJ, 2009, FEMS MICROBIOL ECOL, V67, P6, DOI 10.1111/j.1574-6941.2008.00629.x; Smith CJ, 2006, ENVIRON MICROBIOL, V8, P804, DOI 10.1111/j.1462-2920.2005.00963.x; Suz LM, 2008, FEMS MICROBIOL LETT, V285, P72, DOI 10.1111/j.1574-6968.2008.01213.x; Taylor AFS, 2002, PLANT SOIL, V244, P19, DOI 10.1023/A:1020279815472; van der Linde S, 2009, FEMS MICROBIOL ECOL, V69, P344, DOI 10.1111/j.1574-6941.2009.00716.x; Voriskova J, 2014, NEW PHYTOL, V201, P269, DOI 10.1111/nph.12481; Wallander H, 2013, SOIL BIOL BIOCHEM, V57, P1034, DOI 10.1016/j.soilbio.2012.08.027; Wang X., 2012, EDIBLE ECTOMYCORRHIZ, P227, DOI [10.1007/978-3-642-33823-6_13, DOI 10.1007/978-3-642-33823-6_13]; Zambonelli A., 2012, SOIL BIOL, V34, P105, DOI [10.1007/978-3-642-33823-6, DOI 10.1007/978-3-642-33823-6, 10.1007/978-3-642, DOI 10.1007/978-3-642-33823-6_]; Zampieri E, 2010, FEMS MICROBIOL ECOL, V71, P43, DOI 10.1111/j.1574-6941.2009.00783.x; Zhou ZH, 2001, J PLANT RES, V114, P179, DOI 10.1007/PL00013981	57	22	25	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115921	10.1371/journal.pone.0115921	http://dx.doi.org/10.1371/journal.pone.0115921			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25535741	gold, Green Published, Green Submitted			2022-12-27	WOS:000348563300086
J	Napoli, PE; Coronella, F; Satta, GM; Galantuomo, MS; Fossarello, M				Napoli, Pietro Emanuele; Coronella, Franco; Satta, Giovanni Maria; Galantuomo, Maria Silvana; Fossarello, Maurizio			Evaluation of the Adhesive Properties of the Cornea by Means of Optical Coherence Tomography in Patients with Meibomian Gland Dysfunction and Lacrimal Tear Deficiency	PLOS ONE			English	Article							OCULAR SURFACE EPITHELIUM; DRY EYE DISEASE; BREAK-UP TIME; CONJUNCTIVAL EPITHELIA; ARTIFICIAL TEARS; FILM STABILITY; FLUORESCEIN; THICKNESS; MUCIN; CARBOXYMETHYLCELLULOSE	Objective: The aim was to determine the influence of meibomian gland dysfunction (MGD) and aqueous tear deficiency dry eye (ADDE) on the adhesive properties of the central cornea by means of optical coherence tomography (OCT), and to investigate the relationship between corneal adhesiveness and classical tear tests, as well as the reliability of results, in these lacrimal functional unit disorders. Design: Prospective, case-control study. Methods: Twenty-eight patients with MGD and 27 patients with ADDE were studied. A group of 32 healthy subjects of similar age and gender distribution served as a control group. The adhesive properties of the anterior corneal surface were measured by OCT, based on the retention time of adhesion marker above it, in all participants. Results: An excellent (>= 5 minutes), borderline (within 3-5 minutes), fair (within 1-3 minutes) and poor (< 1 minute) values of corneal adhesiveness were found, respectively, in 0%, 7.1%, 64.3% and 28.6% of MGD, in 0%, 7.4%, 63% and 29.6% of ADDE, and in 31.3%, 65.6%, 3.1% and 0% of healthy patients. The differences in time of corneal adhesiveness between MGD and healthy patients, as well as between ADDE and healthy patients, were found to be statistically significant (p<0.001; p<0.001; respectively). Conversely, no statistical significant differences between MGD and ADDE were found (p=0.952). Data analysis revealed a statistically significant correlation between corneal adhesiveness and clinical tests of dry eye, as well as an excellent degree of inter-rater reliability and reproducibility for OCT measurements (p<0.001). Conclusion: ADDE and MGD share similar abnormalities on OCT imaging. Decreased adhesive properties of the anterior cornea were identified as a common feature of MGD and ADDE. This simple OCT approach may provide new clues into the mechanism and evaluation of dry eye syndrome.	[Napoli, Pietro Emanuele; Coronella, Franco; Satta, Giovanni Maria; Galantuomo, Maria Silvana; Fossarello, Maurizio] Univ Cagliari, Dept Surg Sci, Eye Clin, Cagliari, Italy	University of Cagliari	Napoli, PE (corresponding author), Univ Cagliari, Dept Surg Sci, Eye Clin, Cagliari, Italy.	pietronapoli@ymail.com	Fossarello, Maurizio/AAD-8235-2021; Napoli, Pietro/AAP-8423-2020; Fossarello, Maurizio/G-2032-2015	Napoli, Pietro Emanuele/0000-0001-7020-0823; Fossarello, Maurizio/0000-0003-1520-7760				Afonso AA, 1999, OPHTHALMOLOGY, V106, P803, DOI 10.1016/S0161-6420(99)90170-7; Amano S, 2010, J EYE ATARASHII GANK, V27, P627; [Anonymous], 2007, OCUL SURF, V52, P93; [Anonymous], 2007, OCUL SURF, V52, P108; Braun RJ, 2003, MATH MED BIOL, V20, P1; Bron AJ, 2003, CORNEA, V22, P640, DOI 10.1097/00003226-200310000-00008; Bron AJ, 2001, SURV OPHTHALMOL, V45, pS221, DOI 10.1016/S0039-6257(00)00201-0; Cho P, 1998, OPHTHAL PHYSL OPT, V18, P319, DOI 10.1046/j.1475-1313.1998.00385.x; Danjo Y, 1998, INVEST OPHTH VIS SCI, V39, P2602; de Paiva CS, 2003, OPHTHALMOLOGY, V110, P1102; Garrett Q, 2007, INVEST OPHTH VIS SCI, V48, P1559, DOI 10.1167/iovs.06-0848; Gipson IK, 1997, PROG RETIN EYE RES, V16, P81, DOI 10.1016/S1350-9462(96)00022-5; Goto E, 2003, ARCH OPHTHALMOL-CHIC, V121, P173; Goto E, 2002, AM J OPHTHALMOL, V133, P181, DOI 10.1016/S0002-9394(01)01365-4; Goto T, 2003, AM J OPHTHALMOL, V135, P607, DOI 10.1016/S0002-9394(02)02221-3; INATOMI T, 1995, INVEST OPHTH VIS SCI, V36, P1818; Johnson ME, 2005, CORNEA, V24, P811, DOI 10.1097/01.ico.0000154378.67495.40; King-Smith PE, 1999, OPTOMETRY VISION SCI, V76, P19, DOI 10.1097/00006324-199901000-00025; Koh S, 2008, INVEST OPHTH VIS SCI, V49, P133, DOI 10.1167/iovs.07-0762; KORB DR, 1994, CORNEA, V13, P354, DOI 10.1097/00003226-199407000-00012; Lemp MA, 2008, AM J OPHTHALMOL, V146, P350, DOI 10.1016/j.ajo.2008.05.016; Lemp MA, 2007, OCUL SURF, V5, P75; McNamara NA, 1997, INVEST OPHTH VIS SCI, V38, P1830; MENGHER LS, 1986, ACTA OPHTHALMOL, V64, P441; Napoli PE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109843; Napoli PE, 2014, INVEST OPHTH VIS SCI, V55, P4533, DOI 10.1167/iovs.14-14666; Napoli PE, 2014, INVEST OPHTH VIS SCI, V55, P3179, DOI 10.1167/iovs.13-13613; Napoli PE, 2014, CAN J OPHTHALMOL, V49, P210, DOI 10.1016/j.jcjo.2013.10.003; PATEL S, 1985, AM J OPTOM PHYS OPT, V62, P188; Pflugfelder SC, 2000, INVEST OPHTH VIS SCI, V41, P1316; Sommer A., 1982, NUTR BLINDNESS XEROP; Sweeney DF, 2013, EXP EYE RES, V117, P28, DOI 10.1016/j.exer.2013.08.010; Wang JH, 2006, INVEST OPHTH VIS SCI, V47, P4349, DOI 10.1167/iovs.05-1654; Wang JH, 2006, INVEST OPHTH VIS SCI, V47, P3325, DOI 10.1167/iovs.06-0055	34	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115762	10.1371/journal.pone.0115762	http://dx.doi.org/10.1371/journal.pone.0115762			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536051	gold, Green Published, Green Submitted			2022-12-27	WOS:000348563300071
J	Ni, HM; Bhakta, A; Wang, SG; Li, ZR; Manley, S; Huang, HQ; Copple, B; Ding, WX				Ni, Hong-Min; Bhakta, Amar; Wang, Shaogui; Li, Zhenrui; Manley, Sharon; Huang, Heqing; Copple, Bryan; Ding, Wen-Xing			Role of Hypoxia Inducing Factor-1 beta in Alcohol-Induced Autophagy, Steatosis and Liver Injury in Mice	PLOS ONE			English	Article							IN-VIVO; THERAPEUTIC TARGETS; LIPID-METABOLISM; ADIPOSE-TISSUE; FATTY LIVER; ETHANOL; INDUCTION; HIF-1-ALPHA; ACTIVATION; DISEASE	Chronic alcohol causes liver hypoxia and steatosis, which eventually develops into alcoholic liver disease (ALD). While it has been known that alcohol consumption activates hepatic hypoxia inducing factor-1 alpha (HIF-1 alpha), conflicting results regarding the role of HIF-1 alpha in alcohol-induced liver injury and steatosis in mice have been reported. In the present study, we aimed to use hepatocyte-specific HIF-1 beta knockout mice to eliminate the possible compensatory effects of the single knockout of the 1 alpha subunit of HIF to study the role of HIFs in ALD. C57BL/6 wild type mice were treated with acute ethanol to mimic human binge drinking. Matched wild-type and hepatocyte specific HIF-1 beta knockout mice were also subjected to a recently established Gao-binge alcohol model to mimic chronic plus binge conditions, which is quite common in human alcoholics. We found that acute alcohol treatment increased BNIP3 and BNIP3L/NIX expression in primary cultured hepatocytes and in mouse livers, suggesting that HIF may be activated in these models. We further found that hepatocyte-specific HIF-1 beta knockout mice developed less steatosis and liver injury following the Gao-binge model or acute ethanol treatment compared with their matched wild type mice. Mechanistically, protection against Gao-binge treatment-induced steatosis and liver injury was likely associated with increased FoxO3a activation and subsequent induction of autophagy in hepatocyte-specific HIF-1 beta knockout mice.	[Ni, Hong-Min; Bhakta, Amar; Wang, Shaogui; Li, Zhenrui; Manley, Sharon; Copple, Bryan; Ding, Wen-Xing] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA; [Wang, Shaogui; Huang, Heqing] Sun Yat Sen Univ, Sch Pharmaceut Sci, Lab Pharmacol & Toxicol, Guangzhou 510275, Guangdong, Peoples R China	University of Kansas; University of Kansas Medical Center; Sun Yat Sen University	Ding, WX (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA.	wxding@kumc.edu		Li, Zhenrui/0000-0001-7172-7643; Manley, Sharon/0000-0002-2411-9706	National Instiute on Alcohol Abuse and Alcoholism [R01 AA020518]; National Center for Research Resources [5P20RR021940]; National Institute of General Medical Sciences [8P20 GM103549, T32 ES007079]; Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health [P20 GM103418]; National Institutes of Health [DK073566]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103549, P20GM103418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA020518, R01AA020518] Funding Source: NIH RePORTER	National Instiute on Alcohol Abuse and Alcoholism; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by grant R01 AA020518 (to WXD) from National Instiute on Alcohol Abuse and Alcoholism (http://www.niaaa.nih.gov/; 5P20RR021940 (to WXD) from National Center for Research Resources (http://dnrc.nih.gov/reports/programs/ncrr.asp); 8P20 GM103549 and T32 ES007079 (to WXD) from the National Institute of General Medical Sciences (http://www.nigms.nih.gov/Pages/default.aspx); P20 GM103418 (to WXD) from Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health (http://www.nigms.nih.gov/Pages/default.aspx; DK073566 (to BC) National Institutes of Health http://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arteel GE, 1997, HEPATOLOGY, V25, P920, DOI 10.1002/hep.510250422; Band M, 2009, FASEB J, V23, P2327, DOI 10.1096/fj.08-122978; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Bertola A, 2013, NAT PROTOC, V8, P627, DOI 10.1038/nprot.2013.032; Bohensky J, 2007, AUTOPHAGY, V3, P207, DOI 10.4161/auto.3708; Chacko BK, 2011, HEPATOLOGY, V54, P153, DOI 10.1002/hep.24377; Czaja MJ, 2013, AUTOPHAGY, V9, P1131, DOI 10.4161/auto.25063; Ding WX, 2011, AUTOPHAGY, V7, P248, DOI 10.4161/auto.7.2.14347; Ding WX, 2010, GASTROENTEROLOGY, V139, P1740, DOI 10.1053/j.gastro.2010.07.041; Dolganiuc A, 2012, ALCOHOL CLIN EXP RES, V36, P1301, DOI 10.1111/j.1530-0277.2012.01742.x; Fromenty B, 1997, J HEPATOL, V26, P43, DOI 10.1016/S0168-8278(97)80496-5; Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002; Kang L, 2007, J BIOL CHEM, V282, P28465, DOI 10.1074/jbc.M705503200; Kang XQ, 2009, HEPATOLOGY, V50, P1241, DOI 10.1002/hep.23090; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Li J, 2004, EXP MOL PATHOL, V77, P184, DOI 10.1016/j.yexmp.2004.08.002; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Mansouri A, 1997, J HEPATOL, V27, P96, DOI 10.1016/S0168-8278(97)80286-3; Mathews S, 2014, AM J PHYSIOL-GASTR L, V306, pG819, DOI 10.1152/ajpgi.00041.2014; Mazure NM, 2010, CURR OPIN CELL BIOL, V22, P177, DOI 10.1016/j.ceb.2009.11.015; Mazure NM, 2009, AUTOPHAGY, V5, P868, DOI 10.4161/auto.9042; Mehal WZ, 2012, J HEPATOL, V56, P311, DOI 10.1016/j.jhep.2011.09.009; Menrad H, 2010, HEPATOLOGY, V51, P2183, DOI 10.1002/hep.23597; Nath B, 2011, HEPATOLOGY, V53, P1526, DOI 10.1002/hep.24256; Ni HM, 2014, J HEPATOL, V61, P617, DOI 10.1016/j.jhep.2014.04.043; Ni HM, 2013, AM J PATHOL, V183, P1815, DOI 10.1016/j.ajpath.2013.08.011; Ni HM, 2012, TOXICOL SCI, V127, P438, DOI 10.1093/toxsci/kfs133; Ni HM, 2012, HEPATOLOGY, V55, P222, DOI 10.1002/hep.24690; Ni HM, 2011, AUTOPHAGY, V7, P188, DOI 10.4161/auto.7.2.14181; Nishiyama Y, 2012, J HEPATOL, V56, P441, DOI 10.1016/j.jhep.2011.07.024; Rankin EB, 2009, MOL CELL BIOL, V29, P4527, DOI 10.1128/MCB.00200-09; Reue K, 2008, FEBS LETT, V582, P90, DOI 10.1016/j.febslet.2007.11.014; Rouschop KMA, 2009, CURR MOL MED, V9, P417, DOI 10.2174/156652409788167131; Seo Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.260; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Thomes PG, 2013, AUTOPHAGY, V9, P63, DOI 10.4161/auto.22490; Tikhanovich I, 2013, HEPATOLOGY; Tikhanovich I, 2013, J GASTROEN HEPATOL, V28, P125, DOI 10.1111/jgh.12021; Tomita S, 2000, MOL ENDOCRINOL, V14, P1674, DOI 10.1210/me.14.10.1674; Tumurbaatar B, 2013, AM J PATHOL, V183, P1803, DOI 10.1016/j.ajpath.2013.08.013; van der Vos KE, 2008, ONCOGENE, V27, P2289, DOI 10.1038/onc.2008.22; van der Vos KE, 2012, NAT CELL BIOL, V14, P829, DOI 10.1038/ncb2536; Walshe TE, 2008, ANNU REV PATHOL-MECH, V3, P615, DOI 10.1146/annurev.pathmechdis.3.121806.151501; Williams JA, 2014, WORLD J GASTROENTERO, V20, P12908, DOI 10.3748/wjg.v20.i36.12908; Yang LL, 2014, FREE RADICAL BIO MED, V68, P260, DOI 10.1016/j.freeradbiomed.2013.12.026; Yin HQ, 2014, GASTROENTEROLOGY, V146, P801, DOI 10.1053/j.gastro.2013.11.008; You M, 2002, J BIOL CHEM, V277, P29342, DOI 10.1074/jbc.M202411200; Zelickson BR, 2011, BBA-BIOENERGETICS, V1807, P1573, DOI 10.1016/j.bbabio.2011.09.011; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004; Zhao Y, 2010, NAT CELL BIOL, V12, P665, DOI 10.1038/ncb2069; Zhong W, 2012, AM J PATHOL, V180, P998, DOI 10.1016/j.ajpath.2011.11.017	51	28	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115849	10.1371/journal.pone.0115849	http://dx.doi.org/10.1371/journal.pone.0115849			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536043	Green Published, Green Submitted, gold			2022-12-27	WOS:000348563300079
J	Blanco, Y; Rivas, LA; Garcia-Moyano, A; Aguirre, J; Cruz-Gil, P; Palacin, A; van Heerden, E; Parro, V				Blanco, Yolanda; Rivas, Luis A.; Garcia-Moyano, Antonio; Aguirre, Jacobo; Cruz-Gil, Patricia; Palacin, Arantxa; van Heerden, Esta; Parro, Victor			Deciphering the Prokaryotic Community and Metabolisms in South African Deep-Mine Biofilms through Antibody Microarrays and Graph Theory	PLOS ONE			English	Article							SULFUR-OXIDIZING BACTERIUM; SP-NOV.; MICROBIAL COMMUNITY; WITWATERSRAND BASIN; GOLD MINE; GEN. NOV.; SUBSURFACE; WATER; DIVERSITY; SEQUENCE	In the South African deep mines, a variety of biofilms growing in mine corridor walls as water seeps from intersections or from fractures represents excellent proxies for deep-subsurface environments. However, they may be greatly affected by the oxygen inputs through the galleries of mining activities. As a consequence, the interaction between the anaerobic water coming out from the walls with the oxygen inputs creates new conditions that support rich microbial communities. The inherent difficulties for sampling these delicate habitats, together with transport and storage conditions may alter the community features and composition. Therefore, the development of in situ monitoring methods would be desirable for quick evaluation of the microbial community. In this work, we report the usefulness of an antibody-microarray (EMChip66) immunoassay for a quick check of the microbial diversity of biofilms located at 1.3 km below surface within the Beatrix deep gold mine (South Africa). In addition, a deconvolution method, previously described and used for environmental monitoring, based on graph theory and applied on antibody cross-reactivity was used to interpret the immunoassay results. The results were corroborated and further expanded by 16S rRNA gene sequencing analysis. Both culture-independent techniques coincided in detecting features related to aerobic sulfur-oxidizers, aerobic chemoorganotrophic Alphaproteobacteria and metanotrophic Gammaproteobacteria. 16S rRNA gene sequencing detected phylotypes related to nitrate-reducers and anaerobic sulfur-oxidizers, whereas the EMChip66 detected immunological features from methanogens and sulfate-reducers. The results reveal a diverse microbial community with syntrophic metabolisms both anaerobic (fermentation, methanogenesis, sulphate and nitrate reduction) and aerobic (methanotrophy, sulphur oxidation). The presence of oxygen-scavenging microbes might indicate that the system is modified by the artificial oxygen inputs from the mine galleries.	[Blanco, Yolanda; Rivas, Luis A.; Aguirre, Jacobo; Cruz-Gil, Patricia; Parro, Victor] INTA CSIC, Ctr Astrobiol, Dept Mol Evolut, Madrid 28850, Spain; [Garcia-Moyano, Antonio; van Heerden, Esta] Univ Free State, Dept Biotechnol, TIA UFS Metagen Platform, ZA-9300 Bloemfontein, South Africa; [Palacin, Arantxa] Ctr Biotecnol & Genom Plantas, Madrid 28223, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); University of the Free State	Parro, V (corresponding author), INTA CSIC, Ctr Astrobiol, Dept Mol Evolut, Carretera Ajalvir,Km 4, Madrid 28850, Spain.	parrogv@cab.inta-csic.es	Aguirre, Jacobo/K-5855-2014; Garcia-Moyano, Antonio/AAI-8647-2020; Parro, Victor/K-3788-2014	Aguirre, Jacobo/0000-0003-2196-5103; Garcia-Moyano, Antonio/0000-0003-1997-8589; Parro, Victor/0000-0003-3738-0724; Rivas, Luis Alfonso/0000-0001-8392-3000	Spanish Ministerio de Ciencia e Innovacion (MICINN) [AYA2008-04013, AYA2011-24803, FIS2011-27569]; Comunidad de Madrid (Spain) [MODELICO-CM S2009ESP-1691]	Spanish Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad de Madrid (Spain)(Comunidad de Madrid)	This work has been funded by the Spanish Ministerio de Ciencia e Innovacion (MICINN), grant No. AYA2008-04013, AYA2011-24803 and FIS2011-27569, and Comunidad de Madrid (Spain) under project MODELICO-CM S2009ESP-1691. http://www.idi.mineco.gob.es/portal/site/MICINN/; http://www.madrimasd.org/.	Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Baker BJ, 2003, ENVIRON MICROBIOL, V5, P267, DOI 10.1046/j.1462-2920.2003.00408.x; Blanco Y, 2012, ENVIRON MICROBIOL, V14, P2495, DOI 10.1111/j.1462-2920.2012.02767.x; Borgonie G, 2011, NATURE, V474, P79, DOI 10.1038/nature09974; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gihring TM, 2006, GEOMICROBIOL J, V23, P415, DOI 10.1080/01490450600875696; Gonzalez RM, 2008, J PROTEOME RES, V7, P2406, DOI 10.1021/pr700822t; Gorg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hirayama H, 2005, EXTREMOPHILES, V9, P169, DOI 10.1007/s00792-005-0433-8; Inagaki F, 2003, EXTREMOPHILES, V7, P307, DOI 10.1007/s00792-003-0324-9; Ito T, 2005, INT J SYST EVOL MICR, V55, P1059, DOI 10.1099/ijs.0.63467-0; Kelly DP, 2000, INT J SYST EVOL MICR, V50, P547, DOI 10.1099/00207713-50-2-547; Li HY, 2012, ANAL CHEM, V84, P4776, DOI 10.1021/ac3003177; Lin LH, 2006, GEOMICROBIOL J, V23, P475, DOI 10.1080/01490450600875829; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Mori K, 2008, INT J SYST EVOL MICR, V58, P1885, DOI 10.1099/ijs.0.65754-0; Morris JJ, 2008, APPL ENVIRON MICROB, V74, P4530, DOI 10.1128/AEM.02479-07; Moser DP, 2005, APPL ENVIRON MICROB, V71, P8773, DOI 10.1128/AEM.71.12.8773-8783.2005; Moser DP, 2003, GEOMICROBIOL J, V20, P517, DOI 10.1080/713851170; Onstott TC, 2006, GEOMICROBIOL J, V23, P369, DOI 10.1080/01490450600875688; Onstott TC, 2003, ENVIRON MICROBIOL, V5, P1168, DOI 10.1046/j.1462-2920.2003.00512.x; Parro V, 2005, PLANET SPACE SCI, V53, P729, DOI 10.1016/j.pss.2005.02.003; Parro V, 2010, HDB HYDROCARBON LIPI, P2699; Parro V, 2011, ASTROBIOLOGY, V11, P969, DOI 10.1089/ast.2011.0654; Parro V, 2011, ASTROBIOLOGY, V11, P29, DOI 10.1089/ast.2010.0510; Pfiffner SM, 2006, GEOMICROBIOL J, V23, P431, DOI 10.1080/01490450600875712; Pla-Roca M, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011460; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Puente-Sanchez F, 2014, GEOBIOLOGY, V12, P34, DOI 10.1111/gbi.12065; Rastogi G, 2009, J MICROBIOL, V47, P371, DOI 10.1007/s12275-008-0249-1; Rivas LA, 2008, ANAL CHEM, V80, P7970, DOI 10.1021/ac8008093; Rivas LA, 2011, ENVIRON MICROBIOL, V13, P1421, DOI 10.1111/j.1462-2920.2011.02442.x; Robb FT, 2001, METHOD ENZYMOL, V330, P134; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Slater GF, 2006, GEOMICROBIOL J, V23, P453, DOI 10.1080/01490450600875787; Southerland IW, 2009, MICROBIOLOGY, V147, P3; Takai K, 2001, APPL ENVIRON MICROB, V67, P5750, DOI 10.1128/AEM.67.21.5750-5760.2001; Vannini C, 2008, SYST APPL MICROBIOL, V31, P461, DOI 10.1016/j.syapm.2008.07.003; Wang Z, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-453; Wanger G, 2008, GEOBIOLOGY, V6, P325, DOI 10.1111/j.1472-4669.2008.00163.x; Wanger G, 2006, GEOMICROBIOL J, V23, P443, DOI 10.1080/01490450600875746; Ward NL, 2009, APPL ENVIRON MICROB, V75, P2046, DOI 10.1128/AEM.02294-08; Weiner RM, 2000, INT J SYST EVOL MICR, V50, P459, DOI 10.1099/00207713-50-2-459; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Yurkov VV, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 5, THIRD EDITION, P562, DOI 10.1007/0-387-30745-1_23	48	15	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e114180	10.1371/journal.pone.0114180	http://dx.doi.org/10.1371/journal.pone.0114180			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531640	Green Published, gold, Green Submitted			2022-12-27	WOS:000348845100011
J	Eser, E; Can, T; Ferhatosmanoglu, H				Eser, Elif; Can, Tolga; Ferhatosmanoglu, Hakan			Div-BLAST: Diversification of Sequence Search Results	PLOS ONE			English	Article							PROTEIN; DATABASE; DIVERSITY; ENTROPY; TOOL	Sequence similarity tools, such as BLAST, seek sequences most similar to a query from a database of sequences. They return results significantly similar to the query sequence and that are typically highly similar to each other. Most sequence analysis tasks in bioinformatics require an exploratory approach, where the initial results guide the user to new searches. However, diversity has not yet been considered an integral component of sequence search tools for this discipline. Some redundancy can be avoided by introducing non-redundancy during database construction, but it is not feasible to dynamically set a level of non-redundancy tailored to a query sequence. We introduce the problem of diverse search and browsing in sequence databases that produce non-redundant results optimized for any given query. We define diversity measures for sequences and propose methods to obtain diverse results extracted from current sequence similarity search tools. We also propose a new measure to evaluate the diversity of a set of sequences that is returned as a result of a sequence similarity query. We evaluate the effectiveness of the proposed methods in post-processing BLAST and PSI-BLAST results. We also assess the functional diversity of the returned results based on available Gene Ontology annotations. Additionally, we include a comparison with a current redundancy elimination tool, CD-HIT. Our experiments show that the proposed methods are able to achieve more diverse yet significant result sets compared to static non-redundancy approaches. In both sequence-based and functional diversity evaluation, the proposed diversification methods significantly outperform original BLAST results and other baselines. A web based tool implementing the proposed methods, Div-BLAST, can be accessed at cedar.cs.bilkent.edu.tr/Div-BLAST	[Eser, Elif; Ferhatosmanoglu, Hakan] Bilkent Univ, Dept Comp Engn, Ankara, Turkey; [Can, Tolga] Middle E Tech Univ, Dept Comp Engn, TR-06531 Ankara, Turkey	Ihsan Dogramaci Bilkent University; Middle East Technical University	Eser, E (corresponding author), Bilkent Univ, Dept Comp Engn, Ankara, Turkey.	elif.eser@bilkent.edu.tr	Can, Tolga/D-1395-2010	Can, Tolga/0000-0002-5532-0154	Scientific and Technological Research Council of Turkey [EEEAG 111E217]; Turkish Academy of Sciences	Scientific and Technological Research Council of Turkey(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Turkish Academy of Sciences(Turkish Academy of Sciences)	This study was funded by The Scientific and Technological Research Council of Turkey (www.tubitak.gov.tr) under grant EEEAG 111E217 and Turkish Academy of Sciences (tuba.gov.tr), both to Hakan Ferhatosmanoglu. The funders are research funding agencies and had no role in study design.	Almonacid DE, 2011, CURR OPIN CHEM BIOL, V15, P435, DOI 10.1016/j.cbpa.2011.03.008; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aspnas M, 2010, J COMPUT BIOL, V17, P819, DOI 10.1089/cmb.2008.0053; Berman P, 1999, P 3 ANN INT C COMP M, P50; Carbonell J, 1998, P 21 ANN INT ACM SIG, P333; Dondoshansky I, 2002, BLASTCLUST NCBI SOFT; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Haritsa Jayant R., 2009, IEEE DATA ENG B, V32, P15; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Jagadish H. V., 2009, PVLDB, V2, P133; Jain A, 2004, LECT NOTES ARTIF INT, V3056, P404; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Leinonen R, 2004, BIOINFORMATICS, V20, P3236, DOI 10.1093/bioinformatics/bth191; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li WZ, 2002, BIOINFORMATICS, V18, P77, DOI 10.1093/bioinformatics/18.1.77; MURTAGH F, 1983, COMPUT J, V26, P354, DOI 10.1093/comjnl/26.4.354; Omelchenko MV, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-31; Pavoine S, 2005, THEOR POPUL BIOL, V67, P231, DOI 10.1016/j.tpb.2005.01.004; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Raghava GPS, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-47; RAO CR, 1982, THEOR POPUL BIOL, V21, P24, DOI 10.1016/0040-5809(82)90004-1; SANDER C, 1991, PROTEINS, V9, P56, DOI 10.1002/prot.340090107; Siddiqui AS, 2001, BIOINFORMATICS, V17, P200, DOI 10.1093/bioinformatics/17.2.200; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; The Uniprot Consortium, 2009, NUCLEIC ACIDS RES, V39, P214; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Wang JZ, 2007, BIOINFORMATICS, V23, P1274, DOI 10.1093/bioinformatics/btm087; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269	30	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115445	10.1371/journal.pone.0115445	http://dx.doi.org/10.1371/journal.pone.0115445			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531115	Green Published, gold, Green Submitted			2022-12-27	WOS:000348845100066
J	Lee, KM; Kim, TW; Weinreb, RN; Lee, EJ; Girard, MJA; Mari, JM				Lee, Kyoung Min; Kim, Tae-Woo; Weinreb, Robert N.; Lee, Eun Ji; Girard, Michael J. A.; Mari, Jean Martial			Anterior Lamina Cribrosa Insertion in Primary Open-Angle Glaucoma Patients and Healthy Subjects	PLOS ONE			English	Article							OPTIC-NERVE HEAD; COHERENCE TOMOGRAPHY IMAGES; CEREBROSPINAL-FLUID SPACE; AGE-RELATED-CHANGES; BRUCHS MEMBRANE; EXTRACELLULAR-MATRIX; REGIONAL DIFFERENCES; CONNECTIVE-TISSUE; THICKNESS; DEPTH	Purpose: To determine using swept-source optical coherence tomography (SS-OCT) whether there are differences in the location of the anterior lamina cribrosa insertion (ALI) in primary open-angle glaucoma (POAG) patients and healthy subjects. Methods: Fifty three eyes from 53 patients with POAG, and 53 eyes from 53 age-matched healthy subjects were included prospectively in Seoul National University Bundang Hospital. Twelve radial line B-scans centered on the optic disc in every half-clock-hour meridian were acquired using SS-OCT. The ALI position was assessed by measuring two parameters: (1) ALI distance (ALID)-the distance from the anterior scleral canal opening (ASCO) to the ALI; and (2) marginal anterior lamina cribrosa surface depth (mALCSD)-the perpendicular distance from the ASCO plane to the anterior lamina cribrosa surface. These parameters were compared between the two groups for each meridian. Results: Both ALID (256 +/- 54 vs. 209 +/- 37 mm, mean +/- SD, p < 0.001) and mALCSD (232 +/- 63 vs. 187 +/- 40 mm, p < 0.001) were significantly greater in the POAG group than in the normal group. The largest difference was observed at the 6.5 o'clock and 11.5 o'clock meridians for both ALID and mALCSD. Multiple regression analysis revealed a negative correlation between age and both ALID and mALCSD in the control group, and a negative correlation between mean deviation of the visual field test and both ALID and mALCSD in the POAG group. Conclusions: The ALI was displaced posteriorly in eyes with POAG compared to those of healthy controls. This finding suggests that the posteriorly located lamina cribrosa insertion is an important component of glaucomatous optic nerve excavation.	[Lee, Kyoung Min; Kim, Tae-Woo; Lee, Eun Ji] Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Weinreb, Robert N.] Univ Calif San Diego, Dept Ophthalmol, La Jolla, CA 92093 USA; [Weinreb, Robert N.] Univ Calif San Diego, Hamilton Glaucoma Ctr, La Jolla, CA 92093 USA; [Girard, Michael J. A.] Natl Univ Singapore, Dept Bioengn, Singapore 117548, Singapore; [Girard, Michael J. A.] Singapore Eye Res Inst, Singapore, Singapore; [Mari, Jean Martial] Univ Lyon, INSERM, U1032, Lyon, France	Seoul National University (SNU); University of California System; University of California San Diego; University of California System; University of California San Diego; National University of Singapore; National University of Singapore; Singapore National Eye Center; Institut National de la Sante et de la Recherche Medicale (Inserm)	Kim, TW (corresponding author), Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea.	twkim7@snu.ac.kr	Girard, Michael/F-9323-2015; Bui, Bang/AAD-2679-2021	Girard, Michael/0000-0003-4408-5918; Bui, Bang/0000-0001-7298-1352; Mari, Jean Martial/0000-0002-1169-6547; Kim, Tae-Woo/0000-0002-5180-0978	National Research Foundation of Korea - Korean Government [2013R1A1A1A05004781]; Research to Prevent Blindness (New York, NY)	National Research Foundation of Korea - Korean Government(National Research Foundation of KoreaKorean Government); Research to Prevent Blindness (New York, NY)(Research to Prevent Blindness (RPB))	The work was supported by a grant from the National Research Foundation of Korea funded by the Korean Government (no. 2013R1A1A1A05004781) and an unrestricted grant from Research to Prevent Blindness (New York, NY). The funding organizations had no role in the design or conduct of this research.	Albon J, 2000, BRIT J OPHTHALMOL, V84, P311, DOI 10.1136/bjo.84.3.311; Albon J, 2000, BRIT J OPHTHALMOL, V84, P318, DOI 10.1136/bjo.84.3.318; ANDERSON DR, 1969, ARCH OPHTHALMOL-CHIC, V82, P800; Bellezza AJ, 2003, INVEST OPHTH VIS SCI, V44, P623, DOI 10.1167/iovs.01-1282; Burgoyne CF, 2005, PROG RETIN EYE RES, V24, P39, DOI 10.1016/j.preteyeres.2004.06.001; Burgoyne CF, 2004, INVEST OPHTH VIS SCI, V45, P4388, DOI 10.1167/iovs.04-0022; Burgoyne CF, 2001, J GLAUCOMA, V10, pS16, DOI 10.1097/00061198-200110001-00007; Burgoyne CF, 2008, J GLAUCOMA, V17, P318, DOI 10.1097/IJG.0b013e31815a343b; Chauhan BC, 2013, AM J OPHTHALMOL, V156, P218, DOI 10.1016/j.ajo.2013.04.016; Downs JC, 2011, EXP EYE RES, V93, P133, DOI 10.1016/j.exer.2010.08.004; Furlanetto RL, 2013, INVEST OPHTH VIS SCI, V54, P4836, DOI 10.1167/iovs.12-11530; Girard MJA, 2011, INVEST OPHTH VIS SCI, V52, P7738, DOI 10.1167/iovs.10-6925; HAYREH SS, 1974, BRIT J OPHTHALMOL, V58, P863, DOI 10.1136/bjo.58.10.863; Hernandez MR, 2008, PROG BRAIN RES, V173, P353, DOI 10.1016/S0079-6123(08)01125-4; Hernandez MR, 2000, PROG RETIN EYE RES, V19, P297, DOI 10.1016/S1350-9462(99)00017-8; HERNANDEZ MR, 1989, AM J OPHTHALMOL, V107, P476, DOI 10.1016/0002-9394(89)90491-1; Hussain AA, 2014, INVEST OPHTH VIS SCI, V55, P2358, DOI 10.1167/iovs.13-12503; Johnstone J, 2014, INVEST OPHTH VIS SCI, V55, P2004, DOI 10.1167/iovs.13-12937; Jonas JB, 2004, INVEST OPHTH VIS SCI, V45, P2660, DOI 10.1167/iovs.03-1363; Jonas JB, 1997, OPHTHALMOLOGY, V104, P1934, DOI 10.1016/S0161-6420(97)30004-9; Jonas Jost B, 2013, J Ophthalmic Vis Res, V8, P257; Kotecha A, 2006, BRIT J OPHTHALMOL, V90, P1531, DOI 10.1136/bjo.2006.100388; Kumar A, 2010, INVEST OPHTH VIS SCI, V51, P2664, DOI 10.1167/iovs.09-4195; Lee EJ, 2014, INVEST OPHTHALMOL VI; Lee EJ, 2013, GRAEF ARCH CLIN EXP, V251, P847, DOI 10.1007/s00417-012-2145-y; Lee EJ, 2011, AM J OPHTHALMOL, V152, P87, DOI 10.1016/j.ajo.2011.01.024; Mari JM, 2013, INVEST OPHTH VIS SCI, V54, P2238, DOI 10.1167/iovs.12-11327; Miki A, 2013, CLIN OPHTHALMOL, V7, P1995, DOI 10.2147/OPTH.S50120; Morgan JE, 2004, EYE, V18, P1089, DOI 10.1038/sj.eye.6701574; Park HYL, 2014, AM J OPHTHALMOL, V157, P550, DOI 10.1016/j.ajo.2013.11.008; Park HYL, 2012, OPHTHALMOLOGY, V119, P10, DOI 10.1016/j.ophtha.2011.07.033; Park SC, 2012, INVEST OPHTH VIS SCI, V53, P1610, DOI 10.1167/iovs.11-7577; Park SC, 2012, OPHTHALMOLOGY, V119, P3, DOI 10.1016/j.ophtha.2011.07.012; Pena JDO, 1998, EXP EYE RES, V67, P517, DOI 10.1006/exer.1998.0539; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P137; QUIGLEY HA, 1983, AM J OPHTHALMOL, V95, P673, DOI 10.1016/0002-9394(83)90389-6; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P635, DOI 10.1001/archopht.1981.03930010635009; Ren RJ, 2014, INVEST OPHTH VIS SCI, V55, P1531, DOI 10.1167/iovs.13-13382; Ren RJ, 2010, OPHTHALMOLOGY, V117, P259, DOI 10.1016/j.ophtha.2009.06.058; Takayama K, 2013, INVEST OPHTH VIS SCI, V54, P4798, DOI 10.1167/iovs.13-11677; Tatham AJ, 2014, OPHTHALMOLOGY, V121, P110, DOI 10.1016/j.ophtha.2013.08.018; Vongphanit J, 2002, AM J OPHTHALMOL, V133, P679, DOI 10.1016/S0002-9394(02)01339-9; Wang NL, 2012, OPHTHALMOLOGY, V119, P2065, DOI 10.1016/j.ophtha.2012.03.054; Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192; WILCZEK M, 1947, BRIT J OPHTHALMOL, V31, P551, DOI 10.1136/bjo.31.9.551; Witmer MT, 2010, SURV OPHTHALMOL, V55, P403, DOI 10.1016/j.survophthal.2010.01.002; Yang HL, 2007, INVEST OPHTH VIS SCI, V48, P5068, DOI 10.1167/iovs.07-0790; Yang HL, 2011, INVEST OPHTH VIS SCI, V52, P7109, DOI 10.1167/iovs.11-7448; Yang HL, 2011, INVEST OPHTH VIS SCI, V52, P345, DOI 10.1167/iovs.09-5122; Yoshikawa M, 2014, INVEST OPHTH VIS SCI, V55, P477, DOI 10.1167/iovs.13-11897; You JY, 2013, JAMA OPHTHALMOL, V131, P314, DOI 10.1001/jamaophthalmol.2013.1926	51	42	42	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e114935	10.1371/journal.pone.0114935	http://dx.doi.org/10.1371/journal.pone.0114935			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531761	Green Published, Green Submitted, gold			2022-12-27	WOS:000348845100032
J	Chang, SN; Lai, YH; Yen, CH; Tsai, CT; Lin, JW; Bulwer, BE; Hung, TC; Hou, CJY; Kuo, JY; Hung, CL; Hwang, JJ; Yeh, HI				Chang, Sheng-Nan; Lai, Yau-Huei; Yen, Chih-Hsuan; Tsai, Chia-Ti; Lin, Jou-Wei; Bulwer, Bernard E.; Hung, Ta-Chuan; Hou, Charles Jia-Yin; Kuo, Jen-Yuan; Hung, Chung-Lieh; Hwang, Juey-Jen; Yeh, Hung-I			Cardiac Mechanics and Ventricular Twist by Three-Dimensional Strain Analysis in Relation to B-Type Natriuretic Peptide as a Clinical Prognosticator for Heart Failure Patients	PLOS ONE			English	Article							PRESERVED EJECTION FRACTION; MYOCARDIAL DEFORMATION; CIRCUMFERENTIAL STRAIN; DIASTOLIC DYSFUNCTION; CARDIOVASCULAR EVENTS; 2-DIMENSIONAL STRAIN; ECHOCARDIOGRAPHY; PROGNOSIS; DISEASE; CARDIOMYOPATHY	Background: Three dimensional (3D) echocardiography-derived measurements of myocardial deformation and twist have recently advanced as novel clinical tools. However, with the exception of left ventricular ejection fraction and mass quantifications in hypertension and heart failure populations, the prognostic value of such imaging techniques remains largely unexplored. Methods: We studied 200 subjects (mean age: 60.2 +/- 16 years, 54% female, female n=107) with known hypertension (n=51), diastolic heart failure (n=61), or systolic heart failure (n=30), recruited from heart failure outpatient clinics. Fifty-eight healthy volunteers were used as a control group. All participants underwent 3D-based myocardial deformation and twist analysis (Artida, Toshiba Medical Systems, Tokyo, Japan). We further investigated associations between these measures and brain natriuretic peptide levels and clinical outcomes. Results: The global 3D strain measurements of the healthy, hypertension, diastolic heart failure, and systolic heart failure groups were 28.03%, 24.43%, 19.70%, and 11.95%, respectively (all p < 0.001). Global twist measurements were estimated to be 9.49 degrees, 9.77 degrees, 8.32 degrees, and 4.56 degrees, respectively. We observed significant differences regarding 3D-derived longitudinal, radial, and global 3D strains between the different disease categories (p < 0.05), even when age, gender, BMI and heart rate were matched. In addition, 3D-derived longitudinal, circumferential, and 3D strains were all highly correlated with brain natriuretic peptide levels (p < 0.001). At a mean 567.7 days follow-up (25th-75th IQR: 197-909 days), poorer 3D-derived longitudinal, radial, and global 3D strain measurements remained independently associated with a higher risk of cardiovascular related death or hospitalization due to heart failure, after adjusting for age, gender, and left ventricular ejection fraction (all p < 0.05). Conclusions: 3D-based strain analysis may be a feasible and useful diagnostic tool for discriminating the extent of myocardial dysfunction. Furthermore, it is able to provide a prognostic value beyond traditional echocardiographic parameters in terms of ejection fraction.	[Chang, Sheng-Nan] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Chang, Sheng-Nan; Lin, Jou-Wei] Natl Taiwan Univ Hosp, Div Cardiol, Dept Internal Med, Yun Lin Branch, Dou Liu City, Taiwan; [Lai, Yau-Huei; Yen, Chih-Hsuan; Hung, Ta-Chuan; Hou, Charles Jia-Yin; Kuo, Jen-Yuan; Hung, Chung-Lieh; Yeh, Hung-I] Mackay Mem Hosp, Div Cardiol, Dept Internal Med, Taipei, Taiwan; [Tsai, Chia-Ti; Hwang, Juey-Jen] Natl Taiwan Univ Hosp, Dept Internal Med, Div Cardiol, Taipei 100, Taiwan; [Bulwer, Bernard E.] Brigham & Womens Hosp, Cardiovasc Div, Boston, MA 02115 USA; [Hung, Chung-Lieh; Yeh, Hung-I] Mackay Med Coll, New Taipei City, Taiwan; [Hung, Chung-Lieh] Natl Taiwan Univ, Inst Hlth Policy & Management, Coll Publ Hlth, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; Mackay Memorial Hospital; National Taiwan University; National Taiwan University Hospital; Harvard University; Brigham & Women's Hospital; Mackay Medical College; National Taiwan University	Hung, CL (corresponding author), Mackay Mem Hosp, Div Cardiol, Dept Internal Med, Taipei, Taiwan.	jotaro3791@gmail.com	Kuo, Jen-Yuan/AAX-5448-2021	Hwang, Juey-Jen/0000-0001-6437-0455; CHANG, SHENG NAN/0000-0002-2663-5042; TSAI, CHIA-TI/0000-0002-4853-8665	Medical Research Department, Mackay Memorial Hospital, Taipei, Taiwan; NT 100000 dollars	Medical Research Department, Mackay Memorial Hospital, Taipei, Taiwan; NT 100000 dollars	This study was supported from the funding comes from the Medical Research Department, Mackay Memorial Hospital, Taipei, Taiwan. The funding was NT 100000 dollars. The authors would like to thank Toshiba's hardware and software support for data processing and collection. The funders and the Toshiba Company had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WT, 2011, J CARD FAIL, V17, P710, DOI 10.1016/j.cardfail.2011.05.006; Ashraf M, 2012, J AM SOC ECHOCARDIOG, V25, P121, DOI 10.1016/j.echo.2011.09.001; Bluemke DA, 2008, J AM COLL CARDIOL, V52, P2148, DOI 10.1016/j.jacc.2008.09.014; Donal E, 2011, EUR J ECHOCARDIOGR, V12, P619, DOI 10.1093/ejechocard/jer089; Drazner MH, 2011, CIRCULATION, V123, P327, DOI 10.1161/CIRCULATIONAHA.108.845792; DUBOIS D, 1989, NUTRITION, V5, P303; Edvardsen T, 2002, CIRCULATION, V106, P50, DOI 10.1161/01.CIR.0000019907.77526.75; Fox KF, 2001, EUR HEART J, V22, P228, DOI 10.1053/euhj.2000.2289; Hoffmann R, 2002, Z KARDIOL, V91, P677, DOI 10.1007/s00392-002-0824-0; Hung CL, 2010, J AM COLL CARDIOL, V56, P1812, DOI 10.1016/j.jacc.2010.06.044; Kim H, 2011, CLIN CARDIOL, V34, P494, DOI 10.1002/clc.20932; King M, 2012, AM FAM PHYSICIAN, V85, P1161; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lee CH, 2011, INT J CLIN PRACT, V65, P852, DOI 10.1111/j.1742-1241.2011.02699.x; Lee DS, 2009, CIRCULATION, V119, P3070, DOI 10.1161/CIRCULATIONAHA.108.815944; Leitman M, 2004, J AM SOC ECHOCARDIOG, V17, P1021, DOI 10.1016/j.echo.2004.06.019; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levy D, 1996, JAMA-J AM MED ASSOC, V275, P1557, DOI 10.1001/jama.275.20.1557; Liao ZY, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.003053; Matsumoto K, 2012, J AM SOC ECHOCARDIOG, V25, P1299, DOI 10.1016/j.echo.2012.09.018; Migrino RQ, 2008, ULTRASOUND MED BIOL, V34, P208, DOI 10.1016/j.ultrasmedbio.2007.07.018; Nahum J, 2010, CIRC-CARDIOVASC IMAG, V3, P249, DOI 10.1161/CIRCIMAGING.109.910893; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Paterson DI, 2011, CURR OPIN CARDIOL, V26, P132, DOI 10.1097/HCO.0b013e32834380e7; de Isla LP, 2009, J AM SOC ECHOCARDIOG, V22, P325, DOI 10.1016/j.echo.2009.01.001; Redfield MM, 2005, CIRCULATION, V112, P2254, DOI 10.1161/CIRCULATIONAHA.105.541078; Sengupta PP, 2008, JACC-CARDIOVASC IMAG, V1, P366, DOI 10.1016/j.jcmg.2008.02.006; Seo Y, 2009, CIRC-CARDIOVASC IMAG, V2, P451, DOI 10.1161/CIRCIMAGING.109.858480; Solomon SD, 2007, LANCET, V369, P2079, DOI 10.1016/S0140-6736(07)60980-5; Sutherland GR, 2004, J AM SOC ECHOCARDIOG, V17, P788, DOI 10.1016/j.echo.2004.03.027; Wang J, 2008, EUR HEART J, V29, P1283, DOI 10.1093/eurheartj/ehn141; Watanabe S, 2011, J CARDIOL, V58, P245, DOI 10.1016/j.jjcc.2011.07.005	32	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115260	10.1371/journal.pone.0115260	http://dx.doi.org/10.1371/journal.pone.0115260			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545637	gold, Green Submitted, Green Published			2022-12-27	WOS:000347120200031
J	Frank, KL; Colomer-Winter, C; Grindle, SM; Lemos, JA; Schlievert, PM; Dunny, GM				Frank, Kristi L.; Colomer-Winter, Cristina; Grindle, Suzanne M.; Lemos, Jose A.; Schlievert, Patrick M.; Dunny, Gary M.			Transcriptome Analysis of Enterococcus faecalis during Mammalian Infection Shows Cells Undergo Adaptation and Exist in a Stringent Response State	PLOS ONE			English	Article							GENE-EXPRESSION; VIRULENCE DETERMINANTS; SURFACE-PROTEINS; VIBRIO-CHOLERAE; STRESS; IDENTIFICATION; STREPTOCOCCUS; ENDOCARDITIS; METABOLISM; GLS24	As both a commensal and a major cause of healthcare-associated infections in humans, Enterococcus faecalis is a remarkably adaptable organism. We investigated how E. faecalis adapts in a mammalian host as a pathogen by characterizing changes in the transcriptome during infection in a rabbit model of subdermal abscess formation using transcriptional microarrays. The microarray experiments detected 222 and 291 differentially regulated genes in E. faecalis OG1RF at two and eight hours after subdermal chamber inoculation, respectively. The profile of significantly regulated genes at two hours post-inoculation included genes involved in stress response, metabolism, nutrient acquisition, and cell surface components, suggesting genome-wide adaptation to growth in an altered environment. At eight hours post-inoculation, 88% of the differentially expressed genes were down-regulated and matched a transcriptional profile consistent with a (p) ppGpp-mediated stringent response. Subsequent subdermal abscess infections with E. faecalis mutants lacking the (p) ppGpp synthetase/hydrolase RSH, the small synthetase RelQ, or both enzymes, suggest that intracellular (p) ppGpp levels, but not stringent response activation, influence persistence in the model. The ability of cells to synthesize (p) ppGpp was also found to be important for growth in human serum and whole blood. The data presented in this report provide the first genome-wide insights on E. faecalis in vivo gene expression and regulation measured by transcriptional profiling during infection in a mammalian host and show that (p) ppGpp levels affect viability of E. faecalis in multiple conditions relevant to mammalian infection. The subdermal abscess model can serve as a novel experimental system for studying the E. faecalis stringent response in the context of the mammalian immune system.	[Frank, Kristi L.; Grindle, Suzanne M.; Schlievert, Patrick M.; Dunny, Gary M.] Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA; [Colomer-Winter, Cristina; Lemos, Jose A.] Univ Rochester, Sch Med & Dent, Ctr Oral Biol, Rochester, NY USA; [Colomer-Winter, Cristina; Lemos, Jose A.] Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Rochester; University of Rochester	Frank, KL (corresponding author), Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA.	fran0616@umn.edu		Lemos, Jose/0000-0003-0791-5863; Colomer Winter, Cristina/0000-0003-0103-4977; Schlievert, Patrick/0000-0001-8314-9369	National Institute of Allergy and Infectious Diseases [F32AI082881, R01AI58134]; National Institute of Dental and Craniofacial Research [T32DE007288]; American Heart Association [10POST3290026]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI082881, R01AI058134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007288] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was supported by Award Number R01AI58134 from the National Institute of Allergy and Infectious Diseases to GMD. KLF was supported by Award Number F32AI082881 from the National Institute of Allergy and Infectious Diseases, Award Number T32DE007288 from the National Institute of Dental and Craniofacial Research, and Award Number 10POST3290026 from the American Heart Association. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases, the National Institute of Dental and Craniofacial Research, the National Institutes of Health, or the American Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abranches J, 2009, J BACTERIOL, V191, P2248, DOI 10.1128/JB.01726-08; Attia AS, 2013, PATHOG DIS; Benachour A, 2009, CAN J MICROBIOL, V55, P967, DOI [10.1139/W09-052, 10.1139/w09-052]; Bohle LA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-135; Chaffin DO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041329; Churchill GA, 2002, NAT GENET, V32, P490, DOI 10.1038/ng1031; COQUE TM, 1995, J INFECT DIS, V171, P1223, DOI 10.1093/infdis/171.5.1223; Creti R, 2004, J MED MICROBIOL, V53, P13, DOI 10.1099/jmm.0.05353-0; de Marques EB, 2004, J MED MICROBIOL, V53, P1069, DOI 10.1099/jmm.0.45654-0; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DUNNY GM, 1978, P NATL ACAD SCI USA, V75, P3479, DOI 10.1073/pnas.75.7.3479; Dupre I, 2003, J MED MICROBIOL, V52, P491, DOI 10.1099/jmm.0.05038-0; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fabretti F, 2006, INFECT IMMUN, V74, P4164, DOI 10.1128/IAI.00111-06; Frank KL, 2012, INFECT IMMUN, V80, P539, DOI 10.1128/IAI.05964-11; Gaca AO, 2013, MBIO, V4, DOI 10.1128/mBio.00646-13; Gaca AO, 2012, MICROBIOL-SGM, V158, P1994, DOI 10.1099/mic.0.060236-0; Geiger T, 2014, J BACTERIOL, V196, P894, DOI 10.1128/JB.01201-13; Giard JC, 2000, J BACTERIOL, V182, P4512, DOI 10.1128/JB.182.16.4512-4520.2000; Graham MR, 2006, AM J PATHOL, V169, P927, DOI 10.2353/ajpath.2006.060112; Hanin A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011879; Herrmann KM, 1999, ANNU REV PLANT PHYS, V50, P473, DOI 10.1146/annurev.arplant.50.1.473; Holt JF, 2014, INFECT IMMUN; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Johansson D, 2013, MICROB PATHOGENESIS, V55, P28, DOI 10.1016/j.micpath.2012.09.009; Jorth P, 2013, J BACTERIOL, V195, P4991, DOI 10.1128/JB.00875-13; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Lasa I, 2011, P NATL ACAD SCI USA, V108, P20172, DOI 10.1073/pnas.1113521108; Le Jeune A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009658; Lebreton F., 2014, ENTEROCOCCI COMMENSA; Lindenstrauss AG, 2014, ARCH MICROBIOL, V196, P423, DOI 10.1007/s00203-014-0982-2; Lopez G, 2012, BIOMETALS, V25, P737, DOI 10.1007/s10534-012-9539-5; Maadani A, 2007, INFECT IMMUN, V75, P2634, DOI 10.1128/IAI.01372-06; Maisonneuve E, 2013, CELL, V154, P1140, DOI 10.1016/j.cell.2013.07.048; Mandlik A, 2011, CELL HOST MICROBE, V10, P165, DOI 10.1016/j.chom.2011.07.007; Mehra S, 2006, J IND MICROBIOL BIOT, V33, P159, DOI 10.1007/s10295-005-0034-7; de Oliveira NEM, 2011, MICROBIOL-SGM, V157, P656, DOI 10.1099/mic.0.041897-0; Nanamiya H, 2008, MOL MICROBIOL, V67, P291, DOI 10.1111/j.1365-2958.2007.06018.x; Nannini EC, 2005, INFECT IMMUN, V73, P7772, DOI 10.1128/IAI.73.11.7772-7774.2005; Nygaard P, 1996, J BACTERIOL, V178, P846, DOI 10.1128/jb.178.3.846-853.1996; Orihuela CJ, 2004, INFECT IMMUN, V72, P5582, DOI 10.1128/IAI.72.10.5582-5596.2004; Paganelli FL, 2012, TRENDS MICROBIOL, V20, P40, DOI 10.1016/j.tim.2011.11.001; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Priyadarshi A, 2009, BBA-PROTEINS PROTEOM, V1794, P1030, DOI 10.1016/j.bbapap.2009.03.006; Reffuveille F, 2011, MICROBIOL-SGM, V157, P3001, DOI 10.1099/mic.0.053314-0; ROE BA, 1996, DNA ISOLATION SEQUEN; Roggiani M, 2000, METH MOLEC MED, V36, P59, DOI 10.1385/1-59259-216-3:59; Sava IG, 2010, CLIN MICROBIOL INFEC, V16, P533, DOI 10.1111/j.1469-0691.2010.03213.x; Sebbane F, 2006, P NATL ACAD SCI USA, V103, P11766, DOI 10.1073/pnas.0601182103; Shah P, 2008, MICROB PATHOGENESIS, V45, P167, DOI 10.1016/j.micpath.2008.05.001; Shepard BD, 2002, INFECT IMMUN, V70, P4344, DOI 10.1128/IAI.70.8.4344-4352.2002; Sievert DM, 2013, INFECT CONT HOSP EP, V34, P1, DOI 10.1086/668770; Skvortsov TA, 2013, ACTA NATURAE, V5, P62, DOI 10.32607/20758251-2013-5-2-62-69; Solheim M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-194; Stintzi A, 2005, INFECT IMMUN, V73, P1797, DOI 10.1128/IAI.73.3.1797-1810.2005; Talaat AM, 2004, P NATL ACAD SCI USA, V101, P4602, DOI 10.1073/pnas.0306023101; Tanenbaum DM, 2010, STAND GENOMIC SCI, V2, P229, DOI 10.4056/sigs.651139; Teng F, 2005, J INFECT DIS, V191, P472, DOI 10.1086/427191; TIGHT RR, 1975, ANTIMICROB AGENTS CH, V8, P495, DOI 10.1128/AAC.8.4.495; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; Torrieri R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047436; Traxler MF, 2008, MOL MICROBIOL, V68, P1128, DOI 10.1111/j.1365-2958.2008.06229.x; Traxler MF, 2011, MOL MICROBIOL, V79, P830, DOI 10.1111/j.1365-2958.2010.07498.x; Vebo HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012489; Vebo HC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007660; Xu Q, 2003, P NATL ACAD SCI USA, V100, P1286, DOI 10.1073/pnas.0337479100; Yan X, 2009, MICROBIOL-SGM, V155, P3226, DOI 10.1099/mic.0.026146-0; Yarwood JM, 2002, J BACTERIOL, V184, P1095, DOI 10.1128/jb.184.4.1095-1101.2002	71	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115839	10.1371/journal.pone.0115839	http://dx.doi.org/10.1371/journal.pone.0115839			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545155	gold, Green Published, Green Submitted			2022-12-27	WOS:000347120200074
J	Goodswen, SJ; Kennedy, PJ; Ellis, JT				Goodswen, Stephen J.; Kennedy, Paul J.; Ellis, John T.			Enhancing In Silico Protein-Based Vaccine Discovery for Eukaryotic Pathogens Using Predicted Peptide-MHC Binding and Peptide Conservation Scores	PLOS ONE			English	Article							T-CELL RESPONSES; TOXOPLASMA-GONDII; REVERSE VACCINOLOGY; PROTECTION; EPITOPES; ANTIGEN; MICE; IDENTIFICATION; ADJUVANTS; SELECTION	Given thousands of proteins constituting a eukaryotic pathogen, the principal objective for a high-throughput in silico vaccine discovery pipeline is to select those proteins worthy of laboratory validation. Accurate prediction of T-cell epitopes on protein antigens is one crucial piece of evidence that would aid in this selection. Prediction of peptides recognised by T-cell receptors have to date proved to be of insufficient accuracy. The in silico approach is consequently reliant on an indirect method, which involves the prediction of peptides binding to major histocompatibility complex (MHC) molecules. There is no guarantee nevertheless that predicted peptide-MHC complexes will be presented by antigen-presenting cells and/or recognised by cognate T-cell receptors. The aim of this study was to determine if predicted peptide-MHC binding scores could provide contributing evidence to establish a protein's potential as a vaccine. Using T-Cell MHC class I binding prediction tools provided by the Immune Epitope Database and Analysis Resource, peptide binding affinity to 76 common MHC I alleles were predicted for 160 Toxoplasma gondii proteins: 75 taken from published studies represented proteins known or expected to induce T-cell immune responses and 85 considered less likely vaccine candidates. The results show there is no universal set of rules that can be applied directly to binding scores to distinguish a vaccine from a non-vaccine candidate. We present, however, two proposed strategies exploiting binding scores that provide supporting evidence that a protein is likely to induce a T-cell immune response-one using random forest (a machine learning algorithm) with a 72% sensitivity and 82.4% specificity and the other, using amino acid conservation scores with a 74.6% sensitivity and 70.5% specificity when applied to the 160 benchmark proteins. More importantly, the binding score strategies are valuable evidence contributors to the overall in silico vaccine discovery pool of evidence.	[Goodswen, Stephen J.; Ellis, John T.] Univ Technol Sydney, Sch Med & Mol Sci, Ultimo, NSW, Australia; [Kennedy, Paul J.] Univ Technol Sydney, Sch Software, Fac Engn & Informat Technol, Ultimo, NSW, Australia; [Kennedy, Paul J.] Univ Technol Sydney, Ctr Quantum Computat & Intelligent Syst, Ultimo, NSW, Australia	University of Technology Sydney; University of Technology Sydney; University of Technology Sydney	Ellis, JT (corresponding author), Univ Technol Sydney, Sch Med & Mol Sci, Ultimo, NSW, Australia.	John.Ellis@uts.edu.au	Kennedy, Paul/GPC-6789-2022; Ellis, John T/L-6988-2016	Kennedy, Paul/0000-0001-7837-3171; Ellis, John T/0000-0001-7328-4831; Goodswen, Stephen/0000-0001-6184-3157	Zoetis (Pfizer) Animal Health	Zoetis (Pfizer) Animal Health	SJG gratefully acknowledges receipt of a PhD scholarship from Zoetis (Pfizer) Animal Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariel N, 2002, INFECT IMMUN, V70, P6817, DOI 10.1128/IAI.70.12.6817-6827.2002; Batchelor JD, 2011, NAT STRUCT MOL BIOL, V18, P908, DOI 10.1038/nsmb.2088; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bui HH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-361; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Che FY, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000745; Cong H, 2008, VACCINE, V26, P3913, DOI 10.1016/j.vaccine.2008.04.046; Cong H, 2012, HUM IMMUNOL, V73, P1, DOI 10.1016/j.humimm.2011.10.006; Cong Hua, 2010, Immunome Res, V6, P12, DOI 10.1186/1745-7580-6-12; Cong H, 2011, VACCINE, V29, P754, DOI 10.1016/j.vaccine.2010.11.015; Deavin AJ, 1996, MOL IMMUNOL, V33, P145, DOI 10.1016/0161-5890(95)00120-4; Elsheikha HM, 2004, PARASITOL RES, V94, P452, DOI 10.1007/s00436-004-1237-y; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Escobar Andres J. Gutierrez, 2006, In Silico Biology, V6, P347; Fatoohi F, 2006, JPN J OPHTHALMOL, V50, P103, DOI 10.1007/s10384-005-0295-8; Flower Darren R, 2010, Immunome Res, V6 Suppl 2, pS1, DOI 10.1186/1745-7580-6-S2-S1; GODARD I, 1994, MOL IMMUNOL, V31, P1353, DOI 10.1016/0161-5890(94)90054-X; Goodswen SJ, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-315; Goodswen SJ, 2013, BRIEF BIOINFORM, V14, P753, DOI 10.1093/bib/bbs066; Guglietta S, 2007, MICROBES INFECT, V9, P127, DOI 10.1016/j.micinf.2006.10.017; Hoof I, 2009, IMMUNOGENETICS, V61, P1, DOI 10.1007/s00251-008-0341-z; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Johansson F, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-388; Jordan KA, 2009, INFECT IMMUN, V77, P3894, DOI 10.1128/IAI.00024-09; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kelly DF, 2005, ADV EXP MED BIOL, V568, P217; Kim K, 2004, INT J PARASITOL, V34, P423, DOI 10.1016/j.ijpara.2003.12.009; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Leuzzi R., 2006, HDB MENINGOCOCCAL DI, P391; Lin HH, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-8; Montigiani S, 2002, INFECT IMMUN, V70, P368, DOI 10.1128/IAI.70.1.368-379.2002; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Morrison DA, 2009, TRENDS PARASITOL, V25, P375, DOI 10.1016/j.pt.2009.05.010; Moutaftsi M, 2006, NAT BIOTECHNOL, V24, P817, DOI 10.1038/nbt1215; Nielsen HV, 1999, INFECT IMMUN, V67, P6358; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Peters B, 2005, PLOS BIOL, V3, P379, DOI 10.1371/journal.pbio.0030091; Peters B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-132; Peters B, 2006, PLOS COMPUT BIOL, V2, P574, DOI 10.1371/journal.pcbi.0020065; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Platt JC, 2000, ADV NEUR IN, P61; Prigione I, 2006, MICROBES INFECT, V8, P552, DOI 10.1016/j.micinf.2005.08.008; Rappuoli R, 2001, VACCINE, V19, P2688, DOI 10.1016/S0264-410X(00)00554-5; Rappuoli R, 2007, CURR OPIN BIOTECH, V18, P521, DOI 10.1016/j.copbio.2007.11.001; Rappuoli R, 2007, NAT BIOTECHNOL, V25, P1361, DOI 10.1038/nbt1207-1361; Roos DS, 2005, SCIENCE, V309, P72, DOI 10.1126/science.1115252; Ross BC, 2001, VACCINE, V19, P4135, DOI 10.1016/S0264-410X(01)00173-6; Sacks D, 2002, NAT IMMUNOL, V3, P1041, DOI 10.1038/ni1102-1041; Serino L, 2006, REVERSE VACCINOLOGY, P533; Serruto D, 2009, VACCINE, V27, P3245, DOI 10.1016/j.vaccine.2009.01.072; Sette A, 2010, IMMUNITY, V33, P530, DOI 10.1016/j.immuni.2010.09.017; Sidney John, 2008, Immunome Res, V4, P2, DOI 10.1186/1745-7580-4-2; Tan TG, 2010, VACCINE, V28, P3977, DOI 10.1016/j.vaccine.2010.03.028; Tong JC, 2007, BRIEF BIOINFORM, V8, P96, DOI 10.1093/bib/bbl038; Valdar WSJ, 2002, PROTEINS, V48, P227, DOI 10.1002/prot.10146; Valizadeh V, 2014, INFECT GENET EVOL, V21, P424, DOI 10.1016/j.meegid.2013.12.012; Vivona S, 2008, TRENDS BIOTECHNOL, V26, P190, DOI 10.1016/j.tibtech.2007.12.006; Wang P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000048; Williams TM, 2001, J MOL DIAGN, V3, P98, DOI 10.1016/S1525-1578(10)60658-7; Wizemann TM, 2001, INFECT IMMUN, V69, P1593, DOI 10.1128/IAI.69.3.1593-1598.2001; Yano A, 1997, BIOCHEM BIOPH RES CO, V236, P257, DOI 10.1006/bbrc.1997.6904	61	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115745	10.1371/journal.pone.0115745	http://dx.doi.org/10.1371/journal.pone.0115745			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545691	Green Submitted, Green Published, gold			2022-12-27	WOS:000347120200064
J	Hotson, G; Fifer, MS; Acharya, S; Benz, HL; Anderson, WS; Thakor, NV; Crone, NE				Hotson, Guy; Fifer, Matthew S.; Acharya, Soumyadipta; Benz, Heather L.; Anderson, William S.; Thakor, Nitish V.; Crone, Nathan E.			Coarse Electrocorticographic Decoding of Ipsilateral Reach in Patients with Brain Lesions	PLOS ONE			English	Article							EVENT-RELATED DESYNCHRONIZATION; HUMAN SENSORIMOTOR CORTEX; STEM-CELLS; CORTICAL REPRESENTATION; MOVEMENT TRAJECTORIES; COMPUTER INTERFACE; SPECTRAL-ANALYSIS; PREMOTOR CORTEX; ECOG-RECORDINGS; ARM MOVEMENTS	In patients with unilateral upper limb paralysis from strokes and other brain lesions, strategies for functional recovery may eventually include brain-machine interfaces (BMIs) using control signals from residual sensorimotor systems in the damaged hemisphere. When voluntary movements of the contralateral limb are not possible due to brain pathology, initial training of such a BMI may require use of the unaffected ipsilateral limb. We conducted an offline investigation of the feasibility of decoding ipsilateral upper limb movements from electrocorticographic (ECoG) recordings in three patients with different lesions of sensorimotor systems associated with upper limb control. We found that the first principal component (PC) of unconstrained, naturalistic reaching movements of the upper limb could be decoded from ipsilateral ECoG using a linear model. ECoG signal features yielding the best decoding accuracy were different across subjects. Performance saturated with very few input features. Decoding performances of 0.77, 0.73, and 0.66 (median Pearson's r between the predicted and actual first PC of movement using nine signal features) were achieved in the three subjects. The performance achieved here with small numbers of electrodes and computationally simple decoding algorithms suggests that it may be possible to control a BMI using ECoG recorded from damaged sensorimotor brain systems.	[Hotson, Guy] Johns Hopkins Univ, Dept Elect & Comp Engn, Baltimore, MD 21218 USA; [Fifer, Matthew S.; Acharya, Soumyadipta; Benz, Heather L.; Thakor, Nitish V.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21205 USA; [Anderson, William S.] Johns Hopkins Univ, Dept Neurosurg, Baltimore, MD 21287 USA; [Crone, Nathan E.] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Hotson, G (corresponding author), Johns Hopkins Univ, Dept Elect & Comp Engn, Baltimore, MD 21218 USA.	ghotson1@jhu.edu	Thakor, Nitish/G-9110-2015; Thakor, Nitish V/A-5878-2008; Coish, Elizabeth/AAU-1245-2020	Thakor, Nitish/0000-0002-9981-9395; Fifer, Matthew/0000-0003-3425-7552; Anderson, William/0000-0003-0958-050X; Benz, Heather/0000-0002-6707-9695	National Institute of Neurological Disorders and Stroke [3R01NS0405956-09S1]; National Institute of Biomedical Imaging and Bioengineering [5T32EB003383-08]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB003383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040596] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by the National Institute of Neurological Disorders and Stroke under grant 3R01NS0405956-09S1 (MSF, HLB) and by the National Institute of Biomedical Imaging and Bioengineering under grant 5T32EB003383-08 (GH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya S, 2010, J NEURAL ENG, V7, DOI [10.1088/1741-2560/7/4/046002, 10.2202/1553-3840.1324]; Anderson NR, 2012, EXP BRAIN RES, V223, P1, DOI 10.1007/s00221-012-3226-1; Barnes S, 1901, BRAIN, V24; Birbaumer N, 1999, NATURE, V398, P297, DOI 10.1038/18581; Brown JA, 2006, NEUROSURGERY, V58, P464, DOI 10.1227/01.NEU.0000197100.63931.04; Bundy DT, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036011; Chapman H, 2002, EUR J NEUROSCI, V15, P2037, DOI 10.1046/j.1460-9568.2002.02021.x; Chen C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083534; Cisek P, 2003, J NEUROPHYSIOL, V89, P922, DOI 10.1152/jn.00607.2002; Collinger JL, 2013, LANCET, V381, P557, DOI 10.1016/S0140-6736(12)61816-9; Crone NE, 1998, BRAIN, V121, P2271, DOI 10.1093/brain/121.12.2271; Crone NE, 1998, BRAIN, V121, P2301, DOI 10.1093/brain/121.12.2301; Duncan JS, 2004, NEUROIMAGE, V23, pS34, DOI 10.1016/j.neuroimage.2004.07.027; Fifer M, 2013, IEEE T NEURAL SYST R; Filimon F, 2007, NEUROIMAGE, V37, P1315, DOI 10.1016/j.neuroimage.2007.06.008; Galletti C, 1997, EUR J NEUROSCI, V9, P410, DOI 10.1111/j.1460-9568.1997.tb01410.x; Ganguly K, 2009, J NEUROSCI, V29, P12948, DOI 10.1523/JNEUROSCI.2471-09.2009; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Gunduz A, 2009, I IEEE EMBS C NEUR E, P260; Hanlon RE, 1996, ARCH PHYS MED REHAB, V77, P811, DOI 10.1016/S0003-9993(96)90262-2; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Kleim JA, 2003, NEUROL RES, V25, P789, DOI 10.1179/016164103771953862; Kubanek J, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/6/066001; LEVINE DN, 1978, NEUROLOGY, V28, P556, DOI 10.1212/WNL.28.6.556; Lo AC, 2010, NEW ENGL J MED, V362, P1772, DOI 10.1056/NEJMoa0911341; McFarland DJ, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/3/036007; McFarland DJ, 1997, ELECTROEN CLIN NEURO, V103, P386, DOI 10.1016/S0013-4694(97)00022-2; McMullen DP, 2014, IEEE T NEUR SYS REH, V22, P784, DOI 10.1109/TNSRE.2013.2294685; Moran DW, 1999, J NEUROPHYSIOL, V82, P2676, DOI 10.1152/jn.1999.82.5.2676; Nakanishi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072085; Ojakangas CL, 2006, J CLIN NEUROPHYSIOL, V23, P577, DOI 10.1097/01.wnp.0000233323.87127.14; Oki K, 2012, STEM CELLS, V30, P1120, DOI 10.1002/stem.1104; PFURTSCHELLER G, 1991, ELECTROEN CLIN NEURO, P58; Pineda JA, 2000, IEEE T REHABIL ENG, V8, P219, DOI 10.1109/86.847822; Pistohl T, 2008, J NEUROSCI METH, V167, P105, DOI 10.1016/j.jneumeth.2007.10.001; Reina GA, 2001, J NEUROPHYSIOL, V85, P2576, DOI 10.1152/jn.2001.85.6.2576; Schaechter JD, 2004, PROG NEUROBIOL, V73, P61, DOI 10.1016/j.pneurobio.2004.04.001; Schalk G, 2008, J NEURAL ENG, V5, P75, DOI 10.1088/1741-2560/5/1/008; Schalk G, 2007, J NEURAL ENG, V4, P264, DOI 10.1088/1741-2560/4/3/012; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Suminski AJ, 2010, J NEUROSCI, V30, P16777, DOI 10.1523/JNEUROSCI.3967-10.2010; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Vargas-Irwin CE, 2010, J NEUROSCI, V30, P9659, DOI 10.1523/JNEUROSCI.5443-09.2010; Veizovic T, 2001, STROKE, V32, P1012, DOI 10.1161/01.STR.32.4.1012; Wang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055344; Wisneski KJ, 2008, STROKE, V39, P3351, DOI 10.1161/STROKEAHA.108.518175; WOLPAW JR, 1991, ELECTROEN CLIN NEURO, V78, P252, DOI 10.1016/0013-4694(91)90040-B; Wu W, 2009, IEEE T NEUR SYS REH, V17, P370, DOI 10.1109/TNSRE.2009.2023307; Yanagisawa T, 2011, J NEUROSURG, V114, P1715, DOI 10.3171/2011.1.JNS101421; Yarosh CA, 2004, J NEUROPHYSIOL, V92, P3276, DOI 10.1152/jn.00549.2004	51	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115236	10.1371/journal.pone.0115236	http://dx.doi.org/10.1371/journal.pone.0115236			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545500	gold, Green Published, Green Submitted			2022-12-27	WOS:000347120200030
J	Yang, HJ; Huang, X; Zhou, ZH; Wang, HHX; Tong, XY; Wang, ZH; Wang, JJ; Lu, ZX				Yang, Huajie; Huang, Xiang; Zhou, Zhiheng; Wang, Harry H. X.; Tong, Xinyue; Wang, Zhihong; Wang, Jiaji; Lu, Zuxun			Determinants of Initial Utilization of Community Healthcare Services among Patients with Major Non-Communicable Chronic Diseases in South China	PLOS ONE			English	Article							WORKFORCE; PHYSICIAN; BURDEN; EUROPE	Background: Although expected to act as gate-keeping primary care providers, as community health service (CHS) facilities are severely under-utilized; Chinese people in both rural and urban areas used predominantly higher-tier facilities for primary care purpose, with significant financial and outcome consequences. This study intends to explore the determinants of initial utilization of CHS among patients with major non-communicable chronic diseases (NCDs) in order to understand the care-seeking behavior among urban and rural residents in South China. Methods: A multi-stage cluster random sampling methodology was adopted to create a sample of 19,466 adults with NCDs from 7,970 urban households and 32,035 adults with NCDs from 3,860 rural households in Guangdong, China. Interviews and physical examinations were conducted in 2010 to collect data on patient characteristics, medical conditions, and awareness and utilization of healthcare. Descriptive analysis and logistic regression analysis were performed to study utilization patterns and the factors associated with the patterns. Results: Prevalence of major NCDs in urban areas was significantly higher than that in rural areas (12.55% vs. 8.70%; p<0.001). Second-tier district hospitals were most preferred for initial consultation (46.05% in rural areas vs. 45.32% in urban areas; p<0.001), followed by tertiary general or specialized hospitals (28.39% in rural areas vs. 33.89% in urban areas; p<0.001). The proportion of patients who had initial use of CHS was relatively low (25.56% in rural areas vs. 20.79% in urban areas; p<0.001). Awareness of self-care and the presence of medical insurance were leading factors associated with first contact of CHS facilities in both urban and rural areas. Conclusion: The study suggests that CHS facilities are not often used as the first contact for patients in both rural and urban areas in south China. Much effect must be made to enhance the gatekeeper system and improve medical insurance coverage in future healthcare reforms.	[Yang, Huajie; Tong, Xinyue; Lu, Zuxun] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Wuhan 430030, Peoples R China; [Huang, Xiang; Zhou, Zhiheng; Wang, Jiaji] Guangzhou Med Univ, Sch Publ Hlth, Guangzhou 510182, Guangdong, Peoples R China; [Wang, Harry H. X.] Chinese Univ Hong Kong, Fac Med, Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China; [Wang, Harry H. X.] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow G12 9LX, Lanark, Scotland; [Wang, Zhihong] Huazhong Univ Sci & Technol, Affiliated Liyuan Hosp, Tongji Med Coll, Wuhan 430077, Peoples R China	Huazhong University of Science & Technology; Guangzhou Medical University; Chinese University of Hong Kong; University of Glasgow; Huazhong University of Science & Technology	Wang, JJ (corresponding author), Guangzhou Med Univ, Sch Publ Hlth, Guangzhou 510182, Guangdong, Peoples R China.	wjiaji@163.com; zuxunlu@yahoo.com	zhou, zhiheng/AAC-1519-2019; Wang, Harry H.X./E-9027-2015; WANG, Jia Ji/E-9059-2015	Wang, Harry H.X./0000-0002-0361-6527; 	National Natural Science Foundation of China [71373090, 81172753]; Department of Education, Guangdong Province, P. R. China [BKZZ2011047]; Medical Research Fund, Chinese Medical Association, P. R. China; Guangdong Medical Doctor Association of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Education, Guangdong Province, P. R. China; Medical Research Fund, Chinese Medical Association, P. R. China; Guangdong Medical Doctor Association of China	This research was funded by National Natural Science Foundation of China (71373090, 81172753); Department of Education, Guangdong Province, P. R. China (BKZZ2011047); Medical Research Fund, Chinese Medical Association, P. R. China (2010-08-05); and Guangdong Medical Doctor Association of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, MANUAL COMMUNITY APP; Bodenheimer T, 2009, HEALTH AFFAIR, V28, P64, DOI 10.1377/hlthaff.28.1.64; Boerma WGW, 1998, SOC SCI MED, V47, P445, DOI 10.1016/S0277-9536(98)00074-4; Boerma WGW, 1997, BRIT J GEN PRACT, V47, P481; Chernew ME, 2009, HEALTH AFFAIR, V28, P1327, DOI 10.1377/hlthaff.28.5.1327; Collins SR, 2010, COMPREHENSIVE CONGRE; Delnoij DMJ, 1994, PHYS PAYMENT SYSTEMS; Department of diseases control MOH China CDC, 2006, REP CHRON DIS CHIN; Dongfen C, 2006, THESIS ZHEIIANG U; Dupuits FMHM, 1998, COMPUT METH PROG BIO, V55, P39, DOI 10.1016/S0169-2607(97)00046-1; Fleming DM, 1993, EUROPEAN STUDY REFER; Groenewegen PP, 1997, WAT ZOU NEDERLAND ZI; Harrington DW, 2012, HEALTH PLACE, V18, P814, DOI 10.1016/j.healthplace.2012.03.011; Institute of Social Science Survey ISSS, 2009, CHIN FAM DYN; Kong L.Z, 2012, CHINESE J PREVENTION, V20, P502; Kroneman MW, 2006, HEALTH POLICY, V76, P72, DOI 10.1016/j.healthpol.2005.05.003; LaVeist T, 2011, HEALTH AFFAIR, V30, P1880, DOI 10.1377/hlthaff.2011.0640; Li P, 2011, ANAL REPORTED INCIDE; Liu J, 2003, CHINESE HLTH EC, V11, P22; Longhua HJ, 2011, CHINESE HLTH RESOURC, V14, P124; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Majun Shanshan L, 2008, CHINESE J PUBLIC HLT, V24, P907; Mo T.J., 1993, POVERTY SOCIAL SECUR; Murray C., 1996, GLOBAL BURDEN DIS IN, V1; Ningxiu L, 2001, CHINESE HLTH SERVICE, V2, P101; Shi LY, 2012, J AMBUL CARE MANAG, V35, P60, DOI 10.1097/JAC.0b013e31823abf07; STARFIELD B, 1994, LANCET, V344, P1129, DOI 10.1016/S0140-6736(94)90634-3; United Nations, 2003, WORLD POPULATION PRO; Wang H H X, 2013, Malays Fam Physician, V8, P2; Wang HHX, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0188-0; Wang HHX, 2013, ANN FAM MED, V11, P517, DOI 10.1370/afm.1545; Wang HHX, 2015, BRIT J GEN IN PRESS; Wang Jian, 2006, CHINESE HLTH EC, V25, P45; Wang N, 2011, CHINESE GEN PRACTICE, V1; WHO, 2012, LAUNCH WHO PROGR INC; Wright DB, 2010, SOC SCI MED, V70, P2006, DOI 10.1016/j.socscimed.2010.02.043; Zurn P, 2011, HUM RESOUR HEALTH, V9, DOI 10.1186/1478-4491-9-8; 陈兆杰, 2009, [中国老年学杂志, Chinese Journal of Gerontology], V29, P2107	39	22	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e116051	10.1371/journal.pone.0116051	http://dx.doi.org/10.1371/journal.pone.0116051			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7UN	25545636	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000347120200094
J	Ao, MX; Li, XM; Huang, C; Hou, ZQ; Qiu, WQ; Wang, W				Ao, Mingxin; Li, Xuemin; Huang, Chen; Hou, Zhiqiang; Qiu, Weiqiang; Wang, Wei			Significant Improvement in Dynamic Visual Acuity after Cataract Surgery: A Promising Potential Parameter for Functional Vision	PLOS ONE			English	Article							CONTRAST SENSITIVITY; MOTION PERCEPTION; PERFORMANCE; SYSTEM; AGE; ORGANIZATION; PATHWAYS; GLAUCOMA; DRIVERS	Purpose: Dynamic visual acuity (DVA) is a relatively independent parameter for evaluating the ability to distinguish details of a moving target. The present study has been designed to discuss the extent to which age-related cataract impacts DVA in elderly individuals and to determine whether it could be restored after bilateral phacoemulsification combined with intraocular lens implantation surgery. Methods: Twenty-six elderly cataract patients scheduled for binocular cataract surgery and 30 elderly volunteers without cataract were enrolled in the study. DVA at 15, 30, 60 and 90 degree per second (dps) was assessed, and velocity-dependent visual acuity decreases between consecutive speed levels were calculated. Results: Compared with the control group, the patient group exhibited significantly worse DVA performance at all speed levels (p<0.001), and the decreases in velocity-dependent visual acuity were more serious in the patient group at the intervals of 0-15 dps (p<0.001), 15-30 dps (p=0.007) and 30-60 dps (p=0.008). Postoperatively, DVA performance at every speed level in the patient group clearly improved (p<0.001) and recovered to levels compatible to the control group. The decrease in visual acuity with increasing speed was less pronounced than during the preoperative phase (p(0-15 dps)=0.001, p(15-30) (dps) <0.001 and p(30-60) (dps)=0.001) and became similar to that of the control group. The postoperative visual benefit regarding DVA was more pronounced than the improvement in static visual acuity (p(15 dps)=0.001 and p<0.001 at 30 dps, 60 dps and 90 dps). Conclusions: The impact of age-related cataract on DVA was more severe than its effects on static visual acuity. After cataract surgery, not only static vision of the	[Ao, Mingxin; Li, Xuemin; Hou, Zhiqiang; Qiu, Weiqiang; Wang, Wei] Peking Univ, Hosp 3, Dept Ophthalmol, Beijing 100871, Peoples R China; [Ao, Mingxin; Li, Xuemin; Hou, Zhiqiang; Qiu, Weiqiang; Wang, Wei] Minist Educ, Key Lab Vis Loss & Restorat, Beijing, Peoples R China; [Huang, Chen] Peking Univ, Hosp 3, Med Res Ctr, Beijing 100871, Peoples R China	Peking University; Peking University	Wang, W (corresponding author), Peking Univ, Hosp 3, Dept Ophthalmol, Beijing 100871, Peoples R China.	puh3_ww@bjmu.edu.cn		Hou, Zhiqiang/0000-0001-5638-6553	Academic Award for Excellent Doctorial Candidates of the Ministry of Education of China	Academic Award for Excellent Doctorial Candidates of the Ministry of Education of China	The research has been supported by Academic Award for Excellent Doctorial Candidates of the Ministry of Education of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertone A, 2011, NEUROREPORT, V22, P951, DOI 10.1097/WNR.0b013e32834d2f49; BURG A, 1966, J APPL PSYCHOL, V50, P460, DOI 10.1037/h0023982; CAMPBELL FW, 1978, VISION RES, V18, P1297, DOI 10.1016/0042-6989(78)90219-5; Castelo-Branco M, 2004, INVEST OPHTH VIS SCI, V45, P499, DOI 10.1167/iovs.03-0815; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; Committee on Vision of the National Research Council (US), 1985, EM TECHN ASS VIS PER; Erickson GB, 2011, OPTOMETRY, V82, P528, DOI 10.1016/j.optm.2011.01.012; GEER I, 1993, OPTOMETRY VISION SCI, V70, P552, DOI 10.1097/00006324-199307000-00006; GILMORE GC, 1992, PSYCHOL AGING, V7, P654, DOI 10.1037/0882-7974.7.4.654; Hendry SHC, 1998, TRENDS NEUROSCI, V21, P344, DOI 10.1016/S0166-2236(98)01245-4; HOFFMAN LG, 1981, J AM OPTOM ASSOC, V52, P883; ISHIGAKI H, 1994, PERCEPT MOTOR SKILL, V78, P363, DOI 10.2466/pms.1994.78.2.363; Lewis P, 2011, VISION RES, V51, P1829, DOI 10.1016/j.visres.2011.06.011; LONG GM, 1990, PSYCHOL AGING, V5, P138, DOI 10.1037/0882-7974.5.1.138; LONG GM, 1992, OPTOMETRY VISION SCI, V69, P915, DOI 10.1097/00006324-199212000-00001; Mateus C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055348; McGregor LN, 2005, HUM FACTORS, V47, P469, DOI 10.1518/001872005774859953; McKendrick AM, 2007, INVEST OPHTH VIS SCI, V48, P2115, DOI 10.1167/iovs.06-1208; Owsley C, 2011, VISION RES, V51, P1610, DOI 10.1016/j.visres.2010.10.020; Patel I, 2006, INVEST OPHTH VIS SCI, V47, P65, DOI 10.1167/iovs.05-0582; Pilz KS, 2010, VISION RES, V50, P211, DOI 10.1016/j.visres.2009.11.014; Rouse M W, 1988, J Am Optom Assoc, V59, P946; Schneck Marilyn E, 2003, Ophthalmol Clin North Am, V16, P269, DOI 10.1016/S0896-1549(03)00008-7; Schneiders AG, 2010, PHYS THER SPORT, V11, P47, DOI 10.1016/j.ptsp.2010.01.001; SHINAR D, 1991, HUM FACTORS, V33, P507, DOI 10.1177/001872089103300503; Smither JAA, 2010, APPL ERGON, V41, P266, DOI 10.1016/j.apergo.2009.07.008; Spering M, 2011, VISION RES, V51, P836, DOI 10.1016/j.visres.2010.10.017; THYLEFORS B, 1990, INT OPHTHALMOL, V14, P211, DOI 10.1007/BF00158321; Uchida Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031530; Watson TL, 2009, CURR BIOL, V19, P1040, DOI 10.1016/j.cub.2009.04.052; Wilkins L, 2013, INVEST OPHTH VIS SCI, V54, P8364, DOI 10.1167/iovs.13-12774; Wood JM, 2002, HUM FACTORS, V44, P482, DOI 10.1518/0018720024497664	32	13	14	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115812	10.1371/journal.pone.0115812	http://dx.doi.org/10.1371/journal.pone.0115812			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541959	Green Published, Green Submitted, gold			2022-12-27	WOS:000347239900092
J	dos Santos, IC; de Almeida, AAF; Anhert, D; da Conceicao, AS; Pirovani, CP; Pires, JL; Valle, RR; Baligar, VC				dos Santos, Ivanildes C.; de Almeida, Alex-Alan Furtado; Anhert, Dario; da Conceicao, Alessandro S.; Pirovani, Carlos P.; Pires, Jose L.; Valle, Raul Rene; Baligar, Virupax C.			Molecular, Physiological and Biochemical Responses of Theobroma cacao L. Genotypes to Soil Water Deficit	PLOS ONE			English	Article							2 CONTRASTING POPULATIONS; OXIDATIVE STRESS; DROUGHT-STRESS; ADAPTIVE RESPONSES; GROWTH-RESPONSES; GENE-EXPRESSION; LEAF-AREA; PLANTS; CLONES; PHOTOSYNTHESIS	Six months-old seminal plants of 36 cacao genotypes grown under greenhouse conditions were subjected to two soil water regimes (control and drought) to assess, the effects of water deficit on growth, chemical composition and oxidative stress. In the control, soil moisture was maintained near field capacity with leaf water potentials (Psi WL) ranging from -0.1 to -0.5 MPa. In the drought treatment, the soil moisture was reduced gradually by withholding additional water until Psi WL reached values of between -2.0 to -2.5 MPa. The tolerant genotypes PS-1319, MO-20 and MA-15 recorded significant increases in guaiacol peroxidase activity reflecting a more efficient antioxidant metabolism. In relation to drought tolerance, the most important variables in the distinguishing contrasting groups were: total leaf area per plant; leaf, stem and total dry biomass; relative growth rate; plant shoot biomass and leaf content of N, Ca, and Mg. From the results of these analyses, six genotypes were selected with contrasting characteristics for tolerance to soil water deficit [CC-40, C. SUL-4 and SIC-2 (non-tolerant) and MA-15, MO-20, and PA-13 (tolerant)] for further assessment of the expression of genes NCED5, PP2C, psbA and psbO to water deficit. Increased expression of NCED5, PP2C, psbA and psbO genes were found for non-tolerant genotypes, while in the majority of tolerant genotypes there was repression of these genes, with the exception of PA-13 that showed an increased expression of psbA. Mutivariate analysis showed that growth variables, leaf and total dry biomass, relative growth rate as well as Mg content of the leaves were the most important factor in the classification of the genotypes as tolerant, moderately tolerant and sensitive to water deficit. Therefore these variables are reliable plant traits in the selection of plants tolerant to drought.	[dos Santos, Ivanildes C.; de Almeida, Alex-Alan Furtado; Anhert, Dario; da Conceicao, Alessandro S.; Pirovani, Carlos P.] Univ Estadual Santa Cruz, Dept Ciencias Biol, Ilheus, BA, Brazil; [Pires, Jose L.; Valle, Raul Rene] Comissao Execut Plano Lavoura Cacaueira CEPEC CEP, Ctr Pesquisas Cacau, BR-45650000 Ilheus, BA, Brazil; [Baligar, Virupax C.] ARS, USDA, Beltsville, MD 20705 USA	Universidade Estadual de Santa Cruz; United States Department of Agriculture (USDA)	de Almeida, AAF (corresponding author), Univ Estadual Santa Cruz, Dept Ciencias Biol, Campus Soane Nazare de Andrade,Rod Jorge Amado, Ilheus, BA, Brazil.	alexalan@uesc.br	Pirovani, Carlos P/J-3426-2017; Pirovani, Carlos Priminho/N-1153-2019	Pirovani, Carlos P/0000-0002-6176-4069; Pirovani, Carlos Priminho/0000-0002-6176-4069				Alvim P. D. T., 1977, ECOPHYSIOLOGY TROPIC, P279; Anjum SA, 2011, AFR J AGR RES, V6, P2026; [Anonymous], 1997, MAN MET AN SOL; Arend M, 2011, TREE PHYSIOL, V31, P287, DOI 10.1093/treephys/tpr004; Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; Bae H, 2008, PLANT PHYSIOL BIOCH, V46, P174, DOI 10.1016/j.plaphy.2007.10.014; Bagci SA, 2007, J AGRON CROP SCI, V193, P198, DOI 10.1111/j.1439-037X.2007.00256.x; BALASIMHA D, 1988, 10TH INTERNATIONAL COCOA RESEARCH CONFERENCE, P215; Bargali K, 2004, J ARID ENVIRON, V58, P505, DOI 10.1016/j.jaridenv.2004.01.002; Bartley BGD, 2005, GENETIC DIVERSITY OF CACAO AND ITS UTILIZATION: BOTANY, PRODUCTION AND USES, P1, DOI 10.1079/9780851996196.0000; Bruck H, 2000, CROP SCI, V40, P120, DOI 10.2135/cropsci2000.401120x; Burman U, 2009, J PLANT NUTR, V32, P668, DOI 10.1080/01904160802715620; Cakmak I, 2000, NEW PHYTOL, V146, P185, DOI 10.1046/j.1469-8137.2000.00630.x; Chao YY, 2012, PLANT GROWTH REGUL, V66, P1, DOI 10.1007/s10725-011-9623-9; Cheesman E. E., 1944, TROP AGRIC [TRINIDAD], V21, P144; Christmann A, 2006, PLANT BIOLOGY, V8, P314, DOI 10.1055/s-2006-924120; CHRISTOPHER DA, 1994, PLANT PHYSIOL, V104, P1119, DOI 10.1104/pp.104.4.1119; Almeida Alex-Alan F. de, 2007, Braz. J. Plant Physiol., V19, P83, DOI 10.1590/S1677-04202007000200001; de Carvalho MHC, 2008, PLANT SIGNAL BEHAV, V3, P156, DOI 10.4161/psb.3.3.5536; Ding Y, 2006, ANN APPL BIOL, V149, P111, DOI 10.1111/j.1744-7348.2006.00080.x; Frey A, 2012, PLANT J, V70, P501, DOI 10.1111/j.1365-313X.2011.04887.x; GASPAR T, 1985, PHYSIOL PLANTARUM, V64, P418, DOI 10.1111/j.1399-3054.1985.tb03362.x; Geiger D, 2009, P NATL ACAD SCI USA, V106, P21425, DOI 10.1073/pnas.0912021106; Giardi MT, 1996, PLANTA, V199, P118, DOI 10.1007/BF00196888; Gill SS, 2010, PLANT SIGNAL BEHAV, V5, P26, DOI 10.4161/psb.5.1.10291; Guo XY, 2010, J PLANT ECOL, V3, P79, DOI 10.1093/jpe/rtq007; Hansch R, 2009, CURR OPIN PLANT BIOL, V12, P259, DOI 10.1016/j.pbi.2009.05.006; Hair J., 2010, MULTIVARIATE DATA AN, V7; Hermans C, 2006, TRENDS PLANT SCI, V11, P610, DOI 10.1016/j.tplants.2006.10.007; Hermans C, 2010, NEW PHYTOL, V187, P132, DOI 10.1111/j.1469-8137.2010.03257.x; Hu YC, 2005, J PLANT NUTR SOIL SC, V168, P541, DOI 10.1002/jpln.200420516; Hunt R., 1990, BASIC GROWTH ANAL, DOI [10.1007/978-94-010-9117-6, DOI 10.1007/978-94-010-9117-6]; Jiang MY, 2002, J EXP BOT, V53, P2401, DOI 10.1093/jxb/erf090; Jolly WM, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023252; JOLY RJ, 1989, ANN BOT-LONDON, V64, P1; Jones J.B., 1991, PLANT ANAL HDB PRACT; Jouili H, 2003, CR BIOL, V326, P639, DOI 10.1016/S1631-0691(03)00157-4; Jubany-Mari T, 2010, PLANT PHYSIOL BIOCH, V48, P351, DOI 10.1016/j.plaphy.2010.01.021; Khanna-Chopra R, 2012, PROTOPLASMA, V249, P469, DOI 10.1007/s00709-011-0308-z; Kozlowski TT, 2002, BOT REV, V68, P270, DOI 10.1663/0006-8101(2002)068[0270:AAAROW]2.0.CO;2; Landhausser SM, 1996, CAN J BOT, V74, P686, DOI 10.1139/b96-087; Lee BR, 2007, J EXP BOT, V58, P1271, DOI 10.1093/jxb/erl280; Lei YB, 2006, PHYSIOL PLANTARUM, V127, P182, DOI 10.1111/j.1399-3054.2006.00638.x; Li CY, 2003, FOREST ECOL MANAG, V179, P377, DOI 10.1016/S0378-1127(02)00552-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynch JP, 2004, FIELD CROP RES, V90, P101, DOI 10.1016/j.fcr.2004.07.008; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Maathuis FJM, 2009, CURR OPIN PLANT BIOL, V12, P250, DOI 10.1016/j.pbi.2009.04.003; MacRobbie EAC, 1998, PHILOS T ROY SOC B, V353, P1475, DOI 10.1098/rstb.1998.0303; Marron N, 2003, TREE PHYSIOL, V23, P1225, DOI 10.1093/treephys/23.18.1225; MARTINS DV, 1976, THESIS U FEDERAL BAH; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Motamayor JC, 2002, HEREDITY, V89, P380, DOI 10.1038/sj.hdy.6800156; Munoz F, 2001, AGROFOREST SYST, V51, P119, DOI 10.1023/A:1010651203815; Murakami R, 2005, FEBS J, V272, P2165, DOI 10.1111/j.1742-4658.2005.04636.x; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; Nepomuceno AL, 2000, PESQUI AGROPECU BRAS, V35, P1407, DOI 10.1590/S0100-204X2000000700015; Pawlowicz I, 2012, ACTA PHYSIOL PLANT, V34, P1915, DOI 10.1007/s11738-012-0992-0; Peuke AD, 2011, TREE PHYSIOL, V31, P196, DOI 10.1093/treephys/tpr007; Pirovani CP, 2008, ELECTROPHORESIS, V29, P2391, DOI 10.1002/elps.200700743; RADFORD PJ, 1967, CROP SCI, V7, P171, DOI 10.2135/cropsci1967.0011183X000700030001x; Rascher U, 2004, PLANT CELL ENVIRON, V27, P1239, DOI 10.1111/j.1365-3040.2004.01231.x; Regier N, 2009, PLANT CELL ENVIRON, V32, P1724, DOI 10.1111/j.1365-3040.2009.02030.x; Rehem BC, 2011, PHOTOSYNTHETICA, V49, P127, DOI 10.1007/s11099-011-0021-3; RICHARDS F. J, 1969, PLANT PHYSL TREATISE, V5A, P3; Rivero RM, 2001, PLANT SCI, V160, P315, DOI 10.1016/S0168-9452(00)00395-2; Rucker K. S., 1995, Peanut Science, V22, P14, DOI 10.3146/pnut.22.1.0003; Ruiz JM, 1998, PHYTOCHEMISTRY, V48, P269, DOI 10.1016/S0031-9422(97)01132-1; Saibo NJM, 2009, ANN BOT-LONDON, V103, P609, DOI 10.1093/aob/mcn227; Sanchez-Diaz M, 2007, TREE PHYSIOL, V27, P1415, DOI 10.1093/treephys/27.10.1415; SCHOLANDER PF, 1965, SCIENCE, V148, P339, DOI 10.1126/science.148.3668.339; Schroeder JI, 2001, ANNU REV PLANT PHYS, V52, P627, DOI 10.1146/annurev.arplant.52.1.627; Seo M, 2004, PLANT CELL PHYSIOL, V45, P1694, DOI 10.1093/pcp/pch198; Silva W. S. da, 1998, Agrotropica, V10, P31; Souza Júnior José Olimpio de, 2008, Rev. Bras. Ciênc. Solo, V32, P2367; Tan BC, 2003, PLANT J, V35, P44, DOI 10.1046/j.1365-313X.2003.01786.x; Tschaplinski TJ, 1998, TREE PHYSIOL, V18, P653; Tuteja N, 2008, PLANT SIGNAL BEHAV, V3, P525, DOI 10.4161/psb.3.8.6186; Umezawa T, 2010, PLANT CELL PHYSIOL, V51, P1821, DOI 10.1093/pcp/pcq156; Vanderauwera S, 2005, PLANT PHYSIOL, V139, P806, DOI 10.1104/pp.105.065896; Wang Y, 2010, MOL PLANT, V3, P280, DOI 10.1093/mp/ssq006; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; White PJ, 2003, ANN BOT-LONDON, V92, P487, DOI 10.1093/aob/mcg164; Wilkinson S, 2002, PLANT CELL ENVIRON, V25, P195, DOI 10.1046/j.0016-8025.2001.00824.x; Xiao XW, 2008, SILVA FENN, V42, P705, DOI 10.14214/sf.224; Yang YQ, 2005, PHYSIOL PLANTARUM, V124, P431, DOI 10.1111/j.1399-3054.2005.00517.x; Yin CY, 2005, ENVIRON EXP BOT, V53, P315, DOI 10.1016/j.envexpbot.2004.04.007; Zobel RW, 2007, PLANT SOIL, V297, P243, DOI 10.1007/s11104-007-9341-2	88	21	21	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115746	10.1371/journal.pone.0115746	http://dx.doi.org/10.1371/journal.pone.0115746			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541723	gold, Green Submitted, Green Published			2022-12-27	WOS:000347239900076
J	Duarte-Neto, P; Stoslc, B; Stoslc, T; Lessa, R; Milosevic, MV; Stanley, HE				Duarte-Neto, Paulo; Stosic, Borko; Stosic, Tatijana; Lessa, Rosangela; Milosevic, Milorad V.; Stanley, H. Eugene			Multifractal Properties of a Closed Contour: A Peek beyond the Shape Analysis	PLOS ONE			English	Article							FISH OTOLITHS; MATURITY; CLASSIFICATION; GROWTH; SIZE; AGE	In recent decades multifractal analysis has been successfully applied to characterize the complex temporal and spatial organization of such diverse natural phenomena as heartbeat dynamics, the dendritic shape of neurons, retinal vessels, rock fractures, and intricately shaped volcanic ash particles. The characterization of multifractal properties of closed contours has remained elusive because applying traditional methods to their quasi-one-dimensional nature yields ambiguous answers. Here we show that multifractal analysis can reveal meaningful and sometimes unexpected information about natural structures with a perimeter well-defined by a closed contour. To this end, we demonstrate how to apply multifractal detrended fluctuation analysis, originally developed for the analysis of time series, to an arbitrary shape of a given study object. In particular, we show the application of the method to fish otoliths, calcareous concretions located in fish's inner ear. Frequently referred to as the fish's "black box", they contain a wealth of information about the fish's life history and thus have recently attracted increasing attention. As an illustrative example, we show that a multifractal approach can uncover unexpected relationships between otolith contours and size and age of fish at maturity.	[Duarte-Neto, Paulo; Stosic, Borko; Stosic, Tatijana] Univ Fed Rural Pernambuco, Dept Estat & Informat, Recife, PE, Brazil; [Lessa, Rosangela] Univ Fed Rural Pernambuco, Dept Pesca & Aquicultura, Recife, PE, Brazil; [Duarte-Neto, Paulo; Milosevic, Milorad V.] Univ Antwerp, Dept Fys, Antwerp, Belgium; [Stanley, H. Eugene] Boston Univ, Ctr Polymer Studies, Boston, MA 02215 USA; [Stanley, H. Eugene] Boston Univ, Dept Phys, Boston, MA 02215 USA	Universidade Federal Rural de Pernambuco (UFRPE); Universidade Federal Rural de Pernambuco (UFRPE); University of Antwerp; Boston University; Boston University	Duarte-Neto, P (corresponding author), Univ Fed Rural Pernambuco, Dept Estat & Informat, Recife, PE, Brazil.	pjduarteneto@gmail.com	Stosic, Borko/B-5808-2014; LESSA, ROSANGELA PAULA TEIXEIRA/D-5043-2013; Stosic, Tatijana/J-3974-2013; Milosevic, Milorad V/H-9393-2012; Milosevic, Milorad/AAN-6233-2021; Duarte-Neto, Paulo J/J-5623-2016	Milosevic, Milorad V/0000-0002-5431-377X; Milosevic, Milorad/0000-0002-5431-377X; Duarte-Neto, Paulo J/0000-0002-2592-7297; Stanley, H./0000-0003-2800-4495; Stosic, Tatijana/0000-0002-5691-945X; Lessa, Rosangela/0000-0002-9217-1215; Stosic, Borko/0000-0001-5031-6968	CNPq, Brazil [201506/2011-4, 303251/2010-7, 306719/2012-6]; Flemish Science Foundation (FWO-Vlaanderen); CAPES PVE action [BEX1392/11-5]	CNPq, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Flemish Science Foundation (FWO-Vlaanderen)(FWO); CAPES PVE action(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Funding: This work was supported by CNPq, Brazil (Projects No. 201506/2011-4, No. 303251/2010-7, and No. 306719/2012-6). MVM acknowledges support from Flemish Science Foundation (FWO-Vlaanderen) and CAPES PVE action No. BEX1392/11-5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allemand D, 2007, FISH OTOLITH CALCIFI, P291; Campana SE, 1999, MAR ECOL PROG SER, V188, P263, DOI 10.3354/meps188263; Costa LD, 2009, IMAGE PROCESS SER, P1; Dellino P, 2002, J VOLCANOL GEOTH RES, V113, P1, DOI 10.1016/S0377-0273(01)00247-5; Drolon H, 2000, PATTERN RECOGN LETT, V21, P473, DOI 10.1016/S0167-8655(00)00010-6; Duarte-Neto P, 2008, ICES J MAR SCI, V65, P1144, DOI 10.1093/icesjms/fsn090; Fablet R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027055; Fernandez E, 1999, J NEUROSCI METH, V89, P151, DOI 10.1016/S0165-0270(99)00066-7; Fontoura NF, 2009, NEOTROP ICHTHYOL, V7, P217, DOI 10.1590/S1679-62252009000200013; GILDEN DL, 1993, PSYCHOL REV, V100, P460, DOI 10.1037/0033-295X.100.3.460; Green BS, 2009, REV-METHODS TECHNOL, V11, P1, DOI 10.1007/978-1-4020-5775-5; HARTE D, 2001, MULTIFRACTALS THEORY; Ivanov PC, 1999, NATURE, V399, P461, DOI 10.1038/20924; Kantelhardt JW, 2002, PHYSICA A, V316, P87, DOI 10.1016/S0378-4371(02)01383-3; Lecomte-Finiger Raymonde, 1999, Annee Biologique, V38, P107; Lestrel PE, 1997, INTRO OVERVIEW FOURI, P22; Lombarte A, 2006, SCI MAR, V70, P147, DOI 10.3989/scimar.2006.70n1147; Mellon-Duval C, 2010, ICES J MAR SCI, V67, P62, DOI 10.1093/icesjms/fsp215; MUGIYA Y, 1987, FISH B-NOAA, V85, P395; MUZY JF, 1991, PHYS REV LETT, V67, P3515, DOI 10.1103/PhysRevLett.67.3515; Nasreddinea K, 2010, FISHERY RES, V98, P8; Oswiecimka P, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016103; PANNELLA G, 1971, SCIENCE, V173, P1124, DOI 10.1126/science.173.4002.1124; Piera J, 2005, MAR FRESHWATER RES, V56, P805, DOI 10.1071/MF04163; Pineiro C, 2003, ICES J MAR SCI, V60, P1086, DOI 10.1016/S1054-3139(03)00086-9; Posadas AND, 2003, SOIL SCI SOC AM J, V67, P1361, DOI 10.2136/sssaj2003.1361; Recasens L, 2008, SCI MAR, V72, P721, DOI 10.3989/scimar.2008.72n4721; Santana FM, 2009, AQUAT BIOL, V7, P199, DOI 10.3354/ab00189; Sollner C, 2003, SCIENCE, V302, P282, DOI 10.1126/science.1088443; Stosic T, 2006, IEEE T MED IMAGING, V25, P1101, DOI 10.1109/TMI.2006.879316; TEL T, 1989, PHYSICA A, V159, P155, DOI 10.1016/0378-4371(89)90563-3; TRIPPEL EA, 1991, CAN J FISH AQUAT SCI, V48, P1446, DOI 10.1139/f91-172; Xie HP, 1999, INT J ROCK MECH MIN, V36, P19, DOI 10.1016/S0148-9062(98)00172-7; Xie S, 2010, NONLINEAR PROC GEOPH, V17, P319, DOI 10.5194/npg-17-319-2010	35	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115262	10.1371/journal.pone.0115262	http://dx.doi.org/10.1371/journal.pone.0115262			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542025	Green Published, gold			2022-12-27	WOS:000347239900030
J	Imajo, K; Hyogo, H; Yoneda, M; Honda, Y; Kessoku, T; Tomeno, W; Ogawa, Y; Taguri, M; Mawatari, H; Nozaki, Y; Fujita, K; Kirikoshi, H; Saito, S; Sumida, Y; Ono, M; Wada, K; Nakajima, A; Eguchi, Y				Imajo, Kento; Hyogo, Hideyuki; Yoneda, Masato; Honda, Yasushi; Kessoku, Takaomi; Tomeno, Wataru; Ogawa, Yuji; Taguri, Masataka; Mawatari, Hironori; Nozaki, Yuichi; Fujita, Koji; Kirikoshi, Hiroyuki; Saito, Satoru; Sumida, Yoshio; Ono, Masafumi; Wada, Koichiro; Nakajima, Atsushi; Eguchi, Yuichiro			LDL-Migration Index (LDL-MI), an Indicator of Small Dense Low-Density Lipoprotein (sdLDL), Is Higher in Non-Alcoholic Steatohepatitis than in Non-Alcoholic Fatty Liver: A Multicenter Cross-Sectional Study	PLOS ONE			English	Article							CORONARY-ARTERY CALCIFICATION; TYPE-2 DIABETES-MELLITUS; METABOLIC SYNDROME; ENDOTHELIAL DYSFUNCTION; CAROTID ATHEROSCLEROSIS; INSULIN-RESISTANCE; RICH LIPOPROTEINS; PARTICLE-SIZE; HEPATITIS-C; DISEASE	Background: Non-alcoholic fatty liver disease (NAFLD) is associated with increased risks of atherosclerotic diseases, including cardiovascular disease. However, the difference in risk between patients with non-alcoholic fatty liver (NAFL) and non-alcoholic steatohepatitis (NASH) has not yet been determined. Accumulating evidence has shown that high amounts of small dense low-density lipoprotein (sdLDL) are closely associated with atherosclerotic diseases. This study investigated differences in risk factors for atherosclerotic diseases, especially LDL-migration index (LDL-MI), an indicator of sdLDL, between patients with NAFL and NASH. Methods: LDL-MI was analyzed in a primary cohort of 156 patients with NAFLD, including 53 with NAFL and 103 with NASH, and a validation cohort of 69 patients with NAFLD, including 25 with NAFL and 44 with NASH. Results: In the primary cohort, NASH was associated with elevated LDL-MI (p=0.039). Multiple regression analysis showed that NASH and the non-use of lipid lowering medications were independently correlated with higher LDL-MI in all patients with NAFLD. Among patients not on lipid lowering medications, those with NASH had significantly higher LDL-MI than those with NAFL (p=0.001). These findings were confirmed in a validation cohort, in that LDL-MI was significantly higher in patients with NASH than with NAFL (p=0.043). Conclusion:This study is the first to show that LDL-MI, an indicator of sdLDL, was higher in patients with NASH than with NAFL, suggesting that the risk of atherosclerotic diseases may be higher in NASH than NAFL. Patients with NASH should be followed closely, especially for the progression of liver pathology and atherosclerotic diseases.	[Imajo, Kento; Yoneda, Masato; Honda, Yasushi; Kessoku, Takaomi; Tomeno, Wataru; Ogawa, Yuji; Mawatari, Hironori; Nozaki, Yuichi; Fujita, Koji; Kirikoshi, Hiroyuki; Saito, Satoru; Nakajima, Atsushi] Yokohama City Univ, Grad Sch Med, Dept Gastroenterol, Yokohama, Kanagawa 232, Japan; [Hyogo, Hideyuki] Hiroshima Univ, Grad Sch Biomed Sci, Dept Med & Mol Sci, Hiroshima, Japan; [Taguri, Masataka] Yokohama City Univ, Grad Sch Med, Dept Biostat & Epidemiol, Yokohama, Kanagawa 232, Japan; [Sumida, Yoshio] Kyoto Prefectural Univ Med, Dept Gastroenterol & Hepatol, Kamigyo Ku, Kyoto, Japan; [Ono, Masafumi] Kochi Med Sch, Dept Gastroenterol & Hepatol, Kochi, Japan; [Wada, Koichiro] Osaka Univ, Grad Sch Dent, Dept Pharmacol, Osaka, Japan; [Eguchi, Yuichiro] Saga Med Sch, Ctr Liver, Div Hepatol, Saga, Japan	Yokohama City University; Hiroshima University; Yokohama City University; Kyoto Prefectural University of Medicine; Kochi University; Osaka University; Saga University	Nakajima, A (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Gastroenterol, Yokohama, Kanagawa 232, Japan.	nakajima-tky@umin.ac.jp	Imajo, Kento/AAF-5744-2020; Sumida, Yoshio/AAL-6723-2020	Imajo, Kento/0000-0002-1931-6326; Kessoku, Takaomi/0000-0002-5587-1386	Japan Science and Technology Agency (J.S.T.); Kiban-B, Shingakujuturyouiki; Japanese Ministry of Health, Labour and Welfare	Japan Science and Technology Agency (J.S.T.)(Japan Science & Technology Agency (JST)); Kiban-B, Shingakujuturyouiki; Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	Work in the authors laboratory was supported by the program "Step A" from the Japan Science and Technology Agency (J.S.T.) and Kiban-B, Shingakujuturyouiki. In addition, the present work was supported in part by grants-in-aid from the Japanese Ministry of Health, Labour and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akabame S, 2008, CIRC J, V72, P618; Badiou S, 2006, TRANSPL P, V38, P2314, DOI 10.1016/j.transproceed.2006.07.003; Bahadir MA, 2009, J ATHEROSCLER THROMB, V16, P684, DOI 10.5551/jat.1123; Banuls C, 2012, CLIN CHIM ACTA, V413, P251, DOI 10.1016/j.cca.2011.09.047; Bozzetto L, 2011, ATHEROSCLEROSIS, V217, P142, DOI 10.1016/j.atherosclerosis.2011.03.012; Brea A, 2005, ARTERIOSCL THROM VAS, V25, P1045, DOI 10.1161/01.ATV.0000160613.57985.18; Brunt EM, 2001, SEMIN LIVER DIS, V21, P3, DOI 10.1055/s-2001-12925; Cali AMG, 2007, DIABETES CARE, V30, P3093, DOI 10.2337/dc07-1088; Chen CH, 2010, DIGEST DIS SCI, V55, P1752, DOI 10.1007/s10620-009-0935-9; Choi CU, 2010, TEX HEART I J, V37, P421; Fujita K, 2009, HEPATOLOGY, V50, P772, DOI 10.1002/hep.23094; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hoefner DM, 2001, CLIN CHEM, V47, P266; Hui JM, 2003, HEPATOLOGY, V38, P420, DOI 10.1053/jhep.2003.50320; Ikewaki Katsunori, 2004, J Atheroscler Thromb, V11, P278; Imajo K, 2014, J GASTROENTEROL, V49, P295, DOI 10.1007/s00535-013-0776-3; Imajo K, 2012, HEPATOL RES, V42, P757, DOI 10.1111/j.1872-034X.2012.00976.x; Imajo K, 2012, CELL METAB, V16, P44, DOI 10.1016/j.cmet.2012.05.012; Karalis DG, 2007, AM J CARDIOL, V100, P445, DOI 10.1016/j.amjcard.2007.03.043; Kim BJ, 2012, CARDIOLOGY, V123, P54, DOI 10.1159/000341248; Kim YK, 2012, J HUM HYPERTENS, V26, P670, DOI 10.1038/jhh.2011.86; Kimura T, 2010, CIRC J, V74, P1392, DOI 10.1253/circj.CJ-09-0849; Krauss RM, 2004, DIABETES CARE, V27, P1496, DOI 10.2337/diacare.27.6.1496; Lalloyer F, 2011, ARTERIOSCL THROM VAS, V31, P1573, DOI 10.1161/ATVBAHA.110.220525; Li XM, 2012, ATHEROSCLEROSIS, V224, P480, DOI 10.1016/j.atherosclerosis.2012.07.002; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Miksztowicz V, 2012, DIABETES-METAB RES, V28, P535, DOI 10.1002/dmrr.2312; Mishima YAM, 1997, J JPN ATHEROSCLER SO, V25, P67; Nelson A, 2009, J CLIN GASTROENTEROL, V43, P990, DOI 10.1097/MCG.0b013e31819c392e; Okazaki M, 2005, ARTERIOSCL THROM VAS, V25, P578, DOI 10.1161/01.ATV.0000155017.60171.88; Orakzai SH, 2009, ATHEROSCLEROSIS, V202, P289, DOI 10.1016/j.atherosclerosis.2008.03.014; OTVOS JD, 1992, CLIN CHEM, V38, P1632; Packard C, 2000, INT J CARDIOL, V74, pS17, DOI 10.1016/S0167-5273(99)00107-2; Packard CJ, 1997, ARTERIOSCL THROM VAS, V17, P3542, DOI 10.1161/01.ATV.17.12.3542; Packard CJ, 2003, BIOCHEM SOC T, V31, P1066; Rizzo M, 2006, QJM-INT J MED, V99, P1, DOI 10.1093/qjmed/hci154; Sanyal AJ, 2006, HEPATOLOGY, V43, P682, DOI 10.1002/hep.21103; Sanyal Arun J, 2011, Hepatology, V54, P344, DOI 10.1002/hep.24376; Schindhelm RK, 2005, EUR J CLIN INVEST, V35, P369, DOI 10.1111/j.1365-2362.2005.01502.x; Senturk O, 2008, INTERN MED J, V38, P183, DOI 10.1111/j.1445-5994.2007.01481.x; Sopkova Z, 2012, ANGIOLOGY, V63, P617, DOI 10.1177/0003319711433811; SWINKELS DW, 1987, J LIPID RES, V28, P1233; Targher G, 2007, ATHEROSCLEROSIS, V191, P235, DOI 10.1016/j.atherosclerosis.2006.08.021; Targher G, 2006, DIABETES CARE, V29, P1325, DOI 10.2337/dc06-0135; Toledo FGS, 2006, DIABETES CARE, V29, P1845, DOI 10.2337/dc06-0455; TRIBBLE DL, 1992, ATHEROSCLEROSIS, V93, P189, DOI 10.1016/0021-9150(92)90255-F; Usui S, 2002, J LIPID RES, V43, P805; Williams PT, 2003, ARTERIOSCL THROM VAS, V23, P314, DOI 10.1161/01.ATV.0000053385.64132.2D; WILLIAMS PT, 1992, J LIPID RES, V33, P765; Winkler K, 2012, ATHEROSCLEROSIS, V220, P189, DOI 10.1016/j.atherosclerosis.2011.10.043; Yoneda M, 2010, HEPATOL RES, V40, P566, DOI 10.1111/j.1872-034X.2010.00644.x; Yoshida A, 2003, INTERNAL MED, V42, P244, DOI 10.2169/internalmedicine.42.244; Yoshida Akihiro, 2004, J Atheroscler Thromb, V11, P215	53	27	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115403	10.1371/journal.pone.0115403	http://dx.doi.org/10.1371/journal.pone.0115403			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541989	gold, Green Submitted, Green Published			2022-12-27	WOS:000347239900041
J	Patel, P; Brooks, C; Seneviratne, A; Hess, DA; Seguin, CA				Patel, Priya; Brooks, Courtney; Seneviratne, Ayesh; Hess, David A.; Seguin, Cheryle A.			Investigating Microenvironmental Regulation of Human Chordoma Cell Behaviour	PLOS ONE			English	Article							TISSUE-GROWTH-FACTOR; EPITHELIAL-MESENCHYMAL TRANSITION; NUCLEUS PULPOSUS CELLS; CANCER STEM-CELLS; MOUSE IMPLICATIONS; PROGENITOR CELLS; HYPOXIA; EXPRESSION; HIF-1-ALPHA; MIGRATION	The tumour microenvironment is complex and composed of many different constituents, including matricellular proteins such as connective tissue growth factor (CCN2), and is characterized by gradients in oxygen levels. In various cancers, hypoxia and CCN2 promote stem and progenitor cell properties, and regulate the proliferation, migration and phenotype of cancer cells. Our study was aimed at investigating the effects of hypoxia and CCN2 on chordoma cells, using the human U-CH1 cell line. We demonstrate that under basal conditions, U-CH1 cells express multiple CCN family members including CCN1, CCN2, CCN3 and CCN5. Culture of U-CH1 cells in either hypoxia or in the presence of recombinant CCN2 peptide promoted progenitor cell-like characteristics specific to the notochordal tissue of origin. Specifically, hypoxia induced the most robust increase in progenitor-like characteristics in U-CH1 cells, including increased expression of the notochord-associated markers T, CD24, FOXA1, ACAN and CA12, increased cell growth and tumour-sphere formation, and a decrease in the percentage of vacuolated cells present in the heterogeneous population. Interestingly, the effects of recombinant CCN2 peptide on U-CH1 cells were more pronounced under normoxia than hypoxia, promoting increased expression of CCN1, CCN2, CCN3 and CCN5, the notochord-associated markers SOX5, SOX6, T, CD24, and FOXA1 as well as increased tumour-sphere formation. Overall, this study highlights the importance of multiple factors within the tumour microenvironment and how hypoxia and CCN2 may regulate human chordoma cell behaviour.	[Patel, Priya] Univ Western Ontario, Schulich Sch Med & Dent, Dept Anat & Cell Biol, London, ON, Canada; [Brooks, Courtney; Seneviratne, Ayesh; Hess, David A.; Seguin, Cheryle A.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON, Canada; [Seneviratne, Ayesh; Hess, David A.] Univ Western Ontario, Robarts Res Inst, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Seguin, CA (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON, Canada.	cheryle.seguin@schulich.uwo.ca	Seguin, Cheryle A/G-4511-2013; Hess, David A/M-2828-2013	Seguin, Cheryle/0000-0001-6503-9107	seed grant from the Chordoma Foundation; Arthritis Society/Canadian Arthritis Network Scholar award; CIHR Banting and Best Canada MSc Scholarship; Ontario Graduate Scholarship	seed grant from the Chordoma Foundation; Arthritis Society/Canadian Arthritis Network Scholar award; CIHR Banting and Best Canada MSc Scholarship; Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This research was funded by a seed grant from the Chordoma Foundation www.chordomafoundation.org (awarded to CAS). CAS was supported by The Arthritis Society/Canadian Arthritis Network Scholar award. PP was supported by CIHR Banting and Best Canada MSc Scholarship and Ontario Graduate Scholarship. AS was supported by an Ontario Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RD, 2013, J SPINAL DISORD TECH, V26, pE86, DOI 10.1097/BSD.0b013e31826e0ca4; Aydemir E, 2012, J NEUROSURG, V116, P810, DOI 10.3171/2011.12.JNS11430; Barrionuevo F, 2006, DEV BIOL, V295, P128, DOI 10.1016/j.ydbio.2006.03.014; Bedore J, 2013, ARTHRITIS RHEUM-US, V65, P2634, DOI 10.1002/art.38075; Bennewith KL, 2009, CANCER RES, V69, P775, DOI 10.1158/0008-5472.CAN-08-0987; BJORNSSON J, 1993, CANCER-AM CANCER SOC, V71, P735, DOI 10.1002/1097-0142(19930201)71:3<735::AID-CNCR2820710314>3.0.CO;2-8; Bruederlein Silke, 2010, Sarcoma, V2010, P630129, DOI 10.1155/2010/630129; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Chen PC, 2013, CARCINOGENESIS, V34, P1669, DOI 10.1093/carcin/bgt103; Cheng S, 2014, TUMOUR BIOL; Chien W, 2013, INT J ONCOL, V38, P1741; Chiou MJ, 2006, BIOCHEM BIOPH RES CO, V349, P750, DOI 10.1016/j.bbrc.2006.08.095; Choi KS, 2008, DEV DYNAM, V237, P3953, DOI 10.1002/dvdy.21805; Chong HC, 2012, J ONCOL, V2012, DOI 10.1155/2012/351089; Dhar G, 2007, CANCER LETT, V254, P63, DOI 10.1016/j.canlet.2007.02.012; El-Heliebi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087663; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Erwin WM, 2006, ARTHRITIS RHEUM-US, V54, P3859, DOI 10.1002/art.22258; Franzen CA, 2009, MOL CANCER RES, V7, P1045, DOI 10.1158/1541-7786.MCR-09-0017; Fritah A, 2008, MOL CELL BIOL, V28, P1114, DOI 10.1128/MCB.01335-07; Fujikuni N, 2014, CANC SCI; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Haque I, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-8; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Higgins DF, 2004, AM J PHYSIOL-RENAL, V287, pF1223, DOI 10.1152/ajprenal.00245.2004; Hirschfeld M, 2009, CANCER RES, V69, P2082, DOI 10.1158/0008-5472.CAN-08-1997; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Hongo K, 2013, J SURG RES, V182, P75, DOI 10.1016/j.jss.2012.08.034; Ji ZG, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-158; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Lee CH, 2010, J CLIN INVEST, V120, P3340, DOI 10.1172/JCI43230; Li PC, 2013, INT J MED SCI, V10, P399, DOI 10.7150/ijms.5407; Li XX, 2012, ONCOL LETT, V3, P1268, DOI 10.3892/ol.2012.645; Liang DM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-201; Maier JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055528; Mamede A C, 2013, ISRN Oncol, V2013, P918207, DOI 10.1155/2013/918207; McCann MR, 2012, DIS MODEL MECH, V5, P73, DOI 10.1242/dmm.008128; McKeown SR, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20130676; McMaster ML, 2001, CANCER CAUSE CONTROL, V12, P1, DOI 10.1023/A:1008947301735; Nagelkerke A, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3373; Nelson AC, 2012, J PATHOL, V228, P274, DOI 10.1002/path.4082; Nishida T, 2009, BONE, V44, P24, DOI 10.1016/j.bone.2008.08.125; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ostroumov E, 2007, SPINE, V32, P2957, DOI 10.1097/BRS.0b013e31815cde91; Park SA, 2008, CLIN NUCL MED, V33, P906, DOI 10.1097/RLU.0b013e31818c4e88; Planque N, 2006, J CELL BIOCHEM, V99, P105, DOI 10.1002/jcb.20887; Presneau N, 2011, J PATHOL, V223, P327, DOI 10.1002/path.2816; Putman DM, 2012, STEM CELLS, V30, P2248, DOI 10.1002/stem.1206; Quail DF, 2013, INT J BIOCHEM CELL B, V45, P885, DOI 10.1016/j.biocel.2012.12.021; Ren TT, 2014, J PATHOL, V234, P526, DOI 10.1002/path.4415; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Scheil S, 2001, GENE CHROMOSOME CANC, V32, P203, DOI 10.1002/gcc.1184; Scheil-Bertram S, 2014, INT J ONCOL, V44, P1041, DOI 10.3892/ijo.2014.2268; Sha W, 2011, J CELL COMMUN SIGNAL, V5, P219, DOI 10.1007/s12079-011-0128-0; Smits P, 2003, DEVELOPMENT, V130, P1135, DOI 10.1242/dev.00331; Soeda A, 2009, ONCOGENE, V28, P3949, DOI 10.1038/onc.2009.252; Sounni NE, 2013, CLIN CHEM, V59, P85, DOI 10.1373/clinchem.2012.185363; Suzuki H, 2001, ONCOGENE, V20, P5779, DOI 10.1038/sj.onc.1204742; Tammela T, 2005, CARDIOVASC RES, V65, P550, DOI 10.1016/j.cardiores.2004.12.002; Tamplin OJ, 2011, DEV BIOL; Tran CM, 2013, MATRIX BIOL, V32, P298, DOI 10.1016/j.matbio.2013.03.006; Tran CM, 2013, J BIOL CHEM, V288, P12654, DOI 10.1074/jbc.M112.448860; Tran CM, 2010, ARTHRITIS RHEUM-US, V62, P1983, DOI 10.1002/art.27445; Urban JPG, 2002, BIOCHEM SOC T, V30, P858, DOI 10.1042/bst0300858; Wahab NA, 2001, BIOCHEM J, V359, P89, DOI 10.1042/0264-6021:3590089; Wang Yue J, 2013, Methods Mol Biol, V980, P281, DOI 10.1007/978-1-62703-287-2_15; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0; Wolf N, 2010, ENDOCRINOLOGY, V151, P2835, DOI 10.1210/en.2009-1195; Yakkioui Y, 2014, BIOCH BIOPHYS ACTA; Yang AT, 2013, INT J MOL MED, V32, P35, DOI 10.3892/ijmm.2013.1380; Yang C, 2010, SPINE, V35, P1257, DOI 10.1097/BRS.0b013e3181c2a8b0; Yang XHR, 2009, NAT GENET, V41, P1176, DOI 10.1038/ng.454; You JJ, 2010, EXP EYE RES, V91, P825, DOI 10.1016/j.exer.2010.10.006; Yue PYK, 2010, J BIOMOL SCREEN, V15, P427, DOI 10.1177/1087057110361772; Zagzag D, 2003, J CELL PHYSIOL, V196, P394, DOI 10.1002/jcp.10306	76	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115909	10.1371/journal.pone.0115909	http://dx.doi.org/10.1371/journal.pone.0115909			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541962	Green Published, Green Submitted, gold			2022-12-27	WOS:000347239900107
J	Peterson, J; Gisslen, M; Zetterberg, H; Fuchs, D; Shacklett, BL; Hagberg, L; Yiannoutsos, CT; Spudich, SS; Price, RW				Peterson, Julia; Gisslen, Magnus; Zetterberg, Henrik; Fuchs, Dietmar; Shacklett, Barbara L.; Hagberg, Lars; Yiannoutsos, Constantin T.; Spudich, Serena S.; Price, Richard W.			Cerebrospinal Fluid (CSF) Neuronal Biomarkers across the Spectrum of HIV Infection: Hierarchy of Injury and Detection	PLOS ONE			English	Article							AIDS DEMENTIA COMPLEX; CENTRAL-NERVOUS-SYSTEM; ACTIVE ANTIRETROVIRAL THERAPY; IMMUNODEFICIENCY-VIRUS-INFECTION; NEUROFILAMENT PROTEIN NFL; AMYLOID PRECURSOR PROTEIN; NEUROCOGNITIVE DISORDERS; ALZHEIMERS-DISEASE; VIRAL LOAD; NEURODEGENERATIVE DISEASES	The character of central nervous system (CNS) HIV infection and its effects on neuronal integrity vary with evolving systemic infection. Using a cross-sectional design and archived samples, we compared concentrations of cerebrospinal fluid (CSF) neuronal biomarkers in 143 samples from 8 HIV-infected subject groups representing a spectrum of untreated systemic HIV progression and viral suppression: primary infection; four groups of chronic HIV infection neuroasymptomatic (NA) subjects defined by blood CD4+ T cells of >350, 200-349, 50-199, and <50 cells/mu L; HAD; treatment-induced viral suppression; and 'elite' controllers. Samples from 20 HIV-uninfected controls were also examined. The neuronal biomarkers included neurofilament light chain protein (NFL), total and phosphorylated tau (t-tau, p-tau), soluble amyloid precursor proteins alpha and beta (sAPP alpha, sAPP beta) and amyloid beta (A beta) fragments 1-42, 1-40 and 1-38. Comparison of the biomarker changes showed a hierarchy of sensitivity in detection and suggested evolving mechanisms with progressive injury. NFL was the most sensitive neuronal biomarker. Its CSF concentration exceeded ageadjusted norms in all HAD patients, 75% of NA CD4<50, 40% of NA CD4 50-199, and 42% of primary infection, indicating common neuronal injury with untreated systemic HIV disease progression as well as transiently during early infection. By contrast, only 75% of HAD subjects had abnormal CSF t-tau levels, and there were no significant differences in t-tau levels among the remaining groups. sAPP alpha and beta were also abnormal (decreased) in HAD, showed less marked change than NFL with CD4 decline in the absence of HAD, and were not decreased in PHI. The CSF Ab peptides and p-tau concentrations did not differ among the groups, distinguishing the HIV CNS injury profile from Alzheimer's disease. These CSF biomarkers can serve as useful tools in selected research and clinical settings for patient classification, pathogenetic analysis, diagnosis and management.	[Peterson, Julia; Price, Richard W.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Gisslen, Magnus; Hagberg, Lars] Univ Gothenburg, Sahlgrenska Acad, Dept Infect Dis, Gothenburg, Sweden; [Zetterberg, Henrik] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Gothenburg, Sweden; [Zetterberg, Henrik] Inst Neurol, London WC1N 3BG, England; [Fuchs, Dietmar] Med Univ Innsbruck, Div Biol Chem, A-6020 Innsbruck, Austria; [Shacklett, Barbara L.] Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; [Yiannoutsos, Constantin T.] Indiana Univ, RM Fairbanks Sch Publ Hlth, Dept Biostat, Indianapolis, IN 46204 USA; [Spudich, Serena S.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA	University of California System; University of California San Francisco; University of Gothenburg; University of Gothenburg; University of London; University College London; Medical University of Innsbruck; University of California System; University of California Davis; Indiana University System; Indiana University-Purdue University Indianapolis; Yale University	Price, RW (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	rwprice@sfgh.ucsf.edu	Fuchs, Dietmar/AAL-8011-2021; Shacklett, Barbara/A-7288-2009; Gisslen, Magnus/D-7454-2015	Fuchs, Dietmar/0000-0003-1627-9563; Shacklett, Barbara/0000-0002-7067-732X; Gisslen, Magnus/0000-0002-2357-1020	National Institutes of Health [P01 DA026134, R01 MH62701, R21MH096619, R21 NS069219, P01 MH094177, R01MH081772, UL1 TR000004]; Sahlgrenska Academy at the University of Gothenburg [ALFGBG-11067]; Swedish Research Council [2007-7092]; Knut and Alice Wallenberg Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000004, UL1TR002529, UL1TR001108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081772, R21MH096619, R01MH062701, P01MH094177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS069219] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA026134] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sahlgrenska Academy at the University of Gothenburg; Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from National Institutes of Health: P01 DA026134, R01 MH62701, R21MH096619, R21 NS069219, P01 MH094177, R01MH081772, and UL1 TR000004 (the UCSF CTSI); and Sahlgrenska Academy at the University of Gothenburg (ALFGBG-11067) and the Swedish Research Council (2007-7092) and the Knut and Alice Wallenberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulle S, 2007, J NEUROL, V254, P1026, DOI 10.1007/s00415-006-0481-8; Ances BM, 2012, JAIDS-J ACQ IMM DEF, V59, P469, DOI 10.1097/QAI.0b013e318249db17; Andreasson U, 2007, BIOMARK MED, V1, P59, DOI 10.2217/17520363.1.1.59; Anthony IC, 2006, ACTA NEUROPATHOL, V111, P529, DOI 10.1007/s00401-006-0037-0; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Arrildt KT, 2012, CURR HIV-AIDS REP, V9, P52, DOI 10.1007/s11904-011-0107-3; Bhaskaran K, 2008, ANN NEUROL, V63, P213, DOI 10.1002/ana.21225; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Bonnet F, 2013, AIDS, V27, P391, DOI 10.1097/QAD.0b013e32835b1019; Brew BJ, 2005, NEUROLOGY, V65, P1490, DOI 10.1212/01.wnl.0000183293.95787.b7; Budka H, 1991, BRAIN PATHOL, V1, P163, DOI 10.1111/j.1750-3639.1991.tb00656.x; Canestri A, 2010, CLIN INFECT DIS, V50, P773, DOI 10.1086/650538; Clifford DB, 2009, NEUROLOGY, V73, P1982, DOI 10.1212/WNL.0b013e3181c5b445; Constantinescu R, 2011, ACTA NEUROL SCAND, V124, P206, DOI 10.1111/j.1600-0404.2010.01451.x; Constantinescu R, 2010, PARKINSONISM RELAT D, V16, P142, DOI 10.1016/j.parkreldis.2009.07.007; Dahl V, 2014, AIDS; Dahl V, 2013, AIDS, V27, P1145, DOI 10.1097/QAD.0b013e32835cf235; DAVIS LE, 1992, NEUROLOGY, V42, P1736, DOI 10.1212/WNL.42.9.1736; Dotevall L, 1999, EUR J NEUROL, V6, P169, DOI 10.1111/j.1468-1331.1999.tb00010.x; Eden A, 2007, J INFECT DIS, V196, P1779, DOI 10.1086/523648; Ellis RJ, 1997, ANN NEUROL, V42, P679, DOI 10.1002/ana.410420503; Ellis RJ, 2011, AIDS, V25, P1747, DOI 10.1097/QAD.0b013e32834a40cd; Ernst T, 2009, ANN NEUROL, V65, P316, DOI 10.1002/ana.21594; Gelman BB, 2004, J NEUROVIROL, V10, P98, DOI 10.1080/13550280490279816; Gelman BB, 2013, JAIDS-J ACQ IMM DEF, V62, P487, DOI 10.1097/QAI.0b013e31827f1bdb; Gisslen M, 1999, J ACQ IMMUN DEF SYND, V21, P271, DOI 10.1097/00126334-199908010-00003; Gisslen M, 2007, J NEUROIMMUNE PHARM, V2, P112, DOI 10.1007/s11481-006-9035-1; Gisslen M, 2007, J INFECT DIS, V195, P1774, DOI 10.1086/518043; Gisslen M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-356; Gisslen M, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-63; Grahn A, 2013, J NEUROL, V260, P1813, DOI 10.1007/s00415-013-6883-5; Gray F, 2001, CLIN NEUROPATHOL, V20, P146; Gunnarsson M, 2011, ANN NEUROL, V69, P83, DOI 10.1002/ana.22247; Hampel H, 2010, EXP GERONTOL, V45, P30, DOI 10.1016/j.exger.2009.10.010; Hansson O, 2006, LANCET NEUROL, V5, P228, DOI 10.1016/S1474-4422(06)70355-6; Heaton RK, 2011, J NEUROVIROL, V17, P3, DOI 10.1007/s13365-010-0006-1; Ho EL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066188; HOFFMAN PN, 1987, P NATL ACAD SCI USA, V84, P3472, DOI 10.1073/pnas.84.10.3472; Hua X, 2013, NEUROIMAGE-CLIN, V3, P132, DOI 10.1016/j.nicl.2013.07.009; JANSSEN RS, 1991, NEUROLOGY, V41, P778; Jernigan TL, 2011, J NEUROVIROL, V17, P248, DOI 10.1007/s13365-011-0032-7; Kaplan Jonathan E., 2009, Morbidity and Mortality Weekly Report, V58, P1; Krut JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088591; Krut JJ, 2013, J NEUROL, V260, P620, DOI 10.1007/s00415-012-6688-y; Lescure FX, 2011, CLIN INFECT DIS, V52, P235, DOI 10.1093/cid/ciq041; Lewczuk P, 2010, MOL PSYCHIATR, V15, P138, DOI 10.1038/mp.2008.84; Mankowski JL, 2002, J NEUROPATH EXP NEUR, V61, P85, DOI 10.1093/jnen/61.1.85; Masliah E, 1996, J NeuroAIDS, V1, P161; Mattsson N, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-51; McArthur JC, 1997, ANN NEUROL, V42, P689, DOI 10.1002/ana.410420504; Mellgren A, 2007, NEUROLOGY, V69, P1536, DOI 10.1212/01.wnl.0000277635.05973.55; Meyer ACL, 2013, NEUROEPIDEMIOLOGY, V41, P208, DOI 10.1159/000354629; Monforte AD, 2004, ANN NEUROL, V55, P320, DOI 10.1002/ana.10827; Murray ME, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt231; NAVIA BA, 1986, ANN NEUROL, V19, P517, DOI 10.1002/ana.410190602; Nebuloni M, 2001, AIDS, V15, P571, DOI 10.1097/00002030-200103300-00005; Norgren N, 2003, BRAIN RES, V987, P25, DOI 10.1016/S0006-8993(03)03219-0; Ortega M, 2014, J NEUROIMMUNE PHARM; Peluso MJ, 2013, J INFECT DIS, V207, P1703, DOI 10.1093/infdis/jit088; Peluso MJ, 2012, AIDS, V26, P1765, DOI 10.1097/QAD.0b013e328355e6b2; POST MJD, 1991, RADIOLOGY, V178, P131, DOI 10.1148/radiology.178.1.1984291; Price RW, 2008, J INFECT DIS, V197, pS294, DOI 10.1086/533419; Price RW, 2014, SEMIN NEUROL, V34, P7, DOI 10.1055/s-0034-1372337; Price RW, 2013, J NEUROIMMUNE PHARM, V8, P1147, DOI 10.1007/s11481-013-9491-3; PRICE RW, 1990, J ACQ IMMUN DEF SYND, V3, pS51; Price RW, 1999, AIDS, V13, P1677, DOI 10.1097/00002030-199909100-00011; Price RW, 2001, AIDS, V15, P1251, DOI 10.1097/00002030-200107060-00006; PRICE RW, 1988, J INFECT DIS, V158, P1079, DOI 10.1093/infdis/158.5.1079; PRICE RW, 1988, SCIENCE, V239, P586, DOI 10.1126/science.3277272; Probasco JC, 2010, AIDS, V24, P1001, DOI 10.1097/QAD.0b013e328331e15b; Quintanar JL, 2003, PARASITOL RES, V90, P261, DOI 10.1007/s00436-003-0850-5; Risacher SL, 2013, SEMIN NEUROL, V33, P386, DOI 10.1055/s-0033-1359312; ROSENBLUM MK, 1990, PATHOL ANNU, V25, P117; Rosengren LE, 1999, NEUROLOGY, V52, P1090, DOI 10.1212/WNL.52.5.1090; Rosengren LE, 1996, J NEUROCHEM, V67, P2013, DOI 10.1046/j.1471-4159.1996.67052013.x; Saag M, 2010, CLIN INFECT DIS, V51, P239, DOI 10.1086/653678; Schnell G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002286; SIDTIS JJ, 1993, ANN NEUROL, V33, P343, DOI 10.1002/ana.410330403; SIDTIS JJ, 1994, RES P ARNMD, V72, P273; Simioni S, 2010, AIDS, V24, P1243, DOI 10.1097/QAD.0b013e3283354a7b; Sjogren M, 2001, J NEUROL NEUROSUR PS, V70, P624, DOI 10.1136/jnnp.70.5.624; Spudich S, 2011, J INFECT DIS, V204, P753, DOI 10.1093/infdis/jir387; Spudich SS, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-98; Studahl M, 2000, J NEUROL, V247, P636, DOI 10.1007/s004150070134; Tozzi V, 1999, AIDS, V13, P1889, DOI 10.1097/00002030-199910010-00011; Valcour V, 2012, J INFECT DIS, V206, P275, DOI 10.1093/infdis/jis326; VAZEUX R, 1987, AM J PATHOL, V126, P403; Waldo ML, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-54; YARCHOAN R, 1987, LANCET, V1, P132, DOI 10.1016/S0140-6736(87)91968-4; Zetterberg H, 2008, ARCH NEUROL-CHICAGO, V65, P1102, DOI 10.1001/archneur.65.8.1102; Zetterberg H, 2014, EXPERT REV NEUROTHER, V14, P621, DOI 10.1586/14737175.2014.915740; Zhu T, 2013, J NEUROVIROL, V19, P10, DOI 10.1007/s13365-012-0135-9	92	66	66	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e116081	10.1371/journal.pone.0116081	http://dx.doi.org/10.1371/journal.pone.0116081			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541953	Green Published, gold			2022-12-27	WOS:000347239900140
J	Zeppilli, D; Bongiorni, L; Santos, RS; Vanreusel, A				Zeppilli, Daniela; Bongiorni, Lucia; Santos, Ricardo Serrao; Vanreusel, Ann			Changes in Nematode Communities in Different Physiographic Sites of the Condor Seamount (North-East Atlantic Ocean) and Adjacent Sediments	PLOS ONE			English	Article							ECOLOGICAL QUALITY STATUS; DEEP-SEA BIODIVERSITY; BENTHIC BIODIVERSITY; SPATIAL VARIATION; MICROHABITAT TYPE; SPECIES RICHNESS; ORGANIC-MATTER; DIVERSITY; ASSEMBLAGES; MEIOFAUNA	Several seamounts are known as 'oases' of high abundances and biomass and hotspots of biodiversity in contrast to the surrounding deep-sea environments. Recent studies have indicated that each single seamount can exhibit a high intricate habitat turnover. Information on alpha and beta diversity of single seamount is needed in order to fully understand seamounts contribution to regional and global biodiversity. However, while most of the seamount research has been focused on summits, studies considering the whole seamount structure are still rather poor. In the present study we analysed abundance, biomass and diversity of nematodes collected in distinct physiographic sites and surrounding sediments of the Condor Seamount (Azores, North-East Atlantic Ocean). Our study revealed higher nematode biomass in the seamount bases and values 10 times higher in the Condor sediments than in the far-field site. Although biodiversity indices did not showed significant differences comparing seamount sites and far-field sites, significant differences were observed in term of nematode composition. The Condor summit harboured a completely different nematode community when compared to the other seamount sites, with a high number of exclusive species and important differences in term of nematode trophic diversity. The oceanographic conditions observed around the Condor Seamount and the associated sediment mixing, together with the high quality of food resources available in seamount base could explain the observed patterns. Our results support the hypothesis that seamounts maintain high biodiversity through heightened beta diversity and showed that not only summits but also seamount bases can support rich benthic community in terms of standing stocks and diversity. Furthermore functional diversity of nematodes strongly depends on environmental conditions link to the local setting and seamount structure. This finding should be considered in future studies on seamounts, especially in view of the potential impacts due to current and future anthropogenic threats.	[Zeppilli, Daniela; Bongiorni, Lucia; Santos, Ricardo Serrao] Univ Azores, Ctr IMAR, P-9901862 Horta, Azores, Portugal; [Zeppilli, Daniela; Bongiorni, Lucia; Santos, Ricardo Serrao] LARSyS Associated Lab, P-9901862 Horta, Azores, Portugal; [Zeppilli, Daniela] IFREMER, Ctr Brest, REM EEP LEP, Inst Carnot Ifremer EDROME, Plouzane, France; [Zeppilli, Daniela] Univ Brest, Inst Univ Europeen Mer, CNRS IRD UBO, Lab Sci Environm Marin, Plouzane, France; [Bongiorni, Lucia] Natl Res Council ISMAR CNR, Inst Marine Sci, Venice, Italy; [Santos, Ricardo Serrao] Univ Azores, Dept Ocenog & Fisheries, P-9901862 Horta, Azores, Portugal; [Vanreusel, Ann] Univ Ghent, Dept Biol, Marine Biol sect, B-9000 Ghent, Belgium	Universidade dos Acores; Ifremer; Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM); Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR); Universidade dos Acores; Ghent University	Zeppilli, D (corresponding author), Univ Azores, Ctr IMAR, P-9901862 Horta, Azores, Portugal.	Daniela.Zeppilli@ifremer.fr	Santos, Ricardo/B-3960-2008; Zeppilli, Daniela/AAD-4608-2022; Bongiorni, Lucia/AAL-1488-2021; CNR, Ismar/P-1247-2014	Santos, Ricardo/0000-0002-2536-1369; Bongiorni, Lucia/0000-0001-9033-4992; CNR, Ismar/0000-0001-5351-1486; ZEPPILLI, DANIELA/0000-0002-0809-2566	CONDOR; EEA [PT0040/2008]; Fundacao para a Ciencia e Tecnologia, Portugal (FCT) [PTDC/MAR/105486/2008]; Portuguese Foundation for Science and Technology (FCT) through FCT [531, Pest/OE/EEI/LA0009/2011-2014]; Azores Fund for Science and Technology (FRCT) by OE; COMPETE; QREN; ProConvergencia; FCT [-Pest/OE/EEI/LA0009/2014]; "Laboratoire d'Excellence" LabexMER - French government under the program "Investissements d'Avenir" [ANR-10-LABX-19]; Regional Council of Brittany; project "Deep-sea hYdrothermal Vent nematodes as potential source of new Antibiotics" (DYVA) by Fondation Total and Ifremer; RITMARE flagship project - MIUR	CONDOR; EEA; Fundacao para a Ciencia e Tecnologia, Portugal (FCT)(Portuguese Foundation for Science and Technology); Portuguese Foundation for Science and Technology (FCT) through FCT; Azores Fund for Science and Technology (FRCT) by OE; COMPETE; QREN; ProConvergencia; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); "Laboratoire d'Excellence" LabexMER - French government under the program "Investissements d'Avenir"(French National Research Agency (ANR)); Regional Council of Brittany(Region Bretagne); project "Deep-sea hYdrothermal Vent nematodes as potential source of new Antibiotics" (DYVA) by Fondation Total and Ifremer; RITMARE flagship project - MIUR	Funding: This study was funded by the CONDOR project (Observatory for long term study and monitoring of Azorean ecosystem, EEA Grants PT0040/2008, (Iceland, Liechtenstein), the Fundacao para a Ciencia e Tecnologia, Portugal (FCT Project BIOMOUNT, PTDC/MAR/105486/2008, COMPETE/FEDERE funds). IMAR-DOP/UAz is Research and Development Unit no. 531 and LARSyS-Associated Laboratory no. 9 funded by the Portuguese Foundation for Science and Technology (FCT) through FCT - Pest/OE/EEI/LA0009/2011-2014 and by the Azores Fund for Science and Technology (FRCT), funded by OE, COMPETE, QREN and ProConvergencia. The Open Access of this paper is funded by FCT -Pest/OE/EEI/LA0009/2014 (OE, COMPETE and QREN). DZ was partly supported by the "Laboratoire d'Excellence" LabexMER (ANR-10-LABX-19), co-funded by a grant from the French government under the program "Investissements d'Avenir" by a grant from the Regional Council of Brittany (SAD programme), and by the project "Deep-sea hYdrothermal Vent nematodes as potential source of new Antibiotics" (DYVA) funded by Fondation Total and Ifremer. LB was supported by the RITMARE flagship project 2012-2016 funded by MIUR and coordinated by CNR, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves AS, 2013, ECOL INDIC, V24, P462, DOI 10.1016/j.ecolind.2012.07.013; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Andrassy I., 1956, Archivum Zoologicum Budapest, V2, P1; Bashmachnikov I, 2013, DEEP-SEA RES PT II, V98, P38, DOI 10.1016/j.dsr2.2013.09.014; BONGERS T, 1991, MAR ECOL PROG SER, V76, P135, DOI 10.3354/meps076135; Bongiorni L, 2013, DEEP-SEA RES PT II, V98, P75, DOI 10.1016/j.dsr2.2013.08.006; Braga-Henriques A, 2013, BIOGEOSCIENCES, V10, P4009, DOI 10.5194/bg-10-4009-2013; Chivers AJ, 2013, BIOGEOSCIENCES, V10, P3535, DOI 10.5194/bg-10-3535-2013; Clark M. R., 2010, 46 NZ AQ ENV BIOD; Clark MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029232; Clark MR, 2010, ANNU REV MAR SCI, V2, P253, DOI 10.1146/annurev-marine-120308-081109; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Danovaro R, 2009, MAR ECOL PROG SER, V396, P197, DOI 10.3354/meps08269; Danovaro R., 2010, METHODS STUDY DEEP S; Danovaro R, 2008, ECOGRAPHY, V31, P231, DOI 10.1111/j.0906-7590.2008.5484.x; Danovaro R, 2008, CURR BIOL, V18, P1, DOI 10.1016/j.cub.2007.11.056; FABIANO M, 1995, CONT SHELF RES, V15, P1453, DOI 10.1016/0278-4343(94)00088-5; Feller R.J., 1988, P181; Froese Rainer, 2004, University of British Columbia Fisheries Centre Research Reports, V12, P25; Gad G, 2004, ARCH FISH MAR RES, V51, P30; Gad Gunnar, 2009, Marine Biodiversity, V39, P57; Gambi C, 2003, DEEP-SEA RES PT I, V50, P103, DOI 10.1016/S0967-0637(02)00143-7; Gambi C, 2014, GLOBAL ECOL BIOGEOGR, V23, P24, DOI 10.1111/geb.12094; Genin A, 2004, J MARINE SYST, V50, P3, DOI 10.1016/j.jmarsys.2003.10.008; George Kai Horst, 2013, Meiofauna Marina, V20, P1; Giere O, 2009, MEIOBENTHOLOGY MICRO, DOI 10.1007/978-3-540-68661-3; Gray JS, 2000, J EXP MAR BIOL ECOL, V250, P23, DOI 10.1016/S0022-0981(00)00178-7; Hein JR, 2010, OCEANOGRAPHY, V23, P184, DOI 10.5670/oceanog.2010.70; Heinz P, 2004, MAR BIOL, V144, P985, DOI 10.1007/s00227-003-1257-7; INGELS J, 2011, PLOS ONE, DOI DOI 10.1371/JOURNAL.PONE.0020094; Lambshead PJD, 2004, NEMATOLOGY: ADVANCES AND PERSPECTIVES, VOL 1: NEMATODE MORPHOLOGY, PHYSIOLOGY AND ECOLOGY, P438, DOI 10.1079/9780851996455.0438; Lambshead PJD, 2003, J BIOGEOGR, V30, P475, DOI 10.1046/j.1365-2699.2003.00843.x; Leduc D, 2012, MAR ECOL PROG SER, V454, P53, DOI 10.3354/meps09609; Legendre P, 2005, ECOL MONOGR, V75, P435, DOI 10.1890/05-0549; Lundsten L, 2009, MAR ECOL PROG SER, V374, P23, DOI 10.3354/meps07745; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; McClain CR, 2010, MAR ECOL, V31, P1; McClain CR, 2007, J BIOGEOGR, V34, P2001, DOI 10.1111/j.1365-2699.2007.01783.x; MIRTOS AC, 2014, AQUACULT ENV INTERAC, V5, P17; Moens T., 2013, NEMATODA, P109, DOI DOI 10.1515/9783110274257.109; Morato T, 2010, P NATL ACAD SCI USA, V107, P9707, DOI 10.1073/pnas.0910290107; Moreno M, 2011, ECOL INDIC, V11, P328, DOI 10.1016/j.ecolind.2010.05.011; Muinos SB, 2013, MAR GEORESOUR GEOTEC, V31, P40, DOI 10.1080/1064119X.2012.661215; Ndaro SGM, 1999, HYDROBIOLOGIA, V405, P133, DOI 10.1023/A:1003874122971; Pape E, 2013, BIOGEOSCIENCES, V10, P3127, DOI 10.5194/bg-10-3127-2013; PLATT HM, 1988, BRIT CHROMADORIDS 2; PLATT HM, 1983, BRIT ENOPLIDS 1; PROBERT PK, 2007, SEAMOUNTS ECOLOGY FI, P442, DOI DOI 10.1002/9780470691953.CH20; Pusceddu A, 2014, P NATL ACAD SCI USA, V111, P8861, DOI 10.1073/pnas.1405454111; Pusceddu A, 2009, DEEP-SEA RES PT II, V56, P755, DOI 10.1016/j.dsr2.2008.10.012; Raes M, 2006, DEEP-SEA RES PT I, V53, P1880, DOI 10.1016/j.dsr.2006.08.012; Raes M, 2007, CORAL REEFS, V26, P113, DOI 10.1007/s00338-006-0184-8; Raes M, 2008, J BIOGEOGR, V35, P2207, DOI 10.1111/j.1365-2699.2008.01945.x; Ramalho SP, 2014, DEEP-SEA RES PT I, V83, P102, DOI 10.1016/j.dsr.2013.09.010; Roberts S, 2004, FRONT ECOL ENVIRON, V2, P123, DOI 10.2307/3868237; ROGERS AD, 1994, ADV MAR BIOL, V30, P305, DOI 10.1016/S0065-2881(08)60065-6; Rowden AA, 2010, MAR ECOL-EVOL PERSP, V31, P95, DOI 10.1111/j.1439-0485.2010.00369.x; Samadi S, 2006, MAR BIOL, V149, P1463, DOI 10.1007/s00227-006-0306-4; SANDULLI R, 2014, ITAL J ZOOLOG; Schlacher TA, 2014, DIVERS DISTRIB, V20, P491, DOI 10.1111/ddi.12142; Semprucci F, 2015, J MAR BIOL ASSOC UK, V95, P247, DOI 10.1017/S0025315414001271; Semprucci F, 2013, MEDITERR MAR SCI, V14, P48, DOI 10.12681/mms.366; Soetaert K, 2009, MAR ECOL PROG SER, V392, P123, DOI 10.3354/meps08202; Steyaert M, 2003, ESTUAR COAST SHELF S, V58, P353, DOI 10.1016/S0272-7714(03)00086-6; Tempera F, 2012, ELSEV INSIGHT, P807, DOI 10.1016/B978-0-12-385140-6.00059-1; Thresher RE, 2011, SCI REP-UK, V1, DOI 10.1038/srep00119; TIETJEN JH, 1992, NATO ADV SCI I C-MAT, V360, P45; Vanreusel A, 2010, MAR ECOL-EVOL PERSP, V31, P6, DOI 10.1111/j.1439-0485.2009.00352.x; Wang SP, 2014, ECOL LETT, V17, P891, DOI 10.1111/ele.12292; Warwick R. M., 1998, SYNOPSIS FREELIVING; Weber ME, 2000, MAR GEOL, V163, P169, DOI 10.1016/S0025-3227(99)00103-6; WHITE M, 2007, SEAMOUNTS ECOLOGY FI, P65, DOI DOI 10.1002/9780470691953CH4; Wieser W., 1953, ARK ZOOL, V2, P439; WILLEMS KA, 1982, J MAR BIOL ASSOC UK, V62, P535, DOI 10.1017/S0025315400019731; Worm B, 2003, P NATL ACAD SCI USA, V100, P9884, DOI 10.1073/pnas.1333941100; Zeppilli D, 2013, DEEP-SEA RES PT II, V98, P87, DOI 10.1016/j.dsr2.2013.08.009; Zeppilli D, 2012, DIVERS DISTRIB, V18, P832, DOI 10.1111/j.1472-4642.2011.00859.x	78	20	20	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115601	10.1371/journal.pone.0115601	http://dx.doi.org/10.1371/journal.pone.0115601			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541988	Green Published, gold			2022-12-27	WOS:000347239900056
J	Fujiwara, S; Hoshikawa, S; Ueno, T; Hirata, M; Saito, T; Ikeda, T; Kawaguchi, H; Nakamura, K; Tanaka, S; Ogata, T				Fujiwara, Sayaka; Hoshikawa, Shinya; Ueno, Takaaki; Hirata, Makoto; Saito, Taku; Ikeda, Toshiyuki; Kawaguchi, Hiroshi; Nakamura, Kozo; Tanaka, Sakae; Ogata, Toru			SOX10 Transactivates S100B to Suppress Schwann Cell Proliferation and to Promote Myelination	PLOS ONE			English	Article							TRANSCRIPTION FACTOR SOX10; GENE-EXPRESSION; WAARDENBURG-SYNDROME; GROWTH-FACTOR; PROTEINS; ACTIVATION; DIFFERENTIATION; DISEASE; IDENTITY; MUTATION	Schwann cells are an important cell source for regenerative therapy for neural disorders. We investigated the role of the transcription factor sex determining region Y (SRY)-box 10 (SOX10) in the proliferation and myelination of Schwann cells. SOX10 is predominantly expressed in rat sciatic nerve-derived Schwann cells and is induced shortly after birth. Among transcription factors known to be important for the differentiation of Schw ann cells, SOX10 potently transactivates the S100B promoter. In cultures of Schwann cells, overexpressing SOX10 dramatically induces S100B expression, while knocking down SOX10 with shRNA suppresses S100B expression. Here, we identify three core response elements of SOX10 in the S100B promoter and intron 1 with a putative SOX motif. Knockdown of either SOX10 or S100B enhances the proliferation of Schwann cells. In addition, using dissociated cultures of dorsal root ganglia, we demonstrate that suppressing S100B with shRNA impairs myelination of Schwann cells. These results suggest that the SOX10-S100B signaling axis critically regulates Schwann cell proliferation and myelination, and therefore is a putative therapeutic target for neuronal disorders.	[Fujiwara, Sayaka; Hoshikawa, Shinya; Ueno, Takaaki; Hirata, Makoto; Ikeda, Toshiyuki; Kawaguchi, Hiroshi; Nakamura, Kozo; Tanaka, Sakae] Univ Tokyo, Fac Med, Dept Sensory & Motor Syst Med, Tokyo 113, Japan; [Saito, Taku] Univ Tokyo, Fac Med, Tokyo 113, Japan; [Ogata, Toru] Natl Rehabil Ctr Persons Disabil, Res Inst, Dept Rehabil Movement Funct, Saitama, Japan	University of Tokyo; University of Tokyo	Ogata, T (corresponding author), Natl Rehabil Ctr Persons Disabil, Res Inst, Dept Rehabil Movement Funct, Saitama, Japan.	ogata-toru@rehab.go.jp	Ikeda, Toshiyuki/GVS-5588-2022; Tanaka, Sakae/Y-3061-2019; Ogata, Toru/ADC-3560-2022	Tanaka, Sakae/0000-0001-9210-9414; Ogata, Toru/0000-0001-9011-8640	Japanese Ministry of Education, Culture, Sports, Science, and Technology [23300204]; Grants-in-Aid for Scientific Research [24592254] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (#23300204). http://www.jsps.go.jp/english/index.html. This grant has been received by TO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLORE R, 1988, SCIENCE, V239, P1311, DOI 10.1126/science.2964086; Arcuri C, 2005, J BIOL CHEM, V280, P4402, DOI 10.1074/jbc.M406440200; Atanasoski S, 2008, MOL CELL NEUROSCI, V37, P519, DOI 10.1016/j.mcn.2007.11.005; AZMITIA EC, 1990, BRAIN RES, V516, P354, DOI 10.1016/0006-8993(90)90942-5; Bhatheja K, 2006, INT J BIOCHEM CELL B, V38, P1995, DOI 10.1016/j.biocel.2006.05.007; Bondurand N, 2001, HUM MOL GENET, V10, P2783, DOI 10.1093/hmg/10.24.2783; Bowles J, 2000, DEV BIOL, V227, P239, DOI 10.1006/dbio.2000.9883; Donato R, 1999, BBA-MOL CELL RES, V1450, P191, DOI 10.1016/S0167-4889(99)00058-0; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; Donato R, 2009, BBA-MOL CELL RES, V1793, P1008, DOI 10.1016/j.bbamcr.2008.11.009; EINHEBER S, 1995, J CELL BIOL, V129, P443, DOI 10.1083/jcb.129.2.443; Finzsch M, 2010, J CELL BIOL, V189, P701, DOI 10.1083/jcb.200912142; Ghislain J, 2006, EMBO REP, V7, P52, DOI 10.1038/sj.embor.7400573; Gonzalez-Martinez T, 2003, MICROSC RES TECHNIQ, V60, P633, DOI 10.1002/jemt.10304; Haldin CE, 2010, INT J BIOCHEM CELL B, V42, P441, DOI 10.1016/j.biocel.2009.11.014; Ikeda T, 2004, ARTHRITIS RHEUM-US, V50, P3561, DOI 10.1002/art.20611; Inoue K, 2002, ANN NEUROL, V52, P836, DOI 10.1002/ana.10404; Ito Y, 2006, P NATL ACAD SCI USA, V103, P7871, DOI 10.1073/pnas.0602332103; Jessen KR, 2002, J ANAT, V200, P367, DOI 10.1046/j.1469-7580.2002.00046.x; Jessen Kristjan R, 2010, F1000 Biol Rep, V2, DOI 10.3410/B2-19; Kao SC, 2009, SCIENCE, V323, P651, DOI 10.1126/science.1166562; Kioussi C, 1996, TRENDS GENET, V12, P84, DOI 10.1016/0168-9525(96)81411-9; Kitamura T, 1998, INT J HEMATOL, V67, P351; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; Lang D, 2003, HUM MOL GENET, V12, P937, DOI 10.1093/hmg/ddg107; Ludwig A, 2004, FEBS LETT, V556, P236, DOI 10.1016/S0014-5793(03)01446-7; Marenholz I, 2004, BIOCHEM BIOPH RES CO, V322, P1111, DOI 10.1016/j.bbrc.2004.07.096; Mathon NF, 2001, SCIENCE, V291, P872, DOI 10.1126/science.1056782; Melnikova IN, 2000, EUR J PHARMACOL, V393, P75, DOI 10.1016/S0014-2999(99)00884-5; MONUKI ES, 1989, NEURON, V3, P783, DOI 10.1016/0896-6273(89)90247-X; Mrak RE, 2004, J NEUROPATH EXP NEUR, V63, P679, DOI 10.1093/jnen/63.7.679; Nishiyama H, 2002, NEUROSCI LETT, V321, P49, DOI 10.1016/S0304-3940(01)02549-6; Ogata T, 2004, J NEUROSCI, V24, P6724, DOI 10.1523/JNEUROSCI.5520-03.2004; Paratore C, 2001, DEVELOPMENT, V128, P3949; Peirano RI, 2000, MOL CELL BIOL, V20, P3198, DOI 10.1128/MCB.20.9.3198-3209.2000; Reiprich S, 2010, J NEUROCHEM, V112, P744, DOI 10.1111/j.1471-4159.2009.06498.x; Roh J, 2006, DIFFERENTIATION, V74, P542, DOI 10.1111/j.1432-0436.2006.00084.x; Saito T, 2007, EMBO REP, V8, P504, DOI 10.1038/sj.embor.7400934; Salama I, 2008, EJSO-EUR J SURG ONC, V34, P357, DOI 10.1016/j.ejso.2007.04.009; Schepers GE, 2000, NUCLEIC ACIDS RES, V28, P1473, DOI 10.1093/nar/28.6.1473; Schlierf B, 2006, J MOL BIOL, V361, P11, DOI 10.1016/j.jmb.2006.05.072; SELINFREUND RH, 1991, P NATL ACAD SCI USA, V88, P3554, DOI 10.1073/pnas.88.9.3554; Shimotake T, 2007, J PEDIATR SURG, V42, P725, DOI 10.1016/j.jpedsurg.2006.12.003; Sock E, 2001, MOL CELL BIOL, V21, P6951, DOI 10.1128/MCB.21.20.6951-6959.2001; Srinivasan R, 2012, NUCLEIC ACIDS RES, V40, P6449, DOI 10.1093/nar/gks313; Stolt CC, 2010, INT J BIOCHEM CELL B, V42, P437, DOI 10.1016/j.biocel.2009.07.014; Tateishi Narito, 2006, JAPANESE JOURNAL OF NEUROPSYCHOPHARMACOLOGY, V26, P11; Verastegui C, 2000, J BIOL CHEM, V275, P30757, DOI 10.1074/jbc.C000445200; Verheij JBGM, 2006, EUR J PAEDIATR NEURO, V10, P11, DOI 10.1016/j.ejpn.2005.10.004; Wegner M, 2005, TRENDS NEUROSCI, V28, P583, DOI 10.1016/j.tins.2005.08.008; Wegner M, 1999, NUCLEIC ACIDS RES, V27, P1409, DOI 10.1093/nar/27.6.1409; Wei Q, 2004, J NEUROSCI RES, V78, P796, DOI 10.1002/jnr.20342; Yano F, 2005, BIOCHEM BIOPH RES CO, V333, P1300, DOI 10.1016/j.bbrc.2005.06.041	53	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115400	10.1371/journal.pone.0115400	http://dx.doi.org/10.1371/journal.pone.0115400			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536222	Green Submitted, Green Published, gold			2022-12-27	WOS:000348563300037
J	Olson, CR; Owen, DC; Ryabinin, AE; Mello, CV				Olson, Christopher R.; Owen, Devin C.; Ryabinin, Andrey E.; Mello, Claudio V.			Drinking Songs: Alcohol Effects on Learned Song of Zebra Finches	PLOS ONE			English	Article							SPEECH; INTOXICATION; BIRDSONG; LANGUAGE; ETHANOL; ADOLESCENTS; PERFORMANCE; METABOLISM; MODULATION; CIRCUIT	Speech impairment is one of the most intriguing and least understood effects of alcohol on cognitive function, largely due to the lack of data on alcohol effects on vocalizations in the context of an appropriate experimental model organism. Zebra finches, a representative songbird and a premier model for understanding the neurobiology of vocal production and learning, learn song in a manner analogous to how humans learn speech. Here we show that when allowed access, finches readily drink alcohol, increase their blood ethanol concentrations (BEC) significantly, and sing a song with altered acoustic structure. The most pronounced effects were decreased amplitude and increased entropy, the latter likely reflecting a disruption in the birds' ability to maintain the spectral structure of song under alcohol. Furthermore, specific syllables, which have distinct acoustic structures, were differentially influenced by alcohol, likely reflecting a diversity in the neural mechanisms required for their production. Remarkably, these effects on vocalizations occurred without overt effects on general behavioral measures, and importantly, they occurred within a range of BEC that can be considered risky for humans. Our results suggest that the variable effects of alcohol on finch song reflect differential alcohol sensitivity of the brain circuitry elements that control different aspects of song production. They also point to finches as an informative model for understanding how alcohol affects the neuronal circuits that control the production of learned motor behaviors.	[Olson, Christopher R.; Ryabinin, Andrey E.; Mello, Claudio V.] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA; [Owen, Devin C.] Lewis & Clark Coll, Dept Psychol, Portland, OR 97219 USA	Oregon Health & Science University	Mello, CV (corresponding author), Oregon Hlth & Sci Univ, Dept Behav Neurosci, 3181 SW Sam Jackson Pk Rd L470, Portland, OR 97201 USA.	melloc@ohsu.edu	olson, Christopher/ABC-3812-2020	olson, Christopher/0000-0002-8351-0633; Mello, Claudio/0000-0002-9826-8421	National Institutes of Health through Portland Alcohol Research Center (PARC) [R24-GM092842, F32-NS062609, P60-AA010760]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM092842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS062609] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P60AA010760] Funding Source: NIH RePORTER	National Institutes of Health through Portland Alcohol Research Center (PARC)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by National Institutes of Health grants R24-GM092842 (CVM), F32-NS062609 (CRO) and P60-AA010760 through the Portland Alcohol Research Center (PARC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson A, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-229; Bachtell RK, 1999, BRAIN RES, V847, P157, DOI 10.1016/S0006-8993(99)02019-3; Becker HC, 2013, CURR TOP BEHAV NEURO, V13, P355, DOI 10.1007/7854_2012_203; Bloom L, 2001, MONOGR SOC RES CHILD, V66, pVII, DOI 10.1111/1540-5834.00162; Brown SA, 2000, ALCOHOL CLIN EXP RES, V24, P164, DOI 10.1111/j.1530-0277.2000.tb04586.x; Brumm H, 2009, BEHAV ECOL SOCIOBIOL, V63, P1387, DOI 10.1007/s00265-009-0749-y; Cowan JM, 1996, J ANAL TOXICOL, V20, P287, DOI 10.1093/jat/20.5.287; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Glenberg AM, 2008, Q J EXP PSYCHOL, V61, P905, DOI 10.1080/17470210701625550; Grant KA, 2003, PHARMACOL THERAPEUT, V100, P235, DOI 10.1016/j.pharmthera.2003.08.004; Grisel JE, 2002, ALCOHOL CLIN EXP RES, V26, P610, DOI 10.1097/00000374-200205000-00004; Haesler S, 2007, PLOS BIOL, V5, P2885, DOI 10.1371/journal.pbio.0050321; Hessler NA, 1999, NAT NEUROSCI, V2, P209, DOI 10.1038/6306; Hollien H, 2001, J ACOUST SOC AM, V110, P3198, DOI 10.1121/1.1413751; Jarvis ED, 1998, NEURON, V21, P775, DOI 10.1016/S0896-6273(00)80594-2; Jarvis ED, 2004, ANN NY ACAD SCI, V1016, P749, DOI 10.1196/annals.1298.038; Jesse F, 2012, BEHAV PROCESS, V91, P262, DOI 10.1016/j.beproc.2012.09.006; JOHNSON K, 1990, PHONETICA, V47, P215, DOI 10.1159/000261863; Kao MH, 2005, NATURE, V433, P638, DOI 10.1038/nature03127; Kao MH, 2006, J NEUROPHYSIOL, V96, P1441, DOI 10.1152/jn.01138.2005; KLINGHOLZ F, 1988, J ACOUST SOC AM, V84, P929, DOI 10.1121/1.396661; Kuhl PK, 2008, PHILOS T R SOC B, V363, P979, DOI 10.1098/rstb.2007.2154; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Lombardino AJ, 2000, J NEUROSCI, V20, P5054; Mahrt EJ, 2013, J NEUROSCI, V33, P5573, DOI 10.1523/JNEUROSCI.5054-12.2013; Medina KL, 2008, ALCOHOL CLIN EXP RES, V32, P386, DOI 10.1111/j.1530-0277.2007.00602.x; Office of Research Translation and Communications N NIH DHHS, 2004, NIAAA NEWSL, P1; Petkov Christopher I, 2012, Front Evol Neurosci, V4, P12, DOI 10.3389/fnevo.2012.00012; PISONI DB, 1989, ALCOHOL CLIN EXP RES, V13, P577, DOI 10.1111/j.1530-0277.1989.tb00381.x; Porrino LJ, 1998, ALCOHOL CLIN EXP RES, V22, P176, DOI 10.1097/00000374-199802000-00024; Poulsen MB, 2007, EUR J APPL PHYSIOL, V101, P513, DOI 10.1007/s00421-007-0511-y; Pytte CL, 2007, DEV NEUROBIOL, V67, P1699, DOI 10.1002/dneu.20520; Reiner A, 2005, ANAT REC PART A, V287A, P1080, DOI 10.1002/ar.a.20253; Rochefort C, 2007, DEV NEUROBIOL, V67, P809, DOI 10.1002/dneu.20393; Sakata JT, 2008, J NEUROPHYSIOL, V99, P1700, DOI 10.1152/jn.01296.2007; Sakata JT, 2012, J EXP BIOL, V215, P201, DOI 10.1242/jeb.056911; Schweinsburg AD, 2010, ALCOHOL, V44, P111, DOI 10.1016/j.alcohol.2009.09.032; Speakman JR, 2005, J EXP BIOL, V208, P1717, DOI 10.1242/jeb.01556; Sturdy CB, 1999, J COMP PSYCHOL, V113, P194, DOI 10.1037/0735-7036.113.2.194; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Tisljar-Szabo E, 2013, J PSYCHOLINGUIST RES; Williams H, 2004, ANN NY ACAD SCI, V1016, P1, DOI 10.1196/annals.1298.029; Zhang Y, 2011, DEVELOPMENTAL SCI, V14, P566, DOI 10.1111/j.1467-7687.2010.01004.x	43	11	11	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115427	10.1371/journal.pone.0115427	http://dx.doi.org/10.1371/journal.pone.0115427			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536524	gold, Green Published, Green Submitted			2022-12-27	WOS:000348563300040
J	Torres, TS; Luz, PM; Derrico, M; Velasque, L; Grinsztejn, E; Veloso, VG; Cardoso, SW; Santini-Oliveira, M; Grinsztejn, B; De Boni, RB				Torres, Thiago S.; Luz, Paula M.; Derrico, Monica; Velasque, Luciane; Grinsztejn, Eduarda; Veloso, Valdilea G.; Cardoso, Sandra W.; Santini-Oliveira, Marilia; Grinsztejn, Beatriz; De Boni, Raquel Brandini			Factors Associated with Tobacco Smoking and Cessation among HIV-Infected Individuals under Care in Rio de Janeiro, Brazil	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL THERAPY; CIGARETTE-SMOKING; RISK-FACTORS; POSITIVE PATIENTS; CLINICAL CARE; HEALTH-RISKS; USE PATTERNS; MORTALITY; SMOKERS	Worldwide the prevalence of smoking among people living with HIV/AIDS is elevated compared to the general population. This probably reflects the cluster of individual characteristics that have shared risk factors for HIV infection and smoking. A cross-sectional study, enrolling a convenience sample from a Brazilian HIV clinical cohort was conducted to evaluate the prevalence of tobacco smoking and the factors associated with current smoking and abstinence. A total of 2,775 HIV-infected individuals were interviewed: 46.2% have never smoked, 29.9% were current smokers and 23.9% were former smokers. Current smokers had a higher prevalence of alcohol and illicit drug use when compared to the other two groups. A higher proportion of heterosexual individuals were former smokers or never smokers while among men who have sex with men (MSM) a higher proportion were current smokers. Former smokers had been more frequently diagnosed with high blood pressure, diabetes mellitus, cardiovascular diseases and depression, while for current smokers lung diseases were more frequent. Former smokers and current smokers were more likely to have had any hospital admission (42.0% and 41.2%, respectively) than participants who never smoked (33.5%) (p<0.001). Multivariate model results showed that current smokers (versus never smokers) were more likely to be less educated, to report the use of alcohol, crack and cocaine and to present clinical comorbidities. Former smokers (versus current smokers) were more likely to be older, to have smoked for a shorter amount of time and to have smoked >31 cigarettes/day. MSM (compared to heterosexuals) and cocaine users (versus non-users) had lower odds of being former smokers. Considering our results, smoking cessation interventions should be tailored to younger individuals, MSM and substance users.	[Torres, Thiago S.; Luz, Paula M.; Derrico, Monica; Velasque, Luciane; Grinsztejn, Eduarda; Veloso, Valdilea G.; Cardoso, Sandra W.; Santini-Oliveira, Marilia; Grinsztejn, Beatriz; De Boni, Raquel Brandini] Fundacao Oswaldo Cruz, HIV AIDS Clin Res Ctr, Inst Pesquisa Clin Evandro Chagas, Rio De Janeiro, Brazil; [Velasque, Luciane] Univ Fed Estado Rio de Janeiro UniRio, Dept Matemat, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Universidade Federal do Estado do Rio de Janeiro	Torres, TS (corresponding author), Fundacao Oswaldo Cruz, HIV AIDS Clin Res Ctr, Inst Pesquisa Clin Evandro Chagas, Rio De Janeiro, Brazil.	thiago.torres@ipec.fiocruz.br	Cardoso, Sandra W/D-7965-2015; DE BONI, RAQUEL BRANDINI/D-4212-2013; TORRES, THIAGO SILVA/D-6548-2014	Cardoso, Sandra W/0000-0001-5230-0003; DE BONI, RAQUEL BRANDINI/0000-0002-2455-5997; TORRES, THIAGO SILVA/0000-0002-2557-601X; Luz, Paula/0000-0001-9746-719X				Alavi-Naini R, 2013, J RES MED SCI, V18, P52; Amiya RM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-677; Arcavi L, 2004, ARCH INTERN MED, V164, P2206, DOI 10.1001/archinte.164.20.2206; Batista Joanna d’Arc Lyra, 2013, Rev. bras. epidemiol., V16, P432, DOI 10.1590/S1415-790X2013000200018; Benard A, 2007, AIDS PATIENT CARE ST, V21, P458, DOI 10.1089/apc.2006.0142; Benard A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008896; Berhe Gebretsadik, 2013, Ethiop Med J, V51, P227; Collins RL, 2001, HEALTH PSYCHOL, V20, P351, DOI 10.1037//0278-6133.20.5.351; Crabtree-Ramirez B, 2014, JAIDS-J ACQ IMM DEF, V67, pS96, DOI 10.1097/QAI.0000000000000261; Cropsey KL, 2013, ADDICT BEHAV, V38, P2541, DOI 10.1016/j.addbeh.2013.05.003; Dale L C, 1997, Tob Control, V6, P181; Dube S. R., 2010, Morbidity and Mortality Weekly Report, V59, P1135; Duval X, 2008, ANTIVIR THER, V13, P389; Ehrlich RI, 2004, INT J TUBERC LUNG D, V8, P369; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Feldman DN, 2009, AIDS EDUC PREV, V21, P81, DOI 10.1521/aeap.2009.21.3_supp.81; Fuster M, 2009, HIV MED, V10, P614, DOI 10.1111/j.1468-1293.2009.00735.x; Goren A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093014; Grinsztejn B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059768; Grinsztejn B, 2009, AIDS, V23, P2107, DOI 10.1097/QAD.0b013e32832ec494; Gritz ER, 2013, CLIN INFECT DIS, V57, P608, DOI 10.1093/cid/cit349; Gritz ER, 2004, NICOTINE TOB RES, V6, P71, DOI 10.1080/14622200310001656885; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Helleberg M, 2013, CLIN INFECT DIS, V56, P727, DOI 10.1093/cid/cis933; Humfleet GL, 2013, NICOTINE TOB RES, V15, P1436, DOI 10.1093/ntr/ntt005; Humfleet GL, 2009, AIDS EDUC PREV, V21, P54, DOI 10.1521/aeap.2009.21.3_supp.54; Jaquet A, 2009, INT J TUBERC LUNG D, V13, P1433; Kumar SR, 2009, INDIAN J MED RES, V130, P15; Lewden C, 2005, INT J EPIDEMIOL, V34, P121, DOI 10.1093/ije/dyh307; Lifson AR, 2012, CURR HIV-AIDS REP, V9, P223, DOI 10.1007/s11904-012-0121-0; Lifson AR, 2010, AM J PUBLIC HEALTH, V100, P1896, DOI 10.2105/AJPH.2009.188664; Louwagie GMC, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1031; Malta DC, 2013, CAD SAUDE PUBLICA, V29, P812, DOI [10.1590/S0102-311X2013000400018, 10.1590/S0102-311X2013000800018]; Mamary EM, 2002, AIDS PATIENT CARE ST, V16, P39, DOI 10.1089/108729102753429389; Matthews AK, 2013, AIDS PATIENT CARE ST, V27, P22, DOI 10.1089/apc.2012.0253; Mayer KH, 2012, LANCET, V380, P378, DOI 10.1016/S0140-6736(12)60835-6; Ministerio da Saude do Brasil, 2012, B EP ESP TUB; Munyati SS, 2006, INT J TUBERC LUNG D, V10, P1279; Nahvi S, 2009, AIDS EDUC PREV, V21, P14, DOI 10.1521/aeap.2009.21.3_supp.14; Naidoo P, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-396; Nakhaee F, 2009, SEX HEALTH, V6, P129, DOI 10.1071/SH08007; Narasimhan P, 2013, PULM MED, V2013, DOI 10.1155/2013/828939; Niaura R, 2000, CLIN INFECT DIS, V31, P808, DOI 10.1086/314048; O'Cleirigh C, 2015, AIDS BEHAV, V19, P178, DOI 10.1007/s10461-014-0762-7; Oka F, 2013, J INFECT CHEMOTHER, V19, P542, DOI 10.1007/s10156-012-0489-1; Pacek LR, 2013, AIDS BEHAV; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; Peretti-Watel P, 2006, DRUG ALCOHOL DEPEN, V82, pS71, DOI 10.1016/S0376-8716(06)80012-8; Pines H, 2011, AIDS BEHAV, V15, P243, DOI 10.1007/s10461-010-9682-3; Reynolds NR, 2009, AIDS EDUC PREV, V21, P106, DOI 10.1521/aeap.2009.21.3_supp.106; Ribeiro SR, 2014, ANTIVIR THER, V19, P387, DOI 10.3851/IMP2716; Robinson WT, 2014, AIDS BEHAV, V18, pS324, DOI 10.1007/s10461-013-0585-y; Saves M, 2003, CLIN INFECT DIS, V37, P292, DOI 10.1086/375844; Shirley DK, 2013, AIDS PATIENT CARE ST, V27, P604, DOI 10.1089/apc.2013.0128; Shirley DK, 2013, CLIN INFECT DIS, V57, P275, DOI 10.1093/cid/cit207; Smith CJ, 2014, LANCET, V384, P241, DOI 10.1016/S0140-6736(14)60604-8; Souza PRB, 2007, CLINICS, V62, P579, DOI 10.1590/S1807-59322007000500008; Tesoriero JM, 2010, AIDS BEHAV, V14, P824, DOI 10.1007/s10461-008-9449-2; Torres TS, 2013, BRAZ J INFECT DIS, V17, P324, DOI 10.1016/j.bjid.2012.10.024; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; van Wijk JPH, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/201027; Vidrine DJ, 2006, AIDS, V20, P253, DOI 10.1097/01.aids.0000198094.23691.58; Villanti A, 2012, AIDS EDUC PREV, V24, P132, DOI 10.1521/aeap.2012.24.2.132; Waweru P, 2013, SAMJ S AFR MED J, V103, P858, DOI [10.7196/SAMJ.7388, 10.7196/samj.7388]; Webb MS, 2007, J BEHAV MED, V30, P371, DOI 10.1007/s10865-007-9112-9; Webb MS, 2009, AIDS EDUC PREV, V21, P94, DOI 10.1521/aeap.2009.21.3_supp.94; World Health Organization, 2007, UN TUB LUNG DIS WHO	67	18	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115900	10.1371/journal.pone.0115900	http://dx.doi.org/10.1371/journal.pone.0115900			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ9UY	25536064	Green Published, gold, Green Submitted			2022-12-27	WOS:000348563300081
J	Bentler, SE; Morgan, RO; Virnig, BA; Wolinsky, FD				Bentler, Suzanne E.; Morgan, Robert O.; Virnig, Beth A.; Wolinsky, Fredric D.			The Association of Longitudinal and Interpersonal Continuity of Care with Emergency Department Use, Hospitalization, and Mortality among Medicare Beneficiaries	PLOS ONE			English	Article							HEALTH; PHYSICIAN; ACCESS; DIMENSION; OUTCOMES; MODEL	Background: Continuity of medical care is widely believed to lead to better health outcomes and service utilization patterns for patients. Most continuity studies, however, have only used administrative claims to assess longitudinal continuity with a provider. As a result, little is known about how interpersonal continuity (the patient's experience at the visit) relates to improved health outcomes and service use. Methods: We linked claims-based longitudinal continuity and survey-based self-reported interpersonal continuity indicators for 1,219 Medicare beneficiaries who completed the National Health and Health Services Use Questionnaire. With these linked data, we prospectively evaluated the effect of both types of continuity of care indicators on emergency department use, hospitalization, and mortality over a five-year period. Results: Patient-reported continuity was associated with reduced emergency department use, preventable hospitalization, and mortality. Most of the claims-based measures, including those most frequently used to assess continuity, were not associated with reduced utilization or mortality. Conclusion: Our results indicate that the patient-and claims-based indicators of continuity have very different effects on these important health outcomes, suggesting that reform efforts must include the patient-provider experience when evaluating health care quality.	[Bentler, Suzanne E.] Univ Iowa, Publ Policy Ctr, Iowa City, IA 52242 USA; [Morgan, Robert O.] Univ Texas Houston, Sch Publ Hlth, Div Management Policy & Community Hlth, Houston, TX 77030 USA; [Virnig, Beth A.] Univ Minnesota, Sch Publ Hlth, Div Hlth Serv Res & Policy, Minneapolis, MN 55455 USA; [Wolinsky, Fredric D.] Univ Iowa, Coll Publ Hlth, Dept Hlth Management & Policy, Iowa City, IA 52246 USA	University of Iowa; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Minnesota System; University of Minnesota Twin Cities; University of Iowa	Bentler, SE (corresponding author), Univ Iowa, Publ Policy Ctr, 217 South Quad, Iowa City, IA 52242 USA.	suzanne-bentler@uiowa.edu	Wolinsky, Fredric D/F-9231-2011	Wolinsky, Fredric/0000-0002-0916-4955	Alvin R. Tarlov & John E. Ware Jr. Doctoral Dissertation Award; University of Iowa John W. Colloton Chair awarded	Alvin R. Tarlov & John E. Ware Jr. Doctoral Dissertation Award; University of Iowa John W. Colloton Chair awarded	This work was supported by an Alvin R. Tarlov & John E. Ware Jr. Doctoral Dissertation Award (http://www.hal-health.org/awards.htm#tarlov) awarded to SB and funds from the University of Iowa John W. Colloton Chair awarded to FW. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AG HEALTHC RES QU, 2011, AHRQ QUAL IND VERS 4; *AM MED ASS, 2003, CURR PROC TERM 2004; Andersen R., 1968, THESIS PURDUE U W LA; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; ASPER F, 2007, RESDAC PUB, V9; Austin PC, 2010, J CLIN EPIDEMIOL, V63, P46, DOI 10.1016/j.jclinepi.2009.03.012; BENSIRA Z, 1980, J HEALTH SOC BEHAV, V21, P170, DOI 10.2307/2136736; Bentler SE, 2014, MED CARE RES REV, V71, P156, DOI 10.1177/1077558713505909; Bentler SE, 2014, QUAL LIFE RES, V23, P185, DOI 10.1007/s11136-013-0472-z; BICE TW, 1977, MED CARE, V15, P347, DOI 10.1097/00005650-197704000-00010; BINDMAN AB, 1995, JAMA-J AM MED ASSOC, V274, P305, DOI 10.1001/jama.274.4.305; Boyer CA, 2010, J HEALTH SOC BEHAV, V51, pS80, DOI 10.1177/0022146510383489; BRESLAU N, 1975, J MED EDUC, V50, P965; Cabana MD, 2004, J FAM PRACTICE, V53, P974; EJLERTSSON G, 1984, MED CARE, V22, P231, DOI 10.1097/00005650-198403000-00006; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; ERIKSSON EA, 1983, MED CARE, V21, P858, DOI 10.1097/00005650-198309000-00003; Freeman GK, 2003, FAM PRACT, V20, P623, DOI 10.1093/fampra/cmg601; GINSBURG PB, 2008, POLICY PERSPECTIVE, V1; Gruneir A, 2011, MED CARE RES REV, V68, P131, DOI 10.1177/1077558710379422; Gulliford MC, 2006, ANN FAM MED, V4, P548, DOI 10.1370/afm.578; Gupta R, 2013, JAMA INTERN MED, V173, P1885, DOI 10.1001/jamainternmed.2013.7341; Haggerty JL, 2003, BRIT MED J, V327, P1219, DOI 10.1136/bmj.327.7425.1219; Institute of Medicine (IOM), 2003, PRIOR AR NAT ACT TRA; *IOM, 1996, PRIM CAR AM HLTH NEW; Jee SH, 2006, MED CARE RES REV, V63, P158, DOI 10.1177/1077558705285294; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Kalbfleisch J.D., 2002, STAT ANAL FAILURE TI; Leleu H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071669; MAGILL MK, 1987, J FAM PRACTICE, V24, P165; Mainous AG, 1998, AM J PUBLIC HEALTH, V88, P1539, DOI 10.2105/AJPH.88.10.1539; *MEDPAC, 2005, REPORT TO THE CONGRE, P83; Morgan RO, 2008, J AM GERIATR SOC, V56, P2053, DOI 10.1111/j.1532-5415.2008.01993.x; Nutting Paul A, 2003, Ann Fam Med, V1, P149, DOI 10.1370/afm.63; Nyweide DJ, 2013, JAMA INTERN MED, V173, P1879, DOI 10.1001/jamainternmed.2013.10059; Pandhi N, 2007, FAM MED, V39, P266; Parchman ML, 2002, MED CARE, V40, P137, DOI 10.1097/00005650-200202000-00008; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rodriguez HP, 2008, J GEN INTERN MED, V23, P1499, DOI 10.1007/s11606-008-0692-z; Saultz John W, 2003, Ann Fam Med, V1, P134, DOI 10.1370/afm.23; Saultz JW, 2005, ANN FAM MED, V3, P159, DOI 10.1370/afm.285; SMEDBY O, 1986, MED CARE, V24, P511; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; STEINWACHS DM, 1979, MED CARE, V17, P551, DOI 10.1097/00005650-197906000-00001; Sturmberg J P, 2001, Aust Fam Physician, V30, P513; Sturmberg JP, 2002, FAM PRACT, V19, P85, DOI 10.1093/fampra/19.1.85; Uijen AA, 2011, J CLIN EPIDEMIOL, V64, P1391, DOI 10.1016/j.jclinepi.2011.03.006; van Walraven C, 2010, J EVAL CLIN PRACT, V16, P947, DOI 10.1111/j.1365-2753.2009.01235.x; Ware JE Jr, 2001, SCORE INTERPRET SING; Wolinsky FD, 2007, J GERONTOL B-PSYCHOL, V62, pS160, DOI 10.1093/geronb/62.3.S160; Wolinsky FD, 2010, J GERONTOL A-BIOL, V65, P421, DOI 10.1093/gerona/glp188; [No title captured]; [No title captured]	53	27	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115088	10.1371/journal.pone.0115088	http://dx.doi.org/10.1371/journal.pone.0115088			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA3ZY	25531108	gold, Green Published			2022-12-27	WOS:000348845100036
J	Dou, F; Wight, JP; Wilson, LT; Storlien, JO; Hons, FM				Dou, Fugen; Wight, Jason P.; Wilson, Lloyd T.; Storlien, Joseph O.; Hons, Frank M.			Simulation of Biomass Yield and Soil Organic Carbon under Bioenergy Sorghum Production	PLOS ONE			English	Article							CROP RESIDUE REMOVAL; LONG-TERM EXPERIMENTS; NITROGEN-FERTILIZATION; MATTER FRACTIONS; ROOT CARBON; DNDC MODEL; TILLAGE; SEQUESTRATION; SYSTEMS; MANAGEMENT	Developing sustainable management practices including appropriate residue removal and nitrogen (N) fertilization for bioenergy sorghum is critical. However, the effects of residue removal and N fertilization associated with bioenergy sorghum production on soil organic carbon (SOC) are less studied compared to other crops. The objective of our research was to assess the impacts of residue removal and N fertilization on biomass yield and SOC under biomass sorghum production. Field measurements were used to calibrate the DNDC model, then verified the model by comparing simulated results with measured results using the field management practices as agronomic inputs. Both residue removal and N fertilization affected bioenergy sorghum yields in some years. The average measured SOC at 0-50 cm across the treatments and the time-frame ranged from 47.5 to 78.7 Mg C ha(-1), while the simulated SOC was from 56.3 to 67.3 Mg C ha(-1). The high correlation coefficients (0.65 to 0.99) and low root mean square error (3 to 18) between measured and simulated values indicate the DNDC model accurately simulated the effects of residue removal with N fertilization on bioenergy sorghum production and SOC. The model predictions revealed that there is, in the long term, a trend for higher SOC under bioenergy sorghum production regardless of residue management.	[Dou, Fugen; Wilson, Lloyd T.] Texas A&M AgriLife Res & Extens Ctr Beaumont, Beaumont, TX 77713 USA; [Wight, Jason P.; Storlien, Joseph O.; Hons, Frank M.] Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Dou, F (corresponding author), Texas A&M AgriLife Res & Extens Ctr Beaumont, Beaumont, TX 77713 USA.	f-dou@aesrg.tamu.edu	Wilson, Lloyd T/E-9971-2011	Wight, Jason/0000-0002-3523-4101	Texas A&M AgriLife Research Cropping Systems Program and USDA/NIFA Agriculture and Food Research Initiative [2011-67009-30050]	Texas A&M AgriLife Research Cropping Systems Program and USDA/NIFA Agriculture and Food Research Initiative	This research was funded by the Texas A&M AgriLife Research Cropping Systems Program and USDA/NIFA Agriculture and Food Research Initiative (grant #2011-67009-30050). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker JM, 2007, AGR ECOSYST ENVIRON, V118, P1, DOI 10.1016/j.agee.2006.05.014; Balesdent J, 2000, SOIL TILL RES, V53, P215, DOI 10.1016/S0167-1987(99)00107-5; Blanco-Canqui H, 2013, BIOENERG RES, V6, P358, DOI 10.1007/s12155-012-9221-3; Blanco-Canqui H, 2009, CRIT REV PLANT SCI, V28, P139, DOI 10.1080/07352680902776507; CAMBARDELLA CA, 1994, SOIL SCI SOC AM J, V58, P1501, DOI 10.2136/sssaj1994.03615995005800050033x; CAMBARDELLA CA, 1994, SOIL SCI SOC AM J, V58, P123, DOI 10.2136/sssaj1994.03615995005800010017x; Chirinda N, 2012, PLANT SOIL, V359, P321, DOI 10.1007/s11104-012-1208-5; Cibin R, 2012, HYDROL PROCESS, V26, P1629, DOI 10.1002/hyp.8280; Dou FG, 2013, PEDOSPHERE, V23, P409, DOI 10.1016/S1002-0160(13)60033-8; Dou F, 2008, SOIL SCI SOC AM J, V72, P1445, DOI 10.2136/sssaj2007.0230; Dou F, 2008, COMMUN SOIL SCI PLAN, V39, P667, DOI 10.1080/00103620701879117; Dou FG, 2006, SOIL SCI SOC AM J, V70, P1896, DOI 10.2136/sssaj2005.0229; Duiker SW, 1999, SOIL TILL RES, V52, P73, DOI 10.1016/S0167-1987(99)00059-8; Erickson JE, 2012, BIOENERG RES, V5, P86, DOI 10.1007/s12155-011-9129-3; Follett RF, 2001, SOIL TILL RES, V61, P77, DOI 10.1016/S0167-1987(01)00180-5; Galdos MV, 2009, SOIL SCI SOC AM J, V73, P802, DOI 10.2136/sssaj2007.0285; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Hammerbeck AL, 2012, SOIL SCI SOC AM J, V76, P1390, DOI 10.2136/sssaj2011.0421; Hobbie SE, 2005, ECOSYSTEMS, V8, P644, DOI 10.1007/s10021-003-0110-7; Kering MK, 2012, BIOENERG RES, V5, P61, DOI 10.1007/s12155-011-9167-x; Lal R, 2004, GEODERMA, V123, P1, DOI 10.1016/j.geoderma.2004.01.032; Leip A, 2008, BIOGEOSCIENCES, V5, P73, DOI 10.5194/bg-5-73-2008; Li C., 2012, STEPS CALIBRATION VA; Li CS, 2006, ECOL MODEL, V196, P116, DOI 10.1016/j.ecolmodel.2006.02.007; Li CS, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002045; Li CS, 1997, GEODERMA, V81, P45, DOI 10.1016/S0016-7061(97)00080-3; Maughan M, 2012, AGRON J, V104, P1032, DOI 10.2134/agronj2011.0408; Moebius-Clune BN, 2008, SOIL SCI SOC AM J, V72, P960, DOI 10.2136/sssaj2007.0248; OADES JM, 1984, PLANT SOIL, V76, P319, DOI 10.1007/BF02205590; Ouyang W, 2013, ECOL MODEL, V252, P228, DOI 10.1016/j.ecolmodel.2012.05.009; Pedroli B, 2013, BIOMASS BIOENERG, V55, P73, DOI 10.1016/j.biombioe.2012.09.054; Peltoniemi M, 2007, SILVA FENN, V41, P575, DOI 10.14214/sf.290; Rasse DP, 2005, PLANT SOIL, V269, P341, DOI 10.1007/s11104-004-0907-y; Reeves DW, 1997, SOIL TILL RES, V43, P131, DOI 10.1016/S0167-1987(97)00038-X; Rufino MC, 2011, AGR SYST, V104, P175, DOI 10.1016/j.agsy.2010.06.001; Segoli M, 2013, ECOL MODEL, V263, P1, DOI 10.1016/j.ecolmodel.2013.04.010; Six J, 2000, SOIL BIOL BIOCHEM, V32, P2099, DOI 10.1016/S0038-0717(00)00179-6; Six J, 2002, PLANT SOIL, V241, P155, DOI 10.1023/A:1016125726789; Smith P, 1997, GEODERMA, V81, P153, DOI 10.1016/S0016-7061(97)00087-6; Smith WN, 2012, AGR ECOSYST ENVIRON, V161, P27, DOI 10.1016/j.agee.2012.07.024; Solberg ED, 1998, ADV SOIL S, P235; Stewart CE, 2007, BIOGEOCHEMISTRY, V86, P19, DOI 10.1007/s10533-007-9140-0; Tang HJ, 2006, GEODERMA, V134, P200, DOI 10.1016/j.geoderma.2005.10.005; Wang LG, 2008, GEODERMA, V147, P47, DOI 10.1016/j.geoderma.2008.07.009; West TO, 2002, SOIL SCI SOC AM J, V66, P1930, DOI 10.2136/sssaj2002.1930; Wight JP, 2012, BIOMASS BIOENERG, V46, P593, DOI 10.1016/j.biombioe.2012.06.036; Wilhelm WW, 2004, AGRON J, V96, P1, DOI 10.2134/agronj2004.0001; Zhang F, 2006, BIOGEOSCIENCES, V3, P451, DOI 10.5194/bg-3-451-2006; Zhao G, 2013, GLOBAL CHANGE BIOL, V19, P1585, DOI 10.1111/gcb.12145	49	23	24	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115598	10.1371/journal.pone.0115598	http://dx.doi.org/10.1371/journal.pone.0115598			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531758	Green Published, Green Submitted, gold			2022-12-27	WOS:000348845100082
J	Huang, QL; Duan, ZG; Yang, JF; Ma, XY; Zhan, RT; Xu, H; Chen, WW				Huang, Qionglin; Duan, Zhonggang; Yang, Jinfen; Ma, Xinye; Zhan, Ruoting; Xu, Hui; Chen, Weiwen			SNP Typing for Germplasm Identification of Amomum villosum Lour. Based on DNA Barcoding Markers	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; MOLECULAR AUTHENTICATION; MEDICINAL-PLANTS; SEQUENCE; PHYLOGENY; RDNA; NUCLEAR; REGION	Amomum villosum Lour., produced from Yangchun, Guangdong Province, China, is a Daodi medicinal material of Amomi Fructus in traditional Chinese medicine. This herb germplasm should be accurately identified and collected to ensure its quality and safety in medication. In the present study, single nucleotide polymorphism typing method was evaluated on the basis of DNA barcoding markers to identify the germplasm of Amomi Fructus. Genomic DNA was extracted from the leaves of 29 landraces representing three Amomum species (A. villosum Lour., A. xanthioides Wall. ex Baker and A. longiligulare T. L. Wu) by using the CTAB method. Six barcoding markers (ITS, ITS2, LSU D1-D3, matK, rbcL and trnH-psbA) were PCR amplified and sequenced; SNP typing and phylogenetic analysis were performed to differentiate the landraces. Results showed that high-quality bidirectional sequences were acquired for five candidate regions (ITS, ITS2, LSU D1-D3, matK, and rbcL) except trnH-psbA. Three ribosomal regions, namely, ITS, ITS2, and LSU D1-D3, contained more SNP genotypes (STs) than the plastid genes rbcL and matK. In the 29 specimens, 19 STs were detected from the combination of four regions (ITS, LSU D1-D3, rbcL, and matK). Phylogenetic analysis results further revealed two clades. Minimum-spanning tree demonstrated the existence of two main groups: group I was consisting of 9 STs (ST1-8 and ST11) of A. villosum Lour., and group II was composed of 3 STs (ST16-18) of A. longiligulare T. L. Wu. Our results suggested that ITS and LSU D1-D3 should be incorporated with the core barcodes rbcL and matK. The four combined regions could be used as a multiregional DNA barcode to precisely differentiate the Amomi Fructus landraces in different producing areas.	[Huang, Qionglin; Yang, Jinfen; Ma, Xinye; Zhan, Ruoting; Xu, Hui; Chen, Weiwen] Guangzhou Univ Chinese Med, Res Ctr Chinese Med Resource Sci & Engn, Guangzhou, Guangdong, Peoples R China; [Huang, Qionglin; Yang, Jinfen; Ma, Xinye; Zhan, Ruoting; Xu, Hui; Chen, Weiwen] Minist Educ, Key Lab Chinese Med Resource Lingnan, Guangzhou, Guangdong, Peoples R China; [Duan, Zhonggang] Huizhou Univ, Dept Life Sci, Huizhou, Guangdong, Peoples R China	Guangzhou University of Chinese Medicine; Huizhou University	Chen, WW (corresponding author), Guangzhou Univ Chinese Med, Res Ctr Chinese Med Resource Sci & Engn, Guangzhou, Guangdong, Peoples R China.	gdmchql2013@163.com			Special fund project of college discipline and specialty construction in Guangdong province of China [2013CXZDA011]	Special fund project of college discipline and specialty construction in Guangdong province of China	Special fund project of college discipline and specialty construction in Guangdong province of China (2013CXZDA011).	Achtman M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002776; Asahina H, 2010, J NAT MED-TOKYO, V64, P133, DOI 10.1007/s11418-009-0379-8; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; CHATTERTON NJ, 1992, PLANT MOL BIOL, V20, P163, DOI 10.1007/BF00029161; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Chen W, 2007, STUDIES DAODI MED MA, P33; Chinese Pharmacopoeia Commission, 2010, PHARMACOPOEIA PEOPLE, V1, P236; de Paula Careta Francisco, 2012, Recent Pat DNA Gene Seq, V6, P122; Duan ZG, 2008, DNA BARCODING CHINES, P60; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Gao T, 2010, J ETHNOPHARMACOL, V130, P116, DOI 10.1016/j.jep.2010.04.026; Germano J, 1999, THEOR APPL GENET, V99, P37, DOI 10.1007/s001220051206; Heubl G, 2010, PLANTA MED, V76, P1963, DOI 10.1055/s-0030-1250519; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Huang Q, 2010, J GUANGZHOU U TRAD C, V27, P151; Kim S, 2007, ANNU REV BIOMED ENG, V9, P289, DOI 10.1146/annurev.bioeng.9.060906.152037; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Kurtzman CP, 1998, ANTON LEEUW INT J G, V73, P331, DOI 10.1023/A:1001761008817; Kuzoff RK, 1998, MOL BIOL EVOL, V15, P251, DOI 10.1093/oxfordjournals.molbev.a025922; Lee Ok Ran, 2012, Methods Mol Biol, V862, P135, DOI 10.1007/978-1-61779-609-8_11; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Lou SK, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-402; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Maiden MCJ, 2013, NAT REV MICROBIOL, V11, P728, DOI 10.1038/nrmicro3093; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Song JY, 2009, J ETHNOPHARMACOL, V124, P434, DOI 10.1016/j.jep.2009.05.042; Sonnenberg R, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-6; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tate JA, 2003, SYST BOT, V28, P723; Tripathi AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057934; Wang HT, 2012, GENE, V494, P92, DOI 10.1016/j.gene.2011.11.026; Wang H, 2011, J PHARMACEUT BIOMED, V55, P972, DOI 10.1016/j.jpba.2011.03.037; Xu GJ, 2013, GENOME, V56, P109, DOI 10.1139/gen-2012-0182; Yamamoto T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-267; Yuan Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep05395; Zhao ZZ, 2012, J ETHNOPHARMACOL, V140, P476, DOI 10.1016/j.jep.2012.01.048	38	23	27	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e114940	10.1371/journal.pone.0114940	http://dx.doi.org/10.1371/journal.pone.0114940			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531885	Green Published, Green Submitted, gold			2022-12-27	WOS:000348845100033
J	Nilsen, ET; Freeman, J; Grene, R; Tokuhisa, J				Nilsen, Erik T.; Freeman, Joshua; Grene, Ruth; Tokuhisa, James			A Rootstock Provides Water Conservation for a Grafted Commercial Tomato (Solanum lycopersicum L.) Line in Response to Mild-Drought Conditions: A Focus on Vegetative Growth and Photosynthetic Parameters	PLOS ONE			English	Article							TOLERANCE; STRESS; PLANTS; PRODUCTIVITY	The development of water stress resistant lines of commercial tomato by breeding or genetic engineering is possible, but will take considerable time before commercial varieties are available for production. However, grafting commercial tomato lines on drought resistant rootstock may produce drought tolerant commercial tomato lines much more rapidly. Due to changing climates and the need for commercial production of vegetables in low quality fields there is an urgent need for stress tolerant commercial lines of vegetables such as tomato. In previous observations we identified a scion root stock combination ('BHN 602' scion grafted onto 'Jjak Kkung' rootstock hereafter identified as 602/Jjak) that had a qualitative drought-tolerance phenotype when compared to the non-grafted line. Based on this initial observation, we studied photosynthesis and vegetative above-ground growth during mild-drought for the 602/Jjak compared with another scion-rootstock combination ('BHN 602' scion grafted onto 'Cheong Gang' rootstock hereafter identified as 602/Cheong) and a non-grafted control. Overall above ground vegetative growth was significantly lower for 602/Jjak in comparison to the other plant lines. Moreover, water potential reduction in response to mild drought was significantly less for 602/Jjak, yet stomatal conductance of all plant-lines were equally inhibited by mild-drought. Light saturated photosynthesis of 602/Jjak was less affected by low water potential than the other two lines as was the % reduction in mesophyll conductance. Therefore, the Jjak Kkung rootstock caused aboveground growth reduction, water conservation and increased photosynthetic tolerance of mild drought. These data show that different rootstocks can change the photosynthetic responses to drought of a high yielding, commercial tomato line. Also, this rapid discovery of one scion-rootstock combination that provided mild-drought tolerance suggests that screening more scion-rootstock combination for stress tolerance may rapidly yield commercially viable, stress tolerant lines of tomato.	[Nilsen, Erik T.; Tokuhisa, James] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA; [Freeman, Joshua] Univ Florida, North Florida Res & Educ Ctr, Quincy, FL 32611 USA; [Grene, Ruth] Virginia Tech, Dept Plant Pathol Physiol & Weed Sci, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; State University System of Florida; University of Florida; Virginia Polytechnic Institute & State University	Nilsen, ET (corresponding author), Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA.	enilsen@vt.edu	Tokuhisa, James G/B-5664-2008	Tokuhisa, James G/0000-0002-3834-5149	Integrated Internal Competitive Grants Program	Integrated Internal Competitive Grants Program	This project was funded through the Integrated Internal Competitive Grants Program managed by the Virginia Agricultural Experiment Station (http://www.vaes.vt.edu). All authors were PIs on this award (JHF RG JGT ETN). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Albacete A, 2009, PLANT CELL ENVIRON, V32, P928, DOI 10.1111/j.1365-3040.2009.01973.x; Bargmann BOR, 2009, PLANT CELL PHYSIOL, V50, P78, DOI 10.1093/pcp/pcn173; Bausher MG, 2011, HORTSCIENCE, V46, P596, DOI 10.21273/HORTSCI.46.4.596; BOYER JS, 1982, SCIENCE, V218, P443, DOI 10.1126/science.218.4571.443; Martinez-Ballesta MC, 2010, SCI HORTIC-AMSTERDAM, V127, P112, DOI 10.1016/j.scienta.2010.08.002; Choi JY, 2011, PLANT CELL REP, V30, P867, DOI 10.1007/s00299-010-0989-3; CORNIC G, 1992, PHOTOSYNTHETICA, V27, P295; DEMMIGADAMS B, 1992, ANNU REV PLANT PHYS, V43, P599, DOI 10.1146/annurev.pp.43.060192.003123; Erzin V, 2010, ELECT J ENV AGR FOOD, V9, P1641; Fischer I, 2011, NEW PHYTOL, V190, P1032, DOI 10.1111/j.1469-8137.2011.03648.x; Gong PJ, 2010, J EXP BOT, V61, P3563, DOI 10.1093/jxb/erq167; He Y, 2009, ENVIRON EXP BOT, V66, P270, DOI 10.1016/j.envexpbot.2009.02.007; Holbrook NM, 2002, J EXP BOT, V53, P1503, DOI 10.1093/jexbot/53.373.1503; Isaakidis A, 2004, NEW ZEAL J CROP HORT, V32, P355, DOI 10.1080/01140671.2004.9514316; Jensen CR, 2010, AGR WATER MANAGE, V98, P403, DOI 10.1016/j.agwat.2010.10.018; Krishnamurthy KS, 2008, INDIAN J HORTIC, V65, P204; Lee JungMyung, 2003, Chronica Horticulturae, V43, P13; Liu YB, 2007, SCI CHINA SER C, V50, P15, DOI 10.1007/s11427-007-0002-8; Pire R, 2010, J FOOD AGRIC ENVIRON, V8, P703; Rivard CL, 2008, PHYTOPATHOLOGY, V98, pS133; Rivard CL, 2008, HORTSCIENCE, V43, P2104, DOI 10.21273/HORTSCI.43.7.2104; Sanchez-Rodriguez E, 2011, J PLANT PHYSIOL, V168, P816, DOI 10.1016/j.jplph.2010.11.018; Schwarz D, 2010, SCI HORTIC-AMSTERDAM, V127, P162, DOI 10.1016/j.scienta.2010.09.016; Sharma S, 2008, J HORTIC SCI BIOTECH, V83, P658, DOI 10.1080/14620316.2008.11512439; Silva VA, 2010, PESQUI AGROPECU BRAS, V45, P457, DOI 10.1590/S0100-204X2010000500004; Sommer KJ, 2010, S AFR J ENOL VITIC, V31, P181; Tuwei G, 2008, EXP AGR, V44, P537, DOI 10.1017/S0014479708006947; Xie TT, 2010, PAK J BOT, V42, P3981; Ziaf K, 2011, PLANT CELL PHYSIOL, V52, P1055, DOI 10.1093/pcp/pcr057	29	25	29	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115380	10.1371/journal.pone.0115380	http://dx.doi.org/10.1371/journal.pone.0115380			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531435	Green Published, gold, Green Submitted			2022-12-27	WOS:000348845100059
J	Chen, LL; Liu, T; Zhou, JH; Wang, YF; Wang, XR; Di, W; Zhang, S				Chen, Lilan; Liu, Ting; Zhou, Jinhua; Wang, Yunfei; Wang, Xinran; Di, Wen; Zhang, Shu			Citrate Synthase Expression Affects Tumor Phenotype and Drug Resistance in Human Ovarian Carcinoma	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; VIMENTIN EXPRESSION; CISPLATIN-RESISTANCE; ERCC1 EXPRESSION; CELL SURVIVAL; EP-CAM; CANCER; PROTEIN; GENE; REPAIR	Citrate synthase (CS), one of the key enzymes in the tricarboxylic acid (TCA) cycle, catalyzes the reaction between oxaloacetic acid and acetyl coenzyme A to generate citrate. Increased CS has been observed in pancreatic cancer. In this study, we found higher CS expression in malignant ovarian tumors and ovarian cancer cell lines compared to benign ovarian tumors and normal human ovarian surface epithelium, respectively. CS knockdown by RNAi could result in the reduction of cell proliferation, and inhibition of invasion and migration of ovarian cancer cells in vitro. The drug resistance was also inhibited possibly through an excision repair cross complementing 1 (ERCC1)-dependent mechanism. Finally, upon CS knockdown we observed significant increase expression of multiple genes, including ISG15, IRF7, CASP7, and DDX58 in SKOV3 and A2780 cells by microarray analysis and real-time PCR. Taken together, these results suggested that CS might represent a potential therapeutic target for ovarian carcinoma.	[Chen, Lilan; Liu, Ting; Zhou, Jinhua; Wang, Yunfei; Wang, Xinran; Di, Wen; Zhang, Shu] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Obstet & Gynecol, Shanghai 200127, Peoples R China; [Chen, Lilan; Liu, Ting; Zhou, Jinhua; Wang, Yunfei; Wang, Xinran; Di, Wen; Zhang, Shu] Shanghai Key Lab Gynecol Oncol, Shanghai 200127, Peoples R China	Shanghai Jiao Tong University	Di, W (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Obstet & Gynecol, Shanghai 200127, Peoples R China.	diwen163@163.com; drzhangshu@hotmail.com			Shanghai Committee of Science and Technology [10dz2212100, 12411950200]; National Natural Science Foundation [81072137, 81172479]; Shanghai Health Bureau Key Disciplines and Specialties Foundation; Shanghai Education Commission Key Disciplines Foundation; Key Discipline Project of Ren Ji Hospital; Shanghai Jiao Tong University School of Medicine	Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Shanghai Health Bureau Key Disciplines and Specialties Foundation; Shanghai Education Commission Key Disciplines Foundation; Key Discipline Project of Ren Ji Hospital; Shanghai Jiao Tong University School of Medicine	This work was supported by Shanghai Committee of Science and Technology (Grant No. 10dz2212100 and Grant No. 12411950200 to Wen Di), National Natural Science Foundation (Grant No. 81072137 to Wen Di, Grant No. 81172479 to Shu Zhang), Shanghai Health Bureau Key Disciplines and Specialties Foundation, Shanghai Education Commission Key Disciplines Foundation, the Key Discipline Project of Ren Ji Hospital, and the Shanghai Jiao Tong University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AS, 2013, EXP CELL RES, V319, P1431, DOI 10.1016/j.yexcr.2013.02.017; Atsumi Y, 2013, J BIOL CHEM, V288, P13269, DOI 10.1074/jbc.M112.402560; AUERSPERG N, 1984, IN VITRO CELL DEV B, V20, P743; Berchuck A, 1997, BIOCHEM PHARMACOL, V54, P541, DOI 10.1016/S0006-2952(97)00061-0; Bidwell B. N., 2012, NAT MED; Cufi S, 2012, ONCOTARGET; De Dosso S., 2013, CANC CHEMOTHER PHARM; Desai SD, 2008, MOL CANCER THER, V7, P1430, DOI 10.1158/1535-7163.MCT-07-2345; Dunfield Lesley D., 2002, Biol Proced Online, V4, P55; Erener S, 2012, MOL CELL, V46, P200, DOI 10.1016/j.molcel.2012.02.016; FIDLER IJ, 1990, J NATL CANCER I, V82, P166, DOI 10.1093/jnci/82.3.166; FRANKE WW, 1982, DIFFERENTIATION, V23, P43, DOI 10.1111/j.1432-0436.1982.tb01266.x; Gaude E, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-10; Gilles C, 1996, J PATHOL, V180, P175, DOI 10.1002/(SICI)1096-9896(199610)180:2<175::AID-PATH630>3.0.CO;2-G; Green DR, 2000, CELL, V102, P1, DOI 10.1016/S0092-8674(00)00003-9; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Horimoto Y, 2012, CELL ADHES MIGR, V6, P193, DOI 10.4161/cam.20631; Jeggo P, 2007, ONCOGENE, V26, P7717, DOI 10.1038/sj.onc.1210868; Jiang FG, 2011, NATURE, V479, P423, DOI 10.1038/nature10537; Kawashima A, 2012, ADV UROL, V2012, DOI 10.1155/2012/812398; Ko JC, 2010, BIOCHEM PHARMACOL, V79, P655, DOI 10.1016/j.bcp.2009.09.024; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Kusao I, 2008, CANCER GROWTH METAST, V1, P3; Lee WK, 2009, LUNG CANCER, V65, P19, DOI 10.1016/j.lungcan.2008.10.022; Li W, 2012, ONCOGENE, V31, P2412, DOI 10.1038/onc.2011.426; Lin CC, 2012, SCI REP-UK, V2, DOI 10.1038/srep00785; LITVINOV SV, 1994, CELL ADHES COMMUN, V2, P417, DOI 10.3109/15419069409004452; LITVINOV SV, 1994, J CELL BIOL, V125, P437, DOI 10.1083/jcb.125.2.437; Lord RVN, 2002, CLIN CANCER RES, V8, P2286; MCDONNELL TJ, 1989, CELL, V57, P79, DOI 10.1016/0092-8674(89)90174-8; McInroy L, 2007, BIOCHEM BIOPH RES CO, V360, P109, DOI 10.1016/j.bbrc.2007.06.036; McKinnon PJ, 2007, ANNU REV GENOM HUM G, V8, P37, DOI 10.1146/annurev.genom.7.080505.115648; Milovic-Kovacevic M, 2011, J BUON, V16, P708; MUKHERJEE A, 1976, J BIOL CHEM, V251, P2155; Poulikakos PI, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001948; Qvarnstrom OF, 2009, INT J ONCOL, V35, P41, DOI 10.3892/ijo_00000311; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Schlichtholz B, 2005, PANCREAS, V30, P99, DOI 10.1097/01.mpa.0000153326.69816.7d; Shao W, 2007, AUTOPHAGY, V3, P10, DOI 10.4161/auto.3270; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; SOMMERS CL, 1992, CANCER RES, V52, P5190; Sun YH, 2009, CANCER INVEST, V27, P891, DOI 10.3109/07357900902744536; Tester AM, 2001, CLIN EXP METASTAS, V18, P553, DOI 10.1023/A:1011953118186; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; Wang J, 2007, CANCER RES, V67, P11933, DOI 10.1158/0008-5472.CAN-07-5185; Wang YF, 2013, BIOMATERIALS, V34, P4068, DOI 10.1016/j.biomaterials.2012.12.033; Wang ZU, 2013, ANTI-CANCER DRUG, V24, P355, DOI 10.1097/CAD.0b013e32835df8b5; Wood LM, 2012, CANCER IMMUNOL IMMUN, V61, P689, DOI 10.1007/s00262-011-1129-9; Zhang P, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.526	50	46	48	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115708	10.1371/journal.pone.0115708	http://dx.doi.org/10.1371/journal.pone.0115708			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545012	Green Published, gold, Green Submitted			2022-12-27	WOS:000347120200058
J	Hargrave, B; Strange, R; Navare, S; Stratton, M; Burcus, N; Murray, L; Lundberg, C; Bulysheva, A; Li, FY; Heller, R				Hargrave, Barbara; Strange, Robert, Jr.; Navare, Sagar; Stratton, Michael; Burcus, Nina; Murray, Len; Lundberg, Cathryn; Bulysheva, Anna; Li, Fanying; Heller, Richard			Gene Electro Transfer of Plasmid Encoding Vascular Endothelial Growth Factor for Enhanced Expression and Perfusion in the Ischemic Swine Heart	PLOS ONE			English	Article							LEFT-VENTRICULAR VOLUMES; MYOCARDIAL-INFARCTION; EJECTION FRACTION; ELECTROPORATION; ECHOCARDIOGRAPHY; DELIVERY; THERAPY; DNA	Myocardial ischemia can damage heart muscle and reduce the heart's pumping efficiency. This study used an ischemic swine heart model to investigate the potential for gene electro transfer of a plasmid encoding vascular endothelial growth factor for improving perfusion and, thus, for reducing cardiomyopathy following acute coronary syndrome. Plasmid expression was significantly greater in gene electro transfer treated tissue compared to injection of plasmid encoding vascular endothelial growth factor alone. Higher gene expression was also seen in ischemic versus non-ischemic groups with parameters 20 Volts (p<0.03), 40 Volts (p<0.05), and 90 Volts (p<0.05), but not with 60 Volts (p<0.09) while maintaining a pulse width of 20 milliseconds. The group with gene electro transfer of plasmid encoding vascular endothelial growth factor had increased perfusion in the area at risk compared to control groups. Troponin and creatine kinase increased across all groups, suggesting equivalent ischemia in all groups prior to treatment. Echocardiography was used to assess ejection fraction, cardiac output, stroke volume, left ventricular end diastolic volume, and left ventricular end systolic volume. No statistically significant differences in these parameters were detected during a 2-week time period. However, directional trends of these variables were interesting and offer valuable information about the feasibility of gene electro transfer of vascular endothelial growth factor in the ischemic heart. The results demonstrate that gene electro transfer can be applied safely and can increase perfusion in an ischemic area. Additional study is needed to evaluate potential efficacy.	[Hargrave, Barbara; Burcus, Nina; Lundberg, Cathryn; Bulysheva, Anna; Li, Fanying; Heller, Richard] Old Dominion Univ, Frank Reidy Res Ctr Bioelect, Norfolk, VA 23529 USA; [Hargrave, Barbara; Heller, Richard] Old Dominion Univ, Coll Hlth Sci, Sch Med Diagnost & Translat Sci, Norfolk, VA USA; [Strange, Robert, Jr.; Navare, Sagar; Stratton, Michael] Naval Med Ctr Portsmouth, Portsmouth, VA USA; [Murray, Len] Sobran Inc, Fairfax, VA USA	Old Dominion University; Old Dominion University; United States Department of Defense; United States Navy	Heller, R (corresponding author), Old Dominion Univ, Frank Reidy Res Ctr Bioelect, Norfolk, VA 23529 USA.	rheller@odu.edu	Heller, Richard/ABF-1445-2020; Navare, Sagar/AAZ-1097-2021	Heller, Richard/0000-0003-1899-3859; Bulysheva, Anna/0000-0002-7287-9371	National Institutes of Health [R33 HL005441]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R33HL089017] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding for this work came from the National Institutes of Health R33 HL005441. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blenkie I, 1973, AM J CARDIOL, V31, P755; DARBELA PG, 1986, BRIT HEART J, V56, P445; Detter C, 2007, CIRCULATION, V116, P1007, DOI 10.1161/CIRCULATIONAHA.106.655936; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Ferrara N, 2001, ACTA HAEMATOL-BASEL, V106, P148, DOI 10.1159/000046610; Fihn SD, 2012, J AM COLL CARDIOL, V60, P1; Fortuin FD, 2003, AM J CARDIOL, V92, P436, DOI 10.1016/S0002-9149(03)00661-1; Hargrave B, 2013, GENE THER, V20, P151, DOI 10.1038/gt.2012.15; Harrison RL, 1998, FEBS LETT, V435, P1, DOI 10.1016/S0014-5793(98)00987-9; Hartikka J, 2001, MOL THER, V4, P407, DOI 10.1006/mthe.2001.0483; Heller LC, 2006, HUM GENE THER, V17, P890, DOI 10.1089/hum.2006.17.890; HENNING H, 1975, CIRCULATION, V52, P1069, DOI 10.1161/01.CIR.52.6.1069; Institute for Laboratory Animal Research, 2011, GUIDE CARE USE LAB A; KOSTUK WJ, 1973, CIRCULATION, V47, P1174, DOI 10.1161/01.CIR.47.6.1174; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Marshall WG, 2010, GENE THER, V17, P419, DOI 10.1038/gt.2009.153; Mayo Clinic Staff, 2013, MYOC ISCH; Mcfee RM, 2012, CELL TISSUE RES, V349, P635, DOI 10.1007/s00441-012-1330-y; NEUMANN E, 1982, EMBO J, V1, P841, DOI 10.1002/j.1460-2075.1982.tb01257.x; POMBO JF, 1971, CIRCULATION, V43, P480, DOI 10.1161/01.CIR.43.4.480; POPP RL, 1973, AM J CARDIOL, V31, P152, DOI 10.1016/0002-9149(73)90974-0; Toivonen R, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-296; Udelson JE, 2011, CIRCULATION, V124, pE540, DOI 10.1161/CIRCULATIONAHA.111.071696; Yla-Herttuala S, 2013, GENE, V525, P217, DOI 10.1016/j.gene.2013.03.051; Zhao TQ, 2010, MICROVASC RES, V80, P188, DOI 10.1016/j.mvr.2010.03.014	25	8	8	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115235	10.1371/journal.pone.0115235	http://dx.doi.org/10.1371/journal.pone.0115235			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545364	Green Published, gold, Green Submitted			2022-12-27	WOS:000347120200029
J	Sarkar, T; Thankappan, R; Kumar, A; Mishra, GP; Dobaria, JR				Sarkar, Tanmoy; Thankappan, Radhakrishnan; Kumar, Abhay; Mishra, Gyan P.; Dobaria, Jentilal Ramjibhai			Heterologous Expression of the AtDREB1A Gene in Transgenic Peanut-Conferred Tolerance to Drought and Salinity Stresses	PLOS ONE			English	Article							ABIOTIC STRESS; TRANSCRIPTION FACTOR; TRANSPIRATION EFFICIENCY; PROLINE ACCUMULATION; LOW-TEMPERATURE; OXIDATIVE STRESS; TOBACCO PLANTS; SALT TOLERANCE; ARABIDOPSIS; L.	Research on genetic transformation in various crop plants using the DREB1A transcription factor has shown better abiotic stress tolerance in transgenic crops. The AtDREB1A transgenic peanut (Arachis hypogaea L. cv. GG 20), which was previously developed, was characterized in terms of its physio-biochemical, molecular and growth parameters. The tolerance of this transgenic peanut to drought and salinity stresses was evaluated at the seedling (18 days old) and maturity stages. Transgenic peanut lines showed improved tolerance to both stresses over wild-type, as observed by delayed and less severe wilting of leaves and by improved growth parameters that were correlated with physio-biochemical parameters such as proline content, total chlorophyll content, osmotic potential, electrolytic leakage and relative water content. The expression pattern of the AtDREB1A gene evaluated using qPCR at different time points demonstrated that transgene expression was induced within two hours of stress imposition. The better performance of transgenic AtDREB1A peanut at the seedling stage and the improved growth parameters were due to the expression of the transgene, which is a transcription factor, and the possible up-regulation of various stress-inducible, downstream genes in the signal transduction pathway under abiotic stress.	[Sarkar, Tanmoy; Thankappan, Radhakrishnan; Kumar, Abhay; Mishra, Gyan P.; Dobaria, Jentilal Ramjibhai] Directorate Groundnut Res, Crop Improvement Div, Junagadh, Gujarat, India	Indian Council of Agricultural Research (ICAR); ICAR - Directorate of Groundnut Research	Thankappan, R (corresponding author), Directorate Groundnut Res, Crop Improvement Div, Junagadh, Gujarat, India.	radhakrishnan.nrcg@gmail.com	Mishra, Gyan P./E-5980-2010; SARKAR, TANMOY/I-5145-2019; KUMAR, ABHAY/H-3073-2019	Mishra, Gyan P./0000-0002-7023-2638; SARKAR, TANMOY/0000-0002-1885-2864; KUMAR, ABHAY/0000-0002-1104-6771	Indian Council of Agricultural Research, New Delhi, India	Indian Council of Agricultural Research, New Delhi, India(Indian Council of Agricultural Research (ICAR))	This work was funded by the Indian Council of Agricultural Research, New Delhi, India, under the project entitled "ICAR Network Project on Transgenic Crops.'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal P, 2010, MOL BIOL REP, V37, P1125, DOI 10.1007/s11033-009-9885-8; Agarwal PK, 2006, PLANT CELL REP, V25, P1263, DOI 10.1007/s00299-006-0204-8; Akcay UC, 2010, PLANT GROWTH REGUL, V61, P21, DOI 10.1007/s10725-010-9445-1; Ban QY, 2011, J PLANT PHYSIOL, V168, P449, DOI 10.1016/j.jplph.2010.08.013; BARRS HD, 1962, AUST J BIOL SCI, V15, P413, DOI 10.1071/BI9620413; Bartels D, 2001, TRENDS PLANT SCI, V6, P284, DOI 10.1016/S1360-1385(01)01983-5; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Behnam B., 2006, PLANT BIOTECHNOL-NAR, V23, P169, DOI [10.5511/plantbiotechnology.23.169, DOI 10.5511/PLANTBIOTECHNOLOGY.23.169]; Benjamin JG, 2006, FIELD CROP RES, V97, P248, DOI 10.1016/j.fcr.2005.10.005; Bharati Pandey, 2014, Australian Journal of Crop Science, V8, P44; Bhat SR, 2002, PLANT SCI, V163, P673, DOI 10.1016/S0168-9452(02)00152-8; Bhatnagar-Mathur P, 2008, PLANT CELL REP, V27, P411, DOI 10.1007/s00299-007-0474-9; Bhatnagar-Mathur P, 2007, PLANT CELL REP, V26, P2071, DOI 10.1007/s00299-007-0406-8; Bhatnagar-Mathur P, 2014, MOL BREEDING, V33, P327, DOI 10.1007/s11032-013-9952-7; Bhatnagar-Mathur P, 2009, J PLANT PHYSIOL, V166, P1207, DOI 10.1016/j.jplph.2009.01.001; Bhauso T. D., 2014, Australian Journal of Crop Science, V8, P413; Bouaziz D, 2013, MOL BIOTECHNOL, V54, P803, DOI 10.1007/s12033-012-9628-2; Calcagno AM, 2011, AUST J CROP SCI, V5, P695; Chen JH, 2009, BIOCHEM BIOPH RES CO, V378, P483, DOI 10.1016/j.bbrc.2008.11.071; Chen M, 2007, PLANT SOIL ENVIRON, V53, P490, DOI 10.17221/2302-PSE; Datta K, 2012, PLANT BIOTECHNOL J, V10, P579, DOI 10.1111/j.1467-7652.2012.00688.x; Rolla AAD, 2014, TRANSGENIC RES, V23, P75, DOI 10.1007/s11248-013-9723-6; DIAZPEREZ JC, 1995, J AM SOC HORTIC SCI, V120, P435, DOI 10.21273/JASHS.120.3.435; Du NX, 2012, PLANT CELL TISS ORG, V108, P181, DOI 10.1007/s11240-011-0026-4; Farooq M, 2009, SUSTAINABLE AGRICULTURE, P153, DOI 10.1051/agro:2008021; FOBERT PR, 1991, PLANT MOL BIOL, V17, P837, DOI 10.1007/BF00037065; GOLDSBROUGH A, 1991, PLANT MOL BIOL, V16, P263, DOI 10.1007/BF00020557; HANDA S, 1986, PLANT PHYSIOL, V80, P938, DOI 10.1104/pp.80.4.938; Hasthanasombut S, 2011, PLANT CELL TISS ORG, V104, P79, DOI 10.1007/s11240-010-9807-4; HISCOX JD, 1979, CAN J BOT, V57, P1332, DOI 10.1139/b79-163; Holbrook CC, 2011, AGRONOMY-BASEL, V1, P3, DOI 10.3390/agronomy1010003; Hou XN, 2013, PLANT MOL BIOL REP, V31, P791, DOI 10.1007/s11105-012-0549-9; Huynh LN, 2005, J EXP BOT, V56, P1397, DOI 10.1093/jxb/eri141; Jagana S. R., 2012, Journal of SAT Agricultural Research, V10, punpaginated; Jami SK, 2008, PLANT PHYSIOL BIOCH, V46, P1019, DOI 10.1016/j.plaphy.2008.07.006; Kasuga M, 2004, PLANT CELL PHYSIOL, V45, P346, DOI 10.1093/pcp/pch037; Kasuga M, 1999, NAT BIOTECHNOL, V17, P287, DOI 10.1038/7036; Khare N, 2010, PLANT CELL TISS ORG, V103, P267, DOI 10.1007/s11240-010-9776-7; Krishnamurthy L, 2007, FIELD CROP RES, V103, P189, DOI 10.1016/j.fcr.2007.06.009; Li C, 2013, PLANT PHYSIOL BIOCH, V70, P164, DOI 10.1016/j.plaphy.2013.05.005; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Liu QL, 2013, PLANT PHYSIOL BIOCH, V69, P27, DOI 10.1016/j.plaphy.2013.04.016; Liu XL, 2008, BIOTECHNOL LETT, V30, P1275, DOI 10.1007/s10529-008-9672-y; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052126; Mackova H, 2013, J EXP BOT, V64, P2805, DOI 10.1093/jxb/ert131; Mao XG, 2012, J EXP BOT, V63, P2933, DOI 10.1093/jxb/err462; Martinez Beltran J., 2005, International salinity forum - managing saline soils and water: science, technology and social issues. Oral Presentation Abstracts, Riverside Convention Center, Riverside, California, USA, 25-28 April 2005, P311; Maruyama K, 2004, PLANT J, V38, P982, DOI 10.1111/j.1365-313X.2004.02100.x; Morran S, 2011, PLANT BIOTECHNOL J, V9, P230, DOI 10.1111/j.1467-7652.2010.00547.x; Oh SJ, 2005, PLANT PHYSIOL, V138, P341, DOI 10.1104/pp.104.059147; Pardo JM, 2010, CURR OPIN BIOTECH, V21, P185, DOI 10.1016/j.copbio.2010.02.005; Prabhavathi V, 2007, PLANT SCI, V173, P50, DOI 10.1016/j.plantsci.2007.04.004; Prabhavathi V, 2002, MOL BREEDING, V9, P137, DOI 10.1023/A:1026765026493; Rai AC, 2012, PLANT PHYSIOL BIOCH, V61, P108, DOI 10.1016/j.plaphy.2012.09.010; Rai AC, 2013, PHYTOCHEMISTRY, V85, P44, DOI 10.1016/j.phytochem.2012.09.007; Rai GK, 2013, PLANT PHYSIOL BIOCH, V69, P90, DOI 10.1016/j.plaphy.2013.05.002; Ravikumar G, 2014, TRANSGENIC RES, V23, P421, DOI 10.1007/s11248-013-9776-6; Reguera M, 2012, BBA-GENE REGUL MECH, V1819, P186, DOI 10.1016/j.bbagrm.2011.08.005; Sarkar T, 2013, P NAT C PLANT PHYS 1, P383; Sharma KK, 2000, IN VITRO CELL DEV-PL, V36, P83, DOI 10.1007/s11627-000-0019-1; Shoba D, 2012, EUPHYTICA, V188, P265, DOI 10.1007/s10681-012-0718-9; Singh R, 2007, J SAT AGR RES, V5; Surekha C, 2014, PLANT CELL TISS ORG, V116, P27, DOI 10.1007/s11240-013-0378-z; TAHARA M, 1990, EUPHYTICA, V49, P255; Tang LL, 2013, PLANT PHYSIOL BIOCH, V71, P22, DOI 10.1016/j.plaphy.2013.06.024; Vadez V., 2007, Journal of SAT Agricultural Research, V5, P1; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Wang YC, 2010, J PLANT PHYSIOL, V167, P222, DOI 10.1016/j.jplph.2009.09.008; Wang Z, 2008, PLANT SOIL, V310, P137, DOI 10.1007/s11104-008-9641-1; Wilson RA, 2014, J ENVIRON BIOL, V35, P383; WRIGHT GC, 1994, CROP SCI, V34, P92, DOI 10.2135/cropsci1994.0011183X003400010016x; Xiao H, 2006, PLANT CELL ENVIRON, V29, P1410, DOI 10.1111/j.1365-3040.2006.01524.x; Yadav NS, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-188; Zhang HJ, 2009, MOL BREEDING, V23, P289, DOI 10.1007/s11032-008-9233-z; Zhao JS, 2007, PLANT CELL REP, V26, P1521, DOI 10.1007/s00299-007-0362-3	76	54	61	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e110507	10.1371/journal.pone.0110507	http://dx.doi.org/10.1371/journal.pone.0110507			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545786	Green Published, Green Submitted, gold			2022-12-27	WOS:000347120200001
J	Corominas-Murtra, B; Fuchs, B; Thurner, S				Corominas-Murtra, Bernat; Fuchs, Benedikt; Thurner, Stefan			Detection of the Elite Structure in a Virtual Multiplex Social System by Means of a Generalised K-Core	PLOS ONE			English	Article							COMPLEX NETWORKS; COMMUNITY STRUCTURE; ORGANIZATION; EMERGENCE; SOCIETY	Elites are subgroups of individuals within a society that have the ability and means to influence, lead, govern, and shape societies. Members of elites are often well connected individuals, which enables them to impose their influence to many and to quickly gather, process, and spread information. Here we argue that elites are not only composed of highly connected individuals, but also of intermediaries connecting hubs to form a cohesive and structured elite-subgroup at the core of a social network. For this purpose we present a generalization of the K-core algorithm that allows to identify a social core that is composed of well-connected hubs together with their 'connectors'. We show the validity of the idea in the framework of a virtual world defined by a massive multiplayer online game, on which we have complete information of various social networks. Exploiting this multiplex structure, we find that the hubs of the generalised K-core identify those individuals that are high social performers in terms of a series of indicators that are available in the game. In addition, using a combined strategy which involves the generalised K-core and the recently introduced M-core, the elites of the different 'nations' present in the game are perfectly identified as modules of the generalised K-core. Interesting sudden shifts in the composition of the elite cores are observed at deep levels. We show that elite detection with the traditional K-core is not possible in a reliable way. The proposed method might be useful in a series of more general applications, such as community detection.	[Corominas-Murtra, Bernat; Fuchs, Benedikt; Thurner, Stefan] Med Univ Vienna, Sect Sci Complex Syst, A-1090 Vienna, Austria; [Thurner, Stefan] Santa Fe Inst, Santa Fe, NM 87501 USA; [Thurner, Stefan] IIASA, A-2361 Laxenburg, Austria	Medical University of Vienna; The Santa Fe Institute; International Institute for Applied Systems Analysis (IIASA)	Thurner, S (corresponding author), Med Univ Vienna, Sect Sci Complex Syst, Spitalgasse 23, A-1090 Vienna, Austria.	stefan.thurner@meduniwien.ac.at		Corominas-Murtra, Bernat/0000-0001-9806-5643	Austrian Science Fund FWF [KPP23378FW]; EU LASAGNE project [318132]; MULTIPLEX project [318132]; EU; Austrian Science Fund (FWF) [P 23378] Funding Source: researchfish	Austrian Science Fund FWF(Austrian Science Fund (FWF)); EU LASAGNE project; MULTIPLEX project; EU(European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Funding provided by Austrian Science Fund FWF under KPP23378FW, http://www.fwf.ac.at/en/, EU LASAGNE project, no. 318132 and the EU http://lasagne-project.eu/ and MULTIPLEX project, no. 318132, http://www.multiplexproject.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bianconi G, 2006, EUROPHYS LETT, V74, P740, DOI 10.1209/epl/i2005-10574-3; Bianconi G, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.062806; Bollobas B., 1984, GRAPH THEORY COMBINA, P35; Bottomore T, 1993, ELITES SOC; Castronova Edward, 2005, SYNTHETIC WORLDS BUS; Colizza V, 2006, NAT PHYS, V2, P110, DOI 10.1038/nphys209; Colomer-de-Simon P, 2013, SCI REP-UK, V3, DOI 10.1038/srep02517; Corominas-Murtra B, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/18004; Corominas-Murtra B, 2008, J PHYS A-MATH THEOR, V41, DOI 10.1088/1751-8113/41/38/385003; Davidsen J, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.128701; Dorogovtsev SN, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.040601; Freeman LC, 1978, SOC NETWORKS, P215; FRIEDKIN NE, 1984, SOCIOL METHOD RES, V12, P235, DOI 10.1177/0049124184012003001; Fuchs B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103503; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; HARARY F, 1957, SOCIOMETRY, V20, P205, DOI 10.2307/2785673; Keller Suzanne, 1963, RULING CLASS; Klimek P, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/6/063008; Mills C. Wright, 1956, POWER ELITE; MILLS CW, 1958, BRIT J SOCIOL, V9, P29, DOI 10.2307/587620; Mucha PJ, 2010, SCIENCE, V328, P876, DOI 10.1126/science.1184819; Newman ME, 2001, PHYS REV E, V64; Nicosia V, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.058701; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Pierce William, 1967, WHO RULES AM, P17; RAPOPORT ANATOL, 1953, BULL MATH BIOPHYS, V15, P523, DOI 10.1007/BF02476440; SEIDMAN SB, 1983, SOC NETWORKS, V5, P269, DOI 10.1016/0378-8733(83)90028-X; Szell M, 2012, ADV COMPLEX SYST, V15, DOI 10.1142/S0219525912500646; Szell M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00457; Szell M, 2010, SOC NETWORKS, V32, P313, DOI 10.1016/j.socnet.2010.06.001; Szell M, 2010, P NATL ACAD SCI USA, V107, P13636, DOI 10.1073/pnas.1004008107; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478	34	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e112606	10.1371/journal.pone.0112606	http://dx.doi.org/10.1371/journal.pone.0112606			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX9RO	25541957	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000347239900005
J	Desta, AF; Assefa, F; Leta, S; Stomeo, F; Wamalwa, M; Njahira, M; Appolinaire, D				Desta, Adey Feleke; Assefa, Fassil; Leta, Seyoum; Stomeo, Francesca; Wamalwa, Mark; Njahira, Moses; Appolinaire, Djikeng			Microbial Community Structure and Diversity in an Integrated System of Anaerobic-Aerobic Reactors and a Constructed Wetland for the Treatment of Tannery Wastewater in Modjo, Ethiopia	PLOS ONE			English	Article							BACTERIAL COMMUNITY; BIOLOGICAL NITROGEN; PHOSPHORUS REMOVAL; CHROMIUM REMOVAL; DIFFERENT PLANTS; SP NOV.; DYNAMICS; EFFLUENT; PERFORMANCE	A culture-independent approach was used to elucidate the microbial diversity and structure in the anaerobic-aerobic reactors integrated with a constructed wetland for the treatment of tannery wastewater in Modjo town, Ethiopia. The system has been running with removal efficiencies ranging from 94%-96% for COD, 91%-100% for SO4(2-) and S2-, 92%-94% for BOD, 56%-82% for total Nitrogen and 2%-90% for NH3-N. 16S rRNA gene clone libraries were constructed and microbial community assemblies were determined by analysis of a total of 801 unique clone sequences from all the sites. Operational Taxonomic Unit (OTU) -based analysis of the sequences revealed highly diverse communities in each of the reactors and the constructed wetland. A total of 32 phylotypes were identified with the dominant members affiliated to Clostridia (33%), Betaproteobacteria (10%), Bacteroidia (10%), Deltaproteobacteria (9%) and Gammaproteobacteria (6%). Sequences affiliated to the class Clostridia were the most abundant across all sites. The 801 sequences were assigned to 255 OTUs, of which 3 OTUs were shared among the clone libraries from all sites. The shared OTUs comprised 80 sequences belonging to Clostridiales Family XIII Incertae Sedis, Bacteroidetes and unclassified bacterial group. Significantly different communities were harbored by the anaerobic, aerobic and rhizosphere sites of the constructed wetland. Numerous representative genera of the dominant bacterial classes obtained from the different sample sites of the integrated system have been implicated in the removal of various carbon-containing pollutants of natural and synthetic origins. To our knowledge, this is the first report of microbial community structure in tannery wastewater treatment plant from Ethiopia.	[Desta, Adey Feleke; Assefa, Fassil] Univ Addis Ababa, Inst Biotechnol, Addis Ababa, Ethiopia; [Leta, Seyoum] Univ Addis Ababa, Coll Nat Sci, Ctr Environm Sci, Addis Ababa, Ethiopia; [Stomeo, Francesca; Wamalwa, Mark; Njahira, Moses; Appolinaire, Djikeng] Biosci Eastern & Cent Africa Int Livestock Res Be, Nairobi, Kenya	Addis Ababa University; Addis Ababa University	Desta, AF (corresponding author), Univ Addis Ababa, Inst Biotechnol, Addis Ababa, Ethiopia.	adey.desta@gmail.com		Wamalwa, Mark/0000-0001-7714-2697; Djikeng, Appolinaire/0000-0001-9271-3419; Leta, Seyoum/0000-0003-3774-4663; Desta, Adey/0000-0001-6431-7363	Swedish International Development cooperation Agency (SIDA) via East African Regional Programme; Research Network for Biotechnology, Biosafety and Policy Development (BID-EARN); Syngenta Foundation for Sustainable Agriculture (SFSA) via biosciences Eastern and Central Africa (BecA)	Swedish International Development cooperation Agency (SIDA) via East African Regional Programme; Research Network for Biotechnology, Biosafety and Policy Development (BID-EARN); Syngenta Foundation for Sustainable Agriculture (SFSA) via biosciences Eastern and Central Africa (BecA)	Funding: Funding was provided by the Swedish International Development cooperation Agency (SIDA) via the East African Regional Programme and Research Network for Biotechnology, Biosafety and Policy Development (BID-EARN) and Syngenta Foundation for Sustainable Agriculture (SFSA) via the biosciences Eastern and Central Africa (BecA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER KTW, 1992, J SOC LEATH TECH CH, V76, P17; Amann R, 1998, FEMS MICROBIOL ECOL, V25, P205, DOI 10.1111/j.1574-6941.1998.tb00473.x; American Public Health Association (APHA), 1998, AM PHYS ED REV, V20th; Blackall LL, 2002, ANTON LEEUW INT J G, V81, P681, DOI 10.1023/A:1020538429009; Bosnic M, 2000, USRAS92120 UN IND DE, P17; Bruser T, 2000, J BIOL CHEM, V275, P1691, DOI 10.1074/jbc.275.3.1691; Burns AS, 2012, BIODEGRADATION, V23, P415, DOI 10.1007/s10532-011-9520-y; Calheiros CSC, 2010, WATER RES, V44, P5032, DOI 10.1016/j.watres.2010.07.017; Calheiros CSC, 2009, BIORESOURCE TECHNOL, V100, P3228, DOI 10.1016/j.biortech.2009.02.033; Castello E, 2011, WATER SCI TECHNOL, V64, P2265, DOI 10.2166/wst.2011.706; Cheng L, 2013, FEMS MICROBIOL ECOL, V85, P568, DOI 10.1111/1574-6941.12141; Collins B, 2004, ECOL ENG, V23, P107, DOI 10.1016/j.ecoleng.2004.07.005; Contzen M, 2000, SYST APPL MICROBIOL, V23, P487, DOI 10.1016/S0723-2020(00)80022-3; Dabert P, 2001, WATER SCI TECHNOL, V43, P1; Domingo JWS, 2011, BIOFOULING, V27, P993, DOI 10.1080/08927014.2011.618637; Dong YR, 2011, BIODEGRADATION, V22, P431, DOI 10.1007/s10532-010-9416-2; Dubbels BL, 2009, INT J SYST EVOL MICR, V59, P1576, DOI 10.1099/ijs.0.000638-0; Durai G., 2011, Journal of Environmental Science and Technology, V4, P1; EPA (Federal Environmental Protection Authority of Ethiopia), 2003, STAND IND POLL CON 3; Espinoza-Quinones FR, 2009, CHEM ENG J, V151, P59, DOI 10.1016/j.cej.2009.01.043; Gunther S, 2012, ENVIRON SCI TECHNOL, V46, P84, DOI 10.1021/es2010682; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Ibekwe AM, 2003, APPL ENVIRON MICROB, V69, P5060, DOI 10.1128/AEM.69.9.5060-5069.2003; Khan R, 2013, REV ENVIRON SCI BIO, V12, P75, DOI 10.1007/s11157-012-9287-6; Kleinsteuber S, 2006, APPL ENVIRON MICROB, V72, P3531, DOI 10.1128/AEM.72.5.3531-3542.2006; Koch C, 2013, NAT PROTOC, V8, P190, DOI 10.1038/nprot.2012.149; Krause L, 2008, J BIOTECHNOL, V136, P91, DOI 10.1016/j.jbiotec.2008.06.003; Lefebvre O, 2006, EXTREMOPHILES, V10, P505, DOI 10.1007/s00792-006-0524-1; Leta S, 2005, WORLD J MICROB BIOT, V21, P545, DOI 10.1007/s11274-004-3272-3; Leta S, 2004, APPL MICROBIOL BIOT, V66, P333, DOI 10.1007/s00253-004-1715-2; Leta S., 2003, ETHIOP J BIOL SCI, V2, P157; Li H, 2013, BIORESOURCE TECHNOL, V137, P286, DOI 10.1016/j.biortech.2013.02.050; Liang YM, 2012, ENVIRON TECHNOL, V33, P937, DOI 10.1080/09593330.2011.603362; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Martin HG, 2006, NAT BIOTECHNOL, V24, P1263, DOI 10.1038/nbt1247; Mbadinga SM, 2012, APPL MICROBIOL BIOT, V96, P531, DOI 10.1007/s00253-011-3828-8; Mekonnen Girma, 2003, P 10 ANN C ETH SOC A; Metcalf W, 1991, WASTEWATER ENG TREAT; Ministry of Trade and Industry (MoTI), 2008, EXP AGR PROD ETH; Paschoal FMM, 2009, J HAZARD MATER, V166, P531, DOI 10.1016/j.jhazmat.2008.11.058; Aguilar JRP, 2008, INT J PHYTOREMEDIAT, V10, P359, DOI 10.1080/15226510802100390; Paisio CE, 2012, ENVIRON SCI POLLUT R, V19, P3430, DOI 10.1007/s11356-012-0870-8; Preethi V, 2009, J HAZARD MATER, V166, P150, DOI 10.1016/j.jhazmat.2008.11.035; Rameshraja D, 2011, INT J ENVIRON RES, V5, P349; Ravenschlag K, 2001, APPL ENVIRON MICROB, V67, P387, DOI 10.1128/AEM.67.1.387-395.2001; Reemtsma T, 1997, WATER RES, V31, P1035, DOI 10.1016/S0043-1354(96)00382-X; Rittiruk U., 2011, International Journal of Agricultural Technology, V7, P215; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sheik CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040059; Sivaprakasam S, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-15; Song Z, 2004, DESALINATION, V164, P249, DOI 10.1016/S0011-9164(04)00193-6; Song Z, 2000, WATER RES, V34, P2171, DOI 10.1016/S0043-1354(99)00358-9; Tadesse I, 2003, WATER SCI TECHNOL, V48, P307, DOI 10.2166/wst.2003.0135; Tiglyene S, 2008, ENVIRON TECHNOL, V29, P613, DOI 10.1080/09593330801983888; UNEP (United Nations Environment Program), 1991, UNEP IEO UN PUBL SER, VIII; Vyrides I, 2011, ENVIRON ENG SCI, V28, P661, DOI 10.1089/ees.2010.0431; WANG BZ, 1991, WATER SCI TECHNOL, V24, P9, DOI 10.2166/wst.1991.0107; Wang L, 2006, WATER SCI TECHNOL, V54, P429, DOI 10.2166/wst.2006.923; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Zhang LL, 2012, AFR J MICROBIOL RES, V6, P6444, DOI 10.5897/AJMR12.718	60	33	34	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115576	10.1371/journal.pone.0115576	http://dx.doi.org/10.1371/journal.pone.0115576			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541981	Green Published, Green Submitted, gold			2022-12-27	WOS:000347239900053
J	Liegl, R; Langer, J; Seidensticker, F; Reznicek, L; Haritoglou, C; Ulbig, MW; Neubauer, AS; Kampik, A; Kernt, M				Liegl, Raffael; Langer, Julian; Seidensticker, Florian; Reznicek, Lukas; Haritoglou, Christos; Ulbig, Michael W.; Neubauer, Aljoscha S.; Kampik, Anselm; Kernt, Marcus			Comparative Evaluation of Combined Navigated Laser Photocoagulation and Intravitreal Ranibizumab in the Treatment of Diabetic Macular Edema	PLOS ONE			English	Article								Objective: To evaluate if a standardized combination therapy regimen, utilizing 3 monthly ranibizumab injections followed by navigated laser photocoagulation, reduces the number of total ranibizumab injections required for treatment of diabetic macular edema (DME). Research Design and Methods: A 12-month, prospective comparison of 66 patients with center-involving DME: 34 patients with combination therapy were compared to 32 patients treated with ranibizumab monotherapy. All patients initially received 3 monthly ranibizumab injections (loading phase) and additional injections pro re nata (PRN). Combination therapy patients additionally received navigated laser photocoagulation after the loading phase. Main outcome measures were mean number of injections after the loading phase and change in BCVA from baseline to month 12. Results: Navigated laser combination therapy and ranibizumab monotherapy similarly improved mean BCVA letter score (+8.41 vs. +6.31 letters, p=0.258). In the combination group significantly less injections were required after the 3 injection loading phase (0.88 +/- 1.23 vs. 3.88 +/- 2.32, p<=0.001). By month 12, 84% of patients in the monotherapy group had required additional ranibizumab injections as compared to 35% in the combination group (p<=0.001). Conclusions: Navigated laser combination therapy demonstrated significant visual gains in most patients. Retreatment rate and number of injections were significantly lower compared to ranibizumab monotherapy and compared to the results of conventional laser combination therapy previously reported in pivotal anti-VEGF studies.	[Liegl, Raffael; Langer, Julian; Seidensticker, Florian; Reznicek, Lukas; Haritoglou, Christos; Ulbig, Michael W.; Neubauer, Aljoscha S.; Kampik, Anselm; Kernt, Marcus] Univ Munich, Dept Ophthalmol, Munich, Germany	University of Munich	Kernt, M (corresponding author), Univ Munich, Dept Ophthalmol, Munich, Germany.	Marcus.Kernt@med.uni-muenchen.de						Bandello F, 2012, EYE, V26, P485, DOI 10.1038/eye.2011.337; Bandello F, 2013, ACTA DIABETOL; Barteselli G, 2014, BR J OPHTHALMOL; Brynskov T, 2013, ACTA OPHTHALMOL, V91, pE243, DOI 10.1111/aos.12014; Chen E, 2010, CURR MED RES OPIN, V26, P1587, DOI 10.1185/03007995.2010.482503; Cohen SY, 2009, AM J OPHTHALMOL, V148, P409, DOI 10.1016/j.ajo.2009.04.001; Do DV, 2012, ARCH OPHTHALMOL-CHIC, P1; Elman MJ, 2010, OPHTHALMOLOGY, V117, P1064, DOI 10.1016/j.ophtha.2010.02.031; Kernt M, 2012, CLIN OPHTHALMOL, V6, P289, DOI 10.2147/OPTH.S27859; Kernt M, 2013, DIABETES RES CLIN PR, V100, pE11, DOI 10.1016/j.diabres.2013.01.006; Kernt M, 2011, ACTA OPHTHALMOL, V89, pe662, DOI 10.1111/j.1755-3768.2010.02017.x; Kozak I, 2011, OPHTHALMOLOGY, V118, P1119, DOI 10.1016/j.ophtha.2010.10.007; Massin P, 2010, DIABETES CARE, V33, P2399, DOI 10.2337/dc10-0493; Mitchell P, 2011, OPHTHALMOLOGY, V118, P615, DOI 10.1016/j.ophtha.2011.01.031; Neubauer AS, 2013, CLIN OPHTHALMOL, V7, P121, DOI 10.2147/OPTH.S38559; Ober MD, 2013, GRAEF ARCH CLIN EXP, V251, P1049, DOI 10.1007/s00417-012-2119-0; PATZ A, 1985, ARCH OPHTHALMOL-CHIC, V103, P1796, DOI 10.1001/archopht.1985.01050120030015; Nguyen QD, 2012, OPHTHALMOLOGY, V119, P789, DOI 10.1016/j.ophtha.2011.12.039; Quan DN, 2010, OPHTHALMOLOGY, V117, P2146, DOI 10.1016/j.ophtha.2010.08.016	19	33	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e113981	10.1371/journal.pone.0113981	http://dx.doi.org/10.1371/journal.pone.0113981			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541960	Green Submitted, Green Published, gold			2022-12-27	WOS:000347239900008
J	Liu, J; Wang, XB; Ren, YW; Li, XL; Zhang, XC; Zhou, BS				Liu, Jing; Wang, Xiaobo; Ren, Yangwu; Li, Xuelian; Zhang, Xichen; Zhou, Baosen			Effect of Single Nucleotide Polymorphism Rs189037 in ATM Gene on Risk of Lung Cancer in Chinese: A Case-Control Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BREAST-CANCER; DNA; SUSCEPTIBILITY; SMOKING; PATHWAY; TRANSCRIPTION; POPULATION; ACTIVATION; VARIANTS	Background: Accumulated evidence has indicated that ataxia-telangiectasia mutated (ATM) gene polymorphisms are closely related to lung cancer. We aimed to explore the prognostic value of rs189037 (G>A), one of ATM single nucleotide polymorphisms (SNPs), and detect whether it involves in the risk of lung cancer in Chinese Han people. Methods: In this hospital-based matched case-control study, 852 lung cancer patients and 852 healthy controls have been put into comparison to analyze the association between rs189037 and lung cancer risk in Chinese. The single nucleotide polymorphisms were determined by TaqMan real-time PCR and we used SPSS software to perform the statistical analyses. Results: Individuals carrying variant AA genotype of rs189037 had higher lung cancer risk (adjusted OR: 1.56) than those carrying GG genotype. After analyzing data respectively from different groups divided by genders and smoking status, we observed that the risk effect of AA genotype on the lung cancer was significant in females, non-smokers and female non-smokers, as well as the risk effect of GA genotype in male smokers. Compared with non-smokers carrying GG genotype, smokers carrying at least one A allele had higher risk of developing lung cancer than those with GG genotype (adjusted OR: 3.52 vs. adjusted OR: 2.53). Conclusions: This study suggested that rs189037 (G>A) polymorphism is associated with lung cancer risk in Chinese Han population. AA genotype and A allele may be dangerous lung cancer signals in Chinese and make contribution to diagnostic and treatment value.	[Liu, Jing; Wang, Xiaobo; Ren, Yangwu; Li, Xuelian; Zhang, Xichen; Zhou, Baosen] China Med Univ, Sch Publ Hlth, Dept Epidemiol, Shenyang 110001, Liaoning Provin, Peoples R China; [Liu, Jing; Wang, Xiaobo; Ren, Yangwu; Li, Xuelian; Zhang, Xichen; Zhou, Baosen] Univ Liaoning Prov, Key Lab Canc Etiol & Intervent, Shenyang, Peoples R China; [Liu, Jing; Wang, Xiaobo] China Med Univ, Clin Med Seven Syst, Shenyang, Peoples R China	China Medical University; China Medical University	Zhou, BS (corresponding author), China Med Univ, Sch Publ Hlth, Dept Epidemiol, Shenyang 110001, Liaoning Provin, Peoples R China.	bszhou@mail.cmu.edu.cn			National Natural Science Foundation of China [81272293]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grant no. 81272293 from National Natural Science Foundation of China; BZ received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bau DT, 2010, LARYNGOSCOPE, V120, P2417, DOI 10.1002/lary.21009; Bridevaux Pierre-Olivier, 2006, Rev Med Suisse, V2, P2611; Broderick P, 2009, CANCER RES, V69, P6633, DOI 10.1158/0008-5472.CAN-09-0680; Chen T, 2010, MECH AGEING DEV, V131, P636, DOI 10.1016/j.mad.2010.08.009; Chen Wanqing, 2010, Zhongguo Fei Ai Za Zhi, V13, P488, DOI 10.3779/j.issn.1009-3419.2010.05.20; Dong J, 2012, MOL CARCINOGEN, V51, P546, DOI 10.1002/mc.20819; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; Hsia TC, 2013, ANTICANCER RES, V33, P4067; Ito H, 2012, J THORAC ONCOL, V7, P790, DOI 10.1097/JTO.0b013e3182475028; Khalil HS, 2012, EXP BIOL MED, V237, P622, DOI 10.1258/ebm.2012.011378; Khalil HS, 2011, CURR OPIN BIOTECH, V22, pS115, DOI 10.1016/j.copbio.2011.05.374; Kim JH, 2006, HUM MOL GENET, V15, P1181, DOI 10.1093/hmg/ddl033; Kwasniewska Magdalena, 2003, Pol Merkur Lekarski, V15, P559; LEASK A, 1991, P NATL ACAD SCI USA, V88, P7948, DOI 10.1073/pnas.88.18.7948; Li YF, 2010, LANCET ONCOL, V11, P321, DOI 10.1016/S1470-2045(10)70042-5; Li ZX, 2013, FERTIL STERIL, V100, P1536, DOI 10.1016/j.fertnstert.2013.07.1995; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; Lo YL, 2010, LUNG CANCER, V69, P148, DOI 10.1016/j.lungcan.2009.11.007; Lou JL, 2006, TOXICOLOGY, V224, P138, DOI 10.1016/j.tox.2006.04.040; Mu LN, 2013, CANCER CAUSE CONTROL, V24, P439, DOI 10.1007/s10552-012-0130-8; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Prokopcova J, 2007, BREAST CANCER RES TR, V104, P121, DOI 10.1007/s10549-006-9406-6; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Schneider J, 2008, ARCH MED RES, V39, P226, DOI 10.1016/j.arcmed.2007.08.004; Shen L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096911; Shen L, 2012, MOL BIOL REP, V39, P5719, DOI 10.1007/s11033-011-1381-2; Shields PG, 2002, ONCOGENE, V21, P6870, DOI 10.1038/sj.onc.1205832; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Talukder KA, 2012, MICROB PATHOGENESIS, V52, P311, DOI 10.1016/j.micpath.2012.02.007; Tang L, 2010, ENVIRON HEALTH PERSP, V118, P1257, DOI 10.1289/ehp.0901587; Van Dyck E, 1999, NATURE, V398, P728, DOI 10.1038/43942; Wang HC, 2010, ANTICANCER RES, V30, P5217; Williams RS, 2007, BIOCHEM CELL BIOL, V85, P509, DOI 10.1139/O07-069; Xiong HH, 2013, INT J RADIAT ONCOL, V85, P1066, DOI 10.1016/j.ijrobp.2012.09.024; Xu L, 2012, J CLIN ENDOCR METAB, V97, P1913, DOI 10.1210/jc.2011-3299; Yang DQ, 2011, DRUG DISCOV TODAY, V16, P332, DOI 10.1016/j.drudis.2011.02.001; Yang HS, 2007, INT J CANCER, V121, P2254, DOI 10.1002/ijc.22918	38	19	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115845	10.1371/journal.pone.0115845	http://dx.doi.org/10.1371/journal.pone.0115845			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541996	Green Submitted, Green Published, gold			2022-12-27	WOS:000347239900096
J	Slattery, ML; Lundgreen, A				Slattery, Martha L.; Lundgreen, Abbie			The Influence of the CHIEF Pathway on Colorectal Cancer-Specific Mortality	PLOS ONE			English	Article							PROTEIN-KINASE CASCADE; INSULIN-RELATED GENES; HUMAN BREAST-CANCER; LIFE-STYLE FACTORS; RECTAL-CANCER; COLON-CANCER; TUMOR ANGIOGENESIS; ENERGY-BALANCE; MICROSATELLITE INSTABILITY; PHYSICAL-ACTIVITY	Many components of the CHIEF (Convergence of Hormones, Inflammation, and Energy Related Factors) pathway could influence survival given their involvement in cell growth, apoptosis, angiogenesis, and tumor invasion stimulation. We used ARTP (Adaptive Rank Truncation Product) to test if genes in the pathway were associated with colorectal cancer-specific mortality. Colon cancer (n=1555) and rectal cancer (n=754) cases were followed over five years. Age, center, stage at diagnosis, and tumor molecular phenotype were considered when calculating ARTP p values. A polygenic risk score was used to summarize the magnitude of risk associated with this pathway. The JAK/STAT/SOC was significant for colon cancer survival (P-ARTP=0.035). Fifteen genes (DUSP2, INFGR1, IL6, IRF2, JAK2, MAP3K10, MMP1, NFkB1A, NOS2A, PIK3CA, SEPX1, SMAD3, TLR2, TYK2, and VDR) were associated with colon cancer mortality (P-ARTP<0.05); JAK2 (P-ARTP =0.0086), PIK3CA (P-ARTP=0.0098), and SMAD3 (P-ARTP=0.0059) had the strongest associations. Over 40 SNPs were significantly associated with survival within the 15 significant genes (P-ARTP<0.05). SMAD3 had the strongest association with survival (HRGG 2.46 95% CI 1.44,4.21 P-Ttrnd=0.0002). Seven genes (IL2RA, IL8RA, IL8RB, IRF2, RAF1, RUNX3, and SEPX1) were significantly associated with rectal cancer (P-ARTP<0.05). The HR for colorectal cancer-specific mortality among colon cancer cases in the upper at-risk alleles group was 11.81 (95% CI 7.07, 19. 74) and was 10.99 (95% CI 5.30, 22.78) for rectal cancer. These results suggest that several genes in the CHIEF pathway are important for colorectal cancer survival; the risk associated with the pathway merits validation in other studies.	[Slattery, Martha L.; Lundgreen, Abbie] Univ Utah, Dept Internal Med, Hlth Sci Ctr, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Slattery, ML (corresponding author), Univ Utah, Dept Internal Med, Hlth Sci Ctr, 383 Colorow Bldg, Salt Lake City, UT 84112 USA.	marty.slattery@hsc.utah.edu			National Institute of Health [CA48998]; NATIONAL CANCER INSTITUTE [R01CA048998, U01CA048998] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding was provided by the National Institute of Health (CA48998), which had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1998, BBA-MOL CELL BIOL L, V1436, P151, DOI 10.1016/S0005-2760(98)00133-7; Guervsos MA, 2007, CELL ONCOL, V29, P327; Caan BJ, 1998, INT J OBESITY, V22, P178, DOI 10.1038/sj.ijo.0800561; Carling D, 2004, CURR BIOL, V14, pR220, DOI 10.1016/j.cub.2004.02.048; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Ditsch N, 2012, J HISTOCHEM CYTOCHEM, V60, P121, DOI 10.1369/0022155411429155; Fedirko V, 2012, CANCER EPIDEM BIOMAR, V21, P582, DOI 10.1158/1055-9965.EPI-11-1065; Forsti A, 2010, GENE CHROMOSOME CANC, V49, P270, DOI 10.1002/gcc.20738; Gordon KJ, 2008, BBA-MOL BASIS DIS, V1782, P197, DOI 10.1016/j.bbadis.2008.01.006; Gunter MJ, 2006, CANCER EPIDEM BIOMAR, V15, P1126, DOI 10.1158/1055-9965.EPI-06-0042; Habermann N, 2013, GENES NUTR, V8, P115, DOI 10.1007/s12263-012-0302-x; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Hsieh FC, 2005, BIOCHEM BIOPH RES CO, V335, P292, DOI 10.1016/j.bbrc.2005.07.075; Isaksson-Mettavainio M, 2006, ANTICANCER RES, V26, P507; Jacobs EJ, 2005, JNCI-J NATL CANCER I, V97, P975, DOI 10.1093/jnci/dji173; Lee DF, 2007, CELL CYCLE, V6, P3011, DOI 10.4161/cc.6.24.5085; Lee DF, 2007, CELL, V130, P440, DOI 10.1016/j.cell.2007.05.058; Lee SJ, 2014, ANN SURG ONCOL; Miteva LD, 2014, TUMOUR BIOL; Murtaugh MA, 2006, NUTR CANCER, V55, P35, DOI 10.1207/s15327914nc5501_5; Nakanishi C, 2004, ONCOLOGY-BASEL, V67, P476, DOI 10.1159/000082933; Ono M, 2008, CANCER SCI, V99, P1501, DOI 10.1111/j.1349-7006.2008.00853.x; Park J, 2012, INVEST NEW DRUG, V30, P1404, DOI 10.1007/s10637-011-9710-9; Przybylowska K, 2006, BREAST CANCER RES TR, V95, P65, DOI 10.1007/s10549-005-9042-6; Puri MC, 2003, P NATL ACAD SCI USA, V100, P12753, DOI 10.1073/pnas.2133552100; Samowitz WS, 2001, CANCER EPIDEM BIOMAR, V10, P917; Samowitz WS, 2005, GASTROENTEROLOGY, V129, P837, DOI 10.1053/j.gastro.2005.06.020; Scharf PJ, 2004, PROTEIN SCI, V13, P2541, DOI 10.1110/ps.04884704; Slattery ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037312; Slattery ML, 2012, MUTAT RES-FUND MOL M, V734, P30, DOI 10.1016/j.mrfmmm.2012.04.002; Slattery ML, 2009, CANCER PREV RES, V2, P922, DOI 10.1158/1940-6207.CAPR-08-0191; Slattery ML, 2009, DIS COLON RECTUM, V52, P1304, DOI 10.1007/DCR.0b013e3181a0e5df; Slattery ML, 2000, J NATL CANCER I, V92, P1831, DOI 10.1093/jnci/92.22.1831; Slattery ML, 1997, CANCER RES, V57, P75; Slattery ML, 2003, NUTR CANCER, V46, P166, DOI 10.1207/S15327914NC4602_09; Slattery ML, 2003, AM J EPIDEMIOL, V158, P214, DOI 10.1093/aje/kwg134; Slattery ML, 2006, CANCER CAUSE CONTROL, V17, P239, DOI 10.1007/s10552-005-0411-6; Slattery ML, 2005, INT J CANCER, V115, P148, DOI 10.1002/ijc.20843; Slattery ML, 2013, MOL CARCINOG; Slattery ML, 2014, CARCINOGENESIS; Tekautz TM, 2006, BBA-MOL CELL RES, V1763, P1000, DOI 10.1016/j.bbamcr.2006.06.014; Ting WC, 2013, J KOREAN MED SCI, V28, P1302, DOI 10.3346/jkms.2013.28.9.1302; Tsamandas AC, 2004, STRAHLENTHER ONKOL, V180, P201, DOI 10.1007/s00066-004-1149-x; Viollet B, 2003, BIOCHEM SOC T, V31, P216, DOI 10.1042/bst0310216; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Waldner MJ, 2010, J EXP MED, V207, P2855, DOI 10.1084/jem.20100438; Watson CJ, 2000, CYTOKINE, V12, P1232, DOI 10.1006/cyto.2000.0692; Wink DA, 1998, CARCINOGENESIS, V19, P711, DOI 10.1093/carcin/19.5.711; Xie W, 2003, CANCER J, V9, P302, DOI 10.1097/00130404-200307000-00013; Xiong H, 2008, NEOPLASIA, V10, P287, DOI 10.1593/neo.07971; Yang HA, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-92; Yu K, 2009, GENET EPIDEMIOL, V33, P700, DOI 10.1002/gepi.20422; Zgaga L, 2014, J CLIN ONCOL	54	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e116169	10.1371/journal.pone.0116169	http://dx.doi.org/10.1371/journal.pone.0116169			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541970	Green Published, Green Submitted, gold			2022-12-27	WOS:000347239900155
J	Wong, CCL; Au, SLK; Tse, APW; Xu, IMJ; Lai, RKH; Chiu, DKC; Wei, LL; Fan, DNY; Tsang, FHC; Lo, RCL; Wong, CM; Ng, IOL				Wong, Carmen Chak-Lui; Au, Sandy Leung-Kuen; Tse, Aki Pui-Wah; Xu, Iris Ming-Jing; Lai, Robin Kit-Ho; Chiu, David Kung-Chun; Wei, Larry Lai; Fan, Dorothy Ngo-Yin; Tsang, Felice Ho-Ching; Lo, Regina Cheuk-Lam; Wong, Chun-Ming; Ng, Irene Oi-Lin			Switching of Pyruvate Kinase Isoform L to M2 Promotes Metabolic Reprogramming in Hepatocarcinogenesis	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; CANCER CELLS; TUMOR-GROWTH; MICRORNA-122; REGULATOR; HYPOXIA; MIRNAS; GENE	Hepatocellular carcinoma (HCC) is an aggressive tumor, with a high mortality rate due to late symptom presentation and frequent tumor recurrences and metastasis. It is also a rapidly growing tumor supported by different metabolic mechanisms; nevertheless, the biological and molecular mechanisms involved in the metabolic reprogramming in HCC are unclear. In this study, we found that pyruvate kinase M2 (PKM2) was frequently over-expressed in human HCCs and its over-expression was associated with aggressive clinicopathological features and poor prognosis of HCC patients. Furthermore, knockdown of PKM2 suppressed aerobic glycolysis and cell proliferation in HCC cell lines in vitro. Importantly, knockdown of PKM2 hampered HCC growth in both subcutaneous injection and orthotopic liver implantation models, and reduced lung metastasis in vivo. Of significance, PKM2 over-expression in human HCCs was associated with a down-regulation of a liver-specific microRNA, miR-122. We further showed that miR-122 interacted with the 3UTR of the PKM2 gene. Re-expression of miR-122 in HCC cell lines reduced PKM2 expression, decreased glucose uptake in vitro, and suppressed HCC tumor growth in vivo. Our clinical data and functional studies have revealed a novel biological mechanism involved in HCC metabolic reprogramming.	[Wong, Carmen Chak-Lui; Au, Sandy Leung-Kuen; Tse, Aki Pui-Wah; Xu, Iris Ming-Jing; Lai, Robin Kit-Ho; Chiu, David Kung-Chun; Wei, Larry Lai; Fan, Dorothy Ngo-Yin; Tsang, Felice Ho-Ching; Lo, Regina Cheuk-Lam; Wong, Chun-Ming; Ng, Irene Oi-Lin] Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Wong, Carmen Chak-Lui; Lo, Regina Cheuk-Lam; Wong, Chun-Ming; Ng, Irene Oi-Lin] Univ Hong Kong, State Key Lab Liver Res, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Wong, CCL (corresponding author), Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China.	carmencl@pathology.hku.hk; iolng@hku.hk	Fan, Dorothy Ngo-yin/AAQ-2998-2020; WONG, Chun-Ming/A-6739-2009; Wong, Carmen Chak Lui/C-4660-2009; Lo, Cheuk Lam Regina/E-9874-2010	WONG, Chun-Ming/0000-0002-2497-7858; Wong, Carmen Chak Lui/0000-0001-5866-4705; Xu, Mingjing/0000-0002-9128-1172; Ng, Irene Oi-lin/0000-0001-7532-2029; Lo, Cheuk Lam Regina/0000-0001-6213-0343; Chiu, David Kung-Chun/0000-0002-9700-4707	University of Hong Kong [20120159055]; Hong Kong Research Grants Council Collaborative Research Fund [HKU 7/CRG/09]; SK Yee Medical Research Fund	University of Hong Kong(University of Hong Kong); Hong Kong Research Grants Council Collaborative Research Fund(Hong Kong Research Grants Council); SK Yee Medical Research Fund	This work was partly funded by Seed Funding Program for Basic Research Project Funding of the University of Hong Kong (20120159055) and Hong Kong Research Grants Council Collaborative Research Fund (HKU 7/CRG/09)) and SK Yee Medical Research Fund 2011. I.O.L. Ng is Loke Yew Professor in Pathology.	Anastasiou D, 2012, NAT CHEM BIOL, V8, P839, DOI 10.1038/NCHEMBIO.1060; Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Burchard J, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.58; Chan SY, 2009, CELL METAB, V10, P273, DOI 10.1016/j.cmet.2009.08.015; Chen YH, 2013, MIRNA 93 INHIBITS GL; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Hatziapostolou M, 2013, TRENDS ENDOCRIN MET, V24, P361, DOI 10.1016/j.tem.2013.03.002; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Horie T, 2009, BIOCHEM BIOPH RES CO, V389, P315, DOI 10.1016/j.bbrc.2009.08.136; Israelsen WJ, 2013, CELL, V155, P397, DOI 10.1016/j.cell.2013.09.025; Jung CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027740; Kim N, 2011, HEPATOL RES, V41, P170, DOI 10.1111/j.1872-034X.2010.00752.x; Lim JY, 2012, WORLD J GASTROENTERO, V18, P4037, DOI 10.3748/wjg.v18.i30.4037; Liu AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086872; Lv L, 2011, MOL CELL, V42, P719, DOI 10.1016/j.molcel.2011.04.025; NG IOL, 1995, CANCER, V76, P2443, DOI 10.1002/1097-0142(19951215)76:12<2443::AID-CNCR2820761207>3.0.CO;2-F; NOGUCHI T, 1987, J BIOL CHEM, V262, P14366; Tsai WC, 2012, J CLIN INVEST, V122, P2884, DOI 10.1172/JCI63455; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wong CCL, 2011, P NATL ACAD SCI USA, V108, P16369, DOI 10.1073/pnas.1113483108; Zhang H, 2012, ONCOGENE, V31, P1757, DOI 10.1038/onc.2011.365; Zhou CF, 2012, IUBMB LIFE, V64, P775, DOI 10.1002/iub.1066	29	41	42	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115036	10.1371/journal.pone.0115036	http://dx.doi.org/10.1371/journal.pone.0115036			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541689	Green Published, gold, Green Submitted			2022-12-27	WOS:000347239900019
J	Anzar, M; Grochulski, P; Bonnet, B				Anzar, Muhammad; Grochulski, Pawel; Bonnet, Brennan			Synchrotron X-Ray Diffraction to Detect Glass or Ice Formation in the Vitrified Bovine Cumulus-Oocyte Complexes and Morulae	PLOS ONE			English	Article							HIGH SURVIVAL RATE; EMBRYO CRYOPRESERVATION; OPS VITRIFICATION; FROZEN SYSTEMS; COOLING RATE; FERTILIZATION; MATURATION; CRYOPROTECTANTS; QUANTIFICATION; DIFFRACTOMETRY	Vitrification of bovine cumulus-oocyte complexes (COCs) is not as successful as bovine embryos, due to oocyte's complex structure and chilling sensitivity. Synchrotron X-ray diffraction (SXRD), a powerful method to study crystal structure and phase changes, was used to detect the glass or ice formation in water, tissue culture medium (TCM)-199, vitrification solution 2 (VS2), and vitrified bovine COCs and morulae. Data revealed Debye's rings and peaks associated with the hexagonal ice crystals at 3.897, 3.635, 3.427, 2.610, 2.241, 1.912 and 1.878 A in both water and TCM-199, whereas VS2 showed amorphous (glassy) appearance, at 102K (2171 degrees C). An additional peak of sodium phosphate monobasic hydrate (NaH2PO4. H2O) crystals was observed at 2.064 A degrees in TCM-199 only. All ice and NaH2PO4. H2O peaks were detected in the non-vitrified (control) and vitrified COCs, except two ice peaks (3.145 and 2.655 angstrom) were absent in the vitrified COCs. The intensities of majority of ice peaks did not differ between the non-vitrified and vitrified COCs. The non-vitrified bovine morulae in TCM-199 demonstrated all iceand NaH2PO4. H2O-associated Debye's rings and peaks, found in TCM-199 alone. There was no Debye's ring present in the vitrified morulae. In conclusion, SXRD is a powerful method to confirm the vitrifiability of a solution and to detect the glass or ice formation in vitrified cells and tissues. The vitrified bovine COCs exhibited the hexagonal ice crystals instead of glass formation whereas the bovine morulae underwent a typical vitrification.	[Anzar, Muhammad] Agr & Agri Food Canada, Saskatoon Res Ctr, Canadian Anim Genet Resource Program, Cryobiol Lab, Saskatoon, SK, Canada; [Anzar, Muhammad] Univ Saskatchewan, Dept Vet Biomed Sci, Saskatoon, SK, Canada; [Grochulski, Pawel; Bonnet, Brennan] Canadian Light Source, Saskatoon, SK, Canada	University of Saskatchewan; University of Saskatchewan	Anzar, M (corresponding author), Agr & Agri Food Canada, Saskatoon Res Ctr, Canadian Anim Genet Resource Program, Cryobiol Lab, Saskatoon, SK, Canada.	Muhammad.Anzar@agr.gc.ca		Anzar, Muhammad/0000-0001-8379-8852	Canadian Animal Genetic Resource Program	Canadian Animal Genetic Resource Program	This study was financially supported by the Canadian Animal Genetic Resource Program, Agriculture and Agri-Food Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2005, BIOL REPROD, V72, P1416, DOI 10.1095/biolreprod.104.037051; Albarracin JL, 2005, MOL REPROD DEV, V72, P239, DOI 10.1002/mrd.20326; Arav A, 2014, THERIOGENOLOGY, V81, P96, DOI 10.1016/j.theriogenology.2013.09.011; ARAV A, 1993, J REPROD FERTIL, V99, P353, DOI 10.1530/jrf.0.0990353; Arav A, 2014, REPROD FERT DEVELOP, V26, P83, DOI 10.1071/RD13295; BRACKETT BG, 1975, BIOL REPROD, V12, P260, DOI 10.1095/biolreprod12.2.260; Chian RC, 2004, J REPROD DEVELOP, V50, P685, DOI 10.1262/jrd.50.685; Diez C, 2005, THERIOGENOLOGY, V64, P317, DOI 10.1016/j.theriogenology.2004.11.023; DOWELL LG, 1960, NATURE, V188, P1144, DOI 10.1038/1881144a0; Fodje M, 2012, J SYNCHROTRON RADIAT, V19, P274, DOI 10.1107/S0909049511056305; FUKU E, 1992, CRYOBIOLOGY, V29, P485, DOI 10.1016/0011-2240(92)90051-3; Grochulski Pawel, 2012, Journal of Structural and Functional Genomics, V13, P49, DOI 10.1007/s10969-012-9123-9; Grochulski P, 2011, J SYNCHROTRON RADIAT, V18, P681, DOI 10.1107/S0909049511019431; Hammersley AP, 1996, HIGH PRESSURE RES, V14, P235, DOI 10.1080/08957959608201408; HUNTER JE, 1995, HUM REPROD, V10, P1184, DOI 10.1093/oxfordjournals.humrep.a136115; Hyttel P, 2000, MOL REPROD DEV, V56, P80, DOI 10.1002/(SICI)1098-2795(200005)56:1&lt;80::AID-MRD10&gt;3.0.CO;2-U; Kasai M, 2002, HUM REPROD, V17, P1863, DOI 10.1093/humrep/17.7.1863; Kasai N, 2010, XRAY DIFFRACTION MAC; Kuwayama M, 2007, THERIOGENOLOGY, V67, P73, DOI 10.1016/j.theriogenology.2006.09.014; Larman Mark G, 2014, Methods Mol Biol, V1092, P153, DOI 10.1007/978-1-60327-292-6_10; Leibo SP, 2008, THERIOGENOLOGY, V69, P37, DOI 10.1016/j.theriogenology.2007.10.006; LEIBO SP, 1975, CRYOBIOLOGY, V12, P579, DOI 10.1016/0011-2240(75)90123-6; Liebermann Juergen, 2003, Reprod Biomed Online, V7, P623; Martino A, 1996, BIOL REPROD, V54, P1059, DOI 10.1095/biolreprod54.5.1059; Massip A, 2003, REPROD NUTR DEV, V43, P325, DOI 10.1051/rnd:2003024; MAZUR P, 1970, SCIENCE, V168, P939, DOI 10.1126/science.168.3934.939; Men HS, 2002, THERIOGENOLOGY, V57, P1095, DOI 10.1016/S0093-691X(01)00679-3; Minasi MG, 2012, FERTIL STERIL, V97, P1220, DOI 10.1016/j.fertnstert.2012.02.022; Morato R, 2008, MOL REPROD DEV, V75, P1318, DOI 10.1002/mrd.20873; NAKAGATA N, 1989, J REPROD FERTIL, V87, P479, DOI 10.1530/jrf.0.0870479; Nunes C, 2005, PHARM RES-DORDR, V22, P1942, DOI 10.1007/s11095-005-7626-9; PARRISH JJ, 1995, THERIOGENOLOGY, V44, P859, DOI 10.1016/0093-691X(95)00271-9; Pereira RM, 2008, CELL TISSUE BANK, V9, P267, DOI 10.1007/s10561-008-9075-2; Prentice JR, 2011, THERIOGENOLOGY, V75, P602, DOI 10.1016/j.theriogenology.2010.09.027; Prentice Jennifer R, 2010, Vet Med Int, V2011, DOI 10.4061/2011/146405; Prentice-Biensch JR, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-73; RALL WF, 1985, NATURE, V313, P573, DOI 10.1038/313573a0; Saragusty J, 2011, REPRODUCTION, V141, P1, DOI 10.1530/REP-10-0236; Seki S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036058; Shaw JM, 2000, THERIOGENOLOGY, V53, P59, DOI 10.1016/S0093-691X(99)00240-X; Snell EH, 2007, J SYNCHROTRON RADIAT, V14, P109, DOI 10.1107/S090904950604605X; Vajta G, 1998, MOL REPROD DEV, V51, P53, DOI 10.1002/(SICI)1098-2795(199809)51:1&lt;53::AID-MRD6&gt;3.0.CO;2-V; Varshney DB, 2006, PHARM RES-DORDR, V23, P2368, DOI 10.1007/s11095-006-9051-0; Varshney DB, 2009, J PHYS CHEM B, V113, P6177, DOI 10.1021/jp900404m; Varshney DB, 2009, PHARM RES-DORDR, V26, P1596, DOI 10.1007/s11095-009-9868-4; Weiss ADH, 2010, CRYOBIOLOGY, V61, P123, DOI 10.1016/j.cryobiol.2010.05.008; Will G., 2006, POWDER DIFFRACTION R; Wu B, 1999, MOL REPROD DEV, V54, P388, DOI 10.1002/(SICI)1098-2795(199912)54:4&lt;388::AID-MRD9&gt;3.0.CO;2-7; Yang CY, 2013, CRYOBIOLOGY, V67, P7, DOI 10.1016/j.cryobiol.2013.04.003; Yavin S, 2007, THERIOGENOLOGY, V67, P81, DOI 10.1016/j.theriogenology.2006.09.029; Zhou XL, 2010, CRYOBIOLOGY, V61, P66, DOI 10.1016/j.cryobiol.2010.05.002	51	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e114801	10.1371/journal.pone.0114801	http://dx.doi.org/10.1371/journal.pone.0114801			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536435	gold, Green Published, Green Submitted			2022-12-27	WOS:000348563300021
J	Cuervo-Escobar, S; Losada-Barragan, M; Umana-Perez, A; Porrozzi, R; Saboia-Vahia, L; Miranda, LHM; Morgado, FN; Menezes, RC; Sanchez-Gomez, M; Cuervo, P				Cuervo-Escobar, Sergio; Losada-Barragan, Monica; Umana-Perez, Adriana; Porrozzi, Renato; Saboia-Vahia, Leonardo; Miranda, Luisa H. M.; Morgado, Fernanda N.; Menezes, Rodrigo C.; Sanchez-Gomez, Myriam; Cuervo, Patricia			T-Cell Populations and Cytokine Expression Are Impaired in Thymus and Spleen of Protein Malnourished BALB/c Mice Infected with Leishmania infantum	PLOS ONE			English	Article							EXPERIMENTAL VISCERAL LEISHMANIASIS; GROWTH-FACTOR-I; ENERGY MALNUTRITION; DONOVANI INFECTION; IMMUNE-RESPONSE; NORTHEASTERN BRAZIL; CHAGASI INFECTION; GAMMA-INTERFERON; MIGRATION; VACCINE	Visceral leishmaniasis (VL) is a parasitic infectious disease that causes significant morbidity and mortality in the tropical and subtropical regions of the world. Although infections with visceralizing Leishmania may be asymptomatic, factors such as undernutrition increase the likelihood of progressing to clinical disease. Protein malnutrition, the most deleterious cause of malnutrition in developing countries, has been considered as a primary risk factor for the development of clinical VL. However, data regarding the immunological basis of this association are scarce. With the aim to analyze the effects of protein malnutrition on Leishmania infantum infection, we used BALB/c mice subjected to control or low protein isocaloric diets. Each animal group was divided into two subgroups and one was infected with L. infantum resulting in four study groups: animals fed 14% protein diet (CP), animals fed 4% protein diet (LP), animals fed 14% protein diet and infected (CPi), and animals fed 4% protein diet and infected (LPi). The susceptibility to L. infantum infection and immune responses were assessed in terms of body and lymphoid organ weight, parasite load, lymphocyte subpopulations, and cytokine expression. LPi mice had a significant reduction of body and lymphoid organ weight and exhibited a severe decrease of lymphoid follicles in the spleen. Moreover, LPi animals showed a significant decrease in CD4(+)CD8(+) T cells in the thymus, whereas there was an increase of CD4(+) and CD8(+) T cells percentages in the spleen. Notably, the cytokine mRNA levels in the thymus and spleen of protein	[Cuervo-Escobar, Sergio; Umana-Perez, Adriana; Sanchez-Gomez, Myriam] Univ Nacl Colombia, Dept Quim, Lab Hormonas, Bogota, Colombia; [Losada-Barragan, Monica; Porrozzi, Renato; Saboia-Vahia, Leonardo; Morgado, Fernanda N.; Cuervo, Patricia] Fiocruz MS, Inst Oswaldo Cruz, Lab Pesquisa Leishmaniose, BR-21045900 Rio De Janeiro, Brazil; [Miranda, Luisa H. M.; Menezes, Rodrigo C.] Fiocruz MS, IPEC, Inst Pesquisa Cliin Evandro Chagas, BR-21045900 Rio De Janeiro, Brazil	Universidad Nacional de Colombia; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Sanchez-Gomez, M (corresponding author), Univ Nacl Colombia, Dept Quim, Lab Hormonas, Bogota, Colombia.	pcuervo@fiocruz.br; mysanchezd@unal.edu.co	Porrozzi, Renato/U-2166-2019; Porrozzi, Renato/U-2059-2019; Cuervo, Patricia/F-9896-2012; Saboia-Vahia, Leonardo/F-7240-2013; Morgado, Fernanda N/K-2527-2013; Morgado, Fernanda/O-3577-2017; Menezes, Rodrigo/I-5149-2012; Menezes, Rodrigo/O-8722-2019; Miranda, Luisa/ABB-7298-2020; Cuervo, Patricia/Y-6048-2019; Morgado, Fernanda/AAV-4435-2021	Porrozzi, Renato/0000-0003-2167-316X; Morgado, Fernanda N/0000-0002-7188-251X; Morgado, Fernanda/0000-0002-7188-251X; Menezes, Rodrigo/0000-0003-1853-3449; Cuervo, Patricia/0000-0002-6245-4185; Morgado, Fernanda/0000-0002-7188-251X; Losada Barragan, Monica/0000-0003-1141-1828; Sanchez-Gomez, Myriam/0000-0002-9481-7534; Umana-Perez, Adriana/0000-0001-9262-2699	Convenio bilateral Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil); Departamento Administrativo de Ciencia, Tecnologia e Innovacion (Colciencias, Colombia) [490992/2008-0, 490560/2013-0, 11263-576-2009]; CNPq-TWAS (Third World Academy of Sciences) [190405/2011-2]; FIOCRUZ-CNPq [476727/2010-3]; National University of Colombia Research Council [14233, 16433]	Convenio bilateral Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil); Departamento Administrativo de Ciencia, Tecnologia e Innovacion (Colciencias, Colombia)(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); CNPq-TWAS (Third World Academy of Sciences); FIOCRUZ-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National University of Colombia Research Council	This work was supported by the following Brazilian and Colombian agencies: Convenio bilateral Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil) and Departamento Administrativo de Ciencia, Tecnologia e Innovacion (Colciencias, Colombia) [P.C. CNPq grant #490992/2008-0; P.C. CNPq grant #490560/2013-0; M.S.G. Colciencias grant #11263-576-2009], CNPq-TWAS (Third World Academy of Sciences) [M.L.B. grant #190405/2011-2], FIOCRUZ-CNPq [P.C., R.P., L.S.V. and M.L.B. PROEP grant #476727/2010-3] and the National University of Colombia Research Council [M.S.G., S.C.E. and A.U.P. DIB grant #14233, 16433].	Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Anstead GM, 2009, PROSTAG LEUKOTR ESS, V81, P41, DOI 10.1016/j.plefa.2009.04.011; Anstead GM, 2003, J LEUKOCYTE BIOL, V74, P982, DOI 10.1189/jlb.0203064; Anstead GM, 2001, INFECT IMMUN, V69, P4709, DOI 10.1128/IAI.69.8.4709-4718.2001; Arias JR, 1996, EMERG INFECT DIS, V2, P145, DOI 10.3201/eid0202.960213; BADARO R, 1986, J INFECT DIS, V154, P639, DOI 10.1093/infdis/154.4.639; BARONE KS, 1993, CELL IMMUNOL, V148, P226, DOI 10.1006/cimm.1993.1105; Basu R, 2007, INFECT IMMUN, V75, P5956, DOI 10.1128/IAI.00944-07; Belkaid Y, 2002, J IMMUNOL, V168, P3992, DOI 10.4049/jimmunol.168.8.3992; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Borelli P, 2007, BRIT J NUTR, V97, P307, DOI 10.1017/S0007114507172731; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carrion J, 2006, PARASITE IMMUNOL, V28, P173, DOI 10.1111/j.1365-3024.2006.00817.x; CERF BJ, 1987, J INFECT DIS, V156, P1030, DOI 10.1093/infdis/156.6.1030; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; Colmenares M, 2003, INFECT IMMUN, V71, P3172, DOI 10.1128/IAI.71.6.3172-3182.2003; Cunningham-Rundles S, 2008, NUTR PEDIAT, P262; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; DYE C, 1993, P ROY SOC B-BIOL SCI, V254, P33, DOI 10.1098/rspb.1993.0123; Engwerda CR, 2004, TRENDS PARASITOL, V20, P524, DOI 10.1016/j.pt.2004.08.009; Evans D, 1989, HDB ISOLATION CULTIV; Golbert DCF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S6-S3; Franke CR, 2002, T ROY SOC TROP MED H, V96, P236, DOI 10.1016/S0035-9203(02)90087-8; GOMEZ F, 1956, LANCET, V271, P121; Gurunathan S, 1997, J EXP MED, V186, P1137, DOI 10.1084/jem.186.7.1137; Hodge DL, 2012, EUR J IMMUNOL, V42, P2644, DOI 10.1002/eji.201242408; Ibrahim MK, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002329; Iyer SS, 2012, J IMMUNOL, V188, P77, DOI 10.4049/jimmunol.1004027; Jeronimo SMB, 2004, SCAND J INFECT DIS, V36, P443, DOI 10.1080/00365540410020451; Jeronimo SMB, 2000, CLIN INFECT DIS, V30, P608, DOI 10.1086/313697; KAYE PM, 1992, INFECT IMMUN, V60, P4335, DOI 10.1128/IAI.60.10.4335-4342.1992; Lima ID, 2012, AM J TROP MED HYG, V86, P99, DOI 10.4269/ajtmh.2012.10-0492; Maciel BLL, 2008, AM J TROP MED HYG, V79, P591, DOI 10.4269/ajtmh.2008.79.591; Malafaia G, 2009, PARASITE IMMUNOL, V31, P41, DOI 10.1111/j.1365-3024.2008.01069.x; Marlet MVL, 2003, T ROY SOC TROP MED H, V97, P515, DOI 10.1016/S0035-9203(03)80012-3; Mello AS, 2014, INFLAMMATION; Mendes-da-Cruz DA, 2012, FASEB J, V26, P4390, DOI 10.1096/fj.11-202952; Miranda LHM, 2011, VET J, V190, P408, DOI 10.1016/j.tvjl.2010.12.004; Morrot A, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001268; Naranjo WM, 2002, ENDOCRINOLOGY, V143, P2233, DOI 10.1210/en.143.6.2233; Nieto A, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-39; Cunha MCR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058872; Rey Luís C., 2005, J. Pediatr. (Rio J.), V81, P73, DOI [10.2223/JPED.1286, 10.1590/S0021-75572005000100014]; Rodriguez-Galan MC, 2005, J IMMUNOL, V174, P2796, DOI 10.4049/jimmunol.174.5.2796; Perez AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034360; Sanchez-Gomez M, 1999, BRIT J NUTR, V81, P145, DOI 10.1017/S0007114599000288; Santana CC, 2008, PARASITE IMMUNOL, V30, P515, DOI 10.1111/j.1365-3024.2008.01051.x; Savino W, 2002, EUR J CLIN NUTR, V56, pS46, DOI 10.1038/sj.ejcn.1601485; Savino W, 2007, BRIT J NUTR, V98, pS11, DOI 10.1017/S0007114507832880; Savino W, 2006, PLOS PATHOG, V2, P472, DOI 10.1371/journal.ppat.0020062; Savino W, 2012, ANN NY ACAD SCI, V1261, P49, DOI 10.1111/j.1749-6632.2012.06637.x; Savino W, 2010, P NUTR SOC, V69, P636, DOI 10.1017/S0029665110002545; Serafim TD, 2010, MEM I OSWALDO CRUZ, V105, P811, DOI 10.1590/S0074-02762010000600014; Silva ES, 2001, MEM I OSWALDO CRUZ, V96, P285, DOI 10.1590/S0074-02762001000300002; Stager S, 2003, NAT MED, V9, P1287, DOI 10.1038/nm933; STERN JJ, 1988, J IMMUNOL, V140, P3971; THISSEN JP, 1992, J ENDOCRINOL, V132, P141, DOI 10.1677/joe.0.1320141; United Nations Children's Fund; WHO; The World Bank, 2012, UNICEF WHO WORLD BAN; Wang X, 2008, CYTOKINE, V43, P15, DOI 10.1016/j.cyto.2008.04.009; Wiig H, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-12; Willems E, 2008, ANAL BIOCHEM, V379, P127, DOI 10.1016/j.ab.2008.04.036; Wilson ME, 2005, MICROB PATHOGENESIS, V38, P147, DOI 10.1016/j.micpath.2004.11.002; World Health Organization, 2011, GLOB HLTH OBS DAT RE; World Health Organization, 2010, LAB MAN EX PROC HUM, P10; Xavier JG, 2007, HISTOL HISTOPATHOL, V22, P651, DOI 10.14670/HH-22.651; Yarilin AA, 2004, CURR MED CHEM, V11, P447, DOI 10.2174/0929867043455972	66	26	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e114584	10.1371/journal.pone.0114584	http://dx.doi.org/10.1371/journal.pone.0114584			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25535967	Green Submitted, Green Published, gold			2022-12-27	WOS:000348563300015
J	El-Ashmawy, M; Delgado, O; Cardentey, A; Wright, WE; Shay, JW				El-Ashmawy, Mariam; Delgado, Oliver; Cardentey, Agnelio; Wright, Woodring E.; Shay, Jerry W.			CDDO-Me Protects Normal Lung and Breast Epithelial Cells but Not Cancer Cells from Radiation	PLOS ONE			English	Article							SYNTHETIC TRITERPENOIDS; IONIZING-RADIATION; METHYL ESTER; BARDOXOLONE METHYL; ETHYL AMIDE; PREVENTION; IMMORTALIZATION; CARCINOGENESIS; AMIFOSTINE; RISK	Although radiation therapy is commonly used for treatment for many human diseases including cancer, ionizing radiation produces reactive oxygen species that can damage both cancer and healthy cells. Synthetic triterpenoids, including CDDO-Me, act as anti-inflammatory and antioxidant modulators primarily by inducing the transcription factor Nrf2 to activate downstream genes containing antioxidant response elements (AREs). In the present series of experiments, we determined if CDDO-Me can be used as a radioprotector in normal non-cancerous human lung and breast epithelial cells, in comparison to lung and breast cancer cell lines. A panel of normal non-cancerous, partially cancer progressed, and cancer cell lines from both lung and breast tissue was exposed to gamma radiation with and without pre-treatment with CDDO-Me. CDDO-Me was an effective radioprotector when given,18 hours before radiation in epithelial cells (average dose modifying factor (DMF) 51.3), and Nrf2 function was necessary for CDDO-Me to exert these radioprotective effects. CDDO-Me did not protect cancer lines tested from radiation-induced cytotoxicity, nor did it protect experimentally transformed human bronchial epithelial cells (HBECs) with progressive oncogenic manipulations. CDDO-Me also protected human lymphocytes against radiation-induced DNA damage. A therapeutic window exists in which CDDO-Me protects normal cells from radiation by activating the Nrf2 pathway, but does not protect experimentally transformed or cancer cell lines. This suggests that use of this oral available, non-toxic class of drug can protect non-cancerous healthy cells during radiotherapy, resulting in better outcomes and less toxicity for patients.	[El-Ashmawy, Mariam; Cardentey, Agnelio; Wright, Woodring E.; Shay, Jerry W.] UT Southwestern Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Delgado, Oliver] Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Houston, TX 77030 USA; [Shay, Jerry W.] King Abdulaziz Univ, Ctr Excellence Genom Med Res, Jeddah 21413, Saudi Arabia	University of Texas System; UTMD Anderson Cancer Center; King Abdulaziz University	Shay, JW (corresponding author), UT Southwestern Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA.	Jerry.Shay@UTSouthwestern.edu		El-Ashmawy, Mariam/0000-0002-2335-4827; Delgado, Oliver/0000-0003-2547-5857	National Aeronautics and Space Administration [NNJ05HD36GD, NNX09AU95G, NNX11AC1G]; National Cancer Institute [Lung SPORE P50CA70907]; Howard Hughes Medical Institute Gilliam Fellowship; National Institutes of Health [C06 RR30414]; NATIONAL CANCER INSTITUTE [P50CA070907] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR030414] Funding Source: NIH RePORTER	National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute Gilliam Fellowship(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by the National Aeronautics and Space Administration (NNJ05HD36GD, NNX09AU95G, and NNX11AC1G); the National Cancer Institute (Lung SPORE P50CA70907) (JWS); Howard Hughes Medical Institute Gilliam Fellowship (ME). This work was performed in laboratories constructed with support from National Institutes of Health grant C06 RR30414 (JWS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreassen CN, 2003, SEMIN RADIAT ONCOL, V13, P62, DOI 10.1053/srao.2003.50006; Bernier J, 2004, NAT REV CANCER, V4, P737, DOI 10.1038/nrc1451; Casas F, 2004, HEMATOL ONCOL CLIN N, V18, P461, DOI 10.1016/j.hoc.2003.12.007; Cucinotta FA, 2012, HEALTH PHYS, V103, P643, DOI 10.1097/HP.0b013e318267b3ad; Daroczi B, 2009, MOL CANCER THER, V8, P2625, DOI 10.1158/1535-7163.MCT-09-0198; Eskiocak U, 2010, RADIAT RES, V174, P27, DOI 10.1667/RR2155.1; Gyori BM, 2014, REDOX BIOL, V2, P457, DOI 10.1016/j.redox.2013.12.020; Honda T, 2011, J MED CHEM, V54, P1762, DOI 10.1021/jm101445p; Hong DS, 2012, CLIN CANCER RES, V18, P3396, DOI 10.1158/1078-0432.CCR-11-2703; Kim SB, 2012, P NATL ACAD SCI USA, V109, pE2949, DOI 10.1073/pnas.1207718109; Kim YH, 2014, CANCER LETT, V354, P132, DOI 10.1016/j.canlet.2014.07.048; Koukourakis MI, 2004, CANCER CHEMOTH PHARM, V53, P8, DOI 10.1007/s00280-003-0691-z; Levy S, 2010, IUBMB LIFE, V62, P237, DOI 10.1002/iub.314; Liby K, 2005, CANCER RES, V65, P4789, DOI 10.1158/0008-5472.CAN-04-4539; Liby K, 2008, CLIN CANCER RES, V14, P4556, DOI 10.1158/1078-0432.CCR-08-0040; Liby K, 2007, CANCER RES, V67, P2414, DOI 10.1158/0008-5472.CAN-06-4534; Liby K, 2009, CANCER PREV RES, V2, P1050, DOI 10.1158/1940-6207.CAPR-09-0085; Liby KT, 2014, DOSE-RESPONSE, V12, P136, DOI 10.2203/dose-response.13-018.Liby; Liby KT, 2012, PHARMACOL REV, V64, P972, DOI 10.1124/pr.111.004846; Liby KT, 2010, CANCER PREV RES, V3, P1427, DOI 10.1158/1940-6207.CAPR-10-0197; Mitsuishi Y, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00200; Newhauser WD, 2011, NAT REV CANCER, V11, P438, DOI 10.1038/nrc3069; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Pergola PE, 2011, NEW ENGL J MED, V365, P327, DOI 10.1056/NEJMoa1105351; PIKE MC, 1964, BRIT J RADIOL, V37, P458, DOI 10.1259/0007-1285-37-438-458; RADFORD EP, 1980, RADIAT RES, V84, P369, DOI 10.2307/3575478; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Sato M, 2006, CANCER RES, V66, P2116, DOI 10.1158/0008-5472.CAN-05-2521; Shanmugam MK, 2014, CANCER LETT, V346, P206, DOI 10.1016/j.canlet.2014.01.016; SHAY JW, 1993, EXP CELL RES, V209, P45, DOI 10.1006/excr.1993.1283; SHAY JW, 1995, MOL CELL BIOL, V15, P425, DOI 10.1128/MCB.15.1.425; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Solis LM, 2010, CLIN CANCER RES, V16, P3743, DOI 10.1158/1078-0432.CCR-09-3352; Wang YY, 2014, MOL CANCER, V13, DOI [10.1186/1476-4598-13-30, 10.1186/s12934-014-0151-y]; WARD JF, 1988, PROG NUCLEIC ACID RE, V35, P95, DOI 10.1016/S0079-6603(08)60611-X; Wasserman TH, 2001, ONCOLOGY-NY, V15, P1349	38	13	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115600	10.1371/journal.pone.0115600	http://dx.doi.org/10.1371/journal.pone.0115600			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536195	Green Submitted, Green Published, gold			2022-12-27	WOS:000348563300055
J	Nizami, SM; Zhang, YP; Sha, LQ; Wei, Z; Xiang, Z				Nizami, Syed Moazzam; Zhang Yiping; Sha Liqing; Wei Zhao; Xiang Zhang			Managing Carbon Sinks in Rubber (Hevea brasilensis) Plantation by Changing Rotation length in SW China	PLOS ONE			English	Article							OLD-GROWTH FORESTS; SOIL CARBON; SEQUESTRATION; MANAGEMENT; AGRICULTURE; BIOMASS; STORAGE; CLIMATE; STAND	Extension of the rotation length in forest management has been highlighted in Article 3.4 of the Kyoto Protocol to help the countries in their commitments for reduction in greenhouse gas emissions. CO2FIX Model Ver.3.2 was used to examine the dynamics of carbon stocks (C stocks) in a rubber plantation in South Western China with the changing rotation lengths. To estimate the efficiency of increasing the rotation length as an Article 3.4 activity, study predicted that the rubber production and C stocks of the ecosystem increased with the increasing rotation (25, 30, 35, 40 and 45 years). While comparing the pace of growth both in economical (rubber production) and ecological (C stocks) terms in each rotation, 40 years rotation length showed maximum production and C stocks. After elongation of 40 year rotation to four consecutive cycles, it was concluded that the total C stocks of the ecosystem were 186.65 Mg ha(-1). The longer rotation lengths showed comparatively increased C stocks in below ground C stock after consecutive four rotations. The pace of C input (Mg C ha(-1)yr(-1)) and rubber production indicated that 40years rotation is best suited for rubber plantation. The study has developed carbon mitigation based on four rotation scenarios. The possible stimulated increase in C stocks of the entire ecosystem after consecutive long rotations indicated that the emphasis must be paid on deciding the rotation of rubber plantation in SW China for reporting under article 3.4 of the Kyoto Protocol.	[Nizami, Syed Moazzam; Zhang Yiping; Sha Liqing; Wei Zhao; Xiang Zhang] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Menglun 666303, Yunnan, Peoples R China; [Wei Zhao; Xiang Zhang] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Nizami, Syed Moazzam] Arid Agr Univ, Fac Forestry Range Management & Wildlife, Rawalpindi 46300, Pakistan	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Nizami, SM (corresponding author), Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Menglun 666303, Yunnan, Peoples R China.	moazzam@xtbg.org.cn; yipingzh@xtbg.ac.cn	Nizami, Syed Moazzam/V-7754-2019; Zhang, Xiang/A-7030-2016	Zhang, Xiang/0000-0001-6952-8784	National Natural Science Foundation of China [41271056, U1202234, 31290221]; "Strategic Priority Research Program" of the Chinese Academy of Sciences [XDA05020303, XDA05050601, XDA05050206]; CAS 135 program [XTBG-T03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Strategic Priority Research Program" of the Chinese Academy of Sciences(Chinese Academy of Sciences); CAS 135 program	This study was supported by the National Natural Science Foundation of China (41271056, U1202234, 31290221), the "Strategic Priority Research Program" of the Chinese Academy of Sciences, (XDA05020303, XDA05050601, XDA05050206) and the CAS 135 program (XTBG-T03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao Min, 1996, Tropical Ecology, V37, P183; Castillo A, 2004, ABOVEGROUND CARBON S; COOPER CF, 1983, CAN J FOREST RES, V13, P155, DOI 10.1139/x83-022; Cotta M, 2005, THESIS U FEDERAL VIC; de Blecourt M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069357; Deng X, 2010, FOREST ECOSYSTEM XIS; Egbe A. E., 2012, Journal of Ecology and the Natural Environment, V4, P154; Egbe EA, 2011, APPL ECOL ENV RES, V9, P369, DOI 10.15666/aeer/0904_369385; Gisel R., 1992, WOOD DENSITIES TROPI; Harmon ME, 2002, CAN J FOREST RES, V32, P863, DOI [10.1139/x01-216, 10.1139/X01-216]; Huber M., 2012, CARBON SEQUESTRATION; Jandl R, 2007, GEODERMA, V137, P253, DOI 10.1016/j.geoderma.2006.09.003; Jia Kaixin, 2006, Shengtaixue Zazhi, V25, P1028; Kaipainen T, 2004, ENVIRON SCI POLICY, V7, P205, DOI 10.1016/j.envsci.2004.03.001; Kaul M, 2010, MITIG ADAPT STRAT GL, V15, P489, DOI 10.1007/s11027-010-9230-5; Kirschbaum MUF, 2008, SOIL BIOL BIOCHEM, V40, P392, DOI 10.1016/j.soilbio.2007.09.003; Liao CZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010867; Liski J, 2001, CAN J FOREST RES, V31, P2004, DOI 10.1139/cjfr-31-11-2004; Luyssaert S, 2008, NATURE, V455, P213, DOI 10.1038/nature07276; Masera OR, 2003, ECOL MODEL, V164, P177, DOI 10.1016/S0304-3800(02)00419-2; Murray B., 2000, LAND USE LAND USE CH, P53; Nabuurs GJ., 2002, ECOL INDIC, V1, P213, DOI [DOI 10.1016/S1470-160X(02)00007-9, 10.1016/S1470-160X(02)00007-9]; Paul KI, 2002, FOREST ECOL MANAG, V168, P241, DOI 10.1016/S0378-1127(01)00740-X; Philip M.S., 1994, MEASURING TREES FORE, P324; Pretty JN, 2002, PHILOS T R SOC A, V360, P1741, DOI 10.1098/rsta.2002.1029; Priyadarshan PM, 2005, J CROP IMPROV, V14, P221, DOI 10.1300/J411v14n01_10; Pussinen A, 2002, FOREST ECOL MANAG, V158, P103, DOI 10.1016/S0378-1127(00)00675-7; Ren YH CM, 1999, ACTA PHYTOECOLOGICA, V23; Running SW, 2008, SCIENCE, V321, P652, DOI 10.1126/science.1159607; Salimon C.I., 2009, J APPL SCI, V4, P57; Schelhaas MJ, 2004, 1068 ALTERRA; SFA, 2008, SFA B FOR EC CONSTR, P49; Song QH, 2013, IFOREST, V7, P42, DOI 10.3832/ifor0891-007; Song Qing-hai, 2010, Shengtaixue Zazhi, V29, P1887; Sun Y, 2013, THESIS U CHINESE ACA; Tschakert P, 2007, ECOL ECON, V60, P807, DOI 10.1016/j.ecolecon.2006.02.001; UNFCCC, 2001, C PART 6 SESS 2; UNFCCC, 1997, FCCCCP19977ADD UNFCC; van Dijk AIJM, 2007, FOREST ECOL MANAG, V251, P1, DOI 10.1016/j.foreco.2007.06.010; Vieira S, 2005, P NATL ACAD SCI USA, V102, P18502, DOI 10.1073/pnas.0505966102; Wang QK, 2009, FOREST ECOL MANAG, V258, P1437, DOI 10.1016/j.foreco.2009.06.050; Watson R.T., 2000, IMPL DIFF DEF GEN IS, P375; Wauters JB, 2008, FOREST ECOL MANAG, V255, P2347, DOI 10.1016/j.foreco.2007.12.038; Winjum JK, 1997, AGR FOREST METEOROL, V84, P153, DOI 10.1016/S0168-1923(96)02383-0; [吴志祥 Wu Zhixiang], 2009, [热带作物学报, Chinese Journal of Tropical Crops], V30, P135; Yang YH, 2011, NEW PHYTOL, V190, P977, DOI 10.1111/j.1469-8137.2011.03645.x; Zhou GY, 2006, SCIENCE, V314, P1417, DOI 10.1126/science.1130168	47	22	24	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115234	10.1371/journal.pone.0115234	http://dx.doi.org/10.1371/journal.pone.0115234			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536041	Green Published, gold, Green Submitted			2022-12-27	WOS:000348563300034
J	Omondi, EC; Kniss, AR				Omondi, Emmanuel Chiwo; Kniss, Andrew R.			Interplanting Annual Ryegrass, Wheat, Oat, and Corn to Mitigate Iron Deficiency in Dry Beans	PLOS ONE			English	Article							FE DEFICIENCY; CHLOROSIS; SUNFLOWER; NITROGEN; PLANTS; CHLOROPHYLL; NUTRITION; MANGANESE; NITRATE; ZINC	This study evaluated whether grass intercropping can be used to alleviate Fe deficiency chlorosis in dry beans (Phaseolus vulgaris L.) grown in high pH, calcareous soils with low organic matter. Field studies were conducted at the University of Wyoming Sustainable Agriculture Research and Extension Center in 2009 and 2010. Black- and navy beans were grown alone or intercropped with annual ryegrass (Lolium multiflorum Lam.), oat (Avena sativa L.), corn (Zea mays L.), or spring wheat (Triticum aestivum L.) in a two-factor factorial strip-plot randomized complete block design. All four grass species increased chlorophyll intensity in dry beans. However, grass species did not increase iron (Fe) concentration in dry bean tissues suggesting inefficient utilization of Fe present in the dry bean tissues. In 2009, nitrate-nitrogen (NO3-N) and manganese (Mn) concentration in bean tissue were greater in bean monoculture than in grass intercropped beans. Bean monoculture also had greater soil NO3-N concentrations than grass intercropped treatments. In 2009, grass intercrops reduced dry bean yield >25% compared to bean monoculture. Annual ryegrass was the least competitive of the four annual grass species. This suggests that competition from grasses for nutrients, water, or light may have outweighed benefits accruing from grass intercropping. Additional studies are required to determine the appropriate grass and dry bean densities, as well as the optimum time of grass removal.	[Omondi, Emmanuel Chiwo] Univ Wyoming, Dept Ecosyst Sci & Management, Laramie, WY 82071 USA; [Kniss, Andrew R.] Univ Wyoming, Dept Plant Sci, Laramie, WY 82071 USA	University of Wyoming; University of Wyoming	Omondi, EC (corresponding author), Univ Wyoming, Dept Ecosyst Sci & Management, 1000 East Univ Ave, Laramie, WY 82071 USA.	chiwomondi@yahoo.com	; Kniss, Andrew/B-3247-2010	Omondi, Emmanuel/0000-0002-3870-0809; Kniss, Andrew/0000-0003-2551-4959	Western Sustainable Agriculture Research and Extension Graduate Student grant	Western Sustainable Agriculture Research and Extension Graduate Student grant	This study was supported in part by a grant from the Western Sustainable Agriculture Research and Extension Graduate Student grant. The authors are also grateful to the University of Wyoming, Department of Plant Sciences for providing additional funds required to complete the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABADIA J, 1992, J PLANT NUTR, V15, P1699, DOI 10.1080/01904169209364432; AGBOOLA AA, 1972, AGRON J, V64, P409, DOI 10.2134/agronj1972.00021962006400040001x; AGGARWAL PK, 1992, AGRON J, V84, P71, DOI 10.2134/agronj1992.00021962008400010015x; Agrios GN, 2005, PLANT PATHOLOGY; AKTAS M, 1979, PLANT SOIL, V51, P257, DOI 10.1007/BF02232888; Alcaniz S, 2005, ACTA HORTIC, P535, DOI 10.17660/ActaHortic.2005.697.70; AMBLER JE, 1970, PLANT PHYSIOL, V46, P320, DOI 10.1104/pp.46.2.320; Bierman PM, 2005, NUTR MANAGEMENT FRUI; Bloom PR, 2011, SOIL SCI SOC AM J, V75, P2233, DOI 10.2136/sssaj2010.0391; Campbell CR, 1991, SO COOPERATIVE SERIE, V368, P1; CAMPBELL RJ, 1990, HORTSCIENCE, V25, P330, DOI 10.21273/HORTSCI.25.3.330; Castelli F, 1996, J AGRON CROP SCI, V177, P275, DOI 10.1111/j.1439-037X.1996.tb00246.x; Celik H., 2008, American-Eurasian Journal of Agricultural and Environmental Science, V3, P169; Combs S.M., 1998, N CENTRAL REG RES PU, P57; Cornell R.M., 2003, IRON OXIDES, Vsecond; DEAN RB, 1951, ANAL CHEM, V23, P636, DOI 10.1021/ac60052a025; EPSTEIN E, 1972, P412; Evers G. W., 1997, Ecology, production, and management of Lolium for forage in the USA., P29; Fageria Nand K., 2008, P245, DOI 10.1007/978-1-4020-6860-7_10; Fageria NK, 2001, COMMUN SOIL SCI PLAN, V32, P1659, DOI 10.1081/CSS-100104220; Gonzalez-Vallejo EB, 2000, PLANT PHYSIOL, V122, P337, DOI 10.1104/pp.122.2.337; Hamrick D, 2003, CROP PRODUCTION, V2; INSKEEP WP, 1987, AGRON J, V79, P779, DOI 10.2134/agronj1987.00021962007900050005x; Jacobsen J, 2003, FERTILIZER GUIDELINE; JOHNSON CLARENCE M., 1959, BULL CALIFORNIA AGRIC EXPT STA, V766, P25; Kabata-Pendias A., 1992, Trace elements in soils and plants.; KASHIRAD A, 1974, PLANT SOIL, V41, P91, DOI 10.1007/BF00017947; Keeney D. R., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P643; KIM J, 1994, BIOCHEMISTRY-US, V33, P389, DOI 10.1021/bi00168a001; Kirkland KJ, 2000, WEED TECHNOL, V14, P692, DOI 10.1614/0890-037X(2000)014[0692:ACSRWH]2.0.CO;2; Kosegarten HU, 1999, PLANT PHYSIOL, V121, P1069, DOI 10.1104/pp.121.4.1069; Krouma A, 2008, SYMBIOSIS, V46, P137; Krouma A, 2006, J PLANT PHYSIOL, V163, P1094, DOI 10.1016/j.jplph.2005.08.013; LINDSAY WL, 1978, SOIL SCI SOC AM J, V42, P421, DOI 10.2136/sssaj1978.03615995004200030009x; Ling QH, 2011, PHOTOSYNTH RES, V108, P89, DOI 10.1007/s11120-011-9648-y; Loh FCW, 2002, HORTTECHNOLOGY, V12, P682, DOI 10.21273/HORTTECH.12.4.682; Ludwick A.E., 2002, W FERTILIZER HDB; MARSCHNER H, 1994, PLANT SOIL, V165, P261, DOI 10.1007/BF00008069; Marschner H., 1995, MARSCHNERS MINERAL N, DOI DOI 10.1016/B978-0-12-473542-2.X5000-7; MENGEL K, 1988, PHYSIOL PLANTARUM, V72, P460, DOI 10.1111/j.1399-3054.1988.tb09151.x; MENGEL K, 1994, PLANT SOIL, V165, P275, DOI 10.1007/BF00008070; Mengel K, 1982, Principles of plant nutrition.; MENGEL K, 1994, J PLANT NUTR, V17, P1053, DOI 10.1080/01904169409364787; Morales F, 1998, J PLANT NUTR, V21, P815, DOI 10.1080/01904169809365444; MORTVEDT JJ, 1991, PLANT SOIL, V130, P273, DOI 10.1007/BF00011883; OLSEN RA, 1981, AM SCI, V69, P378; Omondi EC, 2010, J SUSTAIN AGR, V34, P244, DOI 10.1080/10440041003613230; Paul E. A., 1989, Soil microbiology and biochemistry.; Pinkard L, 2006, PRUNING THINNING COO, P64; Raju K. V., 1972, Zeitschrift fur Pflanzenernahrung und Bodenkunde, V133, P227, DOI 10.1002/jpln.19731330305; Robinson NJ, 1999, NATURE, V397, P694, DOI 10.1038/17800; ROMHELD V, 1984, PLANT PHYSIOL, V76, P603, DOI 10.1104/pp.76.3.603; SAS Institute Inc, 2008, SAS STAT VERS 9 2; SHAXSON L, 1992, EXP AGR, V28, P211, DOI 10.1017/S0014479700019657; SIDERIS CP, 1949, PLANT PHYSIOL, V24, P416, DOI 10.1104/pp.24.3.416; Stevens B, 2005, NUTR MANAGEMENT GUID; STORER DA, 1984, COMMUN SOIL SCI PLAN, V15, P759, DOI 10.1080/00103628409367515; Suzuki K, 1997, BIOMETALS, V10, P77, DOI 10.1023/A:1018323021721; Sylvia D., 2005, PRINCIPLES APPL SOIL, Vsecond; TWYMAN E. S., 1951, New Phytologist, V50, P210, DOI 10.1111/j.1469-8137.1951.tb05186.x; USDA National Agriculture Statistical Service, 2008, N DAK ANN STAT B; USEPA-United States Environmental Protection Agency, 1992, TEST METH EV SOL WAS; Vansuyt G, 2000, PLANT PHYSIOL BIOCH, V38, P499, DOI 10.1016/S0981-9428(00)00763-4; WALLACE A, 1976, Communications in Soil Science and Plant Analysis, V7, P37, DOI 10.1080/00103627609366609; WALLACE ARTHUR, 1960, PROC AMER SOC HORT SCI, V75, P819; WEIHING RM, 1963, AGRON J, V55, P519, DOI 10.2134/agronj1963.00021962005500060004x; Whitney DA, 1998, RECOMMENDED CHEM SOI, V221, P59	67	2	2	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115673	10.1371/journal.pone.0115673	http://dx.doi.org/10.1371/journal.pone.0115673			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536084	Green Published, Green Submitted, gold			2022-12-27	WOS:000348563300063
J	Batenburg, A; Das, E				Batenburg, Anika; Das, Enny			An Experimental Study on the Effectiveness of Disclosing Stressful Life Events and Support Messages: When Cognitive Reappraisal Support Decreases Emotional Distress, and Emotional Support Is Like Saying Nothing at All	PLOS ONE			English	Article							SOCIAL SUPPORT; INDIVIDUAL-DIFFERENCES; PERCEPTIONS; HEALTH; EXPERIENCES; COMPETENCE; OUTCOMES; VICTIMS; IMPACT	How can we best support others in difficult times? Studies testing the effects of supportive communication revealed mixed findings. The current study focuses on the effects of supportive communication following different disclosure styles, and includes outcome measures to assess emotional well-being. Hypotheses were tested in a 2 (disclosure style: cognitive reappraisal disclosure vs. emotional disclosure) 63 (support message: cognitive reappraisal response vs. socio-affective response vs. no response) between subjects factorial design. Receiving a cognitive reappraisal response, rather than a socio-affective response or no response, decreased emotional distress in the emotional disclosure group. Support messages showed no effects in the cognitive reappraisal disclosure group. Although socio-affective responses were positively evaluated, cognitive reappraisal responses may be more effective during emotional upheaval because they provide a positive way out of negative emotions.	[Batenburg, Anika] Vrije Univ Amsterdam, Fac Social Sci, Dept Commun Sci, Amsterdam, Netherlands; [Das, Enny] Radboud Univ Nijmegen, Ctr Language Studies, NL-6525 ED Nijmegen, Netherlands	Vrije Universiteit Amsterdam; Radboud University Nijmegen	Batenburg, A (corresponding author), Vrije Univ Amsterdam, Fac Social Sci, Dept Commun Sci, Amsterdam, Netherlands.	A.E.Batenburg@vu.nl		Batenburg, Anika/0000-0001-5197-6423	Network Institute of the VU University Amsterdam (formerly named CAMeRA Centre of Advanced Media Research Amsterdam)	Network Institute of the VU University Amsterdam (formerly named CAMeRA Centre of Advanced Media Research Amsterdam)	The current study was financially supported by the Network Institute of the VU University Amsterdam (formerly named CAMeRA Centre of Advanced Media Research Amsterdam). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychological Association, 2010, AM PSYCHOL, V65, P493, DOI [DOI 10.1037/A0020168, 10.1037/a0020168]; BAKER JM, 1997, THESIS ARIZONA STATE; Baum A., 1984, HDB PSYCHOL HLTH; Burleson B.R., 1998, HDB COMMUNICATION EM, P245, DOI DOI 10.1016/B978-012057770-5/50011-4; Burleson B. R., 2002, HDB INTERPERSONAL CO, V3rd, P374; BURLESON BR, 1985, COMMUN MONOGR, V52, P103, DOI 10.1080/03637758509376099; Burleson BR, 2009, J SOC PERS RELAT, V26, P21, DOI 10.1177/0265407509105519; Clark R.A., 1998, COMMUN STUD, V49, P224, DOI [10.1080/10510979809368533, DOI 10.1080/10510979809368533]; COCHRANE R, 1973, J PSYCHOSOM RES, V17, P135, DOI 10.1016/0022-3999(73)90014-7; COSTANZA RS, 1988, J EXP SOC PSYCHOL, V24, P182, DOI 10.1016/0022-1031(88)90020-0; Cunningham M.R., 2000, CLOSE RELATIONSHIPS, P273, DOI [10.4135/9781452220437.n20, DOI 10.4135/9781452220437.N20]; Cutrona C. E., 1994, COMMUNICATION SOCIAL, P113; Cutrona C. E., 1990, SOCIAL SUPPORT INTER, P319, DOI DOI 10.1111/J.1083-6101.2007.00367.X; CUTRONA CE, 1992, COMMUN RES, V19, P154, DOI 10.1177/009365092019002002; DAKOF GA, 1990, J PERS SOC PSYCHOL, V58, P80, DOI 10.1037/0022-3514.58.1.80; Goldsmith DJ, 2000, J SOC PERS RELAT, V17, P369, DOI 10.1177/0265407500173004; Goldsmith DJ, 2000, HUM COMMUN RES, V26, P234, DOI 10.1111/j.1468-2958.2000.tb00757.x; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; JACKSON S, 1983, HUM COMMUN RES, V9, P169, DOI 10.1111/j.1468-2958.1983.tb00691.x; JACOBSON DE, 1986, J HEALTH SOC BEHAV, V27, P250, DOI 10.2307/2136745; Johansson P, 2006, CONSCIOUS COGN, V15, P673, DOI 10.1016/j.concog.2006.09.004; John OP, 2004, J PERS, V72, P1301, DOI 10.1111/j.1467-6494.2004.00298.x; John OP, 2007, HDB EMOTION REGULATI; Jones S, 2004, COMMUN RES, V31, P338, DOI 10.1177/0093650204263436; Jones SM, 1997, COMMUN RES, V24, P530, DOI 10.1177/009365097024005004; Jones SM, 2001, HUM COMMUN RES, V27, P567, DOI 10.1111/j.1468-2958.2001.tb00793.x; Jones SM, 2006, HUM COMMUN RES, V32, P217, DOI 10.1111/j.1468-2958.2006.00274.x; KANIASTY K, 1992, AM J COMMUN PSYCHOL, V20, P211, DOI 10.1007/BF00940837; Lazarus R.S., 1984, EMOTION ADAPTATION; LEHMAN DR, 1990, J SOC PERS RELAT, V7, P563, DOI 10.1177/0265407590074012; Lepore SJ, 2002, WRITING CURE EXPRESS, P99, DOI DOI 10.1037/10451-005; Linden W., 1984, CAN J COUNS PSYCHOT, V18, P106; Low CA, 2006, HEALTH PSYCHOL, V25, P181, DOI 10.1037/0278-6133.25.2.181; Lu QA, 2010, PSYCHOL HEALTH, V25, P669, DOI 10.1080/08870440902883196; NISBETT RE, 1977, PSYCHOL REV, V84, P231, DOI 10.1037/0033-295X.84.3.231; Pennebaker J.W., 1982, PSYCHOL PHYS SYMPTOM; PENNEBAKER JW, 1993, BEHAV RES THER, V31, P539, DOI 10.1016/0005-7967(93)90105-4; Pennebaker JW, 1997, PSYCHOL SCI, V8, P162, DOI 10.1111/j.1467-9280.1997.tb00403.x; Pennebaker JW, 1996, COGNITION EMOTION, V10, P601, DOI 10.1080/026999396380079; PENNEBAKER JW, 1986, J ABNORM PSYCHOL, V95, P274, DOI 10.1037/0021-843X.95.3.274; PENNEBAKER JW, 1988, J CONSULT CLIN PSYCH, V56, P239, DOI 10.1037/0022-006X.56.2.239; Pennebaker JW, 2007, FDN HLTH PSYCHOL, P263; Peterkin AD, 2009, MED HUMANIT, V35, P80, DOI 10.1136/jmh.2009.001636; PIERCE LI, 1996, HEALTH PSYCHOL, V15, P38, DOI DOI 10.1037/0278-6133.15.1.38; Rime B., 2007, HDB EMOTION REGULATI, P466, DOI DOI 10.4324/9780203148211.CH23; RIMEB FC, 1998, EUROPEAN REV SOCIAL, V9, P145, DOI DOI 10.1080/14792779843000072; Smyth JM, 1999, JAMA-J AM MED ASSOC, V281, P1304, DOI 10.1001/jama.281.14.1304; SWANSONHYLAND EF, 1996, THESIS I IOWA IOWA C; Tamres LK, 2002, PERS SOC PSYCHOL REV, V6, P2, DOI 10.1207/S15327957PSPR0601_1; Tausczik YR, 2010, J LANG SOC PSYCHOL, V29, P24, DOI 10.1177/0261927X09351676; TIJHUIS MAR, 1995, SOC SCI MED, V40, P1513, DOI 10.1016/0277-9536(94)00276-Y; Vlachopoulos SP, 2006, MEAS PHYS EDUC EXERC, V10, P179, DOI 10.1207/s15327841mpee1003_4; Wade TD, 2000, PSYCHOL MED, V30, P965, DOI 10.1017/S0033291799002251; WEISS RS, 1976, SUPPORT SYSTEMS MUTU, P213; WINSTEAD BA, 1992, COMMUN RES, V19, P193, DOI 10.1177/009365092019002004; Zijlstra H., 2004, GEDRAG GEZOND, V32, P271	57	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e114169	10.1371/journal.pone.0114169	http://dx.doi.org/10.1371/journal.pone.0114169			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA3ZY	25531509	Green Published, Green Submitted, gold			2022-12-27	WOS:000348845100010
J	Koh, O; Lee, J; Tan, MLS; Tai, ES; Foo, CJ; Chong, KJ; Goh, SY; Bee, YM; Thumboo, J; Cheung, YB; Singh, A; Wee, HL				Koh, Odelia; Lee, Jeannette; Tan, Maudrene L. S.; Tai, E-Shyong; Foo, Ce Jin; Chong, Kok Joon; Goh, Su-Yen; Bee, Yong Mong; Thumboo, Julian; Cheung, Yin-Bun; Singh, Avjeet; Wee, Hwee-Lin			Establishing the Thematic Framework for a Diabetes-Specific Health-Related Quality of Life Item Bank for Use in an English-Speaking Asian Population	PLOS ONE			English	Article							PEOPLE; QUESTIONNAIRE; ADAPTATION; MELLITUS	Aims: To establish a thematic framework for a Diabetes Mellitus (DM)-specific health-related quality of life (HRQoL) item bank by identifying important HRQoL themes and content gaps in existing DM-specific HRQoL measures and determining whether Patient-Reported Outcomes Measurement Information System (PROMIS) item banks are useful as a starting point. Methodology: English-speaking Type 2 DM patients were recruited from an outpatient specialist clinic in Singapore. Thematic analysis was performed through open coding and axial coding. Items from four existing DM-specific measures and PROMIS Version 1.0 and 2.0 item banks were compared with identified themes and sub-themes. Results: 42 patients participated (25 men and 17 women; 28 Chinese, 4 Malay, 8 Indians, 2 other ethnicities). Median age was 53.70 years (IQR45.82-56.97) and the median disease duration was 11.13 (SD9.77) years. 10 subthemes (neutral emotions, coping emotions, empowered to help others, support from family, spend more time with family, relationships, financial burden on family, improved relationship, social support and religion/spirituality) were not covered by existing DM-specific measures. PROMIS covered 5 of 6 themes, 15 of 30 subthemes and 19 of 35 codes identified. Emotional distress (frustration, fear and anxiety) was most frequently mentioned (200 times). Conclusions: We had developed a thematic framework for assessing DM-specific HRQoL in a multi-ethnic Asian population, identified new items that needed to be written and confirmed that PROMIS was a useful starting point. We hope that better understanding and measurement of HRQoL of Asian DM patients will translate to better quality of care for them.	[Koh, Odelia] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117595, Singapore; [Lee, Jeannette; Tan, Maudrene L. S.; Tai, E-Shyong] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Tai, E-Shyong] Natl Univ Singapore Hosp, Dept Med, Div Endocrinol, Singapore 117548, Singapore; [Tai, E-Shyong; Chong, Kok Joon; Thumboo, Julian] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117595, Singapore; [Foo, Ce Jin] Natl Univ Singapore Hosp, Dept Corp Planning & Dev, Singapore 117548, Singapore; [Goh, Su-Yen; Bee, Yong Mong] Singapore Gen Hosp, Dept Endocrinol, Singapore, Singapore; [Thumboo, Julian; Wee, Hwee-Lin] Singapore Gen Hosp, Dept Rheumatol & Immunol, Singapore, Singapore; [Thumboo, Julian] Duke NUS Grad Med Sch Singapore, Off Clin Sci, Singapore, Singapore; [Cheung, Yin-Bun] Duke NUS Grad Med Sch Singapore, Ctr Quantitat Med, Singapore, Singapore; [Cheung, Yin-Bun] Univ Tampere, FIN-33101 Tampere, Finland; [Singh, Avjeet; Wee, Hwee-Lin] Natl Univ Singapore, Fac Sci, Dept Pharm, Singapore 117548, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Singapore General Hospital; Singapore General Hospital; National University of Singapore; National University of Singapore; National University of Singapore	Wee, HL (corresponding author), Singapore Gen Hosp, Dept Rheumatol & Immunol, Singapore, Singapore.	phawhl@nus.edu.sg	Wee, Hwee Lin/D-4126-2012	Wee, Hwee Lin/0000-0002-7150-1801; Tai, E Shyong/0000-0003-2929-8966	National University of Singapore [R-148-000-103-133]; Duke-NUS Signature Research Program Block Fund; Singapore Ministry of Health's National Medical Research Council under its Clinician Scientist Award	National University of Singapore(National University of Singapore); Duke-NUS Signature Research Program Block Fund; Singapore Ministry of Health's National Medical Research Council under its Clinician Scientist Award(Ministry of Health-SingaporeNational Medical Research Council, Singapore)	This study was funded by a start-up grant from the National University of Singapore (WBS: R-148-000-103-133) and in part by the Duke-NUS Signature Research Program Block Fund. YBC was supported by the Singapore Ministry of Health's National Medical Research Council under its Clinician Scientist Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdoli S, 2008, INT NURS REV, V55, P447, DOI 10.1111/j.1466-7657.2008.00664.x; Boyer JG, 1997, MED CARE, V35, P440, DOI 10.1097/00005650-199705000-00003; Bradley C, 1999, QUAL LIFE RES, V8, P79, DOI 10.1023/A:1026485130100; Cheng AY, 1999, DIABETES RES CLIN PR, V46, P259, DOI 10.1016/S0168-8227(99)00091-1; DAVIS WK, 1988, DIABETES CARE, V11, P538, DOI 10.2337/diacare.11.7.538; Pena MMEY, 2010, DIABETES METAB, V36, P305, DOI 10.1016/j.diabet.2010.02.003; Gibbs G.R., 2007, ANAL QUALITATIVE DAT; International Diabetes Federation, 2006, DIABETES ATLAS; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Koch T, 2000, J CLIN NURS, V9, P247, DOI 10.1046/j.1365-2702.2000.00341.x; Kong DL, 2011, DIABETES RES CLIN PR, V94, P45, DOI 10.1016/j.diabres.2011.05.026; Lai JS, 2003, QUAL LIFE RES, V12, P485, DOI 10.1023/A:1025014509626; Lasch KE, 2010, QUAL LIFE RES, V19, P1087, DOI 10.1007/s11136-010-9677-6; Maddigan SL, 2006, AM J PUBLIC HEALTH, V96, P1649, DOI 10.2105/AJPH.2005.067728; Meadows KA, 2000, DIABETIC MED, V17, P572, DOI 10.1046/j.1464-5491.2000.00322.x; Pilkonis PA, 2011, ASSESSMENT, V18, P263, DOI 10.1177/1073191111411667; Pope C, 2006, QUALITATIVE RES HLTH; Ryan G.W., 2003, FIELD METHOD, V15, P85, DOI DOI 10.1177/1525822X02239569; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shim YT, 2012, DIABETIC MED, V29, pE241, DOI 10.1111/j.1464-5491.2012.03689.x; Tang KC, 1995, FAM PRACT, V12, P474, DOI 10.1093/fampra/12.4.474; Unden AL, 2008, GENDER MED, V5, P162, DOI 10.1016/j.genm.2008.05.003; World Health Organization, 1946, PREAMBL CONST WHO AD	23	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115654	10.1371/journal.pone.0115654	http://dx.doi.org/10.1371/journal.pone.0115654			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA3ZY	25531429	gold, Green Published, Green Submitted			2022-12-27	WOS:000348845100089
J	Maggio, R; Viscomi, C; Andreozzi, P; D'Ettorre, G; Viscogliosi, G; Barbaro, B; Gori, M; Vullo, V; Balsano, C				Maggio, Roberta; Viscomi, Carmela; Andreozzi, Paola; D'Ettorre, Gabriella; Viscogliosi, Giovanni; Barbaro, Barbara; Gori, Manuele; Vullo, Vincenzo; Balsano, Clara			Normocaloric Low Cholesterol Diet Modulates Th17/Treg Balance in Patients with Chronic Hepatitis C Virus Infection	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TH17 CELLS; LIVER FIBROSIS; AUTOIMMUNE; INFLAMMATION; SERUM; INTERLEUKIN-17; PERSISTENCE; EXPRESSION; DISEASE	Hepatitis C virus (HCV) infection is associated with hepatic and extrahepatic manifestations, including immunological disorders. Chronic Hepatitis C (CHC) is often characterized by cholesterol and lipid metabolism alterations, leading to hepatic steatosis. Cholesterol metabolism, in fact, is crucial for the viral life cycle. Recent works described that a higher dietary cholesterol intake is associated with the progression of HCV-related liver disease. CHC patients have increased levels of T helper 17 (Th17)-cells, a lymphocytic population involved in the pathogenesis of liver inflammation and autoimmune hepatitis. The balance between Th17 and regulatory T (Treg) cells is crucial for chronic inflammation and autoimmunity. Th17-cell differentiation is deeply influenced by the activation LXRs, nuclear receptors modulating cholesterol homeostasis. Moreover, HCV may affect these nuclear receptors, and cholesterol metabolism, through both direct and indirect mechanisms. On these bases, we hypothesized that modulation of cholesterol levels through Normocaloric Low Cholesterol Diet (NLCD) may represent an innovative strategy to reduce the progression of HCV infection, through the modulation of peripheral Th17/Treg balance. To this end, we performed a pilot study to investigate whether a Normocaloric Low Cholesterol Diet may be able to modulate Th17/Treg balance in patients affected by chronic HCV infection. After 30 days of NLCD CHC patients showed a significant reduction in Th17 cells frequency, which correlated with strong reduction of IL-17 and IL-22 serum levels. At the same time, we appreciated an increase in the percentage of Treg cells, thus improving Treg/Th17balance. Moreover, we observed an increased expression of LXRs and their target genes: SREBP-1c and ABCA-1. In conclusion, NLCD finely regulates Th17/Treg balance, improving immune system response in CHC patients. This study could pave the way for new treatments of CHC patients, suggesting that change in lifestyle could support the management of these patients, promoting wellbeing and possibly hindering disease progression.	[Maggio, Roberta; Viscomi, Carmela; Barbaro, Barbara; Gori, Manuele; Balsano, Clara] Francesco Balsano Fdn, Lab Mol Virol & Oncol, Rome, Italy; [Andreozzi, Paola; Viscogliosi, Giovanni] Univ Roma La Sapienza, Predict Med Unit, I-00185 Rome, Italy; [D'Ettorre, Gabriella; Vullo, Vincenzo] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, I-00185 Rome, Italy; [Maggio, Roberta; Balsano, Clara] CNR, Inst Mol Biol & Pathol, Rome, Italy	Sapienza University Rome; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR)	Balsano, C (corresponding author), Francesco Balsano Fdn, Lab Mol Virol & Oncol, Rome, Italy.	clara.balsano@cnr.it	Wang, Jing/B-2431-2014; d'Ettorre, Gabriella/K-4511-2016; Barbaro, Barbara/K-5588-2016; Gori, Manuele/J-9184-2016; Balsano, Clara/AAK-9870-2020; Gori, Manuele/AAE-7052-2021	Barbaro, Barbara/0000-0002-2208-5370; Gori, Manuele/0000-0001-6957-2718; Balsano, Clara/0000-0002-9615-7031; MAGGIO, ROBERTA/0000-0001-8319-4418; d'Ettorre, Gabriella/0000-0002-3571-5677; Andreozzi, Paola/0000-0003-0369-8750	Ministry of Education, University and Research (MIUR) [RBAP10A9H9, RBAP10TPXK]; Umberto Veronesi Foundation	Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); Umberto Veronesi Foundation(Fondazione Umberto Veronesi)	This project was supported by grants obtained from: Ministry of Education, University and Research (MIUR) - Research projects of national interest (PRIN) (prot. 2009, YNERCE); MIUR-Fund for investment in basic research (FIRB) (prot. 2010, RBAP10A9H9); MIUR-FIRB (prot. 2010, RBAP10TPXK). In particular, R. Maggio's fellowship was supported by Umberto Veronesi Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arciello M, 2012, DIGEST LIVER DIS, V44, P245, DOI 10.1016/j.dld.2011.10.022; Balanescu P, 2012, Rom J Intern Med, V50, P13; Barbi J, 2013, IMMUNOL REV, V252, P52, DOI 10.1111/imr.12029; Barsic N, 2012, WORLD J GASTROENTERO, V18, P3945, DOI 10.3748/wjg.v18.i30.3945; Billerbeck E, 2010, P NATL ACAD SCI USA, V107, P3006, DOI 10.1073/pnas.0914839107; Chang Q, 2012, J GASTROEN HEPATOL, V27, P273, DOI 10.1111/j.1440-1746.2011.06782.x; Chen X, 2014, J LEUKOC BIOL; Claassen MAA, 2010, J HEPATOL, V52, P315, DOI 10.1016/j.jhep.2009.12.013; Cosmi L, 2008, J EXP MED, V205, P1903, DOI 10.1084/jem.20080397; Cui GL, 2011, J CLIN INVEST, V121, P658, DOI 10.1172/JCI42974; Dooley S, 2012, CELL TISSUE RES, V347, P245, DOI 10.1007/s00441-011-1246-y; Felmlee DJ, 2013, VIRUSES-BASEL, V5, P1292, DOI 10.3390/v5051292; Foster RG, 2012, DIGEST DIS SCI, V57, P381, DOI 10.1007/s10620-011-1997-z; Haines CJ, 2013, CELL REP, V3, P1378, DOI 10.1016/j.celrep.2013.03.035; Heaton NS, 2011, TRENDS MICROBIOL, V19, P368, DOI 10.1016/j.tim.2011.03.007; Heller JJ, 2011, J CLIN INVEST, V121, P519, DOI 10.1172/JCI45939; Hou WQ, 2009, J EXP MED, V206, P313, DOI 10.1084/jem.20082030; Huber S, 2006, FRONT BIOSCI-LANDMRK, V11, P1014, DOI 10.2741/1859; Kang YH, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00346; Kanzler S, 2001, J VIRAL HEPATITIS, V8, P430, DOI 10.1046/j.1365-2893.2001.00314.x; Kapadia SB, 2007, J VIROL, V81, P374, DOI 10.1128/JVI.01134-06; Kleinewietfeld M, 2013, NATURE, V496, P518, DOI 10.1038/nature11868; Li J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039307; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Marwaha AK, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00129; Miossec P, 2012, NAT REV DRUG DISCOV, V11, P763, DOI 10.1038/nrd3794; Moriishi K, 2007, P NATL ACAD SCI USA, V104, P1661, DOI 10.1073/pnas.0607312104; Neuman Manuela G, 2002, Rom J Gastroenterol, V11, P97; Noack M, 2014, AUTOIMMUN REV, V13, P668, DOI 10.1016/j.autrev.2013.12.004; Oukka M, 2007, ANN RHEUM DIS, V66, P87, DOI 10.1136/ard.2007.078527; Pavio N, 2003, J BIOSCIENCES, V28, P287, DOI 10.1007/BF02970148; Poynard T, 2003, LANCET, V362, P2095, DOI 10.1016/S0140-6736(03)15109-4; Rosenberg WMC, 2004, GASTROENTEROLOGY, V127, P1704, DOI 10.1053/j.gastro.2004.08.052; Simonetta F, 2010, EUR J IMMUNOL, V40, P2528, DOI 10.1002/eji.201040531; Sousa GM, 2012, CYTOKINE, V60, P138, DOI 10.1016/j.cyto.2012.06.003; Tang Y, 2011, CLIN EXP IMMUNOL, V166, P281, DOI 10.1111/j.1365-2249.2011.04471.x; Tesmer LA, 2008, IMMUNOL REV, V223, P87, DOI 10.1111/j.1600-065X.2008.00628.x; Tsutsumi T, 2002, HEPATOLOGY, V35, P937, DOI 10.1053/jhep.2002.32470; Veldhoen M, 2006, TRENDS IMMUNOL, V27, P358, DOI 10.1016/j.it.2006.06.001; Weaver CT, 2009, NAT REV IMMUNOL, V9, P883, DOI 10.1038/nri2660; Wrzesinski SH, 2007, CLIN CANCER RES, V13, P5262, DOI 10.1158/1078-0432.CCR-07-1157; Xu JH, 2009, J LEUKOCYTE BIOL, V86, P401, DOI 10.1189/jlb.1008600; Yan JW, 2014, EXPERT OPIN THER TAR, V18, P29, DOI 10.1517/14728222.2013.843669; Yu L, 2013, CLIN GASTROENTEROL H, V11, P1661, DOI 10.1016/j.cgh.2013.05.018; Zhu RT, 2012, MOL MED REP, V5, P895, DOI 10.3892/mmr.2012.758; Zimmermann A, 2011, EUR J INTERN MED, V22, P305, DOI 10.1016/j.ejim.2011.01.011	46	22	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e112346	10.1371/journal.pone.0112346	http://dx.doi.org/10.1371/journal.pone.0112346			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25532016	Green Submitted, Green Published, gold			2022-12-27	WOS:000348845100003
J	Qu, L; Ali, MM; Aguirre, SD; Liu, HX; Jiang, YY; Li, YF				Qu, Long; Ali, M. Monsur; Aguirre, Sergio D.; Liu, Hongxia; Jiang, Yuyang; Li, Yingfu			Examination of Bacterial Inhibition Using a Catalytic DNA	PLOS ONE			English	Article							BACILLUS-SUBTILIS SPORES; IN-VITRO; ANTIMICROBIAL PEPTIDES; COMBINATORIAL DESIGN; POLYMYXIN-B; ENZYME; COLONIZATION; COMPETITION; PROBIOTICS; MECHANISM	Determination of accurate dosage of existing antibiotics and discovery of new antimicrobials or probiotics entail simple but effective methods that can conveniently track bacteria growth and inhibition. Here we explore the application of a previously reported fluorogenic E. coli-specific DNAzyme (catalytic DNA), RFD-EC1, as a molecular probe for monitoring bacterial inhibition exerted by antibiotics and for studying bacterial competition as a result of cohabitation. Because the DNAzyme method provides a convenient way to monitor the growth of E. coli, it is capable of determining the minimal inhibitory concentration (MIC) of antibiotics much faster than the conventional optical density (OD) method. In addition, since the target for RFD-EC1 is an extracellular protein molecule from E. coli, RFD-EC1 is able to identify pore-forming antibiotics or compounds that can cause membrane leakage. Finally, RFD-EC1 can be used to analyse the competition of cohabitating bacteria, specifically the inhibition of growth of E. coli by Bacillus subtilis. The current work represents the first exploration of a catalytic DNA for microbiological applications and showcases the utility of bacteria-sensing fluorogenic DNAzymes as simple molecular probes to facilitate antibiotic and probiotic research.	[Qu, Long] Tsinghua Univ, Dept Chem, Beijing 100084, Peoples R China; [Qu, Long; Ali, M. Monsur; Aguirre, Sergio D.; Li, Yingfu] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [Qu, Long; Ali, M. Monsur; Aguirre, Sergio D.; Li, Yingfu] McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON, Canada; [Qu, Long; Liu, Hongxia; Jiang, Yuyang] Tsinghua Univ, Grad Sch Shenzhen, State Key Lab Breeding Base, Shenzhen 518057, Peoples R China; [Qu, Long; Liu, Hongxia; Jiang, Yuyang] Tsinghua Univ, Grad Sch Shenzhen, Shenzhen Key Lab Chem Biol, Shenzhen 518057, Peoples R China	Tsinghua University; McMaster University; McMaster University; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School	Jiang, YY (corresponding author), Tsinghua Univ, Grad Sch Shenzhen, State Key Lab Breeding Base, Shenzhen 518057, Peoples R China.	jiangyy@mail.sz.tsinghua.edu.cn; liying@mcmaster.ca	Ali, Monsur/AAA-5655-2020; jiang, yu/HGU-0029-2022		Natural Sciences and Engineering Research Council of Canada Discovery [2275942009]; Ministry of Science and Technology of China [2012ZX09506001-010]; National Natural Science Foundation of China [21302108]	Natural Sciences and Engineering Research Council of Canada Discovery(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The research work was supported by the Natural Sciences and Engineering Research Council of Canada Discovery Grant (2275942009), the Ministry of Science and Technology of China (2012ZX09506001-010), and National Natural Science Foundation of China (No. 21302108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abranches J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064875; Aguirre SD, 2012, JOVE-J VIS EXP, DOI 10.3791/3961; Aguirre SD, 2013, BIOMOLECULES, V3, DOI 10.3390/biom3030563; Ali MM, 2011, ANGEW CHEM INT EDIT, V50, P3751, DOI 10.1002/anie.201100477; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; BernetCamard MF, 1997, APPL ENVIRON MICROB, V63, P2747, DOI 10.1128/AEM.63.7.2747-2753.1997; BROWN DA, 1978, J ANTIBIOT, V31, P603, DOI 10.7164/antibiotics.31.603; CALVORI C, 1965, NATURE, V207, P417, DOI 10.1038/207417a0; Che YH, 2001, BIOSENS BIOELECTRON, V16, P791, DOI 10.1016/S0956-5663(01)00222-6; Cherif M, 2007, AM NAT, V169, P709, DOI 10.1086/516844; Chiuman W, 2006, CHEM BIOL, V13, P1061, DOI 10.1016/j.chembiol.2006.08.009; Coconnier MH, 1998, APPL ENVIRON MICROB, V64, P4573; Coconnier MH, 1997, ANTIMICROB AGENTS CH, V41, P1046, DOI 10.1128/AAC.41.5.1046; do JS, 2014, PLOS ONE, V9, P1; Dobson AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076521; Erickson KL, 2000, J NUTR, V130, p403S, DOI 10.1093/jn/130.2.403S; Guo XH, 2006, ANTON LEEUW INT J G, V90, P139, DOI 10.1007/s10482-006-9067-9; Heaslet H, 2009, PROTEINS, V76, P706, DOI 10.1002/prot.22383; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Jacobsen CN, 1999, APPL ENVIRON MICROB, V65, P4949; JONES RN, 1987, J CLIN MICROBIOL, V25, P1920, DOI 10.1128/JCM.25.10.1920-1925.1987; Jorgensen JH, 2009, CLIN INFECT DIS, V49, P1749, DOI 10.1086/647952; Kandadai SA, 2005, NUCLEIC ACIDS RES, V33, P7164, DOI 10.1093/nar/gki1013; Kandadai SA, 2009, BIOCHEMISTRY-US, V48, P7383, DOI 10.1021/bi900631u; Kaushik JK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008099; Kolar M, 2001, INT J ANTIMICROB AG, V17, P357, DOI 10.1016/S0924-8579(01)00317-X; Kwa A, 2007, EXPERT REV ANTI-INFE, V5, P811, DOI 10.1586/14787210.5.5.811; La Ragione RM, 2003, VET MICROBIOL, V94, P245, DOI 10.1016/S0378-1135(03)00077-4; La Ragione RM, 2001, VET MICROBIOL, V79, P133, DOI 10.1016/S0378-1135(00)00350-3; Lawrence SJ, 2005, J MED MICROBIOL, V54, P905, DOI 10.1099/jmm.0.46096-0; Lazcka O, 2007, BIOSENS BIOELECTRON, V22, P1205, DOI 10.1016/j.bios.2006.06.036; Lee SY, 2013, BIOSENS BIOELECTRON, V53, P123; Li YF, 2011, FUTURE MICROBIOL, V6, P973, DOI [10.2217/FMB.11.79, 10.2217/fmb.11.79]; Liu ZJ, 2003, J AM CHEM SOC, V125, P7539, DOI 10.1021/ja035208+; Marks JR, 2011, J AM CHEM SOC, V133, P8995, DOI 10.1021/ja2017416; MCCUTCHEON AR, 1992, J ETHNOPHARMACOL, V37, P213, DOI 10.1016/0378-8741(92)90036-Q; MCGOWAN JE, 1983, REV INFECT DIS, V5, P1033; Mei SHJ, 2003, J AM CHEM SOC, V125, P412, DOI 10.1021/ja0281232; MISUMI M, 1980, BIOCHEM BIOPH RES CO, V92, P647, DOI 10.1016/0006-291X(80)90382-4; Mondhe M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089082; Mossialos E, 2010, POLICIES INCENTIVES; Napolitano F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082359; Napolitano F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084177; Porco TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046505; Ranaallo RT, 2014, VACCINE, V32, P1754, DOI 10.1016/j.vaccine.2013.12.068; Rathinakumar R, 2008, J AM CHEM SOC, V130, P9849, DOI 10.1021/ja8017863; Rathinakumar R, 2010, FASEB J, V24, P3232, DOI 10.1096/fj.10-157040; Rathinakumar R, 2009, J AM CHEM SOC, V131, P7609, DOI 10.1021/ja8093247; Rausch JM, 2001, ANAL BIOCHEM, V293, P258, DOI 10.1006/abio.2001.5137; Rea MC, 2013, J MED MICROBIOL, V62, P1369, DOI 10.1099/jmm.0.058933-0; Rubin PH, 2004, REGULATION, V27, P34; Sang Yongming, 2008, Animal Health Research Reviews, V9, P227, DOI 10.1017/S1466252308001497; Sovova K, 2013, ANALYST, V138, P4795, DOI 10.1039/c3an00472d; Surawicz CM, 2000, CLIN INFECT DIS, V31, P1012, DOI 10.1086/318130; Tram K, 2014, ANGEW CHEM INT EDIT, V53, P12799, DOI 10.1002/anie.201407021; Tram K, 2012, J NUCLEIC ACIDS, V2012, DOI 10.1155/2012/958683; Vaseeharan B, 2003, LETT APPL MICROBIOL, V36, P83, DOI 10.1046/j.1472-765X.2003.01255.x; Vital M, 2012, WATER RES, V46, P6279, DOI 10.1016/j.watres.2012.08.043; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; WAXMAN DJ, 1983, ANNU REV BIOCHEM, V52, P825, DOI 10.1146/annurev.bi.52.070183.004141; Wimley WC, 2011, J MEMBRANE BIOL, V239, P27, DOI 10.1007/s00232-011-9343-0; WISSEMAN CL, 1954, J BACTERIOL, V67, P662, DOI 10.1128/JB.67.6.662-673.1954; WOLFE AD, 1965, BIOCHIM BIOPHYS ACTA, V95, P146, DOI 10.1016/0005-2787(65)90219-4; Wullt M, 2003, SCAND J INFECT DIS, V35, P365, DOI 10.1080/00365540310010985	64	4	4	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115640	10.1371/journal.pone.0115640	http://dx.doi.org/10.1371/journal.pone.0115640			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531274	gold, Green Published, Green Submitted			2022-12-27	WOS:000348845100087
J	Dave, K; Averineni, R; Sahdev, P; Perumal, O				Dave, Kaushalkumar; Averineni, Ranjith; Sahdev, Preety; Perumal, Omathanu			Transpapillary Drug Delivery to the Breast	PLOS ONE			English	Article							OUTER-MEMBRANE VESICLES; C-TYPE LECTIN; NEISSERIA-MENINGITIDIS LIPOPOLYSACCHARIDE; LINKED-IMMUNOSORBENT-ASSAY; HUMAN DENDRITIC CELLS; SEROGROUP-B DISEASE; CORE LIPOPOLYSACCHARIDE; ADJUVANT ACTIVITY; ESCHERICHIA-COLI; IMMUNE-RESPONSES	The study was aimed at investigating localized topical drug delivery to the breast via mammary papilla (nipple). 5-fluorouracil (5-FU) and estradiol (EST) were used as model hydrophilic and hydrophobic compounds respectively. Porcine and human nipple were used for in-vitro penetration studies. The removal of keratin plug enhanced the drug transport through the nipple. The drug penetration was significantly higher through the nipple compared to breast skin. The drug's lipophilicity had a significant influence on drug penetration through nipple. The ducts in the nipple served as a major transport pathway to the underlying breast tissue. Results showed that porcine nipple could be a potential model for human nipple. The topical application of 5-FU on the rat nipple resulted in high drug concentration in the breast and minimal drug levels in plasma and other organs. Overall, the findings from this study demonstrate the feasibility of localized drug delivery to the breast through nipple.	[Dave, Kaushalkumar; Averineni, Ranjith; Sahdev, Preety; Perumal, Omathanu] S Dakota State Univ, Dept Pharmaceut Sci, Brookings, SD 57007 USA	South Dakota State University	Perumal, O (corresponding author), S Dakota State Univ, Dept Pharmaceut Sci, Brookings, SD 57007 USA.	omathanu.perumal@sdstate.edu		Dave, Kaushalkumar/0000-0001-6179-9483	Governor's Translational Cancer Research Center, South Dakota State University (SDSU), Brookings, South Dakota; Functional Core Genomics Facility at South Dakota University	Governor's Translational Cancer Research Center, South Dakota State University (SDSU), Brookings, South Dakota; Functional Core Genomics Facility at South Dakota University	This work was funded by the Governor's 2010 Translational Cancer Research Center, South Dakota State University (SDSU), Brookings, South Dakota. Fluorescence microscopy studies were supported by funding from Functional Core Genomics Facility at South Dakota University. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Al-Bader T, 2004, CELL MICROBIOL, V6, P651, DOI 10.1111/j.1462-5822.2004.00392.x; Al-Bader T, 2003, INFECT IMMUN, V71, P5590, DOI 10.1128/IAI.71.10.5590-5597.2003; ALAALDEEN DAA, 1994, INFECT IMMUN, V62, P2984, DOI 10.1128/IAI.62.7.2984-2990.1994; Andrews SM, 2014, LANCET INFECT DIS, V14, P426, DOI 10.1016/S1473-3099(13)70341-4; Arigita C, 2005, VACCINE, V23, P5091, DOI 10.1016/j.vaccine.2005.06.001; Arigita C, 2003, VACCINE, V21, P950, DOI 10.1016/S0264-410X(02)00546-7; Baldridge JR, 1999, METHODS, V19, P103, DOI 10.1006/meth.1999.0834; BARCLAY GR, 1987, INFECT IMMUN, V55, P2706, DOI 10.1128/IAI.55.11.2706-2714.1987; Bjerre A, 2002, J INFECT DIS, V185, P220, DOI 10.1086/338269; Borrow R, 2001, MENINGOCOCCAL VACCIN; Callaghan MJ, 2011, INFECT IMMUN, V79, P2810, DOI 10.1128/IAI.01338-10; Caminschi I, 2001, MOL IMMUNOL, V38, P365, DOI 10.1016/S0161-5890(01)00067-0; de Vries JJC, 2009, VACCINE, V27, P947, DOI 10.1016/j.vaccine.2008.11.046; Fisseha M, 2005, INFECT IMMUN, V73, P4070, DOI 10.1128/IAI.73.7.4070-4080.2005; Fransen F, 2007, INFECT IMMUN, V75, P5939, DOI 10.1128/IAI.00846-07; FREDRIKSEN J H, 1991, NIPH (National Institute of Public Health) Annals (Oslo), V14, P67; FREDRIKSEN JH, 1991, NIPH ANN, V14, P79; Gringhuis SI, 2007, IMMUNITY, V26, P605, DOI 10.1016/j.immuni.2007.03.012; Holst J, 2007, HUM VACCINES, V3, P290, DOI 10.4161/hv.4513; Holst J, 2013, HUM VACC IMMUNOTHER, V9, P1241, DOI 10.4161/hv.24129; IDANPAANHEIKKILA I, 1995, J MED MICROBIOL, V43, P335, DOI 10.1099/00222615-43-5-335; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jennings MP, 1995, MOL MICROBIOL, V18, P729, DOI 10.1111/j.1365-2958.1995.mmi_18040729.x; Kaisho T, 2001, J IMMUNOL, V166, P5688, DOI 10.4049/jimmunol.166.9.5688; Keiser PB, 2011, VACCINE, V29, P1413, DOI 10.1016/j.vaccine.2010.12.039; Klena J, 2005, J BACTERIOL, V187, P1710, DOI 10.1128/JB.187.5.1710-1715.2005; LESSE AJ, 1990, J IMMUNOL METHODS, V126, P109, DOI 10.1016/0022-1759(90)90018-Q; Lewis S, 2009, EXPERT REV VACCINES, V8, P729, DOI [10.1586/erv.09.30, 10.1586/ERV.09.30]; LINDBERG AA, 1980, J GEN MICROBIOL, V116, P25; MCGUINNESS B, 1990, J EXP MED, V171, P1871, DOI 10.1084/jem.171.6.1871; Nagaoka K, 2005, INT IMMUNOL, V17, P827, DOI 10.1093/intimm/dxh264; Nagaputra JC, 2014, CLIN VACCINE IMMUNOL, V21, P234, DOI 10.1128/CVI.00561-13; Park CG, 2001, INT IMMUNOL, V13, P1283, DOI 10.1093/intimm/13.10.1283; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; PLIKAYTIS BD, 1991, J CLIN MICROBIOL, V29, P1439, DOI 10.1128/JCM.29.7.1439-1446.1991; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rosenqvist E, 2001, METH MOLEC MED, V66, P255, DOI 10.1385/1-59259-148-5:255; Saleem M, 2012, METHODS MOL BIOL, V799, P91, DOI 10.1007/978-1-61779-346-2_6; Steeghs L, 2006, CELL MICROBIOL, V8, P316, DOI 10.1111/j.1462-5822.2005.00623.x; Steeghs L, 2008, INFECT IMMUN, V76, P3801, DOI 10.1128/IAI.00005-08; Stoddard MB, 2010, CLIN VACCINE IMMUNOL, V17, P98, DOI 10.1128/CVI.00342-09; Svajger U, 2010, CELL SIGNAL; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tappero JW, 1999, JAMA-J AM MED ASSOC, V281, P1520, DOI 10.1001/jama.281.16.1520; van der Ley P, 2001, INFECT IMMUN, V69, P5981, DOI 10.1128/IAI.69.10.5981-5990.2001; vanderLey P, 1997, FEMS MICROBIOL LETT, V146, P247, DOI 10.1016/S0378-1097(96)00484-3; Wetzler LM, 2010, FUTURE MICROBIOL, V5, P749, DOI 10.2217/FMB.10.41; Weynants V, 2009, INFECT IMMUN, V77, P2084, DOI 10.1128/IAI.01108-08; Wright JC, 2004, J BACTERIOL, V186, P6970, DOI 10.1128/JB.186.20.6970-6982.2004; Wright JC, 2006, HDB MENINGOCOCCAL DI; Zimmer SM, 2007, GLYCOBIOLOGY, V17, P847, DOI 10.1093/glycob/cwm057	52	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115712	10.1371/journal.pone.0115712	http://dx.doi.org/10.1371/journal.pone.0115712			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545150	Green Submitted, Green Published, gold			2022-12-27	WOS:000347120200059
J	Hatamoto, M; Kimura, M; Sato, T; Koizumi, M; Takahashi, M; Kawakami, S; Araki, N; Yamaguchi, T				Hatamoto, Masashi; Kimura, Masafumi; Sato, Takafumi; Koizumi, Masato; Takahashi, Masanobu; Kawakami, Shuji; Araki, Nobuo; Yamaguchi, Takashi			Enrichment of Denitrifying Methane-Oxidizing Microorganisms Using Up-Flow Continuous Reactors and Batch Cultures	PLOS ONE			English	Article							DEPENDENT ANAEROBIC METHANE; METHANOTROPHIC BACTERIA; OXIDATION PROCESS; WASTE-WATER; NITRITE; AMMONIUM; DENITRIFICATION; MICROBES; NITROGEN; REMOVAL	Denitrifying anaerobic methane oxidizing (DAMO) microorganisms were enriched from paddy field soils using continuous-flow and batch cultures fed with nitrate or nitrite as a sole electron acceptor. After several months of cultivation, the continuous-flow cultures using nitrite showed remarkable simultaneous methane oxidation and nitrite reduction and DAMO bacteria belonging to phylum NC10 were enriched. A maximum volumetric nitrite consumption rate of 70.4 +/- 3.4 mg N.L-1.day(-1) was achieved with very short hydraulic retention time of 2.1 hour. In the culture, about 68% of total microbial cells were bacteria and no archaeal cells were detected by fluorescence in situ hybridization. In the nitrate-fed continuous-flow cultures, 58% of total microbial cells were bacteria while archaeal cells accounted for 7% of total cell numbers. Phylogenetic analysis of pmoA gene sequence showed that enriched DAMO bacteria in the continuous-flow cultivation had over 98% sequence similarity to DAMO bacteria in the inoculum. In contrast, for batch culture, the enriched pmoA gene sequences had 89-91% sequence similarity to DAMO bacteria in the inoculum. These results indicate that electron acceptor and cultivation method strongly affect the microbial community structures of DAMO consortia.	[Hatamoto, Masashi; Kimura, Masafumi; Sato, Takafumi; Koizumi, Masato; Takahashi, Masanobu; Yamaguchi, Takashi] Nagaoka Univ Technol, Dept Civil & Environm Engn, Nagaoka, Niigata 9402188, Japan; [Takahashi, Masanobu] Tohoku Univ, Dept Civil & Environm Engn, Sendai, Miyagi 9808579, Japan; [Kawakami, Shuji] Anan Natl Coll Technol, Dept Construct Syst Engn, Anan, Tokushima 7740017, Japan; [Araki, Nobuo] Nagaoka Natl Coll Technol, Dept Civil Engn, Nagaoka, Niigata 9408532, Japan	Nagaoka University of Technology; Tohoku University	Hatamoto, M (corresponding author), Nagaoka Univ Technol, Dept Civil & Environm Engn, Nagaoka, Niigata 9402188, Japan.	hatamoto@vos.nagaokaut.ac.jp	Hatamoto, Masashi/E-3111-2010		Exploratory Research of Adaptable and Seamless Technology Transfer Program through target-driven R&D program (A-STEP) from Japan Science and Technology Agency; JSPS KAKENHI [25701010]; Institute for Fermentation, Osaka; Grants-in-Aid for Scientific Research [25701010] Funding Source: KAKEN	Exploratory Research of Adaptable and Seamless Technology Transfer Program through target-driven R&D program (A-STEP) from Japan Science and Technology Agency; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Institute for Fermentation, Osaka(Institute for Fermentation (IFO)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was partially supported by Exploratory Research of Adaptable and Seamless Technology Transfer Program through target-driven R&D program (A-STEP) from Japan Science and Technology Agency, and JSPS KAKENHI Grant Number 25701010, and by a Grant-in-Aid from the Institute for Fermentation, Osaka. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; Ettwig KF, 2008, ENVIRON MICROBIOL, V10, P3164, DOI 10.1111/j.1462-2920.2008.01724.x; Ettwig KF, 2010, NATURE, V464, P543, DOI 10.1038/nature08883; Ettwig KF, 2009, APPL ENVIRON MICROB, V75, P3656, DOI 10.1128/AEM.00067-09; Haroon MF, 2013, NATURE, V500, P567, DOI 10.1038/nature12375; Hatamoto M, 2007, APPL ENVIRON MICROB, V73, P1332, DOI 10.1128/AEM.02053-06; Hatamoto M, 2010, WATER RES, V44, P1409, DOI 10.1016/j.watres.2009.11.021; Hu SH, 2011, ENV MICROBIOL REP, V3, P315, DOI 10.1111/j.1758-2229.2010.00227.x; Hu SH, 2009, ENV MICROBIOL REP, V1, P377, DOI 10.1111/j.1758-2229.2009.00083.x; Imachi H, 2011, ISME J, V5, P1913, DOI 10.1038/ismej.2011.64; Kampman C, 2014, J HAZARD MATER, V274, P428, DOI 10.1016/j.jhazmat.2014.04.031; Kampman C, 2012, J HAZARD MATER, V227, P164, DOI 10.1016/j.jhazmat.2012.05.032; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Luesken FA, 2011, APPL MICROBIOL BIOT, V92, P845, DOI 10.1007/s00253-011-3361-9; Luesken FA, 2011, APPL ENVIRON MICROB, V77, P6802, DOI 10.1128/AEM.05539-11; Meulepas RJW, 2009, BIOTECHNOL BIOENG, V104, P458, DOI 10.1002/bit.22412; Narihiro T, 2013, MICROBES ENVIRON, V28, P163, DOI 10.1264/jsme2.ME2802rh; Raghoebarsing AA, 2006, NATURE, V440, P918, DOI 10.1038/nature04617; Shen LD, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00269; Shi Y, 2013, ENVIRON SCI TECHNOL, V47, P11577, DOI 10.1021/es402775z; Stahl D. A., 1991, NUCL ACID TECHNIQUES; Wang Y, 2012, FEMS MICROBIOL LETT, V336, P79, DOI 10.1111/j.1574-6968.2012.02654.x; Zhu BL, 2012, APPL ENVIRON MICROB, V78, P8657, DOI 10.1128/AEM.02102-12; Zhu BL, 2011, BIOCHEM SOC T, V39, P1822, DOI 10.1042/BST20110704	25	26	28	1	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115823	10.1371/journal.pone.0115823	http://dx.doi.org/10.1371/journal.pone.0115823			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545013	Green Submitted, Green Published, gold			2022-12-27	WOS:000347120200073
J	Herrador, Z; Sordo, L; Gadisa, E; Buno, A; Gomez-Rioja, R; Iturzaeta, JM; de Armas, LF; Benito, A; Aseffa, A; Moreno, J; Canavate, C; Custodio, E				Herrador, Zaida; Sordo, Luis; Gadisa, Endalamaw; Buno, Antonio; Gomez-Rioja, Ruben; Manuel Iturzaeta, Jose; Fernandez de Armas, Lisset; Benito, Agustin; Aseffa, Abraham; Moreno, Javier; Canavate, Carmen; Custodio, Estefania			Micronutrient Deficiencies and Related Factors in School-Aged Children in Ethiopia: A Cross-Sectional Study in Libo Kemkem and Fogera Districts, Amhara Regional State	PLOS ONE			English	Article							VITAMIN-A-DEFICIENCY; DEVELOPING-COUNTRIES; SOUTHERN ETHIOPIA; RISK-FACTORS; NORTHWEST ETHIOPIA; NUTRITIONAL-STATUS; NORTHERN ETHIOPIA; PREVALENCE; HEALTH; ZINC	Introduction: The present study describes the distribution of selected micronutrients and anaemia among school-aged children living in Libo Kemkem and Fogera (Amhara State, Ethiopia), assessing differences by socio-demographic characteristics, health status and dietary habits. Methods: A cross-sectional survey was carried out during May-December 2009. Socio-demographic characteristics, health status and dietary habits were collected. Biomarkers were determined for 764 children. Bivariate and multivariable statistical methods were employed to assess micronutrient deficiencies (MD), anaemia, and their association with different factors. Results: More than two thirds of the school-aged children (79.5%) had at least one MD and 40.5% had two or more coexisting micronutrient deficiencies. The most prevalent deficiencies were of zinc (12.5%), folate (13.9%), vit A (29.3%) and vit D (49%). Anaemia occurred in 30.9% of the children. Children living in rural areas were more likely to have vit D insufficiency [OR: 5.9 (3.7-9.5)] but less likely to have folate deficiency [OR: 0.2 (0.1-0.4)] and anaemia [OR: 0.58 (0.35-0.97)]. Splenomegaly was positively associated with folate deficiency and anaemia [OR: 2.77 (1.19-6.48) and 4.91 (2.47-9.75)]. Meat and fish consumption were inversely correlated with zinc and ferritin deficiencies [OR: 0.2 (0.1-0.8) and 0.2 (0.1-0.9)], while oil consumption showed a negative association with anaemia and deficiencies of folate and vitamin A [0.58 (0.3-0.9), OR: 0.5 (0.3-0.9) and 0.6 (0.40.9)]. Serum ferritin levels were inversely correlated to the presence of anaemia (p<0.005). Conclusion: There is a high prevalence of vitamin A deficiency and vitamin D insufficiency and a moderate prevalence of zinc and folate deficiencies in schoolaged children in this area. The inverse association of anaemia and serum ferritin levels may be due to the presence of infectious diseases in the area. To effectively tackle malnutrition, strategies should target not only isolated micronutrient supplementation but also diet diversification.	[Herrador, Zaida; Benito, Agustin; Custodio, Estefania] Inst Salud Carlos III, Natl Ctr Trop Med, Madrid, Spain; [Herrador, Zaida; Benito, Agustin; Custodio, Estefania] Trop Dis Res Network RICET Spanish, Madrid, Spain; [Sordo, Luis] ISCIII, Natl Ctr Epidemiol, Madrid, Spain; [Sordo, Luis] Univ Complutense, Fac Med, Dept Prevent Med & Publ Hlth, E-28040 Madrid, Spain; [Sordo, Luis] Epidemiol & Publ Hlth CIBERESP Spanish, Network Biomed Res Ctr, Madrid, Spain; [Gadisa, Endalamaw; Aseffa, Abraham] Armauer Hansen Res Inst, Addis Ababa, Ethiopia; [Buno, Antonio; Gomez-Rioja, Ruben; Manuel Iturzaeta, Jose] Univ Hosp La Paz, Madrid, Spain; [Fernandez de Armas, Lisset] Orense Univ Hosp, Orense, Spain; [Moreno, Javier; Canavate, Carmen] ISCIII, Natl Ctr Microbiol, Madrid, Spain	Instituto de Salud Carlos III; Centro Nacional de Medicina Tropical (CNMT); Instituto de Salud Carlos III; Complutense University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Hospital Universitario La Paz; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM)	Custodio, E (corresponding author), Inst Salud Carlos III, Natl Ctr Trop Med, Madrid, Spain.	ecustodio2014@gmail.com	Aseffa, Abraham/J-3248-2016; Moreno, Javier/AAB-5386-2021; Soto, Antonio Buño/AAM-4851-2020	Aseffa, Abraham/0000-0002-8028-1150; Soto, Antonio Buño/0000-0002-8306-889X; Herrador, Zaida/0000-0002-6508-3818; sordo, Luis/0000-0003-1760-9472; Benito, Agustin/0000-0001-8229-5540; Moreno, Javier/0000-0003-0087-4659	UBS Optimus Foundation	UBS Optimus Foundation	Funding was provided by UBS Optimus Foundation. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Adebara OV, 2011, OPEN J PEDIAT, V1, P12; Adelekan DA, 2003, NUTRITION, V19, P473, DOI 10.1016/S0899-9007(03)00032-7; Allen L, 2008, Med Trop (Mars), V68, P182; Allen L, 2006, GUIDELINES FOOD FORT; Allen LH, 2003, J NUTR, V133, p3875S, DOI 10.1093/jn/133.11.3875S; Amare B, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-108; Amare B, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-752; [Anonymous], 2009, WHO GLOBAL DATABASE; Arabi A, 2010, NAT REV ENDOCRINOL, V6, P550, DOI 10.1038/nrendo.2010.146; Arimond M, 2004, J NUTR, V134, P2579, DOI 10.1093/jn/134.10.2579; Arimond M, 2002, PROGR DEV INFANT CHI; Arnaud J, 2001, BRIT J NUTR, V85, P741, DOI 10.1079/BJN2001362; Belachew T, 2005, E AFR MED J, V82; Belew TA, 2008, NUTR COUNTRY PROFILE; Bhaskaram P, 2002, NUTR REV, V60, pS40, DOI 10.1301/00296640260130722; Bischoff-Ferrari HA, 2006, AM J CLIN NUTR, V84, P18, DOI 10.1093/ajcn/84.1.18; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Prieto MB, 2011, INT J ENV RES PUB HE, V8, P4353, DOI 10.3390/ijerph8114353; Brown KH, 2004, 1 IZINCG; Centers for Disease Control and Prevention (CDC), 2012, 2 CDC; Central Statistical Agency,, 2012, ETH DEM HLTH SURV 20; Custodio E, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001813; Das JK, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-67; de Benoist B, 2006, LANCET, V367, P816, DOI 10.1016/S0140-6736(06)68334-7; Degarege Abraham, 2010, BMC Res Notes, V3, P143, DOI 10.1186/1756-0500-3-143; Degye Goshu, 2013, Journal of Development and Agricultural Economics, V5, P174; Demissie T, 2010, FOOD NUTR BULL, V31, P234, DOI 10.1177/156482651003100206; Dong YB, 2010, PEDIATRICS, V125, P1104, DOI 10.1542/peds.2009-2055; *ETH FED MIN HLTH, 2004, NAT GUID CONTR PREV; Ethiopian Investment Agency, 2012, INV OPP PROF PALM OI; *FAO, 2001, TARG NUTR IMPR RES A; Ferro-Luzzi A, 2001, INT FOOD POLICY RES; Gebremedhin S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-898; Gibson RS, 2008, J NUTR, V138, P581, DOI 10.1093/jn/138.3.581; Gillespie S, 1998, P C HELD SEPT 16 17; Haidar J, 2010, J HEALTH POPUL NUTR, V28, P359; Hall A, 2008, TROP MED INT HEALTH, V13, P1518, DOI 10.1111/j.1365-3156.2008.02168.x; Headey D.D., 2012, IMPROVING MEASUREMEN; Hermiston ML, 2002, PEDIATR CLIN N AM, V49, P877, DOI 10.1016/S0031-3955(02)00029-9; Herrador Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105880; HOLICK MF, 1989, LANCET, V2, P1104; Household Economy Approach (HEA), TAN ZUR LIV ZON TZA; International Zinc Nutrition Consultative Group (IZiNCG), 2007, DET RISK ZINC DEF AS; IZiNCG, 2007, ASS POP ZINC STAT SE; Joint statement by the World Health Organization (WHO) the World Food Programme (WFP) and the United Nations Children's Fund (UNICEF), 2007, PREV CONTR MICR DEF; Kassaye T, 2001, B WORLD HEALTH ORGAN, V79, P415; Kassu A, 2008, BIOL TRACE ELEM RES, V122, P97, DOI 10.1007/s12011-007-8067-6; Kennedy G., 2011, GUID MEAS HOUS IND D; Kim SunHyo, 2006, Korean Journal of Nutrition, V39, P381; Lim HS, 2002, J NUTR SCI VITAMINOL, V48, P290, DOI 10.3177/jnsv.48.290; Lulseged S, 1999, E AFR MED J, V76, P457; Mahmud MA, 2013, PATHOG GLOB HEALTH, V107, P58, DOI 10.1179/2047773213Y.0000000074; McLean E, 2008, FOOD NUTR BULL, V29, pS38, DOI 10.1177/15648265080292S107; Micronutrient Initiative FFI Global Alliance for Improved Nutrition (GAIN) United States Agency for International Development (USAID) The World Bank United Nations Children's Fund (UNICEF), 2009, INV FUT UN CALL ACTI; Organization WH, 2009, GLOB HLTH RISKS MORT; Pettifor JM, 2004, AM J CLIN NUTR, V80, p1725S, DOI 10.1093/ajcn/80.6.1725S; Prentice A, 2009, CLIN REV BONE MINER, V7, P94, DOI 10.1007/s12018-009-9038-6; Radhika M. S., 2003, Food and Nutrition Bulletin, V24, P208; Sauberlich HE., 1999, LAB TESTS ASSESSMENT; Schleicher RL, 2009, AM J CLIN NUTR, V90, P1252, DOI 10.3945/ajcn.2008.27016; Semba RD, 2012, WORLD REV NUTR DIET, V104, P1; Siekmann JH, 2003, J NUTR, V133, p3972S, DOI 10.1093/jn/133.11.3972S; Sordo L, 2012, AM J TROP MED HYG, V86, P955, DOI 10.4269/ajtmh.2012.11-0436; Stoecker BJ, 2009, EUR J CLIN NUTR, V63, P916, DOI 10.1038/ejcn.2008.77; UNICEF and MI, 2004, VIT MIN DEF GLOB DAM; United Nations Children's Fund (UNICEF), 2013, IMPR CHILD NUTR ACH; van den Broek N, 2003, BRIT MED BULL, V67, P149, DOI 10.1093/bmb/ldg004; WHO, 2007, ASS IR STAT POP INCL; *WHO, 1996, IND ASS VIT A DEF TH; WHO, 2001, IRON DEFICIENCY ANAE; World Health Organization, 2011, SER FERR CONC ASS IR; [World Health Organization (WHO) Regional Office for Africa], 2006, HLTH PEOPL AFR REG H; World Health Organization (WHO), 2014, 2012 2013 BIENN REP; World Health Organization (WHO), CHILD HLTH ETH	74	35	36	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e112858	10.1371/journal.pone.0112858	http://dx.doi.org/10.1371/journal.pone.0112858			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546056	gold, Green Published, Green Submitted			2022-12-27	WOS:000347120200003
J	Liu, M; Xu, RQ; Merrill, C; Hong, LW; Von Lanken, C; Hunt, AG; Li, QSQ				Liu, Man; Xu, Ruqiang; Merrill, Carrie; Hong, Liwei; Von Lanken, Carol; Hunt, Arthur G.; Li, Qingshun Q.			Integration of Developmental and Environmental Signals via a Polyadenylation Factor in Arabidopsis	PLOS ONE			English	Article							MESSENGER-RNA POLYADENYLATION; LATERAL ROOT-FORMATION; ZINC-FINGER PROTEINS; SPECIFICITY FACTOR; FACTOR SUBUNIT; PLANT DEVELOPMENT; SITE CHOICE; CLEAVAGE; INTERACTS; ORTHOLOG	The ability to integrate environmental and developmental signals with physiological responses is critical for plant survival. How this integration is done, particularly through posttranscriptional control of gene expression, is poorly understood. Previously, it was found that the 30 kD subunit of Arabidopsis cleavage and polyadenylation specificity factor (AtCPSF30) is a calmodulin-regulated RNA-binding protein. Here we demonstrated that mutant plants (oxt6) deficient in AtCPSF30 possess a novel range of phenotypes-reduced fertility, reduced lateral root formation, and altered sensitivities to oxidative stress and a number of plant hormones (auxin, cytokinin, gibberellic acid, and ACC). While the wild-type AtCPSF30 (C30G) was able to restore normal growth and responses, a mutant AtCPSF30 protein incapable of interacting with calmodulin (C30GM) could only restore wild-type fertility and responses to oxidative stress and ACC. Thus, the interaction with calmodulin is important for part of AtCPSF30 functions in the plant. Global poly(A) site analysis showed that the C30G and C30GM proteins can restore wild-type poly(A) site choice to the oxt6 mutant. Genes associated with hormone metabolism and auxin responses are also affected by the oxt6 mutation. Moreover, 19 genes that are linked with calmodulin-dependent CPSF30 functions, were identified through genome-wide expression analysis. These data, in conjunction with previous results from the analysis of the oxt6 mutant, indicate that the polyadenylation factor AtCPSF30 is a regulatory hub where different signaling cues are transduced, presumably via differential mRNA 39 end formation or alternative polyadenylation, into specified phenotypic outcomes. Our results suggest a novel function of a polyadenylation factor in environmental and developmental signal integration.	[Liu, Man; Xu, Ruqiang; Li, Qingshun Q.] Miami Univ, Dept Biol, Oxford, OH 45045 USA; [Merrill, Carrie; Von Lanken, Carol; Hunt, Arthur G.] Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY 40506 USA; [Hong, Liwei; Li, Qingshun Q.] Xiamen Univ, Key Lab, Minist Educ Costal Wetland Ecosyst, Coll Environm & Ecol, Xiamen 361102, Fujian, Peoples R China; [Li, Qingshun Q.] Fujian Acad Agr Sci, Rice Res Inst, Fuzhou 350003, Fujian, Peoples R China	University System of Ohio; Miami University; University of Kentucky; Xiamen University; Fujian Academy of Agricultural Sciences	Hunt, AG (corresponding author), Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY 40506 USA.	aghunt00@uky.edu; liq@miamioh.edu	Xu, Ruqiang/GWQ-6267-2022	Xu, Ruqiang/0000-0002-8966-2670; Hunt, Arthur/0000-0002-0008-4158; Li, Qingshun/0000-0003-4105-1480	US National Science Foundation [IOS0817818]; Ohio Plant Biotech Consortium; Fujian Hundred Talent Plan; Xiamen University	US National Science Foundation(National Science Foundation (NSF)); Ohio Plant Biotech Consortium; Fujian Hundred Talent Plan; Xiamen University(Xiamen University)	US National Science Foundation (IOS0817818) to QQL and AGH, and a grant from Ohio Plant Biotech Consortium to QQL. QQL also received funding support while working on this paper from the Fujian Hundred Talent Plan and from Xiamen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addepalli B, 2008, FEBS LETT, V582, P2577, DOI 10.1016/j.febslet.2008.06.029; Addepalli B, 2008, ARCH BIOCHEM BIOPHYS, V473, P88, DOI 10.1016/j.abb.2008.02.027; Addepalli B, 2008, PROTEIN PEPTIDE LETT, V15, P76; Addepalli B, 2007, NUCLEIC ACIDS RES, V35, P4453, DOI 10.1093/nar/gkm457; Addepalli B, 2010, FEBS LETT, V584, P4408, DOI 10.1016/j.febslet.2010.09.043; Barabino SML, 1997, GENE DEV, V11, P1703, DOI 10.1101/gad.11.13.1703; Bashandy T, 2011, PLANT SIGNAL BEHAV, V6, P117, DOI 10.4161/psb.6.1.14203; Bell SA, 2010, FEBS LETT, V584, P1449, DOI 10.1016/j.febslet.2010.03.007; Benjamins R, 2003, PLANT PHYSIOL, V132, P1623, DOI 10.1104/pp.103.019943; Brown VL, 2015, METHODS MOL BIOL, V1203, P175, DOI 10.1007/978-1-4939-1357-2_17; Bruggeman Q, 2014, PLANT PHYSIOL, V165, P732, DOI 10.1104/pp.114.236083; Cecchetti V, 2008, PLANT CELL, V20, P1760, DOI 10.1105/tpc.107.057570; Chan S, 2011, WIRES RNA, V2, P321, DOI 10.1002/wrna.54; Chan SL, 2014, GENE DEV, V28, P2370, DOI 10.1101/gad.250993.114; Chen CW, 2006, PLANT CELL PHYSIOL, V47, P1, DOI 10.1093/pcp/pci216; Chen YH, 2012, PROTOPLASMA, V249, P187, DOI 10.1007/s00709-011-0277-2; Cheng H, 2004, DEVELOPMENT, V131, P1055, DOI 10.1242/dev.00992; Cheng H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000440; Colgan DF, 1997, GENE DEV, V11, P2755, DOI 10.1101/gad.11.21.2755; Collart C, 2005, GENES CELLS, V10, P897, DOI 10.1111/j.1365-2443.2005.00887.x; Collart C, 2009, DEVELOPMENT, V136, P3451, DOI 10.1242/dev.027714; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Delaney KJ, 2006, PLANT PHYSIOL, V140, P1507, DOI 10.1104/pp.105.070672; Doerner P, 2008, CSH PROTOC, V2008; Fukaki H, 2009, PLANT MOL BIOL, V69, P437, DOI 10.1007/s11103-008-9417-2; Gapper C, 2006, PLANT PHYSIOL, V141, P341, DOI 10.1104/pp.106.079079; Hall AE, 2003, PLANT CELL, V15, P2032, DOI 10.1105/tpc.013060; Herr AJ, 2006, P NATL ACAD SCI USA, V103, P14994, DOI 10.1073/pnas.0606536103; Hunt AG, 2008, CURR TOP MICROBIOL, V326, P151; Hunt AG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-220; Ito T, 2007, PLANT CELL, V19, P3516, DOI 10.1105/tpc.107.055467; Kauschmann A, 1996, PLANT J, V9, P701, DOI 10.1046/j.1365-313X.1996.9050701.x; Keller W, 1997, CURR OPIN CELL BIOL, V9, P329, DOI 10.1016/S0955-0674(97)80004-X; KELLER W, 1991, EMBO J, V10, P4241, DOI 10.1002/j.1460-2075.1991.tb05002.x; Lalanne E, 2002, PLANT PHYSIOL, V129, P865, DOI 10.1104/pp.003301; Liu FQ, 2010, SCIENCE, V327, P94, DOI 10.1126/science.1180278; Liu YF, 2008, PLANT J, V55, P844, DOI 10.1111/j.1365-313X.2008.03557.x; Ma LY, 2014, METHODS, V67, P74, DOI 10.1016/j.ymeth.2013.06.037; Ma LY, 2014, P NATL ACAD SCI USA, V111, P9, DOI 10.1073/pnas.1321025111; MACDONALD CC, 1994, MOL CELL BIOL, V14, P6647, DOI 10.1128/MCB.14.10.6647; Malamy JE, 1997, DEVELOPMENT, V124, P33; Mandel CR, 2008, CELL MOL LIFE SCI, V65, P1099, DOI 10.1007/s00018-007-7474-3; Millevoi S, 2010, NUCLEIC ACIDS RES, V38, P2757, DOI 10.1093/nar/gkp1176; Peret B, 2009, TRENDS PLANT SCI, V14, P399, DOI 10.1016/j.tplants.2009.05.002; Rao S, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-51; Riefler M, 2006, PLANT CELL, V18, P40, DOI 10.1105/tpc.105.037796; Simpson GG, 2003, CELL, V113, P777, DOI 10.1016/S0092-8674(03)00425-2; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Snedden WA, 2001, NEW PHYTOL, V151, P35, DOI 10.1046/j.1469-8137.2001.00154.x; Sonmez C, 2011, P NATL ACAD SCI USA, V108, P8508, DOI 10.1073/pnas.1105334108; Tacahashi Y, 2003, NUCLEIC ACIDS RES, V31, P1744, DOI 10.1093/nar/gkg265; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Thomas PE, 2012, PLANT CELL, V24, P4376, DOI 10.1105/tpc.112.096107; Usadel B, 2005, PLANT PHYSIOL, V138, P1195, DOI 10.1104/pp.105.060459; Xing DH, 2008, PLANT J, V54, P899, DOI 10.1111/j.1365-313X.2008.03455.x; Xing DH, 2008, PLANT PHYSIOL, V148, P2059, DOI 10.1104/pp.108.129817; Xing SP, 2011, PLANT SIGNAL BEHAV, V6, P934, DOI 10.4161/psb.6.7.15668; Xu RQ, 2006, PLANT MOL BIOL, V61, P799, DOI 10.1007/s11103-006-0051-6; Yang Q, 2011, WIRES RNA, V2, P732, DOI 10.1002/wrna.88; Zhang JX, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002410; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999	62	17	17	4	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115779	10.1371/journal.pone.0115779	http://dx.doi.org/10.1371/journal.pone.0115779			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546057	Green Submitted, Green Published, gold			2022-12-27	WOS:000347120200067
J	Wang, X; Li, YL; Han, R; He, C; Wang, GL; Wang, JW; Zheng, JL; Pei, M; Wei, L				Wang, Xin; Li, Yanlin; Han, Rui; He, Chuan; Wang, Guoliang; Wang, Jianwei; Zheng, Jiali; Pei, Mei; Wei, Lei			Demineralized Bone Matrix Combined Bone Marrow Mesenchymal Stem Cells, Bone Morphogenetic Protein-2 and Transforming Growth Factor-beta 3 Gene Promoted Pig Cartilage Defect Repair	PLOS ONE			English	Article							CHONDROGENIC DIFFERENTIATION; COLLAGEN SCAFFOLDS; EXPRESSION; CONSTRUCTION; CHONDROCYTES; TGF-BETA-3; STRATEGIES; VECTOR; MSC	Objectives: To investigate whether a combination of demineralized bone matrix (DBM) and bone marrow mesenchymal stem cells (BMSCs) infected with adenovirus-mediated-bone morphogenetic protein (Ad-BMP-2) and transforming growth factor-beta 3 (Ad-TGF-beta 3) promotes the repair of the full-thickness cartilage lesions in pig model. Methods: BMSCs isolated from pig were cultured and infected with Ad-BMP-2(B group), Ad-TGF-beta 3 (T group), Ad-BMP-2 + Ad-TGF-beta 3(BT group), cells infected with empty Ad served as a negative group(N group), the expression of the BMP-2 and TGF-beta 3 were confirmed by immunofluorescence, PCR, and ELISA, the expression of SOX-9, type II collagen(COL-2A), aggrecan (ACAN) in each group were evaluated by real-time PCR at 1w, 2w, 3w, respectively. The chondrogenic differentiation of BMSCs was evaluated by type II collagen at 21d with immunohistochemical staining. The third-passage BMSCs infected with Ad-BMP-2 and Ad-TGF-beta 3 were suspended and cultured with DBM for 6 days to construct a new type of tissue engineering scaffold to repair full-thickness cartilage lesions in the femur condyles of pig knee, the regenerated tissue was evaluated at 1,2 and 3 months after surgery by gross appearance, H&E, safranin O staining and O'driscoll score. Results: Ad-BMP-2 and Ad-TGF-beta 3 (BT group) infected cells acquired strong type II collagen staining compared with Ad-BMP-2 (B group) and Ad-TGF-beta 3 (T group) along. The Ad-BMP-2 and Ad-TGF-beta 3 infected BMSCs adhered and propagated well in DBM and the new type of tissue engineering scaffold produced hyaline cartilage morphology containing a stronger type II collagen and safranin O staining, the O'driscoll score was higher than other groups. Conclusions: The DBM compound with Ad-BMP-2 and Ad-TGF-beta 3 infected BMSCs scaffold has a good biocompatibility and could well induce cartilage regeneration to repair the defects of joint cartilage. This technology may be efficiently employed for cartilage lesions repair in vivo.	[Wang, Xin; Li, Yanlin; He, Chuan; Wang, Guoliang; Wang, Jianwei; Zheng, Jiali] Kunming Med Univ, Affiliated Hosp 1, Dept Sports Med, Kunming, Peoples R China; [Han, Rui] Kunming Med Univ, Affiliated Hosp 1, Dept Diabetol, Kunming, Peoples R China; [Pei, Mei] W Virginia Univ, Dept Orthoped, Morgantown, WV 26506 USA; [Wei, Lei] Brown Univ, Warren Alpert Med Sch, Dept Orthoped, Providence, RI 02912 USA	Kunming Medical University; Kunming Medical University; West Virginia University; Brown University	Li, YL (corresponding author), Kunming Med Univ, Affiliated Hosp 1, Dept Sports Med, Kunming, Peoples R China.	852387873@qq.com	Pei, Ming/N-8175-2017		Specialized Research Fund for the Doctoral Program of Higher Education [20115317110001]; Natural Science Foundation of Yunnan Province [2011FB169]	Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation of Yunnan Province(Natural Science Foundation of Yunnan Province)	(No. 20115317110001) Specialized Research Fund for the Doctoral Program of Higher Education www.cutech.edu.cn and (No. 2011FB169) Natural Science Foundation of Yunnan Province www.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah BM, 2008, GENE THER, V15, P109, DOI 10.1038/sj.gt.3303067; Aulin C, 2013, LAB ANIM-UK, V47, P58, DOI 10.1177/0023677212473716; Becher C, 2010, KNEE SURG SPORT TR A, V18, P656, DOI 10.1007/s00167-009-1036-1; Bhang SH, 2011, BIOTECHNOL APPL BIOC, V58, P271, DOI 10.1002/bab.39; Caron MMJ, 2013, OSTEOARTHR CARTILAGE, V21, P604, DOI 10.1016/j.joca.2013.01.009; Esquivies L, 2014, J BIOL CHEM, V289, P1788, DOI 10.1074/jbc.M113.529180; Fan HB, 2010, J BIOMED MATER RES A, V95A, P982, DOI 10.1002/jbm.a.32899; Feng JAQ, 2010, FASEB J, V24, P1879, DOI 10.1096/fj.09-144659; Froelich K, 2012, INT J ARTIF ORGANS, V35, P1047, DOI 10.5301/ijao.5000132; Gao C, 2013, EUR CELLS MATER, V26, P195, DOI 10.22203/eCM.v026a14; Grunder T, 2004, OSTEOARTHR CARTILAGE, V12, P559, DOI 10.1016/j.joca.2004.04.001; Hui JHP, 2013, ARTHROSCOPY, V29, P1992, DOI 10.1016/j.arthro.2013.06.009; Hwang NS, 2006, STEM CELLS, V24, P284, DOI 10.1634/stemcells.2005-0024; Jeng L, 2013, TISSUE ENG PT A, V19, P2267, DOI [10.1089/ten.tea.2013.0013, 10.1089/ten.TEA.2013.0013]; Kurkalli BGS, 2010, CURR STEM CELL RES T, V5, P49, DOI 10.2174/157488810790442831; Lehmann M, 2013, EUR J HISTOCHEM, V57, P205, DOI 10.4081/ejh.2013.e31; Liao IC, 2013, ADV FUNCT MATER, V23, P5833, DOI 10.1002/adfm.201300483; Liu DP, 2013, MOL MED REP, V7, P659, DOI 10.3892/mmr.2012.1237; Mafi P, 2012, CURR STEM CELL RES T, V7, P302, DOI 10.2174/157488812800793045; Minehara H, 2011, CELL TISSUE BANK, V12, P199, DOI 10.1007/s10561-010-9185-5; Muller S, 2010, OPEN ORTHOP J, V4, P111; Neumann AJ, 2013, TISSUE ENG PT A, V19, P1285, DOI [10.1089/ten.tea.2012.0411, 10.1089/ten.TEA.2012.0411]; O'Driscoll SW, 2001, CLIN ORTHOP RELAT R, pS397; Oryan A, 2014, J ORTHOP SURG RES, V9, DOI 10.1186/1749-799X-9-18; Pourmohammadali H, 2013, P I MECH ENG H, V227, P310, DOI 10.1177/0954411912468638; Redman S N, 2005, Eur Cell Mater, V9, P23; Reyes R, 2013, EUR CELLS MATER, V25, P351, DOI 10.22203/eCM.v025a25; Ronziere MC, 2010, BIO-MED MATER ENG, V20, P145, DOI 10.3233/BME-2010-0626; Rui YF, 2010, CHINESE MED J-PEKING, V123, P3040, DOI 10.3760/cma.j.issn.0366-6999.2010.21.017; Santhagunam A, 2012, BIOTECHNOL APPL BIOC, V59, P121, DOI 10.1002/bab.1016; Shintani N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053086; Stevens MM, 2004, J ORTHOP RES, V22, P1114, DOI 10.1016/j.orthres.2003.12.021; Tsuzuki N, 2013, CAN VET J, V54, P573; Wu W, 2013, J HUAZHONG U SCI TEC; Zhang F, 2010, J CONTROL RELEASE, V142, P70, DOI 10.1016/j.jconrel.2009.09.027; Zhang XJ, 2006, ADV DRUG DELIVER REV, V58, P515, DOI 10.1016/j.addr.2006.03.006; Zhu L, 2010, BRIT J ORAL MAX SURG, V48, P462, DOI 10.1016/j.bjoms.2009.08.012	37	33	35	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e116061	10.1371/journal.pone.0116061	http://dx.doi.org/10.1371/journal.pone.0116061			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545777	Green Published, Green Submitted, gold			2022-12-27	WOS:000347120200096
J	Diopere, E; Maes, GE; Komen, H; Volckaert, FAM; Groenen, MAM				Diopere, Eveline; Maes, Gregory E.; Komen, Hans; Volckaert, Filip A. M.; Groenen, Martien A. M.			A Genetic Linkage Map of Sole (Solea solea): A Tool for Evolutionary and Comparative Analyses of Exploited (Flat)Fishes	PLOS ONE			English	Article							TURBOT SCOPHTHALMUS-MAXIMUS; COMMON SOLE; MICROSATELLITE MARKERS; COMPARATIVE GENOMICS; MARINE FISHES; POPULATIONS; TIME; DIVERGENCE; PLEURONECTIFORMES; SENEGALENSIS	Linkage maps based on markers derived from genes are essential evolutionary tools for commercial marine fish to help identify genomic regions associated with complex traits and subject to selective forces at play during exploitation or selective breeding. Additionally, they allow the use of genomic information from other related species for which more detailed information is available. Sole (solea solea L.) is a commercially important flatfish species in the North Sea, subject to overexploitation and showing evidence of fisheries-induced evolutionary changes in growth- and maturation-related traits. Sole would definitely benefit from a linkage map to better understand how evolution has shaped its genome structure. This study presents a linkage map of sole based on 423 single nucleotide polymorphisms derived from expressed sequence tags and 8 neutral microsatellite markers. The total map length is 1233.8 cM and consists of 38 linkage groups with a size varying between 0 to 92.1 cM. Being derived from expressed sequence tags allowed us to align the map with the genome of four model fish species, namely medaka (Oryzias latipes), Nile tilapia (Oreochromis niloticus), three-spined stickleback (Gasterosteus aculeatus) and green spotted pufferfish (Tetraodon nigroviridis). This comparison revealed multiple conserved syntenic regions with all four species, and suggested that the linkage groups represent 21 putative sole chromosomes. The map was also compared to the linkage map of turbot (Scophthalmus maximus), another commercially important flatfish species and closely related to sole. For all putative sole chromosomes (except one) a turbot homolog was detected, confirming the even higher degree of synteny between these two flatfish species.	[Diopere, Eveline; Maes, Gregory E.; Volckaert, Filip A. M.] Univ Leuven, Lab Biodivers & Evolutionary Genom, B-3000 Leuven, Belgium; [Komen, Hans; Groenen, Martien A. M.] Wageningen Univ, Anim Breeding & Genom Ctr, NL-6700 AH Wageningen, Netherlands; [Maes, Gregory E.] James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld 4811, Australia	KU Leuven; Wageningen University & Research; James Cook University	Diopere, E (corresponding author), Univ Leuven, Lab Biodivers & Evolutionary Genom, Ch Deberiotstr 32, B-3000 Leuven, Belgium.	eveline.diopere@bio.kuleuven.be	Groenen, Martien/D-8408-2012; Maes, Gregory/C-5450-2008; Komen, Hans/D-8876-2012; Maes, Gregory/N-4983-2019; Volckaert, Filip/AAC-7691-2019	Groenen, Martien/0000-0003-0484-4545; Maes, Gregory/0000-0002-1531-7321; Maes, Gregory/0000-0002-1531-7321; Diopere, Eveline/0000-0001-5773-2294	European Science Foundation programme Advances in Farm Animal Genomic Resources (LESC) [EX/3285]; European Community seventh Framework Programme [KBBE-212399]; Research Foundation-Flanders (FWO-Vlaanderen)	European Science Foundation programme Advances in Farm Animal Genomic Resources (LESC); European Community seventh Framework Programme(European Commission); Research Foundation-Flanders (FWO-Vlaanderen)(FWO)	Research was funded by the European Science Foundation programme Advances in Farm Animal Genomic Resources (LESC) (grant no EX/3285). The development of the SNP markers was funded by the European Community seventh Framework Programme during the FishPopTrace project (grant agreement no KBBE-212399). E.D. acknowledges a PhD grant from the Research Foundation-Flanders (FWO-Vlaanderen). G.E.M. was a post-doctoral researcher funded by the Research Foundation-Flanders (FWO-Vlaanderen) during the writing of this article and is now lecturer at James Cook University (Australia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf FW, 2008, TRENDS ECOL EVOL, V23, P327, DOI 10.1016/j.tree.2008.02.008; Betancur-R R., 2013, PLOS CURR, V18; Betancur R, 2013, SYST BIOL, V62, P763, DOI 10.1093/sysbio/syt039; Blonk RJW, 2010, THESIS WAGENINGEN U; Blonk RJW, 2010, GENETICS, V184, P213, DOI 10.1534/genetics.109.110536; Blonk RJW, 2010, AQUACULTURE, V300, P43, DOI 10.1016/j.aquaculture.2009.12.028; Blonk RJW, 2009, AQUACULTURE, V289, P26, DOI 10.1016/j.aquaculture.2009.01.012; BOUZA C, 1994, MAR BIOL, V120, P609, DOI 10.1007/BF00350082; Bouza C, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-54; Brunet FG, 2006, MOL BIOL EVOL, V23, P1808, DOI 10.1093/molbev/msl049; Canario AVM, 2008, REV FISH SCI, V16, P3, DOI 10.1080/10641260802319479; Castano-Sanchez C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-554; Cerda J, 2010, J FISH BIOL, V77, P1045, DOI 10.1111/j.1095-8649.2010.02695.x; Cerda J, 2013, GENES NUTR, V8, P5, DOI 10.1007/s12263-012-0312-8; CHAKRAVARTI A, 1991, GENETICS, V128, P175; Conover DO, 2006, J FISH BIOL, V69, P21, DOI 10.1111/j.1095-8649.2006.01274.x; Fishman L, 2001, GENETICS, V159, P1701; Garoia F, 2006, MOL ECOL NOTES, V6, P144, DOI 10.1111/j.1471-8286.2005.01169.x; Gibson N.R., 2005, FLATFISHES BIOL EXPL; Green P, 1990, DOCUMENTATION CRI MA; Guyon R, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-222; Guyon R, 2010, GENOMICS, V96, P228, DOI 10.1016/j.ygeno.2010.07.007; Hermida M, 2014, AQUACULTURE, V420, pS111, DOI 10.1016/j.aquaculture.2013.02.041; Howell BR, 1997, AQUACULTURE, V155, P355, DOI 10.1016/S0044-8486(97)00103-8; Hutchings JA, 2004, BIOSCIENCE, V54, P297, DOI 10.1641/0006-3568(2004)054[0297:MFPCCF]2.0.CO;2; ICES, 2012, REP ICES ADV COMM; Imsland AK, 2003, REV FISH BIOL FISHER, V13, P379, DOI 10.1007/s11160-004-1632-6; Iyengar A, 2000, MAR BIOTECHNOL, V2, P49; Jorgensen C, 2007, SCIENCE, V318, P1247, DOI 10.1126/science.1148089; Kai W, 2011, GENOME BIOL EVOL, V3, P424, DOI 10.1093/gbe/evr041; Kang JH, 2008, INT J BIOL SCI, V4, P143, DOI 10.7150/ijbs.4.143; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Kenchington E, 2003, ICES J MAR SCI, V60, P1172, DOI 10.1016/S1054-3139(03)00136-X; Kuparinen A, 2007, TRENDS ECOL EVOL, V22, P652, DOI 10.1016/j.tree.2007.08.011; Lee AP, 2011, MOL BIOL EVOL, V28, P1205, DOI 10.1093/molbev/msq304; Li Xin, 2009, Journal of Bioinformatics and Computational Biology, V7, P521, DOI 10.1142/S0219720009004217; Liao XL, 2009, MAR BIOTECHNOL, V11, P699, DOI 10.1007/s10126-009-9184-3; Mabuchi K, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-10; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Meynard CN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036443; Moen T, 2009, ANIM GENET, V40, P993, DOI 10.1111/j.1365-2052.2009.01938.x; Molina-Luzon MJ, 2012, MOL ECOL RESOUR, V12, P956, DOI 10.1111/j.1755-0998.2012.03163.x; Mollet FM, 2007, MAR ECOL PROG SER, V351, P189, DOI 10.3354/meps07138; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Nielsen EE, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1845; Nielsen EE, 2009, MOL ECOL, V18, P3128, DOI 10.1111/j.1365-294X.2009.04272.x; Pardo BG, 2001, HEREDITY, V86, P531, DOI 10.1046/j.1365-2540.2001.00802.x; POSTLETHWAIT JH, 1994, SCIENCE, V264, P699, DOI 10.1126/science.8171321; Reid DP, 2007, GENETICS, V177, P1193, DOI 10.1534/genetics.107.075374; Ruan XH, 2010, AQUACULTURE, V308, P89, DOI 10.1016/j.aquaculture.2010.08.010; Sarropoulou E, 2008, MAR BIOTECHNOL, V10, P227, DOI 10.1007/s10126-007-9066-5; Setiamarga DHE, 2009, BIOL LETTERS, V5, P812, DOI 10.1098/rsbl.2009.0419; Sharpe DMT, 2009, EVOL APPL, V2, P260, DOI 10.1111/j.1752-4571.2009.00080.x; Song WT, 2013, CURR ZOOL, V59, P99, DOI 10.1093/czoolo/59.1.99; Storz JF, 2005, MOL ECOL, V14, P671, DOI 10.1111/j.1365-294X.2005.02437.x; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Walsh MR, 2006, ECOL LETT, V9, P142, DOI 10.1111/j.1461-0248.2005.00858.x; Wenne R, 2007, AQUAT LIVING RESOUR, V20, P241, DOI 10.1051/alr:2007037; Yu JK, 2004, MOL GENET GENOMICS, V271, P742, DOI 10.1007/s00438-004-1027-3	59	11	11	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115040	10.1371/journal.pone.0115040	http://dx.doi.org/10.1371/journal.pone.0115040			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541971	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000347239900020
J	Jacquet, N; Navarre, C; Desmecht, D; Boutry, M				Jacquet, Nicolas; Navarre, Catherine; Desmecht, Daniel; Boutry, Marc			Hydrophobin Fusion of an Influenza Virus Hemagglutinin Allows High Transient Expression in Nicotiana benthamiana, Easy Purification and Immune Response with Neutralizing Activity	PLOS ONE			English	Article							RECOMBINANT PROTEINS; RAPID PRODUCTION; TABACUM; PLANTS; IMMUNOGENICITY; ANTIBODIES; CHALLENGE; PARTICLES; EFFICIENT; VACCINES	The expression of recombinant hemagglutinin in plants is a promising alternative to the current egg-based production system for the influenza vaccines. Protein-stabilizing fusion partners have been developed to overcome the low production yields and the high downstream process costs associated with the plant expression system. In this context, we tested the fusion of hydrophobin I to the hemagglutinin ectodomain of the influenza A (H1N1)pdm09 virus controlled by the hybrid En(2)PMA4 transcriptional promoter to rapidly produce high levels of recombinant antigen by transient expression in agro-infiltrated Nicotiana benthamiana leaves. The fusion increased the expression level by a factor of similar to 2.5 compared to the unfused protein allowing a high accumulation level of 8.6% of the total soluble proteins. Hemagglutinin was located in ER-derived protein bodies and was successfully purified by combining an aqueous-two phase partition system and a salting out step. Hydrophobin interactions allowed the formation of high molecular weight hemagglutinin structures, while unfused proteins were produced as monomers. Purified protein was shown to be biologically active and to induce neutralizing antibodies after mice immunization. Hydrophobin fusion to influenza hemagglutinin might therefore be a promising approach for rapid, easy, and low cost production of seasonal or pandemic influenza vaccines in plants.	[Jacquet, Nicolas; Navarre, Catherine; Boutry, Marc] Univ Louvain, Inst Life Sci, Louvain, Belgium; [Desmecht, Daniel] Univ Liege, Fac Vet Med, Dept Pathol, Liege, Belgium	University of Liege	Boutry, M (corresponding author), Univ Louvain, Inst Life Sci, Louvain, Belgium.			Boutry, Marc/0000-0002-2315-6900	Service public de Wallonie [Waleo3 08/1/6861]; Belgian Fund for Scientific Research; Fonds pour la Formation a la Recherche dans l'Industrie et l'Agriculture (Belgium); STFC [ST/I001816/1, ST/K000853/1] Funding Source: UKRI	Service public de Wallonie; Belgian Fund for Scientific Research(Fonds de la Recherche Scientifique - FNRS); Fonds pour la Formation a la Recherche dans l'Industrie et l'Agriculture (Belgium)(Fonds de la Recherche Scientifique - FNRS); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This work was supported in part by grants from the Service public de Wallonie (Waleo3 08/1/6861) and the Belgian Fund for Scientific Research. NJ is recipient of a fellowship from the Fonds pour la Formation a la Recherche dans l'Industrie et l'Agriculture (Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimanianda V, 2009, NATURE, V460, P1117, DOI 10.1038/nature08264; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURNET F. M., 1941, AUSTRALIAN JOUR EXP BIOL AND MED SCI, V19, P291, DOI 10.1038/icb.1941.44; Conley AJ, 2011, PLANT BIOTECHNOL J, V9, P419, DOI 10.1111/j.1467-7652.2011.00596.x; Crouzet J, 2013, PLANT MOL BIOL, V82, P181, DOI 10.1007/s11103-013-0053-0; Cummings JF, 2014, VACCINE, V32, P2251, DOI 10.1016/j.vaccine.2013.10.017; D'Aoust MA, 2008, PLANT BIOTECHNOL J, V6, P930, DOI 10.1111/j.1467-7652.2008.00384.x; D'Aoust MA, 2010, PLANT BIOTECHNOL J, V8, P607, DOI 10.1111/j.1467-7652.2009.00496.x; De Muynck B, 2009, TRANSGENIC RES, V18, P467, DOI 10.1007/s11248-008-9240-1; Duby G, 2010, PROTEOMICS, V10, P2545, DOI 10.1002/pmic.200900527; Floss DM, 2010, TRENDS BIOTECHNOL, V28, P37, DOI 10.1016/j.tibtech.2009.10.004; Gutierrez SP, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-40; Phan HT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099347; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Joensuu JJ, 2012, METHODS MOL BIOL, V824, P527, DOI 10.1007/978-1-61779-433-9_28; Joensuu JJ, 2010, PLANT PHYSIOL, V152, P622, DOI 10.1104/pp.109.149021; Kanagarajan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033010; Kershaw MJ, 1998, FUNGAL GENET BIOL, V23, P18, DOI 10.1006/fgbi.1997.1022; Khurana S, 2011, VACCINE, V29, P5657, DOI 10.1016/j.vaccine.2011.06.014; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Leuzinger K, 2013, JOVE-J VIS EXP, DOI 10.3791/50521; Linder MB, 2004, BIOCHEMISTRY-US, V43, P11873, DOI 10.1021/bi0488202; Moriau L, 1999, PLANT J, V19, P31, DOI 10.1046/j.1365-313X.1999.00495.x; Mortimer E, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-14; Musiychuk K, 2007, INFLUENZA OTHER RESP, V1, P19, DOI 10.1111/j.1750-2659.2006.00005.x; NAGATA T, 1992, INT REV CYTOL, V132, P1, DOI 10.1016/S0074-7696(08)62452-3; NakariSetala T, 1996, EUR J BIOCHEM, V235, P248, DOI 10.1111/j.1432-1033.1996.00248.x; Navarre C, 2006, TRANSGENIC RES, V15, P325, DOI 10.1007/s11248-006-0002-7; OIE - World Organization for Animal Health, 2005, MANUAL DIAGNOSTIC TE; Perez-Bueno ML, 2004, PROTEOMICS, V4, P418, DOI 10.1002/pmic.200300655; Phan HT, 2013, PLANT BIOTECHNOL J, V11, P582, DOI 10.1111/pbi.12049; Reuter LJ, 2014, PLANT BIOTECHNOL J, V12, P402, DOI 10.1111/pbi.12147; Rybicki EP, 2010, PLANT BIOTECHNOL J, V8, P620, DOI 10.1111/j.1467-7652.2010.00507.x; Sainsbury F, 2009, PLANT BIOTECHNOL J, V7, P682, DOI 10.1111/j.1467-7652.2009.00434.x; Santiago FW, 2012, VACCINE, V30, P4606, DOI 10.1016/j.vaccine.2012.05.005; Shaw A, 2012, VACCINE, V30, P4927, DOI 10.1016/j.vaccine.2012.04.095; Shoji Y, 2009, VACCINE, V27, P1087, DOI 10.1016/j.vaccine.2008.11.108; Shoji Y, 2008, VACCINE, V26, P2930, DOI 10.1016/j.vaccine.2008.03.045; Shoji Y, 2012, INFLUENZA OTHER RESP, V6, P204, DOI 10.1111/j.1750-2659.2011.00295.x; Shoji Y, 2011, HUM VACCINES, V7, P41, DOI 10.4161/hv.7.0.14561; Szilvay GR, 2006, BIOCHEMISTRY-US, V45, P8590, DOI 10.1021/bi060620y; Tognotti E, 2009, J INFECT DEV COUNTR, V3, P331, DOI 10.3855/jidc.239; Torrent M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-5; van der Fits L, 2000, PLANT MOL BIOL, V43, P495, DOI 10.1023/A:1006440221718; Wang W, 2012, INT J PHARMACEUT, V431, P1, DOI 10.1016/j.ijpharm.2012.04.040; Weaver EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018314; Yusibov V., 2010, BIOL, V65, P195	47	11	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115944	10.1371/journal.pone.0115944	http://dx.doi.org/10.1371/journal.pone.0115944			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541987	Green Published, gold			2022-12-27	WOS:000347239900113
J	Joosten, H; Visser, ST; van Eersel, ME; Gansevoort, RT; Bilo, HJG; Slaets, JP; Izaks, GJ				Joosten, Hanneke; Visser, Sipke T.; van Eersel, Marlise E.; Gansevoort, Ron T.; Bilo, Henk J. G.; Slaets, Joris P.; Izaks, Gerbrand J.			Statin Use and Cognitive Function: Population-Based Observational Study with Long-Term Follow-Up	PLOS ONE			English	Article							CARDIOVASCULAR RISK PROFILE; OLDER-ADULTS; DISEASE; DEMENTIA; CHOLESTEROL; PREVENTION; IMPAIRMENT	We aimed to evaluate the association between statin use and cognitive function. Cognitive function was measured with the Ruff Figural Fluency Test (RFFT; worst score, 0; best score, 175 points) and the Visual Association Test (VAT; low performance, 0-10; high performance, 11-12 points) in an observational study that included 4,095 community-dwelling participants aged 35-82 years. Data on statin use were obtained from a computerized pharmacy database. Analysis were done for the total cohort and subsamples matched on cardiovascular risk (N=1232) or propensity score for statin use (N=3609). We found that a total of 904 participants (10%) used a statin. Statin users were older than non-users: mean age (SD) 61 (10) vs. 52 (11) years (p<0.001). The median duration of statin use was 3.8 (interquartile range, 1.6-4.5) years. Unadjusted, statin users had worse cognitive performance than non-users. The mean RFFT score (SD) in statin users and non-users was 58 (23) and 72 (26) points, respectively (p<0.001). VAT performance was high in 261 (29%) statin users and 1351 (43%) non-users (p<0.001). However, multiple regression analysis did not show a significant association of RFFT score with statin use (B, -0.82; 95% CI, -2.77 to 1.14; p=0.41) nor with statin solubility, statin dose or duration of statin use. Statin users with high doses or long-term use had similar cognitive performance as non-users. This was found in persons with low as well as high cardiovascular risk, and in younger as well as older subjects. Also, the mean RFFT score per quintile of propensity score for statin use was comparable for statin users and non-users. Similar results were found for the VAT score as outcome measure. In conclusion, statin use was not associated with cognitive function. This was independent of statin dose or duration of statin use.	[Joosten, Hanneke; Bilo, Henk J. G.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Groningen, Netherlands; [Visser, Sipke T.] Univ Groningen, Dept Pharm, Groningen, Netherlands; [van Eersel, Marlise E.; Slaets, Joris P.; Izaks, Gerbrand J.] Univ Groningen, Univ Med Ctr Groningen, Univ Ctr Geriatr Med, Groningen, Netherlands; [Gansevoort, Ron T.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Div Nephrol, Groningen, Netherlands; [Bilo, Henk J. G.] Isala Clin, Ctr Diabet, Dept Internal Med, Zwolle, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen; Isala Clinics	Joosten, H (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Groningen, Netherlands.	j.m.h.joosten@umcg.nl	Izaks, Gerbrand/F-5089-2014	Izaks, Gerbrand/0000-0003-3213-7637	Dutch Alzheimer Association; Dutch Kidney Foundation [E.033]	Dutch Alzheimer Association; Dutch Kidney Foundation	This study was partly supported by the Dutch Alzheimer Association: www.alzheimer-nederland.nl (only in Dutch). Grant awarded on 9 October 2008 and received by GJI and JPJS. The PREVEND study is funded by the Dutch Kidney Foundation (grant E.033). Grant received by RTG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini JV, 2007, J AM GERIATR SOC, V55, P420, DOI 10.1111/j.1532-5415.2007.01071.x; Benito-Leon J, 2010, J ALZHEIMERS DIS, V21, P95, DOI 10.3233/JAD-2010-100180; Bernick C, 2005, NEUROLOGY, V65, P1388, DOI 10.1212/01.wnl.0000182897.18229.ec; Bryan J, 2000, J CLIN EXP NEUROPSYC, V22, P40, DOI 10.1076/1380-3395(200002)22:1;1-8;FT040; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Cramer C, 2008, NEUROLOGY, V71, P344, DOI 10.1212/01.wnl.0000319647.15752.7b; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; de Simone G, 2013, HYPERTENSION, V62, P463, DOI 10.1161/HYPERTENSIONAHA.113.00727; Glasser SP, 2010, CLIN CARDIOL, V33, P280, DOI 10.1002/clc.20758; Haag MDM, 2009, J NEUROL NEUROSUR PS, V80, P13, DOI 10.1136/jnnp.2008.150433; Izaks GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017045; Jick H, 2000, LANCET, V356, P1627, DOI 10.1016/S0140-6736(00)03155-X; Joosten H, 2013, STROKE, V44, P1543, DOI 10.1161/STROKEAHA.111.000496; Joosten H, 2011, CLIN J AM SOC NEPHRO, V6, P1400, DOI 10.2215/CJN.05530610; Kaffashian S, 2011, EUR HEART J, V32, P2326, DOI 10.1093/eurheartj/ehr133; Kalaria RN, 2012, STROKE, V43, P2526, DOI 10.1161/STROKEAHA.112.655803; Karlamangla AS, 2004, J AM GERIATR SOC, V52, P487, DOI 10.1111/j.1532-5415.2004.52152.x; Kipivelo M, 2001, BMJ-BRIT MED J, V322, P1447; Lambers Heerspink HJ, 2008, AM J EPIDEMIOL, V168, P897, DOI 10.1093/aje/kwn209; Lindeboom J, 1996, VISUAL ASS TEST PROF; Mahmoodi BK, 2009, JAMA-J AM MED ASSOC, V17, P1791; McGuinness B, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003160.pub2; Middleton LE, 2009, ARCH NEUROL-CHICAGO, V66, P1210, DOI 10.1001/archneurol.2009.201; Muangpaisan W, 2010, GERIATR GERONTOL INT, V10, P199, DOI 10.1111/j.1447-0594.2009.00579.x; Reijmer YD, 2012, J AM GERIATR SOC, V60, P1426, DOI 10.1111/j.1532-5415.2012.04081.x; Reynolds CA, 2010, J AM GERIATR SOC, V58, P501, DOI 10.1111/j.1532-5415.2010.02739.x; Rockwood K, 2002, ARCH NEUROL-CHICAGO, V59, P223, DOI 10.1001/archneur.59.2.223; Ruff R. M., 1996, RUFF FIGURAL FLUENCY; RUFF RM, 1987, DEV NEUROPSYCHOL, V3, P37, DOI 10.1080/87565648709540362; Solomon A, 2007, NEUROLOGY, V68, P751, DOI 10.1212/01.wnl.0000256368.57375.b7; Steenland K, 2013, J AM GERIATR SOC, V61, P1449, DOI 10.1111/jgs.12414; Swiger KJ, 2013, MAYO CLIN PROC, V88, P1213, DOI 10.1016/j.mayocp.2013.07.013; Trompet S, 2010, J NEUROL, V257, P85, DOI 10.1007/s00415-009-5271-7; Visser ST, 2013, EXPERT REV PHARM OUT, V13, P285, DOI [10.1586/ERP.13.20, 10.1586/erp.13.20]; Whalley LJ, 2004, AGEING RES REV, V3, P369, DOI 10.1016/j.arr.2004.05.001; Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P1439, DOI 10.1001/archneur.57.10.1439; Wolozin B, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-20	37	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115755	10.1371/journal.pone.0115755	http://dx.doi.org/10.1371/journal.pone.0115755			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541708	Green Published, Green Submitted, gold			2022-12-27	WOS:000347239900079
J	Lambinet, V; Hayden, ME; Bieri, M; Gries, G				Lambinet, Veronika; Hayden, Michael E.; Bieri, Marco; Gries, Gerhard			Does the Earth's Magnetic Field Serve as a Reference for Alignment of the Honeybee Waggle Dance?	PLOS ONE			English	Article							APIS-MELLIFERA; ORIENTATION; BEES; MAGNETORECEPTION; COMMUNICATION; INFORMATION; SENSITIVITY; INTENSITY; DIRECTION; PERCEIVE	The honeybee (Apis mellifera) waggle dance, which is performed inside the hive by forager bees, informs hive mates about a potent food source, and recruits them to its location. It consists of a repeated figure-8 pattern: two oppositely directed turns interspersed by a short straight segment, the "waggle run''. The waggle run consists of a single stride emphasized by lateral waggling motions of the abdomen. Directional information pointing to a food source relative to the sun's azimuth is encoded in the angle between the waggle run line and a reference line, which is generally thought to be established by gravity. Yet, there is tantalizing evidence that the local (ambient) geomagnetic field (LGMF) could play a role. We tested the effect of the LGMF on the recruitment success of forager bees by placing observation hives inside large Helmholtz coils, and then either reducing the LGMF to 2% or shifting its apparent declination. Neither of these treatments reduced the number of nest mates that waggle dancing forager bees recruited to a feeding station located 200 m north of the hive. These results indicate that the LGMF does not act as the reference for the alignment of waggle-dancing bees.	[Lambinet, Veronika; Gries, Gerhard] Simon Fraser Univ, Dept Biol, Burnaby, BC V5A 1S6, Canada; [Hayden, Michael E.; Bieri, Marco] Simon Fraser Univ, Dept Phys, Burnaby, BC V5A 1S6, Canada	Simon Fraser University; Simon Fraser University	Gries, G (corresponding author), Simon Fraser Univ, Dept Biol, Burnaby, BC V5A 1S6, Canada.	gries@sfu.ca			Natural Sciences and Engineering Research Council of Canada; NSERC-IRC; Contech Enterprises Inc.; Global Forest Science	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NSERC-IRC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Contech Enterprises Inc.; Global Forest Science	This work was supported by the Natural Sciences and Engineering Research Council of Canada; NSERC-IRC; http://www.nserc-crsng.gc.ca (GG); Contech Enterprises Inc. (industrial sponsor of NSERC IRC); http://www.contech-inc.com (GG); and Global Forest Science (not-for-profit sponsor of NSERC-IRC); globalforestscience.org (GG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breeze TD, 2011, AGR ECOSYST ENVIRON, V142, P137, DOI 10.1016/j.agee.2011.03.020; DEJONG D, 1982, J COMP PHYSIOL, V147, P495, DOI 10.1007/BF00612015; Desoil M, 2005, J PHYS CONF SER, V17, P45, DOI 10.1088/1742-6596/17/1/007; DRELLER C, 1993, NATURWISSENSCHAFTEN, V80, P319, DOI 10.1007/BF01141904; Finlay CC, 2010, GEOPHYS J INT, V183, P1216, DOI 10.1111/j.1365-246X.2010.04804.x; FRISCH K V, 1949, Experientia, V5, P142; GOULD JL, 1978, SCIENCE, V201, P1026, DOI 10.1126/science.201.4360.1026; Hsu CY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000395; HSU CY, 1994, SCIENCE, V265, P95, DOI 10.1126/science.265.5168.95; Kirschvink JL, 1997, J EXP BIOL, V200, P1363; KIRSCHVINK JL, 1991, AM ZOOL, V31, P169; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; KUTERBACH DA, 1986, J EXP BIOL, V126, P375; LINDAUER M, 1959, Z VERGL PHYSIOL, V42, P334, DOI 10.1007/BF00298125; LINDAUER M, 1968, Z VERGL PHYSIOL, V60, P219, DOI 10.1007/BF00298600; MARTIN H, 1977, J COMP PHYSIOL, V122, P145, DOI 10.1007/BF00611888; MICHELSEN A, 1992, BEHAV ECOL SOCIOBIOL, V30, P143, DOI 10.1007/BF00166696; MICHELSEN A, 1993, J COMP PHYSIOL A, V173, P135, DOI 10.1007/BF00192972; Nieh JC, 2000, J EXP BIOL, V203, P1573; Riley JR, 2005, NATURE, V435, P205, DOI 10.1038/nature03526; Rohrseitz K, 1999, J COMP PHYSIOL A, V184, P463, DOI 10.1007/s003590050346; Tanner D, 2009, APIDOLOGIE, V40, P55, DOI 10.1051/apido:2008074; Tanner DA, 2008, BEHAV ECOL SOCIOBIOL, V62, P1891, DOI 10.1007/s00265-008-0619-z; Thom C, 2007, PLOS BIOL, V5, P1862, DOI 10.1371/journal.pbio.0050228; Tsujiuchi S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000234; Valkova T, 2012, B ENTOMOL RES, V102, P461, DOI 10.1017/S0007485311000824; Von Frisch K, 1968, DANCE LANGUAGE ORIEN; VONFRISCH K, 1948, NATURWISSENSCHAFTEN, V35, P38; Walker MM, 2008, J THEOR BIOL, V250, P85, DOI 10.1016/j.jtbi.2007.09.030; WALKER MM, 1989, J COMP PSYCHOL, V103, P62; WALKER MM, 1989, J EXP BIOL, V145, P489; WALKER MM, 1989, J EXP BIOL, V141, P447; WENNER ADRIAN M., 1962, ANIMAL BEHAVIOUR, V10, P79, DOI 10.1016/0003-3472(62)90135-5	33	3	3	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115665	10.1371/journal.pone.0115665	http://dx.doi.org/10.1371/journal.pone.0115665			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541731	Green Submitted, gold, Green Published			2022-12-27	WOS:000347239900067
J	Lin, J; Yang, J; Wen, XM; Yang, L; Deng, ZQ; Qian, Z; Ma, JC; Guo, H; Zhang, YY; Qian, W; Qian, J				Lin, Jiang; Yang, Jing; Wen, Xiang-mei; Yang, Lei; Deng, Zhao-qun; Qian, Zhen; Ma, Ji-chun; Guo, Hong; Zhang, Ying-ying; Qian, Wei; Qian, Jun			Detection of SRSF2-P95 Mutation by High-Resolution Melting Curve Analysis and Its Effect on Prognosis in Myelodysplastic Syndrome	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; SPLICEOSOMAL MACHINERY; SPLICING MACHINERY; PATHWAY; SF3B1; IMPACT; U2AF1	Hotspot mutations of serine/arginine-rich splicing factor 2 (SRSF2) gene have been identified in a proportion of hematologic malignancies including myelodysplastic syndrome (MDS). The aim of the present study was to develop a new approach to screen SRSF2 mutation and analyze the clinical relevance of SRSF2 mutations in Chinese MDS. A protocol based on high-resolution melting analysis (HRMA) was established to screen SRSF2-P95 mutation in 108 MDS patients and was compared with Sanger sequencing. The clinical relevance of SRSF2 mutations was further evaluated. HRMA identified five (4.6%) cases with SRSF2 mutation, completely validated by Sanger sequencing without false positive or negative results. The sensitivities of HRMA and Sanger sequencing were 10% and 25% for the detection of SRSF2-P95H mutation, respectively, against the background of wild-type DNA. Patients with SRSF2 mutation had shorter overall survival time than those with wild-type SRSF2 in both the whole cohort of cases and those with normal karyotype (P=0.069 and 0.023, respectively). Multivariate analysis confirmed SRSF2 mutation as an independent risk factor in both patient populations. We established a fast, high-throughput, and inexpensive HRMA-based method to screen SRSF2 mutation, which could be used in clinical diagnostic laboratories. SRSF2 mutations were significantly associated with mortality rate in the MDS affected Chinese.	[Lin, Jiang; Wen, Xiang-mei; Ma, Ji-chun; Guo, Hong; Qian, Wei] Jiangsu Univ, Affiliated Peoples Hosp, Lab Ctr, Zhenjiang, Jiangsu, Peoples R China; [Yang, Jing; Yang, Lei; Deng, Zhao-qun; Qian, Zhen; Zhang, Ying-ying; Qian, Jun] Jiangsu Univ, Affiliated Peoples Hosp, Dept Hematol, Zhenjiang, Jiangsu, Peoples R China	Jiangsu University; Jiangsu University	Qian, W (corresponding author), Jiangsu Univ, Affiliated Peoples Hosp, Lab Ctr, Zhenjiang, Jiangsu, Peoples R China.	dwqian@yahoo.com; qianjun0007@hotmail.com			National Natural Science foundation of China [81270630, 81172592]; Science and Technology Special Project in Clinical Medicine of Jiangsu Province [BL2012056]; 333 Project of Jiangsu Province [BRA2011085, BRA2013136]; Science and Technology Infrastructure Program of Zhenjiang [SS2012003]; Social Development Foundation of Zhenjiang [SH2013042, SH2013082]; Research and Development Foundation of Clinical Medicine of Jiangsu University [JLY20120013]; Key Medical Talent Program of Zhenjiang City; Jiangsu Government Scholarship for Overseas Studies	National Natural Science foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Special Project in Clinical Medicine of Jiangsu Province; 333 Project of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Science and Technology Infrastructure Program of Zhenjiang; Social Development Foundation of Zhenjiang; Research and Development Foundation of Clinical Medicine of Jiangsu University; Key Medical Talent Program of Zhenjiang City; Jiangsu Government Scholarship for Overseas Studies	This study was supported by National Natural Science foundation of China (81270630, 81172592), Science and Technology Special Project in Clinical Medicine of Jiangsu Province (BL2012056), 333 Project of Jiangsu Province (BRA2011085, BRA2013136), Science and Technology Infrastructure Program of Zhenjiang (SS2012003), Social Development Foundation of Zhenjiang (SH2013042, SH2013082), Research and Development Foundation of Clinical Medicine of Jiangsu University (JLY20120013), Key Medical Talent Program of Zhenjiang City, and Jiangsu Government Scholarship for Overseas Studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamia S, 2014, CLIN CANCER RES, V20, P1135, DOI 10.1158/1078-0432.CCR-13-0956; Bejar R, 2012, J CLIN ONCOL, V30, P3376, DOI 10.1200/JCO.2011.40.7379; BENNETT JM, 1985, ANN INTERN MED, V103, P620, DOI 10.7326/0003-4819-103-4-620; Bourgeois CF, 2004, PROG NUCLEIC ACID RE, V78, P37, DOI 10.1016/S0079-6603(04)78002-2; Damm F, 2012, BLOOD, V119, P3211, DOI 10.1182/blood-2011-12-400994; David CJ, 2010, GENE DEV, V24, P2343, DOI 10.1101/gad.1973010; Greenberg P, 1997, BLOOD, V89, P2079, DOI 10.1182/blood.V89.6.2079; Hanssens K, 2014, HAEMATOLOGICA, V99, P830, DOI 10.3324/haematol.2013.095133; Je EM, 2013, INT J CANCER, V133, P260, DOI 10.1002/ijc.28011; Kelemen O, 2013, GENE, V514, P1, DOI 10.1016/j.gene.2012.07.083; Lasho TL, 2012, BLOOD, V120, P4168, DOI 10.1182/blood-2012-05-429696; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Maciejewski JP, 2012, BRIT J HAEMATOL, V158, P165, DOI 10.1111/j.1365-2141.2012.09158.x; Makishima H, 2012, BLOOD, V119, P3203, DOI 10.1182/blood-2011-12-399774; Meggendorfer M, 2012, BLOOD, V120, P3080, DOI 10.1182/blood-2012-01-404863; Mian SA, 2013, HAEMATOLOGICA, V98, P1058, DOI 10.3324/haematol.2012.075325; Pajares MJ, 2007, LANCET ONCOL, V8, P349, DOI 10.1016/S1470-2045(07)70104-3; Patnaik MM, 2013, AM J HEMATOL, V88, P201, DOI 10.1002/ajh.23373; Qian J, 2010, CLIN CHIM ACTA, V411, P2097, DOI 10.1016/j.cca.2010.08.020; Swen JJ, 2012, CLIN CHEM LAB MED, V50, P279, DOI 10.1515/CCLM.2011.758; Swerdlow SH, 2008, WHO CLASSIFICATION T; Thol F, 2012, BLOOD, V119, P3578, DOI 10.1182/blood-2011-12-399337; Vannucchi AM, 2013, LEUKEMIA, V27, P1861, DOI 10.1038/leu.2013.119; Visconte V, 2012, LEUKEMIA, V26, P2447, DOI 10.1038/leu.2012.130; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Ward AJ, 2010, J PATHOL, V220, P152, DOI 10.1002/path.2649; Wu SJ, 2012, BLOOD, V120, P3106, DOI 10.1182/blood-2012-02-412296; Yang J, 2013, GENET TEST MOL BIOMA, V17, P342, DOI 10.1089/gtmb.2012.0364; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Zhou ZH, 2013, CHROMOSOMA, V122, P191, DOI 10.1007/s00412-013-0407-z	31	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115693	10.1371/journal.pone.0115693	http://dx.doi.org/10.1371/journal.pone.0115693			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541999	Green Published, Green Submitted, gold			2022-12-27	WOS:000347239900072
J	Moyen, N; Thiberville, SD; Pastorino, B; Nougairede, A; Thirion, L; Mombouli, JV; Dimi, Y; Leparc-Goffart, I; Capobianchi, MR; Lepfoundzou, AD; de Lamballerie, X				Moyen, Nanikaly; Thiberville, Simon-Djamel; Pastorino, Boris; Nougairede, Antoine; Thirion, Laurence; Mombouli, Jean-Vivien; Dimi, Yannick; Leparc-Goffart, Isabelle; Capobianchi, Maria Rosaria; Lepfoundzou, Amelia Dzia; de Lamballerie, Xavier			First Reported Chikungunya Fever Outbreak in the Republic of Congo, 2011	PLOS ONE			English	Article							VIRUS-INFECTION; ISLAND; GABON	Background: Chikungunya is an Aedes -borne disease characterised by febrile arthralgia and responsible for massive outbreaks. We present a prospective clinical cohort study and a retrospective serological study relating to a CHIK outbreak, in the Republic of Congo in 2011. Methodology and Findings: We analysed 317 suspected cases, of which 308 (97.2%) lived in the city of Brazzaville (66.6% in the South area). Amongst them, 37 (11.7%) were CHIKV+ve patients (i.e., biologically confirmed by a real-time RT-PCR assay), of whom 36 (97.3%) had fever, 22 (66.7%) myalgia and 32 (86.5%) arthralgia. All tested negative for dengue. The distribution of incident cases within Brazzaville districts was compared with CHIKV seroprevalence before the outbreak (34.4% in 517 blood donors), providing evidence for previous circulation of CHIKV. We applied a CHIK clinical score to 126 patients recruited within the two first day of illness (including 28 CHIKV+ves (22.2%)) with sensitivity (78.6%) and specificity (72.4%) values comparing with those of the referent study in Reunion Island. The negative predictive value was high (92%), but the positive predictive value (45%) indicate poor potential contribution to medical practice to identify CHIKV+ve patients in low prevalence outbreaks. However, the score allowed a slightly more accurate follow-up of the evolution of the outbreak than the criterion "fever+arthralgia". The complete sequencing of a Congolase isolate (Brazza_MRS1) demonstrated belonging to the East/Central/South African lineage and was further used for producing a robust genome-scale CHIKV phylogenetic analysis. Conclusions/Significance: We describe the first Chikungunya outbreak declared in the Republic of Congo. The seroprevalence study conducted amongst blood donors before outbreak provided evidence for previous CHIKV circulation. We suggest that a more systematic survey of the entomological situation and of arbovirus circulation is necessary in Central Africa for better understanding the environmental, microbiological and sociological determinants of emergence.	[Moyen, Nanikaly; Thiberville, Simon-Djamel; Pastorino, Boris; Nougairede, Antoine; Thirion, Laurence; de Lamballerie, Xavier] Aix Marseille Univ, EHESP French Sch Publ Hlth, IRD French Inst Res Dev, EPV UMR D 190 Emergence Pathol Virales, F-13005 Marseille, France; [Dimi, Yannick; Lepfoundzou, Amelia Dzia] Ctr Natl Transfus Sanguine, Brazzaville, Rep Congo; [Mombouli, Jean-Vivien] Lab Natl Sante Publ, Brazzaville, Rep Congo; [Leparc-Goffart, Isabelle] IRBA Armed Forces Biomed Res Inst, French Natl Reference Ctr Arboviruses, F-13013 Marseille, France; [Capobianchi, Maria Rosaria] Natl Inst Infect Dis L Spallanzani, Virol Lab, I-00149 Rome, Italy	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; IRCCS Lazzaro Spallanzani	Moyen, N (corresponding author), Aix Marseille Univ, EHESP French Sch Publ Hlth, IRD French Inst Res Dev, EPV UMR D 190 Emergence Pathol Virales, F-13005 Marseille, France.	moyenmimi@gmail.com		pastorino, boris/0000-0001-5233-5193; Laurence, THIRION/0000-0003-4301-2944; Capobianchi, Maria Rosaria/0000-0003-3465-0071	EPV UMR_D 190 "Emergence des Pathologies Virales", Marseille, France	EPV UMR_D 190 "Emergence des Pathologies Virales", Marseille, France	Funding provided by EPV UMR_D 190 "Emergence des Pathologies Virales"13005 Marseille, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boelle PY, 2008, VECTOR-BORNE ZOONOT, V8, P207, DOI 10.1089/vbz.2006.0620; Bonilauri P, 2008, EMERG INFECT DIS, V14, P852, DOI 10.3201/eid1405.071144; Chow A, 2011, J INFECT DIS, V203, P149, DOI 10.1093/infdis/jiq042; de Lamballerie X, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-33; Demanou Maurice, 2010, BMC Res Notes, V3, P128, DOI 10.1186/1756-0500-3-128; Gerardin P, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4137; Gerardin P, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-99; IRIN, 2011, CONGO OUTBR DENG LIK; Kelvin AA, 2011, J INFECT DEV COUNTR, V5, P441, DOI 10.3855/jidc.2171; Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9; Leparc-Goffart I, 2009, J CLIN VIROL, V45, P61, DOI 10.1016/j.jcv.2009.02.010; Leroy EM, 2009, EMERG INFECT DIS, V15, P591, DOI 10.3201/eid1504.080664; Lokireddy S, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-77; Mombouli JV, 2013, EMERG INFECT DIS, V19, P1542, DOI 10.3201/eid1909.130451; Moro ML, 2012, J INFECTION, V65, P165, DOI 10.1016/j.jinf.2012.04.005; Nkoghe D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001517; Parola P, 2006, EMERG INFECT DIS, V12, P1493, DOI 10.3201/eid1210.060610; Pastorino B, 2005, J VIROL METHODS, V124, P65, DOI 10.1016/j.jviromet.2004.11.002; Pistone T, 2009, TRAVEL MED INFECT DI, V7, P52, DOI 10.1016/j.tmaid.2008.10.001; ProMED-mail, 2011, CHIKUNGUNYA AFRICA R; Reinert JF, 2000, J AM MOSQUITO CONTR, V16, P175; ROBINSON M C, 1955, Trans R Soc Trop Med Hyg, V49, P28, DOI [10.1016/0035-9203(57)90022-6, 10.1016/0035-9203(55)90080-8]; ROSS R. W., 1956, JOUR HYG, V54, P177; Salez N, 2014, J INFECT; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Sergon K, 2008, AM J TROP MED HYG, V78, P333, DOI 10.4269/ajtmh.2008.78.333; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thiberville SD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002004; Thiberville SD, 2013, ANTIVIR RES, V99, P345, DOI 10.1016/j.antiviral.2013.06.009; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; Volk SM, 2010, J VIROL, V84, P6497, DOI 10.1128/JVI.01603-09; WHO, 2011, OUTBR B; Win MK, 2010, J CLIN VIROL, V49, P111, DOI 10.1016/j.jcv.2010.07.004; Wurtz N, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-336	37	42	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115938	10.1371/journal.pone.0115938	http://dx.doi.org/10.1371/journal.pone.0115938			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541718	Green Published, gold, Green Submitted			2022-12-27	WOS:000347239900112
J	Pei, RG; Zhou, YF; Wang, GX; Wang, HP; Huang, XY; Yan, XX; Yang, XH				Pei, Renguang; Zhou, Yunfeng; Wang, Guoxiang; Wang, Heping; Huang, Xinyu; Yan, Xiaoxing; Yang, Xiaohua			Outcomes of Bronchial Artery Embolization for Life-Threatening Hemoptysis Secondary to Tuberculosis	PLOS ONE			English	Article							MASSIVE HEMOPTYSIS; PULMONARY TUBERCULOSIS; MANAGEMENT; IMMEDIATE	Objective: To appraise the immediate and long-term outcomes of bronchial arterial embolization for life-threatening hemoptysis secondary to tuberculosis. Methods: 112 patients with life-threatening hemoptysis due to tuberculosis underwent bronchial artery embolization from January 2004 to February 2014. Life-threatening hemoptysis was defined as expectoration of at least 400 ml of blood in 24 hour. The median follow-up is 20 months, ranging from 2 to 52 months. Results: The hemoptysis control rate was 86.6% at 14 days, 84.8% at 30 days, 78.6% at 240 days, 75.9% at 360 days, respectively. None of these characteristics, including gender, age and tuberculosis status, was significantly associated with immediate control of bleeding. Patients with active tuberculosis had a significantly longer recurrence-free duration than did patients with inactive tuberculosis (P=0.040), which was further confirmed by Cox regression hazards model (P=0.046). There was no spinal cord complication or mortality related to bronchial artery embolization. The most common complication was transient chest pain. Conclusion: Bronchial arterial embolization is an effective and safe technique in the management of life-threatening hemoptysis secondary to tuberculosis. Active tuberculosis may be associated with a lower rate of recurrence of hemoptysis.	[Pei, Renguang; Wang, Guoxiang; Wang, Heping; Huang, Xinyu; Yan, Xiaoxing; Yang, Xiaohua] Yijishan Hosp, Wannan Med Coll, Dept Intervent Therapy, Wuhu, Peoples R China; [Zhou, Yunfeng] Yijishan Hosp, Wannan Med Coll, Dept Radiol, Wuhu, Peoples R China	Wannan Medical College; Wannan Medical College	Pei, RG (corresponding author), Yijishan Hosp, Wannan Med Coll, Dept Intervent Therapy, Wuhu, Peoples R China.	mediprg@bjmu.edu.cn						Anuradha C, 2012, DIAGN INTERV RADIOL, V18, P96, DOI 10.4261/1305-3825.DIR.3876-11.2; Chan VL, 2009, INT J TUBERC LUNG D, V13, P1167; Chun JY, 2010, CARDIOVASC INTER RAD, V33, P240, DOI 10.1007/s00270-009-9788-z; Chun JY, 2010, EUR RADIOL, V20, P558, DOI 10.1007/s00330-009-1591-3; CROCCO JA, 1968, ARCH INTERN MED, V121, P495, DOI 10.1001/archinte.121.6.495; DICHIRO G, 1974, RADIOLOGY, V112, P231; FRASER RS, 1993, PATHOL ANNU, V28, P231; Haponik EF, 2000, CHEST, V118, P1431, DOI 10.1378/chest.118.5.1431; HAYAKAWA K, 1992, CARDIOVASC INTER RAD, V15, P154, DOI 10.1007/BF02735578; Hwang HG, 2013, TUBERC RESPIR DIS, V74, P111, DOI 10.4046/trd.2013.74.3.111; Ibrahim WH, 2008, EUR RESPIR J, V32, P1131, DOI 10.1183/09031936.00080108; IM JG, 1993, RADIOLOGY, V186, P653, DOI 10.1148/radiology.186.3.8430169; Jean-Baptiste E, 2000, CRIT CARE MED, V28, P1642, DOI 10.1097/00003246-200005000-00066; KARDJIEV V, 1974, RADIOLOGY, V112, P81, DOI 10.1148/112.1.81; Lee Samuel, 2008, Hong Kong Medical Journal, V14, P14; Mal H, 1999, CHEST, V115, P996, DOI 10.1378/chest.115.4.996; Mossi Francesca, 2003, Radiol Med, V105, P48; Najarian KE, 1998, J THORAC IMAG, V13, P93, DOI 10.1097/00005382-199804000-00004; Osaki S, 2000, RESPIRATION, V67, P412, DOI 10.1159/000029540; RABKIN JE, 1987, RADIOLOGY, V163, P361, DOI 10.1148/radiology.163.2.3562815; REMY J, 1977, RADIOLOGY, V122, P33, DOI 10.1148/122.1.33; REMY J, 1974, ANN RADIOL, V17, P5; Shin BS, 2011, INT J TUBERC LUNG D, V15, P1093, DOI 10.5588/ijtld.10.0659; Sopko David R, 2011, Semin Intervent Radiol, V28, P48, DOI 10.1055/s-0031-1273940; Swanson KL, 2002, CHEST, V121, P789, DOI 10.1378/chest.121.3.789; Tanaka N, 1997, J VASC INTERV RADIOL, V8, P65, DOI 10.1016/S1051-0443(97)70517-7; UFLACKER R, 1985, RADIOLOGY, V157, P637, DOI 10.1148/radiology.157.3.4059552; van den Heuvel MM, 2007, INT J TUBERC LUNG D, V11, P909; Wang LX, 2014, LANCET, V383, P2057, DOI 10.1016/S0140-6736(13)62639-2	29	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115956	10.1371/journal.pone.0115956	http://dx.doi.org/10.1371/journal.pone.0115956			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541693	Green Published, Green Submitted, gold			2022-12-27	WOS:000347239900115
J	Zhang, Y; Li, L; Dong, XC; Kong, M; Gao, L; Dong, XJ; Xu, WT				Zhang, Ying; Li, Lin; Dong, Xiaochun; Kong, Mei; Gao, Lu; Dong, Xiaojing; Xu, Wenti			Influenza Surveillance and Incidence in a Rural Area in China during the 2009/2010 Influenza Pandemic	PLOS ONE			English	Article							DISEASE; INFORMATION; SPACE; TIME	Background: Most influenza surveillance is based on data from urban sentinel hospitals; little is known about influenza activity in rural communities. We conducted influenza surveillance in a rural region of China with the aim of detecting influenza activity in the 2009/2010 influenza season. Methods: The study was conducted from October 2009 to March 2010. Real-time polymerase chain reaction was used to confirm influenza cases. Over-the-counter (OTC) drug sales were daily collected in drugstores and hospitals/clinics. Space-time scan statistics were used to identify clusters of ILI in community. The incidence rate of ILI/influenza was estimated on the basis of the number of ILI/influenza cases detected by the hospitals/clinics. Results: A total of 434 ILI cases (3.88% of all consultations) were reported; 64.71% of these cases were influenza A (H1N1) pdm09. The estimated incidence rate of ILI and influenza were 5.19/100 and 0.40/100, respectively. The numbers of ILI cases and OTC drug purchases in the previous 7 days were strongly correlated (Spearman rank correlation coefficient [r] = 0.620, P = 0.001). Four ILI outbreaks were detected by space-time permutation analysis. Conclusions: This rural community surveillance detected influenza A (H1N1) pdm09 activity and outbreaks in the 2009/2010 influenza season and enabled estimation of the incidence rate of influenza. It also provides a scientific data for public health measures.	[Zhang, Ying; Li, Lin; Dong, Xiaochun; Gao, Lu; Xu, Wenti] Tianjin Ctr Dis Control & Prevent, Dept Infect Dis, Tianjin, Peoples R China; [Kong, Mei] Tianjin Ctr Dis Control & Prevent, Inst Pathogen Microbiol, Tianjin, Peoples R China; [Dong, Xiaojing] Hangu Centers Dis Control & Prevent, Binhai New Area, Tianjin, Peoples R China	Tianjin Center for Disease Control & Prevention; Tianjin Center for Disease Control & Prevention	Xu, WT (corresponding author), Tianjin Ctr Dis Control & Prevent, Dept Infect Dis, Tianjin, Peoples R China.	wenti_xwt@163.com			Health Bureau of Tianjin [09KZ43]	Health Bureau of Tianjin	Funding: The project was funded by the Health Bureau of Tianjin (Grant: 09KZ43).	Adjemian JZ, 2009, AM J TROP MED HYG, V80, P72, DOI 10.4269/ajtmh.2009.80.72; Boyle JR, 2011, MED J AUSTRALIA, V194, pS28; Cooper DL, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-16; Das D, 2005, MMWR-MORBID MORTAL W, V54, pS41; Fleming DM, 2003, EUR J PUBLIC HEALTH, V13, P80, DOI 10.1093/eurpub/13.suppl_1.80; Ghosh TS, 2008, AM J PUBLIC HEALTH, V98, P213, DOI 10.2105/AJPH.2006.106138; Guo Jian-Hua, 2008, Zhonghua Liu Xing Bing Xue Za Zhi, V29, P307; Horst MA, 2010, J AM BOARD FAM MED, V23, P32, DOI 10.3122/jabfm.2010.01.090137; Huang SS, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000238; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; Lee JS, 2007, EPIDEMIOL INFECT, V135, P1117, DOI 10.1017/S0950268807007820; Mainassara HB, 2010, GEOSPATIAL HEALTH, V5, P93, DOI 10.4081/gh.2010.190; Metzger KB, 2004, MMWR-MORBID MORTAL W, V53, pS106; Pearl DL, 2006, EPIDEMIOL INFECT, V134, P699, DOI 10.1017/S0950268805005741; Socan M, 2012, CENT EUR J PUBL HEAL, V20, P156, DOI 10.21101/cejph.a3735; Uphoff H, 2004, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, V47, P279, DOI 10.1007/s00103-003-0768-1; van den Wijngaard CC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010406; Wang X, 2011, EPIDEMIOL INFECT, V139, P1551, DOI 10.1017/S0950268810002694; Yang P, 2011, INT J INFECT DIS, V15, pE151, DOI 10.1016/j.ijid.2010.11.001	19	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115347	10.1371/journal.pone.0115347	http://dx.doi.org/10.1371/journal.pone.0115347			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542003	Green Published, Green Submitted, gold			2022-12-27	WOS:000347239900036
J	Zhang, ZH				Zhang, Zhihua			The Evolution of Heterogeneities Altered by Mutational Robustness, Gene Expression Noise and Bottlenecks in Gene Regulatory Networks	PLOS ONE			English	Article							NONGENETIC HETEROGENEITY; PLASTICITY	Intra-population heterogeneity is commonly observed in natural and cellular populations and has profound influence on their evolution. For example, intra-tumor heterogeneity is prevalent in most tumor types and can result in the failure of tumor therapy. However, the evolutionary process of heterogeneity remains poorly characterized at both genotypic and phenotypic level. Here we study the evolution of intra-population heterogeneities of gene regulatory networks (GRN), in particular mutational robustness and gene expression noise as contributors to the development of heterogeneities. By in silico simulations, it was found that the impact of these factors on GRN can, under certain conditions, promote phenotypic heterogeneity. We also studied the effect of population bottlenecks on the evolution of GRN. When the GRN population passes through such bottlenecks, neither mutational robustness nor population fitness was observed to be substantially altered. Interestingly, however, we did detect a significant increase in the number of potential "generator" genes which can substantially induce population fitness, when stimulated by mutational hits.	Chinese Acad Sci, Beijing Inst Genom, Key Lab Genome Sci & Informat, Beijing, Peoples R China	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Zhang, ZH (corresponding author), Chinese Acad Sci, Beijing Inst Genom, Key Lab Genome Sci & Informat, Beijing, Peoples R China.	zhangzhihua@big.ac.cn			National Nature Science Foundation of China (NSFC) [31271398, 91131012]; National Basic Research Program of China (the 973 Program) [2014CB542002]; 100 Talents Project	National Nature Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (the 973 Program)(National Basic Research Program of China); 100 Talents Project(Chinese Academy of Sciences)	This work was supported by grants from the National Nature Science Foundation of China (NSFC, http://www.nsfc.cov.cn/. Grant No. 31271398, 91131012), National Basic Research Program of China (the 973 Program. http://www.973.gov.cn/English/index.aspx. Grant No. 2014CB542002), and the 100 Talents Project (http://www.cas.cn/ggzy/rcpy/brjh/) to ZZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktipis CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026100; Almendro V, 2013, ANNU REV PATHOL-MECH, V8, P277, DOI 10.1146/annurev-pathol-020712-163923; Attolini CSO, 2009, ANN NY ACAD SCI, V1168, P23, DOI 10.1111/j.1749-6632.2009.04880.x; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Brock A, 2009, NAT REV GENET, V10, P336, DOI 10.1038/nrg2556; Ciliberti S, 2007, P NATL ACAD SCI USA, V104, P13591, DOI 10.1073/pnas.0705396104; Ciliberti S, 2007, PLOS COMPUT BIOL, V3, P164, DOI 10.1371/journal.pcbi.0030015; de Krom M, 2002, MOL CELL, V9, P1319, DOI 10.1016/S1097-2765(02)00558-0; Drake JW, 1998, GENETICS, V148, P1667; Durrett R, 2011, GENETICS, V188, P461, DOI 10.1534/genetics.110.125724; Espinosa-Soto C, 2011, J EVOLUTION BIOL, V24, P1284, DOI 10.1111/j.1420-9101.2011.02261.x; Espinosa-Soto C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-5; Fraser HB, 2004, PLOS BIOL, V2, P834, DOI 10.1371/journal.pbio.0020137; Harary F., 1969, GRAPH THEORY; Hodgkinson A, 2011, NAT REV GENET, V12, P756, DOI 10.1038/nrg3098; Huang S, 2009, DEVELOPMENT, V136, P3853, DOI 10.1242/dev.035139; Imhof M, 2001, P NATL ACAD SCI USA, V98, P1113, DOI 10.1073/pnas.98.3.1113; Kaufmann BB, 2007, PLOS BIOL, V5, P1973, DOI 10.1371/journal.pbio.0050239; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Pisco AO, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3467; Sanjuan R, 2004, P NATL ACAD SCI USA, V101, P8396, DOI 10.1073/pnas.0400146101; Sun W, 2010, GENETICS, V185, P349, DOI 10.1534/genetics.110.114280; TEMPLETON AR, 1980, GENETICS, V94, P1011; van Nimwegen E, 1999, P NATL ACAD SCI USA, V96, P9716, DOI 10.1073/pnas.96.17.9716; Waddington C H, 1957, STRATEGY GENES DISCU; WAGNER A, 1994, P NATL ACAD SCI USA, V91, P4387, DOI 10.1073/pnas.91.10.4387; Wagner A, 1996, EVOLUTION, V50, P1008, DOI 10.1111/j.1558-5646.1996.tb02342.x; Wagner A., 2005, ROBUSTNESS EVOLVABIL; Wagner A, 2008, NAT REV GENET, V9, P965, DOI 10.1038/nrg2473; Weinberg RA, 2007, BIOL CANC; WILSON RE, 1984, CANCER, V53, P1420, DOI 10.1002/1097-0142(19840315)53:6<1420::AID-CNCR2820530634>3.0.CO;2-R; Zhang ZH, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.58	34	0	0	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e116167	10.1371/journal.pone.0116167	http://dx.doi.org/10.1371/journal.pone.0116167			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541720	Green Published, Green Submitted, gold			2022-12-27	WOS:000347239900154
J	Kienhofer, D; Hahn, J; Schubert, I; Reinwald, C; Ipseiz, N; Lang, SC; Borras, EB; Amann, K; Sjowall, C; Barron, AE; Hueber, AJ; Agerberth, B; Schett, G; Hoffmann, MH				Kienhofer, D.; Hahn, J.; Schubert, I.; Reinwald, C.; Ipseiz, N.; Lang, S. C.; Borras, E. Bosch; Amann, K.; Sjowall, C.; Barron, A. E.; Hueber, A. J.; Agerberth, B.; Schett, G.; Hoffmann, M. H.			No Evidence of Pathogenic Involvement of Cathelicidins in Patient Cohorts and Mouse Models of Lupus and Arthritis	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; PRISTANE-INDUCED LUPUS; ANTIMICROBIAL PEPTIDE; REVISED CRITERIA; INFLAMMATION; LL-37; SELF; INTERFERON; BLOOD; DNA	Apart from their role in the immune defence against pathogens evidence of a role of antimicrobial peptides (AMPs) in autoimmune diseases has accumulated in the past years. The aim of this project was to examine the functional impact of the human cathelicidin LL-37 and the mouse cathelicidin-related AMP (CRAMP) on the pathogenesis of lupus and arthritis. Serum LL-37 and anti-LL-37 levels were measured by ELISA in healthy donors and patients with Systemic Lupus Erythematosus (SLE) and Rheumatoid arthritis (RA). Pristane-induced lupus was induced in female wild type (WT) and cathelicidin-deficient (CRAMP(-/-)) mice. Serum levels of anti-Sm/RNP, anti-dsDNA, and anti-histone were determined via ELISA, cytokines in sera and peritoneal lavages were measured via Multiplex. Expression of Interferon I stimulated genes (ISG) was determined by real-time PCR. Collagen-induced arthritis (CIA) was induced in male WT and CRAMP(-/-) mice and arthritis severity was visually scored and analysed histomorphometrically by OsteoMeasure software. Serum levels of anti-LL-37 were higher in SLE-patients compared to healthy donors or patients with RA. However, no correlation to markers of disease activity or organ involvement was observed. No significant differences of autoantibody or cytokine/chemokine levels, or of expression of ISGs were observed between WT and CRAMP(-/-) mice after pristane-injection. Furthermore, lung and kidney pathology did not differ in the absence of CRAMP. Incidence and severity of CIA and histological parameters (inflammation, cartilage degradation, and bone erosion) were not different in WT and CRAMP(-/-) mice. Although cathelicidins are upregulated in mouse models of lupus and arthritis, cathelicidin-deficiency did not persistently affect the diseases. Also in patients with SLE, autoantibodies against cathelicidins did not correlate with disease manifestation. Reactivity against cathelicidins in lupus and arthritis could thus be an epiphenomenon caused by extensive overexpression in blood and affected tissues. In addition, other cationic AMPs could functionally compensate for the deficiency of cathelicidins.	[Kienhofer, D.; Hahn, J.; Schubert, I.; Reinwald, C.; Ipseiz, N.; Lang, S. C.; Hueber, A. J.; Schett, G.; Hoffmann, M. H.] Univ Klinikum Erlangen, Dept Internal Med 3, Erlangen, Germany; [Borras, E. Bosch] Univ Autonoma Barcelona, E-08193 Barcelona, Spain; [Amann, K.] Univ Klinikum Erlangen, Dept Nephropathol, Erlangen, Germany; [Sjowall, C.] Linkoping Univ, Dept Clin & Expt Med, Rheumatol AIR, Linkoping, Sweden; [Barron, A. E.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Agerberth, B.] Karolinska Univ, Dept Lab Med, Div Clin Microbiol, Huddinge, Sweden	University of Erlangen Nuremberg; Autonomous University of Barcelona; University of Erlangen Nuremberg; Linkoping University; Stanford University; Karolinska Institutet; Karolinska University Hospital	Hoffmann, MH (corresponding author), Univ Klinikum Erlangen, Dept Internal Med 3, Erlangen, Germany.	markus.hoffmann@uk-erlangen.de	Sjöwall, Christopher/C-9678-2009; Ipseiz, Natacha/AAG-6390-2019	Sjöwall, Christopher/0000-0003-0900-2048; Ipseiz, Natacha/0000-0001-5008-8889; Barron, Annelise/0000-0002-0735-6873; Hahn, Jonas/0000-0003-3944-2108; Hueber, Axel/0000-0001-6454-1234; Hoffmann, Markus/0000-0001-9698-9922	ELAN program of the University Erlangen-Nuremberg [12-03-07-1-Hoffmann]; Austrian Science fund (FWF) [J3102-B13]; Swedish society for Medical research (SSMF); Swedish Medical council [58X-11217-14-3]; EU [HEALTH-F2-2008-223404]; IMI program BTCure; Austrian Science Fund (FWF) [J 3102] Funding Source: researchfish	ELAN program of the University Erlangen-Nuremberg; Austrian Science fund (FWF)(Austrian Science Fund (FWF)); Swedish society for Medical research (SSMF); Swedish Medical council(Swedish Medical Research Council (SMRC)); EU(European Commission); IMI program BTCure; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The research was funded by the ELAN program of the University Erlangen-Nuremberg (grant number 12-03-07-1-Hoffmann), the Austrian Science fund (FWF, project J3102-B13), the Swedish society for Medical research (SSMF), the Swedish Medical council (58X-11217-14-3), the EU project Masterswitch (HEALTH-F2-2008-223404), and the IMI program BTCure.	Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Baumann CL, 2010, J EXP MED, V207, P2689, DOI 10.1084/jem.20101111; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Calvani N, 2005, J IMMUNOL, V175, P4777, DOI 10.4049/jimmunol.175.7.4777; Chamilos G, 2012, BLOOD, V120, P3699, DOI 10.1182/blood-2012-01-401364; Dietz AB, 2006, TRANSFUSION, V46, P2083, DOI 10.1111/j.1537-2995.2006.01033.x; Gallo RL, 1997, J BIOL CHEM, V272, P13088, DOI 10.1074/jbc.272.20.13088; Ganguly D, 2009, J EXP MED, V206, P1983, DOI 10.1084/jem.20090480; Garcia-Romo GS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001201; Gudmundsson GH, 1996, EUR J BIOCHEM, V238, P325, DOI 10.1111/j.1432-1033.1996.0325z.x; Herman S, 2012, AUTOIMMUNITY; Hoffmann MH, 2013, ANN RHEUM DIS, V72, P1239, DOI 10.1136/annrheumdis-2012-202218; Johansson J, 1998, J BIOL CHEM, V273, P3718, DOI 10.1074/jbc.273.6.3718; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kraan TCTMV, 2007, ANN RHEUM DIS, V66, P1008, DOI 10.1136/ard.2006.063412; Lande R, 2014, EUR J IMMUNOL; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Lande R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001180; Lee PY, 2008, J IMMUNOL, V180, P5101, DOI 10.4049/jimmunol.180.7.5101; Lee PY, 2008, J EXP MED, V205, P2995, DOI 10.1084/jem.20080462; Leiss H, 2013, LUPUS, V22, P778, DOI 10.1177/0961203313492869; Neubert K, 2008, NAT MED, V14, P748, DOI 10.1038/nm1763; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Reeves WH, 2009, TRENDS IMMUNOL, V30, P455, DOI 10.1016/j.it.2009.06.003; Schauer C, 2014, NAT MED, V20, P511, DOI 10.1038/nm.3547; Sorensen OE, 2001, BLOOD, V97, P3951, DOI 10.1182/blood.V97.12.3951; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tewary P, 2013, J IMMUNOL, V191, P865, DOI 10.4049/jimmunol.1201648; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639; ZANETTI M, 1995, FEBS LETT, V374, P1, DOI 10.1016/0014-5793(95)01050-O	33	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115474	10.1371/journal.pone.0115474	http://dx.doi.org/10.1371/journal.pone.0115474			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25535966	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000348563300042
J	Heiss, EH; Kramer, MP; Atanasov, AG; Beres, H; Schachner, D; Dirsch, VM				Heiss, Elke H.; Kramer, Matthias P.; Atanasov, Atanas G.; Beres, Hortenzia; Schachner, Daniel; Dirsch, Verena M.			Glycolytic Switch in Response to Betulinic Acid in Non-Cancer Cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; PERMEABILITY TRANSITION PORE; ENDOTHELIAL-CELLS; CANCER CELLS; GLUCOSE; AMPK; METABOLISM; PHOSPHORYLATION; MITOCHONDRIA; DERIVATIVES	The naturally occurring triterpenoid betulinic acid (BA) shows pronounced polypharmacology ranging from anti-inflammatory to anti-lipogenic activities. Recent evidence suggests that rather diverse cellular signaling events may be attributed to the same common upstream switch in cellular metabolism. In this study we therefore examined the metabolic changes induced by BA (10 mM) administration, with focus on cellular glucose metabolism. We demonstrate that BA elevates the rates of cellular glucose uptake and aerobic glycolysis in mouse embryonic fibroblasts with concomitant reduction of glucose oxidation. Without eliciting signs of obvious cell death BA leads to compromised mitochondrial function, increased expression of mitochondrial uncoupling proteins (UCP) 1 and 2, and liver kinase B1 (LKB1)-dependent activation AMP-activated protein kinase. AMPK activation accounts for the increased glucose uptake and glycolysis which in turn are indispensable for cell viability upon BA treatment. Overall, we show for the first time a significant impact of BA on cellular bioenergetics which may be a central mediator of the pleiotropic actions of BA.	[Heiss, Elke H.; Kramer, Matthias P.; Atanasov, Atanas G.; Beres, Hortenzia; Schachner, Daniel; Dirsch, Verena M.] Univ Vienna, Dept Pharmacognosy, A-1090 Vienna, Austria	University of Vienna	Heiss, EH (corresponding author), Univ Vienna, Dept Pharmacognosy, Althanstr 14, A-1090 Vienna, Austria.	elke.heiss@univie.ac.at	Kramer, Matthias/L-1782-2016; Atanasov, Atanas G./C-5535-2013; Heiss, Elke/B-6086-2015; Kramer, Matthias P/A-6224-2009	Kramer, Matthias/0000-0002-0289-5261; Atanasov, Atanas G./0000-0003-2545-0967; Heiss, Elke/0000-0001-7618-5505; Dirsch, Verena/0000-0002-9261-5293	Austrian Science Fund [23317]; Austrian Science Fund (FWF) [P 23317] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was supported by Austrian Science Fund (grant number 23317) to EHH Herzfelder 'sche Familienstiftung to EHH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azoulay-Zohar H, 2004, BIOCHEM J, V377, P347, DOI 10.1042/BJ20031465; Bernardo TC, 2013, BIOORGAN MED CHEM, V21, P7239, DOI 10.1016/j.bmc.2013.09.066; Carling D, 2008, INT J OBESITY, V32, pS55, DOI 10.1038/ijo.2008.124; Choi JY, 2009, MOLECULES, V14, P266, DOI 10.3390/molecules14010266; Chung MY, 2006, PLANTA MED, V72, P267, DOI 10.1055/s-2005-916178; Dehelean CA, 2013, J BIOMED NANOTECHNOL, V9, P577, DOI 10.1166/jbn.2013.1563; Fakhrudin N, 2010, MOL PHARMACOL, V77, P559, DOI 10.1124/mol.109.062141; Fendt SM, 2013, CANCER RES, V73, P4429, DOI 10.1158/0008-5472.CAN-13-0080; Fisslthaler B, 2009, CIRC RES, V105, P114, DOI 10.1161/CIRCRESAHA.109.201590; Florez-Duquet M, 1998, AM J PHYSIOL-REG I, V274, pR196, DOI 10.1152/ajpregu.1998.274.1.R196; Fulda S, 1998, J BIOL CHEM, V273, P33942, DOI 10.1074/jbc.273.51.33942; Fulda S, 2009, MOL NUTR FOOD RES, V53, P140, DOI 10.1002/mnfr.200700491; Gao MH, 2014, ARCH TOXICOL, V88, P755, DOI 10.1007/s00204-013-1162-x; Genet C, 2010, J MED CHEM, V53, P178, DOI 10.1021/jm900872z; Gongol B, 2013, P NATL ACAD SCI USA, V110, P3161, DOI 10.1073/pnas.1222051110; Hardie DG, 2004, REV ENDOCR METAB DIS, V5, P119, DOI 10.1023/B:REMD.0000021433.63915.bb; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Heiss EH, 2013, REDOX BIOL, V1, P359, DOI 10.1016/j.redox.2013.06.001; Heiss EH, 2012, PLANTA MED, V78, P678, DOI 10.1055/s-0031-1298242; Kim J, 2012, PHYTOTHER RES, V26, P1103, DOI 10.1002/ptr.3672; Kim SJ, 2014, J AGR FOOD CHEM, V62, P434, DOI 10.1021/jf4030739; Kropat C, 2013, MOL NUTR FOOD RES, V57, P545, DOI 10.1002/mnfr.201200504; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Ledesma A, 2002, GENOME BIOL, V3; Liobikas J, 2011, J NAT PROD, V74, P1640, DOI 10.1021/np200060p; Luo ZJ, 2010, FUTURE ONCOL, V6, P457, DOI 10.2217/FON.09.174; Metallo CM, 2013, MOL CELL, V49, P388, DOI 10.1016/j.molcel.2013.01.018; Metallo CM, 2010, GENE DEV, V24, P2717, DOI 10.1101/gad.2010510; Mullauer FB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005361; Mullauer FB, 2009, APOPTOSIS, V14, P191, DOI 10.1007/s10495-008-0290-x; PISHA E, 1995, NAT MED, V1, P1046, DOI 10.1038/nm1095-1046; Qian KD, 2009, J MED CHEM, V52, P3248, DOI 10.1021/jm900136j; Quan HY, 2013, BIOCHEM PHARMACOL, V85, P1330, DOI 10.1016/j.bcp.2013.02.007; Russo GL, 2013, BIOCHEM PHARMACOL, V86, P339, DOI 10.1016/j.bcp.2013.05.023; Salt IP, 2012, EXPERT OPIN INV DRUG, V21, P1155, DOI 10.1517/13543784.2012.696609; Santos RC, 2011, BIOCHIMIE, V93, P1065, DOI 10.1016/j.biochi.2011.02.014; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Steinkamp-Fenske K, 2007, J PHARMACOL EXP THER, V322, P836, DOI 10.1124/jpet.107.123356; Sun L, 2008, MOL CELL BIOL, V28, P1007, DOI 10.1128/MCB.00224-07; Takada Y, 2003, J IMMUNOL, V171, P3278, DOI 10.4049/jimmunol.171.6.3278; Tsai JC, 2011, AM J CHINESE MED, V39, P943, DOI 10.1142/S0192415X11009329; Vadivelu RK, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/251362; Van Beersel G, 2013, BIOSCIENCE REP, V33, P243, DOI 10.1042/BSR20120104; Viji V, 2011, BRIT J PHARMACOL, V162, P1291, DOI 10.1111/j.1476-5381.2010.01112.x; WARBURG O, 1956, SCIENCE, V124, P269; Wilson-Fritch L, 2003, MOL CELL BIOL, V23, P1085, DOI 10.1128/MCB.23.3.1085-1094.2003; Wu CA, 2013, BBA-MOL CELL RES, V1833, P1147, DOI 10.1016/j.bbamcr.2013.01.025; Wu SB, 2012, BBA-MOL BASIS DIS, V1822, P233, DOI 10.1016/j.bbadis.2011.09.014; Xu QA, 2010, J CELL MOL MED, V14, P2604, DOI 10.1111/j.1582-4934.2010.01179.x; Yoon JJ, 2010, BIOCHEM BIOPH RES CO, V391, P96, DOI 10.1016/j.bbrc.2009.11.009; Zhao GJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074782; Zorov DB, 2009, CARDIOVASC RES, V83, P213, DOI 10.1093/cvr/cvp151	52	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115683	10.1371/journal.pone.0115683	http://dx.doi.org/10.1371/journal.pone.0115683			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531780	Green Published, Green Submitted, gold			2022-12-27	WOS:000348845100093
J	Milagres, LG; Costa, PR; Silva, GP; Carvalho, KI; Pereira-Manfro, WF; Ferreira, B; Barreto, DM; Frota, ACC; Hofer, CB; Kallas, EG				Milagres, Lucimar G.; Costa, Priscilla R.; Silva, Giselle P.; Carvalho, Karina I.; Pereira-Manfro, Wania F.; Ferreira, Bianca; Barreto, Daniella M.; Frota, Ana Cristina C.; Hofer, Cristina B.; Kallas, Esper G.			Subsets of Memory CD4(+) T Cell and Bactericidal Antibody Response to Neisseria meningitidis Serogroup C after Immunization of HIV-Infected Children and Adolescents	PLOS ONE			English	Article							VACCINE; ACTIVATION; DISEASE; MARKER	Meningococcal disease is endemic in Brazil, with periodic outbreaks and case fatality rates reach as high as 18 to 20% of cases. Conjugate vaccines against meningococci are immunogenic in healthy children. However, we have previously shown a poor bactericidal antibody response to a Men C conjugate vaccine in Brazilian HIV-infected children and adolescents after a single vaccine administration. The goal of the present work was to investigate associations between bactericidal antibody response induced by MenC vaccine and the frequency and activation profile (expression of CD38, HLA-DR and CCR5 molecules) of total CD4(+) memory T cell sub-populations in HIV-1-infected children and adolescents. Responders to vaccination against MenC had a predominance (about 44%) of CD4(+) T-INTERMEDIATE subset followed by T-TRANSITIONAL memory subset (23 to 26%). Importantly, CD4(+) T-INT frequency was positively associated with bactericidal antibody response induced by vaccination. The positive correlation persisted despite the observation that the frequency T-INT CD38(+)HLA-DR+ was higher in responders. In contrast, CD4(+) T-CENTRAL MEMORY (T-CM) subset negatively correlated with bactericidal antibodies. In conclusion, these data indicate that less differentiated CD+ T cells, like TCM may be constantly differentiating into intermediate and later differentiated CD4(+) T cell subsets. These include CD4 T-INT subset which showed a positive association with bactericidal antibodies.	[Milagres, Lucimar G.; Silva, Giselle P.; Pereira-Manfro, Wania F.] Univ Estado Rio De Janeiro, Dept Microbiol Immunol & Parasitol, Rio De Janeiro, RJ, Brazil; [Costa, Priscilla R.; Carvalho, Karina I.; Kallas, Esper G.] Univ Sao Paulo, Sch Med, Div Clin Immunol & Allergy, Sao Paulo, Brazil; [Hofer, Cristina B.] Univ Fed Rio de Janeiro, Inst Puericultura & Pediat Martagao Gesteira, Rio De Janeiro, RJ, Brazil; [Ferreira, Bianca; Barreto, Daniella M.; Frota, Ana Cristina C.; Hofer, Cristina B.] Univ Fed Rio de Janeiro, Sch Med, Dept Prevent Med, Rio De Janeiro, RJ, Brazil	Universidade do Estado do Rio de Janeiro; Universidade de Sao Paulo; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Milagres, LG (corresponding author), Univ Estado Rio De Janeiro, Dept Microbiol Immunol & Parasitol, Rio De Janeiro, RJ, Brazil.	lucimar@uerj.br	Carvalho, Karina IL/J-6789-2012; Manfro, Wania FP/M-5882-2013; frota, Ana Cristina Cisne/L-3644-2018; milagres, lucimar g/K-7072-2012	Carvalho, Karina IL/0000-0002-7763-8139; frota, Ana Cristina Cisne/0000-0002-2825-4374; milagres, lucimar g/0000-0002-0860-818X; Manfro, Wania/0000-0003-0166-8144; Kallas, Esper/0000-0003-2026-6925	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [573879/2008-7, 552497/2011-8]; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro [E-26/112.645/2012]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2009/54055-5]; Fogarty Institute of the National Institutes of Health [5R01TW008397]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; FOGARTY INTERNATIONAL CENTER [R01TW008397] Funding Source: NIH RePORTER	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fogarty Institute of the National Institutes of Health; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was funded by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, grants (#573879/2008-7 to EGK and #552497/2011-8 (Edital Casadinho) to LGM and EGK); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (#E-26/112.645/2012 to LGM); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (#2009/54055-5 to EGK); Fogarty Institute of the National Institutes of Health under award number 5R01TW008397 to CBH. PRC received scholarship support from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. GSP received scholarship support from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett LG, 2014, J IMMUNOL, V192, P3607, DOI 10.4049/jimmunol.1301284; Borrow R, 2013, VACCINE, V31, P4477, DOI 10.1016/j.vaccine.2013.07.083; Breton G, 2013, J IMMUNOL, V191, P2194, DOI 10.4049/jimmunol.1200646; Burgers WA, 2009, J IMMUNOL, V182, P4751, DOI 10.4049/jimmunol.0803801; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; Farber DL, 2014, NAT REV IMMUNOL, V14, P24, DOI 10.1038/nri3567; Frota AC, PED INFECT IN PRESS; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Maslanka SE, 1997, CLIN DIAGN LAB IMMUN, V4, P156, DOI 10.1128/CDLI.4.2.156-167.1997; Milagres LG, 2013, AIDS, V27, P2697, DOI 10.1097/QAD.0000000000000007; Ministerio da Saude. Secretaria de Vigilancia em Saude. Departamento de Vigilancia Epidemiologica, MAN CTR REF IM ESP A; Safadi MAP, 2012, J PEDIAT-BRAZIL, V88, P195, DOI 10.2223/JPED.2167; Pallikkuth S, 2012, BLOOD, V120, P985, DOI 10.1182/blood-2011-12-396648; Rosignoli G, 2007, AIDS, V21, P1379, DOI 10.1097/QAD.0b013e3281de7296; Safadi MAP, 2013, EPIDEMIOL INFECT, V141, P447, DOI 10.1017/S0950268812001689; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Yue FY, 2004, J IMMUNOL, V172, P2476, DOI 10.4049/jimmunol.172.4.2476	17	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115887	10.1371/journal.pone.0115887	http://dx.doi.org/10.1371/journal.pone.0115887			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25532028	gold, Green Published, Green Submitted			2022-12-27	WOS:000348845100114
J	Mohri, Z; Rowland, EM; Clarke, LA; De Luca, A; Peiffer, V; Krams, R; Sherwin, SJ; Weinberg, PD				Mohri, Zahra; Rowland, Ethan M.; Clarke, Lindsey A.; De Luca, Amalia; Peiffer, Veronique; Krams, Rob; Sherwin, Spencer J.; Weinberg, Peter D.			Elevated Uptake of Plasma Macromolecules by Regions of Arterial Wall Predisposed to Plaque Instability in a Mouse Model	PLOS ONE			English	Article							RABBIT AORTIC-WALL; LOW-DENSITY-LIPOPROTEIN; TERM ALBUMIN UPTAKE; SHEAR-STRESS; ENDOTHELIAL PERMEABILITY; NITRIC-OXIDE; ATHEROSCLEROTIC LESIONS; IN-VIVO; MICE; PATTERNS	Atherosclerosis may be triggered by an elevated net transport of lipid-carrying macromolecules from plasma into the arterial wall. We hypothesised that whether lesions are of the thin-cap fibroatheroma (TCFA) type or are less fatty and more fibrous depends on the degree of elevation of transport, with greater uptake leading to the former. We further hypothesised that the degree of elevation can depend on haemodynamic wall shear stress characteristics and nitric oxide synthesis. Placing a tapered cuff around the carotid artery of apolipoprotein E -/- mice modifies patterns of shear stress and eNOS expression, and triggers lesion development at the upstream and downstream cuff margins; upstream but not downstream lesions resemble the TCFA. We measured wall uptake of a macromolecular tracer in the carotid artery of C57bl/6 mice after cuff placement. Uptake was elevated in the regions that develop lesions in hyperlipidaemic mice and was significantly more elevated where plaques of the TCFA type develop. Computational simulations and effects of reversing the cuff orientation indicated a role for solid as well as fluid mechanical stresses. Inhibiting NO synthesis abolished the difference in uptake between the upstream and downstream sites. The data support the hypothesis that excessively elevated wall uptake of plasma macromolecules initiates the development of the TCFA, suggest that such uptake can result from solid and fluid mechanical stresses, and are consistent with a role for NO synthesis. Modification of wall transport properties might form the basis of novel methods for reducing plaque rupture.	[Mohri, Zahra; Rowland, Ethan M.; Clarke, Lindsey A.; Peiffer, Veronique; Krams, Rob; Weinberg, Peter D.] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England; [De Luca, Amalia; Peiffer, Veronique; Sherwin, Spencer J.] Univ London Imperial Coll Sci Technol & Med, Dept Aeronaut, London, England	Imperial College London; Imperial College London	Weinberg, PD (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England.	p.weinberg@imperial.ac.uk	Sherwin, Spencer/C-1167-2010	Sherwin, Spencer/0000-0001-7681-2820	British Heart Foundation [PG/08/053/25192]; Imperial College's British Heart Foundation Centre of Research Excellence; British Heart Foundation [PG/13/16/30040] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Imperial College's British Heart Foundation Centre of Research Excellence; British Heart Foundation(British Heart Foundation)	This study was funded by a British Heart Foundation (www.bhf.org.uk) project grant PG/08/053/25192. EMR, LAC, ADL and VP were supported by Imperial College's British Heart Foundation Centre of Research Excellence (http://www3.imperial.ac.uk/bhfcre). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes SE, 1998, ARTERIOSCL THROM VAS, V18, P300, DOI 10.1161/01.ATV.18.2.300; Barnes SE, 2001, EXP MOL PATHOL, V71, P161, DOI 10.1006/exmp.2001.2395; BELL FP, 1974, EXP MOL PATHOL, V20, P57, DOI 10.1016/0014-4800(74)90043-4; BRATZLER RL, 1977, ATHEROSCLEROSIS, V28, P289, DOI 10.1016/0021-9150(77)90177-0; Cancel LM, 2010, ATHEROSCLEROSIS, V208, P335, DOI 10.1016/j.atherosclerosis.2009.07.051; Cheng C, 2005, BLOOD, V106, P3691, DOI 10.1182/blood-2005-06-2326; Cheng C, 2007, J CLIN INVEST, V117, P616, DOI 10.1172/JCI28180; Cheng C, 2006, CIRCULATION, V113, P2744, DOI 10.1161/CIRCULATIONAHA.105.590018; Clarke LA, 2012, ATHEROSCLEROSIS, V224, P417, DOI 10.1016/j.atherosclerosis.2012.08.001; CORNHILL JF, 1980, ATHEROSCLEROSIS, V35, P321, DOI 10.1016/0021-9150(80)90130-6; Courtman DW, 1998, AM J PATHOL, V153, P1723, DOI 10.1016/S0002-9440(10)65687-8; DRAIJER R, 1995, CIRC RES, V76, P199, DOI 10.1161/01.RES.76.2.199; Ewins BA, 2002, J BIOMECH ENG-T ASME, V124, P684, DOI 10.1115/1.1517063; Feintuch A, 2007, AM J PHYSIOL-HEART C, V292, pH884, DOI 10.1152/ajpheart.00796.2006; Finn AV, 2010, ARTERIOSCL THROM VAS, V30, P1282, DOI 10.1161/ATVBAHA.108.179739; Forster BA, 1997, ARTERIOSCL THROM VAS, V17, P1361, DOI 10.1161/01.ATV.17.7.1361; Fothergill JE, 1964, FLUORESCENT PROTEIN, P34; GALIS ZS, 1995, P NATL ACAD SCI USA, V92, P402, DOI 10.1073/pnas.92.2.402; Glasunow M, 1926, VIRCHOWS ARCH PATH A, V261, P837; Greve JM, 2006, AM J PHYSIOL-HEART C, V291, pH1700, DOI 10.1152/ajpheart.00274.2006; Grinberg L, 2009, CLIN EXP PHARMACOL P, V36, P194, DOI 10.1111/j.1440-1681.2008.05010.x; HARRISHOOKER S, 1992, CELL BIOL INT REP, V16, P433, DOI 10.1016/S0309-1651(06)80063-9; Harrison M, 2013, ARTERIOSCL THROM VAS, V33, P694, DOI 10.1161/ATVBAHA.112.300379; Hartley CJ, 2000, AM J PHYSIOL-HEART C, V279, pH2326, DOI 10.1152/ajpheart.2000.279.5.H2326; Huang H, 2001, CIRCULATION, V103, P1051, DOI 10.1161/01.CIR.103.8.1051; Janssen BJA, 2004, AM J PHYSIOL-HEART C, V287, pH1618, DOI 10.1152/ajpheart.01192.2003; KARNIADAKIS G. E., 2005, SPECTRAL HP ELEMENT; Kubes Pal, 1995, Microcirculation (New York), V2, P235, DOI 10.3109/10739689509146769; Kuebler WM, 2010, CELL PHYSIOL BIOCHEM, V26, P29, DOI 10.1159/000315103; Levick JR, 2009, INTRO CARDIOVASCULAR, P157; Mynard JP, 2013, ATHEROSCLEROSIS, V227, P259, DOI 10.1016/j.atherosclerosis.2013.01.026; Najafi AH, 2013, DIS MODEL MECH, V6, P323, DOI 10.1242/dmm.009977; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; Nielsen LB, 1996, ATHEROSCLEROSIS, V123, P1, DOI 10.1016/0021-9150(96)05802-9; Sanchez FA, 2006, AM J PHYSIOL-HEART C, V291, pH1058, DOI 10.1152/ajpheart.00370.2006; Schwartz SM, 2007, ARTERIOSCL THROM VAS, V27, P705, DOI 10.1161/01.ATV.0000261709.34878.20; SCHWENKE DC, 1988, CIRC RES, V62, P699, DOI 10.1161/01.RES.62.4.699; Sebkhi A, 1996, ARTERIOSCL THROM VAS, V16, P317, DOI 10.1161/01.ATV.16.2.317; SEBKHI A, 1994, J PHYSIOL-LONDON, V479P, pP77; Somerville JN, 2004, CALCIFIED TISSUE INT, V74, P469, DOI 10.1007/s00223-003-0101-x; Staughton TJ, 2004, TRENDS IN ATHEROSCLEROSIS RESEARCH, P123; Staughton TJ, 2001, AM J PHYSIOL-HEART C, V281, pH53, DOI 10.1152/ajpheart.2001.281.1.H53; Vincent PE, 2009, BIOPHYS J, V96, P3102, DOI 10.1016/j.bpj.2009.01.022; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065; Warboys CM, 2012, CELL MOL BIOENG, V5, P184, DOI 10.1007/s12195-012-0220-4; Warboys CM, 2010, AM J PHYSIOL-HEART C, V298, pH1850, DOI 10.1152/ajpheart.00114.2010; Weinberg PD, 2004, J VASC RES, V41, P1, DOI 10.1159/000076124; Weinberg PD, 2007, J BIOMECH, V40, P1594, DOI 10.1016/j.jbiomech.2006.07.020; WIKLUND O, 1985, ARTERIOSCLEROSIS, V5, P135, DOI 10.1161/01.ATV.5.2.135; Zilberberg J, 2001, MICROVASC RES, V62, P410, DOI 10.1006/mvre.2001.2362	50	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115728	10.1371/journal.pone.0115728	http://dx.doi.org/10.1371/journal.pone.0115728			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531765	Green Published, gold, Green Submitted			2022-12-27	WOS:000348845100102
J	Priou, P; Le Vaillant, M; Meslier, N; Paris, A; Pigeanne, T; Nguyen, XL; Alizon, C; Bizieux-Thaminy, A; Leclair-Visonneau, L; Humeau, MP; Gagnadoux, F				Priou, Pascaline; Le Vaillant, Marc; Meslier, Nicole; Paris, Audrey; Pigeanne, Thierry; Xuan-Lan Nguyen; Alizon, Claire; Bizieux-Thaminy, Acya; Leclair-Visonneau, Laurene; Humeau, Marie-Pierre; Gagnadoux, Frederic		IRSR Sleep Cohort Grp	Cumulative Association of Obstructive Sleep Apnea Severity and Short Sleep Duration with the Risk for Hypertension	PLOS ONE			English	Article							AIRWAY PRESSURE TREATMENT; BLOOD-PRESSURE; RESISTANT HYPERTENSION; SYMPATHETIC ACTIVITY; DAYTIME SLEEPINESS; INSOMNIA; CPAP	Obstructive sleep apnea (OSA) and short sleep duration are individually associated with an increased risk for hypertension (HTN). The aim of this multicenter cross-sectional study was to test the hypothesis of a cumulative association of OSA severity and short sleep duration with the risk for prevalent HTN. Among 1,499 patients undergoing polysomnography for suspected OSA, 410 (27.3%) previously diagnosed as hypertensive and taking antihypertensive medication were considered as having HTN. Patients with total sleep time (TST),6 h were considered to be short sleepers. Logistic regression procedures were performed to determine the independent association of HTN with OSA and sleep duration. Considering normal sleepers (TST >= 6 h) without OSA as the reference group, the odds ratio (OR) (95% confidence intervals) for having HTN was 2.51 (1.35-4.68) in normal sleepers with OSA and 4.37 (2.18-8.78) in short sleepers with OSA after adjustment for age, gender, obesity, diabetes, depression, current smoking, use of thyroid hormones, daytime sleepiness, poor sleep complaint, time in bed, sleep architecture and fragmentation, and study site. The risk for HTN appeared to present a cumulative association with OSA severity and short sleep duration (p<0.0001 for linear trend). The higher risk for HTN was observed in short sleepers with severe OSA (AHI >= 30) (OR, 4.29 [2.03-9.07]). In patients investigated for suspected OSA, sleep-disordered breathing severity and short sleep duration have a cumulative association with the risk for prevalent HTN. Further studies are required to determine whether interventions to optimize sleep may contribute to lower BP in patients with OSA.	[Priou, Pascaline; Meslier, Nicole; Gagnadoux, Frederic] Univ Angers, CHU, Dept Pneumol, Angers, France; [Priou, Pascaline; Meslier, Nicole; Gagnadoux, Frederic] INSERM 1063, Angers, France; [Le Vaillant, Marc] CERMES, CNRS UMR8211, EHESS, Inserm U988, Villejuif, France; [Paris, Audrey] Ctr Hosp, Serv Pneumol, Le Mans, France; [Pigeanne, Thierry] Pole Sante Olonnes, Unite Pneumol, Olonne Sur Mer, France; [Xuan-Lan Nguyen] Grp Hosp Est Parisien, Hop St Antoine, Ctr Etud & Traitement Troubles Sommeil St Antoine, Paris, France; [Alizon, Claire] Ctr Hosp, Serv Pneumol, Cholet, France; [Bizieux-Thaminy, Acya] Ctr Hosp, Serv Pneumol, La Roche Sur Yon, France; [Leclair-Visonneau, Laurene] Hop Laennec, Serv Explorat Fonct, Nantes, France; [Humeau, Marie-Pierre] Nouvelles Clin Nantaises, Nantes, France	Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre Hospitalier Le Mans; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; CHD Vendee; Nantes Universite; CHU de Nantes	Gagnadoux, F (corresponding author), Univ Angers, CHU, Dept Pneumol, Angers, France.	frgagnadoux@chu-angers.fr	Leclair-Visonneau, Laurène/GZL-7934-2022	Leclair-Visonneau, Laurène/0000-0001-6379-0765				Bixler EO, 2000, ARCH INTERN MED, V160, P2289, DOI 10.1001/archinte.160.15.2289; Chouchou F, 2013, EUR HEART J, V34, P2122, DOI 10.1093/eurheartj/eht208; Collop NA, 2007, J CLIN SLEEP MED, V3, P737; Dettoni JL, 2012, J APPL PHYSIOL, V113, P232, DOI 10.1152/japplphysiol.01604.2011; Fernandez-Mendoza J, 2012, HYPERTENSION, V60, P929, DOI 10.1161/HYPERTENSIONAHA.112.193268; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; Friedman O, 2010, AM J HYPERTENS, V23, P174, DOI 10.1038/ajh.2009.220; Fung MM, 2011, HYPERTENSION, V58, P596, DOI 10.1161/HYPERTENSIONAHA.111.174409; Gagnadoux F, 2004, EUR RESPIR J, V23, P891, DOI 10.1183/09031936.04.00089604; Gagnadoux F, 2014, CHEST, V145, P1025, DOI 10.1378/chest.13-2373; Guo XF, 2013, SLEEP MED, V14, P324, DOI 10.1016/j.sleep.2012.12.001; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kendzerska T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001599; Knutson KL, 2010, SLEEP, V33, P37, DOI 10.1093/sleep/33.1.37; Knutson KL, 2009, ARCH INTERN MED, V169, P1055, DOI 10.1001/archinternmed.2009.119; Lavie P, 2000, BRIT MED J, V320, P479, DOI 10.1136/bmj.320.7233.479; Lozano L, 2010, J HYPERTENS, V28, P2161, DOI 10.1097/HJH.0b013e32833b9c63; Lusardi P, 1996, AM J HYPERTENS, V9, P503, DOI 10.1016/0895-7061(95)00389-4; Lusardi P, 1999, AM J HYPERTENS, V12, P63, DOI 10.1016/S0895-7061(98)00200-3; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; Marin JM, 2012, JAMA-J AM MED ASSOC, V307, P2169, DOI 10.1001/jama.2012.3418; Martinez-Garcia MA, 2013, JAMA-J AM MED ASSOC, V310, P2407, DOI 10.1001/jama.2013.281250; Montemurro LT, 2012, CHEST, V142, P1222, DOI 10.1378/chest.11-2963; Montesi SB, 2012, J CLIN SLEEP MED, V8, P587, DOI 10.5664/jcsm.2170; Narkiewicz K, 1998, CIRCULATION, V97, P943; Nieto FJ, 2000, JAMA-J AM MED ASSOC, V283, P1829, DOI 10.1001/jama.283.14.1829; Parati G, 2013, EUR RESPIR J, V41, P523, DOI 10.1183/09031936.00226711; Pedrosa RP, 2011, HYPERTENSION, V58, P811, DOI 10.1161/HYPERTENSIONAHA.111.179788; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Risso TT, 2013, SLEEP BREATH, V17, P837, DOI 10.1007/s11325-012-0774-3; Societe de Pneumologie de Langue Francaise, 2010, Rev Mal Respir, V27, P806, DOI 10.1016/j.rmr.2010.05.011; Tamisier R, 2011, EUR RESPIR J, V37, P119, DOI 10.1183/09031936.00204209; Ucar ZZ, 2012, SLEEP DISORD; Van Cauter E, 2000, JAMA-J AM MED ASSOC, V284, P861, DOI 10.1001/jama.284.7.861; Vgontzas AN, 2009, SLEEP, V32, P491, DOI 10.1093/sleep/32.4.491	36	26	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115666	10.1371/journal.pone.0115666	http://dx.doi.org/10.1371/journal.pone.0115666			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531468	Green Submitted, Green Published, gold			2022-12-27	WOS:000348845100090
J	Zhang, DL; Liu, X; Chen, J; Liu, B				Zhang, Delong; Liu, Xian; Chen, Jun; Liu, Bo			Distinguishing Patients with Parkinson's Disease Subtypes from Normal Controls Based on Functional Network Regional Efficiencies	PLOS ONE			English	Article							RESTING-STATE; BRAIN NETWORKS; SUBTHALAMIC NUCLEUS; BASAL GANGLIA; GLOBAL SIGNAL; CONNECTIVITY; TREMOR; MOTOR; PATHOPHYSIOLOGY; OSCILLATIONS	Many studies have demonstrated that the pathophysiology and clinical symptoms of Parkinson's disease (PD) are inhomogeneous. However, the symptom-specific intrinsic neural activities underlying the PD subtypes are still not well understood. Here, 15 tremor-dominant PD patients, 10 non-tremor-dominant PD patients, and 20 matched normal controls (NCs) were recruited and underwent resting-state functional magnetic resonance imaging (fMRI). Functional brain networks were constructed based on randomly generated anatomical templates with and without the cerebellum. The regional network efficiencies (i.e., the local and global efficiencies) were further measured and used to distinguish subgroups of PD patients (i.e., with tremor-dominant PD and non-tremor-dominant PD) from the NCs using linear discriminant analysis. The results demonstrate that the subtypespecific functional networks were small-world-organized and that the network regional efficiency could discriminate among the individual PD subgroups and the NCs. Brain regions involved in distinguishing between the study groups included the basal ganglia (i.e., the caudate and putamen), limbic regions (i.e., the hippocampus and thalamus), the cerebellum, and other cerebral regions (e.g., the insula, cingulum, and calcarine sulcus). In particular, the performances of the regional local efficiency in the functional network were better than those of the global efficiency, and the performances of global efficiency were dependent on the inclusion of the cerebellum in the analysis. These findings provide new evidence for the neurological basis of differences between PD subtypes and suggest that the cerebellum may play different roles in the pathologies of different PD subtypes. The present study demonstrated the power of the combination of graph-based network analysis and discrimination analysis in elucidating the neural basis of different PD subtypes.	[Zhang, Delong; Liu, Xian; Chen, Jun; Liu, Bo] Guangdong Prov Hosp Chinese Med, Dept Radiol, Guangzhou, Guangdong, Peoples R China; [Zhang, Delong] Guangzhou Univ Chinese Med, Postdoctoral Mobile Res Stn, Guangzhou, Guangdong, Peoples R China	Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine	Liu, B (corresponding author), Guangdong Prov Hosp Chinese Med, Dept Radiol, Guangzhou, Guangdong, Peoples R China.	lbgdhtcm@163.com	Chen, Jun/AAD-7667-2020	CHEN, JUN/0000-0001-5049-5759	Natural Science Foundation of China [31371049]; Guangdong Science and Technology Department [2008B080703041, 2010B080701025]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Science and Technology Department	This work was supported by the Natural Science Foundation of China (Nos. 31371049), Guangdong Science and Technology Department (Nos. 2008B080703041 and 2010B080701025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Bassett DS, 2011, P NATL ACAD SCI USA, V108, P7641, DOI 10.1073/pnas.1018985108; Berardelli A, 2001, BRAIN, V124, P2131, DOI 10.1093/brain/124.11.2131; Dai ZJ, 2012, NEUROIMAGE, V59, P2187, DOI 10.1016/j.neuroimage.2011.10.003; Dubbelink KTEO, 2014, BRAIN, V137, P197, DOI 10.1093/brain/awt316; Eckert Thomas, 2005, NeuroRx, V2, P361, DOI 10.1007/BF03206677; Finkbiner AP, 2008, MOVEMENT DISORD, V23, P1632; Fishman PS, 2008, MOVEMENT DISORD, V23, P168, DOI 10.1002/mds.21736; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Gottlich M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077336; Hacker CD, 2012, BRAIN, V135, P3699, DOI 10.1093/brain/aws281; He BJ, 2007, CURR OPIN NEUROL, V20, P655, DOI 10.1097/WCO.0b013e3282f1c720; Helmich RC, 2012, BRAIN, V135, P3206, DOI 10.1093/brain/aws023; Helmich RC, 2011, ANN NEUROL, V69, P269, DOI 10.1002/ana.22361; JANKOVIC J, 1990, NEUROLOGY, V40, P1529, DOI 10.1212/WNL.40.10.1529; Jellinger KA, 1999, J NEURAL TRANSM-SUPP, P1; JELLINGER KA, 1991, MOL CHEM NEUROPATHOL, V14, P153, DOI 10.1007/BF03159935; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Lewinger JP, 2005, GENET EPIDEMIOL, V29, P262; Liu H, 2013, PSYCHIAT RES-NEUROIM, V211, P64, DOI 10.1016/j.pscychresns.2012.10.007; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Moran A, 2008, BRAIN, V131, P3395, DOI 10.1093/brain/awn270; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; PAULUS W, 1991, J NEUROPATH EXP NEUR, V50, P743, DOI 10.1097/00005072-199111000-00006; Payoux P, 2004, ARCH NEUROL-CHICAGO, V61, P1307, DOI 10.1001/archneur.61.8.1307; Poston KL, 2012, NEUROIMAGE, V62, P2261, DOI 10.1016/j.neuroimage.2011.12.021; Rivlin-Etzion M, 2006, CURR OPIN NEUROBIOL, V16, P629, DOI 10.1016/j.conb.2006.10.002; Skidmore F, 2011, NEUROSCI LETT, V499, P47, DOI 10.1016/j.neulet.2011.05.030; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Weinberger M, 2009, J NEUROPHYSIOL, V101, P789, DOI 10.1152/jn.90837.2008; Wu T, 2013, BRAIN, V136, P696, DOI 10.1093/brain/aws360; Wu T, 2009, NEUROSCI LETT, V460, P6, DOI 10.1016/j.neulet.2009.05.046; Zaidel A, 2009, CURR OPIN NEUROL, V22, P387, DOI 10.1097/WCO.0b013e32832d9d67; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027	38	13	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115131	10.1371/journal.pone.0115131	http://dx.doi.org/10.1371/journal.pone.0115131			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531436	Green Published, Green Submitted, gold			2022-12-27	WOS:000348845100039
J	Cioli, C; Abdi, H; Beaton, D; Burnod, Y; Mesmoudi, S				Cioli, Claudia; Abdi, Herve; Beaton, Derek; Burnod, Yves; Mesmoudi, Salma			Differences in Human Cortical Gene Expression Match the Temporal Properties of Large-Scale Functional Networks	PLOS ONE			English	Article							HUMAN CEREBRAL-CORTEX; KISS-AND-RUN; CALCIUM-CHANNEL; NEUROTRANSMITTER RELEASE; SODIUM-CHANNELS; HUMAN BRAIN; PATTERNS; ORGANIZATION; CONNECTIVITY; MODULATION	We explore the relationships between the cortex functional organization and genetic expression (as provided by the Allen Human Brain Atlas). Previous work suggests that functional cortical networks (resting state and task based) are organized as two large networks (differentiated by their preferred information processing mode) shaped like two rings. The first ring-Visual-SensorimotorAuditory (VSA)-comprises visual, auditory, somatosensory, and motor cortices that process real time world interactions. The second ring-Parieto-Temporo-Frontal (PTF)-comprises parietal, temporal, and frontal regions with networks dedicated to cognitive functions, emotions, biological needs, and internally driven rhythms. We found-with correspondence analysis-that the patterns of expression of the 938 genes most differentially expressed across the cortex organized the cortex into two sets of regions that match the two rings. We confirmed this result using discriminant correspondence analysis by showing that the genetic profiles of cortical regions can reliably predict to what ring these regions belong. We found that several of the proteins-coded by genes that most differentiate the rings-were involved in neuronal information processing such as ionic channels and neurotransmitter release. The systematic study of families of genes revealed specific proteins within families preferentially expressed in each ring. The results showed strong congruence between the preferential expression of subsets of genes, temporal properties of the proteins they code, and the preferred processing modes of the rings. Ionic channels and release-related proteins more expressed in the VSA ring favor temporal precision of fast evoked neural transmission (Sodium channels SCNA1, SCNB1 potassium channel KCNA1, calcium channel CACNA2D2, Synaptotagmin SYT2, Complexin CPLX1, Synaptobrevin VAMP1). Conversely, genes expressed in the PTF ring favor slower, sustained, or rhythmic activation ( Sodium channels SCNA3, SCNB3, SCN9A potassium channels KCNF1, KCNG1) and facilitate spontaneous transmitter release (calcium channel CACNA1H, Synaptotagmins SYT5, Complexin CPLX3, and synaptobrevin VAMP2).	[Cioli, Claudia; Burnod, Yves] Univ Paris 06, Lab Imagerie Biomed, UMR UMR S 1146 7371, Sorbonne Univ, Paris, France; [Cioli, Claudia; Burnod, Yves; Mesmoudi, Salma] ISC PIF Inst Syst Complexes Paris Ile de France, Paris, France; [Abdi, Herve; Beaton, Derek] Univ Texas Dallas, Sch Behav & Brain Sci, Dallas, TX 75230 USA; [Mesmoudi, Salma] Univ Paris 01, Sorbonne Univ, Equipement Excellence MATRICE, F-75231 Paris 05, France	UDICE-French Research Universities; Sorbonne Universite; University of Texas System; University of Texas Dallas; UDICE-French Research Universities; Sorbonne Universite	Cioli, C (corresponding author), Univ Paris 06, Lab Imagerie Biomed, UMR UMR S 1146 7371, Sorbonne Univ, Paris, France.	claudia.cioli.c@gmail.com		Abdi, Herve/0000-0002-9522-1978	French National Agency; region Paris-Ile de France; EURIAS fellowship at the "Institut d'Etudes Avancees de Paris'' (France); European Union's 7th Framework Program for Research; French State managed by the Agence Nationale de la Recherche, program "investissements d'avenir,'' [ANR-11-LABX-0027-01 Labex RFIEA+]; NIH Training Award from the National Institute on Drug Abuse NRSA [F31DA035039]; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA035039] Funding Source: NIH RePORTER	French National Agency(French National Research Agency (ANR)); region Paris-Ile de France; EURIAS fellowship at the "Institut d'Etudes Avancees de Paris'' (France); European Union's 7th Framework Program for Research; French State managed by the Agence Nationale de la Recherche, program "investissements d'avenir,''(French National Research Agency (ANR)); NIH Training Award from the National Institute on Drug Abuse NRSA; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work benefitted from a grant from the French National Agency for Research investment ANR "Investissement Avenir'' (MATRICE project). CC's work benefitted from a doctoral fellowship from the "region Paris-Ile de France.'' HA's work benefitted from an EURIAS fellowship at the "Institut d'Etudes Avancees de Paris'' (France) made possible with the support of the European Union's 7th Framework Program for Research, and from funding from the French State managed by the Agence Nationale de la Recherche, program "investissements d'avenir,'' (ANR-11-LABX-0027-01 Labex RFIEA+). DB's work benefitted from a NIH Training Award from the National Institute on Drug Abuse NRSA # F31DA035039. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H., 2007, ENCY MEASUREMENT STA, V3, P103; Abdi H., 2007, ENCY MEASUREMENT STA, P270; Abdi H., 2014, ENCY SOCIAL NETWORK, P275, DOI DOI 10.1007/978-1-4614-6170-8_140; Abdi H, 2010, ENCY RES DESIGN, P267; Abdi H, 2009, NEUROIMAGE, V45, P89, DOI 10.1016/j.neuroimage.2008.11.008; Allen PD, 2012, J NEUROSCI, V32, P2538, DOI 10.1523/JNEUROSCI.1958-11.2012; Aman TK, 2009, J NEUROSCI, V29, P2027, DOI 10.1523/JNEUROSCI.4531-08.2009; Baccei ML, 2014, NEUROSCIENTIST, V20, P197, DOI 10.1177/1073858414521499; Beaton D, 2014, COMPUT STAT DATA AN, V72, P176, DOI 10.1016/j.csda.2013.11.006; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Bocksteins E, 2012, PHYSIOLOGY, V27, P73, DOI 10.1152/physiol.00023.2011; Bohland JW, 2010, METHODS, V50, P105, DOI 10.1016/j.ymeth.2009.09.001; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Cao P, 2013, J NEUROSCI, V33, P1714, DOI 10.1523/JNEUROSCI.4087-12.2013; Catterall WA, 2008, NEURON, V59, P882, DOI 10.1016/j.neuron.2008.09.005; Catterall WA, 2014, EXP PHYSIOL, V99, P35, DOI 10.1113/expphysiol.2013.071969; Cauda F, 2014, NEUROIMAGE-CLIN, V4, P676, DOI 10.1016/j.nicl.2014.04.007; Cauda F, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00104; Cheong E, 2013, PHYSIOL REV, V93, P961, DOI 10.1152/physrev.00010.2012; Chung C, 2013, J NEUROCHEM, V126, P146, DOI 10.1111/jnc.12245; Cummins TR, 2001, J NEUROSCI, V21, P5952, DOI 10.1523/JNEUROSCI.21-16-05952.2001; Cusdin FS, 2010, J BIOL CHEM, V285, P33404, DOI 10.1074/jbc.M110.114058; Doucet G, 2011, J NEUROPHYSIOL, V105, P2753, DOI 10.1152/jn.00895.2010; Edvardson S, 2013, J MED GENET, V50, P118, DOI 10.1136/jmedgenet-2012-101223; Estacion M, 2010, EXP NEUROL, V224, P362, DOI 10.1016/j.expneurol.2010.04.012; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813, DOI 10.1109/NSSMIC.1993.373602; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; French Leon, 2011, Front Neuroinform, V5, P12, DOI 10.3389/fninf.2011.00012; French L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001049; Friedland DR, 2008, HEARING RES, V243, P105, DOI 10.1016/j.heares.2008.06.009; Fuster J., 1989, DISSERT ABSTRACTS IN, V60, P255; Fuster JM, 2006, INT J PSYCHOPHYSIOL, V60, P125, DOI 10.1016/j.ijpsycho.2005.12.015; Fuster JM, 2012, TRENDS COGN SCI, V16, P207, DOI 10.1016/j.tics.2012.03.005; Gittelman JX, 2006, J NEUROPHYSIOL, V96, P1203, DOI 10.1152/jn.00092.2005; Goel P, 2014, HUM BRAIN MAPP, V35, P4204, DOI 10.1002/hbm.22471; Goyal MS, 2014, CELL METAB, V19, P49, DOI 10.1016/j.cmet.2013.11.020; Granados-Fuentes D, 2012, J NEUROSCI, V32, P10045, DOI 10.1523/JNEUROSCI.0174-12.2012; Grange P, 2011, STAT ANAL COEXPRESSI; Grange P, 2014, P NATL ACAD SCI USA, V111, P5397, DOI 10.1073/pnas.1312098111; Greenacre Michael, 1984, THEORY APPL CORRES A; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Harata NC, 2006, J NEUROCHEM, V97, P1546, DOI 10.1111/j.1471-4159.2006.03987.x; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Hoppa MB, 2012, NATURE, V486, P122, DOI 10.1038/nature11033; Ison JR, 2012, JARO-J ASSOC RES OTO, V13, P351, DOI 10.1007/s10162-011-0312-1; Jones AR, 2009, NAT REV NEUROSCI, V10, P821, DOI 10.1038/nrn2722; Jorquera RA, 2012, J NEUROSCI, V32, P18234, DOI 10.1523/JNEUROSCI.3212-12.2012; Kaeser-Woo YJ, 2012, J NEUROSCI, V32, P2877, DOI 10.1523/JNEUROSCI.3360-11.2012; Karcz A, 2011, J PHYSIOL-LONDON, V589, P1143, DOI 10.1113/jphysiol.2010.203331; Kiebel SJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000209; Kochubey O, 2011, NEURON, V69, P736, DOI 10.1016/j.neuron.2011.01.013; Kramer JW, 1998, AM J PHYSIOL-CELL PH, V274, pC1501, DOI 10.1152/ajpcell.1998.274.6.C1501; Krishnan A, 2011, NEUROIMAGE, V56, P455, DOI 10.1016/j.neuroimage.2010.07.034; Lacinova L, 2004, ARCH BIOCHEM BIOPHYS, V425, P207, DOI 10.1016/j.abb.2004.03.010; Laird AR, 2011, J COGNITIVE NEUROSCI, V23, P4022, DOI 10.1162/jocn_a_00077; Lebart L., 1984, MULTIVARIATE DESCRIP; Luria A. R., 2012, HIGHER CORTICAL FUNC; Martin JA, 2011, CURR BIOL, V21, P97, DOI 10.1016/j.cub.2010.12.014; Mesmoudi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067444; MILNER B, 1985, HUM NEUROBIOL, V4, P137; Moghadam Paanteha K, 2013, Front Endocrinol (Lausanne), V4, P124, DOI 10.3389/fendo.2013.00124; Murray JD, 2014, NAT NEUROSCI, V17, P1661, DOI 10.1038/nn.3862; Premi E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106500; Qu Y, 2001, MOL CELL NEUROSCI, V18, P570, DOI 10.1006/mcne.2001.1039; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Saegusa C, 2002, J BIOL CHEM, V277, P24499, DOI 10.1074/jbc.M202767200; Sansom SN, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002519; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Schacter DL, 2007, NAT REV NEUROSCI, V8, P657, DOI 10.1038/nrn2213; Schlaggar BL, 2011, NEURON, V72, P499, DOI 10.1016/j.neuron.2011.10.024; Sepulcre J, 2012, J NEUROSCI, V32, P10649, DOI 10.1523/JNEUROSCI.0759-12.2012; Sepulcre J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000808; Shankle WR, 1998, P NATL ACAD SCI USA, V95, P4023, DOI 10.1073/pnas.95.7.4023; Shelley C, 2012, J PHYSIOL-LONDON, V590, P5723, DOI 10.1113/jphysiol.2012.238006; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Soden ME, 2013, NEURON, V80, P997, DOI 10.1016/j.neuron.2013.07.044; Sudhof TC, 2013, NEURON, V80, P675, DOI 10.1016/j.neuron.2013.10.022; Thirion B, 2014, LECT NOTES COMPUT SC, V8674, P741, DOI 10.1007/978-3-319-10470-6_92; Vanoye CG, 2013, J GEN PHYSIOL, V141, P193, DOI 10.1085/jgp.201210919; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Weiss N, 2012, J BIOL CHEM, V287, P2810, DOI 10.1074/jbc.M111.290882; Weller S.C., 1990, METRIC SCALING CORRE; Wolf L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002040; Yan H, 2009, NEUROIMAGE, V47, P1579, DOI 10.1016/j.neuroimage.2009.05.080; Yang XF, 2013, P NATL ACAD SCI USA, V110, P20777, DOI 10.1073/pnas.1321367110; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zeng HK, 2012, CELL, V149, P483, DOI 10.1016/j.cell.2012.02.052; Zhang Q, 2009, SCIENCE, V323, P1448, DOI 10.1126/science.1167373; Zimmermann J, 2014, J NEUROPHYSIOL, V112, P1559, DOI 10.1152/jn.00340.2014	89	36	36	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115913	10.1371/journal.pone.0115913	http://dx.doi.org/10.1371/journal.pone.0115913			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546015	Green Submitted, Green Published, gold			2022-12-27	WOS:000347120200082
J	Dunn, JM; Krause, PJ; Davis, S; Vannier, EG; Fitzpatrick, MC; Rollend, L; Belperron, AA; States, SL; Stacey, A; Bockenstedt, LK; Fish, D; Diuk-Wasser, MA				Dunn, Jessica M.; Krause, Peter J.; Davis, Stephen; Vannier, Edouard G.; Fitzpatrick, Meagan C.; Rollend, Lindsay; Belperron, Alexia A.; States, Sarah L.; Stacey, Andrew; Bockenstedt, Linda K.; Fish, Durland; Diuk-Wasser, Maria A.			Borrelia burgdorferi Promotes the Establishment of Babesia microti in the Northeastern United States	PLOS ONE			English	Article							WHITE-FOOTED MICE; TICK-BORNE PATHOGENS; IXODES-SCAPULARIS TICKS; HUMAN GRANULOCYTIC EHRLICHIOSIS; SENSU-STRICTO STRAINS; LYME-DISEASE PATIENTS; PEROMYSCUS-LEUCOPUS; HEMATOGENOUS DISSEMINATION; ANAPLASMA-PHAGOCYTOPHILUM; C3H/HEJ MICE	Babesia microti and Borrelia burgdorferi, the respective causative agents of human babesiosis and Lyme disease, are maintained in their enzootic cycles by the blacklegged tick (Ixodes scapularis) and use the white-footed mouse (Peromyscus leucopus) as primary reservoir host. The geographic range of both pathogens has expanded in the United States, but the spread of babesiosis has lagged behind that of Lyme disease. Several studies have estimated the basic reproduction number (R-0) for B. microti to be below the threshold for persistence (<1), a finding that is inconsistent with the persistence and geographic expansion of this pathogen. We tested the hypothesis that host coinfection with B. burgdorferi increases the likelihood of B. microti transmission and establishment in new areas. We fed I. scapularis larva on P. leucopus mice that had been infected in the laboratory with B. microti and/or B. burgdorferi. We observed that coinfection in mice increases the frequency of B. microti infected ticks. To identify the ecological variables that would increase the probability of B. microti establishment in the field, we integrated our laboratory data with field data on tick burden and feeding activity in an R0 model. Our model predicts that high prevalence of B. burgdorferi infected mice lowers the ecological threshold for B. microti establishment, especially at sites where larval burden on P. leucopus is lower and where larvae feed simultaneously or soon after nymphs infect mice, when most of the transmission enhancement due to coinfection occurs. Our studies suggest that B. burgdorferi contributes to the emergence and expansion of B. microti and provides a model to predict the ecological factors that are sufficient for emergence of B. microti in the wild.	[Dunn, Jessica M.; Davis, Stephen; Stacey, Andrew] RMIT Univ, Sch Math & Geospatial Sci, Melbourne, Vic, Australia; [Krause, Peter J.; Fitzpatrick, Meagan C.; Rollend, Lindsay; States, Sarah L.; Fish, Durland; Diuk-Wasser, Maria A.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA; [Krause, Peter J.; Belperron, Alexia A.; Bockenstedt, Linda K.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Vannier, Edouard G.] Tufts Med Ctr, Div Geog Med & Infect Dis, Boston, MA USA; [States, Sarah L.; Diuk-Wasser, Maria A.] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY USA	Royal Melbourne Institute of Technology (RMIT); Yale University; Yale University; Tufts Medical Center; Columbia University	Diuk-Wasser, MA (corresponding author), Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA.	mad2256@columbia.edu	Fitzpatrick, Meagan C/K-5083-2012	Fitzpatrick, Meagan C/0000-0002-5248-2668; States, Sarah/0000-0002-4278-0901	Gordon and Llura Gund Foundation; NIAID Multidisciplinary Parasitology Training Program [2T32AI007404]; National Science Foundation/National Institute of Health Ecology and Evolution of Infectious Diseases Program [NIH R01 GM10524601]; Environmental Protection Agency [835120]; G. Harold and Leila Y. Mathers Charitable Foundation; US Department of Agriculture-Agricultural Research Service Cooperative Agreement [58-0790-5068]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105246] Funding Source: NIH RePORTER	Gordon and Llura Gund Foundation; NIAID Multidisciplinary Parasitology Training Program; National Science Foundation/National Institute of Health Ecology and Evolution of Infectious Diseases Program; Environmental Protection Agency(United States Environmental Protection Agency); G. Harold and Leila Y. Mathers Charitable Foundation; US Department of Agriculture-Agricultural Research Service Cooperative Agreement(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Gordon and Llura Gund Foundation (PJK, EV); the NIAID Multidisciplinary Parasitology Training Program 2T32AI007404 (MCF); the National Science Foundation/National Institute of Health Ecology and Evolution of Infectious Diseases Program award NIH R01 GM10524601 (MD); the Environmental Protection Agency 835120 (MD); The G. Harold and Leila Y. Mathers Charitable Foundation (DF); and the US Department of Agriculture-Agricultural Research Service Cooperative Agreement no. 58-0790-5068 (DF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JF, 1987, APPL ENVIRON MICROB, V53, P892, DOI 10.1128/AEM.53.4.892-894.1987; ANDERSON JF, 1991, J CLIN MICROBIOL, V29, P2779, DOI 10.1128/JCM.29.12.2779-2783.1991; Belongia EA, 2002, VECTOR-BORNE ZOONOT, V2, P265, DOI 10.1089/153036602321653851; Bockenstedt LK, 2006, INFECT IMMUN, V74, P2154, DOI 10.1128/IAI.74.4.2154-2160.2006; Borggraefe I, 2006, INFECT IMMUN, V74, P3204, DOI 10.1128/IAI.01560-05; Brunner JL, 2008, ECOLOGY, V89, P2259, DOI 10.1890/07-0665.1; Bunikis J, 2004, J INFECT DIS, V189, P1515, DOI 10.1086/382594; Bunikis J, 2004, MICROBIOL-SGM, V150, P1741, DOI 10.1099/mic.0.26944-0; Casalegno JS, 2010, CLIN MICROBIOL INFEC, V16, P326, DOI 10.1111/j.1469-0691.2010.03167.x; Davis S, 2011, J THEOR BIOL, V269, P96, DOI 10.1016/j.jtbi.2010.10.011; Derdakova M, 2004, APPL ENVIRON MICROB, V70, P6783, DOI 10.1128/AEM.70.11.6783-6788.2004; Devevey G, 2012, PARASITOLOGY, V139, P915, DOI 10.1017/S003118201200008X; Diekmann O, 2000, MATH EPIDEMIOLOGY IN, Vxvi; Diterich I, 2003, INFECT IMMUN, V71, P3979, DOI 10.1128/IAI.71.7.3979-3987.2003; Diuk-Wasser MA, 2014, EMERG INFECT DIS, V20, P225, DOI 10.3201/eid2002.130644; Diuk-Wasser MA, 2012, AM J TROP MED HYG, V86, P320, DOI 10.4269/ajtmh.2012.11-0395; Diuk-Wasser MA, 2010, GLOBAL ECOL BIOGEOGR, V19, P504, DOI 10.1111/j.1466-8238.2010.00526.x; Druilhe P, 2005, TRENDS PARASITOL, V21, P359, DOI 10.1016/j.pt.2005.06.011; Dunn JM, 2013, J THEOR BIOL, V335, P213, DOI 10.1016/j.jtbi.2013.06.035; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Ezenwa VO, 2011, INTEGR COMP BIOL, V51, P540, DOI 10.1093/icb/icr058; FISH D, 1993, ECOLOGY ENV MANAGEME; Gatewood AG, 2009, APPL ENVIRON MICROB, V75, P2476, DOI 10.1128/AEM.02633-08; Giambartolomei GH, 1998, INFECT IMMUN, V66, P2691, DOI 10.1128/IAI.66.6.2691-2697.1998; Gibson LR, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-248; Ginsberg HS, 2008, EXP APPL ACAROL, V46, P29, DOI 10.1007/s10493-008-9175-5; Hamer SA, 2012, TICKS TICK-BORNE DIS, V3, P65, DOI 10.1016/j.ttbdis.2011.11.004; Hamer SA, 2010, ECOHEALTH, V7, P47, DOI 10.1007/s10393-010-0287-0; Hanincova K, 2008, APPL ENVIRON MICROB, V74, P153, DOI 10.1128/AEM.01567-07; Hanincova K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073066; Hartemink NA, 2008, AM NAT, V171, P743, DOI 10.1086/587530; Hersh MH, 2012, EMERG INFECT DIS, V18, P1951, DOI 10.3201/eid1812.111392; Homer MJ, 2000, CLIN MICROBIOL REV, V13, P451, DOI 10.1128/CMR.13.3.451-469.2000; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Joseph JT, 2011, EMERG INFECT DIS, V17, P843, DOI 10.3201/eid1705.101334; Krause PJ, 2013, NEW ENGL J MED, V368, P291, DOI 10.1056/NEJMc1215469; Krause PJ, 2003, AM J TROP MED HYG, V68, P431, DOI 10.4269/ajtmh.2003.68.431; Krause PJ, 1996, JAMA-J AM MED ASSOC, V275, P1657, DOI 10.1001/jama.275.21.1657; KRAUSE PJ, 1991, J CLIN MICROBIOL, V29, P1; Lawn SD, 2006, CLIN INFECT DIS, V42, P1040, DOI 10.1086/501018; Lello J, 2008, AM NAT, V171, P176, DOI 10.1086/525257; Levin ML, 2001, VECTOR-BORNE ZOONOT, V1, P139, DOI 10.1089/153036601316977741; Levin ML, 2000, INFECT IMMUN, V68, P2183, DOI 10.1128/IAI.68.4.2183-2186.2000; Li S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039612; Liveris D, 1996, J CLIN MICROBIOL, V34, P1306, DOI 10.1128/JCM.34.5.1306-1309.1996; Liveris D, 1999, J CLIN MICROBIOL, V37, P565, DOI 10.1128/JCM.37.3.565-569.1999; Lopez-Villavicencio M, 2011, EVOLUTION, V65, P1357, DOI 10.1111/j.1558-5646.2010.01207.x; Magnarelli LA, 1997, J WILDLIFE DIS, V33, P466, DOI 10.7589/0090-3558-33.3.466; MAGNARELLI LA, 1995, J CLIN MICROBIOL, V33, P3054, DOI 10.1128/JCM.33.11.3054-3057.1995; Magnarelli LA, 2013, J WILDLIFE DIS, V49, P294, DOI 10.7589/2012-06-172; MATHER TN, 1990, EXP PARASITOL, V70, P55, DOI 10.1016/0014-4894(90)90085-Q; Menis M, 2012, EMERG INFECT DIS, V18, P128, DOI 10.3201/eid1801.110305; Nazario S, 1998, AM J TROP MED HYG, V58, P780, DOI 10.4269/ajtmh.1998.58.780; Nonaka E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011745; Ogden NH, 2013, J APPL ECOL, V50, P510, DOI [10.1111/1365-2664.12050, 10.1111/]; PIESMAN J, 1982, EXP PARASITOL, V53, P242, DOI 10.1016/0014-4894(82)90065-0; PIESMAN J, 1987, J CLIN MICROBIOL, V25, P557, DOI 10.1128/JCM.25.3.557-558.1987; PIESMAN J, 1986, ACTA TROP, V43, P263; PIESMAN J, 1986, J CLIN MICROBIOL, V24, P446, DOI 10.1128/JCM.24.3.446-447.1986; Randolph SE, 2000, PARASITOLOGY, V121, P15, DOI 10.1017/S0031182099006083; Richer LM, 2014, J INFECT DIS, V209, P1972, DOI 10.1093/infdis/jiu005; Rollend L, 2013, VECTOR-BORNE ZOONOT, V13, P784, DOI 10.1089/vbz.2011.0935; Salgame P, 2013, NAT IMMUNOL, V14, P1118, DOI 10.1038/ni.2736; SCHUG MD, 1991, J MAMMAL, V72, P360, DOI 10.2307/1382107; Scoles GA, 2001, VECTOR-BORNE ZOONOT, V1, P21, DOI 10.1089/153036601750137624; Seinost G, 1999, INFECT IMMUN, V67, P3518, DOI 10.1128/IAI.67.7.3518-3524.1999; Snyder DP, 1956, SURVIVAL RATES LONGE; Stafford KC, 1999, J CLIN MICROBIOL, V37, P2887, DOI 10.1128/JCM.37.9.2887-2892.1999; States SL, 2014, INFECT GENET EVOL; Steiner FE, 2008, J MED ENTOMOL, V45, P289, DOI 10.1603/0022-2585(2008)45[289:IACROA]2.0.CO;2; Swanson SJ, 2006, CLIN MICROBIOL REV, V19, P708, DOI 10.1128/CMR.00011-06; Telfer S, 2010, SCIENCE, V330, P243, DOI 10.1126/science.1190333; Tokarz R, 2010, VECTOR-BORNE ZOONOT, V10, P217, DOI 10.1089/vbz.2009.0036; Tsao JI, 2004, P NATL ACAD SCI USA, V101, P18159, DOI 10.1073/pnas.0405763102; Vannier E, 2012, NEW ENGL J MED, V366, P2397, DOI 10.1056/NEJMra1202018; Varde S, 1998, EMERG INFECT DIS, V4, P97, DOI 10.3201/eid0401.980113; Voordouw MJ, 2013, VECTOR-BORNE ZOONOT, V13, P203, DOI 10.1089/vbz.2012.1003; Wang G, 2001, INFECT IMMUN, V69, P4303, DOI 10.1128/IAI.69.7.4303-4312.2001; Wormser GP, 2008, J INFECT DIS, V198, P1358, DOI 10.1086/592279; Wormser GP, 1999, J INFECT DIS, V180, P720, DOI 10.1086/314922; Zeidner NS, 2000, PARASITE IMMUNOL, V22, P581, DOI 10.1046/j.1365-3024.2000.00339.x	81	71	72	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115494	10.1371/journal.pone.0115494	http://dx.doi.org/10.1371/journal.pone.0115494			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545393	gold, Green Published, Green Submitted			2022-12-27	WOS:000347120200045
J	Namjou, B; Ni, YZ; Harley, ITW; Chepelev, I; Cobb, B; Kottyan, LC; Gaffney, PM; Guthridge, JM; Kaufman, K; Harley, JB				Namjou, Bahram; Ni, Yizhao; Harley, Isaac T. W.; Chepelev, Iouri; Cobb, Beth; Kottyan, Leah C.; Gaffney, Patrick M.; Guthridge, Joel M.; Kaufman, Kenneth; Harley, John B.			The Effect of Inversion at 8p23 on BLK Association with Lupus in Caucasian Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HUMAN-CHROMOSOME 8P23; CHINESE HAN; ERYTHEMATOSUS; POLYMORPHISM; HAPLOTYPE; VARIANTS; GENE; TRANSCRIPTION; IMPACT	To explore the potential influence of the polymorphic 8p23.1 inversion on known autoimmune susceptibility risk at or near BLK locus, we validated a new bioinformatics method that utilizes SNP data to enable accurate, high-throughput genotyping of the 8p23.1 inversion in a Caucasian population. Methods: Principal components analysis (PCA) was performed using markers inside the inversion territory followed by k-means cluster analyses on 7416 European derived and 267 HapMaP CEU and TSI samples. A logistic regression conditional analysis was performed. Results: Three subgroups have been identified; inversion homozygous, heterozygous and non-inversion homozygous. The status of inversion was further validated using HapMap samples that had previously undergone Fluorescence in situ hybridization (FISH) assays with a concordance rate of above 98%. Conditional analyses based on the status of inversion were performed. We found that overall association signals in the BLK region remain significant after controlling for inversion status. The proportion of lupus cases and controls (cases/controls) in each subgroup was determined to be 0.97 for the inverted homozygous group (1067 cases and 1095 controls), 1.12 for the inverted heterozygous group (1935 cases 1717 controls) and 1.36 for non-inverted subgroups (924 cases and 678 controls). After calculating the linkage disequilibrium between inversion status and lupus risk haplotype we found that the lupus risk haplotype tends to reside on non-inversion background. As a result, a new association effect between non-inversion status and lupus phenotype has been identified ((p=8.18 x 10(-7), OR=1.18, 95%CI=1.10-1.26). Conclusion: Our results demonstrate that both known lupus risk haplotype and inversion status act additively in the pathogenesis of lupus. Since inversion regulates expression of many genes in its territory, altered expression of other genes might also be involved in the development of lupus.	[Namjou, Bahram; Harley, Isaac T. W.; Chepelev, Iouri; Cobb, Beth; Kottyan, Leah C.; Kaufman, Kenneth; Harley, John B.] Cincinnati Childrens Hosp Med Ctr, Ctr Autoimmune Genom & Etiol, Cincinnati, OH 45229 USA; [Namjou, Bahram; Harley, Isaac T. W.; Chepelev, Iouri; Cobb, Beth; Kottyan, Leah C.; Kaufman, Kenneth; Harley, John B.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Ni, Yizhao] Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH 45229 USA; [Harley, Isaac T. W.] Univ Colorado Denver, Div Rheumatol, Aurora, CO 80045 USA; [Harley, Isaac T. W.] Univ Colorado Denver, Dept Internal Med, Aurora, CO 80045 USA; [Gaffney, Patrick M.; Guthridge, Joel M.] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA; [Harley, John B.] Dept Vet Affairs Med Ctr, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Oklahoma Medical Research Foundation; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Cincinnati VA Medical Center	Namjou, B (corresponding author), Cincinnati Childrens Hosp Med Ctr, Ctr Autoimmune Genom & Etiol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	Bahram.namjou@cchmc.org	Kottyan, Leah C./H-3050-2019	Kottyan, Leah C./0000-0003-3979-2220; Harley, Isaac/0000-0003-1282-5395; Guthridge, Joel/0000-0002-9308-237X; Chepelev, Iouri/0000-0002-2121-8805; Gaffney, Patrick/0000-0002-1580-869X; Ni, Yizhao/0000-0001-8599-454X	National Human Genomic Research Institute: NIH [U01 HG006828, R37 AI024717, P01 AI083194]; US Department of Veterans Affairs (IMMA9) Department of Defense [PR094002]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI083194, R37AI024717] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001834] Funding Source: NIH RePORTER	National Human Genomic Research Institute: NIH; US Department of Veterans Affairs (IMMA9) Department of Defense; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	This study was supported by the National Human Genomic Research Institute: NIH (U01 HG006828, R37 AI024717, P01 AI083194)-BN-JBH-KK-BC-LC-IC and the US Department of Veterans Affairs (IMMA9) Department of Defense (PR094002)-JBH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonacci F, 2009, HUM MOL GENET, V18, P2555, DOI 10.1093/hmg/ddp187; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Broman KW, 2003, INST MATH S, V40, P237; Delgado-Vega AM, 2012, ANN RHEUM DIS, V71, P1219, DOI 10.1136/annrheumdis-2011-200987; Deng LB, 2008, HUM MUTAT, V29, P1209, DOI 10.1002/humu.20775; Giglio S, 2001, AM J HUM GENET, V68, P874, DOI 10.1086/319506; Gourh P, 2010, J AUTOIMMUN, V34, P155, DOI 10.1016/j.jaut.2009.08.014; Graham RR, 2008, NAT GENET, V40, P1059, DOI 10.1038/ng.200; Gregersen PK, 2009, NAT GENET, V41, P820, DOI 10.1038/ng.395; Guthridge JM, 2014, AM J HUM GENET, V94, P586, DOI 10.1016/j.ajhg.2014.03.008; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Hoffmann AA, 2008, ANNU REV ECOL EVOL S, V39, P21, DOI 10.1146/annurev.ecolsys.39.110707.173532; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Jaarola M, 1998, AM J HUM GENET, V63, P218, DOI 10.1086/301900; Kirkpatrick M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000501; Lessard CJ, 2013, NAT GENET, V45, P1284, DOI 10.1038/ng.2792; Ma JZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040224; Myers AJ, 2007, NEUROBIOL DIS, V25, P561, DOI 10.1016/j.nbd.2006.10.018; Namjou B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069404; Namjou B, 2012, ARTHRITIS RHEUM-US, V64, P1960, DOI 10.1002/art.34361; Navarro A, 2005, NAT GENET, V37, P115, DOI 10.1038/ng0205-115; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Salm MPA, 2012, GENOME RES, V22, P1144, DOI 10.1101/gr.126037.111; Sayers EW, 2011, NUCLEIC ACIDS RES, V39, pD38, DOI 10.1093/nar/gkq1172; Sugawara H, 2003, GENOMICS, V82, P238, DOI 10.1016/S0888-7543(03)00108-3; Tsuchiya Naoyuki, 2010, Nihon Rinsho Meneki Gakkai Kaishi, V33, P57; Yin H, 2009, ARTHRITIS RHEUM-US, V60, P2468, DOI 10.1002/art.24701; Zhang Z, 2010, ARCH DERMATOL RES, V302, P619, DOI 10.1007/s00403-010-1029-4	29	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115614	10.1371/journal.pone.0115614	http://dx.doi.org/10.1371/journal.pone.0115614			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545785	gold, Green Published, Green Submitted			2022-12-27	WOS:000347120200049
J	Rath, T; Zwaschka, L; Hage, L; Kugler, M; Menendez, K; Naehrlich, L; Schulz, R; Roderfeld, M; Roeb, E				Rath, Timo; Zwaschka, Lisa; Hage, Lisa; Kuegler, Marion; Menendez, Katrin; Naehrlich, Lutz; Schulz, Richard; Roderfeld, Martin; Roeb, Elke			Identification of Neutrophil Activation Markers as Novel Surrogate Markers of CF Lung Disease	PLOS ONE			English	Article							CYSTIC-FIBROSIS; MATRIX METALLOPROTEINASES; PHENOTYPE CORRELATIONS; PULMONARY-FUNCTION; SPUTUM BIOMARKERS; FUNCTION DECLINE; YKL-40; AIRWAY; INFLAMMATION; MORTALITY	Background and aims: Cystic Fibrosis (CF) lung disease is characterized by progressively declining lung function and represents a major factor contributing to the high morbidity and mortality associated with CF. However, apart from spirometry, respiratory disease surrogate markers reliably indicating CF lung disease and the occurrence of pulmonary exacerbations (PEx) are still lacking. Within this study, we aimed to identify new experimental biomarkers for the detection of CF lung disease. Methods: 54 adult and 26 pediatric CF patients were included in the study and serum concentrations of MMP-1, -2, -8, -9, -13, TIMP-1, TIMP-2, YKL-40, hyaluronic acid, procollagen III peptide were quantified by ELISA. CF lung disease was diagnosed by lung function test, PEx was defined based on a clinical scoring established by Rosenfeld in 2001. Results: Adults and children with moderate to severe CF lung disease exhibited significantly increased serum expression of MMP-8, MMP-9, YKL-40 and TIMP-1. Further, MMP-8, MMP-9 and YKL-40 were significantly increased in adult CF patients suffering from PEx compared to those without clinical signs of respiratory exacerbation. MMP-8, MMP-9, YKL-40, and TIMP-1 serum levels were unaffected by the presence or absence of CF liver disease or pancreatic insufficiency. Conclusions: MMP-8, MMP-9, and YKL-40 might serve as novel non-invasive biomarkers of CF lung disease and PEx.	[Rath, Timo; Zwaschka, Lisa; Hage, Lisa; Kuegler, Marion; Menendez, Katrin; Roderfeld, Martin; Roeb, Elke] Univ Giessen, Dept Gastroenterol, D-35390 Giessen, Germany; [Rath, Timo] Univ Erlangen Nurnberg, Dept Med 1, D-91054 Erlangen, Germany; [Naehrlich, Lutz] Univ Giessen, Dept Pediat, Div Pulmonol, D-35390 Giessen, Germany; [Schulz, Richard] Univ Giessen, Dept Pulmonol, D-35390 Giessen, Germany	Justus Liebig University Giessen; University of Erlangen Nuremberg; Justus Liebig University Giessen; Justus Liebig University Giessen	Roeb, E (corresponding author), Univ Giessen, Dept Gastroenterol, D-35390 Giessen, Germany.	Elke.Roeb@innere.med.uni-giessen.de	, Martin/AHD-5202-2022; Naehrlich, Lutz/F-4574-2015	, Martin/0000-0002-3232-1277; Naehrlich, Lutz/0000-0002-7146-6997; Rath, Timo/0000-0002-7728-9338	Deutsche Forschungsgemeinschaft [RO 957/7-1, RO 957/8-1]; University Medical Center Giessen Marburg (UKGM) [10/2010 GI]; ZooMAP (Bundesministerium fur Bildung und Forschung, BMBF) [01KI1003E]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University Medical Center Giessen Marburg (UKGM); ZooMAP (Bundesministerium fur Bildung und Forschung, BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (RO 957/7-1 and RO 957/8-1), a research Grant of the University Medical Center Giessen & Marburg (UKGM 10/2010 GI), and from ZooMAP (01KI1003E, Bundesministerium fur Bildung und Forschung, BMBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyle MP, 2007, JAMA-J AM MED ASSOC, V298, P1787, DOI 10.1001/jama.298.15.1787; CAMPOCCIA D, 1993, BIOMATERIALS, V14, P1135, DOI 10.1016/0142-9612(93)90156-V; Chupp GL, 2007, NEW ENGL J MED, V357, P2016, DOI 10.1056/NEJMoa073600; Corey M, 1997, J PEDIATR-US, V131, P809, DOI 10.1016/S0022-3476(97)70025-8; Corey M, 1996, AM J EPIDEMIOL, V143, P1007, DOI 10.1093/oxfordjournals.aje.a008664; Dakin C, 2001, PEDIATR PULM, V31, P436, DOI 10.1002/ppul.1072; Debray D, 2011, J CYST FIBROS, V10, pS29, DOI 10.1016/S1569-1993(11)60006-4; DORING G, 1994, AM J RESP CRIT CARE, V150, pS114; Dray X, 2003, GASTROENTEROLOGY, V125, P1286, DOI 10.1016/j.gastro.2003.08.016; Durno C, 2002, GASTROENTEROLOGY, V123, P1857, DOI 10.1053/gast.2002.37042; Elkington PTG, 2006, THORAX, V61, P259, DOI 10.1136/thx.2005.051979; Fantino E, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-28; Ferkol T, 2006, J PEDIATR-US, V148, P259, DOI 10.1016/j.jpeds.2005.10.019; Flume PA, 2007, AM J RESP CRIT CARE, V176, P957, DOI 10.1164/rccm.200705-664OC; Gaggar A, 2008, J IMMUNOL, V180, P5662, DOI 10.4049/jimmunol.180.8.5662; Gaggar A, 2007, AM J PHYSIOL-LUNG C, V293, pL96, DOI 10.1152/ajplung.00492.2006; Gault Rachel, 2002, Pediatr Phys Ther, V14, P157; Gressner OA, 2007, CLIN CHIM ACTA, V381, P107, DOI 10.1016/j.cca.2007.02.038; Gueders MM, 2006, EUR J PHARMACOL, V533, P133, DOI 10.1016/j.ejphar.2005.12.082; Hartl D, 2007, NAT MED, V13, P1423, DOI 10.1038/nm1690; Harutyunyan M, 2013, IMMUNOBIOLOGY, V218, P945, DOI 10.1016/j.imbio.2012.10.015; Hector A, 2011, PLOS ONE, V6; Hilliard TN, 2007, THORAX, V62, P1074, DOI 10.1136/thx.2006.074641; Jackson PL, 2010, MOL MED, V16, P159, DOI 10.2119/molmed.2009.00109; Kadoglou PE, 2014, EXP CLIN ENDOCR DIAB, V122, P44, DOI 10.1055/s-0033-1358762; KEREM E, 1992, NEW ENGL J MED, V326, P1187, DOI 10.1056/NEJM199204303261804; Kerem Eitan, 2005, J Cyst Fibros, V4, P7, DOI 10.1016/j.jcf.2004.12.002; Kraynack NC, 2011, PEDIATR PULM, V46, P870, DOI 10.1002/ppul.21442; Lee JH, 2012, J DIABETES COMPLICAT, V26, P308, DOI 10.1016/j.jdiacomp.2012.04.012; Letuve S, 2008, J IMMUNOL, V181, P5167, DOI 10.4049/jimmunol.181.7.5167; Lewandowski KC, 2011, ARCH MED SCI, V7, P294, DOI 10.5114/aoms.2011.22081; Ma YG, 2014, ATHEROSCLEROSIS, V232, P231, DOI 10.1016/j.atherosclerosis.2013.09.013; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Mayer-Hamblett N, 2007, AM J RESP CRIT CARE, V175, P822, DOI 10.1164/rccm.200609-1354OC; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Nordenbaek C, 1999, J INFECT DIS, V180, P1722, DOI 10.1086/315050; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Parks WC, 2001, RESP RES, V2, P10, DOI 10.1186/rr33; Perez A, 2008, AM J PHYSIOL-LUNG C, V295, pL303, DOI 10.1152/ajplung.90276.2008; RAMSEY BW, 1994, J PEDIATR-US, V124, P177, DOI 10.1016/S0022-3476(94)70301-9; Rath T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058955; Ratjen F, 2002, THORAX, V57, P930, DOI 10.1136/thorax.57.11.930; Rosenfeld M, 2001, J PEDIATR-US, V139, P359, DOI 10.1067/mpd.2001.117288; Sagel SD, 2012, AM J RESP CRIT CARE, V186, P857, DOI 10.1164/rccm.201203-0507OC; Sagel SD, 2005, PEDIATR PULM, V39, P224, DOI 10.1002/ppul.20165; Shoki AH, 2013, CHEST, V144, P1659, DOI 10.1378/chest.13-0693; Volck B, 1998, P ASSOC AM PHYSICIAN, V110, P351; Walsh DE, 2001, J BIOL CHEM, V276, P35494, DOI 10.1074/jbc.M103543200	48	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115847	10.1371/journal.pone.0115847	http://dx.doi.org/10.1371/journal.pone.0115847			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545245	Green Published, gold, Green Submitted			2022-12-27	WOS:000347120200075
J	Song, YF; Forsgren, S; Liu, JX; Yu, JG; Stal, P				Song, Yafeng; Forsgren, Sture; Liu, Jing-Xia; Yu, Ji-Guo; Stal, Per			Unilateral Muscle Overuse Causes Bilateral Changes in Muscle Fiber Composition and Vascular Supply	PLOS ONE			English	Article							THYROID-HORMONE REGULATION; MAMMALIAN SKELETAL-MUSCLE; CROSS-EDUCATION; VASTUS-LATERALIS; ELECTRICAL-STIMULATION; ISOFORM COMPOSITION; POSSIBLE MECHANISMS; GENE-EXPRESSION; SOLEUS MUSCLE; STRENGTH	Unilateral strength training can cause cross-transfer strength effects to the homologous contralateral muscles. However, the impact of the cross-over effects on the muscle tissue is unclear. To test the hypothesis that unilateral muscle overuse causes bilateral alterations in muscle fiber composition and vascular supply, we have used an experimental rabbit model with unilateral unloaded overstrain exercise via electrical muscle stimulation (E/EMS). The soleus (SOL) and gastrocnemius (GA) muscles of both exercised (E) and contralateral non-exercised (NE) legs (n=24) were morphologically analyzed after 1w, 3w and 6w of EMS. Non-exercised rabbits served as controls (n=6). After unilateral intervention the muscles of both E and NE legs showed myositis and structural and molecular tissue changes that to various degrees mirrored each other. The fiber area was bilaterally smaller than in controls after 3w of E/EMS in both SOL (E 4420 and NE 4333 mu m(2) vs. 5183 mu m(2), p<0.05) and GA (E 3572 and NE 2983 mu m(2) vs. 4697 mu m(2), p<0.02) muscles. After 6w of E/ EMS, the percentage of slow MyHCI fibers was lower than in controls in the NE legs of SOL (88.1% vs. 98.1%, p, 0.009), while the percentage of fast MyHCIIa fibers was higher in the NE legs of GA (25.7% vs. 15.8%, p=0.02). The number of capillaries around fibers in the E and NE legs was lower (SOL 13% and 15%, respectively, GA 25% and 23%, respectively, p<0.05) than in controls. The overall alterations were more marked in the fast GA muscle than in the slow SOL muscle, which on the other hand showed more histopathological muscle changes. We conclude that unilateral repetitive unloaded overuse exercise via EMS causes myositis and muscle changes in fiber type proportions, fiber area and fiber capillarization not only in the exercised leg, but also in the homologous muscles in the non-exercised leg.	[Song, Yafeng; Forsgren, Sture; Liu, Jing-Xia; Stal, Per] Umea Univ, Sect Anat, Dept Integrat Med Biol, Umea, Sweden; [Yu, Ji-Guo] Umea Univ, Sports Med Unit, Dept Surg & Perioperat Sci, Umea, Sweden	Umea University; Umea University	Stal, P (corresponding author), Umea Univ, Sect Anat, Dept Integrat Med Biol, Umea, Sweden.	per.stal@anatomy.umu.se		Stal, Per/0000-0002-9340-5298; Yu, Jiguo/0000-0001-7607-475X	Faculty of Medicine; Umea University; Swedish National Centre for Research in Sports (CIF); J. C. Kempe Memorial Foundation; Seth M. Kempe Memorial Foundation; China Scholarship Council	Faculty of Medicine; Umea University; Swedish National Centre for Research in Sports (CIF); J. C. Kempe Memorial Foundation; Seth M. Kempe Memorial Foundation; China Scholarship Council(China Scholarship Council)	Financial support was received from the Faculty of Medicine, Umea University, the Swedish National Centre for Research in Sports (CIF) and the J. C. Kempe and Seth M. Kempe Memorial Foundations. A stipendium was provided from China Scholarship Council. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN JL, 1994, ACTA PHYSIOL SCAND, V151, P135, DOI 10.1111/j.1748-1716.1994.tb09730.x; Andersson G, 2011, BRIT J SPORT MED, V45, P399, DOI 10.1136/bjsm.2009.068122; ARMSTRONG RB, 1982, AM J ANAT, V163, P87, DOI 10.1002/aja.1001630107; BACKMAN C, 1990, J ORTHOPAED RES, V8, P541, DOI 10.1002/jor.1100080410; Baldwin KM, 2002, AM J PHYS MED REHAB, V81, pS40, DOI 10.1097/00002060-200211001-00006; Bezerra P, 2009, MUSCLE NERVE, V40, P430, DOI 10.1002/mus.21329; Borisov AB, 2000, ANAT REC, V258, P292; Brey EM, 2002, MICROVASC RES, V63, P279, DOI 10.1006/mvre.2002.2395; BRZANK KD, 1986, ANAT ANZEIGER, V161, P243; CABRIC M, 1987, INT J SPORTS MED, V8, P256, DOI 10.1055/s-2008-1025665; CAIOZZO VJ, 1992, J APPL PHYSIOL, V73, P1432, DOI 10.1152/jappl.1992.73.4.1432; Canepari M, 1998, ARCH PHYSIOL BIOCHEM, V106, P308, DOI 10.1076/apab.106.4.308.4373; Carroll TJ, 2006, J APPL PHYSIOL, V101, P1514, DOI 10.1152/japplphysiol.00531.2006; Chang YW, 2010, J PAIN, V11, P119, DOI 10.1016/j.jpain.2009.06.009; Charifi N, 2004, J PHYSIOL-LONDON, V554, P559, DOI 10.1113/jphysiol.2003.046953; CHO M, 1994, J CELL SCI, V107, P2361; Ciciliot S, 2010, CURR PHARM DESIGN, V16, P906, DOI 10.2174/138161210790883453; CORSI A, 1990, J EXP BIOL, V152, P265; Dalakas MC, 2012, AUTOIMMUN REV, V11, P203, DOI 10.1016/j.autrev.2011.05.013; Dedkov EI, 2002, MICROVASC RES, V63, P96, DOI 10.1006/mvre.2001.2372; DEVINE KL, 1981, PHYS THER, V61, P898, DOI 10.1093/ptj/61.6.898; Dubowitz V, 2007, MUSCLE BIOPSY, P37; ESBJORNSSON M, 1993, ACTA PHYSIOL SCAND, V149, P245, DOI 10.1111/j.1748-1716.1993.tb09618.x; Farthing JP, 2009, J APPL PHYSIOL, V106, P830, DOI 10.1152/japplphysiol.91331.2008; Fitts R H, 1996, Exerc Sport Sci Rev, V24, P427; GOLLNICK PD, 1974, PFLUG ARCH EUR J PHY, V348, P247, DOI 10.1007/BF00587415; GRIMBY G, 1976, SCAND J REHABIL MED, V8, P37; Hamalainen N, 1996, FEBS LETT, V399, P220, DOI 10.1016/S0014-5793(96)01325-7; Heil M, 2006, J CELL MOL MED, V10, P45, DOI 10.1111/j.1582-4934.2006.tb00290.x; Heil M, 2007, CURR PHARM BIOTECHNO, V8, P35, DOI 10.2174/138920107779941408; HOH JFY, 1975, BIOCHEMISTRY-US, V14, P742, DOI 10.1021/bi00675a015; Hortobagyi T, 1997, MED SCI SPORT EXER, V29, P107, DOI 10.1097/00005768-199701000-00015; Hortobagyi T, 1999, MOTOR CONTROL, V3, P205, DOI 10.1123/mcj.3.2.205; Hortobagyi T, 2000, J PHYSIOL-LONDON, V524, P293, DOI 10.1111/j.1469-7793.2000.00293.x; Howatson G, 2007, EUR J APPL PHYSIOL, V101, P207, DOI 10.1007/s00421-007-0489-5; Hudlicka O, 2003, J PHYSIOL-LONDON, V546, P813, DOI 10.1113/jphysiol.2002.030569; HUGHES SM, 1993, DEV BIOL, V158, P183, DOI 10.1006/dbio.1993.1178; JANSSON E, 1978, ACTA PHYSIOL SCAND, V104, P235, DOI 10.1111/j.1748-1716.1978.tb06272.x; Kelly S, 2007, EUR J NEUROSCI, V26, P935, DOI 10.1111/j.1460-9568.2007.05737.x; Koltzenburg M, 1999, TRENDS NEUROSCI, V22, P122, DOI 10.1016/S0166-2236(98)01302-2; LARSSON L, 1995, ACTA PHYSIOL SCAND, V153, P109, DOI 10.1111/j.1748-1716.1995.tb09841.x; Lee M, 2007, SPORTS MED, V37, P1, DOI 10.2165/00007256-200737010-00001; LEVINE JD, 1985, J RHEUMATOL, V12, P406; Liu JX, 2002, J HISTOCHEM CYTOCHEM, V50, P171, DOI 10.1177/002215540205000205; Liu Y, 2003, J APPL PHYSIOL, V94, P2282, DOI 10.1152/japplphysiol.00830.2002; Lu DX, 1997, ANAT REC, V248, P355; Lucas K, 2012, J IMMUNOL, V189, P1237, DOI 10.4049/jimmunol.1103264; McCall GE, 1998, CAN J APPL PHYSIOL, V23, P594, DOI 10.1139/h98-034; Munn J, 2005, J APPL PHYSIOL, V99, P1880, DOI 10.1152/japplphysiol.00559.2005; Munn J, 2004, J APPL PHYSIOL, V96, P1861, DOI 10.1152/japplphysiol.00541.2003; Osterlund C, 2013, HISTOCHEM CELL BIOL; Paddon-Jones D, 2001, EUR J APPL PHYSIOL, V85, P466, DOI 10.1007/s004210100467; PANIN N, 1961, Arch Phys Med Rehabil, V42, P47; Perez M, 2002, PFLUG ARCH EUR J PHY, V443, P866, DOI 10.1007/s00424-001-0769-6; PETTE D, 1985, MUSCLE NERVE, V8, P676, DOI 10.1002/mus.880080810; Pette D, 2000, MICROSC RES TECHNIQ, V50, P500, DOI 10.1002/1097-0029(20000915)50:6<500::AID-JEMT7>3.0.CO;2-7; Pette D, 1997, Int Rev Cytol, V170, P143, DOI 10.1016/S0074-7696(08)61622-8; Pettersson J, 2010, J PLAST RECONSTR AES, V63, P1893, DOI 10.1016/j.bjps.2009.11.024; Schiaffino S., 2008, SKELETAL MUSCLE REPA; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; SEWRY CA, 1995, HISTOCHEM J, V27, P497; Shenker N, 2003, RHEUMATOLOGY, V42, P1279, DOI 10.1093/rheumatology/keg397; Shima N, 2002, EUR J APPL PHYSIOL, V86, P287, DOI 10.1007/s00421-001-0559-z; SILBERSTEIN L, 1986, CELL, V46, P1075, DOI 10.1016/0092-8674(86)90707-5; Sluka KA, 2001, MUSCLE NERVE, V24, P37, DOI 10.1002/1097-4598(200101)24:1<37::AID-MUS4>3.0.CO;2-8; Song Y, 2013, ISRN INFLAMMATION, V2013, P19; Song YF, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-134; Song YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052230; Spang C, 2012, INFLAMMATION, V35, P39, DOI 10.1007/s10753-010-9287-z; Stal PS, 2000, J ANAT, V197, P275, DOI 10.1017/S0021878299006627; Starbuck C, 2012, EUR J APPL PHYSIOL, V112, P1005, DOI 10.1007/s00421-011-2053-6; Staron RS, 1998, HISTOCHEM CELL BIOL, V110, P73, DOI 10.1007/s004180050267; STERNBERGER LA, 1979, J HISTOCHEM CYTOCHEM, V27, P1657, DOI 10.1177/27.12.392001; Tse KH, 2010, J BIOMED MATER RES A, V95A, P701, DOI 10.1002/jbm.a.32889; Twining CM, 2004, PAIN, V110, P299, DOI 10.1016/j.pain.2004.04.008; WARHOL MJ, 1985, AM J PATHOL, V118, P331; Weir JP, 1997, J ORTHOP SPORT PHYS, V25, P264, DOI 10.2519/jospt.1997.25.4.264; Wilson JM, 2012, J STRENGTH COND RES, V26, P1724, DOI 10.1519/JSC.0b013e318234eb6f; Zhou S, 2000, Exerc Sport Sci Rev, V28, P177	79	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e116455	10.1371/journal.pone.0116455	http://dx.doi.org/10.1371/journal.pone.0116455			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545800	gold, Green Published, Green Submitted			2022-12-27	WOS:000347120200113
J	Todberg, T; Koch, A; Andersson, M; Olsen, SF; Lous, J; Homoe, P				Todberg, Tanja; Koch, Anders; Andersson, Mikael; Olsen, Sjurdur F.; Lous, Jorgen; Homoe, Preben			Incidence of Otitis Media in a Contemporary Danish National Birth Cohort	PLOS ONE			English	Article							UNITED-STATES; CHILDREN; EPIDEMIOLOGY; TYMPANOMETRY; POPULATION; VALIDITY; HEALTH; BIAS; CARE	Objectives: In recent years welfare in Denmark has increased which might be expected to reduce otitis media (OM) incidence. We examined the age-specific incidence of OM in a nation-wide cohort of children aged 0-7 years born in 19962003 (Danish National Birth Cohort, DNBC). Only selection was ability to understand and speak Danish. Methods: Information of OM and ventilation tubes (VT) was collected through three maternal interviews at 6-month, 18-month and 7-years of age and based on this age-specific and cumulative incidence of OM was calculated. As different numbers of the total population answered the different interviews, the calculations are done with different denominators. The information in DNBC was validated against two population based registries containing information of VT insertions. Results: Cumulative incidence of OM at 7 years was 60.6% (31,982/52,755). For children with OM, 16.2% (7143/44194) had their first OM episodes between 06 months of age, 44.3% (19579/44194) between 7-18 months, and 39.5% (17472/44194) between 19 months and 7 years. Four or more OM episodes before 7 years were reported by 39.5% (12620/31982) and by 64.0% (2482/3881) of those who had their OM debut between 0-6 months; by 48.2% (4998/10378) with debut between 7-18 months; and by 28.7% (4996/17344) with debut between 19 months and 7 years. These figures are essentially unchanged from earlier figures from Denmark. VT insertion at least once was reported by 26,1% in the 7-year interview. Assuming recordings in the Danish National Patient Registry to be gold standard, maternal self-reportings in DNBC of insertion of VTshowed high sensitivity (96.4%), specificity (98.2%), and positive (94.8%) and negative predictive values (98.8%). Conclusion: OM affects nearly 2/3 of preschool children in Denmark despite reduction in known OM risk factors.	[Todberg, Tanja; Homoe, Preben] Univ Copenhagen Hosp, Rigshosp, Dept Otolaryngol Head & Neck Surg & Audiol, DK-2100 Copenhagen, Denmark; [Todberg, Tanja; Koch, Anders; Andersson, Mikael; Olsen, Sjurdur F.] Statens Serum Inst, Ctr Fetal Programming, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Lous, Jorgen] Univ Southern Denmark, Inst Publ Hlth, Res Unit Gen Practice, Odense, Denmark; [Homoe, Preben] Koge Univ Hosp, Dept Otorhinolaryngol & Maxillofacial Surg, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Statens Serum Institut; University of Southern Denmark	Todberg, T (corresponding author), Univ Copenhagen Hosp, Rigshosp, Dept Otolaryngol Head & Neck Surg & Audiol, DK-2100 Copenhagen, Denmark.	gjb710@gmail.com		Koch, Anders/0000-0001-9205-1048; Homoe, Preben/0000-0003-2877-3518; Olsen, Sjurdur/0000-0003-3017-7096	Danish National Research Foundation; Danish Pharmaceutical Association; March of Dimes Birth Defects Foundation; Danish Council for Independent Research; Ministry of Science, Innovation and Higher Education	Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Pharmaceutical Association; March of Dimes Birth Defects Foundation(March of Dimes); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Ministry of Science, Innovation and Higher Education	Main sponsors for The Danish National Birth Cohort were The Danish National Research Foundation, The Danish Pharmaceutical Association and The March of Dimes Birth Defects Foundation. This study was sponsored by The Danish Council for Independent Research, which is a part of The Ministry of Science, Innovation and Higher Education. The Danish Council for Independent Research funds specific research activities based on researchers' own initiatives. Amount: 110,000 DKR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams SW, 2011, CURR ALLERGY ASTHM R, V11, P508, DOI 10.1007/s11882-011-0218-3; Cars O, 2001, LANCET, V357, P1851, DOI 10.1016/S0140-6736(00)04972-2; FIELLAUNIKOLAJSEN M, 1979, ARCH OTOLARYNGOL, V105, P461; Froom J, 2001, J Am Board Fam Pract, V14, P406; Greene N, 2011, EPIDEMIOLOGY, V22, P815, DOI 10.1097/EDE.0b013e31822939fd; Hansen AE, 2003, BARSELSORLOV 100 ARS; Hellstrom S, 2011, OTOLARYNG HEAD NECK, V145, P383, DOI 10.1177/0194599811409862; Ingvarsson L, 1985, Auris Nasus Larynx, V12 Suppl 1, pS105; Jacobsen TN, 2010, EUR J EPIDEMIOL, V25, P349, DOI 10.1007/s10654-010-9448-2; Jansen AGSC, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001480.pub3; Jensen RG, 2012, PEDIATR INFECT DIS J, V31, P139, DOI 10.1097/INF.0b013e318238c0a4; Johansen Eva Charlotte Jung, 2010, Ugeskr Laeger, V172, P2530; Karevold G, 2007, INT J PEDIATR OTORHI, V71, P1035, DOI 10.1016/j.ijporl.2007.03.010; Klemmensen AK, 2007, AM J EPIDEMIOL, V166, P117, DOI 10.1093/aje/kwm139; Kogan MD, 2000, AM J PUBLIC HEALTH, V90, P245, DOI 10.2105/AJPH.90.2.245; Labout JAM, 2011, EUR J EPIDEMIOL, V26, P61, DOI 10.1007/s10654-010-9500-2; Laine MK, 2010, PEDIATRICS, V125, pE1154, DOI 10.1542/peds.2009-2689; Liese JG, 2014, EPIDEMIOL INFECT, V142, P1778, DOI 10.1017/S0950268813002744; LOUS J, 1981, INT J PEDIATR OTORHI, V3, P303, DOI 10.1016/0165-5876(81)90055-0; Lous J, 2012, INT J PEDIATR OTORHI, V76, P370, DOI 10.1016/j.ijporl.2011.12.011; Marom T, 2014, JAMA PEDIATR, V168, P68, DOI 10.1001/jamapediatrics.2013.3924; Moller L F, 1994, Ugeskr Laeger, V156, P7197; Monasta L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036226; Nohr EA, 2006, EPIDEMIOLOGY, V17, P413, DOI 10.1097/01.ede.0000220549.14177.60; Nystad W, 2008, ACTA PAEDIATR, V97, P657, DOI 10.1111/j.1651-2227.2008.00756.x; Olsen J, 2001, SCAND J PUBLIC HEALT, V29, P300, DOI 10.1177/14034948010290040201; Pichichero ME, 2008, PEDIATR INFECT DIS J, V27, P958, DOI 10.1097/INF.0b013e318179a2ac; PUKANDER J, 1982, ACTA OTO-LARYNGOL, V94, P479, DOI 10.3109/00016488209128938; Rosenfeld RM, 2013, OTOLARYNG HEAD NECK, V149, P8, DOI 10.1177/0194599813490141; Schappert S M, 1992, Adv Data, P1; Schilder AGM, 2004, INT J PEDIATR OTORHI, V68, P29, DOI 10.1016/j.ijporl.2003.09.002; Sigsgaard J., 1978, FOLKEBORNEHAVE SOCIA; Silva P A, 1990, Paediatr Perinat Epidemiol, V4, P76, DOI 10.1111/j.1365-3016.1990.tb00621.x; STANGERUP SE, 1986, AM J OTOLARYNG, V7, P47, DOI 10.1016/S0196-0709(86)80034-5; Vernacchio L, 2007, J AM BOARD FAM MED, V20, P160, DOI 10.3122/jabfm.2007.02.060125; VESTERMARK V, 1991, SCAND J SOC MED, V19, P105, DOI 10.1177/140349489101900205; VINTHER B, 1979, ACTA OTO-LARYNGOL, P135	37	48	51	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e111732	10.1371/journal.pone.0111732	http://dx.doi.org/10.1371/journal.pone.0111732			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7UN	25545891	Green Published, gold, Green Submitted			2022-12-27	WOS:000347120200002
J	D' Andrea, EL; Ferravante, A; Scudiero, I; Zotti, T; Reale, C; Pizzulo, M; De La Motte, LR; De Maio, C; Mazzone, P; Telesio, G; Vito, P; Stilo, R				D' Andrea, Egildo Luca; Ferravante, Angela; Scudiero, Ivan; Zotti, Tiziana; Reale, Carla; Pizzulo, Maddalena; De La Motte, Luigi Regenburgh; De Maio, Chiara; Mazzone, Pellegrino; Telesio, Gianluca; Vito, Pasquale; Stilo, Romania			The Dishevelled, EGL-10 and Pleckstrin (DEP) Domain-Containing Protein DEPDC7 Binds to CARMA2 and CARMA3 Proteins, and Regulates NF-kappa B Activation	PLOS ONE			English	Article							ESSENTIAL MODULATOR; FAMILY MEMBER; LYMPHOCYTE; BCL10; PROLIFERATION; EXPRESSION; CELLS; CARD	The molecular complexes containing BCL10, MALT1 and CARMA proteins (CBM complex) have been recently identified as a key component in the signal transduction pathways that regulate activation of Nuclear Factor kappaB (NF-kappa B) transcription factor. Herein we identified the DEP domain-containing protein DEPDC7 as cellular binding partners of CARMA2 and CARMA3 proteins. DEPDC7 displays a cytosolic distribution and its expression induces NF-kappa B activation. Conversely, shRNA-mediated abrogation of DEPDC7 results in impaired NF-kappa B activation following G protein-coupled receptors stimulation, or stimuli that require CARMA2 and CARMA3, but not CARMA1. Thus, this study identifies DEPDC7 as a CARMA interacting molecule, and provides evidence that DEPDC7 may be required to specifically convey on the CBM complex signals coming from activated G protein-coupled receptors.	[D' Andrea, Egildo Luca; Zotti, Tiziana; De La Motte, Luigi Regenburgh; Vito, Pasquale; Stilo, Romania] Univ Sannio, Dipartimento Sci & Tecnol, I-82100 Benevento, Italy; [Ferravante, Angela; Scudiero, Ivan; Reale, Carla; Pizzulo, Maddalena; De La Motte, Luigi Regenburgh; De Maio, Chiara; Mazzone, Pellegrino; Telesio, Gianluca; Vito, Pasquale] Biogem Consortium, I-83031 Ariano Irpino, AV, Italy; [Stilo, Romania] SannioTech Consortium, Benevento, Italy	University of Sannio	Vito, P (corresponding author), Univ Sannio, Dipartimento Sci & Tecnol, Via Port'Arsa 11, I-82100 Benevento, Italy.	vito@unisannio.it	vito, pasquale/ABF-5505-2020; Zotti, Tiziana/AAV-6768-2021; Reale, Carla/AAB-7939-2020; Mazzone, Pellegrino/AAC-6576-2020	Zotti, Tiziana/0000-0003-4753-116X; Reale, Carla/0000-0001-7682-4784; Mazzone, Pellegrino/0000-0002-6217-1505; scudiero, ivan/0000-0001-5559-5548; ferravante, angela/0000-0002-4932-3877; vito, pasquale/0000-0002-5721-7716				Battaglia F, 2008, J LEUKOCYTE BIOL, V83, P648, DOI 10.1189/jlb.0607349; Blonska M, 2011, CELL RES, V21, P55, DOI 10.1038/cr.2010.182; Consonni SV, 2014, NAT REV MOL CELL BIO, V15, P357, DOI 10.1038/nrm3791; Delekta PC, 2010, J BIOL CHEM, V285, P41432, DOI 10.1074/jbc.M110.158949; Egawa T, 2003, CURR BIOL, V13, P1252, DOI 10.1016/S0960-9822(03)00491-3; Gaide O, 2001, FEBS LETT, V496, P121, DOI 10.1016/S0014-5793(01)02414-0; Grabiner BC, 2007, GENE DEV, V21, P984, DOI 10.1101/gad.1502507; Guiet C, 2002, CELL DEATH DIFFER, V9, P138, DOI 10.1038/sj/cdd/4400947; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Lee JS, 2008, SCAND J IMMUNOL, V67, P77, DOI 10.1111/j.1365-3083.2007.02040.x; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Marasco D, 2009, BIOCHEM J, V422, P553, DOI 10.1042/BJ20090055; McAllister-Lucas LM, 2007, P NATL ACAD SCI USA, V104, P139, DOI 10.1073/pnas.0601947103; McAllister-Lucas LM, 2001, J BIOL CHEM, V276, P30589, DOI 10.1074/jbc.M103824200; Newton K, 2003, CURR BIOL, V13, P1247, DOI 10.1016/S0960-9822(03)00458-5; Scudiero I, 2014, J CELL PHYSIOL, V229, P990, DOI 10.1002/jcp.24543; Scudiero I, 2011, J CELL PHYSIOL, V226, P3121, DOI 10.1002/jcp.22667; Stilo R, 2004, J BIOL CHEM, V279, P34323, DOI 10.1074/jbc.M402244200; Stilo R, 2002, FEBS LETT, V521, P165, DOI 10.1016/S0014-5793(02)02869-7; Stilo R, 2008, J CELL SCI, V121, P1165, DOI 10.1242/jcs.021105; Sun J, 2010, WORLD J BIOL CHEM, V1, P353; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Vessichelli M, 2012, J BIOL CHEM, V287, P13722, DOI 10.1074/jbc.M111.304436; Vito P, 2014, IMMUNOL LETT, V160, P102, DOI 10.1016/j.imlet.2014.02.002; Wang L, 2001, J BIOL CHEM, V276, P21405, DOI 10.1074/jbc.M102488200; Zotti T, 2011, J BIOL CHEM, V286, P22924, DOI 10.1074/jbc.M110.215426	26	18	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e116062	10.1371/journal.pone.0116062	http://dx.doi.org/10.1371/journal.pone.0116062			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541973	Green Published, Green Submitted, gold			2022-12-27	WOS:000347239900137
J	Hong, HS; Li, J; Jin, Y; Li, Q; Li, WM; Wu, JS; Huang, ZM				Hong, Huisuo; Li, Jia; Jin, Yin; Li, Qiao; Li, Weimin; Wu, Jiansheng; Huang, Zhiming			Performance of Real-Time Elastography for the Staging of Hepatic Fibrosis: A Meta-Analysis	PLOS ONE			English	Article							LIVER FIBROSIS; TRANSIENT ELASTOGRAPHY; NONINVASIVE ASSESSMENT; TISSUE ELASTOGRAPHY; DIAGNOSIS; ELASTICITY; DISEASE; INDEX; ARFI	Background: With the rapid development of real-time elastography (RTE), a variety of measuring methods have been developed for the assessment of hepatic fibrosis. We evaluated the overall performance of four methods based on RTE by performing meta-analysis of published literature. Methods: Online journal databases and a manual search from April 2000 to April 2014 were used. Studies from different databases that meet inclusion criteria were enrolled. The statistical analysis was performed using a random-effects model and fixed-effects model for the overall effectiveness of RTE. The area under the receiver operating characteristic curve (AUROC) was calculated for various means. Fagan plot analysis was used to estimate the clinical utility of RTE, and the heterogeneity of the studies was explored with meta-regression analysis. Results: Thirteen studies from published articles were enrolled and analyzed. The combined AUROC of the liver fibrosis index (LFI) for the evaluation of significant fibrosis (F >= 2), advanced fibrosis (F >= 3), and cirrhosis (F = 4) were 0.79, 0.94, and 0.85, respectively. The AUROC of the elasticity index (EI) ranged from 0.75 to 0.92 for F >= 2 and 0.66 to 0.85 for F = 4. The overall AUROC of the elastic ratio of the liver for the intrahepatic venous vessels were 0.94, 0.93, and 0.96, respectively. The AUROC of the elastic ratio of the liver for the intercostal muscle in diagnosing advanced fibrosis and cirrhosis were 0.96 and 0.92, respectively. There was significant heterogeneity in the diagnostic odds ratio (DOR) for F >= 2 of LFI mainly due to etiology (p < 0.01). Conclusion: The elastic ratio of the liver for the intrahepatic vein has excellent precision in differentiating each stage of hepatic fibrosis and is recommend to be applied to the clinic.	[Hong, Huisuo; Li, Jia; Jin, Yin; Li, Weimin; Wu, Jiansheng; Huang, Zhiming] Wenzhou Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Wenzhou, Zhejiang, Peoples R China; [Li, Qiao] Wenzhou Med Univ, Affiliated Hosp 1, Ultrasound Imaging Ctr, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University	Wu, JS (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Wenzhou, Zhejiang, Peoples R China.	honghuisuo@126.com	Wu, Jian/AAU-5221-2020; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wu, Jian/0000-0002-3394-1507				Arena U, 2008, GUT, V57, P1288, DOI 10.1136/gut.2008.149708; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bedossa P, 2008, GASTROEN CLIN BIOL, V32, P4, DOI 10.1016/S0399-8320(08)73989-7; Bedossa P, 2003, HEPATOLOGY, V38, P1449, DOI 10.1016/j.hep.2003.09.022; Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; Chon YE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044930; Chung JH, 2013, CLIN MOL HEPATOL, V19, P156, DOI 10.3350/cmh.2013.19.2.156; Colombo S, 2012, J GASTROENTEROL, V47, P461, DOI 10.1007/s00535-011-0509-4; Craxi A, 2011, J HEPATOL, V55, P245, DOI 10.1016/j.jhep.2011.02.023; Ferraioli G, 2012, HEPATOLOGY, V56, P2125, DOI 10.1002/hep.25936; Ferraioli G, 2012, AM J ROENTGENOL, V199, P19, DOI 10.2214/AJR.11.7517; Fraquelli M, 2007, GUT, V56, P968, DOI 10.1136/gut.2006.111302; Friedrich-Rust M, 2008, GASTROENTEROLOGY, V134, P960, DOI 10.1053/j.gastro.2008.01.034; Friedrich-Rust M, 2007, AM J ROENTGENOL, V188, P758, DOI 10.2214/AJR.06.0322; Fujimoto K, 2013, ONCOLOGY-BASEL, V84, P3, DOI 10.1159/000345883; Germani G, 2011, SEMIN LIVER DIS, V31, P82, DOI 10.1055/s-0031-1272836; Gheorghe L, 2008, J GASTROINTEST LIVER, V17, P469; Guo Y, 2014, ABDOM IMAGING, P1; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Haque M, 2010, ANN HEPATOL, V9, P289, DOI 10.1016/S1665-2681(19)31639-4; Hellmich M, 2005, METHOD INFORM MED, V44, P124; Hu Q, 2014, CLIN RADIOL, V69, P194, DOI 10.1016/j.crad.2013.10.003; Kanamoto M, 2009, J HEPATO-BILIARY-PAN, V16, P463, DOI 10.1007/s00534-009-0075-9; Kim SU, 2010, J GASTROEN HEPATOL, V25, P1472, DOI 10.1111/j.1440-1746.2010.06432.x; Koizumi Y, 2011, RADIOLOGY, V258, P610, DOI 10.1148/radiol.10100319; Kwok R, 2014, ALIMENT PHARM THER, V39, P254, DOI 10.1111/apt.12569; Lin SH, 2013, ULTRASOUND MED BIOL, V39, P1215, DOI 10.1016/j.ultrasmedbio.2013.02.013; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Moreno-Otero R, 2006, GUT, V55, P1055; Nishimura M, 2013, HEPATOL RES, V43, P1078, DOI 10.1111/hepr.12048; Ochi H, 2012, HEPATOLOGY, V56, P1271, DOI 10.1002/hep.25756; Orlacchio A, 2012, ULTRASOUND MED BIOL, V38, P537, DOI 10.1016/j.ultrasmedbio.2011.12.023; Paparo F, 2013, EUR J RADIOL, V82, pE755, DOI 10.1016/j.ejrad.2013.08.038; Rockey DC, 2009, HEPATOLOGY, V49, P1017, DOI 10.1002/hep.22742; Sporea I, 2012, ULTRASCHALL MED, V33, P550, DOI 10.1055/s-0032-1313011; Tomeno W, 2013, HEPATOL RES, V43, P735, DOI 10.1111/hepr.12023; Tsochatzis EA, 2011, J HEPATOL, V54, P650, DOI 10.1016/j.jhep.2010.07.033; Wang J, 2012, EUR J RADIOL, V81, pE31, DOI 10.1016/j.ejrad.2010.12.013; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Xie LM, 2012, J ULTRAS MED, V31, P1053; Yada N, 2013, ONCOLOGY-BASEL, V84, P13, DOI 10.1159/000345884; Ying L, 2012, EUR J RADIOL, V81, P2576, DOI 10.1016/j.ejrad.2011.10.026; Zamora Javier, 2006, BMC Med Res Methodol, V6, P31, DOI 10.1186/1471-2288-6-31	43	16	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115702	10.1371/journal.pone.0115702	http://dx.doi.org/10.1371/journal.pone.0115702			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541695	Green Published, gold, Green Submitted			2022-12-27	WOS:000347239900073
J	Ismail, S; Stokes, CA; Prestwich, EC; Roberts, RL; Juss, JK; Sabroe, I; Parker, LC				Ismail, Saila; Stokes, Clare A.; Prestwich, Elizabeth C.; Roberts, Rebecca L.; Juss, Jatinder K.; Sabroe, Ian; Parker, Lisa C.			Phosphoinositide-3 Kinase Inhibition Modulates Responses to Rhinovirus by Mechanisms that Are Predominantly Independent of Autophagy	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; VIRAL RECOGNITION; MAMMALIAN TARGET; I INTERFERON; RAPAMYCIN; PATHWAY; LY294002; VIRUS; 3-METHYLADENINE	Human rhinoviruses (HRV) are a major cause of exacerbations of airways disease. Aspects of cell signalling responses to HRV infection remain unclear, particularly with regard to signalling via PI3K, and the PI3K-dependent pathway, autophagy. We investigated the roles of PI3K and autophagy in the responses of epithelial cells to major and minor group HRV infection. The PI3K inhibitor 3-MA, commonly used to inhibit autophagy, markedly reduced HRV-induced cytokine induction. Further investigation of potential targets of 3-MA and comparison of results using this inhibitor to a panel of general and class I-selective PI3K inhibitors showed that several PI3Ks cooperatively regulate responses to HRV. Targeting by siRNA of the autophagy proteins Beclin-1, Atg7, LC3, alone or in combination, or targeting of the autophagy-specific class III PI3K had at most only modest effects on HRV-induced cell signalling as judged by induction of proinflammatory cytokine production. Our data indicate that PI3K and mTOR are involved in induction of proinflammatory cytokines after HRV infection, and that autophagy has little role in the cytokine response to HRV or control of HRV replication.	[Ismail, Saila; Stokes, Clare A.; Prestwich, Elizabeth C.; Roberts, Rebecca L.; Sabroe, Ian; Parker, Lisa C.] Univ Sheffield, Fac Med Dent & Hlth, Dept Infect & Immun, Acad Unit Resp Med, Sheffield S10 2RX, S Yorkshire, England; [Juss, Jatinder K.] Univ Cambridge, Addenbrookes & Papworth Hosp, Sch Clin Med, Dept Med, Cambridge CB2 2QQ, England	University of Sheffield; Papworth Hospital; University of Cambridge	Parker, LC (corresponding author), Univ Sheffield, Fac Med Dent & Hlth, Dept Infect & Immun, Acad Unit Resp Med, Beech Hill Rd, Sheffield S10 2RX, S Yorkshire, England.	l.c.parker@sheffield.ac.uk	Sabroe, Ian/AAE-5858-2019; Roberts, Rebecca/J-9535-2015; Sabroe, Ian/I-5981-2013	Roberts, Rebecca/0000-0001-8231-2611; Ismail, Saila/0000-0002-5676-9893; Sabroe, Ian/0000-0001-9750-8975; Stokes, Clare/0000-0002-4076-5361	University of Sheffield; Putra University, Malaysia (UPM); Medical Research Council [MR/J010154/1]; MRC [MR/J010154/1] Funding Source: UKRI	University of Sheffield; Putra University, Malaysia (UPM); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	SI was supported by a PhD studentship funded by The University of Sheffield and Putra University, Malaysia (UPM). LCP is supported by a New Investigator Research Grant from the Medical Research Council, Reference MR/J010154/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett JA, 2012, J VIROL, V86, P6595, DOI 10.1128/JVI.06755-11; Brabec-Zaruba M, 2007, J VIROL, V81, P10815, DOI 10.1128/JVI.00143-07; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; Cao WP, 2008, NAT IMMUNOL, V9, P1157, DOI 10.1038/ni.1645; Codogno P, 2012, NAT REV MOL CELL BIO, V13, P7, DOI 10.1038/nrm3249; Dennis PB, 1996, MOL CELL BIOL, V16, P6242; Deretic V, 2012, J IMMUNOL, V189, P15, DOI 10.4049/jimmunol.1102108; Dupont N, 2011, EMBO J, V30, P4701, DOI 10.1038/emboj.2011.398; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Foster FM, 2003, J CELL SCI, V116, P3037, DOI 10.1242/jcs.00609; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Harris J, 2011, J BIOL CHEM, V286, P9587, DOI 10.1074/jbc.M110.202911; Hrincius ER, 2011, CELL MICROBIOL, V13, P1907, DOI 10.1111/j.1462-5822.2011.01680.x; Iwasaki A, 2007, AUTOPHAGY, V3, P354, DOI 10.4161/auto.4114; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Johnston Sebastian L, 2005, Proc Am Thorac Soc, V2, P150, DOI 10.1513/pats.200502-018AW; Juss JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045933; Klein KA, 2011, J VIROL, V85, P9651, DOI 10.1128/JVI.00316-11; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Kong DX, 2010, EUR J CANCER, V46, P1111, DOI 10.1016/j.ejca.2010.01.005; Lau C, 2008, J IMMUNOL, V180, P870, DOI 10.4049/jimmunol.180.2.870; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Lin YC, 2012, J IMMUNOL, V189, P4154, DOI 10.4049/jimmunol.1102739; Lu XY, 2011, MOL IMMUNOL, V48, P1417, DOI 10.1016/j.molimm.2011.03.017; Morris GE, 2006, FASEB J, V20, P2153, DOI 10.1096/fj.06-5910fje; Newcomb DC, 2008, AM J RESP CRIT CARE, V177, P1111, DOI 10.1164/rccm.200708-1243OC; Newcomb DC, 2005, J BIOL CHEM, V280, P36952, DOI 10.1074/jbc.M502449200; NOAH TL, 1995, IN VITRO CELL DEV-AN, V31, P738; Piper SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063365; Raynaud FI, 2007, CANCER RES, V67, P5840, DOI 10.1158/0008-5472.CAN-06-4615; REDDEL RR, 1988, CANCER RES, V48, P1904; Sachs LA, 2011, J VIROL METHODS, V171, P212, DOI 10.1016/j.jviromet.2010.10.027; Slater L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001178; Stokes CA, 2011, J VIROL, V85, P7912, DOI 10.1128/JVI.02649-10; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Yordy B, 2013, INT IMMUNOL, V25, P1, DOI 10.1093/intimm/dxs101; Zhao JW, 2010, MOL IMMUNOL, V48, P294, DOI 10.1016/j.molimm.2010.07.014; Zhao W, 2012, FEBS LETT, V586, P705, DOI 10.1016/j.febslet.2012.01.016	39	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e116055	10.1371/journal.pone.0116055	http://dx.doi.org/10.1371/journal.pone.0116055			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541728	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000347239900136
J	Ohno, M; Kanayama, T; Moore, R; Ray, M; Negishi, M				Ohno, Marumi; Kanayama, Tomohiko; Moore, Rick; Ray, Manas; Negishi, Masahiko			The Roles of Co-Chaperone CCRP/DNAJC7 in Cyp2b10 Gene Activation and Steatosis Development in Mouse Livers	PLOS ONE			English	Article							NUCLEAR RECEPTOR CAR; ARYL-HYDROCARBON RECEPTOR; CONSTITUTIVE ACTIVE/ANDROSTANE RECEPTOR; X-ASSOCIATED PROTEIN-2; INTERACTING PROTEIN; J-DOMAIN; INDUCTION; COMPLEX; EXPRESSION; ELEMENTS	Cytoplasmic constitutive active/androstane receptor (CAR) retention protein (CCRP and also known as DNAJC7) is a co-chaperone previously characterized to retain nuclear receptor CAR in the cytoplasm of HepG2 cells. Here we have produced CCRP knockout (KO) mice and demonstrated that CCRP regulates CAR at multiple steps in activation of the cytochrome (Cyp) 2b10 gene in liver: nuclear accumulation, RNA polymerase II recruitment and epigenetic modifications. Phenobarbital treatment greatly increased nuclear CAR accumulation in the livers of KO males as compared to those of wild type (WT) males. Despite this accumulation, phenobarbital-induced activation of the Cyp2b10 gene was significantly attenuated. In ChIP assays, a CAR/retinoid X receptor-alpha (RXRa) heterodimer binding to the Cyp2b10 promoter was already increased before phenobarbital treatment and further pronounced after treatment. However, RNA polymerase II was barely recruited to the promoter even after phenobarbital treatment. Histone H3K27 on the Cyp2b10 promoter was de-methylated only after phenobarbital treatment in WT but was fully de-methylated before treatment in KO males. Thus, CCRP confers phenobarbital-induced de-methylation capability to the promoter as well as the phenobarbital responsiveness of recruiting RNA polymerase II, but is not responsible for the binding between CAR and its cognate sequence, phenobarbital responsive element module. In addition, KO males developed steatotic livers and increased serum levels of total cholesterol and high density lipoprotein in response to fasting. CCRP appears to be involved in various hepatic regulations far beyond CAR-mediated drug metabolism.	[Ohno, Marumi; Kanayama, Tomohiko; Moore, Rick; Negishi, Masahiko] NIEHS, Pharmacogenet Sect, Reprod & Dev Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Ray, Manas] NIEHS, Knockout Core, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Negishi, M (corresponding author), NIEHS, Pharmacogenet Sect, Reprod & Dev Biol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	negishi@niehs.nih.gov	Negishi, Masahiko/F-7805-2019	Negishi, Masahiko/0000-0002-2076-8928; Ohno, Marumi/0000-0003-1086-8244	National Institutes of Health [Z01ES1005-01]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZICES102425, ZICES102445, ZIAES080040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Intramural Research program:: Z01ES1005-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell DR, 2000, J BIOL CHEM, V275, P36407, DOI 10.1074/jbc.M004236200; Brychzy A, 2003, EMBO J, V22, P3613, DOI 10.1093/emboj/cdg362; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Echeverria PC, 2009, MOL CELL BIOL, V29, P4788, DOI 10.1128/MCB.00649-09; Greene MK, 1998, P NATL ACAD SCI USA, V95, P6108, DOI 10.1073/pnas.95.11.6108; Hedman E, 2006, PROTEOMICS, V6, P3114, DOI 10.1002/pmic.200500266; Hestermann EV, 2003, MOL CELL BIOL, V23, P7920, DOI 10.1128/MCB.23.21.7920-7925.2003; Honkakoski P, 1998, J BIOCHEM MOL TOXIC, V12, P3; Inagaki M, 2008, GENESIS, V46, P431, DOI 10.1002/dvg.20418; Kakizaki S, 2003, BBA-GEN SUBJECTS, V1619, P239, DOI 10.1016/S0304-4165(02)00482-8; Kawamoto T, 1999, MOL CELL BIOL, V19, P6318; Kobayashi K, 2003, MOL PHARMACOL, V64, P1069, DOI 10.1124/mol.64.5.1069; Koike C, 2007, MOL PHARMACOL, V71, P1217, DOI 10.1124/mol.107.034538; Kubo N, 2013, BIOCHEM BIOPH RES CO, V430, P1034, DOI 10.1016/j.bbrc.2012.11.121; LAMB JR, 1995, TRENDS BIOCHEM SCI, V20, P257, DOI 10.1016/S0968-0004(00)89037-4; Lempiainen H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018216; Lin BC, 2007, J BIOL CHEM, V282, P35924, DOI 10.1074/jbc.M705471200; Meyer BK, 1998, MOL CELL BIOL, V18, P978, DOI 10.1128/MCB.18.2.978; Meyer BK, 1999, BIOCHEMISTRY-US, V38, P8907, DOI 10.1021/bi982223w; Moffatt NSC, 2008, BIOCHEMISTRY-US, V47, P8203, DOI 10.1021/bi800770g; Mutoh S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003705; Nakamura K, 2007, J BIOL CHEM, V282, P9768, DOI 10.1074/jbc.M610072200; Nukaya M, 2010, J BIOL CHEM, V285, P35599, DOI 10.1074/jbc.M110.132043; Petrulis JR, 2000, J BIOL CHEM, V275, P37448, DOI 10.1074/jbc.M006873200; Phillips JM, 2007, TOXICOL SCI, V96, P72, DOI 10.1093/toxsci/kfl188; Riggs DL, 2003, EMBO J, V22, P1158, DOI 10.1093/emboj/cdg108; Saito K, 2013, BIOCHEM BIOPH RES CO, V436, P730, DOI 10.1016/j.bbrc.2013.06.025; Saito K, 2013, TOXICOL SCI, V132, P151, DOI 10.1093/toxsci/kfs338; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Schulke JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011717; Shi YH, 1998, GENE DEV, V12, P654, DOI 10.1101/gad.12.5.654; Squires EJ, 2004, J BIOL CHEM, V279, P49307, DOI 10.1074/jbc.M407281200; Sueyoshi T, 2001, ANNU REV PHARMACOL, V41, P123, DOI 10.1146/annurev.pharmtox.41.1.123; Sueyoshi T, 1999, J BIOL CHEM, V274, P6043, DOI 10.1074/jbc.274.10.6043; SUEYOSHI T, 1995, MOL CELL BIOL, V15, P4158; Sugatani J, 2002, BIOCHEM BIOPH RES CO, V292, P492, DOI 10.1006/bbrc.2002.6683; Ueda A, 2002, MOL PHARMACOL, V61, P1, DOI 10.1124/mol.61.1.1; Warrier M, 2010, ENDOCRINOLOGY, V151, P3225, DOI 10.1210/en.2009-1158; Wei P, 2000, NATURE, V407, P920, DOI 10.1038/35038112; Wiwi CA, 2004, MOL ENDOCRINOL, V18, P1975, DOI 10.1210/me.2004-0129; Yamamoto Y, 2004, CANCER RES, V64, P7197, DOI 10.1158/0008-5472.CAN-04-1459; Yamamoto Y, 2003, ARCH BIOCHEM BIOPHYS, V409, P207, DOI 10.1016/S0003-9861(02)00456-3; Yang H, 2014, MOL PHARMACOL, V85, P249, DOI 10.1124/mol.113.089763	43	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115663	10.1371/journal.pone.0115663	http://dx.doi.org/10.1371/journal.pone.0115663			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542016	Green Published, gold, Green Submitted			2022-12-27	WOS:000347239900066
J	Pasam, RK; Sharma, R; Walther, A; Ozkan, H; Graner, A; Kilian, B				Pasam, Raj K.; Sharma, Rajiv; Walther, Alexander; Ozkan, Hakan; Graner, Andreas; Kilian, Benjamin			Genetic Diversity and Population Structure in a Legacy Collection of Spring Barley Landraces Adapted to a Wide Range of Climates	PLOS ONE			English	Article							HORDEUM-VULGARE L.; MULTILOCUS GENOTYPE DATA; LINKAGE DISEQUILIBRIUM; EVOLUTIONARY HISTORY; MOLECULAR DIVERSITY; CULTIVATED BARLEY; ETHIOPIAN BARLEYS; ALLELIC RICHNESS; RESISTANCE GENE; POWDERY MILDEW	Global environmental change and increasing human population emphasize the urgent need for higher yielding and better adapted crop plants. One strategy to achieve this aim is to exploit the wealth of so called landraces of crop species, representing diverse traditional domesticated populations of locally adapted genotypes. In this study, we investigated a comprehensive set of 1485 spring barley landraces (LRC1485) adapted to a wide range of climates, which were selected from one of the largest genebanks worldwide. The landraces originated from 5 degrees to 62.5 degrees N and 16 degrees to 71 degrees E. The whole collection was genotyped using 42 SSR markers to assess the genetic diversity and population structure. With an average allelic richness of 5.74 and 372 alleles, LRC1485 harbours considerably more genetic diversity than the most polymorphic current GWAS panel for barley. Ten major clusters defined most of the population structure based on geographical origin, row type of the ear and caryopsis type - and were assigned to specific climate zones. The legacy core reference set LRC648 established in this study will provide a long-lasting resource and a very valuable tool for the scientific community. LRC648 is best suited for multi-environmental field testing to identify candidate genes underlying quantitative traits but also for allele mining approaches.	[Pasam, Raj K.; Sharma, Rajiv; Graner, Andreas; Kilian, Benjamin] Leibniz Inst Plant Genet & Crop Plant Res IPK, Dept Genebank, Corrensstr 3, D-06466 Gatersleben, Germany; [Walther, Alexander] Univ Gothenburg, Dept Earth Sci, SE-40530 Gothenburg, Sweden; [Ozkan, Hakan] Cukurova Univ, Fac Agr, Dept Field Crops, TR-01330 Adana, Turkey	Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; University of Gothenburg; Cukurova University	Sharma, R (corresponding author), Leibniz Inst Plant Genet & Crop Plant Res IPK, Dept Genebank, Corrensstr 3, D-06466 Gatersleben, Germany.	rajiv.sharma@hutton.ac.uk; benjamin.kilian@bayer.com	ÖZKAN, Hakan/C-8510-2011; Sharma, Rajiv/W-9683-2019	ÖZKAN, Hakan/0000-0003-3530-2626; Sharma, Rajiv/0000-0003-3488-8688; Kilian, Benjamin/0000-0002-9145-6980; Pasam, Raj/0000-0003-0908-1882; Graner, Andreas/0000-0003-3246-6393	Federal Ministry of Education and Research (BMBF), project GABI-GENOBAR [FKZ 0315066C]	Federal Ministry of Education and Research (BMBF), project GABI-GENOBAR	This work has been funded by the Federal Ministry of Education and Research (BMBF) - funded project GABI-GENOBAR (FKZ 0315066C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghani AH, 2015, GENET RESOUR CROP EV, V62, P275, DOI 10.1007/s10722-014-0152-z; Acquaah G., 2012, PRINCIPLES PLANT GEN; Alderman PD., 2013, P WORKSH MOD WHEAT R; ALLARD RW, 1992, GENETICS, V131, P957; ALLARD RW, 1972, GENETICS, V72, P489; [Anonymous], 2008, GLOBAL STRATEGY EX S, P1; Backes G, 2009, GENET RESOUR CROP EV, V56, P85, DOI 10.1007/s10722-008-9347-5; Bailey-Serres J, 2010, RICE, V3, P138, DOI 10.1007/s12284-010-9048-5; Bellucci E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083891; Bhullar NK, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-88; Bhullar NK, 2009, P NATL ACAD SCI USA, V106, P9519, DOI 10.1073/pnas.0904152106; Bjornstad A, 1997, THEOR APPL GENET, V94, P514, DOI 10.1007/s001220050445; Bjornstad A, 2010, CROP SCI, V50, P1579, DOI 10.2135/cropsci2009.12.0719; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Castillo A, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-266; CHAKRABORTY R, 1993, HUM BIOL, V65, P875; Comadran J, 2011, THEOR APPL GENET, V122, P1363, DOI 10.1007/s00122-011-1537-4; Comadran J, 2012, NAT GENET, V44, P1388, DOI 10.1038/ng.2447; Cuesta-Marcos A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-707; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Dubcovsky J, 2005, MOL BREEDING, V15, P395, DOI 10.1007/s11032-005-0084-6; Escudero A, 2003, BIOL CONSERV, V113, P351, DOI 10.1016/S0006-3207(03)00122-8; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Fischbeck G, 2003, DEV PL GEN, V7, P29, DOI 10.1016/S0168-7972(03)80005-1; Glaszmann JC, 2010, CURR OPIN PLANT BIOL, V13, P167, DOI 10.1016/j.pbi.2010.01.004; Gong X, 2009, GENOME, V52, P849, DOI [10.1139/G09-058, 10.1139/g09-058]; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Gouesnard B, 2001, J HERED, V92, P93, DOI 10.1093/jhered/92.1.93; GRANER A, 1993, THEOR APPL GENET, V86, P689, DOI 10.1007/BF00222657; Graner A, 2003, DEV PL GEN, V7, P121, DOI 10.1016/S0168-7972(03)80009-9; Hadado TT, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-121; Hamblin MT, 2011, TRENDS GENET, V27, P98, DOI 10.1016/j.tig.2010.12.003; Hamblin MT, 2010, CROP SCI, V50, P556, DOI 10.2135/cropsci2009.04.0198; Hamilton NRS., 2002, ACCESSION MANAGEMENT; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Haseneyer G, 2010, PLANT BREEDING, V129, P271, DOI 10.1111/j.1439-0523.2009.01725.x; Hoisington D, 1999, P NATL ACAD SCI USA, V96, P5937, DOI 10.1073/pnas.96.11.5937; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Igartua E, 2013, GENET RESOUR CROP EV, V60, P251, DOI 10.1007/s10722-012-9831-9; Jakob SS, 2014, GENOME BIOL EVOL, V6, P685, DOI 10.1093/gbe/evu047; Jilal A, 2008, GENET RESOUR CROP EV, V55, P1221, DOI 10.1007/s10722-008-9322-1; Jones H, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-320; Keilwagen J, 2014, SCI REP-UK, V4, DOI 10.1038/srep05231; Kihara H., 1983, P 6 INT WHEAT GEN S; Kilian B, 2006, MOL GENET GENOMICS, V276, P230, DOI 10.1007/s00438-006-0136-6; Kilian B, 2014, GENET RESOUR CROP EV, V61, P89, DOI 10.1007/s10722-013-0017-x; Kilian B, 2012, BRIEF FUNCT GENOMICS, V11, P38, DOI 10.1093/bfgp/elr046; Knupffer H, 2009, PLANT GENET GENOMICS, V7, P31, DOI 10.1007/978-0-387-77489-3_2; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Leberg PL, 2002, MOL ECOL, V11, P2445, DOI 10.1046/j.1365-294X.2002.01612.x; Lehmann CO, 1957, KULTURPFLANZE, V5, P108, DOI [10.1007/BF02095492, DOI 10.1007/BF02095492]; Leino MW, 2010, MOL BIOL EVOL, V27, P964, DOI 10.1093/molbev/msp308; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Mackay I, 2007, TRENDS PLANT SCI, V12, P57, DOI 10.1016/j.tplants.2006.12.001; Malosetti M, 2007, GENETICS, V175, P879, DOI 10.1534/genetics.105.054932; Malysheva-Otto LV, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-6; Mansfeld R, 1950, HORDEUM VULGARE L ZU, V20, P8; MAROOF MAS, 1994, P NATL ACAD SCI USA, V91, P5466, DOI 10.1073/pnas.91.12.5466; Mascher M, 2013, PLANT J, V76, P494, DOI 10.1111/tpj.12294; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; MEZAKA I, 2013, ADV BARLEY SCI, P25; Munoz-Amatriain M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094688; NEVO E, 1992, THEOR APPL GENET, V84, P958, DOI 10.1007/BF00227410; Newton AC, 2010, AGRON SUSTAIN DEV, V30, P237, DOI 10.1051/agro/2009032; Long NV, 2013, THEOR APPL GENET, V126, P2335, DOI 10.1007/s00122-013-2139-0; Orabi J, 2007, THEOR APPL GENET, V114, P1117, DOI 10.1007/s00122-007-0505-5; Pandey M, 2006, THEOR APPL GENET, V113, P715, DOI 10.1007/s00122-006-0340-0; Pasam RK, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-16; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Piffanelli P, 2004, NATURE, V430, P887, DOI 10.1038/nature02781; Pourkheirandish M, 2007, ANN BOT-LONDON, V100, P999, DOI 10.1093/aob/mcm139; Prada D, 2009, J EXP BOT, V60, P2541, DOI 10.1093/jxb/erp130; Pritchard JK, 2000, GENETICS, V155, P945; Rodriguez M, 2012, THEOR APPL GENET, V125, P171, DOI 10.1007/s00122-012-1824-8; Rosenberg MS, 2011, METHODS ECOL EVOL, V2, P229, DOI 10.1111/j.2041-210X.2010.00081.x; Russell J, 2011, NEW PHYTOL, V191, P564, DOI 10.1111/j.1469-8137.2011.03704.x; Russell JR, 2003, THEOR APPL GENET, V107, P413, DOI 10.1007/s00122-003-1261-9; Schiemann E, 1939, NATURWISSENSCHAFTEN, V27, P394, DOI 10.1007/BF01489506; SCHIEMANN E., 1943, ERGEB BIOL, V19, P409; SCHIEMANN E, 1951, J HERED, V5, P305; SCHOEN DJ, 1993, P NATL ACAD SCI USA, V90, P10623, DOI 10.1073/pnas.90.22.10623; Semenov MA, 2013, FOOD ENERGY SECUR, V2, P185, DOI 10.1002/fes3.34; Stein N, 2007, THEOR APPL GENET, V114, P823, DOI 10.1007/s00122-006-0480-2; Stracke S, 2009, THEOR APPL GENET, V118, P259, DOI 10.1007/s00122-008-0896-y; Sutton T, 2007, SCIENCE, V318, P1446, DOI 10.1126/science.1146853; Szucs P, 2007, MOL GENET GENOMICS, V277, P249, DOI 10.1007/s00438-006-0195-8; Taketa S, 2004, THEOR APPL GENET, V108, P1236, DOI 10.1007/s00122-003-1560-1; Taketa S, 2008, P NATL ACAD SCI USA, V105, P4062, DOI 10.1073/pnas.0711034105; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Tondelli A, 2013, PLANT GENOME-US, V6, DOI 10.3835/plantgenome2013.03.0007; Tsehaye Y, 2012, EUPHYTICA, V188, P309, DOI 10.1007/s10681-012-0764-3; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; Varshney RK, 2010, MOL BREEDING, V26, P229, DOI 10.1007/s11032-009-9373-9; Varshney RK, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001883; Ward DJ, 1962, USDA TECHNICAL B, V1276; Waugh R, 2009, CURR OPIN PLANT BIOL, V12, P218, DOI 10.1016/j.pbi.2008.12.007; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Weir BS., 1996, GENETIC DATA ANAL; WELTZIEN E, 1988, PLANT BREEDING, V101, P95, DOI 10.1111/j.1439-0523.1988.tb00273.x; Yahiaoui S, 2008, THEOR APPL GENET, V116, P271, DOI 10.1007/s00122-007-0665-3; Yahiaoui S, 2014, PLANT BREEDING, V133, P218, DOI 10.1111/pbr.12148; Yan L, 2003, P NATL ACAD SCI USA, V100, P6263, DOI 10.1073/pnas.0937399100; Yan L, 2006, P NATL ACAD SCI USA, V103, P19581, DOI 10.1073/pnas.0607142103; Yan LL, 2004, SCIENCE, V303, P1640, DOI 10.1126/science.1094305; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zohary D, 2012, DOMESTICATION OF PLANTS IN THE OLD WORLD: THE ORIGIN AND SPREAD OF DOMESTICATED PLANTS IN SOUTH-WEST ASIA, EUROPE, AND THE MEDITERRANEAN BASIN, 4TH EDITION, P1, DOI 10.1093/acprof:osobl/9780199549061.001.0001	109	30	31	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e116164	10.1371/journal.pone.0116164	http://dx.doi.org/10.1371/journal.pone.0116164			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541702	Green Published, gold, Green Submitted			2022-12-27	WOS:000347239900151
J	Wex, E; Thaler, E; Blum, S; Lamb, D				Wex, Eva; Thaler, Eva; Blum, Sylvia; Lamb, David			A Novel Model of IgE-Mediated Passive Pulmonary Anaphylaxis in Rats	PLOS ONE			English	Article							HUMAN MAST-CELL; TYROSINE KINASE; AIRWAY HYPERRESPONSIVENESS; ALLERGIC-ASTHMA; SYK; INFLAMMATION; INHIBITION; ACTIVATION; RHINITIS; MOUSE	Mast cells are central effector cells in allergic asthma and are augmented in the airways of asthma patients. Attenuating mast cell degranulation and with it the early asthmatic response is an important intervention point to inhibit bronchoconstriction, plasma exudation and tissue oedema formation. To validate the efficacy of novel pharmacological interventions, appropriate and practicable in vivo models reflecting mast cell-dependent mechanisms in the lung, are missing. Thus, we developed a novel model of passive pulmonary anaphylaxis in rats. Rats were passively sensitized by concurrent intratracheal and intradermal (ear) application of an antiDNP IgE antibody. Intravenous application of the antigen, DNP-BSA in combination with Evans blue dye, led to mast cell degranulation in both tissues. Quantification of mast cell degranulation in the lung was determined by (1) mediator release into bronchoalveolar lavage, (2) extravasation of Evans blue dye into tracheal and bronchial lung tissue and (3) invasive measurement of antigen-induced bronchoconstriction. Quantification of mast cell degranulation in the ear was determined by extravasation of Evans blue dye into ear tissue. We pharmacologically validated our model using the SYK inhibitor Fostamatinib, the H1-receptor antagonist Desloratadine, the mast cell stabilizer disodium cromoglycate (DSCG) and the beta(2)-adrenergic receptor agonist Formoterol. Fostamatinib was equally efficacious in lung and ear. Desloratadine effectively inhibited bronchoconstriction and ear vascular leakage, but was less effective against pulmonary vascular leakage, perhaps reflecting the differing roles for histamine receptor sub-types. DSCG attenuated both vascular leakage in the lung and bronchoconstriction, but with a very short duration of action. As an inhaled approach, Formoterol was more effective in the lung than in the ear. This model of passive pulmonary anaphylaxis provides a tissue relevant readout of early mast cell activity and pharmacological benchmarking broadly reflects responses observed in patients with asthma.	[Wex, Eva; Thaler, Eva; Blum, Sylvia; Lamb, David] Boehringer Ingelheim Pharma GmbH & Co KG, Resp Dis Res, Biberach, Germany	Boehringer Ingelheim	Wex, E (corresponding author), Boehringer Ingelheim Pharma GmbH & Co KG, Resp Dis Res, Biberach, Germany.	eva.wex@boehringer-ingelheim.com		Wex, Eva/0000-0002-4643-1899	Boehringer Ingelheim Pharma GmbH Co. KG	Boehringer Ingelheim Pharma GmbH Co. KG(Boehringer Ingelheim)	The funder (Boehringer Ingelheim Pharma GmbH & Co. KG) provided support in the form of salaries for authors [EW, ET, SB, DL], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions section.	Andersson CK, 2011, J ALLERGY CLIN IMMUN, V127, P905, DOI 10.1016/j.jaci.2011.01.022; Barnes PJ, 2011, J BIOL CHEM, V286, P32899, DOI 10.1074/jbc.R110.206466; BARNES PJ, 1991, AGENT ACTION SUPPL, V33, P103; Brightling CE, 2002, NEW ENGL J MED, V346, P1699, DOI 10.1056/NEJMoa012705; Castells MC, 2011, ANAPHYLAXIS AND HYPERSENSITIVITY REACTIONS, P1, DOI 10.1007/978-1-60327-951-2; Church Martin K, 2013, Indian J Dermatol, V58, P219, DOI 10.4103/0019-5154.110832; Genovese A, 1997, CLIN EXP ALLERGY, V27, P559, DOI 10.1046/j.1365-2222.1997.270860.x; Gonzalez-Nunez V, 2013, EXPERT OPIN DRUG SAF, V12, P445, DOI 10.1517/14740338.2013.788148; Hart PH, 2001, IMMUNOL CELL BIOL, V79, P149, DOI 10.1046/j.1440-1711.2001.00983.x; Lemanske Robert F. Jr., 2003, Journal of Allergy and Clinical Immunology, V111, pS502; MACONOCHIE JG, 1979, BRIT J CLIN PHARMACO, V7, P231, DOI 10.1111/j.1365-2125.1979.tb00927.x; Matsubara S, 2006, AM J RESP CELL MOL, V34, P426, DOI 10.1165/rcmb.2005-0298OC; Matsubara S, 2006, AM J RESP CRIT CARE, V173, P56, DOI 10.1164/rccm.200503-361OC; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; MURPHY S, 1987, DRUG INTEL CLIN PHAR, V21, P22, DOI 10.1177/10600280870211P102; Nials AT, 2008, DIS MODEL MECH, V1, P213, DOI 10.1242/dmm.000323; O'Byrne PM, 2009, ALLERGY ASTHMA IMMUN, V1, P3, DOI 10.4168/aair.2009.1.1.3; OVARY Z, 1958, J IMMUNOL, V81, P355; Ruzza P, 2009, EXPERT OPIN THER PAT, V19, P1361, DOI 10.1517/13543770903207039; SCHWARTZ LB, 1989, J CLIN INVEST, V83, P1551, DOI 10.1172/JCI114051; THOMSON DS, 1973, CLIN EXP IMMUNOL, V13, P537; Ulanova M, 2005, EXPERT OPIN THER TAR, V9, P901, DOI 10.1517/14728222.9.5.901; Weston MC, 1998, GEN PHARMACOL-VASC S, V31, P715, DOI 10.1016/S0306-3623(98)00080-9; Wex E, 2011, EUR J IMMUNOL, V41, P3208, DOI 10.1002/eji.201141502; Xu YD, 2010, RESP RES, V11, DOI [10.1186/1465-9921-11-166, 10.1186/1465-9921-11-107]	25	10	11	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e116166	10.1371/journal.pone.0116166	http://dx.doi.org/10.1371/journal.pone.0116166			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541997	Green Submitted, gold, Green Published			2022-12-27	WOS:000347239900153
J	Kleiner-Fisman, G; Khoo, E; Moncrieffe, N; Forbell, T; Gryfe, P; Fisman, D				Kleiner-Fisman, Galit; Khoo, Edwin; Moncrieffe, Nikohl; Forbell, Triina; Gryfe, Pearl; Fisman, David			A Randomized, Placebo Controlled Pilot Trial of Botulinum Toxin for Paratonic Rigidity in People with Advanced Cognitive Impairment	PLOS ONE			English	Article							UPPER-LIMB SPASTICITY; CERVICAL DYSTONIA; DOUBLE-BLIND; ALZHEIMERS-DISEASE; CARER BURDEN; NT 201; EFFICACY; SAFETY; NEUROTOXIN; INJECTION	Objective: Evaluate safety and efficacy of Incobotulinumtoxin A in elderly patients with dementia and paratonia. Setting: University-affiliated hospital, spasticity management Clinic. Participants: Ten subjects were enrolled. Inclusion criteria: 1) severe cognitive impairment 2) diagnosis of Alzheimer's disease, vascular dementia, or frontotemporal dementia, and 3) score >3 on the paratonic assessment instrument, with posture in an arm(s) interfering with provision of care. Exclusion criteria: 1) alternate etiologies for increased tone and 2) injection with botulinum toxin within the 6 months preceding the study. Design: Single center, randomized, double blind, placebo-controlled, crossover trial with two treatment cycles of 16 weeks. Assessments occurred at 2, 6, 12 and 16 weeks following injections. Subjects received up to 300 U of Incobotulinumtoxin A in arm(s). Primary and Secondary Outcome Measures: Primary outcome measure was the modified caregiver burden scale (mCBS); exploratory secondary outcome measures were also performed. Analysis of variance and mixed modeling techniques were used to evaluate treatment effects. Results: Incobotulinumtoxin A treatment produced significant improvement in mCBS total score 21.11 (-2.04 to 20.18) (Treatment effect and 95% CI), dressing sub-score 20.36 (-0.59 to 0.12), and cleaning under the left and right armpits subscore 20.5 (-0.96 to 20.04), 20.41 (-0.79 to 20.04) respectively. PROM in the left and right elbow increased by 27.67 degrees (13.32-42.02) and 22.07 degrees (9.76-34.39) respectively. PROM in the left and right shoulder increased by 11.92 degrees (5.46-18.38) and 8.58 degrees (3.73-13.43) respectively. No significant treatment effect was found for GAS, VAS and PAINAD scales or change in time to perform care. No adverse drug reactions occurred. Conclusions: Administration of Incobotulinumtoxin A in elderly people with advanced dementia and paratonia may be an efficacious and safe treatment to increase range of motion and reduce functional burden. Further studies are needed to confirm results.	[Kleiner-Fisman, Galit; Moncrieffe, Nikohl; Forbell, Triina; Gryfe, Pearl] Assist Technol Clin, Jeff & Diane Ross Movement Disorders Clin, Toronto, ON, Canada; [Kleiner-Fisman, Galit] Univ Toronto, Baycrest Ctr Geriatr Hlth, Toronto, ON, Canada; [Kleiner-Fisman, Galit] Univ Toronto, Dept Med, Div Neurol, Toronto, ON, Canada; [Khoo, Edwin; Fisman, David] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Baycrest; University of Toronto; University of Toronto	Kleiner-Fisman, G (corresponding author), Assist Technol Clin, Jeff & Diane Ross Movement Disorders Clin, Toronto, ON, Canada.	gkleinerfisman@yahoo.com			Merz Pharmaceuticals GmbH [NT-036]	Merz Pharmaceuticals GmbH	Merz Pharmaceuticals GmbH (NT-036; http://www.merz.com/company/merz_pharmaceuticals/index.jsp), who supplied study drug and provided funding for the study, had no role in influencing study design, data collection, data analysis or interpretation, in the writing of the manuscript, or in the decision to submit the manuscript for publication.	Bhakta BB, 2000, J NEUROL NEUROSUR PS, V69, P217, DOI 10.1136/jnnp.69.2.217; Brashear A, 2002, NEW ENGL J MED, V347, P395, DOI 10.1056/NEJMoa011892; Comella CL, 2011, J NEUROL SCI, V308, P103, DOI 10.1016/j.jns.2011.05.041; Delagi EF, 1980, ANATOMIC GUIDES ELEC; Dowding CH, 2006, DRUG AGING, V23, P693, DOI 10.2165/00002512-200623090-00001; Dupre E, 1910, REV NEUROL-FRANCE, V20, P54; Elovic EP, 2008, ARCH PHYS MED REHAB, V89, P799, DOI 10.1016/j.apmr.2008.01.007; FRANSSEN EH, 1993, ARCH NEUROL-CHICAGO, V50, P1029, DOI 10.1001/archneur.1993.00540100024010; Giovannelli M, 2007, CLIN REHABIL, V21, P331, DOI 10.1177/0269215507072772; GREENE P, 1990, NEUROLOGY, V40, P1213, DOI 10.1212/WNL.40.8.1213; Hobbelen JSM, 2012, INT PSYCHOGERIATR, V24, P834, DOI 10.1017/S1041610211002468; Hobbelen JSM, 2008, INT PSYCHOGERIATR, V20, P840, DOI 10.1017/S1041610207006424; Hobbelen Johannes S M, 2007, BMC Geriatr, V7, P30, DOI 10.1186/1471-2318-7-30; Kanovsky P, 2009, CLIN NEUROPHARMACOL, V32, P259, DOI 10.1097/WNF.0b013e3181b13308; KAO I, 1976, SCIENCE, V193, P1256, DOI 10.1126/science.785600; Lam K, 2012, J AM MED DIR ASSOC, V13, P477, DOI 10.1016/j.jamda.2012.03.005; Lew MF, 1997, NEUROLOGY, V49, P701, DOI 10.1212/WNL.49.3.701; Naumann M, 2002, J NEUROL, V249, P57, DOI 10.1007/PL00007848; Rabe-Hesketh S., 2012, MULTILEVEL LONGITUDI; Simpson DM, 2009, J NEUROL NEUROSUR PS, V80, P380, DOI 10.1136/jnnp.2008.159657; Smetanin P., 2011, LIFE EC IMPACT MAJOR; Souren LEM, 1997, J GERIATR PSYCH NEUR, V10, P93, DOI 10.1177/089198879701000301; Truong D, 2005, MOVEMENT DISORD, V20, P783, DOI 10.1002/mds.20403; Waardenburg H, 1999, NEDERLANDS TIJDSCHRI, V102, P30; Waltz C. F., 1991, MEASUREMENT NURSING; Warden Victoria, 2003, J Am Med Dir Assoc, V4, P9, DOI 10.1097/00130535-200301000-00002	26	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e114733	10.1371/journal.pone.0114733	http://dx.doi.org/10.1371/journal.pone.0114733			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536218	gold, Green Submitted, Green Published			2022-12-27	WOS:000348563300019
J	Lamont, EA; Wang, P; Enomoto, S; Borewicz, K; Abdallah, A; Isaacson, RE; Sreevatsan, S				Lamont, Elise A.; Wang, Ping; Enomoto, Shinichiro; Borewicz, Klaudyna; Abdallah, Ahmed; Isaacson, Richard E.; Sreevatsan, Srinand			A Combined Enrichment and Aptamer Pulldown Assay for Francisella tularensis Detection in Food and Environmental Matrices	PLOS ONE			English	Article							DNA APTAMERS; PASTEURELLA TULARENSIS; MYCOBACTERIUM-TUBERCULOSIS; SMALL INOCULA; TULAREMIA; GROWTH; ANTIBODIES; SELECTION; CELLS; MULTIPLICATION	Francisella tularensis, a Gram-negative bacterium and causative agent of tularemia, is categorized as a Class A select agent by the Centers for Disease Control and Prevention due to its ease of dissemination and ability to cause disease. Oropharyngeal and gastrointestinal tularemia may occur due to ingestion of contaminated food and water. Despite the concern to public health, little research is focused on F. tularensis detection in food and environmental matrices. Current diagnostics rely on host responses and amplification of F. tularensis genetic elements via Polymerase Chain Reaction; however, both tools are limited by development of an antibody response and limit of detection, respectively. During our investigation to develop an improved culture medium to aid F. tularensis diagnostics, we found enhanced F. tularensis growth using the spent culture filtrate. Addition of the spent culture filtrate allowed for increased detection of F. tularensis in mixed cultures of food and environmental matrices. Ultraperformance liquid chromatography (UPLC)/MS analysis identified several unique chemicals within the spent culture supernatant of which carnosine had a matching m/z ratio. Addition of 0.625 mg/mL of carnosine to conventional F. tularensis medium increased the growth of F. tularensis at low inoculums. In order to further enrich F. tularensis cells, we developed a DNA aptamer cocktail to physically separate F. tularensis from other bacteria present in food and environmental matrices. The combined enrichment steps resulted in a detection range of 1-106 CFU/mL (starting inoculums) in both soil and lettuce backgrounds. We propose that the two-step enrichment process may be utilized for easy field diagnostics and subtyping of suspected F. tularensis contamination as well as a tool to aid in basic research of F. tularensis ecology.	[Lamont, Elise A.; Wang, Ping; Abdallah, Ahmed; Sreevatsan, Srinand] Univ Minnesota, Dept Vet Populat Med, St Paul, MN 55108 USA; [Isaacson, Richard E.; Sreevatsan, Srinand] Univ Minnesota, Dept Vet Biomed Sci, St Paul, MN 55108 USA; [Enomoto, Shinichiro] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Borewicz, Klaudyna] Wageningen Univ, Mol Ecol Grp, NL-6703 HB Wageningen, Netherlands	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Utah System of Higher Education; University of Utah; Wageningen University & Research	Sreevatsan, S (corresponding author), Univ Minnesota, Dept Vet Populat Med, St Paul, MN 55108 USA.	sreev001@umn.edu	Sreevatsan, Srinand/V-6808-2019	Sreevatsan, Srinand/0000-0002-5162-2403; Lamont, Elise/0000-0001-7085-9740	Department of Homeland Security's National Center for Food Protection and Defense [3002-11364-00022511]	Department of Homeland Security's National Center for Food Protection and Defense	This study was funded by the Department of Homeland Security's National Center for Food Protection and Defense (#3002-11364-00022511) awarded to SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd H, 2003, APPL ENVIRON MICROB, V69, P600, DOI 10.1128/AEM.69.1.600-606.2003; Antwerpen MH, 2013, GENOME ANNOUNC, V1; BEVANGER L, 1988, J CLIN MICROBIOL, V26, P433, DOI 10.1128/JCM.26.3.433-437.1988; BEVANGER L, 1994, CLIN DIAGN LAB IMMUN, V1, P238, DOI 10.1128/CDLI.1.2.238-240.1994; Broekhuijsen M, 2003, J CLIN MICROBIOL, V41, P2924, DOI 10.1128/JCM.41.7.2924-2931.2003; Brombacher E, 2003, MICROBIOL-SGM, V149, P2847, DOI 10.1099/mic.0.26306-0; Chang YC, 2013, SCI REP-UK, V3, DOI 10.1038/srep01863; Chaudhuri RR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000352; Day JB, 2009, FOOD MICROBIOL, V26, P932, DOI 10.1016/j.fm.2009.06.005; Day JB, 2009, J FOOD PROTECT, V72, P1156, DOI 10.4315/0362-028X-72.6.1156; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Duan N, 2013, J MICROBIOL METHODS; Egan JR, 2011, BIOSECUR BIOTERROR, V9, P331, DOI 10.1089/bsp.2011.0004; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; Foley JE, 2010, VET MICROBIOL, V140, P332, DOI 10.1016/j.vetmic.2009.07.017; Fulop M, 1996, AM J TROP MED HYG, V54, P364, DOI 10.4269/ajtmh.1996.54.364; Gill V, 1997, Semin Respir Infect, V12, P61; Gold L, 1995, Harvey Lect, V91, P47; Guiotto A, 2005, CURR MED CHEM, V12, P2293, DOI 10.2174/0929867054864796; HALMANN M, 1967, J GEN MICROBIOL, V49, P461, DOI 10.1099/00221287-49-3-461; HALMANN M, 1967, J GEN MICROBIOL, V49, P451, DOI 10.1099/00221287-49-3-451; Hartnett E, 2009, RISK ANAL, V29, P1506, DOI 10.1111/j.1539-6924.2009.01286.x; Hennessy DA, 2008, BIOSECUR BIOTERROR, V6, P66, DOI 10.1089/bsp.2007.0016; Humrighouse BW, 2011, APPL ENVIRON MICROB, V77, P6729, DOI 10.1128/AEM.05226-11; Joshi R, 2009, MOL CELL PROBE, V23, P20, DOI 10.1016/j.mcp.2008.10.006; Lamont EA, 2011, ANALYST, V136, P3884, DOI 10.1039/c1an15352h; Martin-Serradilla JI, 2004, REV CLIN ESP, V204, P351, DOI 10.1157/13063525; MASSEY ED, 1974, APPL MICROBIOL, V27, P25, DOI 10.1128/AEM.27.1.25-27.1974; MERRIOTT J, 1961, J INFECT DIS, V108, P136, DOI 10.1093/infdis/108.2.136; Mukamolova GV, 1999, ARCH MICROBIOL, V172, P9, DOI 10.1007/s002030050733; Ojeda SS, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-215; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; Petersen JM, 2009, LETT APPL MICROBIOL, V48, P663, DOI 10.1111/j.1472-765X.2009.02589.x; Petrosino JF, 2006, J BACTERIOL, V188, P6977, DOI 10.1128/JB.00506-06; Rasmussen R, 2001, RAPID CYCLE REAL TIM, P21, DOI [10.1007/978-3-642-59524-0_3, DOI 10.1007/978-3-642-59524-0_3]; SANSONETTI PJ, 1986, INFECT IMMUN, V51, P461, DOI 10.1128/IAI.51.2.461-469.1986; Sharma N, 2013, CLIN VACCINE IMMUNOL, V20, P9, DOI 10.1128/CVI.00516-12; Shleeva MO, 2002, MICROBIOL-SGM, V148, P1581, DOI 10.1099/00221287-148-5-1581; Sridhar S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-598; STORRS EE, 1974, SCIENCE, V183, P851, DOI 10.1126/science.183.4127.851; Sun ZH, 1999, J BACTERIOL, V181, P7626, DOI 10.1128/JB.181.24.7626-7628.1999; TIAN Y, 1995, RNA, V1, P317; Versage JL, 2003, J CLIN MICROBIOL, V41, P5492, DOI 10.1128/JCM.41.12.5492-5499.2003; Vivekananda J, 2006, LAB INVEST, V86, P610, DOI 10.1038/labinvest.3700417; Wang P, 2011, EXP BIOL MED, V236, P466, DOI 10.1258/ebm.2011.010323; Whitehouse CA, 2012, LETT APPL MICROBIOL, V54, P313, DOI 10.1111/j.1472-765X.2012.03214.x; Wilke A, 2009, J MED MICROBIOL, V58, P112, DOI 10.1099/jmm.0.002279-0; Wongphatcharachai M, 2013, J CLIN MICROBIOL, V51, P46, DOI 10.1128/JCM.02118-12; Zelada-Guillen GA, 2009, ANGEW CHEM INT EDIT, V48, P7334, DOI 10.1002/anie.200902090	50	14	14	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e114622	10.1371/journal.pone.0114622	http://dx.doi.org/10.1371/journal.pone.0114622			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536105	Green Published, Green Submitted, gold			2022-12-27	WOS:000348563300018
J	Ono, YJ; Tanabe, A; Nakamura, Y; Yamamoto, H; Hayashi, A; Tanaka, T; Sasaki, H; Hayashi, M; Terai, Y; Ohmichi, M				Ono, Yoshihiro J.; Tanabe, Akiko; Nakamura, Yoko; Yamamoto, Hikaru; Hayashi, Atsushi; Tanaka, Tomohito; Sasaki, Hiroshi; Hayashi, Masami; Terai, Yoshito; Ohmichi, Masahide			A Low-Testosterone State Associated with Endometrioma Leads to the Apoptosis of Granulosa Cells	PLOS ONE			English	Article							RECEPTOR MESSENGER-RNA; IN-VITRO FERTILIZATION; GROWTH-FACTOR-I; ANDROGEN RECEPTOR; OOCYTE MATURATION; TRANSCRIPTION FACTOR; OVARIAN RESERVE; POOR RESPONDERS; GENE-EXPRESSION; BIM	Although endometriosis is suspected to be a cause of premature ovarian insufficiency (POI), the mechanism(s) underlying this process have not been elucidated. Recently, androgens were shown to promote oocyte maturation and to play a role in folliculogenesis. In addition, several reports have documented low testosterone levels in the follicular fluid obtained from endometriosis patients. We therefore examined whether the low levels of serum that testosterone inhibited apoptosis induced by sex steroids depletion via the PI3K/Akt-FoxO3a pathway in the COV434 cells. In conclusion, we elucidated the mechanism underlying the anti- apoptotic effects of testosterone on granulosa cells, and found that a low- testosterone status is a potentially important step in the development of premature ovarian insufficiency in patients with endometriosis.	[Ono, Yoshihiro J.; Tanabe, Akiko; Nakamura, Yoko; Yamamoto, Hikaru; Hayashi, Atsushi; Tanaka, Tomohito; Sasaki, Hiroshi; Hayashi, Masami; Terai, Yoshito; Ohmichi, Masahide] Osaka Med Coll, Dept Obstet & Gynecol, Osaka, Japan	Osaka Medical College	Tanabe, A (corresponding author), Osaka Med Coll, Dept Obstet & Gynecol, Osaka, Japan.	gyn074@poh.osaka-med.ac.jp		tanaka, tomohito/0000-0003-4210-701X	JSPS KAKENHI [21592117]; Grants-in-Aid for Scientific Research [26861347] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by JSPS KAKENHI (Grant Number 21592117 to AT; http://www.mhlw.go.jp/english/index.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERIESZ C, 1995, HUM REPROD, V10, P2377; Bono Y, 2012, BRIT J CANCER, V106, P1205, DOI 10.1038/bjc.2012.26; Bosdou JK, 2012, HUM REPROD UPDATE, V18, P127, DOI 10.1093/humupd/dmr051; Brosens I, 2004, FERTIL STERIL, V81, P1198, DOI 10.1016/j.fertnstert.2003.09.071; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cardenas H, 2002, REPRODUCTION, V123, P527, DOI 10.1530/rep.0.1230527; Dijkers PF, 2002, J CELL BIOL, V156, P531, DOI 10.1083/jcb.200108084; EPPIG JJ, 1983, DEV BIOL, V100, P39, DOI 10.1016/0012-1606(83)90198-7; Eskenazi B, 1997, OBSTET GYN CLIN N AM, V24, P235, DOI 10.1016/S0889-8545(05)70302-8; Essafi A, 2005, ONCOGENE, V24, P2317, DOI 10.1038/sj.onc.1208421; Evsen MS, 2014, CLIN EXP OBSTET GYN, V41, P432; Fang ZJ, 2002, J CLIN ENDOCR METAB, V87, P3460, DOI 10.1210/jc.87.7.3460; Gill A, 2004, MOL ENDOCRINOL, V18, P97, DOI 10.1210/me.2003-0326; Giudice LC, 2004, LANCET, V364, P1789, DOI 10.1016/S0140-6736(04)17403-5; Guo SW, 2009, HUM REPROD UPDATE, V15, P441, DOI 10.1093/humupd/dmp007; Hammes SR, 2004, MOL ENDOCRINOL, V18, P769, DOI 10.1210/me.2003-0317; Hansen KR, 2012, MENOPAUSE, V19, P164, DOI 10.1097/gme.0b013e31823b0b2e; Havelock JC, 2004, MOL CELL ENDOCRINOL, V228, P67, DOI 10.1016/j.mce.2004.04.018; HIRAI M, 1994, J STEROID BIOCHEM, V49, P1, DOI 10.1016/0960-0760(94)90294-1; Hsu SY, 1996, ENDOCRINOLOGY, V137, P4837, DOI 10.1210/en.137.11.4837; Hu YC, 2004, P NATL ACAD SCI USA, V101, P11209, DOI 10.1073/pnas.0404372101; HUGHES EG, 1993, FERTIL STERIL, V59, P963; Hwu YM, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-80; Jamnongjit M, 2005, SEMIN REPROD MED, V23, P234, DOI 10.1055/s-2005-872451; Jamnongjit M, 2005, P NATL ACAD SCI USA, V102, P16257, DOI 10.1073/pnas.0508521102; Johnson AL, 1999, ENDOCRINOLOGY, V140, P4521, DOI 10.1210/en.140.10.4521; Juengel JL, 2006, REPRODUCTION, V131, P81, DOI 10.1530/rep.1.00704; Kaipia A, 1997, ANNU REV PHYSIOL, V59, P349, DOI 10.1146/annurev.physiol.59.1.349; Kao LC, 2003, ENDOCRINOLOGY, V144, P2870, DOI 10.1210/en.2003-0043; Kim CH, 2011, FERTIL STERIL, V95, P679, DOI 10.1016/j.fertnstert.2010.07.1077; Liu L, 2007, DEVELOPMENT, V134, P199, DOI 10.1242/dev.02667; Lu Q, 2014, J ASSIST REPROD GEN, V31, P485, DOI 10.1007/s10815-014-0186-3; Massin N, 2006, HUM REPROD, V21, P1204, DOI 10.1093/humrep/dei481; Nielsen ME, 2011, MOL HUM REPROD, V17, P63, DOI 10.1093/molehr/gaq073; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Olivennes F, 2003, J Gynecol Obstet Biol Reprod (Paris), V32, pS45; Pellicer A, 1998, FERTIL STERIL, V69, P1135, DOI 10.1016/S0015-0282(98)00085-5; RATTS VS, 1995, ENDOCRINOLOGY, V136, P3665, DOI 10.1210/en.136.8.3665; Sasson IE, 2008, ANN NY ACAD SCI, V1127, P106, DOI 10.1196/annals.1434.014; Shiina H, 2006, P NATL ACAD SCI USA, V103, P224, DOI 10.1073/pnas.0506736102; Soules Michael R., 2001, Fertility and Sterility, V76, P874, DOI 10.1016/S0015-0282(01)02909-0; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; Steckler T, 2005, ENDOCRINOLOGY, V146, P3185, DOI 10.1210/en.2004-1444; Toya M, 2000, FERTIL STERIL, V73, P344, DOI 10.1016/S0015-0282(99)00507-5; Urbich C, 2005, FASEB J, V19, P974, DOI 10.1096/fj.04-2727fje; Vendola K, 1999, HUM REPROD, V14, P2328, DOI 10.1093/humrep/14.9.2328; Vendola K, 1999, BIOL REPROD, V61, P353, DOI 10.1095/biolreprod61.2.353; Wang XL, 2012, J BIOL CHEM, V287, P10166, DOI 10.1074/jbc.M111.293274; Zeitoun K, 1999, MOL ENDOCRINOL, V13, P239, DOI 10.1210/me.13.2.239; Zeitoun KM, 1999, FERTIL STERIL, V72, P961, DOI 10.1016/S0015-0282(99)00393-3; Zhang H, 2000, MOL HUM REPROD, V6, P146, DOI 10.1093/molehr/6.2.146	51	16	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115618	10.1371/journal.pone.0115618	http://dx.doi.org/10.1371/journal.pone.0115618			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536335	gold, Green Published, Green Submitted			2022-12-27	WOS:000348563300056
J	Hossain, GS; Li, JH; Shin, HD; Du, GC; Wang, M; Liu, L; Chen, J				Hossain, Gazi Sakir; Li, Jianghua; Shin, Hyun-dong; Du, Guocheng; Wang, Miao; Liu, Long; Chen, Jian			One-Step Biosynthesis of alpha-Keto-gamma-Methylthiobutyric Acid from L-Methionine by an Escherichia coli Whole-Cell Biocatalyst Expressing an Engineered L-Amino Acid Deaminase from Proteus vulgaris	PLOS ONE			English	Article							ANTIBACTERIAL PROTEIN; KETOGLUTARIC ACID; GLUTAMIC-ACID; PURIFICATION; APOPTOSIS; MEDIATOR	alpha-Keto-gamma-methylthiobutyric acid (KMTB), a keto derivative of L-methionine, has great potential for use as an alternative to L-methionine in the poultry industry and as an anti-cancer drug. This study developed an environment friendly process for KMTB production from L-methionine by an Escherichia coli whole-cell biocatalyst expressing an engineered L-amino acid deaminase (L-AAD) from Proteus vulgaris. We first overexpressed the P. vulgaris L-AAD in E. coli BL21 (DE3) and further optimized the whole-cell transformation process. The maximal molar conversion ratio of L-methionine to KMTB was 71.2% (mol/mol) under the optimal conditions (70 g/L L-methionine, 20 g/L whole-cell biocatalyst, 5 mM CaCl2, 40 degrees C, 50 mM Tris-HCl [pH 8.0]). Then, error-prone polymerase chain reaction was used to construct P. vulgaris L-AAD mutant libraries. Among approximately 10(4) mutants, two mutants bearing lysine 104 to arginine and alanine 337 to serine substitutions showed 82.2% and 80.8% molar conversion ratios, respectively. Furthermore, the combination of these mutations enhanced the catalytic activity and molar conversion ratio by 1.3-fold and up to 91.4% with a KMTB concentration of 63.6 g/L. Finally, the effect of immobilization on whole-cell transformation was examined, and the immobilized whole-cell biocatalyst with Ca2+ alginate increased reusability by 41.3% compared to that of free cell production. Compared with the traditional multi-step chemical synthesis, our one-step biocatalytic production of KMTB has an advantage in terms of environmental pollution and thus has great potential for industrial KMTB production.	[Hossain, Gazi Sakir; Li, Jianghua; Du, Guocheng; Liu, Long] Jiangnan Univ, Key Lab Carbohydrate Chem & Biotechnol, Minist Educ, Wuxi, Peoples R China; [Li, Jianghua; Du, Guocheng; Liu, Long; Chen, Jian] Jiangnan Univ, Key Lab Ind Biotechnol, Minist Educ, Wuxi, Peoples R China; [Li, Jianghua; Du, Guocheng; Liu, Long; Chen, Jian] Synerget Innovat Ctr Food Safety & Nutr, Wuxi, Peoples R China; [Shin, Hyun-dong] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA; [Hossain, Gazi Sakir; Wang, Miao] Jiangnan Univ, Sch Food Sci & Technol, Wuxi, Peoples R China	Jiangnan University; Jiangnan University; University System of Georgia; Georgia Institute of Technology; Jiangnan University	Wang, M (corresponding author), Jiangnan Univ, Sch Food Sci & Technol, Wuxi, Peoples R China.	mwang@jiangnan.edu.cn; longliu@jiangnan.edu.cn	li, jianghua/GXG-4735-2022; Hossain, Gazi Sakir/AAE-5391-2020		Ministry of Science and Technology [2012AA022202]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1135]; National High Technology Research and Development Program of China (863 Program) [2014AA021201]; Priority Academic Program Development of Jiangsu Higher Education Institutions; 111 Project [111-2-06]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Priority Academic Program Development of Jiangsu Higher Education Institutions; 111 Project(Ministry of Education, China - 111 Project)	This work was financially supported by the Ministry of Science and Technology (2012AA022202), the Program for Changjiang Scholars and Innovative Research Team in University (No. IRT1135), the National High Technology Research and Development Program of China (863 Program, 2014AA021201), the Priority Academic Program Development of Jiangsu Higher Education Institutions, and the 111 Project (111-2-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dilger RN, 2007, J NUTR, V137, P1868, DOI 10.1093/jn/137.8.1868; DODEVSKI I, 2011, ENG INTEGRAL MEMBRAN, P277; Garcia-Garcia M, 2008, BIOTECHNOL PROGR, V24, P187, DOI 10.1021/bp0702424; Hossain GS, 2014, J BIOTECHNOL, V169, P112, DOI 10.1016/j.jbiotec.2013.10.026; James SG, 1996, APPL ENVIRON MICROB, V62, P2783, DOI 10.1128/AEM.62.8.2783-2788.1996; Liu L, 2013, J BIOTECHNOL, V164, P97, DOI 10.1016/j.jbiotec.2013.01.005; Lucas-Elio P, 2005, BBA-GEN SUBJECTS, V1721, P193, DOI 10.1016/j.bbagen.2004.11.002; NAM KC, 1995, J LABELLED COMPD RAD, V36, P431, DOI 10.1002/jlcr.2580360505; Pantaleone DP, 2001, J MOL CATAL B-ENZYM, V11, P795, DOI 10.1016/S1381-1177(00)00155-7; Quash G, 2009, CURR MED CHEM, V16, P3686, DOI 10.2174/092986709789104966; QUASH G, 1995, BIOCHEM J, V305, P1017, DOI 10.1042/bj3051017; Quash G, 2004, B CANC, V91, P61; Rey P, 2010, US Pat, Patent No. [US20100178380A1, 20100178380]; Subhi AL, 2003, J BIOL CHEM, V278, P49868, DOI 10.1074/jbc.M308451200; Takahashi E, 1999, BIOSCI BIOTECH BIOCH, V63, P2244, DOI 10.1271/bbb.63.2244	15	27	32	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e114291	10.1371/journal.pone.0114291	http://dx.doi.org/10.1371/journal.pone.0114291			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531756	gold, Green Published, Green Submitted			2022-12-27	WOS:000348845100012
J	Jiang, L; Li, JY; Shen, C; Yang, SC; Han, ZG				Jiang, Li; Li, Jingyu; Shen, Chao; Yang, Sicong; Han, Zhangang			Obstacle Optimization for Panic Flow - Reducing the Tangential Momentum Increases the Escape Speed	PLOS ONE			English	Article							DYNAMICS; CROWD; EVACUATION; SIMULATION; DESIGN; MODELS	A disastrous form of pedestrian behavior is a stampede occurring in an event involving a large crowd in a panic situation. To deal with such stampedes, the possibility to increase the outflow by suitably placing a pillar or some other shaped obstacles in front of the exit has been demonstrated. We present a social force based genetic algorithm to optimize the best design of architectural entities to deal with large crowds. Unlike existing literature, our simulation results indicate that appropriately placing two pillars on both sides but not in front of the door can maximize the escape efficiency. Human experiments using 80 participants correspond well with the simulations. We observed a peculiar property named tangential momentum, the escape speed and the tangential momentum are found to be negatively correlated. The idea to reduce the tangential momentum has practical implications in crowd architectural design.	[Jiang, Li; Li, Jingyu; Shen, Chao; Yang, Sicong; Han, Zhangang] Beijing Normal Univ, Sch Syst Sci, Beijing 100875, Peoples R China; [Li, Jingyu] Chinese Acad Sci, Inst Policy & Management, Beijing 100190, Peoples R China; [Shen, Chao] Natl Univ Denfense Technol, Coll Informat Syst & Management, Changsha 410073, Hunan, Peoples R China	Beijing Normal University; Chinese Academy of Sciences; CAS Institutes of Science & Development; National University of Defense Technology - China	Han, ZG (corresponding author), Beijing Normal Univ, Sch Syst Sci, Beijing 100875, Peoples R China.	zhan@bnu.edu.cn	Li, Jingyu/GSD-1924-2022	Yang, Sicong/0000-0003-3339-1549	China National Natural Science Foundation [61074116, 61374165, 31261160495]; Fundamental Research Funds for the Central Universities of China; BNU State Key Laboratory of ESPRE [2012-TDZY-21]	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); BNU State Key Laboratory of ESPRE	This research is supported by China National Natural Science Foundation grants 61074116, 61374165 and 31261160495, as well as the Fundamental Research Funds for the Central Universities of China. This work was also supported by BNU State Key Laboratory of ESPRE (2012-TDZY-21). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Marroquin F, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.020301; Batty M, 2003, INT J GEOGR INF SCI, V17, P673, DOI 10.1080/1365881031000135474; Escobar R, 2003, LECT NOTES ARTIF INT, V2801, P97; Frank GA, 2011, PHYSICA A, V390, P2135, DOI 10.1016/j.physa.2011.01.015; Helbing D, 2005, TRANSPORT SCI, V39, P1, DOI 10.1287/trsc.1040.0108; Helbing D, 2000, NATURE, V407, P487, DOI 10.1038/35035023; Helbing D., 1992, Complex Systems, V6, P391; Helbing D, 2002, PEDESTRIAN AND EVACUATION DYNAMICS, P21; Helbing D., 2009, PEDESTRIAN CROWD EVA; Helbing D, 2014, ARXIV14027011; Hoogendoorn SP, 2003, LECT NOTES COMPUTATI, V32, P275, DOI DOI 10.1007/978-3-662-07969-027; Hughes RL, 2003, ANNU REV FLUID MECH, V35, P169, DOI 10.1146/annurev.fluid.35.101101.161136; Hughes RL, 2002, TRANSPORT RES B-METH, V36, P507, DOI 10.1016/S0191-2615(01)00015-7; Johansson Anders, 2007, PEDESTRIAN EVACUATIO, P267, DOI DOI 10.1007/978-3-540-47064-9; Johanssons A, 2007, ADV COMPLEX SYST, p[10, 271], DOI DOI 10.1142/S0219525907001355; Kallus N, 2014, ARXIV14022308; Kirchner A, 2004, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2004/10/P10011; Kirkland JA, 2003, IEEE SYS MAN CYBERN, P4328; Klupfel H, 2003, TRAFFIC AND GRANULAR FLOW'01, P549; LOVAS GG, 1994, TRANSPORT RES B-METH, V28, P429, DOI 10.1016/0191-2615(94)90013-2; Moussaid M, 2011, P NATL ACAD SCI USA, V108, P6884, DOI 10.1073/pnas.1016507108; Schadschneider A., 2001, CONDMAT0112117 ARXIV; Shiwakoti N, 2014, SAFETY SCI, V66, P1, DOI 10.1016/j.ssci.2014.01.010; Shiwakoti N, 2013, TRANSPORT RES C-EMER, V37, P260, DOI 10.1016/j.trc.2013.04.009; Shukla PK, 2009, LECT NOTES ARTIF INT, V5865, P22, DOI 10.1007/978-3-642-10427-5_3; SRINIVAS M, 1994, IEEE T SYST MAN CYB, V24, P656, DOI 10.1109/21.286385; Willis A, 2000, P SEM K EUR TRANSP C, V445; Wright A, 1990, F GENETIC ALGORITHMS, P205; Yanagisawa Daichi, 2010, SICE Journal of Control, Measurement, and System Integration, V3, P395, DOI 10.9746/jcmsi.3.395; Yang XL, 2011, PHYSICA A, V390, P2375, DOI 10.1016/j.physa.2010.10.019; Yu WJ, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.026112; Zheng Y, 2011, PHYSICA A, V390, P3147, DOI 10.1016/j.physa.2011.04.011; Zhou D, 2012, THEOR COMPUT SCI, V436, P106, DOI 10.1016/j.tcs.2012.01.010; Zuriguel I, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.278001	34	36	37	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115463	10.1371/journal.pone.0115463	http://dx.doi.org/10.1371/journal.pone.0115463			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531676	Green Submitted, gold, Green Published			2022-12-27	WOS:000348845100071
J	Silambarasan, T; Manivannan, J; Priya, MK; Suganya, N; Chatterjee, S; Raja, B				Silambarasan, Thangarasu; Manivannan, Jeganathan; Priya, Mani Krishna; Suganya, Natarajan; Chatterjee, Suvro; Raja, Boobalan			Sinapic Acid Prevents Hypertension and Cardiovascular Remodeling in Pharmacological Model of Nitric Oxide Inhibited Rats	PLOS ONE			English	Article							MYOCARDIAL INFARCTED RATS; OXIDATIVE STRESS; CARDIAC-HYPERTROPHY; GENE-EXPRESSION; DIASTOLIC DYSFUNCTION; CLINICAL-IMPLICATIONS; ENDOTHELIAL-CELLS; HYDROGEN-PEROXIDE; S-NITROSYLATION; ANGIOTENSIN-II	Objectives: Hypertensive heart disease is a constellation of abnormalities that includes cardiac fibrosis in response to elevated blood pressure, systolic and diastolic dysfunction. The present study was undertaken to examine the effect of sinapic acid on high blood pressure and cardiovascular remodeling. Methods: An experimental hypertensive animal model was induced by L-NAME intake on rats. Sinapic acid (SA) was orally administered at a dose of 10, 20 and 40 mg/kg body weight (b.w.). Blood pressure was measured by tail cuff plethysmography system. Cardiac and vascular function was evaluated by Langendorff isolated heart system and organ bath studies, respectively. Fibrotic remodeling of heart and aorta was assessed by histopathologic analyses. Oxidative stress was measured by biochemical assays. mRNA and protein expressions were assessed by RT-qPCR and western blot, respectively. In order to confirm the protective role of SA on endothelial cells through its antioxidant property, we have utilized the in vitro model of H2O2-induced oxidative stress in EA.hy926 endothelial cells. Results: Rats with hypertension showed elevated blood pressure, declined myocardial performance associated with myocardial hypertrophy and fibrosis, diminished vascular response, nitric oxide (NO) metabolites level, elevated markers of oxidative stress (TBARS, LOOH), ACE activity, depleted antioxidant system (SOD, CAT, GPx, reduced GSH), aberrant expression of TGF-beta, beta-MHC, eNOS mRNAs and eNOS protein. Remarkably, SA attenuated high blood pressure, myocardial, vascular dysfunction, cardiac fibrosis, oxidative stress and ACE activity. Level of NO metabolites, antioxidant system, and altered gene expression were also repaired by SA treatment. Results of in vitro study showed that, SA protects endothelial cells from oxidative stress and enhance the production of NO in a concentration dependent manner. Conclusions: Taken together, these results suggest that SA may have beneficial role in the treatment of hypertensive heart disease by attenuating fibrosis and oxidative stress through its antioxidant potential.	[Silambarasan, Thangarasu; Manivannan, Jeganathan; Raja, Boobalan] Annamalai Univ, Fac Sci, Dept Biochem & Biotechnol, Cardiovasc Biol Lab, Annamalainagar 608002, Tamil Nadu, India; [Manivannan, Jeganathan; Priya, Mani Krishna; Suganya, Natarajan; Chatterjee, Suvro] Anna Univ, AU KBC Res Ctr, Vasc Biol Lab, Chennai 600025, Tamil Nadu, India; [Chatterjee, Suvro] Anna Univ, Dept Biotechnol, Chennai 600025, Tamil Nadu, India	Annamalai University; Anna University; Anna University Chennai; Anna University; Anna University Chennai	Raja, B (corresponding author), Annamalai Univ, Fac Sci, Dept Biochem & Biotechnol, Cardiovasc Biol Lab, Annamalainagar 608002, Tamil Nadu, India.	drrajaau@gmail.com	Raja, B./Z-1358-2019; Natarajan, Suganya/CAH-2845-2022	Raja, B./0000-0003-0685-4931; Natarajan, Suganya/0000-0002-9976-5403; Jeganathan, Manivannan/0000-0003-3948-0155				Andreasen MF, 2001, J AGR FOOD CHEM, V49, P4090, DOI 10.1021/jf0101758; Attia DM, 2001, J AM SOC NEPHROL, V12, P2585, DOI 10.1681/ASN.V12122585; Becker LB, 2004, CARDIOVASC RES, V61, P461, DOI 10.1016/j.cardiores.2003.10.025; BOLUYT MO, 1994, CIRC RES, V75, P23, DOI 10.1161/01.RES.75.1.23; Cataliotti A, 2011, CIRCULATION, V123, P1297, DOI 10.1161/CIRCULATIONAHA.110.981720; Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0; Colonna VD, 2002, EUR J PHARMACOL, V450, P61; Diez J, 2002, CIRCULATION, V105, P2512, DOI 10.1161/01.CIR.0000017264.66561.3D; Dikalov SI, 2013, AM J PHYSIOL-HEART C, V305, pH1417, DOI 10.1152/ajpheart.00089.2013; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Fang WT, 2010, ACTA PHARMACOL SIN, V31, P485, DOI 10.1038/aps.2010.23; Fenning A, 2005, AM J PHYSIOL-HEART C, V289, pH1408, DOI 10.1152/ajpheart.00140.2005; Galderisi M, 2008, J CARDIOVASC PHARM, V51, P523, DOI 10.1097/FJC.0b013e31817751a7; Hiremath P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097424; Jia LQ, 2012, J ETHNOPHARMACOL, V143, P100, DOI 10.1016/j.jep.2012.06.007; JIANG ZY, 1992, ANAL BIOCHEM, V202, P384, DOI 10.1016/0003-2697(92)90122-N; Juranek I, 2005, GEN PHYSIOL BIOPHYS, V24, P263; Kai H, 2006, HYPERTENS RES, V29, P711, DOI 10.1291/hypres.29.711; KAKKAR P, 1984, INDIAN J BIOCHEM BIO, V21, P130; Kanchana G., 2011, GLOB J PHARM, V5, P33; Kazakov A, 2013, CARDIOVASC RES, V100, P211, DOI 10.1093/cvr/cvt181; Kehat I, 2010, CIRCULATION, V122, P2727, DOI 10.1161/CIRCULATIONAHA.110.942268; Krenz M, 2004, J AM COLL CARDIOL, V44, P2390, DOI 10.1016/j.jacc.2004.09.044; Kumar S., 2010, INT J RES PHARM SCI, V1, P300, DOI [10.1002/cbf.1331, DOI 10.1002/CBF.1331]; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Li H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048872; Li YQ, 2013, ACTA PHARMACOL SIN, V34, P352, DOI 10.1038/aps.2012.164; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Majithiya JB, 2005, CARDIOVASC RES, V66, P150, DOI 10.1016/j.cardiores.2004.12.025; Manabe I, 2002, CIRC RES, V91, P1103, DOI 10.1161/01.RES.0000046452.67724.B8; Mapanga RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047322; Matsushita K, 2003, CELL, V115, P139, DOI 10.1016/S0092-8674(03)00803-1; Maytin M, 2004, CIRCULATION, V109, P1168, DOI 10.1161/01.CIR.0000117229.60628.2F; Morrell CN, 2005, P NATL ACAD SCI USA, V102, P3782, DOI 10.1073/pnas.0408310102; Murdoch CE, 2006, CARDIOVASC RES, V71, P208, DOI 10.1016/j.cardiores.2006.03.016; NIEHAUS WG, 1968, EUR J BIOCHEM, V6, P126, DOI 10.1111/j.1432-1033.1968.tb00428.x; Pandya K, 2011, CIRC RES, V109, P609, DOI 10.1161/CIRCRESAHA.111.252619; Paravicini TM, 2008, DIABETES CARE, V31, pS170, DOI 10.2337/dc08-s247; Pari L, 2011, CHEM-BIOL INTERACT, V194, P40, DOI 10.1016/j.cbi.2011.08.004; Rodrigo R, 2013, DIS MARKERS, V2013, P773, DOI 10.1155/2013/974358; Rosenkranz S, 2004, CARDIOVASC RES, V63, P423, DOI 10.1016/j.cardiores.2004.04.030; ROTRUCK JT, 1973, SCIENCE, V179, P588, DOI 10.1126/science.179.4073.588; Roy SJ, 2013, EUR J PHARMACOL, V699, P213, DOI 10.1016/j.ejphar.2012.11.012; Roy SJ, 2012, FOOD CHEM TOXICOL, V50, P3984, DOI 10.1016/j.fct.2012.08.017; Sabri A, 2003, ANTIOXID REDOX SIGN, V5, P731, DOI 10.1089/152308603770380034; Saravanakumar M, 2011, EUR J PHARMACOL, V671, P87, DOI 10.1016/j.ejphar.2011.08.052; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Senthil SS, 2004, CLIN CHIM ACTA, V348, P131, DOI 10.1016/j.cccn.2004.05.004; Seymour EM, 2008, J GERONTOL A-BIOL, V63, P1034, DOI 10.1093/gerona/63.10.1034; Sharma DK, 2012, EUR J PHARMACOL, V691, P198, DOI 10.1016/j.ejphar.2012.07.022; Siamwala JH, 2013, J NUTR BIOCHEM, V24, P595, DOI 10.1016/j.jnutbio.2012.02.016; SINHA AK, 1972, ANAL BIOCHEM, V47, P389, DOI 10.1016/0003-2697(72)90132-7; Sukumaran SV, 2013, PHARMACOL RES, V78, P18, DOI 10.1016/j.phrs.2013.09.005; Susic D, 2007, AM J PHYSIOL-HEART C, V292, pH175, DOI 10.1152/ajpheart.00660.2006; Taniyama Y, 2003, HYPERTENSION, V42, P1075, DOI 10.1161/01.HYP.0000100443.09293.4F; Tawfik HE, 2008, AM J PHYSIOL-HEART C, V295, pH1736, DOI 10.1152/ajpheart.87.2008; Xu HB, 2007, VASC PHARMACOL, V47, P18, DOI 10.1016/j.vph.2007.03.002; Zhang Y, 2014, HYPERTENS RES, V37, P43, DOI 10.1038/hr.2013.119; Zhao WY, 2008, MOL CELL BIOCHEM, V317, P43, DOI 10.1007/s11010-008-9803-8; Zobali F, 2001, PHARMACOLOGY, V63, P58, DOI 10.1159/000056113; Zou YN, 2002, J AGR FOOD CHEM, V50, P5884, DOI 10.1021/jf020496z	61	64	66	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115682	10.1371/journal.pone.0115682	http://dx.doi.org/10.1371/journal.pone.0115682			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531679	Green Published, gold, Green Submitted			2022-12-27	WOS:000348845100092
J	Bhullar, D; Jalodia, R; Kalia, M; Vrati, S				Bhullar, Deepika; Jalodia, Richa; Kalia, Manjula; Vrati, Sudhanshu			Cytoplasmic Translocation of Polypyrimidine Tract-Binding Protein and Its Binding to Viral RNA during Japanese Encephalitis Virus Infection Inhibits Virus Replication	PLOS ONE			English	Article							RIBOSOME ENTRY SITE; MOUSE HEPATITIS-VIRUS; NITRIC-OXIDE SYNTHASE; 3' NONCODING REGION; MESSENGER-RNA; 3'-UNTRANSLATED REGION; UNTRANSLATED REGION; INTERNAL INITIATION; NUCLEAR-LOCALIZATION; WEST-NILE	Japanese encephalitis virus (JEV) has a single-stranded, positive-sense RNA genome containing a single open reading frame flanked by the 59- and 39-non-coding regions (NCRs). The virus genome replicates via a negative-sense RNA intermediate. The NCRs and their complementary sequences in the negative-sense RNA are the sites for assembly of the RNA replicase complex thereby regulating the RNA synthesis and virus replication. In this study, we show that the 55-kDa polypyrimidine tract-binding protein (PTB) interacts in vitro with both the 59-NCR of the positive-sense genomic RNA - 5NCR(+), and its complementary sequence in the negative-sense replication intermediate RNA - 3NCR(-). The interaction of viral RNA with PTB was validated in infected cells by JEV RNA co-immunoprecipitation and JEV RNA-PTB co-localization experiments. Interestingly, we observed phosphorylation-coupled translocation of nuclear PTB to cytoplasmic foci that co-localized with JEV RNA early during JEV infection. Our studies employing the PTB silencing and over-expression in cultured cells established an inhibitory role of PTB in JEV replication. Using RNA-protein binding assay we show that PTB competitively inhibits association of JEV 3NCR(-) RNA with viral RNA-dependent RNA polymerase (NS5 protein), an event required for the synthesis of the plus-sense genomic RNA. cAMP is known to promote the Protein kinase A (PKA)mediated PTB phosphorylation. We show that cells treated with a cAMP analogue had an enhanced level of phosphorylated PTB in the cytoplasm and a significantly suppressed JEV replication. Data presented here show a novel, cAMP-induced,	[Bhullar, Deepika; Jalodia, Richa; Vrati, Sudhanshu] Natl Inst Immunol, New Delhi 110067, India; [Kalia, Manjula; Vrati, Sudhanshu] Translat Hlth Sci & Technol Inst, Vaccine & Infect Dis Res Ctr, Gurgaon, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI)	Vrati, S (corresponding author), Natl Inst Immunol, New Delhi 110067, India.	vrati@thsti.res.in	Kalia, Manjula/AAM-2767-2021	Kalia, Manjula/0000-0002-3376-3659	National institute of Immunology; Translational Health Science and Technology Institute; Department of Biotechnology, Govt. of India [BT/MB/01/VIDRC/08]	National institute of Immunology; Translational Health Science and Technology Institute; Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India)	This work was supported by the core grants of the National institute of Immunology and the Translational Health Science and Technology Institute and grant no. BT/MB/01/VIDRC/08 from Department of Biotechnology, Govt. of India to SV.	Aizaki H, 2006, J BIOMED SCI, V13, P469, DOI 10.1007/s11373-006-9088-4; ALI N, 1995, J VIROL, V69, P6367, DOI 10.1128/JVI.69.10.6367-6375.1995; Alvarez DE, 2005, J VIROL, V79, P6631, DOI 10.1128/JVI.79.11.6631-6643.2005; [Anonymous], 1998, Wkly Epidemiol Rec, V73, P337; Anwar A, 2009, J BIOL CHEM, V284, P17021, DOI 10.1074/jbc.M109.006239; Agis-Juarez RA, 2009, J GEN VIROL, V90, P2893, DOI 10.1099/vir.0.013433-0; BORMAN A, 1993, J GEN VIROL, V74, P1775, DOI 10.1099/0022-1317-74-9-1775; BRINTON MA, 1988, VIROLOGY, V162, P290, DOI 10.1016/0042-6822(88)90468-0; Castelo-Branco P, 2004, MOL CELL BIOL, V24, P4174, DOI 10.1128/MCB.24.10.4174-4183.2004; Chang KS, 2006, VIRUS RES, V115, P1, DOI 10.1016/j.virusres.2005.06.012; Chen CJ, 1997, J VIROL, V71, P3466, DOI 10.1128/JVI.71.5.3466-3473.1997; Chien HL, 2011, J VIROL, V85, P4698, DOI 10.1128/JVI.01950-10; Chio CC, 2004, CELL SIGNAL, V16, P565, DOI 10.1016/j.cellsig.2003.10.003; Choi KS, 2002, VIROLOGY, V303, P58, DOI 10.1006/viro.2002.1675; Coles LS, 2004, EUR J BIOCHEM, V271, P648, DOI 10.1111/j.1432-1033.2003.03968.x; Das R, 2007, P NATL ACAD SCI USA, V104, P93, DOI 10.1073/pnas.0609033103; De Nova-Ocampo M, 2002, VIROLOGY, V295, P337, DOI 10.1006/viro.2002.1407; Domitrovich AM, 2005, VIROLOGY, V335, P72, DOI 10.1016/j.virol.2005.02.009; Emara MM, 2007, P NATL ACAD SCI USA, V104, P9041, DOI 10.1073/pnas.0703348104; Espada-Murao LA, 2011, J VIROL, V85, P6736, DOI 10.1128/JVI.00233-11; Florez PM, 2005, J VIROL, V79, P6172, DOI 10.1128/JVI.79.10.6172-6179.2005; Fred RG, 2006, CURR DIABETES REV, V2, P363, DOI 10.2174/157339906777950570; Gebhard LG, 2011, VIRUSES-BASEL, V3, P1739, DOI 10.3390/v3091739; GHETTI A, 1992, NUCLEIC ACIDS RES, V20, P3671, DOI 10.1093/nar/20.14.3671; Gutierrez AL, 1997, J VIROL, V71, P3826; HAHN CS, 1987, J MOL BIOL, V198, P33, DOI 10.1016/0022-2836(87)90455-4; Hamilton BJ, 2003, MOL CELL BIOL, V23, P510, DOI 10.1128/MCB.23.2.510-525.2003; Huang JL, 2004, J MED VIROL, V74, P589, DOI 10.1002/jmv.20218; Isken O, 2003, EMBO J, V22, P5655, DOI 10.1093/emboj/cdg562; Ito T, 1999, VIROLOGY, V254, P288, DOI 10.1006/viro.1998.9541; Jang SK, 2006, VIRUS RES, V119, P2, DOI 10.1016/j.virusres.2005.11.003; Jiang LB, 2009, BIOCHEM BIOPH RES CO, V385, P187, DOI 10.1016/j.bbrc.2009.05.036; Kamath RV, 2001, MOL BIOL CELL, V12, P3808, DOI 10.1091/mbc.12.12.3808; Karakasiliotis I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009562; Kim SM, 2006, VIRUS RES, V115, P131, DOI 10.1016/j.virusres.2005.07.013; Li B, 2002, J BIOL CHEM, V277, P10306, DOI 10.1074/jbc.M109686200; Li HP, 1999, J VIROL, V73, P772, DOI 10.1128/JVI.73.1.772-777.1999; Lodeiro MF, 2009, J VIROL, V83, P993, DOI 10.1128/JVI.01647-08; Luo GX, 1999, VIROLOGY, V256, P105, DOI 10.1006/viro.1999.9639; Mackenzie JM, 2007, J GEN VIROL, V88, P1163, DOI 10.1099/vir.0.82552-0; Martinez-Salas E, 2008, J GEN VIROL, V89, P611, DOI 10.1099/vir.0.83426-0; Matus-Nicodemos R, 2011, J IMMUNOL, V186, P2164, DOI 10.4049/jimmunol.1003236; Millevoi S, 2009, NUCLEIC ACIDS RES, V37, P4672, DOI 10.1093/nar/gkp470; Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008; Nazmi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021761; Niepmann M, 1997, J VIROL, V71, P8330, DOI 10.1128/JVI.71.11.8330-8339.1997; Panyasrivanit M, 2009, J GEN VIROL, V90, P448, DOI 10.1099/vir.0.005355-0; Paranjape SM, 2007, J BIOL CHEM, V282, P30497, DOI 10.1074/jbc.M705755200; Pautz A, 2006, J BIOL CHEM, V281, P32294, DOI 10.1074/jbc.M603915200; Perez I, 1997, RNA, V3, P764; Romanelli MG, 2002, EUR J BIOCHEM, V269, P2727, DOI 10.1046/j.1432-1033.2002.02942.x; Salonen A, 2005, CURR TOP MICROBIOL, V285, P139; Sawicka K, 2008, BIOCHEM SOC T, V36, P641, DOI 10.1042/BST0360641; SINGH R, 1995, SCIENCE, V268, P1173, DOI 10.1126/science.7761834; Sola I, 2011, J VIROL, V85, P5136, DOI 10.1128/JVI.00195-11; Song YT, 2005, RNA, V11, P1809, DOI 10.1261/rna.7430405; Sooryanarain H, 2012, ARCH VIROL, V157, P1905, DOI 10.1007/s00705-012-1386-8; Spellman R, 2006, TRENDS BIOCHEM SCI, V31, P73, DOI 10.1016/j.tibs.2005.12.003; Spellman R, 2005, BIOCHEM SOC T, V33, P457, DOI 10.1042/BST0330457; Spriggs KA, 2005, CELL DEATH DIFFER, V12, P585, DOI 10.1038/sj.cdd.4401642; SUMIYOSHI H, 1987, VIROLOGY, V161, P497, DOI 10.1016/0042-6822(87)90144-9; Ta M, 2000, J VIROL, V74, P5108, DOI 10.1128/JVI.74.11.5108-5115.2000; Tillmar L, 2002, J BIOL CHEM, V277, P1099, DOI 10.1074/jbc.M108340200; Tischendorf JJW, 2004, ARCH VIROL, V149, P1955, DOI 10.1007/s00705-004-0341-8; Uchil PD, 2003, J BIOL CHEM, V278, P24388, DOI 10.1074/jbc.M301717200; Vashist S, 2011, DNA CELL BIOL, V30, P339, DOI 10.1089/dna.2010.1114; Vashist S, 2009, J GEN VIROL, V90, P1343, DOI 10.1099/vir.0.010850-0; Verma B, 2010, J GEN VIROL, V91, P1245, DOI 10.1099/vir.0.018507-0; Vrati S, 1999, J GEN VIROL, V80, P1665, DOI 10.1099/0022-1317-80-7-1665; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007; Xie JY, 2003, P NATL ACAD SCI USA, V100, P8776, DOI 10.1073/pnas.1432696100; Xu MG, 2007, BIOL REPROD, V76, P1025, DOI 10.1095/biolreprod.107.060079; Yadav M, 2004, J IMMUNOL, V172, P5588, DOI 10.4049/jimmunol.172.9.5588; Yi ZG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001255; Yu L, 2008, VIROLOGY, V374, P170, DOI 10.1016/j.virol.2007.12.035; Zhang Y, 2002, BIOCHEM PHARMACOL, V63, P273, DOI 10.1016/S0006-2952(01)00831-0	76	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e114931	10.1371/journal.pone.0114931	http://dx.doi.org/10.1371/journal.pone.0114931			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545659	gold, Green Published, Green Submitted			2022-12-27	WOS:000347120200015
J	Gonzalez-Perez, S; Garces-Claver, A; Mallor, C; de Miera, LES; Fayos, O; Pomar, F; Merino, F; Silvar, C				Gonzalez-Perez, Susana; Garces-Claver, Ana; Mallor, Cristina; Saenz de Miera, Luis E.; Fayos, Oreto; Pomar, Federico; Merino, Fuencisla; Silvar, Cristina			New Insights into Capsicum spp Relatedness and the Diversification Process of Capsicum annuum in Spain	PLOS ONE			English	Article							CHILI-PEPPERS CAPSICUM; LINKAGE MAP; GENETIC DIVERSITY; MICROSATELLITE MARKERS; PROVIDES INSIGHTS; HIGH-RESOLUTION; GENUS CAPSICUM; SSR MARKERS; L.; SEQUENCE	The successful exploitation of germplasm banks, harbouring plant genetic resources indispensable for plant breeding, will depend on our ability to characterize their genetic diversity. The Vegetable Germplasm Bank of Zaragoza (BGHZ) (Spain) holds an important Capsicum annuum collection, where most of the Spanish pepper variability is represented, as well as several accessions of other domesticated and non-domesticated Capsicum spp from all over the five continents. In the present work, a total of 51 C. annuum landraces (mainly from Spain) and 51 accessions from nine Capsicum species maintained at the BGHZ were evaluated using 39 microsatellite (SSR) markers spanning the whole genome. The 39 polymorphic markers allowed the detection of 381 alleles, with an average of 9.8 alleles per locus. A sizeable proportion of alleles (41.2%) were recorded as specific alleles and the majority of these were present at very low frequencies (rare alleles). Multivariate and model-based analyses partitioned the collection in seven clusters comprising the ten different Capsicum spp analysed: C. annuum, C. chinense, C. frutescens, C. pubescens, C. bacatum, C. chacoense and C. eximium. The data clearly showed the close relationships between C. chinense and C. frutescens. C. cardenasii and C. eximium were indistinguishable as a single, morphologically variable species. Moreover, C. chacoense was placed between C. baccatum and C. pubescens complexes. The C. annuum group was structured into three main clusters, mostly according to the pepper fruit shape, size and potential pungency. Results suggest that the diversification of C. annuum in Spain may occur from a rather limited gene pool, still represented by few landraces with ancestral traits. This ancient population would suffer from local selection at the distinct	[Gonzalez-Perez, Susana; Pomar, Federico; Merino, Fuencisla; Silvar, Cristina] Univ A Coruna, Dept Ecol Plant & Anim Biol, La Coruna, Spain; [Garces-Claver, Ana; Mallor, Cristina; Fayos, Oreto] Agrifood Res & Technol Ctr Aragon CITA, Zaragoza, Spain; [Saenz de Miera, Luis E.] Univ Leon, Dept Mol Biol, E-24071 Leon, Spain	Universidade da Coruna; Universidad de Leon	Silvar, C (corresponding author), Univ A Coruna, Dept Ecol Plant & Anim Biol, La Coruna, Spain.	c.silvar@udc.es	Sáenz de Miera, Luis/ABA-4573-2021; Avellan, Oreto Fayos/W-7716-2018; Mallor, Cristina/AAK-9043-2020; Silvar, Cristina/G-5141-2010; GARCES-CLAVER, ANA/J-8545-2017; de Miera, Luis E Sáenz/D-6864-2018; Pomar, Federico/F-2236-2010	Sáenz de Miera, Luis/0000-0003-1871-7379; Avellan, Oreto Fayos/0000-0001-9332-3199; Mallor, Cristina/0000-0002-3150-5496; Silvar, Cristina/0000-0002-1782-8045; GARCES-CLAVER, ANA/0000-0002-6727-5928; de Miera, Luis E Sáenz/0000-0003-1871-7379; Pomar, Federico/0000-0001-8035-7103	Spanish Institute for Agricultural and Food Research and Technology (INIA); European Regional Development Fund (FEDER) [RTA2011-00118]	Spanish Institute for Agricultural and Food Research and Technology (INIA)(Instituto de Investigacion Agropecuaria (INIA)); European Regional Development Fund (FEDER)(European Commission)	This work was supported by the Spanish Institute for Agricultural and Food Research and Technology (INIA) and co-financed by the European Regional Development Fund (FEDER) (Project RTA2011-00118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YK, 2014, SCI HORTIC-AMSTERDAM, V170, P123, DOI 10.1016/j.scienta.2014.03.007; Albrecht E, 2012, GENET RESOUR CROP EV, V59, P517, DOI 10.1007/s10722-011-9700-y; ANDREWS J, 1993, GEOGR REV, V83, P194, DOI 10.2307/215257; Andrews J., 1984, PEPPERS DOMESTICATED; Ashrafi Hamid, 2012, BMC Genomics, V13, P571, DOI 10.1186/1471-2164-13-571; Baral J. B., 2002, Capsicum & Eggplant Newsletter, P11; Barchi L, 2007, GENOME, V50, P51, DOI 10.1139/G06-140; Bosland P. W., 2012, Peppers: vegetable and spice capsicums, DOI 10.1079/9781845938253.0000; Bosland PW, 1988, 530 NEW MEX STAT U C, V530; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Breton C, 2008, PLANT SCI, V175, P524, DOI 10.1016/j.plantsci.2008.05.025; Carravedo M, 2005, CATALOGO GENETICO PI; DeWitt D., 1996, PEPPERS WORLD IDENTI; Djian-Caporalino C, 2007, GENETIC RESOURCES CH, V3, P185, DOI [10.1201/9781420009569.ch6, DOI 10.1201/9781420009569.CH6]; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Eshbaugh W. H., 1993, New crops., P132; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; FAO, 2010, MEJ GEN REC FIT NUEV; dos Santos ARF, 2011, TREE GENET GENOMES, V7, P1041, DOI 10.1007/s11295-011-0393-3; Geleta LF, 2005, BIODIVERS CONSERV, V14, P2361, DOI 10.1007/s10531-004-1669-9; Greenleaf WH, 1986, BREEDING VEGETABLE C, P67; Hamblin MT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001367; Hammer K, 2003, NATURWISSENSCHAFTEN, V90, P241, DOI 10.1007/s00114-003-0433-4; Hill TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056200; Huang SW, 2001, EUPHYTICA, V117, P163, DOI 10.1023/A:1004059722512; Ibiza VP, 2012, GENET RESOUR CROP EV, V59, P1077, DOI 10.1007/s10722-011-9744-z; Ince AG, 2010, PLANT MOL BIOL REP, V28, P285, DOI 10.1007/s11105-009-0151-y; Ince AG, 2010, BIOCHEM GENET, V48, P83, DOI 10.1007/s10528-009-9297-4; IPGRI AVRDC CATIE, 1995, DESCR CAPS; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jeong HJ, 2010, GENOME, V53, P1029, DOI 10.1139/G10-094; Kang BC, 2001, THEOR APPL GENET, V102, P531, DOI 10.1007/s001220051678; Kim Seungill, 2014, Nat Genet, V46, P270, DOI 10.1038/ng.2877; Kraft KH, 2014, P NATL ACAD SCI USA, V111, P6165, DOI 10.1073/pnas.1308933111; Kumar S, 2006, HANDBOOK OF HERBS AND SPICES, VOL 3, P299, DOI 10.1533/9781845691717.3.299; Lanteri S, 2003, GENET RESOUR CROP EV, V50, P723, DOI 10.1023/A:1025075118200; Lanteri S., 1993, Euphytica, V67, P155, DOI 10.1007/BF00022739; Lee JM, 2004, THEOR APPL GENET, V108, P619, DOI 10.1007/s00122-003-1467-x; LEFEBVRE V, 1993, EUPHYTICA, V71, P189, DOI 10.1007/BF00040408; McLeod M. J., 1979, The biology and taxonomy of the Solanaceae, P701; Mimura Y, 2012, BREEDING SCI, V62, P93, DOI 10.1270/jsbbs.62.93; Minamiyama Y, 2006, MOL BREEDING, V18, P157, DOI 10.1007/s11032-006-9024-3; Moscone EA, 2007, ACTA HORTIC, P137, DOI 10.17660/ActaHortic.2007.745.5; Moses M, 2014, GENET RESOUR CROP EV, V61, P741, DOI 10.1007/s10722-013-0069-y; Nagy I, 2007, GENOME, V50, P668, DOI 10.1139/G07-047; NEI M, 1974, GENETICS, V76, P379; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Nicolai M, 2013, GENET RESOUR CROP EV, V60, P2375, DOI 10.1007/s10722-013-0006-0; Nimmakayala P, 2014, MOL GENET GENOMICS, V289, P513, DOI 10.1007/s00438-014-0827-3; Nuez F., 1996, CULTIVO PIMIENTOS CH; Ogundiwin EA, 2005, GENOME, V48, P698, DOI 10.1139/G05-028; Olmstead RG, 2008, TAXON, V57, P1159, DOI 10.1002/tax.574010; Onus AN, 2004, ANN BOT-LONDON, V94, P289, DOI 10.1093/aob/mch139; Ortiz R, 2010, SCI HORTIC-AMSTERDAM, V126, P186, DOI 10.1016/j.scienta.2010.07.007; Panda Ramesh C., 2004, Cytologia (Tokyo), V69, P203, DOI 10.1508/cytologia.69.203; Paran I, 1998, EUPHYTICA, V99, P167, DOI 10.1023/A:1018301215945; Paran I, 2007, J EXP BOT, V58, P3841, DOI 10.1093/jxb/erm257; Park S.D.E., 2001, TRYPANOTOLERANCE W A; Park SDE, 2001, EXC MICR TOOLK; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Perry L, 2007, SCIENCE, V315, P986, DOI 10.1126/science.1136914; PICKERSGILL B, 1988, BIOL ZBL, V107, P381; Pickersgill B, 1997, EUPHYTICA, V96, P129, DOI 10.1023/A:1002913228101; Pickersgill B., 1991, Chromosome engineering in plants: genetics, breeding, evolution. Part B., P139; Pickersgill B, 2007, ANN BOT-LONDON, V100, P925, DOI 10.1093/aob/mcm193; Porras-Hurtado Liliana, 2013, Frontiers in Genetics, V4, P98, DOI 10.3389/fgene.2013.00098; Portis E, 2007, PLANT SCI, V172, P640, DOI 10.1016/j.plantsci.2006.11.016; Portis E, 2006, CROP SCI, V46, P2517, DOI 10.2135/cropsci2006.04.0216; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Qin C, 2014, P NATL ACAD SCI USA, V111, P5135, DOI 10.1073/pnas.1400975111; R Core Team, 2021, R LANGUAGE ENV STAT; Rai VP, 2013, PHYSIOL MOL BIOL PLA, V19, P575, DOI 10.1007/s12298-013-0185-3; Rodriguez-Maza MJ, 2012, MOL BREEDING, V30, P889, DOI 10.1007/s11032-011-9672-9; Ryzhova NN, 2004, RUSS J GENET+, V40, P892, DOI 10.1023/B:RUGE.0000039723.90902.b0; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Shirasawa K, 2013, MOL BREEDING, V31, P101, DOI 10.1007/s11032-012-9774-z; Sugita T, 2013, MOL BREEDING, V31, P909, DOI 10.1007/s11032-013-9844-x; Tam SM, 2009, THEOR APPL GENET, V119, P973, DOI 10.1007/s00122-009-1102-6; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tong N, 1999, EUPHYTICA, V109, P71, DOI 10.1023/A:1003421217077; van Dooijeweert W, 2010, MEJORA GENETICA RECU, P513; Varshney RK, 2005, TRENDS PLANT SCI, V10, P621, DOI 10.1016/j.tplants.2005.10.004; Votava EJ, 2005, ECON BOT, V59, P8, DOI 10.1663/0013-0001(2005)059[0008:GDOCCA]2.0.CO;2; Walsh BM, 2001, INT J PLANT SCI, V162, P1409, DOI 10.1086/323273; Wu FN, 2009, THEOR APPL GENET, V118, P1279, DOI 10.1007/s00122-009-0980-y; Yi GB, 2006, THEOR APPL GENET, V114, P113, DOI 10.1007/s00122-006-0415-y; Yoon JB, 2006, BREEDING SCI, V56, P31, DOI 10.1270/jsbbs.56.31; Yumnam JS, 2012, PLANT MOL BIOL REP, V30, P1470, DOI 10.1007/s11105-012-0466-y; ZIJLSTRA S, 1991, HORTSCIENCE, V26, P585, DOI 10.21273/HORTSCI.26.5.585	90	34	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e0116276	10.1371/journal.pone.0116276	http://dx.doi.org/10.1371/journal.pone.0116276			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545628	gold, Green Published, Green Submitted			2022-12-27	WOS:000347120200110
J	Hernandez, BY; Goodman, MT; Lynch, CF; Cozen, W; Unger, ER; Steinau, M; Thompson, T; Saber, MS; Altekruse, SF; Lyu, C; Saraiya, M				Hernandez, Brenda Y.; Goodman, Marc T.; Lynch, Charles F.; Cozen, Wendy; Unger, Elizabeth R.; Steinau, Martin; Thompson, Trevor; Saber, Maria Sibug; Altekruse, Sean F.; Lyu, Christopher; Saraiya, Mona		HPV Typing Canc Workgrp	Human Papillomavirus Prevalence in Invasive Laryngeal Cancer in the United States	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMAS; GENDER-DIFFERENCES; ORAL-CAVITY; HPV-DNA; HEAD; RISK; INFECTION; P53; ASSOCIATION; SURVIVAL	Purpose: Human papillomavirus (HPV) is a major risk factor for specific cancers of the head and neck, particularly malignancies of the tonsil and base of the tongue. However, the role of HPV in the development of laryngeal cancer has not been definitively established. We conducted a population-based, cancer registry study to evaluate and characterize the genotype-specific prevalence of HPV in invasive laryngeal cancer cases diagnosed in the U.S. Methods: The presence of genotype-specific HPV DNA was evaluated using the Linear Array HPV Genotyping Test and the INNO-LiPA HPV Genotyping Assay in formalin-fixed paraffin embedded tissue from 148 invasive laryngeal cancer cases diagnosed in 1993-2004 within the catchment area of three U. S. SEER cancer registries. Results: HPV DNA was detected in 31 of 148 (21%) invasive laryngeal cancers. Thirteen different genotypes were detected. Overall, HPV 16 and HPV 33 were the most commonly detected types. HPV was detected in 33% (9/27) of women compared with 18% (22/121) of men (p=0.08). After adjustment for age and year of diagnosis, female patients were more likely to have HPV-positive laryngeal tumors compared to males (adjusted OR 2.84, 95% CI 1.07-7.51). Viral genotype differences were also observed between the sexes. While HPV 16 and 18 constituted half of HPV-positive cases occurring in men, among women, only 1 was HPV 16 positive and none were positive for HPV 18. Overall 5-year survival did not vary by HPV status. Conclusions: HPV may be involved in the development of a subset of laryngeal cancers and its role may be more predominant in women compared to men.	[Hernandez, Brenda Y.] Univ Hawaii, Ctr Canc, Honolulu, HI 96822 USA; [Goodman, Marc T.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Lynch, Charles F.] Univ Iowa, Coll Publ Hlth, Dept Epidemiol, Iowa City, IA USA; [Cozen, Wendy; Saber, Maria Sibug] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, USC Keck Sch Med, Los Angeles, CA 90033 USA; [Cozen, Wendy; Saber, Maria Sibug] Univ So Calif, Dept Prevent Med, USC Keck Sch Med, Los Angeles, CA 90089 USA; [Cozen, Wendy; Saber, Maria Sibug] Univ So Calif, Dept Pathol, USC Keck Sch Med, Los Angeles, CA 90089 USA; [Unger, Elizabeth R.; Steinau, Martin] Ctr Dis Control & Prevent, Div High Consequence Pathogens & Pathol, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA; [Thompson, Trevor; Saraiya, Mona] Ctr Dis Control & Prevent, Div Canc Prevent & Control, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA; [Altekruse, Sean F.] NCI, Div Canc Control & Populat Sci, Rockville, MD USA; [Lyu, Christopher] Battelle Mem Inst, Durham, NC USA	Cancer Research Center of Hawaii; University of Hawaii System; Cedars Sinai Medical Center; University of Iowa; University of Southern California; University of Southern California; University of Southern California; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Hernandez, BY (corresponding author), Univ Hawaii, Ctr Canc, Honolulu, HI 96822 USA.	brenda@cc.hawaii.edu		Goodman, Marc/0000-0002-4839-3021; Rhoda, Dale/0000-0003-0948-1368; Unger, Elizabeth/0000-0002-2925-5635	Centers for Disease Control and Prevention (CDC); SEER Program; National Institutes of Health, Department of Health and Human Services [N01-PC-35139, N01-PC-35143, N01-PC-35137]; CDC intramural funds; Vaccine for Children Funds; California Department of Health Services, California Health and Safety [103885]; NationalCancer Institute, National Institutes of Health, Department of Health and Human Services [N01-PC-2010-00035]; Centers for Disease Control and Prevention [1U58DP000807-3]; NATIONAL CANCER INSTITUTE [P30CA071789] Funding Source: NIH RePORTER; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U58DP000807] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); SEER Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CDC intramural funds; Vaccine for Children Funds; California Department of Health Services, California Health and Safety; NationalCancer Institute, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This project was supported in part by the Centers for Disease Control and Prevention (CDC) and the SEER Program, National Institutes of Health, Department of Health and Human Services, under Contracts N01-PC-35139 (Los Angeles), N01-PC-35143 (Iowa) and N01-PC-35137 (Hawaii). The support for coordination of genotyping data and genotyping was largely supported by CDC intramural funds and Vaccine for Children Funds. The collection of data from California was largely supported by the California Department of Health Services as part of the statewide cancer reporting program mandated by California Health and Safety Code Section 103885; by the NationalCancer Institute, National Institutes of Health, Department of Health and Human Services under Contract N01-PC-2010-00035; and cooperative agreement number 1U58DP000807-3 from the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; ANSINK AC, 1994, GYNECOL ONCOL, V52, P180, DOI 10.1006/gyno.1994.1028; Applebaum KM, 2007, JNCI-J NATL CANCER I, V99, P1801, DOI 10.1093/jnci/djm233; Baumann JL, 2009, LARYNGOSCOPE, V119, P1531, DOI 10.1002/lary.20509; BLOT WJ, 1988, CANCER RES, V48, P3282; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; Chiba I, 1996, ONCOGENE, V12, P1663; DAY GL, 1993, JNCI-J NATL CANCER I, V85, P465, DOI 10.1093/jnci/85.6.465; DERIENZO DP, 1991, ARCH OTOLARYNGOL, V117, P681; Derkay CS, 2008, LARYNGOSCOPE, V118, P1236, DOI 10.1097/MLG.0b013e31816a7135; Fakhry C, 2008, JNCI-J NATL CANCER I, V100, P261, DOI 10.1093/jnci/djn011; Fakhry C, 2006, J CLIN ONCOL, V24, P2606, DOI 10.1200/JCO.2006.06.1291; FOURET P, 1995, DIAGN MOL PATHOL, V4, P122, DOI 10.1097/00019606-199506000-00008; Fritz A, 2000, INT CLASSIFICATION D; Gargano JW, 2012, J LOW GENIT TRACT DI, V16, P471, DOI 10.1097/LGT.0b013e3182472947; Gillison ML, 2008, JNCI-J NATL CANCER I, V100, P407, DOI 10.1093/jnci/djn025; Gillison Maura L., 1999, Current Opinion in Oncology, V11, P191, DOI 10.1097/00001622-199905000-00010; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Goodman MT, 2005, HUM PATHOL, V36, P812, DOI 10.1016/j.humpath.2005.03.010; Haraf DJ, 1996, CLIN CANCER RES, V2, P755; Heck JE, 2010, INT J EPIDEMIOL, V39, P166, DOI 10.1093/ije/dyp350; Howlader N, 2014, SEER CANC STAT REV 1; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2007, IARC Monogr Eval Carcinog Risks Hum, V90, P1; Igissinov N, 2013, ASIAN PAC J CANCER P, V14, P7033, DOI 10.7314/APJCP.2013.14.11.7033; International Agency for Researchon Cancer(IARC), 2005, WORK GROUP EV CARC R, V90; KOKOSKA MS, 1995, ANN OTO RHINOL LARYN, V104, P419, DOI 10.1177/000348949510400601; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Kumar B, 2008, J CLIN ONCOL, V26, P3128, DOI 10.1200/JCO.2007.12.7662; de Souza DLB, 2011, CANCER EPIDEMIOL, V35, P328, DOI 10.1016/j.canep.2011.02.003; Li W, 2003, INT J CANCER, V106, P553, DOI 10.1002/ijc.11261; Licitra L, 2006, J CLIN ONCOL, V24, P5630, DOI 10.1200/JCO.2005.04.6136; Lont AP, 2006, INT J CANCER, V119, P1078, DOI 10.1002/ijc.21961; Lortet-Tieulent J, 2013, EUR J CANC; Lubin JH, 2011, CANCER CAUSE CONTROL, V22, P1217, DOI 10.1007/s10552-011-9792-x; Ma XL, 1998, J MED VIROL, V54, P186, DOI 10.1002/(SICI)1096-9071(199803)54:3&lt;186::AID-JMV8&gt;3.0.CO;2-1; Mellin H, 2000, INT J CANCER, V89, P300, DOI 10.1002/1097-0215(20000520)89:3<300::AID-IJC14>3.0.CO;2-G; MONK BJ, 1995, OBSTET GYNECOL, V85, P709, DOI 10.1016/0029-7844(95)00045-S; Morshed K, 2010, J MED VIROL, V82, P1017, DOI 10.1002/jmv.21749; Munoz N, 2006, VACCINE, V24, P1, DOI 10.1016/j.vaccine.2006.05.115; Piccirillo J. F., 2007, SEER SURVIVAL MONOGR; Pintos J, 1999, CANCER-AM CANCER SOC, V85, P1903, DOI 10.1002/(SICI)1097-0142(19990501)85:9<1903::AID-CNCR4>3.0.CO;2-6; Reimers N, 2007, INT J CANCER, V120, P1731, DOI 10.1002/ijc.22355; Ritchie JM, 2003, INT J CANCER, V104, P336, DOI 10.1002/ijc.10960; Schwartz SR, 2001, OTOLARYNG HEAD NECK, V125, P1, DOI 10.1067/mhn.2001.116979; SHIDARA K, 1994, LARYNGOSCOPE, V104, P1008; Steinau M, 2011, J MOL DIAGN, V13, P377, DOI 10.1016/j.jmoldx.2011.03.007; Stephen JK, 2012, OTOLARYNG HEAD NECK, V146, P730, DOI 10.1177/0194599811434482; SUZUKI T, 1994, JPN J CANCER RES, V85, P1087, DOI 10.1111/j.1349-7006.1994.tb02911.x; Syrjanen S, 2005, J CLIN VIROL, V32, pS59, DOI 10.1016/j.jcv.2004.11.017; Vu HL, 2010, CANCER LETT, V288, P149, DOI 10.1016/j.canlet.2009.06.026; Young JL, 2001, NIH PUB	51	30	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115931	10.1371/journal.pone.0115931	http://dx.doi.org/10.1371/journal.pone.0115931			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546150	gold, Green Submitted, Green Published			2022-12-27	WOS:000347120200083
J	Zhao, BY; Xu, P; Jiang, LG; Paaske, B; Kromann-Hansen, T; Jensen, JK; Sorensen, HP; Liu, Z; Nielsen, JT; Christensen, A; Hosseini, M; Sorensen, KK; Nielsen, NC; Jensen, KJ; Huang, MD; Andreasen, PA				Zhao, Baoyu; Xu, Peng; Jiang, Longguang; Paaske, Berit; Kromann-Hansen, Tobias; Jensen, Jan K.; Sorensen, Hans Peter; Liu, Zhuo; Nielsen, Jakob T.; Christensen, Anni; Hosseini, Masood; Sorensen, Kasper K.; Nielsen, Niels Christian; Jensen, Knud J.; Huang, Mingdong; Andreasen, Peter A.			A Cyclic Peptidic Serine Protease Inhibitor: Increasing Affinity by Increasing Peptide Flexibility	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR; UROKINASE; SPECIFICITY; SYSTEM; METASTASIS; LIBRARIES; MECHANISM; CANCER	Peptides are attracting increasing interest as protease inhibitors. Here, we demonstrate a new inhibitory mechanism and a new type of exosite interactions for a phage-displayed peptide library-derived competitive inhibitor, mupain-1 (CPAYSRYLDC), of the serine protease murine urokinase-type plasminogen activator (uPA). We used X-ray crystal structure analysis, site-directed mutagenesis, liquid state NMR, surface plasmon resonance analysis, and isothermal titration calorimetry and wild type and engineered variants of murine and human uPA. We demonstrate that Arg(6) inserts into the S1 specificity pocket, its carbonyl group aligning improperly relative to Ser(195) and the oxyanion hole, explaining why the peptide is an inhibitor rather than a substrate. Substitution of the P1 Arg with novel unnatural Arg analogues with aliphatic or aromatic ring structures led to an increased affinity, depending on changes in both P1 - S1 and exosite interactions. Site-directed mutagenesis showed that exosite interactions, while still supporting high affinity binding, differed substantially between different uPA variants. Surprisingly, high affinity binding was facilitated by Ala-substitution of Asp(9) of the peptide, in spite of a less favorable binding entropy and loss of a polar interaction. We conclude that increased flexibility of the peptide allows more favorable exosite interactions, which, in combination with the use of novel Arg analogues as P1 residues, can be used to manipulate the affinity and specificity of this peptidic inhibitor, a concept different from conventional attempts at improving inhibitor affinity by reducing the entropic burden.	[Zhao, Baoyu; Jiang, Longguang; Huang, Mingdong; Andreasen, Peter A.] Chinese Acad Sci, Fujian Inst Res Struct Matter, Danish Chinese Ctr Proteases & Canc, Fuzhou 350002, Peoples R China; [Xu, Peng; Kromann-Hansen, Tobias; Jensen, Jan K.; Sorensen, Hans Peter; Liu, Zhuo; Christensen, Anni; Andreasen, Peter A.] Aarhus Univ, Danish Chinese Ctr Proteases & Canc, Dept Mol Biol & Genet, Aarhus, Denmark; [Paaske, Berit; Nielsen, Jakob T.; Nielsen, Niels Christian] Univ Aarhus, Nanosci Ctr, Aarhus, Denmark; [Paaske, Berit; Nielsen, Jakob T.; Nielsen, Niels Christian] Univ Aarhus, Dept Chem, Aarhus, Denmark; [Hosseini, Masood; Sorensen, Kasper K.; Jensen, Knud J.] Univ Copenhagen, Dept Chem, Fac Sci, DK-2100 Copenhagen, Denmark	Chinese Academy of Sciences; Fujian Institute of Research on the Structure of Matter, CAS; Aarhus University; Aarhus University; Aarhus University; University of Copenhagen	Andreasen, PA (corresponding author), Chinese Acad Sci, Fujian Inst Res Struct Matter, Danish Chinese Ctr Proteases & Canc, Fuzhou 350002, Peoples R China.	pa@mbg.au.dk	Xu, Peng/GXF-8681-2022; Jensen, Knud J/D-1145-2016; Nielsen, Jakob/E-7993-2017; Huang, Mingdong/J-4278-2017	Xu, Peng/0000-0003-3968-7279; Jensen, Knud J/0000-0003-3525-5452; Nielsen, Jakob/0000-0002-9554-4662; Huang, Mingdong/0000-0003-0085-9141; Jiang, Longguang/0000-0002-4734-3778; Nielsen, Niels Chr./0000-0003-2978-4366	Danish National Research Foundation [26-331-6]; Natural Science Foundation of China [31161130356, 31170707, 31370737]; Natural Science Foundation of the Fujian Province [2012J05071]; Lundbeck Foundation [R83-A7826]; Carlsberg Foundation [2012_01_0642]; Cancer Research Foundation; Chinese Academy of Sciences [2012T1G0023]; Aarhus University Research Foundation [10]	Danish National Research Foundation(Danmarks Grundforskningsfond); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of the Fujian Province(Natural Science Foundation of Fujian Province); Lundbeck Foundation(Lundbeckfonden); Carlsberg Foundation(Carlsberg Foundation); Cancer Research Foundation; Chinese Academy of Sciences(Chinese Academy of Sciences); Aarhus University Research Foundation	This work was supported by the Danish National Research Foundation (http://dg.dk; grant number 26-331-6 to PAA), the Natural Science Foundation of China (http://en.ustc.edu.cn/dictionary/201105/t20110509_111378.html; grant numbers 31161130356, 31170707, 31370737 to M. Huang), the Natural Science Foundation of the Fujian Province (grant number 2012J05071 to M. Huang), the Lundbeck Foundation (http://www.lundbeckfoundation.com; grant number R83-A7826 to PAA), the Carlsberg Foundation (http://www.carlsbergfondet.dk; grant number 2012_01_0642 to PAA), and the Cancer Research Foundation of 1989 (to PAA). PAA was awarded a Chinese Academy of Sciences visiting professorship for senior international scientists (grant number 2012T1G0023). M. Huang was awarded an Aarhus University Research Foundation visiting professorship (reference number 10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen LM, 2008, BIOCHEM J, V412, P447, DOI 10.1042/BJ20071646; Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z; Andreasen PA, 2000, CELL MOL LIFE SCI, V57, P25, DOI 10.1007/s000180050497; Angelini A, 2012, ACS CHEM BIOL, V7, P817, DOI 10.1021/cb200478t; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chen SY, 2013, J AM CHEM SOC, V135, P6562, DOI 10.1021/ja400461h; DANO K, 1985, ADV CANCER RES, V44, P139, DOI 10.1016/S0065-230X(08)60028-7; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Demmer O, 2009, DESIGN PEPTIDES PROT, P133; Drag M, 2010, NAT REV DRUG DISCOV, V9, P690, DOI 10.1038/nrd3053; ELLIS V, 1991, J BIOL CHEM, V266, P12752; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FURIE B, 1988, CELL, V53, P505, DOI 10.1016/0092-8674(88)90567-3; Hajdin K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010445; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Heinis C, 2009, NAT CHEM BIOL, V5, P502, DOI 10.1038/nchembio.184; Hosseini M, 2011, MOL PHARMACOL, V80, P585, DOI 10.1124/mol.111.072280; Jiang LG, 2011, J MOL BIOL, V412, P235, DOI 10.1016/j.jmb.2011.07.028; Kjaergaard M, 2011, J BIOMOL NMR, V49, P139, DOI 10.1007/s10858-011-9472-x; KOIVUNEN E, 1994, METHOD ENZYMOL, V245, P346; Lin ZH, 2011, J BIOL CHEM, V286, P7027, DOI 10.1074/jbc.M110.204537; Nielsen HM, 2009, CHALLENGES DELIVERY, P1; Otwinowski Z., 1997, PROCESSING XRAY DIFF, P307; Puente Xose S., 2008, P3, DOI 10.1007/978-0-387-69057-5_1; Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111; Roodbeen R, 2013, CHEMBIOCHEM; Schubert M, 2002, J BIOMOL NMR, V24, P149, DOI 10.1023/A:1020997118364; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; SPRAGGON G, 1995, STRUCTURE, V3, P681, DOI 10.1016/S0969-2126(01)00203-9; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Zhao GX, 2007, J STRUCT BIOL, V160, P1, DOI 10.1016/j.jsb.2007.06.003	32	35	35	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115872	10.1371/journal.pone.0115872	http://dx.doi.org/10.1371/journal.pone.0115872			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545505	Green Published, gold, Green Submitted			2022-12-27	WOS:000347120200077
J	Kao, LT; Lee, CZ; Liu, SP; Tsai, MC; Lin, HC				Kao, Li-Ting; Lee, Cha-Ze; Liu, Shih-Ping; Tsai, Ming-Chieh; Lin, Herng-Ching			Psoriasis and the Risk of Pneumonia: A Population-Based Study	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; OBSTRUCTIVE PULMONARY-DISEASE; METABOLIC SYNDROME; IFN-GAMMA; COMORBIDITIES; HOSPITALIZATION; EPIDEMIOLOGY; SEVERITY; DATABASE; MODERATE	Background: Psoriasis is a prevalent autoimmune disorder. Various studies have reported on the relationship between psoriasis and chronic diseases but very few have explored the association between psoriasis and subsequent acute infection. This retrospective cohort study aimed to compare the risk of pneumonia between subjects with and those without psoriasis. Methods: The medical records of 14,022 patients with psoriasis and 14,022 without psoriasis were obtained from the Taiwan Longitudinal Health Insurance Database 2000. Each patient was followed-up for a three-year period. Cox proportional hazard regressions were performed to compare difference of subsequent pneumonia incidence between subjects with and those without psoriasis. Results: There were 206 (1.47%) subjects with psoriasis and 138 (0.98%) without psoriasis hospitalized for pneumonia. By Cox proportional hazard regressions analysis, the HR (hazard ratio) of pneumonia requiring hospitalization for patients with psoriasis was 1.50 (95% confidence interval [CI]: 1.21-1.86) compared to patients without psoriasis. The adjusted HR was 1.40 (95% CI: 1.12-1.73). The adjusted HR of pneumonia hospitalization for subjects with mild and severe psoriasis was 1.36 (95% CI: 1.09-1.70) and 1.68 (95% CI: 1.12-2.52), respectively, compared to those without psoriasis. Conclusions: Patients with psoriasis have significantly higher incidence of pneumonia compared to those without psoriasis.	[Kao, Li-Ting] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Kao, Li-Ting; Lin, Herng-Ching] Taipei Med Univ Hosp, Sleep Res Ctr, Taipei, Taiwan; [Lee, Cha-Ze] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Liu, Shih-Ping] Natl Taiwan Univ Hosp, Dept Urol, Taipei 100, Taiwan; [Liu, Shih-Ping] Coll Med, Taipei, Taiwan; [Tsai, Ming-Chieh] Cathay Gen Hosp, Dept Internal Med, Div Gastroenterol, Taipei, Taiwan; [Tsai, Ming-Chieh; Lin, Herng-Ching] Taipei Med Univ, Sch Hlth Care Adm, Taipei, Taiwan	National Defense Medical Center; Taipei Medical University; Taipei Medical University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Cathay General Hospital; Taipei Medical University	Tsai, MC (corresponding author), Cathay Gen Hosp, Dept Internal Med, Div Gastroenterol, Taipei, Taiwan.	tsaimj106@yahool.com.tw	Kao, Li-Ting/W-9287-2018	Kao, Li-Ting/0000-0003-0692-7408; LIU, SHIH-PING/0000-0002-8015-0695				Almirall J, 2008, EUR RESPIR J, V31, P1274, DOI 10.1183/09031936.00095807; Arican O, 2005, MEDIAT INFLAMM, P273, DOI 10.1155/MI.2005.273; Baik I, 2000, ARCH INTERN MED, V160, P3082, DOI 10.1001/archinte.160.20.3082; Barlow GD, 2003, LANCET INFECT DIS, V3, P476, DOI 10.1016/S1473-3099(03)00721-7; Barnes PJ, 2008, J CLIN INVEST, V118, P3546, DOI 10.1172/JCI36130; Chandran V, 2010, J AUTOIMMUN, V34, pJ314, DOI 10.1016/j.jaut.2009.12.001; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Davidovici BB, 2010, J INVEST DERMATOL, V130, P1785, DOI 10.1038/jid.2010.103; Dreiher J, 2008, BRIT J DERMATOL, V159, P956, DOI 10.1111/j.1365-2133.2008.08749.x; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Fernandez-Real JM, 2003, ENDOCR REV, V24, P278, DOI 10.1210/er.2002-0010; Gottlieb AB, 2008, J DERMATOL TREAT, V19, P5, DOI 10.1080/09546630701364768; Gottlieb AB, 2009, AM J MED, V122, DOI 10.1016/j.amjmed.2009.06.021; Green MS, 1996, J AM ACAD DERMATOL, V34, P911, DOI 10.1016/S0190-9622(96)90078-X; Gutierrez F, 2008, DRUG AGING, V25, P585, DOI 10.2165/00002512-200825070-00005; Kalb RE, 2009, J AM ACAD DERMATOL, V60, P824, DOI 10.1016/j.jaad.2008.11.906; Kang JH, 2010, ANN RHEUM DIS, V69, P1165, DOI 10.1136/ard.2009.116178; Kieseier BC, 2012, AUTOIMMUN REV, V11, P191, DOI 10.1016/j.autrev.2011.05.011; Langley RGB, 2005, ANN RHEUM DIS, V64, P18, DOI 10.1136/ard.2004.033217; LINDEGARD B, 1986, DERMATOLOGICA, V172, P298, DOI 10.1159/000249365; Polverino E, 2011, MINERVA ANESTESIOL, V77, P196; Raychaudhuri SK, 2014, AUTOIMMUN REV, V13, P490, DOI 10.1016/j.autrev.2014.01.008; Schmitt J, 2005, DERMATOLOGY, V210, P194, DOI 10.1159/000083509; Smith ECA, 2008, INT J DERMATOL, V47, P514, DOI 10.1111/j.1365-4632.2008.03470.x; Sommer DM, 2006, ARCH DERMATOL RES, V298, P321, DOI 10.1007/s00403-006-0703-z; Stern RS, 2004, J INVEST DERM SYMP P, V9, P136, DOI 10.1046/j.1087-0024.2003.09102.x; Szegedi A, 2003, IMMUNOL LETT, V86, P277, DOI 10.1016/S0165-2478(03)00025-7; Takahashi H, 2010, CLIN EXP DERMATOL, V35, P645, DOI 10.1111/j.1365-2230.2009.03704.x; Tsai TF, 2011, J DERMATOL SCI, V63, P40, DOI 10.1016/j.jdermsci.2011.03.002; Wakkee M, 2011, J AM ACAD DERMATOL, V65, P1135, DOI 10.1016/j.jaad.2010.08.036; Wakkee M, 2009, DERMATOL CLIN, V27, P137, DOI 10.1016/j.det.2008.11.013; Yende S, 2005, AM J RESP CRIT CARE, V172, P1440, DOI 10.1164/rccm.200506-888OC; Yu AP, 2009, CURR MED RES OPIN, V25, P2429, DOI 10.1185/03007990903185557	33	28	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e116077	10.1371/journal.pone.0116077	http://dx.doi.org/10.1371/journal.pone.0116077			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541712	Green Submitted, gold, Green Published			2022-12-27	WOS:000347239900139
J	Takagi, Y; Matsuda, H; Taniguchi, Y; Iwaisaki, H				Takagi, Yu; Matsuda, Hirokazu; Taniguchi, Yukio; Iwaisaki, Hiroaki			Predicting the Phenotypic Values of Physiological Traits Using SNP Genotype and Gene Expression Data in Mice	PLOS ONE			English	Article							HETEROGENEOUS STOCK MICE; COMPLEX TRAITS; MOLECULAR MARKERS; GENOME; SELECTION; PEDIGREE; LASSO	Predicting phenotypes using genome-wide genetic variation and gene expression data is useful in several fields, such as human biology and medicine, as well as in crop and livestock breeding. However, for phenotype prediction using gene expression data for mammals, studies remain scarce, as the available data on gene expression profiling are currently limited. By integrating a few sources of relevant data that are available in mice, this study investigated the accuracy of phenotype prediction for several physiological traits. Gene expression data from two tissues as well as single nucleotide polymorphisms (SNPs) were used. For the studied traits, the variance of the effects of the expression levels was more likely to differ among the genes than were the effects of SNPs. For the glucose concentration, the total cholesterol amount, and the total tidal volume, the accuracy by cross validation tended to be higher when the gene expression data rather than the SNP genotype data were used, and a statistically significant increase in the accuracy was obtained when the gene expression data from the liver were used alone or jointly with the SNP genotype data. For these traits, there were no additional gains in accuracy from using the gene expression data of both the liver and lung compared to that of individual use. The accuracy of prediction using genes that were selected differently was examined; the use of genes with a higher tissue specificity tended to result in an accuracy that was similar to or greater than that associated with the use of all of the available genes for traits such as the glucose concentration and total cholesterol amount. Although relatively few animals were evaluated, the current results suggest that gene expression levels could be used as explanatory variables. However, further studies are essential to confirm our findings using additional animal samples.	[Takagi, Yu; Matsuda, Hirokazu; Taniguchi, Yukio; Iwaisaki, Hiroaki] Kyoto Univ, Grad Sch Agr, Kyoto 6068502, Japan	Kyoto University	Matsuda, H (corresponding author), Kyoto Univ, Grad Sch Agr, Kyoto 6068502, Japan.	hmatsuda@kais.kyoto-u.ac.jp			Japan Society for the Promotion of Science (JSPS), Japan [25850185]; Grants-in-Aid for Scientific Research [25850185] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding: This research was supported by the Grant-in-Aid for Young Scientists B (25850185) of the Japan Society for the Promotion of Science (JSPS), Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Bair E, 2006, J AM STAT ASSOC, V101, P119, DOI 10.1198/016214505000000628; Barbosa-Morais NL, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp942; Bhattacharjee M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026959; Chen BJ, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.69; Chen Z, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002956; Cheung VG, 2003, NAT GENET, V33, P422, DOI 10.1038/ng1094; Christensen OF, 2012, ANIMAL, V6, P1565, DOI 10.1017/S1751731112000742; de los Campos G, 2009, GENETICS, V182, P375, DOI 10.1534/genetics.109.101501; Donitz J, 2008, NUCLEIC ACIDS RES, V36, pD689, DOI 10.1093/nar/gkm940; DUNN OJ, 1971, J AM STAT ASSOC, V66, P904, DOI 10.2307/2284252; Ehsani A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-456; Fu JY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002431; Gilbert S.F., 2003, DEV BIOL, V7th Edn; Hu XL, 2011, AM J HUM GENET, V89, P496, DOI 10.1016/j.ajhg.2011.09.002; Huang GJ, 2009, GENOME RES, V19, P1133, DOI 10.1101/gr.088120.108; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Lee SH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000231; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; O'Hara RB, 2009, BAYESIAN ANAL, V4, P85, DOI 10.1214/09-BA403; Ober U, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002685; Park T, 2008, J AM STAT ASSOC, V103, P681, DOI 10.1198/016214508000000337; Pedroso I, 2011, COLD SPRING HARBOR P, V2011; Perez P, 2010, PLANT GENOME-US, V3, P106, DOI 10.3835/plantgenome2010.04.0005; Ruderfer DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006907; Solberg LC, 2006, MAMM GENOME, V17, P129, DOI 10.1007/s00335-005-0112-1; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Valdar W, 2006, GENETICS, V174, P959, DOI 10.1534/genetics.106.060004; Valdar W, 2006, NAT GENET, V38, P879, DOI 10.1038/ng1840; van Wieringen WN, 2009, COMPUT STAT DATA AN, V53, P1590, DOI 10.1016/j.csda.2008.05.021; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Visscher PM, 2010, HFSP J, V4, P6, DOI 10.2976/1.3292182; Yanai I, 2006, TRENDS GENET, V22, P132, DOI 10.1016/j.tig.2006.01.006	38	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115532	10.1371/journal.pone.0115532	http://dx.doi.org/10.1371/journal.pone.0115532			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541966	Green Published, gold, Green Submitted			2022-12-27	WOS:000347239900050
J	Choi, DH; Kim, JH; Seo, JH; Lee, J; Choi, WS; Kim, YS				Choi, Dong-Hee; Kim, Ji-Hye; Seo, Joo-Ha; Lee, Jongmin; Choi, Wahn Soo; Kim, Yoon-Seong			Matrix Metalloproteinase-3 Causes Dopaminergic Neuronal Death through Nox1-Regenerated Oxidative Stress	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CENTRAL-NERVOUS-SYSTEM; NADPH OXIDASE ACTIVITY; SMOOTH-MUSCLE-CELLS; PARKINSONS-DISEASE; REACTIVE OXYGEN; ALPHA-SYNUCLEIN; NOX ENZYMES; SUBSTANTIA-NIGRA; CROSS-TALK	In the present study we investigated the interplay between matrix metalloproteinase 3 (MMP3) and NADPH oxidase 1 (Nox1) in the process of dopamine (DA) neuronal death. We found that MMP3 activation causes the induction of Nox1 via mitochondrial reactive oxygen species (ROS) production and subsequently Rac1 activation, eventually leading to Nox1-derived superoxide generation in a rat DA neuronal N27 cells exposed to 6-OHDA. While a MMP3 inhibitor, NNGH, largely attenuated mitochondrial ROS and subsequent Nox1 induction, both apocynin, a putative Nox inhibitor and GKT137831, a Nox1 selective inhibitor failed to reduce 6-OHDA-induced mitochondrial ROS. However, both inhibitors for MMP3 and Nox1 similarly attenuated 6-OHDA-induced N27 cell death. RNAi-mediated selective inhibition of MMP3 or Nox1 showed that knockdown of either MMP3 or Nox1 significantly reduced 6-OHDA-induced ROS generation in N27 cells. While 6-OHDA-induced Nox1 was abolished by MMP3 knockdown, Nox1 knockdown did not alter MMP3 expression. Direct overexpression of autoactivated MMP3 (actMMP3) in N27 cells or in rat substantia nigra (SN) increased expression of Nox1. Selective knockdown of Nox1 in the SN achieved by adeno-associated virus-mediated overexpression of Nox1-specific shRNA largely attenuated the actMMP3-mediated dopaminergic neuronal loss. Furthermore, Nox1 expression was significantly attenuated in Mmp3 null mice treated with N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Together we established novel molecular mechanisms underlying oxidative stress-mediated dopaminergic neuronal death in which MMP3 activation is a key upstream event that leads to mitochondrial ROS, Nox1 induction and eventual dopaminergic neuronal death. Our findings may lead to the development of novel therapeutic approach.	[Choi, Dong-Hee; Kim, Ji-Hye; Seo, Joo-Ha; Lee, Jongmin] Konkuk Univ, Inst Biomed Sci & Technol, Neurosci Res Ctr, Seoul 143701, South Korea; [Choi, Dong-Hee] Konkuk Univ, Sch Med, Dept Med Sci, Seoul 143701, South Korea; [Lee, Jongmin] Konkuk Univ, Sch Med, Dept Rehabil Med, Seoul 143701, South Korea; [Choi, Wahn Soo] Konkuk Univ, Coll Med, Funct Genom Inst, Dept Immunol & Physiol, Chungju 380701, South Korea; [Kim, Yoon-Seong] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32827 USA	Konkuk University; Konkuk University Medical Center; Konkuk University; Konkuk University Medical Center; Konkuk University; Konkuk University Medical Center; Konkuk University; Konkuk University Medical Center; State University System of Florida; University of Central Florida	Choi, DH (corresponding author), Konkuk Univ, Inst Biomed Sci & Technol, Neurosci Res Ctr, Seoul 143701, South Korea.	dchoi@konkuk.ac.kr; yskim@mail.ucf.edu	Lee, Jongmin/Q-4909-2019	Lee, Jongmin/0000-0001-8718-0099	National Research Foundation of Korea (NRF) grant - Korea government (MEST) [2011-0017016]; Korean Health Technology R&F Project, Ministry of Health & Welfare, Republic of Korea [A090123]; National Institutes of Health [RO1 NS062827]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062827] Funding Source: NIH RePORTER	National Research Foundation of Korea (NRF) grant - Korea government (MEST); Korean Health Technology R&F Project, Ministry of Health & Welfare, Republic of Korea; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) No. 2011-0017016 (DHC) and a grant of the Korean Health Technology R&F Project, Ministry of Health & Welfare, Republic of Korea No. A090123 (DHC) and the National Institutes of Health grant RO1 NS062827 (YSK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam ZI, 1997, J NEUROCHEM, V69, P1326; Andres-Mateos E, 2007, P NATL ACAD SCI USA, V104, P14807, DOI 10.1073/pnas.0703219104; Aoyama T, 2012, HEPATOLOGY, V56, P2316, DOI 10.1002/hep.25938; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bokoch GM, 2002, BLOOD, V100, P2692, DOI 10.1182/blood-2002-04-1149; Choi DH, 2008, J NEUROCHEM, V106, P405, DOI 10.1111/j.1471-4159.2008.05399.x; Choi DH, 2012, ANTIOXID REDOX SIGN, V16, P1033, DOI 10.1089/ars.2011.3960; Choi DH, 2011, ANTIOXID REDOX SIGN, V14, P2137, DOI 10.1089/ars.2009.3059; Choi DH, 2011, J BIOL CHEM, V286, P14168, DOI 10.1074/jbc.M111.222430; Chung YC, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/370526; Cristovao AC, 2009, ANTIOXID REDOX SIGN, V11, P2105, DOI [10.1089/ars.2009.2459, 10.1089/ARS.2009.2459]; Cristovao AC, 2012, J NEUROSCI, V32, P14465, DOI 10.1523/JNEUROSCI.2246-12.2012; Debbabi M, 2013, FASEB J, V27, P1733, DOI 10.1096/fj.12-216432; Desouki MM, 2005, CANCER BIOL THER, V4, P1367, DOI 10.4161/cbt.4.12.2233; DEXTER DT, 1989, J NEUROCHEM, V52, P381, DOI 10.1111/j.1471-4159.1989.tb09133.x; Flex A, 2006, J GERONTOL A-BIOL, V61, P1065, DOI 10.1093/gerona/61.10.1065; GRIENDLING KK, 1994, CIRC RES, V74, P1141, DOI 10.1161/01.RES.74.6.1141; Guo SZ, 2006, BRAIN RES, V1111, P222, DOI 10.1016/j.brainres.2006.06.041; Harraz MM, 2008, J CLIN INVEST, V118, P659, DOI 10.1172/JCI34060; Heymes C, 2003, J AM COLL CARDIOL, V41, P2164, DOI 10.1016/S0735-1097(03)00471-6; Jellinger KA, 2002, J NEURAL TRANSM-SUPP, P347; Katsuyama M, 2005, BIOCHEM J, V386, P255, DOI 10.1042/BJ20041180; Kim EM, 2014, BIOCH BIOPHYS RES CO; Kim EM, 2010, J BIOL CHEM, V285, P16444, DOI 10.1074/jbc.M109.093799; Kim ST, 2010, NEUROCHEM INT, V56, P161, DOI 10.1016/j.neuint.2009.09.014; Kim YS, 2007, FASEB J, V21, P179, DOI 10.1096/fj.06-5865com; Kuroda J, 2005, GENES CELLS, V10, P1139, DOI 10.1111/j.1365-2443.2005.00907.x; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lee K, 2012, MOL BIOL CELL, V23, P4097, DOI 10.1091/mbc.E12-02-0166; Lee SB, 2006, J BIOL CHEM, V281, P36228, DOI 10.1074/jbc.M606702200; Levin J, 2009, EXP NEUROL, V215, P201, DOI 10.1016/j.expneurol.2008.10.010; Lokkegaard A, 2001, HIPPOCAMPUS, V11, P726, DOI 10.1002/hipo.1088; Lorenzl S, 2002, EXP NEUROL, V178, P13, DOI 10.1006/exnr.2002.8019; Lu WQ, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001326; Miller JP, 2010, NEURON, V67, P199, DOI 10.1016/j.neuron.2010.06.021; Nayernia Z, 2013, ANTIOXID REDOX SIGNA; Nelson CM, 2008, J CELL BIOCHEM, V105, P25, DOI 10.1002/jcb.21821; PRASAD KN, 1994, IN VITRO CELL DEV-AN, V30A, P596; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; SIMS NR, 1990, J NEUROCHEM, V55, P698, DOI 10.1111/j.1471-4159.1990.tb04189.x; Sorce S, 2009, ANTIOXID REDOX SIGN, V11, P2481, DOI [10.1089/ars.2009.2578, 10.1089/ARS.2009.2578]; Sorce S, 2012, CELL MOL LIFE SCI, V69, P2387, DOI 10.1007/s00018-012-1014-5; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Sung JY, 2005, J BIOL CHEM, V280, P25216, DOI 10.1074/jbc.M503341200; Wojtera M, 2005, FOLIA NEUROPATHOL, V43, P311; Wosniak J, 2009, ANTIOXID REDOX SIGN, V11, P1265, DOI 10.1089/ars.2009.2392; Zhang J, 1999, AM J PATHOL, V154, P1423, DOI 10.1016/S0002-9440(10)65396-5	47	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115954	10.1371/journal.pone.0115954	http://dx.doi.org/10.1371/journal.pone.0115954			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536219	Green Published, gold			2022-12-27	WOS:000348563300093
J	Chong, Y; Zhang, J; Guo, XZ; Li, GJ; Zhang, SQ; Li, C; Jiao, ZJ; Shao, M				Chong, Yang; Zhang, Jie; Guo, Xinzhen; Li, Guojun; Zhang, Shiqian; Li, Chao; Jiao, Zhijian; Shao, Ming			MicroRNA-503 Acts as a Tumor Suppressor in Osteosarcoma by Targeting L1CAM	PLOS ONE			English	Article							REGULATES METASTATIC FUNCTION; GASTRIC-CANCER; HEPATOCELLULAR-CARCINOMA; CYCLIN D1; CELL; PROGRESSION; PROLIFERATION; EXPRESSION; MOTILITY; INVASION	Deregulated microRNAs and their roles in tumorigenesis have attracted much attention in recent years. Although miR-503 was shown to be important in tumorigenesis, its role in osteosarcoma remains unknown. In this study, we focused on the expression and mechanisms of miR-503 in osteosarcoma development. We found that miR-503 was down-regulated in osteosarcoma cell lines and primary tumor samples, and the restoration of miR-503 reduced cell proliferation, migration and invasion. Low level of miR-503 in patients with osteosarcoma was associated with considerably shortened disease-free survival. Furthermore, bioinformatic prediction and experimental validation revealed that the anti-tumor effect of miR-503 was probably exerted through targeting and repressing of L1CAM expression. L1CAM was up-regulated in osteosarcoma cell lines and primary tumor samples and the expression level of L1CAM were negatively correlated with miR-503 levels in osteosarcoma tissues. Collectively, our data identify the important roles of miR-503 in osteosarcoma pathogenesis, indicating its potential application in cancer therapy.	[Chong, Yang; Zhang, Jie; Guo, Xinzhen; Li, Guojun; Zhang, Shiqian; Li, Chao; Jiao, Zhijian; Shao, Ming] Harbin Med Univ, Affiliated Hosp 1, Dept Orthoped Surg, Harbin 150001, Heilongjiang Pr, Peoples R China	Harbin Medical University	Shao, M (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Dept Orthoped Surg, 23 Youzheng St, Harbin 150001, Heilongjiang Pr, Peoples R China.	fj3q3q@yeah.net			National Natural Science Foundation of Heilongjiang Province [H201308]	National Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province)	The work was supported by National Natural Science Foundation of Heilongjiang Province (H201308). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen DL, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-43; Chen L, 2013, FEBS LETT, V587, P1366, DOI 10.1016/j.febslet.2013.03.007; Donadeu FX, 2013, DOMEST ANIM ENDOCRIN, V45, P122, DOI 10.1016/j.domaniend.2013.06.006; Gigek CO, 2012, EPIGENOMICS-UK, V4, P279, DOI [10.2217/EPI.12.22, 10.2217/epi.12.22]; Grage-Griebenow E, 2014, MOL ONCOL, V8, P982, DOI 10.1016/j.molonc.2014.03.001; Held-Feindt J, 2012, NEUROCHEM INT, V61, P1183, DOI 10.1016/j.neuint.2012.08.011; Hoja-Lukowicz D, 2013, GLYCOCONJUGATE J, V30, P205, DOI 10.1007/s10719-012-9374-5; Hughes DPM, 2009, CANCER TREAT RES, V152, P479, DOI 10.1007/978-1-4419-0284-9_28; Ito T, 2014, ANN SURG ONCOL, V21, P560, DOI 10.1245/s10434-013-3246-5; Jiang Q, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-194; Jones KB, 2012, CANCER RES, V72, P1865, DOI 10.1158/0008-5472.CAN-11-2663; Karakatsanis A, 2013, MOL CARCINOGEN, V52, P297, DOI 10.1002/mc.21864; Kiefel H, 2012, CELL ADHES MIGR, V6, P374, DOI 10.4161/cam.20832; Kobayashi Eisuke, 2012, Sarcoma, V2012, P359739, DOI 10.1155/2012/359739; Liang WQ, 2013, FRONT BIOSCI-LANDMRK, V18, P788, DOI 10.2741/4142; Long XH, 2013, EXP THER MED, V5, P1048, DOI 10.3892/etm.2013.959; Namlos HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048086; Rainusso N, 2013, CURR ONCOL REP, V15, P296, DOI 10.1007/s11912-013-0321-9; Schafer MKE, 2012, CELL TISSUE RES, V349, P39, DOI 10.1007/s00441-012-1345-4; Schafer MKE, 2010, CELL MOL LIFE SCI, V67, P2425, DOI 10.1007/s00018-010-0339-1; Schirmer U, 2014, ONCOTARGET, V5, P462, DOI 10.18632/oncotarget.1552; Wang TS, 2014, CHINESE MED J-PEKING, V127, P2357, DOI 10.3760/cma.j.issn.0366-6999.20140318; Xiao FQ, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-195; Xu YY, 2013, FEBS J, V280, P3768, DOI 10.1111/febs.12365; Yang JL, 2013, CURR OPIN ONCOL, V25, P398, DOI 10.1097/CCO.0b013e3283622c1b; Yi YS, 2014, PHARMAZIE, V69, P461, DOI 10.1691/ph.2014.3880; Zhou J, 2014, J SURG RES, V188, P129, DOI 10.1016/j.jss.2013.12.006; Zhou J, 2011, J SURG ONCOL, V104, P278, DOI 10.1002/jso.21941; Zhu WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087780	29	55	57	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e114585	10.1371/journal.pone.0114585	http://dx.doi.org/10.1371/journal.pone.0114585			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536034	Green Published, Green Submitted, gold			2022-12-27	WOS:000348563300016
J	Liu, LF; Lai, YY; Cheng, JP; Wang, L; Du, WL; Wang, ZF; Zhang, HS				Liu, Liangfeng; Lai, Yanyan; Cheng, Jinping; Wang, Ling; Du, Wenli; Wang, Zhoufei; Zhang, Hongsheng			Dynamic Quantitative Trait Locus Analysis of Seed Vigor at Three Maturity Stages in Rice	PLOS ONE			English	Article							LOW-TEMPERATURE GERMINABILITY; DESICCATION-TOLERANCE; PHYSIOLOGICAL-CHANGES; MOLECULAR DISSECTION; GENETIC ARCHITECTURE; GRAIN; QTLS; GERMINATION; DORMANCY; GROWTH	Seed vigor is an important characteristic of seed quality. In this study, one rice population of recombinant inbred lines (RILs) was used to determine the genetic characteristics of seed vigor, including the germination potential, germination rate, germination index and time for 50% of germination, at 4 (early), 5 (middle) and 6 weeks (late) after heading in two years. A total of 24 additive and 9 epistatic quantitative trait loci (QTL) for seed vigor were identified using QTL Cartographer and QTLNetwork program respectively in 2012; while 32 simple sequence repeat (SSR) markers associated with seed vigor were detected using bulked segregant analysis (BSA) in 2013. The additive, epistatic and QTL x development interaction effects regulated the dry maturity developmental process to improve seed vigor in rice. The phenotypic variation explained by each additive, epistatic QTL and QTL x development interaction ranged from 5.86 to 40.67%, 4.64 to 11.28% and 0.01 to 1.17%, respectively. The QTLs were rarely co-localized among the different maturity stages; more QTLs were expressed at the early maturity stage followed by the late and middle stages. Twenty additive QTLs were stably expressed in two years which might play important roles in establishment of seed vigor in different environments. By comparing chromosomal positions of these stably expressed additive QTLs with those previously identified, the regions of QTL for seed vigor are likely to coincide with QTL for grain size, low temperature germinability and seed dormancy; while 5 additive QTL might represent novel genes. Using four selected RILs, three cross combinations of seed vigor for the development of RIL populations were predicted; 19 elite alleles could be pyramided by each combination.	[Liu, Liangfeng; Lai, Yanyan; Cheng, Jinping; Wang, Ling; Du, Wenli; Wang, Zhoufei; Zhang, Hongsheng] Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Lab Seed Sci & Technol, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Wang, ZF (corresponding author), Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Lab Seed Sci & Technol, Nanjing, Jiangsu, Peoples R China.	wzf@njau.edu.cn; hszhang@njau.edu.cn			National Natural Science Foundation of China [31271806, 31000748]; Fundamental Research Funds for the Central Universities [KYZ201402, KYZ201202-9]; Special Fund for Agro-scientific Research in the Public Interest [201203052]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Special Fund for Agro-scientific Research in the Public Interest	This work was supported by the National Natural Science Foundation of China (Grant No. 31271806; 31000748), the Fundamental Research Funds for the Central Universities (Grant No. KYZ201402; KYZ201202-9), and the Special Fund for Agro-scientific Research in the Public Interest (Grant No. 201203052). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai XF, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-16; Bailey PC, 1999, THEOR APPL GENET, V98, P281, DOI 10.1007/s001220051069; Bewley D., 2013, SEEDS PHYSL DEV GERM, V3; Cheng JP, 2014, MOL BREEDING, V34, P501, DOI 10.1007/s11032-014-0053-z; Cheng XX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080002; Cui KH, 2002, THEOR APPL GENET, V105, P745, DOI 10.1007/s00122-002-0908-2; Farrant JM, 2011, CURR OPIN PLANT BIOL, V14, P340, DOI 10.1016/j.pbi.2011.03.018; Foolad Majid R, 2007, Int J Plant Genomics, V2007, P97386, DOI [10.1155/2007/64358, 10.1155/2007/97386]; Fujino K, 2004, THEOR APPL GENET, V108, P794, DOI 10.1007/s00122-003-1509-4; Fujino K, 2008, P NATL ACAD SCI USA, V105, P12623, DOI 10.1073/pnas.0805303105; Gu XY, 2005, THEOR APPL GENET, V110, P1108, DOI 10.1007/s00122-005-1939-2; Guan YJ, 2013, SCI HORTIC-AMSTERDAM, V154, P25, DOI 10.1016/j.scienta.2013.02.016; Guan YJ, 2009, J ZHEJIANG UNIV-SC B, V10, P427, DOI 10.1631/jzus.B0820373; Gutierrez L, 2007, TRENDS PLANT SCI, V12, P294, DOI 10.1016/j.tplants.2007.06.003; HATTORI T, 1994, PLANT MOL BIOL, V24, P805, DOI 10.1007/BF00029862; Huang DQ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-140; Huang H, 2012, J PROTEOMICS, V75, P1247, DOI 10.1016/j.jprot.2011.10.036; Jiang L, 2006, FIELD CROP RES, V98, P68, DOI 10.1016/j.fcr.2005.12.015; Joosen RVL, 2010, PLANT J, V62, P148, DOI 10.1111/j.1365-313X.2009.04116.x; Ma CX, 2002, GENETICS, V161, P1751; MCCARTY DR, 1991, CELL, V66, P895, DOI 10.1016/0092-8674(91)90436-3; McCouch SR, 2008, RICE, V1, P72, DOI 10.1007/s12284-008-9004-9; Miura K, 2002, THEOR APPL GENET, V104, P981, DOI 10.1007/s00122-002-0872-x; Niu Y, 2013, MOL BREEDING, V31, P785, DOI 10.1007/s11032-012-9833-5; Salunkhe AS, 2011, MOL BIOTECHNOL, V49, P90, DOI 10.1007/s12033-011-9382-x; Shao GN, 2010, J GENET GENOMICS, V37, P523, DOI 10.1016/S1673-8527(09)60072-2; Singh R, 2012, J PLANT BIOCHEM BIOT, V21, P157, DOI 10.1007/s13562-011-0080-3; Sugimoto K, 2010, P NATL ACAD SCI USA, V107, P5792, DOI 10.1073/pnas.0911965107; Sun Qun, 2007, Agricultural Sciences in China, V6, P1060, DOI 10.1016/S1671-2927(07)60147-3; Sun YP, 2010, MOL BREEDING, V26, P493, DOI 10.1007/s11032-010-9390-8; Takai T, 2005, J EXP BOT, V56, P2107, DOI 10.1093/jxb/eri209; Venuprasad R, 2009, THEOR APPL GENET, V120, P177, DOI 10.1007/s00122-009-1168-1; Wan XY, 2005, THEOR APPL GENET, V110, P1334, DOI 10.1007/s00122-005-1976-x; Wang L, 2014, PLANTA, V239, P411, DOI 10.1007/s00425-013-1991-0; Wang ZF, 2010, J ZHEJIANG UNIV-SC B, V11, P958, DOI 10.1631/jzus.B1000238; Wang ZF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051202; Wang ZF, 2012, THEOR APPL GENET, V125, P807, DOI 10.1007/s00122-012-1873-z; Wang ZF, 2011, EUPHYTICA, V178, P297, DOI 10.1007/s10681-010-0287-8; Wu RL, 2006, NAT REV GENET, V7, P229, DOI 10.1038/nrg1804; Wu RL, 2004, GENETICS, V168, P2383, DOI 10.1534/genetics.104.034447; Wu RL, 2004, BIOMETRICS, V60, P729, DOI 10.1111/j.0006-341X.2004.00223.x; Wu RL, 2004, GENETICS, V166, P1541, DOI 10.1534/genetics.166.3.1541; Wu RL, 2003, BIOSCIENCE, V53, P1041, DOI 10.1641/0006-3568(2003)053[1041:MDOAOA]2.0.CO;2; Wu RL, 2003, PHYSIOL GENOMICS, V14, P241, DOI 10.1152/physiolgenomics.00013.2003; Wu RL, 2002, J THEOR BIOL, V217, P275; Wurschum T, 2011, THEOR APPL GENET, V123, P109, DOI 10.1007/s00122-011-1570-3; Yan JQ, 1998, THEOR APPL GENET, V97, P267, DOI 10.1007/s001220050895; Yang J, 2005, QTLNETWORK 2 0; Zhang MengYu, 2012, African Journal of Biotechnology, V11, P6305, DOI 10.5897/AJB11.3740; Zhang S, 2007, AUST J AGR RES, V58, P811, DOI 10.1071/AR06253; Zhang XJ, 2012, P NATL ACAD SCI USA, V109, P21534, DOI 10.1073/pnas.1219776110; Zhang ZH, 2005, FIELD CROP RES, V91, P161, DOI 10.1016/j.fcr.2004.06.004	52	20	21	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115732	10.1371/journal.pone.0115732	http://dx.doi.org/10.1371/journal.pone.0115732			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536503	gold, Green Published, Green Submitted			2022-12-27	WOS:000348563300067
J	Schmidt, A; Frensch, M; Schleheck, D; Schink, B; Muller, N				Schmidt, Alexander; Frensch, Marco; Schleheck, David; Schink, Bernhard; Mueller, Nicolai			Degradation of Acetaldehyde and Its Precursors by Pelobacter carbinolicus and P-acetylenicus	PLOS ONE			English	Article							ALDEHYDE-FERREDOXIN OXIDOREDUCTASE; SYNTROPHIC ETHANOL OXIDATION; DEFINED CHEMOSTAT COCULTURES; DEHYDROGENASE ENZYME-SYSTEM; CARBON-MONOXIDE OXIDATION; SP-NOV; FORMATE DEHYDROGENASE; METHANOGENIC BACTERIA; EUBACTERIUM-ACIDAMINOPHILUM; METHANOBACILLUS-OMELIANSKII	Pelobacter carbinolicus and P. acetylenicus oxidize ethanol in syntrophic cooperation with methanogens. Cocultures with Methanospirillum hungatei served as model systems for the elucidation of syntrophic ethanol oxidation previously done with the lost "`Methanobacillus omelianskii" coculture. During growth on ethanol, both Pelobacter species exhibited NAD(+)-dependent alcohol dehydrogenase activity. Two different acetaldehyde-oxidizing activities were found: a benzyl viologen-reducing enzyme forming acetate, and a NAD(+)-reducing enzyme forming acetyl-CoA. Both species synthesized ATP from acetyl-CoA via acetyl phosphate. Comparative 2D-PAGE of ethanol-grown P. carbinolicus revealed enhanced expression of tungsten-dependent acetaldehyde: ferredoxin oxidoreductases and formate dehydrogenase. Tungsten limitation resulted in slower growth and the expression of a molybdenum-dependent isoenzyme. Putative comproportionating hydrogenases and formate dehydrogenase were expressed constitutively and are probably involved in interspecies electron transfer. In ethanol-grown cocultures, the maximum hydrogen partial pressure was about 1,000 Pa (1 mM) while 2 mM formate was produced. The redox potentials of hydrogen and formate released during ethanol oxidation were calculated to be E-H2=-358 +/- 12 mV and E-HCOOH=-366 +/- 19 mV, respectively. Hydrogen and formate formation and degradation further proved that both carriers contributed to interspecies electron transfer. The maximum Gibbs free energy that the Pelobacter species could exploit during growth on ethanol was -35 to -28 kJ per mol ethanol. Both species could be cultivated axenically on acetaldehyde, yielding energy from its disproportionation to ethanol and acetate. Syntrophic cocultures grown on acetoin revealed a two-phase degradation: first acetoin degradation to acetate and ethanol without involvement of the methanogenic partner, and subsequent syntrophic ethanol oxidation. Protein expression and activity patterns of both Pelobacter spp. grown with the named substrates were highly similar suggesting that both share the same steps in ethanol and acetalydehyde metabolism. The early assumption that acetaldehyde is a central intermediate in Pelobacter metabolism was now proven biochemically.	[Schmidt, Alexander; Frensch, Marco; Schleheck, David; Schink, Bernhard; Mueller, Nicolai] Univ Konstanz, Dept Biol, D-78457 Constance, Germany	University of Konstanz	Muller, N (corresponding author), Univ Konstanz, Dept Biol, D-78457 Constance, Germany.	nicolai.mueller@uni-konstanz.de		Frensch, Marco/0000-0002-7161-0928	Deutsche Forschungsgemeinschaft (DFG) [SCHI 180/10]; University of Konstanz	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); University of Konstanz	This work was funded by the Deutsche Forschungsgemeinschaft (DFG grants SCHI 180/10) and by the University of Konstanz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aklujkar M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-690; ASAKAWA S, 1993, INT J SYST BACTERIOL, V43, P683, DOI 10.1099/00207713-43-4-683; ASAKAWA S, 1994, INT J SYST BACTERIOL, V44, P185, DOI 10.1099/00207713-44-1-185; BALCH WE, 1979, MICROBIOL REV, V43, P260, DOI 10.1128/MMBR.43.2.260-296.1979; Balows A., 1992, PROKARYOTES, P3352, DOI [10.1007/978-1-4757-2191-1_21, DOI 10.1007/978-1-4757-2191-1_]; BARKER H. A., 1940, ANTONIE VAN LEEUWENHOEK JOUR MICROBIOL SEROL, V6, P201; BERGMEYER HU, 1963, BIOCHEM Z, V338, P114; Bergmeyer HU, 1974, METHODEN ENZYMATISCH; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRYANT MP, 1967, ARCH MIKROBIOL, V59, P20, DOI 10.1007/BF00406313; Butler JE, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-471; Butler JE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-103; CHAN MK, 1995, SCIENCE, V267, P1463, DOI 10.1126/science.7878465; da Silva SM, 2011, J BACTERIOL, V193, P2909, DOI 10.1128/JB.00042-11; DANIELS L, 1977, J BACTERIOL, V132, P118, DOI 10.1128/JB.132.1.118-126.1977; DIEKERT GB, 1978, J BACTERIOL, V136, P597, DOI 10.1128/JB.136.2.597-606.1978; DUBOURGUIER HC, 1986, ARCH MICROBIOL, V145, P248, DOI 10.1007/BF00443653; EVERS S, 1993, SYST APPL MICROBIOL, V16, P216; FERRY JG, 1974, INT J SYST BACTERIOL, V24, P465, DOI 10.1099/00207713-24-4-465; FRIMMER U, 1989, ARCH MICROBIOL, V152, P479, DOI 10.1007/BF00446933; Hagedoorn PL, 2005, J BIOL INORG CHEM, V10, P259, DOI 10.1007/s00775-005-0637-5; Hauschild E, 1997, BIOCH ENERGETIK SYNT; Haveman SA, 2008, APPL ENVIRON MICROB, V74, P4277, DOI 10.1128/AEM.02901-07; Haveman SA, 2006, APPL ENVIRON MICROB, V72, P6980, DOI 10.1128/AEM.01128-06; HENSGENS CMH, 1995, J BACTERIOL, V177, P6195, DOI 10.1128/jb.177.21.6195-6200.1995; HOLZER H, 1957, BIOCHEM Z, V329, P192; Kaden J, 1998, WASSERSTOFFTRANSFER; Klebensberger J, 2006, ARCH MICROBIOL, V185, P417, DOI 10.1007/s00203-006-0111-y; KROTO HW, 1974, CHEM PHYS LETT, V29, P265, DOI 10.1016/0009-2614(74)85029-3; Kung JW, 2010, J AM CHEM SOC, V132, P9850, DOI 10.1021/ja103448u; KUYKENDALL JR, 1994, MUTAT RES-FUND MOL M, V311, P49, DOI 10.1016/0027-5107(94)90072-8; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laukel M, 2003, EUR J BIOCHEM, V270, P325, DOI 10.1046/j.1432-1033.2003.03391.x; LOVLEY DR, 1995, APPL ENVIRON MICROB, V61, P2132, DOI 10.1128/AEM.61.6.2132-2138.1995; Makdessi K, 2001, J BIOL CHEM, V276, P24557, DOI 10.1074/jbc.M101293200; MCKELLAR RC, 1979, J BACTERIOL, V139, P231, DOI 10.1128/JB.139.1.231-238.1979; Mota CS, 2011, J BACTERIOL, V193, P2917, DOI 10.1128/JB.01531-10; Muller E, 1927, ADV SYNTH CATAL, V116, P175; Muller N, 2008, ENVIRON MICROBIOL, V10, P1501, DOI 10.1111/j.1462-2920.2007.01565.x; Nishimura JS, 1981, METHOD ENZYMOL, V71, P311; Omeljanskij VL, 1916, ANN I PASTEUR PARIS, V30, P56; OPPERMANN FB, 1994, J BACTERIOL, V176, P469, DOI 10.1128/JB.176.2.469-485.1994; OPPERMANN FB, 1989, FEMS MICROBIOL LETT, V60, P113, DOI 10.1016/0378-1097(89)90087-6; OPPERMANN FB, 1988, FEMS MICROBIOL LETT, V55, P47; OPPERMANN FB, 1991, J BACTERIOL, V173, P757, DOI 10.1128/jb.173.2.757-767.1991; Pau RN, 2002, MET IONS BIOL SYST, V39, P31; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; PRINCE RC, 1987, J BIOL CHEM, V262, P5125; Rauh D, 2004, EUR J BIOCHEM, V271, P212, DOI 10.1111/j.1432-1033.2004.03922.x; REDDY CA, 1972, J BACTERIOL, V110, P133, DOI 10.1128/JB.110.1.133-138.1972; REDDY CA, 1972, J BACTERIOL, V110, P126, DOI 10.1128/JB.110.1.126-132.1972; Roy R, 2002, MET IONS BIOL SYST, V39, P673; SCHINK B, 1985, ARCH MICROBIOL, V142, P295, DOI 10.1007/BF00693407; Schink B, 1997, MICROBIOL MOL BIOL R, V61, P262, DOI 10.1128/.61.2.262-280.1997; SCHINK B, 1984, ARCH MICROBIOL, V137, P33, DOI 10.1007/BF00425804; Schink B, 2006, PROKARYOTES, V3, P5, DOI DOI 10.1007/0-387-30747-8_1; Schlegel H. G., 1992, ALLGEMEINE MIKROBIOL; Schmidhofer A, 2013, IEEE EPE, P1; Schut GJ, 2009, J BACTERIOL, V191, P4451, DOI 10.1128/JB.01582-08; Schwarz G, 2007, MOL BIOL HEAVY METAL, P423; SEITZ HJ, 1990, FEMS MICROBIOL LETT, V71, P83; SEITZ HJ, 1990, ARCH MICROBIOL, V155, P82, DOI 10.1007/BF00291279; SEITZ HJ, 1990, ARCH MICROBIOL, V155, P89, DOI 10.1007/BF00291280; Sieber JR, 2012, ANNU REV MICROBIOL, V66, P429, DOI 10.1146/annurev-micro-090110-102844; SIGEL A, 2002, MOLYBDENUM TUNGSTEN; STACKEBRANDT E, 1989, SYST APPL MICROBIOL, V11, P257; Strohm TO, 2002, SYNTROPHE ETHANOL OX; tenBrink F, 2011, J BACTERIOL, V193, P1229, DOI 10.1128/JB.01057-10; THAUER RK, 1977, BACTERIOL REV, V41, P100, DOI 10.1128/MMBR.41.1.100-180.1977; Valentine DL, 2000, J MICROBIOL METH, V39, P243, DOI 10.1016/S0167-7012(99)00125-6; WALLRABENSTEIN C, 1994, ARCH MICROBIOL, V162, P136; Wang M, 2000, CHEM RES TOXICOL, V13, P1149, DOI 10.1021/tx000118t; Wang SN, 2013, J BACTERIOL, V195, P4373, DOI 10.1128/JB.00678-13; WIDDEL F, 1981, ARCH MICROBIOL, V129, P395, DOI 10.1007/BF00406470; Worral S, 2011, ADVERSE DRUG REACT T, V20, P133; Zeikus JG, 1975, A VANLEEUWENHOEK, V41; ZIEGENHORN J, 1976, CLIN CHEM, V22, P151	77	16	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115902	10.1371/journal.pone.0115902	http://dx.doi.org/10.1371/journal.pone.0115902			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536080	Green Submitted, Green Published, gold			2022-12-27	WOS:000348563300082
J	Takeda, A; Nakamura, M; Fujii, H; Uematsu, C; Minamino, T; Adlard, PA; Bush, AI; Tamano, H				Takeda, Atsushi; Nakamura, Masatoshi; Fujii, Hiroaki; Uematsu, Chihiro; Minamino, Tatsuya; Adlard, Paul A.; Bush, Ashley I.; Tamano, Haruna			Amyloid beta-Mediated Zn2+ Influx into Dentate Granule Cells Transiently Induces a Short-Term Cognitive Deficit	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; ALZHEIMERS-DISEASE; MOLECULAR-MECHANISMS; SYNAPTIC PLASTICITY; INTERSTITIAL FLUID; NATURAL OLIGOMERS; FREE ZINC; IN-VIVO; CALCIUM; NEURONS	We examined an idea that short-term cognition is transiently affected by a state of confusion in Zn2+ transport system due to a local increase in amyloid-beta (A beta) concentration. A single injection of A beta (25 pmol) into the dentate gyrus affected dentate gyrus long-term potentiation (LTP) 1 h after the injection, but not 4 h after the injection. Simultaneously, 1-h memory of object recognition was affected when the training was performed 1 h after the injection, but not 4 h after the injection. A beta-mediated impairments of LTP and memory were rescued in the presence of zinc chelators, suggesting that Zn2+ is involved in A beta action. When A beta was injected into the dentate gyrus, intracellular Zn2+ levels were increased only in the injected area in the dentate gyrus, suggesting that A beta induces the influx of Zn2+ into cells in the injected area. When A beta was added to hippocampal slices, A beta did not increase intracellular Zn2+ levels in the dentate granule cell layer in ACSF without Zn2+, but in ACSF containing Zn2+. The increase in intracellular Zn2+ levels was inhibited in the presence of CaEDTA, an extracellular zinc chelator, but not in the presence of CNQX, an AMPA receptor antagonist. The present study indicates that A beta-mediated Zn2+ influx into dentate granule cells, which may occur without AMPA receptor activation, transiently induces a short-term cognitive deficit. Extracellular Zn2+ may play a key role for transiently A beta-induced cognition deficits.	[Takeda, Atsushi; Minamino, Tatsuya; Tamano, Haruna] Univ Shizuoka, Sch Pharmaceut Sci, Dept Neurophysiol, Shizuoka 4228526, Japan; [Takeda, Atsushi; Nakamura, Masatoshi; Fujii, Hiroaki; Uematsu, Chihiro; Tamano, Haruna] Univ Shizuoka, Sch Pharmaceut Sci, Dept Med Biochem, Shizuoka 4228526, Japan; [Adlard, Paul A.; Bush, Ashley I.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Oxidat Biol Unit, Parkville, Vic 3052, Australia	University of Shizuoka; University of Shizuoka; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Takeda, A (corresponding author), Univ Shizuoka, Sch Pharmaceut Sci, Dept Neurophysiol, Shizuoka 4228526, Japan.	takedaa@u-shizuoka-ken.ac.jp	Perry, George/A-8611-2009; Coulson, Elizabeth J./C-8766-2009; Bush, Ashley I/A-1186-2007; Bush, Ashley/Y-2457-2019	Perry, George/0000-0002-6547-0172; Coulson, Elizabeth J./0000-0003-3783-6197; Bush, Ashley I/0000-0001-8259-9069; Bush, Ashley/0000-0001-8259-9069				Abramov AY, 2003, J NEUROSCI, V23, P5088; Arispe N, 1996, P NATL ACAD SCI USA, V93, P1710, DOI 10.1073/pnas.93.4.1710; Brouillette J, 2012, J NEUROSCI, V32, P7852, DOI 10.1523/JNEUROSCI.5901-11.2012; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Bush AI, 2013, J ALZHEIMERS DIS, V33, pS277, DOI 10.3233/JAD-2012-129011; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Cirrito JR, 2003, J NEUROSCI, V23, P8844; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Colvin RA, 2008, AM J PHYSIOL-CELL PH, V294, pC726, DOI 10.1152/ajpcell.00541.2007; Crews L, 2010, HUM MOL GENET, V19, pR12, DOI 10.1093/hmg/ddq160; Fagan AM, 2007, ARCH NEUROL-CHICAGO, V64, P343, DOI 10.1001/archneur.64.3.noc60123; Faux NG, 2010, J ALZHEIMERS DIS, V20, P509, DOI 10.3233/JAD-2010-1390; Frederickson CJ, 2006, EXP NEUROL, V198, P285, DOI 10.1016/j.expneurol.2005.08.030; FREDERICKSON CJ, 1989, INT REV NEUROBIOL, V31, P145; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; GomezIsla T, 1996, J NEUROSCI, V16, P4491; He F., 2011, BIO-PROTOCOL, V1, pe80, DOI [DOI 10.21769/BIOPROTOC.80, 10.21769/BioProtoc.80]; Hirano T, 2002, J AM CHEM SOC, V124, P6555, DOI 10.1021/ja025567p; HYMAN BT, 1984, SCIENCE, V225, P1168, DOI 10.1126/science.6474172; Iijima K, 2004, P NATL ACAD SCI USA, V101, P6623, DOI 10.1073/pnas.0400895101; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Kametani F, 2008, CURR ALZHEIMER RES, V5, P165, DOI 10.2174/156720508783954776; Kayed R, 2013, J ALZHEIMERS DIS, V33, pS67, DOI 10.3233/JAD-2012-129001; Kim J, 2007, J NEUROSCI, V27, P627, DOI 10.1523/JNEUROSCI.4849-06.2007; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; Lin H, 2001, FASEB J, V15, P2433, DOI 10.1096/fj.01-0377com; Matsuo R, 2000, J NEUROCHEM, V74, P2239, DOI 10.1046/j.1471-4159.2000.0742239.x; Mattson MP, 2001, J MOL NEUROSCI, V17, P205, DOI 10.1385/JMN:17:2:205; MCNAUGHTON BL, 1977, J COMP NEUROL, V175, P439, DOI 10.1002/cne.901750404; Minami A, 2006, J NEUROSCI RES, V83, P167, DOI 10.1002/jnr.20714; Mintun MA, 2006, NEUROLOGY, V67, P446, DOI 10.1212/01.wnl.0000228230.26044.a4; Morrison JH, 1997, SCIENCE, V278, P412, DOI 10.1126/science.278.5337.412; Nestor PJ, 2004, NAT MED, V10, pS34, DOI 10.1038/nrn1433; Puzzo D, 2011, ANN NEUROL, V69, P819, DOI 10.1002/ana.22313; Ritchie CW, 2003, ARCH NEUROL-CHICAGO, V60, P1685, DOI 10.1001/archneur.60.12.1685; Scheff SW, 2006, NEUROBIOL AGING, V27, P1372, DOI 10.1016/j.neurobiolaging.2005.09.012; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Sensi SL, 1997, J NEUROSCI, V17, P9554; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Sindreu CB, 2003, CEREB CORTEX, V13, P823, DOI 10.1093/cercor/13.8.823; Takamura Y, 2014, NEUROBIOL AGING, V35, P532, DOI 10.1016/j.neurobiolaging.2013.08.037; Takeda A, 2014, FRONT AGING NEUROSCI, V6; Takeda A, 2007, J NEUROSCI RES, V85, P3666, DOI 10.1002/jnr.21449; Takeda A, 2007, J NEUROSCI RES, V85, P1310, DOI 10.1002/jnr.21233; Takeda A, 2014, HIPPOCAMPUS, V24, P1404, DOI 10.1002/hipo.22322; Takeda A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028615; Takeda A, 2010, BRAIN RES, V1354, P188, DOI 10.1016/j.brainres.2010.07.039; Ueno S, 2002, J CELL BIOL, V158, P215, DOI 10.1083/jcb.200204066; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a	55	31	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115923	10.1371/journal.pone.0115923	http://dx.doi.org/10.1371/journal.pone.0115923			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536033	gold, Green Published, Green Submitted			2022-12-27	WOS:000348563300088
J	Ateba-Ngoa, U; Mombo-Ngoma, G; Zettlmeissi, E; van der Vlugt, LEPM; de Jong, S; Matsiegui, PB; Ramharter, M; Kremsner, PG; Yazdanbakhsh, M; Adegnika, AA				Ateba-Ngoa, Ulysse; Mombo-Ngoma, Ghyslain; Zettlmeissi, Eva; van der Vlugt, Lucien E. P. M.; de Jong, Sanne; Matsiegui, Pierre-Blaise; Ramharter, Michael; Kremsner, Peter G.; Yazdanbakhsh, Maria; Adegnika, Ayola Akim			CD4(+)CD25(hi)FOXP3(+) Cells in Cord Blood of Neonates Born from Filaria Infected Mother Are Negatively Associated with CD(4+)Tbet(+) and CD4(+)ROR gamma t(+) T Cells	PLOS ONE			English	Article							PATENT LYMPHATIC FILARIASIS; IN-UTERO SENSITIZATION; WUCHERERIA-BANCROFTI; IMMUNE-RESPONSES; HELMINTH; MALARIA; EPIDEMIOLOGY; HOMEOSTASIS; PARASITES; NEWBORNS	Background: Children who have been exposed in utero to maternal filarial infection are immunologically less responsive to filarial antigens, have less pathology, and are more susceptible to acquire infection than offspring of uninfected mothers. Moreover children from filaria infected mothers have been shown to be less responsive to vaccination as a consequence of an impairment of their immune response. However, it is not well known how in utero exposure to parasite antigens affects cellular immune responses. Methodology: Here, 30 pregnant women were examined for the presence of microfilaria of Loa loa and Mansonella perstans in peripheral blood. At delivery, cord blood mononuclear cells (CBMC) were obtained and the CD4(+)T cells were phenotyped by expression of the transcription factors Tbet, ROR gamma t, and FOXP3. Results: No significant difference was observed between newborns from infected versus uninfected mothers in the frequencies of total CD4(+)T cells and CD4(+)T cells subsets including CD4(+)Tbet(+), CD4(+)ROR gamma t(+) T and CD4(+)CD25(hi)FOXP3(+) T cells. However, there was a negative association between CD4(+)CD25(hi)FOXP3(+)T cells and CD4(+)Tbet(+) as well as CD4(+)ROR gamma t(+) T cells in the infected group only (B=-0.242, P=0.002; B=-0.178, P=0.013 respectively). Conclusion: Our results suggest that filarial infection during pregnancy leads to an expansion of functionally active regulatory T cells that keep TH1 and TH17 in check.	[Ateba-Ngoa, Ulysse; Mombo-Ngoma, Ghyslain; Matsiegui, Pierre-Blaise; Ramharter, Michael; Kremsner, Peter G.; Yazdanbakhsh, Maria; Adegnika, Ayola Akim] Ctr Rech Med Lambarene, Lambarene, Gabon; [Ateba-Ngoa, Ulysse; Mombo-Ngoma, Ghyslain; van der Vlugt, Lucien E. P. M.; de Jong, Sanne; Yazdanbakhsh, Maria; Adegnika, Ayola Akim] Leiden Univ, Med Ctr, Dept Parasitol, NL-2333 ZA Leiden, Netherlands; [Ateba-Ngoa, Ulysse; Mombo-Ngoma, Ghyslain; Zettlmeissi, Eva; Ramharter, Michael; Kremsner, Peter G.; Adegnika, Ayola Akim] Univ Tubingen, Inst Tropenmed, D-72074 Tubingen, Germany; [Mombo-Ngoma, Ghyslain] Univ Sci Sante, Dept Parasitol Mycol, Libreville, Gabon; [Matsiegui, Pierre-Blaise] Ctr Rech Med Ngounie, Fougamou, Gabon; [Ramharter, Michael] Med Univ Vienna, Div Infect Dis & Trop Med, Dept Med 1, A-1090 Vienna, Austria	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Eberhard Karls University of Tubingen; Medical University of Vienna	Adegnika, AA (corresponding author), Ctr Rech Med Lambarene, BP 118, Lambarene, Gabon.	ayola-akim.adegnika@medizin.uni-tuebingen.de	Mombo-Ngoma, Ghyslain/I-4305-2019; Yazdanbakhsh, Maria/AAI-3996-2020; ADEGNIKA, Ayola Akim/AAK-7307-2020; de Jong, Sanne E./K-2242-2015; Ramharter, Michael/C-5273-2013	Mombo-Ngoma, Ghyslain/0000-0003-2658-8706; Yazdanbakhsh, Maria/0000-0002-7666-1441; de Jong, Sanne E./0000-0002-6696-7359; Ramharter, Michael/0000-0002-9259-1885	EU [HEALTH-F3-2009-241642]; Deutsche Forschungsgemeinschaft [1150/6-1]	EU(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the EU-funded project the Immunological Interplay between Poverty Related Diseases and Helminth infections: An African-European Research Initiative "IDEA" (HEALTH-F3-2009-241642) and the Deutsche Forschungsgemeinschaft-funded project Deutsch-Afrikanische Kooperationsprojekte in der Infektiologie (DFG-Projekt KR 1150/6-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegnika AA, 2008, J INFECT DIS, V198, P928, DOI 10.1086/591057; Adegnika AA, 2012, CURR OPIN HIV AIDS, V7, P221, DOI 10.1097/COH.0b013e3283524d90; Akue JP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001329; Anosike J. C., 1994, Applied Parasitology, V35, P294; Babu S, 2006, J IMMUNOL, V176, P3248, DOI 10.4049/jimmunol.176.5.3248; Babu S, 2005, INFECT IMMUN, V73, P3394, DOI 10.1128/IAI.73.6.3394-3401.2005; Bal MS, 2010, PARASITOLOGY, V137, P669, DOI 10.1017/S0031182009991478; Breitling LP, 2006, INFECT IMMUN, V74, P5725, DOI 10.1128/IAI.00682-06; Broen K, 2007, MOL BIOCHEM PARASIT, V151, P1, DOI 10.1016/j.molbiopara.2006.10.001; Bueno LL, 2012, ACTA TROP, V123, P53, DOI 10.1016/j.actatropica.2012.02.071; Chakir H, 2003, J IMMUNOL METHODS, V278, P157, DOI 10.1016/S0022-1759(03)00200-X; EBERHARD ML, 1993, J PARASITOL, V79, P62, DOI 10.2307/3283278; Gallagher M, 2005, AIDS, V19, P1849, DOI 10.1097/01.aids.0000189846.90946.5d; GOLDSMID JM, 1970, J CLIN PATHOL, V23, P632, DOI 10.1136/jcp.23.7.632; Grzanka J, 2013, INT IMMUNOPHARMACOL, V16, P343, DOI 10.1016/j.intimp.2013.02.004; Kurtis JD, 2011, INFECT IMMUN, V79, P1254, DOI 10.1128/IAI.01072-10; Lalor MK, 2009, J INFECT DIS, V199, P795, DOI 10.1086/597069; Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183; Malhotra I, 2003, INFECT IMMUN, V71, P5231, DOI 10.1128/IAI.71.9.5231-5237.2003; Malhotra I, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000116; McCall MBB, 2010, J LEUKOCYTE BIOL, V88, P1131, DOI 10.1189/jlb.0310137; Merlin M, 1990, Med Trop (Mars), V50, P39; Metenou S, 2010, J IMMUNOL, V184, P5375, DOI 10.4049/jimmunol.0904067; Nkoghe D, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-33; Perlaza BL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-27; Peterson RA, 2012, TOXICOL PATHOL, V40, P186, DOI 10.1177/0192623311430693; Planche T, 2001, AM J TROP MED HYG, V65, P599, DOI 10.4269/ajtmh.2001.65.599; Schwarz NG, 2008, CLIN INFECT DIS, V47, P1017, DOI 10.1086/591968; Seydel LS, 2012, AM J TROP MED HYG, V86, P613, DOI 10.4269/ajtmh.2012.11-0463; Soboslay PT, 1999, CLIN EXP IMMUNOL, V117, P130; Taylor MD, 2012, TRENDS IMMUNOL, V33, P181, DOI 10.1016/j.it.2012.01.001; Wammes LJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001655; Wammes LJ, 2010, EUR J IMMUNOL, V40, P437, DOI 10.1002/eji.200939699; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437	34	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e114630	10.1371/journal.pone.0114630	http://dx.doi.org/10.1371/journal.pone.0114630			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531674	Green Submitted, gold, Green Published			2022-12-27	WOS:000348845100021
J	da Silva, JS; Fischer, FM				da Silva-Junior, Joao Silvestre; Fischer, Frida Marina			Long-Term Sickness Absence Due to Mental Disorders Is Associated with Individual Features and Psychosocial Work Conditions	PLOS ONE			English	Article							EFFORT-REWARD IMBALANCE; JOB STRESS MODELS; RISK-FACTORS; FOLLOW-UP; DISABILITY PENSION; HEALTH; STRAIN; ABSENTEEISM; QUESTIONNAIRE; ENVIRONMENT	Aims: Sickness absence is a socioeconomic global burden. In Brazil, mental disorders are the third leading cause of social security benefits payments. The aim of the present study was to compare factors associated with long-term sickness absence between workers who claimed social benefits due to mental disorders or by other causes. We investigated individual features and occupational characteristics. In addition, we evaluated psychosocial factors at work assessed by the Demand-Control-Support (DCS) and Effort-Reward Imbalance (ERI) models, and whether they were associated with long-term sickness absence due to mental disorders (LTSA-MD). Methods: The present case-control study was conducted in Sao Paulo, Brazil. The sample (n=385) included workers on sick leave for more than 15 days. Cases were the participants with disabling psychiatric illnesses, and controls were the ones with other disabling diseases. Interviews were conducted to assess individual features (sociodemographic data, health habits/lifestyle, health conditions) and occupational characteristics. The participants' perception of exposure to dimensions of the DCS and ERI models was also recorded. Multiple logistic regressions were performed to evaluate the association between independent variables and LTSA-MD. Results: All the regression analyses showed that LTSA-MD was associated with female sex, self-reported white skin color, higher education level, high tobacco consumption, high alcohol intake, two or more comorbidities, exposure to violence at work, high job strain and low social support at work, effort-reward imbalance and high overcommitment to work. LTSA-MD was associated with separate and combined DCS and ERI stress models. Conclusions: Individual features and work conditions were associated with LTSA-MD. Combined analysis of stress models showed that psychosocial factors at work were significantly associated with LTSA-MD. Resourceful use of this information may contribute to the implementation of preventive actions and strategies to facilitate return to work targeting the populations most susceptible to mental disorders.	[da Silva-Junior, Joao Silvestre] Minist Social Secur, Natl Social Secur Inst, Sao Paulo, Brazil; [da Silva-Junior, Joao Silvestre; Fischer, Frida Marina] Univ Sao Paulo, Sch Publ Hlth, Dept Environm Hlth, Sao Paulo, Brazil	Universidade de Sao Paulo	da Silva, JS (corresponding author), Minist Social Secur, Natl Social Secur Inst, Sao Paulo, Brazil.	silvajunior.js@gmail.com	Fischer, Frida Marina/I-1486-2012; da Silva-Junior, Joao Silvestre/B-9564-2011	da Silva-Junior, Joao Silvestre/0000-0001-7541-5946	Laboratory of Population Studies (LEP); Public Health Graduate Program, School of Public Health, University of Sao Paulo, Brazil	Laboratory of Population Studies (LEP); Public Health Graduate Program, School of Public Health, University of Sao Paulo, Brazil	The authors would like to thank: the National Social Security Institute (INSS) of Brazilian Social Security Ministry, for granting permission for data collection; the Laboratory of Population Studies (LEP) and the Public Health Graduate Program, School of Public Health, University of Sao Paulo, Brazil, for technical assistance and funding, respectively.	Allebeck P, 2004, SCAND J PUBLIC HEALT, V32, P49, DOI 10.1080/14034950410021853; Alves MGD, 2004, REV SAUDE PUBL, V38, P164, DOI 10.1590/S0034-89102004000200003; Belkic KL, 2004, SCAND J WORK ENV HEA, V30, P85, DOI 10.5271/sjweh.769; Bosma H, 1998, AM J PUBLIC HEALTH, V88, P68, DOI 10.2105/AJPH.88.1.68; Burr H, 2011, SCAND J PUBLIC HEALT, V39, P147, DOI 10.1177/1403494811401480; Calnan M, 2004, SCAND J PUBLIC HEALT, V32, P84, DOI 10.1080/14034940310001668; Chor D, 2008, CAD SAUDE PUBLICA, V24, P219, DOI 10.1590/S0102-311X2008000100022; Cornelius LR, 2011, J OCCUP REHABIL, V21, P259, DOI 10.1007/s10926-010-9261-5; da Silva JS, 2014, REV SAUDE PUBL, V48, P186, DOI 10.1590/S0034-8910.2014048004802; Dewa CS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005533; Ferreira RC, 2012, REV SAUDE PUBL, V46, P259, DOI 10.1590/S0034-89102012005000018; Figlie N. B, 1997, J BRAS PSIQUIATR, P589; FISCHER FM, 1986, INT ARCH OCC ENV HEA, V58, P301, DOI 10.1007/BF00377887; Foss L, 2010, J OCCUP ENVIRON MED, V52, P698, DOI 10.1097/JOM.0b013e3181e98731; Griep RH, 2011, REV SAUDE PUBL, V45, P145, DOI 10.1590/S0034-89102011000100017; Griep RH, 2010, WORK STRESS, V24, P179, DOI 10.1080/02678373.2010.493083; HALTY LUIS SUÁREZ, 2002, J. Pneumologia, V28, P180, DOI 10.1590/S0102-35862002000400002; Hasselhorn H-M, 2005, NEXT SCI REP JUL 200; ILO-International Labour Office, 1984, JOINT ILO WHO COMM O; Janssens H, 2014, EUR J PUBLIC HEALTH, V24, P428, DOI 10.1093/eurpub/cku009; KARASEK RA, 1979, ADMIN SCI QUART, V24, P285, DOI 10.2307/2392498; Koopmans PC, 2011, INT ARCH OCC ENV HEA, V84, P193, DOI 10.1007/s00420-010-0540-4; Krokstad S, 2002, INT J EPIDEMIOL, V31, P1183, DOI 10.1093/ije/31.6.1183; Lu XS, 2010, J OCCUP ENVIRON MED, V52, P913, DOI 10.1097/JOM.0b013e3181f12ee0; Markussen S, 2011, J HEALTH ECON, V30, P277, DOI 10.1016/j.jhealeco.2010.12.003; MARMOT M, 1995, J EPIDEMIOL COMMUN H, V49, P124, DOI 10.1136/jech.49.2.124; Matsudo S, 2001, REV BRAS ATIV SAUDE, V6, P5, DOI DOI 10.12820/RBAFS.V.6N2P5-18; Ndjaboue R, 2014, OCCUP ENVIRON MED, V71, P40, DOI 10.1136/oemed-2013-101375; Niedhammer I, 2013, EUR J PUBLIC HEALTH, V23, P622, DOI 10.1093/eurpub/cks124; NORTH F, 1993, BRIT MED J, V306, P361, DOI 10.1136/bmj.306.6874.361; Roelen CAM, 2006, OCCUP MED-OXFORD, V56, P442, DOI 10.1093/occmed/kql087; Rugulies R, 2007, WORK STRESS, V21, P293, DOI 10.1080/02678370701747549; Sanne B, 2005, SCAND J PUBLIC HEALT, V33, P166, DOI 10.1080/14034940410019217; Siegrist J, 2004, SOC SCI MED, V58, P1483, DOI 10.1016/S0277-9536(03)00351-4; Siegrist J, 1996, J Occup Health Psychol, V1, P27, DOI 10.1037/1076-8998.1.1.27; Siegrist J, 2008, SCAND J WORK ENV HEA, P163; Silva AA, 2010, REV SAUDE PUBL, V44, P718, DOI 10.1590/S0034-89102010000400016; Stansfeld SA, 2011, OCCUP ENVIRON MED, V68, P408, DOI 10.1136/oem.2010.056994; Svedberg P, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-763; Vahtera T, 2000, J EPIDEMIOL COMMUN H, V54, P484, DOI 10.1136/jech.54.7.484; Vezina M, 2004, SOC SCI MED, V59, P29, DOI 10.1016/j.socscimed.2003.09.033; Wang MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096025	42	27	28	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115885	10.1371/journal.pone.0115885	http://dx.doi.org/10.1371/journal.pone.0115885			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA3ZY	25531900	Green Published, gold, Green Submitted			2022-12-27	WOS:000348845100113
J	Danielson, E; Lee, SH				Danielson, Eric; Lee, Sang H.			SynPAnal: Software for Rapid Quantification of the Density and Intensity of Protein Puncta from Fluorescence Microscopy Images of Neurons	PLOS ONE			English	Article							DENDRITIC SPINES; EXCITATORY SYNAPSES; PLASTICITY; DISORDERS	Continuous modification of the protein composition at synapses is a driving force for the plastic changes of synaptic strength, and provides the fundamental molecular mechanism of synaptic plasticity and information storage in the brain. Studying synaptic protein turnover is not only important for understanding learning and memory, but also has direct implication for understanding pathological conditions like aging, neurodegenerative diseases, and psychiatric disorders. Proteins involved in synaptic transmission and synaptic plasticity are typically concentrated at synapses of neurons and thus appear as puncta (clusters) in immunofluorescence microscopy images. Quantitative measurement of the changes in puncta density, intensity, and sizes of specific proteins provide valuable information on their function in synaptic transmission, circuit development, synaptic plasticity, and synaptopathy. Unfortunately, puncta quantification is very labor intensive and time consuming. In this article, we describe a software tool designed for the rapid semi-automatic detection and quantification of synaptic protein puncta from 2D immunofluorescence images generated by confocal laser scanning microscopy. The software, dubbed as SynPAnal (for Synaptic Puncta Analysis), streamlines data quantification for puncta density and average intensity, thereby increases data analysis throughput compared to a manual method. SynPAnal is stand-alone software written using the JAVA programming language, and thus is portable and platform-free.	[Danielson, Eric; Lee, Sang H.] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Lee, Sang H.] Med Coll Wisconsin, Neurosci Res Ctr, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin	Lee, SH (corresponding author), Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA.	shlee@mcw.edu	Lee, Sang/R-7518-2019	Lee, Sang H./0000-0001-5467-0331; Danielson, Eric/0000-0002-5442-0460	NIH [MH078135]; Research and Education Program, a component of the Advancing a Healthier Wisconsin endowment at the Medical College of Wisconsin; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078135] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research and Education Program, a component of the Advancing a Healthier Wisconsin endowment at the Medical College of Wisconsin; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the NIH grant MH078135 and by funding provided through the Research and Education Program, a component of the Advancing a Healthier Wisconsin endowment at the Medical College of Wisconsin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Cheng J, 2007, J NEUROSCI METH, V165, P122, DOI 10.1016/j.jneumeth.2007.05.020; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Danielson E, 2012, J NEUROSCI, V32, P6967, DOI 10.1523/JNEUROSCI.0025-12.2012; El-Hussein AE, 2000, SCIENCE, V290, P1364; Hebb D.O., 2002, ORG BEHAV NEUROPSYCH; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Kandel E., 2000, PRINCIPLES NEURAL SC; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Koh IYY, 2002, NEURAL COMPUT, V14, P1283, DOI 10.1162/089976602753712945; Morrison JH, 2012, NAT REV NEUROSCI, V13, P240, DOI 10.1038/nrn3200; Okabe S, 2007, MOL CELL NEUROSCI, V34, P503, DOI 10.1016/j.mcn.2007.01.006; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Pozueta J, 2012, NEUROSCIENCE; Rodriguez A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001997; Schmitz SK, 2011, J NEUROSCI METH, V195, P185, DOI 10.1016/j.jneumeth.2010.12.011; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Shin SM, 2012, NAT NEUROSCI, V15, P1655, DOI 10.1038/nn.3259; Ting JT, 2012, ANNU REV NEUROSCI, V35, P49, DOI 10.1146/annurev-neuro-062111-150442; Yi JJ, 2005, NEURON, V47, P629, DOI 10.1016/j.neuron.2005.07.008; Zhang Y, 2007, NEUROIMAGE, V36, P346, DOI 10.1016/j.neuroimage.2007.02.044	22	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115298	10.1371/journal.pone.0115298	http://dx.doi.org/10.1371/journal.pone.0115298			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531531	Green Published, Green Submitted, gold			2022-12-27	WOS:000348845100050
J	Fujita, N; Ono, M; Tomioka, T; Deie, M				Fujita, Naoto; Ono, Miharu; Tomioka, Tomoka; Deie, Masataka			Effects of Hyperbaric Oxygen at 1.25 Atmospheres Absolute with Normal Air on Macrophage Number and Infiltration during Rat Skeletal Muscle Regeneration	PLOS ONE			English	Article							CONTRACTILE FUNCTION; CRUSH INJURY; EXERCISE; THERAPY; HYPOXIA; EXPRESSION; APOPTOSIS; SORENESS; GROWTH; BLOOD	Use of mild hyperbaric oxygen less than 2 atmospheres absolute (2026.54 hPa) with normal air is emerging as a common complementary treatment for severe muscle injury. Although hyperbaric oxygen at over 2 atmospheres absolute with 100% O2 promotes healing of skeletal muscle injury, it is not clear whether mild hyperbaric oxygen is equally effective. The purpose of the present study was to investigate the impact of hyperbaric oxygen at 1.25 atmospheres absolute (1266.59 hPa) with normal air on muscle regeneration. The tibialis anterior muscle of male Wistar rats was injured by injection of bupivacaine hydrochloride, and rats were randomly assigned to a hyperbaric oxygen experimental group or to a nonhyperbaric oxygen control group. Immediately after the injection, rats were exposed to hyperbaric oxygen, and the treatment was continued for 28 days. The cross-sectional area of centrally nucleated muscle fibers was significantly larger in rats exposed to hyperbaric oxygen than in controls 5 and 7 days after injury. The number of CD68- or CD68- and CD206-positive cells was significantly higher in rats exposed to hyperbaric oxygen than in controls 24 h after injury. Additionally, tumor necrosis factor-a and interleukin-10 mRNA expression levels were significantly higher in rats exposed to hyperbaric oxygen than in controls 24 h after injury. The number of Pax7- and MyoD- or MyoD- and myogenin-positive nuclei per mm(2) and the expression levels of these proteins were significantly higher in rats exposed to hyperbaric oxygen than in controls 5 days after injury. These results suggest that mild hyperbaric oxygen promotes skeletal muscle regeneration in the early phase after injury, possibly due to reduced hypoxic conditions leading to accelerated macrophage infiltration and phenotype transition. In conclusion, mild hyperbaric oxygen less than 2 atmospheres absolute with normal air is an appropriate support therapy for severe muscle injuries.	[Fujita, Naoto; Ono, Miharu; Tomioka, Tomoka; Deie, Masataka] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Hiroshima, Hiroshima, Japan; [Fujita, Naoto; Deie, Masataka] Hiroshima Univ, Fac Med, Hiroshima, Hiroshima, Japan	Hiroshima University; Hiroshima University	Fujita, N (corresponding author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Hiroshima, Hiroshima, Japan.	fujitan@hiroshima-u.ac.jp		Fujita, Naoto/0000-0001-9416-3502	Japanese Ministry of Education, Culture, Sports, Science, and Technology [25750202]	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by Grants-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (no. 25750202 to NF). The URL of the funder's website is http://www.mext.go.jp/english/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano T, 2007, CIRC J, V71, P405, DOI 10.1253/circj.71.405; Babul S, 2003, CLIN J SPORT MED, V13, P138, DOI 10.1097/00042752-200305000-00003; Bajek S, 2011, COLLEGIUM ANTROPOL, V35, P91; Best TM, 1998, AM J SPORT MED, V26, P367, DOI 10.1177/03635465980260030401; Bosco MC, 2004, J IMMUNOL, V172, P1681, DOI 10.4049/jimmunol.172.3.1681; Bozok S, 2012, EUR J MED RES, V17, DOI 10.1186/2047-783X-17-14; Chaillou T, 2014, PFLUG ARCH EUR J PHY, V466, P587, DOI 10.1007/s00424-013-1336-7; Deng B, 2012, J IMMUNOL, V189, P3669, DOI 10.4049/jimmunol.1103180; Escribese MM, 2012, IMMUNOBIOLOGY, V217, P1233, DOI 10.1016/j.imbio.2012.07.002; Germain G, 2003, UNDERSEA HYPERBAR M, V30, P135; Gregorevic P, 2000, J APPL PHYSIOL, V89, P1477, DOI 10.1152/jappl.2000.89.4.1477; Gregorevic P, 2002, MED SCI SPORT EXER, V34, P630, DOI 10.1097/00005768-200204000-00011; Harrison BC, 2001, MED SCI SPORT EXER, V33, P36; Kawada S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072603; Kharraz Y, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/491497; Lewis JS, 1999, J LEUKOCYTE BIOL, V66, P889, DOI 10.1002/jlb.66.6.889; Lu PG, 2013, J NEUROSURG SCI, V57, P253; Malm C, 2000, J PHYSIOL-LONDON, V529, P243, DOI 10.1111/j.1469-7793.2000.00243.x; Mekjavic IB, 2000, MED SCI SPORT EXER, V32, P558, DOI 10.1097/00005768-200003000-00002; Novak ML, 2014, J PATHOL, V232, P344, DOI 10.1002/path.4301; Novak ML, 2013, AM J PATHOL, V183, P1352, DOI 10.1016/j.ajpath.2013.06.034; Otis JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092363; Rigamonti E, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/560629; Shefer G, 2006, DEV BIOL, V294, P50, DOI 10.1016/j.ydbio.2006.02.022; Takagi R, 2011, J APPL PHYSIOL, V110, P382, DOI 10.1152/japplphysiol.01187.2010; Takeuchi K, 2014, ACTA HISTOCHEM, V116, P327, DOI 10.1016/j.acthis.2013.08.010; Thom SR, 2009, J APPL PHYSIOL, V106, P988, DOI 10.1152/japplphysiol.91004.2008; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; Ueng SWN, 2013, J ORTHOP RES, V31, P376, DOI 10.1002/jor.22235; Villalta SA, 2009, HUM MOL GENET, V18, P482, DOI 10.1093/hmg/ddn376; Yu JG, 2002, HISTOCHEM CELL BIOL, V118, P29, DOI 10.1007/s00418-002-0423-1; Yu JG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062056; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007	33	15	18	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115685	10.1371/journal.pone.0115685	http://dx.doi.org/10.1371/journal.pone.0115685			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531909	Green Submitted, Green Published, gold			2022-12-27	WOS:000348845100094
J	Lam, PK				Lam, Pui K.			Special Relativity at the Quantum Scale	PLOS ONE			English	Article							DIRAC-EQUATION; NET	It has been suggested that the space-time structure as described by the theory of special relativity is a macroscopic manifestation of a more fundamental quantum structure (pre-geometry). Efforts to quantify this idea have come mainly from the area of abstract quantum logic theory. Here we present a preliminary attempt to develop a quantum formulation of special relativity based on a model that retains some geometric attributes. Our model is Feynman's "checker-board'' trajectory for a 1-D relativistic free particle. We use this model to guide us in identifying (1) the quantum version of the postulates of special relativity and (2) the appropriate quantum "coordinates''. This model possesses a useful feature that it admits an interpretation both in terms of paths in space-time and in terms of quantum states. Based on the quantum version of the postulates, we derive a transformation rule for velocity. This rule reduces to the Einstein's velocity-addition formula in the macroscopic limit and reveals an interesting aspect of time. The 3-D case, timedilation effect, and invariant interval are also discussed in term of this new formulation. This is a preliminary investigation; some results are derived, while others are interesting observations at this point.	Univ Hawaii Manoa, Dept Phys & Astron, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa	Lam, PK (corresponding author), Univ Hawaii Manoa, Dept Phys & Astron, Honolulu, HI 96822 USA.	plam@hawaii.edu						Einstein A, 1905, ANN PHYS-BERLIN, V17, P891; Einstein A., 1945, MEANING RELATIVITY; Feynman R. P., 1985, QED STRANGE THEORY L; Feynman R. P., 1965, QUANTUM MECH PATH IN, P35; FINKELSTEIN D, 1969, PHYS REV, V184, P1261, DOI 10.1103/PhysRev.184.1261; FINKELSTEIN D, 1989, INT J THEOR PHYS, V28, P441, DOI 10.1007/BF00673296; FINKELSTEIN D, 1991, INT J THEOR PHYS, V30, P463, DOI 10.1007/BF00672892; GERSCH HA, 1981, INT J THEOR PHYS, V20, P491, DOI 10.1007/BF00669436; JACOBSON T, 1984, J PHYS A-MATH GEN, V17, P2433, DOI 10.1088/0305-4470/17/12/015; JACOBSON T, 1984, J PHYS A-MATH GEN, V17, P375, DOI 10.1088/0305-4470/17/2/023; Landau LD, 1996, CLASSICAL THEORY FIE, P2; Marlow JR, 1980, QUANTUM THEORY GRAVI, P36; Michelson AA, 1887, AM J SCI, V34, P333, DOI [DOI 10.2475/AJS.S3-34.203.333, 10.2475/ajs.s3-34.203.333]; ORD GN, 1993, PHYS LETT A, V173, P343, DOI 10.1016/0375-9601(93)90247-W; Penrose R., 1984, SPINORS SPACE TIME, V1; ROSEN G, 1983, PHYS REV A, V28, P1139, DOI 10.1103/PhysRevA.28.1139; Schwinger J., 1958, SELECTED PAPERS QUAN; SELESNICK SA, 1991, INT J THEOR PHYS, V30, P1273, DOI 10.1007/BF01026175; von Weizsacker C. F., 1975, Quantum theory and the structures of time and space, P213; Wheeler J. A., 1989, P WORKSH COMPL ENTR, P3; Wheeler J. A., 1980, QUANTUM THEORY GRAVI, P1	22	1	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115810	10.1371/journal.pone.0115810	http://dx.doi.org/10.1371/journal.pone.0115810			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531675	Green Published, gold, Green Submitted			2022-12-27	WOS:000348845100111
J	Taylor, PN; Wang, Y; Goodfellow, M; Dauwels, J; Moeller, F; Stephani, U; Baier, G				Taylor, Peter Neal; Wang, Yujiang; Goodfellow, Marc; Dauwels, Justin; Moeller, Friederike; Stephani, Ulrich; Baier, Gerold			A Computational Study of Stimulus Driven Epileptic Seizure Abatement	PLOS ONE			English	Article							ABSENCE SEIZURES; DYNAMICS; SPIKE; MODEL; STIMULATION; INHIBITION; OSCILLATIONS; THALAMUS; DISEASES	Active brain stimulation to abate epileptic seizures has shown mixed success. In spike-wave (SW) seizures, where the seizure and background state were proposed to coexist, single-pulse stimulations have been suggested to be able to terminate the seizure prematurely. However, several factors can impact success in such a bistable setting. The factors contributing to this have not been fully investigated on a theoretical and mechanistic basis. Our aim is to elucidate mechanisms that influence the success of single-pulse stimulation in noise-induced SW seizures. In this work, we study a neural population model of SW seizures that allows the reconstruction of the basin of attraction of the background activity as a four dimensional geometric object. For the deterministic (noise-free) case, we show how the success of response to stimuli depends on the amplitude and phase of the SW cycle, in addition to the direction of the stimulus in state space. In the case of spontaneous noise-induced seizures, the basin becomes probabilistic introducing some degree of uncertainty to the stimulation outcome while maintaining qualitative features of the noise-free case. Additionally, due to the different time scales involved in SW generation, there is substantial variation between SW cycles, implying that there may not be a fixed set of optimal stimulation parameters for SW seizures. In contrast, the model suggests an adaptive approach to find optimal stimulation parameters patient-specifically, based on real-time estimation of the position in state space. We discuss how the modelling work can be exploited to rationally design a successful stimulation protocol for the abatement of SW seizures using real-time SW detection.	[Taylor, Peter Neal; Wang, Yujiang] Newcastle Univ, Sch Comp Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Goodfellow, Marc] Univ Exeter, Coll Engn, Exeter, Devon, England; [Dauwels, Justin] Nanyang Technol Univ, Sch Elect & Elect Engn, Singapore 639798, Singapore; [Moeller, Friederike; Stephani, Ulrich] Univ Med Ctr Schleswig Holstein, Dept Neuropediat, Kiel, Germany; [Baier, Gerold] UCL, London, England	Newcastle University - UK; University of Exeter; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of Kiel; Schleswig Holstein University Hospital; University of London; University College London	Baier, G (corresponding author), UCL, London, England.	g.baier@ucl.ac.uk	Stephani, Ulrich/D-1004-2010; Taylor, Peter/E-8927-2011	Wang, Yujiang/0000-0002-4847-6273; Baier, Gerold/0000-0002-2540-3100; Moeller, Friederike/0000-0003-2434-2825; Taylor, Peter/0000-0003-2144-9838	EPSRC [EP/K026992/1]; BBSRC; DTC for Systems Biology (University of Manchester); Nanyang Technological University Singapore; Engineering and Physical Sciences Research Council [EP/K026992/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); DTC for Systems Biology (University of Manchester); Nanyang Technological University Singapore(Nanyang Technological University); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the EPSRC (EP/K026992/1), the BBSRC, the DTC for Systems Biology (University of Manchester), and the Nanyang Technological University Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Otaibi FA, 2011, NEUROSURGERY, V69, P957, DOI 10.1227/NEU.0b013e31822b30cd; AMARI SI, 1977, BIOL CYBERN, V27, P77, DOI 10.1007/BF00337259; Anderson WS, 2007, BIOL CYBERN, V97, P173, DOI 10.1007/s00422-007-0166-0; Avoli M, 2012, EPILEPSIA, V53, P779, DOI 10.1111/j.1528-1167.2012.03421.x; Barnes GN, 2008, NAT CLIN PRACT NEURO, V4, P650, DOI 10.1038/ncpneuro0947; Berenyi A, 2012, SCIENCE, V337, P735, DOI 10.1126/science.1223154; Breakspear M, 2006, CEREB CORTEX, V16, P1296, DOI 10.1093/cercor/bhj072; Cagnan H, 2013, BRAIN, V136, P3062, DOI 10.1093/brain/awt239; Caplan R, 2008, EPILEPSIA, V49, P1838, DOI 10.1111/j.1528-1167.2008.01680.x; Chakravarthy N, 2009, ANN BIOMED ENG, V37, P565, DOI 10.1007/s10439-008-9625-6; Conte A, 2007, NEUROSCI RES, V57, P140, DOI 10.1016/j.neures.2006.09.015; Cope DW, 2009, NAT MED, V15, P1392, DOI 10.1038/nm.2058; da Silva FL, 2003, EPILEPSIA, V44, P72, DOI 10.1111/j.0013-9580.2003.12005.x; Dedeurwaerdere S, 2004, EPILEPSY RES, V59, P191, DOI 10.1016/j.eplepsyres.2004.04.005; Destexhe A, 1998, J NEUROSCI, V18, P9099; Foss J, 2002, BIO MED PHY, P283; Frohlich F, 2010, J NEUROSCI, V30, P10734, DOI 10.1523/JNEUROSCI.1239-10.2010; Goodfellow M, 2011, NEUROIMAGE, V55, P920, DOI 10.1016/j.neuroimage.2010.12.074; Kramer MA, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.041928; Marten F, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.021911; McCormick DA, 2001, ANNU REV PHYSIOL, V63, P815, DOI 10.1146/annurev.physiol.63.1.815; Meeren H, 2005, ARCH NEUROL-CHICAGO, V62, P371, DOI 10.1001/archneur.62.3.371; Meeren HKM, 2002, J NEUROSCI, V22, P1480, DOI 10.1523/JNEUROSCI.22-04-01480.2002; MILTON J, 1995, CHAOS, V5, P8, DOI 10.1063/1.166103; Moeller F, 2008, EPILEPSIA, V49, P1510, DOI 10.1111/j.1528-1167.2008.01626.x; Moeller F, 2013, HUM BRAIN MAPP, V34, P1896, DOI 10.1002/hbm.22026; Moeller F, 2010, EPILEPSIA, V51, P2000, DOI 10.1111/j.1528-1167.2010.02698.x; Motamedi GK, 2002, EPILEPSIA, V43, P1441, DOI 10.1111/j.0013-9580.2002.4311a29.x; Oprisan SA, 2003, BIOPHYS J, V84, P2919, DOI 10.1016/S0006-3495(03)70019-8; Osorio I, 2009, INT J NEURAL SYST, V19, P149, DOI 10.1142/S0129065709001926; Paz JT, 2013, NAT NEUROSCI, V16, P64, DOI 10.1038/nn.3269; Pinault Didier, 2005, Thalamus & Related Systems, V3, P181, DOI 10.1017/S1472928807000209; RAJNA P, 1989, EPILEPSIA, V30, P168, DOI 10.1111/j.1528-1157.1989.tb05450.x; Robinson PA, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041924; Rodrigues S, 2006, PHYS LETT A, V355, P352, DOI 10.1016/j.physleta.2006.03.003; Saillet S, 2013, BRAIN STIMUL, V6, P241, DOI 10.1016/j.brs.2012.05.009; Selai C, 2005, EPILEPSIA, V46, P50, DOI 10.1111/j.1528-1167.2005.463010.x; Sinha N, 2014, P IEEE SMC; Steriade M, 1998, J NEUROPHYSIOL, V80, P1439, DOI 10.1152/jn.1998.80.3.1439; Suffczynski P, 2006, IEEE T BIO-MED ENG, V53, P524, DOI 10.1109/TBME.2005.869800; Suffczynski P, 2004, NEUROSCIENCE, V126, P467, DOI 10.1016/j.neuroscience.2004.03.014; Takens F, 1981, DYNAMICAL SYSTEMS TU, P366, DOI [10.1007/BFb0091924, DOI 10.1007/BFB0091924]; Taylor PN, 2013, 2013 IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE, COGNITIVE ALGORITHMS, MIND, AND BRAIN (CCMB), P53, DOI 10.1109/CCMB.2013.6609165; Taylor PN, 2014, J NEUROSCI METH, V236, P51, DOI 10.1016/j.jneumeth.2014.08.010; Taylor PN, 2013, BIOL CYBERN, V107, P83, DOI 10.1007/s00422-012-0534-2; Taylor PN, 2011, J COMPUT NEUROSCI, V31, P679, DOI 10.1007/s10827-011-0332-1; Terry JR, 2012, EPILEPSIA, V53, pe166, DOI 10.1111/j.1528-1167.2012.03560.x; THEILER J, 1995, PHYS LETT A, V196, P335, DOI 10.1016/0375-9601(94)00856-K; Wang YJ, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.061918; Yousif NAB, 2005, EUR J NEUROSCI, V22, P3179, DOI 10.1111/j.1460-9568.2005.04496.x	51	67	70	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e114316	10.1371/journal.pone.0114316	http://dx.doi.org/10.1371/journal.pone.0114316			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531883	Green Published, gold			2022-12-27	WOS:000348845100013
J	van der Linden, A; Blokker, BM; Kap, M; Weustink, AC; Riegman, PHJ; Oosterhuis, JW				van der Linden, Anita; Blokker, Britt M.; Kap, Marcel; Weustink, Annick C.; Riegman, Peter H. J.; Oosterhuis, J. Wolter			Post-Mortem Tissue Biopsies Obtained at Minimally Invasive Autopsy: An RNA-Quality Analysis	PLOS ONE			English	Article							MESSENGER-RNA; HETEROGENEITY; PERCEPTIONS; INTEGRITY	Introduction: Bereaved relatives often refuse to give consent for post-mortem investigation of deceased cancer patients, mainly because of the mutilation due to conventional autopsy (CA). Minimally invasive autopsy (MIA) may be a more acceptable alternative and, if implemented in clinical practice, creates an opportunity to more often obtain post-mortem tissue samples of (recurred) primary tumors and metastases for molecular research. As a measure for tissue quality for molecular studies, we hereby present a feasibility study, comparing the RNA quality of MIA and CA samples, and fresh frozen samples as reference. Materials and methods: Tissue samples of heart, liver and kidney were prospectively collected from 24 MIAs followed by CA, and compared to corresponding archival fresh frozen tissue. After RNA isolation and RT-qPCR, RNA integrity numbers (RIN) and GAPDH expression (six amplicon sizes ranging from 71 to 530 base pairs) were measured. RIN values and GAPDH Cq values were analyzed and compared between all sample groups and post-mortem intervals (PMI). Results: RIN values in MIA samples were significantly higher than those in CA samples. GAPDH was expressed significantly higher in MIA samples than in CA samples and 530 bp PCR products could be measured in all cases. GAPDH expression was significantly lower in samples with PMI >15 hours. As expected, the samples of the fresh frozen reference standard performed best in all analyses. Conclusion: MIA samples showed better RNA quality than CA samples, probably due to shorter PMI. Both had lower RNA quality and expression levels than fresh frozen tissue, however, remaining GAPDH RNA was still sufficiently intact. Therefore, other highly expressed genes are most likely also detectable. Gene array analysis should be performed to gain insight into the quality of entire postmortem genomes. Reducing PMI will further improve the feasibility of demanding molecular research on post-mortem tissues, this is most likely more feasible with MIA than CA.	[van der Linden, Anita; Blokker, Britt M.; Kap, Marcel; Riegman, Peter H. J.; Oosterhuis, J. Wolter] Erasmus MC, Dept Pathol, Rotterdam, Netherlands; [Weustink, Annick C.] Erasmus MC, Dept Radiol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Oosterhuis, JW (corresponding author), Erasmus MC, Dept Pathol, Rotterdam, Netherlands.	j.w.oosterhuis@erasmusmc.nl	Riegman, Peter/GLS-0041-2022; Cappello, Francesco/F-9153-2012	Cappello, Francesco/0000-0001-9288-1148	Muntendam Prize of the Dutch Cancer Society [md11.009]	Muntendam Prize of the Dutch Cancer Society	The work described in this article was funded by the Muntendam Prize of the Dutch Cancer Society 2011 (number md11.009, http://www.kwf.nl/english/pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aickin M, 1996, AM J PUBLIC HEALTH, V86, P726, DOI 10.2105/AJPH.86.5.726; Allison KH, 2014, ONCOLOGY WILLISTON P, V15, P28; Bauer Martin, 2003, Leg Med (Tokyo), V5, P220, DOI 10.1016/j.legalmed.2003.08.001; Beach TG, 2009, 2009 BRN S 27; Bedard PL, 2013, NATURE, V501, P355, DOI 10.1038/nature12627; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Birdsill AC, 2011, CELL TISSUE BANK, V12, P311, DOI 10.1007/s10561-010-9210-8; BROWN HG, 1990, HUM PATHOL, V21, P154, DOI 10.1016/0046-8177(90)90123-M; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Byard RW, 2012, FORENSIC SCI MED PAT, V8, P402, DOI 10.1007/s12024-012-9322-5; Finkbeiner WE, 2009, AUTOPSY PATHOLOGY MA, P93; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; Gupta S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-26; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heinrich M, 2007, INT J LEGAL MED, V121, P136, DOI 10.1007/s00414-006-0131-9; Hoefnagel LDC, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2645; Junttila MR, 2013, NATURE, V501, P346, DOI 10.1038/nature12626; Kim BJ, 2013, MOL VIS, V19, P1290; Koppelkamm A, 2011, INT J LEGAL MED, V125, P573, DOI 10.1007/s00414-011-0578-1; Kristensen T, 2011, APPL IMMUNOHISTO M M, V19, P460, DOI 10.1097/PAI.0b013e318214e523; Mager SR, 2007, EUR J CANCER, V43, P828, DOI 10.1016/j.ejca.2007.01.002; MCPHEE SJ, 1986, AM J MED, V80, P665, DOI 10.1016/0002-9343(86)90822-3; Oluwasola OA, 2009, ARCH PATHOL LAB MED, V133, P78, DOI 10.1043/1543-2165-133.1.78; Partemi S, 2010, FORENSIC SCI INT, V203, P99, DOI 10.1016/j.forsciint.2010.07.005; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Romero IG, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-42; Rubin MA, 2000, CLIN CANCER RES, V6, P1038; Sampaio-Silva F, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056507, 10.1371/annotation/cb8b37ac-cbe2-45e3-b9fe-d62e7ced4b25]; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Sieuwerts AM, 2009, BREAST CANCER RES TR, V118, P455, DOI 10.1007/s10549-008-0290-0; Stan AD, 2006, BRAIN RES, V1123, P1, DOI 10.1016/j.brainres.2006.09.025; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Vennemann M, 2010, FORENSIC SCI INT, V203, P76, DOI 10.1016/j.forsciint.2010.07.007; Viertler C, 2012, J MOL DIAGN, V14, P458, DOI 10.1016/j.jmoldx.2012.05.002; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049; Weustink AC, 2009, RADIOLOGY, V250, P897, DOI 10.1148/radiol.2503080421	36	29	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115675	10.1371/journal.pone.0115675	http://dx.doi.org/10.1371/journal.pone.0115675			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531551	gold, Green Published, Green Submitted			2022-12-27	WOS:000348845100091
J	Kendziorra, C; Meyer, H; Dewey, M				Kendziorra, Carsten; Meyer, Henning; Dewey, Marc			Implementation of a Phase Detection Algorithm for Dynamic Cardiac Computed Tomography Analysis Based on Time Dependent Contrast Agent Distribution	PLOS ONE			English	Article							PERFUSION CT; BLOOD-FLOW; ACCURACY	This paper presents a phase detection algorithm for four-dimensional (4D) cardiac computed tomography (CT) analysis. The algorithm detects a phase, i.e. a specific three-dimensional (3D) image out of several time-distributed 3D images, with high contrast in the left ventricle and low contrast in the right ventricle. The purpose is to use the automatically detected phase in an existing algorithm that automatically aligns the images along the heart axis. Decision making is based on the contrast agent distribution over time. It was implemented in KardioPerfusion - a software framework currently being developed for 4D CT myocardial perfusion analysis. Agreement of the phase detection algorithm with two reference readers was 97% (95% CI: 82-100%). Mean duration for detection was 0.020 s (95% CI: 0.018-0.022 s), which was 800 times less than the readers needed (16 +/- 7s, p<0.001). Thus, this algorithm is an accurate and fast tool that can improve work flow of clinical examinations.	[Kendziorra, Carsten; Meyer, Henning; Dewey, Marc] Charite, Dept Radiol, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Kendziorra, C (corresponding author), Charite, Dept Radiol, D-13353 Berlin, Germany.	carsten.kendziorra@charite.de		Dewey, Marc/0000-0002-4402-2733	Heisenberg Program of the DFG [DE 1361/14-1]; FP7 Program of the European Commission [6032662, HEALTH-2012.2.4.-2]; European Regional Development Fund [20072013 2/05, 20072013 2/48]; German Heart Foundation/German Foundation of Heart Research [F/23/08, F/27/10]; German Research Foundation (DFG) [01KG1013, 01KG1110]; German Federal Ministry of Education and Research (BMBF) [01KG1013, 01KG1110]; GE Healthcare; Bracco; Bracco, Guerbet; Toshiba Medical Systems; Guerbet; Cardiac MR Academy Berlin; Bayer (Schering-Berlex)	Heisenberg Program of the DFG(German Research Foundation (DFG)); FP7 Program of the European Commission; European Regional Development Fund(European Commission); German Heart Foundation/German Foundation of Heart Research; German Research Foundation (DFG)(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); GE Healthcare(General ElectricGE Healthcare); Bracco; Bracco, Guerbet; Toshiba Medical Systems; Guerbet; Cardiac MR Academy Berlin; Bayer (Schering-Berlex)	Prof. Dewey has received grant support from the Heisenberg Program of the DFG for a professorship (DE 1361/14-1), the FP7 Program of the European Commission for the randomized multicenter DISCHARGE trial (6032662, HEALTH-2012.2.4.-2), the European Regional Development Fund (20072013 2/05, 20072013 2/48), the German Heart Foundation/German Foundation of Heart Research (F/23/08, F/27/10), the Joint Program from the German Research Foundation (DFG) and the German Federal Ministry of Education and Research (BMBF) for meta-analyses (01KG1013, 01KG1110, 01KG1110), GE Healthcare, Bracco, Guerbet, and Toshiba Medical Systems. Prof. Dewey has received lecture fees from Toshiba Medical Systems, Guerbet, Cardiac MR Academy Berlin, and Bayer (Schering-Berlex). Prof. Dewey is a consultant to Guerbet and one of the principal investigators of multi-center studies (CORE-64 and 320) on coronary CT angiography sponsored by Toshiba Medical Systems. He is also the editor of Coronary CT Angiography and Cardiac CT, both published by Springer, and offers hands-on workshops on cardiovascular imaging (www.ct-kurs.de). Prof. Dewey is an associate editor of Radiology and European Radiology. Institutional master research agreements exist with Siemens Medical Solutions, Philips Medical Systems, and Toshiba Medical Systems. The terms of these arrangements are managed by the legal department of Charite-Universitatsmedizin Berlin. There were no financial conflicts for the other authors. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Christodoulou AG, 2011, IEEE ENG MED BIO, P3732, DOI 10.1109/IEMBS.2011.6090635; Chu S, 2013, SPINE, V38, pE1418, DOI 10.1097/BRS.0b013e3182a40838; deKemp RA, 1996, PHYSIOL MEAS, V17, P95, DOI 10.1088/0967-3334/17/2/004; Dewey M, 2009, CIRCULATION, V120, P867, DOI 10.1161/CIRCULATIONAHA.109.859280; Helck A, 2013, EUROPEAN RADIOLOGY, P1; Kawaji H, 2013, J NEURORADIOLOGY, V40, P303, DOI 10.1016/j.neurad.2013.04.005; Li H., 2013, PREPRINT, P1, DOI DOI 10.48550/ARXIV.1303.3997; Lowekamp B, 2013, BINSHRINK MULTIRESOL; Lv YT, 2013, ANN NEUROL, V73, P136, DOI 10.1002/ana.23763; Neto RS, 2013, EINSTEIN-SAO PAULO, V11, P400, DOI 10.1590/S1679-45082013000300025; Osimani M, 2012, AM J ROENTGENOL, V199, P1042, DOI 10.2214/AJR.11.8267; Prowle JR, 2012, CRIT CARE MED, V40, P1768, DOI 10.1097/CCM.0b013e318246bd85; Reiner CS, 2012, ACAD RADIOL, V19, P613, DOI 10.1016/j.acra.2011.12.015; Schertler T, 2009, ACAD RADIOL, V16, P708, DOI 10.1016/j.acra.2009.01.014; Shi JY, 2013, EUR J RADIOL, V82, pE894, DOI 10.1016/j.ejrad.2013.08.023; Snyder K, 2011, CLIN RADIOLOGY, V66, P566	17	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e116103	10.1371/journal.pone.0116103	http://dx.doi.org/10.1371/journal.pone.0116103			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545863	Green Submitted, Green Published, gold			2022-12-27	WOS:000347120200097
J	de Moraes, GP; Vieira, AAH				de Moraes, Guilherme Pavan; Augusto Henriques Vieira, Armando			Fourier Transform Infrared with Attenuated Total Reflectance Applied to the Discrimination of Freshwater Planktonic Coccoid Green Microalgae	PLOS ONE			English	Article							SELENASTRACEAE CHLOROPHYCEAE; FTIR SPECTROSCOPY; IDENTIFICATION; CLASSIFICATION; PHYLOGENY; BACTERIA; ALGAE; TOOL; ACID	Despite the recent advances on fine taxonomic discrimination in microorganisms, namely using molecular biology tools, some groups remain particularly problematic. Fine taxonomy of green algae, a widely distributed group in freshwater ecosystems, remains a challenge, especially for coccoid forms. In this paper, we propose the use of the Fourier Transform Infrared (FTIR) spectroscopy as part of a polyphasic approach to identify and classify coccoid green microalgae (mainly order Sphaeropleales), using triplicated axenic cultures. The attenuated total reflectance (ATR) technique was tested to reproducibility of IR spectra of the biological material, a primary requirement to achieve good discrimination of microalgal strains. Spectral window selection was also tested, in conjunction with the first derivative treatment of spectra, to determine which regions of the spectrum provided better separation and clustering of strains. The non-metric multidimensional scaling (NMDS), analysis of similarities (ANOSIM) and hierarchical clusters (HCA), demonstrated a correct discrimination and classification of closely related strains of chlorophycean coccoid microalgae, with respect to currently accepted classifications. FTIR-ATR was highly reproducible, and provided an excellent discrimination at the strain level. The best separation was achieved by analyzing the spectral windows of 1500-1200 cm(-1) and 900-675 cm(-1), which differs from those used in previously studies for the discrimination of broad algal groups, and excluding spectral regions related to storage compounds, which were found to give poor discrimination. Furthermore, hierarchical cluster analyses have positioned the strains tested into clades correctly, reproducing their taxonomic orders and families. This study demonstrates that FTIR-ATR has great potential to complement classical approaches for fine taxonomy of coccoid green microalgae, though a careful spectrum region selection is needed.	[de Moraes, Guilherme Pavan; Augusto Henriques Vieira, Armando] Univ Fed Sao Carlos, Dept Bot, Lab Phycol, BR-13560 Sao Carlos, SP, Brazil	Universidade Federal de Sao Carlos	de Moraes, GP (corresponding author), Univ Fed Sao Carlos, Dept Bot, Lab Phycol, BR-13560 Sao Carlos, SP, Brazil.	gpdemoraes@gmail.com			Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2011/50054-4]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Msc Scolarship	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Msc Scolarship	This research was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Grant Number 2011/50054-4, http://www.fapesp.br/ and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Msc Scolarship, http://www.capes.gov.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen R. A., 2005, ALGAL CULTURING TECH; Beardall J, 2001, AQUAT SCI, V63, P107, DOI 10.1007/PL00001342; Beebe K.R., 1998, CHEMOMETRICS PRACTIC, V1st; BROWN MR, 1991, J EXP MAR BIOL ECOL, V145, P79, DOI 10.1016/0022-0981(91)90007-J; Dean AP, 2010, BIORESOURCE TECHNOL, V101, P4499, DOI 10.1016/j.biortech.2010.01.065; Domenighini A, 2009, J PHYCOL, V45, P522, DOI 10.1111/j.1529-8817.2009.00662.x; Fawley MW, 2006, J PHYCOL, V42, P142, DOI 10.1111/j.1529-8817.2006.00169.x; Giordano M, 2001, J PHYCOL, V37, P271, DOI 10.1046/j.1529-8817.2001.037002271.x; Giordano M, 2009, PLANT ECOL DIVERS, V2, P155, DOI 10.1080/17550870903353088; Giroldo D, 2005, J PLANKTON RES, V27, P695, DOI 10.1093/plankt/fbi043; Griffiths MJ, 2009, J APPL PHYCOL, V21, P493, DOI 10.1007/s10811-008-9392-7; GUILLARD RR, 1972, J PHYCOL, V8, P10, DOI 10.1111/j.0022-3646.1972.00010.x; Harwood JL, 2009, BIOCHIMIE, V91, P679, DOI 10.1016/j.biochi.2008.11.004; Hegewald E, 2010, PHYCOLOGIA, V49, P325, DOI 10.2216/09-61.1; HELM D, 1991, J GEN MICROBIOL, V137, P69, DOI 10.1099/00221287-137-1-69; HELM D, 1991, J MICROBIOL METH, V14, P127, DOI 10.1016/0167-7012(91)90042-O; Hirschmugl CJ, 2006, INFRARED PHYS TECHN, V49, P57, DOI 10.1016/j.infrared.2006.01.032; Huss VAR, 1999, J PHYCOL, V35, P587, DOI 10.1046/j.1529-8817.1999.3530587.x; Kansiz M, 1999, PHYTOCHEMISTRY, V52, P407, DOI 10.1016/S0031-9422(99)00212-5; Krienitz L, 2001, J PHYCOL, V37, P852, DOI 10.1046/j.1529-8817.2001.01004.x; Krienitz L, 2012, HYDROBIOLOGIA, P1; Lang IK, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-124; Mariey L, 2001, VIB SPECTROSC, V26, P151, DOI 10.1016/S0924-2031(01)00113-8; Montechiaro F, 2006, PLANT CELL ENVIRON, V29, P2198, DOI 10.1111/j.1365-3040.2006.01593.x; NAUMANN D, 1988, J MOL STRUCT, V174, P165, DOI 10.1016/0022-2860(88)80152-2; Naumann D., 1985, Proceedings of the SPIE - The International Society for Optical Engineering, V553, P268, DOI 10.1117/12.970803; Naumann D., 2000, ENCY ANAL CHEM; NORRIS K P, 1959, J Hyg (Lond), V57, P326; Pace NR, 2009, MICROBIOL MOL BIOL R, V73, P565, DOI 10.1128/MMBR.00033-09; Preisner O, 2007, ANAL BIOANAL CHEM, V387, P1739, DOI 10.1007/s00216-006-0851-1; R Development Core Team, 2012, R LANG ENV STAT COMP; Rodolfi L, 2009, BIOTECHNOL BIOENG, V102, P100, DOI 10.1002/bit.22033; Sackett O, 2014, BIOGEOSCIENCES, V11, P5795, DOI 10.5194/bg-11-5795-2014; Stehfest K, 2005, PLANT PHYSIOL BIOCH, V43, P717, DOI 10.1016/j.plaphy.2005.07.001; Stuart B., 2004, INFRARED SPECTROSCOP, DOI DOI 10.1111/j.1750-3841.2008.00799.x; Thomas L. C, 1954, SPECTROCHIM ACTA, V6, P302, DOI DOI 10.1016/0371-1951(54)80013-0	36	2	3	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e114458	10.1371/journal.pone.0114458	http://dx.doi.org/10.1371/journal.pone.0114458			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541701	gold, Green Published, Green Submitted			2022-12-27	WOS:000347239900010
J	Herrnberger, L; Hennig, R; Kremer, W; Hellerbrand, C; Goepferich, A; Kalbitzer, HR; Tamm, ER				Herrnberger, Leonie; Hennig, Robert; Kremer, Werner; Hellerbrand, Claus; Goepferich, Achim; Kalbitzer, Hans Robert; Tamm, Ernst R.			Formation of Fenestrae in Murine Liver Sinusoids Depends on Plasmalemma Vesicle-Associated Protein and Is Required for Lipoprotein Passage	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; RAT-LIVER; PAL-E; PHENOTYPIC HETEROGENEITY; NMR-SPECTROSCOPY; PV-1; SIEVE; CAPILLARIES; METABOLISM; MECHANISMS	Liver sinusoidal endothelial cells (LSEC) are characterized by the presence of fenestrations that are not bridged by a diaphragm. The molecular mechanisms that control the formation of the fenestrations are largely unclear. Here we report that mice, which are deficient in plasmalemma vesicle-associated protein (PLVAP), develop a distinct phenotype that is caused by the lack of sinusoidal fenestrations. Fenestrations with a diaphragm were not observed in mouse LSEC at three weeks of age, but were present during embryonic life starting from embryonic day 12.5. PLVAP was expressed in LSEC of wild-type mice, but not in that of Plvap-deficient littermates. Plvap(-/)-LSEC showed a pronounced and highly significant reduction in the number of fenestrations, a finding, which was seen both by transmission and scanning electron microscopy. The lack of fenestrations was associated with an impaired passage of macromolecules such as FITC-dextran and quantum dot nanoparticles from the sinusoidal lumen into Disse's space. Plvap-deficient mice suffered from a pronounced hyperlipoproteinemia as evidenced by milky plasma and the presence of lipid granules that occluded kidney and liver capillaries. By NMR spectroscopy of plasma, the nature of hyperlipoproteinemia was identified as massive accumulation of chylomicron remnants. Plasma levels of low density lipoproteins (LDL) were also significantly increased as were those of cholesterol and triglycerides. In contrast, plasma levels of high density lipoproteins (HDL), albumin and total protein were reduced. At around three weeks of life, Plvap-deficient livers developed extensive multivesicular steatosis, steatohepatitis, and fibrosis. PLVAP is critically required for the formation of fenestrations in LSEC. Lack of fenestrations caused by PLVAP deficiency substantially impairs the passage of chylomicron remnants between liver sinusoids and hepatocytes, and finally leads to liver damage.	[Herrnberger, Leonie; Tamm, Ernst R.] Univ Regensburg, Dept Human Anat & Embryol, D-93053 Regensburg, Germany; [Hennig, Robert; Goepferich, Achim] Univ Regensburg, Dept Pharmaceut Technol, D-93053 Regensburg, Germany; [Kremer, Werner; Kalbitzer, Hans Robert] Univ Regensburg, Dept Biophys & Phys Biochem, D-93053 Regensburg, Germany; [Kremer, Werner; Kalbitzer, Hans Robert] Univ Regensburg, Ctr Magnet Resonance Chem & Biomed, D-93053 Regensburg, Germany; [Hellerbrand, Claus] Univ Regensburg, Dept Internal Med 1, D-93053 Regensburg, Germany	University of Regensburg; University of Regensburg; University of Regensburg; University of Regensburg; University of Regensburg	Tamm, ER (corresponding author), Univ Regensburg, Dept Human Anat & Embryol, D-93053 Regensburg, Germany.	ernst.tamm@vkl.uni-regensburg.de	Goepferich, Achim/G-1151-2016; Tamm, Ernst/AAB-9772-2019	Goepferich, Achim/0000-0002-7646-0252; Tamm, Ernst/0000-0002-6679-8743; Kalbitzer, Hans Robert/0000-0002-6514-2355	Deutsche Forschungsgemeinschaft [FOR 1075, TP5]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft (FOR 1075, TP5); www.dfg.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae; BANKSTON PW, 1980, AM J ANAT, V159, P1, DOI 10.1002/aja.1001590102; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Braet F, 1998, P NATL ACAD SCI USA, V95, P13635, DOI 10.1073/pnas.95.23.13635; Braet F, 1996, HEPATOLOGY, V24, P627; Braet Filip, 2002, Comp Hepatol, V1, P1, DOI 10.1186/1476-5926-1-1; Carpenter B, 2005, DEVELOPMENT, V132, P3293, DOI 10.1242/dev.01902; Chung CH, 2013, CLIN MOL HEPATOL, V19, P99, DOI 10.3350/cmh.2013.19.2.99; Cogger VC, 2006, ATHEROSCLEROSIS, V189, P273, DOI 10.1016/j.atherosclerosis.2005.12.025; Cohen DE, 2013, SEMIN LIVER DIS, V33, P380, DOI 10.1055/s-0033-1358519; DeLeve LD, 2007, SEMIN LIVER DIS, V27, P390, DOI 10.1055/s-2007-991515; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621; Fisher EA, 2012, ARTERIOSCL THROM VAS, V32, P2813, DOI 10.1161/ATVBAHA.112.300133; FRASER R, 1995, HEPATOLOGY, V21, P863, DOI 10.1016/0270-9139(95)90542-1; FREUND J, 1995, J BIOMOL NMR, V5, P321, DOI 10.1007/BF00211760; Gerber HP, 1999, DEVELOPMENT, V126, P1149; GHITESCU L, 1984, J CELL BIOL, V99, P639, DOI 10.1083/jcb.99.2.639; Guo JS, 2007, SEMIN LIVER DIS, V27, P413, DOI 10.1055/s-2007-991517; Hellerbrand C, 2013, PFLUG ARCH EUR J PHY, V465, P775, DOI 10.1007/s00424-012-1209-5; Herrnberger L, 2012, EXP EYE RES, V105, P27, DOI 10.1016/j.exer.2012.09.011; Herrnberger L, 2012, HISTOCHEM CELL BIOL, V138, P709, DOI 10.1007/s00418-012-0987-3; Ioannidou S, 2006, P NATL ACAD SCI USA, V103, P16770, DOI 10.1073/pnas.0603501103; Jacobs F, 2011, CARDIOVASC PATHOL, V20, P44, DOI 10.1016/j.carpath.2009.09.002; Jacobs F, 2010, AM J PATHOL, V176, P14, DOI 10.2353/ajpath.2010.090136; Jonas A, 2008, N COMP BIOC, P485, DOI 10.1016/B978-044453219-0.50019-2; Kawano Y, 2013, J GASTROENTEROL, V48, P434, DOI 10.1007/s00535-013-0758-5; Keuschnigg J, 2012, BLOOD, V120, P232, DOI 10.1182/blood-2012-01-406876; Keuschnigg J, 2009, BLOOD, V114, P478, DOI 10.1182/blood-2008-11-188763; Kremer W., 2005, Patents, Patent No. [US 7927878, 7927878]; Lee S, 2010, SEMIN THROMB HEMOST, V36, P352, DOI 10.1055/s-0030-1253457; Mansbach CM, 2010, ANNU REV PHYSIOL, V72, P315, DOI 10.1146/annurev-physiol-021909-135801; McCuskey RS, 2008, ANAT REC, V291, P661, DOI 10.1002/ar.20663; MCGUIRE RF, 1992, HEPATOLOGY, V15, P989, DOI 10.1002/hep.1840150603; NAITO M, 1978, CELL TISSUE RES, V190, P371; Niemela H, 2005, BLOOD, V106, P3405, DOI 10.1182/blood-2005-01-0254; Pelta MD, 2002, MAGN RESON CHEM, V40, pS147, DOI 10.1002/mrc.1107; Petersen AK, 2012, HUM MOL GENET, V21, P1433, DOI 10.1093/hmg/ddr580; Pollinger K, 2013, P NATL ACAD SCI USA, V110, P6115, DOI 10.1073/pnas.1220281110; Sarin H, 2010, VASC CELL, V2, DOI 10.1186/2040-2384-2-14; SCHAFFNER F, 1963, GASTROENTEROLOGY, V44, P239; Schuppan D, 2013, J CLIN INVEST, V123, P1887, DOI 10.1172/JCI66028; Shearer GC, 2006, KIDNEY INT, V70, P647, DOI 10.1038/sj.ki.5000318; Stan RV, 2012, DEV CELL, V23, P1203, DOI 10.1016/j.devcel.2012.11.003; Stan RV, 1999, J CELL BIOL, V145, P1189, DOI 10.1083/jcb.145.6.1189; Stan RV, 2001, GENOMICS, V72, P304, DOI 10.1006/geno.2000.6489; Stan RV, 1999, P NATL ACAD SCI USA, V96, P13203, DOI 10.1073/pnas.96.23.13203; Stan RV, 2005, BBA-MOL CELL RES, V1746, P334, DOI 10.1016/j.bbamcr.2005.08.008; Svistounov D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046134; WILLNOW TE, 1995, P NATL ACAD SCI USA, V92, P4537, DOI 10.1073/pnas.92.10.4537; Willnow TE, 1997, DIABETIC MED, V14, pS75, DOI 10.1002/(SICI)1096-9136(199708)14:3+<S75::AID-DIA449>3.3.CO;2-0; Wisse E, 2008, GENE THER, V15, P1193, DOI 10.1038/gt.2008.60; WISSE E, 1985, HEPATOLOGY, V5, P683, DOI 10.1002/hep.1840050427; Wisse E, 1996, TOXICOL PATHOL, V24, P100, DOI 10.1177/019262339602400114	54	40	44	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115005	10.1371/journal.pone.0115005	http://dx.doi.org/10.1371/journal.pone.0115005			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541982	Green Submitted, Green Published, gold			2022-12-27	WOS:000347239900017
J	Kornthong, N; Cummins, SF; Chotwiwatthanakun, C; Khornchatri, K; Engsusophon, A; Hanna, PJ; Sobhon, P				Kornthong, Napamanee; Cummins, Scott F.; Chotwiwatthanakun, Charoonroj; Khornchatri, Kanjana; Engsusophon, Attakorn; Hanna, Peter J.; Sobhon, Prasert			Identification of Genes Associated with Reproduction in the Mud Crab (Scylla olivacea) and Their Differential Expression following Serotonin Stimulation	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; PIGMENT-CONCENTRATING HORMONE; CRAYFISH PROCAMBARUS-CLARKII; GIANT TIGER SHRIMP; METHYL FARNESOATE; OVARIAN MATURATION; WHITE SHRIMP; MANDIBULAR ORGAN; ESTROGEN SULFOTRANSFERASE; LITOPENAEUS-VANNAMEI	The central nervous system (CNS) is often intimately involved in reproduction control and is therefore a target organ for transcriptomic investigations to identify reproduction-associated genes. In this study, 454 transcriptome sequencing was performed on pooled brain and ventral nerve cord of the female mud crab (Scylla olivacea) following serotonin injection (5 mu g/g BW). A total of 197,468 sequence reads was obtained with an average length of 828 bp. Approximately 38.7% of 2,183 isotigs matched with significant similarity (E value < 1e(-4)) to sequences within the Genbank non-redundant (nr) database, with most significant matches being to crustacean and insect sequences. Approximately 32 putative neuropeptide genes were identified from nonmatching blast sequences. In addition, we identified full-length transcripts for crustacean reproductive-related genes, namely farnesoic acid o-methyltransferase (FAMeT), estrogen sulfotransferase (ESULT) and prostaglandin F synthase (PGFS). Following serotonin injection, which would normally initiate reproductive processes, we found up-regulation of FAMeT, ESULT and PGFS expression in the female CNS and ovary. Our data here provides an invaluable new resource for understanding the molecular role of the CNS on reproduction in S. olivacea.	[Kornthong, Napamanee] Thammasat Univ, Chulabhorn Int Coll Med, Pathum Thani 12121, Thailand; [Kornthong, Napamanee; Chotwiwatthanakun, Charoonroj; Khornchatri, Kanjana; Engsusophon, Attakorn; Hanna, Peter J.; Sobhon, Prasert] Mahidol Univ, Fac Sci, Dept Anat, Bangkok 10400, Thailand; [Cummins, Scott F.] Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, Maroochydore, Qld 4558, Australia; [Chotwiwatthanakun, Charoonroj] Mahidol Univ, Nakhonsawan 60130, Thailand; [Hanna, Peter J.] Deakin Univ, Fac Sci Engn & Built Environm, Pro Vice Chancellors Off, Geelong, Vic 3220, Australia	Chulabhorn Research Institute; Thammasat University; Mahidol University; University of the Sunshine Coast; Mahidol University; Deakin University	Cummins, SF (corresponding author), Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, Maroochydore, Qld 4558, Australia.	scummins@usc.edu.au; prasert.sob@mahidol.ac.th	Chotwiwatthanakun, Charoonroj/T-4838-2019; Kornthong, Napamanee/J-4827-2014; Cummins, Scott/I-6420-2016	Kornthong, Napamanee/0000-0002-0422-2546; Cummins, Scott/0000-0002-1454-2076; Chotwiwatthanakun, Charoonroj/0000-0001-9137-8444	Distinguished Research Professor Grant; Thailand Research Fund; Commission on Higher Education (CHE); Mahidol University; Australian Research Council; CHE-Ph.D. Scholarship	Distinguished Research Professor Grant; Thailand Research Fund(Thailand Research Fund (TRF)); Commission on Higher Education (CHE)(Office of Higher Education Commission (OHEC)); Mahidol University; Australian Research Council(Australian Research Council); CHE-Ph.D. Scholarship	The study was financially supported by grants of a Distinguished Research Professor Grant, co-funded by the Thailand Research Fund, the Commission on Higher Education (CHE), and Mahidol University (to P. Sobhon), the Australian Research Council (to S. F. Cummins), and a CHE-Ph.D. Scholarship (to N. Kornthong). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Borst DW, 2001, AM ZOOL, V41, P430, DOI 10.1668/0003-1569(2001)041[0430:ROTCMO]2.0.CO;2; Claerhout T, 1996, BIOL BULL, V191, P304, DOI 10.1086/BBLv191n2p304; Cole GB, 2010, P NATL ACAD SCI USA, V107, P6222, DOI 10.1073/pnas.0914904107; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; David P, 2003, MOL ECOL, V12, P2473, DOI 10.1046/j.1365-294X.2003.01913.x; DIRCKSEN H, 1988, CELL TISSUE RES, V251, P3, DOI 10.1007/BF00215441; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gao J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-585; Goodsell DS, 2006, ONCOLOGIST, V11, P418, DOI 10.1634/theoncologist.11-4-418; Guan ZB, 2014, AQUACULTURE, V418, P67, DOI 10.1016/j.aquaculture.2013.10.010; He L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033735, 10.1371/journal.pone.0045607]; Heckmann LH, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-11; Homola E, 1997, COMP BIOCHEM PHYS B, V117, P347, DOI 10.1016/S0305-0491(96)00337-9; Hui JHL, 2010, PEPTIDES, V31, P451, DOI 10.1016/j.peptides.2009.10.003; Hui JHL, 2008, PEPTIDES, V29, P252, DOI 10.1016/j.peptides.2007.08.033; Jiang HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105122; Jo QT, 1999, INVERTEBR REPROD DEV, V36, P79, DOI 10.1080/07924259.1999.9652681; Jung H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027938; Kornthong N, 2014, MICROSC RES TECHNIQ, V77, P189, DOI 10.1002/jemt.22327; Kornthong N, 2013, GEN COMP ENDOCR, V185, P28, DOI 10.1016/j.ygcen.2013.01.011; Kwok R, 2005, J INSECT PHYSIOL, V51, P367, DOI 10.1016/j.jinsphys.2004.12.010; LANDAU M, 1989, INVERTEBR REPROD DEV, V16, P165, DOI 10.1080/07924259.1989.9672073; Laufer H, 1998, GEN COMP ENDOCR, V111, P113, DOI 10.1006/gcen.1998.7109; Leekitcharoenphon Pimlapas, 2010, BMC Research Notes, V3, DOI 10.1186/1756-0500-3-295; Leelatanawit R, 2009, COMP BIOCHEM PHYS A, V152, P66, DOI 10.1016/j.cbpa.2008.09.004; Leopoldo J, 2010, AQUACULTURE, V310, P84, DOI 10.1016/j.aquaculture.2010.09.038; Leu JH, 2011, MAR BIOTECHNOL, V13, P608, DOI 10.1007/s10126-010-9286-y; Ma KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039727; Makkapan W, 2011, AQUACULTURE, V321, P101, DOI 10.1016/j.aquaculture.2011.08.016; MANGERICH S, 1986, CELL TISSUE RES, V245, P377; Miki Y, 2002, J CLIN ENDOCR METAB, V87, P5760, DOI 10.1210/jc.2002-020670; Min XJ, 2005, NUCLEIC ACIDS RES, V33, pW677, DOI 10.1093/nar/gki394; Nagaraju GPC, 2003, CRUSTACEANA, V76, P1171, DOI 10.1163/156854003773123401; Nagaraju GPC, 2004, AQUACULTURE, V232, P603, DOI [10.1016/S0044-8486(03)00519-2, 10.1016/s0044-8486(03)00519-2]; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; QUINITIO ET, 1994, COMP BIOCHEM PHYS C, V109, P21, DOI 10.1016/0742-8413(94)00044-B; Reddy PR, 2004, J CRUSTACEAN BIOL, V24, P511, DOI 10.1651/C-2478; Rowley AF, 2005, J EXP BIOL, V208, P3, DOI 10.1242/jeb.01275; Ruan YC, 2011, PHYSIOLOGY, V26, P156, DOI 10.1152/physiol.00036.2010; Song WC, 2001, ANN NY ACAD SCI, V948, P43; Sousa GL, 2008, GEN COMP ENDOCR, V156, P454, DOI 10.1016/j.ygcen.2008.03.008; Southey BR, 2006, NUCLEIC ACIDS RES, V34, pW267, DOI 10.1093/nar/gkl161; SPAZIANI EP, 1993, J COMP PHYSIOL B, V163, P541, DOI 10.1007/BF00302112; Stollewerk Angelika, 2010, J Biol, V9, P21, DOI 10.1186/jbiol212; Sullivan JM, 2005, J NEUROBIOL, V65, P157, DOI 10.1002/neu.20195; Tahara D, 2003, AQUACULTURE, V220, P791, DOI 10.1016/S0044-8486(02)00402-7; Tassanakajon A, 2006, GENE, V384, P104, DOI 10.1016/j.gene.2006.07.012; Tinikul Y, 2011, CELL TISSUE RES, V345, P103, DOI 10.1007/s00441-011-1176-8; Tinikul Y, 2009, CRUSTACEANA, V82, P1007, DOI 10.1163/156854009X448844; Vaca AA, 2000, AQUACULTURE, V182, P373, DOI 10.1016/S0044-8486(99)00267-7; Wainwright G, 1998, BIOCHEM J, V334, P651, DOI 10.1042/bj3340651; Wang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084921; Wanggren K, 2008, HUM REPROD, V23, P2359, DOI 10.1093/humrep/den260; Warrier SR, 2001, COMP BIOCHEM PHYS A, V130, P283, DOI 10.1016/S1095-6433(01)00385-3; Wimuttisuk W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076934	56	17	17	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115867	10.1371/journal.pone.0115867	http://dx.doi.org/10.1371/journal.pone.0115867			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542017	Green Published, Green Submitted, gold			2022-12-27	WOS:000347239900099
J	Lee, A; Kanuri, N; Zhang, YH; Sayuk, GS; Li, E; Ciorba, MA				Lee, Alexander; Kanuri, Navya; Zhang, Yuanhao; Sayuk, Gregory S.; Li, Ellen; Ciorba, Matthew A.			IDO1 and IDO2 Non-Synonymous Gene Variants: Correlation with Crohn's Disease Risk and Clinical Phenotype	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; INDOLEAMINE 2,3 DIOXYGENASE; TRYPTOPHAN; 2,3-DIOXYGENASE; EXPRESSION; CANCER	Background: Crohn's disease (CD) is a chronic inflammatory disease of the gastrointestinal tract. Genetic polymorphisms can confer CD risk and influence disease phenotype. Indoleamine 2,3 dioxygenase-1 (IDO1) is one of the most over-expressed genes in CD and mediates potent anti-inflammatory effects via tryptophan metabolism along the kynurenine pathway. We aimed to determine whether non-synonymous polymorphisms in IDO1 or IDO2 (a gene paralog) are important either as CD risk alleles or as modifiers of CD phenotype. Methods: Utilizing a prospectively collected database, clinically phenotyped CD patients (n=734) and non-IBD controls (n=354) were genotyped for established IDO1 and IDO2 non-synonymous single nucleotide polymorphisms (SNPs) and novel genetic variants elucidated in the literature. Allelic frequencies between CD and non-IBD controls were compared. Genotype-phenotype analysis was conducted. IDO1 enzyme activity was assessed by calculating the serum kynurenine to tryptophan ratio (K/T). Results: IDO1 SNPs were rare (1.7% non-IBD vs 1.1% CD; p=NS) and not linked to Crohn's disease diagnosis in this population. IDO1 SNPs did however associate with a severe clinical course, presence of perianal disease, extraintestinal manifestations and a reduced serum K/T ratio during active disease suggesting lower IDO1 function. IDO2 minor allele variants were common and one of them, rs45003083, associated with reduced risk of Crohn's disease (p=0.025). No IDO2 SNPs associated with a particular Crohn's disease clinical phenotype. Conclusions: This work highlights the functional importance of IDO enzymes in human Crohn's disease and establishes relative rates of IDO genetic variants in a US population.	[Lee, Alexander; Kanuri, Navya; Sayuk, Gregory S.; Ciorba, Matthew A.] Washington Univ, Sch Med, Div Gastroenterol, St Louis, MO 63110 USA; [Zhang, Yuanhao] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA; [Sayuk, Gregory S.] Vet Affairs Med Ctr, John Cochrane Div, Div Gastroenterol, St Louis, MO USA; [Li, Ellen] SUNY Stony Brook, Div Gastroenterol, Stony Brook, NY 11794 USA	Washington University (WUSTL); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; US Department of Veterans Affairs; Veterans Health Administration (VHA); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Ciorba, MA (corresponding author), Washington Univ, Sch Med, Div Gastroenterol, St Louis, MO 63110 USA.	mciorba@wustl.edu			National Institutes of Health [DK089016, DK100737, AI095776, P30 DK52574, DK084113]; Crohn's and Colitis Foundation of America Career Development Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574, R03DK100737, K23DK084113, K08DK089016] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America Career Development Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK089016, DK100737 and AI095776 to MAC; P30 DK52574 to the Washington University Digestive Diseases Research Core Center; DK084113 to GSS; a Crohn's and Colitis Foundation of America Career Development Award to MAC. AL was a scholar of The Mentors in Medicine Program and the Clinical Science Training and Research Pathway in the Department of Medicine at Washington University in St Louis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arefayene M, 2009, PHARMACOGENET GENOM, V19, P464, DOI 10.1097/FPC.0b013e32832c005a; Beatty GL, 2013, J CLIN ONCOL, V31; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cader MZ, 2013, GUT, V62, P1653, DOI 10.1136/gutjnl-2012-303955; Chen HY, 2011, DIS COLON RECTUM, V54, P1020, DOI 10.1007/DCR.0b013e31821b94b3; Cho JH, 2011, GASTROENTEROLOGY, V140, P1704, DOI 10.1053/j.gastro.2011.02.046; Choi BK, 2006, CYTOKINE, V34, P233, DOI 10.1016/j.cyto.2006.04.008; Ciorba MA, 2013, CURR OPIN GASTROEN, V29, P146, DOI 10.1097/MOG.0b013e32835c9cb3; Ciorba MA, 2010, J IMMUNOL, V184, P3907, DOI 10.4049/jimmunol.0900291; Cutler JA, 2012, J PSYCHOPHARMACOL, V26, P360, DOI 10.1177/0269881111434622; Ferdinande L, 2008, INT J IMMUNOPATH PH, V21, P289, DOI 10.1177/039463200802100205; Fields KK, 2013, J CLIN ONCOL, V31, DOI 10.1200/jco.2013.31.31_suppl.96; Fowler EV, 2005, J MED GENET, V42, P523, DOI 10.1136/jmg.2004.027425; Fujigaki H, 2012, ANAL BIOANAL CHEM, V403, P1777, DOI 10.1007/s00216-012-5946-2; Fukunaga M, 2012, J HISTOCHEM CYTOCHEM; Gupta NK, 2012, INFLAMM BOWEL DIS, V18, P1214, DOI 10.1002/ibd.21849; Gurtner GJ, 2003, GASTROENTEROLOGY, V125, P1762, DOI 10.1053/j.gastro.2003.08.031; Iskandar HN, 2012, TRANSL RES, V159, P313, DOI 10.1016/j.trsl.2012.01.001; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Lichtenstein GR, 2009, AM J GASTROENTEROL, V104, P465, DOI 10.1038/ajg.2008.168; Lob S, 2009, CANCER IMMUNOL IMMUN, V58, P153, DOI 10.1007/s00262-008-0513-6; Mahanonda R, 2007, J IMMUNOL, V178, P1151, DOI 10.4049/jimmunol.178.2.1151; Metz R, 2014, INT IMMUNOL; Metz R, 2007, CANCER RES, V67, P7082, DOI 10.1158/0008-5472.CAN-07-1872; Munn DH, 2013, TRENDS IMMUNOL, V34, P137, DOI 10.1016/j.it.2012.10.001; Nishizawa H, 2010, AM J REPROD IMMUNOL, V64, P68, DOI 10.1111/j.1600-0897.2010.00820.x; Prendergast GC, 2011, CURR MED CHEM, V18, P2257, DOI 0929-8673/11 $58.00+.00; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; Schrocksnadel K, 2006, CLIN CHIM ACTA, V364, P82, DOI 10.1016/j.cca.2005.06.013; Schroecksnadel K, 2006, CLIN RHEUMATOL, V25, P334, DOI 10.1007/s10067-005-0056-6; Tardito S, 2013, HUM IMMUNOL, V74, P166, DOI 10.1016/j.humimm.2012.11.008; Thaker AI, 2013, GASTROENTEROLOGY, V145, P416, DOI 10.1053/j.gastro.2013.05.002; Widner B, 1997, CLIN CHEM, V43, P2424; Witkiewicz AK, 2009, J AM COLL SURGEONS, V208, P781, DOI 10.1016/j.jamcollsurg.2008.12.018; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Zhang TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037139	36	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115848	10.1371/journal.pone.0115848	http://dx.doi.org/10.1371/journal.pone.0115848			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541686	gold, Green Published, Green Submitted			2022-12-27	WOS:000347239900097
J	Murata, T; Hamada, T; Shimokawa, T; Tanifuji, M; Yanagida, T				Murata, Tsutomu; Hamada, Takashi; Shimokawa, Tetsuya; Tanifuji, Manabu; Yanagida, Toshio			Stochastic Process Underlying Emergent Recognition of Visual Objects Hidden in Degraded Images	PLOS ONE			English	Article							PERCEPTUAL DECISION-MAKING; TOP-DOWN FACILITATION; INFEROTEMPORAL CORTEX; REVERSE HIERARCHY; NEURONS; ACTIVATION; MODELS; CHOICE; ORGANIZATION; MECHANISMS	When a degraded two-tone image such as a "Mooney'' image is seen for the first time, it is unrecognizable in the initial seconds. The recognition of such an image is facilitated by giving prior information on the object, which is known as top-down facilitation and has been intensively studied. Even in the absence of any prior information, however, we experience sudden perception of the emergence of a salient object after continued observation of the image, whose processes remain poorly understood. This emergent recognition is characterized by a comparatively long reaction time ranging from seconds to tens of seconds. In this study, to explore this time-consuming process of emergent recognition, we investigated the properties of the reaction times for recognition of degraded images of various objects. The results show that the time-consuming component of the reaction times follows a specific exponential function related to levels of image degradation and subject's capability. Because generally an exponential time is required for multiple stochastic events to co-occur, we constructed a descriptive mathematical model inspired by the neurophysiological idea of combination coding of visual objects. Our model assumed that the coincidence of stochastic events complement the information loss of a degraded image leading to the recognition of its hidden object, which could successfully explain the experimental results. Furthermore, to see whether the present results are specific to the task of emergent recognition, we also conducted a comparison experiment with the task of perceptual decision making of degraded images, which is well known to be modeled by the stochastic diffusion process. The results indicate that the exponential dependence on the level of image degradation is specific to emergent recognition. The present study suggests that emergent recognition is caused by the underlying stochastic process which is based on the coincidence of multiple stochastic events.	[Murata, Tsutomu; Shimokawa, Tetsuya; Yanagida, Toshio] Natl Inst Informat & Commun Technol, Ctr Informat & Neural Networks, Suita, Osaka, Japan; [Murata, Tsutomu; Shimokawa, Tetsuya; Yanagida, Toshio] Osaka Univ, Suita, Osaka, Japan; [Murata, Tsutomu; Hamada, Takashi; Shimokawa, Tetsuya; Yanagida, Toshio] NICT, Adv ICT Res Ctr, Kobe, Hyogo, Japan; [Hamada, Takashi; Shimokawa, Tetsuya; Yanagida, Toshio] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka, Japan; [Tanifuji, Manabu] RIKEN, Brain Sci Inst, Lab Integrat Neural Syst, Wako, Saitama, Japan	National Institute of Information & Communications Technology (NICT) - Japan; Osaka University; National Institute of Information & Communications Technology (NICT) - Japan; Osaka University; RIKEN	Murata, T (corresponding author), Natl Inst Informat & Commun Technol, Ctr Informat & Neural Networks, Suita, Osaka, Japan.	benmura@nict.go.jp	Tanifuji, Manabu/H-1744-2019	Tanifuji, Manabu/0000-0001-7754-7774	Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Society for the Promotion of Science, Japan [25120004]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported in part by the "Special Coordination Funds for Promoting Science and Technology: Yuragi Project" and the "Global COE Program: Center of Human-Friendly Robotics Based on Cognitive Neuroscience" of the Ministry of Education, Culture, Sports, Science and Technology, Japan. MT was supported by "Grant-in-Aid for Scientific Research on Innovative Areas, Sparse Modeling (25120004)" of Japan Society for the Promotion of Science, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahissar M, 2004, TRENDS COGN SCI, V8, P457, DOI 10.1016/j.tics.2004.08.011; AUDLEY RJ, 1965, BRIT J MATH STAT PSY, V18, P207, DOI 10.1111/j.2044-8317.1965.tb00342.x; Bar M, 2003, J COGNITIVE NEUROSCI, V15, P600, DOI 10.1162/089892903321662976; Bar M, 2004, NAT REV NEUROSCI, V5, P617, DOI 10.1038/nrn1476; Bogacz R, 2006, PSYCHOL REV, V113, P700, DOI 10.1037/0033-295X.113.4.700; Camprodon JA, 2010, J COGNITIVE NEUROSCI, V22, P1262, DOI 10.1162/jocn.2009.21253; Cox DR, 1966, STAT ANAL SERIES EVE; Dakin SC, 2002, CURR BIOL, V12, pR476, DOI 10.1016/S0960-9822(02)00960-0; DESIMONE R, 1984, J NEUROSCI, V4, P2051; Dolan RJ, 1997, NATURE, V389, P596, DOI 10.1038/39309; Edelman G, 2001, ANN NY ACAD SCI, V929, P111; Eger E, 2007, CEREB CORTEX, V17, P2123, DOI 10.1093/cercor/bhl119; Evans M, 2000, STAT DISTRIBUTIONS, P85; FUJITA I, 1992, NATURE, V360, P343, DOI 10.1038/360343a0; GIRARD P, 1989, J NEUROPHYSIOL, V62, P1287, DOI 10.1152/jn.1989.62.6.1287; Goffaux V, 2004, NEUROSCI LETT, V354, P14, DOI 10.1016/j.neulet.2003.09.029; Heekeren HR, 2004, NATURE, V431, P859, DOI 10.1038/nature02966; Hegde J, 2010, J NEUROSCI, V30, P15124, DOI 10.1523/JNEUROSCI.4415-09.2010; Ho TC, 2009, J NEUROSCI, V29, P8675, DOI 10.1523/JNEUROSCI.5984-08.2009; Hsieh PJ, 2010, J NEUROPHYSIOL, V103, P1501, DOI 10.1152/jn.00812.2009; James TW, 2000, CURR BIOL, V10, P1017, DOI 10.1016/S0960-9822(00)00655-2; Juan CH, 2003, EXP BRAIN RES, V150, P259, DOI 10.1007/s00221-003-1478-5; Koch Christof, 1999, P1; Koivisto M, 2011, J NEUROSCI, V31, P2488, DOI 10.1523/JNEUROSCI.3074-10.2011; Kriegeskorte N, 2008, NEURON, V60, P1126, DOI 10.1016/j.neuron.2008.10.043; Lamme VAF, 2006, TRENDS COGN SCI, V10, P494, DOI 10.1016/j.tics.2006.09.001; Lansky P, 2006, J COMPUT NEUROSCI, V21, P211, DOI 10.1007/s10827-006-8527-6; Lebedev NN, 1972, SPECIAL FUNCTIONS TH, P5; Luce RD, 1986, RESPONSE TIMES THEIR; Ludmer R, 2011, NEURON, V69, P1002, DOI 10.1016/j.neuron.2011.02.013; McKeeff TJ, 2007, CEREB CORTEX, V17, P669, DOI 10.1093/cercor/bhk015; Newcombe R. G., 2000, STAT CONFIDENCE, V2, P45; O'Connell RG, 2012, NAT NEUROSCI, V15, P1729, DOI 10.1038/nn.3248; Pascual-Leone A, 2001, SCIENCE, V292, P510, DOI 10.1126/science.1057099; Philiastides MG, 2006, CEREB CORTEX, V16, P509, DOI 10.1093/cercor/bhi130; Pike G., 2005, COGNITIVE PSYCHOL, P71; Pins D, 1996, PERCEPT PSYCHOPHYS, V58, P390, DOI 10.3758/BF03206815; Pollen DA, 1999, CEREB CORTEX, V9, P4, DOI 10.1093/cercor/9.1.4; Ratcliff R, 1999, PSYCHOL REV, V106, P261, DOI 10.1037/0033-295X.106.2.261; Ratcliff R, 1998, PSYCHOL SCI, V9, P347, DOI 10.1111/1467-9280.00067; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; REYNOLDS RI, 1985, PERCEPTION, V14, P49, DOI 10.1068/p140049; Rock I., 1984, PERCEPTION; Rossion B, 2004, PERCEPTION, V33, P217, DOI 10.1068/p5117; Sato T, 2009, CEREB CORTEX, V19, P1870, DOI 10.1093/cercor/bhn218; Smith PL, 2004, TRENDS NEUROSCI, V27, P161, DOI 10.1016/j.tins.2004.01.006; TallonBaudry C, 1997, J NEUROSCI, V17, P722; TANAKA K, 1991, J NEUROPHYSIOL, V66, P170, DOI 10.1152/jn.1991.66.1.170; Thielscher A, 2007, J NEUROSCI, V27, P2908, DOI 10.1523/JNEUROSCI.3024-06.2007; Tovee MJ, 1996, NEUROREPORT, V7, P2757, DOI 10.1097/00001756-199611040-00070; Tsodyks M, 1999, SCIENCE, V286, P1943, DOI 10.1126/science.286.5446.1943; Tsunoda K, 2001, NAT NEUROSCI, V4, P832, DOI 10.1038/90547; Ullman S., 1996, HIGH LEVEL VISION OB; Ungerleider LG, 2011, VISION RES, V51, P782, DOI 10.1016/j.visres.2010.10.002; Voss A, 2008, J MATH PSYCHOL, V52, P1, DOI 10.1016/j.jmp.2007.09.005; Voss A, 2007, BEHAV RES METHODS, V39, P767, DOI 10.3758/BF03192967; Yamane Y, 2006, J NEUROPHYSIOL, V96, P3147, DOI 10.1152/jn.01224.2005	57	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115658	10.1371/journal.pone.0115658	http://dx.doi.org/10.1371/journal.pone.0115658			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX9RO	25542034	Green Published, Green Submitted, gold			2022-12-27	WOS:000347239900063
J	Neupane, B; Richer, D; Bonner, AJ; Kibret, T; Beyene, J				Neupane, Binod; Richer, Danielle; Bonner, Ashley Joel; Kibret, Taddele; Beyene, Joseph			Network Meta-Analysis Using R: A Review of Currently Available Automated Packages	PLOS ONE			English	Article							MIXED TREATMENT COMPARISONS; RANDOMIZED CONTROLLED-TRIALS; META-REGRESSION; CONSISTENCY	Network meta-analysis (NMA) - a statistical technique that allows comparison of multiple treatments in the same meta-analysis simultaneously - has become increasingly popular in the medical literature in recent years. The statistical methodology underpinning this technique and software tools for implementing the methods are evolving. Both commercial and freely available statistical software packages have been developed to facilitate the statistical computations using NMA with varying degrees of functionality and ease of use. This paper aims to introduce the reader to three R packages, namely, gemtc, pcnetmeta, and netmeta, which are freely available software tools implemented in R. Each automates the process of performing NMA so that users can perform the analysis with minimal computational effort. We present, compare and contrast the availability and functionality of different important features of NMA in these three packages so that clinical investigators and researchers can determine which R packages to implement depending on their analysis needs. Four summary tables detailing (i) data input and network plotting, (ii) modeling options, (iii) assumption checking and diagnostic testing, and (iv) inference and reporting tools, are provided, along with an analysis of a previously published dataset to illustrate the outputs available from each package. We demonstrate that each of the three packages provides a useful set of tools, and combined provide users with nearly all functionality that might be desired when conducting a NMA.	[Neupane, Binod; Richer, Danielle; Bonner, Ashley Joel; Beyene, Joseph] McMaster Univ, Dept Clin Epidemiol & Biostatist, Hamilton, ON L8S 4K1, Canada; [Kibret, Taddele; Beyene, Joseph] McMaster Univ, Dept Math & Stat, Hamilton, ON L8S 4K1, Canada	McMaster University; McMaster University	Beyene, J (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostatist, MDCL 3200,1280 Main St West, Hamilton, ON L8S 4K1, Canada.	beyene@mcmaster.ca	Kibret, Taddele/AAM-1388-2020		NSERC; CIHR	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR(Canadian Institutes of Health Research (CIHR))	Funding: Funding for this work came form NSERC and CIHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bafeta A, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1741; Beyene J, 2014, NETWORK METAANALYSIS, P117; Biondi-Zoccai G, 2014, NETWORK METAANALYSIS, P103; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Bucher HC, 1997, J CLIN EPIDEMIOL, V50, P683, DOI 10.1016/S0895-4356(97)00049-8; Cipriani A, 2013, ANN INTERN MED, V159, P130, DOI 10.7326/0003-4819-159-2-201307160-00008; Dias S, 2010, STAT MED, V29, P932, DOI 10.1002/sim.3767; Dias S, 2013, MED DECIS MAKING, V33, P618, DOI 10.1177/0272989X13485157; Dias S, 2013, MED DECIS MAKING, V33, P607, DOI 10.1177/0272989X12458724; Donegan S, 2013, RES SYNTH METHODS, V4, P291, DOI 10.1002/jrsm.1085; Elliott WJ, 2007, LANCET, V369, P201, DOI 10.1016/S0140-6736(07)60108-1; Gagnier JJ, 2014, NETWORK META ANAL EV, P171; Higgins JPT, 2012, RES SYNTH METHODS, V3, P98, DOI 10.1002/jrsm.1044; Hoaglin DC, 2011, VALUE HEALTH, V14, P429, DOI 10.1016/j.jval.2011.01.011; Hong H, 2013, MED DECIS MAKING, V33, P702, DOI 10.1177/0272989X13481110; Katsanos K, 2014, NETWORK METAANALYSIS, P191; Konig J, 2013, STAT MED, V32, P5414, DOI 10.1002/sim.6001; Krahn U, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-35; Kuiper, 2014, GEMTC GEMTC NETWORK; Lee AW, 2014, J CLIN EPIDEMIOL, V67, P138, DOI 10.1016/j.jclinepi.2013.07.014; Lin L., 2014, PCNETMETA METHODS PA; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Lu G, 2006, J AM STAT ASS, V101; Lumley T, 2002, STAT MED, V21, P2313, DOI 10.1002/sim.1201; Nikolakopoulou A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086754; Rucker G, 2014, NETMETA NETWORK META; Rucker G, 2012, RES SYNTH METHODS, V3, P312, DOI 10.1002/jrsm.1058; Salanti G, 2012, RES SYNTH METHODS, V3, P80, DOI 10.1002/jrsm.1037; Salanti G, 2011, J CLIN EPIDEMIOL, V64, P163, DOI 10.1016/j.jclinepi.2010.03.016; Salanti G, 2010, STAT MED, V29, P2369, DOI 10.1002/sim.4001; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; van Valkenhoef G, 2014, AUTOMATED G IN PRESS; van Valkenhoef G, 2012, RES SYNTH METHODS, V3, P285, DOI 10.1002/jrsm.1054; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; White IR, 2012, RES SYNTH METHODS, V3, P111, DOI 10.1002/jrsm.1045; Xiong TB, 2013, J CLIN EPIDEMIOL, V66, P184, DOI 10.1016/j.jclinepi.2012.06.022; Zhang J, 2014, CLIN TRIALS	37	184	184	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115065	10.1371/journal.pone.0115065	http://dx.doi.org/10.1371/journal.pone.0115065			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541687	Green Published, gold, Green Submitted			2022-12-27	WOS:000347239900022
J	Kim, SH; Cho, BY; Choi, H; Shin, ES; Ye, YM; Lee, JE; Park, HS				Kim, Seung-Hyun; Cho, Bo-Young; Choi, Hyunna; Shin, Eun-Soon; Ye, Young-Min; Lee, Jong-Eun; Park, Hae-Sim			The SNP rs3128965 of HLA-DPB1 as a Genetic Marker of the AERD Phenotype	PLOS ONE			English	Article							EXACERBATED RESPIRATORY-DISEASE; TRIGGERED 15-HETE GENERATION; ASPIRIN-INTOLERANT ASTHMA; KOREAN POPULATION; HYPERSENSITIVITY; ASSOCIATION; SENSITIVITY; LEUKOCYTES; PREDICT	Background: Two common clinical syndromes of acetylsalicylic acid (aspirin) hypersensitivity, aspirin-exacerbated respiratory disease (AERD) and aspirin-exacerbated cutaneous disease (AECD), were subjected to a genome-wide association study to identify strong genetic markers for aspirin hypersensitivity in a Korean population. Methods: A comparison of SNP genotype frequencies on an Affymetrix Genome-Wide Human SNP array of 179 AERD patients and 1989 healthy normal control subjects (NC) revealed SNPs on chromosome 6 that were associated with AERD, but not AECD. To validate the association, we enrolled a second cohort comprising AERD (n=264), NC (n=238) and disease-control (aspirin tolerant asthma; ATA, n=387) groups. Results: The minor genotype frequency (AG or AA) of a particular SNP, rs3128965, in the HLA-DPB1 region was higher in the AERD group compared to the ATA or NC group (P=0.001, P=0.002, in a co-dominant analysis model, respectively). Comparison of rs3128965 alleles with the clinical features of asthmatics revealed that patients harboring the A allele had increased bronchial hyperresponsiveness to inhaled aspirin and methacholine, and higher 15-HETE levels, than those without the A allele (P=0.039, 0.037, and 0.004, respectively). Conclusions: This implies the potential of rs3128965 as a genetic marker for diagnosis and prediction of the AERD phenotype.	[Kim, Seung-Hyun; Cho, Bo-Young; Choi, Hyunna; Ye, Young-Min; Park, Hae-Sim] Ajou Univ, Sch Med, Dept Allergy & Clin Immunol, Suwon 441749, South Korea; [Shin, Eun-Soon; Lee, Jong-Eun] DNA Link Inc, Seoul, South Korea	Ajou University; DNA Link, Inc.	Kim, SH (corresponding author), Ajou Univ, Sch Med, Dept Allergy & Clin Immunol, Suwon 441749, South Korea.	kimsh@ajou.ac.kr; hspark@ajou.ac.kr	Park, Hae-Sim/S-7974-2019	Kim, Seung-Hyun/0000-0003-1789-8964; Park, Hae-Sim/0000-0003-2614-0303	Korea Health 21 R&D Project, the Ministry of Health and Welfare, Republic of Korea [HI14C0065]	Korea Health 21 R&D Project, the Ministry of Health and Welfare, Republic of Korea	This study was supported by the Korea Health 21 R&D Project, the Ministry of Health and Welfare, Republic of Korea (HI14C0065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayuso P, 2013, CLIN EXP ALLERGY, V43, P1097, DOI 10.1111/cea.12140; Choi JH, 2004, J ALLERGY CLIN IMMUN, V113, P562, DOI 10.1016/j.jaci.2003.12.012; Dekker JW, 1997, CLIN EXP ALLERGY, V27, P574, DOI 10.1046/j.1365-2222.1997.540848.x; Hopkins C, 2007, OTOLARYNG HEAD NECK, V137, P555, DOI 10.1016/j.otohns.2007.02.004; Kim JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013818; Kim SH, 2013, IMMUNOL ALLERGY CLIN, V33, P177, DOI 10.1016/j.iac.2012.10.003; Kim SH, 2010, RESP MED, V104, P626, DOI 10.1016/j.rmed.2009.11.024; Kim SH, 2005, CLIN EXP ALLERGY, V35, P339, DOI 10.1111/j.1365-2222.2004.02197.x; Korosec P, 2011, RESP MED, V105, pS81, DOI 10.1016/S0954-6111(11)70017-8; Kowalski ML, 2005, ALLERGY, V60, P1139, DOI 10.1111/j.1398-9995.2005.00836.x; Liu C, 2009, AM J PHYSIOL-LUNG C, V297, pL196, DOI 10.1152/ajplung.00036.2008; Mascia K, 2005, J ALLERGY CLIN IMMUN, V116, P970, DOI 10.1016/j.jaci.2005.08.035; Nizankowska-Mogilnicka E, 2007, ALLERGY, V62, P1111, DOI 10.1111/j.1398-9995.2007.01409.x; Park BL, 2013, HUM GENET, V132, P313, DOI 10.1007/s00439-012-1247-2; Park HS, 2004, J ALLERGY CLIN IMMUN, V114, P688, DOI 10.1016/j.jaci.2004.05.051; PARK HS, 1995, CLIN EXP ALLERGY, V25, P38, DOI 10.1111/j.1365-2222.1995.tb01000.x; Park SM, 2013, ALLERGY ASTHMA IMMUN, V5, P258, DOI 10.4168/aair.2013.5.5.258; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sanchez-Borges M, 2013, IMMUNOL ALLERGY CLIN, V33, P251, DOI 10.1016/j.iac.2012.10.004; Wenzel S, 2012, CLIN EXP ALLERGY, V42, P650, DOI 10.1111/j.1365-2222.2011.03929.x	20	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e111220	10.1371/journal.pone.0111220	http://dx.doi.org/10.1371/journal.pone.0111220			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536158	Green Published, gold, Green Submitted			2022-12-27	WOS:000348563300002
J	Troisi, R; Ganmaa, D; Silva, ID; Davaalkham, D; Rosenberg, PS; Rich-Edwards, J; Frasier, L; Houghton, L; Janes, C; Stanczyk, F; Hoover, RN				Troisi, Rebecca; Ganmaa, Daavasambuu; Silva, Isabel dos Santos; Davaalkham, Dambadarjaa; Rosenberg, Philip S.; Rich-Edwards, Janet; Frasier, Lindsay; Houghton, Lauren; Janes, Craig; Stanczyk, Frank; Hoover, Robert N.			The Role of Hormones in the Differences in the Incidence of Breast Cancer between Mongolia and the United Kingdom	PLOS ONE			English	Article							RISK; WOMEN	Background: There are striking differences in breast cancer incidence between Asian and western women. Rates vary substantially within Asia also, with Mongolia's even lower than China's. These profound differences have been speculated to be due in part to diet, mediated by circulating hormone concentrations. Methods: Sex steroid hormone concentrations were measured in women living in Ulaanbaatar, Mongolia and the United Kingdom (U.K.). Diet was obtained by interview and national survey data. Mean hormone differences were compared by country, and systematic variation by number of days since last menstrual period was modeled and adjusted for age and parity; difference in overall area under the curves was assessed. Findings: The diet in Mongolia was higher in meat and dairy than in the U.K. Mean testosterone concentrations were 18.5% lower (p<0.0001) while estradiol concentrations were 19.1% higher (p=0.02) in Mongolian than British women, adjusted for age and parity. Progesterone was almost 50% higher in Mongolian women (p=0.04), particularly during the follicular phase and early luteal surge. Hormone concentrations generally were similar in Mongolian women born in Ulaanbaatar compared with those born in rural areas, although there was a decreasing progesterone trend by degree of westernization (rural Mongolia; urban Mongolia; U.K.). Mean hormone differences were similar when restricted to parous women, and with further adjustment for body mass index, height, and smoking status. Interpretation: These data augment accumulating evidence that circulating estrogens are unlikely to explain reduced breast cancer rates in Asia compared with the west, and suggest casting a wider net with respect to biomarkers. Lower testosterone and higher progesterone in Mongolian women raise the possibility that these hormones may be important to consider. In addition, the almost exclusive dietary reliance of Mongolians on meat and dairy argues against beneficial effects of a low-fat diet on circulating hormones explaining international breast cancer differences.	[Troisi, Rebecca; Rosenberg, Philip S.; Houghton, Lauren; Hoover, Robert N.] NCI, Epidemiol & Biostat Program, Div Canc Epidemiol & Genet, NIH,Dept Hlth & Human Serv, Rockville, MD 20850 USA; [Ganmaa, Daavasambuu] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Ganmaa, Daavasambuu] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Ganmaa, Daavasambuu; Davaalkham, Dambadarjaa] Hlth Sci Univ Mongolia, Ulaanbaatar, Mongolia; [Silva, Isabel dos Santos] Univ London London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1E 7HT, England; [Rich-Edwards, Janet] Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Lab,Dept Med, Boston, MA 02115 USA; [Rich-Edwards, Janet] Harvard Univ, Brigham & Womens Hosp, Sch Med, Connors Ctr Womens Hlth & Gender Biol, Boston, MA 02115 USA; [Frasier, Lindsay] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Janes, Craig] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Stanczyk, Frank] Univ So Calif, Keck Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90033 USA; [Stanczyk, Frank] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Mongolian National University of Medical Sciences; University of London; London School of Hygiene & Tropical Medicine; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Simon Fraser University; University of Southern California; University of Southern California	Troisi, R (corresponding author), NCI, Epidemiol & Biostat Program, Div Canc Epidemiol & Genet, NIH,Dept Hlth & Human Serv, Rockville, MD 20850 USA.	troisir@mail.nih.gov	Houghton, Lauren C./ABC-8638-2021	Houghton, Lauren C./0000-0002-1432-1580; Stanczyk, Frank/0000-0002-3607-121X; Davaalkham, Dambadarjaa/0000-0001-6999-9367; Rosenberg, Philip/0000-0001-6349-9126	U.S. National Cancer Institute, National Institutes of Health, Department of Health and Human Services	U.S. National Cancer Institute, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Institute of Neurological Disorders & Stroke (NINDS))	All funding for this study was provided by the U.S. National Cancer Institute, National Institutes of Health, Department of Health and Human Services. Drs. Troisi and Hoover represented the NCI and had a role in the study design, data collection and analysis, decision to publish and preparation of the ms.	Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Fletcher O, 2011, JNCI-J NATL CANCER I, V103, P425, DOI 10.1093/jnci/djq563; Ganmaa D, 2013, INT HEALTH, V5, P244, DOI 10.1093/inthealth/iht020; GOEBELSMANN U, 1973, J CLIN ENDOCR METAB, V36, P867, DOI 10.1210/jcem-36-5-867; Goebelsmann U, 1979, VASECTOMY IMMUNOLOGI, P165; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hoover RN, 2012, BRIT J CANCER, V107, P408, DOI 10.1038/bjc.2012.134; James RE, 2011, CANCER PREV RES, V4, P1626, DOI 10.1158/1940-6207.CAPR-11-0090; Johnson N, 2012, JNCI-J NATL CANCER I, V104, P657, DOI 10.1093/jnci/djs156; Kaaks R, 2014, INT J CANCER, V134, P1947, DOI 10.1002/ijc.28528; Key TJ, 2013, LANCET ONCOL, V14, P1009, DOI 10.1016/S1470-2045(13)70301-2; Matsuno RK, 2007, CANCER EPIDEM BIOMAR, V16, P1437, DOI 10.1158/1055-9965.EPI-07-0108; Probst-Hensch NM, 1999, ENDOCR-RELAT CANCER, V6, P165, DOI 10.1677/erc.0.0060165; SASAKI S, 1993, PREV MED, V22, P187, DOI 10.1006/pmed.1993.1016; Troisi R, 2012, CANCER CAUSE CONTROL, V23, P1047, DOI 10.1007/s10552-012-9973-2; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Zhai FY, 2009, NUTR REV, V67, pS56, DOI 10.1111/j.1753-4887.2009.00160.x; ZIEGLER RG, 1993, JNCI-J NATL CANCER I, V85, P1819, DOI 10.1093/jnci/85.22.1819	18	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e114455	10.1371/journal.pone.0114455	http://dx.doi.org/10.1371/journal.pone.0114455			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536229	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000348563300012
J	Bao, YP; Wang, W; Zhou, ZG; Sun, CH				Bao, Yongping; Wang, Wei; Zhou, Zhigang; Sun, Changhao			Benefits and Risks of the Hormetic Effects of Dietary Isothiocyanates on Cancer Prevention	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; CELL-LINES; PHENETHYL ISOTHIOCYANATE; ENDOTHELIAL-CELLS; SIGNALING PATHWAY; STRESS-RESPONSE; BLADDER-CANCER; HUMAN PLASMA; DUAL ROLES; NRF2	The isothiocyanate (ITC) sulforaphane (SFN) was shown at low levels (1-5 mu M) to promote cell proliferation to 120-143% of the controls in a number of human cell lines, whilst at high levels (10-40 mM) it inhibited such cell proliferation. Similar dose responses were observed for cell migration, i. e. SFN at 2.5 mu M increased cell migration in bladder cancer T24 cells to 128% whilst high levels inhibited cell migration. This hormetic action was also found in an angiogenesis assay where SFN at 2.5 mu M promoted endothelial tube formation (118% of the control), whereas at 10-20 mu M it caused significant inhibition. The precise mechanism by which SFN influences promotion of cell growth and migration is not known, but probably involves activation of autophagy since an autophagy inhibitor, 3-methyladenine, abolished the effect of SFN on cell migration. Moreover, low doses of SFN offered a protective effect against free-radical mediated cell death, an effect that was enhanced by co-treatment with selenium. These results suggest that SFN may either prevent or promote tumour cell growth depending on the dose and the nature of the target cells. In normal cells, the promotion of cell growth may be of benefit, but in transformed or cancer cells it may be an undesirable risk factor. In summary, ITCs have a biphasic effect on cell growth and migration. The benefits and risks of ITCs are not only determined by the doses, but are affected by interactions with Se and the measured endpoint.	[Bao, Yongping; Wang, Wei; Zhou, Zhigang] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England; [Zhou, Zhigang] Nantong Univ, Dept Cardiovasc Med, Affiliated Hosp, Nantong, Jiangsu, Peoples R China; [Sun, Changhao] Harbin Med Univ, Sch Publ Hlth, Harbin, Heilongjiang, Peoples R China	University of East Anglia; Nantong University; Harbin Medical University	Bao, YP (corresponding author), Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England.	y.bao@uea.ac.uk	Bao, Yongping/A-6951-2010; SUN, CHANG/GXM-3680-2022	Bao, Yongping/0000-0002-6425-0370; 	National Natural Science Foundation of China (NSFC) [81128011]; Cancer Prevention Research Trust, United Kingdom	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Cancer Prevention Research Trust, United Kingdom	This study was supported in part by a grant from the National Natural Science Foundation of China (NSFC No. 81128011) and an award from the Cancer Prevention Research Trust, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfadda AA, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/936486; Arlt A, 2013, ONCOGENE, V32, P4825, DOI 10.1038/onc.2012.493; Barrera LN, 2012, BBA-MOL CELL RES, V1823, P1914, DOI 10.1016/j.bbamcr.2012.07.007; Brigelius-Flohe Regina, 2012, Int J Cell Biol, V2012, P486147, DOI 10.1155/2012/486147; Calabrese EJ, 2013, HUM EXP TOXICOL, V32, P120, DOI 10.1177/0960327112455069; Calabrese EJ, 2013, CRIT REV TOXICOL, V43, P580, DOI 10.3109/10408444.2013.808172; Calabrese EJ, 2010, HUM EXP TOXICOL, V29, P980, DOI 10.1177/0960327110383625; Calabrese EJ, 2005, CRIT REV TOXICOL, V35, P463, DOI 10.1080/10408440591034502; Calabrese V, 2012, BBA-MOL BASIS DIS, V1822, P729, DOI 10.1016/j.bbadis.2011.12.003; Cheung KL, 2010, AAPS J, V12, P87, DOI 10.1208/s12248-009-9162-8; Clarke JD, 2011, PHARMACOL RES, V64, P456, DOI 10.1016/j.phrs.2011.07.005; Clayton RF, 2005, LIVER INT, V25, P389, DOI 10.1111/j.1478-3231.2005.01017.x; Cooley LS, 2010, J CELL SCI, V123, P3808, DOI 10.1242/jcs.064279; Cornelius C, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-15; Cramer JM, 2011, NUTR CANCER, V63, P196, DOI 10.1080/01635581.2011.523495; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Dinkova-Kostova AT, 2012, TRENDS MOL MED, V18, P337, DOI 10.1016/j.molmed.2012.04.003; Ekiz F, 2010, EUR J GASTROEN HEPAT, V22, P898, DOI 10.1097/MEG.0b013e32832fa632; FENWICK GR, 1983, CRC CR REV FOOD SCI, V18, P123, DOI 10.1080/10408398209527361; Fimognari C, 2007, MUTAT RES-REV MUTAT, V635, P90, DOI 10.1016/j.mrrev.2006.10.004; Fimognari C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035267; Galgano F, 2007, J FOOD SCI, V72, pS130, DOI 10.1111/j.1750-3841.2006.00258.x; Gamet-Payrastre L, 2000, CANCER RES, V60, P1426; Giudice A, 2006, BIOESSAYS, V28, P169, DOI 10.1002/bies.20359; Gupta P, 2014, MOL NUTR FOOD RES; Hahm ER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044957; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hayes JD, 2010, ANTIOXID REDOX SIGN, V13, P1713, DOI 10.1089/ars.2010.3221; Hendrickx W, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00239; Herman-Antosiewicz A, 2006, CANCER RES, V66, P5828, DOI 10.1158/0008-5472.CAN-06-0139; Homma S, 2009, CLIN CANCER RES, V15, P3423, DOI 10.1158/1078-0432.CCR-08-2822; Jackson SJT, 2004, J NUTR, V134, P2229, DOI 10.1093/jn/134.9.2229; Jakubikova J, 2005, INT J ONCOL, V27, P1449; Ji Y, 2003, ANAL BIOCHEM, V323, P39, DOI 10.1016/j.ab.2003.08.011; Kensler TW, 2013, TOP CURR CHEM, V329, P163, DOI 10.1007/128_2012_339; Kensler TW, 2010, CARCINOGENESIS, V31, P90, DOI 10.1093/carcin/bgp231; Keum YS, 2005, DRUG NEWS PERSPECT, V18, P445, DOI 10.1358/dnp.2005.18.7.939350; Kuang LH, 2013, INT J BIOL SCI, V9, P656, DOI 10.7150/ijbs.5887; Lau A, 2008, PHARMACOL RES, V58, P262, DOI 10.1016/j.phrs.2008.09.003; Li D, 2012, FOOD CHEM, V133, P300, DOI 10.1016/j.foodchem.2012.01.026; Li Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035122; Lister A, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-37; Ma XD, 2012, CANCER CHEMOTH PHARM, V69, P485, DOI 10.1007/s00280-011-1722-9; Mattson MP, 2008, AGEING RES REV, V7, P43, DOI 10.1016/j.arr.2007.08.004; Mattson MP, 2008, AGEING RES REV, V7, P1, DOI 10.1016/j.arr.2007.08.007; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; McNaughton SA, 2003, BRIT J NUTR, V90, P687, DOI 10.1079/BJN2003917; Melchini A, 2012, J MED CHEM, V55, P9682, DOI 10.1021/jm300929v; Michaud DS, 1999, JNCI-J NATL CANCER I, V91, P605, DOI 10.1093/jnci/91.7.605; Miller PE, 2012, NUTR CLIN PRACT, V27, P599, DOI 10.1177/0884533612456043; Misiewicz I, 2004, ACTA BIOCHIM POL, V51, P711; Mitsuishi Y, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00200; Moy KA, 2009, INT J CANCER, V125, P2652, DOI 10.1002/ijc.24583; Na HK, 2014, FREE RADICAL BIO MED, V67, P353, DOI 10.1016/j.freeradbiomed.2013.10.819; Navarro SL, 2009, CANCER EPIDEM BIOMAR, V18, P2974, DOI 10.1158/1055-9965.EPI-09-0701; Nishikawa T, 2010, ANGIOGENESIS, V13, P227, DOI 10.1007/s10456-010-9180-2; Oehme I, 2013, P NATL ACAD SCI USA, V110, pE2592, DOI 10.1073/pnas.1300113110; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; Pietsch K, 2011, BIOGERONTOLOGY, V12, P329, DOI 10.1007/s10522-011-9334-7; Rand D, 2011, NANO LETT, V11, P2678, DOI 10.1021/nl200858y; Ren DM, 2011, P NATL ACAD SCI USA, V108, P1433, DOI 10.1073/pnas.1014275108; Rungapamestry V, 2007, BRIT J NUTR, V97, P644, DOI 10.1017/S0007114507381403; Santos IS, 2013, BIOTECHNOL ADV, V31, P514, DOI 10.1016/j.biotechadv.2012.08.005; Sestili P, 2010, MUTAT RES-FUND MOL M, V689, P65, DOI 10.1016/j.mrfmmm.2010.05.003; Shan YJ, 2013, J NUTR BIOCHEM, V24, P1062, DOI 10.1016/j.jnutbio.2012.08.004; Shelton P, 2013, FASEB J, V27, P414, DOI 10.1096/fj.12-217257; Son TG, 2008, NEUROMOL MED, V10, P236, DOI 10.1007/s12017-008-8037-y; Speciale A, 2011, CURR MOL MED, V11, P770, DOI 10.2174/156652411798062395; Sporn MB, 2012, NAT REV CANCER, V12, P564, DOI 10.1038/nrc3278; Suppipat K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051251; Surh YJ, 2008, PLANTA MED, V74, P1526, DOI 10.1055/s-0028-1088302; Thimmulappa RK, 2002, CANCER RES, V62, P5196; Vargas AJ, 2010, NUTR REV, V68, P418, DOI 10.1111/j.1753-4887.2010.00301.x; Wang XJ, 2008, CARCINOGENESIS, V29, P1235, DOI 10.1093/carcin/bgn095; Warwick E, 2012, BRIT J NUTR, V108, P2158, DOI 10.1017/S0007114512000554; Watson JD, 2014, LANCET, V383, P841, DOI 10.1016/S0140-6736(13)62365-X; Watson J, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120144; Xu TZ, 2012, ANTI-CANCER AGENT ME, V12, P1132, DOI 10.2174/187152012803529691; Ye LX, 2002, CLIN CHIM ACTA, V316, P43, DOI 10.1016/S0009-8981(01)00727-6; Yu X, 2005, MUTAT RES-FUND MOL M, V591, P93, DOI 10.1016/j.mrfmmm.2005.04.017; Zanichelli F, 2012, AGE, V34, P281, DOI 10.1007/s11357-011-9231-7; Zhang DD, 2010, ANTIOXID REDOX SIGN, V13, P1623, DOI 10.1089/ars.2010.3301; Zhang YS, 2004, MUTAT RES-FUND MOL M, V555, P173, DOI 10.1016/j.mrfmmm.2004.04.017; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399; Zhang YS, 2005, FREE RADICAL BIO MED, V38, P70, DOI 10.1016/j.freeradbiomed.2004.09.033; Zhang Y, 2007, ACTA PHARMACOL SIN, V28, P1343, DOI 10.1111/j.1745-7254.2007.00679.x; Zhao CR, 2010, CANCER EPIDEMIOL, V34, P523, DOI 10.1016/j.canep.2010.06.012	87	54	56	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e114764	10.1371/journal.pone.0114764	http://dx.doi.org/10.1371/journal.pone.0114764			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25532034	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000348845100024
J	Starr, ME; Steele, AM; Saito, M; Hacker, BJ; Evers, BM; Saito, H				Starr, Marlene E.; Steele, Allison M.; Saito, Mizuki; Hacker, Bill J.; Evers, B. Mark; Saito, Hiroshi			A New Cecal Slurry Preparation Protocol with Improved Long-Term Reproducibility for Animal Models of Sepsis	PLOS ONE			English	Article							AGE-DEPENDENT VULNERABILITY; SYSTEMIC INFLAMMATION; GUT MICROBIOTA; ADIPOSE-TISSUE; MORTALITY; LIGATION; MICE; ENDOTOXEMIA; IMMUNITY	Sepsis, a life-threatening systemic inflammatory response syndrome induced by infection, is widely studied using laboratory animal models. While cecal-ligation and puncture (CLP) is considered the gold standard model for sepsis research, it may not be preferable for experiments comparing animals of different size or under different dietary regimens. By comparing cecum size, shape, and cecal content characteristics in mice under different experimental conditions (aging, diabetes, pancreatitis), we show that cecum variability could be problematic for some CLP experiments. The cecal slurry (CS) injection model, in which the cecal contents of a laboratory animal are injected intraperitoneally to other animals, is an alternative method for inducing polymicrobial sepsis; however, the CS must be freshly prepared under conventional protocols, which is a major disadvantage with respect to reproducibility and convenience. The objective of this study was to develop an improved CS preparation protocol that allows for long-term storage of CS with reproducible results. Using our new CS preparation protocol we found that bacterial viability is maintained for at least 6 months when the CS is prepared in 15% glycerol-PBS and stored at -80 degrees C. To test sepsis-inducing efficacy of stored CS stocks, various amounts of CS were injected to young (4-6 months old), middle-aged (12-14 months old), and aged (24-26 months old) male C57BL/6 mice. Dose- and age-dependent mortality was observed with high reproducibility. Circulating bacteria levels strongly correlated with mortality suggesting an infection-mediated death. Further, injection with heat-inactivated CS resulted in acute hypothermia without mortality, indicating that CS-mediated death is not due to endotoxic shock. This new CS preparation protocol results in CS stocks which are durable for freezing preservation without loss of bacterial viability, allowing experiments to be performed more conveniently and with higher reproducibility than before.	[Starr, Marlene E.; Steele, Allison M.; Saito, Mizuki; Saito, Hiroshi] Univ Kentucky, Aging & Crit Care Res Lab, Lexington, KY 40536 USA; [Starr, Marlene E.; Hacker, Bill J.; Evers, B. Mark; Saito, Hiroshi] Univ Kentucky, Dept Surg, Lexington, KY 40536 USA; [Steele, Allison M.; Saito, Hiroshi] Univ Kentucky, Dept Physiol, Lexington, KY 40536 USA; [Saito, Mizuki; Evers, B. Mark; Saito, Hiroshi] Univ Kentucky, Markey Canc Ctr, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky	Saito, H (corresponding author), Univ Kentucky, Aging & Crit Care Res Lab, Lexington, KY 40536 USA.	hiroshi.saito@uky.edu		Owen, Allison M./0000-0001-5623-4891; Raju, Raghavan/0000-0002-4516-8654	National Institutes of Health [R01 AG039732]; NATIONAL INSTITUTE ON AGING [R01AG039732] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the National Institutes of Health grants (R01 AG039732). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBROZE WL, 1991, DIS COLON RECTUM, V34, P563, DOI 10.1007/BF02049895; Angus DC, 2013, NEW ENGL J MED, V369, P2063, DOI 10.1056/NEJMc1312359; Buras JA, 2005, NAT REV DRUG DISCOV, V4, P854, DOI 10.1038/nrd1854; Campbell JH, 2012, ISME J, V6, P2033, DOI 10.1038/ismej.2012.54; CROSS AS, 1993, INFECT IMMUN, V61, P2741, DOI 10.1128/IAI.61.7.2741-2747.1993; Dejager L, 2011, TRENDS MICROBIOL, V19, P198, DOI 10.1016/j.tim.2011.01.001; Gentile LF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094404; Gentile LF, 2014, J IMMUNOL, V192, P3156, DOI 10.4049/jimmunol.1301726; Hamilton MJ, 2012, AM J GASTROENTEROL, V107, P761, DOI 10.1038/ajg.2011.482; Hildebrand F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r4; Hubbard WJ, 2005, SHOCK, V24, P52, DOI 10.1097/01.shk.0000191414.94461.7e; Hufeldt MR, 2010, COMPARATIVE MED, V60, P336; LANG CH, 1983, J SURG RES, V35, P201, DOI 10.1016/S0022-4804(83)80005-5; Maniatis T., 1982, MOL CLONING; Miller RA, 2000, J GERONTOL A-BIOL, V55, pB117, DOI 10.1093/gerona/55.3.B117; Okamura D, 2012, AGING CELL, V11, P760, DOI 10.1111/j.1474-9726.2012.00841.x; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Rosczyk HA, 2008, EXP GERONTOL, V43, P840, DOI 10.1016/j.exger.2008.06.004; Saito H, 2003, MECH AGEING DEV, V124, P1047, DOI 10.1016/j.mad.2003.08.002; Sam Albert D. Ii, 1997, Frontiers in Bioscience, V2, pE72; Shrum Bradly, 2014, BMC Res Notes, V7, P233, DOI 10.1186/1756-0500-7-233; Starr ME, 2014, AGING DIS, V5, P126, DOI 10.14336/AD.2014.0500126; Starr ME, 2013, AGING CELL, V12, P194, DOI 10.1111/acel.12040; Starr ME, 2011, FREE RADICAL BIO MED, V50, P371, DOI 10.1016/j.freeradbiomed.2010.11.013; Starr ME, 2010, BLOOD, V115, P4886, DOI 10.1182/blood-2009-10-246678; Starr ME, 2009, J GERONTOL A-BIOL, V64, P723, DOI 10.1093/gerona/glp046; Turnbull IR, 2003, SHOCK, V19, P310, DOI 10.1097/00024382-200304000-00003; WICHTERMAN KA, 1980, J SURG RES, V29, P189, DOI 10.1016/0022-4804(80)90037-2; WOOD W, 1993, J CLIN PATHOL, V46, P769, DOI 10.1136/jcp.46.8.769; Wynn JL, 2007, SHOCK, V28, P675, DOI 10.1097/shk.0b013e3180556d09; Zanotti-Cavazzoni SL, 2009, CRIT CARE CLIN, V25, P703, DOI 10.1016/j.ccc.2009.08.005	31	81	82	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115705	10.1371/journal.pone.0115705	http://dx.doi.org/10.1371/journal.pone.0115705			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531402	Green Published, gold, Green Submitted			2022-12-27	WOS:000348845100098
J	Wang, TF; Chen, H				Wang, Tengfei; Chen, Hao			Carbon Disulfide Mediates Socially-Acquired Nicotine Self-Administration	PLOS ONE			English	Article							CIGARETTE-SMOKING; TOBACCO; ADOLESCENTS; AMYGDALA; BREATH; CUES; 1ST	The social environment plays a critical role in smoking initiation as well as relapse. We previously reported that rats acquired nicotine self-administration with an olfactogustatory cue only when another rat consuming the same cue was present during self-administration. Because carbon disulfide (CS2) mediates social learning of food preference in rodents, we hypothesized that socially acquired nicotine self-administration is also mediated by CS2. We tested this hypothesis by placing female adolescent Sprague-Dawley rats in operant chambers equipped with two lickometers. Licking on the active spout meeting a fixed-ratio 10 schedule triggered the concurrent delivery of an i.v. infusion (saline, or 30 mu g/kg nicotine, free base) and an appetitive olfactogustatory cue containing CS2 (0-500 ppm). Rats that self-administered nicotine with the olfactogustatory cue alone licked less on the active spout than on the inactive spout. Adding CS2 to the olfactogustatory cue reversed the preference for the spouts. The group that received 500 ppm CS2 and the olfactogustatory cue obtained a significantly greater number of nicotine infusions than other groups. After extinction training, the original self-administration context reinstated nicotine-seeking behavior in all nicotine groups. In addition, in rats that received the olfactogustatory cue and 500 ppm CS2 during SA, a social environment where the nicotine-associated olfactory cue is present, induced much stronger drug-seeking behavior compared to a social environment lacking the olfactogustatory cue. These data established that CS2 is a critical signal that mediates social learning of nicotine self-administration with olfactogustatory cues in rodents. Additionally, these data showed that the social context can further enhance the drug-seeking behavior induced by the drug-taking environment.	[Wang, Tengfei; Chen, Hao] Univ Tennessee, Hlth Sci Ctr, Dept Pharmacol, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Chen, H (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Pharmacol, Memphis, TN 38163 USA.	hchen@uthsc.edu	Chen, Hao/AAX-5849-2020	Chen, Hao/0000-0002-2680-6921				Chen H, 2007, NEUROPSYCHOPHARMACOL, V32, P700, DOI 10.1038/sj.npp.1301135; Chen H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044234; Chen H, 2011, NEUROPSYCHOPHARMACOL, V36, P2629, DOI 10.1038/npp.2011.149; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Conklin CA, 2008, EXP CLIN PSYCHOPHARM, V16, P207, DOI 10.1037/1064-1297.16.3.207; DAVIS JD, 1992, BEHAV NEUROSCI, V106, P217, DOI 10.1037/0735-7044.106.1.217; Eissenberg T, 2000, DRUG ALCOHOL DEPEN, V59, pS41; Galef BG, 2012, BEHAV BRAIN RES, V231, P266, DOI 10.1016/j.bbr.2011.07.021; GALEF BG, 1988, PHYSIOL BEHAV, V42, P119, DOI 10.1016/0031-9384(88)90285-5; Greenlund KJ, 1997, AM J PUBLIC HEALTH, V87, P1345, DOI 10.2105/AJPH.87.8.1345; HAHN G, 1990, ADDICT BEHAV, V15, P439, DOI 10.1016/0306-4603(90)90030-2; Hofstetter CR, 2007, NICOTINE TOB RES, V9, P1277, DOI 10.1080/14622200701704863; Hu MC, 2006, AM J PUBLIC HEALTH, V96, P299, DOI 10.2105/AJPH.2004.057232; Hurlemann R, 2010, J NEUROSCI, V30, P4999, DOI 10.1523/JNEUROSCI.5538-09.2010; Jones-Price C, 1984, PB84192343 NITS; Kamboures MA, 2005, P NATL ACAD SCI USA, V102, P15762, DOI 10.1073/pnas.0507263102; Munger SD, 2010, CURR BIOL, V20, P1438, DOI 10.1016/j.cub.2010.06.021; PHILLIPS M, 1993, J CLIN PATHOL, V46, P861, DOI 10.1136/jcp.46.9.861; POPIK P, 1993, BEHAV NEURAL BIOL, V59, P63, DOI 10.1016/0163-1047(93)91173-K; Powell LM, 2005, J HEALTH ECON, V24, P950, DOI 10.1016/j.jhealeco.2005.02.002; Racicot S, 2013, DRUG ALCOHOL DEPEN, V130, P38, DOI 10.1016/j.drugalcdep.2012.10.006; Schepis TS, 2005, CURR OPIN PEDIATR, V17, P607, DOI 10.1097/01.mop.0000176442.49743.31; Spear L, 2000, ALCOHOL RES HEALTH, V24, P115; Stoffelmayr B, 2003, ADDICT BEHAV, V28, P1351, DOI 10.1016/S0306-4603(02)00250-2; Thiel KJ, 2009, PSYCHOPHARMACOLOGY, V204, P391, DOI 10.1007/s00213-009-1470-2; Umber BJ, 2013, CLIN TRANSL MED, V2, DOI 10.1186/2001-1326-2-13; Urberg KA, 1997, DEV PSYCHOL, V33, P834, DOI 10.1037/0012-1649.33.5.834; Wang T, 2014, GENES BRAIN BEHAV, V13, P202, DOI 10.1111/gbb.12112; Wells AM, 2011, LEARN MEMORY, V18, P693, DOI 10.1101/lm.2273111; White VM, 2008, BRIT J CANCER, V98, P1475, DOI 10.1038/sj.bjc.6604250; Zentall TR, 2012, J COMP PSYCHOL, V126, P114, DOI 10.1037/a0025381; Zhou XL, 2009, ADDICT BEHAV, V34, P365, DOI 10.1016/j.addbeh.2008.11.013	32	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115222	10.1371/journal.pone.0115222	http://dx.doi.org/10.1371/journal.pone.0115222			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25532105	Green Submitted, Green Published, gold			2022-12-27	WOS:000348845100045
J	Wee, S; Niklasson, M; Marinescu, VD; Segerman, A; Schmidt, L; Hermansson, A; Dirks, P; Forsberg-Nilsson, K; Westermark, B; Uhrbom, L; Linnarsson, S; Nelander, S; Andang, M				Wee, Shimei; Niklasson, Maria; Marinescu, Voichita Dana; Segerman, Anna; Schmidt, Linnea; Hermansson, Annika; Dirks, Peter; Forsberg-Nilsson, Karin; Westermark, Bengt; Uhrbom, Lene; Linnarsson, Sten; Nelander, Sven; Andang, Michael			Selective Calcium Sensitivity in Immature Glioma Cancer Stem Cells	PLOS ONE			English	Article							TUMOR-INITIATING CELLS; BRAIN-TUMORS; RNA-SEQ; GLIOBLASTOMA; IDENTIFICATION; CHEMOTHERAPY	Tumor-initiating cells are a subpopulation in aggressive cancers that exhibit traits shared with stem cells, including the ability to self-renew and differentiate, commonly referred to as stemness. In addition, such cells are resistant to chemo- and radiation therapy posing a therapeutic challenge. To uncover stemness-associated functions in glioma-initiating cells (GICs), transcriptome profiles were compared to neural stem cells (NSCs) and gene ontology analysis identified an enrichment of Ca2+ signaling genes in NSCs and the more stem-like (NSC-proximal) GICs. Functional analysis in a set of different GIC lines regarding sensitivity to disturbed homeostasis using A23187 and Thapsigargin, revealed that NSC-proximal GICs were more sensitive, corroborating the transcriptome data. Furthermore, Ca2+ drug sensitivity was reduced in GICs after differentiation, with most potent effect in the NSC-proximal GIC, supporting a stemness-associated Ca2+ sensitivity. NSCs and the NSC-proximal GIC line expressed a larger number of ion channels permeable to potassium, sodium and Ca2+. Conversely, a higher number of and higher expression levels of Ca2+ binding genes that may buffer Ca2+, were expressed in NSC-distal GICs. In particular, expression of the AMPA glutamate receptor subunit GRIA1, was found to associate with Ca2+ sensitive NSC-proximal GICs, and decreased as GICs differentiated along with reduced Ca2+ drug sensitivity. The correlation between high expression of Ca2+ channels (such as GRIA1) and sensitivity to Ca2+ drugs was confirmed in an additional nine novel GIC lines. Calcium drug sensitivity also correlated with expression of the NSC markers nestin (NES) and FABP7 (BLBP, brain lipid-binding protein) in this extended analysis. In summary, NSC-associated NES+/FABP7(+)/GRIA1(+) GICs were selectively sensitive to disturbances in Ca2+ homeostasis, providing a potential target mechanism for eradication of an immature population of malignant cells.	[Wee, Shimei; Andang, Michael] Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden; [Niklasson, Maria; Linnarsson, Sten] Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; [Marinescu, Voichita Dana; Segerman, Anna; Schmidt, Linnea; Hermansson, Annika; Forsberg-Nilsson, Karin; Westermark, Bengt; Uhrbom, Lene; Nelander, Sven] Uppsala Univ, Dept Immunol Genet & Pathol, S-75185 Uppsala, Sweden; [Dirks, Peter] Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada	Karolinska Institutet; Karolinska Institutet; Uppsala University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Andang, M (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden.	Michael.Andang@ki.se	Forsberg-Nilsson, Karin/D-9604-2019; Segerman, Anna/ABH-2607-2021; Andäng, Michael/GRE-9898-2022; Linnarsson, Sten/HCH-3909-2022	Forsberg-Nilsson, Karin/0000-0003-0692-6245; Segerman, Anna/0000-0002-5070-7587; Nelander, Sven/0000-0003-1758-1262; Westermark, Bengt/0000-0001-7153-5545; Andang, Michael/0000-0002-2886-7891	Swedish Childhood Cancer foundation [PR2013-0084]; Swedish Cancer Foundation [CAN 2011/783]; Swedish Research Council [2011-4567]; Karolinska Institutet; Linnaeus center in Developmental Biology for Regenerative Medicine; Swedish Cancer Foundation	Swedish Childhood Cancer foundation(European Commission); Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet); Linnaeus center in Developmental Biology for Regenerative Medicine; Swedish Cancer Foundation	Swedish Childhood Cancer foundation PR2013-0084 (www.barncancerfonden.se), Swedish Cancer Foundation CAN 2011/783 (www.cancerfonden.se), Swedish Research Council 2011-4567 (vr.se), Karolinska Institutet (www.ki.se), Linnaeus center in Developmental Biology for Regenerative Medicine (www.dbrm.se). SW was partially funded by the Karolinska Institutet PhD scholarship program. MN was funded by a postdoc scholarship from the Swedish Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; CHOUCAIR AK, 1986, J NEUROSURG, V65, P654, DOI 10.3171/jns.1986.65.5.0654; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Haas BR, 2010, CANCER RES, V70, P5597, DOI 10.1158/0008-5472.CAN-09-4666; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Huang Z, 2010, PROTEIN CELL, V1, P638, DOI 10.1007/s13238-010-0078-y; Ignatova TN, 2002, GLIA, V39, P193, DOI 10.1002/glia.10094; Islam S, 2011, GENOME RES, V21, P1160, DOI 10.1101/gr.110882.110; Kapur N, 2007, AM J PHYSIOL-CELL PH, V292, pC1510, DOI 10.1152/ajpcell.00181.2006; Khananshvili D, 2013, MOL ASPECTS MED, V34, P220, DOI 10.1016/j.mam.2012.07.003; Kitambi SS, 2014, CELL, V157, DOI 10.1016/j.cell.2014.02.021; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Mogami H, 1998, EMBO J, V17, P435, DOI 10.1093/emboj/17.2.435; Monteith GR, 2012, J BIOL CHEM, V287, P31666, DOI 10.1074/jbc.R112.343061; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nociari MM, 1998, J IMMUNOL METHODS, V213, P157, DOI 10.1016/S0022-1759(98)00028-3; Oh MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047846; Park DM, 2009, MOL CELLS, V28, P7, DOI 10.1007/s10059-009-0111-2; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Prevarskaya N, 2010, TRENDS MOL MED, V16, P107, DOI 10.1016/j.molmed.2010.01.005; Ramskold D, 2012, METHODS MOL BIOL, V802, P259, DOI 10.1007/978-1-61779-400-1_17; Resende RR, 2010, BBA-MOL CELL RES, V1803, P246, DOI 10.1016/j.bbamcr.2009.11.008; Sachlos E, 2012, CELL, V149, P1284, DOI 10.1016/j.cell.2012.03.049; Sammels E, 2010, CELL CALCIUM, V47, P297, DOI 10.1016/j.ceca.2010.02.001; Singh SK, 2003, CANCER RES, V63, P5821; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Zhao W, 2013, CANCER CELL, V23, P541, DOI 10.1016/j.ccr.2013.02.025	32	21	22	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115698	10.1371/journal.pone.0115698	http://dx.doi.org/10.1371/journal.pone.0115698			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531110	gold, Green Submitted, Green Published			2022-12-27	WOS:000348845100096
J	Zhang, ZM; Shi, Y; Zhao, SH; Li, JJ; Li, CC; Mao, BY				Zhang, Zuming; Shi, Yu; Zhao, Shuhua; Li, Jiejing; Li, Chaocui; Mao, Bingyu			Xenopus Nkx6.3 Is a Neural Plate Border Specifier Required for Neural Crest Development	PLOS ONE			English	Article							CRANIAL PLACODES; PARAXIAL MESODERM; FACTOR NKX6.1; BMP GRADIENT; BETA-CATENIN; CELL FATES; INDUCTION; GENES; SPECIFICATION; EXPRESSION	In vertebrates, the neural plate border (NPB) is established by a group of transcription factors including Dlx3, Msx1 and Zic1. The crosstalk between these NPB specifiers governs the separation of the NPB region into placode and neural crest (NC) territories and also their further differentiation. Understanding the mechanisms of NPB formation and NC development is critical for our knowledge of related human diseases. Here we identified Nkx6.3, a transcription factor of the Nkx family, as a new NPB specifier required for neural crest development in Xenopus embryos. XNkx6.3 is expressed in the ectoderm of the neural plate border region at neurula stages, covering the epidermis, placode and neural crest territories, but not the neural plate. Inhibition of Nkx6.3 by dominant negative construct or specific morpholino leads to neural crest defects, while overexpression of Nkx6.3 induces ectopic neural crest in the anterior neural fold. In animal caps, Nkx6.3 alone is able to initiate the whole neural crest regulatory network and induces neural crest fate robustly. We showed that overexpression of Nkx6.3 affects multiple signaling pathways, creating a high-Wnt, low-BMP environment required for neural crest development. Gain-and loss-of-function of Nkx6.3 have compound effects on the expression of known NPB genes, which is largely opposite to that of Dlx3. Overexpression of Dlx3 blocks the NC inducing activity of Nkx6.3. The crosstalk between Nkx6.3, Dlx3 and Msx1 is likely crucial for proper NPB formation and neural crest development in Xenopus.	[Zhang, Zuming; Zhao, Shuhua; Li, Jiejing; Li, Chaocui; Mao, Bingyu] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Shi, Yu] Chongqing Med Univ, Childrens Hosp, Dept Clin Lab, Chongqing, Peoples R China; [Shi, Yu] Minist Educ, Key Lab Child Dev & Disorders, Chongqing, Peoples R China; [Shi, Yu] Key Lab Pediat Chongqing, Chongqing, Peoples R China; [Shi, Yu] Chongqing Int Sci & Technol Cooperat Ctr Child De, Chongqing, Peoples R China; [Zhang, Zuming] Univ Chinese Acad Sci, Kunming Coll Life Sci, Kunming, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chongqing Medical University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Mao, BY (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China.	mao@mail.kiz.ac.cn		Mao, Bingyu/0000-0002-7993-3158	CAS Key Project [KSCX2-EW-R-05]; National Natural Science Foundation of China [81102519]; Chongqing Science and Technology Committee [cstc2012jjA0147]	CAS Key Project(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Science and Technology Committee	This work was supported by grants from the CAS Key Project (KSCX2-EW-R-05) to BM, National Natural Science Foundation of China (81102519) and the Chongqing Science and Technology Committee (cstc2012jjA0147) to YS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens K, 2005, DEV BIOL, V288, P40, DOI 10.1016/j.ydbio.2005.07.022; Aybar MJ, 2003, DEVELOPMENT, V130, P483, DOI 10.1242/dev.00238; Baker CVH, 2001, DEV BIOL, V232, P1, DOI 10.1006/dbio.2001.0156; Beanan MJ, 2000, MECH DEVELOP, V91, P227, DOI 10.1016/S0925-4773(99)00303-2; Binot AC, 2010, DEV BIOL, V340, P397, DOI 10.1016/j.ydbio.2010.01.025; Brugmann SA, 2004, DEVELOPMENT, V131, P5871, DOI 10.1242/dev.01516; David R, 2001, MECH DEVELOP, V103, P189, DOI 10.1016/S0925-4773(01)00355-0; Deardorff MA, 2001, DEVELOPMENT, V128, P3655; Dichmann DS, 2011, DEV BIOL, V349, P378, DOI 10.1016/j.ydbio.2010.10.030; Feledy JA, 1999, NUCLEIC ACIDS RES, V27, P764, DOI 10.1093/nar/27.3.764; Feledy JA, 1999, DEV BIOL, V212, P455, DOI 10.1006/dbio.1999.9374; Groves AK, 2014, DEV BIOL, V389, P2, DOI 10.1016/j.ydbio.2013.11.027; Hong CS, 2008, DEVELOPMENT, V135, P3903, DOI 10.1242/dev.026229; Hong CS, 2007, MOL BIOL CELL, V18, P2192, DOI 10.1091/mbc.E06-11-1047; Jorgensen MC, 1999, FEBS LETT, V461, P287, DOI 10.1016/S0014-5793(99)01436-2; Li JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027198; Luo T, 2001, MOL REPROD DEV, V60, P331, DOI 10.1002/mrd.1095; Ma PC, 2013, DEV GENES EVOL, V223, P253, DOI 10.1007/s00427-013-0437-9; Marchant L, 1998, DEV BIOL, V198, P319, DOI 10.1006/dbio.1998.8902; McLarren KW, 2003, DEV BIOL, V259, P34, DOI 10.1016/S0012-1606(03)00177-5; Meulemans D, 2004, DEV CELL, V7, P291, DOI 10.1016/j.devcel.2004.08.007; Milet C, 2012, DEV BIOL, V366, P22, DOI 10.1016/j.ydbio.2012.01.013; Mirmira RG, 2000, J BIOL CHEM, V275, P14743, DOI 10.1074/jbc.275.19.14743; Monsoro-Burq AH, 2005, DEV CELL, V8, P167, DOI 10.1016/j.devcel.2004.12.017; Monsoro-Burq AH, 2003, DEVELOPMENT, V130, P3111, DOI 10.1242/dev.00531; Nakagawa T, 2012, J STEROID BIOCHEM, V132, P247, DOI 10.1016/j.jsbmb.2012.05.007; Nakata K, 1998, MECH DEVELOP, V75, P43, DOI 10.1016/S0925-4773(98)00073-2; Nichane M, 2008, DEV BIOL, V322, P355, DOI 10.1016/j.ydbio.2008.08.003; Pandur PD, 2000, MECH DEVELOP, V96, P253, DOI 10.1016/S0925-4773(00)00396-8; Patthey C, 2009, DEVELOPMENT, V136, P73, DOI 10.1242/dev.025890; Phillips BT, 2006, DEV BIOL, V294, P376, DOI 10.1016/j.ydbio.2006.03.001; Pieper M, 2012, DEVELOPMENT, V139, P1175, DOI 10.1242/dev.074468; Sasai N, 2001, DEVELOPMENT, V128, P2525; Sato S, 2010, DEV BIOL, V344, P158, DOI 10.1016/j.ydbio.2010.04.029; Sato T, 2005, DEVELOPMENT, V132, P2355, DOI 10.1242/dev.01823; Sauka-Spengler T, 2008, NAT REV MOL CELL BIO, V9, P557, DOI 10.1038/nrm2428; Schohl A, 2003, EMBO J, V22, P3303, DOI 10.1093/emboj/cdg328; Smith ST, 1996, DEVELOPMENT, V122, P3141; St-Jeannet JP, 2014, DEV BIOL, V389, P13, DOI 10.1016/j.ydbio.2014.02.011; Stuhlmiller TJ, 2012, CELL MOL LIFE SCI, V69, P3715, DOI 10.1007/s00018-012-0991-8; Suri C, 2004, DEV BIOL, V265, P90, DOI 10.1016/j.ydbio.2003.09.017; Taylor BL, 2013, CELL REP, V4, P1262, DOI 10.1016/j.celrep.2013.08.010; Theveneau E, 2012, DEV BIOL, V366, P34, DOI 10.1016/j.ydbio.2011.12.041; Tribulo C, 2003, DEVELOPMENT, V130, P6441, DOI 10.1242/dev.00878; Tucker JA, 2008, DEV CELL, V14, P108, DOI 10.1016/j.devcel.2007.11.004; Woda JM, 2003, DEVELOPMENT, V130, P331, DOI 10.1242/dev.00212; Zeng WL, 2010, BIOCHEM BIOPH RES CO, V394, P1024, DOI 10.1016/j.bbrc.2010.03.115; Zhang HL, 1997, MOL CELL BIOL, V17, P2920, DOI 10.1128/MCB.17.5.2920; Zhao SH, 2007, DEV GENES EVOL, V217, P477, DOI 10.1007/s00427-007-0155-2	49	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115165	10.1371/journal.pone.0115165	http://dx.doi.org/10.1371/journal.pone.0115165			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531524	Green Submitted, Green Published, gold			2022-12-27	WOS:000348845100040
J	Lundbo, LF; Clausen, LN; Weis, N; Schonning, K; Rosenorn, L; Benfield, T; Christensen, PB				Lundbo, Lene Fogt; Clausen, Louise Nygaard; Weis, Nina; Schonning, Kristian; Rosenorn, Lene; Benfield, Thomas; Christensen, Peer Brehm			Influence of Hepatitis C Virus and IL28B Genotypes on Liver Stiffness	PLOS ONE			English	Article							GENETIC-VARIATION; VIRAL LOAD; TRANSIENT ELASTOGRAPHY; SPONTANEOUS CLEARANCE; FIBROSIS PROGRESSION; ANTIVIRAL TREATMENT; HEMOPHILIC PATIENTS; INFECTED PATIENTS; NATURAL-HISTORY; HCV	Objective: Liver fibrosis has been associated with hepatitis C virus (HCV) genotype and genetic variation near the interleukin 28B (IL28B) gene, but the relative contribution is unknown. We aimed to investigate the relation between HCV genotypes, IL28B and development of liver stiffness. Patients and Methods: This cross-sectional study consists of 369 patients with chronic hepatitis C (CHC). Liver stiffness was evaluated using transient elastograhy (TE). Factors associated with development of liver fibrosis were identified by logistic regression analysis. Results: We identified 369 patients with CHC. 235 were male, 297 Caucasians, and 223 had been exposed to HCV through intravenous drug use. The overall median TE value was 7.4 kPa (interquartile range (IQR) 5.7-12.1). HCV replication was enhanced in patients carrying the IL28B CC genotype compared to TT and TC (5.8 vs. 5.4 log(10) IU/mL, p=0.03). Patients infected with HCV genotype 3 had significantly higher TE values (8.2 kPa; IQR, 5.9-14.5) compared to genotype 1 (6.9 kPa; IQR, 5.4-10.9) and 2 (6.7 kPa; IQR, 4.9-8.8) (p=0.02). Within patients with genotype 3, IL28B CC genotype had the highest TE values (p=0.04). However, in multivariate logistic regression, using various cut-off values for fibrosis and cirrhosis, only increasing age (odds ratio (OR) 1.09 (95% confidence interval (CI), 1.05-1.14 per year increment)), ALT (OR 1.01 (95% CI, 1.002-1.011), per unit increment) and HCV genotype 3 compared to genotype 1 (OR 2.40 (95% CI, 1.19-.81), were consistently associated with cirrhosis (TE> 17.1 kPa). Conclusions: Age, ALT and infection with HCV genotype 3 were associated with cirrhosis assessed by TE. However, IL28B genotype was not an independent predictor of fibrosis in our study.	[Lundbo, Lene Fogt; Clausen, Louise Nygaard; Weis, Nina; Rosenorn, Lene; Benfield, Thomas] Univ Copenhagen, Hvidovre Hosp, Dept Infect Dis, Copenhagen, Denmark; [Lundbo, Lene Fogt; Clausen, Louise Nygaard; Benfield, Thomas] Univ Copenhagen, Hvidovre Hosp, Clin Res Ctr, Copenhagen, Denmark; [Lundbo, Lene Fogt; Clausen, Louise Nygaard; Weis, Nina; Schonning, Kristian; Benfield, Thomas] Univ Copenhagen, Dept Clin Med, Fac Hlth & Med Sci, Copenhagen, Denmark; [Schonning, Kristian] Univ Copenhagen, Hvidovre Hosp, Dept Clin Microbiol, Copenhagen, Denmark; [Christensen, Peer Brehm] Odense Univ Hosp, Dept Infect Dis, DK-5000 Odense, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Southern Denmark; Odense University Hospital	Lundbo, LF (corresponding author), Univ Copenhagen, Hvidovre Hosp, Dept Infect Dis, Copenhagen, Denmark.	lene.lundbo@gmail.com	Christensen, Peer B./B-8042-2015; Weis, Nina/GLT-4232-2022	Weis, Nina/0000-0002-3133-2724; Benfield, Thomas/0000-0003-0698-9385; Christensen, Peer Brehm/0000-0003-1394-058X; Fogt Lundbo, Lene/0000-0001-8595-859X	Preben and Anna Simonsen's Foundation; Danish Agency for Science, Technology and Innovation [12127717]	Preben and Anna Simonsen's Foundation; Danish Agency for Science, Technology and Innovation	The IL28B genotyping was supported by Preben and Anna Simonsen's Foundation. The Danish Agency for Science, Technology and Innovation supported 50% redeeming from clinical work to research for Nina Weis (grant no 12127717). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adinolfi LE, 2001, HEPATOLOGY, V33, P1358, DOI 10.1053/jhep.2001.24432; Ahmed MM, 1999, HAEMOPHILIA, V5, P49; Asselah T, 2006, GUT, V55, P123, DOI 10.1136/gut.2005.069757; Barreiro P, 2006, CLIN INFECT DIS, V42, P1032, DOI 10.1086/501021; Barreiro P, 2011, J INFECT DIS, V203, P1629, DOI 10.1093/infdis/jir113; Bochud PY, 2009, J HEPATOL, V51, P655, DOI 10.1016/j.jhep.2009.05.016; Bruno S, 2007, HEPATOLOGY, V46, P1350, DOI 10.1002/hep.21826; Cai T, 2011, J HEPATOL, V55, P529, DOI 10.1016/j.jhep.2010.12.020; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Castera L, 2008, J HEPATOL, V48, P835, DOI 10.1016/j.jhep.2008.02.008; Clausen LN, 2012, AIDS, V26, P1509, DOI 10.1097/QAD.0b013e3283553581; Clausen LN, 2011, SCAND J INFECT DIS, V43, P798, DOI 10.3109/00365548.2011.589077; Degos F, 2010, J HEPATOL, V53, P1013, DOI 10.1016/j.jhep.2010.05.035; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Hansen N, 2009, J VIRAL HEPATITIS, V16, P659, DOI 10.1111/j.1365-2893.2009.01126.x; Krarup HB, 1998, SCAND J CLIN LAB INV, V58, P415, DOI 10.1080/00365519850186391; Krarup HB, 2000, J VIRAL HEPATITIS, V7, P435, DOI 10.1046/j.1365-2893.2000.00258.x; Labarga P, 2011, AIDS, V25, P761, DOI 10.1097/QAD.0b013e32834488e7; Marabita F, 2011, HEPATOLOGY, V54, P1127, DOI 10.1002/hep.24503; McCarthy JJ, 2010, GASTROENTEROLOGY, V138, P2307, DOI 10.1053/j.gastro.2010.02.009; Murphy DG, 2007, J CLIN MICROBIOL, V45, P1102, DOI 10.1128/JCM.02366-06; Nijman IJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-95; Noureddin M, 2013, HEPATOLOGY, V58, P1548, DOI 10.1002/hep.26506; Petit JM, 2001, J HEPATOL, V35, P279, DOI 10.1016/S0168-8278(01)00143-X; Pittaluga F, 2008, J MED VIROL, V80, P254, DOI 10.1002/jmv.21073; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Probst A, 2011, J VIRAL HEPATITIS, V18, P745, DOI 10.1111/j.1365-2893.2011.01481.x; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Rembeck K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029370; Rodriguez S, 2009, AM J EPIDEMIOL, V169, P505, DOI 10.1093/aje/kwn359; Sabin CA, 1997, J INFECT DIS, V175, P164, DOI 10.1093/infdis/175.1.164; Tapper EB, 2012, CLIN GASTROENTEROL H, V10, P932, DOI 10.1016/j.cgh.2012.01.015; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Tillmann HL, 2011, J HEPATOL, V55, P1195, DOI 10.1016/j.jhep.2011.03.015; Westin J, 2002, J HEPATOL, V37, P837, DOI 10.1016/S0168-8278(02)00299-4; Westin J, 2007, J VIRAL HEPATITIS, V14, P29, DOI 10.1111/j.1365-2893.2006.00777.x; World Health Organization (WHO), HEP C; Ydreborg M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080172; Yee TT, 2000, GUT, V47, P845, DOI 10.1136/gut.47.6.845; Ziol M, 2005, HEPATOLOGY, V41, P48, DOI 10.1002/hep.20506	40	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115882	10.1371/journal.pone.0115882	http://dx.doi.org/10.1371/journal.pone.0115882			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545640	Green Submitted, gold, Green Published			2022-12-27	WOS:000347120200078
J	Xie, Y; Hu, LX; Du, ZM; Sun, XY; Amombo, E; Fan, JB; Fu, JM				Xie, Yan; Hu, Longxing; Du, Zhimin; Sun, Xiaoyan; Amombo, Erick; Fan, Jibiao; Fu, Jinmin			Effects of Cadmium Exposure on Growth and Metabolic Profile of Bermudagrass [Cynodon dactylon (L.) Pers.]	PLOS ONE			English	Article							GAS-CHROMATOGRAPHY; CHLOROPHYLL FLUORESCENCE; PHRAGMITES-AUSTRALIS; SOLANUM-NIGRUM; HEAVY-METALS; AMINO-ACIDS; RICE PLANTS; TOXICITY; STRESS; ZINC	Metabolic responses to cadmium (Cd) may be associated with variations in Cd tolerance in plants. The objectives of this study were to examine changes in metabolic profiles in bermudagrass in response to Cd stress and to identify predominant metabolites associated with differential Cd tolerance using gas chromatography-mass spectrometry. Two genotypes of bermudagrass with contrasting Cd tolerance were exposed to 0 and 1.5 mM CdSO4 for 14 days in hydroponics. Physiological responses to Cd were evaluated by determining turf quality, growth rate, chlorophyll content and normalized relative transpiration. All these parameters exhibited higher tolerance in WB242 than in WB144. Cd treated WB144 transported more Cd to the shoot than in WB242. The metabolite analysis of leaf polar extracts revealed 39 Cd responsive metabolites in both genotypes, mainly consisting of amino acids, organic acids, sugars, fatty acids and others. A difference in the metabolic profiles was observed between the two bermudagrass genotypes exposed to Cd stress. Seven amino acids (norvaline, glycine, proline, serine, threonine, glutamic acid and gulonic acid), four organic acids (glyceric acid, oxoglutaric acid, citric acid and malic acid,) and three sugars (xylulose, galactose and talose) accumulated more in WB242 than WB144. However, compared to the control, WB144 accumulated higher quantities of sugars than WB242 in the Cd regime. The differential accumulation of these metabolites could be associated with the differential Cd tolerance in bermudagrass.	[Xie, Yan; Hu, Longxing; Du, Zhimin; Sun, Xiaoyan; Amombo, Erick; Fan, Jibiao; Fu, Jinmin] Chinese Acad Sci, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan Bot Garden, Wuhan, Hubei, Peoples R China; [Xie, Yan; Du, Zhimin; Sun, Xiaoyan; Fan, Jibiao] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Fu, JM (corresponding author), Chinese Acad Sci, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan Bot Garden, Wuhan, Hubei, Peoples R China.	jfu@wbgcas.cn	Amombo, Erick/P-2440-2019; Hu, Longxing/AAS-8287-2020	Du, Zhimin/0000-0002-3287-738X	Young Scientists Fund of the National Natural Science Foundation of China [31101563]; National Natural Science Foundation of China [31272194]; China-Africa Center for Research and Education, CAS [SAJC201325]	Young Scientists Fund of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China-Africa Center for Research and Education, CAS	This work was financially supported by the Young Scientists Fund of the National Natural Science Foundation of China (Grant No. 31101563), National Natural Science Foundation of China (Grant No. 31272194) and the China-Africa Center for Research and Education, CAS (SAJC201325). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MA, 1999, ANAL BIOCHEM, V266, P77, DOI 10.1006/abio.1998.2906; Ali NA, 2002, PLANT SOIL, V239, P103, DOI 10.1023/A:1014995321560; [Anonymous], 1991, TURFGRASS MANAGEMENT; Archer MJG, 2004, WATER AIR SOIL POLL, V157, P257, DOI 10.1023/B:WATE.0000038900.66771.bf; Arthur E, 2000, INT J PHYTOREMEDIAT, V2, P1, DOI 10.1080/15226510008500027; Bailey NJC, 2003, PHYTOCHEMISTRY, V62, P851, DOI 10.1016/S0031-9422(02)00719-7; Baryla A, 2001, PLANTA, V212, P696, DOI 10.1007/s004250000439; BASSI R, 1993, ANN BOT-LONDON, V72, P151, DOI 10.1006/anbo.1993.1093; Bi XL, 2013, ENVIRON SCI TECHNOL, V47, P7593, DOI 10.1021/es402545j; Boddi B, 1995, PHOTOSYNTHETICA CZEC; Chaffei C, 2004, PLANT CELL PHYSIOL, V45, P1681, DOI 10.1093/pcp/pch192; Chen YX, 2003, CHEMOSPHERE, V50, P789, DOI 10.1016/S0045-6535(02)00220-5; Ciscato M, 1999, Z NATURFORSCH C, V54, P735; Costa G, 1997, PLANT SCI, V128, P131, DOI 10.1016/S0168-9452(97)00148-9; Das P, 1997, ENVIRON POLLUT, V98, P29, DOI 10.1016/S0269-7491(97)00110-3; Davidson C.M., 2013, HEAVY METALS SOILS, P97, DOI [10.1007/978-94-007-4470-7_4, DOI 10.1007/978-94-007-4470-7_4]; DAVIES BE, 1980, APPL SOIL TRACE ELEM; Dixon RA, 2001, NATURE, V411, P843, DOI 10.1038/35081178; Du HM, 2012, J AM SOC HORTIC SCI, V137, P411, DOI 10.21273/JASHS.137.6.411; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Fu JM, 2003, J PLANT NUTR, V26, P81, DOI 10.1081/PLN-120016498; Gao Y, 2010, J HAZARD MATER, V181, P771, DOI 10.1016/j.jhazmat.2010.05.080; Garg AK, 2002, P NATL ACAD SCI USA, V99, P15898, DOI 10.1073/pnas.252637799; Guy C, 2008, PHYSIOL PLANTARUM, V132, P220, DOI 10.1111/j.1399-3054.2007.00999.x; Hall JL, 2002, J EXP BOT, V53, P1, DOI 10.1093/jexbot/53.366.1; Hediji H, 2010, ECOTOX ENVIRON SAFE, V73, P1965, DOI 10.1016/j.ecoenv.2010.08.014; HISCOX JD, 1979, CAN J BOT, V57, P1332, DOI 10.1139/b79-163; HOAGLAND D. R., 1950, Circular. California Agricultural Experiment Station, V347; Hoekstra FA, 2001, TRENDS PLANT SCI, V6, P431, DOI 10.1016/S1360-1385(01)02052-0; Jamers A, 2013, AQUAT TOXICOL, V126, P355, DOI 10.1016/j.aquatox.2012.09.007; Kaplan F, 2004, PLANT PHYSIOL, V136, P4159, DOI 10.1104/pp.104.052142; Kieffer P, 2008, PROTEOMICS, V8, P2514, DOI 10.1002/pmic.200701110; Kishor PBK, 2005, CURR SCI INDIA, V88, P424; Koch KE, 1996, ANNU REV PLANT PHYS, V47, P509, DOI 10.1146/annurev.arplant.47.1.509; Kramer U, 1996, FREE HISTIDINE METAL; KRUPA Z, 1995, ACTA PHYSIOL PLANT, V17, P177; Larbi A, 2002, FUNCT PLANT BIOL, V29, P1453, DOI 10.1071/FP02090; Larsson EH, 1998, J EXP BOT, V49, P1031, DOI 10.1093/jexbot/49.323.1031; Lea PJ, 2007, ANN APPL BIOL, V150, P1, DOI 10.1111/j.1744-7348.2006.00104.x; Leita L, 1996, J PLANT NUTR, V19, P527, DOI 10.1080/01904169609365140; Madejon P, 2006, ENVIRON MONIT ASSESS, V114, P169, DOI 10.1007/s10661-006-2523-1; MOYA JL, 1995, J PLANT GROWTH REGUL, V14, P61, DOI 10.1007/BF00203115; NARAYAN VS, 1990, PHYTOCHEMISTRY, V29, P367, DOI 10.1016/0031-9422(90)85081-P; NISHIZONO H, 1989, PLANT CELL PHYSIOL, V30, P595, DOI 10.1093/oxfordjournals.pcp.a077780; PADMAJA K, 1990, PHOTOSYNTHETICA, V24, P399; Pietrini F, 2003, PLANT PHYSIOL, V133, P829, DOI 10.1104/pp.103.026518; Qiu Y, 2007, ANAL CHIM ACTA, V583, P277, DOI 10.1016/j.aca.2006.10.025; Quartacci MF, 2005, CHEMOSPHERE, V59, P1249, DOI 10.1016/j.chemosphere.2004.11.053; Rai VK, 2002, BIOL PLANTARUM, V45, P481, DOI 10.1023/A:1022308229759; RASCIO N, 1993, ARCH ENVIRON CON TOX, V25, P244, DOI 10.1007/BF00212136; Rizhsky L, 2004, PLANT PHYSIOL, V134, P1683, DOI 10.1104/pp.103.033431; Roessner U, 2000, PLANT J, V23, P131, DOI 10.1046/j.1365-313x.2000.00774.x; Salt DE, 1999, ENVIRON SCI TECHNOL, V33, P713, DOI 10.1021/es980825x; Sanita di Toppi L, 1999, ENVIRON EXP BOT, V41, P105, DOI 10.1016/S0098-8472(98)00058-6; Sarret G, 2002, PLANT PHYSIOL, V130, P1815, DOI 10.1104/pp.007799; Shah K, 1998, BIOL PLANTARUM, V40, P121, DOI 10.1023/A:1000956803911; Sheen J, 1999, CURR OPIN PLANT BIOL, V2, P410, DOI 10.1016/S1369-5266(99)00014-X; Shulaev V, 2008, PHYSIOL PLANTARUM, V132, P199, DOI 10.1111/j.1399-3054.2007.01025.x; Smeekens S, 2000, ANNU REV PLANT PHYS, V51, P49, DOI 10.1146/annurev.arplant.51.1.49; SMIRNOFF N, 1987, NEW PHYTOL, V107, P671, DOI 10.1111/j.1469-8137.1987.tb00905.x; SRINIVAS V, 1995, LANGMUIR, V11, P2830, DOI 10.1021/la00007a077; Vasquez-Robinet C, 2008, J EXP BOT, V59, P2109, DOI 10.1093/jxb/ern073; Vassilev A, 1997, PHOTOSYNTHETICA, V34, P293, DOI 10.1023/A:1006805010560; Verkleij J., 1990, MECH METAL TOLERANCE; Vetter J, 2000, TOXICON, V38, P11, DOI 10.1016/S0041-0101(99)00128-2; Wagner GJ, 1993, ADV AGRONOMY, V51; Wagner GJ, 1993, ADV AGRONOMY; Wu FB, 2005, CHEMOSPHERE, V60, P1437, DOI 10.1016/j.chemosphere.2005.01.071; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Xie Y., 2014, EMERGING MEMORY TECH, P1; Xu J, 2012, NEW PHYTOL, V196, P110, DOI 10.1111/j.1469-8137.2012.04235.x; Xu J, 2009, PLANT CELL REP, V28, P325, DOI 10.1007/s00299-008-0643-5; Yu XZ, 2007, ARCH ENVIRON CON TOX, V52, P503, DOI 10.1007/s00244-006-0155-7; Zhou WB, 2005, PLANT SCI, V169, P737, DOI 10.1016/j.plantsci.2005.05.030	75	53	57	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115279	10.1371/journal.pone.0115279	http://dx.doi.org/10.1371/journal.pone.0115279			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545719	gold, Green Published, Green Submitted			2022-12-27	WOS:000347120200033
J	Deshmukh, NP; Kang, HJ; Billings, SD; Taylor, RH; Hager, GD; Boctor, EM				Deshmukh, Nishikant P.; Kang, Hyun Jae; Billings, Seth D.; Taylor, Russell H.; Hager, Gregory D.; Boctor, Emad M.			Elastography Using Multi-Stream GPU: An Application to Online Tracked Ultrasound Elastography, In-Vivo and the da Vinci Surgical System	PLOS ONE			English	Article							REAL-TIME ELASTOGRAPHY; TRANSIENT ELASTOGRAPHY; MALIGNANCY; TISSUE; PERFORMANCE; ELASTICITY; FIBROSIS; CANCER; TOOL	A system for real-time ultrasound (US) elastography will advance interventions for the diagnosis and treatment of cancer by advancing methods such as thermal monitoring of tissue ablation. A multi-stream graphics processing unit (GPU) based accelerated normalized cross-correlation (NCC) elastography, with a maximum frame rate of 78 frames per second, is presented in this paper. A study of NCC window size is undertaken to determine the effect on frame rate and the quality of output elastography images. This paper also presents a novel system for Online Tracked Ultrasound Elastography (O-TRuE), which extends prior work on an offline method. By tracking the US probe with an electromagnetic (EM) tracker, the system selects in-plane radio frequency (RF) data frames for generating high quality elastograms. A novel method for evaluating the quality of an elastography output stream is presented, suggesting that O-TRuE generates more stable elastograms than generated by untracked, free-hand palpation. Since EM tracking cannot be used in all systems, an integration of real-time elastography and the da Vinci Surgical System is presented and evaluated for elastography stream quality based on our metric. The da Vinci surgical robot is outfitted with a laparoscopic US probe, and palpation motions are autonomously generated by customized software. It is found that a stable output stream can be achieved, which is affected by both the frequency and amplitude of palpation. The GPU framework is validated using data from in-vivo pig liver ablation; the generated elastography images identify the ablated region, outlined more clearly than in the corresponding B-mode US images.	[Deshmukh, Nishikant P.; Kang, Hyun Jae; Billings, Seth D.; Taylor, Russell H.; Hager, Gregory D.; Boctor, Emad M.] Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21218 USA; [Boctor, Emad M.] Johns Hopkins Med Inst, Dept Radiol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Deshmukh, NP (corresponding author), Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21218 USA.	nishikant@cs.jhu.edu			NIH SBIR Grant [CA134169, CA112852]; Johns Hopkins University; Intuitive Surgical Inc.; NATIONAL CANCER INSTITUTE [R44CA112852, R43CA112852, R44CA134169] Funding Source: NIH RePORTER	NIH SBIR Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins University(Johns Hopkins University); Intuitive Surgical Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	NIH SBIR Grant (PI: Dr. Everett Burdette) CA134169 and CA112852, and The Johns Hopkins University internal funds supported this work. Intuitive Surgical Inc. provided partial funding and equipment loan of the da Vinci Surgical System. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bercoff J, 2004, IEEE T ULTRASON FERR, V51, P396, DOI 10.1109/TUFFC.2004.1295425; Billings S, 2012, MED IMAGING 2012 IMA; Boctor EM, 2009, SPIE MED IMAGING, p72650R; Boni E, 2012, IEEE T ULTRASON FERR, V59, P1378, DOI 10.1109/TUFFC.2012.2338; Brock M, 2012, J UROLOGY, V187, P2039, DOI 10.1016/j.juro.2012.01.063; Cappelli C, 2012, J ULTRAS MED, V31, P1777; Deshmukh N, 2009, P INT C MED IM COMP; Ferraioli G, 2012, AM J ROENTGENOL, V199, P19, DOI 10.2214/AJR.11.7517; Foroughi P, 2013, ULTRASOUND MED BIOL, V39, P211, DOI 10.1016/j.ultrasmedbio.2012.09.006; Hinz T, 2013, DERMATOLOGY, V226, P81, DOI 10.1159/000346942; Kang H- J, 2012, SPIE MED IMAGING; Kang HJ, 2012, MIDAS J; Mak TM, 2013, ULTRASOUND MED BIOL, V39, P956, DOI 10.1016/j.ultrasmedbio.2013.01.009; Nair SP, 2011, IEEE T MED IMAGING, V30, P497, DOI 10.1109/TMI.2010.2087344; Nakashima K, 2013, J MED ULTRASON, V40, P359, DOI 10.1007/s10396-013-0457-0; NVIDIA, 2011, NVIDIA CUDA C PROGR; OPHIR J, 1991, ULTRASONIC IMAGING, V13, P111, DOI 10.1016/0161-7346(91)90079-W; Parkin DM, 2006, BREAST J, V12, pS70, DOI 10.1111/j.1075-122X.2006.00205.x; Popescu A, 2011, MED ULTRASON, V13, P33; Raj JJR, 2012, INT J ENG SCI TECHNO, V4; Rivaz H, 2008, LECT NOTES COMPUT SC, V5242, P458, DOI 10.1007/978-3-540-85990-1_55; Schneider FK, 2010, IEEE T INF TECHNOL B, V14, P538, DOI 10.1109/TITB.2009.2025653; Sen HT, 2012, SPIE MED IMAGING; Sumura M, 2007, INT J UROL, V14, P811, DOI 10.1111/j.1442-2042.2007.01829.x; Thomas A, 2006, ULTRASOUND OBST GYN, V28, P335, DOI 10.1002/uog.2823; Trimboli P, 2012, J CLIN ENDOCR METAB, V97, P4524, DOI 10.1210/jc.2012-2951; Turgay E, 2006, ULTRASOUND MED BIOL, V32, P221, DOI 10.1016/j.ultrasmedbio.2005.09.015; Wojcinski S, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-159; Xiao X, 2012, AIP CONF PROC, V1503, P135, DOI 10.1063/1.4769931; Xie M, 2013, J ULTRAS MED, V32, P257, DOI 10.7863/jum.2013.32.2.257; Yang X, 2011, IEEE T ULTRASON FERR, V58, P2631, DOI 10.1109/TUFFC.2011.2126; Yoo JC, 2009, CIRC SYST SIGNAL PR, V28, P819, DOI [10.1007/s00034-009-9130-7, 10.1007/S00034-009-9130-7]	32	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115881	10.1371/journal.pone.0115881	http://dx.doi.org/10.1371/journal.pone.0115881			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541954	Green Published, Green Submitted, gold			2022-12-27	WOS:000347239900104
J	Ng, SK; Huang, YT; Lee, YC; Low, EL; Chiu, CH; Chen, SL; Mao, LC; Chang, MDT				Ng, Sim-Kun; Huang, Yu-Tsyr; Lee, Yuan-Chuan; Low, Ee-Ling; Chiu, Cheng-Hsun; Chen, Shiu-Ling; Mao, Liang-Chi; Chang, Margaret Dah-Tsyr			A Recombinant Horseshoe Crab Plasma Lectin Recognizes Specific Pathogen-Associated Molecular Patterns of Bacteria through Rhamnose	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; BINDING LECTINS; ANIMAL LECTINS; DEFICIENT MUTANT; DTDP-RHAMNOSE; LIPOPOLYSACCHARIDE; GENE; POLYSACCHARIDE; CORE; BIOSYNTHESIS	Horseshoe crab is an ancient marine arthropod that, in the absence of a vertebrate-like immune system, relies solely on innate immune responses by defense molecules found in hemolymph plasma and granular hemocytes for host defense. A plasma lectin isolated from the hemolymph of Taiwanese Tachypleus tridentatus recognizes bacteria and lipopolysaccharides (LPSs), yet its structure and mechanism of action remain unclear, largely because of limited availability of horseshoe crabs and the lack of a heterogeneous expression system. In this study, we have successfully expressed and purified a soluble and functional recombinant horseshoe crab plasma lectin (rHPL) in an Escherichia coli system. Interestingly, rHPL bound not only to bacteria and LPSs like the native HPL but also to selective medically important pathogens isolated from clinical specimens, such as Gram-negative Pseudomonas aeruginosa and Klebsiella pneumoniae and Gram-positive Streptococcus pneumoniae serotypes. The binding was demonstrated to occur through a specific molecular interaction with rhamnose in pathogen-associated molecular patterns (PAMPs) on the bacterial surface. Additionally, rHPL inhibited the growth of P. aeruginosa PAO1 in a concentration-dependent manner. The results suggest that a specific protein-glycan interaction between rHPL and rhamnosyl residue may further facilitate development of novel diagnostic and therapeutic strategies for microbial pathogens.	[Ng, Sim-Kun; Huang, Yu-Tsyr; Lee, Yuan-Chuan; Low, Ee-Ling; Chang, Margaret Dah-Tsyr] Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan; [Ng, Sim-Kun; Huang, Yu-Tsyr; Lee, Yuan-Chuan; Low, Ee-Ling; Chang, Margaret Dah-Tsyr] Natl Tsing Hua Univ, Dept Med Sci, Hsinchu, Taiwan; [Lee, Yuan-Chuan] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Chiu, Cheng-Hsun; Chen, Shiu-Ling] Chang Gung Mem Hosp, Dept Pediat, Taoyuan, Hsien, Taiwan; [Mao, Liang-Chi] Simpson Biotech Co Ltd, Kuei Shan, Taoyuan County, Taiwan	National Tsing Hua University; National Tsing Hua University; Johns Hopkins University; Chang Gung Memorial Hospital	Chang, MDT (corresponding author), Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan.	dtchang@life.nthu.edu.tw			National Science Council, Taiwan [NSC 100-2628-B-007-003-MY3]; Ministry of Science and Technology, Taiwan [MOST 103-2627-M-007-006]; Chang Gung Memorial Hospital-National Tsing Hua University Collaborative Project [101N2762E1]; Simpson Biotech Co.; Shen's Culture & Education Foundation (Apex Biotechnology Corporation, Taiwan)	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital-National Tsing Hua University Collaborative Project; Simpson Biotech Co.; Shen's Culture & Education Foundation (Apex Biotechnology Corporation, Taiwan)	Funding: This work was supported in part by grants from the National Science Council, Taiwan (NSC 100-2628-B-007-003-MY3), Ministry of Science and Technology, Taiwan (MOST 103-2627-M-007-006), Chang Gung Memorial Hospital-National Tsing Hua University Collaborative Project (101N2762E1), and Simpson Biotech Co. Sim-Kun Ng was supported by Shen's Culture & Education Foundation (Apex Biotechnology Corporation, Taiwan). The funding sources had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Mawgoud AM, 2010, APPL MICROBIOL BIOT, V86, P1323, DOI 10.1007/s00253-010-2498-2; Bozue JA, 2005, MICROB PATHOGENESIS, V38, P1, DOI 10.1016/j.micpath.2004.10.001; Burrows LL, 1996, MOL MICROBIOL, V22, P481, DOI 10.1046/j.1365-2958.1996.1351503.x; Bystrova OV, 2006, FEMS IMMUNOL MED MIC, V46, P85, DOI 10.1111/j.1574-695X.2005.00004.x; Bystrova OV, 2002, EUR J BIOCHEM, V269, P2194, DOI 10.1046/j.1432-1033.2002.02875.x; Chen SC, 2001, J BIOL CHEM, V276, P9631, DOI 10.1074/jbc.M008414200; Chiang SL, 1999, INFECT IMMUN, V67, P976, DOI 10.1128/IAI.67.2.976-980.1999; Chiou ST, 2000, J BIOL CHEM, V275, P1630, DOI 10.1074/jbc.275.3.1630; Collins BE, 2004, CURR OPIN CHEM BIOL, V8, P617, DOI 10.1016/j.cbpa.2004.10.004; Eckstein TM, 1998, J BACTERIOL, V180, P5567, DOI 10.1128/JB.180.21.5567-5573.1998; FIEDLER F, 1984, ARCH MICROBIOL, V138, P321, DOI 10.1007/BF00410898; Fox JL, 2013, NAT BIOTECHNOL, V31, P379, DOI 10.1038/nbt.2572; Gasparini F, 2008, DEV COMP IMMUNOL, V32, P1177, DOI 10.1016/j.dci.2008.03.006; Gupta GS, 2012, ANIMAL LECTINS FORM; Heimburg-Molinaro Jamie, 2011, Curr Protoc Protein Sci, VChapter 12, DOI 10.1002/0471140864.ps1210s64; HOSONO M, 1993, BIOL PHARM BULL, V16, P239; Inamori K, 1999, J BIOL CHEM, V274, P3272, DOI 10.1074/jbc.274.6.3272; Iwanaga S., 1998, FRONT BIOSCI-LANDMRK, V3, P973; Jia WZ, 2010, FISH PHYSIOL BIOCHEM, V36, P451, DOI 10.1007/s10695-009-9315-9; Jiang WQ, 2004, J MAGN MAGN MATER, V283, P210, DOI 10.1016/j.jmmm.2004.05.022; JIANG XM, 1991, MOL MICROBIOL, V5, P695, DOI 10.1111/j.1365-2958.1991.tb00741.x; Kaltner H, 1998, ACTA ANAT, V161, P162; Kerr KG, 2009, J HOSP INFECT, V73, P338, DOI 10.1016/j.jhin.2009.04.020; Kilpatrick DC, 2002, BBA-GEN SUBJECTS, V1572, P187, DOI 10.1016/S0304-4165(02)00308-2; Kjaer TR, 2013, INFECT IMMUN, V81, P452, DOI 10.1128/IAI.01148-12; Kuo TH, 2006, BIOCHEM J, V393, P757, DOI 10.1042/BJ20051108; Li Q, 2000, MICROBIOL-UK, V146, P2291, DOI 10.1099/00221287-146-9-2291; Loris R, 2002, BBA-GEN SUBJECTS, V1572, P198, DOI 10.1016/S0304-4165(02)00309-4; Ma YF, 2001, ANTIMICROB AGENTS CH, V45, P1407, DOI 10.1128/AAC.45.5.1407-1416.2001; Matsuura M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00109; Muta T, 1996, CURR OPIN IMMUNOL, V8, P41, DOI 10.1016/S0952-7915(96)80103-8; Naganuma T, 2006, MOL DIVERS, V10, P607, DOI 10.1007/s11030-006-9051-3; Nitta K, 2007, YAKUGAKU ZASSHI, V127, P553, DOI 10.1248/yakushi.127.553; OZEKI Y, 1991, BIOCHEMISTRY-US, V30, P2391, DOI 10.1021/bi00223a014; Poole K, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00065; Raman R, 2005, NAT METHODS, V2, P817, DOI 10.1038/NMETH807; Rautemaa R, 1999, MICROBES INFECT, V1, P785, DOI 10.1016/S1286-4579(99)80081-1; Rocchetta HL, 1999, MICROBIOL MOL BIOL R, V63, P523, DOI 10.1128/MMBR.63.3.523-553.1999; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Sadovskaya I, 1998, EUR J BIOCHEM, V255, P673, DOI 10.1046/j.1432-1327.1998.2550673.x; Shirai T, 2009, J MOL BIOL, V391, P390, DOI 10.1016/j.jmb.2009.06.027; Spectral Diagnostics, 2008, ANN REP LEAD BATTL S; Sugihara R, 2000, IMMUNOPHARMACOLOGY, V49, P325, DOI 10.1016/S0162-3109(00)00247-2; Tateno H, 2002, DEV COMP IMMUNOL, V26, P543, DOI 10.1016/S0145-305X(02)00007-1; Tateno H, 2001, BIOSCI BIOTECH BIOCH, V65, P1328, DOI 10.1271/bbb.65.1328; Tateno H, 1998, J BIOL CHEM, V273, P19190, DOI 10.1074/jbc.273.30.19190; Terada T, 2007, BBA-GEN SUBJECTS, V1770, P617, DOI 10.1016/j.bbagen.2006.11.003; Vasta G.R., 1996, Progress in Molecular and Subcellular Biology, V17, P158; VASTA GR, 1994, ANN NY ACAD SCI, V712, P55, DOI 10.1111/j.1749-6632.1994.tb33562.x; Watanabe Y, 2009, DEV COMP IMMUNOL, V33, P187, DOI 10.1016/j.dci.2008.08.008; Watanabe Y, 2008, DEV COMP IMMUNOL, V32, P487, DOI 10.1016/j.dci.2007.08.007; Wright GD, 2007, NAT REV MICROBIOL, V5, P175, DOI 10.1038/nrmicro1614; Xia XH, 2000, SYST BIOL, V49, P87, DOI 10.1080/10635150050207401; YADOMAE T, 1979, CARBOHYD RES, V75, P191, DOI 10.1016/S0008-6215(00)84638-8; Yamashita Y, 1999, INFECT IMMUN, V67, P3693, DOI 10.1128/IAI.67.7.3693-3697.1999; Yang SY, 2008, J MAGN MAGN MATER, V320, P2688, DOI 10.1016/j.jmmm.2008.05.048	56	14	14	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115296	10.1371/journal.pone.0115296	http://dx.doi.org/10.1371/journal.pone.0115296			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541995	gold, Green Submitted, Green Published			2022-12-27	WOS:000347239900033
J	Challacombe, JF; Stubben, CJ; Klimko, CP; Welkos, SL; Kern, SJ; Bozue, JA; Worsham, PL; Cote, CK; Wolfe, DN				Challacombe, Jean F.; Stubben, Chris J.; Klimko, Christopher P.; Welkos, Susan L.; Kern, Steven J.; Bozue, Joel A.; Worsham, Patricia L.; Cote, Christopher K.; Wolfe, Daniel N.			Interrogation of the Burkholderia pseudomallei Genome to Address Differential Virulence among Isolates	PLOS ONE			English	Article							ANTIBIOTIC SUSCEPTIBILITY; NORTHERN AUSTRALIA; CARBON METABOLISM; CAUSATIVE AGENT; GENE-EXPRESSION; MELIOIDOSIS; RPOS; ADAPTATION; SURVIVAL; EPIDEMIOLOGY	Infection by the Gram-negative pathogen Burkholderia pseudomallei results in the disease melioidosis, acquired from the environment in parts of southeast Asia and northern Australia. Clinical symptoms of melioidosis range from acute (fever, pneumonia, septicemia, and localized infection) to chronic (abscesses in various organs and tissues, most commonly occurring in the lungs, liver, spleen, kidney, prostate and skeletal muscle), and persistent infections in humans are difficult to cure. Understanding the basic biology and genomics of B. pseudomallei is imperative for the development of new vaccines and therapeutic interventions. This formidable task is becoming more tractable due to the increasing number of B. pseudomallei genomes that are being sequenced and compared. Here, we compared three B. pseudomallei genomes, from strains MSHR668, K96243 and 1106a, to identify features that might explain why MSHR668 is more virulent than K96243 and 1106a in a mouse model of B. pseudomallei infection. Our analyses focused on metabolic, virulence and regulatory genes that were present in MSHR668 but absent from both K96243 and 1106a. We also noted features present in K96243 and 1106a but absent from MSHR668, and identified genomic differences that may contribute to variations in virulence noted among the three B. pseudomallei isolates. While this work contributes to our understanding of B. pseudomallei genomics, more detailed experiments are necessary to characterize the relevance of specific genomic features to B. pseudomallei metabolism and virulence. Functional analyses of metabolic networks, virulence and regulation shows promise for examining the effects of B. pseudomallei on host cell metabolism and will lay a foundation for future prediction of the virulence of emerging strains. Continued emphasis in this area will be critical for protection against melioidosis, as a better understanding of what constitutes a fully virulent Burkholderia isolate may provide for better diagnostic and medical countermeasure strategies.	[Challacombe, Jean F.; Stubben, Chris J.] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM 87545 USA; [Klimko, Christopher P.; Welkos, Susan L.; Bozue, Joel A.; Worsham, Patricia L.; Cote, Christopher K.] US Army Med Res Inst Infect Dis, Bacteriol Div, Ft Detrick, MD USA; [Kern, Steven J.] US Army Med Res Inst Infect Dis, Div Biostat, Ft Detrick, MD USA; [Wolfe, Daniel N.] Def Threat Reduct Agcy, Chem & Biol Technol Dept, Ft Belvoir, VA USA	United States Department of Energy (DOE); Los Alamos National Laboratory; United States Army Medical Research Institute of Infectious Diseases; United States Department of Defense; United States Army; United States Army Medical Research Institute of Infectious Diseases; United States Department of Defense; United States Army	Challacombe, JF (corresponding author), Los Alamos Natl Lab, Biosci Div, Los Alamos, NM 87545 USA.	jchalla@lanl.gov	Bozue, Joel/AAE-4363-2022; Bozue, Joel/AAE-4357-2022	Bozue, Joel/0000-0001-6959-8176; Bozue, Joel/0000-0001-6959-8176; Stubben, Chris/0000-0002-3390-4888	Defense Threat Reduction Agency (CCAR) [CB3846 PPE-1, CBS119924543-7049-BASIC]	Defense Threat Reduction Agency (CCAR)(United States Department of DefenseDefense Threat Reduction Agency)	This project was funded by the Defense Threat Reduction Agency (CCAR# CB3846 PPE-1 Burkholderia and CBS119924543-7049-BASIC). The funder had no role in study design, data collection and analysis, or decision to publish the manuscript. DNW contributed to the writing of the manuscript.	Abu Kwaik Y, 2013, CELL MICROBIOL, V15, P882, DOI 10.1111/cmi.12138; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; ATKINSON MR, 1990, J BACTERIOL, V172, P4758, DOI 10.1128/jb.172.9.4758-4765.1990; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Aziz RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048053; Barbier T, 2011, FEBS LETT, V585, P2929, DOI 10.1016/j.febslet.2011.08.011; Berg G, 2005, ENVIRON MICROBIOL, V7, P1673, DOI 10.1111/j.1462-2920.2005.00891.x; Brinkac LM, 2010, NUCLEIC ACIDS RES, V38, pD408, DOI 10.1093/nar/gkp850; Caspi R, 2010, NUCLEIC ACIDS RES, V38, pD473, DOI 10.1093/nar/gkp875; Chen LH, 2012, NUCLEIC ACIDS RES, V40, pD641, DOI 10.1093/nar/gkr989; Cheng AC, 2004, J CLIN MICROBIOL, V42, P5477, DOI 10.1128/JCM.42.12.5477-5483.2004; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Chieng S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-328; Chin CY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-672; Choy JL, 2000, ACTA TROP, V74, P153, DOI 10.1016/S0001-706X(99)00065-0; Currie BJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000900; Currie BJ, 2003, EUR RESPIR J, V22, P542, DOI 10.1183/09031936.03.00006203; Currie BJ, 2001, AM J TROP MED HYG, V65, P177, DOI 10.4269/ajtmh.2001.65.177; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; DEJSIRILERT S, 1991, JPN J MED SCI BIOL, V44, P63, DOI 10.7883/yoken1952.44.63; DeShazer D, 1998, MOL MICROBIOL, V30, P1081, DOI 10.1046/j.1365-2958.1998.01139.x; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Eisenreich W, 2010, NAT REV MICROBIOL, V8, P401, DOI 10.1038/nrmicro2351; FANG FC, 1992, P NATL ACAD SCI USA, V89, P11978, DOI 10.1073/pnas.89.24.11978; Fisher SH, 1999, MOL MICROBIOL, V32, P223, DOI 10.1046/j.1365-2958.1999.01333.x; Fuchs TM, 2012, FEMS MICROBIOL REV, V36, P435, DOI 10.1111/j.1574-6976.2011.00301.x; Fujita Y, 2009, BIOSCI BIOTECH BIOCH, V73, P245, DOI 10.1271/bbb.80479; Gal D, 2004, AM J TROP MED HYG, V71, P360, DOI 10.4269/ajtmh.2004.71.360; Galyov EE, 2010, ANNU REV MICROBIOL, V64, P495, DOI 10.1146/annurev.micro.112408.134030; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; Inglis TJJ, 2009, BRAZ J INFECT DIS, V13, P59, DOI 10.1590/S1413-86702009000100013; Jenney AWJ, 2001, INT J ANTIMICROB AG, V17, P109, DOI 10.1016/S0924-8579(00)00334-4; Kaestli M, 2012, ENVIRON MICROBIOL, V14, P2058, DOI 10.1111/j.1462-2920.2011.02671.x; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karp Peter D, 2002, Bioinformatics, V18 Suppl 1, pS225; Lengwehasatit I, 2008, MICROB PATHOGENESIS, V44, P238, DOI 10.1016/j.micpath.2007.08.017; Lerat E, 2005, NUCLEIC ACIDS RES, V33, P3125, DOI 10.1093/nar/gki631; Lerat E, 2004, GENOME RES, V14, P2273, DOI 10.1101/gr.2925604; Limmathurotsakul D, 2011, BRIT MED BULL, V99, P125, DOI 10.1093/bmb/ldr007; Loprasert S, 2000, GENE, V254, P129, DOI 10.1016/S0378-1119(00)00279-1; Mao XJ, 2007, NUCLEIC ACIDS RES, V35, P1432, DOI 10.1093/nar/gkl1142; Markowitz VM, 2006, NUCLEIC ACIDS RES, V34, pD344, DOI 10.1093/nar/gkj024; MAYS EE, 1975, CHEST, V68, P261, DOI 10.1378/chest.68.2.261; Mendes R, 2013, FEMS MICROBIOL REV, V37, P634, DOI 10.1111/1574-6976.12028; Nandi T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000845; Ngauy V, 2005, J CLIN MICROBIOL, V43, P970, DOI 10.1128/JCM.43.2.970-972.2005; Novichkov PS, 2010, NUCLEIC ACIDS RES, V38, pD111, DOI 10.1093/nar/gkp894; Ooi WF, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003795; Pearson T, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-78; Potvin E, 2008, FEMS MICROBIOL REV, V32, P38, DOI 10.1111/j.1574-6976.2007.00092.x; Rattanavong S, 2011, APPL ENVIRON MICROB, V77, P532, DOI 10.1128/AEM.01822-10; REZNIKOFF WS, 1985, ANNU REV GENET, V19, P355, DOI 10.1146/annurev.ge.19.120185.002035; Robertson J, 2010, AM J TROP MED HYG, V82, P88, DOI 10.4269/ajtmh.2010.09-0226; Rodrigues F, 2006, J BACTERIOL, V188, P8178, DOI 10.1128/JB.01006-06; Sarovich DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091682; Sim SH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000178; Suebrasri T., 2013, African Journal of Microbiology Research, V7, P1940; Thibault FM, 2004, J ANTIMICROB CHEMOTH, V54, P1134, DOI 10.1093/jac/dkh471; Trung TT, 2011, APPL ENVIRON MICROB, V77, P6486, DOI 10.1128/AEM.00735-11; Tuanyok A, 2007, J BACTERIOL, V189, P9044, DOI 10.1128/JB.01264-07; Tuanyok A, 2006, INFECT IMMUN, V74, P5465, DOI 10.1128/IAI.00737-06; Tuanyok A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-566; Tumapa S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-190; Ulett GC, 2000, INFECT IMMUN, V68, P2034, DOI 10.1128/IAI.68.4.2034-2042.2000; Utaisincharoen P, 2006, MICROB PATHOGENESIS, V40, P184, DOI 10.1016/j.micpath.2006.01.002; Velapatino B, 2012, MICROBES INFECT, V14, P335, DOI 10.1016/j.micinf.2011.11.011; Walker DR, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P333; White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0; Wongtrakoongate P, 2012, MICROBIOL IMMUNOL, V56, P281, DOI 10.1111/j.1348-0421.2012.00447.x; Xiang ZS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r150; Yang J, 2011, TRENDS MICROBIOL, V19, P128, DOI 10.1016/j.tim.2010.12.001; Zhang YJJ, 2013, CELL MICROBIOL, V15, P1079, DOI 10.1111/cmi.12140	73	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115951	10.1371/journal.pone.0115951	http://dx.doi.org/10.1371/journal.pone.0115951			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536074	Green Submitted, gold, Green Published			2022-12-27	WOS:000348563300091
J	Churi, CR; Shroff, R; Wang, Y; Rashid, A; Kang, HC; Weatherly, J; Zuo, MX; Zinner, R; Hong, D; Meric-Bernstam, F; Janku, F; Crane, CH; Mishra, L; Vauthey, JN; Wolff, RA; Mills, G; Javle, M				Churi, Chaitanya R.; Shroff, Rachna; Wang, Ying; Rashid, Asif; Kang, HyunSeon C.; Weatherly, Jacqueline; Zuo, Mingxin; Zinner, Ralph; Hong, David; Meric-Bernstam, Funda; Janku, Filip; Crane, Christopher H.; Mishra, Lopa; Vauthey, Jean-Nicholas; Wolff, Robert A.; Mills, Gordon; Javle, Milind			Mutation Profiling in Cholangiocarcinoma: Prognostic and Therapeutic Implications	PLOS ONE			English	Article							INTRAHEPATIC CHOLANGIOCARCINOMA; GALLBLADDER CANCER; FREQUENT MUTATION; BAP1; IDENTIFICATION; EPIDEMIOLOGY; EXPRESSION; MORTALITY; TRENDS; ERBB2	Background: Cholangiocarcinoma (CCA) is clinically heterogeneous; intra and extrahepatic CCA have diverse clinical presentations. Next generation sequencing (NGS) technology may identify the genetic differences between these entities and identify molecular subgroups for targeted therapeutics. Methods: We describe successful NGS-based testing of 75 CCA patients along with the prognostic and therapeutic implications of findings. Mutation profiling was performed using either a) NGS panel of hotspot regions in 46 cancer-related genes using a 318-chip on Ion PGM Sequencer or b) Illumina HiSeq 2000 sequencing platform for 3,769 exons of 236 cancer-related genes plus 47 introns from 19 genes to an average depth of 1000X. Clinical data was abstracted and correlated with clinical outcome. Patients with targetable mutations were referred to appropriate clinical trials. Results: There were significant differences between intrahepatic (n = 55) and extrahepatic CCA (n = 20) in regard to the nature and frequency of the genetic aberrations (GAs). IDH1 and DNA repair gene alterations occurred more frequently in intrahepatic CCA, while ERBB2 GAs occurred in the extrahepatic group. Commonly occurring GAs in intrahepatic CCA were TP53 (35%), KRAS (24%), ARID1A (20%), IDH1 (18%), MCL1 (16%) and PBRM1 (11%). Most frequent GAs in extrahepatic CCA (n = 20) were TP53 (45%), KRAS (40%), ERBB2 (25%), SMAD4 (25%), FBXW7 (15%) and CDKN2A (15%). In intrahepatic CCA, KRAS, TP53 or MAPK/mTOR GAs were significantly associated with a worse prognosis while FGFR GAs correlated with a relatively indolent disease course. IDH1 GAs did not have any prognostic significance. GAs in the chromatin modulating genes, BAP1 and PBRM1 were associated with bone metastases and worse survival in extrahepatic CCA. Radiologic responses and clinical benefit was noted with EGFR, FGFR, C-met, B-RAF and MEK inhibitors. Conclusion: There are significant genetic differences between intra and extrahepatic CCA. NGS can potentially identify disease subsets with distinct prognostic and therapeutic implications.	[Churi, Chaitanya R.; Shroff, Rachna; Wang, Ying; Rashid, Asif; Kang, HyunSeon C.; Weatherly, Jacqueline; Zuo, Mingxin; Zinner, Ralph; Hong, David; Meric-Bernstam, Funda; Janku, Filip; Crane, Christopher H.; Mishra, Lopa; Vauthey, Jean-Nicholas; Wolff, Robert A.; Mills, Gordon; Javle, Milind] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Javle, M (corresponding author), Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA.	mjavle@mdanderson.org	Janku, Filip/ABB-9136-2020; Shroff, Rachna/AAR-5802-2020; Zuo, Mingxin/E-1063-2015	Mishra, Lopa/0000-0002-6850-0808; Kang, Hyunseon/0000-0001-5313-3526	Cholangiocarcinoma Foundation;  [PO1 CA130821-01]; NATIONAL CANCER INSTITUTE [P01CA130821, P30CA016672] Funding Source: NIH RePORTER	Cholangiocarcinoma Foundation; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by funds from the Cholangiocarcinoma Foundation. PO1 CA130821-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, Acta Trop, V88, P169; Arai Toshiyuki, 2006, Nihon Rinsho, V64 Suppl 1, P476; Bertuccio P, 2013, ANN ONCOL, V24, P1667, DOI 10.1093/annonc/mds652; Borad MJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004135; Borger DR, 2012, ONCOLOGIST, V17, P72, DOI 10.1634/theoncologist.2011-0386; Bose P, 2009, EXPERT OPIN INV DRUG, V18, P1735, DOI 10.1517/13543780903305428; Bose R, 2013, CANCER DISCOV, V3, P224, DOI 10.1158/2159-8290.CD-12-0349; Chen TC, 2012, ANN SURG ONCOL, V19, pS675, DOI [10.1245/s10434-012-2224-7, 10.1245/s10434-012-2451-y]; Choi W, 2014, CANCER CELL, V25, P152, DOI 10.1016/j.ccr.2014.01.009; Chung JY, 2009, CLIN CANCER RES, V15, P660, DOI 10.1158/1078-0432.CCR-08-1084; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Goeppert B, 2014, MODERN PATHOL, V27, P1028, DOI 10.1038/modpathol.2013.206; Hamidi H, 2014, BR J CANC; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Herter-Sprie GS, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00086; Javle M, 2014, HUM PATHOL, V45, P701, DOI 10.1016/j.humpath.2013.11.001; Jiao YC, 2013, NAT GENET, V45, P1470, DOI 10.1038/ng.2813; Kanagal-Shamanna R, 2014, MODERN PATHOL, V27, P314, DOI 10.1038/modpathol.2013.122; Khan SA, 2012, J HEPATOL, V56, P848, DOI 10.1016/j.jhep.2011.11.015; Kipp BR, 2012, HUM PATHOL, V43, P1552, DOI 10.1016/j.humpath.2011.12.007; Lee JW, 2006, CANCER LETT, V237, P89, DOI 10.1016/j.canlet.2005.05.026; Murali R, 2013, PATHOLOGY, V45, P116, DOI 10.1097/PAT.0b013e32835d0efb; Nakayama N, 2008, BRIT J CANCER, V99, P2020, DOI 10.1038/sj.bjc.6604783; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Parsi MA, 2013, WORLD J GASTROENTERO, V19, P457, DOI 10.3748/wjg.v19.i4.457; Patel T, 2001, HEPATOLOGY, V33, P1353, DOI 10.1053/jhep.2001.25087; Pirozzi CJ, 2013, CANCER CELL, V23, P570, DOI 10.1016/j.ccr.2013.04.024; Roa Ivan, 2014, Gastrointest Cancer Res, V7, P42; Ross JS, 2011, AM J CLIN PATHOL, V136, P527, DOI 10.1309/AJCPR1SVT1VHUGXW; Shaib Y, 2004, SEMIN LIVER DIS, V24, P115, DOI 10.1055/s-2004-828889; Shaib YH, 2004, J HEPATOL, V40, P472, DOI 10.1016/j.jhep.2003.11.030; Shin HR, 2010, J KOREAN MED SCI, V25, P1011, DOI 10.3346/jkms.2010.25.7.1011; Sia D, 2013, ONCOGENE, V32, P4861, DOI 10.1038/onc.2012.617; Subbiah IM, 2013, ONCOTARGET, V4, P156; Tyson GL, 2011, HEPATOLOGY, V54, P173, DOI 10.1002/hep.24351; Valle J, 2010, NEW ENGL J MED, V362, P1273, DOI 10.1056/NEJMoa0908721; van Essen TH, 2014, BR J OPHTHALMOL; Wiesner T, 2011, NAT GENET, V43, P1018, DOI 10.1038/ng.910; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Wu YM, 2013, CANCER DISCOV, V3, P636, DOI 10.1158/2159-8290.CD-13-0050; Yamasaki Susumu, 2003, J Hepatobiliary Pancreat Surg, V10, P288, DOI 10.1007/s00534-002-0732-8; Yoshikawa D, 2008, BRIT J CANCER, V98, P418, DOI 10.1038/sj.bjc.6604129	44	290	305	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115383	10.1371/journal.pone.0115383	http://dx.doi.org/10.1371/journal.pone.0115383			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536104	Green Submitted, Green Published, gold			2022-12-27	WOS:000348563300036
J	Goldstein, P; Korol, AB; Reiner-Benaim, A				Goldstein, Pavel; Korol, Abraham B.; Reiner-Benaim, Anat			Two-Stage Genome-Wide Search for Epistasis with Implementation to Recombinant Inbred Lines (RIL) Populations	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; FALSE DISCOVERY RATE; NETWORK ANALYSIS; MAPPING ANALYSIS; ASSOCIATION; PACKAGE; CROSSES; MARKERS; MODELS; QTL	Objective and Methods: This paper proposes an inegrative two-stage genome-wide search for pairwise epistasis on expression quantitative trait loci (eQTL). The traits are clustered into multi-trait complexes that account for correlations between them that may result from common epistasis effects. The search is done by first screening for epistatic regions and then using dense markers within the identified regions, resulting in substantial reduction in the number of tests for epistasis. The FDR is controlled using a hierarchical procedure that accounts for the search structure. Each combination of trait and marker-pair is tested using a model that accounts for both statistical and functional interpretations of epistasis and considers orthogonal effects, such that their contributions to heritability can be estimated individually. We examine the impact of using multi-trait complexes rather than single traits, and of using a hierarchical search for epistasis rather than skipping the initial screen for epistatic regions. We apply the proposed algorithm on Arabidopsis transcription data. Principal Findings: Both epistasis detection power and heritability contributed by epistasis increased when using multi-trait complexes rather than single traits. Epistatic effects common to the eQTLs included in the complexes have higher chance of being identified by analysis of multi-trait complexes, particularly when epistatic effects on individual traits are small. Compared to direct testing for all potential epistatic effects, the hierarchical search was substantially more powerful in detecting epistasis, while controlling the FDR at the desired level. Association in functional roles within genomic regions was observed, supporting an initial screen for epistatic QTLs.	[Goldstein, Pavel; Reiner-Benaim, Anat] Univ Haifa, Dept Stat, IL-3498838 Haifa, Israel; [Korol, Abraham B.] Univ Haifa, Dept Evolutionary & Environm Biol, IL-3498838 Haifa, Israel; [Korol, Abraham B.] Univ Haifa, Inst Evolut, IL-3498838 Haifa, Israel	University of Haifa; University of Haifa; University of Haifa	Reiner-Benaim, A (corresponding author), Univ Haifa, Dept Stat, IL-3498838 Haifa, Israel.	areiner@stat.haifa.ac.il	Reiner-Benaim, Anat/HGQ-1183-2022	Reiner-Benaim, Anat/0000-0001-8709-3112	Israeli Science Foundation [1303/10, 800-2010]	Israeli Science Foundation(Israel Science Foundation)	AR was supported by the Israeli Science Foundation (http://www.isf.org.il/) grant number 1303/10. Abraham B. Korol was supported by the Israeli Science Foundation grant number 800-2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Castro JM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000062; Alvarez-Castro JM, 2007, GENETICS, V176, P1151, DOI 10.1534/genetics.106.067348; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; Carter GW, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003010; deVisser JAGM, 1997, EVOLUTION, V51, P1499, DOI 10.1111/j.1558-5646.1997.tb01473.x; Doerge RW, 2002, NAT REV GENET, V3, P43, DOI 10.1038/nrg703; Dudley AM, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100004; Elena SF, 1997, NATURE, V390, P395, DOI 10.1038/37108; Evans DM, 2006, PLOS GENET, V2, P1424, DOI 10.1371/journal.pgen.0020157; Goeman JJ, 2014, STAT MED, V33, P1946, DOI 10.1002/sim.6082; Guo MY, 2010, BIOSTATISTICS, V11, P473, DOI 10.1093/biostatistics/kxq012; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Jiang CJ, 1997, GENETICA, V101, P47, DOI 10.1023/A:1018394410659; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Korol AB, 2001, GENETICS, V157, P1789; Lan H, 2003, GENETICS, V164, P1607; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee S, 2012, BIOINFORMATICS, V28, pI137, DOI 10.1093/bioinformatics/bts227; Mester DI, 2004, COMPUT BIOL CHEM, V28, P281, DOI 10.1016/j.compbiolchem.2004.08.003; Rau Christoph D., 2013, Frontiers in Genetics, V4, P28, DOI 10.3389/fgene.2013.00028; Reiner-Benaim A, 2007, BIOINFORMATICS, V23, P2239, DOI 10.1093/bioinformatics/btm300; Reshef DN, 2011, SCIENCE, V334, P1518, DOI 10.1126/science.1205438; Ronin YI, 1999, GENETICS, V151, P387; Rouzic AL, 2012, NOIA IMPLEMENTATION; Schifano ED, 2013, AM J HUM GENET, V92, P744, DOI 10.1016/j.ajhg.2013.04.004; Storey JD, 2005, P NATL ACAD SCI USA, V102, P12837, DOI 10.1073/pnas.0504609102; Templeton AR, 2000, EPISTASIS EVOLUTIONA, P27; Voorman A, 2012, BIOINFORMATICS, V28, P1818, DOI 10.1093/bioinformatics/bts291; Wei WH, 2010, HEREDITY, V104, P401, DOI 10.1038/hdy.2009.129; West MAL, 2007, GENETICS, V175, P1441, DOI 10.1534/genetics.106.064972; Yandell BS, 2007, BIOINFORMATICS, V23, P641, DOI 10.1093/bioinformatics/btm011; Yandell BS, 2013, QTLBIM QTL BAYESIAN; Yekutieli D, 2008, J AM STAT ASSOC, V103, P309, DOI 10.1198/016214507000001373; Yi NJ, 2007, GENETICS, V176, P1865, DOI 10.1534/genetics.107.071365; Zeng ZB, 2005, GENETICS, V169, P1711, DOI 10.1534/genetics.104.035857; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang W, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000642	39	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115680	10.1371/journal.pone.0115680	http://dx.doi.org/10.1371/journal.pone.0115680			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536193	Green Published, gold, Green Submitted			2022-12-27	WOS:000348563300064
J	Lin, YH; Huang, SM; Huang, CY; Tu, YN; Huang, TC				Lin, Yang-Hsien; Huang, Shih-Min; Huang, Chin-Yi; Tu, Yun-Niang; Huang, Tzung-Chi			Quantitative Analysis of Respiration-Related Movement for Abdominal Artery in Multiphase Hepatic CT	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; COMPUTED-TOMOGRAPHY; LIVER-TUMORS; MOTION; INJECTION; PERFUSION	Objectives: Respiration-induced motion in the liver causes potential errors on the measurement of contrast medium in abdominal artery from multiphase hepatic CT scans. In this study, we investigated the use of hepatic CT images to quantitatively estimate the abdominal artery motion due to respiration by optical flow method. Materials and Methods: A total of 132 consecutive patients were included in our patient cohort. We apply the optical flow method to compute the motion of the abdominal artery due to respiration. Results: The minimum and maximum displacement of the abdominal artery motion were 0.02 and 30.87 mm by manual delineation, 0.03 and 40.75 mm calculated by optical flow method, respectively. Both high consistency and correlation between the present method and the physicians' manual delineations were acquired with the regression equation of movement, y=0.81x+0.25, r=0.95, p<0.001. Conclusion: We estimated the motion of abdominal artery due to respiration using the optical flow method in multiphase hepatic CT scans and the motion estimations were validated with the visualization of physicians. The quantitative analysis of respiration-related movement of abdominal artery could be used for motion correction in the measurement of contrast medium passing though abdominal artery in multiphase CT liver scans.	[Lin, Yang-Hsien; Huang, Chin-Yi; Tu, Yun-Niang] Minist Hlth & Welf, Peng Hu Hosp, Dept Diagnost Radiol, Peng Hu City, Taiwan; [Huang, Shih-Min] China Med Univ Hosp, Dept Radiol, Taichung, Taiwan; [Huang, Tzung-Chi] ChinaMed Univ, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan; [Huang, Tzung-Chi] Asia Univ, Dept Biomed Informat, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan	Huang, TC (corresponding author), ChinaMed Univ, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan.	tzungchi.huang@mail.cmu.edu.tw	huang, tzungchi/O-4434-2015		school project of China Medical University, Taiwan; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [DOH102-TD-B-111-004]	school project of China Medical University, Taiwan; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence	This study was financially supported by the school project of China Medical University, Taiwan, and by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (DOH102-TD-B-111-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beddar AS, 2007, INT J RADIAT ONCOL, V67, P630, DOI 10.1016/j.ijrobp.2006.10.007; Brandner ED, 2006, INT J RADIAT ONCOL, V65, P554, DOI 10.1016/j.ijrobp.2005.12.042; Clifford Mark A, 2002, Comput Aided Surg, V7, P291, DOI 10.3109/10929080209146038; Fleischmann D, 2010, RADIOL CLIN N AM, V48, P237, DOI 10.1016/j.rcl.2010.02.002; Ford EC, 2003, MED PHYS, V30, P88, DOI 10.1118/1.1531177; Guerrero T, 2004, PHYS MED BIOL, V49, P4147, DOI 10.1088/0031-9155/49/17/022; Hallman JL, 2012, INT J RADIAT ONCOL, V83, P435, DOI 10.1016/j.ijrobp.2011.06.1970; Horn B. K. P., 1981, DETERMINING OPTICAL, V17, P185, DOI DOI 10.1016/0004-3702(81)90024-2; Huang TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075903; Huang TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058886; Ippolito D, 2008, ACAD RADIOL, V15, P919, DOI 10.1016/j.acra.2008.02.005; Kandel S, 2012, INSIGHTS IMAGING, V3, P323, DOI 10.1007/s13244-012-0169-9; Kim T, 1999, ABDOM IMAGING, V24, P473, DOI 10.1007/s002619900543; Kubas A, 2008, CANCER RADIOTHER, V12, P768, DOI 10.1016/j.canrad.2008.04.011; Laghi A, 2003, RADIOLOGY, V226, P543, DOI 10.1148/radiol.2262012043; MERINE D, 1990, RADIOLOGY, V175, P707, DOI 10.1148/radiology.175.3.2160675; Mok GSP, 2013, IEEE T BIO-MED ENG, V60, P1927, DOI 10.1109/TBME.2013.2245132; Sahani DV, 2007, RADIOLOGY, V243, P736, DOI 10.1148/radiol.2433052020; Takemura A, 2008, RADIOL PHYS TECHNOL, V1, P178, DOI 10.1007/s12194-008-0025-2; Wagman R, 2003, INT J RADIAT ONCOL, V55, P659, DOI 10.1016/S0360-3016(02)03941-X; Wu CC, 2011, MICROVASC RES, V81, P252, DOI 10.1016/j.mvr.2011.01.003	21	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e114222	10.1371/journal.pone.0114222	http://dx.doi.org/10.1371/journal.pone.0114222			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536144	Green Published, Green Submitted, gold			2022-12-27	WOS:000348563300011
J	Mo, ST; Chiang, SJ; Lai, TY; Cheng, YL; Chung, CE; Kuo, SCH; Reece, KM; Chen, YC; Chang, NS; Wadzinski, BE; Chiang, CW				Mo, Shu-Ting; Chiang, Shang-Ju; Lai, Tai-Yu; Cheng, Yu-Ling; Chung, Cheng-En; Kuo, Spencer C. H.; Reece, Kelie M.; Chen, Yung-Cheng; Chang, Nan-Shan; Wadzinski, Brian E.; Chiang, Chi-Wu			Visualization of Subunit Interactions and Ternary Complexes of Protein Phosphatase 2A in Mammalian Cells	PLOS ONE			English	Article							REGULATORY SUBUNIT; CATALYTIC SUBUNIT; SUBCELLULAR-LOCALIZATION; B-SUBUNIT; PP2A; ALPHA-4; HOLOENZYME; EXPRESSION; BINDING; FAMILY	Protein phosphatase 2A (PP2A) is a ubiquitous phospho-serine/threonine phosphatase that controls many diverse cellular functions. The predominant form of PP2A is a heterotrimeric holoenzyme consisting of a scaffolding A subunit, a variable regulatory B subunit, and a catalytic C subunit. The C subunit also associates with other interacting partners, such as alpha 4, to form non-canonical PP2A complexes. We report visualization of PP2A complexes in mammalian cells. Bimolecular fluorescence complementation (BiFC) analysis of PP2A subunit interactions demonstrates that the B subunit plays a key role in directing the subcellular localization of PP2A, and confirms that the A subunit functions as a scaffold in recruiting the B and C subunits to form a heterotrimeric holoenzyme. BiFC analysis also reveals that alpha 4 promotes formation of the AC core dimer. Furthermore, we demonstrate visualization of specific ABC holoenzymes in cells by combining BiFC and fluorescence resonance energy transfer (BiFC-FRET). Our studies not only provide direct imaging data to support previous biochemical observations on PP2A complexes, but also offer a promising approach for studying the spatiotemporal distribution of individual PP2A complexes in cells.	[Mo, Shu-Ting; Chiang, Shang-Ju; Cheng, Yu-Ling; Chung, Cheng-En; Chen, Yung-Cheng; Chang, Nan-Shan; Chiang, Chi-Wu] Natl Cheng Kung Univ, Coll Med, Inst Mol Med, Tainan 70101, Taiwan; [Lai, Tai-Yu; Chang, Nan-Shan; Chiang, Chi-Wu] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan; [Kuo, Spencer C. H.] Natl Cheng Kung Univ, Coll Med, Dept Med, Tainan 70101, Taiwan; [Chang, Nan-Shan; Chiang, Chi-Wu] Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Tainan 70101, Taiwan; [Reece, Kelie M.; Wadzinski, Brian E.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; Vanderbilt University	Wadzinski, BE (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA.	brian.wadzinski@vanderbilt.edu; chiangcw@mail.ncku.edu.tw			Headquarters of University Advancement, National Cheng Kung University [D100-35B58]; National Science Council [NSC99-2320-B-006024-MY3]; National Institutes of Health [GM051366]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM051366, R01GM051366] Funding Source: NIH RePORTER	Headquarters of University Advancement, National Cheng Kung University; National Science Council(Ministry of Science and Technology, Taiwan); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the Headquarters of University Advancement, National Cheng Kung University (D100-35B58 to C.W.C.), National Science Council (NSC99-2320-B-006024-MY3 to C.W.C.) and National Institutes of Health (GM051366 to B.E.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baharians Z, 1998, J BIOL CHEM, V273, P19019, DOI 10.1074/jbc.273.30.19019; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; Chung HY, 1999, BIOCHEMISTRY-US, V38, P10371, DOI 10.1021/bi990902g; Csortos C, 1996, J BIOL CHEM, V271, P2578, DOI 10.1074/jbc.271.5.2578; Dagda RK, 2003, J BIOL CHEM, V278, P24976, DOI 10.1074/jbc.M302832200; DiComo CJ, 1996, GENE DEV, V10, P1904, DOI 10.1101/gad.10.15.1904; FORSTER T, 1959, DISCUSS FARADAY SOC, P7; Gentry MS, 2002, MOL BIOL CELL, V13, P3477, DOI 10.1091/mbc.02-05-0065; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Harper Jane V., 2004, V296, P157; HEALY AM, 1991, MOL CELL BIOL, V11, P5767, DOI 10.1128/MCB.11.11.5767; HENDRIX P, 1993, J BIOL CHEM, V268, P15267; Inui S, 1998, BLOOD, V92, P539, DOI 10.1182/blood.V92.2.539.414k23_539_546; Ito A, 2003, AM J PATHOL, V162, P479, DOI 10.1016/S0002-9440(10)63842-4; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; Jares-Erijman EA, 2003, NAT BIOTECHNOL, V21, P1387, DOI 10.1038/nbt896; Jiang L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2663; Kerppola TK, 2008, METHOD CELL BIOL, V85, P431, DOI 10.1016/S0091-679X(08)85019-4; Kong M, 2004, SCIENCE, V306, P695, DOI 10.1126/science.1100537; Kong M, 2007, J BIOL CHEM, V282, P29712, DOI 10.1074/jbc.M703159200; Kong M, 2009, MOL CELL, V36, P51, DOI 10.1016/j.molcel.2009.09.025; Kremmer E, 1997, MOL CELL BIOL, V17, P1692, DOI 10.1128/MCB.17.3.1692; Kuo YC, 2008, J BIOL CHEM, V283, P1882, DOI 10.1074/jbc.M709585200; Lee TY, 2010, J BIOL CHEM, V285, P21567, DOI 10.1074/jbc.M109.094953; MAYER RE, 1991, BIOCHEMISTRY-US, V30, P3589, DOI 10.1021/bi00229a001; McConnell JL, 2010, BIOCHEMISTRY-US, V49, P1713, DOI 10.1021/bi901837h; McCright B, 1996, J BIOL CHEM, V271, P22081, DOI 10.1074/jbc.271.36.22081; MCCRIGHT B, 1995, J BIOL CHEM, V270, P26123, DOI 10.1074/jbc.270.44.26123; Moreno CS, 2000, J BIOL CHEM, V275, P5257, DOI 10.1074/jbc.275.8.5257; MUMBY M, 1995, SEMIN CANCER BIOL, V6, P229, DOI 10.1006/scbi.1995.0030; Murata K, 1997, P NATL ACAD SCI USA, V94, P10624, DOI 10.1073/pnas.94.20.10624; PALLAS DC, 1990, CELL, V60, P167, DOI 10.1016/0092-8674(90)90726-U; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Shyu YJ, 2008, P NATL ACAD SCI USA, V105, P151, DOI 10.1073/pnas.0705181105; SONTAG E, 1993, CELL, V75, P887, DOI 10.1016/0092-8674(93)90533-V; Strack S, 1999, FEBS LETT, V460, P462, DOI 10.1016/S0014-5793(99)01377-0; Strack S, 1999, J COMP NEUROL, V413, P373; Strack S, 1998, J COMP NEUROL, V392, P515; TUNG HYL, 1985, EUR J BIOCHEM, V148, P253, DOI 10.1111/j.1432-1033.1985.tb08833.x; WADZINSKI BE, 1992, J BIOL CHEM, V267, P16883; Wang N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038569; Watkins GR, 2012, J BIOL CHEM, V287, P24207, DOI 10.1074/jbc.M112.368613; Xu YH, 2008, MOL CELL, V31, P873, DOI 10.1016/j.molcel.2008.08.006; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Yang J, 2007, BIOCHEMISTRY-US, V46, P8807, DOI 10.1021/bi7007118; Youvan D. C., 1997, BIOTECHNOLOGY, V3, P1; ZOLNIEROWICZ S, 1994, BIOCHEMISTRY-US, V33, P11858, DOI 10.1021/bi00205a023	48	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e116074	10.1371/journal.pone.0116074	http://dx.doi.org/10.1371/journal.pone.0116074			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536081	Green Submitted, Green Published, gold			2022-12-27	WOS:000348563300099
J	Rolden, HJA; van Bodegom, D; Westendorp, RGJ				Rolden, Herbert J. A.; van Bodegom, David; Westendorp, Rudi G. J.			Changes in Health Care Expenditure after the Loss of a Spouse: Data on 6,487 Older Widows and Widowers in the Netherlands	PLOS ONE			English	Article							CONJUGAL BEREAVEMENT; INFORMAL CARE; FORMAL CARE; HOME-CARE; MORTALITY; DEATH; SUBSTITUTE; MARRIAGE; INSTITUTIONALIZATION; ADJUSTMENT	Background: In ageing populations, informal care holds great potential to limit rising health care expenditure. The majority of informal care is delivered by spouses. The loss of informal care due to the death of the spouse could therefore increase expenditure levels for formal care. Objective: To investigate the impact of the death of the spouse on health care expenditure by older people through time. Additionally, to examine whether the impact differs between socio-demographic groups, and what health services are affectedmost. Design: Longitudinal data on health care expenditure (from July 2007 through 2010) from a regional Dutch health care insurer was matched with data on marital status (2004-2011) from the Central Bureau of Statistics. Linear mixed models with log transformed health care expenditure, generalized linear models and two-part models were used to retrieve standardized levels of monthly health care expenditure of 6,487 older widowed subjects in the 42 months before and after the loss of the spouse. Results: Mean monthly health care expenditure in married subjects was (sic)502 in the 42 months before the death of the spouse, and expenditure levels rose by (sic)239 (48%) in the 42 months after the death of the spouse. The increase in expenditure after the death of the spouse was highest for men ((sic)319; 59%) and the oldest old ((sic)553; 82%). Expenditure levels showed the highest increase for hospital and home care services (together (sic)166). Conclusions: The loss of the spouse is associated with an increase in health care expenditure. The relatively high rise in long-term care expenses suggests that the loss of informal care is an important determinant of this rise.	[Rolden, Herbert J. A.; van Bodegom, David; Westendorp, Rudi G. J.] Leyden Acad Vital & Ageing, Leiden, Netherlands; [Rolden, Herbert J. A.; van Bodegom, David; Westendorp, Rudi G. J.] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Rolden, HJA (corresponding author), Radboud Univ Nijmegen, Radboud Inst Hlth Sci, Dept Hlth Evidence, Med Ctr, NL-6525 ED Nijmegen, Netherlands.	herbert.rolden@radboudumc.nl	Rolden, Herbert/E-2464-2016	van Bodegom, David/0000-0002-5691-8342				Arno PS, 1999, HEALTH AFFAIR, V18, P182, DOI 10.1377/hlthaff.18.2.182; Barendregt JJ, 1997, NEW ENGL J MED, V337, P1052, DOI 10.1056/NEJM199710093371506; Bolin K, 2008, HEALTH ECON, V17, P393, DOI 10.1002/hec.1275; Bonsang E, 2009, J HEALTH ECON, V28, P143, DOI 10.1016/j.jhealeco.2008.09.002; BUSS DM, 1985, AM SCI, V73, P47; Cartwright A, 1982, J R Coll Gen Pract, V32, P215; Charles KK, 2005, J HEALTH ECON, V24, P1174, DOI 10.1016/j.jhealeco.2005.05.001; Del Bono E, 2009, HEALTH SOC CARE COMM, V17, P267, DOI 10.1111/j.1365-2524.2008.00826.x; Elwert F, 2008, AM J PUBLIC HEALTH, V98, P2092, DOI 10.2105/AJPH.2007.114348; Espinosa J, 2008, J HEALTH ECON, V27, P1326, DOI 10.1016/j.jhealeco.2008.04.001; GARBACZ C, 1983, J HUM RESOUR, V18, P147, DOI 10.2307/145662; Gaugler Joseph E, 2007, BMC Geriatr, V7, P13, DOI 10.1186/1471-2318-7-13; Hoekstra J, 2008, KOSTEN ZIEKTEN NEDER; Iwashyna TJ, 2003, SOC SCI MED, V57, P2137, DOI 10.1016/S0277-9536(02)00546-4; KAPRIO J, 1987, AM J PUBLIC HEALTH, V77, P283, DOI 10.2105/AJPH.77.3.283; KEMPER P, 1992, HEALTH SERV RES, V27, P421; LEU RE, 1983, SOC SCI MED, V17, P1907, DOI 10.1016/0277-9536(83)90168-5; Luppa M, 2010, AGE AGEING, V39, P31, DOI 10.1093/ageing/afp202; Martikainen P, 1996, AM J PUBLIC HEALTH, V86, P1087, DOI 10.2105/AJPH.86.8_Pt_1.1087; MASCIETAYLOR CGN, 1989, BEHAV GENET, V19, P223, DOI 10.1007/BF01065906; Miller EA, 2000, MED CARE RES REV, V57, P259, DOI 10.1177/107755870005700301; Mullahy J, 1998, J HEALTH ECON, V17, P247, DOI 10.1016/S0167-6296(98)00030-7; Nihtila E, 2008, AM J PUBLIC HEALTH, V98, P1228, DOI 10.2105/AJPH.2007.119271; Pezzin LE, 1996, J HUM RESOUR, V31, P650, DOI 10.2307/146270; Portrait F, 2000, HEALTH ECON, V9, P513, DOI 10.1002/1099-1050(200009)9:6<513::AID-HEC534>3.0.CO;2-R; Prigerson HG, 2000, GERONTOLOGIST, V40, P349, DOI 10.1093/geront/40.3.349; Raveis VH, 1999, SOC WORK HEALTH CARE, V29, P13; Rodrigues R., 2012, FACTS FIGURES HLTH A; SCHAEFER C, 1995, AM J EPIDEMIOL, V141, P1142, DOI 10.1093/oxfordjournals.aje.a117387; Schulz R, 2001, JAMA-J AM MED ASSOC, V285, P3123, DOI 10.1001/jama.285.24.3123; Simeonova E, 2013, J HEALTH ECON, V32, P33, DOI 10.1016/j.jhealeco.2012.10.010; Temple NJ, 2012, EUR J PUBLIC HEALTH, V22, P618, DOI 10.1093/eurpub/ckr139; van den Berg Bernard, 2004, Eur J Health Econ, V5, P36, DOI 10.1007/s10198-003-0189-y; van den Berg GJ, 2011, J HEALTH ECON, V30, P774, DOI 10.1016/j.jhealeco.2011.05.011; van Duin C, 2009, BEVOLKINGSPROGNOSE 2; Van Houtven CH, 2004, J HEALTH ECON, V23, P1159, DOI 10.1016/j.jhealeco.2004.04.008; WOLINSKY FD, 1992, J GERONTOL, V47, pS8, DOI 10.1093/geronj/47.1.S8; Wong A, 2011, HEALTH ECON, V20, P379, DOI 10.1002/hec.1597; Wong A, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-110	39	18	18	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115478	10.1371/journal.pone.0115478	http://dx.doi.org/10.1371/journal.pone.0115478			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ9UY	25536040	gold, Green Submitted, Green Published			2022-12-27	WOS:000348563300043
J	Sharma, A; Berga-Bolanos, R; Sen, JM				Sharma, Archna; Berga-Bolanos, Rosa; Sen, Jyoti Misra			T Cell Factor-1 Controls the Lifetime of CD4+CD8+Thymocytes In Vivo and Distal T Cell Receptor alpha-Chain Rearrangement Required for NKT Cell Development	PLOS ONE			English	Article							THYMOCYTE SURVIVAL; TCRA REARRANGEMENT; LINEAGE; DIFFERENTIATION; SPECIFICATION; PATHWAY; REPERTOIRE; SELECTION; WNT	Natural killer T (NKT) cells are a component of innate and adaptive immune systems implicated in immune, autoimmune responses and in the control of obesity and cancer. NKT cells develop from common CD4+ CD8+ double positive (DP) thymocyte precursors after the rearrangement and expression of T cell receptor (TCR) V alpha 14-J alpha 18 gene. Temporal regulation and late appearance of V alpha 14-J alpha 18 rearrangement in immature DP thymocytes has been demonstrated. However, the precise control of lifetime of DP thymocytes in vivo that enables distal rearrangements remains incompletely defined. Here we demonstrate that T cell factor (TCF)-1, encoded by the Tcf7 gene, is critical for the extended lifetime of DP thymocytes. TCF-1-deficient DP thymocytes fail to undergo TCR V alpha 14-J alpha 18 rearrangement and produce significantly fewer NKT cells. Ectopic expression of Bcl-x(L) permits V alpha 14-J alpha 18 rearrangement and rescues NKT cell development. We report that TCF-1 regulates expression of ROR gamma t, which regulates DP thymocyte survival by controlling expression of Bcl-x(L). We posit that TCF-1 along with its cofactors controls the lifetime of DP thymocytes in vivo.	[Sharma, Archna; Berga-Bolanos, Rosa; Sen, Jyoti Misra] NIA, Immune Cells & Inflammat Sect, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Sen, JM (corresponding author), NIA, Immune Cells & Inflammat Sect, NIH, Baltimore, MD 21224 USA.	Jyoti-Sen@nih.gov	Sharma, Archna/R-9377-2016	Sharma, Archna/0000-0003-4745-0220	Intramural Research Program of the National Institute on Aging at the NIH; NATIONAL INSTITUTE ON AGING [ZIAAG000772] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute on Aging at the NIH; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the Intramural Research Program of the National Institute on Aging at the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Bezbradica JS, 2005, P NATL ACAD SCI USA, V102, P5114, DOI 10.1073/pnas.0408449102; D'Cruz LM, 2010, NAT IMMUNOL, V11, P240, DOI 10.1038/ni.1845; Dose M, 2009, P NATL ACAD SCI USA, V106, P8641, DOI 10.1073/pnas.0812255106; Egawa T, 2005, IMMUNITY, V22, P705, DOI 10.1016/j.immuni.2005.03.011; Germar K, 2011, P NATL ACAD SCI USA, V108, P20060, DOI 10.1073/pnas.1110230108; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Gumperz JE, 2002, J EXP MED, V195, P625, DOI 10.1084/jem.20011786; Guo J, 2002, NAT IMMUNOL, V3, P469, DOI 10.1038/ni791; Hager E, 2007, J IMMUNOL, V179, P2228, DOI 10.4049/jimmunol.179.4.2228; Hu TS, 2010, NAT IMMUNOL, V11, P435, DOI 10.1038/ni.1865; Ioannidis V, 2001, NAT IMMUNOL, V2, P691, DOI 10.1038/90623; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Lee YJ, 2013, NAT IMMUNOL, V14, P1146, DOI 10.1038/ni.2731; Matsuda JL, 2005, CURR OPIN IMMUNOL, V17, P122, DOI 10.1016/j.coi.2005.01.002; Monticelli LA, 2009, P NATL ACAD SCI USA, V106, P19461, DOI 10.1073/pnas.0908249106; Sharma A, 2012, J IMMUNOL, V188, P3859, DOI 10.4049/jimmunol.1103729; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; Staal FJT, 2008, EUR J IMMUNOL, V38, P1788, DOI 10.1002/eji.200738118; Stanic AK, 2004, J IMMUNOL, V172, P2265, DOI 10.4049/jimmunol.172.4.2265; Steinke FC, 2014, IMMUNOL RES, V59, P45, DOI 10.1007/s12026-014-8545-9; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; Wang RQ, 2011, J IMMUNOL, V187, P5964, DOI 10.4049/jimmunol.1101205; Weber BN, 2011, NATURE, V476, P63, DOI 10.1038/nature10279; Xu YY, 2003, NAT IMMUNOL, V4, P1177, DOI 10.1038/ni1008; Yu Q, 2010, IMMUNOL RES, V47, P45, DOI 10.1007/s12026-009-8137-2	26	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115803	10.1371/journal.pone.0115803	http://dx.doi.org/10.1371/journal.pone.0115803			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536344	Green Published, gold, Green Submitted			2022-12-27	WOS:000348563300076
J	Ng, SH; Lin, CY; Chan, SC; Lin, YC; Yen, TC; Liao, CT; Chang, JTC; Ko, SF; Wang, HM; Chang, CJ; Wang, JJ				Ng, Shu-Hang; Lin, Chien-Yu; Chan, Sheng-Chieh; Lin, Yu-Chun; Yen, Tzu-Chen; Liao, Chun-Ta; Chang, Joseph Tung-Chieh; Ko, Sheung-Fat; Wang, Hung-Ming; Chang, Chee-Jen; Wang, Jiun-Jie			Clinical Utility of Multimodality Imaging with Dynamic Contrast-Enhanced MRI, Diffusion-Weighted MRI, and F-18-FDG PET/CT for the Prediction of Neck Control in Oropharyngeal or Hypopharyngeal Squamous Cell Carcinoma Treated with Chemoradiation	PLOS ONE			English	Article							METABOLIC TUMOR VOLUME; PROGNOSTIC-FACTOR; FDG-PET; ORGAN PRESERVATION; PEDIATRIC-PATIENTS; ORAL-CAVITY; HEAD; CANCER; SURVIVAL; PARAMETERS	The clinical usefulness of pretreatment imaging techniques for predicting neck control in patients with oropharyngeal or hypopharyngeal squamous cell carcinoma (OHSCC) treated with chemoradiation remains unclear. In this prospective study, we investigated the role of pretreatment dynamic contrast-enhanced perfusion MR imaging (DCE-PWI), diffusion-weighted MR imaging (DWI), and [F-18] fluorodeoxyglucose-positron emission tomography (F-18-FDG PET)/CT derived imaging markers for the prediction of neck control in OHSCC patients treated with chemoradiation. Patients with untreated OHSCC scheduled for chemoradiation between August, 2010 and July, 2012 were eligible for the study. Clinical variables and the following imaging parameters of metastatic neck lymph nodes were examined in relation to neck control: transfer constant, volume of blood plasma, and volume of extracellular extravascular space (V-e) on DCE-PWI; apparent diffusion coefficient (ADC) on DWI; maximum standardized uptake value, metabolic tumor volume, and total lesion glycolysis on F-18-FDG PET/CT. There were 69 patients (37 with oropharynx SCC and 32 with hypopharynx SCC) with successful pretreatment DCE-PWI and DWI available for analysis. After a median follow-up of 31 months, 25 (36.2%) participants had neck failure. Multivariate analysis identified hemoglobin level < 14.3 g/dL (P=0.019), V-e < 0.23 (P=0.040), and ADC>1.14x10(-3) mm(2)/s (P=0.003) as independent prognostic factors for 3-year neck control. A prognostic scoring system was formulated by summing up the three significant predictors of neck control. Patients with scores of 2-3 had significantly poorer neck control and overall survival rates than patients with scores of 0-1. We conclude that hemoglobin levels, V-e, and ADC are independent pretreatment prognostic factors for neck control in OHSCC treated with chemoradiation. Their combination may identify a subgroup of patients at high risk of developing neck failure.	[Ng, Shu-Hang; Chan, Sheng-Chieh; Yen, Tzu-Chen] Chang Gung Univ, Chang Gung Mem Hosp, Mol Imaging Ctr, Taoyuan, Taiwan; [Ng, Shu-Hang; Lin, Yu-Chun; Ko, Sheung-Fat] Chang Gung Univ, Chang Gung Mem Hosp, Dept Diagnost Radiol, Taoyuan, Taiwan; [Ng, Shu-Hang; Lin, Yu-Chun; Wang, Jiun-Jie] Chang Gung Univ, Chang Gung Mem Hosp, Dept Med Imaging & Radiol Sci, Taoyuan, Taiwan; [Lin, Chien-Yu; Chang, Joseph Tung-Chieh] Chang Gung Univ, Chang Gung Mem Hosp, Dept Radiat Oncol, Taoyuan, Taiwan; [Chan, Sheng-Chieh; Yen, Tzu-Chen] Chang Gung Univ, Chang Gung Mem Hosp, Dept Nucl Med, Taoyuan, Taiwan; [Liao, Chun-Ta] Chang Gung Univ, Chang Gung Mem Hosp, Dept Otorhinolaryngol Head & Neck Surg, Taoyuan, Taiwan; [Wang, Hung-Ming] Chang Gung Univ, Chang Gung Mem Hosp, Dept Med Oncol, Taoyuan, Taiwan; [Chang, Chee-Jen] Chang Gung Univ, Chang Gung Mem Hosp, Clin Informat, Taoyuan, Taiwan; [Chang, Chee-Jen] Chang Gung Univ, Chang Gung Mem Hosp, Med Stat Res Ctr, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Wang, JJ (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Dept Med Imaging & Radiol Sci, Taoyuan, Taiwan.	jwang@mail.cgu.edu.tw	Chan, Sheng Chieh/AAF-9127-2019	Chan, Sheng Chieh/0000-0003-3236-395X; Wang, Jiun-Jie/0000-0002-2422-9059; Chang, Chee Jen/0000-0002-7725-7555	National Science Council-Taiwan [99-2314-B-182A-095-MY3]	National Science Council-Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by a grant from the National Science Council-Taiwan (99-2314-B-182A-095-MY3). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allal AS, 2004, INT J RADIAT ONCOL, V59, P1295, DOI 10.1016/j.ijrobp.2003.12.039; Becker A, 2000, INT J RADIAT ONCOL, V46, P459, DOI 10.1016/S0360-3016(99)00384-3; Cao Y, 2008, INT J RADIAT ONCOL, V72, P1287, DOI 10.1016/j.ijrobp.2008.08.024; Chan SC, 2013, ORAL ONCOL, V49, P71, DOI 10.1016/j.oraloncology.2012.07.016; Chan SC, 2011, EUR J NUCL MED MOL I, V38, P1607, DOI 10.1007/s00259-011-1824-y; Chawla S, 2011, AM J NEURORADIOL, V32, P778, DOI 10.3174/ajnr.A2376; Chawla S, 2013, AM J ROENTGENOL, V200, P35, DOI 10.2214/AJR.12.9432; Chen SW, 2009, HEAD NECK-J SCI SPEC, V31, P709, DOI 10.1002/hed.21011; Choi HS, 2013, KOREAN J RADIOL, V14, P487, DOI 10.3348/kjr.2013.14.3.487; Cooper RA, 2000, RADIOTHER ONCOL, V57, P53, DOI 10.1016/S0167-8140(00)00259-0; Demirci U, 2011, ASIAN PAC J CANCER P, V12, P1817; Glaser CM, 2001, INT J RADIAT ONCOL, V50, P705, DOI 10.1016/S0360-3016(01)01488-2; Guo JY, 2012, CANCER-AM CANCER SOC, V118, P3776, DOI 10.1002/cncr.26701; Halfpenny W, 2002, BRIT J CANCER, V86, P512, DOI 10.1038/sj.bjc.6600114; Hatakenaka M, 2011, INT J RADIAT ONCOL, V81, P339, DOI 10.1016/j.ijrobp.2010.05.051; Hatakenaka Masamitsu, 2008, Magn Reson Med Sci, V7, P23, DOI 10.2463/mrms.7.23; Higgins KA, 2012, INT J RADIAT ONCOL, V82, P548, DOI 10.1016/j.ijrobp.2010.11.050; Humphries PD, 2007, RADIOLOGY, V245, P848, DOI 10.1148/radiol.2452061535; JAIN RK, 1987, CANCER RES, V47, P3039; Jansen JFA, 2012, INT J RADIAT ONCOL, V82, P299, DOI 10.1016/j.ijrobp.2010.11.022; Kamijo T, 2000, CLIN CANCER RES, V6, P3159; Kim S, 2010, AM J NEURORADIOL, V31, P262, DOI 10.3174/ajnr.A1817; Kim S, 2009, CLIN CANCER RES, V15, P986, DOI 10.1158/1078-0432.CCR-08-1287; King AD, 2010, EUR RADIOL, V20, P2213, DOI 10.1007/s00330-010-1769-8; Kubicek GJ, 2010, HEAD NECK ONCOL, V2, DOI 10.1186/1758-3284-2-19; Liao CT, 2009, EUR J NUCL MED MOL I, V36, P1783, DOI 10.1007/s00259-009-1180-3; Lin YC, 2012, MAGN RESON MED; Ng SH, 2005, J NUCL MED, V46, P1136; Ng SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072230; Ohnishi K, 2011, J RADIAT RES, V52, P522, DOI 10.1269/jrr.10178; Pike MM, 2009, MAGN RESON MED, V61, P615, DOI 10.1002/mrm.21931; Schabel MC, 2008, PHYS MED BIOL, V53, P2345, DOI 10.1088/0031-9155/53/9/010; Schwartz DL, 2004, ARCH OTOLARYNGOL, V130, P1361, DOI 10.1001/archotol.130.12.1361; Seol YM, 2010, ACTA ONCOL, V49, P201, DOI 10.3109/02841860903440270; Stadler P, 1999, INT J RADIAT ONCOL, V44, P749, DOI 10.1016/S0360-3016(99)00115-7; Studer G, 2007, ACTA ONCOL, V46, P386, DOI 10.1080/02841860600815407; Tang C, 2012, INT J RADIAT ONCOL, V83, P1514, DOI 10.1016/j.ijrobp.2011.10.023; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; Tofts PS, 1997, JMRI-J MAGN RESON IM, V7, P91, DOI 10.1002/jmri.1880070113; Torizuka T, 2009, AM J ROENTGENOL, V192, pW156, DOI 10.2214/AJR.08.1429; Urba SG, 2005, J CLIN ONCOL, V23, P88, DOI 10.1200/JCO.2005.04.017; Vernon MR, 2008, INT J RADIAT ONCOL, V70, P678, DOI 10.1016/j.ijrobp.2007.10.044; Wang HM, 2002, CANCER, V94, P2989, DOI 10.1002/cncr.10570; Worden FP, 2008, J CLIN ONCOL, V26, P3138, DOI 10.1200/JCO.2007.12.7597	44	44	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115933	10.1371/journal.pone.0115933	http://dx.doi.org/10.1371/journal.pone.0115933			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531391	Green Published, gold, Green Submitted			2022-12-27	WOS:000348845100118
J	Plumer, L; Davison, J; Saarma, U				Plumer, Liivi; Davison, John; Saarma, Urmas			Rapid Urbanization of Red Foxes in Estonia: Distribution, Behaviour, Attacks on Domestic Animals, and Health-Risks Related to Zoonotic Diseases	PLOS ONE			English	Article							VULPES-VULPES POPULATION; BADGERS MELES-MELES; ECHINOCOCCUS-MULTILOCULARIS; URBAN FOXES; SARCOPTIC MANGE; CITY; SWITZERLAND; GRANULOSUS; PATTERNS; WILDLIFE	Urban areas are becoming increasingly important for wildlife as diminishing natural habitats no longer represent a suitable environment for many species. Red foxes (Vulpes vulpes) are nowadays common in many cities worldwide, and in recent years they have colonized urban areas in Estonia. We used a public web-based questionnaire approach to evaluate the distribution and behaviour of Estonian urban foxes, to detect related problems and to assess health risks to humans and domestic animals. In total, 1205 responses were collected throughout the country. Foxes have colonized the majority of Estonian towns (33 out of 47) in a relatively short period of time, and have already established breeding dens in several towns. Despite their recent arrival, the behaviour of Estonian urban foxes is similar to that reported in longer-established urban fox populations: they are mostly active during night-time, often visit city centres and some also have dens in such locations. Certain characteristics of urban foxes serve as a basis for conflict with humans: foxes have entered houses and attacked domestic animals, killing cats and poultry. About 8% of reported foxes exhibited symptoms of sarcoptic mange, a disease that also infects domestic animals, especially dogs. The proportion of mange-infected foxes was higher in large urban areas. In addition to mange, a substantial fraction of red foxes in Estonia are known to be infected with the life-threatening tapeworm Echinococcus multilocularis, the causative agent of alveolar echinococcosis. Therefore, urban foxes may represent a source of serious infectious disease for pets and humans.	[Plumer, Liivi; Davison, John; Saarma, Urmas] Univ Tartu, Inst Ecol & Earth Sci, Dept Zool, EE-50090 Tartu, Estonia	University of Tartu; Tartu University Institute of Ecology & Earth Sciences	Saarma, U (corresponding author), Univ Tartu, Inst Ecol & Earth Sci, Dept Zool, Ulikooli 18, EE-50090 Tartu, Estonia.	Urmas.Saarma@ut.ee	Saarma, Urmas/J-6448-2015; Saarma, Urmas/AAC-9813-2019; Cameron, Elissa/B-8053-2014	Saarma, Urmas/0000-0002-3222-571X; Saarma, Urmas/0000-0002-3222-571X; Cameron, Elissa/0000-0002-9243-0547	Estonian Research Council [IUT-2032, ESF-8793]; European Union through the European Regional Development Fund (Centre of Excellence FIBIR); Estonian Doctoral School of Ecology and Environmental Sciences	Estonian Research Council(Estonian Research Council); European Union through the European Regional Development Fund (Centre of Excellence FIBIR)(European Commission); Estonian Doctoral School of Ecology and Environmental Sciences	This work was supported by the Estonian Research Council (IUT-2032; ESF-8793), the European Union through the European Regional Development Fund (Centre of Excellence FIBIR) and the Estonian Doctoral School of Ecology and Environmental Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, ZOONOOSIDE ARUANNE, P20; Baker PJ, 2007, MAMMAL REV, V37, P297, DOI 10.1111/j.1365-2907.2007.00102.x; Baker PJ, 2007, BEHAV ECOL, V18, P716, DOI 10.1093/beheco/arm035; Baker PJ, 2000, ANIM BEHAV, V59, P127, DOI 10.1006/anbe.1999.1285; Balestrieri A, 2011, CENT EUR J BIOL, V6, P283, DOI 10.2478/s11535-010-0106-1; Bateman PW, 2012, J ZOOL, V287, P1, DOI 10.1111/j.1469-7998.2011.00887.x; Bornstein S, 2006, VET DERMATOL, V17, P411, DOI 10.1111/j.1365-3164.2006.00548.x; Cassidy A, 2012, ENVIRON COMMUN, V6, P494, DOI 10.1080/17524032.2012.716370; Contesse P, 2004, MAMM BIOL, V69, P81, DOI 10.1078/1616-5047-00123; Davidson RK, 2008, VET PARASITOL, V156, P277, DOI 10.1016/j.vetpar.2008.05.019; Delahay RJ, 2009, MAMMAL REV, V39, P53, DOI 10.1111/j.1365-2907.2008.00135.x; Deplazes P, 2004, TRENDS PARASITOL, V20, P77, DOI 10.1016/j.pt.2003.11.011; DONCASTER CP, 1990, J MAMMAL, V71, P188, DOI 10.2307/1382166; Dudus L, 2014, MAMM BIOL, V79, P71, DOI 10.1016/j.mambio.2013.08.001; Eckert J., 2001, WHO OIE MANUAL ECHIN; Francis RA, 2012, APPL GEOGR, V32, P514, DOI 10.1016/j.apgeog.2011.06.013; Gloor S, 2001, MAMM BIOL, V66, P155; Haase D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066531; HARRIS S, 1986, J ANIM ECOL, V55, P575, DOI 10.2307/4740; Hegglin D, 2007, FUNCTIONAL ECOLOGY, V21, P55; Hegglin D, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-247; Hindrikson M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046465; Janko C, 2012, ACTA THERIOL, V57, P245, DOI 10.1007/s13364-012-0074-0; Konig A, 2008, EUR J WILDLIFE RES, V54, P101, DOI 10.1007/s10344-007-0117-z; Konig A, 2012, WILDLIFE RES, V39, P488, DOI 10.1071/WR11077; Laurimaa L, 2015, EMERGING INFECT DIS; McKinney M. L., 2008, Urban Ecosystems, V11, P161, DOI 10.1007/s11252-007-0045-4; Moks E, 2008, PARASITOLOGY, V135, P647, DOI 10.1017/S0031182008004198; Moks E, 2006, J WILDLIFE DIS, V42, P359, DOI 10.7589/0090-3558-42.2.359; Moks E, 2005, EMERG INFECT DIS, V11, P1973, DOI 10.3201/eid1112.050339; Niin E, 2008, VACCINE, V26, P3556, DOI 10.1016/j.vaccine.2008.04.056; Partel A, 2013, B OIE, V3, P58; Randi E, 2008, MOL ECOL, V17, P285, DOI 10.1111/j.1365-294X.2007.03417.x; Saarma U, 2009, PARASITOLOGY, V136, P317, DOI 10.1017/S0031182008005453; Sadlier LMJ, 2004, MAMMAL REV, V34, P75, DOI 10.1046/j.0305-1838.2003.00029.x; Scott DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099059; Seto KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023777; Soulsbury CD, 2007, MAMMAL REV, V37, P278, DOI 10.1111/j.1365-2907.2007.00101.x; Soulsbury CD, 2011, J MAMMAL, V92, P190, DOI 10.1644/09-MAMM-A-187.1; Uraguchi K, 2009, POPULATION ECOLOGY, V51, P217; Vuorisalo T, 2014, LANDSCAPE URBAN PLAN, V124, P109, DOI 10.1016/j.landurbplan.2013.12.002; Whiteside HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022145	42	44	45	2	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115124	10.1371/journal.pone.0115124	http://dx.doi.org/10.1371/journal.pone.0115124			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531399	Green Submitted, gold, Green Published			2022-12-27	WOS:000348845100038
J	Xu, XB; Lan, WY; Jin, XX; Wang, B; Yan, HB; Chen, X; Lai, XW; Zhang, L; Zhang, XH; Li, ZS				Xu, Xiaobing; Lan, Wenya; Jin, Xinxin; Wang, Bin; Yan, Hongbo; Chen, Xi; Lai, Xiaowei; Zhang, Li; Zhang, Xiaohua; Li, Zhaoshen			Regulated Expression of PTPRJ by COX-2/PGE(2) Axis in Endothelial Cells	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; BREAST-CANCER CELLS; INDOMETHACIN THERAPY; TUMOR ANGIOGENESIS; RECEPTOR; DEP-1; PROGRESSION; GROWTH; MURINE; CD148	Background: This study was designed to examine a novel role of COX-2/PGE(2) signaling as a regulator of PTPRJ expression in endothelial cells. Methods: A bioinformatics analysis of a whole genome array was carried out to search for regulators of PTPRJ expression in endothelial cells. PTPRJ expression was also measured in endothelial cells derived from a balloon injury-induced neointimal hyperplasia model in male New Zealand Rabbits. Changes in PTPRJ expression in HUVEC cells was examined by RT-PCR and western blotting after transfection of COX-2 plasmids or treatment with varying concentrations of a COX-2 inhibitor. Results: A significant correlation was identified between COX-2 and PTPRJ in GSE39264 (Pearson correlation coefficient = -0.87; n = 22; P < 0.01, two-tailed). PTPRJ expression was reduced during the progression of neointimal hyperplasia after balloon injury, which correlated with an increase in COX-2 expression. In HUVECs, after transfection with 1 mu g/ml, 0.5 mu g/ml, or 0.25 mg/ml COX-2 plasmids, PTPRJ protein expression was reduced to 0.60- (+/- 0.08), 0.75- (+/- 0.09), and 0.88- (+/- 0.04) fold, respectively, while mRNA expression was reduced to 0.15- (+/- 0.03), 0.26- (+/- 0.05), and 0.47- (+/- 0.09) fold, respectively. After treatment of HUVECs with 10 mmol/L or 20 mmol/L celecoxib, the reduction in PTPRJ expression induced by COX-2 over-expression was not only rescued but in fact increased by 2.05-fold (+/- 0.28) and 3.34-fold (+/- 0.37), respectively, compared with control. Conclusions: Our results suggest that COX-2/PGE2 signaling may function as a negative regulator of PTPRJ expression in endothelial cells both in vivo and vitro.	[Xu, Xiaobing; Jin, Xinxin; Wang, Bin; Zhang, Xiaohua] Second Mil Med Univ, Clin Sch Nanjing, Jinling Hosp, Dept Gastroenterol & Hepatol, Nanjing, Jiangsu, Peoples R China; [Xu, Xiaobing; Lai, Xiaowei; Li, Zhaoshen] Second Mil Med Univ, Changhai Hosp, Dept Gastroenterol, Shanghai, Peoples R China; [Lan, Wenya; Zhang, Li] Nanjing Med Univ, Nanjing Brain Hosp, Dept Geriatr Neurol, Nanjing, Jiangsu, Peoples R China; [Yan, Hongbo; Chen, Xi] Beijing Inst Radiat Med, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing, Peoples R China	Naval Medical University; Naval Medical University; Nanjing Medical University; Academy of Military Medical Sciences - China	Zhang, XH (corresponding author), Second Mil Med Univ, Clin Sch Nanjing, Jinling Hosp, Dept Gastroenterol & Hepatol, Nanjing, Jiangsu, Peoples R China.	jszhxh@sina.com; zhaoshenli@hotmail.com						Askarian-Amiri ME, 2011, RNA, V17, P878, DOI 10.1261/rna.2528811; Boivin B, 2008, P NATL ACAD SCI USA, V105, P9959, DOI 10.1073/pnas.0804336105; Borges LG, 1996, CIRC RES, V79, P570, DOI 10.1161/01.RES.79.3.570; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chang SH, 2004, P NATL ACAD SCI USA, V101, P591, DOI 10.1073/pnas.2535911100; Dave RK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068306; Gaya A, 1999, LEUKEMIA LYMPHOMA, V35, P237, DOI 10.3109/10428199909145726; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harris R.E, 2003, COX 2 BLOCKADE CANC; Iuliano R, 2003, CANCER RES, V63, P882; Keane MM, 1996, CANCER RES, V56, P4236; Kellie S, 2004, J CELL SCI, V117, P609, DOI 10.1242/jcs.00879; Kerbel RS, 2000, CARCINOGENESIS, V21, P505, DOI 10.1093/carcin/21.3.505; Khan Z, 2011, CURR DRUG TARGETS, V12, P1082, DOI 10.2174/138945011795677764; Kipshidze N, 2004, J AM COLL CARDIOL, V44, P733, DOI 10.1016/j.jacc.2004.04.048; Kovalenko M, 2000, J BIOL CHEM, V275, P16219, DOI 10.1074/jbc.275.21.16219; Kumar BNP, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-273; Lala PK, 1997, INT J CANCER, V73, P371, DOI 10.1002/(SICI)1097-0215(19971104)73:3<371::AID-IJC12>3.0.CO;2-G; LALA PK, 1986, CELL IMMUNOL, V99, P108, DOI 10.1016/0008-8749(86)90220-0; Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080; Le Pera I, 2005, ONCOGENE, V24, P3187, DOI 10.1038/sj.onc.1208510; Lin J, 2004, J IMMUNOL, V173, P2324, DOI 10.4049/jimmunol.173.4.2324; Izquierdo CL, 2011, AM J PATHOL, V178, P1361, DOI 10.1016/j.ajpath.2010.11.074; OSTMAN A, 1994, P NATL ACAD SCI USA, V91, P9680, DOI 10.1073/pnas.91.21.9680; Palka HL, 2003, J BIOL CHEM, V278, P5728, DOI 10.1074/jbc.M210656200; Rozic JG, 2001, INT J CANCER, V93, P497, DOI 10.1002/ijc.1376; Ruivenkamp CAL, 2002, NAT GENET, V31, P295, DOI 10.1038/ng903; Seno H, 2002, CANCER RES, V62, P506; Smart CE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040742; Timoshenko AV, 2004, INT J CANCER, V108, P384, DOI 10.1002/ijc.11575; Timoshenko AV, 2003, EXP CELL RES, V289, P265, DOI 10.1016/S0014-4827(03)00269-6; Toomey DP, 2009, SURG-J R COLL SURG E, V7, P174, DOI 10.1016/S1479-666X(09)80042-5; Tsuboi N, 2008, BIOCHEM J, V413, P193, DOI 10.1042/BJ20071317; Wang DZ, 2004, P NATL ACAD SCI USA, V101, P415, DOI 10.1073/pnas.0307640100; Wang MT, 2007, CANCER METAST REV, V26, P525, DOI 10.1007/s10555-007-9096-5; Williams CS, 1999, ONCOGENE, V18, P7908, DOI 10.1038/sj.onc.1203286; Wu LY, 2011, CARDIOVASC DRUG THER, V25, P233, DOI 10.1007/s10557-011-6305-9; Yamashita A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/424929	39	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e114996	10.1371/journal.pone.0114996	http://dx.doi.org/10.1371/journal.pone.0114996			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25532119	gold, Green Published, Green Submitted			2022-12-27	WOS:000348845100035
J	Zill, JM; Christalle, E; Muller, E; Harter, M; Dirmaier, J; Scholl, I				Zill, Joerdis M.; Christalle, Eva; Mueller, Evamaria; Haerter, Martin; Dirmaier, Joerg; Scholl, Isabelle			Measurement of Physician-Patient Communication-A Systematic Review	PLOS ONE			English	Review							HABITS CODING SCHEME; INTERVIEW CLASSIFICATION-SYSTEM; STATUS MEASUREMENT INSTRUMENTS; METHODOLOGICAL QUALITY; MEDICAL ENCOUNTER; PRIMARY-CARE; CONSULTATION SKILLS; COSMIN CHECKLIST; MAAS SCALE; RELIABILITY	Background: Effective communication with health care providers has been found as relevant for physical and psychological health outcomes as well as the patients' adherence. However, the validity of the findings depends on the quality of the applied measures. This study aimed to provide an overview of measures of physician-patient communication and to evaluate the methodological quality of psychometric studies and the quality of psychometric properties of the identified measures. Methods: A systematic review was performed to identify psychometrically tested instruments which measure physician-patient communication. The search strategy included three databases (EMBASE, PsycINFO, PubMed), reference and citation tracking and personal knowledge. Studies that report the psychometric properties of physician-patient communication measures were included. Two independent raters assessed the methodological quality of the selected studies with the COSMIN (COnsensus based Standards for the selection of health status Measurement INtruments) checklist. The quality of psychometric properties was evaluated with the quality criteria of Terwee and colleagues. Results: Data of 25 studies on 20 measures of physician-patient communication were extracted, mainly from primary care samples in Europe and the USA. Included studies reported a median of 3 out of the nine COSMIN criteria. Scores for internal consistency and content validity were mainly fair or poor. Reliability and structural validity were rated mainly of fair quality. Hypothesis testing scored mostly poor. The quality of psychometric properties of measures evaluated with Terwee et al.'s criteria was rated mainly intermediate or positive. Discussion: This systematic review identified a number of measures of physician-patient communication. However, further psychometric evaluation of the measures is strongly recommended. The application of quality criteria like the COSMIN	[Zill, Joerdis M.; Christalle, Eva; Mueller, Evamaria; Haerter, Martin; Dirmaier, Joerg; Scholl, Isabelle] Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Zill, JM (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany.	j.zill@uke.de	Scholl, Isabelle/AAN-9450-2020	Scholl, Isabelle/0000-0002-7639-0880; Harter, Martin/0000-0001-7443-9890	German Federal Ministry of Education and Research [01GX1043]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This project is funded by the German Federal Ministry of Education and Research (project number 01GX1043). The funding sources did not affect the study design; the collection, analysis, and interpretation of data; or the writing of the article and the decision to submit it for publication.	Adeyemi JD, 1998, EUR J PSYCHIAT, V12, P233; Baig LA, 2009, BMC MED EDUC, V9, DOI 10.1186/1472-6920-9-22; Batalden P, 2002, HEALTH AFFAIR, V21, P103, DOI 10.1377/hlthaff.21.5.103; Baumann M, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-244; Bieber C, 2010, J CLIN PSYCHOL MED S, V17, P125, DOI 10.1007/s10880-010-9189-0; Boon H, 1998, PATIENT EDUC COUNS, V35, P161, DOI 10.1016/S0738-3991(98)00063-9; BUIJS R, 1984, SOC SCI MED, V19, P683, DOI 10.1016/0277-9536(84)90240-5; Burt J, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004339; Campbell C, 2007, MED EDUC, V41, P123, DOI 10.1111/j.1365-2929.2006.02657.x; Cegala DJ, 1998, HEALTH COMMUN, V10, P261, DOI 10.1207/s15327027hc1003_5; Clever SL, 2008, HEALTH SERV RES, V43, P1505, DOI 10.1111/j.1475-6773.2008.00849.x; Committee on Quality of Health Care in America, 2001, CROSSING QUALITY CHA; Del Piccolo L, 2005, PATIENT EDUC COUNS, V58, P252, DOI 10.1016/j.pec.2005.01.001; Del Piccolo L, 2004, PATIENT EDUC COUNS, V53, P47, DOI 10.1016/S0738-3991(03)00115-0; Del Piccolo L, 1999, Epidemiol Psichiatr Soc, V8, P56; Dobson F, 2012, OSTEOARTHR CARTILAGE, V20, P1548, DOI 10.1016/j.joca.2012.08.015; Dobson F, 2012, ARTHRIT CARE RES, V64, P1565, DOI 10.1002/acr.21707; Enzer I, 2003, INT J QUAL HEALTH C, V15, P407, DOI 10.1093/intqhc/mzg056; Greenhalgh T, 2005, BRIT MED J, V331, P1064, DOI 10.1136/bmj.38636.593461.68; Gulbrandsen P, 2008, PATIENT EDUC COUNS, V72, P388, DOI 10.1016/j.pec.2008.05.012; Ishikawa H, 2013, SOC SCI MED, V96, P147, DOI 10.1016/j.socscimed.2013.07.026; Jensen BF, 2011, BMJ QUAL SAF, V20, P885, DOI 10.1136/bmjqs-2011-000021; Jensen BF, 2010, PATIENT EDUC COUNS, V80, P405, DOI 10.1016/j.pec.2010.06.032; Katsuyama K, 2010, INT J HEALTH CARE Q, V23, P378, DOI 10.1108/09526861011037443; Krupat E, 2006, PATIENT EDUC COUNS, V62, P38, DOI 10.1016/j.pec.2005.04.015; Makoul G, 2001, PATIENT EDUC COUNS, V45, P23, DOI 10.1016/S0738-3991(01)00136-7; Makoul G, 2007, PATIENT EDUC COUNS, V67, P333, DOI 10.1016/j.pec.2007.05.005; Mauksch LB, 2008, ARCH INTERN MED, V168, P1387, DOI 10.1001/archinte.168.13.1387; McMillan Rhona, 2011, Qual Prim Care, V19, P347; Michie S, 2003, PATIENT EDUC COUNS, V51, P197, DOI 10.1016/S0738-3991(02)00194-5; Mokkink LB, 2010, BMC MED RES METHODOL, V10, P1471; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; Mokkink LB, 2009, QUAL LIFE RES, V18, P313, DOI 10.1007/s11136-009-9451-9; ONG LML, 1995, SOC SCI MED, V40, P903, DOI 10.1016/0277-9536(94)00155-M; Ong LML, 1998, PSYCHO-ONCOL, V7, P387, DOI 10.1002/(SICI)1099-1611(1998090)7:5<387::AID-PON316>3.3.CO;2-7; Robinson J, 2002, BRIT J GEN PRACT, V52, P889; Roter DL, 1991, ROTER METHOD INTERAC; Salt E, 2013, CHRONIC ILLN, V9, P103, DOI 10.1177/1742395312455440; Scholl I, 2014, PATIENT EDUC COUNS, V94, P224, DOI 10.1016/j.pec.2013.10.006; Shapiro J, 1981, Urban Health, V10, P10; Siminoff LA, 2011, J HEALTH COMMUN, V16, P178, DOI 10.1080/10810730.2010.535109; Street RL, 2009, PATIENT EDUC COUNS, V74, P295, DOI 10.1016/j.pec.2008.11.015; Terwee CB, 2012, QUAL LIFE RES, V21, P651, DOI 10.1007/s11136-011-9960-1; Terwee CB, 2009, QUAL LIFE RES, V18, P1115, DOI 10.1007/s11136-009-9528-5; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Tijssen M, 2011, BMC MUSCULOSKEL DIS, V12, P1471; Venetis MK, 2009, PATIENT EDUC COUNS, V77, P379, DOI 10.1016/j.pec.2009.09.015; Wachira J, 2013, PSYCHOMETRIC ASSESSM, V2013; Zandbelt LC, 2005, SOC SCI MED, V61, P661, DOI 10.1016/j.socscimed.2004.12.006; Zandbelt LC, 2007, MED CARE, V45, P330, DOI 10.1097/01.mlr.0000250482.07970.5f; Zolnierek KBH, 2009, MED CARE, V47, P826, DOI 10.1097/MLR.0b013e31819a5acc	51	73	76	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e112637	10.1371/journal.pone.0112637	http://dx.doi.org/10.1371/journal.pone.0112637			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA3ZY	25532118	Green Published, gold, Green Submitted			2022-12-27	WOS:000348845100004
J	Guidolin, AS; Fresia, P; Consoli, FL				Guidolin, Aline S.; Fresia, Pablo; Consoli, Fernando L.			The Genetic Structure of an Invasive Pest, the Asian Citrus Psyllid Diaphorina citri (Hemiptera: Liviidae)	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; POPULATION-GENETICS; CYTOCHROME-OXIDASE; BIOLOGY; CONSERVATION; PARASITOIDS; HYMENOPTERA; HOMOPTERA; SEQUENCES; HISTORY	The Asian citrus psyllid Diaphorina citri is currently the major threat to the citrus industry as it is the vector of Candidatus Liberibacter, the causal agent of huanglongbing disease (HLB). D. citri is native to Asia and now colonizes the Americas. Although it has been known in some countries for a long time, invasion routes remain undetermined. There are no efficient control methods for the HLB despite the intensive management tools currently in use. We investigated the genetic variability and structure of populations of D. citri to aid in the decision making processes toward sustainable management of this species/disease. We employed different methods to quantify and compare the genetic diversity and structure of D. citri populations among 36 localities in Brazil, using an almost complete sequence of the cytochrome oxidase I (COI) gene. Our analyses led to the identification of two geographically and genetically structured groups. The indices of molecular diversity pointed to a recent population expansion, and we discuss the role of multiple invasion events in this scenario. We also argue that such genetic diversity and population structure may have implications for the best management strategies to be adopted for controlling this psyllid and/or the disease it vectors in Brazil.	[Guidolin, Aline S.; Consoli, Fernando L.] Univ Sao Paulo, Lab Interacoes Insetos, Dept Entomol & Acarol, ESALQ, BR-13418900 Sao Paulo, Brazil; [Fresia, Pablo] Univ Sao Paulo, Lab Resistencia Artropodes Tat Controle, Dept Entomol & Acarol, ESALQ, BR-13418900 Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Consoli, FL (corresponding author), Univ Sao Paulo, Lab Interacoes Insetos, Dept Entomol & Acarol, ESALQ, Av Padua Dias 11, BR-13418900 Sao Paulo, Brazil.	fconsoli@usp.br	Guidolin, Aline Sartori/K-6897-2019; FRESIA, pablo/AGF-5679-2022; Guidolin, Aline Sartori/A-1197-2013; Consoli, Fernando Luis/D-5706-2012	Guidolin, Aline Sartori/0000-0001-5521-9067; Guidolin, Aline Sartori/0000-0001-5521-9067; Consoli, Fernando Luis/0000-0002-2287-0782	CNPq; CAPES; Fundecitrus; MAPA/CNPq [2008-9/578797]; FAPESP [2010/50412-5]; Sao Paulo Research Foundation	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundecitrus; MAPA/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	ASG was a MSc fellow from CNPq. PFC was a post-doctoral fellow from CAPES. FLC received funding support from Fundecitrus, MAPA/CNPq (Grant # 2008-9/578797) and FAPESP (Grant # 2010/50412-5, Sao Paulo Research Foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa Kenryo, 2007, Research Bulletin of the Plant Protection Service Japan, V43, P23; Ascunce MS, 2011, SCIENCE, V331, P1066, DOI 10.1126/science.1198734; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Ballard JWO, 2010, MOL ECOL, V19, P1523, DOI 10.1111/j.1365-294X.2010.04594.x; Ballard JWO, 2007, EVOLUTION, V61, P1735, DOI 10.1111/j.1558-5646.2007.00133.x; Barnabe C, 2000, PARASITOLOGY, V120, P513, DOI 10.1017/S0031182099005661; Barrientos A, 2002, GENE, V286, P53, DOI 10.1016/S0378-1119(01)00803-4; Boina DR, 2009, ENVIRON ENTOMOL, V38, P1250, DOI 10.1603/022.038.0436; Bonani JP, 2010, ENTOMOL EXP APPL, V134, P35, DOI 10.1111/j.1570-7458.2009.00937.x; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Bove JM, 2006, J PLANT PATHOL, V88, P7; Boykin LM, 2012, B ENTOMOL RES, V17, P1; Carmichael LE, 2007, MOL ECOL, V16, P3466, DOI 10.1111/j.1365-294X.2007.03381.x; Chapman RE, 2001, ECOL LETT, V4, P650, DOI 10.1046/j.1461-0248.2001.00253.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; CRANDALL KA, 1993, GENETICS, V134, P959; de Leon JH, 2011, ANN ENTOMOL SOC AM, V104, P1392, DOI 10.1603/AN11086; Donadio LC, 2005, CITROS, P3; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Fundecitrus, 2014, LEV; Guidolin AS, 2013, MICROB ECOL, V65, P475, DOI 10.1007/s00248-012-0150-7; Guillemaud T, 2011, CR BIOL, V334, P237, DOI 10.1016/j.crvi.2010.12.008; Halbert SE, 2004, FLA ENTOMOL, V87, P330, DOI 10.1653/0015-4040(2004)087[0330:ACPSPA]2.0.CO;2; Hall DG, 2013, ENTOMOL EXP APPL, V146, P207, DOI 10.1111/eea.12025; HARRISON RG, 1989, TRENDS ECOL EVOL, V4, P6, DOI 10.1016/0169-5347(89)90006-2; Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Jourdie V, 2010, MOL ECOL, V19, P2168, DOI 10.1111/j.1365-294X.2010.04625.x; Kobori Y, 2011, APPL ENTOMOL ZOOL, V46, P27, DOI 10.1007/s13355-010-0004-z; Lima A. M. da C, 1936, TERCEIRO CATALOGO IN; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Lopes SA, 2007, EUR J PLANT PATHOL, V119, P463, DOI 10.1007/s10658-007-9173-1; Marsaro Jr AL, 2010, C BRAS ENT; McFarland CD, 2001, FLA ENTOMOL, V84, P227, DOI 10.2307/3496171; Meiklejohn CD, 2007, TRENDS GENET, V23, P259, DOI 10.1016/j.tig.2007.03.008; MORITZ C, 1994, MOL ECOL, V3, P401, DOI 10.1111/j.1365-294X.1994.tb00080.x; Nachman MW, 1998, GENETICA, V102-3, P61, DOI 10.1023/A:1017030708374; Nava DE, 2007, J APPL ENTOMOL, V131, P709, DOI 10.1111/j.1439-0418.2007.01230.x; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Pennings PS, 2011, J EVOLUTION BIOL, V24, P871, DOI 10.1111/j.1420-9101.2010.02223.x; Pichaud N, 2012, EVOLUTION, V66, P3189, DOI 10.1111/j.1558-5646.2012.01683.x; Pinho C, 2007, BIOL J LINN SOC, V91, P121, DOI 10.1111/j.1095-8312.2007.00774.x; Porretta D, 2007, J APPL ECOL, V44, P682, DOI 10.1111/j.1365-2664.2007.01301.x; Rand DM, 2004, TRENDS ECOL EVOL, V19, P645, DOI 10.1016/j.tree.2004.10.003; Remais JV, 2011, PLOS PATH, V7, P4; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Segelbacher G, 2010, CONSERV GENET, V11, P375, DOI 10.1007/s10592-009-0044-5; Shao R, 2007, PARASITOLOGY, V134, P153, DOI 10.1017/S0031182006001429; Silva A. G. A., 1968, QUARTO CATALOGO INSE, V1a; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Texeira DC, 2005, PLANT DIS, V89, P107, DOI 10.1094/PD-89-0107A; Tsai JH, 2000, J ECON ENTOMOL, V93, P1721, DOI 10.1603/0022-0493-93.6.1721; YAMAMOTO PT, 2009, BIOASSAY, V4, P9; Zayed A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000868; Zhang DX, 1997, INSECT MOL BIOL, V6, P143, DOI 10.1111/j.1365-2583.1997.tb00082.x	60	20	21	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115749	10.1371/journal.pone.0115749	http://dx.doi.org/10.1371/journal.pone.0115749			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545788	Green Published, Green Submitted, gold			2022-12-27	WOS:000347120200065
J	Bal, G; Rivot, E; Bagliniere, JL; White, J; Prevost, E				Bal, Guillaume; Rivot, Etienne; Bagliniere, Jean-Luc; White, Jonathan; Prevost, Etienne			A Hierarchical Bayesian Model to Quantify Uncertainty of Stream Water Temperature Forecasts	PLOS ONE			English	Article							SALMON SALMO-SALAR; CLIMATE-CHANGE IMPACTS; ATLANTIC SALMON; NEW-BRUNSWICK; BROWN TROUT; RIVER; GROWTH; L.; CONSERVATION; CALIBRATION	Providing generic and cost effective modelling approaches to reconstruct and forecast freshwater temperature using predictors as air temperature and water discharge is a prerequisite to understanding ecological processes underlying the impact of water temperature and of global warming on continental aquatic ecosystems. Using air temperature as a simple linear predictor of water temperature can lead to significant bias in forecasts as it does not disentangle seasonality and long term trends in the signal. Here, we develop an alternative approach based on hierarchical Bayesian statistical time series modelling of water temperature, air temperature and water discharge using seasonal sinusoidal periodic signals and time varying means and amplitudes. Fitting and forecasting performances of this approach are compared with that of simple linear regression between water and air temperatures using i) an emotive simulated example, ii) application to three French coastal streams with contrasting bio-geographical conditions and sizes. The time series modelling approach better fit data and does not exhibit forecasting bias in long term trends contrary to the linear regression. This new model also allows for more accurate forecasts of water temperature than linear regression together with a fair assessment of the uncertainty around forecasting. Warming of water temperature forecast by our hierarchical Bayesian model was slower and more uncertain than that expected with the classical regression approach. These new forecasts are in a form that is readily usable in further ecological analyses and will allow weighting of outcomes from different scenarios to manage climate change impacts on freshwater wildlife.	[Bal, Guillaume; Bagliniere, Jean-Luc] INRA, UMR ESE Ecol & Sante Ecosyst 0985, F-35042 Rennes, France; [Bal, Guillaume; White, Jonathan] Inst Marine, Oranmore, Ireland; [Rivot, Etienne] Agrocampus Ouest, UMR ESE Ecol & Sante Ecosyst 0985, Rennes, France; [Prevost, Etienne] INRA, UMR Ecobiop Ecol Comportementale & Biol Populat P, St Pee Sur Nivelle, France; [Prevost, Etienne] Univ Pau & Pays Adour, UMR Ecobiop Ecol Comportementale & Biol Populat P, Anglet, France	INRAE; Marine Institute Ireland; Institut Agro; Agrocampus Ouest; INRAE; Universite de Pau et des Pays de l'Adour; Universite de Pau et des Pays de l'Adour	Bal, G (corresponding author), INRA, UMR ESE Ecol & Sante Ecosyst 0985, F-35042 Rennes, France.	guillaume.bal.pro@gmail.com		Rivot, Etienne/0000-0002-5442-121X	French Ministry of Education and Research; French Ministry of Ecology and Sustainable Development 'Programme GICC2: Gestion et Impact du Changement Climatique'	French Ministry of Education and Research; French Ministry of Ecology and Sustainable Development 'Programme GICC2: Gestion et Impact du Changement Climatique'	This research was performed while Dr. Guillaume Bal was a Ph.D. student sponsored by the French Ministry of Education and Research. A grant from the French Ministry of Ecology and Sustainable Development 'Programme GICC2: Gestion et Impact du Changement Climatique' also supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi-Nedushan B, 2007, HYDROL PROCESS, V21, P21, DOI 10.1002/hyp.6353; Almodovar A, 2012, GLOBAL CHANGE BIOL, V18, P1549, DOI 10.1111/j.1365-2486.2011.02608.x; Bagliniere JL, 2005, ICES J MAR SCI, V62, P695, DOI 10.1016/j.icesjms.2005.02.008; Bagliniere JL, 2002, PROD ANIM, V15, P319; Bal G, 2011, J FISH BIOL, V78, P1002, DOI 10.1111/j.1095-8649.2011.02902.x; BENYAHYA L, 2007, CANADIAN WATER RESOU, V31, P179, DOI DOI 10.4296/CWRJ3203179; Benyahya L, 2007, J ENVIRON ENG SCI, V6, P437, DOI [10.1139/S06-067, 10.1139/s06-067]; Beschta RL, 1987, STREAMSIDE MANAGEMEN, P191; Betts RA, 2011, PHILOS T R SOC A, V369, P67, DOI 10.1098/rsta.2010.0292; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Buisson L, 2008, ECOL FRESHW FISH, V17, P244, DOI 10.1111/j.1600-0633.2007.00276.x; Caissie D, 2006, FRESHWATER BIOL, V51, P1389, DOI 10.1111/j.1365-2427.2006.01597.x; Caissie D, 1998, CAN J CIVIL ENG, V25, P250, DOI 10.1139/cjce-25-2-250; Caissie D, 2007, J HYDROL, V336, P303, DOI 10.1016/j.jhydrol.2007.01.008; Chenard JF, 2008, HYDROL PROCESS, V22, P3361, DOI 10.1002/hyp.6928; Clark JS, 2005, ECOL LETT, V8, P2, DOI 10.1111/j.1461-0248.2004.00702.x; Cragg-Hine D, 2006, J FISH BIOL, V68, P1891, DOI 10.1111/j.0022-1112.2006.01062.x; Cunjak RA, 2005, OECOLOGIA, V144, P636, DOI 10.1007/s00442-005-0101-9; Daufresne M, 2007, GLOBAL CHANGE BIOL, V13, P2467, DOI 10.1111/j.1365-2486.2007.01449.x; Daufresne M, 2007, OECOLOGIA, V151, P544, DOI 10.1007/s00442-006-0655-1; Dumas J, 2007, BFPP-CONNAISS GEST P, P39, DOI 10.1051/kmae:2007009; Erickson TR, 2000, J HYDROL ENG, V5, P317, DOI 10.1061/(ASCE)1084-0699(2000)5:3(317); Forseth T, 2001, FRESHWATER BIOL, V46, P173, DOI 10.1046/j.1365-2427.2001.00631.x; GELMAN A, 2012, BAYESIAN DATA ANALYS; Gibelin AL, 2003, CLIM DYNAM, V20, P327, DOI 10.1007/s00382-002-0277-1; Graham CT, 2009, J FISH BIOL, V74, P1143, DOI 10.1111/j.1095-8649.2009.02180.x; Harwood J, 2003, TRENDS ECOL EVOL, V18, P617, DOI 10.1016/j.tree.2003.08.001; Heino J, 2009, BIOL REV, V84, P39, DOI 10.1111/j.1469-185X.2008.00060.x; *INT PAN CLIM CHAN, 2007, SCIENCE BASIS INTERG; JANSSEN PHM, 1995, ECOL MODEL, V83, P55, DOI 10.1016/0304-3800(95)00084-9; Jonsson B, 2009, J FISH BIOL, V75, P2381, DOI 10.1111/j.1095-8649.2009.02380.x; Jutila E, 2006, ECOL FRESHW FISH, V15, P321, DOI 10.1111/j.1600-0633.2006.00171.x; Kielbassa J, 2010, ECOL MODEL, V221, P2475, DOI 10.1016/j.ecolmodel.2010.07.001; Koch H, 2010, HYDROL PROCESS, V24, P3826, DOI 10.1002/hyp.7814; KOTHANDARAMAN V, 1971, J SANIT ENG DIV ASCE, V97, P19; Lassalle G, 2008, BIOL CONSERV, V141, P1105, DOI 10.1016/j.biocon.2008.02.010; Li F, 2014, CONSERV BIOL, V28, P498, DOI 10.1111/cobi.12219; Litchman E, 2010, ECOL LETT, V13, P1560, DOI 10.1111/j.1461-0248.2010.01544.x; Malcolm IA, 2008, HYDROL PROCESS, V22, P968, DOI 10.1002/hyp.6996; Marce R, 2008, HYDROL PROCESS, V22, P3418, DOI 10.1002/hyp.6955; Marschall EA, 1998, CAN J FISH AQUAT SCI, V55, P48, DOI 10.1139/cjfas-55-S1-48; Mearns LO, 2010, CLIMATIC CHANGE, V100, P77, DOI 10.1007/s10584-010-9841-6; Monk WA, 2009, AM FISH S S, V69, P215; Moradkhani H, 2008, WATER SCI TECHNOL LI, V63, P1; MORIN G, 1994, CAN J CIVIL ENG, V21, P63, DOI 10.1139/l94-006; Ormerod SJ, 2009, AQUAT CONSERV, V19, P609, DOI 10.1002/aqc.1062; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pedersen NL, 2007, HYDROL PROCESS, V21, P348, DOI 10.1002/hyp.6237; Perkins DM, 2010, HYDROBIOLOGIA, V657, P181, DOI 10.1007/s10750-009-0080-7; Piffady J, 2010, FRESHWATER BIOL, V55, P2359, DOI 10.1111/j.1365-2427.2010.02453.x; Pilgrim JM, 1998, J AM WATER RESOUR AS, V34, P1109, DOI 10.1111/j.1752-1688.1998.tb04158.x; Plummer M., 2003, JAGS PROGRAM ANAL BA, DOI DOI 10.1.1.13.3406; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Pont D, 2005, CAN J FISH AQUAT SCI, V62, P163, DOI 10.1139/F04-183; *R DEV COR TEAM, 2013, R A LANGUAGE ENVIRON; Rahel FJ, 2008, CONSERV BIOL, V22, P521, DOI 10.1111/j.1523-1739.2008.00950.x; Rivot E, 2004, ECOL MODEL, V179, P463, DOI 10.1016/j.ecolmodel.2004.05.011; Schindler DW, 2001, CAN J FISH AQUAT SCI, V58, P18, DOI 10.1139/cjfas-58-1-18; SINOKROT BA, 1993, WATER RESOUR RES, V29, P2299, DOI 10.1029/93WR00540; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; STEFAN HG, 1993, WATER RESOUR BULL, V29, P27; Sutton RJ, 2007, RIVER RES APPL, V23, P775, DOI 10.1002/rra.1026; Thorpe JE, 1998, EVOL ECOL, V12, P581, DOI 10.1023/A:1022351814644; Tixier G, 2009, HYDROBIOLOGIA, V624, P13, DOI 10.1007/s10750-008-9663-y; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Webb BW, 2008, HYDROL PROCESS, V22, P902, DOI 10.1002/hyp.6994; Webb BW, 2004, HYDROL PROCESS, V18, P2117, DOI 10.1002/hyp.1463; Webb BW, 2003, HYDROL PROCESS, V17, P3069, DOI 10.1002/hyp.1280; WEHRLY KE, 2004, AMERICAN FISHERIES S, V48, DOI DOI 10.1577/T09-153.1; Woodward G, 2010, PHILOS T R SOC B, V365, P2093, DOI 10.1098/rstb.2010.0055	70	19	20	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115659	10.1371/journal.pone.0115659	http://dx.doi.org/10.1371/journal.pone.0115659			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541732	Green Submitted, Green Published, gold			2022-12-27	WOS:000347239900064
J	Khadaroo, RG; Fortis, S; Salim, SY; Streutker, C; Churchill, TA; Zhang, HB				Khadaroo, Rachel G.; Fortis, Spyridon; Salim, Saad Y.; Streutker, Catherine; Churchill, Thomas A.; Zhang, Haibo			I-FABP as Biomarker for the Early Diagnosis of Acute Mesenteric Ischemia and Resultant Lung Injury	PLOS ONE			English	Article							ACID-BINDING PROTEIN; MULTIPLE ORGAN DYSFUNCTION; INTESTINAL ISCHEMIA; PANETH CELLS; BACTERIAL TRANSLOCATION; REPERFUSION INJURY; XANTHINE-OXIDASE; CRITICALLY-ILL; HOST-DEFENSE; FAILURE	Acute mesenteric ischemia (AMI) is a life-threatening condition that can result in multiple organ injury and death. A timely diagnosis and treatment would have a significant impact on the morbidity and mortality in high-risk patient population. The purpose of this study was to investigate if intestinal fatty acid binding protein (IFABP) and alpha-defensins can be used as biomarkers for early AMI and resultant lung injury. C57BL/6 mice were subjected to intestinal ischemia by occlusion of the superior mesenteric artery. A time course of intestinal ischemia from 0.5 to 3 h was performed and followed by reperfusion for 2 h. Additional mice were treated with N-acetyl-cysteine (NAC) at 300 mg/kg given intraperitoneally prior to reperfusion. AMI resulted in severe intestinal injury characterized by neutrophil infiltrate, myeloperoxidase (MPO) levels, cytokine/chemokine levels, and tissue histopathology. Pathologic signs of ischemia were evident at 1 h, and by 3 h of ischemia, the full thickness of the intestine mucosa had areas of coagulative necrosis. It was noted that the levels of alpha-defensins in intestinal tissue peaked at 1 h and I-FABP in plasma peaked at 3 h after AMI. Intestinal ischemia also resulted in lung injury in a time-dependent manner. Pretreatment with NAC decreased the levels of intestinal alpha-defensins and plasma I-FABP, as well as lung MPO and cytokines. In summary, the concentrations of intestinal alpha-defensins and plasma I-FABP predicted intestinal ischemia prior to pathological evidence of ischemia and I-FABP directly correlated with resultant lung injury. The antioxidant NAC reduced intestinal and lung injury induced by AMI, suggesting a role for oxidants in the mechanism for distant organ injury. I-FABP and alpha-defensins are promising biomarkers, and may guide the treatment with antioxidant in early intestinal and distal organ injury.	[Khadaroo, Rachel G.; Salim, Saad Y.; Churchill, Thomas A.] Univ Alberta, Dept Surg, Edmonton, AB, Canada; [Khadaroo, Rachel G.] Univ Alberta, Div Crit Care Med, Edmonton, AB, Canada; [Fortis, Spyridon; Zhang, Haibo] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Dept Anesthesia, Dept Physiol & Med, Toronto, ON M5B 1W8, Canada; [Fortis, Spyridon; Zhang, Haibo] Univ Toronto, Toronto, ON, Canada; [Streutker, Catherine; Zhang, Haibo] St Michaels Hosp, Dept Pathol, Toronto, ON M5B 1W8, Canada	University of Alberta; University of Alberta; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Khadaroo, RG (corresponding author), Univ Alberta, Dept Surg, Edmonton, AB, Canada.	khadaroo@ualberta.ca	Fortis, Spyridon/Q-3295-2018; Fortis, Spyridon/AAK-3171-2020	Fortis, Spyridon/0000-0001-7807-6740; Fortis, Spyridon/0000-0001-7807-6740	Edmonton Civics Employees University of Alberta; Canadian Institutes of Health Research (CIHR)	Edmonton Civics Employees University of Alberta; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Funding: RGK was supported by Edmonton Civics Employees University of Alberta. HZ was supported by Canadian Institutes of Health Research (CIHR) Grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta S, 2012, J THROMB THROMBOLYS, V33, P355, DOI 10.1007/s11239-011-0660-z; Adams JM, 2001, CRIT CARE MED, V29, P2194, DOI 10.1097/00003246-200111000-00023; Al-Khowaiter SS, 2014, CAN ASSOC RADIOL J, V65, P67, DOI 10.1016/j.carj.2012.01.002; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Machado MCC, 2012, CRIT CARE, V16, DOI 10.1186/cc11653; Clevers HC, 2013, ANNU REV PHYSIOL, V75, P289, DOI 10.1146/annurev-physiol-030212-183744; Cronk Daniel R, 2006, Curr Surg, V63, P322, DOI 10.1016/j.cursur.2006.05.006; Cunliffe RN, 2001, GUT, V48, P176, DOI 10.1136/gut.48.2.176; Davreux CJ, 1997, SHOCK, V8, P432, DOI 10.1097/00024382-199712000-00007; Dayal SD, 2002, J TRAUMA, V52, P1048, DOI 10.1097/00005373-200206000-00005; de Groot H, 2007, TRANSPL P, V39, P481, DOI 10.1016/j.transproceed.2006.12.012; Deitch EA, 2002, SURGERY, V131, P241, DOI 10.1067/msy.2002.116408; DEITCH EA, 1994, SHOCK, V1, P141, DOI 10.1097/00024382-199402000-00010; Derikx JPM, 2007, SHOCK, V28, P544, DOI 10.1097/shk.0b013e3180644e32; EISENHAUER PB, 1992, INFECT IMMUN, V60, P3556, DOI 10.1128/IAI.60.9.3556-3565.1992; Evennett NJ, 2009, WORLD J SURG, V33, P1374, DOI 10.1007/s00268-009-0074-7; Glenister KM, 2004, ANZ J SURG, V74, P260, DOI 10.1111/j.1445-2197.2004.02956.x; GRANGER DN, 1988, AM J PHYSIOL, V255, pH1269, DOI 10.1152/ajpheart.1988.255.6.H1269; Grootjans J, 2010, AM J PATHOL, V176, P2283, DOI 10.2353/ajpath.2010.091069; HARWARD TRS, 1993, J VASC SURG, V18, P459, DOI 10.1016/0741-5214(93)90264-M; Howard TJ, 1996, AM J SURG, V171, P405, DOI 10.1016/S0002-9610(97)89619-5; JONES DE, 1993, FEBS LETT, V315, P187, DOI 10.1016/0014-5793(93)81160-2; JONES DE, 1992, J BIOL CHEM, V267, P23216; KANDA T, 1995, GUT, V36, P788, DOI 10.1136/gut.36.5.788; Kanda T, 2011, J GASTROENTEROL, V46, P492, DOI 10.1007/s00535-011-0373-2; Kassahun WT, 2008, LANGENBECK ARCH SURG, V393, P163, DOI 10.1007/s00423-007-0263-5; Khadaroo RG, 2008, CRIT CARE, V12, DOI 10.1186/cc7001; Klempnauer J, 1997, SURGERY, V121, P239, DOI 10.1016/S0039-6060(97)90351-2; Lieberman JM, 1997, SURGERY, V121, P335, DOI 10.1016/S0039-6060(97)90363-9; Maya ML, 2010, REV ESP ENFERM DIG, V102, P478, DOI 10.4321/s1130-01082010000800004; MARSHALL JC, 1993, ANN SURG, V218, P111, DOI 10.1097/00000658-199308000-00001; MCKELVEY TG, 1988, AM J PHYSIOL, V254, pG753, DOI 10.1152/ajpgi.1988.254.5.G753; OCKNER RK, 1974, J CLIN INVEST, V54, P326, DOI 10.1172/JCI107768; OUELLETTE AJ, 1990, J BIOL CHEM, V265, P9831; Pastores SM, 1996, AM J GASTROENTEROL, V91, P1697; Phua J, 2009, AM J RESP CRIT CARE, V179, P220, DOI 10.1164/rccm.200805-722OC; SACCHETTINI JC, 1990, J BIOL CHEM, V265, P19199; SELSTED ME, 1992, J CELL BIOL, V118, P929, DOI 10.1083/jcb.118.4.929; SHENG ZY, 1991, CHINESE MED J-PEKING, V104, P897; Thuijls G, 2011, ANN SURG, V253, P303, DOI 10.1097/SLA.0b013e318207a767; Vincent JL, 2002, CHEST, V121, P1602, DOI 10.1378/chest.121.5.1602; Whyte AJ, 2010, J EMERG MED, V39, P607, DOI 10.1016/j.jemermed.2008.05.007; WILCOX MG, 1995, DIGEST DIS SCI, V40, P709, DOI 10.1007/BF02064966; WILSON C, 1987, BRIT J SURG, V74, P279, DOI 10.1002/bjs.1800740417	44	28	32	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115242	10.1371/journal.pone.0115242	http://dx.doi.org/10.1371/journal.pone.0115242			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541714	Green Published, Green Submitted, gold			2022-12-27	WOS:000347239900028
J	Lourenco, L; Colley, G; Nosyk, B; Shopin, D; Montaner, JSG; Lima, VD				Lourenco, Lillian; Colley, Guillaume; Nosyk, Bohdan; Shopin, Dmitry; Montaner, Julio S. G.; Lima, Viviane D.		STOP HIV AIDS Study Grp	High Levels of Heterogeneity in the HIV Cascade of Care across Different Population Subgroups in British Columbia, Canada	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; INJECTION-DRUG USERS; UNITED-STATES; HEALTH-CARE; MEDICATION ADHERENCE; DISEASE PROGRESSION; TREATMENT OUTCOMES; PROSPECTIVE COHORT; VIRAL LOAD; INFECTION	Background: The HIV cascade of care (cascade) is a comprehensive tool which identifies attrition along the HIV care continuum. We executed analyses to explicate heterogeneity in the cascade across key strata, as well as identify predictors of attrition across stages of the cascade. Methods: Using linked individual-level data for the population of HIV-positive individuals in BC, we considered the 2011 calendar year, including individuals diagnosed at least 6 months prior, and excluding individuals that died or were lost to follow-up before January 1st, 2011. We defined five stages in the cascade framework: HIV 'diagnosed', 'linked' to care, 'retained' in care, 'on HAART' and virologically 'suppressed'. We stratified the cascade by sex, age, risk category, and regional health authority. Finally, multiple logistic regression models were built to predict attrition across each stage of the cascade, adjusting for stratification variables. Results: We identified 7621 HIV diagnosed individuals during the study period; 80% were male and 5% were <30, 17% 30-39, 37% 40-49 and 40% were >= 50 years. Of these, 32% were MSM, 28% IDU, 8% MSM/IDU, 12% heterosexual, and 20% other. Overall, 85% of individuals 'on HAART' were 'suppressed'; however, this proportion ranged from 60%-93% in our various stratifications. Most individuals, in all subgroups, were lost between the stages: 'linked' to 'retained' and 'on HAART' to 'suppressed'. Subgroups with the highest attrition between these stages included females and individuals <30 years (regardless of transmission risk group). IDUs experienced the greatest attrition of all subgroups. Logistic regression results found extensive statistically significant heterogeneity in attrition across the cascade between subgroups and regional health authorities. Conclusions: We found that extensive heterogeneity in attrition existed across subgroups and regional health authorities along the HIV cascade of care in B.C., Canada. Our results provide critical information to optimize engagement in care and health service delivery.	[Lourenco, Lillian; Colley, Guillaume; Nosyk, Bohdan; Shopin, Dmitry; Montaner, Julio S. G.; Lima, Viviane D.] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Nosyk, Bohdan] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Montaner, Julio S. G.; Lima, Viviane D.] Univ British Columbia, Fac Med, Vancouver, BC, Canada	B.C. Centre for Excellence in HIV/AIDS; Simon Fraser University; University of British Columbia	Lima, VD (corresponding author), British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada.	vlima@cfenet.ubc.ca			British Columbia Ministry of Health; Michael Smith Foundation for Health Research; CIHR; Canadian Institutes of Health Research [MOP-125948]; US National Institute on Drug Abuse [R03DA033851-01]; US National Institutes of Health [R01DA036307]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA036307, R03DA033851] Funding Source: NIH RePORTER	British Columbia Ministry of Health; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding: This study was funded by the British Columbia Ministry of Health-funded Seek and Treat for Optimal Prevention of HIV & AIDS pilot project. VDL is supported by a Scholar Award from the Michael Smith Foundation for Health Research, a New Investigator Award from CIHR and two grants from the Canadian Institutes of Health Research (MOP-125948) and the US National Institute on Drug Abuse (R03DA033851-01). JSGM is supported by the British Columbia Ministry of Health and by the US National Institutes of Health (R01DA036307). BN is supported by a Scholar Award from the Michael Smith Foundation for Health Research. The funders had no role in the design, data collection, data analysis, data interpretation, or writing of the report. The remaining authors report no disclosures.	Alvarez-Uria G., 2013, Interdisciplinary Perspectives on Infectious Diseases, V2013, P384805, DOI 10.1155/2013/384805; Aziz M, 2011, CLIN INFECT DIS, V52, pS231, DOI 10.1093/cid/ciq047; Bangsberg DR, 2000, AIDS, V14, P357, DOI 10.1097/00002030-200003100-00008; BCMJ, 2013, BRIT COLUMBIA MED J, V55; Benbow N SS, 2012, AIDS C WASH DC; Berg KM, 2004, J GEN INTERN MED, V19, P1111, DOI 10.1111/j.1525-1497.2004.30445.x; Boden D, 1999, JAMA-J AM MED ASSOC, V282, P1135, DOI 10.1001/jama.282.12.1135; British Columbia Centre for Excellence in HIV/AIDS, 2011, CHIN IMPL BC CFES TR; Carr RL, 2004, J ASSOC NURSE AIDS C, V15, P30, DOI 10.1177/1055329003261981; Carter A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092334; Cheever LW, 2007, CLIN INFECT DIS, V44, P1500, DOI 10.1086/517534; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cook JA, 2002, J ACQ IMMUN DEF SYND, V30, P401, DOI [10.1097/00042560-200208010-00005, 10.1097/01.QAI.0000018280.16783.FE]; Cunningham WE, 1999, MED CARE, V37, P1270, DOI 10.1097/00005650-199912000-00010; Fang CT, 2004, J INFECT DIS, V190, P879, DOI 10.1086/422601; Gardner EM, 2014, LANCET INFECT DIS, V14, P5, DOI 10.1016/S1473-3099(13)70272-X; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Giordano TP, 2007, CLIN INFECT DIS, V44, P1493, DOI 10.1086/516778; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Grinsztejn B, 2014, LANCET INFECT DIS, V14, P281, DOI 10.1016/S1473-3099(13)70692-3; Group EAT, 2013, FRANC AD NEW NAT POL; Hall HI, 2013, JAMA INTERN MED, V173, P1337, DOI 10.1001/jamainternmed.2013.6841; Heath K, 2014, INT J EPIDEMIOLOGY; Helleberg M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072257; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Hogg RS, 2001, JAMA-J AM MED ASSOC, V286, P2568, DOI 10.1001/jama.286.20.2568; Horstmann E, 2010, CLIN INFECT DIS, V50, P752, DOI 10.1086/649933; Hosek Sybil G, 2008, J HIV AIDS Prev Child Youth, V9, P192, DOI 10.1080/15538340902824118; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Joy R, 2008, JAIDS-J ACQ IMM DEF, V47, P500, DOI 10.1097/QAI.0b013e3181648dfd; Krusi A, 2010, INT J DRUG POLICY, V21, P4, DOI 10.1016/j.drugpo.2009.08.003; Lima VD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010991; Losina E, 2009, CLIN INFECT DIS, V49, P1570, DOI 10.1086/644772; MacDonell KE, 2010, J PEDIATR PSYCHOL, V35, P593, DOI 10.1093/jpepsy/jsp080; Malta M, 2008, ADDICTION, V103, P1242, DOI 10.1111/j.1360-0443.2008.02269.x; Malta M, 2010, AIDS BEHAV, V14, P731, DOI 10.1007/s10461-008-9489-7; Merenstein D, 2009, AIDS PATIENT CARE ST, V23, P289, DOI 10.1089/apc.2008.0161; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; Minniear TD, 2013, AIDS RES HUM RETROV, V29, P99, DOI [10.1089/aid.2012.0267, 10.1089/AID.2012.0267]; Moatti JP, 2000, AIDS, V14, P151, DOI 10.1097/00002030-200001280-00010; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Mugavero MJ, 2011, CLIN INFECT DIS, V52, pS238, DOI 10.1093/cid/ciq048; Muthulingam D, 2013, JAIDS-J ACQ IMM DEF, V63, P112, DOI 10.1097/QAI.0b013e3182894555; Nosyk B, 2014, LANCET INFECT DIS, V14, P40, DOI 10.1016/S1473-3099(13)70254-8; Nosyk B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054416; Oxenius A, 2000, P NATL ACAD SCI USA, V97, P3382, DOI 10.1073/pnas.97.7.3382; Palepu A, 2004, ANTIVIR THER, V9, P713; Palepua A, 2006, DRUG ALCOHOL DEPEN, V84, P188, DOI 10.1016/j.drugalcdep.2006.02.003; Poole WK, 2001, J EPIDEMIOL COMMUN H, V55, P66, DOI 10.1136/jech.55.1.66; Puskas Cathy M, 2011, Curr HIV/AIDS Rep, V8, P277, DOI 10.1007/s11904-011-0098-0; Rao D, 2007, AIDS CARE, V19, P28, DOI 10.1080/09540120600652303; Rodger A, 2014, 21 C RETR OPP INF BO; Rudy BJ, 2009, AIDS PATIENT CARE ST, V23, P185, DOI 10.1089/apc.2008.0162; Samji H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081355; Shacham E, 2010, AIDS PATIENT CARE ST, V24, P229, DOI 10.1089/apc.2009.0275; Sterne JAC, 2005, LANCET, V366, P378, DOI 10.1016/S0140-6736(05)67022-5; Tapp C, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-86; Taylor Barbara S, 2013, Top Antivir Med, V21, P75; Ulett KB, 2009, AIDS PATIENT CARE ST, V23, P41, DOI 10.1089/apc.2008.0132; Weber R, 2013, HIV MED, V14, P195, DOI 10.1111/j.1468-1293.2012.01051.x; Wood E, 2003, J INFECT DIS, V188, P1164, DOI 10.1086/378703; Wood E, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1649	62	52	53	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115277	10.1371/journal.pone.0115277	http://dx.doi.org/10.1371/journal.pone.0115277			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX9RO	25541682	Green Published, Green Submitted, gold			2022-12-27	WOS:000347239900031
J	Mueller, KF; Briel, M; Strech, D; Meerpohl, JJ; Lang, B; Motschall, E; Gloy, V; Lamontagne, F; Bassler, D				Mueller, Katharina F.; Briel, Matthias; Strech, Daniel; Meerpohl, Joerg J.; Lang, Britta; Motschall, Edith; Gloy, Viktoria; Lamontagne, Francois; Bassler, Dirk			Dissemination Bias in Systematic Reviews of Animal Research: A Systematic Review	PLOS ONE			English	Article							PUBLICATION BIAS; METAANALYSES; PROTOCOL	Background: Systematic reviews of preclinical studies, in vivo animal experiments in particular, can influence clinical research and thus even clinical care. Dissemination bias, selective dissemination of positive or significant results, is one of the major threats to validity in systematic reviews also in the realm of animal studies. We conducted a systematic review to determine the number of published systematic reviews of animal studies until present, to investigate their methodological features especially with respect to assessment of dissemination bias, and to investigate the citation of preclinical systematic reviews on clinical research. Methods: Eligible studies for this systematic review constitute systematic reviews that summarize in vivo animal experiments whose results could be interpreted as applicable to clinical care. We systematically searched Ovid Medline, Embase, ToxNet, and ScienceDirect from 1st January 2009 to 9th January 2013 for eligible systematic reviews without language restrictions. Furthermore we included articles from two previous systematic reviews by Peters et al. and Korevaar et al. Results: The literature search and screening process resulted in 512 included full text articles. We found an increasing number of published preclinical systematic reviews over time. The methodological quality of preclinical systematic reviews was low. The majority of preclinical systematic reviews did not assess methodological quality of the included studies (71%), nor did they assess heterogeneity (81%) or dissemination bias (87%). Statistics quantifying the importance of clinical research citing systematic reviews of animal studies showed that clinical studies referred to the preclinical research mainly to justify their study or a future study (76%). Discussion: Preclinical systematic reviews may have an influence on clinical research but their methodological quality frequently remains low. Therefore, systematic reviews of animal research should be critically appraised before translating them to a clinical context.	[Mueller, Katharina F.] Univ Childrens Hosp Tuebingen, Ctr Pediat Clin Studies, Tubingen, Germany; [Briel, Matthias; Gloy, Viktoria] Univ Basel Hosp, Basel Inst Clin Epidemiol & Biostat, CH-4031 Basel, Switzerland; [Briel, Matthias] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Strech, Daniel] Leibniz Univ Hannover, CELLS, D-30167 Hannover, Germany; [Meerpohl, Joerg J.; Lang, Britta] Univ Freiburg, Med Ctr, German Cochrane Ctr, D-79106 Freiburg, Germany; [Motschall, Edith] Univ Freiburg, Med Ctr, Ctr Med Biometry & Med Informat, D-79106 Freiburg, Germany; [Lamontagne, Francois] Univ Sherbrooke, CHU Sherbrooke, Clin Res Ctr Clin, Sherbrooke, PQ J1K 2R1, Canada; [Bassler, Dirk] Univ Zurich Hosp, Dept Neonatol, CH-8091 Zurich, Switzerland	Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; University of Basel; McMaster University; Leibniz University Hannover; University of Freiburg; University of Freiburg; University of Sherbrooke; University of Zurich; University Zurich Hospital	Bassler, D (corresponding author), Univ Zurich Hosp, Dept Neonatol, CH-8091 Zurich, Switzerland.	dirk.bassler@usz.ch	Briel, Matthias/AAT-9284-2021; Meerpohl, Joerg J/J-4224-2013	Meerpohl, Joerg J/0000-0002-1333-5403; Motschall, Edith/0000-0001-7795-242X; Lang, Britta/0000-0002-2113-4708; Bassler, Dirk/0000-0003-2358-4419; Lamontagne, Francois/0000-0002-0360-3427; Strech, Daniel/0000-0002-9153-079X; Briel, Matthias/0000-0002-2070-5230	European Union Seventh Framework Programme (FP7) [285453]	European Union Seventh Framework Programme (FP7)	The OPEN Project (www. open-project. eu) is funded by the European Union Seventh Framework Programme (FP7 - HEALTH.2011.4.12) under grant agreement no 285453. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Briel M, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-23; Crossley NA, 2008, STROKE, V39, P929, DOI 10.1161/STROKEAHA.107.498725; Hooijmans CR, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-43; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Korevaar DA, 2011, LAB ANIM-UK, V45, P225, DOI 10.1258/la.2011.010121; Liu Shimin, 2009, J Exp Stroke Transl Med, V2, P16; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Mignini Luciano E, 2006, BMC Med Res Methodol, V6, P10, DOI 10.1186/1471-2288-6-10; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Mueller KF, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-60; Muller KF, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-34; Nordmann AJ, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13518; Perrin S, 2014, NATURE, V507, P423, DOI 10.1038/507423a; Peters JL, 2006, J ENVIRON SCI HEAL B, V41, P1245, DOI 10.1080/03601230600857130; Pound P, 2004, BMJ-BRIT MED J, V328, P514, DOI 10.1136/bmj.328.7438.514; Pound P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3387; Sandercock P, 2002, LANCET, V360, P586, DOI 10.1016/S0140-6736(02)09812-4; Schardt C, 2007, BMC MED INFORM DECIS, V7, DOI 10.1186/1472-6947-7-16; Sena ES, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000344; Song F, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14080; ter Riet G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043404; Tsilidis KK, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001609; Varga O, 2010, EMBO REP, V11, P500, DOI 10.1038/embor.2010.91; Vesterinen HM, 2014, J NEUROSCI METH, V221, P92, DOI 10.1016/j.jneumeth.2013.09.010	25	19	19	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e116016	10.1371/journal.pone.0116016	http://dx.doi.org/10.1371/journal.pone.0116016			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541734	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000347239900127
J	Ortega, CE; Seidner, Y; Dominguez, I				Ortega, Charina E.; Seidner, Yoshua; Dominguez, Isabel			Mining CK2 in Cancer	PLOS ONE			English	Article							PROTEIN-KINASE CK2; GENE-EXPRESSION PATTERNS; SQUAMOUS-CELL CARCINOMAS; HUMAN PROSTATE-CANCER; CASEIN KINASE-2; OVARIAN-CANCER; BREAST-CANCER; PANCREATIC ADENOCARCINOMA; DROSOPHILA-MELANOGASTER; COLORECTAL-CANCER	Cancer is a leading cause of death worldwide. Cancer cells proliferate uncontrollably and, many cases, spread to other parts of the body. A protein historically involved in cancer is protein kinase CK2. CK2 is a serine-threonine kinase that has been involved in cell growth, cell proliferation and cell apoptosis. CK2 functions as an oncogene when overexpressed in mouse tissues, and can synergize with known oncogenes, such as ras, to induce cell transformation in cells in culture. CK2, typically the CK2 alpha protein, is found elevated in a number of human tumors. However, we have little information on CK2 alpha' and CK2 beta proteins, and scarce information on CK2 gene transcript expression. Here, we explore the expression of CK2 transcripts in primary tumor tissues using the database Oncomine in the six cancers with the highest mortality in the U.S.A. In addition, we studied the correlation between CK2 expression and overall survival using the Kaplan-Meier Plotter database in breast, ovarian, and lung cancers. We found widespread upregulation in the expression of CK2 genes in primary tumor tissues. However, we found underexpression of CK2 alpha' transcripts in some tumors, increased CK2 beta transcripts in some invasive tumors, and deregulation of CK2 transcripts in some tumor precursors. There was also correlation between CK2 expression levels and patient survival. These data provides additional evidence for CK2 as a biomarker for cancer studies and as a target for cancer therapy.	[Ortega, Charina E.; Seidner, Yoshua; Dominguez, Isabel] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA	Boston University	Dominguez, I (corresponding author), Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA.	isdoming@bu.edu		Ortega, Charina/0000-0002-8814-8629; /0000-0001-9617-4141	National Institutes of General Medical Sciences [1R01GM098367]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098367] Funding Source: NIH RePORTER	National Institutes of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: The following resources that were used in this manuscript: buying of computers, maintenance of computers and software, and PI salary. These resource were acquired with funding from the National Institutes of General Medical Sciences; 1R01GM098367 (http://www.nigms.nih.gov/Pages/default.aspx). Therefore, indirectly, this R01 grant supported this work. There are no other sources of funding. The work was performed by two undergraduate students that had no funding, and volunteer their time and effort for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adib TR, 2004, BRIT J CANCER, V90, P686, DOI 10.1038/sj.bjc.6601603; Ahmad KA, 2008, ADV ENZYME REGUL, V48, P179, DOI 10.1016/j.advenzreg.2008.04.002; Ahmed K, 2002, TRENDS CELL BIOL, V12, P226, DOI 10.1016/S0962-8924(02)02279-1; AHMED K, 1974, RES COMMUN CHEM PATH, V9, P771; Ahmed K, 2000, J CELL BIOCHEM, P130; Allada R, 2005, MOL CELL BIOCHEM, V274, P141, DOI 10.1007/s11010-005-2943-1; Axtell RC, 2006, J IMMUNOL, V177, P8542, DOI 10.4049/jimmunol.177.12.8542; Battistutta R, 2009, CELL MOL LIFE SCI, V66, P1868, DOI 10.1007/s00018-009-9155-x; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Bibby AC, 2005, INT J BIOL SCI, V1, P67; Bonome T, 2008, CANCER RES, V68, P5478, DOI 10.1158/0008-5472.CAN-07-6595; Buchholz M, 2005, ONCOGENE, V24, P6626, DOI 10.1038/sj.onc.1208804; Canton DA, 2006, CELL SIGNAL, V18, P267, DOI 10.1016/j.cellsig.2005.07.008; Costa R, 2014, BBA-PROTEINS PROTEOM, V1844, P722, DOI 10.1016/j.bbapap.2014.01.014; Cozza G, 2013, CURR MED CHEM, V20, P671, DOI 10.2174/092986713804999312; Currier N, 2005, TOXICOL PATHOL, V33, P726, DOI 10.1080/01926230500352226; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; DAYAMAKIN M, 1994, CANCER RES, V54, P2262; Deplus R, 2014, CELL REP, V8, P743, DOI 10.1016/j.celrep.2014.06.048; Deshiere A, 2013, ONCOGENE, V32, P1373, DOI 10.1038/onc.2012.165; Di Maira G, 2007, ONCOGENE, V26, P6915, DOI 10.1038/sj.onc.1210495; Dominguez I, 2009, CELL MOL LIFE SCI, V66, P1850, DOI 10.1007/s00018-009-9153-z; Drygin D, 2013, CK2 LOGICAL TARGET C, P383; Duncan JS, 2008, BBA-PROTEINS PROTEOM, V1784, P33, DOI 10.1016/j.bbapap.2007.08.017; Eom GH, 2011, CIRCULATION, V123, P2392, DOI 10.1161/CIRCULATIONAHA.110.003665; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Gaedcke J, 2010, GENE CHROMOSOME CANC, V49, P1024, DOI 10.1002/gcc.20811; GAPANY M, 1995, MOL MED, V1, P659, DOI 10.1007/BF03401606; Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798; Gyorffy B, 2012, ENDOCR-RELAT CANCER, V19, P197, DOI 10.1530/ERC-11-0329; Hauck L, 2008, NAT MED, V14, P315, DOI 10.1038/nm1729; Hong Y, 2010, CLIN EXP METASTAS, V27, P83, DOI 10.1007/s10585-010-9305-4; Hou J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010312; Howlader N, 2013, SEER CANC STAT REV 1; Hung MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011418; Iacobuzio-Donahue CA, 2003, AM J PATHOL, V162, P1151, DOI 10.1016/S0002-9440(10)63911-9; Ki DH, 2007, INT J CANCER, V121, P2005, DOI 10.1002/ijc.22975; Kramerov AA, 2008, MOL CELL BIOCHEM, V316, P177, DOI 10.1007/s11010-008-9831-4; Landesman-Bollag E, 2001, ONCOGENE, V20, P3247, DOI 10.1038/sj.onc.1204411; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Laramas M, 2007, EUR J CANCER, V43, P928, DOI 10.1016/j.ejca.2006.11.021; Lin KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017193; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Logsdon CD, 2003, CANCER RES, V63, P2649; Lu KH, 2004, CLIN CANCER RES, V10, P3291, DOI 10.1158/1078-0432.CCR-03-0409; Luo W, 2013, CANCER RES, V73, P2289, DOI 10.1158/0008-5472.CAN-12-4119; Lupp S, 2013, MOL CELL BIOCHEM, V384, P71, DOI 10.1007/s11010-013-1782-8; O-charoenrat P, 2004, CLIN CANCER RES, V10, P5792, DOI 10.1158/1078-0432.CCR-03-0317; Okayama H, 2012, CANCER RES, V72, P100, DOI 10.1158/0008-5472.CAN-11-1403; Olenkina OM, 2012, BIOCHEMISTRY-MOSCOW+, V77, P1285, DOI 10.1134/S0006297912110077; Olenkina OM, 2012, GENE, V499, P143, DOI 10.1016/j.gene.2012.03.023; Pilarsky C, 2004, NEOPLASIA, V6, P744, DOI 10.1593/neo.04277; Pinna L A, 1997, Prog Cell Cycle Res, V3, P77; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Ruzzene M, 2010, BBA-PROTEINS PROTEOM, V1804, P499, DOI 10.1016/j.bbapap.2009.07.018; Sabates-Bellver J, 2007, FALK SYMP, V158, P27; Salvi M, 2006, FEBS LETT, V580, P3948, DOI 10.1016/j.febslet.2006.06.031; Sarno S, 2008, MOL BIOSYST, V4, P889, DOI 10.1039/b805534c; SEITZ G, 1989, BIOCHEM BIOPH RES CO, V163, P635, DOI 10.1016/0006-291X(89)92184-0; Seldin DC, 2005, MOL CELL BIOCHEM, V274, P63, DOI 10.1007/s11010-005-3078-0; SELDIN DC, 1995, CURR OPIN IMMUNOL, V7, P665, DOI 10.1016/0952-7915(95)80075-1; Seldin DC, 2013, ONCOGENIC POTENTIAL, P293; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Singh NN, 2008, J MOL MED, V86, P887, DOI 10.1007/s00109-008-0352-0; Skrzypczak M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013091; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; STALTER G, 1994, BIOCHEM BIOPH RES CO, V202, P141, DOI 10.1006/bbrc.1994.1904; Talbot SG, 2005, CANCER RES, V65, P3063, DOI 10.1158/0008-5472.CAN-04-1985; Tawfic S, 2001, HISTOL HISTOPATHOL, V16, P573, DOI 10.14670/HH-16.573; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Trembley J.H., 2013, CK2 SUPPRESSION APOP, P219; Trembley JH, 2010, BIOFACTORS, V36, P187, DOI 10.1002/biof.96; US Cancer Statistics Working Group, 2014, US CANC STAT 1999 20; Wallace TA, 2008, CANCER RES, V68, P927, DOI 10.1158/0008-5472.CAN-07-2608; Welsh JB, 2001, CANCER RES, V61, P5974; WHO, 2010, GLOB STAT REP NONC D; WIRKNER U, 1992, BIOCHIM BIOPHYS ACTA, V1131, P220, DOI 10.1016/0167-4781(92)90083-C; Xu X, 1999, MOL CELL BIOCHEM, V191, P65, DOI 10.1023/A:1006866412652; Yamagata N, 2003, CLIN CANCER RES, V9, P4695; Yaylim I, 2002, ANTICANCER RES, V22, P215; YENICE S, 1994, PROSTATE, V24, P11, DOI 10.1002/pros.2990240105; Yoshihara K, 2009, CANCER SCI, V100, P1421, DOI 10.1111/j.1349-7006.2009.01204.x; Zhang J., 2011, DATABASE J BIOL DATA; Zhao HJ, 2004, MOL BIOL CELL, V15, P2523, DOI 10.1091/mbc.E03-11-0786; Zou JJ, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-97	89	113	120	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115609	10.1371/journal.pone.0115609	http://dx.doi.org/10.1371/journal.pone.0115609			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541719	gold, Green Published, Green Submitted			2022-12-27	WOS:000347239900058
J	Schuldt, K; Ehmen, C; Evans, J; May, J; Ansong, D; Sievertsen, J; Muntau, B; Ruge, G; Agbenyega, T; Horstmann, RD				Schuldt, Kathrin; Ehmen, Christa; Evans, Jennifer; May, Juergen; Ansong, Daniel; Sievertsen, Juergen; Muntau, Birgit; Ruge, Gerd; Agbenyega, Tsiri; Horstmann, Rolf D.			Endothelial Protein C Receptor Gene Variants Not Associated with Severe Malaria in Ghanaian Children	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; PLASMA-LEVELS; EPCR GENE; PROCR; RISK; DISEASE; LOCI; POLYMORPHISMS; ORGANIZATION; COAGULATION	Background: Two recent reports have identified the Endothelial Protein C Receptor (EPCR) as a key molecule implicated in severe malaria pathology. First, it was shown that EPCR in the human microvasculature mediates sequestration of Plasmodium falciparum-infected erythrocytes. Second, microvascular thrombosis, one of the major processes causing cerebral malaria, was linked to a reduction in EPCR expression in cerebral endothelial layers. It was speculated that genetic variation affecting EPCR functionality could influence susceptibility to severe malaria phenotypes, rendering PROCR, the gene encoding EPCR, a promising candidate for an association study. Methods: Here, we performed an association study including high-resolution variant discovery of rare and frequent genetic variants in the PROCR gene. The study group, which previously has proven to be a valuable tool for studying the genetics of malaria, comprised 1,905 severe malaria cases aged 1-156 months and 1,866 apparently healthy children aged 2-161 months from the Ashanti Region in Ghana, West Africa, where malaria is highly endemic. Association of genetic variation with severe malaria phenotypes was examined on the basis of single variants, reconstructed haplotypes, and rare variant analyses. Results: A total of 41 genetic variants were detected in regulatory and coding regions of PROCR, 17 of which were previously unknown genetic variants. In association tests, none of the single variants, haplotypes or rare variants showed evidence for an association with severe malaria, cerebral malaria, or severe malaria anemia. Conclusion: Here we present the first analysis of genetic variation in the PROCR gene in the context of severe malaria in African subjects and show that genetic variation in the PROCR gene in our study population does not influence susceptibility to major severe malaria phenotypes.	[Schuldt, Kathrin; Ehmen, Christa; Evans, Jennifer; Sievertsen, Juergen; Muntau, Birgit; Ruge, Gerd; Horstmann, Rolf D.] Bernhard Nocht Inst Trop Med, Dept Mol Med, D-20359 Hamburg, Germany; [May, Juergen] Bernhard Nocht Inst Trop Med, Infect Dis Epidemiol Grp, D-20359 Hamburg, Germany; [Ansong, Daniel; Agbenyega, Tsiri] Kwame Nkrumah Univ Sci & Technol, Sch Med Sci, Kumasi, Ghana	Bernhard Nocht Institut fur Tropenmedizin; Bernhard Nocht Institut fur Tropenmedizin; Kwame Nkrumah University Science & Technology	Schuldt, K (corresponding author), Bernhard Nocht Inst Trop Med, Dept Mol Med, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.	schuldt@bnitm.de		ANSONG, Daniel/0000-0003-1328-9117; May, Jurgen/0000-0001-7831-8420	Bernhard Nocht Institute for Tropical Medicine (BNITM)	Bernhard Nocht Institute for Tropical Medicine (BNITM)	The study was funded by the Bernhard Nocht Institute for Tropical Medicine (BNITM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2014, BLOOD, V123, P163, DOI 10.1182/blood-2013-09-521005; Bongfen SE, 2009, TRENDS PARASITOL, V25, P417, DOI 10.1016/j.pt.2009.05.012; Bush WS, 2010, BIOINFORMATICS, V26, P578, DOI 10.1093/bioinformatics/btp678; Dennis J, 2012, BLOOD, V119, P2392, DOI 10.1182/blood-2011-10-383448; Esser C, 2014, CELL MICROBIOL, V16, P701, DOI 10.1111/cmi.12270; Gleeson EM, 2012, CELL MOL LIFE SCI, V69, P717, DOI 10.1007/s00018-011-0825-0; Hayashi T, 1999, GENE, V238, P367, DOI 10.1016/S0378-1119(99)00360-1; Kallel C, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-103; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Lavstsen T, 2012, P NATL ACAD SCI USA, V109, pE1791, DOI 10.1073/pnas.1120455109; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Maier AG, 2003, NAT MED, V9, P87, DOI 10.1038/nm807; May J, 2007, JAMA-J AM MED ASSOC, V297, P2220, DOI 10.1001/jama.297.20.2220; Medina P, 2004, THROMB HAEMOSTASIS, V91, P905, DOI 10.1160/TH03-10-0657; Mollica LR, 2006, BLOOD, V108, P1251, DOI 10.1182/blood-2006-02-001461; Mosnier LO, 2007, BLOOD, V109, P3161, DOI 10.1182/blood-2006-09-003004; Moxon CA, 2013, BLOOD, V122, P842, DOI 10.1182/blood-2013-03-490219; Naka I, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-105; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Pintao MC, 2011, J THROMB HAEMOST, V9, P969, DOI 10.1111/j.1538-7836.2011.04256.x; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reiner AP, 2008, J THROMB HAEMOST, V6, P1625, DOI 10.1111/j.1538-7836.2008.03118.x; San Lucas FA, 2012, BIOINFORMATICS, V28, P421, DOI 10.1093/bioinformatics/btr667; Saposnik B, 2004, BLOOD, V103, P1311, DOI 10.1182/blood-2003-07-2520; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Schuldt K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002066; Simmonds RE, 1999, BLOOD, V94, P632, DOI 10.1182/blood.V94.2.632.414k24_632_641; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Smith NL, 2010, CIRCULATION, V121, P1382, DOI 10.1161/CIRCULATIONAHA.109.869156; Tang WH, 2010, BLOOD, V116, P5032, DOI 10.1182/blood-2010-05-283739; Timmann C, 2012, NATURE, V489, P443, DOI 10.1038/nature11334; Turner L, 2013, NATURE, V498, P502, DOI 10.1038/nature12216	34	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115770	10.1371/journal.pone.0115770	http://dx.doi.org/10.1371/journal.pone.0115770			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541704	Green Published, gold, Green Submitted			2022-12-27	WOS:000347239900082
J	Soderlund, CA; Nelson, WM; Goff, SA				Soderlund, Carol A.; Nelson, William M.; Goff, Stephen A.			Allele Workbench: Transcriptome Pipeline and Interactive Graphics for Allele-Specific Expression	PLOS ONE			English	Article							RNA-SEQ DATA; GENE-EXPRESSION; SEQUENCING DATA; DIFFERENTIAL EXPRESSION; REFERENCE GENOME; VARIANTS; BIAS; ANNOTATION; GENERATION; FRAMEWORK	Sequencing the transcriptome can answer various questions such as determining the transcripts expressed in a given species for a specific tissue or condition, evaluating differential expression, discovering variants, and evaluating allele-specific expression. Differential expression evaluates the expression differences between different strains, tissues, and conditions. Allele-specific expression evaluates expression differences between parental alleles. Both differential expression and allele-specific expression have been studied for heterosis (hybrid vigor), where the hybrid has improved performance over the parents for one or more traits. The Allele Workbench software was developed for a heterosis study that evaluated allele-specific expression for a mouse F1 hybrid using libraries from multiple tissues with biological replicates. This software has been made into a distributable package, which includes a pipeline, a Java interface to build the database, and a Java interface for query and display of the results. The required input is a reference genome, annotation file, and one or more RNA-Seq libraries with optional replicates. It evaluates allelic imbalance at the SNP and transcript level and flags transcripts with significant opposite directional allele-specific expression. The Java interface allows the user to view data from libraries, replicates, genes, transcripts, exons, and variants, including queries on allele imbalance for selected libraries. To determine the impact of allele-specific SNPs on protein folding, variants are annotated with their effect (e.g., missense), and the parental protein sequences may be exported for protein folding analysis. The Allele Workbench processing results in transcript files and read counts that can be used as input to the previously published Transcriptome Computational Workbench, which has a new algorithm for determining a trimmed set of gene ontology terms. The software with demo files is available from https://code.google.com/p/alleleworkbench. Additionally, all software is ready for immediate use from an Atmosphere Virtual Machine Image available from the iPlant Collaborative (www.iplantcollaborative.org).	[Soderlund, Carol A.; Nelson, William M.] Univ Arizona, Inst BIO5, Tucson, AZ 85721 USA; [Goff, Stephen A.] Univ Arizona, iPlant Collaborat, Tucson, AZ USA	University of Arizona; University of Arizona	Soderlund, CA (corresponding author), Univ Arizona, Inst BIO5, Tucson, AZ 85721 USA.	cari@agcol.arizona.edu			National Science Foundation [DBI-1265383, IOS-1248090]; Division Of Integrative Organismal Systems [1248090] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation (http://www.nsf.gov) grants DBI-1265383 (PI SAG) and IOS-1248090 (PI SAG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anders S, 2014, HTSEQ PYTHON FRAMEWO, DOI [10.1101/ 002824, DOI 10.1101/002824, 10.1101/002824]; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Bell GDM, 2013, GENOME BIOL EVOL, V5, P1309, DOI 10.1093/gbe/evt072; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Degner JF, 2009, BIOINFORMATICS, V25, P3207, DOI 10.1093/bioinformatics/btp579; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fontanillas P, 2010, MOL ECOL, V19, P212, DOI 10.1111/j.1365-294X.2010.04472.x; Goff SA, 2011, NEW PHYTOL, V189, P923, DOI 10.1111/j.1469-8137.2010.03574.x; Goncalves A, 2011, BIOINFORMATICS, V27, P867, DOI 10.1093/bioinformatics/btr012; Graze RM, 2012, MOL BIOL EVOL, V29, P1521, DOI 10.1093/molbev/msr318; Guo M, 2006, THEOR APPL GENET, V113, P831, DOI 10.1007/s00122-006-0335-x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee WP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090581; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li G, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks280; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Marth G, 2012, ARXIV12073907V2; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Mooney S, 2005, BRIEF BIOINFORM, V6, P44, DOI 10.1093/bib/6.1.44; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Pandey RV, 2013, MOL ECOL RESOUR, V13, P740, DOI 10.1111/1755-0998.12110; Pastinen T, 2010, NAT REV GENET, V11, P533, DOI 10.1038/nrg2815; Perumbakkam S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-64; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Quinn A, 2014, BIOINFORMATICS, V30, P2603, DOI 10.1093/bioinformatics/btu342; Roberts A, 2013, NAT METHODS, V10, P71, DOI [10.1038/NMETH.2251, 10.1038/nmeth.2251]; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rozowsky J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.54; Satya RV, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks425; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Shabalina SA, 2013, NUCLEIC ACIDS RES, V41, P2073, DOI 10.1093/nar/gks1205; Shen YF, 2010, GENOME RES, V20, P273, DOI 10.1101/gr.096388.109; Skelly DA, 2011, GENOME RES, V21, P1728, DOI 10.1101/gr.119784.110; Smedley D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22; Soderlund C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069401; Stevenson KR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-536; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Turro E, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r13; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wei Xiaoxing, 2013, Genomics Proteomics & Bioinformatics, V11, P247, DOI 10.1016/j.gpb.2013.05.006; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Yalcin B, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r18; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Yu XQ, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-274; Zhai RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060668	58	7	7	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115740	10.1371/journal.pone.0115740	http://dx.doi.org/10.1371/journal.pone.0115740			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541944	gold, Green Published, Green Submitted			2022-12-27	WOS:000347239900074
J	Xie, XY; Yang, YF; Chi, Q; Li, ZP; Zhang, H; Li, Y; Yang, Y				Xie, Xiangyang; Yang, Yanfang; Chi, Qiang; Li, ZhiPing; Zhang, Hui; Li, Ying; Yang, Yang			Controlled Release of Dutasteride from Biodegradable Microspheres: In Vitro and In Vivo Studies	PLOS ONE			English	Article							BENIGN PROSTATIC HYPERPLASIA; BURST RELEASE; DRUG; OPTIMIZATION; FABRICATION; EFFICIENCY; DELIVERY; MODEL	The aim of the present work was to study the in vitro/in vivo characteristics of dutasteride loaded biodegradable microspheres designed for sustained release of dutasteride over four weeks. An O/W emulsion-solvent evaporation method was used to incorporate dutasteride, which is of interest in the treatment of benign prostatic hyperplasia (BPH), into poly(lactide-co-glycolide) (PLGA). A response surface method (RSM) with central composite design (CCD) was employed to optimize the formulation variables. A prolonged in vitro drug release profile was observed, with a complete release of the entrapped drug within 28 days. The pharmacokinetics study showed sustained plasma drug concentration-time profile of dutasteride loaded microspheres after subcutaneous injection into rats. The in vitro drug release in rats correlated well with the in vivo pharmacokinetics profile. The pharmacodynamics evaluated by determination of the BPH inhibition in the rat models also showed a prolonged pharmacological response. These results suggest the potential use of dutasteride loaded biodegradable microspheres for the management of BPH over long periods.	[Xie, Xiangyang; Yang, Yang] Guangzhou Mil Command, Wuhan Gen Hosp, Dept Pharm, Wuhan, Peoples R China; [Yang, Yanfang] Chinese Acad Med Sci, Inst Mat Med, Beijing Key Lab Drug Delivery Technol & Novel For, Beijing 100050, Peoples R China; [Yang, Yanfang] Peking Union Med Coll, Beijing 100021, Peoples R China; [Chi, Qiang] 215th Clin 406th Hosp, Chinese Peoples Liberat Army, Dept Pharm, Dalian, Peoples R China; [Li, ZhiPing; Zhang, Hui; Li, Ying; Yang, Yang] Beijing Inst Pharmacol & Toxicol, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Academy of Military Medical Sciences - China	Yang, Y (corresponding author), Guangzhou Mil Command, Wuhan Gen Hosp, Dept Pharm, Wuhan, Peoples R China.	xxysypu@163.com						Beak IH, 2012, CHEM PHARM BULL, V60, P1468, DOI 10.1248/cpb.c12-00563; Clark RV, 2004, J CLIN ENDOCR METAB, V89, P2179, DOI 10.1210/jc.2003-030330; Coimbra PA, 2008, J MICROENCAPSUL, V25, P170, DOI [10.1080/02652040701814140, 10.1080/02652040701814140 ]; Emberton M, 2003, UROLOGY, V61, P267, DOI 10.1016/S0090-4295(02)02371-3; Freitas S, 2005, J CONTROL RELEASE, V102, P313, DOI 10.1016/j.jconrel.2004.10.015; Govender S, 2005, INT J PHARMACEUT, V306, P24, DOI 10.1016/j.ijpharm.2005.07.026; Guo QL, 2004, BIOL PHARM BULL, V27, P333, DOI 10.1248/bpb.27.333; Hameed BH, 2008, J HAZARD MATER, V158, P324, DOI 10.1016/j.jhazmat.2008.01.088; Hassan AS, 2009, EUR J PHARM BIOPHARM, V73, P337, DOI 10.1016/j.ejpb.2009.07.009; Hickey T, 2002, BIOMATERIALS, V23, P1649, DOI 10.1016/S0142-9612(01)00291-5; Kim BK, 2002, J MICROENCAPSUL, V19, P811, DOI 10.1080/0265204021000022770; Mahmoudi M, 2009, J COLLOID INTERF SCI, V336, P510, DOI 10.1016/j.jcis.2009.04.046; NASLUND MJ, 1986, J UROLOGY, V136, P1136, DOI 10.1016/S0022-5347(17)45239-6; Qandil Amjad M., 2013, Journal of Pharmaceutical Investigation, V43, P171, DOI 10.1007/s40005-013-0065-4; Roehrborn CG, 2005, BJU INT, V96, P572, DOI 10.1111/j.1464-410X.2005.05686.x; Shi GX, 2002, POLYM ADVAN TECHNOL, V13, P227, DOI 10.1002/pat.178; Singh B, 2005, CRIT REV THER DRUG, V22, P215, DOI 10.1615/CritRevTherDrugCarrierSyst.v22.i3.10; Sun H, 2008, J ETHNOPHARMACOL, V115, P203, DOI 10.1016/j.jep.2007.09.026; Tatemichi S, 2006, J UROLOGY, V176, P1236, DOI 10.1016/j.juro.2006.04.029; Veloso AAS, 1997, INVEST OPHTH VIS SCI, V38, P665; Viswanathan NB, 1999, J CONTROL RELEASE, V58, P9, DOI 10.1016/S0168-3659(98)00140-0; WAGNER JG, 1963, J PHARM SCI, V52, P610, DOI 10.1002/jps.2600520629; Wang J, 2002, J CONTROL RELEASE, V82, P289, DOI 10.1016/S0168-3659(02)00137-2; Wu J, 2013, ACTA BIOMATER, V9, P7410, DOI 10.1016/j.actbio.2013.03.022; Wu XJ, 2014, UROLOGY, V83, P539, DOI 10.1016/j.urology.2013.10.007; Xie XY, 2015, PHARM DEV TECHNOL, V20, P633, DOI 10.3109/10837450.2014.892131; Yang Y, 2013, PHARM DEV TECHNOL, V18, P1169, DOI 10.3109/10837450.2011.618948; Yang Y, 2011, PHARMAZIE, V66, P694, DOI 10.1691/ph.2011.1007; Zolnik BS, 2008, J CONTROL RELEASE, V127, P137, DOI 10.1016/j.jconrel.2008.01.004	29	8	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e114835	10.1371/journal.pone.0114835	http://dx.doi.org/10.1371/journal.pone.0114835			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541985	Green Published, Green Submitted, gold			2022-12-27	WOS:000347239900014
J	Yadav, DK; Prasad, A; Kruk, J; Pospisil, P				Yadav, Deepak Kumar; Prasad, Ankush; Kruk, Jerzy; Pospisil, Pavel			Evidence for the Involvement of Loosely Bound Plastosemiquinones in Superoxide Anion Radical Production in Photosystem II	PLOS ONE			English	Article							PLASTOQUINONE-POOL; CYTOCHROME B(559); OXYGEN REDUCTION; ELECTRON-ACCEPTOR; MANGANESE COMPLEX; REDOX CHANGES; OXIDATION; QUINONE; EVOLUTION; CLUSTER	Recent evidence has indicated the presence of novel plastoquinone-binding sites, Q(C) and Q(D), in photosystem II (PSII). Here, we investigated the potential involvement of loosely bound plastosemiquinones in superoxide anion radical (O-2(-)) formation in spinach PSII membranes using electron paramagnetic resonance (EPR) spin-trapping spectroscopy. Illumination of PSII membranes in the presence of the spin trap EMPO (5-(ethoxycarbonyl)-5-methyl-1-pyrroline N-oxide) resulted in the formation of O-2(-), which was monitored by the appearance of EMPO-OOH adduct EPR signal. Addition of exogenous short-chain plastoquinone to PSII membranes markedly enhanced the EMPO-OOH adduct EPR signal. Both in the unsupplemented and plastoquinone-supplemented PSII membranes, the EMPO-OOH adduct EPR signal was suppressed by 50% when the urea-type herbicide DCMU (3-(3,4-dichlorophenyl)-1,1-dimethylurea) was bound at the Q(B) site. However, the EMPO-OOH adduct EPR signal was enhanced by binding of the phenolic-type herbicide dinoseb (2,4-dinitro-6-sec-butylphenol) at the Q(D) site. Both in the unsupplemented and plastoquinone-supplemented PSII membranes, DCMU and dinoseb inhibited photoreduction of the high-potential form of cytochrome b(559) (cyt b(559)). Based on these results, we propose that O-2(-) is formed via the reduction of molecular oxygen by plastosemiquinones formed through one-electron reduction of plastoquinone at the Q(B) site and one-electron oxidation of plastoquinol by cyt b(559) at the Q(C) site. On the contrary, the involvement of a plastosemiquinone formed via the one-electron oxidation of plastoquinol by cyt b(559) at the Q(D) site seems to be ambiguous. In spite of the fact that the existence of Q(C) and Q(D) sites is not generally accepted yet, the present study provided more spectroscopic data on the potential functional role of these new plastoquinone-binding sites.	[Yadav, Deepak Kumar; Prasad, Ankush; Pospisil, Pavel] Palacky Univ, Fac Sci, Ctr Reg Hana Biotechnol & Agr Res, Dept Biophys, CR-77147 Olomouc, Czech Republic; [Kruk, Jerzy] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Plant Physiol & Biochem, Krakow, Poland	Palacky University Olomouc; Jagiellonian University	Pospisil, P (corresponding author), Palacky Univ, Fac Sci, Ctr Reg Hana Biotechnol & Agr Res, Dept Biophys, CR-77147 Olomouc, Czech Republic.	pavel.pospisil@upol.cz	POSPÍŠIL, Pavel/AAH-4451-2019; Prasad, Ankush/G-6690-2011	POSPÍŠIL, Pavel/0000-0001-9126-2011; Prasad, Ankush/0000-0002-2009-8987; Yadav, Deepak Kumar/0000-0002-4555-3851	Ministry of Education, Youth and Sports of the Czech Republic [LO1204, CZ.1.07/2.3.00/20.0057, CZ.1.07/2.3.00/30.0041]	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	Funding: This work was supported by the Ministry of Education, Youth and Sports of the Czech Republic grants no. LO1204 (National Program of Sustainability I), no. CZ.1.07/2.3.00/20.0057 (Progress and Internationalization of Biophysical Research at the Faculty of Science, Palacky University) and no. CZ.1.07/2.3.00/30.0041 (Support for Building Excellent Research Teams and Intersectoral Mobility at Palacky University). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANANYEV G, 1994, PHOTOSYNTH RES, V41, P327, DOI 10.1007/BF00019410; Arato A, 2004, BBA-BIOENERGETICS, V1608, P171, DOI 10.1016/j.bbabio.2003.12.003; BERTHOLD DA, 1981, FEBS LETT, V134, P231, DOI 10.1016/0014-5793(81)80608-4; Bondarava N, 2010, PHYSIOL PLANTARUM, V138, P463, DOI 10.1111/j.1399-3054.2009.01312.x; Brudvig GW, 2008, PHILOS T R SOC B, V363, P1211, DOI 10.1098/rstb.2007.2217; Buchel C, 1999, P NATL ACAD SCI USA, V96, P14288, DOI 10.1073/pnas.96.25.14288; Cardona T, 2012, BBA-BIOENERGETICS, V1817, P26, DOI 10.1016/j.bbabio.2011.07.012; Cleland RE, 1999, FEBS LETT, V457, P348, DOI 10.1016/S0014-5793(99)01067-4; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; FORD RC, 1983, FEBS LETT, V160, P159, DOI 10.1016/0014-5793(83)80957-0; Frankel LK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058042; Frankel LK, 2012, BIOCHEMISTRY-US, V51, P6371, DOI 10.1021/bi300650n; Fufezan C, 2002, FEBS LETT, V532, P407, DOI 10.1016/S0014-5793(02)03724-9; Grundmeier A, 2012, BBA-BIOENERGETICS, V1817, P88, DOI 10.1016/j.bbabio.2011.07.004; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Hasegawa K, 2014, PHOTOSYNTH RES, V120, P113, DOI 10.1007/s11120-012-9787-9; HAUSKA G, 1983, BIOCHIM BIOPHYS ACTA, V726, P97, DOI 10.1016/0304-4173(83)90002-2; Ivanov B, 2007, FEBS LETT, V581, P1342, DOI 10.1016/j.febslet.2007.02.044; Kaminskaya O, 2007, BBA-BIOENERGETICS, V1767, P550, DOI 10.1016/j.bbabio.2007.02.005; Kaminskaya O, 2007, BIOCHEMISTRY-US, V46, P1091, DOI 10.1021/bi0613022; Kaminskaya OP, 2013, BBA-BIOENERGETICS, V1827, P471, DOI 10.1016/j.bbabio.2013.01.007; Kato Y, 2009, P NATL ACAD SCI USA, V106, P17365, DOI 10.1073/pnas.0905388106; Khorobrykh S, 2004, BBA-BIOENERGETICS, V1657, P164, DOI 10.1016/j.bbabio.2004.04.009; KLIMOV VV, 1979, DOKL AKAD NAUK SSSR+, V249, P227; KRIEGER A, 1995, BBA-BIOENERGETICS, V1229, P193, DOI 10.1016/0005-2728(95)00002-Z; Kruk J, 2001, J BIOL CHEM, V276, P86, DOI 10.1074/jbc.M003602200; Kruk J, 2006, BBA-BIOENERGETICS, V1757, P1669, DOI 10.1016/j.bbabio.2006.08.004; Lambreva MD, 2014, CURR PROTEIN PEPT SC, V15, P285, DOI 10.2174/1389203715666140327104802; Mubarakshina M, 2006, BBA-BIOENERGETICS, V1757, P1496, DOI 10.1016/j.bbabio.2006.09.004; Mubarakshina MM, 2010, PHYSIOL PLANTARUM, V140, P103, DOI 10.1111/j.1399-3054.2010.01391.x; Muh F, 2012, BBA-BIOENERGETICS, V1817, P44, DOI 10.1016/j.bbabio.2011.05.021; Pospisil P, 2004, BIOCHEMISTRY-US, V43, P6783, DOI 10.1021/bi036219i; Pospisil P, 2006, BIOCHEM J, V397, P321, DOI 10.1042/BJ20060068; Pospisil P, 2012, BBA-BIOENERGETICS, V1817, P218, DOI 10.1016/j.bbabio.2011.05.017; Pospisil P, 2011, J PHOTOCH PHOTOBIO B, V104, P341, DOI 10.1016/j.jphotobiol.2011.02.013; Pospisil P, 2009, BBA-BIOENERGETICS, V1787, P1151, DOI 10.1016/j.bbabio.2009.05.005; Rappaport F, 2008, COORDIN CHEM REV, V252, P259, DOI 10.1016/j.ccr.2007.07.016; Renger G, 2005, ADV PHOTO RESPIRAT, V22, P139; Shibamoto T, 2009, BIOCHEMISTRY-US, V48, P10682, DOI 10.1021/bi901691j; Sinha RK, 2010, J BIOENERG BIOMEMBR, V42, P337, DOI 10.1007/s10863-010-9299-2; Snyrychova I, 2006, PHOTOSYNTH RES, V88, P323, DOI 10.1007/s11120-006-9061-0; Tiwari A, 2009, BBA-BIOENERGETICS, V1787, P985, DOI 10.1016/j.bbabio.2009.03.017; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Vass I, 2012, BBA-BIOENERGETICS, V1817, P209, DOI 10.1016/j.bbabio.2011.04.014; WOOD PM, 1987, TRENDS BIOCHEM SCI, V12, P250, DOI 10.1016/0968-0004(87)90123-X; WYDRZYNSKI T, 1987, BIOCHIM BIOPHYS ACTA, V893, P33, DOI 10.1016/0005-2728(87)90145-9; Zhang H, 2000, FEBS LETT, V473, P58, DOI 10.1016/S0014-5793(00)01498-8; Zhang SP, 2003, PHOTOSYNTH RES, V75, P41, DOI 10.1023/A:1022439009587	48	17	17	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115466	10.1371/journal.pone.0115466	http://dx.doi.org/10.1371/journal.pone.0115466			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541694	Green Published, gold, Green Submitted			2022-12-27	WOS:000347239900046
J	El Farouki, K; Lagarde, E; Orriols, L; Bouvard, MP; Contrand, B; Galera, C				El Farouki, Kamal; Lagarde, Emmanuel; Orriols, Ludivine; Bouvard, Manuel-Pierre; Contrand, Benjamin; Galera, Cedric			The Increased Risk of Road Crashes in Attention Deficit Hyperactivity Disorder (ADHD) Adult Drivers: Driven by Distraction? Results from a Responsibility Case-Control Study	PLOS ONE			English	Article							DEFICIT/HYPERACTIVITY DISORDER; IMPAIRMENTS; DETERMINANTS; METAANALYSIS; MEDICATION; NETWORK; DRUGS; MIND	Background and Objective: Both distractions (external and internal) and attention-deficit/hyperactivity disorder (ADHD) are serious risk factors for traffic crashes and injuries. However, it is still unknown if ADHD (a chronic condition) modifies the effect of distractions (irregular hazards) on traffic crashes. The objective of this study was to assess the effects of distractions and ADHD on traffic crash responsibility. Methods: A responsibility case-control study was conducted in the adult emergency department of Bordeaux University Hospital, France. Subjects were recruited among drivers injured in a motor vehicle crash between April 2010 and August 2011. Responsibility levels were estimated using a standardized method. Frequencies of exposures were compared between drivers responsible and drivers not responsible for the crash. Independent risk factors were identified using a multivariate logistic regression including test interactions between distractions and ADHD. Results: A total of 777 subjects were included in the analysis. Factors associated with responsibility were distraction induced by an external event (adjusted OR (aOR) = 1.47; 95% confidence interval (CI) [1.06-2.05]), distraction induced by an internal thought (aOR=2.38; CI: [1.50-3.77]) and ADHD (aOR=2.18 CI: [1.22-3.88]). The combined effect of ADHD and external distractions was strongly associated with responsibility for the crash (aOR=5.79 CI: [2.06-16.32]). Interaction assessment showed that the attributable proportion due to the interaction among participants with both exposures was 68%. Discussion: Adults with ADHD are a population at higher risk of being responsible for a road traffic crash when exposed to external distractions. This result reinforces the need to diagnose adult ADHD and to include road safety awareness messages delivered by the physician. Developing advanced driver assistance systems devoted to the management of attention lapses is also increasingly relevant for these drivers.	[El Farouki, Kamal; Lagarde, Emmanuel; Orriols, Ludivine; Contrand, Benjamin; Galera, Cedric] Univ Bordeaux, ISPED, Ctr INSERM Epidemiol Biostat U897, Bordeaux, France; [El Farouki, Kamal; Lagarde, Emmanuel; Orriols, Ludivine; Contrand, Benjamin; Galera, Cedric] Ctr INSERM Epidemiol Biostat U897, INSERM, Equipe Prevent & Prise Charge Traumatismes, ISPED, Bordeaux, France; [Bouvard, Manuel-Pierre; Galera, Cedric] Univ Bordeaux, Charles Perrens Hosp, Dept Child & Adolescent Psychiat, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	El Farouki, K (corresponding author), Univ Bordeaux, ISPED, Ctr INSERM Epidemiol Biostat U897, Bordeaux, France.	kamalef@gmail.com	contrand, benjamin/T-1994-2019; Galera, Cedric/T-4896-2019; Lagarde, Emmanuel/F-7132-2013	Norton, William/0000-0002-3244-0145; GALERA, CEDRIC/0000-0003-0549-9608; Lagarde, Emmanuel/0000-0001-8031-7400	ANR (French National Research Agency) [ANR-09-VTT-04]	ANR (French National Research Agency)(French National Research Agency (ANR))	The research was supported by an ANR (French National Research Agency) grant (ANR-09-VTT-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler Lenard A, 2006, Ann Clin Psychiatry, V18, P145, DOI 10.1080/10401230600801077; [Anonymous], 2001, A5 U FLOR CTR RES PS; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Bakiri S, 2013, ACCIDENT ANAL PREV, V59, P588, DOI 10.1016/j.aap.2013.06.004; Barkley RA, 2004, PSYCHIAT CLIN N AM, V27, P233, DOI 10.1016/S0193-953X(03)00091-1; Barkley RA, 2007, J SAFETY RES, V38, P113, DOI 10.1016/j.jsr.2006.09.004; Chang Z, 2014, JAMA PSYCHIAT, V71, P319, DOI 10.1001/jamapsychiatry.2013.4174; Christoff K, 2012, BRAIN RES, V1428, P51, DOI 10.1016/j.brainres.2011.09.060; Galera C, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e8105; Horberry T, 2006, ACCIDENT ANAL PREV, V38, P185, DOI 10.1016/j.aap.2005.09.007; Hurts K., 2011, REV HUM FACTORS ERGO, V7, P3, DOI [DOI 10.1177/1557234X11410387, 10.1177/1557234X11410387]; Jerome Laurence, 2006, Curr Psychiatry Rep, V8, P416, DOI 10.1007/s11920-006-0045-8; Jerome L, 2006, J CAN ACAD CHILD ADO, V15, P105; Kessler RC, 2005, PSYCHOL MED, V35, P245, DOI 10.1017/S0033291704002892; Killingsworth MA, 2010, SCIENCE, V330, P932, DOI 10.1126/science.1192439; Klauer S.G., 2006, IMPACT DRIVER INATTE, DOI [10.1037/e729262011-001, DOI 10.1037/E729262011-001]; Kooij SJJ, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-67; Lara C, 2009, BIOL PSYCHIAT, V65, P46, DOI 10.1016/j.biopsych.2008.10.005; Laumon B, 2005, BRIT MED J, V331, P1371, DOI 10.1136/bmj.38648.617986.1F; Lee John, 2008, DRIVER DISTRACTION, P31, DOI 10.1201/9781420007497.ch3; Lowenstein SR, 2001, J TRAUMA, V50, P313, DOI 10.1097/00005373-200102000-00019; Martinussen R, 2005, J AM ACAD CHILD PSY, V44, P377, DOI 10.1097/01.chi.0000153228.72591.73; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Orriols L, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000366; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Ranney TA, 2008, 810787 DOT HS USDOT; Reimer B, 2010, ACCIDENT ANAL PREV, V42, P842, DOI 10.1016/j.aap.2009.06.021; Rescorla LA, 2004, MANUAL ASEBA OLDER A; Riccio CA, 2005, ARCH CLIN NEUROPSYCH, V20, P249, DOI 10.1016/j.acn.2004.07.005; ROBERTSON MD, 1994, ACCIDENT ANAL PREV, V26, P243, DOI 10.1016/0001-4575(94)90094-9; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Salmi LR, 2014, INJURY PREV, V20, P380, DOI 10.1136/injuryprev-2013-041143; Schooler JW, 2011, TRENDS COGN SCI, V15, P319, DOI 10.1016/j.tics.2011.05.006; Simon V, 2009, BRIT J PSYCHIAT, V194, P204, DOI 10.1192/bjp.bp.107.048827; Sobanski E, 2006, EUR ARCH PSY CLIN N, V256, P26, DOI 10.1007/s00406-006-1004-4; Solanto MV, 2010, AM J PSYCHIAT, V167, P958, DOI 10.1176/appi.ajp.2009.09081123; Staubach M, 2009, ACCIDENT ANAL PREV, V41, P1025, DOI 10.1016/j.aap.2009.06.014; Willcutt EG, 2005, BIOL PSYCHIAT, V57, P1336, DOI 10.1016/j.biopsych.2005.02.006; World Health Organization, 2013, GLOB STAT REP ROAD S; Young KL, 2013, ACCIDENT ANAL PREV, V58, P218, DOI 10.1016/j.aap.2012.06.001; Young KL, 2012, APPL ERGON, V43, P738, DOI 10.1016/j.apergo.2011.11.007; Zylowska L, 2008, J ATTEN DISORD, V11, P737, DOI 10.1177/1087054707308502	42	20	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115002	10.1371/journal.pone.0115002	http://dx.doi.org/10.1371/journal.pone.0115002			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ9UY	25536069	Green Submitted, Green Published, gold			2022-12-27	WOS:000348563300026
J	Howell, B; Lad, SP; Grill, WM				Howell, Bryan; Lad, Shivanand P.; Grill, Warren M.			Evaluation of Intradural Stimulation Efficiency and Selectivity in a Computational Model of Spinal Cord Stimulation	PLOS ONE			English	Article							LOW-BACK-PAIN; ELECTRICAL-CONDUCTIVITY; ELECTRODE GEOMETRY; DORSAL COLUMNS; FIBERS; LAMINECTOMY; MECHANISMS; TISSUE; IMPLANTATION; MORPHOMETRY	Spinal cord stimulation (SCS) is an alternative or adjunct therapy to treat chronic pain, a prevalent and clinically challenging condition. Although SCS has substantial clinical success, the therapy is still prone to failures, including lead breakage, lead migration, and poor pain relief. The goal of this study was to develop a computational model of SCS and use the model to compare activation of neural elements during intradural and extradural electrode placement. We constructed five patient-specific models of SCS. Stimulation thresholds predicted by the model were compared to stimulation thresholds measured intraoperatively, and we used these models to quantify the efficiency and selectivity of intradural and extradural SCS. Intradural placement dramatically increased stimulation efficiency and reduced the power required to stimulate the dorsal columns by more than 90%. Intradural placement also increased selectivity, allowing activation of a greater proportion of dorsal column fibers before spread of activation to dorsal root fibers, as well as more selective activation of individual dermatomes at different lateral deviations from the midline. Further, the results suggest that current electrode designs used for extradural SCS are not optimal for intradural SCS, and a novel azimuthal tripolar design increased stimulation selectivity, even beyond that achieved with an intradural paddle array. Increased stimulation efficiency is expected to increase the battery life of implantable pulse generators, increase the recharge interval of rechargeable implantable pulse generators, and potentially reduce stimulator volume. The greater selectivity of intradural stimulation may improve the success rate of SCS by mitigating the sensitivity of pain relief to malpositioning of the electrode. The outcome of this effort is a better quantitative understanding of how intradural electrode placement can potentially increase the selectivity and efficiency of SCS, which, in turn, provides predictions that can be tested in future clinical studies assessing the potential therapeutic benefits of intradural SCS.	[Howell, Bryan; Grill, Warren M.] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Grill, Warren M.] Duke Univ, Dept Elect & Comp Engn, Durham, NC 27706 USA; [Grill, Warren M.] Duke Univ, Dept Neurobiol, Durham, NC 27706 USA; [Lad, Shivanand P.; Grill, Warren M.] Duke Univ, Dept Surg, Durham, NC 27706 USA	Duke University; Duke University; Duke University; Duke University	Grill, WM (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.	warren.grill@duke.edu		Grill, Warren/0000-0001-5240-6588	NeuroAccess Technologies; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040894, F31NS079105] Funding Source: NIH RePORTER	NeuroAccess Technologies; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a research grant sponsored by NeuroAccess Technologies and two grants, a Ruth L. Kirschstein F31 NS079105 Predoctoral Fellowship and Grant R01 NS040894, from the National Institute of Neurological Disorders and Stroke of the National Institutes of Health. The funder provided support in the form of salaries for authors, BH and WMG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alo KM, 2002, NEUROSURGERY, V50, P690, DOI 10.1097/00006123-200204000-00003; Babu R, 2013, NEUROMODULATION, V16, P418, DOI 10.1111/ner.12065; BAROLAT G, 1991, STEREOT FUNCT NEUROS, V56, P77, DOI 10.1159/000099395; Baumann SB, 1997, IEEE T BIO-MED ENG, V44, P220, DOI 10.1109/10.554770; Bell GK, 1997, J PAIN SYMPTOM MANAG, V13, P286, DOI 10.1016/S0885-3924(96)00323-5; Bossetti CA, 2008, J NEURAL ENG, V5, P44, DOI 10.1088/1741-2560/5/1/005; Brumberg JC, 2000, J NEUROSCI, V20, P4829; Butson CR, 2005, CLIN NEUROPHYSIOL, V116, P2490, DOI 10.1016/j.clinph.2005.06.023; Cajal SRY, 1999, TEXTURE OF THE NERVOUS SYSTEM OF MAN AND THE VERTEBRATES, VOL I, P263; Cameron T, 2004, J NEUROSURG, V100, P254, DOI 10.3171/spi.2004.100.3.0254; Dagenais S, 2008, SPINE J, V8, P8, DOI 10.1016/j.spinee.2007.10.005; DAVIDOFF RA, 1989, NEUROLOGY, V39, P1377, DOI 10.1212/WNL.39.10.1377; Dimitrijevic M R, 1980, Int Rehabil Med, V2, P76; ELLIOTT HC, 1945, ANAT REC, V93, P287, DOI 10.1002/ar.1090930306; Feirabend HKP, 2002, BRAIN, V125, P1137, DOI 10.1093/brain/awf111; GIELEN FLH, 1984, MED BIOL ENG COMPUT, V22, P569, DOI 10.1007/BF02443872; GILAD I, 1985, J ANAT, V143, P115; Haggqvist G., 1936, Zeitschrift fuer Mikroskopisch-Anatomische Forschung, V39, P1; Holsheimer J, 2002, NEUROMODULATION, V5, P25, DOI 10.1046/j.1525-1403.2002._2005.x; Holsheimer J, 1997, MED BIOL ENG COMPUT, V35, P493, DOI 10.1007/BF02525529; HOLSHEIMER J, 1995, MED BIOL ENG COMPUT, V33, P676, DOI 10.1007/BF02510785; Holsheimer J, 1998, NEUROMODULATION, V1, P14, DOI 10.1111/j.1525-1403.1998.tb00026.x; Holsheimer J, 1995, ADV STER F, V11, P119; Howard MA, 2011, J APPL PHYS, V110, P1; Howell B, 2014, IEEE T BIO-MED ENG, V61, P297, DOI 10.1109/TBME.2013.2292025; Huang QJ, 2014, MED BIOL ENG COMPUT, V52, P531, DOI 10.1007/s11517-014-1157-7; Jackson A, 2006, SPINE, V31, P2783, DOI 10.1097/01.brs.0000245842.02717.1b; Ko HY, 2004, SPINAL CORD, V42, P35, DOI 10.1038/sj.sc.3101538; KOSTERICH JD, 1983, IEEE T BIO-MED ENG, V30, P81, DOI 10.1109/TBME.1983.325201; Kreis P.G., 2009, SPINAL CORD STIMULAT; Kumar K, 1998, SURG NEUROL, V50, P110, DOI 10.1016/S0090-3019(98)00012-3; Latikka J, 2001, PHYS MED BIOL, V46, P1611, DOI 10.1088/0031-9155/46/6/302; Long DM, 1998, SURG NEUROL, V49, P142, DOI 10.1016/S0090-3019(97)00227-9; Manola L, 2004, NEUROMODULATION, V7, P231, DOI 10.1111/j.1094-7159.2004.04207.x; McIntyre CC, 2002, J NEUROPHYSIOL, V87, P995, DOI 10.1152/jn.00353.2001; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; Miklavcic D., 2006, WILEY ENCY BIOMEDICA; NASHOLD B, 1972, EXP NEUROL, V36, P273, DOI 10.1016/0014-4886(72)90023-4; NORTH RB, 1993, NEUROSURGERY, V32, P384, DOI 10.1227/00006123-199303000-00008; North RB, 2002, NEUROSURGERY, V51, P381, DOI 10.1097/00006123-200208000-00015; Oakley JC, 2006, NEUROMODULATION, V9, P192, DOI 10.1111/j.1525-1403.2006.00060.x; OHNISHI A, 1976, J NEUROL SCI, V27, P163, DOI 10.1016/0022-510X(76)90058-7; Prescott SA, 2012, CURR OPIN NEUROBIOL, V22, P631, DOI 10.1016/j.conb.2012.02.010; RANCK JB, 1965, EXP NEUROL, V11, P451, DOI 10.1016/0014-4886(65)90059-2; RATTAY F, 1986, IEEE T BIO-MED ENG, V33, P974, DOI 10.1109/TBME.1986.325670; Renard VM, 2006, J NEUROSURG-SPINE, V4, P300, DOI 10.3171/spi.2006.4.4.300; Rosenow JM, 2006, J NEUROSURG-SPINE, V5, P183, DOI 10.3171/spi.2006.5.3.183; Sankarasubramanian V, 2011, J NEURAL ENG, V8, P1741; Sankarasubramanian V, 2013, NEUROSURGERY, V72, P483, DOI 10.1227/NEU.0b013e31827d0e12; Simpson Andrew K, 2006, Curr Pain Headache Rep, V10, P431, DOI 10.1007/s11916-006-0074-3; SMITH MC, 1984, BRAIN, V107, P671, DOI 10.1093/brain/107.3.671; Struijk J. J., 1993, IEEE Transactions on Rehabilitation Engineering, V1, P101, DOI 10.1109/86.242424; Struijk J J, 1998, IEEE Trans Rehabil Eng, V6, P277, DOI 10.1109/86.712224; STRUIJK JJ, 1993, IEEE T BIO-MED ENG, V40, P632, DOI 10.1109/10.237693; STRUIJK JJ, 1992, IEEE T BIO-MED ENG, V39, P903, DOI 10.1109/10.256423; Sweeney J. D., 1987, Proceedings of the Ninth Annual Conference of the IEEE Engineering in Medicine and Biology Society (Cat. No.87CH2513-0), P1577; Szarowski DH, 2003, BRAIN RES, V983, P23, DOI 10.1016/S0006-8993(03)03023-3; Taylor RS, 2014, PAIN PRACT, V14, P489, DOI 10.1111/papr.12095; Todd AJ, 2010, NAT REV NEUROSCI, V11, P823, DOI 10.1038/nrn2947; Tschirhart CE, 2007, J BIOMECH, V40, P46, DOI 10.1016/j.jbiomech.2005.11.014; Villavicencio AT, 2000, NEUROSURGERY, V46, P399, DOI 10.1097/00006123-200002000-00025; Walker BF, 2000, J SPINAL DISORD, V13, P205, DOI 10.1097/00002517-200006000-00003; Wei XF, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/046008; Wesselink WA, 1998, IEEE T BIO-MED ENG, V45, P1355, DOI 10.1109/10.725332; Zhang TC, 2014, J NEUROPHYS IN PRESS; Zhang THC, 2014, BRAIN RES, V1569, P19, DOI 10.1016/j.brainres.2014.04.039; Zheng JH, 2010, J PHYSIOL-LONDON, V588, P2065, DOI 10.1113/jphysiol.2010.188052	67	39	47	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e114938	10.1371/journal.pone.0114938	http://dx.doi.org/10.1371/journal.pone.0114938			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536035	Green Published, gold, Green Submitted			2022-12-27	WOS:000348563300025
J	Lilly, JL; Sheldon, PR; Hoversten, LJ; Romero, G; Balasubramaniam, V; Berron, BJ				Lilly, Jacob L.; Sheldon, Phillip R.; Hoversten, Liv J.; Romero, Gabriela; Balasubramaniam, Vivek; Berron, Brad J.			Interfacial Polymerization for Colorimetric Labeling of Protein Expression in Cells	PLOS ONE			English	Article							SIGNAL AMPLIFICATION; FILMS; SENSITIVITY	Determining the location of rare proteins in cells typically requires the use of on-sample amplification. Antibody based recognition and enzymatic amplification is used to produce large amounts of visible label at the site of protein expression, but these techniques suffer from the presence of nonspecific reactivity in the biological sample and from poor spatial control over the label. Polymerization based amplification is a recently developed alternative means of creating an on-sample amplification for fluorescence applications, while not suffering from endogenous labels or loss of signal localization. This manuscript builds upon polymerization based amplification by developing a stable, archivable, and colorimetric mode of amplification termed Polymer Dye Labeling. The basic concept involves an interfacial polymer grown at the site of protein expression and subsequent staining of this polymer with an appropriate dye. The dyes Evans Blue and eosin were initially investigated for colorimetric response in a microarray setting, where both specifically stained polymer films on glass. The process was translated to the staining of protein expression in human dermal fibroblast cells, and Polymer Dye Labeling was specific to regions consistent with desired protein expression. The labeling is stable for over 200 days in ambient conditions and is also compatible with modern mounting medium.	[Lilly, Jacob L.; Sheldon, Phillip R.; Romero, Gabriela; Berron, Brad J.] Univ Kentucky, Dept Chem & Mat Engn, Lexington, KY 40506 USA; [Hoversten, Liv J.; Balasubramaniam, Vivek] Univ Colorado, Dept Pediat, Denver, CO 80202 USA	University of Kentucky; University of Colorado System; University of Colorado Denver	Berron, BJ (corresponding author), Univ Kentucky, Dept Chem & Mat Engn, Lexington, KY 40506 USA.	brad.berron@uky.edu		Romero, Gabriela/0000-0001-8081-2946; Hoversten, Liv J./0000-0002-7732-6055	National Institute of Biomedical Imaging and Bioengineering [R21 EB012188]; National Science Foundation [CBET-1351531]; National Cancer Institute [R25CA153954]; NATIONAL CANCER INSTITUTE [R25CA153954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB012188] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Science Foundation(National Science Foundation (NSF)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the National Institute of Biomedical Imaging and Bioengineering (R21 EB012188), the National Science Foundation (CBET-1351531), and the National Cancer Institute (R25CA153954). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JC, 1992, J HISTOCHEM CYTOCHEM, V40, P1457, DOI 10.1177/40.10.1527370; Avens HJ, 2009, ABSTR PAP AM CHEM S, V237; Avens HJ, 2011, J HISTOCHEM CYTOCHEM, V59, P76, DOI 10.1369/jhc.2010.955948; Avens HJ, 2011, J NANOPART RES, V13, P331, DOI 10.1007/s11051-010-0034-z; Berron BJ, 2012, LAB CHIP, V12, P708, DOI 10.1039/c2lc21101g; Berron BJ, 2011, BIOTECHNOL BIOENG, V108, P1521, DOI 10.1002/bit.23101; Cruise GM, 1998, BIOTECHNOL BIOENG, V57, P655, DOI 10.1002/(SICI)1097-0290(19980320)57:6<655::AID-BIT3>3.0.CO;2-K; de Matos LL, 2010, BIOMARK INSIGHTS, V5, P9; Rojo MG, 2009, FOLIA HISTOCHEM CYTO, V47, P349, DOI 10.2478/v10042-008-0114-4; Hansen RR, 2008, ANAL BIOANAL CHEM, V392, P167, DOI 10.1007/s00216-008-2259-6; Hansen RR, 2008, BIOMACROMOLECULES, V9, P355, DOI 10.1021/bm700672z; Hansen RR, 2009, ANAL BIOCHEM, V386, P285, DOI 10.1016/j.ab.2008.12.009; Johnson LM, 2009, AUST J CHEM, V62, P877, DOI 10.1071/CH09095; Kaastrup K, 2013, ANAL CHEM, V85, P8055, DOI 10.1021/ac4018988; Kaastrup K, 2012, LAB CHIP, V12, P4055, DOI 10.1039/c2lc40584a; Khire VS, 2006, MACROMOLECULES, V39, P5081, DOI 10.1021/ma060073o; Lakowicz JR, 1983, PRINCIPLES FLUORESCE, P187, DOI 10.1007/978-1-4615-7658-7_7; Lee JK, 2012, BIOMACROMOLECULES, V13, P1136, DOI 10.1021/bm300037t; Lou XH, 2005, ANAL CHEM, V77, P4698, DOI 10.1021/ac050706h; Moss L, 2002, J DENT RES, V81; Okelo GO, 2007, BIOSENS BIOELECTRON, V23, P588, DOI 10.1016/j.bios.2007.06.011; Qian H, 2009, ANAL CHEM, V81, P9824, DOI 10.1021/ac900959v; Qian H, 2009, ANAL CHEM, V81, P4536, DOI 10.1021/ac900401m; Sikes HD, 2008, NAT MATER, V7, P52, DOI 10.1038/nmat2042; Sikes HD, 2009, LAB CHIP, V9, P653, DOI 10.1039/b816198d; Singh I, 2011, TXB HUMAN HISTOLOGY; Woo HY, 2005, J AM CHEM SOC, V127, P14721, DOI 10.1021/ja052906g; Wu YF, 2009, ANAL CHEM, V81, P7015, DOI 10.1021/ac9011254	28	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115630	10.1371/journal.pone.0115630	http://dx.doi.org/10.1371/journal.pone.0115630			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536421	Green Published, Green Submitted, gold			2022-12-27	WOS:000348563300057
J	Zhang, T; Yu, LX; McCord, P; Miller, D; Bhamidimarri, S; Johnson, D; Monteros, MJ; Ho, J; Reisen, P; Samac, DA				Zhang, Tiejun; Yu, Long-Xi; McCord, Per; Miller, David; Bhamidimarri, Suresh; Johnson, David; Monteros, Maria J.; Ho, Julie; Reisen, Peter; Samac, Deborah A.			Identification of Molecular Markers Associated with Verticillium Wilt Resistance in Alfalfa (Medicago Sativa L.) Using High-Resolution Melting	PLOS ONE			English	Article							LINKAGE MAPS; FORAGE YIELD; ALBO-ATRUM; GENETICS; MODEL; MICROSATELLITE; MECHANISMS; TRUNCATULA; CULTIVARS; QTL	Verticillium wilt, caused by the soilborne fungus, Verticillium alfalfae, is one of the most serious diseases of alfalfa (Medicago sativa L.) worldwide. To identify loci associated with resistance to Verticillium wilt, a bulk segregant analysis was conducted in susceptible or resistant pools constructed from 13 synthetic alfalfa populations, followed by association mapping in two F1 populations consisted of 352 individuals. Simple sequence repeat (SSR) and single nucleotide polymorphism (SNP) markers were used for genotyping. Phenotyping was done by manual inoculation of the pathogen to replicated cloned plants of each individual and disease severity was scored using a standard scale. Marker-trait association was analyzed by TASSEL. Seventeen SNP markers significantly associated with Verticillium wilt resistance were identified and they were located on chromosomes 1, 2, 4, 7 and 8. SNP markers identified on chromosomes 2, 4 and 7 co-locate with regions of Verticillium wilt resistance loci reported in M. truncatula. Additional markers identified on chromosomes 1 and 8 located the regions where no Verticillium resistance locus has been reported. This study highlights the value of SNP genotyping by high resolution melting to identify the disease resistance loci in tetraploid alfalfa. With further validation, the markers identified in this study could be used for improving resistance to Verticillium wilt in alfalfa breeding programs.	[Zhang, Tiejun; Yu, Long-Xi; McCord, Per] ARS, USDA, Prosser, WA 99350 USA; [Miller, David; Bhamidimarri, Suresh] DuPont Pioneer, Arlington, WI USA; [Johnson, David] Alforex Seeds, Salem, WI USA; [Monteros, Maria J.] Samuel Roberts Noble Fdn Inc, Forage Improvement Div, Ardmore, OK USA; [Ho, Julie; Reisen, Peter] Forage Genet Int Inc, Davis, CA USA; [Samac, Deborah A.] ARS, USDA, St Paul, MN USA	United States Department of Agriculture (USDA); Noble Research Institute; United States Department of Agriculture (USDA)	Yu, LX (corresponding author), ARS, USDA, 24106 N Bunn Rd, Prosser, WA 99350 USA.	Longxi.yu@ars.usda.gov	Samac, Deborah/ABC-8744-2021	Samac, Deborah/0000-0002-1847-0508; Monteros, Maria/0000-0002-6061-3883	USDA-ARS National Program [5354-21000-015-00D]; National Alfalfa and Forage Alliance	USDA-ARS National Program; National Alfalfa and Forage Alliance	This work was supported by USDA-ARS National Program Project No. 5354-21000-015-00D and by a grant from the National Alfalfa and Forage Alliance to L-X Yu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya SN, 2003, ADVANCES IN PLANT DISEASE MANAGEMENT, P345; Ben C, 2013, J EXP BOT, V64, P317, DOI 10.1093/jxb/ers337; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Brouwer DJ, 2000, CROP SCI, V40, P1387, DOI 10.2135/cropsci2000.4051387x; Cho MH, 2008, CLIN CHEM, V54, P2055, DOI 10.1373/clinchem.2008.109744; Croxford AE, 2008, NEW PHYTOL, V180, P594, DOI 10.1111/j.1469-8137.2008.02588.x; D'hoop BB, 2010, THEOR APPL GENET, V121, P1151, DOI 10.1007/s00122-010-1379-5; De Koeyer D, 2010, MOL BREEDING, V25, P67, DOI 10.1007/s11032-009-9309-4; Garritano S, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-5; GRAU CR, 1991, PLANT DIS, V75, P82, DOI 10.1094/PD-75-0082; Grau CR, 1991, STANDARD TESTS CHARA; Gupta PK, 1999, PLANT BREEDING, V118, P369, DOI 10.1046/j.1439-0523.1999.00401.x; Han Y., 2011, BMC GENOMICS, V12, P350, DOI DOI 10.1186/1471-2164-12-350; Han YH, 2012, MOL BREEDING, V29, P489, DOI 10.1007/s11032-011-9566-x; Heffner EL, 2009, CROP SCI, V49, P1, DOI 10.2135/cropsci2008.08.0512; Huang HC, 2003, CAN J PLANT PATHOL, V25, P328; HUANG HC, 1985, PHYTOPATHOLOGY, V75, P482, DOI 10.1094/Phyto-75-482; Inderbitzin P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028341; Julier Bernadette, 2003, BMC Plant Biology, V3, P9, DOI 10.1186/1471-2229-3-9; Knepper Caleb, 2010, Arabidopsis Book, V8, pe012, DOI 10.1199/tab.0124; Kwok Pui-Yan, 2003, Current Issues in Molecular Biology, V5, P43; Larsen RC, 2007, PHYTOPATHOLOGY, V97, P1519, DOI 10.1094/PHYTO-97-11-1519; Leath K. T., 1988, Alfalfa and alfalfa improvement., P621; Li XH, 2012, AGRONOMY-BASEL, V2, P40, DOI 10.3390/agronomy2010040; Mackie JM, 2007, THEOR APPL GENET, V114, P1417, DOI 10.1007/s00122-007-0527-z; Malosetti M, 2007, GENETICS, V175, P879, DOI 10.1534/genetics.105.054932; McDonald BA, 2002, ANNU REV PHYTOPATHOL, V40, P349, DOI 10.1146/annurev.phyto.40.120501.101443; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; MILLER PR, 1991, CROP SCI, V31, P1492, DOI 10.2135/cropsci1991.0011183X003100060019x; Musial JM, 2007, THEOR APPL GENET, V114, P1427, DOI 10.1007/s00122-007-0528-y; Papadopoulos YA, 1987, THESIS U GUELPH GUEL; Pennypacker BW, 2000, PHYSIOL MOL PLANT P, V57, P87, DOI 10.1006/pmpp.2000.0284; Rampling LR, 2001, AUST J AGR RES, V52, P1131, DOI 10.1071/AR01027; Reed GH, 2004, CLIN CHEM, V50, P1748, DOI 10.1373/clinchem.2003.029751; Robins JG, 2007, CROP SCI, V47, P11, DOI 10.2135/cropsci2006.07.0447; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Smith EG, 1995, AGRON J, V87, P1206, DOI 10.2134/agronj1995.00021962008700060028x; Studer B, 2009, MOL BREEDING, V24, P191, DOI 10.1007/s11032-009-9291-x; VIANDS DR, 1985, CROP SCI, V25, P1096, DOI 10.2135/cropsci1985.0011183X002500060047x; VIANDS DR, 1992, J PROD AGRIC, V5, P504, DOI 10.2134/jpa1992.0504; Yang SS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-199; Yang SM, 2008, P NATL ACAD SCI USA, V105, P12164, DOI 10.1073/pnas.0802518105; Zhu HY, 2005, PLANT PHYSIOL, V137, P1189, DOI 10.1104/pp.104.058891	43	16	17	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115953	10.1371/journal.pone.0115953	http://dx.doi.org/10.1371/journal.pone.0115953			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536106	Green Published, Green Submitted, gold			2022-12-27	WOS:000348563300092
J	Huynh, FC; Jones, FE				Huynh, Felicia C.; Jones, Frank E.			MicroRNA-7 Inhibits Multiple Oncogenic Pathways to Suppress HER2 Delta 16 Mediated Breast Tumorigenesis and Reverse Trastuzumab Resistance	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; GENE-EXPRESSION; CANCER-CELLS; HER2; SRC; PROTEIN	The oncogenic isoform of HER2, HER2 Delta 16, is expressed with HER2 in nearly 50% of HER2 positive breast tumors where HER2 Delta 16 drives metastasis and resistance to multiple therapeutic interventions including tamoxifen and trastuzumab. In recent years microRNAs have been shown to influence multiple aspects of tumorigenesis and tumor cell response to therapy. Accordingly, the HER2 Delta 16 oncogene alters microRNA expression to promote endocrine resistance. With the goal of identifying microRNA suppressors of HER2 Delta 16 oncogenic activity we investigated the contribution of altered microRNA expression to HER2 Delta 16 mediated tumorigenesis and trastuzumab resistance. Using a gene array strategy comparing microRNA expression profiles of MCF-7 to MCF-7/HER2 Delta 16 cells, we found that expression of HER2 Delta 16 significantly altered expression of 16 microRNAs by 2-fold or more including a 4.8 fold suppression of the miR-7 tumor suppressor. Reestablished expression of miR-7 in the MCF-7/HER2 Delta 16 cell line caused a G1 cell cycle arrest and reduced both colony formation and cell migration activity to levels of parental MCF-7 cells. Suppression of miR-7 in the MCF-7 cell line resulted in enhanced colony formation activity but not cell migration, indicating that miR-7 suppression is sufficient to drive tumor cell proliferation but not migration. MiR-7 inhibited MCF-7/HER2 Delta 16 Delta cell migration through a mechanism involving suppression of the miR-7 target gene EGFR. In contrast, miR-7 inhibition of MCF-7/HER2 Delta 16 cell proliferation involved a pathway where miR-7 expression resulted in the inactivation of Src kinase independent of suppressed EGFR expression. Also independent of EGFR suppression, reestablished miR-7 expression sensitized refractory MCF-7/HER2 Delta 16 cells to trastuzumab. Our results demonstrate that reestablished miR-7 expression abolishes HER2 Delta 16 induced cell proliferation and migration while sensitizing HER2 Delta 16 expressing cells to trastuzumab therapy. We propose that miR-7 regulated pathways, including EGFR and Src kinase, represent targets for the therapeutic intervention of refractory and metastatic HER2 Delta 16 driven breast cancer.	[Huynh, Felicia C.] Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA; [Jones, Frank E.] Tulane Univ, Tulane Canc Ctr, Dept Cell & Mol Biol, New Orleans, LA 70118 USA	Tulane University; Tulane University	Jones, FE (corresponding author), Tulane Univ, Tulane Canc Ctr, Dept Cell & Mol Biol, New Orleans, LA 70118 USA.	fjones3@tulane.edu						Arteaga CL, 2012, NAT REV CLIN ONCOL, V9, P16, DOI 10.1038/nrclinonc.2011.177; Barrett A, 2002, INT J CANCER, V101, P581, DOI 10.1002/ijc.10644; Barrett A, 2007, INT J CANCER, V121, P265, DOI 10.1002/ijc.22673; Cittelly DM, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-317; Cittelly DM, 2010, ONCOGENIC HER2DELTA1; DiGiovanna MP, 2005, J CLIN ONCOL, V23, P1152, DOI 10.1200/JCO.2005.09.055; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Jiang L, 2010, BIOCHEM J, V432, P199, DOI 10.1042/BJ20100859; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Kong XB, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041523, 10.1371/journal.pone.0033381]; Mitra D., 2010, J BIOL CHEM, V286, P40531; Mitra D, 2009, MOL CANCER THER, V8, P2152, DOI 10.1158/1535-7163.MCT-09-0295; Naresh A, 2008, CANCER RES, V68, P6387, DOI 10.1158/0008-5472.CAN-08-0538; Okuda H, 2013, CANCER RES, V73, P1434, DOI 10.1158/0008-5472.CAN-12-2037; Pencheva N, 2013, NAT CELL BIOL, V15, P546, DOI 10.1038/ncb2769; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Playford MP, 2004, ONCOGENE, V23, P7928, DOI 10.1038/sj.onc.1208080; Reddy SDN, 2008, CANCER RES, V68, P8195, DOI 10.1158/0008-5472.CAN-08-2103; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Sanchez N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065671; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sridhar J, 2014, BIOORG MED CHEM LETT, V24, P126, DOI 10.1016/j.bmcl.2013.11.064; Thor AD, 2000, J CLIN ONCOL, V18, P3230, DOI 10.1200/JCO.2000.18.18.3230; Verghese ET, 2008, J PATHOL, V215, P214, DOI 10.1002/path.2359; Wang H, 2012, PLOS ONE, V7, P34210, DOI DOI 10.1371/J0URNAL.P0NE.0034210; Webster RJ, 2009, J BIOL CHEM, V284, P5731, DOI 10.1074/jbc.M804280200; Yamamoto S, 2014, CANCER CELL, V25, P762, DOI 10.1016/j.ccr.2014.04.024; Zhang SY, 2011, NAT MED, V17, P461, DOI 10.1038/nm.2309; Zhou M, 2010, J BIOL CHEM, V285, P21496, DOI 10.1074/jbc.M109.083337	32	42	45	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e114419	10.1371/journal.pone.0114419	http://dx.doi.org/10.1371/journal.pone.0114419			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25532106	Green Published, Green Submitted, gold			2022-12-27	WOS:000348845100015
J	Qian, JJ; Yang, J; Xu, Y				Qian, Jianjun; Yang, Jian; Xu, Yong			General Regression and Representation Model for Classification	PLOS ONE			English	Article							ROBUST FACE RECOGNITION; SPARSE REPRESENTATION; IMAGE	Recently, the regularized coding-based classification methods (e.g. SRC and CRC) show a great potential for pattern classification. However, most existing coding methods assume that the representation residuals are uncorrelated. In real-world applications, this assumption does not hold. In this paper, we take account of the correlations of the representation residuals and develop a general regression and representation model (GRR) for classification. GRR not only has advantages of CRC, but also takes full use of the prior information (e.g. the correlations between representation residuals and representation coefficients) and the specific information (weight matrix of image pixels) to enhance the classification performance. GRR uses the generalized Tikhonov regularization and K Nearest Neighbors to learn the prior information from the training data. Meanwhile, the specific information is obtained by using an iterative algorithm to update the feature (or image pixel) weights of the test sample. With the proposed model as a platform, we design two classifiers: basic general regression and representation classifier (B-GRR) and robust general regression and representation classifier (R-GRR). The experimental results demonstrate the performance advantages of proposed methods over state-of-the-art algorithms.	[Qian, Jianjun; Yang, Jian] Nanjing Univ Sci & Technol, Sch Comp Sci & Engn, Nanjing 210094, Jiangsu, Peoples R China; [Xu, Yong] Harbin Inst Technol, Shenzhen Grad Sch, Biocomp Res Ctr, Shenzhen 518055, Peoples R China	Nanjing University of Science & Technology; Harbin Institute of Technology; University Town of Shenzhen	Yang, J (corresponding author), Nanjing Univ Sci & Technol, Sch Comp Sci & Engn, Nanjing 210094, Jiangsu, Peoples R China.	csjyang@njust.edu.cn			National Science Fund for Distinguished Young Scholars [61125305, 61472187, 61233011, 61373063]; Key Project of Chinese Ministry of Education [313030]; 973 Program [2014CB349303]; Fundamental Research Funds for the Central Universities [30920140121005]; Program for Changjiang Scholars and Innovative Research Team in University [IRT13072]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Key Project of Chinese Ministry of Education(Ministry of Education, China); 973 Program(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was partially supported by the National Science Fund for Distinguished Young Scholars under Grant Nos. 61125305, 61472187, 61233011 and 61373063, the Key Project of Chinese Ministry of Education under Grant No. 313030, the 973 Program No. 2014CB349303, Fundamental Research Funds for the Central Universities No. 30920140121005, and Program for Changjiang Scholars and Innovative Research Team in University No. IRT13072. The funders had no role in study design, data collection and analysis or preparation of the manuscript.	Chien JT, 2002, IEEE T PATTERN ANAL, V24, P1644, DOI 10.1109/TPAMI.2002.1114855; De Maesschalck R, 2000, CHEMOMETR INTELL LAB, V50, P1, DOI 10.1016/S0169-7439(99)00047-7; Deng ZH, 2014, IEEE T CYBERNETICS, V44, P2585, DOI 10.1109/TCYB.2014.2311014; Deng ZH, 2011, IEEE T FUZZY SYST, V19, P210, DOI 10.1109/TFUZZ.2010.2091961; Gao SH, 2013, IEEE T IMAGE PROCESS, V22, P423, DOI 10.1109/TIP.2012.2215620; He R, 2010, 24 AAAI C ART INT AA; He R., 2012, CVPR; He R, 2014, IEEE T PATTERN ANAL, V36, P261, DOI 10.1109/TPAMI.2013.102; He R, 2011, NEURAL COMPUT, V23, P2074, DOI 10.1162/NECO_a_00155; He R, 2011, IEEE T PATTERN ANAL, V33, P1561, DOI 10.1109/TPAMI.2010.220; Kariya T, 2004, GEN LEAST SQUARES; Kim SJ, 2007, IEEE J-STSP, V1, P606, DOI 10.1109/JSTSP.2007.910971; Kuan CM, 2004, STAT CONCEPTS METHOD; Laaksonen J, 1997, P INT C ART NEUR NET, P637; Lee KC, 2005, IEEE T PATTERN ANAL, V27, P684, DOI 10.1109/TPAMI.2005.92; Li SZ, 1999, IEEE T NEURAL NETWOR, V10, P439, DOI 10.1109/72.750575; LI SZ, 1998, COMP VIS PATT REC 19, P839; Li XX, 2013, IEEE T IMAGE PROCESS, V22, P1889, DOI 10.1109/TIP.2013.2237920; Liao SX, 1996, IEEE T PATTERN ANAL, V18, P254, DOI 10.1109/34.485554; Mairal J, 2008, MULTISCALE MODEL SIM, V7, P214, DOI 10.1137/070697653; Martinez A., 1998, AR FACE DATABASE CVC; Naseem I, 2010, IEEE T PATTERN ANAL, V32, P2106, DOI 10.1109/TPAMI.2010.128; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Ou WH, 2014, PATTERN RECOGN, V47, P1559, DOI 10.1016/j.patcog.2013.10.017; Pan SJ, 2010, IEEE T KNOWL DATA EN, V22, P1345, DOI 10.1109/TKDE.2009.191; Qian J, 2013, BIOM WORKSH CONJ CVP; Rigamonti R., 2011, CVPR; Serre T., 2006, THESIS MIT; Shi Q., 2011, CVPR; Theodorakopoulos I, 2013, LECT NOTES COMPUT SC, V8033, P496, DOI 10.1007/978-3-642-41914-0_49; Theodorakopoulos I, 2011, IEEE I CONF COMP VIS, P1647, DOI 10.1109/ICCV.2011.6126426; Tikhonov AN, 1995, NUMERICAL METHODS SO, DOI DOI 10.1007/978-94-015-8480-7; Tseng YH, 1998, PATTERN RECOGN, V31, P1601, DOI 10.1016/S0031-3203(98)00043-0; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Wright J, 2010, P IEEE, V98, P1031, DOI 10.1109/JPROC.2010.2044470; Wright J, 2009, IEEE T PATTERN ANAL, V31, P210, DOI 10.1109/TPAMI.2008.79; Xu Y, 2013, INFORM SCIENCES, V238, P138, DOI 10.1016/j.ins.2013.02.051; Xu Y, 2013, PATTERN RECOGN, V46, P1151, DOI 10.1016/j.patcog.2012.11.003; Yang J., 2009, CVPR; Yang J. C., 2008, CVPR; Yang J, 2012, PATTERN RECOGN, V45, P1104, DOI 10.1016/j.patcog.2011.08.022; Yang M., 2011, CVPR; Yang M., 2012, CVPR; Yang M., 2010, ECCV; Yang M, 2013, PATTERN RECOGN, V46, P1865, DOI 10.1016/j.patcog.2012.06.022; Yang M, 2013, IEEE T IMAGE PROCESS, V22, P1753, DOI 10.1109/TIP.2012.2235849; Zhang B, 2012, INFORM SCIENCES, V200, P78, DOI 10.1016/j.ins.2012.03.003; Zhang L., 2011, ICCV; Zhang Y., 2013, ICCV; Zhou H., 2004, TECHNICAL REPORT; Zhou Z., 2009, ICCV	51	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115214	10.1371/journal.pone.0115214	http://dx.doi.org/10.1371/journal.pone.0115214			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531882	Green Published, gold, Green Submitted			2022-12-27	WOS:000348845100043
J	Ning, XJ; Zhan, CQ; Yang, YH; Yang, L; Tu, J; Gu, HF; Su, TC; Wang, JH				Ning, Xianjia; Zhan, Changqing; Yang, Yihe; Yang, Li; Tu, Jun; Gu, Hongfei; Su, Ta-Chen; Wang, Jinghua			Secular Trends in Prevalence of Overweight and Obesity among Adults in Rural Tianjin, China from 1991 to 2011: A Population-Based Study	PLOS ONE			English	Article							BODY-MASS INDEX; ALL-CAUSE MORTALITY; AGED FINNISH MEN; PHYSICAL-ACTIVITY; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; RISK-FACTORS; US ADULTS; HYPERTENSION; PREVENTION	Objectives: Obesity is associated with cardiovascular diseases and has become the main public health issue in western countries and urban China. However, the prevalence and secular trends of obesity in rural China are currently unknown. The aim of this study was to investigate secular trends in the prevalence of overweight and obesity among rural adults in northern China between 1991 and 2011. Method: The prevalence of overweight and obesity was assessed in adults aged 35-74 years living in a rural area in northern China by comparing two surveys that were conducted in 1991 and 2011, respectively. Result: The age-adjusted prevalence of overweight increased from 24.5% in 1991 to 42.0% in 2011, and the prevalence of obesity increased from 5.7% in 1991 to 19.6% in 2011. Over the 21-year period, there were significant increases in the prevalence of overweight and obesity for both men and women in all age groups; however, the greatest increase was observed in men aged 35-44 years, with an 10.3-fold increase in obesity prevalence. The prevalence of obesity increased significantly in all risk factors categories, including education levels, blood pressure categories, diabetes previous history, current smoking situation and alcohol drinking situation over the past 21 years overall (p<0.05). The greatest increase in obesity prevalence appeared among those who consumed alcohol (increased by 8.0-fold). Next, there was a 5.3-fold increase in the prevalence of obesity in illiterate residents. Conclusion: The prevalence of overweight and obesity has increased rapidly among rural adults in Tianjin over the past 21 years, with the most dramatic increase observed in young men. Therefore, the burden of obesity should serve as a call for action.	[Ning, Xianjia; Zhan, Changqing; Tu, Jun; Wang, Jinghua] Tianjin Neurol Inst, Dept Epidemiol, Tianjin, Peoples R China; [Ning, Xianjia; Zhan, Changqing; Yang, Li; Tu, Jun; Wang, Jinghua] Tianjin Med Univ, Gen Hosp, Dept Neurol, Tianjin, Peoples R China; [Yang, Yihe] Northwestern Univ, Feinberg Sch Med, Dept Publ Hlth, Chicago, IL 60611 USA; [Gu, Hongfei] Tianjin Dagang Oilfield Gen Hosp, Dept Neurol, Tianjin, Peoples R China; [Su, Ta-Chen] Natl Taiwan Univ Hosp, Ctr Cardiovasc, Taipei, Taiwan; [Su, Ta-Chen] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan	Tianjin Medical University; Chicago Department of Public Health; Northwestern University; Feinberg School of Medicine; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Ning, XJ (corresponding author), Tianjin Neurol Inst, Dept Epidemiol, Tianjin, Peoples R China.	xjn0906@gmail.com; jhw8799@yahoo.com		SU, TA-CHEN/0000-0001-7523-7166	Tianjin Medical University General Hospital; People's Republic of China Ministry of Science and Technology; Ministry of Health through the 7th, 8th, and 10th National Five-Year Key Research Plan [85-915-01-01, 85-91501-02, 2001BA703B01]	Tianjin Medical University General Hospital; People's Republic of China Ministry of Science and Technology; Ministry of Health through the 7th, 8th, and 10th National Five-Year Key Research Plan	This study was supported in part by Tianjin Medical University General Hospital, and the People's Republic of China Ministry of Science and Technology and the Ministry of Health through the 7th, 8th, and 10th National Five-Year Key Research Plan (contracts 85-915-01-01, 85-91501-02, and 2001BA703B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad OB, 2001, GPE DISCUSSION PAPER, V31, P1; Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Arnett DK, 2002, AM J EPIDEMIOL, V156, P929, DOI 10.1093/aje/kwf133; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Gu Dongfeng, 2002, Zhonghua Yi Xue Za Zhi, V82, P1018; Hu G, 2004, ARCH INTERN MED, V164, P892, DOI 10.1001/archinte.164.8.892; Hu G, 2004, EUR HEART J, V25, P2212, DOI 10.1016/j.ehj.2004.10.020; Hu G, 2004, HYPERTENSION, V43, P25, DOI 10.1161/01.HYP.0000107400.72456.19; Hu G, 2005, INT J OBESITY, V29, P894, DOI 10.1038/sj.ijo.0802870; James PT, 2004, CLIN DERMATOL, V22, P276, DOI 10.1016/j.clindermatol.2004.01.010; James PT, 2004, EUR J CARDIOV PREV R, V11, P3, DOI 10.1097/01.hjr.0000114707.27531.48; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Lu Y, 2014, LANCET, V383, P970, DOI 10.1016/S0140-6736(13)61836-X; Malta Deborah Carvalho, 2014, Rev. bras. epidemiol., V17, P267, DOI 10.1590/1809-4503201400050021; Ministries of Health and Science and Technology and the National Bureau of Statistics of the Peoples Republic of China, 2004, NUTR HLTH STAT CHIN; Ng M, 2014, LANCET, V6736, P604; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Panagiotakos DB, 2004, OBES RES, V12, P1914, DOI 10.1038/oby.2004.239; Reynolds K, 2007, OBESITY, V15, P10, DOI 10.1038/oby.2007.527; Singh GP, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064893, 10.1371/journal.pone.0065174]; Song Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053069; Sun XR, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0096503, 10.1371/journal.pone.0105469, 10.1371/journal.pone.0091068]; von Ruesten A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027455; Wang J, 2014, J HUM HYPERTENS, V28, P25, DOI 10.1038/jhh.2013.44; Wang JH, 2014, STROKE, V45, P1626, DOI 10.1161/STROKEAHA.113.003899; Wang Jinghua, 2014, NEUROLOGY IN PRESS; Wang LD, 2005, LANCET, V366, P1821, DOI 10.1016/S0140-6736(05)67344-8; Wang YC, 2007, OBESITY, V15, P2855, DOI 10.1038/oby.2007.339; Wang YF, 2008, OBESITY, V16, P2323, DOI 10.1038/oby.2008.351; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; World Health Organization, 2000, WHO TECHN REP SER, V894, DOI DOI 10.1007/978-0-387-71799-9_454; Wormser D, 2011, LANCET, V377, P1085, DOI 10.1016/S0140-6736(11)60105-0; Yang X.G., 2005, P INT S NEW ADV NUTR, V8, P9; Zaninotto P, 2009, J EPIDEMIOL COMMUN H, V63, P140, DOI 10.1136/jech.2008.077305; Zhang XG, 2008, OBESITY, V16, P168, DOI 10.1038/oby.2007.43; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P245	40	23	23	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e116019	10.1371/journal.pone.0116019	http://dx.doi.org/10.1371/journal.pone.0116019			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25544990	Green Published, Green Submitted, gold			2022-12-27	WOS:000347120200089
J	Chen, GH; Li, WS; Tzekov, R; Jiang, FZ; Mao, SH; Tong, YH				Chen, Guohai; Li, Wensheng; Tzekov, Radouil; Jiang, Fangzheng; Mao, Sihong; Tong, Yuhua			Ranibizumab Monotherapy or Combined with Laser versus Laser Monotherapy for Diabetic Macular Edema: A Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PLUS PROMPT LASER; DEFERRED LASER; INTRAVITREAL RANIBIZUMAB; SYSTEMIC SAFETY; TRIAMCINOLONE; RESTORE; EFFICACY	Objective: To evaluate the relative efficacy of ranibizumab (RBZ) monotherapy or combined with laser (RBZ + Laser) versus laser monotherapy for the treatment of diabetic macular edema (DME). Methods: A comprehensive literature search using PUBMED, ClinicalTrials.gov, and the Cochrane Library to identify randomized controlled trials (RCTs) comparing RBZ or RBZ + Laser to laser monotherapy in patients with DME. Efficacy estimates were determined by comparing weighted mean differences (WMD) in the change of best corrected visual acuity (BCVA) and central macular thickness (CMT) from baseline, and the risk ratios (RR) for the proportions of patients with at least 15 letters change from baseline. Safety analysis estimated the RR of cardiac disorders at 6 to 12 months in RBZ therapy vs. laser monotherapy. Statistical analysis was performed using the RevMan 5.1 software. Results: Seven RCTs were selected for this meta-analysis, including 1749 patients (394 patients in the RBZ group 642 patients in the RBZ + Laser group and 713 patients in the laser group). RBZ and RBZ + Laser were superior to laser monotherapy in the mean change of BCVA and CMT from baseline (WMD=5.65, 95% confidence interval (CI), 4.44-6.87, P<0.00001; WMD =5.02, 95% CI, 3.83-6.20, P<0.00001, and WMD =-57.91, 95% CI, -77.62 to -38.20, P<0.00001; WMD =-56.63, 95% CI, -104.81 to -8.44, P=0.02, respectively). The pooled RR comparing the proportions of patients with at least 15 letters improvement or deterioration were also in favor of RBZ and RBZ + Laser (RR=2.94, 95% CI, 1.82-4.77, P<0.00001; RR=2.04, 95% CI, 1.50-2.78, P<0.00001, and RR=0.21, 95% CI, 0.06-0.71, P=0.01; RR=0.52, 95% CI, 0.29-0.95, P=0.03, respectively). There were no significant differences between RBZ and RBZ + Laser for any of the parameters. There were no difference in the safety profile between RBZ and laser. Conclusion: RBZ and RBZ + Laser had better visual and anatomic outcomes than laser monotherapy in the treatment of DME. RBZ + Laser seemed to be equivalent to RBZ.	[Chen, Guohai; Jiang, Fangzheng; Mao, Sihong; Tong, Yuhua] Quzhou Peoples Hosp, Dept Ophthalmol, Quzhou, Zhejiang, Peoples R China; [Li, Wensheng] Xiamen Univ, Xiamen Eye Ctr, Xiamen, Fujian, Peoples R China; [Tzekov, Radouil] Roskamp Inst, Sarasota, FL USA; [Tzekov, Radouil] Univ S Florida, Dept Ophthalmol, Tampa, FL USA	Xiamen University; State University System of Florida; University of South Florida	Li, WS (corresponding author), Xiamen Univ, Xiamen Eye Ctr, Xiamen, Fujian, Peoples R China.	drlws@vip.tom.com		Tzekov, Radouil/0000-0002-3662-9818				Abouammoh MA, 2013, CAN J OPHTHALMOL, V48, P317, DOI 10.1016/j.jcjo.2013.03.004; Ahmadieh H, 2008, GRAEF ARCH CLIN EXP, V246, P483, DOI 10.1007/s00417-007-0688-0; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Bandello F, 2010, DEV OPHTHALMOL, V47, P73, DOI 10.1159/000320075; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Berger A, 2013, CAN J DIABETES, V37, pS48; Brown DM, 2013, OPHTHALMOLOGY, V120, P2013, DOI 10.1016/j.ophtha.2013.02.034; Chen GH, 2015, RETINA-J RET VIT DIS, V35, P187, DOI 10.1097/IAE.0000000000000301; Clinicaltrials.gov. Novartis, NOV EFF SAF RAN INTR; Comyn O, 2014, AM J OPHTHALMOL, V157, P960, DOI 10.1016/j.ajo.2014.02.019; Cunningham ET, 2005, OPHTHALMOLOGY, V112, P1747, DOI 10.1016/j.ophtha.2005.06.007; Do DV, 2013, JAMA OPHTHALMOL, V131, P139, DOI 10.1001/2013.jamaophthalmol.91; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Elman MJ, 2012, OPHTHALMOLOGY, V119, P2312, DOI 10.1016/j.ophtha.2012.08.022; Elman MJ, 2011, OPHTHALMOLOGY, V118, P609, DOI 10.1016/j.ophtha.2010.12.033; Elman MJ, 2010, OPHTHALMOLOGY, V117, P1064, DOI 10.1016/j.ophtha.2010.02.031; Enders P, 2015, RETINA-J RET VIT DIS, V35, P454, DOI 10.1097/IAE.0000000000000320; Frank RN, 2004, NEW ENGL J MED, V350, P48, DOI 10.1056/NEJMra021678; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; KLEIN R, 1984, OPHTHALMOLOGY, V91, P1464; Lang GE, 2013, OPHTHALMOLOGY, V120, P2004, DOI 10.1016/j.ophtha.2013.02.019; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Massin P, 2010, DIABETES CARE, V33, P2399, DOI 10.2337/dc10-0493; Mitchell P, 2011, OPHTHALMOLOGY, V118, P615, DOI 10.1016/j.ophtha.2011.01.031; Nguyen QD, 2009, OPHTHALMOLOGY, V116, P2175, DOI 10.1016/j.ophtha.2009.04.023; PATZ A, 1985, ARCH OPHTHALMOL-CHIC, V103, P1796, DOI 10.1001/archopht.1985.01050120030015; Quan DN, 2010, OPHTHALMOLOGY, V117, P2146, DOI 10.1016/j.ophtha.2010.08.016; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Schmidt-Erfurth U, 2014, OPHTHALMOLOGY, V121, P1045, DOI 10.1016/j.ophtha.2013.11.041; Schmucker C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042701; Virgili G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007419.pub3; Wang HY, 2012, CURR EYE RES, V37, P661, DOI 10.3109/02713683.2012.675616; Yanagida Y, 2014, RETINA-J RET VIT DIS, V34, P629, DOI 10.1097/IAE.0000000000000116; Zechmeister-Koss I, 2012, BRIT J OPHTHALMOL, V96, P167, DOI 10.1136/bjophthalmol-2011-300674	35	14	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115797	10.1371/journal.pone.0115797	http://dx.doi.org/10.1371/journal.pone.0115797			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541937	gold, Green Submitted, Green Published			2022-12-27	WOS:000347239900089
J	Du, FZ; Jiang, R; Gu, M; He, C; Guan, J				Du, Fei-Zhou; Jiang, Rui; Gu, Ming; He, Ci; Guan, Jing			The Accuracy of Spot Sign in Predicting Hematoma Expansion after Intracerebral Hemorrhage: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY ANGIOGRAPHY; IN-HOSPITAL MORTALITY; CONTRAST EXTRAVASATION; DIAGNOSTIC-TEST; IDENTIFIES PATIENTS; HIGHEST RISK; CT; GROWTH; SECONDARY; SCORE	Purpose: The role of spot sign on computed tomography angiography (CTA) for predicting hematoma expansion (HE) after primary intracerebral hemorrhage (ICH) has been the focus of many studies. Our study sought to evaluate the predictive accuracy of spot signs for HE in a meta-analytic approach. Materials and Methods: The database of Pubmed, Embase, and the Cochrane Library were searched for eligible studies. Researches were included if they reported data on HE in primary ICH patients, assessed by spot sign on first-pass CTA. Studies with additional data of second-pass CTA, post-contrast CT (PCCT) and CT perfusion (CTP) were also included. Results: 18 studies were pooled into the meta-analysis, including 14 studies of first-pass CTA, and 7 studies of combined CT modalities. In evaluating the accuracy of spot sign for predicting HE, studies of first-pass CTA showed that the sensitivity was 53% (95% CI, 49%-57%) with a specificity of 88% (95% CI, 86%-89%). The pooled positive likelihood ratio (PLR) was 4.70 (95% CI, 3.28-6.74) and the negative likelihood ratio (NLR) was 0.44 (95% CI, 0.34-0.58). For studies of combined CT modalities, the sensitivity was 73% (95% CI, 67%-79%) with a specificity of 88% (95% CI, 86%-90%). The aggregated PLR was 6.76 (95% CI, 3.70-12.34) and the overall NLR was 0.17 (95% CI 0.06-0.48). Conclusions: Spot signs appeared to be a reliable imaging biomarker for HE. The additional detection of delayed spot sign was helpful in improving the predictive accuracy of early spot signs. Awareness of our results may impact the primary ICH care by providing supportive evidence for the use of combined CT modalities in detecting spot signs.	[Du, Fei-Zhou; Jiang, Rui; Gu, Ming; He, Ci; Guan, Jing] Chengdu Mil Gen Hosp, Dept Radiol, Chengdu, Peoples R China		Gu, M (corresponding author), Chengdu Mil Gen Hosp, Dept Radiol, Chengdu, Peoples R China.	minggu_001@163.com						Almandoz JED, 2012, J NEUROINTERV SURG, V4, P442, DOI 10.1136/neurintsurg-2011-010061; Almandoz JED, 2010, STROKE, V41, P54, DOI 10.1161/STROKEAHA.109.565382; Almandoz JED, 2009, STROKE, V40, P2994, DOI 10.1161/STROKEAHA.109.554667; Becker KJ, 1999, STROKE, V30, P2025, DOI 10.1161/01.STR.30.10.2025; Boulouis G, 2014, STROKE, V45, P1154, DOI 10.1161/STROKEAHA.114.004844; Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; Brouwers HB, 2014, NEUROLOGY, V83, P883, DOI 10.1212/WNL.0000000000000747; Brouwers HB, 2014, JAMA NEUROL, V71, P158, DOI 10.1001/jamaneurol.2013.5433; Brouwers HB, 2012, NEUROCRIT CARE, V17, P421, DOI 10.1007/s12028-012-9765-2; Brouwers HB, 2012, STROKE, V43, P3427, DOI 10.1161/STROKEAHA.112.664003; Chakraborty S, 2010, BRIT J RADIOL, V83, pE216, DOI 10.1259/bjr/74416385; Chakraborty S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090431; d'Esterre CD, 2011, AM J NEURORADIOL, V32, P1879, DOI 10.3174/ajnr.A2669; Davis SM, 2006, NEUROLOGY, V66, P1175, DOI 10.1212/01.wnl.0000208408.98482.99; Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; Del Giudice A, 2014, CEREBROVASC DIS, V37, P268, DOI 10.1159/000360754; Delcourt C, 2012, NEUROLOGY, V79, P314, DOI 10.1212/WNL.0b013e318260cbba; Demchuk AM, 2012, LANCET NEUROL, V11, P307, DOI 10.1016/S1474-4422(12)70038-8; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dowlatshahi D, 2014, STROKE, V45, P277, DOI 10.1161/STROKEAHA.113.003387; Dowlatshahi D, 2011, INT J STROKE, V6, P201, DOI 10.1111/j.1747-4949.2010.00563.x; Ederies A, 2009, STROKE, V40, P1672, DOI 10.1161/STROKEAHA.108.541201; Evans A, 2010, STROKE, V41, P2210, DOI 10.1161/STROKEAHA.110.593970; Bermejo PG, 2010, NEUROLOGY, V75, P834, DOI 10.1212/WNL.0b013e3181f07074; Gazzola S, 2008, STROKE, V39, P1177, DOI 10.1161/STROKEAHA.107.499442; Goldstein JN, 2007, NEUROLOGY, V68, P889, DOI 10.1212/01.wnl.0000257087.22852.21; Hallevi H, 2010, CEREBROVASC DIS, V29, P217, DOI 10.1159/000267842; Havsteen I, 2014, CEREBROVASC DIS, V37, P164, DOI 10.1159/000357397; Huang APH, 2011, J TRAUMA, V71, P1593, DOI 10.1097/TA.0b013e31822c8865; Huynh TJ, 2014, STROKE, V45, P107, DOI 10.1161/STROKEAHA.113.002502; Huynh TJ, 2013, STROKE, V44, P972, DOI 10.1161/STROKEAHA.111.000410; Huynh TJ, 2012, ARCH NEUROL-CHICAGO, P1; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; Kim J, 2008, AM J NEURORADIOL, V29, P520, DOI 10.3174/ajnr.A0859; Koculym A, 2013, AM J NEURORADIOL, V34, P965, DOI 10.3174/ajnr.A3338; Letourneau-Guillon L, 2012, AJNR AM J NEURORADIO; Lindholm L, 2000, J EPIDEMIOL COMMUN H, V54, P617, DOI 10.1136/jech.54.8.617; Mayer SA, 2008, NEW ENGL J MED, V358, P2127, DOI 10.1056/NEJMoa0707534; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; MOSES LE, 1993, STAT MED, V12, P1293, DOI 10.1002/sim.4780121203; Murai Y, 1999, J NEUROSURG, V91, P424, DOI 10.3171/jns.1999.91.3.0424; Ovesen C, 2014, STROKE, V45, P994, DOI 10.1161/STROKEAHA.113.003608; Radmanesh F, 2014, STROKE, V45, P1833, DOI 10.1161/STROKEAHA.114.005276; Rodriguez-Luna D, 2011, NEUROLOGY, V77, P1599, DOI 10.1212/WNL.0b013e3182343387; Rodriguez-Luna D, 2014, STROKE, V45, P734, DOI 10.1161/STROKEAHA.113.003007; Romero JM, 2013, STROKE, V44, P3097, DOI 10.1161/STROKEAHA.113.002752; Romero JM, 2012, NAT REV NEUROL, V8, P300, DOI 10.1038/nrneurol.2012.93; Romero JM, 2012, EMERG RADIOL, V19, P195, DOI 10.1007/s10140-012-1020-9; Rosa M, 2013, ARQ NEURO-PSIQUIAT, V71, P791, DOI 10.1590/0004-282X20130124; SACKETT DL, 1979, J CHRON DIS, V32, P51, DOI 10.1016/0021-9681(79)90012-2; Sorimachi T, 2013, STROKE, V44, P1830, DOI 10.1161/STROKEAHA.113.001498; Sun SJ, 2013, EUR RADIOL, V23, P1846, DOI 10.1007/s00330-013-2803-4; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Tan LA, 2014, CLIN IMAG, V38, P508, DOI 10.1016/j.clinimag.2014.02.013; Van den Bruel A, 2010, LANCET, V375, P834, DOI 10.1016/S0140-6736(09)62000-6; Verhaegen J, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e6077; Wada R, 2007, STROKE, V38, P1257, DOI 10.1161/01.STR.0000259633.59404.f3; Wardlaw JM, 2012, LANCET NEUROL, V11, P294, DOI 10.1016/S1474-4422(12)70045-5; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Zamora Javier, 2006, BMC Med Res Methodol, V6, P31, DOI 10.1186/1471-2288-6-31	60	48	50	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115777	10.1371/journal.pone.0115777	http://dx.doi.org/10.1371/journal.pone.0115777			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541717	Green Submitted, Green Published, gold			2022-12-27	WOS:000347239900085
J	May, T; Ozden, I; Brush, B; Borton, D; Wagner, F; Agha, N; Sheinberg, DL; Nurmikko, AV				May, Travis; Ozden, Ilker; Brush, Benjamin; Borton, David; Wagner, Fabien; Agha, Naubahar; Sheinberg, David L.; Nurmikko, Arto V.			Detection of Optogenetic Stimulation in Somatosensory Cortex by Non-Human Primates - Towards Artificial Tactile Sensation	PLOS ONE			English	Article							ELECTRICAL-STIMULATION; CORTICAL-NEURONS; NEURAL CIRCUITS; MICROSTIMULATION; DISCRIMINATION; ACTIVATION; MOTOR; INFORMATION; POPULATIONS; BEHAVIOR	Neuroprosthesis research aims to enable communication between the brain and external assistive devices while restoring lost functionality such as occurs from stroke, spinal cord injury or neurodegenerative diseases. In future closed-loop sensorimotor prostheses, one approach is to use neuromodulation as direct stimulus to the brain to compensate for a lost sensory function and help the brain to integrate relevant information for commanding external devices via, e.g. movement intention. Current neuromodulation techniques rely mainly of electrical stimulation. Here we focus specifically on the question of eliciting a biomimetically relevant sense of touch by direct stimulus of the somatosensory cortex by introducing optogenetic techniques as an alternative to electrical stimulation. We demonstrate that light activated opsins can be introduced to target neurons in the somatosensory cortex of non-human primates and be optically activated to create a reliably detected sensation which the animal learns to interpret as a tactile sensation localized within the hand. The accomplishment highlighted here shows how optical stimulation of a relatively small group of mostly excitatory somatosensory neurons in the nonhuman primate brain is sufficient for eliciting a useful sensation from data acquired by simultaneous electrophysiology and from behavioral metrics. In this first report to date on optically neuromodulated behavior in the somatosensory cortex of nonhuman primates we do not yet dissect the details of the sensation the animals exerience or contrast it to those evoked by electrical stimulation, issues of considerable future interest.	[May, Travis; Ozden, Ilker; Brush, Benjamin; Borton, David; Agha, Naubahar; Nurmikko, Arto V.] Brown Univ, Sch Engn, Providence, RI 02912 USA; [Borton, David] Ecole Polytech Fed Lausanne, Swiss Fed Inst Technol, Ctr Neuroprosthet, CH-1015 Lausanne, Switzerland; [Wagner, Fabien; Sheinberg, David L.] Brown Univ, Dept Neurosci, Providence, RI 02912 USA; [Nurmikko, Arto V.] Brown Univ, Dept Phys, Providence, RI 02912 USA	Brown University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Brown University; Brown University	Nurmikko, AV (corresponding author), Brown Univ, Sch Engn, Providence, RI 02912 USA.	Arto_Nurmikko@brown.edu	Wagner, Fabien/ABC-4084-2020; Coish, Elizabeth/AAU-1245-2020; Ozden, Ilker/AAJ-3856-2020; Core, Vector/CAF-4832-2022	Wagner, Fabien/0000-0002-9582-6109; 	United States Defense Advanced Research Projects Agency [N66001-10-C-2010]; National Science Foundation [CBET-1402803, CBET-1264816]; United States National Science Foundation [0937848]	United States Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National Science Foundation(National Science Foundation (NSF)); United States National Science Foundation(National Science Foundation (NSF))	This work was supported by grants REPAIR Program (N66001-10-C-2010) from the United States Defense Advanced Research Projects Agency, from the National Science Foundation (CBET-1402803 and CBET-1264816), and Emerging Frontiers in Research and Innovation from the United States National Science Foundation (0937848). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bensmaia SJ, 2014, NAT REV NEUROSCI, V15, P313, DOI 10.1038/nrn3724; Berg J, 2013, IEEE T NEURAL SYSTEM; Bernstein JG, 2011, TRENDS COGN SCI, V15, P592, DOI 10.1016/j.tics.2011.10.003; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Butovas S, 2003, J NEUROPHYSIOL, V90, P3024, DOI 10.1152/jn.00245.2003; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Collinger JL, 2013, LANCET, V381, P557, DOI 10.1016/S0140-6736(12)61816-9; Covington HE, 2010, J NEUROSCI, V30, P16082, DOI 10.1523/JNEUROSCI.1731-10.2010; Dai J, 2014, CURR BIOL, V24, P63, DOI 10.1016/j.cub.2013.11.011; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Diester I, 2011, NAT NEUROSCI, V14, P387, DOI 10.1038/nn.2749; Doty R, 1969, ANN REV PSYCHOL; Ga Tabot, 2013, P NATL ACAD SCI US; Gerits A., 2012, CURR BIOL, P1; Ghazanfar AA, 2000, J NEUROSCI, V20, P3761, DOI 10.1523/JNEUROSCI.20-10-03761.2000; Goodwin AW, 2004, ANNU REV NEUROSCI, V27, P53, DOI 10.1146/annurev.neuro.26.041002.131032; Guo ZCV, 2014, NEURON, V81, P179, DOI 10.1016/j.neuron.2013.10.020; Han X, 2012, PROG BRAIN RES, V196, P215, DOI 10.1016/B978-0-444-59426-6.00011-2; Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553; Hernandez A, 1997, J NEUROSCI, V17, P6391; Histed M, 2014, P NAT 2013; Histed MH, 2013, PROG NEUROBIOL, V103, P115, DOI 10.1016/j.pneurobio.2012.01.006; Histed MH, 2009, NEURON, V63, P508, DOI 10.1016/j.neuron.2009.07.016; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Houweling AR, 2008, NATURE, V451, P65, DOI 10.1038/nature06447; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; Jazayeri M, 2012, NAT NEUROSCI, V15, P1368, DOI 10.1038/nn.3210; Johansson RS, 2009, NAT REV NEUROSCI, V10, P345, DOI 10.1038/nrn2621; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; London BM, 2008, IEEE T NEUR SYS REH, V16, P32, DOI 10.1109/TNSRE.2007.907544; Luna R, 2005, NAT NEUROSCI, V8, P1210, DOI 10.1038/nn1513; Mateo C, 2011, CURR BIOL, V21, P1593, DOI 10.1016/j.cub.2011.08.028; Murphey DK, 2007, CURR BIOL, V17, P862, DOI 10.1016/j.cub.2007.03.066; Murphey DK, 2009, P NATL ACAD SCI USA, V106, P5389, DOI 10.1073/pnas.0804998106; Nevalainen P, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00158; Ni AM, 2010, CURR BIOL, V20, P824, DOI 10.1016/j.cub.2010.02.065; Nicolelis MAL, 1998, NAT NEUROSCI, V1, P621, DOI 10.1038/2855; O'Connor DH, 2013, NAT NEUROSCI, V16, P958, DOI 10.1038/nn.3419; O'Doherty JE, 2012, IEEE T NEUR SYS REH, V20, P85, DOI 10.1109/TNSRE.2011.2166807; O'Doherty JE, 2011, NATURE, V479, P228, DOI 10.1038/nature10489; O'Doherty JE, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.020.2009; Ochoa JL, 2010, NEUROSCI LETT, V470, P162, DOI 10.1016/j.neulet.2009.10.007; Ohayon S, 2013, J NEUROSCI, V33, P16684, DOI 10.1523/JNEUROSCI.2675-13.2013; Ozden I, 2013, J NEUROSCI METH, P1; Packer AM, 2013, NAT NEUROSCI, V16, P805, DOI 10.1038/nn.3427; Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Rolston John D, 2009, Front Neuroeng, V2, P12, DOI 10.3389/neuro.16.012.2009; Romo R, 1998, NATURE, V392, P387, DOI 10.1038/32891; Romo R, 1996, NEUROREPORT, V7, P1273, DOI 10.1097/00001756-199605170-00011; Shaikhouni A, 2013, J NEUROPHYSIOL, V109, P2192, DOI 10.1152/jn.00368.2012; Stamatakis AM, 2013, NEURON, V80, P1039, DOI 10.1016/j.neuron.2013.08.023; Tabot GA, 2014, NEUROBIOL DIS; Tehovnik EJ, 2006, J NEUROPHYSIOL, V96, P512, DOI 10.1152/jn.00126.2006; Tye KM, 2013, NATURE, V493, P537, DOI 10.1038/nature11740; Tye KM, 2012, NAT REV NEUROSCI, V13, P251, DOI 10.1038/nrn3171; Venkatraman S, 2011, IEEE T NEUR SYS REH, V19, P317, DOI 10.1109/TNSRE.2011.2117441; Warden MR, 2012, NATURE, V492, P428, DOI 10.1038/nature11617; Weber DJ, 2012, J MOTOR BEHAV, V44, P403, DOI 10.1080/00222895.2012.735283; Wickens TD, 2001, ELEMENTARY SIGNAL DE, V1; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360	62	30	30	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e114529	10.1371/journal.pone.0114529	http://dx.doi.org/10.1371/journal.pone.0114529			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541938	Green Published, gold, Green Submitted			2022-12-27	WOS:000347239900011
J	O'Neil, SF; Mac, A; Rhodes, G; Webster, MA				O'Neil, Sean F.; Mac, Amy; Rhodes, Gillian; Webster, Michael A.			Adding Years to Your Life (or at Least Looking Like It): A Simple Normalization Underlies Adaptation to Facial Age	PLOS ONE			English	Article							FACE RECOGNITION; PERCEPTION; SHAPE; IDENTITY; GENDER; REPRESENTATION; EXPRESSIONS; MECHANISMS; TEXTURE; SYSTEM	Adaptation has been widely used to probe how experience shapes the visual encoding of faces, but the pattern of perceptual changes produced by adaptation and the neural mechanisms these imply remain poorly characterized. We explored how adaptation alters the perceived age of faces, a fundamental facial attribute which can uniquely and reliably be scaled by observers. This allowed us to measure how adaptation to one age level affected the full continuum of perceived ages. Participants guessed the ages of faces ranging from 18-89, before or after adapting to a different set of faces composed of younger, older, or middle-aged adults. Adapting to young or old faces induced opposite linear shifts in perceived age that were independent of the model's age. Specifically, after adapting to younger or older faces, faces of all ages appeared 2 to 3 years older or younger, respectively. In contrast, middle-aged adaptors induced no aftereffects. This pattern suggests that adaptation leads to a simple and uniform renormalization of age perception, and is consistent with a norm-based neural code for the mechanisms mediating the perception of facial age.	[O'Neil, Sean F.; Mac, Amy; Webster, Michael A.] Univ Nevada, Dept Psychol, Reno, NV 89557 USA; [Rhodes, Gillian; Webster, Michael A.] Univ Western Australia, Sch Psychol, ARC Ctr Excellence Cognit & Its Disorders, Perth, WA 6009, Australia	Nevada System of Higher Education (NSHE); University of Nevada Reno; University of Western Australia	Webster, MA (corresponding author), Univ Nevada, Dept Psychol, Reno, NV 89557 USA.	mwebster@unr.edu		Rhodes, Gillian/0000-0002-3631-8518; Webster, Michael/0000-0001-8262-7525	National Institutes of Health [EY-10834]; Australian Research Council [ARC-CE110001021, ARC-DP08773791, ARC DP130102300]; NATIONAL EYE INSTITUTE [R29EY010834, R01EY010834] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council(Australian Research Council); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	MW, SO, and AM were supported by National Institutes of Health EY-10834. GR was supported by Australian Research Council ARC-CE110001021, ARC-DP08773791, and ARC DP130102300. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BURT DM, 1995, P ROY SOC B-BIOL SCI, V259, P137, DOI 10.1098/rspb.1995.0021; Calder AJ, 2008, J EXP PSYCHOL GEN, V137, P244, DOI 10.1037/0096-3445.137.2.244; Dickinson JE, 2010, J VISION, V10, DOI 10.1167/10.13.5; Durgin FH, 1996, SPATIAL VISION, V9, P423, DOI 10.1163/156856896X00204; Engell AD, 2010, PERCEPTION, V39, P931, DOI 10.1068/p6633; Enlow D.H., 1982, HDB FACIAL GROWTH; Fang F, 2005, NEURON, V45, P793, DOI 10.1016/j.neuron.2005.01.037; George PA, 2000, VIS COGN, V7, P485, DOI 10.1080/135062800394621; Lai M, 2013, CORTEX, V49, P252, DOI 10.1016/j.cortex.2011.09.010; Lai M, 2012, CORTEX, V48, P477, DOI 10.1016/j.cortex.2010.11.014; Leopold DA, 2001, NAT NEUROSCI, V4, P89, DOI 10.1038/82947; McKone E, 2014, VISION RES, V98, P1, DOI 10.1016/j.visres.2014.01.007; Minear M, 2004, BEHAV RES METH INS C, V36, P630, DOI 10.3758/BF03206543; O'Neil SF, 2011, VIS COGN, V19, P534, DOI 10.1080/13506285.2011.561262; O'Toole AJ, 1999, VISION RES, V39, P3145, DOI 10.1016/S0042-6989(99)00034-6; Rhodes G, 2003, PSYCHOL SCI, V14, P558, DOI 10.1046/j.0956-7976.2003.psci_1465.x; Rhodes G., 2011, OXFORD HDB FACE PERC, P263, DOI DOI 10.1093/OXFORDHB/9780199559053.001.0001; Rhodes G, 2006, VISION RES, V46, P2977, DOI 10.1016/j.visres.2006.03.002; Robbins R, 2007, J EXP PSYCHOL HUMAN, V33, P570, DOI 10.1037/0096-1523.33.3.570; Ross DA, 2013, PSYCHON B REV; Russell R, 2006, PERCEPTION, V35, P749, DOI 10.1068/p5490; Schweinberger SR, 2010, VISION RES, V50, P2570, DOI 10.1016/j.visres.2010.08.017; Skinner AL, 2010, PSYCHOL SCI, V21, P1248, DOI 10.1177/0956797610380702; Storrs KR, 2012, VISION RES, V64, P7, DOI 10.1016/j.visres.2012.04.020; Susilo T, 2010, VISION RES, V50, P300, DOI 10.1016/j.visres.2009.11.016; VALENTINE T, 1991, Q J EXP PSYCHOL-A, V43, P161, DOI 10.1080/14640749108400966; Webster MA, 1999, PSYCHON B REV, V6, P647, DOI 10.3758/BF03212974; Webster MA, 2004, NATURE, V428, P557, DOI 10.1038/nature02420; WEBSTER MA, 1995, NATURE, V373, P694, DOI 10.1038/373694a0; Webster MA, 2011, PHILOS T R SOC B, V366, P1702, DOI 10.1098/rstb.2010.0360; Webster MA, 2008, J OPT SOC AM A, V25, P2817, DOI 10.1364/JOSAA.25.002817; Wright DB, 2003, ACTA PSYCHOL, V114, P101, DOI 10.1016/S0001-6918(03)00052-0; Wuerger SM, 1996, VISION RES, V36, P3107, DOI 10.1016/0042-6989(96)00057-0; Xu H, 2008, J NEUROSCI, V28, P3374, DOI 10.1523/JNEUROSCI.0182-08.2008; Yovel G, 2013, TRENDS COGN SCI, V17, P263, DOI 10.1016/j.tics.2013.04.004; Zaske R, 2013, ACTA PSYCHOL, V144, P583, DOI 10.1016/j.actpsy.2013.09.009; Zaidi Q, 1998, J OPT SOC AM A, V15, P1767, DOI 10.1364/JOSAA.15.001767; Zhao C, 2011, VISION RES, V51, P2021, DOI 10.1016/j.visres.2011.07.014	38	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e116105	10.1371/journal.pone.0116105	http://dx.doi.org/10.1371/journal.pone.0116105			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX9RO	25541948	gold, Green Submitted, Green Published			2022-12-27	WOS:000347239900143
J	Unno, K; Ono, M; Winder, AD; Maniar, KP; Paintal, AS; Yu, Y; Wei, JJ; Lurain, JR; Kim, JJ				Unno, Kenji; Ono, Masanori; Winder, Abigail D.; Maniar, Kruti P.; Paintal, Ajit S.; Yu, Yanni; Wei, Jian-Jun; Lurain, John R.; Kim, J. Julie			Establishment of Human Patient-Derived Endometrial Cancer Xenografts in NOD scid Gamma Mice for the Study of Invasion and Metastasis	PLOS ONE			English	Article							PAPILLARY SEROUS CARCINOMA; E-CADHERIN; MOUSE; ACCUMULATION; RECEPTOR; PATHWAY; CAPSULE; MODELS; TUMORS; CELLS	Objective: Most endometrial cancers are detected early and have a good prognosis, while some endometrial cancers are highly invasive, metastasize early, and respond suboptimally to therapy. Currently, appropriate model systems to study the aggressive nature of these tumors are lacking. The objective of this study was to establish a mouse xenograft model of endometrial tumors derived from patients in order to study the biological aggressive characteristics that underlie invasion and metastasis. Methods: Endometrial tumor tissue fragments (1.5 mm x 1.5 mm) from patients undergoing surgery, were transplanted under the renal capsule of NOD scid gamma mice. After 6-8 weeks, tumors were excised and serially transplanted into additional mice for propagation. Immunohistochemical analysis of the tumors was done for various tumor markers. Results: Four cases of different subtypes of endometrial cancer were grown and propagated in mice. Three of the four tumor cases invaded into the kidneys and to adjacent organs. While all tumors exhibited minimal to no staining for estrogen receptor a, progesterone receptor staining was observed for tumor grafts. In addition, levels and localization of E-cadherin, cytokeratin and vimentin varied depending on subtype. Finally, all tumor xenografts stained positively for urokinase plasminogen activator while 3 tumor xenografts, which showed invasive characteristics, stained positively for urokinase plasminogen activator receptor. Conclusion: Endometrial tumors transplanted under the renal capsule exhibit growth, invasion and local spread. These tumors can be propagated and used to study aggressive endometrial cancer.	[Unno, Kenji; Ono, Masanori; Yu, Yanni; Kim, J. Julie] Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Div Reprod Sci Med, Chicago, IL 60611 USA; [Winder, Abigail D.; Lurain, John R.] Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Div Gynecol Oncol, Chicago, IL 60611 USA; [Maniar, Kruti P.; Paintal, Ajit S.; Wei, Jian-Jun] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Kim, JJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Div Reprod Sci Med, Chicago, IL 60611 USA.	j-kim4@northwestern.edu	WEI, JJ/AAN-2638-2020	Kim, J Julie/0000-0001-9834-8213	National Cancer Institute [RO1CA155513]; NATIONAL CANCER INSTITUTE [P30CA060553, R01CA155513] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Cancer Institute RO1CA155513. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ass K, 2008, CANCER TREAT REV, V34, P122, DOI 10.1016/j.ctrv.2007.10.005; Colas E, 2012, CLIN TRANSL ONCOL, V14, P715, DOI 10.1007/s12094-012-0866-3; Dowdy SC, 2006, MOL CANCER THER, V5, P2767, DOI 10.1158/1535-7163.MCT-06-0209; Elston MS, 2009, J CLIN ENDOCR METAB, V94, P1436, DOI 10.1210/jc.2008-2075; Ferber EC, 2008, J BIOL CHEM, V283, P12691, DOI 10.1074/jbc.M708887200; Ge X, 2013, INT J GYNECOL CANCER, V23, P52, DOI 10.1097/IGC.0b013e31827912b8; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; GOFF BA, 1994, GYNECOL ONCOL, V54, P264, DOI 10.1006/gyno.1994.1208; HENDRICKSON M, 1982, AM J SURG PATHOL, V6, P93, DOI 10.1097/00000478-198203000-00002; Ishii K, 2005, LAB INVEST, V85, P1086, DOI 10.1038/labinvest.3700310; Ishikawa H, 2010, ENDOCRINOLOGY, V151, P2433, DOI 10.1210/en.2009-1225; Kamat AA, 2007, CLIN CANCER RES, V13, P7487, DOI 10.1158/1078-0432.CCR-07-1017; Kim JJ, 2013, ENDOCR REV, V34, P130, DOI 10.1210/er.2012-1043; Kwaan HC, 2013, SEMIN THROMB HEMOST, V39, P382, DOI 10.1055/s-0033-1338127; Lee CH, 2005, GYNECOL ONCOL, V96, P48, DOI 10.1016/j.ygyno.2004.09.025; Lee JW, 2010, CLIN CANCER RES, V16, P2562, DOI 10.1158/1078-0432.CCR-10-0017; Memarzedeh S, 2002, P NATL ACAD SCI USA, V99, P10647, DOI 10.1073/pnas.152127499; Moore KN, 2011, CLIN OBSTET GYNECOL, V54, P278, DOI 10.1097/GRF.0b013e318218c755; Morgan J, 2009, GYNECOL ONCOL, V114, P293, DOI 10.1016/j.ygyno.2009.04.036; Ono M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036935; OTT CE, 1976, FED PROC, V35, P1872; Pant A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041593; Parmar H, 2002, ENDOCRINOLOGY, V143, P4886, DOI 10.1210/en.2002-220570; Press JZ, 2008, GYNECOL ONCOL, V110, P256, DOI 10.1016/j.ygyno.2008.03.011; Salahshor S, 2008, MODERN PATHOL, V21, P271, DOI 10.1038/modpathol.3800990; Setiawan VW, 2013, J CLIN ONCOL, V31, P2607, DOI 10.1200/JCO.2012.48.2596; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Silverberg SG, 2000, MODERN PATHOL, V13, P309, DOI 10.1038/modpathol.3880053; Smith HO, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2007.01.004; Spoelstra NS, 2006, CANCER RES, V66, P3893, DOI 10.1158/0008-5472.CAN-05-2881; Takahashi K, 2011, CANCER SCI, V102, P2272, DOI 10.1111/j.1349-7006.2011.02099.x; Tashiro H, 1997, AM J PATHOL, V150, P177; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009	34	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e116064	10.1371/journal.pone.0116064	http://dx.doi.org/10.1371/journal.pone.0116064			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542024	Green Published, Green Submitted, gold			2022-12-27	WOS:000347239900138
J	Wang, WW; Ye, CBH; Liu, JJ; Zhang, D; Kimata, JT; Zhou, P				Wang, Weiming; Ye, Chaobaihui; Liu, Jingjing; Zhang, Di; Kimata, Jason T.; Zhou, Paul			CCR5 Gene Disruption via Lentiviral Vectors Expressing Cas9 and Single Guided RNA Renders Cells Resistant to HIV-1 Infection	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ONE-STEP GENERATION; T-CELLS; GENOME; NUCLEASE; CRISPR/CAS9; MICE; INDIVIDUALS; DISTINCT; ALLELES	CCR5, a coreceptor for HIV-1 entry, is a major target for drug and genetic intervention against HIV-1. Genetic intervention strategies have knocked down CCR5 expression levels by shRNA or disrupted the CCR5 gene using zinc finger nucleases (ZFN) or Transcription activator-like effector nuclease (TALEN). In the present study, we silenced CCR5 via CRISPR associated protein 9 (Cas9) and single guided RNAs (sgRNAs). We constructed lentiviral vectors expressing Cas9 and CCR5 sgRNAs. We show that a single round transduction of lentiviral vectors expressing Cas9 and CCR5 sgRNAs into HIV-1 susceptible human CD4(+) cells yields high frequencies of CCR5 gene disruption. CCR5 gene-disrupted cells are not only resistant to R5-tropic HIV-1, including transmitted/founder (T/F) HIV-1 isolates, but also have selective advantage over CCR5 gene-undisrupted cells during R5-tropic HIV-1 infection. Importantly, using T7 endonuclease I assay we did not detect genome mutations at potential off-target sites that are highly homologous to these CCR5 sgRNAs in stably transduced cells even at 84 days post transduction. Thus we conclude that silencing of CCR5 via Cas9 and CCR5-specific sgRNAs could be a viable alternative strategy for engineering resistance against HIV-1.	[Wang, Weiming; Ye, Chaobaihui; Liu, Jingjing; Zhou, Paul] Chinese Acad Sci, Inst Pasteur Shanghai, Unit Antiviral Immun & Genet Therapy, Key Lab Mol Virol & Immunol, Shanghai 200025, Peoples R China; [Zhang, Di] Shanghai Jiao Tong Univ, Bio X Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Minist Educ, Shanghai 200030, Peoples R China; [Kimata, Jason T.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Shanghai Jiao Tong University; Baylor College of Medicine	Zhou, P (corresponding author), Chinese Acad Sci, Inst Pasteur Shanghai, Unit Antiviral Immun & Genet Therapy, Key Lab Mol Virol & Immunol, Shanghai 200025, Peoples R China.	blzhou@sibs.ac.cn		Kimata, Jason/0000-0002-0504-0090	Chinese National Science Foundation [31170871, 81161160569]; National Science and Technology Major Projects [2012ZX10001-008, 2014ZX10001-001]; French Energy Company Areva; National Institutes of Health [AI106574]; Baylor-UTHouston CFAR [P30AI036211]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211, R01AI106574] Funding Source: NIH RePORTER	Chinese National Science Foundation(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Projects; French Energy Company Areva; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baylor-UTHouston CFAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by research grants from the Chinese National Science Foundation (31170871 and 81161160569), National Science and Technology Major Projects (2012ZX10001-008 and 2014ZX10001-001) and French Energy Company Areva to P.Z. and by research grants from National Institutes of Health to J.T.K. (AI106574) and the Baylor-UTHouston CFAR (P30AI036211). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkina R, 2003, ANTICANCER RES, V23, P1997; Allers K, 2011, BLOOD, V117, P2791, DOI 10.1182/blood-2010-09-309591; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Chelli M, 2001, J BIOL CHEM, V276, P46975, DOI 10.1074/jbc.M106432200; Cho S. W., 2013, GENOME RES; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Dickinson DJ, 2013, NAT METHODS, V10, P1028, DOI 10.1038/NMETH.2641; DiGiusto DL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000931; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; FREED EO, 1989, J VIROL, V63, P4670, DOI 10.1128/JVI.63.11.4670-4675.1989; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim HJ, 2009, GENOME RES, V19, P1279, DOI 10.1101/gr.089417.108; Kothe DL, 2007, VIROLOGY, V360, P218, DOI 10.1016/j.virol.2006.10.017; KOYANAGI Y, 1987, SCIENCE, V236, P819, DOI 10.1126/science.3646751; Landry JJM, 2013, G3-GENES GENOM GENET, V3, P1213, DOI 10.1534/g3.113.005777; Levine BL, 2006, P NATL ACAD SCI USA, V103, P17372, DOI 10.1073/pnas.0608138103; Li LJ, 2013, MOL THER, V21, P1259, DOI 10.1038/mt.2013.65; Liu LH, 2013, J VIROL, V87, P1899, DOI 10.1128/JVI.01038-12; Liu LH, 2011, J VIROL, V85, P8467, DOI 10.1128/JVI.00520-11; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Maggio I, 2014, SCI REP-UK, V4, DOI 10.1038/srep05105; Maier DA, 2013, HUM GENE THER, V24, P245, DOI 10.1089/hum.2012.172; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Miller AD, 1996, J VIROL, V70, P5564, DOI 10.1128/JVI.70.8.5564-5571.1996; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Nazari R, 2008, CURR GENE THER, V8, P264, DOI 10.2174/156652308785160674; Ochsenbauer C, 2012, J VIROL, V86, P2715, DOI 10.1128/JVI.06157-11; Overbaugh J, 1996, AIDS RES HUM RETROV, V12, P107, DOI 10.1089/aid.1996.12.107; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Ray N, 2006, CURR TOP MICROBIOL, V303, P97, DOI 10.1007/978-3-540-33397-5_5; Sampson TR, 2013, NATURE, V497, P254, DOI 10.1038/nature12048; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Shang H, 2011, J BIOL CHEM, V286, P14531, DOI 10.1074/jbc.M111.224527; Shaw GM, 2012, COLD SPRING HARB PER, V2; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; Swan CH, 2006, GENE THER, V13, P1480, DOI 10.1038/sj.gt.3302801; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Theodore TS, 1996, AIDS RES HUM RETROV, V12, P191, DOI 10.1089/aid.1996.12.191; Tsai CJ, 2009, J NANOPART RES, V11, P1, DOI 10.1007/s11051-008-9474-0; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wen M, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-79; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Ye L, 2014, P NATL ACAD SCI USA, V111, P9591, DOI 10.1073/pnas.1407473111; Yu ZS, 2013, GENETICS, V195, P289, DOI 10.1534/genetics.113.153825; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166	56	35	45	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115987	10.1371/journal.pone.0115987	http://dx.doi.org/10.1371/journal.pone.0115987			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541967	Green Published, Green Submitted, gold			2022-12-27	WOS:000347239900125
J	Cleather, DJ; Southgate, DFL; Bull, AMJ				Cleather, Daniel J.; Southgate, Dominic F. L.; Bull, Anthony M. J.			On the Role of the Patella, ACL and Joint Contact Forces in the Extension of the Knee	PLOS ONE			English	Article							MOMENT ARM LENGTH; IN-VIVO; CRUCIATE LIGAMENT; PROVIDES INSIGHT; TENDON; MUSCLE; MODEL; PATELLECTOMY; FLEXION; CHAIN	Traditional descriptions of the knee suggest that the function of the patella is to facilitate knee extension by increasing the moment arm of the quadriceps muscles. Through modelling and evidence from the literature it is shown in this paper that the presence of the patella makes the ability of the quadriceps to rotate the thigh greater than their ability to rotate the tibia. Furthermore, this difference increases as the knee is flexed, thus demonstrating a pattern that is consistent with many human movements. This paper also shows that the anterior cruciate ligament plays a previously unheralded role in extending the shank and that translation at the tibiofemoral and patellofemoral joints is important in improving the capacity for thigh rotation when the knee is flexed. This study provides new insights as to how the structure of the knee is adapted to its purpose and illustrates how the functional anatomy of the knee contributes to its extension function.	[Cleather, Daniel J.] St Marys Univ, Sch Sport Hlth & Appl Sci, Twickenham, England; [Southgate, Dominic F. L.; Bull, Anthony M. J.] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England	St Mary's University Twickenham London; Imperial College London	Cleather, DJ (corresponding author), St Marys Univ, Sch Sport Hlth & Appl Sci, Twickenham, England.	daniel.cleather@smuc.ac.uk	Cleather, Daniel J/AAB-6053-2020; Bull, Anthony M J/C-2317-2008	Cleather, Daniel J/0000-0001-7852-3440; Bull, Anthony M J/0000-0002-4473-8264	Wellcome Trust; Engineering and Physical Sciences Research Council	Wellcome Trust(Wellcome TrustEuropean Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was partially supported by the Wellcome Trust and the Engineering and Physical Sciences Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amis AA., 1996, CURR ORTHOPAED, V10, P102; [Anonymous], 1945, LANCET, V246, P53, DOI 10.1016/S0140-6736(45)91805-8; BEYNNON BD, 1995, AM J SPORT MED, V23, P24, DOI 10.1177/036354659502300105; Beynnon BD, 1998, J BIOMECH, V31, P519, DOI 10.1016/S0021-9290(98)00044-X; Bishop R. E. D., 1977, Engineering in Medicine, V6, P53, DOI 10.1243/EMED_JOUR_1977_006_013_02; BUFF HU, 1988, J BIOMECH, V21, P17, DOI 10.1016/0021-9290(88)90187-X; BUTLER DL, 1980, J BONE JOINT SURG AM, V62, P259, DOI 10.2106/00004623-198062020-00013; Cleather DJ, 2015, J THEOR BIOL, V365, P217, DOI 10.1016/j.jtbi.2014.10.020; Cleather DJ, 2012, P I MECH ENG H, V226, P120, DOI 10.1177/0954411911432104; Cleather DJ, 2011, ANN BIOMED ENG, V39, P2476, DOI 10.1007/s10439-011-0340-3; Cleather DJ, 2011, ANN BIOMED ENG, V39, P1925, DOI 10.1007/s10439-011-0303-8; Cleather DJ, 2011, ANN BIOMED ENG, V39, P147, DOI 10.1007/s10439-010-0161-9; DeFrate LE, 2007, J BIOMECH, V40, P1716, DOI 10.1016/j.jbiomech.2006.08.009; Escamilla RF, 1998, MED SCI SPORT EXER, V30, P556, DOI 10.1097/00005768-199804000-00014; Gill HS, 1996, CLIN BIOMECH, V11, P81, DOI 10.1016/0268-0033(95)00021-6; HERZOG W, 1993, J ANAT, V182, P213; Horsman MDK, 2007, CLIN BIOMECH, V22, P239, DOI 10.1016/j.clinbiomech.2006.10.003; HUBERTI H H, 1984, Journal of Orthopaedic Research, V2, P49, DOI 10.1002/jor.1100020108; HUNGERFORD DS, 1979, CLIN ORTHOP RELAT R, P9; KAUFER H, 1971, J BONE JOINT SURG AM, VA 53, P1551, DOI 10.2106/00004623-197153080-00007; Komatsu T, 2005, J ORTHOP RES, V23, P334, DOI 10.1016/j.orthres.2004.08.001; Nha KW, 2008, J ORTHOP RES, V26, P1067, DOI 10.1002/jor.20554; NISELL R, 1986, ACTA ORTHOP SCAND, V57, P41, DOI 10.3109/17453678608993213; REILLY DT, 1972, ACTA ORTHOP SCAND, V43, P126, DOI 10.3109/17453677208991251; SHOEMAKER SC, 1986, J BONE JOINT SURG AM, V68A, P71, DOI 10.2106/00004623-198668010-00009; SHORBE HB, 1958, J BONE JOINT SURG AM, V40, P1281, DOI 10.2106/00004623-195840060-00008; SMIDT GL, 1973, J BIOMECH, V6, P79, DOI 10.1016/0021-9290(73)90040-7; SUTTON FS, 1976, J BONE JOINT SURG AM, V58, P537, DOI 10.2106/00004623-197658040-00017; Tsaopoulos DE, 2007, J BIOMECH, V40, P3325, DOI 10.1016/j.jbiomech.2007.05.005; Tsaopoulos DE, 2006, CLIN BIOMECH, V21, P657, DOI 10.1016/j.clinbiomech.2006.02.009; VANEIJDEN TMGJ, 1986, J BIOMECH, V19, P219, DOI 10.1016/0021-9290(86)90154-5; YAMAGUCHI GT, 1989, J BIOMECH, V22, P1, DOI 10.1016/0021-9290(89)90179-6	32	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115670	10.1371/journal.pone.0115670	http://dx.doi.org/10.1371/journal.pone.0115670			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536067	Green Published, Green Accepted, gold			2022-12-27	WOS:000348563300062
J	Miao, SJ; Qiao, YF; Han, XZ; Franco, RB; Burger, M				Miao, Shujie; Qiao, Yunfa; Han, Xiaozeng; Franco, Roberta Brancher; Burger, Martin			Frozen Cropland Soil in Northeast China as Source of N2O and CO2 Emissions	PLOS ONE			English	Article							NITROUS-OXIDE; CARBON-DIOXIDE; AGRICULTURAL SOIL; FLUXES; FOREST; SEASON; DYNAMICS; FALLOW; CH4	Agricultural soils are important sources of atmospheric N2O and CO2. However, in boreal agro-ecosystems the contribution of the winter season to annual emissions of these gases has rarely been determined. In this study, soil N2O and CO2 fluxes were measured for 6 years in a corn-soybean-wheat rotation in northeast China to quantify the contribution of wintertime N2O and CO2 fluxes to annual emissions. The treatments were chemical fertilizer (NPK), chemical fertilizer plus composted pig manure (NPKOM), and control (Cont.). Mean soil N2O fluxes among all three treatments in the winter (November-March), when soil temperatures are below -7 degrees C for extended periods, were 0.89-3.01 mu g N m(-2) h(-1), and in between the growing season and winter (October and April), when freeze-thaw events occur, 1.73-5.48 mu g N m(-2) h(-1). The cumulative N2O emissions were on average 0.27-1.39, 0.03-0.08 and 0.03-0.11 kg N2O-N ha(-1) during the growing season, October and April, and winter, respectively. The average contributions of winter N2O efflux to annual emissions were 6.3-12.1%. In all three seasons, the highest N2O emissions occurred in NPKOM, while NPK and Cont. emissions were similar. Cumulative CO2 emissions were 2.73-4.94, 0.13-0.20 and 0.07-0.11 Mg CO2-C ha(-1) during growing season, October and April, and winter, respectively. The contribution of winter CO2 to total annual emissions was 2.0-2.4%. Our results indicate that in boreal agricultural systems in northeast China, CO2 and N2O emissions continue throughout the winter.	[Miao, Shujie; Qiao, Yunfa; Han, Xiaozeng] Chinese Acad Sci, Northeast Inst Geog & Agroecol, Key Lab Mollisols Agroecol, Harbin, Peoples R China; [Miao, Shujie; Qiao, Yunfa; Franco, Roberta Brancher; Burger, Martin] Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA	Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS; University of California System; University of California Davis	Burger, M (corresponding author), Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA.	mburger@ucdavis.edu	Bond-Lamberty, Benjamin/C-6058-2008	Bond-Lamberty, Benjamin/0000-0001-9525-4633; Franco, Roberta/0000-0002-3323-444X	National Natural Science Foundation of China [41371297, 41101219]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Natural Science Foundation of China (41371297, 41101219). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm J, 1999, BIOGEOCHEMISTRY, V44, P163, DOI 10.1023/A:1006074606204; Benoit R.E., 1972, P 1972 TUNDR BIOM S, P111; Brooks PD, 1996, BIOGEOCHEMISTRY, V32, P93, DOI 10.1007/BF00000354; Ding WX, 2010, GEODERMA, V155, P381, DOI 10.1016/j.geoderma.2009.12.023; Fernandez-Luqueno F, 2009, SCI TOTAL ENVIRON, V407, P4289, DOI 10.1016/j.scitotenv.2009.04.016; Filippa G, 2009, BIOGEOCHEMISTRY, V95, P131, DOI 10.1007/s10533-009-9304-1; FIRESTONE MK, 1989, LIFE SCI R, V47, P7; Flanagan PW, 1972, P 1972 TUNDR BIOM S, P110; GOODROAD LL, 1984, J ENVIRON QUAL, V13, P448, DOI 10.2134/jeq1984.00472425001300030024x; Groffman PM, 2011, BIOGEOCHEMISTRY, V102, P223, DOI 10.1007/s10533-010-9436-3; Guo ZL, 2009, AGROFOREST SYST, V76, P67, DOI 10.1007/s10457-008-9170-1; Kariyapperuma KA, 2012, CAN J SOIL SCI, V92, P315, DOI 10.4141/CJSS2011-059; Kessavalou A, 1998, J ENVIRON QUAL, V27, P1094, DOI 10.2134/jeq1998.00472425002700050015x; Li HB, 2009, COMMUN SOIL SCI PLAN, V40, P1350, DOI 10.1080/00103620902761585; Li RP, 2010, CHINESE SCI BULL, V55, P2723, DOI 10.1007/s11434-010-3181-9; Maljanen M, 2007, TELLUS B; Maljanen M, 2010, CAN J FOREST RES, V40, P565, DOI 10.1139/X10-004; Merbold L, 2013, BIOGEOSCIENCES, V10, P3185, DOI 10.5194/bg-10-3185-2013; Metz B, 2007, MITIGATION CLIMATE C; Ohkubo S, 2012, AGR FOREST METEOROL, V165, P25, DOI 10.1016/j.agrformet.2012.06.012; Oquist MG, 2004, FEMS MICROBIOL ECOL, V49, P371, DOI 10.1016/j.femsec.2004.04.006; Panikov NS, 2007, FEMS MICROBIOL ECOL, V59, P500, DOI 10.1111/j.1574-6941.2006.00210.x; Pfab H, 2011, J PLANT NUTR SOIL SC, V174, P545, DOI 10.1002/jpln.201000123; Phillips RL, 2012, SOIL BIOL BIOCHEM, V45, P14, DOI 10.1016/j.soilbio.2011.09.012; Qiao YF, 2014, FIELD CROP RES, V161, P98, DOI 10.1016/j.fcr.2014.03.005; RAICH JW, 1995, GLOBAL BIOGEOCHEM CY, V9, P23, DOI 10.1029/94GB02723; Rochette P, 1998, CAN J SOIL SCI, V78, P283, DOI 10.4141/S97-066; Roehm CL, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001889; Shi XH, 2012, GLOBAL BIOGEOCHEM CY, V26; SOIL SURVEY STAFF, 2014, KEYS SOIL TAXONOMY, V12th; Song Chuang-ye, 2009, Journal of Forestry Research (Harbin), V20, P117, DOI 10.1007/s11676-009-0021-3; Teepe R, 2000, SOIL BIOL BIOCHEM, V32, P1807, DOI 10.1016/S0038-0717(00)00078-X; van Bochove E, 2000, GLOBAL BIOGEOCHEM CY, V14, P113, DOI 10.1029/1999GB900101; Wagner-Riddle C, 2007, GLOBAL CHANGE BIOL, V13, P1722, DOI 10.1111/j.1365-2486.2007.01388.x; Wang W, 2010, SOIL BIOL BIOCHEM, V42, P451, DOI 10.1016/j.soilbio.2009.11.028; Wilson HM, 2008, APPL SOIL ECOL, V39, P264, DOI 10.1016/j.apsoil.2007.12.013; ZIMOV SA, 1993, J GEOPHYS RES-ATMOS, V98, P5017, DOI 10.1029/92JD02473; Zou JW, 2009, GLOBAL CHANGE BIOL, V15, P229, DOI 10.1111/j.1365-2486.2008.01775.x	38	10	11	7	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115761	10.1371/journal.pone.0115761	http://dx.doi.org/10.1371/journal.pone.0115761			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536036	Green Published, gold, Green Submitted			2022-12-27	WOS:000348563300070
J	Qiu, JH; Wang, XW; Meng, XD; Zheng, Y; Li, G; Ma, JY; Ye, G; Li, Y; Li, J				Qiu, Jianhong; Wang, Xiangwei; Meng, Xiaodong; Zheng, Yan; Li, Gang; Ma, Jiyao; Ye, Gang; Li, Yong; Li, Jie			Attenuated NER Expressions of XPF and XPC Associated with Smoking Are Involved in the Recurrence of Bladder Cancer	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; DNA-REPAIR; RESISTANCE; RISK; MECHANISM; GENES; CELLS	The varied NER genes and smoking are two important risk factors of bladder cancer, but the mechanism of the NER protein and smoking in cancer progression, however, remains unclear. In this report, we compared the expressions of NER genes in 79 bladder cancer tissues with or without any recurrence by real-time PCR and then analyzed the varied NER genes by immunochemistry in 219 bladder cancer tissue samples. Based on the clinical data, we analyzed the clinical value of varied NER genes and smoking in 219 bladder cancers by the Kaplan-Meier method and Cox proportional hazards regression. We found the expressions of the NER gene XPF and XPC were significantly lower in bladder cancer tissues with a recurrence compared with those without a recurrence at mRNA level. Also, the patients with the XPF and XPC defect had a statistically significant lower median recurrence-free survival time than those without the XPF and XPC defect, and smoking can make this difference more remarkable. Our results suggest that XPF and XPC expression may be a potential predictive factor for bladder cancer, and smoking can not only influence the recurrence of bladder cancer as a single factor but also aggravate the results of the XPF defect and XPC defect.	[Qiu, Jianhong; Meng, Xiaodong; Zheng, Yan; Li, Gang; Ma, Jiyao; Li, Yong; Li, Jie] Bethune Int Peace Hosp, Dept Urol, Shijiazhuang, Peoples R China; [Wang, Xiangwei; Ye, Gang] Third Mil Med Univ, Affiliated Hosp 2, Dept Urol, Chongqing, Peoples R China	Army Medical University	Li, J (corresponding author), Bethune Int Peace Hosp, Dept Urol, Shijiazhuang, Peoples R China.	li_jie8301@163.com	Wu, Yuqi/AAL-9861-2020		National Science & Technology Pillar Program of China [2011A322]	National Science & Technology Pillar Program of China	The study was supported by the National Science & Technology Pillar Program of China (No. 2011A322). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barckhausen C, 2013, ONCOGENE; Boffetta P, 2008, SCAND J UROL NEPHROL, V42, P45, DOI 10.1080/03008880802283664; Chen ZW, 2007, CANCER RES, V67, P4578, DOI 10.1158/0008-5472.CAN-06-0877; Dydensborg AB, 2006, AM J PHYSIOL-GASTR L, V290, pG1067, DOI 10.1152/ajpgi.00234.2005; Ferreccio C, 2013, EPIDEMIOLOGY, V24, P898, DOI 10.1097/EDE.0b013e31829e3e03; Hakem R, 2008, EMBO J, V27, P589, DOI 10.1038/emboj.2008.15; Han WN, 2012, CANCER PREV RES, V5, P1155, DOI 10.1158/1940-6207.CAPR-12-0185-T; Houtsmuller AB, 1999, SCIENCE, V284, P958, DOI 10.1126/science.284.5416.958; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Katiyar SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021410; Kim WJ, 2008, CANCER SCI, V99, P646, DOI 10.1111/j.1349-7006.2008.00735.x; Kornguth DG, 2005, INT J RADIAT ONCOL, V62, P665, DOI 10.1016/j.ijrobp.2004.11.026; Li J, 2012, MED SCI MONITOR, V18, pBR156, DOI 10.12659/MSM.882618; Liu Y, 2012, ONCOL REP, V28, P337, DOI 10.3892/or.2012.1759; Martinez-Lacaci I, 2007, CLIN TRANSL ONCOL, V9, P13, DOI 10.1007/s12094-007-0004-9; Meijerman I, 2008, CANCER TREAT REV, V34, P505, DOI 10.1016/j.ctrv.2008.03.002; Melis JPM, 2013, DNA REPAIR, V12, P1081, DOI 10.1016/j.dnarep.2013.08.019; Melis JPM, 2013, TOXICOL APPL PHARM, V266, P289, DOI 10.1016/j.taap.2012.11.004; Meulenbroek EM, 2013, NUCLEIC ACIDS RES, V41, P1363, DOI 10.1093/nar/gks1127; Neumann AS, 2005, MOL CARCINOGEN, V42, P65, DOI 10.1002/mc.20069; Nouspikel T, 2009, CELL MOL LIFE SCI, V66, P994, DOI 10.1007/s00018-009-8737-y; Nouspikel T, 2011, MECH AGEING DEV, V132, P355, DOI 10.1016/j.mad.2011.03.003; Ray A, 2013, DNA REPAIR, V12, P273, DOI 10.1016/j.dnarep.2013.01.003; Roelofzen JH, 2014, UROL ONCOL; Rouissi K, 2011, PATHOL ONCOL RES, V17, P879, DOI 10.1007/s12253-011-9398-3; Theodorescu D, 2003, HISTOL HISTOPATHOL, V18, P259, DOI 10.14670/HH-18.259; vanderSpek PJ, 1996, NUCLEIC ACIDS RES, V24, P2551, DOI 10.1093/nar/24.13.2551; Wang M, 2010, ONCOGENE, V29, P1920, DOI 10.1038/onc.2009.484; Wood RD, 2005, MUTAT RES-FUND MOL M, V577, P275, DOI 10.1016/j.mrfmmm.2005.03.007; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; Wyszynski A, 2014, CANCER-AM CANCER SOC, V120, P408, DOI 10.1002/cncr.28394; Yeh KT, 2012, ANN SURG ONCOL, V19, P734, DOI 10.1245/s10434-011-1992-9	32	12	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115224	10.1371/journal.pone.0115224	http://dx.doi.org/10.1371/journal.pone.0115224			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25535740	Green Published, Green Submitted, gold			2022-12-27	WOS:000348563300032
J	Acker, J; Nguyen, NTT; Vandamme, M; Tavenet, A; Briand-Suleau, A; Conesa, C				Acker, Joel; Ngoc-Thuy-Trinh Nguyen; Vandamme, Marie; Tavenet, Arounie; Briand-Suleau, Audrey; Conesa, Christine			Sub1 and Maf1, Two Effectors of RNA Polymerase III, Are Involved in the Yeast Quiescence Cycle	PLOS ONE			English	Article							SENSITIVE PHOSPHOPROTEOME REVEALS; CHROMATIN-ASSOCIATED PROTEIN; MULTIPLE FUNCTIONS; LIFE-SPAN; TRANSCRIPTION; REPRESSION; NUTRIENT; STRESS; DNA; TOR	Sub1 and Maf1 exert an opposite effect on RNA polymerase III transcription interfering with different steps of the transcription cycle. In this study, we present evidence that Sub1 and Maf1 also exhibit an opposite role on yeast chronological life span. First, cells lacking Sub1 need more time than wild type to exit from resting and this lag in re-proliferation is correlated with a delay in transcriptional reactivation. Second, our data show that the capacity of the cells to properly establish a quiescent state is impaired in the absence of Sub1 resulting in a premature death that is dependent on the Ras/PKA and Tor1/Sch9 signalling pathways. On the other hand, we show that maf1D cells are long-lived mutant suggesting a connection between Pol III transcription and yeast longevity.	[Acker, Joel; Ngoc-Thuy-Trinh Nguyen; Vandamme, Marie; Tavenet, Arounie; Briand-Suleau, Audrey; Conesa, Christine] iBiTec S CEA, FRE3377, Gif Sur Yvette, France; [Acker, Joel; Ngoc-Thuy-Trinh Nguyen; Vandamme, Marie; Tavenet, Arounie; Briand-Suleau, Audrey; Conesa, Christine] CNRS, FRE3377, Gif Sur Yvette, France; [Acker, Joel; Ngoc-Thuy-Trinh Nguyen; Vandamme, Marie; Tavenet, Arounie; Briand-Suleau, Audrey; Conesa, Christine] Univ Paris 11, FRE3377, Gif Sur Yvette, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Acker, J (corresponding author), iBiTec S CEA, FRE3377, Gif Sur Yvette, France.	joel.acker@cea.fr; christine.conesa@cea.fr	Acker, Joël/F-5138-2010; Briand-Suleau, Audrey/O-8620-2017; BRIAND-SULEAU, Audrey/A-9956-2019	Acker, Joël/0000-0002-0855-875X; 	French National Research Agency [2010-BLAN-1605-01]; International PhD Program of the CEA	French National Research Agency(French National Research Agency (ANR)); International PhD Program of the CEA	This work was supported by the French National Research Agency (grant 2010-BLAN-1605-01) and the International PhD Program of the CEA to AT and NTTN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvers AL, 2009, AGING CELL, V8, P353, DOI 10.1111/j.1474-9726.2009.00469.x; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Beltrao P, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000134; Boer VM, 2008, P NATL ACAD SCI USA, V105, P6930, DOI 10.1073/pnas.0802601105; Boguta M, 2013, BBA-GENE REGUL MECH, V1829, P376, DOI 10.1016/j.bbagrm.2012.11.004; Budovskaya YV, 2005, P NATL ACAD SCI USA, V102, P13933, DOI 10.1073/pnas.0501046102; Cabart P, 2008, J BIOL CHEM, V283, P36108, DOI 10.1074/jbc.M807538200; Calvo O, 2005, EMBO J, V24, P1009, DOI 10.1038/sj.emboj.7600575; Ciesla M, 2007, MOL CELL BIOL, V27, P7693, DOI 10.1128/MCB.01051-07; Conesa C, 2010, RNA BIOL, V7, P287, DOI 10.4161/rna.7.3.11491; Coute Y, 2006, MASS SPECTROM REV, V25, P215, DOI 10.1002/mas.20067; Das C, 2006, MOL CELL BIOL, V26, P8303, DOI 10.1128/MCB.00887-06; De Virgilio C, 2012, FEMS MICROBIOL REV, V36, P306, DOI 10.1111/j.1574-6976.2011.00287.x; Dechampesme AM, 1999, J CELL BIOL, V145, P1369, DOI 10.1083/jcb.145.7.1369; Desai N, 2005, J BIOL CHEM, V280, P6455, DOI 10.1074/jbc.M412375200; Dieci G, 2013, BBA-GENE REGUL MECH, V1829, P331, DOI 10.1016/j.bbagrm.2012.10.009; Drees BL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r38; Duffy SK, 2012, CELL, V149, P936, DOI 10.1016/j.cell.2012.02.064; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Garcia A, 2012, MOL BIOL CELL, V23, P4297, DOI 10.1091/mbc.E12-04-0331; Ghavidel A, 2007, CELL, V131, P915, DOI 10.1016/j.cell.2007.09.042; Gomes P, 2007, MECH AGEING DEV, V128, P383, DOI 10.1016/j.mad.2007.04.003; Haase SB, 2002, CELL CYCLE, V1, P132, DOI 10.4161/cc.1.2.114; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; JU QD, 1994, YEAST, V10, P151, DOI 10.1002/yea.320100203; Kajstura M, 2007, CYTOM PART A, V71A, P125, DOI 10.1002/cyto.a.20357; Karkusiewicz I, 2011, J BIOL CHEM, V286, P39478, DOI 10.1074/jbc.M111.253310; Koyama H, 2008, GENES CELLS, V13, P1113, DOI 10.1111/j.1365-2443.2008.01229.x; Lee J, 2009, J BIOL CHEM, V284, P12604, DOI 10.1074/jbc.C900020200; Longo VD, 2012, CELL METAB, V16, P18, DOI 10.1016/j.cmet.2012.06.002; Moir RD, 2013, BBA-GENE REGUL MECH, V1829, P361, DOI 10.1016/j.bbagrm.2012.11.001; Morawiec E, 2013, GENE, V526, P16, DOI 10.1016/j.gene.2013.04.055; Oficjalska-Pham D, 2006, MOL CELL, V22, P623, DOI 10.1016/j.molcel.2006.04.008; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Radonjic M, 2005, MOL CELL, V18, P171, DOI 10.1016/j.molcel.2005.03.010; Rosonina E, 2009, MOL CELL BIOL, V29, P2308, DOI 10.1128/MCB.01841-08; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Sikorski TW, 2011, MOL CELL, V44, P397, DOI 10.1016/j.molcel.2011.09.013; Smets B, 2010, CURR GENET, V56, P1, DOI 10.1007/s00294-009-0287-1; Soulard A, 2010, MOL BIOL CELL, V21, P3475, DOI 10.1091/mbc.E10-03-0182; Swinnen E, 2013, FEMS YEAST RES; Tavenet A, 2009, P NATL ACAD SCI USA, V106, P14265, DOI 10.1073/pnas.0900162106; Upadhya R, 2002, MOL CELL, V10, P1489, DOI 10.1016/S1097-2765(02)00787-6; VOLLAND C, 1994, J BIOL CHEM, V269, P9833; Wei M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040013; Weinberger M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000748; Whitney ML, 2007, MOL BIOL CELL, V18, P2678, DOI 10.1091/mbc.E07-01-0006; Zheng JS, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.77	48	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e114587	10.1371/journal.pone.0114587	http://dx.doi.org/10.1371/journal.pone.0114587			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531541	gold, Green Published, Green Submitted			2022-12-27	WOS:000348845100020
J	Kashi, VP; Jacob, RA; Shamanna, RA; Menon, M; Balasiddaiah, A; Varghese, RK; Bachu, M; Ranga, U				Kashi, Venkatesh P.; Jacob, Rajesh A.; Shamanna, Raghavendra A.; Menon, Malini; Balasiddaiah, Anangi; Varghese, Rebu K.; Bachu, Mahesh; Ranga, Udaykumar			The Grafting of Universal T-Helper Epitopes Enhances Immunogenicity of HIV-1 Tat Concurrently Improving Its Safety Profile	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CLADE-SPECIFIC DIFFERENCES; IMMUNE-RESPONSES; TYPE-1 TAT; NEUTRALIZING ANTIBODIES; CYNOMOLGUS MONKEYS; RHESUS MACAQUES; 89.6P CHALLENGE; PROTEIN; AIDS	Extracellular Tat (eTat) plays an important role in HIV-1 pathogenesis. The presence of anti-Tat antibodies is negatively correlated with disease progression, hence making Tat a potential vaccine candidate. The cytotoxicity and moderate immunogenicity of Tat however remain impediments for developing Tat-based vaccines. Here, we report a novel strategy to concurrently enhance the immunogenicity and safety profile of Tat. The grafting of universal helper T-lymphocyte (HTL) epitopes, Pan DR Epitope (PADRE) and Pol(711) into the cysteine rich domain (CRD) and the basic domain (BD) abolished the transactivation potential of the Tat protein. The HTL-Tat proteins elicited a significantly higher titer of antibodies as compared to the wild-type Tat in BALB/c mice. While the N-terminal epitope remained immunodominant in HTL-Tat immunizations, an additional epitope in exon-2 was recognized with comparable magnitude suggesting a broader immune recognition. Additionally, the HTL-Tat proteins induced cross-reactive antibodies of high avidity that efficiently neutralized exogenous Tat, thus blocking the activation of a Tat-defective provirus. With advantages such as presentation of multiple B-cell epitopes, enhanced antibody response and importantly, transactivation-deficient Tat protein, this approach has potential application for the generation of Tat-based HIV/AIDS vaccines.	[Kashi, Venkatesh P.; Jacob, Rajesh A.; Shamanna, Raghavendra A.; Menon, Malini; Balasiddaiah, Anangi; Varghese, Rebu K.; Bachu, Mahesh; Ranga, Udaykumar] Jawaharlal Nehru Ctr Adv Sci Res, HIV AIDS Lab, Mol Biol & Genet Unit, Bangalore 560064, Karnataka, India; [Jacob, Rajesh A.] Int Ctr Genet Engn & Biotechnol, Cellular Immunol Grp, Cape Town, South Africa; [Shamanna, Raghavendra A.] NIA, Lab Mol Gerontol, Baltimore, MD 21224 USA	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); International Center for Genetic Engineering & Biotechnology (ICGEB); ICGEB Cape Town; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Ranga, U (corresponding author), Jawaharlal Nehru Ctr Adv Sci Res, HIV AIDS Lab, Mol Biol & Genet Unit, Bangalore 560064, Karnataka, India.	udaykumar@jncasr.ac.in	Bachu, Mahesh/I-4343-2015	Bachu, Mahesh/0000-0002-6494-6642	Indian Council of Medical Research, India [HIV/50/114/09-ECDII, 2008-06300]; Jawaharlal Nehru Center for Advanced Scientific Research to Udaykumar Ranga	Indian Council of Medical Research, India(Indian Council of Medical Research (ICMR)); Jawaharlal Nehru Center for Advanced Scientific Research to Udaykumar Ranga(Department of Science & Technology (India))	This study was supported by grants from the Indian Council of Medical Research, India (HIV/50/114/09-ECDII, IRIS No. 2008-06300) and intramural grants from Jawaharlal Nehru Center for Advanced Scientific Research to Udaykumar Ranga. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo MM, 2001, P NATL ACAD SCI USA, V98, P1781, DOI 10.1073/pnas.98.4.1781; Belliard G, 2005, VACCINE, V23, P1399, DOI 10.1016/j.vaccine.2004.08.037; Butto S, 2003, J INFECT DIS, V188, P1171, DOI 10.1086/378412; Cafaro A, 1999, NAT MED, V5, P643, DOI 10.1038/9488; Campbell GR, 2005, J BIOL CHEM, V280, P38376, DOI 10.1074/jbc.M506630200; Caselli E, 1999, J IMMUNOL, V162, P5631; Cui ZR, 2004, VACCINE, V22, P2631, DOI 10.1016/j.vaccine.2003.12.013; Ensoli B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013540; Fayolle C, 2010, VACCINE, V28, P6930, DOI 10.1016/j.vaccine.2010.07.059; Ferrantelli F, 2011, VACCINE, V29, P2918, DOI 10.1016/j.vaccine.2011.02.006; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Gandhi N, 2009, AIDS RES HUM RETROV, V25, P691, DOI 10.1089/aid.2008.0299; Garber ME, 1998, GENE DEV, V12, P3512, DOI 10.1101/gad.12.22.3512; Gavioli R, 2008, VACCINE, V26, P727, DOI 10.1016/j.vaccine.2007.11.040; Goldstein G, 2012, HUM VACC IMMUNOTHER, V8, P1425, DOI 10.4161/hv.21616; Goldstein G, 2010, VACCINE, V28, P1008, DOI 10.1016/j.vaccine.2009.10.129; Gupta S, 2008, J IMMUNOL, V180, P79, DOI 10.4049/jimmunol.180.1.79; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Jeang KT, 1999, J BIOL CHEM, V274, P28837, DOI 10.1074/jbc.274.41.28837; Kashi VP, 2009, VACCINE, V27, P6739, DOI 10.1016/j.vaccine.2009.08.078; Leifert JA, 2002, GENE THER, V9, P1422, DOI 10.1038/sj.gt.3301819; Liang XP, 2005, J VIROL, V79, P12321, DOI 10.1128/JVI.79.19.12321-12331.2005; Maggiorella MT, 2004, VACCINE, V22, P3258, DOI 10.1016/j.vaccine.2004.03.009; Mishra M, 2008, ANN NEUROL, V63, P366, DOI 10.1002/ana.21292; MODESTI N, 1991, NEW BIOL, V3, P759; Moreau E, 2004, J GEN VIROL, V85, P2893, DOI 10.1099/vir.0.80365-0; Nicoli F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077746; Osterhaus ADME, 1999, VACCINE, V17, P2713, DOI 10.1016/S0264-410X(98)00498-8; Pauza CD, 2000, P NATL ACAD SCI USA, V97, P3515, DOI 10.1073/pnas.070049797; Quah BJC, 2007, NAT PROTOC, V2, P2049, DOI 10.1038/nprot.2007.296; Ramakrishna L, 2004, J VIROL, V78, P9174, DOI 10.1128/JVI.78.17.9174-9189.2004; Ranga U, 2004, J VIROL, V78, P2586, DOI 10.1128/JVI.78.5.2586-2590.2004; Rao VR, 2008, J NEUROSCI, V28, P10010, DOI 10.1523/JNEUROSCI.2955-08.2008; Rayne F, 2010, CELL BIOL INT, V34, P409, DOI 10.1042/CBI20090376; Re MC, 2001, J CLIN VIROL, V21, P81, DOI 10.1016/S1386-6532(00)00189-X; Re MC, 1996, CLIN DIAGN LAB IMMUN, V3, P230, DOI 10.1128/CDLI.3.2.230-232.1996; Rezza G, 2005, J INFECT DIS, V191, P1321, DOI 10.1086/428909; Richardson MW, 2003, BIOMED PHARMACOTHER, V57, P4, DOI 10.1016/S0753-3322(02)00327-X; Romani B, 2010, J GEN VIROL, V91, P1, DOI 10.1099/vir.0.016303-0; Ruckwardt TJ, 2004, J VIROL, V78, P13190, DOI 10.1128/JVI.78.23.13190-13196.2004; Sforza F, 2014, AIDS, V28, P1729, DOI 10.1097/QAD.0000000000000315; Siddappa NB, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-53; Silvera P, 2002, J VIROL, V76, P3800, DOI 10.1128/JVI.76.8.3800-3809.2002; Tikhonov I, 2003, J VIROL, V77, P3157, DOI 10.1128/JVI.77.5.3157-3166.2003; vanBaalen CA, 1997, J GEN VIROL, V78, P1913, DOI 10.1099/0022-1317-78-8-1913; Zagury J F, 1998, J Hum Virol, V1, P282	46	7	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e114155	10.1371/journal.pone.0114155	http://dx.doi.org/10.1371/journal.pone.0114155			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531437	Green Submitted, gold, Green Published			2022-12-27	WOS:000348845100009
J	Shev, A; Fujii, K; Hsieh, F; McCowan, B				Shev, Aaron; Fujii, Kevin; Hsieh, Fushing; McCowan, Brenda			Systemic Testing on Bradley-Terry Model against Nonlinear Ranking Hierarchy	PLOS ONE			English	Article							PROBABILITY	We take a system point of view toward constructing any power or ranking hierarchy onto a society of human or animal players. The most common hierarchy is the linear ranking, which is habitually used in nearly all real-world problems. A stronger version of linear ranking via increasing and unvarying winning potentials, known as Bradley-Terry model, is particularly popular. Only recently non-linear ranking hierarchy is discussed and developed through recognition of dominance information contents beyond direct dyadic win-and-loss. We take this development further by rigorously arguing for the necessity of accommodating system's global pattern information contents, and then introducing a systemic testing on Bradley-Terry model. Our test statistic with an ensemble based empirical distribution favorably compares with the Deviance test equipped with a Chi-squared asymptotic approximation. Several simulated and real data sets are analyzed throughout our development.	[Shev, Aaron; Fujii, Kevin; Hsieh, Fushing] Univ Calif Davis, Dept Stat, Davis, CA 95616 USA; [McCowan, Brenda] Univ Calif Davis, Dept Populat Hlth & Reprod, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Hsieh, F (corresponding author), Univ Calif Davis, Dept Stat, Davis, CA 95616 USA.	fhsieh@ucdavis.edu	McDonnell, Mark/A-8374-2008	McDonnell, Mark/0000-0002-7009-3869	NSF [DMS 1007219]; National Institutes of Health, National Center for Research Resources; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD068335] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011107, R24OD011136] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	FSH was supported in part by NSF under grant no. DMS 1007219. BJM was supported in part by National Institutes of Health, National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 2002, WILEY SERIES PROBABI, DOI 10.1002/0471249688; BRADLEY RA, 1952, BIOMETRIKA, V39, P324, DOI 10.1093/biomet/39.3-4.324; Bradley RA, 1951, 2 VIRG AGR EXP STAT; Fujii K, 2014, TECHNICAL REPORT; Fushing H, 2011, P ROY SOC A-MATH PHY, V467, P3590, DOI 10.1098/rspa.2011.0268; Herbert S., 1962, P AM PHILOS SOC, V106, P467, DOI DOI 10.1080/14759550302804; Huang TK, 2006, J MACH LEARN RES, V7, P85; Hunter DR, 2004, ANN STAT, V32, P384; McCullagh P, 1989, GEN LINEAR MODELS; RAO PV, 1967, J AM STAT ASSOC, V62, P194, DOI 10.2307/2282923; STIGLER SM, 1994, STAT SCI, V9, P94, DOI 10.1214/ss/1177010655; Turner H, 2012, J STAT SOFTW, V48, P1; Zermelo E, 1929, MATH Z, V29, P436, DOI 10.1007/BF01180541	14	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115367	10.1371/journal.pone.0115367	http://dx.doi.org/10.1371/journal.pone.0115367			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531899	Green Published, gold			2022-12-27	WOS:000348845100053
J	Stratonovitch, P; Elias, J; Denholm, I; Slater, R; Semenov, MA				Stratonovitch, Pierre; Elias, Jan; Denholm, Ian; Slater, Russell; Semenov, Mikhail A.			An Individual-Based Model of the Evolution of Pesticide Resistance in Heterogeneous Environments: Control of Meligethes aeneus Population in Oilseed Rape Crops	PLOS ONE			English	Article							POLLEN BEETLE; INSECTICIDE RESISTANCE; SPATIAL DYNAMICS; MANAGEMENT; EXPOSURE; DISPERSAL; EFFICACY; LESSONS; ECOLOGY; SYSTEMS	Preventing a pest population from damaging an agricultural crop and, at the same time, preventing the development of pesticide resistance is a major challenge in crop protection. Understanding how farming practices and environmental factors interact with pest characteristics to influence the spread of resistance is a difficult and complex task. It is extremely challenging to investigate such interactions experimentally at realistic spatial and temporal scales. Mathematical modelling and computer simulation have, therefore, been used to analyse resistance evolution and to evaluate potential resistance management tactics. Of the many modelling approaches available, individual-based modelling of a pest population offers most flexibility to include and analyse numerous factors and their interactions. Here, a pollen beetle (Meligethes aeneus) population was modelled as an aggregate of individual insects inhabiting a spatially heterogeneous landscape. The development of the pest and host crop (oilseed rape) was driven by climatic variables. The agricultural land of the landscape was managed by farmers applying a specific rotation and crop protection strategy. The evolution of a single resistance allele to the pyrethroid lambda cyhalothrin was analysed for different combinations of crop management practices and for a recessive, intermediate and dominant resistance allele. While the spread of a recessive resistance allele was severely constrained, intermediate or dominant resistance alleles showed a similar response to the management regime imposed. Calendar treatments applied irrespective of pest density accelerated the development of resistance compared to ones applied in response to prescribed pest density thresholds. A greater proportion of spring-sown oilseed rape was also found to increase the speed of resistance as it increased the period of insecticide exposure. Our study demonstrates the flexibility and power of an individual-based model to simulate how farming practices affect pest population dynamics, and the consequent impact of different control strategies on the risk and speed of resistance development.	[Stratonovitch, Pierre; Semenov, Mikhail A.] Rothamsted Res, Computat & Syst Biol Dept, Harpenden, Herts, England; [Elias, Jan; Slater, Russell] Syngenta Crop Protect AG, Res Biol, Stein, Switzerland; [Denholm, Ian] Univ Hertfordshire, Human & Environm Sci Dept, Hatfield AL10 9AB, Herts, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Syngenta; University of Hertfordshire	Stratonovitch, P (corresponding author), Rothamsted Res, Computat & Syst Biol Dept, Harpenden, Herts, England.	pierre.stratonovitch@rothamsted.ac.uk	Semenov, Mikhail/HCI-8667-2022; Semenov, Mikhail/W-8060-2019; Stratonovitch, Pierre/H-4833-2019	Semenov, Mikhail/0000-0002-1561-7113; Stratonovitch, Pierre/0000-0002-5806-2066	Syngenta; Biotechnology and Biological Sciences Research Council of the UK	Syngenta(Syngenta); Biotechnology and Biological Sciences Research Council of the UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The research leading to these results has received funding from Syngenta. Rothamsted Research receives strategic funding from the Biotechnology and Biological Sciences Research Council of the UK. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript. The funders collected insecticide efficacy data.	Bourguet D, 2013, TRENDS ECOL EVOL, V28, P110, DOI 10.1016/j.tree.2012.09.001; Buchi R, 2002, AGR ECOSYST ENVIRON, V90, P255, DOI 10.1016/S0167-8809(01)00213-4; Buechs Wolfgang, 2000, IOBC-WPRS Bulletin, V23, P151; Carriere Y, 2012, P NATL ACAD SCI USA, V109, P775, DOI 10.1073/pnas.1117851109; Cook SM, 2007, ANNU REV ENTOMOL, V52, P375, DOI 10.1146/annurev.ento.52.110405.091407; Cook SM, 2006, ENTOMOL EXP APPL, V119, P221, DOI 10.1111/j.1570-7458.2006.00419.x; De Angelis D., 1992, INDIVIDUAL BASED MOD, DOI 10.1201/9781351073462; Denholm I, 2002, SCIENCE, V297, P2222, DOI 10.1126/science.1077266; Ekbom B, 2003, AGRIC FOR ENTOMOL, V5, P247, DOI 10.1046/j.1461-9563.2003.00184.x; Evans MR, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1452; Evans MR, 2012, PHILOS T R SOC B, V367, P163, DOI 10.1098/rstb.2011.0191; Frearson DJT, 2005, ENTOMOL EXP APPL, V116, P21, DOI 10.1111/j.1570-7458.2005.00299.x; Garthwaite D. G., 2008, PESTICIDE USAGE SURV; GEORGHIOU GP, 1977, J ECON ENTOMOL, V70, P319, DOI 10.1093/jee/70.3.319; GEORGHIOU GP, 1977, J ECON ENTOMOL, V70, P653, DOI 10.1093/jee/70.5.653; Gould F, 1997, P NATL ACAD SCI USA, V94, P3519, DOI 10.1073/pnas.94.8.3519; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Grimm V., 2005, INDIVIDUAL BASED MOD; Habekotte B, 1997, FIELD CROP RES, V54, P127, DOI 10.1016/S0378-4290(97)00043-9; Hansen LM, 2003, PEST MANAG SCI, V59, P1057, DOI 10.1002/ps.737; Jonsson M, 2007, PHYSIOL ENTOMOL, V32, P188, DOI 10.1111/j.1365-3032.2007.00562.x; Jorgensen SE, 2001, FUNDAMENTALS ECOLOGI; JUDSON OP, 1994, TRENDS ECOL EVOL, V9, P9, DOI 10.1016/0169-5347(94)90225-9; Kautz M, 2014, ECOL MODEL, V273, P264, DOI 10.1016/j.ecolmodel.2013.11.022; Liu C, 2014, ECOL MODEL, V280, P30, DOI 10.1016/j.ecolmodel.2013.09.007; Liu C, 2013, ECOL MODEL, V248, P92, DOI 10.1016/j.ecolmodel.2012.09.016; Miller FJ, 2000, TOXICOLOGY, V149, P21, DOI 10.1016/S0300-483X(00)00229-8; Nauen R, 2012, PESTIC BIOCHEM PHYS, V103, P173, DOI 10.1016/j.pestbp.2012.04.012; OSBORNE P, 1960, PARASITOLOGY, V50, P91, DOI 10.1017/S0031182000025233; Peck SL, 1999, J ECON ENTOMOL, V92, P1, DOI 10.1093/jee/92.1.1; Perez L, 2011, ECOL INFORM, V6, P62, DOI 10.1016/j.ecoinf.2010.09.003; Perez L, 2010, ENVIRON MODELL SOFTW, V25, P223, DOI 10.1016/j.envsoft.2009.08.004; Potting RPJ, 2005, ECOL MODEL, V182, P199, DOI 10.1016/j.ecolmodel.2004.07.017; ROUSH RT, 1989, PESTIC SCI, V26, P423, DOI 10.1002/ps.2780260409; Schuler TH, 2003, TRANSGENIC RES, V12, P351, DOI 10.1023/A:1023342027192; Semenov MA, 2010, CLIM RES, V44, P3, DOI 10.3354/cr00865; Shi MR, 2012, J STORED PROD RES, V51, P23, DOI 10.1016/j.jspr.2012.06.003; Slater R, 2011, PEST MANAG SCI, V67, P633, DOI 10.1002/ps.2101; Stratonovitch P., 2010, PROC SOCIAL BEHAV SC, V2, P7749, DOI [10.1016/j.sbspro.2010.05.210, DOI 10.1016/J.SBSPRO.2010.05.210]; Tabashnik B.E., 1990, PESTICIDE RESISTANCE, P153; Tabashnik BE, 2013, NAT BIOTECHNOL, V31, P510, DOI 10.1038/nbt.2597; TAYLOR CE, 1979, J ECON ENTOMOL, V72, P105, DOI 10.1093/jee/72.1.105; Thies C, 1999, SCIENCE, V285, P893, DOI 10.1126/science.285.5429.893; Vinatier F, 2012, AGR ECOSYST ENVIRON, V146, P52, DOI 10.1016/j.agee.2011.10.005; Vinatier F, 2009, ECOL MODEL, V220, P2244, DOI 10.1016/j.ecolmodel.2009.06.023; White JW, 2014, OIKOS, V123, P385, DOI 10.1111/j.1600-0706.2013.01073.x; Williams IH, 2007, AGR FOREST ENTOMOL, V9, P279, DOI 10.1111/j.1461-9563.2007.00343.x	47	26	27	3	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115631	10.1371/journal.pone.0115631	http://dx.doi.org/10.1371/journal.pone.0115631			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531104	Green Published, Green Submitted, gold			2022-12-27	WOS:000348845100086
J	Yang, LZ; Zhang, W; Shi, B; Yang, ZY; Wei, ZD; Gu, F; Zhang, J; Cui, GB; Liu, Y; Zhou, YF; Zhang, XC; Rao, HY				Yang, Li-Zhuang; Zhang, Wei; Shi, Bin; Yang, Zhiyu; Wei, Zhengde; Gu, Feng; Zhang, Jing; Cui, Guanbao; Liu, Ying; Zhou, Yifeng; Zhang, Xiaochu; Rao, Hengyi			Electrical Stimulation over Bilateral Occipito-Temporal Regions Reduces N170 in the Right Hemisphere and the Composite Face Effect	PLOS ONE			English	Article							NONINVASIVE BRAIN-STIMULATION; ACQUIRED PROSOPAGNOSIA; PREFRONTAL CORTEX; INTERHEMISPHERIC CONNECTIVITY; EXTRASTRIATE CORTEX; RECOGNITION ABILITY; VISUAL-CORTEX; MOTOR CORTEX; PERCEPTION; TDCS	Transcranial direct current stimulation (tDCS) is a non-invasive brain stimulation technique that can modulate cortical excitability. Although the clinical value of tDCS has been advocated, the potential of tDCS in cognitive rehabilitation of face processing deficits is less understood. Face processing has been associated with the occipito-temporal cortex (OT). The present study investigated whether face processing in healthy adults can be modulated by applying tDCS over the OT. Experiment 1 investigated whether tDCS can affect N170, a face-sensitive ERP component, with a face orientation judgment task. The N170 in the right hemisphere was reduced in active stimulation conditions compared with the sham stimulation condition for both upright faces and inverted faces. Experiment 2 further demonstrated that tDCS can modulate the composite face effect, a type of holistic processing that reflects the obligatory attention to all parts of a face. The composite face effect was reduced in active stimulation conditions compared with the sham stimulation condition. Additionally, the current polarity did not modulate the effect of tDCS in the two experiments. The present study demonstrates that N170 can be causally manipulated by stimulating the OT with weak currents. Furthermore, our study provides evidence that obligatory attention to all parts of a face can be affected by the commonly used tDCS parameter setting.	[Yang, Li-Zhuang; Zhang, Wei; Yang, Zhiyu; Wei, Zhengde; Gu, Feng; Cui, Guanbao; Zhou, Yifeng; Zhang, Xiaochu] Univ Sci & Technol China, CAS Key Lab Brain Funct & Dis, Hefei, Anhui, Peoples R China; [Yang, Li-Zhuang; Zhang, Wei; Yang, Zhiyu; Wei, Zhengde; Gu, Feng; Cui, Guanbao; Zhou, Yifeng; Zhang, Xiaochu] Univ Sci & Technol China, Sch Life Sci, Hefei, Anhui, Peoples R China; [Shi, Bin; Liu, Ying] Anhui Med Univ, Prov Hosp, Hefei, Anhui, Peoples R China; [Zhang, Jing] Anhui Univ Chinese Med, Affiliated Hosp 1, Hefei, Anhui, Peoples R China; [Zhang, Xiaochu] Chinese Acad Sci, Ctr Med Phys & Technol, Hefei Inst Phys Sci, Hefei, Anhui, Peoples R China; [Zhang, Xiaochu] Univ Sci & Technol China, Sch Humanities & Social Sci, Hefei, Anhui, Peoples R China; [Rao, Hengyi] Univ Penn, Ctr Funct Neuroimaging, Dept Neurol & Radiol, Philadelphia, PA 19104 USA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Anhui Medical University; Anhui University of Chinese Medicine; Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Pennsylvania; Pennsylvania Medicine	Yang, LZ (corresponding author), Univ Sci & Technol China, CAS Key Lab Brain Funct & Dis, Hefei, Anhui, Peoples R China.	lzyang@ustc.edu.cn; zxcustc@ustc.edu.cn	Rao, Hengyi/AAQ-4919-2020; Zhang, Xiaochu/AAG-8768-2022; Zhang, Xiaochu/AEW-0582-2022; Yang, Li-Zhuang/AAJ-3623-2020; Rao, Hengyi/A-7064-2009; Yang, Li-Zhuang/F-3648-2016; Rao, Hengyi/K-5152-2019; Zhang, Xiaochu/O-9592-2014	Rao, Hengyi/0000-0003-2735-2500; Yang, Li-Zhuang/0000-0002-0192-4323; Rao, Hengyi/0000-0003-2735-2500; Yang, Li-Zhuang/0000-0002-0192-4323; Zhang, Xiaochu/0000-0002-7541-0130; Wei, Zhengde/0000-0003-4586-0170; Gu, Feng/0000-0002-5954-5596	National Natural Science Foundation of China [31230032, 31171083, 31070984, 31471071]; Fundamental Research Funds for the Central Universities of China [WK2070000033]; 100 Talents Programme of The Chinese Academy of Sciences [BJ2070000047]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); 100 Talents Programme of The Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by grants from the National Natural Science Foundation of China (31230032, 31171083, 31070984, 31471071) (http://www.nsfc.gov.cn/publish/portal0/default.htm), and the Fundamental Research Funds for the Central Universities of China (WK2070000033) (http://www.moe.edu.cn/), and 100 Talents Programme of The Chinese Academy of Sciences (BJ2070000047) (http://www.cas.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avidan G, 2011, NEUROPSYCHOLOGIA, V49, P2541, DOI 10.1016/j.neuropsychologia.2011.05.002; Azabou E, 2013, RESP PHYSIOL NEUROBI, V189, P183, DOI 10.1016/j.resp.2013.07.024; Barton JJS, 2008, J NEUROPSYCHOL, V2, P197, DOI 10.1348/174866407X214172; Barton JJS, 2009, PERCEPTION, V38, P242, DOI 10.1068/p6099; Barton JJS, 2004, PERCEPTION, V33, P939, DOI 10.1068/p5243; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Bikson M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00688; Boggio PS, 2008, DRUG ALCOHOL DEPEN, V92, P55, DOI 10.1016/j.drugalcdep.2007.06.011; Boggio PS, 2008, NEUROSCI LETT, V447, P101, DOI 10.1016/j.neulet.2008.10.009; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Busigny T, 2010, NEUROPSYCHOLOGIA, V48, P4057, DOI 10.1016/j.neuropsychologia.2010.09.017; Busigny T, 2010, CORTEX, V46, P965, DOI 10.1016/j.cortex.2009.07.004; Cecere R, 2013, J NEUROSCI, V33, P6469, DOI 10.1523/JNEUROSCI.3431-12.2013; Dalrymple KA, 2011, NEUROPSYCHOLOGIA, V49, P2553, DOI 10.1016/j.neuropsychologia.2011.05.003; Davies-Thompson J, 2012, J NEUROPHYSIOL, V108, P3087, DOI 10.1152/jn.01171.2011; DeGutis J, 2013, COGNITION, V126, P87, DOI 10.1016/j.cognition.2012.09.004; DERENZI E, 1994, NEUROPSYCHOLOGIA, V32, P893, DOI 10.1016/0028-3932(94)90041-8; DERENZI E, 1986, NEUROPSYCHOLOGIA, V24, P385; Dzhelyova MP, 2011, J COGNITIVE NEUROSCI, V23, P2782, DOI 10.1162/jocn.2011.21604; Eimer M, 2011, BRAIN RES, V1376, P76, DOI 10.1016/j.brainres.2010.12.046; Farah MJ, 1998, PSYCHOL REV, V105, P482, DOI 10.1037/0033-295X.105.3.482; Fecteau S, 2007, J NEUROSCI, V27, P6212, DOI 10.1523/JNEUROSCI.0314-07.2007; Floel A, 2014, NEUROIMAGE, V85, P934, DOI 10.1016/j.neuroimage.2013.05.098; Fregni F, 2008, J CLIN PSYCHIAT, V69, P32, DOI 10.4088/JCP.v69n0105; Gao L, 2009, PSYCHOPHYSIOLOGY, V46, P970, DOI 10.1111/j.1469-8986.2009.00853.x; Gao ZF, 2011, ATTEN PERCEPT PSYCHO, V73, P1477, DOI 10.3758/s13414-011-0109-7; Gauthier I, 2002, J EXP PSYCHOL HUMAN, V28, P431, DOI 10.1037//0096-1523.28.2.431; Gauthier I, 2007, COGNITION, V103, P322, DOI 10.1016/j.cognition.2006.05.003; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; HOLE GJ, 1994, PERCEPTION, V23, P65, DOI 10.1068/p230065; Hsiao JH, 2009, PSYCHOL SCI, V20, P455, DOI 10.1111/j.1467-9280.2009.02315.x; Itier RJ, 2011, NEUROIMAGE, V54, P705, DOI 10.1016/j.neuroimage.2010.07.031; Jacobson L, 2012, EXP BRAIN RES, V216, P1, DOI 10.1007/s00221-011-2891-9; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kongthong N, 2013, NEUROSCI LETT, V544, P141, DOI 10.1016/j.neulet.2013.04.002; Kuo MF, 2014, NEUROIMAGE, V85, P948, DOI 10.1016/j.neuroimage.2013.05.117; Lafontaine MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081721; Le Grand R, 2004, PSYCHOL SCI, V15, P762, DOI 10.1111/j.0956-7976.2004.00753.x; Lindenberg R, 2013, J NEUROSCI, V33, P9176, DOI 10.1523/JNEUROSCI.0055-13.2013; Mattavelli G, 2013, NEUROIMAGE, V76, P24, DOI 10.1016/j.neuroimage.2013.03.020; Maurer D, 2007, NEUROPSYCHOLOGIA, V45, P1438, DOI 10.1016/j.neuropsychologia.2006.11.016; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; McKone E, 2007, TRENDS COGN SCI, V11, P8, DOI 10.1016/j.tics.2006.11.002; Meinzer M, 2012, J NEUROSCI, V32, P1859, DOI 10.1523/JNEUROSCI.4812-11.2012; Mercure E, 2008, J COGNITIVE NEUROSCI, V20, P2070, DOI 10.1162/jocn.2008.20137; Moos K, 2012, J NEUROSCI, V32, P16360, DOI 10.1523/JNEUROSCI.6233-11.2012; Nasr S, 2009, J VISION, V9, DOI 10.1167/9.5.5; Nguyen V.T., 2013, NEUROIMAGE; Nitsche M A, 2012, Front Psychiatry, V3, P58, DOI 10.3389/fpsyt.2012.00058; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2011, RESTOR NEUROL NEUROS, V29, P463, DOI 10.3233/RNN-2011-0618; Okamoto M, 2004, NEUROIMAGE, V21, P99, DOI 10.1016/j.neuroimage.2003.08.026; Park CH, 2013, NEUROSCI LETT, V539, P7, DOI 10.1016/j.neulet.2013.01.047; Pitcher D, 2007, CURR BIOL, V17, P1568, DOI 10.1016/j.cub.2007.07.063; Pitcher D, 2011, EXP BRAIN RES, V209, P481, DOI 10.1007/s00221-011-2579-1; Pitcher D, 2009, CURR BIOL, V19, P319, DOI 10.1016/j.cub.2009.01.007; Ramon M, 2012, BRAIN COGNITION, V78, P7, DOI 10.1016/j.bandc.2011.10.009; Renzi C, 2013, NEUROIMAGE, V74, P45, DOI 10.1016/j.neuroimage.2013.02.015; Richler JJ, 2008, J EXP PSYCHOL LEARN, V34, P1356, DOI 10.1037/a0013080; Richler JJ, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00553; Richler JJ, 2011, J VISION, V11, DOI 10.1167/11.13.17; Richler JJ, 2011, PSYCHOL SCI, V22, P464, DOI 10.1177/0956797611401753; Richler JJ, 2009, ATTEN PERCEPT PSYCHO, V71, P530, DOI 10.3758/APP.71.3.530; Richler JJ, 2013, VIS COGN, V21; Riddoch MJ, 2008, COGN NEUROPSYCHOL, V25, P3, DOI 10.1080/02643290801920113; Rossion B, 1999, BIOL PSYCHOL, V50, P173, DOI 10.1016/S0301-0511(99)00013-7; Rossion B, 2003, NEUROIMAGE, V20, P1609, DOI 10.1016/j.neuroimage.2003.07.010; Rossion B, 2000, J COGNITIVE NEUROSCI, V12, P793, DOI 10.1162/089892900562606; Rossion B, 2013, VIS COGN, V21, P139, DOI 10.1080/13506285.2013.772929; Rossion B, 2011, VISION RES, V51, P1297, DOI 10.1016/j.visres.2011.04.003; Sadeh B, 2010, NEUROIMAGE, V53, P782, DOI 10.1016/j.neuroimage.2010.06.029; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Stagg CJ, 2011, NEUROSCIENTIST, V17, P37, DOI 10.1177/1073858410386614; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; Tanaka JW, 2006, J COGNITIVE NEUROSCI, V18, P1488, DOI 10.1162/jocn.2006.18.9.1488; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; Towler J, 2012, NEUROPSYCHOLOGIA, V50, P3588, DOI 10.1016/j.neuropsychologia.2012.10.017; Tseng P, 2012, J NEUROSCI, V32, P10554, DOI 10.1523/JNEUROSCI.0362-12.2012; Tso RVY, 2014, PSYCHOL SCI, V25, P1757, DOI 10.1177/0956797614541284; Utz KS, 2010, NEUROPSYCHOLOGIA, V48, P2789, DOI 10.1016/j.neuropsychologia.2010.06.002; Van Belle G, 2011, NEUROPSYCHOLOGIA, V49, P3145, DOI 10.1016/j.neuropsychologia.2011.07.010; Wang RS, 2012, PSYCHOL SCI, V23, P169, DOI 10.1177/0956797611420575; Watanabe S, 2003, NEUROSCIENCE, V116, P879, DOI 10.1016/S0306-4522(02)00752-2; Wong ACN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008405; Wong ACN, 2009, PSYCHOL SCI, V20, P1108, DOI 10.1111/j.1467-9280.2009.02430.x; Young A., 1987, PERCEPTION, V10, P747, DOI DOI 10.1068/P160747; Yovel G, 2008, NEUROPSYCHOLOGIA, V46, P3061, DOI 10.1016/j.neuropsychologia.2008.06.017; Zhou GM, 2012, PSYCHON B REV, V19, P157, DOI 10.3758/s13423-011-0174-x	88	10	10	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115772	10.1371/journal.pone.0115772	http://dx.doi.org/10.1371/journal.pone.0115772			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531112	Green Published, gold, Green Submitted			2022-12-27	WOS:000348845100106
J	Zhang, W; Shen, SX; Wang, W; Zhou, CL; Xu, LM; Qiu, JH; Wang, JQ; Meng, XX; Liang, YX; Niu, KJ; Guo, Q				Zhang, Wen; Shen, Suxing; Wang, Wei; Zhou, Chunling; Xu, Limin; Qiu, Jiahe; Wang, Jiaqi; Meng, Xiangxue; Liang, Yixiong; Niu, Kaijun; Guo, Qi			Poor Lower Extremity Function Was Associated with Pre-Diabetes and Diabetes in Older Chinese People	PLOS ONE			English	Article							PHYSICAL PERFORMANCE; MUSCLE STRENGTH; GENDER-DIFFERENCES; HEALTH; ADULTS; FALLS; WOMEN; RISK; MASS; LIMITATIONS	Objective: To determine whether a relationship exists between performance-based physical assessments and pre-diabetes/diabetes in an older Chinese population. Methods: Our study population comprised 976 subjects (mean +/- SD age: 67.6 +/- 6.0 years; 44.5% men) from the Hangu area of Tianjin, China. Diabetes was defined by self-reporting of a physician's diagnosis, or a fasting plasma glucose level >= 126 mg/dL; and pre-diabetes was defined as a fasting plasma glucose level >= 100 mg/dL and <126 mg/dL. Results: When all other variables were adjusted for, men needing longer to finish a Timed Up and Go Test and a decreased usual walking speed had higher odds of pre-diabetes (P for trend=0.007 and 0.008, respectively) and diabetes (P for trend=0.012 and 0.014, respectively). However, women needing longer to finish the test and a decreased usual walking speed had a higher odds of diabetes (P for trend=0.020 and 0.034, respectively) but not of pre-diabetes. There was no apparent association between grip strength and pre-diabetes/diabetes in both sexes. Conclusions: In this study, poor lower extremity function was associated with prediabetes/diabetes in older people.	[Zhang, Wen; Shen, Suxing; Qiu, Jiahe; Wang, Jiaqi; Meng, Xiangxue; Liang, Yixiong; Guo, Qi] Tianjin Med Univ, Dept Rehabil & Sports Med, Tianjin, Peoples R China; [Wang, Wei; Xu, Limin] Tianjin Med Univ, Gen Hosp, Dept Rehabil, Tianjin, Peoples R China; [Zhou, Chunling] Community Serv Ctr, Tianjin, Peoples R China; [Niu, Kaijun] Tianjin Med Univ, Nutr Epidemiol Inst, Tianjin, Peoples R China; [Niu, Kaijun] Tianjin Med Univ, Sch Publ Hlth, Tianjin, Peoples R China; [Guo, Qi] Tianjin Med Univ, TEDA, TEDA Int Cardiovasc Hosp, Cardiovasc Clin Coll,Dept Rehabil Med, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Guo, Q (corresponding author), Tianjin Med Univ, Dept Rehabil & Sports Med, Tianjin, Peoples R China.	guoqijp@gmail.com	LIANG, YIXIONG/ABC-6068-2021; , Yixiong/AAQ-2023-2020	, Yixiong/0000-0002-2260-066X; Niu, Kaijun/0000-0002-8772-2481	National Natural Science Foundation of China [81372118]; Tianjin City High School Science & Technology Fund Planning Project [20120130]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin City High School Science & Technology Fund Planning Project	This work was supported by grant (81372118) from the National Natural Science Foundation of China (QG), and grant (20120130) from the Tianjin City High School Science & Technology Fund Planning Project (QG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal Y, 2010, OTOL NEUROTOL, V31, P1445, DOI 10.1097/MAO.0b013e3181f2f035; Allen MD, 2013, MUSCLE NERVE, V48, P298, DOI 10.1002/mus.23792; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Boulton AJM, 2004, DIABETES CARE, V27, P1458, DOI 10.2337/diacare.27.6.1458; Cesari M, 2004, J GERONTOL A-BIOL, V59, P242; Chau RMW, 2013, DISABIL REHABIL, V35, P1975, DOI 10.3109/09638288.2013.770079; Cigolle CT, 2011, J GEN INTERN MED, V26, P272, DOI 10.1007/s11606-010-1510-y; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Delbaere K, 2012, AGE AGEING, V41, P404, DOI 10.1093/ageing/afs004; Franch-Nadal J, 2014, FAM PRACT; [江朝强 JIANG Chao-qiang], 2009, [中华流行病学杂志, Chinese Journal of Epidemiology], V30, P462; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; IJzerman TH, 2012, DIABETES RES CLIN PR, V95, P345, DOI 10.1016/j.diabres.2011.10.026; Lamb SE, 2005, J AM GERIATR SOC, V53, P1618, DOI 10.1111/j.1532-5415.2005.53455.x; Lauretani F, 2003, J APPL PHYSIOL, V95, P1851, DOI 10.1152/japplphysiol.00246.2003; Lee CG, 2013, J AM GERIATR SOC, V61, P1872, DOI 10.1111/jgs.12502; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Lee PG, 2013, DIABETES CARE, V36, P3076, DOI 10.2337/dc13-0412; Lee PG, 2009, J AM GERIATR SOC, V57, P511, DOI 10.1111/j.1532-5415.2008.02150.x; Lin YC, 2010, J NURS RES, V18, P88, DOI 10.1097/JNR.0b013e3181dda6d8; McDermott MM, 2004, J AM GERIATR SOC, V52, P405, DOI 10.1111/j.1532-5415.2004.52113.x; McInnes L, 2005, WORLDV EVID-BASED NU, V2, P33, DOI 10.1111/j.1524-475X.2005.04094.x; Meigs JB, 2002, DIABETES CARE, V25, P977, DOI 10.2337/diacare.25.6.977; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Nathan DM, 2007, DIABETIC MED, V24, P137; Okumiya K, 1998, J AM GERIATR SOC, V46, P928, DOI 10.1111/j.1532-5415.1998.tb02737.x; Onder G, 2005, J GERONTOL A-BIOL, V60, P74, DOI 10.1093/gerona/60.1.74; Park SW, 2007, DIABETES CARE, V30, P1507, DOI 10.2337/dc06-2537; Perreault L, 2010, OBESITY, V18, P2093, DOI 10.1038/oby.2010.76; Phielix E, 2008, PHYSIOL BEHAV, V94, P252, DOI 10.1016/j.physbeh.2008.01.020; Roman de Mettelinge T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067055; SAID G, 1992, NEW ENGL J MED, V326, P1257, DOI 10.1056/NEJM199205073261905; Sayer AA, 2005, DIABETES CARE, V28, P2541, DOI 10.2337/diacare.28.10.2541; Shimada H, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002424; Stenholm S, 2011, J GERONTOL A-BIOL, V66, P341, DOI 10.1093/gerona/glq226; Tsunoda K, 2013, GERIATR GERONTOL INT, V13, P919, DOI 10.1111/ggi.12032; Visser M, 2005, J GERONTOL A-BIOL, V60, P324, DOI 10.1093/gerona/60.3.324; Visser M, 2002, J GERONTOL A-BIOL, V57, pM326, DOI 10.1093/gerona/57.5.M326; Volpato S, 2012, DIABETES CARE, V35, P1672, DOI 10.2337/dc11-2202; Wander PL, 2011, DIABETES RES CLIN PR, V92, P261, DOI 10.1016/j.diabres.2011.01.007; Wang J, 2011, DIABETES VASC DIS RE, V8, P29, DOI 10.1177/1479164110396743; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118	43	33	34	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115883	10.1371/journal.pone.0115883	http://dx.doi.org/10.1371/journal.pone.0115883			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA3ZY	25531769	gold, Green Published, Green Submitted			2022-12-27	WOS:000348845100112
J	Zhao, L; Cao, XD; Zheng, W; Kan, Y				Zhao, Ling; Cao, Xinde; Zheng, Wei; Kan, Yue			Phosphorus-Assisted Biomass Thermal Conversion: Reducing Carbon Loss and Improving Biochar Stability	PLOS ONE			English	Article							BLACK CARBON; PYROLYSIS TEMPERATURE; CONTAMINATED SOILS; CARBON/CARBON COMPOSITES; OXIDATION RESISTANCE; GRAPHITE OXIDATION; INHIBITION; IMMOBILIZATION; IMPACT; PLANT	There is often over 50% carbon loss during the thermal conversion of biomass into biochar, leading to it controversy for the biochar formation as a carbon sequestration strategy. Sometimes the biochar also seems not to be stable enough due to physical, chemical, and biological reactions in soils. In this study, three phosphorus-bearing materials, H3PO4, phosphate rock tailing (PRT), and triple superphosphate (TSP), were used as additives to wheat straw with a ratio of 1: 0.4-0.8 for biochar production at 500 degrees C, aiming to alleviate carbon loss during pyrolysis and to increase biochar-C stabilization. All these additives remarkably increased the biochar yield from 31.7% (unmodified biochar) to 46.9%-56.9% (modified biochars). Carbon loss during pyrolysis was reduced from 51.7% to 35.5%-47.7%. Thermogravimetric analysis curves showed that the additives had no effect on thermal stability of biochar but did enhance its oxidative stability. Microbial mineralization was obviously reduced in the modified biochar, especially in the TSP-BC, in which the total CO2 emission during 60-d incubation was reduced by 67.8%, compared to the unmodified biochar. Enhancement of carbon retention and biochar stability was probably due to the formation of meta-phosphate or C-O-PO3, which could either form a physical layer to hinder the contact of C with O-2 and bacteria, or occupy the active sites of the C band. Our results indicate that pre-treating biomass with phosphors-bearing materials is effective for reducing carbon loss during pyrolysis and for increasing biochar stabilization, which provides a novel method by which biochar can be designed to improve the carbon sequestration capacity.	[Zhao, Ling; Cao, Xinde; Kan, Yue] Shanghai Jiao Tong Univ, Sch Environm Sci & Engn, Shanghai 200240, Peoples R China; [Zhao, Ling; Zheng, Wei] Univ Illinois, Illinois Sustainable Technol Ctr, Champaign, IL 61820 USA	Shanghai Jiao Tong University; University of Illinois System; University of Illinois Urbana-Champaign	Cao, XD (corresponding author), Shanghai Jiao Tong Univ, Sch Environm Sci & Engn, Shanghai 200240, Peoples R China.	xdcao@sjtu.edu.cn			National Natural Science Foundation of China [21107070, 21377081]; Shanghai Science and Technology Commission [13231202502]; Shanghai Education Commission [14ZZ026]; State Key Laboratory of Pollution Control and Resource Reuse Foundation [PCRRF12009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Education Commission; State Key Laboratory of Pollution Control and Resource Reuse Foundation	This work was supported by the National Natural Science Foundation of China (No. 21107070, 21377081), Shanghai Science and Technology Commission (13231202502), and Shanghai Education Commission (14ZZ026). This work was also partially supported by State Key Laboratory of Pollution Control and Resource Reuse Foundation (NO. PCRRF12009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, D317207A ASTM; ANTAL MJ, 1990, ENERG FUEL, V4, P221, DOI 10.1021/ef00021a001; Bruun S, 2008, ORG GEOCHEM, V39, P839, DOI 10.1016/j.orggeochem.2008.04.020; Bruun S, 2008, ENVIRON SCI TECHNOL, V42, P1388; Cantrell KB, 2012, BIORESOURCE TECHNOL, V107, P419, DOI 10.1016/j.biortech.2011.11.084; Cao RX, 2003, ENVIRON POLLUT, V122, P19, DOI 10.1016/S0269-7491(02)00283-X; Cao XD, 2013, ENVIRON SCI POLLUT R, V20, P5913, DOI 10.1007/s11356-012-1349-3; Cao XD, 2011, ENVIRON SCI TECHNOL, V45, P4884, DOI 10.1021/es103752u; Cao XD, 2010, BIORESOURCE TECHNOL, V101, P5222, DOI 10.1016/j.biortech.2010.02.052; Cao XD, 2009, J HAZARD MATER, V164, P555, DOI 10.1016/j.jhazmat.2008.08.034; Cheng CH, 2006, ORG GEOCHEM, V37, P1477, DOI 10.1016/j.orggeochem.2006.06.022; Cross A, 2013, GCB BIOENERGY, V5, P215, DOI 10.1111/gcbb.12035; Fang YY, 2012, ENVIRON SCI POLLUT R, V19, P1659, DOI 10.1007/s11356-011-0674-2; Harvey OR, 2010, ENVIRON SCI TECHNOL, V46, P1415; Hossain MK, 2011, J ENVIRON MANAGE, V92, P223, DOI 10.1016/j.jenvman.2010.09.008; Kluepfel L, 2014, ENVIRON SCI TECHNOL, V48, P5601, DOI 10.1021/es500906d; Kuzyakov Y, 2009, SOIL BIOL BIOCHEM, V41, P210, DOI 10.1016/j.soilbio.2008.10.016; LeCroy C, 2013, SOIL BIOL BIOCHEM, V58, P248, DOI 10.1016/j.soilbio.2012.11.023; Lee YJ, 2003, CARBON, V41, P1987, DOI 10.1016/S0008-6223(03)00199-4; Lehmann J., 2009, SCI TECHNOL HUM VAL, DOI 10.4324/9781849770552; Li KZ, 2012, CORROS SCI, V60, P314, DOI 10.1016/j.corsci.2012.03.031; Lu WM, 2002, CARBON, V40, P1249, DOI 10.1016/S0008-6223(01)00297-4; Rosas JM, 2012, CARBON, V50, P1523, DOI 10.1016/j.carbon.2011.11.030; Mathews JA, 2008, ENERG POLICY, V36, P940, DOI 10.1016/j.enpol.2007.11.029; Matovic D, 2011, ENERGY, V36, P2011, DOI 10.1016/j.energy.2010.09.031; MCKEE DW, 1984, CARBON, V22, P285, DOI 10.1016/0008-6223(84)90172-6; Meyer S, 2012, ENVIRON SCI TECHNOL, V46, P12726, DOI 10.1021/es302302g; Meyer S, 2011, ENVIRON SCI TECHNOL, V45, P9473, DOI 10.1021/es201792c; Novak JM, 2010, GEODERMA, V154, P281, DOI 10.1016/j.geoderma.2009.10.014; OH SG, 1993, J MATER RES, V8, P2879, DOI 10.1557/JMR.1993.2879; Park JH, 2011, J HAZARD MATER, V185, P829, DOI 10.1016/j.jhazmat.2010.09.095; Peng L, 2014, ENVIRON SCI POLLUT R, V21, P7631, DOI 10.1007/s11356-014-2677-2; Qian TT, 2014, ENVIRON SCI TECHNOL, V48, P10734, DOI 10.1021/es502669s; RICHARDS GN, 1991, J ANAL APPL PYROL, V21, P133, DOI 10.1016/0165-2370(91)80021-Y; Spokas KA, 2009, CHEMOSPHERE, V77, P574, DOI 10.1016/j.chemosphere.2009.06.053; Trompowsky PM, 2005, ORG GEOCHEM, V36, P1480, DOI 10.1016/j.orggeochem.2005.08.001; Uchimiya M, 2014, J AGR FOOD CHEM, V62, P1802, DOI 10.1021/jf4053385; Wan YQ, 2009, J ANAL APPL PYROL, V86, P161, DOI 10.1016/j.jaap.2009.05.006; Whitman T, 2011, ENVIRON SCI TECHNOL, V45, P3687, DOI 10.1021/es103301k; Wu XX, 2006, CARBON, V44, P141, DOI 10.1016/j.carbon.2005.06.038; Yao FX, 2010, CHEMOSPHERE, V80, P724, DOI 10.1016/j.chemosphere.2010.05.026; Zhao L, 2013, J HAZARD MATER, V256, P1, DOI 10.1016/j.jhazmat.2013.04.015; Zimmerman AR, 2010, ENVIRON SCI TECHNOL, V44, P1295, DOI 10.1021/es903140c	43	47	53	16	143	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115373	10.1371/journal.pone.0115373	http://dx.doi.org/10.1371/journal.pone.0115373			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531111	Green Submitted, Green Published, gold			2022-12-27	WOS:000348845100056
J	Sakaguchi, Y; Fujii, N; Shoji, T; Hayashi, T; Rakugi, H; Iseki, K; Tsubakihara, Y; Isaka, Y				Sakaguchi, Yusuke; Fujii, Naohiko; Shoji, Tatsuya; Hayashi, Terumasa; Rakugi, Hiromi; Iseki, Kunitoshi; Tsubakihara, Yoshiharu; Isaka, Yoshitaka		Japanese Soc Dialysis Therapy	Magnesium Modifies the Cardiovascular Mortality Risk Associated with Hyperphosphatemia in Patients Undergoing Hemodialysis: A Cohort Study	PLOS ONE			English	Article							REGULAR DIALYSIS TREATMENT; KIDNEY-DISEASE; MINERAL METABOLISM; DIETARY MAGNESIUM; SERUM MAGNESIUM; CALCIUM; CALCIFICATION; PHOSPHORUS; HYPOMAGNESEMIA; METAANALYSIS	Background: In vitro studies have shown inhibitory effects of magnesium (Mg) on phosphate-induced calcification of vascular smooth muscle cells, raising the possibility that maintaining a high Mg level may be useful for reducing cardiovascular risks of patients with hyperphosphatemia. We examined how serum Mg levels affect the association between serum phosphate levels and the risk of cardiovascular mortality in patients undergoing hemodialysis. Methods: A nationwide register-based cohort study was conducted using database of the Renal Data Registry of the Japanese Society for Dialysis Therapy in 2009. We identified 142,069 patients receiving in-center hemodialysis whose baseline serum Mg and phosphate levels were available. Study outcomes were one-year cardiovascular and all-cause mortality. Serum Mg levels were categorized into three groups (lower, <2.7 mg/dL; intermediate, >= 2.7, <3.1 mg/dL; and higher, >= 3.1 mg/dL). Results: During follow-up, 11,401 deaths occurred, out of which 4,751 (41.7%) were ascribed to cardiovascular disease. In multivariable analyses, an increase in serum phosphate levels elevated the risk of cardiovascular mortality in the lowerand intermediate-Mg groups, whereas no significant risk increment was observed in the higher-Mg group. Moreover, among patients with serum phosphate levels of >= 6.0 mg/dL, the cardiovascular mortality risk significantly decreased with increasing serum Mg levels (adjusted odds ratios [95% confidence intervals] of the lower-, intermediate-, and higher-Mg groups were 1.00 (reference), 0.81 [0.66- 0.99], and 0.74 [0.56-0.97], respectively.). An interaction between Mg and phosphate on the risk of cardiovascular mortality was statistically significant (P=0.03). Conclusion: Serum Mg levels significantly modified the mortality risk associated with hyperphosphatemia in patients undergoing hemodialysis.	[Sakaguchi, Yusuke; Rakugi, Hiromi; Isaka, Yoshitaka] Osaka Univ, Grad Sch Med, Suita, Osaka 5650871, Japan; [Fujii, Naohiko; Iseki, Kunitoshi; Tsubakihara, Yoshiharu] Japanese Soc Dialysis Therapy, Comm Renal Data Registry, Tokyo, Japan; [Shoji, Tatsuya; Hayashi, Terumasa] Osaka Gen Med Ctr, Dept Kidney Dis & Hypertens, Osaka 5588558, Japan	Osaka University	Isaka, Y (corresponding author), Osaka Univ, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	isaka@kid.med.osaka-u.ac.jp	Fujii, Naohiko/ABG-8766-2021	Fujii, Naohiko/0000-0002-6411-8599; Rakugi, Hiromi/0000-0001-6508-4338				[Anonymous], 2009, ANN DAT REP ATL CHRO; Ayus JC, 2007, KIDNEY INT, V71, P336, DOI 10.1038/sj.ki.5002044; Ayus JC, 2005, J AM SOC NEPHROL, V16, P2778, DOI 10.1681/ASN.2005040392; Block GA, 2004, J AM SOC NEPHROL, V15, P2208, DOI 10.1097/01.ASN.0000133041.27682.A2; Bowler M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093625; Covic A, 2013, NEPHROL DIAL TRANSPL, V28, P2383, DOI 10.1093/ndt/gft203; D'Haese PC, 1999, CLIN CHEM, V45, P1548; de Jager DJ, 2009, JAMA-J AM MED ASSOC, V302, P1782, DOI 10.1001/jama.2009.1488; Del Gobbo LC, 2013, AM J CLIN NUTR, V98, P160, DOI 10.3945/ajcn.112.053132; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Hruby A, 2014, JACC-CARDIOVASC IMAG, V7, P59, DOI 10.1016/j.jcmg.2013.10.006; Ishimura E, 2007, CLIN NEPHROL, V68, P222; Kanbay M, 2012, AM J NEPHROL, V36, P228, DOI 10.1159/000341868; Kircelli F, 2012, NEPHROL DIAL TRANSPL, V27, P514, DOI 10.1093/ndt/gfr321; KROLL MH, 1985, CLIN CHEM, V31, P244; Larsson SC, 2012, AM J CLIN NUTR, V95, P362, DOI 10.3945/ajcn.111.022376; Louvet L, 2013, NEPHROL DIAL TRANSPL, V28, P869, DOI 10.1093/ndt/gfs520; Maier JAM, 2012, CLIN SCI, V122, P397, DOI 10.1042/CS20110506; Massy ZA, 2012, CLIN KIDNEY J, V5, P52, DOI 10.1093/ndtplus/sfr167; Moe S, 2006, KIDNEY INT, V69, P1945, DOI 10.1038/sj.ki.5000414; Montezano AC, 2010, HYPERTENSION, V56, P453, DOI 10.1161/HYPERTENSIONAHA.110.152058; Nakai S, 2012, THER APHER DIAL, V16, P483, DOI 10.1111/j.1744-9987.2012.01143.x; Nakai S, 2012, THER APHER DIAL, V16, P11, DOI 10.1111/j.1744-9987.2011.01050.x; Naves-Diaz M, 2011, NEPHROL DIAL TRANSPL, V26, P1938, DOI 10.1093/ndt/gfq304; Qu XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057720; Sakaguchi Y, 2014, KIDNEY INT, V85, P174, DOI 10.1038/ki.2013.327; Stenvinkel P, 2008, CLIN J AM SOC NEPHRO, V3, P505, DOI 10.2215/CJN.03670807; Tentori F, 2008, AM J KIDNEY DIS, V52, P519, DOI 10.1053/j.ajkd.2008.03.020; Tzanakis I, 1997, NEPHROL DIAL TRANSPL, V12, P2036, DOI 10.1093/ndt/12.9.2036; Van Laecke S, 2012, NEPHROL DIAL TRANSPL, V27, P4003, DOI 10.1093/ndt/gfs126; Wyskida K, 2012, J RENAL NUTR, V22, P19, DOI 10.1053/j.jrn.2011.03.001	31	46	47	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e0116273	10.1371/journal.pone.0116273	http://dx.doi.org/10.1371/journal.pone.0116273			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545498	Green Published, gold, Green Submitted			2022-12-27	WOS:000347120200109
J	Dillahunt-Aspillaga, C; Finch, D; Massengale, J; Kretzmer, T; Luther, SL; McCart, JA				Dillahunt-Aspillaga, Christina; Finch, Dezon; Massengale, Jill; Kretzmer, Tracy; Luther, Stephen L.; McCart, James A.			Using Information from the Electronic Health Record to Improve Measurement of Unemployment in Service Members and Veterans with mTBI and Post-Deployment Stress	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; COMMUNITY INTEGRATION; MILITARY VETERANS; SELF-EFFICACY; US ARMY; RETURN; WORK; WAR; REHABILITATION; OUTCOMES	Objective: The purpose of this pilot study is 1) to develop an annotation schema and a training set of annotated notes to support the future development of a natural language processing (NLP) system to automatically extract employment information, and 2) to determine if information about employment status, goals and work-related challenges reported by service members and Veterans with mild traumatic brain injury (mTBI) and post-deployment stress can be identified in the Electronic Health Record (EHR). Design: Retrospective cohort study using data from selected progress notes stored in the EHR. Setting: Post-deployment Rehabilitation and Evaluation Program (PREP), an inpatient rehabilitation program for Veterans with TBI at the James A. Haley Veterans' Hospital in Tampa, Florida. Participants: Service members and Veterans with TBI who participated in the PREP program (N=60). Main Outcome Measures: Documentation of employment status, goals, and work-related challenges reported by service members and recorded in the EHR. Results: Two hundred notes were examined and unique vocational information was found indicating a variety of self-reported employment challenges. Current employment status and future vocational goals along with information about cognitive, physical, and behavioral symptoms that may affect return-to-work were extracted from the EHR. The annotation schema developed for this study provides an excellent tool upon which NLP studies can be developed. Conclusions: Information related to employment status and vocational history is stored in text notes in the EHR system. Information stored in text does not lend itself to easy extraction or summarization for research and rehabilitation planning purposes. Development of NLP systems to automatically extract text-based employment information provides data that may improve the understanding and measurement of employment in this important cohort.	[Dillahunt-Aspillaga, Christina; Finch, Dezon; Luther, Stephen L.; McCart, James A.] James A Haley Vet Hosp, Ctr Innovat Disabil & Rehabil Res CINDRR, Tampa, FL 33612 USA; [Dillahunt-Aspillaga, Christina] Univ S Florida, Dept Rehabil & Mental Hlth Counseling, Tampa, FL USA; [Massengale, Jill; Kretzmer, Tracy] James A Haley Vet Hosp, Tampa, FL 33612 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital	Dillahunt-Aspillaga, C (corresponding author), James A Haley Vet Hosp, Ctr Innovat Disabil & Rehabil Res CINDRR, Tampa, FL 33612 USA.	cdillahuntas@usf.edu		Dillahunt-Aspillaga, Christina/0000-0002-1231-2023	VHA QUERI RRP [12-450]	VHA QUERI RRP	Funding for this work was provided by VHA QUERI RRP 12-450. The views expressed in this work are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the US Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Andelic N, 2012, BRAIN INJURY, V26, P261, DOI 10.3109/02699052.2012.654589; [Anonymous], 2008, MILD TRAUM BRAIN INJ; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Benshoff J, 2008, REHABIL RES POLI ED, V22, P227; Borg J, 2004, J REHABIL MED, V36, P76, DOI 10.1080/16501960410023840; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Carbonell JG, 1987, ENCY ARTIFICIAL INTE, P660; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Cernich AN, 2012, J HEAD TRAUMA REHAB, V27, P253, DOI 10.1097/HTR.0b013e3182585cd5; Cerrito P.B., 2006, DATA TEXT MINING ELE; Chiarini-Tremblay M, 2005, AMCIS 2005 P, P109; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Clemens EV, 2008, CAREER DEV Q, V56, P246, DOI 10.1002/j.2161-0045.2008.tb00039.x; Cohen SI, 2013, WORK, V44, P213, DOI 10.3233/WOR-2012-1417; Daggett VS, 2013, J REHABIL RES DEV, V50, P327, DOI 10.1682/JRRD.2011.09.0168; Defense and Veterans Brain Injury Center, 2013, DOD WORLDW TBI NUMB; DeJong G., 1982, STRATEGIES NATURAL L, P149; Department of Veterans Affairs, 2010, VET HLTH ADM HDB; Dillahunt-Aspillaga C., 2014, SGRJARC, V45, P25; Dillahunt-Aspillaga C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082896; Ettenhofer ML, 2012, MIL MED, V177, P1272, DOI 10.7205/MILMED-D-12-00095; Frain MP, 2010, J REHABIL, V76, P13; Frain MP, 2011, VOC EVAL WORK ADJ AS, V38, P34; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Gubata ME, 2014, J HEAD TRAUMA REHAB, V29, P65, DOI 10.1097/HTR.0b013e318295f590; Guillen R, 2009, P I2B2 WORKSH CHALL, P868; Hannold EM, 2013, J REHABIL RES DEV, V50, P1315, DOI 10.1682/JRRD.2013.04.0084; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Institute of Medicine, 2008, GULF WAR HLTH, V7; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Kretzmer T, 2013, MILITARY TBI CASE MA, V4, P8; Kupersmith J, 2009, J REHABIL RES DEV, V46, pXVII, DOI 10.1682/JRRD.2009.06.0085; Lang KP, 2014, J HEAD TRAUMA REHAB, V29, P44, DOI 10.1097/HTR.0b013e31829c85d0; LEHNERT W, 1995, J EXP THEOR ARTIF IN, V7, P49, DOI 10.1080/09528139508953800; Lew HL, 2007, J REHABIL RES DEV, V44, pVII; Lew HL, 2011, J REHABIL RES DEV, V48, P913, DOI 10.1682/JRRD.2010.08.0140; Madaus JW, 2009, J POSTSECOND EDUC DI, V22, P10; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; National Research Council, 2014, GULF WAR HLTH, V9; Ness BM, 2014, J HEAD TRAUMA REHAB, V29, P33, DOI 10.1097/HTR.0b013e3182a1cd4e; Novack TA, 2010, BRAIN INJURY, V24, P464, DOI 10.3109/02699051003601713; O'Neil M, 2014, J INT NEUROPSYCH SOC, V5, P1; Ogren PV, 2006, P 2006 C N AM CHAPT, P273, DOI [10.3115/1225785.1225791, DOI 10.3115/1225785.1225791], DOI 10.3115/1225785.1225791]; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Okie S, 2006, NEW ENGL J MED, V355, P2609, DOI 10.1056/NEJMp068235; Ommaya AK, 1996, J TRAUMA, V40, P211, DOI 10.1097/00005373-199602000-00007; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Pakhomov SVS, 2008, J AM MED INFORM ASSN, V15, P198, DOI 10.1197/jamia.M2585; Pakhomov Serguei, 2005, P ACL 2005 INT POST, P25, DOI 10.3115/1225753.1225760; Pogoda T, 2014, J HEAD TRAUMA REHABI; Ponsford J., 2014, J HEAD TRAUMA REHABI; Ponsford J, 2013, NEUROREHABILITATION, V32, P803, DOI 10.3233/NRE-130904; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Prigerson HG, 2002, AM J PUBLIC HEALTH, V92, P59, DOI 10.2105/AJPH.92.1.59; Rao R.B., 2006, ACM SIGKDD EXPLOR NE, V8, P3, DOI [10.1145/1147234.1147236.1, DOI 10.1145/1147234.1147236.1]; Rapport L, 2006, J HEAD TRAUMA REHAB, V21, P34, DOI 10.1097/00001199-200601000-00004; Rapport LJ, 2008, ARCH PHYS MED REHAB, V89, P922, DOI 10.1016/j.apmr.2008.01.009; Salter K, 2008, BRAIN INJURY, V22, P820, DOI 10.1080/02699050802425428; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; Sayer N, 2012, STRATEGIC PLAN FY 20; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Sayer NA, 2012, ANNU REV MED, V63, P405, DOI 10.1146/annurev-med-061610-154046; Schonberger M, 2011, J NEUROL NEUROSUR PS, V82, P936, DOI 10.1136/jnnp.2010.210021; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Shigaki CL, 2009, DISABIL REHABIL, V31, P484, DOI 10.1080/09638280802240449; Spackman KA, 1997, J AM MED INFORM ASSN, P640; Stergiou-Kita M, 2011, J OCCUP REHABIL, V21, P374, DOI 10.1007/s10926-010-9282-0; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; The Office of Patient Care Services, 2005, VHA HDB; THOMPSON K, 1968, COMMUN ACM, V11, P419, DOI 10.1145/363347.363387; Tsaousides T, 2009, REHABIL PSYCHOL, V54, P299, DOI 10.1037/a0016807; Turchin A, 2006, J AM MED INFORM ASSN, V13, P691, DOI 10.1197/jamia.M2078; Twamley EW, 2013, J REHABIL RES DEV, V50, P663, DOI 10.1682/JRRD.2012.08.0137; Tyerman A, 2012, NEUROREHABILITATION, V31, P51, DOI 10.3233/NRE-2012-0774; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Vocational Rehabilitation Institute, 2011, CAR V10; Waljas M, 2013, J HEAD TRAU IN PRESS; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Xu H, 2010, J AM MED INFORM ASSN, V17, P19, DOI 10.1197/jamia.M3378; Yasuda S, 2001, AM J PHYS MED REHAB, V80, P852, DOI 10.1097/00002060-200111000-00011; Zeitzer JM, 2009, J REHABIL RES DEV, V46, P827, DOI 10.1682/JRRD.2008.08.0099; Zeng Qing T, 2006, BMC Med Inform Decis Mak, V6, P30, DOI 10.1186/1472-6947-6-30	86	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115873	10.1371/journal.pone.0115873	http://dx.doi.org/10.1371/journal.pone.0115873			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX9RO	25541956	Green Published, Green Submitted, gold			2022-12-27	WOS:000347239900101
J	Lewis, DY; Champion, S; Wyper, D; Dewar, D; Pimlott, S				Lewis, David Y.; Champion, Sue; Wyper, David; Dewar, Deborah; Pimlott, Sally			Assessment of [I-125]WYE-230949 as a Novel Histamine H-3 Receptor Radiopharmaceutical	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; RAT-BRAIN; ISOFLURANE ANESTHESIA; RADIOLIGAND BINDING; GLUCOSE-UTILIZATION; DRUG-METABOLISM; H3 RECEPTOR; IN-VIVO; PET; RELEASE	Histamine H-3 receptor therapeutics have been proposed for several diseases such as schizophrenia, attention deficit hyperactivity disorder, Alzheimer's disease and obesity. We set out to evaluate the novel compound, [I-125] WYE-230949, as a potential radionuclide imaging agent for the histamine H-3 receptor in brain. [I-125] WYE-230949 had a high in vitro affinity for the rat histamine H-3 receptor (K-d of 6.9 nM). The regional distribution of [I-125] WYE-230949 binding sites in rat brain, demonstrated by in vitro autoradiography, was consistent with the known distribution of the histamine H-3 receptor. Rat brain uptake of intravenously injected [I-125] WYE-230949 was low (0.11 % ID/g) and the ratio of specific: non-specific binding was less than 1.4, as determined by ex vivo autoradiography. In plasma, metabolism of [I-125] WYE-230949 into a less lipophilic species occurred, such that less than 38% of the parent compound remained 30 minutes after injection. Brain uptake and metabolism of [I-125] WYE-230949 were increased and specific binding was reduced in anaesthetised compared to conscious rats. [I-125]WYE230949 is not a potential radiotracer for imaging rat histamine H-3 receptors in vivo due to low brain uptake, in vivo metabolism of the parent compound and low specific binding.	[Lewis, David Y.; Champion, Sue; Wyper, David; Dewar, Deborah] Univ Glasgow, Coll Med Vet & Life Sci, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland; [Pimlott, Sally] Greater Glasgow NHS Trust, Dept Clin Phys, Glasgow, Lanark, Scotland; [Pimlott, Sally] Univ Glasgow, Glasgow, Lanark, Scotland	University of Glasgow; University of Glasgow	Lewis, DY (corresponding author), Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge, England.	david.lewis@cruk.cam.ac.uk	Pimlott, Sally Louise/F-8098-2010; Lewis, David/AAN-9235-2021	Pimlott, Sally Louise/0000-0002-8396-3392; Lewis, David/0000-0001-9329-1326	Translational Medicine Research Collaboration [NS_AU_084]; HNS Health Board (Grampian); HNS Health Board (Tayside); HNS Health Board (Lothian); HNS Health Board (Greater Glasgow Clyde); Scottish Enterprise; Wyeth Pharmaceutical; Scottish Imaging Network: A Platform for Scientific Excellence (SINAPSE)	Translational Medicine Research Collaboration; HNS Health Board (Grampian); HNS Health Board (Tayside); HNS Health Board (Lothian); HNS Health Board (Greater Glasgow Clyde); Scottish Enterprise; Wyeth Pharmaceutical(Wyeth); Scottish Imaging Network: A Platform for Scientific Excellence (SINAPSE)	This work was supported by an award (Ref: NS_AU_084) from the Translational Medicine Research Collaboration a consortium made up of the Universities of Aberdeen, Dundee, Edinburgh and Glasgow, the four associated HNS Health Boards (Grampian, Tayside, Lothian and Greater Glasgow & Clyde), Scottish Enterprise and Wyeth Pharmaceutical. Dr. S. Champion is funded by the Scottish Imaging Network: A Platform for Scientific Excellence (SINAPSE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airaksinen AJ, 2006, NUCL MED BIOL, V33, P801, DOI 10.1016/j.nucmedbio.2006.05.008; Anichtchik OV, 2001, NEUROBIOL DIS, V8, P707, DOI 10.1006/nbdi.2001.0413; ARRANG JM, 1983, NATURE, V302, P832, DOI 10.1038/302832a0; ARRANG JM, 1995, BRIT J PHARMACOL, V114, P1518, DOI 10.1111/j.1476-5381.1995.tb13379.x; Ashworth S, 2014, BRIT J PHARMACOL, V171, P1241, DOI 10.1111/bph.12505; Ashworth S, 2010, J NUCL MED, V51, P1021, DOI 10.2967/jnumed.109.071753; Bao XF, 2012, J MED CHEM, V55, P2406, DOI 10.1021/jm201690h; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cain SM, 2009, EPILEPSIA, V50, P1962, DOI 10.1111/j.1528-1167.2009.02095.x; Champion S, 2011, J LABELLED COMPD RAD, V54, P674, DOI 10.1002/jlcr.1899; CLAPHAM J, 1992, BRIT J PHARMACOL, V107, P919, DOI 10.1111/j.1476-5381.1992.tb13386.x; Cole DC, 2010, US Pat Appl Publ US, Patent No. 7820825; Cole DC, 2010, BIOORG MED CHEM LETT, V20, P1237, DOI 10.1016/j.bmcl.2009.11.122; DISCHINO DD, 1983, J NUCL MED, V24, P1030; Dohan O, 2003, ENDOCR REV, V24, P48, DOI 10.1210/er.2001-0029; Elfving B, 2003, EUR J NUCL MED MOL I, V30, P912, DOI 10.1007/s00259-003-1171-8; Funaki Y, 2007, NUCL MED BIOL, V34, P981, DOI 10.1016/j.nucmedbio.2007.07.012; Funke U, 2013, J LABELLED COMPD RAD, V56, P120, DOI 10.1002/jlcr.3038; Hamill TG, 2009, SYNAPSE, V63, P1122, DOI 10.1002/syn.20689; JANSEN FP, 1994, BRIT J PHARMACOL, V113, P355, DOI 10.1111/j.1476-5381.1994.tb16995.x; Jansen FP, 1997, THESIS LEIDEN AMSTER; Jin CY, 2009, BRIT J PHARMACOL, V157, P118, DOI 10.1111/j.1476-5381.2009.00149.x; Jucaite A, 2013, INT J NEUROPSYCHOPH, V16, P1231, DOI 10.1017/S1461145712001411; Lenz C, 1998, ANESTHESIOLOGY, V89, P1480, DOI 10.1097/00000542-199812000-00026; LIGNEAU X, 1994, J PHARMACOL EXP THER, V271, P452; Logan J, 2012, PSYCHOPHARMACOLOGY, V223, P447, DOI 10.1007/s00213-012-2733-x; MAEKAWA T, 1986, ANESTHESIOLOGY, V65, P144, DOI 10.1097/00000542-198608000-00003; Medhurst AD, 2009, BRIT J PHARMACOL, V157, P130, DOI 10.1111/j.1476-5381.2008.00075.x; Panula P, 2013, NAT REV NEUROSCI, V14, P472, DOI 10.1038/nrn3526; Passani MB, 2011, TRENDS PHARMACOL SCI, V32, P242, DOI 10.1016/j.tips.2011.01.003; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pike VW, 2009, TRENDS PHARMACOL SCI, V30, P431, DOI 10.1016/j.tips.2009.05.005; Pillot C, 2002, NEUROSCIENCE, V114, P173, DOI 10.1016/S0306-4522(02)00135-5; Plisson C, 2009, J NUCL MED, V50, P2064, DOI 10.2967/jnumed.109.062919; POLLARD H, 1993, NEUROSCIENCE, V52, P169, DOI 10.1016/0306-4522(93)90191-H; Rahman M, 1996, J APPL TOXICOL, V16, P331; Sasse A, 2001, ARCH PHARM, V334, P45, DOI 10.1002/1521-4184(200102)334:2<45::AID-ARDP45>3.0.CO;2-2; SCHLICKER E, 1989, N-S ARCH PHARMACOL, V340, P633, DOI 10.1007/BF00717738; SCHLICKER E, 1993, J NEURAL TRANSM-GEN, V93, P1, DOI 10.1007/BF01244933; SCHLICKER E, 1988, N-S ARCH PHARMACOL, V337, P588; Schwartz JC, 2011, BRIT J PHARMACOL, V163, P713, DOI 10.1111/j.1476-5381.2011.01286.x; Sheng Y, 2012, J NEUROL SCI, V315, P110, DOI 10.1016/j.jns.2011.11.013; Tavares AAS, 2012, NUCL MED BIOL, V39, P127, DOI 10.1016/j.nucmedbio.2011.06.011; Teuscher C, 2007, P NATL ACAD SCI USA, V104, P10146, DOI 10.1073/pnas.0702291104; Van Laere KJ, 2014, J NUCL MED, V55, P65, DOI 10.2967/jnumed.113.122515; Waterhouse Rikki N, 2003, Mol Imaging Biol, V5, P376, DOI 10.1016/j.mibio.2003.09.014; Wilson AA, 2001, APPL RADIAT ISOTOPES, V54, P203, DOI 10.1016/S0969-8043(00)00269-4; Windhorst AD, 1999, BIOORGAN MED CHEM, V7, P1761, DOI 10.1016/S0968-0896(99)00108-X; Windhorst AD, 1999, NUCL MED BIOL, V26, P651, DOI 10.1016/S0969-8051(99)00014-1; WOOD M, 1984, ANESTH ANALG, V63, P709	50	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115876	10.1371/journal.pone.0115876	http://dx.doi.org/10.1371/journal.pone.0115876			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542008	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000347239900102
J	Moens, SJB; Mooij, HL; Hassing, HC; Kruit, JK; Witjes, JJ; de Sande, MAJV; Nederveen, AJ; Xu, D; Dallinga-Thie, GM; Esko, JD; Stroes, ESG; Nieuwdorp, M				Moens, Sophie J. Bernelot; Mooij, Hans L.; Hassing, H. Carlijne; Kruit, Janine K.; Witjes, Julia J.; de Sande, Michiel A. J. van; Nederveen, Aart J.; Xu, Ding; Dallinga-Thie, Geesje M.; Esko, Jeffrey D.; Stroes, Erik S. G.; Nieuwdorp, Max			Carriers of Loss-of-Function Mutations in EXT Display Impaired Pancreatic Beta-Cell Reserve Due to Smaller Pancreas Volume	PLOS ONE			English	Article							HEREDITARY MULTIPLE EXOSTOSES; INDUCED INSULIN-SECRETION; GLUCAGON-LIKE PEPTIDE-1; HEPARAN-SULFATE; TUMOR SUPPRESSORS; BIOSYNTHESIS; ASSOCIATION; RISK; OSTEOCALCIN; GROWTH	Exotosin (EXT) proteins are involved in the chain elongation step of heparan sulfate (HS) biosynthesis, which is intricately involved in organ development. Loss of function mutations (LOF) in EXT1 and EXT2 result in hereditary exostoses (HME). Interestingly, HS plays a role in pancreas development and beta-cell function, and genetic variations in EXT2 are associated with an increased risk for type 2 diabetes mellitus. We hypothesized that loss of function of EXT1 or EXT2 in subjects with hereditary multiple exostoses (HME) affects pancreatic insulin secretion capacity and development. We performed an oral glucose tolerance test (OGTT) followed by hyperglycemic clamps to investigate first-phase glucose-stimulated insulin secretion (GSIS) in HME patients and age and gender matched non-affected relatives. Pancreas volume was assessed with magnetic resonance imaging (MRI). OGTT did not reveal significant differences in glucose disposal, but there was a markedly lower GSIS in HME subjects during hyperglycemic clamp (iAUC HME: 0.72 [0.46-1.16] vs. controls 1.53 [0.69-3.36] nmol.l(-1).min(-1), p<0.05). Maximal insulin response following arginine challenge was also significantly attenuated (iAUC HME: 7.14 [4.22-10.5] vs. controls 10.2 [7.91-12.70] nmol.l(-1).min(-1) p<0.05), indicative of an impaired beta-cell reserve. MRI revealed a significantly smaller pancreatic volume in HME subjects (HME: 72.0 +/- 15.8 vs. controls 96.5 +/- 26.0 cm(3) p=0.04). In conclusion, loss of function of EXT proteins may affect beta-cell mass and insulin secretion capacity in humans, and render subjects at a higher risk of developing type 2 diabetes when exposed to environmental risk factors.	[Moens, Sophie J. Bernelot; Mooij, Hans L.; Hassing, H. Carlijne; Witjes, Julia J.; Dallinga-Thie, Geesje M.; Stroes, Erik S. G.; Nieuwdorp, Max] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Kruit, Janine K.] Univ Groningen, Univ Med Ctr Groningen, Dept Paediat, Groningen, Netherlands; [de Sande, Michiel A. J. van] LUMC, Dept Orthopaed, Leiden, Netherlands; [Nederveen, Aart J.] Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands; [Xu, Ding; Esko, Jeffrey D.; Nieuwdorp, Max] Univ Calif San Diego, Dept Cellular & Mol Med, San Diego, CA 92103 USA; [Dallinga-Thie, Geesje M.; Nieuwdorp, Max] Univ Amsterdam, Acad Med Ctr, Dept Expt Vasc Med, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Groningen; Leiden University; Leiden University Medical Center (LUMC); University of Amsterdam; Academic Medical Center Amsterdam; University of California System; University of California San Diego; University of Amsterdam; Academic Medical Center Amsterdam	Nieuwdorp, M (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	m.nieuwdorp@amc.uva.nl	Xu, Ding/B-2493-2009; van de Sande, Michiel/N-9607-2019; Kruit, Janine/AGI-8582-2022	Xu, Ding/0000-0001-9380-2712; van de Sande, Michiel/0000-0002-9156-7656; Kruit, Janine/0000-0002-5414-0485; dallinga-thie, geesje/0000-0001-5412-5923; Nederveen, Aart/0000-0002-5477-973X	Nederlandse Organisatie voor Wetenschappelijk Onderzoek(NWO)-VENI grant [016.096.044]; Dutch Diabetes foundation [2009.80.114]; National Institutes of Health [NIH GM33063]; CardioVasculair Onderzoek Nederland (CVON-GENIUS) [CVON2011-19]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033063, R37GM033063] Funding Source: NIH RePORTER	Nederlandse Organisatie voor Wetenschappelijk Onderzoek(NWO)-VENI grant; Dutch Diabetes foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CardioVasculair Onderzoek Nederland (CVON-GENIUS); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	M. Nieuwdorp is supported by Nederlandse Organisatie voor Wetenschappelijk Onderzoek(NWO)-VENI grant 2008 (016.096.044); http://www.nwo.nl/. J.K. Kruit is supported by a grant from the Dutch Diabetes foundation (2009.80.114); http://www.diabetesfonds.nl. J.D. Esko is supported by National Institutes of Health (NIH GM33063); http://www.nih.gob/. S.J. Bernelot Moens and E.S.G. Stroes received a grant from CardioVasculair Onderzoek Nederland (CVON-GENIUS)number CVON2011-19; http://www.cvon.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anower-E-Khuda MF, 2013, GLYCOBIOLOGY, V23, P865, DOI 10.1093/glycob/cwt024; Bari MS, 2012, JCPSP-J COLL PHYSICI, V22, P797, DOI 12.2012/JCPSP.797799; Bellaiche Y, 1998, NATURE, V394, P85, DOI 10.1038/27932; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Booth SL, 2013, NAT REV ENDOCRINOL, V9, P43, DOI 10.1038/nrendo.2012.201; Busse M, 2007, J BIOL CHEM, V282, P32802, DOI 10.1074/jbc.M703560200; Duncan G, 2001, J CLIN INVEST, V108, P511, DOI 10.1172/JCI200113737; FAJANS SS, 1967, J CLIN ENDOCR METAB, V27, P1600, DOI 10.1210/jcem-27-11-1600; Fridlyand LE, 2006, DIABETES OBES METAB, V8, P136, DOI 10.1111/j.1463-1326.2005.00496.x; Fujino T, 2003, P NATL ACAD SCI USA, V100, P229, DOI 10.1073/pnas.0133792100; Hecht JT, 2002, BONE, V31, P199, DOI 10.1016/S8756-3282(02)00796-2; Heijboer AC, 2011, CLIN CHIM ACTA, V412, P1191, DOI 10.1016/j.cca.2011.03.010; Herder C, 2008, HORM METAB RES, V40, P722, DOI 10.1055/s-2008-1078730; Horikoshi M, 2007, DIABETOLOGIA, V50, P2461, DOI 10.1007/s00125-007-0827-5; Jaerger M, 2007, J ORTHOP RES, V25, P1541, DOI 10.1002/jor.20479; KAHN SE, 1993, DIABETES, V42, P1663, DOI 10.2337/diabetes.42.11.1663; Kayed H, 2006, PANCREAS, V32, P119, DOI 10.1097/01.mpa.0000202937.55460.0c; Kifagi C, 2011, GENET TEST MOL BIOMA, V15, P399, DOI 10.1089/gtmb.2010.0199; Kuchuk NO, 2009, J CLIN ENDOCR METAB, V94, P1244, DOI 10.1210/jc.2008-1832; Lewis JP, 2008, DIABETES, V57, P2220, DOI 10.2337/db07-1319; Lind T, 1998, J BIOL CHEM, V273, P26265, DOI 10.1074/jbc.273.41.26265; Liu L, 2013, HUM GENET, V132, P139, DOI 10.1007/s00439-012-1231-x; McCormick C, 1998, NAT GENET, V19, P158, DOI 10.1038/514; McCulloch LJ, 2011, MOL GENET METAB, V104, P648, DOI 10.1016/j.ymgme.2011.08.026; Mizokami A, 2014, BONE, V69, P68, DOI 10.1016/j.bone.2014.09.006; Mizokami A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057375; Mori S, 2008, DIABETES, V57, P791, DOI 10.2337/db07-0979; Nadanaka S, 2008, J BIOCHEM, V144, P7, DOI 10.1093/jb/mvn040; Nadanaka S, 2013, J BIOL CHEM, V288, P9321, DOI 10.1074/jbc.M112.416909; Nijpels G, 2008, J CLIN ENDOCR METAB, V93, P2633, DOI 10.1210/jc.2007-2837; Nybakken K, 2002, BBA-GEN SUBJECTS, V1573, P280, DOI 10.1016/S0304-4165(02)00395-1; Okada M, 2010, BIOCHEM J, V428, P463, DOI 10.1042/BJ20100101; Osman NMS, 2003, ANAT EMBRYOL, V207, P333, DOI 10.1007/s00429-003-0348-z; Park JW, 2013, BRIT J SURG, V100, P1064, DOI 10.1002/bjs.9146; Pedrini E, 2011, J BONE JOINT SURG AM, V93A, P2294, DOI [10.2106/JBJS.J.00949, 10.2106/JBJSJ.00949]; Raats CJI, 1997, J BIOL CHEM, V272, P26734, DOI 10.1074/jbc.272.42.26734; Rong R, 2009, DIABETES, V58, P478, DOI 10.2337/db08-0877; SCHMALE GA, 1994, J BONE JOINT SURG AM, V76A, P986, DOI 10.2106/00004623-199407000-00005; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; SOLOMON L, 1964, AM J HUM GENET, V16, P351; Straub SG, 2004, AM J PHYSIOL-CELL PH, V287, pC565, DOI 10.1152/ajpcell.00079.2004; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329; Takahashi I, 2009, BIOCHEM BIOPH RES CO, V383, P113, DOI 10.1016/j.bbrc.2009.03.140; Thams P, 1999, EUR J ENDOCRINOL, V140, P87, DOI 10.1530/eje.0.1400087; Thomas MK, 2000, DIABETES, V49, P2039, DOI 10.2337/diabetes.49.12.2039; Tripathy D, 2004, DIABETES CARE, V27, P2204, DOI 10.2337/diacare.27.9.2204; Vergeer M, 2010, DIABETES CARE, V33, P869, DOI 10.2337/dc09-1562; Wei JW, 2014, J CLIN INVEST, V124, P1781, DOI 10.1172/JCI72323; Wei JW, 2014, DIABETES, V63, P1021, DOI 10.2337/db13-0887; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; Zertal-Zidani S, 2007, DIABETOLOGIA, V50, P585, DOI 10.1007/s00125-006-0571-2; Ziolkowski AF, 2012, J CLIN INVEST, V122, P132, DOI 10.1172/JCI46177	52	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115662	10.1371/journal.pone.0115662	http://dx.doi.org/10.1371/journal.pone.0115662			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541963	Green Published, Green Submitted, gold			2022-12-27	WOS:000347239900065
J	Simon, G; Larsen, LE; Durrwald, R; Foni, E; Harder, T; Van Reeth, K; Markowska-Daniel, I; Reid, SM; Dan, A; Maldonado, J; Huovilainen, A; Billinis, C; Davidson, I; Aguero, M; Vila, T; Herve, S; Breum, SO; Chiapponi, C; Urbaniak, K; Kyriakis, CS; Brown, IH; Loeffen, W				Simon, Gaelle; Larsen, Lars E.; Duerrwald, Ralf; Foni, Emanuela; Harder, Timm; Van Reeth, Kristien; Markowska-Daniel, Iwona; Reid, Scott M.; Dan, Adam; Maldonado, Jaime; Huovilainen, Anita; Billinis, Charalambos; Davidson, Irit; Agueero, Montserrat; Vila, Thais; Herve, Severine; Breum, Solvej Ostergaard; Chiapponi, Chiara; Urbaniak, Kinga; Kyriakis, Constantinos S.; Brown, Ian H.; Loeffen, Willie		ESNIP3 Consortium	European Surveillance Network for Influenza in Pigs: Surveillance Programs, Diagnostic Tools and Swine Influenza Virus Subtypes Identified in 14 European Countries from 2010 to 2013	PLOS ONE			English	Article							PANDEMIC H1N1 2009; UNIVERSAL PRIMER SET; A VIRUS; GENETIC REASSORTMENT; PCR ASSAY; RT-PCR; TRANSMISSION; H3N2; EVOLUTION; PORCINE	Swine influenza causes concern for global veterinary and public health officials. In continuing two previous networks that initiated the surveillance of swine influenza viruses (SIVs) circulating in European pigs between 2001 and 2008, a third European Surveillance Network for Influenza in Pigs (ESNIP3, 2010-2013) aimed to expand widely the knowledge of the epidemiology of European SIVs. ESNIP3 stimulated programs of harmonized SIV surveillance in European countries and supported the coordination of appropriate diagnostic tools and subtyping methods. Thus, an extensive virological monitoring, mainly conducted through passive surveillance programs, resulted in the examination of more than 9 000 herds in 17 countries. Influenza A viruses were detected in 31% of herds examined from which 1887 viruses were preliminary characterized. The dominating subtypes were the three European enzootic SIVs: avian-like swine H1N1 (53.6%), human-like reassortant swine H1N2 (13%) and human-like reassortant swine H3N2 (9.1%), as well as pandemic A/H1N1 2009 (H1N1pdm) virus (10.3%). Viruses from these four lineages co-circulated in several countries but with very different relative levels of incidence. For instance, the H3N2 subtype was not detected at all in some geographic areas whereas it was still prevalent in other parts of Europe. Interestingly, H3N2-free areas were those that exhibited highest frequencies of circulating H1N2 viruses. H1N1pdm viruses were isolated at an increasing incidence in some countries from 2010 to 2013, indicating that this subtype has become established in the European pig population. Finally, 13.9% of the viruses represented reassortants between these four lineages, especially between previous enzootic SIVs and H1N1pdm. These novel viruses were detected at the same time in several countries, with increasing prevalence. Some of them might become established in pig herds, causing implications for zoonotic infections.	[Simon, Gaelle; Herve, Severine] Anses, Swine Virol Immunol Unit, Ploufragan Plouzane Lab, Ploufragan, France; [Larsen, Lars E.; Breum, Solvej Ostergaard] Tech Univ Denmark, Natl Vet Inst, Copenhagen, Denmark; [Duerrwald, Ralf] IDT Biol GmbH, Dessau Rosslau, Germany; [Foni, Emanuela; Chiapponi, Chiara] Ist Zooprofilatt Sperimentale Lombardia & Emilia, Parma, Italy; [Harder, Timm] Friedrich Loeffler Inst, Greifswald, Germany; [Van Reeth, Kristien] Univ Ghent, Fac Vet Med, Virol Lab, Merelbeke, Belgium; [Markowska-Daniel, Iwona; Urbaniak, Kinga] Natl Inst Vet Res, Pulawy, Poland; [Reid, Scott M.; Brown, Ian H.] Anim Hlth & Vet Labs Agcy, Weybridge, Surrey, England; [Dan, Adam] Mol Biol Lab, Vet Diagnost Directorate, Natl Food Chain Safety Off, Budapest, Hungary; [Maldonado, Jaime] Hipra, Girona, Spain; [Huovilainen, Anita] Finnish Food Safety Author, Helsinki, Finland; [Billinis, Charalambos; Kyriakis, Constantinos S.] Univ Thessaly, Fac Vet Med, Lab Microbiol & Parasitol, Kardhitsa, Greece; [Davidson, Irit] Kimron Vet Inst, Rishon Ltzion, Israel; [Agueero, Montserrat] Lab Cent Vet Sanidad Anim, Algete, Spain; [Vila, Thais] Merial, Lyon, France; [Loeffen, Willie] Wageningen UR, Cent Vet Inst, Lelystad, Netherlands	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Technical University of Denmark; IDT Biologika; IZS Lombardia e Emilia; Friedrich Loeffler Institute; Ghent University; National Veterinary Institute - National Research Institute; Veterinary Laboratories Agency; HIPRA; Finnish Food Authority; University of Thessaly; Kimron Veterinary Institute; Merial SASU; Wageningen University & Research	Simon, G (corresponding author), Anses, Swine Virol Immunol Unit, Ploufragan Plouzane Lab, Ploufragan, France.	gaelle.simon@anses.fr	Loeffen, Willie/M-5344-2015; Dán, Ádám/G-6018-2012; Brown, Ian H/E-1119-2011; Davidson, Irit/Q-4452-2019; Harder, Timm/AAE-2932-2019; Pybus, Oliver G/B-2640-2012; Maldonado, Jaime/ABG-3226-2020; Simon, Gaelle/ABI-1479-2020; Larsen, Lars E/G-3827-2015	Loeffen, Willie/0000-0003-4732-4590; Dán, Ádám/0000-0001-7849-7721; Harder, Timm/0000-0003-2387-378X; Pybus, Oliver G/0000-0002-8797-2667; Simon, Gaelle/0000-0003-1099-5075; Larsen, Lars E/0000-0003-0730-5555; Kyriakis, Constantinos/0000-0001-7171-923X; Markowska-Daniel, Iwona/0000-0003-2889-6745; Chiapponi, Chiara/0000-0001-8808-4680; Urbaniak, Kinga/0000-0002-7965-9216	European Union FP7-INFLUENZA program [259949]	European Union FP7-INFLUENZA program	Financial support to ESNIP3 was provided by European Union FP7-INFLUENZA-2010 program, grant #259949. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balint A, 2012, ACTA VET HUNG, V61, P125; Banyai K, 2012, J VIROL, V86, P13133, DOI 10.1128/JVI.02503-12; Breum SO, 2013, GENOME ANNOUNC, V1; Brookes SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009068; Brown I. H., 2013, Pig Journal, V68, P8; Brown IH, 1998, J GEN VIROL, V79, P2947, DOI 10.1099/0022-1317-79-12-2947; Cardinale E, 2012, EMERG INFECT DIS, V18, P1665, DOI 10.3201/eid1810.120398; CASTRUCCI MR, 1993, VIROLOGY, V193, P503, DOI 10.1006/viro.1993.1155; Cheung TKW, 2007, ANN NY ACAD SCI, V1102, P1, DOI 10.1196/annals.1408.001; Chiapponi C, 2013, GENOME ANNOUNC, V1; Chiapponi C, 2003, SUBTYPING H1N1 H1N2, P257; Chiapponi C, 2012, J VIROL METHODS, V184, P117, DOI 10.1016/j.jviromet.2012.05.020; Chiapponi C, 2010, J VIROL METHODS, V163, P162, DOI 10.1016/j.jviromet.2009.09.017; de Jong JC, 1999, VACCINE, V17, P1321, DOI 10.1016/S0264-410X(98)00392-2; De Vleeschauwer A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006662; Ducatez MF, 2011, EMERG INFECT DIS, V17, P1624, DOI 10.3201/eid1709.110338; Durrwald R, 2010, EMERG INFECT DIS, V16, P1029, DOI 10.3201/eid1606.100138; Epperson S, 2013, CLIN INFECT DIS, V57, pS4, DOI 10.1093/cid/cit272; Fereidouni SR, 2012, J VIROL METHODS, V186, P119, DOI 10.1016/j.jviromet.2012.08.002; Fereidouni SR, 2008, J VIROL METHODS, V154, P14, DOI 10.1016/j.jviromet.2008.09.011; Fouchier RAM, 2000, J CLIN MICROBIOL, V38, P4096, DOI 10.1128/JCM.38.11.4096-4101.2000; Gall A, 2008, J CLIN MICROBIOL, V46, P2561, DOI 10.1128/JCM.00466-08; Gall A, 2009, J CLIN MICROBIOL, V47, P327, DOI 10.1128/JCM.01330-08; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Grontvedt C.A, 2011, INFLUENZA RES TREAT; HAESEBROUCK F, 1985, AM J VET RES, V46, P1926; Harder TC, 2013, J VIROL, V87, P10460, DOI 10.1128/JVI.00381-13; Herve S, 2012, B EPIDEMIOLOGIQUE SA, V51, P22; Hoffmann B, 2010, BERL MUNCH TIERARZTL, V123, P286, DOI 10.2376/0005-9366-123-286; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Hofshagen M, 2009, EUROSURVEILLANCE, V14, P15; Howard WA, 2011, EMERG INFECT DIS, V17, P1049, DOI [10.3201/eid1706.101886, 10.3201/eid/1706.101886]; Howden KJ, 2009, CAN VET J, V50, P1153; Kitikoon P, 2013, J GEN VIROL, V94, P1236, DOI [10.1099/vir.0.51839-0, 10.1099/vir.0.051839-0]; Kowalczyk A, 2013, J VIROL METHODS, V187, P228, DOI 10.1016/j.jviromet.2012.08.011; Kuntz-Simon G, 2009, ZOONOSES PUBLIC HLTH, V56, P310, DOI 10.1111/j.1863-2378.2009.01236.x; Kyriakis CS, 2013, VET MICROBIOL, V162, P543, DOI 10.1016/j.vetmic.2012.11.014; Kyriakis CS, 2011, ZOONOSES PUBLIC HLTH, V58, P93, DOI 10.1111/j.1863-2378.2009.01301.x; Kyriakis CS, 2010, EMERG INFECT DIS, V16, P96, DOI 10.3201/eid1601.091190; Lange E, 2009, J GEN VIROL, V90, P2119, DOI 10.1099/vir.0.014480-0; Lange J, 2013, VET MICROBIOL, V167, P345, DOI 10.1016/j.vetmic.2013.09.024; Liang HY, 2014, J VIROL, V88, P10864, DOI 10.1128/JVI.01327-14; Liu QF, 2012, ARCH VIROL, V157, P555, DOI 10.1007/s00705-011-1203-9; Loeffen WLA, 2011, VET MICROBIOL, V152, P304, DOI 10.1016/j.vetmic.2011.05.027; Markowska-Daniel I, 2013, B VET I PULAWY, V57, P293, DOI 10.2478/bvip-2013-0051; Marozin S, 2002, J GEN VIROL, V83, P735, DOI 10.1099/0022-1317-83-4-735; Moreno Ana, 2010, Open Virol J, V4, P52, DOI 10.2174/1874357901004010052; Munch M, 2001, ARCH VIROL, V146, P87, DOI 10.1007/s007050170193; Nelson MI, 2012, J GEN VIROL, V93, P2584, DOI 10.1099/vir.0.045930-0; Nelson MI, 2012, J GEN VIROL, V93, P2195, DOI 10.1099/vir.0.044974-0; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Nokireki T, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-69; OIE, 2012, MANUAL DIAGNOSTIC TE; PENSAERT M, 1981, B WORLD HEALTH ORGAN, V59, P75; Pol F, 2011, J VIROL METHODS, V171, P241, DOI 10.1016/j.jviromet.2010.11.007; Poon LLM, 2010, CLIN CHEM, V56, P1340, DOI 10.1373/clinchem.2010.149179; Reeth VK, 2012, DIS SWINE, V10th, P557; Simon G, 2013, ISIRV 7 8 MARCH DUBL, P43; Simon G, 2013, B EPIDEMIOLOGIQUE SA, V56, P17; Slomka MJ, 2010, INFLUENZA OTHER RESP, V4, P277, DOI 10.1111/j.1750-2659.2010.00149.x; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Starick E, 2012, J GEN VIROL, V93, P1658, DOI 10.1099/vir.0.042648-0; Starick E, 2011, J GEN VIROL, V92, P1184, DOI 10.1099/vir.0.028662-0; Trebbien R, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-290; Van Reeth K, 2008, INFLUENZA OTHER RESP, V2, P99, DOI 10.1111/j.1750-2659.2008.00043.x; Vijaykrishna D, 2011, NATURE, V473, P519, DOI 10.1038/nature10004; Vincent A, 2014, ZOONOSES PUBLIC HLTH, V61, P4, DOI 10.1111/zph.12049; Welsh MD, 2010, VET REC, V166, P642, DOI 10.1136/vr.4851; Zell R, 2008, ARCH VIROL, V153, P2085, DOI 10.1007/s00705-008-0244-1; Zell R, 2008, J GEN VIROL, V89, P271, DOI 10.1099/vir.0.83338-0; Zell R, 2013, CURR TOP MICROBIOL, V370, P29, DOI 10.1007/82_2012_267	73	78	81	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115815	10.1371/journal.pone.0115815	http://dx.doi.org/10.1371/journal.pone.0115815			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542013	Green Published, gold, Green Submitted			2022-12-27	WOS:000347239900093
J	Vrijenhoek, JEP; Nelissen, BGL; Velema, E; Vons, K; de Vries, JPPM; Eijkemans, MJC; den Ruijter, HM; de Borst, GJ; Moll, FL; Pasterkamp, G				Vrijenhoek, Joyce E. P.; Nelissen, Bastiaan G. L.; Velema, Evelyn; Vons, Kristy; de Vries, Jean-Paul P. M.; Eijkemans, Marinus J. C.; den Ruijter, Hester M.; de Borst, Gert Jan; Moll, Frans L.; Pasterkamp, Gerard			High Reproducibility of Histological Characterization by Whole Virtual Slide Quantification; An Example Using Carotid Plaque Specimens	PLOS ONE			English	Article							EVENTS	Objective: Tissue biobanks are an important source for discovery and validation studies aiming for new proteins that are causally related with disease development. There is an increasing demand for accurate and reproducible histological characterization, especially for subsequent analysis and interpretation of data in association studies. We assessed reproducibility of one semiquantative and two quantitative methods for histological tissue characterization. We introduce a new automated method for whole digital slide quantification. Carotid atherosclerotic plaques were used to test reproducibility. Methods: 50 atherosclerotic plaques that were obtained during carotid endarterectomy were analysed. For the semiquantitative analysis, 6 different plaque characteristics were scored in categories by two independent observers, and Cohen's kappa was used to test intra- and interobserver reproducibility. The computer-aided method (assessed by two independent observers) and automated method were tested on CD68 (for macrophages) and alpha smooth muscle actin (for smooth muscle cells) stainings. Agreement for these two methods (done on a continuous scale) was assessed by intraclass correlation coefficients (ICCs). Results: For the semiquantitative analysis, kappa values ranged from 0.55 to 0.69 for interobserver variability, and were slightly higher for intraobserver reproducibility in both observers. The computer-aided method yielded intra-and interobserver ICCs between 0.6 and 0.9. The new automated method performed most optimal regarding reproducibility, with ICCs ranging from 0.92 to 0.97. Conclusions: The analysis of performance of three methods for histological slide characterization on carotid atherosclerotic plaques showed high precision and agreement in repeated measurements for the automated method for whole digital slide quantification. We suggest that this method can fulfill the need for reproducible histological quantification.	[Vrijenhoek, Joyce E. P.; Nelissen, Bastiaan G. L.; Velema, Evelyn; Vons, Kristy; den Ruijter, Hester M.; Pasterkamp, Gerard] Univ Med Ctr Utrecht, Expt Cardiol Lab, Utrecht, Netherlands; [Vrijenhoek, Joyce E. P.] Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands; [Vrijenhoek, Joyce E. P.; Nelissen, Bastiaan G. L.; de Borst, Gert Jan; Moll, Frans L.] Univ Med Ctr Utrecht, Dept Vasc Surg, Utrecht, Netherlands; [de Vries, Jean-Paul P. M.] St Antonius Hosp, Dept Vasc Surg, Nieuwegein, Netherlands; [Eijkemans, Marinus J. C.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Interuniversity Cardiology Institute of the Netherlands; Utrecht University; Utrecht University; Utrecht University Medical Center; St. Antonius Hospital Utrecht; Utrecht University; Utrecht University Medical Center	Vrijenhoek, JEP (corresponding author), Univ Med Ctr Utrecht, Expt Cardiol Lab, Utrecht, Netherlands.	j.e.p.vrijenhoek@umcutrecht.nl		den Ruijter, Hester/0000-0001-9762-014X				Al-Janabi S, 2012, HISTOPATHOLOGY, V61, P1, DOI 10.1111/j.1365-2559.2011.03814.x; Altaf N, 2007, STROKE, V38, P1633, DOI 10.1161/STROKEAHA.106.473066; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; FLEISS JL, 1973, EDUC PSYCHOL MEAS, V33, P613, DOI 10.1177/001316447303300309; Hellings WE, 2007, J VASC SURG, V46, P1147, DOI 10.1016/j.jvs.2007.08.018; Lindsay AC, 2012, JACC-CARDIOVASC IMAG, V5, P388, DOI 10.1016/j.jcmg.2011.10.007; Lovett JK, 2004, CEREBROVASC DIS, V18, P117, DOI 10.1159/000079259; LOWRY R, KAPPA AS A MEASURE O; Minot DM, 2009, AM J CLIN PATHOL, V132, P133, DOI 10.1309/AJCPJV0SKAF2PCMY; Prlic A, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002802; Qiao Y, 2012, AM J NEURORADIOL, V33, P755, DOI 10.3174/ajnr.A2863; *R PROJ CONTR, R PROJ STAT COMP; Singh N, 2009, RADIOLOGY, V252, P502, DOI 10.1148/radiol.2522080792; Verhoeven BAN, 2004, EUR J EPIDEMIOL, V19, P1127, DOI 10.1007/s10564-004-2304-6; Webster JD, 2014, VET PATHOL, V51, P211, DOI 10.1177/0300985813503570	15	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115907	10.1371/journal.pone.0115907	http://dx.doi.org/10.1371/journal.pone.0115907			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541691	Green Published, Green Submitted, gold			2022-12-27	WOS:000347239900106
J	Durigan, M; Abreu, AG; Zucchi, MI; Franco, RMB; de Souza, AP				Durigan, Mauricio; Abreu, Aluana Goncalves; Zucchi, Maria Imaculada; Bueno Franco, Regina Maura; de Souza, Anete Pereira			Genetic Diversity of Giardia duodenalis: Multilocus Genotyping Reveals Zoonotic Potential between Clinical and Environmental Sources in a Metropolitan Region of Brazil	PLOS ONE			English	Article							POLYMERASE CHAIN-REACTION; MOLECULAR CHARACTERIZATION; CRYPTOSPORIDIUM OOCYSTS; SEQUENCE-ANALYSIS; ASSEMBLAGE-B; INTESTINALIS; WATER; DOGS; IDENTIFICATION; PCR	Background: Giardia duodenalis is a flagellate protozoan that parasitizes humans and several other mammals. Protozoan contamination has been regularly documented at important environmental sites, although most of these studies were performed at the species level. There is a lack of studies that correlate environmental contamination and clinical infections in the same region. The aim of this study is to evaluate the genetic diversity of a set of clinical and environmental samples and to use the obtained data to characterize the genetic profile of the distribution of G. duodenalis and the potential for zoonotic transmission in a metropolitan region of Brazil. Methodology/Principal Findings: The genetic assemblages and subtypes of G. duodenalis isolates obtained from hospitals, a veterinary clinic, a day-care center and important environmental sites were determined via multilocus sequence-based genotyping using three unlinked gene loci. Cysts of Giardia were detected at all of the environmental sites. Mixed assemblages were detected in 25% of the total samples, and an elevated number of haplotypes was identified. The main haplotypes were shared among the groups, and new subtypes were identified at all loci. Ten multilocus genotypes were identified: 7 for assemblage A and 3 for assemblage B. Conclusions/Significance: There is persistent G. duodenalis contamination at important environmental sites in the city. The identified mixed assemblages likely represent mixed infections, suggesting high endemicity of Giardia in these hosts. Most Giardia isolates obtained in this study displayed zoonotic potential. The high degree of genetic diversity in the isolates obtained from both clinical and environmental samples suggests that multiple sources of infection are likely responsible for the detected contamination events. The finding that many multilocus genotypes (MLGs) and haplotypes are shared by different groups suggests that these sources of infection may be related and indicates that there is a notable risk of human infection caused by Giardia in this region.	[Durigan, Mauricio; de Souza, Anete Pereira] Univ Campinas UNICAMP, Mol Biol & Genet Engn Ctr CBMEG, Campinas, SP, Brazil; [Abreu, Aluana Goncalves; Zucchi, Maria Imaculada] APTA Sapaulo Agcy Agribusiness Technol, Piracicaba, SP, Brazil; [Bueno Franco, Regina Maura] Univ Campinas UNICAMP, Inst Biol, Dept Anim Biol, Campinas, SP, Brazil; [de Souza, Anete Pereira] Univ Campinas UNICAMP, Inst Biol, Dept Plant Biol, Campinas, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas	de Souza, AP (corresponding author), Univ Campinas UNICAMP, Mol Biol & Genet Engn Ctr CBMEG, Campinas, SP, Brazil.	anete@unicamp.br	DE SOUZA, ANETE PEREIRA/B-8663-2012; Abreu, Aluana/AGQ-4693-2022; Zucchi, Maria Imaculada/D-2637-2012; Abreu, Aluana G/L-7772-2013; Durigan, Mauricio/GLU-4564-2022; Zucchi, Maria Imaculada/AAC-8157-2019; Franco, Regina Bueno/N-5326-2015	DE SOUZA, ANETE PEREIRA/0000-0003-3831-9829; Abreu, Aluana/0000-0003-2765-3741; Zucchi, Maria Imaculada/0000-0002-4863-1843; Abreu, Aluana G/0000-0003-2765-3741; Zucchi, Maria Imaculada/0000-0002-4863-1843; Franco, Regina Bueno/0000-0003-1920-6140	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq [577032/2008-9, 304914/2010-0]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [MS 2008/52197-4, DD 2011/50413-4]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) through a research grant and a research fellowship awarded to APS (number 577032/2008-9 and 304914/2010-0), by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES - BioComputacional Program) and by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) through a graduate fellowship to MD (MS 2008/52197-4 and DD 2011/50413-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe N, 2003, J VET MED SCI, V65, P29, DOI 10.1292/jvms.65.29; Adam RD, 2001, CLIN MICROBIOL REV, V14, P447, DOI 10.1128/CMR.14.3.447-475.2001; Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Al-Mohammed HI, 2011, PARASITOL RES, V108, P1375, DOI 10.1007/s00436-010-2033-5; ANDREWS RH, 1989, INT J PARASITOL, V19, P183, DOI 10.1016/0020-7519(89)90006-4; Ankarklev J, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001780; Bertrand I, 2007, WATER RES, V41, P3675, DOI 10.1016/j.watres.2007.02.043; Bowman DD, 2010, EXP PARASITOL, V124, P121, DOI 10.1016/j.exppara.2009.01.003; Caccio SM, 2008, INT J PARASITOL, V38, P1523, DOI 10.1016/j.ijpara.2008.04.008; Caccio SA, 2002, INT J PARASITOL, V32, P1023, DOI 10.1016/S0020-7519(02)00068-1; Caccio SM, 2008, MOL BIOCHEM PARASIT, V160, P75, DOI 10.1016/j.molbiopara.2008.04.006; Caccio SM, 2010, EXP PARASITOL, V124, P107, DOI 10.1016/j.exppara.2009.02.007; Neto RC, 2006, WATER SCI TECHNOL, V54, P89, DOI 10.2166/wst.2006.453; Neto RC, 2010, WATER SCI TECHNOL, V62, P217, DOI 10.2166/wst.2010.312; Cardoso F. M., 2005, Revista de Ciencias Medicas, V14, P337; Cavalier-Smith T, 2004, P ROY SOC B-BIOL SCI, V271, P1251, DOI 10.1098/rspb.2004.2705; CDC, 1994, ADDR EM INF DIS THRE; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Dos Santos Luciana Urbano, 2013, ISRN Parasitol, V2013, P713958, DOI 10.5402/2013/713958; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Faust E. C., 1938, American Journal of Tropical Medicine, V18, P169; Franco R M, 1996, Rev Soc Bras Med Trop, V29, P585, DOI 10.1590/S0037-86821996000600010; Franco Regina Maura Bueno, 2001, Revista do Instituto de Medicina Tropical de Sao Paulo, V43, P109, DOI 10.1590/S0036-46652001000200011; Franzen O, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000560; Geurden T, 2012, VET PARASITOL, V190, P383, DOI 10.1016/j.vetpar.2012.06.039; Geurden T, 2008, VET PARASITOL, V155, P142, DOI 10.1016/j.vetpar.2008.05.002; Geurden T, 2010, VET PARASITOL, V172, P337, DOI 10.1016/j.vetpar.2010.05.015; Gioia I, 1992, Rev Soc Bras Med Trop, V25, P177, DOI 10.1590/S0037-86821992000300005; Haramoto E, 2012, FOOD ENVIRON VIROL, V4, P93, DOI 10.1007/s12560-012-9082-0; HOMAN WL, 1992, PARASITOL RES, V78, P316, DOI 10.1007/BF00937090; Hopkins RM, 1997, J PARASITOL, V83, P44, DOI 10.2307/3284315; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kobayashi Jun, 1995, Revista do Instituto de Medicina Tropical de Sao Paulo, V37, P13, DOI 10.1590/S0036-46651995000100003; Kreader CA, 1996, APPL ENVIRON MICROB, V62, P1102, DOI 10.1128/AEM.62.3.1102-1106.1996; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lasek-Nesselquist E, 2010, INT J PARASITOL, V40, P1063, DOI 10.1016/j.ijpara.2010.02.015; Lebbad M, 2008, ACTA TROP, V106, P44, DOI 10.1016/j.actatropica.2008.01.004; Lebbad M, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001262; Lebbad M, 2010, VET PARASITOL, V168, P231, DOI 10.1016/j.vetpar.2009.11.003; Levecke B, 2009, INT J PARASITOL, V39, P1595, DOI 10.1016/j.ijpara.2009.05.013; Li N, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001809; Maddison DR, 1997, SYST BIOL, V46, P590, DOI 10.2307/2413497; MAHBUBANI MH, 1992, J CLIN MICROBIOL, V30, P74, DOI 10.1128/JCM.30.1.74-78.1992; Monis PT, 1996, PARASITOLOGY, V112, P1, DOI 10.1017/S0031182000065021; Monis PT, 1998, PARASITOLOGY, V116, P7, DOI 10.1017/S0031182097002011; Monis PT, 1999, INT J PARASITOL, V29, P381, DOI 10.1016/S0020-7519(98)00216-1; Moura E C, 1997, J Pediatr (Rio J), V73, P406; NASH TE, 1992, EXP PARASITOL, V75, P369, DOI 10.1016/0014-4894(92)90250-E; O'Handley RM, 2002, GIARDIA COSMOPOLITAN; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Palmer CS, 2008, VET PARASITOL, V154, P142, DOI 10.1016/j.vetpar.2008.02.031; Paoletti B, 2010, RES VET SCI, P10; Silva FMPE, 2012, PARASITOL RES, V110, P325, DOI 10.1007/s00436-011-2492-3; Plutzer J, 2008, INT J HYG ENVIR HEAL, V211, P524, DOI 10.1016/j.ijheh.2008.04.004; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Read CM, 2004, INFECT GENET EVOL, V4, P125, DOI 10.1016/j.meegid.2004.02.001; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Santos Luciana Urbano, 2004, Rev. Inst. Med. trop. S. Paulo, V46, P309, DOI 10.1590/S0036-46652004000600003; Sato MIZ, 2013, SCI TOTAL ENVIRON, V442, P389, DOI 10.1016/j.scitotenv.2012.09.077; Savioli L, 2006, TRENDS PARASITOL, V22, P203, DOI 10.1016/j.pt.2006.02.015; Shepherd KM, 1996, APPL ENVIRON MICROB, V62, P1317, DOI 10.1128/AEM.62.4.1317-1322.1996; SMITH AL, 1989, PARASITOLOGY, V99, P329, DOI 10.1017/S0031182000059035; Soliman RH, 2011, PARASITOL INT, V60, P507, DOI 10.1016/j.parint.2011.09.006; Sprong H, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000558; Sulaiman IM, 2003, EMERG INFECT DIS, V9, P1444, DOI 10.3201/eid0911.030084; Sulaiman IM, 2004, DISTRIBUTION GIARDIA; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Gomez-Munoz MT, 2012, RES VET SCI, V93, P836, DOI 10.1016/j.rvsc.2011.12.012; Thompson RCA, 2008, VET J, V177, P18, DOI 10.1016/j.tvjl.2007.09.022; Thompson RCA, 2000, PARASITOL TODAY, V16, P210, DOI 10.1016/S0169-4758(99)01624-5; Wang RJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep04208; WHO, 2002, RED RISKS PROM HLTH; Wielinga CM, 2011, INT J PARASITOL, P1; World Health Organization, 2011, WORLD HLTH STAT 2011; Yoder Jonathan S., 2010, Morbidity and Mortality Weekly Report, V59, P15; Zhang WZ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001826; Zhang WZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031262	78	39	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115489	10.1371/journal.pone.0115489	http://dx.doi.org/10.1371/journal.pone.0115489			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536055	Green Published, Green Submitted, gold			2022-12-27	WOS:000348563300044
J	Fairthorne, J; Hammond, G; Bourke, J; Jacoby, P; Leonard, H				Fairthorne, Jenny; Hammond, Geoff; Bourke, Jenny; Jacoby, Peter; Leonard, Helen			Early Mortality and Primary Causes of Death in Mothers of Children with Intellectual Disability or Autism Spectrum Disorder: A Retrospective Cohort Study	PLOS ONE			English	Article							DOWN-SYNDROME; NEUROFIBROMATOSIS 1; SLEEP PROBLEMS; FRAGILE-X; STRESS; HEALTH; SMOKING; PARENTS; BEHAVIOR	Introduction: Mothers of children with intellectual disability or autism spectrum disorder (ASD) have poorer health than other mothers. Yet no research has explored whether this poorer health is reflected in mortality rates or whether certain causes of death are more likely. We aimed to calculate the hazard ratios for death and for the primary causes of death in mothers of children with intellectual disability or ASD compared to other mothers. Methods: The study population comprised all mothers of live-born children in Western Australia from 1983-2005. We accessed state-wide databases which enabled us to link socio-demographic details, birth dates, diagnoses of intellectual disability or ASD in the children and dates and causes of death for all mothers who had died prior to 2011. Using Cox Regression with death by any cause and death by each of the three primary causes as the event of interest, we calculated hazard ratios for death for mothers of children intellectual disability or ASD compared to other mothers. Results and Discussion: During the study period, mothers of children with intellectual disability or ASD had more than twice the risk of death. Mothers of children with intellectual disability were 40% more likely to die of cancer; 150% more likely to die of cardiovascular disease and nearly 200% more likely to die from misadventure than other mothers. Due to small numbers, only hazard ratios for cancer were calculated for mothers of children with ASD. These mothers were about 50% more likely to die from cancer than other mothers. Possible causes and implications of our results are discussed. Conclusion: Similar studies, pooling data from registries elsewhere, would improve our understanding of factors increasing the mortality of mothers of children with intellectual disability or ASD. This would allow the implementation of informed services and interventions to improve these mothers' longevity.	[Fairthorne, Jenny; Bourke, Jenny; Jacoby, Peter; Leonard, Helen] Univ Western Australia, Telethon Kids Inst, Perth, WA 6009, Australia; [Hammond, Geoff] Hlth Dept Western Australia, Perth, WA, Australia	Telethon Kids Institute; University of Western Australia; University of Western Australia	Fairthorne, J (corresponding author), Univ Western Australia, Telethon Kids Inst, Perth, WA 6009, Australia.	Jenny.Fairthorne@telethonkids.org.au	Fairthorne, Jenny/ABB-3901-2020; Leonard, Helen/A-1010-2013	Leonard, Helen/0000-0001-6405-5834	Australian Postgraduate Award; University of Western Australia Top-up Award	Australian Postgraduate Award(Australian Government); University of Western Australia Top-up Award	Funding provided by Australian Postgraduate Award and University of Western Australia Top-up Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbeduto L, 2004, AM J MENT RETARD, V109, P237, DOI 10.1352/0895-8017(2004)109<237:PWACIM>2.0.CO;2; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Australian Bureau of Statistics, 2012, SOC IND AR INTR US F; Baker BL, 2003, J INTELL DISABIL RES, V47, P217, DOI 10.1046/j.1365-2788.2003.00484.x; Baker-Ericzen MJ, 2005, RES PRACT PERS SEV D, V30, P194, DOI 10.2511/rpsd.30.4.194; Bigby C, 2006, DISABIL SOC, V21, P567, DOI 10.1080/09687590600918032; Bjartveit K, 2005, TOB CONTROL, V14, P315, DOI 10.1136/tc.2005.011932; Black PH, 2002, J PSYCHOSOM RES, V52, P1, DOI 10.1016/S0022-3999(01)00302-6; Bourke-Taylor H, 2012, J PAEDIATR CHILD H, V48, P153, DOI 10.1111/j.1440-1754.2011.02060.x; Caldwell J., 2008, J DISABIL POLICY STU, V19, P68, DOI [10.1177/1044207308316093, DOI 10.1177/1044207308316093]; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Centers for Disease Control and Prevention, 2012, PREV AUT SPECTR DIS; Centers for Disease Control and Prevention, 2002, ICD 10 CAUS DEATH LI; Chida Y, 2008, NAT CLIN PRACT ONCOL, V5, P466, DOI 10.1038/ncponc1134; Corrice AM, 2009, AJIDD-AM J INTELLECT, V114, P254, DOI 10.1352/1944-7558-114.4.254-268; Daniels JL, 2008, PEDIATRICS, V121, pE1357, DOI 10.1542/peds.2007-2296; Department of Health WA, 2011, WHAT WE COLL MAN; Dumas J.E., 1991, EXCEPTIONALITY SPEC, V2, P97, DOI [10.1080/09362839109524770, DOI 10.1080/09362839109524770]; Eoh HJ, 2005, INT J IND ERGONOM, V35, P307, DOI 10.1016/j.ergon.2004.09.006; Finsterer J, 2013, INT J GEN MED, V6, P743, DOI 10.2147/IJGM.S45825; Hagerman RJ, 2006, J DEV BEHAV PEDIATR, V27, P63, DOI 10.1097/00004703-200602000-00012; Hodapp RM, 2001, PARENT-SCI PRACT, V1, P317, DOI 10.1207/S15327922PAR0104_3; Institute for Digital Research and Education, 2014, SUPPL NOT APPL SURV; Kouvonen A, 2005, J EPIDEMIOL COMMUN H, V59, P63, DOI 10.1136/jech.2004.019752; Lawrence D, 2010, CAN J PSYCHIAT, V55, P752, DOI 10.1177/070674371005501202; Lawrence D, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-285; Leonard H, 2006, ANN EPIDEMIOL, V16, P448, DOI 10.1016/j.annepidem.2005.05.002; Leonard H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017875; Norlin D, 2013, J INTELL DISABIL RES, V57, P552, DOI 10.1111/j.1365-2788.2012.01564.x; Olsson MB, 2001, J INTELL DISABIL RES, V45, P535, DOI 10.1046/j.1365-2788.2001.00372.x; Petterson B, 2005, ANN HUM BIOL, V32, P237, DOI 10.1080/03014460500075035; Polimeni MA, 2005, J INTELL DISABIL RES, V49, P260, DOI 10.1111/j.1365-2788.2005.00642.x; Rasmussen SA, 2001, AM J HUM GENET, V68, P1110, DOI 10.1086/320121; Richdale A, 2000, J INTELLECT DEV DIS, V25, P147, DOI 10.1080/13269780050033562; Rizk S, 2011, OTJR-OCCUP PART HEAL, V31, P164, DOI 10.3928/15394492-20110415-01; Sanders JL, 1997, CHILD FAM BEHAV THER, V19, P15, DOI 10.1300/J019v19n04_02; Sawyer MG, 2010, J AUTISM DEV DISORD, V40, P620, DOI 10.1007/s10803-009-0912-3; Sen E, 2007, J SPEC PEDIATR NURS, V12, P238, DOI 10.1111/j.1744-6155.2007.00119.x; Smith JP, 1999, J ECON PERSPECT, V13, P145, DOI 10.1257/jep.13.2.145; Takahashi Y, 2001, JAPAN MED ASS J, V44, P359; Thiel C, 2011, INT J SPORTS MED, V32, P142, DOI 10.1055/s-0030-1268436; Watt M, 2012, COMMUNITY WORK FAMIL, V16, P1; Webster RI, 2008, J CHILD NEUROL, V23, P32, DOI 10.1177/0883073807307977; Woodward M., 2013, EPIDEMIOLOGY STUDY D; YearginAllsopp M, 1997, DEV MED CHILD NEUROL, V39, P142	45	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e113430	10.1371/journal.pone.0113430	http://dx.doi.org/10.1371/journal.pone.0113430			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ9UY	25535971	Green Accepted, Green Published, gold			2022-12-27	WOS:000348563300006
J	Mohsen, H; Haddad, P; Allam, A; Hassan, A				Mohsen, Hassan; Haddad, Pascale; Allam, Ayman; Hassan, Azza			Patterns in Place of Cancer Death in the State of Qatar: A Population-Based Study	PLOS ONE			English	Article							TERMINALLY-ILL PATIENTS; OF-LIFE CARE; UNITED-STATES; REGIONAL-VARIATIONS; PREFERRED PLACE; PALLIATIVE CARE; SOUTH-AUSTRALIA; PEOPLE DIE; HOME; END	Background: International studies show that most people prefer to die at home; however, hospitals remain the most common place of death (PoD). This study aims to investigate the patterns in PoD and the associated factors, which are crucial for end-of-life cancer care enhancement. Method: This retrospective, population-based study analyzed all registered cancer deaths in Qatar between January 1, 2006 and December 31, 2012 (n=1,224). The main outcome measures were patient characteristics: age, gender, nationality, cancer diagnosis, year of death, and PoD. Time trends for age-standardized proportions of death in individual PoDs were evaluated using chi-square analysis. Odds ratio (OR) were determined for variables associated with the most preferred (acute palliative care unit [APCU] and hematology/oncology ward) versus least preferred (ICU and general medicine ward) PoDs in Qatar, stratified by nationality. Results: The hematology/oncology ward was the most common PoD (32.4%; 95% CI 26.7-35.3%) followed by ICU (31.4%; 95% CI 28.7-34.3%), APCU (26.9%; 95% CI 24.3-29.6%), and general medicine ward (9.2%; 95% CI 7.6-11.1%). APCU trended upward (+0.057/year; p<0.001), while the hematology/oncology ward trended downward (-0.055/year; p<0.001). No statistically significant changes occurred in the other PoDs; home deaths remained low (0.4%; 95% Cl 0.38-0.42). Qataris who died from liver cancer (OR 0.23) and aged 65 or older (OR 0.64) were less likely to die in the APCU or hematology/oncology ward (p<0.05). Non-Qataris who died from pancreatic cancer (OR 3.12) and female (OR 2.05) were more likely to die in the APCU or hematology/oncology ward (p<0.05). Both Qataris and non-Qataris who died from hematologic malignancy (OR 0.18 and 0.41, respectively) were more likely to die in the ICU or general medicine ward (p<0.05). Conclusion: A high percentage of cancer deaths in Qatar occur in hospital. As home was the preferred PoD for most people, effective home care and hospice programs are needed to improve end-of-life cancer care.	[Mohsen, Hassan; Haddad, Pascale; Hassan, Azza] Weill Cornell Med Coll, Doha, Qatar; [Allam, Ayman; Hassan, Azza] Natl Ctr Canc Care & Res, Doha, Qatar; [Hassan, Azza] Univ Alexandria, Med Res Inst, Canc Management & Res, Alexandria, Egypt	Qatar Foundation (QF); Weill Cornell Medical College Qatar; Hamad Medical Corporation; Egyptian Knowledge Bank (EKB); Alexandria University	Hassan, A (corresponding author), Weill Cornell Med Coll, Doha, Qatar.	ahassan15@hmc.org.qa			Biostatistics, Epidemiology, and Biomathematics Research Core at the Weill Cornell Medical College in Qatar	Biostatistics, Epidemiology, and Biomathematics Research Core at the Weill Cornell Medical College in Qatar	Dr. Reyad H. Mohsen, Dr. Laith J. Abu Raddad, Dr. Mouyyad Zaza, and Dr. Naveed Anwar for their invaluable support, encouragement, and clinical acumen. Additional support was provided by the Biostatistics, Epidemiology, and Biomathematics Research Core at the Weill Cornell Medical College in Qatar. The statements made herein are solely the responsibility of the authors.	Ahlner-Elmqvist M, 2004, PALLIATIVE MED, V18, P585, DOI 10.1191/0269216304pm924oa; Al-Kindi SG, 2013, AM J HOSP PALLIAT ME, V30, P25, DOI 10.1177/1049909112439931; American Cancer Society, 2014, CANCER FACTS FIGURES; Barnato AE, 2007, MED CARE, V45, P386, DOI 10.1097/01.mlr.0000255248.79308.41; Barnato AE, 2010, MED CARE, V48, P125, DOI 10.1097/MLR.0b013e3181c161e4; Beccaro M, 2006, J EPIDEMIOL COMMUN H, V60, P412, DOI 10.1136/jech.2005.043646; Bruera E, 1999, CAN MED ASSOC J, V161, P290; Castillo-Guzman S, 2013, AM J HOSP PALLIAT ME, V30, P249, DOI 10.1177/1049909112448228; Centers for Disease Control and Prevention National Center for Health Statistics (CDC NCHS), 2012, UNDERLYING CAUSE OF; Cohen J, 2010, J CLIN ONCOL, V28, P2267, DOI 10.1200/JCO.2009.23.2850; Conlon KC, 1996, ANN SURG, V223, P273, DOI 10.1097/00000658-199603000-00007; Cress RD, 2006, CANCER CAUSE CONTROL, V17, P403, DOI 10.1007/s10552-005-0539-4; European Association for Palliative Care, 2010, EAPC TASK FORCE ON T; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Fisher ES, 2004, HEALTH AFFAIR, V23, pVAR19, DOI 10.1377/hlthaff.var.19; Fisher ES, 2003, PERSPECT BIOL MED, V46, P69, DOI 10.1353/pbm.2003.0004; Foreman LM, 2006, PALLIATIVE MED, V20, P447, DOI 10.1191/0269216306pm1149oa; Gao W, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001410; Gomes B, 2006, BMJ-BRIT MED J, V332, P515, DOI 10.1136/bmj.38740.614954.55; Gomes B, 2012, ANN ONCOL, V23, P2006, DOI 10.1093/annonc/mdr602; Gomes B, 2008, PALLIATIVE MED, V22, P33, DOI 10.1177/0269216307084606; Gott M, 2004, PALLIATIVE MED, V18, P460, DOI 10.1191/0269216304pm889oa; Gruneir A, 2007, MED CARE RES REV, V64, P351, DOI 10.1177/1077558707301810; Howell DA, 2013, BMC PALLIAT CARE, V12, DOI 10.1186/1472-684X-12-42; Hunt R, 1996, PALLIATIVE MED, V10, P5, DOI 10.1177/026921639601000103; HUNT RW, 1991, MED J AUSTRALIA, V155, P549, DOI 10.5694/j.1326-5377.1991.tb93893.x; IMF, 2013, WOR ECON OUTLOOK, P1; Karim-Kos HE, 2008, EUR J CANCER, V44, P1345, DOI 10.1016/j.ejca.2007.12.015; Lin HC, 2007, SUPPORT CARE CANCER, V15, P1333, DOI 10.1007/s00520-006-0204-9; Lindqvist O, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001173; MACADAM M, 2004, HOME HLTH CARE MANAG, V16, P393; Marie Curie Cancer Care, 2012, UNDERSTANDING THE CO; Mariotto AB, 2011, JNCI-J NATL CANCER I, V103, P117, DOI 10.1093/jnci/djq495; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Menec V., 2004, PATTERNS OF HEALTH C; Mitchell AJ, 2011, LANCET ONCOL, V12, P160, DOI 10.1016/S1470-2045(11)70002-X; Murray MA, 2003, J PALLIATIVE CARE, V19, P176, DOI 10.1177/082585970301900305; Mystakidou K, 2009, J PAIN SYMPTOM MANAG, V38, P309, DOI 10.1016/j.jpainsymman.2008.09.007; National Center for Health Statistics, 2011, HEALTH UNITED STATES; National Health Strategy, 2011, QATAR NATIONAL CANCE; O'Brien M, 2010, HEALTH SOC CARE COMM, V18, P337, DOI 10.1111/j.1365-2524.2009.00897.x; PINZON LCE, 2011, J PAIN SYMPTOM MANAG, V41, P893, DOI DOI 10.1016/J.JPAINSYMMAN.2010.07.016; Qatar Statistics Authority, 2013, POPULATION STRUCTURE; Richards M, 2008, END OF LIFE CARE STR; Riley GF, 2010, HEALTH SERV RES, V45, P565, DOI 10.1111/j.1475-6773.2010.01082.x; Schmidt CM, 2004, ARCH SURG-CHICAGO, V139, P718, DOI 10.1001/archsurg.139.7.718; Tang ST, 2003, CANCER NURS, V26, P245, DOI 10.1097/00002820-200306000-00012; United Nations. Department of Economic and Social Affairs Population Division, 2013, WORLD POPULATION PRO; Warren JL, 2011, J NATL CANCER I, V103, P853, DOI 10.1093/jnci/djr145; Wilson DM, 2009, SOC SCI MED, V68, P1752, DOI 10.1016/j.socscimed.2009.03.006; Winter JM, 2006, J GASTROINTEST SURG, V10, P1199, DOI 10.1016/j.gassur.2006.08.018; World Health Organization, 2012, LOBAL HEALTH OBSERVA; World Health Organization, 2004, BETTER PALLIATIVE CA; World Health Organization Division of Control of Tropical Diseases Schistosomiasis and Intestinal Parasites Unit., 2004, THE SOLID FACTS PALL, P28; World Heath Organization, 2004, THE SOLID FACTS PALL, P28; Wright AA, 2010, J CLIN ONCOL, V28, P4457, DOI 10.1200/JCO.2009.26.3863	57	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e109615	10.1371/journal.pone.0109615	http://dx.doi.org/10.1371/journal.pone.0109615			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ9UY	25536076	gold, Green Submitted, Green Published			2022-12-27	WOS:000348563300001
J	Qin, ZP; Robichaud, P; He, TY; Fisher, GJ; Voorhees, JJ; Quan, TH				Qin, Zhaoping; Robichaud, Patrick; He, Tianyuan; Fisher, Gary J.; Voorhees, John J.; Quan, Taihao			Oxidant Exposure Induces Cysteine-Rich Protein 61 (CCN1) via c-Jun/AP-1 to Reduce Collagen Expression in Human Dermal Fibroblasts	PLOS ONE			English	Article							TRANSCRIPTION FACTOR AP-1; GROWTH-FACTOR-BETA; HUMAN SKIN; ULTRAVIOLET-IRRADIATION; C-JUN; MATRIX METALLOPROTEINASE-1; EXTRACELLULAR-MATRIX; CONNECTIVE-TISSUE; NEGATIVE REGULATOR; OXIDATIVE STRESS	Human skin is a primary target of oxidative stress from reactive oxygen species (ROS) generated from both extrinsic and intrinsic sources. Oxidative stress inhibits the production of collagen, the most abundant protein in skin, and thus contributes to connective tissue aging. Here we report that cysteine-rich protein 61 (CCN1), a negative regulator of collagen production, is markedly induced by ROS and mediates loss of type I collagen in human dermal fibroblasts. Conversely, antioxidant N-acetyl-L-cysteine significantly reduced CCN1 expression and prevented ROS-induced loss of type I collagen in both human dermal fibroblasts and human skin in vivo. ROS increased c-Jun, a critical member of transcription factor AP-1 complex, and increased c-Jun binding to the AP-1 site of the CCN1 promoter. Functional blocking of c-Jun significantly reduced CCN1 promoter and gene expression and thus prevented ROS-induced loss of type I collagen. Targeting the c-Jun/CCN1 axis may provide clinical benefit for connective tissue aging in human skin.	[Qin, Zhaoping; Robichaud, Patrick; He, Tianyuan; Fisher, Gary J.; Voorhees, John J.; Quan, Taihao] Univ Michigan, Sch Med, Dept Dermatol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Quan, TH (corresponding author), Univ Michigan, Sch Med, Dept Dermatol, Ann Arbor, MI 48109 USA.	thquan@umich.edu	Voorhees, John/AAM-9966-2020; Zhou, Zhongjun/C-4476-2009	Voorhees, John/0000-0003-1856-785X; Quan, Taihao/0000-0002-0954-5109; Zhou, Zhongjun/0000-0001-7092-8128	National Institutes of Health [RO1-ES014697, RO1-ES014697-S1, RO1-AG019364]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019364] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grants RO1-ES014697; NIH RO1-ES014697-S1; and NIH RO1-AG019364. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGEL P, 1988, NATURE, V332, P166, DOI 10.1038/332166a0; Bissell MJ, 2005, COLD SH Q B, V70, P343, DOI 10.1101/sqb.2005.70.013; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; Brigstock DR, 2003, J ENDOCRINOL, V178, P169, DOI 10.1677/joe.0.1780169; BROWN PH, 1994, ONCOGENE, V9, P791; Chen CC, 2009, INT J BIOCHEM CELL B, V41, P771, DOI 10.1016/j.biocel.2008.07.025; Chung JH, 2000, J INVEST DERMATOL, V115, P177, DOI 10.1046/j.1523-1747.2000.00009.x; Dasgupta J, 2010, J CELL PHYSIOL, V225, P52, DOI 10.1002/jcp.22193; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Firuzi O, 2011, CURR MED CHEM, V18, P3871, DOI 10.2174/092986711803414368; Fisher GJ, 2009, AM J PATHOL, V174, P101, DOI 10.2353/ajpath.2009.080599; Fisher GJ, 2000, J CLIN INVEST, V106, P663, DOI 10.1172/JCI9362; Fisher GJ, 2002, ARCH DERMATOL, V138, P1462, DOI 10.1001/archderm.138.11.1462; Fisher GJ, 1997, NEW ENGL J MED, V337, P1419, DOI 10.1056/NEJM199711133372003; FISHER LJ, 1991, NEURON, V6, P371, DOI 10.1016/0896-6273(91)90246-V; HALAZONETIS TD, 1988, CELL, V55, P917, DOI 10.1016/0092-8674(88)90147-X; Han JS, 2003, EUR J BIOCHEM, V270, P3408, DOI 10.1046/j.1432-1033.2003.03723.x; HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124; HARMAN D, 1992, MUTAT RES, V275, P257, DOI 10.1016/0921-8734(92)90030-S; Jun JI, 2011, NAT REV DRUG DISCOV, V10, P945, DOI 10.1038/nrd3599; Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070; Juric V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031303; Kang S, 2003, J INVEST DERMATOL, V120, P835, DOI 10.1046/j.1523-1747.2003.12122.x; Kim KH, 2013, MOL CELL BIOL, V33, P2078, DOI 10.1128/MCB.00049-13; Kunz M, 2003, J BIOL CHEM, V278, P45651, DOI 10.1074/jbc.M301373200; Lau LF, 1999, EXP CELL RES, V248, P44, DOI 10.1006/excr.1999.4456; LAVKER RM, 1979, J INVEST DERMATOL, V73, P59, DOI 10.1111/1523-1747.ep12532763; Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270; Lee HY, 2007, CIRC RES, V100, P372, DOI 10.1161/01.RES.0000257945.97958.77; Lo YYC, 1996, J BIOL CHEM, V271, P15703, DOI 10.1074/jbc.271.26.15703; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Malnou CE, 2010, J BIOL CHEM, V285, P6552, DOI 10.1074/jbc.M109.032680; Pashkow FJ, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/514623; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; Qin ZP, 2014, AGE, V36, P353, DOI 10.1007/s11357-013-9565-4; Qin ZP, 2013, J BIOL CHEM, V288, P12386, DOI 10.1074/jbc.M112.424358; Quan TH, 2006, AM J PATHOL, V169, P482, DOI 10.2353/ajpath.2006.060128; Quan TH, 2012, J CELL BIOCHEM, V113, P3011, DOI 10.1002/jcb.24179; Quan TH, 2011, J CELL COMMUN SIGNAL, V5, P201, DOI 10.1007/s12079-011-0144-0; Quan TH, 2011, EXP DERMATOL, V20, P572, DOI 10.1111/j.1600-0625.2011.01278.x; Quan TH, 2009, J CELL COMMUN SIGNAL, V3, P19, DOI 10.1007/s12079-009-0044-8; Quan TH, 2010, J INVEST DERMATOL, V130, P1697, DOI 10.1038/jid.2010.29; Quan TH, 2010, J INVEST DERMATOL, V130, P415, DOI 10.1038/jid.2009.224; Quan TH, 2005, J BIOL CHEM, V280, P8079, DOI 10.1074/jbc.M409647200; Quan TH, 2004, AM J PATHOL, V165, P741, DOI 10.1016/S0002-9440(10)63337-8; Quan TH, 2001, J BIOL CHEM, V276, P26349, DOI 10.1074/jbc.M010835200; Ryter SW, 2007, ANTIOXID REDOX SIGN, V9, P49, DOI 10.1089/ars.2007.9.49; Scharffetter-Kochanek K, 2000, EXP GERONTOL, V35, P307, DOI 10.1016/S0531-5565(00)00098-X; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; SMITH JG, 1962, J INVEST DERMATOL, V39, P347, DOI 10.1038/jid.1962.122; UITTO J, 1986, DERMATOL CLIN, V4, P433, DOI 10.1016/S0733-8635(18)30806-4; VANDAM H, 1993, EMBO J, V12, P479, DOI 10.1002/j.1460-2075.1993.tb05680.x; Yaar M, 2007, BRIT J DERMATOL, V157, P874, DOI 10.1111/j.1365-2133.2007.08108.x	53	32	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115402	10.1371/journal.pone.0115402	http://dx.doi.org/10.1371/journal.pone.0115402			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536346	Green Published, gold, Green Submitted			2022-12-27	WOS:000348563300038
J	Raleigh, MD; Pentel, PR; LeSage, MG				Raleigh, Michael D.; Pentel, Paul R.; LeSage, Mark G.			Pharmacokinetic Correlates of the Effects of a Heroin Vaccine on Heroin Self-Administration in Rats	PLOS ONE			English	Article							MORPHINE CONJUGATE VACCINE; 6-MONOACETYLMORPHINE; METABOLITES; OXYCODONE; RELAPSE; BRAIN; ANTIBODIES; BINDING; POLICY; MODEL	The purpose of this study was to evaluate the effects of a morphine-conjugate vaccine (M-KLH) on the acquisition, maintenance, and reinstatement of heroin self-administration (HSA) in rats, and on heroin and metabolite distribution during heroin administration that approximated the self-administered dosing rate. Vaccination with M-KLH blocked heroin-primed reinstatement of heroin responding. Vaccination also decreased HSA at low heroin unit doses but produced a compensatory increase in heroin self-administration at high unit doses. Vaccination shifted the heroin dose-response curve to the right, indicating reduced heroin potency, and behavioral economic demand curve analysis further confirmed this effect. In a separate experiment heroin was administered at rates simulating heroin exposure during HSA. Heroin and its active metabolites, 6-acetylmorphine (6-AM) and morphine, were retained in plasma and metabolite concentrations were reduced in brain in vaccinated rats compared to controls. Reductions in 6-AM concentrations in brain after vaccination were consistent with the changes in HSA rates accompanying vaccination. These data provide evidence that 6-AM is the principal mediator of heroin reinforcement, and the principal target of the M-KLH vaccine, in this model. While heroin vaccines may have potential as therapies for heroin addiction, high antibody to drug ratios appear to be important for obtaining maximal efficacy.	[Raleigh, Michael D.; Pentel, Paul R.; LeSage, Mark G.] Minneapolis Med Res Fdn Inc, Minneapolis, MN 55417 USA; [Raleigh, Michael D.; Pentel, Paul R.; LeSage, Mark G.] Hennepin Healthcare Syst, Minneapolis, MN USA; [Pentel, Paul R.; LeSage, Mark G.] Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA; [Pentel, Paul R.] Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA; [LeSage, Mark G.] Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Raleigh, MD (corresponding author), Minneapolis Med Res Fdn Inc, Minneapolis, MN 55417 USA.	rale0011@umn.edu	LeSage, Mark G./AAS-8628-2020		National Institute of Health National Institute on Drug Abuse [DA026300, DA030715]; Minneapolis Medical Research Foundation; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA026300, R01DA030715] Funding Source: NIH RePORTER	National Institute of Health National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Minneapolis Medical Research Foundation; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institute of Health National Institute on Drug Abuse (grants DA026300, DA030715) (PRP) and a Postdoctoral fellowship award from the Minneapolis Medical Research Foundation (MDR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JM, 2009, J PHARMACOL EXP THER, V331, P153, DOI 10.1124/jpet.109.152462; [Anonymous], RES 2012 NAT SURV DR; [Anonymous], 2012, WORLD DRUG REP 2012; Anton B, 2006, VACCINE, V24, P3232, DOI 10.1016/j.vaccine.2006.01.047; Antonilli L, 2005, PSYCHOPHARMACOLOGY, V182, P58, DOI 10.1007/s00213-005-0030-7; BazinRedureau MI, 1997, J PHARM PHARMACOL, V49, P277, DOI 10.1111/j.2042-7158.1997.tb06795.x; Beardsley PM, 2004, EXP CLIN PSYCHOPHARM, V12, P163, DOI 10.1037/1064-1297.12.3.163; Bogen IL, 2014, J PHARMACOL EXP THER, V349, P568, DOI 10.1124/jpet.113.212035; BONESE KF, 1974, NATURE, V252, P708, DOI 10.1038/252708a0; Carrera MRA, 2000, P NATL ACAD SCI USA, V97, P6202, DOI 10.1073/pnas.97.11.6202; Comer SD, 1999, PSYCHOPHARMACOLOGY, V143, P327, DOI 10.1007/s002130050956; CORRIGALL WA, 1988, PHARMACOL BIOCHEM BE, V30, P443, DOI 10.1016/0091-3057(88)90478-9; Curran-Everett D, 2000, AM J PHYSIOL-REG I, V279, pR1, DOI 10.1152/ajpregu.2000.279.1.R1; Girardin F, 2003, CLIN PHARMACOL THER, V74, P341, DOI 10.1016/S0009-9236(03)00199-1; Gottas A, 2013, BRIT J PHARMACOL, V170, P546, DOI 10.1111/bph.12305; Grebenstein P, 2013, PHARMACOL BIOCHEM BE, V114, P70, DOI 10.1016/j.pbb.2013.10.020; Hursh SR, 2008, PSYCHOL REV, V115, P186, DOI 10.1037/0033-295X.115.1.186; Hursh SR, 2013, J EXP ANAL BEHAV, V99, P98, DOI 10.1002/jeab.7; INTURRISI CE, 1983, LIFE SCI, V33, P773, DOI 10.1016/0024-3205(83)90616-1; Jones JM, 2013, J PHARMACEUT BIOMED, V74, P291, DOI 10.1016/j.jpba.2012.10.033; Kosten TA, 2013, PROG NEURO-PSYCHOPH, V45, P223, DOI 10.1016/j.pnpbp.2013.05.012; Li QQ, 2011, J NEUROCHEM, V119, P1271, DOI 10.1111/j.1471-4159.2011.07502.x; Ma Li-xia, 2006, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V22, P368; Moreno AY, 2010, MOL PHARMACEUT, V7, P431, DOI 10.1021/mp900213u; Pravetoni M, 2012, VACCINE, V30, P4617, DOI 10.1016/j.vaccine.2012.04.101; Pravetoni M, 2012, J PHARMACOL EXP THER, V341, P225, DOI 10.1124/jpet.111.189506; Raleigh MD, 2013, J PHARMACOL EXP THER, V344, P397, DOI 10.1124/jpet.112.201194; Rentsch KM, 2001, CLIN PHARMACOL THER, V70, P237, DOI 10.1067/mcp.2001.117981; Schlosburg JE, 2013, P NATL ACAD SCI USA, V110, P9036, DOI 10.1073/pnas.1219159110; Selley DE, 2001, BIOCHEM PHARMACOL, V62, P447, DOI 10.1016/S0006-2952(01)00689-X; Stowe GN, 2011, J MED CHEM, V54, P5195, DOI 10.1021/jm200461m; WAINER BH, 1973, J IMMUNOL, V110, P667	32	29	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115696	10.1371/journal.pone.0115696	http://dx.doi.org/10.1371/journal.pone.0115696			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536404	gold, Green Published, Green Submitted			2022-12-27	WOS:000348563300066
J	Sample, SJ; Heaton, CM; Behan, M; Bleedorn, JA; Racette, MA; Hao, ZL; Muir, P				Sample, Susannah J.; Heaton, Caitlin M.; Behan, Mary; Bleedorn, Jason A.; Racette, Molly A.; Hao, Zhengling; Muir, Peter			Role of Calcitonin Gene-Related Peptide in Functional Adaptation of the Skeleton	PLOS ONE			English	Article							SYMPATHETIC-NERVOUS-SYSTEM; IN-VIVO; STRESS-FRACTURES; BONE-RESORPTION; CGRP; RAT; EXPRESSION; MICE; INNERVATION; MICRODAMAGE	Peptidergic sensory nerve fibers innervating bone and periosteum are rich in calcitonin gene-related peptide (CGRP), an osteoanabolic neurotransmitter. There are two CGRP isoforms, CGRP alpha and CGRP beta. Sensory fibers are a potential means by which the nervous system may detect and respond to loading events within the skeleton. However, the functional role of the nervous system in the response of bone to mechanical loading is unclear. We used the ulna end-loading model to induce an adaptive modeling response in CGRP alpha and CGRP beta knockout mouse lines and their respective wildtype controls. For each knockout mouse line, groups of mice were treated with cyclic loading or sham-loading of the right ulna. A third group of mice received brachial plexus anesthesia (BPA) of the loaded limb before mechanical loading. Fluorochrome labels were administered at the time of loading and 7 days later. Ten days after loading, bone responses were quantified morphometrically. We hypothesized that CGRP signaling is required for normal mechanosensing and associated load-induced bone formation. We found that mechanically-induced activation of periosteal mineralizing surface in mice and associated blocking with BPA were eliminated by knockout of CGRP alpha signaling. This effect was not evident in CGRP beta knockout mice. We also found that mineral apposition responses to mechanical loading and associated BPA blocking were retained with CGRP alpha deletion. We conclude that activation of periosteal mineralizing surfaces in response to mechanical loading of bone is CGRP alpha-dependent in vivo. This suggests that release of CGRP from sensory peptidergic fibers in periosteum and bone has a functional role in load-induced bone formation.	[Sample, Susannah J.; Heaton, Caitlin M.; Bleedorn, Jason A.; Racette, Molly A.; Hao, Zhengling; Muir, Peter] Univ Wisconsin, Sch Vet Med, Comparat Orthopaed Res Lab, Madison, WI 53706 USA; [Behan, Mary] Univ Wisconsin, Sch Vet Med, Dept Comparat Biosci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Muir, P (corresponding author), Univ Wisconsin, Sch Vet Med, Comparat Orthopaed Res Lab, Madison, WI 53706 USA.	muirp@vetmed.wisc.edu	Muir, Peter/AAH-8057-2021	Muir, Peter/0000-0003-0028-6005	AO Research Fund of the AO Foundation Switzerland [S-08-22M]; National Institutes of Health [T32 RR023916]; NATIONAL CENTER FOR RESEARCH RESOURCES [T32RR023916] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T35OD011078, T32OD010423] Funding Source: NIH RePORTER	AO Research Fund of the AO Foundation Switzerland; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by a grant from the AO Research Fund of the AO Foundation Switzerland (Project S-08-22M). Susannah J. Sample also received support from National Institutes of Health (T32 RR023916). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMARA SG, 1985, SCIENCE, V229, P1094, DOI 10.1126/science.2994212; Ballica R, 1999, J BONE MINER RES, V14, P1067, DOI 10.1359/jbmr.1999.14.7.1067; Baron R, 2006, CURR TOP DEV BIOL, V76, P103, DOI 10.1016/S0070-2153(06)76004-5; Burge R, 2007, J BONE MINER RES, V22, P465, DOI [10.1359/jbmr.061113, 10.1359/JBMR.061113]; Burr DB, 1997, J BONE MINER RES, V12, P6, DOI 10.1359/jbmr.1997.12.1.6; Cherian PP, 2005, MOL BIOL CELL, V16, P3100, DOI 10.1091/mbc.E04-10-0912; de Souza RL, 2005, J BONE MINER RES, V20, P2159, DOI 10.1359/JBMR.050812; Drissi H, 1997, J BONE MINER RES, V12, P1805, DOI 10.1359/jbmr.1997.12.11.1805; Drissi H, 1999, CYTOKINE, V11, P200, DOI 10.1006/cyto.1998.0415; Elefteriou F, 2005, NATURE, V434, P514, DOI 10.1038/nature03398; HERT J, 1971, Folia Morphologica (Prague), V19, P290; HILL EL, 1991, CELL TISSUE RES, V264, P469, DOI 10.1007/BF00319037; Hirt D, 1997, PEPTIDES, V18, P1461, DOI 10.1016/S0196-9781(97)00199-X; Imai S, 1997, J BONE MINER RES, V12, P1018, DOI 10.1359/jbmr.1997.12.7.1018; Irie K, 2002, MICROSC RES TECHNIQ, V58, P85, DOI 10.1002/jemt.10122; Jimenez-Andrade JM, 2010, BONE, V46, P306, DOI 10.1016/j.bone.2009.09.013; LANYON LE, 1984, J BIOMECH, V17, P897, DOI 10.1016/0021-9290(84)90003-4; Lappe J, 2005, J BONE MINER RES, V20, P571, DOI 10.1359/JBMR.041208; Lee KCL, 2002, BONE, V31, P407, DOI 10.1016/S8756-3282(02)00842-6; Li L, 2007, J ORTHOP RES, V25, P1204, DOI 10.1002/jor.20406; Li JA, 2010, J ORTHOP RES, V28, P1643, DOI 10.1002/jor.21169; Long H, 2010, ACTA ORTHOP, V81, P639, DOI 10.3109/17453674.2010.504609; Mach DB, 2002, NEUROSCIENCE, V113, P155, DOI 10.1016/S0306-4522(02)00165-3; Martin CD, 2007, NEUROSCI LETT, V427, P148, DOI 10.1016/j.neulet.2007.08.055; MCBRYDE AM, 1976, AM J SPORTS MED, V5, P212; Mrak E, 2010, J CELL PHYSIOL, V225, P701, DOI 10.1002/jcp.22266; Muir P, 2006, BONE, V38, P342, DOI 10.1016/j.bone.2005.08.020; Muir P, 1999, BONE, V25, P571, DOI 10.1016/S8756-3282(99)00205-7; Plotkin LI, 2005, AM J PHYSIOL-CELL PH, V289, pC633, DOI 10.1152/ajpcell.00278.2004; Robling AG, 2002, BONE, V31, P562, DOI 10.1016/S8756-3282(02)00871-2; Sample SJ, 2008, J BONE MINER RES, V23, P1372, DOI [10.1359/jbmr.080407, 10.1359/JBMR.080407]; Sample SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020386; Sample SJ, 2010, J BONE MINER RES, V25, P2016, DOI 10.1002/jbmr.101; Saxon LK, 2005, BONE, V36, P454, DOI 10.1016/j.bone.2004.12.001; Schinke T, 2004, J BONE MINER RES, V19, P2049, DOI 10.1359/JBMR.040915; Schutz B, 2004, J COMP NEUROL, V476, P32, DOI 10.1002/cne.20211; Serre CM, 1999, BONE, V25, P623, DOI 10.1016/S8756-3282(99)00215-X; Silberstein SD, 2013, NEUROLOGY, V81, P1184, DOI 10.1212/WNL.0b013e3182a6cc33; TORRANCE AG, 1994, CALCIFIED TISSUE INT, V54, P241, DOI 10.1007/BF00301686; Verborgt O, 2000, J BONE MINER RES, V15, P60, DOI 10.1359/jbmr.2000.15.1.60; Villa I, 2003, AM J PHYSIOL-ENDOC M, V284, pE627, DOI 10.1152/ajpendo.00307.2002; Villa I, 2000, EUR J PHARMACOL, V409, P273, DOI 10.1016/S0014-2999(00)00872-4; Wang LP, 2010, BONE, V46, P1369, DOI 10.1016/j.bone.2009.11.029; Wu Q, 2009, NEUROSCI LETT, V463, P254, DOI 10.1016/j.neulet.2009.07.078	44	19	21	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e113959	10.1371/journal.pone.0113959	http://dx.doi.org/10.1371/journal.pone.0113959			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536054	Green Published, gold, Green Submitted			2022-12-27	WOS:000348563300008
J	Tan, L; Pu, YQ; Pattathil, S; Avci, U; Qian, J; Arter, A; Chen, LW; Hahn, MG; Ragauskas, AJ; Kieliszewski, MJ				Tan, Li; Pu, Yunqiao; Pattathil, Sivakumar; Avci, Utku; Qian, Jin; Arter, Allison; Chen, Liwei; Hahn, Michael G.; Ragauskas, Arthur J.; Kieliszewski, Marcia J.			Changes in Cell Wall Properties Coincide with Overexpression of Extensin Fusion Proteins in Suspension Cultured Tobacco Cells	PLOS ONE			English	Article							INTERMOLECULAR CROSS-LINK; O-GLYCOSYLATION CODES; ARABINOGALACTAN-PROTEINS; DI-ISODITYROSINE; EXPRESSION; GLYCOPROTEIN; CELLULASE; IMPROVES; TYROSINE; GROWTH	Extensins are one subfamily of the cell wall hydroxyproline-rich glycoproteins, containing characteristic SerHyp(4) glycosylation motifs and intermolecular cross-linking motifs such as the TyrXaaTyr sequence. Extensins are believed to form a cross-linked network in the plant cell wall through the tyrosine-derivatives isodityrosine, pulcherosine, and di-isodityrosine. Overexpression of three synthetic genes encoding different elastin-arabinogalactan protein-extensin hybrids in tobacco suspension cultured cells yielded novel cross-linking glycoproteins that shared features of the extensins, arabinogalactan proteins and elastin. The cell wall properties of the three transgenic cell lines were all changed, but in different ways. One transgenic cell line showed decreased cellulose crystallinity and increased wall xyloglucan content; the second transgenic cell line contained dramatically increased hydration capacity and notably increased cell wall biomass, increased di-isodityrosine, and increased protein content; the third transgenic cell line displayed wall phenotypes similar to wild type cells, except changed xyloglucan epitope extractability. These data indicate that overexpression of modified extensins may be a route to engineer plants for bioenergy and biomaterial production.	[Tan, Li; Pattathil, Sivakumar; Avci, Utku; Qian, Jin; Hahn, Michael G.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Tan, Li; Pattathil, Sivakumar; Avci, Utku; Qian, Jin; Hahn, Michael G.] Univ Georgia, BioEnergy Sci Ctr, Athens, GA 30602 USA; [Hahn, Michael G.] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; [Pu, Yunqiao; Ragauskas, Arthur J.] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN USA; [Arter, Allison; Chen, Liwei; Kieliszewski, Marcia J.] Ohio Univ, Dept Chem & Biochem, Athens, OH 45701 USA; [Chen, Liwei] Suzhou Inst Nanotech & Nanobion SINANO, Suzhou, Peoples R China	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; United States Department of Energy (DOE); Oak Ridge National Laboratory; University System of Ohio; Ohio University	Tan, L (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA.	tan@ccrc.uga.edu	Hahn, Michael/AHC-5847-2022; Ragauskas, Art/J-7486-2016; AVCI, UTKU/AAC-5794-2020; Pu, Yunqiao/H-3206-2016	Ragauskas, Art/0000-0002-3536-554X; AVCI, UTKU/0000-0001-5355-9906; , Sivakumar Pattathil/0000-0003-3870-4137; Pu, Yunqiao/0000-0003-2554-1447	National Science Foundation [MCB9874744]; Herman Frasch Foundation [526-HF02]; Department of Energy Bioenergy Research Center Award DOE [DE-PS02-06ER64304]; Office of Biological and Environmental Research in the Department of Energy Office of Science	National Science Foundation(National Science Foundation (NSF)); Herman Frasch Foundation; Department of Energy Bioenergy Research Center Award DOE(United States Department of Energy (DOE)); Office of Biological and Environmental Research in the Department of Energy Office of Science	This research was funded by grants to MK from the National Science Foundation (MCB9874744) and the Herman Frasch Foundation (526-HF02); and to LT, MGH, and AJR by the Department of Energy Bioenergy Research Center Award DOE DE-PS02-06ER64304. The BioEnergy Science Center is a United States Department of Energy Bioenergy Research Center supported by the Office of Biological and Environmental Research in the Department of Energy Office of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson M, 2010, PLANT SCI, V178, P61, DOI 10.1016/j.plantsci.2009.11.003; An G, 1988, PLANT MOL BIOL MAN A, V3, P1; Bergman T., 1986, ADV METHODS PROTEIN, P45; Blemenkrantz N, 1973, ANAL BIOCHEM, V54, P484; Brady JD, 1996, BIOCHEM J, V315, P323, DOI 10.1042/bj3150323; Brady JD, 1998, PHYTOCHEMISTRY, V47, P349, DOI 10.1016/S0031-9422(97)00592-X; Cannon MC, 2008, P NATL ACAD SCI USA, V105, P2226, DOI 10.1073/pnas.0711980105; Dai ZY, 2000, TRANSGENIC RES, V9, P43, DOI 10.1023/A:1008922404834; Fu CX, 2011, P NATL ACAD SCI USA, V108, P3803, DOI 10.1073/pnas.1100310108; Held MA, 2004, J BIOL CHEM, V279, P55474, DOI 10.1074/jbc.M408396200; HERBERS K, 1995, NAT BIOTECHNOL, V13, P63, DOI DOI 10.1038/NBT0195-63; Jung HJG, 2012, PLANT SCI, V185, P65, DOI 10.1016/j.plantsci.2011.10.014; Kieliszewski MJ, 2001, PHYTOCHEMISTRY, V57, P319, DOI 10.1016/S0031-9422(01)00029-2; Kieliszewski MJ, 2014, USA patent, Patent No. [US 08623812, 08623812]; KOMALAVILAS P, 1989, CARBOHYD RES, V189, P261, DOI 10.1016/0008-6215(89)84102-3; Lamport DTA, 2011, PLANT PHYSIOL, V156, P11, DOI 10.1104/pp.110.169011; Park YW, 2003, PLANT J, V33, P1099, DOI 10.1046/j.1365-313X.2003.01696.x; Pattathil Sivakumar, 2012, Methods Mol Biol, V908, P61, DOI 10.1007/978-1-61779-956-3_6; Pattathil S, 2010, PLANT PHYSIOL, V153, P514, DOI 10.1104/pp.109.151985; Pechar M, 2007, MACROMOL BIOSCI, V7, P56, DOI 10.1002/mabi.200600196; POPE DG, 1977, PLANT PHYSIOL, V59, P894, DOI 10.1104/pp.59.5.894; Pu YQ, 2006, CARBOHYD RES, V341, P591, DOI 10.1016/j.carres.2005.12.012; Reiersen H, 1998, J MOL BIOL, V283, P255, DOI 10.1006/jmbi.1998.2067; Sage E H, 1977, Adv Exp Med Biol, V79, P291; Schnabelrauch LS, 1996, PLANT J, V9, P477, DOI 10.1046/j.1365-313X.1996.09040477.x; Showalter AM, 2001, CELL MOL LIFE SCI, V58, P1399, DOI 10.1007/PL00000784; Shpak E, 1999, P NATL ACAD SCI USA, V96, P14736, DOI 10.1073/pnas.96.26.14736; Shpak E, 2001, J BIOL CHEM, V276, P11272, DOI 10.1074/jbc.M011323200; Tan L, 2003, PLANT PHYSIOL, V132, P1362, DOI 10.1104/pp.103.021766; URRY DW, 1993, ANGEW CHEM INT EDIT, V32, P819, DOI 10.1002/anie.199308191; Wang HZ, 2012, IND CROP PROD, V37, P170, DOI 10.1016/j.indcrop.2011.12.014; Wang HZ, 2012, MOL PLANT, V5, P297, DOI 10.1093/mp/ssr098; Xu JF, 2007, BIOTECHNOL BIOENG, V97, P997, DOI 10.1002/bit.21407; Xu JF, 2010, TRANSGENIC RES, V19, P849, DOI 10.1007/s11248-010-9367-8; Zhang D, 2011, BIOENERG RES, V4, P276, DOI 10.1007/s12155-011-9138-2	35	8	10	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115906	10.1371/journal.pone.0115906	http://dx.doi.org/10.1371/journal.pone.0115906			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536327	Green Published, Green Submitted, gold			2022-12-27	WOS:000348563300084
J	Arsenault, BJ; Barter, P; DeMicco, DA; Bao, WH; Preston, GM; LaRosa, JC; Grundy, SM; Deedwania, P; Greten, H; Wenger, NK; Shepherd, J; Waters, DD; Kastelein, JJP				Arsenault, Benoit J.; Barter, Philip; DeMicco, David A.; Bao, Weihang; Preston, Gregory M.; LaRosa, John C.; Grundy, Scott M.; Deedwania, Prakash; Greten, Heiner; Wenger, Nanette K.; Shepherd, James; Waters, David D.; Kastelein, John J. P.		Treating New Targets Tnt Investig	Prediction of Cardiovascular Events in Statin-Treated Stable Coronary Patients of the Treating to New Targets Randomized Controlled Trial by Lipid and Non-Lipid Biomarkers	PLOS ONE			English	Article							C-REACTIVE PROTEIN; HEART-DISEASE; NATRIURETIC PEPTIDE; RISK PREDICTION; ATORVASTATIN; ATHEROSCLEROSIS; INFLAMMATION; THERAPY; MEN; PROGRESSION	Several plasma non-lipid biomarkers have been shown to predict major cardiovascular events (MCVEs) in population studies. Our objective was to investigate the relationship between lipid and non-lipid biomarkers levels achieved during statin therapy and the incidence of MCVEs in patients with stable coronary heart disease (CHD). We conducted a substudy of the TNT (Treating to New Targets) study, which was a randomized trial that compared the efficacy of high (80 mg) versus low (10 mg) dose atorvastatin for the secondary prevention of CHD. Fasting plasma levels of standard lipids and of 18 non-lipid biomarkers were obtained after an 8-week run-in period on atorvastatin 10 mg in 157 patients who experienced MCVEs during the 4.9 years of study follow-up and in 1349 controls. MCVE was defined as CHD death, nonfatal, non-procedure-related myocardial infarction, resuscitated cardiac arrest, and fatal or nonfatal stroke. After adjusting for age, sex and treatment arm, plasma levels of high-density lipoprotein (HDL) cholesterol, triglycerides, high-sensitivity C-reactive protein (hsCRP), insulin, neopterin, N-terminal pro-brain natriuretic peptide (BNP), lipoprotein(a) [Lp(a)], and the soluble receptor for advanced glycation end products (sRAGE) were predictive of recurrent MCVEs (P <= 0.02 for each doubling of plasma concentration). However, no significant association was observed between the risk of recurrent MCVEs and plasma levels of low-density lipoprotein cholesterol, adiponectin, cystatin C, lipoprotein-associated phospholipase A2, monocyte chemotactic protein-1, matrix metalloproteinase-9, myeloperoxidase, osteopontin, soluble CD40 ligand, soluble intercellular adhesion molecule-1, or soluble vascular cell adhesion molecule-1. After further adjustment for diabetes, hypertension, smoking, and BMI, the relationship between hsCRP, insulin and MCVE were no longer significant, while the relationship between Lp(a), neopterin, NT-proBNP and sRAGE and MCVE remained statistically significant. In conclusion, in patients with CHD treated with atorvastatin, plasma levels of Lp(a), neopterin, NT-proBNP, and sRAGE are associated with the risk of recurrent MCVEs.	[Arsenault, Benoit J.; Kastelein, John J. P.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Barter, Philip] Heart Res Inst, Sydney, NSW, Australia; [DeMicco, David A.; Bao, Weihang; Preston, Gregory M.] Pfizer Inc, New York, NY USA; [LaRosa, John C.] SUNY Hlth Sci Ctr, Brooklyn, NY USA; [Grundy, Scott M.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Deedwania, Prakash] Vet Affairs Cent Calif Hlth Care Syst, San Francisco, CA USA; [Deedwania, Prakash] Univ Calif San Francisco, Sch Med, San Francisco, CA USA; [Greten, Heiner] Univ Klinikum, Eppendorf, Germany; [Wenger, Nanette K.] Emory Univ, Sch Med, Atlanta, GA USA; [Shepherd, James] Univ Glasgow, Glasgow, Lanark, Scotland; [Waters, David D.] San Francisco Gen Hosp, San Francisco, CA 94110 USA	University of Amsterdam; Academic Medical Center Amsterdam; University of Sydney; Heart Research Institute; Pfizer; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Francisco; Emory University; University of Glasgow; San Francisco General Hospital Medical Center	Kastelein, JJP (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.j.kastelein@amc.uva.nl	Kastelein, John/AAF-7950-2020		Pfizer Inc.; Fonds de la recherche en sante du Quebec; Fondation de l'Institut universitaire de cardiologie et de pneumologie de Quebec; Pfizer	Pfizer Inc.(Pfizer); Fonds de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec); Fondation de l'Institut universitaire de cardiologie et de pneumologie de Quebec; Pfizer(Pfizer)	This study was funded by Pfizer Inc. Benoit J. Arsenault is supported by a post-doctoral fellowship from the Fonds de la recherche en sante du Quebec and the Fondation de l'Institut universitaire de cardiologie et de pneumologie de Quebec. Two authors are Pfizer employees and may hold stock in the company. As sponsor, Pfizer in cooperation with the steering committee had a role in all aspects of the study. The secondary biomarker analysis was funded by Pfizer. However, the decision to publish and preparation of the manuscript was driven solely by the authors.	[Anonymous], 2013, J AM COLL CARDIOL, V61, P1750; Arsenault Benoit J, 2011, J Am Coll Cardiol, V57, P63, DOI 10.1016/j.jacc.2010.06.052; Boekholdt SM, 2006, ATHEROSCLEROSIS, V187, P415, DOI 10.1016/j.atherosclerosis.2005.09.023; Bonnet J, 2008, CLIN THER, V30, P2298, DOI 10.1016/j.clinthera.2008.12.023; Clarke R, 2009, NEW ENGL J MED, V361, P2518, DOI 10.1056/NEJMoa0902604; Colhoun HM, 2011, DIABETES, V60, P2379, DOI 10.2337/db11-0291; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; Deshmukh HA, 2012, J LIPID RES, V53, P1000, DOI 10.1194/jlr.P021113; Di Angelantonio E, 2009, CIRCULATION, V120, P2177, DOI 10.1161/CIRCULATIONAHA.109.884866; Emberson JR, 2007, J AM COLL CARDIOL, V49, P311; Helfand M, 2009, ANN INTERN MED, V151, P496, DOI 10.7326/0003-4819-151-7-200910060-00010; Hopewell JC, 2013, EUR HEART J, V34, P982, DOI 10.1093/eurheartj/ehs344; Kamstrup PR, 2009, JAMA-J AM MED ASSOC, V301, P2331, DOI 10.1001/jama.2009.801; Koh KK, 2010, J AM COLL CARDIOL, V55, P1209, DOI 10.1016/j.jacc.2009.10.053; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Meuwese MC, 2008, ATHEROSCLEROSIS, V197, P916, DOI 10.1016/j.atherosclerosis.2007.08.011; Morrow DA, 2006, CIRCULATION, V114, P281, DOI 10.1161/CIRCULATIONAHA.106.628909; Nissen SE, 2004, JAMA-J AM MED ASSOC, V291, P1071, DOI 10.1001/jama.291.9.1071; Packard RRS, 2008, CLIN CHEM, V54, P24, DOI 10.1373/clinchem.2007.097360; Ray KK, 2007, CIRCULATION, V115, P3071, DOI 10.1161/CIRCULATIONAHA.106.666511; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2009, LANCET, V373, P1175, DOI 10.1016/S0140-6736(09)60447-5; Ridker PM, 2008, CIRCULATION, V118, P2243, DOI 10.1161/CIRCULATIONAHA.108.814251; Ridker PM, 2005, NEW ENGL J MED, V352, P20, DOI 10.1056/NEJMoa042378; Sarwar N, 2007, EUR HEART J, V28, P2491, DOI 10.1093/eurheartj/ehm115; Scirica BM, 2009, CLIN CHEM, V55, P265, DOI 10.1373/clinchem.2008.117192; Singh U, 2008, AM J CARDIOL, V102, P321, DOI 10.1016/j.amjcard.2008.03.057; West MJ, 2008, EUR HEART J, V29, P923, DOI 10.1093/eurheartj/ehn007	29	36	36	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e114519	10.1371/journal.pone.0114519	http://dx.doi.org/10.1371/journal.pone.0114519			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531109	gold, Green Published			2022-12-27	WOS:000348845100016
J	Mirone, A; Brun, E; Coan, P				Mirone, Alessandro; Brun, Emmanuel; Coan, Paola			A Dictionary Learning Approach with Overlap for the Low Dose Computed Tomography Reconstruction and Its Vectorial Application to Differential Phase Tomography	PLOS ONE			English	Article							ITERATIVE IMAGE-RECONSTRUCTION; ALGORITHM; SPARSE; INDEX	X-ray based Phase-Contrast Imaging (PCI) techniques have been demonstrated to enhance the visualization of soft tissues in comparison to conventional imaging methods. Nevertheless the delivered dose as reported in the literature of biomedical PCI applications often equals or exceeds the limits prescribed in clinical diagnostics. The optimization of new computed tomography strategies which include the development and implementation of advanced image reconstruction procedures is thus a key aspect. In this scenario, we implemented a dictionary learning method with a new form of convex functional. This functional contains in addition to the usual sparsity inducing and fidelity terms, a new term which forces similarity between overlapping patches in the superimposed regions. The functional depends on two free regularization parameters: a coefficient multiplying the sparsity-inducing L-1 norm of the patch basis functions coefficients, and a coefficient multiplying the L-2 norm of the differences between patches in the overlapping regions. The solution is found by applying the iterative proximal gradient descent method with FISTA acceleration. The gradient is computed by calculating projection of the solution and its error backprojection at each iterative step. We study the quality of the solution, as a function of the regularization parameters and noise, on synthetic data for which the solution is a-priori known. We apply the method on experimental data in the case of Differential Phase Tomography. For this case we use an original approach which consists in using vectorial patches, each patch having two components: one per each gradient component. The resulting algorithm, implemented in the European Synchrotron Radiation Facility tomography reconstruction code PyHST, has proven to be efficient and well-adapted to strongly reduce the required dose and the number of projections in medical tomography.	[Mirone, Alessandro; Brun, Emmanuel] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Brun, Emmanuel; Coan, Paola] Univ Munich, Dept Phys, D-85748 Garching, Germany; [Coan, Paola] Ludwig Maximilians Univ Hosp Munich, Inst Clin Radiol, Munich, Germany	European Synchrotron Radiation Facility (ESRF); University of Munich; University of Munich	Brun, E (corresponding author), European Synchrotron Radiat Facil, BP 220, F-38043 Grenoble, France.	emmanuel.brun@esrf.fr	Brun, emmanuel/J-7942-2018; Coan, Paola/L-8804-2013; Coan, Paola/GPC-5718-2022; brun, emmanuel/U-8780-2019	Brun, emmanuel/0000-0002-0332-4903; Coan, Paola/0000-0003-1399-2398; Coan, Paola/0000-0003-1399-2398; brun, emmanuel/0000-0002-0332-4903	DFG-Cluster of Excellence Munich-Centre for Advanced Photonics [EXE158]; internal ESRF funding	DFG-Cluster of Excellence Munich-Centre for Advanced Photonics(German Research Foundation (DFG)); internal ESRF funding	This work was partially supported by the DFG-Cluster of Excellence Munich-Centre for Advanced Photonics EXE158. Other funding is internal ESRF funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon M, 2006, IEEE T SIGNAL PROCES, V54, P4311, DOI 10.1109/TSP.2006.881199; Beck A, 2009, SIAM J IMAGING SCI, V2, P183, DOI 10.1137/080716542; Bravin A, 2013, PHYS MED BIOL, V58, pR1, DOI 10.1088/0031-9155/58/1/R1; Chambolle A, 2004, J MATH IMAGING VIS, V20, P89; Chapman D, 1997, PHYS MED BIOL, V42, P2015, DOI 10.1088/0031-9155/42/11/001; Combettes PL, 2011, SPRINGER SER OPTIM A, V49, P185, DOI 10.1007/978-1-4419-9569-8_10; Diemoz PC, 2012, OPT EXPRESS, V20, P2789, DOI 10.1364/OE.20.002789; Dilmanian FA, 2000, PHYS MED BIOL, V45, P933, DOI 10.1088/0031-9155/45/4/309; Elad M, 2006, IEEE T IMAGE PROCESS, V15, P3736, DOI 10.1109/TIP.2006.881969; Fahimian BP, 2013, MED PHYS, V40, DOI 10.1118/1.4791644; Gasilov S, 2014, OPT EXPRESS, V22, P5216, DOI 10.1364/OE.22.005216; Liao HY, 2009, J OPT SOC AM A, V26, P2311, DOI 10.1364/JOSAA.26.002311; Mirone A, 2013, GPL RELEASE PY UNPUB; Mirone A, 2014, NUCL INSTRUM METH B, V324, P41, DOI 10.1016/j.nimb.2013.09.030; Olivo A, 2008, PHYS MED BIOL, V53, P6461, DOI 10.1088/0031-9155/53/22/012; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Sunaguchi N, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4824075; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Weitkamp T, 2005, OPT EXPRESS, V13, P6296, DOI 10.1364/OPEX.13.006296; Wen YW, 2012, IEEE T IMAGE PROCESS, V21, P1770, DOI 10.1109/TIP.2011.2181401; Xu QF, 2012, OPT EXPRESS, V20, P10724, DOI 10.1364/OE.20.010724; Xu Q, 2012, IEEE T MED IMAGING, V31, P1682, DOI 10.1109/TMI.2012.2195669; Zhao B, 2012, PHYS MED BIOL, V57, DOI 10.1088/0031-9155/57/24/8217; Zhao YZ, 2012, P NATL ACAD SCI USA, V109, P18290, DOI 10.1073/pnas.1204460109	25	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e114325	10.1371/journal.pone.0114325	http://dx.doi.org/10.1371/journal.pone.0114325			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531987	Green Published, gold, Green Submitted			2022-12-27	WOS:000348845100014
J	Zalewski, W; Gasparis, S; Boczkowska, M; Rajchel, IK; Kala, M; Orczyk, W; Nadolska-Orczyk, A				Zalewski, Wojciech; Gasparis, Sebastian; Boczkowska, Maja; Rajchel, Izabela K.; Kala, Maciej; Orczyk, Waclaw; Nadolska-Orczyk, Anna			Expression Patterns of HvCKX Genes Indicate Their Role in Growth and Reproductive Development of Barley	PLOS ONE			English	Article							CYTOKININ OXIDASE/DEHYDROGENASE GENES; TRANSGENIC BARLEY; ARABIDOPSIS; RICE; IDENTIFICATION; WEIGHT; FAMILY; MAIZE; AUXIN; WHEAT	Cytokinin oxidase/dehydrogenase proteins (CKX) are encoded by a multigene family of CKX genes with a varying number of members depending on species. For some of the genes, spectacular effects on grain production in selected cereals have been observed. Despite the fact that partial or full length sequences of most HvCKX genes in barley (Hordeum vulgare) have already been published, in most cases their specific biological functions have not been reported. Detailed expression patterns for five HvCKX genes in different organs/tissues of developing barley plants coupled with analysis of RNAi silent for two genes are presented to test the hypothesis that these expression profiles might indicate their function. Elevated expression for four of them - HvCKX1, HvCKX9, HvCKX4, and HvCKX11 - was found in developing kernels of wild-type plants compared to other tissues. HvCKX5 was mainly expressed in leaf tissue. Lower expression was noted for HvCKX1 in seedling roots and for HvCKX9 in leaves. The documented effect of RNAi silencing of HvCKX1 and a trend for HvCKX9 was higher plant productivity, and the trait was inherited through four generations. Higher plant yield was determined by higher numbers of seeds and spikes. Increased productivity was significantly greater in HvCKX1 silenced plants showing higher relative expression of HvCKX1 in developing kernels of wild-type plants compared to the expression of HvCKX9. Both HvCKX1 silenced T-1 seedlings of cv. Golden Promise and the newly transformed breeding line STH7308 showed greater root mass, but this trait was not inherited in the next generation. Similarly HvCKX9 silenced T-1 seedlings exhibited greater plant height without inheritance in the next generation. It is suggested that these effects were not inherited because of compensation by other genes co-ordinately regulating reproductive development. One line with untypically changed, inherited phenotype, which was selected from several dozen silenced lines showing stable and common phenotypes is presented.	[Zalewski, Wojciech; Gasparis, Sebastian; Boczkowska, Maja; Rajchel, Izabela K.; Kala, Maciej; Nadolska-Orczyk, Anna] Natl Res Inst, Plant Breeding & Acclimatizat Inst, Dept Funct Gen, Blonie, Poland; [Orczyk, Waclaw] Natl Res Inst, Plant Breeding & Acclimatizat Inst, Dept Genet Engn, Blonie, Poland	Institute of Plant Breeding & Acclimatization; Institute of Plant Breeding & Acclimatization	Nadolska-Orczyk, A (corresponding author), Natl Res Inst, Plant Breeding & Acclimatizat Inst, Dept Funct Gen, Blonie, Poland.	a.orczyk@ihar.edu.pl	Gasparis, Sebastian/ABF-3685-2020; Boczkowska, Maja/J-3654-2019	Gasparis, Sebastian/0000-0003-0521-086X; Boczkowska, Maja/0000-0001-8691-410X; Nadolska-Orczyk, Anna/0000-0001-6127-3860	Polish Ministry of Science and Higher Education [620/N-COST/09/2010/0]; Polish Ministry of Agriculture and Rural Development [1-1-01-4-04]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Polish Ministry of Agriculture and Rural Development	This research was supported by grant 620/N-COST/09/2010/0 from the Polish Ministry of Science and Higher Education, statutory grant 1-1-01-4-04 and PB No. 5 from the Polish Ministry of Agriculture and Rural Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Bartlett JG, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-22; Bartrina I, 2011, PLANT CELL, V23, P69, DOI 10.1105/tpc.110.079079; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brugiere N, 2003, PLANT PHYSIOL, V132, P1228, DOI 10.1104/pp.102.017707; Frebort I, 2002, ANAL BIOCHEM, V306, P1, DOI 10.1006/abio.2002.5670; Galuszka P, 2004, EUR J BIOCHEM, V271, P3990, DOI 10.1111/j.1432-1033.2004.04334.x; Galuszka P, 2002, NCBI GENBANK; Gao SP, 2014, PLANT PHYSIOL, V165, P1035, DOI 10.1104/pp.114.238584; Gimenez MJ, 2011, PLANTA, V233, P163, DOI 10.1007/s00425-010-1290-y; Hensel G, 2008, J PLANT PHYSIOL, V165, P71, DOI 10.1016/j.jplph.2007.06.015; Horvath H, 2000, P NATL ACAD SCI USA, V97, P1914, DOI 10.1073/pnas.030527497; Hou BK, 2004, J BIOL CHEM, V279, P47822, DOI 10.1074/jbc.M409569200; Kakimoto T, 2001, PLANT CELL PHYSIOL, V42, P677, DOI 10.1093/pcp/pce112; Mameaux S, 2012, PLANT BIOTECHNOL J, V10, P67, DOI 10.1111/j.1467-7652.2011.00645.x; Matsumoto T, 2011, PLANT PHYSIOL, V156, P20, DOI 10.1104/pp.110.171579; Mok DWS, 2001, ANNU REV PLANT PHYS, V52, P89, DOI 10.1146/annurev.arplant.52.1.89; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Novina CD, 2004, NATURE, V430, P161, DOI 10.1038/430161a; Przetakiewicz A, 2003, PLANT CELL TISS ORG, V73, P245, DOI 10.1023/A:1023030511800; Sakakibara H, 2006, ANNU REV PLANT BIOL, V57, P431, DOI 10.1146/annurev.arplant.57.032905.105231; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schmulling T, 2003, J PLANT RES, V116, P241, DOI 10.1007/s10265-003-0096-4; Song JC, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-78; Takei K, 2002, J EXP BOT, V53, P971, DOI 10.1093/jexbot/53.370.971; Waterhouse PM, 2003, NAT REV GENET, V4, P29, DOI 10.1038/nrg982; Werner T, 2003, PLANT CELL, V15, P2532, DOI 10.1105/tpc.014928; Werner T, 2001, P NATL ACAD SCI USA, V98, P10487, DOI 10.1073/pnas.171304098; Werner T, 2006, PLANT BIOLOGY, V8, P371, DOI 10.1055/s-2006-923928; Werner T, 2010, PLANT CELL, V22, P3905, DOI 10.1105/tpc.109.072694; Werner T, 2009, CURR OPIN PLANT BIOL, V12, P527, DOI 10.1016/j.pbi.2009.07.002; Zalewski W, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-206; Zalewski W, 2010, J EXP BOT, V61, P1839, DOI 10.1093/jxb/erq052; Zhang L, 2012, NEW PHYTOL, V195, P574, DOI 10.1111/j.1469-8137.2012.04194.x	35	32	32	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115729	10.1371/journal.pone.0115729	http://dx.doi.org/10.1371/journal.pone.0115729			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531889	Green Published, gold, Green Submitted			2022-12-27	WOS:000348845100103
J	Furtado, J; Bento, M; Correia, E; Inacio, JM; Belo, JA				Furtado, Joao; Bento, Margaret; Correia, Elizabeth; Inacio, Jose Manuel; Belo, Jose Antonio			Expression and Function of Ccbe1 in the Chick Early Cardiogenic Regions Are Required for Correct Heart Development	PLOS ONE			English	Article							CARDIAC PROGENITOR CELLS; AVIAN PRECARDIAC CELLS; NEURAL CREST; EXTRACELLULAR-MATRIX; TRANSCRIPTION FACTOR; VENTRAL MORPHOGENESIS; MOVEMENT PATTERNS; CONDUCTION SYSTEM; TUBE FORMATION; MIGRATION	During the course of a differential screen to identify transcripts specific for chick heart/hemangioblast precursor cells, we have identified Ccbe1 (Collagen and calcium-binding EGF-like domain 1). While the importance of Ccbe1 for the development of the lymphatic system is now well demonstrated, its role in cardiac formation remained unknown. Here we show by whole-mount in situ hybridization analysis that cCcbe1 mRNA is initially detected in early cardiac progenitors of the two bilateral cardiogenic fields (HH4), and at later stages on the second heart field (HH9-18). Furthermore, cCcbe1 is expressed in multipotent and highly proliferative cardiac progenitors. We characterized the role of cCcbe1 during early cardiogenesis by performing functional studies. Upon morpholino-induced cCcbe1 knockdown, the chick embryos displayed heart malformations, which include aberrant fusion of the heart fields, leading to incomplete terminal differentiation of the cardiomyocytes. cCcbe1 overexpression also resulted in severe heart defects, including cardia bifida. Altogether, our data demonstrate that although cardiac progenitors cells are specified in cCcbe1 morphants, the migration and proliferation of cardiac precursors cells are impaired, suggesting that cCcbe1 is a key gene during early heart development.	[Furtado, Joao; Bento, Margaret; Correia, Elizabeth; Inacio, Jose Manuel; Belo, Jose Antonio] Univ Algarve, Regenerat Med Program, Dept Ciencias Biomed & Med, Faro, Portugal; [Furtado, Joao; Bento, Margaret; Correia, Elizabeth; Inacio, Jose Manuel; Belo, Jose Antonio] Univ Algarve, IBB Inst Biotechnol & Bioengn, Ctr Biomed Mol & Estrutural, P-8005135 Faro, Portugal; [Inacio, Jose Manuel; Belo, Jose Antonio] Univ Nova Lisboa, Fac Ciencias Med, CEDOC, NOVA Med Sch, P-1169056 Lisbon, Portugal	Universidade do Algarve; Universidade do Algarve; Universidade Nova de Lisboa	Belo, JA (corresponding author), Univ Algarve, Regenerat Med Program, Dept Ciencias Biomed & Med, Faro, Portugal.	jose.belo@fcm.unl.pt	Belo, José A. A/F-4444-2012; Inacio, Jose M/O-1455-2018	Belo, José A. A/0000-0001-7384-0949; Inacio, Jose M/0000-0002-9790-8335; Furtado, Joao/0000-0003-0689-1978	FCT [SFRH/BD/65628/2009, SFRH/BPD/86497/2012, SFRH/BPD/41081/2007]; F.C.T.B.I. fellowship [PTDC/SAU-BID/114902/ 2009]; FCT; Institute for Biotechnology Bioengineering (Centro Biomedicina Molecular e Celular (IBB/CBME), Laboratorio Associado (LA) in the frame of Project [PestOE/EQB/LA0023/2013]	FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); F.C.T.B.I. fellowship; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Institute for Biotechnology Bioengineering (Centro Biomedicina Molecular e Celular (IBB/CBME), Laboratorio Associado (LA) in the frame of Project	J. Furtado is a PhD student funded by FCT (SFRH/BD/65628/2009). M. Bento (SFRH/BPD/86497/2012) and J. M. Inacio (SFRH/BPD/41081/2007) are Fundacao Ciencia e Tecnologia (FCT) pos-doctoral fellows. E. Correia is a recipient of a F.C.T.B.I. fellowship (PTDC/SAU-BID/114902/ 2009). This work was supported by research grants from FCT to J. A. Belo and from Institute for Biotechnology Bioengineering (Centro Biomedicina Molecular e Celular (IBB/CBME), Laboratorio Associado (LA) in the frame of Project Ref o PestOE/EQB/LA0023/2013.	Abu-Issa R, 2007, ANNU REV CELL DEV BI, V23, P45, DOI 10.1146/annurev.cellbio.23.090506.123331; Alders M, 2009, NAT GENET, V41, P1272, DOI 10.1038/ng.484; AOYAMA N, 1995, LAB INVEST, V72, P355; Barton CA, 2010, BRIT J CANCER, V102, P87, DOI 10.1038/sj.bjc.6605429; Bento M, 2011, GENE EXPR PATTERNS, V11, P437, DOI 10.1016/j.gep.2011.07.002; Blom NA, 1999, CIRCULATION, V99, P800, DOI 10.1161/01.CIR.99.6.800; Bos FL, 2011, CIRC RES, V109, P486, DOI 10.1161/CIRCRESAHA.111.250738; BRONNERFRASER M, 1987, DEV BIOL, V123, P321, DOI 10.1016/0012-1606(87)90390-3; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Camp E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051948; Chuck ET, 1997, DEV DYNAM, V209, P182, DOI 10.1002/(SICI)1097-0177(199706)209:2<182::AID-AJA4>3.3.CO;2-T; Connell F, 2010, HUM GENET, V127, P231, DOI 10.1007/s00439-009-0766-y; ENGEL J, 1989, FEBS LETT, V251, P1, DOI 10.1016/0014-5793(89)81417-6; Facucho-Oliveira J, 2011, INT J DEV BIOL, V55, P1007, DOI 10.1387/ijdb.113394jf; Glickman NS, 2002, SEMIN CELL DEV BIOL, V13, P507, DOI 10.1016/S1084952102001040; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Harvey RP, 2002, NAT REV GENET, V3, P544, DOI 10.1038/nrg843; Hogan BM, 2009, NAT GENET, V41, P396, DOI 10.1038/ng.321; Hutson Mary Redmond, 2003, Birth Defects Research, V69, P2, DOI 10.1002/bdrc.10002; Jeltsch M, 2014, CIRCULATION, V129, P1962, DOI 10.1161/CIRCULATIONAHA.113.002779; Keyte A, 2012, DIFFERENTIATION, V84, DOI 10.1016/j.diff.2012.04.005; Kirby ML, 2002, PEDIATR DEVEL PATHOL, V5, P516, DOI 10.1007/s10024-002-0004-2; Kuo CT, 1997, GENE DEV, V11, P1048, DOI 10.1101/gad.11.8.1048; Laugwitz KL, 2008, DEVELOPMENT, V135, P193, DOI 10.1242/dev.001883; LINASK KK, 1988, DEV BIOL, V129, P324, DOI 10.1016/0012-1606(88)90379-X; LINASK KK, 1988, DEV BIOL, V129, P315, DOI 10.1016/0012-1606(88)90378-8; LITTLE CD, 1995, EXPERIENTIA, V51, P873, DOI 10.1007/BF01921738; Mjaatvedt CH, 2001, DEV BIOL, V238, P97, DOI 10.1006/dbio.2001.0409; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Momose T, 1999, DEV GROWTH DIFFER, V41, P335; Munsterberg A, 2008, CELL ADHES MIGR, V2, P74, DOI 10.4161/cam.2.2.6295; Nakajima Y, 2001, ANAT RECORD, V263, P326, DOI 10.1002/ar.1099; Nakamura T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2319; New DAT, 1955, EMBRYOL EXP MORPHOL, V3, P326; Noseda M, 2011, CIRC RES, V108, P129, DOI 10.1161/CIRCRESAHA.110.223792; Rawles Mary E., 1943, PHYSIOL ZOOL, V16, P22; Rozario T, 2010, DEV BIOL, V341, P126, DOI 10.1016/j.ydbio.2009.10.026; SISSMAN J, 1966, NATURE, V210, P504; Song JF, 2014, P NATL ACAD SCI USA, V111, P7337, DOI 10.1073/pnas.1321764111; STALSBERG H, 1969, DEV BIOL, V19, P128, DOI 10.1016/0012-1606(69)90052-9; Tavares AT, 2007, DEVELOPMENT, V134, P2051, DOI 10.1242/dev.000901; van den Berg G, 2009, PEDIATR CARDIOL, V30, P580, DOI 10.1007/s00246-008-9369-y; van den Berg G, 2009, CIRC RES, V104, P179, DOI 10.1161/CIRCRESAHA.108.185843; VINCENT M, 1984, DEV BIOL, V103, P468, DOI 10.1016/0012-1606(84)90334-8; Vincent SD, 2010, CURR TOP DEV BIOL, V90, P1, DOI 10.1016/S0070-2153(10)90001-X; Waldo KL, 2001, DEVELOPMENT, V128, P3179; Waldo KL, 2005, DEV BIOL, V281, P66, DOI 10.1016/j.ydbio.2005.02.011; Wilkinson DG., 1992, SITU HYBRIDIZATION P, P75; Yang XS, 2002, DEV CELL, V3, P425, DOI 10.1016/S1534-5807(02)00256-3; Yue Q, 2008, DEVELOPMENT, V135, P1029, DOI 10.1242/dev.015321	51	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115481	10.1371/journal.pone.0115481	http://dx.doi.org/10.1371/journal.pone.0115481			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545279	Green Submitted, gold, Green Published			2022-12-27	WOS:000347120200044
J	Reuter, S; Soonpaa, MH; Firulli, AB; Chang, AN; Field, LJ				Reuter, Sean; Soonpaa, Mark H.; Firulli, Anthony B.; Chang, Audrey N.; Field, Loren J.			Recombinant Neuregulin 1 Does Not Activate Cardiomyocyte DNA Synthesis in Normal or Infarcted Adult Mice	PLOS ONE			English	Article							CARDIAC MYOCYTES; TRANSGENIC MICE; DILATED CARDIOMYOPATHY; VENTRICULAR MYOCYTES; STEM-CELLS; HEART; EXPRESSION; ERBB2; RECEPTOR; PROLIFERATION	Objectives: Neuregulin 1 signaling plays an important role in cardiac trabecular development, and in sustaining functional integrity in adult hearts. Treatment with neuregulin 1 enhances adult cardiomyocyte differentiation, survival and/or function in vitro and in vivo. It has also been suggested that recombinant neuregulin 1 beta 1 (NRG1 beta 1) induces cardiomyocyte proliferation in normal and injured adult hearts. Here we further explore the impact of neuregulin 1 signaling on adult cardiomyocyte cell cycle activity. Methods and Results: Adult mice were subjected to 9 consecutive daily injections of recombinant NRG1 beta 1 or vehicle, and cardiomyocyte DNA synthesis was quantitated via bromodeoxyuridine (BrdU) incorporation, which was delivered using mini-osmotic pumps over the entire duration of NRG1 beta 1 treatment. NRG1 beta 1 treatment inhibited baseline rates of cardiomyocyte DNA synthesis in normal mice (cardiomyocyte labelling index: 0.019 +/- 0.005% vs. 0.003 +/- 0.001%, saline vs. NRG1 beta 1, P<0.05). Acute NRG1 beta 1 treatment did result in activation of Erk1/2 and cardiac myosin regulatory light chain (down-stream mediators of neuregulin signalling), as well as activation of DNA synthesis in non-cardiomyocytes, validating the biological activity of the recombinant protein. In other studies, mice were subjected to permanent coronary artery occlusion, and cardiomyocyte DNA synthesis was monitored via tritiated thymidine incorporation which was delivered as a single injection 7 days post-infarction. Daily NRG1 beta 1 treatment had no impact on cardiomyocyte DNA synthesis in the infarcted myocardium (cardiomyocyte labelling index: 0.039 +/- 0.011% vs. 0.027 +/- 0.021%, saline vs. NRG1 beta 1, P>0.05). Summary: These data indicate that NRG1 beta 1 treatment does not increase cardiomyocyte DNA synthesis (and consequently does not increase the rate of cardiomyocyte renewal) in normal or infarcted adult mouse hearts. Thus, any improvement in cardiac structure and function observed following neuregulin treatment of injured hearts likely occurs independently of overt myocardial regeneration.	[Reuter, Sean; Soonpaa, Mark H.; Firulli, Anthony B.; Field, Loren J.] Indiana Univ, Sch Med, Krannert Inst Cardiol, Indianapolis, IN 46202 USA; [Reuter, Sean; Soonpaa, Mark H.; Firulli, Anthony B.; Field, Loren J.] Wells Ctr Pediat Res, Riley Heart Res Ctr, Indianapolis, IN USA; [Reuter, Sean; Soonpaa, Mark H.; Firulli, Anthony B.; Field, Loren J.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Chang, Audrey N.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington; University of Texas System; University of Texas Southwestern Medical Center Dallas	Field, LJ (corresponding author), Indiana Univ, Sch Med, Krannert Inst Cardiol, Indianapolis, IN 46202 USA.	ljfield@iu.edu		/0000-0001-6687-8949	National Institutes of Health Heart, Lung and Blood Instititue [HL109205, 083126]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122123, R01HL083126, R01HL109205, R01HL120920] Funding Source: NIH RePORTER	National Institutes of Health Heart, Lung and Blood Instititue; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Grant # HL109205 & 083126 from the National Institutes of Health Heart, Lung and Blood Instititue, http://www.nhlbi.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang KL, 2010, AM J PHYSIOL-CELL PH, V298, pC1603, DOI 10.1152/ajpcell.00435.2009; Angert D, 2011, CIRC RES, V108, P1226, DOI 10.1161/CIRCRESAHA.110.239046; Baliga RR, 1999, AM J PHYSL, V277; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Bian Y, 2009, AM J PHYSIOL-HEART C, V297, pH1974, DOI 10.1152/ajpheart.01010.2008; Braun T, 2009, DEV CELL, V17, P151, DOI 10.1016/j.devcel.2009.07.022; Chang AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066720; CREAMER B, 1961, GUT, V2, P110, DOI 10.1136/gut.2.2.110; Engel FB, 2005, GENE DEV, V19, P1175, DOI 10.1101/gad.1306705; Esper RM, 2006, BRAIN RES REV, V51, P161, DOI 10.1016/j.brainresrev.2005.11.006; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Formiga FR, 2013, J CONTROL RELEASE; Fukazawa R, 2003, J MOL CELL CARDIOL, V35, P1473, DOI 10.1016/j.yjmcc.2003.09.012; Fuller SJ, 2008, J MOL CELL CARDIOL, V44, P831, DOI 10.1016/j.yjmcc.2008.02.278; Gao R, 1907, J AM COLL CARDIOL, V55, P1907; Garcia-Rivello H, 2005, AM J PHYSIOL-HEART C, V289, pH1153, DOI 10.1152/ajpheart.00048.2005; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Geiger S, ANTICANCER DRUGS, V21, P578; Giraud MN, 2005, J APPL PHYSIOL, V99, P313, DOI 10.1152/japplphysiol.00609.2004; Grego-Bessa J, 2007, DEV CELL, V12, P415, DOI 10.1016/j.devcel.2006.12.011; Gu X, CARDIOVASC RES, V88, P334; Jabbour A, EUR J HEART FAIL, V13, P83; Junqueira LCU, 1992, BASIC HISTOLOGY; Keulenaer GW De, CIRC RES, V106, P35; KOH GY, 1995, J CLIN INVEST, V96, P2034, DOI 10.1172/JCI118251; Kuramochi Y, 2004, J BIOL CHEM, V279, P51141, DOI 10.1074/jbc.M408662200; Kuramochi Y, 2006, J MOL CELL CARDIOL, V41, P228, DOI 10.1016/j.yjmcc.2006.04.007; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Lemmens K, 2007, CIRCULATION, V116, P954, DOI 10.1161/CIRCULATIONAHA.107.690487; Liu XF, 2006, J AM COLL CARDIOL, V48, P1438, DOI 10.1016/j.jacc.2006.05.057; Marguerie A, 2006, CARDIOVASC RES, V71, P50, DOI 10.1016/j.cardiores.2006.03.021; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Nakajima H, 2006, CIRC RES, V98, P141, DOI 10.1161/01.RES.0000197783.70106.4a; Nakajima H, 2004, CIRC RES, V94, P1606, DOI 10.1161/01.RES.0000132279.99249.f4; Nakajima H, 2000, CIRC RES, V86, P571, DOI 10.1161/01.RES.86.5.571; Odiete O, 2012, CIRC RES, V111, P1376, DOI 10.1161/CIRCRESAHA.112.267286; Ozcelik C, 2002, P NATL ACAD SCI USA, V99, P8880, DOI 10.1073/pnas.122249299; Pasumarthi KBS, 2005, CIRC RES, V96, P110, DOI 10.1161/01.RES.0000152326.91223.4F; Pasumarthi KBS, 2000, CIRC RES, V86, P1069, DOI 10.1161/01.RES.86.10.1069; Rohrbach S, 1999, CIRCULATION, V100, P407, DOI 10.1161/01.CIR.100.4.407; Rohrbach S, 2005, BASIC RES CARDIOL, V100, P240, DOI 10.1007/s00395-005-0514-4; Senyo SE, 2013, NATURE, V493, P433, DOI 10.1038/nature11682; Soonpaa MH, 2013, BBA-MOL CELL RES, V1833, P799, DOI 10.1016/j.bbamcr.2012.10.029; SOONPAA MH, 1994, SCIENCE, V264, P98, DOI 10.1126/science.8140423; Soonpaa MH, 1997, AM J PHYSIOL-HEART C, V272, pH220, DOI 10.1152/ajpheart.1997.272.1.H220; Soonpaa MH, 1997, J CLIN INVEST, V99, P2644, DOI 10.1172/JCI119453; Soonpaa MH, 1998, CIRC RES, V83, P15, DOI 10.1161/01.RES.83.1.15; SOONPAA MH, 1994, AM J PHYSIOL, V266, pH1439, DOI 10.1152/ajpheart.1994.266.4.H1439; Timolati F, 2006, J MOL CELL CARDIOL, V41, P845, DOI 10.1016/j.yjmcc.2006.08.002; Uray IP, 2002, J HEART LUNG TRANSPL, V21, P771, DOI 10.1016/S1053-2498(02)00390-X; Zhao YY, 1998, J BIOL CHEM, V273, P10261, DOI 10.1074/jbc.273.17.10261	52	38	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115871	10.1371/journal.pone.0115871	http://dx.doi.org/10.1371/journal.pone.0115871			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545368	Green Published, Green Submitted, gold			2022-12-27	WOS:000347120200076
J	Chang, CS; Wallace, CG; Hsiao, YC; Chang, CJ; Chen, PKT				Chang, Chun-Shin; Wallace, Christopher Glenn; Hsiao, Yen-Chang; Chang, Chee-Jen; Chen, Philip Kuo-Ting			Botulinum Toxin to Improve Results in Cleft Lip Repair: A Double-Blinded, Randomized, Vehicle-Controlled Clinical Trial	PLOS ONE			English	Article							SCAR FORMATION; FACIAL WOUNDS	Background: Most patients with facial scarring would value even a slight improvement in scar quality. Botulinum toxin A is widely used to alleviate facial dynamic rhytides but is also believed to improve scar quality by reducing wound tension during healing. The main objective was to assess the effect of Botulinum toxin on scars resultant from standardized upper lip wounds. Methods: In this double-blinded, randomized, vehicle-controlled, prospective clinical trial, 60 consecutive consenting adults undergoing cleft lip scar revision (CLSR) surgery between July 2010 and March 2012 were randomized to receive botulinum toxin A (n=30) or vehicle (normal saline; n=30) injections into the subjacent orbicularis oris muscle immediately after wound closure. Scars were independently assessed at 6-months follow-up in blinded fashion using: Vancouver Scar Scale (VSS), Visual Analogue Scale (VAS) and photographic plus ultrasound measurements of scar widths. Results: 58 patients completed the trial. All scar assessment modalities revealed statistically significantly better scars in the experimental than the vehicle-control group. Conclusion: Quality of surgical upper lip scars, which are oriented perpendicular to the direction of pull of the underlying orbicularis oris muscle, is significantly improved by its temporary paralysis during wound healing.	[Chang, Chun-Shin] Chang Gung Univ, Coll Engn, Grad Inst Chem & Mat Engn, Taoyuan, Taiwan; [Chang, Chee-Jen] Chang Gung Univ, Sch Med, Grad Inst Clin Med Sci, Taoyuan, Taiwan; [Chang, Chun-Shin; Wallace, Christopher Glenn; Hsiao, Yen-Chang; Chen, Philip Kuo-Ting] Chang Gung Mem Hosp, Craniofacial Res Ctr, Dept Plast Surg, Dept Med Res, Taoyuan, Taiwan	Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital	Chen, PKT (corresponding author), Chang Gung Mem Hosp, Craniofacial Res Ctr, Dept Plast Surg, Dept Med Res, Taoyuan, Taiwan.	philip@adm.cgmh.org.tw		Chang, Chee Jen/0000-0002-7725-7555	Craniofacial Research Center of Chang Gung Memorial Hospital; Chang Gung University, Taiwan [CMRPG 390731]	Craniofacial Research Center of Chang Gung Memorial Hospital; Chang Gung University, Taiwan	This trial was funded by the Craniofacial Research Center of Chang Gung Memorial Hospital and Chang Gung University, Taiwan (CMRPG 390731). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atiyeh BS, 2007, AESTHET PLAST SURG, V31, P468, DOI 10.1007/s00266-006-0253-y; Atkinson JAM, 2005, PLAST RECONSTR SURG, V116, P1648, DOI 10.1097/01.prs.0000187147.73963.a5; Broughton G, 2006, PLAST RECONSTR SURG, V117, p12S, DOI 10.1097/01.prs.0000225430.42531.c2; CARRUTHERS A, 1995, PLAST RECONSTR SURG, V95, P427, DOI 10.1097/00006534-199502000-00049; Chen PKT, 2009, PLASTIC SURG INDICAT, P545; Dunkin CSJ, 2007, PLAST RECONSTR SURG, V119, P1722, DOI 10.1097/01.prs.0000258829.07399.f0; Flynn TC, 2009, DERMATOL SURG, V35, P182, DOI 10.1111/j.1524-4725.2008.34407.x; Gassner HG, 2000, PLAST RECONSTR SURG, V105, P1948, DOI 10.1097/00006534-200005000-00005; Gassner HG, 2006, MAYO CLIN PROC, V81, P1023, DOI 10.4065/81.8.1023; Gassner HG, 2009, ARCH FACIAL PLAST S, V11, P140, DOI 10.1001/archfacial.2009.3; Gurtner GC, 2011, ANN SURG, V254, P217, DOI 10.1097/SLA.0b013e318220b159; Lee BJ, 2009, CLIN EXP OTORHINOLAR, V2, P20, DOI 10.3342/ceo.2009.2.1.20; Liu A, 2011, DERMATOL SURG, V37, P1740, DOI 10.1111/j.1524-4725.2011.02166.x; Marshall GN, 2010, ORAL MAXIL SURG CLIN, V22, P225, DOI 10.1016/j.coms.2010.01.007; McCarty Morgan, 2010, J Clin Aesthet Dermatol, V3, P39; Ogawa R, 2008, MED HYPOTHESES, V71, P493, DOI 10.1016/j.mehy.2008.05.020; SCOTT AB, 1980, OPHTHALMOLOGY, V87, P1044; Sherris David A, 2002, Facial Plast Surg, V18, P35, DOI 10.1055/s-2002-19825; Stevens DL, 2011, ANAEROBE; Tebble NJ, 2004, J ADV NURS, V47, P417, DOI 10.1111/j.1365-2648.2004.03123.x; Wilson AM, 2006, PLAST RECONSTR SURG, V117, P1758, DOI 10.1097/01.prs.0000209944.45949.d1; Young VL, 2009, PLAST RECONSTR SURG, V124, P256, DOI 10.1097/PRS.0b013e3181a80747	22	51	56	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115690	10.1371/journal.pone.0115690	http://dx.doi.org/10.1371/journal.pone.0115690			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541942	Green Published, gold, Green Submitted			2022-12-27	WOS:000347239900071
J	Lin, WY				Lin, Wan-Yu			Adaptive Combination of P-Values for Family-Based Association Testing with Sequence Data	PLOS ONE			English	Article							UNCOMMON CAUSAL VARIANTS; RARE DISEASE VARIANTS; COMPLEX DISEASES; PRINCIPAL-COMPONENTS; GENETIC ASSOCIATION; COMMON DISEASES; HAPLOTYPE; DISEQUILIBRIUM; GENOME; MODEL	Family-based study design will play a key role in identifying rare causal variants, because rare causal variants can be enriched in families with multiple affected subjects. Furthermore, different from population-based studies, family studies are robust to bias induced by population substructure. It is well known that rare causal variants are difficult to detect from single-locus tests. Therefore, burden tests and non-burden tests have been developed, by combining signals of multiple variants in a chromosomal region or a functional unit. This inevitably incorporates some neutral variants into the test statistics, which can dilute the power of statistical methods. To guard against the noise caused by neutral variants, we here propose an 'adaptive combination of P-values method' (abbreviated as 'ADA'). This method combines per-site P-values of variants that are more likely to be causal. Variants with large P-values (which are more likely to be neutral variants) are discarded from the combined statistic. In addition to performing extensive simulation studies, we applied these tests to the Genetic Analysis Workshop 17 data sets, where real sequence data were generated according to the 1000 Genomes Project. Compared with some existing methods, ADA is more robust to the inclusion of neutral variants. This is a merit especially when dichotomous traits are analyzed. However, there are some limitations for ADA. First, it is more computationally intensive. Second, pedigree structures and founders' sequence data are required for the permutation procedure. Third, unrelated controls cannot be included. We here show that, for family-based studies, the application of ADA is limited to dichotomous trait analyses with full pedigree information.	Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan	National Taiwan University	Lin, WY (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan.	linwy@ntu.edu.tw		LIN, WAN-YU/0000-0002-3385-4702	Ministry of Science and Technology of Taiwan [102-2628-B-002-039-MY3]; National Taiwan University [NTU-CESRP-103R7622-8, NTU-CDP-102R7769]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University(National Taiwan University)	This work was supported by grants 102-2628-B-002-039-MY3 from the Ministry of Science and Technology of Taiwan, NTU-CESRP-103R7622-8, and NTU-CDP-102R7769 from National Taiwan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasy L, 2011, BMC P S9, V5, pS2; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Azzopardi D, 2008, CANCER RES, V68, P358, DOI 10.1158/0008-5472.CAN-07-5733; Bansal V, 2010, NAT REV GENET, V11, P773, DOI 10.1038/nrg2867; BESAG J, 1991, BIOMETRIKA, V78, P301; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Chen H, 2013, GENET EPIDEMIOL, V37, P196, DOI 10.1002/gepi.21703; Cheng KF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074310; Cheung YH, 2012, GENET EPIDEMIOL, V36, P675, DOI 10.1002/gepi.21662; Chung RH, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-199; Chung RH, 2014, GENET EPIDEMIOL; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; De G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0048495; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Donnelly P, 1995, ANNU REV GENET, V29, P401, DOI 10.1146/annurev.ge.29.120195.002153; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; Fan RZ, 2005, ANN HUM GENET, V69, P187, DOI 10.1046/j.1529-8817.2004.00151.x; Fier H, 2012, BIOINFORMATICS, V28, P3027, DOI 10.1093/bioinformatics/bts568; Gorlov IP, 2008, AM J HUM GENET, V82, P100, DOI 10.1016/j.ajhg.2007.09.006; Han F, 2010, HUM HERED, V70, P42, DOI 10.1159/000288704; He ZX, 2014, AM J HUM GENET, V94, P33, DOI 10.1016/j.ajhg.2013.11.021; Hershberger RE, 2010, CIRC-CARDIOVASC GENE, V3, P155, DOI 10.1161/CIRCGENETICS.109.912345; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; HUDSON RR, 1983, THEOR POPUL BIOL, V23, P183, DOI 10.1016/0040-5809(83)90013-8; Ionita-Laza I, 2013, STAT BIOSCI, V5, P54, DOI 10.1007/s12561-012-9062-9; Ionita-Laza I, 2013, EUR J HUM GENET, V21, P1158, DOI 10.1038/ejhg.2012.308; Ionita-Laza I, 2012, AM J HUM GENET, V90, P1002, DOI 10.1016/j.ajhg.2012.04.010; Ionita-Laza I, 2011, GENETICS, V189, P1061, DOI 10.1534/genetics.111.131813; Jiang Y, 2014, AM J HUM GENET, V94, P845, DOI 10.1016/j.ajhg.2014.04.014; Lee S, 2012, BIOSTATISTICS, V13, P762, DOI 10.1093/biostatistics/kxs014; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li Y, 2010, AM J HUM GENET, V87, P728, DOI 10.1016/j.ajhg.2010.10.014; Liang LM, 2007, BIOINFORMATICS, V23, P1565, DOI 10.1093/bioinformatics/btm138; Lin WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094337; Lin WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085728; Lin WY, 2013, GENET EPIDEMIOL, V37, P560, DOI 10.1002/gepi.21740; Lin WY, 2012, GENET EPIDEMIOL, V36, P572, DOI 10.1002/gepi.21650; Lin WY, 2011, BMC P S9, V5, pS118; Liu DJJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001156; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Mathieson I, 2012, NAT GENET, V44, P243, DOI 10.1038/ng.1074; Morris AP, 2010, GENET EPIDEMIOL, V34, P188, DOI 10.1002/gepi.20450; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Oualkacha K, 2013, GENET EPIDEMIOL, V37, P366, DOI 10.1002/gepi.21725; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Saad M, 2011, BMC P S9, V5, pS33; Saad M, 2014, GENET EPIDEMIOL, V38, P1, DOI 10.1002/gepi.21776; Schaid DJ, 2013, HUM GENET, V132, P1301, DOI 10.1007/s00439-013-1335-y; Schaid DJ, 2013, GENET EPIDEMIOL, V37, P409, DOI 10.1002/gepi.21727; Schifano ED, 2012, GENET EPIDEMIOL, V36, P797, DOI 10.1002/gepi.21676; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Svishcheva GR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099407; TERWILLIGER JD, 1992, HUM HERED, V42, P337, DOI 10.1159/000154096; Therneau T, 2012, R PACKAGE VERSION 2; Thornton T, 2010, AM J HUM GENET, V86, P172, DOI 10.1016/j.ajhg.2010.01.001; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Yi NJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002382; Yi NJ, 2011, GENET EPIDEMIOL, V35, P57, DOI 10.1002/gepi.20554; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zawistowski M, 2010, AM J HUM GENET, V87, P604, DOI 10.1016/j.ajhg.2010.10.012; Zhang YW, 2013, GENET EPIDEMIOL, V37, P99, DOI 10.1002/gepi.21691	66	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115971	10.1371/journal.pone.0115971	http://dx.doi.org/10.1371/journal.pone.0115971			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541952	gold, Green Submitted, Green Published			2022-12-27	WOS:000347239900122
J	Kinouchi, M; Uchida, D; Kuribayashi, N; Tamatani, T; Nagai, H; Miyamoto, Y				Kinouchi, Makoto; Uchida, Daisuke; Kuribayashi, Nobuyuki; Tamatani, Tetsuya; Nagai, Hirokazu; Miyamoto, Youji			Involvement of miR-518c-5p to Growth and Metastasis in Oral Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; CHEMOKINE RECEPTOR CXCR4; LYMPH-NODE METASTASIS; MICRORNA EXPRESSION; STEM-CELLS; IDENTIFICATION; TUMORIGENESIS; NICHES	We have previously demonstrated that a stromal cell-derived factor-1 (SDF-1; CXCL12)/CXCR4 system is involved in the establishment of metastasis in oral cancer. Recently, small non coding RNAs, microRNAs (miRNAs) have been shown to be involved in the metastatic process of several types of cancers. However, the miRNAs that contribute to metastases induced by the SDF-1/CXCR4 system in oral cancer are largely unknown. In this study, we examined the metastasis-related miRNAs induced by the SDF-1/CXCR4 system using B88-SDF-1 oral cancer cells, which exhibit functional CXCR4 and distant metastatic potential in vivo. Through miRNA microarray analysis, we identified the upregulation of miR-518c-5p in B88-SDF-1 cells, and confirmed the induction by real-time PCR analysis. Although an LNA-based miR-518c-5p inhibitor did not affect cell growth of B88-SDF-1 cells, it did significantly inhibit the migration of the cells. Next, we transfected a miR-518c expression vector into parental B88 cells and CAL27 oral cancer cells and isolated stable transfectants, B88-518c and CAL27-518c cells, respectively. The anchorage-dependent and -independent growth of miR-518c transfectants was significantly enhanced compared with the growth of mock cells. Moreover, we detected the enhanced migration of these cells. The LNA-based miR-518c-5p inhibitor significantly impaired the enhanced cell growth and migration of miR-518c transfectants, indicating that these phenomena were mainly dependent on the expression of miR-518c-5p. Next, we examined the function of miR-518c-5p in vivo. miR-518c transfectants or mock transfectants were inoculated into the masseter muscle or the blood vessels of nude mice. Tumor volume, lymph nodes metastasis, and lung metastasis were significantly increased in the mice inoculated with the miR-518c transfectants. These results indicated that miR-518c-5p regulates the growth and metastasis of oral cancer as a downstream target of the SDF-1/CXCR4 system.	[Kinouchi, Makoto; Uchida, Daisuke; Kuribayashi, Nobuyuki; Tamatani, Tetsuya; Nagai, Hirokazu; Miyamoto, Youji] Univ Tokushima, Grad Sch, Inst Hlth Biosciences, Dept Oral Surg Subdiv Mol Oral Med,Div Integrated, Tokushima 770, Japan		Uchida, D (corresponding author), Univ Tokushima, Grad Sch, Inst Hlth Biosciences, Dept Oral Surg Subdiv Mol Oral Med,Div Integrated, Tokushima 770, Japan.	daisuke@tokushima-u.ac.jp		Hoque, Mohammad Obaidul/0000-0001-6701-9978	 [25293411];  [26463046]; Grants-in-Aid for Scientific Research [26463046] Funding Source: KAKEN	; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research (B; 25293411 and C; 26463046; http://www.jsps.go.jp/english/e-grants/grants01.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almofti A, 2004, INT J ONCOL, V25, P65; Bouyssou JMC, 2014, BBA-REV CANCER, V1845, P255, DOI 10.1016/j.bbcan.2014.02.002; Chen ZP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069134; Dyrskjot L, 2009, CANCER RES, V69, P4851, DOI 10.1158/0008-5472.CAN-08-4043; Flor I, 2012, J PATHOL, V227, P270, DOI 10.1002/path.4014; Fornari F, 2012, J PATHOL, V227, P275, DOI 10.1002/path.3995; Fukunaga S, 2006, ONCOLOGY-BASEL, V71, P204, DOI 10.1159/000106070; Gellmini S, 2008, J ENDOCRINOL INVEST, V31, P809, DOI 10.1007/BF03349262; Hurst DR, 2009, CANCER RES, V69, P7495, DOI 10.1158/0008-5472.CAN-09-2111; Kasamatsu A, 2005, INT J BIOCHEM CELL B, V37, P1869, DOI 10.1016/j.biocel.2005.04.004; Khan MZ, 2011, J NEUROIMMUNE PHARM, V6, P163, DOI 10.1007/s11481-010-9228-5; Korshunov A, 2010, ACTA NEUROPATHOL, V120, P253, DOI 10.1007/s00401-010-0688-8; Kuribayashi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080773; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Rhodes LV, 2011, EXP CELL RES, V317, P2573, DOI 10.1016/j.yexcr.2011.08.016; Salcedo R, 2003, MICROCIRCULATION, V10, P359, DOI 10.1038/sj.mn.7800200; Sassen S, 2008, VIRCHOWS ARCH, V452, P1, DOI 10.1007/s00428-007-0532-2; Scotton CJ, 2002, CANCER RES, V62, P5930; Toffanin S, 2011, GASTROENTEROLOGY, V140, P1618, DOI 10.1053/j.gastro.2011.02.009; Uchida D, 2003, EXP CELL RES, V290, P289, DOI 10.1016/S0014-4827(03)00344-6; Uchida D, 2007, MOL CANCER RES, V5, P1, DOI DOI 10.1158/1541-7786.MCR-06-0208.PUBMED:17259342; Uchida D, 2013, CLIN EXP METASTAS, V30, P133, DOI 10.1007/s10585-012-9518-9; Uchida D, 2011, EUR J CANCER, V47, P452, DOI 10.1016/j.ejca.2010.09.028; Uchida DE, 2004, LAB INVEST, V84, P1538, DOI 10.1038/labinvest.3700190; Zeelenberg IS, 2003, CANCER RES, V63, P3833; Zhao JJ, 2009, CHILD NERV SYST, V25, P13, DOI 10.1007/s00381-008-0701-x	28	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115936	10.1371/journal.pone.0115936	http://dx.doi.org/10.1371/journal.pone.0115936			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536052	Green Published, gold, Green Submitted			2022-12-27	WOS:000348563300089
J	Nagaraj, VH; Mukhopadhyay, S; Dayarian, A; Sengupta, AM				Nagaraj, Vijayalakshmi H.; Mukhopadhyay, Swagatam; Dayarian, Adel; Sengupta, Anirvan M.			Breaking an Epigenetic Chromatin Switch: Curious Features of Hysteresis in Saccharomyces cerevisiae Telomeric Silencing	PLOS ONE			English	Article							GENE-EXPRESSION; PAF1 COMPLEX; METHYLATION; SIR2; MECHANISM; PROTEIN; HETEROCHROMATIN; IDENTIFICATION; INHERITANCE; DYNAMICS	In addition to gene network switches, local epigenetic modifications to DNA and histones play an important role in all-or-none cellular decision-making. Here, we study the dynamical design of a well-characterized epigenetic chromatin switch: the yeast SIR system, in order to understand the origin of the stability of epigenetic states. We study hysteresis in this system by perturbing it with a histone deacetylase inhibitor. We find that SIR silencing has many characteristics of a nonlinear bistable system, as observed in conventional genetic switches, which are based on activities of a few promoters affecting each other through the abundance of their gene products. Quite remarkably, our experiments in yeast telomeric silencing show a very distinctive pattern when it comes to the transition from bistability to monostability. In particular, the loss of the stable silenced state, upon increasing the inhibitor concentration, does not seem to show the expected saddle node behavior, instead looking like a supercritical pitchfork bifurcation. In other words, the 'off' state merges with the 'on' state at a threshold concentration leading to a single state, as opposed to the two states remaining distinct up to the threshold and exhibiting a discontinuous jump from the 'off' to the 'on' state. We argue that this is an inevitable consequence of silenced and active regions coexisting with dynamic domain boundaries. The experimental observations in our study therefore have broad implications for the understanding of chromatin silencing in yeast and beyond.	[Nagaraj, Vijayalakshmi H.; Sengupta, Anirvan M.] Rutgers State Univ, BioMaPS Inst, Piscataway, NJ 08854 USA; [Mukhopadhyay, Swagatam] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Dayarian, Adel] Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA; [Sengupta, Anirvan M.] Rutgers State Univ, Dept Phys & Astron, Piscataway, NJ USA	Rutgers State University New Brunswick; Cold Spring Harbor Laboratory; University of California System; University of California Santa Barbara; Rutgers State University New Brunswick	Sengupta, AM (corresponding author), Rutgers State Univ, BioMaPS Inst, Piscataway, NJ 08854 USA.	anirvans@physics.rutgers.edu			NHGRI [R01 HG003470]; NSF [PHY11-25915]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003470] Funding Source: NIH RePORTER	NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NSF(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was partially supported by a NHGRI grant R01 HG003470 to AMS. AD acknowledges support of NSF PHY11-25915. AMS also thanks KITP, UCSB (supported in part by NSF Phy11-25915). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 2008, MOL BIOL CELL, Vxxxiii, P1601; Angel A, 2011, NATURE, V476, P105, DOI 10.1038/nature10241; Arkin A, 1998, GENETICS, V149, P1633; Aurell E, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.051914; Aurell E, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.048101; Batenchuk C, 2011, BIOPHYS J, V100, pL56, DOI 10.1016/j.bpj.2011.04.021; Bedalov A, 2001, P NATL ACAD SCI USA, V98, P15113, DOI 10.1073/pnas.261574398; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; BRACHMANN CB, 1995, GENE DEV, V9, P2888, DOI 10.1101/gad.9.23.2888; Burke D, 2000, METHODS YEAST GENETI, Vxvii; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chen LY, 2005, CELL, V120, P37, DOI 10.1016/j.cell.2004.11.030; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; David-Rus D, 2009, J THEOR BIOL, V258, P112, DOI 10.1016/j.jtbi.2008.12.021; Dayarian A, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/3/036005; Dodd IB, 2007, CELL, V129, P813, DOI 10.1016/j.cell.2007.02.053; Donze D, 1999, GENE DEV, V13, P698, DOI 10.1101/gad.13.6.698; Frederiks F, 2008, NAT STRUCT MOL BIOL, V15, P550, DOI 10.1038/nsmb.1432; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Grubisha O, 2005, FEBS J, V272, P4607, DOI 10.1111/j.1742-4658.2005.04862.x; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Kaufman PD, 2010, CURR OPIN CELL BIOL, V22, P284, DOI 10.1016/j.ceb.2010.02.002; Kelemen JZ, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000332; Kitada T, 2012, GENE DEV, V26, P2443, DOI 10.1101/gad.201095.112; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; Kunkel TA, 2004, J BIOL CHEM, V279, P16895, DOI 10.1074/jbc.R400006200; Maillet L, 1996, GENE DEV, V10, P1796, DOI 10.1101/gad.10.14.1796; Micheelsen MA, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/2/026010; Mukhopadhyay S, ROLE MULTIPLE UNPUB; Mukhopadhyay S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003121; Mukhopadhyaya S, 2010, BIOSYSTEMS, V102, P49, DOI 10.1016/j.biosystems.2010.07.012; NINIO J, 1975, BIOCHIMIE, V57, P587, DOI 10.1016/S0300-9084(75)80139-8; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; PILLUS L, 1989, CELL, V59, P637, DOI 10.1016/0092-8674(89)90009-3; Poon Betty P. K., 2012, Frontiers in Genetics, V3, P144, DOI 10.3389/fgene.2012.00144; Posakony J, 2004, COMB CHEM HIGH T SCR, V7, P661; Prohaska SJ, 2010, J THEOR BIOL, V265, P27, DOI 10.1016/j.jtbi.2010.03.011; Pryde FE, 1999, EMBO J, V18, P2538, DOI 10.1093/emboj/18.9.2538; Ptashne M, 2004, GENETIC SWITCH PHAGE, Vxiv; Ptashne M, 1992, GENETIC SWITCH PHAGE, Vix; Radman-Livaja M, 2011, EMBO J, V30, P1012, DOI 10.1038/emboj.2011.30; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Rando OJ, 2007, CELL, V128, P655, DOI 10.1016/j.cell.2007.01.023; Riggs AD, 2004, P NATL ACAD SCI USA, V101, P4, DOI 10.1073/pnas.0307781100; Riggs AD, 1998, CIBA F SYMP, V214, P214; Rohlf T, 2012, EPIGENOMICS-UK, V4, P205, DOI [10.2217/epi.11.117, 10.2217/EPI.11.117]; Roma DM, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.011902; Rossmann MP, 2011, MOL CELL, V42, P127, DOI 10.1016/j.molcel.2011.03.007; Ruault M, 2011, J CELL BIOL, V192, P417, DOI 10.1083/jcb.201008007; Sears FW, 1975, THERMODYNAMICS KINET, Vviii; Sedighi M, 2007, PHYS BIOL, V4, P246, DOI 10.1088/1478-3975/4/4/002; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Sneppen K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002643; Song J, 2012, J CELL SCI, V125, P3723, DOI 10.1242/jcs.084764; Steffen PA, 2012, BIOESSAYS, V34, P901, DOI 10.1002/bies.201200076; Strogatz SH, 1994, NONLINEAR DYNAMICS C, Vxi; Talbert PB, 2006, NAT REV GENET, V7, P793, DOI 10.1038/nrg1920; To TL, 2010, SCIENCE, V327, P1142, DOI 10.1126/science.1178962; Ugolini S, 1996, CURR GENET, V30, P485, DOI 10.1007/s002940050160; Van Leeuwen F, 2002, METHOD ENZYMOL, V350, P165, DOI 10.1016/S0076-6879(02)50962-9; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006; Wood A, 2003, J BIOL CHEM, V278, P34739, DOI 10.1074/jbc.C300269200; Xu EY, 2006, MOL CELL, V23, P219, DOI 10.1016/j.molcel.2006.05.035; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514	71	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e113516	10.1371/journal.pone.0113516	http://dx.doi.org/10.1371/journal.pone.0113516			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536038	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000348563300007
J	Vonberg, I; Ehlen, F; Fromm, O; Klostermann, F				Vonberg, Isabelle; Ehlen, Felicitas; Fromm, Ortwin; Klostermann, Fabian			The Absoluteness of Semantic Processing: Lessons from the Analysis of Temporal Clusters in Phonemic Verbal Fluency	PLOS ONE			English	Article							SPREADING-ACTIVATION THEORY; SPOKEN WORD PRODUCTION; LEXICAL ACCESS; SPEECH PRODUCTION; LANGUAGE PRODUCTION; SENTENCE PRODUCTION; ALZHEIMERS-DISEASE; CATEGORY FLUENCY; PHONOLOGICAL ACTIVATION; SCHIZOPHRENIC-PATIENTS	Background: For word production, we may consciously pursue semantic or phonological search strategies, but it is uncertain whether we can retrieve the different aspects of lexical information independently from each other. We therefore studied the spread of semantic information into words produced under exclusively phonemic task demands. Methods: 42 subjects participated in a letter verbal fluency task, demanding the production of as many s-words as possible in two minutes. Based on curve fittings for the time courses of word production, output spurts (temporal clusters) considered to reflect rapid lexical retrieval based on automatic activation spread, were identified. Semantic and phonemic word relatedness within versus between these clusters was assessed by respective scores (0 meaning no relation, 4 maximum relation). Results: Subjects produced 27.5 (+/- 9.4) words belonging to 6.7 (+/- 2.4) clusters. Both phonemically and semantically words were more related within clusters than between clusters (phon: 0.33 +/- 0.22 vs. 0.19 +/- 0.17, p<.01; sem: 0.65 +/- 0.29 vs. 0.37 +/- 0.29, p<.01). Whereas the extent of phonemic relatedness correlated with high task performance, the contrary was the case for the extent of semantic relatedness. Conclusion: The results indicate that semantic information spread occurs, even if the consciously pursued word search strategy is purely phonological. This, together with the negative correlation between semantic relatedness and verbal output suits the idea of a semantic default mode of lexical search, acting against rapid task performance in the given scenario of phonemic verbal fluency. The simultaneity of enhanced semantic and phonemic word relatedness within the same temporal cluster boundaries suggests an interaction between content and sound-related information whenever a new semantic field has been opened.	[Vonberg, Isabelle; Ehlen, Felicitas; Fromm, Ortwin; Klostermann, Fabian] Charite, Dept Neurol, CBF, Motor & Cognit Grp, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Klostermann, F (corresponding author), Charite, Dept Neurol, CBF, Motor & Cognit Grp, D-13353 Berlin, Germany.	fabian.klostermann@charite.de		Ehlen, Felicitas/0000-0003-4595-1822	German Research Foundation (Clinical Research Group 247) [Kl-1276/4, Kl-1276/5]	German Research Foundation (Clinical Research Group 247)	The work was supported by the German Research Foundation (Kl-1276/4; Kl-1276/5 in Clinical Research Group 247). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abwender DA, 2001, ASSESSMENT, V8, P323, DOI 10.1177/107319110100800308; AMDP, 2007, AMDP SYST MAN DOK PS; Aschenbrenner S., 2000, REGENSBURGER WORTFLU; Beatty WW, 1997, AGING NEUROPSYCHOL C, V4, P273, DOI 10.1080/13825589708256652; Bock K, 1996, PSYCHON B REV, V3, P395, DOI 10.3758/BF03214545; Bousfield WA, 1944, J GEN PSYCHOL, V30, P149, DOI 10.1080/00221309.1944.10544467; BUTTERWORTH B, 1981, LINGUISTICS, V19, P627, DOI 10.1515/ling.1981.19.7-8.627; Caramazza A, 1997, COGNITIVE NEUROPSYCH, V14, P177, DOI 10.1080/026432997381664; COLLINS AM, 1975, PSYCHOL REV, V82, P407, DOI 10.1037/0033-295X.82.6.407; Costa A, 2000, J EXP PSYCHOL LEARN, V26, P1283, DOI 10.1037//0278-7393.26.5.1283; Cutting JC, 1999, J EXP PSYCHOL LEARN, V25, P318, DOI 10.1037/0278-7393.25.2.318; Damian MF, 1999, J EXP PSYCHOL LEARN, V25, P345, DOI 10.1037/0278-7393.25.2.345; DELL GS, 1986, PSYCHOL REV, V93, P283, DOI 10.1037/0033-295X.93.3.283; DELL GS, 1991, PSYCHOL REV, V98, P604, DOI 10.1037/0033-295X.98.4.604; DELL GS, 1981, J VERB LEARN VERB BE, V20, P611, DOI 10.1016/S0022-5371(81)90202-4; Elvevag B, 2002, PSYCHOL MED, V32, P909, DOI 10.1017/S0033291702005597; FITZGERALD JM, 1983, DEV PSYCHOL, V19, P9, DOI 10.1037/0012-1649.19.1.9; GRAESSER A, 1978, J EXP PSYCHOL-HUM L, V4, P86, DOI 10.1037/0278-7393.4.1.86; GRUENEWALD PJ, 1980, J EXP PSYCHOL-HUM L, V6, P225, DOI 10.1037/0278-7393.6.3.225; HARLEY TA, 1993, LANG COGNITIVE PROC, V8, P291, DOI 10.1080/01690969308406957; HARLEY TA, 1984, COGNITIVE SCI, V8, P191; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P284, DOI 10.1037/0894-4105.18.2.284; HERRMANN DJ, 1976, J GEN PSYCHOL, V95, P227, DOI 10.1080/00221309.1976.9711345; HERRMANN DJ, 1981, J MATH PSYCHOL, V24, P139, DOI 10.1016/0022-2496(81)90040-7; HERRMANN DJ, 1979, J GEN PSYCHOL, V101, P205, DOI 10.1080/00221309.1979.9920075; Ho AK, 2002, NEUROPSYCHOLOGIA, V40, P1277, DOI 10.1016/S0028-3932(01)00217-2; Jescheniak JD, 1998, J EXP PSYCHOL LEARN, V24, P1256, DOI 10.1037/0278-7393.24.5.1256; Johnson DM, 1951, J GEN PSYCHOL, V44, P121, DOI 10.1080/00221309.1951.9711240; KEMPEN G, 1983, COGNITION, V14, P185, DOI 10.1016/0010-0277(83)90029-X; Koren R, 2005, ARCH CLIN NEUROPSYCH, V20, P1087, DOI 10.1016/j.acn.2005.06.012; Lanting S, 2009, J INT NEUROPSYCH SOC, V15, P196, DOI 10.1017/S1355617709090237; Leggio MG, 2000, J NEUROL NEUROSUR PS, V69, P102, DOI 10.1136/jnnp.69.1.102; Levelt W.J., 1993, SPEAKING INTENTION A; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; Levelt WJM, 1999, TRENDS COGN SCI, V3, P223, DOI 10.1016/S1364-6613(99)01319-4; LEVELT WJM, 1991, PSYCHOL REV, V98, P122, DOI 10.1037/0033-295X.98.1.122; Levelt WJM, 2001, P NATL ACAD SCI USA, V98, P13464, DOI 10.1073/pnas.231459498; MARTIN A, 1994, NEUROPSYCHOLOGIA, V32, P1487, DOI 10.1016/0028-3932(94)90120-1; Martin N, 1996, LANG COGNITIVE PROC, V11, P257, DOI 10.1080/016909696387187; Morsella E, 2002, J EXP PSYCHOL LEARN, V28, P555, DOI 10.1037//0278-7393.28.3.555; Navarrete E, 2005, J MEM LANG, V53, P359, DOI 10.1016/j.jml.2005.05.001; PERRET E, 1974, NEUROPSYCHOLOGIA, V12, P323, DOI 10.1016/0028-3932(74)90047-5; Peterson RR, 1998, J EXP PSYCHOL LEARN, V24, P539, DOI 10.1037/0278-7393.24.3.539; POLLIO HR, 1969, J VERB LEARN VERB BE, V8, P529, DOI 10.1016/S0022-5371(69)80099-X; POLLIO HR, 1964, J EXP PSYCHOL, V67, P199, DOI 10.1037/h0047503; Rapp B, 2000, PSYCHOL REV, V107, P460, DOI 10.1037/0033-295X.107.3.460; RASKIN SA, 1992, NEUROPSYCHOLOGIA, V30, P95, DOI 10.1016/0028-3932(92)90018-H; Rende B, 2002, NEUROPSYCHOLOGY, V16, P309, DOI 10.1037//0894-4105.16.3.309; Robert PH, 1998, J INT NEUROPSYCH SOC, V4, P539, DOI 10.1017/S1355617798466025; Robert PH, 1997, EUR PSYCHIAT, V12, P124, DOI 10.1016/S0924-9338(97)80200-3; Roelofs A, 1998, COGNITION, V69, P219; ROELOFS A, 1992, COGNITION, V42, P107, DOI 10.1016/0010-0277(92)90041-F; Roelofs A, 1997, COGNITION, V64, P249, DOI 10.1016/S0010-0277(97)00027-9; ROHRER D, 1995, J EXP PSYCHOL LEARN, V21, P1127, DOI 10.1037/0278-7393.21.5.1127; ROSSER A, 1994, J NEUROL NEUROSUR PS, V57, P1389, DOI 10.1136/jnnp.57.11.1389; SCHRIEFERS H, 1990, J MEM LANG, V29, P86, DOI 10.1016/0749-596X(90)90011-N; Schwartz S, 2003, BRAIN LANG, V87, P400, DOI 10.1016/S0093-934X(03)00141-X; Sosa AV, 2012, J SPEECH LANG HEAR R, V55, P596, DOI 10.1044/1092-4388(2011/10-0113); SPITZER M, 1993, BIOL PSYCHIAT, V34, P864, DOI 10.1016/0006-3223(93)90054-H; Sung K, 2013, J CLIN EXP NEUROPSYC, V35, P1015, DOI 10.1080/13803395.2013.845141; Troster AI, 1998, NEUROPSYCHOLOGIA, V36, P295, DOI 10.1016/S0028-3932(97)00153-X; Troyer AK, 1998, J INT NEUROPSYCH SOC, V4, P137, DOI 10.1017/S1355617798001374; Troyer AK, 1997, NEUROPSYCHOLOGY, V11, P138, DOI 10.1037/0894-4105.11.1.138; Troyer AK, 1998, NEUROPSYCHOLOGIA, V36, P499, DOI 10.1016/S0028-3932(97)00152-8; Weiss EM, 2006, J INT NEUROPSYCH SOC, V12, P502, DOI 10.1017/S1355617706060656; WIXTED JT, 1994, PSYCHON B REV, V1, P89, DOI 10.3758/BF03200763	66	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115846	10.1371/journal.pone.0115846	http://dx.doi.org/10.1371/journal.pone.0115846			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ9UY	25535970	gold, Green Submitted, Green Published			2022-12-27	WOS:000348563300078
J	Windolf, CD; Loegters, T; Scholz, M; Windolf, J; Flohe, S				Windolf, Ceylan D.; Loegters, Tim; Scholz, Martin; Windolf, Joachim; Flohe, Sascha			Lysostaphin-Coated Titan-Implants Preventing Localized Osteitis by Staphylococcus aureus in a Mouse Model	PLOS ONE			English	Article							POSTTRAUMATIC OSTEOMYELITIS; ANTIBIOTIC-RESISTANCE; ORTHOPEDIC IMPLANTS; BACTERIOLYTIC AGENT; BIOFILM FORMATION; INFECTIONS; MECHANISMS; SURFACES; PROTEIN; BONE	The increasing incidence of implant-associated infections induced by Staphylococcus aureus (SA) in combination with growing resistance to conventional antibiotics requires novel therapeutic strategies. In the current study we present the first application of the biofilm-penetrating antimicrobial peptide lysostaphin in the context of bone infections. In a standardized implant-associated bone infection model in mice beta-irradiated lysostaphin-coated titanium plates were compared with uncoated plates. Coating of the implant was established with a poly(D, L)-lactide matrix (PDLLA) comprising lysostaphin formulated in a stabilizing and protecting solution (SPS). All mice were osteotomized and infected with a defined count of SA. Fractures were fixed with lysostaphin-coated locking plates. Plates uncoated or PDLLA-coated served as controls. All mice underwent debridement and lavage on Days 7, 14, 28 to determine the bacterial load and local immune reaction. Fracture healing was quantified by conventional radiography. On Day 7 bacterial growth in the lavages of mice with lysostaphin-coated plates showed a significantly lower count to the control groups. Moreover, in the lysostaphin-coated plate groups complete fracture healing were observed on Day 28. The fracture consolidation was accompanied by a diminished local immune reaction. However, control groups developed an osteitis with lysis or destruction of the bone and an evident local immune response. The presented approach of terminally sterilized lysostaphin-coated implants appears to be a promising therapeutic approach for low grade infection or as prophylactic strategy in high risk fracture care e. g. after severe open fractures.	[Windolf, Ceylan D.; Loegters, Tim; Scholz, Martin; Windolf, Joachim; Flohe, Sascha] Univ Dusseldorf, Dept Trauma & Hand Surg, D-40225 Dusseldorf, Germany; [Scholz, Martin] LEUKOCARE AG, D-82152 Martinsried, Germany	Heinrich Heine University Dusseldorf	Windolf, CD (corresponding author), Univ Dusseldorf, Dept Trauma & Hand Surg, Moorenstr 5, D-40225 Dusseldorf, Germany.	ceylan.windolf@uni-duesseldorf.de		Flohe, Sascha/0000-0002-8033-1242	"Zentrales Innnovationsprogramm Mittelstand'' of the German ministry of economics and Technology [KF2790101MK0]; AO-Research foundation (AO Start-Up) [S-11-34F]	"Zentrales Innnovationsprogramm Mittelstand'' of the German ministry of economics and Technology; AO-Research foundation (AO Start-Up)	The work was financially supported by the "Zentrales Innnovationsprogramm Mittelstand'' of the German ministry of economics and Technology; www.zim-bmwi.de; (KF2790101MK0); SF and the AO-Research foundation; https://www.aofoundation.org; (AO Start-Up grant S-11-34F); SF. They were not involved in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.	An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B; Arciola CR, 2012, BIOMATERIALS, V33, P5967, DOI 10.1016/j.biomaterials.2012.05.031; Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044; Campoccia D, 2013, BIOMATERIALS, V34, P8533, DOI 10.1016/j.biomaterials.2013.07.089; Climo MW, 1998, ANTIMICROB AGENTS CH, V42, P1355, DOI 10.1128/AAC.42.6.1355; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Costerton JW, 2005, INT J ARTIF ORGANS, V28, P1062, DOI 10.1177/039139880502801103; Cucarella C, 2001, J BACTERIOL, V183, P2888, DOI 10.1128/JB.183.9.2888-2896.2001; Dajcs JJ, 2002, INVEST OPHTH VIS SCI, V43, P3712; Dajcs JJ, 2001, CURR EYE RES, V22, P451, DOI 10.1076/ceyr.22.6.451.5486; Dajcs JJ, 2000, INVEST OPHTH VIS SCI, V41, P1432; Bastos MDD, 2010, PHARMACEUTICALS, V3, P1139, DOI 10.3390/ph3041139; Diener T., 2003, PROGR BIOMEDICAL RES, V8, P82; Fei J, 2010, ORTHOPEDICS, V33, P310, DOI DOI 10.HTTP://DX.D0I.0RG/10; Garcia LG, 2013, J ANTIMICROB CHEMOTH, V68, P1455, DOI 10.1093/jac/dkt072; Gargis SR, 2010, APPL ENVIRON MICROB, V76, P6944, DOI 10.1128/AEM.01066-10; Gollwitzer H, 2005, J ORTHOP RES, V23, P802, DOI 10.1016/j.orthres.2005.02.003; Goodman SB, 2013, BIOMATERIALS, V34, P3174, DOI 10.1016/j.biomaterials.2013.01.074; Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x; Greiner SH, 2008, ACTA ORTHOP, V79, P717, DOI 10.1080/17453670810016768; Grundmann S, 2007, J AM COLL CARDIOL, V50, P351, DOI 10.1016/j.jacc.2007.03.046; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Hudson MC, 1999, FEMS MICROBIOL LETT, V173, P279, DOI 10.1016/S0378-1097(99)00079-8; Kaplan SL, 2014, J INFECTION, V68, pS51, DOI 10.1016/j.jinf.2013.09.014; Kempf B, 2006, PRACTICE INTRAMEDULL, P283, DOI 10.1007/3-540-32345-7_29; Kokai-Kun JF, 2003, ANTIMICROB AGENTS CH, V47, P1589, DOI 10.1128/AAC.47.5.1589-1597.2003; Kokai-Kun JF, 2007, J ANTIMICROB CHEMOTH, V60, P1051, DOI 10.1093/jac/dkm347; Kokai-Kun JF, 2009, J ANTIMICROB CHEMOTH, V64, P94, DOI 10.1093/jac/dkp145; Kumar JK, 2008, APPL MICROBIOL BIOT, V80, P555, DOI 10.1007/s00253-008-1579-y; Lakdawala M., 2013, INT J SCI NATURE, V4, P522; Meghji S, 1998, BRIT J RHEUMATOL, V37, P1095; Montanaro L, 2011, INT J ARTIF ORGANS, V34, P781, DOI 10.5301/ijao.5000052; O'Gara JP, 2007, FEMS MICROBIOL LETT, V270, P179, DOI 10.1111/j.1574-6968.2007.00688.x; Pulverer G, 1968, Z Med Mikrobiol Immunol, V154, P49, DOI 10.1007/BF02123078; Sabala I, 2014, FEBS J, V281, P4112, DOI 10.1111/febs.12929; Sadowska B, 2013, ARCH IMMUNOL THER EX, V61, P413, DOI 10.1007/s00005-013-0240-3; SCHINDLER CA, 1964, P NATL ACAD SCI USA, V51, P414, DOI 10.1073/pnas.51.3.414; Schmidmaier G, 2001, J BIOMED MATER RES, V58, P449; Stefansdottir A, 2009, SCAND J INFECT DIS, V41, P831, DOI 10.3109/00365540903186207; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; TRAYER HR, 1970, J BIOL CHEM, V245, P4842; Vester H, 2010, INJURY, V41, P1053, DOI 10.1016/j.injury.2010.05.010; Wagner C, 2005, INT J ARTIF ORGANS, V28, P1172, DOI 10.1177/039139880502801115; Wagner C, 2003, SHOCK, V20, P503, DOI 10.1097/01.shk.0000093542.78705.e3; Walencka Elzbieta, 2005, Polish Journal of Microbiology, V54, P191; Windolf CD, 2013, J ORTHOP RES, V31, P2013, DOI 10.1002/jor.22446; Wu JA, 2003, ANTIMICROB AGENTS CH, V47, P3407, DOI 10.1128/AAC.47.11.3407-3414.2003; Xiao L, 2012, BIOMEDICAL SCI ENG T, P471; Yarwood JM, 2003, J CLIN INVEST, V112, P1620, DOI 10.1172/JCI200320442	50	36	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115940	10.1371/journal.pone.0115940	http://dx.doi.org/10.1371/journal.pone.0115940			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536060	Green Published, gold, Green Submitted			2022-12-27	WOS:000348563300090
J	de Araujo, RF; Reinaldo, MPOD; Brito, GAD; Cavalcanti, PD; Freire, MAD; de Medeiros, CAX; de Araujo, AA				de Araujo Junior, Raimundo Fernandes; Oliveira da Silva Reinaldo, Maria Patricia; de Castro Brito, Gerly Anne; Cavalcanti, Pedro de Franca; de Moura Freire, Marco Aurelio; Xavier de Medeiros, Caroline Addison; de Araujo, Aurigena Antunes			Olmesartan Decreased Levels of IL-1 beta and TNF-alpha, Down-Regulated MMP-2, MMP-9, COX-2, RANK/RANKL and Up-Regulated SOCs-1 in an Intestinal Mucositis Model	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; THERAPY; PATHOGENESIS; NEUTROPENIA; TELMISARTAN; ACTIVATION; LOSARTAN; STRESS; DAMAGE; RANKL	Methotrexate (MTX) is a pro-oxidant compound that depletes dihydrofolate pools and is widely used in the treatment of leukaemia and other malignancies. The efficacy of methotrexate is often limited by mucositis and intestinal injury, which are major causes of morbidity in children and adults. The aim of this study was to evaluate the effect of olmesartan (OLM), an angiotensin II receptor antagonist, on an Intestinal Mucositis Model (IMM) induced by MTX in Wistar rats. IMM was induced via intraperitoneal (i.p.) administration of MTX (7 mg/kg) for three consecutive days. The animals were pre-treated with oral OLM at 0.5, 1 or 5 mg/kg or with vehicle 30 min prior to exposure to MTX. Small intestinal homogenates were assayed for levels of the IL-1 beta, IL-10 and TNF-alpha cytokines, malondialdehyde and myeloperoxidase activity. Additionally, immunohistochemical analyses of MMP-2, MMP-9, COX-2, RANK/RANKL and SOCS-1 and confocal microscopy analysis of SOCS-1 expression were performed. Treatment with MTX + OLM (5 mg/kg) resulted in a reduction of mucosal inflammatory infiltration, ulcerations, vasodilatation and haemorrhagic areas (p < 0.05) as well as reduced concentrations of MPO (p < 0.001) and the pro-inflammatory cytokines IL-1 beta (p < 0.001) and TNF-alpha (p < 0.01), and increase anti-inflammatory cytocine IL-10 (p < 0.05). Additionally, the combined treatment reduced expression of MMP-2, MMP-9, COX-2, RANK and RANKL(p < 0.05) and increased cytoplasmic expression of SOCS-1 (p < 0.05). Our findings confirm the involvement of OLM in reducing the inflammatory response through increased immunosuppressive signalling in an IMM. We also suggest that the beneficial effect of olmesartan treatment is specifically exerted during the damage through blocking inflammatory cytocines.	[de Araujo Junior, Raimundo Fernandes] Univ Fed Rio Grande do Norte, Dept Morphol, Post Grad Program Hlth Sci, Natal, RN, Brazil; [de Araujo Junior, Raimundo Fernandes; Oliveira da Silva Reinaldo, Maria Patricia] Univ Fed Rio Grande do Norte, Post Grad Program Funct & Struct Biol, Natal, RN, Brazil; [de Castro Brito, Gerly Anne] Univ Fed Ceara, Dept Morphol, Post Grad Program Pharmacol, Fortaleza, Ceara, Brazil; [de Araujo Junior, Raimundo Fernandes; Oliveira da Silva Reinaldo, Maria Patricia; Cavalcanti, Pedro de Franca] Univ Fed Rio Grande do Norte, Dept Morphol, Natal, RN, Brazil; [Cavalcanti, Pedro de Franca; de Moura Freire, Marco Aurelio] Edmond & Lily Safra Int Inst Neurosci Natal, Natal, RN, Brazil; [Xavier de Medeiros, Caroline Addison; de Araujo, Aurigena Antunes] Univ Fed Rio Grande do Norte, Dept Biophys & Pharmacol, Natal, RN, Brazil; [de Araujo, Aurigena Antunes] Univ Fed Rio Grande do Norte, Dept Biophys & Pharmacol, Post Grad Program Publ Hlth, Natal, RN, Brazil; [de Araujo, Aurigena Antunes] Univ Fed Rio Grande do Norte, Post Grad Program Pharmaceut Sci, Natal, RN, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Ceara; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte	de Araujo, RF (corresponding author), Univ Fed Rio Grande do Norte, Dept Morphol, Post Grad Program Hlth Sci, Natal, RN, Brazil.	araujojr@cb.ufrn.br	Freire, Marco/A-1450-2010; de Araujo, Aurigena/ABI-8455-2020; de Castro Brito, Gerly Anne/C-8597-2013; Brito, Gerly/AHB-3965-2022; Araújo Júnior, Raimundo Fernandes/D-2354-2014	Freire, Marco/0000-0002-6483-0498; de Castro Brito, Gerly Anne/0000-0002-8214-4379; Brito, Gerly/0000-0002-8214-4379; Araújo Júnior, Raimundo Fernandes/0000-0003-2349-2354; Araujo, Aurigena/0000-0001-9264-4695	CNPq [47.6996/2013]; Alberto Santos Dumont Association for Research Support (AASDAP); Financier of Studies and Projects (FINEP); National Institute Brain Machine Interface (INCEMAQ) (INCTs Program CNPq/MCT)	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Alberto Santos Dumont Association for Research Support (AASDAP); Financier of Studies and Projects (FINEP); National Institute Brain Machine Interface (INCEMAQ) (INCTs Program CNPq/MCT)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	CNPq Universal Notice n. 47.6996/2013. MAMF and PFC wish to thank Alberto Santos Dumont Association for Research Support (AASDAP), Financier of Studies and Projects (FINEP), and National Institute Brain Machine Interface (INCEMAQ) (INCTs Program CNPq/MCT) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Dasooqi N, 2010, EXP BIOL MED, V235, P1244, DOI 10.1258/ebm.2010.010082; Araujo AA, 2013, J CLIN PERIODONTOL, V40, P1104, DOI 10.1111/jcpe.12160; Araujo AA, 2013, N-S ARCH PHARMACOL, V386, P875, DOI 10.1007/s00210-013-0886-8; Avritscher Elenir B C, 2004, Semin Oncol Nurs, V20, P3; Boukhettala N, 2009, AM J PHYSIOL-ENDOC M, V296, pE182, DOI 10.1152/ajpendo.90459.2008; Chan ESL, 2013, BULL HOSP JT DIS, V71, pS5; DESOUZA GEP, 1985, AGENTS ACTIONS, V17, P97; Drucker DJ, 2002, GASTROENTEROLOGY, V122, P531, DOI 10.1053/gast.2002.31068; Duncan M, 2003, ALIMENT PHARM THER, V18, P853, DOI 10.1046/j.1365-2036.2003.01784.x; ESTERBAUER H, 1990, METHOD ENZYMOL, V186, P407; Freire MAM, 2007, NEUROTOXICOLOGY, V28, P175, DOI 10.1016/j.neuro.2006.06.007; Fujimoto M, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/470468; Gulgun M, 2010, EXP TOXICOL PATHOL, V62, P109, DOI 10.1016/j.etp.2009.02.120; He Y, 2006, J BIOL CHEM, V281, P5559, DOI 10.1074/jbc.M512338200; Hovsepian E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079445; KENDALL C, 1983, J IMMUNOL METHODS, V56, P329, DOI 10.1016/S0022-1759(83)80022-2; Kolli VK, 2013, CANCER CHEMOTH PHARM, V71, P1209, DOI 10.1007/s00280-013-2115-z; Kong YY, 2000, IMMUNOL TODAY, V21, P495, DOI 10.1016/S0167-5699(00)01718-7; Kubo M, 2003, NAT IMMUNOL, V4, P1169, DOI 10.1038/ni1012; Leitao RFC, 2007, CANCER CHEMOTH PHARM, V59, P603, DOI 10.1007/s00280-006-0301-y; Maine GN, 2007, EMBO J, V26, P436, DOI 10.1038/sj.emboj.7601489; MCKENDRY RJR, 1993, J RHEUMATOL, V20, P1850; Medina C, 2006, J PHARMACOL EXP THER, V318, P933, DOI 10.1124/jpet.106.103465; Miyazono Y, 2004, SCAND J GASTROENTERO, V39, P1119, DOI 10.1080/00365520410003605; Naito Y, 2004, INFLAMM RES, V53, P462, DOI 10.1007/s00011-004-1281-1; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; Nakano A, 2009, HYPERTENS RES, V32, P765, DOI 10.1038/hr.2009.95; Purcell W Thomas, 2003, Curr Oncol Rep, V5, P114, DOI 10.1007/s11912-003-0098-3; Rahimtoola Shahbudin H, 2008, Curr Probl Cardiol, V33, P159, DOI 10.1016/j.cpcardiol.2008.01.003; Refaat R, 2013, EUR J PHARMACOL, V698, P421, DOI 10.1016/j.ejphar.2012.10.024; SAFIEHGARABEDIAN B, 1995, BRIT J PHARMACOL, V115, P1265, DOI 10.1111/j.1476-5381.1995.tb15035.x; Sandmann S, 2006, BLOOD PRESSURE, V15, P116, DOI 10.1080/08037050600586593; Sonis ST, 2004, ORAL ONCOL, V40, P170, DOI 10.1016/S1368-8375(03)00148-9; Sonis ST, 2004, CANCER-AM CANCER SOC, V100, P1995, DOI 10.1002/cncr.20162; Sonis ST, 2004, NAT REV CANCER, V4, P277, DOI 10.1038/nrc1318; Souza MHLP, 2003, BRAZ J MED BIOL RES, V36, P1383, DOI 10.1590/S0100-879X2003001000015; Tewari KS, 2014, GYNECOL ONCOL, V133, P439, DOI 10.1016/j.ygyno.2014.03.013; Totsuka T, 2009, J IMMUNOL, V182, P6079, DOI 10.4049/jimmunol.0711823; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Wang D, 2013, J CELL MOL MED, V17, P1577, DOI 10.1111/jcmm.12128; Yasufuku T, 2013, J INFECT CHEMOTHER, V19, P211, DOI 10.1007/s10156-012-0478-4	41	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e114923	10.1371/journal.pone.0114923	http://dx.doi.org/10.1371/journal.pone.0114923			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531650	Green Published, gold			2022-12-27	WOS:000348845100031
J	Dorj, G; Sunderland, B; Hendrie, D; Parsons, R				Dorj, Gereltuya; Sunderland, Bruce; Hendrie, Delia; Parsons, Richard			Parenteral Medication Prescriptions, Dispensing and Administration Habits in Mongolia	PLOS ONE			English	Article							HEPATITIS-C VIRUS; INJECTION PRACTICES; UNSAFE INJECTIONS; RAPID ASSESSMENT; CARE; INFECTION; COMMUNITY; TRANSMISSION; POPULATION; SETTINGS	High levels of injection prescribing were reported in Mongolia. Understanding the factors influencing the injection prescribing is essential to reduce their inappropriate use. The study evaluated the views, experiences and attitudes of community members associated with the prescribing of injections in Mongolia. A structured questionnaire focusing on respondents' characteristics, experiences and views about injections was developed and administered face-to-face to community members in Ulaanbaatar, Mongolia. Standard descriptive statistics were used to summarize demographic data and responses to the questionnaires. Dependant variables were compared using Kruskal-Wallis Tests for independence. Statistical analyses were performed using SPSS Version 21.0. Six hundred participants were approached and the response rate was 79% (n=474). Almost half of the respondents were aged between 31 and 50 (n=228, 48.1%) and 40.9% of respondents were male (n=194). Most respondents were from Ulaanbaatar city (n=407, 85.7%). All respondents had received injections in the past and 268 (56.5%) had received injection in the past year. The most common reason for having an injection in the past year was reported as treatment of a disease (n=163, 60.8%), or for administration of vitamins (n=70, 26.1%). Injections were prescribed by a doctor (n=353, 74.9%), dispensed by a pharmacist (n=283, 59.7%) and administered by a nurse (n=277, 54.9%). Only 16% of all respondents had the expectation of receiving injections when they visited a doctor (n=77). An important perception regarding injections was that they hastened the recovery process (n=269, 56.8%). When asked their opinion about therapeutic injections, 40% of all respondents agreed that injections were a better medicine (n=190) than oral medications, with older respondents strongly agreeing (p<0.001). Based on this total sample, approximately 1891 injections per 1000 patients were administered.The excessive injection use seems to be promoted by inappropriate prescribing, dispensing and administration of medication by doctors and others.	[Dorj, Gereltuya; Sunderland, Bruce; Parsons, Richard] Curtin Univ, Sch Pharm, Perth, WA 6845, Australia; [Hendrie, Delia] Curtin Univ, Sch Publ Hlth, Perth, WA 6845, Australia	Curtin University; Curtin University	Dorj, G (corresponding author), Curtin Univ, Sch Pharm, Perth, WA 6845, Australia.	gereltuya.dorj@postgrad.curtin.edu.au	Dorj, Gereltuya/K-4714-2019; Dorj, Gereltuya/AAE-6796-2019; Dorj, Gereltuya/AAH-6080-2020	Dorj, Gereltuya/0000-0001-9489-6829; Hendrie, Delia/0000-0001-5022-5281				Altaf A, 2001, PILOT TESTING WHO TO, P42; Altaf Arshad, 2004, J Ayub Med Coll Abbottabad, V16, P35; Ariuntuya S, 2011, HLTH INDICATORS MONG; Berild D, 2002, INT J ANTIMICROB AG, V20, P333, DOI 10.1016/S0924-8579(02)00203-0; Bolormaa TS, 2007, MONG HLTH SYST REV H; Cheraghali A. M., 2006, Journal of Pharmacology and Toxicology, V1, P33; Chowdhury A, 2003, HEPATOLOGY, V37, P802, DOI 10.1053/jhep.2003.50157; Chowdhury AKA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-779; Cobey M, 2011, KNOWLEDGE ATTITUDES; Dashdelger A, 1998, WHO COLLABORAT UNPUB; Davaasuren D, 2006, REPORT ASSESSMENT IN, P20; Dorj G, 2014, EVALUATION PRESCRIBI, P318; DUA V, 1994, SOC SCI MED, V38, P717, DOI 10.1016/0277-9536(94)90462-6; Frank C, 2000, LANCET, V355, P887, DOI 10.1016/S0140-6736(99)06527-7; Gumodoka B, 1996, TROP MED INT HEALTH, V1, P874; Hadiyono JEP, 1996, SOC SCI MED, V42, P1177, DOI 10.1016/0277-9536(95)00391-6; HARKNESS JA, 1998, ZUMA NACHRICHTEN SPE, V0003; Hauri AM, 2004, INT J STD AIDS, V15, P7, DOI 10.1258/095646204322637182; Hutin YJF, 2003, BMJ-BRIT MED J, V327, P1075, DOI 10.1136/bmj.327.7423.1075; Hutin YVF, 2001, PILOT TESTING WHO TO, P10; Janjua NZ, 2005, INT J QUAL HEALTH C, V17, P401, DOI 10.1093/intqhc/mzi048; Jiang Q, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-324; Kermode M, 2004, HEALTH PROMOT INT, V19, P95, DOI 10.1093/heapro/dah110; Khan AJ, 2000, B WORLD HEALTH ORGAN, V78, P956; Lakshman M, 2000, SOC SCI MED, V51, P11, DOI 10.1016/S0277-9536(99)00426-8; Langsten RL, 2005, J HEALTH POPUL NUTR, V23, P282; Logez S, 2004, AM J INFECT CONTROL, V32, P31, DOI 10.1016/j.ajic.2003.06.006; Marx MA, 2003, AM J TROP MED HYG, V68, P258, DOI 10.4269/ajtmh.2003.68.258; Ministry of Health Mongolia, 2009, 6 ESS DRUG LIST MONG; Ministry of Health Mongolia, 2010, GUID AMB CAR; Raglow GJ, 2001, TROP MED INT HEALTH, V6, P69, DOI 10.1046/j.1365-3156.2001.00653.x; Rajasekaran M, 2003, PUBLIC HEALTH, V117, P208, DOI 10.1016/S0033-3506(03)00065-9; Reeler AV, 2000, B WORLD HEALTH ORGAN, V78, P135; REELER AV, 1990, SOC SCI MED, V31, P1119, DOI 10.1016/0277-9536(90)90233-I; Simonsen L, 1999, B WORLD HEALTH ORGAN, V77, P789; Singh S, 2000, SCAND J INFECT DIS, V32, P3, DOI 10.1080/00365540050164137; SURVIVAL II C. H. I. L. D., 2002, INJ PRACT RAP ASS RE; Talaat M, 2003, TROP MED INT HEALTH, V8, P234, DOI 10.1046/j.1365-3156.2003.01015.x; van Staa A, 1996, DAP RES SERIES, P127; Vong S, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-56; World Health Organization and The SIGN alliance, 2001, INJ SAF; Xia GL, 1996, INT HEPATOL COMMUN, V5, P62, DOI 10.1016/S0928-4346(96)82012-3	42	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115384	10.1371/journal.pone.0115384	http://dx.doi.org/10.1371/journal.pone.0115384			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA3ZY	25531766	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000348845100062
J	Guo, Y; Liu, Y; He, JR; Xia, XY; Mo, WJ; Wang, P; Feng, Q; Larson, CP; Xia, HM; Qiu, X				Guo, Yong; Liu, Yu; He, Jian-Rong; Xia, Xiao-Yan; Mo, Wei-Jian; Wang, Ping; Feng, Qiong; Larson, Charles P.; Xia, Hui-Min; Qiu, Xiu			Changes in Birth Weight between 2002 and 2012 in Guangzhou, China	PLOS ONE			English	Article							GESTATIONAL-AGE; TEMPORAL TRENDS; SECULAR TRENDS; MIXTURE MODEL; FETAL-GROWTH; PREVALENCE; PREGNANCY; MORTALITY; BABIES; GAIN	Background: Recent surveillance data suggest that mean birth weight has begun to decline in several developed countries. The aim of this study is to examine the changes in birth weight among singleton live births from 2002 to 2012 in Guangzhou, one of the most rapidly developed cities in China. Methods: We used data from the Guangzhou Perinatal Health Care and Delivery Surveillance System for 34108 and 54575 singleton live births with 28-41 weeks of gestation, who were born to local mothers, in 2002 and 2012, respectively. The trends in birth weight, small (SGA) and large (LGA) for gestational age and gestational length were explored in the overall population and gestational age subgroups. Results: The mean birth weight decreased from 3162 g in 2002 to 3137 g in 2012 (crude mean difference, 225 g; 95% CI, 230 to 219). The adjusted change in mean birth weight appeared to be slight (26 g from 2002 to 2012) after controlling for maternal age, gestational age, educational level, parity, newborn's gender and delivery mode. The percentages of SGA and LGA in 2012 were 0.6% and 1.5% lower than those in 2002, respectively. The mean gestational age dropped from 39.2 weeks in 2002 to 38.9 weeks in 2012. In the stratified analysis, we observed the changes in birth weight differed among gestational age groups. The mean birth weight decreased among very preterm births (28-31 weeks), while remained relatively stable among other gestational age subcategories. Conclusions: Among local population in Guangzhou from 2002 to 2012, birth weight appeared to slightly decrease. The percentage of SGA and LGA also simultaneously dropped, indicating that newborns might gain a healthier weight for gestational age.	[Guo, Yong; Liu, Yu; He, Jian-Rong; Xia, Xiao-Yan; Xia, Hui-Min; Qiu, Xiu] Guangzhou Women & Childrens Med Ctr, Div Birth Cohort Study, Guangzhou, Guangdong, Peoples R China; [Guo, Yong; Liu, Yu; He, Jian-Rong; Xia, Xiao-Yan; Mo, Wei-Jian; Wang, Ping; Feng, Qiong; Qiu, Xiu] Guangzhou Women & Childrens Med Ctr, Dept Hlth Care, Guangzhou, Guangdong, Peoples R China; [Xia, Xiao-Yan] Guangzhou Women & Childrens Med Ctr, Guangzhou, Guangdong, Peoples R China; [Larson, Charles P.] Univ British Columbia, Ctr Int Child Hlth, Vancouver, BC, Canada; [Larson, Charles P.] BC Childrens Hosp, Vancouver, BC, Canada	University of British Columbia; BC Childrens Hospital; University of British Columbia	Qiu, X (corresponding author), Guangzhou Women & Childrens Med Ctr, Div Birth Cohort Study, Guangzhou, Guangdong, Peoples R China.	qxiu0161@163.com		Xia, Xiaoyan/0000-0002-8288-5679; He, Jianrong/0000-0003-3837-5126	Guangzhou Science and Technology Bureau, Guangzhou, China [2011Y2-00025, 2012J5100038]	Guangzhou Science and Technology Bureau, Guangzhou, China	This study was funded by the Guangzhou Science and Technology Bureau, Guangzhou, China (2011Y2-00025 and 2012J5100038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, Obstet Gynecol, V122, P1139, DOI 10.1097/01.AOG.0000437385.88715.4a; Assefa N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039957; Class QA, 2014, AM J EPIDEMIOL, V179, P550, DOI 10.1093/aje/kwt304; Cuesta-Albertos JA, 2008, J R STAT SOC B, V70, P779, DOI 10.1111/j.1467-9868.2008.00657.x; Cundy T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1567; Department of Health Care, 2013, GUANGZH ANN MAT CHIL; Dietz PM, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.10.875; Diouf I, 2011, PAEDIATR PERINAT EP, V25, P210, DOI 10.1111/j.1365-3016.2010.01188.x; Donahue SMA, 2010, OBSTET GYNECOL, V115, P357, DOI 10.1097/AOG.0b013e3181cbd5f5; Edwards NM, 2010, CAN J PUBLIC HEALTH, V101, P138, DOI 10.1007/BF03404359; Ferre C, 2011, MATERN CHILD HLTH J, V15, P29, DOI 10.1007/s10995-010-0570-2; Gage TB, 2013, DEMOGRAPHY, V50, P615, DOI 10.1007/s13524-012-0148-2; Han W, 2011, ACTA OBSTET GYN SCAN, V90, P332, DOI 10.1111/j.1600-0412.2010.01065.x; He JR, 2014, ARCH DIS CHILD; Nguyen HT, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-41; Kramer MS, 2002, J PEDIATR-US, V141, P538, DOI 10.1067/mpd.2002.128029; Lawn JE, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S1; Lopez PO, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-121; Lu YY, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-818; Ma L, 2014, EUR J PEDIATR, V173, P787, DOI 10.1007/s00431-013-2250-x; Meng LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077971; Morisaki N, 2013, OBSTET GYNECOL, V121, P51, DOI [10.1097/AOG.0b013e318278d014, http://10.1097/AOG.0b013e318278d014]; Oken E, 2013, NESTLE NUTR WORKS SE, V71, P103, DOI 10.1159/000342576; Platt RW, 2001, STAT MED, V20, P3491, DOI 10.1002/sim.1095; Schiessl B, 2009, J PERINAT MED, V37, P374, DOI 10.1515/JPM.2009.068; Schoendorf KC, 2006, AM J OBSTET GYNECOL, V194, P911, DOI 10.1016/j.ajog.2005.11.020; Spong CY, 2013, JAMA-J AM MED ASSOC, V309, P2445, DOI 10.1001/jama.2013.6235; Tentoni S, 2004, BJOG-INT J OBSTET GY, V111, P31, DOI 10.1046/j.1471-0528.2003.00006.x; Urquia ML, 2012, ANN EPIDEMIOL, V22, P151, DOI 10.1016/j.annepidem.2012.01.006; Vesco KK, 2014, OBESITY, V22, P1989, DOI 10.1002/oby.20831; Wingate MS, 2007, ANN EPIDEMIOL, V17, P425, DOI 10.1016/j.annepidem.2007.01.035	31	12	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115703	10.1371/journal.pone.0115703	http://dx.doi.org/10.1371/journal.pone.0115703			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531295	gold, Green Published, Green Submitted			2022-12-27	WOS:000348845100097
J	Salim, LZA; Othman, R; Abdulla, MA; Al-Jashamy, K; Ali, HM; Hassandarvish, P; Dehghan, F; Ibrahim, MY; Omer, FAA; Mohan, S				Salim, Landa Zeenelabdin Ali; Othman, Rozana; Abdulla, Mahmood Ameen; Al-Jashamy, Karim; Ali, Hapipah Mohd; Hassandarvish, Pouya; Dehghan, Firouzeh; Ibrahim, Mohamed Yousif; Omer, Fatima Abd Elmutaal Ahmed; Mohan, Syam			Thymoquinone Inhibits Murine Leukemia WEHI-3 Cells In Vivo and In Vitro	PLOS ONE			English	Article							NIGELLA-SATIVA; CYCLE ARREST; BCR-ABL; APOPTOSIS; EXPRESSION; PROLIFERATION; ACTIVATION; INDUCTION; PATHWAY; GROWTH	Background: Thymoquinone is an active ingredient isolated from Nigella sativa (Black Seed). This study aimed to evaluate the in vitro and in vivo anti-leukemic effects of thymoquinone on WEHI-3 cells. Methodology/Principal Findings: The cytotoxic effect of thymoquinone was assessed using an MTT assay, while the inhibitory effect of thymoquinone on murine WEHI-3 cell growth was due to the induction of apoptosis, as evidenced by chromatin condensation dye, Hoechst 33342 and acridine orange/propidium iodide fluorescent staining. In addition, Annexin V staining for early apoptosis was performed using flowcytometric analysis. Apoptosis was found to be associated with the cell cycle arrest at the S phase. Expression of Bax, Bcl2 and HSP 70 proteins were observed by western blotting. The effects of thymoquinone on BALB/c mice injected with WEHI-3 cells were indicated by the decrease in the body, spleen and liver weights of the animal, as compared to the control. Conclusion: Thymoquinone promoted natural killer cell activities. This compound showed high toxicity against WEHI-3 cell line which was confirmed by an increase of the early apoptosis, followed by up-regulation of the anti-apoptotic protein, Bcl2, and down-regulation of the apoptotic protein, Bax. On the other hand, high reduction of the spleen and liver weight, and significant histopathology study of spleen and liver confirmed that thymoquinone inhibited WEHI-3 growth in the BALB/c mice. Results from this study highlight the potential of thymoquinone to be developed as an anti-leukemic agent.	[Salim, Landa Zeenelabdin Ali; Othman, Rozana; Ibrahim, Mohamed Yousif; Omer, Fatima Abd Elmutaal Ahmed] Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur, Malaysia; [Abdulla, Mahmood Ameen] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia; [Al-Jashamy, Karim] SEGi Univ, Fac Med, Dept Pathol, Petaling Jaya, Malaysia; [Ali, Hapipah Mohd] Univ Malaya, Fac Sci, Dept Chem, Kuala Lumpur, Malaysia; [Hassandarvish, Pouya] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Dehghan, Firouzeh] Univ Malaya, Fac Med, Dept Physiol, Kuala Lumpur, Malaysia; [Mohan, Syam] Jazan Univ, Med Res Ctr, Jazan, Saudi Arabia; [Othman, Rozana; Abdulla, Mahmood Ameen; Ali, Hapipah Mohd] Univ Malaya, Ctr Nat Prod & Drug Discovery CENAR, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; SEGi University; Universiti Malaya; Universiti Malaya; Universiti Malaya; Jazan University; Universiti Malaya	Othman, R (corresponding author), Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur, Malaysia.	rozanaothman@um.edu.my	Mohan, Syam/A-1231-2011; Ibrahim, Mohamed Yousif/I-4603-2016; OTHMAN, ROZANA/B-9628-2010; Al-Jashamy, Karim Alwan/D-1609-2010; Hassandarvish, Pouya/K-8112-2012	Ibrahim, Mohamed Yousif/0000-0003-3752-9154; OTHMAN, ROZANA/0000-0002-8260-9252; Al-Jashamy, Karim Alwan/0000-0003-3421-6451; Hassandarvish, Pouya/0000-0003-0364-5587	High Impact Research Grant (HIR) from the Ministry of Higher Education Malaysia [UM.C/HIR/MOHE/SC/09, F000009-21001]; PPP from the University of Malaya [PG141-2012B]; UMRG from the University of Malaya [RP002/2012B]	High Impact Research Grant (HIR) from the Ministry of Higher Education Malaysia; PPP from the University of Malaya; UMRG from the University of Malaya	This research is supported by High Impact Research Grant UM.C/HIR/MOHE/SC/09 (HIR grant F000009-21001) from the Ministry of Higher Education Malaysia, and PPP grant (PG141-2012B) and UMRG grant (RP002/2012B) from the University of Malaya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd Ghafar SA, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/549705; Aggarwal BB, 2008, PLANTA MED, V74, P1560, DOI 10.1055/s-2008-1074578; Ahmad Aftab, 2013, Asian Pacific Journal of Tropical Biomedicine, V3, P337, DOI 10.1016/S2221-1691(13)60075-1; Alabsi AM, 2012, LEUKEMIA RES, V36, P634, DOI 10.1016/j.leukres.2011.11.001; Anasamy T, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/939810; Arbab IA, 2013, J ETHNOPHARMACOL, V145, P343, DOI 10.1016/j.jep.2012.11.020; Arslan SO, 2005, NUTR RES, V25, P673, DOI 10.1016/j.nutres.2005.06.004; Attoub S, 2013, FUND CLIN PHARMACOL, V27, P557, DOI 10.1111/j.1472-8206.2012.01056.x; Bai Y, 2010, CANCER SCI, V101, P488, DOI 10.1111/j.1349-7006.2009.01415.x; Banerjee S, 2010, NUTR CANCER, V62, P938, DOI 10.1080/01635581.2010.509832; BEDI A, 1994, BLOOD, V83, P2038; Chang Y-C, 2011, EVID-BASED COMPL ALT, V2011; Chang YH, 2009, BIOSCI BIOTECH BIOCH, V73, P2589, DOI 10.1271/bbb.90357; da Rocha Adriana B., 2001, Current Opinion in Pharmacology, V1, P364; El Mezayen R, 2006, IMMUNOL LETT, V106, P72, DOI 10.1016/j.imlet.2006.04.012; El-Mahdy MA, 2005, INT J CANCER, V117, P409, DOI 10.1002/ijc.21205; El-Najjar N, 2010, APOPTOSIS, V15, P183, DOI 10.1007/s10495-009-0421-z; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fu WY, 2005, TOXICON, V46, P171, DOI 10.1016/j.toxicon.2005.03.021; Garber JC, 2011, RES IFLA; Guo F, 2005, BLOOD, V105, P1246, DOI 10.1182/blood-2004-05-2041; Harzallah HJ, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/854065; Hosseini M, 2012, J PHARM BIOALLIED SC, V4, P219, DOI 10.4103/0975-7406.99052; Huang LH, 2010, EUR J PHARMACOL, V645, P9, DOI 10.1016/j.ejphar.2010.06.070; Ismail M, 2010, FREE RADICAL BIO MED, V48, P664, DOI 10.1016/j.freeradbiomed.2009.12.002; Ivankovic S., 2006, Experimental Oncology, V28, P220; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Lin CC, 2006, ANTICANCER RES, V26, P1097; Lin JP, 2009, LEUKEMIA RES, V33, P823, DOI 10.1016/j.leukres.2008.09.032; Lu CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036831; Lu HF, 2007, IN VIVO, V21, P285; Lutterodt H, 2010, LWT-FOOD SCI TECHNOL, V43, P1409, DOI 10.1016/j.lwt.2010.04.009; Mohan S, 2010, LEUKEMIA RES, V34, P1483, DOI 10.1016/j.leukres.2010.04.023; Ng KB, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-41; Nigjeh SE, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/783690; Nobili S, 2009, PHARMACOL RES, V59, P365, DOI 10.1016/j.phrs.2009.01.017; Olfert ED, 1993, GUIDE CARE USE EXPT, V1; Paarakh P. M., 2010, Indian Journal of Natural Products and Resources, V1, P409; Salim LZA, 2013, MOLECULES, V18, P11219, DOI 10.3390/molecules180911219; Salminen S, 1998, INT J FOOD MICROBIOL, V44, P93, DOI 10.1016/S0168-1605(98)00128-7; Schneider-Stock R, 2014, DRUG DISCOV TODAY, V19, P18, DOI 10.1016/j.drudis.2013.08.021; Shoieb AM, 2003, INT J ONCOL, V22, P107; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Torres MP, 2010, MOL CANCER THER, V9, P1419, DOI 10.1158/1535-7163.MCT-10-0075; Tsou MF, 2009, LEUKEMIA RES, V33, P1505, DOI 10.1016/j.leukres.2009.01.030; Woo CC, 2012, BIOCHEM PHARMACOL, V83, P443, DOI 10.1016/j.bcp.2011.09.029; Wyllie AH, 2010, MOL NEUROBIOL, V42, P4, DOI 10.1007/s12035-010-8125-5; Yang JS, 2006, ANTICANCER RES, V26, P219; Yeh RD, 2011, ANTICANCER RES, V31, P2821; Yu CS, 2010, PHYTOTHER RES, V24, P163, DOI 10.1002/ptr.2841; Yu FS, 2007, IN VIVO, V21, P407; Zhang B, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/781516	52	30	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115340	10.1371/journal.pone.0115340	http://dx.doi.org/10.1371/journal.pone.0115340			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531768	Green Submitted, Green Published, gold			2022-12-27	WOS:000348845100052
J	Batool, T; Rasool, N; Gull, Y; Noreen, M; Nasim, FU; Yaqoob, A; Zubair, M; Rana, UA; Khan, SUD; Zia-Ul-Haq, M; Jaafar, HZE				Batool, Tannaza; Rasool, Nasir; Gull, Yasmeen; Noreen, Mnaza; Nasim, Faiz-ul-Hassan; Yaqoob, Asma; Zubair, Muhammad; Rana, Usman Ali; Khan, Salah Ud-Din; Zia-Ul-Haq, M.; Jaafar, Hawa Z. E.			A Convenient Method for the Synthesis of (Prop-2-Ynyloxy)Benzene Derivatives via Reaction with Propargyl Bromide, Their Optimization, Scope and Biological Evaluation	PLOS ONE			English	Article							4-COMPONENT REACTION; CLICK SYNTHESIS; EFFICIENT; 1,2,3-TRIAZOLES; ALKYNES; UREASE; PEPTIDOTRIAZOLES; NANOPARTICLES; INHIBITION; DENDRIMERS	A highly convenient method has been developed for the synthesis of (prop-2-ynyloxy) benzene and its derivatives. Differently substituted phenol and aniline derivatives were allowed to react with propargyl bromide in the presence of K2CO3 base and acetone as solvent. The compounds were synthesized in good yields (53-85%). Low cost, high yields and easy availability of compounds helped in the synthesis. Electron withdrawing groups favor the formation of stable phenoxide ion thus in turn favors the formation of product while electron donating groups do not favor the reaction. Phenol derivatives gave good yields as compared to that of aniline. As aprotic polar solvents favor S(N)2 type reactions so acetone provided best solvation for the reactions. K2CO3 was proved to be good for the synthesis. Antibacterial, Antiurease and NO scavenging activity of synthesized compounds were also examined. 4-bromo-2-chloro-1-(prop-2-ynyloxy) benzene 2a was found most active compound against urease enzyme with a percentage inhibition of 82.00 +/- 0.09 at 100 mu g/mL with IC50 value of 60.2. 2-bromo-4-methyl-1-(prop-2-ynyloxy)benzene 2d was found potent antibacterial against Bacillus subtillus showing excellent inhibitory action with percentage inhibition of 55.67 +/- 0.26 at 100 mu g/ml wih IC50 value of 79.9. Based on results, it can be concluded that some of the synthesized compounds may have potential antiurease and antibacterial effects against several harmful substances.	[Batool, Tannaza; Rasool, Nasir; Gull, Yasmeen; Noreen, Mnaza; Zubair, Muhammad] Govt Coll Univ Faisalabad, Dept Chem, Faisalabad, Pakistan; [Nasim, Faiz-ul-Hassan; Yaqoob, Asma] Islamia Univ Bahawalpur, Dept Chem, Bahawalpur, Pakistan; [Rana, Usman Ali; Khan, Salah Ud-Din] King Saud Univ, Coll Engn, Deanship Sci Res, Riyadh, Saudi Arabia; [Zia-Ul-Haq, M.] Patent Off, Karachi, Pakistan; [Jaafar, Hawa Z. E.] Fac Agr, Dept Crop Sci, Upm Serdang 43400, Selangor, Malaysia	Government College University Faisalabad; Islamia University of Bahawalpur; King Saud University; Universiti Putra Malaysia	Rasool, N (corresponding author), Govt Coll Univ Faisalabad, Dept Chem, Faisalabad, Pakistan.	nasirrasool@gcuf.edu.pk; hawazej@gmail.com	Khan, Shahab/GSO-1694-2022; Rasool, Nasir/ABC-6212-2021; Zia-Ul-Haq, Muhammad/J-1798-2015; Nasim, Faiz/F-6397-2015; Nasim, Faiz-ul Hassan/G-5799-2010; rasool, nasir/I-6871-2015; Khan, Salah Ud-Din/ABC-5995-2020	Nasim, Faiz-ul Hassan/0000-0001-9107-7449; 	HEC (HEC Project) [20-1465/R D/09/5458]; Deanship of Scientific Research at King Saud University [RGP-VPP-255]	HEC (HEC Project); Deanship of Scientific Research at King Saud University(King Saud University)	The present data is the part of M. Phil thesis research work of Tannaza Batool. The authors gratefully acknowledge the financial support by HEC (HEC Project No. 20-1465/R& D/09/5458). S. U. Khan would like to extend his sincere appreciation to the Deanship of Scientific Research at King Saud University for its funding through the Research Group Project no RGP-VPP-255. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agag T, 2001, MACROMOLECULES, V34, P7257, DOI 10.1021/ma0107915; Agalave SG, 2011, CHEM-ASIAN J, V6, P2696, DOI 10.1002/asia.201100432; Alonso F, 2012, HETEROCYCLES, V84, P1033, DOI 10.3987/COM-11-S(P)81; Antoni P, 2007, CHEM COMMUN, P2249, DOI 10.1039/b703547k; Bahulayan D, 2012, TETRAHEDRON LETT, V53, P2850, DOI 10.1016/j.tetlet.2012.03.116; Basak A, 2009, INT J CHEM, V1, P63; Binder WH, 2006, CURR ORG CHEM, V10, P1791, DOI 10.2174/138527206778249838; Booth SE, 1994, J CHEM SOC P1, V1, P99; Chippada S.C., 2011, J CHEM BIO PHY SCI, V1, P260; Dabiri M, 2010, J COMB CHEM, V12, P638, DOI 10.1021/cc100043z; Garrat D.C, 1964, QUANTITATIVE ANAL DR, V3rd; Gull Y, 2013, MOLECULES, V18, P8845, DOI 10.3390/molecules18088845; He JB, 2012, BIOORGAN MED CHEM, V20, P1665, DOI 10.1016/j.bmc.2012.01.019; Huang YJ, 2011, INT J HYDROGEN ENERG, V36, P15333, DOI 10.1016/j.ijhydene.2011.08.093; Joshi MC, 2007, BIOORG MED CHEM LETT, V17, P3226, DOI 10.1016/j.bmcl.2007.03.007; Krim J, 2009, ARKIVOC, P142, DOI 10.3998/ark.5550190.0010.d12; Kundu NG, 2001, J ORG CHEM, V66, P20, DOI 10.1021/jo000826j; Lee JW, 2006, B KOR CHEM SOC, V27, P1795; Lee LV, 2003, J AM CHEM SOC, V125, P9588, DOI 10.1021/ja0302836; Martin-Matute B, 2003, J AM CHEM SOC, V125, P5757, DOI 10.1021/ja029125p; Meldal M, 2008, CHEM REV, V108, P2952, DOI 10.1021/cr0783479; Mendoza-Espinosa D, 2014, MOLECULES, V19, P55, DOI 10.3390/molecules19010055; Pal M, 2003, ORG LETT, V5, P349, DOI 10.1021/ol027382t; Quan ZJ, 2013, TETRAHEDRON, V69, P881, DOI 10.1016/j.tet.2012.10.097; Rahman A, 2005, BIOASSAY TECHNIQUES, P8; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Samai S, 2010, TETRAHEDRON LETT, V51, P5555, DOI 10.1016/j.tetlet.2010.08.043; Serwar M, 2009, ARKIVOC, P210, DOI 10.3998/ark.5550190.0010.720; Sharghi H, 2009, ADV SYNTH CATAL, V351, P2391, DOI 10.1002/adsc.200900353; Singh Dharmendra, 2012, INT J PHARM PHARM SC, V2, P42; Sokmen BB, 2012, J SERB CHEM SOC, V77, P1353, DOI 10.2298/JSC120105042S; Speers AE, 2003, J AM CHEM SOC, V125, P4686, DOI 10.1021/ja034490h; Tornoe CW, 2002, J ORG CHEM, V67, P3057, DOI 10.1021/jo011148j; Wang Q, 2003, J AM CHEM SOC, V125, P3192, DOI 10.1021/ja021381e; Wei LL, 2001, TETRAHEDRON, V57, P459, DOI 10.1016/S0040-4020(00)01014-0; Wu P, 2004, ANGEW CHEM INT EDIT, V43, P3928, DOI 10.1002/anie.200454078; Yadav JS, 2009, TETRAHEDRON LETT, V50, P6029, DOI 10.1016/j.tetlet.2009.08.027; Zhang YN, 2011, J POLYM SCI POL CHEM, V49, P4766, DOI 10.1002/pola.24923	38	15	16	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115457	10.1371/journal.pone.0115457	http://dx.doi.org/10.1371/journal.pone.0115457			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545159	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000347120200043
J	LeBlanc, ARH; Reisz, RR				LeBlanc, Aaron R. H.; Reisz, Robert R.			New Postcranial Material of the Early Caseid Casea broilii Williston, 1910 (Synapsida: Caseidae) with a Review of the Evolution of the Sacrum in Paleozoic Non-Mammalian Synapsids	PLOS ONE			English	Article							SOUTH-AFRICA; TETRAPODS; ANATOMY; ORIGIN; EUPELYCOSAURIA; PELYCOSAURIA; HYPOTHESIS; CONSTRAINT; REPTILIA; KANSAS	Here we use the description of a new specimen of the small caseid synapsid Casea broilii that preserves the sacral, pelvic and hind limb regions in great detail and in three dimensions, as a unique opportunity to reevaluate the early stages in the evolution of the sacrum in the lineage that led to mammals. We place this new material in the context of sacral evolution in early caseid synapsids and conclude that the transition from two to three sacral vertebrae occurred in small-bodied species, suggesting that it was not an adaptation to heavy weight bearing. Furthermore, we compare descriptions of sacral anatomy among known early synapsids, including caseids, ophiacodontids, edaphosaurids, varanopids, and sphenacodontians and review sacral evolution in early synapsids. Based on the descriptions of new species of caseids, edaphosaurids, and varanopids over the past several decades, it is clear that a sacrum consisting of three vertebrae evolved independently at least four times in synapsids during the Late Carboniferous and Early Permian. Furthermore, similarities in the morphologies of the sacral vertebrae and ribs of these early synapsids lead us to conclude that an anterior caudal vertebra had been incorporated into the sacral series convergently in these groups. Given the repeated acquisition of a three-vertebra sacrum in early synapsids and no apparent link to body size, we argue that this sacral anatomy was related to more efficient terrestrial locomotion than to increased weight bearing.	[LeBlanc, Aaron R. H.; Reisz, Robert R.] Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada	University of Toronto; University Toronto Mississauga	LeBlanc, ARH (corresponding author), Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada.	aaron.leblanc@mail.utoronto.ca		LeBlanc, Aaron/0000-0002-2497-1296	Natural Sciences and Engineering Research Council of Canada doctoral student scholarship (PGSD); Natural Sciences and Engineering Research Council of Canada Discovery Grant	Natural Sciences and Engineering Research Council of Canada doctoral student scholarship (PGSD)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Sciences and Engineering Research Council of Canada Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	Support for this project came from a Natural Sciences and Engineering Research Council of Canada doctoral student scholarship (PGSD) to ARHL and a Natural Sciences and Engineering Research Council of Canada Discovery Grant to RRR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson RBJ, 2012, J SYST PALAEONTOL, V10, P601, DOI 10.1080/14772019.2011.631042; Berman David S., 2004, Bulletin of Carnegie Museum of Natural History, V35, P1, DOI 10.2992/0145-9058(2004)35[1:ANDDOP]2.0.CO;2; Botha-Brink J, 2009, J VERTEBR PALEONTOL, V29, P389, DOI 10.1671/039.029.0209; Buchholtz EA, 2014, ZOOLOGY, V117, P64, DOI 10.1016/j.zool.2013.09.001; Campione NE, 2010, J VERTEBR PALEONTOL, V30, P724, DOI 10.1080/02724631003762914; CARRIER DR, 1987, PALEOBIOLOGY, V13, P326; Chudinov P. K., 1965, International Geology Review, V7, P1629; Currie P.J., 1979, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V163, P130; CURRIE PJ, 1977, J PALEONTOL, V51, P927; CYS JOHN M., 1967, J PALEONTOL, V41, P776; Frobisch J, 2011, ACTA PALAEONTOL POL, V56, P113, DOI 10.4202/app.2010.0039; Frobisch J, 2011, ZOOL J LINN SOC-LOND, V162, P661, DOI 10.1111/j.1096-3642.2010.00685.x; Harris SK, 2010, NEW MEX MUS NAT HIST, V49, P137; Henderson LJ, 1916, P NATL ACAD SCI USA, V2, P650, DOI 10.1073/pnas.2.11.650; Hook R.W., 1991, Journal of Vertebrate Paleontology, V11, P37; Hurlburt G, 1999, J VERTEBR PALEONTOL, V19, P338, DOI 10.1080/02724634.1999.10011145; Kemp TS, 2006, J EVOLUTION BIOL, V19, P1231, DOI 10.1111/j.1420-9101.2005.01076.x; Langer MC, 2010, BIOL REV, V85, P55, DOI 10.1111/j.1469-185X.2009.00094.x; LANGSTON W JR, 1981, Journal of Vertebrate Paleontology, V1, P73; LAURIN M, 1995, ZOOL J LINN SOC-LOND, V113, P165, DOI 10.1111/j.1096-3642.1995.tb00932.x; Laurin Michel, 1993, Journal of Vertebrate Paleontology, V13, P200; Lucas Spencer G., 2006, Geological Society Special Publication, V265, P65, DOI 10.1144/GSL.SP.2006.265.01.04; Maddin HC, 2008, J VERTEBR PALEONTOL, V28, P160, DOI 10.1671/0272-4634(2008)28[160:CAOETS]2.0.CO;2; Modesto SP, 2011, NATURWISSENSCHAFTEN, V98, P1027, DOI 10.1007/s00114-011-0856-2; Modesto SP, 2010, J VERTEBR PALEONTOL, V30, P1378, DOI 10.1080/02724634.2010.501443; Muller J, 2010, P NATL ACAD SCI USA, V107, P2118, DOI 10.1073/pnas.0912622107; OLSON EC, 1953, J GEOL, V61, P389, DOI 10.1086/626109; OLSON EVERETT C., 1968, FIELDIANA GEOL, V17, P225; Pol D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014572; Ray S, 2003, PALAEONTOLOGY, V46, P151, DOI 10.1111/1475-4983.00292; Reisz R. R., 1986, ENCY PALEOHERPETOLOG; Reisz RR, 2006, J EXP ZOOL PART B, V306B, P261, DOI 10.1002/jez.b.21115; Reisz RR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094518; Reisz RR, 2011, GEODIVERSITAS, V33, P227, DOI 10.5252/g2011n2a2; Reisz RR, 2002, J VERTEBR PALEONTOL, V22, P244, DOI 10.1671/0272-4634(2002)022[0244:OKSNAS]2.0.CO;2; Reisz RR, 2005, J VERTEBR PALEONTOL, V25, P905, DOI 10.1671/0272-4634(2005)025[0905:OANCFT]2.0.CO;2; Reisz RR, 2003, CAN J EARTH SCI, V40, P667, DOI 10.1139/E02-063; REISZ RR, 1986, CAN J EARTH SCI, V23, P77, DOI 10.1139/e86-008; Romer A, 1956, OSTEOLOGY REPTILES; Romer A. S., 1940, REV PELYCOSAURIA; Romer AS, 1927, J GEOL, V35, P673, DOI 10.1086/623462; Roscher M, 2006, GEOL SOC LOND SPEC P, V265, P95, DOI DOI 10.1144/GSL.SP.2006.265.01.05; STOVALL J. WILLIS, 1966, BULL MUS COMP ZOOL HARVARD UNIV, V135, P1; Sues HD, 1998, TRENDS ECOL EVOL, V13, P141, DOI 10.1016/S0169-5347(97)01257-3; Sumida S.S., 1989, Journal of Vertebrate Paleontology, V9, P451; Williston S.W., 1911, AM PERMIAN VERTEBRAT; Zhou CF, 2013, NATURE, V500, P163, DOI 10.1038/nature12429	47	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115734	10.1371/journal.pone.0115734	http://dx.doi.org/10.1371/journal.pone.0115734			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545624	Green Published, gold, Green Submitted			2022-12-27	WOS:000347120200062
J	Rybalka, E; Timpani, CA; Cooke, MB; Williams, AD; Hayes, A				Rybalka, Emma; Timpani, Cara A.; Cooke, Matthew B.; Williams, Andrew D.; Hayes, Alan			Defects in Mitochondrial ATP Synthesis in Dystrophin-Deficient Mdx Skeletal Muscles May Be Caused by Complex I Insufficiency	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; DMD BMD CARRIERS; ENERGY-METABOLISM; OXIDATIVE-PHOSPHORYLATION; INTRAMITOCHONDRIAL CA2+; MOUSE; CALCIUM; BIOENERGETICS; CALMITINE; CHANNELS	Duchenne Muscular Dystrophy is a chronic, progressive and ultimately fatal skeletal muscle wasting disease characterised by sarcolemmal fragility and intracellular Ca2+ dysregulation secondary to the absence of dystrophin. Mounting literature also suggests that the dysfunction of key energy systems within the muscle may contribute to pathological muscle wasting by reducing ATP availability to Ca2+ regulation and fibre regeneration. No study to date has biochemically quantified and contrasted mitochondrial ATP production capacity by dystrophic mitochondria isolated from their pathophysiological environment such to determine whether mitochondria are indeed capable of meeting this heightened cellular ATP demand, or examined the effects of an increasing extramitochondrial Ca2+ environment. Using isolated mitochondria from the diaphragm and tibialis anterior of 12 week-old dystrophin-deficient mdx and healthy control mice (C57BL10/ScSn) we have demonstrated severely depressed Complex I-mediated mitochondrial ATP production rate in mdx mitochondria that occurs irrespective of the macronutrient-derivative substrate combination fed into the Kreb's cycle, and, which is partially, but significantly, ameliorated by inhibition of Complex I with rotenone and stimulation of Complex II-mediated ATP-production with succinate. There was no difference in the MAPR response of mdx mitochondria to increasing extramitochondrial Ca2+ load in comparison to controls, and 400 nM extramitochondrial Ca2+ was generally shown to be inhibitory to MAPR in both groups. Our data suggests that DMD pathology is exacerbated by a Complex I deficiency, which may contribute in part to the severe reductions in ATP production previously observed in dystrophic skeletal muscle.	[Rybalka, Emma; Timpani, Cara A.; Cooke, Matthew B.; Hayes, Alan] Victoria Univ, Coll Hlth & Biomed, Ctr Chron Dis Prevent & Management, Melbourne, Vic 8001, Australia; [Rybalka, Emma; Cooke, Matthew B.; Hayes, Alan] Victoria Univ, Inst Sport Exercise & Act Living, Melbourne, Vic 8001, Australia; [Rybalka, Emma; Cooke, Matthew B.; Hayes, Alan] Western Hlth, Australian Inst Musculoskeletal Sci, Melbourne, Vic, Australia; [Williams, Andrew D.] Univ Tasmania, Sch Human Life Sci, Launceston, Tas 7250, Australia	Victoria University; Victoria University; University of Tasmania	Rybalka, E (corresponding author), Victoria Univ, Coll Hlth & Biomed, Ctr Chron Dis Prevent & Management, Melbourne, Vic 8001, Australia.	emma.rybalka@vu.edu.au	Hayes, Alan/M-4231-2014; Williams, Andrew D/J-4269-2013	Hayes, Alan/0000-0003-1398-3694; Williams, Andrew D/0000-0001-8863-3491; Timpani, Cara/0000-0003-4567-4319; Cooke, Matthew B/0000-0002-4978-4294; Rybalka, Emma/0000-0002-4854-0036				Adam-Vizi V, 2006, TRENDS PHARMACOL SCI, V27, P639, DOI 10.1016/j.tips.2006.10.005; AUSTIN L, 1992, NEUROMUSCULAR DISORD, V2, P27, DOI 10.1016/0960-8966(92)90023-Y; BARBIROLI B, 1992, J NEUROL SCI, V109, P188, DOI 10.1016/0022-510X(92)90167-J; BARBIROLI B, 1992, MUSCLE NERVE, V15, P344, DOI 10.1002/mus.880150313; BHATTACHARYA SK, 1993, J NEUROL SCI, V120, P180, DOI 10.1016/0022-510X(93)90271-Y; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; CHI MMY, 1987, METABOLISM, V36, P761, DOI 10.1016/0026-0495(87)90113-2; Cole MA, 2002, NEUROMUSCULAR DISORD, V12, P247, DOI 10.1016/S0960-8966(01)00278-4; DAS AM, 1990, BIOCHEM SOC T, V18, P554, DOI 10.1042/bst0180554; Dlaskova A, 2008, INT J BIOCHEM CELL B, V40, P2098, DOI 10.1016/j.biocel.2008.02.007; DUNN JF, 1991, J NEUROL SCI, V103, P226, DOI 10.1016/0022-510X(91)90168-7; Eagle M, 2002, NEUROMUSCULAR DISORD, V12, P926, DOI 10.1016/S0960-8966(02)00140-2; EVEN PC, 1994, BIOCHEM J, V304, P649, DOI 10.1042/bj3040649; FONG P, 1990, SCIENCE, V250, P673, DOI 10.1126/science.2173137; FRANCO A, 1990, NATURE, V344, P670, DOI 10.1038/344670a0; Gellerich FN, 2010, BBA-BIOENERGETICS, V1797, P1018, DOI 10.1016/j.bbabio.2010.02.005; Godin R, 2012, J PHYSL; Godin Richard, 2012, J Physiol, V590, P5487, DOI 10.1113/jphysiol.2012.240390; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Kuznetsov AV, 1998, MOL CELL BIOCHEM, V183, P87, DOI 10.1023/A:1006868130002; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; LUCASHERON B, 1990, NEUROSCI LETT, V115, P103, DOI 10.1016/0304-3940(90)90525-E; LUCASHERON B, 1990, J NEUROL SCI, V99, P349, DOI 10.1016/0022-510X(90)90169-N; MCCORMACK JG, 1993, DEV NEUROSCI-BASEL, V15, P165, DOI 10.1159/000111332; MCCORMACK JG, 1993, BIOCHEM SOC T, V21, P793, DOI 10.1042/bst0210793; Millay DP, 2008, NAT MED, V14, P442, DOI 10.1038/nm1736; MONGINI T, 1988, NEUROLOGY, V38, P476, DOI 10.1212/WNL.38.3.476; Onopiuk M, 2009, BIOCHEM BIOPH RES CO, V386, P463, DOI 10.1016/j.bbrc.2009.06.053; Passaquin AC, 2002, NEUROMUSCULAR DISORD, V12, P174, DOI 10.1016/S0960-8966(01)00273-5; Percival JM, 2013, HUM MOL GENET, V22, P153, DOI 10.1093/hmg/dds415; Reutenauer J, 2008, BRIT J PHARMACOL, V155, P574, DOI 10.1038/bjp.2008.285; Robert V, 2001, J BIOL CHEM, V276, P4647, DOI 10.1074/jbc.M006337200; SCHOLTE HR, 1980, J NEUROL SCI, V45, P217, DOI 10.1016/0022-510X(80)90167-7; Schuh RA, 2012, AM J PHYSIOL-REG I, V302, pR712, DOI 10.1152/ajpregu.00229.2011; Sperl W, 1997, MOL CELL BIOCHEM, V174, P71, DOI 10.1023/A:1006880529195; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; Tseng BS, 2002, J APPL PHYSIOL, V93, P537, DOI 10.1152/japplphysiol.00202.2002; Tuon L, 2010, MUSCLE NERVE, V41, P257, DOI 10.1002/mus.21559; WERNETTE ME, 1981, J BIOL CHEM, V256, P2767; WIBOM R, 1990, SCAND J CLIN LAB INV, V50, P143, DOI 10.3109/00365519009089146; Wibom R, 2005, J BIOLUMINESCENCE CH, V6, P123; Williams AD, 2004, J CARD FAIL, V10, P141, DOI 10.1016/j.cardfail.2003.09.004; Williams AD, 2007, J CARD FAIL, V13, P79, DOI 10.1016/j.cardfail.2006.10.017	44	87	88	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115763	10.1371/journal.pone.0115763	http://dx.doi.org/10.1371/journal.pone.0115763			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541951	Green Accepted, Green Published, gold			2022-12-27	WOS:000347239900080
J	Sueta, A; Yamamoto, Y; Yamamoto-Ibusuki, M; Hayashi, M; Takeshita, T; Yamamoto, S; Iwase, H				Sueta, Aiko; Yamamoto, Yutaka; Yamamoto-Ibusuki, Mutsuko; Hayashi, Mitsuhiro; Takeshita, Takashi; Yamamoto, Satoko; Iwase, Hirotaka			An Integrative Analysis of PIK3CA Mutation, PTEN, and INPP4B Expression in Terms of Trastuzumab Efficacy in HER2-Positive Breast Cancer	PLOS ONE			English	Article							PLUS ADJUVANT CHEMOTHERAPY; TUMOR-SUPPRESSOR; SOMATIC MUTATION; PI3K PATHWAY; COPY NUMBER; DIGITAL PCR; FOLLOW-UP; ACTIVATION; RESISTANCE; IMMUNOHISTOCHEMISTRY	The phosphoinositide-3-kinase (PI3K) pathway is commonly deregulated in breast cancer through several mechanisms, including PIK3CA mutation and loss of phosphatase and tensin homolog (PTEN) and inositol polyphosphate 4phosphatase- II (INPP4B). We aimed to evaluate the predictive relevance of these biomarkers to trastuzumab efficacy in HER2-positive disease. We evaluated the effect of trastuzumab in 43 breast cancer patients with HER2-overexpression who received neoadjuvant treatment. PIK3CA mutation was examined by direct sequencing and digital PCR assay, and PIK3CA copy number was assessed by digital PCR assay of pretreatment tissues. PTEN, pAkt, and INPP4B were assessed by immunohistochemistry. Direct sequencing detected mutant DNA in 21% of all patients, but the incidence increased to 49% using digital PCR. The pathological complete response (pCR) rate in patients with PIK3CA mutations was 29% compared with 67% for those without PIK3CA mutations (P=0.093), when the mutation was defined as positive if the mutant proportion was more than 10% of total genetic content by digital PCR. Low PTEN expression was associated with less pCR compared to high expression (33% versus 72%, P=0.034). There were no significant associations of PIK3CA copy number, pAKt, or INPP4B with trastuzumab efficacy. In multivariate analysis, activation of the PI3K pathway due to either PIK3CA mutation or low PTEN were related to poorer response to trastuzumab (OR of predictive pCR was 0.11, 95% CI; 0.03-0.48). In conclusion, activating the PI3K pathway is associated with low pCR to trastuzumab-based treatment in HER2-positive breast cancer. Combined analysis of PIK3CA mutation and PTEN expression may serve as critical indicators to identify patients unlikely to respond to trastuzumab.	[Sueta, Aiko; Yamamoto, Yutaka; Yamamoto-Ibusuki, Mutsuko; Hayashi, Mitsuhiro; Takeshita, Takashi; Yamamoto, Satoko; Iwase, Hirotaka] Kumamoto Univ, Grad Sch Med Sci, Dept Breast & Endocrine Surg, Chuo Ku, Kumamoto 8608556, Japan; [Sueta, Aiko; Yamamoto, Yutaka] Kumamoto Univ Hosp, Dept Mol Targeting Therapy Breast Canc, Chuo Ku, Kumamoto 8608556, Japan	Kumamoto University; Kumamoto University	Yamamoto, Y (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Breast & Endocrine Surg, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	ys-yama@triton.ocn.ne.jp	Takeshita, Takashi/J-1423-2019	Takeshita, Takashi/0000-0002-8559-8181; Hayashi, Mitsuhiro/0000-0001-6656-8502				Agoulnik IU, 2011, ONCOTARGET, V2, P321; Beaver JA, 2014, CLIN CANCER RES, V20, P2643, DOI 10.1158/1078-0432.CCR-13-2933; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chandarlapaty S, 2012, CLIN CANCER RES, V18, P6784, DOI 10.1158/1078-0432.CCR-12-1785; Cizkova M, 2013, BRIT J CANCER, V108, P1807, DOI 10.1038/bjc.2013.164; Dave B, 2011, J CLIN ONCOL, V29, P166, DOI 10.1200/JCO.2009.27.7814; Diaz LA, 2014, J CLIN ONCOL, V32, P579, DOI 10.1200/JCO.2012.45.2011; Dowsett M, 2011, JNCI-J NATL CANCER I, V103, P1656, DOI 10.1093/jnci/djr393; Esteva FJ, 2010, AM J PATHOL, V177, P1647, DOI 10.2353/ajpath.2010.090885; Fedele CG, 2010, P NATL ACAD SCI USA, V107, P22231, DOI 10.1073/pnas.1015245107; Fujita T, 2006, BRIT J CANCER, V94, P247, DOI 10.1038/sj.bjc.6602926; Gabriel N., 2013, J CLIN ONCOL, V31; Gewinner C, 2009, CANCER CELL, V16, P115, DOI 10.1016/j.ccr.2009.06.006; Gonzalez-Angulo AM, 2012, CANCER, V119, P7; Gori S, 2009, ANN ONCOL, V20, P648, DOI 10.1093/annonc/mdn681; Hanker AB, 2013, P NATL ACAD SCI USA, V110, P14372, DOI 10.1073/pnas.1303204110; Hodgson MC, 2011, CANCER RES, V71, P572, DOI 10.1158/0008-5472.CAN-10-2314; Isler JA, 2007, PHARMACOGENOMICS, V8, P353, DOI 10.2217/14622416.8.4.353; Jensen JD, 2012, ANN ONCOL, V23, P2034, DOI 10.1093/annonc/mdr546; Jones N, 2013, INT J CANCER, V133, P323, DOI 10.1002/ijc.28021; Junttila TT, 2009, CANCER CELL, V15, P429, DOI 10.1016/j.ccr.2009.03.020; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Loi S, 2013, JNCI-J NATL CANCER I, V105, P960, DOI 10.1093/jnci/djt121; Loibl S, 2013, 36 SANANTONIO BREAST; Loibl S, 2014, J CLIN ONCOL, V32, P3212, DOI 10.1200/JCO.2014.55.7876; Lopez-Knowles E, 2010, INT J CANCER, V126, P1121, DOI 10.1002/ijc.24831; Montemurro F, 2006, ONCOLOGIST, V11, P318, DOI 10.1634/theoncologist.11-4-318; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Perez EA, 2011, J CLIN ONCOL, V29, P3366, DOI 10.1200/JCO.2011.35.0868; Perez-Lorenzo R, 2014, J INVEST DERMATOL, V134, P1359, DOI 10.1038/jid.2013.511; Pohlmann PR, 2009, CLIN CANCER RES, V15, P7479, DOI 10.1158/1078-0432.CCR-09-0636; Razis E, 2011, BREAST CANCER RES TR, V128, P447, DOI 10.1007/s10549-011-1572-5; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Sakr RA, 2010, APPL IMMUNOHISTO M M, V18, P371, DOI 10.1097/PAI.0b013e3181d50bd5; Smith I, 2007, LANCET, V369, P29, DOI 10.1016/S0140-6736(07)60028-2; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Treilleux I, 2013, J CLIN ONCOL, V31; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719; Vora SR, 2014, CANCER CELL, V26, P136, DOI 10.1016/j.ccr.2014.05.020; Wang HL, 2010, ADV ANAT PATHOL, V17, P23, DOI 10.1097/PAP.0b013e3181c6962f; Whale AS, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks203; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Wu GJ, 2005, BREAST CANCER RES, V7, pR609, DOI 10.1186/bcr1262; Yamamoto S, 2013, BREAST CANCER-TOKYO, V20, P262, DOI 10.1007/s12282-012-0332-7; Yung TKF, 2009, CLIN CANCER RES, V15, P2076, DOI 10.1158/1078-0432.CCR-08-2622	47	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e116054	10.1371/journal.pone.0116054	http://dx.doi.org/10.1371/journal.pone.0116054			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542038	Green Published, Green Submitted, gold			2022-12-27	WOS:000347239900135
J	Djordjevic, MA; Bezos, A; Susanti; Marmuse, L; Driguez, H; Samain, E; Vauzeilles, B; Beau, JM; Kordbacheh, F; Rolfe, BG; Schworer, R; Daines, AM; Gresshoff, PM; Parish, CR				Djordjevic, Michael A.; Bezos, Anna; Susanti; Marmuse, Laurence; Driguez, Hugues; Samain, Eric; Vauzeilles, Boris; Beau, Jean-Marie; Kordbacheh, Farzaneh; Rolfe, Barry G.; Schworer, Ralf; Daines, Alison M.; Gresshoff, Peter M.; Parish, Christopher R.			Lipo-Chitin Oligosaccharides, Plant Symbiosis Signalling Molecules That Modulate Mammalian Angiogenesis In Vitro	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; RECEPTOR-LIKE KINASE; ESCHERICHIA-COLI; NODULATION FACTORS; INNATE IMMUNITY; RHIZOBIUM-LEGUMINOSARUM; ARBUSCULAR MYCORRHIZA; HIGH-AFFINITY; BINDING; CHITOOLIGOSACCHARIDES	Lipochitin oligosaccharides (LCOs) are signaling molecules required by ecologically and agronomically important bacteria and fungi to establish symbioses with diverse land plants. In plants, oligo-chitins and LCOs can differentially interact with different lysin motif (LysM) receptors and affect innate immunity responses or symbiosis-related pathways. In animals, oligo-chitins also induce innate immunity and other physiological responses but LCO recognition has not been demonstrated. Here LCO and LCO-like compounds are shown to be biologically active in mammals in a structure dependent way through the modulation of angiogenesis, a tightly-regulated process involving the induction and growth of new blood vessels from existing vessels. The testing of 24 LCO, LCO-like or oligo-chitin compounds resulted in structure-dependent effects on angiogenesis in vitro leading to promotion, or inhibition or nil effects. Like plants, the mammalian LCO biological activity depended upon the presence and type of terminal substitutions. Un-substituted oligo-chitins of similar chain lengths were unable to modulate angiogenesis indicating that mammalian cells, like plant cells, can distinguish between LCOs and un-substituted oligo-chitins. The cellular mode-of-action of the biologically active LCOs in mammals was determined. The stimulation or inhibition of endothelial cell adhesion to vitronectin or fibronectin correlated with their pro- or anti-angiogenic activity. Importantly, novel and more easily synthesised LCO-like disaccharide molecules were also biologically active and de-acetylated chitobiose was shown to be the primary structural basis of recognition. Given this, simpler chitin disaccharides derivatives based on the structure of biologically active LCOs were synthesised and purified and these showed biological activity in mammalian cells. Since important chronic disease states are linked to either insufficient or excessive angiogenesis, LCO and LCO-like molecules may have the potential to be a new, carbohydrate-based class of therapeutics for modulating angiogenesis.	[Djordjevic, Michael A.; Kordbacheh, Farzaneh; Rolfe, Barry G.] Australian Natl Univ, Coll Med Biol & Environm, Res Sch Biol, Plant Sci Div, Canberra, ACT, Australia; [Bezos, Anna; Susanti; Parish, Christopher R.] Australian Natl Univ, John Curtin Sch Med Res, Coll Med Biol & Environm, Canberra, ACT 2601, Australia; [Marmuse, Laurence; Driguez, Hugues; Samain, Eric] Univ Grenoble Alpes, CERMAV, France CNRS, Grenoble, France; [Vauzeilles, Boris; Beau, Jean-Marie] Univ Paris 11, Inst Chim Mol & Mat Orsay, Orsay, France; [Vauzeilles, Boris; Beau, Jean-Marie] CNRS, Inst Chim Subst Nat, Ctr Rech Gif, Gif Sur Yvette, France; [Schworer, Ralf; Daines, Alison M.] Victoria Univ Wellington, Ferrier Res Inst, Lower Hutt Wellington, New Zealand; [Gresshoff, Peter M.] Univ Queensland, Ctr Integrat Legume Res, Brisbane, Qld, Australia	Australian National University; Australian National University; John Curtin School of Medical Research; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Queensland	Djordjevic, MA (corresponding author), Australian Natl Univ, Coll Med Biol & Environm, Res Sch Biol, Plant Sci Div, GPO Box 4, Canberra, ACT, Australia.	Michael.Djordjevic@anu.edu.au	Djordjevic, Michael/C-9945-2009; Schwörer, Ralf/F-7598-2014; Vauzeilles, Boris/G-2225-2017	Schwörer, Ralf/0000-0002-9352-6559; Djordjevic, Michael/0000-0002-9819-1372; Parish, Christopher/0000-0001-7740-0430	Australian Research Council [DP1096299]; ICMG FR [2607]; PolyNat Carnot Institute; LabEx ARCANE [ANR-11-LABX-0003-01]	Australian Research Council(Australian Research Council); ICMG FR; PolyNat Carnot Institute; LabEx ARCANE	Funding support from the Australian Research Council is acknowledged (DP1096299) to MAD and CRP. The authors acknowledge support from ICMG FR 2607, PolyNat Carnot Institute, and LabEx ARCANE (ANR-11-LABX-0003-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBELDA SM, 1990, FASEB J, V4, P2868, DOI 10.1096/fasebj.4.11.2199285; ARDOUREL M, 1994, PLANT CELL, V6, P1357, DOI 10.1105/tpc.6.10.1357; Auerbach R, 2003, CLIN CHEM, V49, P32, DOI 10.1373/49.1.32; Bakkers J, 1997, P NATL ACAD SCI USA, V94, P7982, DOI 10.1073/pnas.94.15.7982; Brinchmann BC, 2011, ANN AGR ENV MED, V18, P7; Broghammer A, 2012, P NATL ACAD SCI USA, V109, P13859, DOI 10.1073/pnas.1205171109; BROWN KJ, 1995, EXP CELL RES, V217, P132, DOI 10.1006/excr.1995.1072; Brown KJ, 1996, LAB INVEST, V75, P539; Cottaz S, 2005, METAB ENG, V7, P311, DOI 10.1016/j.ymben.2005.05.004; Czaja LF, 2012, PLANT PHYSIOL, V159, P1671, DOI 10.1104/pp.112.195990; D'Haeze W, 2002, GLYCOBIOLOGY, V12, p79R, DOI 10.1093/glycob/12.6.79R; Demont-Caulet N, 1999, PLANT PHYSIOL, V120, P83, DOI 10.1104/pp.120.1.83; DJORDJEVIC MA, 1985, PLANT MOL BIOL, V4, P147, DOI 10.1007/BF02418762; Einarsson JM, 2013, BIOCHEM BIOPH RES CO, V434, P298, DOI 10.1016/j.bbrc.2013.02.122; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Funkhouser JD, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-96; Grenouillat N, 2004, ANGEW CHEM INT EDIT, V43, P4644, DOI 10.1002/anie.200460275; Gressent F, 1999, P NATL ACAD SCI USA, V96, P4704, DOI 10.1073/pnas.96.8.4704; Gupta R, 2009, CIRC RES, V105, P724, DOI 10.1161/CIRCRESAHA.109.200386; Kaga S, 2005, J MOL CELL CARDIOL, V39, P813, DOI 10.1016/j.yjmcc.2005.08.003; Kalo P, 2005, SCIENCE, V308, P1786, DOI 10.1126/science.1110951; Kartha KPR, 1998, J CARBOHYD CHEM, V17, P693, DOI 10.1080/07328309808002346; Kawada M, 2012, ONCOGENE, V31, P3111, DOI 10.1038/onc.2011.498; Laroche RJF, 2013, GENE EXPR PATTERNS, V13, P212, DOI 10.1016/j.gep.2013.02.007; Lee CG, 2011, ANNU REV PHYSIOL, V73, P479, DOI 10.1146/annurev-physiol-012110-142250; Lefebvre B, 2012, J BIOL CHEM, V287, P10812, DOI 10.1074/jbc.M111.281634; LEROUGE P, 1990, NATURE, V344, P781, DOI 10.1038/344781a0; Liang Y, 2013, SCIENCE, V10, P1126; Mac Gabhann F, 2010, WIRES SYST BIOL MED, V2, P694, DOI 10.1002/wsbm.92; Maillet F, 2011, NATURE, V469, P58, DOI 10.1038/nature09622; MCKAY IA, 1993, APPL ENVIRON MICROB, V59, P3385, DOI 10.1128/AEM.59.10.3385-3392.1993; ONEILL HC, 1983, J IMMUNOL METHODS, V64, P257, DOI 10.1016/0022-1759(83)90433-7; Osborn HMI, 2004, J PHARM PHARMACOL, V56, P691, DOI 10.1211/0022357023619; Otrock ZK, 2007, BLOOD CELL MOL DIS, V38, P258, DOI 10.1016/j.bcmd.2006.12.003; Parish CR, 1999, CANCER RES, V59, P3433; Parniske M, 2008, NAT REV MICROBIOL, V6, P763, DOI 10.1038/nrmicro1987; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Pupo E, 2013, FEBS J, V280, P1095, DOI 10.1111/febs.12104; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; Rasmussen MO, 2004, ORG BIOMOL CHEM, V2, P1908, DOI 10.1039/b403575e; Recklies AD, 2002, BIOCHEM J, V365, P119, DOI 10.1042/BJ20020075; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Samain E, 1999, J BIOTECHNOL, V72, P33, DOI 10.1016/S0168-1656(99)00048-6; Samain E, 1997, CARBOHYD RES, V302, P35, DOI 10.1016/S0008-6215(97)00107-9; Sane David C., 2004, Angiogenesis, V7, P193, DOI 10.1007/s10456-004-2699-3; Schimpl M, 2012, BIOCHEM J, V446, P149, DOI 10.1042/BJ20120377; Schworer R, 2013, CHEM-EUR J, V19, P6817, DOI 10.1002/chem.201204519; Semino CE, 2000, INT J DEV BIOL, V44, P183; SPAINK HP, 1994, MOL MICROBIOL, V13, P821, DOI 10.1111/j.1365-2958.1994.tb00474.x; STACEY G, 1994, J BACTERIOL, V176, P620, DOI 10.1128/jb.176.3.620-633.1994; Tang H, 2013, J IMMUNOL, V190, P438, DOI 10.4049/jimmunol.1201827; van Eijk M, 2005, INT IMMUNOL, V17, P1505, DOI 10.1093/intimm/dxh328; Wan JR, 2008, PLANT CELL, V20, P471, DOI 10.1105/tpc.107.056754; Wan JR, 2012, PLANT PHYSIOL, V160, P396, DOI 10.1104/pp.112.201699; Wang JN, 2011, ARTERIOSCL THROM VAS, V31, pE19, DOI 10.1161/ATVBAHA.111.230706; Xia GQ, 2001, EUR J BIOCHEM, V268, P4079, DOI 10.1046/j.1432-1327.2001.02323.x; Zipfel C, 2008, CURR OPIN IMMUNOL, V20, P10, DOI 10.1016/j.coi.2007.11.003	57	11	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e112635	10.1371/journal.pone.0112635	http://dx.doi.org/10.1371/journal.pone.0112635			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536397	Green Published, gold, Green Submitted			2022-12-27	WOS:000348563300004
J	Trinh, NHT; Nadler, DL; Shie, V; Fregni, F; Gilman, SE; Ryan, CM; Schneider, JC				Trinh, Nhi-Ha T.; Nadler, Deborah L.; Shie, Vivian; Fregni, Felipe; Gilman, Stephen E.; Ryan, Colleen M.; Schneider, Jeffrey C.			Psychological Sequelae of the Station Nightclub Fire: Comparing Survivors with and without Physical Injuries Using a Mixed-Methods Analysis	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; DEPRESSION; PREVALENCE; INVENTORY; SCALE	Background: Surveying survivors from a large fire provides an opportunity to explore the impact of emotional trauma on psychological outcomes. Methods: This is a cross-sectional survey of survivors of The Station Fire. Primary outcomes were post-traumatic stress (Impact of Event Scale - Revised) and depressive (Beck Depression Inventory) symptoms. Linear regression was used to examine differences in symptom profiles between those with and without physical injuries. The free-response section of the survey was analyzed qualitatively to compare psychological sequelae of survivors with and without physical injuries. Results: 104 participants completed the study survey; 47% experienced a burn injury. There was a 42% to 72% response rate range. The mean age of respondents was 32 years, 62% were male, and 47% experienced a physical injury. No significant relationships were found between physical injury and depressive or post-traumatic stress symptom profiles. In the qualitative analysis, the emotional trauma that survivors experienced was a major, common theme regardless of physical injury. Survivors without physical injuries were more likely to experience survivor guilt, helplessness, self-blame, and bitterness. Despite the post-fire challenges described, most survivors wrote about themes of recovery and renewal. Conclusions: All survivors of this large fire experienced significant psychological sequelae. These findings reinforce the importance of mental health care for all survivors and suggest a need to understand factors influencing positive outcomes.	[Trinh, Nhi-Ha T.] Massachusetts Gen Hosp, Depress Clin & Res Program, Boston, MA 02114 USA; [Nadler, Deborah L.; Shie, Vivian; Schneider, Jeffrey C.] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Spaulding Rehabil Hosp, Boston, MA USA; [Nadler, Deborah L.; Shie, Vivian; Fregni, Felipe] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Spaulding Ctr Neuromodulat, Boston, MA USA; [Gilman, Stephen E.] Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA; [Gilman, Stephen E.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Gilman, Stephen E.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Ryan, Colleen M.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Sumner Redstone Burn Ctr,Surg Serv, Boston, MA USA; [Ryan, Colleen M.] Shriners Hosp Children Boston, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Spaulding Rehabilitation Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Trinh, NHT (corresponding author), Massachusetts Gen Hosp, Depress Clin & Res Program, Boston, MA 02114 USA.	ntrinh@partners.org	Gilman, Stephen/E-7632-2010; Schneider, Jeffrey/AAO-2126-2020; Trinh, Nhi-Ha/AAH-7836-2019	Gilman, Stephen/0000-0002-8331-6419; Elhai, Jon/0000-0001-5205-9010; Nadler, Deborah/0000-0002-9771-6341; Fregni, Felipe/0000-0001-9359-8643; Ryan, Colleen/0000-0002-6455-936X	International Association of Fire Fighters; Department of Education; National Institute on Disability and Rehabilitation Research [H133A120034]	International Association of Fire Fighters; Department of Education(US Department of Education); National Institute on Disability and Rehabilitation Research	This project was supported in part by a pilot grant from the International Association of Fire Fighters and under a grant from the Department of Education, National Institute on Disability and Rehabilitation Research grant number H133A120034. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Association for Public Opinion Research, 2009, STAND DEF FIN DISP C; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; [Anonymous], 2003, PROVIDENCE J    1005; Baur KM, 1998, J BURN CARE REHABIL, V19, P230, DOI 10.1097/00004630-199805000-00009; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Bland SH, 1996, PSYCHOSOM MED, V58, P18, DOI 10.1097/00006842-199601000-00004; Foa EB, 2006, J CLIN PSYCHIAT, V67, P15; GREEN BL, 1983, J CONSULT CLIN PSYCH, V51, P573, DOI 10.1037/0022-006X.51.4.573; Grosshandler WL, 2005, NIST NCSTAR, V2; HAMNER MB, 1994, GEN HOSP PSYCHIAT, V16, P135, DOI 10.1016/0163-8343(94)90058-2; Karanci N., 2005, TRAUMATOLOGY, V11, P307, DOI DOI 10.1177/153476560501100409; Kildal M, 2002, BURNS, V28, P639, DOI 10.1016/S0305-4179(02)00111-0; Kildal M, 2001, J TRAUMA, V51, P740, DOI 10.1097/00005373-200110000-00020; Latenser BA, 2009, CRIT CARE MED, V37, P2819, DOI 10.1097/CCM.0b013e3181b3a08f; McKibben JBA, 2008, J BURN CARE RES, V29, P22, DOI 10.1097/BCR.0b013e31815f59c4; McNaught C, 2010, QUAL REP, V15, P630; North CS, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0481-9; North CS, 1999, JAMA-J AM MED ASSOC, V282, P755, DOI 10.1001/jama.282.8.755; Patterson DR, 2000, J BURN CARE REHABIL, V21, P490, DOI 10.1097/00004630-200021060-00004; Schneider JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047339; StataCorp, 2013, STATA STAT SOFTW REL; Steer RA, 1999, J CLIN PSYCHOL, V55, P117, DOI 10.1002/(SICI)1097-4679(199901)55:1<117::AID-JCLP12>3.0.CO;2-A; Sundin EC, 2002, BRIT J PSYCHIAT, V180, P205, DOI 10.1192/bjp.180.3.205; Tedstone JE, 2003, CLIN PSYCHOL REV, V23, P409, DOI 10.1016/S0272-7358(03)00031-X; Van Loon AJM, 2003, ANN EPIDEMIOL, V13, P105, DOI 10.1016/S1047-2797(02)00257-0; Weiss Daniel S., 1997, P399; Wiechman SA, 2001, J BURN CARE REHABIL, V22, P417, DOI 10.1097/00004630-200111000-00012	28	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115013	10.1371/journal.pone.0115013	http://dx.doi.org/10.1371/journal.pone.0115013			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ9UY	25536085	Green Published, gold			2022-12-27	WOS:000348563300027
J	Chen, X; Gu, Y; Singh, K; Shang, CW; Barzegar, M; Jiang, SX; Huang, SL				Chen, Xin; Gu, Ying; Singh, Karnika; Shang, Chaowei; Barzegar, Mansoureh; Jiang, Shanxiang; Huang, Shile			Maduramicin Inhibits Proliferation and Induces Apoptosis in Myoblast Cells	PLOS ONE			English	Article							MEDIATED GROWTH-INHIBITION; CYCLE ARREST; CANCER-CELLS; TOXICITY; SALINOMYCIN; DEATH; CARDIOMYOPATHY; LITTER; ANTIBIOTICS; PATHWAYS	Maduramicin, a polyether ionophore antibiotic derived from the bacterium Actinomadura yumaensis, is currently used as a feed additive against coccidiosis in poultry worldwide. It has been clinically observed that maduramicin can cause skeletal muscle and heart cell damage, resulting in skeletal muscle degeneration, heart failure, and even death in animals and humans, if improperly used. However, the mechanism of its toxic action in myoblasts is not well understood. Using mouse myoblasts (C2C12) and human rhabdomyosarcoma (RD and Rh30) cells as an experimental model for myoblasts, here we found that maduramicin inhibited cell proliferation and induced cell death in a concentration-dependent manner. Further studies revealed that maduramicin induced accumulation of the cells at G(0)/G(1) phase of the cell cycle, and induced apoptosis in the cells. Concurrently, maduramicin downregulated protein expression of cyclin D1, cyclin-dependent kinases (CDK4 and CDK6), and CDC25A, and upregulated expression of the CDK inhibitors (p21(Cip1) and p27(Kip1)), resulting in decreased phosphorylation of Rb. Maduramicin also induced expression of BAK, BAD, DR4, TRADD and TRAIL, leading to activation of caspases 8, 9 and 3 as well as cleavage of poly ADP ribose polymerase (PARP). Taken together, our results suggest that maduramicin executes its toxicity in myoblasts at least by inhibiting cell proliferation and inducing apoptotic cell death.	[Chen, Xin; Gu, Ying; Jiang, Shanxiang] Nanjing Agr Univ, Coll Vet Med, Lab Vet Pharmacol & Toxicol, Nanjing, Jiangsu, Peoples R China; [Chen, Xin; Gu, Ying; Singh, Karnika; Shang, Chaowei; Barzegar, Mansoureh; Huang, Shile] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71105 USA; [Shang, Chaowei; Huang, Shile] Louisiana State Univ, Hlth Sci Ctr, Feist Weiller Canc Ctr, Shreveport, LA 71105 USA	Nanjing Agricultural University; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Jiang, SX (corresponding author), Nanjing Agr Univ, Coll Vet Med, Lab Vet Pharmacol & Toxicol, Nanjing, Jiangsu, Peoples R China.	nauvy@sina.com; shuan1@lsuhsc.edu	Barzegar, Mansoureh/ABB-7572-2021; Huang, Shile/I-1632-2019	Huang, Shile/0000-0002-3239-1072	National Natural Science Foundation of China [090600253]; NIH [NCI CA115414]; American Cancer Society [RSG-08-135-01-CNE]; Nanjing Agricultural University; Feist-Weiller Cancer Center; Louisiana State University Health Sciences Center; NATIONAL CANCER INSTITUTE [R01CA115414] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Nanjing Agricultural University; Feist-Weiller Cancer Center; Louisiana State University Health Sciences Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the grants from National Natural Science Foundation of China (No. 090600253, S.J.), NIH (NCI CA115414; S.H.), American Cancer Society (RSG-08-135-01-CNE; S.H.), Nanjing Agricultural University, and the Feist-Weiller Cancer Center, Louisiana State University Health Sciences Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Additives E. P. o, 2011, EFSA J, V9, P1952; Alao JP, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-24; BASTIANELLO SS, 1995, ONDERSTEPOORT J VET, V62, P5; Boehmerle W, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.46; Christofferson DE, 2010, CURR OPIN CELL BIOL, V22, P263, DOI 10.1016/j.ceb.2009.12.003; Dorne JLCM, 2013, TOXICOL APPL PHARM, V270, P196, DOI 10.1016/j.taap.2010.12.014; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; FOURIE N, 1991, ONDERSTEPOORT J VET, V58, P291; Fuchs D, 2009, BIOCHEM BIOPH RES CO, V390, P743, DOI 10.1016/j.bbrc.2009.10.042; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Jayashree M, 2011, J TROP PEDIATRICS, V57, P340, DOI 10.1093/tropej/fmq099; Kant V, 2013, SCI INT, V1, P261, DOI DOI 10.17311/SCIINTL.2013.261.265; Kim JH, 2012, BIOCHEM BIOPH RES CO, V418, P98, DOI 10.1016/j.bbrc.2011.12.141; Kim WK, 2012, INVEST NEW DRUG, V30, P1311, DOI 10.1007/s10637-011-9685-6; Klein EA, 2008, J CELL SCI, V121, P3853, DOI 10.1242/jcs.039131; LABEDA DP, 1985, INT J SYST BACTERIOL, V35, P333, DOI 10.1099/00207713-35-3-333; Lavine MD, 2011, ANTIMICROB AGENTS CH, V55, P745, DOI 10.1128/AAC.01092-10; Lieke T, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-466; LIU CM, 1983, J ANTIBIOT, V36, P343, DOI 10.7164/antibiotics.36.343; Llambi F, 2011, CURR OPIN GENET DEV, V21, P12, DOI 10.1016/j.gde.2010.12.001; Lorenzo HK, 1999, CELL DEATH DIFFER, V6, P516, DOI 10.1038/sj.cdd.4400527; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Odaka Y, 2014, CARCINOGENESIS, V35, P192, DOI 10.1093/carcin/bgt277; Oehme FW, 1999, VET HUM TOXICOL, V41, P251; Park WH, 2003, INT J ONCOL, V22, P855; Park WH, 2003, INT J ONCOL, V22, P377; Park WH, 2003, INT J ONCOL, V23, P197; Park WH, 2002, BRIT J HAEMATOL, V119, P400, DOI 10.1046/j.1365-2141.2002.03834.x; Pisani DF, 2004, CELL DEATH DIFFER, V11, P1157, DOI 10.1038/sj.cdd.4401479; Rosenwald IB, 2004, ONCOGENE, V23, P3230, DOI 10.1038/sj.onc.1207552; SANFORD SE, 1991, CAN VET J, V32, P567; Sharma N, 2005, EMERG MED J, V22, P880, DOI 10.1136/emj.2004.020883; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shimshoni JA, 2014, FOOD CHEM TOXICOL, V68, P283, DOI 10.1016/j.fct.2014.03.034; SHLOSBERG A, 1992, VET RES COMMUN, V16, P45, DOI 10.1007/BF01839204; Shlosberg A, 1997, VET REC, V140, P643, DOI 10.1136/vr.140.25.643; Singh T, 2003, VET PARASITOL, V116, P345, DOI 10.1016/j.vetpar.2003.07.009; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; TSOU HR, 1984, J ANTIBIOT, V37, P1651, DOI 10.7164/antibiotics.37.1651; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R; Wang F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050638; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Zhou HY, 2010, INT J CANCER, V127, P2467, DOI 10.1002/ijc.25255; Zhou J, 2013, TOXICOL LETT, V222, P139, DOI 10.1016/j.toxlet.2013.07.022	45	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115652	10.1371/journal.pone.0115652	http://dx.doi.org/10.1371/journal.pone.0115652			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531367	gold, Green Published, Green Submitted			2022-12-27	WOS:000348845100088
J	Karn, RC; Chung, AG; Laukaitis, CM				Karn, Robert C.; Chung, Amanda G.; Laukaitis, Christina M.			Did Androgen-Binding Protein Paralogs Undergo Neo-and/or Subfunctionalization as the Abp Gene Region Expanded in the Mouse Genome?	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; MUS-MUSCULUS; SEXUAL ISOLATION; EVOLUTIONARY RELATIONSHIPS; PHYLOGENETIC ANALYSIS; MAXIMUM-LIKELIHOOD; ADAPTIVE EVOLUTION; STATISTICAL-MODEL; DUPLICATE GENES; LACRIMAL GLAND	The Androgen-binding protein (Abp) region of the mouse genome contains 30 Abpa genes encoding alpha subunits and 34 Abpbg genes encoding betagamma subunits, their products forming dimers composed of an alpha and a betagamma subunit. We endeavored to determine how many Abp genes are expressed as proteins in tears and saliva, and as transcripts in the exocrine glands producing them. Using standard PCR, we amplified Abp transcripts from cDNA libraries of C57BL/6 mice and found fifteen Abp gene transcripts in the lacrimal gland and five in the submandibular gland. Proteomic analyses identified proteins corresponding to eleven of the lacrimal gland transcripts, all of them different from the three salivary ABPs reported previously. Our qPCR results showed that five of the six transcripts that lacked corresponding proteins are expressed at very low levels compared to those transcripts with proteins. We found 1) no overlap in the repertoires of expressed Abp paralogs in lacrimal gland/tears and salivary glands/saliva; 2) substantial sex-limited expression of lacrimal gland/tear expressed-paralogs in males but no sex-limited expression in females; and 3) that the lacrimal gland/tear expressed-paralogs are found exclusively in ancestral clades 1, 2 and 3 of the five clades described previously while the salivary glands/saliva expressed-paralogs are found only in clade 5. The number of instances of extremely low levels of transcription without corresponding protein production in paralogs specific to tears and saliva suggested the role of subfunctionalization, a derived condition wherein genes that may have been expressed highly in both glands ancestrally were down-regulated subsequent to duplication. Thus, evidence for subfunctionalization can be seen in our data and we argue that the partitioning of paralog expression between lacrimal and salivary glands that we report here occurred as the result of adaptive evolution.	[Karn, Robert C.; Chung, Amanda G.; Laukaitis, Christina M.] Univ Arizona, Coll Med, Tucson, AZ 85724 USA	University of Arizona	Karn, RC (corresponding author), Univ Arizona, Coll Med, Tucson, AZ 85724 USA.	rkarn@butler.edu	Laukaitis, Christina/AAW-2510-2020; Laukaitis, Christina M/AAL-5865-2021; Laukaitis, Christina/ABF-1739-2021	Laukaitis, Christina M/0000-0003-1466-7941; 	partnership for Native American Cancer Prevention [U54 CA143924]; University of Arizona by the Howard Hughes Medical Institute [52006942]; Cancer Center Support Grant [P30 CA23074]; NATIONAL CANCER INSTITUTE [P30CA023074, U54CA143924] Funding Source: NIH RePORTER	partnership for Native American Cancer Prevention; University of Arizona by the Howard Hughes Medical Institute; Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	C.M.L. received salary support from the partnership for Native American Cancer Prevention (U54 CA143924, health.nih.gov). A.G.C. was supported in part by a grant to the University of Arizona by the Howard Hughes Medical Institute (52006942, http://www.hhmi.org). Laboratory space and core facilities were supported by a Cancer Center Support Grant (P30 CA23074, health. nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andon NL, 2002, PROTEOMICS, V2, P1156, DOI 10.1002/1615-9861(200209)2:9<1156::AID-PROT1156>3.0.CO;2-4; Bimova B, 2005, BIOL J LINN SOC, V84, P349, DOI 10.1111/j.1095-8312.2005.00439.x; Bimova BV, 2011, MOL ECOL, V20, P2403, DOI 10.1111/j.1365-294X.2011.05106.x; Burset M, 2000, NUCLEIC ACIDS RES, V28, P4364, DOI 10.1093/nar/28.21.4364; Cancela ML, 2014, ARCH BIOCH BIOPHYS; Clark NL, 2005, PLOS GENET, V1, P335, DOI 10.1371/journal.pgen.0010035; Coyne JA, 1997, GENETICS, V145, P1015; Cusack BP, 2007, TRENDS GENET, V23, P270, DOI 10.1016/j.tig.2007.03.010; DLOUHY SR, 1986, BIOCHEM GENET, V24, P743, DOI 10.1007/BF00499007; DLOUHY SR, 1987, GENETICS, V115, P535; DOMINGUEZ P, 1995, FEBS LETT, V376, P257, DOI 10.1016/0014-5793(95)01294-4; Emes RD, 2004, GENOME RES, V14, P1516, DOI 10.1101/gr.2540304; Force A, 1999, GENETICS, V151, P1531; Hurst LD, 1999, CURR BIOL, V9, P747, DOI 10.1016/S0960-9822(99)80334-0; Janousek V, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-107; Karn R, 2013, INT J BIOCH RES, V3, P328, DOI DOI 10.9734/IJBCRR/2013/5763; Karn RC, 1999, MOL BIOL EVOL, V16, P1192, DOI 10.1093/oxfordjournals.molbev.a026209; Karn RC, 1999, BIOCHEM GENET, V37, P187, DOI 10.1023/A:1018786622052; Karn RC, 2003, BIOCHEMISTRY-US, V42, P7162, DOI 10.1021/bi027424l; KARN RC, 1981, BIOCHEM GENET, V19, P355, DOI 10.1007/BF00504280; Karn RC, 2014, BIOCH SOC T IN PRESS, V42; Karn RC, 2013, PROTEOMES, V1, DOI 10.3390/proteomes1030275; Karn RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047697; Karn RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020979; Karn RC, 2009, GENOME BIOL EVOL, V1, P494, DOI 10.1093/gbe/evp049; Katju V, 2003, GENETICS, V165, P1793; Katju Vaishali, 2013, Frontiers in Genetics, V4, P273, DOI 10.3389/fgene.2013.00273; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-606; Kondrashov FA, 2006, J THEOR BIOL, V239, P141, DOI 10.1016/j.jtbi.2005.08.033; Laukaitis C., 2012, EVOLUTION HOUSE MOUS; Laukaitis CM, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-46; Laukaitis CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035898; Laukaitis CM, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-40; Laukaitis CM, 2005, BIOL J LINN SOC, V84, P493, DOI 10.1111/j.1095-8312.2005.00450.x; Laukaitis CM, 2003, MAMM GENOME, V14, P679, DOI 10.1007/s00335-003-2291-y; Laukaitis CM, 1997, EVOLUTION, V51, P2000, DOI [10.2307/2411020, 10.1111/j.1558-5646.1997.tb05121.x]; Li KL, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-20; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2000, GENETICS, V154, P459; Neme R, 2014, CURR BIOL, V24, pR238, DOI 10.1016/j.cub.2014.02.016; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Ohno S., 1970, EVOLUTION GENE DUPLI; Ohno S., 1967, SEX CHROMOSOMES SEX; Ozyildirim AM, 2005, INVEST OPHTH VIS SCI, V46, P1572, DOI 10.1167/iovs.04-1380; Qian WJ, 2005, MOL CELL PROTEOMICS, V4, P700, DOI 10.1074/mcp.M500045-MCP200; Remington SG, 2005, INVEST OPHTH VIS SCI, V46, P31, DOI 10.1167/iovs.04-0216; Rutter MT, 2012, TRENDS PLANT SCI, V17, P204, DOI 10.1016/j.tplants.2012.01.006; Shevchenko A, 1996, BIOCHEM SOC T, V24, P893, DOI 10.1042/bst0240893; SPOFFORD JB, 1969, GENETICS, V62, P555; Swanson WJ, 2004, GENETICS, V168, P1457, DOI 10.1534/genetics.104.030478; Swanson WJ, 2003, MOL BIOL EVOL, V20, P18, DOI 10.1093/oxfordjournals.molbev.a004233; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Talley HM, 2001, EVOLUTION, V55, P631, DOI 10.1554/0014-3820(2001)055[0631:FPFMSI]2.0.CO;2; Wagner A, 1998, BIOESSAYS, V20, P785, DOI 10.1002/(SICI)1521-1878(199810)20:10<785::AID-BIES2>3.3.CO;2-D; Wang YP, 2012, ANN NY ACAD SCI, V1256, P1, DOI 10.1111/j.1749-6632.2011.06384.x; Yang ZF, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-147; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhao J, 2003, EXP EYE RES, V77, P297, DOI 10.1016/S0014-4835(03)00152-0	62	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115454	10.1371/journal.pone.0115454	http://dx.doi.org/10.1371/journal.pone.0115454			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531410	Green Submitted, gold, Green Published			2022-12-27	WOS:000348845100068
J	Belon, C; Gannoun-Zaki, L; Lutfalla, G; Kremer, L; Blanc-Potard, AB				Belon, Claudine; Gannoun-Zaki, Laila; Lutfalla, Georges; Kremer, Laurent; Blanc-Potard, Anne-Beatrice			Mycobacterium marinum MgtC Plays a Role in Phagocytosis but is Dispensable for Intracellular Multiplication	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; SALMONELLA-ENTERICA; VIRULENCE FACTOR; INTRAMACROPHAGE SURVIVAL; TUBERCULOUS GRANULOMA; EPITHELIAL-CELLS; YERSINIA-PESTIS; ZEBRAFISH; MACROPHAGES; HOST	MgtC is a virulence factor involved in intramacrophage growth that has been reported in several intracellular pathogens, including Mycobacterium tuberculosis and Salmonella enterica serovar Typhimurium. MgtC participates also in adaptation to Mg2+ deprivation. Herein, we have constructed a mgtC mutant in Mycobacterium marinum to further investigate the role of MgtC in mycobacteria. We show that the M. marinum mgtC gene (Mma mgtC) is strongly induced upon Mg2+ deprivation and is required for optimal growth in Mg2+-deprived medium. The behaviour of the Mma mgtC mutant has been investigated in the Danio rerio infection model using a transgenic reporter zebrafish line that specifically labels neutrophils. Although the mgtC mutant is not attenuated in the zebrafish embryo model based on survival curves, our results indicate that phagocytosis by neutrophils is enhanced with the mgtC mutant compared to the wild-type strain following subcutaneous injection. Increased phagocytosis of the mutant strain is also observed ex vivo with the murine J774 macrophage cell line. On the other hand, no difference was found between the mgtC mutant and the wild-type strain in bacterial adhesion to macrophages and in the internalization into epithelial cells. Unlike the role reported for MgtC in other intracellular pathogens, Mma MgtC does not contribute significantly to intramacrophage replication. Taken together, these results indicate an unanticipated function of Mma MgtC at early step of infection within phagocytic cells. Hence, our results indicate that although the MgtC function is conserved among pathogens regarding adaptation to Mg2+ deprivation, its role towards phagocytic cells can differ, possibly in relation with the specific pathogen's lifestyles.	[Belon, Claudine; Gannoun-Zaki, Laila; Lutfalla, Georges; Kremer, Laurent; Blanc-Potard, Anne-Beatrice] Univ Montpellier 2, Lab Dynam Interact Membranaires Normales & Pathol, F-34095 Montpellier 05, France; [Belon, Claudine; Gannoun-Zaki, Laila; Lutfalla, Georges; Kremer, Laurent; Blanc-Potard, Anne-Beatrice] Univ Montpellier I, Lab Dynam Interact Membranaires Normales & Pathol, F-34095 Montpellier 05, France; [Belon, Claudine; Gannoun-Zaki, Laila; Lutfalla, Georges; Kremer, Laurent; Blanc-Potard, Anne-Beatrice] CNRS, UMR5235, Montpellier, France; [Kremer, Laurent] INSERM, Montpellier, France	Universite de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Blanc-Potard, AB (corresponding author), Univ Montpellier 2, Lab Dynam Interact Membranaires Normales & Pathol, Pl Eugene Bataillon, F-34095 Montpellier 05, France.	anne.blanc-potard@univ-montp1.fr	Lutfalla, Georges/AAW-9386-2021; Kremer, Laurent/M-4935-2017; Blanc-Potard, Anne/AAI-9542-2021	Kremer, Laurent/0000-0002-6604-4458; Blanc-Potard, Anne/0000-0001-9963-6786; LUTFALLA, Georges/0000-0002-6591-7894; Gannoun, Laila/0000-0002-9644-1083	French National Agency (ANR ZebraFlam); European Community's Seventh Framework Programme (FP7-PEOPLE-ITN) for the Marie-Curie Initial Training Network FishForPharma [PITN-GA-2011-289209]; French Ministry of Research; Fondation for Medical Research [FRM FDT20140930905]	French National Agency (ANR ZebraFlam)(French National Research Agency (ANR)); European Community's Seventh Framework Programme (FP7-PEOPLE-ITN) for the Marie-Curie Initial Training Network FishForPharma; French Ministry of Research(Ministry of Research, FranceEuropean Commission); Fondation for Medical Research	French National Agency (ANR ZebraFlam) and European Community's Seventh Framework Programme (FP7-PEOPLE-2011-ITN) under Grant Agreement PITN-GA-2011-289209 for the Marie-Curie Initial Training Network FishForPharma. CB is supported by a MRT fellowship from the French Ministry of Research and the Fondation for Medical Research (FRM FDT20140930905). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibaud L, 2014, J BIOL CHEM, V289, P215, DOI 10.1074/jbc.M113.525550; Alibaud L, 2011, MOL MICROBIOL, V80, P919, DOI 10.1111/j.1365-2958.2011.07618.x; Alix E, 2007, TRENDS MICROBIOL, V15, P252, DOI 10.1016/j.tim.2007.03.007; Alix E, 2008, MICROB PATHOGENESIS, V45, P236, DOI 10.1016/j.micpath.2008.06.001; Astarie-Dequeker C, 2010, DRUG DISCOV TODAY DI, V7, pe33, DOI DOI 10.1016/j.ddmec.2010.09.003; Astarie-Dequeker C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000289; BERMUDEZ LE, 1995, TUBERCLE LUNG DIS, V76, P240, DOI 10.1016/S0962-8479(05)80012-7; Blanc-Potard AB, 2003, J MOL EVOL, V57, P479, DOI 10.1007/s00239-003-2496-4; BlancPotard AB, 1997, EMBO J, V16, P5376, DOI 10.1093/emboj/16.17.5376; Buchmeier N, 2000, MOL MICROBIOL, V35, P1375, DOI 10.1046/j.1365-2958.2000.01797.x; Clay H, 2007, CELL HOST MICROBE, V2, P29, DOI 10.1016/j.chom.2007.06.004; Collins CA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000430; Colucci-Guyon E, 2011, J CELL SCI, V124, P3053, DOI 10.1242/jcs.082792; Dobson G., 1995, CHEM METHODS BACTERI, P237; Fine MJ, 1996, JAMA-J AM MED ASSOC, V275, P134, DOI 10.1001/jama.275.2.134; Flesselles B, 1999, FEMS MICROBIOL LETT, V177, P237, DOI 10.1111/j.1574-6968.1999.tb13738.x; Grabenstein JP, 2006, INFECT IMMUN, V74, P3727, DOI 10.1128/IAI.00255-06; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Larsen M.H., 2007, CURRENT PROTOCOLS MI; Lavigne JP, 2005, INFECT IMMUN, V73, P3160, DOI 10.1128/IAI.73.5.3160-3163.2005; Lawley TD, 2006, PLOS PATHOG, V2, P87, DOI 10.1371/journal.ppat.0020011; Lee EJ, 2013, CELL, V154, P146, DOI 10.1016/j.cell.2013.06.004; Maloney KE, 2006, INFECT IMMUN, V74, P5477, DOI 10.1128/IAI.00798-06; Meijer AH, 2014, CELL MICROBIOL, V16, P39, DOI 10.1111/cmi.12236; Mostowy S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003588; Prajsnar TK, 2008, CELL MICROBIOL, V10, P2312, DOI 10.1111/j.1462-5822.2008.01213.x; Ramakrishnan L, 2013, ADV EXP MED BIOL, V783, P251, DOI 10.1007/978-1-4614-6111-1_13; Rang C, 2007, MOL MICROBIOL, V63, P605, DOI 10.1111/j.1365-2958.2006.05542.x; Ren HP, 2007, MOL MICROBIOL, V63, P1345, DOI 10.1111/j.1365-2958.2007.05603.x; Renshaw SA, 2006, BLOOD, V108, P3976, DOI 10.1182/blood-2006-05-024075; Retamal P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005551; Rousseau C, 2003, CELL MICROBIOL, V5, P405, DOI 10.1046/j.1462-5822.2003.00289.x; Sambandamurthy VK, 2002, NAT MED, V8, P1171, DOI 10.1038/nm765; SCHLESINGER LS, 1991, J EXP MED, V174, P1031, DOI 10.1084/jem.174.5.1031; Smith I, 2003, CLIN MICROBIOL REV, V16, P463, DOI 10.1128/CMR.16.3.463-496.2003; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Stamm LM, 2003, J EXP MED, V198, P1361, DOI 10.1084/jem.20031072; Stinear TP, 2008, GENOME RES, V18, P729, DOI 10.1101/gr.075069.107; Stokes RW, 2004, INFECT IMMUN, V72, P5676, DOI 10.1128/IAI.72.10.5676-5686.2004; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Tabouret G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001159; Thompson JA, 2011, MICROBIOL-SGM, V157, P2084, DOI 10.1099/mic.0.048926-0; Tobin DM, 2008, CELL MICROBIOL, V10, P1027, DOI 10.1111/j.1462-5822.2008.01133.x; Torraca V, 2014, DIS MODEL MECH, V7, P785, DOI 10.1242/dmm.015594; Vescovi EG, 1996, CELL, V84, P165, DOI 10.1016/S0092-8674(00)81003-X; Vilcheze C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004115; Walters SB, 2006, MOL MICROBIOL, V60, P312, DOI 10.1111/j.1365-2958.2006.05102.x; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Yang CT, 2012, CELL HOST MICROBE, V12, P301, DOI 10.1016/j.chom.2012.07.009; Yang YS, 2012, J BACTERIOL, V194, P6255, DOI 10.1128/JB.01424-12; Zhou DS, 2005, FEMS MICROBIOL LETT, V250, P85, DOI 10.1016/j.femsle.2005.06.053	51	19	20	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e116052	10.1371/journal.pone.0116052	http://dx.doi.org/10.1371/journal.pone.0116052			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545682	Green Published, gold			2022-12-27	WOS:000347120200095
J	Castley, A; Berry, C; French, M; Fernandez, S; Krueger, R; Nolan, D				Castley, Alison; Berry, Cassandra; French, Martyn; Fernandez, Sonia; Krueger, Romano; Nolan, David			Elevated Plasma Soluble CD14 and Skewed CD16+Monocyte Distribution Persist despite Normalisation of Soluble CD163 and CXCL10 by Effective HIV Therapy: A Changing Paradigm for Routine HIV Laboratory Monitoring?	PLOS ONE			English	Article							MONOCYTE SUBSET; ANTIRETROVIRAL THERAPY; PREDICT MORTALITY; IMMUNE ACTIVATION; INFECTION; INFLAMMATION; TRANSMIGRATION; PROGRESSION; EXPRESSION; BIOMARKERS	Objective: We investigated plasma and flow cytometric biomarkers of monocyte status that have been associated with prognostic utility in HIV infection and other chronic inflammatory diseases, comparing 81 HIV+ individuals with a range of treatment outcomes to a group of 21 healthy control blood donors. Our aim is to develop and optimise monocyte assays that combine biological relevance, clinical utility, and ease of adoption into routine HIV laboratory practice. Design: Cross-sectional evaluation of concurrent plasma and whole blood samples. Methods: A flow cytometry protocol was developed comprising single-tube CD45, CD14, CD16, CD64, CD163, CD143 analysis with appropriately matched isotype controls. Plasma levels of soluble CD14 (sCD14), soluble CD163 (sCD163) and CXCL10 were measured by ELISA. Results: HIV status was associated with significantly increased expression of CD64, CD143 and CD163 on CD16(+) monocytes, irrespective of the virological response to HIV therapy. Plasma levels of sCD14, sCD163 and CXCL10 were also significantly elevated in association with viremic HIV infection. Plasma sCD163 and CXCL10 levels were restored to healthy control levels by effective antiretroviral therapy while sCD14 levels remained elevated despite virological suppression (p<0.001). Conclusions: Flow cytometric and plasma biomarkers of monocyte activation indicate an ongoing systemic inflammatory response to HIV infection, characterised by persistent alterations of CD16(+) monocyte expression profiles and elevated sCD14 levels, that are not corrected by antiretroviral therapy and likely to be prognostically significant. In contrast, sCD163 and CXCL10 levels declined on antiretroviral therapy, suggesting multiple activation pathways revealed by these biomarkers. Incorporation of these assays into routine clinical care is feasible and warrants further consideration, particularly in light of emerging therapeutic strategies that specifically target innate immune activation in HIV infection.	[Castley, Alison; Berry, Cassandra] Murdoch Univ, Sch Vet & Life Sci, Perth, WA, Australia; [Nolan, David] Murdoch Univ, Inst Immunol & Infect Dis, Perth, WA, Australia; [Castley, Alison; French, Martyn; Krueger, Romano; Nolan, David] Royal Perth Hosp, Dept Clin Immunol, Perth, WA 6001, Australia; [French, Martyn; Fernandez, Sonia] Univ Western Australia, Sch Pathol & Lab Med, Perth, WA 6009, Australia	Murdoch University; Murdoch University; Royal Perth Hospital; University of Western Australia; University of Western Australia	Nolan, D (corresponding author), Murdoch Univ, Inst Immunol & Infect Dis, Perth, WA, Australia.	d.nolan@murdoch.edu.au	Fernandez, Sonia/H-9176-2014; Berry, Cassandra/AAX-7145-2020	Fernandez, Sonia/0000-0001-8753-466X; French, Martyn/0000-0002-4644-1982; Berry, Cassandra/0000-0003-0768-0857	Practitioner Research Fellowship; department of Clinical Immunology, Royal Perth Hospital	Practitioner Research Fellowship; department of Clinical Immunology, Royal Perth Hospital	This investigation was funded with support from a Practitioner Research Fellowship awarded to Dr. David Nolan provided by the Royal Perth Hospital Medical Research Foundation. The flow cytometry component was also funded by the department of Clinical Immunology, Royal Perth Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancuta P, 2003, J EXP MED, V197, P1701, DOI 10.1084/jem.20022156; Ancuta P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-403; Burdo TH, 2011, J INFECT DIS, V204, P154, DOI 10.1093/infdis/jir214; Chevalier MF, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003453; Romero-Sanchez MC, 2012, ANTIMICROB AGENTS CH, V56, P5858, DOI 10.1128/AAC.01406-12; Ellery PJ, 2007, J IMMUNOL, V178, P6581, DOI 10.4049/jimmunol.178.10.6581; Fischer-Smith T, 2008, AIDS RES HUM RETROV, V24, P417, DOI 10.1089/aid.2007.0193; Funderburg NT, 2014, CLIN INFECT DIS, V58, P588, DOI 10.1093/cid/cit748; Funderburg NT, 2012, BLOOD, V120, P4599, DOI 10.1182/blood-2012-05-433946; Gale HB, 2013, CLIN INFECT DIS, V56, P1340, DOI 10.1093/cid/cit004; Hattab S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-122; Holl V, 2004, J IMMUNOL, V173, P6274, DOI 10.4049/jimmunol.173.10.6274; Jude C, 2013, SOLUBLE CD163 SERUM; Justice AC, 2012, CLIN INFECT DIS, V54, P984, DOI 10.1093/cid/cir989; Kamat A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030881; Kasang C, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-14; Lake J, 2014, HIV MED IN PRESS FEB; Lawrence P, 2012, AIDS, V26, P785, DOI 10.1097/QAD.0b013e328351426e; Li Y, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3017; Liovat AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046143; Mendez-Lagares G, 2013, J INFECT DIS, V207, P1221, DOI 10.1093/infdis/jit025; Merlini E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046073; Parihar A, 2010, J INNATE IMMUN, V2, P204, DOI 10.1159/000296507; Reiner AP, 2013, ARTERIOSCL THROM VAS, V33, P158, DOI 10.1161/ATVBAHA.112.300421; Rogacev KS, 2012, J AM COLL CARDIOL, V60, P1512, DOI 10.1016/j.jacc.2012.07.019; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; Sax PE, 2013, CLIN INFECT DIS, V56, P1344, DOI 10.1093/cid/cit008; Sereti I, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003890; Simmons RP, 2013, AIDS, V27, P2505, DOI 10.1097/01.aids.0000432455.06476.bc; Subramanian S, 2012, JAMA-J AM MED ASSOC, V308, P379, DOI 10.1001/jama.2012.6698; Tippett E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019968; Ulrich C, 2010, NEPHROL DIAL TRANSPL, V25, P2265, DOI 10.1093/ndt/gfq012; Williams DW, 2012, J LEUKOCYTE BIOL, V91, P401, DOI 10.1189/jlb.0811394; Zawada AM, 2011, BLOOD, V118, pE50, DOI 10.1182/blood-2011-01-326827	34	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115226	10.1371/journal.pone.0115226	http://dx.doi.org/10.1371/journal.pone.0115226			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25544986	Green Submitted, Green Published, gold			2022-12-27	WOS:000347120200026
J	Gonzalez-del Pozo, M; Mendez-Vidal, C; Bravo-Gil, N; Vela-Boza, A; Dopazo, J; Borrego, S; Antinolo, G				Gonzalez-del Pozo, Maria; Mendez-Vidal, Cristina; Bravo-Gil, Nereida; Vela-Boza, Alicia; Dopazo, Joaquin; Borrego, Salud; Antinolo, Guillermo			Exome Sequencing Reveals Novel and Recurrent Mutations with Clinical Significance in Inherited Retinal Dystrophies	PLOS ONE			English	Article							DOMINANT RETINITIS-PIGMENTOSA; CASSETTE TRANSPORTER GENE; SPLICE-SITE; SPANISH PATIENTS; RHODOPSIN GENE; ABCR; POPULATION; DISEASE; SERVER	This study aimed to identify the underlying molecular genetic cause in four Spanish families clinically diagnosed of Retinitis Pigmentosa (RP), comprising one autosomal dominant RP (adRP), two autosomal recessive RP (arRP) and one with two possible modes of inheritance: arRP or X-Linked RP (XLRP). We performed whole exome sequencing (WES) using NimbleGen SeqCap EZ Exome V3 sample preparation kit and SOLID 5500xl platform. All variants passing filter criteria were validated by Sanger sequencing to confirm familial segregation and the absence in local control population. This strategy allowed the detection of: (i) one novel heterozygous splice-site deletion in RHO, c. 937-2_ 944del, (ii) one rare homozygous mutation in C2orf71, c. 1795T>C; p. Cys599Arg, not previously associated with the disease, (iii) two heterozygous null mutations in ABCA4, c. 2041C>T; p. R681* and c. 6088C>T; p. R2030*, and (iv) one mutation, c. 2405-2406delAG; p. Glu802Glyfs* 31 in the ORF15 of RPGR. The molecular findings for RHO and C2orf71 confirmed the initial diagnosis of adRP and arRP, respectively, while patients with the two ABCA4 mutations, both previously associated with Stargardt disease, presented symptoms of RP with early macular involvement. Finally, the X-Linked inheritance was confirmed for the family with the RPGR mutation. This latter finding allowed the inclusion of carrier sisters in our preimplantational genetic diagnosis program.	[Gonzalez-del Pozo, Maria; Mendez-Vidal, Cristina; Bravo-Gil, Nereida; Borrego, Salud; Antinolo, Guillermo] Univ Seville, CSIC, Univ Hosp Virgen del Rocio, Inst Biomed Seville,Dept Genet Reprod & Fetal Med, Seville, Spain; [Gonzalez-del Pozo, Maria; Mendez-Vidal, Cristina; Bravo-Gil, Nereida; Borrego, Salud; Antinolo, Guillermo] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Seville, Spain; [Vela-Boza, Alicia; Dopazo, Joaquin; Antinolo, Guillermo] Genom & Bioinformat Platform Andalusia, Seville, Spain; [Dopazo, Joaquin] Prince Felipe Res Ctr CIPF, Dept Bioinformat, Valencia, Spain; [Dopazo, Joaquin] Prince Felipe Res Ctr CIPF, Funct Genom Node INB, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Prince Felipe Research Center; Prince Felipe Research Center	Antinolo, G (corresponding author), Univ Seville, CSIC, Univ Hosp Virgen del Rocio, Inst Biomed Seville,Dept Genet Reprod & Fetal Med, Seville, Spain.	guillermo.antinolo.sspa@juntadeandalucia.es	IBIS, REPRODUCCION/P-3399-2015; Borrego, Salud/M-6314-2015; Méndez-Vidal, Cristina/F-1366-2015; Gil, Nereida Bravo/C-3954-2015; Dopazo, Joaquin/A-9270-2014; González-del Pozo, María/N-1742-2015; IBIS, GENETICA/P-3384-2015	Méndez-Vidal, Cristina/0000-0002-1282-1688; Gil, Nereida Bravo/0000-0002-2086-0468; Dopazo, Joaquin/0000-0003-3318-120X; González-del Pozo, María/0000-0003-4858-938X; Antinolo Gil, Guillermo/0000-0002-2113-074X	Instituto de Salud Carlos III (ISCIII); Spanish Ministry of Economy and Competitiveness, Spain [PI1102923, CDTIFEDER-Innterconecta EXP00052887/ITC-20111037, BIO2011-27069]; Regional Ministry of Economy, Innovation, Science and Employment of the Autonomous Government of Andalusia [CTS-03687]; Foundation Ramon Areces [CIVP16A1856]; CIBERER is an initiative of the ISCIII, Spanish Ministry of Economy and Competitiveness; ISCIII [FI12/00545]	Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); Spanish Ministry of Economy and Competitiveness, Spain; Regional Ministry of Economy, Innovation, Science and Employment of the Autonomous Government of Andalusia; Foundation Ramon Areces; CIBERER is an initiative of the ISCIII, Spanish Ministry of Economy and Competitiveness; ISCIII(Instituto de Salud Carlos III)	This work was supported by the Instituto de Salud Carlos III (ISCIII), Spanish Ministry of Economy and Competitiveness, Spain (PI1102923, CIBERER ACCI, CDTIFEDER-Innterconecta EXP00052887/ITC-20111037, and BIO2011-27069), Regional Ministry of Economy, Innovation, Science and Employment of the Autonomous Government of Andalusia (CTS-03687), and the Foundation Ramon Areces (CIVP16A1856). The CIBERER is an initiative of the ISCIII, Spanish Ministry of Economy and Competitiveness. NBG is supported by fellowship FI12/00545 from ISCIII. The funders had no role in study design, data	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; ALMAGHTHEH M, 1994, HUM MOL GENET, V3, P205, DOI 10.1093/hmg/3.1.205; Avila-Fernandez A, 2010, MOL VIS, V16, P2550; AYUSO C, 1995, CLIN GENET, V48, P120; Barragan I, 2010, HUM MUTAT, V31, pE1772, DOI 10.1002/humu.21334; BELL C, 1994, BRIT J OPHTHALMOL, V78, P933, DOI 10.1136/bjo.78.12.933; Daiger SP, 2013, CLIN GENET, V84, P132, DOI 10.1111/cge.12203; Daiger SP, 2007, ARCH OPHTHALMOL-CHIC, V125, P151, DOI 10.1001/archopht.125.2.151; den Hollander AI, 2010, J CLIN INVEST, V120, P3042, DOI 10.1172/JCI42258; Ferre F, 2005, NUCLEIC ACIDS RES, V33, pW230, DOI 10.1093/nar/gki412; Pozo MGD, 2014, MOL GENET GENOM MED, V2, P124, DOI 10.1002/mgg3.50; Gonzalez-del Pozo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027894; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; HUMPHRIES P, 1990, CLIN GENET, V38, P1; Jinda W, 2014, INVEST OPHTH VIS SCI, V55, P2259, DOI 10.1167/iovs.13-13567; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lewis RA, 1999, AM J HUM GENET, V64, P422, DOI 10.1086/302251; Maugeri A, 1999, AM J HUM GENET, V64, P1024, DOI 10.1086/302323; Mendez-Vidal C, 2013, MOL VIS, V19, P2187; Neveling Kornelia, 2013, Methods Mol Biol, V935, P3, DOI 10.1007/978-1-62703-080-9_1; Nishiguchi KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041902; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Reese MG, 1997, SPLICE SITE PREDICTI; Reig C, 1996, HUM MUTAT, V8, P93, DOI 10.1002/(SICI)1098-1004(1996)8:1<93::AID-HUMU17>3.0.CO;2-M; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Shroyer NF, 1999, VISION RES, V39, P2537, DOI 10.1016/S0042-6989(99)00037-1; Venselaar H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-548; Vervoort R, 2000, NAT GENET, V25, P462, DOI 10.1038/78182; WEISS ER, 1994, BIOCHEMISTRY-US, V33, P7587, DOI 10.1021/bi00190a011; Whitehead JL, 1998, HUM MUTAT, pS295; Wildeman M, 2008, HUM MUTAT, V29, P6, DOI 10.1002/humu.20654; Xu Y, 2014, HUM GENET, V133, P1255, DOI 10.1007/s00439-014-1460-2	32	12	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e0116176	10.1371/journal.pone.0116176	http://dx.doi.org/10.1371/journal.pone.0116176			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25544989	Green Submitted, Green Published, gold			2022-12-27	WOS:000347120200105
J	Tam, J; Cordier, GA; Balint, S; Alvarez, AS; Borbely, JS; Lakadamyali, M				Tam, Johnny; Alan Cordier, Guillaume; Balint, Stefan; Sandoval Alvarez, Angel; Steven Borbely, Joseph; Lakadamyali, Melike			A Microfluidic Platform for Correlative Live-Cell and Super-Resolution Microscopy	PLOS ONE			English	Article							MITOCHONDRIAL DYNAMICS; LOCALIZATION MICROSCOPY; REVEALS; SYSTEMS; STORM; ORGANELLES; RESOLUTION; MOVEMENT; GRADIENT; DISEASE	Recently, super-resolution microscopy methods such as stochastic optical reconstruction microscopy (STORM) have enabled visualization of subcellular structures below the optical resolution limit. Due to the poor temporal resolution, however, these methods have mostly been used to image fixed cells or dynamic processes that evolve on slow time-scales. In particular, fast dynamic processes and their relationship to the underlying ultrastructure or nanoscale protein organization cannot be discerned. To overcome this limitation, we have recently developed a correlative and sequential imaging method that combines live-cell and super-resolution microscopy. This approach adds dynamic background to ultrastructural images providing a new dimension to the interpretation of super-resolution data. However, currently, it suffers from the need to carry out tedious steps of sample preparation manually. To alleviate this problem, we implemented a simple and versatile microfluidic platform that streamlines the sample preparation steps in between live-cell and super-resolution imaging. The platform is based on a microfluidic chip with parallel, miniaturized imaging chambers and an automated fluid-injection device, which delivers a precise amount of a specified reagent to the selected imaging chamber at a specific time within the experiment. We demonstrate that this system can be used for live-cell imaging, automated fixation, and immunostaining of adherent mammalian cells in situ followed by STORM imaging. We further demonstrate an application by correlating mitochondrial dynamics, morphology, and nanoscale mitochondrial protein distribution in live and super-resolution images.	[Tam, Johnny; Alan Cordier, Guillaume; Balint, Stefan; Sandoval Alvarez, Angel; Steven Borbely, Joseph; Lakadamyali, Melike] ICFO Inst Ciencies Foton ICFO, Castelledefels 08860, Barcelona, Spain	Barcelona Institute of Science & Technology; Universitat Politecnica de Catalunya; Institut de Ciencies Fotoniques (ICFO)	Lakadamyali, M (corresponding author), ICFO Inst Ciencies Foton ICFO, Castelledefels 08860, Barcelona, Spain.	melike.lakadamyali@icfo.es	Tam, Johnny/AHD-6065-2022	Tam, Johnny/0000-0003-2300-0567; Borbely, Joseph/0000-0001-8618-1145	Fundacio CELLEX Barcelona; Systems Microscopy Network of Excellence consortium [FP-7-HEALTH.2010.2.1.2.2]; ERC-Starting grant [337191-MOTORS]; Plan Nacional Grant from the Spanish Ministry (Ministerio de Economia y Competitividad) [FIS2012-37753]; Whitaker International Fellows and Scholars Program	Fundacio CELLEX Barcelona(Foundation CELLEXEuropean Commission); Systems Microscopy Network of Excellence consortium; ERC-Starting grant(European Research Council (ERC)); Plan Nacional Grant from the Spanish Ministry (Ministerio de Economia y Competitividad); Whitaker International Fellows and Scholars Program	This project was financially supported by Fundacio CELLEX Barcelona, by the Systems Microscopy Network of Excellence consortium (call identifier number FP-7-HEALTH.2010.2.1.2.2) and by ERC-Starting grant (grant agreement number 337191-MOTORS) and the Plan Nacional Grant from the Spanish Ministry (Ministerio de Economia y Competitividad FIS2012-37753) to M.L. J.T was supported by the Whitaker International Fellows and Scholars Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balint S, 2013, P NATL ACAD SCI USA, V110, P3375, DOI 10.1073/pnas.1219206110; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Berthier E, 2012, LAB CHIP, V12, P1224, DOI 10.1039/c2lc20982a; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Cattoni DI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076268; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Cheong R, 2009, MOL CELL PROTEOMICS, V8, P433, DOI 10.1074/mcp.M800291-MCP200; Collins TJ, 2002, EMBO J, V21, P1616, DOI 10.1093/emboj/21.7.1616; Conrad C, 2011, NAT METHODS, V8, P246, DOI [10.1038/nmeth.1558, 10.1038/NMETH.1558]; Conrad C, 2010, J CELL BIOL, V188, P453, DOI 10.1083/jcb.200910105; Dempsey GT, 2011, NAT METHODS, V8, P1027, DOI [10.1038/NMETH.1768, 10.1038/nmeth.1768]; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Fahraeus R, 1931, AM J PHYSIOL, V96, P562, DOI 10.1152/ajplegacy.1931.96.3.562; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Huang B, 2008, NAT METHODS, V5, P1047, DOI 10.1038/nmeth.1274; Jans DC, 2013, P NATL ACAD SCI USA, V110, P8936, DOI 10.1073/pnas.1301820110; Jeon NL, 2000, LANGMUIR, V16, P8311, DOI 10.1021/la000600b; Jones SA, 2011, NAT METHODS, V8, P499, DOI [10.1038/NMETH.1605, 10.1038/nmeth.1605]; Lakadamyali M., 2013, CHEMPHYSCHEM; Lakadamyali M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030826; Lock JG, 2010, EXP CELL RES, V316, P1438, DOI 10.1016/j.yexcr.2010.04.001; Lovas JR, 2013, BBA-MOL CELL RES, V1833, P184, DOI 10.1016/j.bbamcr.2012.04.007; Mao HB, 2002, J AM CHEM SOC, V124, P4432, DOI 10.1021/ja017625x; Mitra Kasturi, 2010, Curr Protoc Cell Biol, VChapter 4, DOI 10.1002/0471143030.cb0425s46; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Nikic I, 2011, NAT MED, V17, P495, DOI 10.1038/nm.2324; Plucinska G, 2012, J NEUROSCI, V32, P16203, DOI 10.1523/JNEUROSCI.1327-12.2012; Ruhnow F, 2011, BIOPHYS J, V100, P2820, DOI 10.1016/j.bpj.2011.04.023; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Shim SH, 2012, P NATL ACAD SCI USA, V109, P13978, DOI 10.1073/pnas.1201882109; Shroff H, 2008, NAT METHODS, V5, P417, DOI [10.1038/nmeth.1202, 10.1038/NMETH.1202]; Tam J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101772; Toepke MW, 2006, LAB CHIP, V6, P1484, DOI 10.1039/b612140c; Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113; Weibel DB, 2006, CURR OPIN CHEM BIOL, V10, P584, DOI 10.1016/j.cbpa.2006.10.016; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; Wurm CA, 2011, P NATL ACAD SCI USA, V108, P13546, DOI 10.1073/pnas.1107553108; Xu K, 2013, SCIENCE, V339, P452, DOI 10.1126/science.1232251; Young EWK, 2010, CHEM SOC REV, V39, P1036, DOI 10.1039/b909900j; Zhu L, 2012, NAT METHODS, V9, P721, DOI [10.1038/NMETH.1978, 10.1038/nmeth.1978]	41	27	27	4	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115512	10.1371/journal.pone.0115512	http://dx.doi.org/10.1371/journal.pone.0115512			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545548	Green Published, Green Submitted, gold			2022-12-27	WOS:000347120200046
J	Al-Sobhi, MM; Hussain, Z; Al-Zahrani, B				Al-Sobhi, Mashail M.; Hussain, Zawar; Al-Zahrani, Bander			General Randomized Response Techniques Using Polya's Urn Process as a Randomization Device	PLOS ONE			English	Article							MODEL; EPIDEMICS; CARRIERS; SPREAD	In this paper, interesting improvements in [1] and [2] randomized response techniques have been proposed. The proposed randomized response technique applies Polya's urn process (see [3]) to obtain data from respondents. One of the suggested technique requires reporting the number of draws to observe a fixed number of cards of certain type. On the contrary, the number of cards of a certain type is to be reported in case of second proposed randomized response model. Based on the information collected through the suggested techniques, two different unbiased estimators of proportion of a sensitive attribute have been suggested. A detailed comparative simulation study has also been done. The results are also supported by means of a small scale survey.	[Al-Sobhi, Mashail M.] Umm Alqura Univ, Dept Math, Mecca 21421, Saudi Arabia; [Hussain, Zawar] Quaid I Azam Univ, Dept Stat, Islamabad 45320, Pakistan; [Al-Zahrani, Bander] King Abdulaziz Univ, Dept Stat, Jeddah 80203, Saudi Arabia	Umm Al Qura University; Quaid I Azam University; King Abdulaziz University	Hussain, Z (corresponding author), Quaid I Azam Univ, Dept Stat, Islamabad 45320, Pakistan.	zhlangah@yahoo.com	Hussain, Zawar/I-1616-2012		Institute of Scientific Research and Revival of Islamic Heritage at Umm Alqura University [43305030]	Institute of Scientific Research and Revival of Islamic Heritage at Umm Alqura University	Funding: The work has been funded by the Institute of Scientific Research and Revival of Islamic Heritage at Umm Alqura University (grant#43305030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang HJ, 2001, METRIKA, V53, P269, DOI 10.1007/s001840100109; Christofides TC, 2003, METRIKA, V57, P195, DOI 10.1007/s001840200216; DIETZ K, 1966, J APPL PROBAB, V3, P375, DOI 10.2307/3212126; Faucounau J, 1975, MATH SCI HUMAINES, V52, P55; FOLSOM RE, 1973, J AM STAT ASSOC, V68, P525, DOI 10.2307/2284771; Gi-Sung Lee K-HH, 2012, J KOREAN DATA ANAL S, V15, P1755; Gjestvang CR, 2006, J R STAT SOC B, V68, P523, DOI 10.1111/j.1467-9868.2006.00554.x; GREENBERG BG, 1969, J AM STAT ASSOC, V64, P520, DOI 10.2307/2283636; Grewal, 2013, INT J CONT MATH SCI, V8, DOI [10.12988/ijcms.2013.13025, DOI 10.12988/ijcms.2013.13025]; Guerriero M, 2007, J STAT PLAN INFER, V137, P2184, DOI 10.1016/j.jspi.2006.07.004; Horvitz DG, 1967, P SOC STAT SECT AM S, P65; Johnson N.L., 1977, URN MODELS THEIR APP; Kim J., 1978, GROUP, V1, P351; KRYSCIO RJ, 1974, BIOMETRIKA, V61, P200, DOI 10.1093/biomet/61.1.200; KUK AYC, 1990, BIOMETRIKA, V77, P436, DOI 10.2307/2336828; LIU PT, 1976, J AM STAT ASSOC, V71, P72, DOI 10.2307/2285733; Mahmoud H., 2008, POLYA URN MODELS; MANGAT NS, 1990, BIOMETRIKA, V77, P439, DOI 10.2307/2336829; MANGAT NS, 1994, J ROY STAT SOC B MET, V56, P93; MOORS JJA, 1971, J AM STAT ASSOC, V66, P627, DOI 10.2307/2283543; Odumade O, 2009, COMMUN STAT-SIMUL C, V38, P473, DOI 10.1080/03610910802536736; Perri P. F, 2008, MODEL ASSISTED STAT, V3, P233, DOI DOI 10.3233/MAS-2008-3307; Rosenberger W. F., 2002, SEQUENTIAL ANAL, V21, P1; Singh S, 2013, METRON, V71, P3, DOI 10.1007/s40300-013-0002-3; WARNER SL, 1965, J AM STAT ASSOC, V60, P63, DOI 10.2307/2283137; WEISS GEORGE H., 1965, BIOMETRICS, V21, P481, DOI 10.2307/2528105	26	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115612	10.1371/journal.pone.0115612	http://dx.doi.org/10.1371/journal.pone.0115612			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541936	gold, Green Published, Green Submitted			2022-12-27	WOS:000347239900059
J	Cao, C; Ding, QL; Lv, D; Dong, Z; Sun, SF; Chen, ZB; Shen, HH; Deng, ZC				Cao, Chao; Ding, Qunli; Lv, Dan; Dong, Zhe; Sun, Shifang; Chen, Zhongbo; Shen, Huahao; Deng, Zaichun			Vascular Endothelial Growth Factor Genotypes and Haplotypes Contribute to the Susceptibility of Obstructive Sleep Apnea Syndrome	PLOS ONE			English	Article							FACTOR GENE; GASTRIC-CANCER; VEGF GENE; POLYMORPHISM; HYPOXIA; RISK; ASSOCIATION; POPULATION; INFLAMMATION; EXPRESSION	Background: To investigate whether VEGF polymorphisms (-460T/C, +405G/C, and +936C/T)/haplotypes influence the susceptibility of obstructive sleep apnea (OSA). Method: A prospective case-control study was conducted to evaluate the genetic effects of VEGF polymorphisms on the development of OSA. 150 patients and 225 healthy controls were recruited for this study and their genotypes were determined by polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP). The odds ratios (OR) and 95% confidence intervals (CI) were calculated by logistic regression analysis. Result: Our study showed that the -460C allele (C vs. T: OR=1.95, 95% CI=1.38-2.76) and +936T allele (T vs. C: OR=1.48, 95% CI=1.02-2.15) were associated with an increased OSA risk, whereas +405C allele was associated with a decreased susceptibility to OSA (C vs. G: OR=0.61, 95% CI=0.45-0.83). Compared with the most common haplotype CCT, CGC (OR=2.22, 95% CI=1.19-4.13) and TGC (OR=3.83, 95% CI=1.56-9.40) were associated with a significantly increased risk of OSA. Conclusion: These observations implied that VEGF gene polymorphisms might be associated with the susceptibility to OSA. These results need to be validated by other independent studies, especially in diverse ethnic populations.	[Cao, Chao; Ding, Qunli; Lv, Dan; Sun, Shifang; Chen, Zhongbo; Deng, Zaichun] Ningbo Univ, Affiliated Hosp, Sch Med, Dept Resp Med, Ningbo 315020, Zhejiang, Peoples R China; [Cao, Chao; Lv, Dan; Shen, Huahao] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Resp & Crit Care Med, Hangzhou 310009, Zhejiang, Peoples R China; [Dong, Zhe] Zhejiang Univ, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China	Ningbo University; Zhejiang University; Zhejiang University	Deng, ZC (corresponding author), Ningbo Univ, Affiliated Hosp, Sch Med, Dept Resp Med, Ningbo 315020, Zhejiang, Peoples R China.	dengzaichun982136@hotmail.com			grant of Natural Science Foundation of Ningbo [2012A610257]	grant of Natural Science Foundation of Ningbo	This work was supported by grant of Natural Science Foundation of Ningbo (No. 2012A610257, Z Deng). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara K, 2013, SLEEP BREATH, V17, P597, DOI 10.1007/s11325-012-0726-y; Awata T, 2002, DIABETES, V51, P1635, DOI 10.2337/diabetes.51.5.1635; Bhushan B, 2009, RESP MED, V103, P386, DOI 10.1016/j.rmed.2008.10.001; Buck D, 2010, SLEEP MED, V11, P213, DOI 10.1016/j.sleep.2009.06.009; Cao C, 2010, ARCH MED RES, V41, P548, DOI 10.1016/j.arcmed.2010.09.006; Chae YS, 2006, ONCOLOGY-BASEL, V71, P266, DOI 10.1159/000106788; Chen WH, 2012, AM J OTOLARYNG, V33, P31, DOI 10.1016/j.amjoto.2010.12.005; Ciftci TU, 2011, ANN SAUDI MED, V31, P14, DOI 10.4103/0256-4947.75772; Ding Q, 2014, SLEEP BREAT IN PRESS; Garvey JF, 2009, EUR RESPIR J, V33, P1195, DOI 10.1183/09031936.00111208; Gozal D, 2002, SLEEP, V25, P59, DOI 10.1093/sleep/25.1.59; Kaczmarek E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070559; Kataoka N, 2006, CANCER EPIDEM BIOMAR, V15, P1148, DOI 10.1158/1055-9965.EPI-05-0871; Ke Q, 2008, MOL CARCINOGEN, V47, P647, DOI 10.1002/mc.20435; Koyama RG, 2009, SLEEP MED, V10, P1107, DOI 10.1016/j.sleep.2008.12.012; LIU YX, 1995, CIRC RES, V77, P638, DOI 10.1161/01.RES.77.3.638; Ma J, 2007, J HUAZHONG U SCI-MED, V27, P157, DOI 10.1007/s11596-007-0212-0; Mishra HK, 2013, SLEEP BREATH, V17, P1029, DOI 10.1007/s11325-012-0795-y; Ogus C, 2010, BIOCHEM GENET, V48, P516, DOI 10.1007/s10528-010-9335-2; Papaioannou AI, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-128; Peled N, 2007, RESPIRATION, V74, P50, DOI 10.1159/000095675; Renner W, 2000, J VASC RES, V37, P443, DOI 10.1159/000054076; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Stevens A, 2003, CANCER RES, V63, P812; Sun SF, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0410-x; Takahashi S, 2005, RESP MED, V99, P1125, DOI 10.1016/j.rmed.2005.02.027; Teramoto S, 2003, INTERNAL MED, V42, P681, DOI 10.2169/internalmedicine.42.681; Vincenti V, 1996, CIRCULATION, V93, P1493, DOI 10.1161/01.CIR.93.8.1493; Yamazaki Y, 2006, MOL DIVERS, V10, P515, DOI 10.1007/s11030-006-9027-3	30	4	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e114582	10.1371/journal.pone.0114582	http://dx.doi.org/10.1371/journal.pone.0114582			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541696	Green Published, Green Submitted, gold			2022-12-27	WOS:000347239900013
J	Schry, AR; Norberg, MM; Maddox, BB; White, SW				Schry, Amie R.; Norberg, Melissa M.; Maddox, Brenna B.; White, Susan W.			Gender Matters: The Relationship between Social Anxiety and Alcohol-Related Consequences	PLOS ONE			English	Article							COLLEGE-STUDENTS; UNIVERSITY-STUDENTS; DRINKING BEHAVIOR; PHOBIA; DISORDERS	Background and Objectives: Identification of risk factors for alcohol-related consequences is an important public health concern. Both gender and social anxiety have been associated with alcohol-related consequences broadly, but it is unknown whether these variables are differentially related to specific types of alcohol-related consequences for American college students. Methods: In the present study, 573 undergraduate students (M-age=19.86 years, SD=1.40; range 18 to 25; 68.9% female) completed an on-line assessment of social anxiety, alcohol use, and four types of alcohol-related consequences (personal, social, physical, and role). Poisson regressions were run to examine social anxiety, gender, and the interaction between social anxiety and gender as predictors of each type of alcohol-related consequences. Results: After controlling for alcohol use, social anxiety was positively associated with all four types of consequences, and females endorsed higher rates of physical, personal, and role consequences. The interaction between social anxiety and gender was statistically significant only for physical consequences, with social anxiety having a stronger effect for males. Discussion and Conclusions: These findings, which diverge somewhat from those of a prior study with Australian college students, are discussed in the context of a biopsychosocial model of social anxiety and substance use problems.	[Schry, Amie R.; Maddox, Brenna B.; White, Susan W.] Virginia Tech, Dept Psychol, Blacksburg, VA USA; [Norberg, Melissa M.] Macquarie Univ, Dept Psychol, Sydney, NSW 2109, Australia	Virginia Polytechnic Institute & State University; Macquarie University	Schry, AR (corresponding author), Vet Affairs Mid Atlantic Mental Illness Res, Educ & Clin Ctr, Durham, NC 27705 USA.	amie.schry@va.gov	; Norberg, Melissa/H-8365-2014	White, Susan/0000-0002-6274-3147; Norberg, Melissa/0000-0001-7840-9007	Department of Veterans Affairs Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and Treatment; Durham Veterans Affairs Medical Center; Department of Veterans Affairs Mid-Atlantic Region Mental Illness Research, Education, and Clinical Center (MIRECC)	Department of Veterans Affairs Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and Treatment(US Department of Veterans Affairs); Durham Veterans Affairs Medical Center; Department of Veterans Affairs Mid-Atlantic Region Mental Illness Research, Education, and Clinical Center (MIRECC)	Funding: Amie Schry's contributions to this manuscript were partially supported by the Department of Veterans Affairs Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and Treatment, the Durham Veterans Affairs Medical Center, and the Department of Veterans Affairs Mid-Atlantic Region Mental Illness Research, Education, and Clinical Center (MIRECC).	American Psychiatric Association (APA), 2013, DIAGN STAT MAN MENT; Buckner JD, 2013, DEPRESS ANXIETY, V30, P276, DOI 10.1002/da.22032; Buckner JD, 2011, J ANXIETY DISORD, V25, P631, DOI 10.1016/j.janxdis.2011.02.003; Buckner JD, 2010, PSYCHOL ADDICT BEHAV, V24, P640, DOI 10.1037/a0020968; Hallett J, 2013, HEALTH PROMOT J AUST, V24, P170, DOI 10.1071/HE13094; Ham LS, 2003, CLIN PSYCHOL REV, V23, P719, DOI 10.1016/S0272-7358(03)00071-0; HEIMBERG RG, 1992, BEHAV THER, V23, P53, DOI 10.1016/S0005-7894(05)80308-9; Hingson R, 2014, J STUD ALCOHOL DRUGS, V75, P158, DOI 10.15288/jsad.2014.75.158; Holmila M, 2005, ADDICTION, V100, P1763, DOI 10.1111/j.1360-0443.2005.01249.x; International Center for Alcohol Policies, 2013, MIN AG LIM WORLDW; KUSHNER MG, 1993, ADDICT BEHAV, V18, P543, DOI 10.1016/0306-4603(93)90070-P; Mattick RP, 1998, BEHAV RES THER, V36, P455, DOI 10.1016/S0005-7967(97)10031-6; McBride O, 2009, DRUG ALCOHOL DEPEN, V100, P258, DOI 10.1016/j.drugalcdep.2008.10.011; Norberg MM, 2011, ADDICT BEHAV, V36, P821, DOI 10.1016/j.addbeh.2011.03.010; Norberg MM, 2009, PSYCHOL ADDICT BEHAV, V23, P586, DOI 10.1037/a0016994; Osman A, 1998, J PSYCHOPATHOL BEHAV, V20, P249, DOI 10.1023/A:1023067302227; Park CL, 2005, ADDICT BEHAV, V30, P755, DOI 10.1016/j.addbeh.2004.08.021; Pemberton MR, 2008, UNDERAGE ALCOHOL USE; Perkins HW, 2002, J STUDIES ALCOHOL, V14; Roche AM, 1999, DRUG ALCOHOL REV, V18, P389; Schry AR, 2013, ADDICT BEHAV, V38, P2690, DOI 10.1016/j.addbeh.2013.06.014; Schry AR, 2013, J STUD ALCOHOL DRUGS, V74, P803, DOI 10.15288/jsad.2013.74.803; Slutske WS, 2005, ARCH GEN PSYCHIAT, V62, P321, DOI 10.1001/archpsyc.62.3.321; SUWAKI H, 1985, J STUD ALCOHOL, V46, P196, DOI 10.15288/jsa.1985.46.196; Vik PW, 2000, PSYCHOL ADDICT BEHAV, V14, P91, DOI 10.1037/0893-164X.14.2.91; Virginia Tech, 2013, 2012 2013 ON CAMPUS; Wechsler H, 2002, J AM COLL HEALTH, V50, P223, DOI 10.1080/07448480209595714	27	3	3	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115361	10.1371/journal.pone.0115361	http://dx.doi.org/10.1371/journal.pone.0115361			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX9RO	25541722	Green Published, Green Submitted, gold			2022-12-27	WOS:000347239900037
J	Fu, Q; Vaughn, MG; Wu, LT; Heath, AC				Fu, Qiang; Vaughn, Michael G.; Wu, Li-Tzy; Heath, Andrew C.			Psychiatric Correlates of Snuff and Chewing Tobacco Use	PLOS ONE			English	Article							NATIONAL EPIDEMIOLOGIC SURVEY; ALCOHOL-USE DISORDER; INTERVIEW SCHEDULE AUDADIS; SMOKELESS TOBACCO; NICOTINE DEPENDENCE; ABUSE DIAGNOSES; UNITED-STATES; COOCCURRENCE; RELIABILITY; VALIDITY	Compared to the association between cigarette smoking and psychiatric disorders, relatively little is known about the relationship between smokeless tobacco use and psychiatric disorders. To identify the psychiatric correlates of smokeless tobacco use, the analysis used a national representative sample from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) wave 1. Smokeless tobacco use was classified as exclusive snuff use, exclusive chewing tobacco, and dual use of both snuff and chewing tobacco at some time in the smokeless tobacco user's life. Lifetime psychiatric disorders were obtained via structured diagnostic interviews. The results show that the prevalence of lifetime exclusive snuff use, exclusive chewing tobacco, and dual use of both snuff and chewing tobacco was 2.16%, 2.52%, and 2.79%, respectively. After controlling for sociodemographic variables and cigarette smoking, the odds of exclusive chewing tobacco in persons with panic disorder and specific phobia were 1.53 and 1.41 times the odds in persons without those disorders, respectively. The odds of exclusive snuff use, exclusive chewing tobacco, and dual use of both products for individuals with alcohol use disorder were 1.97, 2.01, and 2.99 times the odds for those without alcohol use disorder, respectively. Respondents with cannabis use disorder were 1.44 times more likely to use snuff exclusively than those without cannabis use disorder. Respondents with inhalant/solvent use disorder were associated with 3.33 times the odds of exclusive chewing tobacco. In conclusion, this study highlights the specific links of anxiety disorder, alcohol, cannabis, and inhalant/solvent use disorders with different types of smokeless tobacco use.	[Fu, Qiang] St Louis Univ, Coll Publ Hlth & Social Just, Dept Biostat, St Louis, MO 63103 USA; [Vaughn, Michael G.] St Louis Univ, Coll Publ Hlth & Social Just, Sch Social Work, St Louis, MO 63103 USA; [Wu, Li-Tzy] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA; [Heath, Andrew C.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA	Saint Louis University; Saint Louis University; Duke University; Washington University (WUSTL)	Fu, Q (corresponding author), St Louis Univ, Coll Publ Hlth & Social Just, Dept Biostat, St Louis, MO 63103 USA.	qjfu@slu.edu	Vaughn, Michael/W-2694-2019; WU, LI-TZY/I-7481-2012	WU, LI-TZY/0000-0002-5909-2259	National Cancer Institute [K07CA104119]; National Institutes of Health [DA027503, DA019623, DA019901]; NATIONAL CANCER INSTITUTE [K07CA104119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019901, R21DA027503, R33DA027503, R01DA019623] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Qiang Fu was supported by National Cancer Institute grant (K07CA104119) and Li-Tzy Wu was supported by National Institutes of Health grants (DA027503, DA019623, and DA019901). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2009, DRUG ALCOHOL DEPEN, V99, P240, DOI 10.1016/j.drugalcdep.2008.08.007; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Berggren U, 2007, ALCOHOL ALCOHOLISM, V42, P267, DOI 10.1093/alcalc/agm031; Bhattacharyya N, 2012, LARYNGOSCOPE, V122, P2175, DOI 10.1002/lary.23448; Boffetta P, 2008, LANCET ONCOL, V9, P667, DOI 10.1016/S1470-2045(08)70173-6; Boffetta P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3060; Canino G, 1999, J STUD ALCOHOL, V60, P790, DOI 10.15288/jsa.1999.60.790; Goodwin RD, 2008, PSYCHOL MED, V38, P1277, DOI 10.1017/S0033291708003012; Grant BF, 2004, ARCH GEN PSYCHIAT, V61, P1107, DOI 10.1001/archpsyc.61.11.1107; Grant BF, 2003, DRUG ALCOHOL DEPEN, V71, P7, DOI 10.1016/S0376-8716(03)00070-X; Grant BF, 2004, ARCH GEN PSYCHIAT, V61, P807, DOI 10.1001/archpsyc.61.8.807; Grant BF, 2004, ARCH GEN PSYCHIAT, V61, P361, DOI 10.1001/archpsyc.61.4.361; GRANT BF, 1995, DRUG ALCOHOL DEPEN, V39, P37, DOI 10.1016/0376-8716(95)01134-K; Grant BF, 2003, SOURCE ACCURACY STAT; Hasin D, 1997, ALCOHOL CLIN EXP RES, V21, P213, DOI 10.1111/j.1530-0277.1997.tb03752.x; Hasin D, 1999, ALCOHOL CLIN EXP RES, V23, P144, DOI 10.1097/00000374-199901000-00021; Hasin DS, 2004, ARCH GEN PSYCHIAT, V61, P891, DOI 10.1001/archpsyc.61.9.891; HELANDER A, 1991, ALCOHOL CLIN EXP RES, V15, P1, DOI 10.1111/j.1530-0277.1991.tb00510.x; IARC, 2007, INT AG RES CANC SMOK; Lee PN, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-36; McClave A., 2010, Morbidity and Mortality Weekly Report, V59, P1400; Nelson DE, 2006, AM J PUBLIC HEALTH, V96, P897, DOI 10.2105/AJPH.2004.061580; *RES TRIANGL I, 2008, SUDAAN LANG MAN REL; Riley WT, 1996, ADDICT BEHAV, V21, P135, DOI 10.1016/0306-4603(95)00030-5; Roosaar A, 2008, INT J CANCER, V123, P168, DOI 10.1002/ijc.23469; ROUSE B A, 1989, NCI (National Cancer Institute) Monographs, P29; Sihvola E, 2008, ADDICTION, V103, P2045, DOI 10.1111/j.1360-0443.2008.02363.x	27	11	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e113196	10.1371/journal.pone.0113196	http://dx.doi.org/10.1371/journal.pone.0113196			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ9UY	25535739	Green Submitted, gold, Green Published			2022-12-27	WOS:000348563300005
J	Li, J; Zou, X; Wu, YL; Guo, JC; Yun, JP; Xu, M; Feng, QS; Chen, LZ; Bei, JX; Zeng, YX; Chen, MY				Li, Jing; Zou, Xiong; Wu, Yun-Long; Guo, Jing-Cui; Yun, Jing-Ping; Xu, Miao; Feng, Qi-Sheng; Chen, Li-Zhen; Bei, Jin-Xin; Zeng, Yi-Xin; Chen, Ming-Yuan			A Comparison between the Sixth and Seventh Editions of the UICC/AJCC Staging System for Nasopharyngeal Carcinoma in a Chinese Cohort	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; INTENSITY-MODULATED RADIOTHERAPY; PROGNOSTIC VALUE; RETROPHARYNGEAL LYMPHADENOPATHY; CANCER; SUGGESTIONS; INVOLVEMENT; EXTENSION	Background: The International Union Against Cancer/American Joint Committee on Cancer (UICC/AJCC) TNM staging system of nasopharyngeal carcinoma (NPC) is the most important system for survival prediction. The TNM 7th edition UICC/AJCC TNM staging system for NPC was adopted in January 2009, and is now internationally recommended. In comparison with the TNM 6th edition, there were several revisions in the new edition staging system. This study aims to evaluate the prognostic value of the TNM 7th edition for NPC patients in comparison with the TNM 6th edition. Method: Clinical data of 2,629 NPC patients from the Sun Yat-sen University Cancer Center between January 2006 and December 2010 were retrospectively collected and all the patients were restaged according to the criteria of the TNM 6th edition and TNM 7th edition UICC/AJCC staging manual. Univariate and multivariate COX proportional hazards analyses were applied to evaluate the prognostic values between adjacent stage categories of the TNM 6th edition and TNM 7th edition. Results: In comparison with the TNM 6th edition, a significant alteration of the distribution of N categories was observed when the TNM 7th edition was applied (x(2) = 20.589, P<0.001), with 119 (119/670, 17.8%) patients up-staging from No to N1. With regard to T and overall stage, 37 (37/561, 6.6%) patients were downstaged from T2a with the TNM 6th edition to T1 with the TNM 7th edition, and finally two patients were up-staged to overall stage II (2/118, 1.7%). Moreover, the survival curves were significantly segregated (P,0.05) between T1 and T2 as well as N1 and N2 with the TNM 7th edition. Conclusions: The TNM 7th edition led to a significant alteration in the distribution of N categories and it is superior to the TNM 6th edition in predicting the frequency of overall survival and distant metastasis-free survival.	[Li, Jing; Zou, Xiong; Wu, Yun-Long; Guo, Jing-Cui; Yun, Jing-Ping; Xu, Miao; Feng, Qi-Sheng; Chen, Li-Zhen; Bei, Jin-Xin; Zeng, Yi-Xin; Chen, Ming-Yuan] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou 510060, Guangdong, Peoples R China; [Li, Jing; Wu, Yun-Long; Guo, Jing-Cui; Xu, Miao; Feng, Qi-Sheng; Chen, Li-Zhen; Bei, Jin-Xin; Zeng, Yi-Xin] Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, Guangzhou 510060, Guangdong, Peoples R China; [Zou, Xiong; Chen, Ming-Yuan] Sun Yat Sen Univ, Ctr Canc, Dept Nasopharyngeal Carcinoma, Guangzhou 510060, Guangdong, Peoples R China; [Yun, Jing-Ping] Sun Yat Sen Univ, Ctr Canc, Dept Pathol, Guangzhou 510060, Guangdong, Peoples R China; [Li, Jing] Zhengzhou Univ, Affiliated Hosp 1, Dept Oncol, Zhengzhou 450052, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Zhengzhou University	Zeng, YX (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou 510060, Guangdong, Peoples R China.	zengyix@mail.sysu.edu.cn; chmingy@mail.sysu.edu.cn	Chen, Ming/GVU-8412-2022; Bei, Jin-Xin/AAO-1259-2020		Program for New Century Excellent Talents in University [NCET-12-0562]; Sun Yat-Sen University Clinical Research 5010 Program [201310]; National Natural Science Foundation of China [81071890]; Guangdong Provincial Natural Science Foundation of China [S2013020012726]; National High Technology Research and Development Program of China 863 Program [2012AA02A501]	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Sun Yat-Sen University Clinical Research 5010 Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Natural Science Foundation of China(National Natural Science Foundation of Guangdong Province); National High Technology Research and Development Program of China 863 Program(National High Technology Research and Development Program of China)	This work was supported by the Program for New Century Excellent Talents in University (NCET-12-0562), Sun Yat-Sen University Clinical Research 5010 Program (201310), National Natural Science Foundation of China (Grants No. 81071890), Guangdong Provincial Natural Science Foundation of China (S2013020012726), and National High Technology Research and Development Program of China (863 Program, No. 2012AA02A501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Au JSK, 2003, INT J RADIAT ONCOL, V56, P413, DOI 10.1016/S0360-3016(02)04610-2; Boyer AL, 2001, INT J RADIAT ONCOL, V51, P880, DOI 10.1016/S0360-3016(01)01749-7; Casselman J W, 1994, J Belge Radiol, V77, P67; Chang JTC, 2005, INT J RADIAT ONCOL, V63, P1354, DOI 10.1016/j.ijrobp.2005.05.042; Chen MY, 2013, CHIN J CANCER, V32, P604, DOI 10.5732/cjc.013.10148; Chong VFH, 1995, EUR J RADIOL, V21, P100, DOI 10.1016/0720-048X(95)00689-N; Chua DTT, 1997, CANCER, V79, P869, DOI 10.1002/(SICI)1097-0142(19970301)79:5<869::AID-CNCR1>3.3.CO;2-S; Gospodarowicz MK, 2004, CANCER, V100, P1, DOI 10.1002/cncr.11898; Greene FL, 2008, CA-CANCER J CLIN, V58, P180, DOI 10.3322/CA.2008.0001; Groome PA, 2001, HEAD NECK-J SCI SPEC, V23, P613, DOI 10.1002/hed.1087; Ho HC, 2008, ACTA OTO-LARYNGOL, V128, P790, DOI 10.1080/00016480701714269; Hong MH, 2000, CANCER, V89, P242, DOI 10.1002/1097-0142(20000715)89:2<242::AID-CNCR6>3.0.CO;2-Z; Kalogera-Fountzila A, 2006, STRAHLENTHER ONKOL, V182, P458, DOI 10.1007/s00066-006-1538-4; Lai SZ, 2011, INT J RADIAT ONCOL, V80, P661, DOI 10.1016/j.ijrobp.2010.03.024; Lee AWM, 2005, J CLIN ONCOL, V23, P6966, DOI 10.1200/JCO.2004.00.7542; Lee AWM, 2004, CLIN ONCOL-UK, V16, P269, DOI 10.1016/j.clon.2004.01.008; Li WF, 2012, CHIN J CANCER, V31, P579, DOI 10.5732/cjc.012.10095; Liao XB, 2008, INT J RADIAT ONCOL, V72, P1368, DOI 10.1016/j.ijrobp.2008.03.017; Liu MZ, 2008, INT J RADIAT ONCOL, V70, P1115, DOI 10.1016/j.ijrobp.2007.07.2353; Ma J, 2001, INT J RADIAT ONCOL, V50, P1181, DOI 10.1016/S0360-3016(01)01537-1; Ma J, 2007, CLIN CANCER RES, V13, P1445, DOI 10.1158/1078-0432.CCR-06-2059; Mao YP, 2009, INT J RADIAT ONCOL, V73, P1326, DOI 10.1016/j.ijrobp.2008.07.062; NEEL HB, 1985, ANN OTO RHINOL LARYN, V94, P529, DOI 10.1177/000348948509400601; Ng WT, 2007, RADIOTHER ONCOL, V82, P70, DOI 10.1016/j.radonc.2006.11.010; OuYang PY, 2013, BRIT J CANCER, V109, P2987, DOI 10.1038/bjc.2013.659; Sayegh Mazin E, 2004, Gastric Cancer, V7, P140; Spratt DE, 2012, ONCOTARGETS THER, V5, P297, DOI 10.2147/OTT.S28032; Sultanem K, 2000, INT J RADIAT ONCOL, V48, P711, DOI 10.1016/S0360-3016(00)00702-1; Sun R, 2013, J CANCER RES CLIN, V139, P307, DOI 10.1007/s00432-012-1333-9; Tang LL, 2010, RADIOLOGY, V257, P151, DOI 10.1148/radiol.10100033; Tang LL, 2008, CANCER, V113, P347, DOI 10.1002/cncr.23555; Tham IWK, 2009, HEAD NECK-J SCI SPEC, V31, P468, DOI 10.1002/hed.21008; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; Yu MC, 2002, SEMIN CANCER BIOL, V12, P421, DOI 10.1016/S1044579X02000858; Zhang GY, 2010, RADIOLOGY, V255, P605, DOI 10.1148/radiol.10090289	36	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e116261	10.1371/journal.pone.0116261	http://dx.doi.org/10.1371/journal.pone.0116261			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536307	Green Published, Green Submitted, gold			2022-12-27	WOS:000348563300101
J	Liang, W; Menke, AL; Driessen, A; Koek, GH; Lindeman, JH; Stoop, R; Havekes, LM; Kleemann, R; van den Hoek, AM				Liang, Wen; Menke, Aswin L.; Driessen, Ann; Koek, Ger H.; Lindeman, Jan H.; Stoop, Reinout; Havekes, Louis M.; Kleemann, Robert; van den Hoek, Anita M.			Establishment of a General NAFLD Scoring System for Rodent Models and Comparison to Human Liver Pathology	PLOS ONE			English	Article							MORBIDLY OBESE-PATIENTS; NONALCOHOLIC STEATOHEPATITIS; TRANSGENIC MICE; SAMPLING VARIABILITY; CHRONIC INFLAMMATION; CLINICAL-RESEARCH; DISEASE; BIOPSY; ATHEROSCLEROSIS; PERSPECTIVE	Background and aims: The recently developed histological scoring system for non-alcoholic fatty liver disease (NAFLD) by the NASH Clinical Research Network (NASH-CRN) has been widely used in clinical settings, but is increasingly employed in preclinical research as well. However, it has not been systematically analyzed whether the human scoring system can directly be converted to preclinical rodent models. To analyze this, we systematically compared human NAFLD liver pathology, using human liver biopsies, with liver pathology of several NAFLD mouse models. Based upon the features pertaining to mouse NAFLD, we aimed at establishing a modified generic scoring system that is applicable to broad spectrum of rodent models. Methods: The histopathology of NAFLD was analyzed in several different mouse models of NAFLD to define generic criteria for histological assessment (preclinical scoring system). For validation of this scoring system, 36 slides of mouse livers, covering the whole spectrum of NAFLD, were blindly analyzed by ten observers. Additionally, the livers were blindly scored by one observer during two separate assessments longer than 3 months apart. Results: The criteria macrovesicular steatosis, microvesicular steatosis, hepatocellular hypertrophy, inflammation and fibrosis were generally applicable to rodent NAFLD. The inter-observer reproducibility (evaluated using the Intraclass Correlation Coefficient) between the ten observers was high for the analysis of macrovesicular steatosis and microvesicular steatosis (ICC=0.784 and 0.776, all p<0.001, respectively) and moderate for the analysis of hypertrophy and inflammation (ICC=0.685 and 0.650, all p<0.001, respectively). The intra-observer reproducibility between the different observations of one observer was high for the analysis of macrovesicular steatosis, microvesicular steatosis and hypertrophy (ICC=0.871, 0.871 and 0.896, all p<0.001, respectively) and very high for the analysis of inflammation (ICC=0.931, p<0.001). Conclusions: We established a simple NAFLD scoring system with high reproducibility that is applicable for different rodent models and for all stages of NAFLD etiology.	[Liang, Wen; Stoop, Reinout; Havekes, Louis M.; Kleemann, Robert; van den Hoek, Anita M.] Netherlands Org Appl Sci Res TNO, Dept Metab Hlth Res, Leiden, Netherlands; [Liang, Wen; Havekes, Louis M.] Leiden Univ, Med Ctr, Dept Endocrinol & Metab Dis, Leiden, Netherlands; [Menke, Aswin L.] TNO Triskel, Zeist, Netherlands; [Driessen, Ann] Univ Antwerp, Univ Antwerp Hosp, Dept Pathol, Edegem, Belgium; [Koek, Ger H.] Univ Med Ctr Maastricht, Dept Internal Med, Div Gastroenterol & Hepatol, Maastricht, Netherlands; [Lindeman, Jan H.] Leiden Univ, Med Ctr, Dept Vasc Surg, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Netherlands Organization Applied Science Research; University of Antwerp; Maastricht University; Maastricht University Medical Centre (MUMC); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van den Hoek, AM (corresponding author), Netherlands Org Appl Sci Res TNO, Dept Metab Hlth Res, Leiden, Netherlands.	a.vandenhoek@tno.nl	Driessen, Ann/D-3768-2017; Menke, Aswin/AAC-6809-2021	Driessen, Ann/0000-0003-4148-610X; Menke, Aswin/0000-0002-0724-0897	PREDICCT; TNO research program 'Personalized Prevention and Therapy - Systems Medicine.'	PREDICCT; TNO research program 'Personalized Prevention and Therapy - Systems Medicine.'	This research was performed within the framework of CTMM, the Center for Translational Molecular Medicine (www.ctmm.nl), project PREDICCT. It was also financially supported by the TNO research program 'Personalized Prevention and Therapy - Systems Medicine.' TNO-Triskelion provided support in the form of a salary for author ALM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Bedossa P, 2012, HEPATOLOGY, V56, P1751, DOI 10.1002/hep.25889; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brunt EM, 2010, NAT REV GASTRO HEPAT, V7, P195, DOI 10.1038/nrgastro.2010.21; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Brunt EM, 2001, SEMIN LIVER DIS, V21, P3, DOI 10.1055/s-2001-12925; Caldwell S, 2010, J HEPATOL, V53, P719, DOI 10.1016/j.jhep.2010.04.031; Fukusato T, 2005, HEPATOL RES, V33, P122, DOI 10.1016/j.hepres.2005.09.018; Goldstein NS, 2005, AM J CLIN PATHOL, V123, P382, DOI [10.1309/EY72F1EN0XCB1KXX, 10.1309/EY72F1EN9XCB1KXX]; JIANG XC, 1992, J CLIN INVEST, V90, P1290, DOI 10.1172/JCI115993; Juluri R, 2011, J CLIN GASTROENTEROL, V45, P55, DOI 10.1097/MCG.0b013e3181dd1348; Kleiner DE, 2012, SEMIN LIVER DIS, V32, P3, DOI 10.1055/s-0032-1306421; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lackner C, 2011, EXPERT REV GASTROENT, V5, P223, DOI [10.1586/EGH.11.8, 10.1586/egh.11.8]; Lazo M, 2008, SEMIN LIVER DIS, V28, P339, DOI 10.1055/s-0028-1091978; Liang W, 2014, LAB INVEST, V94, P491, DOI 10.1038/labinvest.2014.11; Merriman RB, 2006, HEPATOLOGY, V44, P874, DOI 10.1002/hep.21346; Munro, 1997, STAT METHODS HLTH CA; NISHINA PM, 1990, J LIPID RES, V31, P859; Ratziu V, 2005, GASTROENTEROLOGY, V128, P1898, DOI 10.1053/j.gastro.2005.03.084; Tiniakos DG, 2010, ANNU REV PATHOL-MECH, V5, P145, DOI 10.1146/annurev-pathol-121808-102132; van den Hoek AM, 2014, DIABETES OBES METAB, V16, P537, DOI 10.1111/dom.12252; VANDENMAAGDENBERG AMJM, 1993, J BIOL CHEM, V268, P10540; Verschuren L, 2009, CIRC RES, V105, P99, DOI 10.1161/CIRCRESAHA.109.199166; Vuppalanchi R, 2009, CLIN GASTROENTEROL H, V7, P481, DOI 10.1016/j.cgh.2008.12.015; Westerterp M, 2006, ARTERIOSCL THROM VAS, V26, P2552, DOI 10.1161/01.ATV.0000243925.65265.3c; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Younossi ZM, 2008, ALIMENT PHARM THER, V28, P2, DOI 10.1111/j.1365-2036.2008.03710.x; Younossi ZM, 1998, MODERN PATHOL, V11, P560	28	190	198	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115922	10.1371/journal.pone.0115922	http://dx.doi.org/10.1371/journal.pone.0115922			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25535951	Green Published, gold, Green Submitted			2022-12-27	WOS:000348563300087
J	Timme, N; Ito, S; Myroshnychenko, M; Yeh, FC; Hiolski, E; Hottowy, P; Beggs, JM				Timme, Nicholas; Ito, Shinya; Myroshnychenko, Maxym; Yeh, Fang-Chin; Hiolski, Emma; Hottowy, Pawel; Beggs, John M.			Multiplex Networks of Cortical and Hippocampal Neurons Revealed at Different Timescales	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; SLICE CULTURES; ORGANOTYPIC CULTURES; SYNAPTIC DEVELOPMENT; BRAIN CONNECTIVITY; CEREBRAL-CORTEX; NEURAL ACTIVITY; HUB NEURONS; ORGANIZATION; FREQUENCY	Recent studies have emphasized the importance of multiplex networks - interdependent networks with shared nodes and different types of connections - in systems primarily outside of neuroscience. Though the multiplex properties of networks are frequently not considered, most networks are actually multiplex networks and the multiplex specific features of networks can greatly affect network behavior (e. g. fault tolerance). Thus, the study of networks of neurons could potentially be greatly enhanced using a multiplex perspective. Given the wide range of temporally dependent rhythms and phenomena present in neural systems, we chose to examine multiplex networks of individual neurons with time scale dependent connections. To study these networks, we used transfer entropy -an information theoretic quantity that can be used to measure linear and nonlinear interactions - to systematically measure the connectivity between individual neurons at different time scales in cortical and hippocampal slice cultures. We recorded the spiking activity of almost 12,000 neurons across 60 tissue samples using a 512-electrode array with 60 micrometer inter-electrode spacing and 50 microsecond temporal resolution. To the best of our knowledge, this preparation and recording method represents a superior combination of number of recorded neurons and temporal and spatial recording resolutions to any currently available in vivo system. We found that highly connected neurons ("hubs'') were localized to certain time scales, which, we hypothesize, increases the fault tolerance of the network. Conversely, a large proportion of non-hub neurons were not localized to certain time scales. In addition, we found that long and short time scale connectivity was uncorrelated. Finally, we found that long time scale networks were significantly less modular and more disassortative than short time scale networks in both tissue types. As far as we are aware, this analysis represents the first systematic study of temporally dependent multiplex networks among individual neurons.	[Timme, Nicholas; Yeh, Fang-Chin; Beggs, John M.] Indiana Univ, Dept Phys, Bloomington, IN 47405 USA; [Ito, Shinya] Univ Calif Santa Cruz, Santa Cruz Inst Particle Phys, Santa Cruz, CA 95064 USA; [Myroshnychenko, Maxym] Indiana Univ, Program Neurosci, Bloomington, IN 47405 USA; [Hiolski, Emma] Univ Calif Santa Cruz, Dept Microbiol & Environm Toxicol, Santa Cruz, CA 95064 USA; [Hottowy, Pawel] AGH Univ Sci & Technol, PL-30059 Krakow, Poland	Indiana University System; Indiana University Bloomington; University of California System; University of California Santa Cruz; Indiana University System; Indiana University Bloomington; University of California System; University of California Santa Cruz; AGH University of Science & Technology	Timme, N (corresponding author), Indiana Univ, Dept Phys, Bloomington, IN 47405 USA.	nmtimme@umail.iu.edu	Hottowy, Pawel/R-4981-2019	Timme, Nicholas/0000-0002-7127-4418	National Science Foundation [090813, 1058291, IIS 0904413, CNS-0723054, CNS-0521433]	National Science Foundation(National Science Foundation (NSF))	This research was supported by National Science Foundation (http://www.nsf.gov) grants 090813 (JMB), 1058291 (JMB), and IIS 0904413 (Alan Litke). Via the use of computing resources at Indiana University, this material is based upon work supported by the National Science Foundation under Grant Nos. CNS-0723054 and CNS-0521433. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Akam T, 2014, NAT REV NEUROSCI, V15, P111, DOI 10.1038/nrn3668; Alivisatos AP, 2012, NEURON, V74, P970, DOI 10.1016/j.neuron.2012.06.006; Amblard PO, 2011, J COMPUT NEUROSCI, V30, P7, DOI 10.1007/s10827-010-0231-x; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; Baker RE, 1997, DEV BRAIN RES, V98, P21, DOI 10.1016/S0165-3806(96)00163-0; Bausch SB, 2000, J NEUROPHYSIOL, V84, P2918, DOI 10.1152/jn.2000.84.6.2918; Baxter GJ, 2014, UNDERST COMPLEX SYST, P37, DOI 10.1007/978-3-319-03518-5_2; Bedo N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088940; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Besserve M, 2010, J COMPUT NEUROSCI, V29, P547, DOI 10.1007/s10827-010-0236-5; Bianconi G, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.062806; Boccaletti S, 2014, PHYS REP, V544, P1, DOI 10.1016/j.physrep.2014.07.001; BOLZ J, 1990, NATURE, V346, P359, DOI 10.1038/346359a0; Bonifazi P, 2009, SCIENCE, V326, P1419, DOI 10.1126/science.1175509; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; Brummitt CD, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.045102; BUCHS PA, 1993, DEV BRAIN RES, V71, P81, DOI 10.1016/0165-3806(93)90108-M; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Bullmore E, 2009, NAT REV NEUROSCI, V10, DOI 10.1038/nrn2618; Buzsaki G, 2004, TRENDS NEUROSCI, V27, P186, DOI 10.1016/j.tins.2004.02.007; Buzsaki G., 2006, RHYTHMS BRAIN; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; Cardillo A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01344; Chavez M, 2003, J NEUROSCI METH, V124, P113, DOI 10.1016/S0165-0270(02)00367-9; Cossart R, 2014, CURR OPIN NEUROBIOL, V26, P51, DOI 10.1016/j.conb.2013.12.002; Crossley NA, 2014, BRAIN, V137, P2382, DOI 10.1093/brain/awu132; D'Agostino G, 2014, UNDERST COMPLEX SYST, pVII; Damoiseaux JS, 2009, BRAIN STRUCT FUNCT, V213, P525, DOI 10.1007/s00429-009-0208-6; David O, 2008, PLOS BIOL, V6, P2683, DOI 10.1371/journal.pbio.0060315; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Ding M., 2006, HDB TIME SERIES ANAL, P437, DOI DOI 10.1002/9783527609970.CH17; Douw L, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-103; Downes JH, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002522; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Eytan D, 2006, J NEUROSCI, V26, P8465, DOI 10.1523/JNEUROSCI.1627-06.2006; Feldt S, 2011, TRENDS NEUROSCI, V34, P225, DOI 10.1016/j.tins.2011.02.007; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Friston KJ, 2011, NEUROIMAGE, V56, P1202, DOI 10.1016/j.neuroimage.2010.12.039; Gao JX, 2012, NAT PHYS, V8, P40, DOI 10.1038/nphys2180; Garofalo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006482; Gerhard F, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003138; GEWEKE JF, 1984, J AM STAT ASSOC, V79, P907, DOI 10.2307/2288723; Gire DH, 2013, NEURON, V78, P416, DOI 10.1016/j.neuron.2013.04.033; Gomez-Gardenes J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00620; Goni J, 2014, P NATL ACAD SCI USA, V111, P833, DOI 10.1073/pnas.1315529111; GOTZ M, 1992, J NEUROBIOL, V23, P783, DOI 10.1002/neu.480230702; Gourevitch B, 2007, J NEUROPHYSIOL, V97, P2533, DOI 10.1152/jn.01106.2006; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Grewe BF, 2014, NEUROMETHODS, V85, P133, DOI 10.1007/978-1-62703-785-3_9; Grewe BF, 2010, NAT METHODS, V7, P399, DOI 10.1038/nmeth.1453; Grinstein G, 2005, P NATL ACAD SCI USA, V102, P9948, DOI 10.1073/pnas.0504127102; Groppe DM, 2011, PSYCHOPHYSIOLOGY, V48, P1711, DOI 10.1111/j.1469-8986.2011.01273.x; Gutierrez R, 1999, BRAIN RES, V815, P304, DOI 10.1016/S0006-8993(98)01101-9; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Horn A, 2014, NEUROIMAGE, V102, P142, DOI 10.1016/j.neuroimage.2013.09.069; Horwitz B, 2003, NEUROIMAGE, V19, P466, DOI 10.1016/S1053-8119(03)00112-5; Ito S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105324; Ito SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027431; Izquierdo EJ, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002890; Johnson S, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.108702; Kaiser M, 2011, NEUROIMAGE, V57, P892, DOI 10.1016/j.neuroimage.2011.05.025; Kiebel SJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000209; Klostermann O, 1999, NEUROSCIENCE, V92, P1243, DOI 10.1016/S0306-4522(99)00009-3; Koenig T, 2005, PHILOS T R SOC B, V360, P1015, DOI 10.1098/rstb.2005.1649; Kuhnert MT, 2012, CHAOS, V22, DOI 10.1063/1.4729185; Kurant M, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.138701; Lee KM, 2014, UNDERST COMPLEX SYST, P53, DOI 10.1007/978-3-319-03518-5_3; Leicht EA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118703; LEIMAN AL, 1986, BRAIN RES, V365, P205, DOI 10.1016/0006-8993(86)91631-8; Litke AM, 2004, IEEE T NUCL SCI, V51, P1434, DOI 10.1109/TNS.2004.832706; Lizier JT, 2011, J COMPUT NEUROSCI, V30, P85, DOI 10.1007/s10827-010-0271-2; Lungarella M, 2006, PLOS COMPUT BIOL, V2, P1301, DOI 10.1371/journal.pcbi.0020144; Ma CF, 2013, COGN NEURODYNAMICS, V7, P253, DOI 10.1007/s11571-012-9239-4; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Meunier D, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00200; Mielke JG, 2005, DEV BRAIN RES, V160, P275, DOI 10.1016/j.devbrainres.2005.09.009; Morgan RJ, 2008, P NATL ACAD SCI USA, V105, P6179, DOI 10.1073/pnas.0801372105; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; MULLER D, 1993, DEV BRAIN RES, V71, P93, DOI 10.1016/0165-3806(93)90109-N; Nakhnikian A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089443; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Noraberg J, 2005, CNS NEUROL DISORD-DR, V4, P435, DOI 10.2174/1568007054546108; O'Reilly JX, 2013, P NATL ACAD SCI USA, V110, P13982, DOI 10.1073/pnas.1305062110; Panzeri S, 2010, TRENDS NEUROSCI, V33, P111, DOI 10.1016/j.tins.2009.12.001; Pena F, 2010, CURR MED CHEM, V17, P987, DOI 10.2174/092986710790820679; Picardo MA, 2011, NEURON, V71, P695, DOI 10.1016/j.neuron.2011.06.018; Pouget A, 2000, NAT REV NEUROSCI, V1, P125, DOI 10.1038/35039062; Quilichini PP, 2012, NEURON, V74, P57, DOI 10.1016/j.neuron.2012.01.026; Rolston JD, 2007, NEUROSCIENCE, V148, P294, DOI 10.1016/j.neuroscience.2007.05.025; Royer S, 2010, EUR J NEUROSCI, V31, P2279, DOI 10.1111/j.1460-9568.2010.07250.x; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rykhlevskaia E, 2008, PSYCHOPHYSIOLOGY, V45, P173, DOI 10.1111/j.1469-8986.2007.00621.x; Saalmann YB, 2012, SCIENCE, V337, P753, DOI 10.1126/science.1223082; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Sasaki T, 2008, J NEUROPHYSIOL, V100, P1668, DOI 10.1152/jn.00084.2008; Scholvinck ML, 2013, NEUROIMAGE, V80, P297, DOI 10.1016/j.neuroimage.2013.04.010; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Sharott A, 2005, J PHYSIOL-LONDON, V562, P951, DOI 10.1113/jphysiol.2004.073189; Shimono M, 2015, CEREB CORTEX, V25, P3743, DOI 10.1093/cercor/bhu252; Song C, 2013, J NEUROSCI, V33, P18781, DOI 10.1523/JNEUROSCI.4201-12.2013; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns Olaf, 2013, Dialogues Clin Neurosci, V15, P247; Staal JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022040; Stetter O, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002653; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tang A, 2008, J NEUROSCI, V28, P505, DOI 10.1523/JNEUROSCI.3359-07.2008; Tomasi D, 2011, NEUROIMAGE, V57, P908, DOI 10.1016/j.neuroimage.2011.05.024; Valdes-Sosa PA, 2011, NEUROIMAGE, V58, P339, DOI 10.1016/j.neuroimage.2011.03.058; van den Heuvel MP, 2013, TRENDS COGN SCI, V17, P683, DOI 10.1016/j.tics.2013.09.012; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vicente R, 2011, J COMPUT NEUROSCI, V30, P45, DOI 10.1007/s10827-010-0262-3; Wagenaar DA, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-11; Wang Z, 2013, NEURON, V78, P1116, DOI 10.1016/j.neuron.2013.04.023; Wibral M, 2014, UNDERST COMPLEX SYST, P1, DOI 10.1007/978-3-642-54474-3; Wibral M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055809; Wibral M, 2011, PROG BIOPHYS MOL BIO, V105, P80, DOI 10.1016/j.pbiomolbio.2010.11.006; Wollstadt P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102833; Yuan WJ, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.022818; Yuan WJ, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.016116; ZIMMER J, 1984, J COMP NEUROL, V228, P432, DOI 10.1002/cne.902280310; Zubler F, 2015, BRAIN TOPOGR, V28, P305, DOI 10.1007/s10548-014-0370-x	139	30	30	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115764	10.1371/journal.pone.0115764	http://dx.doi.org/10.1371/journal.pone.0115764			43	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536059	gold, Green Published			2022-12-27	WOS:000348563300072
J	Xiao, YM; Fu, HJ; Han, XJ; Hu, XX; Gu, HY; Chen, YL; Wei, Q; Hu, QS				Xiao, Yongmei; Fu, Hongjun; Han, Xiaojie; Hu, Xiaoxia; Gu, Huaiyu; Chen, Yilin; Wei, Qing; Hu, Qiansheng			Role of Synaptic Structural Plasticity in Impairments of Spatial Learning and Memory Induced by Developmental Lead Exposure in Wistar Rats	PLOS ONE			English	Article							LONG-TERM POTENTIATION; CELL-ADHESION MOLECULES; SEQUENTIAL-CHANGES; DENTATE GYRUS; STEM-CELLS; PSA-NCAM; HIPPOCAMPUS; DEFICITS; NEUROGENESIS; CHILDREN	Lead (Pb) is found to impair cognitive function. Synaptic structural plasticity is considered to be the physiological basis of synaptic functional plasticity and has been recently found to play important roles in learning and memory. To study the effect of Pb on spatial learning and memory at different developmental stages, and its relationship with alterations of synaptic structural plasticity, postnatal rats were randomly divided into three groups: Control; Pre-weaning Pb (Parents were exposed to 2 mM PbCl2 3 weeks before mating until weaning of pups); Post-weaning Pb (Weaned pups were exposed to 2 mM PbCl2 for 9 weeks). The spatial learning and memory of rats was measured by Morris water maze (MWM) on PND 85-90. Rat pups in Pre-weaning Pb and Post-weaning Pb groups performed significantly worse than those in Control group (p<0.05). However, there was no significant difference in the performance of MWM between the two Pb-exposure groups. Before MWM (PND 84), the number of neurons and synapses significantly decreased in Pre-weaning Pb group, but not in Post-weaning Pb group. After MWM (PND 91), the number of synapses in Pre-weaning Pb group increased significantly, but it was still less than that of Control group (p<0.05); the number of synapses in Post-weaning Pb group was also less than that of Control group (p<0.05), although the number of synapses has no differences between Post-weaning Pb and Control groups before MWM. In both Pre-weaning Pb and Post-weaning Pb groups, synaptic structural parameters such as thickness of postsynaptic density (PSD), length of synaptic active zone and synaptic curvature increased significantly while width of synaptic cleft decreased significantly compared to Control group (p<0.05). Our data demonstrated that both early and late developmental Pb exposure impaired spatial learning and memory as well as synaptic structural plasticity in Wistar rats.	[Xiao, Yongmei; Han, Xiaojie; Hu, Xiaoxia; Chen, Yilin; Wei, Qing; Hu, Qiansheng] Sun Yat Sen Univ, Sch Publ Hlth, Dept Prevent Med, Guangzhou 510080, Guangdong, Peoples R China; [Fu, Hongjun] Jackson Lab, Bar Harbor, ME 04609 USA; [Gu, Huaiyu] Sun Yat Sen Univ, Sch Med, Guangzhou 510080, Guangdong, Peoples R China	Sun Yat Sen University; Jackson Laboratory; Sun Yat Sen University	Hu, QS (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Dept Prevent Med, Guangzhou 510080, Guangdong, Peoples R China.	huqsh@mail.sysu.edu.cn	FU, HONGJUN/H-4498-2011; Hu, Qian/GWZ-7617-2022; Fu, Hongjun/ABB-3558-2021	FU, HONGJUN/0000-0001-5346-7075; 	National Basic Research Program of China [2012CB525003]; National Natural Science Foundation of China [81072271]; Fundamental Research Funds for the Central Universities [09ykpy58]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grants from the National Basic Research Program of China [2012CB525003], the National Natural Science Foundation of China [No. 81072271], and the Fundamental Research Funds for the Central Universities [No. 09ykpy58]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baranowska-Bosiacka I, 2013, TOXICOLOGY, V303, P187, DOI 10.1016/j.tox.2012.10.027; BELLINGER D, 1991, PEDIATRICS, V87, P219; BELLINGER D, 1987, NEW ENGL J MED, V316, P1037, DOI 10.1056/NEJM198704233161701; Benson DL, 2000, TRENDS CELL BIOL, V10, P473, DOI 10.1016/S0962-8924(00)01838-9; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bonfanti L, 2006, PROG NEUROBIOL, V80, P129, DOI 10.1016/j.pneurobio.2006.08.003; Cao XJ, 2008, DEV PSYCHOBIOL, V50, P307, DOI 10.1002/dev.20287; Choi S, 2000, NAT NEUROSCI, V3, P330, DOI 10.1038/73895; DIETRICH KN, 1991, NEUROTOXICOL TERATOL, V13, P203, DOI 10.1016/0892-0362(91)90012-L; Dribben WH, 2011, NEUROTOXICOL TERATOL, V33, P473, DOI 10.1016/j.ntt.2011.05.006; EDELMAN GM, 1991, ANNU REV BIOCHEM, V60, P155, DOI 10.1146/annurev.bi.60.070191.001103; FERRER I, 1994, NEUROSCI LETT, V182, P77, DOI 10.1016/0304-3940(94)90210-0; Gilbert ME, 2005, TOXICOL SCI, V86, P365, DOI 10.1093/toxsci/kfi156; GULDNER FH, 1980, NEUROSCI LETT, V17, P27, DOI 10.1016/0304-3940(80)90056-7; Han XJ, 2014, BIOL PHARM BULL, V37, P466, DOI 10.1248/bpb.b13-00892; Hidalgo A, 2003, MECH DEVELOP, V120, P1311, DOI 10.1016/j.mod.2003.06.004; Hu QS, 2008, NEUROTOXICOLOGY, V29, P675, DOI 10.1016/j.neuro.2008.04.002; Huang FN, 2004, NEUROTOXICOLOGY, V25, P1001, DOI 10.1016/j.neuro.2004.03.010; Itsykson P, 2005, MOL CELL NEUROSCI, V30, P24, DOI 10.1016/j.mcn.2005.05.004; Jaako-Movits K, 2005, INT J DEV NEUROSCI, V23, P627, DOI 10.1016/j.ijdevneu.2005.07.005; Jett DA, 1997, PHARMACOL BIOCHEM BE, V57, P271, DOI 10.1016/S0091-3057(96)00350-4; JONES DG, 1978, BRAIN RES, V147, P47, DOI 10.1016/0006-8993(78)90771-0; Klemann CJHM, 2011, SYNAPSE, V65, P1222, DOI 10.1002/syn.20962; Kuhlmann AC, 1997, NEUROSCI LETT, V233, P101, DOI 10.1016/S0304-3940(97)00633-2; Lanphear BP, 2000, PUBLIC HEALTH REP, V115, P521, DOI 10.1093/phr/115.6.521; Lee SH, 2000, CURR OPIN NEUROBIOL, V10, P125, DOI 10.1016/S0959-4388(99)00046-X; Liu MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043924; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Margeta MA, 2010, MOL CELL NEUROSCI, V43, P261, DOI 10.1016/j.mcn.2009.11.009; MARKUS EJ, 1989, SYNAPSE, V3, P1, DOI 10.1002/syn.890030102; Muller Dominique, 2002, Current Molecular Medicine (Hilversum), V2, P605, DOI 10.2174/1566524023362041; MULLER LJ, 1984, NEUROSCIENCE, V12, P1045, DOI 10.1016/0306-4522(84)90003-4; Murphy KJ, 1999, J NEUROCHEM, V72, P2099, DOI 10.1046/j.1471-4159.1999.0722099.x; Patrick L, 2006, ALTERN MED REV, V11, P2; Plusquellec P, 2007, NEUROTOXICOL TERATOL, V29, P527, DOI 10.1016/j.ntt.2007.07.002; Ruan DY, 2000, CHEMOSPHERE, V41, P165, DOI 10.1016/S0045-6535(99)00406-3; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Surkan PJ, 2007, NEUROTOXICOLOGY, V28, P1170, DOI 10.1016/j.neuro.2007.07.007; Verina T, 2007, NEUROSCIENCE, V145, P1037, DOI 10.1016/j.neuroscience.2006.12.040; Weeks ACW, 2001, SYNAPSE, V40, P74, DOI 10.1002/1098-2396(200104)40:1<74::AID-SYN1028>3.0.CO;2-D; Weeks ACW, 2000, SYNAPSE, V36, P286, DOI 10.1002/(SICI)1098-2396(20000615)36:4<286::AID-SYN5>3.0.CO;2-T; Xu XH, 2013, HORM BEHAV, V63, P766, DOI 10.1016/j.yhbeh.2013.03.004; Yang YX, 2003, EXP NEUROL, V184, P489, DOI 10.1016/S0014-4886(03)00272-3	43	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115556	10.1371/journal.pone.0115556	http://dx.doi.org/10.1371/journal.pone.0115556			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536363	gold, Green Published, Green Submitted			2022-12-27	WOS:000348563300049
J	Cheng, Z; Xu, ZL; Zhang, L; Wang, XW				Cheng, Zhe; Xu, Zaoli; Zhang, Lei; Wang, Xinwei			Thermophysical Properties of Lignocellulose: A Cell-Scale Study Down to 41K	PLOS ONE			English	Article							THERMAL-CONDUCTIVITY; HEAT-CAPACITY; THERMODYNAMIC PROPERTIES; ONION EPIDERMIS; BIOMASS; PYROLYSIS; COMBUSTION; ANISOTROPY; GROWTH; ENERGY	Thermal energy transport is of great importance in lignocellulose pyrolysis for biofuels. The thermophysical properties of lignocellulose significantly affect the overall properties of bio-composites and the related thermal transport. In this work, cell-scale lignocellulose (mono-layer plant cells) is prepared to characterize their thermal properties from room temperature down to similar to 40 K. The thermal conductivities of cell-scale lignocellulose along different directions show a little anisotropy due to the cell structure anisotropy. It is found that with temperature going down, the volumetric specific heat of the lignocellulose shows a slower decreasing trend against temperature than microcrystalline cellulose, and its value is always higher than that of microcrystalline cellulose. The thermal conductivity of lignocellulose decreases with temperature from 243 K to 317 K due to increasing phonon-phonon scatterings. From 41 K to 243 K, the thermal conductivity rises with temperature and its change mainly depends on the heat capacity's change.	[Cheng, Zhe; Xu, Zaoli; Wang, Xinwei] Iowa State Univ, Dept Mech Engn, Ames, IA 50011 USA; [Zhang, Lei] Hubei Univ Technol, Dept Foreign Language, Wuhan 430065, Hunan, Peoples R China	Iowa State University; Hubei University of Technology	Wang, XW (corresponding author), Iowa State Univ, Dept Mech Engn, 2010 Black Engn Bldg, Ames, IA 50011 USA.	xwang3@iastate.edu	Cheng, Zhe/AAT-2105-2021; Cheng, Zhe/N-3703-2016; Wang, Xinwei/AAH-4694-2019	Cheng, Zhe/0000-0001-7827-2979; Cheng, Zhe/0000-0001-7827-2979; 	Army Research Office [W911NF-12-1-0272]; Office of Naval Research [N000141210603]; National Science Foundation [CBET1235852, CMMI1264399]; Eastern Scholar Program of Shanghai, China	Army Research Office; Office of Naval Research(Office of Naval Research); National Science Foundation(National Science Foundation (NSF)); Eastern Scholar Program of Shanghai, China	Support of this work by Army Research Office (W911NF-12-1-0272), Office of Naval Research (N000141210603), and National Science Foundation (CBET1235852, CMMI1264399) is gratefully acknowledged. X. W. thanks the partial support of the "Eastern Scholar'' Program of Shanghai, China.	Alsina OLS, 2005, POLYM TEST, V24, P81, DOI 10.1016/j.polymertesting.2004.07.005; Averous L, 2006, CARBOHYD POLYM, V66, P480, DOI 10.1016/j.carbpol.2006.04.004; Beck JV, 1992, HEAT CONDUCTION USIN; Blokhin AV, 2011, J CHEM ENG DATA, V56, P3523, DOI 10.1021/je200270t; CHEN HS, 1969, J APPL PHYS, V40, P4214, DOI 10.1063/1.1657175; Dobircau L, 2009, COMPOS PART A-APPL S, V40, P329, DOI 10.1016/j.compositesa.2008.11.004; Feng X, 2011, ACTA MATER, V59, P1934, DOI 10.1016/j.actamat.2010.11.059; Feng XH, 2011, THIN SOLID FILMS, V519, P5700, DOI 10.1016/j.tsf.2011.03.043; Guo JQ, 2007, J APPL PHYS, V101, DOI 10.1063/1.2714679; Gupta M, 2003, FUEL, V82, P919, DOI 10.1016/S0016-2361(02)00398-8; Incropera FP., 2011, FUNDAMENTALS HEAT MA; Kerstens S, 2001, PLANT PHYSIOL, V127, P381, DOI 10.1104/pp.010423; Kumar J, 2011, BIOSENS BIOELECTRON, V26, P4399, DOI 10.1016/j.bios.2011.04.049; Kutschera U, 2008, ANN BOT-LONDON, V101, P615, DOI 10.1093/aob/mcn015; Le Digabel F, 2004, J APPL POLYM SCI, V93, P428, DOI 10.1002/app.20426; Leadbetter AJ, 1969, J PHYS C SOLID STATE, V2; Lee J, 1997, J BIOTECHNOL, V56, P1, DOI 10.1016/S0168-1656(97)00073-4; Liang XH, 2000, FUEL, V79, P1477, DOI 10.1016/S0016-2361(99)00286-0; Lin H, 2013, SMALL, V9, P2585, DOI 10.1002/smll.201202877; Liu G, 2014, J VISUALIZED EXPT, V83; Mettler MS, 2012, ENERG ENVIRON SCI, V5, P7797, DOI 10.1039/c2ee21679e; Naik AD, 2010, SMALL, V6, P2842, DOI 10.1002/smll.201001527; Park BK, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4807471; RAMIRES MLV, 1995, J PHYS CHEM REF DATA, V24, P1377, DOI 10.1063/1.555963; Sakuratani T, 1979, J AGR METEOROLOGY; Shimazaki Y, 2007, BIOMACROMOLECULES, V8, P2976, DOI 10.1021/bm7004998; Singha AS, 2009, INT J POLYM MATER, V58, P21, DOI 10.1080/00914030802461857; Stankovic SB, 2008, POLYM TEST, V27, P41, DOI 10.1016/j.polymertesting.2007.08.003; Sun Y, 2002, BIORESOURCE TECHNOL, V83, P1, DOI 10.1016/S0960-8524(01)00212-7; Suslov D, 2006, J EXP BOT, V57, P2183, DOI 10.1093/jxb/erj177; Suslov D, 2009, J EXP BOT, V60, P4175, DOI 10.1093/jxb/erp251; Wang F, 2010, BIOSENS BIOELECTRON, V25, P2238, DOI 10.1016/j.bios.2010.02.033; Wang L, 2001, J NON-CRYST SOLIDS, V296, P139, DOI 10.1016/S0022-3093(01)00902-4; Yapici F, 2011, BIORESOURCES, V6, P2757; YOKOKAWA H, 1979, J PHYS CHEM SOLIDS, V40, P445, DOI 10.1016/0022-3697(79)90060-X; Zabaniotou A, 2008, INT J HYDROGEN ENERG, V33, P2433, DOI 10.1016/j.ijhydene.2008.02.080	36	7	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e114821	10.1371/journal.pone.0114821	http://dx.doi.org/10.1371/journal.pone.0114821			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25532131	Green Submitted, Green Published, gold			2022-12-27	WOS:000348845100025
J	Das, D; Das, D; Padinhateeri, R				Das, Dipjyoti; Das, Dibyendu; Padinhateeri, Ranjith			Force-Induced Dynamical Properties of Multiple Cytoskeletal Filaments Are Distinct from that of Single Filaments	PLOS ONE			English	Article							ACTIN POLYMERIZATION; ATP-HYDROLYSIS; RATE CONSTANTS; STALL FORCE; INSTABILITY; MICROTUBULES; MODEL; GTP; CATASTROPHES; GENERATION	How cytoskeletal filaments collectively undergo growth and shrinkage is an intriguing question. Collective properties of multiple bio-filaments (actin or microtubules) undergoing hydrolysis have not been studied extensively earlier within simple theoretical frameworks. In this paper, we study the collective dynamical properties of multiple filaments under force, and demonstrate the distinct properties of a multi-filament system in comparison to a single filament. Comparing stochastic simulation results with recent experimental data, we show that multifilament collective catastrophes are slower than catastrophes of single filaments. Our study also shows further distinctions as follows: (i) force-dependence of the cap-size distribution of multiple filaments are quantitatively different from that of single filaments, (ii) the diffusion constant associated with the system length fluctuations is distinct for multiple filaments, and (iii) switching dynamics of multiple filaments between capped and uncapped states and the fluctuations therein are also distinct. We build a unified picture by establishing interconnections among all these collective phenomena. Additionally, we show that the collapse times during catastrophes can be sharp indicators of collective stall forces exceeding the additive contributions of single filaments.	[Das, Dipjyoti; Das, Dibyendu] Indian Inst Technol, Dept Phys, Mumbai 400076, Maharashtra, India; [Padinhateeri, Ranjith] Indian Inst Technol, Dept Biosci & Bioengn, Mumbai 400076, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Das, D (corresponding author), Indian Inst Technol, Dept Phys, Mumbai 400076, Maharashtra, India.	dipjyoti@phy.iitb.ac.in; dibyendu@phy.iitb.ac.in; ranjithp@iitb.ac.in	Das, Dipjyoti/GYE-1057-2022	Das, Dipjyoti/0000-0002-5947-9090	CSIR India (JRF award) [09/087(0572)/2009-EMR-I]; IYBA, Department of Biotechnology India [BT/01/1YBAl2009]	CSIR India (JRF award); IYBA, Department of Biotechnology India	This work was supported by CSIR India (JRF award no. 09/087(0572)/2009-EMR-I) and IYBA, Department of Biotechnology India (No: BT/01/1YBAl2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antal T, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.041907; Bowne-Anderson H, 2013, BIOESSAYS, V35, P452, DOI 10.1002/bies.201200131; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Brun L, 2009, P NATL ACAD SCI USA, V106, P21173, DOI 10.1073/pnas.0910774106; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Dimitrov A, 2008, SCIENCE, V322, P1353, DOI 10.1126/science.1165401; Dipjyoti D, 2014, NEW J PHYS, V16; Dogterom M, 1997, SCIENCE, V278, P856, DOI 10.1126/science.278.5339.856; DOGTEROM M, 1993, PHYS REV LETT, V70, P1347, DOI 10.1103/PhysRevLett.70.1347; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; Emanuel M, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.061907; Flyvbjerg H, 1996, PHYS REV E, V54, P5538, DOI 10.1103/PhysRevE.54.5538; FLYVBJERG H, 1994, PHYS REV LETT, V73, P2372, DOI 10.1103/PhysRevLett.73.2372; Footer MJ, 2007, P NATL ACAD SCI USA, V104, P2181, DOI 10.1073/pnas.0607052104; Fujiwara I, 2002, NAT CELL BIOL, V4, P666, DOI 10.1038/ncb841; FYGENSON DK, 1994, PHYS REV E, V50, P1579, DOI 10.1103/PhysRevE.50.1579; Garner EC, 2004, SCIENCE, V306, P1021, DOI 10.1126/science.1101313; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; HILL TL, 1981, P NATL ACAD SCI-BIOL, V78, P5613, DOI 10.1073/pnas.78.9.5613; Howard J, 2001, MECH MOTOR PROTEINS; Howard J, 2009, NAT REV MOL CELL BIO, V10, P569, DOI 10.1038/nrm2713; Janson ME, 2003, J CELL BIOL, V161, P1029, DOI 10.1083/jcb.200301147; Jegou A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001161; Jemseena V, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.032717; KORN ED, 1987, SCIENCE, V238, P638, DOI 10.1126/science.3672117; Krawczyk J, 2011, EPL-EUROPHYS LETT, V93, DOI 10.1209/0295-5075/93/28006; Laan L, 2008, P NATL ACAD SCI USA, V105, P8920, DOI 10.1073/pnas.0710311105; Li X, 2013, J PHYS CHEM B, V117, P9217, DOI 10.1021/jp404794f; Li X, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.048102; MELKI R, 1990, BIOCHEMISTRY-US, V29, P8921, DOI 10.1021/bi00490a007; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Mogilner A, 1996, BIOPHYS J, V71, P3030, DOI 10.1016/S0006-3495(96)79496-1; Padinhateeri R, 2012, BIOPHYS J, V102, P1274, DOI 10.1016/j.bpj.2011.12.059; PANTALONI D, 1985, P NATL ACAD SCI USA, V82, P7207, DOI 10.1073/pnas.82.21.7207; Phillips R., 2009, PHYS BIOL CELL; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; Ramachandran S, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4817193; Ranjith P, 2010, BIOPHYS J, V98, P1418, DOI 10.1016/j.bpj.2009.12.4306; Ranjith P, 2009, BIOPHYS J, V96, P2146, DOI 10.1016/j.bpj.2008.12.3920; Schaus TE, 2008, BIOPHYS J, V95, P1393, DOI 10.1529/biophysj.107.125005; Stukalin EB, 2006, BIOPHYS J, V90, P2673, DOI 10.1529/biophysj.105.074211; Stukalin EB, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1858859; Tsekouras K, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/10/103032; van Doorn GS, 2000, EUR BIOPHYS J BIOPHY, V29, P2, DOI 10.1007/s002490050245; VanBuren V, 2005, BIOPHYS J, V89, P2911, DOI 10.1529/biophysj.105.060913; VanBuren V, 2002, P NATL ACAD SCI USA, V99, P6035, DOI 10.1073/pnas.092504999; Vandecandelaere A, 1999, BIOCHEMISTRY-US, V38, P8179, DOI 10.1021/bi9830765; Vavylonis D, 2005, P NATL ACAD SCI USA, V102, P8543, DOI 10.1073/pnas.0501435102; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437; Wu ZH, 2012, BIOPHYS J, V102, P2687, DOI 10.1016/j.bpj.2012.05.003; Zelinski B, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.012703	51	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e114014	10.1371/journal.pone.0114014	http://dx.doi.org/10.1371/journal.pone.0114014			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531397	Green Published, Green Submitted, gold			2022-12-27	WOS:000348845100008
J	Nile, DL; Brown, AE; Kumaheri, MA; Blair, HR; Heggie, A; Miwa, S; Cree, LM; Payne, B; Chinnery, PF; Brown, L; Gunn, DA; Walker, M				Nile, Donna L.; Brown, Audrey E.; Kumaheri, Meutia A.; Blair, Helen R.; Heggie, Alison; Miwa, Satomi; Cree, Lynsey M.; Payne, Brendan; Chinnery, Patrick F.; Brown, Louise; Gunn, David A.; Walker, Mark			Age-Related Mitochondrial DNA Depletion and the Impact on Pancreatic Beta Cell Function	PLOS ONE			English	Article							STIMULATED INSULIN-SECRETION; COPY NUMBER; TRANSCRIPTION FACTOR; DIABETES-MELLITUS; GLUCOSE-TOLERANCE; US POPULATION; LINE; MTDNA; MAINTENANCE; DYSFUNCTION	Type 2 diabetes is characterised by an age-related decline in insulin secretion. We previously identified a 50% age-related decline in mitochondrial DNA (mtDNA) copy number in isolated human islets. The purpose of this study was to mimic this degree of mtDNA depletion in MIN6 cells to determine whether there is a direct impact on insulin secretion. Transcriptional silencing of mitochondrial transcription factor A, TFAM, decreased mtDNA levels by 40% in MIN6 cells. This level of mtDNA depletion significantly decreased mtDNA gene transcription and translation, resulting in reduced mitochondrial respiratory capacity and ATP production. Glucose-stimulated insulin secretion was impaired following partial mtDNA depletion, but was normalised following treatment with glibenclamide. This confirms that the deficit in the insulin secretory pathway precedes K+ channel closure, indicating that the impact of mtDNA depletion is at the level of mitochondrial respiration. In conclusion, partial mtDNA depletion to a degree comparable to that seen in aged human islets impaired mitochondrial function and directly decreased insulin secretion. Using our model of partial mtDNA depletion following targeted gene silencing of TFAM, we have managed to mimic the degree of mtDNA depletion observed in aged human islets, and have shown how this correlates with impaired insulin secretion. We therefore predict that the age-related mtDNAdepletion in human islets is not simply a biomarker of the aging process, but will contribute to the age-related risk of type 2 diabetes.	[Nile, Donna L.; Brown, Audrey E.; Kumaheri, Meutia A.; Blair, Helen R.; Heggie, Alison; Walker, Mark] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Miwa, Satomi] Newcastle Univ, Inst Ageing, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England; [Cree, Lynsey M.] Univ Auckland, Fac Med & Hlth Sci, Dept Obstet & Gynaecol, Auckland 1142, New Zealand; [Payne, Brendan; Chinnery, Patrick F.] Newcastle Univ, Wellcome Ctr Mitochondrial Res, Inst Med Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Brown, Louise; Gunn, David A.] Unilever R&D, Bedford MK44 1LQ, England	Newcastle University - UK; Newcastle University - UK; University of Auckland; Newcastle University - UK; Unilever	Walker, M (corresponding author), Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	mark.walker@ncl.ac.uk	Payne, Brendan/I-1233-2016	Payne, Brendan/0000-0002-3101-3512; Gunn, David/0000-0001-9866-3221; Cree, Lynsey/0000-0003-2090-1589; Nile, Donna/0000-0002-4415-9502; Brown, Audrey/0000-0002-0222-4214; Chinnery, Patrick/0000-0002-7065-6617; Miwa, Satomi/0000-0002-1239-1198	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/G529991/1]; Unilever; Newcastle National Institute for Health Research Biomedical Research Centre (NIHR BRC); Medical Research Council [G0800470] Funding Source: researchfish; National Institute for Health Research [CL-2013-01-004] Funding Source: researchfish; MRC [G0800470] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Unilever(Unilever); Newcastle National Institute for Health Research Biomedical Research Centre (NIHR BRC); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Biotechnology and Biological Sciences Research Council (BBSRC) Industrial CASE Studentship (grant reference BB/G529991/1) and as such, financial support was provided by Unilever. The authors acknowledge support of the Newcastle National Institute for Health Research Biomedical Research Centre (NIHR BRC). Co-authors Dr. David Gunn and Dr. Louise Brown are employed by Unilever R&D. Unilever R&D provided support in the form of salaries for authors Dr. David Gunn and Dr. Louise Brown, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cellbio.4.1.289; Babu DA, 2007, MOL GENET METAB, V92, P43, DOI 10.1016/j.ymgme.2007.06.008; Basu R, 2003, DIABETES, V52, P1738, DOI 10.2337/diabetes.52.7.1738; Bonnen PE, 2013, AM J HUM GENET, V93, P471, DOI 10.1016/j.ajhg.2013.07.017; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Brand MD, 2005, BIOCHEM SOC T, V33, P897, DOI 10.1042/BST0330897; Campbell CT, 2012, BBA-GENE REGUL MECH, V1819, P921, DOI 10.1016/j.bbagrm.2012.03.002; Chang AM, 2003, AM J PHYSIOL-ENDOC M, V284, pE7, DOI 10.1152/ajpendo.00366.2002; Cowie CC, 2006, DIABETES CARE, V29, P1263, DOI 10.2337/dc06-0062; Cowie CC, 2009, DIABETES CARE, V32, P287, DOI 10.2337/dc08-1296; Cree LM, 2008, DIABETOLOGIA, V51, P1440, DOI 10.1007/s00125-008-1054-4; Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63; Durham SE, 2005, NEUROLOGY, V65, P453, DOI 10.1212/01.wnl.0000171861.30277.88; Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109; Fontanesi F, 2006, AM J PHYSIOL-CELL PH, V291, pC1129, DOI 10.1152/ajpcell.00233.2006; Gauthier BR, 2009, CELL METAB, V10, P110, DOI 10.1016/j.cmet.2009.07.002; GROOP LC, 1992, DIABETES CARE, V15, P737, DOI 10.2337/diacare.15.6.737; HARRIS MI, 1987, DIABETES, V36, P523, DOI 10.2337/diabetes.36.4.523; Hayakawa T, 1998, J BIOL CHEM, V273, P20300, DOI 10.1074/jbc.273.32.20300; Ihm SH, 2006, DIABETES, V55, P1361, DOI 10.2337/db05-1333; ISHIHARA H, 1994, J BIOL CHEM, V269, P3081; Kaaman M, 2007, DIABETOLOGIA, V50, P2526, DOI 10.1007/s00125-007-0818-6; Kennedy ED, 1998, DIABETES, V47, P374, DOI 10.2337/diabetes.47.3.374; Koeck T, 2011, CELL METAB, V13, P80, DOI 10.1016/j.cmet.2010.12.007; Laderman KA, 1996, J BIOL CHEM, V271, P15891, DOI 10.1074/jbc.271.27.15891; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701; Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002; Litonin D, 2010, J BIOL CHEM, V285, P18129, DOI 10.1074/jbc.C110.128918; Lu HF, 2010, DIABETES, V59, P448, DOI 10.2337/db09-0129; Lynn S, 2003, DIABETOLOGIA, V46, P296, DOI 10.1007/s00125-002-1018-z; Maassen JA, 2004, DIABETES, V53, pS103, DOI 10.2337/diabetes.53.2007.S103; Maassen JA, 2001, EXP CLIN ENDOCR DIAB, V109, P127, DOI 10.1055/s-2001-14834; Maechler P, 2001, NATURE, V414, P807, DOI 10.1038/414807a; Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Ohgaki K, 2007, J BIOCHEM, V141, P201, DOI 10.1093/jb/mvm020; Proks P, 2002, DIABETES, V51, pS368, DOI 10.2337/diabetes.51.2007.S368; RUDENSKI AS, 1988, DIABETIC MED, V5, P36, DOI 10.1111/j.1464-5491.1988.tb00938.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102; Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649; Soejima A, 1996, J BIOL CHEM, V271, P26194, DOI 10.1074/jbc.271.42.26194; Sorensen L, 2001, J NEUROSCI, V21, P8082, DOI 10.1523/JNEUROSCI.21-20-08082.2001; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Tsuruzoe K, 1998, DIABETES, V47, P621, DOI 10.2337/diabetes.47.4.621; Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089; Wollheim CB, 2000, DIABETOLOGIA, V43, P265, DOI 10.1007/s001250050044	48	31	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115433	10.1371/journal.pone.0115433	http://dx.doi.org/10.1371/journal.pone.0115433			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25532126	Green Published, gold, Green Submitted			2022-12-27	WOS:000348845100065
J	Guo, XJ; Liu, SF; Wu, LF; Tang, LL				Guo, Xiaojun; Liu, Sifeng; Wu, Lifeng; Tang, Lingling			Application of a Novel Grey Self-Memory Coupling Model to Forecast the Incidence Rates of Two Notifiable Diseases in China: Dysentery and Gonorrhea	PLOS ONE			English	Article							INFECTIOUS-DISEASES; PREDICTION MODEL; DEVELOPING-COUNTRIES; PANDEMIC INFLUENZA; NEURAL-NETWORKS; TIME; SURVEILLANCE; DYNAMICS; SYSTEM	Objective: In this study, a novel grey self-memory coupling model was developed to forecast the incidence rates of two notifiable infectious diseases (dysentery and gonorrhea); the effectiveness and applicability of this model was assessed based on its ability to predict the epidemiological trend of infectious diseases in China. Methods: The linear model, the conventional GM(1,1) model and the GM(1,1) model with self-memory principle (SMGM(1,1) model) were used to predict the incidence rates of the two notifiable infectious diseases based on statistical incidence data. Both simulation accuracy and prediction accuracy were assessed to compare the predictive performances of the three models. The best-fit model was applied to predict future incidence rates. Results: Simulation results show that the SMGM(1,1) model can take full advantage of the systematic multi-time historical data and possesses superior predictive performance compared with the linear model and the conventional GM(1,1) model. By applying the novel SMGM(1,1) model, we obtained the possible incidence rates of the two representative notifiable infectious diseases in China. Conclusion: The disadvantages of the conventional grey prediction model, such as sensitivity to initial value, can be overcome by the self-memory principle. The novel grey self-memory coupling model can predict the incidence rates of infectious diseases more accurately than the conventional model, and may provide useful references for making decisions involving infectious disease prevention and control.	[Guo, Xiaojun] Nantong Univ, Sch Sci, Nantong, Jiangsu, Peoples R China; [Guo, Xiaojun; Liu, Sifeng; Wu, Lifeng] Nanjing Univ Aeronaut & Astronaut, Coll Econ & Management, Nanjing, Jiangsu, Peoples R China; [Tang, Lingling] Cornell Univ, Sch Elect & Comp Engn, Ithaca, NY USA	Nantong University; Nanjing University of Aeronautics & Astronautics; Cornell University	Guo, XJ (corresponding author), Nantong Univ, Sch Sci, Nantong, Jiangsu, Peoples R China.	guoxj159@163.com		Liu, Sifeng/0000-0002-5872-9457; Wu, Lifeng/0000-0002-9548-9747	National Natural Science Foundation of China [71401051]; Nantong Science and Technology Program [HS2013026]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nantong Science and Technology Program	This work was partially supported by the National Natural Science Foundation of China (No. 71401051) and the Funding of Nantong Science and Technology Program (No. HS2013026). But the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrus JK, 2011, VACCINE, V29, pD126, DOI 10.1016/j.vaccine.2011.06.023; Apisarnthanarak A, 2006, INFECT CONT HOSP EP, V27, P885, DOI 10.1086/505924; Brouqui P, 2009, CLIN MICROBIOL INFEC, V15, P700, DOI 10.1111/j.1469-0691.2009.02873.x; CAO HX, 1993, SCI CHINA SER B, V36, P845; Cao HX, 2002, SELF MEMORY PRINCIPL; Cui J, 2013, APPL MATH MODEL, V37, P4399, DOI 10.1016/j.apm.2012.09.052; Ding F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027295; Ding F, 2011, INFECT GENET EVOL, V11, P222, DOI 10.1016/j.meegid.2010.09.015; Dopson SA, 2009, BIOSECUR BIOTERROR, V7, P55, DOI 10.1089/bsp.2008.0021; [范习辉 Fan Xihui], 2003, [系统工程理论与实践, Systems Engineering-Theory & Practice], V23, P114; Gao L, 2014, AM J TROP MED HYG, V90, P697, DOI 10.4269/ajtmh.13-0198; Getachew Y, 2013, STAT MED, V32, P3224, DOI 10.1002/sim.5752; Gonzalez-Castillo J, 2013, ENFERM INFEC MICR CL, V31, P173, DOI 10.1016/j.eimc.2012.01.025; Guo H, 2013, APPL MATH COMPUT, V225, P216, DOI 10.1016/j.amc.2013.08.094; Guo Xiao-jun, 2014, Systems Engineering and Electronics, V36, P1124, DOI 10.3969/j.issn.1001-506X.2014.06.17; Hall IM, 2007, EPIDEMIOL INFECT, V135, P372, DOI 10.1017/S0950268806007084; Hsu LC, 2003, TECHNOL FORECAST SOC, V70, P563, DOI 10.1016/S0040-1625(02)00195-6; Hu MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038978; Jakopanec I, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-33; Li DC, 2012, OMEGA-INT J MANAGE S, V40, P767, DOI 10.1016/j.omega.2011.07.007; Li GD, 2011, INT J ELEC POWER, V33, P809, DOI 10.1016/j.ijepes.2010.11.005; Li J, 2006, PETROL SCI, V3, P89; Lin WZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049040; LIU SF, 2013, J GREY SYST UK, V0025, P00001; [刘湘平 Liu Xiangping], 2010, [岩土工程学报, Chinese Journal of Geotechnical Engineering], V32, P1535; Liu ZJ, 2013, NONLINEAR ANAL-REAL, V14, P1286, DOI 10.1016/j.nonrwa.2012.09.016; Lu HM, 2010, IEEE T KNOWL DATA EN, V22, P565, DOI 10.1109/TKDE.2009.115; Ma JQ, 2007, BIOMED ENVIRON SCI, V20, P208; Nishiura H, 2014, THEOR BIOL MED MODEL, V11, DOI 10.1186/1742-4682-11-5; Nishiura H, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-15; Nunes B, 2011, STAT METHODS MED RES, V20, P331, DOI 10.1177/0962280209340201; Osei FB, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-118; Padhi R, 2009, COMPUT METH PROG BIO, V94, P207, DOI 10.1016/j.cmpb.2008.12.010; Rao VSH, 2010, NONLINEAR ANAL-REAL, V11, P1810, DOI 10.1016/j.nonrwa.2009.04.006; Ren YD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042055; Shen XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060601; Song B, 2010, SCI CHINA TECHNOL SC, V53, P2049, DOI 10.1007/s11431-010-3173-7; Sunil Bhatnagar, 2012, INDIAN J PUBLIC HLTH, V56, P281; The Ministry of Health of the People's Republic of China, 2013, CHIN HLTH STAT YB 20; Thomas S, 2013, EXPERT REV VACCINES, V12, P1301, DOI 10.1586/14760584.2013.840092; Wang W, 2012, CHINESE SCI BULL, V57, P3430, DOI 10.1007/s11434-012-5386-6; Watkins RE, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-263; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Wu LF, 2013, APPL MATH MODEL, V37, P6577, DOI 10.1016/j.apm.2013.01.018; Xie NM, 2013, APPL MATH MODEL, V37, P5059, DOI 10.1016/j.apm.2012.10.037; Xu R, 2012, APPL MATH COMPUT, V218, P7927, DOI 10.1016/j.amc.2012.01.076; Yaesoubi R, 2011, EUR J OPER RES, V215, P679, DOI 10.1016/j.ejor.2011.07.016; Zhang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031076; Zhang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063116; 陈向东, 2009, [中国科学. E辑, 技术科学, Science in China. Series E, Engineering and Materials Science], V39, P341	50	5	5	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115664	10.1371/journal.pone.0115664	http://dx.doi.org/10.1371/journal.pone.0115664			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546054	Green Submitted, Green Published, gold			2022-12-27	WOS:000347120200051
J	De Schacht, C; Hoffman, HJ; Mabunda, N; Lucas, C; Alons, CL; Madonela, A; Vubil, A; Ferreira, OC; Calu, N; Santos, IS; Jani, IV; Guay, L				De Schacht, Caroline; Hoffman, Heather J.; Mabunda, Nedio; Lucas, Carlota; Alons, Catharina L.; Madonela, Ana; Vubil, Adolfo; Ferreira, Orlando C., Jr.; Calu, Nurbai; Santos, Iolanda S.; Jani, Ilesh V.; Guay, Laura			High Rates of HIV Seroconversion in Pregnant Women and Low Reported Levels of HIV Testing among Male Partners in Southern Mozambique: Results from a Mixed Methods Study	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; MALE INVOLVEMENT; EASTERN UGANDA; INCIDENT HIV; PREVENTION; INFECTION; DETERMINANTS; ATTENDANCE; DELIVERY; SERVICES	Introduction: Prevention of acute HIV infections in pregnancy is required to achieve elimination of pediatric HIV. Identification and support for HIV negative pregnant women and their partners, particularly serodiscordant couples, are critical. A mixed method study done in Southern Mozambique estimated HIV incidence during pregnancy, associated risk factors and factors influencing partner's HIV testing. Methods: Between April 2008 and November 2011, a prospective cohort of 1230 HIV negative pregnant women was followed during pregnancy. A structured questionnaire, HIV testing, and collection of dried blood spots were done at 2-3 scheduled visits. HIV incidence rates were calculated by repeat HIV testing and risk factors assessed by Poisson regression. A qualitative study including 37 individual interviews with men, women, and nurses and 11 focus group discussions (n=94) with men, women and grandmothers explored motivators and barriers to uptake of male HIV testing. Results: HIV incidence rate was estimated at 4.28/100 women-years (95% CI: 2.33-7.16). Significant risk factors for HIV acquisition were early sexual debut (RR 3.79, 95% CI: 1.04-13.78, p=0.04) and living in Maputo Province (RR 4.35, 95% CI: 0.97-19.45, p=0.05). Nineteen percent of women reported that their partner had tested for HIV (93% knew the result with 8/213 indicating an HIV positive partner), 56% said their partner had not tested and 19% did not know their partner test status. Of the 14 seroconversions, only one reported being in a serodiscordant relationship. Fear of discrimination or stigma was reported as a key barrier to male HIV testing, while knowing the importance of getting tested and receiving care was the main motivator. Conclusions: HIV incidence during pregnancy is high in Southern Mozambique, but knowledge of partners' HIV status remains low. Knowledge of both partners' HIV status is critical for maximal effectiveness of prevention and treatment services to reach elimination of pediatric HIV/AIDS.	[De Schacht, Caroline; Lucas, Carlota; Alons, Catharina L.; Madonela, Ana] Elizabeth Glaser Pediat AIDS Fdn, Res Dept, Maputo, Mozambique; [Hoffman, Heather J.; Guay, Laura] George Washington Univ, Milken Inst Sch Publ Hlth, Dept Epidemiol & Biostat, Washington, DC USA; [Mabunda, Nedio; Vubil, Adolfo; Jani, Ilesh V.] Inst Nacl Saude, Maputo, Mozambique; [Ferreira, Orlando C., Jr.] Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, Brazil; [Calu, Nurbai] Minist Hlth, Xai Xai, Mozambique; [Santos, Iolanda S.] Minist Hlth, Matola, Mozambique; [Alons, Catharina L.; Guay, Laura] Elizabeth Glaser Pediat AIDS Fdn, Res Dept, Washington, DC USA	George Washington University; Universidade Federal do Rio de Janeiro	De Schacht, C (corresponding author), Elizabeth Glaser Pediat AIDS Fdn, Res Dept, Maputo, Mozambique.	carolineds11@gmail.com	Hoffman, Heather/AAF-6429-2020	Jani, Ilesh/0000-0002-6880-6655	Elizabeth Glaser Pediatric AIDS Foundation; Bill and Melinda Gates Foundation	Elizabeth Glaser Pediatric AIDS Foundation; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The study was supported by the Elizabeth Glaser Pediatric AIDS Foundation and the Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker S, 2010, AIDS BEHAV, V14, P558, DOI 10.1007/s10461-009-9607-1; Byamugisha R, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-43; Byamugisha R, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-12; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; De Schacht C, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18808; Ditekemena J, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-32; Drake AL, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001608; Dube K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084979; Ediau M, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-189; Feldblum PJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097547; Fishel JD, 2011, HIV COUPLES MOZAMBIQ; Gray RH, 2005, LANCET, V366, P1182, DOI 10.1016/S0140-6736(05)67481-8; INS INE GTM, 2013, ROND VIG EP HIV SIF; Katz DA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007602; Kieffer MP, 2011, JAIDS-J ACQ IMM DEF, V57, pE85, DOI 10.1097/QAI.0b013e31821acc6e; Kinuthia J, 2014, C RETR OPP INF BOST; LEROY V, 1994, AIDS, V8, P983, DOI 10.1097/00002030-199407000-00017; Mbizvo M T, 2001, Cent Afr J Med, V47, P115; Mburu G, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.4.17386; Moodley D, 2009, AIDS, V23, P1255, DOI 10.1097/QAD.0b013e32832a5934; Msuya SE, 2008, AIDS CARE, V20, P700, DOI 10.1080/09540120701687059; Njau B, 2012, AIDS CARE, V24, P413, DOI 10.1080/09540121.2011.608796; Nuwaha F, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17423; Orne-Gliemann J, 2013, AIDS, V27, P1167, DOI 10.1097/QAD.0b013e32835f1d8c; Peltzer K, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-57; Peltzer K, 2013, AIDS BEHAV, V17, P508, DOI 10.1007/s10461-012-0185-2; Sherr L, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.4.17378; Ulin PR, 2005, QUALITATIVE METHODS; World Health Organization, 2010, PMTCT STRAT VIS 2010	29	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115014	10.1371/journal.pone.0115014	http://dx.doi.org/10.1371/journal.pone.0115014			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542035	Green Published, Green Submitted, gold			2022-12-27	WOS:000347239900018
J	Klein, JD; Sherrill, JB; Morello, GM; Miguel, PJS; Ding, ZM; Liangpunsakul, S; Liang, TB; Muir, WM; Lumeng, L; Lossie, AC				Klein, Jonathon D.; Sherrill, Jeremy B.; Morello, Gabriella M.; Miguel, Phillip J. San; Ding, Zhenming; Liangpunsakul, Suthat; Liang, Tiebing; Muir, William M.; Lumeng, Lawrence; Lossie, Amy C.			A Snapshot of the Hepatic Transcriptome: Ad Libitum Alcohol Intake Suppresses Expression of Cholesterol Synthesis Genes in Alcohol-Preferring (P) Rats	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; LIVER-DISEASE; MULTIPLE CONCENTRATIONS; CARDIOVASCULAR-DISEASE; SINGLE CONCENTRATION; CONCURRENT ACCESS; MESSENGER-RNA; ETHANOL; METABOLISM; PROTEIN	Research is uncovering the genetic and biochemical effects of consuming large quantities of alcohol. One prime example is the J- or U-shaped relationship between the levels of alcohol consumption and the risk of atherosclerotic cardiovascular disease. Moderate alcohol consumption in humans (about 30 g ethanol/d) is associated with reduced risk of coronary heart disease, while abstinence and heavier alcohol intake is linked to increased risk. However, the hepatic consequences of moderate alcohol drinking are largely unknown. Previous data from alcohol-preferring (P) rats showed that chronic consumption does not produce significant hepatic steatosis in this well-established model. Therefore, free-choice alcohol drinking in P rats may mimic low risk or nonhazardous drinking in humans, and chronic exposure in P animals can illuminate the molecular underpinnings of free-choice drinking in the liver. To address this gap, we captured the global, steady-state liver transcriptome following a 23 week free-choice, moderate alcohol consumption regimen (similar to 7.43 g ethanol/kg/day) in inbred alcoholpreferring (iP10a) rats. Chronic consumption led to down-regulation of nine genes in the cholesterol biosynthesis pathway, including HMG-CoA reductase, the rate-limiting step for cholesterol synthesis. These findings corroborate our phenotypic analyses, which indicate that this paradigm produced animals whose hepatic triglyceride levels, cholesterol levels and liver histology were indistinguishable from controls. These findings explain, at least in part, the J- or U-shaped relationship between cardiovascular risk and alcohol intake, and provide outstanding candidates for future studies aimed at understanding the mechanisms that underlie the salutary cardiovascular benefits of chronic low risk and nonhazardous alcohol intake.	[Klein, Jonathon D.; Muir, William M.; Lossie, Amy C.] Purdue Univ, Interdisciplinary Life Sci Grad Program, W Lafayette, IN 47907 USA; [Klein, Jonathon D.; Sherrill, Jeremy B.; Morello, Gabriella M.; Muir, William M.; Lossie, Amy C.] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA; Purdue Univ, Core Facil, W Lafayette, IN 47907 USA; [Miguel, Phillip J. San] Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA; [Ding, Zhenming] Indiana Univ, Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [Liangpunsakul, Suthat; Liang, Tiebing; Muir, William M.; Lumeng, Lawrence; Lossie, Amy C.] Indiana Univ, Sch Med, Dept Med, Indianapolis, IN USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Lossie, AC (corresponding author), NIH, Off Behav & Social Sci Res, Off Director, Bldg 10, Bethesda, MD 20892 USA.	amy.lossie@nih.gov	Morello, Gabriela/P-1005-2017; SanMiguel, Phillip J/I-2196-2015	Morello, Gabriela/0000-0002-5439-969X; SanMiguel, Phillip J/0000-0002-3742-9527; Liang, Tiebing/0000-0002-8445-3765; Ding, Zheng-Ming/0000-0001-9202-4007	National Center for Advancing Translational Science [UL1TR00110801]; National Institute on Alcohol Abuse and Alcoholism [R24 AA015512 06, R24 AA015512 06S1, P60 AA007611 24]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R24AA015512, U24AA015512, P60AA007611] Funding Source: NIH RePORTER	National Center for Advancing Translational Science; National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was funded by grant numbers: UL1TR00110801 (National Center for Advancing Translational Science; http://www.ncats.nih.gov) to ACL and LL; R24 AA015512 06, R24 AA015512 06S1 and P60 AA007611 24 (National Institute on Alcohol Abuse and Alcoholism; http://www.niaaa.nih.gov) to LL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmegeed MA, 2005, J PHARMACOL EXP THER, V315, P203, DOI 10.1124/jpet.105.084608; Bardag-Gorce F, 2002, GASTROENTEROLOGY, V123, P325, DOI 10.1053/gast.2002.34177; Bardag-Gorce F, 2006, EXP MOL PATHOL, V81, P191, DOI 10.1016/j.yexmp.2006.07.007; Bell RL, 2006, ADDICT BIOL, V11, P270, DOI 10.1111/j.1369-1600.2005.00029.x; Bell RL, 2004, ALCOHOL, V33, P107, DOI [10.1016/S0741-8329(04)00096-5, 10.1016/j.alcohol.2004.06.001]; Bell RL, 2003, ALCOHOL, V29, P137, DOI 10.1016/S0741-8329(03)00022-3; Bhave SV, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-59; Boujedidi H, 2012, ALCOHOL CLIN EXP RES, V36, P258, DOI 10.1111/j.1530-0277.2011.01627.x; Bradford BU, 2005, HEPATOLOGY, V41, P336, DOI 10.1002/hep.20532; Brandon-Warner E, 2012, ALCOHOL; Carnevale R, 2012, VASC PHARMACOL, V57, P69, DOI 10.1016/j.vph.2012.06.005; Carr LG, 2006, BEHAV GENET, V36, P285, DOI 10.1007/s10519-005-9021-z; CEDERBAUM AI, 1987, ANN NY ACAD SCI, V492, P35, DOI 10.1111/j.1749-6632.1987.tb48651.x; Cederbaum AI, 2012, CLIN LIVER DIS, V16, P667, DOI 10.1016/j.cld.2012.08.002; Crabb DW, 2004, P NUTR SOC, V63, P49, DOI 10.1079/PNS2003327; Deaciuc IV, 2004, ALCOHOL, V33, P17, DOI 10.1016/j.alcohol.2004.04.001; Deaciuc IV, 2004, ALCOHOL, V32, P113, DOI 10.1016/j.alcohol.2003.12.001; Esfandiari F, 2005, AM J PHYSIOL-GASTR L, V289, pG54, DOI 10.1152/ajpgi.00542.2004; Gunzerath L, 2004, ALCOHOL CLIN EXP RES, V28, P829, DOI 10.1097/01.ALC.0000128382.79375.B6; Hall PDM, 2001, ALCOHOL CLIN EXP RES, V25, p254S, DOI 10.1111/j.1530-0277.2001.tb02405.x; Hannuksela ML, 2002, CRIT REV CL LAB SCI, V39, P225, DOI 10.1080/10408360290795529; Jeong KS, 2000, ARCH BIOCHEM BIOPHYS, V384, P81, DOI 10.1006/abbi.2000.2119; Joenje H, 2011, NATURE, V475, P45, DOI 10.1038/475045a; Kannel WB, 1996, CLIN CHIM ACTA, V246, P59; KELLER H, 1993, ANN NY ACAD SCI, V684, P157, DOI 10.1111/j.1749-6632.1993.tb32279.x; Lakshman R, 2010, GENES NUTR, V5, P111, DOI 10.1007/s12263-009-0161-2; LAKSHMANAN MR, 1977, J LIPID RES, V18, P325; Leppala JM, 1999, CIRCULATION, V100, P1209, DOI 10.1161/01.CIR.100.11.1209; LESTER D, 1973, Pharmacology Biochemistry and Behavior, V1, P103, DOI 10.1016/0091-3057(73)90062-2; LIEBER CS, 1989, ALCOHOL ALCOHOLISM, V24, P197; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Majchrowicz E, 1979, BIOCH PHARM ETHANOL; MARMOT M, 1991, BMJ-BRIT MED J, V303, P565, DOI 10.1136/bmj.303.6802.565; Mason JB, 2005, ALCOHOL, V35, P235, DOI 10.1016/j.alcohol.2005.03.012; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mureddu GF, 2012, J CARDIOVASC MED, V13, P575, DOI 10.2459/JCM.0b013e32834bb3c8; Murphy JM, 2002, BEHAV GENET, V32, P363, DOI 10.1023/A:1020266306135; Muzio G, 2012, FREE RADICAL BIO MED, V52, P735, DOI 10.1016/j.freeradbiomed.2011.11.033; O'Keefe JH, 2007, J AM COLL CARDIOL, V50, P1009, DOI 10.1016/j.jacc.2007.04.089; Park SH, 2008, FOOD CHEM TOXICOL, V46, P1378, DOI 10.1016/j.fct.2007.08.029; Ramos EM, 2014, EUR J HUM GENET, V22, P144, DOI 10.1038/ejhg.2013.96; Rao MN, 2003, METABOLISM, V52, P1287, DOI 10.1016/S0026-0495(03)00191-4; Rimm EB, 1999, BMJ-BRIT MED J, V319, P1523, DOI 10.1136/bmj.319.7224.1523; Sakakura Y, 2001, BIOCHEM BIOPH RES CO, V286, P176, DOI 10.1006/bbrc.2001.5375; Seth D, 2011, J GASTROEN HEPATOL, V26, P1089, DOI 10.1111/j.1440-1746.2011.06756.x; SONG BJ, 1986, J BIOL CHEM, V261, P6689; TSUKAMOTO H, 1984, AM J PHYSIOL, V247, pR595, DOI 10.1152/ajpregu.1984.247.3.R595; TSUTSUMI M, 1993, ARCH BIOCHEM BIOPHYS, V304, P209, DOI 10.1006/abbi.1993.1341; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Yin HQ, 2007, TOXICOL APPL PHARM, V223, P225, DOI 10.1016/j.taap.2007.06.018; Yin HQ, 2009, TOXICOL APPL PHARM, V235, P312, DOI 10.1016/j.taap.2008.12.018; Yip-Schneider MT, 2011, ALCOHOL CLIN EXP RES, V35, P2216, DOI 10.1111/j.1530-0277.2011.01568.x; Yoon Y, 1998, AM J PHYSIOL-GASTR L, V274, pG757, DOI 10.1152/ajpgi.1998.274.4.G757; Zakhari S, 2006, ALCOHOL RES HEALTH, V29, P245	54	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e110501	10.1371/journal.pone.0110501	http://dx.doi.org/10.1371/journal.pone.0110501			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542004	Green Published, Green Submitted, gold			2022-12-27	WOS:000347239900003
J	Song, L; Zhang, JR; Li, C; Yao, J; Jiang, C; Li, Y; Liu, SK; Liu, ZJ				Song, Lin; Zhang, Jiaren; Li, Chao; Yao, Jun; Jiang, Chen; Li, Yun; Liu, Shikai; Liu, Zhanjiang			Genome-Wide Identification of Hsp40 Genes in Channel Catfish and Their Regulated Expression after Bacterial Infection	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; MULTIPLE SEQUENCE ALIGNMENT; RNA-SEQ ANALYSIS; DIFFERENTIAL EXPRESSION; PLASMODIUM-FALCIPARUM; J-DOMAIN; RECEPTOR; HSP70; INNATE; RESPONSES	Heat shock proteins (HSPs) consist of a large group of chaperones whose expression is induced by high temperature, hypoxia, infection and a number of other stresses. Among all the HSPs, Hsp40 is the largest HSP family, which bind to Hsp70 ATPase domain in assisting protein folding. In this study, we identified 57 hsp40s in channel catfish (Ictalurus punctatus) through in silico analysis using RNA-Seq and genome databases. These genes can be classified into three different types, Type I, II and III, based on their structural similarities. Phylogenetic and syntenic analyses provided strong evidence in supporting the orthologies of these HSPs. Meta-analyses of RNA-Seq datasets were conducted to analyze expression profile of Hsp40s following bacterial infection. Twenty seven hsp40s were found to be significantly up-or down-regulated in the liver after infection with E. ictaluri; 19 hsp40s were found to be significantly regulated in the intestine after infection with E. ictaluri; and 19 hsp40s were found to be significantly regulated in the gill following infection with F. columnare. Altogether, a total of 42 Hsp40 genes were regulated under disease situations involving three tissues and two bacterial infections. The significant regulated expression of Hsp40 genes after bacterial infection suggested their involvement in disease defenses in catfish.	[Song, Lin; Zhang, Jiaren; Li, Chao; Yao, Jun; Jiang, Chen; Li, Yun; Liu, Shikai; Liu, Zhanjiang] Auburn Univ, Sch Fisheries Aquaculture & Aquat Sci, Aquat Genom Unit, Fish Mol Genet & Biotechnol Lab, Auburn, AL 36849 USA	Auburn University System; Auburn University	Liu, ZJ (corresponding author), Auburn Univ, Sch Fisheries Aquaculture & Aquat Sci, Aquat Genom Unit, Fish Mol Genet & Biotechnol Lab, 203 Swingle Hall, Auburn, AL 36849 USA.	liuzhan@auburn.edu	song, ling/GQZ-5934-2022; Liu, Zhanjiang/R-9633-2019; Song, Lin/GMW-6891-2022; Li, Chao/GSM-8117-2022; Liu, Shikai/D-4664-2013	Song, Lin/0000-0002-1245-681X; Li, Chao/0000-0001-6110-6210; Liu, Shikai/0000-0001-5777-489X; Li, Chao/0000-0002-1950-0190	Agriculture and Food Research Initiative from the USDA National Institute of Food and Agriculture (NIFA) [2009-35205-05101, 2010-65205-20356]	Agriculture and Food Research Initiative from the USDA National Institute of Food and Agriculture (NIFA)	This project was supported by Agriculture and Food Research Initiative Competitive Grants 2009-35205-05101 and 2010-65205-20356 from the USDA National Institute of Food and Agriculture (NIFA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman PA, 2001, J AQUAT ANIM HEALTH, V13, P173, DOI 10.1577/1548-8667(2001)013&lt;0173:PACSRO&gt;2.0.CO;2; Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; Basu S, 2001, IMMUNITY, V14, P303, DOI 10.1016/S1074-7613(01)00111-X; BECKMANN RP, 1990, SCIENCE, V248, P850, DOI 10.1126/science.2188360; Botha M, 2007, INT J BIOCHEM CELL B, V39, P1781, DOI 10.1016/j.biocel.2007.02.011; Brinker A, 2002, J BIOL CHEM, V277, P19265, DOI 10.1074/jbc.M109002200; Cha IS, 2013, FISH SHELLFISH IMMUN, V34, P1455, DOI 10.1016/j.fsi.2013.03.355; Cheetham ME, 1998, CELL STRESS CHAPERON, V3, P28, DOI 10.1379/1466-1268(1998)003<0028:SFAEOD>2.3.CO;2; Chen F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011546; Chen W, 1999, J IMMUNOL, V162, P3212; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Dong CW, 2006, FISH SHELLFISH IMMUN, V21, P146, DOI 10.1016/j.fsi.2005.11.002; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ELLIS J, 1987, NATURE, V328, P378, DOI 10.1038/328378a0; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Forsyth RB, 1997, J AQUAT ANIM HEALTH, V9, P18, DOI 10.1577/1548-8667(1997)009&lt;0018:SPEICS&gt;2.3.CO;2; FREEMAN BC, 1995, EMBO J, V14, P2281, DOI 10.1002/j.1460-2075.1995.tb07222.x; Habich C, 2002, J IMMUNOL, V168, P569, DOI 10.4049/jimmunol.168.2.569; Hennessy F, 2005, PROTEIN SCI, V14, P1697, DOI 10.1110/ps.051406805; Hennessy F, 2000, CELL STRESS CHAPERON, V5, P347, DOI 10.1379/1466-1268(2000)005<0347:AOTLOC>2.0.CO;2; Houry WA, 2001, CURR PROTEIN PEPT SC, V2, P227, DOI 10.2174/1389203013381134; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kelley WL, 1998, TRENDS BIOCHEM SCI, V23, P222, DOI 10.1016/S0968-0004(98)01215-8; Kol A, 2000, J IMMUNOL, V164, P13, DOI 10.4049/jimmunol.164.1.13; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lassmann T, 2006, NUCLEIC ACIDS RES, V34, pW596, DOI 10.1093/nar/gkl191; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Li C, 2012, FISH SHELLFISH IMMUN, V32, P816, DOI 10.1016/j.fsi.2012.02.004; Liu FH, 1999, J BIOL CHEM, V274, P34425, DOI 10.1074/jbc.274.48.34425; Liu SK, 2013, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-595; Liu SK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-53; Mayer MP, 1999, J MOL BIOL, V289, P1131, DOI 10.1006/jmbi.1999.2844; Morahan BJ, 2011, EUKARYOT CELL, V10, P1492, DOI 10.1128/EC.05155-11; Nair S, 2013, J CANCER RES THER, V9, P624, DOI 10.4103/0973-1482.126460; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Oshlack A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-220; Peatman E, 2013, MOL IMMUNOL, V56, P317, DOI 10.1016/j.molimm.2013.04.014; Pockley AG, 2003, LANCET, V362, P469, DOI 10.1016/S0140-6736(03)14075-5; Pridgeon JW, 2010, J FISH DIS, V33, P497, DOI 10.1111/j.1365-2761.2010.01159.x; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Roberts RJ, 2010, J FISH DIS, V33, P789, DOI 10.1111/j.1365-2761.2010.01183.x; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Singh-Jasuja H, 2000, EUR J IMMUNOL, V30, P2211, DOI 10.1002/1521-4141(2000)30:8<2211::AID-IMMU2211>3.0.CO;2-0; Srivastava P, 2002, NAT REV IMMUNOL, V2, P185, DOI 10.1038/nri749; Sun FY, 2012, DEV COMP IMMUNOL, V38, P169, DOI 10.1016/j.dci.2012.05.006; Sung YY., 2011, J AQUACUL RES DEV, V2, P006, DOI [10.4172/2155-9546, DOI 10.4172/2155-9546.S2-006, DOI 10.4172/2155-9546]; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tsai J, 1996, J BIOL CHEM, V271, P9347, DOI 10.1074/jbc.271.16.9347; Vabulas RM, 2001, J BIOL CHEM, V276, P31332, DOI 10.1074/jbc.M103217200; Walsh P, 2004, EUROPEAN MOL BIOL OR, V5, P5, DOI DOI 10.1038/SJ.EMB0R.7400172; Wang RJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-929; Wang S, 2011, SNP DISCOVERY EST DA; WELCH WJ, 1993, SCI AM, V268, P56, DOI 10.1038/scientificamerican0593-56	55	25	26	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115752	10.1371/journal.pone.0115752	http://dx.doi.org/10.1371/journal.pone.0115752			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542027	gold, Green Submitted, Green Published			2022-12-27	WOS:000347239900078
J	Zhou, Y; Li, NN; Grace, J; Yang, M; Lu, C; Geng, XM; Lei, GC; Zhu, W; Deng, YF				Zhou, Yan; Li, Nana; Grace, John; Yang, Meng; Lu, Cai; Geng, Xuemeng; Lei, Guangchun; Zhu, Wei; Deng, Yongfeng			Impact of Groundwater Table and Plateau Zokors (Myospalax baileyi) on Ecosystem Respiration in the Zoige Peatlands of China	PLOS ONE			English	Article							CARBON-DIOXIDE FLUX; NITROUS-OXIDE; ORGANIC-CARBON; SOIL; METHANE; EMISSIONS; SLURRY; FONTANIERII; TEMPERATURE; VEGETATION	Peatlands contain large amount of carbon stock that is vulnerable to release into the atmosphere. Mostly because of human impact, the peatlands at Zoige Wetlands face severe degradation, and the groundwater table is now lower than before, which has increased the population of the plateau zokor, a burrowing rodent. However, the impact of these changes on ecosystem carbon flows has not been studied. To investigate how the plateau zokor and the groundwater level alter the ecosystem respiration of the Zoige peatlands, we sampled the CO2 flux of hummocks shaped by the zokors and compared it with the CO2 flux of undisturbed sites with different groundwater table levels. The soil organic carbon (SOC), soil water content (SWC) and soil temperature at 5 cm (T-5) were measured. SOC showed no significant difference among the four sampling sites and did not correlate with the CO2 flux, while SWC was found to partly determine the CO2 flux. A linear equation could adequately describe the relationship between the natural logarithm of the ecosystem respiration and the soil temperature. It is demonstrated that descending groundwater table might accelerate ecosystem respiration and the CO2 flux from hummocks was higher than the CO2 flux from the control site in the non-growing season. With rising temperature, the CO2 flux from the control site accelerated faster than that from the hummocks. Our results show that ecosystem respiration was significantly lower from hummocks than at the control site in the growing season. The results on the impact of zokors on greenhouse gas emissions presented in this paper provide a useful reference to help properly manage not only this, but other litter-burrowing mammals at peatland sites.	[Zhou, Yan; Li, Nana; Yang, Meng; Lu, Cai; Geng, Xuemeng; Lei, Guangchun] Beijing Forestry Univ, Sch Nat Conservat, Beijing, Peoples R China; [Grace, John] Univ Edinburgh, Sch Geosci, Edinburgh, Midlothian, Scotland; [Zhu, Wei; Deng, Yongfeng] Management Bur Zoige Natl Nat Reserve, Qingchuan, Sichuan, Peoples R China	Beijing Forestry University; University of Edinburgh	Lei, GC (corresponding author), Beijing Forestry Univ, Sch Nat Conservat, Beijing, Peoples R China.	leiguangchunbjfu@gmail.com	Guangchun, Lei/ABC-8081-2021; Grace, John/N-9280-2013	Zhou, Yan/0000-0003-1774-7402	Special Research Program for Public-welfare Forestry [200804005]	Special Research Program for Public-welfare Forestry	Funding: This work was financially supported by the Special Research Program for Public-welfare Forestry (200804005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beetz S, 2013, BIOGEOSCIENCES, V10, P1067, DOI 10.5194/bg-10-1067-2013; Chadwick DR, 1997, AGR ECOSYST ENVIRON, V63, P51, DOI 10.1016/S0167-8809(96)01119-X; Chen H, 2009, ATMOS ENVIRON, V43, P4995, DOI 10.1016/j.atmosenv.2009.07.001; Chen L, 2010, J CHINA W NORMAL U N, V31, P122; Chen WW, 2011, PLANT SOIL, V340, P291, DOI 10.1007/s11104-010-0367-5; Couwenberg J, 2010, GLOBAL CHANGE BIOL, V16, P1715, DOI 10.1111/j.1365-2486.2009.02016.x; Davidson AD, 2012, FRONT ECOL ENVIRON, V10, P477, DOI 10.1890/110054; Davidson EA, 2006, GLOBAL CHANGE BIOL, V12, P154, DOI 10.1111/j.1365-2486.2005.01065.x; Delibes-Mateos M, 2011, BIOL CONSERV, V144, P1335, DOI 10.1016/j.biocon.2011.02.012; Fan NaiChang, 1999, Ecologically-based management of rodent pests., P285; Fan ZS, 2013, GLOBAL CHANGE BIOL, V19, P604, DOI 10.1111/gcb.12041; Giardina CP, 2000, NATURE, V404, P858, DOI 10.1038/35009076; GORHAM E, 1991, ECOL APPL, V1, P182, DOI 10.2307/1941811; Grace J, 2000, NATURE, V404, P819, DOI 10.1038/35009170; Hogan BW, 2010, PLATEAU PIKA KEYSTON; Inc S, 2009, PASW STAT 17 0; Ives SL, 2013, ECOHYDROLOGY, V6, P38, DOI 10.1002/eco.274; Jagermeyr J, 2014, GLOBAL CHANGE BIOL, V20, P1191, DOI 10.1111/gcb.12443; Juszczak R, 2013, PLANT SOIL, V366, P505, DOI 10.1007/s11104-012-1441-y; Leifeld J, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051856; Limbach WE, 2000, FORMATION EVOLUTION, P509; Liu YS, 2013, PLANT SOIL, V366, P491, DOI 10.1007/s11104-012-1442-x; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Luo Q, 2008, PLATEAU MOUNTAIN MET, P44; Makiranta P, 2012, SOIL BIOL BIOCHEM, V48, P1, DOI 10.1016/j.soilbio.2012.01.005; Maljanen M, 2001, PLANT SOIL, V231, P113, DOI 10.1023/A:1010372914805; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; Rochette P, 2004, SOIL SCI SOC AM J, V68, P1410, DOI 10.2136/sssaj2004.1410; Rochette P, 2008, CAN J SOIL SCI, V88, P175, DOI 10.4141/CJSS06016; Rodhe L, 2006, SOIL USE MANAGE, V22, P229, DOI 10.1111/j.1475-2743.2006.00043.x; Schmidt-Nielsen K., 1997, Animal physiology: adaptation and environment.; Semenov MV, 2010, EURASIAN SOIL SCI+, V43, P541, DOI 10.1134/S1064229310050078; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Turunen J, 2002, HOLOCENE, V12, P69, DOI 10.1191/0959683602hl522rp; Urbanova Z, 2012, PLANT ECOL DIVERS, V5, P89, DOI 10.1080/17550874.2012.688069; Yu Z., 2011, EOS T AM GEOPHYS UN, V92, P97, DOI DOI 10.1029/2011EO120001; Yu Zicheng, 2010, GEOPHYS RES LETT, V37; Zhang LH, 2012, EUR J SOIL BIOL, V48, P24, DOI 10.1016/j.ejsobi.2011.10.001; Zhang YM, 2003, MAMMAL REV, V33, P284, DOI 10.1046/j.1365-2907.2003.00020.x; Zhang YM, 2003, J MAMMAL, V84, P644, DOI 10.1644/1545-1542(2003)084&lt;0644:EOPZMF&gt;2.0.CO;2	40	8	10	3	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115542	10.1371/journal.pone.0115542	http://dx.doi.org/10.1371/journal.pone.0115542			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542023	Green Submitted, gold, Green Published			2022-12-27	WOS:000347239900051
J	Downey, JS; Mashburn-Warren, L; Ayala, EA; Senadheera, DB; Hendrickson, WK; McCall, LW; Sweet, JG; Cvitkovitch, DG; Spatafora, GA; Goodman, SD				Downey, Jennifer S.; Mashburn-Warren, Lauren; Ayala, Eduardo A.; Senadheera, Dilani B.; Hendrickson, Whitney K.; McCall, Lathan W.; Sweet, Julie G.; Cvitkovitch, Dennis G.; Spatafora, Grace A.; Goodman, Steven D.			In vitro Manganese-Dependent Cross-Talk between Streptococcus mutans VicK and GcrR: Implications for Overlapping Stress Response Pathways	PLOS ONE			English	Article							GROUP-A STREPTOCOCCUS; GLUCOSYLTRANSFERASE GTFBC OPERON; SIGNAL-TRANSDUCTION SYSTEM; BIOFILM FORMATION; 2-COMPONENT SYSTEM; GENETIC COMPETENCE; REGULATORY SYSTEM; EXPRESSION; VIRULENCE; GROWTH	Streptococcus mutans, a major acidogenic component of the dental plaque biofilm, has a key role in caries etiology. Previously, we demonstrated that the VicRK two-component signal transduction system modulates biofilm formation, oxidative stress and acid tolerance responses in S. mutans. Using in vitro phosphorylation assays, here we demonstrate for the first time, that in addition to activating its cognate response regulator protein, the sensor kinase, VicK can transphosphorylate a non-cognate stress regulatory response regulator, GcrR, in the presence of manganese. Manganese is an important micronutrient that has been previously correlated with caries incidence, and which serves as an effector of SloR-mediated metalloregulation in S. mutans. Our findings supporting regulatory effects of manganese on the VicRK, GcrR and SloR, and the cross-regulatory networks formed by these components are more complex than previously appreciated. Using DNaseI footprinting we observed overlapping DNA binding specificities for VicR and GcrR in native promoters, consistent with these proteins being part of the same transcriptional regulon. Our results also support a role for SloR as a positive regulator of the vicRK two component signaling system, since its transcription was drastically reduced in a SloR-deficient mutant. These findings demonstrate the regulatory complexities observed with the S. mutans manganese-dependent response, which involves cross-talk between non-cognate signal transduction systems (VicRK and GcrR) to modulate stress response pathways.	[Downey, Jennifer S.; Ayala, Eduardo A.] Univ So Calif, Div Biomed Sci, Herman Ostrow Sch Dent, Los Angeles, CA USA; [Mashburn-Warren, Lauren; Goodman, Steven D.] Nationwide Childrens Hosp, Res Inst, Ctr Microbial Pathogenesis, Columbus, OH USA; [Senadheera, Dilani B.; Cvitkovitch, Dennis G.] Univ Toronto, Fac Dent, Dent Res Inst, Toronto, ON, Canada; [Hendrickson, Whitney K.; McCall, Lathan W.; Sweet, Julie G.; Spatafora, Grace A.] Middlebury Coll, Dept Biol, Middlebury, VT 05753 USA	University of Southern California; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University of Toronto	Spatafora, GA (corresponding author), Middlebury Coll, Dept Biol, Middlebury, VT 05753 USA.	spatafor@middlebury.edu; steven.goodman@nationwidechildrens.org	Goodman, Steven/C-5732-2013; H, W/AAM-2887-2020; Cvitkovitch, Dennis/AAF-9311-2020	Spatafora, Grace/0000-0003-2043-4853; Hendrickson, Whitney/0000-0003-4603-2879	National Institutes 6 of Health [5R01DE013230-09, 5R01DE014711-09]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013230] Funding Source: NIH RePORTER	National Institutes 6 of Health; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the following grants funded by the National Institutes 6 of Health: 5R01DE013230-09 to S. D. G. & D. G. C. and 5R01DE014711-09 to G. A. S. & S. D. G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the mansucript.	Adkins B L, 1970, N Y State Dent J, V36, P618; Ahn SJ, 2007, J BACTERIOL, V189, P8519, DOI 10.1128/JB.01180-07; Ahn SJ, 2007, J BACTERIOL, V189, P6293, DOI 10.1128/JB.00546-07; Ajdic D, 2002, P NATL ACAD SCI USA, V99, P14434, DOI 10.1073/pnas.172501299; Anjem A, 2009, MOL MICROBIOL, V72, P844, DOI 10.1111/j.1365-2958.2009.06699.x; ARCHIBALD FS, 1981, J BACTERIOL, V146, P928, DOI 10.1128/JB.146.3.928-936.1981; Arirachakaran P, 2007, CARIES RES, V41, P497, DOI 10.1159/000110882; Ayala E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108027; Banas JA, 2004, FRONT BIOSCI-LANDMRK, V9, P1267, DOI 10.2741/1305; BELLI WA, 1991, APPL ENVIRON MICROB, V57, P1134, DOI 10.1128/AEM.57.4.1134-1138.1991; Biswas S, 2006, J BACTERIOL, V188, P988, DOI 10.1128/JB.188.3.988-998.2006; Chevallet M, 2006, NAT PROTOC, V1, P1852, DOI 10.1038/nprot.2006.288; Cho KH, 2005, MOL MICROBIOL, V57, P1545, DOI 10.1111/j.1365-2958.2005.04786.x; Chong P, 2008, J BACTERIOL, V190, P4478, DOI 10.1128/JB.01961-07; Clausen VA, 2003, J MOL MICROB BIOTECH, V5, P252, DOI 10.1159/000071077; Dalton TL, 2006, J BACTERIOL, V188, P77, DOI 10.1128/JB.188.1.77-85.2006; Dalton TL, 2004, J BACTERIOL, V186, P3928, DOI 10.1128/JB.186.12.3928-3937.2004; Daly MJ, 2009, NAT REV MICROBIOL, V7, P237, DOI 10.1038/nrmicro2073; Deng DM, 2007, J DENT RES, V86, P606, DOI 10.1177/154405910708600705; Dmitriev A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020127; Dubrac S, 2004, J BACTERIOL, V186, P1175, DOI 10.1128/JB.186.4.1175-1181.2004; Dubrac S, 2007, J BACTERIOL, V189, P8257, DOI 10.1128/JB.00645-07; Dubrac S, 2008, MOL MICROBIOL, V70, P1307, DOI 10.1111/j.1365-2958.2008.06483.x; Dunning DW, 2008, MICROBIOL-SGM, V154, P1132, DOI 10.1099/mic.0.2007/012492-0; Duque C, 2011, INFECT IMMUN, V79, P786, DOI 10.1128/IAI.00725-10; Eguchi Y, 2011, ANTIMICROB AGENTS CH, V55, P1475, DOI 10.1128/AAC.01646-10; Fabret C, 1998, J BACTERIOL, V180, P6375; Fozo EM, 2004, J BACTERIOL, V186, P4152, DOI 10.1128/JB.186.13.4152-4158.2004; Froehlich BJ, 2009, J BACTERIOL, V191, P673, DOI 10.1128/JB.01256-08; Fujiwara T, 2002, J DENT RES, V81, P109, DOI 10.1177/154405910208100205; Goodman SD, 2000, PLASMID, V43, P85, DOI 10.1006/plas.1999.1444; Graham MR, 2005, AM J PATHOL, V166, P455, DOI 10.1016/S0002-9440(10)62268-7; Graham MR, 2002, P NATL ACAD SCI USA, V99, P13855, DOI 10.1073/pnas.202353699; Gryllos I, 2003, P NATL ACAD SCI USA, V100, P4227, DOI 10.1073/pnas.0636231100; Guckes KR, 2013, P NATL ACAD SCI USA, V110, P16592, DOI 10.1073/pnas.1315320110; Hamilton IR, 1998, ORAL MICROBIOL IMMUN, V13, P292, DOI 10.1111/j.1399-302X.1998.tb00710.x; Hanna MN, 2001, J BACTERIOL, V183, P5964, DOI 10.1128/JB.183.20.5964-5973.2001; Hoch JA, 1995, 2 COMPONENT SIGNAL T; Idone V, 2003, INFECT IMMUN, V71, P4351, DOI 10.1128/IAI.71.8.4351-4360.2003; Jakubovics NS, 2002, MICROBIOL-SGM, V148, P3255, DOI 10.1099/00221287-148-10-3255; Jakubovics NS, 2001, MICROBIOL-SGM, V147, P1709, DOI 10.1099/00221287-147-7-1709; Kitten T, 2000, INFECT IMMUN, V68, P4441, DOI 10.1128/IAI.68.8.4441-4451.2000; KOBAYASHI H, 1986, J BIOL CHEM, V261, P627; Kremer BHA, 2001, J BACTERIOL, V183, P2543, DOI 10.1128/JB.183.8.2543-2552.2001; Li YH, 2002, J BACTERIOL, V184, P6333, DOI 10.1128/JB.184.22.6333-6342.2002; Li YH, 2001, J BACTERIOL, V183, P897, DOI 10.1128/JB.183.3.897-908.2001; Li YH, 2001, MICROBIOL-SGM, V147, P2841, DOI 10.1099/00221287-147-10-2841; Liang Z, 2013, J BIOL CHEM, V288, P6561, DOI 10.1074/jbc.M112.442657; Loo CY, 2000, J BACTERIOL, V182, P1374, DOI 10.1128/JB.182.5.1374-1382.2000; LULU, 1992, INFECT IMMUN, V60, P3807; Mattos-Graner RO, 2006, J BACTERIOL, V188, P3813, DOI 10.1128/JB.01845-05; Mattos-Graner RO, 2004, J CLIN MICROBIOL, V42, P4586, DOI 10.1128/JCM.42.10.4586-4592.2004; Monchois V, 1999, FEMS MICROBIOL REV, V23, P131, DOI 10.1016/S0168-6445(98)00041-2; Ong CLY, 2013, INFECT IMMUN, V81, P421, DOI 10.1128/IAI.00805-12; Paik S, 2003, J BACTERIOL, V185, P5967, DOI 10.1128/JB.185.20.5967-5975.2003; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Quivey RG, 2000, ADV MICROB PHYSIOL, V42, P239, DOI 10.1016/S0065-2911(00)42004-7; Rolerson E, 2006, J BACTERIOL, V188, P5033, DOI 10.1128/JB.00155-06; Senadheera D, 2009, J BACTERIOL, V191, P6415, DOI 10.1128/JB.00793-09; Senadheera DB, 2012, J BACTERIOL, V194, P1307, DOI 10.1128/JB.06071-11; Senadheera MD, 2007, J BACTERIOL, V189, P1451, DOI 10.1128/JB.01161-06; Senadheera MD, 2005, J BACTERIOL, V187, P4064, DOI 10.1128/JB.187.12.4064-4076.2005; Shaw W V, 1975, Methods Enzymol, V43, P737; Spatafora G, 2001, MICROBIOL-SGM, V147, P1599, DOI 10.1099/00221287-147-6-1599; Stipp RN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058271; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Virtaneva K, 2005, P NATL ACAD SCI USA, V102, P9014, DOI 10.1073/pnas.0503671102; Wagner C, 2002, INFECT IMMUN, V70, P6121, DOI 10.1128/IAI.70.11.6121-6128.2002; Wang C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001493; Wayne KJ, 2012, MOL MICROBIOL, V86, P645, DOI 10.1111/mmi.12006; WEXLER DL, 1993, INFECT IMMUN, V61, P1259, DOI 10.1128/IAI.61.4.1259-1267.1993; Zeng L, 2008, MOL MICROBIOL, V70, P197, DOI 10.1111/j.1365-2958.2008.06403.x	72	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115975	10.1371/journal.pone.0115975	http://dx.doi.org/10.1371/journal.pone.0115975			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536343	Green Published, gold, Green Submitted			2022-12-27	WOS:000348563300094
J	Gonzalez-Granado, JM; Navarro-Puche, A; Molina-Sanchez, P; Blanco-Berrocal, M; Viana, R; de Mora, JF; Andres, V				Gonzalez-Granado, Jose M.; Navarro-Puche, Ana; Molina-Sanchez, Pedro; Blanco-Berrocal, Marta; Viana, Rosa; Font de Mora, Jaime; Andres, Vicente			Sorting Nexin 6 Enhances Lamin A Synthesis and Incorporation into the Nuclear Envelope	PLOS ONE			English	Article							A-TYPE LAMINS; ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEINS; CHROMATIN ORGANIZATION; MULTIPLE MECHANISMS; MUSCULAR-DYSTROPHY; C-FOS; CELLS; TRANSPORT; RETROMER	Nuclear lamins are important structural and functional proteins in mammalian cells, but little is known about the mechanisms and cofactors that regulate their traffic into the nucleus. Here, we demonstrate that trafficking of lamin A, but not lamin B1, and its assembly into the nuclear envelope are regulated by sorting nexin 6 (SNX6), a major component of the retromer that targets proteins and other molecules to specific subcellular locations. SNX6 interacts with lamin A in vitro and in vivo and links it to the outer surface of the endoplasmic reticulum in human and mouse cells. SNX6 transports its lamin A cargo to the nuclear envelope in a process that takes several hours. Lamin A protein levels in the nucleus augment or decrease, respectively, upon gain or loss of SNX6 function. We further show that SNX6-dependent lamin A nuclear import occurs across the nuclear pore complex via a RAN-GTP-dependent mechanism. These results identify SNX6 as a key regulator of lamin A synthesis and incorporation into the nuclear envelope.	[Gonzalez-Granado, Jose M.; Navarro-Puche, Ana; Molina-Sanchez, Pedro; Blanco-Berrocal, Marta; Andres, Vicente] Ctr Nacl Invest Cardiovasc, Dept Atherothrombosis Imaging & Epidemiol, Madrid, Spain; [Viana, Rosa] CSIC, Inst Biomed Valencia, Valencia, Spain; [Font de Mora, Jaime] Univ Catolica Valencia San Vicente Martir, Fac Med, Fdn Invest Hosp La Fe, Valencia, Spain; [Font de Mora, Jaime] Univ Catolica Valencia San Vicente Martir, Fac Med, Inst Valenciano Patol, Valencia, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); Universidad Catolica de Valencia San Vicente Martir; Universidad Catolica de Valencia San Vicente Martir	Andres, V (corresponding author), Ctr Nacl Invest Cardiovasc, Dept Atherothrombosis Imaging & Epidemiol, Madrid, Spain.	vandres@cnic.es	Molina-Sánchez, Pedro/AAA-5721-2022; Andres, Vicente/I-6440-2014; de Mora, Jaime Font/H-6304-2015; de Mora, Jaime Font/AAK-7591-2021; Viana, Rosa/L-1922-2014; Gonzalez-Granado, Jose M/A-2952-2015; LARIJANI, Professor Banafshe/H-3909-2015	Andres, Vicente/0000-0002-0125-7209; de Mora, Jaime Font/0000-0002-6816-2095; de Mora, Jaime Font/0000-0002-6816-2095; Viana, Rosa/0000-0002-0036-0669; Gonzalez-Granado, Jose M/0000-0002-1177-869X; LARIJANI, Professor Banafshe/0000-0003-4735-1169; MOLINA SANCHEZ, PEDRO/0000-0003-1108-5145	Ministerio de Economia y Competitividad (MINECO); Fondo Europeo de Desarrollo Regional (FEDER) [SAF2010-16044]; Instituto de Salud Carlos III (ISCIII) [RD12/0042/0028]; Progeria Research Foundation; European Commission [317916-Liphos]; Sara Borrell ISCIII program [CP11/00145]; Miguel Servet ISCIII program [CP11/00145]; MINECO; Fundacion Pro-CNIC	Ministerio de Economia y Competitividad (MINECO)(Spanish Government); Fondo Europeo de Desarrollo Regional (FEDER)(European CommissionSpanish Government); Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); Progeria Research Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); Sara Borrell ISCIII program; Miguel Servet ISCIII program; MINECO(Spanish Government); Fundacion Pro-CNIC	Work in VA's laboratory is supported by the Ministerio de Economia y Competitividad (MINECO) and Fondo Europeo de Desarrollo Regional (FEDER) (SAF2010-16044), Instituto de Salud Carlos III (ISCIII) (RD12/0042/0028), The Progeria Research Foundation, and the European Commission (Grant No 317916-Liphos). JMGG received salary support from the Sara Borrell and Miguel Servet (CP11/00145) ISCIII programs. The Centro Nacional de Investigaciones Cardiovasculares (CNIC) is supported by MINECO and Fundacion Pro-CNIC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RL, 2013, CELL, V152, P1218, DOI 10.1016/j.cell.2013.02.042; Anderson DJ, 2008, J CELL BIOL, V182, P911, DOI 10.1083/jcb.200805140; Andres V, 2009, J CELL BIOL, V187, P945, DOI 10.1083/jcb.200904124; Beaudouin J, 2002, CELL, V108, P83, DOI 10.1016/S0092-8674(01)00627-4; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Braunagel SC, 2007, P NATL ACAD SCI USA, V104, P9307, DOI 10.1073/pnas.0703186104; Broers JLV, 2006, PHYSIOL REV, V86, P967, DOI 10.1152/physrev.00047.2005; Broers JLV, 1999, J CELL SCI, V112, P3463; Burke B, 2013, NAT REV MOL CELL BIO, V14, P13, DOI 10.1038/nrm3488; Carlton J, 2004, CURR BIOL, V14, P1791, DOI 10.1016/j.cub.2004.09.077; Carlton JG, 2005, CURR BIOL, V15, pR819, DOI 10.1016/j.cub.2005.10.012; Carroll P, 2001, DEV DYNAM, V221, P431, DOI 10.1002/dvdy.1163; Cavet ME, 2008, FASEB J, V22, P3607, DOI 10.1096/fj.07-094086; Claessen JHL, 2012, TRENDS CELL BIOL, V22, P22, DOI 10.1016/j.tcb.2011.09.010; Coppi MV, 1997, FEBS LETT, V405, P281, DOI 10.1016/S0014-5793(97)00182-8; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Cullen PJ, 2008, NAT REV MOL CELL BIO, V9, P574, DOI 10.1038/nrm2427; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Dechat T, 2007, P NATL ACAD SCI USA, V104, P4955, DOI 10.1073/pnas.0700854104; Domart MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051150; FEY EG, 1984, J CELL BIOL, V98, P1973, DOI 10.1083/jcb.98.6.1973; FISKUM G, 1985, CELL CALCIUM, V6, P25, DOI 10.1016/0143-4160(85)90032-6; Fong LG, 2006, J CLIN INVEST, V116, P743, DOI 10.1172/JCI27125; Fuster JJ, 2010, FASEB J, V24, P2998, DOI 10.1096/fj.09-138255; Georgatos SD, 1997, J CELL SCI, V110, P2129; Giri DK, 2005, MOL CELL BIOL, V25, P11005, DOI 10.1128/MCB.25.24.11005-11018.2005; Goldberg MW, 2008, J CELL SCI, V121, P215, DOI 10.1242/jcs.022020; Goldberg MW, 2008, BIOCHEM SOC T, V36, P1339, DOI 10.1042/BST0361339; Gonzalez Jose M, 2011, Front Biosci (Schol Ed), V3, P1133; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Haraguchi T, 2008, J CELL SCI, V121, P2540, DOI 10.1242/jcs.033597; Hetzer M, 2001, NAT CELL BIOL, V3, P1086, DOI 10.1038/ncb1201-1086; Ibiza S, 2008, P NATL ACAD SCI USA, V105, P10507, DOI 10.1073/pnas.0711062105; Ivorra' C, 2006, GENE DEV, V20, P307, DOI 10.1101/gad.349506; Izaurralde E, 1997, EMBO J, V16, P6535, DOI 10.1093/emboj/16.21.6535; Kazgan N, 2010, MOL BIOL CELL, V21, P3433, DOI 10.1091/mbc.E10-04-0347; Kilic F, 1999, FEBS LETT, V450, P61, DOI 10.1016/S0014-5793(99)00482-2; King MC, 2006, NATURE, V442, P1003, DOI 10.1038/nature05075; Lattanzi G, 2007, J CELL BIOCHEM, V102, P1149, DOI 10.1002/jcb.21467; Levine T, 2005, CURR OPIN CELL BIOL, V17, P362, DOI 10.1016/j.ceb.2005.06.005; Malik P, 2010, CELL MOL LIFE SCI, V67, P1353, DOI 10.1007/s00018-010-0257-2; Gonzalez JM, 2008, J CELL BIOL, V183, P653, DOI 10.1083/jcb.200805049; Massie C, 2006, NAT REV CANCER, V6, P403, DOI 10.1038/nrc1882; Moir RD, 2000, J CELL BIOL, V151, P1155, DOI 10.1083/jcb.151.6.1155; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Niu Y, 2013, NAT CELL BIOL, V15, P417, DOI 10.1038/ncb2710; Ohba T, 2004, J CELL BIOL, V167, P1051, DOI 10.1083/jcb.200409149; Okada H, 2010, FASEB J, V24, P2783, DOI 10.1096/fj.09-146357; Ostlund C, 2006, BIOCHEMISTRY-US, V45, P1374, DOI 10.1021/bi052156n; Parks WT, 2001, J BIOL CHEM, V276, P19332, DOI 10.1074/jbc.M100606200; Raharjo WH, 2001, J CELL SCI, V114, P4447; Saksena S, 2004, P NATL ACAD SCI USA, V101, P12537, DOI 10.1073/pnas.0404934101; Saksena S, 2006, NAT STRUCT MOL BIOL, V13, P500, DOI 10.1038/nsmb1098; Sandvig K, 2005, GENE THER, V12, P865, DOI 10.1038/sj.gt.3302525; Scott KL, 2009, NATURE, V459, P1085, DOI 10.1038/nature08109; Shibata Y, 2008, J BIOL CHEM, V283, P18892, DOI 10.1074/jbc.M800986200; Shimi T, 2008, GENE DEV, V22, P3409, DOI 10.1101/gad.1735208; Small SA, 2008, ARCH NEUROL-CHICAGO, V65, P323, DOI 10.1001/archneurol.2007.64; SOULLAM B, 1993, J CELL BIOL, V120, P1093, DOI 10.1083/jcb.120.5.1093; Stewart CL, 2007, SCIENCE, V318, P1408, DOI 10.1126/science.1142034; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Tapley EC, 2011, MOL BIOL CELL, V22, P1739, DOI 10.1091/mbc.E10-08-0733; Teasdale RD, 2012, BIOCHEM J, V441, P39, DOI 10.1042/BJ20111226; Turgay Y, 2010, EMBO J, V29, P2262, DOI 10.1038/emboj.2010.119; van Weering JRT, 2012, EMBO J, V31, P4466, DOI 10.1038/emboj.2012.283; Verges M, 2007, FRONT BIOSCI-LANDMRK, V12, P3825, DOI 10.2741/2355; Verstraeten VLRM, 2007, CURR MED CHEM, V14, P1231; VINDELOV LL, 1977, VIRCHOWS ARCH B, V24, P227; Wilson KL, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000554; Worby CA, 2002, NAT REV MOL CELL BIO, V3, P919, DOI 10.1038/nrm974; Xia WF, 2013, J CELL BIOL, V200, P821, DOI 10.1083/jcb.201207154; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325; Zuleger N, 2008, BIOCHEM SOC T, V36, P1373, DOI 10.1042/BST0361373	74	2	2	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115571	10.1371/journal.pone.0115571	http://dx.doi.org/10.1371/journal.pone.0115571			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25535984	Green Published, gold, Green Submitted			2022-12-27	WOS:000348563300051
J	Wang, D; Ren, M; Guo, JM; Yang, G; Long, XH; Hu, R; Shen, WJ; Wang, XF; Zeng, KB				Wang, Dan; Ren, Min; Guo, Jiamei; Yang, Guang; Long, Xianghua; Hu, Rong; Shen, Wenjing; Wang, Xuefeng; Zeng, Kebin			The Inhibitory Effects of Npas4 on Seizures in Pilocarpine-Induced Epileptic Rats	PLOS ONE			English	Article							PAS DOMAIN PROTEIN; SYNAPTIC REORGANIZATION; NEURAL ACTIVITY; SYNAPSIN-I; PHOSPHORYLATION; IDENTIFICATION; TRANSCRIPTION; EXCITABILITY; EXPRESSION; OUTGROWTH	To explore the effects of neuronal Per-Arnt-Sim domain protein 4 (Npas4) on seizures in pilocarpine-induced epileptic rats, Npas4 expression was detected by double-label immunofluorescence, immunohistochemistry, and Western blotting in the brains of pilocarpine-induced epileptic model rats at 6 h, 24 h, 72 h, 7 d, 14 d, 30 d, and 60 d after status epilepticus. Npas4 was localized primarily in the nucleus and in the cytoplasm of neurons. The Npas4 protein levels increased in the acute phase of seizures (between 6 h and 72 h) and decreased in the chronic phases (between 7 d and 60 d) in the rat model. Npas4 expression was knocked down by specific siRNA interference. Then, the animals were treated with pilocarpine, and the effects on seizures were evaluated on the 7th day. The onset latencies of pilocarpine-induced seizures were decreased, while the seizure frequency, duration and attack rate increased in these rats. Our study indicates that Npas4 inhibits seizure attacks in pilocarpine-induced epileptic rats.	[Wang, Dan; Ren, Min; Yang, Guang; Long, Xianghua; Hu, Rong; Shen, Wenjing; Wang, Xuefeng; Zeng, Kebin] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing Key Lab Neurol, Chongqing, Peoples R China; [Guo, Jiamei] Chongqing Med Univ, Affiliated Hosp 1, Dept Psychiat, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University	Zeng, KB (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing Key Lab Neurol, Chongqing, Peoples R China.	zkebin2008@aliyun.com			Chongqing Health Bureau Fund, China [2011-2-118]; Science Foundation of Chongqing Science and Technology Commission, China [CSTC2012jjA10065]; National Key Clinical Specialty Discipline Construction Program of China	Chongqing Health Bureau Fund, China; Science Foundation of Chongqing Science and Technology Commission, China; National Key Clinical Specialty Discipline Construction Program of China	The study was supported by Chongqing Health Bureau Fund, China (No. 2011-2-118 to KBZ), a grant from Science Foundation of Chongqing Science and Technology Commission, China (No. CSTC2012jjA10065 to KBZ), and the National Key Clinical Specialty Discipline Construction Program of China to Department of Neurology, the First Affiliated Hospital of Chongqing Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ataie Z, 2013, ADV PHARM BULL, V3, P353, DOI 10.5681/apb.2013.057; Bersten DC, 2014, BBA-GENE REGUL MECH, V1839, P13, DOI 10.1016/j.bbagrm.2013.11.004; Bonanomi D, 2005, J NEUROSCI, V25, P7299, DOI 10.1523/JNEUROSCI.1573-05.2005; Brenner RP, 2004, J CLIN NEUROPHYSIOL, V21, P319; Brunskill EW, 1999, MECH DEVELOP, V88, P237, DOI 10.1016/S0925-4773(99)00182-3; Butz M, 2009, BRAIN RES REV, V60, P287, DOI 10.1016/j.brainresrev.2008.12.023; Bykhovskaia M, 2011, SEMIN CELL DEV BIOL, V22, P387, DOI 10.1016/j.semcdb.2011.07.003; Cavazos JE, 2006, EPILEPSY BEHAV, V8, P483, DOI 10.1016/j.yebeh.2006.01.011; Flood WD, 2004, EUR J NEUROSCI, V20, P1819, DOI 10.1111/j.1460-9568.2004.03646.x; Fornasiero EF, 2010, CELL MOL LIFE SCI, V67, P1383, DOI 10.1007/s00018-009-0227-8; Jutrast MJ, 2010, CURR OPIN NEUROBIOL, V20, P150, DOI 10.1016/j.conb.2010.02.006; Kanter-Schlifke I, 2007, NEUROREPORT, V18, P845, DOI 10.1097/WNR.0b013e32811e1506; Klaric TS, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt453; Leslie JH, 2011, PROG NEUROBIOL, V94, P223, DOI 10.1016/j.pneurobio.2011.05.002; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; Majores M, 2007, EPILEPSIA, V48, P4, DOI 10.1111/j.1528-1167.2007.01062.x; Malas S, 2003, NEUROSCIENCE, V119, P421, DOI 10.1016/S0306-4522(03)00158-1; Mennerick S, 2000, MOL NEUROBIOL, V22, P41; Ooe N, 2004, MOL CELL BIOL, V24, P608, DOI 10.1128/MCB.24.2.608-616.2004; Ooe N, 2009, J BIOL CHEM, V284, P1057, DOI 10.1074/jbc.M805196200; Pantakani DVK, 2008, J NEUROCHEM, V106, P613, DOI 10.1111/j.1471-4159.2008.05414.x; Pitkanen A, 2007, EPILEPSIA, V48, P13, DOI 10.1111/j.1528-1167.2007.01063.x; Pruunsild P, 2011, J NEUROSCI, V31, P3295, DOI 10.1523/JNEUROSCI.4540-10.2011; Ramamoorthi K, 2011, SCIENCE, V334, P1669, DOI 10.1126/science.1208049; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Seifert G, 2010, BRAIN RES REV, V63, P212, DOI 10.1016/j.brainresrev.2009.10.004; Shamloo M, 2006, EUR J NEUROSCI, V24, P2705, DOI 10.1111/j.1460-9568.2006.05172.x; Shupliakov O, 2011, SEMIN CELL DEV BIOL, V22, P393, DOI 10.1016/j.semcdb.2011.07.006; Sim SY, 2013, J NEUROSCI, V33, P7928, DOI 10.1523/JNEUROSCI.1571-12.2013; SUTULA T, 1989, ANN NEUROL, V26, P321, DOI 10.1002/ana.410260303; Talathi SS, 2009, NEUROSCI LETT, V455, P145, DOI 10.1016/j.neulet.2009.03.057; Teng JL, 2001, J CELL BIOL, V155, P65, DOI 10.1083/jcb.200106025; Wang LA, 2010, NEUROCHEM INT, V57, P899, DOI 10.1016/j.neuint.2010.09.009; Xu YL, 2012, AM J PATHOL, V180, P1950, DOI 10.1016/j.ajpath.2012.01.024; Yun J, 2013, J BIOL CHEM, V288, P2655, DOI 10.1074/jbc.M112.413310; Zeng KB, 2009, NEUROCHEM RES, V34, P899, DOI 10.1007/s11064-008-9856-9; Zhou YD, 1997, P NATL ACAD SCI USA, V94, P713, DOI 10.1073/pnas.94.2.713	38	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115801	10.1371/journal.pone.0115801	http://dx.doi.org/10.1371/journal.pone.0115801			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536221	Green Published, Green Submitted, gold			2022-12-27	WOS:000348563300075
J	Andres, C; Aguilar, J; Gonzalez-Ramirez, R; Elias-Vinas, D; Felix, R; Delgado-Lezama, R				Andres, Carmen; Aguilar, Justo; Gonzalez-Ramirez, Ricardo; Elias-Vinas, David; Felix, Ricardo; Delgado-Lezama, Rodolfo			Extrasynaptic alpha(6) Subunit-Containing GABA(A) Receptors Modulate Excitability in Turtle Spinal Motoneurons	PLOS ONE			English	Article							GRANULE CELLS; MESSENGER-RNAS; TONIC INHIBITION; CORD; ACTIVATION; DIVERSITY; NEURONS	Motoneurons are furnished with a vast repertoire of ionotropic and metabotropic receptors as well as ion channels responsible for maintaining the resting membrane potential and involved in the regulation of the mechanisms underlying its membrane excitability and firing properties. Among them, the GABA(A) receptors, which respond to GABA binding by allowing the flow of Cl- ions across the membrane, mediate two distinct forms of inhibition in the mature nervous system, phasic and tonic, upon activation of synaptic or extrasynaptic receptors, respectively. In a previous work we showed that furosemide facilitates the monosynaptic reflex without affecting the dorsal root potential. Our data also revealed a tonic inhibition mediated by GABA(A) receptors activated in motoneurons by ambient GABA. These data suggested that the high affinity GABA(A) extrasynaptic receptors may have an important role in motor control, though the molecular nature of these receptors was not determined. By combining electrophysiological, immunofluorescence and molecular biology techniques with pharmacological tools here we show that GABA(A) receptors containing the alpha(6) subunit are expressed in adult turtle spinal motoneurons and can function as extrasynaptic receptors responsible for tonic inhibition. These results expand our understanding of the role of GABA(A) receptors in motoneuron tonic inhibition.	[Andres, Carmen; Aguilar, Justo; Delgado-Lezama, Rodolfo] IPN, CINVESTAV, Dept Fisiol Biofis & Neurociencias, Mexico City 07738, DF, Mexico; [Gonzalez-Ramirez, Ricardo] Hosp Gen Dr Manuel Gea Gonzalez, Dept Biol Mol Histocompatibilidad, Mexico City, DF, Mexico; [Elias-Vinas, David] IPN, CINVESTAV, Dept Bioelect, Mexico City 07738, DF, Mexico; [Felix, Ricardo] IPN, CINVESTAV, Dept Biol Celular, Mexico City 07738, DF, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Delgado-Lezama, R (corresponding author), IPN, CINVESTAV, Dept Fisiol Biofis & Neurociencias, Mexico City 07738, DF, Mexico.	rdelgado@fisio.cinvestav.mx	González-Ramírez, Ricardo/O-1792-2014; Felix, Ricardo/A-6989-2008	González-Ramírez, Ricardo/0000-0003-1399-8036; Felix, Ricardo/0000-0002-5383-7176	National Council for Science and Technology (Conacyt) [128125, 128707]	National Council for Science and Technology (Conacyt)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by grants from The National Council for Science and Technology (Conacyt) to RDL (128125) and RF (128707). http://www.conacyt.mx/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bautista W, 2010, J PHYSIOL-LONDON, V588, P2621, DOI 10.1113/jphysiol.2010.188979; Bohlhalter S, 1996, J NEUROSCI, V16, P283, DOI 10.1523/jneurosci.16-01-00283.1996; Brickley SG, 1996, J PHYSIOL-LONDON, V497, P753, DOI 10.1113/jphysiol.1996.sp021806; Castro A, 2011, NEUROSCIENCE, V192, P74, DOI 10.1016/j.neuroscience.2011.06.073; Castro A, 2011, BIOCHEM BIOPH RES CO, V412, P26, DOI 10.1016/j.bbrc.2011.07.026; Delgado-Lezama R, 2004, J NEUROPHYSIOL, V91, P40, DOI 10.1152/jn.00569.2003; Delgado-Lezama R, 2013, CURR PHARM DESIGN, V19, P4485, DOI 10.2174/1381612811319240013; Drummond GB, 2009, J PHYSIOL-LONDON, V587, P713, DOI 10.1113/jphysiol.2008.167387; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Glykys J, 2007, NEURON, V56, P763, DOI 10.1016/j.neuron.2007.11.002; Hamann M, 2002, NEURON, V33, P625, DOI 10.1016/S0896-6273(02)00593-7; Hevers W, 1998, MOL NEUROBIOL, V18, P35, DOI 10.1007/BF02741459; Hochman DW, 2000, J NEUROPHYSIOL, V83, P406, DOI 10.1152/jn.2000.83.1.406; HOUNSGAARD J, 1988, J PHYSIOL-LONDON, V398, P575, DOI 10.1113/jphysiol.1988.sp017058; KAILA K, 1994, PROG NEUROBIOL, V42, P489, DOI 10.1016/0301-0082(94)90049-3; KANEDA M, 1995, J PHYSIOL-LONDON, V485, P419, DOI 10.1113/jphysiol.1995.sp020739; KORPI ER, 1995, MOL PHARMACOL, V47, P283; Loeza-Alcocer E, 2013, J NEUROPHYSIOL, V110, P2175, DOI 10.1152/jn.00330.2013; MA W, 1993, J COMP NEUROL, V338, P337, DOI 10.1002/cne.903380303; Nusser Z, 1998, J NEUROSCI, V18, P1693; Nusser Z, 2002, J NEUROPHYSIOL, V87, P2624, DOI 10.1152/jn.2002.87.5.2624; PERSOHN E, 1991, NEUROSCIENCE, V42, P497, DOI 10.1016/0306-4522(91)90392-2; Petri S, 2005, J NEUROL SCI, V238, P25, DOI 10.1016/j.jns.2005.06.005; Pinard A, 2010, ADV PHARMACOL, V58, P231, DOI 10.1016/S1054-3589(10)58010-4; Ruano D, 2000, NEUROREPORT, V11, P3169, DOI 10.1097/00001756-200009280-00025; Semyanov A, 2004, TRENDS NEUROSCI, V27, P262, DOI 10.1016/j.tins.2004.03.005; Thompson SA, 1999, MOL PHARMACOL, V55, P993, DOI 10.1124/mol.55.6.993; Wall MJ, 2003, NEUROPHARMACOLOGY, V44, P56, DOI 10.1016/S0028-3908(02)00331-3; WISDEN W, 1991, MOL BRAIN RES, V10, P179, DOI 10.1016/0169-328X(91)90109-B	29	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115378	10.1371/journal.pone.0115378	http://dx.doi.org/10.1371/journal.pone.0115378			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531288	Green Published, Green Submitted, gold			2022-12-27	WOS:000348845100057
J	Canham, M; Charsou, C; Stewart, J; Moncur, S; Hoodless, L; Bhatia, R; Cong, DD; Cubie, H; Busby-Earle, C; Williams, A; McLoughlin, V; Campbell, JDM; Cuschieri, K; Howie, S				Canham, Maurice; Charsou, Chara; Stewart, June; Moncur, Sharon; Hoodless, Laura; Bhatia, Ramya; Cong, Duanduan; Cubie, Heather; Busby-Earle, Camille; Williams, Alistair; McLoughlin, Victoria; Campbell, John D. M.; Cuschieri, Kate; Howie, Sarah			Increased Cycling Cell Numbers and Stem Cell Associated Proteins as Potential Biomarkers for High Grade Human Papillomavirus plus ve Pre-Neoplastic Cervical Disease	PLOS ONE			English	Article							P53 HOMOLOG P63; PROSPECTIVE IDENTIFICATION; CANCER; EXPRESSION; SOX2; PODOCALYXIN; CARCINOMA; BREAST; EZRIN; MARKERS	High risk (oncogenic) human papillomavirus (HPV) infection causes cervical cancer. Infections are common but most clear naturally. Persistent infection can progress to cancer. Pre-neoplastic disease (cervical intraepithelial neoplasia/CIN) is classified by histology (CIN1-3) according to severity. Cervical abnormalities are screened for by cytology and/or detection of high risk HPV but both methods are imperfect for prediction of which women need treatment. There is a need to understand the host virus interactions that lead to different disease outcomes and to develop biomarker tests for accurate triage of infected women. As cancer is increasingly presumed to develop from proliferative, tumour initiating, cancer stem cells (CSCs), and as other oncogenic viruses induce stem cell associated gene expression, we evaluated whether presence of mRNA (detected by qRT-PCR) or proteins (detected by flow cytometry and antibody based proteomic microarray) from stem cell associated genes and/or increased cell proliferation (detected by flow cytometry) could be detected in well-characterised, routinely collected cervical samples from high risk HPV+ve women. Both cytology and histology results were available for most samples with moderate to high grade abnormality. We found that stem cell associated proteins including human chorionic gonadotropin, the oncogene TP63 and the transcription factor SOX2 were upregulated in samples from women with CIN3 and that the stem cell related, cell surface, protein podocalyxin was detectable on cells in samples from a subset of women with CIN3. SOX2, TP63 and human gonadotrophin mRNAs were upregulated in high grade disease. Immunohistochemistry showed that SOX2 and TP63 proteins clearly delineated tumour cells in invasive squamous cervical cancer. Samples from women with CIN3 showed increased proliferating cells. We believe that these markers may be of use to develop triage tests for women with high grade cervical abnormality to distinguish those who may progress to cancer from those who may be treated more conservatively.	[Canham, Maurice; Bhatia, Ramya; Cubie, Heather] Univ Edinburgh, Human Papillomavirus Grp, Edinburgh, Midlothian, Scotland; [Canham, Maurice; Campbell, John D. M.] Univ Edinburgh, Med Res Council Ctr Regenerat Med, Edinburgh, Midlothian, Scotland; [Charsou, Chara; Stewart, June; Moncur, Sharon; Hoodless, Laura; Cong, Duanduan; Howie, Sarah] Univ Edinburgh, Med Res Council Ctr Inflammat Res, Edinburgh, Midlothian, Scotland; [Busby-Earle, Camille] Royal Infirm Edinburgh NHS Trust, Simpson Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland; [Williams, Alistair] Univ Edinburgh, Simpson Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland; [McLoughlin, Victoria; Campbell, John D. M.] Natl Sci Lab, Scottish Natl Blood Transfus Serv, Edinburgh, Midlothian, Scotland; [Cuschieri, Kate] Royal Infirm Edinburgh NHS Trust, Scottish Human Papillomavirus Reference Lab, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh; University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh	Howie, S (corresponding author), Univ Edinburgh, Med Res Council Ctr Inflammat Res, Edinburgh, Midlothian, Scotland.	s.e.m.howie@ed.ac.uk	Campbell, John/A-5792-2011	Campbell, John/0000-0002-6752-3493; Canham, Maurice/0000-0003-1620-8044; Hoodless, Laura/0000-0002-9679-0611; Howie, Sarah/0000-0001-7291-3499	Chief Scientist Office, Scotland [ETM/145]; Medical Research Council [1586600] Funding Source: researchfish; Chief Scientist Office [CZB/4/658] Funding Source: researchfish; MRC [G0901697] Funding Source: UKRI	Chief Scientist Office, Scotland; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by grant number ETM/145 from the Chief Scientist Office, Scotland (http://www.cso.scot.nhs.uk/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; ANDREWS PW, 1984, HYBRIDOMA, V3, P347, DOI 10.1089/hyb.1984.3.347; Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; Auvinen E, 2013, NEOPLASMA, V60, P56, DOI 10.4149/neo_2013_008; Badcock G, 1999, CANCER RES, V59, P4715; Barbareschi M, 2001, AM J SURG PATHOL, V25, P1054, DOI 10.1097/00000478-200108000-00010; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Boumahdi S, 2014, NATURE, V511, P246, DOI 10.1038/nature13305; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chen YP, 2008, J BIOL CHEM, V283, P17969, DOI 10.1074/jbc.M802917200; Cipollone JA, 2012, CLIN EXP METASTAS, V29, P239, DOI 10.1007/s10585-011-9446-0; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Cuschieri K, 2013, DIAGN MOL PATHOL, V22, P85, DOI 10.1097/PDM.0b013e31827f3f7e; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Forse CL, 2013, BREAST CANCER RES TR, V137, P709, DOI 10.1007/s10549-012-2392-y; Hameed A, 1999, INT J GYNECOL PATHOL, V18, P381, DOI 10.1097/00004347-199910000-00014; Hsu YH, 2010, AM J PATHOL, V176, P3050, DOI 10.2353/ajpath.2010.090539; Huang CF, 2014, J ORAL PATHOL MED, V43, P492, DOI 10.1111/jop.12159; Iles RK, 2007, MOL CELL ENDOCRINOL, V260, P264, DOI 10.1016/j.mce.2006.02.019; Ji J, 2010, HUM PATHOL, V41, P1438, DOI 10.1016/j.humpath.2009.11.021; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kim YT, 2005, YONSEI MED J, V46, P597, DOI 10.3349/ymj.2005.46.5.597; Kondo S, 2011, J VIROL, V85, P11255, DOI 10.1128/JVI.00188-11; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Ma RS, 2014, J CLIN ENDOCR METAB, V99, pE400, DOI 10.1210/jc.2013-3545; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; Machida K, 2012, J GASTROEN HEPATOL, V27, P19, DOI 10.1111/j.1440-1746.2011.07010.x; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Okubo T, 2006, GENE DEV, V20, P2654, DOI 10.1101/gad.1457106; Orlando RA, 2001, J AM SOC NEPHROL, V12, P1589, DOI 10.1681/ASN.V1281589; Pinto AE, 2011, PATHOL RES PRACT, V207, P623, DOI 10.1016/j.prp.2011.07.007; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Quade BJ, 2001, GYNECOL ONCOL, V80, P24, DOI 10.1006/gyno.2000.5953; Que J, 2007, DEVELOPMENT, V134, P2521, DOI 10.1242/dev.003855; Ramsey MR, 2013, J CLIN INVEST, V123, P3525, DOI 10.1172/JCI68899; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rudin CM, 2012, NAT GENET, V44, P1111, DOI 10.1038/ng.2405; Sanada Y, 2006, PANCREAS, V32, P164, DOI 10.1097/01.mpa.0000202947.80117.a0; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Schopperle WM, 2007, STEM CELLS, V25, P723, DOI 10.1634/stemcells.2005-0597; Schopperle WM, 2010, BIOCHEM BIOPH RES CO, V398, P372, DOI 10.1016/j.bbrc.2010.06.074; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Shah RB, 2002, AM J SURG PATHOL, V26, P1161, DOI 10.1097/00000478-200209000-00006; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sizemore S, 2007, CANCER RES, V67, P6183, DOI 10.1158/0008-5472.CAN-06-3575; Sun D, 2014, WORLD J GASTROENTERO, V20, P6974, DOI 10.3748/wjg.v20.i22.6974; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tan J, 2011, TUMOR BIOL, V32, P1241, DOI 10.1007/s13277-011-0228-8; Walter V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056823; Wang L, 2013, MOL CELL BIOCHEM, V379, P7, DOI 10.1007/s11010-013-1621-y; Wang TY, 2001, HUM PATHOL, V32, P479, DOI 10.1053/hupa.2001.24324; Watanabe H, 2014, J CLIN INVEST, V124, P1636, DOI 10.1172/JCI71545; Yang CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099412; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Yasuoka H, 2012, J CLIN PATHOL, V65, P399, DOI 10.1136/jclinpath-2011-200359; Zhang JW, 2013, INT J GYNECOL CANCER, V23, P318, DOI 10.1097/IGC.0b013e31827f6f06; Zhu D, 2014, INT J GYNECOL CANCER, V24, P643, DOI 10.1097/IGC.0000000000000122; ZUR HH, 2009, VIROLOGY, V384, P260, DOI DOI 10.1016/J.VIROL.2008.11.046	59	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115379	10.1371/journal.pone.0115379	http://dx.doi.org/10.1371/journal.pone.0115379			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531390	Green Published, gold, Green Submitted			2022-12-27	WOS:000348845100058
J	Corre, G; Stockholm, D; Arnaud, O; Kaneko, G; Vinuelas, J; Yamagata, Y; Thi, MANN; Kupiec, JJ; Beslon, G; Gandrillon, O; Paldi, A				Corre, Guillaume; Stockholm, Daniel; Arnaud, Ophelie; Kaneko, Gael; Vinuelas, Jose; Yamagata, Yoshiaki; Thi My Anh Neildez-Nguyen; Kupiec, Jean-Jacques; Beslon, Guillaume; Gandrillon, Olivier; Paldi, Andras			Stochastic Fluctuations and Distributed Control of Gene Expression Impact Cellular Memory	PLOS ONE			English	Article							NOISE	Despite the stochastic noise that characterizes all cellular processes the cells are able to maintain and transmit to their daughter cells the stable level of gene expression. In order to better understand this phenomenon, we investigated the temporal dynamics of gene expression variation using a double reporter gene model. We compared cell clones with transgenes coding for highly stable mRNA and fluorescent proteins with clones expressing destabilized mRNA-s and proteins. Both types of clones displayed strong heterogeneity of reporter gene expression levels. However, cells expressing stable gene products produced daughter cells with similar level of reporter proteins, while in cell clones with short mRNA and protein half-lives the epigenetic memory of the gene expression level was completely suppressed. Computer simulations also confirmed the role of mRNA and protein stability in the conservation of constant gene expression levels over several cell generations. These data indicate that the conservation of a stable phenotype in a cellular lineage may largely depend on the slow turnover of mRNA-s and proteins.	[Corre, Guillaume; Stockholm, Daniel; Thi My Anh Neildez-Nguyen; Paldi, Andras] Univ Evry Val dEssonne, INSERM, UMR 951, F-91002 Evry, France; [Corre, Guillaume; Stockholm, Daniel; Thi My Anh Neildez-Nguyen; Paldi, Andras] Ecole Prat Hautes Etud, Paris, France; [Arnaud, Ophelie; Kaneko, Gael; Vinuelas, Jose; Gandrillon, Olivier] Univ Lyon 1, Ctr Genet & Physiol Mol & Cellulaire CGPhiMC, CNRS, UMR5534, F-69622 Lyon, France; [Kaneko, Gael; Beslon, Guillaume] Univ Lyon, INSA Lyon, Lab InfoRmat Image & Syst Informat LIRIS, INRIA,CNRS UMR5205, F-69621 Lyon, France; [Kupiec, Jean-Jacques] Ecole Normale Super, Ctr Cavailles, F-75005 Paris, France; [Yamagata, Yoshiaki] Yamaguchi Univ, Grad Sch Med, Dept Obstet & Gynaecol, Ube, Yamaguchi 755, Japan	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Inria; Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Yamaguchi University	Paldi, A (corresponding author), Univ Evry Val dEssonne, INSERM, UMR 951, F-91002 Evry, France.	paldi@genethon.fr	corre, guillaume/T-9696-2019; Corre, Guillaume/G-8392-2015	corre, guillaume/0000-0002-0755-8336; Corre, Guillaume/0000-0002-0755-8336; Beslon, Guillaume/0000-0001-8562-0732	Agence National de Recherche, grant Stochagene, Genethon [BSV6 014 02]; Genopole Research-Evry; University Evry Val d'Essonne; Conseil General de l'Essonne; Region Ile de France; AXA PhD fellowship; Department of Obstetrics and Gynaecology, Yamaguchi University Graduate School of Medicine, Ube, Japan	Agence National de Recherche, grant Stochagene, Genethon(French National Research Agency (ANR)); Genopole Research-Evry; University Evry Val d'Essonne; Conseil General de l'Essonne(General Electric); Region Ile de France(Region Ile-de-France); AXA PhD fellowship(AXA Research Fund); Department of Obstetrics and Gynaecology, Yamaguchi University Graduate School of Medicine, Ube, Japan	Agence National de Recherche, grant Stochagene grant no. BSV6 014 02, Genethon. Equipment funds were from Genopole Research-Evry, University Evry Val d'Essonne, Conseil General de l'Essonne and from Region Ile de France. GC was a recipient of an AXA PhD fellowship. YY was financed by Department of Obstetrics and Gynaecology, Yamaguchi University Graduate School of Medicine, Ube, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balazsi G, 2011, CELL, V144, P910, DOI 10.1016/j.cell.2011.01.030; Benjamin D, 2006, MOL BIOSYST, V2, P561, DOI 10.1039/b609448a; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Fallaux FJ, 1996, HUM GENE THER, V7, P215, DOI 10.1089/hum.1996.7.2-215; Golubev A, 2012, BIOESSAYS, V34, P311, DOI 10.1002/bies.201100119; Huang S, 2009, DEVELOPMENT, V136, P3853, DOI 10.1242/dev.035139; Huh D, 2011, NAT GENET, V43, P95, DOI 10.1038/ng.729; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kitsera N, 2007, BIOTECHNIQUES, V43, P222, DOI 10.2144/000112479; Lestas I, 2010, NATURE, V467, P174, DOI 10.1038/nature09333; Levsky JM, 2003, TRENDS CELL BIOL, V13, P4, DOI 10.1016/S0962-8924(02)00002-8; Neildez-Nguyen TMA, 2008, DIFFERENTIATION, V76, P33, DOI 10.1111/j.1432-0436.2007.00219.x; Pedraza JM, 2008, SCIENCE, V319, P339, DOI 10.1126/science.1144331; Schwanhausser B, 2013, BIOESSAYS, V35, P597, DOI 10.1002/bies.201300017; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Team RDCao, 2005, R LANG ENV STAT COMP; Uren AG, 2009, NAT PROTOC, V4, P789, DOI 10.1038/nprot.2009.64; Vinayagam A, 2014, NAT METHODS, V11, P94, DOI [10.1038/nmeth.2733, 10.1038/NMETH.2733]; Vinuelas J, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-15; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	20	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115574	10.1371/journal.pone.0115574	http://dx.doi.org/10.1371/journal.pone.0115574			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531401	gold, Green Published			2022-12-27	WOS:000348845100078
J	Liu, M; Li, Y; Zhang, YQ; Zhao, XL; Zhai, B; Zhang, QY; Wang, LJ; Zhao, Y; Li, HH; Wang, QS; Gao, CJ; Huang, WR; Yu, L				Liu, Mingjuan; Li, Yan; Zhang, Yongqing; Zhao, Xiaoli; Zhai, Bing; Zhang, Qingyi; Wang, Lijun; Zhao, Yu; Li, Honghua; Wang, Quanshun; Gao, Chunji; Huang, Wenrong; Yu, Li			Secondary Antifungal Prophylaxis in Hematological Malignancy Patients with Previous Invasive Fungal Disease: A Retrospective Analysis	PLOS ONE			English	Article							CELL TRANSPLANT RECIPIENTS; RISK-FACTORS; LEUKEMIA PATIENTS; INFECTION; ASPERGILLOSIS; EPIDEMIOLOGY; VORICONAZOLE; SCT; EFFICACY; IMPACT	Background: Invasive fungal disease (IFD) causes morbidity and mortality in patients with hematological malignancy. Recurrence of IFD after chemotherapy or hematopoietic stem cell transplantation (HSCT) is associated with poor prognosis. The present study aimed to investigate the efficacy of different strategies of secondary antifungal prophylaxis (SAP) for IFD and choose an appropriate SAP regimen. Methods: Clinical data of patients with previous IFD who underwent chemotherapy or HSCT between Jan 2008 and Jun 2013 were retrospectively reviewed and followed up to 180 days post-chemotherapy or HSCT. The clinical characteristics and diagnosis were analyzed according to the diagnostic criteria for IFD. The efficacy of different strategies for SAP and risk factors influencing the failure of SAP were evaluated. Results: Of the 164 patients enrolled, 121 patients received SAP regimen (73.78%), and IFD recurred in 40 patients: 16.5% (20/121) in SAP group and 46.5% (20/43) in non-SAP group. In SAP group, 58 received SAP agents which were proven effective for their previous IFD, while other 63 patients received other broad-spectrum antifungal agents. There was no significant difference in the recurrence rates between these two subgroups (13.8% (8/58) vs 19.0% (12/63), P=0.437). The IFD recurrence rates were statistically significant between patients with allogeneic HSCTand chemotherapy or autologous HSCT (25% vs 8.2%, P=0.013). Multivariate analysis indicated that allogeneic HSCT was the independent risk factor of IFD recurrence after SAP. Conclusions: Secondary antifungal prophylaxis is necessary to prevent IFD recurrence in patients with hematological malignancy, especially for patients in the setting of allogeneic HSCT.	[Liu, Mingjuan; Li, Yan; Zhao, Xiaoli; Zhai, Bing; Zhang, Qingyi; Wang, Lijun; Zhao, Yu; Li, Honghua; Wang, Quanshun; Gao, Chunji; Huang, Wenrong; Yu, Li] Chinese Peoples Liberat Army Gen Hosp, Dept Hematol, Beijing 100853, Peoples R China; [Liu, Mingjuan; Li, Yan; Zhao, Xiaoli; Zhai, Bing; Zhang, Qingyi; Wang, Lijun; Zhao, Yu; Li, Honghua; Wang, Quanshun; Gao, Chunji; Huang, Wenrong; Yu, Li] Chinese Peoples Liberat Army Gen Hosp, BMT Ctr, Beijing 100853, Peoples R China; [Liu, Mingjuan; Zhang, Yongqing] Chinese Peoples Liberat Army, Hosp 309, Dept Hematol, Beijing 100091, Peoples R China; [Li, Yan; Huang, Wenrong] Chinese Peoples Liberat Army Gen Hosp, Dept Hematol, Hainan Branch, Sanya City 572013, Hainan, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Huang, WR (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Hematol, 28 Fuxing Rd, Beijing 100853, Peoples R China.	huangwr301@163.com; chunhuiliyu@yahoo.com		Yu, Li/0000-0001-6872-2665	National Basic Research Program of China [2005CB522400]; National Natural Science Foundation of China [90919044, 30971297, 81170518, 81270611]; Capital Medical Development Scientific Research Fund [SF2001-5001-07]; National Public Health Grant Research Foundation [201202017]; capital of the public health project [Z111107067311070]; Technology Innovation Nursery Foundation [13KMM01]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Capital Medical Development Scientific Research Fund; National Public Health Grant Research Foundation; capital of the public health project; Technology Innovation Nursery Foundation	This work was supported by grants from the National Basic Research Program of China (2005CB522400), National Natural Science Foundation of China (90919044, 30971297, 81170518, 81270611), Capital Medical Development Scientific Research Fund (SF2001-5001-07), National Public Health Grant Research Foundation (201202017), the capital of the public health project (Z111107067311070) and Technology Innovation Nursery Foundation (13KMM01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aki ZS, 2008, TRANSPL P, V40, P1579, DOI 10.1016/j.transproceed.2008.03.149; Allinson K, 2008, J ANTIMICROB CHEMOTH, V61, P734, DOI 10.1093/jac/dkm521; Auberger J, 2008, INT J HEMATOL, V88, P508, DOI 10.1007/s12185-008-0184-2; Avivi I, 2004, AM J HEMATOL, V75, P6, DOI 10.1002/ajh.10447; Cahuayme-Zuniga L, 2012, MED MYCOL, V50, P543, DOI 10.3109/13693786.2011.631152; Chinese Invasive Fungal Infections Cooperative Group, 2010, CHINESE J INTERN MED, V49, P451; Cordonnier C, 2004, BONE MARROW TRANSPL, V33, P943, DOI 10.1038/sj.bmt.1704469; Cordonnier C, 2010, HAEMATOL-HEMATOL J, V95, P1762, DOI 10.3324/haematol.2009.020073; Cornely OA, 2008, INFECTION, V36, P296, DOI 10.1007/s15010-008-7357-z; Cornely OA, 2008, J ANTIMICROB CHEMOTH, V61, P939, DOI 10.1093/jac/dkn027; de Fabritiis P, 2007, BONE MARROW TRANSPL, V40, P245, DOI 10.1038/sj.bmt.1705720; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; El-Cheikh J, 2010, LEUKEMIA LYMPHOMA, V51, P1705, DOI 10.3109/10428194.2010.500433; Fukuda T, 2004, BIOL BLOOD MARROW TR, V10, P494, DOI 10.1016/j.bbmt.2004.02.006; Georgiadou SP, 2013, BONE MARROW TRANSPL, V48, P141, DOI 10.1038/bmt.2012.89; Kontoyiannis DP, 2010, CLIN INFECT DIS, V50, P1091, DOI 10.1086/651263; Lee Ji Yean, 2012, Korean J Hematol, V47, P255, DOI 10.5045/kjh.2012.47.4.255; Li Y, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-255; Li Yan, 2013, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V21, P161, DOI 10.7534/j.issn.1009-2137.2013.01.033; Liu F, 2013, TRANSPL INFECT DIS, V15, P243, DOI 10.1111/tid.12068; Maertens J, 2011, BONE MARROW TRANSPL, V46, P709, DOI 10.1038/bmt.2010.175; Masamoto Y, 2011, J CHEMOTHERAPY, V23, P17, DOI 10.1179/joc.2011.23.1.17; Maschmeyer G, 2007, DRUGS, V67, P1567, DOI 10.2165/00003495-200767110-00004; Neofytos D, 2009, CLIN INFECT DIS, V48, P265, DOI 10.1086/595846; Offner F, 1998, CLIN INFECT DIS, V26, P1098, DOI 10.1086/520274; Salmenniemi U, 2013, BONE MARROW TRANSPL, V48, P1262, DOI 10.1038/bmt.2013.45; Sipsas NV, 2006, CLIN INFECT DIS, V42, P1584, DOI 10.1086/503844; Song A, 2010, INT J HEMATOL, V92, P725, DOI 10.1007/s12185-010-0723-5; Upton A, 2007, CLIN INFECT DIS, V44, P531, DOI 10.1086/510592; Vehreschild JJ, 2009, INT J ANTIMICROB AG, V34, P446, DOI 10.1016/j.ijantimicag.2009.06.025; Zhang P, 2009, BONE MARROW TRANSPL, V43, P533, DOI 10.1038/bmt.2008.356	31	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115461	10.1371/journal.pone.0115461	http://dx.doi.org/10.1371/journal.pone.0115461			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531544	Green Published, gold, Green Submitted			2022-12-27	WOS:000348845100070
J	Song, LW; Yang, MC; Knoff, JN; Wu, TC; Hung, CF				Song, Liwen; Yang, Ming-Chieh; Knoff, Jayne; Wu, T. -C.; Hung, Chien-Fu			Cancer Immunotherapy Employing an Innovative Strategy to Enhance CD4+T Cell Help in the Tumor Microenvironment	PLOS ONE			English	Article							CROSS-PRESENTATION; ANTIGENIC PEPTIDE; IMMUNE-RESPONSES; VACCINE POTENCY; CPG DNA; ADJUVANT; RADIOTHERAPY; COMBINATION; DELIVERY	Chemotherapy and/or radiation therapy are widely used as cancer treatments, but the antitumor effects they produce can be enhanced when combined with immunotherapies. Chemotherapy kills tumor cells, but it also releases tumor antigen and allows the cross-presentation of the tumor antigen to trigger antigen-specific cell-mediated immune responses. Promoting CD4+ T helper cell immune responses can be used to enhance the cross-presentation of the tumor antigen following chemotherapy. The pan HLA-DR binding epitope (PADRE peptide) is capable of generating antigen-specific CD4+ T cells that bind various MHC class II molecules with high affinity and has been widely used in conjunction with vaccines to improve their potency by enhancing CD4+ T cell responses. Here, we investigated whether intratumoral injection of PADRE and the adjuvant CpG into HPV16 E7-expressing TC-1 tumors following cisplatin chemotherapy could lead to potent antitumor effects and antigen-specific cell-mediated immune responses. We observed that treatment with all three agents produced the most potent antitumor effects compared to pairwise combinations. Moreover, treatment with cisplatin, CpG and PADRE was able to control tumors at a distant site, indicating that our approach is able to induce cross-presentation of the tumor antigen. Treatment with cisplatin, CpG and PADRE also enhanced the generation of PADRE-specific CD4+ T cells and E7-specific CD8+ T cells and decreased the number of MDSCs in tumor loci. The treatment regimen presented here represents a universal approach to cancer control.	[Song, Liwen] Tongji Univ, Shanghai Peoples Hosp 10, Dept Obstet & Gynecol, Shanghai 200092, Peoples R China; [Song, Liwen] Fudan Univ, Sch Pharm, Shanghai 200433, Peoples R China; [Song, Liwen] Shanghai Inst Planned Parenthood Res, Dept Pharmacol & Toxicol, Shanghai, Peoples R China; [Song, Liwen; Knoff, Jayne; Wu, T. -C.; Hung, Chien-Fu] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA; [Wu, T. -C.] Johns Hopkins Med Inst, Dept Obstet & Gynecol, Baltimore, MD 21205 USA; [Wu, T. -C.] Johns Hopkins Med Inst, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Wu, T. -C.; Hung, Chien-Fu] Johns Hopkins Med Inst, Dept Oncol, Baltimore, MD 21205 USA; [Yang, Ming-Chieh] Kaohsiung Vet Gen Hosp, Kaohsiung, Taiwan	Tongji University; Fudan University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Kaohsiung Veterans General Hospital	Hung, CF (corresponding author), Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA.	chung2@jhmi.edu		Bissonette, Jayne/0000-0001-8376-9242	National Institutes of Health/National Cancer Institute Cervical Cancer [SPORE P50CA098252, 2R01CA114425-06]; NATIONAL CANCER INSTITUTE [P50CA098252, R01CA114425] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute Cervical Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health/National Cancer Institute Cervical Cancer SPORE P50CA098252 and 2R01CA114425-06 grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER J, 1994, IMMUNITY, V1, P751, DOI 10.1016/S1074-7613(94)80017-0; Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377; Bauer S, 2001, P NATL ACAD SCI USA, V98, P9237, DOI 10.1073/pnas.161293498; Carpentier AF, 1999, CANCER RES, V59, P5429; Chuang TH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108808; Ellerby HM, 1999, NAT MED, V5, P1032, DOI 10.1038/12469; Gray RC, 2007, J LEUKOCYTE BIOL, V81, P1075, DOI 10.1189/jlb.1006606; Hung CF, 2007, MOL THER, V15, P1211, DOI 10.1038/sj.mt.6300121; Kang TH, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-48; Kang TH, 2013, CANCER RES, V73, P2493, DOI 10.1158/0008-5472.CAN-12-4241; Kang TH, 2013, MOL THER, V21, P542, DOI 10.1038/mt.2012.233; Kim D, 2008, GENE THER, V15, P677, DOI 10.1038/sj.gt.3303102; Kuchtey J, 2005, J IMMUNOL, V175, P2244, DOI 10.4049/jimmunol.175.4.2244; La Rosa C, 2012, J INFECT DIS, V205, P1294, DOI 10.1093/infdis/jis107; Lee S, 2010, CANCER IMMUNOL IMMUN, V59, P1073, DOI 10.1007/s00262-010-0834-0; Lin KY, 1996, CANCER RES, V56, P21; Link BK, 2006, J IMMUNOTHER, V29, P558, DOI 10.1097/01.cji.0000211304.60126.8f; Meng YX, 2005, INT J CANCER, V116, P992, DOI 10.1002/ijc.21131; Peng SW, 2013, CANCER IMMUNOL IMMUN, V62, P171, DOI 10.1007/s00262-012-1322-5; Shirota H, 2014, EXPERT REV VACCINES, V13, P299, DOI 10.1586/14760584.2014.863715; Sinha P, 2011, BLOOD, V117, P5381, DOI 10.1182/blood-2010-11-321752; Wierecky J, 2006, CANCER RES, V66, P5910, DOI 10.1158/0008-5472.CAN-05-3905; Wu A, 2011, GENE THER, V18, P304, DOI 10.1038/gt.2010.151; Wu CY, 2014, CLIN CANCER RES, V20, P644, DOI 10.1158/1078-0432.CCR-13-1334; Wu CY, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-88; Zoglmeier C, 2011, CLIN CANCER RES, V17, P1765, DOI 10.1158/1078-0432.CCR-10-2672	26	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115711	10.1371/journal.pone.0115711	http://dx.doi.org/10.1371/journal.pone.0115711			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531529	gold, Green Submitted, Green Published			2022-12-27	WOS:000348845100100
J	Zhang, WY; Xu, YC; Li, WL; Yang, L; Yue, X; Zhang, XS; Zhao, XY				Zhang, Wei Yang; Xu, Yong Chao; Li, Wen Lan; Yang, Long; Yue, Xun; Zhang, Xian Sheng; Zhao, Xiang Yu			Transcriptional Analyses of Natural Leaf Senescence in Maize	PLOS ONE			English	Article							HARVESTING-COMPLEX-II; E3 UBIQUITIN LIGASE; CELL-DEATH; CHLOROPHYLL BREAKDOWN; PLANT SENESCENCE; GENE-EXPRESSION; HYPERSENSITIVE RESPONSE; WRKY53 TRANSCRIPTION; REGULATORY CASCADE; ARABIDOPSIS LEAVES	Leaf senescence is an important biological process that contributes to grain yield in crops. To study the molecular mechanisms underlying natural leaf senescence, we harvested three different developmental ear leaves of maize, mature leaves (ML), early senescent leaves (ESL), and later senescent leaves (LSL), and analyzed transcriptional changes using RNA-sequencing. Three sets of data, ESL vs. ML, LSL vs. ML, and LSL vs. ESL, were compared, respectively. In total, 4,552 genes were identified as differentially expressed. Functional classification placed these genes into 18 categories including protein metabolism, transporters, and signal transduction. At the early stage of leaf senescence, genes involved in aromatic amino acids (AAAs) biosynthetic process and transport, cellular polysaccharide biosynthetic process, and the cell wall macromolecule catabolic process, were up-regulated. Whereas, genes involved in amino acid metabolism, transport, apoptosis, and response to stimulus were up-regulated at the late stage of leaf senescence. Further analyses reveals that the transport-related genes at the early stage of leaf senescence potentially take part in enzyme and amino acid transport and the genes upregulated at the late stage are involved in sugar transport, indicating nutrient recycling mainly takes place at the late stage of leaf senescence. Comparison between the data of natural leaf senescence in this study and previously reported data for Arabidopsis implies that the mechanisms of leaf senescence in maize are basically similar to those in Arabidopsis. A comparison of natural and induced leaf senescence in maize was performed. Athough many basic biological processes involved in senescence occur in both types of leaf senescence, 78.07% of differentially expressed genes in natural leaf senescence were not identifiable in induced leaf senescence, suggesting that differences in gene regulatory network may exist between these two leaf senescence programs. Thus, this study provides important information for understanding the mechanism of leaf senescence in maize.	[Zhang, Wei Yang; Li, Wen Lan; Zhang, Xian Sheng; Zhao, Xiang Yu] Shandong Agr Univ, Coll Life Sci, Shandong Key Lab Crop Biol, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China; [Xu, Yong Chao; Yang, Long] Shandong Agr Univ, Coll Plant Protect, Tai An, Shandong, Peoples R China; [Yue, Xun] Shandong Agr Univ, Coll Informat Sci & Engn, Tai An, Shandong, Peoples R China	Shandong Agricultural University; Shandong Agricultural University; Shandong Agricultural University	Zhao, XY (corresponding author), Shandong Agr Univ, Coll Life Sci, Shandong Key Lab Crop Biol, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China.	zhxy@sdau.edu.cn	zhang, xian/GYA-0290-2022	Yang, Long/0000-0002-9990-8398	Key Projects of National Plant Transgenic Genes of China [2013ZX08003-003]; Ministry of Agriculture of the People's Republic of China	Key Projects of National Plant Transgenic Genes of China; Ministry of Agriculture of the People's Republic of China(Ministry of Agriculture & Rural Affairs)	This work was financially supported by grants from the Key Projects of National Plant Transgenic Genes of China (To XSZ and XYZ, Project no. 2013ZX08003-003) from Ministry of Agriculture of the People's Republic of China (http://english.agri.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSARI MI, 2011, INT J RECENT TRENDS, V1, P110; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Balazadeh S, 2008, PLANT BIOLOGY, V10, P63, DOI 10.1111/j.1438-8677.2008.00088.x; Balazadeh S, 2011, MOL PLANT, V4, P346, DOI 10.1093/mp/ssq080; Balazadeh S, 2010, PLANT J, V62, P250, DOI 10.1111/j.1365-313X.2010.04151.x; Besseau S, 2012, J EXP BOT, V63, P2667, DOI 10.1093/jxb/err450; Breeze E, 2011, PLANT CELL, V23, P873, DOI 10.1105/tpc.111.083345; Brusslan JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033151; Buchanan-Wollaston V, 2005, PLANT J, V42, P567, DOI 10.1111/j.1365-313X.2005.02399.x; Cai SQ, 2008, PLANT PHYSIOL, V146, P1305, DOI 10.1104/pp.107.110908; Cantu D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-492; D'haeseleer K, 2010, PLANT CELL PHYSIOL, V51, P1416, DOI 10.1093/pcp/pcq104; Dietz KJ, 2003, INT REV CYTOL, V228, P141, DOI 10.1016/S0074-7696(03)28004-9; Doyle EA, 2007, PLANT CELL ENVIRON, V30, P388, DOI 10.1111/j.1365-3040.2006.01624.x; Du YY, 2008, J INTEGR PLANT BIOL, V50, P1318, DOI 10.1111/j.1744-7909.2008.00741.x; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Eason JR, 2000, POSTHARVEST BIOL TEC, V18, P81, DOI 10.1016/S0925-5214(99)00058-7; Ellis CM, 2005, DEVELOPMENT, V132, P4563, DOI 10.1242/dev.02012; Farage-Barhom S, 2008, J EXP BOT, V59, P3247, DOI 10.1093/jxb/ern176; Friso G, 2004, PLANT CELL, V16, P478, DOI 10.1105/tpc.017814; Gambino G, 2008, PHYTOCHEM ANALYSIS, V19, P520, DOI 10.1002/pca.1078; Gepstein S, 2003, PLANT J, V36, P629, DOI 10.1046/j.1365-313X.2003.01908.x; Grassl J, 2012, J PROTEOME RES, V11, P5443, DOI 10.1021/pr300691k; Gregersen PL, 2013, PLANT MOL BIOL, V82, P603, DOI 10.1007/s11103-013-0013-8; Gregersen PL., 2011, MOL PHYSL BASIS NUTR, P83, DOI DOI 10.1002/9780470960707; Griffiths CM, 1997, PLANT MOL BIOL, V34, P815, DOI 10.1023/A:1005896713830; Guiboileau A, 2010, CR BIOL, V333, P382, DOI 10.1016/j.crvi.2010.01.016; Guo Y, 2004, PLANT CELL ENVIRON, V27, P521, DOI 10.1111/j.1365-3040.2003.01158.x; Guo YF, 2006, PLANT J, V46, P601, DOI 10.1111/j.1365-313X.2006.02723.x; Guo YF, 2011, PLANT PHYSIOL, V156, P1612, DOI 10.1104/pp.111.177022; He YH, 2001, PLANT MOL BIOL, V47, P595, DOI 10.1023/A:1012211011538; Heber U, 2006, J EXP BOT, V57, P1211, DOI 10.1093/jxb/erj104; Hickman R, 2013, PLANT J, V75, P26, DOI 10.1111/tpj.12194; Himelblau E, 2000, CURR OPIN PLANT BIOL, V3, P205, DOI 10.1016/S1369-5266(00)00065-0; Hinderhofer K, 2001, PLANTA, V213, P469, DOI 10.1007/s004250000512; Hortensteiner S, 2002, J EXP BOT, V53, P927, DOI 10.1093/jexbot/53.370.927; Hou K, 2013, PLANT PHYSIOL, V161, P1002, DOI 10.1104/pp.112.212787; Jan A, 2013, PLANT PHYSIOL, V161, P1202, DOI 10.1104/pp.112.205385; Jia YX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065687; Kim HJ, 2006, P NATL ACAD SCI USA, V103, P814, DOI 10.1073/pnas.0505150103; Kim JH, 2009, SCIENCE, V323, P1053, DOI 10.1126/science.1166386; Kim YS, 2013, PLANT CELL PHYSIOL, V54, P1660, DOI 10.1093/pcp/pct113; Kinoshita T, 1999, PLANT J, V19, P43, DOI 10.1046/j.1365-313X.1999.00497.x; Koyama T, 2013, PLANT PHYSIOL, V162, P991, DOI 10.1104/pp.113.218115; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lim PO, 2007, PLANT J, V52, P1140, DOI 10.1111/j.1365-313X.2007.03317.x; Lim PO, 2007, ANNU REV PLANT BIOL, V58, P115, DOI 10.1146/annurev.arplant.57.032905.105316; Lin JF, 2004, PLANT J, V39, P612, DOI 10.1111/j.1365-313X.2004.02160.x; Liu L, 2008, PLANT MOL BIOL, V67, P37, DOI 10.1007/s11103-008-9300-1; LOHMAN KN, 1994, PHYSIOL PLANTARUM, V92, P322, DOI 10.1111/j.1399-3054.1994.tb05343.x; Maeda H, 2012, ANNU REV PLANT BIOL, V63, P73, DOI 10.1146/annurev-arplant-042811-105439; Masclaux-Daubresse C, 2007, PLANT PHYSIOL, V143, P434, DOI 10.1104/pp.106.091355; Matallana-Ramirez LP, 2013, MOL PLANT, V6, P1438, DOI 10.1093/mp/sst012; McLellan H, 2009, NEW PHYTOL, V183, P408, DOI 10.1111/j.1469-8137.2009.02865.x; Miao Y, 2008, PLANT BIOLOGY, V10, P110, DOI 10.1111/j.1438-8677.2008.00083.x; Miao Y, 2004, PLANT MOL BIOL, V55, P853, DOI 10.1007/s11103-005-2142-1; Miao Y, 2007, PLANT CELL, V19, P819, DOI 10.1105/tpc.106.042705; Miao Y, 2010, PLANT J, V63, P179, DOI 10.1111/j.1365-313X.2010.04233.x; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakabayashi K, 1999, PLANT CELL PHYSIOL, V40, P504, DOI 10.1093/oxfordjournals.pcp.a029571; Noh YS, 1999, PLANT MOL BIOL, V41, P181, DOI 10.1023/A:1006342412688; Park JH, 1998, PLANT MOL BIOL, V37, P445, DOI 10.1023/A:1005958300951; Perez-Rodriguez P, 2010, NUCLEIC ACIDS RES, V38, pD822, DOI 10.1093/nar/gkp805; Pourtau N, 2006, PLANTA, V224, P556, DOI 10.1007/s00425-006-0243-y; Pruzinska A, 2005, PLANT PHYSIOL, V139, P52, DOI 10.1104/pp.105.065870; Quirino BF, 2001, PLANT MOL BIOL, V46, P447, DOI 10.1023/A:1010639015959; Raab S, 2009, PLANT J, V59, P39, DOI 10.1111/j.1365-313X.2009.03846.x; Robatzek S, 2002, GENE DEV, V16, P1139, DOI 10.1101/gad.222702; Robinson WD, 2012, NEW PHYTOL, V196, P1024, DOI 10.1111/nph.12006; ROBINSONBEERS K, 1992, PLANT CELL, V4, P1237, DOI 10.1105/tpc.4.10.1237; Rolletschek H, 2005, PLANT PHYSIOL, V137, P1236, DOI 10.1104/pp.104.056523; Sakuraba Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5636; Sakuraba Y, 2013, BIOCHEM BIOPH RES CO, V430, P32, DOI 10.1016/j.bbrc.2012.11.050; Sakuraba Y, 2012, PLANT CELL, V24, P507, DOI 10.1105/tpc.111.089474; Schelbert S, 2009, PLANT CELL, V21, P767, DOI 10.1105/tpc.108.064089; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Sekhon RS, 2012, PLANT PHYSIOL, V159, P1730, DOI 10.1104/pp.112.199224; SMART CM, 1995, PHYSIOL PLANTARUM, V93, P673, DOI 10.1111/j.1399-3054.1995.tb05116.x; Smykowski A, 2010, PLANT PHYSIOL, V153, P1321, DOI 10.1104/pp.110.157180; Soudry E, 2005, J EXP BOT, V56, P695, DOI 10.1093/jxb/eri054; Suzuki M, 2004, PLANT J, V37, P750, DOI 10.1111/j.1365-313X.2004.02003.x; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Uauy C, 2006, SCIENCE, V314, P1298, DOI 10.1126/science.1133649; Van der Graaff E, 2006, PLANT PHYSIOL, V141, P776, DOI 10.1104/pp.106.079293; Vescovi M, 2012, J EXP BOT, V63, P2825, DOI 10.1093/jxb/ers008; Veyres N, 2008, PLANT J, V55, P665, DOI 10.1111/j.1365-313X.2008.03541.x; Vogelmann K, 2012, PLANT PHYSIOL, V159, P1477, DOI 10.1104/pp.112.196220; Wagner R, 2011, NEW PHYTOL, V191, P449, DOI 10.1111/j.1469-8137.2011.03684.x; Weaver LM, 1999, PLANT PHYSIOL, V119, P1209, DOI 10.1104/pp.119.4.1209; Woo HR, 2001, PLANT CELL, V13, P1779, DOI 10.1105/tpc.13.8.1779; Woo HR, 2010, J EXP BOT, V61, P3947, DOI 10.1093/jxb/erq206; Wu AH, 2012, PLANT CELL, V24, P482, DOI 10.1105/tpc.111.090894; Wu XY, 2012, J INTEGR PLANT BIOL, V54, P936, DOI 10.1111/jipb.12005; Yang SD, 2011, PLANT CELL, V23, P2155, DOI 10.1105/tpc.111.084913; Yoshida S, 2001, PLANT CELL PHYSIOL, V42, P170, DOI 10.1093/pcp/pce021; Zelisko A, 2005, P NATL ACAD SCI USA, V102, P13699, DOI 10.1073/pnas.0503472102; Zhang BY, 2012, MOL CELLS, V34, P367, DOI 10.1007/s10059-012-0111-5; Zhang H, 2011, NUCLEIC ACIDS RES, V39, pD1114, DOI 10.1093/nar/gkq1141; Zhang KW, 2013, P NATL ACAD SCI USA, V110, P14807, DOI 10.1073/pnas.1302702110; Zhang KW, 2012, PLANT PHYSIOL, V158, P961, DOI 10.1104/pp.111.190876; Zhang Q, 2012, PLANT MOL BIOL REP, V30, P539, DOI 10.1007/s11105-011-0366-6; Zhang ZS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042936; Zheng MS, 2005, PLANT SCI, V168, P415, DOI 10.1016/j.plantsci.2004.09.016; Zhou CJ, 2009, PLANT PHYSIOL, V150, P167, DOI 10.1104/pp.108.133439; Zhou X, 2011, MOL CELLS, V31, P303, DOI 10.1007/s10059-011-0047-1	105	37	41	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115617	10.1371/journal.pone.0115617	http://dx.doi.org/10.1371/journal.pone.0115617			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25532107	gold, Green Published, Green Submitted			2022-12-27	WOS:000348845100085
J	Fernandes, BJT; Cavalcanti, GDC; Ren, TI				Fernandes, Bruno J. T.; Cavalcanti, George D. C.; Ren, Tsang I.			Constructive Autoassociative Neural Network for Facial Recognition	PLOS ONE			English	Article							EXPRESSION RECOGNITION; RECEPTIVE-FIELD; LATERAL INHIBITION; ALGORITHMS; UNITS	Autoassociative artificial neural networks have been used in many different computer vision applications. However, it is difficult to define the most suitable neural network architecture because this definition is based on previous knowledge and depends on the problem domain. To address this problem, we propose a constructive autoassociative neural network called CANet (Constructive Autoassociative Neural Network). CANet integrates the concepts of receptive fields and autoassociative memory in a dynamic architecture that changes the configuration of the receptive fields by adding new neurons in the hidden layer, while a pruning algorithm removes neurons from the output layer. Neurons in the CANet output layer present lateral inhibitory connections that improve the recognition rate. Experiments in face recognition and facial expression recognition show that the CANet outperforms other methods presented in the literature.	[Fernandes, Bruno J. T.] Univ Pernambuco, Escola Politecn, Recife, PE, Brazil; [Cavalcanti, George D. C.; Ren, Tsang I.] Univ Fed Pernambuco, Ctr Informat, Recife, PE, Brazil	Universidade de Pernambuco (UPE); Universidade Federal de Pernambuco	Fernandes, BJT (corresponding author), Univ Pernambuco, Escola Politecn, Recife, PE, Brazil.	bjtf@ecomp.poli.br	Cavalcanti, George DC/C-2364-2017; Fernandes, Bruno J T/R-1237-2016; Ren, Tsang Ing/AAD-3221-2022	Cavalcanti, George DC/0000-0001-7714-2283; Fernandes, Bruno J T/0000-0002-6001-3925; 	CNPq; CAPES; Facepe	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Facepe(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE))	This work was partially supported by Brazilian agencies: CNPq, CAPES and Facepe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, NEURAL NETWORKS BRAI; Arkachar P, 2007, NEUROCOMPUTING, V70, P991, DOI 10.1016/j.neucom.2006.03.017; Ash T., 1989, Connection Science, V1, P365, DOI 10.1080/09540098908915647; Bashyal S, 2008, ENG APPL ARTIF INTEL, V21, P1056, DOI 10.1016/j.engappai.2007.11.010; Bishop C.M., 2007, NEURAL NETWORKS PATT, V1st; Cavalcanti GDC, 2004, P BRAZ S ART NEUR NE, V3656, P1; Cheng F, 2010, IEEE T NEURAL NETWOR, V21, P1685, DOI 10.1109/TNN.2010.2064176; Fahlman S.E., 1990, CARNEGIE MELLON U PI; Farabet C, 2013, IEEE T PATTERN ANAL, V35, P1915, DOI 10.1109/TPAMI.2012.231; Fernandes BJT, 2013, EXPERT SYST APPL, V40, P7258, DOI 10.1016/j.eswa.2013.06.080; Fernandes BJT, 2009, NEURAL NETW WORLD, V19, P21; Fernandes BJT, 2013, IEEE T CYBERNETICS, V43, P2082, DOI 10.1109/TCYB.2013.2240295; Ghosh K, 2010, IEEE T SYST MAN CY A, V40, P758, DOI 10.1109/TSMCA.2010.2044503; Grigorescu C, 2003, IEEE T IMAGE PROCESS, V12, P729, DOI 10.1109/TIP.2003.814250; Haykin S. O., 2008, NEURAL NETWORKS LEAR; HONAVAR V, 1993, INFORM SCIENCES, V70, P75, DOI 10.1016/0020-0255(93)90049-R; HORNIK K, 1989, NEURAL NETWORKS, V2, P359, DOI 10.1016/0893-6080(89)90020-8; HUBEL DAVID H., 1963, SCI AMER, V209, P54; Igel C, 2003, NEUROCOMPUTING, V50, P105, DOI 10.1016/S0925-2312(01)00700-7; Islam MM, 2009, IEEE T SYST MAN CY B, V39, P705, DOI 10.1109/TSMCB.2008.2008724; JONES JP, 1987, J NEUROPHYSIOL, V58, P1233, DOI 10.1152/jn.1987.58.6.1233; Kameyama K, 1997, 1997 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS, VOLS 1-4, P1523, DOI 10.1109/ICNN.1997.614119; Kwok TY, 1997, IEEE T NEURAL NETWOR, V8, P1131, DOI 10.1109/72.623214; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Lei H., 2005, THESIS STATE U NEW Y; Lyons M. J., 1997, JAPANESE FEMALE FACI; Ma L, 2004, IEEE T SYST MAN CY B, V34, P1588, DOI 10.1109/TSMCB.2004.825930; Ma L, 2003, NEUROCOMPUTING, V51, P361, DOI 10.1016/S0925-2312(02)00597-0; Mao ZH, 2007, IEEE T NEURAL NETWOR, V18, P55, DOI 10.1109/TNN.2006.883724; Maronidis A, 2011, NEURAL NETWORKS, V24, P814, DOI 10.1016/j.neunet.2011.05.015; Martinez A. M., 1998, TECHNICAL REPORT; Martinez AM, 2001, IEEE T PATTERN ANAL, V23, P228, DOI 10.1109/34.908974; Mi JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059430; Mi JX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042461; Nabet B, 1991, SENSORY NEURAL NETWO; Parekh R, 2000, IEEE T NEURAL NETWOR, V11, P436, DOI 10.1109/72.839013; Perez CA, 2003, IEEE T SYST MAN CY B, V33, P258, DOI 10.1109/TSMCB.2003.810441; Phung SL, 2007, IEEE T NEURAL NETWOR, V18, P329, DOI 10.1109/TNN.2006.884677; Rao KS, 2011, EXPERT SYST APPL, V38, P13181, DOI 10.1016/j.eswa.2011.04.129; REED R, 1993, IEEE T NEURAL NETWOR, V4, P740, DOI 10.1109/72.248452; RIEDMILLER M, 1993, 1993 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS, VOLS 1-3, P586, DOI 10.1109/ICNN.1993.298623; RIZZOLATTI G, 1975, BRAIN RES, V88, P357, DOI 10.1016/0006-8993(75)90399-6; Samaria F. S., 1994, Proceedings of the Second IEEE Workshop on Applications of Computer Vision (Cat. No.94TH06742), P138, DOI 10.1109/ACV.1994.341300; Sharma S. K., 2010, Proceedings of the 2010 International Conference on Computational Intelligence and Communication Networks (CICN 2010), P139, DOI 10.1109/CICN.2010.38; Sharma SK, 2010, INT J ENG SCI TECHNO, V2, P7847; Sun C, 2004, NEUROSCIENCE, V125, P495, DOI 10.1016/j.neuroscience.2004.01.036; Thompson BB, 2002, IEEE IJCNN, P2878, DOI 10.1109/IJCNN.2002.1007605; Wang M, 2005, IEEE T NEURAL NETWOR, V16, P557, DOI 10.1109/TNN.2005.847839; Wilson NR, 2012, NATURE, V488, P343, DOI 10.1038/nature11347; Zavaschi THH, 2013, EXPERT SYST APPL, V40, P646, DOI 10.1016/j.eswa.2012.07.074; Zhi RC, 2011, IEEE T SYST MAN CY B, V41, P38, DOI 10.1109/TSMCB.2010.2044788; Zhu QH, 2013, PLOS ONE, P8	53	4	4	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115967	10.1371/journal.pone.0115967	http://dx.doi.org/10.1371/journal.pone.0115967			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542018	Green Published, gold			2022-12-27	WOS:000347239900120
J	Markwart, R; Condotta, SA; Requardt, RP; Borken, F; Schubert, K; Weigel, C; Bauer, M; Griffith, TS; Forster, M; Brunkhorst, FM; Badovinac, VP; Rubio, I				Markwart, Robby; Condotta, Stephanie A.; Requardt, Robert P.; Borken, Farina; Schubert, Katja; Weigel, Cynthia; Bauer, Michael; Griffith, Thomas S.; Foerster, Martin; Brunkhorst, Frank M.; Badovinac, Vladimir P.; Rubio, Ignacio			Immunosuppression after Sepsis: Systemic Inflammation and Sepsis Induce a Loss of Naive T-Cells but No Enduring Cell-Autonomous Defects in T-Cell Function	PLOS ONE			English	Article							IMPROVES SURVIVAL; CECAL LIGATION; INTENSIVE-CARE; SEPTIC SHOCK; MURINE MODEL; CYTOMEGALOVIRUS REACTIVATION; POLYMICROBIAL SEPSIS; BACTERIAL CLEARANCE; INDUCED APOPTOSIS; EFFECTOR FUNCTION	Sepsis describes the life-threatening systemic inflammatory response (SIRS) of an organism to an infection and is the leading cause of mortality on intensive care units (ICU) worldwide. An acute episode of sepsis is characterized by the extensive release of cytokines and other mediators resulting in a dysregulated immune response leading to organ damage and/or death. This initial pro-inflammatory burst often transits into a state of immune suppression characterised by loss of immune cells and T-cell dysfunction at later disease stages in sepsis survivors. However, despite these appreciations, the precise nature of the evoked defect in T-cell immunity in post-acute phases of SIRS remains unknown. Here we present an in-depth functional analysis of T-cell function in post-acute SIRS/sepsis. We document that T-cell function is not compromised on a per cell basis in experimental rodent models of infection-free SIRS (LPS or CpG) or septic peritonitis. Transgenic antigen-specific T-cells feature an unaltered cytokine response if challenged in vivo and ex vivo with cognate antigens. Isolated CD4(+)/CD8(+) T-cells from post-acute septic animals do not exhibit defects in T-cell receptor-mediated activation at the the level of receptor-proximal signalling, activation marker upregulation or expansion. However, SIRS/sepsis induced transient lymphopenia and gave rise to an environment of immune attenuation at post acute disease stages. Thus, systemic inflammation has an acute impact on T-cell numbers and adaptive immunity, but does not cause major cell-autonomous enduring functional defects in T-cells.	[Markwart, Robby; Requardt, Robert P.; Borken, Farina; Schubert, Katja; Weigel, Cynthia; Bauer, Michael; Brunkhorst, Frank M.; Rubio, Ignacio] Jena Univ Hosp, CSCC, Integrated Res & Treatment Ctr, Jena, Germany; [Condotta, Stephanie A.; Badovinac, Vladimir P.] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA; [Bauer, Michael] Jena Univ Hosp, Dept Anaesthesiol & Intens Care Med, Jena, Germany; [Griffith, Thomas S.] Minneapolis Vet Affairs Hlth Care Syst, Minneapolis, MN USA; [Griffith, Thomas S.] Univ Minnesota, Ctr Immunol, Minneapolis, MN USA; [Foerster, Martin] Jena Univ Hosp, Clin Internal Med, Jena, Germany; [Brunkhorst, Frank M.] Jena Univ Hosp, Ctr Clin Studies, Jena, Germany; [Rubio, Ignacio] Jena Univ Hosp, Ctr Mol Biomed, Inst Mol Cell Biol, Jena, Germany	Friedrich Schiller University of Jena; University of Iowa; Friedrich Schiller University of Jena; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Rubio, I (corresponding author), Jena Univ Hosp, CSCC, Integrated Res & Treatment Ctr, Jena, Germany.	ignacio.rubio@med.uni-jena.de	Griffith, Thomas/ABF-8225-2020; badovinac, Vladimir/O-7760-2015	Badovinac, Vladimir/0000-0003-3180-2439; Markwart, Robby/0000-0003-0338-3433; Bauer, Michael/0000-0002-1521-3514; Weigel, Cynthia/0000-0003-3132-4203	Federal Ministry of Education and Research (BMBF), Germany [FKZ: 01EO1002]; U.S. National Institutes of Health [AI83286, AI114543]; American Heart Association; U.S. Department of Veterans Affairs Merit Review Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083286, R01AI114543] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001324] Funding Source: NIH RePORTER	Federal Ministry of Education and Research (BMBF), Germany(Federal Ministry of Education & Research (BMBF)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); U.S. Department of Veterans Affairs Merit Review Award(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	Funding: This work was supported by the Federal Ministry of Education and Research (BMBF), Germany, FKZ: 01EO1002 (IR), by U.S. National Institutes of Health grants AI83286 and AI114543 (VPB), an award from American Heart Association (SAC), and a U.S. Department of Veterans Affairs Merit Review Award (TSG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Arndt B, 2013, J IMMUNOL METHODS, V387, P276, DOI 10.1016/j.jim.2012.11.006; Behrens EM, 2011, J CLIN INVEST, V121, P2264, DOI 10.1172/JCI43157; Ben-Sasson SZ, 2011, CYTOKINE, V56, P122, DOI 10.1016/j.cyto.2011.07.006; Ben-Sasson SZ, 2013, J EXP MED, V210, P491, DOI 10.1084/jem.20122006; Berg NN, 1998, J IMMUNOL, V161, P2919; BONE RC, 1992, CHEST, V101, P1481, DOI 10.1378/chest.101.6.1481; Boomer JS, 2012, CRIT CARE, V16, DOI 10.1186/cc11404; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Bosmann M, 2011, SHOCK, V36, P396, DOI 10.1097/SHK.0b013e3182295f5f; BROOKE MS, 1965, NATURE, V206, P635, DOI 10.1038/206635a0; Cabrera-Perez J, 2014, J LEUKOCYTE BIOL, V96, P767, DOI 10.1189/jlb.5MR0114-067R; Carson WF, 2010, EUR J IMMUNOL, V40, P998, DOI 10.1002/eji.200939739; Chang KC, 2013, CRIT CARE, V17, DOI 10.1186/cc12711; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Chen X, 2007, J IMMUNOL, V179, P154, DOI 10.4049/jimmunol.179.1.154; Chung CS, 2006, AM J PHYSIOL-REG I, V291, pR1338, DOI 10.1152/ajpregu.00283.2006; Chung CS, 2010, SHOCK, V34, P150, DOI 10.1097/SHK.0b013e3181cf70fb; Condotta SA, 2013, CRIT REV IMMUNOL, V33, P23, DOI 10.1615/CritRevImmunol.2013006721; Condotta SA, 2013, J IMMUNOL, V190, P1991, DOI 10.4049/jimmunol.1202379; Condotta SA, 2012, ADV IMMUNOL, V113, P51, DOI 10.1016/B978-0-12-394590-7.00005-1; Croker BA, 2014, CURR OPIN IMMUNOL, V26, P128, DOI 10.1016/j.coi.2013.12.002; Cuenca AG, 2011, MOL MED, V17, P281, DOI 10.2119/molmed.2010.00178; Cuthbertson BH, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-116; De AK, 1997, CLIN IMMUNOL IMMUNOP, V82, P73, DOI 10.1006/clin.1996.4289; Duong S, 2014, J IMMUNOL, V192, P3618, DOI 10.4049/jimmunol.1303460; Enoh VT, 2008, SHOCK, V29, P56, DOI 10.1097/shk.0b013e318070c8b9; Enoh VT, 2007, SHOCK, V27, P507, DOI 10.1097/SHK.0b013e31802b5d9f; ERTEL W, 1992, SURGERY, V111, P177; Fry DE, 2012, AM SURGEON, V78, P1; Gentile LF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094404; Gonnert FA, 2012, SHOCK, V37, P399, DOI 10.1097/SHK.0b013e31824a670b; Gonnert FA, 2011, J SURG RES, V170, pE123, DOI 10.1016/j.jss.2011.05.019; Gurung P, 2011, J IMMUNOL, V187, P2148, DOI 10.4049/jimmunol.1101180; Heidecke CD, 2000, CHIRURG, V71, P159, DOI 10.1007/s001040050028; Heininger A, 2011, CRIT CARE, V15, DOI 10.1186/cc10069; Heuer JG, 2005, J IMMUNOL, V174, P7141, DOI 10.4049/jimmunol.174.11.7141; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Hotchkiss RS, 2001, J IMMUNOL, V166, P6952, DOI 10.4049/jimmunol.166.11.6952; Hotchkiss RS, 2005, J IMMUNOL, V174, P5110, DOI 10.4049/jimmunol.174.8.5110; Hotchkiss RS, 1999, CRIT CARE MED, V27, P1230, DOI 10.1097/00003246-199907000-00002; Hotchkiss RS, 2000, NAT IMMUNOL, V1, P496, DOI 10.1038/82741; Hotchkiss RS, 1997, CRIT CARE MED, V25, P1298, DOI 10.1097/00003246-199708000-00015; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Inoue S, 2013, CRIT CARE MED, V41, P810, DOI 10.1097/CCM.0b013e318274645f; Inoue S, 2011, SHOCK, V36, P38, DOI 10.1097/SHK.0b013e3182168cce; Inoue S, 2010, J IMMUNOL, V184, P1401, DOI 10.4049/jimmunol.0902307; Kasten KR, 2010, INFECT IMMUN, V78, P4714, DOI 10.1128/IAI.00456-10; Kessel A, 2009, J AUTOIMMUN, V32, P211, DOI 10.1016/j.jaut.2009.02.014; Kuhlhorn F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065109; Lambeck S, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00284; Limaye AP, 2008, JAMA-J AM MED ASSOC, V300, P413, DOI 10.1001/jama.300.4.413; Marshall JC, 2005, SHOCK, V24, P1, DOI 10.1097/01.shk.0000191383.34066.4b; Marshall JC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001341; Martin MD, 2011, J IMMUNOL, V187, P2923, DOI 10.4049/jimmunol.1100698; Masters SL, 2012, IMMUNITY, V37, P1009, DOI 10.1016/j.immuni.2012.08.027; McAleer JP, 2008, CRIT REV IMMUNOL, V28, P281; Meisel C, 2009, AM J RESP CRIT CARE, V180, P640, DOI 10.1164/rccm.200903-0363OC; Mohr A, 2012, EUR J IMMUNOL, V42, P341, DOI 10.1002/eji.201141692; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Myhren H, 2010, CRIT CARE, V14, DOI 10.1186/cc8870; Nolz JC, 2012, P NATL ACAD SCI USA, V109, P6199, DOI 10.1073/pnas.1118868109; Otto GP, 2011, CRIT CARE, V15, DOI 10.1186/cc10332; PIRCHER H, 1989, EMBO J, V8, P719, DOI 10.1002/j.1460-2075.1989.tb03431.x; Recknagel P, 2013, LIVER INT, V33, P283, DOI 10.1111/liv.12012; Reim D, 2009, SHOCK, V31, P245, DOI 10.1097/SHK.0b013e31817fd02c; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Roth G, 2003, BIOCHEM BIOPH RES CO, V308, P840, DOI 10.1016/S0006-291X(03)01482-7; Stromberg PE, 2009, FASEB J, V23, P1817, DOI 10.1096/fj.08-119024; Suffredini AF, 2011, JAMA-J AM MED ASSOC, V306, P194, DOI 10.1001/jama.2011.909; Tisoncik JR, 2012, MICROBIOL MOL BIOL R, V76, P16, DOI 10.1128/MMBR.05015-11; Tschoep J, 2008, J LEUKOCYTE BIOL, V83, P581, DOI 10.1189/jlb.0707507; Ulloa L, 2005, TRENDS MOL MED, V11, P56, DOI 10.1016/j.molmed.2004.12.007; Unsinger J, 2010, J IMMUNOL, V184, P3768, DOI 10.4049/jimmunol.0903151; van Schaik SM, 2007, EUR J IMMUNOL, V37, P3101, DOI 10.1002/eji.200737295; Vincent JL, 2014, LANCET RESP MED, V2, P380, DOI 10.1016/S2213-2600(14)70061-X; Wang XQ, 2008, J IMMUNOL, V180, P6703, DOI 10.4049/jimmunol.180.10.6703; Winters BD, 2010, CRIT CARE MED, V38, P1276, DOI 10.1097/CCM.0b013e3181d8cc1d; Zhang Y, 2011, CRIT CARE, V15, DOI 10.1186/cc10059; Zhang Y, 2010, CRIT CARE, V14, DOI 10.1186/cc9354	82	46	54	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e0115094	10.1371/journal.pone.0115094	http://dx.doi.org/10.1371/journal.pone.0115094			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541945	gold, Green Submitted, Green Published			2022-12-27	WOS:000347239900023
J	Munjal, A; Sakhadeo, UR; Muller, KE; Glueck, DH; Kreidler, SM				Munjal, Aarti; Sakhadeo, Uttara R.; Muller, Keith E.; Glueck, Deborah H.; Kreidler, Sarah M.			GLIMMPSE Lite: Calculating Power and Sample Size on Smartphone Devices	PLOS ONE			English	Article								Researchers seeking to develop complex statistical applications for mobile devices face a common set of difficult implementation issues. In this work, we discuss general solutions to the design challenges. We demonstrate the utility of the solutions for a free mobile application designed to provide power and sample size calculations for univariate, one-way analysis of variance (ANOVA), GLIMMPSE Lite. Our design decisions provide a guide for other scientists seeking to produce statistical software for mobile platforms.	[Munjal, Aarti; Sakhadeo, Uttara R.; Glueck, Deborah H.; Kreidler, Sarah M.] Univ Colorado, Dept Biostat & Informat, Denver, CO 80202 USA; [Muller, Keith E.] Univ Florida, Gainesville, FL USA	University of Colorado System; University of Colorado Denver; State University System of Florida; University of Florida	Munjal, A (corresponding author), Univ Colorado, Dept Biostat & Informat, Denver, CO 80202 USA.	aarti.munjal@ucdenver.edu			NIDCR [1 R01 DE020832-01A1]; NIH/NIDCR [U54-DE019261]; NIH/NCRR [K30-RR022258]; NIH/NHLBI [R01-HL091005]; NIH/NIAAA [R01-AA013458-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [K30RR022258] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE020832, U54DE019261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013458] Funding Source: NIH RePORTER	NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH/NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The GLIMMPSE Lite project was funded by NIDCR 1 R01 DE020832-01A1 to the University of Florida (Keith Muller, PI; Deborah Glueck, University of Colorado site PI). Additional support for Dr. Muller was provided in part by NIH/NIDCR grants U54-DE019261, NIH/NCRR grant K30-RR022258, NIH/NHLBI grant R01-HL091005 and NIH/NIAAA grant R01-AA013458-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adobe Systems, 2003, PHONEGAP; Amazon, 2012, AMAZON WEB SERVICES; [Anonymous], 2012, XCODE; [Anonymous], 2012, SPSS; Apple, 2012, APPL STOR; Borenstein M., 2012, POWER PRECISION; Cowan John, 2006, EXTENSIBLE MARKUP LA; Crockford Douglas, 2012, JSON; Eclipse Foundation, 2012, ECLIPSE; Education P, 2012, POW ED; Google, 2012, JELLY BEAN; Google, 2012, ANDR; Google, 2012, HONEYCOMB; Google, 2012, GOOGL PLAY; Google, 2012, GINGERBREAD; Google, 2012, ICE CREAM SANDWICH; HP, 2011, PALM WEBOS; Johnson JL, 2009, J STAT SOFTWARE; Kreidler SM, 2013, J STAT SOFTWARE, V54; Lie H., 2008, CASCADING STYLE SHEE; McGovern J, 2003, ARCHITECTURE; Microsoft, 2012, WIND PHON; NCSS, 2008, PASS POW AN SAMPL SI; Noelios Technologies, 2011, RESTL VERS 2 0 10; Raudenbush SW, 2000, PSYCHOL METHODS, V5, P199, DOI 10.1037//1082-989X.5.2.199; RG O, 2003, UNIFYPOW; Samsung, 2012, GALAXYSIII; Samsung, 2012, STRATOSPHERE; Samsung, 2012, NEXUS S; Samsung, 2011, BADA; SAS, 2011, SAS IML SOFTW VERS 9; SAS Institute Inc, 2011, SAS 9 2 SOFTW VERS 9; Statistical Solutions, 2008, NQUER ADV SAMPL SIZ; Statistics F, 2012, FREE STAT; Thompson M, 2012, AFNETWORKING; W3C, 1999, HTML 4 01 SPEC CAT; Wikipedia, 2012, LIK SCAL; Williams VV, 2011, STOC 44 S THEOR COMP	38	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e102082	10.1371/journal.pone.0102082	http://dx.doi.org/10.1371/journal.pone.0102082			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541688	gold, Green Published, Green Submitted			2022-12-27	WOS:000347239900001
J	Park, JC; Kim, JS; Park, SH; Webster, MJ; Lee, S; Song, WY; Han, Y				Park, Justin C.; Kim, Jin Sung; Park, Sung Ho; Webster, Matthew J.; Lee, Soyoung; Song, William Y.; Han, Youngyih			Four Dimensional Digital Tomosynthesis Using on-Board Imager for the Verification of Respiratory Motion	PLOS ONE			English	Article							CONE-BEAM-CT; GUIDED RADIATION-THERAPY; POSITIONING VERIFICATION; PROSTATE-CANCER; RECONSTRUCTION; RADIOTHERAPY; SYSTEM; MODEL; ARTIFACTS; ALGORITHM	Purpose: To evaluate respiratory motion of a patient by generating four-dimensional digital tomosynthesis (4D DTS), extracting respiratory signal from patients' on-board projection data, and ensuring the feasibility of 4D DTS as a localization tool for the targets which have respiratory movement. Methods and Materials: Four patients with lung and liver cancer were included to verify the feasibility of 4D-DTS with an on-board imager. CBCT acquisition (650670 projections) was used to reconstruct 4D DTS images and the breath signal of the patients was generated by extracting the motion of diaphragm during data acquisition. Based on the extracted signal, the projection data was divided into four phases: peak-exhale phase, mid-inhale phase, peak-inhale phase, and mid-exhale phase. The binned projection data was then used to generate 4D DTS, where the total scan angle was assigned as +/- 22.5 degrees from rotation center, centered on 0 degrees and 180 degrees for coronal "half-fan'' 4D DTS, and 90 degrees and 270 degrees for sagittal "half-fan'' 4D DTS. The result was then compared with 4D CBCT which we have also generated with the same phase distribution. Results: The motion of the diaphragm was evident from the 4D DTS results for peak-exhale, mid-inhale, peak-inhale and mid-exhale phase assignment which was absent in 3D DTS. Compared to the result of 4D CBCT, the view aliasing effect due to arbitrary angle reconstruction was less severe. In addition, the severity of metal artifacts, the image distortion due to presence of metal, was less than that of the 4D CBCT results. Conclusion: We have implemented on-board 4D DTS on patients data to visualize the movement of anatomy due to respiratory motion. The results indicate that 4D-DTS could be a promising alternative to 4D CBCT for acquiring the respiratory motion of internal organs just prior to radiotherapy treatment.	[Park, Justin C.; Lee, Soyoung] Univ Florida, Dept Radiat Oncol, Gainesville, FL USA; [Kim, Jin Sung; Han, Youngyih] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiat Oncol, Seoul, South Korea; [Park, Sung Ho] Ulsan Univ Hosp, Dept Neurosurg, Ulsan, South Korea; [Webster, Matthew J.] Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA; [Song, William Y.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Radiat Oncol & Med Biophys, Toronto, ON, Canada	State University System of Florida; University of Florida; Sungkyunkwan University (SKKU); Samsung Medical Center; University of Ulsan; Ulsan University Hospital; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Kim, JS (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiat Oncol, Seoul, South Korea.	jinsung.k@gmail.com			National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2013M2A2A7043507]; Ministry of Education, Science and Technology [NRF-2011-0022021]; Samsung Medical Center grant [GFO1130081]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Samsung Medical Center grant(Samsung)	This research was supported by the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2013M2A2A7043507), Ministry of Education, Science and Technology (NRF-2011-0022021) and Samsung Medical Center grant [GFO1130081]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balter JM, 1996, INT J RADIAT ONCOL, V36, P167, DOI 10.1016/S0360-3016(96)00275-1; Bissonnette JP, 2009, INT J RAD ONCOL BIOL; Byrne TE, 2005, MED DOSIM, V30, P155, DOI 10.1016/j.meddos.2005.03.005; Chang JW, 2006, MED PHYS, V33, P2354, DOI 10.1118/1.2207136; Dietrich L, 2006, PHYS MED BIOL, V51, P2939, DOI 10.1088/0031-9155/51/11/017; Dobbins JT, 2008, J THORAC IMAG, V23, P86, DOI 10.1097/RTI.0b013e318173e162; Dzyubak O, 2014, MED PHYS, V41, DOI 10.1118/1.4896101; FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612; Godfrey DJ, 2006, MED PHYS, V33, P655, DOI 10.1118/1.2170398; Herman MG, 2005, SEMIN RADIAT ONCOL, V15, P157, DOI 10.1016/j.semradonc.2005.01.002; Islam MK, 2006, MED PHYS, V33, P1573, DOI 10.1118/1.2198169; Jia X, 2012, MED PHYS, V39, P5592, DOI 10.1118/1.4745559; Kupelian PA, 2008, INT J RADIAT ONCOL, V70, P1151, DOI 10.1016/j.ijrobp.2007.07.2371; Li T, 2007, MED PHYS, V34, P3688, DOI 10.1118/1.2767144; Lujan AE, 2003, MED PHYS, V30, P2643, DOI 10.1118/1.1609057; Maltz JS, 2009, MED PHYS, V36, P1624, DOI 10.1118/1.3110067; Maurer J, 2008, MED PHYS, V35, P3574, DOI 10.1118/1.2953561; Morin O, 2006, MED DOSIM, V31, P51, DOI 10.1016/j.meddos.2005.12.009; Oelfke U, 2006, MED DOSIM, V31, P62, DOI 10.1016/j.meddos.2005.12.008; Oldham M, 2005, RADIOTHER ONCOL, V75, P271, DOI 10.1016/j.radonc.2005.03.026; Park JC, 2013, MED PHYS, V40, DOI 10.1118/1.4829504; Park JC, 2012, MED PHYS, V39, P6431, DOI 10.1118/1.4754658; Park JC, 2012, MED PHYS, V39, P1207, DOI 10.1118/1.3679865; Park JC, 2011, TECHNOL CANCER RES T, V10, P295, DOI 10.7785/tcrt.2012.500206; Pouliot J, 2005, INT J RADIAT ONCOL, V61, P552, DOI 10.1016/j.ijrobp.2004.10.011; Ren L, 2008, MED PHYS, V35, P664, DOI 10.1118/1.2831903; Santoro J, 2010, MED PHYS, V37, P1237, DOI 10.1118/1.3312276; Shimizu S, 2000, INT J RADIAT ONCOL, V46, P1127, DOI 10.1016/S0360-3016(99)00352-1; Smitsmans MHP, 2005, INT J RADIAT ONCOL, V63, P975, DOI 10.1016/j.ijrobp.2005.07.973; Sonke JJ, 2005, MED PHYS, V32, P1176, DOI 10.1118/1.1869074; Wang G, 2002, MED PHYS, V29, P1807, DOI 10.1118/1.1494989; Yan H, 2007, MED PHYS, V34, P3768, DOI 10.1118/1.2779945; Yoo S, 2009, INT J RADIAT ONCOL, V73, P296, DOI 10.1016/j.ijrobp.2008.09.006; Zhang J, 2007, MED PHYS, V34, P2607, DOI 10.1118/1.2761583; Zhang J, 2009, INT J RADIAT ONCOL, V73, P952, DOI 10.1016/j.ijrobp.2008.10.036; Zhang QH, 2010, MED PHYS, V37, P2901, DOI 10.1118/1.3397460; Zhang YB, 2007, INT J RADIAT ONCOL, V67, P924, DOI 10.1016/j.ijrobp.2006.09.045	37	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115795	10.1371/journal.pone.0115795	http://dx.doi.org/10.1371/journal.pone.0115795			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541710	gold, Green Submitted, Green Published			2022-12-27	WOS:000347239900088
J	Li, SB; Huang, J; Zhou, RC; Xu, SR; Jin, YX				Li Shubin; Huang Juan; Zhou RenChao; Xu ShiRu; Jin YuanXiao			Fungal Endophytes of Alpinia officinarum Rhizomes: Insights on Diversity and Variation across Growth Years, Growth Sites, and the Inner Active Chemical Concentration	PLOS ONE			English	Article							PRIMARY SUCCESSION GRADIENT; MOLECULAR PHYLOGENY; HOST-PLANT; T-RFLP; COMMUNITIES; TRAITS; ROOTS	In the present study, the terminal-restriction fragment length polymorphism (T-RFLP) technique, combined with the use of a clone library, was applied to assess the baseline diversity of fungal endophyte communities associated with rhizomes of Alpinia officinarum Hance, a medicinal plant with a long history of use. A total of 46 distinct T-RFLP fragment peaks were detected using HhaI or MspI mono-digestion-targeted, amplified fungal rDNA ITS sequences from A. officinarum rhizomes. Cloning and sequencing of representative sequences resulted in the detection of members of 10 fungal genera: Pestalotiopsis, Sebacina, Penicillium, Marasmius, Fusarium, Exserohilum, Mycoleptodiscus, Colletotrichum, Meyerozyma, and Scopulariopsis. The T-RFLP profiles revealed an influence of growth year of the host plant on fungal endophyte communities in rhizomes of this plant species; whereas, the geographic location where A. officinarum was grown contributed to only limited variation in the fungal endophyte communities of the host tissue. Furthermore, non-metric multidimensional scaling (NMDS) analysis across all of the rhizome samples showed that the fungal endophyte community assemblages in the rhizome samples could be grouped according to the presence of two types of active indicator chemicals: total volatile oils and galangin. Our present results, for the first time, address a diverse fungal endophyte community is able to internally colonize the rhizome tissue of A. officinarum. The diversity of the fungal endophytes found in the A. officinarum rhizome appeared to be closely correlated with the accumulation of active chemicals in the host plant tissue. The present study also provides the first systematic overview of the fungal endophyte communities in plant rhizome tissue using a culture-independent method.	[Li Shubin; Huang Juan; Zhou RenChao; Xu ShiRu; Jin YuanXiao] S China Normal Univ, Coll Life Sci, Guangdong Prov Key Lab Biotechnol Plant Dev, Guangzhou, Guangdong, Peoples R China	South China Normal University	Li, SB (corresponding author), S China Normal Univ, Coll Life Sci, Guangdong Prov Key Lab Biotechnol Plant Dev, Guangzhou, Guangdong, Peoples R China.	shuli_1990@126.com			National Natural Science Foundation of China [31070003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financially supported by the National Natural Science Foundation of China (Grant No. 31070003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey JK, 2005, CAN J BOT, V83, P356, DOI [10.1139/b05-008, 10.1139/B05-008]; Balint M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053987; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; Blaalid R, 2012, MOL ECOL, V21, P1897, DOI 10.1111/j.1365-294X.2011.05214.x; Camarinha-Silva A, 2012, FEMS MICROBIOL ECOL, V79, P98, DOI 10.1111/j.1574-6941.2011.01197.x; Debbab A, 2012, FUNGAL DIVERS, V57, P45, DOI 10.1007/s13225-012-0191-8; Ding T, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-1; Dutta, 2010, EUROPEAN J BIOL SCI, V2, P8; Gazis R, 2010, FUNGAL ECOL, V3, P240, DOI 10.1016/j.funeco.2009.12.001; Hazalin NAMN, 2012, PHYTOMEDICINE, V19, P609, DOI 10.1016/j.phymed.2012.01.007; Hu FY, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-18; Hubbard M, 2014, J APPL MICROBIOL, V116, P109, DOI 10.1111/jam.12311; [蒋妮 Jiang Ni], 2012, [植物保护, Plant Protection], V38, P104; Khan AL, 2015, CRIT REV BIOTECHNOL, V35, P62, DOI 10.3109/07388551.2013.800018; Ko TWK, 2011, FUNGAL DIVERS, V50, P113, DOI 10.1007/s13225-011-0130-0; Koo HJ, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-27; Kusari P, 2013, FUNGAL DIVERS, V60, P137, DOI 10.1007/s13225-012-0216-3; Kusari S, 2013, PHYTOCHEMISTRY, V91, P81, DOI 10.1016/j.phytochem.2012.07.021; Kwasna H, 2008, APPL SOIL ECOL, V40, P44, DOI 10.1016/j.apsoil.2008.03.005; Lamit LJ, 2014, AM J BOT, V101, P467, DOI 10.3732/ajb.1400034; Langenfeld A, 2013, FUNGAL BIOL-UK, V117, P124, DOI 10.1016/j.funbio.2012.12.005; Lee J, 2009, J ETHNOPHARMACOL, V126, P258, DOI 10.1016/j.jep.2009.08.033; Liu QF, 2012, J ETHNOPHARMACOL, V143, P772, DOI 10.1016/j.jep.2012.06.019; Liu Zhun, 2013, Mycosystema, V32, P812; Lu W, 2006, CHINA PHARM, V15, P19; Mei L, 2014, MICROB ECOL, V67, P402, DOI 10.1007/s00248-013-0319-8; Miller KI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035953; Mishra A, 2012, MICROB ECOL, V64, P388, DOI 10.1007/s00248-012-0029-7; National Pharmacopoeia Committee, 2010, CHINESE PHARMACOPOEI; Nongalleima K., 2013, International Journal of PharmTech Research, V5, P301; Persoh D, 2013, FUNGAL DIVERS, V60, P55, DOI 10.1007/s13225-013-0225-x; Porras-Alfaro A, 2011, ANNU REV PHYTOPATHOL, V49, P291, DOI 10.1146/annurev-phyto-080508-081831; Qadri M, 2014, MICROB ECOL, V67, P877, DOI 10.1007/s00248-014-0379-4; Rajala T, 2013, FUNGAL BIOL-UK, V117, P182, DOI 10.1016/j.funbio.2013.01.006; Rao K, 2011, APPL BIOCHEM BIOTECH, V165, P1366, DOI 10.1007/s12010-011-9353-5; Rao S, 2013, CURR MICROBIOL, V66, P185, DOI 10.1007/s00284-012-0256-7; Rivera-Orduna FN, 2011, FUNGAL DIVERS, V47, P65, DOI 10.1007/s13225-010-0045-1; Saunders M, 2010, EVOL APPL, V3, P525, DOI 10.1111/j.1752-4571.2010.00141.x; Saunders M, 2009, NEW PHYTOL, V182, P229, DOI 10.1111/j.1469-8137.2008.02746.x; Sivakumar AS, 2011, CHEM-BIOL INTERACT, V193, P141, DOI 10.1016/j.cbi.2011.06.003; Sun JJ, 2014, APPL MICROBIOL BIOT, V98, P3143, DOI 10.1007/s00253-013-5300-4; Sun LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049867; Tao L, 2006, S AFR J BOT, V72, P163, DOI 10.1016/j.sajb.2005.06.007; Tejesvi MV, 2010, FUNGAL DIVERS, V41, P125, DOI 10.1007/s13225-009-0016-6; van Dorst J, 2014, FEMS MICROBIOL ECOL, V89, P316, DOI 10.1111/1574-6941.12308; White JF, 2010, PHYSIOL PLANTARUM, V138, P440, DOI 10.1111/j.1399-3054.2009.01332.x; Xu L, 2008, LETT APPL MICROBIOL, V46, P68, DOI 10.1111/j.1472-765X.2007.02264.x; Yu M, 2009, J PLANT PATHOL, V91, P417; Yuan ZL, 2010, APPL ENVIRON MICROB, V76, P1642, DOI 10.1128/AEM.01911-09; Zhang D, 2013, FOOD CHEM, V141, P347, DOI 10.1016/j.foodchem.2013.02.082; Zimmerman NB, 2012, P NATL ACAD SCI USA, V109, P13022, DOI 10.1073/pnas.1209872109	51	7	8	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115289	10.1371/journal.pone.0115289	http://dx.doi.org/10.1371/journal.pone.0115289			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536070	gold, Green Published, Green Submitted			2022-12-27	WOS:000348563300035
J	Poortinga, S; Van den Akker-Scheek, I; Bulstra, SK; Stewart, RE; Stevens, M				Poortinga, Sietske; Van den Akker-Scheek, Inge; Bulstra, Sjoerd K.; Stewart, Roy E.; Stevens, Martin			Preoperative Physical Activity Level Has No Relationship to the Degree of Recovery One Year after Primary Total Hip or Knee Arthroplasty: A Cohort Study	PLOS ONE			English	Article							ACTIVITY QUESTIONNAIRE; HEALTH; REPLACEMENT; EXERCISE; ADULTS; CARE	Background: When it comes to prevalidation, it is assumed that a higher preoperative level of physical activity leads to better postoperative recovery. However current literature is inconclusive about the effect of prevalidation on functional recovery of patients with primary osteoarthritis (OA) who underwent a THA or TKA. Therefore the aim of this study is to analyse one of the major assumptions underlying the potential effectiveness of prevalidation namely the relationship between preoperative physical activity level and postoperative recovery one year after THA or TKA in a group of 658 OA patients. Methods and Results: From 2006 to 2012, 1061 patients underwent a primary THA or TKA at University Medical Center Groningen. Preoperative and one-year postoperative patients filled in the SQUASH questionnaire to get an impression of their physical activity level, and the WOMAC questionnaire to obtain insight into degree of recovery. Missing data were multiply imputed. No relationship was found between the preoperative total (B-coefficient=0.03, CI95% = -0.033-0.093) and leisure-time physical activity level (B-coefficient=0.042, CI95% = -0.009-0.093) neither for preoperative compliance with the Dutch Recommendation for Health-Enhancing Physical Activity (B-coefficient=0.002, CI95% = -0.053-0.057), and the degree of recovery one year after surgery. Conclusion: The preoperative physical activity level had no relation with the degree of recovery one year after THA or TKA. The results do not support one of the major assumptions behind prevalidation, which assumes that a higher preoperative physical activity level will lead to a better recovery after THA or TKA.	[Poortinga, Sietske; Van den Akker-Scheek, Inge; Bulstra, Sjoerd K.; Stevens, Martin] Univ Groningen, Univ Med Ctr Groningen, Dept Orthopaed, Groningen, Netherlands; [Stewart, Roy E.] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci Community & Occupat Sci, Groningen, Netherlands	University of Groningen; University of Groningen	Stevens, M (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Orthopaed, Groningen, Netherlands.	m.stevens@umcg.nl	Stevens, Martin/A-5196-2013	Stevens, Martin/0000-0001-8183-6894; Stewart, Roy/0000-0001-9227-433X; van den Akker-Scheek, Inge/0000-0002-1614-8419				Ackerman IN, 2004, AUST J PHYSIOTHER, V50, P25, DOI 10.1016/S0004-9514(14)60245-2; Bauman A, 2009, J PHYS ACT HEALTH, V6, pS5, DOI 10.1123/jpah.6.s1.s5; Bouchard C, 1990, P INT C EX FITN HLTH; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Dauty M, 2007, Ann Readapt Med Phys, V50, P462, DOI 10.1016/j.annrmp.2007.04.012; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Hoogeboom TJ, 2010, CLIN REHABIL, V24, P901, DOI 10.1177/0269215510371427; Katz JN, 2006, BEST PRACT RES CL RH, V20, P145, DOI 10.1016/j.berh.2005.09.003; Oosting E, 2012, ARCH PHYS MED REHAB, V93, P610, DOI 10.1016/j.apmr.2011.11.006; Rijksinstituut voor Volksgezondheid en Millieu RIVM, 2013, NAT KOMP VOLKSG ARTR; Rooks DS, 2006, ARTHRIT RHEUM-ARTHR, V55, P700, DOI 10.1002/art.22223; Roorda LD, 2004, ANN RHEUM DIS, V63, P36, DOI 10.1136/ard.2002.001784; RUBIN DB, 1991, STAT MED, V10, P585, DOI 10.1002/sim.4780100410; Rubin DB, 2009, MULTIPLE IMPUTATION, V307; Wagenmakers R, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-141; Wendel-Vos GCW, 2003, J CLIN EPIDEMIOL, V56, P1163, DOI 10.1016/S0895-4356(03)00220-8; Whitney JAD, 2002, APPL NURS RES, V15, P19, DOI 10.1053/apnr.2002.29519	17	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115559	10.1371/journal.pone.0115559	http://dx.doi.org/10.1371/journal.pone.0115559			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25535744	Green Published, Green Submitted, gold			2022-12-27	WOS:000348563300050
J	Shimoda, N; Hirose, K; Kaneto, R; Izawa, T; Yokoi, H; Hashimoto, N; Kikuchi, Y				Shimoda, Nobuyoshi; Hirose, Kentaro; Kaneto, Reiya; Izawa, Toshiaki; Yokoi, Hayato; Hashimoto, Naohiro; Kikuchi, Yutaka			No Evidence for AID/MBD4-Coupled DNA Demethylation in Zebrafish Embryos	PLOS ONE			English	Article							METHYLATION; AID; GENOME; GLYCOSYLASE; DEAMINASE; CELLS; MBD4; MICE; IDENTIFICATION; ACTIVATION	The mechanisms responsible for active DNA demethylation remain elusive in Metazoa. A previous study that utilized zebrafish embryos provided a potent mechanism for active demethylation in which three proteins, AID, MBD4, and GADD45 are involved. We recently found age-dependent DNA hypomethylation in zebrafish, and it prompted us to examine if AID and MBD4 could be involved in the phenomenon. Unexpectedly, however, we found that most of the findings in the previous study were not reproducible. First, the injection of a methylated DNA fragment into zebrafish eggs did not affect either the methylation of genomic DNA, injected methylated DNA itself, or several loci tested or the expression level of aid, which has been shown to play a role in demethylation. Second, aberrant methylation was not observed at certain CpG islands following the injection of antisense morpholino oligonucleotides against aid and mbd4. Furthermore, we demonstrated that zebrafish MBD4 cDNA lacked a coding region for the methyl-CpG binding domain, which was assumed to be necessary for guidance to target regions. Taken together, we concluded that there is currently no evidence to support the proposed roles of AID and MBD4 in active demethylation in zebrafish embryos.	[Shimoda, Nobuyoshi; Hashimoto, Naohiro] Natl Ctr Geriatr & Gerontol, Natl Inst Longev Sci, Dept Regenerat Med, Obu, Aichi 4748522, Japan; [Hirose, Kentaro; Kaneto, Reiya; Kikuchi, Yutaka] Hiroshima Univ, Grad Sch Sci, Dept Biol Sci, Higashihiroshima, Hiroshima 7398526, Japan; [Izawa, Toshiaki] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Yokoi, Hayato] Tohoku Univ, Grad Sch Agr Sci, Aoba Ku, Sendai, Miyagi 9818555, Japan	National Center for Geriatrics & Gerontology; Hiroshima University; Max Planck Society; Tohoku University	Shimoda, N (corresponding author), Natl Ctr Geriatr & Gerontol, Natl Inst Longev Sci, Dept Regenerat Med, 35 Gengo, Obu, Aichi 4748522, Japan.	shimoda@ncgg.go.jp	Izawa, Toshiaki/AAN-6792-2021; Izawa, Toshiaki/U-1389-2019; Izawa, Toshiaki/AAU-9160-2021; Yokoi, Hayato/H-6521-2011; Deng, Dajun/D-4605-2009	Yokoi, Hayato/0000-0003-1020-6160; Deng, Dajun/0000-0001-5161-5943; Kikuchi, Yutaka/0000-0001-5688-7358	MEXT (KAKENHI) [23616002]; Grants-in-Aid for Scientific Research [24780178] Funding Source: KAKEN	MEXT (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid for Scientific Research from the MEXT (KAKENHI 23616002; http://www.mext.go.jp/) to YK.	Abdouni H, 2013, NUCLEIC ACIDS RES, V41, P5457, DOI 10.1093/nar/gkt212; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Collas P, 1998, NUCLEIC ACIDS RES, V26, P4454, DOI 10.1093/nar/26.19.4454; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Engel N, 2009, EPIGENETICS-US, V4, P98, DOI 10.4161/epi.4.2.7858; Etard C, 2010, J CELL BIOL, V189, P527, DOI 10.1083/jcb.200912125; Fritz EL, 2013, NAT IMMUNOL, V14, P749, DOI 10.1038/ni.2616; Ge L, 2014, MOL CELL BIOL, V34, P989, DOI 10.1128/MCB.01061-13; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Jiang L, 2013, CELL, V153, P773, DOI 10.1016/j.cell.2013.04.041; Jin SG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000013; Jiricny J, 2008, CELL, V135, P1167, DOI 10.1016/j.cell.2008.12.008; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Kumar R, 2013, NATURE, V500, P89, DOI 10.1038/nature12299; Leung T, 2006, BLOOD, V108, P160, DOI 10.1182/blood-2005-09-3706; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Martin CC, 1999, DEV BIOL, V206, P189, DOI 10.1006/dbio.1998.9105; Mei J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004979; Mhanni AA, 2001, GENESIS, V30, P213, DOI 10.1002/gene.1067; Mikl MC, 2005, MOL CELL BIOL, V25, P7270, DOI 10.1128/MCB.25.16.7270-7277.2005; Millar CB, 2002, SCIENCE, V297, P403, DOI 10.1126/science.1073354; Morcos PA, 2007, BIOCHEM BIOPH RES CO, V358, P521, DOI 10.1016/j.bbrc.2007.04.172; Nabel CS, 2012, NAT CHEM BIOL, V8, P751, DOI [10.1038/NCHEMBIO.1042, 10.1038/nchembio.1042]; Petronzelli F, 2000, J BIOL CHEM, V275, P32422, DOI 10.1074/jbc.M004535200; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Potok ME, 2013, CELL, V153, P759, DOI 10.1016/j.cell.2013.04.030; Rai K, 2010, CELL, V142, P930, DOI 10.1016/j.cell.2010.08.030; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Rangam G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043279; Sabag O, 2014, NAT STRUCT MOL BIOL, V21, P110, DOI 10.1038/nsmb.2734; Shimoda N, 2005, DEV DYNAM, V233, P1509, DOI 10.1002/dvdy.20455; Shimoda N, 2014, AGE, V36, P103, DOI 10.1007/s11357-013-9548-5; Wakae K, 2006, INT IMMUNOL, V18, P41, DOI 10.1093/intimm/dxh347; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wong E, 2002, P NATL ACAD SCI USA, V99, P14937, DOI 10.1073/pnas.232579299; Zhu B, 2000, NUCLEIC ACIDS RES, V28, P4157, DOI 10.1093/nar/28.21.4157	42	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e114816	10.1371/journal.pone.0114816	http://dx.doi.org/10.1371/journal.pone.0114816			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536520	Green Published, Green Submitted, gold			2022-12-27	WOS:000348563300022
J	Cai, WK; Andres, DA				Cai, Weikang; Andres, Douglas A.			mTORC2 Is Required for Rit-Mediated Oxidative Stress Resistance	PLOS ONE			English	Article							NOONAN SYNDROME; SIGNALING PATHWAY; NEURONAL DIFFERENTIATION; GROWTH-CONTROL; SMALL GTPASES; P38 MAPK; COMPLEX; PROTEIN; SIN1; TOR	Rit, a member of the Ras family of GTPases, has been shown to promote cell survival in response to oxidative stress, in part by directing an evolutionarily conserved p38 MAPK-Akt survival cascade. Aberrant Rit signaling has recently been implicated as a driver mutation in human cancer, adding importance to the characterization of critical Rit effector pathways. However, the mechanism by which Rit-p38 signaling regulated Akt activity was unknown. Here, we identify mTORC2 as a critical downstream mediator of Rit-dependent survival signaling in response to reactive oxygen species (ROS) stress. Rit interacts with Sin1 (MAPKAP1), and Rit loss compromises ROS-dependent mTORC2 complex activation, blunting mTORC2-mediated phosphorylation of Akt kinase. Taken together, our findings demonstrate that the p38/mTORC2/Akt signaling cascade mediates Rit-dependent oxidative stress survival. Inhibition of this previously unrecognized cascade should be explored as a potential therapy of Rit-dependent malignancies.	[Cai, Weikang; Andres, Douglas A.] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40506 USA	University of Kentucky	Andres, DA (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40506 USA.	dandres@uky.edu	Cai, Weikang/K-2394-2019	Cai, Weikang/0000-0001-5638-0805	National Institutes of Health (NIH) [NS045103, P20 GM103486]; Kentucky Spinal Cord and Head Injury Research Trust [12-1A]; University of Kentucky Research Professorship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS045103, R01NS045103] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kentucky Spinal Cord and Head Injury Research Trust; University of Kentucky Research Professorship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) NS045103 (DAA) and P20 GM103486 (DAA), Kentucky Spinal Cord and Head Injury Research Trust Grant 12-1A (DAA), and University of Kentucky Research Professorship (DAA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki Y, 2013, AM J HUM GENET, V93, P173, DOI 10.1016/j.ajhg.2013.05.021; Berger AH, 2014, ONCOGENE, V33, P4418, DOI 10.1038/onc.2013.581; Bertola DR, 2014, AM J MED GENET A, V164, P2952, DOI 10.1002/ajmg.a.36722; Cai HQ, 2010, J CELL BIOL, V190, P233, DOI 10.1083/jcb.201001129; Cai WK, 2011, MOL BIOL CELL, V22, P3231, DOI 10.1091/mbc.E11-05-0400; Chen PC, 2014, P NATL ACAD SCI USA, V111, P11473, DOI 10.1073/pnas.1324128111; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Cully M, 2010, MOL CELL BIOL, V30, P481, DOI 10.1128/MCB.00688-09; Duran RV, 2012, EMBO REP, V13, P121, DOI 10.1038/embor.2011.257; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Gomez-Segui I, 2013, LEUKEMIA, V27, P1943, DOI 10.1038/leu.2013.179; Gos M, 2014, AM J MED GENET A, V164, P2310, DOI 10.1002/ajmg.a.36646; Ikeda K, 2008, CELL CYCLE, V7, P358, DOI 10.4161/cc.7.3.5245; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Lamming DW, 2014, FASEB J, V28, P300, DOI 10.1096/fj.13-237743; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee S, 1999, MOL BIOL CELL, V10, P2829, DOI 10.1091/mbc.10.9.2829; Li Y, 2003, J BIOL CHEM, V278; Liu LH, 2011, J CELL BIOL, V194, P815, DOI 10.1083/jcb.201102090; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Makino C, 2006, GENES CELLS, V11, P1239, DOI 10.1111/j.1365-2443.2006.01016.x; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Masui K, 2013, CELL METAB, V18, P726, DOI 10.1016/j.cmet.2013.09.013; Niles BJ, 2014, CELL REP, V6, P541, DOI 10.1016/j.celrep.2013.12.040; Oh WJ, 2011, CELL CYCLE, V10, P2305, DOI 10.4161/cc.10.14.16586; Rusyn EV, 2000, ONCOGENE, V19, P4685, DOI 10.1038/sj.onc.1203836; Saci A, 2011, MOL CELL, V42, P50, DOI 10.1016/j.molcel.2011.03.017; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schroder WA, 2007, CELL SIGNAL, V19, P1279, DOI 10.1016/j.cellsig.2007.01.013; Shi GX, 2013, CELL SIGNAL, V25, P2060, DOI 10.1016/j.cellsig.2013.06.002; Shi GX, 2011, MOL CELL BIOL, V31, P1938, DOI 10.1128/MCB.01380-10; Shi GX, 2005, J BIOL CHEM, V280, P37599, DOI 10.1074/jbc.M507364200; Shimada K, 2013, MOL CELL, V51, P829, DOI 10.1016/j.molcel.2013.08.019; Sparks CA, 2010, ONCOGENE, V29, P3733, DOI 10.1038/onc.2010.139; Tatebe H, 2010, CURR BIOL, V20, P1975, DOI 10.1016/j.cub.2010.10.026; Thomanetz V, 2013, J CELL BIOL, V201, P293, DOI 10.1083/jcb.201205030; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wilkinson MG, 1999, EMBO J, V18, P4210, DOI 10.1093/emboj/18.15.4210; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Zheng M, 2011, NAT CELL BIOL, V13, P263, DOI 10.1038/ncb2168	41	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115602	10.1371/journal.pone.0115602	http://dx.doi.org/10.1371/journal.pone.0115602			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531880	Green Submitted, Green Published, gold			2022-12-27	WOS:000348845100083
J	Penet, L; Guyader, S; Petro, D; Salles, M; Busslere, F				Penet, Laurent; Guyader, Sebastien; Petro, Dalila; Salles, Michele; Busslere, Francois			Direct Splash Dispersal Prevails over Indirect and Subsequent Spread during Rains in Colletotrichum gloeosporioides Infecting Yams	PLOS ONE			English	Article							RUST SPORES; SIMULATED RAIN; ACUTATUM; WIND; ANTHRACNOSE; INTENSITY; SURVIVAL; INOCULUM; DISEASE; TRITICI	Plant pathogens have evolved many dispersal mechanisms, using biotic or abiotic vectors or a combination of the two. Rain splash dispersal is known from a variety of fungi, and can be an efficient driver of crop epidemics, with infectious strains propagating rapidly among often genetically homogenous neighboring plants. Splashing is nevertheless a local dispersal process and spores taking the droplet ride seldom move farther than a few decimeters. In this study, we assessed rain splash dispersal of conidia of the yam anthracnose agent, Colletotrichum gloeosporioides, in an experimental setting using a rain simulator, with emphasis on the impact of soil contamination (i.e., effect of re-splashing events). Spores dispersed up to 50 cm from yam leaf inoculum sources, though with an exponential decrease with increasing distance. While few spores were dispersed via re-splash from spore-contaminated soil, the proportion deposited via this mechanism increased with increasing distance from the initial source. We found no soil contamination carryover from previous rains, suggesting that contamination via re-splashing from contaminated soils mainly occurred within single rains. We conclude that most dispersal occurs from direct splashing, with a weaker contribution of indirect dispersal via re-splash.	[Penet, Laurent; Guyader, Sebastien; Petro, Dalila; Salles, Michele; Busslere, Francois] INRA, ASTRO Agrosyst Trop, UR1321, F-97170 Petit Bourg, Guadeloupe, France	INRAE	Penet, L (corresponding author), INRA, ASTRO Agrosyst Trop, UR1321, F-97170 Petit Bourg, Guadeloupe, France.	laurent.penet@antilles.inra.fr		Penet, Laurent/0000-0003-1512-6303	AGROECOTROP project; European Union (Fond Europeen de Developpement Regional); Guadeloupe Regional Council; AGROECOTROP project; European Union (Fond Europeen de Developpement Regional); Guadeloupe Regional Council	AGROECOTROP project; European Union (Fond Europeen de Developpement Regional); Guadeloupe Regional Council; AGROECOTROP project; European Union (Fond Europeen de Developpement Regional); Guadeloupe Regional Council	This work was funded as part of AGROECOTROP project, co-financed by the European Union (Fond Europeen de Developpement Regional) and the Guadeloupe Regional Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahimera N, 2004, PHYTOPATHOLOGY, V94, P1189, DOI 10.1094/PHYTO.2004.94.11.1189; AYLOR DE, 1990, ANNU REV PHYTOPATHOL, V28, P73, DOI 10.1146/annurev.py.28.090190.000445; Aylor DE, 1999, AGR FOREST METEOROL, V97, P275, DOI 10.1016/S0168-1923(99)00072-6; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Cai L, 2011, TROP PLANT PATHOL, V36, P205, DOI 10.1590/S1982-56762011000400001; Cannon PF, 2012, STUD MYCOL, P181, DOI 10.3114/sim0014; COOK RD, 1977, TECHNOMETRICS, V19, P15, DOI 10.2307/1268249; Cornet D, 2014, EUR J AGRON, V55, P100, DOI 10.1016/j.eja.2014.02.002; DAG O, 2014, AID AN R PACKAGE TO; FITT BDL, 1989, ANNU REV PHYTOPATHOL, V27, P241, DOI 10.1146/annurev.py.27.090189.001325; FITZELL RD, 1984, ANN APPL BIOL, V104, P53, DOI 10.1111/j.1744-7348.1984.tb05586.x; Freeman S, 2002, PLANT DIS, V86, P965, DOI 10.1094/PDIS.2002.86.9.965; FURBISH DJ, 2007, J GEOPHYS RES, V112; Geagea L, 1999, PLANT PATHOL, V48, P472, DOI 10.1046/j.1365-3059.1999.00372.x; Geagea L, 2000, AGR FOREST METEOROL, V101, P53, DOI 10.1016/S0168-1923(99)00155-0; Green K. R., 1994, THESIS; GREGORY PH, 1959, J GEN MICROBIOL, V20, P328, DOI 10.1099/00221287-20-2-328; Hooper D., 2008, ARTICLES, V2, DOI DOI 10.1080/10705519909540118; Horberg HM, 2002, EUR J PLANT PATHOL, V108, P73, DOI 10.1023/A:1013936624884; Hu LT, 1998, PSYCHOL METHODS, V3, P424, DOI 10.1037/1082-989X.3.4.424; Huber L, 1997, AGR FOREST METEOROL, V87, P201, DOI 10.1016/S0168-1923(97)00016-6; Hyde KD, 2009, FUNGAL DIVERS, V39, P147; KLIEJUNAS JT, 1976, PHYTOPATHOLOGY, V66, P457, DOI 10.1094/Phyto-66-457; Lacey J, 1996, MYCOL RES, V100, P641, DOI 10.1016/S0953-7562(96)80194-8; LI DW, 1994, GRANA, V33, P166, DOI 10.1080/00173139409428995; Lovell DJ, 2004, PLANT PATHOL, V53, P11, DOI 10.1046/j.1365-3059.2003.00939.x; MacCallum RC, 2000, ANNU REV PSYCHOL, V51, P201, DOI 10.1146/annurev.psych.51.1.201; Madden LV, 1996, PHYTOPATHOLOGY, V86, P864, DOI 10.1094/Phyto-86-864; MCCARTNEY HA, 1994, GRANA, V33, P76, DOI 10.1080/00173139409427835; MILLS PR, 1992, FEMS MICROBIOL LETT, V98, P137, DOI 10.1016/0378-1097(92)90145-E; MITCHELL RJ, 1992, FUNCT ECOL, V6, P123, DOI 10.2307/2389745; Ntahimpera N, 1999, PHYTOPATHOLOGY, V89, P555, DOI 10.1094/PHYTO.1999.89.7.555; Ntahimpera N, 1998, PHYTOPATHOLOGY, V88, P536, DOI 10.1094/PHYTO.1998.88.6.536; OOKA JJ, 1977, PHYTOPATHOLOGY, V67, P1023, DOI 10.1094/Phyto-67-1023; Petraitis PS, 1996, FUNCT ECOL, V10, P421, DOI 10.2307/2389934; Pietravalle S, 2001, AGR FOREST METEOROL, V109, P171, DOI 10.1016/S0168-1923(01)00267-2; R Core Team, 2012, R LANG ENV STAT COMP; REYNOLDS KM, 1987, PHYTOPATHOLOGY, V77, P921, DOI 10.1094/Phyto-77-921; Ripoche A, 2008, APPL SOIL ECOL, V38, P270, DOI 10.1016/j.apsoil.2007.10.015; Sache I, 2000, AGRONOMIE, V20, P757, DOI 10.1051/agro:2000102; Saint-Jean S, 2006, AGR FOREST METEOROL, V141, P257, DOI 10.1016/j.agrformet.2006.10.009; Van Dijk AIJM, 2003, HYDROL PROCESS, V17, P153, DOI 10.1002/hyp.1154; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; YANG X, 1990, PHYTOPATHOLOGY, V80, P1115, DOI 10.1094/Phyto-80-1115; YANG X, 1990, PHYTOPATHOLOGY, V80, P590, DOI 10.1094/Phyto-80-590; YANG XB, 1992, PHYTOPATHOLOGY, V82, P1219, DOI 10.1094/Phyto-82-1219	46	22	23	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115757	10.1371/journal.pone.0115757	http://dx.doi.org/10.1371/journal.pone.0115757			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25532124	Green Published, gold, Green Submitted			2022-12-27	WOS:000348845100105
J	Xu, HT; Zhao, L; Fang, QJ; Sun, JM; Zhang, SY; Zhan, C; Liu, SJ; Zhang, YB				Xu, Haitao; Zhao, Liang; Fang, Qiuju; Sun, Jianmin; Zhang, Songyan; Zhan, Chao; Liu, Shujie; Zhang, Yubao			MiR-338-3p Inhibits Hepatocarcinoma Cells and Sensitizes These Cells to Sorafenib by Targeting Hypoxia-Induced Factor 1 alpha	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; HEPATOCELLULAR-CARCINOMA; INDUCIBLE FACTOR-1-ALPHA; GENE-EXPRESSION; DOWN-REGULATION; CANCER-CELLS; MDR1 GENE; PROLIFERATION; ANGIOGENESIS; RESISTANCE	Hypoxia is a common feature of solid tumors and an important contributor to anti-tumor drug resistance. Hypoxia inducible factor-1 (HIF-1) is one of the key mediators of the hypoxia signaling pathway, and was recently proven to be required for sorafenib resistance in hepatocarcinoma (HCC). MicroRNAs have emerged as important posttranslational regulators in HCC. It was reported that miR-338-3p levels are associated with clinical aggressiveness of HCC. However, the roles of miR-338-3p in HCC disease and resistance to its therapeutic drugs are unknown. In this study, we found that miR-338-3p was frequently down-regulated in 14 HCC clinical samples and five cell lines. Overexpression of miR-338-3p inhibited HIF-1 alpha 3'-UTR luciferase activity and HIF-1 alpha protein levels in HepG2, SMMC-7721, and Huh7 cells. miR-338-3p significantly reduced cell viability and induced cell apoptosis of HCC cells. Additionally, HIF-1 alpha overexpression rescued and HIF-1a knock-down abrogated the anti-HCC activity of miR-338-3p. Furthermore, miR-338-p sensitized HCC cells to sorafenib in vitro and in a HCC subcutaneous nude mice tumor model by inhibiting HIF-1 alpha. Collectively, miR-338-3p inhibits HCC tumor growth and sensitizes HCC cells to sorafenib by down-regulating HIF-1 alpha. Our data indicate that miR-338-3p could be a potential candidate for HCC therapeutics.	[Xu, Haitao; Zhao, Liang; Sun, Jianmin; Zhang, Songyan; Zhan, Chao; Zhang, Yubao] Harbin Med Univ Canc Hosp, Dept Hepatopancreatobiliary Surg, Harbin, Heilongjiang, Peoples R China; [Fang, Qiuju] Heilongjiang Prov Hosp, Dept Internal Med, Harbin, Heilongjiang, Peoples R China; [Liu, Shujie] Harbin Med Univ Canc Hosp, Dept Operat, Harbin, Heilongjiang, Peoples R China		Zhang, YB (corresponding author), Harbin Med Univ Canc Hosp, Dept Hepatopancreatobiliary Surg, Harbin, Heilongjiang, Peoples R China.	zhyb88077@sina.com			Natural Science Foundation of Heilongjiang Province [2009026]	Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province)	This work was supported by the Natural Science Foundation of Heilongjiang Province (No. 2009026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asghar U, 2012, J HEPATOL, V56, P686, DOI 10.1016/j.jhep.2011.07.031; Baek JH, 2000, ONCOGENE, V19, P4621, DOI 10.1038/sj.onc.1203814; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Chen CH, 2001, J BIOL CHEM, V276, P9519, DOI 10.1074/jbc.M010144200; Chen CM, 2012, J ELECTRON MATER, V41, P1, DOI 10.1007/s11664-011-1777-8; Chen X, 2013, FEBS LETT, V587, P3729, DOI 10.1016/j.febslet.2013.09.044; Comerford KM, 2002, CANCER RES, V62, P3387; Dvorak AM, 1996, J LEUKOCYTE BIOL, V59, P100, DOI 10.1002/jlb.59.1.100; DVORAK HF, 1992, ANN NY ACAD SCI, V667, P101, DOI 10.1111/j.1749-6632.1992.tb51603.x; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Emerling BM, 2008, P NATL ACAD SCI USA, V105, P2622, DOI 10.1073/pnas.0706790105; Esser S, 1998, J CELL BIOL, V140, P947, DOI 10.1083/jcb.140.4.947; Fardel O, 1996, GEN PHARMACOL, V27, P1283, DOI 10.1016/S0306-3623(96)00081-X; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Fu XY, 2012, INT J MOL SCI, V13, P8514, DOI 10.3390/ijms13078514; Goldstein LJ, 1996, EUR J CANCER, V32A, P1039, DOI 10.1016/0959-8049(96)00100-1; Gwak GY, 2005, J HEPATOL, V42, P358, DOI 10.1016/j.jhep.2004.11.020; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Huang XH, 2011, J PATHOL, V225, P463, DOI 10.1002/path.2877; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jin SK, 1998, MOL CELL BIOL, V18, P4377, DOI 10.1128/MCB.18.7.4377; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; Kim KW, 1998, CANCER RES, V58, P348; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Lai JP, 2004, GASTROENTEROLOGY, V126, P231, DOI 10.1053/j.gastro.2003.09.043; Li P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066782; Liang YJ, 2013, HEPATOLOGY, V57, P1847, DOI 10.1002/hep.26224; Liu LP, 2012, CLIN CANCER RES, V18, P5662, DOI 10.1158/1078-0432.CCR-12-0552; Livraghi T, 2011, SCAND J SURG, V100, P22, DOI 10.1177/145749691110000105; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; Mazure NM, 2001, TUMOR BIOL, V22, P310, DOI 10.1159/000050632; MILLAUER B, 1994, NATURE, V367, P576, DOI 10.1038/367576a0; Miller TE, 2008, J BIOL CHEM, V283, P29897, DOI 10.1074/jbc.M804612200; Nasser MW, 2008, J BIOL CHEM, V283, P33394, DOI 10.1074/jbc.M804788200; Nath B, 2012, HEPATOLOGY, V55, P622, DOI 10.1002/hep.25497; Ogretmen B, 1999, BIOCHEMISTRY-US, V38, P2189, DOI 10.1021/bi982236+; Olson AL, 1996, ANNU REV NUTR, V16, P235, DOI 10.1146/annurev.nu.16.070196.001315; Palmer DH, 2008, NEW ENGL J MED, V359, P2498; PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0; Poller B, 2011, MOL PHARMACEUT, V8, P571, DOI 10.1021/mp1003898; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Powis G, 2004, MOL CANCER THER, V3, P647; Roberts WG, 1997, CANCER RES, V57, P765; Rosmorduc O, 2010, SEMIN LIVER DIS, V30, P258, DOI 10.1055/s-0030-1255355; Semenza GL, 2002, TRENDS MOL MED, V8, pS62, DOI 10.1016/S1471-4914(02)02317-1; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Tak E, 2011, J HEPATOL, V54, P328, DOI 10.1016/j.jhep.2010.06.045; Tredan O, 2007, J NATL CANCER I, V99, P1441, DOI 10.1093/jnci/djm135; VAUPEL P, 1977, MICROVASC RES, V13, P399, DOI 10.1016/0026-2862(77)90106-6; Won KY, 2013, HUM PATHOL, V44, P1648, DOI 10.1016/j.humpath.2013.01.016; Wu XZ, 2007, J GASTROEN HEPATOL, V22, P1178, DOI 10.1111/j.1440-1746.2007.04997.x; Xue Q, 2014, JPN J CLIN ONCOL, V44, P13, DOI 10.1093/jjco/hyt181; Yang W, 2011, CANCER BIOTHER RADIO, V26, P565, DOI 10.1089/cbr.2011.0955; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444	59	64	66	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115565	10.1371/journal.pone.0115565	http://dx.doi.org/10.1371/journal.pone.0115565			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531114	Green Submitted, gold, Green Published			2022-12-27	WOS:000348845100076
J	Li, TX; Liu, JN; Smith, WW				Li, Tianxia; Liu, Jingnan; Smith, Wanli W.			Synphilin-1 Binds ATP and Regulates Intracellular Energy Status	PLOS ONE			English	Article							ALPHA-SYNUCLEIN; INTERACTING PROTEIN; INCLUSION FORMATION; PHOSPHORYLATION	Recent studies have suggested that synphilin-1, a cytoplasmic protein, is involved in energy homeostasis. Overexpression of synphilin-1 in neurons results in hyperphagia and obesity in animal models. However, the mechanism by which synphilin-1 alters energy homeostasis is unknown. Here, we used cell models and biochemical approaches to investigate the cellular functions of synphilin-1 that may affect energy balance. Synphilin-1 was pulled down by ATP-agarose beads, and the addition of ATP and ADP reduced this binding, indicating that synphilin-1 bound ADP and ATP. Synphilin-1 also bound GMP, GDP, and GTP but with a lower affinity than it bound ATP. In contrast, synphilin-1 did not bind with CTP. Overexpression of synphilin-1 in HEK293T cells significantly increased cellular ATP levels. Genetic alteration to abolish predicted ATP binding motifs of synphilin-1 or knockdown of synphilin-1 by siRNA reduced cellular ATP levels. Together, these data demonstrate that synphilin-1 binds and regulates the cellular energy molecule, ATP. These findings provide a molecular basis for understanding the actions of synphilin-1 in energy homeostasis.	[Li, Tianxia; Liu, Jingnan; Smith, Wanli W.] Univ Maryland, Dept Pharmaceut Sci, Sch Pharm, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Smith, WW (corresponding author), Univ Maryland, Dept Pharmaceut Sci, Sch Pharm, Baltimore, MD 21201 USA.	wsmith@rx.umaryland.edu			National Institutes of Health [DK083410]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083410] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health, Grants: DK083410 to WWS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Castelao B, 2011, CELL MOL LIFE SCI, V68, P2643, DOI 10.1007/s00018-010-0592-3; Avraham E, 2005, J BIOL CHEM, V280, P42877, DOI 10.1074/jbc.M505608200; Bergman J., 1999, CREATION RES SOC Q, V36; Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144; Engelender S, 1999, NAT GENET, V22, P110, DOI 10.1038/8820; Giaime E, 2006, J BIOL CHEM, V281, P11515, DOI 10.1074/jbc.M508619200; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hernandez-Vargas R, 2011, GENESIS, V49, P392, DOI 10.1002/dvg.20740; Lee G, 2004, J BIOL CHEM, V279, P6834, DOI 10.1074/jbc.M312760200; Li X, 2012, INT J OBESITY, V36, P1215, DOI 10.1038/ijo.2011.235; Li X, 2010, NEUROSCIENCE, V165, P455, DOI 10.1016/j.neuroscience.2009.10.042; Liu J, 2012, INT J OBESITY, V36, P1529, DOI 10.1038/ijo.2012.111; Marx FP, 2007, FASEB J, V21, P1759, DOI 10.1096/fj.06-6734com; Nagano Y, 2003, J BIOL CHEM, V278, P51504, DOI 10.1074/jbc.M306347200; O'Farrell C, 2001, MOL BRAIN RES, V97, P94, DOI 10.1016/S0169-328X(01)00292-3; Ribeiro CS, 2002, J BIOL CHEM, V277, P23927, DOI 10.1074/jbc.M201115200; Smith WW, 2010, HUM MOL GENET, V19, P2087, DOI 10.1093/hmg/ddq086; Smith WW, 2005, J NEUROSCI, V25, P5544, DOI 10.1523/JNEUROSCI.0482-05.2005; Szargel R, 2008, CELL MOL LIFE SCI, V65, P80, DOI 10.1007/s00018-007-7343-0; Wakabayashi K, 2000, ANN NEUROL, V47, P521, DOI 10.1002/1531-8249(200004)47:4<521::AID-ANA18>3.3.CO;2-2	20	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115233	10.1371/journal.pone.0115233	http://dx.doi.org/10.1371/journal.pone.0115233			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545246	Green Submitted, Green Published, gold			2022-12-27	WOS:000347120200028
J	Bower, KJ; McGinley, JL; Miller, KJ; Clark, RA				Bower, Kelly J.; McGinley, Jennifer L.; Miller, Kimberly J.; Clark, Ross A.			Instrumented Static and Dynamic Balance Assessment after Stroke Using Wii Balance Boards: Reliability and Association with Clinical Tests	PLOS ONE			English	Article							SIT-TO-STAND; POSTURAL CONTROL; PRESSURE MEASURES; INDIVIDUALS; POSTSTROKE; VALIDITY; PERFORMANCE; SYSTEM; GAIT	Background and Objectives: The Wii Balance Board (WBB) is a globally accessible device that shows promise as a clinically useful balance assessment tool. Although the WBB has been found to be comparable to a laboratory-grade force platform for obtaining centre of pressure data, it has not been comprehensively studied in clinical populations. The aim of this study was to investigate the measurement properties of tests utilising the WBB in people after stroke. Methods: Thirty individuals who were more than three months post-stroke and able to stand unsupported were recruited from a single outpatient rehabilitation facility. Participants performed standardised assessments incorporating the WBB and customised software (static stance with eyes open and closed, static weight-bearing asymmetry, dynamic mediolateral weight shifting and dynamic sit-to-stand) in addition to commonly employed clinical tests (10 Metre Walk Test, Timed Up and Go, Step Test and Functional Reach) on two testing occasions one week apart. Test-retest reliability and construct validity of the WBB tests were investigated. Results: All WBB-based outcomes were found to be highly reliable between testing occasions (ICC =0.82 to 0.98). Correlations were poor to moderate between WBB variables and clinical tests, with the strongest associations observed between task-related activities, such as WBB mediolateral weight shifting and the Step Test. Conclusions: The WBB, used with customised software, is a reliable and potentially useful tool for the assessment of balance and weight-bearing asymmetry following stroke. Future research is recommended to further investigate validity and responsiveness.	[Bower, Kelly J.; McGinley, Jennifer L.] Univ Melbourne, Dept Physiotherapy, Melbourne, Vic, Australia; [Bower, Kelly J.] Royal Melbourne Hosp, Dept Physiotherapy, Melbourne, Vic, Australia; [Miller, Kimberly J.] Univ British Columbia, Dept Phys Therapy, Vancouver, BC V5Z 1M9, Canada; [Bower, Kelly J.; Clark, Ross A.] Australian Catholic Univ, Sch Exercise Sci, Melbourne, Vic, Australia	University of Melbourne; Royal Melbourne Hospital; University of British Columbia; Australian Catholic University	Bower, KJ (corresponding author), Univ Melbourne, Dept Physiotherapy, Melbourne, Vic, Australia.	kelly.bower@mh.org.au	Clark, Ross A/R-5664-2018; Clark, Ross/K-7613-2019	Clark, Ross A/0000-0002-7291-8553; Clark, Ross/0000-0002-7291-8553; McGinley, Jennifer/0000-0003-3775-9267; Miller, Kimberly/0000-0002-9826-7269	National Health and Medical Research Council	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Funding: This study was funded in part by a National Health and Medical Research Council postgraduate scholarship (https://www.nhmrc.gov.au/) awarded to author KB. The authors received no additional specific funding for this work.	Barra J, 2009, NEUROLOGY, V72, P1582, DOI 10.1212/WNL.0b013e3181a4123a; Batchelor FA, 2012, INT J STROKE, V7, P482, DOI 10.1111/j.1747-4949.2012.00796.x; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Bower KJ, 2014, CLIN REHABIL, V28, P912, DOI 10.1177/0269215514527597; Chang JO, 2013, CLIN J SPORT MED; Cheng PT, 1998, ARCH PHYS MED REHAB, V79, P1043, DOI 10.1016/S0003-9993(98)90168-X; Chien CW, 2007, ARCH PHYS MED REHAB, V88, P374, DOI 10.1016/j.apmr.2006.11.019; Chou SW, 2003, AM J PHYS MED REHAB, V82, P42, DOI 10.1097/01.PHM.0000043769.93584.4D; Clark RA, 2010, GAIT POSTURE, V31, P307, DOI 10.1016/j.gaitpost.2009.11.012; Clark RA, 2011, GAIT POSTURE, V34, P288, DOI 10.1016/j.gaitpost.2011.04.010; de Haart M, 2005, ARCH PHYS MED REHAB, V86, P755, DOI 10.1016/j.apmr.2004.10.010; de Oliveira CB, 2008, J REHABIL RES DEV, V45, P1215, DOI 10.1682/JRRD.2007.09.0150; DUNCAN PW, 1990, J GERONTOL, V45, pM192, DOI 10.1093/geronj/45.6.M192; Eng JJ, 2002, ARCH PHYS MED REHAB, V83, P1138, DOI 10.1053/apmr.2002.33644; Fleiss J.L., 1986, DESIGN ANAL CLIN EXP; Frykberg GE, 2007, J REHABIL MED, V39, P448, DOI 10.2340/16501977-0071; Geurts ACH, 2005, GAIT POSTURE, V22, P267, DOI 10.1016/j.gaitpost.2004.10.002; Gray VL, 2014, GAIT POSTURE, V40, P198, DOI 10.1016/j.gaitpost.2014.03.191; Hill KD, 1996, PHYSIOTHER CAN, V48, P257, DOI DOI 10.3138/PTC.48.4.257; Holmes JD, 2013, CLIN REHABIL, V27, P361, DOI 10.1177/0269215512458684; Huurnink A, 2013, J BIOMECH, V46, P1392, DOI 10.1016/j.jbiomech.2013.02.018; Hyndman D, 2009, NEUROREHAB NEURAL RE, V23, P847, DOI 10.1177/1545968309338192; Kamper SJ, 2009, J MAN MANIP THER, V17, P163, DOI 10.1179/jmt.2009.17.3.163; Kamphuis JF, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/692137; Karlsson A, 2000, CLIN BIOMECH, V15, P365, DOI 10.1016/S0268-0033(99)00096-0; Leroux A, 2006, AM J PHYS MED REHAB, V85, P820, DOI 10.1097/01.phm.0000233179.64769.8c; Liston RAL, 1996, ARCH PHYS MED REHAB, V77, P425, DOI 10.1016/S0003-9993(96)90028-3; Lomaglio MJ, 2005, GAIT POSTURE, V22, P126, DOI 10.1016/j.gaitpost.2004.08.002; Mokkink LB, 2010, J CLIN EPIDEMIOL, V63, P737, DOI 10.1016/j.jclinepi.2010.02.006; Nardone A, 2009, GAIT POSTURE, V30, P5, DOI 10.1016/j.gaitpost.2009.02.006; Niam S, 1999, ARCH PHYS MED REHAB, V80, P1227, DOI 10.1016/S0003-9993(99)90020-5; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Portney LG, 2009, FDN CLIN RES APPL PR, V3rd, DOI DOI 10.1016/S0039-6257(02)00362-4; Ruhe A, 2010, GAIT POSTURE, V32, P436, DOI 10.1016/j.gaitpost.2010.09.012; Sawacha Z, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-95; Scaglioni-Solano P, 2014, INT J REHABIL RES, V37, P138, DOI 10.1097/MRR.0000000000000046; Sullivan JE, 2013, PHYS THER, V93, P1383, DOI 10.2522/ptj.20120492; van Bloemendaal M, 2012, DISABIL REHABIL, V34, P2207, DOI 10.3109/09638288.2012.680649; Visser JE, 2008, CLIN NEUROPHYSIOL, V119, P2424, DOI 10.1016/j.clinph.2008.07.220	40	31	32	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115282	10.1371/journal.pone.0115282	http://dx.doi.org/10.1371/journal.pone.0115282			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541939	Green Published, gold, Green Submitted			2022-12-27	WOS:000347239900032
J	Hobbs, CV; Dixit, S; Penzak, SR; Sahu, T; Orr-Gonzalez, S; Lambert, L; Zeleski, K; Chen, JY; Neal, J; Borkowsky, W; Wu, YM; Duffy, PE				Hobbs, Charlotte V.; Dixit, Saurabh; Penzak, Scott R.; Sahu, Tejram; Orr-Gonzalez, Sachy; Lambert, Lynn; Zeleski, Katie; Chen, Jingyang; Neal, Jillian; Borkowsky, William; Wu, Yimin; Duffy, Patrick E.			Neither the HIV Protease Inhibitor Lopinavir-Ritonavir nor the Antimicrobial Trimethoprim-Sulfamethoxazole Prevent Malaria Relapse in Plasmodium cynomolgi-Infected Non-Human Primates	PLOS ONE			English	Article							ANTIMALARIAL-DRUGS; RHESUS-MONKEYS; MACACA-MULATTA; LIVER STAGES; IN-VITRO; PHARMACOKINETICS; HYPNOZOITE; FALCIPARUM; QUININE; VIVAX	Plasmodium vivax malaria causes significant morbidity and mortality worldwide, and only one drug is in clinical use that can kill the hypnozoites that cause P. vivax relapses. HIV and P. vivax malaria geographically overlap in many areas of the world, including South America and Asia. Despite the increasing body of knowledge regarding HIV protease inhibitors (HIV PIs) on P. falciparum malaria, there are no data regarding the effects of these treatments on P. vivax's hypnozoite form and clinical relapses of malaria. We have previously shown that the HIV protease inhibitor lopinavir-ritonavir (LPV-RTV) and the antibiotic trimethoprim sulfamethoxazole (TMP-SMX) inhibit Plasmodium actively dividing liver stages in rodent malarias and in vitro in P. falciparum, but effect against Plasmodium dormant hypnozoite forms remains untested. Separately, although other antifolates have been tested against hypnozoites, the antibiotic trimethoprim sulfamethoxazole, commonly used in HIV infection and exposure management, has not been evaluated for hypnozoite-killing activity. Since Plasmodium cynomolgi is an established animal model for the study of liver stages of malaria as a surrogate for P. vivax infection, we investigated the antimalarial activity of these drugs on Plasmodium cynomolgi relapsing malaria in rhesus macaques. Herein, we demonstrate that neither TMP-SMX nor LPV-RTV kills hypnozoite parasite liver stage forms at the doses tested. Because HIV and malaria geographically overlap, and more patients are being managed for HIV infection and exposure, understanding HIV drug impact on malaria infection is important.	[Hobbs, Charlotte V.; Dixit, Saurabh; Sahu, Tejram; Orr-Gonzalez, Sachy; Lambert, Lynn; Zeleski, Katie; Chen, Jingyang; Neal, Jillian; Wu, Yimin; Duffy, Patrick E.] NIAID, Lab Malaria Immunol & Vaccinol, NIH, Rockville, MD 20852 USA; [Penzak, Scott R.] Univ North Texas Syst Coll Pharm, Dept Pharmacotherapy, Ft Worth, TX 76107 USA; [Borkowsky, William] NYU, Dept Pediat, Sch Med, Div Infect Dis & Immunol, New York, NY 10016 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); New York University	Hobbs, CV (corresponding author), NIAID, Lab Malaria Immunol & Vaccinol, NIH, Rockville, MD 20852 USA.	charlotte.hobbs@nih.gov	Smolovich, Anatoly/R-8144-2017; dixit, saurabh/E-3296-2013	Smolovich, Anatoly/0000-0002-7557-272X; Hobbs, Charlotte/0000-0003-4829-0791; dixit, saurabh/0000-0002-9140-9543; Sahu, Tejram/0000-0002-0912-7660	National Institutes of Health Division of Intramural Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIGAI001047, ZIAAI001135] Funding Source: NIH RePORTER	National Institutes of Health Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding: This work was supported by the National Institutes of Health Division of Intramural Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achan J, 2012, NEW ENGL J MED, V367, P2110, DOI 10.1056/NEJMoa1200501; Akabane T, 2010, DRUG METAB DISPOS, V38, P308, DOI 10.1124/dmd.109.028829; Andrews KT, 2006, ANTIMICROB AGENTS CH, V50, P639, DOI 10.1128/AAC.50.2.639-648.2006; [Anonymous], 2013, TREATM MAL GUID CLIN; Baird JK, 2013, CLIN MICROBIOL REV, V26, P36, DOI 10.1128/CMR.00074-12; Baird JK, 2005, NEW ENGL J MED, V352, P1565, DOI 10.1056/NEJMra043207; Birkett DJ., 2010, PHARMACOKINETICS MAD; Carpenter J.W., 2005, EXOTIC ANIMAL FORMUL, V3; COGSWELL FB, 1992, CLIN MICROBIOL REV, V5, P26, DOI 10.1128/CMR.5.1.26-35.1992; Collins WE, 2009, J PARASITOL, V95, P349, DOI 10.1645/GE-1797.1; Craig WA, 1973, J INFECT DIS S, V128; Dangerous Drugs England Dangerous Drugs Scotland., 2013, CONTROLLED DRUGS SUP; DAVIDSON DE, 1976, AM J TROP MED HYG, V25, P26, DOI 10.4269/ajtmh.1976.25.26; Dembele L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018162; Deye GA, 2012, AM J TROP MED HYG, V86, P931, DOI 10.4269/ajtmh.2012.11-0552; Dow GS, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-212; Eastman RT, 2013, ANTIMICROB AGENTS CH, V57, P425, DOI 10.1128/AAC.00920-12; Ersmark K, 2006, MED RES REV, V26, P626, DOI 10.1002/med.20082; EYLES DE, 1962, AM J TROP MED HYG, V11, P175, DOI 10.4269/ajtmh.1962.11.175; FISK TL, 1989, AM J TROP MED HYG, V40, P235, DOI 10.4269/ajtmh.1989.40.235; Flateau C, 2011, LANCET INFECT DIS, V11, P541, DOI 10.1016/S1473-3099(11)70031-7; Gantt SM, 1998, ANTIMICROB AGENTS CH, V42, P2731, DOI 10.1128/AAC.42.10.2731; Hobbs CV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100138; Hobbs CV, 2013, AIDS, V27, P1674, DOI 10.1097/QAD.0b013e3283621dd4; Hobbs CV, 2012, J INFECT DIS, V206, P1706, DOI 10.1093/infdis/jis602; Hobbs CV, 2009, J INFECT DIS, V199, P134, DOI 10.1086/594369; Hobbs CV, 2013, J INFECT DIS; Ikilezi G, 2013, AM J TROP MED HYG; Ishimatsu M, 2007, MICROBES INFECT, V9, P475, DOI 10.1016/j.micinf.2007.01.005; JIANG JB, 1988, T ROY SOC TROP MED H, V82, P56, DOI 10.1016/0035-9203(88)90262-3; Krishna S, 1996, CLIN PHARMACOKINET, V30, P263, DOI 10.2165/00003088-199630040-00002; Laboratories A KALETRA, LOP TABL LOP RIT OR; Lek-Uthai U, 2008, ANTIMICROB AGENTS CH, V52, P2435, DOI 10.1128/AAC.00169-08; Li YJ, 2011, ANTIMICROB AGENTS CH, V55, P3039, DOI 10.1128/AAC.00085-11; Martins TM, 2006, ACTA TROP, V97, P212, DOI 10.1016/j.actatropica.2005.11.001; Moon SU, 2011, EXP PARASITOL, V128, P127, DOI 10.1016/j.exppara.2011.02.015; Nsanzabana C, 2011, ANTIMICROB AGENTS CH; Nyunt MM, 2012, CLIN PHARMACOL THER, V91, P889, DOI 10.1038/clpt.2011.326; Parikh S, 2005, ANTIMICROB AGENTS CH, V49, P2983, DOI 10.1128/AAC.49.7.2983-2985.2005; Peatey CL, 2010, ANTIMICROB AGENTS CH, V54, P1334, DOI 10.1128/AAC.01512-09; PURI S K, 1990, Journal of Communicable Diseases, V22, P98; Redmond AM, 2007, AIDS, V21, P763, DOI 10.1097/QAD.0b013e328031f41a; Robert Coatney G., 1971, PRIMATE MALARIAS, Vix; SCHMIDT LH, 1986, AM J TROP MED HYG, V35, P1077, DOI 10.4269/ajtmh.1986.35.1077; SHANKS GD, 1994, AM J TROP MED HYG, V50, P641, DOI 10.4269/ajtmh.1994.50.641; Skinner-Adams TS, 2004, J INFECT DIS, V190, P1998, DOI 10.1086/425584; Soyinka JO, 2010, BRIT J CLIN PHARMACO, V69, P262, DOI 10.1111/j.1365-2125.2009.03566.x; White NJ, 2007, LANCET INFECT DIS, V7, P549, DOI 10.1016/S1473-3099(07)70187-1; WHO, 1995, WHO MOD PERSCR INF D	49	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115506	10.1371/journal.pone.0115506	http://dx.doi.org/10.1371/journal.pone.0115506			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541998	Green Submitted, gold, Green Published			2022-12-27	WOS:000347239900048
J	Li, YB; Zang, DW				Li, Yubo; Zang, Dawei			The Neuron Regrowth Is Associated with the Proliferation of Neural Precursor Cells after Leukemia Inhibitory Factor Administration following Spinal Cord Injury in Mice	PLOS ONE			English	Article							OLIGODENDROCYTE DIFFERENTIATION; STEM/PRECURSOR CELLS; MOUSE MODEL; STEM-CELLS; BRAIN; LIF; ASTROCYTES; DEMYELINATION; TRANSPORT; RECOVERY	Objectives: To explore whether LIF could promote the proliferation of neural precursor cells (NPCs) and to analyze the correlation between increased NPCs and FluoroGold (FG) labeled neurons in mice after spinal cord injury (SCI). Methods: Motor behavior was assessed using Rotarod and Platform Hang tests; neurons in the corticospinal and rubrospinal systems were labeled with FG, NPCs were immustained with nestin-FITC conjugate. The numbers of FG-labeled neurons and NPCs were estimated, and the correlation between FG-labeled neurons and NPCs was assessed. Results: Mice in the SCI group showed negligible recovery of locomotor behavior; in contrast, mice in the LIF group showed a statically significant improvement. Both FG-labeled neurons and NPCs were significantly increased in the LIF group compared to the SCI group, and this increase in FG-labeled neurons and NPCs showed a clear association above the lesion level. Conclusions: LIF could promote locomotive behaviors in mice post-SCI by encouraging the proliferation of NPCs; LIF may in fact be a potential cytokine for the induction of NPCs post-SCI.	[Li, Yubo] Capital Med Univ, Beijing 100069, Peoples R China; [Zang, Dawei] Tianjin Med Univ, Tianjin Ctr 1, Dept Neurol, Tianjin 300192, Peoples R China	Capital Medical University; Tianjin Medical University	Zang, DW (corresponding author), Tianjin Med Univ, Tianjin Ctr 1, Dept Neurol, Tianjin 300192, Peoples R China.	zangdawei@gmail.com			Tianjin Health Bureau [11KG104]	Tianjin Health Bureau	This work was supported by Tianjin Health Bureau (11KG104). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen RK, 2009, NEUROSCI LETT, V464, P203, DOI 10.1016/j.neulet.2009.08.050; Asano H, 2009, STEM CELLS, V27, P2744, DOI 10.1002/stem.176; Azari MF, 2005, EUR J NEUROL, V12, P638, DOI 10.1111/j.1468-1331.2005.01066.x; Azari MF, 2006, J NEUROPATH EXP NEUR, V65, P914, DOI 10.1097/01.jnen.0000235855.77716.25; Bambakidis NC, 2009, J NEUROSURG-SPINE, V10, P171, DOI 10.3171/2008.10.SPI08231; Bazley FA, 2012, IEEE ENG MED BIO, P82, DOI 10.1109/EMBC.2012.6345876; Beatus P, 2011, DEV NEUROBIOL, V71, P619, DOI 10.1002/dneu.20871; Christie KJ, 2013, ADV EXP MED BIOL, V786, P129, DOI 10.1007/978-94-007-6621-1_8; Covey MV, 2011, ANN NEUROL, V70, P616, DOI 10.1002/ana.22473; Cusimano M, 2012, BRAIN, V135, P447, DOI 10.1093/brain/awr339; Daadi MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041120; Dooley D, 2014, PHARMACOL THERAPEUT, V141, P21, DOI 10.1016/j.pharmthera.2013.08.001; Gauthier MK, 2013, EUR J NEUROSCI, V38, P2693, DOI 10.1111/ejn.12268; Gresle MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047379; Guadagno J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.59; Hawryluk GWJ, 2012, STEM CELLS DEV, V21, P2222, DOI 10.1089/scd.2011.0596; Jin Y, 2012, J NEUROSCI RES, V90, P2065, DOI 10.1002/jnr.23099; Juan L, 2007, NEUROL RES, V29, P204, DOI 10.1179/174313206X152519; Karimi-Abdolrezaee S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037589; Kerr BJ, 2005, GLIA, V51, P73, DOI 10.1002/glia.20177; Kumamaru H, 2013, STEM CELLS, V31, P1535, DOI 10.1002/stem.1404; Laterza C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3597; Lee JW, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00167; Liu J, 2009, NEUROL RES, V31, P681, DOI 10.1179/174313209X382368; Lopez-Arenas E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045018; Mathieu ME, 2012, STEM CELL REV REP, V8, P1, DOI 10.1007/s12015-011-9261-7; Moghadam FH, 2009, DIFFERENTIATION, V78, P59, DOI 10.1016/j.diff.2009.06.005; Mothe AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027079; Mutoh T, 2012, STEM CELLS, V30, P561, DOI 10.1002/stem.1019; Pan WH, 2008, CURR PHARM DESIGN, V14, P1620, DOI 10.2174/138161208784705450; Pan WH, 2006, J NEUROIMMUNOL, V174, P119, DOI 10.1016/j.jneuroim.2006.02.006; Suehiro K, 2014, SCI REP-UK, V4, DOI 10.1038/srep04972; Tu J, 2010, SPINE, V35, P1116, DOI 10.1097/BRS.0b013e3181ba6ce4; Urayama S, 2013, CELL STRUCT FUNCT, V38, P55, DOI 10.1247/csf.12034; Wang YP, 2011, J NEUROSCI, V31, P6053, DOI 10.1523/JNEUROSCI.5524-09.2011; Weible MW, 2007, GLIA, V55, P1156, DOI 10.1002/glia.20539; Weinger J.G., 2013, CURR PROTOC STEM CEL, V26; White RE, 2011, J NEUROSCI, V31, P15173, DOI 10.1523/JNEUROSCI.3441-11.2011; Zang DW, 2003, J NEUROTRAUM, V20, P1215, DOI 10.1089/089771503770802880	39	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e116031	10.1371/journal.pone.0116031	http://dx.doi.org/10.1371/journal.pone.0116031			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542011	Green Published, gold, Green Submitted			2022-12-27	WOS:000347239900132
J	Salomaki, H; Heinaniemi, M; Vahatalo, LH; Ailanen, L; Eerola, K; Ruohonen, ST; Pesonen, U; Koulu, M				Salomaki, Henriikka; Heinaniemi, Merja; Vahatalo, Laura H.; Ailanen, Liisa; Eerola, Kim; Ruohonen, Suvi T.; Pesonen, Ullamari; Koulu, Markku			Prenatal Metformin Exposure in a Maternal High Fat Diet Mouse Model Alters the Transcriptome and Modifies the Metabolic Responses of the Offspring	PLOS ONE			English	Article							WHITE ADIPOSE-TISSUE; GESTATIONAL DIABETES-MELLITUS; ACTIVATED PROTEIN-KINASE; GLUCOSE-TOLERANCE; RESPIRATORY-CHAIN; BROWN ADIPOCYTES; OBESE MICE; MECHANISM; EXPRESSION; INSULIN	Aims: Despite the wide use of metformin in metabolically challenged pregnancies, the long-term effects on the metabolism of the offspring are not known. We studied the long-term effects of prenatal metformin exposure during metabolically challenged pregnancy in mice. Materials and Methods: Female mice were on a high fat diet (HFD) prior to and during the gestation. Metformin was administered during gestation from E0.5 to E17.5. Male and female offspring were weaned to a regular diet (RD) and subjected to HFD at adulthood (10-11 weeks). Body weight and several metabolic parameters (e.g. body composition and glucose tolerance) were measured during the study. Microarray and subsequent pathway analyses on the liver and subcutaneous adipose tissue of the male offspring were performed at postnatal day 4 in a separate experiment. Results: Prenatal metformin exposure changed the offspring's response to HFD. Metformin exposed offspring gained less body weight and adipose tissue during the HFD phase. Additionally, prenatal metformin exposure prevented HFD-induced impairment in glucose tolerance. Microarray and annotation analyses revealed metformin-induced changes in several metabolic pathways from which electron transport chain (ETC) was prominently affected both in the neonatal liver and adipose tissue. Conclusion: This study shows the beneficial effects of prenatal metformin exposure on the offspring's glucose tolerance and fat mass accumulation during HFD. The transcriptome data obtained at neonatal age indicates major effects on the genes involved in mitochondrial ATP production and adipocyte differentiation suggesting the mechanistic routes to improved metabolic phenotype at adulthood.	[Salomaki, Henriikka; Vahatalo, Laura H.; Ailanen, Liisa; Eerola, Kim; Ruohonen, Suvi T.; Pesonen, Ullamari; Koulu, Markku] Univ Turku, Inst Biomed, Dept Pharmacol Drug Dev & Therapeut, FI-20014 Turku, Finland; [Salomaki, Henriikka; Vahatalo, Laura H.; Ailanen, Liisa; Eerola, Kim] Univ Turku, Drug Res Doctoral Programme, Turku, Finland; [Heinaniemi, Merja] Univ Eastern Finland, Inst Biomed, Sch Med, FI-70211 Kuopio, Finland; [Vahatalo, Laura H.; Ailanen, Liisa; Eerola, Kim; Ruohonen, Suvi T.] Univ Turku, Turku Ctr Dis Modeling, FI-20014 Turku, Finland	University of Turku; University of Turku; University of Eastern Finland; University of Turku	Koulu, M (corresponding author), Univ Turku, Inst Biomed, Dept Pharmacol Drug Dev & Therapeut, FI-20014 Turku, Finland.	markku.koulu@utu.fi	Eerola, Kim/L-8819-2019	Pesonen, Ullamari/0000-0002-9962-212X	Academy of Finland [134131, 252441]; FinPharma Doctoral Program	Academy of Finland(Academy of Finland); FinPharma Doctoral Program	This study was supported by the Academy of Finland http://www.aka.fi/en-GB/A/ (grants 134131 and 252441 to MK and STR, respectively) and FinPharma Doctoral Program http//fpdp.fi/index.php?id=42(grant to HS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainge H, 2011, INT J OBESITY, V35, P325, DOI 10.1038/ijo.2010.149; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; Caton PW, 2011, DIABETES OBES METAB, V13, P1097, DOI 10.1111/j.1463-1326.2011.01466.x; Cho NH, 2000, J PEDIATR-US, V136, P587, DOI 10.1067/mpd.2000.105129; COETZEE EJ, 1979, DIABETOLOGIA, V16, P241, DOI 10.1007/BF01221950; Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973; Dabelea D, 2000, DIABETES, V49, P2208, DOI 10.2337/diabetes.49.12.2208; Dominguez E, 2014, NAT CHEM BIOL, V10, P113, DOI 10.1038/nchembio.1429; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Fukui Y, 2000, DIABETES, V49, P759, DOI 10.2337/diabetes.49.5.759; Gluckman PD, 2009, NAT REV ENDOCRINOL, V5, P401, DOI 10.1038/nrendo.2009.102; Goh JEL, 2011, DIABETIC MED, V28, P1082, DOI 10.1111/j.1464-5491.2011.03361.x; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; Hou M, 2010, BIOCHEM BIOPH RES CO, V397, P537, DOI 10.1016/j.bbrc.2010.05.152; Hundal RS, 2003, DRUGS, V63, P1879, DOI 10.2165/00003495-200363180-00001; Hundal RS, 2000, DIABETES, V49, P2063, DOI 10.2337/diabetes.49.12.2063; Hwang LL, 2010, OBESITY, V18, P463, DOI 10.1038/oby.2009.273; Ijas H, 2011, BJOG-INT J OBSTET GY, V118, P880, DOI 10.1111/j.1471-0528.2010.02763.x; Koenen TB, 2011, DIABETES, V60, P517, DOI 10.2337/db10-0266; Kopecky J, 1995, J CLIN INVEST, V96, P2914, DOI 10.1172/JCI118363; Levin BE, 2006, PHILOS T R SOC B, V361, P1107, DOI 10.1098/rstb.2006.1851; Liang CY, 2010, METABOLISM, V59, P943, DOI 10.1016/j.metabol.2009.10.015; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Lu XD, 2012, ENDOCRINOLOGY, V153, P3123, DOI 10.1210/en.2012-1151; Maida A, 2011, DIABETOLOGIA, V54, P339, DOI 10.1007/s00125-010-1937-z; Morin-Papunen L, 2012, J CLIN ENDOCR METAB, V97, P1492, DOI 10.1210/jc.2011-3061; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Parlee SD, 2014, METHOD ENZYMOL, V537, P93, DOI 10.1016/B978-0-12-411619-1.00006-9; Patwari P, 2009, J BIOL CHEM, V284, P24996, DOI 10.1074/jbc.M109.018093; Pernicova I, 2014, NAT REV ENDOCRINOL, V10, P143, DOI 10.1038/nrendo.2013.256; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; Rena G, 2013, DIABETOLOGIA, V56, P1898, DOI 10.1007/s00125-013-2991-0; Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740; Rowan JA, 2008, NEW ENGL J MED, V358, P2003, DOI 10.1056/NEJMoa0707193; Rowan JA, 2011, DIABETES CARE, V34, P2279, DOI 10.2337/dc11-0660; Salomaki H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056594; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; SILVERMAN BL, 1995, DIABETES CARE, V18, P611, DOI 10.2337/diacare.18.5.611; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Symonds ME, 2009, NAT REV ENDOCRINOL, V5, P604, DOI 10.1038/nrendo.2009.195; Tertti K, 2013, DIABETES OBES METAB, V15, P246, DOI 10.1111/dom.12017; Tertti Kristiina, 2008, Rev Diabet Stud, V5, P95, DOI 10.1900/RDS.2008.5.95; Tong JF, 2011, NUTR DIABETES, V1, DOI 10.1038/nutd.2011.3; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Wei EH, 2010, CELL METAB, V11, P183, DOI 10.1016/j.cmet.2010.02.005; World Obesity, CHILDH OB; Xie ZL, 2011, DIABETES, V60, P1770, DOI 10.2337/db10-0351; Yura S, 2005, CELL METAB, V1, P371, DOI 10.1016/j.cmet.2005.05.005; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	53	40	42	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115778	10.1371/journal.pone.0115778	http://dx.doi.org/10.1371/journal.pone.0115778			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541979	Green Published, Green Submitted, gold			2022-12-27	WOS:000347239900086
J	Hu, JC; Mathias-Santos, C; Greene, CJ; King-Lyons, ND; Rodrigues, JF; Hajishengallis, G; Ferreira, LCS; Connell, TD				Hu, John C.; Mathias-Santos, Camila; Greene, Christopher J.; King-Lyons, Natalie D.; Rodrigues, Juliana F.; Hajishengallis, George; Ferreira, Luis C. S.; Connell, Terry D.			Intradermal Administration of the Type II Heat-Labile Enterotoxins LT-IIb and LT-IIc of Enterotoxigenic Escherichia coli Enhances Humoral and CD8(+) T Cell Immunity to a Co-Administered Antigen	PLOS ONE			English	Article							CHOLERA-TOXIN; GANGLIOSIDE-BINDING; DIFFERENTIATION; IMMUNIZATION; VACCINATION; ADJUVANTS; VARIANT	Vaccinations are extremely effective at combating infectious diseases. Many conserved antigen (Ag) targets, however, are poorly immunogenic. Protein subunit vaccines frequently elicit only humoral immune responses and fail to confer protection against serious intracellular pathogens. These barriers to vaccine development are often overcome by the use of appropriate adjuvants. Heat-labile enterotoxins (HLT) produced by enterotoxigenic strains of Escherichia coli are potent adjuvants when administered by mucosal or systemic routes. The efficacy of the type II HLT, however, has not been well-defined when administered by the intradermal (ID) route. Using a murine ID immunization model, the adjuvant properties of LT-IIb and LT-IIc, two type II HLTs, were compared with those of LT-I, a prototypical type I HLT. While all three HLTadjuvants enhanced Ag-specific humoral responses to similar levels, LT-IIb and LT-IIc, in contrast to LT-I, induced a more vigorous Ag-specific CD8(+) T cell response and proffered faster clearance of Listeria monocytogenes in a challenge model. Additionally, LT-IIb and LT-IIc induced distinct differences in the profiles of the Ag-specific CD8(+) T cell responses. While LT-IIc stimulated a robust and rapid primary CD8(+) T cell response, LT-IIb exhibited slower CD8(+) T cell expansion and contraction kinetics with the formation of higher percentages of effector memory cells. In comparison to LT-I and LT-IIc, LT-IIb evoked better long-term protection after immunization. Furthermore, LT-IIb and LT-IIc enhanced the total number of dendritic cells (DC) in the draining lymph node (DLN) and expression of costimulatory molecules CD80, CD86, and CD40 on DCs. In contrast to LT-I, LT-IIb and LT-IIc induced less edema, cellular infiltrates, and general inflammation at the site of ID injection. Thus, LT-IIb and LT-IIc are attractive comprehensive ID adjuvants with unique characteristic that enhance humoral and cellular immunity to a co-administered protein Ag.	[Hu, John C.; Greene, Christopher J.; King-Lyons, Natalie D.; Connell, Terry D.] SUNY Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14260 USA; [Hu, John C.; Greene, Christopher J.; King-Lyons, Natalie D.; Connell, Terry D.] SUNY Buffalo, Witebsky Ctr Microbial Pathogenesis & Immunol, Buffalo, NY 14260 USA; [Mathias-Santos, Camila; Rodrigues, Juliana F.] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Sao Paulo, Brazil; [Hajishengallis, George] Univ Penn, Sch Dent Med, Dept Microbiol, Philadelphia, PA 19104 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Universidade de Sao Paulo; University of Pennsylvania	Connell, TD (corresponding author), SUNY Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14260 USA.	connell@buffalo.edu	Hajishengallis, George N./K-1117-2019; Ferreira, Luis Carlos S/M-3954-2014; LYONS, NATALIE/K-8058-2019; Rodrigues, Juliana/AAC-3512-2019	Hajishengallis, George N./0000-0001-7392-8852; Ferreira, Luis Carlos S/0000-0002-4883-1693; 	U.S. Dept. of Health [DE13833, DE017138, DE015254]; John R. Oishei Foundation; Sao Paulo Research Foundation - FAPESP; National Council for Scientific and Technological Development (CNPq); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017138, R01DE015254] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R56DE013833, R01DE013833] Funding Source: NIH RePORTER	U.S. Dept. of Health; John R. Oishei Foundation; Sao Paulo Research Foundation - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The work was supported by the following: T.D.C. - U.S. Dept. of Health, (DE13833, DE017138); T.D.C. - The John R. Oishei Foundation; G.H. - U.S. Dept. of Health, (DE015254); L.C.S.F. - Sao Paulo Research Foundation - FAPESP; and L.C.S.F. - The National Council for Scientific and Technological Development (CNPq).	Arce S, 2005, INFECT IMMUN, V73, P2718, DOI 10.1128/IAI.73.5.2718-2727.2005; Barnighausen T, 2011, VACCINE, V29, P2371, DOI 10.1016/j.vaccine.2010.11.090; Berenson CS, 2010, GLYCOBIOLOGY, V20, P41, DOI 10.1093/glycob/cwp141; Bloom DE, 2011, ADV EXP MED BIOL, V697, P1, DOI 10.1007/978-1-4419-7185-2_1; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Calabro S, 2011, VACCINE, V29, P1812, DOI 10.1016/j.vaccine.2010.12.090; Connell TD, 2007, EXPERT REV VACCINES, V6, P821, DOI 10.1586/14760584.6.5.821; Foulds KE, 2002, J IMMUNOL, V168, P1528, DOI 10.4049/jimmunol.168.4.1528; Greene CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069678; Hajishengallis G, 2013, VET IMMUNOL IMMUNOP, V152, P68, DOI 10.1016/j.vetimm.2012.09.034; Harty JT, 2008, NAT REV IMMUNOL, V8, P107, DOI 10.1038/nri2251; Koup RA, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a007252; Lasaro MA, 2009, FEMS IMMUNOL MED MIC, V55, P93, DOI 10.1111/j.1574-695X.2008.00506.x; Levine OS, 2011, LANCET, V378, P439, DOI 10.1016/S0140-6736(11)60406-6; Liang SA, 2010, IMMUNOL INVEST, V39, P449, DOI 10.3109/08820130903563998; Lu FJ, 2013, VACCINE, V31, P3979, DOI 10.1016/j.vaccine.2013.05.107; Martin M, 2000, INFECT IMMUN, V68, P281, DOI 10.1128/IAI.68.1.281-287.2000; Mathias-Santos C, 2011, CLIN VACCINE IMMUNOL, V18, P1243, DOI 10.1128/CVI.00012-11; Meza-Sanchez D, 2011, EUR J IMMUNOL, V41, P2894, DOI 10.1002/eji.201040997; Nawar HF, 2011, VACCINE, V29, P721, DOI 10.1016/j.vaccine.2010.11.020; Nawar HF, 2010, INFECT IMMUN, V78, P4705, DOI 10.1128/IAI.00730-10; Nawar HF, 2010, CLIN VACCINE IMMUNOL, V17, P969, DOI 10.1128/CVI.00076-10; Nicolas JF, 2008, EXPERT REV VACCINES, V7, P1201, DOI 10.1586/14760584.7.8.1201; Reed SG, 2013, NAT MED, V19, P1597, DOI 10.1038/nm.3409; Vitoriano-Souza J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040745; Wherry EJ, 2004, J VIROL, V78, P5535, DOI 10.1128/JVI.78.11.5535-5545.2004; Zoeteweij JP, 2006, J IMMUNOL, V177, P1197, DOI 10.4049/jimmunol.177.2.1197	27	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e113978	10.1371/journal.pone.0113978	http://dx.doi.org/10.1371/journal.pone.0113978			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536061	Green Published, gold, Green Submitted			2022-12-27	WOS:000348563300009
J	Huang, YS; Wen, XF; Yang, ZY; Wu, YL; Lu, Y; Zhou, LF				Huang, Yan-Shan; Wen, Xiao-Fang; Yang, Zhi-Yu; Wu, Yi-Liang; Lu, You; Zhou, Lin-Fu			Development and Characterization of a Novel Fusion Protein of a Mutated Granulocyte Colony-Stimulating Factor and Human Serum Albumin in Pichia pastoris	PLOS ONE			English	Article							BINDING; GLYCOSYLATION; MUTAGENESIS; EXPRESSION; WARFARIN; CELLS	The purpose of the present work was to develop a novel, long-acting and potent human serum albumin/granulocyte colony stimulating factor (HSA/G-CSF) therapeutic fusion protein. The novel fusion protein, called HMG, was constructed by genetically fusing mutated human derived G-CSF (mG-CSF) to the C-terminal of HSA and then prepared in Pichia pastoris. The molecular mass of HMG was about 85 kDa and the isoelectric point was 5.3. Circular dichroism spectroscopy suggested that mG-CSF retained nearly all of its native secondary structure, regardless of fusion. The binding capabilities of mG-CSF moiety to G-CSF receptor and HSA moiety to warfarin showed very little change after fusing. The bioactivity of HMG (11.0 x 10(6) IU/mg) was more than twice that of rHSA/G-CSF (4.6 x 10(6) IU/mg). A mutation was made at the 718th amino acid of HMG, substituting Ala for Thr, to investigate the glycosylation of HMG expressed in P. pastoris. Data indicated that HMG was modified at Thr718, speculatively with the addition of a mannose chain. In conclusion, a novel HSA/G-CSF fusion protein was successfully constructed based on a mutated G-CSF. This protein showed more potent bioactivity than rHSA/G-CSF and thus may be a suitable long-acting G-CSF.	[Huang, Yan-Shan; Wen, Xiao-Fang; Zhou, Lin-Fu] Zhejiang Univ, Med Biotechnol Lab, Hangzhou 310003, Zhejiang, Peoples R China; [Yang, Zhi-Yu; Wu, Yi-Liang; Lu, You] Jiangsu T Mab Biopharmaceut Co Ltd, Taizhou, Jiangsu, Peoples R China	Zhejiang University	Zhou, LF (corresponding author), Zhejiang Univ, Med Biotechnol Lab, Hangzhou 310003, Zhejiang, Peoples R China.	239zlf@zju.edu.cn	Khan, Rizwan Hasan/F-8276-2014	Khan, Rizwan Hasan/0000-0002-9965-8982	National Natural Science Foundation of China [81273418]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (No. 81273418, http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amet N, 2009, PHARM RES-DORDR, V26, P523, DOI 10.1007/s11095-008-9767-0; Apte-Deshpande A, 2009, J BIOTECHNOL, V143, P44, DOI 10.1016/j.jbiotec.2009.06.002; Arai R, 2001, PROTEIN ENG, V14, P529, DOI 10.1093/protein/14.8.529; Bai Y, 2006, PHARM RES-DORDR, V23, P2116, DOI 10.1007/s11095-006-9059-5; Bhagavan NV, 2003, CLIN CHEM, V49, P581, DOI 10.1373/49.4.581; Bretthauer RK, 1999, BIOTECHNOL APPL BIOC, V30, P193; DUBOIS M, 1951, NATURE, V168, P167, DOI 10.1038/168167a0; Gemmill TR, 1999, BBA-GEN SUBJECTS, V1426, P227, DOI 10.1016/S0304-4165(98)00126-3; Gong B, 2014, J CHROMATOGR B, V945, P135, DOI 10.1016/j.jchromb.2013.11.031; Huang YS, 2010, EUR J PHARM BIOPHARM, V74, P435, DOI 10.1016/j.ejpb.2009.12.002; KUGA T, 1989, BIOCHEM BIOPH RES CO, V159, P103, DOI 10.1016/0006-291X(89)92410-8; Lam JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001009; MAES V, 1982, MOL PHARMACOL, V21, P100; OHEDA M, 1988, J BIOCHEM-TOKYO, V103, P544, DOI 10.1093/oxfordjournals.jbchem.a122305; Peters Jr. T., 1995, ALL ALBUMIN BIOCH GE; Petersen CE, 2002, PROTEINS, V47, P116, DOI 10.1002/prot.10068; Reinhard Fleer AF, 1997, FUSION POLYPEPTIDES	17	5	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115840	10.1371/journal.pone.0115840	http://dx.doi.org/10.1371/journal.pone.0115840			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25535738	Green Published, gold, Green Submitted			2022-12-27	WOS:000348563300077
J	Rao, HL; Addepalli, UK; Yadav, RK; Choudhari, NS; Senthil, S; Garudadri, CS				Rao, Harsha L.; Addepalli, Uday K.; Yadav, Ravi K.; Choudhari, Nikhil S.; Senthil, Sirisha; Garudadri, Chandra S.			Factors Affecting the Ability of the Spectral Domain Optical Coherence Tomograph to Detect Photographic Retinal Nerve Fiber Layer Defects	PLOS ONE			English	Article							DIAGNOSTIC-ACCURACY; PREPERIMETRIC GLAUCOMA; CIRRUS OCT; THICKNESS; STRATUS; ATROPHY; DISC; BIAS	Purpose: To evaluate the ability of normative database classification (color-coded maps) of spectral domain optical coherence tomograph (SDOCT) in detecting wedge shaped retinal nerve fiber layer (RNFL) defects identified on photographs and the factors affecting the ability of SDOCT in detecting these RNFL defects. Methods: In a cross-sectional study, 238 eyes (476 RNFL quadrants) of 172 normal subjects and 85 eyes (103 RNFL quadrants with wedge shaped RNFL defects) of 66 glaucoma patients underwent RNFL imaging with SDOCT. Logistic regression models were used to evaluate the factors associated with false positive and false negative RNFL classifications of the color-coded maps of SDOCT. Results: False positive classification at a p value of <5% was seen in 108 of 476 quadrants (22.8%). False negative classification at a p value of,5% was seen in 16 of 103 quadrants (15.5%). Of the 103 quadrants with RNFL defects, 64 showed a corresponding VF defect in the opposite hemisphere and 39 were preperimetric. Higher signal strength index (SSI) of the scan was less likely to have a false positive classification (odds ratio: 0.97, p=0.01). Presence of an associated visual field defect (odds ratio: 0.17, p=0.01) and inferior quadrant RNFL defects as compared to superior (odds ratio: 0.24, p=0.04) were less likely to show false negative classifications. Conclusions: Scans with lower signal strengths were more likely to show false positive RNFL classifications, and preperimetric and superior quadrant RNFL defects were more likely to show false negative classifications on color-coded maps of SDOCT.	[Rao, Harsha L.; Addepalli, Uday K.; Yadav, Ravi K.; Choudhari, Nikhil S.; Senthil, Sirisha; Garudadri, Chandra S.] LV Prasad Eye Inst, VST Glaucoma Ctr, Hyderabad, Andhra Pradesh, India	L. V. Prasad Eye Institute	Rao, HL (corresponding author), LV Prasad Eye Inst, VST Glaucoma Ctr, Banjara Hills, Hyderabad, Andhra Pradesh, India.	harshalaxmanarao@gmail.com	Choudhari, Nikhil/AAD-7157-2019	Rao, Harsha/0000-0001-5866-9856				Anderson DR, 1999, AUTOMATED STATIC PER, P152; GLYNN RJ, 1992, ARCH OPHTHALMOL-CHIC, V110, P381, DOI 10.1001/archopht.1992.01080150079033; HOYT WF, 1973, INVEST OPHTH VISUAL, V12, P814; Hwang YH, 2013, OPHTHALMOLOGY, V120, P1380, DOI 10.1016/j.ophtha.2012.12.048; Jeoung JW, 2010, INVEST OPHTH VIS SCI, V51, P938, DOI 10.1167/iovs.08-3335; Kang SH, 2010, INVEST OPHTH VIS SCI, V51, P4075, DOI 10.1167/iovs.09-4737; Kim NR, 2011, OPHTHALMOLOGY, V118, P1774, DOI 10.1016/j.ophtha.2011.01.058; Kim NR, 2010, ARCH OPHTHALMOL-CHIC, V128, P1121, DOI 10.1001/archophthalmol.2010.204; Kim SY, 2012, INVEST OPHTH VIS SCI, V53, P4475, DOI 10.1167/iovs.12-9682; Medeiros FA, 2007, INVEST OPHTH VIS SCI, V48, P214, DOI 10.1167/iovs.06-0618; Nukada M, 2014, J GLAUCOMA, V23, P150, DOI 10.1097/IJG.0b013e3182707456; Nukada M, 2011, OPHTHALMOLOGY, V118, P1038, DOI 10.1016/j.ophtha.2010.10.025; Oner V, 2013, BRIT J OPHTHALMOL, V97, P75, DOI 10.1136/bjophthalmol-2012-301865; Rao HL, 2014, EYE, V28, P654, DOI 10.1038/eye.2014.46; Rao HL, 2014, AM J OPHTHALMOL, V157, P719, DOI 10.1016/j.ajo.2013.12.012; Rao HL, 2013, INVEST OPHTH VIS SCI, V54, P7252, DOI 10.1167/iovs.13-12731; Rao HL, 2012, INVEST OPHTH VIS SCI, V53, P1058, DOI 10.1167/iovs.11-8463; Rao HL, 2011, INVEST OPHTH VIS SCI, V52, P1103, DOI 10.1167/iovs.10-5997; Savini G, 2013, J GLAUCOMA, V22, P384, DOI 10.1097/IJG.0b013e31824c9423; SOMMER A, 1991, ARCH OPHTHALMOL-CHIC, V109, P77, DOI 10.1001/archopht.1991.01080010079037; TUULONEN A, 1993, OPHTHALMOLOGY, V100, P587; Wu ZQ, 2009, J GLAUCOMA, V18, P213, DOI 10.1097/IJG.0b013e31817eee20	22	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e116115	10.1371/journal.pone.0116115	http://dx.doi.org/10.1371/journal.pone.0116115			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536188	Green Published, gold, Green Submitted			2022-12-27	WOS:000348563300100
J	Schmucker, C; Schell, LK; Portalupi, S; Oeller, P; Cabrera, L; Bassler, D; Schwarzer, G; Scherer, RW; Antes, G; von Elm, E; Meerpohl, JJ				Schmucker, Christine; Schell, Lisa K.; Portalupi, Susan; Oeller, Patrick; Cabrera, Laura; Bassler, Dirk; Schwarzer, Guido; Scherer, Roberta W.; Antes, Gerd; von Elm, Erik; Meerpohl, Joerg J.		OPEN Consortium	Extent of Non-Publication in Cohorts of Studies Approved by Research Ethics Committees or Included in Trial Registries	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; CROSS-SECTIONAL ANALYSIS; CLINICAL-TRIALS; FOLLOW-UP; RETROSPECTIVE COHORT; DELAYED PUBLICATION; RESEARCH PROTOCOLS; INCREASING VALUE; REDUCING WASTE; BIAS	Background: The synthesis of published research in systematic reviews is essential when providing evidence to inform clinical and health policy decision-making. However, the validity of systematic reviews is threatened if journal publications represent a biased selection of all studies that have been conducted (dissemination bias). To investigate the extent of dissemination bias we conducted a systematic review that determined the proportion of studies published as peer-reviewed journal articles and investigated factors associated with full publication in cohorts of studies (i) approved by research ethics committees (RECs) or (ii) included in trial registries. Methods and Findings: Four bibliographic databases were searched for methodological research projects (MRPs) without limitations for publication year, language or study location. The searches were supplemented by handsearching the references of included MRPs. We estimated the proportion of studies published using prediction intervals (PI) and a random effects meta-analysis. Pooled odds ratios (OR) were used to express associations between study characteristics and journal publication. Seventeen MRPs (23 publications) evaluated cohorts of studies approved by RECs; the proportion of published studies had a PI between 22% and 72% and the weighted pooled proportion when combining estimates would be 46.2% (95% CI 40.2%-52.4%, I-2=94.4%). Twenty-two MRPs (22 publications) evaluated cohorts of studies included in trial registries; the PI of the proportion published ranged from 13% to 90% and the weighted pooled proportion would be 54.2% (95% CI 42.0%-65.9%, I-2=98.9%). REC-approved studies with statistically significant results (compared with those without statistically significant results) were more likely to be published (pooled OR 2.8; 95% CI 2.2-3.5). Phase-III trials were also more likely to be published than phase II trials (pooled OR 2.0; 95% CI 1.6-2.5). The probability of publication within two years after study completion ranged from 7% to 30%. Conclusions: A substantial part of the studies approved by RECs or included in trial registries remains unpublished. Due to the large heterogeneity a prediction of the publication probability for a future study is very uncertain. Non-publication of research is not a random process, e. g., it is associated with the direction of study findings. Our findings suggest that the dissemination of research findings is biased.	[Schmucker, Christine; Schell, Lisa K.; Portalupi, Susan; Oeller, Patrick; Cabrera, Laura; Antes, Gerd; Meerpohl, Joerg J.] Univ Freiburg, Med Ctr, German Cochrane Ctr, D-79110 Freiburg, Germany; [Schwarzer, Guido] Univ Freiburg, Med Ctr, Inst Med Biometry & Stat, D-79110 Freiburg, Germany; [Bassler, Dirk] Univ Zurich Hosp, Dept Neonatol, CH-8091 Zurich, Switzerland; [von Elm, Erik] Univ Lausanne Hosp, Inst Social & Prevent Med IUMSP, Cochrane Switzerland, CH-1010 Lausanne, Switzerland; [Scherer, Roberta W.] Johns Hopkins Bloomberg Sch Publ Hlth, US Cochrane Ctr, Baltimore, MD USA	University of Freiburg; University of Freiburg; University of Zurich; University Zurich Hospital; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Meerpohl, JJ (corresponding author), Univ Freiburg, Med Ctr, German Cochrane Ctr, Berliner Allee 29, D-79110 Freiburg, Germany.	meerpohl@cochrane.de	Gallus, Silvano/AAB-4127-2019; Trinquart, Ludovic/H-4961-2019; Schwarzer, Guido/A-8168-2009; Garattini, Silvio/AAA-6390-2020; Meerpohl, Joerg J/J-4224-2013; Malički, Mario/E-8621-2016	Gallus, Silvano/0000-0002-8967-0400; Trinquart, Ludovic/0000-0002-3028-4900; Schwarzer, Guido/0000-0001-6214-9087; Garattini, Silvio/0000-0003-0647-9297; Meerpohl, Joerg J/0000-0002-1333-5403; Malički, Mario/0000-0003-0698-1930; Boutron, Isabelle/0000-0002-5263-6241; Bonfill Cosp, Xavier/0000-0003-1530-3509; Bertele', Vittorio/0000-0002-0032-7033; Strech, Daniel/0000-0002-9153-079X; von Elm, Erik/0000-0002-7412-0406; Wager, Elizabeth/0000-0002-4202-7813; Bassler, Dirk/0000-0003-2358-4419; Schmucker, Christine/0000-0002-1188-3158; La Vecchia, Carlo/0000-0003-1441-897X; Reis, Andreas/0000-0002-8218-2615	European Union Seventh Framework Programme (FP7) [285453]	European Union Seventh Framework Programme (FP7)	The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no 285453. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blumle A, 2008, J MED ETHICS, V34, DOI 10.1136/jme.2008.024521; Blumle A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087184; Blumle A, 2011, COCHRANE DATABASE S, P126; Bourgeois FT, 2010, ANN INTERN MED, V153, P158, DOI 10.7326/0003-4819-153-3-201008030-00006; Briel M, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-23; Chahal J, 2012, AM J SPORT MED, V40, P1970, DOI 10.1177/0363546512448363; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Cooper H, 1997, PSYCHOL METHODS, V2, P447, DOI 10.1037/1082-989X.2.4.447; de Jong JP, 2010, J CLIN EPIDEMIOL, V63, P1342, DOI 10.1016/j.jclinepi.2010.01.018; Decullier E, 2005, BMJ-BRIT MED J, V331, P19, DOI 10.1136/bmj.38488.385995.8F; Decullier E, 2007, J EPIDEMIOL COMMUN H, V61, P190, DOI 10.1136/jech.2006.048603; DICKERSIN K, 1992, JAMA-J AM MED ASSOC, V267, P374, DOI 10.1001/jama.267.3.374; DICKERSIN K, 1990, JAMA-J AM MED ASSOC, V263, P1385, DOI 10.1001/jama.263.10.1385; Dickersin K, 1990, CONTROLLED CLIN TRIA, V11, P255; Dwan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066844; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; EASTERBROOK PJ, 1992, J ROY SOC MED, V85, P71; Eyding D, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4737; Gandhi R, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-278; Gopal RK, 2012, CONTEMP CLIN TRIALS, V33, P486, DOI 10.1016/j.cct.2012.02.001; Guo SW, 2013, OBSTET GYNECOL, V121, P1281, DOI 10.1097/AOG.0b013e318291f299; Hall R, 2007, CAN J ANAESTH, V54, P380, DOI 10.1007/BF03022661; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2009, J R STAT SOC A STAT, V172, P137, DOI 10.1111/j.1467-985X.2008.00552.x; Hopewell S., 2009, COCHRANE DATABASE SY, V21; Hurley MN, 2012, J CYST FIBROS, V11, P14, DOI 10.1016/j.jcf.2011.08.004; Huser Vojtech, 2012, AMIA Annu Symp Proc, V2012, P400; Huser V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068409; Ioannidis JPA, 2014, LANCET, V383, P166, DOI 10.1016/S0140-6736(13)62227-8; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Ioannidis JPA, 1998, JAMA-J AM MED ASSOC, V279, P281, DOI 10.1001/jama.279.4.281; Jones CW, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6104; Khan NA, 2012, ARTHRITIS RHEUM-US, V64, P2059, DOI 10.1002/art.34393; Liu XM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012676; Menzel S, 2007, DEUT MED WOCHENSCHR, V132, P2313, DOI 10.1055/s-2007-991648; Muller KF, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-34; Olofsson B O, 2000, Lakartidningen, V97, P1974; Rodriguez SP, 2009, ARCH ARGENT PEDIATR, V107, P504, DOI 10.1590/S0325-00752009000600006; Pich J, 2003, LANCET, V361, P1015, DOI 10.1016/S0140-6736(03)12799-7; Portalupi S, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-2; Prenner JL, 2011, RETINA-J RET VIT DIS, V31, P401, DOI 10.1097/IAE.0b013e3181eef2ad; Ramsey S, 2008, ONCOLOGIST, V13, P925, DOI 10.1634/theoncologist.2008-0133; Ross JS, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7292; Ross JS, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000144; Salman RA, 2014, LANCET, V383, P176, DOI 10.1016/S0140-6736(13)62297-7; Scherer RW, 2007, COCHRANE DB SYST REV, V18; Schmucker C, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-24; Shamliyan T, 2012, PEDIATRICS, V129, pE1291, DOI 10.1542/peds.2010-2847; Shamliyan TA, 2012, NEUROUROL URODYNAM, V31, P22, DOI 10.1002/nau.21220; SIMES RJ, 1986, J CLIN ONCOL, V4, P1529, DOI 10.1200/JCO.1986.4.10.1529; Smith HN, 2012, J ARTHROPLASTY, V27, P1283, DOI 10.1016/j.arth.2011.11.005; Song FJ, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-79; Stern JM, 1997, BMJ-BRIT MED J, V315, P640, DOI 10.1136/bmj.315.7109.640; Sune P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054583; Sune-Martin P, 2003, LANCET, V361, P2245, DOI 10.1016/S0140-6736(03)13751-8; Tfelt-Hansen PC, 2011, J HEADACHE PAIN, V12, P399, DOI 10.1007/s10194-011-0327-3; Thorn JC, 2013, PHARMACOECONOMICS, V31, P77, DOI 10.1007/s40273-012-0004-7; Turer AT, 2007, AM HEART J, V153, P674, DOI 10.1016/j.ahj.2007.01.005; Vawdrey DK, 2013, J BIOMED INFORM, V46, P139, DOI 10.1016/j.jbi.2012.08.007; von Elm E, 2008, SWISS MED WKLY, V138, P197, DOI 2008/13/smw-12027; Wildt S, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000309; Wise P, 1996, BRIT MED J, V313, P1245, DOI 10.1136/bmj.313.7067.1245	62	131	132	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e114023	10.1371/journal.pone.0114023	http://dx.doi.org/10.1371/journal.pone.0114023			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ9UY	25536072	Green Published, Green Accepted, gold			2022-12-27	WOS:000348563300010
J	Baral, S; Ketende, S; Green, JL; Chen, PA; Grosso, A; Sithole, B; Ntshangase, C; Yam, E; Kerrigan, D; Kennedy, CE; Adams, D				Baral, Stefan; Ketende, Sosthenes; Green, Jessie L.; Chen, Ping-An; Grosso, Ashley; Sithole, Bhekie; Ntshangase, Cebisile; Yam, Eileen; Kerrigan, Deanna; Kennedy, Caitlin E.; Adams, Darrin			Reconceptualizing the HIV Epidemiology and Prevention Needs of Female Sex Workers (FSW) in Swaziland	PLOS ONE			English	Article							TRANSMISSION; RISK; CARE; AFRICA	Background: HIV is hyperendemic in Swaziland with a prevalence of over 25% among those between the ages of 15 and 49 years old. The HIV response in Swaziland has traditionally focused on decreasing HIV acquisition and transmission risks in the general population through interventions such as male circumcision, increasing treatment uptake and adherence, and risk-reduction counseling. There is emerging data from Southern Africa that key populations such as female sex workers ( FSW) carry a disproportionate burden of HIV even in generalized epidemics such as Swaziland. The burden of HIV and prevention needs among FSW remains unstudied in Swaziland. Methods: A respondent-driven-sampling survey was completed between August-October, 2011 of 328 FSW in Swaziland. Each participant completed a structured survey instrument and biological HIV and syphilis testing according to Swazi Guidelines. Results: Unadjusted HIV prevalence was 70.3% (n = 223/317) among a sample of women predominantly from Swaziland (95.2%, n = 300/316) with a mean age of 21(median 25) which was significantly higher than the general population of women. Approximately one-half of the FSW(53.4%, n = 167/313) had received HIV prevention information related to sex work in the previous year, and about one-in-ten had been part of a previous research project(n = 38/313). Rape was common with nearly 40% (n = 123/314) reporting at least one rape; 17.4% (n = 23/314) reported being raped 6 or more times. Reporting blackmail (34.8%, n = 113/314) and torture(53.2%, n = 173/314) was prevalent. Conclusions: While Swaziland has a highly generalized HIV epidemic, reconceptualizing the needs of key populations such as FSW suggests that these women represent a distinct population with specific vulnerabilities and a high burden of HIV compared to other women. These women are understudied and underserved resulting in a limited characterization of their HIV prevention, treatment, and care needs and only sparse specific and competent programming. FSW are an important population for further investigation and rapid scale-up of combination HIV prevention including biomedical, behavioral, and structural interventions.	[Baral, Stefan; Ketende, Sosthenes; Chen, Ping-An; Grosso, Ashley] Johns Hopkins Sch Publ Hlth, Ctr Publ Hlth & Human Rights, Dept Epidemiol, Key Populat Program, Baltimore, MD 21205 USA; [Green, Jessie L.] Populat Serv Int, Mbanane, Swaziland; [Sithole, Bhekie] Rock Of Hope, Mbabane, Swaziland; [Ntshangase, Cebisile] Minist Hlth, Strateg Informat Div, Swaziland Natl AIDS Program, Mbabane, Swaziland; [Yam, Eileen] Johns Hopkins Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD USA; [Kennedy, Caitlin E.; Adams, Darrin] Johns Hopkins Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Kerrigan, Deanna] Johns Hopkins Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Baral, S (corresponding author), Johns Hopkins Sch Publ Hlth, Ctr Publ Hlth & Human Rights, Dept Epidemiol, Key Populat Program, Baltimore, MD 21205 USA.	sbaral@jhu.edu	Grosso, Ashley/AAH-9924-2020; Baral, Stefan/AAG-4818-2020	Baral, Stefan/0000-0002-5482-2419; Grosso, Ashley/0000-0001-5759-7125	U.S. Agency for International Development [GHH-I-00-07-00032-00]; President's Emergency Plan for AIDS Relief	U.S. Agency for International Development(United States Agency for International Development (USAID)); President's Emergency Plan for AIDS Relief(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The USAID vertical bar Project SEARCH, Task Order No. 2, is funded by the U.S. Agency for International Development under Contract No. GHH-I-00-07-00032-00, beginning September 30, 2008, and supported by the President's Emergency Plan for AIDS Relief. The Research to Prevention (R2P) Project is led by the Johns Hopkins Center for Global Health and managed by the Johns Hopkins Bloomberg School of Public Health Center for Communication Programs (CCP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anglemyer A, 2013, COCHRANE DB SYST REV, V4; Arnott J, 2009, RIGHTS RESCURE REPOR; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; Baggaley RF, 2010, CURR OPIN HIV AIDS, V5, P269, DOI 10.1097/COH.0b013e32833a51b2; Baggaley RF, 2008, INT J EPIDEMIOL, V37, P1255, DOI 10.1093/ije/dyn151; Baral S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-482; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Beyrer C, 2011, JAIDS-J ACQ IMM DEF, V57, pS96, DOI 10.1097/QAI.0b013e31821db944; Bicego GT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077101; Chersich MF, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.17980; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Heckathorn DD, 2002, AIDS BEHAV, V6, P55; Johnston L, 2010, AIDS BEHAV, V14, P922, DOI 10.1007/s10461-008-9362-8; Kerrigan D, 2013, DIR DEV, P1, DOI 10.1596/978-0-8213-9774-9; Macro International Inc. Swaziland Central Statistical Office, 2008, SWAZ DEM HLTH SURV 2; McCreesh N, 2012, EPIDEMIOLOGY, V23, P138, DOI 10.1097/EDE.0b013e31823ac17c; Mtetwa S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-698; Ngugi EN, 2012, SAHARA J-J SOC ASP H, V9, P148, DOI 10.1080/17290376.2012.743825; Reed JB, 2012, ESTIMATING NATL HIV; Salganik MJ, 2012, EPIDEMIOLOGY, V23, P148, DOI 10.1097/EDE.0b013e31823b6979; Schonlau M, 2012, STATA J, V12, P72, DOI 10.1177/1536867X1201200106; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; Scorgie F, 2013, CULT HEALTH SEX, V15, P450, DOI 10.1080/13691058.2012.763187; Semugoma P, 2012, SAHARA J-J SOC ASP H, V9, P173, DOI 10.1080/17290376.2012.744177; SHIMS, 2012, SWAZ HIV INC MEAS SU; StataCorp, 2010, STAT STAT SOFTW REL; Swaziland National Emergency Response Council on HIV/AIDS, 2009, SWAZ HIV PREV RESP M; Tanser F, 2014, CURR OPIN HIV AIDS, V9, P115, DOI 10.1097/COH.0000000000000034; UNAIDS, 2012, REP GLOB AIDS EP; UNAIDS NERCHA Swaziland Ministry of Health UNICEF, 2010, MON DECL COMM HIV AI; UNFPA UNAIDS Swaziland Ministry of Health and Social Welfare Swaziland National Emergency Response Council on HIV/AIDS, 2007, SIT AN COMM SEX WORK; Weiser SD, 2007, PLOS MED, V4, P1589, DOI 10.1371/journal.pmed.0040260; Wright J, 2010, J PUBLIC HEALTH-UK, V32, P277, DOI 10.1093/pubmed/fdp129; Yam EA, 2013, SEX TRANSM DIS, V40, P406, DOI 10.1097/OLQ.0b013e318283c16d	34	19	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115465	10.1371/journal.pone.0115465	http://dx.doi.org/10.1371/journal.pone.0115465			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA3ZY	25531771	Green Submitted, Green Published, gold			2022-12-27	WOS:000348845100072
J	Cai, B; Allexandre, D; Rajagopalan, V; Jiang, ZG; Siemionow, V; Ranganathan, VK; Davis, MP; Walsh, D; Dai, KR; Yue, GH				Cai, Bin; Allexandre, Didier; Rajagopalan, Venkateswaran; Jiang, Zhiguo; Siemionow, Vlodek; Ranganathan, Vinoth K.; Davis, Mellar P.; Walsh, Declan; Dai, Kerong; Yue, Guang H.			Evidence of Significant Central Fatigue in Patients with Cancer-Related Fatigue during Repetitive Elbow Flexions till Perceived Exhaustion	PLOS ONE			English	Article							QUALITY-OF-LIFE; LOCALIZED PROSTATE-CANCER; HUMAN MUSCLE FATIGUE; BREAST-CANCER; RADIATION-THERAPY; RADIOTHERAPY; CONTRACTIONS; SURVIVORS; MECHANISMS; EXERCISE	Objective: To investigate whether fatigue induced by an intermittent motor task in patients with cancer-related fatigue (CRF) is more central or peripheral. Methods: Ten patients with CRF who were off chemo and radiation therapies and 14 age-matched healthy controls were enrolled. Participants completed a Brief Fatigue Inventory (BFI) and performed a fatigue task consisting of intermittent elbow-flexion contractions at submaximal (40% maximal voluntary contraction) intensity till self-perceived exhaustion. Twitch force was elicited by an electrical stimulation applied to the biceps brachii muscle. The relative degree of peripheral (muscle) vs. central contribution to fatigue induced by the intermittent motor task (IMT) was assessed using twitch force ratio (TFratio) defined as post IMT twitch force to pre IMT twitch force. The total number of trials (intermittent contractions) and total duration of all trials performed by each subject were also quantified. Results: BFI scores were higher (p<0.001) in CRF than controls, indicating greater feeling of fatigue in CRF patients than controls. A significantly smaller number of trials and shorter total duration of the trials (p<0.05) were observed in CRF than control participants. The TFratio (0.81 +/- 0.05) in CRF was higher (p<0.05) compared with that of controls (0.62 +/- 0.05), suggesting CRF patients experienced a significantly lower degree of muscle (peripheral) fatigue at the time of perceived exhaustion. Conclusion: Consistent with prior findings for fatigue under submaximal sustained contraction, our results indicate that motor fatigue in CRF is more of central than peripheral origin during IMT. Significant central fatigue in CRF patients limits their ability to prolong motor performance.	[Cai, Bin] Shanghai Jiao Tong Univ, Peoples Hosp 9, Sch Med, Dept Rehabil Med, Shanghai 200011, Peoples R China; [Cai, Bin] Shanghai Jiao Tong Univ, Inst Rehabil Engn, Shanghai 200030, Peoples R China; [Allexandre, Didier; Rajagopalan, Venkateswaran; Jiang, Zhiguo; Yue, Guang H.] Kessler Fdn Res Ctr, Human Performance & Engn Lab, W Orange, NJ 07052 USA; [Siemionow, Vlodek; Yue, Guang H.] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44195 USA; [Ranganathan, Vinoth K.; Yue, Guang H.] Cleveland Clin, Dept Phys Med & Rehabil, Cleveland, OH 44195 USA; [Davis, Mellar P.; Walsh, Declan] Cleveland Clin, Harry R Horvitz Ctr Palliat Med, Taussig Canc Inst, Cleveland, OH 44195 USA; [Dai, Kerong] Shanghai Jiao Tong Univ, Peoples Hosp 9, Sch Med, Dept Orthopaed, Shanghai 200011, Peoples R China; [Dai, Kerong] Engn Res Ctr Digital Med & Clin Translat, Minist Educ, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Kessler Institute for Rehabilitation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Shanghai Jiao Tong University	Dai, KR (corresponding author), Shanghai Jiao Tong Univ, Peoples Hosp 9, Sch Med, Dept Orthopaed, 639 Zhizaoju Rd, Shanghai 200011, Peoples R China.	krdai@163.com; GYue@kesslerfoundation.org	R, Venkateswaran/GOV-7176-2022	R, Venkateswaran/0000-0001-9040-0785; Walsh, (Thomas) Declan/0000-0002-9310-1729; Allexandre, Didier/0000-0002-0178-0956	National Institutes of Health (NIH) [R21CA165943]; NATIONAL CANCER INSTITUTE [R01CA189665, R21CA165943] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by a National Institutes of Health (NIH) grant (R21CA165943). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt CA, 2011, MUSCLE NERVE, V43, P415, DOI 10.1002/mus.21913; ANDREWS PLR, 2004, FATIGUE CANC, P51; Benwell NM, 2006, EXP BRAIN RES, V175, P626, DOI 10.1007/s00221-006-0579-3; BIGLANDRITCHIE B, 1984, MUSCLE NERVE, V7, P691, DOI 10.1002/mus.880070902; Bower JE, 2005, PSYCHOSOM MED, V67, P277, DOI 10.1097/01.psy.0000155666.55034.c6; Bower JE, 2002, PSYCHOSOM MED, V64, P604, DOI 10.1097/00006842-200207000-00010; BRUERA E, 1988, J NATL CANCER I, V80, P282, DOI 10.1093/jnci/80.4.282; Cella D, 2001, J CLIN ONCOL, V19, P3385, DOI 10.1200/JCO.2001.19.14.3385; Chaudhuri A, 2004, LANCET, V363, P978, DOI 10.1016/S0140-6736(04)15794-2; Curt G A, 2000, Oncologist, V5, P353, DOI 10.1634/theoncologist.5-5-353; Di Lazzaro V, 2003, EXP BRAIN RES, V149, P535, DOI 10.1007/s00221-003-1408-6; Enoka RM, 2008, J PHYSIOL-LONDON, V586, P11, DOI 10.1113/jphysiol.2007.139477; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Janda M, 2000, CANCER-AM CANCER SOC, V89, P1322, DOI 10.1002/1097-0142(20000915)89:6<1322::AID-CNCR18>3.0.CO;2-D; Kisiel-Sajewicz K, 2012, J PAIN SYMPTOM MANAG, V44, P351, DOI 10.1016/j.jpainsymman.2011.08.007; Liu JZ, 2003, J NEUROPHYSIOL, V90, P300, DOI 10.1152/jn.00821.2002; Lou JS, 2012, PHYS MED REH CLIN N, V23, P11, DOI 10.1016/j.pmr.2011.11.003; Mendoza TR, 1999, CANCER-AM CANCER SOC, V85, P1186, DOI 10.1002/(SICI)1097-0142(19990301)85:5<1186::AID-CNCR24>3.0.CO;2-N; Mock V, 2000, ONCOLOGY-NY, V14, P151; Mock Victoria, 2004, J Natl Cancer Inst Monogr, P112; Monga U, 2005, J REHABIL RES DEV, V42, P391, DOI 10.1682/JRRD.2004.06.0071; Monga U, 1997, ARCH PHYS MED REHAB, V78, P961, DOI 10.1016/S0003-9993(97)90058-7; Monga U, 1999, RADIAT ONCOL INVESTI, V7, P178, DOI 10.1002/(SICI)1520-6823(1999)7:3<178::AID-ROI7>3.0.CO;2-0; Monga U, 2007, ARCH PHYS MED REHAB, V88, P1416, DOI 10.1016/j.apmr.2007.08.110; Morrow GR, 2005, CANCER INVEST, V23, P229, DOI 10.1081/CNV-200055960; Morrow GR, 2002, SUPPORT CARE CANCER, V10, P389, DOI 10.1007/s005200100293; PIPER BF, 1993, SUPPORT CARE CANCER, V1, P285, DOI 10.1007/BF00364963; Ranieri F, 2012, NEUROMUSCULAR DISORD, V22, pS157, DOI 10.1016/j.nmd.2012.10.006; Rosler KM, 2009, EXP BRAIN RES, V197, P111, DOI 10.1007/s00221-009-1897-z; Ryan JL, 2007, ONCOLOGIST, V12, P22, DOI 10.1634/theoncologist.12-S1-22; Sogaard K, 2006, J PHYSIOL-LONDON, V573, P511, DOI 10.1113/jphysiol.2005.103598; Taylor JL, 2008, J APPL PHYSIOL, V104, P542, DOI 10.1152/japplphysiol.01053.2007; Vogelzang NJ, 1997, SEMIN HEMATOL, V34, P4; Vollestad NK, 1997, J NEUROSCI METH, V74, P219, DOI 10.1016/S0165-0270(97)02251-6; Wang XS, 2008, CLIN J ONCOL NURS, V12, P11, DOI 10.1188/08.CJON.S2.11-20; Yavuzsen T, 2009, J PAIN SYMPTOM MANAG, V38, P587, DOI 10.1016/j.jpainsymman.2008.12.003	36	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115370	10.1371/journal.pone.0115370	http://dx.doi.org/10.1371/journal.pone.0115370			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25532032	Green Published, gold, Green Submitted			2022-12-27	WOS:000348845100054
J	Langjahr, P; Diaz-Jimenez, D; De la Fuente, M; Rubio, E; Golenbock, D; Bronfman, FC; Quera, R; Gonzalez, MJ; Hermoso, MA				Langjahr, Patricia; Diaz-Jimenez, David; De la Fuente, Marjorie; Rubio, Estefhany; Golenbock, Douglas; Bronfman, Francisca C.; Quera, Rodrigo; Gonzalez, Maria-Julieta; Hermoso, Marcela A.			Metalloproteinase-Dependent TLR2 Ectodomain Shedding is Involved in Soluble Toll-Like Receptor 2 (sTLR2) Production	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTORS; NEGATIVE REGULATION; MATRIX METALLOPROTEINASES; MONOCYTES; INHIBITOR; ADAM10; MACROPHAGES; EXPRESSION; PROTEIN; ALPHA	Toll-like receptor (TLR) 2, a type I membrane receptor that plays a key role in innate immunity, recognizes conserved molecules in pathogens, and triggering an inflammatory response. It has been associated with inflammatory and autoimmune diseases. Soluble TLR2 (sTLR2) variants have been identified in human body fluids, and the TLR2 ectodomain can negatively regulate TLR2 activation by behaving as a decoy receptor. sTLR2 generation does not involve alternative splicing mechanisms, indicating that this process might involve a post-translational modification of the full-length receptor; however, the specific mechanism has not been studied. Using CD14(+) peripheral human monocytes and the THP-1 monocytic leukemia-derived cell line, we confirm that sTLR2 generation increases upon treatment with pro-inflammatory agents and requires a post-translational mechanism. We also find that the constitutive and ligand-induced release of sTLR2 is sensitive to pharmacological metalloproteinase activator and inhibitors leading us to conclude that metalloproteinase TLR2 shedding contributes to soluble receptor production. By expressing human TLR2 in ADAM10- or ADAM17-deficient MEF cells, we find both enzymes to be implicated in TLR2 ectodomain shedding. Moreover, using a deletion mutant of the TLR2 juxtamembrane region, we demonstrate that this domain is required for sTLR2 generation. Functional analysis suggests that sTLR2 generated by metalloproteinase activation inhibits TLR2-induced cytokine production by this monocytic leukemia-derived cell line. The identification of the mechanisms involved in regulating the availability of soluble TLR2 ectodomain and cell surface receptors may contribute further research on TLR2-mediated processes in innate immunity and inflammatory disorders.	[Langjahr, Patricia; Diaz-Jimenez, David; De la Fuente, Marjorie; Rubio, Estefhany; Hermoso, Marcela A.] Univ Chile, Fac Med, Inst Biomed Sci, Disciplinary Program Immunol, Santiago, Chile; [Golenbock, Douglas] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA; [Bronfman, Francisca C.] Pontificia Univ Catolica Chile, Fac Biol Sci, Millennium Nucleus Regenerat Biol MINREB, Dept Physiol, Santiago, Chile; [Quera, Rodrigo] Clin Las Condes, Gastroenterol Unit, Santiago, Chile; [Gonzalez, Maria-Julieta] Univ Chile, Fac Med, Inst Biomed Sci, Cell & Mol Biol Program, Santiago, Chile	Universidad de Chile; University of Massachusetts System; University of Massachusetts Worcester; Pontificia Universidad Catolica de Chile; Clinica Las Condes; Universidad de Chile	Hermoso, MA (corresponding author), Univ Chile, Fac Med, Inst Biomed Sci, Disciplinary Program Immunol, Santiago, Chile.	mhermoso@med.uchile.cl	Hermoso, Marcela/L-1500-2014; Hermoso, Marcela A./AAF-6893-2021; Langjahr, Patricia/AEX-7806-2022	Hermoso, Marcela A./0000-0002-7936-7571; Langjahr, Patricia/0000-0001-9793-3373; Quera, Rodrigo/0000-0001-5854-0526	Fondo Nacional de Ciencia y Tecnologia (National Fund for Science and Technology; FONDECYT) [1080290, 1120577]	Fondo Nacional de Ciencia y Tecnologia (National Fund for Science and Technology; FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	The sources of funding that have supported the work are Fondo Nacional de Ciencia y Tecnologia (National Fund for Science and Technology; FONDECYT) grants 1080290 and 1120577 (MAH) (www.fondecyt.cl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliprantis AO, 2000, EMBO J, V19, P3325, DOI 10.1093/emboj/19.13.3325; Arancibia S, 2011, J CELL MOL MED, V15, P339, DOI 10.1111/j.1582-4934.2009.00958.x; Bell JH, 2007, J LEUKOCYTE BIOL, V82, P173, DOI 10.1189/jlb.0307193; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Burns K, 2003, J EXP MED, V197, P263, DOI 10.1084/jem.20021790; Candia E, 2012, IMMUNOBIOLOGY; Cauwe B, 2007, CRIT REV BIOCHEM MOL, V42, P113, DOI 10.1080/10409230701340019; Chockalingam A, 2011, EUR J IMMUNOL, V41, P2176, DOI 10.1002/eji.201041034; Coll RC, 2010, J INNATE IMMUN, V2, P406, DOI 10.1159/000315469; COLOTTA F, 1994, IMMUNOL TODAY, V15, P562, DOI 10.1016/0167-5699(94)90217-8; CROWE PD, 1995, J EXP MED, V181, P1205, DOI 10.1084/jem.181.3.1205; Deuss M, 2008, CURR ALZHEIMER RES, V5, P187, DOI 10.2174/156720508783954686; Dulay AT, 2009, J IMMUNOL, V182, P7244, DOI 10.4049/jimmunol.0803517; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Fields J, 2011, J NEUROCHEM, V118, P93, DOI 10.1111/j.1471-4159.2011.07203.x; Garbers C, 2011, J BIOL CHEM, V286, P14804, DOI 10.1074/jbc.M111.229393; Gebbia JA, 2004, J INFECT DIS, V189, P113, DOI 10.1086/380414; Gibb DR, 2011, MOL IMMUNOL, V48, P1319, DOI 10.1016/j.molimm.2010.12.005; Gomez-Pina V, 2007, J IMMUNOL, V179, P4065, DOI 10.4049/jimmunol.179.6.4065; Haehnel V, 2002, J IMMUNOL, V168, P5629, DOI 10.4049/jimmunol.168.11.5629; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Heggelund L, 2004, AIDS, V18, P2437; Hundhausen C, 2007, J IMMUNOL, V178, P8064, DOI 10.4049/jimmunol.178.12.8064; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Iwami K, 2000, J IMMUNOL, V165, P6682, DOI 10.4049/jimmunol.165.12.6682; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kuroishi T, 2007, MOL IMMUNOL, V44, P1969, DOI 10.1016/j.molimm.2006.09.028; Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200; LeBouder E, 2003, J IMMUNOL, V171, P6680, DOI 10.4049/jimmunol.171.12.6680; Lee CC, 2012, NAT REV IMMUNOL, V12, P168, DOI 10.1038/nri3151; Levine SJ, 2004, J IMMUNOL, V173, P5343, DOI 10.4049/jimmunol.173.9.5343; Li CH, 2006, J LEUKOCYTE BIOL, V79, P867, DOI 10.1189/jlb.0905505; Li Yongming, 2010, BMC Res Notes, V3, P309, DOI 10.1186/1756-0500-3-309; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Lim EK, 2013, J BIOL CHEM, V288, P21126, DOI 10.1074/jbc.M113.453514; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; MANN JS, 1993, BIOL REPROD, V48, P1006, DOI 10.1095/biolreprod48.5.1006; MOHLER KM, 1994, NATURE, V370, P218, DOI 10.1038/370218a0; Murphy G, 2008, TRENDS IMMUNOL, V29, P75, DOI 10.1016/j.it.2007.10.009; Palsson-McDermott EM, 2007, IRISH J MED SCI, V176, P253, DOI 10.1007/s11845-007-0103-1; Raby AC, 2009, J IMMUNOL, V183, P506, DOI 10.4049/jimmunol.0802909; Roomi MW, 2014, INT J ONCOL, V44, P27, DOI 10.3892/ijo.2013.2159; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tsukada H, 2005, INT J MOL MED, V15, P519; Ueland T, 2006, J CARD FAIL, V12, P659, DOI 10.1016/j.cardfail.2006.07.002; ULISSE S, 1994, ENDOCRINOLOGY, V135, P2479, DOI 10.1210/en.135.6.2479; Waldhauer I, 2008, CANCER RES, V68, P6368, DOI 10.1158/0008-5472.CAN-07-6768; Weber ANR, 2004, J BIOL CHEM, V279, P34589, DOI 10.1074/jbc.M403830200; Weskamp G, 2006, NAT IMMUNOL, V7, P1293, DOI 10.1038/ni1399; Yang RB, 1999, J IMMUNOL, V163, P639; Yun MR, 2014, CELL SIGNAL, V26, P705, DOI 10.1016/j.cellsig.2013.12.010; Zhang GL, 2002, J BIOL CHEM, V277, P7059, DOI 10.1074/jbc.M109537200	54	26	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e104624	10.1371/journal.pone.0104624	http://dx.doi.org/10.1371/journal.pone.0104624			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531754	Green Submitted, Green Published, gold			2022-12-27	WOS:000348845100001
J	Raschle, NM; Smith, SA; Zuk, J; Dauvermann, MR; Figuccio, MJ; Gaab, N				Raschle, Nora Maria; Smith, Sara Ashley; Zuk, Jennifer; Dauvermann, Maria Regina; Figuccio, Michael Joseph; Gaab, Nadine			Investigating the Neural Correlates of Voice versus Speech-Sound Directed Information in Pre-School Children	PLOS ONE			English	Article							SUPERIOR TEMPORAL SULCUS; SCANNER BACKGROUND-NOISE; CORTICAL REPRESENTATION; FUNCTIONAL-ANATOMY; BRAIN ACTIVATION; RIGHT-HEMISPHERE; AUDITORY-CORTEX; PERCEPTION; FMRI; IDENTIFICATION	Studies in sleeping newborns and infants propose that the superior temporal sulcus is involved in speech processing soon after birth. Speech processing also implicitly requires the analysis of the human voice, which conveys both linguistic and extra-linguistic information. However, due to technical and practical challenges when neuroimaging young children, evidence of neural correlates of speech and/ or voice processing in toddlers and young children remains scarce. In the current study, we used functional magnetic resonance imaging (fMRI) in 20 typically developing preschool children (average age = 5.8 y; range 5.2-6.8 y) to investigate brain activation during judgments about vocal identity versus the initial speech sound of spoken object words. FMRI results reveal common brain regions responsible for voice-specific and speech-sound specific processing of spoken object words including bilateral primary and secondary language areas of the brain. Contrasting voice-specific with speech-sound specific processing predominantly activates the anterior part of the right-hemispheric superior temporal sulcus. Furthermore, the right STS is functionally correlated with left-hemispheric temporal and right hemispheric prefrontal regions. This finding underlines the importance of the right superior temporal sulcus as a temporal voice area and indicates that this brain region is specialized, and functions similarly to adults by the age of five. We thus extend previous knowledge of voice-specific regions and their functional connections to the young brain which may further our understanding of the neuronal mechanism of speech-specific processing in children with developmental disorders, such as autism or specific language impairments.	[Raschle, Nora Maria; Smith, Sara Ashley; Zuk, Jennifer; Dauvermann, Maria Regina; Figuccio, Michael Joseph; Gaab, Nadine] Boston Childrens Hosp, Dept Dev Med, Div Dev Med, Labs Cognit Neurosci, Boston, MA 02115 USA; [Raschle, Nora Maria; Zuk, Jennifer; Dauvermann, Maria Regina; Gaab, Nadine] Harvard Univ, Sch Med, Boston, MA USA; [Raschle, Nora Maria] Psychiat Univ Clin Basel, Dept Child & Adolescent Psychiat, Basel, Switzerland; [Gaab, Nadine] Harvard Univ, Grad Sch Educ, Cambridge, MA 02138 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Basel; Harvard University	Raschle, NM (corresponding author), Boston Childrens Hosp, Dept Dev Med, Div Dev Med, Labs Cognit Neurosci, Boston, MA 02115 USA.	nora.raschle@childrens.harvard.edu	Gaab, Nadine/AAD-9144-2022; Dauvermann, Maria/ABA-8847-2021; Smith, Sara/GVS-8735-2022	Dauvermann, Maria/0000-0002-2873-8512; Zuk, Jennifer/0000-0001-9113-3973; Gaab, Nadine/0000-0002-7548-413X	Eunice Kennedy Shriver National Institute of Child Health & Human Development [1R01HD065762-01/02/03]; Charles H. Hood Foundation; Boston Children's Hospital Pilot Grant; Swiss National Foundation; Janggen-Pohn Stiftung; National Institute of Health Institutional Training Grant [NIH T32 DC000038-22]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065762, P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000038] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Charles H. Hood Foundation; Boston Children's Hospital Pilot Grant; Swiss National Foundation(Swiss National Science Foundation (SNSF)); Janggen-Pohn Stiftung; National Institute of Health Institutional Training Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the Eunice Kennedy Shriver National Institute of Child Health & Human Development (1R01HD065762-01/02/03 to N.G.); Charles H. Hood Foundation (to N.G.); Boston Children's Hospital Pilot Grant (to N.G.); the Swiss National Foundation (to N.M.R.); the Janggen-Pohn Stiftung (to N.M.R.); and the National Institute of Health Institutional Training Grant (NIH T32 DC000038-22 to J.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman NR, 2001, RADIOLOGY, V221, P56, DOI 10.1148/radiol.2211010074; Andics A, 2010, NEUROIMAGE, V52, P1528, DOI 10.1016/j.neuroimage.2010.05.048; Belin P, 2003, NEUROREPORT, V14, P2105, DOI 10.1097/00001756-200311140-00019; Belin P, 2004, TRENDS COGN SCI, V8, P129, DOI 10.1016/j.tics.2004.01.008; Belin P, 2002, COGNITIVE BRAIN RES, V13, P17, DOI 10.1016/S0926-6410(01)00084-2; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Belin P, 2011, BRIT J PSYCHOL, V102, P711, DOI 10.1111/j.2044-8295.2011.02041.x; Berl MM, 2010, BRAIN LANG, V114, P115, DOI 10.1016/j.bandl.2010.06.002; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; Bitan T, 2007, NEUROIMAGE, V38, P564, DOI 10.1016/j.neuroimage.2007.07.048; Blasi A, 2011, CURR BIOL, V21, P1220, DOI 10.1016/j.cub.2011.06.009; Bookheimer SY, 2000, MENT RETARD DEV D R, V6, P161, DOI 10.1002/1098-2779(2000)6:3<161::AID-MRDD2>3.0.CO;2-W; BOROD JC, 1990, J COMMUN DISORD, V23, P247, DOI 10.1016/0021-9924(90)90003-H; Bosch V, 2000, J MAGN RESON IMAGING, V11, P61, DOI 10.1002/(SICI)1522-2586(200001)11:1<61::AID-JMRI9>3.0.CO;2-C; Casey BJ, 2008, ANN NY ACAD SCI, V1124, P111, DOI 10.1196/annals.1440.010; Charest I, 2012, CEREB CORTEX; COHEN MJ, 1994, BRAIN LANG, V47, P171, DOI 10.1006/brln.1994.1047; Dehaene S, 1997, NEUROREPORT, V8, P3809, DOI 10.1097/00001756-199712010-00030; Dehaene-Lambertz G, 1998, NEUROREPORT, V9, P1885, DOI 10.1097/00001756-199806010-00040; Dehaene-Lambertz G, 2002, SCIENCE, V298, P2013, DOI 10.1126/science.1077066; Dick AS, 2012, DEVELOPMENTAL SCI, V15, P165, DOI 10.1111/j.1467-7687.2011.01100.x; EcklundFlores L, 1996, DEV PSYCHOBIOL, V29, P205, DOI 10.1002/(SICI)1098-2302(199604)29:3<205::AID-DEV2>3.0.CO;2-V; Ethofer T, 2009, CURR BIOL, V19, P1028, DOI 10.1016/j.cub.2009.04.054; Fecteau S, 2004, NEUROIMAGE, V23, P840, DOI 10.1016/j.neuroimage.2004.09.019; Formisano E, 2008, SCIENCE, V322, P970, DOI 10.1126/science.1164318; Gaab N, 2003, NEUROIMAGE, V19, P1417, DOI 10.1016/S1053-8119(03)00224-6; Gaab N, 2008, HUM BRAIN MAPP, V29, P858, DOI 10.1002/hbm.20578; Gaab N, 2007, HUM BRAIN MAPP, V28, P703, DOI 10.1002/hbm.20298; Gaab N, 2007, HUM BRAIN MAPP, V28, P721, DOI 10.1002/hbm.20299; Gervais H, 2004, NAT NEUROSCI, V7, P801, DOI 10.1038/nn1291; Goncalves MS, 2001, NEUROIMAGE, V14, P1353, DOI 10.1006/nimg.2001.0954; Greimel E., 2012, BRAIN STRUCT FUNCT; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Grossmann T, 2010, NEURON, V65, P852, DOI 10.1016/j.neuron.2010.03.001; Hailstone JC, 2011, BRAIN, V134, P2535, DOI 10.1093/brain/awr205; Hall DA, 1999, HUM BRAIN MAPP, V7, P213, DOI 10.1002/(SICI)1097-0193(1999)7:3<213::AID-HBM5>3.0.CO;2-N; HARTMAN DE, 1976, J ACOUST SOC AM, V59, P713, DOI 10.1121/1.380894; Herholz SC, 2012, J COGNITIVE NEUROSCI, V24, P1382, DOI 10.1162/jocn_a_00216; Hickok G, 2000, TRENDS COGN SCI, V4, P131, DOI 10.1016/S1364-6613(00)01463-7; Homae F, 2006, NEUROSCI RES, V54, P276, DOI 10.1016/j.neures.2005.12.006; Hornak J, 1996, NEUROPSYCHOLOGIA, V34, P247, DOI 10.1016/0028-3932(95)00106-9; Hyde KL, 2008, NEUROPSYCHOLOGIA, V46, P632, DOI 10.1016/j.neuropsychologia.2007.09.004; Iidaka Tetsuya, 2012, Brain and Nerve (Tokyo), V64, P737; Imaizumi S, 1997, VOCAL IDENTIFICATION; Kahn I, 2008, J NEUROPHYSIOL, V100, P129, DOI 10.1152/jn.00077.2008; Kaufman A. S., 1997, KBIT 2 KAUFMAN BRIEF; Kriegstein KV, 2004, NEUROIMAGE, V22, P948, DOI 10.1016/j.neuroimage.2004.02.020; Langer N, 2013, CEREB CORTEX; Langers DRM, 2011, BRAIN CONNECT, V1, P233, DOI 10.1089/brain.2011.0023; LASS NJ, 1976, J ACOUST SOC AM, V59, P675, DOI 10.1121/1.380917; Latinus M, 2011, CEREB CORTEX, V21, P2820, DOI 10.1093/cercor/bhr077; Lattner S, 2005, HUM BRAIN MAPP, V24, P11, DOI 10.1002/hbm.20065; Lavner Y, 2000, SPEECH COMMUN, V30, P9, DOI 10.1016/S0167-6393(99)00028-X; Linden DEJ, 2011, CEREB CORTEX, V21, P330, DOI 10.1093/cercor/bhq097; Loui P, 2012, NEUROIMAGE, V63, P632, DOI 10.1016/j.neuroimage.2012.07.030; Lu LH, 2009, CEREB CORTEX, V19, P2595, DOI 10.1093/cercor/bhp011; Marsh R, 2008, J AM ACAD CHILD PSY, V47, P1233, DOI 10.1097/CHI.0b013e318185e703; MAZOYER BM, 1993, J COGNITIVE NEUROSCI, V5, P467, DOI 10.1162/jocn.1993.5.4.467; McGettigan C, 2013, J COGNITIVE NEUROSCI, V25, P1875, DOI 10.1162/jocn_a_00427; Mende-Siedlecki P., 2012, SOC COGN AFFECT NEUR; Meyer M, 2005, COGNITIVE BRAIN RES, V24, P291, DOI 10.1016/j.cogbrainres.2005.02.008; Mier D, 2010, PSYCHOL MED, V40, P1607, DOI 10.1017/S0033291709992133; Nath AR, 2011, J NEUROSCI, V31, P13963, DOI 10.1523/JNEUROSCI.2605-11.2011; Patterson ML, 2003, DEVELOPMENTAL SCI, V6, P191, DOI 10.1111/1467-7687.00271; Pell MD, 2003, COGN AFFECT BEHAV NE, V3, P275, DOI 10.3758/CABN.3.4.275; Pena M, 2003, P NATL ACAD SCI USA, V100, P11702, DOI 10.1073/pnas.1934290100; Petkov CI, 2008, NAT NEUROSCI, V11, P367, DOI 10.1038/nn2043; Petkov CI, 2009, NEUROSCIENTIST, V15, P419, DOI 10.1177/1073858408326430; Price CJ, 2000, J ANAT, V197, P335, DOI 10.1046/j.1469-7580.2000.19730335.x; Puce A, 2003, PHILOS T R SOC B, V358, P435, DOI 10.1098/rstb.2002.1221; Raschle N. M., 2009, JOVE, V29; Raschle N, 2012, ANN NY ACAD SCI, V1252, P43, DOI 10.1111/j.1749-6632.2012.06457.x; Raschle NM, 2012, P NATL ACAD SCI USA, V109, P2156, DOI 10.1073/pnas.1107721109; Redcay E, 2008, NEUROSCI BIOBEHAV R, V32, P123, DOI 10.1016/j.neubiorev.2007.06.004; Rogier O, 2010, INT J PSYCHOPHYSIOL, V75, P44, DOI 10.1016/j.ijpsycho.2009.10.013; Saxe R, 2006, SOC NEUROSCI-UK, V1, pI, DOI 10.1080/17470910601117463; SCHERER KR, 1995, J VOICE, V9, P235, DOI 10.1016/S0892-1997(05)80231-0; Schlaggar BL, 2002, SCIENCE, V296, P1476, DOI 10.1126/science.1069464; Scott SK, 2000, BRAIN, V123, P2400, DOI 10.1093/brain/123.12.2400; Semel E, 2000, CHILD EVALUATION LAN; Shultz S, 2012, J COGNITIVE NEUROSCI, V24, P1224, DOI 10.1162/jocn_a_00208; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Talairach J, 1988, COPLANAR STEREOTAXIE; Thomason ME, 2005, NEUROIMAGE, V25, P824, DOI 10.1016/j.neuroimage.2004.12.026; Torgesen J.K., 1999, COMPREHENSIVE TEST P; Van der Wyk BC, 2012, DEV COGN NEUROSCI; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; VANDERLELY HKJ, 2000, VERB AGREEMENT TENSE; VANDOMMELEN WA, 1990, LANG SPEECH, V33, P259, DOI 10.1177/002383099003300302; VANLANCKER DR, 1989, J CLIN EXP NEUROPSYC, V11, P665, DOI 10.1080/01688638908400923; VANLANCKER DR, 1988, CORTEX, V24, P195, DOI 10.1016/S0010-9452(88)80029-7; von Kriegstein K, 2003, COGNITIVE BRAIN RES, V17, P48, DOI 10.1016/S0926-6410(03)00079-X; von Kriegstein K, 2010, J NEUROSCI, V30, P629, DOI 10.1523/JNEUROSCI.2742-09.2010; Wang YY, 2014, BRAIN CONNECT, V4, P273, DOI 10.1089/brain.2013.0190; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Wolf M., 2005, RAN RAS RAPID AUTOMA; ZATORRE RJ, 1988, J ACOUST SOC AM, V84, P566, DOI 10.1121/1.396834	97	7	7	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115549	10.1371/journal.pone.0115549	http://dx.doi.org/10.1371/journal.pone.0115549			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25532132	Green Published, gold, Green Submitted			2022-12-27	WOS:000348845100075
J	Winking, J				Winking, Jeffrey			Anonymity versus Privacy in the Dictator Game: Revealing Donor Decisions to Recipients Does Not Substantially Impact Donor Behavior	PLOS ONE			English	Article							PUBLIC-GOODS; AUDIENCE; RECIPROCITY; GENEROSITY; EVOLUTION; ALTRUISM; IMAGE; CUES	Anonymity is often offered in economic experiments in order to eliminate observer effects and induce behavior that would be exhibited under private circumstances. However, anonymity differs from privacy in that interactants are only unaware of each others' identities, while having full knowledge of each others' actions. Such situations are rare outside the laboratory and anonymity might not meet the requirements of some participants to psychologically engage as if their actions were private. In order to explore the impact of a lack of privacy on prosocial behaviors, I expand on a study reported in Dana et al. (2006) in which recipients were left unaware of the Dictator Game and given donations as "bonuses'' to their show-up fees for other tasks. In the current study, I explore whether differences between a private Dictator Game (sensu Dana et al. (2006)) and a standard anonymous one are due to a desire by dictators to avoid shame or to pursue prestige. Participants of a Dictator Game were randomly assigned to one of four categories-one in which the recipient knew of (1) any donation by an anonymous donor (including zero donations), (2) nothing at all, (3) only zero donations, and (4) and only non-zero donations. The results suggest that a lack of privacy increases the shame that selfish-acting participants experience, but that removing such a cost has only minimal effects on actual behavior.	Texas A&M Univ, Dept Anthropol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Winking, J (corresponding author), Texas A&M Univ, Dept Anthropol, College Stn, TX 77843 USA.	jwinking@tamu.edu		Winking, Jeffrey/0000-0002-2298-3680	Texas A&M College of Liberal Arts Research Bursary; University Libraries; Office of the Vice President for Research; Texas A&M University Online Access to Knowledge (OAK) Fund	Texas A&M College of Liberal Arts Research Bursary; University Libraries; Office of the Vice President for Research; Texas A&M University Online Access to Knowledge (OAK) Fund	This work was supported by the Texas A&M College of Liberal Arts Research Bursary. The open access publishing fees for this article have been covered by the Texas A&M University Online Access to Knowledge (OAK) Fund, supported by the University Libraries and the Office of the Vice President for Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031461; Andreoni J, 2004, J PUBLIC ECON, V88, P1605, DOI 10.1016/S0047-2727(03)00040-9; ANDREONI J, 1990, ECON J, V100, P464, DOI 10.2307/2234133; Andreoni J, 2009, ECONOMETRICA, V77, P1607, DOI 10.3982/ECTA7384; Bateson M, 2006, BIOL LETTERS, V2, P412, DOI 10.1098/rsbl.2006.0509; Broberg T, 2007, ECON LETT, V94, P32, DOI 10.1016/j.econlet.2006.07.006; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Dana J, 2006, ORGAN BEHAV HUM DEC, V100, P193, DOI 10.1016/j.obhdp.2005.10.001; Dana J, 2007, ECON THEOR, V33, P67, DOI 10.1007/s00199-006-0153-z; Fehr E, 2004, EVOL HUM BEHAV, V25, P63, DOI 10.1016/S1090-5138(04)00005-4; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Fessler DMT., 2009, J ECON BEHAV ORGAN, V71, P575, DOI [10.1016/j.jebo.2009.03.007., DOI 10.1016/J.JEBO.2009.03.007]; Filiz-Ozbay E, 2014, EXP ECON, V17, P200, DOI 10.1007/s10683-013-9363-y; Franzen A, 2012, J ECON BEHAV ORGAN, V81, P74, DOI 10.1016/j.jebo.2011.09.005; Gintis H, 2000, J THEOR BIOL, V206, P169, DOI 10.1006/jtbi.2000.2111; Goodman JK, 2013, J BEHAV DECIS MAKING, V26, P213, DOI 10.1002/bdm.1753; Haley KJ, 2005, EVOL HUM BEHAV, V26, P245, DOI 10.1016/j.evolhumbehav.2005.01.002; Hardy CL, 2006, PERS SOC PSYCHOL B, V32, P1402, DOI 10.1177/0146167206291006; Henrich J, 2001, EVOL HUM BEHAV, V22, P165, DOI 10.1016/S1090-5138(00)00071-4; Henrich J, 2004, FDN HUMAN SOCIALITY, P382; HOFFMAN E, 1994, GAME ECON BEHAV, V7, P346, DOI 10.1006/game.1994.1056; Jacobsen KJ, 2011, J ECON PSYCHOL, V32, P818, DOI 10.1016/j.joep.2011.07.003; Kurzban R, 2007, EVOL HUM BEHAV, V28, P75, DOI 10.1016/j.evolhumbehav.2006.06.001; Lazear EP, 2012, AM ECON J-APPL ECON, V4, P136, DOI 10.1257/app.4.1.136; Milinski M, 2002, NATURE, V415, P424, DOI 10.1038/415424a; Neilson WS, 2009, GAME ECON BEHAV, V66, P394, DOI 10.1016/j.geb.2008.04.004; Nettle D, 2013, EVOL HUM BEHAV, V34, P35, DOI 10.1016/j.evolhumbehav.2012.08.004; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; Petit E, 2012, CAHIERS GRETHA, P2012; Raihani NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073131; Rand DG, 2012, J THEOR BIOL, V299, P172, DOI 10.1016/j.jtbi.2011.03.004; Rigdon M, 2009, J ECON PSYCHOL, V30, P358, DOI 10.1016/j.joep.2009.02.002; Samek AS, 2014, EXPT EC; Smith T. W., 2003, ALTRUISM CONT AM REP; Stoop J, 2013, EXPT EC, P1; Winking J, 2013, EVOL HUM BEHAV, V34, P288, DOI 10.1016/j.evolhumbehav.2013.04.002; Zizzo DJ, 2010, EXP ECON, V13, P75, DOI 10.1007/s10683-009-9230-z	39	2	2	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115419	10.1371/journal.pone.0115419	http://dx.doi.org/10.1371/journal.pone.0115419			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA3ZY	25532025	Green Published, Green Submitted, gold			2022-12-27	WOS:000348845100064
J	De Buyser, SL; Petrovic, M; Taes, YE; Vetrano, DL; Onder, G				De Buyser, Stefanie L.; Petrovic, Mirko; Taes, Youri E.; Vetrano, Davide L.; Onder, Graziano			A Multicomponent Approach to Identify Predictors of Hospital Outcomes in Older In-Patients: A Multicentre, Observational Study	PLOS ONE			English	Article							LENGTH-OF-STAY; ACUTE GERIATRIC WARD; ACUTE-CARE; GRIP STRENGTH; GAIT SPEED; PEOPLE; ADULTS; MORTALITY; ADMISSION; MOBILITY	Background: The identification of older patients at risk of poor hospital outcomes (e.g. longer hospital stay, in-hospital mortality, and institutionalisation) is important to provide an effective healthcare service. Objective: To identify factors related to older patients' clinical, nutritional, functional and socio-demographic profiles at admission to an acute care ward that can predict poor hospital outcomes. Design and Setting: The CRiteria to assess appropriate Medication use among Elderly complex patients project was a multicentre, observational study performed in geriatric and internal medicine acute care wards of seven Italian hospitals. Subjects: One thousand one hundred twenty-three consecutively admitted patients aged 65 years or older. Methods: Hospital outcomes were length of stay, in-hospital mortality, and institutionalisation. Results: Mean age of participants was 81 years, 56% were women. Median length of stay was 10 (7-14) days, 41 patients died during hospital stay and 37 were newly institutionalised. Number of drugs before admission, metastasized cancer, renal failure or dialysis, infection, falls at home during the last year, pain, and walking speed were independent predictors of LoS. Total dependency in activities of daily living and inability to perform grip strength test were independent predictors of in-hospital mortality. Malnutrition and total dependency in activities of daily living were independent predictors of institutionalisation. Conclusions: Our results confirm that not only diseases, but also multifaceted aspects of ageing such as physical function and malnutrition are strong predictors of hospital outcomes and suggest that these variables should be systematically recorded.	[De Buyser, Stefanie L.; Petrovic, Mirko] Ghent Univ Hosp, Dept Geriatr, Ghent, Belgium; [Taes, Youri E.] Ghent Univ Hosp, Dept Endocrinol, Ghent, Belgium; [Taes, Youri E.] Ghent Univ Hosp, Unit Osteoporosis & Metab Bone Dis, Ghent, Belgium; [Vetrano, Davide L.; Onder, Graziano] Univ Cattolica Sacro Cuore, Ctr Med Invecchiamento, Rome, Italy	Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	De Buyser, SL (corresponding author), Ghent Univ Hosp, Dept Geriatr, Ghent, Belgium.	stefanie.debuyser@UGent.be	; Vetrano, Davide Liborio/K-7417-2016	De Buyser, Stefanie/0000-0002-9584-5529; Vetrano, Davide Liborio/0000-0002-3099-4830	Italian Ministry of Labour, Health and Social Policy	Italian Ministry of Labour, Health and Social Policy(Ministry of Health, Italy)	Funding: This work was supported by the Italian Ministry of Labour, Health and Social Policy who funded the CRIME project (Bando Giovani Ricercatori 2007, convenzione no 4). YT is a Postdoctoral Fellow with the 'Fonds voor Wetenschappelijk Onderzoek - Vlaanderen (FWO; Research Foundation - Flanders)'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon T, 1999, AGE AGEING, V28, P429, DOI 10.1093/ageing/28.5.429; Bernabei R, 2002, AGING CLIN EXP RES, V14, P247; Campbell SE, 2005, AGE AGEING, V34, P467, DOI 10.1093/ageing/afi141; Campbell SE, 2004, AGE AGEING, V33, P110, DOI 10.1093/ageing/afh036; De Buyser SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096398; Espallargues M, 2008, QJM-INT J MED, V101, P99, DOI 10.1093/qjmed/hcm136; FOLSTEIN MF, 1983, ARCH GEN PSYCHIAT, V40, P812; Gan N, 2006, AUST J PHYSIOTHER, V52, P141, DOI 10.1016/S0004-9514(06)70050-2; Graves N, 2005, INFECT CONT HOSP EP, V26, P293, DOI 10.1086/502542; Incalzi RA, 1997, J INTERN MED, V242, P291, DOI 10.1046/j.1365-2796.1997.00132.x; Inouye SK, 1998, JAMA-J AM MED ASSOC, V279, P1187, DOI 10.1001/jama.279.15.1187; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kerr A, 2006, AGE AGEING, V35, P82, DOI 10.1093/ageing/afj010; Lang PO, 2006, J AM GERIATR SOC, V54, P1031, DOI 10.1111/j.1532-5415.2006.00767.x; Lauretani F, 2003, J APPL PHYSIOL, V95, P1851, DOI 10.1152/japplphysiol.00246.2003; MAGUIRE PA, 1986, BRIT MED J, V292, P1251, DOI 10.1136/bmj.292.6530.1251; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nobili A, 2011, EUR J CLIN PHARMACOL, V67, P507, DOI 10.1007/s00228-010-0977-0; Onder G, 2005, EUR J CLIN PHARMACOL, V61, P453, DOI 10.1007/s00228-005-0928-3; Onder G, 2014, DRUG AGING, V31, P33, DOI 10.1007/s40266-013-0134-4; Ostir GV, 2012, ARCH INTERN MED, V172, P353, DOI 10.1001/archinternmed.2011.1615; Parmelee PA, 1989, PSYCHOL ASSESSMENT J, V1, P331, DOI DOI 10.1037/1040-3590.1.4.331; Purser JL, 2005, J REHABIL RES DEV, V42, P535, DOI 10.1682/JRRD.2004.07.0087; Reuben DB, 2004, J GERONTOL A-BIOL, V59, P1056; Roberts HC, 2012, AGE AGEING, V41, P641, DOI 10.1093/ageing/afs089; Sallinen J, 2010, J AM GERIATR SOC, V58, P1721, DOI 10.1111/j.1532-5415.2010.03035.x; Studenshi SA, 2012, ARCH INTERN MED, V172, P358, DOI 10.1001/archinternmed.2011.1951; Studenski S, 2003, J AM GERIATR SOC, V51, P314, DOI 10.1046/j.1532-5415.2003.51104.x; Tosato M, 2013, CURR DRUG SAF, V8, P98, DOI 10.2174/1574886311308020002; Van Nes MC, 2001, AGE AGEING, V30, P221, DOI 10.1093/ageing/30.3.221; Vetrano DL, 2014, EUR J INTERN MED, V25, P56, DOI 10.1016/j.ejim.2013.08.709; Vetrano DL, 2014, J GERONTOL A-BIOL, P1; Volpato S, 2008, J GERONTOL A-BIOL, V63, P1393, DOI 10.1093/gerona/63.12.1393	33	26	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115413	10.1371/journal.pone.0115413	http://dx.doi.org/10.1371/journal.pone.0115413			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX9RO	25542042	Green Published, Green Submitted, gold			2022-12-27	WOS:000347239900042
J	Joensen, O; Paff, T; Haarman, EG; Skovgaard, IM; Jensen, PO; Bjarnsholt, T; Nielsen, KG				Joensen, Odin; Paff, Tamara; Haarman, Eric G.; Skovgaard, Ib M.; Jensen, Peter O.; Bjarnsholt, Thomas; Nielsen, Kim G.			Exhaled Breath Analysis Using Electronic Nose in Cystic Fibrosis and Primary Ciliary Dyskinesia Patients with Chronic Pulmonary Infections	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA INFECTION; VOLATILE ORGANIC-COMPOUNDS; PNEUMONIA SCORE; EXACERBATIONS; COLONIZATION; METABOLOMICS; SIGNATURE; DIAGNOSIS	The current diagnostic work-up and monitoring of pulmonary infections may be perceived as invasive, is time consuming and expensive. In this explorative study, we investigated whether or not a non-invasive exhaled breath analysis using an electronic nose would discriminate between cystic fibrosis (CF) and primary ciliary dyskinesia (PCD) with or without various well characterized chronic pulmonary infections. We recruited 64 patients with CF and 21 with PCD based on known chronic infection status. 21 healthy volunteers served as controls. An electronic nose was employed to analyze exhaled breath samples. Principal component reduction and discriminant analysis were used to construct internally cross-validated receiver operator characteristic (ROC) curves. Breath profiles of CF and PCD patients differed significantly from healthy controls p=0.001 and p=0.005, respectively. Profiles of CF patients having a chronic P. aeruginosa infection differed significantly from to non-chronically infected CF patients p=0.044. We confirmed the previously established discriminative power of exhaled breath analysis in separation between healthy subjects and patients with CF or PCD. Furthermore, this method significantly discriminates CF patients suffering from a chronic pulmonary P. aeruginosa (PA) infection from CF patients without a chronic pulmonary infection. Further studies are needed for verification and to investigate the role of electronic nose technology in the very early diagnostic workup of pulmonary infections before the establishment of a chronic infection.	[Joensen, Odin; Bjarnsholt, Thomas] Univ Copenhagen, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Paff, Tamara; Haarman, Eric G.] Vrije Univ Amsterdam, Med Ctr Amsterdam, Dept Pulm Dis, Amsterdam, Netherlands; [Skovgaard, Ib M.] Univ Copenhagen, Dept Math Sci, Copenhagen, Denmark; [Jensen, Peter O.; Bjarnsholt, Thomas] Rigshosp, Dept Clin Microbiol, DK-2100 Copenhagen, Denmark; [Nielsen, Kim G.] Rigshosp, Danish Paediat Pulm Serv, DK-2100 Copenhagen, Denmark	University of Copenhagen; Vrije Universiteit Amsterdam; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Nielsen, KG (corresponding author), Rigshosp, Danish Paediat Pulm Serv, DK-2100 Copenhagen, Denmark.	kgn@dadlnet.dk	Jensen, Peter Ostrup/HGD-7725-2022; Bjarnsholt, Thomas/ABD-6178-2021; Nielsen, KG/AAE-6575-2020	Nielsen, KG/0000-0001-5906-9449; Bjarnsholt, Thomas/0000-0002-8003-7414; Jensen, Peter Ostrup/0000-0003-1648-7186	Danmarks lungeforening; A.P. Moller og Hustru Chastine Mc-Kinney Moller Fond; John and Birthe Meyer Foundation; European Union [8305404]	Danmarks lungeforening; A.P. Moller og Hustru Chastine Mc-Kinney Moller Fond; John and Birthe Meyer Foundation; European Union(European Commission)	Funding: Funding provided by the following: Danmarks lungeforening (https://www.lunge.dk/); no grant number; receiver OJ. A.P. Moller og Hustru Chastine Mc-Kinney Moller Fond til almene Formaal (http://www.apmollerfonde.dk/); no grant number; receiver OJ. The John and Birthe Meyer Foundation (no website); no grant number; receiver KGN. European Union Seventh, Framework Programme (FP7/2007-2013); (http://ec.europa.eu/research/fp7/index_en.cfm); grant agreement n8305404 (BESTCILIA); receiver KGN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allardyce RA, 2006, DIAGN MICR INFEC DIS, V55, P255, DOI 10.1016/j.diagmicrobio.2006.01.031; Amann A, 2010, EUR RESPIR MONOGR, P96, DOI 10.1183/1025448x.00018509; Amirav I, 2009, PAEDIATR RESPIR REV, V10, P58, DOI 10.1016/j.prrv.2008.11.003; Barker M, 2006, EUR RESPIR J, V27, P929, DOI 10.1183/09031936.06.00085105; Bos LDJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003311; Chambers ST, 2011, MED MYCOL, V49, pS54, DOI 10.3109/13693786.2010.508187; Dam JS, 2012, NAT PHOTONICS, V6, P788, DOI [10.1038/NPHOTON.2012.231, 10.1038/nphoton.2012.231]; de Heer K, 2013, J CLIN MICROBIOL, V51, P1490, DOI 10.1128/JCM.02838-12; Dragonieri S, 2007, J ALLERGY CLIN IMMUN, V120, P856, DOI 10.1016/j.jaci.2007.05.043; *DTU NAN, DEVICE FOR DIAGNOSIS; Frederiksen B, 1997, PEDIATR PULM, V23, P330, DOI 10.1002/(SICI)1099-0496(199705)23:5<330::AID-PPUL4>3.0.CO;2-O; FUCHS HJ, 1994, NEW ENGL J MED, V331, P637, DOI 10.1056/NEJM199409083311003; Gangell C, 2011, CLIN INFECT DIS, V53, P425, DOI 10.1093/cid/cir399; Gilchrist FJ, 2013, J BREATH RES, V7, DOI 10.1088/1752-7155/7/2/026010; Hansen CR, 2008, J CYST FIBROS, V7, P523, DOI 10.1016/j.jcf.2008.06.009; Hanson CW, 2005, ANESTHESIOLOGY, V102, P63, DOI 10.1097/00000542-200501000-00013; Hauser AR, 2011, CLIN MICROBIOL REV, V24, P29, DOI 10.1128/CMR.00036-10; Hockstein NG, 2005, ANN OTO RHINOL LARYN, V114, P504, DOI 10.1177/000348940511400702; Hockstein NG, 2004, LARYNGOSCOPE, V114, P1701, DOI 10.1097/00005537-200410000-00005; Hoiby N, 2005, J Cyst Fibros, V4 Suppl 2, P49, DOI 10.1016/j.jcf.2005.05.018; HOIBY N, 1977, SCAND J RESPIR DIS, V58, P65; Hoiby N, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-32; Kang NK, 2010, SENSOR ACTUAT B-CHEM, V147, P55, DOI 10.1016/j.snb.2010.03.025; Kharitonov SA, 2001, AM J RESP CRIT CARE, V163, P1693, DOI 10.1164/ajrccm.163.7.2009041; Kuehni CE, 2010, EUR RESPIR J, V36, P1248, DOI 10.1183/09031936.00001010; Lai SY, 2002, LARYNGOSCOPE, V112, P975, DOI 10.1097/00005537-200206000-00007; Lee Tim W R, 2003, J Cyst Fibros, V2, P29, DOI 10.1016/S1569-1993(02)00141-8; Maglione M, 2014, PEDIATR PULM, V49, P1243, DOI 10.1002/ppul.22984; Marthin JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057262; McGrath LT, 2000, EUR RESPIR J, V16, P1065, DOI 10.1034/j.1399-3003.2000.16f08.x; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; O'Sullivan BP, 2009, LANCET, V373, P1891, DOI 10.1016/S0140-6736(09)60327-5; Paff T, 2013, J CYST FIBROS, V12, P454, DOI 10.1016/j.jcf.2012.12.010; Proesmans M, 2006, EUR RESPIR J, V27, P937, DOI 10.1183/09031936.06.00100805; Rabin HR, 2004, PEDIATR PULM, V37, P400, DOI 10.1002/ppul.20023; Robroeks CMHHT, 2010, PEDIATR RES, V68, P75, DOI 10.1203/00006450-201011001-00143; Rogers GB, 2010, J CLIN MICROBIOL, V48, P78, DOI 10.1128/JCM.01324-09; Savelev SU, 2011, LETT APPL MICROBIOL, V52, P610, DOI 10.1111/j.1472-765X.2011.03049.x; Schulz S, 2007, NAT PROD REP, V24, P814, DOI 10.1039/b507392h; Scott-Thomas A, 2011, J BREATH RES, V5, DOI 10.1088/1752-7155/5/4/046002; Scott-Thomas AJ, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-56; Smith D, 2011, J BREATH RES, V5, DOI 10.1088/1752-7155/5/2/022001; Thorn RMS, 2012, J BREATH RES, V6, DOI 10.1088/1752-7155/6/2/024001	44	35	36	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115584	10.1371/journal.pone.0115584	http://dx.doi.org/10.1371/journal.pone.0115584			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542036	Green Published, Green Submitted, gold			2022-12-27	WOS:000347239900054
J	Laiho, A; Elo, LL				Laiho, Asta; Elo, Laura L.			A Note on an Exon-Based Strategy to Identify Differentially Expressed Genes in RNA-Seq Experiments	PLOS ONE			English	Article							STATISTICAL-METHODS; REPRODUCIBILITY; ANNOTATION	RNA-sequencing (RNA-seq) has rapidly become the method of choice in many genome-wide transcriptomic studies. To meet the high expectations posed by this technology, powerful computational techniques are needed to translate the measurements into biological and biomedical understanding. A number of statistical procedures have already been developed to identify differentially expressed genes between distinct sample groups. With these methods statistical testing is typically performed after the data has been summarized at the gene level. As an alternative strategy, developed with the aim to improve the results, we demonstrate a method in which statistical testing at the exon level is performed prior to the summary of the results at the gene level. Using publicly available RNA-seq datasets as case studies, we illustrate how this exon-based strategy can improve the performance of the widely used differential expression software packages as compared to the conventional gene-based strategy. In particular, we show how it enables robust detection of moderate but systematic changes that are missed when relying on single gene-level summary counts only.	[Laiho, Asta; Elo, Laura L.] Univ Turku, Turku Ctr Biotechnol, Turku, Finland; [Laiho, Asta; Elo, Laura L.] Abo Akad Univ, Turku, Finland; [Elo, Laura L.] Univ Turku, Dept Math & Stat, Turku, Finland	University of Turku; Abo Akademi University; University of Turku	Laiho, A (corresponding author), Univ Turku, Turku Ctr Biotechnol, Turku, Finland.	asta.laiho@btk.fi; laliel@utu.fi	Elo, Laura/A-9449-2015	Elo, Laura/0000-0001-5648-4532	Academy of Finland [127575]; JDRF [2-2013-32]	Academy of Finland(Academy of Finland); JDRF(Juvenile Diabetes Research Foundation)	This work was supported by the Academy of Finland, http://www.aka.fi, grant number 127575 to L.L.E.; and JDRF, http://jdrf.org, grant number 2-2013-32 to L.L.E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERS S, 2010, GENOME BIOL, V11; Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Eksi R, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003314; Elo LL, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni193; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; Hardcastle TJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-422; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Johnston CM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040009; Kvam VM, 2012, AM J BOT, V99, P248, DOI 10.3732/ajb.1100340; Laajala E, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r77; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lemon WJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r67; Li HD, 2014, PROTEOMICS; Li J, 2011, COMPUT MATH METHOD M, V2011, DOI 10.1155/2011/527610; Liu XJ, 2006, BIOINFORMATICS, V22, P2107, DOI 10.1093/bioinformatics/btl361; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Pepke S, 2009, NAT METHODS, V6, pS22, DOI [10.1038/NMETH.1371, 10.1038/nmeth.1371]; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Rapaport F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r95; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Seyednasrollah F, 2013, BRIEF BIOINFORM; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Soneson C, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-91; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450	34	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115964	10.1371/journal.pone.0115964	http://dx.doi.org/10.1371/journal.pone.0115964			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541961	Green Published, Green Submitted, gold			2022-12-27	WOS:000347239900119
J	Levin, ML; Killmaster, LF; Zemtsova, GE; Ritter, JM; Langham, G				Levin, Michael L.; Killmaster, Lindsay F.; Zemtsova, Galina E.; Ritter, Jana M.; Langham, Gregory			Clinical Presentation, Convalescence, and Relapse of Rocky Mountain Spotted Fever in Dogs Experimentally Infected via Tick Bite	PLOS ONE			English	Article							RICKETTSIA-RICKETTSII; PATHOGENESIS; EFFICACY; IXODIDAE; ACARI	Rocky Mountain spotted fever (RMSF) is a tick-borne disease caused by R. rickettsii in North and South America. Domestic dogs are susceptible to infection and canine RMSF can be fatal without appropriate treatment. Although clinical signs of R. rickettsii infection in dogs have been described, published reports usually include descriptions of either advanced clinical cases or experimental infections caused by needle-inoculation of cultured pathogen rather than by tick bite. The natural progression of a tick-borne R. rickettsii infection has not been studied in sufficient detail. Here, we provide a detailed description of clinical, hematological, molecular, and serological dynamics of RMSF in domestic dogs from the day of experimental exposure to infected ticks through recovery. Presented data indicate that neither the height/duration of fever nor detection of rickettsial DNA in dogs' blood by PCR are good indicators for clinical prognosis. Only the apex and subsequent subsidence of neutrophilia seem to mark the beginning of recovery and allow predicting a favorable outcome in Rickettsia-infected dogs, even despite the continuing persistence of mucosal petechiae and skin rash. On the other hand the appropriate (doxycycline) antibiotic therapy of sufficient duration is crucial in prevention of RMSF relapses in dogs.	[Levin, Michael L.; Killmaster, Lindsay F.; Zemtsova, Galina E.] Ctr Dis Control & Prevent, Rickettsial Zoonoses Branch, Atlanta, GA 30333 USA; [Ritter, Jana M.] Ctr Dis Control & Prevent, Infect Dis Pathol Branch, Atlanta, GA USA; [Langham, Gregory] Ctr Dis Control & Prevent, Anim Resources Branch, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Levin, ML (corresponding author), Ctr Dis Control & Prevent, Rickettsial Zoonoses Branch, Atlanta, GA 30333 USA.	MLevin@cdc.gov			US Government within CDC budget	US Government within CDC budget	Funding: Funding for work was provided by the US Government within the CDC budget. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASH M, 1995, MED J AUSTRALIA, V163, P167, DOI 10.5694/j.1326-5377.1995.tb127987.x; Barreto MC, 2008, REV INST MED TROP SP, V50, P297, DOI 10.1590/S0036-46652008000500009; Beaty B., 1995, DIAGNOSTIC PROCEDURE; BOZEMAN FM, 1967, AM J TROP MED HYG, V16, P48, DOI 10.4269/ajtmh.1967.16.48; Breitschwerdt E. B., 2000, Textbook of veterinary internal medicine: diseases of the dog and cat, Volumes 1 and 2., P400; Breitschwerdt EB, 1999, ANTIMICROB AGENTS CH, V43, P813, DOI 10.1128/AAC.43.4.813; BREITSCHWERDT EB, 1988, AM J VET RES, V49, P70; BREITSCHWERDT EB, 1985, AM J VET RES, V46, P2124; BREITSCHWERDT EB, 1991, ANTIMICROB AGENTS CH, V35, P2375, DOI 10.1128/AAC.35.11.2375; Clark K. L., 1996, Journal of Agromedicine, V3, P45, DOI 10.1300/J096v03n04_05; DAVIDSON MG, 1989, J AM VET MED ASSOC, V194, P777; Demma LJ, 2005, NEW ENGL J MED, V353, P587, DOI 10.1056/NEJMoa050043; Elchos BN, 2003, J AM VET MED ASSOC, V223, P1450, DOI 10.2460/javma.2003.223.1450; Eremeeva ME, 2003, J CLIN MICROBIOL, V41, P5466, DOI 10.1128/JCM.41.12.5466-5472.2003; Figueiredo Luiz Tadeu Moraes, 1999, Revista da Sociedade Brasileira de Medicina Tropical, V32, P613, DOI 10.1590/S0037-86821999000600002; Folkema AM, 2012, AM J TROP MED HYG, V86, P152, DOI 10.4269/ajtmh.2012.11-0269; Gasser AM, 2001, J AM ANIM HOSP ASSOC, V37, P41, DOI 10.5326/15473317-37-1-41; GORDON JC, 1983, J INFECT DIS, V148, P1123, DOI 10.1093/infdis/148.6.1123; GREENE CE, 1987, J AM VET MED ASSOC, V191, P666; GREENE CE, 1985, J AM VET MED ASSOC, V186, P465; Greene CE., 2006, INFECT DIS DOG CAT, P232; Greene CE, 1998, INFECT DIS DOG CAT, P155; HILL GD, 1982, J AM VET MED ASSOC, V180, P26; Karpathy SE, 2007, J CLIN MICROBIOL, V45, P2545, DOI 10.1128/JCM.00367-07; KEENAN KP, 1977, J INFECT DIS, V135, P911, DOI 10.1093/infdis/135.6.911; KEENAN KP, 1977, AM J VET RES, V38, P851; KOCH HG, 1982, J MED ENTOMOL, V19, P293, DOI 10.1093/jmedent/19.3.293; Labruna MB, 2009, EMERG INFECT DIS, V15, P458, DOI 10.3201/eid1503.081227; McQuiston JH, 2011, ZOONOSES PUBLIC HLTH, V58, P85, DOI 10.1111/j.1863-2378.2009.01300.x; Morrison W.I, 2010, MERCK VET MANUAL, V10, P33; Ober CP, 2004, VET RADIOL ULTRASOUN, V45, P458, DOI 10.1111/j.1740-8261.2004.04079.x; Pacheco RC, 2011, MED VET ENTOMOL, V25, P148, DOI 10.1111/j.1365-2915.2010.00915.x; Paddock CD, 2008, CLIN INFECT DIS, V47, P1188, DOI 10.1086/592254; Piranda EM, 2008, MEM I OSWALDO CRUZ, V103, P696, DOI 10.1590/S0074-02762008000700012; Plumb D.C., 2011, PLUMBS VET DRUGS, V7e; RAOULT D, 1991, ANTIMICROB AGENTS CH, V35, P2457, DOI 10.1128/AAC.35.12.2457; Rodgers S J, 1989, J Vet Diagn Invest, V1, P154; SHAKED Y, 1989, J INFECTION, V18, P35, DOI 10.1016/S0163-4453(89)93567-6; Stiles J, 2000, VET CLIN N AM-SMALL, V30, P1135, DOI 10.1016/S0195-5616(00)05011-7; Troughton DR, 2007, J MED ENTOMOL, V44, P732, DOI 10.1603/0022-2585(2007)44[732:LCOSIT]2.0.CO;2; YAGUPSKY P, 1985, T ROY SOC TROP MED H, V79, P139, DOI 10.1016/0035-9203(85)90265-2; Zemtsova G, 2010, EXP APPL ACAROL, V52, P383, DOI 10.1007/s10493-010-9375-7	42	28	28	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115105	10.1371/journal.pone.0115105	http://dx.doi.org/10.1371/journal.pone.0115105			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542001	gold, Green Published			2022-12-27	WOS:000347239900024
J	Peng, QL; Yang, S; Lao, XJ; Li, RL; Chen, ZP; Wang, J; Qin, X; Li, S				Peng, Qiliu; Yang, Shi; Lao, Xianjun; Li, Ruolin; Chen, Zhiping; Wang, Jian; Qin, Xue; Li, Shan			Association of Single Nucleotide Polymorphisms in VDR and DBP Genes with HBV-Related Hepatocellular Carcinoma Risk in a Chinese Population	PLOS ONE			English	Article							D-BINDING PROTEIN; D-RECEPTOR VDR; BONE-MINERAL DENSITY; BREAST-CANCER RISK; VITAMIN-D; COLORECTAL-CANCER; PROSTATE-CANCER; FOKI; SUSCEPTIBILITY; VARIANTS	Background: Polymorphisms of genes encoding components of the vitamin D pathway including vitamin D receptor (VDR) and vitamin D binding protein (DBP) have been widely investigated because of the complex role played by vitamin D in cancer tumorogenesis. In this study, we investigated the association between VDR and DBP gene polymorphisms and HBV-related HCC risk in a Chinese population. Methods: Study subjects were divided into three groups: 184 HBV patients with HCC, 296 HBV patients without HCC, and 180 healthy controls. The VDR rs2228570, and rs3782905 and the DBP rs7041 polymorphisms were genotyped using PCR-RFLP and the VDR rs11568820 polymorphism was genotyped by PCR-SSP, respectively. DNA sequencing was performed to validate the genotype results. Results: We found that there were significant differences in the genotype and allele frequencies of the VDR rs2228570 and DBP rs7041 polymorphisms between HBV patients with HCC and healthy controls. The rs2228570 T allele was associated with a significant increased HBV-related HCC risk as compared with the C allele. The rs2228570 TT and TT/TC genotypes were correlated with a significant increased HBV-related HCC risk when compared with the wild-type CC homozygote. Similarly, the rs7041 G allele was associated with a significant increased HBV-related HCC risk as compared with the T allele. The rs7041 GG and GG/TG genotypes were correlated with a significant increased HBV-related HCC risk when compared with the wild-type TT homozygote. However, we did not observe any significant effect of VDR rs11568820, and rs3782905 polymorphisms on HBV-related HCC risk in this population. In haplotype analysis, we also did not find any significant differences in haplotype frequencies of the VDR gene between HBV patients with HCC and the healthy controls. Conclusions: We conclude that the VDR rs2228570 and DBP rs7041 polymorphisms may contribute to increased susceptibility to HBV-related HCC in the Chinese population. Due to the marginal significance, further large and well-designed studies in diverse ethnic populations are needed to confirm our results.	[Peng, Qiliu; Yang, Shi; Lao, Xianjun; Wang, Jian; Qin, Xue; Li, Shan] Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning, Guangxi, Peoples R China; [Li, Ruolin] Guangxi Med Univ, Affiliated Hosp 1, Dept Med Res, Nanning, Guangxi, Peoples R China; [Chen, Zhiping] Guangxi Med Univ, Sch Publ Hlth, Dept Occupat Hlth & Environm Hlth, Nanning, Guangxi, Peoples R China	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University	Qin, X (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning, Guangxi, Peoples R China.	qinxue919@126.com; lis8858@126.com			National Natural Science Foundation of China [81260302]; Guangxi education and innovation projects for graduate student [YCBZ2014031]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi education and innovation projects for graduate student	The study was supported by the National Natural Science Foundation of China (No. 81260302) and the Guangxi education and innovation projects for graduate student in 2014 (No. YCBZ2014031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LN, 2011, CANCER EPIDEM BIOMAR, V20, P1708, DOI 10.1158/1055-9965.EPI-11-0300; Anic GM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102966; Arai H, 1997, J BONE MINER RES, V12, P915, DOI 10.1359/jbmr.1997.12.6.915; Bai YH, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-125; BAKER AR, 1988, P NATL ACAD SCI USA, V85, P3294, DOI 10.1073/pnas.85.10.3294; Beilfuss A, 2014, GUT; Bikle D, 2009, J CLIN ENDOCR METAB, V94, P26, DOI 10.1210/jc.2008-1454; Chen YZ, 2013, J IMMUNOL, V190, P3687, DOI 10.4049/jimmunol.1203273; Chishimba L, 2010, THORAX, V65, P456, DOI 10.1136/thx.2009.128793; Dalessandri KM, 2012, J AM COLL SURGEONS, V215, P652, DOI 10.1016/j.jamcollsurg.2012.06.413; Deeb KK, 2007, NAT REV CANCER, V7, P684, DOI 10.1038/nrc2196; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Fu BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061423; Gu HY, 2014, MED ONCOL, V31, DOI 10.1007/s12032-013-0827-x; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kaabachi W, 2014, MOL BIOL REP; Kaabachi W, 2014, MOL BIOL REP, V41, P6545, DOI 10.1007/s11033-014-3538-2; Kidd LCR, 2005, PROSTATE, V64, P272, DOI 10.1002/pros.20204; Kuper H, 2000, INT J CANCER, V85, P498, DOI 10.1002/(SICI)1097-0215(20000215)85:4&lt;498::AID-IJC9&gt;3.0.CO;2-F; Mohapatra S, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-37; Nykjaer A, 1999, CELL, V96, P507, DOI 10.1016/S0092-8674(00)80655-8; Pibiri F, 2014, CANCER CAUSE CONTROL, V25, P561, DOI 10.1007/s10552-014-0361-y; Powe CE, 2011, J BONE MINER RES, V26, P1609, DOI 10.1002/jbmr.387; Poynter JN, 2010, CANCER EPIDEM BIOMAR, V19, P525, DOI 10.1158/1055-9965.EPI-09-0662; Rasool Sabha, 2014, Oncol Res Treat, V37, P345, DOI 10.1159/000362859; Sarkissyan M, 2014, CANCER-AM CANCER SOC, V120, P1387, DOI 10.1002/cncr.28565; Seng KC, 2008, EUR J HUM GENET, V16, P554, DOI 10.1038/ejhg.2008.12; Shafia S, 2013, BLOOD CELL MOL DIS, V51, P56, DOI 10.1016/j.bcmd.2013.02.001; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Shui IM, 2012, JNCI-J NATL CANCER I, V104, P690, DOI 10.1093/jnci/djs189; Sinotte M, 2009, AM J CLIN NUTR, V89, P634, DOI 10.3945/ajcn.2008.26445; Slattery ML, 2007, NUTR REV, V65, pS102, DOI 10.1111/j.1753-4887.2007.tb00332.x; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Uitterlinden AG, 2004, GENE, V338, P143, DOI 10.1016/j.gene.2004.05.014; WALTERS MR, 1992, ENDOCR REV, V13, P719, DOI 10.1210/er.13.4.719; Wang W, 2014, INT J MOL EPIDEMIOL, V5, P31; Zhao XZ, 2014, ARCH DERMATOL RES, V306, P545, DOI 10.1007/s00403-014-1464-8; Zhou HY, 2009, CLIN ENDOCRINOL, V70, P938, DOI 10.1111/j.1365-2265.2008.03413.x; Zhou LQ, 2012, INT J CLIN EXP MED, V5, P72	39	34	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e116026	10.1371/journal.pone.0116026	http://dx.doi.org/10.1371/journal.pone.0116026			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541958	gold, Green Submitted, Green Published			2022-12-27	WOS:000347239900131
J	Perez-Trallero, E; Esnal, O; Marimon, JM				Perez-Trallero, Emilio; Esnal, Olatz; Marimon, Jose M.			Progressive Decrease in the Potential Usefulness of Meningococcal Serogroup B Vaccine (4CMenB, Bexsero (R)) in Gipuzkoa, Northern Spain	PLOS ONE			English	Article							MULTICOMPONENT VACCINE; STRAIN COVERAGE; DIVERSITY; IDENTIFICATION; CANDIDATE; ANTIGENS; PROTEIN; PORA; NADA	The effectiveness of a vaccine is determined not only by the immunogenicity of its components, but especially by how widely it covers the disease-causing strains circulating in a given region. Because vaccine coverage varies over time, this study aimed to detect possible changes that could affect vaccine protection during a specific period in a southern European region. The 4CMenB vaccine is licensed for use in Europe, Canada, and Australia and is mainly directed against Neisseria meningitidis serogroup B. This vaccine contains four main immunogenic components: three recombinant proteins, FHbp, Nhba and NadA, and an outer membrane vesicle [PorA P1.4]. The allelic distribution of FHbp, Nhba, NadA, and PorA antigens in 82 invasive isolates (B and non-B serogroups) isolated from January 2008 to December 2013 were analyzed. 4CMenB was likely protective against 61.8% and 50% of serogroup B and non-B meningococci, respectively, in the entire period, but between 2012 and 2013, the predicted protection fell below 45% (42.1% for serogroup B isolates). The observed decreasing trend in the predicted protection during the 6 years of the study (X-2 for trend = 4.68, p=0.03) coincided with a progressive decrease of several clonal complexes (e. g., cc11, cc32 and cc41/44), which had one or more antigens against which the vaccine would offer protection.	[Perez-Trallero, Emilio; Marimon, Jose M.] Hosp Donostia IIS Biodonostia, Microbiol Serv, San Sebastian, Spain; [Perez-Trallero, Emilio; Marimon, Jose M.] Hosp Donostia IIS Biodonostia, Reference Lab Meningococcal Infect Basque Country, San Sebastian, Spain; [Perez-Trallero, Emilio; Esnal, Olatz; Marimon, Jose M.] Biomed Res Ctr Network Resp Dis CIBERES, San Sebastian, Spain; [Perez-Trallero, Emilio] Univ Basque Country UPV EHU, Fac Med, San Sebastian, Spain	University Hospital Donostia; University Hospital Donostia; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; CIBERESP; University of Basque Country	Perez-Trallero, E (corresponding author), Hosp Donostia IIS Biodonostia, Microbiol Serv, San Sebastian, Spain.	mikrobiol@terra.com	MARIMON, JOSE MARIA/AAM-5581-2021	MARIMON, JOSE MARIA/0000-0002-2787-7094	Education Department of the Basque Country Government to the UPV/EHU [IT656-13]	Education Department of the Basque Country Government to the UPV/EHU	This work was supported by a grant from the Education Department of the Basque Country Government to the UPV/EHU (IT656-13). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, Prescrire Int, V23, P201; [Anonymous], CLON COMPL ASS SER B; [Anonymous], NEISS PORA VAR REGIO; Bambini S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065043; Bettinger JA, 2013, VACCINE, V32, P124, DOI 10.1016/j.vaccine.2013.03.063; Comanducci M, 2004, INFECT IMMUN, V72, P4217, DOI 10.1128/IAI.72.7.4217-4223.2004; Donnelly J, 2010, P NATL ACAD SCI USA, V107, P19490, DOI 10.1073/pnas.1013758107; Galloway Y, 2009, INT J EPIDEMIOL, V38, P413, DOI 10.1093/ije/dyn228; Giuliani MM, 2010, VACCINE, V28, P5023, DOI 10.1016/j.vaccine.2010.05.014; Harrison LH, 2009, VACCINE, V27, pB51, DOI 10.1016/j.vaccine.2009.04.063; Holst J, 2014, VACCINE, V32, P2722, DOI 10.1016/j.vaccine.2014.02.068; Hong E, 2013, VACCINE, V31, P1113, DOI 10.1016/j.vaccine.2012.12.022; Jacobsson S, 2006, VACCINE, V24, P2161, DOI 10.1016/j.vaccine.2005.11.006; Lucidarme J, 2010, CLIN VACCINE IMMUNOL, V17, P919, DOI 10.1128/CVI.00027-10; Lucidarme J, 2009, J CLIN MICROBIOL, V47, P3577, DOI 10.1128/JCM.00936-09; McNeil LK, 2013, MICROBIOL MOL BIOL R, V77, P234, DOI 10.1128/MMBR.00056-12; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Rappuoli R, 2000, CURR OPIN MICROBIOL, V3, P445, DOI 10.1016/S1369-5274(00)00119-3; Rodriguez AP, 1999, MEM I OSWALDO CRUZ, V94, P433, DOI 10.1590/S0074-02761999000400002; Sacchi CT, 1998, CLIN DIAGN LAB IMMUN, V5, P845, DOI 10.1128/CDLI.5.6.845-855.1998; Serruto D, 2012, VACCINE, V30, pB87, DOI 10.1016/j.vaccine.2012.01.033; Taha MK, 2000, J CLIN MICROBIOL, V38, P855, DOI 10.1128/JCM.38.2.855-857.2000; Tzanakaki G, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-111; Vicente D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008501; Vogel U, 2013, LANCET INFECT DIS, V13, P416, DOI 10.1016/S1473-3099(13)70006-9	25	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e0116024	10.1371/journal.pone.0116024	http://dx.doi.org/10.1371/journal.pone.0116024			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541709	Green Published, gold, Green Submitted			2022-12-27	WOS:000347239900130
J	Wang, S; Wei, W; Luo, XN; Cai, XP				Wang, Shuai; Wei, Wei; Luo, Xuenong; Cai, Xuepeng			Genome-Wide Comparisons of Phylogenetic Similarities between Partial Genomic Regions and the Full-Length Genome in Hepatitis E Virus Genotyping	PLOS ONE			English	Article							GENETIC-VARIABILITY; EVOLUTION; SEQUENCE; CLASSIFICATION; DIVERSITY; PROTEINS; TREES	Besides the complete genome, different partial genomic sequences of Hepatitis E virus (HEV) have been used in genotyping studies, making it difficult to compare the results based on them. No commonly agreed partial region for HEV genotyping has been determined. In this study, we used a statistical method to evaluate the phylogenetic performance of each partial genomic sequence from a genome wide, by comparisons of evolutionary distances between genomic regions and the full-length genomes of 101 HEV isolates to identify short genomic regions that can reproduce HEV genotype assignments based on full-length genomes. Several genomic regions, especially one genomic region at the 39-terminal of the papain-like cysteine protease domain, were detected to have relatively high phylogenetic correlations with the full-length genome. Phylogenetic analyses confirmed the identical performances between these regions and the full-length genome in genotyping, in which the HEV isolates involved could be divided into reasonable genotypes. This analysis may be of value in developing a partial sequence-based consensus classification of HEV species.	[Wang, Shuai; Wei, Wei; Luo, Xuenong; Cai, Xuepeng] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS	Cai, XP (corresponding author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China.	wslanzhou@126.com	WEI, Wei/AAK-9139-2021; Wang, Shuai/ABE-4447-2022	WEI, Wei/0000-0002-6478-5973; Wang, Shuai/0000-0001-7028-8503	National Natural Science Foundation of China [31372433]; Science Fund for Creative Research Groups of Gansu Province [1210RJIA006]; State Key Laboratory of Veterinary Etiological Biology of Lanzhou Veterinary Research Institute	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Fund for Creative Research Groups of Gansu Province(Science Fund for Creative Research Groups); State Key Laboratory of Veterinary Etiological Biology of Lanzhou Veterinary Research Institute	This study was financially supported by the National Natural Science Foundation of China (31372433), the Science Fund for Creative Research Groups of Gansu Province (Grant No. 1210RJIA006), and State Key Laboratory of Veterinary Etiological Biology of Lanzhou Veterinary Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao Z., 2013, PLOS ONE, V8; Bartholomeusz A, 2004, REV MED VIROL, V14, P3, DOI 10.1002/rmv.400; Chen GB, 2004, WORLD J GASTROENTERO, V10, P2045, DOI 10.3748/wjg.v10.i14.2045; Craig RA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-6; Goh CS, 2000, J MOL BIOL, V299, P283, DOI 10.1006/jmbi.2000.3732; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; Hngtyszyn HJ, 2005, ANTIVIR THER, V10, P1; Inoue J, 2006, J VIROL METHODS, V137, P325, DOI 10.1016/j.jviromet.2006.07.004; Kann MG, 2009, J MOL BIOL, V385, P91, DOI 10.1016/j.jmb.2008.09.078; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kumar S, 2012, BIOINFORMATICS, V28, P2685, DOI 10.1093/bioinformatics/bts507; Liu P, 2012, INFECT GENET EVOL, V12, P428, DOI 10.1016/j.meegid.2012.01.017; Lu L, 2006, REV MED VIROL, V16, P5, DOI 10.1002/rmv.482; Mirazo S, 2014, EMERG INFECT DIS, V20, P171, DOI 10.3201/eid2001.131471; Okamoto H, 2007, VIRUS RES, V127, P216, DOI 10.1016/j.virusres.2007.02.002; Oliveira EF, 2013, VET MICROBIOL, V165, P148, DOI 10.1016/j.vetmic.2013.01.026; Pazos F, 2001, PROTEIN ENG, V14, P609, DOI 10.1093/protein/14.9.609; Peralta B, 2009, VIRUS RES, V139, P111, DOI 10.1016/j.virusres.2008.09.008; PIONTEK M, 1991, Z GASTROENTEROL, V29, P43; Press W. H., 1992, ART SCI COMPUTING; Purdy MA, 2011, VIRUS RES, V161, P31, DOI 10.1016/j.virusres.2011.04.030; Raj VS, 2012, EMERG INFECT DIS, V18, P1369, DOI 10.3201/eid1808.111659; Schlauder GG, 2001, J MED VIROL, V65, P282, DOI 10.1002/jmv.2031; Smith DB, 2014, J GEN VIROL, V95, P2223, DOI 10.1099/vir.0.068429-0; Smith DB, 2013, J VIROL, V87, P4161, DOI 10.1128/JVI.02762-12; Smith DB, 2012, J GEN VIROL, V93, P2408, DOI 10.1099/vir.0.045351-0; Takahashi M, 2014, VIRUS RES, V180, P59, DOI 10.1016/j.virusres.2013.12.014; Takahashi M, 2011, J GEN VIROL, V92, P902, DOI 10.1099/vir.0.029470-0; Xun PC, 2007, INTERVIROLOGY, V50, P328, DOI 10.1159/000106805; Zhai LJ, 2006, VIRUS RES, V120, P57, DOI 10.1016/j.virusres.2006.01.013; Zhao CY, 2009, J MED VIROL, V81, P1371, DOI 10.1002/jmv.21536	31	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115785	10.1371/journal.pone.0115785	http://dx.doi.org/10.1371/journal.pone.0115785			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542033	Green Published, Green Submitted, gold			2022-12-27	WOS:000347239900087
J	Kipreos, ET				Kipreos, Edward T.			Implications of an Absolute Simultaneity Theory for Cosmology and Universe Acceleration	PLOS ONE			English	Article							RELATIVISTIC TIME GAINS; WORLD ATOMIC CLOCKS; LORENTZ INVARIANCE; EARTHS ROTATION; HYDROGEN-MASER; IA SUPERNOVAE; ONE-WAY; LIGHT; SPEED; VELOCITY	An alternate Lorentz transformation, Absolute Lorentz Transformation (ALT), has similar kinematics to special relativity yet maintains absolute simultaneity in the context of a preferred reference frame. In this study, it is shown that ALT is compatible with current experiments to test Lorentz invariance only if the proposed preferred reference frame is locally equivalent to the Earth-centered non-rotating inertial reference frame, with the inference that in an ALT framework, preferred reference frames are associated with centers of gravitational mass. Applying this theoretical framework to cosmological data produces a scenario of universal time contraction in the past. In this scenario, past time contraction would be associated with increased levels of blueshifted light emissions from cosmological objects when viewed from our current perspective. The observation that distant Type Ia supernovae are dimmer than predicted by linear Hubble expansion currently provides the most direct evidence for an accelerating universe. Adjusting for the effects of time contraction on a redshift-distance modulus diagram produces a linear distribution of supernovae over the full redshift spectrum that is consistent with a non-accelerating universe.	Univ Georgia, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Kipreos, ET (corresponding author), Univ Georgia, Athens, GA 30602 USA.	ekipreos@uga.edu						Ahmed MF, 2012, INDIAN J PHYS, V86, P835, DOI 10.1007/s12648-012-0112-4; Alley C, 1983, QUANTUM OPTICS EXPT, V94, P363; Amanullah R, 2010, ASTROPHYS J, V716, P712, DOI 10.1088/0004-637X/716/1/712; ANDERSON R, 1994, AM J PHYS, V62, P975, DOI 10.1119/1.17656; Ashby Neil, 2003, Living Rev Relativ, V6, P1, DOI 10.12942/lrr-2003-1; BAILEY J, 1977, NATURE, V268, P301, DOI 10.1038/268301a0; Bocquet JP, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.241601; Bunn EF, 2009, AM J PHYS, V77, P688, DOI 10.1119/1.3129103; CHAMPENEY DC, 1963, PHYS LETT, V7, P241, DOI 10.1016/0031-9163(63)90312-3; Chodorowski MJ, 2011, MON NOT R ASTRON SOC, V413, P585, DOI 10.1111/j.1365-2966.2010.18154.x; Chodorowski MJ, 2007, CONCEPTS PHYS, V4, P17; Davis TM, 2004, PUBL ASTRON SOC AUST, V21, P97, DOI 10.1071/AS03040; Eagle A, 1938, PHILOS MAG, V26, P410; Einstein A, 1905, ANN PHYS-BERLIN, V17, P891; Freedman WL, 2010, ANNU REV ASTRON ASTR, V48, P673, DOI 10.1146/annurev-astro-082708-101829; Frieman JA, 2008, ANNU REV ASTRON ASTR, V46, P385, DOI 10.1146/annurev.astro.46.060407.145243; FRISCH DH, 1963, AM J PHYS, V31, P342, DOI 10.1119/1.1969508; Goldhaber G, 1997, NATO ADV SCI I C-MAT, V486, P777; Gurzadyan VG, 2007, NUOVO CIMENTO B, V122, P515, DOI [10.1393/ncb/i2007-10393-7, 10.1393/neb/i2007-10393-7]; Gurzadyan VC, 2005, MOD PHYS LETT A, V20, P19, DOI 10.1142/S0217732305016294; HAFELE JC, 1972, SCIENCE, V177, P168, DOI 10.1126/science.177.4044.168; HAFELE JC, 1972, SCIENCE, V177, P166, DOI 10.1126/science.177.4044.166; Hubble E, 1929, P NATL ACAD SCI USA, V15, P168, DOI 10.1073/pnas.15.3.168; Janssen M, 2002, PHYS PERSPECT, V4, P421, DOI 10.1007/s000160200003; Katzir S, 2005, PHYS PERSPECT, V7, P268, DOI 10.1007/s00016-004-0234-y; Kowalski M, 2008, ASTROPHYS J, V686, P749, DOI 10.1086/589937; KRISHER TP, 1990, PHYS REV D, V42, P731, DOI 10.1103/PhysRevD.42.731; Larmor J., 1900, AETHER AND MATTER; Leibundgut B, 1996, ASTROPHYS J, V466, pL21, DOI 10.1086/310164; Lorentz H. A., 1895, VERSUCH THEORIE ELEK, P89; MANSOURI R, 1977, GEN RELAT GRAVIT, V8, P497, DOI 10.1007/BF00762634; MANSOURI R, 1977, GEN RELAT GRAVIT, V8, P809, DOI 10.1007/BF00759585; MANSOURI R, 1977, GEN RELAT GRAVIT, V8, P515, DOI 10.1007/BF00762635; Mattingly D, 2005, LIVING REV RELATIV, V8, DOI 10.12942/lrr-2005-5; Melia F, 2012, MON NOT R ASTRON SOC, V422, P1418, DOI 10.1111/j.1365-2966.2012.20714.x; Metromnia, 2005, DEM REL FLYING AT CL; Michelson AA, 1925, ASTROPHYS J, V61, P137, DOI 10.1086/142878; Michelson AA, 1925, ASTROPHYS J, V61, P140, DOI 10.1086/142879; MURDOCH HS, 1977, Q J ROY ASTRON SOC, V18, P242; Narlikar JV, 2001, ANNU REV ASTRON ASTR, V39, P211, DOI 10.1146/annurev.astro.39.1.211; National Physical Laboratory, 2011, NPL NEWS; Nussbaumer H, 2009, DISCOVERING THE EXPANDING UNIVERSE, P1; Pascual-Sanchez JF, 2007, ANN PHYS-BERLIN, V16, P258, DOI 10.1002/andp.200610229; Peebles PJE, 2012, ANNU REV ASTRON ASTR, V50, P1, DOI 10.1146/annurev-astro-081811-125526; Perlmutter S, 1999, ASTROPHYS J, V517, P565, DOI 10.1086/307221; Pospelov M, 2004, PHYS TODAY, V57, P40, DOI 10.1063/1.1784301; POST EJ, 1967, REV MOD PHYS, V39, P475, DOI 10.1103/RevModPhys.39.475; Preikschat E, 1968, THESIS U BIRMINGHAM; Puccini GD, 2002, NUOVO CIMENTO B, V117, P283; Riess AG, 1998, ASTRON J, V116, P1009, DOI 10.1086/300499; RIIS E, 1988, PHYS REV LETT, V60, P81, DOI 10.1103/PhysRevLett.60.81; Rindler W., 1977, ESSENTIAL RELATIVITY; Ryden B, 2003, INTRO COSMOLOGY; Sereno M, 2007, PHYS REV D, V75, DOI 10.1103/PhysRevD.75.064031; Smoot GF, 2007, REV MOD PHYS, V79, P1349, DOI 10.1103/RevModPhys.79.1349; Tangherlini, 1961, SUPPL NUOVO CIMENTO, V20, P1; Tangherlini F. R., 1958, THESIS STANFORD U; Tangherlini F.R, 2014, J MOD PHYS, V5, P230; TURNER KC, 1964, PHYS REV B, V134, pB252, DOI 10.1103/PhysRev.134.B252; VESSOT RFC, 1980, PHYS REV LETT, V45, P2081, DOI 10.1103/PhysRevLett.45.2081; VESSOT RFC, 1979, GEN RELAT GRAVIT, V10, P181, DOI 10.1007/BF00759854; Weinberg S., 2008, COSMOLOGY; Whittaker E., 1910, HIST THEORIES AETHER	63	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115550	10.1371/journal.pone.0115550	http://dx.doi.org/10.1371/journal.pone.0115550			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536116	Green Published, Green Submitted, gold			2022-12-27	WOS:000348563300047
J	Maro, JC; Fryback, DG; Lieu, TA; Lee, GM; Martin, DB				Maro, Judith C.; Fryback, Dennis G.; Lieu, Tracy A.; Lee, Grace M.; Martin, David B.			Responding to Vaccine Safety Signals during Pandemic Influenza: A Modeling Study	PLOS ONE			English	Article							GUILLAIN-BARRE-SYNDROME; SWINE-FLU; IMMUNIZATION-PROGRAM; SCHOOL CLOSURE; ADVERSE EVENTS; UNITED-STATES; H1N1; SURVEILLANCE; SIMULATION; MITIGATION	Background: Managing emerging vaccine safety signals during an influenza pandemic is challenging. Federal regulators must balance vaccine risks against benefits while maintaining public confidence in the public health system. Methods: We developed a multi-criteria decision analysis model to explore regulatory decision-making in the context of emerging vaccine safety signals during a pandemic. We simulated vaccine safety surveillance system capabilities and used an age-structured compartmental model to develop potential pandemic scenarios. We used an expert-derived multi-attribute utility function to evaluate potential regulatory responses by combining four outcome measures into a single measure of interest: 1) expected vaccination benefit from averted influenza; 2) expected vaccination risk from vaccine-associated febrile seizures; 3) expected vaccination risk from vaccine-associated Guillain-Barre Syndrome; and 4) expected change in vaccine-seeking behavior in future influenza seasons. Results: Over multiple scenarios, risk communication, with or without suspension of vaccination of high-risk persons, were the consistently preferred regulatory responses over no action or general suspension when safety signals were detected during a pandemic influenza. On average, the expert panel valued near-term vaccine-related outcomes relative to long-term projected outcomes by 3:1. However, when decision-makers had minimal ability to influence near-term outcomes, the response was selected primarily by projected impacts on future vaccine-seeking behavior. Conclusions: The selected regulatory response depends on how quickly a vaccine safety signal is identified relative to the peak of the pandemic and the initiation of vaccination. Our analysis suggested two areas for future investment: efforts to improve the size and timeliness of the surveillance system and behavioral research to understand changes in vaccine-seeking behavior.	[Maro, Judith C.; Lee, Grace M.] Harvard Univ, Sch Med, Dept Populat Med, Boston, MA 02138 USA; [Maro, Judith C.; Lee, Grace M.] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Fryback, Dennis G.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Populat Hlth Sci, Madison, WI USA; [Lieu, Tracy A.] Kaiser Permanente No Calif, Div Res, Oakland, CA USA; [Martin, David B.] Food & Drug Adm, Ctr Biol Evaluat & Res, Silver Spring, MD USA	Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; University of Wisconsin System; University of Wisconsin Madison; Kaiser Permanente	Maro, JC (corresponding author), Harvard Univ, Sch Med, Dept Populat Med, Boston, MA 02138 USA.	jmaro@mit.edu		Maro, Judith/0000-0001-9900-2142	Mini-Sentinel Contract; U.S. Food and Drug Administration (USFDA) through the Department of Health and Human Services [HHSF223200910006I]	Mini-Sentinel Contract; U.S. Food and Drug Administration (USFDA) through the Department of Health and Human Services	This project is supported by the Mini-Sentinel Contract, which is funded by the U.S. Food and Drug Administration (USFDA) through the Department of Health and Human Services Contract Number HHSF223200910006I. The funders had no role in data collection and analysis. The USFDA reviewed and approved this report before submission.	Armstrong PK, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2010-000016; Bansal S, 2006, PLOS MED, V3, P1816, DOI 10.1371/journal.pmed.0030387; BASS FM, 1969, MANAGE SCI, V15, P215, DOI 10.1287/mnsc.15.5.215; Bish A, 2011, VACCINE, V29, P6472, DOI 10.1016/j.vaccine.2011.06.107; Blyth CC, 2014, VACCINE, V32, P4075, DOI 10.1016/j.vaccine.2014.05.055; Bohmer MM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-938; Brown ST, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-353; Bults M, 2011, VACCINE, V29, P6226, DOI 10.1016/j.vaccine.2011.06.075; Chao DL, 2011, AM J EPIDEMIOL, V173, P1121, DOI 10.1093/aje/kwq497; Conway JM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-932; Cooley P, 2011, J URBAN HEALTH, V88, P982, DOI 10.1007/s11524-011-9603-4; Davey VJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002606; Dodd CN, 2013, VACCINE, V31, P4448, DOI 10.1016/j.vaccine.2013.06.032; European Medicines Agency, 2010, BENEFIT RISK METHODO; FIELDING JE, 1978, AM J LAW MED, V4, P35; Gaydos JC, 2006, EMERG INFECT DIS, V12, P23, DOI 10.3201/eid1201.050965; Geroski PA, 2000, RES POLICY, V29, P603, DOI 10.1016/S0048-7333(99)00092-X; Gold MR, 2002, ANNU REV PUBL HEALTH, V23, P115, DOI 10.1146/annurev.publhealth.23.100901.140513; Halloran ME, 2008, P NATL ACAD SCI USA, V105, P4639, DOI 10.1073/pnas.0706849105; Hilleman MR, 1996, JAMA-J AM MED ASSOC, V275, P241, DOI 10.1001/jama.275.3.241; Horney JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011226; Iskander J, 2013, EMERG INFECT DIS, V19, P879, DOI 10.3201/eid1906.121478; Keeney R. L., 1976, DECISIONS WITH MULTI; Keeney RL, 2011, J RISK UNCERTAINTY, V43, P1, DOI 10.1007/s11166-011-9121-5; Keeney RL, 2013, FOUNDATIONS FOR GROU; Kenah E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019515; Knipl DH, 2011, MATH BIOSCI ENG, V8, P123, DOI 10.3934/mbe.2011.8.123; Knobler SL, 2005, THE THREAT OF PANDEM; Krause R, 2006, EMERG INFECT DIS, V12, P40, DOI 10.3201/eid1201.051132; Lee BY, 2011, HUM VACCINES, V7, P115, DOI 10.4161/hv.7.1.13740; Lee BY, 2010, VACCINE, V28, P4875, DOI 10.1016/j.vaccine.2010.05.002; Lee GM, 2011, AM J PREV MED, V41, P121, DOI 10.1016/j.amepre.2011.04.004; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Maro JC, 2013, EPIDEMIOLOGY, V24, P692, DOI 10.1097/EDE.0b013e31829dde59; Matrajt L, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002964; Medlock J, 2009, SCIENCE, V325, P1705, DOI 10.1126/science.1175570; Nguyen M, 2012, PHARMACOEPIDEM DR S, V21, P291, DOI 10.1002/pds.2323; National Research Council, 1978, THE SWINE FLU AFFAIR; Peres R, 2010, INT J RES MARK, V27, P91, DOI 10.1016/j.ijresmar.2009.12.012; Petousis-Harris H, 2012, VACCINE, V30, P4945, DOI 10.1016/j.vaccine.2012.05.052; Poland GA, 2010, VACCINE, V28, pD3, DOI 10.1016/j.vaccine.2010.08.024; Potter MA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-977; Salmon DA, 2013, LANCET, V381, P1461, DOI 10.1016/S0140-6736(12)62189-8; Salmon DA, 2011, PEDIATRICS, V127, pS78, DOI 10.1542/peds.2010-1722L; SCHONBERGER LB, 1979, AM J EPIDEMIOL, V110, P105, DOI 10.1093/oxfordjournals.aje.a112795; Sencer DJ, 2011, CLIN INFECT DIS, V52, pS4, DOI 10.1093/cid/ciq006; Sencer DJ, 2006, EMERG INFECT DIS, V12, P29; Stoto MA, 2002, PUBLIC HEALTH REP, V117, P546, DOI 10.1016/S0033-3549(04)50199-1; Tse A, 2012, VACCINE, V30, P2024, DOI 10.1016/j.vaccine.2012.01.027; Wagner M, 2011, ONLINE J PUBLIC HEAL, V3, DOI [10.5210/ojphi.v3i3.3798, DOI 10.5210/OJPHI.V3I3.3798]; WECHT CH, 1978, AM J LAW MED, V3, P425; WHO, 2009, PANDEMIC INFLUENZA P; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373; Yih WK, 2012, AM J EPIDEMIOL, V175, P1120, DOI 10.1093/aje/kws197; Yih WK, 2013, ACCESSING THE FRESHE	56	9	9	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115553	10.1371/journal.pone.0115553	http://dx.doi.org/10.1371/journal.pone.0115553			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ9UY	25536228	Green Published, Green Submitted, gold			2022-12-27	WOS:000348563300048
J	Vonck, S; Staelens, AS; Mesens, T; Tomsin, K; Gyselaers, W				Vonck, Sharona; Staelens, Anneleen Simone; Mesens, Tinne; Tomsin, Kathleen; Gyselaers, Wilfried			Hepatic Hemodynamics and Fetal Growth: A Relationship of Interest for Further Research	PLOS ONE			English	Article							MATERNAL CARDIAC-FUNCTION; IMPEDANCE CARDIOGRAPHY; VENOUS HEMODYNAMICS; NORMAL-PREGNANCY; PREECLAMPSIA; OUTPUT; RELIABILITY; LIMITATIONS; HEART	Background: It is well known that hepatic hemodynamics is an important physiologic mechanism in the regulation of cardiac output (CO). It has been reported that maternal cardiac output relates to neonatal weight at birth. Aims: In this study, we assessed the correlation between maternal hepatic vein Doppler flow parameters, cardiac output and neonatal birth weight. Methods: Healthy women with uncomplicated second or third trimester pregnancy attending the outpatient antenatal clinic of Ziekenhuis Oost-Limburg in Genk (Belgium), had a standardized combined electrocardiogram-Doppler ultrasound with Impedance Cardiography, for measurement of Hepatic Vein Impedance Index (HVI = [maximum velocity - minimum velocity]/maximum velocity), venous pulse transit time (VPTT = time interval between corresponding ECG and Doppler wave characteristics) and cardiac output (heart rate x stroke volume). After delivery, a population-specific birth weight chart, established from a cohort of 27000 neonates born in the index hospital, was used to define customized birth weight percentiles (BW%). Correlations between HVI, VPTT, CO and BW% were calculated using Spearman's rho, linear regression analysis and R-2 goodness of fit in SPSS 22.0. Results: A total of 73 women were included. There was a negative correlation between HVI and VPTT (rho = -0.719, p<0.001). Both HVI and VPTT correlated with CO (rho = -0.403, p<0.001 and rho=0.332, p<0.004 resp.) and with BW% (rho=-0.341, p<0.003 and rho=0.296, p<0.011 resp.) Conclusion: Our data illustrate that the known contribution of hepatic hemodynamics in the regulation of cardiac output is also true for women with uncomplicated pregnancies. Our study is the first to illustrate a potential link between maternal hepatic hemodynamics and neonatal birth weight. Whether this link is purely associative or whether hepatic vascular physiology has a direct impact on fetal growth is to be evaluated in more extensive clinical and experimental research.	[Vonck, Sharona; Staelens, Anneleen Simone; Gyselaers, Wilfried] Hasselt Univ, Fac Med & Life Sci, Hasselt, Belgium; [Vonck, Sharona; Staelens, Anneleen Simone; Mesens, Tinne; Tomsin, Kathleen; Gyselaers, Wilfried] Ziekenhuis Oost Limburg, Dept Obstet Gynaecol, Genk, Belgium; [Gyselaers, Wilfried] Hasselt Univ, Dept Physiol, Hasselt, Belgium	Hasselt University; East Limburg Hospital; Hasselt University	Vonck, S (corresponding author), Hasselt Univ, Fac Med & Life Sci, Hasselt, Belgium.	sharona.vonck@zol.be	Vonck, Sharona/AAM-9019-2021		Agency for Innovation by Science and Technology (IWT) in Brussels, Belgium; Limburg Clinical Research Project (LCRP) at Hasselt University, Belgium	Agency for Innovation by Science and Technology (IWT) in Brussels, Belgium; Limburg Clinical Research Project (LCRP) at Hasselt University, Belgium	This research is funded by a Ph.D. grant from the Agency for Innovation by Science and Technology (IWT) in Brussels, Belgium and part of the Limburg Clinical Research Project (LCRP) at Hasselt University, Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamfo JEAK, 2007, ULTRASOUND OBST GYN, V29, P51, DOI 10.1002/uog.3901; Boron W, 2005, MED PHYSL, P448; Bosio PM, 1999, OBSTET GYNECOL, V94, P978, DOI 10.1016/S0029-7844(99)00430-5; CLARK SL, 1994, OBSTET GYNECOL, V83, P669; Desai DK, 2004, OBSTET GYNECOL, V104, P20, DOI 10.1097/01.AOG.0000128170.15161.1d; DUVEKOT JJ, 1995, ACTA OBSTET GYN SCAN, V74, P693, DOI 10.3109/00016349509021176; DUVEKOT JJ, 1993, AM J OBSTET GYNECOL, V169, P1382, DOI 10.1016/0002-9378(93)90405-8; Gelman S, 2008, ANESTHESIOLOGY, V108, P735, DOI 10.1097/ALN.0b013e3181672607; Gelson E, 2011, OBSTET GYNECOL, V117, P886, DOI 10.1097/AOG.0b013e31820cab69; GUYTON AC, 1968, ANESTHESIOLOGY, V29, P314, DOI 10.1097/00000542-196803000-00016; GUYTON AC, 1959, AM J PHYSIOL, V196, P1008, DOI 10.1152/ajplegacy.1959.196.5.1008; Gyselaers W, 2011, ULTRASOUND OBST GYN, V38, P123, DOI 10.1002/uog.9061; Gyselaers W., 2014, ULTRASOUND OBSTET GY; Gyselaers W, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-212; Klabunde R., 2011, CARDIOVASCULAR PHYSL, P60; Laut W, 2009, CAPACITANCE HEPATIC; LAUTT WW, 1976, AM J PHYSIOL, V231, P292, DOI 10.1152/ajplegacy.1976.231.2.292; Matsunaga T, 1984, Nihon Sanka Fujinka Gakkai Zasshi, V36, P795; Moertl MG, 2012, PHYSIOL MEAS, V33, P1015, DOI 10.1088/0967-3334/33/6/1015; Oben J, 2014, J MATERN FETAL NEONA; Staelens A, 2013, EXPERT REV MED DEVIC, V10, P765, DOI 10.1586/17434440.2013.853466; Staelens ASE, 2014, ULTRASOUND MED BIOL, V40, P1722, DOI 10.1016/j.ultrasmedbio.2014.01.014; Tomsin K, 2013, FACTS VIEWS VIS OBGY, V5, P116; Tomsin K, 2012, Ultraschall Med, V33, pE119, DOI 10.1055/s-0029-1245698; Tomsin K, 2012, J OBSTET GYNAECOL, V32, P630, DOI 10.3109/01443615.2012.673036; Tomsin K, 2013, EUR J OBSTET GYN R B, V169, P218, DOI 10.1016/j.ejogrb.2013.03.016; Tomsin K, 2013, CLIN EXP PHARMACOL P, V40, P438, DOI 10.1111/1440-1681.12105; Tomsin K, 2012, REPROD SCI, V19, P431, DOI 10.1177/1933719111424440; Tomsin K, 2011, CLIN PHYSIOL FUNCT I, V31, P145, DOI 10.1111/j.1475-097X.2010.00993.x; Turan OM, 2008, ULTRASOUND OBST GYN, V32, P849, DOI 10.1002/uog.5354; Valensise H, 2003, ACTA DIABETOL, V40, pS216, DOI 10.1007/s00592-003-0070-6; Vasapollo B, 2004, ULTRASOUND OBST GYN, V24, P23, DOI 10.1002/uog.1095	32	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115594	10.1371/journal.pone.0115594	http://dx.doi.org/10.1371/journal.pone.0115594			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536071	Green Published, Green Submitted, gold			2022-12-27	WOS:000348563300053
J	Warland, J; Dorrian, J				Warland, Jane; Dorrian, Jillian			Accuracy of Self-Reported Sleep Position in Late Pregnancy	PLOS ONE			English	Article							INTRAUTERINE RESUSCITATION; MATERNAL SLEEP; DURATION; WOMEN; RISK; STILLBIRTH; DISORDERS; QUALITY; LABOR	Background: There is emerging research to suggest that supine maternal sleep position in late pregnancy may adversely affect fetal wellbeing. However, these studies have all been based on maternal report of sleeping position. Before recommendations to change sleep position can be made it is important to determine the validity of these studies by investigating how accurate pregnant women are in reporting their sleep position. If avoiding the supine sleeping position reduces risk of poor pregnancy outcome, it is also important to know how well women can comply with the instruction to avoid this position and sleep on their left. Method: Thirty women in late pregnancy participated in a three-night observational study and were asked to report their sleeping position. This was compared to sleep position as recorded by a night capable video recording. The participants were instructed to settle to sleep on their left side and if they woke overnight to settle back to sleep on their left. Results: There was a moderate correlation between reported and video-determined left-side sleep time (r = 0.48), mean difference = 3 min (SD = 3.5 h). Participants spent an average of 59.60% (SD = 16.73%) of time in bed on their left side (ICC across multiple nights = 0.67). Those who included left side among their typical sleep positions reported significantly longer sleep during the study (p < 0.01). Conclusions: On average participant reports of sleep position were relatively accurate but there were large individual differences in reporting accuracy and in objectively-determined time on left side. Night-to-night consistency was substantial. For those who do not ordinarily sleep on that side, asking participants to sleep on their left may result in reduced sleep duration. This is an important consideration during a sleep-critical time such as late pregnancy.	[Warland, Jane] Univ S Australia, Sch Nursing & Midwifery, Adelaide, SA 5001, Australia; [Dorrian, Jillian] Univ S Australia, Sch Psychol Social Work & Social Policy, Adelaide, SA 5001, Australia; [Dorrian, Jillian] Univ S Australia, Ctr Sleep Res, Adelaide, SA 5001, Australia	Flinders University South Australia; University of South Australia; University of South Australia; University of South Australia	Warland, J (corresponding author), Univ S Australia, Sch Nursing & Midwifery, Adelaide, SA 5001, Australia.	jane.warland@unisa.edu.au	Dorrian, Jillian/C-1339-2010; Warland, Jane/B-1760-2009; Dorrian, Jillian/K-6496-2019	Dorrian, Jillian/0000-0002-6485-1643; Warland, Jane/0000-0002-9390-787X; 	University of South Australia School of Nursing and Midwifery research development grant	University of South Australia School of Nursing and Midwifery research development grant	The project was funded by a University of South Australia School of Nursing and Midwifery research development grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew H W Jr, 1966, Psychophysiology, V2, P263, DOI 10.1111/j.1469-8986.1966.tb02650.x; Aldrich CJ, 2005, BJOG, V102, P14; American Pregnancy Association, 2014, SLEEP POS PREGN; Chang JJ, 2010, SLEEP MED REV, V14, P107, DOI 10.1016/j.smrv.2009.05.001; Chappell LC, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3659; Cluver C, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007623.pub3; Cooke K, 2009, UP DUFF, P276; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; Farine D, 2007, J OBSTET GYNAECOL CA, V29, P841, DOI 10.1016/S1701-2163(16)32633-0; Gangwisch JE, 2007, SLEEP, V30, P1667, DOI 10.1093/sleep/30.12.1667; Gordon A, OBSTET GYNE IN PRESS; Herring SJ, 2014, SLEEP MED, V15, P51, DOI 10.1016/j.sleep.2013.07.018; HOLMES F, 1960, Anaesthesia, V15, P298, DOI 10.1111/j.1365-2044.1960.tb13341.x; Hutchison BL, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-144; Kavey NB, 1982, SLEEP RES, P152; KERR MG, 1964, BRIT MED J, V1, P532; McCowan L, 2014, SUPINE SLEEP POSITIO, P54; MILLS GH, 1994, ANAESTHESIA, V49, P249; Murkoff H, 2008, WHAT EXPECT YOU ARE, P247; O'Brien LM, 2014, EARLY HUM DEV, V90, P315, DOI 10.1016/j.earlhumdev.2014.03.001; O'Keeffe M, 2013, INT J OBESITY, V37, P765, DOI 10.1038/ijo.2012.142; Okun ML, 2007, J REPROD IMMUNOL, V73, P158, DOI 10.1016/j.jri.2006.06.006; Okun ML, 2011, SLEEP, V34, P1493, DOI 10.5665/sleep.1384; Owusu JT, 2013, INT J GYNECOL OBSTET, V121, P261, DOI 10.1016/j.ijgo.2013.01.013; Platts J, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-171; Qiu CF, 2010, BMC WOMENS HEALTH, V10, DOI 10.1186/1472-6874-10-17; Signal TL, 2007, AUST NZ J OBSTET GYN, V47, P16, DOI 10.1111/j.1479-828X.2006.00672.x; Simpson KR, 2005, OBSTET GYNECOL, V105, P1362, DOI 10.1097/01.AOG.0000164474.03350.7c; Stacey T, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3403; Thurlow JA, 2002, INT J OBSTET ANESTH, V11, P105, DOI 10.1054/ijoa.2001.0933; Trott P, 2004, J ALLIED HLTH SCI PR, V2, P7; Van Dongen HPA, 2004, METHOD ENZYMOL, V384, P139; Williams MA, 2010, SLEEP, V33, P1363, DOI 10.1093/sleep/33.10.1363	33	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115760	10.1371/journal.pone.0115760	http://dx.doi.org/10.1371/journal.pone.0115760			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25535960	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000348563300069
J	Bailey, KM; Cornnell, HH; Ibrahim-Hashim, A; Wojtkowiak, JW; Hart, CP; Zhang, XM; Leos, R; Martinez, GV; Baker, AF; Gillies, RJ				Bailey, Kate M.; Cornnell, Heather H.; Ibrahim-Hashim, Arig; Wojtkowiak, Jonathan W.; Hart, Charles P.; Zhang, Xiaomeng; Leos, Rafael; Martinez, Gary V.; Baker, Amanda F.; Gillies, Robert J.			Evaluation of the "Steal" Phenomenon on the Efficacy of Hypoxia Activated Prodrug TH-302 in Pancreatic Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; TUMOR OXYGENATION; IN-VIVO; TIRAPAZAMINE; METABOLISM; CISPLATIN; HYDRALAZINE; METASTASES; RADIATION; DEFECTS	Pancreatic ductal adenocarcinomas are desmoplastic and hypoxic, both of which are associated with poor prognosis. Hypoxia-activated prodrugs (HAPs) are specifically activated in hypoxic environments to release cytotoxic or cytostatic effectors. TH-302 is a HAP that is currently being evaluated in a Phase III clinical trial in pancreatic cancer. Using animal models, we show that tumor hypoxia can be exacerbated using a vasodilator, hydralazine, improving TH-302 efficacy. Hydralazine reduces tumor blood flow through the "steal" phenomenon, in which atonal immature tumor vasculature fails to dilate in coordination with normal vasculature. We show that MIA PaCa-2 tumors exhibit a "steal" effect in response to hydralazine, resulting in decreased tumor blood flow and subsequent tumor pH reduction. The effect is not observed in SU.86.86 tumors with mature tumor vasculature, as measured by CD31 and smooth muscle actin (SMA) immunohistochemistry staining. Combination therapy of hydralazine and TH-302 resulted in a reduction in MIA PaCa-2 tumor volume growth after 18 days of treatment. These studies support a combination mechanism of action for TH-302 with a vasodilator that transiently increases tumor hypoxia.	[Bailey, Kate M.; Cornnell, Heather H.; Ibrahim-Hashim, Arig; Wojtkowiak, Jonathan W.; Zhang, Xiaomeng; Martinez, Gary V.; Gillies, Robert J.] H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Imaging & Metab, Tampa, FL 33612 USA; [Bailey, Kate M.; Cornnell, Heather H.; Ibrahim-Hashim, Arig; Wojtkowiak, Jonathan W.; Zhang, Xiaomeng; Martinez, Gary V.; Gillies, Robert J.] Res Inst, Tampa, FL 33612 USA; [Gillies, Robert J.] H Lee Moffitt Canc Ctr & Res Inst, Dept Radiol, Tampa, FL 33612 USA; [Leos, Rafael; Baker, Amanda F.] Univ Arizona, Coll Med, Arizona Canc Ctr, Hematol Oncol Sect, Tucson, AZ 85724 USA; [Hart, Charles P.] Threshold Pharmaceut, San Francisco, CA 94080 USA; [Bailey, Kate M.] Univ S Florida, Canc Biol PhD Program, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; Arizona Center Cancer Care; University of Arizona; State University System of Florida; University of South Florida	Gillies, RJ (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Imaging & Metab, Tampa, FL 33612 USA.	Robert.Gillies@Moffitt.org		Hart, Charles/0000-0003-4440-726X	 [R01CA125627-02];  [R01CA077575-10];  [P30CA076292-16];  [P30CA023074-35]; NATIONAL CANCER INSTITUTE [R01CA077575, R01CA125627, P30CA076292, P30CA023074] Funding Source: NIH RePORTER	; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by grants R01CA125627-02; R01CA077575-10; P30CA076292-16 (Robert J. Gillies) and P30CA023074-35 (Amanda F. Baker). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi E, 1999, ONCOL RES, V11, P179; Bhujwalla Z M, 1990, NMR Biomed, V3, P178, DOI 10.1002/nbm.1940030406; BHUJWALLA ZM, 1990, RADIOTHER ONCOL, V19, P281, DOI 10.1016/0167-8140(90)90155-P; Bhujwalla ZM, 1996, MAGN RESON MED, V36, P204, DOI 10.1002/mrm.1910360206; Borad MJ, 2012, P 103 ANN M AM ASS C, pLB; Brizel DM, 1996, CANCER RES, V56, P941; Cairns RA, 2007, P NATL ACAD SCI USA, V104, P9445, DOI 10.1073/pnas.0611662104; Cardenas-Rodriguez J, 2012, MAGN RESON IMAGING, V30, P1002, DOI 10.1016/j.mri.2012.02.015; Chu GC, 2007, J CELL BIOCHEM, V101, P887, DOI 10.1002/jcb.21209; Dorie MJ, 1997, CANCER CHEMOTH PHARM, V39, P361, DOI 10.1007/s002800050584; Duan JX, 2008, J MED CHEM, V51, P2412, DOI 10.1021/jm701028q; Erkan MM, 2009, NEOPLASIA, V11, P497, DOI 10.1593/neo.81618; GATENBY RA, 1988, INT J RADIAT ONCOL, V14, P831, DOI 10.1016/0360-3016(88)90002-8; Gatzemeier U, 1998, BRIT J CANCER, V77, P15, DOI 10.1038/bjc.1998.431; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hicks KO, 2010, CLIN CANCER RES, V16, P4946, DOI 10.1158/1078-0432.CCR-10-1439; Hicks KO, 1998, INT J RADIAT ONCOL, V42, P641, DOI 10.1016/S0360-3016(98)00268-5; HORSMAN MR, 1995, BRIT J CANCER, V72, P1474, DOI 10.1038/bjc.1995.532; Junttila MR, 2013, NATURE, V501, P346, DOI 10.1038/nature12626; Kyle AH, 1999, CANCER CHEMOTH PHARM, V43, P213, DOI 10.1007/s002800050886; Le QTX, 2009, J CLIN ONCOL, V27, P3014, DOI 10.1200/JCO.2008.21.3868; Liu Q, 2012, CANCER CHEMOTH PHARM, V69, P1487, DOI 10.1007/s00280-012-1852-8; Mahadevan D, 2007, MOL CANCER THER, V6, P1186, DOI 10.1158/1535-7163.MCT-06-0686; Matsumoto S, 2014, ANTIOXIDANTS REDOX S; Meng FY, 2012, MOL CANCER THER, V11, P740, DOI 10.1158/1535-7163.MCT-11-0634; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Reddy SB, 2009, EXPERT OPIN INV DRUG, V18, P77, DOI [10.1517/13543780802567250, 10.1517/13543780802567250 ]; Rischin D, 2010, J CLIN ONCOL, V28, P2989, DOI 10.1200/JCO.2009.27.4449; Saito K, 2012, MAGN RESON MED, V67, P801, DOI 10.1002/mrm.23065; SECOMB TW, 1995, ACTA ONCOL, V34, P313, DOI 10.3109/02841869509093981; Society AC, 2014, CANC FACTS FIG 2014; Sun JD, 2012, CLIN CANCER RES, V18, P758, DOI 10.1158/1078-0432.CCR-11-1980; Takakusagi Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107995; TEICHER BA, 1994, CANCER METAST REV, V13, P139, DOI 10.1007/BF00689633; TROTTER MJ, 1989, INT J RADIAT ONCOL, V17, P785, DOI 10.1016/0360-3016(89)90067-9; Van der Heijden MS, 2004, AM J PATHOL, V165, P651, DOI 10.1016/S0002-9440(10)63329-9; Weinmann M, 2004, FASEB J, V18, P1906, DOI 10.1096/fj.04-1918fje; Wojtkowiak JW, 2014, CANC METABO IN PRESS; Zhang XM, 2010, J NUCL MED, V51, P1167, DOI 10.2967/jnumed.109.068981	40	17	17	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e113586	10.1371/journal.pone.0113586	http://dx.doi.org/10.1371/journal.pone.0113586			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25532146	gold, Green Published, Green Submitted			2022-12-27	WOS:000348845100005
J	Gordon, KA; Deighton, MR; Abbasalipour, P; Papsin, BC				Gordon, Karen A.; Deighton, Michael R.; Abbasalipour, Parvaneh; Papsin, Blake C.			Perception of Binaural Cues Develops in Children Who Are Deaf through Bilateral Cochlear Implantation	PLOS ONE			English	Article							AUDITORY BRAIN-STEM; UNILATERAL HEARING-LOSS; PLACE-OF-STIMULATION; SOUND LOCALIZATION; ELECTRICAL-STIMULATION; SPEECH-LANGUAGE; USERS; LATERALIZATION; SENSITIVITY; INHIBITION	There are significant challenges to restoring binaural hearing to children who have been deaf from an early age. The uncoordinated and poor temporal information available from cochlear implants distorts perception of interaural timing differences normally important for sound localization and listening in noise. Moreover, binaural development can be compromised by bilateral and unilateral auditory deprivation. Here, we studied perception of both interaural level and timing differences in 79 children/adolescents using bilateral cochlear implants and 16 peers with normal hearing. They were asked on which side of their head they heard unilaterally or bilaterally presented click-or electrical pulse- trains. Interaural level cues were identified by most participants including adolescents with long periods of unilateral cochlear implant use and little bilateral implant experience. Interaural timing cues were not detected by new bilateral adolescent users, consistent with previous evidence. Evidence of binaural timing detection was, for the first time, found in children who had much longer implant experience but it was marked by poorer than normal sensitivity and abnormally strong dependence on current level differences between implants. In addition, children with prior unilateral implant use showed a higher proportion of responses to their first implanted sides than children implanted simultaneously. These data indicate that there are functional repercussions of developing binaural hearing through bilateral cochlear implants, particularly when provided sequentially; nonetheless, children have an opportunity to use these devices to hear better in noise and gain spatial hearing.	[Gordon, Karen A.; Deighton, Michael R.; Abbasalipour, Parvaneh; Papsin, Blake C.] Hosp Sick Children, Archies Cochlear Implant Lab, Toronto, ON M5G 1X8, Canada; [Gordon, Karen A.; Papsin, Blake C.] Univ Toronto, Dept Otolaryngol Head & Neck Surg, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Gordon, KA (corresponding author), Hosp Sick Children, Archies Cochlear Implant Lab, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	karen.gordon@utoronto.ca			Canadian Institutes of Health Research Team Grant	Canadian Institutes of Health Research Team Grant(Canadian Institutes of Health Research (CIHR))	Funding provided by a Canadian Institutes of Health Research Team Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein LR, 2002, J ACOUST SOC AM, V112, P1026, DOI 10.1121/1.1497620; Bernstein LR, 2001, J NEUROSCI RES, V66, P1035, DOI 10.1002/jnr.10103; Bierer JA, 2010, EAR HEAR; Brand A, 2002, NATURE, V417, P543, DOI 10.1038/417543a; Chadha NK, 2011, OTOL NEUROTOL, V32, P1057, DOI 10.1097/MAO.0b013e3182267de7; Colburn HS, 2009, JARO-J ASSOC RES OTO, V10, P91, DOI 10.1007/s10162-008-0141-z; Geers AE, 2004, ARCH OTOLARYNGOL, V130, P634, DOI 10.1001/archotol.130.5.634; Geers AE, 2013, J SPEECH LANG HEAR R, V56, P643, DOI 10.1044/1092-4388(2012/11-0347); Gordon KA, 2006, AUDIOL NEURO-OTOL, V11, P7, DOI 10.1159/000088851; Gordon KA, 2012, COCHLEAR IMPLANTS IN; Gordon KA, 2008, OTOL NEUROTOL, V29, P193, DOI 10.1097/mao.0b013e318162514c; Gordon KA, 2013, BRAIN, V136, P1609, DOI 10.1093/brain/awt052; Gordon KA, 2012, J NEUROSCI, V32, P4212, DOI 10.1523/JNEUROSCI.5741-11.2012; Gordon KA, 2010, OTOL NEUROTOL, V31, P1293, DOI 10.1097/MAO.0b013e3181e8f965; Gordon KA, 2009, OTOL NEUROTOL, V30, P319, DOI 10.1097/MAO.0b013e31819a8f4c; Gordon Karen Ann, 2012, Cochlear Implants Int, V13, P220, DOI 10.1179/1754762811Y.0000000022; Goupell MJ, 2013, J ACOUST SOC AM, V133, P2272, DOI 10.1121/1.4792936; Graham John, 2009, Cochlear Implants Int, V10, P119, DOI 10.1179/cim.2009.10.3.119; Grieco-Calub TM, 2010, EAR HEARING, V31, P645, DOI 10.1097/AUD.0b013e3181e50a1d; Grothe B, 2010, PHYSIOL REV, V90, P983, DOI 10.1152/physrev.00026.2009; Hopyan T, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00425; Illg A, 2013, OTOL NEUROTOL, V34, P682, DOI 10.1097/MAO.0b013e31828bb75e; Ingham NJ, 2005, J NEUROSCI, V25, P6187, DOI 10.1523/JNEUROSCI.0146-05.2005; JEFFRESS LA, 1948, J COMP PHYSIOL PSYCH, V41, P35, DOI 10.1037/h0061495; Kan A, 2013, J ACOUST SOC AM, V134, P2923, DOI 10.1121/1.4820889; Kerber S, 2012, EAR HEARING, V33, P445, DOI 10.1097/AUD.0b013e318257607b; Kral A, 2013, BRAIN, V136, P180, DOI 10.1093/brain/aws305; Kral A, 2010, NEW ENGL J MED, V363, P1438, DOI 10.1056/NEJMra0911225; Lieu JEC, 2013, B-ENT, V9, P107; Lieu JEC, 2004, ARCH OTOLARYNGOL, V130, P524, DOI 10.1001/archotol.130.5.524; Lieu JEC, 2010, PEDIATRICS, V125, pE1348, DOI 10.1542/peds.2009-2448; Litovsky RY, 2012, J AM ACAD AUDIOL, V23, P476, DOI 10.3766/jaaa.23.6.9; Litovsky RY, 2010, J ACOUST SOC AM, V127, P400, DOI 10.1121/1.3257546; Loizou PC, 2009, J ACOUST SOC AM, V125, P372, DOI 10.1121/1.3036175; Magnusson AK, 2005, J PHYSIOL-LONDON, V568, P497, DOI 10.1113/jphysiol.2005.094763; Moore DR, 2009, NAT NEUROSCI, V12, P686, DOI 10.1038/nn.2326; Papsin BC, 2008, CURR OPIN OTOLARYNGO, V16, P69, DOI 10.1097/MOO.0b013e3282f5e97c; Papsin BC, 2007, NEW ENGL J MED, V357, P2380, DOI 10.1056/NEJMct0706268; Salloum CAM, 2010, EAR HEARING, V31, P441, DOI 10.1097/AUD.0b013e3181d4f228; Takesian AE, 2009, FUTUR NEUROL, V4, P331, DOI 10.2217/FNL.09.5; Van Deun L, 2010, EAR HEARING, V31, P702, DOI 10.1097/AUD.0b013e3181e40dfe; van Hoesel RJM, 2012, HEARING RES, V288, P100, DOI 10.1016/j.heares.2011.11.014; van Hoesel RJM, 2009, JARO-J ASSOC RES OTO, V10, P557, DOI 10.1007/s10162-009-0175-x; van Hoesel RJM, 2004, AUDIOL NEURO-OTOL, V9, P234, DOI 10.1159/000078393; van Hoesel RJM, 2003, J ACOUST SOC AM, V113, P1617, DOI 10.1121/1.1539520; Vandali A, 2013, HEARING RES, V302, P32, DOI 10.1016/j.heares.2013.05.004; VANDENHONERT C, 1986, HEARING RES, V21, P109, DOI 10.1016/0378-5955(86)90033-X; VANDENHONERT C, 1984, HEARING RES, V14, P225, DOI 10.1016/0378-5955(84)90052-2; Xu H, 2010, J NEUROSCI, V30, P331, DOI 10.1523/JNEUROSCI.4554-09.2010; ZWISLOCKI J, 1956, J ACOUST SOC AM, V28, P860, DOI 10.1121/1.1908495	50	42	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e114841	10.1371/journal.pone.0114841	http://dx.doi.org/10.1371/journal.pone.0114841			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531107	Green Published, gold, Green Submitted			2022-12-27	WOS:000348845100026
J	Guerriero, E; Sorice, A; Capone, F; Napolitano, V; Colonna, G; Storti, G; Castello, G; Costantini, S				Guerriero, Eliana; Sorice, Angela; Capone, Francesca; Napolitano, Virginia; Colonna, Giovanni; Storti, Gabriella; Castello, Giuseppe; Costantini, Susan			Vitamin C Effect on Mitoxantrone-Induced Cytotoxicity in Human Breast Cancer Cell Lines	PLOS ONE			English	Article							HISTONE H2AX PHOSPHORYLATION; ASCORBIC-ACID; INDUCED CARDIOTOXICITY; MULTIPLE-SCLEROSIS; IN-VITRO; DEATH; DOXORUBICIN; MECHANISMS; EXPRESSION; APOPTOSIS	In recent years the use of natural dietary antioxidants to minimize the cytotoxicity and the damage induced in normal tissues by antitumor agents is gaining consideration. In literature, it is reported that vitamin C exhibits some degree of antineoplastic activity whereas Mitoxantrone (MTZ) is a synthetic anti-cancer drug with significant clinical effectiveness in the treatment of human malignancies but with severe side effects. Therefore, we have investigated the effect of vitamin C alone or combined with MTZ on MDA-MB231 and MCF7 human breast cancer cell lines to analyze their dose-effect on the tumor cellular growth, cellular death, cell cycle and cell signaling. Our results have evidenced that there is a dose-dependence on the inhibition of the breast carcinoma cell lines, MCF7 and MDA-MB231, treated with vitamin C and MTZ. Moreover, their combination induces: i) a cytotoxic effect by apoptotic death, ii) a mild G2/M elongation and iii) H2AX and mild PI3K activation. Hence, the formulation of vitamin C with MTZ induces a higher cytotoxicity level on tumor cells compared to a disjointed treatment. We have also found that the vitamin C enhances the MTZ effect allowing the utilization of lower chemotherapic concentrations in comparison to the single treatments.	[Guerriero, Eliana; Sorice, Angela; Capone, Francesca; Napolitano, Virginia; Castello, Giuseppe; Costantini, Susan] IRCCS, Fdn Giovanni Pascale, Ist Nazl Studio & Cura Tumori, Ctr Ric Oncol Mercogliano, I-80131 Naples, Italy; [Colonna, Giovanni] Univ Naples 2, Dept Biochem Biophys & Gen Pathol, I-80138 Naples, Italy; [Storti, Gabriella] SG Moscati Hosp, Dept Oncohematol, I-83100 Avellino, Italy	IRCCS Fondazione Pascale; Universita della Campania Vanvitelli; San Giuseppe Moscati Hospital	Costantini, S (corresponding author), IRCCS, Fdn Giovanni Pascale, Ist Nazl Studio & Cura Tumori, Ctr Ric Oncol Mercogliano, I-80131 Naples, Italy.	s.costantini@istitutotumori.na.it	Capone, Francesca/AAS-7458-2021; Colonna, Giovanni/AAY-3568-2021; Costantini, Susan/J-9914-2018	Costantini, Susan/0000-0002-7538-4657; Sorice, Angela/0000-0003-4900-6107; Colonna, Giovanni/0000-0002-0473-1455; Capone, Francesca/0000-0002-5402-6228				Anders CK, 2013, HEMATOL ONCOL CLIN N, V27, P737, DOI 10.1016/j.hoc.2013.05.003; Avasarala JR, 2003, MULT SCLER, V9, P59, DOI 10.1191/1352458503ms896oa; BAADER SL, 1994, ANTICANCER RES, V14, P221; Banath JP, 2003, CANCER RES, V63, P4347; Bruck TB, 2011, BIOCHIMIE, V93, P217, DOI 10.1016/j.biochi.2010.09.015; Chen Q, 2008, P NATL ACAD SCI USA, V105, P11105, DOI 10.1073/pnas.0804226105; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Du J, 2012, BBA-REV CANCER, V1826, P443, DOI 10.1016/j.bbcan.2012.06.003; Du JA, 2010, CLIN CANCER RES, V16, P509, DOI 10.1158/1078-0432.CCR-09-1713; Fan JT, 2011, J NAT PROD, V74, P2069, DOI 10.1021/np2002918; Griffiths Carrie L, 2012, J Pharm Pract, V25, P319, DOI 10.1177/0897190012442062; Guerriero E, 2011, MOLECULES, V16, P6365, DOI 10.3390/molecules16086365; Hahm E, 2007, J CELL BIOCHEM, V102, P1002, DOI 10.1002/jcb.21336; Heaney ML, 2008, CANCER RES, V68, P8031, DOI 10.1158/0008-5472.CAN-08-1490; HENDERSON IC, 1989, J CLIN ONCOL, V7, P560, DOI 10.1200/JCO.1989.7.5.560; Hong SW, 2007, ONCOL REP, V18, P811; Huang X, 2003, CELL CYCLE, V2, P614, DOI 10.4161/cc.2.6.565; Hudis CA, 2011, ONCOLOGIST, V16, P1, DOI 10.1634/theoncologist.2011-S1-01; Jiao XY, 2013, BREAST CANCER RES TR, V139, P717, DOI 10.1007/s10549-013-2607-x; Kang JS, 2005, J CELL PHYSIOL, V204, P192, DOI 10.1002/jcp.20286; KAO TL, 1993, CANCER LETT, V70, P101, DOI 10.1016/0304-3835(93)90080-S; Khan SN, 2010, BIOSCIENCE REP, V30, P375, DOI 10.1042/BSR20090119; Kim J, 2012, FREE RADICAL BIO MED, V53, P1607, DOI 10.1016/j.freeradbiomed.2012.07.079; Krishnaja AP, 2003, TERATOGEN CARCIN MUT, P99, DOI 10.1002/tcm.10064; Kurbacher CM, 1996, CANCER LETT, V103, P183, DOI 10.1016/0304-3835(96)04212-7; LEE YS, 1994, CANCER LETT, V78, P19, DOI 10.1016/0304-3835(94)90026-4; Ma Y, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007154; Mamede AC, 2011, NUTR CANCER, V63, P479, DOI 10.1080/01635581.2011.539315; Maramag C, 1997, PROSTATE, V32, P188, DOI 10.1002/(SICI)1097-0045(19970801)32:3<188::AID-PROS5>3.0.CO;2-H; Neuhaus O, 2006, PHARMACOL THERAPEUT, V109, P198, DOI 10.1016/j.pharmthera.2005.07.002; Podhorecka M, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/920161; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rossato LG, 2013, ARCH TOXICOL, V87, P1809, DOI 10.1007/s00204-013-1040-6; Seifrtova M, 2011, FOLIA BIOL-PRAGUE, V57, P74; Seiter Karen, 2005, Expert Opin Drug Saf, V4, P219, DOI 10.1517/14740338.4.2.219; Sorice A, 2014, MINI-REV MED CHEM, V14, P444, DOI 10.2174/1389557514666140428112602; Tate CR, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3192; Toh YM, 2011, CLIN CANCER RES, V17, P5026, DOI 10.1158/1078-0432.CCR-11-0235; Verrax J, 2008, BIOCHEM PHARMACOL, V76, P1644, DOI 10.1016/j.bcp.2008.09.024; Vibet S, 2007, DRUG METAB DISPOS, V35, P822, DOI 10.1124/dmd.106.013474; Wang JH, 2012, CHEM BIOL DRUG DES, V80, P909, DOI 10.1111/cbdd.12038; YANAGISAWASHIOTA F, 1995, ANTICANCER RES, V15, P259; Zhao H, 2008, CYTOM PART A, V73A, P480, DOI 10.1002/cyto.a.20574; Zordoky BNM, 2014, BBA-GEN SUBJECTS, V1840, P1943, DOI 10.1016/j.bbagen.2014.01.023	44	38	39	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115287	10.1371/journal.pone.0115287	http://dx.doi.org/10.1371/journal.pone.0115287			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531443	Green Submitted, gold, Green Published			2022-12-27	WOS:000348845100049
J	McConnell, ER; Bell, SM; Cote, I; Wang, RL; Perkins, EJ; Garcia-Reyero, N; Gong, P; Burgoon, LD				McConnell, Emma R.; Bell, Shannon M.; Cote, Ila; Wang, Rong-Lin; Perkins, Edward J.; Garcia-Reyero, Natalia; Gong, Ping; Burgoon, Lyle D.			Systematic Omics Analysis Review (SOAR) Tool to Support Risk Assessment	PLOS ONE			English	Review							GENE-EXPRESSION; CIGARETTE-SMOKE; TRANSCRIPTOME; TCDD; EXPOSURE	Environmental health risk assessors are challenged to understand and incorporate new data streams as the field of toxicology continues to adopt new molecular and systems biology technologies. Systematic screening reviews can help risk assessors and assessment teams determine which studies to consider for inclusion in a human health assessment. A tool for systematic reviews should be standardized and transparent in order to consistently determine which studies meet minimum quality criteria prior to performing in-depth analyses of the data. The Systematic Omics Analysis Review (SOAR) tool is focused on assisting risk assessment support teams in performing systematic reviews of transcriptomic studies. SOAR is a spreadsheet tool of 35 objective questions developed by domain experts, focused on transcriptomic microarray studies, and including four main topics: test system, test substance, experimental design, and microarray data. The tool will be used as a guide to identify studies that meet basic published quality criteria, such as those defined by the Minimum Information About a Microarray Experiment standard and the Toxicological Data Reliability Assessment Tool. Seven scientists were recruited to test the tool by using it to independently rate 15 published manuscripts that study chemical exposures with microarrays. Using their feedback, questions were weighted based on importance of the information and a suitability cutoff was set for each of the four topic sections. The final validation resulted in 100% agreement between the users on four separate manuscripts, showing that the SOAR tool may be used to facilitate the standardized and transparent screening of microarray literature for environmental human health risk assessment.	[McConnell, Emma R.; Bell, Shannon M.] Oak Ridge Inst Sci & Educ, Res Triangle Pk, NC USA; [Cote, Ila] US EPA, Natl Ctr Environm Assessment, Off Res & Dev, Arlington, VA USA; [Wang, Rong-Lin] US EPA, Natl Exposure Res Lab, Off Res & Dev, Cincinnati, OH USA; [Perkins, Edward J.] US Army, Corps Engineers, Dept Army, Dept Def, Vicksburg, MS 39180 USA; [Garcia-Reyero, Natalia] Jackson State Univ, Dept Chem & Biochem, Jackson, MS USA; [Gong, Ping] SpecPro Inc, Vicksburg, MS USA; [Burgoon, Lyle D.] US EPA, Natl Ctr Environm Assessment, Off Res & Dev, Res Triangle Pk, NC 27711 USA	Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education; United States Environmental Protection Agency; United States Environmental Protection Agency; United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC); Jackson State University; United States Environmental Protection Agency	Burgoon, LD (corresponding author), US EPA, Natl Ctr Environm Assessment, Off Res & Dev, Res Triangle Pk, NC 27711 USA.	Burgoon.Lyle@epa.gov	Burgoon, Lyle D./I-2894-2019	Burgoon, Lyle D./0000-0003-4977-5352	US EPA's Human Health Risk Assessment Program; SpecPro, Inc	US EPA's Human Health Risk Assessment Program; SpecPro, Inc	This work was funded by the US EPA's Human Health Risk Assessment Program. The funders had no role in study design, or data collection and analysis. EPA management cleared the manuscript for publication, which included helpful suggestions that improved the overall quality of the manuscript, consistent with the US EPA Scientific Integrity Policy. Co-author Ping Gong is employed by SpecPro, Inc. SpecPro, Inc provided support in the form of salary for author PG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Andreasen EA, 2006, TOXICOL SCI, V92, P254, DOI 10.1093/toxsci/kfj118; Boyle JO, 2010, CANCER PREV RES, V3, P266, DOI 10.1158/1940-6207.CAPR-09-0192; Carolan BJ, 2006, CANCER RES, V66, P10729, DOI 10.1158/0008-5472.CAN-06-2224; Chen J, 2008, PHYSIOL GENOMICS, V33, P148, DOI 10.1152/physiolgenomics.00214.2007; Dreij K, 2010, CARCINOGENESIS, V31, P1149, DOI 10.1093/carcin/bgq073; Eden J, 2011, FINDING WHAT WORKS IN HEALTH CARE: STANDARDS FOR SYSTEMATIC REVIEWS, P1; *ENV PROT AG, 2012, BENCHM DOS TECHN GUI; Fertuck KC, 2003, PHYSIOL GENOMICS, V15, P127, DOI 10.1152/physiolgenomics.00058.2003; Fostel JM, 2007, TOXICOL SCI, V99, P26, DOI 10.1093/toxsci/kfm090; Fracchiolla NS, 2011, TOXICOLOGY, V283, P18, DOI 10.1016/j.tox.2011.01.025; Frericks M, 2008, TOXICOL APPL PHARM, V232, P268, DOI 10.1016/j.taap.2008.07.009; *FUNCT GEN DAT SOC, 2007, MIAME 2 0 MIAME FGED; Gebel S, 2010, TOXICOL SCI, V115, P238, DOI 10.1093/toxsci/kfq039; Gottipolu RR, 2009, ENVIRON HEALTH PERSP, V117, P38, DOI 10.1289/ehp.11647; Heiden TCK, 2008, REPROD TOXICOL, V25, P47, DOI 10.1016/j.reprotox.2007.07.013; Hirano M, 2013, ENVIRON TOXICOL, V28, P652, DOI 10.1002/tox.20761; Kong EC, 2010, ALCOHOL CLIN EXP RES, V34, P302, DOI 10.1111/j.1530-0277.2009.01093.x; Landi MT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001651; McHale CM, 2009, GENOMICS, V93, P343, DOI 10.1016/j.ygeno.2008.12.006; *NAT RES COUN, REV ENV PROT AG DRAF; Nilsson E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036129; Pedersen MB, 2007, J INVEST DERMATOL, V127, P2585, DOI 10.1038/sj.jid.5700902; Permenter MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027730; Schneider K, 2009, TOXICOL LETT, V189, P138, DOI 10.1016/j.toxlet.2009.05.013; Song MO, 2009, PHYSIOL GENOMICS, V38, P386, DOI 10.1152/physiolgenomics.00083.2009; Song RF, 2009, TOXICOL LETT, V185, P23, DOI 10.1016/j.toxlet.2008.11.011; Stevens T, 2008, TOXICOL SCI, V102, P359, DOI 10.1093/toxsci/kfn006; Suvorov A, 2010, ENVIRON HEALTH PERSP, V118, P97, DOI 10.1289/ehp.0901031; Woods CG, 2009, TOXICOL APPL PHARM, V238, P27, DOI 10.1016/j.taap.2009.04.007	29	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e110379	10.1371/journal.pone.0110379	http://dx.doi.org/10.1371/journal.pone.0110379			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531884	Green Published, gold, Green Submitted			2022-12-27	WOS:000348845100002
J	Stavros, F; Yang, A; Leon, A; Nuttall, M; Rasmussen, HS				Stavros, Fiona; Yang, Alex; Leon, Alejandro; Nuttall, Mark; Rasmussen, Henrik S.			Characterization of Structure and Function of ZS-9, alpha K+ Selective Ion Trap	PLOS ONE			English	Article							HEART-FAILURE; HYPERKALEMIA; POTASSIUM; SPIRONOLACTONE; ZIRCONIUM; MORTALITY; RESIN	Hyperkalemia, a condition in which serum potassium ions (K+) exceed 5.0 mmol/L, is a common electrolyte disorder associated with substantial morbidity. Current methods of managing hyperkalemia, including organic polymer resins such as sodium polystyrene sulfonate (SPS), are poorly tolerated and/or not effective. Sodium zirconium cyclosilicate (ZS-9) is under clinical development as an orally administered, non-absorbed, novel, inorganic microporous zirconium silicate compound that selectively removes excess K+ in vivo. The development, structure and ion exchange properties of ZS-9 and its hypothesized mechanism of action are described. Based on calculation of the interatomic distances between the atoms forming the ZS-9 micropores, the size of the pore opening was determined to be similar to 3 angstrom (similar to diameter of unhydrated K+). Unlike nonspecific organic polymer resins like SPS, the ZS-9 K+ exchange capacity (KEC) was unaffected by the presence of calcium (Ca2+) or magnesium ions (Mg2+) and showed. 25-fold selectivity for K+ over either Ca2+ or Mg2+. Conversely, the selectivity of SPS for K+ was only 0.2-0.3 times its selectivity for Ca2+ or Mg2+ in mixed ionic media. It is hypothesized that the high K+ specificity of ZS-9 is attributable to the chemical composition and diameter of the micropores, which possibly act in an analogous manner to the selectivity filter utilized by physiologic K+ channels. This hypothesized mechanism of action is supported by the multi-ion exchange studies. The effect of pH on the KEC of ZS-9 was tested in different media buffered to mimic different portions of the human gastrointestinal tract. Rapid K+ uptake was observed within 5 minutes - mainly in the simulated small intestinal and large intestinal fluids, an effect that was sustained for up to 1 hour. If approved, ZS-9 will represent a novel, first-in-class therapy for hyperkalemia with improved capacity, selectivity, and speed for entrapping K+ when compared to currently available options.	[Stavros, Fiona; Leon, Alejandro; Nuttall, Mark; Rasmussen, Henrik S.] ZS Pharma Inc, Coppell, TX 75019 USA; [Yang, Alex] Xelay Acumen Inc, Belmont, CA USA		Stavros, F (corresponding author), ZS Pharma Inc, Coppell, TX 75019 USA.	fstavros@zspharma.com			ZS Pharma, Inc.	ZS Pharma, Inc.	These studies were funded by ZS Pharma, Inc. http://www.zspharma.com/. The funder had a role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Agar JWM, 2010, NEPHROLOGY, V15, P406, DOI 10.1111/j.1440-1797.2010.01321.x; [Anonymous], 2014, SUMM REP DET ZIRC SI; Ash S, 2014, KIDNEY INT IN PRESS; Ash SR, 2009, SEMIN DIALYSIS, V22, P615, DOI 10.1111/j.1525-139X.2009.00657.x; Bem D, 2001, ASAIO J, V47, P151; Bem D, 1999, Patent No. [005891417A, 005891417]; Bem D, 1999, Patent No. [005888472A, 005888472]; Bem DS, 1999, MATER RES SOC SYMP P, V549, P73; BERLYNE GM, 1966, LANCET, V1, P169; Derthoo D, 2013, ACTA CARDIOL, V68, P51, DOI 10.1080/AC.68.1.2959632; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Elliott MJ, 2010, CAN MED ASSOC J, V182, P1631, DOI 10.1503/cmaj.100461; EMMETT M, 1995, GASTROENTEROLOGY, V108, P752, DOI 10.1016/0016-5085(95)90448-4; Fang J, 2000, J GEN INTERN MED, V15, P885, DOI 10.1046/j.1525-1497.2000.91021.x; Fulton TB, DIFFUSION TRANSPORT; Gennari FJ, 2002, CRIT CARE CLIN, V18, P273, DOI 10.1016/S0749-0704(01)00009-4; Kim HJ, 2002, NEPHRON, V92, P33, DOI 10.1159/000065375; Kosiborod M, 2014, JAMA-J AM MED ASSOC, V312, P2223, DOI 10.1001/jama.2014.15688; Lee DBN, 2010, ASAIO J, V56, P550, DOI 10.1097/MAT.0b013e3181e73f20; Lehnhardt A, 2011, PEDIATR NEPHROL, V26, P377, DOI 10.1007/s00467-010-1699-3; Marieb EN, 2010, HUMAN ANATOMY PHYSL; Matoba S, 1999, CIRCULATION, V99, P817, DOI 10.1161/01.CIR.99.6.817; National Kidney Foundation Kidney Disease Outcomes Quality Initiative (NKF KDOQI), 2002, CLIN PRACT GUID BON; Navaneethan SD, 2009, CLIN J AM SOC NEPHRO, V4, P542, DOI 10.2215/CJN.04750908; Packham DK, 2015, NEW ENGL J MED, V372, P222, DOI 10.1056/NEJMoa1411487; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; SCHROEDER HA, 1966, J CHRON DIS, V19, P573, DOI 10.1016/0021-9681(66)90095-6; Sterns RH, 2010, J AM SOC NEPHROL, V21, P733, DOI 10.1681/ASN.2010010079; Stevens Marc S., 2000, International Urology and Nephrology, V32, P177; Svensson M, 2004, J CARD FAIL, V10, P297, DOI 10.1016/j.cardfail.2003.10.012; Tamirisa KP, 2004, AM HEART J, V148, P971, DOI 10.1016/j.ahj.2004.10.005; Volkov AG, 1997, BIOELECTROCH BIOENER, V42, P153, DOI 10.1016/S0302-4598(96)05097-0; Watson M, 2010, CLIN J AM SOC NEPHRO, V5, P1723, DOI 10.2215/CJN.03700410; Yang A, 2014, AM J KIDNEY DIS, V63, pA115	34	104	114	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e114686	10.1371/journal.pone.0114686	http://dx.doi.org/10.1371/journal.pone.0114686			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531770	Green Submitted, Green Published, gold			2022-12-27	WOS:000348845100022
J	Somsouk, M; Dunham, RM; Cohen, M; Albright, R; Abdel-Mohsen, M; Liegler, T; Lifson, J; Piatak, M; Gorelick, R; Huang, Y; Wu, Y; Hsue, PY; Martin, JN; Deeks, SG; McCune, JM; Hunt, PW				Somsouk, Ma; Dunham, Richard M.; Cohen, Michelle; Albright, Rebecca; Abdel-Mohsen, Mohamed; Liegler, Teri; Lifson, Jeffrey; Piatak, Michael; Gorelick, Robert; Huang, Yong; Wu, Yuaner; Hsue, Priscilla Y.; Martin, Jeffrey N.; Deeks, Steven G.; McCune, Joseph M.; Hunt, Peter W.			The Immunologic Effects of Mesalamine in Treated HIV-Infected Individuals with Incomplete CD4+T Cell Recovery: A Randomized Crossover Trial	PLOS ONE			English	Article							COMBINATION ANTIRETROVIRAL THERAPY; INFLAMMATORY-BOWEL-DISEASE; POLYMERASE CHAIN-REACTION; VIRUS TYPE-1 RNA; 5-AMINOSALICYLIC ACID; ULCERATIVE-COLITIS; IMMUNE ACTIVATION; MICROBIAL TRANSLOCATION; CYCLOOXYGENASE TYPE-2; KAPPA-B	The anti-inflammatory agent, mesalamine (5-aminosalicylic acid) has been shown to decrease mucosal inflammation in ulcerative colitis. The effect of mesalamine in HIV-infected individuals, who exhibit abnormal mucosal immune activation and microbial translocation (MT), has not been established in a placebo-controlled trial. We randomized 33 HIV-infected subjects with CD4 counts <350 cells/mm(3) and plasma HIV RNA levels <40 copies/ml on antiretroviral therapy (ART) to add mesalamine vs. placebo to their existing regimen for 12 weeks followed by a 12 week crossover to the other arm. Compared to placebo-treated subjects, mesalamine-treated subjects did not experience any significant change in the percent CD38+ HLA-DR+ peripheral blood CD4+ and CD8+ T cells at week 12 (P =0.38 and P =0.63, respectively), or in the CD4+ T cell count at week 12 (P =0.83). The percent CD38+ HLA-DR+ CD4+ and CD8+ T cells also did not change significantly in rectal tissue (P =0.86, P =0.84, respectively). During the period of mesalamine administration, plasma sCD14, IL-6, D-dimer, and kynurenine to tryptophan ratio were not changed significantly at week 12 and were similarly unchanged at week 24. This study suggests that, at least under the conditions studied, the persistent immune activation associated with HIV infection is not impacted by the anti-inflammatory effects of mesalamine.	[Somsouk, Ma; Huang, Yong; Wu, Yuaner] Univ Calif San Francisco, Dept Med, Div Gastroenterol, San Francisco, CA 94110 USA; [Dunham, Richard M.; Albright, Rebecca; McCune, Joseph M.] Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA 94110 USA; [Cohen, Michelle; Abdel-Mohsen, Mohamed; Liegler, Teri; Martin, Jeffrey N.; Deeks, Steven G.; Hunt, Peter W.] Univ Calif San Francisco, Dept Med, Posit Hlth Program, San Francisco, CA 94110 USA; [Lifson, Jeffrey; Piatak, Michael; Gorelick, Robert] Frederick Natl Lab, Leidos Biomed Res Inc, AIDS & Canc Virus Program, Frederick, MD USA; [Hsue, Priscilla Y.] Univ Calif San Francisco, Dept Med, Div Cardiol, San Francisco, CA 94110 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California San Francisco	Somsouk, M (corresponding author), Univ Calif San Francisco, Dept Med, Div Gastroenterol, San Francisco, CA 94110 USA.	ma.somsouk@ucsf.edu	Fremes, Stephen E/P-7928-2015; Hunt, Peter W./P-2976-2017	Fremes, Stephen E/0000-0003-1723-3049; Hunt, Peter W./0000-0002-4571-4870; Deeks, Steven/0000-0001-6371-747X; Abdel-Mohsen, Mohamed/0000-0002-9945-4314	Salix Pharmaceuticals, Inc.; California HIV/AIDS Research Program IDEA award; amfAR Research Consortium on HIV Eradication; NCI/NIH, Center for AIDS Research (CFAR) [K23 CA157929, HHSN261200800001E, P30 AI27763]; Delaney AIDS Research Enterprise (DARE); Leidos Biomedical Research Inc.;  [UL1 RR024131]; NATIONAL CANCER INSTITUTE [K23CA157929] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000004] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, U19AI096113, U19AI096109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062246] Funding Source: NIH RePORTER	Salix Pharmaceuticals, Inc.; California HIV/AIDS Research Program IDEA award; amfAR Research Consortium on HIV Eradication; NCI/NIH, Center for AIDS Research (CFAR); Delaney AIDS Research Enterprise (DARE); Leidos Biomedical Research Inc.; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by an investigator-initiated research grant from Salix Pharmaceuticals, Inc. and the California HIV/AIDS Research Program IDEA award. It was also supported in part by the amfAR Research Consortium on HIV Eradication and with federal funds from NCI/NIH K23 CA157929, NCI/NIH Contract HHSN261200800001E, P30 AI27763 Center for AIDS Research (CFAR), Delaney AIDS Research Enterprise (DARE), and UL1 RR024131. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-authors J. Lifson, M. Piatak and R. Gorelick are employed by Leidos Biomedical Research Inc. Leidos Biomedical Research Inc. provided support in the form of salaries for authors JL, MP and RG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Alvarez S, 2005, J NEUROCHEM, V94, P850, DOI 10.1111/j.1471-4159.2005.03267.x; Anderson TJ, 2011, CIRCULATION, V123, P163, DOI 10.1161/CIRCULATIONAHA.110.953653; Anton P, 2001, 1 IAS C HIV PATH TRE, pA663; Baan B, 2012, GUT, V61, P1708, DOI 10.1136/gutjnl-2011-301626; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brown TT, 2010, DIABETES CARE, V33, P2244, DOI 10.2337/dc10-0633; Buzon MJ, 2010, NAT MED, V16, P460, DOI 10.1038/nm.2111; Byakwaga H, 2014, J INFECT DIS, V210, P383, DOI 10.1093/infdis/jiu115; Cassol E, 2010, J INFECT DIS, V202, P723, DOI 10.1086/655229; Corasaniti MT, 2000, BIOCHEM BIOPH RES CO, V274, P664, DOI 10.1006/bbrc.2000.3160; Deeks SG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3172; Donald AE, 2008, J AM COLL CARDIOL, V51, P1959, DOI 10.1016/j.jacc.2008.02.044; Estes JD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001052; Ferre AL, 2009, BLOOD, V113, P3978, DOI 10.1182/blood-2008-10-182709; Ford ES, 2010, AIDS, V24, P1509, DOI 10.1097/QAD.0b013e32833ad914; Frieri G, 2000, GUT, V47, P410, DOI 10.1136/gut.47.3.410; Gori A, 2011, MUCOSAL IMMUNOL, V4, P554, DOI 10.1038/mi.2011.15; Ho JE, 2012, AIDS; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Hsue PY, 2009, AIDS, V23, P2021, DOI 10.1097/QAD.0b013e32832e7140; Huang AL, 2007, ARTERIOSCL THROM VAS, V27, P2113, DOI 10.1161/ATVBAHA.107.147322; Hunt PW, 2011, J INFECT DIS, V203, P1474, DOI 10.1093/infdis/jir060; Hunt PW, 2010, CURR OPIN HIV AIDS, V5, P189, DOI 10.1097/COH.0b013e32833647d9; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; Jiang W, 2009, J INFECT DIS, V199, P1177, DOI 10.1086/597476; Johansson CC, 2004, AIDS, V18, P951, DOI 10.1097/00002030-200404090-00015; Joo K, 2009, EUR J PHARMACOL, V618, P91, DOI 10.1016/j.ejphar.2009.07.009; Justice AC, 2012, CLIN INFECT DIS, V54, P984, DOI 10.1093/cid/cir989; Kamat A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015533; Kamm MA, 2007, GASTROENTEROLOGY, V132, P66, DOI 10.1053/j.gastro.2006.10.011; Kim CJ, 2012, MUCOSAL IMMUNOL, V5, P670, DOI 10.1038/mi.2012.72; Kristoff J, 2014, J CLIN INVEST, V124, P2802, DOI 10.1172/JCI75090; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Kumar AM, 2007, J NEUROVIROL, V13, P210, DOI 10.1080/13550280701327038; Kvale D, 2006, AIDS, V20, P813, DOI 10.1097/01.aids.0000218544.54586.f1; Lewden C, 2007, JAIDS-J ACQ IMM DEF, V46, P72; Li QS, 2008, J INFECT DIS, V197, P420, DOI 10.1086/525046; Lichtenstein GR, 2010, ALIMENT PHARM THER, V32, P990, DOI 10.1111/j.1365-2036.2010.04438.x; LIN PKT, 1992, NUCLEIC ACIDS RES, V20, P5149; Lohse N, 2007, ANN INTERN MED, V146, P87, DOI 10.7326/0003-4819-146-2-200701160-00003; Love BL, 2012, ANN PHARMACOTHER, V46, P1529, DOI 10.1345/aph.1R171; Managlia E, 2013, INFLAMM BOWEL DIS, V19, P2051, DOI 10.1097/MIB.0b013e318297d741; Marchetti G, 2008, AIDS, V22, P2035, DOI 10.1097/QAD.0b013e3283112d29; Munding J, 2012, CARCINOGENESIS, V33, P637, DOI 10.1093/carcin/bgr306; NIELSEN OH, 1987, DIGEST DIS SCI, V32, P577, DOI 10.1007/BF01296156; O'Brien M, 2013, JAIDS-J ACQ IMM DEF, V63, P280, DOI 10.1097/QAI.0b013e31828a292c; Palmer S, 2003, J CLIN MICROBIOL, V41, P4531, DOI 10.1128/JCM.41.10.4531-4536.2003; Pereira CF, 2000, J LEUKOCYTE BIOL, V68, P423; PESKAR BM, 1986, AGENTS ACTIONS, V18, P381, DOI 10.1007/BF01965001; Pettersen FO, 2011, J VIROL, V85, P6557, DOI 10.1128/JVI.00073-11; Prideaux L, 2012, INFLAMM BOWEL DIS, V18, P1340, DOI 10.1002/ibd.21903; Rodriguez-Torres M, 2006, DIGEST DIS SCI, V51, P161, DOI 10.1007/s10620-006-3102-6; Rousseaux C, 2005, J EXP MED, V201, P1205, DOI 10.1084/jem.20041948; Salix, 2009, MED LETT DRUGS THER, V51, P38; Sandler NG, 2014, J INFECT DIS; Shacklett BL, 2003, J IMMUNOL METHODS, V279, P17, DOI 10.1016/S0022-1759(03)00255-2; Stiksrud B, 2014, C RETR OPP INF, P342; Stolfi C, 2008, BIOCHEM PHARMACOL, V75, P668, DOI 10.1016/j.bcp.2007.09.020; Sutherland L, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000543.pub2; Tenorio AR, 2014, C RETR OPP INF, P339; Tien PC, 2010, JAIDS-J ACQ IMM DEF, V55, P316, DOI 10.1097/QAI.0b013e3181e66216; Weber CK, 2000, GASTROENTEROLOGY, V119, P1209, DOI 10.1053/gast.2000.19458	63	44	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e116306	10.1371/journal.pone.0116306	http://dx.doi.org/10.1371/journal.pone.0116306			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545673	Green Published, gold			2022-12-27	WOS:000347120200111
J	Van der Goten, J; Vanhove, W; Lemaire, K; Van Lommel, L; Machiels, K; Wollants, WJ; De Preter, V; De Hertogh, G; Ferrante, M; Van Assche, G; Rutgeerts, P; Schuit, F; Vermeire, S; Arijs, I				Van der Goten, Jan; Vanhove, Wiebe; Lemaire, Katleen; Van Lommel, Leentje; Machiels, Kathleen; Wollants, Willem-Jan; De Preter, Vicky; De Hertogh, Gert; Ferrante, Marc; Van Assche, Gert; Rutgeerts, Paul; Schuit, Frans; Vermeire, Severine; Arijs, Ingrid			Integrated miRNA and mRNA Expression Profiling in Inflamed Colon of Patients with Ulcerative Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; MUCOSAL GENE-EXPRESSION; MESENCHYMAL TRANSITION; INTESTINAL FIBROSIS; MICRORNA EXPRESSION; MIR-200B; IDENTIFICATION; PATHOGENESIS; BIOMARKERS; VARIANT	Background: Ulcerative colitis (UC) is associated with differential colonic expression of genes involved in immune response (e. g. IL8) and barrier integrity (e. g. cadherins). MicroRNAs (miRNAs) are regulators of gene expression and are involved in various immune-related diseases. In this study, we investigated (1) if miRNA expression in UC mucosa is altered and (2) if any of these changes correlate with mucosal mRNA expression. Integration of mRNA and miRNA expression profiling may allow the identification of functional links between dysregulated miRNAs and their target mRNA. Methodology: Colonic mucosal biopsies were obtained from 17 UC (10 active and 7 inactive) patients and 10 normal controls. Total RNA was used to analyze miRNA and mRNA expression via Affymetrix miRNA 2.0 and Affymetrix Human Gene 1.0ST arrays, respectively. Both miRNA and gene expression profiles were integrated by correlation analysis to identify dysregulated miRNAs with their corresponding predicted target mRNA. Microarray data were validated with qRT-PCR. Regulation of IL8 and CDH11 expression by hsa-miR-200c-3p was determined by luciferase reporter assays. Results: When comparing active UC patients vs. controls, 51 miRNAs and 1543 gene probe sets gave significantly different signals. In contrast, in inactive UC vs. controls, no significant miRNA expression differences were found while 155 gene probe sets had significantly different signals. We then identified potential target genes of the significantly dysregulated miRNAs and genes in active UC vs. controls and found a highly significant inverse correlation between hsa-miR-200c-3p and IL8, an inflammatory marker, and between hsa-miR-200c-3p and CDH11, a gene related to intestinal epithelial barrier function. We could demonstrate that hsa-miR-200c-3p directly regulates IL8 and CDH11 expression. Conclusion: Differential expression of immune- and barrier-related genes in inflamed UC mucosa may be influenced by altered expression of miRNAs. Integrated analysis of miRNA and mRNA expression profiles revealed hsa-miR-200c-3p for use of miRNA mimics as therapeutics.	[Van der Goten, Jan; Vanhove, Wiebe; Machiels, Kathleen; Wollants, Willem-Jan; De Preter, Vicky; Ferrante, Marc; Van Assche, Gert; Rutgeerts, Paul; Vermeire, Severine; Arijs, Ingrid] Katholieke Univ Leuven, Translat Res Ctr Gastrointestinal Disorders TARGI, Dept Clin & Expt Med, Leuven, Belgium; [Van der Goten, Jan; Lemaire, Katleen; Van Lommel, Leentje; Schuit, Frans; Arijs, Ingrid] Katholieke Univ Leuven, Dept Cellular & Mol Med, Gene Express Unit, Leuven, Belgium; [De Hertogh, Gert] Katholieke Univ Leuven, Dept Imaging & Pathol, Leuven, Belgium	KU Leuven; KU Leuven; KU Leuven	Arijs, I (corresponding author), Katholieke Univ Leuven, Translat Res Ctr Gastrointestinal Disorders TARGI, Dept Clin & Expt Med, Leuven, Belgium.	ingrid.arijs@med.kuleuven.be	Arijs, Ingrid/AAJ-3163-2020; De Preter, Vicky/P-6131-2019	Arijs, Ingrid/0000-0002-9415-083X; Vermeire, Severine/0000-0001-9942-3019	Fund for Scientific Research-Flanders (FWO-Flanders), Belgium (FWO project) [G.0582.08, G.0479.10]	Fund for Scientific Research-Flanders (FWO-Flanders), Belgium (FWO project)(FWO)	This work was supported by grants from the Fund for Scientific Research-Flanders (FWO-Flanders), Belgium (FWO project nr. G.0582.08 and nr. G.0479.10). IA is a postdoctoral fellow and SV is a clinical researcher of FWO-Flanders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archanioti P, 2011, J CROHNS COLITIS, V5, P520, DOI 10.1016/j.crohns.2011.05.007; Arijs I, 2009, GUT, V58, P1612, DOI 10.1136/gut.2009.178665; Arijs I, 2011, AM J GASTROENTEROL, V106, P748, DOI 10.1038/ajg.2011.27; Arijs I, 2010, INFLAMM BOWEL DIS, V16, P2090, DOI 10.1002/ibd.21301; Arijs I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007984; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bengtsson H., 2008, 745 U CAL DEP STAT; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhattacharyya S, 2011, J BIOL CHEM, V286, P11604, DOI 10.1074/jbc.M110.198390; Bhaumik D, 2008, ONCOGENE, V27, P5643, DOI 10.1038/onc.2008.171; Biton M, 2011, NAT IMMUNOL, V12, P239, DOI 10.1038/ni.1994; Borcherding F, 2010, AM J PATHOL, V176, P1816, DOI 10.2353/ajpath.2010.090461; Brenner MB, 2013, United States patent, Patent No. [US 13/702,018, 13702018]; Brest P, 2011, NAT GENET, V43, P242, DOI 10.1038/ng.762; Breynaert C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068876; Chang SK, 2011, P NATL ACAD SCI USA, V108, P8402, DOI 10.1073/pnas.1019437108; Chen Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.22; Chen YW, 2012, INT J MOL MED, V29, P601, DOI 10.3892/ijmm.2012.894; Chuang TD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095370; Clark PM, 2012, INFLAMM BOWEL DIS, V18, P2315, DOI 10.1002/ibd.22958; Coskun M, 2013, WORLD J GASTROENTERO, V19, P4289, DOI 10.3748/wjg.v19.i27.4289; Coskun M, 2012, WORLD J GASTROENTERO, V18, P4629, DOI 10.3748/wjg.v18.i34.4629; Costello CM, 2005, PLOS MED, V2, P771, DOI 10.1371/journal.pmed.0020199; Dai Yang, 2010, Open Access Bioinformatics, V2, P29; Dalmasso G, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019293, 10.1371/journal.pone.0023806]; Danese S, 2011, NEW ENGL J MED, V365, P1713, DOI 10.1056/NEJMra1102942; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Fasseu M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013160; Geboes K, 2000, GUT, V47, P404, DOI 10.1136/gut.47.3.404; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hur K, 2013, GUT, V62, P1315, DOI 10.1136/gutjnl-2011-301846; Iborra M, 2013, CLIN EXP IMMUNOL, V173, P250, DOI 10.1111/cei.12104; Iborra M, 2012, AUTOIMMUN REV, V11, P305, DOI 10.1016/j.autrev.2010.07.002; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Lin JM, 2014, MODERN PATHOL, V27, P602, DOI 10.1038/modpathol.2013.152; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Luo DY, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-57; Min M, 2014, INFLAMM BOWEL DIS, V20, P652, DOI 10.1097/MIB.0000000000000009; MITSUYAMA K, 1994, CLIN EXP IMMUNOL, V96, P432; Muzes G, 2012, WORLD J GASTROENTERO, V18, P5848, DOI 10.3748/wjg.v18.i41.5848; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2012, ANNU REV IMMUNOL, V30, P295, DOI 10.1146/annurev-immunol-020711-075013; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Olaru AV, 2011, INFLAMM BOWEL DIS, V17, P221, DOI 10.1002/ibd.21359; Pekow JR, 2012, INFLAMM BOWEL DIS, V18, P187, DOI 10.1002/ibd.21691; Quinn SR, 2011, INT IMMUNOL, V23, P421, DOI 10.1093/intimm/dxr034; Rieder F, 2009, NAT REV GASTRO HEPAT, V6, P228, DOI 10.1038/nrgastro.2009.31; Ruike Y, 2008, J HUM GENET, V53, P515, DOI 10.1007/s10038-008-0279-x; Schaefer JS, 2011, J IMMUNOL, V187, P5834, DOI 10.4049/jimmunol.1100922; Schneider DJ, 2012, FASEB J, V26, P503, DOI 10.1096/fj.11-186098; SCHROEDER KW, 1987, NEW ENGL J MED, V317, P1625, DOI 10.1056/NEJM198712243172603; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Takagi T, 2010, J GASTROEN HEPATOL, V25, pS129, DOI 10.1111/j.1440-1746.2009.06216.x; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; van Rooij E, 2012, CIRC RES, V110, P496, DOI 10.1161/CIRCRESAHA.111.247916; Wendlandt EB, 2012, INNATE IMMUN-LONDON, V18, P846, DOI 10.1177/1753425912443903; Worm J, 2009, NUCLEIC ACIDS RES, V37, P5784, DOI 10.1093/nar/gkp577; Wu F, 2008, GASTROENTEROLOGY, V135, P1624, DOI 10.1053/j.gastro.2008.07.068; Wu F, 2010, INFLAMM BOWEL DIS, V16, P1729, DOI 10.1002/ibd.21267; Zahm AM, 2014, J CROHNS COLITIS, V8, P1108, DOI 10.1016/j.crohns.2014.02.012; Zwiers A, 2012, J IMMUNOL, V188, P1573, DOI 10.4049/jimmunol.1101494	66	56	57	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e116117	10.1371/journal.pone.0116117	http://dx.doi.org/10.1371/journal.pone.0116117			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546151	Green Published, gold, Green Submitted			2022-12-27	WOS:000347120200099
J	Huemer, P; Mutanen, M; Sefc, KM; Hebert, PDN				Huemer, Peter; Mutanen, Marko; Sefc, Kristina M.; Hebert, Paul D. N.			Testing DNA Barcode Performance in 1000 Species of European Lepidoptera: Large Geographic Distances Have Small Genetic Impacts	PLOS ONE			English	Article							BUTTERFLIES; WOLBACHIA; LIBRARY; FAUNA	This study examines the performance of DNA barcodes (mt cytochrome c oxidase 1 gene) in the identification of 1004 species of Lepidoptera shared by two localities (Finland, Austria) that are 1600 km apart. Maximum intraspecific distances for the pooled data were less than 2% for 880 species (87.6%), while deeper divergence was detected in 124 species. Despite such variation, the overall DNA barcode library possessed diagnostic COI sequences for 98.8% of the taxa. Because a reference library based on Finnish specimens was highly effective in identifying specimens from Austria, we conclude that barcode libraries based on regional sampling can often be effective for a much larger area. Moreover, dispersal ability (poor, good) and distribution patterns (disjunct, fragmented, continuous, migratory) had little impact on levels of intraspecific geographic divergence. Furthermore, the present study revealed that, despite the intensity of past taxonomic work on European Lepidoptera, nearly 20% of the species shared by Austria and Finland require further work to clarify their status. Particularly discordant BIN (Barcode Index Number) cases should be checked to ascertain possible explanatory factors such as incorrect taxonomy, hybridization, introgression, and Wolbachia infections.	[Huemer, Peter] Tiroler Landesmuseen Betriebsges mbH, Nat Wissenschaftl Sammlungen, Innsbruck, Austria; [Mutanen, Marko] Univ Oulu, Dept Biol, Biodivers Unit, Oulu, Finland; [Sefc, Kristina M.] Graz Univ, Inst Zool, A-8010 Graz, Austria; [Hebert, Paul D. N.] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada	University of Oulu; University of Graz; University of Guelph	Huemer, P (corresponding author), Tiroler Landesmuseen Betriebsges mbH, Nat Wissenschaftl Sammlungen, Innsbruck, Austria.	p.huemer@tiroler-landesmuseen.at	Hebert, Paul DN/C-4161-2013	Hebert, Paul DN/0000-0002-3081-6700; Sefc, Kristina/0000-0001-8108-8339	Genome Canada; Ontario Genomics Institute; Ontario Ministry of Research and Innovation; Kone Foundation; Finnish Cultural Foundation; Erlebnis naturschau Dornbirn	Genome Canada(Genome Canada); Ontario Genomics Institute; Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Kone Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Erlebnis naturschau Dornbirn	This work was supported by Genome Canada (PDNH) (www.genomecanada.ca/, Ontario Genomics Institute (PDNH) (www.ontariogenomics.ca/), Ontario Ministry of Research and Innovation (PDNH) (https://www.ontario.ca/ministry-research-innovation), Kone Foundation (MM) (www.koneensaatio,fi/en/), Finnish Cultural Foundation (MM) (https://www.skr.fi/en), and Erlebnis naturschau Dornbirn (PH) (http://www.inatura.at). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, DISTRIBUTION ATLAS B; Bergsten J, 2012, SYST BIOL, V61, P851, DOI 10.1093/sysbio/sys037; Bucklin A, 2011, ANNU REV MAR SCI, V3, P471, DOI 10.1146/annurev-marine-120308-080950; Buszko Jaroslaw, 2000, Polish Entomological Monographs, V1, P1; Candek K, 2015, MOL ECOL RESOUR, V15, P268, DOI 10.1111/1755-0998.12304; Dewaard JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018290; DeWaard Jeremy R., 2008, V410, P275; Dinca V, 2011, P ROY SOC B-BIOL SCI, V278, P347, DOI 10.1098/rspb.2010.1089; Ekrem T, 2007, MOL PHYLOGENET EVOL, V43, P530, DOI 10.1016/j.ympev.2006.11.021; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Gaedike R, 1999, ENTOMOLOGISCHE NACHR, V5, P1; Hausmann A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084518; Hausmann A, 2011, SPIXIANA, V34, P47; Hausmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017134; Hebert PDN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068535; Hebert PDN, 2010, BIOL LETTERS, V6, P359, DOI 10.1098/rsbl.2009.0848; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Huemer P, 2013, SYSTEMATISCHE FAUNIS, V12; Ivinskis P, 2004, LEPIDOPTERA LITHUANI; Janzen DH, 2005, PHILOS T R SOC B, V360, P1835, DOI 10.1098/rstb.2005.1715; Kodandaramaiah U, 2013, ECOL EVOL, V3, P5167, DOI 10.1002/ece3.886; Kullberg J, 2008, CHECKLIST FINNISH LE; Lastuvka Z, 2011, ANNOTATED CHECKLIST; Leneveu J, 2009, BIOL J LINN SOC, V97, P346, DOI 10.1111/j.1095-8312.2009.01208.x; Lopez-Vaamonde Carlos, 2010, BioRisk, V4, P603; Lukhtanov VA, 2009, MOL ECOL RESOUR, V9, P1302, DOI 10.1111/j.1755-0998.2009.02577.x; Mutanen M, 2013, SCI REP-UK, V3, DOI 10.1038/srep02901; Mutanen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047214; Pentinsaari M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108651; Pinheiro J, 2020, R PACKAGE VERSION 31; R Core Team, 2021, R LANGUAGE ENV STAT; Ratnasingham S., 2013, BOLD BARCODE LIFE DA; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Ritter S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078107; Savenkov N, 2010, LATVIAN LEPIDOPTERA; Schintlmeister A., 2008, Palaearctic Macrolepidoptera, Volume 1: Notodontidae; Sinev S.Yu., 2008, CATALOGUE LEPIDOPTER; Smith A, 2012, MOL ECOLOGY RESOURCE, V13, P168, DOI DOI 10.1111/1755-0998; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Virgilio M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-206; Zahiri R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092797; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3	44	112	122	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115774	10.1371/journal.pone.0115774	http://dx.doi.org/10.1371/journal.pone.0115774			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541991	gold, Green Published, Green Submitted			2022-12-27	WOS:000347239900084
J	Lakon, CM; Hipp, JR				Lakon, Cynthia M.; Hipp, John R.			On Social and Cognitive Influences: Relating Adolescent Networks, Generalized Expectancies, and Adolescent Smoking	PLOS ONE			English	Article							HEALTH BELIEF MODEL; CIGARETTE-SMOKING; TIME PERSPECTIVE; RISK-PERCEPTION; EARLY DEATH; DRUG-USE; BEHAVIOR; MORTALITY; SELECTION; ALCOHOL	We examine the moderating role of friendship and school network characteristics in relationships between 1) youths' friends smoking behavior and youths' own generalized expectancies regarding risk and future orientation and 2) generalized expectancies of youths' friends and youths' own generalized expectancies. We then relate these constructs to smoking. Using a longitudinal sample from the National Longitudinal Study of Adolescent Health (N=15,142), the relationship between friends' generalized expectancies and youths' expectancies is stronger for those more central in the network, with more reachability, or stronger network ties, and weaker for those with denser friendship networks. Risk expectancies exhibited an inverted U shaped relationship with smoking at the next time point, whereas future orientation expectancies displayed a nonlinear accelerating negative relationship. There was also a feedback effect in which smoking behavior led to higher risk expectancies and lower future orientation expectancies in instrumental variable analyses.	[Lakon, Cynthia M.] Univ Calif Irvine, Program Publ Hlth, Dept Populat Hlth & Dis Prevent, Irvine, CA USA; [Hipp, John R.] Univ Calif Irvine, Dept Criminol Law & Soc, Irvine, CA 92697 USA; [Hipp, John R.] Univ Calif Irvine, Dept Sociol, Irvine, CA USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Hipp, JR (corresponding author), Univ Calif Irvine, Dept Criminol Law & Soc, Irvine, CA 92697 USA.	hippj@uci.edu			National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) [R21 DA03115201A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD031921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA031152] Funding Source: NIH RePORTER	National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institute on Drug Abuse (NIDA), and National Institutes of Health (NIH) grant R21 DA03115201A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel G, 2002, DRUG-EDUC PREV POLIC, V9, P325, DOI 10.1080/09687630210157636; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Albert D, 2011, J RES ADOLESCENCE, V21, P211, DOI 10.1111/j.1532-7795.2010.00724.x; ARY DV, 1988, J BEHAV MED, V11, P361, DOI 10.1007/BF00844936; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; BAUMAN KE, 1984, J APPL SOC PSYCHOL, V14, P28, DOI 10.1111/j.1559-1816.1984.tb02218.x; BENTHIN A, 1993, J ADOLESCENCE, V16, P153, DOI 10.1006/jado.1993.1014; BERKMAN LF, 1979, AM J EPIDEMIOL, V109, P186, DOI 10.1093/oxfordjournals.aje.a112674; BILLY JOG, 1985, SOC PSYCHOL QUART, V48, P27, DOI 10.2307/3033779; BONACICH P, 1987, AM J SOCIOL, V92, P1170, DOI 10.1086/228631; Brewer NT, 2007, HEALTH PSYCHOL, V26, P136, DOI 10.1037/0278-6133.26.2.136; Brezina T, 2009, CRIMINOLOGY, V47, P1091, DOI 10.1111/j.1745-9125.2009.00170.x; Burk WJ, 2007, INT J BEHAV DEV, V31, P397, DOI 10.1177/0165025407077762; Caldwell RM, 2006, J YOUTH ADOLESCENCE, V35, P591, DOI 10.1007/s10964-006-9031-z; Chen P, 2011, DEV PSYCHOL, V47, P1633, DOI 10.1037/a0025327; CHRISTIANSEN BA, 1989, J CONSULT CLIN PSYCH, V57, P93, DOI 10.1037/0022-006X.57.1.93; COHN LD, 1995, HEALTH PSYCHOL, V14, P217, DOI 10.1037/0278-6133.14.3.217; CONRAD KM, 1992, BRIT J ADDICT, V87, P1711; DeLay D, 2013, J RES ADOLESCENCE, V23, P464, DOI 10.1111/jora.12017; Duke NN, 2011, J PEDIATR HEALTH CAR, V25, P224, DOI 10.1016/j.pedhc.2010.03.004; Ennett ST, 2006, J RES ADOLESCENCE, V16, P159, DOI 10.1111/j.1532-7795.2006.00127.x; ENNETT ST, 1993, J HEALTH SOC BEHAV, V34, P226, DOI 10.2307/2137204; Fischhoff B, 2000, PUBLIC OPIN QUART, V64, P189, DOI 10.1086/317762; Flament C., 1963, APPL GRAPH THEORY GR; Gerrard M, 1996, PSYCHOL BULL, V119, P390, DOI 10.1037/0033-2909.119.3.390; Gerrard M, 1996, HEALTH PSYCHOL, V15, P344, DOI 10.1037/0278-6133.15.5.344; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Harary F., 1965, STRUCTURAL MODELS IN; Harris KM, 2009, NATL LONGITUDINAL ST; Haynie DL, 2001, AM J SOCIOL, V106, P1013, DOI 10.1086/320298; Hine DW, 1997, J SOC ISSUES, V53, P35, DOI 10.1111/0022-4537.419974; Hirschi T., 1969, CAUSE OF DELINQUENCY; HOUSE JS, 1982, AM J EPIDEMIOL, V116, P123, DOI 10.1093/oxfordjournals.aje.a113387; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Jessor R., 1977, PROBLEM BEHAV PSYCHO; KANDEL DB, 1978, AM J SOCIOL, V84, P427, DOI 10.1086/226792; KASTENBAUM R, 1961, J GEN PSYCHOL, V65, P203, DOI 10.1080/00221309.1961.9920473; Keough KA, 1999, BASIC APPL SOC PSYCH, V21, P149, DOI 10.1207/S15324834BA210207; Kirke DM, 2004, SOC NETWORKS, V26, P3, DOI 10.1016/j.socnet.2003.12.001; Kobus K, 2003, ADDICTION, V98, P37, DOI 10.1046/j.1360-0443.98.s1.4.x; Lakon CM, 2010, AM J PUBLIC HEALTH, V100, P1218, DOI 10.2105/AJPH.2009.167973; Mathys C, 2013, J RES ADOLESCENCE, V23, P513, DOI 10.1111/jora.12031; McDade TW, 2011, SOC SCI MED, V73, P391, DOI 10.1016/j.socscimed.2011.06.005; Mercken L, 2007, ADDICTION, V102, P1483, DOI 10.1111/j.1360-0443.2007.01905.x; Moody J, 2001, AM J SOCIOL, V107, P679, DOI 10.1086/338954; Moody J, 2002, SOC FORCES, V81, P25, DOI 10.1353/sof.2002.0056; Moody J, 1998, SPAN SAS PROGRAMS AN; NURMI JE, 1991, DEV REV, V11, P1, DOI 10.1016/0273-2297(91)90002-6; Paxton P., 2011, NONRECURSIVE MODELS; Nguyen Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036324; ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P354, DOI 10.1177/109019817400200405; Rotter J.B., 1972, APPL SOCIAL LEARNING; Rotter J.B., 1954, SOCIAL LEARNING CLIN; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.2307/2335739; Schaefer David R, 2012, Am J Public Health, V102, pe12, DOI 10.2105/AJPH.2012.300705; SCHOENBACH VJ, 1986, AM J EPIDEMIOL, V123, P577, DOI 10.1093/oxfordjournals.aje.a114278; Snijders TAB, 2010, SOC NETWORKS, V32, P44, DOI 10.1016/j.socnet.2009.02.004; Song AV, 2009, J ADOLESCENT HEALTH, V45, P618, DOI 10.1016/j.jadohealth.2009.04.022; STACY AW, 1991, J ABNORM PSYCHOL, V100, P502, DOI 10.1037/0021-843X.100.4.502; Valente TW, 2005, J ADOLESCENT HEALTH, V37, P323, DOI 10.1016/j.jadohealth.2004.10.016; Wahl SK, 2005, NICOTINE TOB RES, V7, P613, DOI 10.1080/14622200500185579; WEINSTEIN ND, 1989, PSYCHOL BULL, V105, P31, DOI 10.1037/0033-2909.105.1.31; Zimbardo PG, 1999, J PERS SOC PSYCHOL, V77, P1271, DOI 10.1037/0022-3514.77.6.1271	63	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115668	10.1371/journal.pone.0115668	http://dx.doi.org/10.1371/journal.pone.0115668			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ9UY	25536039	Green Published, gold			2022-12-27	WOS:000348563300061
J	Rivetti, I; Fraschetti, S; Lionello, P; Zambianchi, E; Boero, F				Rivetti, Irene; Fraschetti, Simonetta; Lionello, Piero; Zambianchi, Enrico; Boero, Ferdinando			Global Warming and Mass Mortalities of Benthic Invertebrates in the Mediterranean Sea	PLOS ONE			English	Article							CLIMATE-CHANGE; LIGURIAN SEA; SPECIES RICHNESS; MARINE; BIODIVERSITY; TEMPERATURE; POPULATIONS; INCREASES; CNIDARIA; DISEASE	Satellite data show a steady increase, in the last decades, of the surface temperature (upper few millimetres of the water surface) of the Mediterranean Sea. Reports of mass mortalities of benthic marine invertebrates increased in the same period. Some local studies interpreted the two phenomena in a cause-effect fashion. However, a basin-wide picture of temperature changes combined with a systematic assessment on invertebrate mass mortalities was still lacking. Both the thermal structure of the water column in the Mediterranean Sea over the period 1945-2011 and all documented invertebrate mass mortality events in the basin are analysed to ascertain if: 1-documented mass mortalities occurred under conditions of positive temperature trends at basin scale, and 2-atypical thermal conditions were registered at the smaller spatial and temporal scale of mass mortality events. The thermal structure of the shallow water column over the last 67 years was reconstructed using data from three public sources: MEDAR-MEDATLAS, World Ocean Database, MFS-VOS programme. A review of the mass mortality events of benthic invertebrates at Mediterranean scale was also carried out. The analysis of in situ temperature profiles shows that the Mediterranean Sea changed in a nonhomogeneous fashion. The frequency of mass mortalities is increasing. The areas subjected to these events correspond to positive thermal anomalies. Statistically significant temperature trends in the upper layers of the Mediterranean Sea show an increase of up to 0.07 degrees C/yr for a large fraction of the basin. Mass mortalities are consistent with both the temperature increase at basin scale and the thermal changes at local scale, up to 5.2 degrees C. Our research supports the existence of a causal link between positive thermal anomalies and observed invertebrate mass mortalities in the Mediterranean Sea, invoking focused mitigation initiatives in sensitive areas.	[Rivetti, Irene; Fraschetti, Simonetta; Lionello, Piero; Boero, Ferdinando] Univ Salento, Dipartimento Sci & Tecnol Biol Ambientali, CoNISMa, Lecce, Italy; [Lionello, Piero; Boero, Ferdinando] CMCC Euromediterranean Ctr Climate Change, Lecce, Italy; [Zambianchi, Enrico] Univ Napoli Parthenope, CoNISMa, Dipartimento Sci Ambiente, Naples, Italy; [Boero, Ferdinando] CNR, Ist Sci Marine, Genoa, Italy	CoNISMa; University of Salento; Centro Euro-Mediterraneo sui Cambiamenti Climatici (CMCC); CoNISMa; Parthenope University Naples; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR)	Rivetti, I (corresponding author), Univ Salento, Dipartimento Sci & Tecnol Biol Ambientali, CoNISMa, Lecce, Italy.	irene.rivetti@unisalento.it	lionello, piero/B-4370-2010; Fraschetti, Simonetta/R-8716-2019	lionello, piero/0000-0002-0779-5681; Fraschetti, Simonetta/0000-0002-1780-1651; zambianchi, enrico/0000-0001-5474-7466; Boero, Ferdinando/0000-0002-6317-2710	Centro Euro Mediterraneo sui Cambiamenti Climatici; flagship italian project RITMARE; European Community's 7th Framework Programmes (FP7) [287844, 287600]; Italian Ministry of the Research PRIN TETRIS	Centro Euro Mediterraneo sui Cambiamenti Climatici; flagship italian project RITMARE; European Community's 7th Framework Programmes (FP7); Italian Ministry of the Research PRIN TETRIS	IR was supported by the Centro Euro Mediterraneo sui Cambiamenti Climatici (www.cmcc.it).The research leading to these results received financial support from the flagship italian project RITMARE (http://www.ritmare.it/).The research also received funding from the European Community's 7th Framework Programmes (FP7/2007-2013) for the project COCONET Grant agreement No. 287844, http://www.coconet-fp7.eu/) and PERSEUS Grant agreement No. 287600, http://www.perseus-net.eu/site/content.php). The support by the European Union from VECTORS http://www.marine-vectors.eu/) and from the Italian Ministry of the Research PRIN TETRIS is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, J ICRU, V8, P5, DOI 10.1093/jicru/ndn022; Bally M, 2007, GLOBAL CHANGE BIOL, V13, P2078, DOI 10.1111/j.1365-2486.2007.01423.x; Belkin IM, 2009, PROG OCEANOGR, V81, P207, DOI 10.1016/j.pocean.2009.04.011; Bensoussan N, 2010, ESTUAR COAST SHELF S, V87, P431, DOI 10.1016/j.ecss.2010.01.008; Bertocci I, 2005, ECOLOGY, V86, P2061, DOI 10.1890/04-1698; BETHOUX JP, 1990, NATURE, V347, P660, DOI 10.1038/347660a0; Bethoux JP, 1999, PROG OCEANOGR, V44, P131, DOI 10.1016/S0079-6611(99)00023-3; Bethoux JP, 1999, J MARINE SYST, V20, P33, DOI 10.1016/S0924-7963(98)00069-4; Betti F, 2012, MAR ECOL-EVOL PERSP, V33, P49, DOI [10.1111/j.1439-0485.2012.00525.x, 10.1111/j.1439-0485.2011.00456.x]; BHAUD M, 1995, J THERM BIOL, V20, P91, DOI 10.1016/0306-4565(94)00031-D; Bianchi C. N., 1994, B MUS I BIOL U GEN, V58-59, P181; Bianchi CN, 2007, HYDROBIOLOGIA, V580, P7, DOI 10.1007/s10750-006-0469-5; Bianchi Carlo Nike, 1993, Porcupine Newsletter, V5, P156; Boero F, 2015, REND LINCEI-SCI FIS, V26, P3, DOI 10.1007/s12210-014-0340-y; Boudouresque CF, 2002, MAR POLLUT BULL, V44, P32, DOI 10.1016/S0025-326X(01)00150-3; Brankart JM, 2001, J PHYS OCEANOGR, V31, P2307, DOI 10.1175/1520-0485(2001)031<2307:ACOTML>2.0.CO;2; Brierley AS, 2009, CURR BIOL, V19, pR602, DOI 10.1016/j.cub.2009.05.046; Cerrano C, 2000, ECOL LETT, V3, P284, DOI 10.1046/j.1461-0248.2000.00152.x; Cerrano C, 2005, AQUAT CONSERV, V15, P147, DOI 10.1002/aqc.661; Cerrano C, 2008, CHEM ECOL, V24, P73, DOI 10.1080/02757540801979648; Cerrano C, 2006, ITAL J ZOOL, V73, P355, DOI 10.1080/11250000600911675; Chevaldonne P, 2003, ECOL LETT, V6, P371, DOI 10.1046/j.1461-0248.2003.00439.x; Coll M, 2012, GLOBAL ECOL BIOGEOGR, V21, P465, DOI 10.1111/j.1466-8238.2011.00697.x; Coma R, 2006, MAR ECOL PROG SER, V327, P51, DOI 10.3354/meps327051; Coma R, 2009, P NATL ACAD SCI USA, V106, P6176, DOI 10.1073/pnas.0805801106; Corriero G., 1996, THALASSIA SALENT, V22, P51; Criado-Aldeanueva F, 2008, GLOBAL PLANET CHANGE, V60, P563, DOI 10.1016/j.gloplacha.2007.07.003; Crisci C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023814; Cupido R, 2008, AQUAT CONSERV, V18, P984, DOI 10.1002/aqc.904; Danovaro R, 2001, TRENDS ECOL EVOL, V16, P505, DOI 10.1016/S0169-5347(01)02215-7; Despalatovic M., 2008, CIESM WORKS MONOGR, P35; EMANUEL KA, 1987, NATURE, V326, P483, DOI 10.1038/326483a0; Ferrier-Pages C, 2013, LIMNOL OCEANOGR, V58, P1409, DOI 10.4319/lo.2013.58.4.1409; Fichaut M, 2003, ELSEV OCEANOGR SERIE, V69, P645; Fonda Umani Serena, 2008, CIESM Workshop Monographs, V35, P59; Galil BS, 2008, HYDROBIOLOGIA, V606, P105, DOI 10.1007/s10750-008-9342-z; Garrabou J, 2009, GLOBAL CHANGE BIOL, V15, P1090, DOI 10.1111/j.1365-2486.2008.01823.x; Garrabou J, 2001, MAR ECOL PROG SER, V217, P263, DOI 10.3354/meps217263; Gili JM, 1998, TRENDS ECOL EVOL, V13, P316, DOI 10.1016/S0169-5347(98)01365-2; Gouretski V, 2010, DEEP-SEA RES PT I, V57, P812, DOI 10.1016/j.dsr.2010.03.011; Gravili C, 2013, MAR ECOL-EVOL PERSP, V34, P41, DOI 10.1111/maec.12023; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Harmelin JG, 1984, 306 FAO, P99; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Helmuth B, 2006, ANNU REV ECOL EVOL S, V37, P373, DOI 10.1146/annurev.ecolsys.37.091305.110149; Hiddink JG, 2008, GLOBAL CHANGE BIOL, V14, P453, DOI 10.1111/j.1365-2486.2007.01518.x; Huete-Stauffer C, 2011, MAR ECOL-EVOL PERSP, V32, P107, DOI 10.1111/j.1439-0485.2011.00429.x; Hughes AR, 2007, ECOL LETT, V10, P849, DOI 10.1111/j.1461-0248.2007.01075.x; Ishii M, 2009, J OCEANOGR, V65, P287, DOI 10.1007/s10872-009-0027-7; Johnson DR, 2013, 23 NODC; Krahmann G, 1998, GEOPHYS RES LETT, V25, P4209, DOI 10.1029/1998GL900143; Lejeusne C, 2010, TRENDS ECOL EVOL, V25, P250, DOI 10.1016/j.tree.2009.10.009; Lopes RHC., 2011, INT ENCY STAT SCI, P718, DOI [DOI 10.1007/978-3-642-04898-2_326, 10.1007/978-3-642-04898-2_326]; Manzella GMR, 2007, OCEAN SCI, V3, P245, DOI 10.5194/os-3-245-2007; Micheli F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040832; Michener WK, 1997, ECOL APPL, V7, P770, DOI 10.1890/1051-0761(1997)007[0770:CCHATS]2.0.CO;2; Munda G., 2008, SOCIAL MULTICRITERIA; Nykjaer L, 2009, CLIM RES, V39, P11, DOI 10.3354/cr00794; OBRIEN ST, 1992, CLIMATIC CHANGE, V22, P175, DOI 10.1007/BF00143026; Occhipinti-Ambrogi A, 2003, MAR POLLUT BULL, V46, P542, DOI 10.1016/S0025-326X(02)00363-6; Painter SC, 2003, CONT SHELF RES, V23, P1507, DOI 10.1016/j.csr.2003.08.008; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Parry ML, 2007, CLIMATE CHANGE 2007; Puce S, 2009, MAR ECOL-EVOL PERSP, V30, P313, DOI 10.1111/j.1439-0485.2009.00283.x; Raper S.C.B., 1993, CLIMATE SEA EVE CHAN, P192; Reseghetti F, 2007, OCEAN SCI, V3, P59, DOI 10.5194/os-3-59-2007; Riera F, 1995, PEIXOS BALEARS; Rixen M, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022702; Rodolfo-Metalpa R, 2005, ITAL J ZOOL, V72, P271, DOI 10.1080/11250000509356685; Rodolfo-Metalpa R, 2006, MAR BIOL, V150, P45, DOI 10.1007/s00227-006-0329-x; ROHLING EJ, 1992, J GEOPHYS RES-OCEANS, V97, P11191, DOI 10.1029/92JC00767; Romano JC, 2000, CR ACAD SCI III-VIE, V323, P415, DOI 10.1016/S0764-4469(00)00141-4; Rosenzweig C, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P79; Sparnocchia S, 2006, ANN GEOPHYS-GERMANY, V24, P443, DOI 10.5194/angeo-24-443-2006; Stabili L, 2012, MICROB ECOL, V64, P802, DOI 10.1007/s00248-012-0068-0; Streftaris N, 2006, MEDITERR MAR SCI, V7, P87, DOI 10.12681/mms.180; Torrents O, 2008, J EXP MAR BIOL ECOL, V357, P7, DOI 10.1016/j.jembe.2007.12.006; Vargas-Yanez M, 2009, SCI MAR, V73, P7, DOI 10.3989/scimar.2009.73n1007; Vezzulli L, 2010, ENVIRON MICROBIOL, V12, P2007, DOI 10.1111/j.1462-2920.2010.02209.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Ward JR, 2004, PLOS BIOL, V2, P542, DOI 10.1371/journal.pbio.0020120	83	91	95	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115655	10.1371/journal.pone.0115655	http://dx.doi.org/10.1371/journal.pone.0115655			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25535973	gold, Green Submitted, Green Published			2022-12-27	WOS:000348563300060
J	Boulanger, J; Stenhouse, GB				Boulanger, John '; Stenhouse, Gordon B.			The Impact of Roads on the Demography of Grizzly Bears in Alberta	PLOS ONE			English	Article							HABITAT SELECTION; BRITISH-COLUMBIA; BODY-CONDITION; MORTALITY; SURVIVAL; FRAGMENTATION; POPULATIONS; DISTURBANCE; MOUNTAINS; INVENTORY	One of the principal factors that have reduced grizzly bear populations has been the creation of human access into grizzly bear habitat by roads built for resource extraction. Past studies have documented mortality and distributional changes of bears relative to roads but none have attempted to estimate the direct demographic impact of roads in terms of both survival rates, reproductive rates, and the interaction of reproductive state of female bears with survival rate. We applied a combination of survival and reproductive models to estimate demographic parameters for threatened grizzly bear populations in Alberta. Instead of attempting to estimate mean trend we explored factors which caused biological and spatial variation in population trend. We found that sex and age class survival was related to road density with subadult bears being most vulnerable to road-based mortality. A multi-state reproduction model found that females accompanied by cubs of the year and/or yearling cubs had lower survival rates compared to females with two year olds or no cubs. A demographic model found strong spatial gradients in population trend based upon road density. Threshold road densities needed to ensure population stability were estimated to further refine targets for population recovery of grizzly bears in Alberta. Models that considered lowered survival of females with dependant offspring resulted in lower road density thresholds to ensure stable bear populations. Our results demonstrate likely spatial variation in population trend and provide an example how demographic analysis can be used to refine and direct conservation measures for threatened species.	[Boulanger, John '] Integrated Ecol Res, Nelson, BC, Canada; [Stenhouse, Gordon B.] Foothills Res Inst, Hinton, AB, Canada		Boulanger, J (corresponding author), Integrated Ecol Res, Nelson, BC, Canada.	boulange@ecological.bc.ca	Margalida, Antoni/A-2723-2011	Margalida, Antoni/0000-0002-0576-3993; Boulanger, John/0000-0001-8222-1445	Foothills Research Institute; National Science and Engineering Research Council (NSERC); Canadian Forestry Company (CANFOR); Conoco Phillips; Shell Canada Ltd.; Suncor Energy Inc.; Sundance Forest Industry Ltd.; Talisman Energy Inc.; TransCanada Pipelines Ltd.; Weyerhaeuser Company Ltd.; Foothills Research Institute Grizzly Bear Project	Foothills Research Institute; National Science and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Forestry Company (CANFOR); Conoco Phillips; Shell Canada Ltd.; Suncor Energy Inc.; Sundance Forest Industry Ltd.; Talisman Energy Inc.; TransCanada Pipelines Ltd.; Weyerhaeuser Company Ltd.; Foothills Research Institute Grizzly Bear Project	Funding for this work was from the Foothills Research Institute, National Science and Engineering Research Council (NSERC), Canadian Forestry Company (CANFOR), Conoco Phillips, Shell Canada Ltd., Suncor Energy Inc., Sundance Forest Industry Ltd., Talisman Energy Inc., TransCanada Pipelines Ltd., Weyerhaeuser Company Ltd. and other research partners of the Foothills Research Institute Grizzly Bear Project. The full list of research partners and funders of the Foothill Research Institute are: Ainsworth Lumber, Alberta Biodiversity Monitoring Program, Alberta Conservation Association, Alberta Upstream Oil and Gas Research Fund, Alberta Energy Regulator, Alberta Ecotrust, Alberta Environment Sustainable Research and Development (Government of Alberta), Alberta Fish and Game, Alberta Newsprint, Alberta Advanced Education and Technology (Innovation and Science), Alberta Innovates -Biosolutions, Alberta Upstream Petroleum Research Fund, Anadarko Anderson Exploration Ltd., Anderson Resources Ltd., BP Canada Energy Company, Banff National Park, BC Oil & Gas Commission, Buchanan Lumber-Tolko, Burlington Resources Ltd., Canada Centre for Remote Sensing, Canadian Hunter, Canadian Wildlife Service, Canfor, Cardinal River Operations, Canadian Forest Service, Conoco Phillips Ltd.,	Alberta Grizzly Bear Recovery Team, 2008, ALB GRIZZL BEAR REC; Alberta Sustainable Resource Development Alberta Conservation Association, 2010, 37 ALB SUST RES DEV; Archibald W.R., 1987, INT C BEAR RES MAN, V7, P251; Ben-David M, 2004, OECOLOGIA, V138, P465, DOI 10.1007/s00442-003-1442-x; Benn B, 2002, URSUS, V13, P213; Berland A, 2008, FOREST ECOL MANAG, V256, P1875, DOI 10.1016/j.foreco.2008.07.019; Boulanger J, 2013, WILDLIFE BIOL, V19, P274, DOI 10.2981/12-088; Bourbonnais ML, 2013, PLOS ONE, V8, DOI [10.1371/journal.po, 10.1371/journal.pone.0083768]; BOYCE M.S., 2001, INT ASS BEAR RES MAN, V4; BROWNIE C, 1993, BIOMETRICS, V49, P1173, DOI 10.2307/2532259; Burnham K. P., 1998, MODEL SELECTION INFE; Canadian Council on Animal Care, 2003, CCAC GUID CAR US WIL; Caswell H, 1989, MATRIX POPULATION MO; Cattet M, 2008, J MAMMAL, V89, P973, DOI 10.1644/08-MAMM-A-095.1; Cattet MRL, 2003, J WILDLIFE DIS, V39, P649, DOI 10.7589/0090-3558-39.3.649; Cattet MRL, 2003, URSUS-SERIES, V14, P88; Cattet MRL, 2002, CAN J ZOOL, V80, P1156, DOI 10.1139/Z02-103; Dinsmore SJ, 2002, ECOLOGY, V83, P3476, DOI 10.1890/0012-9658(2002)083[3476:ATFMAN]2.0.CO;2; Franklin SE, 2001, CAN J REMOTE SENS, V27, P579, DOI 10.1080/07038992.2001.10854899; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Garshelis DL, 2005, J WILDLIFE MANAGE, V69, P277, DOI 10.2193/0022-541X(2005)069<0277:GBDIAA>2.0.CO;2; Graham K, 2010, URSUS, V21, P43, DOI 10.2192/09GR010.1; Harris RB, 2011, URSUS, V22, P24, DOI 10.2192/URSUS-D-10-00028.1; Hood GM, 2009, POPTOOLS VERSION 3 0; Kennedy RE, 2014, FRONT ECOL ENVIRON, V12, P339, DOI 10.1890/130066; Linke J, 2009, PHOTOGRAMM ENG REM S, V75, P981, DOI 10.14358/PERS.75.8.981; Macbeth BJ, 2010, CAN J ZOOL, V88, P925; Mace RD, 1996, J APPL ECOL, V33, P1395, DOI 10.2307/2404779; Mace RD, 2012, J WILDLIFE MANAGE, V76, P119, DOI 10.1002/jwmg.250; Manly B.F.J., 1997, RANDOMIZATION MONTE; McDermid GJ, 2009, FOREST ECOL MANAG, V257, P2262, DOI 10.1016/j.foreco.2009.03.005; McDermid GJ, 2005, PROG PHYS GEOG, V29, P449, DOI 10.1191/0309133305pp455ra; MCLELLAN BN, 1989, CAN J ZOOL, V67, P1856, DOI 10.1139/z89-264; McLellan BN, 1999, J WILDLIFE MANAGE, V63, P911, DOI 10.2307/3802805; Nielsen S.E., 2009, J CONSERVATION PLANN, V5, P38; Nielsen SE, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-31; Nielsen SE, 2010, BIOL CONSERV, V143, P1623, DOI 10.1016/j.biocon.2010.04.007; Nielsen SE, 2006, BIOL CONSERV, V130, P217, DOI 10.1016/j.biocon.2005.12.016; Nielsen SE, 2004, BIOL CONSERV, V120, P101, DOI 10.1016/j.biocon.2004.02.020; Nielsen SE, 2004, FOREST ECOL MANAG, V199, P51, DOI 10.1016/j.foreco.2004.04.014; Northrup JM, 2012, J APPL ECOLOGY; Proctor MF, 2005, P ROY SOC B-BIOL SCI, V272, P2409, DOI 10.1098/rspb.2005.3246; Proctor MF, 2002, URSUS, V13, P153; Proctor MF, 2012, WILDLIFE MONOGR, P1, DOI 10.1002/wmon.6; Roever CL, 2008, FOREST ECOL MANAG, V256, P1262, DOI 10.1016/j.foreco.2008.06.006; Roever CL, 2008, GRIZZLY BEARS FOREST; Runge JP, 2006, AM NAT, V167, P925, DOI 10.1086/503531; Schwartz CC, 2005, WILDLIFE MONOGRAPHS, V161; Schwartz CC, 2008, URSUS, V19, P1, DOI 10.2192/07GR003R.1; Schwartz CC, 2010, J WILDLIFE MANAGE, V74, P654, DOI 10.2193/2009-206; Stewart B. P., 2009, CANADIAN J REMOTE SE, V35, P509; Steyaert SMJG, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0624; Theberge JC, 2002, SCALE DEPENDENT SELE; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; White GC, 2000, METH C CONS, P288	55	59	59	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115535	10.1371/journal.pone.0115535	http://dx.doi.org/10.1371/journal.pone.0115535			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25532035	gold, Green Published			2022-12-27	WOS:000348845100074
J	Jin, X; Nowell, CS; Ulyanchenko, S; Stenhouse, FH; Blackburn, CC				Jin, Xin; Nowell, Craig S.; Ulyanchenko, Svetlana; Stenhouse, Frances H.; Blackburn, C. Clare			Long-Term Persistence of Functional Thymic Epithelial Progenitor Cells In Vivo under Conditions of Low FOXN1 Expression	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; DIFFERENTIATION; IDENTIFICATION; ORGANOGENESIS; COMMITMENT; GENERATION; INVOLUTION; AIRE	Normal thymus function reflects interactions between developing T-cells and several thymic stroma cell types. Within the stroma, key functions reside in the distinct cortical and medullary thymic epithelial cell (TEC) types. It has been demonstrated that, during organogenesis, all TECs can be derived from a common thymic epithelial progenitor cell (TEPC). The properties of this common progenitor are thus of interest. Differentiation of both cTEC and mTEC depends on the epithelial-specific transcription factor FOXN1, although formation of the common TEPC from which the TEC lineage originates does not require FOXN1. Here, we have used a revertible severely hypomorphic allele of Foxn1, Foxn1(R), to test the stability of the common TEPC in vivo. By reactivating Foxn1 expression postnatally in Foxn1(R/-) mice we demonstrate that functional TEPCs can persist in the thymic rudiment until at least 6 months of age, and retain the potential to give rise to both cortical and medullary thymic epithelial cells (cTECs and mTECs). These data demonstrate that the TEPC-state is remarkably stable in vivo under conditions of low Foxn1 expression, suggesting that manipulation of FOXN1 activity may prove a valuable method for long term maintenance of TEPC in vitro.	[Jin, Xin; Nowell, Craig S.; Ulyanchenko, Svetlana; Stenhouse, Frances H.; Blackburn, C. Clare] Univ Edinburgh, Sch Biol Sci, MRC Ctr Regenerat Med, Inst Stem Cell Res, Edinburgh EH16 4UU, Midlothian, Scotland	University of Edinburgh	Blackburn, CC (corresponding author), Univ Edinburgh, Sch Biol Sci, MRC Ctr Regenerat Med, Inst Stem Cell Res, SCRM Bldg,5 Little France Dr, Edinburgh EH16 4UU, Midlothian, Scotland.	c.blackburn@ed.ac.uk	Blackburn, Clare/AAM-7954-2020; Blackburn, Clare/B-2847-2009	Blackburn, Clare/0000-0002-6326-640X; Blackburn, Clare/0000-0002-6326-640X; Ulyanchenko, Svetlana/0000-0003-3124-9178	Leukaemia and Lymphoma Research [10014]; School of Biological Sciences, University of Edinburgh; Medical Research Council (MRC Centre) [G0300058, MR/K017047/1]; European Union [200720, EU223098]; Medical Research Council [G0300058, MR/L012766/1, MR/K017047/1] Funding Source: researchfish; MRC [MR/K017047/1, G0300058, MR/L012766/1] Funding Source: UKRI	Leukaemia and Lymphoma Research; School of Biological Sciences, University of Edinburgh(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council (MRC Centre)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Leukaemia and Lymphoma Research grant number 10014 (CCB) School of Biological Sciences, University of Edinburgh, PhD studentship to XJ Medical Research Council (MRC Centre grant, G0300058 and renewal MR/K017047/1, CCB; MRC studentship to CSN) European Union Seventh Framework Programme (FP7/2007-2013) collaborative project EuroSyStem (CCB, FHS and CSN) under grant agreement number 200720 European Union Seventh Framework Programme (FP7/2007-2013) collaborative project Optistem (CCB, FHS, SU and CSN) under grant agreement number EU223098. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Bennett AR, 2002, IMMUNITY, V16, P803, DOI 10.1016/S1074-7613(02)00321-7; Blackburn CC, 1996, P NATL ACAD SCI USA, V93, P5742, DOI 10.1073/pnas.93.12.5742; Blackburn CC, 2004, NAT REV IMMUNOL, V4, P278, DOI 10.1038/nri1331; Bleul CC, 2006, NATURE, V441, P992, DOI 10.1038/nature04850; Bredenkamp N, 2014, DEVELOPMENT, V141, P1627, DOI 10.1242/dev.103614; Chinn IK, 2012, SEMIN IMMUNOL, V24, P309, DOI 10.1016/j.smim.2012.04.005; Depreter MGL, 2008, P NATL ACAD SCI USA, V105, P961, DOI 10.1073/pnas.0711170105; Dudakov JA, 2010, TRENDS IMMUNOL, V31, P191, DOI 10.1016/j.it.2010.02.002; Gill J, 2002, NAT IMMUNOL, V3, P635, DOI 10.1038/ni812; GODFREY DI, 1990, IMMUNOLOGY, V70, P66; GODFREY DI, 1993, J IMMUNOL, V150, P4244; Gordon J, 2004, NAT IMMUNOL, V5, P546, DOI 10.1038/ni1064; Gordon J, 2011, DEVELOPMENT, V138, P3865, DOI 10.1242/dev.059998; Griffith AV, 2012, AGING CELL, V11, P169, DOI 10.1111/j.1474-9726.2011.00773.x; Guy-Grand D, 2003, J EXP MED, V197, P333, DOI 10.1084/jem.20021639; Hameyer D, 2007, PHYSIOL GENOMICS, V31, P32, DOI 10.1152/physiolgenomics.00019.2007; Jenkinson WE, 2007, BLOOD, V109, P954, DOI 10.1182/blood-2006-05-023143; Klug DB, 1998, P NATL ACAD SCI USA, V95, P11822, DOI 10.1073/pnas.95.20.11822; Klug DB, 2000, J IMMUNOL, V164, P1881, DOI 10.4049/jimmunol.164.4.1881; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; MILLER JF, 1961, LANCET, V2, P748; Nehls M, 1996, SCIENCE, V272, P886, DOI 10.1126/science.272.5263.886; Nowell CS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002348; Nowell Craig S, 2007, Methods Mol Biol, V380, P125; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Ortman CL, 2002, INT IMMUNOL, V14, P813, DOI 10.1093/intimm/dxf042; Rossi SW, 2007, EUR J IMMUNOL, V37, P2411, DOI 10.1002/eji.200737275; Rossi SW, 2006, NATURE, V441, P988, DOI 10.1038/nature04813; Zook EC, 2011, BLOOD, V118, P5723, DOI 10.1182/blood-2011-03-342097	30	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e114842	10.1371/journal.pone.0114842	http://dx.doi.org/10.1371/journal.pone.0114842			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531271	Green Submitted, Green Published, gold			2022-12-27	WOS:000348845100027
J	Lin, YX; Fu, FM; Chen, MY; Huang, M; Wang, C				Lin, Yuxiang; Fu, Fangmeng; Chen, Minyan; Huang, Meng; Wang, Chuan			Associations of Two Common Genetic Variants with Breast Cancer Risk in a Chinese Population: A Stratified Interaction Analysis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCUS; ESTROGEN-RECEPTOR; EPIDEMIOLOGY; ALLELES; POLYMORPHISMS; TRANSCRIPTION; MUTATIONS; 6Q25.1; 1P11.2	Recent genome-wide association studies (GWAS) have identified a series of new genetic susceptibility loci for breast cancer (BC). However, the correlations between these variants and breast cancer are still not clear. In order to explore the role of breast cancer susceptibility variants in a Southeast Chinese population, we genotyped two common SNPs at chromosome 6q25 (rs2046210) and in TOX3 (rs4784227) in a case-control study with a total of 702 breast cancer cases and 794 healthy-controls. In addition, we also evaluated the multiple interactions among genetic variants, risk factors, and tumor subtypes. Associations of genotypes with breast cancer risk was evaluated using multivariate logistic regression to estimate odds ratios (OR) and their 95% confidence intervals (95% CI). The results indicated that both polymorphisms were significantly associated with the risk of breast cancer, with per allele OR=1.35, (95% CI=1.17-1.57) for rs2046210 and per allele OR=1.24 (95% CI=1.06-1.45) for rs4784227. Furthermore, in subgroup stratified analyses, we observed that the T allele of rs4784227 was significantly associated with elevated OR among postmenopausal populations (OR=1.44, 95% CI 1.11-1.87) but not in premenopausal populations, with the heterogeneity P value of P=0.064. These findings suggest that the genetic variants at chromosome 6q25 and in the TOX3 gene may play important roles in breast cancer development in a Chinese population and the underlying biological mechanisms need to be further elucidated.	[Lin, Yuxiang] Fujian Med Univ, Union Hosp Sch, Fuzhou, Peoples R China; [Fu, Fangmeng; Chen, Minyan; Wang, Chuan] Fujian Med Univ, Dept Gen Surg, Union Hosp, Fuzhou, Peoples R China; [Huang, Meng] Fujian Ctr Dis Control & Prevent, Fuzhou, Peoples R China	Fujian Medical University; Fujian Medical University	Wang, C (corresponding author), Fujian Med Univ, Dept Gen Surg, Union Hosp, Fuzhou, Peoples R China.	chuanwang1968@hotmail.com			National Key Clinical Specialty Construction Program [201030404]; Sci-Tech Key Program of Fujian Province [2013Y0040]	National Key Clinical Specialty Construction Program; Sci-Tech Key Program of Fujian Province	This work was supported by grants from National Key Clinical Specialty Construction Program (201030404#) and Sci-Tech Key Program of Fujian Province (2013Y0040). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Antoniou AC, 2011, HUM MOL GENET, V20, P3304, DOI 10.1093/hmg/ddr226; Cai QY, 2011, CANCER RES, V71, P1344, DOI 10.1158/0008-5472.CAN-10-2733; Chen YC, 2005, CA-CANCER J CLIN, V55, P45, DOI 10.3322/canjclin.55.1.45; Cowper-Sal-lari R, 2012, NAT GENET, V44, P1191, DOI 10.1038/ng.2416; Dittmer S, 2011, J CELL SCI, V124, P252, DOI 10.1242/jcs.068759; Dorgan JF, 2002, JNCI-J NATL CANCER I, V94, P606; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Fan L, 2014, LANCET ONCOL, V15, pE279, DOI 10.1016/S1470-2045(13)70567-9; Gaudet MM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001183; Grose R, 2005, CYTOKINE GROWTH F R, V16, P179, DOI 10.1016/j.cytogfr.2005.01.003; He XQ, 2014, INT J MOL SCI, V15, P2130, DOI 10.3390/ijms15022130; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Jones JO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074102; KELSEY JL, 1991, CA-CANCER J CLIN, V41, P146, DOI 10.3322/canjclin.41.3.146; Lakhani SR, 2002, J CLIN ONCOL, V20, P2310, DOI 10.1200/JCO.2002.09.023; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Liu CL, 2013, J BREAST CANCER, V16, P366, DOI 10.4048/jbc.2013.16.4.366; Long JR, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002532; Long JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001002; Low YL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001012; McPherson K, 2000, BMJ-BRIT MED J, V321, P624, DOI 10.1136/bmj.321.7261.624; Missmer SA, 2004, JNCI-J NATL CANCER I, V96, P1856, DOI 10.1093/jnci/djh336; Moffa AB, 2004, MOL CANCER RES, V2, P643; O'Flaherty E, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-13; Pharoah PDP, 2004, NAT REV CANCER, V4, P850, DOI 10.1038/nrc1476; Purohit A, 2002, STEROIDS, V67, P979, DOI 10.1016/S0039-128X(02)00046-6; Robinson DR, 2013, NAT GENET, V45, P1446, DOI 10.1038/ng.2823; Sangrajrang S, 2010, BREAST CANCER RES TR, V123, P885, DOI 10.1007/s10549-010-0804-4; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Stacey SN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001029; Suzuki T, 2008, CARCINOGENESIS, V29, P356, DOI 10.1093/carcin/bgm295; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; Tworoger SS, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3040; Walsh T, 2007, CANCER CELL, V11, P103, DOI 10.1016/j.ccr.2007.01.010; Yuan SH, 2009, P NATL ACAD SCI USA, V106, P2909, DOI 10.1073/pnas.0805555106; Zaman Khalil, 2012, Rev Med Suisse, V8, P1101; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318; Zheng YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040494	41	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115707	10.1371/journal.pone.0115707	http://dx.doi.org/10.1371/journal.pone.0115707			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531440	gold, Green Submitted, Green Published			2022-12-27	WOS:000348845100099
J	Zangle, TA; Teitell, MA; Reed, J				Zangle, Thomas A.; Teitell, Michael A.; Reed, Jason			Live Cell Interferometry Quantifies Dynamics of Biomass Partitioning during Cytokinesis	PLOS ONE			English	Article							SIZE HOMEOSTASIS; PAR PROTEINS; DIVISION; MITOSIS; MECHANISMS; SPINDLE; GROWTH; CYTOSKELETON; MICROSCOPY; SEPARATION	The equal partitioning of cell mass between daughters is the usual and expected outcome of cytokinesis for self-renewing cells. However, most studies of partitioning during cell division have focused on daughter cell shape symmetry or segregation of chromosomes. Here, we use live cell interferometry (LCI) to quantify the partitioning of daughter cell mass during and following cytokinesis. We use adherent and non-adherent mouse fibroblast and mouse and human lymphocyte cell lines as models and show that, on average, mass asymmetries present at the time of cleavage furrow formation persist through cytokinesis. The addition of multiple cytoskeleton-disrupting agents leads to increased asymmetry in mass partitioning which suggests the absence of active mass partitioning mechanisms after cleavage furrow positioning.	[Zangle, Thomas A.; Teitell, Michael A.] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA; [Zangle, Thomas A.; Teitell, Michael A.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA; [Teitell, Michael A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Teitell, Michael A.] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA; [Teitell, Michael A.] Univ Calif Los Angeles, Broad Stem Cell Res Ctr, Los Angeles, CA 90095 USA; [Teitell, Michael A.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Reed, Jason] Virginia Commonwealth Univ, Dept Phys, Richmond, VA 23284 USA; [Reed, Jason] VCU Massey Canc Ctr, Richmond, VA USA	University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Virginia Commonwealth University; Virginia Commonwealth University	Zangle, TA (corresponding author), Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA.	tzangle@ucla.edu; jcreed@vcu.edu		Zangle, Thomas/0000-0001-5899-3517	National Institutes of Health [K25CA157940, R01CA90571, R01CA156674, R01GM073981, P01GM081621, R01CA185189, R01GM094388]; NantWorks, LLC - University of California Discovery Biotechnology Award [Bio07-10663]; California Institute for Regenerative Medicine Basic Biology 1 Award [RB1-01397]; Broad Stem Cell Research Center at UCLA; Caltech-UCLA Joint Center for Translational Medicine; NATIONAL CANCER INSTITUTE [R01CA185189, K25CA157940, R01CA090571, R01CA156674] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081621, R01GM073981, R01GM094388] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NantWorks, LLC - University of California Discovery Biotechnology Award; California Institute for Regenerative Medicine Basic Biology 1 Award; Broad Stem Cell Research Center at UCLA; Caltech-UCLA Joint Center for Translational Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study is supported by National Institutes of Health awards K25CA157940 (TAZ), R01CA90571, R01CA156674, R01GM073981, P01GM081621 (MAT), R01CA185189 (MAT and JR), and R01GM094388 (JR), by a NantWorks, LLC - University of California Discovery Biotechnology Award (Bio07-10663) (MAT), by a California Institute for Regenerative Medicine Basic Biology 1 Award (RB1-01397) (MAT), by the Broad Stem Cell Research Center at UCLA (TAZ and MAT), and by a Translational Acceleration Grant from the Caltech-UCLA Joint Center for Translational Medicine (www.jctm.caltech.edu) (MAT). The funders had no role in study design, decision to publish, or preparation of the manuscript.	Afonso O, 2014, SCIENCE, V345, P332, DOI 10.1126/science.1251121; BARER R, 1954, Q J MICROSC SCI, V95, P399; BARER R, 1952, NATURE, V169, P366, DOI 10.1038/169366b0; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Coelho M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001886; Coelho M, 2013, CURR BIOL, V23, P1844, DOI 10.1016/j.cub.2013.07.084; Conlon IJ, 2001, NAT CELL BIOL, V3, P918, DOI 10.1038/ncb1001-918; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; Effler JC, 2007, CELL CYCLE, V6, P30, DOI 10.4161/cc.6.1.3674; Effler JC, 2006, CURR BIOL, V16, P1962, DOI 10.1016/j.cub.2006.08.027; Fuentealba LC, 2008, P NATL ACAD SCI USA, V105, P7732, DOI 10.1073/pnas.0803027105; Ghiglia D.C., 1998, 2 DIMENSIONAL PHASE, V1st; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; GRADY L, 2006, IEEE T PATTERN ANAL, V0028, P00001, DOI DOI 10.1109/TPAMI.2006.233; Kafri R, 2013, NATURE, V494, P480, DOI 10.1038/nature11897; Kiyomitsu T, 2013, CELL, V154, P391, DOI 10.1016/j.cell.2013.06.010; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Koonin EV, 2013, CELL, V152, P942, DOI 10.1016/j.cell.2013.02.008; Kotak S, 2013, CURR OPIN CELL BIOL, V25, P741, DOI 10.1016/j.ceb.2013.07.008; Mammoto A, 2009, CURR OPIN CELL BIOL, V21, P864, DOI 10.1016/j.ceb.2009.08.001; Mir M, 2011, P NATL ACAD SCI USA, V108, P13124, DOI 10.1073/pnas.1100506108; Mohan K, 2012, EXP CELL RES, V318, P1428, DOI 10.1016/j.yexcr.2012.03.028; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Nance J, 2011, DEVELOPMENT, V138, P799, DOI 10.1242/dev.053538; Pardo M, 2003, SCIENCE, V300, P1569, DOI 10.1126/science.1084671; Peterson JR, 2002, CHEM BIOL, V9, P1275, DOI 10.1016/S1074-5521(02)00284-3; Reed J, 2011, BIOPHYS J, V101, P1025, DOI 10.1016/j.bpj.2011.07.022; Ross K. F. A., 1967, PHASE CONTRAST INTER; Stevermann L, 2012, CURR OPIN CELL BIOL, V24, P816, DOI 10.1016/j.ceb.2012.10.005; Stewart MP, 2011, NATURE, V469, P226, DOI 10.1038/nature09642; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Sung YJ, 2013, P NATL ACAD SCI USA, V110, P16687, DOI 10.1073/pnas.1315290110; Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307; Topham CH, 2013, CURR OPIN CELL BIOL, V25, P780, DOI 10.1016/j.ceb.2013.07.003; Tse HTK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038986; Tzur A, 2009, SCIENCE, V325, P167, DOI 10.1126/science.1174294; Zangle TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068916; Zangle TA, 2013, BIOPHYS J, V105, P593, DOI 10.1016/j.bpj.2013.06.041; Zar JH., 2010, BIOSTAT ANAL, V5th; Zernicka-Goetz MZ, 2005, NAT REV MOL CELL BIO, V6, P919, DOI 10.1038/nrm1782	40	14	14	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115726	10.1371/journal.pone.0115726	http://dx.doi.org/10.1371/journal.pone.0115726			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531652	Green Published, gold, Green Submitted			2022-12-27	WOS:000348845100101
J	Zhang, ZC; Huang, JW; Li, MH; Sui, YX; Wang, S; Liu, LR; Xu, LX; Yan, RF; Song, XK; Li, XR				Zhang, ZhenChao; Huang, JingWei; Li, MengHui; Sui, YuXia; Wang, Shuai; Liu, LianRui; Xu, LiXin; Yan, RuoFeng; Song, XiaoKai; Li, XiangRui			Identification and Molecular Characterization of Microneme 5 of Eimeria acervulina	PLOS ONE			English	Article							ANTICOCCIDIAL DRUGS; PROTECTIVE IMMUNITY; COAGULATION-FACTOR; DNA IMMUNIZATION; FACTOR-XI; TENELLA; PROTEIN; RESPONSES; ANTIGEN; COCCIDIOSIS	In the present study, the microneme 5 gene of Eimeria acervulina (E. acervulina) (EaMIC5) was cloned and characterized. Specific primers for the rapid amplification of cDNA ends (RACE) were designed based on the expressed sequence tag (EST, GenBank Accession No. EH386430.1) to amplify the 3'-and 5'-ends of EaMIC5. The full length cDNA of this gene was obtained by overlapping the sequences of 3'-and 5'-extremities and amplification by reverse transcription PCR. Sequence analysis revealed that the open reading frame (ORF) of EaMIC5 was 336 bp and encoded a protein of 111 amino acids with 12.18 kDa. The ORF was inserted into pET-32a (+) to produce recombinant EaMIC5. Using western blotting assay, the recombinant protein was successfully recognized by the sera of chicks experimentally infected with E. acervulina, while the native protein in the somatic extract of sporozoites was as well detected by sera from rats immunized with the recombinant protein of EaMIC5. Immunofluorescence analysis using antibody against recombinant protein EaMIC5 indicated that this protein was expressed in the sporozoites and merozoites stages of E. acervulina. Animal challenge experiments demonstrated that the recombinant protein of EaMIC5 could significantly increase the average body weight gains, decrease the mean lesion scores and the oocyst outputs of the immunized chickens, and presented anticoccidial index (ACI) more than 160. All the above results suggested that the EaMIC5 was a novel E. acervulina antigen and could be an effective candidate for the development of a new vaccine against this parasite.	[Zhang, ZhenChao; Huang, JingWei; Li, MengHui; Sui, YuXia; Wang, Shuai; Liu, LianRui; Xu, LiXin; Yan, RuoFeng; Song, XiaoKai; Li, XiangRui] Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Li, XR (corresponding author), Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China.	Lixiangrui@njau.edu.cn			National Natural Science Foundation of P.R. China [31372428]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of P.R. China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was funded by a grant from the National Natural Science Foundation of P.R. China (No. 31372428) and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal A, 2013, J BIOL CHEM, V288, P1590, DOI 10.1074/jbc.M112.411934; Blake DP, 2012, MOL BIOCHEM PARASIT, V184, P48, DOI 10.1016/j.molbiopara.2012.03.004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown PJ, 2000, MOL BIOCHEM PARASIT, V107, P91, DOI 10.1016/S0166-6851(00)00179-1; Brydges SD, 2006, EUKARYOT CELL, V5, P2174, DOI 10.1128/EC.00163-06; Carruthers VB, 1999, MOL MICROBIOL, V31, P421, DOI 10.1046/j.1365-2958.1999.01174.x; Carruthers Vern B., 2008, V47, P33; CHAPMAN HD, 1989, RES VET SCI, V46, P114, DOI 10.1016/S0034-5288(18)31129-9; Chapman HD, 1998, INT J PARASITOL, V28, P1141, DOI 10.1016/S0020-7519(98)00024-1; CHUNG DW, 1986, BIOCHEMISTRY-US, V25, P2410, DOI 10.1021/bi00357a017; Friedrich N, 2010, J BIOL CHEM, V285, P2064, DOI 10.1074/jbc.M109.060988; FUJIKAWA K, 1986, BIOCHEMISTRY-US, V25, P2417, DOI 10.1021/bi00357a018; Gadde U, 2011, POULTRY SCI, V90, P2243, DOI 10.3382/ps.2011-01558; Graat EAM, 1998, PREV VET MED, V33, P297, DOI 10.1016/S0167-5877(97)00008-1; JEFFERS TK, 1974, AVIAN DIS, V18, P331, DOI 10.2307/1589101; JOHNSON J, 1970, EXP PARASITOL, V28, P30, DOI 10.1016/0014-4894(70)90063-9; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kim DK, 2012, AVIAN DIS, V56, P97, DOI 10.1637/9720-031711-Reg.1; Klotz C, 2007, VACCINE, V25, P6625, DOI 10.1016/j.vaccine.2007.06.048; Lai L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002296; Lee SH, 2012, AVIAN DIS, V56, P402, DOI 10.1637/9906-082411-ResNote.1; Lillehoj HS, 2005, AVIAN DIS, V49, P112, DOI 10.1637/7249-073004R; LILLEHOJ HS, 1990, IMMUNOLOGY, V71, P127; Lu TX, 2011, J IMMUNOL, V187, P3362, DOI 10.4049/jimmunol.1101235; MARTIN A, 1995, AVIAN DIS, V39, P538, DOI 10.2307/1591807; Merck Sharp & Dohme Company Ltd, 1998, MSD TECHN BOOKL, P2; MOREHOUSE NF, 1970, EXP PARASITOL, V28, P25, DOI 10.1016/0014-4894(70)90062-7; Peek HW, 2003, AVIAN PATHOL, V32, P391, DOI 10.1080/0307945031000121149; Periz J, 2007, J BIOL CHEM, V282, P16891, DOI 10.1074/jbc.M702407200; Qi NS, 2013, PARASITOL RES, V112, P2281, DOI 10.1007/s00436-013-3389-0; ROSE ME, 1983, PARASITE IMMUNOL, V5, P479, DOI 10.1111/j.1365-3024.1983.tb00762.x; Saouros S, 2012, J BIOL CHEM, V287, P36029, DOI 10.1074/jbc.M112.389825; Sasai K, 2008, J PARASITOL, V94, P1432, DOI 10.1645/GE-1558.1; Shah MAA, 2010, VET PARASITOL, V169, P185, DOI 10.1016/j.vetpar.2009.12.035; Shah MAA, 2010, EXP PARASITOL, V124, P330, DOI 10.1016/j.exppara.2009.11.010; Shah MAA, 2010, PARASITOL RES, V107, P747, DOI 10.1007/s00436-010-1940-9; Shah MAA, 2011, RES VET SCI, V90, P72, DOI 10.1016/j.rvsc.2010.05.003; Song HY, 2010, VET PARASITOL, V173, P219, DOI 10.1016/j.vetpar.2010.06.030; Song HY, 2010, EXP PARASITOL, V126, P224, DOI 10.1016/j.exppara.2010.05.015; Song XK, 2009, VET PARASITOL, V159, P30, DOI 10.1016/j.vetpar.2008.10.015; Talebi A, 2005, EXP PARASITOL, V110, P342, DOI 10.1016/j.exppara.2005.03.026; TOMKINSON BE, 1989, J IMMUNOL, V142, P2230; Willsie SK, 1996, J LEUKOCYTE BIOL, V59, P813, DOI 10.1002/jlb.59.6.813; Xu QM, 2008, VET PARASITOL, V156, P319, DOI 10.1016/j.vetpar.2008.05.025; Yanming S, 2007, PARASITE IMMUNOL, V29, P319, DOI 10.1111/j.1365-3024.2007.00949.x; Zajkowska J, 2001, INFECTION, V29, P71, DOI 10.1007/s15010-001-1078-x; Zhu HL, 2012, MOL BIOCHEM PARASIT, V186, P21, DOI 10.1016/j.molbiopara.2012.09.002; Zhu HL, 2012, PARASITOLOGY, V139, P1711, DOI 10.1017/S0031182012001163	48	24	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115411	10.1371/journal.pone.0115411	http://dx.doi.org/10.1371/journal.pone.0115411			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531898	Green Published, gold, Green Submitted			2022-12-27	WOS:000348845100063
J	Zhu, JH; Hua, RX; Jiang, J; Zhao, LQ; Sun, XW; Luan, JW; Lang, YG; Sun, YQ; Shang, K; Peng, SY; Ma, JQ				Zhu, Jinhong; Hua, Rui-Xi; Jiang, Jing; Zhao, Li-Qin; Sun, Xiuwei; Luan, Jinwei; Lang, Yaoguo; Sun, Yanqi; Shang, Kun; Peng, Shiyun; Ma, Jianqun			Association Studies of ERCC1 Polymorphisms with Lung Cancer Susceptibility: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							DNA-REPAIR GENES; SINGLE NUCLEOTIDE POLYMORPHISMS; CHINESE POPULATION; RISK; HAPLOTYPES; CAPACITY; SMOKING	Background: Excision repair cross-complimentary group 1 (ERCC1) is an essential component of the nucleotide excision repair system that is responsible for repairing damaged DNA. Functional genetic variations in the ERCC1 gene may alter DNA repair capacity and modulate cancer risk. The putative roles of ERCC1 gene polymorphisms in lung cancer susceptibility have been widely investigated. However, the results remain controversial. Objectives: An updated meta-analysis was conducted to explore whether lung cancer risk could be attributed to the following ERCC1 polymorphisms: rs11615 (T>C), rs3212986 (C>A), rs3212961 (A>C), rs3212948 (G>C), rs2298881 (C>A). Methods: Several major databases (MEDLINE, EMBASE and Scopus) and the Chinese Biomedical database were searched for eligible studies. Crude odds ratios (ORs) with 95% confidence intervals (CIs) were used to measure the strength of associations. Results: Sixteen studies with 10,106 cases and 13,238 controls were included in this meta-analysis. Pooled ORs from 11 eligible studies (8,215 cases vs. 11,402 controls) suggested a significant association of ERCC1 rs11615 with increased risk for lung cancer (homozygous: CC versus TT, OR = 1.24, 95% CI: 1.04-1.48, P = 0.02). However, such an association was disproportionately driven by a single study. Removal of that study led to null association. Moreover, initial analyses suggested that ERCC1 rs11615 exerts a more profound effect on the susceptibility of non-smokers to lung cancer than that of smokers. Moreover, no statistically significant association was found between remaining ERCC1 polymorphisms of interest and lung cancer risk, except for rs3212948 variation (heterozygous: CG vs. GG, OR = 0.78, 95% CI: 0.67-0.90, P = 0.001; dominant: CG/CC vs. GG, OR = 0.79, 95% CI: 0.69-0.91, P= 0.001). Conclusion: Overall, this meta-analysis suggests that ERCC1 rs3212948 G>C, but not others, is a lung cancer risk-associated polymorphism. Carefully designed studies with large sample size involving different ethnicity, smoking status, and cancer types are needed to validate these findings.	[Zhu, Jinhong] Harbin Med Univ, Canc Hosp, Mol Epidemiol Lab, Harbin, Heilongjiang, Peoples R China; [Hua, Rui-Xi] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Jiang, Jing; Sun, Xiuwei] Harbin Med Univ, Canc Hosp, Dept Oncol, Harbin, Heilongjiang, Peoples R China; [Zhao, Li-Qin] Univ South China, Affiliated Hosp 1, Dept Hematol, Hengyang, Hunan, Peoples R China; [Luan, Jinwei] Harbin Med Univ, Canc Hosp, Dept Radiol, Harbin, Heilongjiang, Peoples R China; [Lang, Yaoguo; Sun, Yanqi; Ma, Jianqun] Harbin Med Univ, Canc Hosp, Dept Thorac Surg, Harbin, Heilongjiang, Peoples R China; [Shang, Kun] Capital Med Univ, Xuanwu Hosp, Dept Nucl Med, Beijing, Peoples R China; [Peng, Shiyun] Harbin Med Univ, Canc Hosp, Dept Lab Med, Harbin, Heilongjiang, Peoples R China	Harbin Medical University; Sun Yat Sen University; Harbin Medical University; University of South China; Harbin Medical University; Harbin Medical University; Capital Medical University; Harbin Medical University	Peng, SY (corresponding author), Harbin Med Univ, Canc Hosp, Dept Lab Med, Harbin, Heilongjiang, Peoples R China.	hydzlyyjyk@126.com; jianqunma@gmail.com	Zhang, Min/ACY-2759-2022; Thakolwiboon, Smathorn/S-1183-2019; Zhu, Jianhui/H-4665-2011	Zhang, Min/0000-0003-3331-3583; , Jianqun/0000-0002-7021-1298; Hua, Rui-Xi/0000-0001-5319-656X; Zhu, Jianhui/0000-0002-0051-7777; Zhu, Jinhong/0000-0002-0408-3101; Thakolwiboon, Smathorn/0000-0003-0607-904X	Heilongjiang Education Department of China [1252HQ016]; Harbin Medical University Cancer Hospital	Heilongjiang Education Department of China; Harbin Medical University Cancer Hospital	This research was supported by a grant (1252HQ016) funded by Heilongjiang Education Department of China and a grant funded by Harbin Medical University Cancer Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao C, 2011, CHINESE MED J-PEKING, V124, P2203, DOI 10.3760/cma.j.issn.0366-6999.2011.14.022; Deng QH, 2011, MED ONCOL, V28, P667, DOI 10.1007/s12032-010-9507-2; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gorlova OY, 2008, CANCER EPIDEM BIOMAR, V17, P1322, DOI 10.1158/1055-9965.EPI-07-2591; He J, 2013, INT J CANCER, V133, P1765, DOI 10.1002/ijc.28089; He J, 2012, HUM GENET, V131, P1235, DOI 10.1007/s00439-012-1152-8; Holm K, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-600; Jones NR, 2011, CANCER EPIDEMIOL, V35, P175, DOI 10.1016/j.canep.2010.08.007; Kang H, 2011, MODERN ONCOLOGY, V19, P1275; Kazma R, 2012, CARCINOGENESIS, V33, P1059, DOI 10.1093/carcin/bgs116; Kietthubthew S, 2006, INT J HYG ENVIR HEAL, V209, P21, DOI 10.1016/j.ijheh.2005.06.002; Li YC, 2007, EUR J HUM GENET, V15, P967, DOI 10.1038/sj.ejhg.5201855; Ma HX, 2007, PHARMACOGENET GENOM, V17, P417, DOI 10.1097/01.fpc.0000239975.77088.17; MANTEL N, 1959, J NATL CANCER I, V22, P719; Matullo G, 2006, CARCINOGENESIS, V27, P997, DOI 10.1093/carcin/bgi280; Sakoda LC, 2012, INT J MOL EPIDEMIOL, V3, P1; Shen HB, 2003, INT J CANCER, V107, P84, DOI 10.1002/ijc.11346; Shen M, 2005, INT J CANCER, V116, P768, DOI 10.1002/ijc.21117; Thorisson GA, 2005, GENOME RES, V15, P1592, DOI 10.1101/gr.4413105; Vogel U, 2004, MUTAT RES-FUND MOL M, V546, P65, DOI 10.1016/j.mrfmmm.2003.11.001; Yin JY, 2008, MUTAT RES-FUND MOL M, V641, P12, DOI 10.1016/j.mrfmmm.2008.02.004; Yin JY, 2012, LUNG CANCER, V76, P286, DOI 10.1016/j.lungcan.2012.01.001; Yin JY, 2011, MUTAT RES-FUND MOL M, V713, P1, DOI 10.1016/j.mrfmmm.2011.05.003; Yin JY, 2006, CANCER GENET CYTOGEN, V164, P66, DOI 10.1016/j.cancergencyto.2005.07.003; Yin JY, 2005, BIOCHEM GENET, V43, P543, DOI 10.1007/s10528-005-8170-3; Yin ZH, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-439; Yu DK, 2008, CLIN CANCER RES, V14, P2878, DOI 10.1158/1078-0432.CCR-07-1612; Zhang LQ, 2012, MUTAGENESIS, V27, P67, DOI 10.1093/mutage/ger062; Zhang Zengli, 2008, Zhongguo Fei Ai Za Zhi, V11, P183, DOI 10.3779/j.issn.1009-3419.2008.02.022; Zhou W, 2005, CANCER EPIDEM BIOMAR, V14, P491, DOI 10.1158/1055-9965.EPI-04-0612; Zienolddiny S, 2006, CARCINOGENESIS, V27, P560, DOI 10.1093/carcin/bgi232	32	85	87	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97616	10.1371/journal.pone.0097616	http://dx.doi.org/10.1371/journal.pone.0097616			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	25536077	gold, Green Published, Green Submitted			2022-12-27	WOS:000340948600051
J	Lv, YN; Qi, RQ; Xu, J; Di, ZH; Zheng, H; Huo, W; Zhang, L; Chen, HD; Gao, XH				Lv, Yani; Qi, Ruiqun; Xu, Jing; Di, Zhenghong; Zheng, Heng; Huo, Wei; Zhang, Li; Chen, Hongduo; Gao, Xinghua			Profiling of Serum and Urinary MicroRNAs in Children with Atopic Dermatitis	PLOS ONE			English	Article							CANCER; LUPUS; CELLS	Background: Atopic dermatitis (AD) is the most prevalent chronic inflammatory skin disease in children characterized by dermatitis and pruritus. MicroRNAs (miRNAs) have been shown as great potential biomarkers for disease fingerprints to predict prognostics. We aimed to identify miRNA signature from serum and urine for the prognosis of AD patient by genome-wide miRNA profiling analysis. Methods: Serum and urine from 30 children with AD and 28 healthy children were collected and their genome-wide miRNA expression profiles were measured by TaqMan-based array and confirmed by quantitative real-time PCR. Inflammatory factors in serum were detected by Antibody Array System. Results: miR-203 and miR-483-5p were significantly up-regulated in serum of children with AD compared with healthy children. The level of miR-483-5p in serum was significantly associated with other atopic conditions, such as rhinitis and/or asthma. However, miR-203 was markedly decreased in urine of children with AD compared with healthy children. Down-regulated miR-203 in urine was significant associated with abnormal level of serum IgE in AD patients. 7 inflammatory factors in serum were altered in children with AD compared with healthy children. Up-regulated miR-203 in serum was significantly associated with increased sTNFRI and sTNFRII. Conclusions: Up-regulated miR-483-5p in serum may be indicative of other atopic conditions in children with AD. Down-regulated miR-203 in urine may serve as a biomarker for the severity of inflammation in children with AD.	[Lv, Yani; Qi, Ruiqun; Huo, Wei; Zhang, Li; Chen, Hongduo; Gao, Xinghua] China Med Univ, Hosp 1, Dept Dermatol, Shenyang 110001, Liaoning, Peoples R China; [Xu, Jing; Di, Zhenghong; Zheng, Heng] China Med Univ, Shengjing Hosp, Dept Dermatol, Shenyang 110001, Liaoning, Peoples R China	China Medical University; China Medical University	Gao, XH (corresponding author), China Med Univ, Hosp 1, Dept Dermatol, Shenyang 110001, Liaoning, Peoples R China.	gaobarry@hotmail.com	Shan, Anshan/U-9119-2019	Wang, Jiajun/0000-0002-2086-2105	Public Welfare Research Fund for Healthcare [201202013]; Innovative Research Teams in Universities, Liaoning Bureau of Education [LT2012012]	Public Welfare Research Fund for Healthcare; Innovative Research Teams in Universities, Liaoning Bureau of Education	This work was supported by Public Welfare Research Fund for Healthcare (201202013) and Innovative Research Teams in Universities, Liaoning Bureau of Education (LT2012012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argyropoulos C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054662; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Dai R, 2011, TRANSL RES, V157, P163, DOI 10.1016/j.trsl.2011.01.007; Di ZH, 2010, BRIT J DERMATOL, V163, P1132, DOI 10.1111/j.1365-2133.2010.09959.x; Ecelbarger CA, 1997, J CLIN INVEST, V99, P1852, DOI 10.1172/JCI119352; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Hanke M, 2010, UROL ONCOL-SEMIN ORI, V28, P655, DOI 10.1016/j.urolonc.2009.01.027; Leung DYM, 2004, J CLIN INVEST, V113, P651, DOI 10.1172/JCI200421060; Li A, 2013, INT J BIOCH CELL BIO; Lipozencic Jasna, 2011, Acta Medica Croatica, V65, P87; Luo Y, 2013, CLIN CHEM, V59, P658, DOI 10.1373/clinchem.2012.195297; Mattes J, 2009, P NATL ACAD SCI USA, V106, P18704, DOI 10.1073/pnas.0905063106; Qi RQ, 2012, HEPATOLOGY, V55, P1640, DOI 10.1002/hep.25558; Sonkoly E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000610; Sonkoly E, 2010, J ALLERGY CLIN IMMUN, V126, P581, DOI 10.1016/j.jaci.2010.05.045; Tang YJ, 2009, ARTHRITIS RHEUM-US, V60, P1065, DOI 10.1002/art.24436; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vickery BP, 2007, CURR OPIN PEDIATR, V19, P89, DOI 10.1097/MOP.0b013e328012315a; Wang G, 2011, LUPUS, V20, P493, DOI 10.1177/0961203310389841; Wang HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038885; Wang N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051140; Wu TH, 2012, FISH PHYSIOL BIOCHEM, V38, P1299, DOI 10.1007/s10695-012-9617-1; Zen K, 2012, MED RES REV, V32, P326, DOI 10.1002/med.20215; Zernecke A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000610; Zhang XY, 2012, IN VITRO CELL DEV-AN, V48, P131, DOI 10.1007/s11626-012-9482-3; Zhou YF, 2014, MOL ONCOL, V8, P83, DOI 10.1016/j.molonc.2013.09.004	27	164	174	3	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115448	10.1371/journal.pone.0115448	http://dx.doi.org/10.1371/journal.pone.0115448			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	24466055	gold, Green Published, Green Submitted			2022-12-27	WOS:000348845100067
J	Zhu, JH; Thakolwiboon, S; Liu, XH; Zhang, M; Lubman, DM				Zhu, Jianhui; Thakolwiboon, Smathorn; Liu, Xinhua; Zhang, Min; Lubman, David M.			Overexpression of CD90 (Thy-1) in Pancreatic Adenocarcinoma Present in the Tumor Microenvironment	PLOS ONE			English	Article							CANCER STEM-CELLS; ENDOTHELIAL-CELLS; PROGENITOR CELLS; EXPRESSION; POPULATION; FIBROBLASTS; LIVER	CD90 (Thy-1) plays important roles in oncogenesis and shows potential as a candidate marker for cancer stem cells (CSCs) in various malignancies. Herein, we investigated the expression of CD90 in pancreatic adenocarcinoma (PDAC), with a comparison to normal pancreas and non-malignant pancreatic disease, by immunohistochemical (IHC) analysis of tissue microarrays containing 183 clinical tissue specimens. Statistical analysis was performed to evaluate the correlation between CD90 expression and the major clinicopathological factors after adjustment of age and gender. The IHC data showed that CD90 was significantly overexpressed in PDAC and its metastatic cancers as compared to chronic pancreatitis and benign islet tumors, while it was negati ve in normal pancreas and 82.7% of adjacent normal pancreas tissues. The abundant CD90 expression was predominantly present in PDAC stroma, such as fibroblasts and vascular endothelial cells, which could serve as a promising marker to distinguish pancreatic adenocarcinoma from normal pancreas and non-malignant pancreatic diseases. Double immunostaining of CD90 with CD24, a CSC marker for PDAC, showed that there was little overlap between these two markers. However, CD90(+) fibroblast cells were clustered around CD24(+) malignant ducts, suggesting that CD90 may be involved in the tumor-stroma interactions and promote pancreatic cancer development. Furthermore, CD90 mostly overlapped with alpha-smooth muscle actin (alpha SMA, a marker of activated pancreatic stellate cells (PSCs)) in PDAC stroma, which demonstrated that CD90(+) stromal cells consist largely of activated PSCs. Double immunostaining of CD90 and a vascular endothelial cell marker CD31 demonstrated that CD90 expression on vascular endothelial cells was significantly increased in PDACs as compared to normal pancreas and non-malignant pancreatic diseases. Our findings suggest that CD90 could serve as a promising marker for pancreatic adenocarcinoma where desmoplastic stroma plays an important role in tumor growth and angiogenesis.	[Zhu, Jianhui; Thakolwiboon, Smathorn; Liu, Xinhua; Lubman, David M.] Univ Michigan, Med Ctr, Dept Surg, Ann Arbor, MI 48109 USA; [Thakolwiboon, Smathorn] Mahidol Univ, Fac Med, Dept Med, Siriraj Hosp, Bangkok 10700, Thailand; [Liu, Xinhua] Shanghai Univ Tradit Chinese Med, Expt Ctr Sci & Technol, Shanghai 201203, Peoples R China; [Zhang, Min] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Mahidol University; Shanghai University of Traditional Chinese Medicine; University of Michigan System; University of Michigan	Lubman, DM (corresponding author), Univ Michigan, Med Ctr, Dept Surg, Ann Arbor, MI 48109 USA.	dmlubman@umich.edu	Zhang, Min/ACY-2759-2022; Thakolwiboon, Smathorn/S-1183-2019; Zhu, Jianhui/H-4665-2011	Zhang, Min/0000-0003-3331-3583; , Jianqun/0000-0002-7021-1298; Hua, Rui-Xi/0000-0001-5319-656X; Zhu, Jianhui/0000-0002-0051-7777; Zhu, Jinhong/0000-0002-0408-3101; Thakolwiboon, Smathorn/0000-0003-0607-904X	National Cancer Institute [1R01CA154455]; National Institutes of Health [R01 GM 49500]	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Cancer Institute grant 1R01CA154455 (DML) and the National Institutes of Health grant R01 GM 49500 (DML). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwaheeb S, 2005, J CLIN PATHOL, V58, P987, DOI 10.1136/jcp.2004.025221; Apte MV, 2004, PANCREAS, V29, P179, DOI 10.1097/00006676-200410000-00002; Bartholin L, 2012, PANCREATIC CANC TUMO; Chu GC, 2007, J CELL BIOCHEM, V101, P887, DOI 10.1002/jcb.21209; CRAIG W, 1993, J EXP MED, V177, P1331, DOI 10.1084/jem.177.5.1331; Dan YY, 2006, P NATL ACAD SCI USA, V103, P9912, DOI 10.1073/pnas.0603824103; Davies Karen, 2009, Curr Gastroenterol Rep, V11, P119; Dennis JE, 2007, STEM CELLS, V25, P2575, DOI 10.1634/stemcells.2007-0204; Erkan M, 2008, CLIN GASTROENTEROL H, V6, P1155, DOI 10.1016/j.cgh.2008.05.006; Foygel K, 2013, GASTROENTEROLOGY, V145, P885, DOI 10.1053/j.gastro.2013.06.011; Guillot-Delost M, 2012, J IMMUNOL, V188, P981, DOI 10.4049/jimmunol.1101592; He JT, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.010744; Herrera MB, 2006, STEM CELLS, V24, P2840, DOI 10.1634/stemcells.2006-0114; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Jacob J, 2004, PANCREATOLOGY, V4, P454, DOI 10.1159/000079824; Jiang J, 2012, ONCOGENE, V31, P671, DOI 10.1038/onc.2011.282; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Mahadevan D, 2007, MOL CANCER THER, V6, P1186, DOI 10.1158/1535-7163.MCT-06-0686; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; Rasheed ZA, 2012, PATHOLOGY PANCREATIC; Rege TA, 2006, FASEB J, V20, P1045, DOI 10.1096/fj.05-5460rev; Saalbach A, 1999, CELL TISSUE RES, V298, P307, DOI 10.1007/s004419900079; Samaniego R, 2013, J INVEST DERMATOL, V133, P2255, DOI 10.1038/jid.2013.88; Schubert K, 2013, AM J PATHOL, V182, P266, DOI 10.1016/j.ajpath.2012.10.003; Scognamiglio G, 2014, AM J CLIN PATHOL, V141, P841, DOI 10.1309/AJCP8Y0EBQMKWQEI; Subramaniam KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068923; Sukowati CHC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076830; Tang KH, 2013, CANCER RES, V73, P2322, DOI 10.1158/0008-5472.CAN-12-2991; VIDAL M, 1990, EMBO J, V9, P833, DOI 10.1002/j.1460-2075.1990.tb08180.x; Vonlaufen A, 2008, CANCER RES, V68, P2085, DOI 10.1158/0008-5472.CAN-07-2477; Yamashita T, 2013, HEPATOLOGY, V57, P1484, DOI 10.1002/hep.26168; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Zhu JH, 2013, J PROTEOME RES, V12, P2791, DOI 10.1021/pr400139c; Zhu JH, 2012, J PROTEOME RES, V11, P2272, DOI 10.1021/pr201059g	34	85	87	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2014	9	12							e115507	10.1371/journal.pone.0115507	http://dx.doi.org/10.1371/journal.pone.0115507			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ9UY	25536077	gold, Green Published, Green Submitted			2022-12-27	WOS:000348563300046
J	Lv, YF; Wang, JJ; Gao, H; Wang, ZY; Dong, N; Ma, QQ; Shan, AS				Lv, Yinfeng; Wang, Jiajun; Gao, He; Wang, Zeyun; Dong, Na; Ma, Qingquan; Shan, Anshan			Antimicrobial Properties and Membrane-Active Mechanism of a Potential alpha-Helical Antimicrobial Derived from Cathelicidin PMAP-36	PLOS ONE			English	Article							BIOLOGICAL-ACTIVITY; PEPTIDES; DESIGN; HYDROPHOBICITY; MODEL; PORE; IDENTIFICATION; TRANSLOCATION; SELECTIVITY; IMPROVEMENT	Antimicrobial peptides (AMPs), which present in the non-specific immune system of organism, are amongst the most promising candidates for the development of novel antimicrobials. The modification of naturally occurring AMPs based on their residue composition and distribution is a simple and effective strategy for optimization of known AMPs. In this study, a series of truncated and residue-substituted derivatives of antimicrobial peptide PMAP-36 were designed and synthesized. The 24-residue truncated peptide, GI24, displayed antimicrobial activity comparable to the mother peptide PMAP-36 with MICs ranging from 1 to 4 mu M, which is lower than the MICs of bee venom melittin. Although GI24 displayed high antimicrobial activity, its hemolytic activity was much lower than melittin, suggesting that GI24 have optimal cell selectivity. In addition, the crucial site of GI24 was identified through single site-mutation. An amino acid with high hydrophobicity at position 23 played an important role in guaranteeing the high antimicrobial activity of GI24. Then, lipid vesicles and whole bacteria were employed to investigate the membrane-active mechanisms. Membrane-simulating experiments showed that GI24 interacted strongly with negatively charged phospholipids and weakly with zwitterionic phospholipids, which corresponded well with the data of its biological activities. Membrane permeabilization and flow cytometry provide the evidence that GI24 killed microbial cells by permeabilizing the cell membrane and damaging membrane integrity. GI24 resulted in greater cell morphological changes and visible pores on cell membrane as determined using scanning electron microscopy (SEM) and transmission electron microscope (TEM). Taken together, the peptide GI24 may provide a promising antimicrobial agent for therapeutic applications against the frequently-encountered bacteria.	[Lv, Yinfeng; Wang, Jiajun; Gao, He; Wang, Zeyun; Dong, Na; Ma, Qingquan; Shan, Anshan] Northeast Agr Univ, Inst Anim Nutr, Lab Mol Nutr & Immun, Harbin, Heilongjiang, Peoples R China	Northeast Agricultural University - China	Shan, AS (corresponding author), Northeast Agr Univ, Inst Anim Nutr, Lab Mol Nutr & Immun, Harbin, Heilongjiang, Peoples R China.	asshan@neau.edu.cn	Shan, Anshan/U-9119-2019	Wang, Jiajun/0000-0002-2086-2105	National Natural Research Foundation of China [31272453]; National Basic Research Program [2012CB124703]; China Agriculture Research System [CARS-36]	National Natural Research Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program(National Basic Research Program of China); China Agriculture Research System	This work was supported by the National Natural Research Foundation of China (31272453), the National Basic Research Program (2012CB124703), and the China Agriculture Research System (CARS-36). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2012, CURR PROTEIN PEPT SC, V13, P211, DOI 10.2174/138920312800785076; Allende D, 2005, BIOPHYS J, V88, P1828, DOI 10.1529/biophysj.104.049817; Baek JH, 2010, TOXICON, V55, P711, DOI 10.1016/j.toxicon.2009.10.023; Brogden NK, 2011, INT J ANTIMICROB AG, V38, P217, DOI 10.1016/j.ijantimicag.2011.05.004; Brown KL, 2006, CURR OPIN IMMUNOL, V18, P24, DOI 10.1016/j.coi.2005.11.004; Carballar-Lejarazu R, 2008, CELL MOL LIFE SCI, V65, P3081, DOI 10.1007/s00018-008-8250-8; Chen YX, 2007, ANTIMICROB AGENTS CH, V51, P1398, DOI 10.1128/AAC.00925-06; Chou HT, 2008, INT J ANTIMICROB AG, V32, P130, DOI 10.1016/j.ijantimicag.2008.04.003; Dobrzynska I, 2005, MOL CELL BIOCHEM, V276, P113, DOI 10.1007/s11010-005-3557-3; Dong N, 2012, PROTEIN PEPTIDE LETT, V19, P1212, DOI 10.2174/092986612803217006; Dong N, 2012, ANTIMICROB AGENTS CH, V56, P2994, DOI 10.1128/AAC.06327-11; Dong N, 2012, PROTEIN PEPTIDE LETT, V19, P430, DOI 10.2174/092986612799789323; Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030; Friedrich CL, 2001, J BIOL CHEM, V276, P24015, DOI 10.1074/jbc.M009691200; Gopal R, 2013, AMINO ACIDS, V44, P645, DOI 10.1007/s00726-012-1388-6; Haines LR, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000373; Herce HD, 2007, P NATL ACAD SCI USA, V104, P20805, DOI 10.1073/pnas.0706574105; Kiyota T, 1996, BIOCHEMISTRY-US, V35, P13196, DOI 10.1021/bi961289t; Ladokhin AS, 2001, BBA-BIOMEMBRANES, V1514, P253, DOI 10.1016/S0005-2736(01)00382-0; Lee DL, 2004, J PEPT RES, V63, P69, DOI 10.1046/j.1399-3011.2003.00106.x; Lee EK, 2011, PEPTIDES, V32, P1123, DOI 10.1016/j.peptides.2011.03.024; Lee KH, 2006, BIOCHEM J, V394, P105, DOI 10.1042/BJ20051574; Li YM, 2012, PEPTIDES, V37, P207, DOI 10.1016/j.peptides.2012.07.001; Liu YF, 2013, BIOMATERIALS, V34, P237, DOI 10.1016/j.biomaterials.2012.09.032; Matsuzaki K, 1997, BIOPHYS J, V73, P831, DOI 10.1016/S0006-3495(97)78115-3; Naito A, 2000, BIOPHYS J, V78, P2405, DOI 10.1016/S0006-3495(00)76784-1; Oren Z, 2000, BIOCHEMISTRY-US, V39, P6103, DOI 10.1021/bi992408i; Park SC, 2006, BIOCHEM BIOPH RES CO, V343, P222, DOI 10.1016/j.bbrc.2006.02.090; Park Y, 2004, BIOCHEM BIOPH RES CO, V321, P109, DOI 10.1016/j.bbrc.2004.06.113; Paulsen VS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053326; PIERS KL, 1994, ANTIMICROB AGENTS CH, V38, P2311, DOI 10.1128/AAC.38.10.2311; Rabbani G, 2013, APPL MICROB IN PRESS; Rabbani G, 2012, CELL BIOCHEM BIOPHYS, V62, P487, DOI 10.1007/s12013-011-9335-9; Rabbani G, 2011, CELL BIOCHEM BIOPHYS, V61, P551, DOI 10.1007/s12013-011-9237-x; Sang YM, 2009, DEV COMP IMMUNOL, V33, P334, DOI 10.1016/j.dci.2008.05.006; Sato H, 2006, BBA-BIOMEMBRANES, V1758, P1245, DOI 10.1016/j.bbamem.2006.02.021; Scocchi M, 2005, FEBS J, V272, P4398, DOI 10.1111/j.1742-4658.2005.04852.x; Skerlavaj B, 1996, J BIOL CHEM, V271, P28375, DOI 10.1074/jbc.271.45.28375; Stark M, 2002, ANTIMICROB AGENTS CH, V46, P3585, DOI 10.1128/AAC.46.11.3585-3590.2002; Steinberg DA, 1997, ANTIMICROB AGENTS CH, V41, P1738, DOI 10.1128/AAC.41.8.1738; STORICI P, 1994, FEBS LETT, V337, P303, DOI 10.1016/0014-5793(94)80214-9; Stromstedt AA, 2009, ANTIMICROB AGENTS CH, V53, P593, DOI 10.1128/AAC.00477-08; Strom MB, 2002, BIOCHEM CELL BIOL, V80, P65, DOI 10.1139/o01-236; Tam JP, 2002, EUR J BIOCHEM, V269, P923, DOI 10.1046/j.0014-2956.2001.02728.x; Teixeira V, 2012, PROG LIPID RES, V51, P149, DOI 10.1016/j.plipres.2011.12.005; Vedovato N, 2007, EUR BIOPHYS J BIOPHY, V36, P771, DOI 10.1007/s00249-007-0152-4; Vila-Farres X, 2012, CLIN MICROBIOL INFEC, V18, P383, DOI 10.1111/j.1469-0691.2011.03581.x; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Wu MH, 1999, BIOCHEMISTRY-US, V38, P7235, DOI 10.1021/bi9826299; Yang L, 2001, BIOPHYS J, V81, P1475, DOI 10.1016/S0006-3495(01)75802-X; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhu WL, 2006, BIOCHEM BIOPH RES CO, V349, P769, DOI 10.1016/j.bbrc.2006.08.094	52	164	174	3	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86364	10.1371/journal.pone.0086364	http://dx.doi.org/10.1371/journal.pone.0086364			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466055	Green Published, Green Submitted, gold			2022-12-27	WOS:000330244500238
